PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Awasthi, JP; Saha, B; Regon, P; Sahoo, S; Chowra, U; Pradhan, A; Roy, A; Panda, SK				Awasthi, Jay Prakash; Saha, Bedabrata; Regon, Preetom; Sahoo, Smita; Chowra, Umakanta; Pradhan, Amit; Roy, Anupam; Panda, Sanjib Kumar			Morpho-physiological analysis of tolerance to aluminum toxicity in rice varieties of North East India	PLOS ONE			English	Article							LIPID-PEROXIDATION; OXIDATIVE STRESS; PHENOTYPIC INDEX; AL TOLERANCE; ROOT-GROWTH; HEMATOXYLIN; WHEAT; MECHANISMS; DETOXIFICATION; TRANSPORTER	Aluminum (Al) is the third most abundant metal in earth crust, whose chemical form is mainly dependent on soil pH. The most toxic form of Al with respect to plants is Al3+, which exists in soil pH <5. Acidic soil significantly limits crop production mainly due to Al3+ toxicity worldwide, impacting approximately 50% of the world's arable land (in North-Eastern India 80% soil are acidic). Al3+ toxicity in plants ensues root growth inhibition leading to less nutrient and water uptake impacting crop productivity as a whole. Rice is one of the chief grains which constitutes the staple food of two-third of the world population including India and is not untouched by Al3+ toxicity. Al contamination is a critical constraint to plant production in agricultural soils of North East India. 24 indigenous Indica rice varieties (including Bad-shahbhog as tolerant check and Mashuri as sensitive check) were screened for Al stress tolerance in hydroponic plant growth system. Results show marked difference in growth parameters (relative growth rate, Root tolerance index, fresh and dry weight of root) of rice seedlings due to Al (100 mu M) toxicity. Al3+ uptake and lipid peroxidation level also increased concomitantly under Al treatment. Histochemical assay were also performed to elucidate uptake of aluminum, loss of membrane integrity and lipid peroxidation, which were found to be more in sensitive genotypes at higher Al concentration. This study revealed that aluminum toxicity is a serious harmful problem for rice crop productivity in acid soil. Based on various parameters studied it's concluded that Disang is a comparatively tolerant variety whereas Joymati a sensitive variety. Western blot hybridization further strengthened the claim, as it demonstrated more accumulation of Glutathione reductase (GR) protein in Disang rice variety than Joymati under stressed condition. This study also observed that the emergence of lethal toxic symptoms occurs only after 48h irrespective of the dose used in the study.	[Awasthi, Jay Prakash; Saha, Bedabrata; Regon, Preetom; Sahoo, Smita; Chowra, Umakanta; Pradhan, Amit; Roy, Anupam; Panda, Sanjib Kumar] Assam Univ, Plant Mol Biotechnol Lab, Dept Life Sci & Bioinformat, Silchar, India	Assam University	Panda, SK (corresponding author), Assam Univ, Plant Mol Biotechnol Lab, Dept Life Sci & Bioinformat, Silchar, India.	drskpanda@gmail.com	Regon, Preetom/AAH-8425-2019; AWASTHI, JAY PRAKASH/H-3170-2017; Saha, Bedabrata/P-1104-2015	AWASTHI, JAY PRAKASH/0000-0001-6858-5189; PRADHAN, AMIT KUMAR/0000-0003-1705-3347; Chowra, Uma kanta/0000-0002-7323-5092; Saha, Bedabrata/0000-0001-8731-6435; Panda, Sanjib Kumar/0000-0003-2207-2382; Regon, Preetom/0000-0002-6862-5379; Panda, Sanjib Kumar/0000-0001-5131-9693	UGC, India	UGC, India(University Grants Commission, India)	JPA acknowledges UGC, India for UGC-NON NET fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Our sincere thanks to Regional Agricultural Research Station, Akbarpur (Karimganj), India, and Regional Rainfed Lowland Rice Research Station (RRLRRS) Gerua, Guwahati, Assam, India for providing us with rice seeds. We acknowledge Dr. Shigeto Morita of Kyoto Prefectural University for the generous gift of GR antibody. We would also like to thank Centre for Environmental, IIT Guwahati, India, for providing the facility of Atomic Absorption Spectroscopy for sample analysis. JPA acknowledges UGC, India for UGC-NON NET fellowship.	Aggarwal A, 2015, ENVIRON EXP BOT, V120, P43, DOI 10.1016/j.envexpbot.2015.08.003; Alia FJ, 2015, INT J AGRIC BIOL, V17, P702, DOI 10.17957/IJAB/14.0019; Alvim MN, 2012, J BIOSCIENCES, V37, P1079, DOI 10.1007/s12038-012-9275-6; [Anonymous], 1996, PLANT ADAPTATION MIN; Barah BC, 2001, STATUS RICE PRODUCTI, P50; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAKMAK I, 1991, PHYSIOL PLANTARUM, V83, P463, DOI 10.1111/j.1399-3054.1991.tb00121.x; Cancado GMA, 1999, THEOR APPL GENET, V99, P747, DOI 10.1007/s001220051293; Chandran D, 2008, PLANTA, V228, P151, DOI 10.1007/s00425-008-0726-0; Choudhary AK, 2011, AUST J CROP SCI, V5, P1419; Darko E, 2004, PLANT SCI, V166, P583, DOI 10.1016/j.plantsci.2003.10.023; DELHAIZE E, 1995, PLANT PHYSIOL, V107, P315, DOI 10.1104/pp.107.2.315; Du BG, 2010, ACTA PHYSIOL PLANT, V32, P883, DOI 10.1007/s11738-010-0476-z; Famoso AN, 2010, PLANT PHYSIOL, V153, P1678, DOI 10.1104/pp.110.156794; Farmer EE, 2013, ANNU REV PLANT BIOL, V64, P429, DOI 10.1146/annurev-arplant-050312-120132; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; GANESAN K, 1993, COMMUN SOIL SCI PLAN, V24, P2179, DOI 10.1080/00103629309368947; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; HAVAS M, 1986, WATER AIR SOIL POLL, V30, P735, DOI 10.1007/BF00303339; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Hoekenga OA, 2003, PLANT PHYSIOL, V132, P936, DOI 10.1104/pp.103.023085; Hore DK, 2005, GENET RESOUR CROP EV, V52, P1129, DOI 10.1007/s10722-004-6084-2; Hoshikawa K, 1993, SCI RICE PLANT, V1, P91; Huang CF, 2012, PLANT J, V69, P857, DOI 10.1111/j.1365-313X.2011.04837.x; Ishikawa S, 1998, PLANT CELL PHYSIOL, V39, P516, DOI 10.1093/oxfordjournals.pcp.a029399; Jeeva S. R. D. N., 2006, TRADITIONAL AGR PRAC; Jensen WA., 1962, BOT HISTOCHEMISTRY P; Kang DongJin, 2012, Journal of Crop Science and Biotechnology, V15, P25, DOI 10.1007/s12892-011-0083-6; Kikui S, 2005, J INORG BIOCHEM, V99, P1837, DOI 10.1016/j.jinorgbio.2005.06.031; Kochian LV, 2015, ANNU REV PLANT BIOL, V66, P571, DOI 10.1146/annurev-arplant-043014-114822; Kumar A, 2013, INDIAN J GENET PL BR, V73, P153, DOI 10.5958/j.0975-6906.73.2.022; Kuo MC, 2003, BIOL PLANTARUM, V46, P149, DOI 10.1023/A:1022356322373; Li JY, 2014, P NATL ACAD SCI USA, V111, P6503, DOI 10.1073/pnas.1318975111; Ma BH, 2012, PLANT CELL REP, V31, P687, DOI 10.1007/s00299-011-1187-7; Ma JF, 1997, PLANT SOIL, V191, P133, DOI 10.1023/A:1004257711952; Ma JF, 2014, PLANT SOIL, V381, P1, DOI 10.1007/s11104-014-2073-1; Mandal C, 2013, PHYSIOL MOL BIOL PLA, V19, P91, DOI 10.1007/s12298-012-0144-4; Matsumoto H, 2013, PLANT ROOTS HIDD; Moore DP, 1976, SCREENING WHEAT ALUM, P287; Motoda H, 2011, PLANT SIGNAL BEHAV, V6, P98, DOI 10.4161/psb.6.1.14148; Ngachan SV, 2011, STATUS PAPER RICE NE, P4; OWNBY JD, 1993, PHYSIOL PLANTARUM, V87, P371, DOI 10.1111/j.1399-3054.1993.tb01744.x; Panda SK, 2010, BIOMETALS, V23, P753, DOI 10.1007/s10534-010-9342-0; Panda SK, 2009, PLANT SIGNAL BEHAV, V4, P592, DOI 10.4161/psb.4.7.8903; Pandey P, 2016, ENVIRON SCI POLLUT R, V23, P1516, DOI 10.1007/s11356-015-5392-8; Pandey P, 2013, ECOTOXICOLOGY, V22, P656, DOI 10.1007/s10646-013-1058-9; Parker D. R., 1995, Chemical equilibrium and reaction models. Proceedings San Antonio, Texas, USA, 23 and 24 October, 1990., P253; Passos L. P., 2012, Agricultural Sciences, V3, P230, DOI 10.4236/as.2012.32027; POLLE E, 1978, CROP SCI, V18, P823, DOI 10.2135/cropsci1978.0011183X001800050035x; POMPELLA A, 1987, AM J PATHOL, V129, P295; Ramel F, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-28; Rao MV, 1999, PLANT J, V17, P603, DOI 10.1046/j.1365-313X.1999.00400.x; Rosello M, 2015, J INORG BIOCHEM, V152, P160, DOI 10.1016/j.jinorgbio.2015.08.021; Roy B, 2005, EUPHYTICA, V145, P221, DOI 10.1007/s10681-005-0055-3; Roy B, 2014, RICE SCI, V21, P217, DOI 10.1016/S1672-6308(13)60182-1; Roy B, 2013, INDIAN J GENET PL BR, V73, P194, DOI 10.5958/j.0975-6906.73.2.028; Sasaki M, 1997, SOIL SCI PLANT NUTR, V43, P469, DOI 10.1080/00380768.1997.10414772; Schutzendubel A, 2001, PLANT PHYSIOL, V127, P887, DOI 10.1104/pp.010318; Shao JF, 2015, PLANT SOIL, V395, P307, DOI 10.1007/s11104-015-2566-6; Sharma M, 2015, ADV AGRONOMY PLANT S, V01, P1, DOI DOI 10.19046/ABP.V01I01.01; Sharma P, 2007, PLANT CELL REP, V26, P2027, DOI 10.1007/s00299-007-0416-6; Silva S, 2012, PLANT PHYSIOL BIOCH, V54, P105, DOI 10.1016/j.plaphy.2012.02.004; Simoes CC, 2012, GENET MOL RES, V11, P1949, DOI 10.4238/2012.July.19.14; Vardar F, 2011, ACTA BIOL HUNG, V62, P156, DOI 10.1556/ABiol.62.2011.2.6; VONUEXKULL HR, 1995, PLANT SOIL, V171, P1, DOI 10.1007/BF00009558; Wang L, 2015, PLANTA, V242, P1391, DOI 10.1007/s00425-015-2376-3; WEATHERLEY P. E., 1950, NEW PHYTOL, V49, P81, DOI 10.1111/j.1469-8137.1950.tb05146.x; Wu DM, 2014, J EXP BOT, V65, P5305, DOI 10.1093/jxb/eru292; Xia JX, 2013, PLANT J, V76, P345, DOI 10.1111/tpj.12296; Xia JX, 2010, P NATL ACAD SCI USA, V107, P18381, DOI 10.1073/pnas.1004949107; Yamamoto Y, 2001, PLANT PHYSIOL, V125, P199, DOI 10.1104/pp.125.1.199; Yang JL, 2008, PLANT PHYSIOL, V146, P602, DOI 10.1104/pp.107.111989; Yin LN, 2010, PLANT PHYSIOL, V152, P1406, DOI 10.1104/pp.109.151449; Yokosho K, 2011, PLANT J, V68, P1061, DOI 10.1111/j.1365-313X.2011.04757.x	74	53	54	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176357	10.1371/journal.pone.0176357	http://dx.doi.org/10.1371/journal.pone.0176357			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448589	gold, Green Published, Green Submitted			2022-12-26	WOS:000400383600066
J	Dhamorikar, AH; Mehta, P; Bargall, H; Gore, K				Dhamorikar, Aniruddha H.; Mehta, Prakash; Bargall, Harendra; Gore, Kedar			Characteristics of human - sloth bear (Melursus ursinus) encounters and the resulting human casualties in the Kanha-Pench corridor, Madhya Pradesh, India	PLOS ONE			English	Article								Sloth bears (Melursus ursinus) caused the highest number of human deaths between 2001 and 2015 and ranked second compared to other wild animals in causing human casualties in the Kanha-Pench corridor area. We studied the patterns of sloth bear attacks in the region to understand the reasons for conflict. We interviewed 166 victims of sloth bear attacks which occurred between 2004 and 2016 and found that most attacks occurred in forests (81%), with the greatest number of those (42%) occurring during the collection of Non-Timber Forest Produce (NTFP), 15% during the collection of fuelwood and 13% during grazing of livestock. The remainder took place at forest edges or in agricultural fields (19%), most occurring when person(s) were working in fields (7%), defecating (5%), or engaged in construction work (3%). Most victims were between the ages of 31 to 50 (57%) and most (54%) were members of the Gond tribe. The majority of attacks occurred in summer (40%) followed by monsoon (35%) and winter (25%). Forty-four percent of victims were rescued by people, while 43% of the time bears retreated by themselves. In 60% of attacks, a single bear was involved, whereas 25% involved adult females with dependent cubs and the remainder (15%) of the cases involved a pair of bears. We discuss the compensation program for attack victims as well as other governmental programs which can help reduce conflict. Finally, we recommend short-term mitigation measures for forest-dependent communities.	[Dhamorikar, Aniruddha H.; Mehta, Prakash] Corbett Fdn, Kanha Div, Baherakhar, Madhya Pradesh, India; [Bargall, Harendra] Corbett Fdn, Corbett Div, Uttarakhand, India; [Gore, Kedar] Corbett Fdn, Bombay, Maharashtra, India		Dhamorikar, AH (corresponding author), Corbett Fdn, Kanha Div, Baherakhar, Madhya Pradesh, India.	aniruddha.dhamorikar@gmail.com			DeFries-Bajpai Foundation	DeFries-Bajpai Foundation	Financial support was provided by DeFries-Bajpai Foundation. The fund agency had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Madhya Pradesh Forest Department, especially Balaghat Circle, Seoni Circle, and the Kanha Tiger Reserve, for providing the details of the human wildlife conflict; and to the chairman of The Corbett Foundation, Mr. Dilip Khatau, for providing the logistical support. We are grateful to DeFries-Bajpai Foundation for providing the grant to undertake this study. We thank Mr. Dharmendra Choudhary, Mr. Anil Dhurvey, Mr. Sukman Dhurvey, and Mr. Tarachand Pancheshwar for assisting in the survey, to Mr. Anand S for permitting to use the map of India and to Ms. Snehal Gole for helping in creating the map of Kanha-Pench corridor area. Our gratitude to Mr. Everett Hanna for copy-editing the manuscript. We also thank Dr. Tom Smith and one anonymous reviewer for providing their insights in improving the manuscript.	Agrawal S, KANHA PENCH CORRIDOR; Akhtar N, 2008, INDIAN FOR, p1349 ; Bargali H.S., 2012, World Journal of Zoology, V7, P312; Bargali HS, 2005, URSUS, V16, P263, DOI 10.2192/1537-6176(2005)016[0263:COSBAA]2.0.CO;2; Bargali HS, 2004, URSUS, V15, P212, DOI 10.2192/1537-6176(2004)015<0212:FEOSBI>2.0.CO;2; Can OE, 2014, CONSERV LETT, V7, P501, DOI 10.1111/conl.12117; Census of India 2011 (Government of India), 2015, GOVT IND REP SER 12, V24; Champion H. G., 1968, REVISED SURVEY FORES, P404; Charoo SA, 2011, URSUS, V22, P106, DOI 10.2192/URSUS-D-10-00021.1; Chauhan N.P.S., 1989, URSUS, V14, P84; Dutta T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123384; Forest Department [Internet], 2001, D1 D4 OFF DAT ENTR W; Garshelis DL, 2008, IUCN RED LIST THREAT; Government of India, 2016, PRADH MANTR UJJW YOJ; Government of India [Internet], 2015, AV ANN INC HOUS BEN; Government of India [Internet], 2015, DISTR WIS FOR COV; Jena J., 2011, LIFELINE TIGERS STAT; Jhala YV, 2011, TR2011003 NAT TIG CO; Khanal S, 2014, J I SCI TECHNOLOGY, V19, p118 ; Liu F, 2011, BIOL CONSERV, V144, P538, DOI 10.1016/j.biocon.2010.10.009; Loe J, 2004, AMBIO, V33, P283, DOI 10.1639/0044-7447(2004)033[0283:LCAHSA]2.0.CO;2; Ministry of Drinking Water and Sanitation [Internet], 2016, SWACHH BHAR MISS GRA; Ministry of Panchayat Raj, 2011, REP COMM OWN PRIC FI; Minor Forest Produce Federation D Tendu Patta [Internet], 2016, TEND PATT; Misra AK, 2013, ENVIRON DEV SUSTAIN, V16, P361; MPForest. org [Internet], 2016, MIN MON SYST; Muralidharan B, 2010, EVALUATION MANAGEMEN; Pandey D, 2002, TECHNICAL REPORT; Sathyakumar S, 2012, TECHNICAL REPORT; Sharma S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1506; The World Bank Group [Internet], 2016, POV EQ; Vattakavan J., 2010, TECHNICAL REPORT; YOGANAND K., 2013, MAMMALS S ASIA, V1, P438	33	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176612	10.1371/journal.pone.0176612	http://dx.doi.org/10.1371/journal.pone.0176612			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448565	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383600113
J	Han, H; Gabriel, KP; Kohl, HW				Han, Ho; Gabriel, Kelley Pettee; Kohl, Harold Willis, III			Application of the transtheoretical model to sedentary behaviors and its association with physical activity status	PLOS ONE			English	Article							SITTING TIME; EXERCISE; RELIABILITY; VALIDITY; SMOKING; RISK	Background The Transtheoretical Model (TTM) is a successful framework for guiding behavior change programs for several health behaviors, yet its application to reduce of sedentary behavior has been neglected. In addition, no data exist regarding the association between determinants of sedentary behaviors based on the TTM and physical activity behavior. The purpose of this study was to investigate college students' stages of motivational readiness to avoid sedentary behaviors and relevant psychological determinants using newly developed TTM questionnaires and to identify the association between current physical activity and sedentary behaviors based on TTM constructs. Methods Data were obtained from 225 college students enrolled in health education and physical education courses. Participants completed a package of questionnaires including validated TTM, physical activity and sitting time questionnaires. Participants also wore an accelerometer for seven consecutive days. MANOVAs were conducted to determine mean differences in psychological constructs across the TTM stages, and Chi-square tests and Spearman correlation were used to evaluate the associations between current physical activity and sedentary behavior. Results A majority of the participants were in the sedentary stages, and men and women differed in proportion of individuals in the stages (78.0% vs. 68.1%, respectively). The gender difference was also found in use of the processes of change. In general, the mean scores of the TTM constructs increased as the stages progressed. No significant associations were found between the TTM constructs for sedentary behavior and current physical activity levels (p>0.05). Conclusions A high proportion of college students were in sedentary stages regardless of physical activity levels, but different distributions in men and women. Participants in earlier stages were less likely to utilize the TTM constructs to reduce sedentary behaviors than those in later stages. A lack of association between physical activity and the psychological determinants of sedentary behavior was found.	[Han, Ho; Kohl, Harold Willis, III] Univ Texas Austin, Dept Kinesiol & Hlth Educ, Austin, TX 78712 USA; [Gabriel, Kelley Pettee; Kohl, Harold Willis, III] Univ Texas Austin, Sch Publ Hlth, Epidemiol Human Genet & Environm Sci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Han, H (corresponding author), Univ Texas Austin, Dept Kinesiol & Hlth Educ, Austin, TX 78712 USA.	hanho@utexas.edu	Han, Ho/AAP-6922-2021	Han, Ho/0000-0003-4241-7317				Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Beunza JJ, 2007, AM J HYPERTENS, V20, P1156, DOI 10.1016/j.amjhyper.2007.06.007; Buckworth J, 2004, J AM COLL HEALTH, V53, P28, DOI 10.3200/JACH.53.1.28-34; Carbonari JP, 2000, J CONSULT CLIN PSYCH, V68, P810, DOI 10.1037/0022-006X.68.5.810; Cohen J, 1977, STAT POWER ANAL BEHA, V2 2 ed, DOI DOI 10.1016/B978-0-12-179060-8.50006-2; DICLEMENTE CC, 1991, J CONSULT CLIN PSYCH, V59, P295, DOI 10.1037/0022-006X.59.2.295; Epstein LH, 2005, ANN BEHAV MED, V29, P200, DOI 10.1207/s15324796abm2903_6; Fountaine C.J., 2011, INT J EXERC SCI, V4, P102; Gabriel KKP, 2012, J PHYS ACT HEALTH, V9, pS11, DOI 10.1123/jpah.9.s1.s11; Gabriel KP, 2011, PUBLIC HEALTH NUTR, V14, P435, DOI 10.1017/S1368980010002612; Gabriel KP, 2009, MED SCI SPORT EXER, V41, P1403, DOI 10.1249/MSS.0b013e31819b2482; Han H, 2015, AM J HEALTH BEHAV, V39, P601, DOI 10.5993/AJHB.39.5.2; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; KRISKA AM, 1990, DIABETES CARE, V13, P401, DOI 10.2337/diacare.13.4.401; MARCUS BH, 1992, HEALTH PSYCHOL, V11, P386, DOI 10.1037/0278-6133.11.6.386; MARCUS BH, 1992, RES Q EXERCISE SPORT, V63, P60, DOI 10.1080/02701367.1992.10607557; Marcus BH, 2000, AM J PREV MED, V19, P121, DOI 10.1016/S0749-3797(00)00186-0; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; MUTZ DC, 1993, COMMUN RES, V20, P51, DOI 10.1177/009365093020001003; Owen N, 2000, Exerc Sport Sci Rev, V28, P153; Owen N, 2012, PREV MED, V55, P535, DOI 10.1016/j.ypmed.2012.08.024; Owen N, 2011, AM J PREV MED, V41, P189, DOI 10.1016/j.amepre.2011.05.013; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; PINTO BM, 1995, J AM COLL HEALTH, V44, P27, DOI 10.1080/07448481.1995.9937506; PROCHASKA JO, 1983, J CONSULT CLIN PSYCH, V51, P390, DOI 10.1037//0022-006X.51.3.390; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38; PROCHASKA JO, 1994, HEALTH PSYCHOL, V13, P39, DOI 10.1037/0278-6133.13.1.39; Taveras EM, 2007, PEDIATRICS, V119, pE314, DOI 10.1542/peds.2005-2974; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Velasquez MM, 2005, J ADDICT NURS, V16, P31, DOI 10.1080/10884600590917174; Whitfield G, 2014, J PHYS ACT HEALTH, V11, P165, DOI 10.1123/jpah.2011-0420; Whitfield GP, 2013, RES Q EXERCISE SPORT, V84, P323, DOI 10.1080/02701367.2013.814041	33	27	27	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176330	10.1371/journal.pone.0176330	http://dx.doi.org/10.1371/journal.pone.0176330			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET6EL	28448531	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383600062
J	Hertig, V; Tardif, K; Meus, MA; Duquette, N; Villeneuve, L; Toussaint, F; Ledoux, J; Calderone, A				Hertig, Vanessa; Tardif, Kim; Meus, Marc Andre; Duquette, Natacha; Villeneuve, Louis; Toussaint, Fanny; Ledoux, Jonathan; Calderone, Angelino			Nestin expression is upregulated in the fibrotic rat heart and is localized in collagen-expressing mesenchymal cells and interstitial CD31((+))-cells	PLOS ONE			English	Article							PROTEIN-KINASE-C; ENDOTHELIAL-CELLS; CARDIAC FIBROBLASTS; MYOCARDIAL-INFARCTION; SCAR MYOFIBROBLASTS; PANCREATIC-CANCER; GROWTH-FACTOR; FIBROSIS; PROLIFERATION; ACTIVATION	Renal and lung fibrosis was characterized by the accumulation of collagen-immunoreactive mesenchymal cells expressing the intermediate filament protein nestin. The present study tested the hypothesis that nestin expression was increased in the hypertrophied/fibrotic left ventricle of suprarenal abdominal aorta constricted adult male Sprague-Dawley rats and induced in ventricular fibroblasts by pro-fibrotic peptide growth factors. Nestin protein levels were upregulated in the pressure-overloaded left ventricle and expression positively correlated with the rise of mean arterial pressure. In sham and pressure-overloaded hearts, nestin immunoreactivity was detected in collagen type I(+)-and CD31((+))-cells identified in the interstitium and perivascular region whereas staining was absent in smooth muscle alpha-actin((+))-cells. A significantly greater number of collagen type I(+)-cells co-expressing nestin was identified in the left ventricle of pressure-overloaded rats. Moreover, an accumulation of nestin((+))-cells lacking collagen, CD31 and smooth muscle alpha-actin staining was selectively observed at the adventitial region of predominantly large calibre blood vessels in the hypertrophied/fibrotic left ventricle. Angiotensin II and TGF-beta(1) stimulation of ventricular fibroblasts increased nestin protein levels via phosphatidylinositol 3-kinase- and protein kinase C/SMAD3-dependent pathways, respectively. CD31/eNOS((+))-rat cardiac microvascular endothelial cells synthesized/secreted collagen type I, expressed prolyl 4-hydroxylase and TGF-beta(1) induced nestin expression. The selective accumulation of adventitial nestin((+))-cells highlighted a novel feature of large vessel remodelling in the pressure-overloaded heart and increased appearance of collagen type I/nestin((+))-cells may reflect an activated phenotype of ventricular fibroblasts. CD31/collagen/nestin((+))-interstitial cells could represent displaced endothelial cells displaying an unmasked mesenchymal phenotype, albeit contribution to the reactive fibrotic response of the pressure-overloaded heart remains unknown.	[Hertig, Vanessa; Tardif, Kim; Meus, Marc Andre; Duquette, Natacha; Villeneuve, Louis; Toussaint, Fanny; Ledoux, Jonathan; Calderone, Angelino] Montreal Heart Inst, Res Ctr, Montreal, PQ, Canada; [Hertig, Vanessa; Tardif, Kim; Meus, Marc Andre; Duquette, Natacha; Villeneuve, Louis; Toussaint, Fanny; Ledoux, Jonathan; Calderone, Angelino] Univ Montreal, Montreal, PQ, Canada; [Toussaint, Fanny; Calderone, Angelino] Univ Montreal, Dept Pharmacol & Physiol, Montreal, PQ, Canada; [Ledoux, Jonathan] Univ Montreal, Dept Med, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Calderone, A (corresponding author), Montreal Heart Inst, Res Ctr, Montreal, PQ, Canada.; Calderone, A (corresponding author), Univ Montreal, Montreal, PQ, Canada.; Calderone, A (corresponding author), Univ Montreal, Dept Pharmacol & Physiol, Montreal, PQ, Canada.	angelino.calderone@umontreal.ca	Ledoux, Jonathan/D-2945-2012	Ledoux, Jonathan/0000-0001-8540-7763	Fondation de Recherche d'Institut de Cardiologie (FRIC) de Montreal; Fonds de Recherche du Quebec Sante (FRQS)	Fondation de Recherche d'Institut de Cardiologie (FRIC) de Montreal; Fonds de Recherche du Quebec Sante (FRQS)	This work was funded by the Fondation de Recherche d'Institut de Cardiologie (FRIC) de Montreal. Fanny Toussaint received a student scholarship from Fonds de Recherche du Quebec Sante (FRQS).	Abera MB, 2015, MOL PHARMACOL, V87, P832, DOI 10.1124/mol.115.097725; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Ali SR, 2014, CIRC RES, V115, P625, DOI 10.1161/CIRCRESAHA.115.303794; Beguin PC, 2012, J CELL PHYSIOL, V227, P813, DOI 10.1002/jcp.22794; BOOZ GW, 1994, AM J PHYSIOL-CELL PH, V267, pC1308, DOI 10.1152/ajpcell.1994.267.5.C1308; Boyle AJ, 2005, J MOL CELL CARDIOL, V39, P213, DOI 10.1016/j.yjmcc.2005.03.008; Bradford C, 2007, J CLIN INVEST, V117, P568; Camboa N, 2014, J CLIN INVEST, V124, P2921; Chabot A, 2016, J CELL PHYSIOL, V231, P1601, DOI 10.1002/jcp.25257; Chemaly ER, 2013, J PHYSIOL-LONDON, V591, P5337, DOI 10.1113/jphysiol.2013.258731; Chow JYC, 2008, AM J PHYSIOL-GASTR L, V294, pG899, DOI 10.1152/ajpgi.00411.2007; Colombo F, 2001, J MOL CELL CARDIOL, V33, P1091, DOI 10.1006/jmcc.2001.1381; El-Helou V, 2012, J CELL BIOCHEM, V113, P2442, DOI 10.1002/jcb.24117; El-Helou V, 2013, J CELL PHYSIOL, V228, P1844, DOI 10.1002/jcp.24345; Garg R, 2014, ONCOGENE, V33, P5225, DOI 10.1038/onc.2013.524; HOWARD BV, 1976, P NATL ACAD SCI USA, V73, P2361, DOI 10.1073/pnas.73.7.2361; Huang YL, 2009, J BIOCHEM, V146, P307, DOI 10.1093/jb/mvp070; Ieronimakis N, 2013, J MOL CELL CARDIOL, V63, P122, DOI 10.1016/j.yjmcc.2013.07.014; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Kanisicak O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12260; Kong P, 2014, CELL MOL LIFE SCI, V71, P549, DOI 10.1007/s00018-013-1349-6; Liu JK, 2015, BRAIN RES, V1610, P1, DOI 10.1016/j.brainres.2015.03.044; Luo YF, 2015, J PATHOL, V236, P384, DOI 10.1002/path.4530; MAHER JJ, 1990, J CLIN INVEST, V86, P1641, DOI 10.1172/JCI114886; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Mendoza FA, 2016, ARTHRITIS RHEUMATOL, V68, P210, DOI 10.1002/art.39421; Meus MA, 2016, J CELL PHYSL; Narita K, 2014, INT J ONCOL, V44, P1118, DOI 10.3892/ijo.2014.2278; Prabhu SD, 2016, CIRC RES, V119, P91, DOI 10.1161/CIRCRESAHA.116.303577; Principe DR, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt369; SAGE H, 1981, ARTERIOSCLEROSIS, V1, P427, DOI 10.1161/01.ATV.1.6.427; Sakairi T, 2007, KIDNEY INT, V72, P307, DOI 10.1038/sj.ki.5002277; Scobioala S, 2008, FASEB J, V22, P1021, DOI 10.1096/fj.07-8252com; Stavroulaki M, 2008, J CELL PHYSIOL, V214, P363, DOI 10.1002/jcp.21207; Su HT, 2013, MOL CANCER RES, V11, P768, DOI 10.1158/1541-7786.MCR-12-0511; Takeji M, 2006, J BIOL CHEM, V281, P40193, DOI 10.1074/jbc.M602182200; Tardif K, 2015, AM J PHYSIOL-HEART C, V308, pH1265, DOI 10.1152/ajpheart.00804.2014; Tomasek JJ, 2013, WOUND REPAIR REGEN, V21, P166, DOI 10.1111/wrr.12001; Tomioka M, 2010, NEPHROLOGY, V15, P568, DOI 10.1111/j.1440-1797.2010.01342.x; Xue XJ, 2010, MOL CELL NEUROSCI, V45, P26, DOI 10.1016/j.mcn.2010.05.006	40	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176147	10.1371/journal.pone.0176147	http://dx.doi.org/10.1371/journal.pone.0176147			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448522	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383600041
J	Kamoshita, M; Kato, T; Fujiwara, K; Namiki, T; Matsumura, K; Hyon, SH; Ito, J; Kashiwazaki, N				Kamoshita, Maki; Kato, Tsubasa; Fujiwara, Katsuyoshi; Namiki, Takafumi; Matsumura, Kazuaki; Hyon, Suong-Hyu; Ito, Junya; Kashiwazaki, Naomi			Successful vitrification of pronuclear-stage pig embryos with a novel cryoprotective agent, carboxylated epsilon-poly-L-lysine	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; ZINC-FINGER NUCLEASES; SUCCESSFUL CRYOPRESERVATION; DEVELOPMENTAL ABILITY; BOAR SPERMATOZOA; CURRENT PROGRESS; PORCINE OOCYTES; MOUSE OOCYTES; CUMULUS CELLS; KNOCKOUT	Vitrification is a powerful tool for the efficient production of offspring derived from cryopreserved oocytes or embryos in mammalian species including domestic animals. Genome editing technologies such as transcription activator-like effector nucleases (TALENs) and clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) 9 are now available even for domestic species, suggesting that the vitrification of embryos at the pronuclear stage (PN) will be more important because they could provide genomic host cells to be targeted by TALENs or CRISPR/Cas9. Although we reported the successful production of piglets derived from vitrified PN embryos by a solid-surface vitrification method with glutathione supplementation, further improvements are required. The cryoprotective agent (CPA) carboxylated epsilon-poly-L-lysine (COOH-PLL) was introduced in 2009. COOH-PLL reduces the physical and physiological damage caused by cryopreservation in mammalian stem cells and the vitrification of mouse oocytes and embryos. Those results suggested that vitrification of COOH-PLL may help improve the developmental ability of pig embryos vitrified at the PN stage. However, it remains unclear whether COOH-PLL is available as a CPA for the vitrification of embryos in domestic species. In this study, we evaluated COOH-PLL as a CPA with ethylene glycol (EG) and Cryotop as a device for the vitrification of PN pig embryos. Exposure to vitrification solution supplemented with COOHPLL up to 30% did not decrease developmental ability to the 2-cell stage and the blastocyst stage. After warming, most of the vitrified embryos survived regardless of the concentration of COOH-PLL (76.0 +/- 11.8% to 91.8 +/- 4.6%). However, the vitrified embryos without COOH-PLL showed a lower development rate up to the blastocyst stage (1.3 +/- 1.0%) compared to the fresh embryos (28.4 +/- 5.0%) (p < 0.05). In contrast, supplementation of 20% (w/v) COOH-PLL in the vitrification solution dramatically improved the developmental ability to blastocysts of the vitrified embryos (19.4 +/- 4.6%) compared to those without COOH-PLL (p<0.05). After the transfer of embryos vitrified with 30% (v/v) EG and 20% (w/v) COOHPLL, we successfully obtained 15 piglets from 8 recipients. Taken together, our present findings demonstrate for the first time that COOH-PLL is an effective CPA for embryo vitrification pig. COOH-PLL is a promising CPA for further improvements in the vitrification of oocytes and embryos in mammalian species.	[Kamoshita, Maki; Kato, Tsubasa; Fujiwara, Katsuyoshi; Namiki, Takafumi; Ito, Junya; Kashiwazaki, Naomi] Azabu Univ, Grad Sch Vet Sci, Lab Anim Reprod, Sagamihara, Kanagawa, Japan; [Matsumura, Kazuaki] Japan Adv Inst Sci & Technol, Nomi, Japan; [Hyon, Suong-Hyu] Kyoto Inst Technol, Ctr Fiber & Text Sci, Kyoto, Japan; [Ito, Junya; Kashiwazaki, Naomi] Azabu Univ, Sch Vet Med, Sagamihara, Kanagawa, Japan	Azabu University; Japan Advanced Institute of Science & Technology (JAIST); Kyoto Institute of Technology; Azabu University	Ito, J (corresponding author), Azabu Univ, Grad Sch Vet Sci, Lab Anim Reprod, Sagamihara, Kanagawa, Japan.; Ito, J (corresponding author), Azabu Univ, Sch Vet Med, Sagamihara, Kanagawa, Japan.	itoj@azabu-u.ac.jp			JSPS KAKENHI Grant [JP25242050, JP25660215, JP15H04584]; Azabu University Research Services Division; Interuniversity Bio-Backup Project (IBBP)	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Azabu University Research Services Division; Interuniversity Bio-Backup Project (IBBP)	This work was supported in part by Grants-in-Aid for Scientific Research from JSPS KAKENHI Grant Number JP25242050 (SH.H. and K.M.), JP25660215 (N.K.) and JP15H04584 (J.I.). This research was partially supported by a research project grant awarded by the Azabu University Research Services Division to J.I. and N.K.. This work was also supported by Collaborative Research Project organized by the Interuniversity Bio-Backup Project (IBBP) to KM..	BRINSTER RL, 1980, NATURE, V283, P499, DOI 10.1038/283499a0; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Eroglu A, 2009, BIOL REPROD, V80, P70, DOI 10.1095/biolreprod.108.070383; Fujiwara K, 2017, ANIM SCI J, V88, P180, DOI 10.1111/asj.12666; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Hauschild J, 2011, P NATL ACAD SCI USA, V108, P12013, DOI 10.1073/pnas.1106422108; Hirose M, 2013, ANIM SCI J, V84, P693, DOI 10.1111/asj.12061; Hisamatsu S, 2015, ANIM SCI J, V86, P132, DOI 10.1111/asj.12259; Ito J, 2010, ANIM SCI J, V81, P34, DOI 10.1111/j.1740-0929.2009.00699.x; Kikuchi K, 1998, THERIOGENOLOGY, V50, P615, DOI 10.1016/S0093-691X(98)00166-6; Kikuchi K, 2002, BIOL REPROD, V66, P1033, DOI 10.1095/biolreprod66.4.1033; Kohaya N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058063; Kohaya N, 2011, J REPROD DEVELOP, V57, P675, DOI 10.1262/jrd.11-066H; KONO T, 1988, CRYOBIOLOGY, V25, P170, DOI 10.1016/0011-2240(88)90011-9; Kuwayama M, 2008, FERTIL STERIL, V90, P281; Kuwayama M, 2007, THERIOGENOLOGY, V67, P73, DOI 10.1016/j.theriogenology.2006.09.014; Lagares MA, 2009, CRYOLETTERS, V30, P408; Lillico SG, 2013, SCI REP-UK, V3, DOI 10.1038/srep02847; Mandawala AA, 2016, THERIOGENOLOGY, V86, P1637, DOI 10.1016/j.theriogenology.2016.07.018; Matsumura K, 2016, ACS BIOMATER SCI ENG, V2, P1023, DOI 10.1021/acsbiomaterials.6b00150; Matsumura K, 2010, CELL TRANSPLANT, V19, P691, DOI 10.3727/096368910X508780; Matsumura K, 2009, BIOMATERIALS, V30, P4842, DOI 10.1016/j.biomaterials.2009.05.025; NAGASHIMA H, 1994, BIOL REPROD, V51, P618, DOI 10.1095/biolreprod51.4.618; NAGASHIMA H, 1995, NATURE, V374, P416, DOI 10.1038/374416a0; Ogawa B, 2010, J REPROD DEVELOP, V56, P356, DOI 10.1262/jrd.10-005H; PETTERS RM, 1993, J REPROD FERTIL, P61; RALL WF, 1985, NATURE, V313, P573, DOI 10.1038/313573a0; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Saragusty J, 2011, REPRODUCTION, V141, P1, DOI 10.1530/REP-10-0236; Seita Y, 2009, CRYOBIOLOGY, V59, P226, DOI 10.1016/j.cryobiol.2009.07.007; Shibao Y, 2014, CRYOBIOLOGY, V68, P200, DOI 10.1016/j.cryobiol.2014.01.008; SMORAG Z, 1989, THERIOGENOLOGY, V31, P1227, DOI 10.1016/0093-691X(89)90092-7; Somfai T, 2009, BIOL REPROD, V80, P42, DOI 10.1095/biolreprod.108.070235; Somfai T, 2012, J REPROD DEVELOP, V58, P17, DOI 10.1262/jrd.11-140N; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Suzuki K, 2002, INT J ANDROL, V25, P84, DOI 10.1046/j.1365-2605.2002.00330.x; Vajta G, 2000, ANIM REPROD SCI, V60, P357, DOI 10.1016/S0378-4320(00)00097-X; Vajta G., 2000, ANIM REPROD SCI, V2, P60; Vorontsov DA, 2014, J PHYS CHEM B, V118, P10240, DOI 10.1021/jp507697q; Watanabe H, 2013, PLOS ONE, V23; Watanabe H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083613; Whitworth KM, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.121723; Wu J, 2017, CELL, V26; Wu J, 2017, CELL, V168, P473, DOI 10.1016/j.cell.2016.12.036; Wu J, 2015, CELL STEM CELL, V17, P509, DOI 10.1016/j.stem.2015.10.009; Zeron Y, 1999, CRYOBIOLOGY, V38, P35, DOI 10.1006/cryo.1998.2139	46	16	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176711	10.1371/journal.pone.0176711	http://dx.doi.org/10.1371/journal.pone.0176711			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448636	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383600123
J	Lopez-Soriano, P; Noguera, P; Gorris, MT; Puchades, R; Maquieira, A; Marco-Noales, E; Lopez, MM				Lopez-Soriano, Pablo; Noguera, Patricia; Teresa Gorris, Maria; Puchades, Rosa; Maquieira, Angel; Marco-Noales, Ester; Lopez, Maria M.			Lateral flow immunoassay for on-site detection of Xanthomonas arboricola pv. pruni in symptomatic field samples	PLOS ONE			English	Article							PCR PROTOCOL; IDENTIFICATION; DEVICE	Xanthomonas arboricola pv. pruni is a quarantine pathogen and the causal agent of the bacterial spot disease of stone fruits and almond, a major threat to Prunus species. Rapid and specific detection methods are essential to improve disease management, and therefore a prototype of a lateral flow immunoassay (LFIA) was designed for the detection of X. arboricola pv. pruni in symptomatic field samples. It was developed by producing polyclonal antibodies which were then combined with carbon nanoparticles and assembled on nitrocellulose strips. The specificity of the LFIA was tested against 87 X. arboricola pv. pruni strains from different countries worldwide, 47 strains of other Xanthomonas species and 14 strains representing other bacterial genera. All X. arboricola pv. pruni strains were detected and cross-reactions were observed only with four strains of X. arboricola pv. corylina, a hazelnut pathogen that does not share habitat with X. arboricola pv. pruni. The sensitivity of the LFIA was assessed with suspensions from pure cultures of three X. arboricola pv. pruni strains and with spiked leaf extracts prepared from four hosts inoculated with this pathogen (almond, apricot, Japanese plum and peach). The limit of detection observed with both pure cultures and spiked samples was 10(4) CFU ml(-1). To demonstrate the accuracy of the test, 205 samples naturally infected with X. arboricola pv. pruni and 113 samples collected from healthy plants of several different Prunus species were analyzed with the LFIA. Results were compared with those obtained by plate isolation and real time PCR and a high correlation was found among techniques. Therefore, we propose this LFIA as a screening tool that allows a rapid and reliable diagnosis of X. arboricola pv. pruni in symptomatic plants.	[Lopez-Soriano, Pablo; Teresa Gorris, Maria; Marco-Noales, Ester; Lopez, Maria M.] Inst Valenciano Invest Agrarias, Ctr Protecc Vegetal, Valencia, Spain; [Noguera, Patricia; Puchades, Rosa; Maquieira, Angel] Univ Politecn Valencia, Dept Quim, Inst Univ Reconocimiento Mol & Desarrollo Tecnol, Valencia, Spain	Instituto Valenciano de Investigaciones Agrarias (IVIA); Universitat Politecnica de Valencia	Lopez, MM (corresponding author), Inst Valenciano Invest Agrarias, Ctr Protecc Vegetal, Valencia, Spain.	mlopez@ivia.es	Lopez, Maria/HHC-3659-2022; Marco-Noales, Ester/A-5404-2009; López, Maria M/D-2584-2015; Marco-Noales, Ester/AAH-2322-2019	Marco-Noales, Ester/0000-0001-7973-0345; Marco-Noales, Ester/0000-0001-7973-0345; Noguera, Patricia/0000-0001-7155-0710	Instituto Nacional de Tecnologia Agraria y Alimentaria, Project [RTA-2011-00140-C03-01]; Instituto Nacional de Tecnologia Agraria y Alimentaria, FPI-INIA grant; Generalitat Valenciana [Prometeo II 2014/040]; Ministerio de Economia y Competitividad (MINECO) [CTQ2013-45875R]; European Social Fund; European Regional Development Fund	Instituto Nacional de Tecnologia Agraria y Alimentaria, Project; Instituto Nacional de Tecnologia Agraria y Alimentaria, FPI-INIA grant; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Ministerio de Economia y Competitividad (MINECO)(Spanish Government); European Social Fund(European Social Fund (ESF)); European Regional Development Fund(European Commission)	The work was supported by the following: Instituto Nacional de Tecnologia Agraria y Alimentaria, Project RTA-2011-00140-C03-01 (http://www.inia.es), PLS MTG EMN MML; Instituto Nacional de Tecnologia Agraria y Alimentaria, FPI-INIA grant (http://www.inia.es), PLS; Generalitat Valenciana (Prometeo II 2014/040) (http://www.gva.es), PN RP AM; Ministerio de Economia y Competitividad (MINECO) (CTQ2013-45875R) (http://www.mineco.gob.es), PN RP AM; European Social Fund, PLS MTG EMN MML; and European Regional Development Fund, PLS MTG EMN MML.	Ballard EL, 2011, PLANT DIS, V95, P1109, DOI 10.1094/PDIS-09-10-0650; Battilani P., 1999, Journal of Plant Pathology, V81, P161; Boonham N, 2008, EUR J PLANT PATHOL, V121, P355, DOI 10.1007/s10658-008-9284-3; Braun-Kiewnick A, 2011, J MICROBIOL METH, V87, P1, DOI 10.1016/j.mimet.2011.06.015; Buhlmann A, 2013, PLANT PATHOL, V62, P475, DOI 10.1111/j.1365-3059.2012.02654.x; Cambra M, P 4 INT C PLANT PATH; Cubero J, 2015, PHYTOMA ESPANA, V271, P21; De Boer SH, 2012, ANNU REV PHYTOPATHOL, V50, P197, DOI 10.1146/annurev-phyto-081211-172942; del Campo R, 2009, FEMS MICROBIOL LETT, V298, P143, DOI 10.1111/j.1574-6968.2009.01709.x; [EPPO OEPP/EPPO], 2006, B OEPP EPPO B, V36, P129; EPPO, 2014, EPPO B, V44, P117, DOI [10.1111/epp.12118, DOI 10.1111/EPP.12118]; Garita-Cambronero J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00573; Ghezzi JI, 1999, FEMS MICROBIOL ECOL, V30, P203, DOI 10.1111/j.1574-6941.1999.tb00648.x; Golmohammadi M, 2013, J LIFE SCI, V7, P1019; Hodgetts J, 2015, PLANT PATHOL, V64, P559, DOI 10.1111/ppa.12289; Lamichhane JR, 2014, PLANT PATHOL, V63, P243, DOI 10.1111/ppa.12152; Lane CR, 2007, PLANT PATHOL, V56, P828, DOI 10.1111/j.1365-3059.2007.01615.x; Lopez MM, 2010, J PLANT PATHOL S1, V92; Lopez MM, 2012, J PLANT PATHOL S1, V94; Noguera P, 2011, ANAL BIOANAL CHEM, V399, P831, DOI 10.1007/s00216-010-4334-z; O'Keeffe M, 2003, J IMMUNOL METHODS, V278, P117, DOI 10.1016/S0022-1759(03)00207-2; Olmos A., 2008, B SEF, V63, P7; Pagani M.C., 2004, THESIS N CAROLINA ST; Palacio-Bielsa A, 2012, J PLANT PATHOL S1, V94; Palacio-Bielsa A, 2011, APPL ENVIRON MICROB, V77, P89, DOI 10.1128/AEM.01593-10; Park SY, 2010, J MICROBIOL, V48, P554, DOI 10.1007/s12275-010-0072-3; Posthuma-Trumpie GA, 2009, ANAL BIOANAL CHEM, V393, P569, DOI 10.1007/s00216-008-2287-2; Pothier JF, 2011, J MICROBIOL METH, V86, P16, DOI 10.1016/j.mimet.2011.03.019; Pothier JF, 2011, FEMS MICROBIOL LETT, V323, P52, DOI 10.1111/j.1574-6968.2011.02352.x; Ride M., 1969, BACTERIOSES VIROSES; Rosello M, 2012, J PLANT PATHOL S1, V94; Safenkova IV, 2014, APPL BIOCHEM MICRO+, V50, P675, DOI 10.1134/S0003683814120011; Safenkova IV, 2016, ANAL BIOANAL CHEM, V408, P6009, DOI 10.1007/s00216-016-9463-6; Safenkova IV, 2012, ANAL BIOANAL CHEM, V403, P1595, DOI 10.1007/s00216-012-5985-8; Saux MFL, 2015, APPL ENVIRON MICROB, V81, P4651, DOI 10.1128/AEM.00050-15; Smith E., 1903, SCIENCE, V17, P456, DOI DOI 10.1126/SCIENCE.17.420.114-A; Thornton CR, 2004, PHYTOPATHOLOGY, V94, P280, DOI 10.1094/PHYTO.2004.94.3.280; Tjou-Tam-Sin NNA, 2012, PLANT DIS, V96, P759, DOI 10.1094/PDIS-04-11-0265-PDN	38	17	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176201	10.1371/journal.pone.0176201	http://dx.doi.org/10.1371/journal.pone.0176201			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448536	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383600046
J	Pettengill, M; Matute, JD; Tresenriter, M; Hibbert, J; Burgner, D; Richmond, P; Millian, JL; Ozonoff, A; Strunk, T; Currie, A; Levy, O				Pettengill, Matthew; Matute, Juan D.; Tresenriter, Megan; Hibbert, Julie; Burgner, David; Richmond, Peter; Millian, Jose Luis; Ozonoff, Al; Strunk, Tobias; Currie, Andrew; Levy, Ofer			Human alkaline phosphatase dephosphorylates microbial products and is elevated in preterm neonates with a history of late-onset sepsis	PLOS ONE			English	Article							GUT MICROBIOTA; LIPOPOLYSACCHARIDE; ADENOSINE; INFLAMMATION; DEFENSE; PHAGOCYTES; TOXICITY; MICE	Background A host defense function for Alkaline phosphatases (ALPs) is suggested by the contribution of intestinal ALP to detoxifying bacterial lipopolysaccharide (endotoxin) in animal models in vivo and the elevation of ALP activity following treatment of human cells with inflammatory stimuli in vitro. However the activity of ALP in human plasma (primarily tissue-nonspecific ALP; TNAP) on lipopolysaccharide and other microbial products has not been assessed, nor has its expression been studied in preterm newborns, a vulnerable population at high risk of sepsis. In this context, the aim of our study was to characterize the activity of TNAP on Toll-like receptor (TLR) agonists and assess the concentrations of plasma ALP during late-onset sepsis in preterm newborns. Methods Recombinant human TNAP was incubated with microbial products and phosphate release was measured by malachite green assay. Plasma ALP activity was measured serially in a cohort of preterm (N = 129) infants at high risk of late-onset sepsis (LOS). Results TNAP dephosphorylates poly-inosine: cytosine (Toll-like receptor (TLR) 3 agonist) and LPS from Klebsiella pneumoniae and Salmonella minnesota (TLR4 agonists). Plasma ALP significantly increased postnatally over the first 4 weeks of life in preterm and term newborns. Bacteremic LOS in preterm infants (gestational age <= 30 weeks) was associated with significantly elevated plasma ALP at 4 weeks postnatal age. Conclusions TNAP, the main circulating isozyme of ALP, de-phosphorylates TLR agonists, demonstrates a post-natal age dependent increase in preterm and term plasma across the first 4 weeks of life, and is elevated in association with preterm LOS.	[Pettengill, Matthew; Levy, Ofer] Boston Childrens Hosp, Div Infect Dis, Precis Vaccines Program, Boston, MA 02115 USA; [Pettengill, Matthew; Matute, Juan D.; Ozonoff, Al; Levy, Ofer] Harvard Med Sch, Boston, MA 02115 USA; [Tresenriter, Megan] Univ Calif Davis, Sch Med, Davis, CA 95616 USA; [Hibbert, Julie; Strunk, Tobias; Currie, Andrew] Univ Western Australia, Crawley, WA, Australia; [Burgner, David] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Burgner, David; Richmond, Peter] Univ Melbourne, Dept Paediat, Parkville, Vic, Australia; [Burgner, David] Monash Univ, Dept Paediat, Clayton, Vic, Australia; [Millian, Jose Luis] Sanford Burnham Med Res Inst, Sanford Childrens Hlth Res Ctr, La Jolla, CA USA; [Currie, Andrew] Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA, Australia	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of California System; University of California Davis; University of Western Australia; Murdoch Children's Research Institute; University of Melbourne; Monash University; Sanford Burnham Prebys Medical Discovery Institute; Murdoch University	Levy, O (corresponding author), Boston Childrens Hosp, Div Infect Dis, Precis Vaccines Program, Boston, MA 02115 USA.; Levy, O (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	ofer.levy@chiIdrens.harvard.edu	Currie, Andrew/C-2778-2015; Richmond, Peter C/G-3379-2012; Strunk, Tobias/AIE-3407-2022	Richmond, Peter C/0000-0001-7562-7228; Strunk, Tobias/0000-0001-7079-2339; Matute, Juan/0000-0002-1703-8115; Burgner, David/0000-0002-8304-4302; Pettengill, Matthew/0000-0002-4579-0187; Currie, Andrew/0000-0002-5193-3404; Levy, Ofer/0000-0002-5859-1945; Hibbert, Julie/0000-0002-8839-3966	Bill & Melinda Gates Foundation [OPPGH5284, OPP1035192]; NIH [1R01AI100135-01, 3R01AI067353-05S1, T32 HD055148, R01 DE12889]; NHMRC [APP1064629, APP37601100]; honorary NHFA Future Leaders Fellowship [100026]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012889] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); honorary NHFA Future Leaders Fellowship; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study in OL's lab was supported by Global Health (OPPGH5284) and Grand Challenges Explorations (OPP1035192) awards from the Bill & Melinda Gates Foundation http://www.gatesfoundation.org/) and by NIH grant 1R01AI100135-01 and its administrative supplement 3R01AI067353-05S1 (https://www.nih.gov/). MP was supported by NIH Training Grant T32 HD055148. DB is supported by an NHMRC Senior Research Fellowship (APP1064629) (https://www.nhmrc.gov.au/) and an honorary NHFA Future Leaders Fellowship (100026) (http:// heartfoundation.org.au/). JLM is supported by NIH grant R01 DE12889. Samples collection from infants at King Edward Memorial Hospital was funded by an NHMRC project grant (APP37601100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates JM, 2007, CELL HOST MICROBE, V2, P371, DOI 10.1016/j.chom.2007.10.010; Bentala H, 2002, SHOCK, V18, P561, DOI 10.1097/00024382-200212000-00013; Beumer C, 2003, J PHARMACOL EXP THER, V307, P737, DOI 10.1124/jpet.103.056606; Chen KT, 2010, AM J PHYSIOL-GASTR L, V299, pG467, DOI 10.1152/ajpgi.00364.2009; Cinel I, 2009, CRIT CARE MED, V37, P291, DOI 10.1097/CCM.0b013e31819267fb; CRONSTEIN BN, 1985, J IMMUNOL, V135, P1366; Dahl R, 2009, J MED CHEM, V52, P6919, DOI 10.1021/jm900383s; Eltzschig HK, 2004, BLOOD, V104, P3986, DOI 10.1182/blood-2004-06-2066; Gallo RL, 1997, J INVEST DERMATOL, V109, P597, DOI 10.1111/1523-1747.ep12337529; Ghazal P, 2013, CURR OPIN INFECT DIS, V26, P213, DOI 10.1097/QCO.0b013e32835fb8bf; Goldberg RF, 2008, P NATL ACAD SCI USA, V105, P3551, DOI 10.1073/pnas.0712140105; Healy CM, 2004, PEDIATRICS, V114, P953, DOI 10.1542/peds.2004-0043; Henneke P, 2006, INFECT IMMUN, V74, P3085, DOI 10.1128/IAI.01551-05; Hoylaerts MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119874; Kaliannan K, 2013, P NATL ACAD SCI USA, V110, P7003, DOI 10.1073/pnas.1220180110; Kenzel S, 2006, CURR OPIN INFECT DIS, V19, P264, DOI 10.1097/01.qco.0000224821.27482.bd; Koyama I, 2002, CLIN BIOCHEM, V35, P455, DOI 10.1016/S0009-9120(02)00330-2; Lei W, 2013, REPRODUCTION, V146, P419, DOI 10.1530/REP-13-0153; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Maldonado O, 1998, J CLIN GASTROENTEROL, V27, P342, DOI 10.1097/00004836-199812000-00013; Malo MS, 2010, GUT, V59, P1476, DOI 10.1136/gut.2010.211706; Malo MS, 2014, AM J PHYSIOL-GASTR L, V306, pG826, DOI 10.1152/ajpgi.00357.2013; Moss AK, 2013, AM J PHYSIOL-GASTR L, V304, pG597, DOI 10.1152/ajpgi.00455.2012; Peters E, 2015, BRIT J PHARMACOL, V172, P4932, DOI 10.1111/bph.13261; Pettengill M, 2013, J BIOL CHEM, V288, P27315, DOI 10.1074/jbc.M113.484212; Pickkers P, 2009, EUR J CLIN PHARMACOL, V65, P393, DOI 10.1007/s00228-008-0591-6; Pickkers P, 2012, CRIT CARE, V16, DOI 10.1186/cc11159; Shanmugham LN, 2007, ARCH MED RES, V38, P39, DOI 10.1016/j.arcmed.2006.05.016; Strunk T, 2007, CURR OPIN INFECT DIS, V20, P370, DOI 10.1097/QCO.0b013e3281a7ec98; Strunk T, 2012, PEDIATRICS, V129, pE134, DOI 10.1542/peds.2010-3493; Tuin A, 2006, AM J PHYSIOL-GASTR L, V290, pG377, DOI 10.1152/ajpgi.00147.2005; Wiwanitkit V, 2001, BMC Fam Pract, V2, P2, DOI 10.1186/1471-2296-2-2; Wong J, 2015, SEMIN DIALYSIS, V28, P59, DOI 10.1111/sdi.12280; Wynn J, 2010, PEDIATRICS, V125, P1031, DOI 10.1542/peds.2009-3301	35	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0175936	10.1371/journal.pone.0175936	http://dx.doi.org/10.1371/journal.pone.0175936			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448526	Green Published, gold			2022-12-26	WOS:000400383600032
J	Poliakov, E; Samuel, W; Duncan, T; Gutierrez, DB; Mata, NL; Redmond, TM				Poliakov, Eugenia; Samuel, William; Duncan, Todd; Gutierrez, Danielle B.; Mata, Nathan L.; Redmond, T. Michael			Inhibitory effects of fenretinide metabolites N-[4-methoxyphenyl]retinamide (MPR) and 4-oxo-N-(4-hydroxyphenyl)retinamide (3-keto-HPR) on fenretinide molecular targets beta-carotene oxygenase 1, stearoyl-CoA desaturase 1 and dihydroceramide Delta 4-desaturase 1	PLOS ONE			English	Article							RETINOL-BINDING-PROTEIN; N-(4-HYDROXYPHENYL)RETINAMIDE INDUCES APOPTOSIS; PIGMENT EPITHELIAL-CELLS; BREAST-CANCER PATIENTS; PLASMA RETINOL; TISSUE TRANSGLUTAMINASE; INSULIN-RESISTANCE; GROWTH-INHIBITION; MAMMARY-GLAND; VITAMIN-A	The therapeutic capacity of fenretinide (N-[4-hydroxyphenyl] retinamide; 4-HPR) has been demonstrated for several conditions, including cancer, obesity, diabetes, and ocular disease. Yet, the mechanisms of action for its pleiotropic effects are still undefined. We hypothesized that investigation of two of the major physiological metabolites of fenretinide, N-[4methoxyphenyl] retinamide (MPR) and 4-oxo-N-(4-hydroxyphenyl) retinamide (3-keto-HPR), might begin to resolve the multifaceted effects of this synthetic retinoid. We analyzed the effects of fenretinide, MPR, 3-keto-HPR, and the non-retinoid RBP4 ligand A1120, on the activity of known targets of fenretinide, stearoyl-CoA desaturase 1 (SCD1) and dihydroceramide Delta 4-desaturase 1 (DES1) in ARPE-19 cells, and purified recombinant mouse betacarotene oxygenase 1 (BCO1) in vitro. Lipids and retinoids were extracted and quantified by liquid chromatography-mass spectrometry and reversed phase HPLC, respectively. The data demonstrate that while fenretinide is an inhibitor of the activities of these three enzymes, that 3-keto-HPR is a more potent inhibitor of all three enzymes, potentially mediating most of the in vivo beneficial effects of fenretinide. However, while MPR does not affect SCD1 and DES1 activity, it is a potent specific inhibitor of BCO1. We conclude that a deeper understanding of the mechanisms of action of fenretinide and its metabolites provides new avenues for therapeutic specificity. For example, administration of 3-keto-HPR instead of fenretinide may be preferential if inhibition of SCD1 or DES1 activity is the goal (cancer), while MPR may be better for BCO1 modulation (carotenoid metabolism). Continued investigation of fenretinide metabolites in the context of fenretinide's various therapeutic uses will begin to resolve the pleotropic nature of this compound.	[Poliakov, Eugenia; Samuel, William; Duncan, Todd; Gutierrez, Danielle B.; Redmond, T. Michael] NEI, Lab Retinal Cell & Mol Biol, NIH, Bethesda, MD 20892 USA; [Mata, Nathan L.] Acucela Inc, Seattle, WA USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Poliakov, E; Redmond, TM (corresponding author), NEI, Lab Retinal Cell & Mol Biol, NIH, Bethesda, MD 20892 USA.	poliakove@nei.nih.gov; redmondd@helix.nih.gov		Redmond, T. Michael/0000-0002-1813-5291	Intramural Research Program of the National Eye Institute, National Institutes of Health; Acucela Inc.; NATIONAL EYE INSTITUTE [ZIAEY000260] Funding Source: NIH RePORTER	Intramural Research Program of the National Eye Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Acucela Inc.; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Intramural Research Program of the National Eye Institute, National Institutes of Health. Acucela Inc. provided support in the form of salaries for author NM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	BERNI R, 1993, FASEB J, V7, P1179, DOI 10.1096/fasebj.7.12.8375617; Bhatti RA, 2003, INVEST OPHTH VIS SCI, V44, P44, DOI 10.1167/iovs.02-0167; Bikman BT, 2012, J BIOL CHEM, V287, P17426, DOI 10.1074/jbc.M112.359950; Bu PL, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-236; Cazzaniga M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/172897; Chichili GR, 2005, INVEST OPHTH VIS SCI, V46, P3562, DOI 10.1167/iovs.05-0089; Cooper JP, 2011, BRIT J PHARMACOL, V163, P1263, DOI 10.1111/j.1476-5381.2011.01310.x; De Palo G, 2002, GYNECOL ONCOL, V86, P24, DOI 10.1006/gyno.2002.6663; DELIA D, 1993, CANCER RES, V53, P6036; Dillon R, 2008, ANAL CHIM ACTA, V627, P99, DOI 10.1016/j.aca.2008.05.012; Dobri N, 2013, INVEST OPHTH VIS SCI, V54, P85, DOI 10.1167/iovs.12-10050; Erdreich-Epstein A, 2002, J BIOL CHEM, V277, P49531, DOI 10.1074/jbc.M209962200; Fabbi M, 1999, CELL DEATH DIFFER, V6, P992, DOI 10.1038/sj.cdd.4400573; FORMELLI F, 1989, CANCER RES, V49, P6149; Giandomenico V, 1999, CARCINOGENESIS, V20, P1133, DOI 10.1093/carcin/20.6.1133; Golczak M, 2008, J BIOL CHEM, V283, P9543, DOI 10.1074/jbc.M708982200; Gutierrez DB, 2010, PHOTOCH PHOTOBIO SCI, V9, P1513, DOI 10.1039/c0pp00230e; Hansen LA, 2000, CARCINOGENESIS, V21, P1271, DOI 10.1093/carcin/21.7.1271; HULTIN TA, 1986, DRUG METAB DISPOS, V14, P714; Kraveka JM, 2007, J BIOL CHEM, V282, P16718, DOI 10.1074/jbc.M700647200; Lovat PE, 2000, EXP CELL RES, V260, P50, DOI 10.1006/excr.2000.4988; Masood MA, 2012, LIPIDS, V47, P209, DOI 10.1007/s11745-011-3633-2; Mata NL, 2013, RETINA-J RET VIT DIS, V33, P498, DOI 10.1097/IAE.0b013e318265801d; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Mcilroy GD, 2013, DIABETES, V62, P825, DOI 10.2337/db12-0458; MEHTA RG, 1991, EUR J CANCER, V27, P138, DOI 10.1016/0277-5379(91)90471-O; MEHTA RG, 1988, BIOCHEM J, V256, P579, DOI 10.1042/bj2560579; Mehta RR, 1998, EUR J CANCER, V34, P902, DOI 10.1016/S0959-8049(98)00032-X; Mershon SM, 2007, BIOORG MED CHEM LETT, V17, P836, DOI 10.1016/j.bmcl.2006.10.050; MOON RC, 1979, CANCER RES, V39, P1339; Motani A, 2009, J BIOL CHEM, V284, P7673, DOI 10.1074/jbc.M809654200; Oridate N, 1996, CLIN CANCER RES, V2, P855; Pavan B, 2008, BIOSCIENCE REP, V28, P327, DOI 10.1042/BSR20080103; Poliakov E, 2005, J BIOL CHEM, V280, P29217, DOI 10.1074/jbc.M500409200; Poliakov E, 2012, ADV EXP MED BIOL, V723, P167, DOI 10.1007/978-1-4614-0631-0_23; Preitner F, 2009, AM J PHYSIOL-ENDOC M, V297, pE1420, DOI 10.1152/ajpendo.00362.2009; Radu RA, 2005, INVEST OPHTH VIS SCI, V46, P4393, DOI 10.1167/iovs.05-0820; Rahmaniyan M, 2011, J BIOL CHEM, V286, P24754, DOI 10.1074/jbc.M111.250779; Sabichi AL, 1998, J NATL CANCER I, V90, P597, DOI 10.1093/jnci/90.8.597; Samuel W, 2013, J CELL PHYSL; Samuel W, 2006, J CELL PHYSIOL, V209, P854, DOI 10.1002/jcp.20774; Samuel WK R, 2005, INVEST OPHTH VIS SCI, P5140; SHEIKH MS, 1995, CARCINOGENESIS, V16, P2477, DOI 10.1093/carcin/16.10.2477; Tiberio P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013362; Tosetti F, 2003, MOL PHARMACOL, V63, P565, DOI 10.1124/mol.63.3.565; Veronesi U, 2006, ANN ONCOL, V17, P1065, DOI 10.1093/annonc/mdl047; Veterans Medical Research Foundation UoC San Diego, 2008, RAND DOUBL BLIND STU; Villani MG, 2006, CANCER RES, V66, P3238, DOI 10.1158/0008-5472.CAN-05-3362; Villani MG, 2004, CLIN CANCER RES, V10, P6265, DOI 10.1158/1078-0432.CCR-04-0655; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Zanotti G, 2004, VITAM HORM, V69, P271, DOI 10.1016/S0083-6729(04)69010-8	51	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176487	10.1371/journal.pone.0176487	http://dx.doi.org/10.1371/journal.pone.0176487			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448568	Green Submitted, gold, Green Published			2022-12-26	WOS:000400383600088
J	Rueda-Zarate, HA; Imaz-Rosshandler, I; Cardenas-Ovando, RA; Castillo-Fernandez, JE; Noguez-Monroy, J; Rangel-Escareno, C				Rueda-Zarate, Hector A.; Imaz-Rosshandler, Ivan; Cardenas-Ovando, Roberto A.; Castillo-Fernandez, Juan E.; Noguez-Monroy, Julieta; Rangel-Escareno, Claudia			A computational toxicogenomics approach identifies a list of highly hepatotoxic compounds from a large microarray database	PLOS ONE			English	Article							TOXICOLOGY; SUMMARIES; NETWORK	The liver and the kidney are the most common targets of chemical toxicity, due to their major metabolic and excretory functions. However, since the liver is directly involved in biotransformation, compounds in many currently and normally used drugs could affect it adversely. Most chemical compounds are already labeled according to FDA-approved labels using DILI-concern scale. Drug Induced Liver Injury (DILI) scale refers to an adverse drug reaction. Many compounds do not exhibit hepatotoxicity at early stages of development, so it is important to detect anomalies at gene expression level that could predict adverse reactions in later stages. In this study, a large collection of microarray data is used to investigate gene expression changes associated with hepatotoxicity. Using TG-GATEs a large-scale toxicogenomics database, we present a computational strategy to classify compounds by toxicity levels in human and animal models through patterns of gene expression. We combined machine learning algorithms with time series analysis to identify genes capable of classifying compounds by FDA-approved labeling as DILI-concern toxic. The goal is to define gene expression profiles capable of distinguishing the different subtypes of hepatotoxicity. The study illustrates that expression profiling can be used to classify compounds according to different hepatotoxic levels; to label those that are currently labeled as undertemined; and to determine if at the molecular level, animal models are a good proxy to predict hepatotoxicity in humans.	[Rueda-Zarate, Hector A.; Cardenas-Ovando, Roberto A.; Noguez-Monroy, Julieta] Tecnol Monterrey Mexico City, Sch Sci & Engn, Mexico City, DF, Mexico; [Imaz-Rosshandler, Ivan; Castillo-Fernandez, Juan E.; Rangel-Escareno, Claudia] Inst Nacl Med Genom, Computat Genom Lab, Mexico City, DF, Mexico	Tecnologico de Monterrey; Instituto Nacional de Medicina Genomica	Rangel-Escareno, C (corresponding author), Inst Nacl Med Genom, Computat Genom Lab, Mexico City, DF, Mexico.	crangel@inmegen.gob.mx	Rangel-Escareno, Claudia/F-4587-2012	Rangel-Escareno, Claudia/0000-0003-1303-0834; Castillo-Fernandez, Juan/0000-0002-0034-8029; Imaz Rosshandler, Ivan/0000-0001-5975-0138; Noguez, Julieta/0000-0002-6000-3452	Consejo Nacional de Ciencia y Tecnologia CONACYT [242368, 342425, 301519]	Consejo Nacional de Ciencia y Tecnologia CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Research partially sponsored by Consejo Nacional de Ciencia y Tecnologia CONACYT grant No. 242368 granted to CRE. Graduate fellowships also sponsored by Consejo Nacional de Ciencia y Tecnologia CONACYT granted to HRZ with No. 342425 and to RCO with No. 301519. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Aardema MJ, 2002, MUTAT RES-FUND MOL M, V499, P13, DOI 10.1016/S0027-5107(01)00292-5; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chen MJ, 2011, DRUG DISCOV TODAY, V16, P697, DOI 10.1016/j.drudis.2011.05.007; Dundaroz R, 2001, KOCATEPE TIP DERGISI, V2, P153; Evans JG, 2003, TARGET ORGAN PATHOLO; Guerreiro N, 2003, TOXICOL PATHOL, V31, P471, DOI 10.1080/01926230390224656; Hamadeh Hisham K., 2002, Current Issues in Molecular Biology, V4, P45; Hoaglin DC, 1983, UNDERSTANDING ROBUST, V3; Igarashi Y, 2014, NUCL ACIDS RES; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Keller KA, 2006, TOXICOLOGICAL TESTIN; Khor TO, 2006, PHARM RES-DORDR, V23, P1659, DOI 10.1007/s11095-006-9003-8; Kiyosawa N, 2010, GENOMICS, V96, P39, DOI 10.1016/j.ygeno.2010.03.014; Lord PG, 2006, BASIC CLIN PHARMACOL, V98, P537, DOI 10.1111/j.1742-7843.2006.pto_444.x; Ruepp Stefan, 2005, Toxicol Appl Pharmacol, V207, P161, DOI 10.1016/j.taap.2005.05.008; Steiner S, 2000, TOXICOL LETT, V112, P467, DOI 10.1016/S0378-4274(99)00236-2; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tai Y., 2007, TIMECOURSE STAT ANAL, V1; Tai YC, 2006, ANN STAT, V34, P2387, DOI 10.1214/009053606000000759; Tai YC, 2009, BIOMETRICS, V65, P40, DOI 10.1111/j.1541-0420.2008.01057.x; Uehara T, 2010, MOL NUTR FOOD RES, V54, P218, DOI 10.1002/mnfr.200900169; Urushidani T., 2008, PREDICTION HEPATOTOX, P507; Waters MD, 2004, NAT REV GENET, V5, P936, DOI 10.1038/nrg1493; Zhang JD, 2014, PHARMACOGENOMICS J, V14, P208, DOI 10.1038/tpj.2013.39	25	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176284	10.1371/journal.pone.0176284	http://dx.doi.org/10.1371/journal.pone.0176284			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448553	Green Submitted, gold, Green Published			2022-12-26	WOS:000400383600056
J	Morandini, V; Ferrer, M				Morandini, Virginia; Ferrer, Miguel			How to plan reintroductions of long-lived birds	PLOS ONE			English	Article							DENSITY-DEPENDENT FECUNDITY; LESSER KESTREL; POPULATION; SUCCESS; CONSERVATION; CRITERIA; EAGLE	Reintroductions have been increasingly used for species restoration and it seems that this conservation tool is going to be more used in the future. Nevertheless, there is not a clear consensus about the better procedure for that, consequently a better knowledge of how to optimize this kind of management is needed. Here we examined the dynamics of released long-lived bird populations (lesser kestrel, Falco naumanni, Bonelli's eagle Aquila fasciata, and bearded vulture Gypaetus barbatus) in object-oriented simulated reintroduction programs. To do that, number of young per year and number of years of released necessary to achieve a successful reintroduced population were calculated. We define a successful reintroduction as one in which when the probability of extinction during two times the maximum live-span period for the species (20, 50, and 64 years respectively) was less than 0.001 (P<0.001) and they showed a positive trend in population size (r>0.00). Results showed that a similar total number of young (mean 98.33 +/- 5.26) must be released in all the species in all the scenarios in order to get a successful reintroduction. Consequently, as more young per year are released the new population is going to be larger at the end of the simulations, the lesser the negative effects in the donor population and the lowest the total budget needed will be.	[Morandini, Virginia; Ferrer, Miguel] CSIC, Appl Ecol Grp, Estn Biol Donana, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Morandini, V (corresponding author), CSIC, Appl Ecol Grp, Estn Biol Donana, Seville, Spain.	morandini@ebd.csic.es	Ferrer, Miguel/AFU-8286-2022; Ferrer Baena, Miguel/G-3519-2015; Morandini, Virginia/E-8986-2016	Ferrer Baena, Miguel/0000-0003-0092-8450; Morandini, Virginia/0000-0003-0665-5713				Alcaide M, 2010, CONSERV GENET, V11, P331, DOI 10.1007/s10592-009-9810-7; [Anonymous], [No title captured]; Armstrong DP, 2008, TRENDS ECOL EVOL, V23, P20, DOI 10.1016/j.tree.2007.10.003; Balbontin J, 2003, BIOL CONSERV, V109, P417, DOI 10.1016/S0006-3207(02)00168-4; Beck B. B., 1994, P265; DONAZAR JA, 1993, J APPL ECOL, V30, P504, DOI 10.2307/2404190; Ferguson-Lees J., 2003, RAPTORS WORLD; Ferrer M, 1996, ECOLOGY, V77, P69, DOI 10.2307/2265655; Ferrer M, 2014, J APPL ECOL, V51, P1255, DOI 10.1111/1365-2664.12308; GRIFFITH B, 1989, SCIENCE, V245, P477, DOI 10.1126/science.245.4917.477; Hiraldo F, 1996, J APPL ECOL, V33, P1085, DOI 10.2307/2404688; IUCN/SSC, 2013, GUID REINTR OTH CONS; Lack D., 1954, P343; Lacy Robert C., 2000, Ecological Bulletins, V48, P191; Mora C, 2013, SCIENCE, V341, DOI 10.1126/science.1237254; Muriel R, 2011, ARDEOLA, V58, P323, DOI 10.13157/arla.58.2.2011.323; Muriel R, 2010, ARDEOLA, V57, P175; Newton I., 1998, POPULATION LIMITATIO; O'Rourke E, 2014, LAND USE POLICY, V38, P129, DOI 10.1016/j.landusepol.2013.10.020; Parker K. A., 2013, NOTORNIS, V29, P4470; Real J, 2001, BIRD STUDY, V48, P221, DOI 10.1080/00063650109461221; Robert A, 2015, ANIM CONSERV, V18, P413, DOI 10.1111/acv.12244; Robert A, 2015, ANIM CONSERV, V18, P397, DOI 10.1111/acv.12188; Sarrazin F, 1996, TRENDS ECOL EVOL, V11, P474, DOI 10.1016/0169-5347(96)20092-8; Seddon PJ, 2015, ANIM CONSERV, V18, P407, DOI 10.1111/acv.12239; Seddon PJ, 2007, CONSERV BIOL, V21, P303, DOI 10.1111/j.1523-1739.2006.00627.x; Seddon PJ, 2014, SCIENCE, V345, P406, DOI 10.1126/science.1251818; Seddon PJ, 1999, TRENDS ECOL EVOL, V14, P503, DOI 10.1016/S0169-5347(99)01720-6; Shier DM, 2015, ANIM CONSERV, V18, P411, DOI 10.1111/acv.12242; Soorae PS, 2016, GLOBAL REINTRODUCTIO; Soutullo A, 2008, BIOL CONSERV, V141, P1013, DOI 10.1016/j.biocon.2008.01.011; Sutherland WJ, 2010, CONSERV LETT, V3, P229, DOI 10.1111/j.1755-263X.2010.00113.x; Sutton AE, 2015, PEERJ, V3, DOI 10.7717/peerj.1012	33	10	10	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0174186	10.1371/journal.pone.0174186	http://dx.doi.org/10.1371/journal.pone.0174186			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445473	gold, Green Submitted, Green Published			2022-12-26	WOS:000400309200004
J	Marcombe, S; Bobichon, J; Somphong, B; Phommavan, N; Maithaviphet, S; Nambanya, S; Corbel, V; Brey, PT				Marcombe, Sebastien; Bobichon, Julie; Somphong, Boutsady; Phommavan, Nothasin; Maithaviphet, Santi; Nambanya, Simone; Corbel, Vincent; Brey, Paul T.			Insecticide resistance status of malaria vectors in Lao PDR	PLOS ONE			English	Article							GATED SODIUM-CHANNEL; KNOCKDOWN RESISTANCE; PYRETHROID RESISTANCE; ANOPHELES-MINIMUS; IDENTIFICATION; MUTATION; DDT; KDR; POPULATIONS; MECHANISMS	Knowledge on insecticide resistance in Anopheles species is a basic requirement to guide malaria vector control programs. In Lao PDR, vector control relies on insecticide residual spraying (IRS) and impregnated bed-nets (ITNs) with the use of pyrethroids. Here, the susceptibility of Anopheles species, including several malaria vectors (An. maculatus and An. minimus), to various insecticides was investigated in ten provinces of Lao PDR through a north-south transect. Bioassays were performed on field caught female mosquitoes using the standard WHO susceptibility tests with DDT (4%), deltamethrin (0.05%) and permethrin (0.75%). In addition, the DIIS6 region of the para-type sodium channel gene was amplified and sequenced to identify knockdown resistance mutations (kdr). Resistance to DDT and permethrin was detected in suspected malaria vectors, such as An. nivipes and An. philippinensis in Lao PDR. Resistance to the formerly used DDT was found in a population of An. maculatus s.l. from Luang Prabang province. No resistance to pyrethroids was found in primary vectors, indicating that these insecticides are still adequate for malaria vector control. However, high resistance levels to pyrethroids was found in-vector species and reduced susceptibility to permethrin in An. minimus and An. maculatus was reported in specific localities which raises concerns for pyrethroid-based control in the future. No kdr mutation was found in any of the resistant populations tested hence suggesting a probable role detoxification enzymes in resistance. This study highlights the necessity to continue the monitoring of insecticide susceptibility to early detect potential occurrence and/or migration of insecticide resistance in malaria vectors in Lao PDR.	[Marcombe, Sebastien; Bobichon, Julie; Somphong, Boutsady; Phommavan, Nothasin; Brey, Paul T.] Minist Hlth, Inst Pasteur Laos, Viangchan, Laos; [Maithaviphet, Santi; Nambanya, Simone] Minist Hlth, Ctr Malariol Parasitol & Entomol, Viangchan, Laos; [Corbel, Vincent] UM1CNRS 5290 IRD 224, Inst Rech Dev, MIVEGEC, Montpellier, France	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Marcombe, S (corresponding author), Minist Hlth, Inst Pasteur Laos, Viangchan, Laos.	s.marcombe@pasteur.la		corbel, vincent/0000-0003-0995-3257	French Ministry of Foreign Affairs and International Development [12INI212]	French Ministry of Foreign Affairs and International Development	This work was supported by contract no 12INI212 with Initiative 5%, http://www.initiative5pour100.fr/er/, French Ministry of Foreign Affairs and International Development. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Chandre F, 1999, J AM MOSQUITO CONTR, V15, P53; Chareonviriyaphap T, 2003, J VECTOR ECOL, V28, P108; Corbel V, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P579, DOI 10.5772/56117; Davies TGE, 2007, IUBMB LIFE, V59, P151, DOI 10.1080/15216540701352042; Dimond JB, 1996, ENVIRON POLLUT, V92, P227, DOI 10.1016/0269-7491(95)00059-3; Dykes CL, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0946-7; FINNEY D J, 1971, P333; Garros C, 2004, AM J TROP MED HYG, V70, P583, DOI 10.4269/ajtmh.2004.70.583; Jones CM, 2012, P NATL ACAD SCI USA, V109, P6614, DOI 10.1073/pnas.1201475109; Jorgensen P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-59; Kobayashi J, 2004, ACTA TROP, V89, P299, DOI 10.1016/j.actatropica.2003.10.009; Manguin S, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P1, DOI 10.5772/3392; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Minisrtry of Health LP, 2010, NAT STRAT MAL CO PRE; MNREPCD, 2016, LAO PEOPL DEM REP NA; O'Reilly AO, 2006, BIOCHEM J, V396, P255, DOI 10.1042/BJ20051925; Overgaard HJ, 2006, MALARIA MOSQUITO RES; Perera MDB, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-168; Pongvongsa T, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-262; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Rattanarithikul Rampa, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P1; Rongnoparut P, 2003, J VECTOR ECOL, V28, P150; Syafruddin D, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-315; Tran T., 2013, PERSISTENT ORGANIC P, P157; Van Bortel W, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-102; Verhaeghen K, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-59; Verhaeghen K, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-84; Walton C, 1999, MED VET ENTOMOL, V13, P24, DOI 10.1046/j.1365-2915.1999.00142.x; Walton C, 2007, INFECT GENET EVOL, V7, P93, DOI 10.1016/j.meegid.2006.05.001; WHO, 2012, GLOB PLAN INS RES MA; WHO, 2016, 2016 WHO; WHO, 2014, WHO GUID COUNT COMB; Wood OR, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-67; World Health Organization, 2016, TEST PROC INREMO, V2nd, DOI DOI 10.1007/978-3-642-10565-4; World Health Organization, 2016, WHO MAL TERM; World Health Organization, 2015, WORLD MALARIA REPORT; Yang C, 2016, CHINA MALAR J, P15	38	13	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0175984	10.1371/journal.pone.0175984	http://dx.doi.org/10.1371/journal.pone.0175984			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437449	Green Published, Green Submitted, gold			2022-12-26	WOS:000400287600026
J	Warfield, BM; Anderson, PC				Warfield, Becka M.; Anderson, Peter C.			Molecular simulations and Markov state modeling reveal the structural diversity and dynamics of a theophylline-binding RNA aptamer in its unbound state	PLOS ONE			English	Article							PROTEIN RECOGNITION; SOFTWARE PACKAGE; FOLDING KINETICS; SINGLE-MOLECULE; INDUCED FIT; IN-VITRO; SELECTION; DISCRIMINATION; IMPLEMENTATION; VISUALIZATION	RNA aptamers are oligonucleotides that bind with high specificity and affinity to target ligands. In the absence of bound ligand, secondary structures of RNA aptamers are generally stable, but single-stranded and loop regions, including ligand binding sites, lack defined structures and exist as ensembles of conformations. For example, the well-characterized theophylline-binding aptamer forms a highly stable binding site when bound to theophylline, but the binding site is unstable and disordered when theophylline is absent. Experimental methods have not revealed at atomic resolution the conformations that the theophylline aptamer explores in its unbound state. Consequently, in the present study we applied 21 microseconds of molecular dynamics simulations to structurally characterize the ensemble of conformations that the aptamer adopts in the absence of theophylline. Moreover, we apply Markov state modeling to predict the kinetics of transitions between unbound conformational states. Our simulation results agree with experimental observations that the theophylline binding site is found in many distinct binding-incompetent states and show that these states lack a binding pocket that can accommodate theophylline. The binding-incompetent states interconvert with binding-competent states through structural rearrangement of the binding site on the nanosecond to microsecond timescale. Moreover, we have simulated the complete theophylline binding pathway. Our binding simulations supplement prior experimental observations of slow theophylline binding kinetics by showing that the binding site must undergo a large conformational rearrangement after the aptamer and theophylline form an initial complex, most notably, a major rearrangement of the C27 base from a buried to solvent-exposed orientation. Theophylline appears to bind by a combination of conformational selection and induced fit mechanisms. Finally, our modeling indicates that when Mg2+ ions are present the population of binding-competent aptamer states increases more than twofold. This population change, rather than direct interactions between Mg2+ and theophylline, accounts for altered theophylline binding kinetics.	[Warfield, Becka M.; Anderson, Peter C.] Univ Washington, Dept Phys Sci, Bothell, WA 98011 USA	University of Washington; University of Washington Bothell	Anderson, PC (corresponding author), Univ Washington, Dept Phys Sci, Bothell, WA 98011 USA.	pca4@uw.edu						Al-Hashimi HM, 2008, CURR OPIN STRUC BIOL, V18, P321, DOI 10.1016/j.sbi.2008.04.004; Antczak M, 2014, NUCLEIC ACIDS RES, V42, pW368, DOI 10.1093/nar/gku330; Barducci A, 2011, WIRES COMPUT MOL SCI, V1, P826, DOI 10.1002/wcms.31; Barducci A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.020603; Bastian AA, 2012, NAT CHEM, V4, P789, DOI [10.1038/NCHEM.1402, 10.1038/nchem.1402]; Beauchamp KA, 2011, J CHEM THEORY COMPUT, V7, P3412, DOI 10.1021/ct200463m; Beauchamp KA, 2012, P NATL ACAD SCI USA, V109, P17807, DOI 10.1073/pnas.1201810109; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Bowman GR, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4755751; Bowman GR, 2009, METHODS, V49, P197, DOI 10.1016/j.ymeth.2009.04.013; Bowman GR, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3216567; Brion P, 1997, ANNU REV BIOPH BIOM, V26, P113, DOI 10.1146/annurev.biophys.26.1.113; Burnett JC, 2012, CHEM BIOL, V19, P60, DOI 10.1016/j.chembiol.2011.12.008; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chen SJ, 2000, P NATL ACAD SCI USA, V97, P646, DOI 10.1073/pnas.97.2.646; Chodera JD, 2014, CURR OPIN STRUC BIOL, V25, P135, DOI 10.1016/j.sbi.2014.04.002; Cordero P, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004473; Creighton T. E., 1993, PROTEINS STRUCTURES; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DASILVA AWS, 2012, BMC RES NOTES, V5, DOI DOI 10.1186/1756-0500-5-367; Dill KA, 1999, PROTEIN SCI, V8, P1166, DOI 10.1110/ps.8.6.1166; Ding YL, 2014, NATURE, V505, P696, DOI 10.1038/nature12756; Draper DE, 1996, TRENDS BIOCHEM SCI, V21, P145; ELLINGTON AD, 1994, CURR BIOL, V4, P427, DOI 10.1016/S0960-9822(00)00093-2; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Famulok M, 2000, ACCOUNTS CHEM RES, V33, P591, DOI 10.1021/ar960167q; Famulok M, 1999, CURR OPIN STRUC BIOL, V9, P324, DOI 10.1016/S0959-440X(99)80043-8; Famulok M, 2011, ACCOUNTS CHEM RES, V44, P1349, DOI 10.1021/ar2000293; Fang XH, 2010, ACCOUNTS CHEM RES, V43, P48, DOI 10.1021/ar900101s; Frankel AD, 1998, CELL, V92, P149, DOI 10.1016/S0092-8674(00)80908-3; GRUBMULLER H, 1995, PHYS REV E, V52, P2893, DOI 10.1103/PhysRevE.52.2893; Han K, 2010, SENSORS-BASEL, V10, P4541, DOI 10.3390/s100504541; Hermann T, 2000, SCIENCE, V287, P820, DOI 10.1126/science.287.5454.820; Hermann T, 2000, STRUCTURE, V8, pR47, DOI 10.1016/S0969-2126(00)00110-6; HERSCHLAG D, 1995, J BIOL CHEM, V270, P20871, DOI 10.1074/jbc.270.36.20871; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Hoogstraten CG, 2000, BIOCHEMISTRY-US, V39, P9951, DOI 10.1021/bi0007627; Hornak V, 2006, P NATL ACAD SCI USA, V103, P915, DOI 10.1073/pnas.0508452103; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huang XH, 2010, BIOCOMPUT-PAC SYM, P228; Hub JS, 2010, J CHEM THEORY COMPUT, V6, P3713, DOI 10.1021/ct100494z; JENISON RD, 1994, SCIENCE, V263, P1425, DOI 10.1126/science.7510417; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jucker FM, 2003, BIOCHEMISTRY-US, V42, P2560, DOI 10.1021/bi027103+; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Keller BG, 2014, J AM CHEM SOC, V136, P4534, DOI 10.1021/ja4098719; Latham MP, 2009, J AM CHEM SOC, V131, P5052, DOI 10.1021/ja900695m; Leulliot N, 2001, BIOCHEMISTRY-US, V40, P7947, DOI 10.1021/bi010680y; Lin PH, 2010, BIOTECHNOL J, V5, P1069, DOI 10.1002/biot.201000212; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mortimer SA, 2014, NAT REV GENET, V15, P469, DOI 10.1038/nrg3681; Noe F, 2008, CURR OPIN STRUC BIOL, V18, P154, DOI 10.1016/j.sbi.2008.01.008; Noe F, 2009, P NATL ACAD SCI USA, V106, P19011, DOI 10.1073/pnas.0905466106; Noe F, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2916718; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Patriksson A, 2008, PHYS CHEM CHEM PHYS, V10, P2073, DOI 10.1039/b716554d; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prinz JH, 2011, PHYS CHEM CHEM PHYS, V13, P16912, DOI 10.1039/c1cp21258c; Prinz JH, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3565032; Radom F, 2013, BIOTECHNOL ADV, V31, P1260, DOI 10.1016/j.biotechadv.2013.04.007; Salvalaglio M, 2014, J CHEM THEORY COMPUT, V10, P1420, DOI 10.1021/ct500040r; Senne M, 2012, J CHEM THEORY COMPUT, V8, P2223, DOI 10.1021/ct300274u; Singhal N, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2116947; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Sundaram P, 2013, EUR J PHARM SCI, V48, P259, DOI 10.1016/j.ejps.2012.10.014; Swope WC, 2004, J PHYS CHEM B, V108, P6582, DOI 10.1021/jp037422q; Tinoco I, 1999, J MOL BIOL, V293, P271, DOI 10.1006/jmbi.1999.3001; Tiwary P, 2015, P NATL ACAD SCI USA, V112, pE386, DOI 10.1073/pnas.1424461112; Tiwary P, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.230602; Treiber DK, 1999, CURR OPIN STRUC BIOL, V9, P339, DOI 10.1016/S0959-440X(99)80045-1; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tucker BJ, 2005, CURR OPIN STRUC BIOL, V15, P342, DOI 10.1016/j.sbi.2005.05.003; UHLENBECK OC, 1995, RNA, V1, P4; Voelz VA, 2010, J AM CHEM SOC, V132, P1526, DOI 10.1021/ja9090353; Voter AF, 1997, PHYS REV LETT, V78, P3908, DOI 10.1103/PhysRevLett.78.3908; Walker RC, 2008, J COMPUT CHEM, V29, P1019, DOI 10.1002/jcc.20857; Wang SL, 1999, BIOCHEMISTRY-US, V38, P14363, DOI 10.1021/bi9913202; Wedekind JE, 1999, NAT STRUCT BIOL, V6, P261, DOI 10.1038/6700; Williamson JR, 2000, NAT STRUCT BIOL, V7, P834, DOI 10.1038/79575; Woodson SA, 2000, NAT STRUCT BIOL, V7, P349, DOI 10.1038/75106; Zheng WH, 2011, J PHYS CHEM B, V115, P1512, DOI 10.1021/jp1089596; Zhou JH, 2017, NAT REV DRUG DISCOV, V16, P181, DOI 10.1038/nrd.2016.199; Zhuang XW, 2000, SCIENCE, V288, P2048, DOI 10.1126/science.288.5473.2048; Zimmerman MI, 2015, J CHEM THEORY COMPUT, V11, P5747, DOI 10.1021/acs.jctc.5b00737; Zimmermann GR, 1997, NAT STRUCT BIOL, V4, P644, DOI 10.1038/nsb0897-644; Zimmermann GR, 1997, THESIS	91	22	22	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176229	10.1371/journal.pone.0176229	http://dx.doi.org/10.1371/journal.pone.0176229			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437473	Green Published, gold, Green Submitted			2022-12-26	WOS:000400287600037
J	Zhao, DY; Cao, XY; Huang, R; Zeng, J; Wu, QLL				Zhao, Dayong; Cao, Xinyi; Huang, Rui; Zeng, Jin; Wu, Qinglong L.			Variation of bacterial communities in water and sediments during the decomposition of Microcystis biomass	PLOS ONE			English	Article							LAKE TAIHU; CELLULOSE DEGRADATION; ENCLOSURE EXPERIMENT; SP NOV.; CLOSTRIDIUM; CHINA; DIVERSITY; BLOOMS; IDENTIFICATION; RELEASE	The bacterial community composition in water and sediment samples during the decomposition of Microcystis biomass were analyzed using the 454 pyrosequencing technique. We found dramatic shifts in the bacterial community composition of water and sediments after the addition of Microcystis biomass. Among all the detected phyla, only Firmicutes was found to be dominant in both water and sediment samples. The genus Clostridium sensu stricto was the absolutely dominant group in Firmicutes and showed drastic variations with incubation time during the decomposition process. Peak values in relative abundance of Clostridium sensu stricto appeared in the first few days for water and sediment samples. Environmental factors such as pH, dissolved oxygen (DO), and dissolved organic carbon (DOC) in water samples showed drastic variations during the decomposing process, which might be the prominent forces driving the variation of bacterial communities. The abundant genus, Clostridium sensu stricto, were thought to be well adapted to higher DOC and turbidity and lower pH and DO conditions. Compared with the sediment samples, the decomposition of Microcystis biomass had greater influence on the bacterial community composition in water and Clostridium sensu stricto might play important roles in the process of Microcystis biomass decomposition.	[Zhao, Dayong; Cao, Xinyi; Huang, Rui] Hohai Univ, Coll Hydrol & Water Resources, State Key Lab Hydrol Water Resources & Hydraul En, Nanjing, Jiangsu, Peoples R China; [Cao, Xinyi; Huang, Rui; Zeng, Jin; Wu, Qinglong L.] Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing, Jiangsu, Peoples R China	Hohai University; Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS	Zeng, J (corresponding author), Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing, Jiangsu, Peoples R China.	jzeng@niglas.ac.cn	Zeng, Jin/AAQ-7810-2020	Zeng, Jin/0000-0002-3298-4820	National Natural Science Foundation of China [41571108, U1202231]; Natural Science Foundation of Jiangsu Province, China [BK20151614]; National Key Technology RD Program [2015BAD13601]; Youth Innovation Promotion Association of Chinese Academy of Sciences [2013203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); National Key Technology RD Program(National Key Technology R&D Program); Youth Innovation Promotion Association of Chinese Academy of Sciences	JZ received funding from the National Natural Science Foundation of China (41571108) (http://www.nsfc.gov.cn/). JZ received funding from the Natural Science Foundation of Jiangsu Province, China (BK20151614) (http://www.jstd.gov.in/). QW received funding from the National Natural Science Foundation of China (U1202231) (http://www.nsfc.gov.cn/). QW received funding from the National Key Technology R&D Program (2015BAD13601) (http://www.most.gov.cn/). JZ received funding from the Youth Innovation Promotion Association of Chinese Academy of Sciences (2013203) (http://www.cas.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buchan A, 2014, NAT REV MICROBIOL, V12, P686, DOI 10.1038/nrmicro3326; Burrell PC, 2004, APPL ENVIRON MICROB, V70, P2414, DOI 10.1128/AEM.70.4.2414-2419.2004; Chen MJ, 2010, FEMS MICROBIOL ECOL, V74, P19, DOI 10.1111/j.1574-6941.2010.00923.x; Chen YW, 2003, J PLANKTON RES, V25, P445, DOI 10.1093/plankt/25.4.445; Das M, 2007, APPL ENVIRON MICROB, V73, P756, DOI 10.1128/AEM.01170-06; Dickinson C. H., 2012, BIOL PLANT LITTER DE; Dilly O, 2004, APPL ENVIRON MICROB, V70, P468, DOI 10.1128/AEM.70.1.468-474.2004; Eiler A, 2004, ENVIRON MICROBIOL, V6, P1228, DOI 10.1111/j.1462-2920.2004.00657.x; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Grossart HP, 2006, ENVIRON MICROBIOL, V8, P1074, DOI 10.1111/j.1462-2920.2006.00999.x; Guo L, 2007, SCIENCE, V317, P1166, DOI 10.1126/science.317.5842.1166; Gupta RS, 2009, INT J SYST EVOL MICR, V59, P285, DOI 10.1099/ijs.0.001792-0; Herring CD, 2016, APPL MICROBIOL BIOT, V100, P2907, DOI 10.1007/s00253-016-7294-1; Hill TCJ, 2003, FEMS MICROBIOL ECOL, V43, P1, DOI 10.1111/j.1574-6941.2003.tb01040.x; Jin X. C., 1990, SURVEY SPECIFICATION; Kato S, 2004, FEMS MICROBIOL ECOL, V51, P133, DOI 10.1016/j.femsec.2004.07.015; Landa M, 2016, ISME J, V10, P39, DOI 10.1038/ismej.2015.105; Leff JW, 2012, ECOSYSTEMS, V15, P284, DOI 10.1007/s10021-011-9510-2; Li HB, 2012, FEMS MICROBIOL ECOL, V79, P773, DOI 10.1111/j.1574-6941.2011.01262.x; Liu LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081232; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Parveen B, 2013, ENV MICROBIOL REP, V5, P716, DOI 10.1111/1758-2229.12071; Qin BQ, 2007, HYDROBIOLOGIA, V581, P3, DOI 10.1007/s10750-006-0521-5; Schoefer L, 2003, APPL ENVIRON MICROB, V69, P5849, DOI 10.1128/AEM.69.10.5849-5854.2003; Shao KQ, 2014, SCI TOTAL ENVIRON, V488, P236, DOI [10.1016/j.scitotenv2014.04.101, 10.1016/j.scitotenv.2014.04.101]; Shao KQ, 2013, J BASIC MICROB, V53, P549, DOI 10.1002/jobm.201100532; Shi XL, 2007, MAR FRESHWATER RES, V58, P634, DOI 10.1071/MF06212; Shiratori H, 2009, INT J SYST EVOL MICR, V59, P1764, DOI 10.1099/ijs.0.003483-0; Strickland MS, 2009, ECOLOGY, V90, P441, DOI 10.1890/08-0296.1; Wang SG, 2015, ENVIRON SCI POLLUT R, V22, P14269, DOI 10.1007/s11356-015-4652-y; Wu YF, 2014, INT J SYST EVOL MICR, V64, P3844, DOI 10.1099/ijs.0.064345-0; Xie LQ, 2003, ENVIRON POLLUT, V122, P391, DOI 10.1016/S0269-7491(02)00305-6; Xing P, 2011, ISME J, V5, P792, DOI 10.1038/ismej.2010.176; Zeng J, 2016, ENVIRON MICROBIOL, V18, P5175, DOI 10.1111/1462-2920.13526; Zeng J, 2012, APPL ENVIRON MICROB, V78, P177, DOI 10.1128/AEM.05117-11; Zhang ZY, 2016, J HAZARD MATER, V315, P126, DOI 10.1016/j.jhazmat.2016.05.011; Zhao DY, 2014, APPL MICROBIOL BIOT, V98, P9119, DOI 10.1007/s00253-014-5920-3; Zhou JZ, 2014, P NATL ACAD SCI USA, V111, pE836, DOI 10.1073/pnas.1324044111; Zhu MY, 2013, ENVIRON SCI POLLUT R, V20, P1803, DOI 10.1007/s11356-012-1084-9	39	28	29	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176397	10.1371/journal.pone.0176397	http://dx.doi.org/10.1371/journal.pone.0176397			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437480	Green Published, gold, Green Submitted			2022-12-26	WOS:000400287600047
J	Irfan, M; Alam, S; Manzoor, N; Abid, M				Irfan, Mohammad; Alam, Shadab; Manzoor, Nikhat; Abid, Mohammad			Effect of quinoline based 1,2,3-triazole and its structural analogues on growth and virulence attributes of Candida albicans	PLOS ONE			English	Article							MEMBRANE H+-ATPASE; IN-VITRO; ANTIFUNGAL AGENTS; DESIGN; PROTEINASES; DERIVATIVES; ACTIVATION; DIMORPHISM; GLUCOSE; HYBRIDS	Candida albicans, along with some other non-albicans Candida species, is a group of yeast, which causes serious infections in humans that can be both systemic and superficial. Despite the fact that extensive efforts have been put into the discovery of novel antifungal agents, the frequency of these fungal infections has increased drastically worldwide. In our quest for the discovery of novel antifungal compounds, we had previously synthesized and screened quinoline containing 1,2,3-triazole (3a) as a potent Candida spp inhibitor. In the present study, two structural analogues of 3a (3b and 3c) have been synthesized to determine the role of quinoline and their anti-Candida activities have been evaluated. Preliminary results helped us to determine 3a and 3b as lead inhibitors. The IC50 values of compound 3a for C. albicans ATCC 90028 (standard) and C. albicans (fluconazole resistant) strains were 0.044 and 2.3 mu g/ml, respectively while compound 3b gave 25.4 and 32.8 mu g/ml values for the same strains. Disk diffusion, growth and time kill curve assays showed significant inhibition of C. albicans in the presence of compounds 3a and 3b. Moreover, 3a showed fungicidal nature while 3b was fungistatic. Both the test compounds significantly lower the secretion of proteinases and phospholipases. While, 3a inhibited proteinase secretion in C. albicans (resistant strain) by 45%, 3b reduced phospholipase secretion by 68% in C. albicans ATCC90028 at their respective MIC values. Proton extrusion and intracellular pH measurement studies suggested that both compounds potentially inhibit the activity of H+ ATPase, a membrane protein that is crucial for various cell functions. Similarly, 95-97% reduction in ergosterol content was measured in the presence of the test compounds at MIC and MIC/2. The study led to identification of two quinoline based potent inhibitors of C. albicans for further structural optimization and pharmacological investigation.	[Irfan, Mohammad; Alam, Shadab; Abid, Mohammad] Jamia Millia Islamia, Dept Biosci, Med Chem Lab, New Delhi, India; [Irfan, Mohammad; Manzoor, Nikhat] Jamia Millia Islamia, Dept Biosci, Med Mycol Lab, New Delhi, India; [Manzoor, Nikhat] Taibah Univ, Coll Appl Med Sci, Al Madinah Al Munawarah, Saudi Arabia; [Abid, Mohammad] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68182 USA	Jamia Millia Islamia; Jamia Millia Islamia; Taibah University; University of Nebraska System; University of Nebraska Medical Center	Abid, M (corresponding author), Jamia Millia Islamia, Dept Biosci, Med Chem Lab, New Delhi, India.; Manzoor, N (corresponding author), Jamia Millia Islamia, Dept Biosci, Med Mycol Lab, New Delhi, India.; Manzoor, N (corresponding author), Taibah Univ, Coll Appl Med Sci, Al Madinah Al Munawarah, Saudi Arabia.; Abid, M (corresponding author), Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68182 USA.	nikhatmanzoor@yahoo.co.in; mabid@jmi.ac.in		Manzoor, Nikhat/0000-0002-6850-6142; ABID, MOHAMMAD/0000-0002-0507-8451	UGC, Govt. of India for RAMAN Postdoctoral Fellowship in USA [5-123/2016 (IC)]; UGC, India	UGC, Govt. of India for RAMAN Postdoctoral Fellowship in USA; UGC, India(University Grants Commission, India)	Mohammad Abid gratefully acknowledges UGC, Govt. of India for RAMAN Postdoctoral Fellowship in USA (F. No. 5-123/2016 (IC)). MI acknowledges Non-NET fellowship support from UGC, India.; Mohammad Abid gratefully acknowledges UGC, Govt. of India for RAMAN Postdoctoral Fellowship in USA (F. No. 5-123/2016 (IC)). MI acknowledges Non-NET fellowship support from UGC, India. The authors are thankful to Dr. Shabana I. Khan, Principal Scientist, National Center for Natural Products Research (NCNPR), School of Pharmacy, University of Mississippi, MS 38677, USA for doing cell-proliferation assay on Vero cells (monkey kidney fibroblasts). We are also thankful to Prof. Luqman A. Khan, JMI for providing the clinical strains of C. albicans and Ms. Babita Aneja for helping in spectral characterization.	Ahmad A, 2010, FITOTERAPIA, V81, P1157, DOI 10.1016/j.fitote.2010.07.020; Aneja B, 2016, ORG BIOMOL CHEM, V14, P10599, DOI [10.1039/C6OB01718E, 10.1039/c6ob01718e]; Arthington-Skaggs BA, 2000, ANTIMICROB AGENTS CH, V44, P2081, DOI 10.1128/AAC.44.8.2081-2085.2000; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Calderone Richard A., 2002, P15; Campetelli AN, 2005, FEBS J, V272, P5742, DOI 10.1111/j.1742-4658.2005.04959.x; Cao XF, 2014, J MED CHEM, V57, P3687, DOI 10.1021/jm4016284; de Montellano PRO, 2010, CHEM REV, V110, P932, DOI 10.1021/cr9002193; Di Santo R, 2005, J MED CHEM, V48, P5140, DOI 10.1021/jm048997u; Gacser A, 2007, INFECT IMMUN, V75, P4710, DOI 10.1128/IAI.00372-07; Groll Andreas H, 2012, Future Microbiol, V7, P179, DOI 10.2217/fmb.11.154; Irfan M, 2015, EUR J MED CHEM, V93, P246, DOI 10.1016/j.ejmech.2015.02.007; Jacobsen ID, 2012, EXPERT REV ANTI-INFE, V10, P85, DOI [10.1586/eri.11.152, 10.1586/ERI.11.152]; Kauffman CA, 2000, CLIN INFECT DIS, V30, P14, DOI 10.1086/313583; KAUR S, 1988, BIOCHIM BIOPHYS ACTA, V972, P277, DOI 10.1016/0167-4889(88)90202-9; Khan A, 2014, RES MICROBIOL, V165, P411, DOI 10.1016/j.resmic.2014.05.031; Kumar D. A., 2015, British Microbiology Research Journal, V5, P68; Maertens J, 2004, CLIN INFECT DIS, V39, P1563, DOI 10.1086/423381; Manohar S, 2012, ACS MED CHEM LETT, V3, P555, DOI 10.1021/ml3000808; Manzoor Nikhat, 2002, Indian Journal of Experimental Biology, V40, P785; Martins N, 2014, MYCOPATHOLOGIA, V177, P223, DOI 10.1007/s11046-014-9749-1; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Neelofar K, 2011, CAN J MICROBIOL, V57, P204, DOI 10.1139/W10-117; Perlin DS, 1997, ANN NY ACAD SCI, V834, P609, DOI 10.1111/j.1749-6632.1997.tb52330.x; PRICE MF, 1982, SABOURAUDIA, V20, P7; RUCHEL R, 1982, SABOURAUDIA, V20, P233; Schaller M, 1999, MOL MICROBIOL, V34, P169, DOI 10.1046/j.1365-2958.1999.01590.x; Schiaffella F, 2005, J MED CHEM, V48, P7658, DOI 10.1021/jm050685j; SERRANO R, 1983, FEBS LETT, V156, P11, DOI 10.1016/0014-5793(83)80237-3; SetoYoung D, 1997, BBA-BIOMEMBRANES, V1326, P249, DOI 10.1016/S0005-2736(97)00028-X; Sheng CQ, 2006, J MED CHEM, V49, P2512, DOI 10.1021/jm051211n; Theiss S, 2006, INT J MED MICROBIOL, V296, P405, DOI 10.1016/j.ijmm.2006.03.003; Tobudic S, 2012, MYCOSES, V55, P24, DOI 10.1111/j.1439-0507.2011.02146.x; Wachtler B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036952; Wang SZ, 2014, ACS MED CHEM LETT, V5, P506, DOI 10.1021/ml400492t; Wayne, 2002, PERFORMANCE STANDARD, V12, P1; Yao B, 2007, J MED CHEM, V50, P5293, DOI 10.1021/jm0701167	37	32	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0175710	10.1371/journal.pone.0175710	http://dx.doi.org/10.1371/journal.pone.0175710			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430797	gold, Green Submitted, Green Published			2022-12-26	WOS:000399876100016
J	Karml, SH; Holt, SH; Song, LH; Tamir, S; Luo, YT; Bai, F; Adenwalla, A; Darash-Yahana, M; Sohn, YS; Jennings, PA; Azad, RK; Onuchic, JN; Morcos, F; Nechushtail, R; Mittler, R				Karml, Sarah H.; Holt, Sarah H.; Song, Luhua; Tamir, Sagi; Luo, Yuting; Bai, Fang; Adenwalla, Ammar; Darash-Yahana, Merav; Sohn, Yang-Sung; Jennings, Patricia A.; Azad, Rajeev K.; Onuchic, Jose' N.; Morcos, Faruck; Nechushtail, Rachel; Mittler, Ron			Interactions between mitoNEET and NAF-1 in cells	PLOS ONE			English	Article							MITOCHONDRIAL-MEMBRANE PROTEIN; FE-S CLUSTER; DRUG TARGET MITONEET; BREAST-CANCER; 2FE-2S CLUSTER; SIGNALING PATHWAY; WOLFRAM-SYNDROME; NEET PROTEINS; TUMOR-GROWTH; IRON	The NEET proteins mitoNEET (mNT) and nutrient-deprivation autophagy factor-1 (NAF-1) are required for cancer cell proliferation and resistance to oxidative stress. NAF-1 and mNT are also implicated in a number of other human pathologies including diabetes, neurodegeneration and cardiovascular disease, as well as in development, differentiation and aging. Previous studies suggested that mNT and NAF-1 could function in the same pathway in mammalian cells, preventing the over-accumulation of iron and reactive oxygen species (ROS) in mitochondria. Nevertheless, it is unknown whether these two proteins directly interact in cells, and how they mediate their function. Here we demonstrate, using yeast two-hybrid, in vivo bimolecular fluorescence complementation (BiFC), direct coupling analysis (DCA), RNA-sequencing, ROS and iron imaging, and single and double shRNA lines with suppressed mNT, NAF-1 and mNT/NAF-1 expression, that mNT and NAF-1 directly interact in mammalian cells and could function in the same cellular pathway. We further show using an in vitro cluster transfer assay that mNT can transfer its clusters to NAF-1. Our study highlights the possibility that mNT and NAF-1 function as part of an iron-sulfur (2Fe-2S) cluster relay to maintain the levels of iron and Fe-S clusters under control in the mitochondria of mammalian cells, thereby preventing the activation of apoptosis and/or autophagy and supporting cellular proliferation.	[Karml, Sarah H.; Tamir, Sagi; Darash-Yahana, Merav; Sohn, Yang-Sung; Nechushtail, Rachel] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Edmond J Safra Campus Givat Ram, Jerusalem, Israel; [Holt, Sarah H.; Song, Luhua; Luo, Yuting; Azad, Rajeev K.; Mittler, Ron] Univ North Texas, Dept Biol Sci, Denton, TX 76203 USA; [Holt, Sarah H.; Song, Luhua; Luo, Yuting; Azad, Rajeev K.; Mittler, Ron] Univ North Texas, BioDiscovery Inst, Denton, TX 76203 USA; [Bai, Fang; Onuchic, Jose' N.] Rice Univ, Ctr Theoret Biol Phys, Houston, TX USA; [Bai, Fang; Onuchic, Jose' N.] Rice Univ, Dept Phys & Astron, Houston, TX USA; [Bai, Fang; Onuchic, Jose' N.] Rice Univ, Dept Chem, Houston, TX USA; [Bai, Fang; Onuchic, Jose' N.] Rice Univ, Dept Biosci, Houston, TX USA; [Adenwalla, Ammar; Morcos, Faruck] Univ Texas Dallas, Dept Biol Sci, Richardson, TX 75083 USA; [Adenwalla, Ammar; Morcos, Faruck] Univ Texas Dallas, Dept Bioengn, Richardson, TX 75083 USA; [Jennings, Patricia A.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Azad, Rajeev K.] Univ North Texas, Dept Math, Denton, TX 76203 USA; [Nechushtail, Rachel] Hebrew Univ Jerusalem, Wolfson Inst Appl Struct Biol, Edmond J Safra Campus Givat Ram, Jerusalem, Israel	Hebrew University of Jerusalem; University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton; Rice University; Rice University; Rice University; Rice University; University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Dallas; University of California System; University of California San Diego; University of North Texas System; University of North Texas Denton; Hebrew University of Jerusalem	Nechushtail, R (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Edmond J Safra Campus Givat Ram, Jerusalem, Israel.; Mittler, R (corresponding author), Univ North Texas, Dept Biol Sci, Denton, TX 76203 USA.; Mittler, R (corresponding author), Univ North Texas, BioDiscovery Inst, Denton, TX 76203 USA.; Nechushtail, R (corresponding author), Hebrew Univ Jerusalem, Wolfson Inst Appl Struct Biol, Edmond J Safra Campus Givat Ram, Jerusalem, Israel.	rachel@mail.huji.ac.il; ron.mittler@unt.edu	Mittler, Ron/ABE-6496-2020	Morcos, Faruck/0000-0001-6208-1561; Adenwalla, Ammar/0000-0001-9447-1441	Israel Science Foundation [ISF-865/13]; National Science Foundation [IOS-1353886, IOS-0639964, IOS-0743954, IOS-1557787, MCB-1613462]; National Institutes of Health [DK54441]; Center for Theoretical Biological Physics - National Science Foundation [PHY-1427654, NSF-MCB-1214457]; Cancer and Prevention Institute of Texas (CPRIT) [R1110]; University of North Texas, College of Arts and Sciences; Direct For Biological Sciences [1214457] Funding Source: National Science Foundation; Direct For Mathematical & Physical Scien [1427654] Funding Source: National Science Foundation; Div Of Molecular and Cellular Bioscience [1613462] Funding Source: National Science Foundation	Israel Science Foundation(Israel Science Foundation); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Theoretical Biological Physics - National Science Foundation(National Science Foundation (NSF)); Cancer and Prevention Institute of Texas (CPRIT); University of North Texas, College of Arts and Sciences; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by funding from the Israel Science Foundation (ISF-865/13) awarded to RN, funding from the National Science Foundation (IOS-1353886, IOS-0639964, IOS-0743954, IOS-1557787, MCB-1613462), and the University of North Texas, College of Arts and Sciences, awarded to RM,and funding from the National Institutes of Health DK54441 awarded to PAJ. JNO is supported by the Center for Theoretical Biological Physics sponsored by the National Science Foundation (grants PHY-1427654 and NSF-MCB-1214457) and by the Cancer and Prevention Institute of Texas (CPRIT - grant R1110).The funders had no role in the design, data collection, analysis, decision to publish, or preparation of the manuscript.	Acheson JF, 2015, BIOCHEMISTRY-US, V54, P5980, DOI 10.1021/acs.biochem.5b00692; Amr S, 2007, AM J HUM GENET, V81, P673, DOI 10.1086/520961; Bai F, 2015, P NATL ACAD SCI USA, V112, P3698, DOI 10.1073/pnas.1502960112; Banci L, 2014, P NATL ACAD SCI USA, V111, P6203, DOI 10.1073/pnas.1400102111; Beilschmidt LK, 2014, BIOCHIMIE, V100, P48, DOI 10.1016/j.biochi.2014.01.009; Benson SK, 2016, INORG CHEM COMMUN, V63, P86, DOI 10.1016/j.inoche.2015.11.022; Beranger F, 1997, NUCLEIC ACIDS RES, V25, P2035, DOI 10.1093/nar/25.10.2035; Bystrom LM, 2015, FREE RADICAL BIO MED, V79, P337, DOI 10.1016/j.freeradbiomed.2014.04.035; Bystrom LM, 2014, ANTIOXID REDOX SIGN, V20, P1917, DOI 10.1089/ars.2012.5014; Cabantchik ZI, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00045; Chang NC, 2010, EMBO J, V29, P606, DOI 10.1038/emboj.2009.369; Chen B, 2015, INT J CLIN EXP PATHO, V8, P13725; Chen YF, 2009, GENE DEV, V23, P1183, DOI 10.1101/gad.1779509; Colca JR, 2004, AM J PHYSIOL-ENDOC M, V286, pE252, DOI 10.1152/ajpendo.00424.2003; Conlan AR, 2009, J MOL BIOL, V392, P143, DOI 10.1016/j.jmb.2009.06.079; Danielpur L, 2016, J CLIN ENDOCR METAB, V101, P3592, DOI 10.1210/jc.2016-2240; Darash-Yahana M, 2016, P NATL ACAD SCI USA, V113, P10890, DOI 10.1073/pnas.1612736113; dos Santos RN, 2015, SCI REP-UK, V5, DOI 10.1038/srep13652; Du XH, 2015, CELL BIOL INT, V39, P816, DOI 10.1002/cbin.10453; Ferecatu I, 2014, J BIOL CHEM, V289, P28070, DOI 10.1074/jbc.M114.548438; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Habener A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156054; Holt SH, 2016, J CELL SCI, V129, P155, DOI 10.1242/jcs.178293; Kim JY, 2016, J BIOCHEM, V160, P101, DOI 10.1093/jb/mvw016; Landry AP, 2015, FREE RADICAL BIO MED, V81, P119, DOI 10.1016/j.freeradbiomed.2015.01.017; Lipper CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139699; Lu SM, 2014, P NATL ACAD SCI USA, V111, pE5292, DOI 10.1073/pnas.1421055111; Maio N, 2015, BBA-MOL CELL RES, V1853, P1493, DOI 10.1016/j.bbamcr.2014.09.009; Morcos F, 2013, P NATL ACAD SCI USA, V110, P20533, DOI 10.1073/pnas.1315625110; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Nechushtai R, 2012, PLANT CELL, V24, P2139, DOI 10.1105/tpc.112.097634; Noel JK, 2010, NUCLEIC ACIDS RES, V38, pW657, DOI 10.1093/nar/gkq498; Paddock ML, 2007, P NATL ACAD SCI USA, V104, P14342, DOI 10.1073/pnas.0707189104; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Roberts ME, 2013, BIOCHEMISTRY-US, V52, P8969, DOI 10.1021/bi401038w; Salem AF, 2012, CELL CYCLE, V11, P4174, DOI 10.4161/cc.22376; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; Sohn YS, 2013, P NATL ACAD SCI USA, V110, P14676, DOI 10.1073/pnas.1313198110; Sulkowska JI, 2012, P NATL ACAD SCI USA, V109, P10340, DOI 10.1073/pnas.1207864109; Tamir S, 2015, BBA-MOL CELL RES, V1853, P1294, DOI 10.1016/j.bbamcr.2014.10.014; Tamir S, 2014, ACTA CRYSTALLOGR D, V70, P1572, DOI 10.1107/S1399004714005458; Tamir S, 2014, P NATL ACAD SCI USA, V111, P5177, DOI 10.1073/pnas.1403770111; Tamir S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061202; Tan GQ, 2016, BIOCHEM BIOPH RES CO, V470, P226, DOI 10.1016/j.bbrc.2016.01.040; Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495; VOJTEK AB, 1995, METHOD ENZYMOL, V255, P331; Wang L, 2016, ONCOTARGET, V7, P3791, DOI 10.18632/oncotarget.6302; Wiley SE, 2007, J BIOL CHEM, V282, P23745, DOI 10.1074/jbc.C700107200; Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104; Wojcik J, 2002, J MOL BIOL, V323, P763, DOI 10.1016/S0022-2836(02)01009-4; Yang L, 2016, ONCOTARGET, V7, P22720, DOI 10.18632/oncotarget.8150; Yuan H, 2016, BIOCHEM BIOPH RES CO, V478, P838, DOI 10.1016/j.bbrc.2016.08.034; Zhang J, 2011, STRUCTURE, V19, P1784, DOI 10.1016/j.str.2011.09.022; Zuris JA, 2011, P NATL ACAD SCI USA, V108, P13047, DOI 10.1073/pnas.1109986108	56	16	16	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175796	10.1371/journal.pone.0175796	http://dx.doi.org/10.1371/journal.pone.0175796			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426722	Green Published, Green Submitted, gold			2022-12-26	WOS:000399875900048
J	Kastien-Hilka, T; Rosenkranz, B; Sinanovic, E; Bennett, B; Schwenkglenks, M				Kastien-Hilka, Tanja; Rosenkranz, Bernd; Sinanovic, Edina; Bennett, Bryan; Schwenkglenks, Matthias			Health-related quality of life in South African patients with pulmonary tuberculosis	PLOS ONE			English	Article							IMPORTANT DIFFERENCE; DEPRESSION; IMPACT; QUESTIONNAIRE; ANXIETY; FEASIBILITY; RELIABILITY; LATENT; ADULTS; TB	Background The evaluation of patient-reported health-related quality of life (HRQOL) in pulmonary tuberculosis (TB) contributes to a comprehensive understanding of the burden associated with this disease. The aim of this study was to assess the overall impact of TB on the health status and on single health domains identified in the WHO definition of health, including physical, mental and social health aspects. Methods Four instruments for HRQOL evaluation were applied in a longitudinal multicentre study during six-month standard TB treatment in South Africa. These included the generic SF-12 and EQ-5D-5L, the disease-specific St. George's Respiratory Questionnaire (SGRQ) and the condition-specific Hospital Anxiety and Depression Scale (HADS). Statistical analysis included significance testing, univariable and multivariable analysis, and repeated measures ANOVA. Change over time in the physical component score (PCS) of SF-12 was defined as primary endpoint. A target sample size of 96 patients was estimated. Results HRQOL of the study participants was impaired in all physical, mental and psycho-social health domains at treatment start. HRQOL improved significantly and in a clinically meaningful manner during the course of standard TB treatment, over the period of the study. The greatest improvement (95%) was observed in mental health. Younger patients with higher education and who were employed had a better HRQOL. Discussion This study demonstrates the need for an integrative understanding of TB with HRQOL as core element to inform gaps in current TB management. Improvements in the management of TB following an integrative patient-centred approach will contribute towards meeting the United Nations Sustainable Development Goal 3 (SDG3) target and will support the End TB strategy of the WHO.	[Kastien-Hilka, Tanja] Swiss Trop & Publ Hlth Inst Swiss TPH, Basel, Switzerland; [Kastien-Hilka, Tanja; Schwenkglenks, Matthias] Univ Basel, Basel, Switzerland; [Kastien-Hilka, Tanja; Sinanovic, Edina] Univ Cape Town, Hlth Econ Unit, Fac Hlth Sci, Cape Town, South Africa; [Rosenkranz, Bernd] Stellenbosch Univ, Div Clin Pharmacol, Fac Med & Hlth Sci, Cape Town, South Africa; [Rosenkranz, Bernd] Fundisa African Acad Med Dev, Cape Town, South Africa; [Bennett, Bryan] Adelphi Values, Patient Ctr Outcomes, Bollington, England; [Schwenkglenks, Matthias] Univ Basel, Inst Pharmaceut Med, Basel, Switzerland; [Schwenkglenks, Matthias] Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Cape Town; Stellenbosch University; Adelphi Group Ltd; University of Basel; University of Zurich	Schwenkglenks, M (corresponding author), Univ Basel, Basel, Switzerland.; Schwenkglenks, M (corresponding author), Univ Basel, Inst Pharmaceut Med, Basel, Switzerland.; Schwenkglenks, M (corresponding author), Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland.	m.schwenkglenks@unibas.ch	Sinanovic, Edina/AAR-2590-2020	Schwenkglenks, Matthias/0000-0001-7217-1173	University of Cape Town (Cape Town/SouthAfrica); Swiss Tropical and Public Health Institute (Basel, Switzerland)	University of Cape Town (Cape Town/SouthAfrica); Swiss Tropical and Public Health Institute (Basel, Switzerland)	Expenses to conduct the field work were borne by Swiss Tropical and Public Health Institute, the employment institution of the first author. No funding from a third party was received. This study was part of a Ph D research project and was also supported through the University of Cape Town (Cape Town/SouthAfrica).; This study is part of the Swiss South African bilateral cooperation and was mainly financed by the Swiss Tropical and Public Health Institute (Basel, Switzerland) and supported by the University of Cape Town (Cape Town, South Africa).	Aamir S, 2010, JCPSP-J COLL PHYSICI, V20, P703, DOI 10.2010/JCPSP.703704; Adeyeye OO, 2014, J PUBLIC HEALTH AFR, V5, P88, DOI [10.4081/jbhia.2014.366, 10.4081/jphia.2014.366]; Aggarwal AN, 2013, INT J TUBERC LUNG D, V17, P947, DOI 10.5588/ijtld.12.0299; Aggarwal AN, 2010, LUNG INDIA, V27, P1, DOI 10.4103/0970-2113.59259; Atif M, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-19; Awaisu A, 2012, TOB INDUC DIS, V10, DOI 10.1186/1617-9625-10-2; Babikako HM, 2010, HEALTH QUAL LIFE OUT, V8, P1, DOI 10.1186/1477-7525-8-93; Balgude Abhishek, 2012, Indian J Med Sci, V66, P71; Bauer M, 2013, QUAL LIFE RES, V22, P2213, DOI 10.1007/s11136-012-0329-x; Bauer M, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0250-4; Chamla D, 2004, INT J TUBERC LUNG D, V8, P1100; Chang B, 2004, QUAL LIFE RES, V13, P1633, DOI 10.1007/s11136-004-0374-1; Chung WS, 2013, INT J TUBERC LUNG D, V17, P425, DOI 10.5588/ijtld.12.0701; Chung WS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-630; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cremers AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119861; Deribew A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-408; Dhuria M, 2009, ASIA-PAC J PUBLIC HE, V21, P312, DOI 10.1177/1010539509336242; Dion MJ, 2004, QUAL LIFE RES, V13, P653, DOI 10.1023/B:QURE.0000021320.89524.64; Doward LC, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-89; Duko B, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0598-3; El Achhab Y, 2008, DIABETES RES CLIN PR, V80, P171, DOI 10.1016/j.diabres.2007.12.020; Forde Y., 2009, ST GEORGES RESP QUES; Guo N, 2008, VALUE HEALTH, V11, P1154, DOI 10.1111/j.1524-4733.2008.00355.x; Guo N, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-6; Guo N, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-14; Hansel NN, 2004, QUAL LIFE RES, V13, P639, DOI 10.1023/B:QURE.0000021317.12945.f0; Husain Mohammed O, 2008, Clin Pract Epidemiol Ment Health, V4, P4, DOI 10.1186/1745-0179-4-4; Issa Baba A, 2009, Ment Health Fam Med, V6, P133; Jaber AAS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156258; Jelsma Jennifer, 2003, Popul Health Metr, V1, P11, DOI 10.1186/1478-7954-1-11; Jones Paul W, 2005, COPD, V2, P75; Kakhki AD, 2015, TUBERC RESPIR DIS, V78, P309, DOI 10.4046/trd.2015.78.4.309; Kastien-Hilka T, 2016, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2016.00125; Kastien-Hilka T, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0442-6; Kittikraisak W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029775; Kruijshaar ME, 2010, INT J TUBERC LUNG D, V14, P296; Dias AAL, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-595; Louw Julia, 2012, Health Qual Life Outcomes, V10, P77, DOI 10.1186/1477-7525-10-77; Louw JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151892; Maguire GP, 2009, INT J TUBERC LUNG D, V13, P1500; Marra CA, 2008, CHEST, V133, P396, DOI 10.1378/chest.07-1494; Marra Carlo A, 2004, Health Qual Life Outcomes, V2, P58, DOI 10.1186/1477-7525-2-58; Maruish ME, 2009, GUIDE DEV CERTIFIED; Masumoto S, 2014, QUAL LIFE RES, V23, P1523, DOI 10.1007/s11136-013-0571-x; Naidoo P, 2010, SOC BEHAV PERSONAL, V38, P1323, DOI 10.2224/sbp.2010.38.10.1323; Othman GQ, 2011, AFR J PHARM PHARMACO, V5, P547; Ottermann B., PREVALENCE DIABETES; Pasipanodya JG, 2007, CHEST, V132, P1591, DOI 10.1378/chest.07-0755; Peltzer K, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-89; Puhan MA, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-46; Ralph AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080302; Snaith RP., 1994, HOSP ANXIETY DEPRESS; Van Rie A, 2008, TROP MED INT HEALTH, V13, P21, DOI 10.1111/j.1365-3156.2007.01971.x; Walters SJ, 2005, QUAL LIFE RES, V14, P1523, DOI 10.1007/s11136-004-7713-0; Walters Stephen J, 2004, Health Qual Life Outcomes, V2, P26, DOI 10.1186/1477-7525-2-26; Westaway M S, 2001, Curationis, V24, P74; WESTAWAY MS, 1992, SOC SCI MED, V35, P1311, DOI 10.1016/0277-9536(92)90184-R; *WHO, 2015, THE END TB STRAT; World Health Organization, 2015, GLOB TUB REP 2015; World Health Organization (WHO), 2015, HTLH 2015 MDGS MILL; World Health Organization (WHO), 2015, MDGS SDGS WHO LAUNCH	62	26	26	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0174605	10.1371/journal.pone.0174605	http://dx.doi.org/10.1371/journal.pone.0174605			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KM	28426759	Green Published, gold			2022-12-26	WOS:000399875900010
J	Maia, CM; Volpato, GL				Maia, Caroline Marques; Volpato, Gilson Luiz			Preference index supported by motivation tests in Nile tilapia	PLOS ONE			English	Article							ENVIRONMENTAL COLOR; STRESS-RESPONSE; LIGHT SPECTRUM; GROWTH; FISH	The identification of animal preferences is assumed to provide better rearing environments for the animals in question. Preference tests focus on the frequency of approaches or the time an animal spends in proximity to each item of the investigated resource during a multiple- choice trial. Recently, a preference index (PI) was proposed to differentiate animal preferences from momentary responses (Sci Rep, 2016, 6: 28328, DOI: 10.1038/srep28328). This index also quantifies the degree of preference for each item. Each choice response is also weighted, with the most recent responses weighted more heavily, but the index includes the entire bank of tests, and thus represents a history-based approach. In this study, we compared this PI to motivation tests, which consider how much effort is expended to access a resource. We performed choice tests over 7 consecutive days for 34 Nile tilapia fish that presented with different colored compartments in each test. We first detected the preferred and non-preferred colors of each fish using the PI and then tested their motivation to reach these compartments. We found that fish preferences varied individually, but the results were consistent with the motivation profiles, as individual fish were more motivated (the number of touches made on transparent, hinged doors that prevented access to the resource) to access their preferred items. On average, most of the 34 fish avoided the color yellow and showed less motivation to reach yellow and red colors. The fish also exhibited greater motivation to access blue and green colors (the most preferred colors). These results corroborate the PI as a reliable tool for the identification of animal preferences. We recommend this index to animal keepers and researchers to identify an animal's preferred conditions.	[Maia, Caroline Marques; Volpato, Gilson Luiz] UNESP, IB, Lab Anim Physiol & Behav, Botucatu, SP, Brazil	Universidade Estadual Paulista	Maia, CM (corresponding author), UNESP, IB, Lab Anim Physiol & Behav, Botucatu, SP, Brazil.	carolmm_luzi@hotmail.com	Maia, Caroline Marques/H-7646-2016	Maia, Caroline Marques/0000-0002-5549-1017	Fundacao de Amparo Pesquisa do Estado de Sao Paulo (FAPESP) [2012/06104-0]; FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2012/06104-0]	Fundacao de Amparo Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Fundacao de Amparo Pesquisa do Estado de Sao Paulo (FAPESP) through grant 2012/06104-0 to CMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Jose Maia Filho for his assistance with the construction of the experimental apparatus, Patricia Tatemoto for assistance with data collection and Elisabeth Aparecida Marques Maia for assistance with extracting behavioral data from the video records. We also thank Dr. Victoria Anne Braithwaite for suggestions on the editing the English language in a first version of the manuscript. This project was founded by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; process # 2012/06104-0).	Asher L, 2009, APPL ANIM BEHAV SCI, V118, P152, DOI 10.1016/j.applanim.2009.02.029; Browne WJ, 2010, BEHAV PROCESS, V83, P72, DOI 10.1016/j.beproc.2009.10.004; Dawkins MS, 2006, APPL ANIM BEHAV SCI, V100, P4, DOI 10.1016/j.applanim.2006.04.010; Duncan IJH, 2006, APPL ANIM BEHAV SCI, V100, P11, DOI 10.1016/j.applanim.2006.04.011; Forstmeier W, 2004, ANIM BEHAV, V68, P1017, DOI 10.1016/j.anbehav.2004.02.007; Freitas RHA, 2013, J APPL ICHTHYOL, V29, P239, DOI 10.1111/jai.12026; Freitas RHA, 2014, ZOOLOGY, V117, P179, DOI 10.1016/j.zool.2013.09.005; Galhardo L, 2011, APPL ANIM BEHAV SCI, V130, P60, DOI 10.1016/j.applanim.2010.12.008; Barcellos LJG, 2009, AQUACULTURE, V288, P51, DOI 10.1016/j.aquaculture.2008.11.002; Girguis PR, 2006, SCIENCE, V312, P231, DOI 10.1126/science.1125286; GODIN JGJ, 1995, ANIM BEHAV, V49, P1427, DOI 10.1016/0003-3472(95)90063-2; GOODMAN LA, 1964, ANN MATH STAT, V35, P716, DOI 10.1214/aoms/1177703569; Graber RE, 2015, ETHOLOGY, V121, P17, DOI 10.1111/eth.12313; Head AB, 2000, J WORLD AQUACULT SOC, V31, P73, DOI 10.1111/j.1749-7345.2000.tb00700.x; Houpt KA, 2012, ANIM WELFARE, V21, P1; Johnsson JI, 2000, BEHAV ECOL SOCIOBIOL, V48, P373, DOI 10.1007/s002650000244; Karakatsouli N, 2008, AQUACULT ENG, V38, P36, DOI 10.1016/j.aquaeng.2007.10.006; Karakatsouli N, 2010, AQUACULT ENG, V42, P121, DOI 10.1016/j.aquaeng.2010.01.001; Liste G, 2014, ETHOLOGY, V120, P1199, DOI 10.1111/eth.12294; Luchiari AC, 2009, J APPL ICHTHYOL, V25, P162, DOI 10.1111/j.1439-0426.2008.01203.x; Luchiari AC, 2007, J ETHOL, V25, P169, DOI 10.1007/s10164-006-0013-0; Maia CM, 2016, SCI REP-UK, V6, DOI 10.1038/srep28328; Maia CM, 2013, ZOOLOGY, V116, P64, DOI 10.1016/j.zool.2012.08.001; Mason GJ, 2001, NATURE, V410, P35, DOI 10.1038/35065157; MATTHEWS LR, 1994, ANIM BEHAV, V47, P713, DOI 10.1006/anbe.1994.1096; Mendonca FZ, 2010, J FISH BIOL, V77, P1439, DOI 10.1111/j.1095-8649.2010.02754.x; O'Rourke CF, 2010, BEHAV PROCESS, V85, P157, DOI 10.1016/j.beproc.2010.07.005; Ruchin AB, 2004, FISH PHYSIOL BIOCHEM, V30, P175, DOI 10.1007/s10695-005-1263-4; Sekiya Y, 2004, ZOOL SCI, V21, P859, DOI 10.2108/zsj.21.859; Sherwin CM, 2004, ANIM BEHAV, V67, P711, DOI 10.1016/j.anbehav.2003.08.018; Spady TC, 2006, MOL BIOL EVOL, V23, P1538, DOI 10.1093/molbev/msl014; Spence R, 2008, ETHOLOGY, V114, P582, DOI 10.1111/j.1439-0310.2008.01515.x; Suter HC, 2002, J FISH BIOL, V61, P606, DOI 10.1006/jfbi.2002.2084; Volpato GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059134; Volpato GL, 2009, ILAR J, V50, P329, DOI 10.1093/ilar.50.4.329; Volpato GL, 2007, DIS AQUAT ORGAN, V75, P165, DOI 10.3354/dao075165; Volpato Gilson Luiz, 2009, Oecologia Brasiliensis, V13, P5; Volpato GL, 2004, BRAZ J MED BIOL RES, V37, P479, DOI 10.1590/S0100-879X2004000400004; Volpato GL, 2001, BRAZ J MED BIOL RES, V34, P1041, DOI 10.1590/S0100-879X2001000800011	39	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175821	10.1371/journal.pone.0175821	http://dx.doi.org/10.1371/journal.pone.0175821			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KM	28426689	Green Published, gold, Green Submitted			2022-12-26	WOS:000399875900053
J	Antignani, A; Segal, D; Simon, N; Kreitman, RJ; Huang, D; FitzGerald, DJ				Antignani, A.; Segal, D.; Simon, N.; Kreitman, R. J.; Huang, D.; FitzGerald, D. J.			Essential role for Bim in mediating the apoptotic and antitumor activities of immunotoxins	ONCOGENE			English	Article							HAIRY-CELL LEUKEMIA; PSEUDOMONAS EXOTOXIN; CANCER CELLS; PROTEINS; CYTOSOL; TOXIN; DEATH; GUIDE; BAX	Protein synthesis is crucial for regulating cell homeostasis and, when unrestricted, it can lead to tumorigenesis. Immunotoxins derived from Pseudomonas exotoxin are antibody-toxin fusion proteins that inhibit protein synthesis of mammalian cells via ADP-ribosylation of the eukaryotic elongation factor-2. Here we investigate the role of the Bcl-2 family proteins in the response of cancer cells to immunotoxin challenge. Besides the well-known reduction of the prosurvival Bcl-2 family member, Mcl-1, following inhibition of protein synthesis, we show for the first time that immunotoxins also reduce the levels of selected proapoptotic BH-3-only proteins. Among these, only Bim protein levels correlated with the ability of immunotoxins to induce an apoptotic response. To support our findings, we verified that a Bim knockout completely abolished immunotoxin-mediated apoptosis. Further, mice bearing either wild-type or Bid knockout tumors responded to immunotoxin treatment with a decrease in growth kinetics, whereas mice engrafted with Bim knockout tumors showed no reduction in tumor size or prolongation of survival following immunotoxin treatment. From these results, we conclude that Bim expression is a major susceptibility factor for tumor cell death and, as such, constitutes a potential biomarker that could be evaluated before immunotoxin treatment. In support of this hypothesis, clinically, we analyzed patient cells before immunotoxin treatment and report that samples of hairy cell leukemia with high levels of Bim protein responded with a greater decrease in leukemic cell count compared with those samples expressing a low level of Bim.	[Antignani, A.; Simon, N.; Kreitman, R. J.; FitzGerald, D. J.] NCI, Lab Mol Biol, CCR, NIH, Bldg 37,Room 5124,37 Convent Dr, Bethesda, MD 20892 USA; [Segal, D.; Huang, D.] Walter & Eliza Hall Inst Med Res, Canc & Haematol Div, Melbourne, Vic, Australia; [Segal, D.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Melbourne	Antignani, A; FitzGerald, DJ (corresponding author), NCI, Lab Mol Biol, CCR, NIH, Bldg 37,Room 5124,37 Convent Dr, Bethesda, MD 20892 USA.	antignaa@mail.nih.gov; fitzgerd@helix.nih.gov	Huang, David C. S./C-7586-2013	Huang, David C. S./0000-0002-3101-4873	National Cancer Institute, NIH; Australian National Health and Medical Research Council [1057742, 1016701, 9000220]; Cancer Council Victoria; Leukemia and Lymphoma Society (Specialized Centers of Research) [7001-13]; Australian Cancer Research Foundation; Victorian State Government; NATIONAL CANCER INSTITUTE [ZIABC010301, ZIABC008757] Funding Source: NIH RePORTER	National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Leukemia and Lymphoma Society (Specialized Centers of Research)(Leukemia and Lymphoma Society); Australian Cancer Research Foundation; Victorian State Government; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank R Anderson and W Welch for the gift of reagents and Jianan Gong and Stephen Wilcox for assistance with sequence validation of CRISPR/Cas9 knockout cell lines. We thank E Arons for advice on the RT-PCR. This work was funded by the intramural programs of the National Cancer Institute, NIH and is supported by fellowships, and grants from the Australian National Health and Medical Research Council (research fellowships to DCSH; project grant 1057742 (DCSH); program grant 1016701; and Independent Research Institutes Infrastructure Support Scheme (grant 9000220)), the Cancer Council Victoria (grant-in-aid to DCSH), the Leukemia and Lymphoma Society (Specialized Centers of Research grants 7001-13), the Australian Cancer Research Foundation, a Victorian State Government Operational Infrastructure Support grant.	Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Alewine C, 2015, ONCOLOGIST, V20, P176, DOI 10.1634/theoncologist.2014-0358; Andersson Y, 2004, INT J CANCER, V112, P475, DOI 10.1002/ijc.20371; Antignani A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161415; Antignani A, 2014, MOL CANCER THER, V13, P1655, DOI 10.1158/1535-7163.MCT-13-0998; Antignani A, 2013, TOXINS, V5, P1486, DOI 10.3390/toxins5081486; Aubrey BJ, 2015, CELL REP, V10, P1422, DOI 10.1016/j.celrep.2015.02.002; BUCHNER J, 1992, ANAL BIOCHEM, V205, P263, DOI 10.1016/0003-2697(92)90433-8; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; FitzGerald DJ, 2011, CANCER RES, V71, P6300, DOI 10.1158/0008-5472.CAN-11-1374; Hata AN, 2015, CANCER DISCOV, V5, P475, DOI 10.1158/2159-8290.CD-15-0011; Hollevoet K, 2014, J IMMUNOTHER, V37, P8, DOI 10.1097/CJI.0000000000000010; Kreitman RJ, 2015, BEST PRACT RES CL HA, V28, P236, DOI 10.1016/j.beha.2015.09.003; Kreitman RJ, 2012, J CLIN ONCOL, V30, P1822, DOI 10.1200/JCO.2011.38.1756; Lindqvist LM, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.149; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Salvatore G, 2002, BIOCHEM BIOPH RES CO, V294, P813, DOI 10.1016/S0006-291X(02)00560-0; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Traini R, 2010, MOL CANCER THER, V9, P2007, DOI 10.1158/1535-7163.MCT-10-0257; Wayne AS, 2014, BLOOD, V123, P2470, DOI 10.1182/blood-2014-01-492256; Weldon JE, 2011, FEBS J, V278, P4683, DOI 10.1111/j.1742-4658.2011.08182.x; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289	24	7	8	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 31	2017	36	35					4953	4962		10.1038/onc.2017.111	http://dx.doi.org/10.1038/onc.2017.111			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FF3AV	28436946				2022-12-26	WOS:000408768800001
J	Cheng, XQ; Hao, Y; Shu, WJ; Zhao, MJ; Zhao, C; Wu, Y; Peng, XD; Yao, PF; Xiao, DB; Qing, GL; Pan, ZY; Yin, L; Hu, DS; Du, HN				Cheng, Xiaoqing; Hao, Yuan; Shu, Wenjie; Zhao, Mengjie; Zhao, Chen; Wu, Yuan; Peng, Xiaodan; Yao, Pinfang; Xiao, Daibiao; Qing, Guoliang; Pan, Zhengying; Yin, Lei; Hu, Desheng; Du, Hai-Ning			Cell cycle-dependent degradation of the methyltransferase SETD3 attenuates cell proliferation and liver tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE METHYLTRANSFERASE; UBIQUITIN LIGASE; S-PHASE; CHROMATIN MODIFICATIONS; TARGETING PR-SET7/SET8; LYSINE METHYLATION; OXIDATIVE STRESS; EXPRESSION; REPLICATION; PROGRESSION	Histone modifications, including lysine methylation, are epigenetic marks that influence many biological pathways. Accordingly, many methyltransferases have critical roles in various biological processes, and their dysregulation is often associated with cancer. However, the biological functions and regulation of many methyltransferases are unclear. Here, we report that a human homolog of the methyltransferase SET (SU(var), enhancer of zeste, and trithorax) domain containing 3 (SETD3) is cell cycle-regulated; SETD3 protein levels peaked in S phase and were lowest in M phase. We found that the beta-isoform of the tumor suppressor F-box and WD repeat domain containing 7 (FBXW7 beta) specifically mediates SETD3 degradation. Aligning the SETD3 sequence with those of well known FBXW7 substrates, we identified six potential non-canonical Cdc4 phosphodegrons (CPDs), and one of them, CPD1, is primarily phosphorylated by the kinase glycogen synthase kinase 3 (GSK3 beta), which is required for FBXW7 beta-mediated recognition and degradation. Moreover, depletion or inhibition of GSK3 beta or FBXW7 beta resulted in elevated SETD3 levels. Mutations of the phosphorylated residues in CPD1 of SETD3 abolished the interaction between FBXW7 beta and SETD3 and prevented SETD3 degradation. Our data further indicated that SETD3 levels positively correlated with cell proliferation of liver cancer cells and liver tumorigenesis in a xenograft mouse model, and that overexpression of FBXW7 beta counteracts the SETD3's tumorigenic role. We also show that SETD3 levels correlate with cancer malignancy, indicated by SETD3 levels that the 54 liver tumors are 2-fold higher than those in the relevant adjacent tissues. Collectively, these data elucidated that a GSK3 beta-FBXW7 beta-dependent mechanism controls SETD3 protein levels during the cell cycle and attenuates its oncogenic role in liver tumorigenesis.	[Cheng, Xiaoqing; Shu, Wenjie; Zhao, Mengjie; Zhao, Chen; Yin, Lei; Du, Hai-Ning] Wuhan Univ, Coll Life Sci, Hubei Key Lab Cell Homeostasis, Wuhan 430072, Peoples R China; [Hao, Yuan] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Gen Surg, Shanghai 200092, Peoples R China; [Wu, Yuan; Yao, Pinfang; Hu, Desheng] Hubei Canc Hosp, Dept Radiotherapy, 116 Zhuodaoquan Rd, Wuhan 430079, Peoples R China; [Peng, Xiaodan] Peking Univ, Shenzhen Hosp, Dept Oncol, Shenzhen 518083, Peoples R China; [Xiao, Daibiao; Qing, Guoliang] Wuhan Univ, Med Res Inst, Wuhan 430071, Peoples R China; [Pan, Zhengying] Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Key Lab Chem Genom, Shenzhen 518055, Peoples R China	Wuhan University; Shanghai Jiao Tong University; Peking University; Wuhan University; Peking University; University Town of Shenzhen	Du, HN (corresponding author), Wuhan Univ, Coll Life Sci, Hubei Key Lab Cell Homeostasis, Wuhan 430072, Peoples R China.; Hao, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Gen Surg, Shanghai 200092, Peoples R China.; Hu, DS (corresponding author), Hubei Canc Hosp, Dept Radiotherapy, 116 Zhuodaoquan Rd, Wuhan 430079, Peoples R China.	haoyuan@medmail.com.cn; hds_05@163.com; hainingdu@whu.edu.cn	Du, Hai-Ning/AAI-2020-2021; du, hai-ning/AAE-5626-2022	Du, Hai-Ning/0000-0001-8062-5411; Shu, Wenjie/0000-0001-5270-055X	Major State Basic Research Development Program of China [2013CB910700]; National Natural Science Foundation of China [31271369, 81401913]; Shenzhen Science and Technology Innovation Commission [JCYJ20150422150029096]	Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Science and Technology Innovation Commission	This work was supported by Major State Basic Research Development Program of China Grant 2013CB910700 (to H.-N.D), National Natural Science Foundation of China Grants 31271369 (to H.-N.D.) and 81401913 (to Y.W.), and Shenzhen Science and Technology Innovation Commission Grant JCYJ20150422150029096 (to H.-N.D). The authors declare that they have no conflicts of interest with the contents of this article.	Abbas T, 2010, MOL CELL, V40, P9, DOI 10.1016/j.molcel.2010.09.014; Beck DB, 2012, GENE DEV, V26, P325, DOI 10.1101/gad.177444.111; Binda O, 2013, EPIGENETICS-US, V8, P177, DOI 10.4161/epi.23416; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Chen A, 2016, BBA-GENE REGUL MECH, V1859, P420, DOI 10.1016/j.bbagrm.2016.01.003; Chen ZG, 2013, HAEMATOLOGICA, V98, P739, DOI 10.3324/haematol.2012.066977; Cohn O, 2016, SCI REP-UK, V6, DOI 10.1038/srep37115; Cooper SE, 2015, CELL CYCLE, V14, P2509, DOI 10.1080/15384101.2015.1053667; Crusio KM, 2010, ONCOGENE, V29, P4865, DOI 10.1038/onc.2010.222; Davis RJ, 2014, CANCER CELL, V26, P455, DOI 10.1016/j.ccell.2014.09.013; Dorn ES, 2011, EPIGENETICS-US, V6, P552, DOI 10.4161/epi.6.5.15082; Ekholm-Reed S, 2013, MOL CELL BIOL, V33, P3627, DOI 10.1128/MCB.00535-13; Eom GH, 2011, J BIOL CHEM, V286, P34733, DOI 10.1074/jbc.M110.203307; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Herz HM, 2013, TRENDS BIOCHEM SCI, V38, P621, DOI 10.1016/j.tibs.2013.09.004; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; Houston SI, 2008, J BIOL CHEM, V283, P19478, DOI 10.1074/jbc.M710579200; Inuzuka H, 2011, NATURE, V471, P104, DOI 10.1038/nature09732; Jorgensen S, 2007, J CELL BIOL, V179, P1337, DOI 10.1083/jcb.200706150; Kamnasaran D, 2002, J MED GENET, V39, P81, DOI 10.1136/jmg.39.2.81; Kim DW, 2011, BIOSCI BIOTECH BIOCH, V75, P289, DOI 10.1271/bbb.100648; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Levy D, 2011, NAT IMMUNOL, V12, P29, DOI 10.1038/ni.1968; Li F, 2013, CELL, V153, P590, DOI 10.1016/j.cell.2013.03.025; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Oda H, 2010, MOL CELL, V40, P364, DOI 10.1016/j.molcel.2010.10.011; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Pesavento JJ, 2008, MOL CELL BIOL, V28, P468, DOI 10.1128/MCB.01517-07; Rice JC, 2002, GENE DEV, V16, P2225, DOI 10.1101/gad.1014902; Rizzardi LF, 2012, GENETICS, V192, P371, DOI 10.1534/genetics.112.142349; Seki A, 2008, J CELL BIOL, V181, P65, DOI 10.1083/jcb.200712027; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Tardat M, 2007, J CELL BIOL, V179, P1413, DOI 10.1083/jcb.200706179; Tessarz P, 2014, NAT REV MOL CELL BIO, V15, P703, DOI 10.1038/nrm3890; Tian EM, 2014, GENE CHROMOSOME CANC, V53, P549, DOI 10.1002/gcc.22165; Trausch-Azar JS, 2015, J CELL PHYSIOL, V230, P842, DOI 10.1002/jcp.24812; Vershinin Z, 2016, J BIOL CHEM, V291, P6786, DOI 10.1074/jbc.M115.697292; Wang R, 2013, CELL RES, V23, P803, DOI 10.1038/cr.2013.42; Wang ZW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10185; Welcker M, 2004, CURR BIOL, V14, P1852, DOI 10.1016/j.cub.2004.09.083; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Wu SM, 2010, GENE DEV, V24, P2531, DOI 10.1101/gad.1984210; Xiao B, 2005, GENE DEV, V19, P1444, DOI 10.1101/gad.1315905; Xu WS, 2016, SEMIN CANCER BIOL, V36, P62, DOI 10.1016/j.semcancer.2015.09.005; Yin Y, 2008, CELL CYCLE, V7, P1423, DOI 10.4161/cc.7.10.5867	46	32	32	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9022	9033		10.1074/jbc.M117.778001	http://dx.doi.org/10.1074/jbc.M117.778001			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28442573	Green Published, hybrid			2022-12-26	WOS:000402538900003
J	Gonzalez-Ferreiro, E; Arellano-Perez, S; Castedo-Dorado, F; Hevia, A; Vega, JA; Vega-Nieva, D; Alvarez-Gonzalez, JG; Ruiz-Gonzalez, AD				Gonzalez-Ferreiro, Eduardo; Arellano-Perez, Stefano; Castedo-Dorado, Fernando; Hevia, Andrea; Antonio Vega, Jose; Vega-Nieva, Daniel; Gabriel Alvarez-Gonzalez, Juan; Daria Ruiz-Gonzalez, Ana			Modelling the vertical distribution of canopy fuel load using national forest inventory and low-density airbone laser scanning data	PLOS ONE			English	Article							RADIATA D. DON; FIRE BEHAVIOR; LIDAR; VARIABLES; BIOMASS; PARAMETERS; EQUATIONS; HEIGHT; STANDS; SIZE	The fuel complex variables canopy bulk density and canopy base height are often used to predict crown fire initiation and spread. Direct measurement of these variables is impractical, and they are usually estimated indirectly by modelling. Recent advances in predicting crown fire behaviour require accurate estimates of the complete vertical distribution of canopy fuels. The objectives of the present study were to model the vertical profile of available canopy fuel in pine stands by using data from the Spanish national forest inventory plus low-density airborne laser scanning (ALS) metrics. In a first step, the vertical distribution of the canopy fuel load was modelled using the Weibull probability density function. In a second step, two different systems of models were fitted to estimate the canopy variables defining the vertical distributions; the first system related these variables to stand variables obtained in a field inventory, and the second system related the canopy variables to airborne laser scanning metrics. The models of each system were fitted simultaneously to compensate the effects of the inherent cross-model correlation between the canopy variables. Heteroscedasticity was also analyzed, but no correction in the fitting process was necessary. The estimated canopy fuel load profiles from field variables explained 84% and 86% of the variation in canopy fuel load for maritime pine and radiata pine respectively; whereas the estimated canopy fuel load profiles from ALS metrics explained 52% and 49% of the variation for the same species. The proposed models can be used to assess the effectiveness of different forest management alternatives for reducing crown fire hazard.	[Gonzalez-Ferreiro, Eduardo; Arellano-Perez, Stefano; Gabriel Alvarez-Gonzalez, Juan; Daria Ruiz-Gonzalez, Ana] Univ Santiago de Compostela, Dept Ingn Agroforestal, Unidad Gest Forestal Sostenible, Lugo, Spain; [Castedo-Dorado, Fernando] Univ Leon, Dept Ingn & Ciencias Agr, Campus Ponferrada, Ponferrada, Spain; [Hevia, Andrea] Forest & Wood Technol Res Ctr CETEMAS, Sustainable Forest Management Area, Carbayin, Siero Asturias, Spain; [Antonio Vega, Jose] Ctr Invest Forestal Lourizan, Pontevedra, Spain; [Vega-Nieva, Daniel] Univ Juarez Estado de Durango, Inst Silviculture & Ind Madera, Ciudad Univ, Durango, Mexico; [Gonzalez-Ferreiro, Eduardo] Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA; [Gonzalez-Ferreiro, Eduardo] US Forest Serv, Lab Applicat Remote Sensing Ecol, USDA, Pacific Northwest Res Stn, Corvallis, OR USA	Universidade de Santiago de Compostela; Universidad de Leon; Oregon State University; United States Department of Agriculture (USDA); United States Forest Service	Alvarez-Gonzalez, JG (corresponding author), Univ Santiago de Compostela, Dept Ingn Agroforestal, Unidad Gest Forestal Sostenible, Lugo, Spain.	juangabriel.alvarez@usc.es	Gonzalez-Ferreiro, Eduardo/Q-9709-2016; Gonzalez-Ferreiro, Eduardo/AAO-4841-2020; Castedo-Dorado, Fernando/E-5449-2012; Alvarez, Juan/GSD-7155-2022; CABAL, ANDREA AHC HEVIA/M-1361-2014	Gonzalez-Ferreiro, Eduardo/0000-0002-4565-2155; Gonzalez-Ferreiro, Eduardo/0000-0002-4565-2155; Castedo-Dorado, Fernando/0000-0002-1656-5255; CABAL, ANDREA AHC HEVIA/0000-0001-6352-1442; Ruiz Gonzalez, Ana Daria/0000-0001-9596-1709; Vega-Nieva, Daniel Jose/0000-0002-1463-6523; Alvarez-Gonzalez, Juan Gabriel/0000-0002-5206-9128; Arellano-Perez, Stefano/0000-0003-2164-8618	DIABOLO [GA 633464]; GEPRIF [RTA 2014-00011-c06-04]; Galician Government; European Social Fund [POS-A/2013/049, 52]	DIABOLO; GEPRIF; Galician Government; European Social Fund(European Social Fund (ESF))	Funding was provided by projects DIABOLO (H2020 GA 633464) and GEPRIF (RTA 2014-00011-c06-04). The funders did not participate in designing the study, data collection and analysis, decision to publish or preparation of the manuscript. We are grateful to the Galician Government and European Social Fund (Official Journal of Galicia DOG no 52, 17/03/2014, p. 11343, exp: POS-A/2013/049) for financing the postdoctoral research stays of Dr Eduardo Gonzalez-Ferreiro at different institutions. Copyright of LiDAR data, Instituto Geografico Nacional-Xunta de Galicia.; We are grateful to the Galician Government and European Social Fund (Official Journal of Galicia DOG no 52, 17/03/2014, p. 11343, exp: POS-A/2013/049) for financing the postdoctoral research stays of Dr Eduardo Gonzalez-Ferreiro at different institutions. Copyright of LiDAR data, Instituto Geografico Nacional-Xunta de Galicia.	Alberdi I., 2010, NATL FOREST INVENTOR, P527; Alexander ME, 2011, PNWGTR854 USDA FOR S; Andersen HE, 2005, REMOTE SENS ENVIRON, V94, P441, DOI 10.1016/j.rse.2004.10.013; Barreiro-Fernandez L, 2016, J APPL REMOTE SENS, V10, DOI 10.1117/1.JRS.10.016014; Belsley D. A., 1991, CONDITIONING DIAGNOS; Boudreau J, 2008, REMOTE SENS ENVIRON, V112, P3876, DOI 10.1016/j.rse.2008.06.003; Breidenbach J, 2008, CAN J FOREST RES, V38, P1611, DOI 10.1139/X07-237; Cao QV, 1982, DIAMETER DISTRIBUTIO; Comunidad Autonoma de Galicia, 2011, CUART INV FOR NAC CO; Crecente-Campo F, 2013, FORESTRY, V86, P481, DOI 10.1093/forestry/cpt019; Crecente-Campo F, 2009, FOREST ECOL MANAG, V257, P2370, DOI 10.1016/j.foreco.2009.03.038; Cruz MG, 2008, AUSTRAL FOR, V71, P113, DOI 10.1080/00049158.2008.10676278; Ruiz-Gonzalez AD, 2011, CAN J FOREST RES, V41, P839, DOI [10.1139/X10-237, 10.1139/x10-237]; Dieguez-Aranda U., 2009, HERRAMIENTAS SELVICO; Erdody TL, 2010, REMOTE SENS ENVIRON, V114, P725, DOI 10.1016/j.rse.2009.11.002; Fernandes PM, 2009, CAN J FOREST RES, V39, P2529, DOI 10.1139/X09-145; Gobakken T, 2005, SCAND J FOREST RES, V20, P490, DOI 10.1080/02827580500373186; Gobakken T, 2004, INT ARCH PHOTOGRAMM, V36-8, P224; Gobakken T, 2009, CAN J FOREST RES, V39, P1036, DOI 10.1139/X09-025; Gonzalez-Ferreiro E, 2014, INT J WILDLAND FIRE, V23, P350, DOI 10.1071/WF13054; Gonzalez-Ferreiro E, 2012, FORESTRY, V85, P281, DOI 10.1093/forestry/cps002; Hall SA, 2005, FOREST ECOL MANAG, V208, P189, DOI 10.1016/j.foreco.2004.12.001; Hevia A, 2016, REV TELEDETEC, P41, DOI 10.4995/raet.2016.3979; Jimenez E, 2013, CAN J FOREST RES, V43, P149, DOI 10.1139/cjfr-2012-0374; Kankare V, 2013, REMOTE SENS-BASEL, V5, P2257, DOI 10.3390/rs5052257; Keane RE, 2001, INT J WILDLAND FIRE, V10, P301, DOI 10.1071/WF01028; Keyes CR, 2002, WEST J APPL FOR, V17, P101, DOI 10.1093/wjaf/17.2.101; Keyser T, 2010, FOREST SCI, V56, P156; KRAUS K, 1972, PHOTOGRAMM ENG, V38, P1016; Kraus K, 1998, ISPRS J PHOTOGRAMM, V53, P193, DOI 10.1016/S0924-2716(98)00009-4; LILLIEFO.HW, 1969, J AM STAT ASSOC, V64, P387, DOI 10.2307/2283748; MARM, 2010, AN EST; Naesset E, 2002, REMOTE SENS ENVIRON, V79, P105, DOI 10.1016/S0034-4257(01)00243-7; Reinhardt E, 2006, CAN J FOREST RES, V36, P2803, DOI 10.1139/X06-157; Reitberger J, 2008, INT J REMOTE SENS, V29, P1407, DOI 10.1080/01431160701736448; REYNOLDS MR, 1988, FOREST SCI, V34, P373; Riano D, 2003, REMOTE SENS ENVIRON, V86, P177, DOI 10.1016/S0034-4257(03)00098-1; Ruiz-Gonzalez AD, 2007, P 4 INT WILDL FIR C; Sando R. W, 1972, NC84 USDA FOR SERV; SAS Institute Inc, 2009, BAS SAS 9 2 PROC GUI; Scott J.H., 2001, RMRSRP29 USDA FOR SE; Skowronski NS, 2011, REMOTE SENSING ENV, V115; Stocks BJ, 2004, CAN J FOREST RES, V34, P1548, DOI 10.1139/X04-054; Thomas V, 2006, CAN J FOREST RES, V36, P34, DOI [10.1139/x05-230, 10.1139/X05-230]; Wagner C. E. van, 1977, Canadian Journal of Forest Research, V7, P23, DOI 10.1139/x77-004; Wagner W, 2008, INT J REMOTE SENS, V29, P1433, DOI 10.1080/01431160701736398; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; White J.C., 2013, FIX010 CAN WOOD FIBR; WILLIAMS DF, 1978, 3 DEP CONS ENV	49	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176114	10.1371/journal.pone.0176114	http://dx.doi.org/10.1371/journal.pone.0176114			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448524	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383600040
J	Peshti, V; Obolensky, A; Nahum, L; Kanfi, Y; Rathaus, M; Avraham, M; Tinman, S; Alt, FW; Banin, E; Cohen, HY				Peshti, Victoria; Obolensky, Alexey; Nahum, Liat; Kanfi, Yariv; Rathaus, Moran; Avraham, Maytal; Tinman, Simon; Alt, Fredrick W.; Banin, Eyal; Cohen, Haim Y.			Characterization of physiological defects in adult SIRT6(-/-) mice	PLOS ONE			English	Article							HISTONE DEACETYLASE SIRT6; EXTENDS LIFE-SPAN; RETINAL DEGENERATION; RD10 MOUSE; CALORIE RESTRICTION; DNA-REPAIR; INSTABILITY; ACTIVATOR; PROTEIN; STRESS	The NAD+-dependent SIRT6 deacetylase was shown to be a major regulator of lifespan and healthspan. Mice deficient for SIRT6 develop a premature aging phenotype and metabolic defects, and die before four weeks of age. Thus, the effect of SIRT6 deficiency in adult mice is unknown. Here we show that SIRT6 (-/-)mice in mixed 129/SvJ/BALB/c background reach adulthood, allowing examination of SIRT6-related metabolic and developmental phenotypes in adult mice. In this mixed background, at 200 days of age, more than 80% of the female knock-out mice were alive whereas only 10% of male knock-out mice survived. In comparison to their wild-type littermates, SIRT6 deficient mice have reduced body weight, increased glucose uptake and exhibit an age-dependent progressive impairment of retinal function accompanied by thinning of retinal layers. Together, these results demonstrate a role for SIRT6 in metabolism and age-related ocular changes in adult mice and suggest a gender specific regulation of lifespan by SIRT6.	[Peshti, Victoria; Nahum, Liat; Kanfi, Yariv; Rathaus, Moran; Avraham, Maytal; Tinman, Simon; Cohen, Haim Y.] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Obolensky, Alexey; Banin, Eyal] Hadassah Hebrew Univ Med Ctr, Dept Ophthalmol, Jerusalem, Israel; [Alt, Fredrick W.] Harvard Univ, Sch Med, Boston, MA USA	Bar Ilan University; Hebrew University of Jerusalem; Harvard University; Harvard Medical School	Cohen, HY (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel.	Haim.Cohen@biu.ac.il	Kornweitz, Haya/L-6469-2018	Kornweitz, Haya/0000-0002-3562-0141; Cohen, Haim Y./0000-0002-6613-8710	Israeli Academy of Sciences; I-Core; Binational US-Israel Science Foundation; Israel Cancer Association; Koret Foundation; Israel Cancer Research Fund; Israel Ministry of Health; Lir'ot association; TEVA NNE program; EFSD; D- Cure; ERC: European Research Council; Yedidut Research Fund; European Foundation for the Study of Diabetes [MSD 2014_1] Funding Source: researchfish	Israeli Academy of Sciences; I-Core; Binational US-Israel Science Foundation(US-Israel Binational Science Foundation); Israel Cancer Association; Koret Foundation; Israel Cancer Research Fund; Israel Ministry of Health; Lir'ot association; TEVA NNE program(Teva Pharmaceutical Industries); EFSD; D- Cure; ERC: European Research Council(European Research Council (ERC)); Yedidut Research Fund; European Foundation for the Study of Diabetes	This study was supported by the Israeli Academy of Sciences, I-Core, Binational US-Israel Science Foundation, Israel Cancer Association, Koret Foundation, Israel Cancer Research Fund, the Israel Ministry of Health, Lir'ot association, TEVA NNE program, EFSD, D- Cure, the ERC: European Research Council and the Yedidut Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the members of the Cohen lab, in particular Shoshana Naiman, for their helpful comments on the manuscript. This study was supported by the Israeli Academy of Sciences, I-Core, Binational US-Israel Science Foundation, Israel Cancer Association, Koret Foundation, Israel Cancer Research Fund, the Israel Ministry of Health, Lir'ot association, TEVA NNE program, EFSD, D- Cure, the ERC: European Research Council and the Yedidut Research Fund.	Atsumi Y, 2015, CELL REP, V13, P2728, DOI 10.1016/j.celrep.2015.11.054; Barot M, 2011, CURR EYE RES, V36, P1069, DOI 10.3109/02713683.2011.607536; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Elhanati S, 2016, CELL REP, V14, P234, DOI 10.1016/j.celrep.2015.12.023; Elhanati S, 2013, CELL REP, V4, P905, DOI 10.1016/j.celrep.2013.08.006; Galbinur T, 2009, J OCUL PHARMACOL TH, V25, P475, DOI 10.1089/jop.2009.0020; Gertler AA, 2013, BIOGERONTOLOGY, V14, P629, DOI 10.1007/s10522-013-9478-8; Ghosh S, 2015, CELL REP, V13, P1396, DOI 10.1016/j.celrep.2015.10.006; Gil R, 2013, NUCLEIC ACIDS RES, V41, P8537, DOI 10.1093/nar/gkt642; Hollyfield JG, 2010, INVEST OPHTH VIS SCI, V51, P1276, DOI 10.1167/iovs.09-4478; Jaliffa C, 2009, INVEST OPHTH VIS SCI, V50, P3562, DOI 10.1167/iovs.08-2817; Jiang H, 2013, NATURE, V496, P110, DOI 10.1038/nature12038; Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296; Kaidi A, 2010, SCIENCE, V329, P1348, DOI 10.1126/science.1192049; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Kanfi Y, 2010, AGING CELL, V9, P162, DOI 10.1111/j.1474-9726.2009.00544.x; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kolesnikov AV, 2010, J NEUROSCI, V30, P11222, DOI 10.1523/JNEUROSCI.4239-09.2010; Kubota S, 2010, AM J PATHOL, V177, P1725, DOI 10.2353/ajpath.2010.100098; Lerrer B, 2016, CARCINOGENESIS, V37, P108, DOI 10.1093/carcin/bgv167; Li CB, 2001, OPTOMETRY VISION SCI, V78, P425, DOI 10.1097/00006324-200106000-00015; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Mulero F, 2010, NAT COMMUN, V1, P3; Obolensky A, 2011, FREE RADICAL BIO MED, V51, P1482, DOI 10.1016/j.freeradbiomed.2011.07.014; Ozawa Y, 2010, OPHTHALMIC RES, V44, P199, DOI 10.1159/000316484; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; Silberman DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098831; Tennen RI, 2011, TRENDS BIOCHEM SCI, V36, P39, DOI 10.1016/j.tibs.2010.07.009; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Xiao CY, 2010, J BIOL CHEM, V285, P36776, DOI 10.1074/jbc.M110.168039; Zeng Y, 2015, BIOCHEM BIOPH RES CO, V468, P167, DOI 10.1016/j.bbrc.2015.10.139; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	40	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176371	10.1371/journal.pone.0176371	http://dx.doi.org/10.1371/journal.pone.0176371			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448551	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383600068
J	Tomic, TT; Olausson, J; Wilzen, A; Sabel, M; Truve, K; Sjogren, H; Dosa, S; Tisell, M; Lannering, B; Enlund, F; Martinsson, T; Aman, P; Abel, F				Tomic, Tajana Tesan; Olausson, Josefin; Wilzen, Annica; Sabel, Magnus; Truve, Katarina; Sjogren, Helene; Dosa, Sandor; Tisell, Magnus; Lannering, Birgitta; Enlund, Fredrik; Martinsson, Tommy; Aman, Pierre; Abel, Frida			A new GTF2I-BRAF fusion mediating MAPK pathway activation in pilocytic astrocytoma	PLOS ONE			English	Article							BRAF GENE; TUMORS; DUPLICATION; 7Q34; CLASSIFICATION; KIAA1549-BRAF; RESISTANCE; MUTATIONS; RECURRENT; CHILDREN	Pilocytic astrocytoma (PA) is the most common pediatric brain tumor. A recurrent feature of PA is deregulation of the mitogen activated protein kinase (MAPK) pathway most often through KIAA1549-BRAF fusion, but also by other BRAF- or RAF1-gene fusions and point mutations (e.g. BRAFV600E). These features may serve as diagnostic and prognostic markers, and also facilitate development of targeted therapy. The aims of this study were to characterize the genetic alterations underlying the development of PA in six tumor cases, and evaluate methods for fusion oncogene detection. Using a combined analysis of RNA sequencing and copy number variation data we identified a new BRAF fusion involving the 5' gene fusion partner GTF2I (7q11.23), not previously described in PA. The new GTF2I-BRAF 19-10 fusion was found in one case, while the other five cases harbored the frequent KIAA1549-BRAF 16-9 fusion gene. Similar to other BRAF fusions, the GTF2I-BRAF fusion retains an intact BRAF kinase domain while the inhibitory N-terminal domain is lost. Functional studies on GTF2I-BRAF showed elevated MAPK pathway activation compared to BRAF WT. Comparing fusion detection methods, we found Fluorescence in situ hybridization with BRAF break apart probe as the most sensitive method for detection of different BRAF rearrangements (GTF2I-BRAF and KIAA1549-BRAF). Our finding of a new BRAF fusion in PA further emphasis the important role of B-Raf in tumorigenesis of these tumor types. Moreover, the consistency and growing list of BRAF/RAF gene fusions suggests these rearrangements to be informative tumor markers in molecular diagnostics, which could guide future treatment strategies.	[Tomic, Tajana Tesan; Olausson, Josefin; Wilzen, Annica; Martinsson, Tommy; Abel, Frida] Univ Gothenburg, Dept Clin Genet, Inst Biomed, Sahlgrenska Acad, Gothenburg, Sweden; [Sabel, Magnus] Queen Silvia Childrens Hosp, Childrens Canc Ctr, Gothenburg, Sweden; [Truve, Katarina; Lannering, Birgitta] Univ Gothenburg, Sahlgrenska Acad, Bioinformat Core Facil, Gothenburg, Sweden; [Sjogren, Helene; Enlund, Fredrik] Sahlgrens Univ Hosp, Dept Clin Chem, Gothenburg, Sweden; [Dosa, Sandor] Sahlgrens Univ Hosp, Dept Pathol, Gothenburg, Sweden; [Tisell, Magnus] Sahlgrens Univ Hosp, Dept Neurosurg, Gothenburg, Sweden; [Aman, Pierre] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Sahlgrenska Canc Ctr, Gothenburg, Sweden; [Abel, Frida] Univ Gothenburg, Dept Clin Genet, Gothenburg, Sweden	University of Gothenburg; Queen Silvia Children's Hospital; University of Gothenburg; Sahlgrenska University Hospital; Sahlgrenska University Hospital; Sahlgrenska University Hospital; University of Gothenburg; University of Gothenburg	Abel, F (corresponding author), Univ Gothenburg, Dept Clin Genet, Inst Biomed, Sahlgrenska Acad, Gothenburg, Sweden.; Abel, F (corresponding author), Univ Gothenburg, Dept Clin Genet, Gothenburg, Sweden.	frida.abel@gu.se	Sabel, Magnus/Q-2816-2016; Tisell, Magnus/AAG-4736-2020; Martinsson, Tommy/J-4140-2013; Sabel, Magnus/AAX-7660-2021	Sabel, Magnus/0000-0002-3072-657X; Martinsson, Tommy/0000-0002-9403-3123; Sabel, Magnus/0000-0002-3072-657X; Aman, Pierre/0000-0002-1482-8875; Truve, Katarina/0000-0002-2449-8283	Swedish Children's Cancer Foundation [PR2013-0010, FoAss10/008, NBCNSDoktBidr11/006, NC2014-0036]; Swedish Assar Gabrielsson Foundation [FB 15-75 2015, FB 13-68 2014]; Swedish Wilhelm and Martina Lundgren Research Foundation; Wilhelm and Martina Lundgren Research Foundation	Swedish Children's Cancer Foundation; Swedish Assar Gabrielsson Foundation; Swedish Wilhelm and Martina Lundgren Research Foundation; Wilhelm and Martina Lundgren Research Foundation	This work was supported by the Swedish Children's Cancer Foundation (grant numbers PR2013-0010, FoAss10/008, NBCNSDoktBidr11/006, 2011-2013 to FA and NC2014-0036 to TT), the Swedish Assar Gabrielsson Foundation (grant numbers FB 15-75 2015 to TT, FB 13-68 2014 to AW); the Swedish Wilhelm and Martina Lundgren Research Foundation (year 2011-2013 to TT, AW and FA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Genomics Core Facility and Bioinformatics resource unit at Gothenburg University for access to Illumina sequencing and qPCR systems and data management support. We are grateful to Anna Djos at Department of Clinical Genetics for assistance and guidance through SNP-array preparation and Carola Andersson at Clinical Molecular Pathology, Sahlgrenska University Hospital, for preparing histopathological material. This work was supported by the Swedish Children's Cancer Foundation (grant numbers PR2013-0010, FoAss10/008, NBCNSDoktBidr11/006, 2011-2013 to FA and NC2014-0036 to TT), the Assar Gabrielsson Foundation (grant numbers FB 15-75 2015 to TT, FB 13-68 2014 to AW); the Wilhelm and Martina Lundgren Research Foundation (year 2011-2013 to TT, AW and FA).	Arbajian E, 2013, GENE CHROMOSOME CANC, V52, P330, DOI 10.1002/gcc.22033; Armstrong GT, 2011, NEURO-ONCOLOGY, V13, P223, DOI 10.1093/neuonc/noq178; Becker AP, 2015, J NEUROPATH EXP NEUR, V74, P743, DOI 10.1097/NEN.0000000000000213; Burkhard C, 2003, J NEUROSURG, V98, P1170, DOI 10.3171/jns.2003.98.6.1170; Carrara M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S7-S2; Cin H, 2011, ACTA NEUROPATHOL, V121, P763, DOI 10.1007/s00401-011-0817-z; Couldwell WT, 2014, J NEUROSURG, V121, P1474, DOI 10.3171/2014.8.JNS132139; Dahiya S, 2012, CASE REP MED, V2012, DOI 10.1155/2012/418672; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; (E. C. A) ECA, 2012, FISH HIST SECT SOL T, P28; Forshew T, 2009, J PATHOL, V218, P172, DOI 10.1002/path.2558; Furtado SV, 2010, J CANCER RES THER, V6, P221, DOI 10.4103/0973-1482.65246; Gilles FH, 2008, PEDIATR DEVEL PATHOL, V11, P108, DOI 10.2350/07-06-0303.1; Hakre S, 2006, MOL CELL, V24, P301, DOI 10.1016/j.molcel.2006.09.005; Jacob K, 2009, BRIT J CANCER, V101, P722, DOI 10.1038/sj.bjc.6605179; Johnson KJ, 2014, CANCER EPIDEM BIOMAR, V23, P2716, DOI 10.1158/1055-9965.EPI-14-0207; Jones DTW, 2009, ONCOGENE, V28, P2119, DOI 10.1038/onc.2009.73; Jones DTW, 2008, CANCER RES, V68, P8673, DOI 10.1158/0008-5472.CAN-08-2097; Jones DTW, 2013, NAT GENET, V45, P927, DOI 10.1038/ng.2682; Jones DTW, 2012, CELL MOL LIFE SCI, V69, P1799, DOI 10.1007/s00018-011-0898-9; Karajannis MA, 2014, NEURO-ONCOLOGY, V16, P1408, DOI 10.1093/neuonc/nou059; Kaul A, 2012, GENE DEV, V26, P2561, DOI 10.1101/gad.200907.112; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Lannering B, 2009, ACTA PAEDIATR, V98, P1620, DOI 10.1111/j.1651-2227.2009.01417.x; Lawson ARJ, 2010, ACTA NEUROPATHOL, V120, P271, DOI 10.1007/s00401-010-0693-y; Li J, 2015, BRIT J HAEMATOL, V168, P904, DOI 10.1111/bjh.13157; Lin A, 2012, J NEUROPATH EXP NEUR, V71, P66, DOI 10.1097/NEN.0b013e31823f2cb0; Liu S, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1234; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Nicorici D, 2014, BIORXIV; Penman CL, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00054; Porther N, 2015, Small GTPases, V6, P135, DOI 10.1080/21541248.2015.1050152; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Ross JS, 2016, INT J CANCER, V138, P881, DOI 10.1002/ijc.29825; Roth JJ, 2015, BRAIN PATHOL, V25, P182, DOI 10.1111/bpa.12167; Roy AL, 2012, GENE, V492, P32, DOI 10.1016/j.gene.2011.10.030; Schindler G, 2011, ACTA NEUROPATHOL, V121, P397, DOI 10.1007/s00401-011-0802-6; Shin Clifford H, 2015, Genes Cancer, V6, P9; Sievert AJ, 2013, P NATL ACAD SCI USA, V110, P5957, DOI 10.1073/pnas.1219232110; Sievert AJ, 2009, BRAIN PATHOL, V19, P449, DOI 10.1111/j.1750-3639.2008.00225.x; Tian YJ, 2011, J MOL DIAGN, V13, P669, DOI 10.1016/j.jmoldx.2011.07.002; Wang QG, 2013, BRIEF BIOINFORM, V14, P506, DOI 10.1093/bib/bbs044	42	21	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0175638	10.1371/journal.pone.0175638	http://dx.doi.org/10.1371/journal.pone.0175638			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448514	Green Published, gold, Green Submitted			2022-12-26	WOS:000400383600020
J	Nanri, A; Mizoue, T; Shimazu, T; Ishihara, J; Takachi, R; Node, M; So, H; Sasazuki, S; Sawada, N; Tsugane, S				Nanri, Akiko; Mizoue, Tetsuya; Shimazu, Taichi; Ishihara, Junko; Takachi, Ribeka; Node, Mitsuhiko; So, Hiroyasu; Sasazuki, Shizuka; Sawada, Norie; Tsugane, Shoichiro		Japan Public Hlth Ctr-Based Prospe	Dietary patterns and all-cause, cancer, and cardiovascular disease mortality in Japanese men and women: The Japan public health center-based prospective study	PLOS ONE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; CORONARY-HEART-DISEASE; FOLLOW-UP SURVEY; DOSE-RESPONSE METAANALYSIS; PROSPECTIVE COHORT; COLORECTAL-CANCER; FATTY-ACIDS; COLLABORATIVE COHORT; COFFEE CONSUMPTION; GASTRIC-CANCER	Objective A meta-analysis showed an inverse association of a prudent/healthy dietary pattern with all cause mortality and no association of a western/unhealthy dietary pattern. However, the association of distinctive dietary patterns of Japanese population with mortality remains unclear. We prospectively investigated the association between dietary patterns and all cause, cancer, and cardiovascular disease mortality among Japanese adults. Methods Participants were 36,737 men and 44,983 women aged 45-74 years who participated in the second survey of the Japan Public Health Center-based Prospective Study ( 1995-1998) and who had no history of serious disease. Dietary patterns were derived from principal component analysis of the consumption of 134 food and beverage items ascertained by a food frequency questionnaire. Hazard ratios of death from the second survey to December 2012 were estimated using cox proportional hazard regression analysis. Results A prudent dietary pattern, which was characterized by high intake of vegetables, fruit, soy products, potatoes, seaweed, mushrooms, and fish, was significantly associated with decreased risk of all-cause and cardiovascular disease mortality. The multivariable-adjusted hazard ratios (95% confidence intervals) of all-cause and cardiovascular disease mortality for the highest versus lowest quartile of the prudent dietary pattern score were 0.82 (0.77 to 0.86) and 0.72 (0.64 to 0.79), respectively (P for trend <0.001 in both). A Westernized dietary pattern, characterized by high intake of meat, processed meat, bread, and dairy products, was also inversely associated with risk of all-cause, cancer, and cardiovascular disease mortality. A traditional Japanese dietary pattern was not associated with these risks. Conclusions The prudent and Westernized dietary patterns were associated with a decreased risk of all-cause and cardiovascular disease mortality in Japanese adults.	[Nanri, Akiko; Mizoue, Tetsuya] Natl Ctr Global Hlth & Med, Dept Epidemiol & Prevent, Bur Int Hlth Cooperat, Tokyo, Japan; [Shimazu, Taichi; Sasazuki, Shizuka] Natl Canc Ctr, Prevent Div, Ctr Publ Hlth Sci, Tokyo, Japan; [Ishihara, Junko] Sagami Womens Univ, Dept Nutr Management, Sagamihara, Kanagawa, Japan; [Takachi, Ribeka] Nara Womens Univ, Fac Human Life & Environm, Nara, Japan; [Node, Mitsuhiko] Natl Ctr Global Hlth & Med, Dept Diabet Res, Tokyo, Japan; [Node, Mitsuhiko] Saitama Med Univ, Dept Endocrinol & Diabet, Saitama, Japan; [So, Hiroyasu] Osaka Univ, Grad Sch Med, Div Social & Environm Med, Dept Publ Hlth, Osaka, Japan; [Sawada, Norie] Natl Canc Ctr, Div Epidemiol, Ctr Publ Hlth Sci, Tokyo, Japan; [Tsugane, Shoichiro] Natl Canc Ctr, Ctr Publ Hlth Sci, Tokyo, Japan	National Center for Global Health & Medicine - Japan; National Cancer Center - Japan; Nara Womens University; National Center for Global Health & Medicine - Japan; Saitama Medical University; Osaka University; National Cancer Center - Japan; National Cancer Center - Japan	Nanri, A (corresponding author), Natl Ctr Global Hlth & Med, Dept Epidemiol & Prevent, Bur Int Hlth Cooperat, Tokyo, Japan.	nanri@ri.ncgm.go.jp	Shimazu, Taichi/A-4470-2015; Noda, Mitsuhiko/W-3905-2019; Tsugane, Shoichiro/A-2424-2015	Shimazu, Taichi/0000-0001-6000-9830; Noda, Mitsuhiko/0000-0003-0413-4631; Tsugane, Shoichiro/0000-0003-4105-2774	National Cancer Centre Research and Development Fund [23-A-31, 26-A-2]; Ministry of Health, Labour and Welfare of Japan; Practical Research Project for Life-Style related Diseases including Cardiovascular Diseases and Diabetes Mellitus from the Japan Agency for Medical Research and Development [15ek0210021h0002]; JSPS KAKENHI [15H04779]; National Centre for Global Health and Medicine [26A-201]	National Cancer Centre Research and Development Fund; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Practical Research Project for Life-Style related Diseases including Cardiovascular Diseases and Diabetes Mellitus from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Centre for Global Health and Medicine	This study was supported by National Cancer Centre Research and Development Fund (23-A-31[toku] and 26-A-2) (since 2011), a Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare of Japan (from 1989 to 2010), Practical Research Project for Life-Style related Diseases including Cardiovascular Diseases and Diabetes Mellitus (15ek0210021h0002) from the Japan Agency for Medical Research and Development, JSPS KAKENHI Grant No 15H04779, and grants-in-aid for research from the National Centre for Global Health and Medicine (26A-201).	Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1326; Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1378; Alexander DD, 2016, BRIT J NUTR, V115, P737, DOI 10.1017/S0007114515005000; Balder HF, 2005, CANCER EPIDEM BIOMAR, V14, P483, DOI 10.1158/1055-9965.EPI-04-0353; Bertuccio P, 2013, ANN ONCOL, V24, P1450, DOI 10.1093/annonc/mdt108; Brunner EJ, 2008, AM J CLIN NUTR, V87, P1414, DOI 10.1093/ajcn/87.5.1414; Cancer information Service, 2008, INT COMP PROP DEATHS; Center for Public Health Sciences National Cancer Center Japan, EV CANC RISK RACT VE; Chen GC, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000329; Crippa A, 2014, AM J EPIDEMIOL, V180, P763, DOI 10.1093/aje/kwu194; Heidemann C, 2008, CIRCULATION, V118, P230, DOI 10.1161/CIRCULATIONAHA.108.771881; Ikeda N, 2011, LANCET, V378, P1094, DOI 10.1016/S0140-6736(11)61055-6; Ishihara J, 2003, J EPIDEMIOL, V13, pS134; Iso H, 2006, CIRCULATION, V113, P195, DOI 10.1161/CIRCULATIONAHA.105.581355; Kim MK, 2005, INT J CANCER, V115, P790, DOI 10.1002/ijc.20943; Kim MK, 2004, INT J CANCER, V110, P435, DOI 10.1002/ijc.20132; Kumagai S, 1999, J Nutr Health Aging, V3, P29; Kumagai Y, 2014, CANCER CAUSE CONTROL, V25, P727, DOI 10.1007/s10552-014-0375-5; Kurotani K, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1209; Kurotani K, 2010, BRIT J NUTR, V104, P1703, DOI 10.1017/S0007114510002606; Li F, 2015, BRIT J NUTR, V113, P16, DOI 10.1017/S000711451400289X; Liu LH, 2015, MOL NUTR FOOD RES, V59, P139, DOI 10.1002/mnfr.201400449; Magalhaes B, 2012, EUR J CANCER PREV, V21, P15, DOI 10.1097/CEJ.0b013e3283472241; Malerba S, 2013, EUR J EPIDEMIOL, V28, P527, DOI 10.1007/s10654-013-9834-7; Maruyama K, 2013, NUTR METAB CARDIOVAS, V23, P519, DOI 10.1016/j.numecd.2011.10.007; Masaki Motofumi, 2003, Asian Pac J Cancer Prev, V4, P61; Ministry of Health Labour and Welfare Japan, 2015, DRINKING WATER QUALI; Mizoue T, 2005, AM J EPIDEMIOL, V161, P338, DOI 10.1093/aje/kwi049; Nanri A, 2012, J EPIDEMIOL, V22, P205, DOI 10.2188/jea.JE20110087; Nie ZL, 2013, NUTR METAB CARDIOVAS, V23, P169, DOI 10.1016/j.numecd.2012.04.015; Odegaard AO, 2014, AM J CLIN NUTR, V100, P877, DOI 10.3945/ajcn.114.086124; Pham TM, 2010, ANN EPIDEMIOL, V20, P356, DOI 10.1016/j.annepidem.2010.02.002; Sasaki S, 2003, J EPIDEMIOL, V13, pS115; Sasaki S, 2003, J EPIDEMIOL, V13, pS13; Sasaki S, 2003, J EPIDEMIOL, V13, pS57; Shimazu T, 2007, INT J EPIDEMIOL, V36, P600, DOI 10.1093/ije/dym005; Tsugane S, 2014, JPN J CLIN ONCOL, V44, P777, DOI 10.1093/jjco/hyu096; Wang X, 2016, PUBLIC HEALTH NUTR, V19, P893, DOI 10.1017/S1368980015002062; Wang ZM, 2012, NUTR METAB CARDIOVAS, V22, P890, DOI 10.1016/j.numecd.2011.04.011; World Cancer Research Fund International, SUMM STRONG EV OUR A; Yamagishi K, 2008, J AM COLL CARDIOL, V52, P988, DOI 10.1016/j.jacc.2008.06.018; Yamagishi K, 2013, EUR HEART J, V34, P1225, DOI 10.1093/eurheartj/eht043	42	65	67	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0174848	10.1371/journal.pone.0174848	http://dx.doi.org/10.1371/journal.pone.0174848			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445513	Green Submitted, Green Published, gold			2022-12-26	WOS:000400309200011
J	Yang, X; He, XQ; Li, GD; Xu, YQ				Yang, Xi; He, Xiao-Qing; Li, Guo-Dong; Xu, Yong-Qing			AntagomiR-451 inhibits oxygen glucose deprivation (OGD)-induced HUVEC necrosis via activating AMPK signaling	PLOS ONE			English	Article							PROTEIN-KINASE AMPK; CELL LUNG-CANCER; COLORECTAL-CANCER; INDUCED APOPTOSIS; OXIDATIVE STRESS; STEM-CELLS; IN-VITRO; MICRORNA-451; MITOCHONDRIAL; PATHWAY	Oxygen glucose deprivation (OGD) application in cultured human umbilical vein endothelial cells (HUVECs) mimics ischemic injuries. AntagomiR-451, the miroRNA-451 ("miR-451") inhibitor, could activate pro-survival AMP-activated protein kinase (AMPK) signaling. In the current study, we showed that forced-expression of antagomiR-451 depleted miRNA-451 and significantly attenuated OGD-induced necrosis of HUVECs. Activation of AMPK was required for antagomiR-451-mediated pro-survival actions. AMPK inhibition, by AMPK alpha shRNA or dominant negative mutation, almost completely abolishedantagomiR-451-mediated HUVEC protection again OGD. Reversely, forced-activation of AMPK by exogenous expression of constructively-active AMPK alpha inhibited OGD-induced HUVEC necrosis. At the molecular level, antagomiR-451 expression in HUVECs inhibited OGD-induced programmed necrosis, the latter was evidenced by mitochondrial p53-cyclophilinD (Cyp-D) association, mitochondrial depolarization as well as reactive oxygen species (ROS) production and lactate dehydrogenase (LDH) breach. Together, we suggest that antagomiR-451 activates AMPK to inhibit OGD-induced programmed necrosis in HUVECs.	[Yang, Xi; He, Xiao-Qing; Li, Guo-Dong; Xu, Yong-Qing] Kunming Gen Hosp, PLA, Dept Orthoped, Kunming, Peoples R China; [Yang, Xi] Third Mil Med Univ, Brigade Postgrad Management, Chongqing, Peoples R China	Kunming General Hospital; Army Medical University	Xu, YQ (corresponding author), Kunming Gen Hosp, PLA, Dept Orthoped, Kunming, Peoples R China.	drxuyongqing@163.com			military logistics research project and research program [AWS14C003]	military logistics research project and research program	This study was supported by the military logistics research project and research program (AWS14C003, to Yong-Qing Xu). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida A, 2002, J NEUROCHEM, V81, P207, DOI 10.1046/j.1471-4159.2002.00827.x; Bian HB, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-20; Bitarte N, 2011, STEM CELLS, V29, P1661, DOI 10.1002/stem.741; Chen MB, 2015, CARCINOGENESIS, V36, P1061, DOI 10.1093/carcin/bgv094; Chen MB, 2014, CELL SIGNAL, V26, P102, DOI 10.1016/j.cellsig.2013.07.017; Chen ZY, 2013, MOL CELL BIOCHEM, V377, P35, DOI 10.1007/s11010-013-1568-z; Cortizo AM, 2000, TOXICOLOGY, V147, P89, DOI 10.1016/S0300-483X(00)00181-5; Dong YY, 2016, TUMOUR BIOL; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Fu ML, 2016, BIOCHEM BIOPH RES CO, V471, P267, DOI 10.1016/j.bbrc.2016.01.030; Godlewski J, 2010, CELL CYCLE, V9, P2742, DOI 10.4161/cc.9.14.12248; Godlewski J, 2010, MOL CELL, V37, P620, DOI 10.1016/j.molcel.2010.02.018; Gong YQ, 2016, ONCOTARGET, V7, P60123, DOI 10.18632/oncotarget.11164; Hardie DG, 2016, TRENDS CELL BIOL, V26, P190, DOI 10.1016/j.tcb.2015.10.013; HUANG AL, 1981, CELL, V27, P245, DOI 10.1016/0092-8674(81)90408-6; Huo HZ, 2013, MOL CELL BIOCHEM, V378, P171, DOI 10.1007/s11010-013-1608-8; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Ji C, 2012, BIOCHEM BIOPH RES CO, V425, P825, DOI 10.1016/j.bbrc.2012.07.160; Kai S, 2014, BIOCHEM BIOPH RES CO, V452, P768, DOI 10.1016/j.bbrc.2014.08.147; Kovalchuk O, 2008, MOL CANCER THER, V7, P2152, DOI 10.1158/1535-7163.MCT-08-0021; Li K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057542; Li Z, 2016, ONCOTARGET; Lu PH, 2016, ONCOTARGET, V7, P45889, DOI 10.18632/oncotarget.9969; Lu PH, 2016, ONCOTARGET; Lv GQ, 2014, BIOCHEM BIOPH RES CO, V453, P13, DOI 10.1016/j.bbrc.2014.09.028; Qin LS, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0174-1; She C, 2014, CELL SIGNAL, V26, P1, DOI 10.1016/j.cellsig.2013.08.046; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; Wang R, 2011, ONCOGENE, V30, P2644, DOI 10.1038/onc.2010.642; Wang X, 2014, BIOCH PHARM; Williams MR, 2000, CURR BIOL, V10, P439, DOI 10.1016/S0960-9822(00)00441-3; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402; Zhang JL, 2014, INT J MOL SCI, V15, P12119, DOI 10.3390/ijms150712119; Zhang YM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146944; Zhao LP, 2013, NEUROCHEM RES, V38, P705, DOI 10.1007/s11064-013-0968-5; Zhao S, 2016, BIOCHEM BIOPH RES CO, V481, P212, DOI 10.1016/j.bbrc.2016.10.104; Zhen Y.F., 2014, J CELL PHYSL; Zheng K., 2017, ONCOTARGET; Zheng K, 2015, BIOCH BIOPHYS RES CO; Zheng KL, 2014, BIOCHEM BIOPH RES CO, V451, P79, DOI 10.1016/j.bbrc.2014.07.072; Zheng L, 2016, J CEREBR BLOOD F MET, V36, P204, DOI 10.1038/jcbfm.2015.152; Zhu YL, 2014, INT J MOL SCI, V15, P11190, DOI 10.3390/ijms150611190	42	11	13	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0175507	10.1371/journal.pone.0175507	http://dx.doi.org/10.1371/journal.pone.0175507			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445531	gold, Green Published, Green Submitted			2022-12-26	WOS:000400309200022
J	Di Capua, I; Maffucci, F; Pannone, R; Mazzocchi, MG; Biffali, E; Amato, A				Di Capua, Iole; Maffucci, Fulvio; Pannone, Raimondo; Mazzocchi, Maria Grazia; Biffali, Elio; Amato, Alberto			Molecular phylogeny of Oncaeidae (Copepoda) using nuclear ribosomal internal transcribed spacer (ITS rDNA)	PLOS ONE			English	Article							SPECIES IDENTIFICATION; BIOLOGICAL IDENTIFICATIONS; REPRODUCTIVE ISOLATION; DNA BARCODES; RED-SEA; MITOCHONDRIAL; CRUSTACEA; ITS2; CALANOIDA; EVOLUTION	Copepods belonging to the Oncaeidae family are commonly and abundantly found in marine zooplankton. In the Mediterranean Sea, forty-seven oncaeid species occur, of which eleven in the Gulf of Naples. In this Gulf, several Oncaea species were morphologically analysed and described at the end of the XIX century by W. Giesbrecht. In the same area, oncaeids are being investigated over seasonal and inter-annual scales at the long-term coastal station LTER-MC. In the present work, we identified six oncaeid species using the nuclear ribosomal internal transcribed spacers (ITS rDNA) and the mitochondrial cytochrome c oxidase subunit I (mtCOI). Phylogenetic analyses based on these two genomic regions validated the sisterhood of the genera Triconia and the Oncaea sensu stricto. ITS1 and ITS2 phylogenies produced incongruent results about the position of Oncaea curta, calling for further investigations on this species. We also characterised the ITS2 region by secondary structure predictions and found that all the sequences analysed presented the distinct eukaryotic hallmarks. A Compensatory Base Change search corroborated the close relationship between O. venusta and O. curta and between O. media and O. venusta already identified by ITS phylogenies. The present results, which stem from the integration of molecular and morphological taxonomy, represent an encouraging step towards an improved knowledge of copepod biodiversity: The two complementary approaches, when applied to long-term copepod monitoring, will also help to better understanding their genetic variations and ecological niches of co-occurring species.	[Di Capua, Iole; Mazzocchi, Maria Grazia; Amato, Alberto] Villa Comunale Naples, Stn Zool Anton Dohrn, Dept Integrat Marine Ecol, Naples, Italy; [Maffucci, Fulvio] Villa Comunale Naples, Aquarium Unit, Stn Zool Anton Dohrn, Dept Res Infrastruct Marine Biol Resources, Naples, Italy; [Pannone, Raimondo; Biffali, Elio] Villa Comunale Naples, Stn Zool Anton Dohrn, Mol Biol & Bioinformat Unit, Dept Res Infrastruct Marine Biol Resources, Naples, Italy; [Amato, Alberto] Univ Grenoble Alpes, Inst Rech Sci & Technol Vivant, Lab Physiol Cellulaire & Vegetale, UMR5168,CNRS,CEA,INRA,CEA Grenoble, 17 Rue Martyrs, Grenoble, France	Stazione Zoologica Anton Dohrn di Napoli; Stazione Zoologica Anton Dohrn di Napoli; Stazione Zoologica Anton Dohrn di Napoli; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Amato, A (corresponding author), Villa Comunale Naples, Stn Zool Anton Dohrn, Dept Integrat Marine Ecol, Naples, Italy.; Amato, A (corresponding author), Univ Grenoble Alpes, Inst Rech Sci & Technol Vivant, Lab Physiol Cellulaire & Vegetale, UMR5168,CNRS,CEA,INRA,CEA Grenoble, 17 Rue Martyrs, Grenoble, France.	amato@szn.it	Amato, Alberto/AAI-3215-2020; Amato, Alberto/AGX-4882-2022	Di Capua, Iole/0000-0003-2959-8977; Amato, Alberto/0000-0002-9126-5535	Flagship project RITMARE (Ricerca ITaliana per it MARE, Italian Research for the Sea); European Union under FP7-People [600407]	Flagship project RITMARE (Ricerca ITaliana per it MARE, Italian Research for the Sea); European Union under FP7-People	IDC and AA were partially supported by the Flagship project RITMARE (Ricerca ITaliana per it MARE, Italian Research for the Sea). AA was funded by the European Union under FP7-People, GA n. 600407.r Ferdinando Tramontano and Gianluca Zazo are acknowledged for sampling at station LTER-MC, Elvira Mauriello for techinal assistance and Lorenzo Longobardi for producing Fig 5. We thank Marco Uttieri for discussions that helped improving the manuscript and Suzanne Rose for language check. IDC and AA were partially supported by the Flagship project RITMARE (Ricerca ITaliana per il MARE, Italian Research for the Sea). AA was funded by the European Union under FP7-People, GA n. 600407. The present results contributed to the ICES-WGIMT and were presented at the ICES/PICES 6ZPS 2016/S4.	Adamowicz SJ, 2007, BIOL J LINN SOC, V90, P279, DOI 10.1111/j.1095-8312.2007.00723.x; Amato A, 2007, PROTIST, V158, P193, DOI 10.1016/j.protis.2006.10.001; Baek SY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157307; Bersano JGF, 1996, NAUPLIUS, V2, P29; Blanco-Bercial L, 2014, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.cdf8b74881f87e3b01d56b43791626d2; Bottger-Schnack R, 2011, HYDROBIOLOGIA, V666, P111, DOI 10.1007/s10750-010-0094-1; Boettger-Schnack Ruth, 2009, Marine Biodiversity, V39, P131; Bottger-Schnack R., 1994, Hydrobiologia, V292-293, P271, DOI 10.1007/BF00229951; Bottger-Schnack R., 2001, B BR MUS LONDON NAT, V67, P25; Bottger-Schnack Ruth, 1999, Mitteilungen aus dem Hamburgischen Zoologischen Museum und Institut, V96, P37; BOTTGERSCHNACK R, 1992, MAR ECOL PROG SER, V80, P301, DOI 10.3354/meps080301; BOTTGERSCHNACK R, 1995, MAR ECOL PROG SER, V118, P81, DOI 10.3354/meps118081; Boxshall G. A., 2004, INTRO COPEPOD DIVERS; Braga E, 1999, MAR BIOL, V133, P79, DOI 10.1007/s002270050445; Bucklin A, 2003, MAR BIOL, V142, P333, DOI 10.1007/s00227-002-0943-1; Bucklin A, 2007, J PLANKTON RES, V29, P483, DOI 10.1093/plankt/fbm031; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; Bucklin A, 2010, DEEP-SEA RES PT II, V57, P40, DOI 10.1016/j.dsr2.2009.08.005; Bucklin A, 2009, J CRUSTACEAN BIOL, V29, P111, DOI 10.1651/07-2879.1; Caudill CC, 2004, HYDROBIOLOGIA, V511, P91, DOI 10.1023/B:HYDR.0000014032.05680.9d; Chu KH, 2001, MAR BIOTECHNOL, V3, P355, DOI 10.1007/s10126001-0014-5; Cornils A, 2013, MOL PHYLOGENET EVOL, V69, P861, DOI 10.1016/j.ympev.2013.06.018; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; D'Alcala MR, 2004, SCI MAR, V68, P65; Di Capuai I, 2008, J MAR BIOL ASSOC UK, V88, P1407, DOI 10.1017/S002531540800194X; Dvoretsky VG, 2009, MAR ECOL PROG SER, V385, P165, DOI 10.3354/meps07984; Edmands S, 2001, MOL ECOL, V10, P1743, DOI 10.1046/j.0962-1083.2001.01306.x; Elvers D, 2006, MAR BIOL, V149, P503, DOI 10.1007/s00227-005-0234-8; Eyun S, 2002, ZOOLOG SCI, V4, P265; Figueroa DF, 2011, J CRUSTACEAN BIOL, V31, P153, DOI 10.1651/10-3341.1; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Giesbrecht W., 1893, SYSTEMATIK FAUNISTIK; Goetze E, 2003, P ROY SOC B-BIOL SCI, V270, P2321, DOI 10.1098/rspb.2003.2505; GUTELL RR, 1994, MICROBIOL REV, V58, P10, DOI 10.1128/MMBR.58.1.10-26.1994; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heron GA, 2000, P BIOL SOC WASH, V113, P1015; Holynska M, 2006, ZOOL J LINN SOC-LOND, V147, P1; Kumar S., 2016, MOL BIOL EVOLUTION, V33, DOI [DOI 10.1093/M0LBEV/MSW054, https://doi.org/10.1093/molbev/msw054, 10.1093/molbev/msw054]; Lee CE, 2000, EVOLUTION, V54, P2014, DOI 10.1111/j.0014-3820.2000.tb01245.x; Machida RJ, 2006, MAR BIOL, V148, P1071, DOI 10.1007/s00227-005-0140-0; Machida RJ, 2004, GENE, V332, P71, DOI 10.1016/j.gene.2004.01.019; Marszalek MA, 2009, HYDROBIOLOGIA, V624, P61, DOI 10.1007/s10750-008-9666-8; MAZZOCCHI MG, 1995, ICES J MAR SCI, V52, P679, DOI 10.1016/1054-3139(95)80081-6; Mazzocchi MG, 2016, PROGR OCEANOGR; Nei M, 2000, MOL EVOLUTION PHYLOG; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Raupach MJ, 2015, PLOS ONE; Razouls C, DIVERSITY GEOGRAPHIC; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sabia L, 2017, EUR ZOOL J, V84, P104, DOI 10.1080/11250003.2016.1276639; Sars GO, 1916, B I OCEANOGR MONACO, V323, P1; SCHONIGER M, 1994, MOL PHYLOGENET EVOL, V3, P240, DOI 10.1006/mpev.1994.1026; Schultz J, 2005, RNA, V11, P361, DOI 10.1261/rna.7204505; Schultz J, 2009, MOL PHYLOGENET EVOL, V52, P520, DOI 10.1016/j.ympev.2009.01.008; Shmeleva A., 1969, Bulletin de l'Institut Oceanographique Monaco, V68, P1; SHMELEVA A. A., 1966, ZOOL ZH, V45, P932; SHMELEVA A A, 1968, Zoologicheskii Zhurnal, V47, P1784; SHMELEVA AA, 1979, ZOOL ZH, V58, P491; Shoemaker KM, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv064; Stocsits RR, 2009, NUCLEIC ACIDS RES, V37, P6184, DOI 10.1093/nar/gkp600; Takahashi K, 2001, MOL BIOL EVOL, V18, P2057, DOI 10.1093/oxfordjournals.molbev.a003747; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Thum RA, 2009, BIOL J LINN SOC, V96, P150, DOI 10.1111/j.1095-8312.2008.01105.x; van de Velde I., 1984, Crustaceana Supplement (Leiden), P404; VANDEVELDE I, 1984, HYDROBIOLOGIA, V109, P3, DOI 10.1007/BF00006297; Walter TC, 2017, WORLD COPEPODS DATAB; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wolf M, 2005, RNA, V11, P1616, DOI 10.1261/rna.2144205; Wyngaard GA, 2010, MOL PHYLOGENET EVOL, V55, P753, DOI 10.1016/j.ympev.2010.02.029; Yebra L, 2016, CHARACTERIZATION PLA; Zagoskin MV, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/926342; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	74	16	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0175662	10.1371/journal.pone.0175662	http://dx.doi.org/10.1371/journal.pone.0175662			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441395	Green Published, gold, Green Submitted			2022-12-26	WOS:000400308800009
J	Nambiar, AM; Anzueto, AR; Peters, JI				Nambiar, Anoop M.; Anzueto, Antonio R.; Peters, Jay I.			Effectiveness and safety of mycophenolate mofetil in idiopathic pulmonary fibrosis	PLOS ONE			English	Article							INTERSTITIAL LUNG-DISEASE; AZATHIOPRINE; ACETYLCYSTEINE; PROLIFERATION; MAINTENANCE; EXPRESSION; AUTOIMMUNE; TRIAL	Background Currently available antifibrotic treatments may slow down disease progression in idiopathic pulmonary fibrosis (IPF), but are associated with potentially significant side effects and are costly. Mycophenolate mofetil (MMF) is well known for its potent immunosuppressive properties and possesses important antiproliferative and antifibrotic effects. The safety and effectiveness of MMF in IPF is unknown. Methods We performed a retrospective multicohort analysis of IPF patients treated with MMF compared to those treated with either ineffective/harmful treatments or no treatment. Longitudinal change in forced vital capacity (FVC) between the groups was analyzed using a mixed model with random intercept and slope allowing for repeated measures within subjects. Categorical change in FVC, median overall survival, and adverse events were also assessed. Results Forty-one IPF patients were included: 11 treated with MMF, 20 treated with ineffective/harmful agents (such as prednisone, azathioprine, and/or NAC), and 10 did not receive any specific treatment for their IPF. After one year, there was a trend towards reduced FVC decline in the MMF-treated group (-76.3 mL, -2.4% of predicted) compared to the non-MMF-treated (-165 mL, -8.9% of predicted) and the no-treatment (-239 mL, -11.5% of predicted) groups, respectively. By categorical change, there was a trend towards greater FVC stability in the MMF-treated group (87.5%) compared to the non-MMF-treated (57%) and the no-treatment groups (50%), respectively. MMF-treated IPF patients had a trend towards improved median overall survival (40.3 months) compared to the non-MMF-treated (25.5 months) and the no-treatment (29.3 months) groups, respectively. Treatment-related adverse events were not different between groups; however, very few adverse events were reported overall. Conclusions MMF treatment was associated with potentially clinically important trends toward reduced annual FVC decline (similar to approved antifibrotics), greater FVC stability and improved overall survival in IPF patients. MMF was generally safe, well tolerated, and relatively inexpensive. Future prospective studies of MMF in combination with antifibrotic therapy in IPF are needed.	[Nambiar, Anoop M.; Anzueto, Antonio R.; Peters, Jay I.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Pulm Dis & Crit Care Med, San Antonio, TX 78229 USA; [Nambiar, Anoop M.; Anzueto, Antonio R.; Peters, Jay I.] South Texas Vet Hlth Care Syst, Div Pulm Dis & Crit Care Med, Dept Med, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Nambiar, AM (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Pulm Dis & Crit Care Med, San Antonio, TX 78229 USA.; Nambiar, AM (corresponding author), South Texas Vet Hlth Care Syst, Div Pulm Dis & Crit Care Med, Dept Med, San Antonio, TX 78229 USA.	Nambiar@uthscsa.edu	Nambiar, Anoop M./P-5319-2017	Nambiar, Anoop M./0000-0003-2778-0433	National Center for Advancing Translational Sciences, National Institutes of Health (NIH) [UL1 TR001120]	National Center for Advancing Translational Sciences, National Institutes of Health (NIH)	The project described was supported by the National Center for Advancing Translational Sciences, National Institutes of Health (NIH), through Grant UL1 TR001120. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison AC, 2000, IMMUNOPHARMACOLOGY, V47, P85, DOI 10.1016/S0162-3109(00)00188-0; Altschuler EL, 2001, MED HYPOTHESES, V57, P701, DOI 10.1054/mehy.2001.1437; Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; Appel GB, 2005, TRANSPLANTATION, V80, pS265, DOI 10.1097/01.tp.0000186389.19911.9c; Canestaro WJ, 2016, CHEST, V149, P756, DOI 10.1016/j.chest.2015.11.013; Chartrand S, 2016, RESP MED, V119, P150, DOI 10.1016/j.rmed.2016.09.002; Contreras G, 2004, NEW ENGL J MED, V350, P971, DOI 10.1056/NEJMoa031855; Demedts M, 2005, NEW ENGL J MED, V353, P2229, DOI 10.1056/NEJMoa042976; Dooley MA, 2011, NEW ENGL J MED, V365, P1886, DOI 10.1056/NEJMoa1014460; Ferreira LM., 2014, PULMONARY FIBRO 1023; Fischer A, 2005, ARTHRITIS RHEUM-US, V52, pS712; Gerbino AJ, 2008, CHEST, V133, P455, DOI 10.1378/chest.06-2861; GOLDBLUM R, 1993, CLIN EXP RHEUMATOL, V11, pS117; Groetzner J, 2006, TRANSPLANTATION, V81, P355, DOI 10.1097/01.tp.0000195781.02268.5e; Grotz W, 1998, LANCET, V352, P1195, DOI 10.1016/S0140-6736(05)60533-8; Guo H, 2005, LUPUS, V14, P583, DOI 10.1191/0961203305lu2170oa; Hyzy R, 2007, CHEST, V132, P1652, DOI 10.1378/chest.07-0299; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Kouba DJ, 2003, BRIT J DERMATOL, V148, P147, DOI 10.1046/j.1365-2133.2003.05042.x; Koutroumpas A, 2010, CLIN RHEUMATOL, V29, P1167, DOI 10.1007/s10067-010-1498-z; Langford CA, 2004, ARTHRIT RHEUM-ARTHR, V51, P278, DOI 10.1002/art.20240; Liossis SNC, 2006, RHEUMATOLOGY, V45, P1005, DOI 10.1093/rheumatology/kei211; Morath C, 2006, CLIN TRANSPLANT, V20, P25, DOI 10.1111/j.1399-0012.2006.00597.x; Morisset J, 2016, CHEST; Olson AL, 2007, AM J RESP CRIT CARE, V176, P277, DOI 10.1164/rccm.200701-044OC; Omair MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124205; Palmer SM, 2001, TRANSPLANTATION, V71, P1772, DOI 10.1097/00007890-200106270-00012; Petrova DT, 2010, THER DRUG MONIT, V32, P405, DOI 10.1097/FTD.0b013e3181e44260; Simeon-Aznar CP, 2011, CLIN RHEUMATOL, V30, P1393, DOI 10.1007/s10067-011-1823-1; Raghu G, 2012, NEW ENGL J MED, V366, P1968, DOI 10.1056/NEJMoa1113354; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Samad AS, 2003, SOUTH MED J, V96, P705, DOI 10.1097/01.SMJ.0000054424.20202.7D; Shimizu H, 2004, TRANSPLANTATION, V77, P1661, DOI 10.1097/01.TP.0000127592.13707.B6; Swigris JJ, 2006, CHEST, V130, P30, DOI 10.1016/S0012-3692(15)50949-5; Tashkin DP, 2016, LANCET RESP MED, V4, P708, DOI 10.1016/S2213-2600(16)30152-7; Tzouvelekis A, 2011, PULM MED, V2011, DOI 10.1155/2011/849035; Tzouvelekis A, 2012, PULM MED, V2012, DOI 10.1155/2012/143637; Waller JR, 2005, TRANSPL P, V37, P164, DOI 10.1016/j.transproceed.2005.01.049; Zamora AC, 2008, RESP MED, V102, P150, DOI 10.1016/j.rmed.2007.07.021	40	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176312	10.1371/journal.pone.0176312	http://dx.doi.org/10.1371/journal.pone.0176312			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441449	Green Published, gold, Green Submitted			2022-12-26	WOS:000400308800043
J	Salehe, BR; Jones, CI; Di Fatta, G; McGuffin, LJ				Salehe, Bajuna Rashid; Jones, Chris Ian; Di Fatta, Giuseppe; McGuffin, Liam James			RAPIDSNPs: A new computational pipeline for rapidly identifying key genetic variants reveals previously unidentified SNPs that are significantly associated with individual platelet responses	PLOS ONE			English	Article							WHOLE-GENOME ASSOCIATION; MISSING HERITABILITY; VARIABLE IMPORTANCE; RIDGE-REGRESSION; COMMON DISEASES; CANDIDATE GENE; WIDE; SELECTION; AGGREGATION; CLASSIFICATION	Advances in omics technologies have led to the discovery of genetic markers, or single nucleotide polymorphisms (SNPs), that are associated with particular diseases or complex traits. Although there have been significant improvements in the approaches used to analyse associations of SNPs with disease, further optimised and rapid techniques are needed to keep up with the rate of SNP discovery, which has exacerbated the 'missing heritability' problem. Here, we have devised a novel, integrated, heuristic-based, hybrid analytical computational pipeline, for rapidly detecting novel or key genetic variants that are associated with diseases or complex traits. Our pipeline is particularly useful in genetic association studies where the genotyped SNP data are highly dimensional, and the complex trait phenotype involved is continuous. In particular, the pipeline is more efficient for investigating small sets of genotyped SNPs defined in high dimensional spaces that may be associated with continuous phenotypes, rather than for the investigation of whole genome variants. The pipeline, which employs a consensus approach based on the random forest, was able to rapidly identify previously unseen key SNPs, that are significantly associated with the platelet response phenotype, which was used as our complex trait case study. Several of these SNPs, such as rs6141803 of COMMD7 and rs41316468 in PKT2B, have independently confirmed associations with cardiovascular diseases (CVDs) according to other unrelated studies, suggesting that our pipeline is robust in identifying key genetic variants. Our new pipeline provides an important step towards addressing the problem of ` missing heritability' through enhanced detection of key genetic variants (SNPs) that are associated with continuous complex traits/ disease phenotypes.	[Salehe, Bajuna Rashid; Jones, Chris Ian; McGuffin, Liam James] Univ Reading, Sch Biol Sci, Reading, Berks, England; [Di Fatta, Giuseppe] Univ Reading, Dept Comp Sci, Reading, Berks, England	University of Reading; University of Reading	Salehe, BR (corresponding author), Univ Reading, Sch Biol Sci, Reading, Berks, England.	b.r.salehe@pgr.reading.ac.uk	McGuffin, Liam/A-5598-2008; Di+Fatta, Giuseppe/ABG-6652-2020	McGuffin, Liam/0000-0003-4501-4767; Di+Fatta, Giuseppe/0000-0003-3096-2844; Jones, Chris/0000-0001-7537-1509; Salehe, Bajuna/0000-0003-2953-4674	Institute of Finance Management under the ministry of finance (MoF) of the Tanzanian Government; 6th Framework Program of the European Union [LSHM-CT-2004-503485]	Institute of Finance Management under the ministry of finance (MoF) of the Tanzanian Government; 6th Framework Program of the European Union(European Commission)	The authors thank the Institute of Finance Management under the ministry of finance (MoF) of the Tanzanian Government for studentship funding (to BRS) and Bloodomics project supported by the 6th Framework Program of the European Union (LSHM-CT-2004-503485) which provided the data.	Ayers KL, 2010, GENET EPIDEMIOL, V34, P879, DOI 10.1002/gepi.20543; Bennett JS, 2001, ANN NY ACAD SCI, V936, P340; Braga-Neto U, 2004, BIOINFORMATICS, V20, P253, DOI 10.1093/bioinformatics/btg399; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Chien MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051051; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Cule E., 2015, PACKAGE RIDGE; Cule E, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-372; de Martino M, 2009, J UROLOGY, V182, P728, DOI 10.1016/j.juro.2009.03.077; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Fontana P, 2003, CIRCULATION, V108, P989, DOI 10.1161/01.CIR.0000085073.69189.88; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Frost S., 2013, CARBONIC ANHYDRASE M; Genuer R, 2010, PATTERN RECOGN LETT, V31, P2225, DOI 10.1016/j.patrec.2010.03.014; Goldstein BA, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1691; Goodall AH, 2010, BLOOD, V116, P4646, DOI 10.1182/blood-2010-04-280925; Han F, 2010, HUM HERED, V70, P42, DOI 10.1159/000288704; Harrell FE, 2001, REGRESSION MODELING; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Hoffmann TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013584; Hoggart CJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000130; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Johnson AD, 2010, NAT GENET, V42, P608, DOI 10.1038/ng.604; Jones CI, 2007, J THROMB HAEMOST, V5, P1756, DOI 10.1111/j.1538-7836.2007.02632.x; Jones CI, 2009, BLOOD, V114, P1405, DOI 10.1182/blood-2009-02-202614; Kamide K, 2007, PHARMACOGENET GENOM, V17, P931, DOI 10.1097/FPC.0b013e3282ef640e; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Koch E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080754; Kohannim O, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00115; Kursa MB, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i11; Kursa MB, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-8; Lawrence R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-367; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li MJ, 2013, NUCLEIC ACIDS RES; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; Lumley T, 2015, PACKAGE LEAPS; Malo N, 2008, AM J HUM GENET, V82, P375, DOI 10.1016/j.ajhg.2007.10.012; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Moore JH, 2010, BIOINFORMATICS, V26, P445, DOI 10.1093/bioinformatics/btp713; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Motsinger AA, 2007, 2007 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN BIOINFORMATICS AND COMPUTATIONAL BIOLOGY, P1; Motyer Allan J, 2011, BMC Proc, V5 Suppl 9, pS24, DOI 10.1186/1753-6561-5-S9-S24; Nakai M., 2011, INT J MATH ANAL, V5, P1; Nicodemus KK, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-110; Nonyane BA, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-71; Offermanns S, 2006, CIRC RES, V99, P1293, DOI 10.1161/01.RES.0000251742.71301.16; Paul J, 2013, ECML WORKSH SOLV COM; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; PYTELA R, 1986, SCIENCE, V231, P1559, DOI 10.1126/science.2420006; Ritchie MD, 2015, NAT REV GENET, V16, P85, DOI 10.1038/nrg3868; Robinson MR, 2014, TRENDS GENET, V30, P124, DOI 10.1016/j.tig.2014.02.003; Saar-Tsechansky M, 2007, J MACH LEARN RES, V8, P1625; Soranzo N, 2009, BLOOD, V113, P3831, DOI 10.1182/blood-2008-10-184234; Stanner S, 2008, CARDIOVASCULAR DIS D; Strobl C., 2008, P 18 INT C COMP STAP; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Nguyen TT, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S2-S5; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Viles-Gonzalez JF, 2004, EUR HEART J, V25, P1197, DOI 10.1016/j.ehj.2004.03.011; Woodman R, 2010, HYPERTENSION, V56, P463, DOI 10.1161/HYPERTENSIONAHA.110.154476; Woulfe D, 2001, J CLIN INVEST, V107, P1503, DOI 10.1172/JCI13361; Wu J, 2010, GENET EPIDEMIOL, V34, P275, DOI 10.1002/gepi.20459; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Wu QY, 2012, IEEE T NANOBIOSCI, V11, P216, DOI 10.1109/TNB.2012.2214232; Wu TT, 2009, BIOINFORMATICS, V25, P714, DOI 10.1093/bioinformatics/btp041; Zhu X., 2014, OPEN J STAT, V4, P933, DOI [DOI 10.4236/OJS.2014.411088, 10.4236/ojs.2014.411088]	72	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0175957	10.1371/journal.pone.0175957	http://dx.doi.org/10.1371/journal.pone.0175957			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441463	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000400308800015
J	Wong, CS; Lin, YC; Sung, LC; Chen, TT; Ma, HP; Hsu, YH; Tsai, SH; Lin, YF; Wu, MY				Wong, Chung-Shun; Lin, Ying-Chin; Sung, Li-Chin; Chen, Tzu-Ting; Ma, Hon-Ping; Hsu, Yung-Ho; Tsai, Shin-Han; Lin, Yuh-Feng; Wu, Mei-Yi			Increased long-term risk of major adverse cardiovascular events in patients with carbon monoxide poisoning: A population-based study in Taiwan	PLOS ONE			English	Article							MORTALITY; MODERATE	Background Carbon monoxide (CO) poisoning may cause toxicity to the cardiovascular system. However, the association between CO poisoning and the risk of major adverse cardiovascular events (MACE) remains unestablished. We investigated the incidence of MACE after CO poisoning in Taiwan and evaluated whether CO-poisoned individuals had a higher risk of MACE than did the general population. Methods Using Taiwan's National Health Insurance Research Database (NHIRD) during 2005-2013, a nationwide population-based cohort study was conducted among patients who experienced CO poisoning between 2005 and 2013. CO poisoning was defined according to the International Classification of Diseases, Ninth Revision, Clinical Modification codes. The study cohort comprised patients with CO poisoning between 2005 and 2010 (N = 13,939). Each patient was matched according to age, sex and index date with four randomly selected controls from the comparison cohort (N = 55,756). All patients were followed from the study date until MACE development, death, or the end of 2013. The hazard ratios for MACE were compared between the two cohorts by using Cox proportional hazards regressions analyses. Results Incident cases of MACE were identified from the NHIRD. After adjustment for potential confounders, the study cohort was independently associated with a higher MACE risk (adjusted hazard ratio, 2.00; 95% confidence interval, 1.83-2.18). Conclusion This population-based cohort study indicated that patients with CO poisoning have a higher risk of MACE than do individuals without CO poisoning.	[Wong, Chung-Shun; Ma, Hon-Ping; Tsai, Shin-Han] Taipei Med Univ, Shuang Ho Hosp, Dept Emergency Med, Taipei, Taiwan; [Wong, Chung-Shun; Lin, Yuh-Feng] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Wong, Chung-Shun; Ma, Hon-Ping; Tsai, Shin-Han] Taipei Med Univ, Coll Med, Sch Med, Dept Emergency Med, Taipei, Taiwan; [Lin, Ying-Chin] Taipei Med Univ, Shuang Ho Hosp, Dept Family Med, Taipei, Taiwan; [Lin, Ying-Chin] Taipei Med Univ, Sch Med, Coll Med, Dept Family Med, Taipei, Taiwan; [Sung, Li-Chin] Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Chen, Tzu-Ting; Wu, Mei-Yi] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei, Taiwan; [Hsu, Yung-Ho; Lin, Yuh-Feng; Wu, Mei-Yi] Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Div Nephrol, Taipei, Taiwan; [Hsu, Yung-Ho; Lin, Yuh-Feng; Wu, Mei-Yi] Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan; [Tsai, Shin-Han] Taipei Med Univ, Coll Publ Hlth & Nutr, Taipei, Taiwan	Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; National Taiwan University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University	Lin, YF (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan.; Wu, MY (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei, Taiwan.; Lin, YF; Wu, MY (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Div Nephrol, Taipei, Taiwan.; Lin, YF; Wu, MY (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan.	linyf@s.tmu.edu.tw; e220121@gmail.com		sung, lichin/0000-0001-6292-7117; Wu, Mei-Yi/0000-0002-5777-2752; Wong, Chung-Shun/0000-0003-3347-3843				Chiew AL, 2014, CRIT CARE, V18, DOI 10.1186/cc13846; Henry CR, 2006, JAMA-J AM MED ASSOC, V295, P398, DOI 10.1001/jama.295.4.398; Kao HK, 2009, PULM PHARMACOL THER, V22, P473, DOI 10.1016/j.pupt.2009.04.006; Lee FY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000624; Nikkanen Heikki, 2011, Emerg Med Pract, V13, P1; Ruth-Sahd LA, 2011, DIMENS CRIT CARE NUR, V30, P303, DOI 10.1097/DCC.0b013e31822fb017; Ryoo SM, 2013, HUM EXP TOXICOL, V32, P1193, DOI 10.1177/0960327112472991; Satran D, 2005, J AM COLL CARDIOL, V45, P1513, DOI 10.1016/j.jacc.2005.01.044; Shie HG, 2007, INHAL TOXICOL, V19, P905, DOI 10.1080/08958370701432173; Szponar Jaroslaw, 2012, Przegl Lek, V69, P528; Teksam O, 2010, EUR J EMERG MED, V17, P192, DOI 10.1097/MEJ.0b013e328320ad48; THORN SR, 1995, ANN EMERG MED, V25, P474, DOI 10.1016/S0196-0644(95)70261-X; Weaver LK, 2009, NEW ENGL J MED, V360, P1217, DOI 10.1056/NEJMcp0808891; Wolf Stephen J, 2008, J Emerg Nurs, V34, pe19, DOI 10.1016/j.jen.2008.02.009; Yanir Y, 2002, ANN EMERG MED, V40, P420, DOI 10.1067/mem.2002.126744	15	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176465	10.1371/journal.pone.0176465	http://dx.doi.org/10.1371/journal.pone.0176465			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441428	Green Published, Green Submitted, gold			2022-12-26	WOS:000400308800061
J	Schaeffer, C; Merella, S; Pasqualetto, E; Lazarevic, D; Rampoldi, L				Schaeffer, Celine; Merella, Stefania; Pasqualetto, Elena; Lazarevic, Dejan; Rampoldi, Luca			Mutant uromodulin expression leads to altered homeostasis of the endoplasmic reticulum and activates the unfolded protein response	PLOS ONE			English	Article							TAMM-HORSFALL PROTEIN; JUVENILE HYPERURICEMIC NEPHROPATHY; GLOMERULOCYSTIC KIDNEY-DISEASE; TRANSCRIPTION FACTOR; SODIUM 4-PHENYLBUTYRATE; GENE-EXPRESSION; STRESS; MUTATIONS; MICE; CELLS	Uromodulin is the most abundant urinary protein in physiological conditions. It is exclusively produced by renal epithelial cells lining the thick ascending limb of Henle's loop (TAL) and it plays key roles in kidney function and disease. Mutations in UMOD, the gene encoding uromodulin, cause autosomal dominant tubulointerstitial kidney disease uromodulin-related (ADTKD-UMOD), characterised by hyperuricemia, gout and progressive loss of renal function. While the primary effect of UMOD mutations, retention in the endoplasmic reticulum (ER), is well established, its downstream effects are still largely unknown. To gain insight into ADTKD-UMOD pathogenesis, we performed transcriptional profiling and biochemical characterisation of cellular models (immortalised mouse TAL cells) of robust expression of wild type or mutant GFP-tagged uromodulin. In this model mutant uromodulin accumulation in the ER does not impact on cell viability and proliferation. Transcriptional profiling identified 109 genes that are differentially expressed in mutant cells relative to wild type ones. Up-regulated genes include several ER resident chaperones and protein disulphide isomerases. Consistently, pathway enrichment analysis indicates that mutant uromodulin expression affects ER function and protein homeostasis. Interestingly, mutant uromodulin expression induces the Unfolded Protein Response (UPR), and specifically the IRE1 branch, as shown by an increased splicing of XBP1. Consistent with UPR induction, we show increased interaction of mutant uromodulin with ER chaperones Bip, calnexin and PDI. Using metabolic labelling, we also demonstrate that while autophagy plays no role, mutant protein is partially degraded by the proteasome through ER-associated degradation. Our work demonstrates that ER stress could play a central role in ADTKD-UMOD pathogenesis. This sets the bases for future work to develop novel therapeutic strategies through modulation of ER homeostasis and associated protein degradation pathways.	[Schaeffer, Celine; Pasqualetto, Elena; Rampoldi, Luca] IRCCS San Raffaele Sci Inst, Div Genet & Cell Biol, Mol Genet Renal Disorders, Milan, Italy; [Merella, Stefania; Lazarevic, Dejan] IRCCS San Raffaele Sci Inst, Ctr Translat Genom & Bioinformat, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Rampoldi, L (corresponding author), IRCCS San Raffaele Sci Inst, Div Genet & Cell Biol, Mol Genet Renal Disorders, Milan, Italy.	rampoldi.luca@hsr.it	Pasqualetto, Elena/AAN-2239-2020; Lazarevic, Dejan/AAN-1861-2020; Schaeffer, Celine/AAC-5208-2022; Rampoldi, Luca/AAN-6228-2020; Schaeffer, Celine/AAU-5713-2020; Rampoldi, Luca/L-3639-2018; Pasqualetto, Elena/ABG-4473-2020	Schaeffer, Celine/0000-0001-5883-3951; Rampoldi, Luca/0000-0002-0544-7042; Schaeffer, Celine/0000-0001-5883-3951; Rampoldi, Luca/0000-0002-0544-7042; Pasqualetto, Elena/0000-0003-2130-1577; lazarevic, dejan/0000-0003-4527-290X	Fondazione Telethon [GGP14263]; Italian Ministry of Health [RF-2010-2319394, PE-2011-02352286]	Fondazione Telethon(Fondazione TelethonEuropean Commission); Italian Ministry of Health(Ministry of Health, Italy)	This work has been funded by Fondazione Telethon (http://www.telethon.it), grant no. GGP14263 (LR); Italian Ministry of Health (http://www.salute.gov.it), grants n. RF-2010-2319394 and PE-2011-02352286 (LR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam J, 2012, AM J KIDNEY DIS, V59, P117, DOI 10.1053/j.ajkd.2011.08.014; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bates JM, 2004, KIDNEY INT, V65, P791, DOI 10.1111/j.1523-1755.2004.00452.x; Bernascone I, 2006, TRAFFIC, V7, P1567, DOI 10.1111/j.1600-0854.2006.00481.x; Bernascone I, 2010, HUM MOL GENET, V19, P2998, DOI 10.1093/hmg/ddq205; Bingham C, 2003, KIDNEY INT, V63, P1645, DOI 10.1046/j.1523-1755.2003.00903.x; Bolar NA, 2016, AM J HUM GENET, V99, P174, DOI 10.1016/j.ajhg.2016.05.028; Brunati M, 2015, ELIFE, V4, DOI 10.7554/eLife.08887; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cantore A, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1405; Chen YM, 2013, J AM SOC NEPHROL, V24, P1223, DOI 10.1681/ASN.2012121149; Choi SW, 2005, J AM SOC NEPHROL, V16, P3006, DOI 10.1681/ASN.2005050461; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Dahan K, 2003, J AM SOC NEPHROL, V14, P2883, DOI 10.1097/01.ASN.0000092147.83480.B5; Darisipudi MN, 2012, J AM SOC NEPHROL, V23, P1783, DOI 10.1681/ASN.2012040338; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Drozdova T, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.86; Eckardt KU, 2015, KIDNEY INT, V88, P676, DOI 10.1038/ki.2015.28; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; El-Achkar TM, 2008, AM J PHYSIOL-RENAL, V295, pF534, DOI 10.1152/ajprenal.00083.2008; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fedeles SV, 2015, J CLIN INVEST, V125, P1955, DOI 10.1172/JCI78863; Follenzi A, 2004, BLOOD, V103, P3700, DOI 10.1182/blood-2003-09-3217; Garimella PS, 2016, AM J KIDNEY DIS; Garimella PS, 2016, CLIN J AM SOC NEPHRO; GAUSH CR, 1966, P SOC EXP BIOL MED, V122, P931; Gudbjartsson DF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001039; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hassan H, 2016, J AM SOC NEPHROL, V27, P1055, DOI 10.1681/ASN.2015020191; Hassler JR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002277; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hetz C, 2015, NAT CELL BIOL, V17, P829, DOI 10.1038/ncb3184; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Jiang DD, 2015, SEMIN CANCER BIOL, V33, P48, DOI 10.1016/j.semcancer.2015.04.010; Kemter E, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep42970; Kemter E, 2014, J BIOL CHEM, V289, P10715, DOI 10.1074/jbc.M113.537035; Kemter E, 2013, HUM MOL GENET, V22, P4148, DOI 10.1093/hmg/ddt263; Kim Y, 2016, J AM SOC NEPHROL, V27, P2974, DOI 10.1681/ASN.2014100986; Kirby A, 2013, NAT GENET, V45, P299, DOI 10.1038/ng.2543; Lee JW, 2015, J AM SOC NEPHROL, V26, P2669, DOI 10.1681/ASN.2014111067; Lens XM, 2005, AM J KIDNEY DIS, V46, P52, DOI 10.1053/j.ajkd.2005.04.003; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Ma LJ, 2012, J BIOL CHEM, V287, P1290, DOI 10.1074/jbc.M111.283036; Mo L, 2004, AM J PHYSIOL-RENAL, V286, pF795, DOI 10.1152/ajprenal.00357.2003; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Moskowitz JL, 2013, CLIN J AM SOC NEPHRO, V8, P1349, DOI 10.2215/CJN.11151012; Nasr SH, 2008, KIDNEY INT, V73, P971, DOI 10.1038/sj.ki.5002679; Pieri M, 2014, J AM SOC NEPHROL, V25, P260, DOI 10.1681/ASN.2012121217; Rampoldi L, 2003, HUM MOL GENET, V12, P3369, DOI 10.1093/hmg/ddg353; Rampoldi L, 2011, KIDNEY INT, V80, P338, DOI 10.1038/ki.2011.134; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sado M, 2009, BRAIN RES, V1257, P16, DOI 10.1016/j.brainres.2008.11.104; Schaeffer C, 2012, KIDNEY INT, V81, P769, DOI 10.1038/ki.2011.456; Scolari F, 2004, AM J KIDNEY DIS, V44, P987, DOI 10.1053/j.ajkd.2004.08.021; SERAFINICESSI F, 1979, BIOCHEM J, V183, P381, DOI 10.1042/bj1830381; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Trudu M, 2013, NAT MED, V19, P1655, DOI 10.1038/nm.3384; Turner JJO, 2003, J CLIN ENDOCR METAB, V88, P1398, DOI 10.1210/jc.2002-021973; Utami SB, 2015, CLIN EXP NEPHROL, V19, P576, DOI 10.1007/s10157-014-1032-8; Vidal RL, 2012, HUM MOL GENET, V21, P2245, DOI 10.1093/hmg/dds040; Walter F, 2015, CELL DEATH DIFFER, V22, P1502, DOI 10.1038/cdd.2014.241; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Wang Y, 2000, J BIOL CHEM, V275, P27013; Whitehead RH, 2009, AM J PHYSIOL-GASTR L, V296, pG455, DOI 10.1152/ajpgi.90381.2008; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4; Zivna M, 2009, AM J HUM GENET, V85, P204, DOI 10.1016/j.ajhg.2009.07.010	71	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0175970	10.1371/journal.pone.0175970	http://dx.doi.org/10.1371/journal.pone.0175970			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437467	Green Published, gold, Green Submitted			2022-12-26	WOS:000400287600024
J	Ito, S; Nagoshi, T; Minai, K; Kashiwagi, Y; Sekiyama, H; Yoshii, A; Kimura, H; Inoue, Y; Ogawa, K; Tanaka, TD; Ogawa, T; Kawai, M; Yoshimura, M				Ito, Satoshi; Nagoshi, Tomohisa; Minai, Kosuke; Kashiwagi, Yusuke; Sekiyama, Hiroshi; Yoshii, Akira; Kimura, Haruka; Inoue, Yasunori; Ogawa, Kazuo; Tanaka, Toshikazu D.; Ogawa, Takayuki; Kawai, Makoto; Yoshimura, Michihiro			Possible increase in insulin resistance and concealed glucose-coupled potassium-lowering mechanisms during acute coronary syndrome documented by covariance structure analysis	PLOS ONE			English	Article							ELEVATION MYOCARDIAL-INFARCTION; NATRIURETIC PEPTIDE LEVELS; SERUM POTASSIUM; INTRAVENOUS GLUCOSE; AKT ACTIVATION; HEART; REPERFUSION; ISCHEMIA; FAILURE; IMPACT	Objective Although glucose-insulin-potassium (GIK) therapy ought to be beneficial for ischemic heart disease in general, variable outcomes in many clinical trials of GIK in acute coronary syndrome (ACS) had a controversial impact. This study was designed to examine whether "insulin resistance" is involved in ACS and to clarify other potential intrinsic compensatory mechanisms for GIK tolerance through highly statistical procedure. Methods and results We compared the degree of insulin resistance during ACS attack and remission phase after treatment in individual patients (n = 104). During ACS, homeostasis model assessment of insulin resistance (HOMA-IR) values were significantly increased (P < 0.001), while serum potassium levels were transiently decreased (degree of which was indicated by Delta K) (P < 0.001). This finding provides a renewed paradox, as Delta K, a surrogate marker of intrinsic GIK cascade activation, probably reflects the validated glucose metabolism during ischemic attack. Indeed, multiple regression analysis revealed that plasma glucose level during ACS was positively correlated with Delta K (P = 0.026), whereas HOMA-IR had no impact on Delta K. This positive correlation between Delta K and glucose was confirmed by covariance structure analysis with a strong impact (beta: 0.398, P = 0.015). Intriguingly, a higher incidence of myocardial infarction relative to unstable angina pectoris, as well as a longer hospitalization period were observed in patients with larger Delta K, indicating that Delta K also reflects disease severity of ACS. Conclusions Insulin resistance most likely increases during ACS; however, Delta K was positively correlated with plasma glucose level, which overwhelmed insulin resistance condition. The present study with covariance structure analysis suggests that there are potential endogenous glu-cose-coupled potassium lowering mechanisms, other than insulin, regulating glucose metabolism during ACS.	[Ito, Satoshi; Nagoshi, Tomohisa; Minai, Kosuke; Kashiwagi, Yusuke; Sekiyama, Hiroshi; Yoshii, Akira; Kimura, Haruka; Inoue, Yasunori; Ogawa, Kazuo; Tanaka, Toshikazu D.; Ogawa, Takayuki; Kawai, Makoto; Yoshimura, Michihiro] Jikei Univ, Div Cardiol, Dept Internal Med, Sch Med, Tokyo, Japan	Jikei University	Nagoshi, T (corresponding author), Jikei Univ, Div Cardiol, Dept Internal Med, Sch Med, Tokyo, Japan.	tnagoshi@jikei.ac.jp	Tanaka, Toshikazu D/K-5989-2018	Tanaka, Toshikazu D/0000-0002-0711-7880; Nagoshi, Tomohisa/0000-0002-8980-881X	Grants-in-Aid for Scientific Research [17K09531] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Caprio M, 2008, CIRC RES, V102, P1359, DOI 10.1161/CIRCRESAHA.108.174235; Dungan KM, 2009, LANCET, V373, P1798, DOI 10.1016/S0140-6736(09)60553-5; Foo K, 2003, HEART, V89, P31, DOI 10.1136/heart.89.1.31; Grossman AN, 2013, CIRCULATION, V127, P1040, DOI 10.1161/CIRCULATIONAHA.112.130625; Iguchi T, 2014, EUR HEART J-CARD IMG, V15, P284, DOI 10.1093/ehjci/jet158; Inoue Y, 2016, METABOLISM, V65, P38, DOI 10.1016/j.metabol.2015.09.019; Kashiwagi Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130605; Kim HJ, 2002, NEPHRON, V92, P33, DOI 10.1159/000065375; Kinoshita K, 2016, INT J CARDIOL, V215, P283, DOI 10.1016/j.ijcard.2016.04.111; Kloner RA, 2008, CIRCULATION, V117, P2423, DOI 10.1161/CIRCULATIONAHA.107.697979; Komukai K, 2012, CIRC J, V76, P145, DOI 10.1253/circj.CJ-11-0727; Lazzeri C, 2014, ANGIOLOGY, V65, P519, DOI 10.1177/0003319713489018; Madias JE, 2000, CHEST, V118, P904, DOI 10.1378/chest.118.4.904; Matsui T, 2001, CIRCULATION, V104, P330; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P437; Minai K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108983; Nagoshi T, 2005, J CLIN INVEST, V115, P2128, DOI 10.1172/JCI23073; Nagoshi T, 2011, CURR PHARM DESIGN, V17, P3846, DOI 10.2174/138161211798357773; Nam MC, 2016, CARDIOVASC DRUGS THE; Ogawa K, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005455; Ramachandran A, 2005, DIABETES CARE, V28, P2492, DOI 10.2337/diacare.28.10.2492; Ramratnam M, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000899; Riehle C, 2016, CIRC RES, V118, P1151, DOI 10.1161/CIRCRESAHA.116.306206; Sack MN, 2003, J AM COLL CARDIOL, V41, P1404, DOI 10.1016/S0735-1097(03)00164-5; Sekiyama H, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-4; Selker HP, 2016, AM HEART J, V178, P168, DOI 10.1016/j.ahj.2016.03.026; Selker HP, 2012, JAMA-J AM MED ASSOC, V307, P1925, DOI 10.1001/jama.2012.426; Selker HP, 2014, AM J CARDIOL, V113, P1599, DOI 10.1016/j.amjcard.2014.02.010; Trifunovic D, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-73; van der Horst ICC, 2012, NAT REV CARDIOL, V9, P377, DOI 10.1038/nrcardio.2012.75; Yagi H, 2010, J CARDIOL, V55, P345, DOI 10.1016/j.jjcc.2009.12.010; Yee J, 1999, CHEST, V115, p149S, DOI 10.1378/chest.115.suppl_2.149S	32	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0176435	10.1371/journal.pone.0176435	http://dx.doi.org/10.1371/journal.pone.0176435			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430816	Green Published, gold, Green Submitted			2022-12-26	WOS:000399876100045
J	Bozkurt, OO; Biricik, G; Taysi, ZC				Bozkurt, Omer Ozgur; Biricik, Goksel; Taysi, Ziya Cihan			Artificial neural network and SARIMA based models for power load forecasting in Turkish electricity market	PLOS ONE			English	Article							SHORT-TERM LOAD; TIME-SERIES; HYBRID MODEL; ALGORITHM; PRICE	Load information plays an important role in deregulated electricity markets, since it is the primary factor to make critical decisions on production planning, day-to-day operations, unit commitment and economic dispatch. Being able to predict the load for a short term, which covers one hour to a few days, equips power generation facilities and traders with an advantage. With the deregulation of electricity markets, a variety of short term load forecasting models are developed. Deregulation in Turkish Electricity Market has started in 2001 and liberalization is still in progress with rules being effective in its predefined schedule. However, there is a very limited number of studies for Turkish Market. In this study, we introduce two different models for current Turkish Market using Seasonal Autoregressive Integrated Moving Average (SARIMA) and Artificial Neural Network (ANN) and present their comparative performances. Building models that cope with the dynamic nature of deregulated market and are able to run in real-time is the main contribution of this study. We also use our ANN based model to evaluate the effect of several factors, which are claimed to have effect on electrical load.	[Bozkurt, Omer Ozgur; Biricik, Goksel; Taysi, Ziya Cihan] Yildiz Tech Univ, Comp Engn Dept, Istanbul, Turkey	Yildiz Technical University	Biricik, G (corresponding author), Yildiz Tech Univ, Comp Engn Dept, Istanbul, Turkey.	goksel@ce.yildiz.edu.tr	Biricik, Göksel/AAA-4020-2022; TAYSI, Ziya Cihan/ABA-3292-2020	Biricik, Göksel/0000-0002-4768-7431; TAYSI, Ziya Cihan/0000-0003-3916-7492	Scientific and Technological Research Council Of Turkey (TUBITAK SME-RDI) [7140008]; Scientific and Technological Research Council of Turkey, Technology and Innovation Funding Programmes Directorate, Information Technologies Grant Committee [7140008]	Scientific and Technological Research Council Of Turkey (TUBITAK SME-RDI); Scientific and Technological Research Council of Turkey, Technology and Innovation Funding Programmes Directorate, Information Technologies Grant Committee	The research stands on the project funded by the Scientific and Technological Research Council Of Turkey, Research, Development & Innovation Grant Programme (TUBITAK SME-RDI) with number 7140008 and the previous studies of the authors. 0 OB: The Scientific and Technological Research Council of Turkey, Technology and Innovation Funding Programmes Directorate, Information Technologies Grant Committee. Grant Number: 7140008. URL: hilps.//wwwtubitak.gov.tr/nl/funds/industryinational-supportprogrammes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedinia O, 2015, INT T ELECT ENERGY; Agalgaonkar A.P., 2014, IEEE IND APPL SOC AN, P1; Al-Hamadi HM, 2004, ELECTR POW SYST RES, V68, P47, DOI 10.1016/S0378-7796(03)00150-0; Almeshaiei E, 2011, ALEX ENG J, V50, P137, DOI 10.1016/j.aej.2011.01.015; Amjady N, 2001, IEEE T POWER SYST, V16, P498, DOI 10.1109/59.932287; Campbell P. R. J., 2006, INT SYST 2006 3 INT, P800, DOI DOI 10.1109/IS.2006.348523; Catalao JPS, 2007, ELECTR POW SYST RES, V77, P1297, DOI 10.1016/j.epsr.2006.09.022; Cevik Hasan Huseyin, 2014, Proceedings of the 2014 6th International Conference on Electronics, Computers and Artificial Intelligence (ECAI), P29, DOI 10.1109/ECAI.2014.7090206; Che JX, 2014, INT J ELEC POWER, V61, P259, DOI 10.1016/j.ijepes.2014.03.056; Chen H, 2001, 2001 IEEE POWER ENGINEERING SOCIETY WINTER MEETING, CONFERENCE PROCEEDINGS, VOLS 1-3, P411, DOI 10.1109/PESW.2001.916876; Chen JF, 1995, ELECTR POW SYST RES, V34, P187, DOI 10.1016/0378-7796(95)00977-1; Deihimi A, 2013, ENERGY, V57, P382, DOI 10.1016/j.energy.2013.06.007; Fattaheian-Dehkordi S, 2014, INT T ELECTR ENERGY, V24, P1650, DOI 10.1002/etep.1791; Feinberg EA, 2005, POWER ELECTRON POWER, P269, DOI 10.1007/0-387-23471-3_12; Feng CXJ, 2006, J MANUF SYST, V25, P239, DOI 10.1016/S0278-6125(08)00006-X; Filik UB, 2013, ENERJI VERIMLILIGI K, P35; Filik UB, 2011, INT J INNOV COMPUT I, V7, P3545; Hahn H, 2009, EUR J OPER RES, V199, P902, DOI 10.1016/j.ejor.2009.01.062; Hardle W, 1997, INT STAT REV, V65, P49; Hooshmand RA, 2013, INT J ELEC POWER, V45, P313, DOI 10.1016/j.ijepes.2012.09.002; Hu ZY, 2015, ENG APPL ARTIF INTEL, V40, P17, DOI 10.1016/j.engappai.2014.12.014; Ishik M.Y., 2015, 3 INT SMART GRID C F, P1; Isikli Esener I, 2015, TURK J ELECTR ENG CO, V23, P370, DOI 10.3906/elk-1209-28; Jaramillo-Moran MA, 2013, INT J ELEC POWER, V49, P253, DOI 10.1016/j.ijepes.2013.01.019; Kalaitzakis K, 2002, ELECTR POW SYST RES, V63, P185, DOI 10.1016/S0378-7796(02)00123-2; Karsaz A, 2010, INT J ELEC POWER, V32, P408, DOI 10.1016/j.ijepes.2009.11.001; Kavousi-Fard A, 2014, EXPERT SYST APPL, V41, P6047, DOI 10.1016/j.eswa.2014.03.053; Kennedy P., 2003, GUIDE ECONOMETRICS; Khatoon S, 2014, 2014 INNOVATIVE APPLICATIONS OF COMPUTATIONAL INTELLIGENCE ON POWER, ENERGY AND CONTROLS WITH THEIR IMPACT ON HUMANITY (CIPECH), P243, DOI 10.1109/CIPECH.2014.7019112; Kolmek MA, 2015, TURK J ELECTR ENG CO, V23, P841, DOI 10.3906/elk-1212-136; Lahouar A, 2015, ENERG CONVERS MANAGE, V103, P1040, DOI 10.1016/j.enconman.2015.07.041; Lange K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130834; Lee CM, 2011, EXPERT SYST APPL, V38, P5902, DOI 10.1016/j.eswa.2010.11.033; Li PH, 2014, INT J ELEC POWER, V55, P749, DOI 10.1016/j.ijepes.2013.10.020; Liu N, 2014, APPL ENERG, V129, P336, DOI 10.1016/j.apenergy.2014.05.023; Manda P, 2006, INT J ELEC POWER, V28, P367, DOI 10.1016/j.ijepes.2005.12.007; Monterio C., 2012, ELECTR POW SYST RES, P1; Mori H, 1996, IEEE T POWER SYST, V11, P390, DOI 10.1109/59.486123; Pagan A., 1999, NONPARAMETRIC ECONOM; Pandey AS, 2010, IEEE T POWER SYST, V25, P1266, DOI 10.1109/TPWRS.2010.2042471; Quan H, 2013, IEEE SYMP COMPUT, P66, DOI 10.1109/CIASG.2013.6611500; Quan H, 2014, IEEE T NEUR NET LEAR, V25, P303, DOI 10.1109/TNNLS.2013.2276053; Rothe JP, 2009, SHORT TERM LOAD FORE; Scott DW, 2009, MULTIVARIATE DENSITY; Shang HL, 2011, MATH COMPUT SIMULAT, V81, P1310, DOI 10.1016/j.matcom.2010.04.027; Shayeghi H, 2015, ENERG CONVERS MANAGE, V95, P371, DOI 10.1016/j.enconman.2015.02.023; Smith BL, 2002, TRANSPORT RES C-EMER, V10, P303, DOI 10.1016/S0968-090X(02)00009-8; Song YH, 2003, OPERATION MARKET ORI; Sudheer G, 2015, ENERGY SCI ENG, V3, P51, DOI 10.1002/ese3.48; Taylor JW, 2007, IEEE T POWER SYST, V22, P2213, DOI 10.1109/TPWRS.2007.907583; Topalli AK, 2003, NEUROCOMPUTING, V51, P495, DOI 10.1016/S0925-2312(02)00870-6; Topalli AK, 2006, INT J ELEC POWER, V28, P437, DOI 10.1016/j.ijepes.2006.02.004; Vilar-Fernandez JM, 2007, COMMUN STAT-SIMUL C, V36, P311, DOI 10.1080/03610910601158377; Wang Y, 2009, PROCEEDINGS OF THE 2009 INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE AND NATURAL COMPUTING, VOL I, P58, DOI 10.1109/CINC.2009.107; Weron R, 2005, P EUR EL MARK EEM 05, P133; Weron R, 2014, INT J FORECASTING, V30, P1030, DOI 10.1016/j.ijforecast.2014.08.008; Wu XH, 2016, J POWER SOURCES, V333, P203, DOI 10.1016/j.jpowsour.2016.09.157; Xiao LY, 2015, INT J ELEC POWER, V64, P311, DOI 10.1016/j.ijepes.2014.07.029; Xiao Z, 2009, EXPERT SYST APPL, V36, P273, DOI 10.1016/j.eswa.2007.09.031; Yang Y, 2013, ABSTR APPL ANAL, DOI 10.1155/2013/208964; Zheng TX, 2000, ELECTR POW SYST RES, V54, P11, DOI 10.1016/S0378-7796(99)00063-2	61	34	36	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175915	10.1371/journal.pone.0175915	http://dx.doi.org/10.1371/journal.pone.0175915			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426739	Green Published, gold, Green Submitted			2022-12-26	WOS:000399875900069
J	Lee, HL; Cheng, HL; Liu, YF; Chou, MC; Yang, SF; Chou, YE				Lee, Hsiang-Lin; Cheng, Hsin-Lin; Liu, Yu-Fan; Chou, Ming-Chih; Yang, Shun-Fa; Chou, Ying-Erh			Functional genetic variant of WW domain-containing oxidoreductase (WWOX) gene is associated with hepatocellular carcinoma risk	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; FRAGILE GENES; CELL-DEATH; EXPRESSION; CANCER; OVARIAN; PROTEIN; BREAST; APOPTOSIS; LUNG	Background Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide. Human WW domain-containing oxidoreductase (WWOX) gene has been identified as a tumor suppressor gene in multiple cancers. We hypothesize that genetic variations in WWOX are associated with HCC risk. Methodology/Principal findings Five single-nucleotide polymorphisms (SNPs) of the WWOX gene were evaluated from 708 normal controls and 354 patients with HCC. We identified a significant association between a WWOX single nucleotide polymorphism (SNP), rs73569323, and decreased risk of HCC. After adjustment for potential confounders, patients with at least one T allele at rs11545028 of WWOX may have a significantly smaller tumor size, reduced levels of alpha-fetoprotein and alanine aminotransferase (ALT). Moreover, the A allele at SNP rs12918952 in WWOX conferred higher risk of vascular invasion. Additional in silico analysis also suggests that WWOX rs12918952 polymorphism tends to affect WWOX expression, which in turn contributes to tumor vascular invasion. Conclusions In conclusion, genetic variations in WWOX may be a significant predictor of early HCC occurrence and a reliable biomarker for disease progression.	[Lee, Hsiang-Lin; Cheng, Hsin-Lin; Chou, Ming-Chih; Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Lee, Hsiang-Lin; Chou, Ming-Chih; Chou, Ying-Erh] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Lee, Hsiang-Lin; Chou, Ming-Chih] Chung Shan Med Univ Hosp, Deptartment Surg, Taichung, Taiwan; [Liu, Yu-Fan; Yang, Shun-Fa] Chung Shan Med Univ, Dept Biomed Sci, Taichung, Taiwan; [Chou, Ying-Erh] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Chou, YE (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.; Chou, YE (corresponding author), Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan.	intointo814@gmail.com	Yang, Shun-Fa/AAN-1519-2020	Yang, Shun-Fa/0000-0002-0365-7927	Chung Shan Medical University Hospital, Taiwan [CSH-2016-C-016, CSH-2016-E-002-Y2]	Chung Shan Medical University Hospital, Taiwan	This study was supported by agrant (CSH-2016-C-016, CSH-2016-E-002-Y2) from Chung Shan Medical University Hospital, Taiwan. The funder had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.	Abu-Remaileh M, 2015, J BIOL CHEM, V290, P30728, DOI 10.1074/jbc.R115.676346; Agnelli L, 2009, GENE CHROMOSOME CANC, V48, P603, DOI 10.1002/gcc.20668; Ambade A, 2016, SCI REP-UK, V6, DOI 10.1038/srep21340; Aqeilan RI, 2007, J CELL PHYSIOL, V212, P307, DOI 10.1002/jcp.21099; Aqeilan RI, 2007, P NATL ACAD SCI USA, V104, P3949, DOI 10.1073/pnas.0609783104; Aqeilan RI, 2004, P NATL ACAD SCI USA, V101, P4401, DOI 10.1073/pnas.0400805101; Aqeilan RI, 2004, CLIN CANCER RES, V10, P3053, DOI 10.1158/1078-0432.CCR-03-0594; Bednarek AK, 2001, CANCER RES, V61, P8068; Cancemi L, 2011, INT J CANCER, V129, P2816, DOI 10.1002/ijc.25937; Chang NS, 2016, EXP BIOL MED, V241, P1306, DOI 10.1177/1535370216644531; Chang NS, 2015, EXP BIOL MED, V240, P281, DOI 10.1177/1535370215574226; Chang NS, 2003, BIOCHEM PHARMACOL, V66, P1347, DOI 10.1016/S0006-2952(03)00484-2; Chen CJ, 1997, J GASTROEN HEPATOL, V12, pS294, DOI 10.1111/j.1440-1746.1997.tb00513.x; Chen THH, 2002, INT J CANCER, V98, P257, DOI 10.1002/ijc.10122; Cheng H. L., 2016, ONCOTARGET; Del Mare S, 2009, J CELL BIOCHEM, V108, P737, DOI 10.1002/jcb.22298; Ekizoglu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115353; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Fu J, 2011, BLOOD, V117, P1652, DOI 10.1182/blood-2010-08-303073; Garg R, 2006, GYNECOL ONCOL, V103, P793, DOI 10.1016/j.ygyno.2006.08.043; Gourley C, 2005, INT J ONCOL, V26, P1681; Gu JA, 2010, CANCER PREV RES, V3, P1176, DOI 10.1158/1940-6207.CAPR-09-0265; Guler G, 2004, CANCER, V100, P1605, DOI 10.1002/cncr.20137; Guo W, 2013, MOL CARCINOGEN, V52, P265, DOI 10.1002/mc.21853; Guo W, 2013, ENVIRON MOL MUTAGEN, V54, P112, DOI 10.1002/em.21748; He D, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0525-y; Hsu LJ, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00141; Huang DS, 2013, MOL CARCINOGEN, V52, P19, DOI 10.1002/mc.21934; Iliopoulos D, 2005, ONCOGENE, V24, P1625, DOI 10.1038/sj.onc.1208398; Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4; Kamiyama T, 2009, ANN SURG ONCOL, V16, P1560, DOI 10.1245/s10434-009-0407-7; Lan YY, 2013, BIOCHEM BIOPH RES CO, V436, P672, DOI 10.1016/j.bbrc.2013.06.014; Lange EM, 2009, PROSTATE, V69, P385, DOI 10.1002/pros.20891; Li G, 2015, CELL BIOCHEM BIOPHYS, V73, P417, DOI 10.1007/s12013-015-0654-0; Li YP, 2013, APMIS, V121, P120, DOI 10.1111/j.1600-0463.2012.02947.x; Lin Jie, 2010, Zhonghua Gan Zang Bing Za Zhi, V18, P357, DOI 10.3760/cma.j.issn.1007-3418.2010.05.011; Liu YR, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-145; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Lo JY, 2015, EXP BIOL MED, V240, P383, DOI 10.1177/1535370214566747; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Mizejewski GJ, 2001, EXP BIOL MED, V226, P377, DOI 10.1177/153537020122600503; Nunez M, 2005, BREAST CANCER RES TR, V89, P99, DOI 10.1007/s10549-004-1474-x; Nunez MI, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-64; Paige AJW, 2001, P NATL ACAD SCI USA, V98, P11417, DOI 10.1073/pnas.191175898; Park SW, 2004, BRIT J CANCER, V91, P753, DOI 10.1038/sj.bjc.6602023; Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2; Pazin Michael J, 2015, Cold Spring Harb Protoc, V2015, P522, DOI 10.1101/pdb.top084988; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Pimenta FJ, 2006, INT J CANCER, V118, P1154, DOI 10.1002/ijc.21446; Potz BA, 2016, J SURG RES, V203, P154, DOI 10.1016/j.jss.2016.03.009; Qin HR, 2006, CANCER RES, V66, P6477, DOI 10.1158/0008-5472.CAN-06-0956; Ramos D, 2008, HISTOPATHOLOGY, V52, P831, DOI 10.1111/j.1365-2559.2008.03033.x; Schirmer MA, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv387; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Su SC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159585; Urata Y, 2016, HEPATOL RES, V46, P434, DOI 10.1111/hepr.12572; Wen CP, 2012, J NATL CANCER I, V104, P1599, DOI 10.1093/jnci/djs372; Yan HC, 2015, MOL MED REP, V12, P1783, DOI 10.3892/mmr.2015.3640; Yarden RI, 2008, BREAST CANCER RES TR, V111, P497, DOI 10.1007/s10549-007-9797-z; Yendamuri S, 2003, CANCER RES, V63, P878; Zhang NN, 2016, ONCOTARGETS THER, V9, P807, DOI 10.2147/OTT.S99106; Zhou Yulong, 2005, J Huazhong Univ Sci Technolog Med Sci, V25, P162	63	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176141	10.1371/journal.pone.0176141	http://dx.doi.org/10.1371/journal.pone.0176141			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426730	Green Published, gold			2022-12-26	WOS:000399875900105
J	Ligasova, A; Konecny, P; Frydrych, I; Koberna, K				Ligasova, Anna; Konecny, Petr; Frydrych, Ivo; Koberna, Karel			Cell cycle profiling by image and flow cytometry: The optimised protocol for the detection of replicational activity using 5-Bromo-2 '-deoxyuridine, low concentration of hydrochloric acid and exonuclease III	PLOS ONE			English	Article							DNA-REPLICATION; S-PHASE; NUCLEAR-ORGANIZATION; MAMMALIAN-CELLS; CLICK CHEMISTRY; PROLIFERATION; DYNAMICS; PROGRESSION; ANTIBODIES; CLUSTERS	The approach for the detection of replicational activity in cells using 5-bromo-2 '-deoxyuridine, a low concentration of hydrochloric acid and exonuclease III is presented in the study. The described method was optimised with the aim to provide a fast and robust tool for the detection of DNA synthesis with minimal impact on the cellular structures using image and flow cytometry. The approach is based on the introduction of breaks into the DNA by the low concentration of hydrochloric acid followed by the subsequent enzymatic extension of these breaks using exonuclease III. Our data showed that the method has only a minimal effect on the tested protein localisations and is applicable both for formaldehyde-and ethanol-fixed cells. The approach partially also preserves the fluorescence of the fluorescent proteins in the HeLa cells expressing Fluorescent Ubiquitin Cell Cycle Indicator. In the case of the short labelling pulses that disabled the use of 5-ethynyl-2 '-deoxyuridine because of the low specific signal, the described method provided a bright signal enabling reliable recognition of replicating cells. The optimized protocol was also successfully tested for the detection of trifluridine, the nucleoside used as an antiviral drug and in combination with tipiracil also for the treatment of some types of cancer.	[Ligasova, Anna; Konecny, Petr; Frydrych, Ivo; Koberna, Karel] Palacky Univ Olomouc, Fac Med & Dent, Inst Mol & Translat Med, Olomouc, Czech Republic; [Konecny, Petr] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Div Immunol, Cape Town, South Africa	Palacky University Olomouc; University of Cape Town	Ligasova, A; Koberna, K (corresponding author), Palacky Univ Olomouc, Fac Med & Dent, Inst Mol & Translat Med, Olomouc, Czech Republic.	anna.ligasova@upol.cz; karel.koberna@upol.cz	KOBERNA, Karel/G-5551-2019; Ligasová, Anna/P-5460-2015	KOBERNA, Karel/0000-0002-7375-4298; Ligasová, Anna/0000-0002-1564-3768	Technology Agency of the Czech Republic [TA03010719, TE02000058]; Ministry of Health of the Czech Republic [AZV15-31604A]; Ministry of Education, Youth and Sports [LO1304, LM2015064]	Technology Agency of the Czech Republic; Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by the Technology Agency of the Czech Republic [TA03010719 and TE02000058]; the Ministry of Health of the Czech Republic [AZV15-31604A] and the Ministry of Education, Youth and Sports [LO1304 and LM2015064]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGENO M, 1969, BIOPHYS J, V9, P1281, DOI 10.1016/S0006-3495(69)86452-0; ATEN JA, 1992, HISTOCHEM J, V24, P251, DOI 10.1007/BF01046839; Buck SB, 2008, BIOTECHNIQUES, V44, P927, DOI 10.2144/000112812; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chou TY, 2014, THER CLIN RISK MANAG, V10, P665, DOI 10.2147/TCRM.S58242; Cristofoli WA, 2007, J MED CHEM, V50, P2851, DOI 10.1021/jm0701472; Dimitrova DS, 2002, J CELL SCI, V115, P4037, DOI 10.1242/jcs.00087; Dimitrova DS, 1999, J CELL BIOL, V146, P709, DOI 10.1083/jcb.146.4.709; Frum Rebecca A, 2013, Methods Mol Biol, V962, P147, DOI 10.1007/978-1-62703-236-0_12; Hua H, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr063; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; Kitao H, 2016, SCI REP-UK, V6, DOI 10.1038/srep25286; Koberna K, 1999, CHROMOSOMA, V108, P325, DOI 10.1007/s004120050384; Kopper F, 2013, P NATL ACAD SCI USA, V110, P16856, DOI 10.1073/pnas.1304355110; Kohlmeier F, 2013, CHROMOSOME RES, V21, P87, DOI 10.1007/s10577-013-9340-5; Li X, 1995, CELL PROLIFERAT, V28, P571, DOI 10.1111/j.1365-2184.1995.tb00045.x; Ligasova A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132393; Ligasova A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117459; Ligasova A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052584; Ligasova A, 2009, J STRUCT BIOL, V165, P204, DOI 10.1016/j.jsb.2008.11.004; Loschberger A, 2014, BIOTECHNOL J, V9, P693, DOI 10.1002/biot.201400026; MANDERS EMM, 1992, J CELL SCI, V103, P857; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Seiler JA, 2007, MOL CELL BIOL, V27, P5806, DOI 10.1128/MCB.02278-06; Sporbert A, 2002, MOL CELL, V10, P1355, DOI 10.1016/S1097-2765(02)00729-3; Stanojcic S, 2008, MOL CELL BIOL, V28, P5265, DOI 10.1128/MCB.00181-08; Techer H, 2013, J MOL BIOL, V425, P4845, DOI 10.1016/j.jmb.2013.03.040; Tkatchenko AV, 2006, BIOTECHNIQUES, V40, P29, DOI 10.2144/000112094; Zeng CB, 2010, BRAIN RES, V1319, P21, DOI 10.1016/j.brainres.2009.12.092	32	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175880	10.1371/journal.pone.0175880	http://dx.doi.org/10.1371/journal.pone.0175880			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426799	Green Published, gold, Green Submitted			2022-12-26	WOS:000399875900063
J	Barrel, MS; Etichetti, CB; Di Benedetto, C; Rosano, GL; Margarit, E; Del Sal, G; Mione, M; Girardini, J				Solange Barrel, Maria; Borini Etichetti, Carla; Di Benedetto, Carolina; Rosano, German L.; Margarit, Ezequiel; Del Sal, Giannino; Mione, Marina; Girardini, Javier			Dynamic regulation of Pin1 expression and function during zebrafish development	PLOS ONE			English	Article							PROLYL-ISOMERASE PIN1; ALZHEIMERS-DISEASE; PHOSPHORYLATED-TAU; PROTEIN STABILITY; CELL CARCINOMA; STEM-CELLS; BETA-TRCP; WILD-TYPE; CANCER; P53	The prolyl isomerase Pin1 plays a key role in the modulation of proline-directed phosphorylation signaling by inducing local conformational changes in phosphorylated protein substrates. Extensive studies showed different roles for Pin1 in physiological processes and pathological conditions such as cancer and neurodegenerative diseases. However, there are still several unanswered questions regarding its biological role. Notably, despite evidences from cultured cells showing that Pin1 expression and activity may be regulated by different mechanisms, little is known on their relevance in vivo. Using Danio rerio (zebrafish) as a vertebrate model organism we showed that pin1 expression is regulated during embryogenesis to achieve specific mRNA and protein distribution patterns. Moreover, we found different subcellular distribution in particular stages and cell types and we extended the study of Pin1 expression to the adult zebrafish brain. The analysis of Pin1 overexpression showed alterations on zebrafish development and the presence of p53-dependent apoptosis. Collectively, our results suggest that specific mechanisms are operated in different cell types to regulate Pin1 function.	[Solange Barrel, Maria; Borini Etichetti, Carla; Di Benedetto, Carolina; Rosano, German L.; Girardini, Javier] Inst Biol Mol & Celular Rosario IBR, CONICET, Rosario, Argentina; [Margarit, Ezequiel] CEFOBI, CONICET, Rosario, Argentina; [Del Sal, Giannino] Lab Nazl CIB, Area Sci Pk Padriciano, Trieste, Italy; [Del Sal, Giannino] Univ Trieste, Dipartimento Sci Vita, Trieste, Italy; [Mione, Marina] Univ Trento, Ctr Integrat Biol CIBIO, Trento, Italy	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Trieste; University of Trento	Girardini, J (corresponding author), Inst Biol Mol & Celular Rosario IBR, CONICET, Rosario, Argentina.	girardini@ibr-conicet.gov.ar	Mione, Maria Caterina/ABG-9926-2021; Rosano, Germán/I-6429-2019	Rosano, Germán/0000-0002-8313-6813; Mione, Maria Caterina/0000-0002-9040-3705; Margarit, Ezequiel/0000-0003-0031-2779	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT 1221]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 11420100100141]; Institute Nacional del Cancer, Ministerio de Salud; Institute Nacional del Cancer, Ministerio de Salud, Argentina	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Institute Nacional del Cancer, Ministerio de Salud; Institute Nacional del Cancer, Ministerio de Salud, Argentina	This work was supported by grants from Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT http://www.agencia.mincyt.gob.ar/, PICT 1221), Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET http://www.conicet.gov.ar/, PIP 11420100100141) and Institute Nacional del Cancer, Ministerio de Salud (http://inc.msal.gov.ar/), to JG. MSI was awarded with a fellowship from Institute Nacional del Cancer, Ministerio de Salud, Argentina, and is a doctoral fellow from CONICET. CBE is a doctoral fellow from CONICET. CD is a doctoral fellow from ANPCyT. JG is a staff member from CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando K, 2013, NEUROBIOL AGING, V34, P757, DOI 10.1016/j.neurobiolaging.2012.08.004; Atchison FW, 2003, DEVELOPMENT, V130, P3579, DOI 10.1242/dev.00584; Ayala G, 2003, CANCER RES, V63, P6244; Baik SH, 2015, ANN NEUROL, V77, P504, DOI 10.1002/ana.24347; Balastik M, 2015, CELL REP, V13, P812, DOI 10.1016/j.celrep.2015.09.026; Bao L, 2004, AM J PATHOL, V164, P1727, DOI 10.1016/S0002-9440(10)63731-5; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Bitomsky N, 2013, P NATL ACAD SCI USA, V110, pE4203, DOI 10.1073/pnas.1310001110; Chan EHY, 2008, CHROMOSOMA, V117, P457, DOI 10.1007/s00412-008-0165-5; Driver JA, 2015, BBA-GEN SUBJECTS, V1850, P2069, DOI 10.1016/j.bbagen.2014.12.025; Eckerdt F, 2005, J BIOL CHEM, V280, P36575, DOI 10.1074/jbc.M504548200; Fanghanel J, 2006, FEBS LETT, V580, P3237, DOI 10.1016/j.febslet.2006.04.087; Girardini JE, 2011, CANCER CELL, V20, P79, DOI 10.1016/j.ccr.2011.06.004; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Grison A, 2011, P NATL ACAD SCI USA, V108, P17979, DOI 10.1073/pnas.1106198108; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Holzer M, 2002, ACTA NEUROPATHOL, V104, P471, DOI 10.1007/s00401-002-0581-1; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kozlowski LP., 2016, BIORXIV; Krishnan N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085427; Kumar R, 2009, J CLIN INVEST, V119, P2887, DOI 10.1172/JCI40784; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lee TH, 2011, MOL CELL, V42, P147, DOI 10.1016/j.molcel.2011.03.005; Lee YC, 2013, J CELL SCI, V126, P4862, DOI 10.1242/jcs.121368; Leung KW, 2009, ONCOL REP, V21, P1097, DOI 10.3892/or_00000329; Li C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.468; Lim J, 2008, J CLIN INVEST, V118, P1877, DOI 10.1172/JCI34308; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Liou YC, 2011, TRENDS BIOCHEM SCI, V36, P501, DOI 10.1016/j.tibs.2011.07.001; Litchfield DW, 2015, BBA-GEN SUBJECTS, V1850, P2077, DOI 10.1016/j.bbagen.2015.02.018; Lu KP, 1996, NATURE, V380, P544; Lu PJ, 1999, NATURE, V399, P784; Lu PJ, 2002, J BIOL CHEM, V277, P2381, DOI 10.1074/jbc.C100228200; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Lufei CC, 2009, FEBS LETT, V583, P271, DOI 10.1016/j.febslet.2008.12.011; Ma SL, 2012, NEUROBIOL AGING, V33, P804, DOI 10.1016/j.neurobiolaging.2010.05.018; Marz M, 2011, DEV DYNAM, V240, P2221, DOI 10.1002/dvdy.22710; Mantovani F, 2004, MOL CELL, V14, P625, DOI 10.1016/j.molcel.2004.05.007; Mantovani F, 2007, NAT STRUCT MOL BIOL, V14, P912, DOI 10.1038/nsmb1306; Mantovani F, 2015, BBA-GEN SUBJECTS, V1850, P2048, DOI 10.1016/j.bbagen.2015.01.013; Mione MC, 2010, DIS MODEL MECH, V3, P517, DOI 10.1242/dmm.004747; Moretto-Zita M, 2010, P NATL ACAD SCI USA, V107, P13312, DOI 10.1073/pnas.1005847107; Nakamura K, 2012, MOL CELL BIOL, V32, P2966, DOI 10.1128/MCB.05688-11; Ramakrishnan P, 2003, NEUROBIOL DIS, V14, P251, DOI 10.1016/S0969-9961(03)00109-8; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Rangasamy V, 2012, P NATL ACAD SCI USA, V109, P8149, DOI 10.1073/pnas.1200804109; Restelli M, 2014, HUM MOL GENET, V23, P3830, DOI 10.1093/hmg/ddu096; Rizzolio F, 2012, CELL DEATH DIFFER, V19, P1152, DOI 10.1038/cdd.2011.202; Rustighi A, 2014, EMBO MOL MED, V6, P99, DOI 10.1002/emmm.201302909; Rustighi A, 2009, NAT CELL BIOL, V11, P133, DOI 10.1038/ncb1822; Ryo A, 2006, J BIOL CHEM, V281, P4117, DOI 10.1074/jbc.M507026200; Ryo A, 2002, MOL CELL BIOL, V22, P5281, DOI 10.1128/MCB.22.15.5281-5295.2002; Shen MH, 1998, GENE DEV, V12, P706, DOI 10.1101/gad.12.5.706; Sorrentino G, 2013, CELL DEATH DIFFER, V20, P198, DOI 10.1038/cdd.2012.112; Suizu F, 2006, MOL CELL BIOL, V26, P1463, DOI 10.1128/MCB.26.4.1463-1479.2006; Tan XG, 2010, CANCER BIOL THER, V9, P111, DOI 10.4161/cbt.9.2.10341; Teng BL, 2011, MOL ONCOL, V5, P465, DOI 10.1016/j.molonc.2011.06.002; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Thorpe JR, 2004, NEUROBIOL DIS, V17, P237, DOI 10.1016/j.nbd.2004.07.008; Tian G, 2009, J BIOL CHEM, V284, P18980, DOI 10.1074/jbc.M109.003160; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Xu YX, 2007, GENE DEV, V21, P2950, DOI 10.1101/gad.1592807; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yeh ES, 2007, NAT REV CANCER, V7, P381, DOI 10.1038/nrc2107; Yeh ES, 2006, J BIOL CHEM, V281, P241, DOI 10.1074/jbc.M505770200; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zhang Y, 2007, ACS CHEM BIOL, V2, P320, DOI 10.1021/cb7000044; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	71	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175939	10.1371/journal.pone.0175939	http://dx.doi.org/10.1371/journal.pone.0175939			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426725	Green Published, gold, Green Submitted			2022-12-26	WOS:000399875900071
J	Wang, ZJ; Deba, F; Mohamed, TS; Chiara, DC; Ramos, K; Hamouda, AK				Wang, Ze-Jun; Deba, Farah; Mohamed, Tasnim S.; Chiara, David C.; Ramos, Kara; Hamouda, Ayman K.			Unraveling amino acid residues critical for allosteric potentiation of (alpha 4)3(beta 2) 2-type nicotinic acetylcholine receptor responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONCANONICAL SUBUNIT INTERFACES; AGONIST BINDING-SITE; THERAPEUTIC TARGETS; NERVOUS-SYSTEM; BETA-2 SUBUNIT; MODULATOR; PHARMACOLOGY; SENSITIVITY; SUBTYPES; NS9283	Neuronal nicotinic acetylcholine receptors (nAChRs) are promising drug targets to manage several neurological disorders and nicotine addiction. Growing evidence indicates that positive allosteric modulators of nAChRs improve pharmacological specificity by binding to unique sites present only in a subpopulation of nAChRs. Furthermore, nAChR positive allosteric modulators such as NS9283 and CMPI have been shown to potentiate responses of (alpha 4)3(beta 2)2 but not (alpha 4)2(beta 2)3 nAChR isoforms. This selective potentiation underlines that the alpha 4: alpha 4 interface, which is present only in the (alpha 4)3(beta 2)2 nAChR, is an important and promising drug target. In this report we used site-directed mutagenesis to substitute specific amino acid residues and computational analyses to elucidate CMPI's binding mode at the alpha 4: alpha 4 subunit extracellular interface and identified a unique set of amino acid residues that determined its affinity. We found that amino acid residues alpha 4Gly-41, alpha 4Lys-64, and alpha 4Thr-66 were critical for (alpha 4)3(beta 2)2 nAChR potentiation by CMPI, but not by NS9283, whereas amino acid substitution at alpha 4His-116, a known determinant of NS9283 and of agonist binding at the alpha 4: alpha 4 subunit interface, did not reduce CMPI potentiation. In contrast, substitutions at alpha 4Gln-124 and alpha 4Thr-126 reduced potentiation by CMPI and NS9283, indicating that their binding sites partially overlap. These results delineate the role of amino acid residues contributing to the alpha 4: alpha 4 subunit extracellular interface in nAChR potentiation. These findings also provide structural information that will facilitate the structure-based design of novel therapeutics that target selectively the (alpha 4)3(beta 2)2 nAChR.	[Wang, Ze-Jun; Deba, Farah; Mohamed, Tasnim S.; Ramos, Kara; Hamouda, Ayman K.] Texas A&M Hlth Sci Ctr, Dept Pharmaceut Sci, Kingsville, TX 78363 USA; [Hamouda, Ayman K.] Texas A&M Hlth Sci Ctr, Dept Neurosci & Expt Therapeut, Bryan, TX 77807 USA; [Chiara, David C.] Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Harvard University; Harvard Medical School	Hamouda, AK (corresponding author), Texas A&M Hlth Sci Ctr, Rangel Coll Pharm, Dept Pharmaceut Sci, Kingsville, TX 78363 USA.	Hamouda@tamhsc.edu		Deba, Farah/0000-0001-9154-430X	National Institutes of Health [NS-093590]; Faculty Development Fund of Texas A&M Health Sciences Center; Direct For Biological Sciences [1355034] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS093590] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Faculty Development Fund of Texas A&M Health Sciences Center; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS-093590 (NINDS; to A. K. H.). This work was also supported in part by Faculty Development Fund of Texas A&M Health Sciences Center (to A. K. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albrecht BK, 2008, BIOORG MED CHEM LETT, V18, P5209, DOI 10.1016/j.bmcl.2008.08.080; BENWELL MEM, 1988, J NEUROCHEM, V50, P1243, DOI 10.1111/j.1471-4159.1988.tb10600.x; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Corringer PJ, 2012, STRUCTURE, V20, P941, DOI 10.1016/j.str.2012.05.003; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Dineley KT, 2015, TRENDS PHARMACOL SCI, V36, P96, DOI 10.1016/j.tips.2014.12.002; Eaton JB, 2014, J PHARMACOL EXP THER, V348, P46, DOI 10.1124/jpet.113.208389; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Grupe M, 2015, BASIC CLIN PHARMACOL, V116, P187, DOI 10.1111/bcpt.12361; Hamouda AK, 2016, MOL PHARMACOL, V89, P575, DOI 10.1124/mol.116.103341; Hamouda AK, 2015, MOL PHARMACOL, V88, P1, DOI 10.1124/mol.115.098913; Hamouda AK, 2013, J NEUROSCI, V33, P485, DOI 10.1523/JNEUROSCI.3483-12.2013; Hamouda AK, 2011, J BIOL CHEM, V286, P20466, DOI 10.1074/jbc.M111.219071; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Hurst R, 2013, PHARMACOL THERAPEUT, V137, P22, DOI 10.1016/j.pharmthera.2012.08.012; Jin XC, 2014, MOL PHARMACOL, V85, P11, DOI 10.1124/mol.113.089979; Jin XC, 2011, J NEUROSCI, V31, P5045, DOI 10.1523/JNEUROSCI.4802-10.2011; Mazzaferro S, 2014, J BIOL CHEM, V289, P21795, DOI 10.1074/jbc.M114.555136; Morales-Perez CL, 2016, NATURE, V538, P411, DOI 10.1038/nature19785; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Nirthanan S, 2008, J BIOL CHEM, V283, P22051, DOI 10.1074/jbc.M801332200; Olsen JA, 2014, J BIOL CHEM, V289, P24911, DOI 10.1074/jbc.M114.568097; Olsen JA, 2013, J BIOL CHEM, V288, P35997, DOI 10.1074/jbc.M113.498618; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; Sala F, 2005, NEUROSCI LETT, V373, P144, DOI 10.1016/j.neulet.2004.10.002; Seo S, 2009, J NEUROSCI, V29, P8734, DOI 10.1523/JNEUROSCI.1859-09.2009; Srivastava S, 2009, J BIOL CHEM, V284, P24939, DOI 10.1074/jbc.M109.019083; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Timmermann DB, 2012, BRIT J PHARMACOL, V167, P164, DOI 10.1111/j.1476-5381.2012.01989.x; Uteshev VV, 2016, CURR PHARM DESIGN, V22, P1986, DOI 10.2174/1381612822666160201115341; Wang JY, 2015, J BIOL CHEM, V290, P28834, DOI 10.1074/jbc.M115.676551; Weltzin MM, 2015, J PHARMACOL EXP THER, V354, P184, DOI 10.1124/jpet.115.223933; Wevers A, 1999, EUR J NEUROSCI, V11, P2551, DOI 10.1046/j.1460-9568.1999.00676.x; Williams DK, 2011, BIOCHEM PHARMACOL, V82, P915, DOI 10.1016/j.bcp.2011.05.001; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105; Zoli M, 1999, EMBO J, V18, P1235, DOI 10.1093/emboj/18.5.1235; Zwart R, 1998, MOL PHARMACOL, V54, P1124, DOI 10.1124/mol.54.6.1124	40	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					9988	10001		10.1074/jbc.M116.771246	http://dx.doi.org/10.1074/jbc.M116.771246			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28446611	Green Published, hybrid			2022-12-26	WOS:000403580600012
J	Zhang, QJ; Meng, XH; Li, DL; Chen, SY; Luo, JM; Zhu, LJ; Singer, RH; Gu, W				Zhang, Qianjun; Meng, Xiuhua; Li, Delin; Chen, Shaoyin; Luo, Jianmin; Zhu, Linjie; Singer, Robert H.; Gu, Wei			Binding of DEAD-box helicase Dhh1 to the 5 '-untranslated region of ASH1 mRNA represses localized translation of ASH1 in yeast cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; STRUCTURAL ELEMENTS; GENE-EXPRESSION; PROTEIN; ELONGATION; TRANSCRIPTION; TRANSPORT; MYOSIN; PHOSPHORYLATION; IDENTIFICATION	Local translation of specific mRNAs is regulated by dynamic changes in their subcellular localization, and these changes are due to complex mechanisms controlling cytoplasmic mRNA transport. The budding yeast Saccharomyces cerevisiae is well suited to studying these mechanisms because many of its transcripts are transported from the mother cell to the budding daughter cell. Here, we investigated the translational control of ASH1 mRNA after transport and localization. We show that although ASH1 transcripts were translated after they reached the bud tip, some mRNAs were bound by the RNA-binding protein Puf6 and were non-polysomal. We also found that the DEAD-box helicase Dhh1 complexed with the untranslated ASH1 mRNA and Puf6. Loss of Dhh1 affected local translation of ASH1 mRNA and resulted in delocalization of ASH1 transcript in the bud. Forcibly shifting the non-polysomal ASH1 mRNA into polysomes was associated with Dhh1 dissociation. We further demonstrated that Dhh1 is not recruited to ASH1 mRNA co-transcriptionally, suggesting that it could bind to ASH1 mRNA within the cytoplasm. Of note, Dhh1 bound to the 5'-UTR of ASH1 mRNA and inhibited its translation in vitro. These results suggest that after localization to the bud tip, a portion of the localized ASH1 mRNA becomes translationally inactive because of binding of Dhh1 and Puf6 to the 5'- and 3'-UTRs of ASH1 mRNA.	[Zhang, Qianjun; Li, Delin; Chen, Shaoyin; Luo, Jianmin; Zhu, Linjie; Gu, Wei] Shantou Univ, Med Coll, Dept Pathophysiol, Key Immunopathol Lab Guangdong Prov, Shantou 515031, Guangdong, Peoples R China; [Meng, Xiuhua; Singer, Robert H.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA	Shantou University; Yeshiva University; Albert Einstein College of Medicine	Gu, W (corresponding author), Shantou Univ, Med Coll, Dept Pathophysiol, Key Immunopathol Lab Guangdong Prov, Shantou 515031, Guangdong, Peoples R China.	weigu1@yahoo.com	Luo, jian/HGE-7331-2022		National Natural Science Foundation of China [31171209]; National Institutes of Health [GM57071]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057071] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Natural Science Foundation of China Grant 31171209 (to W. G.) and National Institutes of Health Grant GM57071 (to R. H. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Bobola N, 1996, CELL, V84, P699, DOI 10.1016/S0092-8674(00)81048-X; Chartrand P, 1999, CURR BIOL, V9, P333, DOI 10.1016/S0960-9822(99)80144-4; Chartrand P, 2002, MOL CELL, V10, P1319, DOI 10.1016/S1097-2765(02)00694-9; Chartrand P, 2001, ANNU REV CELL DEV BI, V17, P297, DOI 10.1146/annurev.cellbio.17.1.297; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; Deng YF, 2008, GENE DEV, V22, P1037, DOI 10.1101/gad.1611308; Dutta A, 2011, J BIOL CHEM, V286, P27454, DOI 10.1074/jbc.M111.220251; Garcia JF, 2015, RNA, V21, P1393, DOI 10.1261/rna.051797.115; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Gonzalez I, 1999, CURR BIOL, V9, P337, DOI 10.1016/S0960-9822(99)80145-6; Gu W, 2004, GENE DEV, V18, P1452, DOI 10.1101/gad.1189004; Gu W, 2008, MOL CELL BIOL, V28, P4963, DOI 10.1128/MCB.00266-08; Hinnebusch AG, 2009, GENE DEV, V23, P891, DOI 10.1101/gad.1800509; Hocine S, 2013, NAT METHODS, V10, P119, DOI 10.1038/nmeth.2305; Irie K, 2002, EMBO J, V21, P1158, DOI 10.1093/emboj/21.5.1158; Jansen RP, 1996, CELL, V84, P687, DOI 10.1016/S0092-8674(00)81047-8; Ka M, 2008, BIOCHEM BIOPH RES CO, V367, P680, DOI 10.1016/j.bbrc.2007.12.169; Larson DR, 2011, SCIENCE, V332, P475, DOI 10.1126/science.1202142; Lionnet T, 2011, NAT METHODS, V8, P165, DOI 10.1038/NMETH.1551; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; Minshall N, 2001, RNA, V7, P1728, DOI 10.1017/S135583820101158X; Minshall N, 2009, MOL BIOL CELL, V20, P2464, DOI 10.1091/mbc.E09-01-0035; Mitchell SF, 2013, NAT STRUCT MOL BIOL, V20, P127, DOI 10.1038/nsmb.2468; Muller M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000611; Nakamura A, 2001, DEVELOPMENT, V128, P3233; Paquin N, 2007, MOL CELL, V26, P795, DOI 10.1016/j.molcel.2007.05.016; Perez-Ortin JE, 2007, TRENDS GENET, V23, P250, DOI 10.1016/j.tig.2007.03.006; Presnyak V, 2013, BBA-GENE REGUL MECH, V1829, P817, DOI 10.1016/j.bbagrm.2013.03.006; Radhakrishnan A, 2016, CELL, V167, P122, DOI 10.1016/j.cell.2016.08.053; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Shahbabian K, 2014, NUCLEIC ACIDS RES, V42, P8692, DOI 10.1093/nar/gku597; Shen ZF, 2010, GENE DEV, V24, P1914, DOI 10.1101/gad.1937510; Shen Z, 2009, MOL BIOL CELL, V20, P2265, DOI 10.1091/mbc.E08-11-1151; Shepard KA, 2003, P NATL ACAD SCI USA, V100, P11429, DOI 10.1073/pnas.2033246100; Sil A, 1996, CELL, V84, P711, DOI 10.1016/S0092-8674(00)81049-1; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Song TT, 2015, J CELL SCI, V128, P1001, DOI 10.1242/jcs.161679; Sweet T, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001342; Takizawa PA, 2000, P NATL ACAD SCI USA, V97, P5273, DOI 10.1073/pnas.080585897; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514; Zobel-Thropp P, 2000, J BIOL CHEM, V275, P37150, DOI 10.1074/jbc.M001005200	45	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9787	9800		10.1074/jbc.M117.776492	http://dx.doi.org/10.1074/jbc.M117.776492			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28450395	hybrid, Green Published			2022-12-26	WOS:000403113000027
J	Guard, BC; Mila, H; Steiner, JM; Mariani, C; Suchodolski, JS; Chastant-Maillard, S				Guard, Blake C.; Mila, Hanna; Steiner, Jorg M.; Mariani, Claire; Suchodolski, Jan S.; Chastant-Maillard, Sylvie			Characterization of the fecal microbiome during neonatal and early pediatric development in puppies	PLOS ONE			English	Article							TRACT NUTRIENT DIGESTIBILITIES; HUMAN GUT MICROBIOME; ESCHERICHIA-COLI; BACTERIAL-POPULATIONS; DIETARY FIBER; HEALTHY DOGS; LARGE-BOWEL; INFANT GUT; MILK; FRUCTOOLIGOSACCHARIDES	Limited information is available describing the development of the neonatal fecal microbiome in dogs. Feces from puppies were collected at 2, 21, 42, and 56 days after birth. Feces were also collected from the puppies' mothers at a single time point within 24 hours after parturition. DNA was extracted from fecal samples and 454-pyrosequencing was used to profile 16S rRNA genes. Species richness continued to increase significantly from 2 days of age until 42 days of age in puppies. Furthermore, microbial communities clustered separately from each other at 2, 21, and 42 days of age. The microbial communities belonging to dams clustered separately from that of puppies at any given time point. Major phylogenetic changes were noted at all taxonomic levels with the most profound changes being a shift from primarily Firmicutes in puppies at 2 days of age to a co-dominance of Bacteroidetes, Fusobacteria, and Firmicutes by 21 days of age. Further studies are needed to elucidate the relationship between puppy microbiota development, physiological growth, neonatal survival, and morbidity.	[Guard, Blake C.; Steiner, Jorg M.; Suchodolski, Jan S.] Texas A&M Univ, Dept Small Anim Clin Sci, Gastrointestinal Lab, College Stn, TX 77843 USA; [Mila, Hanna; Chastant-Maillard, Sylvie] Univ Toulouse, NeoCare, IHAP, Reprod, Toulouse, France; [Mariani, Claire] Royal Canin, Aimargues, France	Texas A&M University System; Texas A&M University College Station; Universite de Toulouse	Chastant-Maillard, S (corresponding author), Univ Toulouse, NeoCare, IHAP, Reprod, Toulouse, France.	schastant@envt.fr	CHASTANT, Sylvie/ABG-2003-2020; Mila, Hanna/ABG-1828-2020	CHASTANT, Sylvie/0000-0003-0790-6377; Mila, Hanna/0000-0002-1274-618X	Royal Canin	Royal Canin	This study was funded by Royal Canin. The funders did not play a role in study design.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.04.004, 10.1016/j.chom.2015.05.012]; BETTELHEIM KA, 1974, J HYG-CAMBRIDGE, V72, P67, DOI 10.1017/S0022172400023226; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Buddington RK, 2003, AM J VET RES, V64, P646, DOI 10.2460/ajvr.2003.64.646; Buffie CG, 2013, NAT REV IMMUNOL, V13, P790, DOI 10.1038/nri3535; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Earing J.E., 2012, ADV MICROBIOL-IRVINE, V2, P79, DOI DOI 10.4236/AIM.2012.22010; Epe C, 2010, VET PARASITOL, V173, P32, DOI 10.1016/j.vetpar.2010.06.015; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Faubladier C, 2014, ANAEROBE, V25, P61, DOI 10.1016/j.anaerobe.2013.11.010; FEENEY AR, 1980, J HYG-CAMBRIDGE, V84, P91, DOI 10.1017/S0022172400026565; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Garcia-Mazcorro JF, 2012, FEMS MICROBIOL ECOL, V80, P624, DOI 10.1111/j.1574-6941.2012.01331.x; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gonzalez-Martinez A, 2015, BIOMED RES INT, V2015, DOI [10.1155/2015/892013, DOI 10.1155/2015/892013]; Guard BC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127259; Hackett T, 2003, J AM ANIM HOSP ASSOC, V39, P52, DOI 10.5326/0390052; Handl S, 2011, FEMS MICROBIOL ECOL, V76, P301, DOI 10.1111/j.1574-6941.2011.01058.x; HEWITT JH, 1976, J HYG-CAMBRIDGE, V77, P129, DOI 10.1017/S0022172400055601; Hijova E, 2007, BRATISL MED J, V108, P354; Hooda S, 2013, BRIT J NUTR, V109, P1637, DOI 10.1017/S0007114512003479; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jia J, 2011, FEMS MICROBIOL ECOL, V78, P395, DOI 10.1111/j.1574-6941.2011.01172.x; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; LARI AR, 1990, BIOL NEONATE, V58, P73; Mackie RI, 1999, AM J CLIN NUTR, V69, p1035S, DOI 10.1093/ajcn/69.5.1035s; Martin R, 2003, J PEDIATR-US, V143, P754, DOI 10.1016/j.jpeds.2003.09.028; Martin R, 2010, VET J, V185, P193, DOI 10.1016/j.tvjl.2009.04.014; MCINTYRE A, 1993, GUT, V34, P386, DOI 10.1136/gut.34.3.386; Minamoto Y, 2015, GUT MICROBES, V6, P33, DOI 10.1080/19490976.2014.997612; Minamoto Y, 2014, VET MICROBIOL, V174, P463, DOI 10.1016/j.vetmic.2014.10.005; Moles L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066986; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Simpson JM, 2002, MICROB ECOL, V44, P186, DOI 10.1007/s00248-002-0001-z; Songer JG, 1996, CLIN MICROBIOL REV, V9, P216, DOI 10.1128/CMR.9.2.216; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051907; Suchodolski JS, 2010, VET MICROBIOL, V142, P394, DOI 10.1016/j.vetmic.2009.11.002; Swanson KS, 2002, J NUTR, V132, P3721, DOI 10.1093/jn/132.12.3721; Swanson KS, 2002, J NUTR, V132, P980, DOI 10.1093/jn/132.5.980; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	45	30	31	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e175718	10.1371/journal.pone.0175718	http://dx.doi.org/10.1371/journal.pone.0175718			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448583	Green Published, gold, Green Submitted			2022-12-26	WOS:000400383600022
J	Rodrigues, J; Viegas, W; Silva, M				Rodrigues, Joana; Viegas, Wanda; Silva, Manuela			45S rDNA external transcribed spacer organization reveals new phylogenetic relationships in Avena genus	PLOS ONE			English	Article							REPETITIVE DNA; RIBOSOMAL DNA; C-GENOME; CYTOGENETIC ANALYSIS; INTERGENIC SPACER; 18S-26S RDNA; OAT; EVOLUTION; MARKERS; LOCUS	The genus Avena comprises four distinct genomes organized in diploid (AA or CC), tetraploid (AABB or AACC) and hexaploid species (AACCDD), constituting an interesting model for phylogenetic analysis. The aim of this work was to characterize 45S rDNA intergenic spacer (IGS) variability in distinct species representative of Avena genome diversity-A. strigosa (AA), A. ventricosa (CvCv), A. eriantha (CpCp), A. barbata (AABB), A. murphyi (AACC), A. sativa (AACCDD) and A. sterilis (AACCDD) through the assessment of the 5' external transcribed spacer (5'-ETS), a promising IGS region for phylogenetic studies poorly studied in Avena genus. In this work, IGS length polymorphisms were detected mainly due to distinct 5'-ETS sequence types resulting from major differences in the number and organization of repeated motifs. Although species with A genome revealed a 5'-ETS organization (A-organization) similar to the one previously described in A. sativa, a distinct organization was unraveled in C genome diploid species (C-organization). Interestingly, such new organization presents a higher similarity with other Poaceae species than A-genome sequences, supporting the hypothesis of C-genome being the ancestral Avena genome. Additionally, polyploid species with both genomes mainly retain the A-genome 5'-ETS organization, confirming the preferential elimination of C-genome sequences in Avena polyploid species. Moreover, 5'-ETS sequences phylogenetic analysis consistently clustered the species studied according to ploidy and genomic constitution supporting the use of ribosomal genes to highlight Avena species evolutive pathways.	[Rodrigues, Joana; Viegas, Wanda; Silva, Manuela] Univ Lisbon, Inst Super Agron, Linking Landscape Environm Agr & Food LEAF, Lisbon, Portugal	Universidade de Lisboa	Silva, M (corresponding author), Univ Lisbon, Inst Super Agron, Linking Landscape Environm Agr & Food LEAF, Lisbon, Portugal.	manuelasilva@isa.ulisboa.pt	Silva, Manuela/ABF-7085-2020; Silva, Manuela/GSN-4031-2022	Silva, Manuela/0000-0003-4677-870X; Rodrigues, Joana/0000-0002-6010-8991; Viegas, Wanda/0000-0003-4660-1226	FCT from Fundacao para a Ciencia e a Tecnologia, Portugal (FCT) [IF/00834/2014]; FCT LEAF [UID/AGR/04129/2013]; FCT [PTDC/BIA-BEC/101964/2008]	FCT from Fundacao para a Ciencia e a Tecnologia, Portugal (FCT); FCT LEAF; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	MS was funded by the FCT Investigator Programme (IF/00834/2014) from Fundacao para a Ciencia e a Tecnologia, Portugal (FCT) and the research work was financed by FCT project PTDC/BIA-BEC/101964/2008, and FCT LEAF (Linking Landscape, Environment, Agriculture and Food) Unit (UID/AGR/04129/2013).	Akhunov ED, 2001, BBA-GENE STRUCT EXPR, V1522, P226, DOI 10.1016/S0167-4781(01)00336-0; Ananiev EV, 2002, GENOME, V45, P431, DOI 10.1139/G01-148; [Anonymous], 2007, CZECH J GENET PLANT, V43, P97; Badaeva ED, 2011, RUSS J GENET+, V47, P691, DOI 10.1134/S1022795411060068; Baldwin BG, 1998, MOL PHYLOGENET EVOL, V10, P449, DOI 10.1006/mpev.1998.0545; Bennett MD, 2012, PLANT DNA C VALUES D; Bento M, 2011, GENOME, V54, P175, DOI 10.1139/G10-107; Boutte J, 2016, G3-GENES GENOM GENET, V6, P29, DOI 10.1534/g3.115.023242; Carvalho A, 2011, J GENET, V90, P203, DOI 10.1007/s12041-011-0051-4; Chang KD, 2010, GENOMICS, V96, P181, DOI 10.1016/j.ygeno.2010.05.005; CLUSTER PD, 1995, GENETICS, V139, P941; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; FOMINAYA A, 1995, GENOME, V38, P548, DOI 10.1139/g95-071; Fu YB, 2008, THEOR APPL GENET, V117, P333, DOI 10.1007/s00122-008-0778-3; Fu YB, 2007, THEOR APPL GENET, V114, P1029, DOI 10.1007/s00122-006-0496-7; Galian JA, 2014, ANN BOT-LONDON, V114, P243, DOI 10.1093/aob/mcu115; GOFFREDA JC, 1992, THEOR APPL GENET, V85, P146, DOI 10.1007/BF00222852; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; He XY, 2012, THEOR APPL GENET, V125, P57, DOI 10.1007/s00122-012-1816-8; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Inacio V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098678; Irigoyen ML, 2001, THEOR APPL GENET, V103, P1160, DOI 10.1007/s001220100723; JELLEN EN, 1994, GENOME, V37, P23, DOI 10.1139/g94-004; Katsiotis A, 2000, ANN BOT-LONDON, V86, P1135, DOI 10.1006/anbo.2000.1284; Katsiotis A, 1997, ANN BOT-LONDON, V79, P103, DOI 10.1006/anbo.1996.0312; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Li CD, 2000, THEOR APPL GENET, V101, P1259, DOI 10.1007/s001220051605; Linares C, 1998, P NATL ACAD SCI USA, V95, P12450, DOI 10.1073/pnas.95.21.12450; Linder CR, 2000, MOL PHYLOGENET EVOL, V14, P285, DOI 10.1006/mpev.1999.0706; Loskutov IG, 2008, GENET RESOUR CROP EV, V55, P211, DOI 10.1007/s10722-007-9229-2; Loskutov IG, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: CEREALS, P109, DOI 10.1007/978-3-642-14228-4_3; MALUSZYNSKA J, 1993, GENOME, V36, P774, DOI 10.1139/g93-102; Morikawa T, 2009, GENES GENET SYST, V84, P199, DOI 10.1266/ggs.84.199; Nikoloudakis N, 2008, THEOR APPL GENET, V117, P273, DOI 10.1007/s00122-008-0772-9; Nikoloudakis N, 2008, MOL PHYLOGENET EVOL, V46, P102, DOI 10.1016/j.ympev.2007.10.007; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Paczos-Grzeda E, 2014, TURK J BOT, V38, P1103, DOI 10.3906/bot-1403-10; Peng YY, 2010, HEREDITAS, V147, P183, DOI 10.1111/j.1601-5223.2010.02172.x; Polanco C, 1997, HEREDITY, V78, P115, DOI 10.1038/hdy.1997.19; POLANCO C, 1994, PLANT MOL BIOL, V25, P751, DOI 10.1007/BF00029613; Pontes O, 2004, P NATL ACAD SCI USA, V101, P18240, DOI 10.1073/pnas.0407258102; Richard GF, 2008, MICROBIOL MOL BIOL R, V72, P686, DOI 10.1128/MMBR.00011-08; Rodionov AV, 2005, RUSS J GENET+, V41, P518, DOI 10.1007/s11177-005-0120-y; Strychar R., 2011, Oats: chemistry and technology, P1; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanhuanpaa P, 2006, GENOME, V49, P282, DOI 10.1139/G05-100; Tomas D, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020203; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	53	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176170	10.1371/journal.pone.0176170	http://dx.doi.org/10.1371/journal.pone.0176170			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448637	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383600043
J	Hashiura, T; Kimura, E; Fujisawa, S; Oikawa, S; Nonaka, S; Kurosaka, D; Hitomi, J				Hashiura, Tetsuya; Kimura, Eiji; Fujisawa, Shizuko; Oikawa, Sayuri; Nonaka, Shigenori; Kurosaka, Daijiro; Hitomi, Jiro			Live imaging of primary ocular vasculature formation in zebrafish	PLOS ONE			English	Article							FAMILIAL EXUDATIVE VITREORETINOPATHY; RETINAL ANGIOGENESIS; ENDOTHELIAL-CELLS; VERTEBRATE; MUTATIONS; EMBRYOS; RETINOPATHY; FRIZZLED-4; SYSTEMS; GENES	Ocular vasculature consists of the central retinal and ciliary vascular systems, which are essential to maintaining visual function. Many researchers have attempted to determine their origins and development; however, the detailed, stepwise process of ocular vasculature formation has not been established. In zebrafish, two angioblast clusters, the rostral and midbrain organizing centers, form almost all of the cranial vasculature, including the ocular vasculature, and these are from where the cerebral arterial and venous angioblast clusters, respectively, differentiate. In this study, we first determined the anatomical architecture of the primary ocular vasculature and then followed its path from the two cerebral angioblast clusters using a time-lapse analysis of living Tg(flk1: EGFP)(k7) zebrafish embryos, in which the endothelial cells specifically expressed enhanced green fluorescent protein. We succeeded in capturing images of the primary ocular vasculature formation and were able to determine the origin of each ocular vessel. In zebrafish, the hyaloid and ciliary arterial systems first organized independently, and then anastomosed via the inner optic circle on the surface of the lens by the lateral transfer of the optic vein. Finally, the choroidal vascular plexus formed around the eyeball to complete the primary ocular vasculature formation. To our knowledge, this study is the first to report successful capture of circular integration of the optic artery and vein, lateral transfer of the optic vein to integrate the hyaloidal and superficial ocular vasculatures, and formation of the choroidal vascular plexus. Furthermore, this new morphological information enables us to assess the entire process of the primary ocular vasculature formation, which will be useful for its precise understanding.	[Hashiura, Tetsuya; Kimura, Eiji; Fujisawa, Shizuko; Oikawa, Sayuri; Hitomi, Jiro] Iwate Med Univ, Dept Anat, 2-1-1 Nishitokuta,Yahaba Cho, Shiwa, Iwate, Japan; [Hashiura, Tetsuya; Fujisawa, Shizuko; Kurosaka, Daijiro] Iwate Med Univ, Dept Ophthalmol, 2-1-1 Nishitokuta,Yahaba Cho, Shiwa, Iwate, Japan; [Nonaka, Shigenori] Natl Inst Basic Biol, Lab Spatiotemporal Regulat, 38 Nishigonaka, Okazaki, Aichi, Japan	Iwate Medical University; Iwate Medical University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Kimura, E (corresponding author), Iwate Med Univ, Dept Anat, 2-1-1 Nishitokuta,Yahaba Cho, Shiwa, Iwate, Japan.	eijik@iwate-med.ac.jp	Nonaka, Shigenori/I-2132-2013	Nonaka, Shigenori/0000-0002-8093-0325	Japan Society for the Promotion of Science (JSPS) [20390054]; Ministry of Education, Culture, Sports, Science and Technology of Japan [S1491001]; NIBB [15-701]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIBB	Iwate Medical University provided support in the form of salaries for all authors. This work was supported by Grant-in-Aid for Scientific Research (KAKENHI) of the Japan Society for the Promotion of Science (JSPS), grant numbers 20390054 (EK and JH), and partly supported by a Grant-in-Aid for Strategic Medical Science Research (S1491001, 2014-2018) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (EK and JH) and the NIBB Cooperative Research Program number 15-701 (EK). None of the funders had any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Y, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-114; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Bussmann J, 2010, DEVELOPMENT, V137, P2653, DOI 10.1242/dev.048207; Cao RH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002748; Collin RWJ, 2013, P NATL ACAD SCI USA, V110, P9856, DOI 10.1073/pnas.1220864110; Condon ED, 1922, CONTRIBUTION EMBRYOL, P47; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Covassin LD, 2009, DEV BIOL, V329, P212, DOI 10.1016/j.ydbio.2009.02.031; Evans HM., 1912, MANUAL HUMAN EMBRYOL, P570; Gilmour DF, 2015, EYE, V29, P1, DOI 10.1038/eye.2014.70; Goldberg MF, 1997, AM J OPHTHALMOL, V124, P587, DOI 10.1016/S0002-9394(14)70899-2; Hartsock A, 2014, DEV BIOL, V394, P327, DOI 10.1016/j.ydbio.2014.07.024; HAUPTMANN G, 1994, TRENDS GENET, V10, P266, DOI 10.1016/0168-9525(90)90008-T; Hellstrom A, 2013, LANCET, V382, P1445, DOI 10.1016/S0140-6736(13)60178-6; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Jiao XD, 2004, AM J HUM GENET, V75, P878, DOI 10.1086/425080; Jin SW, 2007, DEV BIOL, V307, P29, DOI 10.1016/j.ydbio.2007.03.526; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kamei M, 2010, METHOD CELL BIOL, V100, P27, DOI 10.1016/B978-0-12-384892-5.00002-5; Kaufman R, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0066-9; Kimura E, 2015, DEV BIOL, V406, P40, DOI 10.1016/j.ydbio.2015.07.015; Kimura E, 2013, ARTERIOSCL THROM VAS, V33, P1264, DOI 10.1161/ATVBAHA.112.300602; Kitambi SS, 2009, MECH DEVELOP, V126, P464, DOI 10.1016/j.mod.2009.01.002; Klein R, 1997, LANCET, V350, P197, DOI 10.1016/S0140-6736(97)04195-0; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Padget DH, 1948, CONTRIBUTION TP EMBR; Padget DH, 1957, CONTRIBUTION EMBRYOL, P81; Poulter JA, 2010, AM J HUM GENET, V86, P248, DOI 10.1016/j.ajhg.2010.01.012; Proulx K, 2010, DEV BIOL, V348, P34, DOI 10.1016/j.ydbio.2010.08.036; Robitaille J, 2002, NAT GENET, V32, P326, DOI 10.1038/ng957; Sabin FR, 1917, CARNEGIE I WASH, P61; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; SPARKES RS, 1980, SCIENCE, V208, P1042, DOI 10.1126/science.7375916; Streeter GL, 1918, CONTRIBUTION EMBRYOL, P5; Torres-Vazquez J, 2004, DEV CELL, V7, P117, DOI 10.1016/j.devcel.2004.06.008; Wakusawa S, 1968, Nippon Ganka Gakkai Zasshi, V72, P1803; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Weiss O, 2012, DEV BIOL, V369, P191, DOI 10.1016/j.ydbio.2012.06.029; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8	42	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176456	10.1371/journal.pone.0176456	http://dx.doi.org/10.1371/journal.pone.0176456			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445524	Green Published, gold			2022-12-26	WOS:000400309200064
J	Muema, DM; Macharia, GN; Olusola, BA; Hassan, AS; Fegan, GW; Berkley, JA; Urban, BC; Nduati, EW				Muema, Daniel M.; Macharia, Gladys N.; Olusola, Babatunde A.; Hassan, Amin S.; Fegan, Greg W.; Berkley, James A.; Urban, Britta C.; Nduati, Eunice W.			Proportions of circulating follicular helper T cells are reduced and correlate with memory B cells in HIV-infected children	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; DISEASE PROGRESSION; ANTIBODY-RESPONSES; TFH CELLS; ACTIVATION; EXPRESSION; VACCINE; VIREMIA; PRESERVATION	Introduction HIV causes defects in memory B cells in children, but the mechanisms of those defects have not been fully elucidated. One possible mechanism is the lack of T-cell help to B cells during immune reactions. However, few studies have assessed the effect of HIV on follicular helper T cells (T-FH cells) in children. Methods In this study, follicular-homing CD4 T cells and memory B cells were assessed in HIV-infected children and compared with children from the community. CXCR5 and CD45RO were used as markers of follicular-homing T cells and memory T cells, respectively. Memory TFH cells were identified as CD3(+)CD8(-)CD4(+)CXCR5(+)CD45RO(+)PD1(+). Central memory T cells were identified based on CCR7 expression. Relationship between the proportions of follicular-homing CD4 T cells and memory B cells were determined in multivariable regression models. Results Highly viremic HIV-infected children had lower proportions of memory TFH cells when compared with community control children. In multivariable analyses, high proportions of memory TFH cells were associated with increased percentages of resting memory B cells after adjusting for other covariates. Conclusion The impact of HIV on follicular helper T cells could influence the accumulation of memory B cells in HIV-infected children.	[Muema, Daniel M.; Macharia, Gladys N.; Hassan, Amin S.; Fegan, Greg W.; Berkley, James A.; Urban, Britta C.; Nduati, Eunice W.] Wellcome Trust Res Labs, Kenya Med Res Inst, Res Programme, Ctr Geog Med Res Coast, Kilifi, Kenya; [Olusola, Babatunde A.] Univ Ibadan, Dept Virol, Ibadan, Nigeria; [Fegan, Greg W.; Berkley, James A.] Univ Oxford, Nuffield Dept Med, Oxford, England; [Urban, Britta C.] Univ Liverpool Liverpool Sch Trop Med, Dept Parasitol, Liverpool, Merseyside, England; [Muema, Daniel M.] Africa Hlth Res Inst, Durban, South Africa; [Macharia, Gladys N.] Imperial Coll London, Fac Med, London, England; [Fegan, Greg W.] Swansea Univ, Sch Med, Swansea, W Glam, Wales	Kenya Medical Research Institute; University of Ibadan; University of Oxford; Liverpool School of Tropical Medicine; Africa Health Research Institute; Imperial College London; Swansea University	Muema, DM (corresponding author), Wellcome Trust Res Labs, Kenya Med Res Inst, Res Programme, Ctr Geog Med Res Coast, Kilifi, Kenya.; Muema, DM (corresponding author), Africa Hlth Res Inst, Durban, South Africa.	Daniel.muema@ahri.org	Fegan, Greg W/O-8079-2018; Urban, Britta/W-6087-2018; Olusola, Babatunde/AAG-2363-2021	Fegan, Greg W/0000-0002-2663-2765; Urban, Britta/0000-0002-4197-8393; Olusola, Babatunde/0000-0003-4948-2920; Macharia, Gladys/0000-0002-5605-5604; Muema, Daniel/0000-0001-7995-1682; Berkley, James/0000-0002-1236-849X; Hassan, Amin S./0000-0001-5296-4264; Macharia, Gladys/0000-0002-5985-329X	Wellcome Trust UK [095068, 089351, 083579, 079082]; HIV Research Trust	Wellcome Trust UK(Wellcome Trust); HIV Research Trust	This work was supported by Wellcome Trust UK [grant numbers 095068 (EWN), 089351 (ASH), 083579 (JAB) and 079082 (BCU)], https://wellcome.ac.uk/. BAO was supported by HIV Research Trust, http://www.hivresearchtrust.org.uk/.	Bekele Y, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001125; Bekker V, 2006, PEDIATRICS, V118, pE315, DOI 10.1542/peds.2005-2616; Boswell KL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003853; Cohen K, 2014, J VIROL, V88, P13310, DOI 10.1128/JVI.02186-14; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Cubas RA, 2013, NAT MED, V19, P494, DOI 10.1038/nm.3109; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Farquhar C, 2009, PEDIATR INFECT DIS J, V28, P295, DOI 10.1097/INF.0b013e3181903ed3; Fernandes SJ, 2008, VACCINE, V26, P1032, DOI 10.1016/j.vaccine.2007.12.020; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Iwajomo OH, 2011, J INFECT DIS, V204, P534, DOI 10.1093/infdis/jir316; Jacobsen MC, 2008, J INFECT DIS, V198, P481, DOI 10.1086/590215; Jelicic K, 2013, NAT IMMUNOL, V14, P1256, DOI 10.1038/ni.2746; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Lindqvist M, 2012, J CLIN INVEST, V122, P3271, DOI 10.1172/JCI64314; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Moir S, 2010, BLOOD, V116, P5571, DOI 10.1182/blood-2010-05-285528; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Muema DM, 2015, J IMMUNOL, V195, P1082, DOI 10.4049/jimmunol.1500491; National AIDS and STI Control Programme (NASCOP), 2014, KEN AIDS IND SURV 20; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Pallikkuth S, 2012, BLOOD, V120, P985, DOI 10.1182/blood-2011-12-396648; Pensieroso S, 2013, AIDS, V27, P1209, DOI 10.1097/QAD.0b013e32835edc47; Perreau M, 2013, J EXP MED, V210, P143, DOI 10.1084/jem.20121932; Petrovas C, 2012, J CLIN INVEST, V122, P3281, DOI 10.1172/JCI63039; Qiao XG, 2006, NAT IMMUNOL, V7, P302, DOI 10.1038/ni1302; Rethi B, 2013, AIDS, V27, P155, DOI 10.1097/QAD.0b013e32835b8c5e; Rouet F, 2007, JAIDS-J ACQ IMM DEF, V45, P380, DOI 10.1097/QAI.0b013e3180640cf5; Schultz BT, 2016, IMMUNITY, V44, P167, DOI 10.1016/j.immuni.2015.12.011; Spira R, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.5.e56; Titanji K, 2006, BLOOD, V108, P1580, DOI 10.1182/blood-2005-11-013383; World Health Organization, 2010, ANT THER HIV INF INF; Younes SA, 2003, J EXP MED, V198, P1909, DOI 10.1084/jem.20031598	34	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0175570	10.1371/journal.pone.0175570	http://dx.doi.org/10.1371/journal.pone.0175570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445512	Green Published, gold, Green Accepted			2022-12-26	WOS:000400309200024
J	Orkin, AM; Zhan, C; Buick, JE; Drennan, IR; Kleiman, M; Leese, P; Morrison, LJ				Orkin, Aaron M.; Zhan, Chun; Buick, Jason E.; Drennan, Ian R.; Kleiman, Michelle; Leese, Pamela; Morrison, Laurie J.			Out-of-hospital cardiac arrest survival in drugrelated versus cardiac causes in Ontario: A retrospective cohort study	PLOS ONE			English	Article							RESUSCITATION; OUTCOMES; ASSOCIATION; OVERDOSES; PHYSICIAN; UPDATE	Background Drug overdose causes approximately 183,000 deaths worldwide annually and 50,000 deaths in Canada and the United States combined. Drug-related deaths are concentrated among young people, leading to a substantial burden of disease and loss of potential life years. Understanding the epidemiology, patterns of care, and prognosis of drug-related prehospital emergencies may lead to improved outcomes. Methods We conducted a retrospective cohort study of out-of-hospital cardiac arrests with drugrelated and presumed cardiac causes between 2007 and 2013 using the Toronto Regional RescuNet Epistry database. The primary outcome was survival to hospital discharge. We computed standardized case fatality rates, and odds ratios of survival to hospital discharge for cardiac arrests with drug-related versus presumed cardiac causes, adjusting for confounders using logistic regression. Results The analysis involved 21,497 cardiac arrests, including 378 (1.8%) drug-related and 21,119 (98.2%) presumed cardiac. Compared with the presumed cardiac group, drug-related arrest patients were younger and less likely to receive bystander resuscitation, have initial shockable cardiac rhythms, or be transported to hospital. There were no significant differences in emergency medical service response times, return of spontaneous circulation, or survival to discharge. Standardized case fatality rates confirmed that these effects were not due to age or sex differences. Adjusting for known predictors of survival, drug-related cardiac arrest was associated with increased odds of survival to hospital discharge (OR1.44, 95% CI 1.15 - 1.81). Interpretation In out-of-hospital cardiac arrest, patients with drug-related causes are less likely than those with presumed cardiac causes to receive bystander resuscitation or have an initial shockable rhythm, but are more likely to survive after accounting for predictors of survival. The demographics and outcomes among drug-related cardiac arrest patients offers unique opportunities for prehospital intervention.	[Orkin, Aaron M.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Orkin, Aaron M.; Zhan, Chun; Buick, Jason E.; Drennan, Ian R.; Morrison, Laurie J.] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Rescu, Toronto, ON, Canada; [Orkin, Aaron M.] Schwartz Reisman Emergency Med Inst, Toronto, ON, Canada; [Orkin, Aaron M.; Morrison, Laurie J.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Orkin, Aaron M.; Leese, Pamela] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Drennan, Ian R.] Univ Toronto, Fac Med, Inst Med Sci, Toronto, ON, Canada; [Kleiman, Michelle; Morrison, Laurie J.] Univ Toronto, St Michaels Hosp, Div Emergency Med, Toronto, ON, Canada; [Leese, Pamela] Publ Hlth Ontario, Toronto, ON, Canada	University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Orkin, AM (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.; Orkin, AM (corresponding author), Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Rescu, Toronto, ON, Canada.; Orkin, AM (corresponding author), Schwartz Reisman Emergency Med Inst, Toronto, ON, Canada.; Orkin, AM (corresponding author), Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.; Orkin, AM (corresponding author), Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada.	aaron.orkin@mail.utoronto.ca	Drennan, Ian/GQH-9137-2022; Buick, Jason E/K-4816-2013; Drennan, Ian R/K-3046-2013; Orkin, Aaron/K-2500-2014; Morrison, Laurie Jean/A-6325-2012	Buick, Jason E/0000-0002-1859-1713; Drennan, Ian R/0000-0001-8033-4382; Orkin, Aaron/0000-0002-1111-8720; Morrison, Laurie Jean/0000-0001-8369-9774	Dalla Lana School of Public Health; Ontario Ministry of Health and Long-Term Care Clinician Investigator Program; Canadian Institutes of Health Research Fellowship Program; Canadian Institutes of Health Research Banting and Best Doctoral Research Award	Dalla Lana School of Public Health; Ontario Ministry of Health and Long-Term Care Clinician Investigator Program; Canadian Institutes of Health Research Fellowship Program(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research Banting and Best Doctoral Research Award(Canadian Institutes of Health Research (CIHR))	This study received no specific funding. The Dalla Lana School of Public Health, Ontario Ministry of Health and Long-Term Care Clinician Investigator Program, and the Canadian Institutes of Health Research Fellowship Program fund AMO's research and the Canadian Institutes of Health Research Banting and Best Doctoral Research Award funds IRD's research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	British Columbia Coroners Service, 2007, ILLICIT DRUG OVERDOS; British Columbia Government, PROV HLTH OFF DECL P; Buick JE, 2012, CJEM, V15, P1; Centers for Disease Control and Prevention, 2015, NAT VIT STAT SYST MO; Centers for Disease Control and Prevention, 2014, WEB BAS INJ STAT QUE; Davis DP, 2007, PREHOSP EMERG CARE, V11, P369, DOI 10.1080/10903120701537147; Drennan IR, 2016, CMAJ; Elmer J, 2015, RESUSCITATION, V89, P177, DOI 10.1016/j.resuscitation.2015.01.028; Fischer B, 2006, CANADIAN J PUBLIC HL, P384; Gladstone E, 2015, CMAJ; Gomes T, 2014, ADDICTION, V109, P1482, DOI 10.1111/add.12598; Gomes T, 2011, ARCH INTERN MED, V171, P686, DOI 10.1001/archinternmed.2011.117; Health Canada Prescription Drug Status Committee, NOT PRESCR DRUG LIST; Jones CM, 2013, JAMA-J AM MED ASSOC, V309, P657, DOI 10.1001/jama.2013.272; Katz AZ, 2015, RESUSCITATION, V94, P23, DOI 10.1016/j.resuscitation.2015.06.015; Koller AC, 2014, RESUSCITATION; Koller AC, 2014, PREHOSP EMERG CARE, V18, P483, DOI 10.3109/10903127.2014.897780; Lavonas EJ, 2015, CIRCULATION, V132, pS501, DOI 10.1161/CIR.0000000000000264; Lin S, 2011, RESUSCITATION, V82, P419, DOI 10.1016/j.resuscitation.2010.12.006; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Madadi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060600; Morrison LJ, 2008, RESUSCITATION, V78, P161, DOI 10.1016/j.resuscitation.2008.02.020; Murphy Y, 2015, PAIN PHYSICIAN, V18, pE605; National Institute on Drug Abuse (NIDA), 2006, EP TRENDS DRUG AB; Nielsen K, 2011, RESUSCITATION, V82, P1410, DOI 10.1016/j.resuscitation.2011.05.027; Office for National Statistics (United Kingdom), 2013, DEATHS REL DRUG POIS; Ontario Ministry of Health and Long-Term Care, 2010, DEC PAT STAND; Ontario Ministry of Health and Long-Term Care, 2011, ADV LIF SUPP PAT CAR; Penington Institute Australia, 2014, ANN REV 2014; Perkins GD, 2015, CIRCULATION, V132, P1286, DOI 10.1161/CIR.0000000000000144; Rittenberger JC, 2011, RESUSCITATION, V82, P1036, DOI 10.1016/j.resuscitation.2011.03.034; Rudd RA, 2016, MMWR-MORBID MORTAL W, V64, P1378, DOI 10.15585/mmwr.mm6450a3; Salcido DD, 2016, RESUSCITATION, V99, P13, DOI 10.1016/j.resuscitation.2015.11.010; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; SIMS M, 1973, AM J PUBLIC HEALTH, V63, P215, DOI 10.2105/AJPH.63.3.215; Soholm H, 2015, ANN EMERG MED, V65, P523, DOI 10.1016/j.annemergmed.2014.12.009; Sporer KA, 1996, ACAD EMERG MED, V3, P660, DOI 10.1111/j.1553-2712.1996.tb03487.x; Statistics Canada, POP DWELL COUNTS CAN; United Nations Office on Drugs and Crime (UNDOC), 2014, WORLD DRUG REP 2014; Vanden Hoek TL, 2010, CIRCULATION, V122, pS829, DOI 10.1161/CIRCULATIONAHA.110.971069; von Elm E, 2007, EPIDEMIOLOGY, V18, P800, DOI 10.1097/EDE.0b013e3181577654; Wolfenden HH, 1923, J R STAT SOC, V86, P399, DOI 10.2307/2341622	42	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176441	10.1371/journal.pone.0176441	http://dx.doi.org/10.1371/journal.pone.0176441			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445501	Green Submitted, Green Published, gold			2022-12-26	WOS:000400309200061
J	Fallath, T; Kidd, BN; Stiller, J; Davoine, C; Bjorklund, S; Manners, JM; Kazan, K; Schenk, PM				Fallath, Thorya; Kidd, Brendan N.; Stiller, Jiri; Davoine, Celine; Bjorklund, Stefan; Manners, John M.; Kazan, Kemal; Schenk, Peer M.			MEDIATOR18 and MEDIATOR20 confer susceptibility to Fusarium oxysporum in Arabidopsis thaliana	PLOS ONE			English	Article							SIGNALING PATHWAYS; SALICYLIC-ACID; ABSCISIC-ACID; DISEASE RESISTANCE; GENE-EXPRESSION; CROSS-TALK; JASMONATE; DEFENSE; RESPONSES; COMPLEX	The conserved protein complex known as Mediator conveys transcriptional signals by acting as an intermediary between transcription factors and RNA polymerase II. As a result, Mediator subunits play multiple roles in regulating developmental as well as abiotic and biotic stress pathways. In this report we identify the head domain subunits MEDIATOR18 and MEDIATOR20 as important susceptibility factors for Fusarium oxysporum infection in Arabidopsis thaliana. Mutants of MED18 and MED20 display down-regulation of genes associated with jasmonate signaling and biosynthesis while up-regulation of salicylic acid associated pathogenesis related genes and reactive oxygen producing and scavenging genes. We propose that MED18 and MED20 form a sub-domain within Mediator that controls the balance of salicylic acid and jasmonate associated defense pathways.	[Fallath, Thorya; Kidd, Brendan N.; Schenk, Peer M.] Univ Queensland, Sch Agr & Food Sci, Plant Microbe Interact Lab, St Lucia, Qld, Australia; [Kidd, Brendan N.; Stiller, Jiri; Kazan, Kemal] CSIRO Agr & Food, Queensland Biosci Precinct, St Lucia, Qld, Australia; [Davoine, Celine; Bjorklund, Stefan] Umea Univ, Dept Med Biochem & Biophys, Umea Plant Sci Ctr, Umea, Sweden; [Manners, John M.] CSIRO Agr & Food, Canberra, ACT, Australia; [Kazan, Kemal; Schenk, Peer M.] Univ Queensland, QAAFI, St Lucia, Qld, Australia; [Kidd, Brendan N.] CSIRO Agr & Food, Ctr Environm & Life Sci, Floreat, WA 6913, Australia	University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Umea University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Schenk, PM (corresponding author), Univ Queensland, Sch Agr & Food Sci, Plant Microbe Interact Lab, St Lucia, Qld, Australia.; Schenk, PM (corresponding author), Univ Queensland, QAAFI, St Lucia, Qld, Australia.	p.schenk@uq.edu.au	Kidd, Brendan N/D-9801-2017; Kazan, Kemal/B-8032-2008; Stiller, Jiri/E-1564-2012; Manners, John M/A-4922-2008; Schenk, Peer/B-7879-2016; Kidd, Brendan/J-9672-2014	Kazan, Kemal/0000-0002-5169-8934; Schenk, Peer/0000-0003-4878-3799; Kidd, Brendan/0000-0003-1770-1404	Australian Research Council [DP110104354]; Swedish Cancer Society [15 0537]; Swedish Research Council [621-2010-4969]; Swedish Governmental Agency for Innovation Systems; Knut and Alice Wallenberg Foundation [2015-0056]; Kempe Foundation	Australian Research Council(Australian Research Council); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Governmental Agency for Innovation Systems(Vinnova); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Kempe Foundation	This work was supported by the Australian Research Council [htpp://www.arc.gov.au] grant no. DP110104354 to PMS, JMM, and KK. CD and SB were supported by grants from the Swedish Cancer Society (15 0537); the Swedish Research Council (621-2010-4969); the Swedish Governmental Agency for Innovation Systems, the Knut and Alice Wallenberg Foundation (2015-0056) and the Kempe Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JP, 2004, PLANT CELL, V16, P3460, DOI 10.1105/tpc.104.025833; Asturias FJ, 1999, SCIENCE, V283, P985, DOI 10.1126/science.283.5404.985; Backstrom S, 2007, MOL CELL, V26, P717, DOI 10.1016/j.molcel.2007.05.007; Birkenbihl RP, 2012, PLANT PHYSIOL, V159, P266, DOI 10.1104/pp.111.192641; Campbell EJ, 2003, PLANT PHYSIOL, V133, P1272, DOI 10.1104/pp.103.024182; Cevik V, 2012, PLANT PHYSIOL, V160, P541, DOI 10.1104/pp.112.202697; Chen T, 2015, NUCLEIC ACIDS RES, V43, P8283, DOI 10.1093/nar/gkv751; Cole SJ, 2014, MOL PLANT PATHOL, V15, P589, DOI 10.1111/mpp.12117; Cui FH, 2013, PLANT PHYSIOL, V162, P1018, DOI 10.1104/pp.113.219659; Cui P, 2016, PLANT CELL, V28, P770, DOI 10.1105/tpc.15.00771; Derksen H, 2013, PLANT SCI, V207, P79, DOI 10.1016/j.plantsci.2013.03.004; Diener A, 2012, MOL PLANT MICROBE IN, V25, P1531, DOI 10.1094/MPMI-02-12-0042-TA; Dombrecht B, 2007, PLANT CELL, V19, P2225, DOI 10.1105/tpc.106.048017; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Edgar CI, 2006, AUSTRALAS PLANT PATH, V35, P581, DOI 10.1071/AP06060; Gidda SK, 2003, J BIOL CHEM, V278, P17895, DOI 10.1074/jbc.M211943200; Havko NE, 2016, PLANTS-BASEL, V5, DOI 10.3390/plants5010007; Huffaker A, 2007, P NATL ACAD SCI USA, V104, P10732, DOI 10.1073/pnas.0703343104; JEFFERSON RA, 1987, EMBO J, V6, P3901; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; Kidd BN, 2011, SEMIN CELL DEV BIOL, V22, P741, DOI 10.1016/j.semcdb.2011.07.012; Kidd BN, 2011, MOL PLANT MICROBE IN, V24, P733, DOI 10.1094/MPMI-08-10-0194; Kidd BN, 2009, PLANT CELL, V21, P2237, DOI 10.1105/tpc.109.066910; Kim YJ, 2011, EMBO J, V30, P814, DOI 10.1038/emboj.2011.3; Koiwa H, 2004, P NATL ACAD SCI USA, V101, P14539, DOI 10.1073/pnas.0403174101; Koiwa H, 2002, P NATL ACAD SCI USA, V99, P10893, DOI 10.1073/pnas.112276199; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Lai ZB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4064; Laloi C, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00039; Lariviere L, 2012, NATURE, V492, P448, DOI 10.1038/nature11670; Lee KP, 2007, P NATL ACAD SCI USA, V104, P10270, DOI 10.1073/pnas.0702061104; Liao CJ, 2016, PLANT CELL, V28, P1662, DOI 10.1105/tpc.16.00105; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Lyons R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127699; Lyons R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121902; Manavella PA, 2012, CELL, V151, P859, DOI 10.1016/j.cell.2012.09.039; McGrath KC, 2005, PLANT PHYSIOL, V139, P949, DOI 10.1104/pp.105.068544; Miersch O, 1999, PHYTOCHEMISTRY, V50, P517, DOI 10.1016/S0031-9422(98)00596-2; Misas-Villamil JC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003281; Pantelides IS, 2013, PLANT PATHOL, V62, P1302, DOI 10.1111/ppa.12042; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Plaschka C, 2015, NATURE, V518, P376, DOI 10.1038/nature14229; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Samanta S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00757; Schumann Ulrike, 2013, Silence, V4, P3, DOI 10.1186/1758-907X-4-3; Sewelam N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070289; Shaikhibrahim Z, 2009, P NATL ACAD SCI USA, V106, P20728, DOI 10.1073/pnas.0907645106; Shumbe L, 2016, PLANT PHYSIOL, V170, P1757, DOI 10.1104/pp.15.01546; Smakowska E, 2016, CURR OPIN PLANT BIOL, V29, P129, DOI 10.1016/j.pbi.2015.12.005; Thatcher LF, 2016, J EXP BOT, V67, P2367, DOI 10.1093/jxb/erw040; Thatcher LF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126978; Thatcher LF, 2009, PLANT J, V58, P927, DOI 10.1111/j.1365-313X.2009.03831.x; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trusov Y, 2009, PLANT J, V58, P69, DOI 10.1111/j.1365-313X.2008.03755.x; Tsai KL, 2014, CELL, V157, P1430, DOI 10.1016/j.cell.2014.05.015; Tsuda K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000772; Wagner D, 2004, SCIENCE, V306, P1183, DOI 10.1126/science.1103178; Wigge PA, 2011, CURR BIOL, V21, pR374, DOI 10.1016/j.cub.2011.03.038; Windram O, 2014, ANNU REV PHYTOPATHOL, V52, P93, DOI 10.1146/annurev-phyto-102313-050103; Yang Y, 2014, PLANT J, V77, P838, DOI 10.1111/tpj.12440; Zheng XY, 2012, CELL HOST MICROBE, V11, P587, DOI 10.1016/j.chom.2012.04.014; Zheng ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053924	64	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176022	10.1371/journal.pone.0176022	http://dx.doi.org/10.1371/journal.pone.0176022			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441405	Green Published, Green Submitted, gold			2022-12-26	WOS:000400308800020
J	Hayat, T; Qayyum, S; Alsaedi, A; Asghar, S				Hayat, Tasawar; Qayyum, Sajid; Alsaedi, Ahmed; Asghar, Saleem			Radiation effects on the mixed convection flow induced by an inclined stretching cylinder with non-uniform heat source/sink	PLOS ONE			English	Article							STAGNATION-POINT FLOW; NONLINEAR THERMAL-RADIATION; CHEMICAL-REACTION; VISCOELASTIC FLUID; MAXWELL NANOFLUID; MICROPOLAR FLUID; COMPLEX NETWORK; MAGNETIC-FIELD; JEFFREY FLUID; TIME-SERIES	This study investigates the mixed convection flow of Jeffrey liquid by an impermeable inclined stretching cylinder. Thermal radiation and non-uniform heat source/sink are considered. The convective boundary conditions at surface are imposed. Nonlinear expressions of momentum, energy and concentration are transformed into dimensionless systems. Convergent homotopic solutions of the governing systems are worked out by employing homotopic procedure. Impact of physical variables on the velocity, temperature and concentration distributions are sketched and discussed. Numerical computations for skin friction coefficient, local Nusselt and Sherwood numbers are carried out. It is concluded that velocity field enhances for Deborah number while reverse situation is observed regarding ratio of relaxation to retardation times. Temperature and heat transfer rate are enhanced via larger thermal Biot number. Effect of Schmidt number on the concentration and local Sherwood number is quite reverse.	[Hayat, Tasawar; Qayyum, Sajid] Quaid I Azam Univ, Dept Math, Islamabad 45320, Pakistan; [Hayat, Tasawar; Alsaedi, Ahmed] King Abdulaziz Univ, Nonlinear Anal & Appl Math NAAM Res Grp, Fac Sci, Jeddah, Saudi Arabia; [Asghar, Saleem] COMSATS Inst Informat Technol, Dept Math Sci, Islamabad, Pakistan	Quaid I Azam University; King Abdulaziz University; COMSATS University Islamabad (CUI)	Qayyum, S (corresponding author), Quaid I Azam Univ, Dept Math, Islamabad 45320, Pakistan.	sajidqayyum94@gmail.com	Hayat, Tasawar/Y-2524-2019; Alsaedi, Ahmed/A-2094-2013	Alsaedi, Ahmed/0000-0003-3452-8922				Abbasi FM, 2016, J MAGN MAGN MATER, V404, P159, DOI 10.1016/j.jmmm.2015.11.090; Abbasi FM, 2015, AIP ADV, V5, DOI 10.1063/1.4914549; Ashraf MB, 2015, AIP ADV, V5, DOI 10.1063/1.4913719; Aziz A, 2009, COMMUN NONLINEAR SCI, V14, P1064, DOI 10.1016/j.cnsns.2008.05.003; Farooq U, 2015, COMPUT FLUIDS, V111, P69, DOI 10.1016/j.compfluid.2015.01.005; Fetecau C, 2014, Z NATURFORSCH A, V69, P232, DOI 10.5560/ZNA.2014-0022; Fetecau C, 2010, Z ANGEW MATH PHYS, V61, P959, DOI 10.1007/s00033-009-0038-7; Gao ZK, 2016, SCI REP-UK, V6, DOI 10.1038/srep35622; Gao ZK, 2016, CHEM ENG J, V291, P74, DOI 10.1016/j.cej.2016.01.039; Gao ZK, 2015, SCI REP-UK, V5, DOI 10.1038/srep08222; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2016, IEEE T INSTRUM MEAS, V65, P1690, DOI 10.1109/TIM.2016.2540862; Ghanbari M, 2013, APPL COMPUT MATH-BAK, V12, P355; Han SH, 2014, APPL MATH LETT, V38, P87, DOI 10.1016/j.aml.2014.07.013; Hayat T, 2015, COMPUT FLUIDS, V108, P179, DOI 10.1016/j.compfluid.2014.11.016; Hayat T, 2014, APPL MATH MECH-ENGL, V35, P717, DOI 10.1007/s10483-014-1824-6; Hayat T., 2015, THERMAL SCI; Hayat T., 2017, RESULTS PHYS; Hayat T, 2017, J MOL LIQ, V230, P641, DOI 10.1016/j.molliq.2017.01.045; Hayat T, 2016, EUR PHYS J PLUS, V131, DOI 10.1140/epjp/i2016-16422-x; Hayat T, 2016, J MOL LIQ, V224, P801, DOI 10.1016/j.molliq.2016.10.055; Hayat T, 2016, J MOL LIQ, V223, P969, DOI 10.1016/j.molliq.2016.08.102; Hayat T, 2016, INT J HEAT MASS TRAN, V103, P99, DOI 10.1016/j.ijheatmasstransfer.2016.06.055; Hayat T, 2016, AIP ADV, V6, DOI 10.1063/1.4942091; Liao S., 2012, HOMOTOPY ANAL METHOD; Lin YH, 2015, INT J HEAT MASS TRAN, V84, P903, DOI 10.1016/j.ijheatmasstransfer.2015.01.099; Malik R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107989; Narayana PVS, 2016, J TAIWAN INST CHEM E, V59, P18, DOI 10.1016/j.jtice.2015.07.014; Pal D., 2012, INT J NONLINEAR SCI, V14, P115; Ramesh GK, 2012, INT J HEAT MASS TRAN, V55, P4900, DOI 10.1016/j.ijheatmasstransfer.2012.05.003; Rashad AM, 2014, J TAIWAN INST CHEM E, V45, P2163, DOI 10.1016/j.jtice.2014.07.002; Shehzad SA, 2016, J MAGN MAGN MATER, V397, P108, DOI 10.1016/j.jmmm.2015.07.057; Shehzad SA, 2015, B POL ACAD SCI-TECH, V63, P465, DOI 10.1515/bpasts-2015-0053; Sheikholeslami M, 2014, J MOL LIQ, V194, P30, DOI 10.1016/j.molliq.2014.01.005; Sheikholeslami M, J MAGN MAGN MAT, V2105, P36; Singh G, 2015, THERM SCI, V19, P119, DOI 10.2298/TSCI120718110S; Turkyilmazoglu M, 2013, INT J MECH SCI, V77, P263, DOI 10.1016/j.ijmecsci.2013.10.011; Turkyilmazoglu M, 2012, COMMUN NONLINEAR SCI, V17, P4097, DOI 10.1016/j.cnsns.2012.01.030; Wang SW, 2011, INT J HEAT FLUID FL, V32, P88, DOI 10.1016/j.ijheatfluidflow.2010.10.005; Zheng LC, 2013, J FRANKLIN I, V350, P990, DOI 10.1016/j.jfranklin.2013.01.022	40	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0175584	10.1371/journal.pone.0175584	http://dx.doi.org/10.1371/journal.pone.0175584			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441392	Green Submitted, Green Published, gold			2022-12-26	WOS:000400308800008
J	Kang, HW; Kang, HB				Kang, Hyeon-Woo; Kang, Hang-Bong			Prediction of crime occurrence from multi-modal data using deep learning	PLOS ONE			English	Article							VIOLENT CRIME; UNEMPLOYMENT; PREVENTION; INEQUALITY; HOMICIDE; PATTERNS	In recent years, various studies have been conducted on the prediction of crime occurrences. This predictive capability is intended to assist in crime prevention by facilitating effective implementation of police patrols. Previous studies have used data from multiple domains such as demographics, economics, and education. Their prediction models treat data from different domains equally. These methods have problems in crime occurrence prediction, such as difficulty in discovering highly nonlinear relationships, redundancies, and dependencies between multiple datasets. In order to enhance crime prediction models, we consider environmental context information, such as broken windows theory and crime prevention through environmental design. In this paper, we propose a feature-level data fusion method with environmental context based on a deep neural network (DNN). Our dataset consists of data collected from various online databases of crime statistics, demographic and meteorological data, and images in Chicago, Illinois. Prior to generating training data, we select crime-related data by conducting statistical analyses. Finally, we train our DNN, which consists of the following four kinds of layers: spatial, temporal, environmental context, and joint feature representation layers. Coupled with crucial data extracted from various domains, our fusion DNN is a product of an efficient decision-making process that statistically analyzes data redundancy. Experimental performance results show that our DNN model is more accurate in predicting crime occurrence than other prediction models.	[Kang, Hyeon-Woo; Kang, Hang-Bong] Catholic Univ Korea, Dept Digital Media, Bucheon, Gyonggi Do, South Korea	Catholic University of Korea	Kang, HB (corresponding author), Catholic Univ Korea, Dept Digital Media, Bucheon, Gyonggi Do, South Korea.	hbkang@catholic.ac.kr		Kang, Hang-Bong/0000-0002-7064-478X	Basin Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning [2015R1A2A1A10056304]	Basin Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning	This research was supported by Basin Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and future Planning (No. 2015R1A2A1A10056304).	Akers TA, 2009, AM J PUBLIC HEALTH, V99, P397, DOI 10.2105/AJPH.2008.139808; Alves L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077066; ANDERSON CA, 1984, J PERS SOC PSYCHOL, V46, P91, DOI 10.1037/0022-3514.46.1.91; Bengio Y, 2013, IEEE T PATTERN ANAL, V35, P1798, DOI 10.1109/TPAMI.2013.50; Casteel C, 2000, AM J PREV MED, V18, P99, DOI 10.1016/S0749-3797(00)00146-X; Chawla NV, 2010, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, SECOND EDITION, P875, DOI 10.1007/978-0-387-09823-4_45; Chen P, 2008, FIFTH INTERNATIONAL CONFERENCE ON FUZZY SYSTEMS AND KNOWLEDGE DISCOVERY, VOL 5, PROCEEDINGS, P627, DOI 10.1109/FSKD.2008.222; COHEN LE, 1979, AM SOCIOL REV, V44, P588, DOI 10.2307/2094589; Poveda AC, 2012, J INT DEV, V24, P809, DOI 10.1002/jid.2819; Cozens PM, 2005, PROP MANAG, V23, P328, DOI 10.1108/02637470510631483; Cusimano M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008669; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Gerber MS, 2014, DECIS SUPPORT SYST, V61, P115, DOI 10.1016/j.dss.2014.02.003; Gorr W, 2003, INT J FORECASTING, V19, P579, DOI 10.1016/S0169-2070(03)00092-X; He HB, 2009, IEEE T KNOWL DATA EN, V21, P1263, DOI 10.1109/TKDE.2008.239; Hipp JR, 2004, SOC FORCES, V82, P1333, DOI 10.1353/sof.2004.0074; Hojman D., 2002, B LAT AM RES, V21, P121; Hojman DE, 2004, CRIME LAW SOCIAL CH, V41, P33, DOI 10.1023/B:CRIS.0000015327.30140.8d; Jia YQ, 2014, PROCEEDINGS OF THE 2014 ACM CONFERENCE ON MULTIMEDIA (MM'14), P675, DOI 10.1145/2647868.2654889; Kelly M, 2000, REV ECON STAT, V82, P530, DOI 10.1162/003465300559028; Kianmehr K, 2006, I C COMP SYST APPLIC, P951; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Lauritsen JL, 2014, J CONTEMP CRIM JUST, V30, P7, DOI 10.1177/1043986213509024; Levitt SD, 2001, J QUANT CRIMINOL, V17, P377, DOI 10.1023/A:1012541821386; Liu W, 2015, PROC CVPR IEEE, P3013, DOI 10.1109/CVPR.2015.7298920; Lu X, 2014, PROCEEDINGS OF THE 2014 ACM CONFERENCE ON MULTIMEDIA (MM'14), P457, DOI 10.1145/2647868.2654927; McDowall D, 2012, J QUANT CRIMINOL, V28, P389, DOI 10.1007/s10940-011-9145-7; Mohler GO, 2011, J AM STAT ASSOC, V106, P100, DOI 10.1198/jasa.2011.ap09546; Nelson AL, 2001, APPL GEOGR, V21, P249, DOI 10.1016/S0143-6228(01)00008-X; Ngiam J., 2011, P 28 INT C MACH LEAR, P689, DOI DOI 10.5555/3104482.3104569; Pereira DVS, 2016, J ENVIRON PSYCHOL, V46, P116, DOI 10.1016/j.jenvp.2016.04.006; Renjie Liao, 2010, 2010 International Conference on Machine Learning and Cybernetics (ICMLC 2010), P1757, DOI 10.1109/ICMLC.2010.5580971; Rock DJ, 2008, INJURY, V39, P1047, DOI 10.1016/j.injury.2008.03.025; Salesses P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068400; Shingleton JS, 2012, CRIME TREND PREDICTI; Srivastava N, 2014, J MACH LEARN RES, V15, P2949; Wang P., 2010, INT C MANAGEMENT SER, P1, DOI DOI 10.1109/PES.2010.5588163; Wilson JQ, 1982, BROKEN WINDOWS CRITI, P395; Xinyu Chen, 2015, 2015 Systems and Information Engineering Design Symposium. proceedings, P63, DOI 10.1109/SIEDS.2015.7117012; Yan YY, 2000, PERCEPT MOTOR SKILL, V90, P451; Yu Zheng, 2015, IEEE Transactions on Big Data, V1, P16, DOI 10.1109/TBDATA.2015.2465959	41	90	91	4	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176244	10.1371/journal.pone.0176244	http://dx.doi.org/10.1371/journal.pone.0176244			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET4XE	28437486	Green Published, gold, Green Submitted			2022-12-26	WOS:000400287600039
J	Ichinose, N; Yada, T; Wada, H				Ichinose, Natsuhiro; Yada, Tetsushi; Wada, Hiroshi			Estimating optimal sparseness of developmental gene networks using a semi-quantitative model	PLOS ONE			English	Article							SPECIFICATION; STABILITY	To estimate gene regulatory networks, it is important that we know the number of connections, or sparseness of the networks. It can be expected that the robustness to perturbations is one of the factors determining the sparseness. We reconstruct a semi-quantitative model of gene networks from gene expression data in embryonic development and detect the optimal sparseness against perturbations. The dense networks are robust to connection-removal perturbation, whereas the sparse networks are robust to misexpression perturbation. We show that there is an optimal sparseness that serves as a trade-off between these perturbations, in agreement with the optimal result of validation for testing data. These results suggest that the robustness to the two types of perturbations determines the sparseness of gene networks.	[Ichinose, Natsuhiro] Kyoto Univ, Grad Sch Informat, Sakyo Ku, Yoshida Honmachi, Kyoto, Japan; [Yada, Tetsushi] Kyushu Inst Technol, Fac Comp Sci & Syst Engn, Iizuka, Fukuoka, Japan; [Wada, Hiroshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan	Kyoto University; Kyushu Institute of Technology; University of Tsukuba	Ichinose, N (corresponding author), Kyoto Univ, Grad Sch Informat, Sakyo Ku, Yoshida Honmachi, Kyoto, Japan.	ichinose@i.kyoto-u.ac.jp			JSPS KAKENHI Grant [15KT0074]	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 15KT0074. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradley P. S., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P82; Chen LN, 2002, IEEE T CIRCUITS-I, V49, P602, DOI 10.1109/TCSI.2002.1001949; Davidson EH, 2002, DEV BIOL, V246, P162, DOI 10.1006/dbio.2002.0635; GLASS L, 1975, J THEOR BIOL, V54, P85, DOI 10.1016/S0022-5193(75)80056-7; Hastie T, 1996, J ROY STAT SOC B MET, V58, P155; Hoyle NP, 2013, P NATL ACAD SCI USA, V110, pE4316, DOI 10.1073/pnas.1308811110; Ichinose N, 2008, J THEOR BIOL, V255, P378, DOI 10.1016/j.jtbi.2008.09.006; Ikemoto Y, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.042705; Motter AE, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.065102; Oliveri P, 2003, DEV BIOL, V258, P32, DOI 10.1016/S0012-1606(03)00108-8; Osborne MR, 2000, J COMPUT GRAPH STAT, V9, P319, DOI 10.2307/1390657; Pastor-Satorras R, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.066117; Peter IS, 2012, P NATL ACAD SCI USA, V109, P16434, DOI 10.1073/pnas.1207852109; Siegal ML, 2002, P NATL ACAD SCI USA, V99, P10528, DOI 10.1073/pnas.102303999; Wagner A, 1996, EVOLUTION, V50, P1008, DOI 10.1111/j.1558-5646.1996.tb02342.x; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	17	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0176492	10.1371/journal.pone.0176492	http://dx.doi.org/10.1371/journal.pone.0176492			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430819	Green Published, gold			2022-12-26	WOS:000399876100046
J	Lee, SW; Liu, CW; Hu, JY; Chiang, LM; Chuu, CP; Wu, LSH; Kao, YH				Lee, Shih-Wei; Liu, Chi-Wei; Hu, Jia-Ying; Chiang, Li-Mei; Chuu, Chih-Pin; Wu, Lawrence Shih-Hsin; Kao, Yung-Hsi			Suppressors of cytokine signaling in tuberculosis	PLOS ONE			English	Article							GENE-EXPRESSION; CANDIDATE BIOMARKERS; DENDRITIC CELL; SOCS PROTEINS; ACTIVATION; INFLAMMATION; INFECTION	Tuberculosis (TB), a global disease mainly infected by Mycobacterium tuberculosis, remains leading public health problem worldwide. Suppressors of cytokine signaling (SOCSs) play important roles in the protection against microbial infection. However, the relationship between members of the SOCS family and tuberculosis infection remains unclear. Using peripheral blood mononuclear cells, we investigated the mRNA expression profiles of SOCS subfamilies among active TB, latent tuberculosis infection (LTBI), and healthy individuals. Our results showed that active tuberculosis subjects had higher levels of SOCS-3 mRNA, lower expressions of SOCS-2, -4, -5, -6, -7, and cytokine-inducible SH2-containing protein-1 (CIS-1) mRNAs, but not SOCS-1 mRNA than healthy and LTBI subjects. In men, LTBI patients had lower SOCS-3 than healthy subjects, and active TB patients had lower levels of SOCS-4, -5, and CIS-1 mRNAs but higher levels of SOCS-3 mRNA than healthy subjects. In women, LTBI patients had lower SOCS-3 mRNA level than healthy subjects, and active TB patients had lower CIS-1 mRNA level than healthy subjects. In non-aged adults (< 65 years old), TB patients had higher SOCS-3 mRNA and lower levels of SOCS-2, -4, -5, -6, -7, and CIS-1 mRNAs; whereas, aged TB patients (>= 65 years old) had lower levels of SOCS-5 and CIS-1 mRNAs. These data suggest that particular SOCS members and their correlative relationships allow discrimination of active TB from healthy and LTBI subjects.	[Lee, Shih-Wei; Chiang, Li-Mei; Kao, Yung-Hsi] Natl Cent Univ, Dept Life Sci, Taoyuan, Taiwan; [Lee, Shih-Wei; Liu, Chi-Wei; Hu, Jia-Ying] Minist Hlth & Welf, Taoyuan Gen Hosp, Taoyuan, Taiwan; [Chuu, Chih-Pin] Natl Hlth Res Inst, Inst Cellular & Syst Med, Miaoli, Taiwan; [Wu, Lawrence Shih-Hsin] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan	National Central University; National Health Research Institutes - Taiwan; Tzu Chi University	Kao, YH (corresponding author), Natl Cent Univ, Dept Life Sci, Taoyuan, Taiwan.; Wu, LSH (corresponding author), Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan.	lshwu@hotmail.com; ykao@cc.ncu.edu.tw	Chuu, Chih-Pin/N-6697-2019		Taoyuan General Hospital, Taiwan [PTH10227, PTH10310, PTH10327, PTH10419]; Ministry of Sciences and Technologies, Taiwan [MOST105-2311-B008-003]	Taoyuan General Hospital, Taiwan; Ministry of Sciences and Technologies, Taiwan	This study was supported in part by the Taoyuan General Hospital, Taiwan, Grants PTH10227, PTH10310, PTH10327 and PTH10419 to S.-W. Lee and by the Ministry of Sciences and Technologies, Taiwan, Grant MOST105-2311-B008-003 to Y.-H. Kao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balboa L, 2016, INT J MED MICROBIOL, V306, P541, DOI 10.1016/j.ijmm.2016.06.004; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bibova I, 2012, DIAGN MICR INFEC DIS, V72, P68, DOI 10.1016/j.diagmicrobio.2011.09.024; Chang HH, 2012, GEN COMP ENDOCR, V178, P450, DOI 10.1016/j.ygcen.2012.06.024; Chao WC, 2015, MICROBES INFECT, V17, P195, DOI 10.1016/j.micinf.2014.11.009; Collins HL, 2001, IMMUNOLOGY, V103, P1, DOI 10.1046/j.1365-2567.2001.01236.x; da Silva MV, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/639107; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Haan S., 2016, FRONT BIOSCI-LANDMRK, V8, P189, DOI DOI 10.2741/E760; Hu J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007178; Bini EI, 2015, TUBERCULOSIS, V95, P701, DOI 10.1016/j.tube.2015.06.002; Bini EI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093831; Jacobsen M, 2011, CLIN MICROBIOL INFEC, V17, P1323, DOI 10.1111/j.1469-0691.2010.03326.x; Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6; Kedzierski L, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004134; Lee SW, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-015-0848-x; Linke A, 2010, J INVEST DERMATOL, V130, P866, DOI 10.1038/jid.2009.345; Masood KI, 2012, SCAND J IMMUNOL, V76, P398, DOI 10.1111/j.1365-3083.2012.02731.x; Masood KI, 2016, J MICROBIOL IMMUNOL, V49, P984, DOI 10.1016/j.jmii.2015.08.018; Masood KI, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-13; Matsumoto A, 1999, MOL CELL BIOL, V19, P6396; Matthews J, 2005, BIOCHEM BIOPH RES CO, V335, P168, DOI 10.1016/j.bbrc.2005.07.057; McCormick SM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00549; Neuwirt H, 2007, ENDOCR-RELAT CANCER, V14, P1007, DOI 10.1677/ERC-07-0172; Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746; Rodwell GEJ, 2004, PLOS BIOL, V2, P2191, DOI 10.1371/journal.pbio.0020427; Seki Y, 2002, P NATL ACAD SCI USA, V99, P13003, DOI 10.1073/pnas.202477099; Steppan CM, 2005, MOL CELL BIOL, V25, P1569, DOI 10.1128/MCB.25.4.1569-1575.2005; Sun L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092020; Sutherland JS, 2014, CLIN MICROBIOL INFEC, V20, pO230, DOI 10.1111/1469-0691.12383; Trengove MC, 2013, AM J CLIN EXP IMMUNO, V2, P1; Wu LSH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/895179; Yang CH, 2014, TAIWAN TUBERCULOSIS; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Yoshimura A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00020	35	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0176377	10.1371/journal.pone.0176377	http://dx.doi.org/10.1371/journal.pone.0176377			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430824	gold, Green Published, Green Submitted			2022-12-26	WOS:000399876100041
J	Cai, GS; Xiao, FF; Cheng, C; Li, YF; Amos, CI; Whitfield, ML				Cai, Guoshuai; Xiao, Feifei; Cheng, Chao; Li, Yafang; Amos, Christopher I.; Whitfield, Michael L.			Population effect model identifies gene expression predictors of survival outcomes in lung adenocarcinoma for both Caucasian and Asian patients	PLOS ONE			English	Article							RNA-SEQ; CANCER CELLS; OVEREXPRESSION; SMOKING; PROFILE; RISK	Background We analyzed and integrated transcriptome data from two large studies of lung adenocarcinomas on distinct populations. Our goal was to investigate the variable gene expression alterations between paired tumor-normal tissues and prospectively identify those alterations that can reliably predict lung disease related outcomes across populations. Methods We developed a mixed model that combined the paired tumor-normal RNA-seq from two populations. Alterations in gene expression common to both populations were detected and validated in two independent DNA microarray datasets. A 10-gene prognosis signature was developed through a /1 penalized regression approach and its prognostic value was evaluated in a third independent microarray cohort. Results Deregulation of apoptosis pathways and increased expression of cell cycle pathways were identified in tumors of both Caucasian and Asian lung adenocarcinoma patients. We demonstrate that a 10-gene biomarker panel can predict prognosis of lung adenocarcinoma in both Caucasians and Asians. Compared to low risk groups, high risk groups showed significantly shorter overall survival time (Caucasian patients data: HR = 3.63, p-value = 0.007; Asian patients data: HR = 3.25, p-value = 0.001). Conclusions This study uses a statistical framework to detect DEGs between paired tumor and normal tissues that considers variances among patients and ethnicities, which will aid in understanding the common genes and signalling pathways with the largest effect sizes in ethnically diverse cohorts. We propose multifunctional markers for distinguishing tumor from normal tissue and prognosis for both populations studied.	[Cai, Guoshuai; Cheng, Chao; Whitfield, Michael L.] Geisel Sch Med Dartmouth, Dept Mol & Syst Biol, Hanover, NH USA; [Xiao, Feifei] Univ South Carolina, Dept Epidemiol & Biostat, Columbia, SC 29208 USA; [Cheng, Chao; Li, Yafang; Amos, Christopher I.] Dartmouth Coll, Dept Biomed Data Sci, Hanover, NH 03755 USA	Dartmouth College; University of South Carolina System; University of South Carolina Columbia; Dartmouth College	Whitfield, ML (corresponding author), Geisel Sch Med Dartmouth, Dept Mol & Syst Biol, Hanover, NH USA.; Amos, CI (corresponding author), Dartmouth Coll, Dept Biomed Data Sci, Hanover, NH 03755 USA.	Christopher.I.Amos@dartmouth.edu; Michael.L.Whitfield@dartmouth.edu	Xiao, Feifei/AAD-9539-2021; Whitfield, Michael/AAC-5010-2020; Cai, Guoshuai/AAD-9620-2021		NIH [P30B02101, U19CA148127, P30CA023108]; Dr. Ralph and Marian Falk Medical Research Trust Award [P01304]; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Ralph and Marian Falk Medical Research Trust Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grant (P30B02101 to M L. Whitfield, U19CA148127 and P30CA023108 to C I. Amos) and the Dr. Ralph and Marian Falk Medical Research Trust Award (P01304 to M L. Whitfield).	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arinaga M, 2003, ONCOL REP, V10, P1381; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Cai GS, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S13-S5; Chanvorachote P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057466; Chen L, 2013, MOL MED REP, V7, P1477, DOI 10.3892/mmr.2013.1351; Corson TW, 2007, CLIN CANCER RES, V13, P3229, DOI 10.1158/1078-0432.CCR-07-0393; Glorieux C, 2011, BIOCHEM PHARMACOL, V82, P1384, DOI 10.1016/j.bcp.2011.06.007; Haiman CA, 2006, NEW ENGL J MED, V354, P333, DOI 10.1056/NEJMoa033250; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jing LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097522; Kratz JR, 2012, LANCET, V379, P823, DOI 10.1016/S0140-6736(11)61941-7; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; Lane AN, 2015, NUCLEIC ACIDS RES, V43, P2466, DOI 10.1093/nar/gkv047; Lee ES, 2008, CLIN CANCER RES, V14, P7397, DOI 10.1158/1078-0432.CCR-07-4937; Lee SY, 2012, J CLIN INVEST, V122, P3211, DOI 10.1172/JCI60498; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Lu TP, 2010, CANCER EPIDEM BIOMAR, V19, P2590, DOI 10.1158/1055-9965.EPI-10-0332; Luo YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020971; Mazieres J, 2013, J CLIN ONCOL, V31, P1997, DOI 10.1200/JCO.2012.45.6095; Mogi A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/583929; Nishikawa M, 2008, CANCER LETT, V266, P53, DOI 10.1016/j.canlet.2008.02.031; Peters S, 2013, J CLIN ONCOL, V31, pE341, DOI 10.1200/JCO.2012.47.6143; Rotimi CN, 2010, NEW ENGL J MED, V363, P1551, DOI 10.1056/NEJMra0911564; Seo JS, 2012, GENOME RES, V22, P2109, DOI 10.1101/gr.145144.112; Sequist LV, 2007, ONCOLOGIST, V12, P90, DOI 10.1634/theoncologist.12-1-90; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Suzuki C, 2005, CANCER RES, V65, P11314, DOI 10.1158/0008-5472.CAN-05-1507; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Tsugane S, 2005, CANCER SCI, V96, P1, DOI 10.1111/j.1349-7006.2005.00006.x; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Wood K, 2016, JAMA ONCOL, V2, P805, DOI 10.1001/jamaoncol.2016.0405; Wulan SN, 2010, MATURITAS, V65, P315, DOI 10.1016/j.maturitas.2009.12.012; Zhou XS, 2015, ONCOTARGET, V6, P9271, DOI 10.18632/oncotarget.3375	38	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175850	10.1371/journal.pone.0175850	http://dx.doi.org/10.1371/journal.pone.0175850			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426704	gold, Green Submitted, Green Published			2022-12-26	WOS:000399875900057
J	Dai, CS; Zhao, TT; Yang, X; Xiao, XL; Velkov, T; Tang, SS				Dai, Chongshan; Zhao, Tingting; Yang, Xing; Xiao, Xilong; Velkov, Tony; Tang, Shusheng			Pharmacokinetics and relative bioavailability of an oral amoxicillin-apramycin combination in pigs	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; PENICILLIN-RESISTANT; ESCHERICHIA-COLI; RESIDUES; ANIMALS; SYNERGY; PIGLETS; DISEASE; TRACT; FEED	A new compound granular premix of amoxicillin (20% w/w dry mass)/apramycin (5% w/w dry mass) was developed, and its pharmacokinetics and relative bioavailability were determined in pigs following oral administration following a cross-over study design. The pharmacokinetic parameters of amoxicillin (t(1/2 lambda) = 6.43 +/- 4.85h, C-max = 3.2 +/- 1.35 mu g.mL(-1), T-max = 1.92 +/- 0.58, AUC(INF) = 8.98 +/- 2.11 h.mu g.mL(-1)) and apramycin (t(1/2 lambda) = 8.67 +/- 4.4h, C-max = 0.23 +/- 0.12 mu g.mL(-1), T-max = 2.25 +/- 0.82 h, AUC(INF) = 12.37 +/- 8.64h.mu g.mL(-1)) when administered as the amoxicillin-apramycin granular premix did not significantly differ from those for the single-ingredient powder form of each component. The relative bioavailability of amoxicillin following oral administration of the amoxicillin-apramycin granular premix was 22.62% when compared to the intramuscular administration of commercial amoxicillin sodium-powder. This is the first report of a new amoxicillin-apramycin combination which has a potential veterinary application the for prevention and treatment digestive tract infections in pigs.	[Dai, Chongshan; Zhao, Tingting; Yang, Xing; Xiao, Xilong; Tang, Shusheng] China Agr Univ, Dept Pharmacol & Toxicol, Coll Vet Med, Beijing, Peoples R China; [Velkov, Tony] Monash Univ, Monash Inst Pharmaceut Sci, Dept Drug Delivery Disposit & Dynam, Clayton, Vic, Australia	China Agricultural University; Monash University	Tang, SS (corresponding author), China Agr Univ, Dept Pharmacol & Toxicol, Coll Vet Med, Beijing, Peoples R China.; Velkov, T (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Dept Drug Delivery Disposit & Dynam, Clayton, Vic, Australia.	Tony.velkov@monash.edu; tssfj@cau.edu.cn	Dai, Chongshan/AAH-6185-2020	Dai, Chongshan/0000-0002-4677-0524; velkov, tony/0000-0002-0017-7952; Tang, Shusheng/0000-0003-1860-3582	Key Projects in the National Science and Technology Pillar Program [2015BAD11B03]	Key Projects in the National Science and Technology Pillar Program	This study was supported by Key Projects in the National Science and Technology Pillar Program during the 12th Five-year Plan Period (2015BAD11B03). TV is a National Health and Medical Research Council of Australia (NHMRC) CDA2 Industry Fellow.	Afifi NA, 1997, RES VET SCI, V62, P249, DOI 10.1016/S0034-5288(97)90199-5; Agerso H, 1998, J VET PHARMACOL THER, V21, P41, DOI 10.1046/j.1365-2885.1998.00107.x; Allen HK, 2011, MBIO, V2, DOI 10.1128/mBio.00260-11; Anfossi P, 2002, J VET PHARMACOL THER, V25, P329, DOI 10.1046/j.1365-2885.2002.00428.x; Bergamaschi CDC, 2006, INT J ANTIMICROB AG, V27, P417, DOI 10.1016/j.ijantimicag.2006.02.005; (CCVP) CoCVP, 2010, APP CHIN VET PHARM; DarrasJoly C, 1996, ANTIMICROB AGENTS CH, V40, P2147, DOI 10.1128/AAC.40.9.2147; Desbiolles N, 2001, ANTIMICROB AGENTS CH, V45, P3328, DOI 10.1128/AAC.45.12.3328-3333.2001; Godoy C, 2011, J VET PHARMACOL THER, V34, P265, DOI 10.1111/j.1365-2885.2010.01220.x; He J, 2011, J VET PHARMACOL THER, V34, P42, DOI 10.1111/j.1365-2885.2010.01191.x; Hernandez E, 2005, VET J, V170, P237, DOI 10.1016/j.tvjl.2004.06.003; Jacobson M, 2003, RES VET SCI, V74, P163, DOI 10.1016/S0034-5288(02)00187-X; Janczyk P, 2007, ISME J, V1, P180, DOI 10.1038/ismej.2007.29; Lees P, 2002, INT J ANTIMICROB AG, V19, P269, DOI 10.1016/S0924-8579(02)00025-0; Leitner G, 2001, VET QUART, V23, P62, DOI 10.1080/01652176.2001.9695083; Lennernas H, 2002, EUR J PHARM SCI, V15, P271, DOI 10.1016/S0928-0987(02)00005-2; Lombo LH, 2004, J NANJING MED U, V18, P105; Martinez-Larranaga MR, 2004, VET REC, V154, P627, DOI 10.1136/vr.154.20.627; Mathew AG, 2005, FOODBORNE PATHOG DIS, V2, P212, DOI 10.1089/fpd.2005.2.212; Meyer M, 2014, ANTIMICROB AGENTS CH, V58, P6938, DOI 10.1128/AAC.03239-14; Opriessnig T, 2012, VIRUS RES, V164, P20, DOI 10.1016/j.virusres.2011.09.014; Papich MG, 2014, AM J VET RES, V75, P316, DOI 10.2460/ajvr.75.4.316; Schwarz S, 2008, VET MICROBIOL, V126, P178, DOI 10.1016/j.vetmic.2007.06.023; Shang RuoFeng, 2004, Chinese Journal of Veterinary Medicine, V40, P3; Soliman AM, 2013, J VET SCI, V14, P395, DOI 10.4142/jvs.2013.14.4.395; Wang X, 2010, CHINA ANIMAL HUSBAND, V37, P186; Zemanova M, 2008, ACTA VET BRNO, V77, P341, DOI 10.2754/avb200877030341; Zhanel GG, 2006, ANTIMICROB AGENTS CH, V50, P2228, DOI 10.1128/AAC.01620-05; 姚浪群, 2003, [畜牧兽医学报, Acta Veterinaria et Zootechnica Sinica], V34, P250	29	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176149	10.1371/journal.pone.0176149	http://dx.doi.org/10.1371/journal.pone.0176149			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426744	gold, Green Published			2022-12-26	WOS:000399875900108
J	Davidson, J; McDonald, T; Sutherland, C; Mostazirm, M; VanAalten, L; Wilkint, T				Davidson, Jane; McDonald, Timothy; Sutherland, Calum; Mostazirm, Mohammod; VanAalten, Lidy; Wilkint, Terence			Proinsulin is stable at room temperature for 24 hours in EDTA: A clinical laboratory analysis (adAPT 3)	PLOS ONE			English	Article								Aims Reference laboratories advise immediate separation and freezing of samples for the assay of proinsulin, which limit its practicability for smaller centres. Following the demonstration that insulin and C-peptide are stable in EDTA at room temperature for at least 24hours, we undertook simple stability studies to establish whether the same might apply to proinsulin. Methods Venous blood samples were drawn from six adult women, some fasting, some not, aliquoted and assayed immediately and after storage at either 4 degrees C or ambient temperature for periods from 2h to 24h. Results There was no significant variation or difference with storage time or storage condition in either individual or group analysis. Conclusion Proinsulin appears to be stable at room temperature in EDTA for at least 24h. Immediate separation and storage on ice of samples for proinsulin assay is not necessary, which will simplify sample transport, particularly for multicentre trials.	[Davidson, Jane; Sutherland, Calum; VanAalten, Lidy] Univ Dundee, Cardiovasc & Diabet Med, Dundee, Scotland; [McDonald, Timothy] Royal Devon & Exeter NHS Fdn Trust, NIHR Clin Res Facil, Blood Sci, Exeter, Devon, England; [Mostazirm, Mohammod; Wilkint, Terence] Univ Exeter, Sch Med, Inst Hlth Res, Exeter, Devon, England; [Mostazirm, Mohammod] Univ Exeter, CLES, Exeter, Devon, England	University of Dundee; University of Exeter; University of Exeter; University of Exeter	McDonald, T (corresponding author), Royal Devon & Exeter NHS Fdn Trust, NIHR Clin Res Facil, Blood Sci, Exeter, Devon, England.	timothy.mcdonald@nhs.net		Sutherland, Calum/0000-0003-4398-7434; Mostazir, Mohammod/0000-0002-8657-515X; McDonald, Timothy James/0000-0003-3559-6660	Juvenile Diabetes Research Foundation [1-SRA-2014-54-M-A]; Tayside Clinical Trials Unit (TCTU)	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Tayside Clinical Trials Unit (TCTU)	This work was supported by Juvenile Diabetes Research Foundation grant #1-SRA-2014-54-M-A, https://jdrf.org.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Our thanks to the members of the Tayside Clinical Trials Unit (TCTU), who supported this study, and to the volunteers whose blood samples were used. Terence Wilkin passed away before the submission of the final version of this manuscript. Timothy McDonald accepts responsibility for the integrity and validity of the data collected and analysed.	KITABCHI AE, 1977, METABOLISM, V26, P547, DOI 10.1016/0026-0495(77)90099-3; McDonald TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042084; MYKKANEN L, 1995, DIABETOLOGIA, V38, P1176, DOI 10.1007/BF00422366; Pfutzner A, 2004, DIABETES CARE, V27, P682, DOI 10.2337/diacare.27.3.682	4	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0171716	10.1371/journal.pone.0171716	http://dx.doi.org/10.1371/journal.pone.0171716			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426711	Green Submitted, Green Published, gold			2022-12-26	WOS:000399875900001
J	Kadota, Y; Toriuchi, Y; Aki, Y; Mizuno, Y; Kawakami, T; Nakaya, T; Sato, M; Suzuki, S				Kadota, Yoshito; Toriuchi, Yuriko; Aki, Yuka; Mizuno, Yuto; Kawakami, Takashige; Nakaya, Tomoko; Sato, Masao; Suzuki, Shinya			Metallothioneins regulate the adipogenic differentiation of 3T3-L1 cells via the insulin signaling pathway	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; OXYGEN-FREE-RADICALS; ADIPOCYTE DIFFERENTIATION; MOLECULAR REGULATION; CLONAL EXPANSION; NULL MICE; OBESITY; GENES; EXPRESSION; PREADIPOCYTES	Knockout of metallothionein (MT) genes contributes to a heavier body weight in early life and the potential to become obese through the intake of a high fat diet (HFD) in mice. It has thus been suggested that MT genes regulate the formation of adipose tissue, which would become the base for later HFD-induced obesity. We evaluated the fat pads of mice during the lactation stage. The fat mass and adipocyte size of MT1 and MT2 knockout mice were greater than those of wild type mice. Next, we assayed the ability of small interfering RNA (siRNA) to silence MT genes in the 3T3-L1 cell line. The expressions of MT1 and MT2 genes were transiently upregulated during adipocyte differentiation, and the siRNA pretreatment led to the suppression of the expression of both MT mRNAs and proteins. The MT siRNA promoted lipid accumulation in adipocytes and caused proliferation of post-confluent preadipocytes; these effects were suppressed by an inhibitor of phosphatidylinositol 3-kinase (LY294002). In addition, MT siRNA promoted insulin-stimulated phosphorylation of Akt, a downstream kinase of the insulin signaling pathway. Enhanced lipid accumulation in 3T3-L1 cells resulting from MT-gene silencing was inhibited by pretreatment with an antioxidant, N-acetylcysteine, used as a substitute for antioxidant protein MTs. These results suggest that interference in MT expression enhanced the activation of the insulin signaling pathway, resulting in higher lipid accumulation in 3T3-L1 adipocytes.	[Kadota, Yoshito; Toriuchi, Yuriko; Aki, Yuka; Mizuno, Yuto; Kawakami, Takashige; Nakaya, Tomoko; Sato, Masao; Suzuki, Shinya] Tokushima Bunri Univ, Fac Pharmaceut Sci, Tokushima, Japan	Tokushima Bunri University	Kadota, Y (corresponding author), Tokushima Bunri Univ, Fac Pharmaceut Sci, Tokushima, Japan.	ykadota@ph.bunri-u.ac.jp		Kadota, Yoshito/0000-0002-2721-4100	Japan Society for the Promotion of Science (JSPS) KAKENHI [24790133]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 24790133 awarded to Yoshito Kadota. URL: https://www.jsps.go.jp/english/index.html. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Aschner M, 1997, TOXICOL APPL PHARM, V142, P229, DOI 10.1006/taap.1996.8054; Barraco GM, 2014, INT J MOL SCI, V15, P19760, DOI 10.3390/ijms151119760; Bashan N, 2009, PHYSIOL REV, V89, P27, DOI 10.1152/physrev.00014.2008; Beattie JH, 1998, P NATL ACAD SCI USA, V95, P358, DOI 10.1073/pnas.95.1.358; Byun HR, 2011, NEUROBIOL DIS, V44, P125, DOI 10.1016/j.nbd.2011.06.012; Cappellini A, 2003, LEUKEMIA, V17, P2157, DOI 10.1038/sj.leu.2403111; Chen SQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137583; Cousins R J, 1987, Experientia Suppl, V52, P545; Cowherd RM, 1999, SEMIN CELL DEV BIOL, V10, P3, DOI 10.1006/scdb.1998.0276; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Fu J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-462; Giacconi R, 2005, BIOGERONTOLOGY, V6, P407, DOI 10.1007/s10522-005-4907-y; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Haq F, 2003, MUTAT RES-FUND MOL M, V533, P211, DOI 10.1016/j.mrfmmm.2003.07.014; Haynes V, 2013, MOL GENET METAB, V108, P90, DOI 10.1016/j.ymgme.2012.10.012; Kadota Y, 2015, EXP GERONTOL, V66, P21, DOI 10.1016/j.exger.2015.04.007; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kim JR, 2006, EXP MOL MED, V38, P162, DOI 10.1038/emm.2006.20; Kimura T, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030336; Kloting N, 2014, REV ENDOCR METAB DIS, V15, P277, DOI 10.1007/s11154-014-9301-0; Klotz LO, 2015, REDOX BIOL, V6, P51, DOI 10.1016/j.redox.2015.06.019; Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200; Lindeque JZ, 2015, OMICS, V19, P92, DOI 10.1089/omi.2014.0087; Luo KQ, 2015, WORLD J EMERG SURG, V10, DOI 10.1186/s13017-015-0044-3; MASTERS BA, 1994, P NATL ACAD SCI USA, V91, P584, DOI 10.1073/pnas.91.2.584; Mitterberger MC, 2013, J GERONTOL A-BIOL, V68, P1356, DOI 10.1093/gerona/glt019; Mocchegiani E, 2013, CURR PHARM DESIGN, V19, P1753; Nakanishi A, 2014, AGING DIS, V5, P203, DOI 10.14336/AD.2014.0500203; Nordberg M, 1998, TALANTA, V46, P243, DOI 10.1016/S0039-9140(97)00345-7; QUAIFE CJ, 1994, BIOCHEMISTRY-US, V33, P7250, DOI 10.1021/bi00189a029; Raudenska M, 2014, METALLOMICS, V6, P55, DOI 10.1039/c3mt00132f; REED BC, 1980, P NATL ACAD SCI-BIOL, V77, P285, DOI 10.1073/pnas.77.1.285; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Sato M, 2002, TOHOKU J EXP MED, V196, P9, DOI 10.1620/tjem.196.9; SATO M, 1993, FREE RADICAL BIO MED, V14, P325, DOI 10.1016/0891-5849(93)90029-T; Sato M, 2013, CURR PHARM BIOTECHNO, V14, P9; Sato M, 2010, FASEB J, V24, P2375, DOI 10.1096/fj.09-145466; Schmidt C, 1999, ARCH BIOCHEM BIOPHYS, V364, P91, DOI 10.1006/abbi.1999.1107; STENNARD FA, 1994, BBA-GENE STRUCT EXPR, V1218, P357, DOI 10.1016/0167-4781(94)90189-9; Summermatter S, 2016, MOL CELL BIOL; Swindell WR, 2011, AGEING RES REV, V10, P132, DOI 10.1016/j.arr.2010.09.007; Szrok S, 2016, GENES NUTR, V11, DOI 10.1186/s12263-016-0533-3; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Thompson GM, 2004, ANAL BIOCHEM, V330, P21, DOI 10.1016/j.ab.2004.03.061; Trayhurn P, HORM METAB RES HORM, V32, P542; Wu H, 2015, TOXICOL LETT, V232, P340, DOI 10.1016/j.toxlet.2014.11.015; Yang L, 2015, FREE RADICAL RES, V49, P1187, DOI 10.3109/10715762.2015.1013952; Yang L, 2008, AM J PHYSIOL-ENDOC M, V294, pE987, DOI 10.1152/ajpendo.90234.2008; Zhang T, 2016, ENDOCRINE; Zhou SS, 2014, TOXICOL LETT, V227, P113, DOI 10.1016/j.toxlet.2014.03.011	51	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176070	10.1371/journal.pone.0176070	http://dx.doi.org/10.1371/journal.pone.0176070			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426713	Green Published, gold, Green Submitted			2022-12-26	WOS:000399875900096
J	Svensson, T; Kitlinski, M; Engstrom, G; Melander, O				Svensson, Thomas; Kitlinski, Mariusz; Engstrom, Gunnar; Melander, Olle			A genetic risk score for CAD, psychological stress, and their interaction as predictors of CAD, fatal MI, non-fatal MI and cardiovascular death	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MENTAL STRESS; MYOCARDIAL-INFARCTION; PSYCHOSOCIAL FACTORS; PERCEIVED STRESS; JOB STRAIN; ASSOCIATION; VARIANTS; CHOLESTEROL; MORTALITY	Background Psychological stress is an independent risk factor for cardiovascular disease (CVD), but the mechanism by which stress is associated with CVD is not entirely understood. Although genetic factors are implied in both stress responsivity and cardiovascular reactivity, no studies to date have investigated their interactions with stress for cardiovascular end points. The objective was to elucidate the association and interactions between a genetic risk score (GRS), individual genetic variants and stress for three cardiovascular end points: coronary artery disease (CAD), fatal myocardial infarction (MI), non-fatal MI, and cardiovascular death. Methods and findings 18,559 participants from the Malmo Diet Cancer Study, a population-based prospective study, were included in the analyses. Cox proportional hazards regression models were used and adjusted for a large number of known predictors of cardiovascular end points. Mean follow-up time in years was 14.6 (CAD; n = 1938), 14.8 (fatal MI; n = 436), 14.8 (non-fatal MI; n = 1108), and 15.1 (cardiovascular death; n = 1071) respectively. GRS was significantly associated with increased risks of CAD (top quartile hazard ratio [HR], 1.72; 95% confidence interval [CI], 1.51-1.96), fatal MI (top quartile HR, 1.62; 95% CI, 1.23-2.15), non-fatal MI (top quartile HR, 1.55; 95% CI, 1.31-1.84), and cardiovascular death (top quartile HR, 1.29; 95% CI, 1.08-1.53). Stress was not independently associated with any end point and did not interact with GRS. Four individual genetic variants interacted unfavorably with stress for end points with mortality outcomes. Conclusion A GRS composed of 50 SNPs and predictive of CAD was found for the first time to also strongly predict fatal MI, non-fatal MI and cardiovascular death. A stress-sensitive component of the GRS was isolated on the basis of individual genetic variants that interacted unfavorably with stress.	[Svensson, Thomas; Kitlinski, Mariusz; Engstrom, Gunnar; Melander, Olle] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Svensson, Thomas] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Bunkyo Ku, 7-3-1 Hongo, Tokyo, Japan; [Svensson, Thomas] Keio Univ, Sch Med, Dept Neuropsychiat, Shinjuku Ku, 35 Shinanomachi, Keio, Japan; [Kitlinski, Mariusz] Skane Univ Hosp, Dept Cardiol, Malmo, Sweden; [Melander, Olle] Skane Univ Hosp, Dept Internal Med, Malmo, Sweden	Lund University; University of Tokyo; Keio University; Lund University; Skane University Hospital; Lund University; Skane University Hospital	Svensson, T (corresponding author), Lund Univ, Dept Clin Sci, Malmo, Sweden.; Svensson, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Bunkyo Ku, 7-3-1 Hongo, Tokyo, Japan.; Svensson, T (corresponding author), Keio Univ, Sch Med, Dept Neuropsychiat, Shinjuku Ku, 35 Shinanomachi, Keio, Japan.	thomas.svensson@med.lu.se	Svensson, Thomas/AAJ-4578-2020	Svensson, Thomas/0000-0003-1283-358X; Melander, Olle/0000-0002-2581-484X	European Research Council [StG-282255]; Swedish Heart and Lung Foundation; Swedish Research Council; Novo Nordisk Foundation; Skane University Hospital; Medical Faculty; Lund University; clinical research within the national health services; Albert Pahlsson Research Foundation; Region Skane; King Gustav V and Queen Victoria Foundation; Marianne and Marcus Wallenberg Foundation; Novo Nordisk Fonden [NNF14OC0009819, NNF13OC0005339, NNF17OC0026936] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Skane University Hospital; Medical Faculty; Lund University; clinical research within the national health services; Albert Pahlsson Research Foundation; Region Skane; King Gustav V and Queen Victoria Foundation; Marianne and Marcus Wallenberg Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	The study was supported by the European Research Council (StG-282255), the Swedish Heart and Lung Foundation, Swedish Research Council; the Novo Nordisk Foundation, the Skane University Hospital donation funds; the Medical Faculty, Lund University; the Governmental funding of clinical research within the national health services, the Albert Pahlsson Research Foundation, Region Skane, the King Gustav V and Queen Victoria Foundation and the Marianne and Marcus Wallenberg Foundation. Genotyping of the GRS SNPs in the MDC study was performed at the Quest Diagnostics Science and Innovation genotyping facility in Alameda, California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellenguez C, 2012, NAT GENET, V44, P328, DOI 10.1038/ng.1081; BERGLUND G, 1993, J INTERN MED, V233, P45, DOI 10.1111/j.1365-2796.1993.tb00647.x; Brotman DJ, 2007, LANCET, V370, P1089, DOI 10.1016/S0140-6736(07)61305-1; Butterworth AS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002260; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; De Geus EJC, 2007, PSYCHOSOM MED, V69, P356, DOI 10.1097/PSY.0b013e318049cc2d; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Dimsdale JE, 2008, J AM COLL CARDIOL, V51, P1237, DOI 10.1016/j.jacc.2007.12.024; Fujimaki T, 2015, BIOMED REP, V3, P118, DOI 10.3892/br.2014.371; Ghiadoni L, 2000, CIRCULATION, V102, P2473, DOI 10.1161/01.CIR.102.20.2473; Iso H, 2002, CIRCULATION, V106, P1229, DOI 10.1161/01.CIR.0000028145.58654.41; Jain S, 2007, PSYCHOPHYSIOLOGY, V44, P154, DOI 10.1111/j.1469-8986.2006.00480.x; JERNTORP P, 1992, STROKE, V23, P357, DOI 10.1161/01.STR.23.3.357; KARASEK RA, 1979, ADMIN SCI QUART, V24, P285, DOI 10.2307/2392498; Kashani M, 2012, STRESS, V15, P45, DOI 10.3109/10253890.2011.578266; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kivimaki M, 2012, LANCET, V380, P1491, DOI 10.1016/S0140-6736(12)60994-5; Lagerqvist B, 2007, NEW ENGL J MED, V356, P1009, DOI 10.1056/NEJMoa067722; MOBERG E, 1994, DIABETOLOGIA, V37, P247; Mulle JG, 2013, PROG CARDIOVASC DIS, V55, P557, DOI 10.1016/j.pcad.2013.03.005; National Board of Health and Welfare, 2000, EV DIAGN QUAL AC MYO; Ollila HM, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.20; Ozaki K, 2016, J HUM GENET, V61, P71, DOI 10.1038/jhg.2015.70; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Pilling LC, 2016, AGING-US, V8, P547, DOI 10.18632/aging.100930; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Rosvall M, 2002, INT J EPIDEMIOL, V31, P1169, DOI 10.1093/ije/31.6.1169; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1; Sanne B, 2005, SCAND J PUBLIC HEALT, V33, P166, DOI 10.1080/14034940410019217; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Shiffman D, 2008, ARTERIOSCL THROM VAS, V28, P173, DOI 10.1161/ATVBAHA.107.153981; Statistics sweden, 2007, 19824 MIS STAT SWED; Steptoe A, 2013, ANNU REV PUBL HEALTH, V34, P337, DOI 10.1146/annurev-publhealth-031912-114452; Steptoe A, 2012, NAT REV CARDIOL, V9, P360, DOI 10.1038/nrcardio.2012.45; Strike PC, 2006, P NATL ACAD SCI USA, V103, P4322, DOI 10.1073/pnas.0507097103; Svensson T, 2016, EUR HEART J, V37, P890, DOI 10.1093/eurheartj/ehv724; Tada H, 2016, EUR HEART J, V37, P561, DOI 10.1093/eurheartj/ehv462; THEORELL T, 1988, SCAND J WORK ENV HEA, V14, P189, DOI 10.5271/sjweh.1932; World Health Organization, 2010, GLOBAL STATUS REPORT; Wu T, 2010, NEUROSCI BIOBEHAV R, V35, P58, DOI 10.1016/j.neubiorev.2009.12.001; Zgraggen L, 2005, THROMB RES, V115, P175, DOI 10.1016/j.thromres.2004.08.022	41	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176029	10.1371/journal.pone.0176029	http://dx.doi.org/10.1371/journal.pone.0176029			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KM	28426714	gold, Green Submitted, Green Published			2022-12-26	WOS:000399875900089
J	Korge, P; Calmettes, G; John, SA; Weiss, JN				Korge, Paavo; Calmettes, Guillaume; John, Scott A.; Weiss, James N.			Reactive oxygen species production induced by pore opening in cardiac mitochondria: The role of complex III	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; RABBIT HEART-MITOCHONDRIA; CYTOSOLIC-FREE MAGNESIUM; FREE-RADICAL GENERATION; SUPEROXIDE-PRODUCTION; ISCHEMIA-REPERFUSION; MOLECULAR-MECHANISMS; MALATE-DEHYDROGENASE; ELECTRON-TRANSPORT; NADH FLUORESCENCE	Recent evidence has implicated succinate-driven reverse electron transport (RET) through complex I as a major source of damaging reactive oxygen species (ROS) underlying reperfusion injury after prolonged cardiac ischemia. However, this explanation may be incomplete, because RET on reperfusion is self-limiting and therefore transient. RET can only generate ROS when mitochondria are well polarized, and it ceases when permeability transition pores (PTP) open during reperfusion. Because prolonged ischemia/reperfusion also damages electron transport complexes, we investigated whether such damage could lead to ROS production after PTP opening has occurred. Using isolated cardiac mitochondria, we demonstrate a novel mechanism by which antimycin-inhibited complex III generates significant amounts of ROS in the presence of Mg2+ and NAD(+) and the absence of exogenous substrates upon inner membrane pore formation by alamethicin or Ca2+-induced PTP opening. We show that H2O2 production under these conditions is related to Mg2+-dependent NADH generation by malic enzyme. H2O2 production is blocked by stigmatellin, indicating its origin from complex III, and by piericidin, demonstrating the importance of NADH-related ubiquinone reduction for ROS production under these conditions. For maximal ROS production, the rate of NADH generation has to be equal or below that of NADH oxidation, as further increases in [NADH] elevate ubiquinol-related complex III reduction beyond the optimal range for ROS generation. These results suggest that if complex III is damaged during ischemia, PTP opening may result in succinate/malatefueled ROS production from complex III due to activation of malic enzyme by increases in matrix [Mg2+], [NAD(+)], and [ADP].	Univ Calif Los Angeles, David Geffen Sch Med, UCLA Cardiovasc Res Lab, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Med Cardiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Weiss, JN (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Med Cardiol, Los Angeles, CA 90095 USA.	jweiss@mednet.ucla.edu		John, Scott/0000-0002-1232-9140	National Institutes of Health from NHLBI [R01 HL101228, R01 HL117385]; American Heart Association Western States Affiliate [11POST6110007]; American Heart Association [16SDG31180036]; Laubisch and Kawata Endowments; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101228, R01HL117385] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association Western States Affiliate(American Heart Association); American Heart Association(American Heart Association); Laubisch and Kawata Endowments; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants R01 HL101228 and R01 HL117385 from the NHLBI, American Heart Association Western States Affiliate Post-doctoral Research Fellowship 11POST6110007, American Heart Association Scientist Development Grant 16SDG31180036, and the Laubisch and Kawata Endowments. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aidakkak M, 2008, CARDIOVASC RES, V77, P406, DOI 10.1016/j.cardiores.2007.08.008; Aldakkak M, 2008, J CARDIOVASC PHARM, V52, P236, DOI 10.1097/FJC.0b013e3181831337; Aldakkak M, 2009, J CARDIOVASC PHARM, V54, P298, DOI 10.1097/FJC.0b013e3181b2b842; Andrienko T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167300; Becker LB, 1999, AM J PHYSIOL-HEART C, V277, pH2240, DOI 10.1152/ajpheart.1999.277.6.H2240; BELLAMY D, 1962, BIOCHEM J, V82, P218, DOI 10.1042/bj0820218; Berkich DA, 2003, ARCH BIOCHEM BIOPHYS, V420, P279, DOI 10.1016/j.abb.2003.09.021; Blaza JN, 2014, P NATL ACAD SCI USA, V111, P15735, DOI 10.1073/pnas.1413855111; Bleier L, 2013, BBA-BIOENERGETICS, V1827, P1320, DOI 10.1016/j.bbabio.2012.12.002; Blinova K, 2005, BIOCHEMISTRY-US, V44, P2585, DOI 10.1021/bi0485124; Blinova K, 2008, BIOCHEMISTRY-US, V47, P9636, DOI 10.1021/bi800307y; BOLLI R, 1989, P NATL ACAD SCI USA, V86, P4695, DOI 10.1073/pnas.86.12.4695; Calmettes G, 2012, J PHYSIOL-LONDON, V590, P3403, DOI 10.1113/jphysiol.2012.239376; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chen Q, 2008, AM J PHYSIOL-CELL PH, V294, pC460, DOI 10.1152/ajpcell.00211.2007; Chen Q, 2006, J PHARMACOL EXP THER, V319, P1405, DOI 10.1124/jpet.106.110262; Chen Q, 2007, AM J PHYSIOL-CELL PH, V292, pC137, DOI 10.1152/ajpcell.00270.2006; Chen YR, 2014, CIRC RES, V114, P524, DOI 10.1161/CIRCRESAHA.114.300559; Chouchani ET, 2016, CELL METAB, V23, P254, DOI 10.1016/j.cmet.2015.12.009; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; DAVISSON VJ, 1985, BIOCHEM J, V225, P335, DOI 10.1042/bj2250335; Drose S, 2008, J BIOL CHEM, V283, P21649, DOI 10.1074/jbc.M803236200; Drose S, 2012, ADV EXP MED BIOL, V748, P145, DOI 10.1007/978-1-4614-3573-0_6; Drose S, 2011, MOL PHARMACOL, V79, P814, DOI 10.1124/mol.110.070342; EFRON B, 1991, SCIENCE, V253, P390, DOI 10.1126/science.253.5018.390; Genova ML, 2014, BBA-BIOENERGETICS, V1837, P427, DOI 10.1016/j.bbabio.2013.11.002; Gostimskaya IS, 2003, ANAL BIOCHEM, V313, P46, DOI 10.1016/S0003-2697(02)00534-1; Grivennikova VG, 2001, J BIOL CHEM, V276, P9038, DOI 10.1074/jbc.M009661200; Halestrap AP, 2004, CARDIOVASC RES, V61, P372, DOI 10.1016/S0008-6363(03)00533-9; Halestrap AP, 2004, CIRCULATION, V110, pE303, DOI 10.1161/01.CIR.0000141458.28925.D2; HEADRICK JP, 1991, J MOL CELL CARDIOL, V23, P991, DOI 10.1016/0022-2828(91)91635-5; Headrick JP, 1998, J MOL CELL CARDIOL, V30, P1415, DOI 10.1006/jmcc.1998.0710; Hung HC, 2005, BIOCHEM J, V392, P39, DOI 10.1042/BJ20050641; Johnson JD, 1998, J BIOL CHEM, V273, P27573, DOI 10.1074/jbc.273.42.27573; Kareyeva AV, 2012, BBA-BIOENERGETICS, V1817, P1879, DOI 10.1016/j.bbabio.2012.03.033; Kato M, 2009, CARDIOVASC RES, V83, P335, DOI 10.1093/cvr/cvp094; Korge P, 2001, AM J PHYSIOL-CELL PH, V280, pC517, DOI 10.1152/ajpcell.2001.280.3.C517; Korge P, 2008, CIRC RES, V103, P873, DOI 10.1161/CIRCRESAHA.108.180869; Korge P, 2017, J BIOL CHEM, V292, P9896, DOI 10.1074/jbc.M116.768325; Korge P, 2016, FREE RADICAL BIO MED, V96, P22, DOI 10.1016/j.freeradbiomed.2016.04.002; Korge P, 2015, BBA-BIOENERGETICS, V1847, P514, DOI 10.1016/j.bbabio.2015.02.012; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Korshunov SS, 1998, FEBS LETT, V435, P215, DOI 10.1016/S0014-5793(98)01073-4; Kotlyar AB, 2004, BIOCHEM BIOPH RES CO, V318, P987, DOI 10.1016/j.bbrc.2004.04.131; Kubota T, 2005, BBA-MOL CELL RES, V1744, P19, DOI 10.1016/j.bbamcr.2004.10.013; Kushnareva Y, 2002, BIOCHEM J, V368, P545, DOI 10.1042/BJ20021121; Lanciano P, 2013, BBA-BIOENERGETICS, V1827, P1332, DOI 10.1016/j.bbabio.2013.03.009; Lenaz G, 2001, IUBMB LIFE, V52, P159, DOI 10.1080/15216540152845957; Levraut J, 2003, AM J PHYSIOL-HEART C, V284, pH549, DOI 10.1152/ajpheart.00708.2002; Leyssens A, 1996, J PHYSIOL-LONDON, V496, P111, DOI 10.1113/jphysiol.1996.sp021669; LIN RC, 1974, J BIOL CHEM, V249, P3867; Matsumoto-Ida M, 2006, CIRCULATION, V114, P1497, DOI 10.1161/CIRCULATIONAHA.106.628834; MURPHY E, 1989, J BIOL CHEM, V264, P5622; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; NOVGORODOV SA, 1992, J BIOL CHEM, V267, P16274; NOVGORODOV SA, 1994, ARCH BIOCHEM BIOPHYS, V311, P219, DOI 10.1006/abbi.1994.1230; OLSON MS, 1967, J BIOL CHEM, V242, P325; Quinlan CL, 2014, J BIOL CHEM, V289, P8312, DOI 10.1074/jbc.M113.545301; Quinlan CL, 2011, J BIOL CHEM, V286, P31361, DOI 10.1074/jbc.M111.267898; Riess ML, 2002, AM J PHYSIOL-HEART C, V283, pH53, DOI 10.1152/ajpheart.01057.2001; Ross T, 2013, BBA-GEN SUBJECTS, V1830, P4537, DOI 10.1016/j.bbagen.2013.05.035; ROUSLIN W, 1983, AM J PHYSIOL, V244, pH743, DOI 10.1152/ajpheart.1983.244.6.H743; SAUER LA, 1973, FEBS LETT, V33, P251, DOI 10.1016/0014-5793(73)80205-4; Siebels I, 2013, BBA-BIOENERGETICS, V1827, P1156, DOI 10.1016/j.bbabio.2013.06.005; Slodzinski MK, 2008, J MOL CELL CARDIOL, V45, P650, DOI 10.1016/j.yjmcc.2008.07.017; Starkov AA, 2008, ANN NY ACAD SCI, V1147, P37, DOI 10.1196/annals.1427.015; Valls-Lacalle L, 2016, CARDIOVASC RES, V109, P374, DOI 10.1093/cvr/cvv279; Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x; Wojtovich AP, 2008, BBA-BIOENERGETICS, V1777, P882, DOI 10.1016/j.bbabio.2008.03.025; Yin Y, 2010, J BIOL CHEM, V285, P17038, DOI 10.1074/jbc.M110.104364; ZWEIER JL, 1987, P NATL ACAD SCI USA, V84, P1404, DOI 10.1073/pnas.84.5.1404; ZWEIER JL, 1989, J BIOL CHEM, V264, P18890	73	19	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					9882	9895		10.1074/jbc.M116.768317	http://dx.doi.org/10.1074/jbc.M116.768317			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28450391	Green Published, hybrid			2022-12-26	WOS:000403580600003
J	Press, ER; Shao, Q; Kelly, JJ; Chin, K; Alaga, A; Laird, DW				Press, Eric R.; Shao, Qing; Kelly, John J.; Chin, Katrina; Alaga, Anton; Laird, Dale W.			Induction of cell death and gain-of-function properties of connexin26 mutants predict severity of skin disorders and hearing loss	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ICHTHYOSIS-DEAFNESS SYNDROME; FOCAL PALMOPLANTAR KERATODERMA; GAP-JUNCTION; HEMICHANNEL PROPERTIES; SYNDROMIC DEAFNESS; MISSENSE MUTATION; GENE-MUTATIONS; KID SYNDROME; CX26 HEMICHANNELS; INNER-EAR	Connexin26 (Cx26) is a gap junction protein that oligomerizes in the cell to form hexameric transmembrane channels called connexons. Cell surface connexons dock between adjacent cells to allow for gap junctional intercellular communication. Numerous autosomal dominant mutations in the Cx26-encoding GJB2 gene lead to many skin disorders and sensorineural hearing loss. Although some insights have been gained into the pathogenesis of these diseases, it is not fully understood how distinct GJB2 mutations result in hearing loss alone or in skin pathologies with comorbid hearing loss. Here we investigated five autosomal dominant Cx26 mutants (N14K, D50N, N54K, M163V, and S183F) linked to various syndromic or nonsyndromic diseases to uncover the molecular mechanisms underpinning these disease links. We demonstrated that when gap junction-deficient HeLa cells expressed the N14K and D50N mutants, they undergo cell death. The N54K mutant was retained primarily within intracellular compartments and displayed dominant or transdominant properties on wild-type Cx26 and coexpressed Cx30 and Cx43. The S183F mutant formed some gap junction plaques but was largely retained within the cell and exhibited only a mild transdominant reduction in gap junction communication when co-expressed with Cx30. The M163V mutant, which causes only hearing loss, exhibited impaired gap junction function and showed no transdominant interactions. These findings suggest that Cx26 mutants that promote cell death or exert transdominant effects on other connexins in keratinocytes will lead to skin diseases and hearing loss, whereas mutants having reduced channel function but exhibiting no aberrant effects on coexpressed connexins cause only hearing loss. Moreover, cell death-inducing GJB2 mutations lead to more severe syndromic disease.	[Press, Eric R.; Laird, Dale W.] Univ Western Ontario, Dept Anat & Cell Biol, 00077 Dent Sci Bldg,1151 Richmond St, London, ON N6A 5C1, Canada; [Shao, Qing; Kelly, John J.; Chin, Katrina; Alaga, Anton; Laird, Dale W.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Laird, DW (corresponding author), Univ Western Ontario, Dept Anat & Cell Biol, 00077 Dent Sci Bldg,1151 Richmond St, London, ON N6A 5C1, Canada.	dale.laird@schulich.uwo.ca	Laird, Dale W/AAL-2407-2020	Laird, Dale W/0000-0002-4568-3285; Kelly, John Joseph/0000-0002-3626-8629	Canadian Institutes of Health Research [123228]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by Canadian Institutes of Health Research Grant 123228 (to D. W. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Alexander DB, 2003, CURR MED CHEM, V10, P2045, DOI 10.2174/0929867033456927; Avshalumova L, 2014, INT J DERMATOL, V53, P192, DOI 10.1111/ijd.12062; BADEN HP, 1983, J INVEST DERMATOL, V80, P124, DOI 10.1111/1523-1747.ep12532899; Berger AC, 2014, J CELL SCI, V127, P1751, DOI 10.1242/jcs.138230; Bosen F, 2015, FEBS LETT, V589, P1904, DOI 10.1016/j.febslet.2015.05.047; Bruzzone R, 2003, FEBS LETT, V533, P79, DOI 10.1016/S0014-5793(02)03755-9; Burnstock G, 2012, J INVEST DERMATOL, V132, P526, DOI 10.1038/jid.2011.344; Chan DK, 2014, LARYNGOSCOPE, V124, pE34, DOI 10.1002/lary.24332; Coggshall K, 2013, J AM ACAD DERMATOL, V69, P127, DOI 10.1016/j.jaad.2012.12.965; Cohen-Salmon M, 2002, CURR BIOL, V12, P1106, DOI 10.1016/S0960-9822(02)00904-1; Common JEA, 2003, CELL COMMUN ADHES, V10, P347, DOI 10.1080/15419060390263128; D'Adamo P, 2009, EUR J HUM GENET, V17, P284, DOI 10.1038/ejhg.2008.225; de Zwart-Storm EA, 2008, J MED GENET, V45, P161, DOI 10.1136/jmg.2007.052332; de Zwart-Storm EA, 2008, AM J PATHOL, V173, P1113, DOI 10.2353/ajpath.2008.080049; Di WL, 2005, J CELL SCI, V118, P1505, DOI 10.1242/jcs.01733; Di WL, 2001, J INVEST DERMATOL, V117, P958, DOI 10.1046/j.0022-202x.2001.01468.x; Djalilian AR, 2006, J CLIN INVEST, V116, P1243, DOI 10.1172/JCI27186; Donnelly S, 2012, EXP DERMATOL, V21, P592, DOI 10.1111/j.1600-0625.2012.01521.x; Fasciani I, 2013, NEUROPHARMACOLOGY, V75, P479, DOI 10.1016/j.neuropharm.2013.03.040; Garcia IE, 2016, BMC CELL BIOL, V17, DOI 10.1186/s12860-016-0092-x; Garcia IE, 2016, J INVEST DERMATOL, V136, P574, DOI 10.1016/j.jid.2015.11.017; Garcia IE, 2015, J INVEST DERMATOL, V135, P1338, DOI 10.1038/jid.2015.20; Gerido DA, 2007, AM J PHYSIOL-CELL PH, V293, pC337, DOI 10.1152/ajpcell.00626.2006; Huang T, 2013, J CELL SCI, V126, P2857, DOI 10.1242/jcs.123315; Jagger DJ, 2015, CELL TISSUE RES, V360, P633, DOI 10.1007/s00441-014-2029-z; Kelly JJ, 2015, CELL TISSUE RES, V360, P701, DOI 10.1007/s00441-014-2024-4; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Lazic T, 2008, PEDIATR DERMATOL, V25, P535, DOI 10.1111/j.1525-1470.2008.00767.x; Lee JR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001276; Lee JR, 2009, J INVEST DERMATOL, V129, P870, DOI 10.1038/jid.2008.335; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Man YKS, 2007, J MEMBRANE BIOL, V218, P29, DOI 10.1007/s00232-007-9025-0; Marlin S, 2001, ARCH OTOLARYNGOL, V127, P927, DOI 10.1001/archotol.127.8.927; Martin PE, 2014, FEBS LETT, V588, P1304, DOI 10.1016/j.febslet.2014.02.048; Martin PEM, 2015, CELL TISSUE RES, V360, P645, DOI 10.1007/s00441-014-2094-3; Marziano NK, 2003, HUM MOL GENET, V12, P805, DOI 10.1093/hmg/ddg076; Mazereeuw-Hautier J, 2007, BRIT J DERMATOL, V156, P1015, DOI 10.1111/j.1365-2133.2007.07806.x; Mhaske PV, 2013, AM J PHYSIOL-CELL PH, V304, pC1150, DOI 10.1152/ajpcell.00374.2012; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Qu Y, 2012, BIOCHEM BIOPH RES CO, V417, P245, DOI 10.1016/j.bbrc.2011.11.093; Richard G, 2004, J INVEST DERMATOL, V123, P856, DOI 10.1111/j.0022-202X.2004.23470.x; Sanchez HA, 2016, J GEN PHYSIOL, V148, P25, DOI 10.1085/jgp.201611585; Sanchez HA, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00354; Sanchez HA, 2013, J GEN PHYSIOL, V142, P3, DOI 10.1085/jgp.201310962; Scott CA, 2012, BBA-BIOMEMBRANES, V1818, P1952, DOI 10.1016/j.bbamem.2011.09.004; Shuja Z, 2016, J INVEST DERMATOL, V136, P225, DOI 10.1038/JID.2015.389; Teubner B, 2003, HUM MOL GENET, V12, P13, DOI 10.1093/hmg/ddg001; Thomas T, 2005, J CELL SCI, V118, P4451, DOI 10.1242/jcs.02569; Xu J, 2013, BBA-BIOMEMBRANES, V1828, P167, DOI 10.1016/j.bbamem.2012.06.024	49	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9721	9732		10.1074/jbc.M116.770917	http://dx.doi.org/10.1074/jbc.M116.770917			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28428247	Green Published, hybrid			2022-12-26	WOS:000403113000022
J	Capileno, YA; Van den Bergh, R; Donchunk, D; Hinderaker, SG; Hamid, S; Auat, R; Khalid, GG; Fatima, R; Yaqoob, A; van Overloop, C				Capileno, Yuely A.; Van den Bergh, Rafael; Donchunk, Dmytro; Hinderaker, Sven Gudmund; Hamid, Saeed; Auat, Rosa; Khalid, Gui Ghuttai; Fatima, Razia; Yaqoob, Aashifa; van Overloop, Catherine			Management of chronic Hepatitis C at a primary health clinic in the high-burden context of Karachi, Pakistan	PLOS ONE			English	Article							VIRUS-INFECTION; GENOTYPE DISTRIBUTION; SOFOSBUVIR; PREVALENCE	Background The burden of hepatitis C (HCV) infection in Pakistan is among the highest in the world, with a reported national HCV prevalence of 6.7% in 2014. In specific populations, such as in urban communities in Karachi, the prevalence is suspected to be higher. Interferon-free treatment for chronic HCV infection (CHC) could allow scale up, simplification and decentralization of treatment to such communities. We present an interim analysis over the course of February-December 2015 of an interferon-free, decentralised CHC programme in the community clinic in Machar Colony, Karachi, Pakistan. Design A retrospective analysis of a treatment cohort. Results There were 1,089 patients included in this analysis. Aspartate to platelet ratio index score was used to prioritize patients in terms of treatment initiation, with 242 patients placed in high priority for treatment and 202 starting treatment as scheduled. 169 patients started HCV treatment with Sofosbuvir-Ribavirin regimen according to HCV genotype over the course of 2015: of these, 35% had Hemoglobin reductions below 11.0 g/dl during the treatment course. Among the 153 patients (85%) with genotype 3 HCV infection, 84% of patients achieved sustained virologic response at 12 weeks following treatment completion (SVR 12). Conclusion Outcomes of HCV treatment with all oral combination in an integrated, decentralized model of care for CHC in a primary care setting, using simplified diagnostic and treatment algorithms, are comparable to the outcomes achieved in clinical trial settings for Sofosbuvir-based regimens. Our results suggest the feasibility and the pertinence if including interferon-free treatment regimens in the national programme, at both provincial and national levels.	[Capileno, Yuely A.; Van den Bergh, Rafael; Donchunk, Dmytro; Auat, Rosa; Khalid, Gui Ghuttai; van Overloop, Catherine] Medecins Sans Frontieres, Brussels, Belgium; [Hinderaker, Sven Gudmund; Fatima, Razia] Int Union TB & Lung Dis, Paris, France; [Hinderaker, Sven Gudmund] Univ Bergen, Bergen, Norway; [Hamid, Saeed] Aga Khan Univ & Hosp, Karachi, Pakistan; [Fatima, Razia; Yaqoob, Aashifa] Natl TB Control Program, Islamabad, Pakistan	Doctors Without Borders; University of Bergen; Aga Khan University	Capileno, YA (corresponding author), Medecins Sans Frontieres, Brussels, Belgium.	yongerts@gmail.com		Van den Bergh, Rafael/0000-0001-6277-8713	Global Fund; WHO TDR; University of Bergen; Union, Paris, France; Union South-East Asia Office, New Delhi, India; World Health Organization; Global Fund for AIDS, Tuberculosis and Malaria in Pakistan; WHO/TDR	Global Fund; WHO TDR(World Health Organization); University of Bergen; Union, Paris, France; Union South-East Asia Office, New Delhi, India; World Health Organization(World Health Organization); Global Fund for AIDS, Tuberculosis and Malaria in Pakistan; WHO/TDR(World Health Organization)	This research was conducted through the Structured Operational Research and Training Initiative (SORT IT), a global partnership led by the Special Programme for Research and Training in Tropical Diseases at the World Health Organization (WHO/TDR). The training model is based on a course developed jointly by the International Union Against Tuberculosis and Lung Disease (The Union) and Medecins Sans Frontieres (MSF/Doctors Without Borders). The specific SORT IT program which resulted in this publication was implemented by National Tuberculosis Programme Pakistan, through support of The Global Fund and WHO TDR, University of Bergen, The Union, Paris, France, and The Union South-East Asia Office, New Delhi, India. The program was funded by the World Health Organization and the Global Fund for AIDS, Tuberculosis and Malaria in Pakistan. The publication fees were covered by the WHO/TDR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was conducted through the Structured Operational Research and Training Initiative (SORT IT), a global partnership led by the Special Programme for Research and Training in Tropical Diseases at the World Health Organization (WHO/TDR). The training model is based on a course developed jointly by the International Union Against Tuberculosis and Lung Disease (The Union) and Medecins Sans Frontieres (MSF/Doctors Without Borders). The specific SORT IT program which resulted in this publication was implemented by National Tuberculosis Programme Pakistan, through support of The Global Fund and WHO TDR, University of Bergen, The Union, Paris, France, and The Union South-East Asia Office, New Delhi, India.	Ali SA, 2009, INT J INFECT DIS, V13, P9, DOI 10.1016/j.ijid.2008.06.019; Andrieux-Meyer I, 2015, LANCET GLOB HEALTH, V3, pE676, DOI 10.1016/S2214-109X(15)00156-4; Arora S, 2011, NEW ENGL J MED, V364, P2199, DOI 10.1056/NEJMoa1009370; Butt AA, 2016, LIVER INT, V36, P1275, DOI 10.1111/liv.13103; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Jayasekera CR, 2015, DIGEST DIS SCI, V60, P3552, DOI 10.1007/s10620-015-3911-6; Kattakuzhy S, 2016, HEPATOL INT, V10, P861, DOI 10.1007/s12072-016-9748-z; Kattakuzhy S, 2015, HEPATOL INT, V9, P161, DOI 10.1007/s12072-014-9606-9; Khan AA, 2012, J PAK MED ASSOC, V62, P1149; Khan J., 2015, MYTH REAL SOF PAK IN; Lin ZH, 2011, HEPATOLOGY, V53, P726, DOI 10.1002/hep.24105; Mohamoud YA, 2016, INT J INFECT DIS, V46, P116, DOI 10.1016/j.ijid.2016.03.012; Omata M, 2015, HEPATOL INT, V9, P486, DOI 10.1007/s12072-015-9630-4; Pakistan Medical research Council World Health Organization, 2016, 1 WHO PAK MED RES CO; Qureshi H, 2013, J PAK MED ASSOC, V63, P220; Satsangi S, 2016, J GASTROENHEPATOL; Sood A, 2016, J GASTROEN HEPATOL; The PLOS Medicine Editors, 2014, PLOS MED, V18; Umar M, 2012, J PIONEER MED SCI, V2, P68; Umer M, 2016, WORLD J GASTROENTERO, V22, P1684, DOI 10.3748/wjg.v22.i4.1684; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; WHO, 2014, GUID SCREEN CAR TREA; Wu Christina J, 2015, Hawaii J Med Public Health, V74, P3; Zeuzem S, 2014, NEW ENGL J MED, V370, P1993, DOI 10.1056/NEJMoa1316145; Zevin B, 2007, PUBLIC HEALTH REP, V122, P78, DOI 10.1177/00333549071220S215	26	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0175562	10.1371/journal.pone.0175562	http://dx.doi.org/10.1371/journal.pone.0175562			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448576	gold, Green Published, Green Submitted			2022-12-26	WOS:000400383600019
J	Pammi, M; O'Brien, JL; Ajami, NJ; Wong, MC; Versalovic, J; Petrosino, JF				Pammi, Mohan; O'Brien, Jacqueline L.; Ajami, Nadim J.; Wong, Matthew C.; Versalovic, James; Petrosino, Joseph F.			Development of the cutaneous microbiome in the preterm infant: A prospective longitudinal study	PLOS ONE			English	Article							HUMAN SKIN MICROBIOME; STRATUM-CORNEUM; LIFE; DIVERSITY; GUT	Background Neonatal sepsis in preterm infants is often due to organisms that colonize the skin including Staphylococcus spp. and Candida spp. Development and maturation of the skin microbiome in the neonatal period, especially in preterm infants, may be critical in preventing colonization with pathogens and subsequent progression to neonatal sepsis. Development of the skin microbiome in preterm infants or its determinants in the first 4 weeks of life has not been evaluated. Methods We evaluated the skin microbiome from three body sites, antecubital fossa, forehead and gluteal region, in a prospective cohort of 15 preterm (birth weight < 1500 g and < 32 weeks of gestation) and 15 term neonates. The microbiome community membership and relative abundance were evaluated by amplification and sequencing the bacterial V3-V5 region of the16S rRNA gene on the 454 GS FLX platform. We used linear mixed effects models to analyze longitudinal data. Results The structure and composition of the skin microbiome did not differ between the three sampling sites for term and preterm infants in the neonatal period. However, skin bacterial richness was positively associated with gestational age in the first four weeks of life. Intravenous antibiotics negatively impacted the bacterial diversity of the skin but we did not see differences with respect to feeding or mode of delivery. Conclusions Gestational age, which influences the maturity of skin structure and function, is associated with the development of the preterm cutaneous microbiome. Understanding the maturation of a healthy skin microbiome, prevention of pathogen colonization and its role in the development of immunity will be pivotal in the development of novel interventions to prevent infections in critically ill preterm infants.	[Pammi, Mohan] Baylor Coll Med, Dept Pediat, Sect Neonatol, Houston, TX 77030 USA; [O'Brien, Jacqueline L.; Ajami, Nadim J.; Wong, Matthew C.; Petrosino, Joseph F.] Baylor Coll Med, Alkek Ctr Metagen & Microbiome Res, Houston, TX 77030 USA; [O'Brien, Jacqueline L.; Ajami, Nadim J.; Wong, Matthew C.; Petrosino, Joseph F.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Versalovic, James] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Pammi, M (corresponding author), Baylor Coll Med, Dept Pediat, Sect Neonatol, Houston, TX 77030 USA.	mohanv@bcm.edu	Petrosino, Joseph F./AAF-1621-2019; Pammi, Mohan/A-6454-2008	Pammi, Mohan/0000-0002-5571-6239	Microbiota Association Discovery; Alkek Center for Metagenomics and Microbiome Research at Baylor College of Medicine; National Institutes of Health [U01 CA 170930]; NIH [P30 DK56338]	Microbiota Association Discovery; Alkek Center for Metagenomics and Microbiome Research at Baylor College of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a Microbiota Association Discovery award granted to MP by the Alkek Center for Metagenomics and Microbiome Research at Baylor College of Medicine. The work was supported in part by research support from the National Institutes of Health (U01 CA 170930) (JV) and NIH (P30 DK56338) (JV) for the Texas Medical Center Digestive Diseases Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; [Anonymous], 2012, PLOS ONE, V7; Arrieta MC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00427; Brooks B, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-1; Capone KA, 2011, J INVEST DERMATOL, V131, P2026, DOI 10.1038/jid.2011.168; Chiou YB, 2004, SKIN PHARMACOL PHYS, V17, P57, DOI 10.1159/000076015; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Dominguez-Bello MG, 2016, NAT MED, V22, P250, DOI 10.1038/nm.4039; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Grice EA, 2012, ANNU REV GENOM HUM G, V13, P151, DOI 10.1146/annurev-genom-090711-163814; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hirasawa Y, 2010, J INVEST DERMATOL, V130, P614, DOI 10.1038/jid.2009.257; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Iwase T, 2010, NATURE, V465, P346, DOI 10.1038/nature09074; Krutmann J, 2009, J DERMATOL SCI, V54, P1, DOI 10.1016/j.jdermsci.2009.01.002; La Rosa PS, 2014, P NATL ACAD SCI USA, V111, P12522, DOI 10.1073/pnas.1409497111; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; Marchini G, 2005, PEDIATR RES, V58, P613, DOI 10.1203/01.pdr.0000176836.27156.32; McGuire MK, 2015, ADV NUTR, V6, P112, DOI 10.3945/an.114.007435; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Nikolovski J, 2008, J INVEST DERMATOL, V128, P1728, DOI 10.1038/sj.jid.5701239; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Round JL, J AUTOIMMUN, V34, pJ220; Stamatas GN, 2010, PEDIATR DERMATOL, V27, P125, DOI 10.1111/j.1525-1470.2009.00973.x; Stamatas GN, INT J COSMET SCI, V33, P17; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; team RDc, 2014, LANG ENV STAT COMP	31	22	25	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176669	10.1371/journal.pone.0176669	http://dx.doi.org/10.1371/journal.pone.0176669			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448623	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383600118
J	Rey-Banos, R; de Miera, LES; Garcia, P; de la Vega, MP				Rey-Banos, Rita; Saenz de Miera, Luis E.; Garcia, Pedro; Perez de la Vega, Marcelino			Obtaining retrotransposon sequences, analysis of their genomic distribution and use of retrotransposon-derived genetic markers in lentil (Lens culinaris Medik.)	PLOS ONE			English	Article							TY1-COPIA GROUP RETROTRANSPOSONS; TERMINAL-REPEAT RETROTRANSPOSONS; NONAUTONOMOUS RETROELEMENTS; TRANSPOSABLE ELEMENTS; DIVERSITY ANALYSIS; PLANT; EVOLUTION; IPBS; LINKAGE; MICROSATELLITE	Retrotransposons with long terminal repeats (LTR-RTs) are widespread mobile elements in eukaryotic genomes. We obtained a total of 81 partial LTR-RT sequences from lentil corresponding to internal retrotransposon components and LTRs. Sequences were obtained by PCR from genomic DNA. Approximately 37% of the LTR-RT internal sequences presented premature stop codons, pointing out that these elements must be non-autonomous. LTR sequences were obtained using the iPBS technique which amplifies sequences between LTR-RTs. A total of 193 retrotransposon-derived genetic markers, mainly iPBS, were used to obtain a genetic linkage map from 94 F-7 inbred recombinant lines derived from the cross between the cultivar Lupa and the wild ancestor L. culinaris subsp. orientalis. The genetic map included 136 markers located in eight linkage groups. Clusters of tightly linked retrotransposon- derived markers were detected in linkage groups LG1, LG2, and LG6, hence denoting a non-random genomic distribution. Phylogenetic analyses identified the LTR-RT families in which internal and LTR sequences are included. Ty3-gypsy elements were more frequent than Ty1-copia, mainly due to the high Ogre element frequency in lentil, as also occurs in other species of the tribe Vicieae. LTR and internal sequences were used to analyze in silico their distribution among the contigs of the lentil draft genome. Up to 8.8% of the lentil contigs evidenced the presence of at least one LTR-RT similar sequence. A statistical analysis suggested a non-random distribution of these elements within of the lentil genome. In most cases (between 97% and 72%, depending on the LTR-RT type) none of the internal sequences flanked by the LTR sequence pair was detected, suggesting that defective and non-autonomous LTR-RTs are very frequent in lentil. Results support that LTR-RTs are abundant and widespread throughout of the lentil genome and that they are a suitable source of genetic markers useful to carry out further genetic analyses.	[Rey-Banos, Rita; Saenz de Miera, Luis E.; Garcia, Pedro; Perez de la Vega, Marcelino] Univ Leon, Area Genet, Dept Biol Mol, Leon, Spain	Universidad de Leon	de Miera, LES (corresponding author), Univ Leon, Area Genet, Dept Biol Mol, Leon, Spain.	luis.saenzdemiera@unileon.es	de Miera, Luis E Sáenz/D-6864-2018; García, Pedro/D-7281-2018; De La Vega, Marcelino Perez/B-7988-2008; Sáenz de Miera, Luis/ABA-4573-2021	de Miera, Luis E Sáenz/0000-0003-1871-7379; García, Pedro/0000-0002-3800-7326; De La Vega, Marcelino Perez/0000-0002-1744-7437; Sáenz de Miera, Luis/0000-0003-1871-7379	Spanish Ministerio de Ciencia y Tecnologia [AGL2009-07853/AGR]; Spanish Ministerio de Economia y Competitividad [AGL2013-44714-R]; FEDER; Junta de Castilla y Leon to Research Groups [GR113]; Universidad de Leon, Spain	Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministerio de Economia y Competitividad(Spanish Government); FEDER(European Commission); Junta de Castilla y Leon to Research Groups(Junta de Castilla y Leon); Universidad de Leon, Spain	The authors acknowledge financial assistance from the Spanish Ministerio de Ciencia y Tecnologia (grant, AGL2009-07853/AGR), the Spanish Ministerio de Economia y Competitividad (grant AGL2013-44714-R, co-financed with FEDER founds) and the Junta de Castilla y Leon to Research Groups (GR113). The Ph. D. work of RRB was supported by a personal grant from the Universidad de Leon, Spain.	Andeden EE, 2013, J PLANT BIOCHEM BIOT, V22, P453, DOI 10.1007/s13562-012-0175-5; Baloch FS, 2015, BIOCHEM SYST ECOL, V61, P244, DOI 10.1016/j.bse.2015.06.017; Baloch FS, 2015, BIOCHEM SYST ECOL, V58, P162, DOI 10.1016/j.bse.2014.12.002; Bernet GP, 2003, THEOR APPL GENET, V108, P121, DOI 10.1007/s00122-003-1382-1; Bertioli DJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-45; Bett K., 2016, PLANT ANIMAL GENOME, pW222; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; de Givry S, 2005, BIOINFORMATICS, V21, P1703, DOI 10.1093/bioinformatics/bti222; Ellis THN, 1998, MOL GEN GENET, V260, P9, DOI 10.1007/s004380050865; Estep MC, 2013, HEREDITY, V110, P194, DOI 10.1038/hdy.2012.99; Feschotte C, 2002, NAT REV GENET, V3, P329, DOI 10.1038/nrg793; FLAVELL AJ, 1992, MOL GEN GENET, V231, P233, DOI 10.1007/BF00279796; FLAVELL AJ, 1992, NUCLEIC ACIDS RES, V20, P3639, DOI 10.1093/nar/20.14.3639; Flavell AJ, 1998, PLANT J, V16, P643, DOI 10.1046/j.1365-313x.1998.00334.x; Fratini R, 2011, GRAIN LEGUMES, V57, P18; Friesen N, 2001, MOL BIOL EVOL, V18, P1176, DOI 10.1093/oxfordjournals.molbev.a003905; Gao DY, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-015-0867-y; Guo DL, 2014, BIOCHEM SYST ECOL, V52, P27, DOI 10.1016/j.bse.2013.10.008; Hamwieh A, 2005, THEOR APPL GENET, V110, P669, DOI 10.1007/s00122-004-1892-5; Hill P, 2005, MOL GENET GENOMICS, V273, P371, DOI 10.1007/s00438-005-1141-x; HIROCHIKA H, 1993, JPN J GENET, V68, P35, DOI 10.1266/jjg.68.35; Jing RC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-44; Kalendar R, 2004, GENETICS, V166, P1437, DOI 10.1534/genetics.166.3.1437; Kalendar R, 2011, HEREDITY, V106, P520, DOI 10.1038/hdy.2010.93; Kalendar R, 2006, NAT PROTOC, V1, P2478, DOI 10.1038/nprot.2006.377; Kalendar R, 2010, THEOR APPL GENET, V121, P1419, DOI 10.1007/s00122-010-1398-2; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Kumar S., 2016, MOL BIOL EVOL; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Langdon T, 2000, GENETICS, V156, P313; Llorente A., 2001, THESIS; Macas J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-427; Macas J, 2007, GENE, V390, P108, DOI 10.1016/j.gene.2006.08.007; Macas J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143424; Martin Sanz A, 2007, MOL GENET GENOMICS, V278, P433; Meyers BC, 2001, GENOME RES, V11, P1660, DOI 10.1101/gr.188201; Mikic A, 2014, PLANTA, V240, P1139, DOI 10.1007/s00425-014-2136-9; Monden Y, 2014, CURR PLANT BIOL, V1, P40, DOI 10.1016/j.cpb.2014.09.001; Pearce SR, 2000, MOL GEN GENET, V263, P898, DOI 10.1007/s004380000257; Pearce SR, 1999, PLANT J, V19, P711, DOI 10.1046/j.1365-313x.1999.00556.x; Pearce SR, 2007, CELL MOL BIOL LETT, V12, P120, DOI 10.2478/s11658-006-0053-z; Perez de la Vega M., 2011, Genetics, genomics and breeding of cool season grain legumes, P98; Peterson-Burch BD, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r78; Piednoel M, 2013, PLANT J, V75, P699, DOI 10.1111/tpj.12233; R Core Team, 2014, R FDN STAT COMP; Ragupathy R, 2013, TRENDS PLANT SCI, V18, P367, DOI 10.1016/j.tplants.2013.03.005; Rey MR, 2016, THESIS; Roy NS, 2015, GENES GENOM, V37, P141, DOI 10.1007/s13258-014-0252-3; Sabot F, 2006, HEREDITY, V97, P381, DOI 10.1038/sj.hdy.6800903; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schaefer H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-250; Schulman AH, 2013, CURR OPIN VIROL, V3, P604, DOI 10.1016/j.coviro.2013.08.009; Smykal P, 2009, HEREDITY, V103, P157, DOI 10.1038/hdy.2009.45; Smykal P, 2006, J APPL GENET, V47, P221, DOI 10.1007/BF03194627; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Tanskanen JA, 2007, GENE, V390, P166, DOI 10.1016/j.gene.2006.09.009; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-382; Waugh R, 1997, MOL GEN GENET, V253, P687, DOI 10.1007/s004380050372; Wawrzynski A, 2008, PLANT PHYSIOL, V148, P1760, DOI 10.1104/pp.108.127910; Witte CP, 2001, P NATL ACAD SCI USA, V98, P13778, DOI 10.1073/pnas.241341898; Zhao MX, 2013, PROTEIN CELL, V4, P493, DOI 10.1007/s13238-013-3037-6	62	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176728	10.1371/journal.pone.0176728	http://dx.doi.org/10.1371/journal.pone.0176728			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448614	Green Submitted, Green Published, gold			2022-12-26	WOS:000400383600126
J	Slot, E; Zaaijer, HL; Molier, M; Van den Hurk, K; Prinsze, F; Hogema, BM				Slot, Ed; Zaaijer, Hans L.; Molier, Michel; Van den Hurk, Katja; Prinsze, Femmeke; Hogema, Boris M.			Meat consumption is a major risk factor for hepatitis E virus infection	PLOS ONE			English	Article							TRANSMISSION; PREVALENCE; BLOOD; OUTBREAK	Background The incidence of autochthonous hepatitis E virus genotype 3 (HEV gt3) infections in Western Europe is high. Although pigs are a major reservoir of the virus, the exact sources and transmission route(s) of HEV gt3 to humans remain unclear. Methods To determine the role of meat consumption at a population level, the seroprevalence of antiHEV IgG antibodies was compared between Dutch blood donors with a vegetarian lifestyle and donors who consume meat on a daily basis. Results The age-weighted anti-HEV IgG seroprevalence among donors not eating meat was significantly lower than among meat-eating donors (12.4% vs 20.5%, p = 0.002). For both groups the prevalence strongly increased with age and the difference in prevalence was apparent for all age groups. Conclusions Compared with meat-eating donors, the incidence of HEV infection is significantly lower among donors not eating meat, indicating that meat consumption is a major risk factor for HEV infection.	[Slot, Ed; Zaaijer, Hans L.; Molier, Michel; Hogema, Boris M.] Sanquin Res, Dept Blood Borne Infect, Amsterdam, Netherlands; [Zaaijer, Hans L.] Acad Med Ctr, Dept Clin Virol CINIMA, Amsterdam, Netherlands; [Van den Hurk, Katja; Prinsze, Femmeke] Sanquin Res, Dept Donor Studies, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Hogema, BM (corresponding author), Sanquin Res, Dept Blood Borne Infect, Amsterdam, Netherlands.	b.hogema@sanquin.nl	Prinsze, F/U-3784-2019	Slot, Ed/0000-0002-2459-2448	Sanquin [PPOC14-09]	Sanquin	This study was funded by Sanquin (PPOC14-09).	Abravanel F, 2014, J INFECT DIS, V209, P1900, DOI 10.1093/infdis/jiu032; Atsma F, 2011, TRANSFUSION, V51, P412, DOI 10.1111/j.1537-2995.2010.02867.x; Berto Alessandra, 2012, BMC Res Notes, V5, P190, DOI 10.1186/1756-0500-5-190; Caruso C., 2016, TRANSBOUND EMERG DIS; Dalton HR, 2013, CURR OPIN INFECT DIS, V26, P471, DOI 10.1097/01.qco.0000433308.83029.97; Gilsing AMJ, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-156; Grierson S, 2015, EMERG INFECT DIS, V21, P1396, DOI 10.3201/eid2108.141995; Hewitt PE, 2014, LANCET, V384, P1766, DOI 10.1016/S0140-6736(14)61034-5; Hogema BM, 2016, TRANSFUSION, V56, P722, DOI 10.1111/trf.13402; Hogema BM, 2014, TRANSFUSION, V54, P3092, DOI 10.1111/trf.12733; Kamar N, 2014, NEW ENGL J MED, V370, P1111, DOI 10.1056/NEJMoa1215246; Kang YH, 2016, CHINA J MED VIROL; Krumbholz A, 2014, MED MICROBIOL IMMUN, V203, P273, DOI 10.1007/s00430-014-0336-3; Lewis HC, 2010, EPIDEMIOL INFECT, V138, P145, DOI 10.1017/S0950268809990847; Maunula L, 2013, INT J FOOD MICROBIOL, V167, P177, DOI 10.1016/j.ijfoodmicro.2013.09.003; Renou C, 2014, EMERG INFECT DIS, V20, P1945, DOI 10.3201/eid2011.140791; Rosewell A, 2016, MED J AUSTRALIA, V204, P258, DOI 10.5694/mja16.00018; Said B, 2014, EPIDEMIOL INFECT, V142, P1467, DOI 10.1017/S0950268813002318; Said B, 2009, EMERG INFECT DIS, V15, P1738, DOI 10.3201/eid1511.091094; Slot E., 2013, EURO SURVEILL, V18; Wichmann Ole, 2008, J Infect Dis, V198, P1732, DOI 10.1086/593211	21	30	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176414	10.1371/journal.pone.0176414	http://dx.doi.org/10.1371/journal.pone.0176414			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448527	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383600077
J	Teku, GN; Vihinen, M				Teku, Gabriel N.; Vihinen, Mauno			Simulation of the dynamics of primary immunodeficiencies in CD4+T-cells	PLOS ONE			English	Article							ANHIDROTIC ECTODERMAL DYSPLASIA; B-INDUCING KINASE; NONSENSE MUTATION; ALPHA MUTATION; DISEASE GENES; T-CELLS; DEFICIENCY; ITK; NETWORK; FAMILY	Primary immunodeficiencies (PIDs) form a large and heterogeneous group of mainly rare disorders that affect the immune system. T-cell deficiencies account for about one-tenth of PIDs, most of them being monogenic. Apart from genetic and clinical information, lots of other data are available for PID proteins and genes, including functions and interactions. Thus, it is possible to perform systems biology studies on the effects of PIDs on T-cell physiology and response. To achieve this, we reconstructed a T-cell network model based on literature mining and TPPIN, a previously published core T-cell network, and performed semi-quantitative dynamic network simulations on both normal and T-cell PID failure modes. The results for several loss-of-function PID simulations correspond to results of previously reported molecular studies. The simulations for TCR PTPRC, LCK, ZAP70 and ITK indicate profound changes to numerous proteins in the network. Significant effects were observed also in the BCL10, CARD11, MALT1, NEMO, IKKB and MAP3K14 simulations. No major effects were observed for PIDs that are caused by constitutively active proteins. The T-cell model facilitates the understanding of the underlying dynamics of PID disease processes. The approach confirms previous knowledge about T-cell signaling network and indicates several new important proteins that may be of interest when developing novel diagnosis and therapies to treat immunological defects.	[Teku, Gabriel N.; Vihinen, Mauno] Lund Univ, Dept Expt Med Sci, Lund, Sweden	Lund University	Vihinen, M (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	mauno.vihinen@med.lu.se	Teku, Gabriel/F-6146-2014; Vihinen, Mauno/A-8452-2012	Teku, Gabriel/0000-0001-6829-5501; Vihinen, Mauno/0000-0002-9614-7976	Vetenskapradet; Barncancerfonden	Vetenskapradet; Barncancerfonden	This work was supported by Vetenskapradet, (http://www.vr.se/) to GNT and Barncancerfonden, (https://www.barncancerfonden.se) to VM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Altman A, 2002, J BIOCHEM, V132, P841, DOI 10.1093/oxfordjournals.jbchem.a003295; Andreotti AH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002287; Angulo I, 2013, SCIENCE, V342, P866, DOI 10.1126/science.1243292; Baltanas FC, 2013, MOL CELL BIOL, V33, P4562, DOI 10.1128/MCB.01026-13; Boole R. G., 1848, CAMBRIDGE DUBLIN MAT, V3, P183; Cale CM, 1997, ARCH DIS CHILD, V76, P163, DOI 10.1136/adc.76.2.163; Chen ZJJ, 2012, IMMUNOL REV, V246, P95, DOI 10.1111/j.1600-065X.2012.01108.x; Courtois G, 2003, J CLIN INVEST, V112, P1108, DOI 10.1172/JCI200318714; Crank MC, 2014, J CLIN IMMUNOL, V34, P272, DOI 10.1007/s10875-014-0012-9; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; del Sol A, 2010, CURR OPIN BIOTECH, V21, P566, DOI 10.1016/j.copbio.2010.07.010; Doffinger R, 2001, NAT GENET, V27, P277, DOI 10.1038/85837; Fowell DJ, 1999, IMMUNITY, V11, P399, DOI 10.1016/S1074-7613(00)80115-6; Fusco F, 2015, INT REV IMMUNOL, V34, P445, DOI 10.3109/08830185.2015.1055331; Ghosh S, 2014, J CLIN IMMUNOL, V34, P892, DOI 10.1007/s10875-014-0110-8; Gibson S, 1998, BIOCHEM J, V330, P1123, DOI 10.1042/bj3301123; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Granados EL, 2008, HUM MUTAT, V29, P861, DOI 10.1002/humu.20740; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hauck F, 2015, CLIN IMMUNOL, V161, P103, DOI 10.1016/j.clim.2015.07.002; Hauck F, 2012, J ALLERGY CLIN IMMUN, V130, P1144, DOI 10.1016/j.jaci.2012.07.029; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Huck K, 2009, J CLIN INVEST, V119, P1350, DOI 10.1172/JCI37901; Itan Y, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00142; Jabara HH, 2013, J ALLERGY CLIN IMMUN, V132, P151, DOI 10.1016/j.jaci.2013.04.047; Janssen R, 2004, J EXP MED, V200, P559, DOI 10.1084/jem.20040773; Johnston AM, 2016, J CLIN IMMUNOL, V36, P541, DOI 10.1007/s10875-016-0309-y; Jorgensen SE, 2016, J ALLERGY CLIN IMMUN, V138, P1706, DOI 10.1016/j.jaci.2016.05.030; Kannan A, 2012, INT J BIOCHEM CELL B, V44, P2129, DOI 10.1016/j.biocel.2012.08.023; Karaca E, 2013, GENE, V512, P189, DOI 10.1016/j.gene.2012.10.062; Kawai T, 2012, BLOOD, V119, P5458, DOI 10.1182/blood-2011-05-354167; Keerthikumar S, 2009, DNA RES, V16, P345, DOI 10.1093/dnares/dsp019; Klamt S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-56; Kohl M, 2011, METHODS MOL BIOL, V696, P291, DOI 10.1007/978-1-60761-987-1_18; Kosaka Y, 2006, TRENDS IMMUNOL, V27, P453, DOI 10.1016/j.it.2006.08.006; Krumsiek J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-233; Kung C, 2000, NAT MED, V6, P343; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Li Y, 2013, PROTEIN CELL, V4, P62, DOI 10.1007/s13238-012-2120-8; Linka RM, 2012, LEUKEMIA, V26, P963, DOI 10.1038/leu.2011.371; LINSLEY PS, 1993, J IMMUNOL, V150, P3161; Lucas CL, 2014, NAT IMMUNOL, V15, P88, DOI 10.1038/ni.2771; Torres JM, 2014, J CLIN INVEST, V124, P5239, DOI 10.1172/JCI77493; Matsumoto M, 2002, J IMMUNOL, V169, P1151, DOI 10.4049/jimmunol.169.3.1151; McDonald DR, 2007, J ALLERGY CLIN IMMUN, V120, P900, DOI 10.1016/j.jaci.2007.08.035; Mitchell S, 2016, WIRES SYST BIOL MED, V8, P227, DOI 10.1002/wsbm.1331; Morgan NV, 2011, J CLIN INVEST, V121, P695, DOI 10.1172/JCI41931; Mousallem T, 2014, BLOOD, V124, P2046, DOI 10.1182/blood-2014-04-571265; Nakayamada S, 2012, CURR OPIN IMMUNOL, V24, P297, DOI 10.1016/j.coi.2012.01.014; Nielsen C, 2014, J CLIN IMMUNOL, V34, P916, DOI 10.1007/s10875-014-0097-1; Orange JS, 2004, J ALLERGY CLIN IMMUN, V114, P650, DOI 10.1016/j.jaci.2004.06.052; Ortutay C, 2006, CELL IMMUNOL, V244, P87, DOI 10.1016/j.cellimm.2007.01.012; Ortutay C, 2009, NUCLEIC ACIDS RES, V37, P622, DOI 10.1093/nar/gkn982; Pannicke U, 2013, NEW ENGL J MED, V369, P2504, DOI 10.1056/NEJMoa1309199; Picard C, 2015, J CLIN IMMUNOL; Picard C, 2009, EUR J IMMUNOL, V39, P1966, DOI 10.1002/eji.200939385; Piirila H, 2006, HUM MUTAT, V27, P1200, DOI 10.1002/humu.20405; Piro RM, 2012, FEBS J, V279, P678, DOI 10.1111/j.1742-4658.2012.08471.x; Puel A, 2006, AM J HUM GENET, V78, P691, DOI 10.1086/501532; R- Core- Team, 2016, R LANG ENV STAT COMP; Roberts JL, 2012, P NATL ACAD SCI USA, V109, P10456, DOI 10.1073/pnas.1202249109; Saadatpour A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002267; Saez-Rodriguez J, 2007, PLOS COMPUT BIOL, V3, P1580, DOI 10.1371/journal.pcbi.0030163; Sahu N, 2008, J IMMUNOL, V181, P6125, DOI 10.4049/jimmunol.181.9.6125; Samarghitean Crina, 2007, Immunome Res, V3, P6, DOI 10.1186/1745-7580-3-6; Samarghitean C, 2009, J IMMUNOL, V183, P7569, DOI 10.4049/jimmunol.0901837; Sawabe T, 2001, INT J MOL MED, V7, P609; Schaeffer EM, 1999, SCIENCE, V284, P638, DOI 10.1126/science.284.5414.638; Schroeder ML, 2016, BMC MED GENET, V17, DOI 10.1186/s12881-016-0312-4; Shinohara H, 2009, IMMUNOL REV, V232, P300, DOI 10.1111/j.1600-065X.2009.00836.x; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Stepensky P, 2013, J ALLERGY CLIN IMMUN, V131, P477, DOI 10.1016/j.jaci.2012.11.050; Stepensky P, 2011, HAEMATOL-HEMATOL J, V96, P472, DOI 10.3324/haematol.2010.033910; Sugiyama Y, 2012, INT IMMUNOL, V24, P253, DOI 10.1093/intimm/dxr126; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Sun SC, 2012, IMMUNOL REV, V246, P125, DOI 10.1111/j.1600-065X.2011.01088.x; Tchilian EZ, 2001, J IMMUNOL, V166, P1308, DOI 10.4049/jimmunol.166.2.1308; Teku GN, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-17; Thakar J, 2009, J R SOC INTERFACE, V6, P599, DOI 10.1098/rsif.2008.0363; Thomas ML, 1999, IMMUNOL TODAY, V20, P406, DOI 10.1016/S0167-5699(99)01506-6; THOMAS R, 1973, J THEOR BIOL, V42, P563, DOI 10.1016/0022-5193(73)90247-6; Toyabe S, 2001, IMMUNOLOGY, V103, P164, DOI 10.1046/j.1365-2567.2001.01246.x; Turul T, 2009, EUR J PEDIATR, V168, P87, DOI 10.1007/s00431-008-0718-x; Turvey SE, 2014, J ALLERGY CLIN IMMUN, V134, P276, DOI 10.1016/j.jaci.2014.06.015; van der Burg M, 2011, EUR J PEDIATR, V170, P561, DOI 10.1007/s00431-011-1452-3; Vihinen M., 2015, IMMUNODEFICIENCY PRI; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Werlen G, 2002, CURR OPIN IMMUNOL, V14, P299, DOI 10.1016/S0952-7915(02)00339-4; Willmann KL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6360; Wittmann DM, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-98; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Yamamoto M, 2006, J IMMUNOL, V177, P7520, DOI 10.4049/jimmunol.177.11.7520	94	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176500	10.1371/journal.pone.0176500	http://dx.doi.org/10.1371/journal.pone.0176500			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448599	gold, Green Published, Green Submitted			2022-12-26	WOS:000400383600090
J	Li, YF; Deng, T; Hua, H; Li, YX; Zhang, YX				Li, Yangfan; Deng, Tao; Hua, Hong; Li, Yongxiang; Zhang, Yunxiang			Assessment of dental ontogeny in late Miocene hipparionines from the Lamagou fauna of Fugu, Shaanxi Province, China	PLOS ONE			English	Article							TIBETAN PLATEAU; QAIDAM BASIN	A collection of 28 hipparionine skull and mandible fossils with a dated age of approximately 7.4 Ma from Fugu, Shaanxi, northwestern China (belonging to Hipparion chiai and Hipparion cf. coelophyes) shows an age distribution in a successive development sequence. By observing the dentitions in these fossil materials, knowledge of dental ontogeny has been gained, such as the opening time of the posterior wall of post-fossettes, the displacement of the plis hypostyle, the morphologic changes of the protocone and hypocone, etc. Additionally, 4 isolated maxillary cheek teeth and 2 mandibular cheek teeth were cut into slices in the traditional manner for authentication. These discoveries indicate that both of the hipparionine species in the Lamagou fauna are Hipparion cf. chiai exactly and offer further insight into the morphologic changes that occur during dental wear in hipparionines, which may greatly promote the morphological and taxonomic study of hipparionine species.	[Li, Yangfan; Deng, Tao; Hua, Hong; Li, Yongxiang; Zhang, Yunxiang] Northwest Univ Xian, Inst Cenozo Geol & Environm, State Key Lab Continental Dynam, Xian, Peoples R China; [Li, Yangfan; Deng, Tao; Hua, Hong; Li, Yongxiang; Zhang, Yunxiang] Northwest Univ Xian, Dept Geol, Xian, Peoples R China; [Deng, Tao] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China; [Deng, Tao] CAS Ctr Excellence Tibetan Plateau Earth Sci, Beijing, Peoples R China; [Deng, Tao] Univ Chinese Acad Sci, Beijing, Peoples R China	Northwest University Xi'an; Northwest University Xi'an; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Deng, T; Hua, H (corresponding author), Northwest Univ Xian, Inst Cenozo Geol & Environm, State Key Lab Continental Dynam, Xian, Peoples R China.; Deng, T; Hua, H (corresponding author), Northwest Univ Xian, Dept Geol, Xian, Peoples R China.; Deng, T (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China.; Deng, T (corresponding author), CAS Ctr Excellence Tibetan Plateau Earth Sci, Beijing, Peoples R China.; Deng, T (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	dengtao@ivpp.ac.cn; huahong@nwu.edu.cn	li, yong/HDN-3885-2022; li, yongxiang/GPW-6930-2022		National Natural Science Foundation of China [41430102, 41272020, 41290253]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (41430102), the National Natural Science Foundation of China (41272020), and the National Natural Science Foundation of China (41290253).; The authors thank Xiangxu Xue of the Department of Geology at Northwest University for continual guidance and assistance, Yi Shen for figures, and Biye Liu and family for assistance with field work. The reviewers and editors are kindly acknowledged for helpful comments on the manuscript. This work was supported by the National Natural Science Foundation of China (41430102, 41272020, 41290253).	Bernor R.L., 1996, P307; Bernor RL, 2011, B SOC PALEONTOL ITAL, V50, P175, DOI 10.4435/BSPI.2011.16; Bernor RL, 2016, PALAEOBIO PALAEOENV, V96, P453, DOI 10.1007/s12549-016-0235-2; Bernor Raymond L., 2015, Vertebrata Palasiatica, V53, P73; Dai T, 2013, LETHAIA, V46, P262, DOI 10.1111/let.12002; Dai T, 2012, J PALEONTOL, V86, P646, DOI 10.1666/10-164R.1; Dai T, 2011, PALAEONTOLOGY, V54, P1279, DOI 10.1111/j.1475-4983.2011.01102.x; Deng T., 2004, CHINA VERT PALASIAT, V42, P316; Deng T, 2013, NEOGENE BIOSTRATIGRA, P243; Eisenmann V., 1988, STUDYING FOSSIL HORS; Fang XM, 2007, EARTH PLANET SC LETT, V258, P293, DOI 10.1016/j.epsl.2007.03.042; Forsten A., 1985, Bulletin of the Geological Institutions of the University of Uppsala, P113; Gidley JW, 1901, B AM MUS NAT HIST, V14, P91; Gromova VI, 1952, T PALEONT; Kaakinen A, 2005, LONG TERRESTRIAL SEQ; Liu D., 1978, PROFESSIONAL PAPERS, V7, P149; Liu YL, 2013, THESIS; Pang L. P., 2010, THESIS; Pang Li-Bo, 2011, Vertebrata Palasiatica, V49, P210; Qiu ZX, 1987, PALAEONT SIN; SEFVE IVAR, 1927, PALAEONTOLOGIA SINICA SER C, V4, P1; Sisson S, 1953, ANATOMY DOMESTIC ANI, V3; Teryaev VA, 1936, PROBLEMY PALEONTOLOG, V1, P135; Wang XM, 2007, PALAEOGEOGR PALAEOCL, V254, P363, DOI 10.1016/j.palaeo.2007.06.007; Watabe M., 1992, HUM NAT, V1, P35; Wehrli Hans, 1941, PALAEONTOL ZEITSCHR, V22, P321; Xue XX, 1995, CHINESE SCI BULL, V40, P447, DOI [10.1360/csb1995-40-5-447, DOI 10.1360/CSB1995-40-5-447]; Zhang Jun, 2011, Disiji Yanjiu, V31, P614; Zhang Yunxiang, 1995, Journal of Stratigraphy, V19, P214; Zhang YX, 1995, J NW U, V25, P483; Zhang ZQ, 2013, NEOGENE BIOSTRATIGRA, P187; Zouhri S., 2005, Estudios Geologicos (Madrid), V61, P61	32	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0175460	10.1371/journal.pone.0175460	http://dx.doi.org/10.1371/journal.pone.0175460			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445536	gold, Green Submitted, Green Published			2022-12-26	WOS:000400309200020
J	Navarro, G; Martinez-Pinilla, E; Sanchez-Melgar, A; Ortiz, R; Noe, V; Martins, M; Ciudad, C; Franco, R				Navarro, Gemma; Martinez-Pinilla, Eva; Sanchez-Melgar, Alejandro; Ortiz, Raquel; Noe, Veronique; Martins, Mairena; Ciudad, Carlos; Franco, Rafael			A genomics approach identifies selective effects of trans-resveratrol in cerebral cortex neuron and glia gene expression	PLOS ONE			English	Article							INTERACTION NETWORKS; ALZHEIMERS-DISEASE; A-BETA; CELLS; MODEL; TOCOPHEROL; RECEPTORS; ADENOSINE; INCREASES; PROTEINS	The mode of action of trans-resveratrol, a promising lead compound for the development of neuroprotective drugs, is unknown. Data from a functional genomics study were retrieved with the aim to find differentially expressed genes that may be involved in the benefits provided by trans-resveratrol. Genes that showed a significantly different expression (p< 0.05, cut-off of a two-fold change) in mice fed with a control diet or a control diet containing transresveratrol were different in cortex, heart and skeletal muscle. In neocortex, we identified 4 up-regulated (Strap, Pkp4, Rab2a, Cpne3) and 22 down-regulated (Actn1, Arf3, Atp6v01, Atp1a3, Atp1b2, Cacng7, Crtc1, Dbn1, Dnm1, Epn1, Gfap, Hap, Mark41, Rab5b, Nrxn2, Ogt, Palm, Ptprn2, Ptprs, Syn2, Timp2, Vamp2) genes upon trans-resveratrol consumption. Network analysis of gene products provided evidence of plakophilin 4 up-regulation as a triggering factor for down-regulation of events related to synaptic vesicle transport and neurotransmitter release via underexpression of dynamin1 and Vamp2 (synaptobrevin 2) as node-gene drivers. Analysis by RT-qPCR of some of the selected genes in a glioma cell line showed that dynamin 1 mRNA was down-regulated even in acute trans-resveratrol treatments. Taken all together, these results give insight on the glial-neuronal networks involved in the neuroprotective role of trans-resveratrol.	[Navarro, Gemma; Franco, Rafael] Inst Salud Carlos III, CIBERNED, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Navarro, Gemma; Franco, Rafael] Univ Barcelona IBUB, Inst Biomed, Barcelona, Spain; [Navarro, Gemma; Ortiz, Raquel; Franco, Rafael] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biomed, Barcelona, Spain; [Martinez-Pinilla, Eva] Univ Oviedo, Inst Neurociencias Principado Asturias INEUROPA, Dept Morfol & Biol Celular, Fac Med, Asturias, Spain; [Sanchez-Melgar, Alejandro; Martins, Mairena] Univ Castilla La Mancha, Fac Ciencias & Tecnol Quim, Dept Quim Inorgan Organ & Bioquim, CRIB, Ciudad Real, Spain; [Sanchez-Melgar, Alejandro; Martins, Mairena] Univ Castilla La Mancha, Fac Med, Dept Quim Inorgan Organ & Bioquim, CRIB, Ciudad Real, Spain; [Noe, Veronique; Ciudad, Carlos] Univ Barcelona, Dept Biochem & Physiol, Sch Pharm, Barcelona, Spain; [Noe, Veronique; Ciudad, Carlos] Univ Barcelona IN2UB, Inst Nanotechnol, Barcelona, Spain	CIBERNED; Instituto de Salud Carlos III; University of Barcelona; University of Barcelona; University of Oviedo; Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; University of Barcelona; University of Barcelona	Martinez-Pinilla, E (corresponding author), Univ Oviedo, Inst Neurociencias Principado Asturias INEUROPA, Dept Morfol & Biol Celular, Fac Med, Asturias, Spain.	martinezpinillaeva@gmail.com	Martínez-Pinilla, Eva/C-7907-2013; López, Mairena Martín/H-9788-2015; Ciudad, Carlos J./D-7917-2014; Melgar, Alejandro/AAD-2980-2021; Navarro, Gemma/AAO-7866-2021; Sanchez-Melgar, Alejandro/L-1088-2018; Noe, Veronica/K-3615-2014	Martínez-Pinilla, Eva/0000-0002-0572-0926; López, Mairena Martín/0000-0002-6843-3449; Ciudad, Carlos J./0000-0002-7855-392X; Navarro, Gemma/0000-0003-4654-0873; Sanchez-Melgar, Alejandro/0000-0002-9348-3608; Noe, Veronica/0000-0001-7937-8038	Plan Nacional de Investigacion Cientifica" (Spanish Ministry of "Economia e Innovacion") [SAF2014-51825-R]; Junta de Comunidades de Castilla-La Mancha, Spain [PEII-2014-030-P, PRE-8002/2014]	Plan Nacional de Investigacion Cientifica" (Spanish Ministry of "Economia e Innovacion"); Junta de Comunidades de Castilla-La Mancha, Spain(Junta de Comunidades de Castilla-La Mancha)	This work was partially supported by SAF2014-51825-R from Plan Nacional de Investigacion Cientifica" (Spanish Ministry of "Economia e Innovacion") and by grant PEII-2014-030-P from Junta de Comunidades de Castilla-La Mancha, Spain. ASM was awarded a fellowship (PRE-8002/2014) from Junta de Comunidades de Castilla-La Mancha, Spain.r In Memoriam: Prof. Adela Mazo, she was a brilliant Chemistry student and, later, a stunning colleague. This work was partially supported by SAF2014-51825-R from Plan Nacional de Investigacion Cientifica" (Spanish Ministry of "Economia e Innovacion") and by grant PEII-2014-030-P from Junta de Comunidades de Castilla-La Mancha, Spain. ASM was awarded a fellowship (PRE-8002/2014) from Junta de Comunidades de Castilla-La Mancha, Spain.	Castillo CA, 2007, NEUROCHEM RES, V32, P1056, DOI 10.1007/s11064-006-9273-x; Arendt T, 2000, NEUROBIOL AGING, V21, P783, DOI 10.1016/S0197-4580(00)00216-5; Awasaki T, 2004, CURR BIOL, V14, P668, DOI 10.1016/j.cub.2004.04.001; Barger JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002264; Barth RF, 2009, J NEURO-ONCOL, V94, P299, DOI 10.1007/s11060-009-9875-7; BENDA P, 1968, SCIENCE, V161, P370, DOI 10.1126/science.161.3839.370; Bito H, 2003, CELL CALCIUM, V34, P425, DOI 10.1016/S0143-4160(03)00140-4; Borroto-Escuela DO, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0183; BOWRY VW, 1993, J AM CHEM SOC, V115, P6029, DOI 10.1021/ja00067a019; Creutz CE, 1998, J BIOL CHEM, V273, P1393, DOI 10.1074/jbc.273.3.1393; Cuzzola VF, 2011, CNS NEUROL DISORD-DR, V10, P849, DOI 10.2174/187152711798072310; dos Santos AQ, 2006, ARCH BIOCHEM BIOPHYS, V453, P161, DOI 10.1016/j.abb.2006.06.025; Dresen I. M. Gana, 2003, Current Pharmaceutical Biotechnology, V4, P417, DOI 10.2174/1389201033377436; ELFERINK LA, 1989, J BIOL CHEM, V264, P11061; Ferretta A, 2014, BBA-MOL BASIS DIS, V1842, P902, DOI 10.1016/j.bbadis.2014.02.010; Franco R, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00146; Giust D, 2014, J BIOMED NANOTECHNOL, V10, P1610, DOI 10.1166/jbn.2014.1845; Hebbar S, 2004, J NEUROBIOL, V60, P499, DOI 10.1002/neu.20031; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017668; Jin F, 2008, EUR J PHARMACOL, V600, P78, DOI 10.1016/j.ejphar.2008.10.005; Karagiannis TC, 2012, PATHOBIOL AGING AGE, P2; Karuppagounder SS, 2009, NEUROCHEM INT, V54, P111, DOI 10.1016/j.neuint.2008.10.008; Keil R, 2013, BIOL CHEM, V394, P1005, DOI 10.1515/hsz-2013-0114; Khan MM, 2010, BRAIN RES, V1328, P139, DOI 10.1016/j.brainres.2010.02.031; Kim GH, 2015, EXP NEUROBIOL, V24, P325, DOI 10.5607/en.2015.24.4.325; Kitamoto T, 2002, J NEUROGENET, V16, P205, DOI 10.1080/01677060216295; Kontush A, 1996, J LIPID RES, V37, P1436; Ladiwala ARA, 2010, J BIOL CHEM, V285, P24228, DOI 10.1074/jbc.M110.133108; Levitan IB, 2015, NEURON CELL MOL BIOL; Liu DX, 2014, PROG NEURO-PSYCHOPH, V49, P21, DOI 10.1016/j.pnpbp.2013.10.017; Lu KT, 2008, J AGR FOOD CHEM, V56, P6910, DOI 10.1021/jf8007212; Lu XF, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-46; Marambaud P, 2005, J BIOL CHEM, V280, P37377, DOI 10.1074/jbc.M508246200; Michels G, 2006, TOXICOLOGY, V225, P173, DOI 10.1016/j.tox.2006.05.014; Nolze A, 2013, RNA, V19, P1483, DOI 10.1261/rna.037945.112; Perez-Jimenez J, 2011, AM J CLIN NUTR, V93, P1220, DOI 10.3945/ajcn.110.007096; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Prince M, 2015, ALZHEIMERS DIS INT, V2015, P84, DOI DOI 10.1111/J.0963-7214.2004.00293.X; Quincozes-Santos A, 2014, TOXICOL IN VITRO, V28, P544, DOI 10.1016/j.tiv.2013.12.021; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rege SD, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00218; Romeu Antoni, 2014, BMC Res Notes, V7, P188, DOI 10.1186/1756-0500-7-188; Sakai H, 2013, J PHYSIOL-LONDON, V591, P5851, DOI 10.1113/jphysiol.2013.263558; Salmina AB, 2009, J ALZHEIMERS DIS, V16, P485, DOI 10.3233/JAD-2009-0988; Savaskan E, 2003, GERONTOLOGY, V49, P380, DOI 10.1159/000073766; Shen G, 2008, IN VITRO CELL DEV-AN, V44, P280, DOI 10.1007/s11626-008-9115-z; SONTAG JM, 1994, J BIOL CHEM, V269, P4547; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Takaoka M., 1939, NIPPON KAGAKU KAISHI, V60, P1090, DOI [10.1246/nikkashi1921.60.1090, DOI 10.1246/NIKKASHI1921.60.1090]; Thomsen R, 2011, GLIA, V59, P1782, DOI 10.1002/glia.21223; Tomsig JL, 2002, CELL MOL LIFE SCI, V59, P1467, DOI 10.1007/s00018-002-8522-7; Turner RS, 2015, NEUROLOGY, V85, P1383, DOI 10.1212/WNL.0000000000002035; Verkhratsky A., 2007, GLIAL NEUROBIOLOGY T; Villaflores OB, 2012, TAIWAN J OBSTET GYNE, V51, P515, DOI 10.1016/j.tjog.2012.09.005; Wang J, 2006, FASEB J, V20, P2313, DOI 10.1096/fj.06-6281com; WASHBOURNE P, 1995, BIOCHEM J, V305, P721, DOI 10.1042/bj3050721; Winkle CC, 2016, JOVE-J VIS EXP, DOI 10.3791/53743; Zhang F, 2010, EUR J PHARMACOL, V636, P1, DOI 10.1016/j.ejphar.2010.03.043	60	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176067	10.1371/journal.pone.0176067	http://dx.doi.org/10.1371/journal.pone.0176067			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441400	Green Published, Green Submitted, gold			2022-12-26	WOS:000400308800023
J	Can, MT; Kurkcuoglu, Z; Ezeroglu, G; Uyar, A; Kurkcuoglu, O; Doruker, P				Can, Mehmet Tarik; Kurkcuoglu, Zeynep; Ezeroglu, Gokce; Uyar, Arzu; Kurkcuoglu, Ozge; Doruker, Pemra			Conformational dynamics of bacterial trigger factor in apo and ribosome-bound states	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; NASCENT CHAIN; FORCE-FIELD; PROTEIN; SIMULATION; COMPLEX; AMBER; CHAPERONES; MECHANICS; ALGORITHM	The chaperone trigger factor (TF) binds to the ribosome exit tunnel and helps cotranslational folding of nascent chains (NC) in bacterial cells and chloroplasts. In this study, we aim to investigate the functional dynamics of fully-atomistic apo TF and its complex with 50S. As TF accomodates a high percentage of charged residues on its surface, the effect of ionic strength on TF dynamics is assessed here by performing five independent molecular dynamics (MD) simulations (total of 1.3 micro-second duration) at 29 mM and 150 mM ionic strengths. At both concentrations, TF exhibits high inter-and intra-domain flexibility related to its binding (BD), core (CD), and head (HD) domains. Even though large oscillations in gyration radius exist during each run, we do not detect the so-called 'fully collapsed' state with both HD and BD collapsed upon the core. In fact, the extended conformers with relatively open HD and BD are highly populated at the physiological concentration of 150 mM. More importantly, extended TF snapshots stand out in terms of favorable docking onto the 50S subunit. Elastic network modeling (ENM) indicates significant changes in TF's functional dynamics and domain decomposition depending on its conformation and positioning on the 50S. The most dominant slow motions are the lateral sweeping and vertical opening/ closing of HD relative to 50S. Finally, our ENM-based efficient technique -ClustENM-is used to sample atomistic conformers starting with an extended TF-50S complex. Specifically, BD and CD motions are restricted near the tunnel exit, while HD is highly mobile. The atomistic conformers generated without an NC are in agreement with the cryo-EM maps available for TF-ribosome-NC complex.	[Can, Mehmet Tarik; Kurkcuoglu, Zeynep; Ezeroglu, Gokce; Uyar, Arzu; Doruker, Pemra] Bogazici Univ, Dept Chem Engn, Istanbul, Turkey; [Can, Mehmet Tarik; Kurkcuoglu, Zeynep; Ezeroglu, Gokce; Uyar, Arzu; Doruker, Pemra] Bogazici Univ, Polymer Res Ctr, Istanbul, Turkey; [Kurkcuoglu, Ozge] Istanbul Tech Univ, Dept Chem Engn, Istanbul, Turkey; [Kurkcuoglu, Zeynep] Univ Utrecht, Fac Sci, Bijvoet Ctr Biomol Res, Utrecht, Netherlands; [Uyar, Arzu] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Bogazici University; Bogazici University; Istanbul Technical University; Utrecht University; Michigan State University	Doruker, P (corresponding author), Bogazici Univ, Dept Chem Engn, Istanbul, Turkey.; Doruker, P (corresponding author), Bogazici Univ, Polymer Res Ctr, Istanbul, Turkey.	doruker@boun.edu.tr	Kurkcuoglu, Zeynep/AAG-2591-2019; Kurkcuoglu, Ozge/ABF-1400-2020	Kurkcuoglu, Ozge/0000-0003-0228-3211; Doruker, Pemra/0000-0002-4824-2223				ANDERSEN HC, 1983, J COMPUT PHYS, V52, P24, DOI 10.1016/0021-9991(83)90014-1; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Baram D, 2005, P NATL ACAD SCI USA, V102, P12017, DOI 10.1073/pnas.0505581102; Barbet-Massin E, 2015, ANGEW CHEM INT EDIT, V54, P4367, DOI 10.1002/anie.201409393; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; Can MT, 2012, THESIS; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Deeng J, 2016, J MOL BIOL, V428, P3588, DOI 10.1016/j.jmb.2016.06.007; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Doruker P, 2000, PROTEINS, V40, P512, DOI 10.1002/1097-0134(20000815)40:3<512::AID-PROT180>3.3.CO;2-D; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Ezeroglu G., 2014, THESIS; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Ferbitz L, 2004, NATURE, V431, P590, DOI 10.1038/nature02899; Gamerdinger M, 2014, SCIENCE, V344, P590, DOI 10.1126/science.1254064; GRIMES RG, 1994, SIAM J MATRIX ANAL A, V15, P228, DOI 10.1137/S0895479888151111; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hawkins GD, 1996, J PHYS CHEM-US, V100, P19824, DOI 10.1021/jp961710n; HAWKINS GD, 1995, CHEM PHYS LETT, V246, P122, DOI 10.1016/0009-2614(95)01082-K; Hoffmann A, 2012, MOL CELL, V48, P63, DOI 10.1016/j.molcel.2012.07.018; Hoffmann A, 2010, BBA-MOL CELL RES, V1803, P650, DOI 10.1016/j.bbamcr.2010.01.017; Hoffmann A, 2009, NAT STRUCT MOL BIOL, V16, P1006, DOI 10.1038/nsmb1009-1006; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaiser CM, 2006, NATURE, V444, P455, DOI 10.1038/nature05225; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kramer G, 2004, J BIOL CHEM, V279, P14165, DOI 10.1074/jbc.M313635200; Kramer G, 2002, NATURE, V419, P171, DOI 10.1038/nature01047; Kurkcuoglu O, 2009, BIOPHYS J, V97, P1178, DOI 10.1016/j.bpj.2009.06.009; Kurkcuoglu Z, 2016, PLOS ONE, V11, P1; Kurkcuoglu Z, 2016, J CHEM THEORY COMPUT; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; MacKerell AD., 1998, ENCY COMPUTATIONAL C, V1, P271; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Mashaghi A, 2013, NATURE, V500, P98, DOI 10.1038/nature12293; Merz F, 2008, EMBO J, V27, P1622, DOI 10.1038/emboj.2008.89; O'Brien EP, 2012, J AM CHEM SOC, V134, P10920, DOI 10.1021/ja302305u; Patzelt H, 2002, BIOL CHEM, V383, P1611, DOI 10.1515/BC.2002.182; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Preissler S, 2012, TRENDS BIOCHEM SCI, V37, P274, DOI 10.1016/j.tibs.2012.03.002; Saio T, 2014, SCIENCE, V344, P597, DOI 10.1126/science.1250494; Salomon-Ferrer R, 2013, WIRES COMPUT MOL SCI, V3, P198, DOI 10.1002/wcms.1121; Schlunzen F, 2005, STRUCTURE, V13, P1685, DOI 10.1016/j.str.2005.08.007; Singhal K, 2013, PLOS ONE, P8; Srinivasan J, 1999, THEOR CHEM ACC, V101, P426, DOI 10.1007/s002140050460; Thomas AS, 2013, BIOPHYS J, V105, P732, DOI 10.1016/j.bpj.2013.06.028; Wang YM, 2004, J STRUCT BIOL, V147, P302, DOI 10.1016/j.jsb.2004.01.005	52	8	8	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176262	10.1371/journal.pone.0176262	http://dx.doi.org/10.1371/journal.pone.0176262			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437479	Green Published, Green Submitted, gold			2022-12-26	WOS:000400287600040
J	Renner, SW; Walker, LM; Forsberg, LJ; Sexton, JZ; Brenman, JE				Renner, Sarah W.; Walker, Lauren M.; Forsberg, Lawrence J.; Sexton, Jonathan Z.; Brenman, Jay E.			Carbonic anhydrase III (Car3) is not required for fatty acid synthesis and does not protect against high-fat diet induced obesity in mice	PLOS ONE			English	Article							HEPATIC CD36 EXPRESSION; CYTOSOLIC ISOZYME-III; ACTIVE-SITE; PROTEOMIC ANALYSIS; RODENT MODELS; S-THIOLATION; IN-VIVO; LIVER; MOUSE; INSULIN	Carbonic anhydrases are a family of enzymes that catalyze the reversible condensation of water and carbon dioxide to carbonic acid, which spontaneously dissociates to bicarbonate. Carbonic anhydrase III (Car3) is nutritionally regulated at both the mRNA and protein level. It is highly enriched in tissues that synthesize and/or store fat: liver, white adipose tissue, brown adipose tissue, and skeletal muscle. Previous characterization of Car3 knockout mice focused on mice fed standard diets, not high-fat diets that significantly alter the tissues that highly express Car3. We observed lower protein levels of Car3 in high-fat diet fed mice treated with niclosamide, a drug published to improve fatty liver symptoms in mice. However, it is unknown if Car3 is simply a biomarker reflecting lipid accumulation or whether it has a functional role in regulating lipid metabolism. We focused our in vitro studies toward metabolic pathways that require bicarbonate. To further determine the role of Car3 in metabolism, we measured de novo fatty acid synthesis with in vitro radiolabeled experiments and examined metabolic biomarkers in Car3 knockout and wild type mice fed high-fat diet. Specifically, we analyzed body weight, body composition, metabolic rate, insulin resistance, serum and tissue triglycerides. Our results indicate that Car3 is not required for de novo lipogenesis, and Car3 knockout mice fed high-fat diet do not have significant differences in responses to various diets to wild type mice.	[Renner, Sarah W.; Brenman, Jay E.] Univ North Carolina Chapel Hill, Genet & Mol Biol Curriculum, Chapel Hill, NC 27599 USA; [Walker, Lauren M.; Forsberg, Lawrence J.; Brenman, Jay E.] Univ North Carolina Chapel Hill, UNC Neurosci Ctr, Chapel Hill, NC USA; [Sexton, Jonathan Z.] North Carolina Cent Univ, Biomfg Res Inst & Technol Enterprise, Durham, NC USA; [Brenman, Jay E.] Univ North Carolina Chapel Hill, Dept Cell Biol & Physiol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; North Carolina Central University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Renner, SW (corresponding author), Univ North Carolina Chapel Hill, Genet & Mol Biol Curriculum, Chapel Hill, NC 27599 USA.	srenner@email.unc.edu		Walker, Lauren/0000-0003-2122-6271	UNC startup funds; NRSA T32 grant [GM 007092-39]; NIDDK grant [P30DK056350]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER	UNC startup funds; NRSA T32 grant; NIDDK grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by UNC startup funds to JB (http://research.unc.edu/), and NRSA T32 grant GM 007092-39 to SR (https.//www.nigms.nih.gov/). Additionally, this publication was supported by NIDDK grant P30DK056350 to the UNC Nutrition Obesity Research Center (https://www.niddk.nih.gov/). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIDDK or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almind K, 2004, DIABETES, V53, P3274, DOI 10.2337/diabetes.53.12.3274; Alver A, 2004, J ENZYM INHIB MED CH, V19, P279, DOI 10.1080/14756360410001720445; An HQ, 2002, BBA-PROTEINS PROTEOM, V1599, P21, DOI 10.1016/S0167-4838(02)00374-6; Andrikopoulos S, 2005, J ENDOCRINOL, V187, P45, DOI 10.1677/joe.1.06333; Aroor AR, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-29; Aspatwar A, 2014, SUBCELL BIOCHEM, V75, P135, DOI 10.1007/978-94-007-7359-2_8; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bauer M, 2004, PHYSIOL GENOMICS, V17, P230, DOI 10.1152/physiolgenomics.00203.2003; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; Berglund ED, 2008, DIABETES, V57, P1790, DOI 10.2337/db07-1615; Bondia-Pons I, 2011, J NUTRIGENET NUTRIGE, V4, P344, DOI 10.1159/000336075; Caballero VJ, 2011, J PHYSIOL BIOCHEM, V67, P43, DOI 10.1007/s13105-010-0047-1; CABISCOL E, 1995, J BIOL CHEM, V270, P14742, DOI 10.1074/jbc.270.24.14742; Carter WG, 2015, BIOCHEM BIOPH RES CO, V458, P626, DOI 10.1016/j.bbrc.2015.01.158; CHAI YC, 1991, ARCH BIOCHEM BIOPHYS, V284, P270, DOI 10.1016/0003-9861(91)90295-T; Champy MF, 2004, MAMM GENOME, V15, P768, DOI 10.1007/s00335-004-2393-1; Chegwidden WR, 2000, EXS, V90, P13; Chowdhury MKH, 2017, SCI REP-UK, V7, DOI 10.1038/srep40159; Cooper DE, 2015, J BIOL CHEM, V290, P15112, DOI 10.1074/jbc.M115.649970; Deol P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132672; DODGSON SJ, 1991, BIOCHEM CELL BIOL, V69, P761, DOI 10.1139/o91-116; DODGSON SJ, 1993, J APPL PHYSIOL, V75, P1186, DOI 10.1152/jappl.1993.75.3.1186; DODGSON SJ, 1990, ARCH BIOCHEM BIOPHYS, V277, P410, DOI 10.1016/0003-9861(90)90597-R; DUBUC PU, 1985, ANN NUTR METAB, V29, P358, DOI 10.1159/000176992; Duda DM, 2005, BIOCHEMISTRY-US, V44, P10046, DOI 10.1021/bi050610h; Eisinger K, 2014, INT J MOL SCI, V15, P2991, DOI 10.3390/ijms15022991; Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207; Elder I, 2007, PROTEINS, V68, P337, DOI 10.1002/prot.21403; Feng HZ, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00597; GIBSON DM, 1958, BIOCHIM BIOPHYS ACTA, V30, P376, DOI 10.1016/0006-3002(58)90063-5; Grimes A, 1997, BIOCHEM J, V321, P341, DOI 10.1042/bj3210341; Hazen SA, 1996, FASEB J, V10, P481, DOI 10.1096/fasebj.10.4.8647347; HERBERT JD, 1984, ANN NY ACAD SCI, V429, P525, DOI 10.1111/j.1749-6632.1984.tb12381.x; Kharbanda KK, 2009, BIOCHEM BIOPH RES CO, V381, P523, DOI 10.1016/j.bbrc.2009.02.082; Kim G, 2004, MOL CELL BIOL, V24, P9942, DOI 10.1128/MCB.24.22.9942-9947.2004; Koonen DPY, 2007, DIABETES, V56, P2863, DOI 10.2337/db07-0907; Lehenkari P, 1998, EXP CELL RES, V242, P128, DOI 10.1006/excr.1998.4071; LII CK, 1994, ARCH BIOCHEM BIOPHYS, V308, P231, DOI 10.1006/abbi.1994.1033; Lindskog S, 2000, EXS, V90, P175; Liu M, 2007, P NATL ACAD SCI USA, V104, P371, DOI 10.1073/pnas.0609870104; LOGRASSO PV, 1993, BIOCHEMISTRY-US, V32, P5786, DOI 10.1021/bi00073a010; LYNCH CJ, 1993, AM J PHYSIOL, V264, pE621, DOI 10.1152/ajpendo.1993.264.4.E621; LYNCH CJ, 1995, BIOCHEM J, V310, P197, DOI 10.1042/bj3100197; Lynch J, 1992, PYRUVATE CARBOXYLASE; MABROUK GM, 1990, J BIOL CHEM, V265, P6330; Mallis RJ, 2000, FEBS LETT, V482, P237, DOI 10.1016/S0014-5793(00)02022-6; MELDRUM N. IT., 1933, JOUR PHYSIOL, V80, P113; Mendez L, 2017, J NUTR BIOCHEM, V41, P84, DOI 10.1016/j.jnutbio.2016.12.005; Mitterberger MC, 2012, EXP CELL RES, V318, P877, DOI 10.1016/j.yexcr.2012.02.011; Monti DM, 2017, J ENZYM INHIB MED CH, V32, P5, DOI 10.1080/14756366.2016.1225046; Nishimori I, 2007, BIOORGAN MED CHEM, V15, P7229, DOI 10.1016/j.bmc.2007.08.037; Nishimori I, 2009, J ENZYM INHIB MED CH, V24, P70, DOI [10.1080/14756360801907143, 10.1080/14756360801907143 ]; NISHITA T, 1995, INT J BIOCHEM CELL B, V27, P359, DOI 10.1016/1357-2725(94)00090-X; Nixon JP, 2010, OBESITY, V18, P1652, DOI 10.1038/oby.2009.471; Onyenwoke RU, 2012, MOL BIOL CELL, V23, P381, DOI 10.1091/mbc.E11-08-0699; Osorio C, 2007, NEUROBIOL AGING, V28, P1853, DOI 10.1016/j.neurobiolaging.2006.08.011; Patrikainen M, 2014, J BIOMED SCI, V21, DOI 10.1186/s12929-014-0082-2; Pinaud R, 2008, EUR J NEUROSCI, V27, P1409, DOI 10.1111/j.1460-9568.2008.06102.x; Putri M, 2015, BIOCHEM BIOPH RES CO, V457, P520, DOI 10.1016/j.bbrc.2014.12.124; Raisanen SR, 1999, FASEB J, V13, P513, DOI 10.1096/fasebj.13.3.513; Ronchi VP, 2004, INT J BIOCHEM CELL B, V36, P1993, DOI 10.1016/j.biocel.2004.02.019; Shah GN, 2013, P NATL ACAD SCI USA, V110, P7423, DOI 10.1073/pnas.1305805110; Sheedfar F, 2014, AGING-US, V6, P281, DOI 10.18632/aging.100652; SLY WS, 1995, ANNU REV BIOCHEM, V64, P375, DOI 10.1146/annurev.bi.64.070195.002111; STANTON LW, 1991, MOL ENDOCRINOL, V5, P860, DOI 10.1210/mend-5-6-860; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Tao H, 2014, NATURE MED; THOMAS JA, 1995, ARCH BIOCHEM BIOPHYS, V319, P1, DOI 10.1006/abbi.1995.1261; TU CK, 1994, J BIOL CHEM, V269, P23002; Van Schothorst EM, 2005, OBES RES, V13, P1031, DOI 10.1038/oby.2005.121; Wang BX, 2014, CURR DIABETES REV, V10, P131, DOI 10.2174/1573399810666140508121012; Wang CY, 2012, METHODS MOL BIOL, V821, P421, DOI 10.1007/978-1-61779-430-8_27; Wang Y, 2013, P NATL ACAD SCI USA, V110, P16109, DOI 10.1073/pnas.1315292110; Wendel AA, 2013, J BIOL CHEM, V288, P27299, DOI 10.1074/jbc.M113.485219; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Yamada M, 2013, ALCOHOL CLIN EXP RES, V37, pE79, DOI 10.1111/j.1530-0277.2012.01883.x; Zagani R, 2015, ONCOTARGET, V6, P28282, DOI 10.18632/oncotarget.5061; Zhang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027553; Zimmerman UJP, 2004, IUBMB LIFE, V56, P343, DOI 10.1080/1521-6540400000850	80	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176502	10.1371/journal.pone.0176502	http://dx.doi.org/10.1371/journal.pone.0176502			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437447	Green Published, Green Submitted, gold			2022-12-26	WOS:000400287600049
J	Celiberto, LS; Bedani, R; Dejani, NN; de Medeiros, AI; Zuanon, JAS; Spolidorio, LC; Adorno, MAT; Varesche, MBA; Galvao, FC; Valentini, SR; de Valdez, GF; Rossi, EA; Cavallinil, DCU				Sbaglia Celiberto, Larissa; Bedani, Raquel; Dejani, Naiara Naiana; de Medeiros, Alexandra Ivo; Sampaio Zuanon, Jose Antonio; Spolidorio, Luis Carlos; Tallarico Adorno, Maria Angela; Amancio Varesche, Maria Bernadete; Galvao, Fabio Carrilho; Valentini, Sandro Roberto; Font de Valdez, Graciela; Rossi, Elizeu Antonio; Umbelino Cavallinil, Daniela Cardoso			Effect of a probiotic beverage consumption (Enterococcus faecium CRL 183 and Bifidobacterium longum ATCC 15707) in rats with chemically induced colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CHAIN FATTY-ACIDS; DEXTRAN SODIUM-SULFATE; DSS-INDUCED COLITIS; ULCERATIVE-COLITIS; FECAL MICROBIOTA; NITRIC-OXIDE; LACTOBACILLUS-FERMENTUM; 5-AMINOSALICYLIC ACID; INTESTINAL MICROBIOTA	Background Some probiotic strains have the potential to assist in relieving the symptoms of inflammatory bowel disease. The impact of daily ingestion of a soy-based product fermented by Enterococcus faecium CRL 183 and Lactobacillus helveticus 416 with the addition of Bifidobacterium longum ATCC 15707 on chemically induced colitis has been investigated thereof within a period of 30 days. Methods Colitis was induced by dextran sulfate sodium. The animals were randomly assigned into five groups: Group C: negative control; Group CL: positive control; Group CLF: DSS with the fermented product; Group CLP: DSS with the non-fermented product (placebo); Group CLS: DSS with sulfasalazine. The following parameters were monitored: disease activity index, fecal microbial analyses, gastrointestinal survival of probiotic microorganisms and short-chain fatty acids concentration in the feces. At the end of the protocol the animals' colons were removed so as to conduct a macroscopical and histopathological analysis, cytokines and nitrite quantification. Results Animals belonging to the CLF group showed fewer symptoms of colitis during the induction period and a lower degree of inflammation and ulceration in their colon compared to the CL, CLS and CLP groups (p<0.05). The colon of the animals in groups CL and CLS presented severe crypt damage, which was absent in CLF and CLP groups. A significant increase in the population of Lactobacillus spp. and Bifidobacterium spp. at the end of the protocol was verified only in the CLF animals (p<0.05). This group also showed an increase in short-chain fatty acids (propionate and acetate). Furthermore, the intestinal survival of E. faecium CRL 183 and B. longum ATCC 15707 in the CLF group has been confirmed by biochemical and molecular analyzes. Conclusions The obtained results suggest that a regular intake of the probiotic product, and placebo to a lesser extent, can reduce the severity of DSS-induced colitis on rats.	[Sbaglia Celiberto, Larissa; Rossi, Elizeu Antonio; Umbelino Cavallinil, Daniela Cardoso] Univ Estadual Paulista, UNESP, Fac Ciencias Farmaceut, Dept Alimentos & Nutr, Araraquara, SP, Brazil; [Bedani, Raquel] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Tecnol Bioquim Farmaceut, Sao Paulo, SP, Brazil; [Dejani, Naiara Naiana] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Bioquim & Imunol, Ribeirao Preto, SP, Brazil; [Dejani, Naiara Naiana; de Medeiros, Alexandra Ivo; Galvao, Fabio Carrilho; Valentini, Sandro Roberto] Univ Estadual Paulista, UNESP, Fac Ciencias Farmaceut, Dept Ciencias Biol, Araraquara, SP, Brazil; [Sampaio Zuanon, Jose Antonio; Spolidorio, Luis Carlos] Univ Estadual Paulista, UNESP, Fac Odontol, Dept Fisiol & Patol, Araraquara, SP, Brazil; [Tallarico Adorno, Maria Angela; Amancio Varesche, Maria Bernadete] Univ Sao Paulo, Fac Engn, Dept Hidraul & Saneamento, Sao Carlos, SP, Brazil; [Font de Valdez, Graciela] CERELA, Ctr Referencia Lactobacilos, San Miguel De Tucuman, Argentina	Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade de Sao Paulo	Cavallinil, DCU (corresponding author), Univ Estadual Paulista, UNESP, Fac Ciencias Farmaceut, Dept Alimentos & Nutr, Araraquara, SP, Brazil.	cavallinidc@fcfar.unesp.br	Varesche, Maria Bernadete Amancio/K-6127-2012; Spolidorio, Luís Carlos/G-1857-2012; dejani, naiara naiana/AAQ-1395-2020; Valentini, Sandro R/C-4353-2012; Cavallini, Daniela Cardoso Umbelino/B-6447-2012; Bedani, Raquel/C-6463-2012	Varesche, Maria Bernadete Amancio/0000-0003-3124-7471; Spolidorio, Luís Carlos/0000-0002-0592-542X; dejani, naiara naiana/0000-0001-9818-1572; Bedani, Raquel/0000-0001-6806-085X; Celiberto, Larissa/0000-0001-9057-9041; Cavallini, Daniela/0000-0003-2146-662X; Valentini, Sandro Roberto/0000-0003-4453-5413	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo DCUC [2012/07785-0]; Pro-Reitoria de Pesquisa da Universidade Estadual de Pesquisa "Julio de Mesquita Filho - DCUC [PROPe 10/12]; Programa de Apoio ao Desenvolvimento Cientifico da Faculdade de Ciencias Farmaceuticas - UNESP	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo DCUC; Pro-Reitoria de Pesquisa da Universidade Estadual de Pesquisa "Julio de Mesquita Filho - DCUC; Programa de Apoio ao Desenvolvimento Cientifico da Faculdade de Ciencias Farmaceuticas - UNESP	This work was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo DCUC (2012/07785-0), http://www.fapesp.br/; Pro-Reitoria de Pesquisa da Universidade Estadual de Pesquisa "Julio de Mesquita Filho - DCUC (PROPe 10/12), http://unesp.br/portal#!/prope; Programa de Apoio ao Desenvolvimento Cientifico da Faculdade de Ciencias Farmaceuticas - UNESP. DCUC (PADC), http://www2.fcfar.unesp.br/ #!/pesquisa/padc/historico/; and Fundagao de Amparo a Pesquisa do Estado de Sao Paulo - LSC (2012/07706-3), http://www.fapesp.br/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorno M., 2014, AM J ANAL CHEM, V5, P406, DOI [10.4236/ajac.2014.57049, DOI 10.4236/AJAC.2014.57049]; Ahl D, 2016, ACTA PHYSIOL, V217, P300, DOI 10.1111/apha.12695; AIKO S, 1995, GASTROENTEROLOGY, V109, P142, DOI 10.1016/0016-5085(95)90279-1; Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Arab HH, 2014, FOOD CHEM TOXICOL, V69, P294, DOI 10.1016/j.fct.2014.04.032; Basavanna Girishkumar, 2012, Annals Food Science and Technology, V13, P231; Bedani R., 2008, THESIS, P140; Bedani R, 2013, FOOD MICROBIOL, V34, P382, DOI 10.1016/j.fm.2013.01.012; Bedani R, 2011, BRAZ J MICROBIOL, V42, P1238, DOI [10.1590/S1517-83822011000300050, 10.1590/S1517-838220110003000050]; Bedani R, 2010, J SCI FOOD AGR, V90, P233, DOI 10.1002/jsfa.3800; BELL CJ, 1995, AM J PHYSIOL-GASTR L, V268, pG622, DOI 10.1152/ajpgi.1995.268.4.G622; Bento AF, 2012, BIOCHEM PHARMACOL, V84, P1459, DOI 10.1016/j.bcp.2012.09.007; Bertazzoni E, 2013, J CHEMOTHERAPY, V25, P193, DOI 10.1179/1973947813Y.0000000078; Bourlioux P, 2003, AM J CLIN NUTR, V78, P675, DOI 10.1093/ajcn/78.4.675; boyd d., 2008, THESIS; Brigidi P, 2001, RES MICROBIOL, V152, P735, DOI 10.1016/S0923-2508(01)01254-2; Buffie CG, 2013, NAT REV IMMUNOL, V13, P790, DOI 10.1038/nri3535; Bullock Natalie R, 2004, Curr Issues Intest Microbiol, V5, P59; Camuesco D, 2005, INFLAMM BOWEL DIS, V11, P265, DOI 10.1097/01.MIB.0000160808.30988.d9; Cano VPS, 2007, LAIT, V87, P59, DOI 10.1051/lait:2007002; Cavallini DCU, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-126; Celiberto LS, 2015, CRIT REV FOOD SCI NU; Chu HT, 2016, SCIENCE, V352, P1116, DOI 10.1126/science.aad9948; Cook SI, 1998, ALIMENT PHARM THER, V12, P499, DOI 10.1046/j.1365-2036.1998.00337.x; Cui HH, 2004, WORLD J GASTROENTERO, V10, P1521; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Edlund C, 2000, SCAND J INFECT DIS, V32, P81, DOI 10.1080/00365540050164272; Ettreiki C, 2012, WORLD J GASTROENTERO, V18, P2619, DOI 10.3748/wjg.v18.i21.2619; Falony G, 2006, APPL ENVIRON MICROB, V72, P7835, DOI 10.1128/AEM.01296-06; Feagins LA, 2010, INFLAMM BOWEL DIS, V16, P1963, DOI 10.1002/ibd.21281; Fedorak RN, 2004, INFLAMM BOWEL DIS, V10, P286, DOI 10.1097/00054725-200405000-00018; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Forsythe P, 2010, BRAIN BEHAV IMMUN, V24, P9, DOI 10.1016/j.bbi.2009.05.058; Franz CMAP, 2011, INT J FOOD MICROBIOL, V151, P125, DOI 10.1016/j.ijfoodmicro.2011.08.014; Garcia-Lafuente A, 2009, INFLAMM RES, V58, P537, DOI 10.1007/s00011-009-0037-3; Geier MS, 2007, INT J FOOD MICROBIOL, V114, P267, DOI 10.1016/j.ijfoodmicro.2006.09.018; Gisbert JP, 2002, DIGEST DIS SCI, V47, P471, DOI 10.1023/A:1017987229718; Griffiths Keith, 2016, Diseases, V4, DOI 10.3390/diseases4030028; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Hanauer SB, 2006, INFLAMM BOWEL DIS, V12, pS3, DOI 10.1097/01.MIB.0000195385.19268.68; HARIG JM, 1989, NEW ENGL J MED, V320, P23, DOI 10.1056/NEJM198901053200105; Herllinger KR, 2006, AM J GASTROENTEROL, V101, P793, DOI 10.1111/j.1572-0241.2005.00356.x; HOGABOAM CM, 1995, AM J PHYSIOL-GASTR L, V268, pG673, DOI 10.1152/ajpgi.1995.268.4.G673; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Howarth GS, 2008, J GASTROEN HEPATOL, V23, P1777, DOI 10.1111/j.1440-1746.2008.05685.x; Jiang HY, 2011, J NUTR, V141, P1239, DOI 10.3945/jn.110.137414; Jo SG, 2016, J MICROBIOL, V54, P503, DOI 10.1007/s12275-016-6160-2; Jurjus Abdo R., 2004, Journal of Pharmacological and Toxicological Methods, V50, P81, DOI 10.1016/j.vascn.2003.12.002; Kaur IP, 2002, EUR J PHARM SCI, V15, P1, DOI 10.1016/S0928-0987(01)00209-3; Kinouchi FL, 2012, FOOD CHEM TOXICOL, V50, P4144, DOI 10.1016/j.fct.2012.08.038; Kolios G, 2004, IMMUNOLOGY, V113, P427, DOI 10.1111/j.1365-2567.2004.01984.x; Kringston DGI, 1990, CHEM RES TOXICOL, V3, P39; Krzyzanowsky F, 2003, REV INST MED TROP SA; KUCHARZIK T, 1995, CLIN EXP IMMUNOL, V100, P452; Kumar NSN, 2008, J GASTROEN HEPATOL, V23, P1834, DOI 10.1111/j.1440-1746.2008.05723.x; Lam V, 2012, FASEB J, V26, P1727, DOI 10.1096/fj.11-197921; Lane TE, 1996, INFECT IMMUN, V61, P1468; Langa S, 2003, INT J FOOD MICROBIOL, V88, P197, DOI 10.1016/S0168-1605(03)00180-6; LIVINGSTON SJ, 1978, J CLIN MICROBIOL, V7, P448; MAHIDA YR, 1991, GUT, V32, P50, DOI 10.1136/gut.32.1.50; Malago JJ, 2008, J ZHEJIANG UNIV-SC B, V9, P341, DOI 10.1631/jzus.B0720198; Marzotto M, 2006, RES MICROBIOL, V157, P857, DOI 10.1016/j.resmic.2006.06.007; Mater DDG, 2005, FEMS MICROBIOL LETT, V250, P185, DOI 10.1016/j.femsle.2005.07.006; Matsuki T, 1999, APPL ENVIRON MICROB, V65, P4512; Medina M, 2007, CLIN EXP IMMUNOL, V150, P531, DOI 10.1111/j.1365-2249.2007.03522.x; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; Messaoudi M, 2011, BRIT J NUTR, V105, P755, DOI 10.1017/S0007114510004319; Montesi A, 2005, INT J FOOD MICROBIOL, V98, P281, DOI 10.1016/j.ijfoodmicro.2004.06.005; Morampudi V, 2016, MUCOSAL IMMUNOL, V9, P1218, DOI 10.1038/mi.2015.140; Moussa L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049547; MUNOA FJ, 1988, APPL ENVIRON MICROB, V54, P1715; MURTHY SNS, 1993, DIGEST DIS SCI, V38, P1722, DOI 10.1007/BF01303184; Musch E, 2005, CLIN GASTROENTEROL H, V3, P581, DOI 10.1016/S1542-3565(05)00208-9; Mylonaki M, 2005, INFLAMM BOWEL DIS, V11, P481, DOI 10.1097/01.MIB.0000159663.62651.4f; Naruszewicz M, 2002, AM J CLIN NUTR, V76, P1249, DOI 10.1093/ajcn/76.6.1249; Nassri Carlos Guilherme Giazzi, 2008, Rev bras. colo-proctol., V28, P306, DOI 10.1590/S0101-98802008000300006; Nemoto H, 2012, DIGEST DIS SCI, V57, P2955, DOI 10.1007/s10620-012-2236-y; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; O'Hara AM, 2007, THESCIENTIFICWORLDJO, V7, P31, DOI 10.1100/tsw.2007.26; Ocon B, 2013, EUR J NUTR, V52, P457, DOI 10.1007/s00394-012-0347-z; Ohman L, 2010, NAT REV GASTRO HEPAT, V7, P163, DOI 10.1038/nrgastro.2010.4; Osman N, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-31; Ozaki K, 2012, CURR GENE THER, V12, P484, DOI 10.2174/156652312803519814; Panneerselvam S, 2016, BIOCH ANAL BIOCH, V5, P2, DOI DOI 10.4172/2161-1009.1000266; Peran L, 2006, INT J COLORECTAL DIS, V21, P737, DOI 10.1007/s00384-005-0773-y; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; RACHMILEWITZ D, 1995, GUT, V36, P718, DOI 10.1136/gut.36.5.718; Ramiah K, 2008, RES MICROBIOL, V159, P470, DOI 10.1016/j.resmic.2008.06.002; Ranganna K, 2003, MOL CELL BIOCHEM, V254, P21, DOI 10.1023/A:1027383710582; Riviere A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00979; Rogler G, 1998, WORLD J SURG, V22, P382, DOI 10.1007/s002689900401; ROSSI EA, 1984, ARQ BIOL TECNOL, V27, P387; Sakata S, 2002, INT J SYST EVOL MICR, V52, P1945, DOI [10.1099/ijs.0.02221-0, 10.1099/00207713-52-6-1945]; Salim SY, 2011, INFLAMM BOWEL DIS, V17, P362, DOI 10.1002/ibd.21403; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Shahidi N, 2012, INFLAMM BOWEL DIS, V18, P2034, DOI 10.1002/ibd.22901; Sheehan D, 2015, J GASTROENTEROL, V50, P495, DOI 10.1007/s00535-015-1064-1; Shiguemoto GE, 2007, MATURITAS, V57, P261, DOI 10.1016/j.maturitas.2007.01.011; Sivieri K, 2008, EUR FOOD RES TECHNOL, V228, P231, DOI 10.1007/s00217-008-0927-6; Sokol H, 2006, J CLIN MICROBIOL, V44, P3172, DOI 10.1128/JCM.02600-05; Sonnenburg ED, 2016, NATURE, V529, P212, DOI 10.1038/nature16504; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Tilg H, 2002, J IMMUNOL, V169, P2204, DOI 10.4049/jimmunol.169.4.2204; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Toure R, 2003, J APPL MICROBIOL, V95, P1058, DOI 10.1046/j.1365-2672.2003.02085.x; Travis SPL, 2008, J CROHNS COLITIS, V2, P24, DOI 10.1016/j.crohns.2007.11.002; Ubeda C, 2013, INFECT IMMUN, V81, P965, DOI 10.1128/IAI.01197-12; Uronis JM, 2011, INFLAMM BOWEL DIS, V17, P289, DOI 10.1002/ibd.21366; Van de Wiele T, 2004, FEMS MICROBIOL ECOL, V51, P143, DOI 10.1016/j.femsec.2004.07.014; VANDULLEMEN HM, 1995, GASTROENTEROLOGY, V109, P129, DOI 10.1016/0016-5085(95)90277-5; Ventura M, 2009, NAT REV MICROBIOL, V7, P61, DOI 10.1038/nrmicro2047; Vinolo MAR, 2010, THESIS; Vowinkel T, 2004, DIGEST DIS SCI, V49, P556, DOI 10.1023/B:DDAS.0000026298.72088.f7; Weber TE, 2006, VET IMMUNOL IMMUNOP, V113, P139, DOI 10.1016/j.vetimm.2006.04.006; Wine E, 2009, FEMS MICROBIOL LETT, V300, P146, DOI 10.1111/j.1574-6968.2009.01781.x; Wolever TMS, 2002, AM J CLIN NUTR, V75, P1023, DOI 10.1093/ajcn/75.6.1023; Yan F, 2012, GUT MICROBES, V3, P25, DOI 10.4161/gmic.19245; YOSHIOKA H, 1983, PEDIATRICS, V72, P317; Yu J, 2016, NUTRIENTS, V8, DOI 10.3390/nu8060361; Zhou FX, 2012, WORLD J GASTROENTERO, V18, P2344, DOI 10.3748/wjg.v18.i19.2344	121	22	23	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0175935	10.1371/journal.pone.0175935	http://dx.doi.org/10.1371/journal.pone.0175935			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437455	Green Published, gold, Green Submitted			2022-12-26	WOS:000400287600023
J	Lin, LY; Peng, CC; Chen, Y; Huang, BC; Chang, CC; Peng, RY				Lin, Li-Yun; Peng, Chiung-Chi; Chen, Yeh; Huang, Boa-Chan; Chang, Chun Chao; Peng, Robert Y.			Aminoazo dye-protein-adduct enhances inhibitory effect on digestibility and damages to Gastro-Duodenal-Hepatic axis	PLOS ONE			English	Article							LIVER; RATS; CARCINOGENESIS	4-Dimethylaminoazobenzene (DAB, methyl yellow, or butter yellow), a human carcinogen, has been banned for use in foods since 1988. In 2014, DAB adulteration in Tofu occurred in Taiwan. We hypothesize that DAB can form [DAB center dot SBP](adduct) adduct with soybean protein (SBP) which could damage Gastro-Duodenal-Hepatic axis. Sprague-Dawley rats gavage fed [DAB center dot SBP](adduct) adduct revealed severely reduced body weight and damaged duodenum, liver, hepatic mitochondria, and spleen. Hepatic levels of glutathione and ATP were severely reduced. Serum GOT and GPT were substantially elevated. Analysis by the adsorption isotherm clearly revealed DAB formed very stable [DAB center dot SBP](adduct) adduct at 1:1 molar ration (Phase A). The equilibrium constant of this colloidal adduct [DAB center dot SBP](adduct) was K-eqA = proportional to, behaving as the most stable and toxic species. At higher protein concentration (Phase C) it formed conjugate [DABxSBP(gross)](conjugate), with K-eqC = 3.23x10(-2) mg/mL, implicating a moderately strong adsorption. The in vitro pepsin digestibility test showed apparently reduced digestibility by 27% (by Ninhydrin assay) or 8% (by Bradford assay). Conclusively, this is the first report indicating that [DAB center dot SBP](adduct) potentially is capable to damage the Gastro-Duodenal-Hepatic axis.	[Lin, Li-Yun; Huang, Boa-Chan] Hungkuang Univ, Dept Food & Appl Technol, Taichung, Shalu County, Taiwan; [Peng, Chiung-Chi] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Chen, Yeh; Peng, Robert Y.] Hungkuang Univ, Res Inst Biotechnol, Sch Med & Nursing, Sec 6,Taiwan Blvd, Taichung, Taiwan; [Chang, Chun Chao] Taipei Med Univ Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, Taipei, Taiwan; [Chang, Chun Chao] Taipei Med Univ, Div Gastroenterol & Hepatol, Dept Internal Med, Sch Med,Coll Med, Taipei, Taiwan; [Peng, Robert Y.] Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan	Hungkuang University; Taipei Medical University; Hungkuang University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University	Peng, RY (corresponding author), Hungkuang Univ, Res Inst Biotechnol, Sch Med & Nursing, Sec 6,Taiwan Blvd, Taichung, Taiwan.; Chang, CC (corresponding author), Taipei Med Univ Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, Taipei, Taiwan.; Chang, CC (corresponding author), Taipei Med Univ, Div Gastroenterol & Hepatol, Dept Internal Med, Sch Med,Coll Med, Taipei, Taiwan.; Peng, RY (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan.	chunchao@tmu.edu.tw; ypeng@seed.net.tw			Ministry of Agriculture and Food Stuff (Taiwan, ROC); Ministry of Science and Technology (Taiwan, ROC) [MOST 105-2320-B-038-034-MY3, MOST 103-2313-B-038-002-MY3]; Taipei Medical University Shuang Ho Hospital [105TMU-SHH-16]; Chinese Hazard Analysis and Critical Control Point (HACCP) Development Association (Taiwan, ROC) [HK101-171]; Chi Mei Medical Center [106CM-TMU-05]	Ministry of Agriculture and Food Stuff (Taiwan, ROC); Ministry of Science and Technology (Taiwan, ROC)(Ministry of Science and Technology, Taiwan); Taipei Medical University Shuang Ho Hospital; Chinese Hazard Analysis and Critical Control Point (HACCP) Development Association (Taiwan, ROC); Chi Mei Medical Center	The 103-Agriculture-3.1.3.-Food-Stuffs-Z1(5) funding support from the Ministry of Agriculture and Food Stuff (Taiwan, ROC), MOST 105-2320-B-038-034-MY3 from the Ministry of Science and Technology (Taiwan, ROC), and the funding support of 105TMU-SHH-16 from Taipei Medical University Shuang Ho Hospital are gratefully acknowledged.; Financial support of Chinese Hazard Analysis and Critical Control Point (HACCP) Development Association (Taiwan, ROC) (HK101-171) and MOST 105-2320-B-038-034-MY3; MOST 103-2313-B-038-002-MY3 from the Ministry of Science and Technology (Taiwan, ROC), the funding support of 105TMU-SHH-16 from Taipei Medical University Shuang Ho Hospital, and 106CM-TMU-05 from the Chi Mei Medical Center are gratefully acknowledged.	[Anonymous], 2012, SEG MED DICT; [Anonymous], 2012, 2 SPRINGER SCI BUSIN; ARCOS JC, 1958, BIOCHIM BIOPHYS ACTA, V28, P9, DOI 10.1016/0006-3002(58)90421-9; Bryant S, 1997, BR J CAN, V36, P678; DAOUD AH, 1976, CANCER RES, V36, P2885; DELEVE LD, 1991, PHARMACOL THERAPEUT, V52, P287, DOI 10.1016/0163-7258(91)90029-L; Eigenmann PA, 2004, LANCET, V364, P823, DOI 10.1016/S0140-6736(04)16996-1; FLEXNEWS, 2009, FLEXNEWS        0411; Ghanbari-Niaki A, 1999, ARCH PHYSIOL BIOCHEM, V107, P393, DOI 10.1076/1381-3455(199912)107:05;1-5;FT393; LIN JK, 1975, CANCER RES, V35, P844; Malinauskyte E, 2014, FOOD CHEM, V165, P104, DOI 10.1016/j.foodchem.2014.05.078; MILLER EC, 1947, CANCER RES, V7, P468; Ni Q, 2015, ANAL CELL PATHOL, V2015, P5; Opie EL, 1944, J EXP MED, V80, P231, DOI 10.1084/jem.80.3.231; Orr JW, 1940, J PATHOL BACTERIOL, V50, P393, DOI 10.1002/path.1700500302; PORTER KR, 1959, CANCER RES, V19, P997; Saeed S. M. G., 2011, Journal of Pharmacy and Nutrition Sciences, V1, P34; SANCHEZCHIANG L, 1987, COMP BIOCHEM PHYS B, V87, P793, DOI 10.1016/0305-0491(87)90390-7; Sarkar A, 2009, FOOD HYDROCOLLOID, V23, P1563, DOI 10.1016/j.foodhyd.2008.10.014; Sasaki T. YT, 1935, VIRCHOWS ARCH PATH A, V295; Schmahl S, 1975, Z KREBSFORSCHUNG KLI; Suthanthiran A, 1990, P NATL ACAD SCI USA, V87; SWEENEY EA, 1994, ENVIRON HEALTH PERSP, V102, P119, DOI 10.2307/3432164; Tacal O, 2004, J BIOCHEM MOL TOXIC, V18, P253, DOI 10.1002/jbt.20034; Thomas, 2013, ELSEVIER, V7, P147; Toyo'oka T, 2001, BIOMEDICAL CHROMATOG, V15; U.S. Department of Health and Human Services. Public Health Service CfDaH Division of Standards Development and Technology Transfer, 1988, OCC SAF HLTH GUID 4	27	53	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0170555	10.1371/journal.pone.0170555	http://dx.doi.org/10.1371/journal.pone.0170555			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430776	Green Published, gold, Green Submitted			2022-12-26	WOS:000399876100001
J	Sun, CL; Zhang, HL; Liu, M; Wang, W; Crowder, CM				Sun, Chun-Ling; Zhang, Huiliang; Liu, Meng; Wang, Wang; Crowder, C. Michael			A screen for protective drugs against delayed hypoxic injury	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; CAENORHABDITIS-ELEGANS; C-ELEGANS; ISCHEMIA/REPERFUSION INJURY; CEREBRAL-ISCHEMIA; HYDROGEN-PEROXIDE; INHIBITION; RATS; PHENAZOPYRIDINE; CYPERMETHRIN	Despite longstanding efforts to develop cytoprotective drugs against ischemia/reperfusion (IR) injuries, there remains no effective therapeutics to treat hypoxic injury. The failure of traditional strategies at solving this problem suggests the need for novel and unbiased approaches that can lead to previously unsuspected targets and lead compounds. Towards this end, we report here a unique small molecule screen in the nematode C. elegans for compounds that improve recovery when applied after the hypoxic insult, using a C. elegans strain engineered to have delayed cell non-autonomous death. In a screen of 2000 compounds, six were found to produce significant protection of C. elegans from delayed death. Four of the compounds were tested in an ex vivo mouse heart ischemia/reperfusion model and two, meclocycline and 3-amino-1,2,4-triazole, significantly reduced infarction size. Our work demonstrates the feasibility of this novel C. elegans screen to discover hypoxia protective drugs that are also protective in a mammalian model of hypoxic injury.	[Sun, Chun-Ling; Zhang, Huiliang; Liu, Meng; Wang, Wang; Crowder, C. Michael] Univ Washington, Sch Med, Dept Anesthesiol & Pain Med, Seattle, WA USA; [Liu, Meng] Second Mil Med Univ, Dept Anesthesiol, Shanghai, Peoples R China; [Crowder, C. Michael] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA USA; [Liu, Meng] Dept Anesthesiol, Qingdao, Shandong, Peoples R China	University of Washington; University of Washington Seattle; Naval Medical University; University of Washington; University of Washington Seattle	Crowder, CM (corresponding author), Univ Washington, Sch Med, Dept Anesthesiol & Pain Med, Seattle, WA USA.; Crowder, CM (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA USA.	cmc53@uw.edu	Zhang, Huiliang/AAW-7729-2020; wang, wang/GWQ-7272-2022; Zhang, Huiliang/AAP-1243-2020	Zhang, Huiliang/0000-0002-8967-1219; Wang, Wang/0000-0001-9093-412X	NIH Office of Research Infrastructure Programs [P40 OD010440]; National Institute of Neurological Disorders and Stroke [R01NS045905, R21NS084360]; International Anesthesia Research Society Frontiers in Anesthesia Research Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045905] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NIH Office of Research Infrastructure Programs; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); International Anesthesia Research Society Frontiers in Anesthesia Research Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Barbara Scott for her technical contributions to the work. We also grateful to Timothy J Martins and James Annis (Quellos High Throughput Screening Core, UW) for the assistance of high-throughput screen. Strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440).; The work was supported by National Institute of Neurological Disorders and Stroke [Grants R01NS045905, R21NS084360] and by the International Anesthesia Research Society Frontiers in Anesthesia Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMER SM, 1985, MUTAT RES, V155, P135, DOI 10.1016/0165-1218(85)90132-6; Anderson LL, 2009, SCIENCE, V323, P630, DOI 10.1126/science.1166175; AUYEUNG YY, 1995, CIRCULATION, V92, P3318, DOI 10.1161/01.CIR.92.11.3318; BRENNER S, 1974, GENETICS, V77, P71; Divakaruni AS, 2011, PHYSIOLOGY, V26, P192, DOI 10.1152/physiol.00046.2010; Gerczuk PZ, 2012, J AM COLL CARDIOL, V59, P969, DOI 10.1016/j.jacc.2011.07.054; Gong GH, 2013, JOVE-J VIS EXP, DOI 10.3791/50818; Guo S, 2012, CIRC RES, V110, P948, DOI 10.1161/CIRCRESAHA.111.263715; Hu JX, 2013, J APPL TOXICOL, V33, P576, DOI 10.1002/jat.1769; Kagawa N, 2005, FRONT BIOSCI-LANDMRK, V10, P608, DOI 10.2741/1557; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kaufman DM, 2015, CURR BIOL, V25, P2171, DOI 10.1016/j.cub.2015.06.062; Kingma JG, 1996, AM J PHYSIOL-HEART C, V270, pH1165, DOI 10.1152/ajpheart.1996.270.4.H1165; Kosma CI, 2016, SCI TOTAL ENVIRON, V569, P732, DOI 10.1016/j.scitotenv.2016.06.160; Lyche JL, 2009, J TOXICOL ENV HEAL B, V12, P225, DOI 10.1080/10937400903094091; Mabon ME, 2009, GENETICS, V181, P483, DOI 10.1534/genetics.108.097188; MARGOLIASH E, 1958, BIOCHEM J, V68, P468, DOI 10.1042/bj0680468; Menuz V, 2009, SCIENCE, V324, P381, DOI 10.1126/science.1168532; Miller DL, 2009, CURR BIOL, V19, P1233, DOI 10.1016/j.cub.2009.05.066; Morck C, 2009, P NATL ACAD SCI USA, V106, P18285, DOI 10.1073/pnas.0907117106; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; MUNDAY R, 1994, FREE RADICAL RES, V21, P67, DOI 10.3109/10715769409056558; Munday R, 1998, J APPL TOXICOL, V18, P161, DOI 10.1002/(SICI)1099-1263(199803/04)18:2<161::AID-JAT491>3.3.CO;2-V; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; Nistico R, 2008, BRIT J PHARMACOL, V153, P1022, DOI 10.1038/sj.bjp.0707587; Pires PW, 2011, AM J PHYSIOL-HEART C, V301, pH87, DOI 10.1152/ajpheart.01206.2010; Rauthan Manish, 2015, Worm, V4, pe1096490, DOI 10.1080/21624054.2015.1096490; Rauthan M, 2013, P NATL ACAD SCI USA, V110, P5981, DOI 10.1073/pnas.1218778110; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Schwartz J, 2013, TOXICOL APPL PHARM, V273, P172, DOI 10.1016/j.taap.2013.08.027; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Singh AK, 2012, CURR NEUROPHARMACOL, V10, P64, DOI 10.2174/157015912799362779; Singh AK, 2012, NEUROBIOL AGING, V33, P404, DOI 10.1016/j.neurobiolaging.2010.02.018; Sun CL, 2014, CELL DEATH DIFFER, V21, P557, DOI 10.1038/cdd.2013.176; TATENO C, 1993, CELL BIOL TOXICOL, V9, P215, DOI 10.1007/BF00755600; Theruvath TP, 2008, HEPATOLOGY, V47, P236, DOI 10.1002/hep.21912; THOMAS BH, 1990, J PHARM SCI, V79, P321, DOI 10.1002/jps.2600790410; Wojtovich AP, 2012, FEBS LETT, V586, P428, DOI 10.1016/j.febslet.2012.01.021; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496; Yu QJ, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000555	44	5	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176061	10.1371/journal.pone.0176061	http://dx.doi.org/10.1371/journal.pone.0176061			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426808	Green Published, Green Submitted, gold			2022-12-26	WOS:000399875900095
J	Vogeler, S; Galloway, TS; Isupov, M; Bean, TP				Vogeler, Susanne; Galloway, Tamara S.; Isupov, Michail; Bean, Tim P.			Cloning retinoid and peroxisome proliferator-activated nuclear receptors of the Pacific oyster and in silico binding to environmental chemicals	PLOS ONE			English	Article							HIGH-AFFINITY LIGAND; X-RECEPTOR; ENDOCRINE DISRUPTION; ORGANOTIN COMPOUNDS; CRASSOSTREA-GIGAS; GENE-EXPRESSION; ROCK SHELL; ACID; RXR; RAR	Disruption of nuclear receptors, a transcription factor superfamily regulating gene expression in animals, is one proposed mechanism through which pollution causes effects in aquatic invertebrates. Environmental pollutants have the ability to interfere with the receptor's functions through direct binding and inducing incorrect signals. Limited knowledge of invertebrate endocrinology and molecular regulatory mechanisms, however, impede the understanding of endocrine disruptive effects in many aquatic invertebrate species. Here, we isolated three nuclear receptors of the Pacific oyster, Crassostrea gigas: two isoforms of the retinoid X receptor, CgRXR-1 and CgRXR-2, a retinoic acid receptor ortholog CgRAR, and a peroxisome proliferator-activated receptor ortholog CgPPAR. Computer modelling of the receptors based on 3D crystal structures of human proteins was used to predict each receptor's ability to bind to different ligands in silico. CgRXR showed high potential to bind and be activated by 9-cis retinoic acid and the organotin tributyltin (TBT). Computer modelling of CgRAR revealed six residues in the ligand binding domain, which prevent the successful interaction with natural and synthetic retinoid ligands. This supports an existing theory of loss of retinoid binding in molluscan RARs. Modelling of CgPPAR was less reliable due to high discrepancies in sequence to its human ortholog. Yet, there are suggestions of binding to TBT, but not to rosiglitazone. The effect of potential receptor ligands on early oyster development was assessed after 24h of chemical exposure. TBT oxide (0.2 mu g/l), all-trans retinoic acid (ATRA) (0.06 mg/L) and perfluorooctanoic acid (20 mg/L) showed high effects on development (> 74% abnormal developed D-shelled larvae), while rosiglitazone (40 mg/L) showed no effect. The results are discussed in relation to a putative direct (TBT) disruption effect on nuclear receptors. The inability of direct binding of ATRA to CgRAR suggests either a disruptive effect through a pathway excluding nuclear receptors or an indirect interaction. Our findings provide valuable information on potential mechanisms of molluscan nuclear receptors and the effects of environmental pollution on aquatic invertebrates.	[Vogeler, Susanne; Galloway, Tamara S.; Isupov, Michail] Univ Exeter, Coll Life & Environm Sci, Sch Biosci, Exeter, Devon, England; [Vogeler, Susanne; Bean, Tim P.] Ctr Environm Fisheries & Aquaculture Sci, Cefas Weymouth Lab, Weymouth, England	University of Exeter; Centre for Environment Fisheries & Aquaculture Science	Bean, TP (corresponding author), Ctr Environm Fisheries & Aquaculture Sci, Cefas Weymouth Lab, Weymouth, England.	tim.bean@cefas.co.uk	Isupov, Mikhail/AAA-8280-2019; Bean, Tim/H-6792-2014	Vogeler, Susanne/0000-0003-3571-5121; Bean, Tim/0000-0002-2544-9918; Isupov, Michail/0000-0001-6842-4289	Centre for Environment, Fisheries and Aquaculture Science (Cefas); University of Exeter	Centre for Environment, Fisheries and Aquaculture Science (Cefas); University of Exeter	The study was funded by the Centre for Environment, Fisheries and Aquaculture Science (Cefas; https://www.cefas.co.uk) and by the University of Exeter (http://www.exeter.ac.uk).	Abbott BD, 2007, TOXICOL SCI, V98, P571, DOI 10.1093/toxsci/kfm110; Authority EFS, 2012, EFSA J, V10, P10; Bergman A, 2012, TOXICOL LETT, V211, pS3, DOI 10.1016/j.toxlet.2012.03.020; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biasini M., 2014, NUCL ACIDS RES; Bouton D, 2005, J MOL ENDOCRINOL, V34, P567, DOI 10.1677/jme.1.01766; Bridgham JT, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000497; Carter CJ, 2015, J EXP ZOOL PART B, V324, P51, DOI 10.1002/jez.b.22604; Carter CJ, 2010, DEV BIOL, V343, P124, DOI 10.1016/j.ydbio.2010.03.023; Cheng XG, 2008, TOXICOL SCI, V106, P37, DOI 10.1093/toxsci/kfn161; CRETON R, 1993, DEV GROWTH DIFFER, V35, P357; Dawson MI, 2012, BBA-MOL CELL BIOL L, V1821, P21, DOI 10.1016/j.bbalip.2011.09.014; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Egea PF, 2000, EMBO J, V19, P2592, DOI 10.1093/emboj/19.11.2592; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FORMAN BM, 1995, CELL, V81, P541, DOI 10.1016/0092-8674(95)90075-6; Germain P, 2004, EMBO REP, V5, P877, DOI 10.1038/sj.embor.7400235; Germain P, 2006, PHARMACOL REV, V58, P685, DOI 10.1124/pr.58.4.2; Gervois P, 1999, MOL ENDOCRINOL, V13, P400, DOI 10.1210/me.13.3.400; Gesto M, 2013, AQUAT TOXICOL, V142, P96, DOI 10.1016/j.aquatox.2013.08.001; Giesy JP, 2010, AQUATIC TOXICOLOGY P, P1; Gore AC, 2015, ENDOCR REV, V36, pE1, DOI 10.1210/er.2015-1010; Grun F, 2006, MOL ENDOCRINOL, V20, P2141, DOI 10.1210/me.2005-0367; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gutierrez-Mazariegos J, 2014, ENDOCRINOLOGY, V155, P4275, DOI 10.1210/en.2014-1181; Harada S, 2015, SCI REPORTS, P5; Helsen C, 2014, MOL CELL ENDOCRINOL, V382, P97, DOI 10.1016/j.mce.2013.09.009; Heral M., 1989, AQUACULTURE BIOTECHN, P1081; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; Higuera-Ruiz R, 2011, ENVIRON TECHNOL, V32, P583, DOI 10.1080/09593330.2010.506201; Horiguchi T, 2007, AQUAT TOXICOL, V84, P379, DOI 10.1016/j.aquatox.2007.06.019; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Idres N, 2002, J BIOL CHEM, V277, P31491, DOI 10.1074/jbc.M205016200; Ijpenberg A, 1997, J BIOL CHEM, V272, P20108, DOI 10.1074/jbc.272.32.20108; Inoue D, 2010, J HEALTH SCI, V56, P221, DOI 10.1248/jhs.56.221; IPCS IPoCS, 1990, TRIB COMP ENV HLTH C; Kam RKT, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-11; Kamata R, 2008, TOXICOL IN VITRO, V22, P1050, DOI 10.1016/j.tiv.2008.01.002; Kanayama T, 2005, MOL PHARMACOL, V67, P766, DOI 10.1124/mol.104.008409; Kaur S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121259; Klaholz BP, 1998, NAT STRUCT BIOL, V5, P199, DOI 10.1038/nsb0398-199; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; LAUGHLIN RB, 1986, ENVIRON SCI TECHNOL, V20, P201, DOI 10.1021/es00144a016; le Maire A, 2009, EMBO REP, V10, P367, DOI 10.1038/embor.2009.8; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; Leverett D, 2013, OYSTER EMBRYO LARVAL; Levin AA, 1992, 9 CIS RETINOIC ACID; Liberato MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036297; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Matthiessen P, 1998, ENVIRON TOXICOL CHEM, V17, P37, DOI 10.1002/etc.5620170106; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Mhadhbi L, 2012, J ENVIRON MONITOR, V14, P1375, DOI 10.1039/c2em30037k; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Nishikawa J, 2004, ENVIRON SCI TECHNOL, V38, P6271, DOI 10.1021/es049593u; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Pascoal S, 2013, MOL ECOL, V22, P1589, DOI 10.1111/mec.12137; Pignatello MA, 1997, TOXICOL APPL PHARM, V142, P319, DOI 10.1006/taap.1996.8047; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; RUIZ JM, 1995, MAR ENVIRON RES, V40, P363, DOI 10.1016/0141-1136(94)00154-H; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Shmarakov IO, 2015, HEPATOL SURG NUTR, V4, P243, DOI 10.3978/j.issn.2304-3881.2015.05.05; SOPRANO DR, 1995, ANNU REV NUTR, V15, P111, DOI 10.1146/annurev.nu.15.070195.000551; THAIN JE, 1986, WATER SCI TECHNOL, V18, P193, DOI 10.2166/wst.1986.0195; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tsunemasa N, 2011, ARCH ENVIRON CON TOX, V61, P128, DOI 10.1007/s00244-010-9598-y; Urushitani H, 2013, AQUAT TOXICOL, V142, P403, DOI 10.1016/j.aquatox.2013.09.008; Urushitani H, 2011, AQUAT TOXICOL, V103, P101, DOI 10.1016/j.aquatox.2011.02.012; Vanden Heuvel JP, 2006, TOXICOL SCI, V92, P476, DOI 10.1093/toxsci/kfl014; Vierke Lena, 2012, Environmental Sciences Europe, V24, P1, DOI 10.1186/2190-4715-24-16; Vogeler S, 2016, BMC DEV BIOL, V16, DOI 10.1186/s12861-016-0129-6; Vogeler S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-369; WALDOCK MJ, 1983, MAR POLLUT BULL, V14, P411, DOI 10.1016/0025-326X(83)90445-9; WAN YJY, 1994, EXP CELL RES, V210, P56, DOI 10.1006/excr.1994.1009; Wan YJY, 1998, EXP CELL RES, V238, P241, DOI 10.1006/excr.1997.3851; Wu WJ, 2008, EXP PARASITOL, V120, P208, DOI 10.1016/j.exppara.2008.07.005; Yamashita N, 2005, MAR POLLUT BULL, V51, P658, DOI 10.1016/j.marpolbul.2005.04.026; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; ZECHEL C, 1994, EMBO J, V13, P1425, DOI 10.1002/j.1460-2075.1994.tb06396.x; ZECHEL C, 1994, EMBO J, V13, P1414, DOI 10.1002/j.1460-2075.1994.tb06395.x; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang X-k, 1992, HOMODIMER FORMATION	84	26	26	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176024	10.1371/journal.pone.0176024	http://dx.doi.org/10.1371/journal.pone.0176024			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426724	Green Submitted, Green Published, gold			2022-12-26	WOS:000399875900087
J	Ma, HW; Yang, F; Butler, MR; Belcher, J; Redmond, TM; Placzek, AT; Scanlan, TS; Ding, XQ				Ma, Hongwei; Yang, Fan; Butler, Michael R.; Belcher, Joshua; Redmond, T. Michael; Placzek, Andrew T.; Scanlan, Thomas S.; Ding, Xi-Qin			Inhibition of thyroid hormone receptor locally in the retina is a therapeutic strategy for retinal degeneration	FASEB JOURNAL			English	Article						cone degeneration; Leber congenital amaurosis; cone dystrophy; TR antagonist	ENDOPLASMIC-RETICULUM STRESS; CONE OPSIN EXPRESSION; PHOTORECEPTOR DEGENERATION; CELL-DEATH; DEVELOPMENTAL EXPRESSION; TOPICAL APPLICATION; TYPE-3 DEIODINASE; GENE-EXPRESSION; DOWN-REGULATION; ANTAGONIST	Thyroid hormone (TH) signaling regulates cell proliferation, differentiation, and metabolism. Recent studies have implicated TH signaling in cone photoreceptor viability. Using mouse models of retinal degeneration, we demonstrated that antithyroid drug treatment and targeting iodothyronine deiodinases (DIOs) to suppress cellular tri-iodothyronine (T3) production or increase T3 degradation preserves cones. In this work, we investigated the effectiveness of inhibition of the TH receptor (TR). Two genes, THRA and THRB, encode TRs; THRB2 has been associated with cone viability. Using TR antagonists and Thrb2 deletion, we examined the effects of TR inhibition. Systemic and ocular treatment with the TR antagonists NH-3 and 1-850 increased cone density by 30-40% in the Rpe65(-/-) mouse model of Leber congenital amaurosis and reduced the number of TUNEL+ cells. Cone survival was significantly improved in Rpe65(-/-) and Cpfl1 (a model of achromatopsia with Pde6c defect) mice with Thrb2 deletion. Ventral cone density in Cpfl1/Thrb2(-/-) and Rpe65(-/-)/Thrb2(-/-) mice was increased by 1- to 4-fold, compared with age-matched controls. Moreover, the expression levels of TR were significantly higher in the cone-degeneration retinas, suggesting locally elevated TR signaling. This work shows that the effects of antithyroid treatment or targeting DIOs were likely mediated by TRs and that suppressing TR protects cones. Our findings support the view that inhibition of TR locally in the retina is a therapeutic strategy for retinal degeneration management.	[Ma, Hongwei; Yang, Fan; Butler, Michael R.; Belcher, Joshua; Ding, Xi-Qin] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, 940 Stanton L Young Blvd,BMSB 553, Oklahoma City, OK 73104 USA; [Redmond, T. Michael] NEI, Lab Retinal Cell & Mol Biol, NIH, Bethesda, MD 20892 USA; [Placzek, Andrew T.; Scanlan, Thomas S.] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Oregon Health & Science University	Ding, XQ (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, 940 Stanton L Young Blvd,BMSB 553, Oklahoma City, OK 73104 USA.	xi-qin-ding@ouhsc.edu	Yang, Fan/I-5735-2019	Redmond, T. Michael/0000-0002-1813-5291	U.S. NIH/NEI [P30EY021725, T32EY023202, R01EY019490, R21EY024583]; NIH/ NIDDK [DK-52798]; Foundation Fighting Blindness; Knights Templar Eye Foundation; NATIONAL EYE INSTITUTE [R21EY024583, P30EY021725, T32EY023202, R01EY019490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052798, R56DK052798] Funding Source: NIH RePORTER	U.S. NIH/NEI; NIH/ NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Foundation Fighting Blindness(European Commission); Knights Templar Eye Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. Anand Swaroop [U.S. National Institutes of Health (NIH) National Eye Institute (NEI)] for Nrl<SUP>-/-</SUP> mouse line, Dr. Douglas Forrest [NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)] for Thrb2<SUP>-/-</SUP> mouse line, Dr. Bruce Baretz (Lipoid LLC, Newark, NJ, USA) for Phospholipon 90G, and Drs. Cheryl Craft (University of Southern California, Los Angeles, CA, USA), Douglas Forrest, and Muna Naash (University of Houston, Houston, TX, USA) for antibodies against M-opsin, cone arrestin, THRB2, and S-opsin; Dr. Douglas Forrest for a critical reading of the manuscript; and the Imaging Core Facility of the Department of Cell Biology at the University of Oklahoma Health Sciences Center for technical assistance. This work was supported by U.S. NIH/NEI Grants P30EY021725, T32EY023202 (to H.M.), R01EY019490, and R21EY024583 (to X.-Q.D.), NIH/ NIDDK Grant DK-52798 (to T.S.S.), the Foundation Fighting Blindness (to X.-Q.D.), and the Knights Templar Eye Foundation (to H.M.).	Applebury ML, 2007, DEV DYNAM, V236, P1203, DOI 10.1002/dvdy.21155; Brent GA, 2012, J CLIN INVEST, V122, P3035, DOI 10.1172/JCI60047; Ceresini G, 2009, J AM GERIATR SOC, V57, P89, DOI 10.1111/j.1532-5415.2008.02080.x; Chaker L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0329-0; Chang B, 2009, P NATL ACAD SCI USA, V106, P19581, DOI 10.1073/pnas.0907720106; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Chiloeches A, 2008, MOL ENDOCRINOL, V22, P2466, DOI 10.1210/me.2008-0107; Deeb SS, 2010, OPHTHAL PHYSL OPT, V30, P446, DOI 10.1111/j.1475-1313.2010.00735.x; Ding XQ, 2009, HUM MOL GENET, V18, P4770, DOI 10.1093/hmg/ddp440; Dunaief JL, 2002, ARCH OPHTHALMOL-CHIC, V120, P1435, DOI 10.1001/archopht.120.11.1435; Feathers KL, 2008, INVEST OPHTH VIS SCI, V49, P1126, DOI 10.1167/iovs.07-1234; Flamant F, 2006, PHARMACOL REV, V58, P705, DOI 10.1124/pr.58.4.3; Forrest D, 2002, CURR OPIN NEUROBIOL, V12, P49, DOI 10.1016/S0959-4388(02)00289-1; Glaschke A, 2011, J NEUROSCI, V31, P4844, DOI 10.1523/JNEUROSCI.6181-10.2011; Glaschke A, 2010, INVEST OPHTH VIS SCI, V51, P1719, DOI 10.1167/iovs.09-3592; Gopinath B, 2016, INVEST OPHTH VIS SCI, V57, P5273, DOI 10.1167/iovs.16-19735; Gorbatyuk MS, 2010, P NATL ACAD SCI USA, V107, P5961, DOI 10.1073/pnas.0911991107; Grover GJ, 2007, J PHARMACOL EXP THER, V322, P385, DOI 10.1124/jpet.106.116152; Hiroi Y, 2006, P NATL ACAD SCI USA, V103, P14104, DOI 10.1073/pnas.0601600103; Hwang JY, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.200436; Kalmijn S, 2000, CLIN ENDOCRINOL, V53, P733, DOI 10.1046/j.1365-2265.2000.01146.x; Kalyanaraman H, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004911; Komeima K, 2006, P NATL ACAD SCI USA, V103, P11300, DOI 10.1073/pnas.0604056103; Kunchithapautham K, 2009, INVEST OPHTH VIS SCI, V50, P4858, DOI 10.1167/iovs.08-3008; Leaderer D, 2015, EXP EYE RES, V140, P171, DOI 10.1016/j.exer.2015.09.005; Lim W, 2002, J BIOL CHEM, V277, P35664, DOI 10.1074/jbc.M205608200; Liu Y, 2007, VISION RES, V47, P2314, DOI 10.1016/j.visres.2007.04.023; Lu AL, 2009, ENDOCRINOLOGY, V150, P1536, DOI 10.1210/en.2008-1092; Ma HW, 2015, J BIOL CHEM, V290, P20880, DOI 10.1074/jbc.M115.641159; Ma HW, 2014, P NATL ACAD SCI USA, V111, P3602, DOI 10.1073/pnas.1317041111; Ma HW, 2013, HUM MOL GENET, V22, P3906, DOI 10.1093/hmg/ddt245; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Mihara S, 1999, J CLIN ENDOCR METAB, V84, P1378, DOI 10.1210/jc.84.4.1378; Ng L, 2010, J NEUROSCI, V30, P3347, DOI 10.1523/JNEUROSCI.5267-09.2010; Ng L, 2009, NEUROREPORT, V20, P627, DOI 10.1097/WNR.0b013e32832a2c63; Ng L, 2009, ENDOCRINOLOGY, V150, P1952, DOI 10.1210/en.2008-1419; Nguyen NH, 2005, J AM CHEM SOC, V127, P4599, DOI 10.1021/ja0440093; Nguyen NH, 2002, J MED CHEM, V45, P3310, DOI 10.1021/jm0201013; Peeters RP, 2013, ENDOCRINOLOGY, V154, P550, DOI 10.1210/en.2012-1738; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Roberts MR, 2006, P NATL ACAD SCI USA, V103, P6218, DOI 10.1073/pnas.0509981103; Rohrer B, 2005, INVEST OPHTH VIS SCI, V46, P3876, DOI 10.1167/iovs.05-0533; Rowe-Rendleman CL, 2014, INVEST OPHTH VIS SCI, V55, P2714, DOI 10.1167/iovs.13-13707; Sanges D, 2006, P NATL ACAD SCI USA, V103, P17366, DOI 10.1073/pnas.0606276103; Sar P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020861; Schaeferhoff K, 2010, CELL MOL LIFE SCI, V67, P3173, DOI 10.1007/s00018-010-0376-9; Schapira M, 2003, P NATL ACAD SCI USA, V100, P7354, DOI 10.1073/pnas.1131854100; Scheppke L, 2008, J CLIN INVEST, V118, P2337, DOI [10.1172/JC133361, 10.1172/JCI33361]; Schopf LR, 2015, TRANSL VIS SCI TECHN, V4, DOI 10.1167/tvst.4.3.11; Shah V, 2008, MOL CELL ENDOCRINOL, V296, P69, DOI 10.1016/j.mce.2008.09.016; Shahrara S, 1999, AM J VET RES, V60, P848; Shen JK, 2005, J CELL PHYSIOL, V203, P457, DOI 10.1002/jcp.20346; SJOBERG M, 1992, DEVELOPMENT, V114, P39; Thapa A, 2012, J BIOL CHEM, V287, P18018, DOI 10.1074/jbc.M112.342220; Wang S, 2012, CURR DIABETES REP, V12, P355, DOI 10.1007/s11892-012-0289-0; Xu JH, 2013, J NEUROSCI, V33, P14939, DOI 10.1523/JNEUROSCI.0909-13.2013; Xu JH, 2011, INVEST OPHTH VIS SCI, V52, P3557, DOI 10.1167/iovs.10-6358; Yamada-Okabe T, 2003, EUR J BIOCHEM, V270, P3064, DOI 10.1046/j.1432-1033.2003.03686.x; Yamaguchi S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2088; Yang F, 2016, FASEB J, V30, P4313, DOI 10.1096/fj.201600715R; Yang LP, 2007, INVEST OPHTH VIS SCI, V48, P5191, DOI 10.1167/iovs.07-0512; Yoshida T, 2012, EXP EYE RES, V94, P41, DOI 10.1016/j.exer.2011.11.003; Zhang T, 2015, HUM MOL GENET, V24, P1755, DOI 10.1093/hmg/ddu588; Zhang T, 2011, P NATL ACAD SCI USA, V108, P8879, DOI 10.1073/pnas.1017127108; Znoiko SL, 2005, INVEST OPHTH VIS SCI, V46, P1473, DOI 10.1167/iovs.04-0653	65	6	6	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3425	3438		10.1096/fj.201601166RR	http://dx.doi.org/10.1096/fj.201601166RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28428265	Green Published			2022-12-26	WOS:000405932400021
J	Plain, F; Congreve, SD; Yee, RSZ; Kennedy, J; Howie, J; Kuo, CW; Fraser, NJ; Fuller, W				Plain, Fiona; Congreve, Samitha Dilini; Yee, Rachel Sue Zhen; Kennedy, Jennifer; Howie, Jacqueline; Kuo, Chien-Wen; Fraser, Niall J.; Fuller, William			An amphipathic -helix directs palmitoylation of the large intracellular loop of the sodium/calcium exchanger	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acyltransferase; calcium transport; protein acylation; protein palmitoylation; sodium transport; sodium-calcium exchange	SARCOLEMMAL NA+-CA2+ EXCHANGER; SODIUM-CALCIUM EXCHANGE; NA+/CA2+ EXCHANGER; S-PALMITOYLATION; SITES; IDENTIFICATION; INACTIVATION; RECOGNITION; PREDICTION; MECHANISM	The electrogenic sodium/calcium exchanger (NCX) mediates bidirectional calcium transport controlled by the transmembrane sodium gradient. NCX inactivation occurs in the absence of phosphatidylinositol 4,5-bisphosphate and is facilitated by palmitoylation of a single cysteine at position 739 within the large intracellular loop of NCX. The aim of this investigation was to identify the structural determinants of NCX1 palmitoylation. Full-length NCX1 (FL-NCX1) and a YFP fusion protein of the NCX1 large intracellular loop (YFP-NCX1) were expressed in HEK cells. Single amino acid changes around Cys-739 in FL-NCX1 and deletions on the N-terminal side of Cys-739 in YFP-NCX1 did not affect NCX1 palmitoylation, with the exception of the rare human polymorphism S738F, which enhanced FL-NCX1 palmitoylation, and D741A, which modestly reduced it. In contrast, deletion of a 21-amino acid segment enriched in aromatic amino acids on the C-terminal side of Cys-739 abolished YFP-NCX1 palmitoylation. We hypothesized that this segment forms an amphipathic -helix whose properties facilitate Cys-739 palmitoylation. Introduction of negatively charged amino acids to the hydrophobic face or of helix-breaking prolines impaired palmitoylation of both YFP-NCX1 and FL-NCX1. Alanine mutations on the hydrophilic face of the helix significantly reduced FL-NCX1 palmitoylation. Of note, when the helix-containing segment was introduced adjacent to cysteines that are not normally palmitoylated, they became palmitoylation sites. In conclusion, we have identified an amphipathic -helix in the NCX1 large intracellular loop that controls NCX1 palmitoylation. NCX1 palmitoylation is governed by a distal secondary structure element rather than by local primary sequence.	[Plain, Fiona; Congreve, Samitha Dilini; Yee, Rachel Sue Zhen; Kennedy, Jennifer; Howie, Jacqueline; Kuo, Chien-Wen; Fraser, Niall J.; Fuller, William] Univ Dundee, Div Mol & Clin Med, Sch Med, Ninewells Hosp, Dundee DD1 9SY, Scotland	University of Dundee	Fuller, W (corresponding author), Ninewells Hosp, Div Mol & Clin Med, Mail Box 12,Level 5, Dundee DD1 9SY, Scotland.	w.fuller@dundee.ac.uk		Fraser, Niall/0000-0001-7349-5647; Yee, Rachel Sue Zhen/0000-0001-6737-1947; Fuller, William/0000-0002-5883-4433	British Heart Foundation [RG/12/4/29426, PG/16/33/32134, FS/14/68/30988]; British Heart Foundation [SP/16/3/32317, PG/12/6/29366, FS/13/22/30126, RG/17/15/33106] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was supported by British Heart Foundation Grants RG/12/4/29426 and PG/16/33/32134 (to W. F.) and Grant FS/14/68/30988 (to W. F. and N. J. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Blanc Mathieu, 2015, F1000Res, V4, P261, DOI 10.12688/f1000research.6464.1; Chaptal V, 2009, J BIOL CHEM, V284, P14688, DOI 10.1074/jbc.C900037200; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Fukata Y, 2016, CURR TOP MEMBR, V77, P97, DOI 10.1016/bs.ctm.2015.10.003; Fuller W, 2016, CHANNELS, V10, P75, DOI 10.1080/19336950.2015.1099329; Giladi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039985; Hilge M, 2009, P NATL ACAD SCI USA, V106, P14333, DOI 10.1073/pnas.0902171106; HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P905, DOI 10.1085/jgp.100.6.905; Howie J, 2014, P NATL ACAD SCI USA, V111, P17534, DOI 10.1073/pnas.1413627111; John SA, 2011, P NATL ACAD SCI USA, V108, P1699, DOI 10.1073/pnas.1016114108; Kumari B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089246; Lemonidis K, 2015, J BIOL CHEM, V290, P21939, DOI 10.1074/jbc.M115.657668; Lemonidis K, 2014, MOL BIOL CELL, V25, P3870, DOI 10.1091/mbc.E14-06-1169; Li SY, 2015, J CHEM INF MODEL, V55, P2015, DOI 10.1021/acs.jcim.5b00276; Liao J, 2012, SCIENCE, V335, P686, DOI 10.1126/science.1215759; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; Maack C, 2005, CIRC RES, V96, P91, DOI 10.1161/01.RES.0000151334.48676.68; Matsuoka S, 1997, J GEN PHYSIOL, V109, P273, DOI 10.1085/jgp.109.2.273; MATSUOKA S, 1993, P NATL ACAD SCI USA, V90, P3870, DOI 10.1073/pnas.90.9.3870; Nadolski MJ, 2009, J BIOL CHEM, V284, P17720, DOI 10.1074/jbc.M109.005447; Nicoll DA, 1999, J BIOL CHEM, V274, P910, DOI 10.1074/jbc.274.2.910; Ottolia M, 2009, J BIOL CHEM, V284, P32735, DOI 10.1074/jbc.M109.055434; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Reddy K. D., 2016, J BIOMOL STRUCT DYN, V2016, P1; Reilly L, 2015, FASEB J, V29, P4532, DOI 10.1096/fj.15-276493; Remenyi A, 2006, CURR OPIN STRUC BIOL, V16, P676, DOI 10.1016/j.sbi.2006.10.008; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Ren XY, 2013, J MOL CELL CARDIOL, V57, P68, DOI 10.1016/j.yjmcc.2013.01.010; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Shipston MJ, 2011, J BIOL CHEM, V286, P8709, DOI 10.1074/jbc.R110.210005; Thomas GM, 2012, NEURON, V73, P482, DOI 10.1016/j.neuron.2011.11.021	32	30	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10745	10752		10.1074/jbc.M116.773945	http://dx.doi.org/10.1074/jbc.M116.773945			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28432123	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000404115400034
J	de Souza, VA; Oliveira, D; Barbosa, SR; Correa, JOD; Colugnati, FAB; Mansur, HN; Fernandes, NMD; Bastos, MG				de Souza, Viviane Angelina; Oliveira, Dilmerson; Barbosa, Sergio Ribeiro; do Amaral Correa, Jose Otavio; Basile Colugnati, Fernando Antonio; Mansur, Henrique Novais; da Silva Fernandes, Natalia Maria; Bastos, Marcus Gomes			Sarcopenia in patients with chronic kidney disease not yet on dialysis: Analysis of the prevalence and associated factors	PLOS ONE			English	Article							MUSCLE MASS; HEMODIALYSIS-PATIENTS; OLDER PERSONS; INFLAMMATION; OBESITY; MORTALITY; CONSENSUS; STRENGTH; MARKER	Introduction Sarcopenia is a chronic condition that is associated with aging and characterized by a reduction of muscle mass, strength, and function. Sarcopenia is prevalent in patients with chronic kidney disease (CKD) and associated with increased morbidity and mortality, as well as cardiovascular complications. Objectives To investigate the prevalence of sarcopenia in patients with CKD not yet on dialysis and its correlation with clinical and laboratory variables and inflammatory markers. Methods A total of 100 patients of both sexes aged over 18 were evaluated. Sarcopenia was defined using the criteria of the European Working Group on Sarcopenia in Older People (EWGSOP) and of the Foundation for the National Institutes of Health (FNIH) Sarcopenia Project. Sociodemographic and clinical data, activities of daily living, functional capacity, and physical activity were also evaluated. Inflammation was assessed by the serum levels of highsensitivity C-reactive protein (hsCRP) and interleukin (IL) 4 and 6. Results The prevalence of sarcopenia was 11.9% and 28.7% using the EWGSOP and FNIH criteria, respectively. Sarcopenia was more prevalent in the more advanced stages of CKD (34.5% in stages 2 and 3A; and 65.5% in stages 3B, 4, and 5) and associated with worse performance in activities of daily living (p = 0.049), lower walking speeds (p < 0.001), and higher body mass indexes (BMIs) (p = 0.001) in the non-adjusted model. In addition, patients with sarcopenia had lower functional capacity (p = 0.012) and higher prevalence of physical inactivity (p = 0.041) compared with patients without sarcopenia. After adjustment for confounding variables, sarcopenia was still significantly correlated with walking speed (p = 0.004) and BMI (p = 0.002). HsCRP levels were inversely correlated with appendicular lean mass adjusted for BMI (p = 0.007) and were also positively associated with BMI (p = 0.001). IL4 levels were positively correlated with walking speed (p = 0.007) and lean mass in the lower limbs (p = 0.022). Conclusions Sarcopenia is common in patients with CKD, particularly in the most advanced stages of the disease. We observed an association between the levels of inflammatory markers and peripheral lean body mass, physical performance, and BMI. This association between sarcopenia and modifiable factors highlights the importance of early diagnosis and the implementation of therapeutic measures to minimize adverse outcomes in patients with CKD not yet on dialysis.	[de Souza, Viviane Angelina; Barbosa, Sergio Ribeiro; da Silva Fernandes, Natalia Maria; Bastos, Marcus Gomes] Univ Fed Juiz de Fora, Sch Med, Dept Clin Med, Juiz De Fora, Brazil; [Oliveira, Dilmerson] UNIFAMINAS, Sch Phys Educ, Dept Anat, Muriae, Brazil; [do Amaral Correa, Jose Otavio] Univ Fed Juiz de Fora, Sch Pharm, Dept Pharmaceut Sci, Juiz De Fora, Brazil; [Basile Colugnati, Fernando Antonio] Univ Fed Juiz de Fora, Sch Med, Internship Dept, Juiz De Fora, Brazil; [Mansur, Henrique Novais] Fed Inst Educ Sci & Technol Southeast Minas Gerai, Sch Phys Educ, Dept Educ, Campus Rio Pomba, Rio Pomba, Brazil	Universidade Federal de Juiz de Fora; Universidade Federal de Juiz de Fora; Universidade Federal de Juiz de Fora; Instituto Federal do Sudeste de Minas Gerais	de Souza, VA (corresponding author), Univ Fed Juiz de Fora, Sch Med, Dept Clin Med, Juiz De Fora, Brazil.	vivi.reumato@gmail.com	Corrêa, José Otávio do Amaral/AAE-8042-2021; Souza, Viviane/AAU-2771-2021; Colugnati, Fernando A. B./G-1892-2012; Oliveira, Dilmerson/AAC-4729-2021; Colugnati, Fernando/AAQ-9237-2020; Bastos, Marcus/AAM-5255-2020; Fernandes, Natalia M S/J-1307-2016	Colugnati, Fernando/0000-0002-8288-203X; Fernandes, Natalia M S/0000-0001-8728-7937				Bano G, 2017, MATURITAS, V96, P10, DOI 10.1016/j.maturitas.2016.11.006; Batsis J.A., 2016, CLIN NUTR; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Carmeli E, 2012, ARCH GERONTOL GERIAT, V55, P181, DOI 10.1016/j.archger.2011.06.032; Cesari M, 2005, AM J CLIN NUTR, V82, P428, DOI 10.1093/ajcn/82.2.428; Ciconelli RM, 1998, ERV BRAS REUMATOLOGI, V39, P143; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Derbre F, 2014, EUR J SPORT SCI, V14, pS98, DOI 10.1080/17461391.2011.654268; Dogan MH, 2012, ACTA CLIN BELG, V67, P328, DOI 10.2143/ACB.67.5.2062685; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fahal IH, 2014, NEPHROL DIAL TRANSPL, V29, P1655, DOI 10.1093/ndt/gft070; Foley RN, 2007, AM J NEPHROL, V27, P279, DOI 10.1159/000101827; Han E, 2016, METABOLISM, V65, P1531, DOI 10.1016/j.metabol.2016.07.003; Hirai Keiji, 2016, Nephrourol Mon, V8, pe37443, DOI 10.5812/numonthly.37443; Honda H, 2007, AM J CLIN NUTR, V86, P633, DOI 10.1093/ajcn/86.3.633; Ikizler TA, 1999, KIDNEY INT, V55, P1945, DOI 10.1046/j.1523-1755.1999.00410.x; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Kalantar-Zadeh K, 2010, MAYO CLIN PROC, V85, P991, DOI 10.4065/mcp.2010.0336; Kim JK, 2014, CLIN NUTR, V33, P64, DOI 10.1016/j.clnu.2013.04.002; Kim TN, 2010, DIABETES CARE, V33, P1497, DOI 10.2337/dc09-2310; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Leavey SF, 2001, NEPHROL DIAL TRANSPL, V16, P2386, DOI 10.1093/ndt/16.12.2386; Lee JSW, 2007, GERONTOLOGY, V53, P404, DOI 10.1159/000107355; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Malachias MVB, 2016, ARQ BRAS CARDIOL, V107, P1, DOI 10.5935/abc.20160140; Manini TM, 2012, J GERONTOL A-BIOL, V67, P28, DOI 10.1093/gerona/glr010; McLean RR, 2015, J BONE MINER RES, V30, P588, DOI 10.1002/jbmr.2492; Metter EJ, 2002, J GERONTOL A-BIOL, V57, pB359, DOI 10.1093/gerona/57.10.B359; Moon SH, 2008, GUT LIVER, V2, P1, DOI 10.5009/gnl.2008.2.1.1; Patel SS, 2013, J CACHEXIA SARCOPENI, V4, P19, DOI 10.1007/s13539-012-0079-1; Pereira RA, 2015, NEPHROL DIAL TRANSPL, V30, P1718, DOI 10.1093/ndt/gfv133; Pillard F, 2011, CLIN GERIATR MED, V27, P449, DOI 10.1016/j.cger.2011.03.009; Rosenberg IH, 1997, J NUTR, V127, pS990, DOI 10.1093/jn/127.5.990S; Lino VTS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166373; Schaap LA, 2009, J GERONTOL A-BIOL, V64, P1183, DOI 10.1093/gerona/glp097; Sharma D, 2014, CLIN J AM SOC NEPHRO, V9, P2079, DOI 10.2215/CJN.02140214; Souza Viviane Angelina de, 2015, J Bras Nefrol, V37, P98, DOI 10.5935/0101-2800.20150014; TAYLOR HL, 1978, J CHRON DIS, V31, P741, DOI 10.1016/0021-9681(78)90058-9; Walston JD, 2012, CURR OPIN RHEUMATOL, V24, P623, DOI 10.1097/BOR.0b013e328358d59b	39	99	117	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176230	10.1371/journal.pone.0176230	http://dx.doi.org/10.1371/journal.pone.0176230			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET6EL	28448584	Green Published, gold, Green Submitted			2022-12-26	WOS:000400383600048
J	Fukuda, T; Nomura, M; Kato, Y; Tojo, H; Fujii, K; Nagao, T; Bando, Y; Fehniger, TE; Marko-Varga, G; Nakamura, H; Kato, H; Nishimura, T				Fukuda, Tetsuya; Nomura, Masaharu; Kato, Yasufumi; Tojo, Hiromasa; Fujii, Kiyonaga; Nagao, Toshitaka; Bando, Yasuhiko; Fehniger, Thomas E.; Marko-Varga, Gyorgy; Nakamura, Haruhiko; Kato, Harubumi; Nishimura, Toshihide			A selected reaction monitoring mass spectrometric assessment of biomarker candidates diagnosing large-cell neuroendocrine lung carcinoma by the scaling method using endogenous references	PLOS ONE			English	Article							APOLIPOPROTEIN-A-I; PROTEOMIC ANALYSIS; ABSOLUTE QUANTIFICATION; STEM-CELLS; CANCER; PROTEINS; ADENOCARCINOMA; EXPRESSION; MARKER; TUMORS	Selected reaction monitoring mass spectrometry (SRM-MS) -based semi-quantitation was performed to assess the validity of 46 selected candidate proteins for specifically diagnosing large-cell neuroendocrine lung carcinoma (LCNEC) and differentiating it from other lung cancer subtypes. The scaling method was applied in this study using specific SRM peak areas (AUCs) derived from the endogenous reference protein that normalizes all SRM AUCs obtained for the candidate proteins. In a screening verification study, we found that seven out of the 46 candidate proteins were statistically significant for the LCNEC phenotype, including 4F2hc cell surface antigen heavy chain (4F2hc/CD98) (p-ANOVA <= 0.0012), retinal dehydrogenase 1 (p-ANOVA <= 0.0029), apolipoprotein A-I (p-ANOVA <= 0.0004), beta-enolase (p-ANOVA <= 0.0043), creatine kinase B-type (p-ANOVA <= 0.0070), and galectin3- binding protein (p-ANOVA = 0.0080), and phosphatidylethanolamine-binding protein 1 (p-ANOVA <= 0.0012). In addition, we also identified candidate proteins specific to the small-cell lung carcinoma (SCLC) subtype. These candidates include brain acid soluble protein 1 (p-ANOVA < 0.0001) and.-enolase (p-ANOVA <= 0.0013). This new relative quantitation-based approach utilizing the scaling method can be applied to assess hundreds of protein candidates obtained from discovery proteomic studies as a first step of the verification phase in biomarker development processes.	[Fukuda, Tetsuya; Bando, Yasuhiko] Biosys Technol Inc, Tokyo, Japan; [Nomura, Masaharu; Kato, Harubumi] Tokyo Med Univ, Dept Thorac & Thyroid Surg, Tokyo, Japan; [Kato, Yasufumi] Tokyo Med Univ, Dept Thorac Surg, Ibaraki Med Ctr, Ibaraki, Japan; [Tojo, Hiromasa] Osaka Univ, Dept Biophys & Biochem, Grad Sch Med, Osaka, Japan; [Fujii, Kiyonaga; Nakamura, Haruhiko; Nishimura, Toshihide] St Mariana Univ, Dept Translat Med Informat, Sch Med, Kawasaki, Kanagawa, Japan; [Nagao, Toshitaka] Tokyo Med Univ, Dept Clin Pathol, Tokyo, Japan; [Fehniger, Thomas E.; Marko-Varga, Gyorgy; Nishimura, Toshihide] Lund Univ, Ctr Excellence Biol & Med Mass Spectrometry, Lund, Sweden; [Fehniger, Thomas E.; Marko-Varga, Gyorgy] Lund Univ, Dept Biomed Engn, Biomed Ctr, Clin Prot Sci & Imaging, Lund, Sweden; [Nakamura, Haruhiko] St Marianna Univ, Sch Med, Dept Chest Surg, Kawasaki, Kanagawa, Japan; [Kato, Harubumi] Niizashiki Cent Gen Hosp, Chest Surg, Saitama, Japan; [Nomura, Masaharu] Shingoh Cent Clin, Internal Med, Saitama, Japan	Tokyo Medical University; Tokyo Medical University; Osaka University; Saint Marianna University; Tokyo Medical University; Lund University; Lund University; Saint Marianna University	Nishimura, T (corresponding author), St Mariana Univ, Dept Translat Med Informat, Sch Med, Kawasaki, Kanagawa, Japan.; Nishimura, T (corresponding author), Lund Univ, Ctr Excellence Biol & Med Mass Spectrometry, Lund, Sweden.	t-nisimura@marianna-u.ac.jp						Abbatiello SE, 2010, CLIN CHEM, V56, P291, DOI 10.1373/clinchem.2009.138420; Anderson L, 2006, MOL CELL PROTEOMICS, V5, P573, DOI 10.1074/mcp.M500331-MCP200; Baker M, 2015, NATURE, V521, P274, DOI 10.1038/521274a; Bantscheff M, 2012, ANAL BIOANAL CHEM, V404, P939, DOI 10.1007/s00216-012-6203-4; Battafarano RJ, 2005, J THORAC CARDIOV SUR, V130, P166, DOI 10.1016/j.jtcvs.2005.02.064; Birkenkamp-Demtroder K, 2005, NEUROENDOCRINOLOGY, V82, P121, DOI 10.1159/000091207; Brambill E, 2015, WHO CLASSIFICATION T; Chang YH, 2012, J PROTEOME RES, V11, P5167, DOI 10.1021/pr300362g; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Darfler, 2005, BIOTECHNIQUES, P32, DOI DOI 10.2144/05386SU06; Deng S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010277; Dresler CM, 1997, ANN THORAC SURG, V63, P180; Duan XB, 2008, J PROTEOME RES, V7, P4955, DOI 10.1021/pr800295j; Eaton SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072457; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Goodfellow SJ, 2011, BIOCHEM J, V435, P113, DOI 10.1042/BJ20101734; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Green LM, 2009, NUCLEIC ACIDS RES, V37, P431, DOI 10.1093/nar/gkn955; Hamburg MA, 2010, NEW ENGL J MED, V363, P301, DOI 10.1056/NEJMp1006304; Hartl M, 2009, P NATL ACAD SCI USA, V106, P5604, DOI 10.1073/pnas.0812101106; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Kaira K, 2011, ONCOL REP, V26, P931, DOI 10.3892/or.2011.1384; Kawamura T, 2010, J PROTEOMICS, V73, P1089, DOI 10.1016/j.jprot.2009.11.011; Kirkpatrick DS, 2005, METHODS, V35, P265, DOI 10.1016/j.ymeth.2004.08.018; Kurien BT, 2006, METHODS, V38, P283, DOI 10.1016/j.ymeth.2005.11.007; Lai MD, 2006, VIRCHOWS ARCH, V449, P402, DOI 10.1007/s00428-006-0263-9; Liu QX, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/s12957-015-0646-y; Ma I, 2011, STEM CELL REV REP, V7, P292, DOI 10.1007/s12015-010-9208-4; MacKeigan JP, 2003, CANCER RES, V63, P6928; Marko-Varga G, 2007, J PROTEOME RES, V6, P2925, DOI 10.1021/pr070046s; Nawashiro Hiroshi, 2002, Hum Cell, V15, P25, DOI 10.1111/j.1749-0774.2002.tb00096.x; Nishimura T, 2010, J PROTEOMICS, V73, P1100, DOI 10.1016/j.jprot.2009.11.010; Nomura Masaharu, 2011, J Clin Bioinforma, V1, P23, DOI 10.1186/2043-9113-1-23; Nyberg F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022062; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Rifai N, 2006, NAT BIOTECHNOL, V24, P971, DOI 10.1038/nbt1235; Sokal RR, 1994, BIOMETRY PRINCIPLES, V3rd; Sullivan JP, 2010, CANCER RES, V70, P9937, DOI 10.1158/0008-5472.CAN-10-0881; Tomita H, 2016, ONCOTARGET, V7, P11018, DOI 10.18632/oncotarget.6920; TRAVIS WD, 1991, AM J SURG PATHOL, V15, P529, DOI 10.1097/00000478-199106000-00003; Travis WD, 1999, HISTOLOGICAL TYPING; Varlotto JM, 2011, J THORAC ONCOL, V6, P1050, DOI 10.1097/JTO.0b013e318217b6f8; Vizin T, 2015, RADIOL ONCOL, V49, P217, DOI 10.1515/raon-2015-0035; Wisniewski JR, 2016, J PROTEOME RES, V15, P2321, DOI 10.1021/acs.jproteome.6b00403; Yao XL, 2016, AM J RESP CELL MOL, V55, P159, DOI 10.1165/rcmb.2016-0060TR; Yates JR, 2009, ANNU REV BIOMED ENG, V11, P49, DOI 10.1146/annurev-bioeng-061008-124934; Zamanian-Daryoush M, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00265; Zeng HZ, 2011, INT J MOL SCI, V12, P3489, DOI 10.3390/ijms12063489; Zhang H, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M110.005678, 10.1074/mcp.M111.009936, 10.1186/1476-4598-10-108]; Zybailov B, 2005, ANAL CHEM, V77, P6218, DOI 10.1021/ac050846r	52	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176219	10.1371/journal.pone.0176219	http://dx.doi.org/10.1371/journal.pone.0176219			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448532	Green Published, gold, Green Submitted			2022-12-26	WOS:000400383600047
J	Inoue, Y; Shiihara, J; Miyazawa, H; Ohta, H; Higo, M; Nagai, Y; Kobayashi, K; Saijo, Y; Tsuchida, M; Nakayama, M; Hagiwara, K				Inoue, Yoshiaki; Shiihara, Jun; Miyazawa, Hitoshi; Ohta, Hiromitsu; Higo, Megumi; Nagai, Yoshiaki; Kobayashi, Kunihiko; Saijo, Yasuo; Tsuchida, Masanori; Nakayama, Mitsuo; Hagiwara, Koichi			A highly specific and sensitive massive parallel sequencer-based test for somatic mutations in non-small cell lung cancer	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; HARBORING BRAF MUTATIONS; EGFR MUTATION; DRIVER MUTATIONS; GEFITINIB; GENE; ADENOCARCINOMA; THERAPY; NSCLC; CLAMP	Molecular targeting therapy for non-small cell lung cancer (NSCLC) has clarified the importance of mutation testing when selecting treatment regimens. As a result, multiple-gene mutation tests are urgently needed. We developed a next-generation sequencer (NGS)-based, multi-gene test named the MINtS for investigating driver mutations in both cytological specimens and snap-frozen tissue samples. The MINtS was used to investigate the EGFR, KRAS, BRAF genes from DNA, and the ERBB2, and the ALK, ROS1, and RET fusion genes from RNA. We focused on high specificity and sensitivity (>= 0.99) and even included samples with a cancer cell content of 1%. The MINtS enables testing of more than 100 samples in a single run, making it possible to process a large number of samples submitted to a central laboratory, and reducing the cost for a single sample. We investigated 96 cytological samples and 190 surgically resected tissues, both of which are isolated in daily clinical practice. With the cytological samples, we compared the results for the EGFR mutation between the MINtS and the PNA-LNA PCR clamp test, and their results were 99% consistent. In the snap-frozen tissue samples, 188/190 (99%) samples were successfully analyzed for all genes investigated using both DNA and RNA. Then, we used 200 cytological samples that were serially isolated in clinical practice to assess RNA quality. Using our procedure, 196 samples (98%) provided high-quality RNA suitable for analysis with the MINtS. We concluded that the MINtS test system is feasible for analyzing ''druggable'' genes using cytological samples and snap-frozen tissue samples. The MINtS will fill a needs for patients for whom only cytological specimens are available for genetic testing.	[Inoue, Yoshiaki] Saitama Med Univ, Grad Sch, Moroyama, Saitama, Japan; [Inoue, Yoshiaki; Nakayama, Mitsuo] Saitama Med Ctr, Dept Gen Thorac Surg, Kawagoe, Saitama, Japan; [Shiihara, Jun] Tohoku Univ, Grad Sch Med, Dept Resp Med, Sendai, Miyagi, Japan; [Miyazawa, Hitoshi] Saitama Med Univ, Dept Resp Med, Moroyama, Saitama, Japan; [Ohta, Hiromitsu; Nagai, Yoshiaki] Jichi Med Univ, Dept Resp Med, Saitama, Saitama, Japan; [Higo, Megumi; Hagiwara, Koichi] Jichi Med Univ, Clin Labs Cardiovasc Dis, Saitama, Saitama, Japan; [Kobayashi, Kunihiko] Saitama Int Med Ctr, Dept Resp Med, Hidaka, Saitama, Japan; [Saijo, Yasuo] Niigata Univ, Grad Sch Med & Dent Sci, Dept Med Oncol, Niigata, Niigata, Japan; [Tsuchida, Masanori] Niigata Univ, Grad Sch Med & Dent Sceinces, Dept Thorac & Cardiovasc Surg, Niigata, Niigata, Japan; [Hagiwara, Koichi] Jichi Med Univ, Dept Med, Div Pulm Med, Shimotsuke, Tochigi, Japan	Saitama Medical University; Saitama Medical University; Tohoku University; Saitama Medical University; Jichi Medical University; Jichi Medical University; Niigata University; Niigata University; Jichi Medical University	Hagiwara, K (corresponding author), Jichi Med Univ, Clin Labs Cardiovasc Dis, Saitama, Saitama, Japan.; Hagiwara, K (corresponding author), Jichi Med Univ, Dept Med, Div Pulm Med, Shimotsuke, Tochigi, Japan.	hagiwark@me.com			Ministry of Health, Labor, and Welfare, Japan [H25-Sohyaku-lppan-011]	Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by the Ministry of Health, Labor, and Welfare, Japan, H25-Sohyaku-lppan-011 to KH, http://www.mhlw.go.jp/english/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi YL, 2008, CANCER RES, V68, P4971, DOI 10.1158/0008-5472.CAN-07-6158; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; DER CJ, 1982, P NATL ACAD SCI-BIOL, V79, P3637, DOI 10.1073/pnas.79.11.3637; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Goto K, 2012, ANN ONCOL, V23, P2914, DOI 10.1093/annonc/mds121; Hagiwara K, 2013, CANCER SCI, V104, P291, DOI 10.1111/cas.12081; Heitzer E, 2015, CLIN CHEM, V61, P112, DOI 10.1373/clinchem.2014.222679; Kobayashi K, 2013, TARGET ONCOL, V8, P27, DOI 10.1007/s11523-013-0258-9; Kohno T, 2012, NAT MED, V18, P375, DOI 10.1038/nm.2644; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Marchetti A, 2011, J CLIN ONCOL, V29, P3574, DOI 10.1200/JCO.2011.35.9638; Minuti G, 2013, EXPERT OPIN BIOL TH, V13, P1401, DOI 10.1517/14712598.2013.827657; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Miyazawa H, 2008, CANCER SCI, V99, P595, DOI 10.1111/j.1349-7006.2007.00706.x; Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Paik PK, 2011, J CLIN ONCOL, V29, P2046, DOI 10.1200/JCO.2010.33.1280; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Peters S, 2013, J CLIN ONCOL, V31, pE341, DOI 10.1200/JCO.2012.47.6143; Pirker Robert, 2010, J Thorac Oncol, V5, P1706, DOI 10.1097/JTO.0b013e3181f1c8de; Reck M, 2016, J THORAC ONCOL, V11, P1682, DOI 10.1016/j.jtho.2016.05.036; Saito M, 2016, CANCER SCI, V107, P713, DOI 10.1111/cas.12941; Shaw AT, 2014, N ENGL J MED; Shigematsu H, 2005, CANCER RES, V65, P1642, DOI 10.1158/0008-5472.CAN-04-4235; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Tanaka T, 2007, CANCER SCI, V98, P246, DOI 10.1111/j.1349-7006.2006.00377.x; Tomizawa K, 2011, LUNG CANCER, V74, P139, DOI 10.1016/j.lungcan.2011.01.014; Yatabe Y, 2015, J THORAC ONCOL, V10, P438, DOI 10.1097/JTO.0000000000000422	31	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176525	10.1371/journal.pone.0176525	http://dx.doi.org/10.1371/journal.pone.0176525			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448556	Green Submitted, Green Published, gold			2022-12-26	WOS:000400383600096
J	Lugato, E; Paniagua, L; Jones, A; de Vries, W; Leip, A				Lugato, Emanuele; Paniagua, Lily; Jones, Arwyn; de Vries, Wim; Leip, Adrian			Complementing the topsoil information of the Land Use/Land Cover Area Frame Survey (LUCAS) with modelled N2O emissions	PLOS ONE			English	Article							EUROPEAN AGRICULTURAL SOILS; NITROUS-OXIDE EMISSIONS; SCALE; LOSSES; FLUXES; SITES	Two objectives of the Common Agricultural Policy post-2013 (CAP, 2014-2020) in the European Union (EU) are the sustainable management of natural resources and climate smart agriculture. To understand the CAP impact on these priorities, the Land Use/Cover statistical Area frame Survey (LUCAS) employs direct field observations and soil sub-sampling across the EU. While a huge amount of information can be retrieved from LUCAS points for monitoring the environmental status of agroecosystems and assessing soil carbon sequestration, a fundamental aspect relating to climate change action is missing, namely nitrous oxide (N2O) soil emissions. To fill this gap, we ran the DayCent biogeochemistry model for more than 11'000 LUCAS sampling points under agricultural use, assessing also the model uncertainty. The results showed that current annual N2O emissions followed a skewed distribution with a mean and median values of 2.27 and 1.71 kg N ha(-1) yr(-1), respectively. Using a Random Forest regression for upscaling the modelled results to the EU level, we estimated direct soil emissions of N2O in the range of 171-195 Tg yr(-1) of CO2eq. Moreover, the direct regional upscaling using modelled N2O emissions in LUCAS points was on average 0.95 Mg yr(-1) of CO2eq. per hectare, which was within the range of the meta-model upscaling (0.92-1.05 Mg ha(-1) yr(-1) of CO2eq). We concluded that, if information on management practices would be made available and model bias further reduced by N2O flux measurement at representative LUCAS points, the combination of the land use/soil survey with a well calibrated biogeochemistry model may become a reference tool to support agricultural, environmental and climate policies.	[Lugato, Emanuele; Paniagua, Lily; Jones, Arwyn; Leip, Adrian] European Commiss, Joint Res Ctr, Sustainable Resources Directorate, Ispra, Varese, Italy; [Paniagua, Lily; de Vries, Wim] Wageningen Univ & Res, Environm Syst Anal Grp, Wageningen, Netherlands; [de Vries, Wim] Wageningen Univ & Res, Environm Res Alterra, Wageningen, Netherlands	European Commission Joint Research Centre; EC JRC ISPRA Site; Wageningen University & Research; Wageningen University & Research	Lugato, E (corresponding author), European Commiss, Joint Res Ctr, Sustainable Resources Directorate, Ispra, Varese, Italy.	emanuele.lugato@ec.europa.eu	lugato, emanuele/F-6947-2010	lugato, emanuele/0000-0002-8947-352X; de Vries, Wim/0000-0001-9974-0612; Leip, Adrian/0000-0001-7616-5029; Jones, Arwyn/0000-0002-8552-6137	JRC's Institutional Work Programme under the Natural Capital Soil Project, Work Package 5037 Soil for Climate Change [702]	JRC's Institutional Work Programme under the Natural Capital Soil Project, Work Package 5037 Soil for Climate Change	The author(s) received no specific funding for this work. The work was carried out as part of the JRC's Institutional Work Programme under the Natural Capital Soil Project (Project 702), Work Package 5037 Soil for Climate Change.	Ballabio C, 2016, GEODERMA, V261, P110, DOI 10.1016/j.geoderma.2015.07.006; Barton L, 2015, SCI REP-UK, V5, DOI 10.1038/srep15912; Bergamaschi P, 2015, ATMOS CHEM PHYS, V15, P715, DOI 10.5194/acp-15-715-2015; Britz W, 2009, AGR ECOSYST ENVIRON, V133, P267, DOI 10.1016/j.agee.2009.04.026; Butterbach-Bahl K, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0122; Butterbach-Bahl K, 2011, CURR OPIN ENV SUST, V3, P389, DOI 10.1016/j.cosust.2011.08.004; Cayuela ML, 2017, AGR ECOSYST ENVIRON, V238, P25, DOI 10.1016/j.agee.2016.10.006; de Brogniez D, 2015, EUR J SOIL SCI, V66, P121, DOI 10.1111/ejss.12193; de Vries W, 2011, ENVIRON POLLUT, V159, P3254, DOI 10.1016/j.envpol.2011.03.038; De Vries W., 2005, ENVIRON SCI-TOKYO, V2, P217; Del Grosso SJ, 2006, J ENVIRON QUAL, V35, P1451, DOI 10.2134/jeq2005.0160; Del Grosso SJ, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003544; Del Grosso SJ, 2009, GLOBAL PLANET CHANGE, V67, P44, DOI 10.1016/j.gloplacha.2008.12.006; EEA, 2016, 152016 EEA; Field C.B., 2014, CLIM CHANG 2014 IMP, P1, DOI [DOI 10.1038/446727A, 10.1017/CBO9781107415379]; Follador M, 2011, ENVIRON POLLUT, V159, P3233, DOI 10.1016/j.envpol.2011.01.025; Fowler D, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0164; Galloway JN, 2003, BIOSCIENCE, V53, P341, DOI 10.1641/0006-3568(2003)053[0341:TNC]2.0.CO;2; Giltrap DL, 2016, SCI TOTAL ENVIRON, V539, P221, DOI 10.1016/j.scitotenv.2015.08.107; Hengl T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105992; Hollis JM, 2012, EUR J SOIL SCI, V63, P96, DOI 10.1111/j.1365-2389.2011.01412.x; Ivaro-Fuentes J, 2016, AGR ECOSYST ENV; Leip A, 2014, J AGR SCI-CAMBRIDGE, V152, pS20, DOI 10.1017/S0021859613000786; Leip A, 2011, CURR OPIN ENV SUST, V3, P328, DOI 10.1016/j.cosust.2011.07.002; Leip A, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/11/115004; Leip A, 2011, ENVIRON POLLUT, V159, P3223, DOI 10.1016/j.envpol.2010.11.024; Leip A, 2010, CLIMATIC CHANGE, V103, P245, DOI [10.1007/s10584-010-9915-5, 10.1007/S10584-010-9915-5]; Lesschen JP, 2011, ENVIRON POLLUT, V159, P3215, DOI 10.1016/j.envpol.2011.04.001; Li CS, 2005, CLIMATIC CHANGE, V72, P321, DOI 10.1007/s10584-005-6791-5; Lugato E, 2016, GLOBAL CHANGE BIOL, V22, P1976, DOI 10.1111/gcb.13198; Lugato E, 2014, GLOBAL CHANGE BIOL, V20, P313, DOI 10.1111/gcb.12292; Molina-Herrera S, 2016, SCI TOTAL ENVIRON, V553, P128, DOI 10.1016/j.scitotenv.2015.12.099; PARTON WJ, 1988, BIOGEOCHEMISTRY, V5, P109, DOI 10.1007/BF02180320; Parton WJ, 2001, J GEOPHYS RES-ATMOS, V106, P17403, DOI 10.1029/2001JD900101; Paustian K, 2016, NATURE, V532, P49, DOI 10.1038/nature17174; Perlman J, 2014, GLOBAL ECOL BIOGEOGR, V23, P912, DOI 10.1111/geb.12166; Qin D., 2014, CLIM CHANG 2013 PHYS, P5; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; RAWLS WJ, 1982, T ASAE, V25, P1316; Reinds GJ, 2012, BIOGEOSCIENCES, V9, P4527, DOI 10.5194/bg-9-4527-2012; Sacks WJ, 2010, GLOBAL ECOL BIOGEOGR, V19, P607, DOI 10.1111/j.1466-8238.2010.00551.x; Shcherbak I, 2014, P NATL ACAD SCI USA, V111, P9199, DOI 10.1073/pnas.1322434111; Simpson D, 2012, ATMOS CHEM PHYS, V12, P7825, DOI 10.5194/acp-12-7825-2012; Skiba U, 2009, AGR ECOSYST ENVIRON, V133, P139, DOI 10.1016/j.agee.2009.05.018; Sutton MA, 2011, NATURE, V472, P159, DOI 10.1038/472159a; Toth G, 2013, ENVIRON MONIT ASSESS, V185, P7409, DOI 10.1007/s10661-013-3109-3; Velthof GL, 2009, J ENVIRON QUAL, V38, P402, DOI 10.2134/jeq2008.0108; Villa-Vialaneix N, 2012, ENVIRON MODELL SOFTW, V34, P51, DOI 10.1016/j.envsoft.2011.05.003	48	13	14	7	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176111	10.1371/journal.pone.0176111	http://dx.doi.org/10.1371/journal.pone.0176111			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448607	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383600039
J	Richtering, SS; Morris, R; Soh, SE; Barker, A; Bampi, F; Neubeck, L; Coorey, G; Mulley, J; Chalmers, J; Usherwood, T; Peiris, D; Chow, CK; Redfern, J				Richtering, Sarah S.; Morris, Rebecca; Soh, Sze-Ee; Barker, Anna; Bampi, Fiona; Neubeck, Lis; Coorey, Genevieve; Mulley, John; Chalmers, John; Usherwood, Tim; Peiris, David; Chow, Clara K.; Redfern, Julie			Examination of an eHealth literacy scale and a health literacy scale in a population with moderate to high cardiovascular risk: Rasch analyses	PLOS ONE			English	Article							MEASUREMENT MODEL; OLDER-ADULTS; VALIDATION; INFORMATION; DEPRESSION; STRATEGIES; ANXIETY; SKILLS	Introduction Electronic health (eHealth) strategies are evolving making it important to have valid scales to assess eHealth and health literacy. Item response theory methods, such as the Rasch measurement model, are increasingly used for the psychometric evaluation of scales. This paper aims to examine the internal construct validity of an eHealth and health literacy scale using Rasch analysis in a population with moderate to high cardiovascular disease risk. Methods The first 397 participants of the CONNECT study completed the electronic health Literacy Scale (eHEALS) and the Health Literacy Questionnaire (HLQ). Overall Rasch model fit as well as five key psychometric properties were analysed: unidimensionality, response thresholds, targeting, differential item functioning and internal consistency. Results The eHEALS had good overall model fit (chi(2) = 54.8, p = 0.06), ordered response thresholds, reasonable targeting and good internal consistency (person separation index (PSI) 0.90). It did, however, appear to measure two constructs of eHealth literacy. The HLQ subscales (except subscale 5) did not fit the Rasch model (chi(2) : 18.18-60.60, p: 0.00-0.58) and had suboptimal targeting for most subscales. Subscales 6 to 9 displayed disordered thresholds indicating participants had difficulty distinguishing between response options. All subscales did, nonetheless, demonstrate moderate to good internal consistency (PSI: 0.62-0.82). Conclusion Rasch analyses demonstrated that the eHEALS has good measures of internal construct validity although it appears to capture different aspects of eHealth literacy (e.g. using eHealth and understanding eHealth). Whilst further studies are required to confirm this finding, it may be necessary for these constructs of the eHEALS to be scored separately. The nine HLQ subscales were shown to measure a single construct of health literacy. However, participants' scores may not represent their actual level of ability, as distinction between response categories was unclear for the last four subscales. Reducing the response categories of these subscales may improve the ability of the HLQ to distinguish between different levels of health literacy.	[Richtering, Sarah S.; Bampi, Fiona; Neubeck, Lis; Coorey, Genevieve; Mulley, John; Chalmers, John; Usherwood, Tim; Peiris, David; Chow, Clara K.; Redfern, Julie] George Inst Global Hlth, Sydney, NSW, Australia; [Richtering, Sarah S.] Univ Geneva, Hop Univ Geneve, Geneva, Switzerland; [Morris, Rebecca; Soh, Sze-Ee; Barker, Anna] Monash Univ, Sch Publ Hlth & Prevent Med, Fac Med Nursing & Hlth Sci, Melbourne, Vic, Australia; [Soh, Sze-Ee] Monash Univ, Dept Physiotherapy, Melbourne, Vic, Australia; [Neubeck, Lis] Univ Sydney, Sydney Nursing Sch, Charles Perkin Ctr, Sydney, NSW, Australia; [Neubeck, Lis] Edinburgh Napier Univ, Sch Hlth & Social Care, Edinburgh, Midlothian, Scotland; [Coorey, Genevieve; Chalmers, John; Usherwood, Tim; Peiris, David; Chow, Clara K.; Redfern, Julie] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Chow, Clara K.] Westmead Hosp, Sydney, NSW, Australia	George Institute for Global Health; University of Sydney; University of Geneva; Monash University; Monash University; University of Sydney; Edinburgh Napier University; University of Sydney; University of Sydney	Redfern, J (corresponding author), George Inst Global Hlth, Sydney, NSW, Australia.; Redfern, J (corresponding author), Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia.	jredfern@georgeinsitute.org.au	Redfern, Julie/AAM-8617-2020; Neubeck, Lis/AAL-2192-2020; Coorey/AAM-1503-2021	Redfern, Julie/0000-0001-8707-5563; Neubeck, Lis/0000-0001-5852-1034; Barker, Anna/0000-0001-6607-975X; Chalmers, John/0000-0002-9931-0580; Peiris, David/0000-0002-6898-3870	National Health and Medical Research Council; National Heart Foundation; Sydney Medical Foundation Chapman Fellowship; NHMRC [1054754]; National Health and Medical Research Council [APP1067236]; National Health and Medical Research Council Career Development Fellowship [1061793]; National Health and Medical Research Council Project [APP1047508]; National Heart Foundation Future Fellowship [G160523]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation(National Heart Foundation of Australia); Sydney Medical Foundation Chapman Fellowship; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council Project(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation Future Fellowship(National Heart Foundation of Australia)	CKC is funded by a Career Development Fellowship co-funded by the National Health and Medical Research Council and National Heart Foundation and Sydney Medical Foundation Chapman Fellowship. DP is supported by a NHMRC-postdoctoral Fellowship (1054754). AB's salary was funded by a Career Development Fellowship from the National Health and Medical Research Council (APP1067236). JR is funded by a National Health and Medical Research Council Career Development Fellowship (1061793) co-funded with a National Heart Foundation Future Fellowship (G160523). The Consumer Navigation of Electronic Cardiovascular Tools (CONNECT) study is funded by a National Health and Medical Research Council Project Grant (APP1047508).	Barber MN, 2009, HEALTH PROMOT INT, V24, P252, DOI 10.1093/heapro/dap022; Batterham Roy W, 2014, BMC Public Health, V14, P694, DOI 10.1186/1471-2458-14-694; Bo A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1095; Chesser A, 2016, INFORM HEALTH SOC CA, V41, P1, DOI 10.3109/17538157.2014.948171; Chung SY, 2015, CIN-COMPUT INFORM NU, V33, P150, DOI 10.1097/CIN.0000000000000146; Collins SA, 2012, J BIOMED INFORM, V45, P598, DOI 10.1016/j.jbi.2012.04.001; Crengle S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-714; Davis T C, 1991, Fam Med, V23, P433; Elsworth GR, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1754-2; Gothwal VK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118189; Kayser L, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2068-8; Keith Timothy Z., 2006, MULTIPLE REGRESSION; Kripalani S, 2010, PATIENT EDUC COUNS, V81, P177, DOI 10.1016/j.pec.2010.04.030; Lee TW, 2012, ASIAN NURS RES, V6, P128, DOI 10.1016/j.anr.2012.09.001; Linacre John M, 1994, SAMPLE SIZE ITEM CAL; Mitsutake Seigo, 2011, Nihon Koshu Eisei Zasshi, V58, P361; Nguyen Jennifer, 2016, JMIR Public Health Surveill, V2, pe24, DOI 10.2196/publichealth.4967; Noblin Alice M, 2012, Perspect Health Inf Manag, V9, P1; Norman CD, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.4.e27; Norman CD, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.2.e9; Nutbeam D, 1998, HEALTH PROMOT INT, V13, P349, DOI 10.1093/heapro/13.4.349; Oates DJ, 2009, CIRCULATION, V119, P1049, DOI 10.1161/CIRCULATIONAHA.108.818468; Osborne RH, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-658; Paige SR, 2016, PATIENT ED COUNS; Pallant JF, 2007, BRIT J CLIN PSYCHOL, V46, P1, DOI 10.1348/014466506X96931; Perez GP, 2015, REV ESP SALUD PUBLIC, V89, P329, DOI 10.4321/S1135-57272015000300010; PARKER RM, 1995, J GEN INTERN MED, V10, P537, DOI 10.1007/BF02640361; Prieto Luis, 2003, Health Qual Life Outcomes, V1, P27, DOI 10.1186/1477-7525-1-27; Ramp M, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-58; Redfern J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004523; Shea TL, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-21; Smith Everett V Jr, 2002, J Appl Meas, V3, P205; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; Tennant B, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3992; van der Vaart R, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1840; Watkins I, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3318	36	50	50	5	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0175372	10.1371/journal.pone.0175372	http://dx.doi.org/10.1371/journal.pone.0175372			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET6EL	28448497	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383600013
J	Brouwers, N; Martinez, NM; Vernos, I				Brouwers, Nathalie; Mallol Martinez, Nuria; Vernos, Isabelle			Role of Kif15 and its novel mitotic partner KBP in K-fiber dynamics and chromosome alignment	PLOS ONE			English	Article							KINESIN-LIKE PROTEIN; CENTROSOME SEPARATION; MICROTUBULE DYNAMICS; KINETOCHORE FIBERS; SPINDLE POLES; LOCALIZATION; CONGRESSION; DYNEIN; CELLS; MITOCHONDRIA	Faithful segregation of the genetic material during the cell cycle is key for the continuation of life. Central to this process is the assembly of a bipolar spindle that aligns the chromosomes and segregates them to the two daughter cells. Spindle bipolarity is strongly dependent on the activity of the homotetrameric kinesin Eg5. However, another kinesin, Kif15, also provides forces needed to separate the spindle poles during prometaphase and to maintain spindle bipolarity at metaphase. Here we identify KBP as a specific interaction partner of Kif15 in mitosis. We show that KBP promotes the localization of Kif15 to the spindle equator close to the chromosomes. Both Kif15 and KBP are required for the alignment of all the chromosomes to the metaphase plate and the assembly of stable kinetochore fibers of the correct length. Taken together our data uncover a novel role for Kif15 in complex with KBP during mitosis.	[Brouwers, Nathalie; Mallol Martinez, Nuria; Vernos, Isabelle] Barcelona Inst Sci & Technol, Cell & Dev Biol Program, CRG, Dr Aiguader 88, Barcelona, Spain; [Brouwers, Nathalie; Mallol Martinez, Nuria; Vernos, Isabelle] UPF, Barcelona, Spain; [Vernos, Isabelle] ICREA, Pg Lluis Co 23, Barcelona, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; ICREA	Vernos, I (corresponding author), Barcelona Inst Sci & Technol, Cell & Dev Biol Program, CRG, Dr Aiguader 88, Barcelona, Spain.; Vernos, I (corresponding author), UPF, Barcelona, Spain.; Vernos, I (corresponding author), ICREA, Pg Lluis Co 23, Barcelona, Spain.	isabelte.vernos@crg.eu	Vernos, Isabelle/C-1687-2015; Brouwers, Nathalie/L-2089-2014	Vernos, Isabelle/0000-0003-1469-9214; Brouwers, Nathalie/0000-0002-9808-9394	Spanish Ministry of Economy and Competitiveness [BFU2009-10202, BFU2012-37163]; Centro de Excelencia Severo Ochoa [SEV-2012-0208]; Research Foundation Flanders (FWO); ICREA Funding Source: Custom	Spanish Ministry of Economy and Competitiveness(Spanish Government); Centro de Excelencia Severo Ochoa; Research Foundation Flanders (FWO)(FWO); ICREA(ICREA)	This work was funded from grants of the Spanish Ministry of Economy and Competitiveness (BFU2009-10202 and BFU2012-37163), and funds to the CRG from 'Centro de Excelencia Severo Ochoa 2013-2017' (SEV-2012-0208). N.B. was supported by a post-doctoral fellowship and mobility grant from the Research Foundation Flanders (FWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Patrik Meraldi (ETH, Zurich) for his kind gift of the H2B-eGFP/ alpha-tubu-lin-mRFP HeLa cell line, and Maria Alves (University of Groningen, The Netherlands) for her kind gift of the pEGFP-N-hKBP construct. We thank L. Avila for technical assistance, and all members of the Vernos lab for fruitful discussion regarding this work. We thank the Centre for Genomic Regulation Proteomics and Advanced Light Microscopy facilities. This work was supported by grants from the Spanish Ministry of Economy and Competitiveness (BFU2009-10202 and BFU2012-37163), and 'Centro de Excelencia Severo Ochoa 2013-2017' (SEV-2012-0208). N.B. was supported by a post-doctoral fellowship and mobility grant from the Research Foundation Flanders (FWO).	Antonio C, 2000, CELL, V102, P425, DOI 10.1016/S0092-8674(00)00048-9; Bishop JD, 2005, MOL BIOL CELL, V16, P742, DOI 10.1091/mbc.E04-08-0682; Boleti H, 1996, CELL, V84, P49, DOI 10.1016/S0092-8674(00)80992-7; Cai S, 2009, NAT CELL BIOL, V11, P832, DOI 10.1038/ncb1890; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cuylen S, 2016, NATURE, V535, P308, DOI 10.1038/nature18610; DeLuca JG, 2010, METHOD CELL BIOL, V97, P53, DOI 10.1016/S0091-679X(10)97004-0; DeLuca JG, 2002, J CELL BIOL, V159, P549, DOI 10.1083/jcb.200208159; Drechsler H, 2016, P NATL ACAD SCI USA, V113, pE1635, DOI 10.1073/pnas.1516370113; Drechsler H, 2014, ELIFE, V3, DOI 10.7554/eLife.01724; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Funabiki H, 2000, CELL, V102, P411, DOI 10.1016/S0092-8674(00)00047-7; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kevenaar JT, 2016, CURR BIOL, V26, P849, DOI 10.1016/j.cub.2016.01.048; Kingston RE, 2001, CALCIUM PHOSPHATE TR; Lehti MS, 2013, MOL CELL ENDOCRINOL, V377, P44, DOI 10.1016/j.mce.2013.06.030; Levesque AA, 2001, J CELL BIOL, V154, P1135, DOI 10.1083/jcb.200106093; Lyons DA, 2008, DEVELOPMENT, V135, P599, DOI 10.1242/dev.012377; Maliga Z, 2013, NAT CELL BIOL, V15, P325, DOI 10.1038/ncb2689; Mayr MI, 2007, CURR BIOL, V17, P488, DOI 10.1016/j.cub.2007.02.036; Meunier S, 2011, NAT CELL BIOL, V13, P1406, DOI 10.1038/ncb2372; Mitchison TJ, 2005, MOL BIOL CELL, V16, P3064, DOI 10.1091/mbc.E05-02-0174; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Raaijmakers JA, 2012, EMBO J, V31, P4179, DOI 10.1038/emboj.2012.272; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rogers GC, 2000, J CELL BIOL, V150, P499, DOI 10.1083/jcb.150.3.499; Sturgill EG, 2014, CURR BIOL, V24, P2307, DOI 10.1016/j.cub.2014.08.022; Sturgill EG, 2013, CURR BIOL, V23, P1280, DOI 10.1016/j.cub.2013.05.043; Sueishi M, 2000, J BIOL CHEM, V275, P28888, DOI 10.1074/jbc.M003879200; Tanaka K, 2011, J CELL SCI, V124, P2457, DOI 10.1242/jcs.086470; Tanenbaum ME, 2009, CURR BIOL, V19, P1703, DOI 10.1016/j.cub.2009.08.027; Tanenbaum ME, 2008, EMBO J, V27, P3235, DOI 10.1038/emboj.2008.242; Tikhonenko I, 2008, CELL MOTIL CYTOSKEL, V65, P853, DOI 10.1002/cm.20307; Vanneste D, 2009, CURR BIOL, V19, P1712, DOI 10.1016/j.cub.2009.09.019; Vladimirou E, 2013, DEV CELL, V27, P60, DOI 10.1016/j.devcel.2013.08.004; Wittmann T, 1998, J CELL BIOL, V143, P673, DOI 10.1083/jcb.143.3.673; Wozniak MJ, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-35	38	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0174819	10.1371/journal.pone.0174819	http://dx.doi.org/10.1371/journal.pone.0174819			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445502	Green Submitted, gold, Green Published			2022-12-26	WOS:000400309200010
J	Katiraei, S; Hoving, LR; van Beek, L; Mohamedhoesein, S; Carlotti, F; van Diepen, JA; Rensen, PCN; Netea, MG; van Dijk, KW; Berbee, JFP; van Harmelen, V				Katiraei, Saeed; Hoving, Lisa R.; van Beek, Lianne; Mohamedhoesein, Sharida; Carlotti, Francoise; van Diepen, Janna A.; Rensen, Patrick C. N.; Netea, Mihai G.; van Dijk, Ko Willems; Berbee, Jimmy F. P.; van Harmelen, Vanessa			BMT decreases HFD-induced weight gain associated with decreased preadipocyte number and insulin secretion	PLOS ONE			English	Article							ADIPOSE; ADIPOCYTES; CAPACITY; DEPOT; CELLS	Experimental bone marrow transplantation (BMT) in mice is commonly used to assess the role of immune cell-specific genes in various pathophysiological settings. The application of BMT in obesity research is hampered by the significant reduction in high-fat diet (HFD)-induced obesity. We set out to characterize metabolic tissues that may be affected by the BMT procedure and impair the HFD-induced response. Male C57BL/6 mice underwent syngeneic BMT using lethal irradiation. After a recovery period of 8 weeks they were fed a low-fat diet (LFD) or HFD for 16 weeks. HFD-induced obesity was reduced in mice after BMT as compared to HFD-fed control mice, characterized by both a reduced fat (-33%; p<0.01) and lean (-11%; p<0.01) mass, while food intake and energy expenditure were unaffected. As compared to control mice, BMT-treated mice had a reduced mature adipocyte volume (approx. -45%; p<0.05) and reduced numbers of preadipocytes (-38%; p<0.05) and macrophages (-62%; p<0.05) in subcutaneous, gonadal and visceral white adipose tissue. In BMT-treated mice, pancreas weight (-46%; p<0.01) was disproportionally decreased. This was associated with reduced plasma insulin (-68%; p<0.05) and C-peptide (-37%; p<0.01) levels and a delayed glucose clearance in BMT-treated mice on HFD as compared to control mice. In conclusion, the reduction in HFD-induced obesity after BMT in mice is at least partly due to alterations in the adipose tissue cell pool composition as well as to a decreased pancreatic secretion of the anabolic hormone insulin. These effects should be considered when interpreting results of experimental BMT in metabolic studies.	[Katiraei, Saeed; Hoving, Lisa R.; van Beek, Lianne; Mohamedhoesein, Sharida; van Dijk, Ko Willems; van Harmelen, Vanessa] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Katiraei, Saeed; Hoving, Lisa R.; van Beek, Lianne; Mohamedhoesein, Sharida; Carlotti, Francoise; Rensen, Patrick C. N.; van Dijk, Ko Willems; Berbee, Jimmy F. P.; van Harmelen, Vanessa] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [Carlotti, Francoise] Leiden Univ, Med Ctr, Div Nephrol, Dept Med, Leiden, Netherlands; [van Diepen, Janna A.; Netea, Mihai G.] Radboud UMC, Dept Internal Med, Nijmegen, Netherlands; [Rensen, Patrick C. N.; van Dijk, Ko Willems; Berbee, Jimmy F. P.] Leiden Univ, Med Ctr, Div Endocrinol, Dept Med, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Katiraei, S (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands.; Katiraei, S (corresponding author), Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands.	s.katiraei@lumc.ni	Netea, Mihai/N-5155-2014; Carlotti, Françoise/AAN-5018-2021; van Dijk, Ko Willems/AAT-4681-2021; Hoving, Lisa/S-4167-2018; Rensen, Patrick C.N./D-7176-2018; van Diepen, Janna/E-9485-2010; Carlotti, Françoise/H-1060-2014; van Dijk, Ko Willems/A-1798-2008	Carlotti, Françoise/0000-0001-7929-8468; van Dijk, Ko Willems/0000-0002-2172-7394; Hoving, Lisa/0000-0002-3096-7533; Rensen, Patrick C.N./0000-0002-8455-4988; van Diepen, Janna/0000-0001-9091-1075; Carlotti, Françoise/0000-0001-7929-8468; van Dijk, Ko Willems/0000-0002-2172-7394; van Harmelen, Vanessa/0000-0003-0111-9858	Rembrandt Institute of Cardiovascular Sciences (RICS); Cardiovascular Research Netherlands (CVON IN CONTROL); ERC Consolidator Grant [310372]; Veni Grant of the Netherlands Organization for the Scientific Research [91616083]	Rembrandt Institute of Cardiovascular Sciences (RICS); Cardiovascular Research Netherlands (CVON IN CONTROL); ERC Consolidator Grant; Veni Grant of the Netherlands Organization for the Scientific Research	Funded by Rembrandt Institute of Cardiovascular Sciences (RICS) and Cardiovascular Research Netherlands (CVON IN CONTROL). M.G.N was supported by an ERC Consolidator Grant (#310372). J.A.v.D. was supported by a Veni Grant of the Netherlands Organization for the Scientific Research (#91616083).	Ablamunits V, 2007, OBESITY, V15, P1419, DOI 10.1038/oby.2007.170; Aparicio-Vergara M, 2010, ATHEROSCLEROSIS, V213, P335, DOI 10.1016/j.atherosclerosis.2010.05.030; Crossno JT, 2006, J CLIN INVEST, V116, P3220, DOI 10.1172/JCI28510; Ellenbroek JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056922; Gupta RK, 2012, CELL METAB, V15, P230, DOI 10.1016/j.cmet.2012.01.010; Hasegawa Y, 2007, ENDOCRINOLOGY, V148, P2006, DOI 10.1210/en.2006-1351; Hotamisligil GS, 2003, INT J OBESITY, V27, pS53, DOI 10.1038/sj.ijo.0802502; Kathryn E., 2003, J CLIN INVEST, V112, P1785; Kiess W, 2008, BEST PRACT RES CL EN, V22, P135, DOI 10.1016/j.beem.2007.10.002; Majka SM, 2010, P NATL ACAD SCI USA, V107, P14781, DOI 10.1073/pnas.1003512107; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nylander V, 2016, DIABETES; Poglio S, 2009, AM J PATHOL, V174, P44, DOI 10.2353/ajpath.2009.080505; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Ryden M, 2015, CELL METAB, V22, P408, DOI 10.1016/j.cmet.2015.06.011; van Beek L, 2015, OBESITY, V23, P2435, DOI 10.1002/oby.21309; van Beek L, 2015, DIABETOLOGIA, V58, P1601, DOI 10.1007/s00125-015-3594-8; van Harmelen V, 2004, METABOLISM, V53, P632, DOI 10.1016/j.metabol.2003.11.012; Waas MV, 2010, J HEMATOL ONCOL, V32, P171; Wei C, 2015, CLIN ENDOCRINOL, V82, P59, DOI 10.1111/cen.12575	20	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0175524	10.1371/journal.pone.0175524	http://dx.doi.org/10.1371/journal.pone.0175524			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445487	Green Published, gold, Green Submitted			2022-12-26	WOS:000400309200023
J	Zheng, Z; Wang, DD; He, H; Wei, C				Zheng, Zhou; Wang, Dandan; He, Hong; Wei, Cong			Bacterial diversity of bacteriomes and organs of reproductive, digestive and excretory systems in two cicada species (Hemiptera: Cicadidae)	PLOS ONE			English	Article							TRANSOVARIAL TRANSMISSION; INTRACELLULAR SYMBIONTS; XYLEM FLUID; ENDOSYMBIONTS; LEAFHOPPER; GENOMICS; INSECTS; IDENTIFICATION; MEIOTHERMUS; EVOLUTION	Cicadas form intimate symbioses with bacteria to obtain nutrients that are scarce in the xylem fluid they feed on. The obligate symbionts in cicadas are purportedly confined to specialized bacteriomes, but knowledge of bacterial communities associated with cicadas is limited. Bacterial communities in the bacteriomes and organs of reproductive, digestive and excretory systems of two cicada species (Platypleura kaempferi and Meimuna mongolica) were investigated using different methods, and the bacterial diversity and distribution patterns of dominant bacteria in different tissues were compared. Within each species, the bacterial communities of testes are significantly different from those of bacteriomes and ovaries. The dominant endosymbiont Candidatus Sulcia muelleri is found not only in the bacteriomes and reproductive organs, but also in the "filter chamber + conical segment" of both species. The transmission mode of this endosymbiont in the alimentary canal and its effect on physiological processes merits further study. A novel bacterium of Rhizobiales, showing similar to 80% similarity to Candidatus Hodgkinia cicadicola, is dominant in the bacteriomes and ovaries of P. kaempferi. Given that the genome of H. cicadicola exhibits rapid sequence evolution, it is possible that this novel bacterium is a related endosymbiont with beneficial trophic functions similar to that of H. cicadicola in some other cicadas. Failure to detect H. cicadicola in M. mongolica suggests that it has been subsequently replaced by another bacterium, a yeast or gut microbiota which compensates for the loss of H. cicadicola. The distribution of this novel Rhizobiales species in other cicadas and its identification require further investigation to help establish the definition of the bacterial genus Candidatus Hodgkinia and to provide more information on sequence divergence of related endosymbionts of cicadas. Our results highlight the complex bacterial communities of cicadas, and are informative for further studies of the interactions and co- evolution of insect- microbial symbioses in Cicadoidea.	[Wang, Dandan; Wei, Cong] Northwest A&F Univ, Coll Plant Protect, Key Lab Plant Protect Resources & Pest Management, Minist Educ, Yangling, Shaanxi, Peoples R China; [Zheng, Zhou; He, Hong] Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Wei, C (corresponding author), Northwest A&F Univ, Coll Plant Protect, Key Lab Plant Protect Resources & Pest Management, Minist Educ, Yangling, Shaanxi, Peoples R China.; He, H (corresponding author), Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China.	hehong@nwsuaf.edu.cn; congwei@nwsuaf.edu.cn		Wei, Cong/0000-0002-1492-7240	National Natural Science Foundation of China [31572302, 31493021]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was partially funded by the National Natural Science Foundation of China (Grant No. 31572302, No. 31493021) to C.W. (http://www.nsfc.gov.cn/). There was no additional external funding received for this study.	Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Ammar ED, 2011, ARCH MICROBIOL, V193, P35, DOI 10.1007/s00203-010-0637-x; ANDERSEN PC, 1989, ENTOMOL EXP APPL, V50, P149, DOI 10.1007/BF00365399; Anselme C, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-43; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Bressan A, 2013, ENV MICROBIOL REP, V5, P499, DOI 10.1111/1758-2229.12051; Brumin M, 2012, APPL ENVIRON MICROB, V78, P5565, DOI 10.1128/AEM.01184-12; Brumin M, 2011, INSECT SCI, V18, P57, DOI 10.1111/j.1744-7917.2010.01396.x; Bution ML, 2008, MICRON, V39, P1179, DOI 10.1016/j.micron.2008.05.003; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Chou I, 1997, CICADIDAE CHINA HOMO, P1; CLARK TB, 1982, SCIENCE, V217, P57, DOI 10.1126/science.217.4554.57; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Douglas AE, 2009, FUNCT ECOL, V23, P38, DOI 10.1111/j.1365-2435.2008.01442.x; Douglas AE, 2015, ANNU REV ENTOMOL, V60, P17, DOI 10.1146/annurev-ento-010814-020822; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gonella E, 2011, APPL ENVIRON MICROB, V77, P1423, DOI 10.1128/AEM.02121-10; Gosalbes MJ, 2010, INT J MED MICROBIOL, V300, P271, DOI 10.1016/j.ijmm.2009.12.001; Gupta R, 2012, MOL BIOL REP, V39, P5607, DOI 10.1007/s11033-011-1365-2; Haine ER, 2008, P ROY SOC B-BIOL SCI, V275, P353, DOI 10.1098/rspb.2007.1211; Hou Z, 2014, J INSECT SCI, V15, P42; Hurst GDD, 2000, EMERG INFECT DIS, V6, P329, DOI 10.3201/eid0604.000402; Ishii Y, 2013, APPL ENVIRON MICROB, V79, P5013, DOI 10.1128/AEM.01527-13; Jurkevitch E, 2011, BENEFICIAL MICROORGA, P27; Koga R, 2013, ENVIRON MICROBIOL, V15, P2073, DOI 10.1111/1462-2920.12121; Koga R, 2012, P NATL ACAD SCI USA, V109, pE1230, DOI 10.1073/pnas.1119212109; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Lukasik P, 2013, ECOL LETT, V16, P214, DOI 10.1111/ele.12031; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Masurat P, 2005, J APPL MICROBIOL, V98, P727, DOI 10.1111/j.1365-2672.2004.02519.x; Mateos M, 2006, GENETICS, V174, P363, DOI 10.1534/genetics.106.058818; McCutcheon JP, 2010, GENOME BIOL EVOL, V2, P708, DOI 10.1093/gbe/evq055; McCutcheon JP, 2009, P NATL ACAD SCI USA, V106, P15394, DOI 10.1073/pnas.0906424106; McCutcheon JP, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000565; Michalik A, 2014, ARTHROPOD STRUCT DEV, V43, P579, DOI 10.1016/j.asd.2014.07.005; Mitsuhashi W, 2002, INSECT MOL BIOL, V11, P577, DOI 10.1046/j.1365-2583.2002.00368.x; Morales-Jimenez J, 2009, MICROB ECOL, V58, P879, DOI 10.1007/s00248-009-9548-2; Moran NA, 2000, CURR OPIN MICROBIOL, V3, P270, DOI 10.1016/S1369-5274(00)00088-6; Moran NA, 2005, APPL ENVIRON MICROB, V71, P8802, DOI 10.1128/AEM.71.12.8802-8810.2005; Moran NA, 2003, ENVIRON MICROBIOL, V5, P116, DOI 10.1046/j.1462-2920.2003.00391.x; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Muller H. J., 1962, Zeitschrift fuer Morphologie und Oekologie der Tiere Berlin, V51, P190, DOI 10.1007/BF00409635; Noda H, 2012, APPL ENTOMOL ZOOL, V47, P217, DOI 10.1007/s13355-012-0110-1; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Pachebat JA, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00329-3; Perlman SJ, 2006, P ROY SOC B-BIOL SCI, V273, P2097, DOI 10.1098/rspb.2006.3541; Read AF, 2001, SCIENCE, V292, P1099, DOI 10.1126/science.1059410; Redak RA, 2004, ANNU REV ENTOMOL, V49, P243, DOI 10.1146/annurev.ento.49.061802.123403; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; Sacchi L, 2008, TISSUE CELL, V40, P231, DOI 10.1016/j.tice.2007.12.005; Skaljac M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-142; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thao ML, 2000, APPL ENVIRON MICROB, V66, P2898, DOI 10.1128/AEM.66.7.2898-2905.2000; Thao ML, 2004, APPL ENVIRON MICROB, V70, P3401, DOI 10.1128/AEM.70.6.3401-3406.2004; Toth EM, 2006, MICROB ECOL, V51, P13, DOI 10.1007/s00248-005-0090-6; Urban JM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-87; Van Leuven JT, 2014, CELL, V158, P1270, DOI 10.1016/j.cell.2014.07.047; Van Leuven JT, 2012, GENOME BIOL EVOL, V4, P24, DOI 10.1093/gbe/evr125; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Welch EW, 2015, SYMBIOSIS, V66, P1, DOI 10.1007/s13199-015-0332-4; Yassin AF, 2005, INT J SYST EVOL MICR, V55, P1575, DOI 10.1099/ijs.0.63571-0; YOUNG D, 1995, J EXP BIOL, V198, P1001; [Zhang Ying 张瑛], 2015, [微生物学通报, Microbiology China], V42, P516; Zhong HY, 2015, ENTOMOL SCI, V18, P340, DOI 10.1111/ens.12115; Zhou WT, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev113	69	11	11	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0175903	10.1371/journal.pone.0175903	http://dx.doi.org/10.1371/journal.pone.0175903			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437427	Green Submitted, Green Published, gold			2022-12-26	WOS:000400287600020
J	Saputra, S; Jordan, D; Worthing, KA; Norris, JM; Wong, HS; Abraham, R; Trott, DJ; Abraham, S				Saputra, Sugiyono; Jordan, David; Worthing, Kate A.; Norris, Jacqueline M.; Wong, Hui S.; Abraham, Rebecca; Trott, Darren J.; Abraham, Sam			Antimicrobial resistance in coagulase-positive staphylococci isolated from companion animals in Australia: A one year study	PLOS ONE			English	Article							MULTIDRUG-RESISTANT; RISK-FACTORS; AUREUS; PSEUDINTERMEDIUS; PREVALENCE; CATS; ENVIRONMENT; INFECTION; CARRIAGE; PETS	Methicillin-resistant coagulase-positive staphylococci (CoPS) have become increasingly recognised as opportunistic pathogens that limit therapeutic options in companion animals. The frequency of methicillin resistance amongst clinical isolates on an Australia-wide level is unknown. This study determined antimicrobial susceptibility patterns for CoPS isolated from clinical infections in companion animals (dogs, cats and horses) as part of the first nation-wide survey on antimicrobial resistance in animal pathogens in Australia for a one-year period (January 2013 to January 2014). Clinical Staphylococcus spp. isolates (n = 888) obtained from 22 veterinary diagnostic laboratories were identified by MALDI-TOF mass spectrometry and subjected to antimicrobial susceptibility testing for 16 antimicrobials, representing 12 antimicrobial classes. Potential risk factors associated with methicillin resistance in Staphylococcus pseudintermedius isolates from dogs were analysed based on demographic factors and clinical history, including gender, age, previous antimicrobial treatment, chronic and/or recurrent diseases and site of infections. The most commonly identified CoPS were S. pseudintermedius (70.8%; dogs n = 616, cats n = 13) and S. aureus (13.2%, horses n = 53, dogs n = 47 and cats n = 17). Overall, the frequency of methicillin resistance among S. pseudintermedius (MRSP) and S. aureus (MRSA) was 11.8% and 12.8%, respectively. MRSP isolates were strongly associated with resistance to fluoroquinolones (OR 287; 95% CI 91.2-1144.8) and clindamycin (OR 105.2, 95% CI 48.5-231.9). MRSA isolates from dogs and cats were also more likely to be resistant to fluoroquinolones (OR 5.4, 95% CI 0.6-252.1), whereas MRSA from horses were more likely to be resistant to rifampicin. In multivariate analysis, MRSP-positive status was significantly associated with particular infection sites, including surgical (OR 8.8; 95% CI 3.74-20.7), and skin and soft tissue (OR 3.9; 95% CI 1.97-7.51). S. pseudintermedius isolated from dogs with surgical site infections were three times more likely to be methicillin-resistant if cases had received prior antimicrobial treatment. Whilst the survey results indicate the proportion of CoPS obtained from Australian companion animals that are methicillin-resistant is currently moderate, the identified risk factors suggest that it could rapidly increase without adequate biosecurity and infection control procedures in veterinary practice.	[Saputra, Sugiyono; Wong, Hui S.; Abraham, Rebecca; Trott, Darren J.; Abraham, Sam] Univ Adelaide, Australian Ctr Antimicrobial Resistance Ecol, Sch Anim & Vet Sci, Roseworthy, SA, Australia; [Saputra, Sugiyono] Indonesian Inst Sci, Res Ctr Biol, Cibinong, West Java, Indonesia; [Jordan, David] New South Wales Dept Primary Ind, Wollongbar, NSW, Australia; [Worthing, Kate A.; Norris, Jacqueline M.] Univ Sydney, Fac Vet Sci, Camperdown, NSW, Australia; [Abraham, Rebecca; Abraham, Sam] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia	University of Adelaide; Indonesian Institute of Sciences; NSW Department of Primary Industries; University of Sydney; Murdoch University	Trott, DJ; Abraham, S (corresponding author), Univ Adelaide, Australian Ctr Antimicrobial Resistance Ecol, Sch Anim & Vet Sci, Roseworthy, SA, Australia.; Abraham, S (corresponding author), Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia.	darren.trott@adelaide.edu.au; s.abraham@murdoch.edu.au	Jordan, David/P-7281-2019; Worthing, Kate/AAG-4907-2019; Saputra, Sugiyono/AAT-9363-2020	Worthing, Kate/0000-0001-8713-7189; Norris, Jacqueline/0000-0002-0003-6930; Saputra, Sugiyono/0000-0002-5449-3387; Abraham, Sam/0000-0003-0950-2317	Australian Research Council-Linkage Grant [LP130100736]; Australia Awards Scholarship - Australian Department Foreign Affairs and Trade; Zoetis	Australian Research Council-Linkage Grant(Australian Research Council); Australia Awards Scholarship - Australian Department Foreign Affairs and Trade; Zoetis	This work was supported by Zoetis and Australian Research Council-Linkage Grant (grant number LP130100736). SS was supported by an Australia Awards Scholarship sponsored by Australian Department Foreign Affairs and Trade. The funders had no role in study design, data collection and analysis, decision to publish, or identified risk factors suggest that it could rapidly increase without adequate biosecurity and preparation of the manuscript.	Abraham S, 2015, J GLOB ANTIMICROB RE, V3, P273, DOI 10.1016/j.jgar.2015.08.002; [Anonymous], 2014, DEV NAT ANT RES STRA; Axon JE, 2011, AUST VET J, V89, P221, DOI 10.1111/j.1751-0813.2011.00711.x; Ballhausen B, 2014, ANTIMICROB AGENTS CH, V58, P3791, DOI 10.1128/AAC.02731-13; Clinical and Laboratory Standards Institute (CLSI), 2020, PERFORMANCE STANDARD, V5th; CLSI, 2016, ECOFFINDER; CLSI, 2021, PERFORMANCE STANDARD, V5th; Crowley J, 2013, EQUINE VET J, V45, P20, DOI 10.1111/evj.12166; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; EUCAST, 2016, ANT WILD TYP DISTR M; European Food Safety Authority, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4036; Feng YY, 2012, VET MICROBIOL, V160, P517, DOI 10.1016/j.vetmic.2012.06.015; Gandolfi-Decristophoris P, 2013, J VET SCI, V14, P449, DOI 10.4142/jvs.2013.14.4.449; Gingrich EN, 2011, J VET DIAGN INVEST, V23, P947, DOI 10.1177/1040638711407301; Gold RM, 2014, J CLIN MICROBIOL, V52, P3641, DOI 10.1128/JCM.01253-14; Groves MD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146034; Guardabassi L, 2004, J ANTIMICROB CHEMOTH, V54, P321, DOI 10.1093/jac/dkh332; Harrison EM, 2014, MBIO, V5, DOI 10.1128/mBio.00985-13; Johnson AP, 2011, J ANTIMICROB CHEMOTH, V66, pIV43, DOI 10.1093/jac/dkr076; Jordan D, 2011, AUST VET J, V89, P152, DOI 10.1111/j.1751-0813.2011.00710.x; Lehner G, 2014, VET MICROBIOL, V168, P154, DOI 10.1016/j.vetmic.2013.10.023; Magalhaes RJS, 2010, VET RES, V41, DOI 10.1051/vetres/2010028; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Malik S, 2006, J CLIN MICROBIOL, V44, P413, DOI 10.1128/JCM.44.2.413-416.2006; Malik S, 2006, J ANTIMICROB CHEMOTH, V58, P428, DOI 10.1093/jac/dkl253; Merlino J, 2002, J ANTIMICROB CHEMOTH, V49, P793, DOI 10.1093/jac/dkf021; NORM/NORM- VET, 2013, US ANT AG OCC ANT RE; Paul NC, 2011, ZOONOSES PUBLIC HLTH, V58, P533, DOI 10.1111/j.1863-2378.2011.01398.x; Perreten V, 2010, J ANTIMICROB CHEMOTH, V65, P1145, DOI 10.1093/jac/dkq078; Ruscher C, 2010, VET MICROBIOL, V144, P340, DOI 10.1016/j.vetmic.2010.01.008; Savini V, 2013, RES MICROBIOL, V164, P371, DOI 10.1016/j.resmic.2013.02.004; Shaban R.Z., 2014, SURVEILLANCE REPORTI; Siak M, 2014, J MED MICROBIOL, V63, P1228, DOI 10.1099/jmm.0.076117-0; Smith TC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004564; Solyman SM, 2013, J CLIN MICROBIOL, V51, P306, DOI 10.1128/JCM.02421-12; SWEDRES/SVARM, 2015, USE OF ANTIMICROBIAL; Trott D, 2013, MICROBIOL AUST, V34, P25, DOI 10.1071/MA13008; Turnidge J, 2006, CLIN MICROBIOL INFEC, V12, P418, DOI 10.1111/j.1469-0691.2006.01377.x; van Duijkeren E, 2011, VET MICROBIOL, V150, P338, DOI 10.1016/j.vetmic.2011.02.012; Walther B, 2009, J CLIN MICROBIOL, V47, P704, DOI 10.1128/JCM.01626-08; Worthing KA, 2016, J ANTIMICROB CHEMOTH; Youn JH, 2014, COMP IMMUNOL MICROB, V37, P123, DOI 10.1016/j.cimid.2014.01.003; Youn JH, 2011, J VET DIAGN INVEST, V23, P268, DOI 10.1177/104063871102300211	43	57	59	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0176379	10.1371/journal.pone.0176379	http://dx.doi.org/10.1371/journal.pone.0176379			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430811	Green Published, gold			2022-12-26	WOS:000399876100042
J	Imboden, MT; Swartz, AM; Finch, HW; Herber, MP; Kaminsky, LA				Imboden, Mary T.; Swartz, Ann M.; Finch, Holmes W.; Herber, Matthew P.; Kaminsky, Leonard A.			Reference standards for lean mass measures using GE dual energy x-ray absorptiometry in Caucasian adults	PLOS ONE			English	Article							SKELETAL-MUSCLE MASS; BODY-COMPOSITION; FUNCTIONAL IMPAIRMENT; PHYSICAL-DISABILITY; REFERENCE RANGES; OLDER MEN; SARCOPENIA; WOMEN; DXA; FAT	Body composition assessments commonly focus predominantly on fat mass, however lean mass (LM) measurements also provide useful information regarding clinical and nutritional status. LM measurements help predict health outcomes and diagnose sarcopenia, which has been associated with frailty. Dual energy x-ray absorptiometry (DXA) is an established technique used in clinical and research settings to assess body composition including total and regional LM. Currently, there are no reference values available that were derived from GE-Healthcare DXA systems directly for US adults for LM, LM index (LMI), percent LM (% LM), and appendicular lean mass index (ALMI) and it is known that whole-body and regional LM measures differ by DXA manufacturer.	[Imboden, Mary T.; Finch, Holmes W.; Herber, Matthew P.; Kaminsky, Leonard A.] Ball State Univ, Muncie, IN 47306 USA; [Swartz, Ann M.] Univ Wisconsin Milwaukee, Milwaukee, WI USA	Ball State University; University of Wisconsin System; University of Wisconsin Milwaukee	Imboden, MT (corresponding author), Ball State Univ, Muncie, IN 47306 USA.	Mstuttle2@bsu.edu						Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Bijlsma AY, 2013, AGE, V35, P871, DOI 10.1007/s11357-012-9384-z; Castillo EM, 2003, AM J PREV MED, V25, P226, DOI 10.1016/S0749-3797(03)00197-1; Clark P, 2016, CALCIF TISSUE INT; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Delmonico MJ, 2007, J AM GERIATR SOC, V55, P769, DOI 10.1111/j.1532-5415.2007.01140.x; Fan B, 2014, J CLIN DENSITOM, V17, P344, DOI 10.1016/j.jocd.2013.08.019; Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003; Fuller NJ, 1999, INT J OBESITY, V23, P1295, DOI 10.1038/sj.ijo.0801070; Gillette-Guyonnet S, 2003, MECH AGEING DEV, V124, P317, DOI 10.1016/S0047-6374(02)00199-9; Gould H, 2014, CALCIFIED TISSUE INT, V94, P363, DOI 10.1007/s00223-013-9830-7; Guo S., 1997, AGE NUTR, V8, P12; HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P214, DOI 10.1093/ajcn/52.2.214; Hong S, 2011, J KOREAN MED SCI, V26, P1599, DOI 10.3346/jkms.2011.26.12.1599; Hull H, 2009, J CLIN DENSITOM, V12, P95, DOI 10.1016/j.jocd.2008.09.004; Imboden MT, 2017, PLOS ONE; Janssen I, 2004, AM J EPIDEMIOL, V159, P413, DOI 10.1093/aje/kwh058; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Kelly TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007038; Kirschner MM, 2011, MED SCI SPORTS EXERC, V43; Lustgarten MS, 2011, J NUTR HEALTH AGING, V15, P368, DOI 10.1007/s12603-011-0049-x; Melton LJ, 2000, J AM GERIATR SOC, V48, P625; Morrison SA, 2016, J CLIN DENSITOM, V19, P290, DOI 10.1016/j.jocd.2015.06.003; Pan H, 2004, STAT MED, V23, P1749, DOI 10.1002/sim.1692; Rizzoli R, 2013, CALCIFIED TISSUE INT, V93, P101, DOI 10.1007/s00223-013-9758-y; Shepherd JA, 2012, J BONE MINER RES, V27, P2208, DOI 10.1002/jbmr.1654; Stults-Kolehmainen MA, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.5; Van der Ploeg GE, 2003, J APPL PHYSIOL, V94, P499, DOI 10.1152/japplphysiol.00436.2002; Visser M, 1999, J APPL PHYSIOL, V87, P1513, DOI 10.1152/jappl.1999.87.4.1513; Wagner DR, 2000, AM J CLIN NUTR, V71, P1392; Wells JCK, 2010, INT J OBESITY, V34, P649, DOI 10.1038/ijo.2009.249	31	40	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176161	10.1371/journal.pone.0176161	http://dx.doi.org/10.1371/journal.pone.0176161			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426779	Green Published, gold			2022-12-26	WOS:000399875900112
J	Jelinska, A; Zagozdzon, A; Gorecki, M; Wisniewska, A; Frelek, J; Holyst, R				Jelinska, Aldona; Zagozdzon, Anna; Gorecki, Marcin; Wisniewska, Agnieszka; Frelek, Jadwiga; Holyst, Robert			Denaturation of proteins by surfactants studied by the Taylor dispersion analysis	PLOS ONE			English	Article							BOVINE SERUM-ALBUMIN; SODIUM DODECYL-SULFATE; FLUORESCENCE CORRELATION SPECTROSCOPY; DYNAMIC LIGHT-SCATTERING; CIRCULAR-DICHROISM SPECTROSCOPY; X-RAY-SCATTERING; BETA-LACTOGLOBULIN; IONIC SURFACTANTS; AGGREGATION; COMPLEXES	We showed that the Taylor Dispersion Analysis (TDA) is a fast and easy to use method for the study of denaturation proteins. We applied TDA to study denaturation of beta-lactoglobulin, transferrin, and human insulin by anionic surfactant sodium dodecyl sulfate (SDS). A series of measurements at constant protein concentration (for transferrin was 1.9 x 10(-5) M, for beta-lactoglobulin was 7.6 x 10(-5) M, and for insulin was 1.2 x 10(-4) M) and varying SDS concentrations were carried out in the phosphate-buffered saline (PBS). The structural changes were analyzed based on the diffusion coefficients of the complexes formed at various surfactant concentrations. The concentration of surfactant was varied in the range from 1.2 x 10(-4) M to 8.7 x 10(-2) M. We determined the minimum concentration of the surfactant necessary to change the native conformation of the proteins. The minimal concentration of SDS for beta-lactoglobulin and transferrin was 4.3 x 10(-4) M and for insulin 2.3 x 10(-4) M. To evaluate the TDA as a novel method for studying denaturation of proteins we also applied other methods i.e. electronic circular dichroism (ECD) and dynamic light scattering (DLS) to study the same phenomenon. The results obtained using these methods were in agreement with the results from TDA.	[Jelinska, Aldona; Zagozdzon, Anna; Wisniewska, Agnieszka; Holyst, Robert] Polish Acad Sci, Inst Phys Chem, Warsaw, Poland; [Gorecki, Marcin; Frelek, Jadwiga] Polish Acad Sci, Inst Organ Chem, Warsaw, Poland	Polish Academy of Sciences; Institute of Physical Chemistry of the Polish Academy of Sciences; Polish Academy of Sciences; Institute of Organic Chemistry of the Polish Academy of Sciences	Holyst, R (corresponding author), Polish Acad Sci, Inst Phys Chem, Warsaw, Poland.	rholyst@ichf.edu.pl	Górecki, Marcin/W-9352-2019; Wiśniewska, Agnieszka/HCI-1785-2022	Górecki, Marcin/0000-0001-7472-3875; Wiśniewska, Agnieszka/0000-0001-5317-757X; Holyst, Robert/0000-0002-3211-4286	National Science Centre [UMO-2012/07/B/ST4/01400]	National Science Centre(National Science Centre, Poland)	This research was supported by the National Science Centre Grant Opus4 (UMO-2012/07/B/ST4/01400).; This research was supported by the National Science Centre Grant Opus 4 (UMO-2012/07/B/ST4/01400).	Anand U, 2010, J PHYS CHEM B, V114, P15839, DOI 10.1021/jp106703h; Andersen KK, 2008, LANGMUIR, V24, P399, DOI 10.1021/la702890y; Andersen KK, 2009, J MOL BIOL, V391, P207, DOI 10.1016/j.jmb.2009.06.019; Borysik AJ, 2015, ANAL CHEM, V87, P8970, DOI 10.1021/acs.analchem.5b02172; Chalton DA, 2010, ANAL CHEM, V82, P3073, DOI 10.1021/ac902932c; Chamieh J, 2015, BIOMACROMOLECULES, V16, P3945, DOI 10.1021/acs.biomac.5b01260; Cottet H, 2007, BIOMACROMOLECULES, V8, P3235, DOI 10.1021/bm070268j; Cottet H, 2014, ANALYST, V139, P3552, DOI 10.1039/c4an00192c; Fiedler S, 2013, ANAL CHEM, V85, P1868, DOI 10.1021/ac303244g; Geissler E., 1993, DYNAMIC LIGHT SCATTE; Gelamo EL, 2000, SPECTROCHIM ACTA A, V56, P2255, DOI 10.1016/S1386-1425(00)00313-9; Gelamo EL, 2004, J COLLOID INTERF SCI, V277, P471, DOI 10.1016/j.jcis.2004.04.065; Ghosh S, 2008, COLLOID SURFACE B, V66, P178, DOI 10.1016/j.colsurfb.2008.06.011; Gull N, 2009, COLLOID SURFACE B, V69, P122, DOI 10.1016/j.colsurfb.2008.11.009; GUO XH, 1990, BIOPOLYMERS, V29, P335, DOI 10.1002/bip.360290206; Hansted JG, 2011, BBA-PROTEINS PROTEOM, V1814, P713, DOI 10.1016/j.bbapap.2011.03.011; Joshi V, 2014, ANAL CHEM, V86, P11606, DOI 10.1021/ac503140j; Kronberg B, 2014, SURFACE CHEMISTRY OF SURFACTANTS AND POLYMERS, P1, DOI 10.1002/9781118695968; Lad MD, 2003, LANGMUIR, V19, P5098, DOI 10.1021/la0269560; Leclercq L, 2015, MACROMOLECULES, V48, P7216, DOI 10.1021/acs.macromol.5b01824; Lewandrowska A, 2013, ANAL CHEM, V85, P4051, DOI 10.1021/ac4007792; Majcher A, 2015, ANAL CHIM ACTA, V855, P51, DOI 10.1016/j.aca.2014.12.008; Navea S, 2002, ANAL CHEM, V74, P6031, DOI 10.1021/ac025914d; Oshima T, 2012, ANAL CHIM ACTA, V710, P102, DOI 10.1016/j.aca.2011.10.034; Otzen DE, 2002, BIOPHYS J, V83, P2219, DOI 10.1016/S0006-3495(02)73982-9; Sahihi M, 2012, J CHEM THERMODYN, V52, P16, DOI 10.1016/j.jct.2011.12.017; Santos SF, 2003, J COLLOID INTERF SCI, V262, P400, DOI 10.1016/S0021-9797(03)00109-7; Schneider GF, 2008, J AM CHEM SOC, V130, P17384, DOI 10.1021/ja804736t; TAKEDA K, 1992, J COLLOID INTERF SCI, V154, P385, DOI 10.1016/0021-9797(92)90153-D; TANNER RE, 1982, J CHEM PHYS, V76, P3866, DOI 10.1063/1.443528; Thyparambil AA, 2015, LANGMUIR, V31, P11814, DOI 10.1021/acs.langmuir.5b02741; Valstar A, 2000, LANGMUIR, V16, P922, DOI 10.1021/la990423i; Wahlgren M, 1997, J DISPER SCI TECHNOL, V18, P449, DOI 10.1080/01932699708943747; Zhang D, 2008, BIOPHYS J, V95, P3439, DOI 10.1529/biophysj.108.133215; Zhang XZ, 2016, SOFT MATTER, V12, P8186, DOI 10.1039/c6sm01791f; Zhang XZ, 2015, SOFT MATTER, V11, P2512, DOI 10.1039/c5sm00101c	36	12	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175838	10.1371/journal.pone.0175838	http://dx.doi.org/10.1371/journal.pone.0175838			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426809	Green Published, Green Submitted, gold			2022-12-26	WOS:000399875900056
J	Neffatti, H; Lebraud, P; Hottelet, C; Gharbi, J; Challouf, T; Roque-Afonso, AM				Neffatti, Houcine; Lebraud, Patricia; Hottelet, Corinne; Gharbi, Jawher; Challouf, Taieb; Roque-Afonso, Anne-Marie			Southern Tunisia: A still high endemicity area for hepatitis A	PLOS ONE			English	Article							E VIRUS; SEROPREVALENCE; INFECTION; EPIDEMIOLOGY; CHILDREN; AFRICA; AGE	Background Hepatitis A (HAV) and E (HEV) viruses are responsible for enterically transmitted hepatitis. Tunisia is reported to be of intermediate endemicity for HAV and of low seroprevalence for HEV; however, data from rural areas of South Tunisia are lacking. Methods Sera from 216 asymptomatic pregnant women and from 92 patients with acute hepatitis were collected between October 2014 and November 2015. Total and IgM-anti-HAV immunoglobulins and anti-HEV IgG and IgM were investigated. Anti-HAV IgM-positive samples were subjected to RTPCR targeting the VP1/2A region and sequenced. HEV IgM positive samples and all samples from acute hepatitis patients were assessed for HEV RNA. Results Among pregnant women (mean age 32+/-8), HAV seroprevalence was 98.6%, none presented anti-HAV IgM; HEV seroprevalence was 5.1% and three presented weakly reactive anti-HEV IgM without detectable RNA. Among acute hepatitis patients (mean age 18.5 +/-14), HEV seroprevalence was 19,5%, none presented anti-HEV IgM, nor HEV RNA. HAV seroprevalence exceeded 90% by age 5 and acute HAV infection was detected in 20 patients (21,7%), younger than patients with other hepatitis causes (9,8 years vs. 20,4 years, p = 0,004); 65% were male. Most acute HAV infections were observed in a coastal area where HAV infections represented 52% of hepatitis etiology. Phylogenetic analysis identified genotype IA strains, clustering close to previously published Tunisian sequences. Conclusion The present study confirmed a low HEV endemicity and evidenced a still high level of HAV circulation in Southern Tunisia, suggesting distinct dissemination patterns for these viruses.	[Neffatti, Houcine; Lebraud, Patricia; Hottelet, Corinne; Roque-Afonso, Anne-Marie] Hop Paul Brousse, AP HP, Virol, Villejuif, France; [Neffatti, Houcine; Gharbi, Jawher] Univ Monastir, Inst Super Biotechnol, Monastir, Tunisia; [Challouf, Taieb] Hop Medenine, Med Interne, Medenine, Tunisia; [Roque-Afonso, Anne-Marie] INSERM, U1193, Villejuif, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Universite de Monastir; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Roque-Afonso, AM (corresponding author), Hop Paul Brousse, AP HP, Virol, Villejuif, France.; Roque-Afonso, AM (corresponding author), INSERM, U1193, Villejuif, France.	anne-marie.roque@aphp.fr	GHARBI, Jawhar/AHD-9205-2022; Roque-Afonso, Anne-Marie/AAF-9706-2021; Roque-Afonso, Anne-Marie/D-5737-2014	GHARBI, Jawhar/0000-0001-9170-3403; Roque-Afonso, Anne-Marie/0000-0002-6612-2030				[Anonymous], 2012, Wkly Epidemiol Rec, V87; Beji-Hamza A, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0249-9; Ben-Ayed Y, 2015, J MED VIROL, V87, P441, DOI 10.1002/jmv.24082; Bendall R, 2010, J MED VIROL, V82, P799, DOI 10.1002/jmv.21656; Desbois D, 2005, GASTROEN CLIN BIOL, V29, P573, DOI 10.1016/S0399-8320(05)82132-3; Gharbi-Khelifi H, 2006, J VIROL METHODS, V138, P109, DOI 10.1016/j.jviromet.2006.08.001; Gharbi-Khelifi H, 2012, INDIAN J VIROL, V23, P29, DOI 10.1007/s13337-012-0063-6; Hanafiah KM, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-57; Hannachi N, 2011, Pathol Biol (Paris), V59, pe115, DOI 10.1016/j.patbio.2009.06.004; Hasan G, 2016, J INT MED RES, V44, P1115, DOI 10.1177/0300060516659575; Hellara Olfa, 2014, Tunis Med, V92, P201; Jacobsen KH, 2010, VACCINE, V28, P6653, DOI 10.1016/j.vaccine.2010.08.037; Kamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7; Kim JH, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-308; Letaief A, 2005, AM J TROP MED HYG, V73, P40, DOI 10.4269/ajtmh.2005.73.40; Nainan OV, 2005, J INFECT DIS, V191, P957, DOI 10.1086/427992; Neffati H, 2012, CLIN MICROBIOL INFEC, V18, pE119, DOI 10.1111/j.1469-0691.2012.03793.x; Ouardani I, 2016, APPL ENVIRON MICROB, V82, P3834, DOI 10.1128/AEM.00619-16; Pavio N, 2015, CURR OPIN VIROL, V10, P34, DOI 10.1016/j.coviro.2014.12.006; Schwarz NG, 2008, EURO SURVEILL, V13	20	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175887	10.1371/journal.pone.0175887	http://dx.doi.org/10.1371/journal.pone.0175887			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426700	Green Submitted, gold, Green Published			2022-12-26	WOS:000399875900064
J	Nehme, R; Carpenter, B; Singhal, A; Strege, A; Edwards, PC; White, CF; Du, HJ; Grisshammer, R; Tate, CG				Nehme, Rony; Carpenter, Byron; Singhal, Ankita; Strege, Annette; Edwards, Patricia C.; White, Courtney F.; Du, Haijuan; Grisshammer, Reinhard; Tate, Christopher G.			Mini-G proteins: Novel tools for studying GPCRs in their active conformation	PLOS ONE			English	Article							ADENOSINE A(2A) RECEPTOR; BETA-ADRENERGIC-RECEPTORS; COUPLED RECEPTOR; STRUCTURAL BASIS; NEUROTENSIN RECEPTOR; CRYSTAL-STRUCTURE; MEMBRANE-PROTEINS; ACTIVATION; AGONIST; CRYSTALLIZATION	Mini-G proteins are the engineered GTPase domains of G alpha subunits. They couple to GPCRs and recapitulate the increase in agonist affinity observed upon coupling of a native heterotrimeric G protein. Given the small size and stability of mini-G proteins, and their ease of expression and purification, they are ideal for biophysical studies of GPCRs in their fully active state. The first mini-G protein developed was mini-G(s). Here we extend the family of mini-G proteins to include mini-G(olf), mini-G(i1), mini-G(o1) and the chimeras mini-G(s/q) and mini-G(s/i). The mini-G proteins were shown to couple to relevant GPCRs and to form stable complexes with purified receptors that could be purified by size exclusion chromatography. Agonist-bound GPCRs coupled to a mini-G protein showed higher thermal stability compared to the agonist-bound receptor alone. Fusion of GFP at the N-terminus of mini-G proteins allowed receptor coupling to be monitored by fluorescence-detection size exclusion chromatography (FSEC) and, in a separate assay, the affinity of mini-G protein binding to detergent-solubilised receptors was determined. This work provides the foundation for the development of any mini-G protein and, ultimately, for the structure determination of GPCRs in a fully active state.	[Nehme, Rony; Carpenter, Byron; Singhal, Ankita; Strege, Annette; Edwards, Patricia C.; Tate, Christopher G.] MRC Lab Mol Biol, Cambridge, England; [White, Courtney F.; Du, Haijuan; Grisshammer, Reinhard] NINDS, Membrane Prot Struct Funct Unit, NIH, US Dept HHS, Rockville, MD USA; [Carpenter, Byron] Univ Warwick, Warwick Integrat Synthet Biol Ctr, Sch Life Sci, Gibbet Hill Campus, Warwick, England	MRC Laboratory Molecular Biology; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Warwick	Tate, CG (corresponding author), MRC Lab Mol Biol, Cambridge, England.	cgt@mrc-lmb.cam.ac.uk	Carpenter, Byron/S-5206-2019	Carpenter, Byron/0000-0003-1712-3528; Tate, Christopher/0000-0002-2008-9183	European Research Council [EMPSI 339995]; Heptares Therapeutics; Medical Research Council [MC_U105197215]; Intramural Research Program of the National Institutes of Health, National Institute of Neurological Disorders and Stroke [ZIA NS003016-11]; Medical Research Council [1570806] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003016] Funding Source: NIH RePORTER; MRC [MC_U105197215] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Heptares Therapeutics; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Intramural Research Program of the National Institutes of Health, National Institute of Neurological Disorders and Stroke; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by the European Research Council (EMPSI 339995; R.N., A.S., C.G.T.), Heptares Therapeutics (B.C., C.G.T.), the Medical Research Council (MC_U105197215; A.S., P.E., C.G.T.) and the Intramural Research Program of the National Institutes of Health, National Institute of Neurological Disorders and Stroke (ZIA NS003016-11; C.F.W., H.D., R.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carpenter B, 2017, BIOPROTOCOL IN PRESS; Carpenter B, 2016, PROTEIN ENG DES SEL, V29, P583, DOI 10.1093/protein/gzw049; Carpenter B, 2016, NATURE, V536, P104, DOI 10.1038/nature18966; Chan P, 2013, P NATL ACAD SCI USA, V110, P3794, DOI 10.1073/pnas.1220943110; Chan P, 2011, J BIOL CHEM, V286, P2625, DOI 10.1074/jbc.M110.178897; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Clawges HM, 1997, BIOCHEMISTRY-US, V36, P12930, DOI 10.1021/bi970112b; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Conklin BR, 1996, MOL PHARMACOL, V50, P885; Flock T, 2015, NATURE, V524, P173, DOI 10.1038/nature14663; GREEN SA, 1992, MOL PHARMACOL, V41, P889; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Krumm BE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8895; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Kull B, 2000, MOL PHARMACOL, V58, P771, DOI 10.1124/mol.58.4.771; Lebon G, 2012, CURR OPIN STRUCT BIO; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Lebon G, 2011, J MOL BIOL, V409, P298, DOI 10.1016/j.jmb.2011.03.075; Magnani F, 2016, NAT PROTOC, V11, P1554, DOI 10.1038/nprot.2016.088; Nishimura A, 2010, P NATL ACAD SCI USA, V107, P13666, DOI 10.1073/pnas.1003553107; Oldham WM, 2006, Q REV BIOPHYS, V39, P117, DOI 10.1017/S0033583506004306; Pardon E, 2014, NAT PROTOC, V9, P674, DOI 10.1038/nprot.2014.039; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Semack A, 2016, J BIOL CHEM, V291, P17929, DOI 10.1074/jbc.M116.735720; Serrano-Vega MJ, 2009, MOL MEMBR BIOL, V26, P385, DOI 10.3109/09687680903208239; Shibata Y, 2009, J MOL BIOL, V390, P262, DOI 10.1016/j.jmb.2009.04.068; Sounier R, 2015, NATURE, V524, P375, DOI 10.1038/nature14680; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Syrovatkina V, 2016, J MOL BIOL, V428, P3850, DOI 10.1016/j.jmb.2016.08.002; Tate CG, 2012, TRENDS BIOCHEM SCI, V37, P343, DOI 10.1016/j.tibs.2012.06.003; Tate CG, 2010, METHODS MOL BIOL, V601, P187, DOI 10.1007/978-1-60761-344-2_12; Tate CG, 2009, CURR OPIN STRUC BIOL, V19, P386, DOI 10.1016/j.sbi.2009.07.004; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Thomas JA, 2014, J MOL BIOL, V426, P4139, DOI 10.1016/j.jmb.2014.10.012; Venkatakrishnan AJ, 2016, NATURE, V536, P484, DOI 10.1038/nature19107; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Wang C, 2013, SCIENCE, V340, P610, DOI 10.1126/science.1232807; Warne T, 2003, BBA-BIOMEMBRANES, V1610, P133, DOI 10.1016/S0005-2736(02)00716-2; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Zhang J, 2014, NATURE, V509, P119, DOI 10.1038/nature13288; Zhang XJ, 2015, TRENDS BIOCHEM SCI, V40, P79, DOI 10.1016/j.tibs.2014.12.005	51	100	101	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175642	10.1371/journal.pone.0175642	http://dx.doi.org/10.1371/journal.pone.0175642			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426733	Green Published, gold, Green Submitted			2022-12-26	WOS:000399875900036
J	Simon, O; Erlandson, MA; Frayssinet, M; Williams, T; Theilmann, DA; Volkoff, AN; Caballero, P				Simon, Oihane; Erlandson, Martin A.; Frayssinet, Marie; Williams, Trevor; Theilmann, David A.; Volkoff, Anne-Nathalie; Caballero, Primitivo			Lacanobia oleracea nucleopolyhedrovirus (LaolNPV): A new European species of alphabaculovirus with a narrow host range	PLOS ONE			English	Article							CHRYSODEIXIS-CHALCITES NUCLEOPOLYHEDROVIRUS; MAMESTRA-CONFIGURATA LEPIDOPTERA; SPODOPTERA-EXIGUA; GENOME SEQUENCE; MOLECULAR-IDENTIFICATION; GENETIC-VARIATION; BERTHA ARMYWORM; RACHIPLUSIA-OU; BACULOVIRUSES; NOCTUIDAE	During an insect sampling program in alfalfa crops near Montpellier, France in 2011, Lacanobia oleracea larvae were collected that died due to nucleopolyhedrovirus infection (LaolNPV). This virus was subjected to molecular and biological characterization. The virus was a multiple nucleocapsid NPV that showed similar restriction profiles to Mamestra configurata NPV-A (MacoNPV-A) but with significant differences. Polypeptide analysis demonstrated similar proteins in occlusion bodies and occlusion derived virions, to those observed in NPVs from Mamestra spp. Terminal sequencing revealed that the genome organization shared similarity with that of MacoNPV-A. The most homologous virus was MacoNPV-A 90/2 isolate (95.63% identity and 96.47% similarity), followed by MacoNPV-A 90/4 strain (95.37% and 96.26%), MacoNPV-B (89.21% and 93.53%) and M. brassicae MNPV (89.42% and 93.74%). Phylogenetic analysis performed with lef-8, lef-9, polh and a concatenated set of genes showed that LaolNPV and the Mamestra spp. NPVs clustered together with HaMNPV, but with a closer genetic distance to MacoNPV-A strains. The Kimura 2-parameter (K-2-P) distances of the complete genes were greater than 0.05 between LaolNPV and the MbMNPV/MacoNPV-B/HaMNPV complex, which indicates that LaolNPV is a distinct species. K-2-P distances were in the range 0.015-0.050 for comparisons of LaolNPV with MacoNPV-A strains, such that additional biological characteristics should be evaluated to determine species status. While MacoNPV-A was pathogenic to seven lepidopteran species tested, LaolNPV was only pathogenic to Chrysodeixis chalcites. Given these findings, Lacanobia oleracea nucleopolyhedrovirus should be considered as a new species in the Alphabaculovirus genus.	[Simon, Oihane; Caballero, Primitivo] Gobierno Navarra, CSIC UPNA, Inst Agrobiotecnol, Bioinsecticidas Microbianos, Mutilva Baja, Navarra, Spain; [Erlandson, Martin A.] Agr & Agri Food Canada, Sakatoon Res & Dev Ctr, Saskatoon, SK, Canada; [Frayssinet, Marie; Volkoff, Anne-Nathalie] UMR 1333 INRA Univ Montpellier 2, DGIMI, Montpellier, France; [Williams, Trevor; Volkoff, Anne-Nathalie] Inst Ecol AC, Xalapa, Veracruz, Mexico; [Theilmann, David A.] Agr & Agri Food Canada, Summerland Res & Dev Ctr, Summerland, BC, Canada; [Caballero, Primitivo] Univ Publica Navarra, Dept Prod Agraria, Campus Arrosadia S-N, Pamplona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-GN-UPNA - Instituto de Agrobiotecnologia (IDAB); Universidad Publica de Navarra; Agriculture & Agri Food Canada; INRAE; Universite de Montpellier; Instituto de Ecologia - Mexico; Agriculture & Agri Food Canada; Universidad Publica de Navarra	Simon, O (corresponding author), Gobierno Navarra, CSIC UPNA, Inst Agrobiotecnol, Bioinsecticidas Microbianos, Mutilva Baja, Navarra, Spain.	oihane.simon@unavarra.es	Williams, Trevor/F-1447-2011; Caballero, Primitivo/D-5063-2009; Theilmann, David A/N-6024-2017; Williams, Trevor/ABG-3961-2020; Simon, Oihane/G-5703-2014	Williams, Trevor/0000-0003-3414-3440; Caballero, Primitivo/0000-0003-0065-9625; Theilmann, David A/0000-0002-4910-3057; Simon, Oihane/0000-0003-1239-1486; Volkoff, Anne-Nathalie/0000-0002-7211-1370	National Institute of Agricultural Research from the Spanish Ministry [RTA2013-00114-C02-02]; Department of Industry of the Government of Navarre [IIQ1406-RII]; Agriculture and Agri-Food Canada Research [J000197]	National Institute of Agricultural Research from the Spanish Ministry; Department of Industry of the Government of Navarre; Agriculture and Agri-Food Canada Research(Agriculture & Agri Food Canada)	We thank Noelia Gorria and Itxaso Ibanez for insect rearing and Leire Bardaji and Eduardo Aguirre for technical assistance. We thank Doug Baldwin for assistance with bioassays in M. configurata and T. ni. TW received logistical support from Gabriel Mercado (INECOL). This study received financial support from the National Institute of Agricultural Research from the Spanish Ministry project RTA2013-00114-C02-02 (Dr. Oihane Simon) and from the Department of Industry of the Government of Navarre project IIQ1406-RII (Dr. Primitivo Caballero). This study was supported in part by funding from Agriculture and Agri-Food Canada Research Project J000197 (Dr. Martin A. Erlandson).; This study received financial support from the National Institute of Agricultural Research from the Spanish Ministry project RTA2013-00114-C02-02 (Dr. Oihane Simon) and from the Department of Industry of the Government of Navarre project II01406-RI1 (Dr. Primitivo Caballero). This study was supported in part by funding from Agriculture and Agri-Food Canada Research Project J000197 (Dr. Martin A. Erlandson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arrizubieta M, 2014, PEST MANAG SCI, V70, P967, DOI 10.1002/ps.3637; AYRES MD, 1994, VIROLOGY, V202, P586, DOI 10.1006/viro.1994.1380; Barrera G, 2011, BIOL CONTROL, V58, P113, DOI 10.1016/j.biocontrol.2011.04.009; Bernal A, 2013, BIOL CONTROL, V67, P101, DOI 10.1016/j.biocontrol.2013.08.006; BUCHER GE, 1976, CAN ENTOMOL, V108, P1327, DOI 10.4039/Ent1081327-12; Chen XW, 2002, J GEN VIROL, V83, P673, DOI 10.1099/0022-1317-83-3-673; Choi JB, 2013, VIRUS GENES, V47, P133, DOI 10.1007/s11262-013-0922-2; Cory JS, 2005, J INVERTEBR PATHOL, V89, P101, DOI 10.1016/j.jip.2005.03.008; Cory JS, 2003, ANNU REV ECOL EVOL S, V34, P239, DOI 10.1146/annurev.ecolsys.34.011802.132402; Eberle KE, 2009, J GEN VIROL, V90, P662, DOI 10.1099/vir.0.006999-0; ERLANDSON MA, 1990, J INVERTEBR PATHOL, V56, P47, DOI 10.1016/0022-2011(90)90143-T; Erlandson MA, 2013, BIOL CONTROL PROGRAM, P228; Erlandson Martin A., 2009, Virologica Sinica, V24, P458, DOI 10.1007/s12250-009-3052-1; Gomi S, 1999, J GEN VIROL, V80, P1323, DOI 10.1099/0022-1317-80-5-1323; GREENE GL, 1976, J ECON ENTOMOL, V69, P487, DOI 10.1093/jee/69.4.487; Harrison RL, 2003, J GEN VIROL, V84, P1827, DOI 10.1099/vir.0.19146-0; Harrison RL, 1999, J GEN VIROL, V80, P2793, DOI 10.1099/0022-1317-80-10-2793; Harrison RL, 2014, J INVERTEBR PATHOL, V116, P27, DOI 10.1016/j.jip.2013.12.005; Harrison RL, 2009, VIRUS GENES, V38, P155, DOI 10.1007/s11262-008-0297-y; Herniou EA, 2004, J VIROL, V78, P3244, DOI 10.1128/JVI.78.7.3244-3251.2004; Herniou EA, 2003, ANNU REV ENTOMOL, V48, P211, DOI 10.1146/annurev.ento.48.091801.112756; Herniou EA, 2012, 9 INT COMM TAX VIR, P167; HUGHES PR, 1981, J INVERTEBR PATHOL, V37, P154, DOI 10.1016/0022-2011(81)90069-0; IJkel WFJ, 1999, J GEN VIROL, V80, P3289, DOI 10.1099/0022-1317-80-12-3289; Jakubowska AK, 2006, J GEN VIROL, V87, P537, DOI 10.1099/vir.0.81461-0; Jehle JA, 2006, ARCH VIROL, V151, P1257, DOI 10.1007/s00705-006-0763-6; Jehle JA, 2006, VIROLOGY, V346, P180, DOI 10.1016/j.virol.2005.10.032; Kikhno I, 2002, J GEN VIROL, V83, P3013, DOI 10.1099/0022-1317-83-12-3013; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; King A.M., 2012, 9 REP INT COMM TAXON, P486, DOI DOI 10.1016/B978-0-12-384684-6.00034-3; KISLEV N, 1982, VIROLOGY, V119, P219, DOI 10.1016/0042-6822(82)90081-2; Kuzio J, 1999, VIROLOGY, V253, P17, DOI 10.1006/viro.1998.9469; Lange M, 2004, VIROLOGY, V325, P36, DOI 10.1016/j.virol.2004.04.023; Li LL, 2005, J GEN VIROL, V86, P91, DOI 10.1099/vir.0.80488-0; Li LL, 2002, VIROLOGY, V297, P226, DOI 10.1006/viro.2002.1411; Li QJ, 2002, VIROLOGY, V294, P106, DOI 10.1006/viro.2001.1313; Mason PG, 1998, CAN ENTOMOL, V130, P321, DOI 10.4039/Ent130321-3; Mukawa S, 2006, J GEN VIROL, V87, P1491, DOI 10.1099/vir.0.81853-0; Munoz D, 1999, VIRUS RES, V59, P61, DOI 10.1016/S0168-1702(98)00125-7; Murillo R, 2001, J APPL ENTOMOL, V125, P267, DOI 10.1046/j.1439-0418.2001.00533.x; Pang Y, 2001, VIROLOGY, V287, P391, DOI 10.1006/viro.2001.1056; PEARSON WR, 1990, METHOD ENZYMOL, V183, P63; Redman EM, 2016, J ANIM ECOL, V85, P1200, DOI 10.1111/1365-2656.12547; Redman EM, 2010, J INVERTEBR PATHOL, V105, P190, DOI 10.1016/j.jip.2010.06.008; Rovesti L, 2000, J INVERTEBR PATHOL, V75, P2, DOI 10.1006/jipa.1999.4903; Shapiro M, 2000, J ECON ENTOMOL, V93, P572, DOI 10.1603/0022-0493-93.3.572; SHAPIRO M, 1995, J ECON ENTOMOL, V88, P265, DOI 10.1093/jee/88.2.265; Simon O, 2011, J INVERTEBR PATHOL, V107, P33, DOI 10.1016/j.jip.2011.01.002; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang P, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-168; van Oers MM, 2005, J GEN VIROL, V86, P2069, DOI 10.1099/vir.0.80964-0; Willis LG, 2005, VIROLOGY, V338, P209, DOI 10.1016/j.virol.2005.04.041; Zhang CX, 2005, VIROLOGY, V333, P190, DOI 10.1016/j.virol.2004.12.028	54	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176171	10.1371/journal.pone.0176171	http://dx.doi.org/10.1371/journal.pone.0176171			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426736	gold, Green Published, Green Submitted			2022-12-26	WOS:000399875900115
J	Tanner, MR; Pennington, MW; Laragione, T; Gulko, PS; Beeton, C				Tanner, Mark R.; Pennington, Michael W.; Laragione, Teresina; Gulko, Percio S.; Beeton, Christine			KCa1.1 channels regulate beta(1)-integrin function and cell adhesion in rheumatoid arthritis fibroblast-like synoviocytes	FASEB JOURNAL			English	Article						migration; synovial fibroblast; invasion	PROTEIN-PROTEIN INTERACTIONS; GATED POTASSIUM CHANNELS; SYNOVIAL FIBROBLASTS; INTEGRIN ACTIVATION; LARGE-CONDUCTANCE; PLASMA-MEMBRANE; MATRIX PROTEINS; FLOW-CYTOMETRY; SMOOTH-MUSCLE; BETA-1 CHAIN	Large-conductance calcium-activated potassium channel (KCa1.1; BK, Slo1, MaxiK, KCNMA1) is the predominant potassium channel expressed at the plasma membrane of rheumatoid arthritis fibroblast-like synoviocytes (RA-FLSs) isolated from the synovium of patients with RA. It is a critical regulator of RA-FLS migration and invasion and therefore represents an attractive target for the therapy of RA. However, the molecular mechanisms by which KCa1.1 regulates RA-FLS invasiveness have remained largely unknown. Here, we demonstrate that KCa1.1 regulates RA-FLS adhesion through controlling the plasma membrane expression and activation of beta(1) integrins, but not alpha(4), alpha(5), or alpha(6) integrins. Blocking KCa1.1 disturbs calcium homeostasis, leading to the sustained phosphorylation of Akt and the recruitment of talin to beta(1) integrins. Interestingly, the pore-forming a subunit of KCa1.1 coimmunoprecipitates with beta(1) integrins, suggesting that this physical association underlies the functional interaction between these molecules. Together, these data outline a new signaling mechanism by which KCa1.1 regulates beta(1)-integrin function and therefore invasiveness of RA-FLSs.	[Tanner, Mark R.; Beeton, Christine] Baylor Univ, Dept Mol Physiol & Biophys, Mail Stop BCM335, Houston, TX 77030 USA; [Tanner, Mark R.] Baylor Coll Med, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Beeton, Christine] Baylor Coll Med, Biol Inflammat Ctr, Houston, TX 77030 USA; [Beeton, Christine] Baylor Coll Med, Ctr Drug Discovery, Houston, TX 77030 USA; [Pennington, Michael W.] Peptides Int Inc, Louisville, KY USA; [Laragione, Teresina; Gulko, Percio S.] Icahn Sch Med Mt Sinai, Dept Med, Div Rheumatol, New York, NY 10029 USA	Baylor University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Icahn School of Medicine at Mount Sinai	Beeton, C (corresponding author), Baylor Univ, Dept Mol Physiol & Biophys, Mail Stop BCM335, Houston, TX 77030 USA.	beeton@bcm.edu		Tanner, Mark/0000-0002-6516-0166; pennington, michael/0000-0001-5446-3447	Baylor College of Medicine; U.S. National Institutes of Health (NIH) F31 Award [AR069960]; U.S. National Institutes of Health (NIH) T32 Award [GM088129, AI053831]; NIH [RR024574, AI036211, CA125123]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211, T32AI053831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F31AR069960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM088129] Funding Source: NIH RePORTER	Baylor College of Medicine; U.S. National Institutes of Health (NIH) F31 Award; U.S. National Institutes of Health (NIH) T32 Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in part, by funding from the Baylor College of Medicine (to C.B.). M.R.T. was supported by U.S. National Institutes of Health (NIH) F31 Award AR069960 (National Institute of Arthritis and Musculoskeletal and Skin Diseases), and T32 Awards GM088129 [National Institute of General Medical Sciences (NIGMS)] and AI053831 [National Institute of Allergy and Infectious Diseases (NIAID)]. The Cytometry and Cell Sorting Core at Baylor College of Medicine is supported, in part, by the NIH [Grants RR024574 (NIGMS), AI036211 (NIAID), and CA125123 (National Cancer Institute)].	Agarwal SK, 2006, CURR OPIN RHEUMATOL, V18, P268, DOI 10.1097/01.bor.0000218948.42730.39; Ah Kioon Marie-Dominique, 2010, Arthritis Res Ther, V12, pR190, DOI 10.1186/ar3160; Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Arcangeli A, 2004, BIOCHEM SOC T, V32, P826, DOI 10.1042/BST0320826; Artym VV, 2002, J GEN PHYSIOL, V120, P29, DOI 10.1085/jgp.20028607; Bartok B, 2012, AM J PATHOL, V180, P1906, DOI 10.1016/j.ajpath.2012.01.030; Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; Bida AT, 2012, METHODS, V56, P154, DOI 10.1016/j.ymeth.2011.09.005; BODARY SC, 1990, J BIOL CHEM, V265, P5938; Bridgeman JS, 2010, CYTOM PART A, V77A, P338, DOI 10.1002/cyto.a.20840; Calderwood DA, 2004, BIOCHEM SOC T, V32, P434, DOI 10.1042/BST0320434; CANDIA S, 1992, BIOPHYS J, V63, P583, DOI 10.1016/S0006-3495(92)81630-2; Cao FF, 2014, CYTOM PART A, V85, P359, DOI 10.1002/cyto.a.22421; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; Cheung SY, 2015, ENDOCRINOLOGY, V156, P2074, DOI 10.1210/en.2014-1831; Ching LC, 2011, CARDIOVASC RES, V91, P492, DOI 10.1093/cvr/cvr104; Ciurtin C, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-111; Coticchia CM, 2009, BREAST CANCER RES TR, V115, P545, DOI 10.1007/s10549-008-0097-z; Cunningham CA, 2013, EUR J IMMUNOL, V43, P3361, DOI 10.1002/eji.201343635; Danciu TE, 2003, FEBS LETT, V536, P193, DOI 10.1016/S0014-5793(03)00055-3; Davis TR, 2010, JOVE-J VIS EXP, V46, P2066; Deb TB, 2004, J BIOL CHEM, V279, P38903, DOI 10.1074/jbc.M405314200; Dehart GW, 2008, P NATL ACAD SCI USA, V105, P7188, DOI 10.1073/pnas.0708044105; Deswal S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022928; Doerner JF, 2011, J GEN PHYSIOL, V137, P271, DOI 10.1085/jgp.200910388; Gradilone SA, 2010, GASTROENTEROLOGY, V139, P304, DOI 10.1053/j.gastro.2010.04.010; Grimm C, 2005, MOL PHARMACOL, V67, P798, DOI 10.1124/mol.104.006734; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Hu XY, 2012, J BIOL CHEM, V287, P4014, DOI 10.1074/jbc.M111.312264; HUMPHRIES MJ, 1986, J CELL BIOL, V103, P2637, DOI 10.1083/jcb.103.6.2637; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kim W, 2003, FASEB J, V17, P1937, DOI 10.1096/fj.02-1209fje; Kochukov MY, 2006, AM J PHYSIOL-CELL PH, V291, pC424, DOI 10.1152/ajpcell.00553.2005; Kochukov MY, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-49; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Kwan HY, 2009, CIRC RES, V104, P670, DOI 10.1161/CIRCRESAHA.108.188748; Laragione T, 2015, CLIN IMMUNOL, V158, P183, DOI 10.1016/j.clim.2015.04.001; Laragione T, 2010, MOL MED, V16, P352, DOI 10.2119/molmed.2010.00049; LAWSON MA, 1995, NATURE, V377, P75, DOI 10.1038/377075a0; Lee EG, 2011, INFLAMMATION, V34, P335, DOI 10.1007/s10753-010-9239-7; Levite M, 2000, J EXP MED, V191, P1167, DOI 10.1084/jem.191.7.1167; Lowin T, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3464; Lowin T, 2009, ARTHRITIS RHEUM-US, V60, P3623, DOI 10.1002/art.24985; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Matheu MP, 2008, IMMUNITY, V29, P602, DOI 10.1016/j.immuni.2008.07.015; Matta JA, 2007, J PHYSIOL-LONDON, V585, P469, DOI 10.1113/jphysiol.2007.144287; McGarry T, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0664-8; MORGAN AJ, 1994, BIOCHEM J, V300, P665, DOI 10.1042/bj3000665; MullerLadner U, 1997, J RHEUMATOL, V24, P1873; NIKKARI L, 1995, J RHEUMATOL, V22, P16; Nishizuka M, 2014, INT J MOL SCI, V15, P22743, DOI 10.3390/ijms151222743; Patra AK, 2004, J IMMUNOL, V172, P4812, DOI 10.4049/jimmunol.172.8.4812; PELLEGRINI R, 1992, TUMORI, V78, P1; Pennington MW, 1996, BIOCHEMISTRY-US, V35, P16407, DOI 10.1021/bi962463g; Petho Z, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1003-4; Pirila L, 2001, J RHEUMATOL, V28, P478; Rinaldi N, 1997, ANN RHEUM DIS, V56, P45, DOI 10.1136/ard.56.1.45; Roberts MS, 2004, MOL CELL BIOL, V24, P1505, DOI 10.1128/MCB.24.4.1505-1515.2004; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Sanchez M, 1996, NEUROPHARMACOLOGY, V35, P963, DOI 10.1016/0028-3908(96)00137-2; Sarkissian M, 1999, J IMMUNOL, V162, P1772; Schedel J, 2004, SCAND J IMMUNOL, V60, P514, DOI 10.1111/j.0300-9475.2004.01507.x; Schrum Adam G, 2007, Sci STKE, V2007, ppl2, DOI 10.1126/stke.3892007pl2; Seguin L, 2015, TRENDS CELL BIOL, V25, P234, DOI 10.1016/j.tcb.2014.12.006; Singh K, 2008, J IMMUNOL, V180, P1971, DOI 10.4049/jimmunol.180.3.1971; Smith SEP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045722; Somanath PR, 2007, J BIOL CHEM, V282, P22964, DOI 10.1074/jbc.M700241200; Sureshbabu A, 2012, J CELL SCI, V125, P1693, DOI 10.1242/jcs.092882; Tajhya RB, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.324; Tanner MR, 2015, ARTHRITIS RHEUMATOL, V67, P96, DOI 10.1002/art.38883; Wan X, 2014, PFLUG ARCH EUR J PHY, V466, P1273, DOI 10.1007/s00424-013-1345-6; Wu X, 2008, J PHYSIOL-LONDON, V586, P1699, DOI 10.1113/jphysiol.2007.149500; Wu Y, 2013, INT J DISTRIB SENS N, DOI 10.1155/2013/912873; Xu SZ, 2008, NATURE, V451, P69, DOI 10.1038/nature06414; Yang Y, 2010, J BIOL CHEM, V285, P131, DOI 10.1074/jbc.M109.033506; Yarwood SJ, 2001, P NATL ACAD SCI USA, V98, P4472, DOI 10.1073/pnas.081069098; Yoeli-Lerner M, 2005, MOL CELL, V20, P539, DOI 10.1016/j.molcel.2005.10.033; Yoon HJ, 2011, ARTHRITIS RHEUM-US, V63, P1843, DOI 10.1002/art.30229; Zanou N, 2012, J BIOL CHEM, V287, P14524, DOI 10.1074/jbc.M112.341784; Zhou Y, 2014, J GEN PHYSIOL, V144, P415, DOI 10.1085/jgp.201411259	80	18	18	2	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3309	3320		10.1096/fj.201601097R	http://dx.doi.org/10.1096/fj.201601097R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28428266	Green Published			2022-12-26	WOS:000405932400011
J	Ren, DP; Fisher, LA; Zhao, J; Wang, L; Williams, BC; Goldberg, ML; Peng, AM				Ren, Dapeng; Fisher, Laura A.; Zhao, Jing; Wang, Ling; Williams, Byron C.; Goldberg, Michael L.; Peng, Aimin			Cell cycle-dependent regulation of Greatwall kinase by protein phosphatase 1 and regulatory subunit 3B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							M-PHASE ENTRY; XENOPUS EGG EXTRACTS; MITOTIC EXIT; MITOSIS; MASTL; CANCER; DEPHOSPHORYLATION; INACTIVATION; PROGRESSION; EXPRESSION	Greatwall (Gwl) kinase plays an essential role in the regulation of mitotic entry and progression. Mitotic activation of Gwl requires both cyclin-dependent kinase 1 (CDK1)-dependent phosphorylation and its autophosphorylation at an evolutionarily conserved serine this study we show that Gwl associates with protein phosphatase 1 (PP1), particularly PP1 gamma, which mediates the dephosphorylation of Gwl Ser-883. Consistent with the mitotic activation of Gwl, its association with PP1 is disrupted in mitotic cells and egg extracts. During mitotic exit, PP1-dependent dephosphorylation of Gwl Ser-883 occurs prior to dephosphorylation of other mitotic substrates; replacing endogenous Gwl with a phosphomimetic S883E mutant blocks mitotic exit. Moreover, we identified PP1 regulatory subunit 3B (PPP1R3B) as a targeting subunit that can direct PP1 activity toward Gwl. PPP1R3B bridges PP1 and Gwl association and promotes Gwl Ser-883 dephosphorylation. Consistent with the cell cycle-dependent association of Gwl and PP1, Gwl and PPP1R3B dissociate in M phase. Interestingly, up-regulation of PPP1R3B facilitates mitotic exit and blocks mitotic entry. Thus, our study suggests PPP1R3B as a new cell cycle regulator that functions by governing Gwl dephosphorylation.	[Ren, Dapeng; Fisher, Laura A.; Zhao, Jing; Wang, Ling; Peng, Aimin] Univ Nebraska Med Ctr, Dept Oral Biol, Coll Dent, Lincoln, NE 68583 USA; [Williams, Byron C.; Goldberg, Michael L.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska Medical Center; Cornell University	Peng, AM (corresponding author), Univ Nebraska Med Ctr, Dept Oral Biol, Coll Dent, Lincoln, NE 68583 USA.	Aimin.Peng@UNMC.edu	ren, dapeng/AAF-1737-2020	WILLIAMS, BYRON/0000-0002-1517-931X	National Institutes of Health [1R01CA172574, 5P20GM103489]; NATIONAL CANCER INSTITUTE [R01CA172574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048430, P30GM106397, P20GM103489] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants 1R01CA172574 and 5P20GM103489 (to A. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alvarez-Fernandez M, 2013, P NATL ACAD SCI USA, V110, P17374, DOI 10.1073/pnas.1310745110; Anania MC, 2015, ONCOTARGET, V6, P34629, DOI 10.18632/oncotarget.5282; Archambault V, 2007, PLOS GENET, V3, P2163, DOI 10.1371/journal.pgen.0030200; Blake-Hodek KA, 2012, MOL CELL BIOL, V32, P1337, DOI 10.1128/MCB.06525-11; Bollen M, 2009, TRENDS CELL BIOL, V19, P531, DOI 10.1016/j.tcb.2009.06.005; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Castilho PV, 2009, MOL BIOL CELL, V20, P4777, DOI 10.1091/mbc.E09-07-0643; De Wulf P, 2009, CURR OPIN CELL BIOL, V21, P806, DOI 10.1016/j.ceb.2009.08.003; Della Monica R, 2015, ELIFE, V4, DOI 10.7554/eLife.10399; DOHERTY MJ, 1995, FEBS LETT, V375, P294, DOI 10.1016/0014-5793(95)01184-G; Fisher LA, 2014, J BIOL CHEM, V289, P23745, DOI 10.1074/jbc.M114.572149; Gharbi-Ayachi A, 2010, SCIENCE, V330, P1673, DOI 10.1126/science.1197048; Glover DM, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120023; Goldberg ML, 2010, P NATL ACAD SCI USA, V107, P12409, DOI 10.1073/pnas.1006046107; Grallert A, 2015, NATURE, V517, P94, DOI 10.1038/nature14019; Hegarat N, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004004; Heim A, 2015, EMBO REP, V16, P1501, DOI 10.15252/embr.201540876; Hunt Tim, 2013, Adv Biol Regul, V53, P173, DOI 10.1016/j.jbior.2013.04.001; KUMAGAI A, 1992, CELL, V70, P139, DOI 10.1016/0092-8674(92)90540-S; Lens SMA, 2010, NAT REV CANCER, V10, P825, DOI 10.1038/nrc2964; Lesage B, 2004, J BIOL CHEM, V279, P55978, DOI 10.1074/jbc.M411911200; Li Y, 2015, CELL MOL BIOL, V61, P2; Lorca T, 2013, ONCOGENE, V32, P537, DOI 10.1038/onc.2012.79; Ma HT, 2011, BIOCHEM J, V435, P17, DOI 10.1042/BJ20100284; Ma S, 2016, J CELL SCI, V129, P1329, DOI 10.1242/jcs.178855; Manchado E, 2010, CANCER CELL, V18, P641, DOI 10.1016/j.ccr.2010.10.028; Mochida S, 2016, CURR BIOL, V26, P3361, DOI 10.1016/j.cub.2016.10.022; Mochida S, 2010, SCIENCE, V330, P1670, DOI 10.1126/science.1195689; Mochida S, 2009, EMBO J, V28, P2777, DOI 10.1038/emboj.2009.238; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; Nagel R, 2015, MOL CANCER THER, V14, P1434, DOI 10.1158/1535-7163.MCT-14-0846; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Peng A, 2010, ONCOGENE, V29, P5977, DOI 10.1038/onc.2010.371; Peng AM, 2011, J BIOL CHEM, V286, P28996, DOI 10.1074/jbc.M111.257121; Peng AM, 2010, CURR BIOL, V20, P387, DOI 10.1016/j.cub.2010.01.020; Rebelo S, 2015, CELL SIGNAL, V27, P2589, DOI 10.1016/j.cellsig.2015.08.007; Rogers S, 2016, J CELL SCI, V129, P1340, DOI 10.1242/jcs.179754; SILVA EFDE, 1995, J NEUROSCI, V15, P3375; Vera J, 2015, ELIFE, V4, DOI 10.7554/eLife.10115; Vigneron S, 2011, MOL CELL BIOL, V31, P2262, DOI 10.1128/MCB.00753-10; Vigneron S, 2009, EMBO J, V28, P2786, DOI 10.1038/emboj.2009.228; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Voets E, 2010, CELL CYCLE, V9, P3591, DOI 10.4161/cc.9.17.12832; Wang L, 2014, ONCOTARGET, V5, P11479, DOI 10.18632/oncotarget.2565; Wang L, 2011, HYBRIDOMA, V30, P469, DOI 10.1089/hyb.2011.0051; Wang P, 2016, CELL CYCLE, V15, P528, DOI 10.1080/15384101.2015.1127476; Wang P, 2013, J CELL BIOL, V202, P277, DOI 10.1083/jcb.201211141; Williams BC, 2014, ELIFE, V3, DOI 10.7554/eLife.01695; Wurzenberger C, 2011, NAT REV MOL CELL BIO, V12, P469, DOI 10.1038/nrm3149; Yamamoto TM, 2011, MOL BIOL CELL, V22, P2157, DOI 10.1091/mbc.E11-01-0008; YANAGIDA M, 1992, CIBA F SYMP, V170, P130; Yu JT, 2006, MOL CELL, V22, P83, DOI 10.1016/j.molcel.2006.02.022	52	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10026	10034		10.1074/jbc.M117.778233	http://dx.doi.org/10.1074/jbc.M117.778233			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28446604	Green Published, hybrid			2022-12-26	WOS:000403580600015
J	Wang, JL; Saha, TT; Zhang, Y; Zhang, CY; Raikhel, AS				Wang, Jia-Lin; Saha, Tusar T.; Zhang, Yang; Zhang, Changyu; Raikhel, Alexander S.			Juvenile hormone and its receptor methoprene-tolerant promote ribosomal biogenesis and vitellogenesis in the Aedes aegypti mosquito	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KRUPPEL HOMOLOG 1; FAT-BODY; SACCHAROMYCES-CEREVISIAE; REPRODUCTIVE PROCESSES; GENE-EXPRESSION; YELLOW-FEVER; PROTEINS; EMERGENCE; 20-HYDROXYECDYSONE; DYNAMICS	Juvenile hormone (JH) controls many biological activities in insects, including development, metamorphosis, and reproduction. In the Aedes aegypti mosquito, a vector of dengue, yellow fever, chikungunya, and zika viruses, the metabolic tissue (the fat body, which is an analogue of the vertebrate liver) produces yolk proteins for developing oocytes. JH is important for the fat body to acquire competence for yolk protein production. However, the molecular mechanisms of how JH promotes mosquito reproduction are not completely understood. In this study we show that stimulation of the JH receptor methoprene-tolerant (Met) activates expression of genes encoding the regulator of ribosome synthesis 1 (RRS1) and six ribosomal proteins (two ribosomal large subunit proteins, two ribosomal small subunit proteins, and two mitochondrial ribosomal proteins). Moreover, RNAi-mediated depletion of RRS1 decreased biosynthesis of the ribosomal protein L32 (RpL32). Depletion of Met, RRS1, or RpL32 led to retardation of ovarian growth and reduced mosquito fecundity, which may at least in part have resulted from decreased vitellogenin protein production in the fat body. In summary, our results indicate that JH is critical for inducing the expression of ribosomal protein genes and demonstrate that RRS1 mediates the JH signal to enhance both ribosomal biogenesis and vitellogenesis.	[Wang, Jia-Lin; Saha, Tusar T.; Zhang, Yang; Zhang, Changyu; Raikhel, Alexander S.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Wang, Jia-Lin] Cent China Normal Univ, Sch Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan 430079, Peoples R China; [Saha, Tusar T.; Raikhel, Alexander S.] Univ Calif Riverside, Inst Integrat Genom Biol, Riverside, CA 92521 USA; [Zhang, Yang] Chinese Acad Sci, South China Sea Inst Oceanol, Key Lab Trop Marine Bioresources & Ecol, Guangzhou 510301, Guangdong, Peoples R China; [Zhang, Changyu] Guizhou Univ, Coll Agr, Guizhou Key Lab Plant Pest Management Mt Reg, Guiyang 550025, Peoples R China	University of California System; University of California Riverside; Central China Normal University; University of California System; University of California Riverside; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Guizhou University	Raikhel, AS (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.; Raikhel, AS (corresponding author), Univ Calif Riverside, Inst Integrat Genom Biol, Riverside, CA 92521 USA.	alexander.raikhel@ucr.edu		Zhang, Yang/0000-0002-0789-4938	National Institutes of Health [R01 AI036959]; China Scholarship Council of Chinese Ministry of Education [201506775010]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036959] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council of Chinese Ministry of Education; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant R01 AI036959 (to A. S. R.). This work was also supported by Scholar Fellowship 201506775010 (to J.-L. W.) from the China Scholarship Council of Chinese Ministry of Education. The authors declare that they have no conflicts of interest regarding the content of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Attardo GM, 2005, INSECT BIOCHEM MOLEC, V35, P661, DOI 10.1016/j.ibmb.2005.02.013; Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454; Belles X, 2005, REPRO BIOL, V12, P157; Bian GW, 2008, INSECT BIOCHEM MOLEC, V38, P190, DOI 10.1016/j.ibmb.2007.10.008; Charles JP, 2011, P NATL ACAD SCI USA, V108, P21128, DOI 10.1073/pnas.1116123109; Cui YJ, 2014, INSECT BIOCHEM MOLEC, V52, P23, DOI 10.1016/j.ibmb.2014.05.009; Ernst KC, 2017, J MED ENTOMOL, V54, P204, DOI 10.1093/jme/tjw141; Estep AS, 2016, J INSECT PHYSIOL, V90, P17, DOI 10.1016/j.jinsphys.2016.05.001; Guo W, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004702; He F, 2015, CHROMOSOMA, V124, P191, DOI 10.1007/s00412-014-0490-9; James A, 2013, NUCLEUS-PHILA, V4, P123, DOI 10.4161/nucl.23944; Jindra M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005394; Kayukawa T, 2012, P NATL ACAD SCI USA, V109, P11729, DOI 10.1073/pnas.1204951109; Kim M, 2010, J COMP PHYSIOL B, V180, P171, DOI 10.1007/s00360-009-0406-9; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; Li M, 2011, P NATL ACAD SCI USA, V108, P638, DOI 10.1073/pnas.1013914108; Lucas KJ, 2015, P NATL ACAD SCI USA, V112, P1440, DOI 10.1073/pnas.1424408112; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Miura K, 2005, FEBS J, V272, P1169, DOI 10.1111/j.1742-4658.2005.04552.x; Miyoshi K, 2004, FEBS LETT, V565, P106, DOI 10.1016/j.febslet.2004.03.087; Naora H, 1999, IMMUNOL CELL BIOL, V77, P197, DOI 10.1046/j.1440-1711.1999.00816.x; Parthasarathy R, 2010, INSECT BIOCHEM MOLEC, V40, P405, DOI 10.1016/j.ibmb.2010.03.006; RAIKHEL AS, 1986, J INSECT PHYSIOL, V32, P879, DOI 10.1016/0022-1910(86)90103-4; RAIKHEL AS, 1991, TISSUE CELL, V23, P577, DOI 10.1016/0040-8166(91)90015-L; RAIKHEL AS, 1990, GEN COMP ENDOCR, V77, P423, DOI 10.1016/0016-6480(90)90233-C; RAIKHEL AS, 1983, TISSUE CELL, V15, P281, DOI 10.1016/0040-8166(83)90023-X; RAIKHEL AS, 1992, ANNU REV ENTOMOL, V37, P217, DOI 10.1146/annurev.en.37.010192.001245; Roy S, 2016, ADV INSECT PHYSIOL, V51, P115, DOI 10.1016/bs.aiip.2016.05.004; Roy SG, 2007, INSECT BIOCHEM MOLEC, V37, P1317, DOI 10.1016/j.ibmb.2007.08.004; Saha TT, 2016, P NATL ACAD SCI USA, V113, pE735, DOI 10.1073/pnas.1523838113; Smykal V, 2014, INSECT BIOCHEM MOLEC, V45, P69, DOI 10.1016/j.ibmb.2013.12.003; Tsetsarkin KA, 2016, CURR OPIN VIROL, V16, P143, DOI 10.1016/j.coviro.2016.02.007; Tsuno A, 2000, MOL CELL BIOL, V20, P2066, DOI 10.1128/MCB.20.6.2066-2074.2000; Weaver Scott C, 2016, Antiviral Res, V130, P69, DOI 10.1016/j.antiviral.2016.03.010; Wyatt GR, 1996, ADV INSECT PHYSIOL, V26, P1, DOI 10.1016/S0065-2806(08)60030-2; Zhang JY, 2007, GENE DEV, V21, P2580, DOI 10.1101/gad.1569307; Zhang ZL, 2011, J BIOL CHEM, V286, P8437, DOI 10.1074/jbc.M110.191684; Zhao B, 2016, INSECT BIOCHEM MOLEC, V77, P69, DOI 10.1016/j.ibmb.2016.08.003; Zhu JS, 2003, P NATL ACAD SCI USA, V100, P13338, DOI 10.1073/pnas.2234416100; Zou Z, 2013, P NATL ACAD SCI USA, V110, pE2173, DOI 10.1073/pnas.1305293110	40	31	31	1	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10306	10315		10.1074/jbc.M116.761387	http://dx.doi.org/10.1074/jbc.M116.761387			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28446607	Green Published, hybrid			2022-12-26	WOS:000403580600038
J	Wu, DL; Zhao, LH; Feng, ZT; Yu, C; Ding, J; Wang, LY; Wang, F; Liu, D; Zhu, HH; Xing, FY; Conaway, JW; Conaway, RC; Cai, Y; Jin, JJ				Wu, Donglu; Zhao, Linhong; Feng, Zhitong; Yu, Chao; Ding, Jian; Wang, Lingyao; Wang, Fei; Liu, Da; Zhu, Huihui; Xing, Feiyang; Conaway, Joan W.; Conaway, Ronald C.; Cai, Yong; Jin, Jingji			O-Linked N-acetylglucosamine transferase 1 regulates global histone H4 acetylation via stabilization of the nonspecific lethal protein NSL3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLCNAC TRANSFERASE; SUBSTRATE-SPECIFICITY; CYTOSOLIC PROTEINS; GENE-EXPRESSION; MSL COMPLEX; GLCNACYLATION; NUCLEAR; CHROMATIN; OGT; STABILITY	The human males absent on the first (MOF)-containing histone acetyltransferase nonspecific lethal (NSL) complex comprises nine subunits including the O-linked N-acetylglucosamine (O-GlcNAc) transferase, isoform 1 (OGT1). However, whether the O-GlcNAc transferase activity of OGT1 controls histone acetyltransferase activity of the NSL complex and whether OGT1 physically interacts with the other NSL complex subunits remain unclear. Here, we demonstrate that OGT1 regulates the activity of the NSL complex by mainly acetylating histone H4 Lys-16, Lys-5, and Lys-8 via O-GlcNAcylation and stabilization of the NSL complex subunit NSL3. Knocking down or overexpressing OGT1 in human cells remarkably affected the global acetylation of histone H4 residues Lys-16, Lys-5, and Lys-8. Because OGT1 is a subunit of the NSL complex, we also investigated the function of OGT1 in this complex. Co-transfection/co-immunoprecipitation experiments combined with in vitro O-GlcNAc transferase assays confirmed that OGT1 specifically binds to and O-GlcNAcylates NSL3. In addition, wheat germ agglutinin affinity purification verified the occurrence of O-GlcNAc modification on NSL3 in cells. Moreover, O-GlcNAcylation of NSL3 by wild-type OGT1 (OGT1-WT) stabilized NSL3. This stabilization was lost after co-transfection of NSL3 with an OGT1 mutant, OGT1(C964A), that lacks O-GlcNAc transferase activity. Furthermore, stabilization of NSL3 by OGT1-WT significantly increased the global acetylation levels of H4 Lys-5, Lys-8, and Lys-16 in cells. These results suggest that OGT1 regulates the activity of the NSL complex by stabilizing NSL3.	[Wu, Donglu; Zhao, Linhong; Feng, Zhitong; Yu, Chao; Ding, Jian; Wang, Lingyao; Wang, Fei; Zhu, Huihui; Xing, Feiyang; Cai, Yong; Jin, Jingji] Jilin Univ, Minist Educ, Sch Life Sci, Changchun 130012, Peoples R China; [Cai, Yong; Jin, Jingji] Jilin Univ, Minist Educ, Natl Engn Lab AIDS Vaccine, Changchun 130012, Peoples R China; [Cai, Yong; Jin, Jingji] Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130012, Peoples R China; [Liu, Da] Changchun Univ Chinese Med, Sch Pharm, Changchun 130117, Peoples R China; [Conaway, Joan W.; Conaway, Ronald C.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Conaway, Joan W.; Conaway, Ronald C.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Lawrence, KS 66045 USA	Jilin University; Jilin University; Jilin University; Changchun University of Chinese Medicine; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Cai, Y; Jin, JJ (corresponding author), Jilin Univ, Minist Educ, Sch Life Sci, Changchun 130012, Peoples R China.; Cai, Y; Jin, JJ (corresponding author), Jilin Univ, Minist Educ, Natl Engn Lab AIDS Vaccine, Changchun 130012, Peoples R China.; Cai, Y; Jin, JJ (corresponding author), Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130012, Peoples R China.	caiyong62@jlu.edu.cn; jjjin@jlu.edu.cn			National Natural Science Foundation of China [31571316, 31371311]; Project of Jilin Province Science and Technology Development Program [20140414057GH]; Key Laboratory of Regenerative Biology, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences [KLRB201303, KLRB201504]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Jilin Province Science and Technology Development Program; Key Laboratory of Regenerative Biology, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences	This work was supported by National Natural Science Foundation of China Grants 31571316 and 31371311; Project of Jilin Province Science and Technology Development Program Grant 20140414057GH; and Key Laboratory of Regenerative Biology, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences Grants KLRB201303 and KLRB201504. The authors declare that they have no conflicts of interest with the contents of this article.	Bullen JW, 2014, J BIOL CHEM, V289, P10592, DOI 10.1074/jbc.M113.523068; Butkinaree C, 2008, J BIOL CHEM, V283, P23557, DOI 10.1074/jbc.M804116200; Cai Y, 2010, J BIOL CHEM, V285, P4268, DOI 10.1074/jbc.C109.087981; Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; CASEY PJ, 1995, SCIENCE, V268, P221, DOI 10.1126/science.7716512; Chatterjee A, 2016, CELL, V167, P722, DOI 10.1016/j.cell.2016.09.052; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; Dehennaut V, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00155; Deplus R, 2013, EMBO J, V32, P645, DOI 10.1038/emboj.2012.357; Ding XD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145023; Fujiki R, 2011, NATURE, V480, P557, DOI 10.1038/nature10656; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Hansen BF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034274; Hardiville S, 2016, CURR OPIN CHEM BIOL, V33, P88, DOI 10.1016/j.cbpa.2016.06.005; Ito R, 2014, GENES CELLS, V19, P52, DOI 10.1111/gtc.12107; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Lercher L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8978; Liu D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141014; Liu Y, 2015, ONCOTARGET, V6, P14497, DOI 10.18632/oncotarget.3988; Lubas WA, 2000, J BIOL CHEM, V275, P10983, DOI 10.1074/jbc.275.15.10983; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Mazars R, 2010, J BIOL CHEM, V285, P13364, DOI 10.1074/jbc.M109.072579; Meunier S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8889; Nakamura K, 2011, MOL CELL, V41, P515, DOI 10.1016/j.molcel.2011.02.002; Rea S, 2007, ONCOGENE, V26, P5385, DOI 10.1038/sj.onc.1210607; Ronningen T, 2015, GENOME RES, V25, P1825, DOI 10.1101/gr.193748.115; ROQUEMORE EP, 1994, METHOD ENZYMOL, V230, P443; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Taipale M, 2005, MOL CELL BIOL, V25, P6798, DOI 10.1128/MCB.25.15.6798-6810.2005; Vella P, 2013, MOL CELL, V49, P645, DOI 10.1016/j.molcel.2012.12.019; Wells L, 2003, FEBS LETT, V546, P154, DOI 10.1016/S0014-5793(03)00641-0; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Zhao XM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003940; Zhou XL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030340	36	12	12	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10014	10025		10.1074/jbc.M117.781401	http://dx.doi.org/10.1074/jbc.M117.781401			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28450392	hybrid, Green Published			2022-12-26	WOS:000403580600014
J	Anand, R; Chatterjee, S				Anand, Rajat; Chatterjee, Samrat			Tracking disease progression by searching paths in a temporal network of biological processes	PLOS ONE			English	Article							ENRICHMENT ANALYSIS; GENOME; TOOL	Metabolic disorders such as obesity and diabetes are diseases which develop gradually over time through the perturbations of biological processes. These perturbed biological processes usually work in an interdependent way. Systematic experiments tracking disease progression at gene level are usually conducted through a temporal microarray data. There is a need for developing methods to analyze such highly complex data to capture disease progression at the molecular level. In the present study, we have considered temporal microarray data from an experiment conducted to study development of obesity and diabetes in mice. We first constructed a network between biological processes through common genes. We analyzed the data to obtain perturbed biological processes at each time point. Finally, we used the biological process network to find links between these perturbed biological processes. This enabled us to identify paths linking initial perturbed processes with final perturbed processes which capture disease progression. Using different datasets and statistical tests, we established that these paths are highly precise to the dataset from which these are obtained. We also established that the connecting genes present in these paths might contain some biological information and thus can be used for further mechanistic studies. The methods developed in our study are also applicable to a broad array of temporal data.	[Anand, Rajat; Chatterjee, Samrat] Translat Hlth Sci & Technol Inst, NCR Biotech Sci Cluster, Computat & Math Biol Lab, Drug Discovery Res Ctr, Faridabad, India	Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI)	Chatterjee, S (corresponding author), Translat Hlth Sci & Technol Inst, NCR Biotech Sci Cluster, Computat & Math Biol Lab, Drug Discovery Res Ctr, Faridabad, India.	samrat.chatterjee@thsti.res.in						Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Butcher EC, 2004, NAT BIOTECHNOL, V22, P1253, DOI 10.1038/nbt1017; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eren K, 2013, BRIEF BIOINFORM, V14, P279, DOI 10.1093/bib/bbs032; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; He B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018516; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Liu M, 2007, PLOS GENET, V3, P958, DOI 10.1371/journal.pgen.0030096; Lopes M, 2014, GENOMICS, V103, P264, DOI 10.1016/j.ygeno.2013.12.007; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun SY, 2013, SCI REP-UK, V3, DOI 10.1038/srep02268; Tikoo K, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/795072; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935	17	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176172	10.1371/journal.pone.0176172	http://dx.doi.org/10.1371/journal.pone.0176172			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448511	Green Submitted, Green Published, gold			2022-12-26	WOS:000400383600044
J	Guo, Y; Liu, LJ; Tang, P; Lv, YY; Feng, Y; Xu, LA; Jonas, JB				Guo, Yin; Liu, Li Juan; Tang, Ping; Lv, Yan Yun; Feng, Yi; Xu, Liang; Jonas, Jost B.			Outdoor activity and myopia progression in 4-year follow-up of Chinese primary school children: The Beijing Children Eye Study	PLOS ONE			English	Article							INCIDENT MYOPIA; LIGHT EXPOSURE; TIME OUTDOORS; RISK-FACTORS; PREVALENCE; SINGAPORE; STUDENTS; SCHOOLCHILDREN; ASSOCIATIONS; CHILDHOOD	Purpose To investigate factors associated with ocular axial elongation and myopia progression during a 4-year follow-up in primary school children in Beijing. Methods This school-based study included 382 grade-1 children at baseline in 2011 (age: 6.3 +/- 0.4 years) with 305 (79.8%) returning for the follow-up examination in 2015. At baseline and in yearly follow-up examinations, the children underwent a comprehensive eye examination including auto-refractometry, ocular biometry with measurement of axial length, and fundus photography. The parents underwent a standardized interview. Results During the study period, the mean axial length elongated by 1.15 +/- 0.56mm in boys and 1.10 +/- 0.63mm in girls. At baseline and at the end of follow-up, axial length was significantly (P<0.001) longer in boys, with no difference (P = 0.50) between genders in axial elongation. In multivariate analysis, greater axial elongation was associated (regression coefficient r(2):0.15) with less time spent outdoors (P = 0.004; standardized coefficient beta: -0.22), more time spent indoors with studying (P = 0.02; beta: 0.18) and paternal myopia (P = 0.03; beta: 0.16). Larger increases in the axial length/anterior corneal curvature (AL/CC) ratio were associated (r(2):0.09) with less time spent outdoors (PP = 0.003; beta: -0.22) and maternal myopia (PP = 0.02; beta: 0.18). Conclusions Myopic axial elongation during a 4-year follow-up was associated with shorter time spent outdoors and longer time spent indoors studying and with parental myopia. Other factors such as level of paternal education, family income, gender and region of habitation were significantly associated with axial elongation and with myopia progression only in univariate analysis.	[Guo, Yin; Liu, Li Juan; Xu, Liang; Jonas, Jost B.] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Inst Ophthalmol,Beijing Key Lab Ophthalmo, Beijing, Peoples R China; [Guo, Yin; Tang, Ping; Lv, Yan Yun; Feng, Yi] Capital Med Univ, Beijing Tongren Hosp, Tongren Eye Care Ctr, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany	Capital Medical University; Capital Medical University; Ruprecht Karls University Heidelberg	Xu, LA (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Inst Ophthalmol,Beijing Key Lab Ophthalmo, Beijing, Peoples R China.	xibio1@163.com	Guo, Yin/ABC-2134-2020	Guo, Yin/0000-0003-3806-3771; Jonas, Jost/0000-0003-2972-5227	National Natural Science Foundation of China [81400431, 81170890]; National Key Technology R&D Program of the Ministry of Science and Technology [2012BAH05F05, 2013BAH19F04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R&D Program of the Ministry of Science and Technology(National Key Technology R&D Program)	This work was supported by National Natural Science Foundation of China (81400431 and 81170890) and by the National Key Technology R&D Program of the Ministry of Science and Technology (No. 2012BAH05F05 and 2013BAH19F04).	Dirani M, 2009, BRIT J OPHTHALMOL, V93, P997, DOI 10.1136/bjo.2008.150979; Donovan L, 2012, OPTOMETRY VISION SCI, V89, P1196, DOI 10.1097/OPX.0b013e3182640996; Fan DSP, 2004, ANN ACAD MED SINGAP, V33, P39; French AN, 2013, OPHTHALMOLOGY, V120, P2100, DOI 10.1016/j.ophtha.2013.02.035; Fujiwara M, 2012, JPN J OPHTHALMOL, V56, P401, DOI 10.1007/s10384-012-0148-1; Guggenheim JA, 2012, INVEST OPHTH VIS SCI, V53, P2856, DOI 10.1167/iovs.11-9091; Guo K, 2015, INVEST OPHTH VIS SCI, V56, P1769, DOI 10.1167/iovs.14-15737; Guo Y, 2014, INVEST OPHTH VIS SCI, V55, P918, DOI 10.1167/iovs.13-13502; Guo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075260; Guo Y, 2013, OPHTHALMOLOGY, V120, P277, DOI 10.1016/j.ophtha.2012.07.086; He MG, 2015, JAMA-J AM MED ASSOC, V314, P1142, DOI 10.1001/jama.2015.10803; Ip JM, 2008, INVEST OPHTH VIS SCI, V49, P3858, DOI 10.1167/iovs.07-1451; JONAS JB, 1991, INVEST OPHTH VIS SCI, V32, P2942; Jones LA, 2007, INVEST OPHTH VIS SCI, V48, P3524, DOI 10.1167/iovs.06-1118; Jones-Jordan LA, 2012, INVEST OPHTH VIS SCI, V53, P7169, DOI 10.1167/iovs.11-8336; Khader Y. S., 2006, Eastern Mediterranean Health Journal, V12, P434; LITTMANN H, 1982, KLIN MONATSBL AUGENH, V180, P286, DOI 10.1055/s-2008-1055068; Liu HH, 2010, OPHTHALMOLOGY, V117, P1763, DOI 10.1016/j.ophtha.2010.01.020; Lu B, 2009, ARCH OPHTHALMOL-CHIC, V127, P769, DOI 10.1001/archophthalmol.2009.105; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Mutti DO, 2002, INVEST OPHTH VIS SCI, V43, P3633; Ohno-Matsui K, 2015, AM J OPHTHALMOL, V159, P877, DOI 10.1016/j.ajo.2015.01.022; Onal S, 2007, OPTOMETRY VISION SCI, V84, P175, DOI 10.1097/OPX.0b013e3180335c52; Pan CW, 2015, INVEST OPHTH VIS SCI, V56, P3235, DOI 10.1167/iovs.14-16357; Read SA, 2015, INVEST OPHTH VIS SCI, V56, P6779, DOI 10.1167/iovs.14-15978; Rose KA, 2008, ARCH OPHTHALMOL-CHIC, V126, P527, DOI 10.1001/archopht.126.4.527; Rose KA, 2008, OPHTHALMOLOGY, V115, P1279, DOI 10.1016/j.ophtha.2007.12.019; Saw SM, 2002, OPHTHALMOLOGY, V109, P2065, DOI 10.1016/S0161-6420(02)01220-4; Torii H, 2017, EBIOMEDICINE, V15, P210, DOI 10.1016/j.ebiom.2016.12.007; Vitale S, 2009, ARCH OPHTHALMOL-CHIC, V127, P1632, DOI 10.1001/archophthalmol.2009.303; Wu JB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082763, 10.1371/journal.pone.0081986, 10.1371/journal.pone.0081982]; Wu PC, 2013, OPHTHALMOLOGY, V120, P1080, DOI 10.1016/j.ophtha.2012.11.009; Xu LA, 2007, OPHTHALMOLOGY, V114, P216, DOI 10.1016/j.ophtha.2006.06.050; Xu L, 2010, GRAEF ARCH CLIN EXP, V248, P49, DOI 10.1007/s00417-009-1204-5; You QS, 2014, ACTA OPHTHALMOL, V92, pE398, DOI 10.1111/aos.12299	35	50	54	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0175921	10.1371/journal.pone.0175921	http://dx.doi.org/10.1371/journal.pone.0175921			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448513	gold, Green Published, Green Submitted			2022-12-26	WOS:000400383600031
J	Leys, BA; Commerford, JL; McLauchlan, KK				Leys, Berangere A.; Commerford, Julie L.; McLauchlan, Kendra K.			Reconstructing grassland fire history using sedimentary charcoal: Considering count, size and shape	PLOS ONE			English	Article							MACROSCOPIC CHARCOAL; REGIMES; RECORDS; HOLOCENE; LAKE; PYROGEOGRAPHY; FLUCTUATIONS; MANAGEMENT; PARTICLES; DISPERSAL	Fire is a key Earth system process, with 80% of annual fire activity taking place in grassland areas. However, past fire regimes in grassland systems have been difficult to quantify due to challenges in interpreting the charcoal signal in depositional environments. To improve reconstructions of grassland fire regimes, it is essential to assess two key traits: (1) charcoal count, and (2) charcoal shape. In this study, we quantified the number of charcoal pieces in 51 sediment samples of ponds in the Great Plains and tested its relevance as a proxy for the fire regime by examining 13 potential factors influencing charcoal count, including various fire regime components (e.g. the fire frequency, the area burned, and the fire season), vegetation cover and pollen assemblages, and climate variables. We also quantified the width to length (W: L) ratio of charcoal particles, to assess its utility as a proxy of fuel types in grassland environments by direct comparison with vegetation cover and pollen assemblages. Our first conclusion is that charcoal particles produced by grassland fires are smaller than those produced by forest fires. Thus, a mesh size of 120 mu m as used in forested environments is too large for grassland ecosystems. We recommend counting all charcoal particles over 60 mu m in grasslands and mixed grass-forest environments to increase the number of samples with useful data. Second, a W: L ratio of 0.5 or smaller appears to be an indicator for fuel types, when vegetation surrounding the site is before composed of at least 40% grassland vegetation. Third, the area burned within 1060m of the depositional environments explained both the count and the area of charcoal particles. Therefore, changes in charcoal count or charcoal area through time indicate a change in area burned. The fire regimes of grassland systems, including both human and climatic influences on fire behavior, can be characterized by long-term charcoal records.	[Leys, Berangere A.; Commerford, Julie L.; McLauchlan, Kendra K.] Kansas State Univ, Dept Geog, Manhattan, KS 66506 USA; [Commerford, Julie L.] Dartmouth Coll, Dept Geog, Hanover, NH 03755 USA	Kansas State University; Dartmouth College	Leys, BA (corresponding author), Kansas State Univ, Dept Geog, Manhattan, KS 66506 USA.	berangereleys@gmail.com		McLauchlan, Kendra/0000-0002-6612-1097; Leys, Berangere/0000-0001-5485-0156	National Science Foundation [DEB-1145815, DGE-1558228];  [NSF-DEB-1145815]; Emerging Frontiers [1145815] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); ; Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	BAL was funded by National Science Foundation DEB-1145815 to KKM and a portion of the data was produced with National Science Foundation DGE-1558228 to KKM and JLC.; We gratefully acknowledge Rachel Keen and Robert Scharping for assisting with data acquisition, Chris Morris for collection of some of the samples, and Colin Long and Rhett Mohler for helpful discussion. Scott Mooney and an anonymous reviewer provided helpful comments on an earlier version of the manuscript. B.L. was supported by NSF-DEB-1145815 to K.M. A portion of this work was supported by DGE-1558228 to K.M. and J.C. All data used in this manuscript are publicly available via figshare (doi:10.6084/m9.figshare.4873427) or upon request to the corresponding author.	Aleman JC, 2013, HOLOCENE, V23, P1853, DOI 10.1177/0959683613508159; Allen MS, 2011, J VEG SCI, V22, P436, DOI 10.1111/j.1654-1103.2011.01278.x; [Anonymous], ANAL MODERN POLLEN D; Archibald S, 2013, P NATL ACAD SCI USA, V110, P6442, DOI 10.1073/pnas.1211466110; Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; Bond WJ, 2003, GLOBAL CHANGE BIOL, V9, P973, DOI 10.1046/j.1365-2486.2003.00577.x; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brunelle A, 2015, QUATERN INT, V387, P134; Carcaillet C, 2001, CR ACAD SCI II A, V332, P21, DOI 10.1016/S1251-8050(00)01485-3; Carcaillet C., 2007, CHARRED PARTICLE ANA, P1582, DOI [10.1016/B0-44-452747-8/00187-3, DOI 10.1016/B0-44-452747-8/00187-3]; Carcaillet C, 2007, HOLOCENE, V17, P845, DOI 10.1177/0959683607080526; Clark JS, 1998, HOLOCENE, V8, P19, DOI 10.1191/095968398672501165; Commerford J. L., 2013, American Journal of Plant Sciences, V4, P1; Commerford JL, 2016, HOLOCENE, V26, P302, DOI 10.1177/0959683615608691; Conedera M, 2009, QUATERNARY SCI REV, V28, P555, DOI 10.1016/j.quascirev.2008.11.005; Connor SE, 2012, QUATERNARY SCI REV, V55, P114, DOI 10.1016/j.quascirev.2012.08.007; Devine AP, 2015, J ECOL, V103, P473, DOI 10.1111/1365-2745.12367; Dixon AP, 2014, J BIOGEOGR, V41, P2003, DOI 10.1111/jbi.12381; Duffin KI, 2008, HOLOCENE, V18, P279, DOI 10.1177/0959683607086766; Fuhlendorf SD, 2004, J APPL ECOL, V41, P604, DOI 10.1111/j.0021-8901.2004.00937.x; Fuhlendorf SD, 2001, BIOSCIENCE, V51, P625, DOI 10.1641/0006-3568(2001)051[0625:RHOREM]2.0.CO;2; Higuera PE, 2007, QUATERNARY SCI REV, V26, P1790, DOI 10.1016/j.quascirev.2007.03.010; Higuera PE, 2010, INT J WILDLAND FIRE, V19, P996, DOI 10.1071/WF09134; Higuera PE, 2009, ECOL MONOGR, V79, P201, DOI 10.1890/07-2019.1; Jensen K, 2007, HOLOCENE, V17, P907, DOI 10.1177/0959683607082405; Knapp AK, 2001, SCIENCE, V291, P481, DOI 10.1126/science.291.5503.481; Krawchuk MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005102; Leys B, 2013, COMPARISON CHARCOL M, P79; Leys B, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/11/114009; Lynch JA, 2004, CAN J FOREST RES, V34, P1642, DOI 10.1139/X04-071; Marlon JR, 2016, BIOGEOSCIENCES, V13, P3225, DOI 10.5194/bg-13-3225-2016; McLauchlan KK, 2013, VEG HIST ARCHAEOBOT, V22, P171, DOI 10.1007/s00334-012-0369-8; Mohler R, 2016, ASSESSMENT ACCURACY, V2, P253; Mooney S., 2011, MIRES PEAT, V7, P1; Mouillot F, 2005, GLOBAL CHANGE BIOL, V11, P398, DOI 10.1111/j.1365-2486.2005.00920.x; Mueller JR, 2014, J QUATERNARY SCI, V29, P561, DOI 10.1002/jqs.2728; Mustaphi CJC, 2014, PROG PHYS GEOG, V38, P734, DOI 10.1177/0309133314548886; Nelson DM, 2012, GLOBAL CHANGE BIOL, V18, P3160, DOI 10.1111/j.1365-2486.2012.02766.x; Peters ME, 2007, QUATERNARY RES, V67, P304, DOI 10.1016/j.yqres.2006.10.004; Power MJ, 2008, CLIM DYNAM, V30, P887, DOI 10.1007/s00382-007-0334-x; R Core Team, 2021, R LANGUAGE ENV STAT; Roos CI, 2014, J BIOGEOGR, V41, P833, DOI 10.1111/jbi.12285; Tinner W, 2006, HOLOCENE, V16, P287, DOI 10.1191/0959683606hl925rr; Turner R, 2010, J QUATERNARY SCI, V25, P371, DOI 10.1002/jqs.1332; Umbanhowar CE, 1998, HOLOCENE, V8, P341, DOI 10.1191/095968398666496051; Umbanhowar CE, 2009, HOLOCENE, V19, P611, DOI 10.1177/0959683609104039; van der Werf GR, 2006, ATMOS CHEM PHYS, V6, P3423, DOI 10.5194/acp-6-3423-2006; Whitlock C, 2003, ECOL STU AN, V160, P3; Whitlock C., 2002, CHARCOAL FIRE PROXY, P75, DOI [10.1007/0-306-47668-1_5, DOI 10.1007/0-306-47668-1_5]; Woodhouse CA, 1998, B AM METEOROL SOC, V79, P2693, DOI 10.1175/1520-0477(1998)079<2693:YODVIT>2.0.CO;2	51	41	41	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176445	10.1371/journal.pone.0176445	http://dx.doi.org/10.1371/journal.pone.0176445			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448597	Green Submitted, Green Published, gold			2022-12-26	WOS:000400383600080
J	Serban, KA; Petrusca, DN; Mikosz, A; Poirier, C; Lockett, AD; Saint, L; Justice, MJ; Twigg, HL; Campos, MA; Petrache, I				Serban, Karina A.; Petrusca, Daniela N.; Mikosz, Andrew; Poirier, Christophe; Lockett, Angelia D.; Saint, Lauren; Justice, Matthew J.; Twigg, Homer L., III; Campos, Michael A.; Petrache, Irina			Alpha-1 antitrypsin supplementation improves alveolar macrophages efferocytosis and phagocytosis following cigarette smoke exposure	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; HUMAN MONOCYTE ACTIVATION; APOPTOTIC CELL CLEARANCE; AUGMENTATION THERAPY; PSEUDOMONAS-AERUGINOSA; CYSTIC-FIBROSIS; TNF-ALPHA; INHIBITION; RECEPTOR; POLARIZATION	Cigarette smoking (CS), the main risk factor for COPD (chronic obstructive pulmonary disease) in developed countries, decreases alveolar macrophages (AM) clearance of both apoptotic cells and bacterial pathogens. This global deficit of AM engulfment may explain why active smokers have worse outcomes of COPD exacerbations, episodes characterized by airway infection and inflammation that carry high morbidity and healthcare cost. When administered as intravenous supplementation, the acute phase-reactant alpha-1 antitrypsin (A1AT) reduces the severity of COPD exacerbations in A1AT deficient (AATD) individuals and of bacterial pneumonia in murine models, but the effect of A1AT on AM scavenging functions has not been reported. Apoptotic cell clearance (efferocytosis) was measured in human AM isolated from patients with COPD, in primary rat AM or differentiated monocytes exposed to CS ex vivo, and in AM recovered from mice exposed to CS. A1AT (100 mu g/mL, 16 h) significantly ameliorated efferocytosis (by similar to 50%) in AM of active smokers or AM exposed ex vivo to CS. A1AT significantly improved AM global engulfment, including phagocytosis, even when cells were simultaneously challenged with apoptotic and Fc-coated (bacteria-like) targets. The improved efferocytosis in A1AT-treated macrophages was associated with inhibition of tumor necrosis factor-alpha converting enzyme (TACE) activity, decreased mannose receptor shedding, and markedly increased abundance of efferocytosis receptors (mannose-and phosphatidyl serine receptors and the scavenger receptor B2) on AM plasma membrane. Directed airway A1AT treatment (via inhalation of a nebulized solution) restored in situ airway AM efferocytosis after CS exposure in mice. The amelioration of CS-exposed AM global engulfment may render A1AT as a potential therapy for COPD exacerbations.	[Serban, Karina A.; Mikosz, Andrew; Justice, Matthew J.; Petrache, Irina] Natl Jewish Hlth, Div Pulm Crit Care & Sleep Med, Dept Med, Denver, CO 80206 USA; [Serban, Karina A.; Petrusca, Daniela N.; Poirier, Christophe; Lockett, Angelia D.; Saint, Lauren; Justice, Matthew J.; Twigg, Homer L., III; Petrache, Irina] Indiana Univ Sch Med, Pulm Crit Care Sleep & Occupat Med, Indianapolis, IN 46202 USA; [Petrusca, Daniela N.] Indiana Univ Sch Med, Dept Med, Div Hematol Oncol, Indianapolis, IN 46202 USA; [Lockett, Angelia D.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Campos, Michael A.] Univ Miami, Div Pulm & Crit Care Med, Miami, FL USA; [Petrache, Irina] Univ Colorado, Anschutz Med Campus, Aurora, CO USA	National Jewish Health; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Miami; University of Colorado System; University of Colorado Anschutz Medical Campus	Serban, KA (corresponding author), Natl Jewish Hlth, Div Pulm Crit Care & Sleep Med, Dept Med, Denver, CO 80206 USA.; Serban, KA (corresponding author), Indiana Univ Sch Med, Pulm Crit Care Sleep & Occupat Med, Indianapolis, IN 46202 USA.	serbank@njhealth.org	Petrache, Irina/AAZ-9648-2020; Campos, Michael/X-2025-2019	Campos, Michael/0000-0001-5485-9062	Junior Investigator Alpha-1 Foundation; CHEST Foundation Clinical Research grant; VA Merit Review Research Award; Baxter Healthcare, US	Junior Investigator Alpha-1 Foundation; CHEST Foundation Clinical Research grant; VA Merit Review Research Award(US Department of Veterans Affairs); Baxter Healthcare, US	This work was supported by: 1. 2012 Junior Investigator Alpha-1 Foundation and The CHEST Foundation Clinical Research grant to Karina A Serban; 2. VA Merit Review Research Award to Irina Petrache; 3. Baxter Healthcare, US to Irina Petrache. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergin DA, 2010, J CLIN INVEST, V120, P4236, DOI 10.1172/JCI41196; Bianchi SM, 2008, AM J RESP CRIT CARE, V177, P35, DOI 10.1164/rccm.200612-1804OC; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Byers DE, 2010, AM J RESP CELL MOL, V43, P1, DOI 10.1165/rcmb.2009-0407ED; Campos MA, 2009, RESP MED, V103, P1532, DOI 10.1016/j.rmed.2009.04.008; Churg A, 2007, AM J RESP CELL MOL, V37, P144, DOI 10.1165/rcmb.2006-0345OC; Clauss M, 2011, J CLIN INVEST, V121, P2470, DOI 10.1172/JCI43881; Dirksen A, 2009, EUR RESPIR J, V33, P1345, DOI 10.1183/09031936.00159408; Donnelly LE, 2012, CHEST, V141, P1055, DOI 10.1378/chest.11-2348; Gaggar A, 2016, J CYST FIBROS, V15, P227, DOI 10.1016/j.jcf.2015.07.009; Gazi U, 2011, J BIOL CHEM, V286, P7822, DOI 10.1074/jbc.M110.185025; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Han MLK, 2016, LANCET RESP MED, V4, P473, DOI 10.1016/S2213-2600(16)00094-1; Hodge S, 2008, AM J RESP CRIT CARE, V178, P139, DOI 10.1164/rccm.200711-1666OC; Hodge S, 2007, AM J RESP CELL MOL, V37, P748, DOI 10.1165/rcmb.2007-0025OC; Hodge S, 2011, AM J RESP CELL MOL, V44, P673, DOI 10.1165/rcmb.2009-0459OC; Hurley K, 2014, J IMMUNOL, V193, P3978, DOI 10.4049/jimmunol.1400132; Huynh MLN, 2005, AM J RESP CRIT CARE, V172, P972, DOI 10.1164/rccm.200501-035OC; Janciauskiene S, 2004, BIOCHEM BIOPH RES CO, V321, P592, DOI 10.1016/j.bbrc.2004.06.123; Janciauskiene S, 1999, EUR J BIOCHEM, V265, P875, DOI 10.1046/j.1432-1327.1999.00821.x; Janciauskiene S, 2001, ATHEROSCLEROSIS, V158, P41, DOI 10.1016/S0021-9150(00)00767-X; Jonigk D, 2013, P NATL ACAD SCI USA, V110, P15007, DOI 10.1073/pnas.1309648110; Lockett AD, 2013, AM J RESP CELL MOL, V49, P143, DOI 10.1165/rcmb.2012-0515OC; LOMAS DA, 1993, BIOCHEMISTRY-US, V32, P500, DOI 10.1021/bi00053a014; McCaslin CA, 2015, J CYST FIBROS, V14, P70, DOI 10.1016/j.jcf.2014.06.009; Medeiros AI, 2009, J EXP MED, V206, P61, DOI 10.1084/jem.20082058; Moraga F, 2000, J BIOL CHEM, V275, P7693, DOI 10.1074/jbc.275.11.7693; O'Brien ME, 2014, AM J RESP CRIT CARE, V189; Petrache I, 2009, BIOL-TARGETS THER, V3, P193; Petrache L, 2006, AM J RESP CRIT CARE, V173, P1222, DOI 10.1164/rccm.200512-1842OC; Petrusca DN, 2010, J BIOL CHEM, V285, P40322, DOI 10.1074/jbc.M110.137604; Pott Gregory B, 2013, Front Public Health, V1, P19, DOI 10.3389/fpubh.2013.00019; Richens TR, 2009, AM J RESP CRIT CARE, V179, P1011, DOI 10.1164/rccm.200807-1148OC; Sethi Sanjay, 2004, Proc Am Thorac Soc, V1, P109, DOI 10.1513/pats.2306029; Shaykhiev R, 2009, J IMMUNOL, V183, P2867, DOI 10.4049/jimmunol.0900473; Sohrab S, 2009, FASEB J, V23, P3149, DOI 10.1096/fj.09-129304; Stockley RA, 2002, AM J RESP CRIT CARE, V165, P1494, DOI 10.1164/rccm.2109013; Subramaniyam D, 2010, INFLAMM RES, V59, P571, DOI 10.1007/s00011-010-0164-x; Taylor AE, 2010, EUR RESPIR J, V35, P1039, DOI 10.1183/09031936.00036709; Thorp E, 2011, J BIOL CHEM, V286, P33335, DOI 10.1074/jbc.M111.263020; Underhill DM, 2012, NAT REV IMMUNOL, V12, P492, DOI 10.1038/nri3244; Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673; Watt AP, 2005, THORAX, V60, P659, DOI 10.1136/thx.2004.038240; Zizzo G, 2012, J IMMUNOL, V189, P3508, DOI 10.4049/jimmunol.1200662	44	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176073	10.1371/journal.pone.0176073	http://dx.doi.org/10.1371/journal.pone.0176073			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448535	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383600036
J	Du, N; Tan, XF; Li, Q; Liu, X; Zhang, WX; Wang, RQ; Liu, J; Guo, WH				Du, Ning; Tan, Xiangfeng; Li, Qiang; Liu, Xiao; Zhang, Wenxin; Wang, Renqing; Liu, Jian; Guo, Weihua			Dominance of an alien shrub Rhus typhina over a native shrub Vitex negundo var. heterophylla under variable water supply patterns	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; ROBINIA-PSEUDOACACIA; PLANT-COMMUNITIES; HETEROGENEITY; VARIABILITY; PERFORMANCE; RESPONSES; INVASION; DROUGHT; IMPACT	Temporal heterogeneity of a resource supply can have a profound effect on the interactions between alien and native plant species and their potential invasiveness. Precipitation patterns may be variable and result in a higher heterogeneity of water supply with global climate change. In this study, an alien shrub species, Rhus typhina, introduced to China from North America and a native shrub species, Vitex negundo var. heterophylla, were grown in monoculture and mixed culture under different water supply regimes, with four levels of water supply frequencies but with a constant level of total supplied water. After 60 days of treatments, the alien species was found to be the superior competitor in the mixed culture and was unaffected by changes in the water supply pattern. The dominance of R. typhina was mainly owing to its greater biomass and effective modulation of leaf physiology. However, in the mixed culture, V. negundo var. heterophylla exhibited both leaf-and whole-plant-level acclimations, including higher leaf length to petiole length and root to shoot biomass ratios, and lower specific leaf weight and leaf length to leaf width ratio. Plant height of V. negundo var. heterophylla was comparable to that of R. typhina in the mixed culture, which is a strategy to escape shading. Although water treatments had little effect on most traits in both species, the possible influence of water regimes should not be neglected. Compared with high-frequency water supply treatments, more individuals of V. negundo var. heterophylla died in low-water-frequency treatments when in competition with R. typhina, which may lead to species turnover in the field. The authors recommended that caution should be exercised when introducing R. typhina to non-native areas in the context of global climate change.	[Du, Ning; Tan, Xiangfeng; Li, Qiang; Liu, Xiao; Zhang, Wenxin; Wang, Renqing; Guo, Weihua] Shandong Univ, Sch Life Sci, Inst Ecol & Biodivers, Jinan, Shandong, Peoples R China; [Du, Ning; Tan, Xiangfeng; Li, Qiang; Liu, Xiao; Zhang, Wenxin; Wang, Renqing; Guo, Weihua] Shandong Univ, Shandong Prov Engn & Technol Res Ctr Vegetat Ecol, Jinan, Shandong, Peoples R China; [Liu, Jian] Shandong Univ, Inst Environm Res, Jinan, Shandong, Peoples R China; [Tan, Xiangfeng] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada	Shandong University; Shandong University; Shandong University; University of Alberta	Guo, WH (corresponding author), Shandong Univ, Sch Life Sci, Inst Ecol & Biodivers, Jinan, Shandong, Peoples R China.; Guo, WH (corresponding author), Shandong Univ, Shandong Prov Engn & Technol Res Ctr Vegetat Ecol, Jinan, Shandong, Peoples R China.	guo_wh@yahoo.com	Liu, Jian/AAG-9184-2019; Tan, Xiangfeng/GPP-2458-2022; Liu, Jian/T-1760-2017	Liu, Jian/0000-0003-1920-2641; Tan, Xiangfeng/0000-0003-4671-0131; Liu, Jian/0000-0003-1920-2641; Liu, Xiao/0000-0002-0968-2154	National Nature Science Foundation of China [31400173, 31470402]; Natural Science Foundation of Shandong Province [ZR2014CQ038]; Fundamental Research Funds of Shandong University [2014GN023]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Fundamental Research Funds of Shandong University	This study was financially supported by National Nature Science Foundation of China (No. 31400173; No. 31470402), Natural Science Foundation of Shandong Province (ZR2014CQ038), and the Fundamental Research Funds of Shandong University (No. 2014GN023).	Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Davidson AM, 2011, ECOL LETT, V14, P419, DOI 10.1111/j.1461-0248.2011.01596.x; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Du N, 2013, AGROFOREST SYST, V87, P403, DOI 10.1007/s10457-012-9562-0; Feng YL, 2009, P NATL ACAD SCI USA, V106, P1853, DOI 10.1073/pnas.0808434106; Funk JL, 2007, NATURE, V446, P1079, DOI 10.1038/nature05719; Godoy O, 2011, FUNCT ECOL, V25, P1248, DOI 10.1111/j.1365-2435.2011.01886.x; Hagiwara Y, 2012, ECOL RES, V27, P1079, DOI 10.1007/s11284-012-0989-6; Hao GY, 2013, PHYSIOL PLANTARUM, V148, P74, DOI 10.1111/j.1399-3054.2012.01694.x; Hijioka Y, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1327; Knapp AK, 2002, SCIENCE, V298, P2202, DOI 10.1126/science.1076347; Kowarik I., 2003, BIOL INVASIONS, V5, P293, DOI DOI 10.1023/B:BINV.0000005574.15074.66; Krivanek M, 2006, DIVERS DISTRIB, V12, P319, DOI 10.1111/j.1366-9516.2006.00249.x; Leishman MR, 2007, NEW PHYTOL, V176, P635, DOI 10.1111/j.1469-8137.2007.02189.x; Levine JM, 2010, ECOLOGY, V91, P130, DOI 10.1890/08-2039.1; Lichtenthaler H., 1983, BIOCHEM SOC T, V11, P591, DOI [10.1042/bst0110591, 10.1042/BST0110591, DOI 10.1042/BST0110591]; Luo YJ, 2016, TREE PHYSIOL, V36, P345, DOI 10.1093/treephys/tpv123; Luo YJ, 2014, PLANT SOIL, V385, P63, DOI 10.1007/s11104-014-2227-1; Maestre FT, 2007, ECOLOGY, V88, P501, DOI 10.1890/06-0421; Mo L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140664; Novoplansky A, 2001, J VEG SCI, V12, P199, DOI 10.2307/3236604; PARRISH JAD, 1982, ECOLOGY, V63, P314, DOI 10.2307/1938948; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Robinson TMP, 2010, AM J BOT, V97, P1625, DOI 10.3732/ajb.1000125; Schreiber U., 1995, ECOL STUD, P49, DOI DOI 10.1007/978-3-642-79354-7_3; Sher AA, 2004, OECOLOGIA, V141, P353, DOI 10.1007/s00442-003-1435-9; Solomon S., 2007, CLIMATE CHANGE 2007, V374, P941; Tilman D, 1987, FUNCT ECOL, V1, P304, DOI 10.2307/2389785; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Wang GM, 2013, PLANT BIOSYST, V147, P1166, DOI 10.1080/11263504.2013.852632; Wang GM, 2008, J INTEGR PLANT BIOL, V50, P522, DOI 10.1111/j.1744-7909.2008.00660.x; Weber Ewald, 2004, Journal for Nature Conservation (Jena), V12, P171, DOI 10.1016/j.jnc.2004.04.002; Wittenberg R, 2005, INVENTORY ALIEN SPEC, P401; Xu F, 2009, ACTA PHYSIOL PLANT, V31, P553, DOI 10.1007/s11738-008-0265-0; Yuan YF, 2013, PLANT SOIL, V372, P389, DOI 10.1007/s11104-013-1748-3; Zhang WP, 2013, OIKOS, V122, P1147, DOI 10.1111/j.1600-0706.2012.20877.x; Zhang ZJ, 2009, TREE PHYSIOL, V29, P1307, DOI 10.1093/treephys/tpp065	38	8	8	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176491	10.1371/journal.pone.0176491	http://dx.doi.org/10.1371/journal.pone.0176491			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445505	Green Submitted, Green Published, gold			2022-12-26	WOS:000400309200066
J	Andruszkiewicz, EA; Starks, HA; Chavez, FP; Sassoubre, LM; Block, BA; Boehm, AB				Andruszkiewicz, Elizabeth A.; Starks, Hilary A.; Chavez, Francisco P.; Sassoubre, Lauren M.; Block, Barbara A.; Boehm, Alexandria B.			Biomonitoring of marine vertebrates in Monterey Bay using eDNA metabarcoding	PLOS ONE			English	Article							ENVIRONMENTAL DNA; DETECTION PROBABILITIES; OCCUPANCY; DIVERSITY	Molecular analysis of environmental DNA (eDNA) can be used to assess vertebrate biodiversity in aquatic systems, but limited work has applied eDNA technologies to marine waters. Further, there is limited understanding of the spatial distribution of vertebrate eDNA in marine waters. Here, we use an eDNA metabarcoding approach to target and amplify a hypervariable region of the mitochondrial 12S rRNA gene to characterize vertebrate communities at 10 oceanographic stations spanning 45 km within the Monterey Bay National Marine Sanctuary (MBNMS). In this study, we collected three biological replicates of small volume water samples (1 L) at 2 depths at each of the 10 stations. We amplified fish mitochondrial DNA using a universal primer set. We obtained 5,644,299 high quality Illumina sequence reads from the environmental samples. The sequence reads were annotated to the lowest taxonomic assignment using a bioinformatics pipeline. The eDNA survey identified, to the lowest taxonomic rank, 7 families, 3 subfamilies, 10 genera, and 72 species of vertebrates at the study sites. These 92 distinct taxa come from 33 unique marine vertebrate families. We observed significantly different vertebrate community composition between sampling depths (0 m and 20/40 m deep) across all stations and significantly different communities at stations located on the continental shelf (<200 m bottom depth) versus in the deeper waters of the canyons of Monterey Bay (>200 m bottom depth). All but 1 family identified using eDNA metabarcoding is known to occur in MBNMS. The study informs the implementation of eDNA metabarcoding for vertebrate biomonitoring.	[Andruszkiewicz, Elizabeth A.; Sassoubre, Lauren M.; Boehm, Alexandria B.] Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA; [Starks, Hilary A.] Stanford Univ, Ctr Ocean Solut, Stanford, CA 94305 USA; [Chavez, Francisco P.] Monterey Bay Aquarium Res Inst, Moss Landing, CA USA; [Block, Barbara A.] Stanford Univ, Hopkins Marine Stn, Dept Biol, Pacific Grove, CA 93950 USA; [Sassoubre, Lauren M.] Univ Buffalo State Univ New York, Dept Civil Struct & Environm Engn, Buffalo, NY USA	Stanford University; Stanford University; Monterey Bay Aquarium Research Institute; Stanford University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Boehm, AB (corresponding author), Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA.	aboehm@stanford.edu	Allan, Elizabeth Andruszkiewicz/AAD-2255-2021	Allan, Elizabeth Andruszkiewicz/0000-0002-9675-0003; Boehm, Alexandria/0000-0002-8162-5090	Seaver Institute to Woods Institute for the Environment at Stanford University; NASA [NNX14AP62A, NOPP RFP NOAA-NOS-IOOS-2014-2003803]; NOAA [NOPP RFP NOAA-NOS-IOOS-2014-2003803]; BOEM [NOPP RFP NOAA-NOS-IOOS-2014-2003803]; U.S. Integrated Ocean Observing System (IOOS) Program Office; U.S. Environmental Protection Agency (EPA) [F15E211913419]; David and Lucile Packard Foundation	Seaver Institute to Woods Institute for the Environment at Stanford University; NASA(National Aeronautics & Space Administration (NASA)); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); BOEM; U.S. Integrated Ocean Observing System (IOOS) Program Office; U.S. Environmental Protection Agency (EPA)(United States Environmental Protection Agency); David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	This work was supported by a gift from the Seaver Institute to Woods Institute for the Environment at Stanford University and was partially supported by NASA grant NNX14AP62A 'National Marine Sanctuaries as Sentinel Sites for a Demonstration Marine Biodiversity Observation Network (MBON)' funded under the National Ocean Partnership Program (NOPP RFP NOAA-NOS-IOOS-2014-2003803 in partnership between NOAA, BOEM, and NASA), and the U.S. Integrated Ocean Observing System (IOOS) Program Office. This publication was developed under STAR Fellowship Assistance Agreement no. F15E211913419 awarded by the U.S. Environmental Protection Agency (EPA). It has not been formally reviewed by EPA. The views expressed in this publication are solely those of Elizabeth Andruszkiewicz and co-authors, and EPA does not endorse any products or commercial services mentioned in this publication. The CANON cruise was supported by the David and Lucile Packard Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson-Carpenter LL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-30; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Bostrom KH, 2004, LIMNOL OCEANOGR-METH, V2, P365, DOI 10.4319/lom.2004.2.365; Burton EJ, 2013, CHECKLIST FISHES KNO, P1; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chamberlain Scott A, 2013, F1000Res, V2, P191, DOI 10.12688/f1000research.2-191.v1; Clarke K. R., 2001, CHANGES MARINE COMMU; Coll M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003881; De Barba M, 2014, MOL ECOL RESOUR, V14, P306, DOI 10.1111/1755-0998.12188; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Evans NT, 2016, MOL ECOL RESOUR, V16, P29, DOI 10.1111/1755-0998.12433; Ficetola GF, 2015, MOL ECOL RESOUR, V15, P543, DOI 10.1111/1755-0998.12338; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Foote AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041781; Goldberg CS, 2016, METHODS ECOL EVOL, V7, P1299, DOI 10.1111/2041-210X.12595; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Guerrero J, 2014, MONTEREY BAY NATL MA; Haigh R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117533; Haile J, 2007, MOL BIOL EVOL, V24, P982, DOI 10.1093/molbev/msm016; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jorgensen T, 2012, MOL ECOL, V21, P1989, DOI 10.1111/j.1365-294X.2011.05287.x; Karsenti E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001177; Kelly RP, GENETIC MANUAL SURVE; Kelly RP, 2016, PEERJ, V4, DOI 10.7717/peerj.2444; Kelly RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086175; Lahoz-Monfort JJ, 2016, MOL ECOL RESOUR, V16, P673, DOI 10.1111/1755-0998.12486; Laramie MB, 2015, BIOL CONSERV, V183, P29, DOI 10.1016/j.biocon.2014.11.025; MacDougall AS, 2005, ECOLOGY, V86, P42, DOI 10.1890/04-0669; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Mahe F, 2014, PEERJ, V2, DOI 10.7717/peerj.593; McCauley DJ, 2015, SCIENCE, V347, DOI 10.1126/science.1255641; Miya M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150088; O'Donnell JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148698; Oksanen J, 2016, VEGAN INTRO ORDINATI, P1; Pedersen MW, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0383; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Port JA, 2016, MOL ECOL, V25, P527, DOI 10.1111/mec.13481; Radulovici Adriana E., 2010, Diversity, V2, P450; Riaz T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr732; Roberts CM, 1999, TRENDS ECOL EVOL, V14, P241, DOI 10.1016/S0169-5347(98)01584-5; Schnell IB, 2015, MOL ECOL RESOUR, V15, P1289, DOI 10.1111/1755-0998.12402; Schratzberger M, 2002, MAR BIOL, V140, P83, DOI 10.1007/s002270100688; Shelton AO, 2016, ECOL APPL, V26, P1645, DOI 10.1890/15-1733.1; Sigsgaard EE, 2015, BIOL CONSERV, V183, P46, DOI 10.1016/j.biocon.2014.11.023; Spaink HP, 2014, BRIEF FUNCT GENOMICS, V13, P144, DOI 10.1093/bfgp/elt046; Sunagawa S, 2015, SCIENCE, V348, DOI 10.1126/science.1261359; Thomsen PF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165252; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Thomsen PF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005048; Valentini A, 2016, MOL ECOL, V25, P929, DOI 10.1111/mec.13428; Wilcox TM, 2016, BIOL CONSERV, V194, P209, DOI 10.1016/j.biocon.2015.12.023; Xiong W, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2911-1; Yamashiro S, 2016, ENV DNA METABARCODIN, P1; Yoccoz NG, 2012, MOL ECOL, V21, P3647, DOI 10.1111/j.1365-294X.2012.05545.x; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	60	88	95	7	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176343	10.1371/journal.pone.0176343	http://dx.doi.org/10.1371/journal.pone.0176343			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441466	gold, Green Published, Green Submitted			2022-12-26	WOS:000400308800048
J	Companioni, O; Sanz-Anquela, JM; Pardo, ML; Puigdecanet, E; Nonell, L; Garcia, N; Blanco, VP; Lopez, C; Andreu, V; Cuatrecasas, M; Garmendia, M; Gisbert, JP; Gonzalez, CA; Sala, N				Companioni, Osmel; Miguel Sanz-Anquela, Jose; Luisa Pardo, Maria; Puigdecanet, Eulalia; Nonell, Lara; Garcia, Nadia; Parra Blanco, Veronica; Lopez, Consuelo; Andreu, Victoria; Cuatrecasas, Miriam; Garmendia, Maddi; Gisbert, Javier P.; Gonzalez, Carlos A.; Sala, Nuria			Gene expression study and pathway analysis of histological subtypes of intestinal metaplasia that progress to gastric cancer	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; PRENEOPLASTIC LESIONS; IDENTIFICATION; PROTEINS; PROLIFERATION; BIOLOGY; ANTIGEN; MARKER; RISK	Background Intestinal metaplasia (IM) is a precursor lesion that precedes gastric cancer (GC). There are two IM histological subtypes, complete (CIM) and incomplete (IIM), the latter having higher progression rates to GC. This study was aimed at analysing gene expression and molecular processes involved in the progression from normal mucosa to IM, and also from IM subtypes to GC. Methodology We used expression data to compare the transcriptome of healthy gastric mucosa to that of IM not progressing to GC, and the transcriptome of IM subtypes that had progressed to GC to those that did not progress. Some deregulated genes were validated and pathway analyses were performed. Results Comparison of IM subtypes that had progressed to GC with those that did not progress showed smaller differences in the expression profiles than the comparison of IM that did not progress with healthy mucosa. New transcripts identified in IM not progressing to GC included TRIM, TMEM, homeobox and transporter genes and SNORD116. Comparison to normal mucosa identified non tumoral Warburg effect and melatonin degradation as previously unreported processes involved in IM. Overexpressed antigen processing is common to both IM-subtypes progressing to GC, but IIM showed more over-expressed oncogenic genes and molecular processes than CIM. Conclusions There are greater differences in gene expression and molecular processes involved in the progression from normal healthy mucosa to IM than from IM to gastric cancer. While antigen processing is common in both IM-subtypes progressing to GC, more oncogenic processes are observed in the progression of IIM.	[Companioni, Osmel; Garcia, Nadia; Gonzalez, Carlos A.; Sala, Nuria] Inst Catala Oncol, Canc Epidemiol Res Program, Unit Nutr & Canc, Barcelona, Spain; [Miguel Sanz-Anquela, Jose] Univ Alcala, Canc Registry, Hosp Univ Principe Asturias, Madrid, Spain; [Miguel Sanz-Anquela, Jose] Univ Alcala, Dept Pathol, Hosp Univ Principe Asturias, Madrid, Spain; [Miguel Sanz-Anquela, Jose] Univ Alcala, Fac Med, Dept Med & Med Specialties, Madrid, Spain; [Luisa Pardo, Maria] Complejo Hosp Soria, Dept Pathol, Madrid, Spain; [Puigdecanet, Eulalia; Nonell, Lara] Hosp del Mar Med Res Inst IMIM, Microarray Anal Serv, Barcelona, Spain; [Parra Blanco, Veronica] Hosp Univ Gregorio Maranon, Dept Histopathol, Madrid, Spain; [Lopez, Consuelo] Hosp Univ Princesa, Dept Pathol, Madrid, Spain; [Andreu, Victoria] Hosp Viladecans, Dept Gastroenterol, Barcelona, Spain; [Cuatrecasas, Miriam] Univ Barcelona, Hosp Clin Barcelona, Dept Pathol, Biobanc Clin IDIBAPS, Barcelona, Spain; [Garmendia, Maddi] Univ Pais Vasco UPV EHU, Dept Pathol, Hosp Donostia, Inst Biodonostia,CIBEREHD, San Sebastian, Spain; [Garmendia, Maddi] Univ Pais Vasco UPV EHU, Dept Gastroenterol, Hosp Donostia, Inst Biodonostia,CIBEREHD, San Sebastian, Spain; [Gisbert, Javier P.] Hosp Univ La Princesa, Gastroenterol Unit, Madrid, Spain; [Gisbert, Javier P.] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Inst Invest Sanitaria Princesa IIS IP, Madrid, Spain	Catalan Institute of Oncology; Prince of Asturias University Hospital; Universidad de Alcala; Prince of Asturias University Hospital; Universidad de Alcala; Universidad de Alcala; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; General University Gregorio Maranon Hospital; Hospital de La Princesa; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Valdecans; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Investigacion Sanitaria Biodonostia; University Hospital Donostia; University of Basque Country; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Investigacion Sanitaria Biodonostia; University Hospital Donostia; University of Basque Country; Hospital de La Princesa; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Companioni, O; Sala, N (corresponding author), Inst Catala Oncol, Canc Epidemiol Res Program, Unit Nutr & Canc, Barcelona, Spain.	osmel.companioni@yahoo.es; nsala@iconcologia.net	Napoles, Osmel Companioni/AAH-7636-2021; Gisbert, Javier P/ABB-7531-2021; Gisbert, Javier P/GRY-2719-2022; Cuatrecasas, Miriam/C-9156-2019; Puigdecanet, Eulàlia/U-7568-2019; parra-blanco, veronica/ABC-7069-2020; Sala, Nuria/G-8471-2015	Gisbert, Javier P/0000-0003-2090-3445; Cuatrecasas, Miriam/0000-0003-3063-0110; parra-blanco, veronica/0000-0002-7916-5478; Companioni Napoles, Osmel/0000-0001-6605-945X; Sanz-Anquela, Jose Miguel/0000-0001-9723-6615; Sala, Nuria/0000-0003-3585-7613	Fondo de investigaciones Sanitarias del Institute de Salud Carlos III, Spanish Ministry of Health; European Regional Development Funds (ERDF/FEDER) "A way to build Europe" [PI03/0077, PI10/01089, PI10/01031, PI10/01203, RETICC RD12/0036/0018]; Agenda de Gestio d'Ajuts Universitaris i de Recerca (AGAUR), Generalitat de Catalunya, Catalunya, Spain [exp. 2014 SGR 726]; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)	Fondo de investigaciones Sanitarias del Institute de Salud Carlos III, Spanish Ministry of Health; European Regional Development Funds (ERDF/FEDER) "A way to build Europe"; Agenda de Gestio d'Ajuts Universitaris i de Recerca (AGAUR), Generalitat de Catalunya, Catalunya, Spain; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)	Fondo de investigaciones Sanitarias del Institute de Salud Carlos III, Spanish Ministry of Health. Cofounded by European Regional Development Funds (ERDF/FEDER) "A way to build Europe". http://www.isciii.es/. Grant numbers: PI03/0077 (CAG) PI10/01089 (CAG), PI10/01031 (JG), PI10/01203 (JMS) RETICC RD12/0036/0018 (CAG, NS, OC, NG). Agenda de Gestio d'Ajuts Universitaris i de Recerca (AGAUR), Generalitat de Catalunya, Catalunya, Spain. http://agaur.gencat.cat/en/inici/index.html. Grant number: exp. 2014 SGR 726 (CAG, OC, NG, NS). Institut d'Investigacio Biomedica de Bellvitge (IDIBELL), http://www.idibell.cat/en, PhD scholarship to OC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PRISM VERS 5 01 WIND; Aquino PF, 2012, J PROTEOME RES, V11, P5836, DOI 10.1021/pr300612x; Baenke F, 2013, DIS MODEL MECH, V6, P1353, DOI 10.1242/dmm.011338; Bai ZG, 2011, INT J ONCOL, V38, P375, DOI 10.3892/ijo.2010.873; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernatchez PN, 2007, J BIOL CHEM, V282, P30745, DOI 10.1074/jbc.M704798200; Boussioutas A, 2006, CANCER RES, V63, P2569; Chen X, 2003, MOL BIOL CELL, V14, P3208, DOI 10.1091/mbc.E02-12-0833; Chen YX, 2006, BIOCHEM BIOPH RES CO, V340, P758, DOI 10.1016/j.bbrc.2005.12.068; Cleries R, 2012, COMPUT BIOL MED, V42, P438, DOI 10.1016/j.compbiomed.2011.12.012; Correa P, 2012, J DIGEST DIS, V13, P2, DOI 10.1111/j.1751-2980.2011.00550.x; Curt MJC, 2015, GLYCOBIOLOGY, V25, P617, DOI 10.1093/glycob/cwv004; Dinis-Ribeiro M, 2012, VIRCHOWS ARCH, V460, P19, DOI 10.1007/s00428-011-1177-8; Garay J, 2016, CANCER LETT, V371, P90, DOI 10.1016/j.canlet.2015.10.037; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gomes LI, 2005, CANCER RES, V65, P7127, DOI 10.1158/0008-5472.CAN-05-1035; Gonzalez CA, 2016, J GASTROEN HEPATOL, V31, P953, DOI 10.1111/jgh.13249; Gonzalez CA, 2013, INT J CANCER, V133, P1023, DOI 10.1002/ijc.28003; Gonzalez CA, 2010, INT J CANCER, V127, P2654, DOI 10.1002/ijc.25273; Hamamoto T, 1997, J CLIN PATHOL, V50, P841, DOI 10.1136/jcp.50.10.841; Han Y, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0564-1; Hanada K, 2014, INFECT IMMUN, V82, P4182, DOI 10.1128/IAI.02368-14; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hu CY, 2013, INT J ONCOL, V43, P1487, DOI 10.3892/ijo.2013.2078; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ishigami S, 2012, CANCER IMMUNOL IMMUN, V61, P1663, DOI 10.1007/s00262-012-1225-5; Jang BG, 2015, VIRCHOWS ARCH, V467, P285, DOI 10.1007/s00428-015-1793-9; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kameshima H, 2000, WORLD J SURG, V24, P1243, DOI 10.1007/s002680010246; Kim Kyong Rae, 2007, Korean J Gastroenterol, V49, P209; Kim MS, 2012, PATHOLOGY, V44, P576, DOI 10.1097/PAT.0b013e3283583bf6; Kobayashi D, 2007, CANCER SCI, V98, P334, DOI 10.1111/j.1349-7006.2007.00397.x; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Lee HJ, 2010, GASTROENTEROLOGY, V139, P358; Lee K, 2014, GUT LIVER, V8, P131, DOI 10.5009/gnl.2014.8.2.131; Liu Q, 2007, MODERN PATHOL, V20, P1286, DOI 10.1038/modpathol.3800968; Liu R, 2009, MOL CELL PROTEOMICS, V8, P70, DOI 10.1074/mcp.M800195-MCP200; Magnusson PKE, 2001, CANCER RES, V61, P2684; Mesquita Patricia, 2006, Critical Reviews in Oncogenesis, V12, P3; Mimura K, 2013, J IMMUNOL, V191, P6261, DOI 10.4049/jimmunol.1301597; Nam KH, 2013, PATHOBIOLOGY, V80, P87, DOI 10.1159/000341685; Necchi V, 2007, GASTROENTEROLOGY, V132, P1009, DOI 10.1053/j.gastro.2007.01.049; Shiotani A, 2005, AM J GASTROENTEROL, V100, P581, DOI 10.1111/j.1572-0241.2005.41001.x; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Sonachalam Madhankumar, 2012, Frontiers in Genetics, V3, P80, DOI 10.3389/fgene.2012.00080; Sousa JF, 2012, AM J PATHOL, V181, P1560, DOI 10.1016/j.ajpath.2012.07.027; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsai RYL, 2002, GENE DEV, V16, P2991, DOI 10.1101/gad.55671; Wang JH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062876, 10.1371/journal.pone.0080980]; WEE A, 1992, J CLIN PATHOL, V45, P30, DOI 10.1136/jcp.45.1.30; Wu JX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114746; Xie Y, 2015, ONCOTARGETS THER, V8, P567, DOI 10.2147/OTT.S79150; Zang Shizhu, 2014, Genomics Proteomics & Bioinformatics, V12, P276, DOI 10.1016/j.gpb.2014.09.004; Zhang SW, 2015, AM J CANCER RES, V5, P928	54	14	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176043	10.1371/journal.pone.0176043	http://dx.doi.org/10.1371/journal.pone.0176043			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441455	Green Published, gold, Green Submitted			2022-12-26	WOS:000400308800021
J	Li, XY; Xu, W; Hu, N; Liang, X; Huang, W; Jiang, DM; Chen, H				Li, Xinyu; Xu, Wei; Hu, Ning; Liang, Xi; Huang, Wei; Jiang, Dianming; Chen, Hong			Relationship between acromial morphological variation and subacromial impingement: A three-dimensional analysis	PLOS ONE			English	Article							ROTATOR CUFF TEARS; CORACOACROMIAL LIGAMENT; ACROMIOPLASTY; DECOMPRESSION; ASSOCIATION; REPAIR; ANATOMY; SPACE	Purpose: To evaluate the association of acromial morphology and subacromial impingement. Methods: Bilateral shoulder computed tomography was performed in 138 patients who received shoulder arthroscopy. Measured parameters included: acromial tilt (AT), modified acromial tilt (mAT), acromial slope (AS), acromiohumeral interval (AHI), lateral acromial angle (LAA), acromial index (AI), critical shoulder angle (CSA), acromial anterior protrusion (AAP), and acromial inferior protrusion (AIP). Acromial morphological characteristics were compared between groups. Side-to-side differences were assessed between affected and non-affected shoulders. Intra-and inter-observer agreements for each parameter were calculated. Results: AT (25.90 vs. 29.41 degrees E), mAT (18.88 vs. 22.64 degrees E), and AHI (5.46 vs. 6.47 mm) were significantly smaller in impinged patients. The impingement group demonstrated significantly larger AI (63.50 vs. 59.84%), CSA (31.78 vs. 28.74 degrees E), AAP (7.13 vs. 5.32 mm), and AIP (5.51 vs. 4.04 mm). Regarding side-to-side comparison, the acromial morphology was significantly different between the affected and non-affected shoulders in impinged patients, while the difference was slight and insignificant in control patients. All, except AS and LAA, measured parameters demonstrated good intra-and inter-observer agreements. Conclusions: Three-dimensional reconstructed CT scan is a reliable method to measure shoulder morphology. The acromial morphological variation is related with sub acromial impingement, however, the causal relationship of them should be further explored.	[Li, Xinyu] Chongqing Med Univ, Dept Pharm, Affiliated Hosp 1, Chongqing, Peoples R China; [Xu, Wei; Hu, Ning; Liang, Xi; Huang, Wei; Jiang, Dianming; Chen, Hong] Chongqing Med Univ, Dept Orthoped, Affiliated Hosp 1, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Chen, H (corresponding author), Chongqing Med Univ, Dept Orthoped, Affiliated Hosp 1, Chongqing, Peoples R China.	chhong113@126.com	CHEN, Hong/AAC-7879-2019	CHEN, Hong/0000-0002-4152-624X				Balke M, 2016, KNEE SURG SPORT TR A, V24, P2200, DOI 10.1007/s00167-014-3499-y; Balke M, 2013, ACTA ORTHOP, V84, P178, DOI 10.3109/17453674.2013.773413; Banas M P, 1995, J Shoulder Elbow Surg, V4, P454, DOI 10.1016/S1058-2746(05)80038-2; Budoff JE, 2005, ARTHROSCOPY, V21, P1081, DOI 10.1016/j.arthro.2005.05.019; Chahal J, 2012, ARTHROSCOPY, V28, P720, DOI 10.1016/j.arthro.2011.11.022; Codman EA, 1934, SHOULDER RUPTURE SUP, P468; Fujisawa Y, 2014, AM J SPORT MED, V42, P2621, DOI 10.1177/0363546514544683; Gill TJ, 2002, J SHOULDER ELB SURG, V11, P327, DOI 10.1067/mse.2002.124425; Goldberg BA, 2001, CLIN ORTHOP RELAT R, P142, DOI 10.1097/00003086-200109000-00017; Hamid N, 2012, J SHOULDER ELB SURG, V21, P1289, DOI 10.1016/j.jse.2011.09.028; Henkus HE, 2009, J BONE JOINT SURG BR, V91B, P504, DOI 10.1302/0301-620X.91B4.21442; Khan Yousaf, 2013, Open Orthop J, V7, P347, DOI 10.2174/1874325001307010347; Kitay G S, 1995, J Shoulder Elbow Surg, V4, P441, DOI 10.1016/S1058-2746(05)80036-9; Lee TQ, 2001, J SHOULDER ELB SURG, V10, P68, DOI 10.1067/mse.2001.111138; Mackenzie TA, 2015, CLIN BIOMECH, V30, P641, DOI 10.1016/j.clinbiomech.2015.06.001; McCallister WV, 2005, J BONE JOINT SURG AM, V87A, P1278, DOI 10.2106/JBJS.D.02432; Michener LA, 2015, KNEE SURG SPORT TR A, V23, P363, DOI 10.1007/s00167-013-2542-8; Moor BK, 2013, BONE JOINT J, V95B, P935, DOI 10.1302/0301-620X.95B7.31028; Moor BK, 2014, J SHOULDER ELB SURG, V23, P536, DOI 10.1016/j.jse.2013.11.008; NEER CS, 1983, CLIN ORTHOP RELAT R, P70; Nyffeler RW, 2006, J BONE JOINT SURG AM, V88A, P800, DOI 10.2106/JBJS.D.03042; Oh JH, 2010, CLIN ORTHOP RELAT R, V468, P1542, DOI 10.1007/s11999-009-1058-5; Saupe N, 2006, AM J ROENTGENOL, V187, P376, DOI 10.2214/AJR.05.0435; Scheibel M, 2004, J SHOULDER ELB SURG, V13, P272, DOI 10.1016/j.jse.2004.01.007; Shi LL, 2012, ADV ORTHOP, V2012, DOI 10.1155/2012/467571; Su WR, 2009, ARTHROSCOPY, V25, P13, DOI 10.1016/j.arthro.2008.10.004	26	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176193	10.1371/journal.pone.0176193	http://dx.doi.org/10.1371/journal.pone.0176193			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441418	Green Submitted, gold, Green Published			2022-12-26	WOS:000400308800031
J	Wang, YT; Wang, LB; Qiao, PG; Sheng, FG; Han, C; Ye, EM; Lei, Y; Yan, F; Chen, SS; Zhu, YY; Mi, GY; Li, GJ; Yang, Z				Wang, Yituo; Wang, Lubin; Qiao, Penggang; Sheng, Fugeng; Han, Cong; Ye, Enmao; Lei, Yu; Yan, Feng; Chen, Shanshan; Zhu, Yuyang; Mi, Guiyun; Li, Gongjie; Yang, Zheng			Impact of aberrant cerebral perfusion on resting-state functional MRI: A preliminary investigation of Moyamoya disease	PLOS ONE			English	Article							BOLD SIGNAL FLUCTUATIONS; EMISSION COMPUTED-TOMOGRAPHY; CAROTID-ARTERY OCCLUSION; LEVEL-DEPENDENT MRI; CEREBROVASCULAR REACTIVITY; BRAIN-FUNCTION; DEFAULT MODE; BLOOD-FLOW; QUANTITATIVE-EVALUATION; FMRI	The impact of chronic cerebral hypoperfusion on resting-state blood oxygen level-dependent signal fluctuations remains unknown. We aimed to determine whether chronic ischemia induces changes in amplitude of low-frequency fluctuations (ALFF) and to investigate the correlation between ALFF and perfusion-weighted magnetic resonance imaging (PWI) parameters in patients with moyamoya disease (MMD). Thirty patients with pre- and postoperative resting-state functional magnetic resonance imaging and PWI were included, and thirty normal controls underwent resting-state functional magnetic resonance imaging. A decrease in preoperative frontal lobe ALFF was observed in patients with MMD. Postoperative frontal lobe ALFF showed moderate improvement but still remained lower than those in normal controls. The values of mean transit time and time-to-peak, but not cerebral blood volume and cerebral blood flow, correlated significantly with frontal lobe ALFF. Moreover, there were significant negative correlations between changes in frontal lobe PWI parameters and changes in frontal lobe ALFF on both operated side and contralateral side after the unilateral revascularization surgery. Our results demonstrate that reduced ALFF are closely related to the abnormal PWI parameters and vary with the alteration of cerebral perfusion in patients with MMD.	[Wang, Yituo; Wang, Lubin; Ye, Enmao; Lei, Yu; Chen, Shanshan; Zhu, Yuyang; Mi, Guiyun; Yang, Zheng] Beijing Inst Basic Med Sci, Cognit & Mental Hlth Res Ctr, Beijing, Peoples R China; [Wang, Yituo; Qiao, Penggang; Sheng, Fugeng; Yan, Feng; Li, Gongjie] Acad Mil Med Sci, Affiliated Hosp, Dept Radiol, Beijing, Peoples R China; [Han, Cong] Acad Mil Med Sci, Affiliated Hosp, Dept Neurosurg, Beijing, Peoples R China	Academy of Military Medical Sciences - China; Academy of Military Medical Sciences - China; Academy of Military Medical Sciences - China	Yang, Z (corresponding author), Beijing Inst Basic Med Sci, Cognit & Mental Hlth Res Ctr, Beijing, Peoples R China.; Li, GJ (corresponding author), Acad Mil Med Sci, Affiliated Hosp, Dept Radiol, Beijing, Peoples R China.	ligj307@163.com; yangz236@163.com	Wang, Yi-Tuo/GYR-0385-2022; Chen, Shanshan/ACO-4807-2022	Wang, Yi-Tuo/0000-0002-9295-8894; Chen, Shanshan/0000-0001-9723-2403	Youth Programs of Beijing Natural Science Foundation [7144231]; Capital Characteristic Clinic Project [Z141107002514171]	Youth Programs of Beijing Natural Science Foundation; Capital Characteristic Clinic Project	This work was supported by grant 7144231 from the Youth Programs of Beijing Natural Science Foundation (PQ) and by grant Z141107002514171 from Capital Characteristic Clinic Project (GL).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arikan F, 2015, NEUROSURGERY, V76, P302, DOI 10.1227/NEU.0000000000000609; Calamante F, 1999, J CEREBR BLOOD F MET, V19, P701, DOI 10.1097/00004647-199907000-00001; Christen T, 2015, J MAGN RESON IMAGING, V41, P424, DOI 10.1002/jmri.24558; Cohen ER, 2002, J CEREBR BLOOD F MET, V22, P1042, DOI 10.1097/00004647-200209000-00002; Duff EP, 2008, HUM BRAIN MAPP, V29, P778, DOI 10.1002/hbm.20601; Eicker S, 2011, EUR J MED RES, V16, P484, DOI 10.1186/2047-783X-16-11-484; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Fransson P, 2006, NEUROPSYCHOLOGIA, V44, P2836, DOI 10.1016/j.neuropsychologia.2006.06.017; Fukui M, 1997, CLIN NEUROL NEUROSUR, V99, pS238; Fukunaga M, 2008, J CEREBR BLOOD F MET, V28, P1377, DOI 10.1038/jcbfm.2008.25; Han JS, 2011, STROKE, V42, P3047, DOI 10.1161/STROKEAHA.111.615955; Han JS, 2011, STROKE, V42, P1261, DOI 10.1161/STROKEAHA.110.603225; Heeger DJ, 2000, NAT NEUROSCI, V3, P631, DOI 10.1038/76572; Heyn C, 2010, AM J NEURORADIOL, V31, P862, DOI 10.3174/ajnr.A1922; Honda M, 2006, SURG NEUROL, V66, P155, DOI 10.1016/j.surneu.2005.08.022; Hoptman MJ, 2010, SCHIZOPHR RES, V117, P13, DOI 10.1016/j.schres.2009.09.030; Jahanian H, 2016, J CEREB BLOOD FLOW M; Kawano T, 2016, CEREBROVASC DIS, V42, P131, DOI 10.1159/000445696; Kemna LJ, 2001, NEUROIMAGE, V14, P642, DOI 10.1006/nimg.2001.0859; Kim E, 2009, J COMPUT ASSIST TOMO, V33, P546, DOI 10.1097/RCT.0b013e318188887d; Kim JH, 2000, AM J NEURORADIOL, V21, P1450; Kohno K, 1998, NEUROSURGERY, V42, P752, DOI 10.1097/00006123-199804000-00043; Kuhn FP, 2015, J STROKE CEREBROVASC, V24, P965, DOI 10.1016/j.jstrokecerebrovasdis.2014.12.017; Kuroda S, 2008, LANCET NEUROL, V7, P1056, DOI 10.1016/S1474-4422(08)70240-0; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Lv YT, 2013, ANN NEUROL, V73, P136, DOI 10.1002/ana.23763; Mandell DM, 2008, STROKE, V39, P2021, DOI 10.1161/STROKEAHA.107.506709; Mark CI, 2015, J MAGN RESON IMAGING, V42, P231, DOI 10.1002/jmri.24786; Mazerolle EL, 2016, CLIN PHYSL FUNCT IMA; Mitra PP, 1997, MAGNET RESON MED, V37, P511, DOI 10.1002/mrm.1910370407; Nariai T, 2005, J NEUROL NEUROSUR PS, V76, P663, DOI 10.1136/jnnp.2003.025049; Noguchi T, 2013, EUR J RADIOL, V82, pE840, DOI 10.1016/j.ejrad.2013.08.040; Park JC, 2010, CEREBROVASC DIS, V30, P547, DOI 10.1159/000319026; Pelled G, 2004, MAGN RESON MED, V52, P913, DOI 10.1002/mrm.20229; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; SUZUKI J, 1969, ARCH NEUROL-CHICAGO, V20, P288, DOI 10.1001/archneur.1969.00480090076012; Tanaka Y, 2006, J CEREBR BLOOD F MET, V26, P291, DOI 10.1038/sj.jcbfm.9600187; Thomas B, 2013, CHILD NERV SYST, V29, P457, DOI 10.1007/s00381-012-1952-0; Tong Y., 2016, J CEREB BLOOD FLOW M; Wang ZQ, 2011, HUM BRAIN MAPP, V32, P1720, DOI 10.1002/hbm.21140; Yan CG, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00910; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yang H, 2007, NEUROIMAGE, V36, P144, DOI 10.1016/j.neuroimage.2007.01.054; Yun TJ, 2009, RADIOLOGY, V251, P216, DOI 10.1148/radiol.2511080654; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080	48	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176461	10.1371/journal.pone.0176461	http://dx.doi.org/10.1371/journal.pone.0176461			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441445	gold, Green Published, Green Submitted			2022-12-26	WOS:000400308800060
J	Chanwimalueang, T; Aufegger, L; Adjei, T; Wasley, D; Cruder, C; Mandic, DP; Williamon, A				Chanwimalueang, Theerasak; Aufegger, Lisa; Adjei, Tricia; Wasley, David; Cruder, Cinzia; Mandic, Danilo P.; Williamon, Aaron			Stage call: Cardiovascular reactivity to audition stress in musicians	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; TIME-SERIES ANALYSIS; COMPLEXITY; SPECTRA	Auditioning is at the very center of educational and professional life in music and is associated with significant psychophysical demands. Knowledge of how these demands affect cardiovascular responses to psychosocial pressure is essential for developing strategies to both manage stress and understand optimal performance states. To this end, we recorded the electrocardiograms (ECGs) of 16 musicians (11 violinists and 5 flutists) before and during performances in both low-and high-stress conditions: with no audience and in front of an audition panel, respectively. The analysis consisted of the detection of R-peaks in the ECGs to extract heart rate variability (HRV) from the notoriously noisy real-world ECGs. Our data analysis approach spanned both standard (temporal and spectral) and advanced (structural complexity) techniques. The complexity science approaches-namely, multiscale sample entropy and multiscale fuzzy entropy-indicated a statistically significant decrease in structural complexity in HRV from the low-to the high-stress condition and an increase in structural complexity from the pre-performance to performance period, thus confirming the complexity loss theory and a loss in degrees of freedom due to stress. Results from the spectral analyses also suggest that the stress responses in the female participants were more parasympathetically driven than those of the male participants. In conclusion, our findings suggest that interventions to manage stress are best targeted at the sensitive pre-performance period, before an audition begins.	[Chanwimalueang, Theerasak; Adjei, Tricia; Mandic, Danilo P.] Imperial Coll London, Dept Elect & Elect Engn, London, England; [Aufegger, Lisa; Williamon, Aaron] Royal Coll Mus, Ctr Performance Sci, London, England; [Aufegger, Lisa; Williamon, Aaron] Imperial Coll London, Fac Med, London, England; [Wasley, David] Cardiff Metropolitan Univ, Cardiff Sch Sport, Cardiff, S Glam, Wales; [Cruder, Cinzia] Conservatory Southern Switzerland, Dept Res & Dev, Lugano, Switzerland	Imperial College London; Royal College of Music - UK; Imperial College London; Cardiff Metropolitan University	Mandic, DP (corresponding author), Imperial Coll London, Dept Elect & Elect Engn, London, England.; Williamon, A (corresponding author), Royal Coll Mus, Ctr Performance Sci, London, England.; Williamon, A (corresponding author), Imperial Coll London, Fac Med, London, England.	d.mandic@imperial.ac.uk; aaron.williamon@rcm.ac.uk	; Williamon, Aaron/C-5796-2013	Wasley, David/0000-0002-6730-4127; Williamon, Aaron/0000-0002-1713-6161	UK's Arts and Humanities Research Council [AH/K002287/1]; Peter Sowerby Foundation; EPSRC grant [EP/K025643/1]; EPSRC Pathways to Impact Grant [PSA256]; EPSRC Multidisciplinary University Research Initiative [EP/P008461]; Engineering and Physical Sciences Research Council [EP/K025643/1]; Engineering and Physical Sciences Research Council (Multidisciplinary University Research Initiative) [EP/P008461]; Engineering and Physical Sciences Research Council (Pathways to Impact Grant) [PSA256]; Arts and Humanities Research Council [AH/K002287/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/K503733/1] Funding Source: researchfish; AHRC [AH/K002287/1] Funding Source: UKRI; EPSRC [EP/K025643/1] Funding Source: UKRI	UK's Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Peter Sowerby Foundation; EPSRC grant(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC Pathways to Impact Grant(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC Multidisciplinary University Research Initiative(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council (Multidisciplinary University Research Initiative)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council (Pathways to Impact Grant)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We wish to thank the musicians and the adjudicators who took part in this study. The research reported in this article was supported by grants from the UK's Arts and Humanities Research Council (grant ref. AH/K002287/1), the Peter Sowerby Foundation, EPSRC grant EP/K025643/1, EPSRC Pathways to Impact Grant PSA256, and EPSRC.; The research reported in this article was supported by grants from the UK's Arts and Humanities Research Council (grant ref. AH/K002287/1), the Peter Sowerby Foundation, and the Engineering and Physical Sciences Research Council (grant ref. EP/K025643/1, Multidisciplinary University Research Initiative EP/P008461, and Pathways to Impact Grant PSA256).	Abel J.L., 1990, PSYCHOL MUSIC, V18, P171, DOI [10.1177/0305735690182006, DOI 10.1177/0305735690182006]; AHMED AK, 1982, EUR J APPL PHYSIOL O, V50, P95, DOI 10.1007/BF00952248; BERNTSON GG, 1994, PSYCHOPHYSIOLOGY, V31, P599, DOI 10.1111/j.1469-8986.1994.tb02352.x; Berntson GG, 2007, HEART RATE VARIABILI, P57; Billman GE, 2013, FRONT PHYSIOL, V4, DOI [10.3389/fphys.2013.00222, 10.3389/fphys.2013.00026]; BROTONS M, 1994, J MUSIC THER, V31, P63, DOI 10.1093/jmt/31.1.63; BROWN TE, 1993, J APPL PHYSIOL, V75, P2310, DOI 10.1152/jappl.1993.75.5.2310; Camm AJ, 1996, CIRCULATION, V93, P1043; Chanwimalueang T, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON DIGITAL SIGNAL PROCESSING (DSP), P134, DOI 10.1109/ICDSP.2015.7251845; Chanwimalueang T, 2016, INT CONF ACOUST SPEE, P814, DOI 10.1109/ICASSP.2016.7471788; Chen WT, 2007, IEEE T NEUR SYS REH, V15, P266, DOI 10.1109/TNSRE.2007.897025; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; CRASKE MG, 1984, BEHAV RES THER, V22, P267, DOI 10.1016/0005-7967(84)90007-X; Delaney JPA, 2000, PERCEPT MOTOR SKILL, V91, P515, DOI 10.2466/PMS.91.6.515-524; Domitrovich PP, 2002, COMPUT CARDIOL, V29, P665, DOI 10.1109/CIC.2002.1166860; Friedman BH, 1996, CLIN AUTON RES, V6, P147, DOI 10.1007/BF02281901; Johnstone JA, 2012, J SPORT SCI MED, V11, P400; Johnstone JA, 2012, J SPORT SCI MED, V11, P409; Kattimani YR, 2015, INT J SCI STUDY, V3, P48, DOI 10.17354/ijss/2015/154; Kukielka M, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00003; Kuusela T, 2013, HEART RATE VARIABILITY (HRV) SIGNAL ANALYSIS: CLINICAL APPLICATIONS, P9; Lehrer PM, 2003, PSYCHOSOM MED, V65, P796, DOI 10.1097/01.PSY.0000089200.81962.19; LIPSITZ LA, 1992, JAMA-J AM MED ASSOC, V267, P1806, DOI 10.1001/jama.267.13.1806; Lucini D, 2002, HYPERTENSION, V39, P184, DOI 10.1161/hy0102.100784; Mietus JE, 2002, HEART, V88, P378, DOI 10.1136/heart.88.4.378; Milicevic G, 2005, COLLEGIUM ANTROPOL, V29, P295; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; Peltola MA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00148; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Saleh TM, 2007, CLIN EXP PHARMACOL P, V34, P827, DOI 10.1111/j.1440-1681.2007.04663.x; Selye H, 1936, NATURE, V138, P32, DOI 10.1038/138032a0; Singh D., 2004, Journal of Medical Engineering & Technology, V28, P263, DOI 10.1080/03091900410001662350; SLOAN RP, 1994, BIOL PSYCHOL, V37, P89, DOI 10.1016/0301-0511(94)90024-8; Spielberger C.D., 1983, MANUAL STATE TRAIT A, DOI DOI 10.1002/9780470479216.CORPSY0943; Tiller W A, 1996, Altern Ther Health Med, V2, P52; Tuzcu V, 2006, EUROPACE, V8, P398, DOI 10.1093/europace/eul031; Visnovcova Z, 2014, PHYSIOL MEAS, V35, P1319, DOI 10.1088/0967-3334/35/7/1319; Williamon A., 2004, MUSICAL EXCELLENCE S; Williamon A, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0719; Xiong GL, 2010, J ZHEJIANG UNIV-SC A, V11, P270, DOI 10.1631/jzus.A0900360; Yoshie M, 2009, EXP BRAIN RES, V199, P117, DOI 10.1007/s00221-009-1979-y	43	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176023	10.1371/journal.pone.0176023	http://dx.doi.org/10.1371/journal.pone.0176023			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET4XE	28437466	Green Published, Green Submitted, gold			2022-12-26	WOS:000400287600028
J	Pene, V; Lemasson, M; Harper, F; Pierron, G; Rosenberg, AR				Pene, Veronique; Lemasson, Matthieu; Harper, Francis; Pierron, Gerard; Rosenberg, Arielle R.			Role of cleavage at the core-E1 junction of hepatitis C virus polyprotein in viral morphogenesis	PLOS ONE			English	Article							SIGNAL PEPTIDE PEPTIDASE; LIPID DROPLET; PROTEIN; PARTICLES; MEMBRANE; DENSITY; GLYCOPROTEINS; ASSOCIATION; DEGRADATION; MATURATION	In hepatitis C virus (HCV) polyprotein sequence, core protein terminates with E1 envelope signal peptide. Cleavage by signal peptidase (SP) separates E1 from the complete form of core protein, anchored in the endoplasmic reticulum (ER) membrane by the signal peptide. Subsequent cleavage of the signal peptide by signal-peptide peptidase (SPP) releases the mature form of core protein, which preferentially relocates to lipid droplets. Both of these cleavages are required for the HCV infectious cycle, supporting the idea that HCV assembly begins at the surface of lipid droplets, yet SPP-catalyzed cleavage is dispensable for initiation of budding in the ER. Here we have addressed at what step(s) of the HCV infectious cycle SP-catalyzed cleavage at the core-E1 junction is required. Taking advantage of the sole system that has allowed visualization of HCV budding events in the ER lumen of mammalian cells, we showed that, unexpectedly, mutations abolishing this cleavage did not prevent but instead tended to promote the initiation of viral budding. Moreover, even though no viral particles were released from Huh-7 cells transfected with a full-length HCV genome bearing these mutations, intracellular viral particles containing core protein protected by a membrane envelope were formed. These were visualized by electron microscopy as capsid-containing particles with a diameter of about 70 nm and 40 nm before and after delipidation, respectively, comparable to intracellular wild-type particle precursors except that they were non-infectious. Thus, our results show that SP-catalyzed cleavage is dispensable for HCV budding per se, but is required for the viral particles to acquire their infectivity and secretion. These data support the idea that HCV assembly occurs in concert with budding at the ER membrane. Furthermore, capsid- containing particles did not accumulate in the absence of SP-catalyzed cleavage, suggesting the quality of newly formed viral particles is controlled before secretion.	[Pene, Veronique; Lemasson, Matthieu; Rosenberg, Arielle R.] Univ Paris 05, EA 4474, Virol Hepatite C, Paris, France; [Harper, Francis; Pierron, Gerard] CNRS, Inst Gustave Roussy, UMR 9196, Villejuif, France; [Rosenberg, Arielle R.] AP HP, Hop Cochin, Serv Virol, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Pene, V; Rosenberg, AR (corresponding author), Univ Paris 05, EA 4474, Virol Hepatite C, Paris, France.; Rosenberg, AR (corresponding author), AP HP, Hop Cochin, Serv Virol, Paris, France.	veronique.pene@parisdescartes.fr; arielle.rosenberg@parisdescartes.fr		Rosenberg, Arielle/0000-0003-2085-8146	"AVENIR" grant from the INSERM; Fondation Bettencourt-Schueller; Region Ile-de-France; Fondation pour la Recherche Medicale; INSERM	"AVENIR" grant from the INSERM; Fondation Bettencourt-Schueller; Region Ile-de-France(Region Ile-de-France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by an "AVENIR" grant from the INSERM, and by the Fondation Bettencourt-Schueller. V.P. received a fellowship co financed by the INSERM and the Region Ile-de-France, followed by a fellowship from the Fondation pour la Recherche Medicale.; This work was supported by an "AVENIR" grant from the INSERM, and by the Fondation Bettencourt-Schueller. V.P. received a fellowship co-financed by the INSERM and the Region Ile-de-France, followed by a fellowship from the Fondation pour la Recherche Medicale.	Ai LS, 2009, J VIROL, V83, P9923, DOI 10.1128/JVI.00066-09; Aizawa S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11379; Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Bartenschlager R, 2011, TRENDS MICROBIOL, V19, P95, DOI 10.1016/j.tim.2010.11.005; Blanchard E, 2002, J VIROL, V76, P4073, DOI 10.1128/JVI.76.8.4073-4079.2002; Boson B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002144; Boulant S, 2008, TRAFFIC, V9, P1268, DOI 10.1111/j.1600-0854.2008.00767.x; Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0; Boyer A, 2014, J BIOL CHEM, V289, P18904, DOI 10.1074/jbc.M113.538256; BRADLEY D, 1991, J MED VIROL, V34, P206, DOI 10.1002/jmv.1890340315; Catanese MT, 2013, P NATL ACAD SCI USA, V110, P9505, DOI 10.1073/pnas.1307527110; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Clayton RF, 2002, J VIROL, V76, P7672, DOI 10.1128/JVI.76.15.7672-7682.2002; Coller KE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002466; Counihan NA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002302; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Gastaminza P, 2006, J VIROL, V80, P11074, DOI 10.1128/JVI.01150-06; Gentzsch J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003355; Herker E, 2010, NAT MED, V16, P1295, DOI 10.1038/nm.2238; HIJIKATA M, 1993, J VIROL, V67, P1953, DOI 10.1128/JVI.67.4.1953-1958.1993; HIJIKATA M, 1991, P NATL ACAD SCI USA, V88, P5547, DOI 10.1073/pnas.88.13.5547; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Icard V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004233; Jones DM, 2010, J BIOL CHEM, V285, P22732, DOI 10.1074/jbc.R110.133017; Klein KC, 2004, J VIROL, V78, P9257, DOI 10.1128/JVI.78.17.9257-9269.2004; Kopp M, 2010, J VIROL, V84, P1666, DOI 10.1128/JVI.02043-09; Kunkel M, 2001, J VIROL, V75, P2119, DOI 10.1128/JVI.75.5.2119-2129.2001; Lai CK, 2010, J VIROL, V84, P11590, DOI 10.1128/JVI.00587-10; Lavie M, 2007, CURR ISSUES MOL BIOL, V9, P71; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; Majeau N, 2005, J GEN VIROL, V86, P3055, DOI 10.1099/vir.0.81174-0; Majeau N, 2004, J GEN VIROL, V85, P971, DOI 10.1099/vir.0.79775-0; Majeau N, 2009, J BIOL CHEM, V284, P33915, DOI 10.1074/jbc.M109.018549; McLauchlan J, 2000, J VIRAL HEPATITIS, V7, P2; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Nielsen SU, 2008, J GEN VIROL, V89, P2507, DOI 10.1099/vir.0.2008/000083-0; Nielsen SU, 2006, J VIROL, V80, P2418, DOI 10.1128/JVI.80.5.2418-2428.2006; Oehler V, 2012, J VIROL, V86, P7818, DOI 10.1128/JVI.00457-12; Okamoto K, 2008, J VIROL, V82, P8349, DOI 10.1128/JVI.00306-08; Pene V, 2009, J VIRAL HEPATITIS, V16, P705, DOI 10.1111/j.1365-2893.2009.01118.x; Pesne V, 2015, J VIROL, V89, P5462, DOI 10.1128/JVI.03197-14; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Piver E, 2016, GUT; Popescu Costin-Ioan, 2014, Biology (Basel), V3, P892, DOI 10.3390/biology3040892; Popescu CI, 2011, VIRUSES-BASEL, V3, P2238, DOI 10.3390/v3112238; Ribet D, 2008, GENOME RES, V18, P597, DOI 10.1101/gr.073486.107; Roingeard P, 2008, HISTOCHEM CELL BIOL, V130, P561, DOI 10.1007/s00418-008-0447-2; Rouille Y, 2006, J VIROL, V80, P2832, DOI 10.1128/JVI.80.6.2832-2841.2006; Saeed M, 2011, J BIOL CHEM, V286, P37264, DOI 10.1074/jbc.M111.259085; Scholtes C, 2012, HEPATOLOGY, V56, P39, DOI 10.1002/hep.25628; Shavinskaya A, 2007, J BIOL CHEM, V282, P37158, DOI 10.1074/jbc.M707329200; Suzuki T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00038; Targett-Adams P, 2008, J BIOL CHEM, V283, P16850, DOI 10.1074/jbc.M802273200; Vauloup-Fellous C, 2006, J BIOL CHEM, V281, P27679, DOI 10.1074/jbc.M602587200; Vieyres G, 2014, VIRUSES-BASEL, V6, P1149, DOI 10.3390/v6031149; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Yasui K, 1998, J VIROL, V72, P6048, DOI 10.1128/JVI.72.7.6048-6055.1998; Yi MK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000403; Zaidi S, 2010, GASTROENTEROLOGY, V139, P1355; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9739	62	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0175810	10.1371/journal.pone.0175810	http://dx.doi.org/10.1371/journal.pone.0175810			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437468	gold, Green Published, Green Submitted			2022-12-26	WOS:000400287600014
J	Jin, M; Monroig, O; Lu, Y; Yuan, Y; Li, Y; Ding, LY; Tocher, DR; Zhou, QC				Jin, Min; Monroig, Oscar; Lu, You; Yuan, Ye; Li, Yi; Ding, Liyun; Tocher, Douglas R.; Zhou, Qicun			Dietary DHA/EPA ratio affected tissue fatty acid profiles, antioxidant capacity, hematological characteristics and expression of lipid-related genes but not growth in juvenile black seabream (Acanthopagrus schlegelii)	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; SALMON SALMO-SALAR; CATFISH PELTEOBAGRUS-FULVIDRACO; BREAM SPARUS-MACROCEPHALUS; SEA BREAM; FISH-OIL; OXIDATIVE STRESS; YELLOW CATFISH; LIPOPROTEIN METABOLISM; DOCOSAHEXAENOIC ACIDS	An 8-week feeding trial was conducted to investigate the effects of dietary docosahexaenoic to eicosapentaenoic acid ratio (DHA/EPA) on growth performance, fatty acid profiles, antioxidant capacity, hematological characteristics and expression of some lipid metabolism related genes of juvenile black seabream (Acanthopagrus schlegelii) of initial weight 9.47 +/- 0.03 g. Five isonitrogenous and isolipidic diets (45% crude protein and 14% crude lipid) were formulated to contain graded DHA/EPA ratios of 0.65, 1.16, 1.60, 2.03 and 2.67. There were no differences in growth performance and feed utilization among treatments. Fish fed higher DHA/EPA ratios had higher malondialdehyde (MDA) contents in serum than lower ratios. Serum triacylglycerol (TAG) content was significantly higher in fish fed the lowest DHA/EPA ratio. Tissue fatty acid profiles reflected the diets despite down-regulation of LCP-UFA biosynthesis genes, fatty acyl desaturase 2 (fads2) and elongase of very long-chain fatty acids 5 (elovl5), by high DHA/EPA ratios. Expression of acetyl-CoA carboxylase alpha (acc alpha) and carnitine palmitoyl transferase 1A (cpt1a) were up-regulated by high DHA/EPA ratio, whereas sterol regulatory element-binding protein-1 (srebp-1) and hormone-sensitive lipase (hsl) were down-regulated. Fatty acid synthase (fas), 6-phosphogluconate dehydrogenase (6pgd) and peroxisome proliferator-activated receptor alpha (ppar alpha) showed highest expression in fish fed intermediate (1.16) DHA/EPA ratio. Overall, this study indicated that dietary DHA/EPA ratio affected fatty acid profiles and significantly influenced lipid metabolism including LC-PUFA biosynthesis and other anabolic and catabolic pathways, and also had impacts on antioxidant capacity and hematological characteristics.	[Jin, Min; Lu, You; Yuan, Ye; Li, Yi; Ding, Liyun; Zhou, Qicun] Ningbo Univ, Sch Marine Sci, Lab Fish Nutr, Ningbo, Zhejiang, Peoples R China; [Jin, Min; Zhou, Qicun] Ningbo Univ, Collaborat Innovat Ctr Zhejiang Marine High Effic, Ningbo, Zhejiang, Peoples R China; [Monroig, Oscar; Tocher, Douglas R.] Univ Stirling, Sch Nat Sci, Inst Aquaculture, Stirling, Scotland	Ningbo University; Ningbo University; University of Stirling	Zhou, QC (corresponding author), Ningbo Univ, Sch Marine Sci, Lab Fish Nutr, Ningbo, Zhejiang, Peoples R China.; Zhou, QC (corresponding author), Ningbo Univ, Collaborat Innovat Ctr Zhejiang Marine High Effic, Ningbo, Zhejiang, Peoples R China.	zhouqicun@nbu.edu.cn	Monroig, Oscar/K-9117-2014; Tocher, Douglas R/C-5652-2011	Monroig, Oscar/0000-0001-8712-0440; Tocher, Douglas R/0000-0002-8603-9410	National Natural Science Foundation of China [31272670, 41476125]; Major Spark Plan Project of the National Ministry of Science and Technology [2014GA701001]; Open Fund of Zhejiang Provincial Top Key Discipline of Aquaculture in Ningbo University; K. C. Wong Magna Fund; K. C. Wong Education Foundation at Ningbo University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Spark Plan Project of the National Ministry of Science and Technology; Open Fund of Zhejiang Provincial Top Key Discipline of Aquaculture in Ningbo University; K. C. Wong Magna Fund; K. C. Wong Education Foundation at Ningbo University	This research was supported by the National Natural Science Foundation of China (Grant Nos. 31272670 and 41476125), Major Spark Plan Project of the National Ministry of Science and Technology (2014GA701001), the Open Fund of Zhejiang Provincial Top Key Discipline of Aquaculture in Ningbo University, K. C. Wong Magna Fund and K. C. Wong Education Foundation at Ningbo University.	A. O. A. C, 2006, OFFICIAL METHODS OF; Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Bhor VM, 2004, INT J BIOCHEM CELL B, V36, P89, DOI 10.1016/S1357-2725(03)00142-0; Brufau G, 2008, NUTR RES, V28, P217, DOI 10.1016/j.nutres.2008.02.003; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Canaud B, 1999, BLOOD PURIFICAT, V17, P99, DOI 10.1159/000014381; Castro C, 2016, BRIT J NUTR, V116, P19, DOI 10.1017/S000711451600163X; Castro LFC, 2016, PROG LIPID RES, V62, P25, DOI 10.1016/j.plipres.2016.01.001; Chen QL, 2013, ARCH ENVIRON CON TOX, V64, P301, DOI 10.1007/s00244-012-9835-7; Collier T. K., 2012, ECOLOGICAL BIOMARKER, P385; Cowey C.B., 1989, FISH NUTR, V2, P259; DI MASCIO P, 1991, AM J CLIN NUTR, V53, pS194, DOI 10.1093/ajcn/53.1.194S; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Gamboa-Gomez C, 2014, FOOD FUNCT, V5, P927, DOI 10.1039/c3fo60604j; Gao J, 2014, AQUACULTURE, V422, P84, DOI 10.1016/j.aquaculture.2013.11.031; Gilman CI, 2003, GEN COMP ENDOCR, V130, P172, DOI 10.1016/S0016-6480(02)00590-7; Gonzalez EB, 2008, AQUAC RES, V39, P1307, DOI 10.1111/j.1365-2109.2008.01996.x; Gregory MK, 2016, BRIT J NUTR, V115, P1721, DOI 10.1017/S0007114516000830; Gueraud F, 2015, FREE RADICAL BIO MED, V83, P192, DOI 10.1016/j.freeradbiomed.2015.02.023; Jiao BW, 2006, J MOL ENDOCRINOL, V36, P23, DOI 10.1677/jme.1.01945; Jordal AEO, 2005, J NUTR, V135, P2355, DOI 10.1093/jn/135.10.2355; Jothikumar N, 2006, J VIROL METHODS, V131, P65, DOI 10.1016/j.jviromet.2005.07.004; Kerner J, 2000, BBA-MOL CELL BIOL L, V1486, P1, DOI 10.1016/S1388-1981(00)00044-5; Kim SH, 2011, BIOTECHNOL LETT, V33, P1185, DOI 10.1007/s10529-011-0555-2; Koruk M, 2004, ANN CLIN LAB SCI, V34, P57; KOVEN WM, 1993, AQUACULTURE, V116, P71, DOI 10.1016/0044-8486(93)90223-L; Levent G, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-25; Li M, 2014, FISH SHELLFISH IMMUN, V38, P158, DOI 10.1016/j.fsi.2014.03.015; Liang XF, 2002, COMP BIOCHEM PHYS A, V132, P913, DOI 10.1016/S1095-6433(02)00118-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locatelli F, 2003, NEPHROL DIAL TRANSPL, V18, P1272, DOI 10.1093/ndt/gfg074; Lu KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093135; Lu KL, 2013, AQUACULTURE, V408, P160, DOI 10.1016/j.aquaculture.2013.06.003; Ma JJ, 2008, AQUACULT NUTR, V14, P464, DOI 10.1111/j.1365-2095.2007.00551.x; Ma JJ, 2013, J WORLD AQUACULT SOC, V44, P311, DOI 10.1111/jwas.12032; MacKay DS, 2011, EUR J LIPID SCI TECH, V113, P1427, DOI 10.1002/ejlt.201100100; Martinez-Alvarez RM, 2005, REV FISH BIOL FISHER, V15, P75, DOI 10.1007/s11160-005-7846-4; McNamara Robert K., 2013, PharmaNutrition, V1, P41, DOI 10.1016/j.phanu.2012.10.004; Menoyo D, 2004, BRIT J NUTR, V92, P41, DOI 10.1079/BJN20041165; Minghetti M, 2011, BBA-MOL CELL BIOL L, V1811, P194, DOI 10.1016/j.bbalip.2010.12.008; Monroig O, 2011, AVANCES NUTR ACUICOL, V11, P257; Morais S, 2012, BMC GENOMICS, V13, P1; Morais S, 2011, BRIT J NUTR, V106, P1457, DOI 10.1017/S0007114511001954; Morais S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-255; National Research Council (NRC), 2011, NUTR REQ FISH, P102; NILSSONEHLE P, 1980, ANNU REV BIOCHEM, V49, P667, DOI 10.1146/annurev.bi.49.070180.003315; Nip THM, 2003, ENVIRON BIOL FISH, V66, P197, DOI 10.1023/A:1023611207492; Nyska A, 2002, TOXICOL PATHOL, V30, P620, DOI 10.1080/01926230290166724; Panserat S, 2008, BRIT J NUTR, V100, P953, DOI 10.1017/S0007114508981411; Peng M, 2014, AQUACULTURE, V433, P442, DOI 10.1016/j.aquaculture.2014.07.005; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Popovic NT, 2012, J APPL ICHTHYOL, V28, P553, DOI 10.1111/j.1439-0426.2012.01950.x; Qian Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119518; Reitan Kjell Inge, 1994, Aquaculture International, V2, P33, DOI 10.1007/BF00118531; Richard N, 2006, BRIT J NUTR, V96, P299, DOI 10.1079/BJN20061821; Richard N, 2006, AQUACULTURE, V261, P1077, DOI 10.1016/j.aquaculture.2006.07.021; Rodriguez C, 1998, FISH PHYSIOL BIOCHEM, V18, P177, DOI 10.1023/A:1007750218840; Rodriguez C., 1994, Aquaculture and Fisheries Management, V25, P295, DOI 10.1111/j.1365-2109.1994.tb00692.x; Rodriguez C, 1998, AQUACULTURE, V169, P9, DOI 10.1016/S0044-8486(98)00328-7; Rodriguez C, 1997, AQUACULTURE, V150, P77, DOI 10.1016/S0044-8486(96)01472-X; Sargent J, 1995, BROODSTOCK MANAGEMEN, P353, DOI DOI 10.1016/S0044-8486(97)00122-1; SEELIG A, 1974, BIOCHEMISTRY-US, V13, P4839, DOI 10.1021/bi00720a024; Shao QJ, 2008, AQUACULTURE, V277, P92, DOI 10.1016/j.aquaculture.2008.01.029; Stubhaug I, 2005, LIPIDS, V40, P39, DOI 10.1007/s11745-005-1358-4; TAKAI T, 1988, ARCH BIOCHEM BIOPHYS, V266, P313, DOI 10.1016/0003-9861(88)90263-9; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Turchini GM, 2003, AQUACULTURE, V225, P251, DOI 10.1016/S0044-8486(03)00294-1; van der Leij FR, 2007, GENOMICS, V90, P680, DOI 10.1016/j.ygeno.2007.08.004; Visioli F, 1997, NUTR METAB CARDIOVAS, V7, P459; Visioli Francesco, 2013, PharmaNutrition, V1, P9, DOI 10.1016/j.phanu.2012.10.002; WAKIL SJ, 1961, J LIPID RES, V2, P1; Wang XX, 2015, AQUAC RES, V46, P272, DOI 10.1111/are.12176; Wassall SR, 2008, CHEM PHYS LIPIDS, V153, P57, DOI 10.1016/j.chemphyslip.2008.02.010; WATANABE T, 1989, NIPPON SUISAN GAKK, V55, P1635; Watanabe Takeshi, 1993, Journal of the World Aquaculture Society, V24, P152, DOI 10.1111/j.1749-7345.1993.tb00004.x; Weber RE, 1989, LUNG BIOLOGY IN HEAL; Yan J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129937; Yang JH, 2010, CHEMOSPHERE, V81, P548, DOI 10.1016/j.chemosphere.2010.06.028; Zheng JL, 2014, BRIT J NUTR, V112, P698, DOI 10.1017/S0007114514001378; Zheng JL, 2013, GENE, V531, P53, DOI 10.1016/j.gene.2013.08.028; Zhou F, 2011, AQUACULT NUTR, V17, P469, DOI 10.1111/j.1365-2095.2010.00823.x; Zhou F, 2010, AQUACULT NUTR, V16, P194, DOI 10.1111/j.1365-2095.2009.00651.x; Zhou F, 2010, AQUAC RES, V41, pe418, DOI 10.1111/j.1365-2109.2009.02474.x; Zhou QC, 2015, AQUACULTURE, V437, P84, DOI 10.1016/j.aquaculture.2014.11.030; Zuo RT, 2013, BRIT J NUTR, V110, P1220, DOI 10.1017/S0007114513000378; Zuo RT, 2012, AQUACULTURE, V334, P101, DOI 10.1016/j.aquaculture.2011.12.045; Zuo RT, 2014, AQUACULT RES	88	43	45	6	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0176216	10.1371/journal.pone.0176216	http://dx.doi.org/10.1371/journal.pone.0176216			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430821	Green Published, Green Submitted, gold			2022-12-26	WOS:000399876100034
J	Baazizi, R; Mahapatra, M; Clarke, BD; Ait-Oudhia, K; Khelef, D; Parida, S				Baazizi, Ratiba; Mahapatra, Mana; Clarke, Brian Donald; Ait-Oudhia, Khatima; Khelef, Djamel; Parida, Satya			Peste des petits ruminants (PPR): A neglected tropical disease in Maghreb region of North Africa and its threat to Europe	PLOS ONE			English	Article							CANINE-DISTEMPER VIRUS; ASIAN LINEAGE; CATTLE; PHYLOGENETICS; INFECTION; DISTRICT; RECEPTOR; MOROCCO; SPREAD	Background Peste des petits ruminants (PPR) is a contagious disease listed by the World Organisation for Animal health (OIE) as being a specific hazard. It affects sheep, goats, and wild ungulates, and is prevalent throughout the developing world particularly Asia, the Middle East, and Africa. PPR has been targeted for eradication by 2030 by the Food and Agriculture Organization of the United Nations (FAO) and the OIE, after the successful eradication of the related disease, rinderpest in cattle. PPR was first reported in 1942 in the Ivory Coast in Western Africa and has since extended its range in Asia, the Middle East, and Africa posing an immediate threat of incursion into Europe, South East Asia and South Africa. Although robust vaccines are available, the use of these vaccines in a systematic and rational manner is not widespread, resulting in this devastating disease becoming an important neglected tropical disease in the developing world. Methodology We isolated and characterized the PPR virus from an outbreak in Cheraga, northern Algeria, during October 2015 by analyzing the partial N-gene sequence in comparison with other viruses from the Maghreb region. As well as sequencing the full length viral genome and performing real-time RT-PCR on clinical samples. Maximum-likelihood and Bayesian temporal and phylogeographic analyses were performed to assess the persistence and spread of PPRV circulation from Eastern Africa in the Maghreb region of North Africa. Conclusions Recent PPR outbreaks in Cheraga, in the northern part of Algiers (October 2015) and North-West Morocco (June, 2015) highlight that PPRV has spread to the northern border of North Africa and may pose a threat of introduction to Europe. Phylogeographic analysis suggests that lineage IV PPRV has spread from Eastern Africa, most likely from the Sudan 2000 outbreak, into Northern Africa resulting in the 2008 Moroccan outbreak. Maximum-likelihood and Bayesian analysis shows that these North African viruses cluster closely together suggesting the existence of continual regional circulation. Considering the same virus is circulating in Algeria, Morocco and Tunisia, implementation of a common Maghreb PPR eradication strategy would be beneficial for the region.	[Baazizi, Ratiba; Ait-Oudhia, Khatima; Khelef, Djamel] Natl Vet Higher Sch, Algiers, Algeria; [Mahapatra, Mana; Clarke, Brian Donald; Parida, Satya] Pirbright Inst, Woking, Surrey, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Parida, S (corresponding author), Pirbright Inst, Woking, Surrey, England.	satya.parida@pirbright.ac.uk	koulate, liliane/O-6716-2017; Parida, Satya/E-5463-2015	Parida, Satya/0000-0001-8253-9461; Ait-Oudhia, Khatima/0000-0002-2514-5615; Mahapatra, Mana/0000-0002-3977-1465; Clarke, Brian/0000-0001-8447-0381	Biotechnology and Biological Sciences Research Council; European Commission ANIHWA ERA [BB/L004801/1, BB/L013657/1]; Biotechnology and Biological Sciences Research Council [BB/L004801/1, BBS/E/I/00007037, BBS/E/I/00007031, BBS/E/I/00001703] Funding Source: researchfish; BBSRC [BB/L004801/1, BBS/E/I/00007037, BBS/E/I/00001703, BBS/E/I/00007031] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Commission ANIHWA ERA; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank the Biotechnology and Biological Sciences Research Council and the European Commission ANIHWA ERA fund for providing support for PPR epidemiological research under the FADH and IUEPPR projects led by the Pirbright Institute (SP) (BB/L004801/1 and BB/L013657/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Rahim IHAA, 2010, REV SCI TECH OIE, V29, P655, DOI 10.20506/rst.29.3.2004; Alfaro ME, 2006, SYST BIOL, V55, P89, DOI 10.1080/10635150500433565; Alfaro ME, 2006, ANNU REV ECOL EVOL S, V37, P19, DOI 10.1146/annurev.ecolsys.37.091305.110021; Ane C, 2007, MOL BIOL EVOL, V24, P412; Ayari-Fakhfakh E, 2011, VET J, V187, P402, DOI 10.1016/j.tvjl.2010.01.007; Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243; Balamurugan V, 2012, J VET SCI, V13, P203, DOI 10.4142/jvs.2012.13.2.203; Baron MD, 2016, ADV VIRUS RES, V95, P1, DOI 10.1016/bs.aivir.2016.02.001; Batten C, 2011, TRANSBOUNDARY AND EM; Battena CA, 2011, J VIROL METHODS, V171, P401, DOI 10.1016/j.jviromet.2010.11.022; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Bieringer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057488; Birch J, 2013, J VIROL; Bouguedour R, 2016, 12TH JPC REMESA; Bouslikhare M., 2015, CROSS BORDER MOVEMEN; Couacy-Hymann E, 2009, RES VET SCI, V87, P332, DOI 10.1016/j.rvsc.2009.03.002; De Nardi M, 2012, TRANSBOUND EMERG DIS, V59, P214, DOI 10.1111/j.1865-1682.2011.01260.x; Di Nardo A, 2011, REV SCI TECH OIE, V30, P63; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dufour L, 2009, REV EPID SAN ANIM, P243; Fakri F, 2016, VET MICROBIOL, V197, P137, DOI 10.1016/j.vetmic.2016.11.006; Fakri FE, 2016, MICROBIOLOGY FORTHCO; Forsyth MA, 1995, VIRUS RES, V39, P151, DOI 10.1016/0168-1702(95)00076-3; GARGADENNEC L., 1942, Bulletin des Services zootechniques et des epizooties de l'Afrique occidentale francaise, V5, P16; Harder TC, 1997, TRENDS MICROBIOL, V5, P120, DOI 10.1016/S0966-842X(97)01010-X; Kardjadj M, 2015, TROP ANIM HEALTH PRO, V47, P1279, DOI 10.1007/s11250-015-0860-1; Khalafalla AI, 2010, ACTA TROP, V116, P161, DOI 10.1016/j.actatropica.2010.08.002; Khan HA, 2008, TROP ANIM HEALTH PRO, V40, P521, DOI 10.1007/s11250-008-9129-2; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kwiatek O, 2011, EMERG INFECT DIS, V17, P1223, DOI 10.3201/eid1707.101216; Lembo T, 2013, EMERG INFECT DIS, V19, P2037, DOI 10.3201/eid1912.130973; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Libeau G., 2014, Animal Frontiers, V4, P14, DOI 10.2527/af.2014-0003; Mahapatra M, 2015, EMERG INFECT DIS, V21, P2230, DOI 10.3201/eid2112.150223; Mariner JC, 2016, J IMMUNOL, V196, P3499, DOI 10.4049/jimmunol.1502625; Molla B, 2015, TROP ANIM HEALTH PRO, V47, P45, DOI 10.1007/s11250-014-0681-7; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; Muniraju M, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01023-14; Muniraju M, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00096-13; Muniraju M, 2014, EMERG INFECT DIS, V20, P2023, DOI 10.3201/eid2012.140684; Ouagal M, 2010, ACTA TROP, V116, P147, DOI 10.1016/j.actatropica.2010.07.004; Ozkul A, 2002, EMERGING INFECTIOUS, V8; Parida S, 2015, VET MICROBIOL, V181, P90, DOI 10.1016/j.vetmic.2015.08.009; Parida S, 2016, SMALL RUMINANT RESEA; Pratakpiriya W, 2012, J VIROL, V86, P10207, DOI 10.1128/JVI.00824-12; Ratta B, 2016, CURRENT MICROBIOLOGY, P1; Sghaier S, 2014, EMERG INFECT DIS, V20, P2184, DOI 10.3201/eid2012.141116; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Waret-Szkuta A, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-34; Xia J, SEQUENCE ANALYSIS OF	53	40	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175461	10.1371/journal.pone.0175461	http://dx.doi.org/10.1371/journal.pone.0175461			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426782	Green Published, gold, Green Submitted			2022-12-26	WOS:000399875900030
J	Bellworthy, J; Gledhill, M; Esposito, M; Achterberg, EP				Bellworthy, Jessica; Gledhill, Martha; Esposito, Mario; Achterberg, Eric P.			Abundance of the iron containing biomolecule, heme b, during the progression of a spring phytoplankton bloom in a mesocosm experiment	PLOS ONE			English	Article							OCEAN ACIDIFICATION; INCREASED PCO(2); CO2; SPECIATION; SEAWATER; TEMPERATURE; NITRATE; AVAILABILITY; LIMITATION; PHOSPHATE	Concentrations of heme b were determined in a mesocosm experiment situated in Gullmar Fjord off Sweden. The mesocosm experiment lasted for ca. one hundred days and was characterised by the growth of a primary nutrient replete and a secondary nutrient deplete phytoplankton bloom. Heme b varied between 40 +/- 10 pmol L-1 in the prebloom period up to a maximum of 700 +/- 400 pmol L-1 just prior to the time of the primary chlorophyll a maximum. Thereafter, heme b concentrations decreased again to an average of 120 +/- 60 pmol L-1. When normalised to total particulate carbon, heme b was most abundant during the initiation of the nutrient replete spring bloom, when ratios reached 52 +/- 24 mu mol mol(-1); ten times higher than values observed both pre and post the primary bloom. Concentrations of heme b correlated with those of chlorophyll a. Nevertheless, differences were observed in the relative concentrations of the two parameters, with heme b concentrations increasing relative to chlorophyll a during the growth of the primary bloom, decreasing over the period of the secondary bloom and increasing again through the latter period of the experiment. Heme b abundance was therefore influenced by nutrient concentrations and also likely by changing community composition. In half of the mesocosms, pCO(2) was elevated and maintained at ca. 1000 mu atm, however we observed no significant differences between heme b in plus or ambient pCO(2) mesocosms, either in absolute terms, or relative to total particulate carbon and chlorophyll a. The results obtained in this study contribute to our understanding of the distribution of this significant component of the biogenic iron pool, and provide an iron replete coastal water end member that aids the interpretation of the distributions of heme b in more iron deplete open ocean waters.	[Bellworthy, Jessica; Gledhill, Martha; Esposito, Mario; Achterberg, Eric P.] Univ Southampton, Ocean & Earth Sci, Southampton, Hants, England; [Gledhill, Martha; Achterberg, Eric P.] Geomar Helmholtz Inst Ocean Res, Kiel, Germany	University of Southampton; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel	Gledhill, M (corresponding author), Univ Southampton, Ocean & Earth Sci, Southampton, Hants, England.; Gledhill, M (corresponding author), Geomar Helmholtz Inst Ocean Res, Kiel, Germany.	mgledhill@geomar.de	Gledhill, Martha/AAG-6062-2021; Achterberg, Eric P/C-5820-2009; Gledhill, Martha/D-2819-2009; Bellworthy, Jessica/ABG-6390-2020	Gledhill, Martha/0000-0003-3859-2112; Achterberg, Eric P/0000-0002-3061-2767; Gledhill, Martha/0000-0003-3859-2112; 	German Federal Ministry of Science and Education (BMBF) [FKZ 03F06550]; UK Natural Environmental Research Council [NE/E013546/1, NE/H017348/1]	German Federal Ministry of Science and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); UK Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This project was funded by the German Federal Ministry of Science and Education (BMBF) in the framework of the BIOACID II project (FKZ 03F06550). Additional support for MG, JB and EPA was provided by the UK Natural Environmental Research Council (grant numbers NE/E013546/1 and NE/H017348/1).; The authors would like to thank chief scientist Ulf Riebesell and Andrea Ludwig (GEOMAR) for organising and facilitating our participation in the KOSMOS 2013, Gullmar Fjord experiment and the Sven Loven Centre for Marine Sciences, Kristineberg for giving us access to their facilities. Our thanks are extended to Saskia Audritz and Matthias Fischer for POC/N and chlorophyll analysis respectively. This project was funded by the German Federal Ministry of Science and Education (BMBF) in the framework of the BIOACID II project (FKZ 03F06550). Additional support for MG, JB and EPA was provided by the UK Natural Environmental Research Council (grant numbers NE/E013546/1 and NE/H017348/1). The authors would like to thank the anonymous reviewers for their comments on the manuscript.	Avendano L, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00058; Bach LT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159068; Breitbarth E, 2010, BIOGEOSCIENCES, V7, P1065, DOI 10.5194/bg-7-1065-2010; Campbell WH, 2001, CELL MOL LIFE SCI, V58, P194, DOI 10.1007/PL00000847; Carotenuto Y., 2007, BIOGEOSCIENCES DISCU, V4, P3913, DOI DOI 10.5194/BGD-4-3913-2007; Croot PL, 2000, ELECTROANAL, V12, P565, DOI 10.1002/(SICI)1521-4109(200005)12:8<565::AID-ELAN565>3.0.CO;2-L; da Silva J. J. R. Frausto, 2001, BIOL CHEM ELEMENTS; Espinas NA, 2012, PLANT CELL PHYSIOL, V53, P1344, DOI 10.1093/pcp/pcs067; Feng YY, 2009, MAR ECOL PROG SER, V388, P13, DOI 10.3354/meps08133; GEIDER RJ, 1994, PHOTOSYNTH RES, V39, P275, DOI 10.1007/BF00014588; Gledhill M, 2007, MAR CHEM, V103, P393, DOI 10.1016/j.marchem.2006.10.008; Gledhill M, 2015, MAR CHEM, V177, P421, DOI 10.1016/j.marchem.2015.03.016; Gledhill M, 2015, MAR ECOL PROG SER, V532, P29, DOI 10.3354/meps11345; Gledhill M, 2014, ANAL CHIM ACTA, V841, P33, DOI 10.1016/j.aca.2014.06.045; Gledhill M, 2013, GLOBAL BIOGEOCHEM CY, V27, P1072, DOI 10.1002/2013GB004639; Hare CE, 2007, MAR ECOL PROG SER, V352, P9, DOI 10.3354/meps07182; Hartnett A, 2012, METALLOMICS, V4, P1160, DOI 10.1039/c2mt20144e; Hogle SL, 2014, METALLOMICS, V6, P1107, DOI 10.1039/c4mt00031e; Hogle SL, 2016, APPL ENV MICROBIOL; Honey DJ, 2013, MAR ECOL PROG SER, V483, P1, DOI 10.3354/meps10367; Hopkinson BM, 2008, APPL ENVIRON MICROB, V74, P6263, DOI 10.1128/AEM.00964-08; Hopkinson BM, 2012, ENVIRON MICROBIOL, V14, P114, DOI 10.1111/j.1462-2920.2011.02539.x; Hopkinson BM, 2010, LIMNOL OCEANOGR, V55, P2011, DOI 10.4319/lo.2010.55.5.2011; McCarthy A, 2012, J PHYCOL, V48, P635, DOI 10.1111/j.1529-8817.2012.01171.x; Millero FJ, 2009, OCEANOGRAPHY, V22, P72, DOI 10.5670/oceanog.2009.98; Mochizuki N, 2010, TRENDS PLANT SCI, V15, P488, DOI 10.1016/j.tplants.2010.05.012; Nielsdottir MC, 2012, MAR CHEM, V130, P62, DOI 10.1016/j.marchem.2011.12.004; Nielsdottir MC, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003410; Orr JC., 2011, OCEAN ACIDIFICATION, P326; Patey MD, 2008, TRAC-TREND ANAL CHEM, V27, P169, DOI 10.1016/j.trac.2007.12.006; Patey MD, 2010, ANAL CHIM ACTA, V673, P109, DOI 10.1016/j.aca.2010.05.029; Paul AJ, 2015, BIOGEOSCIENCES, V12, P6181, DOI 10.5194/bg-12-6181-2015; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; Riebesell U, 2013, BIOGEOSCIENCES, V10, P1835, DOI 10.5194/bg-10-1835-2013; Riebesell U, 2011, OCEAN ACIDIFICATION, P326; Rijkenberg MJA, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004264; Roe KL, 2013, APPL ENVIRON MICROB, V79, P5753, DOI 10.1128/AEM.01562-13; Rose JM, 2009, MAR ECOL PROG SER, V388, P27, DOI 10.3354/meps08134; Scripps, 2014, KEEP CURV; Shi DL, 2012, P NATL ACAD SCI USA, V109, pE3094, DOI 10.1073/pnas.1216012109; Shi DL, 2010, SCIENCE, V327, P676, DOI 10.1126/science.1183517; Stolpe B, 2010, LIMNOL OCEANOGR, V55, P187, DOI 10.4319/lo.2010.55.1.0187; Strzepek RF, 2011, LIMNOL OCEANOGR, V56, P1983, DOI 10.4319/lo.2011.56.6.1983; Suffrian K, 2008, BIOGEOSCIENCES, V5, P1145, DOI 10.5194/bg-5-1145-2008; TIMMERMANS KR, 1994, MAR BIOL, V121, P389, DOI 10.1007/BF00346749; Ussher SJ, 2007, LIMNOL OCEANOGR, V52, P2530, DOI 10.4319/lo.2007.52.6.2530	46	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176268	10.1371/journal.pone.0176268	http://dx.doi.org/10.1371/journal.pone.0176268			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426768	Green Accepted, Green Published, gold			2022-12-26	WOS:000399875900124
J	Zuzarte, I; Indic, P; Barton, B; Paydarfar, D; Bednarek, F; Bloch-Salisbury, E				Zuzarte, Ian; Indic, Premananda; Barton, Bruce; Paydarfar, David; Bednarek, Francis; Bloch-Salisbury, Elisabeth			Vibrotactile stimulation: A non-pharmacological intervention for opioid-exposed newborns	PLOS ONE			English	Article							NEONATAL ABSTINENCE SYNDROME; STOCHASTIC RESONANCE; SLEEP-DEPRIVATION; OPIATE WITHDRAWAL; INFANTS; MORPHINE; MECHANISMS; TOLERANCE; METHADONE; CHILDREN	Objective To examine the therapeutic potential of stochastic vibrotactile stimulation (SVS) as a complementary non-pharmacological intervention for withdrawal in opioid-exposed newborns. Study design A prospective, within-subjects single-center study was conducted in 26 opioid-exposed newborns (>37 weeks; 16 male) hospitalized since birth and treated pharmacologically for Neonatal Abstinence Syndrome. A specially-constructed mattress delivered low-level SVS (30-60Hz, 10-12 mu m RMS), alternated in 30-min intervals between continuous vibration (ON) and no vibration (OFF) over a 6-8 hr session. Movement activity, heart rate, respiratory rate, axillary temperature and blood-oxygen saturation were calculated separately for ON and OFF. Results There was a 35% reduction in movement activity with SVS (p<0.001), with significantly fewer movement periods >30 sec duration for ON than OFF (p = 0.003). Incidents of tachypneic breaths and tachycardic heart beats were each significantly reduced with SVS, whereas incidents of eupneic breaths and eucardic heart beats each significantly increased with SVS (p<0.03). Infants maintained body temperature and arterial-blood oxygen level independent of stimulation condition. Conclusions SVS reduced hyperirritability and pathophysiological instabilities commonly observed in pharmacologically-managed opioid-exposed newborns. SVS may provide an effective complementary therapeutic intervention for improving autonomic function in newborns with Neonatal Abstinence Syndrome.	[Zuzarte, Ian; Indic, Premananda; Paydarfar, David] Univ Massachusetts, Med Sch, Dept Neurol, Worcester, MA 01605 USA; [Barton, Bruce] Univ Massachusetts, Med Sch, Dept Quantitat Hlth Sci, Worcester, MA 01605 USA; [Paydarfar, David] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Bednarek, Francis; Bloch-Salisbury, Elisabeth] Univ Massachusetts, Med Sch, Dept Pediat, Worcester, MA 01605 USA; [Zuzarte, Ian] Northeastern Univ, Dept Biomed Engn, Boston, MA 02115 USA; [Indic, Premananda] Univ Texas Tyler, Dept Elect Engn, Tyler, TX 75799 USA; [Paydarfar, David] Univ Texas Austin, Dell Med Sch, Dept Neurol, Austin, TX 78712 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; University of Massachusetts System; University of Massachusetts Worcester; Northeastern University; University of Texas System; University of Texas at Tyler; University of Texas System; University of Texas Austin	Bloch-Salisbury, E (corresponding author), Univ Massachusetts, Med Sch, Dept Pediat, Worcester, MA 01605 USA.	Elisabeth.Salisbury@umassmed.edu		Salisbury, Elisabeth/0000-0002-7708-3428; Zuzarte, Ian/0000-0002-1428-6922	Neonatology Associates of Worcester (EBS); National Institute on Drug Abuse [R01 DA042074-01]; Wyss Institute at Harvard University; National Institutes of Health [NIDA R21 DA035355 EBS]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA042074, R21DA035355] Funding Source: NIH RePORTER	Neonatology Associates of Worcester (EBS); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Wyss Institute at Harvard University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by the Neonatology Associates of Worcester (EBS), the National Institute on Drug Abuse R01 DA042074-01(EBS), Wyss Institute at Harvard University (DP), and National Institutes of Health (NIDA R21 DA035355 EBS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand KJS, 2010, PEDIATRICS, V125, pE1208, DOI 10.1542/peds.2009-0489; Anders T, 1971, MANUAL STANDARDIZED; Ardiel EL, 2010, PAED CHILD HEALT-CAN, V15, P153, DOI 10.1093/pch/15.3.153; Attarian S, 2014, BRAIN SCI, V4, P321, DOI 10.3390/brainsci4020321; Bagley SM, 2014, ADDICT SCI CLIN PRAC, V9, DOI 10.1186/1940-0640-9-19; Barr GA, 2011, ILAR J, V52, P329, DOI 10.1093/ilar.52.3.329; Beckwith AM, 2015, CLIN PEDIATR, V54, P328, DOI 10.1177/0009922814549545; Bloch-Salisbury E, 2009, J APPL PHYSIOL, V107, P1017, DOI 10.1152/japplphysiol.00058.2009; Chatterjee D, 2007, BRAIN RES, V1158, P11, DOI 10.1016/j.brainres.2007.04.069; de Graaf J, 2011, PAIN, V152, P1391, DOI 10.1016/j.pain.2011.02.017; Dieckmann R, 2000, PEDIATRIC ED PREHOSP, P43; Ednick M, 2009, SLEEP, V32, P1449, DOI 10.1093/sleep/32.11.1449; Finnegan LP, 1990, CURRENT THERAPY NEON, V2, P262; Fleming S, 2011, LANCET, V377, P1011, DOI 10.1016/S0140-6736(10)62226-X; Franco P, 2004, PEDIATRICS, V114, P192, DOI 10.1542/peds.114.2.e192; Franco P, 2003, SLEEP, V26, P845, DOI 10.1093/sleep/26.7.845; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; HAGAN R, 1977, J APPL PHYSIOL, V42, P362, DOI 10.1152/jappl.1977.42.3.362; HANDELMANN GE, 1985, PEPTIDES, V6, P29, DOI 10.1016/0196-9781(85)90131-7; Holmes AV, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2929; Howard Mary Beth, 2017, Hosp Pediatr, V7, P63, DOI 10.1542/hpeds.2016-0147; Hudak ML, 2012, PEDIATRICS, V129, pE540, DOI 10.1542/peds.2011-3212; Hunt RW, 2008, EARLY HUM DEV, V84, P29, DOI 10.1016/j.earlhumdev.2007.01.013; Jansson LM, 2012, CURR OPIN PEDIATR, V24, P252, DOI 10.1097/MOP.0b013e32834fdc3a; Jansson LM, 2010, DRUG ALCOHOL DEPEN, V109, P198, DOI 10.1016/j.drugalcdep.2010.01.004; Kocek M, 2016, EARLY HUM DEV, V92, P29, DOI 10.1016/j.earlhumdev.2015.11.001; Kocherlakota P, 2014, PEDIATRICS, V134, pE547, DOI 10.1542/peds.2013-3524; Kuschel C, 2007, SEMIN FETAL NEONAT M, V12, P127, DOI 10.1016/j.siny.2007.01.004; Lautenbacher S, 2006, SLEEP MED REV, V10, P357, DOI 10.1016/j.smrv.2005.08.001; Lester BM, 2010, J ADDICT DIS, V29, P259, DOI 10.1080/10550881003684921; MacMullen Nancy J, 2014, Pediatr Nurs, V40, P165; Marx J., 2013, ROSENS EMERGENCY MED; McGlone L, 2015, EARLY HUM DEV, V91, P19, DOI 10.1016/j.earlhumdev.2014.10.006; Mirmiran M, 2003, PEDIATR RES, V53, P933, DOI 10.1203/01.PDR.0000061541.94620.12; Moss F, 2004, CLIN NEUROPHYSIOL, V115, P267, DOI 10.1016/j.clinph.2003.09.014; Muhammad A, 2011, BRAIN RES, V1400, P53, DOI 10.1016/j.brainres.2011.05.038; O'Brien C, 2004, ARCH DIS CHILD-FETAL, V89, pF305, DOI 10.1136/adc.2002.025270; O'Brien CM, 2002, J PAEDIATR CHILD H, V38, P66, DOI 10.1046/j.1440-1754.2002.00724.x; Patrick SW, 2015, J PERINATOL, V35, P667, DOI 10.1038/jp.2015.63; Patrick SW, 2012, JAMA-J AM MED ASSOC, V307, P1934, DOI 10.1001/jama.2012.3951; Peirano P, 2003, J PEDIATR-US, V143, pS70, DOI 10.1067/S0022-3476(03)00404-9; Smith VC, 2015, PEDIATRICS, V136, pE1561, DOI 10.1542/peds.2015-1334; STRAUSS ME, 1976, AM J DRUG ALCOHOL AB, V3, P339, DOI 10.3109/00952997609077202; Sublett J, 2013, MCN-AM J MATERN-CHIL, V38, P102, DOI 10.1097/NMC.0b013e31826e978e; Substance Abuse and Mental Health Services Administration, 2010, NSDUH SER, V38A; Suresh S, 1998, SEMIN PERINATOL, V22, P425, DOI 10.1016/S0146-0005(98)80058-X; Taddio A, 2009, CLIN J PAIN, V25, P418, DOI 10.1097/AJP.0b013e31819b7a3b; Tarullo AR, 2011, INFANT CHILD DEV, V20, P35, DOI 10.1002/icd.685; Tolia VN, 2015, NEW ENGL J MED, V372, P2118, DOI 10.1056/NEJMsa1500439; Velez M, 2008, J ADDICT MED, V2, P113, DOI 10.1097/ADM.0b013e31817e6105; White-Traut Rosemary, 2002, J Perinatol, V22, P291, DOI 10.1038/sj.jp.7210695; Zuzarte I, 2014, IEEE ENG MED BIO, P5466, DOI 10.1109/EMBC.2014.6944863	53	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175981	10.1371/journal.pone.0175981	http://dx.doi.org/10.1371/journal.pone.0175981			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426726	Green Published, gold, Green Submitted			2022-12-26	WOS:000399875900081
J	Egawa, J; Schilling, JM; Cui, WH; Posadas, E; Sawada, A; Alas, B; Zemljic-Harpf, AE; Fannon-Pavlich, MJ; Mandyam, CD; Roth, DM; Patel, HH; Patel, PM; Head, BP				Egawa, Junji; Schilling, Jan M.; Cui, Weihua; Posadas, Edmund; Sawada, Atsushi; Alas, Basheer; Zemljic-Harpf, Alice E.; Fannon-Pavlich, McKenzie J.; Mandyam, Chitra D.; Roth, David M.; Patel, Hemal H.; Patel, Piyush M.; Head, Brian P.			Neuron-specific caveolin-1 overexpression improves motor function and preserves memory in mice subjected to brain trauma	FASEB JOURNAL			English	Article						neuroprotection; MLRs; hippocampus; fear conditioning; inverted grid	MEMBRANE-LIPID RAFTS; ALZHEIMERS-DISEASE; INJURY; EXPRESSION; NEUROINFLAMMATION; MODULATION; ACTIVATION; IMPAIRMENT; PLASTICITY; PROTECTION	Studies in vitro and in vivo demonstrate that membrane/lipid rafts and caveolin (Cav) organize progrowth receptors, and, when overexpressed specifically in neurons, Cav-1 augments neuronal signaling and growth and improves cognitive function in adult and aged mice; however, whether neuronal Cav-1 overexpression can preserve motor and cognitive function in the brain trauma setting is unknown. Here, we generated a neuron-targeted Cav-1-overexpressing transgenic (Tg) mouse [synapsin-driven Cav-1 (SynCav1 Tg)] and subjected it to a controlled cortical impact model of brain trauma and measured biochemical, anatomic, and behavioral changes. SynCav1 Tg mice exhibited increased hippocampal expression of Cav-1 and membrane/lipid raft localization of postsynaptic density protein 95, NMDA receptor, and tropomyosin receptor kinase B. When subjected to a controlled cortical impact, SynCav1 Tg mice demonstrated preserved hippocampus-dependent fear learning and memory, improved motor function recovery, and decreased brain lesion volume compared with wild-type controls. Neuron-targeted overexpression of Cav-1 in the adult brain prevents hippocampus-dependent learning and memory deficits, restores motor function after brain trauma, and decreases brain lesion size induced by trauma. Our findings demonstrate that neuron-targeted Cav-1 can be used as a novel therapeutic strategy to restore brain function and prevent trauma associated maladaptive plasticity.	[Egawa, Junji; Schilling, Jan M.; Cui, Weihua; Posadas, Edmund; Sawada, Atsushi; Alas, Basheer; Zemljic-Harpf, Alice E.; Fannon-Pavlich, McKenzie J.; Mandyam, Chitra D.; Roth, David M.; Patel, Hemal H.; Patel, Piyush M.; Head, Brian P.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Egawa, Junji; Schilling, Jan M.; Cui, Weihua; Posadas, Edmund; Sawada, Atsushi; Alas, Basheer; Zemljic-Harpf, Alice E.; Roth, David M.; Patel, Hemal H.; Patel, Piyush M.; Head, Brian P.] Univ Calif San Diego, Sch Med, Dept Anesthesiol, La Jolla, CA 92093 USA; [Egawa, Junji] Nara Med Univ, Dept Anesthesiol, Kashihara, Nara, Japan; [Cui, Weihua] Capital Med Univ, Beijing Tiantan Hosp, Dept Anesthesiol, Beijing, Peoples R China	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; Nara Medical University; Capital Medical University	Head, BP (corresponding author), Univ Calif San Diego, Dept Anesthesiol, VASDHS 9125,3350 La Jolla Village Dr, San Diego, CA 92161 USA.	bhead@ucsd.edu	mandyam, chitra/C-9189-2013; Patel, Hemal/C-7325-2019	mandyam, chitra/0000-0002-7354-205X; Patel, Hemal/0000-0001-6722-9625	Department of Veterans Affairs [BX001225, BX000783, BX001963]; U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke Grant [NS073653]; NIH National Heart, Lung, and Blood Institute [HL091071, HL107200, HL066941, HL115933]; NIH National Institute on Drug Abuse Grant [DA034140]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091071, R01HL107200, P01HL066941, R01HL115933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA034140] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000783, I01BX003671, I01BX001963, I01BX001225] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke Grant; NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute on Drug Abuse Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Department of Veterans Affairs (Grants BX001225 to B.P.H., BX000783 to D.M.R., and BX001963 to H.H.P.), the U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke Grant NS073653 (to B.P.H.), NIH National Heart, Lung, and Blood Institute Grants HL091071 (to H.H.P.), HL107200, HL066941, and HL115933 (to H.H.P. and D.M.R.), and NIH National Institute on Drug Abuse Grant DA034140 (to C.D.M.). The authors declare no conflicts of interest.	Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Atkins CM, 2013, NEUROSCI LETT, V532, P1, DOI 10.1016/j.neulet.2012.10.019; Atkins CM, 2009, NEUROSCI LETT, V459, P52, DOI 10.1016/j.neulet.2009.04.064; Butler CW, 2015, LEARN MEMORY, V22, P370, DOI 10.1101/lm.037663.114; Carlson CG, 2010, J NEUROSCI METH, V186, P226, DOI 10.1016/j.jneumeth.2009.11.006; Chapman JC, 2014, ALZHEIMERS DEMENT, V10, pS97, DOI 10.1016/j.jalz.2014.04.012; Cramer SC, 2011, BRAIN, V134, P1591, DOI 10.1093/brain/awr039; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Egawa J, 2016, J PHYSIOL-LONDON, V594, P4565, DOI 10.1113/JP270590; English AW, 2013, P NATL ACAD SCI USA, V110, P16217, DOI 10.1073/pnas.1303646110; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Glover CPJ, 2002, MOL THER, V5, P509, DOI 10.1006/mthe.2002.0588; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Guirland C, 2007, ADV EXP MED BIOL, V621, P144, DOI 10.1007/978-0-387-76715-4_11; Head BP, 2008, FASEB J, V22, P828, DOI 10.1096/fj.07-9299com; Head BP, 2014, BBA-BIOMEMBRANES, V1838, P532, DOI 10.1016/j.bbamem.2013.07.018; Head BP, 2011, J BIOL CHEM, V286, P33310, DOI 10.1074/jbc.M111.255976; Huot P, 2014, NEUROPHARMACOLOGY, V82, P76, DOI 10.1016/j.neuropharm.2014.01.012; Institute of Medicine of the National Academies, 2006, AMY LAT SCLER VET RE; Israelsson C, 2014, RESTOR NEUROL NEUROS, V32, P717, DOI 10.3233/RNN-140419; Kaminska K, 2013, PHARMACOL REP, V65, P1144, DOI 10.1016/S1734-1140(13)71472-5; Kassan A, 2017, J NEUROPHYSIOL, V117, P436, DOI 10.1152/jn.00481.2016; King PR, 2015, MIL MED, V180, P863, DOI 10.7205/MILMED-D-14-00472; Krajewska M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024341; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lew HL, 2009, J REHABIL RES DEV, V46, P819, DOI 10.1682/JRRD.2008.09.0129; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Ma J, 2013, NEUROCHEM INT, V62, P84, DOI 10.1016/j.neuint.2012.11.010; Ma MR, 2012, J NEUROTRAUM, V29, P445, DOI 10.1089/neu.2011.2060; Mandyam CD, 2004, J NEUROSCI RES, V76, P783, DOI 10.1002/jnr.20090; Mandyam CD, 2017, BIOL PSYCHIAT, V81, P101, DOI 10.1016/j.biopsych.2015.09.020; Niesman IR, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-39; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Schwab ME, 2014, CURR OPIN NEUROBIOL, V27, P53, DOI 10.1016/j.conb.2014.02.011; Sharp DJ, 2014, INT PSYCHOGERIATR, V26, P1591, DOI 10.1017/S1041610214001689; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Suzuki S, 2004, J CELL BIOL, V167, P1205, DOI 10.1083/jcb.200404106; Suzuki S, 2007, J NEUROSCI, V27, P6417, DOI 10.1523/JNEUROSCI.0690-07.2007; Titus DJ, 2013, J NEUROSCI, V33, P5216, DOI 10.1523/JNEUROSCI.5133-12.2013; Tsutsumi YM, 2008, CIRCULATION, V118, P1979, DOI 10.1161/CIRCULATIONAHA.108.788331; Vincent AS, 2014, ALZHEIMERS DEMENT, V10, pS174, DOI 10.1016/j.jalz.2014.04.006; Zonta Barbara, 2013, Front Synaptic Neurosci, V5, P9, DOI 10.3389/fnsyn.2013.00009	43	16	17	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3403	3411		10.1096/fj.201601288RRR	http://dx.doi.org/10.1096/fj.201601288RRR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28450301	Green Published			2022-12-26	WOS:000405932400019
J	Sahu, I; Pelzl, L; Sukkar, B; Fakhri, H; Al-Maghout, T; Cao, H; Hauser, S; Gutti, R; Gawaz, M; Lang, F				Sahu, Itishri; Pelzl, Lisann; Sukkar, Basma; Fakhri, Hajar; al-Maghout, Tamer; Cao, Hang; Hauser, Stefan; Gutti, Ravi; Gawaz, Meinrad; Lang, Florian			NFAT5-sensitive Orai1 expression and store-operated Ca2+ entry in megakaryocytes	FASEB JOURNAL			English	Article						SOCE; STIM1; platelets; dehydration; hyperosmolarity	GLUCOCORTICOID-INDUCIBLE KINASE; CRAC CHANNEL; CELL-PROLIFERATION; PLASMA-MEMBRANE; ION CHANNELS; TGF-BETA; CALCIUM; SERUM; STIM1; SGK1	The transcription factor nuclear factor of activated T cells 5 (NFAT5) is up-regulated in several clinical disorders, including dehydration. NFAT5-sensitive genes include serum and glucocorticoid-inducible kinase 1 (SGK1). The kinase is a powerful regulator of Orai1, a Ca2+ channel accomplishing store-operated Ca2+ entry (SOCE). Orai1 is stimulated after intracellular store depletion by the Ca2+ sensors stromal interaction molecule 1 (STIM1), or STIM2, or both. In the present study, we explored whether nuclear factor of activated T cell (NFAT)-5 influences Ca2+ signaling in megakaryocytes. To this end, human megakaryocytic (MEG-01) cells were transfected with NFAT5 or with siNFAT5. Platelets and megakaryocytes were isolated from wild-type mice with either access to water ad libitum or dehydration by 36 h of water deprivation. Transcript levels were determined with quantitative RT-PCR and protein abundance by Western blot analysis and flow cytometry, cytosolic (intracellular) Ca2+ concentration ([Ca2+](i)) by fura-2-fluorescence. SOCE was estimated from the increase of [Ca2+](i) following readdition of extracellular Ca2+ after store depletion with thapsigargin (1 mu M). Platelet degranulation was estimated from P-selectin abundance and integrin activation from alpha(IIb)beta(3) integrin abundance determined by flow cytometry. As a result, NFAT5 transfection or exposure to hypertonicity (+40 mu M NaCl) of MEG-01 cells increased Orai1, Orai2, STIM1, and STIM2 transcript levels. Orai1 transcript levels were decreased by NFAT5 silencing. NFAT5 transfection and I kappa B inhibitor BMS 345541 (5 mu M) increased SOCE, whereas NFAT5 silencing and SGK1 inhibitor GSK650394 (10 mu M) decreased SOCE. In the mice, dehydration increased NFAT5 and Orai1 protein abundance in megakaryocytes and NFAT5, Orai1, and Orai2 abundance in platelets. Dehydration further augmented the degranulation and integrin activation by thrombin and collagen-related peptide. In summary, NFAT5 is a powerful regulator of Orai1-expression and SOCE in megakaryocytes.	[Sahu, Itishri; Pelzl, Lisann; Sukkar, Basma; Fakhri, Hajar; al-Maghout, Tamer; Cao, Hang; Gawaz, Meinrad; Lang, Florian] Univ Tubingen, Dept Cardiol & Vasc Med & Physiol, Tubingen, Germany; [Sahu, Itishri; Gutti, Ravi] Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad, Andhra Pradesh, India; [Hauser, Stefan] German Ctr Neurodegenerat Dis, Tubingen, Germany	Eberhard Karls University of Tubingen; University of Hyderabad; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Lang, F (corresponding author), Univ Tubingen, Dept Physiol, Gmelinstr 5, D-72076 Tubingen, Germany.	florian.lang@uni-tuebingen.de	Sukkar, Basma/AAZ-1187-2020	Gutti, Ravi Kumar/0000-0002-0912-5796; Sukkar, Basma/0000-0003-4945-9333; Hauser, Stefan/0000-0002-1022-7482; Sahu, Itishri/0000-0002-6069-656X	Deutsche Forschungsgemeinschaft (DFG) [La315-15]; Klinische Forschergruppe KFO "Platelets-Basic Mechanisms and Translational Implications"; Council of Scientific and Industrial Research (CSIR-SRF) fellowship, Government of India; Deutscher Akademischer Austauschdienst (DAAD); Brigitte-Schlieben-Lange-Programm; Open Access Publishing Fund of the University of Tubingen	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Klinische Forschergruppe KFO "Platelets-Basic Mechanisms and Translational Implications"; Council of Scientific and Industrial Research (CSIR-SRF) fellowship, Government of India; Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Brigitte-Schlieben-Lange-Programm; Open Access Publishing Fund of the University of Tubingen	The authors acknowledge the meticulous preparation of the manuscript by Tanja Loch and Lejla Subasic (both from the University of Tubingen). This work was supported in part by Deutsche Forschungsgemeinschaft (DFG) Grant La315-15 and Klinische Forschergruppe KFO "Platelets-Basic Mechanisms and Translational Implications" (to F.L.), by a Council of Scientific and Industrial Research (CSIR-SRF) fellowship, the Government of India, a Deutscher Akademischer Austauschdienst (DAAD) bi-nationally supervised Ph.D. Fellowship (to I.S.), the Brigitte-Schlieben-Lange-Programm (to L.P.), and the Open Access Publishing Fund of the University of Tubingen. The sponsors had no role in study design, the collection, analysis, and interpretation of data, the writing of the report; or the decision to submit the article for publication. The authors declare no conflicts of interest.	Becchetti A, 2010, ADV EXP MED BIOL, V674, P107; Bergmeier W, 2013, CHANNELS, V7, P379, DOI 10.4161/chan.24302; Bock O, 2005, J PATHOL, V205, P548, DOI 10.1002/path.1744; Borst O, 2015, ARTERIOSCL THROM VAS, V35, P547, DOI 10.1161/ATVBAHA.114.304454; Borst O, 2012, BLOOD, V119, P251, DOI 10.1182/blood-2011-06-359976; Braun A, 2009, BLOOD, V113, P2056, DOI 10.1182/blood-2008-07-171611; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Capiod T, 2013, RECENT PAT ANTI-CANC, V8, P4; Chen SC, 2009, J CLIN INVEST, V119, P1647, DOI 10.1172/JCI35314; Courjaret Raphael, 2012, Front Biosci (Elite Ed), V4, P331; Dong JC, 2015, CELL PHYSIOL BIOCHEM, V35, P160, DOI 10.1159/000369684; Eylenstein A, 2012, J BIOL CHEM, V287, P2719, DOI 10.1074/jbc.M111.275925; Eylenstein A, 2011, FASEB J, V25, P2012, DOI 10.1096/fj.10-178210; Fahmer M, 2009, IMMUNOL REV, V231, P99, DOI 10.1111/j.1600-065X.2009.00815.x; Handler JS, 2001, KIDNEY INT, V60, P408, DOI 10.1046/j.1523-1755.2001.060002408.x; Hernandez-Ochoa EO, 2012, EXP BIOL MED, V237, P1068, DOI 10.1258/ebm.2012.012052; Lang F, 2015, ACTA PHYSIOL, V213, P181, DOI 10.1111/apha.12334; Lang F, 2013, THROMB HAEMOSTASIS, V110, P925, DOI 10.1160/TH13-02-0176; Lang F, 2013, EXPERT OPIN INV DRUG, V22, P701, DOI 10.1517/13543784.2013.778971; Lang F, 2013, FASEB J, V27, P3, DOI 10.1096/fj.12-218230; Leibrock CB, 2015, J AM SOC NEPHROL, V26, P2423, DOI 10.1681/ASN.2014030230; Liu GL, 2015, CELL PHYSIOL BIOCHEM, V37, P1759, DOI 10.1159/000438539; Moccia F, 2012, CURR MED CHEM, V19, P5802, DOI 10.2174/092986712804143240; Neuhofer W, 2010, CURR GENOMICS, V11, P584, DOI 10.2174/138920210793360961; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Parekh AB, 2010, NAT REV DRUG DISCOV, V9, P399, DOI 10.1038/nrd3136; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Ponce CC, 2012, MED ONCOL, V29, P2337, DOI 10.1007/s12032-011-0144-1; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Putney JW, 2007, J CELL SCI, V120, P1959, DOI 10.1242/jcs.03462; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Sakamaki S, 1999, BLOOD, V94, P1961, DOI 10.1182/blood.V94.6.1961.418k17_1961_1970; Salter RD, 2009, IMMUNOL REV, V231, P278, DOI 10.1111/j.1600-065X.2009.00806.x; Schmid E, 2012, CELL PHYSIOL BIOCHEM, V30, P1423, DOI 10.1159/000343330; Shivdasani R. A., 2005, CURR PROTOC IMMUNOL, V67; Smyth JT, 2010, J CELL MOL MED, V14, P2337, DOI 10.1111/j.1582-4934.2010.01168.x; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Waldegger S, 1999, GASTROENTEROLOGY, V116, P1081, DOI 10.1016/S0016-5085(99)70011-9; Yan J, 2015, BIOCHEM BIOPH RES CO, V461, P8, DOI 10.1016/j.bbrc.2015.03.159; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhou Xiaoming, 2016, World J Nephrol, V5, P20, DOI 10.5527/wjn.v5.i1.20	45	13	13	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3439	3448		10.1096/fj.201601211R	http://dx.doi.org/10.1096/fj.201601211R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28446591				2022-12-26	WOS:000405932400022
J	Pontejo, SM; Murphy, PM				Pontejo, Sergio M.; Murphy, Philip M.			Two glycosaminoglycan-binding domains of the mouse cytomegalovirus-encoded chemokine MCK-2 are critical for oligomerization of the full-length protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CC-CHEMOKINE; NEUTRALIZING ANTIBODIES; BETA CHEMOKINE; IDENTIFICATION; HEPARIN; RANTES; HOMOLOG; CELLS; SITE; DISSEMINATION	Chemokines are essential for antimicrobial host defenses and tissue repair. Herpesviruses and poxviruses also encode chemokines, copied from their hosts and repurposed for multiple functions, including immune evasion. The CC chemokine MCK-2 encoded by mouse CMV (MCMV) has an atypical structure consisting of a classic chemokine domain N-terminal to a second unique domain, resulting from the splicing of MCMV ORFs m131 and m129. MCK-2 is essential for full MCMV infectivity in macrophages and for persistent infection in the salivary gland. However, information about its mechanism of action and specific biochemical roles for the two domains has been lacking. Here, using genetic, chemical, and enzymatic analyses of multiple mouse cell lines as well as primary mouse fibroblasts from salivary gland and lung, we demonstrate that MCK-2 binds glycosaminoglycans (GAGs) with affinities in the following order: heparin > heparan sulfate > chondroitin sulfate = dermatan sulfate. Both MCK-2 domains bound these GAGs independently, and computational analysis together with site-directed mutagenesis identified five basic residues distributed across the N terminus and the 30s and 50s loops of the chemokine domain that are important GAG binding determinants. Both domains were required for GAG-dependent oligomerization of fulll-ength MCK-2. Thus, MCK-2 is an atypical viral chemokine consisting of a CC chemokine domain and a unique non-chemokine domain, both of which bind GAGs and are critical for GAG-dependent oligomerization of the full-length protein.	[Pontejo, Sergio M.; Murphy, Philip M.] NIAID, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Murphy, PM (corresponding author), NIH, Bldg 10,Rm 11N111, Bethesda, MD 20892 USA.	pmm@nih.gov	Pontejo, Sergio M./AAN-6403-2020	Pontejo, Sergio M./0000-0002-7756-9831	NIAID, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000615] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the NIAID, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; Ali S, 2005, J IMMUNOL, V175, P1257, DOI 10.4049/jimmunol.175.2.1257; Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Britt W, 2008, CURR TOP MICROBIOL, V325, P417; Campanella GSV, 2006, J IMMUNOL, V177, P6991, DOI 10.4049/jimmunol.177.10.6991; Chang TLY, 2002, J VIROL, V76, P2245, DOI 10.1128/JVI.76.5.2245-2254.2002; Chiuppesi F, 2015, J VIROL, V89, P11884, DOI 10.1128/JVI.01701-15; Ciferri C, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005230; Czaplewski LG, 1999, J BIOL CHEM, V274, P16077, DOI 10.1074/jbc.274.23.16077; Daley-Bauer LP, 2014, CELL HOST MICROBE, V15, P351, DOI 10.1016/j.chom.2014.02.002; Daley-Bauer LP, 2012, IMMUNITY, V37, P122, DOI 10.1016/j.immuni.2012.04.014; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dyer DP, 2016, GLYCOBIOLOGY, V26, P312, DOI 10.1093/glycob/cwv100; Ellyard JI, 2007, J BIOL CHEM, V282, P15238, DOI 10.1074/jbc.M608046200; Fleming P, 1999, J VIROL, V73, P6800, DOI 10.1128/JVI.73.8.6800-6809.1999; Gangavarapu P, 2012, J LEUKOCYTE BIOL, V91, P259, DOI 10.1189/jlb.0511239; GRABAREK Z, 1990, ANAL BIOCHEM, V185, P131, DOI 10.1016/0003-2697(90)90267-D; Graham GJ, 2012, IMMUNOL LETT, V145, P30, DOI 10.1016/j.imlet.2012.04.004; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Hoogewerf AJ, 1997, BIOCHEMISTRY-US, V36, P13570, DOI 10.1021/bi971125s; Iozzo RV, 2015, MATRIX BIOL, V42, P11, DOI 10.1016/j.matbio.2015.02.003; Johnson Z, 2005, CYTOKINE GROWTH F R, V16, P625, DOI 10.1016/j.cytogfr.2005.04.006; Jordan S, 2011, J VIROL, V85, P10346, DOI 10.1128/JVI.00545-11; Koopmann W, 1997, J BIOL CHEM, V272, P10103; Kufareva I, 2015, IMMUNOL CELL BIOL, V93, P372, DOI 10.1038/icb.2015.15; Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d; Lau EK, 2004, J BIOL CHEM, V279, P22294, DOI 10.1074/jbc.M311224200; Laurence JS, 2000, BIOCHEMISTRY-US, V39, P3401, DOI 10.1021/bi9923196; Liang WGG, 2016, P NATL ACAD SCI USA, V113, P5000, DOI 10.1073/pnas.1523981113; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; Lortat-Jacob H, 2002, P NATL ACAD SCI USA, V99, P1229, DOI 10.1073/pnas.032497699; MacDonald MR, 1999, J VIROL, V73, P3682, DOI 10.1128/JVI.73.5.3682-3691.1999; Middleton J, 2002, BLOOD, V100, P3853, DOI 10.1182/blood.V100.12.3853; Monneau Y, 2016, J LEUKOCYTE BIOL, V99, P935, DOI 10.1189/jlb.3MR0915-440R; Montanuy I, 2011, FASEB J, V25, P1960, DOI 10.1096/fj.10-177188; Noda S, 2006, BLOOD, V107, P30, DOI 10.1182/blood-2005-05-1833; Nogalski MT, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003463; Paavola CD, 1998, J BIOL CHEM, V273, P33157, DOI 10.1074/jbc.273.50.33157; Patel DD, 2001, CLIN IMMUNOL, V99, P43, DOI 10.1006/clim.2000.4997; Penfold MET, 1999, P NATL ACAD SCI USA, V96, P9839, DOI 10.1073/pnas.96.17.9839; Peterson FC, 2004, J BIOL CHEM, V279, P12598, DOI 10.1074/jbc.M311633200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Proudfoot AEI, 2001, J BIOL CHEM, V276, P10620, DOI 10.1074/jbc.M010867200; RAJARATHNAM K, 1994, SCIENCE, V264, P90, DOI 10.1126/science.8140420; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Ryckman BJ, 2008, J VIROL, V82, P60, DOI 10.1128/JVI.01910-07; Saederup N, 1999, P NATL ACAD SCI USA, V96, P10881, DOI 10.1073/pnas.96.19.10881; Saederup N, 2001, J VIROL, V75, P9966, DOI 10.1128/JVI.75.20.9966-9976.2001; Safaiyan F, 1999, J BIOL CHEM, V274, P36267, DOI 10.1074/jbc.274.51.36267; Salanga CL, 2011, EXP CELL RES, V317, P590, DOI 10.1016/j.yexcr.2011.01.004; Salanga CL, 2014, J BIOL CHEM, V289, P14896, DOI 10.1074/jbc.M114.547737; Seluanov Andrei, 2010, J Vis Exp, DOI 10.3791/2033; Severin IC, 2010, J BIOL CHEM, V285, P17713, DOI 10.1074/jbc.M109.082552; Shaw JP, 2004, STRUCTURE, V12, P2081, DOI 10.1016/j.str.2004.08.014; Soria G, 2012, NEOPLASIA, V14, P1, DOI 10.1593/neo.111122; Stahl FR, 2015, MUCOSAL IMMUNOL, V8, P57, DOI 10.1038/mi.2014.42; Straschewski S, 2011, J VIROL, V85, P5150, DOI 10.1128/JVI.02100-10; Streblow DN, 2007, CURR OPIN IMMUNOL, V19, P577, DOI 10.1016/j.coi.2007.07.012; TANAKA Y, 1993, IMMUNOL TODAY, V14, P111, DOI 10.1016/0167-5699(93)90209-4; Vives RR, 2002, BIOCHEMISTRY-US, V41, P14779, DOI 10.1021/bi026459i; Wagner FM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003493; Wagner L, 1998, NATURE, V391, P908, DOI 10.1038/36129; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Wen YX, 2014, VACCINE, V32, P3796, DOI 10.1016/j.vaccine.2014.05.004; Wussow F, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004524; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang LJ, 2006, METHOD ENZYMOL, V416, P205, DOI 10.1016/S0076-6879(06)16013-9; Zhao B, 2010, BIOCHEMISTRY-US, V49, P7012, DOI 10.1021/bi100549y	71	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9613	9626		10.1074/jbc.M117.785121	http://dx.doi.org/10.1074/jbc.M117.785121			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28432120	hybrid, Green Published			2022-12-26	WOS:000403113000013
J	Fernandes-Brum, CN; Rezende, PM; Ribeiro, THC; de Oliveira, RR; Cardoso, TCD; do Amaral, LR; Gomes, MD; Chalfun, A				Fernandes-Brum, Christiane Noronha; Rezende, Pamela Marinho; Ribeiro, Thales Henrique Cherubino; Ricon de Oliveira, Raphael; de Sousa Cardoso, Thais Cunha; do Amaral, Laurence Rodrigues; Gomes, Matheus de Souza; Chalfun-Junior, Antonio			A genome-wide analysis of the RNA-guided silencing pathway in coffee reveals insights into its regulatory mechanisms	PLOS ONE			English	Article							POLYMERASE GENE FAMILIES; DIRECTED DNA METHYLATION; DICER-LIKE; EPIGENETIC PATHWAY; MIRNA ABUNDANCE; FLOWERING TIME; PRI-MIRNA; POL IV; IDENTIFICATION; ARABIDOPSIS	microRNAs (miRNAs) are derived from self-complementary hairpin structures, while small-interfering RNAs (siRNAs) are derived from double-stranded RNA (dsRNA) or hairpin precursors. The core mechanism of sRNA production involves DICER-like (DCL) in processing the smallRNAs (sRNAs) and ARGONAUTE (AGO) as effectors of silencing, and siRNA biogenesis also involves action of RNA-Dependent RNA Polymerase (RDR), Pol IV and Pol V in biogenesis. Several other proteins interact with the core proteins to guide sRNA biogenesis, action, and turnover. We aimed to unravel the components and functions of the RNA-guided silencing pathway in a non-model plant species of worldwide economic relevance. The sRNA-guided silencing complex members have been identified in the Coffea canephora genome, and they have been characterized at the structural, functional, and evolutionary levels by computational analyses. Eleven AGO proteins, nine DCL proteins (which include a DCL1-like protein that was not previously annotated), and eight RDR proteins were identified. Another 48 proteins implicated in smallRNA (sRNA) pathways were also identified. Furthermore, we identified 235 miRNA precursors and 317 mature miRNAs from 113 MIR families, and we characterized ccp-MIR156, ccp-MIR172, and ccp-MIR390. Target prediction and gene ontology analyses of 2239 putative targets showed that significant pathways in coffee are targeted by miRNAs. We provide evidence of the expansion of the loci related to sRNA pathways, insights into the activities of these proteins by domain and catalytic site analyses, and gene expression analysis. The number of MIR loci and their targeted pathways highlight the importance of miRNAs in coffee. We identified several roles of sRNAs in C. canephora, which offers substantial insight into better understanding the transcriptional and post-transcriptional regulation of this major crop.	[Fernandes-Brum, Christiane Noronha; Rezende, Pamela Marinho; Ribeiro, Thales Henrique Cherubino; Chalfun-Junior, Antonio] Fed Univ Lavras UFLA, Lab Plant Mol Physiol LFMP, Sect Plant Physiol, Dept Biol, Lavras, MG, Brazil; [Ricon de Oliveira, Raphael] Univ Cordoba UCO, Dept Genet, Cordoba, Spain; [de Sousa Cardoso, Thais Cunha; do Amaral, Laurence Rodrigues; Gomes, Matheus de Souza] Fed Univ Uberlandia UFU, Lab Bioinformat & Mol Anal LBAM, Inst Genet & Biochem INGEB, Campus Patos de Minas, Patos De Minas, MG, Brazil	Universidade Federal de Lavras; Universidad de Cordoba	Chalfun, A (corresponding author), Fed Univ Lavras UFLA, Lab Plant Mol Physiol LFMP, Sect Plant Physiol, Dept Biol, Lavras, MG, Brazil.	chalfunjunior@dbi.ufla.br	Amaral, Laurence Rodrigues do/R-2209-2019; Chalfun, Antonio/AAG-8609-2021; Amaral, Laurence/G-5905-2012; Chalfun-Junior, Antonio/I-5655-2013; de Oliveira, Raphael Ricon/I-8817-2018; de Souza Gomes, Matheus/G-3480-2012	Amaral, Laurence Rodrigues do/0000-0003-4681-5451; Amaral, Laurence/0000-0003-4681-5451; Chalfun-Junior, Antonio/0000-0002-1794-9429; de Oliveira, Raphael Ricon/0000-0002-3971-0021; de Souza Gomes, Matheus/0000-0001-7352-3089; Ribeiro, Thales/0000-0003-2675-7004	National Council for Scientific and Technological Development (CNPq) [308282/2013-2]; Minas Gerais State Research Foundation (FAPEMIG); Coordination of Improvement of Higher Education (CAPES); National Institute of Science and Technology of Coffee (INCT-Cafe)	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Minas Gerais State Research Foundation (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordination of Improvement of Higher Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Institute of Science and Technology of Coffee (INCT-Cafe)	National Council for Scientific and Technological Development (CNPq) provided grant (308282/2013-2, www.cnpq.br to A.C.J.). Minas Gerais State Research Foundation (FAPEMIG), www.fapemig.br, and Coordination of Improvement of Higher Education (CAPES), www.capes.gov.br, provided grants to P.M.R., T.H.C.R., and C.N.F.B. National Institute of Science and Technology of Coffee (INCT-Cafe), www.inctcafe.ufla.br, provided financial resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akter A, 2014, SAUDI J BIOL SCI, V21, P3, DOI 10.1016/j.sjbs.2013.04.007; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Axtell MJ, 2005, PLANT CELL, V17, P1658, DOI 10.1105/tpc.105.032185; Bai M, 2012, GENE, V501, P52, DOI 10.1016/j.gene.2012.02.009; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Baumberger N, 2005, P NATL ACAD SCI USA, P102; Bologna NG, 2014, ANNU REV PLANT BIOL, V65, P473, DOI 10.1146/annurev-arplant-050213-035728; Borges F, 2015, NAT REV MOL CELL BIO, V16, P727, DOI 10.1038/nrm4085; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Cao X, 2002, ROLE ARABIDOPSIS DRM; Chaves SS, 2015, APPL BIOCHEM BIOTECH, V177, P879, DOI 10.1007/s12010-015-1785-x; Chen L, 2012, PLANTA, V235, P375, DOI 10.1007/s00425-011-1514-9; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Chuck G, 2007, NAT GENET, P39; Dai X, 2011, NUCLEIC ACIDS RES, P39; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Cardoso TCD, 2016, PLANT BIOLOGY, V18, P206, DOI 10.1111/plb.12377; Denoeud F, 2014, SCIENCE, V345, P1181, DOI 10.1126/science.1255274; Ding YF, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00235; Dong Z, 2008, P NATL ACAD SCI USA, V105, P9970, DOI 10.1073/pnas.0803356105; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Gardner PP, 2009, RFAM UPDATES RNA FAM; Gomes MD, 2011, GENOMICS, V98, P96, DOI 10.1016/j.ygeno.2011.05.007; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hu WX, 2014, BIOCHEM BIOPH RES CO, V444, P676, DOI 10.1016/j.bbrc.2014.01.171; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jeong IS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074739; Ji XH, 2008, CURR TOP MICROBIOL, V320, P99; Kapoor M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-451; Karlsson P, 2015, P NATL ACAD SCI USA, V112, P14096, DOI 10.1073/pnas.1512865112; Kim YJ, 2011, EMBO J, V30, P814, DOI 10.1038/emboj.2011.3; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kullan JB, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1610-5; Kurihara Y, 2006, RNA, V12, P206, DOI 10.1261/rna.2146906; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Liang G, 2013, PLANTA, V238, P739, DOI 10.1007/s00425-013-1929-6; Liu B, 2005, PLANT PHYSIOL, P139; Liu HH, 2014, PLANT PHYSIOL, V165, P160, DOI 10.1104/pp.114.235564; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Liu X, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-4; Lobbes D, 2006, EMBO REP, V7, P1052, DOI 10.1038/sj.embor.7400806; Loss-Morais G, 2014, GENET MOL BIOL, V37, P671, DOI [10.1590/S1415-47572014005000020, 10.1590/S1415-47572014000500010]; Margis R, 2006, FEBS LETT, V580, P2442, DOI 10.1016/j.febslet.2006.03.072; Matzke MA, 2015, ANNU REV PLANT BIOL, V66, P243, DOI 10.1146/annurev-arplant-043014-114633; Matzke MA, 2014, NAT REV GENET, V15, P394, DOI 10.1038/nrg3683; Moissiard G, 2007, RNA, V13, P1268, DOI 10.1261/rna.541307; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Ostria-Gallardo E, 2016, NEW PHYTOL, V210, P694, DOI 10.1111/nph.13776; Puzey JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033034; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Qian YX, 2011, PLANT CELL REP, V30, P1347, DOI 10.1007/s00299-011-1046-6; Rebijith KB, 2013, J HORTIC SCI BIOTECH, V88, P325, DOI 10.1080/14620316.2013.11512973; Ren GD, 2012, P NATL ACAD SCI USA, V109, P12817, DOI 10.1073/pnas.1204915109; Rogers K, 2013, PLANT CELL, V25, P2383, DOI 10.1105/tpc.113.113159; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHIEBEL W, 1993, J BIOL CHEM, V268, P11858; Smit A.F.A., REPEATMASKER; Speth C, 2013, PLANT J, V76, P433, DOI 10.1111/tpj.12308; Stevens P. F., 2012, ANGIOSPERM PHYLOGENY; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang GL, 2010, SEMIN CELL DEV BIOL, V21, P782, DOI 10.1016/j.semcdb.2010.07.009; Tworak A, 2016, PLANT CELL REP, V35, P1043, DOI 10.1007/s00299-016-1936-8; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Voinnet O, 2008, TRENDS PLANT SCI, V13, P317, DOI 10.1016/j.tplants.2008.05.004; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang XB, 2010, P NATL ACAD SCI USA, V107, P484, DOI 10.1073/pnas.0904086107; Wang Y, 2015, MOL GENET GENOMICS, V290, P471, DOI 10.1007/s00438-014-0931-4; Wassenegger M, 2006, TRENDS PLANT SCI, V11, P142, DOI 10.1016/j.tplants.2006.01.003; Wierzbicki AT, 2012, GENE DEV, V26, P1825, DOI 10.1101/gad.197772.112; Wierzbicki AT, 2009, NAT GENET, V41, P630, DOI 10.1038/ng.365; Willmann Matthew R, 2011, Arabidopsis Book, V9, pe0146, DOI 10.1199/tab.0146; Wu G, 2009, CELL, P138; Xing SP, 2010, PLANT CELL, V22, P3935, DOI 10.1105/tpc.110.079343; Yamaguchi A, 2012, J PLANT RES, V125, P693, DOI 10.1007/s10265-012-0513-7; Yu B, 2008, P NATL ACAD SCI USA, V105, P10073, DOI 10.1073/pnas.0804218105; Yu N, 2010, PLANT CELL, V22, P2322, DOI 10.1105/tpc.109.072579; Zeng Y, 2004, NUCLEIC ACIDS RES, V32, P4776, DOI 10.1093/nar/gkh824; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang C, 2015, FRONT MICROBIOL, V6, DOI [10.3389/fmicb.2015.01237, 10.3389/fmicb.2015.01108]; Zhang H, 2015, CURR OPIN PLANT BIOL, V27, P84, DOI 10.1016/j.pbi.2015.06.011; Zhang RX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057233; Zhou M, 2015, CURR OPIN PLANT BIOL, V27, P154, DOI 10.1016/j.pbi.2015.07.005; Zhu QH, 2011, J EXP BOT, V62, P487, DOI 10.1093/jxb/erq295; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695; Zong J, 2009, GENE, V447, P29, DOI 10.1016/j.gene.2009.07.004	92	9	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176333	10.1371/journal.pone.0176333	http://dx.doi.org/10.1371/journal.pone.0176333			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448529	gold, Green Published			2022-12-26	WOS:000400383600063
J	Kim, HC; Kim, WK; Klein, TA; Chong, ST; Nunn, PV; Kim, JA; Lee, SH; No, JS; Song, JW				Kim, Heung-Chul; Kim, Won-Keun; Klein, Terry A.; Chong, Sung -Tae; Nunn, Peter V.; Kim, Jeong-Ah; Lee, Seung-Ho; No, Jin Sun; Song, Jin-Won			Hantavirus surveillance and genetic diversity targeting small mammals at Camp Humphreys, a US military installation and new expansion site, Republic of Korea	PLOS ONE			English	Article							HANTAAN VIRUS SURVEILLANCE; NORTH TRAINING AREA; FIRING POINTS 10; GYEONGGI PROVINCE; DAGMAR NORTH; ECOLOGICAL SURVEILLANCE; MYODES-REGULUS; MUJU VIRUS; RODENTS; SEOUL	Small mammal surveillance was conducted (2008-2010, 2012) at Camp (Cp) Humphreys, a US Army installation and new expansion site, Republic of Korea (ROK), to identify hemorrhagic fever with renal syndrome health threats to US military/civilian populations during its ongoing expansion phase. Small mammals were collected using Sherman live capture traps and transported to Korea University where they were euthanized, tissues removed, and assayed to determine hantavirus IgG antibody-positive and hantavirus-positive rates by RT-PCR. A total of 2,364 small mammals were captured over 11,300 trap nights (capture rate = 20.92%). Apodemus agrarius was the most commonly collected (76.65%), with capture rates of 9.62% and 21.70% for Cp Humphreys and the expansion site, respectively. Overall, Hantaan virus (HTNV) IgG antibody-positive (Ab+) rate for A. agrarius was 2.15% (39/1,812). A total of 5.43% (10/184) Crocidura lasiura, 0.79% (2/254) Microtus fortis and 2.44% (1/41) Micromys minutus were serologically IgG Ab+ for hantaviruses. HTNV-specific RT-PCR demonstrated that 28.2% (11/39) HTNV Ab+ A. agrarius harbored the 328-nt sequence of the GC glycoprotein-encoding M segment of HTNV. Among them, the whole genome sequences of 3 HTNV strains were obtained by conventional RT-PCR and Rapid Amplification cDNA Ends PCR. Phylogenetic analyses of the HTNV strains from Cp Humphreys and the expansion site, Pyeongtaek, show a greater diversity of rodent-borne hantaviruses compared to HTNV previously identified in Gyeonggi province of the ROK. Thus, this study provides significant insights for raising HFRS threat awareness, analysis, and risk reduction strategies in southern Gyeonggi province.	[Kim, Heung-Chul; Chong, Sung -Tae; Nunn, Peter V.] 65th Med Brigade, Multifunct Med Battal 168, Med Detachment 5, Honolulu, HI USA; [Kim, Won-Keun; Kim, Jeong-Ah; Lee, Seung-Ho; No, Jin Sun; Song, Jin-Won] Korea Univ, Coll Med, Dept Microbiol, Seoul, South Korea; [Klein, Terry A.] 65th Med Brigade, MEDDAC Korea, Honolulu, HI USA; [Nunn, Peter V.] 18th Med Command, Honolulu, HI USA	Korea University; Korea University Medicine (KU Medicine)	Song, JW (corresponding author), Korea Univ, Coll Med, Dept Microbiol, Seoul, South Korea.	jwsong@korea.ac.kr	Song, Jin/HHS-8731-2022	Lee, Seung-Ho/0000-0002-7840-422X	Armed Forces Health Surveillance Branch, Global Emerging Infections Surveillance and Response System (AFHSB-GEIS), Silver Spring, MD; 65th MED BDE; Public Health Command Region-Pacific, Camp Zama, Japan; Agency of Defense Development [UE134020ID/UD160022ID]	Armed Forces Health Surveillance Branch, Global Emerging Infections Surveillance and Response System (AFHSB-GEIS), Silver Spring, MD; 65th MED BDE; Public Health Command Region-Pacific, Camp Zama, Japan; Agency of Defense Development(Agency of Defense Development (ADD), Republic of Korea)	Funding for portions of this work was provided by the Armed Forces Health Surveillance Branch, Global Emerging Infections Surveillance and Response System (AFHSB-GEIS), Silver Spring, MD, the 65th MED BDE, and the Public Health Command Region-Pacific, Camp Zama, Japan, and by a grant from the Agency of Defense Development (UE134020ID/UD160022ID) to JWS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cho HW, 2002, INTERVIROLOGY, V45, P328, DOI 10.1159/000067925; Heinemann P, 2016, J INFECT DIS, V214, P1507, DOI 10.1093/infdis/jiw401; Hinson ER, 2004, AM J TROP MED HYG, V70, P310, DOI 10.4269/ajtmh.2004.70.310; Hong HK, 1984, THESIS INCHON U, V6, P417; Huggins John W., 1997, P745; KANG S W, 1971, Korean Journal of Zoology, V14, P57; Kim HC, 2011, J VECTOR ECOL, V36, P42, DOI 10.1111/j.1948-7134.2011.00139.x; Kim JA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004650; Kim WK, 2016, SCI REP-UK, V6, DOI 10.1038/srep26017; Klein TA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118483; Klein TA, 2012, VECTOR-BORNE ZOONOT, V12, P674, DOI 10.1089/vbz.2011.0618; Klein TA, 2011, J VECTOR ECOL, V36, P373, DOI 10.1111/j.1948-7134.2011.00178.x; Koichiro T, 2013, MOL BIOL EVOL, V28, P2731; Korea Centers for Disease Control and Prevention (K-CDC), 2014, DIS WEB STAT SYST; LEE HW, 1978, J INFECT DIS, V137, P298, DOI 10.1093/infdis/137.3.298; Lee HW, 1972, REPT NAT I HLTH KORE, V9, P295; Lee JG, 2014, VIRUSES-BASEL, V6, P1701, DOI 10.3390/v6041701; Mackelprang R, 2001, EMERG INFECT DIS, V7, P480, DOI 10.3201/eid0703.017328; MILLS JN, 1995, J MAMMAL, V76, P716, DOI 10.2307/1382742; No JS, 2016, MICROBIOL IMMUNOL, V60, P268, DOI 10.1111/1348-0421.12370; O'Guinn ML, 2008, J VECTOR ECOL, V33, P370, DOI 10.3376/1081-1710-33.2.370; Payne KS, 2009, MIL MED, V174, P1061, DOI 10.7205/MILMED-D-00-3809; PON E, 1990, AM J TROP MED HYG, V42, P612, DOI 10.4269/ajtmh.1990.42.612; Sachar DS, 2003, MIL MED, V168, P231, DOI 10.1093/milmed/168.3.231; Sames WJ, 2009, J VECTOR ECOL, V34, P225, DOI [10.1111/j.1948-7134.2009.00030.x, 10.3376/038.034.0208]; Song DH, 2017, AM J TROP MED HYG, V96, P389, DOI 10.4269/ajtmh.16-0683; Song JW, 2009, EMERG INFECT DIS, V15, P1833, DOI 10.3201/eid1511.090076; Song JW, 2009, J VIROL, V83, P6184, DOI 10.1128/JVI.00371-09; Song JS, 1971, REPT NAT I HLTH KORE, V8, P117; Song JW, 2000, VIRUS GENES, V21, P227, DOI 10.1023/A:1008199800011; Song KJ, 2007, J GEN VIROL, V88, P3121, DOI 10.1099/vir.0.83139-0; XIAO SY, 1992, J GEN VIROL, V73, P567; XIAO SY, 1994, VIROLOGY, V198, P205, DOI 10.1006/viro.1994.1023	33	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176514	10.1371/journal.pone.0176514	http://dx.doi.org/10.1371/journal.pone.0176514			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448595	Green Submitted, gold, Green Published			2022-12-26	WOS:000400383600092
J	Sharman, SK; Islam, BN; Hou, YL; Usry, M; Bridges, A; Singh, N; Sridhar, S; Rao, S; Browning, DD				Sharman, Sarah K.; Islam, Bianca N.; Hou, Yali; Usry, Margaux; Bridges, Allison; Singh, Nagendra; Sridhar, Subbaramiah; Rao, Satish; Browning, Darren D.			Sildenafil normalizes bowel transit in preclinical models of constipation	PLOS ONE			English	Article							SMALL-INTESTINAL MOTILITY; PLACEBO-CONTROLLED TRIAL; GUANYLATE-CYCLASE C; PHARMACOLOGICAL-PROPERTIES; GASTROINTESTINAL-TRACT; INDUCED COLITIS; DOUBLE-BLIND; LINACLOTIDE; DIARRHEA; MICE	Guanylyl cyclase-C (GC-C) agonists increase cGMP levels in the intestinal epithelium to promote secretion. This process underlies the utility of exogenous GC-C agonists such as linaclotide for the treatment of chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C). Because GC-C agonists have limited use in pediatric patients, there is a need for alternative cGMP-elevating agents that are effective in the intestine. The present study aimed to determine whether the PDE-5 inhibitor sildenafil has similar effects as linaclotide on preclinical models of constipation. Oral administration of sildenafil caused increased cGMP levels in mouse intestinal epithelium demonstrating that blocking cGMP-breakdown is an alternative approach to increase cGMP in the gut. Both linaclotide and sildenafil reduced proliferation and increased differentiation in colon mucosa, indicating common target pathways. The homeostatic effects of cGMP required gut turnover since maximal effects were observed after 3 days of treatment. Neither linaclotide nor sildenafil treatment affected intestinal transit or water content of fecal pellets in healthy mice. To test the effectiveness of cGMP elevation in a functional motility disorder model, mice were treated with dextran sulfate sodium (DSS) to induce colitis and were allowed to recover for several weeks. The recovered animals exhibited slower transit, but increased fecal water content. An acute dose of sildenafil was able to normalize transit and fecal water content in the DSS-recovery animal model, and also in loperamide-induced constipation. The higher fecal water content in the recovered animals was due to a compromised epithelial barrier, which was normalized by sildenafil treatment. Taken together our results show that sildenafil can have similar effects as linaclotide on the intestine, and may have therapeutic benefit to patients with CIC, IBS-C, and post-infectious IBS.	[Sharman, Sarah K.; Islam, Bianca N.; Hou, Yali; Usry, Margaux; Bridges, Allison; Singh, Nagendra; Browning, Darren D.] Augusta Univ, Dept Biochem & Mol Biol, Canc Res Ctr, Augusta, GA 30912 USA; [Sridhar, Subbaramiah; Rao, Satish] Augusta Univ, Dept Med, Div Gastroenterol & Hepatol, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Browning, DD (corresponding author), Augusta Univ, Dept Biochem & Mol Biol, Canc Res Ctr, Augusta, GA 30912 USA.	dbrowning@augusta.edu		Browning, Darren/0000-0003-0497-7620	National Institutes of Health [R01CA172627-01A1]; NATIONAL CANCER INSTITUTE [R01CA172627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103576] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Support was provided by the National Institutes of Health R01CA172627-01A1 DDB.	[Anonymous], 2015, BMJ, DOI DOI 10.1136/BMJ.H1622; Atkinson W, 2006, GASTROENTEROLOGY, V130, P34, DOI 10.1053/j.gastro.2005.09.031; Bearcroft CP, 1998, GUT, V42, P42, DOI 10.1136/gut.42.1.42; Bortolotti M, 2000, GASTROENTEROLOGY, V118, P253, DOI 10.1016/S0016-5085(00)70206-X; Bryant AP, 2010, LIFE SCI, V86, P760, DOI 10.1016/j.lfs.2010.03.015; Busby RW, 2013, J PHARMACOL EXP THER, V344, P196, DOI 10.1124/jpet.112.199430; Busby RW, 2010, EUR J PHARMACOL, V649, P328, DOI 10.1016/j.ejphar.2010.09.019; Camilleri M, 2008, NEW ENGL J MED, V358, P2344, DOI 10.1056/NEJMoa0800670; Chey WD, 2012, AM J GASTROENTEROL, V107, P1702, DOI 10.1038/ajg.2012.254; Coates MD, 2004, GASTROENTEROLOGY, V126, P1657, DOI 10.1053/j.gastro.2004.03.013; COOPER HS, 1993, LAB INVEST, V69, P238; Coremans G, 2003, DIGESTION, V67, P82, DOI 10.1159/000070202; Costedio MM, 2010, AM J GASTROENTEROL, V105, P1173, DOI 10.1038/ajg.2009.683; Cremonini F, 2003, NEUROGASTROENT MOTIL, V15, P79, DOI 10.1046/j.1365-2982.2003.00389.x; Drossman DA, 2016, GASTROENTEROLOGY, V150, P1262, DOI 10.1053/j.gastro.2016.02.032; Dunlop SP, 2006, AM J GASTROENTEROL, V101, P1288, DOI 10.1111/j.1572-0241.2006.00672.x; Dunlop SP, 2005, CLIN GASTROENTEROL H, V3, P349, DOI 10.1016/S1542-3565(04)00726-8; Eherer AJ, 2002, GUT, V50, P758, DOI 10.1136/gut.50.6.758; Eijkelkamp N, 2007, AM J PHYSIOL-GASTR L, V293, pG749, DOI 10.1152/ajpgi.00114.2007; Eutamene H, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2009.01385.x; Fox M, 2007, NEUROGASTROENT MOTIL, V19, P798, DOI 10.1111/j.1365-2982.2007.00957.x; GORARD DA, 1994, GUT, V35, P496, DOI 10.1136/gut.35.4.496; Grover M, 2014, NEUROGASTROENT MOTIL, V26, P156, DOI 10.1111/nmo.12304; Han XN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016139; HEEL RC, 1978, DRUGS, V15, P33, DOI 10.2165/00003495-197815010-00003; Hoffman JM, 2012, GASTROENTEROLOGY, V142, P844, DOI 10.1053/j.gastro.2011.12.041; Hughes PA, 2009, GUT, V58, P1333, DOI 10.1136/gut.2008.170811; Johnston JM, 2010, GASTROENTEROLOGY, V139, P1877, DOI 10.1053/j.gastro.2010.08.041; Lembo AJ, 2011, NEW ENGL J MED, V365, P527, DOI 10.1056/NEJMoa1010863; Li P, 2007, AM J PATHOL, V171, P1847, DOI 10.2353/ajpath.2007.070198; Lin JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031686; MARKERT T, 1995, J CLIN INVEST, V96, P822, DOI 10.1172/JCI118128; Marona HRN, 2004, LAB ANIM-UK, V38, P257, DOI 10.1258/002367704323133637; Milone M, 2005, DIGEST DIS SCI, V50, P1005, DOI 10.1007/s10620-005-2695-5; O'Sullivan M, 2000, NEUROGASTROENT MOTIL, V12, P449; Pfeifer A, 1996, SCIENCE, V274, P2082, DOI 10.1126/science.274.5295.2082; POL O, 1995, J PHARMACOL EXP THER, V272, P1271; Puig MM, 1996, ANESTHESIOLOGY, V85, P1403, DOI 10.1097/00000542-199612000-00022; Qin HY, 2011, J GASTROENTEROL, V46, P164, DOI 10.1007/s00535-010-0321-6; Rao S, 2012, AM J GASTROENTEROL, V107, P1714, DOI 10.1038/ajg.2012.255; Sager G, 2004, NEUROCHEM INT, V45, P865, DOI 10.1016/j.neuint.2004.03.017; Silos-Santiago I, 2013, PAIN, V154, P1820, DOI 10.1016/j.pain.2013.05.044; Steinbrecher KA, 2002, AM J PATHOL, V161, P2169, DOI 10.1016/S0002-9440(10)64494-X; Wang R, 2014, CELL DEATH DIFFER, V21, P427, DOI 10.1038/cdd.2013.163; Wang R, 2012, AM J PHYSIOL-GASTR L, V303, pG209, DOI 10.1152/ajpgi.00500.2011; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Xu XH, 2006, DIGEST DIS SCI, V51, P671, DOI 10.1007/s10620-006-3190-3; Yan YT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006073; Zhou Q, 2008, PAIN, V134, P9, DOI 10.1016/j.pain.2007.03.029	49	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176673	10.1371/journal.pone.0176673	http://dx.doi.org/10.1371/journal.pone.0176673			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448580	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383600120
J	Ge, ZL; Liu, SY; Li, GP; Huang, Y; Wang, YN				Ge, Zhilei; Liu, Suyun; Li, Guopeng; Huang, Yan; Wang, Yanni			Error model of geomagnetic-field measurement and extended Kalman-filter based compensation method	PLOS ONE			English	Article								The real-time accurate measurement of the geomagnetic-field is the foundation to achieving high-precision geomagnetic navigation. The existing geomagnetic-field measurement models are essentially simplified models that cannot accurately describe the sources of measurement error. This paper, on the basis of systematically analyzing the source of geomagnetic-field measurement error, built a complete measurement model, into which the previously unconsidered geomagnetic daily variation field was introduced. This paper proposed an extended Kalman-filter based compensation method, which allows a large amount of measurement data to be used in estimating parameters to obtain the optimal solution in the sense of statistics. The experiment results showed that the compensated strength of the geomagnetic field remained close to the real value and the measurement error was basically controlled within 5nT. In addition, this compensation method has strong applicability due to its easy data collection and ability to remove the dependence on a high-precision measurement instrument.	[Ge, Zhilei; Liu, Suyun; Li, Guopeng; Huang, Yan; Wang, Yanni] Northwestern Polytech Univ, Sch Astronaut, Xian, Shaanxi Provinc, Peoples R China	Northwestern Polytechnical University	Liu, SY (corresponding author), Northwestern Polytech Univ, Sch Astronaut, Xian, Shaanxi Provinc, Peoples R China.	liusuyun746010936@163.com			National Nature Science Foundation of China [61374209]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research was funded by the National Nature Science Foundation of China (Grant No.61374209). Recipient: ZLG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Deutschmann JK, 2001, J GUID CONTROL DYNAM, V24, P616, DOI 10.2514/2.4753; Dong MJ, 2015, HIGH TECHNOLOGY LETT, V21, P407; Fitzgibbon A, 1999, IEEE T PATTERN ANAL, V21, P476, DOI 10.1109/34.765658; Gebre ED, 2007, J AIRCRAFT, V44, P1361; Goldenberg F, 2006, IEEE POSITION LOCAT, P684, DOI 10.1109/PLANS.2006.1650662; [郭才发 GUO Cai-fa], 2009, [宇航学报, Journal of Chinese Society of Astronautics], V30, P1314; Guo Peng-fei, 2007, Journal of Chinese Inertial Technology, V15, P598; Guo ZD, 2012, INT SYM COMPUT INTEL, P543, DOI 10.1109/ISCID.2012.141; Li J, 2011 INT C INST MEAS; Li Ji, 2013, Journal of National University of Defense Technology, V35, P7; Li Q., 2004, P IEEE 2004, V2004, P335, DOI DOI 10.1109/GMAP.2004.1290055; Li Y, 2012, J SENSOR TECHNOLOGY, V25, P917; Lv CP, 2015, INTERNATIONAL CONFERENCE ON AUTOMATION, MECHANICAL AND ELECTRICAL ENGINEERING (AMEE 2015), P150; Madrid AV, 2005, MICROW OPT TECHN LET, V47, P281, DOI 10.1002/mop.21147; Ming Liu, 2011, Proceedings of the 2011 2nd International Conference on Intelligent Control and Information Processing (ICICIP), P697, DOI 10.1109/ICICIP.2011.6008339; Munschy M, 2007, J APPL GEOPHYS, V61, P168, DOI 10.1016/j.jappgeo.2006.06.004; Munschy M, 2011, GEOPHYS PROSPECT, V59, P1035, DOI 10.1111/j.1365-2478.2011.01007.x; Sengupta A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042093; Sun XD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003758; Timo P, 2011, APPL MATH MODEL, V32, P33; [于振涛 Yu Zhentao], 2014, [哈尔滨工程大学学报, Journal of Harbin Engineering University], V35, P731; Zhang L, 2016, J POWER SOURCES, V314, P28, DOI 10.1016/j.jpowsour.2016.01.066; Zhang L, 2014, ENERGIES, V7, P3204, DOI 10.3390/en7053204; Zhang XJ, 2013, 11 IEEE INT C EL MEA, P693; Zhang XM, 2011, J SCI INSTRUMENT, V30, P2438; Zhou J, 2008, J ASTRONAUTICS, V29, P1; Zou CF, 2016, J POWER SOURCES, V335, P121, DOI 10.1016/j.jpowsour.2016.10.040; Zou CF, 2015, IEEE DECIS CONTR P, P1328, DOI 10.1109/CDC.2015.7402395	28	3	7	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0173962	10.1371/journal.pone.0173962	http://dx.doi.org/10.1371/journal.pone.0173962			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445508	Green Submitted, gold, Green Published			2022-12-26	WOS:000400309200003
J	Chen, J; Huang, CL; Wang, JJ; Zhou, H; Lu, YY; Lou, LH; Zheng, JY; Tian, L; Wang, XP; Cao, ZW; Zeng, Y				Chen, Jing; Huang, Chunlan; Wang, Jingjing; Zhou, Hui; Lu, Yingying; Lou, Lihong; Zheng, Junyuan; Tian, Ling; Wang, Xingpeng; Cao, Zhongwei; Zeng, Yue			Dysbiosis of intestinal microbiota and decrease in paneth cell antimicrobial peptide level during acute necrotizing pancreatitis in rats	PLOS ONE			English	Article							BACTERIAL TRANSLOCATION; TIME-COURSE; INJURY; INFLAMMATION; DYSFUNCTION; HOMEOSTASIS; MECHANISM; NECROSIS; LIVER; MODEL	Objectives Intestinal barrier dysfunction plays an important role in acute necrotizing pancreatitis (ANP) and intestinal microbiota dysbiosis was involved in intestinal barrier failure. Paneth cells protect intestinal barrier and are associated with intestinal microbiota. Here, we investigated changes in intestinal microbiota and antimicrobial peptides of Paneth cells in ileum during ANP. Methods Rats with ANP were established by retrograde injection of 3.5% sodium taurocholate into biliopancreatic duct and sacrificed at 24h and 48h, respectively. Injuries of pancreas and distal ileum were evaluated by histopathological score. Intestinal barrier function was assessed by plasma diamine oxidase activity (DAO) and D-lactate. Systemic and intestinal inflammation was evaluated by TNF alpha, IL-1 beta and IL-17A concentration by ELISA, respectively. 16S rRNA high throughput sequencing on fecal samples was used to investigate the changes in intestinal microbiota in the ANP group at 48h. Lysozyme and alpha-defensin5 were measured by real-time PCR, western blot and immunofluoresence. Results ANP rats had more severe histopathological injuries in pancreas and distal ileum, injured intestinal barrier and increased expression of TNFa, IL-1 beta and IL-17A in plasma and distal ileum compared with those of the sham-operated (SO) group. Principal component analysis (PCA) showed structural segregation between the SO and ANP groups. Operational taxonomic unit (OTU) number and ACE index revealed decreased microbiota diversity in the ANP group. Taxonomic analysis showed dysbiosis of intestinal microbiota structure. At phyla level, Saccharibacteria and Tenericutes decreased significantly. At genus level, Escherichia-Shigella and Phascolarctobacterium increased significantly, while Candidatus_Saccharimonas, Prevotellaceae_UCG-001, Lachnospiraceae_UCG-001, Ruminiclostridium_ 5 and Ruminococcaceae_UCG-008 decreased significantly. Lysozyme and alpha-defensin5 mRNA expression levels decreased significantly in ANP group at 48h. Protein expression of lysozyme decreased in ANP groups at 24h and 48h. Meanwhile, the relative abundance of Escherichia-Shigella correlated inversely with the decrease in lysozyme. Conclusion The disorder in intestinal microbiota and decreases of Paneth cell antimicrobial peptides might participate in the pathogenesis of intestinal barrier dysfunction during ANP.	[Chen, Jing; Huang, Chunlan; Zhou, Hui; Lu, Yingying; Zheng, Junyuan; Wang, Xingpeng; Cao, Zhongwei; Zeng, Yue] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Gastroenterol, Shanghai, Peoples R China; [Wang, Jingjing; Tian, Ling; Zeng, Yue] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Shanghai Key Lab Pancreat Dis, Shanghai, Peoples R China; [Lou, Lihong] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Int Med Care Ctr, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Cao, ZW; Zeng, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Gastroenterol, Shanghai, Peoples R China.; Zeng, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Shanghai Key Lab Pancreat Dis, Shanghai, Peoples R China.	caozhongwei@medmail.com.cn; zengyue1610@163.com	wang, jing/GRS-7509-2022; WANG, JINGYI/GSJ-1241-2022		medical-engineering cross project of Shanghai Jiao Tong university [YG2015MS29, YG2014ZD10]; Natural Science Foundation for Young Scholars of China [81600500]	medical-engineering cross project of Shanghai Jiao Tong university; Natural Science Foundation for Young Scholars of China	This study was supported by funds from the medical-engineering cross project of Shanghai Jiao Tong university (YG2015MS29, YG2014ZD10) (URL: http//kejichu.sjtu.edu.cn/) and Natural Science Foundation for Young Scholars of China (81600500) (URL: http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Bashashati M, 2015, CURR DRUG TARGETS, V16, P199, DOI 10.2174/1389450116666150120104012; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P484; Clevers HC, 2013, ANNU REV PHYSIOL, V75, P289, DOI 10.1146/annurev-physiol-030212-183744; Dowds CM, 2015, CLIN IMMUNOL, V159, P128, DOI 10.1016/j.clim.2015.05.008; Fernandez MI, 2008, J IMMUNOL, V180, P4924, DOI 10.4049/jimmunol.180.7.4924; Fritz S, 2010, AM J SURG, V200, P111, DOI 10.1016/j.amjsurg.2009.08.019; Grootjans J, 2011, GASTROENTEROLOGY, V140, P529, DOI 10.1053/j.gastro.2010.10.040; Hodin CM, 2011, AM J PATHOL, V179, P2885, DOI 10.1016/j.ajpath.2011.08.030; Liang HY, 2014, J DIGEST DIS, V15, P386, DOI 10.1111/1751-2980.12148; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep26337; Mooney JP, 2015, SCI REP-UK, V5, DOI 10.1038/srep14603; Oto J, 2013, CRIT CARE, V17, DOI 10.1186/cc13169; Park SW, 2012, J IMMUNOL, V189, P5421, DOI 10.4049/jimmunol.1200581; Park SW, 2011, LAB INVEST, V91, P63, DOI 10.1038/labinvest.2010.151; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Qiu ZY, 2016, INFLAMM RES, V65, P647, DOI 10.1007/s00011-016-0947-9; SCHMIDT J, 1992, ANN SURG, V215, P44, DOI 10.1097/00000658-199201000-00007; Schwarz M, 2000, SURGERY, V127, P427, DOI 10.1067/msy.2000.104116; Shaw MH, 2012, J EXP MED, V209, P251, DOI 10.1084/jem.20111703; Shen YF, 2012, INFLAMM RES, V61, P743, DOI 10.1007/s00011-012-0467-1; Sun M, 2015, MUCOSAL IMMUNOL, V8, P969, DOI 10.1038/mi.2015.49; Surbatovic M, 2013, J CLIN GASTROENTEROL, V47, P637, DOI 10.1097/MCG.0b013e31828a6cfc; Tan CC, 2015, PANCREAS, V44, P868, DOI 10.1097/MPA.0000000000000355; Teltschik Z, 2012, HEPATOLOGY, V55, P1154, DOI 10.1002/hep.24789; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Wang YL, 2009, J DIGEST DIS, V10, P30, DOI 10.1111/j.1751-2980.2008.00360.x; Wang YL, 2015, CELL BIOCHEM BIOPHYS, V71, P765, DOI 10.1007/s12013-014-0261-5; Xu GD, 2014, J APPL MATH, DOI 10.1155/2014/568697; Zhang XP, 2007, WORLD J GASTROENTERO, V13, P4566, DOI 10.3748/wjg.v13.i34.4566; Zhang Xi-ping, 2007, Journal of Zhejiang University-Science B, V8, P888, DOI 10.1631/jzus.2007.B0888; Zhang Z, 2016, SCI CHINA LIFE SCI, V59, P463, DOI 10.1007/s11427-016-5018-5	34	66	76	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176583	10.1371/journal.pone.0176583	http://dx.doi.org/10.1371/journal.pone.0176583			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441432	Green Published, gold, Green Submitted			2022-12-26	WOS:000400308800068
J	Claydon, J; Sur, A; Callejas, A; Ladd, M; Kwan, E; Taylor, R; Turvey, SE; Solimano, A; Lavoie, PM; Marr, N				Claydon, Jennifer; Sur, Amitava; Callejas, Allison; Ladd, Mihoko; Kwan, Eddie; Taylor, Richard; Turvey, Stuart E.; Solimano, Alfonso; Lavoie, Pascal M.; Marr, Nico			Respiratory syncytial virus-neutralizing serum antibody titers in infants following palivizumab prophylaxis with an abbreviated dosing regimen	PLOS ONE			English	Article							HUMANIZED MONOCLONAL-ANTIBODY; PHARMACOKINETICS; INFECTION; CHILDREN; HEART	Background Monthly injections of palivizumab during the respiratory syncytial virus (RSV) season in atrisk infants reduces RSV-associated hospitalizations. However, the additive effect of naturally acquired immunity remains unclear. The objective of this study was to assess total neutralizing serum antibodies (NAb) against RSV in at-risk infants who had received an abbreviated course of palivizumab prophylaxis. Methods Serum samples were collected from infants enrolled in the RSV Immunoprophylaxis Program in British Columbia, Canada over 2 consecutive RSV seasons (2013 to 2015). Infants in this program had received an abbreviated course of palivizumab in accordance with the provincial guidelines. Data were compared to adults and infants less than 12 months of age who did not receive palivizumab. Anti-RSV NAb titers were measured using an RSV microneutralization assay. Findings Infants who received palivizumab had anti-RSV NAb titers at the end of the RSV season that persisted beyond what is expected from the pharmacokinetics of palivizumab alone. Moreover, 54% of the control infants who did not receive palivizumab and all tested adults had protective anti-RSV NAb titers. Conclusions Based on our observations, we hypothesize that naturally acquired NAb provide additive protection, which may significantly reduce the need for additional doses of palivizumab in infants at risk of severe RSV infections.	[Claydon, Jennifer; Ladd, Mihoko; Turvey, Stuart E.; Solimano, Alfonso; Lavoie, Pascal M.; Marr, Nico] Univ British Columbia, Dept Pediat, Vancouver, BC, Canada; [Claydon, Jennifer; Ladd, Mihoko; Turvey, Stuart E.; Lavoie, Pascal M.; Marr, Nico] BC Childrens Hosp Res Inst, Vancouver, BC, Canada; [Sur, Amitava; Callejas, Allison; Kwan, Eddie; Turvey, Stuart E.; Solimano, Alfonso; Lavoie, Pascal M.] Childrens & Womens Hlth Ctr British Columbia, Vancouver, BC, Canada; [Taylor, Richard] Univ Victoria, Dept Pediat, Victoria, BC, Canada; [Marr, Nico] Canadian Ctr Vaccinol, Halifax, NS, Canada; [Marr, Nico] Sidra Med & Res Ctr, Doha, Qatar	University of British Columbia; BC Women's Hospital & Health Centre; University of Victoria; Sidra Medical & Research Center	Marr, N (corresponding author), Univ British Columbia, Dept Pediat, Vancouver, BC, Canada.; Marr, N (corresponding author), BC Childrens Hosp Res Inst, Vancouver, BC, Canada.; Marr, N (corresponding author), Canadian Ctr Vaccinol, Halifax, NS, Canada.; Marr, N (corresponding author), Sidra Med & Res Ctr, Doha, Qatar.	nmarr@sidra.org	Marr, Nico/T-7741-2019; Turvey, Stuart/HGV-1191-2022	Marr, Nico/0000-0002-1927-7072; Lavoie, Pascal/0000-0002-2205-0362; Turvey, Stuart/0000-0003-1599-1065; Callejas, Allison/0000-0001-9590-2880	British Columbia Lung Association; Sandra Schmirier Foundation; Canadian Institutes of Health Research	British Columbia Lung Association; Sandra Schmirier Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the British Columbia Lung Association (to NM), the Sandra Schmirier Foundation (to A. Sur, AC and NM), and the Canadian Institutes of Health Research (to PML and SET). SET holds the Aubrey J. Tingle Professorship in Pediatric Immunology and both SET and PML are clinical scholars of the Michael Smith Foundation for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brady MT, 2014, PEDIATRICS, V134, pE620, DOI [10.1542/peds.2014-1665, 10.1542/peds.2014-1666]; Bulkow LR, 2002, PEDIATRICS, V109, P210, DOI 10.1542/peds.109.2.210; DESIERRA TM, 1993, J PEDIATR-US, V122, P787, DOI 10.1016/S0022-3476(06)80027-2; Feltes TF, 2003, J PEDIATR-US, V143, P532, DOI 10.1067/S0022-3476(03)00454-2; Gutfraind A, 2015, JAMA PEDIATR, V169, P341, DOI 10.1001/jamapediatrics.2014.3804; Johnson S, 1997, J INFECT DIS, V176, P1215, DOI 10.1086/514115; Krajden M, 2009, CLIN VACCINE IMMUNOL, V16, P1840, DOI 10.1128/CVI.00238-09; Kwilas AR, 2010, J VIROL, V84, P7770, DOI 10.1128/JVI.00346-10; La Via WV, 2013, PULM PHARMACOL THER, V26, P666, DOI 10.1016/j.pupt.2013.03.007; Lavoie PM, 2016, JAMA PEDIATR, V170, P174, DOI 10.1001/jamapediatrics.2015.3235; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; Meissner HC, 2016, NEW ENGL J MED, V374, P1793, DOI 10.1056/NEJMc1601509; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Robbie GJ, 2012, ANTIMICROB AGENTS CH, V56, P4927, DOI 10.1128/AAC.06446-11; Saez-Llorens X, 1998, PEDIATR INFECT DIS J, V17, P787, DOI 10.1097/00006454-199809000-00007; Shinoff JJ, 2008, J INFECT DIS, V198, P1007, DOI 10.1086/591460; Stensballe LG, 2009, J PEDIATR-US, V154, P296, DOI 10.1016/j.jpeds.2008.07.053; Wang EEL, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.3.e9	18	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176152	10.1371/journal.pone.0176152	http://dx.doi.org/10.1371/journal.pone.0176152			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437470	Green Published, gold, Green Submitted			2022-12-26	WOS:000400287600031
J	Jun, JE; Lee, SE; Lee, YB; Jee, JH; Bae, JC; Jin, SM; Hur, KY; Lee, MK; Kim, JH				Jun, Ji Eun; Lee, Seung-Eun; Lee, You-Bin; Jee, Jae Hwan; Bae, Ji Cheol; Jin, Sang-Man; Hur, Kyu Yeon; Lee, Moon-Kyu; Kim, Jae Hyeon			Increase in serum albumin concentration is associated with prediabetes development and progression to overt diabetes independently of metabolic syndrome	PLOS ONE			English	Article							C-REACTIVE PROTEIN; BETA-CELL FUNCTION; OXIDATIVE STRESS; INSULIN-RESISTANCE; ANTIOXIDANT PROPERTIES; RISK-FACTORS; ATHEROSCLEROSIS; INFLAMMATION; POPULATION; PREDICTION	Aim Serum albumin concentration is associated with both type 2 diabetes and metabolic syndrome (MetS). We sought to investigate whether baseline serum albumin and change in serum albumin could be independent risk factors for prediabetes in subjects without MetS. We further examined the effect of serum albumin on progression to overt diabetes in subjects who developed prediabetes. Methods Among 10,792 participants without diabetes and MetS who consecutively underwent yearly health check-ups over six years, 9,807 subjects without incident MetS were enrolled in this longitudinal retrospective study. The risk of developing prediabetes (impared fasting glucose or hemoglobin A1c) was analyzed according to baseline and percent change in serum albumin concentration using Cox regression analysis. Serial changes in serum albumin concentration were measured from baseline to one year before prediabetes diagnosis, and then from the time of prediabetes diagnosis to progression to overt diabetes or final follow-up. Results A total of 4,398 incident cases of prediabetes developed during 35,807 person-years (median 3.8 years). The hazard ratio for incident prediabetes decreased as percent change in serum albumin concentration (quartiles and per 1%) increased in a crude and fully adjusted model. However, baseline serum albumin concentration itself was not associated with prediabetic risk. Serum albumin levels kept increasing until the end of follow-up in prediabetic subjects who returned to normal glycemic status, whereas these measures did not change in prediabetic subjects who developed type 2 diabetes. Serum albumin concentration measured at the end of follow-up was the highest in the regression group, compared to the stationary (p = 0.014) or progression groups (p = 0.009). Conclusions Increase in serum albumin concentration might protect against early glycemic deterioration and progression to type 2 diabetes even in subjects without MetS.	[Jun, Ji Eun; Lee, Seung-Eun; Lee, You-Bin; Jin, Sang-Man; Hur, Kyu Yeon; Lee, Moon-Kyu; Kim, Jae Hyeon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Endocrinol & Metab, Seoul, South Korea; [Jee, Jae Hwan] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Hlth Promot Ctr, Seoul, South Korea; [Bae, Ji Cheol] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Dept Med,Div Endocrinol & Metab, Chang Won, South Korea; [Kim, Jae Hyeon] Sungkyunkwan Univ, Sch Med, SAIHST, Dept Clin Res Design & Evaluat, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU)	Kim, JH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Endocrinol & Metab, Seoul, South Korea.; Kim, JH (corresponding author), Sungkyunkwan Univ, Sch Med, SAIHST, Dept Clin Res Design & Evaluat, Seoul, South Korea.	jaehyeon@skku.edu	Jin, Sang-Man/AFO-5933-2022	Lee, You-Bin/0000-0003-4058-1738				Abbasi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051496; Abramson JL, 2005, ATHEROSCLEROSIS, V178, P115, DOI 10.1016/j.atherosclerosis.2004.08.007; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Bonora E, 1998, DIABETES, V47, P1643, DOI 10.2337/diabetes.47.10.1643; Bossard M, 2014, INT J CARDIOL, V171, pE24, DOI 10.1016/j.ijcard.2013.11.125; Busher JT, 1990, SERUM ALBUMIN GLOBUL, V3rd; Candiano G, 2009, J PROTEOMICS, V73, P188, DOI 10.1016/j.jprot.2009.06.006; Cho Hye Min, 2012, J Prev Med Public Health, V45, P98, DOI 10.3961/jpmph.2012.45.2.98; Dohi Y, 2007, INT J CARDIOL, V115, P63, DOI 10.1016/j.ijcard.2006.04.006; Ford ES, 2008, DIABETES CARE, V31, P1898, DOI 10.2337/dc08-0423; Galassetti P, 2012, EXP DIABETES RES, DOI 10.1155/2012/943706; Gillespie KM, 2006, CAN MED ASSOC J, V175, P165, DOI 10.1503/cmaj.060244; GUTTERIDGE JMC, 1986, BIOCHIM BIOPHYS ACTA, V869, P119, DOI 10.1016/0167-4838(86)90286-4; HALLIWELL B, 1988, BIOCHEM PHARMACOL, V37, P569, DOI 10.1016/0006-2952(88)90126-8; Ishizaka N, 2007, ATHEROSCLEROSIS, V193, P373, DOI 10.1016/j.atherosclerosis.2006.06.031; Jin SM, 2016, METABOLISM, V65, P1629, DOI 10.1016/j.metabol.2016.08.006; Kunutsor SK, 2015, DIABETOLOGIA, V58, P961, DOI 10.1007/s00125-015-3520-0; Maschirow L, 2015, CLIN BIOCHEM, V48, P581, DOI 10.1016/j.clinbiochem.2015.02.015; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Morimoto A, 2013, DIABETOLOGIA, V56, P1671, DOI 10.1007/s00125-013-2932-y; Nwose EU, 2006, REDOX REP, V11, P99, DOI 10.1179/135100006X116583; Ohn JH, 2016, LANCET DIABETES ENDO, V4, P27, DOI 10.1016/S2213-8587(15)00336-8; Park S, 2013, CLIN ENDOCRINOL, V79, P65, DOI 10.1111/j.1365-2265.2012.04512.x; Rao MS, 2012, NITTE UNIV J HEALTH, V2, P18; Roche M, 2008, FEBS LETT, V582, P1783, DOI 10.1016/j.febslet.2008.04.057; Schmidt MI, 1999, LANCET, V353, P1649, DOI 10.1016/S0140-6736(99)01046-6; Sitar ME, 2013, CLIN LAB, V59, P945, DOI 10.7754/Clin.Lab.2012.121115; Stranges S, 2008, OBESITY, V16, P1370, DOI 10.1038/oby.2008.59	28	20	20	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0176209	10.1371/journal.pone.0176209	http://dx.doi.org/10.1371/journal.pone.0176209			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430803	Green Published, gold, Green Submitted			2022-12-26	WOS:000399876100033
J	Lefevre, EM; Medley, GA; Reeks, T; Alexander, S; Burne, THJ; Eyles, DW				Lefevre, Emilia M.; Medley, Gregory A.; Reeks, Timothy; Alexander, Suzy; Burne, Thomas H. J.; Eyles, Darryl W.			Effect of the glucocorticoid receptor antagonist RU486 on MK-801 induced behavioural sensitisation	PLOS ONE			English	Article							INDUCED CORTICOSTERONE SECRETION; COCAINE-INDUCED SENSITIZATION; STRESS-INDUCED SENSITIZATION; TYROSINE-HYDROXYLASE GENE; MESSENGER-RNA; NEUROENDOCRINE RESPONSES; PLASMA-CORTICOSTERONE; ENVIRONMENTAL CONTEXT; NUCLEUS-ACCUMBENS; RAT-BRAIN	Stress is known to modulate sensitisation to repeated psychostimulant exposure. However, there is no direct evidence linking glucocorticoids and sensitisation achieved by repeated administration of the NMDA receptor antagonist MK-801. We tested the hypothesis that co-administration of RU486, a glucocorticoid receptor (GR) antagonist, prior to repeated daily MK-801 injections would block the expression of locomotor sensitisation due to its dual effects on corticosterone and dopamine. We employed a repeated MK-801 administration locomotor sensitisation paradigm in male Sprague Dawley rats. RU486 or a dimethyl sulfoxide (DMSO) vehicle was co-administered with MK-801 or saline during the induction phase. Subsequent to withdrawal, rats were challenged with MK-801 alone to test for the expression of sensitisation. In a separate cohort of rats, plasma corticosterone levels were quantified from blood samples taken on the 1(st), 4(th) and 7(th) day of induction and at expression. One day after challenge, nucleus accumbens tissue levels of dopamine and its metabolites DOPAC and HVA were measured. During the induction phase, RU486 progressively enhanced locomotor sensitisation to MK-801. RU486 and MK-801 both showed stimulatory effects on corticosterone levels and this was further augmented when given in combination. Contrary to our hypothesis, RU486 did not block the expression of locomotor sensitisation to MK-801 and actually increased levels of dopamine, DOPAC and HVA in nucleus accumbens tissue. Our results showed that RU486 has augmentative rather than inhibitory effects on MK-801-induced sensitisation. This study indicates a divergent role for glucocorticoids in sensitisation to MK-801 compared to sensitisation with other psychostimulants.	[Lefevre, Emilia M.; Medley, Gregory A.; Reeks, Timothy; Alexander, Suzy; Burne, Thomas H. J.; Eyles, Darryl W.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia; [Medley, Gregory A.; Alexander, Suzy; Burne, Thomas H. J.; Eyles, Darryl W.] Pk Ctr Mental Hlth, Queensland Ctr Mental Hlth Res, Richlands, Qld, Australia	University of Queensland; Queensland Centre for Mental Health Research	Eyles, DW (corresponding author), Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia.; Eyles, DW (corresponding author), Pk Ctr Mental Hlth, Queensland Ctr Mental Hlth Res, Richlands, Qld, Australia.	eyles@uq.edu.au	Eyles, Darryl W/X-3386-2018; Burne, Thomas H/C-5656-2009	Eyles, Darryl W/0000-0002-5023-7095; Burne, Thomas H/0000-0003-3502-9789; Lefevre, Emilia/0000-0002-6116-4549; Medley, Gregory/0000-0002-7462-9536	National Health and Medical Research Council [1024239]; NHMRC	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	Support was provided by the National Health and Medical Research Council [https://www.nhmrc.gov.au/] Grant # 1024239 to Darryl Eyles & Thomas Burne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NHMRC project grant 1024239.	Badiani A, 2004, BEHAV PHARMACOL, V15, P327, DOI 10.1097/00008877-200409000-00004; Barik J, 2010, BIOL PSYCHIAT, V68, P231, DOI 10.1016/j.biopsych.2010.03.037; Barrot M, 2000, EUR J NEUROSCI, V12, P973, DOI 10.1046/j.1460-9568.2000.00996.x; Baulieu E-E, 1985, ANTIPROGESTIN STEROI, pix; Baumann MH, 2000, DRUG ALCOHOL DEPEN, V59, P143, DOI 10.1016/S0376-8716(99)00113-1; Bekris S, 2005, BEHAV BRAIN RES, V161, P45, DOI 10.1016/j.bbr.2005.01.005; BOROWSKY B, 1991, BRAIN RES, V543, P301, DOI 10.1016/0006-8993(91)90041-S; CARLSSON A, 1973, J PHARM PHARMACOL, V25, P437, DOI 10.1111/j.2042-7158.1973.tb09129.x; CRISWELL HE, 1993, J PHARMACOL EXP THER, V265, P1001; Dalm S, 2008, J NEUROSCI METH, V170, P77, DOI 10.1016/j.jneumeth.2007.12.021; DAYANITHI G, 1989, ENDOCRINOLOGY, V125, P308, DOI 10.1210/endo-125-1-308; de Jong IEM, 2007, BEHAV BRAIN RES, V177, P329, DOI 10.1016/j.bbr.2006.11.015; de Jong IEM, 2009, PSYCHOPHARMACOLOGY, V204, P693, DOI 10.1007/s00213-009-1498-3; de Jong IEM, 2009, EUR J PHARMACOL, V604, P66, DOI 10.1016/j.ejphar.2008.12.026; DeBattista C, 2006, TRENDS ENDOCRIN MET, V17, P117, DOI 10.1016/j.tem.2006.02.006; DEROCHE V, 1995, J NEUROSCI, V15, P7181; Donoghue K, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0757-1; Flatmark T, 1999, CHEM REV, V99, P2137, DOI 10.1021/cr980450y; FOSSOM LH, 1992, MOL PHARMACOL, V42, P898; Gallagher P, 2005, BIOL PSYCHIAT, V57, P155, DOI 10.1016/j.biopsych.2004.10.017; Gallagher Peter, 2006, Neuropsychiatr Dis Treat, V2, P33; Garcia-Keller C, 2013, EUR J NEUROSCI, V37, P982, DOI 10.1111/ejn.12121; Hagerty T, 2001, J NEUROCHEM, V76, P825, DOI 10.1046/j.1471-4159.2001.00072.x; HOFFMAN PL, 1989, J NEUROCHEM, V52, P1937, DOI 10.1111/j.1471-4159.1989.tb07280.x; HOWLAND RH, 2013, J PSYCHOSOC NURS MEN, V51, P13; Joels M, 2009, BRAIN RES, V1293, P91, DOI 10.1016/j.brainres.2009.03.036; KAKIHANA R, 1968, NATURE, V218, P360, DOI 10.1038/218360a0; KALIVAS PW, 1993, BEHAV PHARMACOL, V4, P315; KNYCH ET, 1979, NEUROENDOCRINOLOGY, V29, P110, DOI 10.1159/000122912; LEE S, 1994, MOL BRAIN RES, V24, P192, DOI 10.1016/0169-328X(94)90132-5; Lefevre EM, 2016, BEHAV BRAIN RES, V298, P241, DOI 10.1016/j.bbr.2015.11.014; LEVY AD, 1992, LIFE SCI, V51, P887, DOI 10.1016/0024-3205(92)90396-7; Lieberman JA, 1997, NEUROPSYCHOPHARMACOL, V17, P205, DOI 10.1016/S0893-133X(97)00045-6; LOVINGER DM, 1989, SCIENCE, V243, P1721, DOI 10.1126/science.2467382; McCullers DL, 2001, J NEUROSCI RES, V64, P277; Mihic SJ, 1999, NEUROCHEM INT, V35, P115, DOI 10.1016/S0197-0186(99)00053-4; MILANES MV, 1993, NEUROPEPTIDES, V24, P279, DOI 10.1016/0143-4179(93)90016-4; Moldow RL, 2005, NEUROSCI LETT, V374, P25, DOI 10.1016/j.neulet.2004.10.016; Nelson AM, 2010, NEUROSCI LETT, V476, P9, DOI 10.1016/j.neulet.2010.03.032; PECHNICK RN, 1990, J PHARMACOL EXP THER, V254, P344; PECHNICK RN, 1989, EUR J PHARMACOL, V164, P257, DOI 10.1016/0014-2999(89)90466-4; Prasad BM, 1996, PSYCHOPHARMACOLOGY, V125, P265, DOI 10.1007/BF02247338; Przegalinski E, 2000, J PHYSIOL PHARMACOL, V51, P193; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; ROBERTS AJ, 1995, J PHARMACOL EXP THER, V275, P790; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; ROUGEPONT F, 1995, J NEUROSCI, V15, P7189; van der Veen R, 2013, PSYCHOPHARMACOLOGY, V230, P547, DOI 10.1007/s00213-013-3176-8; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; VEZZANI A, 1989, J PHARMACOL EXP THER, V249, P278; WEDZONY K, 1994, BRAIN RES, V657, P351, DOI 10.1016/0006-8993(94)90991-1; Wolf ME, 1998, PROG NEUROBIOL, V54, P679, DOI 10.1016/S0301-0082(97)00090-7; WOLF ME, 1993, BEHAV PHARMACOL, V4, P429	53	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0176156	10.1371/journal.pone.0176156	http://dx.doi.org/10.1371/journal.pone.0176156			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430805	gold, Green Published, Green Submitted			2022-12-26	WOS:000399876100028
J	Srut, M; Drechsel, V; Hockner, M				Srut, Maja; Drechsel, Victoria; Hoeckner, Martina			Low levels of Cd induce persisting epigenetic modifications and acclimation mechanisms in the earthworm Lumbricus terrestris	PLOS ONE			English	Article							METALLOTHIONEIN GENE-EXPRESSION; EISENIA-FOETIDA ANNELIDA; GENOMIC DNA METHYLATION; LIFE-CYCLE PARAMETERS; CADMIUM EXPOSURE; ENVIRONMENTAL EPIGENETICS; PHYTOCHELATIN SYNTHASE; HEAVY-METALS; BIOMARKER; RESPONSES	Toxic effects of cadmium (Cd), a common soil pollutant, are still not very well understood, particularly in regard to its epigenetic impact. Therefore, the aim of this study was to assess DNA methylation changes and their persistence in the earthworm Lumbricus terrestris upon chronic low dose Cd exposure using methylation sensitive amplification polymorphism (MSAP). Moreover, the biomarker response and fitness of the earthworms, as well as the expression of detoxification-related genes (metallothionein (MT) and phytochelatin synthase (PCS)) was evaluated. Low levels of Cd caused an increase in genome-wide DNA methylation, which remained partly modified, even after several months of recovery in unpolluted soil. Increased cellular stress seemed to decrease after two weeks of exposure whereas fitness parameters remained unaffected by Cd, probably as a result from the activation of detoxification mechanisms like the expression of MTs. Interestingly, even though the level of Cd exposure was very low, MT expression levels indicate the development of acclimation mechanisms. Taken together, this study demonstrates that acclimation, as well as epigenetic modifications can occur already in moderately polluted environments. In addition, these effects can have long-lasting impacts on key species of soil invertebrates and might persist long after the actual heavy metal challenge has passed.	[Srut, Maja] Univ Zagreb, Fac Sci, Dept Zool, Rooseveltov Trg 6, Zagreb, Croatia; [Drechsel, Victoria; Hoeckner, Martina] Univ Innsbruck, Inst Zool, Dept Ecophysiol, Ctr Mol Biosci, Technikerstr 25, A-6020 Innsbruck, Austria	University of Zagreb; University of Innsbruck	Srut, M (corresponding author), Univ Zagreb, Fac Sci, Dept Zool, Rooseveltov Trg 6, Zagreb, Croatia.; Hockner, M (corresponding author), Univ Innsbruck, Inst Zool, Dept Ecophysiol, Ctr Mol Biosci, Technikerstr 25, A-6020 Innsbruck, Austria.	msrut@biol.pmf.hr; martina.hoeckner@uibk.ac.at	Šrut, Maja/AAZ-7267-2021	Hockner, Martina/0000-0001-8093-3756	University of Innsbruck [194584]; Tyrolean science foundation (TWF) [GZ:UNI-0404/1417, GZ:UNI-0404/1807]; Austrian Agency for International Cooperation in Education and Research (OeAD GmbH) [ICM-2014-07081]; Centre for International Cooperation Mobility (ICM) [HR 08/2016]	University of Innsbruck; Tyrolean science foundation (TWF); Austrian Agency for International Cooperation in Education and Research (OeAD GmbH); Centre for International Cooperation Mobility (ICM)	The study was funded by the University of Innsbruck (Nachwuchsforderprogramm 2014 No. 194584), the Tyrolean science foundation (TWF) (Projects GZ:UNI-0404/1417 and GZ:UNI-0404/1807), an Ernst Mach grant (Austrian Agency for International Cooperation in Education and Research (OeAD GmbH; ICM-2014-07081) awarded to Maja Srut, and a Scientific and Technological Cooperation grant by the Centre for International Cooperation & Mobility (ICM; HR 08/2016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Alonso C, 2016, MOL ECOL RESOUR, V16, P80, DOI 10.1111/1755-0998.12426; Anderson RS, 1999, DEV COMP IMMUNOL, V23, P443, DOI 10.1016/S0145-305X(99)00029-4; Arita A, 2009, METALLOMICS, V1, P222, DOI 10.1039/b903049b; Beaumelle L, 2014, ENVIRON POLLUT, V191, P182, DOI 10.1016/j.envpol.2014.04.021; Benbrahim-Tallaa L, 2007, ENVIRON HEALTH PERSP, V115, P1454, DOI 10.1289/ehp.10207; Brulle F, 2008, ECOTOX ENVIRON SAFE, V71, P47, DOI 10.1016/j.ecoenv.2007.10.032; Brulle F, 2011, SCI TOTAL ENVIRON, V409, P5470, DOI 10.1016/j.scitotenv.2011.08.040; Bundy JG, 2014, ENVIRON SCI TECHNOL, V48, P885, DOI 10.1021/es4054779; Chen YY, 2014, AQUAT TOXICOL, V157, P196, DOI 10.1016/j.aquatox.2014.10.018; Cheng TF, 2012, J APPL TOXICOL, V32, P643, DOI 10.1002/jat.2717; Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188; Doi T, 2011, TOXICOL SCI, V120, P475, DOI 10.1093/toxsci/kfr022; Dolinoy DC, 2008, ENVIRON MOL MUTAGEN, V49, P4, DOI 10.1002/em.20366; Fisker KV, 2013, COMP BIOCHEM PHYS C, V157, P220, DOI 10.1016/j.cbpc.2012.11.007; Fuller-Espie SL, 2011, PEDOBIOLOGIA, V54, pS31, DOI 10.1016/j.pedobi.2011.09.009; Greco M, 2012, J EXP BOT, V63, P695, DOI 10.1093/jxb/err313; Heard E, 2014, CELL, V157, P95, DOI 10.1016/j.cell.2014.02.045; Hobbelen PHF, 2006, ENVIRON POLLUT, V144, P639, DOI 10.1016/j.envpol.2006.01.019; Hockner M, 2015, BIOCHEM BIOPH RES CO, V460, P537, DOI 10.1016/j.bbrc.2015.03.065; Hockner M, 2011, BIOMETALS, V24, P1079, DOI 10.1007/s10534-011-9466-x; Homa J, 2015, ENVIRON TOXICOL CHEM, V34, P1397, DOI 10.1002/etc.2944; Hossain MB, 2012, ENVIRON HEALTH PERSP, V120, P879, DOI 10.1289/ehp.1104600; Huang DJ, 2008, TOXICOL LETT, V179, P43, DOI 10.1016/j.toxlet.2008.03.018; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Jiang GF, 2008, TOXICOLOGY, V244, P49, DOI 10.1016/j.tox.2007.10.028; Jimenez-Chillaron JC, 2015, EPIGENETICS-US, V10, P259, DOI 10.1080/15592294.2015.1020267; Kille P, 2013, SOIL BIOL BIOCHEM, V57, P524, DOI 10.1016/j.soilbio.2012.10.014; Klobucar GIV, 2011, ENVIRON POLLUT, V159, P841, DOI 10.1016/j.envpol.2011.01.009; Langdon CJ, 2003, ENVIRON TOXICOL CHEM, V22, P2344, DOI 10.1897/02-554; Legeay A, 2005, AQUAT TOXICOL, V74, P242, DOI 10.1016/j.aquatox.2005.05.015; Lei YX, 2015, GENET MOL RES, V14, P515, DOI 10.4238/2015.January.26.5; Li M, 2009, CHEMOSPHERE, V74, P621, DOI 10.1016/j.chemosphere.2008.10.048; Li Y SH, 2007, RAPID KINETIC MICROA, V18, P162; Li ZL, 2015, ENVIRON TOXICOL CHEM, V34, P2095, DOI 10.1002/etc.3033; Liebeke M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081271; Lim JP, 2013, TRENDS GENET, V29, P176, DOI 10.1016/j.tig.2012.12.008; Lukkari T, 2004, ENVIRON POLLUT, V129, P377, DOI 10.1016/j.envpol.2003.12.008; Santoyo MM, 2011, ENVIRON POLLUT, V159, P2387, DOI 10.1016/j.envpol.2011.06.041; Martinez-Zamudio R, 2011, EPIGENETICS-US, V6, P820, DOI 10.4161/epi.6.7.16250; Mielke H.W., 2005, INT J ENV RES PUB HE, V2, P308; Mirbahai L, 2014, MUTAT RES-GEN TOX EN, V764, P10, DOI 10.1016/j.mrgentox.2013.10.003; Mustonen M, 2014, ECOTOXICOLOGY, V23, P1732, DOI 10.1007/s10646-014-1338-z; Nahmani J, 2007, ENVIRON POLLUT, V149, P44, DOI 10.1016/j.envpol.2006.12.018; Novo M, 2014, TOXICOL LETT, V229, pS18, DOI 10.1016/j.toxlet.2014.06.095; Otomo PV, 2014, B ENVIRON CONTAM TOX, V92, P285, DOI 10.1007/s00128-013-1157-6; Ou XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041143; Panzarino O, 2016, CHEMOSPHERE, V145, P480, DOI 10.1016/j.chemosphere.2015.11.077; Perez-Figueroa A, 2013, MOL ECOL RESOUR, V13, P522, DOI 10.1111/1755-0998.12064; Pierron F, 2014, ENVIRON SCI TECHNOL, V48, P797, DOI 10.1021/es4048347; Pogribny I, 2004, BIOCHEM BIOPH RES CO, V320, P1253, DOI 10.1016/j.bbrc.2004.06.081; Ray PD, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00201; ReynaLopez GE, 1997, MOL GEN GENET, V253, P703, DOI 10.1007/s004380050374; Rieswijk L, 2016, TOXICOLOGY, V350, P31, DOI 10.1016/j.tox.2016.05.002; Roelofs D, 2009, MOL ECOL, V18, P3227, DOI 10.1111/j.1365-294X.2009.04261.x; Saez G, 2015, ENVIRON TOXICOL, V30, P918, DOI 10.1002/tox.21966; Sandbichler AM, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010139; Sanders AP, 2014, EPIGENETICS-US, V9, P212, DOI 10.4161/epi.26798; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Suarez-Ulloa V, 2015, MAR POLLUT BULL, V98, P5, DOI 10.1016/j.marpolbul.2015.06.020; Takiguchi M, 2003, EXP CELL RES, V286, P355, DOI 10.1016/S0014-4827(03)00062-4; Tang S, 2015, CHEMOSPHERE, V120, P92, DOI 10.1016/j.chemosphere.2014.06.011; van Gestel CAM, 2009, ENVIRON POLLUT, V157, P895, DOI 10.1016/j.envpol.2008.11.002; Vandegehuchte MB, 2009, ENVIRON INT, V35, P700, DOI 10.1016/j.envint.2009.01.002; Vasseur P, 2014, CURR ZOOL, V60, P255, DOI 10.1093/czoolo/60.2.255; Waisberg M, 2003, TOXICOLOGY, V192, P95, DOI 10.1016/S0300-483X(03)00305-6; Wang JH, 2012, ENVIRON TOXICOL CHEM, V31, P2035, DOI 10.1002/etc.1907; Wang XT, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1119; Wu B, 2012, ECOTOX ENVIRON SAFE, V81, P122, DOI 10.1016/j.ecoenv.2012.05.003; Xu ML, 2000, PLANT MOL BIOL REP, V18, P361, DOI 10.1007/BF02825064; Ye S, 2014, MUTAT RES-GEN TOX EN, V773, P34, DOI 10.1016/j.mrgentox.2014.08.004; Yoshida M, 2005, TOXICOLOGY, V213, P74, DOI 10.1016/j.tox.2005.05.008; Zaltauskaite J, 2014, ECOTOX ENVIRON SAFE, V103, P9, DOI 10.1016/j.ecoenv.2014.01.036; Zhang JL, 2009, ENVIRON TOXICOL PHAR, V27, P345, DOI 10.1016/j.etap.2008.11.012; Zhou T, 2004, TOXICOL LETT, V154, P191, DOI 10.1016/j.toxlet.2004.07.015; Zhu J., 2006, J ENVIRON SCI, P1210	77	24	24	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176047	10.1371/journal.pone.0176047	http://dx.doi.org/10.1371/journal.pone.0176047			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426746	Green Published, gold, Green Submitted			2022-12-26	WOS:000399875900092
J	Sun, L; Moritake, T; Ito, K; Matsumoto, Y; Yasui, H; Nakagawa, H; Hirayame, A; Inanami, O; Tsuboi, K				Sun, Lue; Moritake, Takashi; Ito, Kazuya; Matsumoto, Yoshitaka; Yasui, Hironobu; Nakagawa, Hidehiko; Hirayame, Aki; Inanami, Osamu; Tsuboi, Koji			Metabolic analysis of radioresistant medulloblastoma stem-like clones and potential therapeutic targets	PLOS ONE			English	Article							OXYGEN SPECIES PRODUCTION; NF-KAPPA-B; CANCER-CELLS; IONIZING-RADIATION; IN-VITRO; MITOCHONDRIAL FISSION; DICHLOROACETATE DCA; AEROBIC GLYCOLYSIS; HYDROGEN-PEROXIDE; DNA-REPAIR	Medulloblastoma is a fatal brain tumor in children, primarily due to the presence of treatment-resistant medulloblastoma stem cells. The energy metabolic pathway is a potential target of cancer therapy because it is often different between cancer cells and normal cells. However, the metabolic properties of medulloblastoma stem cells, and whether specific metabolic pathways are essential for sustaining their stem cell-like phenotype and radioresistance, remain unclear. We have established radioresistant medulloblastoma stem-like clones (rMSLCs) by irradiation of the human medulloblastoma cell line ONS-76. Here, we assessed reactive oxygen species (ROS) production, mitochondria function, oxygen consumption rate (OCR), energy state, and metabolites of glycolysis and tricarboxylic acid cycle in rMSLCs and parental cells. rMSLCs showed higher lactate production and lower oxygen consumption rate than parental cells. Additionally, rMSLCs had low mitochondria mass, low endogenous ROS production, and existed in a low-energy state. Treatment with the metabolic modifier dichloroacetate (DCA) resulted in mitochondria dysfunction, glycolysis inhibition, elongated mitochondria morphology, and increased ROS production. DCA also increased radiosensitivity by suppression of the DNA repair capacity through nuclear oxidization and accelerated the generation of acetyl CoA to compensate for the lack of ATP. Moreover, treatment with DCA decreased cancer stem cell-like characters (e.g., CD133 positivity and sphere-forming ability) in rMSLCs. Together, our findings provide insights into the specific metabolism of rMSLCs and illuminate potential metabolic targets that might be exploited for therapeutic benefit in medulloblastoma.	[Sun, Lue; Moritake, Takashi] Univ Occupat & Environm Hlth, Inst Ind Ecol Sci, Dept Radiol Hlth Sci, Kitakyushu, Fukuoka, Japan; [Ito, Kazuya] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Radiobiol, Tsukuba, Ibaraki, Japan; [Matsumoto, Yoshitaka; Tsuboi, Koji] Univ Tsukuba, Fac Med, Proton Med Res Ctr, Tsukuba, Ibaraki, Japan; [Yasui, Hironobu] Hokkaido Univ, Cent Inst Isotope Sci, Sapporo, Hokkaido, Japan; [Nakagawa, Hidehiko] Nagoya City Univ, Grad Sch Pharmaceut Sci, Lab Organ & Med Chem, Nagoya, Aichi, Japan; [Hirayame, Aki] Tsukuba Univ Technol, Ctr Integrat Med, Tsukuba, Ibaraki, Japan; [Inanami, Osamu] Hokkaido Univ, Grad Sch Vet Med, Dept Appl Vet Sci, Radiat Biol Lab, Sapporo, Hokkaido, Japan	University of Occupational & Environmental Health - Japan; University of Tsukuba; University of Tsukuba; Hokkaido University; Nagoya City University; Tsukuba University of Technology; Hokkaido University	Moritake, T (corresponding author), Univ Occupat & Environm Hlth, Inst Ind Ecol Sci, Dept Radiol Hlth Sci, Kitakyushu, Fukuoka, Japan.	moritake@med.uoeh-u.ac.jp	Hirayama, Aki/G-7842-2017; Yasui, Hironobu/E-3794-2010; Sun, Lue/H-2479-2019; Inanami, Osamu/A-5197-2012	Hirayama, Aki/0000-0001-5777-4208; Yasui, Hironobu/0000-0002-6757-1110; Sun, Lue/0000-0001-8485-6380; Inanami, Osamu/0000-0001-7895-3918	University of Tsukuba; Japan Society for the Promotion of Science (JSPS) [JP25670616]; JSPS [JP15H06804]; Grants-in-Aid for Scientific Research [17K16668] Funding Source: KAKEN	University of Tsukuba; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by University of Tsukuba Basic Research Support Program Type A (to L.S. and K.T.), http://kiyo.sec.tsukuba.ac.jp/docs/rpg/gaiyo.html; Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Challenging Exploratory Research Number JP25670616 (to T.M.), https://kaken.nil.ac.jp/en/grant/KAKENHI-PROJECT-25670616; and JSPS Grant-in-Aid for Research Activity start-up Number JP15H06804 (to L.S.), https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-15H06804/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, NEUROLOGIA MED CHI S, V49, pS1; Armstrong L, 2010, STEM CELLS, V28, P661, DOI 10.1002/stem.307; ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bhat KPL, 2013, CANCER CELL, V24, P331, DOI 10.1016/j.ccr.2013.08.001; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Brookes PS, 2005, FREE RADICAL BIO MED, V38, P12, DOI 10.1016/j.freeradbiomed.2004.10.016; Buggisch M, 2007, J CELL SCI, V120, P885, DOI 10.1242/jcs.03386; Cao WG, 2008, PROSTATE, V68, P1223, DOI 10.1002/pros.20788; Cheng DH, 2004, J BIOL CHEM, V279, P23892, DOI 10.1074/jbc.M401853200; Chiba T, 2006, HEPATOLOGY, V44, P240, DOI 10.1002/hep.21227; de Antonellis P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024584; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Duan Y, 2013, ONCOTARGETS THER, V6, P189, DOI 10.2147/OTT.S40992; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Fan X, 2008, J CLIN ONCOL, V26, P2821, DOI 10.1200/JCO.2007.15.2264; Feng WG, 2014, STEM CELLS, V32, P1734, DOI 10.1002/stem.1662; Folmes CDL, 2012, CELL STEM CELL, V11, P596, DOI 10.1016/j.stem.2012.10.002; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Fujii H, 2008, RADIOTHER ONCOL, V86, P354, DOI 10.1016/j.radonc.2007.11.020; Gerelchuluun A, 2011, INT J RADIAT BIOL, V87, P57, DOI 10.3109/09553002.2010.518201; GIRBAL L, 1994, J BACTERIOL, V176, P6433, DOI 10.1128/JB.176.21.6433-6438.1994; Grivennikova VG, 2010, BBA-BIOENERGETICS, V1797, P939, DOI 10.1016/j.bbabio.2010.02.013; Guppy M, 2002, BIOCHEM J, V364, P309, DOI 10.1042/bj3640309; Haraguchi N, 2010, J CLIN INVEST, V120, P3326, DOI 10.1172/JCI42550; Harris PS, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-80; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Ho E, 2002, P NATL ACAD SCI USA, V99, P16770, DOI 10.1073/pnas.222679399; Hong ZG, 2013, CIRC RES, V112, P802, DOI 10.1161/CIRCRESAHA.111.300285; Horner MJ, 2009, SEER CANC STAT REV 1; Hosoki A, 2012, J RADIAT RES, V53, P58, DOI 10.1269/jrr.11034; HU JJ, 1995, MUTAT RES-DNA REPAIR, V336, P193, DOI 10.1016/0921-8777(94)00054-A; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Ikeda M, 2012, BIOORG MED CHEM LETT, V22, P1949, DOI 10.1016/j.bmcl.2012.01.042; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Jastroch M, 2010, ESSAYS BIOCHEM, V47, P53, DOI [10.1042/BSE0470053, 10.1042/bse0470053]; Kobashigawa S, 2011, BIOCHEM BIOPH RES CO, V414, P795, DOI 10.1016/j.bbrc.2011.10.006; Lagadinou ED, 2013, CELL STEM CELL, V12, P329, DOI 10.1016/j.stem.2012.12.013; Lin G, 2014, BRIT J CANCER, V111, P375, DOI 10.1038/bjc.2014.281; Lu CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121046; Makinoshima H, 2014, J BIOL CHEM, V289, P20813, DOI 10.1074/jbc.M114.575464; Mao P, 2013, P NATL ACAD SCI USA, V110, P8644, DOI 10.1073/pnas.1221478110; Masson N, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-3; Matsuda T, 2012, JPN J CLIN ONCOL, V42, P139, DOI 10.1093/jjco/hyr184; Matsuhashi T, 2015, J MOL CELL CARDIOL, V82, P116, DOI 10.1016/j.yjmcc.2015.02.021; MEISTER A, 1988, J BIOL CHEM, V263, P17205; Michelakis ED, 2008, BRIT J CANCER, V99, P989, DOI 10.1038/sj.bjc.6604554; Morfouace M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.561; Munshi A, 2006, MOL CANCER THER, V5, P1967, DOI 10.1158/1535-7163.MCT-06-0022; Naka K, 2008, ANTIOXID REDOX SIGN, V10, P1883, DOI 10.1089/ars.2008.2114; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Packer RJ, 2005, J NEURO-ONCOL, V75, P239, DOI 10.1007/s11060-005-6745-9; Palorini R, 2014, J CELL BIOCHEM, V115, P368, DOI 10.1002/jcb.24671; Phang JM, 2008, AMINO ACIDS, V35, P681, DOI 10.1007/s00726-008-0063-4; Prigione A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027352; Rutkowski S, 2010, J CLIN ONCOL, V28, P4961, DOI 10.1200/JCO.2010.30.2299; Sanchez WY, 2013, BRIT J CANCER, V108, P1624, DOI 10.1038/bjc.2013.120; Sandulache VC, 2012, MOL CANCER THER, V11, P1373, DOI 10.1158/1535-7163.MCT-12-0041; SEGAL RA, 1994, P NATL ACAD SCI USA, V91, P12867, DOI 10.1073/pnas.91.26.12867; Sharp WW, 2014, FASEB J, V28, P316, DOI 10.1096/fj.12-226225; Shyh-Chang N, 2015, CELL METAB, V21, P349, DOI 10.1016/j.cmet.2015.02.011; Singh SK, 2003, CANCER RES, V63, P5821; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Sun L, 2013, J RADIAT RES, V54, P61, DOI 10.1093/jrr/rrs078; Takubo K, 2013, CELL STEM CELL, V12, P49, DOI 10.1016/j.stem.2012.10.011; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Tamura K, 2010, J NEUROSURG, V113, P310, DOI 10.3171/2010.2.JNS091607; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Tsatmali M, 2005, BRAIN RES, V1040, P137, DOI 10.1016/j.brainres.2005.01.087; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Viale A, 2014, NATURE, V514, P628, DOI 10.1038/nature13611; Vlashi E, 2011, P NATL ACAD SCI USA, V108, P16062, DOI 10.1073/pnas.1106704108; Wu X, 2012, NATURE, V482, P529, DOI 10.1038/nature10825; Yae T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1892; Yamamori T, 2012, FREE RADICAL BIO MED, V53, P260, DOI 10.1016/j.freeradbiomed.2012.04.033; Zu XL, 2004, BIOCHEM BIOPH RES CO, V313, P459, DOI 10.1016/j.bbrc.2003.11.136	79	14	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176162	10.1371/journal.pone.0176162	http://dx.doi.org/10.1371/journal.pone.0176162			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426747	Green Published, Green Submitted, gold			2022-12-26	WOS:000399875900113
J	Yang, X; Beres, ZT; Jin, L; Parrish, JT; Zhao, WY; Mackey, D; Snow, AA				Yang, Xiao; Beres, Zachery T.; Jin, Lin; Parrish, Jason T.; Zhao, Wanying; Mackey, David; Snow, Allison A.			Effects of over-expressing a native gene encoding 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) on glyphosate resistance in Arabidopsis thaliana	PLOS ONE			English	Article							HERBICIDE RESISTANCE; AMARANTHUS-PALMERI; SHIKIMATE PATHWAY; FITNESS COST; AMPLIFICATION; PLANTS; MECHANISM; EVOLUTION; CELLS; PCR	Widespread overuse of the herbicide glyphosate, the active ingredient in RoundUp((R)), has led to the evolution of glyphosate-resistant weed biotypes, some of which persist by overproducing the herbicide's target enzyme, 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS). EPSPS is a key enzyme in the shikimic acid pathway for biosynthesis of aromatic amino acids, lignin, and defensive compounds, but little is known about how overproducing EPSPS affects downstream metabolites, growth, or lifetime fitness in the absence of glyphosate. We are using Arabidopsis as a model system for investigating phenotypic effects of overproducing EPSPS, thereby avoiding confounding effects of genetic background or other mechanisms of herbicide resistance in agricultural weeds. Here, we report results from the first stage of this project. We designed a binary vector expressing a native EPSPS gene from Arabidopsis under control of the CaMV35S promoter (labelled OX, for overexpression). For both OX and the empty vector (labelled EV), we obtained nine independent T3 lines. Subsets of these lines were used to characterize glyphosate resistance in greenhouse experiments. Seven of the nine OX lines exhibited enhanced glyphosate resistance when compared to EV and wild-type control lines, and one of these was discarded due to severe deformities. The remaining six OX lines exhibited enhanced EPSPS gene expression and glyphosate resistance compared to controls. Glyphosate resistance was correlated with the degree of EPSPS over-expression for both vegetative and flowering plants, indicating that glyphosate resistance can be used as a surrogate for EPSPS expression levels in this system. These findings set the stage for examination of the effects of EPSPS overexpression on fitness-related traits in the absence of glyphosate. We invite other investigators to contact us if they wish to study gene expression, downstream metabolic effects, and other questions with these particular lines.	[Yang, Xiao; Beres, Zachery T.; Snow, Allison A.] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA; [Jin, Lin; Parrish, Jason T.; Zhao, Wanying; Mackey, David] Ohio State Univ, Dept Hort & Crop Sci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Yang, X (corresponding author), Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA.	yangxiao@fudan.edu.cn		Yang, Xiao/0000-0002-2351-4827; Beres, Zachery/0000-0001-6513-6142	Weedy and Invasive Plants Grant Program [2016-67013-24804]; USDA National Institute of Food and Agriculture; International Postdoctoral Exchange Fellowship Program, Office of China	Weedy and Invasive Plants Grant Program; USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); International Postdoctoral Exchange Fellowship Program, Office of China	This project was supported by the Weedy and Invasive Plants Grant Program, Grant No. 2016-67013-24804, from the USDA National Institute of Food and Agriculture (recipient: Ohio State University, AA Snow and DL Mackey). X Yang was partly funded by the International Postdoctoral Exchange Fellowship Program, Office of China	Baerson SR, 2002, WEED SCI, V50, P721, DOI 10.1614/0043-1745(2002)050[0721:ITMOGR]2.0.CO;2; Bergelson J, 1996, P ROY SOC B-BIOL SCI, V263, P1659, DOI 10.1098/rspb.1996.0242; Brotherton JE, 2007, J PLANT PHYSIOL, V164, P1337, DOI 10.1016/j.jplph.2006.08.008; Chen JC, 2015, PLANTA, V242, P859, DOI 10.1007/s00425-015-2324-2; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dinelli G, 2006, PESTIC BIOCHEM PHYS, V86, P30, DOI 10.1016/j.pestbp.2006.01.004; Franz J. E., 1997, GLYPHOSATE UNIQUE GL; Funke T, 2006, P NATL ACAD SCI USA, V103, P13010, DOI 10.1073/pnas.0603638103; Gaines TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065819; Gaines TA, 2011, J AGR FOOD CHEM, V59, P5886, DOI 10.1021/jf104719k; Gaines TA, 2010, P NATL ACAD SCI USA, V107, P1029, DOI 10.1073/pnas.0906649107; Giacomini D, 2014, WEED SCI, V62, P29, DOI 10.1614/WS-D-13-00066.1; Heap I., 2017, INT SURVEY HERBICIDE; Heck GR, 2005, CROP SCI, V45, P329, DOI 10.2135/cropsci2005.0329; Herrmann KM, 1999, ANNU REV PLANT PHYS, V50, P473, DOI 10.1146/annurev.arplant.50.1.473; Jones JD, 1996, PLANT CELL REP, V15, P431, DOI 10.1007/BF00232070; Jugulam M, 2014, PLANT PHYSIOL, V166, P1200, DOI 10.1104/pp.114.242826; KLEE HJ, 1987, MOL GEN GENET, V210, P437, DOI 10.1007/BF00327194; Knezevic SZ, 2007, WEED TECHNOL, V21, P840, DOI 10.1614/WT-06-161.1; Lee RM, 2006, THESIS; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu BR, 2014, NEW PHYTOL, V202, P363, DOI 10.1111/nph.12684; Lu BR, 2014, NEW PHYTOL, V202, P370, DOI 10.1111/nph.12748; Maeda H, 2012, ANNU REV PLANT BIOL, V63, P73, DOI 10.1146/annurev-arplant-042811-105439; Malone JM, 2016, PEST MANAG SCI, V72, P81, DOI 10.1002/ps.4019; Mohseni-Moghadam M, 2013, WEED SCI, V61, P517, DOI 10.1614/WS-D-13-00028.1; Muller A, 1998, PLANTA, V206, P362, DOI 10.1007/s004250050411; Neve P, 2008, PEST MANAG SCI, V64, P392, DOI 10.1002/ps.1495; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Powles SB, 2010, P NATL ACAD SCI USA, V107, P955, DOI 10.1073/pnas.0913433107; Ritz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146021; Roux F, 2005, EVOLUTION, V59, P2264, DOI 10.1111/j.0014-3820.2005.tb00934.x; Sammons RD, 2014, PEST MANAG SCI, V70, P1367, DOI 10.1002/ps.3743; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SHAH DM, 1986, SCIENCE, V233, P478, DOI 10.1126/science.233.4762.478; SUH H, 1993, PLANT MOL BIOL, V22, P195, DOI 10.1007/BF00014928; Tani E, 2015, PLANT MOL BIOL REP; Vila-Aiub MM, 2009, NEW PHYTOL, V184, P751, DOI 10.1111/j.1469-8137.2009.03055.x; Vila-Aiub MM, 2014, PLANTA; Wang W, 2014, NEW PHYTOL, V202, P679, DOI 10.1111/nph.12428; Wiersma AT, 2015, PLANTA, V241, P463, DOI 10.1007/s00425-014-2197-9; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Yanniccari M, 2016, WEED SCI, V64, P71, DOI 10.1614/WS-D-15-00065.1	43	10	13	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175820	10.1371/journal.pone.0175820	http://dx.doi.org/10.1371/journal.pone.0175820			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426703	Green Submitted, gold, Green Published			2022-12-26	WOS:000399875900052
J	Overmiller, AM; Pierluissi, JA; Wermuth, PJ; Sauma, S; Martinez-Outschoorn, U; Tuluc, M; Luginbuhl, A; Curry, J; Harshyne, LA; Wahl, JK; South, AP; Mahoney, MG				Overmiller, Andrew M.; Pierluissi, Jennifer A.; Wermuth, Peter J.; Sauma, Sami; Martinez-Outschoorn, Ubaldo; Tuluc, Madalina; Luginbuhl, Adam; Curry, Joseph; Harshyne, Larry A.; Wahl, James K., III; South, Andrew P.; Mahoney, My G.			Desmoglein 2 modulates extracellular vesicle release from squamous cell carcinoma keratinocytes	FASEB JOURNAL			English	Article						EGFR; exosome; fibroblast; HNSCC	TUMOR MICROENVIRONMENT; EXOSOMES; HEAD; CAVEOLIN-1; EXPRESSION; EGFR; DSG2; PROLIFERATION; ENVIRONMENT; ENDOCYTOSIS	Extracellular vesicles (EVs) are nanoscale membrane-derived vesicles that serve as intercellular messengers carrying lipids, proteins, and genetic material. Substantial evidence has shown that cancer-derived EVs, secreted by tumor cells into the blood and other bodily fluids, play a critical role in modulating the tumor micro-environment and affecting the pathogenesis of cancer. Here we demonstrate for the first time that squamous cell carcinoma (SCC) EVs were enriched with the C-terminal fragment of desmoglein 2 (Dsg2), a desmosomal cadherin often overexpressed in malignancies. Overexpression of Dsg2 increased EV release and mitogenic content including epidermal growth factor receptor and c-Src. Inhibiting ectodomain shedding of Dsg2 with the matrix metalloproteinase inhibitor GM6001 resulted in accumulation of full-length Dsg2 in EVs and reduced EV release. When cocultured with Dsg2/green fluorescence protein-expressing SCC cells, green fluorescence protein signal was detected by fluorescence-activated cell sorting analysis in the CD90(+) fibroblasts. Furthermore, SCC EVs activated Erk1/2 and Akt signaling and enhanced fibroblast cell proliferation. In vivo, Dsg2 was highly up-regulated in the head and neck SCCs, and EVs isolated from sera of patients with SCC were enriched in Dsg2 C-terminal fragment and epidermal growth factor receptor. This study defines a mechanism by which Dsg2 expression in cancer cells can modulate the tumor microenvironment, a step critical for tumor progression.	[Overmiller, Andrew M.; Pierluissi, Jennifer A.; Wermuth, Peter J.; South, Andrew P.; Mahoney, My G.] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, 233 S 10th St,Suite 428 BLSB, Philadelphia, PA 19107 USA; [Sauma, Sami; Harshyne, Larry A.] Thomas Jefferson Univ, Dept Neurol Surg, Philadelphia, PA 19107 USA; [Martinez-Outschoorn, Ubaldo] Thomas Jefferson Univ, Dept Med Oncol, Philadelphia, PA 19107 USA; [Tuluc, Madalina; Luginbuhl, Adam; Curry, Joseph] Thomas Jefferson Univ, Dept Otolaryngol Head & Neck Surg, Philadelphia, PA 19107 USA; [Wahl, James K., III] Univ Nebraska, Dept Oral Biol, Lincoln, NE USA	Jefferson University; Jefferson University; Jefferson University; Jefferson University; University of Nebraska System; University of Nebraska Lincoln	Mahoney, MG (corresponding author), Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, 233 S 10th St,Suite 428 BLSB, Philadelphia, PA 19107 USA.	my.mahoney@jefferson.edu		Wermuth, Peter/0000-0002-0242-7265; Sauma, Sami/0000-0001-7278-341X; Curry, Joseph/0000-0001-9507-4237; Harshyne, Larry/0000-0002-8699-3028; Martinez-Outschoorn, Ubaldo/0000-0003-1483-4551	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR056067]; Thomas Jefferson University Dean's Transformational Science Award; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106397] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Thomas Jefferson University Dean's Transformational Science Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in part, by the U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (Grant AR056067 to M.G.M.), and the Thomas Jefferson University Dean's Transformational Science Award (to M.G.M.). Confocal microscopy was performed in the Bioimaging Core (SKCC; NCI 5 P30 CA-56036). Special thanks to M. Y. Covarrubias (Bioimaging Shared Resource of the Sidney Kimmel Cancer Center, Thomas Jefferson University) for technical assistance and advice. The authors declare no conflicts of interest.	Barber AG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098786; Beckler MD, 2013, MOL CELL PROTEOMICS, V12, P343, DOI 10.1074/mcp.M112.022806; Biedermann K, 2005, J PATHOL, V207, P199, DOI 10.1002/path.1821; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brennan D, 2012, ONCOGENE, V31, P1636, DOI 10.1038/onc.2011.346; Brennan D, 2007, J CELL SCI, V120, P758, DOI 10.1242/jcs.03392; Brennan D, 2009, CELL ADHES MIGR, V3, P148, DOI 10.4161/cam.3.2.7539; Brennan-Crispi DM, 2015, ONCOTARGET, V6, P8593, DOI 10.18632/oncotarget.3309; Brooke MA, 2014, HUM MOL GENET, V23, P4064, DOI 10.1093/hmg/ddu120; Cassell A, 2010, EXPERT OPIN INV DRUG, V19, P709, DOI 10.1517/13543781003769844; Chen WX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095240; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Curry JM, 2014, SEMIN ONCOL, V41, P217, DOI 10.1053/j.seminoncol.2014.03.003; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; Eshkind L, 2002, EUR J CELL BIOL, V81, P592, DOI 10.1078/0171-9335-00278; Goruppi S, 2013, TRENDS CELL BIOL, V23, P593, DOI 10.1016/j.tcb.2013.08.006; Greening DW, 2015, METHODS MOL BIOL, V1295, P179, DOI 10.1007/978-1-4939-2550-6_15; Harshyne LA, 2016, NEURO-ONCOLOGY, V18, P206, DOI 10.1093/neuonc/nov107; Hayer A, 2010, J CELL BIOL, V191, P615, DOI 10.1083/jcb.201003086; Hood JL, 2011, CANCER RES, V71, P3792, DOI 10.1158/0008-5472.CAN-10-4455; Huang YC, 2014, INT J BIOL SCI, V10, P702, DOI 10.7150/ijbs.9326; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Keim SA, 2008, HYBRIDOMA, V27, P249, DOI 10.1089/hyb.2008.0020; Kharaziha P, 2015, ONCOTARGET, V6, P21740, DOI 10.18632/oncotarget.3226; Klessner JL, 2009, MOL BIOL CELL, V20, P328, DOI 10.1091/mbc.E08-04-0356; Kolegraff K, 2011, CELL ADHES MIGR, V5, P306, DOI 10.4161/cam.5.4.16911; Kurzen H, 2003, J CUTAN PATHOL, V30, P621, DOI 10.1034/j.1600-0560.2003.00122.x; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Liang B, 2013, J PROTEOMICS, V80, P171, DOI 10.1016/j.jprot.2012.12.029; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Meckes DG, 2010, P NATL ACAD SCI USA, V107, P20370, DOI 10.1073/pnas.1014194107; Nanbo A, 2013, J VIROL, V87, P10334, DOI 10.1128/JVI.01310-13; Nava P, 2007, MOL BIOL CELL, V18, P4565, DOI 10.1091/mbc.E07-05-0426; Ni SS, 2013, TUMOR BIOL, V34, P1813, DOI 10.1007/s13277-013-0721-3; Oh ST, 2016, DERM-ENDOCRINOL, V8, DOI 10.1080/19381980.2016.1228499; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Overmiller AM, 2016, ONCOTARGET, V7, P37536, DOI 10.18632/oncotarget.7675; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Peterson MF, 2015, METHODS, V87, P31, DOI 10.1016/j.ymeth.2015.04.015; Phuyal S, 2014, FEBS J, V281, P2214, DOI 10.1111/febs.12775; Pilichou K, 2006, CIRCULATION, V113, P1171, DOI 10.1161/CIRCULATIONAHA.105.583674; Rothenberg SM, 2012, J CLIN INVEST, V122, P1951, DOI 10.1172/JCI59889; Sanderson MP, 2008, J CELL BIOCHEM, V103, P1783, DOI 10.1002/jcb.21569; SCHAFER S, 1994, EXP CELL RES, V211, P391, DOI 10.1006/excr.1994.1103; Schmitz S, 2016, CURR TREAT OPTION ON, V17, DOI 10.1007/s11864-016-0412-6; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Svensson KJ, 2013, J BIOL CHEM, V288, P17713, DOI 10.1074/jbc.M112.445403; Tan LY, 2016, ONCOTARGET, V7, P46492, DOI 10.18632/oncotarget.10216; Tan SS, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.22614; Teh MT, 2011, J ORAL PATHOL MED, V40, P67, DOI 10.1111/j.1600-0714.2010.00951.x; Vered M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1030-6; Wang HJ, 2015, J VIROL, V89, P10841, DOI 10.1128/JVI.01425-15; Watt SA, 2011, ONCOGENE, V30, P4666, DOI 10.1038/onc.2011.180; Ng YZ, 2012, CANCER RES, V72, P3522, DOI 10.1158/0008-5472.CAN-11-2996	54	45	45	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3412	3424		10.1096/fj.201601138RR	http://dx.doi.org/10.1096/fj.201601138RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28438789	Green Published			2022-12-26	WOS:000405932400020
J	Li, DM; Bentley, C; Yates, J; Salimi, M; Greig, J; Wiblin, S; Hassanali, T; Benham, AH				Li, Demin; Bentley, Carol; Yates, Jenna; Salimi, Maryam; Greig, Jenny; Wiblin, Sarah; Hassanali, Tasneem; Benham, Alison H.			Engineering chimeric human and mouse major histocompatibility complex (MHC) class I tetramers for the production of T-cell receptor (TCR) mimic antibodies	PLOS ONE			English	Article							FUSION PROTEIN; WILD-TYPE; TUMOR-ERADICATION; TRANSGENIC MICE; PEPTIDE EPITOPE; LYMPHOCYTES; P53; SPECIFICITY; ANTIGEN; THERAPY	Therapeutic monoclonal antibodies targeting cell surface or secreted antigens are among the most effective classes of novel immunotherapies. However, the majority of human proteins and established cancer biomarkers are intracellular. Peptides derived from these intracellular proteins are presented on the cell surface by major histocompatibility complex class I (MHC-I) and can be targeted by a novel class of T-cell receptor mimic (TCRm) antibodies that recognise similar epitopes to T-cell receptors. Humoural immune responses to MHC-I tetramers rarely generate TCRm antibodies and many antibodies recognise the alpha 3 domain of MHC-I and beta 2 microglobulin (beta 2m) that are not directly involved in presenting the target peptide. Here we describe the production of functional chimeric human-murine HLA-A2-H2D(d) tetramers and modifications that increase their bacterial expression and refolding efficiency. These chimeric tetramers were successfully used to generate TCRm antibodies against two epitopes derived from wild type tumour suppressor p53 (RMPEAAPPV and GLAPPQHLIRV) that have been used in vaccination studies. Immunisation with chimeric tetramers yielded no antibodies recognising the human a3 domain and beta 2m and generated TCRm antibodies capable of specifically recognising the target peptide/MHC-I complex in fully human tetramers and on the cell surface of peptide pulsed T2 cells. Chimeric tetramers represent novel immunogens for TCRm antibody production and may also improve the yield of tetramers for groups using these reagents to monitor CD8 T-cell immune responses in HLA-A2 transgenic mouse models of immunotherapy.	[Li, Demin; Bentley, Carol; Yates, Jenna; Salimi, Maryam; Greig, Jenny; Wiblin, Sarah; Hassanali, Tasneem; Benham, Alison H.] Univ Oxford, Radcliffe Dept Med, Nuffield Div Clin Lab Sci, John Radcliffe Hosp, Level 4,Acad Block, Oxford, England	University of Oxford	Li, DM; Benham, AH (corresponding author), Univ Oxford, Radcliffe Dept Med, Nuffield Div Clin Lab Sci, John Radcliffe Hosp, Level 4,Acad Block, Oxford, England.	demin.li@ndcls.ox.ac.uk; alison.banham@ndcls.ox.ac.uk	Li, Demin/O-4065-2019	Li, Demin/0000-0002-7118-3401; Hassanali, Tasneem/0000-0002-8680-6456	Cancer Research UK (CR-UK) programme [A10702]; Cancer Research UK [10702] Funding Source: researchfish	Cancer Research UK (CR-UK) programme(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This research was funded by Cancer Research UK (CR-UK) programme grant A10702 to AHB. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Arber C, 2015, J CLIN INVEST, V125, P157, DOI 10.1172/JCI75876; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; Chames P, 2009, BRIT J PHARMACOL, V157, P220, DOI 10.1111/j.1476-5381.2009.00190.x; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Choi EM, 2002, J IMMUNOL METHODS, V268, P35, DOI 10.1016/S0022-1759(02)00198-9; Cohen M, 2013, ANTIBODIES, V2, P517, DOI 10.3390/antib2030517; Denkberg G, 2006, AUTOIMMUN REV, V5, P252, DOI 10.1016/j.autrev.2005.07.004; Feldman SA, 2015, SEMIN ONCOL, V42, P626, DOI 10.1053/j.seminoncol.2015.05.005; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; GNJATIC S, 1995, EUR J IMMUNOL, V25, P1638, DOI 10.1002/eji.1830250625; Khoo KH, 2014, NAT REV DRUG DISCOV, V13, DOI 10.1038/nrd4288; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kuckelkorn U, 2002, EUR J IMMUNOL, V32, P1368, DOI 10.1002/1521-4141(200205)32:5<1368::AID-IMMU1368>3.0.CO;2-Z; Li D, 2017, CANC RES; Liddy N, 2012, NAT MED, V18, P980, DOI 10.1038/nm.2764; Morello A, 2015, CANC DISCOVERY; Mosquera LA, 2005, J IMMUNOL, V174, P4381, DOI 10.4049/jimmunol.174.7.4381; Pascolo S, 1997, J EXP MED, V185, P2043, DOI 10.1084/jem.185.12.2043; Polakova K, 2000, J IMMUNOL, V165, P5703, DOI 10.4049/jimmunol.165.10.5703; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Reiter Y, 1997, P NATL ACAD SCI USA, V94, P4631, DOI 10.1073/pnas.94.9.4631; Ren D, 2006, PROTEIN EXPRES PURIF, V50, P171, DOI 10.1016/j.pep.2006.08.001; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Smethurst D, 2013, BRIT J CLIN PHARMACO, V76, P173, DOI 10.1111/j.1365-2125.2012.04475.x; Svane IM, 2007, CANCER IMMUNOL IMMUN, V56, P1485, DOI 10.1007/s00262-007-0293-4; Theobald M, 1998, J EXP MED, V188, P1017, DOI 10.1084/jem.188.6.1017; Vierboom MPM, 2000, CANCER RES, V60, P5508; Vierboom MPM, 1997, J EXP MED, V186, P695, DOI 10.1084/jem.186.5.695; VITIELLO A, 1991, J EXP MED, V173, P1007, DOI 10.1084/jem.173.4.1007; Weidanz JA, 2011, INT REV IMMUNOL, V30, P328, DOI 10.3109/08830185.2011.604880; Weidle UH, 2014, CANCER GENOM PROTEOM, V11, P267; Wittman VP, 2006, J IMMUNOL, V177, P4187, DOI 10.4049/jimmunol.177.6.4187	33	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176642	10.1371/journal.pone.0176642	http://dx.doi.org/10.1371/journal.pone.0176642			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448627	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383600117
J	Li, M; Cai, RJ; Song, S; Jiang, ZY; Li, Y; Gou, HC; Chu, PP; Li, CL; Qiu, HJ				Li, Miao; Cai, Ru-Jian; Song, Shuai; Jiang, Zhi-Yong; Li, Yan; Gou, Hong-Chao; Chu, Pin-Pin; Li, Chun-Ling; Qiu, Hua-Ji			Evaluation of immunogenicity and protective efficacy of recombinant outer membrane proteins of Haemophilus parasuis serovar 5 in a murine model	PLOS ONE			English	Article							PROVIDES PROTECTION; VACCINE CANDIDATES; IDENTIFICATION; VIRULENCE; PIGS; TRANSFERRIN; SUBUNIT; STRAIN; OMP31	Glasser's disease is an economically important infectious disease of pigs caused by Haemophilus parasuis. Few vaccines are currently available that could provide effective cross-protection against various serovars of H. parasuis. In this study, five OMPs (OppA, TolC, HxuC, LppC, and HAPS_0926) identified by bioinformatic approaches, were cloned and expressed as recombinant proteins. Antigenicity of the purified proteins was verified through Western blotting, and primary screening for protective potential was evaluated in vivo. Recombinant TolC (rTolC), rLppC, and rHAPS_0926 proteins showing marked protection of mice against H. parasuis infection, and were further evaluated individually or in combination. Mice treated with these three OMPs produced humoral and host cell-mediated responses, with a significant rise in antigen-specific IgG titer and lymphoproliferative response in contrast with the mock-immunized group. Significant increases were noted in CD4(+), CD8(+) T cells, and three cytokines (IL-2, IL-4, and IFN-(Y)) in vaccinated animals. The antisera against candidate antigens could efficiently impede bacterial survival in whole blood bactericidal assay against H. parasuis infection. The multi-protein vaccine induced more pronounced immune responses and offered better protection than individual vaccines. Our findings indicate that these three OMPs are promising antigens for the development of multi-component subunit vaccines against Glasser's disease.	[Li, Miao; Cai, Ru-Jian; Song, Shuai; Jiang, Zhi-Yong; Li, Yan; Gou, Hong-Chao; Chu, Pin-Pin; Li, Chun-Ling] Guangdong Acad Agr Sci, Inst Anim Hlth, Guangzhou, Guangdong, Peoples R China; [Li, Miao; Cai, Ru-Jian; Song, Shuai; Jiang, Zhi-Yong; Li, Yan; Gou, Hong-Chao; Chu, Pin-Pin; Li, Chun-Ling] Guangdong Open Lab Vet Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Li, Miao; Cai, Ru-Jian; Song, Shuai; Jiang, Zhi-Yong; Li, Yan; Gou, Hong-Chao; Chu, Pin-Pin; Li, Chun-Ling] Guangdong Prov Key Lab Livestock Dis Prevent, Guangzhou, Guangdong, Peoples R China; [Qiu, Hua-Ji] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Peoples R China	Guangdong Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Li, CL (corresponding author), Guangdong Acad Agr Sci, Inst Anim Hlth, Guangzhou, Guangdong, Peoples R China.; Li, CL (corresponding author), Guangdong Open Lab Vet Publ Hlth, Guangzhou, Guangdong, Peoples R China.; Li, CL (corresponding author), Guangdong Prov Key Lab Livestock Dis Prevent, Guangzhou, Guangdong, Peoples R China.; Qiu, HJ (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Peoples R China.	lclclare@163.com; huajiqiu@hvri.ac.cn	Qiu, Hua-Ji/AGL-2296-2022		National Key Research and Development Program of China [2016YFD0500709]; Key Project of Guangdong Province [20156020203004]; Applied Science Technology Research and Development Project of Guangdong Province [20156020230004]; International Cooperation Project of Guangdong Province [20156050501007]; Science Technology Plan Project of Guangdong Province [20156070701015]	National Key Research and Development Program of China; Key Project of Guangdong Province; Applied Science Technology Research and Development Project of Guangdong Province; International Cooperation Project of Guangdong Province; Science Technology Plan Project of Guangdong Province	This work was supported by the National Key Research and Development Program of China (2016YFD0500709), Key Project of Guangdong Province (20156020203004), the Applied Science Technology Research and Development Project of Guangdong Province (20156020230004), International Cooperation Project of Guangdong Province (20156050501007), and Science Technology Plan Project of Guangdong Province (20156070701015).	Aragon V, 2012, DIS SWINE, P760; Brockmeier SL, 2013, CLIN VACCINE IMMUNOL, V20, P1466, DOI 10.1128/CVI.00168-13; Cai XW, 2005, VET MICROBIOL, V111, P231, DOI 10.1016/j.vetmic.2005.07.007; Chen SL, 2015, ACTA TROP, V148, P8, DOI 10.1016/j.actatropica.2015.04.009; Costa-Hurtado M, 2013, VET J, V198, P571, DOI 10.1016/j.tvjl.2013.08.027; Doyle CR, 2014, INFECT IMMUN, V82, P2068, DOI 10.1128/IAI.00044-14; Frandoloso R, 2011, CLIN VACCINE IMMUNOL, V18, P50, DOI 10.1128/CVI.00314-10; Fu SL, 2013, VACCINE, V31, P347, DOI 10.1016/j.vaccine.2012.11.003; Ghasemi A, 2015, VACCINE, V33, P5532, DOI 10.1016/j.vaccine.2015.09.013; Golshani M, 2015, MOL IMMUNOL, V65, P287, DOI 10.1016/j.molimm.2015.01.009; Hou B, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/574274; Howell KJ, 2015, J CLIN MICROBIOL, V53, P3812, DOI 10.1128/JCM.01991-15; Huang XH, 2013, CLIN VACCINE IMMUNOL, V20, P912, DOI 10.1128/CVI.00621-12; KIELSTEIN P, 1992, J CLIN MICROBIOL, V30, P862, DOI 10.1128/JCM.30.4.862-865.1992; Kovacs-Simon A, 2011, INFECT IMMUN, V79, P548, DOI 10.1128/IAI.00682-10; Li M, 2016, VACCINE, V34, P2251, DOI 10.1016/j.vaccine.2016.03.014; Li M, 2015, VACCINE, V33, P1695, DOI 10.1016/j.vaccine.2015.02.023; Ma L, 2006, PLOS ONE, V11; de la Fuente AJM, 2009, RES VET SCI, V86, P248, DOI 10.1016/j.rvsc.2008.07.017; de la Fuente AJM, 2009, J COMP PATHOL, V140, P169, DOI 10.1016/j.jcpa.2008.10.007; Martins VT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137683; MINIATS OP, 1991, CAN J VET RES, V55, P33; Morton DJ, 2007, MICROBIOL-SGM, V153, P215, DOI 10.1099/mic.0.2006/000190-0; Okay S, 2012, RES VET SCI, V93, P1261, DOI 10.1016/j.rvsc.2012.05.011; Oliveira S, 2004, VET MICROBIOL, V99, P1, DOI 10.1016/j.vetmic.2003.12.001; Pan JY, 2016, METHODS MOL BIOL, V1404, P519, DOI 10.1007/978-1-4939-3389-1_34; Silva AJ, 2005, FEMS IMMUNOL MED MIC, V43, P393, DOI 10.1016/j.femsim.2004.10.001; Takahashi K, 2001, J VET MED SCI, V63, P487, DOI 10.1292/jvms.63.487; Tanabe M, 2006, INFECT IMMUN, V74, P3687, DOI 10.1128/IAI.01837-05; Thomas S, 2014, BBA-MOL CELL RES, V1843, P1629, DOI 10.1016/j.bbamcr.2013.09.017; Vance DJ, 2015, VACCINE, V33, P417, DOI 10.1016/j.vaccine.2014.11.036; Williamson ED, 2011, VACCINE, V29, P4771, DOI 10.1016/j.vaccine.2011.04.084; Yang M, 2011, INFECT IMMUN, V79, P846, DOI 10.1128/IAI.00314-10; Yang TC, 2012, MOL MED REP, V5, P78, DOI 10.3892/mmr.2011.587; Yue M, 2009, J BACTERIOL, V191, P1359, DOI 10.1128/JB.01682-08; Zheng N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084516; Zhou HZ, 2010, VET MICROBIOL, V144, P377, DOI 10.1016/j.vetmic.2010.01.023; Zhou MG, 2009, VACCINE, V27, P5271, DOI 10.1016/j.vaccine.2009.06.051	38	5	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176537	10.1371/journal.pone.0176537	http://dx.doi.org/10.1371/journal.pone.0176537			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448603	Green Submitted, Green Published, gold			2022-12-26	WOS:000400383600098
J	Miyake, A; Mekata, Y; Fujibayashi, H; Nakanishi, K; Konishi, M; Itoh, N				Miyake, Ayumi; Mekata, Yoko; Fujibayashi, Hidenori; Nakanishi, Kazuya; Konishi, Morichika; Itoh, Nobuyuki			Brorin is required for neurogenesis, gliogenesis, and commissural axon guidance in the zebrafish forebrain	PLOS ONE			English	Article							EMBRYONIC ZEBRAFISH; SONIC HEDGEHOG; PROMOTES NEUROGENESIS; MOLECULAR MECHANISMS; RECEPTOR COMPLEXES; CELL FATE; EXPRESSION; BMP; GENES; VERTEBRATE	Bmps regulate numerous neural functions with their regulators. We previously identified Brorin, a neural-specific secreted antagonist of Bmp signaling, in humans, mice, and zebrafish. Mouse Brorin has two cysteine-rich domains containing 10 cysteine residues in its core region, and these are located in similar positions to those in the cysteine-rich domains of Chordin family members, which are secreted Bmp antagonists. Zebrafish Brorin had two cysteine-rich domains with high similarity to those of mouse Brorin. We herein examined zebrafish brorin in order to elucidate its in vivo actions. Zebrafish brorin was predominantly expressed in developing neural tissues. The overexpression of brorin led to the inactivation of Bmp signaling. On the other hand, the knockdown of brorin resulted in the activation of Bmp signaling and brorin morphants exhibited defective development of the ventral domain in the forebrain. Furthermore, the knockdown of brorin inhibited the generation of. gamma amino-butyric acid (GABA) ergic interneurons and oligodendrocytes and promoted the generation of astrocytes in the forebrain. In addition, brorin was required for axon guidance in the forebrain. The present results suggest that Brorin is a secreted Bmp antagonist predominantly expressed in developing neural tissues and that it plays multiple roles in the development of the zebrafish forebrain.	[Miyake, Ayumi; Mekata, Yoko; Fujibayashi, Hidenori; Nakanishi, Kazuya; Konishi, Morichika; Itoh, Nobuyuki] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biochem Genet, Sakyo Ku, Kyoto, Japan	Kyoto University	Miyake, A (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biochem Genet, Sakyo Ku, Kyoto, Japan.	miykea@pharm.kyoto-u.ac.ip			JSPS KAKENHI Grant [26460096]; Suzuken Memorial Foundation; Takeda Science Foundation; Shimizu Foundation for Immunology and Neuroscience Grant; Grants-in-Aid for Scientific Research [17K08307] Funding Source: KAKEN	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Suzuken Memorial Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Shimizu Foundation for Immunology and Neuroscience Grant; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was in part supported by JSPS KAKENHI Grant Number 26460096, the Suzuken Memorial Foundation (http://www.suzukenzaidan.or.jp), the Takeda Science Foundation (http://www.takeda-sci.or.jp) and the Shimizu Foundation for Immunology and Neuroscience Grant for 2013 (http://www.shimizu-immun-neurosci.or.jp), Japan.	Abreu JG, 2002, GENE, V287, P39, DOI 10.1016/S0378-1119(01)00827-7; Agathon A, 2003, NATURE, V424, P448, DOI 10.1038/nature01822; AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; ALLENDE ML, 1994, DEV BIOL, V166, P509, DOI 10.1006/dbio.1994.1334; Bak M, 2003, DEVELOPMENT, V130, P4999, DOI 10.1242/dev.00713; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; BARTH KA, 1995, DEVELOPMENT, V121, P1755; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Cheng X, 2006, J NEUROSCI, V26, P7640, DOI 10.1523/JNEUROSCI.0714-06.2006; CHITNIS AB, 1990, J NEUROSCI, V10, P1892; Coffinier C, 2002, MECH DEVELOP, V119, pS179, DOI 10.1016/S0925-4773(03)00113-8; Corbin JG, 2001, NAT NEUROSCI, V4, P1177, DOI 10.1038/nn749; Dick A, 2000, DEVELOPMENT, V127, P343; Dickinson PJ, 1996, NEUROPATH APPL NEURO, V22, P188; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Esain V, 2010, DEVELOPMENT, V137, P33, DOI 10.1242/dev.038026; Farah MH, 2000, DEVELOPMENT, V127, P693; Fode C, 2000, GENE DEV, V14, P67; French CR, 2009, DEV BIOL, V333, P37, DOI 10.1016/j.ydbio.2009.06.018; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; Grunwald IC, 2002, CURR OPIN NEUROBIOL, V12, P250, DOI 10.1016/S0959-4388(02)00323-9; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; Hauptmann G, 2002, BRAIN RES BULL, V57, P371, DOI 10.1016/S0361-9230(01)00691-8; HAUPTMANN G, 1994, TRENDS GENET, V10, P266, DOI 10.1016/0168-9525(90)90008-T; Hayes SG, 2003, J COMP NEUROL, V463, P45, DOI 10.1002/cne.10749; Hild M, 1999, DEVELOPMENT, V126, P2149; Himmelstein DS, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-118; Jones E. G., 2002, THALAMUS RELAT SYST, V1, P283; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; Koike N, 2007, J BIOL CHEM, V282, P15843, DOI 10.1074/jbc.M701570200; Korzh V, 1998, DEV DYNAM, V213, P92, DOI 10.1002/(SICI)1097-0177(199809)213:1<92::AID-AJA9>3.0.CO;2-T; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; Lauderdale JD, 1997, MOL CELL NEUROSCI, V9, P293, DOI 10.1006/mcne.1997.0624; Lauter G, 2013, J COMP NEUROL, V521, P1093, DOI 10.1002/cne.23221; MACDONALD R, 1995, DEVELOPMENT, V121, P3267; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Martin SC, 1998, J COMP NEUROL, V396, P253; Maurya AK, 2011, DEVELOPMENT, V138, P755, DOI 10.1242/dev.062521; Mione M, 2001, MECH DEVELOP, V100, P93, DOI 10.1016/S0925-4773(00)00501-3; Miwa H, 2009, FEBS LETT, V583, P3643, DOI 10.1016/j.febslet.2009.10.044; Miyake A, 2005, DEV BIOL, V288, P259, DOI 10.1016/j.ydbio.2005.09.042; Miyake A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110836; Miyake A, 2013, BIOL OPEN, V2, P515, DOI 10.1242/bio.20134226; Miyake A, 2012, MECH DEVELOP, V128, P577, DOI 10.1016/j.mod.2012.01.001; Monuki ES, 2001, NEURON, V32, P591, DOI 10.1016/S0896-6273(01)00504-9; MORITA T, 1995, NEUROSCI LETT, V198, P131, DOI 10.1016/0304-3940(95)11988-9; Nakashima K, 2001, P NATL ACAD SCI USA, V98, P5868, DOI 10.1073/pnas.101109698; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011; Park HC, 2002, DEV BIOL, V248, P356, DOI 10.1006/dbio.2002.0738; Peyron F, 1997, J NEUROSCI RES, V50, P190; Salinas PC, 2003, TRENDS NEUROSCI, V26, P641, DOI 10.1016/j.tins.2003.09.006; Schmid B, 2000, DEVELOPMENT, V127, P957; Scholpp S, 2009, P NATL ACAD SCI USA, V106, P19895, DOI 10.1073/pnas.0910894106; Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6; See J, 2007, MOL CELL NEUROSCI, V35, P171, DOI 10.1016/j.mcn.2007.02.012; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Seth A, 2006, DEVELOPMENT, V133, P725, DOI 10.1242/dev.02244; Shimogori T, 2004, DEVELOPMENT, V131, P5639, DOI 10.1242/dev.01428; Steward O, 2002, CELL, V110, P537, DOI 10.1016/S0092-8674(02)00934-0; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Theil T, 2002, DEVELOPMENT, V129, P3045; TIMSIT S, 1995, J NEUROSCI, V15, P1012; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Ueki T, 2003, J NEUROSCI, V23, P11732; Varga ZM, 2001, DEVELOPMENT, V128, P3497; von Bubnoff A, 2001, DEV BIOL, V239, P1, DOI 10.1006/dbio.2001.0388; Walshe J, 2003, DEVELOPMENT, V130, P4337, DOI 10.1242/dev.00660; Wilson SW, 2000, NEURON, V28, P641, DOI 10.1016/S0896-6273(00)00171-9; WILSON SW, 1990, DEVELOPMENT, V108, P121; Yamauchi K, 2008, DEVELOPMENT, V135, P1119, DOI 10.1242/dev.012989; Yanagisawa M, 2001, NEUROSCI RES, V41, P391, DOI 10.1016/S0168-0102(01)00297-8	76	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176036	10.1371/journal.pone.0176036	http://dx.doi.org/10.1371/journal.pone.0176036			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448525	gold, Green Submitted, Green Published			2022-12-26	WOS:000400383600033
J	Pichlhofer, O; Maier, M; Badr-Eslam, R; Ristl, R; Zebrowska, M; Lang, IM				Pichlhofer, Otto; Maier, Manfred; Badr-Eslam, Roza; Ristl, Robin; Zebrowska, Magdalena; Lang, Irene M.			Clinical presentation and management of stable coronary artery disease in Austria	PLOS ONE			English	Article							RESTING HEART-RATE; PLACEBO-CONTROLLED TRIAL; CARDIOVASCULAR MORTALITY; MYOCARDIAL-ISCHEMIA; CLARIFY REGISTRY; OUTCOMES	Background Cardiovascular disease is the main cause of death in Austria. However, no systematic information exists regarding characteristics and treatments of contemporary patients with stable coronary artery disease (CAD) in Austria. We assembled two retrospective physicians' databases to describe demographics, clinical profiles, and therapeutic strategies in patients with stable CAD. In addition, we compared patient profiles of secondary care internists and hospital- based cardiologists with those of general practitioners in a primary care setting outside of hospital. Methods The study population was identified from retrospective chart review of 1020 patients from 106 primary care physicians in Austria (ProCor II registry), and was merged with a previous similar database of 1280 patients under secondary care (ProCor I registry) to yield a total patient number of 2300. Results Female patients with stable CAD were older, had more angina and/or heart failure symptoms, and more depression than males. Female gender, type 2 diabetes mellitus, higher CCS class and asthma/COPD were predictors of elevated heart rate, while previous coronary events/revascularization predicted a lower heart rate in multivariate analysis. There were no significant differences with regard to characteristics and management of patients of general practitioners in the primary care setting versus internists in secondary care. Conclusions Characteristics and treatments of unselected patients with stable ischemic heart disease in Austria resemble the pattern of large international registries of stable ischemic heart disease, with the exception that diabetes and systemic hypertension were more prevalent.	[Pichlhofer, Otto; Maier, Manfred] Med Univ Vienna, Dept Gen Practice & Family Med, Ctr Publ Hlth, Vienna, Austria; [Badr-Eslam, Roza; Lang, Irene M.] Med Univ Vienna, Vienna Gen Hosp, Div Cardiol, Dept Internal Med 2, Vienna, Austria; [Ristl, Robin; Zebrowska, Magdalena] Med Univ Vienna, Inst Med Stat, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria; [Lang, Irene M.] Med Univ Vienna, Div Cardiol, Dept Internal Med 2, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Lang, IM (corresponding author), Med Univ Vienna, Vienna Gen Hosp, Div Cardiol, Dept Internal Med 2, Vienna, Austria.; Lang, IM (corresponding author), Med Univ Vienna, Div Cardiol, Dept Internal Med 2, Vienna, Austria.	irene.lang@meduniwien.ac.at	Zebrowska, Magdalena/GWU-8417-2022	Zebrowska, Magdalena/0000-0003-0589-4173; Ristl, Robin/0000-0002-4163-9236; Lang, Irene/0000-0003-0485-2692; Pichlhofer, Otto/0000-0002-5294-6661	Servier Austria GmbH	Servier Austria GmbH	Servier Austria GmbH <WWW.SERVIER.AT/> provided help with initial study design, logistics and data collection. Servier had no role in data analysis, decision to publish, or preparation of the manuscript. This fact does not alter our adherence to PLOS ONE policies on sharing data and materials. Regarding this commercial funder, no other relevant declarations relating to employment, consultancy, patents, products in development, marketed products apply.	[Anonymous], 2016, J AM HEART ASS; Anselmino M, 2010, EUR HEART J, V31, P3040, DOI 10.1093/eurheartj/ehq368; Beddhu S, 2009, NEPHROL DIAL TRANSPL, V24, P2482, DOI 10.1093/ndt/gfp057; Bohm M, 2010, LANCET, V376, P886, DOI 10.1016/S0140-6736(10)61259-7; Diaz A, 2005, EUR HEART J, V26, P967, DOI 10.1093/eurheartj/ehi190; Eslam RB, 2010, WIEN KLIN WOCHENSCHR, V122, P486, DOI 10.1007/s00508-010-1419-9; Ferrari R, 2015, EUR HEART J; Fox K, 2008, LANCET, V372, P807, DOI 10.1016/S0140-6736(08)61170-8; Fox K, 2007, J AM COLL CARDIOL, V50, P823, DOI 10.1016/j.jacc.2007.04.079; Jensen MT, 2013, HEART, V99, P882, DOI 10.1136/heartjnl-2012-303375; KANNEL WB, 1987, AM HEART J, V113, P1489, DOI 10.1016/0002-8703(87)90666-1; Nabel EG, 2012, NEW ENGL J MED, V366, P54, DOI 10.1056/NEJMra1112570; PANZA JA, 1992, J AM COLL CARDIOL, V20, P1092, DOI 10.1016/0735-1097(92)90363-R; Pichlhofer O, 2015, EUR J PUBLIC HEALTH, V25, P401, DOI 10.1093/eurpub/cku189; Roth GA, 2015, NEW ENGL J MED, V372, P1333, DOI 10.1056/NEJMoa1406656; Steg PG, 2012, EUR HEART J, V33, P2831, DOI 10.1093/eurheartj/ehs289; Steg PG, 2014, JAMA INTERN MED, V174, P1651, DOI 10.1001/jamainternmed.2014.3773; Swedberg K, 2010, LANCET, V376, P875, DOI 10.1016/S0140-6736(10)61198-1; van Buuren S, 2011, J STAT SOFTW, V45, P1	19	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176257	10.1371/journal.pone.0176257	http://dx.doi.org/10.1371/journal.pone.0176257			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448602	Green Published, gold, Green Submitted			2022-12-26	WOS:000400383600053
J	Wonneberger, R; Ficke, A; Lillemo, M				Wonneberger, Ronja; Ficke, Andrea; Lillemo, Morten			Mapping of quantitative trait loci associated with resistance to net form net blotch (Pyrenophora teres f. teres) in a doubled haploid Norwegian barley population	PLOS ONE			English	Article							FUSARIUM HEAD BLIGHT; SPOT FORM; DISEASE RESISTANCE; HORDEUM-VULGARE; CHROMOSOME 6H; MAJOR GENES; QTLS; IDENTIFICATION; CONSTANS	Barley net blotch caused by the necrotrophic fungus Pyrenophora teres is a major barley disease in Norway. It can cause grain shriveling and yield losses, and resistance in currently grown cultivars is insufficient. In this study, a set of 589 polymorphic SNP markers was used to map resistance loci in a population of 109 doubled haploid lines from a cross between the closely related Norwegian cultivars Arve (moderately susceptible) and Lavrans (moderately resistant). Resistance to three net form net blotch (P. teres f. teres) single spore isolates was evaluated at the seedling stage in the greenhouse and at the adult plant stage under field conditions during three years. Days to heading and plant height were scored to assess their influence on disease severity. At the seedling stage, three to four quantitative trait loci (QTL) associated with resistance were found per isolate used. A major, putatively novel QTL was identified on chromosome 5H, accounting for 23-48% of the genetic variation. Additional QTL explaining between 12 and 16.5% were found on chromosomes 4H, 5H, 6H and 7H, with the one on 6H being race-specific. The major QTL on 5H was also found in adult plants under field conditions in three years (explaining up to 55%) and the 7H QTL was found in field trials in one year. Additional adult plant resistance QTL on 3H, 6H and 7H were significant in single years. The resistance on chromosomes 3H, 5H, 6H and 7H originates from the more resistant parent Lavrans, while the resistance on 4H is conferred by Arve. The genetic markers associated with the QTL found in this study will benefit marker-assisted selection for resistance against net blotch.	[Wonneberger, Ronja; Lillemo, Morten] Norwegian Univ Life Sci, Dept Plant Sci, As, Norway; [Ficke, Andrea] Norwegian Inst Bioecon Res, Div Biotechnol & Plant Hlth, As, Norway	Norwegian University of Life Sciences; Norwegian Institute of Bioeconomy Research	Lillemo, M (corresponding author), Norwegian Univ Life Sci, Dept Plant Sci, As, Norway.	morten.lillemo@nmbu.no	Lillemo, Morten/H-9406-2019	Lillemo, Morten/0000-0002-8594-8794; Ficke, Andrea/0000-0002-3438-3842	Research Council of Norway (NFR) [224833]	Research Council of Norway (NFR)(Research Council of Norway)	This work was supported by funding from the Research Council of Norway (NFR: http://www.forskingsradet.no; project 224833). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Qamar M, 2008, THEOR APPL GENET, V117, P1261, DOI 10.1007/s00122-008-0860-x; Afanasenko O. S., 2015, RUSS J GENET, V5, P242, DOI [10.1134/S2079059715030028, DOI 10.1134/S2079059715030028]; Assveen M, 2000, SORTER 1999 PLANTEFO; Assveen M, 2017, SORTER SORTSPROVING; Campoli C, 2012, PLANT J, V69, P868, DOI 10.1111/j.1365-313X.2011.04839.x; Chen GD, 2013, THEOR APPL GENET, V126, P2511, DOI 10.1007/s00122-013-2151-4; Chono M, 2003, PLANT PHYSIOL, V133, P1209, DOI 10.1104/pp.103.026195; de la Pena RC, 1999, THEOR APPL GENET, V99, P561, DOI 10.1007/s001220051269; Friesen TL, 2006, GENOME, V49, P855, DOI 10.1139/G06-024; Grewal TS, 2008, THEOR APPL GENET, V116, P529, DOI 10.1007/s00122-007-0688-9; Grewal TS, 2012, MOL BREEDING, V30, P267, DOI 10.1007/s11032-011-9616-4; Griffiths S, 2003, PLANT PHYSIOL, V131, P1855, DOI 10.1104/pp.102.016188; Horsley RD, 2006, CROP SCI, V46, P145, DOI 10.2135/cropsci2005.0247; Jayasena KW, 2007, AUSTRALAS PLANT PATH, V36, P429, DOI 10.1071/ap07046; Koladia V, 2016, THEOR APPL GENET, P1; Liu ZH, 2015, MOL PLANT PATHOL, V16, P188, DOI 10.1111/mpp.12172; Liu ZH, 2011, MOL PLANT PATHOL, V12, P1, DOI 10.1111/j.1364-3703.2010.00649.x; Ma ZQ, 2000, PHYTOPATHOLOGY, V90, P1079, DOI 10.1094/PHYTO.2000.90.10.1079; Marquez-Cedillo LA, 2001, THEOR APPL GENET, V103, P625, DOI 10.1007/PL00002919; Mascher M, 2013, PLANT J, V76, P718, DOI 10.1111/tpj.12319; McLean MS, 2009, CROP PASTURE SCI, V60, P499, DOI 10.1071/CP08173_ER; MODE C. J., 1958, AGRON JOUR, V50, P15; Munoz-Amatriain M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094688; Munoz-Amatriain M, 2011, PLANT GENOME-US, V4, P238, DOI 10.3835/plantgenome2011.08.0023; O'Boyle PD, 2011, PLANT DIS, V95, P19, DOI 10.1094/PDIS-02-10-0096; Pasam RK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-16; Richards JK, 2017, THEOR APPL GENET, P1; Saville RJ, 2012, J EXP BOT, V63, P1271, DOI 10.1093/jxb/err350; Spaner D, 1998, CROP SCI, V38, P843, DOI 10.2135/cropsci1998.0011183X003800030037x; STEFFENSON BJ, 1992, PHYTOPATHOLOGY, V82, P407, DOI 10.1094/Phyto-82-407; Steffenson BJ, 1996, THEOR APPL GENET, V92, P552, DOI 10.1007/BF00224557; STEFFENSON BJ, 1997, COMPENDIUM BARLEY DI, P28; Tamang P, 2015, PHYTOPATHOLOGY, V105, P500, DOI 10.1094/PHYTO-04-14-0106-R; TEKAUZ A, 1985, CAN J PLANT PATHOL, V7, P181, DOI 10.1080/07060668509501499; Tinker NA, 1996, CROP SCI, V36, P1053, DOI 10.2135/cropsci1996.0011183X003600040040x; Van Ooijen J., 2006, SOFTWARE CALCULATION, P33; Van Ooijen J.W., 2009, MAPQTL 6 SOFTWARE MA; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang GW, 2010, THEOR APPL GENET, V120, P1559, DOI 10.1007/s00122-010-1276-y; Wang XM, 2015, THEOR APPL GENET, V128, P489, DOI 10.1007/s00122-014-2447-z; Williams KJ, 2001, AUSTRALAS PLANT PATH, V30, P37, DOI 10.1071/AP00063; Zhu H, 1999, THEOR APPL GENET, V99, P1221, DOI 10.1007/s001220051328	42	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e175773	10.1371/journal.pone.0175773	http://dx.doi.org/10.1371/journal.pone.0175773			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448537	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000400383600024
J	Yan, HZ; Wang, YW; Shen, SH; Wu, Z; Wan, PX				Yan, Huize; Wang, Yingwei; Shen, Shuhao; Wu, Zheng; Wan, Pengxia			Corticosteroids effects on LPS-induced rat inflammatory keratocyte cell model	PLOS ONE			English	Article							NF-KAPPA-B; CORNEAL FIBROBLASTS; EXTRACELLULAR-MATRIX; TOPICAL CORTICOSTEROIDS; BACTERIAL KERATITIS; VI COLLAGEN; IN-VITRO; INHIBITION; DEXAMETHASONE; EXPRESSION	Purpose Corticosteroids are efficient anti-inflammation treatments. However, there are still arguments on whether it should be used in keratitis. This study was to observe the effect of corticosteroids on keratocytes both in normal condition and inflammation status in vitro. Methods Rat keratocytes were cultured and used for examination. 10 mu g/ml lipopolysaccharide (LPS) was used to establish the inflammatory keratocyte cell model, and prednisolone acetate (PA), dexamethasone (Dex) and fluorometholone (Flu) were used as corticosteroids treatments. 5 d-growth curve and cell viabilities were assayed by CCK8, and cell morphologies and migration rate were studied. TNF-alpha, IL-6 and IL-1 beta levels were examined by ELISA. Western blotting was used to quantified type VI collagen (Col VI) and matrix metalloproteinase 9 (MMP9) expressions, and immunofluorescence staining assays of Col I and Col VI were carried out. Results In normal condition, proliferation and migration of keratocytes were slightly influenced in PA, Dex and Flu groups. The secretion of Col I and Col VI was suppressed and MMP9 expression increased in corticosteroids groups. But no significant difference was seen in TNF-alpha, IL-6 and IL-1 beta expression levels. In inflammatory status, TNF-alpha, IL-6 and MMP9 levels increased in LPS group, while they significantly decreased in corticosteroids groups. Although keratocytes viabilities and migration were slightly affected in 24 h, no significant differences were seen between LPS group and corticosteroids groups in 5-d proliferation. Col I and Col VI secretion in LPS-keratocytes was maintained with corticosteroids treatments. Conclusions Corticosteroids showed lightly effects on keratocytes proliferation and migration, but it successfully decreased TNF-alpha, IL-6 level and maintained the secretion of and Col I and Col VI, while suppressed the expression of MMP9 in LPS-induced keratocytes. PA was suggested to use in early stage of keratitis clinical treatment.	[Yan, Huize; Wang, Yingwei; Wu, Zheng] Jinan Univ, Dept Dev & Regenerat Biol, Guangzhou, Guangdong, Peoples R China; [Yan, Huize; Wang, Yingwei; Wu, Zheng] Jinan Univ, Key Lab Regenerat Med, Minist Educ, Guangzhou, Guangdong, Peoples R China; [Shen, Shuhao] Jinan Univ, Affiliated Hosp 1, Dept Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Wan, Pengxia] Sun Yat Sen Univ, Affiliated Hosp 1, Ophthalmol Dept, Guangzhou, Guangdong, Peoples R China	Jinan University; Jinan University; Jinan University; Sun Yat Sen University	Wu, Z (corresponding author), Jinan Univ, Dept Dev & Regenerat Biol, Guangzhou, Guangdong, Peoples R China.; Wu, Z (corresponding author), Jinan Univ, Key Lab Regenerat Med, Minist Educ, Guangzhou, Guangdong, Peoples R China.; Wan, PX (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Ophthalmol Dept, Guangzhou, Guangdong, Peoples R China.	wuzheng_jnu@126.com; wanpengxia@gmail.com			National Natural Science Foundation of China [812006592]; Science and Technology Planning Project of Guangdong Province [2014A020211011, 2016A020214012, 2014A010105029]; Basal Research Fund for the Medical Young Scientists of Sun Yat-sen University [14ykpy14]; Science and Technology Planning Project of Guangzhou [201607010063]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province; Basal Research Fund for the Medical Young Scientists of Sun Yat-sen University; Science and Technology Planning Project of Guangzhou	This work was supported by https://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list### National Natural Science Foundation of China to PXW (No.812006592); http://gonggao.gdstc.gov.cn/itemListAction.do?metliod=ltem_List_Select Science and Technology Planning Project of Guangdong Province to PXW (No. 2014A020211011); http://research.sysu.edu.cn/; the Basal Research Fund for the Medical Young Scientists of Sun Yat-sen University to PXW(No. 14ykpy14); http://gonggao.gdstc.gov.cn/itemListAction.do?method=Item_List_Select Science and Technology Planning Project of Guangdong Province to ZW (No. 2016A020214012); http://apply.gzkj.gov.cn/; Science and Technology Planning Project of Guangzhou to ZW (No. 201607010063), and http://gonggao.gdstc.gov.cn/itemListAction.do?method=item_List_Select Science and Technology Planning Project of Guangdong Province to ZW (No.2014A010105029). The corresponding authors PXW and ZW were responsible for conceptualization, formal analysis, funding and review in this study.	Association TEMD, 1980, AM ACAD OPHTHALMOLOG, V2 -5; Atkinson JC, 1996, EXP CELL RES, V228, P283, DOI 10.1006/excr.1996.0328; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; BRUNS RR, 1986, J CELL BIOL, V103, P393, DOI 10.1083/jcb.103.2.393; Carnt N, 2016, OPHTHALMOLOGY, V123, P984, DOI 10.1016/j.ophtha.2016.01.020; Choi HJ, 2011, CYTOKINE, V56, P265, DOI 10.1016/j.cyto.2011.07.004; Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064; David A., 1981, INVEST OPHTH VIS SCI, V10, P738; Djalilian AR, 2006, CORNEA, V25, P709, DOI 10.1097/01.ico.0000208815.02120.90; Gruver-Yates Amanda L, 2013, Cells, V2, P202, DOI 10.3390/cells2020202; Heino J, 2009, INT J BIOCHEM CELL B, V41, P341, DOI 10.1016/j.biocel.2008.08.021; Jester JV, 2005, INVEST OPHTH VIS SCI, V46, P2369, DOI 10.1167/iovs.04-1225; KERN P, 1991, BIOCHEM J, V274, P615, DOI 10.1042/bj2740615; Ladwig GP, 2002, WOUND REPAIR REGEN, V10, P26, DOI 10.1046/j.1524-475X.2002.10903.x; LINSENMAYER TF, 1986, DEV BIOL, V118, P425, DOI 10.1016/0012-1606(86)90013-8; LINSENMAYER TF, 1985, ANN NY ACAD SCI, V460, P232, DOI 10.1111/j.1749-6632.1985.tb51171.x; Lu Y, 2004, INVEST OPHTH VIS SCI, V45, P2998, DOI 10.1167/iovs.04-0051; Lu Y, 2006, INVEST OPHTH VIS SCI, V47, P3796, DOI 10.1167/iovs.06-0319; Mohan RR, 2000, INVEST OPHTH VIS SCI, V41, P1327; Nakao S, 2007, AM J PATHOL, V171, P1058, DOI 10.2353/ajpath.2007.070172; Palioura S, 2016, CLIN OPHTHALMOL, V10, P179, DOI 10.2147/OPTH.S80411; Pan XJ, 2016, INT J OPHTHALMOL-CHI, V9, P53, DOI 10.18240/ijo.2016.01.09; Park SJ, 2016, INFLAMMATION, V39, P727, DOI 10.1007/s10753-015-0299-6; Ray KJ, 2014, JAMA OPHTHALMOL, V132, P737, DOI 10.1001/jamaophthalmol.2014.292; Rothamel D, 2004, CLIN ORAL IMPLAN RES, V15, P443, DOI 10.1111/j.1600-0501.2004.01039.x; Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x; Srinivasan M, 2014, AM J OPHTHALMOL, V157, P327, DOI 10.1016/j.ajo.2013.09.025; Wang N, 2016, INT J OPHTHALMOL-CHI, V9, P384, DOI 10.18240/ijo.2016.03.10; Wang T, 2016, GRAEF ARCH CLIN EXP, V254, P1585, DOI 10.1007/s00417-016-3412-0; West-Mays JA, 2006, INT J BIOCHEM CELL B, V38, P1625, DOI 10.1016/j.biocel.2006.03.010; Yong JH, 2016, ANIM CELLS SYST, V20, P1, DOI 10.1080/19768354.2016.1140676	31	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176639	10.1371/journal.pone.0176639	http://dx.doi.org/10.1371/journal.pone.0176639			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448563	gold, Green Submitted, Green Published			2022-12-26	WOS:000400383600116
J	Langer, JAF; Sharma, R; Schmidt, SI; Bahrdt, S; Horn, HG; Alguero-Muniz, M; Nam, B; Achterberg, EP; Riebesell, U; Boersma, M; Thines, M; Schwenk, K				Langer, Julia A. F.; Sharma, Rahul; Schmidt, Susanne I.; Bahrdt, Sebastian; Horn, Henriette G.; Alguero-Muniz, Maria; Nam, Bora; Achterberg, Eric P.; Riebesell, Ulf; Boersma, Maarten; Thines, Marco; Schwenk, Klaus			Community barcoding reveals little effect of ocean acidification on the composition of coastal plankton communities: Evidence from a long-term mesocosm study in the Gullmar Fjord, Skagerrak	PLOS ONE			English	Article							CO2 CONCENTRATION; ELEVATED CO2; MARINE; PHOSPHATE; SEAWATER; IMPACTS; NITRATE; SEARCH	The acidification of the oceans could potentially alter marine plankton communities with consequences for ecosystem functioning. While several studies have investigated effects of ocean acidification on communities using traditional methods, few have used genetic analyses. Here, we use community barcoding to assess the impact of ocean acidification on the composition of a coastal plankton community in a large scale, in situ, long-term mesocosm experiment. High-throughput sequencing resulted in the identification of a wide range of planktonic taxa (Alveolata, Cryptophyta, Haptophyceae, Fungi, Metazoa, Hydrozoa, Rhizaria, Straminipila, Chlorophyta). Analyses based on predicted operational taxonomical units as well as taxonomical compositions revealed no differences between communities in high CO2 mesocosms (similar to 760 mu atm) and those exposed to present-day CO2 conditions. Observed shifts in the planktonic community composition were mainly related to seasonal changes in temperature and nutrients. Furthermore, based on our investigations, the elevated CO2 did not affect the intraspecific diversity of the most common mesozooplankter, the calanoid copepod Pseudocalanus acuspes. Nevertheless, accompanying studies found temporary effects attributed to a raise in CO2. Differences in taxa composition between the CO2 treatments could, however, only be observed in a specific period of the experiment. Based on our genetic investigations, no compositional long-term shifts of the plankton communities exposed to elevated CO2 conditions were observed. Thus, we conclude that the compositions of planktonic communities, especially those in coastal areas, remain rather unaffected by increased CO2.	[Langer, Julia A. F.; Horn, Henriette G.; Alguero-Muniz, Maria; Boersma, Maarten] Biol Anstalt Helgoland, Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, Helgoland, Germany; [Sharma, Rahul; Nam, Bora; Thines, Marco] Senckenberg Gesell Nat Kunde, Biodivers & Climate Res Ctr BiK F, Frankfurt, Germany; [Sharma, Rahul; Nam, Bora; Thines, Marco] Fac Biol Sci, Inst Ecol Evolut & Divers, Frankfurt, Germany; [Schmidt, Susanne I.; Bahrdt, Sebastian; Schwenk, Klaus] Univ Koblenz Landau, Inst Environm Sci, Landau, Germany; [Achterberg, Eric P.; Riebesell, Ulf] GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany; [Boersma, Maarten] Univ Bremen, Bremen, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); University of Koblenz & Landau; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Bremen	Langer, JAF (corresponding author), Biol Anstalt Helgoland, Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, Helgoland, Germany.	julia.lange@awi.de	Schwenk, Klaus/G-9603-2015; Schmidt, Susanne/Q-1657-2015; Achterberg, Eric P/C-5820-2009; Riebesell, Ulf/AAC-9717-2020; Boersma, Maarten/A-5475-2013; Schmidt, Susanne/ABH-1143-2020; Algueró-Muñiz, María/AAA-9748-2020; Horn, Henriette G./R-7667-2016	Schmidt, Susanne/0000-0003-0051-6480; Achterberg, Eric P/0000-0002-3061-2767; Boersma, Maarten/0000-0003-1010-026X; Schmidt, Susanne/0000-0003-0051-6480; Algueró-Muñiz, María/0000-0001-8064-6212; Horn, Henriette G./0000-0002-4020-5559	German Federal Ministry of Education and Science (BMBF); Swedish Academy of Science [WP 1.14 (FKZ 03F06556)]	German Federal Ministry of Education and Science (BMBF)(Federal Ministry of Education & Research (BMBF)); Swedish Academy of Science	This study is part of the German Federal Ministry of Education and Science (BMBF) funded "Verbundprojekt" BIOACID Phase II (Biological Impacts of Ocean ACIDification), consortium 1, WP 1.14 (FKZ 03F06556) and received funding from the Swedish Academy of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle N, 2013, BIOGEOSCIENCES, V10, P1471, DOI 10.5194/bg-10-1471-2013; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bach LT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159068; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Cripps G, 2014, GLOBAL CHANGE BIOL, V20, P3377, DOI 10.1111/gcb.12582; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Dorey N, 2013, GLOBAL CHANGE BIOL, V19, P3355, DOI 10.1111/gcb.12276; Dray S, 2003, ECOLOGY, V84, P3078, DOI 10.1890/03-0178; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elbrecht V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130324; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FROST BW, 1972, LIMNOL OCEANOGR, V17, P805, DOI 10.4319/lo.1972.17.6.0805; Hadziavdic K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087624; Hansen H.P., 1999, METHODS SEAWATER ANA, P399; Hofmann LC, 2015, OECOLOGIA, V177, P1157, DOI 10.1007/s00442-015-3242-5; Holmes RM, 1999, CAN J FISH AQUAT SCI, V56, P1801, DOI 10.1139/cjfas-56-10-1801; Horn HG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165800; Horn HG, 2015, ICES J MAR SCI; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huys R, 2006, BIOL J LINN SOC, V87, P403, DOI 10.1111/j.1095-8312.2005.00579.x; Ivanova NV, 2007, MOL ECOL NOTES, V7, P544, DOI 10.1111/j.1471-8286.2007.01748.x; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kim JM, 2006, LIMNOL OCEANOGR, V51, P1629, DOI 10.4319/lo.2006.51.4.1629; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Kurihara H, 2004, MAR POLLUT BULL, V49, P721, DOI 10.1016/j.marpolbul.2004.05.005; Lejzerowicz F, 2015, SCI REP-UK, V5, DOI 10.1038/srep13932; Li W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051590; Lischka S., 2015, BIOGEOSCIENCES DISCU, V12, P20025, DOI [10.5194/bgd-12-20025-2015, DOI 10.5194/BGD-12-20025-2015]; Loder MGJ, 2011, MAR BIOL, V158, P1551, DOI 10.1007/s00227-011-1670-2; MESSING J, 1983, METHOD ENZYMOL, V101, P20; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Niehoff B, 2013, BIOGEOSCIENCES, V10, P1391, DOI 10.5194/bg-10-1391-2013; Oksanen J, 2016, COMMUNITY ECOLOGY PA; PALMER MW, 1993, ECOLOGY, V74, P2215, DOI 10.2307/1939575; Patey MD, 2008, TRAC-TREND ANAL CHEM, V27, P169, DOI 10.1016/j.trac.2007.12.006; Peck LS, 2015, GLOBAL CHANGE BIOL, V21, P1907, DOI 10.1111/gcb.12841; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Pochon X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073935; Rao R, 1995, QUESTIIO, V17, P23; Raupach MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139421; Riebesell U, 2008, BIOGEOSCIENCES, V5, P1157, DOI 10.5194/bg-5-1157-2008; Rossoll D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034737; Rouco M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00155; Sala MM, 2016, ICES J MAR SCI, V73, P670, DOI 10.1093/icesjms/fsv130; Sambrook J., 1989, MOLECULAR CLONING A; Schoo KL, 2013, MAR BIOL, V160, P2145, DOI 10.1007/s00227-012-2121-4; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Sharma R.K., 2015, GREEN CHEM, V1, P1, DOI DOI 10.1109/ICRIT0.2015.7359296; Silyakova A, 2013, BIOGEOSCIENCES, V10, P4847, DOI 10.5194/bg-10-4847-2013; Sperling M, 2013, BIOGEOSCIENCES, V10, P181, DOI 10.5194/bg-10-181-2013; Stein ED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051273; Thor P, 2015, MAR BIOL, V162, P799, DOI 10.1007/s00227-015-2625-9; Wood SA, 2013, NEW ZEAL J MAR FRESH, V47, P90, DOI 10.1080/00288330.2012.745885; Zaiko A, 2015, MAR POLLUT BULL, V100, P53, DOI 10.1016/j.marpolbul.2015.09.030	57	8	8	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0175808	10.1371/journal.pone.0175808	http://dx.doi.org/10.1371/journal.pone.0175808			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445483	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000400309200029
J	Voss, C; Dean, PH; Gardner, RF; Duncombe, SL; Harris, KC				Voss, Christine; Dean, Paige H.; Gardner, Ross F.; Duncombe, Stephanie L.; Harris, Kevin C.			Validity and reliability of the Physical Activity Questionnaire for Children (PAQ-C) and Adolescents (PAQ-A) in individuals with congenital heart disease	PLOS ONE			English	Article							OLDER CHILDREN; SELF-REPORT; TASK-FORCE; ASSOCIATION; CALIBRATION; POPULATION; PREVALENCE; VALIDATION; PREVENTION; WORLDWIDE	Objective To assess the criterion validity, internal consistency, reliability and cut-point for the Physical Activity Questionnaire for Children (PAQ-C) and Adolescents (PAQ-A) in children and adolescents with congenital heart disease-a special population at high cardiovascular risk in whom physical activity has not been extensively evaluated. Methods We included 84 participants (13.6 +/- 2.9 yrs, 50% female) with simple (37%), moderate (31%), or severe congenital heart disease (27%), as well as cardiac transplant recipients (6%), from BC Children's Hospital, Canada. They completed the PAQ-C (<= 11yrs, n = 28) or-A (>= 12yrs, n = 56), and also wore a triaxial accelerometer (GT3X+ or GT9X) over the right hip for 7 days (n = 59 met valid wear time criteria). Results Median daily moderate-to-vigorous physical activity was 46.9 minutes per day (IQR 31.6-61.8) and 25% met physical activity guidelines defined as >= 60 minutes of moderate-to-vigorous physical activity per day. Median PAQ-score was 2.6 (IQR 1.9-3.0). PAQ-Scores were significantly related to accelerometry-derived metrics of physical activity (rho = 0.44-0.55, all p<0.01) and sedentary behaviour (rho = -0.53, p<0.001). Internal consistency was high (alpha = 0.837), as was reliability (stability) of PAQ-Scores over a 4-months period (ICC = 0.73, 95% CI 0.55-0.84; p<0.001). We identified that a PAQ-Score cut-point of 2.87 discriminates between those meeting physical guidelines and those that do not in the combined PAQ-C and-A samples (area under the curve = 0.80 (95% CI 0.67-0.92). Conclusion Validity and reliability of the PAQ in children and adolescents with CHD was comparable to or stronger than previous studies in healthy children. Therefore, the PAQ may be used to estimate general levels of physical activity in children and adolescents with CHD.	[Voss, Christine; Dean, Paige H.; Gardner, Ross F.; Duncombe, Stephanie L.; Harris, Kevin C.] BC Childrens Hosp, Childrens Heart Ctr, Vancouver, BC, Canada; [Voss, Christine; Harris, Kevin C.] Univ British Columbia, Dept Pediat, Vancouver, BC, Canada	BC Childrens Hospital; University of British Columbia; University of British Columbia	Harris, KC (corresponding author), BC Childrens Hosp, Childrens Heart Ctr, Vancouver, BC, Canada.; Harris, KC (corresponding author), Univ British Columbia, Dept Pediat, Vancouver, BC, Canada.	kharris2@cw.bc.ca	Voss, Christine/E-7425-2010; Duncombe, Stephanie/ABA-4330-2021	Voss, Christine/0000-0003-3811-2465; Duncombe, Stephanie/0000-0003-0673-6409	Heart and Stroke Foundation of Canada, BC; Yukon division [F1504]	Heart and Stroke Foundation of Canada, BC; Yukon division	We received funding form the Heart and Stroke Foundation of Canada, BC & Yukon division (F1504; PI Harris) to support the ongoing research project from which the current data were drawn. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggio D, 2016, ARCH PUBLIC HEALTH, V74, DOI 10.1186/s13690-016-0115-2; Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Benitez-Porres J, 2016, NUTR HOSP, V33, P1036, DOI 10.20960/nh.564; Benitez-Porres J, 2016, J SCHOOL HEALTH, V86, P677, DOI 10.1111/josh.12418; Bervoets L, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-47; Biddle SJH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-1; Boneva RS, 2001, CIRCULATION, V103, P2376; Canadian Society for Exercise Physiology, 2016, 24 HOUR MOVEMENT GUI; Carson Valerie, 2011, BMC Public Health, V11, P274, DOI 10.1186/1471-2458-11-274; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Colley R. C., 2011, HLTH REPORTS, V22, P15, DOI DOI 10.1016/j.yspm.2011.03.006; Crocker PRE, 1997, MED SCI SPORT EXER, V29, P1344, DOI 10.1097/00005768-199710000-00011; de Onis Mercedes, 2007, Bull World Health Organ, V85, P660; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Gabel L, 2015, MED SCI SPORT EXER, V47, P363, DOI 10.1249/MSS.0000000000000418; Gobbi E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156354; Janz KF, 2008, MED SCI SPORT EXER, V40, P767, DOI 10.1249/MSS.0b013e3181620ed1; Kavey REW, 2006, CIRCULATION, V114, P2710, DOI 10.1161/CIRCULATIONAHA.106.179568; Kowalski K. C., 2004, COLL KINESIOLOGY U S, V87, P1, DOI DOI 10.1186/2049-3258-72-47; Kowalski KC, 1997, PEDIATR EXERC SCI, V9, P342, DOI 10.1123/pes.9.4.342; Kowalski KC, 1997, PEDIATR EXERC SCI, V9, P174, DOI 10.1123/pes.9.2.174; Marelli AJ, 2007, CIRCULATION, V115, P163, DOI 10.1161/CIRCULATIONAHA.106.627224; Marelli AJ, 2014, CIRCULATION, V130, P749, DOI 10.1161/CIRCULATIONAHA.113.008396; Martinez-Gomez D, 2009, REV ESP SALUD PUBLIC, V83, P427, DOI 10.1590/s1135-57272009000300008; Saint-Maurice PF, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-461; Thomas EL, 2014, PSYCHOL SPORT EXERC, V15, P280, DOI 10.1016/j.psychsport.2014.02.002; Thompson AM, 2003, MED SCI SPORT EXER, V35, P1684, DOI 10.1249/01.MSS.0000089244.44914.1F; Trost SG, 2000, MED SCI SPORT EXER, V32, P426, DOI 10.1097/00005768-200002000-00025; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Voss C, 2013, PEDIATR INT, V55, P498, DOI 10.1111/ped.12092; Wang JJ, 2016, BIOMED ENVIRON SCI, V29, P177, DOI 10.3967/bes2016.022; Warnes CA, 2001, J AM COLL CARDIOL, V37, P1170, DOI 10.1016/S0735-1097(01)01272-4; Warnes CA, 2008, CIRCULATION, V118, P2395, DOI [10.1161/CIRCULATIONAHA.108.190811, 10.1016/j.jacc.2008.10.001]; Warren JM, 2010, EUR J CARDIOV PREV R, V17, P127, DOI 10.1097/HJR.0b013e32832ed875; Welk GJ, 2000, RES Q EXERCISE SPORT, V71, pS59, DOI 10.1080/02701367.2000.11082788	38	42	42	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0175806	10.1371/journal.pone.0175806	http://dx.doi.org/10.1371/journal.pone.0175806			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445485	Green Published, Green Submitted, gold			2022-12-26	WOS:000400309200028
J	Cisneros, L; Bussey, KJ; Orr, AJ; Miocevic, M; Lineweaver, CH; Davies, P				Cisneros, Luis; Bussey, Kimberly J.; Orr, Adam J.; Miocevic, Milica; Lineweaver, Charles H.; Davies, Paul			Ancient genes establish stress-induced mutation as a hallmark of cancer	PLOS ONE			English	Article							BREAK-INDUCED REPLICATION; DNA-POLYMERASE-ZETA; TRANSLESION POLYMERASES; CATALYTIC SUBUNIT; ADAPTIVE MUTATION; RESISTANCE; EVOLUTION; GENOME; MULTICELLULARITY; RESPONSES	Cancer is sometimes depicted as a reversion to single cell behavior in cells adapted to live in a multicellular assembly. If this is the case, one would expect that mutation in cancer disrupts functional mechanisms that suppress cell-level traits detrimental to multicellularity. Such mechanisms should have evolved with or after the emergence of multicellularity. This leads to two related, but distinct hypotheses: 1) Somatic mutations in cancer will occur in genes that are younger than the emergence of multicellularity (1000 million years [ MY]); and 2) genes that are frequently mutated in cancer and whose mutations are functionally important for the emergence of the cancer phenotype evolved within the past 1000 million years, and thus would exhibit an age distribution that is skewed to younger genes. In order to investigate these hypotheses we estimated the evolutionary ages of all human genes and then studied the probability of mutation and their biological function in relation to their age and genomic location for both normal germline and cancer contexts. We observed that under a model of uniform random mutation across the genome, controlled for gene size, genes less than 500 MY were more frequently mutated in both cases. Paradoxically, causal genes, defined in the COSMIC Cancer Gene Census, were depleted in this age group. When we used functional enrichment analysis to explain this unexpected result we discovered that COSMIC genes with recessive disease phenotypes were enriched for DNA repair and cell cycle control. The non-mutated genes in these pathways are orthologous to those underlying stress-induced mutation in bacteria, which results in the clustering of single nucleotide variations. COSMIC genes were less common in regions where the probability of observing mutational clusters is high, although they are approximately 2-fold more likely to harbor mutational clusters compared to other human genes. Our results suggest this ancient mutational response to stress that evolved among prokaryotes was co-opted to maintain diversity in the germline and immune system, while the original phenotype is restored in cancer. Reversion to a stress-induced mutational response is a hallmark of cancer that allows for effectively searching ''protected'' genome space where genes causally implicated in cancer are located and underlies the high adaptive potential and concomitant therapeutic resistance that is characteristic of cancer.	[Cisneros, Luis; Bussey, Kimberly J.] NantOmics, Tempe, AZ 85283 USA; [Cisneros, Luis; Davies, Paul] Arizona State Univ, BEYOND Ctr Fundamental Concepts Sci, Tempe, AZ USA; [Bussey, Kimberly J.] Arizona State Univ, Dept Biomed Informat, Tempe, AZ 85287 USA; [Orr, Adam J.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Miocevic, Milica] Arizona State Univ, Dept Psychol, Tempe, AZ 85287 USA; [Lineweaver, Charles H.] Australian Natl Univ, Planetary Sci Inst, Res Sch Astron & Astrophys, Canberra, ACT, Australia; [Lineweaver, Charles H.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Australian National University; Australian National University	Bussey, KJ (corresponding author), NantOmics, Tempe, AZ 85283 USA.; Bussey, KJ (corresponding author), Arizona State Univ, Dept Biomed Informat, Tempe, AZ 85287 USA.	kim.bussey@nantomics.com	Bussey, Kimberly J./D-2567-2011	Bussey, Kimberly/0000-0003-1001-8207; Orr, Adam/0000-0001-9074-4799; Lineweaver, Charles/0000-0003-2047-1558; Cisneros, Luis/0000-0002-7890-1269	Institut National de la Sante A et de la Recherche Medicale (Inserm) of the ICGC program; Barretos Cancer Hospital; Ministry of Education, University, and Research University of Verona; NIH grant [U54CA143862]; NantOmics, LLC; NantOmics; Institut National de la Sante et de la Recherche Medicale (Inserm) within ICGC; Federal Ministry of Education and Research (BMBF); National Health and Medical Research Council (NHMRC); Queensland State Government; University of Queensland; Institute for Molecular Bioscience; Cancer Council NSW; Garvan Institute of Medical Research; Cancer Institute NSW; Italian Ministry of Education, University, and Research; University of Verona; German Cancer Aid (DKH); Ontario Institute for Cancer Research; Prostate Cancer Canada; Pio XII Foundation - Barretos Cancer Hospital; Rene Rachou Research Center [FI0CRUZ]; International Genome Sample Resource (IGSR) - Wellcome Trust [WT104947/Z/14/Z]	Institut National de la Sante A et de la Recherche Medicale (Inserm) of the ICGC program; Barretos Cancer Hospital; Ministry of Education, University, and Research University of Verona; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NantOmics, LLC; NantOmics; Institut National de la Sante et de la Recherche Medicale (Inserm) within ICGC(Institut National de la Sante et de la Recherche Medicale (Inserm)); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Queensland State Government; University of Queensland(University of Queensland); Institute for Molecular Bioscience; Cancer Council NSW(Cancer Council New South Wales); Garvan Institute of Medical Research; Cancer Institute NSW; Italian Ministry of Education, University, and Research(Ministry of Education, Universities and Research (MIUR)); University of Verona; German Cancer Aid (DKH)(Deutsche Krebshilfe); Ontario Institute for Cancer Research; Prostate Cancer Canada; Pio XII Foundation - Barretos Cancer Hospital; Rene Rachou Research Center; International Genome Sample Resource (IGSR) - Wellcome Trust	We thank Susan Rosenberg and Bob Austin for insightful discussions into the role of genomic instability in cancer within an evolutionary context. We also acknowledge the work of the clinical collaborators, data analysis teams, and funders in generating the WGS data in the ICGC database, release 19. In particular, data from Ewing sarcoma sequencing project was supported by grants from the Institut National de la Sante A et de la Recherche Medicale (Inserm) in the frame of the ICGC program. The ICGC/SKCA-BR project was supported by Barretos Cancer Hospital. The ICGC/PACA-IT project was supported by Italian Ministry of Education, University, and Research University of Verona.; This work was supported by NIH grant U54CA143862 (https.//projectreporter.nih.gov) and NantOmics, LLC. The NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NantOmics provided support in the form of salaries for authors KJB and LC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Data used in this study from the International Cancer Genomics Consortium (ICGC) was generated with the support of the following: Institut National de la Sante et de la Recherche Medicale (Inserm) within the framework of the ICGC, Federal Ministry of Education and Research (BMBF), National Health and Medical Research Council (NHMRC), Queensland State Government, University of Queensland, Institute for Molecular Bioscience, The Cancer Council NSW, Garvan Institute of Medical Research, Cancer Institute NSW, Italian Ministry of Education, University, and Research, University of Verona, German Cancer Aid (DKH), Ontario Institute for Cancer Research, Prostate Cancer Canada, Pio XII Foundation - Barretos Cancer Hospital, and Rene Rachou Research Center (FI0CRUZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Data from the 1000 Genomes Project is maintained and supported by the International Genome Sample Resource (IGSR), funded by the Wellcome Trust grant number WT104947/Z/14/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON ED, 1987, DEVELOPMENT, V99, P449; Agarwala R, 2015, NUCLEIC ACIDS RES, V43, pD6, DOI 10.1093/nar/gku1130; Al Mamun AM, 2012, SCIENCE, V338, P1344, DOI 10.1126/science.1226683; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Almassalha LM, 2016, CANCER RES, V76, P5605, DOI 10.1158/0008-5472.CAN-16-0585; Alvarado AS, 2012, CURR BIOL, V22, pR772, DOI 10.1016/j.cub.2012.08.008; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; CAIRNS J, 1988, NATURE, V335, P142, DOI 10.1038/335142a0; CAIRNS J, 1991, GENETICS, V128, P695; Camps M, 2007, CRIT REV BIOCHEM MOL, V42, P313, DOI 10.1080/10409230701597642; Chen H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7367; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Das Thakur M, 2013, NATURE, V494, P251, DOI 10.1038/nature11814; Davies PCW, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015001; Doles J, 2010, P NATL ACAD SCI USA, V107, P20786, DOI 10.1073/pnas.1011409107; Domazet-Loso T, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-66; Enriquez-Navas PM, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7842; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Foster PL, 2004, J BACTERIOL, V186, P4846, DOI 10.1128/JB.186.15.4846-4852.2004; Francioli LC, 2015, NAT GENET, V47, P822, DOI 10.1038/ng.3292; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; HALL BG, 1988, GENETICS, V120, P887; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hara T, 2005, PROSTATE, V65, P268, DOI 10.1002/pros.20282; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Holderfield M, 2014, NAT REV CANCER, V14, P455, DOI 10.1038/nrc3760; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Khurana E, 2013, SCIENCE, V342, P84, DOI 10.1126/science.1235587; Knoll AH, 2011, ANNU REV EARTH PL SC, V39, P217, DOI 10.1146/annurev.earth.031208.100209; Kostadinov RL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003553; Kussell E, 2005, GENETICS, V169, P1807, DOI 10.1534/genetics.104.035352; Lang D, 2007, BIOCHEM PHARMACOL, V73, P1, DOI 10.1016/j.bcp.2006.06.024; Larkin DM, 2009, GENOME RES, V19, P770, DOI 10.1101/gr.086546.108; Lineweaver CH, 2014, BIOESSAYS, V36, P827, DOI 10.1002/bies.201400070; Massey RC, 2002, TRENDS MICROBIOL, V10, P580, DOI 10.1016/S0966-842X(02)02475-7; Matise MP, 1999, ONCOGENE, V18, P7852, DOI 10.1038/sj.onc.1203243; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Moore SW, 2009, PEDIATR BLOOD CANCER, V52, P755, DOI 10.1002/pbc.21831; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; NEUBERGER MS, 1995, CURR OPIN IMMUNOL, V7, P248, DOI 10.1016/0952-7915(95)80010-7; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Paguirigan AL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0763; Penel S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S3; Peng CH, 2016, CANCER RES, V76, P2340, DOI 10.1158/0008-5472.CAN-15-1884; Pepper JW, 2007, PLOS COMPUT BIOL, V3, P2532, DOI 10.1371/journal.pcbi.0030250; Rahbari R, 2016, NAT GENET, V48, P126, DOI 10.1038/ng.3469; Rainey PB, 1993, ADV MICROB ECOL, P263; Rajkumar SV, 2010, LANCET ONCOL, V11, P29, DOI 10.1016/S1470-2045(09)70284-0; Reed TE, 2010, P ROY SOC B-BIOL SCI, V277, P3391, DOI 10.1098/rspb.2010.0771; Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030; Rosenberg SM, 2001, NAT REV GENET, V2, P504, DOI 10.1038/35080556; Sakofsky CJ, 2015, MOL CELL, V60, P860, DOI 10.1016/j.molcel.2015.10.041; Sakofsky CJ, 2014, CELL REP, V7, P1640, DOI 10.1016/j.celrep.2014.04.053; Samuel S, 2005, EUR J CANCER, V41, P2428, DOI 10.1016/j.ejca.2005.08.014; SHAPIRO JA, 1984, MOL GEN GENET, V194, P79, DOI 10.1007/BF00383501; Shee C, 2012, CELL REP, V2, P714, DOI 10.1016/j.celrep.2012.08.033; Shi TY, 2013, MED ONCOL, V30, DOI [10.1007/s12032-013-0500-4, 10.1007/s12032-013-0697-2]; Tenaillon O, 2004, TRENDS MICROBIOL, V12, P264, DOI 10.1016/j.tim.2004.04.002; Tomicic MT, 2014, CANCER RES, V74, P5585, DOI 10.1158/0008-5472.CAN-14-0953; Troussellier M, 1998, OCEANOL ACTA, V21, P965, DOI 10.1016/S0399-1784(99)80019-X; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Wenger Y, 2013, GENOME BIOL EVOL, V5, P1949, DOI 10.1093/gbe/evt142; Xie K, 2010, P NATL ACAD SCI USA, V107, P20792, DOI 10.1073/pnas.1011412107; Xu XY, 2013, P NATL ACAD SCI USA, V110, P18638, DOI 10.1073/pnas.1303958110; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; Zhou WD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083978; Zhu XZ, 2016, ONCOL REP, V35, P1664, DOI 10.3892/or.2016.4549	73	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176258	10.1371/journal.pone.0176258	http://dx.doi.org/10.1371/journal.pone.0176258			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441401	Green Published, Green Submitted, gold			2022-12-26	WOS:000400308800039
J	Odili, JB; Kahar, MNM; Noraziah, A				Odili, Julius Beneoluchi; Kahar, Mohd Nizam Mohmad; Noraziah, A.			Parameters-tuning of PID controller for automatic voltage regulators using the African buffalo optimization	PLOS ONE			English	Article								In this paper, an attempt is made to apply the African Buffalo Optimization (ABO) to tune the parameters of a PID controller for an effective Automatic Voltage Regulator (AVR). Existing metaheuristic tuning methods have been proven to be quite successful but there were observable areas that need improvements especially in terms of the system's gain overshoot and steady steady state errors. Using the ABO algorithm where each buffalo location in the herd is a candidate solution to the Proportional-Integral-Derivative parameters was very helpful in addressing these two areas of concern. The encouraging results obtained from the simulation of the PID Controller parameters-tuning using the ABO when compared with the performance of Genetic Algorithm PID (GA-PID), Particle-Swarm Optimization PID (PSO-PID), Ant Colony Optimization PID (ACO-PID), PID, Bacteria-Foraging Optimization PID (BFO-PID) etc makes ABO-PID a good addition to solving PID Controller tuning problems using metaheuristics.	[Odili, Julius Beneoluchi; Kahar, Mohd Nizam Mohmad; Noraziah, A.] Univ Malaysia Pahang, Fac Comp Syst & Software Engn, Kuantan, Malaysia; [Noraziah, A.] Univ Malaysia Pahang, IBM Ctr Excellence, Kuantan, Malaysia	Universiti Malaysia Pahang; Universiti Malaysia Pahang	Odili, JB (corresponding author), Univ Malaysia Pahang, Fac Comp Syst & Software Engn, Kuantan, Malaysia.	odili_julest@yahoo.com	Odili, Julius/D-4037-2015; Mohmad Kahar, Mohd Nizam/M-5102-2016	Odili, Julius/0000-0002-1195-397X; Mohmad Kahar, Mohd Nizam/0000-0003-0811-0856	Faculty of Computer Systems and Software Engineering, Universiti Malaysia Pahang [GRS 1403118]; Ministry of Higher Education, Malaysia under Fundamental Research Grant Scheme [RDU 140101]	Faculty of Computer Systems and Software Engineering, Universiti Malaysia Pahang; Ministry of Higher Education, Malaysia under Fundamental Research Grant Scheme	The authors are grateful to the Faculty of Computer Systems and Software Engineering, Universiti Malaysia Pahang, for funding this study under Grant GRS 1403118. Also the Ministry of Higher Education, Malaysia for additional funding under Fundamental Research Grant Scheme RDU 140101.; The author is grateful to the Faculty of Computer Systems and Software Engineering, Universiti Malaysia Pahang, Kuantan, Malaysia, for funding this study under Grant GRS 1403118. Also, our gratitude to the Ministry of Higher Education, Malaysia, for additional funding under Fundamental Research Grant Scheme RDU 140101	Aravind P., 2013, INT J ADV RES ELECT, V2, P842; Bayram MB, 2013, POW ENG EN EL DRIV P; Bhatt V.K., 2013, INT J ENG RES APPL I, V3, P1480; Chang WD, 2007, APPL MATH MODEL, V31, P541, DOI 10.1016/j.apm.2005.11.024; Giwa A., 2012, INT J ENG RES TECHNO, V1, P1924; Korkmaz M, 2012, INN INT SYST APPL IN; Kushwah M., 2014, ADV ELECT ELECT ENG, V4, P141; Lees F., 2012, LEESLOSS PREVENTION; Li X, 2011, CONTR AUT ICCA 2011; Liptak B., 2013, PROCESS CONTROL INST; Manuaba IB, 2015, CONTROL INTELLIGENT, V43; Nagaraj B, 2010, COMM CONTR COMP TECH; Neath MJ, 2014, IEEE T POWER ELECTR, V29, P1523, DOI 10.1109/TPEL.2013.2262953; Odili JB, 2013, SCI J ELECT ELECT EN, V2013, P175; Odili JB, 2015, AFRICAN BUFFALO OPTI; Odili JB, 2016, COMPUTATIONAL INTELL, V2016, P12; Odili JB, 2015, SOFTW ENG COMP SYST; Odili JB, 2015, COMPUTATIONAL INTELL, V501; Odili JB, AFRICAN BUFFALO OPTI; Odili JB., 2015, BRIT J MATH COMPUTER, V10, P1, DOI DOI 10.9734/BJMCS/2015/17145; Ramakrishnan V, 2015, P INT C INF ENG MAN; S/rensen K., 2013, ENCY OPERATIONS RES, P960, DOI [10.1007/978-1-4419-1153-7_1167, DOI 10.1007/978-1-4419-1153-7_1167, 10.1007/978-1-4419-1153-7]; Shahrokhi M, 2013, COMP PID CONTROLLER, P1; Sorensen K, 2015, INT T OPER RES, V22, P3, DOI 10.1111/itor.12001; Solihin M.I., 2011, INT J ADV SCI ENG IN, V1, P458, DOI [10.18517/ijaseit.1.4.93, DOI 10.18517/IJASEIT.1.4.93]; Tenne Y., 2010, COMPUTATIONAL INTELL; Unal M, 2012, COMP PID CONTROLLER; Xu H, 2012, IEEE T PATTERN ANAL, V34, P187, DOI 10.1109/TPAMI.2011.177; Zou CF, 2016, IEEE T CONTR SYST T, V24, P1594, DOI 10.1109/TCST.2015.2502899	29	17	17	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0175901	10.1371/journal.pone.0175901	http://dx.doi.org/10.1371/journal.pone.0175901			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441390	Green Submitted, Green Published, gold			2022-12-26	WOS:000400308800012
J	Telenczuk, M; Fontaine, B; Brette, R				Telenczuk, Maria; Fontaine, Bertrand; Brette, Romain			The basis of sharp spike onset in standard biophysical models	PLOS ONE			English	Article							ACTION-POTENTIAL INITIATION; CHANNELS RYANODINE RECEPTORS; PYRAMIDAL NEURONS; SODIUM-CHANNEL; AXON; SEGMENT; BACKPROPAGATION; INACTIVATION; FEATURES; REVEALS	In most vertebrate neurons, spikes initiate in the axonal initial segment (AIS). When recorded in the soma, they have a surprisingly sharp onset, as if sodium (Na) channels opened abruptly. The main view stipulates that spikes initiate in a conventional manner at the distal end of the AIS, then progressively sharpen as they backpropagate to the soma. We examined the biophysical models used to substantiate this view, and we found that spikes do not initiate through a local axonal current loop that propagates along the axon, but through a global current loop encompassing the AIS and soma, which forms an electrical dipole. Therefore, the phenomenon is not adequately modeled as the backpropagation of an electrical wave along the axon, since the wavelength would be as large as the entire system. Instead, in these models, we found that spike initiation rather follows the critical resistive coupling model proposed recently, where the Na current entering the AIS is matched by the axial resistive current flowing to the soma. Besides demonstrating it by examining the balance of currents at spike initiation, we show that the observed increase in spike sharpness along the axon is artifactual and disappears when an appropriate measure of rapidness is used; instead, somatic onset rapidness can be predicted from spike shape at initiation site. Finally, we reproduce the phenomenon in a two-compartment model, showing that it does not rely on propagation. In these models, the sharp onset of somatic spikes is therefore not an artifact of observing spikes at the incorrect location, but rather the signature that spikes are initiated through a global soma-AIS current loop forming an electrical dipole.	[Telenczuk, Maria; Brette, Romain] UPMC Univ Paris 06, Sorbonne Univ, CNRS, Inst Vis,INSERM, Paris, France; [Fontaine, Bertrand] Univ Leuven, Lab Auditory Neurophysiol, Leuven, Belgium	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; KU Leuven	Brette, R (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, CNRS, Inst Vis,INSERM, Paris, France.	romain.brette@inserm.fr	Brette, Romain/I-7120-2016	Brette, Romain/0000-0003-0110-1623	Agence Nationale de la Recherche [ANR-14-CE13-0003]; European Research Council [240132]; Ecole des Neurosciences de Paris (ENP); DIM Cerveau et Pensee; European Union's Horizon 2020 research programme through a Marie Sklodowska-Curie fellowship [AUDICON-655137]	Agence Nationale de la Recherche(French National Research Agency (ANR)); European Research Council(European Research Council (ERC)European Commission); Ecole des Neurosciences de Paris (ENP); DIM Cerveau et Pensee; European Union's Horizon 2020 research programme through a Marie Sklodowska-Curie fellowship	RB was supported by Agence Nationale de la Recherche (ANR-14-CE13-0003, http://www.agence-nationale-recherche.fr/) and the European Research Council (StG 240132, https://erc.europa.eu/). MT was supported by Ecole des Neurosciences de Paris (ENP, http://www.paris-neuroscience.fr/) and DIM Cerveau et Pensee (http://dimcerveaupensee.fr/). BF was supported by the European Union's Horizon 2020 research programme through a Marie Sklodowska-Curie fellowship (AUDICON-655137, https://ec.europa.eu/programmes/horizon2020/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsiero M, 2007, J NEUROSCI, V27, P3274, DOI 10.1523/JNEUROSCI.4937-06.2007; Baranauskas G, 2010, NEUROSCIENCE, V167, P1070, DOI 10.1016/j.neuroscience.2010.02.072; Baranauskas G, 2013, P NATL ACAD SCI USA, V110, P4051, DOI 10.1073/pnas.1215125110; BARRETT JN, 1980, J PHYSIOL-LONDON, V304, P231, DOI 10.1113/jphysiol.1980.sp013322; Bekkers JM, 2007, P NATL ACAD SCI USA, V104, P11447, DOI 10.1073/pnas.0701586104; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; Brette R., 2015, WHAT IS MOST REALIST; Brette R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003338; Debanne D, 2011, PHYSIOL REV, V91, P555, DOI 10.1152/physrev.00048.2009; Dekker JP, 2006, J GEN PHYSIOL, V128, P561, DOI 10.1085/jgp.200609599; Diwakar S, 2009, J NEUROPHYSIOL, V101, P519, DOI 10.1152/jn.90382.2008; Einevoll GT, 2013, NAT REV NEUROSCI, V14, P770, DOI 10.1038/nrn3599; Eyal G, 2014, J NEUROSCI, V34, P8063, DOI 10.1523/JNEUROSCI.5431-13.2014; Fleidervish IA, 2010, NAT NEUROSCI, V13, P852, DOI 10.1038/nn.2574; Hallermann S, 2012, NAT NEUROSCI, V15, P1007, DOI 10.1038/nn.3132; Hay E, 2013, J NEUROPHYSIOL, V109, P2972, DOI 10.1152/jn.00048.2013; Hines ML, 2004, J COMPUT NEUROSCI, V17, P7, DOI 10.1023/B:JCNS.0000023869.22017.2e; Hines ML, 1997, NEURAL COMPUT, P9; Hodgkin AL, 1939, J PHYSIOL-LONDON, V94, P560, DOI 10.1113/jphysiol.1939.sp003702; Holt GR, 1997, CRITICAL REEXAMINATI; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; Huang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037629; Ilin V, 2013, J NEUROSCI, V33, P2281, DOI 10.1523/JNEUROSCI.0771-12.2013; Jack J.J.B., 1975, ELECT CURRENT FLOW E; Joshi S, 2006, J NEUROSCI METH, V156, P37, DOI 10.1016/j.jneumeth.2006.02.004; KOCH C, 1995, J COMPUT NEUROSCI, V2, P63, DOI 10.1007/BF00962708; Kole MHP, 2008, NAT NEUROSCI, V11, P1253, DOI 10.1038/nn.2203; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Kuba H, 2012, J PHYSIOL-LONDON, V590, P5571, DOI 10.1113/jphysiol.2012.237305; Marx SO, 1998, SCIENCE, V281, P818, DOI 10.1126/science.281.5378.818; Marx SO, 2001, CIRC RES, V88, P1151, DOI 10.1161/hh1101.091268; McCormick DA, 2007, NATURE, V445, pE1, DOI 10.1038/nature05523; Milescu LS, 2010, J NEUROSCI, V30, P7740, DOI 10.1523/JNEUROSCI.6136-09.2010; Molina ML, 2006, J BIOL CHEM, V281, P18837, DOI 10.1074/jbc.M600342200; Naundorf B, 2006, NATURE, V440, P1060, DOI 10.1038/nature04610; Naundorf B, 2007, NATURE, V445, pE2, DOI 10.1038/nature05534; Oz P, 2015, J COMPUT NEUROSCI, V39, P63, DOI 10.1007/s10827-015-0561-9; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; Perge JA, 2012, J NEUROSCI, V32, P626, DOI 10.1523/JNEUROSCI.4254-11.2012; Platkiewicz J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000850; Schmidt-Hieber C, 2008, J PHYSIOL-LONDON, V586, P1849, DOI 10.1113/jphysiol.2007.150151; Stimberg M, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00006; Telenczuk B, 2016, ZENODO; UNDROVINAS AI, 1992, CIRC RES, V71, P1231, DOI 10.1161/01.RES.71.5.1231; Wyatt KD, 2005, EUR J NEUROSCI, V21, P2285, DOI 10.1111/j.1460-9568.2005.04053.x; Yu YG, 2008, J NEUROSCI, V28, P7260, DOI 10.1523/JNEUROSCI.1613-08.2008	46	11	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0175362	10.1371/journal.pone.0175362	http://dx.doi.org/10.1371/journal.pone.0175362			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441389	Green Published, Green Submitted, gold			2022-12-26	WOS:000400308800004
J	Estiu, MC; Frailuna, MA; Otero, C; Dericco, M; Williamson, C; Marin, JJG; Macias, RIR				Estiu, Maria C.; Frailuna, Maria A.; Otero, Carla; Dericco, Marcela; Williamson, Catherine; Marin, Jose J. G.; Macias, Rocio I. R.			Relationship between early onset severe intrahepatic cholestasis of pregnancy and higher risk of meconium-stained fluid	PLOS ONE			English	Article							URSODEOXYCHOLIC ACID; MATERNAL CHOLESTASIS; BILE-ACIDS; OXIDATIVE STRESS; AMNIOTIC-FLUID; PROGESTERONE; IMPAIRMENT; APOPTOSIS; PRURITUS	Background Intrahepatic cholestasis of pregnancy (ICP) is the commonest gestational liver disease. The risk of adverse fetal outcome has been associated with the severity of maternal hypercholanemia after diagnosis. Objective To investigate whether there is a relationship between the severity and timing of onset of hypercholanemia and the risk of meconium-stained amniotic fluid (MSAF) and adverse neonatal events. Study design The study included 382 pregnancies complicated by ICP managed at a referral hospital in Buenos Aires (Argentina) between June 2009 and December 2013. The patients were classified into three groups according to the severity of hypercholanemia at diagnosis; mild (10-19.9 mu mol/L), moderate (20-39.9 mu mol/L) and severe (>= 40 mu mol/L). Their clinical characteristics and pregnancy outcomes were investigated in a prospective observational study. Results Higher risk of MSAF was observed when ICP appeared early in gestation or when hypercholanemia was more severe. Taking both parameters into account an MSAF risk factor (MRF) was defined. Based on a model of positive/negative predictive values, a cut-off point of MRF = 3 was selected, which prioritized sensitivity versus specificity. In ICP patients with MRF>3, the probability of MSAF was enhanced 4-fold. An increase in the frequency of MSAF was also associated with higher serum levels at diagnosis of alanine transaminase, alkaline phosphatase and direct bilirubin. Conclusions The risk of MSAF is associated not only with the magnitude of hypercholanemia at diagnosis but also with the early gestational onset of raised maternal serum bile acids.	[Estiu, Maria C.; Frailuna, Maria A.; Otero, Carla; Dericco, Marcela] Ramon Sarda Mothers & Childrens Hosp, Buenos Aires, DF, Argentina; [Williamson, Catherine] Kings Coll London, Womens Hlth Acad Ctr, London, England; [Marin, Jose J. G.; Macias, Rocio I. R.] Univ Salamanca, Expt Hepatol & Drug Targeting HEVEFARM, IBSAL, Natl Inst Study Liver & Gastrointestinal Dis CIBE, Salamanca, Spain	University of London; King's College London; University of Salamanca	Macias, RIR (corresponding author), Univ Salamanca, Expt Hepatol & Drug Targeting HEVEFARM, IBSAL, Natl Inst Study Liver & Gastrointestinal Dis CIBE, Salamanca, Spain.	rociorm@usal.es	Macias, Rocio/ABG-8938-2020; Marin, Jose/D-5017-2011	Macias, Rocio/0000-0002-4748-0326; Williamson, Catherine/0000-0002-6226-7611; Marin, Jose/0000-0003-1186-6849	Spanish Ministerio de Ciencia e Innovacion, "Junta de Castilla y Leon" [SAF2013-40620-R, SA015U13]	Spanish Ministerio de Ciencia e Innovacion, "Junta de Castilla y Leon"	This study was supported by the Spanish Ministerio de Ciencia e Innovacion (SAF2013-40620-R), "Junta de Castilla y Leon" (SA015U13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Hayyeh S, 2016, HEPATOLOGY, V63, P1287, DOI 10.1002/hep.28265; Arrese Marco, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000628; Bacq Y, 2012, GASTROENTEROLOGY, V143, P1492, DOI 10.1053/j.gastro.2012.08.004; Dargaville PA, 2006, PEDIATRICS, V117, P1712, DOI 10.1542/peds.2005-2215; Estiu MC, 2015, BRIT J CLIN PHARMACO, V79, P316, DOI 10.1111/bcp.12480; Friberg AK, 2016, ARCH GYNECOL OBSTET, V294, P709, DOI 10.1007/s00404-016-4019-8; Geenes V, 2014, HEPATOLOGY, V59, P1482, DOI 10.1002/hep.26617; Geenes V, 2009, WORLD J GASTROENTERO, V15, P2049, DOI 10.3748/wjg.15.2049; Glantz A, 2005, HEPATOLOGY, V42, P1399, DOI 10.1002/hep.20952; Glantz A, 2004, HEPATOLOGY, V40, P467, DOI 10.1002/hep.20336; Glantz A, 2008, HEPATOLOGY, V47, P544, DOI 10.1002/hep.21987; HEIKKINEN J, 1980, OBSTET GYNECOL, V56, P60; Herraez E, 2014, J MOL MED, V92, P359, DOI 10.1007/s00109-013-1106-1; Hutton EK, 2014, EARLY HUM DEV, V90, P333, DOI 10.1016/j.earlhumdev.2014.04.005; Kawakita T, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.06.021; KIRWAN WO, 1975, GUT, V16, P894, DOI 10.1136/gut.16.11.894; L Brouwers, 2015, PLOS MED, V212, pe1, DOI DOI 10.1016/J.AJ0G.2014.07.026.25046809; Lammert Frank, 2003, Curr Treat Options Gastroenterol, V6, P123, DOI 10.1007/s11938-003-0013-x; Leslie KK, 2000, OBSTET GYNECOL, V95, P372, DOI 10.1016/S0029-7844(99)00533-5; Lo JO, 2015, J MATERN-FETAL NEO M, V28, P2254, DOI 10.3109/14767058.2014.984605; Luca D, 2009, INTENS CARE MED, V35, P321, DOI 10.1007/s00134-008-1321-3; Macias RIR, 2000, HEPATOLOGY, V31, P975, DOI 10.1053/he.2000.5921; Marschall HU, 2013, HEPATOLOGY, V58, P1385, DOI 10.1002/hep.26444; Martineau M, 2014, EUR J OBSTET GYN R B, V176, P80, DOI 10.1016/j.ejogrb.2013.12.037; Monte MJ, 1996, HEPATOLOGY, V23, P1208; Naritaka N, 2015, CLIN CHIM ACTA, V446, P76, DOI 10.1016/j.cca.2015.04.008; Oruc AS, 2014, J OBSTET GYNAECOL RE, V40, P1883, DOI 10.1111/jog.12444; Papacleovoulou G, 2013, J CLIN INVEST, V123, P3172, DOI 10.1172/JCI68927; Pascual MJ, 2002, CLIN SCI, V102, P587, DOI 10.1042/CS20010258; Perez MJ, 2006, PLACENTA, V27, P34, DOI 10.1016/j.placenta.2004.10.020; Perez MJ, 2005, J HEPATOL, V43, P324, DOI 10.1016/j.jhep.2005.02.028; Puljic A, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.02.012; REYES H, 1979, J CHRON DIS, V32, P499, DOI 10.1016/0021-9681(79)90111-5; Reyes H, 1997, J GASTROEN HEPATOL, V12, P211, DOI 10.1111/j.1440-1746.1997.tb00410.x; RIOSECO AJ, 1994, AM J OBSTET GYNECOL, V170, P890, DOI 10.1016/S0002-9378(94)70304-3; Rodrigues CMP, 1999, GUT, V45, P446, DOI 10.1136/gut.45.3.446; Sentilhes L, 2008, J GYNECOL OBST BIO R, V37, P118, DOI 10.1016/j.jgyn.2006.09.007; Serrano MA, 2003, J PHARMACOL EXP THER, V305, P515, DOI 10.1124/jpet.102.047977; Shemer EAW, 2015, J HEPATOL, V63, P456, DOI 10.1016/j.jhep.2015.03.010; Wensink MJ, 2016, AM J OBSTET GYNECOL, V215, P807, DOI 10.1016/j.ajog.2016.07.033; Williamson C, 2004, BJOG-INT J OBSTET GY, V111, P676, DOI 10.1111/j.1471-0528.2004.00167.x	41	23	27	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176504	10.1371/journal.pone.0176504	http://dx.doi.org/10.1371/journal.pone.0176504			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437442	gold, Green Published, Green Submitted			2022-12-26	WOS:000400287600050
J	Jacob, J; Rajendran, RU; Priya, SH; Purushothaman, J; Amma, DKBNS				Jacob, Jubi; Rajendran, Reshma Uma; Priya, Syama Hari; Purushothaman, Jayamurthy; Amma, Dileep Kumar Bhaskaran Nair Saraswathy			Enhanced antibacterial metabolite production through the application of statistical methodologies by a Streptomyces nogalater NIIST A30 isolated from Western Ghats forest soil	PLOS ONE			English	Article							ANTIFUNGAL PRODUCTION; ANTIBIOTIC-ACTIVITY; OPTIMIZATION; ACTINOMYCETE; IMPROVEMENT	Streptomyces strains isolated from Nelliyampathy forest soil of Western Ghats, Kerala, India were evaluated for their antibacterial efficacy against two indicator pathogenic bacteria (Escherichia coli and Staphylococcus aureus). Among 140 strains tested, sixteen recorded potent antibacterial properties and were further screened against eleven bacterial pathogens. A strain identified as Streptomyces nogalater and designated as NIIST A30 exhibited maximum inhibition against all the test pathogens. Among the eight fermentation media tested, inorganic salts starch broth recorded the best for antibacterial production. The ethyl acetate crude extract exhibited antioxidant properties with IC50 value of 30 mu g/ mL and had no cytotoxicity towards L6, H9c2 and RAW 264.7 cell lines up to a concentration of 50 mu g/ mL. Maximum metabolite production was achieved in pH 7.0 at 35 degrees C after 7 days incubation. The significant media components for maximum metabolite production were optimized through response surface methodology employing Plackett-Burman and Box-Behnken designs. The composition of the final optimized medium was soluble starch, 14.97g; (NH4)(2)SO4, 2.89g; K2HPO4, 2.07g; MgSO4 center dot 7H(2)O, 1g; NaCl, 1g, CaCO3, 2g; FeSO4 center dot 7H(2)O, 1mg; MnCl2.7H(2)O, 1mg; and ZnSO4.7H(2)O, 1mg per litre of distilled water. The optimization resulted an antibacterial activity of 28 +/- 1.5mm against S. epidermidis which was in close accordance with the predicted value of 30 mm. It is also evident from the result that an increase of 86.66% antibacterial production was recorded in optimized media. The chosen method was economical, efficient and useful for future antibacterial drug discovery from a broad spectrum metabolite producer like Streptomyces nogalater NIIST A30.	[Jacob, Jubi; Rajendran, Reshma Uma; Priya, Syama Hari; Purushothaman, Jayamurthy; Amma, Dileep Kumar Bhaskaran Nair Saraswathy] CSIR, NIIST, Agroproc & Technol Div, Thiruvananthapuram, Kerala, India; [Jacob, Jubi; Purushothaman, Jayamurthy; Amma, Dileep Kumar Bhaskaran Nair Saraswathy] CSIR, NIIST, Acad Sci & Innovat Res AcSIR, Thiruvananthapuram, Kerala, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute Interdisciplinary Science & Technology (NIIST); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute Interdisciplinary Science & Technology (NIIST)	Amma, DKBNS (corresponding author), CSIR, NIIST, Agroproc & Technol Div, Thiruvananthapuram, Kerala, India.; Amma, DKBNS (corresponding author), CSIR, NIIST, Acad Sci & Innovat Res AcSIR, Thiruvananthapuram, Kerala, India.	kumardileep@niist.res.in	HP, Syama/GOV-6372-2022		Kerala State Council for Science, Technology and Environment (KSCSTE), Thiruvananthapuram; Department of Science and Technology, New Delhi [IF 130648]	Kerala State Council for Science, Technology and Environment (KSCSTE), Thiruvananthapuram; Department of Science and Technology, New Delhi(Department of Science & Technology (India))	Financial support from Kerala State Council for Science, Technology and Environment (KSCSTE), Thiruvananthapuram and the Department of Science and Technology, New Delhi for Inspire Fellowship (IF 130648) to JJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial support was received from Kerala State Council for Science, Technology and Environment (KSCSTE), Thiruvananthapuram and the Department of Science and Technology, New Delhi for Inspire Fellowship (IF 130648) to JJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo-Shadi M.A., 2010, J AM SCI, V6, P915; Al-Duais M, 2009, EUR FOOD RES TECHNOL, V228, P813, DOI 10.1007/s00217-008-0994-8; Anvari M, 2014, J DAIRY RES, V81, P59, DOI 10.1017/S0022029913000733; Arul Jose Polpass, 2013, Int J Microbiol, V2013, P526260, DOI 10.1155/2013/526260; Berdy J, 2012, J ANTIBIOT, V65, P385, DOI [10.1038/ja.2012.27, 10.1038/ja.2012.54]; Bizuye A, 2013, ASIAN PAC J TROP DIS, V3, P375, DOI DOI 10.1016/S2222-1808(13)60087-0; Box G. E., 1960, TECHNOMETRICS, V2, P455, DOI [10.2307/1266454, DOI 10.2307/1266454, 10.1080/00401706.1960.10489912, DOI 10.1080/00401706.1960.10489912]; Che Q, 2012, ORG LETT, V14, P3438, DOI 10.1021/ol301396h; Chun J, 2000, INT J SYST EVOL MICR, V50, P1909, DOI 10.1099/00207713-50-5-1909; CLSI, 2012, M02A1 CLSI, V7th; Procopio RED, 2012, BRAZ J INFECT DIS, V16, P466, DOI 10.1016/j.bjid.2012.08.014; Dehnad A, 2010, AFR J MICROBIOL RES, V4, P1542; Drummond A. J., 2012, GENEIOUS V5 6; Feng JT, 2011, AFR J AGR RES, V6, P4424; Fukuda T, 2005, J ANTIBIOT, V58, P252, DOI 10.1038/ja.2005.29; GORDON RE, 1974, INT J SYST BACTERIOL, V24, P54, DOI 10.1099/00207713-24-1-54; Grahovac J, 2014, CROP PROT, V65, P143, DOI 10.1016/j.cropro.2014.07.020; IWAI Y, 1982, J ANTIBIOT, V35, P123, DOI 10.7164/antibiotics.35.123; Jose PA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/906097; Larpent JP, 1990, MEMENTO TECHNIQUE MI; Li TL, 2015, APPL BIOCHEM BIOTECH, V175, P2845, DOI 10.1007/s12010-014-1445-6; Magalhaes LM, 2008, ANAL CHIM ACTA, V613, P1, DOI 10.1016/j.aca.2008.02.047; Manivasagan P, 2014, MICROBIOL RES, V169, P262, DOI 10.1016/j.micres.2013.07.014; Messis A, 2014, MED CHEM RES, V23, P310, DOI 10.1007/s00044-013-0627-z; Moraes-De-Souza RA, 2008, CIENC TECNOL ALIMENT, V6, P41, DOI 10.1080/11358120809487626; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nampoothiri KM, 2013, J SCI IND RES INDIA, V72, P617; Nishanth Kumar, 2013, Archives of Phytopathology and Plant Protection, V46, P721, DOI 10.1080/03235408.2012.750815; PLACKETT RL, 1946, BIOMETRIKA 4, V33, P305, DOI DOI 10.1093/BIOMET/33.4.305; Ripa F. A., 2009, Mycobiology, V37, P211, DOI 10.4489/MYCO.2009.37.3.211; Sevilla-Perea A, 2015, INT J ENVIRON SCI TE, V12, P125, DOI 10.1007/s13762-013-0443-5; SHIRLING E. B., 1966, INT J SYST BACTERIOL, V16, P313; Singh LS, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0278-3; Souagui Y, 2015, J MYCOL MED, V25, P108, DOI 10.1016/j.mycmed.2014.12.004; Suganthi V, 2015, J FOOD SCI TECH MYS, V52, P3773, DOI 10.1007/s13197-014-1440-5; Tarkka Mika, 2008, V14, P107; Valgas C, 2007, BRAZ J MICROBIOL, V38, P369, DOI 10.1590/S1517-83822007000200034; Wang YH, 2011, MICROB CELL FACT, V10, DOI [10.1155/2011/672369, 10.1186/1475-2859-10-98]; Watve MG, 2001, ARCH MICROBIOL, V176, P386, DOI 10.1007/s002030100345; Xiong ZQ, 2008, J IND MICROBIOL BIOT, V35, P729, DOI 10.1007/s10295-008-0339-4; Zhu CH, 2007, APPL MICROBIOL BIOT, V73, P1031, DOI 10.1007/s00253-006-0572-6	41	11	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0175919	10.1371/journal.pone.0175919	http://dx.doi.org/10.1371/journal.pone.0175919			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437452	gold, Green Published, Green Submitted			2022-12-26	WOS:000400287600022
J	Montenegro, CF; Casali, BC; Lino, RLB; Pachane, BC; Santos, PK; Horwitz, AR; Selistre-de-Araujo, HS; Lamers, ML				Montenegro, Cyntia F.; Casali, Bruna C.; Lino, Rafael L. B.; Pachane, Bianca C.; Santos, Patty K.; Horwitz, Alan R.; Selistre-de-Araujo, Heloisa S.; Lamers, Marcelo L.			Inhibition of alpha(v)beta(3) integrin induces loss of cell directionality of oral squamous carcinoma cells (OSCC)	PLOS ONE			English	Article							SNAKE-VENOM DISINTEGRIN; ALPHA-ACTININ; MYOSIN-II; MIGRATION; ADHESION; MATRIX; MICROENVIRONMENT; ALPHA(5)BETA(1); ANGIOGENESIS; GLIOBLASTOMA	The connective tissue formed by extracellular matrix (ECM) rich in fibronectin and collagen consists a barrier that cancer cells have to overpass to reach blood vessels and then a metastatic site. Cell adhesion to fibronectin is mediated by alpha(v)beta(3) and alpha(5)beta(1) integrins through an RGD motif present in this ECM protein, thus making these receptors key targets for cell migration studies. Here we investigated the effect of an RGD disintegrin, DisBa-01, on the migration of human fibroblasts (BJ) and oral squamous cancer cells (OSCC, SCC25) on a fibronectin-rich environment. Time-lapse images were acquired on fibronectin-coated glassbottomed dishes. Migration speed and directionality analysis indicated that OSCC cells, but not fibroblasts, showed significant decrease in both parameters in the presence of DisBa-01 (1 mu M and 2 mu M). Integrin expression levels of the alpha(5), alpha(v) and beta(3) subunits were similar in both cell lines, while beta(1) subunit is present in lower levels on the cancer cells. Next, we examined whether the effects of DisBa-01 were related to changes in adhesion properties by using paxillin immunostaining and total internal reflection fluorescence TIRF microscopy. OSCCs in the presence of DisBa-01 showed increased adhesion sizes and number of maturing adhesion. The same parameters were analyzed using beta 3-gfp overexpressing cells and showed that beta(3) overexpression restored cell migration velocity and the number of maturing adhesion that were altered by DisBa-01. Surface plasmon resonance analysis showed that DisBa-01 has 100x higher affinity for a v beta(3) integrin than alpha(v)beta(3) integrin. In conclusion, our results suggest that the alpha(v)beta(3) integrin is the main receptor involved in cell directionality and its blockage may be an interesting alternative against metastasis.	[Montenegro, Cyntia F.; Casali, Bruna C.; Lino, Rafael L. B.; Pachane, Bianca C.; Santos, Patty K.; Selistre-de-Araujo, Heloisa S.] Univ Fed Sao Carlos, Ctr Biol & Hlth Sci, Dept Physiol Sci, Rod Washington Luis, Sao Carlos, SP, Brazil; [Horwitz, Alan R.] Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA; [Lamers, Marcelo L.] Univ Fed Rio Grande do Sul, Inst Basic Hlth Sci, Dept Morphol Sci, Rua Sarmento Leite, Porto Alegre, RS, Brazil	Universidade Federal de Sao Carlos; University of Virginia; Universidade Federal do Rio Grande do Sul	Selistre-de-Araujo, HS (corresponding author), Univ Fed Sao Carlos, Ctr Biol & Hlth Sci, Dept Physiol Sci, Rod Washington Luis, Sao Carlos, SP, Brazil.	hsaraujo@ufscar.br	dos Santos, Patty Karina/Y-1305-2019; LAMERS, MARCELO/A-5291-2013; Pachane, Bianca C/N-7512-2018; Selistre-de-Araujo, Heloisa/A-3792-2016; Bressani Lino, Rafael Luis/P-2512-2016	dos Santos, Patty Karina/0000-0002-4704-2799; LAMERS, MARCELO/0000-0001-5296-5662; Pachane, Bianca C/0000-0002-7302-4498; Selistre-de-Araujo, Heloisa/0000-0002-2372-7814; Bressani Lino, Rafael Luis/0000-0002-5683-7040; Casali, Bruna/0000-0002-1056-8236	National Institute of Health [NIH] [GM23244]; FAPESP [2013/00798-2]; CNPq [140130/2012-8, 308096/2013-4]	National Institute of Health [NIH](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by National Institute of Health [NIH, GM23244], Alan R. Horwitz, https://www.nih.gov; FAPESP 2013/00798-2, HSS Araujo, www.fapesp.br; CNPq 140130/2012-8, CF Montenegro, 308096/2013-4 HSS Araujo, www.cnpq.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AM, 2014, TUMOR BIOL, V35, P8483, DOI 10.1007/s13277-014-2421-z; Anderson HJ, 2016, CELL ONCOL, V39, P229, DOI 10.1007/s13402-016-0267-7; Barnhart EL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001059; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Calvete JJ, 2013, TOXICON, V62, P40, DOI 10.1016/j.toxicon.2012.09.005; Cassini-Vieira P, 2014, TOXICON, V92, P81, DOI 10.1016/j.toxicon.2014.10.007; Chen LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040202; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Christmann M., 2016, ONCOTARGET; Coelho ALJ, 1999, EXP CELL RES, V251, P379, DOI 10.1006/excr.1999.4583; Colley HE, 2011, BRIT J CANCER, V105, P1582, DOI 10.1038/bjc.2011.403; da Silva SD, 2011, ORAL ONCOL, V47, P783, DOI 10.1016/j.oraloncology.2011.07.004; Danen EHJ, 2005, J CELL BIOL, V169, P515, DOI 10.1083/jcb.200412081; Danen EHJ, 2002, J CELL BIOL, V159, P1071, DOI 10.1083/jcb.200205014; Desgrosellier J, 2015, NAT REV, V10, P9, DOI DOI 10.1038/NRC2748.INTEGRINS; Di Cio S, 2016, ACTA BIOMATER, V30, P26, DOI 10.1016/j.actbio.2015.11.027; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; GAN ZR, 1988, J BIOL CHEM, V263, P19827; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gleber-Netto FO, 2015, ORAL ONCOL, V51, P738, DOI 10.1016/j.oraloncology.2015.04.016; HARADA T, 1994, VIRCHOWS ARCH, V424, P257; Huang TF, 1998, CELL MOL LIFE SCI, V54, P527, DOI 10.1007/s000180050181; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kosmehl H, 1999, BRIT J CANCER, V81, P1071, DOI 10.1038/sj.bjc.6690809; Lamers ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022865; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; LEAVESLEY DI, 1992, J CELL BIOL, V117, P1101, DOI 10.1083/jcb.117.5.1101; Lucena S, 2015, TOXICON, V93, P136, DOI 10.1016/j.toxicon.2014.11.228; Marcinkiewicz C, 2013, INT J BIOCHEM CELL B, V45, P1974, DOI 10.1016/j.biocel.2013.06.009; Missirlis D, 2016, SCI REP-UK, V6, DOI 10.1038/srep23258; Montenegro CF, 2012, BIOCHIMIE, V94, P1812, DOI 10.1016/j.biochi.2012.04.020; Morgan MR, 2009, IUBMB LIFE, V61, P731, DOI 10.1002/iub.200; Muntion S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146722; Oakes PW, 2014, CURR OPIN CELL BIOL, V30, P68, DOI 10.1016/j.ceb.2014.06.003; Olfa KZ, 2005, LAB INVEST, V85, P1507, DOI 10.1038/labinvest.3700350; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Parvani JG, 2015, CANCER RES, V75, P2316, DOI 10.1158/0008-5472.CAN-14-3485; Ramos OHP, 2008, CLIN EXP METASTAS, V25, P53, DOI 10.1007/s10585-007-9101-y; Reardon David A, 2011, Genes Cancer, V2, P1159, DOI 10.1177/1947601912450586; Schiller HB, 2013, NAT CELL BIOL, V15, P625, DOI 10.1038/ncb2747; Scully C, 2009, ORAL ONCOL, V45, P301, DOI 10.1016/j.oraloncology.2009.01.004; Selistre-de-Araujo HS, 2010, TOXINS, V2, P2606, DOI 10.3390/toxins2112606; Stupp R, 2014, LANCET ONCOL, V15, P1100, DOI 10.1016/S1470-2045(14)70379-1; Tian J, 2007, TOXICON, V49, P899, DOI 10.1016/j.toxicon.2006.12.013; Vicente-Manzanares M, 2011, J CELL SCI, V124, P3923, DOI 10.1242/jcs.095653	47	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176226	10.1371/journal.pone.0176226	http://dx.doi.org/10.1371/journal.pone.0176226			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437464	gold, Green Published, Green Submitted			2022-12-26	WOS:000400287600035
J	Xie, GL; Zhu, L; Zhang, YM; Zhang, QN; Yu, Q				Xie, Guang-liang; Zhu, Lin; Zhang, Yan-min; Zhang, Qian-nan; Yu, Qing			Change in iron metabolism in rats after renal ischemia/reperfusion injury	PLOS ONE			English	Article							HEPCIDIN GENE-EXPRESSION; OXIDATIVE STRESS; REPERFUSION INJURY; PEPTIDE HEPCIDIN; KIDNEY; FERROPORTIN; TRANSPORTER; THERAPY; CELLS; INFLAMMATION	Previous studies have indicated that hepcidin, which can regulate iron efflux by binding to ferroportin-1 (FPN1) and inducing its internalization and degradation, acts as the critical factor in the regulation of iron metabolism. However, it is unknown whether hepcidin is involved in acute renal ischemia/reperfusion injury (IRI). In this study, an IRI rat model was established via right renal excision and blood interruption for 45 min in the left kidney, and iron metabolism indexes were examined to investigate the change in iron metabolism and to analyze the role of hepcidin during IRI. From 1 to 24 h after renal reperfusion, serum creatinine and blood urea nitrogen were found to be time-dependently increased with different degrees of kidney injury. Regular variations in iron metabolism indexes in the blood and kidneys were observed in renal IRI. Renal iron content, serum iron and serum ferritin increased early after reperfusion and then declined. Hepcidin expression in the liver significantly increased early after reperfusion, and its serum concentration increased beginning at 8 h after reperfusion. The splenic iron content decreased significantly in the early stage after reperfusion and then increased time-dependently with increasing reperfusion time, and the hepatic iron content showed a decrease in the early stage after reperfusion. The early decrease of the splenic iron content and hepatic iron content might indicate their contribution to the increase in serum iron in renal IRI. In addition, the duodenal iron content showed time-dependently decreased since 12 h after reperfusion in the IRI groups compared to the control group. Along with the spleen, the duodenum might contribute to the decrease in serum iron in the later stage after reperfusion. The changes in iron metabolism indexes observed in our study demonstrate an iron metabolism disorder in renal IRI, and hepcidin might be involved in maintaining iron homeostasis in renal IRI. These findings might suggest a self-protection mechanism regulating iron homeostasis in IRI and provide a new perspective on iron metabolism in attenuating renal IRI.	[Xie, Guang-liang; Zhu, Lin; Zhang, Yan-min; Zhang, Qian-nan; Yu, Qing] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Sch Med, Dept Nephrol, Shanghai, Peoples R China	Shanghai Jiao Tong University	Yu, Q (corresponding author), Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Sch Med, Dept Nephrol, Shanghai, Peoples R China.	yuqingsh2014@sina.com			Shanghai Committee of Science and Technology Foundation [14411963300]	Shanghai Committee of Science and Technology Foundation	This research is funded by the Shanghai Committee of Science and Technology Foundation (http://www.stcsm.gov.cn/); the funding number is 14411963300. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Al-Ismaili Z, 2011, PEDIATR NEPHROL, V26, P1781, DOI 10.1007/s00467-010-1727-3; Anderson GJ, 2009, CURR OPIN GASTROEN, V25, P129, DOI 10.1097/MOG.0b013e32831ef1f7; Burne-Taney MJ, 2006, J IMMUNOL, V176, P7015, DOI 10.4049/jimmunol.176.11.7015; Chaston T, 2008, GUT, V57, DOI 10.1136/gut.2007.131722; Costa E, 2008, AM J NEPHROL, V28, P677, DOI 10.1159/000121478; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Ferguson CJ, 2003, KIDNEY INT, V64, P1755, DOI 10.1046/j.1523-1755.2003.00274.x; Fernandes JC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/421304; Ganz T, 2016, SEMIN NEPHROL, V36, P87, DOI 10.1016/j.semnephrol.2016.02.001; Ganz T, 2012, J INNATE IMMUN, V4, P446, DOI 10.1159/000336423; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Garrido P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124048; Garrido P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010028; Golab F, 2009, KIDNEY INT, V75, P783, DOI 10.1038/ki.2008.683; Gu D, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/2093940; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Javedan G, 2016, MOL NUTR FOOD RES, V60, P2665, DOI 10.1002/mnfr.201600112; Jomova K, 2011, TOXICOLOGY, V283, P65, DOI 10.1016/j.tox.2011.03.001; Kyriazis I, 2013, WORLD J UROL, V31, P597, DOI 10.1007/s00345-012-0980-4; Liang HL, 2009, AM J PHYSIOL-RENAL, V296, pF266, DOI 10.1152/ajprenal.90533.2008; Lim CS, 2004, AM J NEPHROL, V24, P569, DOI 10.1159/000082201; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Mena NP, 2006, BIOL RES, V39, P191, DOI 10.4067/S0716-97602006000100022; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Palmer C, 1999, J NEUROSCI RES, V56, P60, DOI 10.1002/(SICI)1097-4547(19990401)56:1<60::AID-JNR8>3.0.CO;2-A; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Ramey G, 2010, HAEMATOL-HEMATOL J, V95, P501, DOI 10.3324/haematol.2009.014399; Rathnasamy G, 2011, J NEUROSCI, V31, P17982, DOI 10.1523/JNEUROSCI.2250-11.2011; Ribeiro S, 2016, BIOFACTORS, V42, P296, DOI 10.1002/biof.1275; Ribeiro S, 2016, BLOOD CELL MOL DIS, V59, P63, DOI 10.1016/j.bcmd.2016.04.008; Ribeiro S, 2016, BIOCHIMIE, V125, P150, DOI 10.1016/j.biochi.2016.03.012; Ribeiro S, 2016, BLOOD REV, V30, P65, DOI 10.1016/j.blre.2015.07.006; Scindia Y, 2015, J AM SOC NEPHROL, V26, P2800, DOI 10.1681/ASN.2014101037; Smith CP, 2009, BBA-GEN SUBJECTS, V1790, P724, DOI 10.1016/j.bbagen.2008.10.010; Thurman JM, 2007, CLIN IMMUNOL, V123, P7, DOI 10.1016/j.clim.2006.09.008; van Eijk LT, 2014, HAEMATOLOGICA, V99, P579, DOI 10.3324/haematol.2013.088047; Veuthey T, 2008, AM J PHYSIOL-RENAL, V295, pF1213, DOI 10.1152/ajprenal.90216.2008; Walker VJ, 2016, SEMIN NEPHROL, V36, P62, DOI 10.1016/j.semnephrol.2016.01.003; Yamaji S, 2004, BLOOD, V104, P2178, DOI 10.1182/blood-2004-03-0829; Yanatori I, 2016, J BIOL CHEM, V291, P17303, DOI 10.1074/jbc.M116.721936; ZAGER RA, 1993, J CLIN INVEST, V91, P702, DOI 10.1172/JCI116251	47	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175945	10.1371/journal.pone.0175945	http://dx.doi.org/10.1371/journal.pone.0175945			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426710	Green Published, gold, Green Submitted			2022-12-26	WOS:000399875900073
J	Yoon, CW; Choi, Y; Jeon, S; Lee, DH; Yoon, BN; Park, HK; Rha, JH				Yoon, Cindy W.; Choi, Yoonjae; Jeon, Seun; Lee, Dae Hyung; Yoon, Byung-Nam; Park, Hee-Kwon; Rha, Joung-Ho			Is antiplatelet treatment effective at attenuating the progression of white matter hyperintensities?	PLOS ONE			English	Editorial Material							ELDERLY-PEOPLE; ROTTERDAM SCAN; LESIONS; STROKE; LEUKOARAIOSIS; POPULATION; PREDICTOR; DECLINE; RISK	Objective We performed this study to assess the effect of an antiplatelet agent on the progression of white matter hyperintensities (WMH). Methods From August 2003 to May 2005, we consecutively enrolled patients who underwent brain magnetic resonance imaging (MRI) for health check-up purposes and showed no significant findings other than WMH of any degree. Patients were divided into two groups based on whether or not they received antiplatelet therapy. All patients had a follow-up brain MRI after 5 years and WMH volume change was measured using imaging analysis software. To minimize selection bias potentially arising from antiplatelet treatment assignment, analyses were inverse probability weighted. Results Among the 93 patients who met the inclusion criteria, 54 patients (58.1%) were grouped as the antiplatelet group (AG), and the remaining 39 patients (41.9%) as the non-antiplatelet group (NAG). After inverse propensity weighting, all baseline characteristics were similar between the two groups, and antiplatelet treatment did not show any significant effect on the total WMH volume change (p = 0.957). Conclusion Antiplatelet medication may not alter the progression of WMH.	[Yoon, Cindy W.; Choi, Yoonjae; Yoon, Byung-Nam; Park, Hee-Kwon; Rha, Joung-Ho] Inha Univ, Dept Neurol, Sch Med, Incheon, South Korea; [Jeon, Seun] McGill Univ, Montreal Neurol Inst, McGill Ctr Integrat Neurosci, Montreal, PQ, Canada; [Lee, Dae Hyung] Inha Univ, Clin Res Ctr, Sch Med, Incheon, South Korea	Inha University; McGill University; Inha University	Rha, JH (corresponding author), Inha Univ, Dept Neurol, Sch Med, Incheon, South Korea.	jhrha@inha.ac.kr	Jeon, Seun/AAK-3204-2020; Yoon, Cindy/HCJ-0079-2022	Jeon, Seun/0000-0003-2817-3352; Yoon, Cindy/0000-0002-4697-6610	NIGMS NIH HHS [T32 GM008169] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allan CL, 2015, BRIT J PSYCHIAT, V206, P308, DOI 10.1192/bjp.bp.114.153536; Choi JC, 2015, J STROKE, V17, P7, DOI 10.5853/jos.2015.17.1.7; de Leeuw FE, 2001, J NEUROL NEUROSUR PS, V70, P9, DOI 10.1136/jnnp.70.1.9; Enzinger C, 2007, J NEUROL SCI, V257, P5, DOI 10.1016/j.jns.2007.01.018; Garde E, 2000, LANCET, V356, P628, DOI 10.1016/S0140-6736(00)02604-0; Gardener H, 2012, ARCH NEUROL-CHICAGO, V69, P251, DOI 10.1001/archneurol.2011.548; HACHINSKI VC, 1987, ARCH NEUROL-CHICAGO, V44, P21, DOI 10.1001/archneur.1987.00520130013009; Hatazawa J, 1997, STROKE, V28, P1944, DOI 10.1161/01.STR.28.10.1944; Inzitari D, 2003, STROKE, V34, P2067, DOI 10.1161/01.STR.0000080934.68280.82; Jeon S, 2011, INT J IMAG SYST TECH, V21, P193, DOI 10.1002/ima.20277; Kuller LH, 2004, STROKE, V35, P1821, DOI 10.1161/01.STR.0000132193.35955.69; Launer Lenore J, 2004, Top Magn Reson Imaging, V15, P365, DOI 10.1097/01.rmr.0000168216.98338.8d; Longstreth WT, 1996, STROKE, V27, P1274, DOI 10.1161/01.STR.27.8.1274; Swan GE, 1998, NEUROLOGY, V51, P986, DOI 10.1212/WNL.51.4.986; Tran T, 2016, J NEUROL NEUROSUR PS, V87, P260, DOI 10.1136/jnnp-2014-309685; Vermeer SE, 2003, STROKE, V34, P1126, DOI 10.1161/01.STR.0000068408.82115.D2; YLIKOSKI A, 1995, STROKE, V26, P1171, DOI 10.1161/01.STR.26.7.1171; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	18	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176300	10.1371/journal.pone.0176300	http://dx.doi.org/10.1371/journal.pone.0176300			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426738	Green Submitted, Green Published, gold			2022-12-26	WOS:000399875900128
J	Niu, N; Mercado-Uribe, I; Liu, J				Niu, N.; Mercado-Uribe, I.; Liu, J.			Dedifferentiation into blastomere-like cancer stem cells via formation of polyploid giant cancer cells	ONCOGENE			English	Article							CLEAVAGE-STAGE EMBRYOS; IN-VITRO; CELLULAR SENESCENCE; OVARIAN TUMORIGENESIS; TUMOR-CELLS; DIFFERENTIATION; CYTOKINESIS; THERAPY; FAILURE; ESCAPE	Our recent perplexing findings that polyploid giant cancer cells (PGCCs) acquired embryonic-like stemness and were capable of tumor initiation raised two important unanswered questions: how do PGCCs acquire such stemness, and to which stage of normal development do PGCCs correspond. Intriguingly, formation of giant cells due to failed mitosis/cytokinesis is common in the blastomere stage of the preimplantation embryo. However, the relationship between PGCCs and giant blastomeres has never been studied. Here, we tracked the fate of single PGCCs following paclitaxel-induced mitotic failure. Morphologically, early spheroids derived from PGCCs were indistinguishable from human embryos at the blastomere, polyploid blastomere, compaction, morula and blastocyst-like stages by light, scanning electron or three-dimensional confocal scanning microscopy. Formation of PGCCs was associated with activation of senescence, while budding of daughter cells was associated with senescence escape. PGCCs showed time- and space-dependent activation of expression of the embryonic stem cell markers OCT4, NANOG, SOX2 and SSEA1 and lacked expression of Xist. PGCCs acquired mesenchymal phenotype and were capable of differentiation into all three germ layers in vitro. The embryonic-like stemness of PGCCs was associated with nuclear accumulation of YAP, a key mediator of the Hippo pathway. Spheroids derived from single PGCCs grew into a wide spectrum of human neoplasms, including germ cell tumors, high-grade and low-grade carcinomas and benign tissues. Daughter cells derived from PGCCs showed attenuated capacity for invasion and increased resistance to paclitaxel. We also observed formation of PGCCs and dedifferentiation in ovarian cancer specimens from patients treated with chemotherapy. Taken together, our findings demonstrate that PGCCs represent somatic equivalents of blastomeres, the most primitive cancer stem cells reported to date. Thus, our studies reveal an evolutionarily conserved archaic embryonic program in somatic cells that can be de-repressed for oncogenesis. Our work offers a new paradigm for cancer origin and disease relapse.	[Liu, J.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Unit 85, Houston, TX 77030 USA; Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Liu, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pathol, Unit 85, Houston, TX 77030 USA.	jliu@mdanderson.org			Cancer Prevention and Research Institute of Texas; MD Anderson Cancer Center Global Academic Programs; National Cancer Institute Cancer Center Support Grant [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas; MD Anderson Cancer Center Global Academic Programs; National Cancer Institute Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a multi-investigator grant from the Cancer Prevention and Research Institute of Texas (JL); a Sister Institution Grant from MD Anderson Cancer Center Global Academic Programs; and National Cancer Institute Cancer Center Support Grant CA016672, which supported the High Resolution Electron Microscopy Facility. We thank Kim Vu for image artwork and Stephanie Deming for editorial assistance. We thank many colleagues for helpful discussions. We apologize for many investigators who embraced embryonic origin of tumor or its variants over past two centuries whose work can not be cited and discussed due to space limitation.	Andrews PW, 2002, PHILOS T R SOC B, V357, P405, DOI 10.1098/rstb.2002.1058; BENKHALIFA M, 1993, HUM REPROD, V8, P895, DOI 10.1093/oxfordjournals.humrep.a138162; Blum B, 2008, ADV CANCER RES, V100, P133, DOI 10.1016/S0065-230X(08)00005-5; Braune EB, 2016, STEM CELL REP, V6, P643, DOI 10.1016/j.stemcr.2016.03.004; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Chakradeo S, 2016, CURR DRUG TARGETS, V17, P460, DOI 10.2174/1389450116666150825113500; Chavez SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2249; Chen HH, 2014, STEM CELL REP, V3, P892, DOI 10.1016/j.stemcr.2014.09.003; Cohnheim J, 1867, PATH ANAT PHYSL KLIN, V40, P1, DOI 10.1007/BF02968135; Davoli T, 2012, CANCER CELL, V21, P765, DOI 10.1016/j.ccr.2012.03.044; Erenpreisa J, 2005, CELL BIOL INT, V29, P1005, DOI 10.1016/j.cellbi.2005.10.008; Erenpreisa JA, 2000, CELL BIOL INT, V24, P635, DOI 10.1006/cbir.2000.0558; Ewald JA, 2010, JNCI-J NATL CANCER I, V102, P1536, DOI 10.1093/jnci/djq364; Forsdahl S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102559; Fox DT, 2013, DEVELOPMENT, V140, P3, DOI 10.1242/dev.080531; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ganem NJ, 2007, CELL, V131, P437, DOI 10.1016/j.cell.2007.10.024; Ganem NJ, 2014, CELL, V158, P833, DOI 10.1016/j.cell.2014.06.029; Gasser R.F., VIRTUAL HUMAN EMBRYO; GURDON JB, 1958, NATURE, V182, P64, DOI 10.1038/182064a0; HARDY K, 1993, J REPROD FERTIL, V98, P549; Iwata K, 2014, J ASSIST REPROD GEN, V31, P421, DOI 10.1007/s10815-014-0195-2; Kamiyama T, 2006, ANN SURG, V244, P451, DOI 10.1097/01.sla.0000234840.74526.2b; KLEINSMITH LJ, 1964, CANCER RES, V24, P1544; Kligman I, 1996, HUM REPROD, V11, P1492; Kumar V.A., 2010, ROBBINS CONTRAN PATH, P262; Kurman RJ, 2016, AM J PATHOL, V186, P733, DOI 10.1016/j.ajpath.2015.11.011; Ledbetter DH, 2009, NAT MED, V15, P490, DOI 10.1038/nm0509-490; Lee AS, 2013, NAT MED, V19, P998, DOI 10.1038/nm.3267; Leikam C, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.71; Liu GZ, 2010, JNCI-J NATL CANCER I, V102, P812, DOI 10.1093/jnci/djq127; Lopez-Sanchez LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099143; Mertzanidou A, 2013, HUM REPROD, V28, P256, DOI 10.1093/humrep/des362; Mosieniak G, 2015, NEOPLASIA, V17, P882, DOI 10.1016/j.neo.2015.11.008; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Niu N, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.75; Niu N, 2011, CELL MOL LIFE SCI, V68, P2481, DOI 10.1007/s00018-010-0572-7; Ogden A, 2015, CANCER LETT, V367, P89, DOI 10.1016/j.canlet.2015.06.025; Ohnishi K, 2014, CELL, V156, P663, DOI 10.1016/j.cell.2014.01.005; Pierce G B, 1967, Curr Top Dev Biol, V2, P223; PIERCE GB, 1988, CANCER RES, V48, P1996; PIERCE GB, 1971, CANCER RES, V31, P127; PIERCE GB, 1983, AM J PATHOL, V113, P115; Puig PE, 2008, CELL BIOL INT, V32, P1031, DOI 10.1016/j.cellbi.2008.04.021; Rohwedel J, 1999, CELLS TISSUES ORGANS, V165, P190, DOI 10.1159/000016699; Sadler T.W., 2012, LANGMANS MEDICAL EMB, V12th; Salmina K, 2010, EXP CELL RES, V316, P2099, DOI 10.1016/j.yexcr.2010.04.030; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; Schrode N, 2014, DEV CELL, V29, P454, DOI 10.1016/j.devcel.2014.04.011; STEVENS LC, 1954, P NATL ACAD SCI USA, V40, P1080, DOI 10.1073/pnas.40.11.1080; STEVENS LC, 1964, P NATL ACAD SCI USA, V52, P654, DOI 10.1073/pnas.52.3.654; Sundaram M, 2004, CANCER BIOL THER, V3, P207, DOI 10.4161/cbt.3.2.663; Szajnik Marta, 2013, Gynecol Obstet (Sunnyvale), VSuppl 4, P3; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Van Royen E, 2003, HUM REPROD, V18, P1062, DOI 10.1093/humrep/deg201; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Walen KH, 2005, CELL BIOL INT, V29, P1057, DOI 10.1016/j.cellbi.2005.10.016; Wang Q, 2013, INT J CANCER, V132, P1505, DOI 10.1002/ijc.27810; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wirka KA, 2014, FERTIL STERIL, V101, P1637, DOI 10.1016/j.fertnstert.2014.02.050; Wutz A, 2007, TRENDS GENET, V23, P457, DOI 10.1016/j.tig.2007.07.004; Yang G, 2006, P NATL ACAD SCI USA, V103, P16472, DOI 10.1073/pnas.0605752103; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zasadil LM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007965; Zhang S, 2014, ONCOGENE, V33, P116, DOI 10.1038/onc.2013.96; Zhang Shiwu, 2016, Genes Cancer, V7, P60, DOI 10.18632/genesandcancer.102; Zhang SW, 2014, INT J CANCER, V134, P508, DOI 10.1002/ijc.28319; Zhang SW, 2013, CANCER LETT, V333, P205, DOI 10.1016/j.canlet.2013.01.037; Zhang WH, 2011, CANCER-AM CANCER SOC, V117, P4092, DOI 10.1002/cncr.26021; Zielke N, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012948	72	121	128	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 24	2017	36	34					4887	4900		10.1038/onc.2017.72	http://dx.doi.org/10.1038/onc.2017.72			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FE5EI	28436947	hybrid, Green Published			2022-12-26	WOS:000408234400006
J	Baruah, IK; Panda, D; Jagadale, MV; Das, DJ; Acharjee, S; Sen, P; Sarmah, BK				Baruah, Indrani K.; Panda, Debashis; Jagadale, M., V; Das, Deba Jit; Acharjee, Sumita; Sen, Priyabrata; Sarmah, Bidyut Kumar			Bruchid egg induced transcript dynamics in developing seeds of black gram (Vigna mungo)	PLOS ONE			English	Article							MOLECULAR-BASIS; PLANT DEFENSE; BIOTIC STRESS; RESPONSES; CDNA; RESISTANCE; TOLERANCE; PROTEIN; GENES; ANNOTATION	Black gram (Vigna mungo) seeds are a rich source of digestible proteins, however, during storage these seeds are severely damaged by bruchids (Callosobruchus spp.), reducing seed quality and yield losses. Most of the cultivated genotypes of black gram are susceptible to bruchids, however, few tolerant genotypes have also been identified but the mechanism of tolerance is poorly understood. We employed Suppression Subtractive Hybridization (SSH) to identify specifically, but rarely expressed bruchid egg induced genes in black gram. In this study, Suppression Subtractive Hybridization (SSH) library was constructed to study the genes involved in defense response in black gram against bruchid infestation. An EST library of 277 clones was obtained for further analyses. Based on CAP3 assembly, 134 unigenes were computationally annotated using Blast2GOPRO software. In all, 20 defense related genes were subject to quantitative PCR analysis (qPCR) out of which 12 genes showed up-regulation in developing seeds of the pods oviposited by bruchids. Few major defense genes like defensin, pathogenesis related protein (PR), lipoxygenase (LOX) showed high expression levels in the oviposited population when compared with the non-oviposited plants. This is the first report on defense related gene transcript dynamics during the bruchid-black gram interaction using SSH library. This library would be useful to clone defense related gene(s) such as defensin as represented in our library for crop improvement.	[Baruah, Indrani K.; Jagadale, M., V; Das, Deba Jit; Acharjee, Sumita; Sarmah, Bidyut Kumar] Assam Agr Univ, DBT AAU Ctr, Jorhat, Assam, India; [Panda, Debashis] Assam Agr Univ, Dept Agr Biotechnol, Distributed Informat Ctr, Jorhat, Assam, India; [Acharjee, Sumita; Sen, Priyabrata] Assam Agr Univ, Dept Agr Biotechnol, Jorhat, Assam, India	Assam Agricultural University; Assam Agricultural University; Assam Agricultural University	Acharjee, S; Sarmah, BK (corresponding author), Assam Agr Univ, DBT AAU Ctr, Jorhat, Assam, India.; Acharjee, S (corresponding author), Assam Agr Univ, Dept Agr Biotechnol, Jorhat, Assam, India.	sumita.aus@gmail.com; bidyutsarmah@aau.ac.in	Das, Debajit/AAT-5677-2021; Sen, Priyabrata/AAD-8490-2019	Das, Debajit/0000-0001-7793-861X; Panda, Debashis/0000-0002-7412-3615; Acharjee, Sumita/0000-0002-9806-0655	DBT-AAU Centre	DBT-AAU Centre	IKB would like to thank DBT-AAU Centre for support in the form of PhD fellowship to pursue this research.	Agarwal P, 2010, MOL BIOL REP, V37, P1125, DOI 10.1007/s11033-009-9885-8; Alvim FC, 2001, PLANT PHYSIOL, V126, P1042, DOI 10.1104/pp.126.3.1042; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bahramnejad B, 2009, PLANT CELL REP, V28, P703, DOI 10.1007/s00299-009-0672-8; Beyaert I, 2012, P ROY SOC B-BIOL SCI, V279, P101, DOI 10.1098/rspb.2011.0468; BRAY EA, 1993, PLANT PHYSIOL, V103, P1035, DOI 10.1104/pp.103.4.1035; Carvalho AD, 2009, PEPTIDES, V30, P1007, DOI 10.1016/j.peptides.2009.01.018; Chen HK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132519; Chen KC, 2002, J AGR FOOD CHEM, V50, P7258, DOI 10.1021/jf020527q; Chen KC, 2002, BOT BULL ACAD SINICA, V43, P251; Choudhury SR, 2013, PLANT SIGNAL BEHAV, V8, DOI [10.4161/psb.23000, 10.4161/psb.23681]; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; de Beer Abre, 2011, BMC Res Notes, V4, P459, DOI 10.1186/1756-0500-4-459; Devoto A, 2003, CURR OPIN PLANT BIOL, V6, P307, DOI 10.1016/S1369-5266(03)00060-8; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Doss RP, 2000, P NATL ACAD SCI USA, V97, P6218, DOI 10.1073/pnas.110054697; DURE L, 1989, PLANT MOL BIOL, V12, P475, DOI 10.1007/BF00036962; Ebrahim S, 2011, SCI MICROBIAL PATHOG, P1043; Fatouros NE, 2013, PLOS ONE, V7; Franco OL, 2011, FEBS LETT, V585, P995, DOI 10.1016/j.febslet.2011.03.008; Geiselhardt S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059661; Gouhier-Darimont C, 2013, J EXP BOT, V64, P665, DOI 10.1093/jxb/ers362; Gutha LR, 2008, PLANT MOL BIOL, V68, P533, DOI 10.1007/s11103-008-9391-8; Hanks JN, 2005, PLANT MOL BIOL, V58, P385, DOI 10.1007/s11103-005-5567-7; Hilker M, 2015, ANNU REV ENTOMOL, V60, P493, DOI 10.1146/annurev-ento-010814-020620; Hilker M, 2006, J CHEM ECOL, V32, P1379, DOI 10.1007/s10886-006-9057-4; HOWE R. W., 1964, BULL ENTOMOL RES, V55, P437, DOI 10.1017/S0007485300049580; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; Jelenska J, 2010, P NATL ACAD SCI USA, V107, P13177, DOI 10.1073/pnas.0910943107; Keneni G, 2011, SUSTAINABILITY-BASEL, V3, P1399, DOI 10.3390/su3091399; Kim DS, 2014, J EXP BOT, V65, P2295, DOI 10.1093/jxb/eru109; Kundu A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124687; La Camera S, 2004, IMMUNOL REV, V198, P267, DOI 10.1111/j.0105-2896.2004.0129.x; Liang YX, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0205-7; Liu ZH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002467; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacDonald MJ, 2007, BIOCHEM CELL BIOL, V85, P273, DOI 10.1139/O07-018; Mantri NL, 2010, ENVIRON EXP BOT, V69, P286, DOI 10.1016/j.envexpbot.2010.05.003; Meng XZ, 2013, ANNU REV PHYTOPATHOL, V51, P245, DOI 10.1146/annurev-phyto-082712-102314; Mithofer A, 2008, PLANT PHYSIOL, V146, P825, DOI 10.1104/pp.107.113118; Morillo SA, 2006, CURR OPIN PLANT BIOL, V9, P460, DOI 10.1016/j.pbi.2006.07.009; Padovan L, 2010, PROTEIN PEPTIDE LETT, V17, P297, DOI 10.2174/092986610790780350; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; Pashalidou FG, 2013, ECOLOGY, V94, P702, DOI 10.1890/12-1561.1; Pelegrini PB, 2008, PROTEINS, V73, P719, DOI 10.1002/prot.22086; Pieterse CMJ, 2007, TRENDS PLANT SCI, V12, P564, DOI 10.1016/j.tplants.2007.09.004; Ponnusamy Duraimurugan, 2014, Vegetos, V27, P60, DOI 10.5958/j.2229-4473.27.1.011; Puthoff DP, 2010, J CHEM ECOL, V36, P1271, DOI 10.1007/s10886-010-9868-1; Reymond P, 2013, PLANTA, V238, P247, DOI 10.1007/s00425-013-1908-y; Rojas CM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00017; Schenk PW, 1999, BBA-MOL CELL RES, V1449, P1, DOI 10.1016/S0167-4889(98)00178-5; Seifi HS, 2010, PLANT SIGNAL BEHAV, V9; SRINIVASAN T., 2010, INDIAN FARMING, V60, P13; Suzuki N, 2012, PLANT CELL ENVIRON, V35, P259, DOI 10.1111/j.1365-3040.2011.02336.x; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; War AR, 2012, PLANT SIGNAL BEHAV, V7, P1306, DOI 10.4161/psb.21663; Wu CT, 2003, PLANT PHYSIOL, V133, P263, DOI 10.1104/pp.103.024687; Zhou ML, 2010, AFR J BIOTECHNOL, V9, P9255	60	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176337	10.1371/journal.pone.0176337	http://dx.doi.org/10.1371/journal.pone.0176337			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448540	gold, Green Published, Green Submitted			2022-12-26	WOS:000400383600064
J	Zhao, MD; Fan, ZL				Zhao, Mingdeng; Fan, Zilong			Hydrodynamic characteristics of submerged vegetation flow with non-constant vertical porosity	PLOS ONE			English	Article							OPEN-CHANNEL FLUME; VELOCITY DISTRIBUTION; ELASTIC WAVES; MODEL; PROPAGATION	In order to investigate the influence of the vertical variation of porosity on open-channel flow with submerged vegetation, vertical non-homogeneous stumps and stems in submerged vegetation flow are simulated with truncated cones in a laboratory flume. First, porosity is defined as a function of water depth. A new governing equation for vegetation flow is established on the basis of the poroelastic media flow theory, and its analytical solution is obtained with the finite analytic method. Then, the fitting expression of permeability is established with experimental data, which shows the variation in permeability with vertical porosity and vegetation density. Finally, the calculated velocity distribution is compared with the measured velocity distribution. The theoretical results are in good agreement with the experimental data, which indicates that the theoretical formula accurately and practically predicts vertical velocity distribution in complex open-channel flow with submerged vegetation.	[Zhao, Mingdeng; Fan, Zilong] Wuhan Univ, State Key Lab Water Resources & Hydropower Engn S, Wuhan, Hubei, Peoples R China	Wuhan University	Fan, ZL (corresponding author), Wuhan Univ, State Key Lab Water Resources & Hydropower Engn S, Wuhan, Hubei, Peoples R China.	zlfan@whu.edu.cn			National Natural Science Foundation of China [51479145]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China. The grant number is 51479145. Mingdeng Zhao received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful for the financial support from the National Natural Science Foundation of China (No. 51479145).	Aberle J, 2013, J HYDRAUL RES, V51, P33, DOI 10.1080/00221686.2012.754795; BIOT MA, 1956, J ACOUST SOC AM, V28, P168, DOI 10.1121/1.1908239; BIOT MA, 1956, J ACOUST SOC AM, V28, P179, DOI 10.1121/1.1908241; Chakraborty P, 2016, INT J RIVER BASIN MA, P1; Chen C J, 1980, AM SOC MECH ENG AM I, V1; Chen SC, 2012, ADV WATER RESOUR, V43, P28, DOI 10.1016/j.advwatres.2012.03.017; Cheng NS, 2012, J HYDRAUL ENG, V138, P673, DOI [10.1061/(ASCE)HY.1943-7900.0000722, 10.1061/(ASCE)HY.1943-7900.0000562]; Choi SU, 2004, J HYDRAUL RES, V42, P3, DOI 10.1080/00221686.2004.9641178; Choi SU, 2016, J HYDRAUL RES, V54, P527, DOI 10.1080/00221686.2016.1168882; Cui J, 2008, J HYDRAUL RES, V46, P307, DOI 10.3826/jhr.2008.3129; Deresiewicz H, 1963, B SEISMOL SOC AM, V53, P783; Dijkstra JT, 2010, WATER RESOUR RES, V46, DOI 10.1029/2010WR009246; Dimitris S, 2011, J HYDRAULIC ENG, V54, P117; Gao GuangHai, 2011, Journal of Water Resource and Protection, V3, P114, DOI 10.4236/jwarp.2011.32013; Ghisalberti M, 2004, WATER RESOUR RES, V40, DOI 10.1029/2003WR002776; Guo JK, 2017, J HYDRAUL RES, V55, P27, DOI 10.1080/00221686.2016.1212945; Hsieh PC, 2006, ADV WATER RESOUR, V29, P1257, DOI 10.1016/j.advwatres.2005.10.004; Huai WX, 2010, ADV WATER RESOUR, V33, P635, DOI 10.1016/j.advwatres.2010.03.006; Huai WX, 2009, ADV WATER RESOUR, V32, P487, DOI 10.1016/j.advwatres.2008.11.014; Huai WX, 2014, ADV WATER RESOUR, V69, P106, DOI 10.1016/j.advwatres.2014.04.001; Huai WX, 2013, J HYDRAUL RES, V51, P708, DOI 10.1080/00221686.2013.818585; King A T, 2012, J FLUID MECH; Kothyari UC, 2009, J HYDRAUL RES, V47, P691, DOI 10.3826/jhr.2009.3283; Li CW, 2011, ADV WATER RESOUR, V34, P468, DOI 10.1016/j.advwatres.2011.01.002; Li YP, 2014, ECOHYDROLOGY, V7, P633, DOI 10.1002/eco.1384; Li YP, 2014, GEOMORPHOLOGY, V204, P314, DOI 10.1016/j.geomorph.2013.08.015; Nezu I, 1999, INT C WEESH SEOUL KO; Ricardo AM, 2016, J HYDRAUL ENG, V142, DOI 10.1061/(ASCE)HY.1943-7900.0001151; Shimizu Y., 1994, J HYDROSCIENCE HYDRA, V11, P57; Xu P, 2008, ADV WATER RESOUR, V31, P74, DOI 10.1016/j.advwatres.2007.06.003; Zhao MD, 2012, J HYDRAUL RES, V50, P52, DOI 10.1080/00221686.2011.641327	31	2	2	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176712	10.1371/journal.pone.0176712	http://dx.doi.org/10.1371/journal.pone.0176712			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448612	gold, Green Published, Green Submitted			2022-12-26	WOS:000400383600124
J	Ravensbergen, SJ; Berends, M; Stienstra, Y; Ott, A				Ravensbergen, Sofanne J.; Berends, Matthijs; Stienstra, Ymkje; Ott, Alewijn			High prevalence of MRSA and ESBL among asylum seekers in the Netherlands	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS	Migration is one of the risk factors for the spread of multidrug-resistant organisms (MDRO). The increasing influx of migrants challenges local health care systems. To provide evidence for both hospital hygiene measure and empirical antibiotic therapy, we analysed all cultures performed in asylum seekers between January 1 st 2014 and December 31 st 2015 for methicillin resistant Staphylococcus aureus (MRSA) and for multidrugresistant Enterobacteriaceae (MDRE). We compared these with cultures from the Dutch patient population with risk factors for carriage of MDRO. A total of 7181 patients were screened for MRSA. 7357 S. aureus were isolated in clinical cultures. Of 898 screened asylum seekers, almost 10% were MRSA positive. Of 118 asylum seekers with S. aureus in clinical cultures almost 19% were MRSA positive. The general patient population had a 1.3% rate of MRSA in S. aureus isolates. A higher rate of Panton-Valentine leukocidin (PVL) positive strains (RR: 2.4; 95% CI: 1.6-3.4) was found in asylum seekers compared to the general patient population. In 33475 patients one or more Enterobacteriaceae were obtained. More than 21% of the asylum seekers were carrier of MDRE, most of them producing extended spectrum beta-lactamases (20.3%). 5.1% of the general patient population was MDRE carrier. It can be concluded that asylum seekers present with higher rate of MDRO compared to the general patient population. These results justify continued screening of asylum seekers to anticipate multidrug-resistant organisms during hospital care of patients.	[Ravensbergen, Sofanne J.; Stienstra, Ymkje] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med Infect Dis, Groningen, Netherlands; [Berends, Matthijs; Ott, Alewijn] Certe, Dept Med Microbiol, Groningen, Netherlands; [Ott, Alewijn] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands	University of Groningen; University of Groningen	Ravensbergen, SJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med Infect Dis, Groningen, Netherlands.	s.j.ravensbergen@umcg.nl	Berends, Matthijs/AFJ-9786-2022; Berends, Matthijs/GYQ-6019-2022; Berends, Matthijs/AAF-6852-2022	Berends, Matthijs/0000-0001-7620-1800; Berends, Matthijs/0000-0001-7620-1800				Angeletti S, 2016, TRAVEL MED INFECT DI, V14, P115, DOI 10.1016/j.tmaid.2016.03.005; Balkhair A, 2014, SCI WORLD J, DOI 10.1155/2014/157102; Dudareva S, 2011, EUROSURVEILLANCE, V16, P2; Hassing RJ, 2015, EURO SURVEILL, V20; Heudorf U, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.2.30109; Jain A, 2008, J MED MICROBIOL, V57, P957, DOI 10.1099/jmm.0.47152-0; Jaton L, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.05.026; Lubbert C, 2015, INT J MED MICROBIOL, V305, P148, DOI 10.1016/j.ijmm.2014.12.001; Ravensbergen SJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154791; Reinheimer C, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.2.30110; Souverein D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148175; Szmigielski S, 1999, ZBL BAKT-INT J MED M, V289, P185; Teicher CL, 2014, EMERG INFECT DIS, V20, P1949, DOI 10.3201/eid2011.140835; Tenenbaum T, 2016, INFECT CONT HOSP EP, V37, P1310; van der Bij AK, 2012, J ANTIMICROB CHEMOTH, V67, P2090, DOI 10.1093/jac/dks214; Wertheim HFL, 2004, J HOSP INFECT, V56, P321, DOI 10.1016/j.jhin.2004.01.026	16	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176481	10.1371/journal.pone.0176481	http://dx.doi.org/10.1371/journal.pone.0176481			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441421	gold, Green Published, Green Submitted			2022-12-26	WOS:000400308800064
J	Lamberti, M; Napolitano, F; Napolitano, P; Arnese, A; Crispino, V; Panariello, G; Di Giuseppe, G				Lamberti, Monica; Napolitano, Francesco; Napolitano, Paola; Arnese, Antonio; Crispino, Vincenzo; Panariello, Gianclaudio; Di Giuseppe, Gabriella			Prevalence of alcohol use disorders among under-and post-graduate healthcare students in Italy	PLOS ONE			English	Article							MEDICAL-STUDENTS; AUDIT-C; IDENTIFICATION TEST; DRUG-USE; RISKY DRINKING; GLOBAL BURDEN; SUBSTANCE USE; UNIVERSITY; CONSUMPTION; MORBIDITY	cross-sectional study was carried out on 641 medical students, 359 students attending a degree course in the healthcare professions, and 500 resident physicians, all undergoing health surveillance at the ambulatory of the Division of Occupational Medicine, Second University of Naples, Italy. 76.1% of the participants drank alcohol, with 85.5% of medical students, 77.4% of resident physicians, and 63% of healthcare-professions students reporting regular alcohol use. In the whole sample, the mean Audit-C score was 1.6 for men and 1.1 for women; only 5.5% of men and 7.1% of women had a hazardous alcohol consumption with an Audit-C score of respectively >= 4 and >= 3. Multivariate regression modeling revealed that regular alcohol use was more likely in individuals who were men, were younger, had a lower body-mass index, were active smokers, were habitual coffee drinkers, and who were resident physicians or medical students rather than healthcare-professions students. This finding identifies a need to assess alcohol use in medical-profession workers in order to identify risky behavior early on and to carry out rapidly effective preventive and curative interventions.	[Lamberti, Monica; Crispino, Vincenzo; Panariello, Gianclaudio] Univ Naples 2, Sch Med, Dept Expt Med, Sect Occupat Med, Naples, Italy; [Napolitano, Francesco; Napolitano, Paola; Arnese, Antonio; Di Giuseppe, Gabriella] Univ Naples 2, Sch Med, Dept Expt Med, Sect Hyg, Naples, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	Lamberti, M (corresponding author), Univ Naples 2, Sch Med, Dept Expt Med, Sect Occupat Med, Naples, Italy.	monica.lamberti@unina2.it		DI GIUSEPPE, Gabriella/0000-0003-4466-6683; Napolitano, Francesco/0000-0003-4694-2418				Andersson A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-229; Ball S, 2002, ACAD MED, V77, P911, DOI 10.1097/00001888-200209000-00023; Beard E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173458; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Bradley KA, 2016, ADDICTION, V111, P1975, DOI 10.1111/add.13505; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Connor J, 2013, ALCOHOL CLIN EXP RES, V37, P1971, DOI 10.1111/acer.12175; Cousins K, 2014, DRUG ALCOHOL DEPEN, V143, P120, DOI 10.1016/j.drugalcdep.2014.07.015; Croen LG, 1997, ACAD MED, V72, P376, DOI 10.1097/00001888-199705000-00017; Davoren MP, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006045; Dawson DA, 2005, ALCOHOL CLIN EXP RES, V29, P844, DOI 10.1097/01.ALC.0000164374.32229.A2; Deressa W, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-660; Dyrbye LN, 2006, ACAD MED, V81, P354, DOI 10.1097/00001888-200604000-00009; Frank E, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2155; Fujii H, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3053-6; Gerstenkorn Andrzej, 2003, Wiad Lek, V56, P402; Guthrie EA, 1995, MED EDUC, V29, P337, DOI 10.1111/j.1365-2923.1995.tb00022.x; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Nash LM, 2010, MED J AUSTRALIA, V193, P161, DOI 10.5694/j.1326-5377.2010.tb03837.x; Newbury-Birch D, 2002, BRIT DENT J, V192, P646, DOI 10.1038/sj.bdj.4801448a; Newbury-Birch D, 2001, DRUG ALCOHOL DEPEN, V64, P265, DOI 10.1016/S0376-8716(01)00128-4; Osaki Y, 2014, ASIAN PAC J CANCER P, V15, P6571, DOI 10.7314/APJCP.2014.15.16.6571; Pickard M, 2000, MED EDUC, V34, P148, DOI 10.1046/j.1365-2923.2000.00491.x; Rehm J, 2003, ALCOHOL RES HEALTH, V27, P39; Rehm J, 2013, EUR NEUROPSYCHOPHARM, V23, P89, DOI 10.1016/j.euroneuro.2012.08.001; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Sarikaya O, 2006, INT J CLIN PRACT, V60, P1414, DOI 10.1111/j.1742-1241.2006.00869.x; Shield KD, 2013, WHO REGIONAL OFFICE, P3; Stata Corporation, 2007, STAT REF MAN REL 10; Stewart SM, 1999, MED EDUC, V33, P243; Voigt K, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-219; Volkow ND, 2005, PHARMACOL THERAPEUT, V108, P3, DOI 10.1016/j.pharmthera.2005.06.021; Webb E, 1996, LANCET, V348, P922, DOI 10.1016/S0140-6736(96)03410-1; Wurst FM, 2013, GEN HOSP PSYCHIAT, V35, P561, DOI 10.1016/j.genhosppsych.2013.04.018	35	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0175719	10.1371/journal.pone.0175719	http://dx.doi.org/10.1371/journal.pone.0175719			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437428	Green Submitted, Green Published, gold			2022-12-26	WOS:000400287600011
J	Jaakkola, S; Nuotio, I; Kiviniemi, TO; Virtanen, R; Issakoff, M; Airaksinen, KEJ				Jaakkola, Samuli; Nuotio, Ilpo; Kiviniemi, Tuomas O.; Virtanen, Raine; Issakoff, Melina; Airaksinen, K. E. Juhani			Incidence and predictors of excessive warfarin anticoagulation in patients with atrial fibrillation-The EWA study	PLOS ONE			English	Article							INTERNATIONAL NORMALIZED RATIO; CHRONIC KIDNEY-DISEASE; ORAL ANTICOAGULATION; RISK-FACTORS; COMPLICATIONS; MORTALITY; OVERANTICOAGULATION; CARDIOVERSION; EPIDEMIOLOGY; HEMODIALYSIS	Vitamin K antagonist warfarin is widely used in clinical practice and excessive anticoagulation is a well-known complication of this therapy. Little is known about permanent and temporary predictors for severe overanticoagulation. The aim of this study was to investigate the occurrence and predicting factors for episodes with very high (>= 9) international normalized ratio (INR) values in warfarin treated patients with atrial fibrillation (AF). Excessive Warfarin Anticoagulation (EWA) study screened all patients (n = 13618) in the Turku University Hospital region with an INR >= 2 between years 2003-2015. Patients using warfarin anticoagulation for AF with very high (>= 9) INR values (EWA Group) were identified (n = 412 patients) and their characteristics were compared to a control group (n = 405) of AF patients with stable INR during long-term follow-up. Over 20% (n = 92) of the EWA patients had more than one event of very high INR and in 105 (25.5%) patients EWA led to a bleeding event. Of the several temporary and permanent EWA risk factors observed, strongest were excessive alcohol consumption in 9.6% of patients (OR 24.4, 95% CI 9.9-50.4, p<0.0001) and reduced renal function (OR 15.2, 95% CI 5.67-40.7, p<0.0001). Recent antibiotic or antifungal medication, recent hospitalization or outpatient clinic visit and the first 6 months of warfarin use were the most significant temporary risk factors for EWA. Excessive warfarin anticoagulation can be predicted with several permanent and temporary clinical risk factors, many of which are modifiable.	[Jaakkola, Samuli; Nuotio, Ilpo; Kiviniemi, Tuomas O.; Virtanen, Raine; Airaksinen, K. E. Juhani] Turku Univ Hosp, Ctr Heart, Turku, Finland; [Jaakkola, Samuli; Nuotio, Ilpo; Kiviniemi, Tuomas O.; Virtanen, Raine; Issakoff, Melina; Airaksinen, K. E. Juhani] Univ Turku, Turku, Finland; [Nuotio, Ilpo] Turku Univ Hosp, Dept Acute Internal Med, Turku, Finland; [Virtanen, Raine] Turku City Hosp, Dept Cardiol, Turku, Finland	University of Turku; University of Turku; University of Turku; University of Turku	Airaksinen, KEJ (corresponding author), Turku Univ Hosp, Ctr Heart, Turku, Finland.; Airaksinen, KEJ (corresponding author), Univ Turku, Turku, Finland.	juhani.airaksinen@tyks.fi	Kiviniemi, Tuomas/A-1107-2016; Airaksinen, Juhani/AAC-7857-2021	Kiviniemi, Tuomas/0000-0002-0908-3741; Airaksinen, Juhani/0000-0002-0193-568X; Jaakkola, Samuli/0000-0001-5944-6814	Finnish Foundation for Cardiovascular Research, Helsinki, Finland: State Clinical Research Fund (EVO) of Turku University Hospital, Turku, Finland [140027, 13016]	Finnish Foundation for Cardiovascular Research, Helsinki, Finland: State Clinical Research Fund (EVO) of Turku University Hospital, Turku, Finland	This study was funded by The Finnish Foundation for Cardiovascular Research, Helsinki, Finland, (140027): State Clinical Research Fund (EVO) of Turku University Hospital, Turku, Finland (13016).	Airaksinen KEJ, 2013, J AM COLL CARDIOL, V62, P1187, DOI 10.1016/j.jacc.2013.04.089; Bergman M, 2014, AM J MED SCI, V348, P71, DOI 10.1097/MAJ.0000000000000209; Boriani G, 2016, SCI REP-UK, V6, DOI 10.1038/srep30271; Buller HR, 2004, CHEST, V126, p401S, DOI 10.1378/chest.126.3_suppl.401S; Dodson JA, 2016, JAMA CARDIOL, V1, P65, DOI 10.1001/jamacardio.2015.0345; Eikelboom JW, 2013, NEW ENGL J MED, V369, P1206, DOI 10.1056/NEJMoa1300615; FIHN SD, 1993, ANN INTERN MED, V118, P511, DOI 10.7326/0003-4819-118-7-199304010-00005; Garg L, 2016, INT J CARDIOL, V222, P47, DOI 10.1016/j.ijcard.2016.07.118; Gasse C, 2005, THROMB HAEMOSTASIS, V94, P537, DOI 10.1160/TH05-03-0166; Grzymala-Lubanski B, 2017, HEART, V103, P198, DOI 10.1136/heartjnl-2016-309585; Harold JG, 2014, J AM COLL CARDIOL, V63, pE57, DOI 10.1016/j.jacc.2014.02.536; Holbrook AM, 2005, ARCH INTERN MED, V165, P1095, DOI 10.1001/archinte.165.10.1095; Hylek EM, 2007, CIRCULATION, V115, P2689, DOI 10.1161/CIRCULATIONAHA.106.653048; Hylek EM, 2003, NEW ENGL J MED, V349, P1019, DOI 10.1056/NEJMoa022913; Hylek EM, 2001, ANN INTERN MED, V135, P393, DOI 10.7326/0003-4819-135-6-200109180-00008; Koo S, 2004, ARCH INTERN MED, V164, P1557, DOI 10.1001/archinte.164.14.1557; Levin A.S., 2013, KIDNEY INT SUPPL, V3, P19, DOI [10.1038/kisup.2012.64, DOI 10.1038/KISUP.2012.64]; Lutz J, 2014, NEPHROL DIAL TRANSPL, V29, P29, DOI 10.1093/ndt/gft209; Luzny Jan, 2014, Acta Medica (Hradec Kralove), V57, P73, DOI 10.14712/18059694.2014.43; Marie I, 2012, QJM-INT J MED, V105, P53, DOI 10.1093/qjmed/hcr136; Oden A, 2002, BMJ-BRIT MED J, V325, P1073, DOI 10.1136/bmj.325.7372.1073; Palareti G, 1996, LANCET, V348, P423, DOI 10.1016/S0140-6736(96)01109-9; Palomaki A, 2016, INT J CARDIOL, V203, P269, DOI 10.1016/j.ijcard.2015.10.168; Pavord S, 2011, BLOOD REV, V25, P271, DOI 10.1016/j.blre.2011.07.001; Pottegard A, 2013, EUR J CLIN PHARMACOL, V69, P641, DOI 10.1007/s00228-012-1363-x; Reddy U, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1282; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109; van Walraven C, 2007, CHEST, V131, P1508, DOI 10.1378/chest.06-2628; Visser LE, 2004, BRIT J HAEMATOL, V127, P85, DOI 10.1111/j.1365-2141.2004.05162.x; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wittkowsky AK, 2004, PHARMACOTHERAPY, V24, P1311, DOI 10.1592/phco.24.14.1311.43144; Wizemann V, 2010, KIDNEY INT, V77, P1098, DOI 10.1038/ki.2009.477	34	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175975	10.1371/journal.pone.0175975	http://dx.doi.org/10.1371/journal.pone.0175975			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426737	Green Submitted, Green Published, gold			2022-12-26	WOS:000399875900079
J	Ma, JJ; Baker, AR; Calabro, A; Derwin, KA				Ma, Jinjin; Baker, Andrew R.; Calabro, Anthony; Derwin, Kathleen A.			Exploratory study on the effect of osteoactivin on muscle regeneration in a rat volumetric muscle loss model	PLOS ONE			English	Article							SKELETAL-MUSCLE; EXTRACELLULAR-MATRIX; LOSS INJURY; BIOLOGIC SCAFFOLD; DEFECT MODEL; MURINE MODEL; TISSUE; TRANSPLANTATION; CELLS; MEDICINE	Wounds causing extensive injury loss of muscle, also known as volumetric muscle loss (VML), are frequently associated with high-energy civilian trauma and combat-related extremity injuries. Currently, no effective clinical therapy is available for promoting de novo muscle tissue regeneration to restore muscle function following VML. Recent studies have shown evidence that osteoactivin (OA), a transmembrane glycoprotein, has the ability to prevent skeletal muscle atrophy in response to denervation. Therefore the objective of this study is to investigate the potential regenerative effect of OA embedded and delivered via a cross-linked gelatin hydrogel within a volumetric tibialis anterior muscle defect in a rat model. After 4 weeks, however, no evidence for muscle formation was found in defects treated with either low (5 mu g/ml) or high (50 mu g/ml) OA. It is possible that a different delivery scaffold, delivery kinetics, or OA concentration may have yielded an alternate outcome, or it is also possible that the spaciostructural environment of VML, or the local (versus systemic) delivery of OA, simply does not support any potential regenerative activity of OA in VML. Together with prior work, this study demonstrates that an efficacious and scalable therapy for regenerating muscle volume and function in VML remains a veritable clinical challenge worthy of continued future research efforts.	[Ma, Jinjin; Baker, Andrew R.; Calabro, Anthony; Derwin, Kathleen A.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Ma, JJ (corresponding author), Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA.	maj3@ccf.org		Ma, Jinjin/0000-0002-5446-2214	Cleveland Clinic LRI Chair's Innovative Research Fund	Cleveland Clinic LRI Chair's Innovative Research Fund	This work was supported by Cleveland Clinic LRI Chair's Innovative Research Fund.; Authors have nothing to disclose. This work was supported by Cleveland Clinic LRI Chair's Innovative Research Fund.	Abdelmagid SM, 2007, J CELL PHYSIOL, V210, P26, DOI 10.1002/jcp.20841; Arosarena OA, 2011, J CELL PHYSIOL, V226, P2943, DOI 10.1002/jcp.22639; Aurora A, 2015, BIOMATERIALS, V67, P393, DOI 10.1016/j.biomaterials.2015.07.040; Bateman JP, 2012, J PERIODONTAL RES, V47, P243, DOI 10.1111/j.1600-0765.2011.01428.x; Bosse MJ, 2002, NEW ENGL J MED, V347, P1924, DOI 10.1056/NEJMoa012604; Brown BN, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00510; Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034; Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040; Bruggeman LA, 2012, CELL MOL BIOENG, V5, P194, DOI 10.1007/s12195-012-0221-3; Corona BT, 2013, AM J PHYSIOL-CELL PH, V305, pC761, DOI 10.1152/ajpcell.00189.2013; Corona BT, 2016, BIOMATERIALS, V104, P238, DOI 10.1016/j.biomaterials.2016.07.020; Corona BT, 2013, BIOMATERIALS, V34, P3324, DOI 10.1016/j.biomaterials.2013.01.061; Furochi Harumi, 2007, J Med Invest, V54, P248, DOI 10.2152/jmi.54.248; Garg K, 2014, CELL TISSUE RES, V358, P857, DOI 10.1007/s00441-014-2006-6; Gentile NE, 2014, AM J PHYS MED REHAB, V93, pS79, DOI 10.1097/PHM.0000000000000145; Grogan BF, 2011, J AM ACAD ORTHOP SUR, V19, pS35, DOI 10.5435/00124635-201102001-00007; Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109; Ma JJ, 2015, J BIOMED MATER RES B, V103, P355, DOI 10.1002/jbm.b.33166; Machingal MA, 2011, TISSUE ENG PT A, V17, P2291, DOI [10.1089/ten.tea.2010.0682, 10.1089/ten.TEA.2010.0682]; MacKenzie EJ, 2007, J BONE JOINT SURG AM, V89A, P1685, DOI 10.2106/JBJS.F.01350; Mase Vincent J Jr, 2010, Orthopedics, V33, P511, DOI 10.3928/01477447-20100526-24; Merritt EK, 2010, TISSUE ENG PT A, V16, P2871, DOI [10.1089/ten.tea.2009.0826, 10.1089/ten.TEA.2009.0826]; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Ogawa T, 2005, AM J PHYSIOL-CELL PH, V289, pC697, DOI 10.1152/ajpcell.00565.2004; Owen TA, 2003, CRIT REV EUKAR GENE, V13, P205; Page RL, 2011, TISSUE ENG PT A, V17, P2629, DOI [10.1089/ten.tea.2011.0024, 10.1089/ten.TEA.2011.0024]; Safadi FF, 2002, J CELL BIOCHEM, V84, P12, DOI 10.1002/jcb.1259; Selim AA, 2003, CRIT REV EUKAR GENE, V13, P265; Serrano AL, 2010, EXP CELL RES, V316, P3050, DOI 10.1016/j.yexcr.2010.05.035; Shikano S, 2001, J BIOL CHEM, V276, P8125, DOI 10.1074/jbc.M008539200; Sicari BM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008085; Sicari BM, 2012, TISSUE ENG PT A, V18, P1941, DOI [10.1089/ten.tea.2012.0475, 10.1089/ten.TEA.2012.0475]; Thorrez L, 2008, BIOMATERIALS, V29, P75, DOI 10.1016/j.biomaterials.2007.09.014; Tonogai I, 2015, J PEDIATR ORTHOP B, V24, P162, DOI 10.1097/BPB.0000000000000117; Turner NJ, 2010, TISSUE ENG PT A, V16, P3309, DOI [10.1089/ten.tea.2010.0169, 10.1089/ten.TEA.2010.0169]; Turner NJ, 2012, J SURG RES, V176, P490, DOI 10.1016/j.jss.2011.11.1029; Valentin JE, 2010, BIOMATERIALS, V31, P7475, DOI 10.1016/j.biomaterials.2010.06.039; Ward CL, 2015, BIORESEARCH OPEN ACC, V4, P198, DOI 10.1089/biores.2015.0009; Wu XW, 2012, BIORESEARCH OPEN ACC, V1, P280, DOI 10.1089/biores.2012.0271	39	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175853	10.1371/journal.pone.0175853	http://dx.doi.org/10.1371/journal.pone.0175853			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426701	Green Published, gold, Green Submitted			2022-12-26	WOS:000399875900058
J	Zeng, F; Chen, EQ; Du, LY; Yan, LB; Li, H; Bai, L; Feng, P; Tang, H				Zeng Fan; Chen EnQiang; Du Ling Yao; Yan LiBo; Li Hong; Bai Lang; Feng Ping; Tang Hong			Neutrophil-lymphocyte ratio predicts short term mortality in patients with hepatitis B virus-related acute-on-chronic liver failure treated with an artificial liver support system	PLOS ONE			English	Article							INJURY	Aim Hepatitis B virus-related acute-on-chronic liver failure has high short-term mortality. Artificial liver support systems (ALSS) may improve outcome and avoid liver transplantation, but predicting short-term prognosis in such patients is difficult. This study aimed to determine whether the neutrophil-lymphocyte ratio (NLR), an inflammation marker, predicted mortality in patients treated with ALSS. Methods A total of 560 patients with hepatitis B virus-related acute-on-chronic liver failure were enrolled, 338 were treated with ALSS and the others treated with standard of care(SOC). Clinical variables and the NLR were evaluated for prognostic value. Results Thirty-day mortality was 28.4% in ALSS and 55.4% in SOC patients. The NLR was lower in survivors than in ALSS or SOC patients who died. Univariate and multivariate analysis found that NLR and the chronic liver failure sequential organ failure assessment scores (CLIF-SOFA) were independently associated with 30-day mortality. Among patients with NLRs <= 3, 3-6, and > 6, 30-day mortality was 7.7%, 23.1%, and 69.2% in ALSS and 25.5%, 50.0%, and 75.0% in SOC patients. Among patients with NLRs <= 3 or 3-6, mortality was lower in ALSS than in SOC patients (P < 0.01). Mortality rates of ALSS and SOC patients with NLRs > 6 did not different (P > 0.05). The area under curve of NLR and CLIF-SOFA was 0.82 and 0.88 in ALSS group, 0.78 and 0.86 in SOC group. The results suggest that liver function in most patients with NLRs <= 3 recovered with ALSS treatment, and patients with NLRs > 6 needed emergency liver transplantation. Conclusion NLR was an independent predictor of mortality in ALSS patients and may assist physicians in determining treatment options.	[Zeng Fan; Chen EnQiang; Du Ling Yao; Yan LiBo; Li Hong; Bai Lang; Feng Ping; Tang Hong] Sichuan Univ, West China Hosp, Ctr Infect Dis, Chengdu, Peoples R China; [Zeng Fan] Hosp Univ Elect Sci, Sichuan Prov Peoples Hosp, Dept Intens Care Unit, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan Provincial People's Hospital	Tang, H (corresponding author), Sichuan Univ, West China Hosp, Ctr Infect Dis, Chengdu, Peoples R China.	htang6198@hotmail.com	Chen, En-Qiang/S-7967-2019		National Natural Science Foundation of China [81300319, 30972622]; National Twelve-Five Project of China [2012ZX10002007-001-003]; Science and Technology Support Program of Sichuan China [No. 2015SZ0049]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Twelve-Five Project of China; Science and Technology Support Program of Sichuan China	Dr HongTang received this three founder: National Natural Science Foundation of China (No.81300319) and National Twelve-Five Project of China (2012ZX10002007-001-003) http//www.nsfc.gov.cnThe funders; Science and Technology Support Program of Sichuan China (No. 2015SZ0049)http//www.scst.gov.cn.Dr EnqiangChen received one funding: National Natural Science Foundation of China (No. 30972622). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azab B, 2011, PANCREATOLOGY, V11, P445, DOI 10.1159/000331494; Bhat T, 2013, EXPERT REV CARDIOVAS, V11, P55, DOI [10.1586/erc.12.159, 10.1586/ERC.12.159]; Bhatia V, 2008, HEPATOL INT, V2, P465, DOI 10.1007/s12072-008-9098-6; Chen TM, 2012, J GASTROEN HEPATOL, V27, P553, DOI 10.1111/j.1440-1746.2011.06910.x; Cisneros-Garza LE, 2014, ANN HEPATOL, V13, P240, DOI 10.1016/S1665-2681(19)30887-7; Du WB, 2005, TRANSPL P, V37, P4359, DOI 10.1016/j.transproceed.2005.11.044; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI DOI 10.1053/JHEP.2002.31250; Laleman W, 2011, EXPERT REV GASTROENT, V5, P523, DOI [10.1586/egh.11.47, 10.1586/EGH.11.47]; Liu H, 2014, J VIRAL HEPATITIS, V21, P499, DOI 10.1111/jvh.12160; Marques PE, 2012, HEPATOLOGY, V56, P1971, DOI 10.1002/hep.25801; Pan HC, 2014, ALIMENT PHARM THER, V40, P1056, DOI 10.1111/apt.12953; Runyon BA, 2004, HEPATOLOGY, V39, P841, DOI 10.1002/hep.20066; Saliba F, 2013, ANN INTERN MED, V159, P522, DOI 10.7326/0003-4819-159-8-201310150-00005; Sarin SK, 2009, HEPATOL INT, V3, P269, DOI 10.1007/s12072-008-9106-x; Seto WK, 2012, J GASTROEN HEPATOL, V27, P662, DOI 10.1111/j.1440-1746.2011.06971.x; Suliman MARM, 2010, ARCH MED RES, V41, P618, DOI 10.1016/j.arcmed.2010.11.006; Tasaka S, 2005, AM J RESP CELL MOL, V32, P504, DOI 10.1165/rcmb.2004-0009OC; Twu YC, 2011, EUR J IMMUNOL, V41, P335, DOI 10.1002/eji.201040639; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016; Wu ZG, 2010, LIVER INT, V30, P782, DOI 10.1111/j.1478-3231.2010.02262.x; Zou ZS, 2009, J CLIN GASTROENTEROL, V43, P182, DOI 10.1097/MCG.0b013e3181624464	21	14	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175332	10.1371/journal.pone.0175332	http://dx.doi.org/10.1371/journal.pone.0175332			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426800	gold, Green Submitted, Green Published			2022-12-26	WOS:000399875900024
J	Dolezal, JM; Wang, HB; Kulkarni, S; Jackson, L; Lu, J; Ranganathan, S; Goetzman, ES; Bharathi, SS; Beezhold, K; Byersdorfer, CA; Prochownik, EV				Dolezal, James M.; Wang, Huabo; Kulkarni, Sucheta; Jackson, Laura; Lu, Jie; Ranganathan, Sarangarajan; Goetzman, Eric S.; Bharathi, Sivakama S.; Beezhold, Kevin; Byersdorfer, Craig A.; Prochownik, Edward V.			Sequential adaptive changes in a c-Myc-driven model of hepatocellular carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-INITIATING CELLS; GLUTAMINE-METABOLISM; GENOMIC INSTABILITY; MELANOMA-CELLS; NONCODING RNA; LIVER-CELLS; DNA-DAMAGE; IN-VITRO; CANCER; PROTEIN	Hepatocellular carcinoma (HCC) is a common cancer that frequently overexpresses the c-Myc (Myc) oncoprotein. Using a mouse model of Myc-induced HCC, we studied the metabolic, biochemical, and molecular changes accompanying HCC progression, regression, and recurrence. These involved altered rates of pyruvate and fatty acid beta-oxidation and the likely re-directing of glutamine into biosynthetic rather than energy-generating pathways. Initial tumors also showed reduced mitochondrial mass and differential contributions of electron transport chain complexes I and II to respiration. The uncoupling of complex II's electron transport function from its succinate dehydrogenase activity also suggested a mechanism by which Myc generates reactive oxygen species. RNA sequence studies revealed an orderly progression of transcriptional changes involving pathways pertinent to DNA damage repair, cell cycle progression, insulin-like growth factor signaling, innate immunity, and further metabolic re-programming. Only a subset of functions deregulated in initial tumors was similarly deregulated in recurrent tumors thereby indicating that the latter can "normalize" some behaviors to suit their needs. An inter-active and freely available software tool was developed to allow continued analyses of these and other transcriptional profiles. Collectively, these studies define the metabolic, biochemical, and molecular events accompanyingHCCevolution, regression, and recurrence in the absence of any potentially confounding therapies.	[Dolezal, James M.; Wang, Huabo; Kulkarni, Sucheta; Lu, Jie; Prochownik, Edward V.] UPMC, Childrens Hosp Pittsburgh, Div Hematol Oncol, Pittsburgh, PA 15224 USA; [Jackson, Laura] UPMC, Childrens Hosp Pittsburgh, Div Newborn Med, Pittsburgh, PA 15224 USA; [Ranganathan, Sarangarajan] UPMC, Childrens Hosp Pittsburgh, Dept Pathol, Pittsburgh, PA 15224 USA; [Goetzman, Eric S.; Bharathi, Sivakama S.] UPMC, Childrens Hosp Pittsburgh, Div Human Genet, Pittsburgh, PA 15224 USA; [Beezhold, Kevin; Byersdorfer, Craig A.] UPMC, Childrens Hosp Pittsburgh, Div Bone Marrow & Stem Cell Transplantat, Pittsburgh, PA 15224 USA; [Prochownik, Edward V.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15213 USA; [Prochownik, Edward V.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15232 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Prochownik, EV (corresponding author), Childrens Hosp Pittsburgh UPMC, Hematol Oncol Sect, Rangos Res Ctr, Rm 5124,4401 Penn Ave, Pittsburgh, PA 15224 USA.	procev@chp.edu		Ranganathan, Sarangarajan/0000-0001-6214-9167; Jackson, Laura/0000-0001-9088-576X; Dolezal, James/0000-0002-6788-7203; Beezhold, Kevin/0000-0001-9305-9324	National Institutes of Health [R01CA174713, R01DK090242, K08HL123631]; NATIONAL CANCER INSTITUTE [U54CA199092, R01CA174713] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL123631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090242] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01CA174713 (to E.V.P.), R01DK090242 (to E.S.G.), and K08HL123631 (to C.A.B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alajez NM, 2012, ONCOTARGET, V3, P1641; Allain C, 2016, CANCER RES, V76, P6374, DOI 10.1158/0008-5472.CAN-16-1559; Altman BJ, 2016, NAT REV CANCER, V16, P619, DOI 10.1038/nrc.2016.71; Barsyte-Lovejoy D, 2006, CANCER RES, V66, P5330, DOI 10.1158/0008-5472.CAN-06-0037; Beauchamp EM, 2013, ONCOGENE, V32, P3923, DOI 10.1038/onc.2012.567; Beck J, 1996, LEUKEMIA, V10, P426; Bei YQ, 2017, CELL MOL NEUROBIOL, V37, P889, DOI 10.1007/s10571-016-0426-4; Bystry RS, 2001, NAT IMMUNOL, V2, P1126, DOI 10.1038/ni735; Ceciliani F, 2002, PROTEIN PEPTIDE LETT, V9, P211, DOI 10.2174/0929866023408779; Celton-Morizur S, 2010, ADV EXP MED BIOL, V676, P123; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; CHIU JH, 1992, J CLIN INVEST, V89, P539, DOI 10.1172/JCI115618; CURTHOYS NP, 1995, ANNU REV NUTR, V15, P133, DOI 10.1146/annurev.nu.15.070195.001025; Dragani TA, 2010, J HEPATOL, V52, P252, DOI 10.1016/j.jhep.2009.11.015; Duncan AW, 2013, SEMIN CELL DEV BIOL, V24, P347, DOI 10.1016/j.semcdb.2013.01.003; Edmunds LR, 2016, ONCOTARGET, V7, P30379, DOI 10.18632/oncotarget.8856; Edmunds LR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134049; Egler RA, 2005, ONCOGENE, V24, P8038, DOI 10.1038/sj.onc.1208821; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Farrar JE, 2016, CANCER RES, V76, P2197, DOI 10.1158/0008-5472.CAN-15-1015; Felsher DW, 1999, P NATL ACAD SCI USA, V96, P3940, DOI 10.1073/pnas.96.7.3940; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gentric G, 2014, AM J PATHOL, V184, P322, DOI 10.1016/j.ajpath.2013.06.035; Giordano S, 2014, J HEPATOL, V60, P442, DOI 10.1016/j.jhep.2013.09.009; Grandhi MS, 2016, SURG ONCOL, V25, P74, DOI 10.1016/j.suronc.2016.03.002; Graves JA, 2009, J BIOL CHEM, V284, P6520, DOI 10.1074/jbc.M807564200; Gray LR, 2014, CELL MOL LIFE SCI, V71, P2577, DOI 10.1007/s00018-013-1539-2; Greten TF, 2005, BRIT J CANCER, V92, P1862, DOI 10.1038/sj.bjc.6602590; Guo XC, 2017, GENE DEV, V31, P247, DOI 10.1101/gad.294348.116; Han S, 2013, ANAL BIOANAL CHEM, V405, P1821, DOI 10.1007/s00216-012-6413-9; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Helmke C, 2016, ONCOGENE, V35, P135, DOI 10.1038/onc.2015.105; Hu S, 2011, CELL METAB, V14, P131, DOI 10.1016/j.cmet.2011.04.012; Huang Q, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-304; Jung KY, 2015, J MED CHEM, V58, P3002, DOI 10.1021/jm501440q; Kawate S, 1999, ONCOLOGY-BASEL, V57, P157, DOI 10.1159/000012024; Keepers TR, 2007, INFECT IMMUN, V75, P1229, DOI 10.1128/IAI.01663-06; Konsavage WM, 2012, AM J PHYSIOL-LUNG C, V302, pL27, DOI 10.1152/ajplung.00174.2011; Kuniyasu H, 2003, CLIN CANCER RES, V9, P4802; Lederer M, 2014, SEMIN CANCER BIOL, V29, P3, DOI 10.1016/j.semcancer.2014.07.006; Li Q, 1999, MOL CELL BIOL, V19, P5339; Li R, 2015, ONCOTARGET, V6, P30968, DOI 10.18632/oncotarget.5038; Lin DC, 2017, CANCER RES, V77, P2255, DOI 10.1158/0008-5472.CAN-16-2822; Liu J, 2014, ONCOTARGET, V5, P2635, DOI 10.18632/oncotarget.1862; Lu LC, 2016, LIVER CANCER, V5, P128, DOI 10.1159/000367754; Madan V, 2016, LEUKEMIA, V30, P2430, DOI 10.1038/leu.2016.237; Mannava S, 2008, CELL CYCLE, V7, P2392, DOI 10.4161/cc.6390; Martinez-Quetglas I, 2016, GASTROENTEROLOGY, V151, P1192, DOI 10.1053/j.gastro.2016.09.001; Maschietto M, 2014, ONCOTARGET, V5, P8014, DOI 10.18632/oncotarget.2485; Masetti R, 2016, ONCOTARGET, V7, P56746, DOI 10.18632/oncotarget.10778; Matouk I, 2013, INT J MOL SCI, V14, P4298, DOI 10.3390/ijms14024298; NAGASUE N, 1992, BRIT J SURG, V79, P667, DOI 10.1002/bjs.1800790723; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; OKADA S, 1994, GASTROENTEROLOGY, V106, P1618, DOI 10.1016/0016-5085(94)90419-7; OKUDA K, 1985, CANCER, V56, P918, DOI 10.1002/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E; Patel MS, 2001, EXP MOL MED, V33, P191, DOI 10.1038/emm.2001.32; Pickard A, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00025; Prochownik EV, 2008, CURR MOL MED, V8, P446, DOI 10.2174/156652408785747988; Raveh E, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0458-2; Reznik E, 2016, ELIFE, V5, DOI 10.7554/eLife.10769; Riegler J L, 1996, Semin Gastrointest Dis, V7, P74; Riehmer V, 2014, GENE CHROMOSOME CANC, V53, P589, DOI 10.1002/gcc.22169; Rua S, 1996, CANCER-AM CANCER SOC, V78, P1195, DOI 10.1002/(SICI)1097-0142(19960915)78:6<1195::AID-CNCR5>3.3.CO;2-3; Santoni-Rugiu E, 1999, AM J PATHOL, V154, P1693, DOI 10.1016/S0002-9440(10)65425-9; Sarin M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.201; Saunier E, 2016, INT J CANCER, V138, P809, DOI 10.1002/ijc.29564; Schlaeger C, 2008, HEPATOLOGY, V47, P511, DOI 10.1002/hep.22033; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schulze K, 2016, J HEPATOL, V65, P1031, DOI 10.1016/j.jhep.2016.05.035; SELL S, 1993, ENVIRON HEALTH PERSP, V101, P15, DOI 10.2307/3431838; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Soucek L, 2007, NAT MED, V13, P1211, DOI 10.1038/nm1649; Tao JY, 2014, GASTROENTEROLOGY, V147, P690, DOI 10.1053/j.gastro.2014.05.004; Tornesello ML, 2013, GENOMICS, V102, P74, DOI 10.1016/j.ygeno.2013.04.001; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tretter L, 2016, BBA-BIOENERGETICS, V1857, P1086, DOI 10.1016/j.bbabio.2016.03.012; Trinei M, 2006, BBA-BIOENERGETICS, V1757, P624, DOI 10.1016/j.bbabio.2006.05.029; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Turato C, 2015, SCI REP-UK, V5, DOI 10.1038/srep17701; Tykwinska K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070612; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Valero V, 2015, J HEPATOCELL CARCINO, V2, P69, DOI 10.2147/JHC.S48505; van den Bent MJ, 2015, NEURO-ONCOLOGY, V17, P935, DOI 10.1093/neuonc/nov013; Vilchez V, 2016, WORLD J GASTROENTERO, V22, P823, DOI 10.3748/wjg.v22.i2.823; Vulcano M, 2001, EUR J IMMUNOL, V31, P812, DOI 10.1002/1521-4141(200103)31:3<812::AID-IMMU812>3.0.CO;2-L; Wang HB, 2016, J BIOL CHEM, V291, P26241, DOI 10.1074/jbc.M116.754218; Wang JY, 2015, ONCOTARGET, V6, P20636, DOI 10.18632/oncotarget.4114; Wang X, 2017, RADIAT RES, V187, P50, DOI 10.1667/RR14503.1; Watanabe K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067234; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Waxman DJ, 1999, ARCH BIOCHEM BIOPHYS, V369, P11, DOI 10.1006/abbi.1999.1351; Wilson KE, 2016, GENES, V7; Xiao WF, 2013, BIOCHEM BIOPH RES CO, V439, P167, DOI 10.1016/j.bbrc.2013.08.071; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Xu WY, 2013, FEBS LETT, V587, P3587, DOI 10.1016/j.febslet.2013.08.047; Xu XL, 2010, CARCINOGENESIS, V31, P167, DOI 10.1093/carcin/bgp232; Yamamoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017149; Yin XY, 1999, ONCOGENE, V18, P1177, DOI 10.1038/sj.onc.1202410; Yin XY, 2001, CANCER RES, V61, P6487; Yuneva MO, 2012, CELL METAB, V15, P157, DOI 10.1016/j.cmet.2011.12.015; Zhao CY, 2010, J ENDOCRINOL, V204, P233, DOI 10.1677/JOE-09-0271; Zhou YJ, 2010, VITAM HORM, V83, P151, DOI 10.1016/S0083-6729(10)83006-7	103	23	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10068	10086		10.1074/jbc.M117.782052	http://dx.doi.org/10.1074/jbc.M117.782052			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28432125	Green Published, hybrid			2022-12-26	WOS:000403580600019
J	Scherer, SL; Cain, MD; Kanai, SM; Kaltenbronn, KM; Blumer, KJ				Scherer, Stephanie L.; Cain, Matthew D.; Kanai, Stanley M.; Kaltenbronn, Kevin M.; Blumer, Kendall J.			Regulation of neurite morphogenesis by interaction between R7 regulator of G protein signaling complexes and G protein subunit G alpha(13)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; ON-BIPOLAR CELLS; RGS PROTEINS; PLASMA-MEMBRANE; NEURONAL CELLS; LYSOPHOSPHATIDIC ACID; R7-BINDING PROTEIN; LIVING CELLS; BRAIN; RECEPTOR	The R7 regulator of G protein signaling family (R7-RGS) critically regulates nervous system development and function. Mice lacking all R7-RGS subtypes exhibit diverse neurological phenotypes, and humans bearing mutations in the retinal R7-RGS isoform RGS9-1 have vision deficits. Although each R7-RGS subtype forms heterotrimeric complexes with G beta(5) and R7-RGS-binding protein (R7BP) that regulate G protein-coupled receptor signaling by accelerating deactivation of G(i/o) alpha-subunits, several neurological phenotypes of R7-RGS knock-out mice are not readily explained by dysregulated G(i/o) signaling. Accordingly, we used tandem affinity purification and LC-MS/MS to search for novel proteins that interact with R7-RGS heterotrimers in the mouse brain. Among several proteins detected, we focused on G alpha(13) because it had not been linked to R7-RGS complexes before. Split-luciferase complementation assays indicated that G alpha(13) in its active or inactive state interacts with R7-RGS heterotrimers containing any R7-RGS isoform. LARG (leukemia-associated Rho guanine nucleotide exchange factor (GEF)), PDZ-RhoGEF, and p115RhoGEF augmented interaction between activated G alpha(13) and R7-RGS heterotrimers, indicating that these effector RhoGEFs can engage G alpha(13).R7-RGS complexes. Because G alpha(13)/R7-RGS interaction required R7BP, we analyzed phenotypes of neuronal cell lines expressing RGS7 and G beta(5) with or without R7BP. We found that neurite retraction evoked by G alpha(12/13)-dependent lysophosphatidic acid receptors was augmented in R7BP-expressing cells. R7BP expression blunted neurite formation evoked by serum starvation by signaling mechanisms involving G alpha(12/13) but not G alpha(i/o). These findings provide the first evidence that R7-RGS heterotrimers interact with G alpha(13) to augment signaling pathways that regulate neurite morphogenesis. This mechanism expands the diversity of functions whereby R7-RGS complexes regulate critical aspects of nervous system development and function.	[Scherer, Stephanie L.; Cain, Matthew D.; Kanai, Stanley M.; Kaltenbronn, Kevin M.; Blumer, Kendall J.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Blumer, KJ (corresponding author), Washington Univ, Sch Med, Box 8228,660 S Euclid Ave, St Louis, MO 63110 USA.	kblumer@wustl.edu			National Institutes of Health [GM044592, HL075632]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM044592 and HL075632 (to K. J. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson GR, 2007, J BIOL CHEM, V282, P4772, DOI 10.1074/jbc.M610518200; Bhattacharyya R, 2009, CELL SIGNAL, V21, P996, DOI 10.1016/j.cellsig.2009.02.010; Blazer LL, 2010, MOL PHARMACOL, V78, P524, DOI 10.1124/mol.110.065128; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; Cheever ML, 2008, NAT STRUCT MOL BIOL, V15, P155, DOI 10.1038/nsmb.1377; Chen CK, 2003, P NATL ACAD SCI USA, V100, P6604, DOI 10.1073/pnas.0631825100; Choi JW, 2013, BBA-MOL CELL BIOL L, V1831, P20, DOI 10.1016/j.bbalip.2012.07.015; Drenan RM, 2005, J CELL BIOL, V169, P623, DOI 10.1083/jcb.200502007; Drenan RM, 2006, J BIOL CHEM, V281, P28222, DOI 10.1074/jbc.M604428200; Gloeckner CJ, 2007, PROTEOMICS, V7, P4228, DOI 10.1002/pmic.200700038; Gloeckner Christian Johannes, 2009, Methods Mol Biol, V564, P359, DOI 10.1007/978-1-60761-157-8_21; Gold SJ, 1997, J NEUROSCI, V17, P8024; Grabowska D, 2008, NEUROSCIENCE, V151, P969, DOI 10.1016/j.neuroscience.2007.11.045; He JCJ, 2005, J BIOL CHEM, V280, P33426, DOI 10.1074/jbc.M502812200; Hooks SB, 2003, J BIOL CHEM, V278, P10087, DOI 10.1074/jbc.M211382200; Hu G, 2002, P NATL ACAD SCI USA, V99, P9755, DOI 10.1073/pnas.152094799; Huang J, 2014, ONCOGENE, V33, P3604, DOI 10.1038/onc.2013.324; Hughes TE, 2001, J BIOL CHEM, V276, P4227, DOI 10.1074/jbc.M007608200; Jia LJ, 2014, J BIOL CHEM, V289, P6249, DOI 10.1074/jbc.M113.531475; Jia LX, 2011, J BIOL CHEM, V286, P13695, DOI 10.1074/jbc.M110.193763; Jordan J. D., 2005, J BIOL; Katoh H, 1998, J BIOL CHEM, V273, P28700, DOI 10.1074/jbc.273.44.28700; Klarenbeek J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122513; Kozasa T, 2011, J BIOCHEM, V150, P357, DOI 10.1093/jb/mvr105; Kranenburg O, 1999, MOL BIOL CELL, V10, P1851, DOI 10.1091/mbc.10.6.1851; Krispel CM, 2003, J NEUROSCI, V23, P6965, DOI 10.1523/JNEUROSCI.23-18-06965.2003; Liu ZY, 2004, J BIOL CHEM, V279, P14120, DOI 10.1074/jbc.M309547200; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Martemyanov KA, 2005, J BIOL CHEM, V280, P5133, DOI 10.1074/jbc.C400596200; Masuho I, 2013, J BIOL CHEM, V288, P25129, DOI 10.1074/jbc.M113.462283; Misra RP, 2002, ENDOCRINE, V19, P229, DOI 10.1385/ENDO:19:3:229; Moers A, 2008, MOL CELL BIOL, V28, P1480, DOI 10.1128/MCB.00651-07; Morgans CW, 2007, EUR J NEUROSCI, V26, P2899, DOI 10.1111/j.1460-9568.2007.05867.x; Neubig RR, 2015, PROG MOL BIOL TRANSL, V133, P13, DOI 10.1016/bs.pmbts.2015.04.010; Nini Lylia, 2007, BMC Biochemistry, V8, P18, DOI 10.1186/1471-2091-8-18; Nishiguchi KM, 2004, NATURE, V427, P75, DOI 10.1038/nature02170; Nurnberg A, 2008, J BIOL CHEM, V283, P35526, DOI 10.1074/jbc.M804972200; Orlandi C, 2015, J BIOL CHEM, V290, P13622, DOI 10.1074/jbc.M115.645374; Orlandi C, 2012, J CELL BIOL, V197, P711, DOI 10.1083/jcb.201202123; Panicker LM, 2010, J NEUROCHEM, V113, P1101, DOI 10.1111/j.1471-4159.2010.06616.x; Patikoglou GA, 2002, J BIOL CHEM, V277, P47004, DOI 10.1074/jbc.M208186200; Popov SG, 2000, J BIOL CHEM, V275, P18962, DOI 10.1074/jbc.M001128200; Posner BA, 1999, J BIOL CHEM, V274, P31087, DOI 10.1074/jbc.274.43.31087; Rao A, 2007, J NEUROSCI, V27, P14199, DOI 10.1523/JNEUROSCI.4934-07.2007; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Sandiford SL, 2009, BIOCHEMISTRY-US, V48, P2282, DOI 10.1021/bi801989c; Sayas CL, 2002, J NEUROSCI, V22, P6863; Shu FJ, 2010, CELL SIGNAL, V22, P366, DOI 10.1016/j.cellsig.2009.10.005; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Snow BE, 1998, P NATL ACAD SCI USA, V95, P13307, DOI 10.1073/pnas.95.22.13307; Sun Y, 2011, MOL CELLS, V31, P483, DOI 10.1007/s10059-011-1036-0; Tayou J, 2016, J BIOL CHEM, V291, P9133, DOI 10.1074/jbc.M115.694075; Villalobos V, 2010, CHEM BIOL, V17, P1018, DOI 10.1016/j.chembiol.2010.06.018; Yamazaki J, 2008, BIOL PHARM BULL, V31, P2216, DOI 10.1248/bpb.31.2216; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P13656, DOI 10.1073/pnas.2232594100; Zhang JH, 2000, J NEUROCHEM, V75, P393, DOI 10.1046/j.1471-4159.2000.0750393.x; Zhang JH, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-03-j0004.2000; Zhang JH, 2011, J NEUROCHEM, V119, P544, DOI 10.1111/j.1471-4159.2011.07457.x; Zheng M, 2011, MOL CELL BIOL, V31, P4887, DOI 10.1128/MCB.05690-11; Zhou H, 2012, P NATL ACAD SCI USA, V109, P19977, DOI 10.1073/pnas.1214337109	60	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					9906	9918		10.1074/jbc.M116.771923	http://dx.doi.org/10.1074/jbc.M116.771923			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28432124	Green Published, hybrid			2022-12-26	WOS:000403580600005
J	Bondar, A; Lazar, J				Bondar, Alexey; Lazar, Josef			The G protein G(i1) exhibits basal coupling but not preassembly with G protein-coupled receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; CB1 CANNABINOID RECEPTOR; LIVING CELLS; INTACT-CELLS; LIVE CELLS; ACTIVATION; AGONIST; MODEL; GPCR; LOCALIZATION	The G(i/o) protein family transduces signals from a diverse group of G protein-coupled receptors (GPCRs). The observed specificity of G(i/o)-GPCR coupling and the high rate of G(i/o) signal transduction have been hypothesized to be enabled by the existence of stable associates between G(i/o) proteins and their cognate GPCRs in the inactive state (G(i/o)-GPCR preassembly). To test this hypothesis, we applied the recently developed technique of two-photon polarization microscopy (2PPM) to G alpha(i1) subunits labeled with fluorescent proteins and four GPCRs: the alpha(2A)-adrenergic receptor, GABA(B), cannabinoid receptor type 1 (CB1R), and dopamine receptor type 2. Our experiments with non-dissociating mutants of fluorescently labeled G alpha(i1) subunits (exhibiting impaired dissociation from activated GPCRs) showed that 2PPM is capable of detecting GPCR-G protein interactions. 2PPM experiments with non-mutated fluorescently labeled G alpha(i1) subunits and alpha(2A)-adrenergic receptor, GABA(B), or dopamine receptor type 2 receptors did not reveal any interaction between the G(i1) protein and the non-stimulated GPCRs. In contrast, non-stimulated CB1R exhibited an interaction with the G(i1) protein. Further experiments revealed that this interaction is caused solely by CB1R basal activity; no preassembly between CB1R and the G(i1) protein could be observed. Our results demonstrate that four diverse GPCRs do not preassemble with non-active G(i1). However, we also show that basal GPCR activity allows interactions between non-stimulated GPCRs and G(i1) (basal coupling). These findings suggest that G(i1) interacts only with active GPCRs and that the well known high speed of GPCR signal transduction does not require preassembly between G proteins and GPCRs.	[Bondar, Alexey; Lazar, Josef] Acad Sci Czech Republ, Inst Microbiol, Ctr Nanobiol & Struct Biol, Zamek 136, Nove Hrady 37333, Czech Republic; [Lazar, Josef] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague 16610, Czech Republic; [Lazar, Josef] Univ South Bohemia, Fac Sci, Ceske Budejovice 37005, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Bondar, A (corresponding author), Acad Sci Czech Republ, Inst Microbiol, Ctr Nanobiol & Struct Biol, Zamek 136, Nove Hrady 37333, Czech Republic.	bondar@nh.cas.cz	Lazar, Josef/H-7487-2014; Lazar, Josef/AAI-7246-2020; Bondar, Alexey/G-9459-2014; Lazar, Josef/D-8523-2012	Lazar, Josef/0000-0002-6285-3995; Bondar, Alexey/0000-0002-1980-2930; Lazar, Josef/0000-0002-8579-8589	Czech Science Foundation [P205/13-10799S, P303/17-14413Y]; University of South Bohemia	Czech Science Foundation(Grant Agency of the Czech Republic); University of South Bohemia	This work was supported by Czech Science Foundation Grants P205/13-10799S (to J.NL.) and P303/17-14413Y (to A. B.) and a University of South Bohemia fellowship (A. B.). J. L. is a founder and co-owner of Innovative Bioimaging LLC.	Ayoub MA, 2007, MOL PHARMACOL, V71, P1329, DOI 10.1124/mol.106.030304; Azpiazu I, 2004, J BIOL CHEM, V279, P27709, DOI 10.1074/jbc.M403712200; BOND RA, 1995, NATURE, V374, P272, DOI 10.1038/374272a0; Bondar A, 2014, J BIOL CHEM, V289, P1271, DOI 10.1074/jbc.M113.493643; Bouaboula M, 1997, J BIOL CHEM, V272, P22330, DOI 10.1074/jbc.272.35.22330; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Challiss RAJ, 2011, NAT CHEM BIOL, V7, P657, DOI 10.1038/nchembio.665; D'Antona AM, 2006, BIOCHEMISTRY-US, V45, P5606, DOI 10.1021/bi060067k; Fowler CE, 2007, J PHYSIOL-LONDON, V580, P51, DOI 10.1113/jphysiol.2006.123216; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Hakak Y, 2003, FEBS LETT, V550, P11, DOI 10.1016/S0014-5793(03)00762-2; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Han Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113873; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; Hein P, 2009, N-S ARCH PHARMACOL, V379, P435, DOI 10.1007/s00210-008-0383-7; Lan TH, 2012, TRAFFIC, V13, P1450, DOI 10.1111/j.1600-0854.2012.01401.x; Lazar J, 2011, NAT METHODS, V8, P684, DOI [10.1038/NMETH.1643, 10.1038/nmeth.1643]; Leaney JL, 2002, J BIOL CHEM, V277, P28803, DOI 10.1074/jbc.M204683200; Leterrier C, 2004, J BIOL CHEM, V279, P36013, DOI 10.1074/jbc.M403990200; Lohse MJ, 2008, BRIT J PHARMACOL, V153, pS125, DOI 10.1038/sj.bjp.0707656; Lohse MJ, 2008, TRENDS PHARMACOL SCI, V29, P159, DOI 10.1016/j.tips.2007.12.002; MAHAMA PA, 1994, BIOPHYS J, V67, P1345, DOI 10.1016/S0006-3495(94)80606-X; Masharina A, 2012, J AM CHEM SOC, V134, P19026, DOI 10.1021/ja306320s; NEUBIG RR, 1988, BIOCHEMISTRY-US, V27, P2374, DOI 10.1021/bi00407a019; Nobles M, 2005, P NATL ACAD SCI USA, V102, P18706, DOI 10.1073/pnas.0504778102; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Oldham WM, 2006, Q REV BIOPHYS, V39, P117, DOI 10.1017/S0033583506004306; Philip F, 2007, J BIOL CHEM, V282, P19203, DOI 10.1074/jbc.M701558200; Qin K, 2008, FASEB J, V22, P2920, DOI 10.1096/fj.08-105775; Qin K, 2011, NAT CHEM BIOL, V7, P740, DOI [10.1038/nchembio.642, 10.1038/NCHEMBIO.642]; Scott CE, 2013, PROTEIN SCI, V22, P101, DOI 10.1002/pro.2192; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Simon AC, 2013, J MOL CELL BIOL, V5, P250, DOI 10.1093/jmcb/mjt014; TOLKOVSKY AM, 1978, BIOCHEMISTRY-US, V17, P3795, DOI 10.1021/bi00611a020; Vasquez C, 1999, J NEUROSCI, V19, P9271; Vilardaga JP, 2009, MOL ENDOCRINOL, V23, P590, DOI 10.1210/me.2008-0204; Wu YL, 2004, J BIOL CHEM, V279, P35287, DOI 10.1074/jbc.M404896200; Zhong HL, 2003, J BIOL CHEM, V278, P7278, DOI 10.1074/jbc.M208819200	39	8	9	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9690	9698		10.1074/jbc.M116.768127	http://dx.doi.org/10.1074/jbc.M116.768127			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28438833	Green Published, hybrid			2022-12-26	WOS:000403113000019
J	Minaya, MA; Korom, M; Wang, H; Belshe, RB; Morrison, LA				Minaya, Miguel A.; Korom, Maria; Wang, Hong; Belshe, Robert B.; Morrison, Lynda A.			The herpevac trial for women: Sequence analysis of glycoproteins from viruses obtained from infected subjects	PLOS ONE			English	Article							TYPE-1 FC-RECEPTOR; SIMPLEX-VIRUS; GENITAL HERPES; CONFORMATIONAL-CHANGES; COMPLEMENT COMPONENT; FUNCTIONAL REGIONS; ANTIBODY-RESPONSE; STRUCTURAL BASIS; HEPARAN-SULFATE; GENE-SEQUENCES	The Herpevac Trial for Women revealed that three dose HSV-2 gD vaccine was 58% protective against culture-positive HSV-1 genital disease, but it was not protective against HSV-2 infection or disease. To determine whether vaccine-induced immune responses had selected for a particular gD sequence in strains infecting vaccine recipients compared with viruses infecting control subjects, genetic sequencing studies were carried out on viruses isolated from subjects infected with HSV-1 or HSV-2. We identified naturally occurring variants among the gD sequences obtained from 83 infected subjects. Unique or low frequency amino acid substitutions in the ectodomain of gD were found in 6 of 39 HSV-1-infected subjects and in 7 of 44 HSV-2-infected subjects. However, no consistent amino acid change was identified in isolates from gD-2 vaccine recipients compared with infected placebo recipients. gC and gE surround and partially shield gD from neutralizing antibody, and gB also participates closely in the viral entry process. Therefore, these genes were sequenced from a number of isolates to assess whether sequence variation may alter protein conformation and influence the virus strain's capacity to be neutralized by vaccine-induced antibody. gC and gE genes sequenced from HSV-1-infected subjects showed more variability than their HSV-2 counterparts. The gB sequences of HSV-1 oral isolates resembled each other more than they did gB sequences rom genital isolates. Overall, however, comparison of glycoprotein sequences of viral isolates obtained from infected subjects did not reveal any singular selective pressure on the viral cell attachment protein or surrounding glycoproteins due to administration of gD-2 vaccine.	[Minaya, Miguel A.; Korom, Maria; Wang, Hong; Morrison, Lynda A.] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA; [Belshe, Robert B.; Morrison, Lynda A.] St Louis Univ, Sch Med, Dept Internal Med, St Louis, MO 63104 USA; [Korom, Maria] George Washington Univ, Sch Med, Dept Microbiol Immunol & Trop Dis, Washington, DC USA; [Wang, Hong] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	Saint Louis University; Saint Louis University; George Washington University; Washington University (WUSTL)	Morrison, LA (corresponding author), St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA.; Morrison, LA (corresponding author), St Louis Univ, Sch Med, Dept Internal Med, St Louis, MO 63104 USA.	morrisla@slu.edu	Minaya, Miguel A./J-2700-2019	Minaya, Miguel A./0000-0002-2573-6087	National Institutes of Health Division of Microbiology and Infectious Diseases Option [10E-12-0106]; National Institute of Allergy and Infectious Diseases, Division of Microbiology and Infectious Diseases, Option [10E-12-0106]	National Institutes of Health Division of Microbiology and Infectious Diseases Option(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases, Division of Microbiology and Infectious Diseases, Option	This work was supported by the National Institutes of Health Division of Microbiology and Infectious Diseases Option 10E-12-0106 to RBB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by National Institute of Allergy and Infectious Diseases, Division of Microbiology and Infectious Diseases, Option 10E-12-0106 to RBB.	Abrao EP, 2015, J MED VIROL, V87, P357, DOI 10.1002/jmv.24061; Abu-Raddad LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002230; Atanasiu D, 2007, P NATL ACAD SCI USA, V104, P18718, DOI 10.1073/pnas.0707452104; Atanasiu D, 2010, J VIROL, V84, P12292, DOI 10.1128/JVI.01700-10; Atanasiu D, 2010, J VIROL, V84, P3825, DOI 10.1128/JVI.02687-09; Belshe RB, 2014, J INFECT DIS, V209, P828, DOI 10.1093/infdis/jit651; Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; Bender FC, 2007, J VIROL, V81, P3827, DOI 10.1128/JVI.02710-06; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bernstein DI, 2013, CLIN INFECT DIS, V56, P344, DOI 10.1093/cid/cis891; Bhattarakosol Parvapan, 2005, J Med Assoc Thai, V88 Suppl 4, pS300; BROWN SM, 1973, J GEN VIROL, V18, P329, DOI 10.1099/0022-1317-18-3-329; Cairns TM, 2015, J VIROL, V89, P9213, DOI 10.1128/JVI.01213-15; Cairns TM, 2014, J VIROL, V88, P12612, DOI 10.1128/JVI.01930-14; Cairns TM, 2014, J VIROL, V88, P2677, DOI 10.1128/JVI.03200-13; Campadelli-Fiume G, 2012, CURR OPIN VIROL, V2, P28, DOI 10.1016/j.coviro.2011.12.001; Carfi A, 2001, MOL CELL, V8, P169, DOI 10.1016/S1097-2765(01)00298-2; Chentoufi AA, 2008, J IMMUNOL, V180, P426, DOI 10.4049/jimmunol.180.1.426; CHIANG HY, 1994, J VIROL, V68, P2529, DOI 10.1128/JVI.68.4.2529-2543.1994; COHEN GH, 1984, J VIROL, V49, P102, DOI 10.1128/JVI.49.1.102-108.1984; Colgrove R, 2014, VIROLOGY, V450, P140, DOI 10.1016/j.virol.2013.12.014; Connolly SA, 2003, J VIROL, V77, P8127, DOI 10.1128/JVI.77.14.8127-8140.2003; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Di Giovine P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002277; DUBIN G, 1991, J VIROL, V65, P7046, DOI 10.1128/JVI.65.12.7046-7050.1991; Dudek TE, 2011, J INFECT DIS, V203, P1434, DOI 10.1093/infdis/jir047; DUFF R, 1971, NATURE-NEW BIOL, V233, P48, DOI 10.1038/newbio233048a0; Eisenberg RJ, 2012, VIRUSES-BASEL, V4, P800, DOI 10.3390/v4050800; EJERCITO PM, 1968, J GEN VIROL, V2, P357, DOI 10.1099/0022-1317-2-3-357; Fan Q, 2014, J VIROL, V88, P6470, DOI 10.1128/JVI.00465-14; FRANK I, 1989, J VIROL, V63, P4479, DOI 10.1128/JVI.63.11.4479-4488.1989; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; FRIEDMAN HM, 1984, NATURE, V309, P633, DOI 10.1038/309633a0; FRIES LF, 1986, J IMMUNOL, V137, P1636; Gallagher JR, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004373; Gallagher JR, 2013, J VIROL, V87, P12656, DOI 10.1128/JVI.01727-13; Geraghty RJ, 1998, SCIENCE, V280, P1618, DOI 10.1126/science.280.5369.1618; Gianni T, 2009, J BIOL CHEM, V284, P17370, DOI 10.1074/jbc.M109.005728; Gilbert M, 2011, CAN J PUBLIC HEALTH, V102, P225, DOI 10.1007/BF03404902; Gray RH, 2004, J INFECT DIS, V189, P1209, DOI 10.1086/382750; Haarr L, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-63; Heldwein EE, 2008, CELL MOL LIFE SCI, V65, P1653, DOI 10.1007/s00018-008-7570-z; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Hook LM, 2008, J VIROL, V82, P6935, DOI 10.1128/JVI.02599-07; JOHNSON DC, 1987, J VIROL, V61, P2208, DOI 10.1128/JVI.61.7.2208-2216.1987; Keller I, 2007, PLOS GENET, V3, P185, DOI 10.1371/journal.pgen.0030022; Khrustalev VV, 2009, COMPUT BIOL CHEM, V33, P295, DOI 10.1016/j.compbiolchem.2009.06.005; KORBER B, 2000, COMPUTATIONAL ANAL H, P55, DOI DOI 10.1007/B112102; Kortekangas-Savolainen O, 2007, SEX TRANSM DIS, V34, P37, DOI 10.1097/01.olq.0000222725.81045.62; Pond SLK, 2006, PLOS COMPUT BIOL, V2, P530, DOI 10.1371/journal.pcbi.0020062; Kumar S., 2016, MOL BIOL EVOLUTION, V33, DOI [DOI 10.1093/M0LBEV/MSW054, https://doi.org/10.1093/molbev/msw054, 10.1093/molbev/msw054]; Kumar SD, 2011, BIOTECHNOL BIOINF BI, V1, P451; Kwon BS, 1997, J BIOL CHEM, V272, P14272, DOI 10.1074/jbc.272.22.14272; Lamers SL, 2015, J VIROL, V89, P8206, DOI 10.1128/JVI.01302-15; Lazear E, 2008, J VIROL, V82, P700, DOI 10.1128/JVI.02192-07; Lazear E, 2012, J VIROL, V86, P1563, DOI 10.1128/JVI.06480-11; Lee CC, 2013, ACTA CRYSTALLOGR D, V69, P1935, DOI 10.1107/S0907444913016776; Looker KJ, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0114989, 10.1371/journal.pone.0140765]; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; Morrison LA, 1996, VIROLOGY, V220, P402, DOI 10.1006/viro.1996.0328; Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030; Ndjamen B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003961; Newman RM, 2015, J VIROL, V89, P8219, DOI 10.1128/JVI.01303-15; Norberg P, 2007, J VIROL, V81, P13158, DOI 10.1128/JVI.01310-07; Pinninti SG, 2013, PEDIATR CLIN N AM, V60, P351, DOI 10.1016/j.pcl.2012.12.005; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; RAWLS WE, 1968, AM J EPIDEMIOL, V87, P647, DOI 10.1093/oxfordjournals.aje.a120855; Roizman B, 2013, FIELDS VIROLOGY, V2, P1823; Rose L, 2013, J MED VIROL, V85, P839, DOI 10.1002/jmv.23541; Rux AH, 2002, VIROLOGY, V294, P324, DOI 10.1006/viro.2001.1326; Ryder N, 2009, SEX TRANSM INFECT, V85, P416, DOI 10.1136/sti.2008.033902; SAKAOKA H, 1987, J GEN VIROL, V68, P749, DOI 10.1099/0022-1317-68-3-749; SAKAOKA H, 1987, J GEN VIROL, V68, P2105, DOI 10.1099/0022-1317-68-8-2105; Samra Z, 2003, SEX TRANSM DIS, V30, P794, DOI 10.1097/01.OLQ.0000079517.04451.79; Schacker T, 1998, JAMA-J AM MED ASSOC, V280, P61, DOI 10.1001/jama.280.1.61; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; SMITH KO, 1964, P SOC EXP BIOL MED, V115, P814, DOI 10.3181/00379727-115-29045; Stampfer SD, 2010, J VIROL, V84, P12924, DOI 10.1128/JVI.01750-10; Stanberry LR, 2002, NEW ENGL J MED, V347, P1652, DOI 10.1056/NEJMoa011915; Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315, DOI 10.1093/oxfordjournals.molbev.a026042; Szpara ML, 2014, J VIROL, V88, P1209, DOI 10.1128/JVI.01987-13; Takahashi K, 1999, J CELL BIOL, V145, P539, DOI 10.1083/jcb.145.3.539; Terhune SS, 1998, J INFECT DIS, V178, P8, DOI 10.1086/515590; Warner MS, 1998, VIROLOGY, V246, P179, DOI 10.1006/viro.1998.9218; Whitbeck JC, 2014, J VIROL, V88, P7786, DOI 10.1128/JVI.00544-14; WILLIAMS LE, 1965, ARCH OPHTHALMOL-CHIC, V73, P112; Zhang X, 2008, CLIN VACCINE IMMUNOL, V15, P1436, DOI 10.1128/CVI.00123-08; Zhang ZL, 2003, NUCLEIC ACIDS RES, V31, P5338, DOI 10.1093/nar/gkg745	89	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176687	10.1371/journal.pone.0176687	http://dx.doi.org/10.1371/journal.pone.0176687			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448558	Green Submitted, Green Published, gold			2022-12-26	WOS:000400383600121
J	Yoshioka, H; Usuda, H; Miura, N; Fukuishi, N; Nonogaki, T; Onosaka, S				Yoshioka, Hiroki; Usuda, Haruki; Miura, Nobuhiko; Fukuishi, Nobuyuki; Nonogaki, Tsunemasa; Onosaka, Satomi			Vitamin D3-induced hypercalcemia increases carbon tetrachloride-induced hepatotoxicity through elevated oxidative stress in mice	PLOS ONE			English	Article							DRUG-METABOLIZING ENZYME; INDUCED LIVER FIBROSIS; LIPID-PEROXIDATION; INDUCED NEPHROTOXICITY; PROTECTIVE ROLE; RAT-LIVER; MECHANISMS; MOUSE; PRETREATMENT; CCL4	The aim of this study was to determine whether calcium potentiates acute carbon tetrachloride (CCl4)-induced toxicity. Elevated calcium levels were induced in mice by pre-treatment with cholecalciferol (vitamin D3; V.D3), a compound that has previously been shown to induce hypercalcemia in human and animal models. As seen previously, mice injected with CCl4 exhibited increased plasma levels of alanine aminotransferase, aspartate aminotransferase, and creatinine; transient body weight loss; and increased lipid peroxidation along with decreased total antioxidant power, glutathione, ATP, and NADPH. Pre-treatment of these animals with V.D3 caused further elevation of the values of these liver functional markers without altering kidney functional markers; continued weight loss; a lower lethal threshold dose of CCl4; and enhanced effects on lipid peroxidation and total antioxidant power. In contrast, exposure to V.D3 alone had no effect on plasma markers of liver or kidney damage or on total antioxidant power or lipid peroxidation. The potentiating effect of V.D3 was positively correlated with elevation of hepatic calcium levels. Furthermore, direct injection of CaCl2 also enhanced CCl4-induced hepatic injury. Since CaCl2 induced hypercalcemia transiently (within 3 h of injection), our results suggest that calcium enhances the CCl4-induced hepatotoxicity at an early stage via potentiation of oxidative stress.	[Yoshioka, Hiroki; Fukuishi, Nobuyuki; Nonogaki, Tsunemasa] Kinjo Gakuin Univ, Coll Pharm, Moriyama Ku, Nagoya, Aichi, Japan; [Yoshioka, Hiroki; Onosaka, Satomi] Kobe Gakuin Univ, Fac Nutr, Nishi Ku, 518 Arise,Ikawadani Cho, Kobe, Hyogo, Japan; [Usuda, Haruki] Shimane Univ, Fac Med, Dept Pharmacol, Enya Cho, Izumo, Shimane, Japan; [Miura, Nobuhiko] Japan Natl Inst Occupat Safety & Hlth, Div Hlth Effects Res, Tama Ku, Kawasaki, Kanagawa, Japan	Kobe Gakuin University; Shimane University; National Institute of Occupational Safety & Health, Japan (JNIOSH)	Yoshioka, H (corresponding author), Kinjo Gakuin Univ, Coll Pharm, Moriyama Ku, Nagoya, Aichi, Japan.	h-yoshioka@kinjo-u.ac.jp		Yoshioka, Hiroki/0000-0002-0977-434X; Usuda, Haruki/0000-0002-3664-5519				Ben Hsouna A, 2011, FOOD CHEM TOXICOL, V49, P3183, DOI 10.1016/j.fct.2011.09.034; BERGER ML, 1987, EXP MOL PATHOL, V46, P245, DOI 10.1016/0014-4800(87)90047-5; BRADY JF, 1991, TOXICOL APPL PHARM, V108, P366, DOI 10.1016/0041-008X(91)90125-X; BRATTIN WJ, 1984, ENVIRON HEALTH PERSP, V57, P321, DOI 10.2307/3429934; Cui XF, 2017, TOXICOL LETT, V265, P17, DOI 10.1016/j.toxlet.2016.11.010; Desai HV, 2010, AM J THER, V17, pE234, DOI 10.1097/MJT.0b013e3181c6c21b; Drocourt L, 2002, J BIOL CHEM, V277, P25125, DOI 10.1074/jbc.M201323200; El-Demerdash FM, 2004, FOOD CHEM TOXICOL, V42, P1563, DOI 10.1016/j.fct.2004.05.001; Fu YM, 2008, MOL PHARMACOL, V73, P399, DOI 10.1124/mol.107.039818; Fudge Neva J, 2004, BMC Physiol, V4, P5, DOI 10.1186/1472-6793-4-5; Godoy P, 2013, ARCH TOXICOL, V87, P1315, DOI 10.1007/s00204-013-1078-5; Han YP, 2013, J GASTROEN HEPATOL, V28, P49, DOI 10.1111/jgh.12016; HEAD B, 1981, TOXICOL APPL PHARM, V61, P286, DOI 10.1016/0041-008X(81)90419-1; Larriba MJ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00060; Khan MR, 2009, J ETHNOPHARMACOL, V122, P91, DOI 10.1016/j.jep.2008.12.006; Khan RA, 2010, FOOD CHEM TOXICOL, V48, P2469, DOI 10.1016/j.fct.2010.06.016; KLINGENSMITH JS, 1982, TOXICOL LETT, V11, P149, DOI 10.1016/0378-4274(82)90120-5; Knockaert L, 2012, LAB INVEST, V92, P396, DOI 10.1038/labinvest.2011.193; Lima CF, 2007, FOOD CHEM TOXICOL, V45, P456, DOI 10.1016/j.fct.2006.09.009; Lips P, 2006, PROG BIOPHYS MOL BIO, V92, P4, DOI 10.1016/j.pbiomolbio.2006.02.016; LOWREY K, 1981, BIOCHEM PHARMACOL, V30, P135, DOI 10.1016/0006-2952(81)90184-2; Manibusan MK, 2007, J ENVIRON SCI HEAL C, V25, P185, DOI 10.1080/10590500701569398; Miura N, 2013, J TOXICOL SCI, V38, P947, DOI 10.2131/jts.38.947; Nishiki K, 2003, EUR J PHARMACOL, V460, P171, DOI 10.1016/S0014-2999(02)02921-7; PARFITT AM, 1969, NEW ENGL J MED, V281, P55, DOI 10.1056/NEJM196907102810201; RECKNAGE RO, 1967, PHARMACOL REV, V19, P145; RECKNAGEL RO, 1982, ADV EXP MED BIOL, V136, P619; RECKNAGEL RO, 1989, PHARMACOL THERAPEUT, V43, P139, DOI 10.1016/0163-7258(89)90050-8; Rivera H, 2008, J APPL TOXICOL, V28, P147, DOI 10.1002/jat.1260; SARKAR S, 1995, J TRACE ELEM MED BIO, V9, P144, DOI 10.1016/S0946-672X(11)80038-6; Sheweita SA, 2001, TOXICOLOGY, V165, P217, DOI 10.1016/S0300-483X(01)00429-2; Shrestha N, 2016, FOOD CHEM TOXICOL, V93, P129, DOI 10.1016/j.fct.2016.04.024; Tsuruoka S, 2000, LIFE SCI, V68, P579, DOI 10.1016/S0024-3205(00)00964-4; TYSON CA, 1983, BIOCHEM BIOPH RES CO, V114, P511, DOI 10.1016/0006-291X(83)90810-0; Wang PY, 1999, HEPATOLOGY, V29, P161, DOI 10.1002/hep.510290109; Wang ZC, 2013, J STEROID BIOCHEM, V136, P54, DOI 10.1016/j.jsbmb.2012.09.012; Weber LWD, 2003, CRIT REV TOXICOL, V33, P105, DOI 10.1080/713611034; Wong FWY, 1998, TOXICOL APPL PHARM, V153, P109, DOI 10.1006/taap.1998.8547; Yoshioka H., 2016, FUNDAM TOXICOL SCI, V3, P151; Yoshioka H, 2016, HELIYON, V2, DOI 10.1016/j.heliyon.2016.e00126; Yoshioka H, 2016, ENVIRON HEALTH PREV, V21, P554, DOI 10.1007/s12199-016-0581-8; Yoshioka H, 2016, CHEM-BIOL INTERACT, V254, P117, DOI 10.1016/j.cbi.2016.06.002; Yoshioka H, 2016, BIOL PHARM BULL, V39, P1042, DOI 10.1248/bpb.b16-00078; Yoshioka H, 2016, J TOXICOL SCI, V41, P55, DOI 10.2131/jts.41.55; ZHOU JY, 1990, P NATL ACAD SCI USA, V87, P3929, DOI 10.1073/pnas.87.10.3929	45	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176524	10.1371/journal.pone.0176524	http://dx.doi.org/10.1371/journal.pone.0176524			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448545	Green Published, gold, Green Submitted			2022-12-26	WOS:000400383600095
J	Miller, B; Hamilton, K; Boushel, R; Williamson, K; Laner, V; Gnaiger, E; Davis, M				Miller, Benjamin; Hamilton, Karyn; Boushel, Robert; Williamson, Katherine; Laner, Verena; Gnaiger, Erich; Davis, Michael			Mitochondrial respiration in highly aerobic canines in the non-raced state and after a 1600-km sled dog race	PLOS ONE			English	Article							SUBSTRATE PATHWAYS; EXERCISE; CARBOHYDRATE; RECOVERY; DESIGN; OXYGEN; WELL	At the annual Iditarod Race, Alaskan Huskies repeatedly run for up to 8 hours at 16 km/h to complete 1600 km. We previously demonstrated high rates of mitochondrial protein synthesis in Alaskan Huskies, which we suspected allowed rapid remodeling of mitochondrial proteins in response to energetic stress. The purpose of this study was to examine mitochondrial respiration in permeabilized skeletal muscle fibers of Alaskan Huskies in the offseason (Non-raced) and following the 1600 km Iditarod Sled Dog Race (Raced). We hypothesized that compared to Non-raced Huskies, raced Huskies that completed a 1600 km race would have greater mitochondrial respiratory capacities, and improvements in capacities of oxidative phosphorylation (OXPHOS) based on NADH-generating substrates as compared to fatty acids. Using high-resolution respirometry (HRR) we investigated the respiration of permeabilized muscle fibers from Alaskan Huskies. Maximum capacities were 254 +/- 26 pmol. s(-1).mg(-1) for OXPHOS (coupled, P) and 254 +/- 37 pmol. s(-1).mg(-1) for the electron transfer system (ETS; non-coupled, E). After racing respiratory capacities from NADHlinked substrates, but not fat-derived substrates increased. Finally, the OXPHOS to ETS capacity ratio (P/E) increased after racing from 0.90 +/- 0.03 to 0.97 +/- 0.02. From our previous studies and the current study, we conclude that Alaskan Huskies maintain high mitochondrial protein turnover to facilitate rapid adaptation to environmental extremes and energetic challenges.	[Miller, Benjamin; Hamilton, Karyn] Colorado State Univ, Dept Hlth & Exercise Sci, Ft Collins, CO 80523 USA; [Boushel, Robert] Univ British Columbia, Sch Kinesiol, Vancouver, BC, Canada; [Williamson, Katherine] Waypoint Vet Educ, Edmond, OK USA; [Laner, Verena] Oroboros Instruments, Innsbruck, Austria; [Gnaiger, Erich] Med Univ Innsbruck, Dept Visceral Transplant & Thorac Surg, D Swarvoski Res Lab, Innsbruck, Austria; [Davis, Michael] Oklahoma State Univ, Dept Physiol Sci, Stillwater, OK 74078 USA	Colorado State University; University of British Columbia; Medical University of Innsbruck; Oklahoma State University System; Oklahoma State University - Stillwater	Davis, M (corresponding author), Oklahoma State Univ, Dept Physiol Sci, Stillwater, OK 74078 USA.	Michael.davis@okstate.edu	Boushel, Robert/ABD-7840-2021	Gnaiger, Erich/0000-0003-3647-5895	K-Regio project MitoFit; Oroboros Instruments	K-Regio project MitoFit; Oroboros Instruments	EG and VL were supported by the K-Regio project MitoFit. EG is the CEO and author VL an employee of Oroboros Instruments, a commercial entity based in Austria that designed and manufactures the high resolution respirometry instruments used in this study. Through the involvement of these authors, Oroboros Instruments provided salary and travel funds for these authors, as well as several "loaner" instruments that were used in addition to instruments owned by other authors for sample analysis, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We acknowledge the continuing enthusiasm and participation of Martin Buser and Happy Trails Kennels. In addition, we acknowledge the assistance of Pierre-Louis Heus and Shannon Massie in performing these studies. EG and VL were supported by the K-Regio project MitoFit.	Banse HE, 2007, EQUINE COMP EXER PHY, V4; Baskin CR, 2000, AM J VET RES, V61, P886, DOI 10.2460/ajvr.2000.61.886; Boushel R, 2011, MITOCHONDRION, V11, P303, DOI 10.1016/j.mito.2010.12.006; Brooks GA, 2004, EXERCISE PHYSL; Conley KE, 2013, EXP PHYSIOL, V98, P768, DOI 10.1113/expphysiol.2012.067314; Davis MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103087; Gerth N, 2010, J COMP PHYSIOL B, V180, P577, DOI 10.1007/s00360-009-0432-7; Gnaiger E, 2015, SCAND J MED SCI SPOR, V25, P126, DOI 10.1111/sms.12612; Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013; Henderson GC, 2007, J PHYSIOL-LONDON, V584, P963, DOI 10.1113/jphysiol.2007.137331; Hinchcliff KW, 1997, AM J VET RES, V58, P1457; Jacobs RA, 2013, J APPL PHYSIOL, V114, P344, DOI 10.1152/japplphysiol.01081.2012; Laner V, 2014, MITOCHONDRIAL PHYSL, V19; LINDSTEDT SL, 1991, NATURE, V353, P748, DOI 10.1038/353748a0; McKenzie E, 2005, MED SCI SPORT EXER, V37, P1307, DOI 10.1249/01.mss.0000175086.41080.01; Miller BF, 2015, J APPL PHYSIOL, V118, P1502, DOI 10.1152/japplphysiol.00588.2014; Miller BF, 2015, J APPL PHYSIOL, V118, P811, DOI 10.1152/japplphysiol.00982.2014; Miller BF, 2012, AM J PHYSIOL-ENDOC M, V302, pE496, DOI 10.1152/ajpendo.00578.2011; Miller BF, 2014, J APPL PHYSL, V118; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Poole DC, 2011, COMPR PHYSIOL, V1, P1, DOI 10.1002/cphy.c091001; REYNOLDS AJ, 1995, J APPL PHYSIOL, V79, P1601, DOI 10.1152/jappl.1995.79.5.1601; Roberts TJ, 1996, J EXP BIOL, V199, P1651; Schlagowski AI, 2014, J APPL PHYSIOL, V116, P364, DOI 10.1152/japplphysiol.01177.2013; Skoglund P, 2015, CURR BIOL, V25, P1515, DOI 10.1016/j.cub.2015.04.019; Vock R, 1996, J EXP BIOL, V199, P1689; Votion DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034890; WEIBEL ER, 1991, P NATL ACAD SCI USA, V88, P10357, DOI 10.1073/pnas.88.22.10357; Yeo WK, 2011, APPL PHYSIOL NUTR ME, V36, P12, DOI 10.1139/H10-089	29	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0174874	10.1371/journal.pone.0174874	http://dx.doi.org/10.1371/journal.pone.0174874			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445477	Green Published, Green Submitted, gold			2022-12-26	WOS:000400309200013
J	Papathanasiou, P; Petvises, S; Hey, YY; Perkins, AC; O'Neill, HC				Papathanasiou, Peter; Petvises, Sawang; Hey, Ying-Ying; Perkins, Andrew C.; O'Neill, Helen C.			Impact of the c-Myb(E308G) mutation on mouse myelopoiesis and dendritic cell development	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; TERM RECONSTITUTING SUBSET; ANTIGEN-PRESENTING CELLS; C-MYB; IN-VITRO; TRANSCRIPTION FACTOR; SELF-RENEWAL; BONE-MARROW; AORTIC ENDOTHELIUM; STROMAL CULTURES	Booreana mice carrying the c-Myb(308G) point mutation were analyzed to determine changes in early hematopoiesis in the bone marrow and among mature cells in the periphery. This point mutation led to increased numbers of early hematopoietic stem and progenitor cells (HSPCs), with a subsequent reduction in the development of B cells, erythroid cells, and neutrophils, and increased numbers of myeloid cells and granulocytes. Myelopoiesis was further investigated by way of particular subsets affected. A specific question addressed whether booreana mice contained increased numbers of dendritic-like cells (L-DC subset) recently identified in the spleen, since L-DCs arise in vitro by direct differentiation from HSPCs co-cultured over splenic stroma. The non-lethal c-Myb mutation in booreana mice was associated with significantly lower representation of splenic CD8(-) conventional dendritic cells (cDCs), inflammatory monocytes, and neutrophils compared to wild-type mice. This result confirmed the bone marrow origin of progenitors for these subsets since c-Myb is essential for their development. Production of L-DCs and resident monocytes was not affected by the c-Myb(E308G) mutation. These subsets may derive from different progenitors than those in bone marrow, and are potentially established in the spleen during embryogenesis. An alternative explanation may be needed for why there was no change in CD8(+) cDCs in booreana spleen since these cells are known to derive from common dendritic progenitors in bone marrow.	[Papathanasiou, Peter; Petvises, Sawang; Hey, Ying-Ying] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Perkins, Andrew C.] Univ Queensland, Mater Res, Translat Res Inst, Brisbane, Qld, Australia; [O'Neill, Helen C.] Bond Univ, Clem Jones Res Ctr Regenerat Med, Fac Hlth Sci & Med, Gold Coast, Qld, Australia	Australian National University; Mater Research; University of Queensland; Bond University	O'Neill, HC (corresponding author), Bond Univ, Clem Jones Res Ctr Regenerat Med, Fac Hlth Sci & Med, Gold Coast, Qld, Australia.	honeill@bond.edu.au	O'NEILL, Helen/AAW-8921-2021; Perkins, Andrew/X-4180-2019; Perkins, Andrew/AAJ-9696-2020	O'NEILL, Helen/0000-0002-9506-284X; Perkins, Andrew/0000-0003-3644-7093; 	National Health and Medical Research Council (NHMRC) of Australia [585443]; NHMRC CJ Martin Fellowship; Australian National University	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC CJ Martin Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian National University(Australian National University)	This work was supported by a project grant #585443 to HO from the National Health and Medical Research Council (NHMRC) of Australia. PP was supported by an NHMRC CJ Martin Fellowship. YH was supported by a postgraduate scholarship from the Australian National University.; This work was supported by a project grant #585443 to HO from the National Health and Medical Research Council (NHMRC) of Australia. PP was supported by an NHMRC CJ Martin Fellowship. YH was supported by a postgraduate scholarship from the Australian National University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Boisset JC, 2010, CELL CYCLE, V9, P2489, DOI 10.4161/cc.9.13.12319; Chao MP, 2008, COLD SH Q B, V73, P439, DOI 10.1101/sqb.2008.73.031; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Hey YY, 2016, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00652; Hinton RA, 2012, SCAND J IMMUNOL, V75, P168, DOI 10.1111/j.1365-3083.2011.02643.x; Hinton RA, 2012, J LEUKOCYTE BIOL, V91, P341, DOI 10.1189/jlb.0611302; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Lieu YK, 2004, P NATL ACAD SCI USA, V101, P14853, DOI 10.1073/pnas.0405338101; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Ni KP, 1997, BRIT J HAEMATOL, V97, P710, DOI 10.1046/j.1365-2141.1997.00135.x; O'Neill HC, 2004, STEM CELLS, V22, P475, DOI 10.1634/stemcells.22-4-475; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Papathanasiou P, 2003, IMMUNITY, V19, P131, DOI 10.1016/S1074-7613(03)00168-7; Papathanasiou P, 2010, BLOOD, V116, P5849, DOI 10.1182/blood-2010-04-269951; Papathanasiou P, 2009, STEM CELLS, V27, P3082, DOI 10.1002/stem.232; Papathanasiou P, 2009, STEM CELLS, V27, P2498, DOI 10.1002/stem.170; Pattabiraman DR, 2014, BLOOD, V123, P2682, DOI 10.1182/blood-2012-02-413187; Periasamy P, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00073; Periasamy P, 2013, EXP HEMATOL, V41, P281, DOI 10.1016/j.exphem.2012.11.003; Periasamy P, 2013, J LEUKOCYTE BIOL, V93, P63, DOI 10.1189/jlb.0512260; Periasamy P, 2009, EXP HEMATOL, V37, P1060, DOI 10.1016/j.exphem.2009.06.001; Petvises S, 2014, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00501; Petvises S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088311; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; Quah B, 2004, INT IMMUNOL, V16, P567, DOI 10.1093/intimm/dxh060; Sandberg ML, 2005, DEV CELL, V8, P153, DOI 10.1016/j.devcel.2004.12.015; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Seita J, 2010, CELL STEM CELL, V7, P145, DOI 10.1016/j.stem.2010.07.006; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Sumner R, 2000, ONCOGENE, V19, P3335, DOI 10.1038/sj.onc.1203660; Tan JKH, 2012, J CELL MOL MED, V16, P1924, DOI 10.1111/j.1582-4934.2011.01490.x; Tan JKH, 2011, J CELL MOL MED, V15, P1189, DOI 10.1111/j.1582-4934.2010.01089.x; Tan JKH, 2010, BLOOD, V115, P3678, DOI 10.1182/blood-2009-06-227108; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Wolber FM, 2002, EXP HEMATOL, V30, P1010, DOI 10.1016/S0301-472X(02)00881-0	48	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e176345	10.1371/journal.pone.0176345	http://dx.doi.org/10.1371/journal.pone.0176345			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445549	Green Published, Green Submitted, gold			2022-12-26	WOS:000400309200048
J	Rokusz, A; Veres, D; Szucs, A; Bugyik, E; Mozes, M; Paku, S; Nagy, P; Dezso, K				Rokusz, Andras; Veres, Daniel; Szuecs, Armanda; Bugyik, Edina; Mozes, Miklos; Paku, Sandor; Nagy, Peter; Dezso, Katalin			Ductular reaction correlates with fibrogenesis but does not contribute to liver regeneration in experimental fibrosis models	PLOS ONE			English	Article							TRANSFORMING GROWTH FACTOR-BETA-1; PROGENITOR-CELL EXPANSION; GENE-EXPRESSION; HEPATITIS-C; OVAL CELL; HEPATOCYTE BUDS; MURINE MODEL; FACTOR-BETA; MICE; RAT	Background and aims Ductular reaction is a standard component of fibrotic liver tissue but its function is largely unknown. It is supposed to interact with the matrix producing myofibroblasts and compensate the declining regenerative capacity of hepatocytes. The relationship between the extent of fibrosis-ductular reaction, proliferative activity of hepatocytes and ductular reaction were studied sequentially in experimental hepatic fibrosis models. Methods Liver fibrosis/cirrhosis was induced in wild type and TGF beta overproducing transgenic mice by carbon tetrachloride and thioacetamide administration. The effect of thioacetamide was modulated by treatment with imatinib and erlotinib. The extent of ductular reaction and fibrosis was measured by morphometry following cytokeratin 19 immunofluorescent labeling and Picro Sirius staining respectively. The proliferative activity of hepatocytes and ductular reaction was evaluated by BrdU incorporation. The temporal distribution of the parameters was followed and compared within and between different experimental groups. Results There was a strong significant correlation between the extent of fibrosis and ductular reaction in each experimental group. Although imatinib and erlotinib temporarily decreased fibrosis this effect later disappeared. We could not observe negative correlation between the proliferation of hepatocytes and ductular reaction in any of the investigated models. Conclusions The stringent connection between ductular reaction and fibrosis, which cannot be influenced by any of our treatment regimens, suggests that there is a close mutual interaction between them instead of a unidirectional causal relationship. Our results confirm a close connection between DR and fibrogenesis. However, since the two parameters changed together we could not establish a causal relationship and were unable to reveal which was the primary event. The lack of inverse correlation between the proliferation of hepatocytes and ductular reaction questions that ductular reaction can compensate for the failing regenerative activity of hepatocytes. No evidences support the persistent antifibrotic property of imatinib or erlotinib.	[Rokusz, Andras; Szuecs, Armanda; Bugyik, Edina; Paku, Sandor; Nagy, Peter; Dezso, Katalin] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, Budapest, Hungary; [Veres, Daniel] Semmelweis Univ, Dept Biophys & Radiat Biol, Budapest, Hungary; [Mozes, Miklos] Semmelweis Univ, Inst Pathophysiol, Budapest, Hungary; [Paku, Sandor] Hungarian Acad Sci, Joint Res Org, Tumor Progress Res Grp, Budapest, Hungary; Semmelweis Univ, Budapest, Hungary	Semmelweis University; Semmelweis University; Semmelweis University; Hungarian Academy of Sciences; Semmelweis University	Nagy, P (corresponding author), Semmelweis Univ, Dept Pathol & Expt Canc Res 1, Budapest, Hungary.	pdrnagy@gmail.com	Bugyik, Edina/AAE-4167-2020; Veres, Daniel S/GNH-2578-2022		Hungarian Scientific Research Fund [OTKA K116301, PD109201]; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences; European Union; State of Hungary - European Social Fund of 'National Excellence Program' [TAMOP 4.2.4.A/1-11-1-2012-0001]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); European Union(European Commission); State of Hungary - European Social Fund of 'National Excellence Program'	This work was supported by the Hungarian Scientific Research Fund (OTKA K116301 and PD109201), Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences, also by the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP 4.2.4.A/1-11-1-2012-0001 'National Excellence Program'.	Benhamouche S, 2010, GENE DEV, V24, P1718, DOI 10.1101/gad.1938710; Berasain C, 2014, J GASTROENTEROL, V49, P9, DOI 10.1007/s00535-013-0907-x; Bissell DM, 2001, HEPATOLOGY, V34, P859, DOI 10.1053/jhep.2001.28457; Borkham-Kamphorst E, 2008, LAB INVEST, V88, P1090, DOI 10.1038/labinvest.2008.71; Bugyik E, 2012, INT J EXP PATHOL, V93, P125, DOI 10.1111/j.1365-2613.2011.00803.x; Chobert MN, 2012, LAB INVEST, V92, P135, DOI 10.1038/labinvest.2011.143; Chung YJ, 2006, LEUKEMIA, V20, P1542, DOI 10.1038/sj.leu.2404310; Clouston AD, 2005, HEPATOLOGY, V41, P809, DOI 10.1002/hep.20650; Clouston AD, 2009, HEPATOLOGY, V49, P1424, DOI 10.1002/hep.22893; Desmet VJ, 2011, VIRCHOWS ARCH, V458, P261, DOI 10.1007/s00428-011-1049-2; Distler JHW, 2010, ANN RHEUM DIS, V69, P48, DOI 10.1136/ard.2009.120196; Eleazar JA, 2004, J HEPATOL, V39, P357; Espanol-Suner R, 2012, GASTROENTEROLOGY, V143, P1564, DOI 10.1053/j.gastro.2012.08.024; EVARTS RP, 1993, CELL GROWTH DIFFER, V4, P555; Fabris L, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/2953727; Falkowski O, 2003, J HEPATOL, V39, P357, DOI 10.1016/S0168-8278(03)00309-X; Fuchs BC, 2014, HEPATOLOGY, V59, P1577, DOI 10.1002/hep.26898; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Goodman ZD, 2007, HEPATOLOGY, V45, P886, DOI 10.1002/hep.21595; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Hoshida Y, 2013, GASTROENTEROLOGY, V144, P1024, DOI 10.1053/j.gastro.2013.01.021; Iqbal Nida, 2014, Chemother Res Pract, V2014, P357027, DOI 10.1155/2014/357027; JHAPPAN C, 1990, CELL, V61, P1137, DOI 10.1016/0092-8674(90)90076-Q; Kallis YN, 2011, GUT, V60, P525, DOI 10.1136/gut.2010.224436; Kaur S, 2015, AM J PATHOL, V185, P2342, DOI 10.1016/j.ajpath.2015.06.004; Kim Y, 2012, LIVER INT, V32, P1008, DOI 10.1111/j.1478-3231.2012.02806.x; Knight B, 2008, GASTROENTEROLOGY, V135, P969, DOI 10.1053/j.gastro.2008.05.077; Lee YA, 2015, GUT, V64, P1337, DOI 10.1136/gutjnl-2014-306842corr1; Lin WR, 2010, HEPATOLOGY, V51, P1017, DOI 10.1002/hep.23483; Lopez-Luque J, 2016, HEPATOLOGY, V63, P604, DOI 10.1002/hep.28134; Miyajima A, 2014, CELL STEM CELL, V14, P561, DOI 10.1016/j.stem.2014.04.010; NAGY P, 1991, HEPATOLOGY, V14, P269, DOI 10.1002/hep.1840140211; Nagy P, 1996, HEPATOLOGY, V23, P71, DOI 10.1053/jhep.1996.v23.pm0008550051; NAKATSUKASA H, 1990, J CLIN INVEST, V85, P1833, DOI 10.1172/JCI114643; Neef M, 2006, J HEPATOL, V44, P167, DOI 10.1016/j.jhep.2005.06.015; Nguyen LN, 2007, HEPATOLOGY, V45, P31, DOI 10.1002/hep.21466; Prakoso E, 2014, LIVER TRANSPLANT, V20, P1508, DOI 10.1002/lt.24007; Richardson MM, 2007, GASTROENTEROLOGY, V133, P80, DOI 10.1053/j.gastro.2007.05.012; Rokusz A, 2016, INT J EXP PATHOL, V97, P389, DOI 10.1111/iep.12209; Rokusz A, 2016, SCAND J GASTROENTERO, V51, P86, DOI 10.3109/00365521.2015.1067902; Roskams T, 2003, AM J PATHOL, V163, P1301, DOI 10.1016/S0002-9440(10)63489-X; Roskams TA, 2004, HEPATOLOGY, V39, P1739, DOI 10.1002/hep.20130; Ruddell RG, 2009, HEPATOLOGY, V49, P227, DOI 10.1002/hep.22597; SANDERSON N, 1995, P NATL ACAD SCI USA, V92, P2572, DOI 10.1073/pnas.92.7.2572; Schaub JR, 2014, CELL REP, V8, P933, DOI 10.1016/j.celrep.2014.07.003; Scheving LA, 2015, AM J PHYSIOL-GASTR L, V308, pG364, DOI 10.1152/ajpgi.00364.2014; Schnur J, 2004, EUR J GASTROEN HEPAT, V16, P127, DOI 10.1097/00042737-200402000-00002; Smith PG, 2012, ONCOTARGET, V3, P518; Stueck AE, 2015, HEPATOLOGY, V61, P1696, DOI 10.1002/hep.27706; Takemura T, 2013, BIOCHEM BIOPH RES CO, V437, P185, DOI 10.1016/j.bbrc.2013.05.097; Tarlow BD, 2014, HEPATOLOGY, V60, P278, DOI 10.1002/hep.27084; Tipping AJ, 2003, EXP HEMATOL, V31, P1073, DOI 10.1016/j.exphem.2003.08.006; Van Hul NKM, 2009, HEPATOLOGY, V49, P1625, DOI 10.1002/hep.22820; Wood MJ, 2014, HEPATOLOGY, V59, P848, DOI 10.1002/hep.26706; Yanger K, 2014, CELL STEM CELL, V15, P340, DOI 10.1016/j.stem.2014.06.003	55	15	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176518	10.1371/journal.pone.0176518	http://dx.doi.org/10.1371/journal.pone.0176518			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445529	Green Accepted, Green Published, gold			2022-12-26	WOS:000400309200068
J	Singh, SK; Aspi, J; Kvist, L; Sharma, R; Pandey, P; Mishra, S; Singh, R; Agrawal, M; Goyal, SP				Singh, Sujeet Kumar; Aspi, Jouni; Kvist, Laura; Sharma, Reeta; Pandey, Puneet; Mishra, Sudhanshu; Singh, Randeep; Agrawal, Manoj; Goyal, Surendra Prakash			Fine-scale population genetic structure of the Bengal tiger (Panthera tigris tigris) in a human-dominated western Terai Arc Landscape, India	PLOS ONE			English	Article							GENOTYPING ERRORS; COMPUTER-PROGRAM; RECENT MIGRATION; SIZE; FLOW; CONSERVATION; EXTINCTION; DIVERSITY; SOFTWARE; PATTERNS	Despite massive global conservation strategies, tiger populations continued to decline until recently, mainly due to habitat loss, human-animal conflicts, and poaching. These factors are known to affect the genetic characteristics of tiger populations and decrease local effective population sizes. The Terai Arc Landscape (TAL) at the foothills of the Himalaya is one of the 42 source sites of tigers around the globe. Therefore, information on how landscape features and anthropogenic factors affect the fine-scale spatial genetic structure and variation of tigers in TAL is needed to develop proper management strategies for achieving long-term conservation goals. We document, for the first time, the genetic characteristics of this tiger population by genotyping 71 tiger samples using 13 microsatellite markers from the western region of TAL (WTAL) of 1800 km(2). Specifically, we aimed to estimate the genetic variability, population structure, and gene flow. The microsatellite markers indicated that the levels of allelic diversity (MNA = 6.6) and genetic variation (Ho = 0.50, H-E = 0.64) were slightly lower than those reported previously in other Bengal tiger populations. We observed moderate gene flow and significant genetic differentiation (F-ST=0.060) and identified the presence of cryptic genetic structure using Bayesian and non-Bayesian approaches. There was low and significantly asymmetric migration between the two main subpopulations of the Rajaji Tiger Reserve and the Corbett Tiger Reserve in WTAL. Sibship relationships indicated that the functionality of the corridor between these subpopulations may be retained if the quality of the habitat does not deteriorate. However, we found that gene flow is not adequate in view of changing land use matrices. We discuss the need to maintain connectivity by implementing the measures that have been suggested previously to minimize the level of human disturbance, including relocation of villages and industries, prevention of encroachment, and banning sand and boulder mining in the corridors.	[Singh, Sujeet Kumar; Aspi, Jouni; Kvist, Laura] Univ Oulu, Dept Ecol & Genet, Oulu, Finland; [Singh, Sujeet Kumar; Pandey, Puneet; Mishra, Sudhanshu; Agrawal, Manoj; Goyal, Surendra Prakash] Wildlife Inst India, Chandrabani, Dehradun, India; [Sharma, Reeta] Inst Gulbenkian Ciencias, Populat & Conservat Genet, Oeiras, Portugal; [Singh, Randeep] Amity Univ, Dept Wildlife Sci, Noida, India	University of Oulu; Wildlife Institute of India; Instituto Gulbenkian de Ciencia; Amity University Noida	Goyal, SP (corresponding author), Wildlife Inst India, Chandrabani, Dehradun, India.	goyalsp@wii.gov.in	Singh, Randeep/I-2713-2016; Aspi, Jouni O/B-3087-2012; MISHRA, SUDHANSHU/E-6732-2011; Singh, Sujeet Kumar/ABC-2594-2020	Singh, Randeep/0000-0001-8461-2327; Singh, Sujeet Kumar/0000-0002-3671-1328; Sharma, Reeta/0000-0001-9862-9218; PANDEY, PUNEET/0000-0001-5891-3927; Aspi, Jouni/0000-0002-2451-3201	Wildlife Institute of India; project "Panthera tigris genome: Implication in wildlife forensics" - Wildlife Institute of India, Dehra Dun, India	Wildlife Institute of India; project "Panthera tigris genome: Implication in wildlife forensics" - Wildlife Institute of India, Dehra Dun, India	This work was supported by Wildlife Institute of India to SPG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscriptr We are grateful to the Director, Dean and Research Coordinator of the Wildlife Institute of India for their strong support. This research was supported by the project "Panthera tigris genome: Implication in wildlife forensics" funded by the Wildlife Institute of India, Dehra Dun, India. We would like to express our thanks to researchers and staff at the wildlife forensic lab for their support during lab work. We also thank officials of the Forest Department of Uttarakhand for providing samples for this study. We also thank the editor and three anonymous reviewers for their constructive comments, which helped us to improve the manuscript.	Allendorf F, 2013, CONSERV GENET, V2nd; [Anonymous], 2008, 312003PT NTCA; Bergl RA, 2007, MOL ECOL, V16, P501, DOI 10.1111/j.1365-294X.2006.03159.x; BRUSSARD PF, 1984, ANNU REV ECOL SYST, V15, P25, DOI 10.1146/annurev.es.15.110184.000325; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Cornuet JM, 1996, GENETICS, V144, P2001; Dixit A., 2010, GLOBAL J ENV RES, V4, P113; Durand E, 2009, MOL BIOL EVOL, V26, P1963, DOI 10.1093/molbev/msp106; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ernest HB, 2003, CONSERV GENET, V4, P353, DOI 10.1023/A:1024069014911; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Francois O, 2010, MOL ECOL RESOUR; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Frankham R, 2009, INTRO CONSERVATION G; Garner A, 2005, CONSERV BIOL; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; GINSBERG JR, 1994, CONSERV BIOL, V8, P157, DOI 10.1046/j.1523-1739.1994.08010157.x; GOTTELLI D, 1994, MOL ECOL, V3, P301, DOI 10.1111/j.1365-294X.1994.tb00070.x; Gottelli D, 2012, ANIM CONSEV; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Haag T, 2010, MOL ECOL, V19, P4906, DOI 10.1111/j.1365-294X.2010.04856.x; Hajkova P, 2009, CONSERV GENET, V10, P1667, DOI 10.1007/s10592-008-9745-4; Harihar A, 2009, ORYX, V43, P35, DOI 10.1017/S0030605307072043; Harihar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040105; Harihar A, 2009, EUR J WILDLIFE RES, V55, P97, DOI 10.1007/s10344-008-0219-2; Hedrick PW, 2014, CONSERV GENET, V15, P1111, DOI 10.1007/s10592-014-0604-1; Holbrook JD, 2012, J MAMMAL, V93, P989, DOI 10.1644/11-MAMM-A-326.2; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Janecka JE, 2008, ANIM CONSERV, V11, P401, DOI 10.1111/j.1469-1795.2008.00195.x; Jhala Y, 2008, STATUS TIGERS COPRED; Jhala Y.V., 2015, STATUS TIGERS INDIA; Johnsingh AJT, 2006, AMBIO, V35, P135, DOI 10.1579/0044-7447(2006)35[135:SACOTT]2.0.CO;2; Johnsingh AJT, 2004, CONSERVATION STATUS; Johnsingh AT, 2003, BIOL CONSERV, V111, P385, DOI 10.1016/S0006-3207(02)00307-5; Johnson PCD, 2007, GENETICS, V175, P827, DOI 10.1534/genetics.106.064618; Jombart T, 2008, HEREDITY, V101, P92, DOI 10.1038/hdy.2008.34; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Joshi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077980; Karanth KU, 2011, J APPL ECOL, V48, P1048, DOI 10.1111/j.1365-2664.2011.02002.x; Laurance WF, 2010, CONSERVATION BIOLOGY FOR ALL, P73; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; Linkie M, 2006, J APPL ECOL, V43, P576, DOI 10.1111/j.1365-2664.2006.01153.x; Loxterman JL, 2011, CONSERV GENET, V12, P1049, DOI 10.1007/s10592-011-0208-y; Luo SJ, 2004, PLOS BIOL, V2, P2275, DOI 10.1371/journal.pbio.0020442; McManus JS, 2015, ECOL EVOL, V5, P335, DOI 10.1002/ece3.1322; McNeely J.A., 1997, CONSERVATION FUTURE; Menotti-Raymond M, 1999, GENOMICS, V57, P9, DOI 10.1006/geno.1999.5743; Miller CR, 2003, P NATL ACAD SCI USA, V100, P4334, DOI 10.1073/pnas.0735531100; Miller MP, 2005, J HERED, V96, P722, DOI 10.1093/jhered/esi119; Mondol S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0496; Mondol S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000585; Morrison JC, 2007, J MAMMAL, V88, P1363, DOI 10.1644/06-MAMM-A-124R2.1; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Peery MZ, 2012, MOL ECOL, V21, P3403, DOI 10.1111/j.1365-294X.2012.05635.x; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Qureshi Q, 2014, TR201402 NTCA WII; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reddy PA, 2012, PLOS ONE, V7; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Segelbacher G, 2010, CONSERV GENET, V11, P375, DOI 10.1007/s10592-009-0044-5; Seidensticker J., 2010, BIOL CONSERVATION WI; Seidensticker J, 2010, INTEGR ZOOL, V5, P285, DOI 10.1111/j.1749-4877.2010.00214.x; Semwal R.L., 2005, TERAI ARC LANDSCAPE; Shahabuddin Ghazala, 2010, MOUNTAIN ECOSYSTEM M; Sharma R, 2008, MOL ECOL RESOUR, V8, P1480, DOI 10.1111/j.1755-0998.2008.02292.x; Sharma R, 2011, MAMM BIOL, V76, P484, DOI 10.1016/j.mambio.2010.10.005; Sharma R, 2009, CONSERV GENET, V10, P909, DOI 10.1007/s10592-008-9568-3; Sharma S, 2013, ECOL EVOL, V3, P48, DOI 10.1002/ece3.432; Singh S.K., 2015, Wildlife Biology in Practice, V11, P1; Singh SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118846; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Sork VL, 1999, TRENDS ECOL EVOL, V14, P219, DOI 10.1016/S0169-5347(98)01585-7; Spong G, 2002, CONSERV ECOL, V6; Stenseth N., 2004, MARINE ECOSYSTEMS CL; Stronen AV, 2014, BMC ECOL, V14, DOI 10.1186/1472-6785-14-11; Sunquist ME, 2002, WILD CATS WORLD; Sweanor LL, 2000, CONSERV BIOL, V14, P798, DOI 10.1046/j.1523-1739.2000.99079.x; Tende T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084288; Valiere N, 2007, CONSERV GENET, V8, P69, DOI 10.1007/s10592-006-9149-2; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vonholdt BM, 2010, MOL ECOL, V19, P4412, DOI 10.1111/j.1365-294X.2010.04769.x; Walston J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000485; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; Wayne Robert K., 1996, P453; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WII, 2011, EC ASS SIT DES COLL; Wikramanayake E, 2010, TIGERS OF THE WORLD: THE SCIENCE, POLITICS, AND CONSERVATION OF PANTHERA TIGRIS, 2ND EDITION, P163, DOI 10.1016/B978-0-8155-1570-8.00010-4; Wilson GA, 2003, GENETICS, V163, P1177; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; Woodroffe R., 2005, IMPACT HUMAN WILDLIF, P1, DOI [10.1017/CBO9780511614774, DOI 10.1017/CBO9780511614774]; Wright LI, 2008, CONSERV GENET, V9, P833, DOI 10.1007/s10592-007-9405-0; Wultsch C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151043; Yumnam B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111207	104	14	14	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0174371	10.1371/journal.pone.0174371	http://dx.doi.org/10.1371/journal.pone.0174371			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445499	gold, Green Published			2022-12-26	WOS:000400309200005
J	Lee, MK; Shaffer, JR; Leslie, EJ; Orlova, E; Carlson, JC; Feingold, E; Marazita, ML; Weinberg, SM				Lee, Myoung Keun; Shaffer, John R.; Leslie, Elizabeth J.; Orlova, Ekaterina; Carlson, Jenna C.; Feingold, Eleanor; Marazita, Mary L.; Weinberg, Seth M.			Genome-wide association study of facial morphology reveals novel associations with FREM1 and PARK2	PLOS ONE			English	Article							MUTATIONS; BRAIN; FACE	Several studies have now shown evidence of association between common genetic variants and quantitative facial traits in humans. The reported associations generally involve simple univariate measures and likely represent only a small fraction of the genetic loci influencing facial morphology. In this study, we applied factor analysis to a set of 276 facial linear distances derived from 3D facial surface images of 2187 unrelated individuals of European ancestry. We retained 23 facial factors, which we then tested for genetic associations using a genome-wide panel of 10,677,593 single nucleotide polymorphisms (SNPs). In total, we identified genome-wide significant (p < 5 x 10(-8)) associations in three regions, including two that are novel: one involving measures of midface height at 6q26 within an intron of PARK2 (lead SNP rs9456748; p = 4.99 x 10(-8)) and another involving measures of central upper lip height at 9p22 within FREM1 (lead SNP rs72713618; p = 2.02 x 10(-8)). In both cases, the genetic association was stronger with the composite facial factor phenotype than with any of the individual linear distances that comprise those factors. While the biological role of PARK2 in the craniofacial complex is currently unclear, there is evidence from both mouse models and Mendelian syndromes that FREM1 may influence facial variation. These results highlight the potential value of data-driven multivariate phenotyping for genetic studies of human facial morphology.	[Lee, Myoung Keun; Leslie, Elizabeth J.; Marazita, Mary L.; Weinberg, Seth M.] Univ Pittsburgh, Dept Oral Biol, Ctr Craniofacial & Dent Genet, Pittsburgh, PA 15260 USA; [Shaffer, John R.; Orlova, Ekaterina; Feingold, Eleanor; Marazita, Mary L.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Carlson, Jenna C.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Marazita, Mary L.] Univ Pittsburgh, Sch Med, Clin & Translat Sci Inst, Pittsburgh, PA USA; [Marazita, Mary L.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Weinberg, Seth M.] Univ Pittsburgh, Dept Anthropol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Weinberg, SM (corresponding author), Univ Pittsburgh, Dept Oral Biol, Ctr Craniofacial & Dent Genet, Pittsburgh, PA 15260 USA.; Weinberg, SM (corresponding author), Univ Pittsburgh, Dept Anthropol, Pittsburgh, PA 15260 USA.	smwst46@pitt.edu	Leslie, Elizabeth/AAP-8941-2021	Leslie, Elizabeth/0000-0002-5735-1712; Carlson, Jenna/0000-0001-5483-0833; Shaffer, John/0000-0003-1897-1131; Weinberg, Seth/0000-0001-9467-4556	National Institute for Dental and Craniofacial Research [U01-DE020078, U01-DE020057, R01-DE016148, K99-DE02560]; National Human Genome Research Institute [X01-HG007821]; University of Washington from the National Institute for Dental and Craniofacial Research [HHSN268201200008I]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R00DE025060, R01DE016148] Funding Source: NIH RePORTER	National Institute for Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); University of Washington from the National Institute for Dental and Craniofacial Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The National Institute for Dental and Craniofacial Research (http://www.nider.nih.gov/) provided funding through the following grants: U01-DE020078; U01-DE020057; R01-DE016148; K99-DE02560. Funding for genotyping was provided by the National Human Genome Research Institute (https://www.genome.gov/): X01-HG007821. Funding for initial genomic data cleaning by the University of Washington was provided by contract #HHSN268201200008I from the National Institute for Dental and Craniofacial Research (http://wm.nidcr.nih.gov/) awarded to the Center for Inherited Disease Research (CIDR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11616; Alazami AM, 2009, AM J HUM GENET, V85, P414, DOI 10.1016/j.ajhg.2009.08.010; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bastir M, 2006, ARCH ORAL BIOL, V51, P814, DOI 10.1016/j.archoralbio.2006.03.009; Changeux JPN, 2000, NAT GENET, V25, P431; Claes P, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004224; Cole JB, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006174; COLE T, 2003, WINEDMA SOFTWARE EUC; Coussens AK, 2005, GENOMICS, V85, P563, DOI 10.1016/j.ygeno.2005.02.002; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Dixon MJ, 2011, NAT REV GENET, V12, P167, DOI 10.1038/nrg2933; Hallgrimsson B, 2007, EVOL DEV, V9, P76, DOI 10.1111/j.1525-142X.2006.00139.x; Heike CL, 2010, HEAD FACE MED, V6, DOI 10.1186/1746-160X-6-18; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Liu F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002932; Lu WS, 2015, HUM MOL GENET, V24, P2390, DOI 10.1093/hmg/ddu731; Nguyen VT A, 2004, NATURE, V427, P636; Parsons TE, 2011, DEV DYNAM, V240, P2233, DOI 10.1002/dvdy.22729; Paternoster L, 2012, AM J HUM GENET, V90, P478, DOI 10.1016/j.ajhg.2011.12.021; Peng SN, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003375; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Shaffer JR, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006149; Slavotinek AM, 2011, J MED GENET, V48, P375, DOI 10.1136/jmg.2011.089631; Smyth I, 2004, P NATL ACAD SCI USA, V101, P13560, DOI 10.1073/pnas.0402760101; Van Laarhoven PM, 2015, HUM MOL GENET, V24, P4443, DOI 10.1093/hmg/ddv180; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Vissers LELM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002278; Weinberg S. M., 2016, CLEFT PALAT IN PRESS; Williams FMK, 2013, ANN RHEUM DIS, V72, P1141, DOI 10.1136/annrheumdis-2012-201551	34	43	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176566	10.1371/journal.pone.0176566	http://dx.doi.org/10.1371/journal.pone.0176566			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441456	gold, Green Published, Green Submitted			2022-12-26	WOS:000400308800066
J	Rovner, GS; Sunnerhagen, KS; Bjorkdahl, A; Gerdle, B; Borsbo, B; Johansson, F; Gillanders, D				Rovner, Graciela S.; Sunnerhagen, Katharina S.; Bjorkdahl, Ann; Gerdle, Bjorn; Borsbo, Bjorn; Johansson, Fredrik; Gillanders, David			Chronic pain and sex-differences; women accept and move, while men feel blue	PLOS ONE			English	Article							CHRONIC MUSCULOSKELETAL PAIN; QUALITY-OF-LIFE; LOW-BACK-PAIN; HOSPITAL ANXIETY; GENDER-DIFFERENCES; HEALTH SURVEY; TAMPA SCALE; SWEDISH; FEAR; KINESIOPHOBIA	Purpose The aim of this study is to explore differences between male and female patients entering a rehabilitation program at a pain clinic in order to gain a greater understanding of different approaches to be used in rehabilitation. Method 1371 patients referred to a specialty pain rehabilitation clinic, completed sociodemographic and pain related questionnaires. They rated their pain acceptance (CPAQ-8), their kinesiophobia (TSK), the impact of pain in their life (MPI), anxiety and depression levels (HAD) and quality of life scales: the SF-36, LiSat-11, and the EQ-5D. Because of the large sample size of the study, the significance level was set at the p <= .01. Results Analysis by t-test showed that when both sexes experience the same pain severity, women report significantly higher activity level, pain acceptance and social support while men report higher kinesiophobia, mood disturbances and lower activity level. Conclusion Pain acceptance (CPAQ-8) and kinesiophobia (TSK) showed the clearest differences between men and women. Pain acceptance and kinesiophobia are behaviorally defined and have the potential to be changed.	[Rovner, Graciela S.; Sunnerhagen, Katharina S.; Bjorkdahl, Ann] Univ Gothenburg, Sahlgrenska Acad, Rehabil Med, Inst Neurosci & Physiol, Gothenburg, Sweden; [Rovner, Graciela S.] Danderyd Hosp, Div Rehabil Med, Dept Clin Sci, Karolinska Inst, Stockholm, Sweden; [Rovner, Graciela S.] Karolinska Inst, Div Physiotherapy, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Bjorkdahl, Ann] Ersta Skondal Univ Coll, Campus Bracke, Gothenburg, Sweden; [Gerdle, Bjorn] Linkoping Univ, Pain & Rehabilitat Ctr, SE-58185 Linkoping, Sweden; [Gerdle, Bjorn] Linkoping Univ, Dept Med & Hlth Sci, SE-58185 Linkoping, Sweden; [Borsbo, Bjorn] Linkoping Univ, Div Community Med, Dept Med & Hlth Sci, Linkoping, Sweden; [Borsbo, Bjorn] Cty Hosp Ryhov, Clin Dept Rehabil Med, Jonkoping, Sweden; [Johansson, Fredrik] Danderyd Hosp, Med Library, Stockholm, Sweden; [Gillanders, David] Univ Edinburgh, Sch Hlth Social Sci, Edinburgh, Midlothian, Scotland	University of Gothenburg; Danderyds Hospital; Karolinska Institutet; Karolinska Institutet; Linkoping University; Linkoping University; Linkoping University; Danderyds Hospital; University of Edinburgh	Sunnerhagen, KS (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Rehabil Med, Inst Neurosci & Physiol, Gothenburg, Sweden.	ks.sunnerhagen@neuro.gu.se	Björkdahl, Ann/ABD-6197-2021; Sunnerhagen, Katharina Stibrant/AAE-2405-2020; Rovner, Graciela/ABF-4482-2020	Björkdahl, Ann/0000-0002-2194-6773; Sunnerhagen, Katharina Stibrant/0000-0002-5940-4400; Rovner, Graciela/0000-0002-6738-1624	Swedish Association of Local Authorities and Regions (SALAR); Vardal Foundation; RehSAM; AFA insurance, Sweden; Swedish Association for Survivors of Accident and Injury (RTP); Renee Eanders Foundation	Swedish Association of Local Authorities and Regions (SALAR); Vardal Foundation; RehSAM; AFA insurance, Sweden; Swedish Association for Survivors of Accident and Injury (RTP); Renee Eanders Foundation	The first author was part-time founded by The Swedish Association for Survivors of Accident and Injury (RTP) and from Renee Eanders Foundation related to the Swedish Association of Physiotherapists. The rest of her time was unfunded. Professor Bjorn Gerdle was funded by the Swedish Association of Local Authorities and Regions (SALAR), the Vardal Foundation, (RehSAM) and AFA insurance, Sweden.; The present study was supported by grants from The Swedish Association for Survivors of Accident and Injury (RTP), Renee Eanders Foundation, the Swedish Association of Local Authorities and Regions (SALAR), the Vardal Foundation, (RehSAM) and AFA insurance, Sweden.	Ahlgren C, 2016, DISABIL REHABIL, V38, P2255, DOI 10.3109/09638288.2015.1127435; American Psychological Association APA, 2010, PUBL MAN AM PSYCH AS, Vxviii; Baranoff J, 2012, INT J BEHAV MED; Bergstrom G, 1998, PAIN, V75, P101, DOI 10.1016/S0304-3959(97)00210-8; Bergstrom KG, 1999, EUR J PAIN-LONDON, V3, P261, DOI 10.1016/S1090-3801(99)90053-8; Berkley KJ, 1997, BEHAV BRAIN SCI, V20, P371, DOI 10.1017/S0140525X97221485; BIEDERMAN JJ, 1994, BEHAV MODIF, V18, P89; Branstrom H, 2008, J REHABIL MED, V40, P375, DOI 10.2340/16501977-0186; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; BROOKS RG, 1991, HEALTH POLICY, V18, P37, DOI 10.1016/0168-8510(91)90142-K; BUCKELEW SP, 1990, PAIN, V42, P287, DOI 10.1016/0304-3959(90)91141-5; Cohen J.E., 1988, STAT POWER ANAL BEHA; Crombez G, 1999, PAIN, V80, P329, DOI 10.1016/S0304-3959(98)00229-2; Dawson A, 2009, J ORAL REHABIL, V36, P271, DOI 10.1111/j.1365-2842.2009.01943.x; Edwards RR, 2003, PAIN, V106, P419, DOI 10.1016/j.pain.2003.09.004; Fejer R, 2006, EUR SPINE J, V15, P834, DOI 10.1007/s00586-004-0864-4; Fillingim RB, 1998, PAIN, V75, P121, DOI 10.1016/S0304-3959(97)00214-5; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; Fish RA, 2013, J PAIN, V14, P233, DOI 10.1016/j.jpain.2012.11.004; Fish RA, 2010, PAIN, V149, P435, DOI 10.1016/j.pain.2009.12.016; FUGELMEYER AR, 1988, SCAND J REHABIL MED, P51; Fugl-Meyer AR, 2002, J REHABIL MED, V34, P239, DOI 10.1080/165019702760279242; Fugl-Meyer AR, 1987, SCANDINAVIAN J REH S, V17, P51; Gatchel RJ., 1999, PSYCHOSOCIAL FACTORS; Gerdle B, 2004, J RHEUMATOL, V31, P1399; Green CR, 2010, J PAIN, V11, P746, DOI 10.1016/j.jpain.2009.11.003; Grotle M, 2010, PAIN, V151, P790, DOI 10.1016/j.pain.2010.09.014; Haukenes I, 2015, EUR J PAIN, V19, P826, DOI 10.1002/ejp.609; Keogh E, 2006, EUR J PAIN, V10, P413, DOI 10.1016/j.ejpain.2005.05.007; King BM, 2010, AM J PHYSIOL-REG I, V298, pR1700, DOI 10.1152/ajpregu.00694.2009; Laursen BS, 2005, EUR J PAIN, V9, P267, DOI 10.1016/j.ejpain.2004.07.003; Lisspers J, 1997, ACTA PSYCHIAT SCAND, V96, P281, DOI 10.1111/j.1600-0447.1997.tb10164.x; Lofgren M, 2006, DISABIL REHABIL, V28, P447, DOI 10.1080/09638280500197891; Lundberg Mari K. E., 2004, Physiotherapy Theory and Practice, V20, P121, DOI 10.1080/09593980490453002; Manson JE, 2010, METABOLISM, V59, pS16, DOI 10.1016/j.metabol.2010.07.013; McCracken LM, 2004, PAIN, V107, P159, DOI 10.1016/j.pain.2003.10.012; Miller RP., 1991, CLIN J PAIN, V7, P51, DOI [10.1097/00002508-199103000-00053, DOI 10.1097/00002508-199103000-00053]; Monticone M, 2015, EUROPEAN J PAIN; Monticone M, 2014, EUR SPINE J, V23, P2105, DOI 10.1007/s00586-014-3478-5; Munce SEP, 2007, PSYCHOSOMATICS, V48, P394, DOI 10.1176/appi.psy.48.5.394; Mykletun A, 2001, BRIT J PSYCHIAT, V179, P540, DOI 10.1192/bjp.179.6.540; Nyberg V, 2011, J REHABIL MED, V43, P50, DOI 10.2340/16501977-0631; Pells J, 2007, CLIN J PAIN, V23, P707, DOI 10.1097/AJP.0b013e31814da3eb; Peolsson M, 2004, J REHABIL MED, V36, P28, DOI 10.1080/11026480310015530; Pieh C, 2012, PAIN, V153, P197, DOI 10.1016/j.pain.2011.10.016; Popescu A, 2010, PAIN, V150, P309, DOI 10.1016/j.pain.2010.05.013; Racine M, 2012, PAIN, V153, P619, DOI 10.1016/j.pain.2011.11.026; Racine M, 2012, PAIN, V153, P602, DOI 10.1016/j.pain.2011.11.025; Riley JL, 1998, PAIN, V74, P181, DOI 10.1016/S0304-3959(97)00199-1; Riley JL, 2001, J PAIN, V2, P354, DOI 10.1054/jpai.2001.27000; Roelofs J, 2007, PAIN, V131, P181, DOI 10.1016/j.pain.2007.01.008; Roelofs J, 2011, PAIN, V152, P1090, DOI 10.1016/j.pain.2011.01.028; Rovner GS, 2014, J REHABIL MED, V46, P73, DOI 10.2340/16501977-1227; Rustoen Tone, 2004, Pain Manag Nurs, V5, P105, DOI 10.1016/j.pmn.2004.01.004; Stubbs D, 2010, PAIN MED, V11, P232, DOI 10.1111/j.1526-4637.2009.00760.x; SULLIVAN M, 1995, SOC SCI MED, V41, P1349, DOI 10.1016/0277-9536(95)00125-Q; Sullivan M., 2002, SF 36 HALSOENKAT SVE; Sullivan M, 2002, SF 36 H LSOENK T SVE; Swinkels-Meewisse IEJ, 2003, PAIN, V105, P371, DOI 10.1016/S0304-3959(03)00255-0; Symonds TL, 1995, SPINE, V20, P2738, DOI 10.1097/00007632-199512150-00016; TURK DC, 1987, BEHAV RES THER, V25, P237, DOI 10.1016/0005-7967(87)90002-7; TURK DC, 1988, J CONSULT CLIN PSYCH, V56, P233, DOI 10.1037/0022-006X.56.2.233; Unruh AM, 1996, PAIN, V65, P123, DOI 10.1016/0304-3959(95)00214-6; Vlaeyen JWS, 2002, CLIN J PAIN, V18, P251, DOI 10.1097/00002508-200207000-00006; VLAEYEN JWS, 1995, PAIN, V62, P363, DOI 10.1016/0304-3959(94)00279-N; Wallin MKM, 2008, EUR J PAIN, V12, P842, DOI 10.1016/j.ejpain.2007.12.008; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wicksell RK, 2009, EUR J PAIN, V13, P760, DOI 10.1016/j.ejpain.2008.09.003; Wijnhoven HAH, 2006, PAIN, V124, P158, DOI 10.1016/j.pain.2006.04.012; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Williams ACdC, 2012, PSYCHOL THERAPIES MA; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	73	57	59	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0175737	10.1371/journal.pone.0175737	http://dx.doi.org/10.1371/journal.pone.0175737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET5FE	28441403	Green Published, gold, Green Submitted			2022-12-26	WOS:000400308800010
J	Yuan, X; Li, Z; Baines, AC; Gavriilaki, E; Ye, ZH; Wen, ZX; Braunstein, EM; Biesecker, LG; Cheng, LZ; Dong, XZ; Brodsky, RA				Yuan, Xuan; Li, Zhe; Baines, Andrea C.; Gavriilaki, Eleni; Ye, Zhaohui; Wen, Zhexing; Braunstein, Evan M.; Biesecker, Leslie G.; Cheng, Linzhao; Dong, Xinzhong; Brodsky, Robert A.			A hypomorphic PIGA gene mutation causes severe defects in neuron development and susceptibility to complement-mediated toxicity in a human iPSC model	PLOS ONE			English	Article							PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; MENTAL-RETARDATION SYNDROME; ANCHOR-SYNTHESIS PATHWAY; PLURIPOTENT STEM-CELLS; GERMLINE MUTATION; CAUSE HYPERPHOSPHATASIA; SOMATIC MUTATION; CD59 DEFICIENCY; A GENE; MICE	Mutations in genes involved in glycosylphosphatidylinositol (GPI) anchor biosynthesis underlie a group of congenital syndromes characterized by severe neurodevelopmental defects. GPI anchored proteins have diverse roles in cell adhesion, signaling, metabolism and complement regulation. Over 30 enzymes are required for GPI anchor biosynthesis and PIGA is involved in the first step of this process. A hypomorphic mutation in the X-linked PIGA gene (c.1234C>T) causes multiple congenital anomalies hypotonia seizure syndrome 2 (MCAHS2), indicating that even partial reduction of GPI anchored proteins dramatically impairs central nervous system development, but the mechanism is unclear. Here, we established a human induced pluripotent stem cell (hiPSC) model containing the PIGAc.1234C>T mutation to study the effects of a hypomorphic allele of PIGA on neuronal development. Neuronal differentiation from neural progenitor cells generated by EB formation in PIGAc.1234C>T is significantly impaired with decreased proliferation, aberrant synapse formation and abnormal membrane depolarization. The results provide direct evidence for a critical role of GPI anchor proteins in early neurodevelopment. Furthermore, neural progenitors derived from PIGAc.1234C>T hiPSCs demonstrate increased susceptibility to complement-mediated cytotoxicity, suggesting that defective complement regulation may contribute to neurodevelopmental disorders.	[Yuan, Xuan; Baines, Andrea C.; Gavriilaki, Eleni; Ye, Zhaohui; Braunstein, Evan M.; Cheng, Linzhao; Brodsky, Robert A.] Johns Hopkins Univ, Sch Med, Dept Med, Div Hematol, Baltimore, MD 21205 USA; [Li, Zhe; Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Ye, Zhaohui; Wen, Zhexing; Cheng, Linzhao] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Stem Cell Program, Baltimore, MD USA; [Biesecker, Leslie G.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Brodsky, RA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Hematol, Baltimore, MD 21205 USA.	brodsro@jhmi.edu	Wen, Zhexing/L-1228-2018	Wen, Zhexing/0000-0002-1518-3845; Ye, Zhaohui/0000-0001-5272-9168; Gavriilaki, Eleni/0000-0002-8883-8208	Maryland Stem Cell Research Fund (MSCRF) [2013-MSCRFII-0082];  [R01 HC133113]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL133113] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200328] Funding Source: NIH RePORTER	Maryland Stem Cell Research Fund (MSCRF); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	1. Maryland Stem Cell Research Fund (MSCRF) (Grants 2013-MSCRFII-0082) 2. R01 HC133113	Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Almeida AM, 2006, NAT MED, V12, P846, DOI 10.1038/nm1410; Amoureux MC, 2000, J NEUROSCI, V20, P3631, DOI 10.1523/JNEUROSCI.20-10-03631.2000; Belet S, 2014, HUM MUTAT, V35, P350, DOI 10.1002/humu.22498; BESSLER M, 1994, EMBO J, V13, P110, DOI 10.1002/j.1460-2075.1994.tb06240.x; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Brodsky RA, 2007, BLOOD; Brodsky RA, 2015, BLOOD, V126, P2459, DOI 10.1182/blood-2015-06-640995; Brodsky RA, 2014, BLOOD, V124, P2804, DOI 10.1182/blood-2014-02-522128; Chen GB, 2008, CELL STEM CELL, V2, P345, DOI 10.1016/j.stem.2008.02.004; Chen SZ, 2003, MOL CELL NEUROSCI, V22, P227, DOI 10.1016/S1044-7431(02)00014-3; CColakoglu G, 2014, P NATL ACAD SCI USA, V111, pE394, DOI 10.1073/pnas.1313769110; Dunn DE, 1996, P NATL ACAD SCI USA, V93, P7938, DOI 10.1073/pnas.93.15.7938; Fauth C, 2016, AM J MED GENET A, V170, P392, DOI 10.1002/ajmg.a.37452; Fritsche LG, 2014, ANNU REV GENOM HUM G, V15, P151, DOI 10.1146/annurev-genom-090413-025610; Gavriilaki E, 2015, BLOOD, V125, P3637, DOI 10.1182/blood-2015-02-629683; Gerlai R, 2001, EUR J NEUROSCI, V14, P1153, DOI 10.1046/j.0953-816x.2001.01724.x; Hansen L, 2013, AM J HUM GENET, V92, P575, DOI 10.1016/j.ajhg.2013.03.008; Hillmen P, 2006, NEW ENGL J MED, V355, P1233, DOI 10.1056/NEJMoa061648; Hochsmann B, 2014, NEW ENGL J MED, V370, P90, DOI 10.1056/NEJMc1308104; Hu WT, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0277-8; Johnston JJ, 2012, AM J HUM GENET, V90, P295, DOI 10.1016/j.ajhg.2011.11.031; Kato M, 2014, NEUROLOGY, V82, P1587, DOI 10.1212/WNL.0000000000000389; Kim YO, 2016, BRAIN DEV; Kinoshita T, 2000, CURR OPIN CHEM BIOL, V4, P632, DOI 10.1016/S1367-5931(00)00151-4; Krawitz PM, 2013, BLOOD, V122, P1312, DOI 10.1182/blood-2013-01-481499; Krawitz PM, 2013, AM J HUM GENET, V92, P584, DOI 10.1016/j.ajhg.2013.03.011; Krawitz PM, 2012, AM J HUM GENET, V91, P146, DOI 10.1016/j.ajhg.2012.05.004; Krawitz PM, 2010, NAT GENET, V42, P827, DOI 10.1038/ng.653; Kuki I, 2013, NEUROLOGY, V81, P1467, DOI 10.1212/WNL.0b013e3182a8411a; Leyton Lisette, 2014, Adv Neurobiol, V8, P3; MIYATA T, 1993, SCIENCE, V259, P1318, DOI 10.1126/science.7680492; Moyo VM, 2004, BRIT J HAEMATOL, V126, P133, DOI 10.1111/j.1365-2141.2004.04992.x; Narisawa S, 2001, J PATHOL, V193, P125, DOI 10.1002/1096-9896(2000)9999:9999&lt;::AID-PATH722&gt;3.0.CO;2-Y; Nevo Y, 2013, BLOOD, V121, P129, DOI 10.1182/blood-2012-07-441857; Ng BG, 2012, AM J HUM GENET, V90, P685, DOI 10.1016/j.ajhg.2012.02.010; Nozaki M, 1999, LAB INVEST, V79, P293; Parker C, 2005, BLOOD, V106, P3699, DOI 10.1182/blood-2005-04-1717; Rafuse VF, 2000, J NEUROSCI, V20, P6529, DOI 10.1523/JNEUROSCI.20-17-06529.2000; Ruseva MM, 2015, P NATL ACAD SCI USA, V112, P14319, DOI 10.1073/pnas.1513698112; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Soden SE, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010076; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Swoboda KJ, 2014, AM J MED GENET A, V164, P17, DOI 10.1002/ajmg.a.36189; TAKEDA J, 1993, CELL, V73, P703, DOI 10.1016/0092-8674(93)90250-T; Tarailo-Graovac M, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0243-8; Trump N, 2016, J MED GENET; Watanabe R, 1998, EMBO J, V17, P877, DOI 10.1093/emboj/17.4.877; Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716; Yuan X, 2013, STEM CELL TRANSL MED, V2, P819, DOI 10.5966/sctm.2013-0069	50	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0174074	10.1371/journal.pone.0174074	http://dx.doi.org/10.1371/journal.pone.0174074			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441409	Green Published, Green Submitted, gold			2022-12-26	WOS:000400308800003
J	Zhan, ZP; Yang, Y; Zhan, YF; Chen, DY; Liang, LQ; Yang, XY				Zhan, Zhongping; Yang, Ying; Zhan, Yanfeng; Chen, Dongying; Liang, Liuqin; Yang, Xiuyan			Fetal outcomes and associated factors of adverse outcomes of pregnancy in southern Chinese women with systemic lupus erythematosus	PLOS ONE			English	Article							PREDICTORS; IMPACT; HYDROXYCHLOROQUINE; RECOMMENDATIONS; NEPHRITIS	This study aims to investigate the fetal outcomes and associated factors of adverse pregnancy outcomes (APOs) in pregnant women with systemic lupus erythematosus (SLE). Clinical data from 251 SLE patients with 263 pregnancies from 2001 to 2015 were analyzed retrospectively. APOs occurred in 70.0% of pregnancies, in which pregnancy loss occurred in 28.5%; preterm delivery occurred in 21.3%; intrauterine growth retardation occurred in 12.2%; and fetal distress occurred in 8.0%. Over time, the rate of APOs decreased from 82.8% during 2001 similar to 2005 to 59.6% during 2011 similar to 2015. In multivariate analysis, predictors of APOs included positive antiphospholipid antibodies (OR 8.4, 95% CI 1.7 similar to 40.8, P = 0.008), lower complement (OR 3.6, 95% CI 1.3 similar to 9.9, P = 0.01), hypoalbuminemia (OR 3.2, 95% CI 1.2 similar to 8.3, P = 0.02), and hypertension (OR 14.6, 95% CI 1.5 similar to 141.6, P = 0.02). The use of antimalarial medications was associated with lower risk for APOs (OR 0.3, 95% CI 0.1 similar to 0.7, P = 0.01). In total, 109 patients underwent fetal umbilical artery Doppler in the third trimester. The The adjusted systole/diastole (S/D) ratio, pulsatility index (PI) and resistance index (RI) of SLE patients with APOs were higher than that of patients without APOs (2.9 +/- 0.9 vs. 2.4 +/- 0.5, P = 0.001). Lupus pregnancy was still at high risk of APOs in terms of pregnancy loss and preterm delivery. Umbilical artery Doppler was a good monitor method for APOs in the third trimester.	[Zhan, Zhongping; Yang, Ying; Chen, Dongying; Liang, Liuqin; Yang, Xiuyan] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Rheumatol, Guangzhou, Guangdong, Peoples R China; [Zhan, Yanfeng] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Chen, DY (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Rheumatol, Guangzhou, Guangdong, Peoples R China.	cdongying@163.com			grants of Guangdong Technology Project [2014A020221009, 2016A020215043]; National Natural Science Foundation of China [81603435]	grants of Guangdong Technology Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by grants of Guangdong Technology Project (No.2014A020221009, No.2016A020215043) and a grant of National Natural Science Foundation of China (81603435).	Al Arfaj AS, 2010, LUPUS, V19, P1665, DOI 10.1177/0961203310378669; Bertsias G, 2008, ANN RHEUM DIS, V67, P195, DOI 10.1136/ard.2007.070367; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Buyon JP, 2015, ANN INTERN MED, V163, P153, DOI 10.7326/M14-2235; Buyon JP, 1999, LUPUS, V8, P677, DOI 10.1191/096120399680411272; Carmona F, 2001, AM J REPROD IMMUNOL, V46, P274, DOI 10.1034/j.1600-0897.2001.d01-13.x; Clark CA, 2003, J RHEUMATOL, V30, P2127; Clowse MEB, 2005, ARTHRITIS RHEUM-US, V52, P514, DOI 10.1002/art.20864; Clowse MEB, 2007, RHEUM DIS CLIN N AM, V33, P237, DOI 10.1016/j.rdc.2007.01.002; Clowse MEB, 2006, ARTHRITIS RHEUM, V54, P3640, DOI 10.1002/art.22159; Clowse MEB, 2013, ANN RHEUM DIS, V72, P1536, DOI 10.1136/annrheumdis-2012-202449; Clowse MEB, 2011, J RHEUMATOL, V38, P1012, DOI 10.3899/jrheum.100746; Cortes-Hernandez J, 2002, RHEUMATOLOGY, V41, P643, DOI 10.1093/rheumatology/41.6.643; Georgiou PE, 2000, RHEUMATOLOGY, V39, P1014, DOI 10.1093/rheumatology/39.9.1014; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Huong DLT, 2006, RHEUMATOLOGY, V45, P332, DOI 10.1093/rheumatology/kei159; Jakes RW, 2012, ARTHRIT CARE RES, V64, P159, DOI 10.1002/acr.20683; Kim MY, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.09.066; Kwok LW, 2011, LUPUS, V20, P829, DOI 10.1177/0961203310397967; Lateef A, 2013, BEST PRACT RES CL RH, V27, P435, DOI 10.1016/j.berh.2013.07.005; Leroux M, 2015, LUPUS, V24, P1384, DOI 10.1177/0961203315591027; Madazli R, 2014, ARCH GYNECOL OBSTET, V289, P49, DOI 10.1007/s00404-013-2935-4; Moroni G, 2002, AM J KIDNEY DIS, V40, P713, DOI 10.1053/ajkd.2002.35678; Moroni G, 2016, J AUTOIMMUN, V74, P6, DOI 10.1016/j.jaut.2016.07.010; Piccoli GB, 2016, NEPHROL DIAL TRANSPL, V31, P1915, DOI 10.1093/ndt/gfv395; de Jesus GR, 2015, AUTOIMMUN DIS, V2015, DOI 10.1155/2015/943490; Ruperto N, 2011, LUPUS, V20, P453, DOI 10.1177/0961203310388445; Saavedra MA, 2012, CLIN RHEUMATOL, V31, P813, DOI 10.1007/s10067-012-1941-4; Smyth A, 2010, CLIN J AM SOC NEPHRO, V5, P2060, DOI 10.2215/CJN.00240110	29	36	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176457	10.1371/journal.pone.0176457	http://dx.doi.org/10.1371/journal.pone.0176457			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441446	gold, Green Submitted, Green Published			2022-12-26	WOS:000400308800057
J	Kim, YG; Shin, D; Park, MY; Lee, S; Jeon, MS; Yoon, D; Park, RW				Kim, Young-Gun; Shin, Dahye; Park, Man Young; Lee, Sukhoon; Jeon, Min Seok; Yoon, Dukyong; Park, Rae Woong			ECG-ViEW II, a freely accessible electrocardiogram database	PLOS ONE			English	Article							WAVE AXIS DEVIATION; QT PROLONGATION; RISK; INTERVAL; WOMEN; MEN	The Electrocardiogram Vigilance with Electronic data Warehouse II (ECG-ViEW II) is a large, single-center database comprising numeric parameter data of the surface electrocardiograms of all patients who underwent testing from 1 June 1994 to 31 July 2013. The electrocardiographic data include the test date, clinical department, RR interval, PR interval, QRS duration, QT interval, QTc interval, P axis, QRS axis, and T axis. These data are connected with patient age, sex, ethnicity, comorbidities, age-adjusted Charlson comorbidity index, prescribed drugs, and electrolyte levels. This longitudinal observational database contains 979,273 electrocardiograms from 461,178 patients over a 19-year study period. This database can provide an opportunity to study electrocardiographic changes caused by medications, disease, or other demographic variables. ECG-ViEW II is freely available at http://www. ecgview. org.	[Kim, Young-Gun; Shin, Dahye; Lee, Sukhoon; Jeon, Min Seok; Yoon, Dukyong; Park, Rae Woong] Ajou Univ, Sch Med, Dept Biomed Informat, Suwon, South Korea; [Park, Man Young] Korea Inst Oriental Med, Mibyeong Res Ctr, Daejeon, South Korea; [Jeon, Min Seok; Park, Rae Woong] Ajou Univ, Grad Sch Med, Dept Biomed Sci, Suwon, South Korea; [Lee, Sukhoon] Kunsan Natl Univ, Dept Software Convergence Engn, Gunsan, South Korea	Ajou University; Korea Institute of Oriental Medicine (KIOM); Ajou University; Kunsan National University	Yoon, D; Park, RW (corresponding author), Ajou Univ, Sch Med, Dept Biomed Informat, Suwon, South Korea.; Park, RW (corresponding author), Ajou Univ, Grad Sch Med, Dept Biomed Sci, Suwon, South Korea.	d.yoon.ajou@gmail.com; veritas@ajou.ac.kr		Kim, Young-Gun/0000-0002-8982-5230	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI16C0992, HI16C0982]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI16C0992 and HI16C0982). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar RD, 2015, J CARDIOVASC THORAC, V7, P154, DOI 10.15171/jcvtr.2015.33; Assanelli D, 2013, J ELECTROCARDIOL, V46, P487, DOI 10.1016/j.jelectrocard.2013.08.002; Bonaccio M, 2015, THROMB HAEMOSTASIS, V114, P1199, DOI 10.1160/TH15-02-0177; Brid SV, 2014, J CLIN DIAGNOSTIC RE, V8; Gupta A, 2007, AM HEART J, V153, P891, DOI 10.1016/j.ahj.2007.01.040; Hagiwara T, 2001, JPN J PHARMACOL, V87, P231, DOI 10.1254/jjp.87.231; Kligfield P, 2012, J ELECTROCARDIOL, V45, P690, DOI 10.1016/j.jelectrocard.2012.07.012; Kligfield P, 2010, AM HEART J, V160, P1023, DOI 10.1016/j.ahj.2010.09.002; Kwok CS, 2016, HEART, V102, P672, DOI 10.1136/heartjnl-2015-308956; Laguna P, 2014, J ELECTROCARDIOL, V47, P408, DOI 10.1016/j.jelectrocard.2014.04.018; Li YB, 2014, AM J CARDIOL, V113, P372, DOI 10.1016/j.amjcard.2013.08.050; Moody GB, 2000, COMPUT CARDIOL, V27, P179, DOI 10.1109/CIC.2000.898485; Moody GB, 2011, IEEE ENG MED BIO, P8327, DOI 10.1109/IEMBS.2011.6092053; Park MY, 2012, CLIN PHARMACOL THER, V92, P393, DOI 10.1038/clpt.2012.93; Park SI, 2016, EXPERT OPINION DRUG; Rago L, 2013, ATHEROSCLEROSIS, V226, P412, DOI 10.1016/j.atherosclerosis.2012.11.010; Rangel MO, 2016, AM J CARDIOL, V117, P100, DOI 10.1016/j.amjcard.2015.10.013; Rautaharju PM, 2001, AM J CARDIOL, V88, P118, DOI 10.1016/S0002-9149(01)01604-6; Ray WA, 2004, NEW ENGL J MED, V351, P1089, DOI 10.1056/NEJMoa040582; Wysowski DK, 2001, AM J GASTROENTEROL, V96, P1698, DOI 10.1016/S0002-9270(01)02490-X; Yun J, 2015, CARDIOVASC TOXICOL, V15, P197, DOI 10.1007/s12012-014-9285-8	21	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176222	10.1371/journal.pone.0176222	http://dx.doi.org/10.1371/journal.pone.0176222			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437484	Green Published, Green Submitted, gold			2022-12-26	WOS:000400287600034
J	El Guerrab, A; Cayre, A; Kwiatkowski, F; Privat, M; Rossignol, JM; Rossignol, F; Penault-Llorca, F; Bignon, YJ				El Guerrab, Abderrahim; Cayre, Anne; Kwiatkowski, Fabrice; Privat, Maud; Rossignol, Jean-Marc; Rossignol, Fabrice; Penault-Llorca, Frederique; Bignon, Yves-Jean			Quantification of hypoxia-related gene expression as a potential approach for clinical outcome prediction in breast cancer	PLOS ONE			English	Article							INDUCIBLE FACTOR-I; PROGNOSTIC-SIGNIFICANCE; SIGNAL-TRANSDUCTION; ERYTHROPOIETIN; FACTOR-1-ALPHA; ACTIVATION; PROTEIN; IDENTIFICATION; SIGNATURES; INVASION	Breast cancers are solid tumors frequently characterized by regions with low oxygen concentrations. Cellular adaptations to hypoxia are mainly determined by "hypoxia inducible factors" that mediate transcriptional modifications involved in drug resistance and tumor progression leading to metastasis and relapse occurrence. In this study, we investigated the prognostic value of hypoxia-related gene expression in breast cancer. A systematic review was conducted to select a set of 45 genes involved in hypoxia signaling pathways and breast tumor progression. Gene expression was quantified by RT-qPCR in a retrospective series of 32 patients with invasive ductal carcinoma. Data were analyzed in relation to classical clinicopathological criteria and relapse occurrence. Coordinated overexpression of selected genes was observed in high-grade and HER2+ tumors. Hierarchical cluster analysis of gene expression significantly segregated relapsed patients (p = 0.008, Chi(2) test). All genes (except one) were up-regulated and six markers were significantly expressed in tumors from recurrent patients. The expression of this 6-gene set was used to develop a basic algorithm for identifying recurrent patients according to a risk score of relapse. Analysis of Kaplan-Meier relapse-free survival curves allowed the definition of a threshold score of 2 (p = 0.021, Mantel-Haenszel test). The risk of recurrence was increased by 40% in patients with a high score. In addition to classical prognostic factors, we showed that hypoxic markers have potential prognostic value for outcome and late recurrence prediction, leading to improved treatment decision-making for patients with early-stage invasive breast cancer. It will be necessary to validate the clinical relevance of this prognostic approach through independent studies including larger prospective patient cohorts.	[El Guerrab, Abderrahim; Cayre, Anne; Kwiatkowski, Fabrice; Privat, Maud; Penault-Llorca, Frederique; Bignon, Yves-Jean] Ctr Jean Perrin, 58 Rue Montalembert, Clermont Ferrand, France; [El Guerrab, Abderrahim; Cayre, Anne; Kwiatkowski, Fabrice; Privat, Maud; Penault-Llorca, Frederique; Bignon, Yves-Jean] Univ Auvergne, Fac Med, ERTICa EA4677, 28 Pl Henri Dunant, Clermont Ferrand, France; [Rossignol, Jean-Marc; Rossignol, Fabrice] Adelbio, 13 Rue Pariou, Aubiere, France	UNICANCER; Centre Jean Perrin; Universite Clermont Auvergne (UCA)	Bignon, YJ (corresponding author), Ctr Jean Perrin, 58 Rue Montalembert, Clermont Ferrand, France.; Bignon, YJ (corresponding author), Univ Auvergne, Fac Med, ERTICa EA4677, 28 Pl Henri Dunant, Clermont Ferrand, France.	yves-jean.bignon@clermont.unicancer.fr	, Maud/ABB-9090-2021; , bignon/Y-3243-2019	, Maud/0000-0002-9373-3902; CAYRE, Anne/0000-0002-2578-8557	Conseil Regional d'Auvergn; Centre Jean Perrin (Clermont-Ferrand, France)	Conseil Regional d'Auvergn; Centre Jean Perrin (Clermont-Ferrand, France)	This work was supported in part by grant from the Conseil Regional d'Auvergne (http://www. auvergne.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study. The internal funding was provided by the Centre Jean Perrin (Clermont-Ferrand, France) where the majority of the authors of this article are employed.	Acs G, 2004, CANCER LETT, V214, P243, DOI 10.1016/j.canlet.2004.04.027; Ahn SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063510; ANAGNOSTOU A, 1994, P NATL ACAD SCI USA, V91, P3974, DOI 10.1073/pnas.91.9.3974; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Binley K, 2003, GENE THER, V10, P540, DOI 10.1038/sj.gt.3301944; Bos R, 2003, CANCER, V97, P1573, DOI 10.1002/cncr.11246; Bos R, 2001, JNCI-J NATL CANCER I, V93, P309, DOI 10.1093/jnci/93.4.309; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; Cardone RA, 2007, MOL BIOL CELL, V18, P1768, DOI 10.1091/mbc.E06-07-0617; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Chia SK, 2001, J CLIN ONCOL, V19, P3660, DOI 10.1200/JCO.2001.19.16.3660; Chitneni SK, 2011, J NUCL MED, V52, P165, DOI 10.2967/jnumed.110.075663; Couvelard A, 2008, CLIN CANCER RES, V14, P6634, DOI 10.1158/1078-0432.CCR-07-5258; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P167; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Ebert BL, 1999, BLOOD, V94, P1864; El Guerrab A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025080; ELSTON CW, 1993, J CLIN PATHOL, V46, P189; Farr Alex, 2013, Rev Obstet Gynecol, V6, P165; Favaro E, 2011, GENOME MED, V3, DOI 10.1186/gm271; Gassmann M, 1997, KIDNEY INT, V51, P567, DOI 10.1038/ki.1997.81; Generali D, 2006, CLIN CANCER RES, V12, P4562, DOI 10.1158/1078-0432.CCR-05-2690; Gilkes DM, 2013, FUTURE ONCOL, V9, P1623, DOI [10.2217/fon.13.92, 10.2217/FON.13.92]; Kwiatkowski F, 2000, B CANCER, V87, P715; LEDOUSSAL V, 1989, CANCER, V64, P1914, DOI 10.1002/1097-0142(19891101)64:9<1914::AID-CNCR2820640926>3.0.CO;2-G; Li XF, 2014, TRANSL ONCOL, V7, P240, DOI 10.1016/j.tranon.2014.02.010; Liang K, 2014, CANCER BIOL THER, V15, P89, DOI 10.4161/cbt.26717; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magnon C, 2007, J CLIN INVEST, V117, P1844, DOI 10.1172/JCI30269; Mangia A, 2009, HISTOPATHOLOGY, V55, P600, DOI 10.1111/j.1365-2559.2009.03424.x; Marxsen JH, 2004, BIOCHEM J, V381, P761, DOI 10.1042/BJ20040620; MAXWELL PH, 1993, P NATL ACAD SCI USA, V90, P2423, DOI 10.1073/pnas.90.6.2423; Metzen E, 2005, BIOCHEM J, V387, P711, DOI 10.1042/BJ20041736; MIURA Y, 1994, J BIOL CHEM, V269, P29962; Moritz KM, 1997, AM J PHYSIOL-REG I, V273, pR1829, DOI 10.1152/ajpregu.1997.273.6.R1829; Oikawa M, 2001, BIOCHEM BIOPH RES CO, V289, P39, DOI 10.1006/bbrc.2001.5927; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Robey IF, 2005, NEOPLASIA, V7, P324, DOI 10.1593/neo.04430; Rundqvist H, 2013, J INTERN MED, V274, P105, DOI 10.1111/joim.12091; Salceda S, 1996, ARCH BIOCHEM BIOPHYS, V334, P389, DOI 10.1006/abbi.1996.0469; Seigneuric R, 2007, RADIOTHER ONCOL, V83, P374, DOI 10.1016/j.radonc.2007.05.002; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Semenza GL, 2002, BIOCHEM PHARMACOL, V64, P993, DOI 10.1016/S0006-2952(02)01168-1; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; Sestak I, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0516-0; Shenolikar S, 2004, PHYSIOLOGY, V19, P362, DOI 10.1152/physiol.00020.2004; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Sotiriou C, 2007, NAT REV CANCER, V7, P545, DOI 10.1038/nrc2173; Tsai YP, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-102; Unruh A, 2003, ONCOGENE, V22, P3213, DOI 10.1038/sj.onc.1206385; Vaupel P, 2001, SEMIN ONCOL, V28, P29, DOI 10.1016/S0093-7754(01)90210-6; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Vaupel P, 2007, ANTIOXID REDOX SIGN, V9, P1221, DOI 10.1089/ars.2007.1628; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang Z., 2011, INFORM RES, V2011, P1, DOI DOI 10.1111/J.1365-313X.2011.04659.X; Winter SC, 2007, CANCER RES, V67, P3441, DOI 10.1158/0008-5472.CAN-06-3322; Wojchowski DM, 1999, EXP CELL RES, V253, P143, DOI 10.1006/excr.1999.4673; Wong C, 2003, GYNECOL ONCOL, V91, P513, DOI 10.1016/j.ygyno.2003.08.022; Zhang DH, 2005, MOL CELL PROTEOMICS, V4, P1686, DOI 10.1074/mcp.M400221-MCP200; Zundel W, 2000, GENE DEV, V14, P391	60	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0175960	10.1371/journal.pone.0175960	http://dx.doi.org/10.1371/journal.pone.0175960			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430808	Green Submitted, Green Published, gold			2022-12-26	WOS:000399876100025
J	Diana, A; Mallard, SR; Haszard, JJ; Purnamasari, DM; Nurulazmi, I; Herliani, PD; Nugraha, GI; Gibson, RS; Houghton, L				Diana, Aly; Mallard, Simonette R.; Haszard, Jillian J.; Purnamasari, Dwi Monik; Nurulazmi, Ikrimah; Herliani, Pratami D.; Nugraha, Gaga I.; Gibson, Rosalind S.; Houghton, Lisa			Consumption of fortified infant foods reduces dietary diversity but has a positive effect on subsequent growth in infants from Sumedang district, Indonesia	PLOS ONE			English	Article							YOUNG-CHILD NUTRITION; FEEDING PRACTICES; LINEAR GROWTH; MILK; ZINC; SCHOOL; IRON; UNDERNUTRITION; INTERVENTIONS; BANGLADESH	Stunting and underweight among under-five children in Indonesia are common, raising public health concerns. Whether inappropriate complementary feeding (CF) practices compromise optimal growth during late infancy in Indonesia is uncertain. Therefore we characterized and evaluated CF practices in Indonesian infants and investigated their relationship with subsequent growth. We enrolled breastfed infants at 6 months of age (n = 230); and followed them at 9 (n = 202) and 12 months of age (n = 190). We collected socio-demographic and anthropometric data and two-day in-home weighed food records. Relations between WHO CF indicators, sentinel foods, and energy and micronutrient intakes at 9 months and growth at 12 months were explored using multiple linear regression. Stunting and underweight increased from 15.8% and 4.4% at 6 months to 22.6% and 10.5% at 12 months, respectively. Median intakes of calcium, iron, zinc, and riboflavin were below WHO recommendations. Infants consuming fortified infant foods (FIFs) at 9 months had diets with a lower dietary diversity (DD) score (2.3 vs. 3.0), energy density, median energy (250 vs. 310 kcal/d) and protein (6.5 vs. 9.1 g/d) intake than non-consumers (p<0.01), despite higher intakes of calcium, iron, and vitamins A and C (p<0.001). Positive relations existed for 9-month consumption of iron-rich/iron fortified infant foods with length-for-age Z-score (LAZ) at 12 months (beta = 0.22; 95% CI: 0.01, 0.44; P = 0.04), and for fortified infant foods alone with both LAZ (beta = 0.29; 95% CI: 0.09, 0.48; P = 0.04) and weight-for-age Z-score (beta = 0.14; 95% CI: 0.02, 0.26; P = 0.02) at 12 months. The positive association of FIFs with subsequent growth may be attributed to their content of both powdered cow's milk and multi-micronutrient fortificants. Nonetheless, mothers should not be encouraged to over-rely on FIFs as they reduce DD.	[Diana, Aly; Purnamasari, Dwi Monik; Nurulazmi, Ikrimah; Herliani, Pratami D.; Nugraha, Gaga I.] Padjadjaran State Univ, Fac Med, Java, Indonesia; [Diana, Aly; Mallard, Simonette R.; Haszard, Jillian J.; Gibson, Rosalind S.; Houghton, Lisa] Univ Otago, Dept Human Nutr, Otago, New Zealand	Universitas Padjadjaran; University of Otago	Diana, A (corresponding author), Padjadjaran State Univ, Fac Med, Java, Indonesia.; Diana, A (corresponding author), Univ Otago, Dept Human Nutr, Otago, New Zealand.	diana.aly@gmail.com	Mallard, Simonette R/AAT-3266-2021		Meat and Livestock Australia; University of Otago Research Grant	Meat and Livestock Australia(Meat and Livestock Australia); University of Otago Research Grant	This work was supported by the Meat and Livestock Australia: (https://www.mia.com.au/) and the University of Otago Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe Y, 2007, J FOOD COMPOS ANAL, V20, P161, DOI 10.1016/j.jfca.2006.09.003; [Anonymous], 2015, NAT NUTR DAT STAND R; Badan Perencanaan Pembangunan Daerah Kabupaten Sumedang, 2014, PROF DAER KAB SUM 20; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Birch LL, 2014, AM J CLIN NUTR, V99, p723S, DOI 10.3945/ajcn.113.069047; Bognar A., 2002, TABLES WEIGHT YIELD; BPS & BKKBN, 2013, IND DEM HLTH SURV 20; Bunch S, 1997, USERS GUIDE OPERATIO; Chan SSL, 2007, J FOOD COMPOS ANAL, V20, P609, DOI 10.1016/j.jfca.2007.03.003; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS27; de Onis M, 2013, MATERN CHILD NUTR, V9, P6, DOI 10.1111/mcn.12075; De-Regil LM, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008959.pub2; Dewey KG, 2008, MATERN CHILD NUTR, V4, P24, DOI 10.1111/j.1740-8709.2007.00124.x; Dewey KG, 2016, MATERN CHILD NUTR, V12, P27, DOI 10.1111/mcn.12282; Dewey KG, 2011, MATERN CHILD NUTR, V7, P129, DOI 10.1111/j.1740-8709.2011.00357.x; Dewey Kathryn G., 2003, Food and Nutrition Bulletin, V24, P5; Dewey KG, 2001, PEDIATR CLIN N AM, V48, P87, DOI 10.1016/S0031-3955(05)70287-X; Dijkhuizen MA, 2001, AM J CLIN NUTR, V73, P786; Dodd KW, 2006, J AM DIET ASSOC, V106, P1640, DOI 10.1016/j.jada.2006.07.011; Du XQ, 2004, BRIT J NUTR, V92, P159, DOI 10.1079/BJN20041118; EFSA, 2013, EFSA J, V11; Faber M, 2005, AM J CLIN NUTR, V82, P1032, DOI 10.1093/ajcn/82.5.1032; FAO/WHO/UNU, 2001, HUM EN REQ REP JOINT; FERGUSON EL, 1993, J NUTR, V123, P1487, DOI 10.1093/jn/123.9.1487; Gibson R, 2005, PRINCIPLES NUTR ASSE; Gibson SR, 2008, INTERACTIVE 24 HOUR; Grillenberger M, 2006, BRIT J NUTR, V95, P379, DOI 10.1079/BJN20051641; Hoppe C, 2006, ANNU REV NUTR, V26, P131, DOI 10.1146/annurev.nutr.26.010506.103757; Hotz C., 2004, Food and Nutrition Bulletin, V25, pS94; Huffman SL, 2014, MATERN CHILD NUTR, V10, P562, DOI 10.1111/mcn.12126; Institute of Medicine, 2010, DIETARY REFERENCE IN; Isabelle M, 2011, ASIA PAC J CLIN NUTR, V20, P141; Jack SJ, 2012, ARCH PEDIAT ADOL MED, V166, P842, DOI 10.1001/archpediatrics.2012.1003; Jones AD, 2014, MATERN CHILD NUTR, V10, P1, DOI 10.1111/mcn.12070; Kimmons JE, 2005, J NUTR, V135, P444, DOI 10.1093/jn/135.3.444; Kolsteren PW, 1997, TROP MED INT HEALTH, V2, P291, DOI 10.1046/j.1365-3156.1997.d01-262.x; KUSIN JA, 1991, EUR J CLIN NUTR, V45, P77; Lind T, 2004, AM J CLIN NUTR, V80, P729; MADDEN JP, 1976, J AM DIET ASSOC, V68, P143; MALCOLM LA, 1970, BRIT J NUTR, V24, P297, DOI 10.1079/BJN19700029; Mallard SR, 2014, J NUTR, V144, P1818, DOI 10.3945/jn.114.199547; Mallard SR, 2016, J NUTR; Marriott BP, 2012, MATERN CHILD NUTR, V8, P354, DOI 10.1111/j.1740-8709.2011.00380.x; Maulen-Radovan I, 1999, SALUD PUBLICA MEXICO, V41, P389; Menon P, 2015, MATERN CHILD NUTR, V11, P73, DOI 10.1111/mcn.12036; Michaelsen KF, 2013, FOOD NUTR BULL, V34, P268, DOI 10.1177/156482651303400224; National Institute of Health Research and Development, 2010, IND BAS HLTH RES 201; National Institute of Health Research and Development, 2013, IND BAS HLTH RES 201; Ng CS, 2012, PUBLIC HEALTH NUTR, V15, P827, DOI 10.1017/S1368980011002485; Nordic Council of Ministers, 2012, NORD NUTR REC INT NU; *PAHO WHO, 2003, GUID PRINC COMPL FEE; Pries AM, 2016, MATERN CHILD NUTR, V12, P22, DOI 10.1111/mcn.12267; ProPAN D Process for the Promotion of Child Feeding, 2015, PROPAN PROC PROM CHI; Rutstein S.O., 2004, DHS COMP REPORTS; Sazawal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012167; Schumacker RE, 2010, BEGINNERS GUIDE STRU; Senarath U, 2012, MATERN CHILD NUTR, V8, P5, DOI 10.1111/j.1740-8709.2011.00371.x; The Chilenje Infant Growth Nutrition and Infection Study Team, 2010, PLOS ONE, V5; WHO, 2004, ANTHR TRAIN VID WHO; WHO, 2006, WHO CHILD GROWTH STA; WHO/FAO, 2004, VIT MIN REQ HUM NUTR, VSecond; Working Group on Infant and Young Child Feeding Indicators, 2006, DEV VAL SIMPL IND DI; Working Group on Infant and Young Child Feeding Indicators, 2007, DEV VAL SIMPL IND DI; World Health Organization, 1998, COMPL FEED YOUNG CHI; World Health Organization, 1995, PHYS STATA US INT AN; World Health Organization, 2008, IND ASS INF YOUNG CH; Zongrone A, 2012, PUBLIC HEALTH NUTR, V15, P1697, DOI 10.1017/S1368980012001073	68	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175952	10.1371/journal.pone.0175952	http://dx.doi.org/10.1371/journal.pone.0175952			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426828	Green Published, Green Submitted, gold			2022-12-26	WOS:000399875900075
J	Schmiedl, A; Roolfs, T; Tutdibi, E; Gortner, L; Monz, D				Schmiedl, Andreas; Roolfs, Torge; Tutdibi, Erol; Gortner, Ludwig; Monz, Dominik			Influence of prenatal hypoxia and postnatal hyperoxia on morphologic lung maturation in mice	PLOS ONE			English	Article							SURFACTANT PROTEIN-B; ENDOTHELIAL GROWTH-FACTOR; BRONCHOPULMONARY DYSPLASIA; NEONATAL HYPEROXIA; MOUSE MODEL; STEREOLOGICAL ESTIMATION; PERINATAL INFLAMMATION; ANIMAL-MODELS; FETAL LUNG; PATHOGENESIS	Background Oxygen supply as a lifesaving intervention is frequently used to treat preterm infants suffering additionally from possible prenatal or perinatal pathogen features. The impact of oxygen and/or physical lung injury may influence the morphological lung development, leading to a chronic postnatal lung disease called bronchopulmonary dysplasia (BPD). At present different experimental BPD models are used. However, there are no systematic comparative studies regarding different influences of oxygen on morphological lung maturation. Objective We investigated the influence of prenatal hypoxia and/or postnatal hyperoxia on morphological lung maturation based on stereological parameters, to find out which model best reflects morphological changes in lung development comparable with alterations found in BPD. Methods Pregnant mice were exposed to normoxia, the offspring to normoxia (No/No) or to hyperoxia (No/Hyper). Furthermore, pregnant mice were exposed to hypoxia and the offspring to normoxia (Hypo/No) or to hyperoxia (Hypo/Hyper). Stereological investigations were performed on all pups at 14 days after birth. Results Compared to controls (No/No) 1) the lung volume was significantly reduced in the No/Hyper and Hypo/Hyper groups, 2) the volume weighted mean volume of the parenchymal air-spaces was significantly higher in the Hypo/Hyper group, 3) the total air space volume was significantly lower in the No/Hyper and Hypo/Hyper groups, 4) the total septal surface showed significantly lower values in the No/Hyper and Hypo/Hyper groups, 5) the wall thickness of septa showed the highest values in the Hypo/Hyper group without reaching significance, 6) the volume density and the volume weighted mean volume of lamellar bodies in alveolar epithelial cells type II (AEII) were significantly lower in the Hypo/Hyper group. Conclusion Prenatal hypoxia and postnatal hyperoxia differentially influence the maturation of lung parenchyma. In 14 day old mice a significant retardation of morphological lung development leading to BPD-like alterations indicated by different parameters was only seen after hypoxia and hyperoxia.	[Schmiedl, Andreas; Roolfs, Torge] Hannover Med Sch, Inst Funct & Appl Anat, Hannover, Germany; [Schmiedl, Andreas] Hannover Med Sch, German Ctr Lung Res DZL, Biomed Res Endstage & Obstruct Lung Dis Hannover, Hannover, Germany; [Schmiedl, Andreas] Hannover Med Sch, REBIRTH Cluster Excellence, Hannover, Germany; [Tutdibi, Erol; Gortner, Ludwig; Monz, Dominik] Saarland Univ, Dept Pediat & Neonatol, Homburg, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Universitatsklinikum des Saarlandes	Schmiedl, A (corresponding author), Hannover Med Sch, Inst Funct & Appl Anat, Hannover, Germany.; Schmiedl, A (corresponding author), Hannover Med Sch, German Ctr Lung Res DZL, Biomed Res Endstage & Obstruct Lung Dis Hannover, Hannover, Germany.; Schmiedl, A (corresponding author), Hannover Med Sch, REBIRTH Cluster Excellence, Hannover, Germany.	Schmiedl.Andreas@mh-hannover.de			Sino-German Center for Research Promotion; Federal Ministry for Education and Research (BMBF) via the German Center for Lung Research (DZL); German Research Federation (DFG) via the Cluster of Excellence REBIRTH	Sino-German Center for Research Promotion; Federal Ministry for Education and Research (BMBF) via the German Center for Lung Research (DZL)(Federal Ministry of Education & Research (BMBF)); German Research Federation (DFG) via the Cluster of Excellence REBIRTH(German Research Foundation (DFG))	This work was in part supported by the Sino-German Center for Research Promotion, by the Federal Ministry for Education and Research (BMBF) via the German Center for Lung Research (DZL) as well as by the German Research Federation (DFG) via the Cluster of Excellence REBIRTH. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. No additional external funding received for this study.	Abman SH, 2008, PEDIATRICS, V122, P658, DOI 10.1542/peds.2008-1599; Albertine KH, 2013, SEMIN PERINATOL, V37, P60, DOI 10.1053/j.semperi.2013.01.001; AMY RWM, 1977, J ANAT, V124, P131; Baker GJ, 1985, ACTA STEREOL, V4, P103; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; Berger J, 2014, AM J PHYSIOL-LUNG C, V307, pL936, DOI 10.1152/ajplung.00159.2014; BLANCO LN, 1991, AM J PHYSIOL, V261, pL370, DOI 10.1152/ajplung.1991.261.6.L370; BRAENDGAARD H, 1986, J NEUROSCI METH, V18, P39, DOI 10.1016/0165-0270(86)90112-3; Brasch F, 2004, AM J RESP CELL MOL, V30, P449, DOI 10.1165/rcmb.2003-0262OC; Buczynski BW, 2013, SEMIN PERINATOL, V37, P69, DOI 10.1053/j.semperi.2013.01.002; Burri PH, 2006, BIOL NEONATE, V89, P313, DOI 10.1159/000092868; BURRI PH, 1984, ANNU REV PHYSIOL, V46, P617, DOI 10.1146/annurev.ph.46.030184.003153; Cerny L, 2008, LUNG, V186, P75, DOI 10.1007/s00408-007-9069-z; Chang YS, 2009, CELL TRANSPLANT, V18, P869, DOI 10.3727/096368909X471189; Chao CM, 2017, J PATHOL, V241, P91, DOI 10.1002/path.4834; Chess PR, 2006, SEMIN PERINATOL, V30, P171, DOI 10.1053/j.semperi.2006.05.003; Chou HC, 2016, AM J TRANSL RES, V8, P342; CLEMENTS JA, 1970, AM REV RESPIR DIS, V101, P984; Coalson JJ, 2006, SEMIN PERINATOL, V30, P179, DOI 10.1053/j.semperi.2006.05.004; Deakins KM, 2009, RESP CARE, V54, P1252; Deng FT, 2015, J HUAZHONG U SCI-MED, V35, P122, DOI 10.1007/s11596-015-1400-y; Fanaroff Avroy A, 2007, Am J Obstet Gynecol, V196, DOI 10.1016/j.ajog.2006.09.014; Fehrenbach A, 1999, J ANAT, V194, P127, DOI 10.1046/j.1469-7580.1999.19410127.x; Gien J, 2011, CURR OPIN PEDIATR, V23, P305, DOI 10.1097/MOP.0b013e328346577f; Gortner L, 2005, BIOL NEONATE, V88, P129, DOI 10.1159/000085895; Gortner L, 2013, ANN ANAT, V195, P351, DOI 10.1016/j.aanat.2013.02.010; Gortner L, 2011, NEONATOLOGY, V99, P112, DOI 10.1159/000313024; Grisaru-Granovsky S, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.08.025; GUNDERSEN HJG, 1985, J MICROSC-OXFORD, V138, P127, DOI 10.1111/j.1365-2818.1985.tb02607.x; Hayes D, 2010, RESPIRATION, V79, P425, DOI 10.1159/000242497; Herring MJ, 2014, AM J PHYSIOL-LUNG C, V307, pL338, DOI 10.1152/ajplung.00094.2014; Hosford GE, 2003, AM J PHYSIOL-LUNG C, V285, pL161, DOI 10.1152/ajplung.00285.2002; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Hyde DM, 2007, AM J PHYSIOL-LUNG C, V293, pL570, DOI 10.1152/ajplung.00467.2006; Jones CV, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0110-5; Kilkenny C, 2012, OSTEOARTHR CARTILAGE, V20, P256, DOI 10.1016/j.joca.2012.02.010; LARSON JE, 1988, PEDIATR RES, V24, P156, DOI 10.1203/00006450-198808000-00003; Lee HJ, 2010, J PERINAT MED, V38, P675, DOI 10.1515/jpm.2010.091; Mammoto T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041596; Manzano RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095844; MASSARO GD, 1973, J CLIN INVEST, V52, P566, DOI 10.1172/JCI107217; McGrath-Morrow SA, 2004, AM J RESP CELL MOL, V30, P635, DOI 10.1165/rcmb.2003-0049OC; MINCHENKO A, 1994, LAB INVEST, V71, P374; Mizikova I, 2015, AM J PHYSIOL-LUNG C, V308, pL1145, DOI 10.1152/ajplung.00039.2015; Monz D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074740; Muhlfeld C, 2015, AM J PHYSIOL-LUNG C, V309, pL526, DOI 10.1152/ajplung.00047.2015; Muhlfeld C, 2013, AM J PHYSIOL-LUNG C, V305, P1205, DOI 10.1152/ajplung.00427.2012; Mund SI, 2008, DEV DYNAM, V237, P2108, DOI 10.1002/dvdy.21633; Nold MF, 2013, P NATL ACAD SCI USA, V110, P14384, DOI 10.1073/pnas.1306859110; Ochs M, 2014, ANN ANAT, V196, P26, DOI 10.1016/j.aanat.2013.10.004; Ochs M, 2013, AM J PHYSIOL-LUNG C, V305, pL15, DOI 10.1152/ajplung.00429.2012; Orgeig S, 2011, RESP PHYSIOL NEUROBI, V178, P129, DOI 10.1016/j.resp.2011.05.015; Pagano A, 2003, ANN NY ACAD SCI, V1010, P405, DOI 10.1196/annals.1299.074; Ratner V, 2009, NEONATOLOGY, V95, P299, DOI 10.1159/000178798; Roth-Kleiner M, 2014, HISTOCHEM CELL BIOL, V141, P75, DOI 10.1007/s00418-013-1132-7; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; SCHERLE W, 1970, Mikroskopie, V26, P57; SCHITTNY JC, 2008, FISHMANS PULMONARY D, P91; Schittny JC, 2008, AM J PHYSIOL-LUNG C, V294, pL246, DOI 10.1152/ajplung.00296.2007; Schneider JP, 2012, METHOD CELL BIOL, V113, P257, DOI 10.1016/B978-0-12-407239-8.00012-4; Schwartz JE, 1998, BIOL NEONATE, V73, P313, DOI 10.1159/000013990; Stahlman MT, 2000, LAB INVEST, V80, P395, DOI 10.1038/labinvest.3780044; TENHAVEOPBROEK AAW, 1991, EXP LUNG RES, V17, P111, DOI 10.3109/01902149109064406; Thebaud B, 2005, CIRCULATION, V112, P2477, DOI 10.1161/CIRCULATIONAHA.105.541524; Tibboel J, 2013, EUR RESPIR J, V42, P776, DOI 10.1183/09031936.00092212; Tsao PN, 2013, NEONATOLOGY, V103, P300, DOI 10.1159/000347103; Tschanz SA, 2011, J MICROSC-OXFORD, V243, P47, DOI 10.1111/j.1365-2818.2010.03481.x; Tschanz S, 2014, ANN ANAT, V196, P3, DOI 10.1016/j.aanat.2013.04.011; Tschanz SA, 2014, J APPL PHYSIOL, V117, P89, DOI 10.1152/japplphysiol.01355.2013; Tuder RM, 2007, J MOL MED, V85, P1317, DOI 10.1007/s00109-007-0280-4; Vadivel A, 2014, AM J RESP CELL MOL, V50, P96, DOI 10.1165/rcmb.2012-0250OC; van Haaften T, 2009, AM J RESP CRIT CARE, V180, P1131, DOI 10.1164/rccm.200902-0179OC; van Tuyl M, 2005, AM J PHYSIOL-LUNG C, V288, pL167, DOI 10.1152/ajplung.00185.2004; VELDHUIZEN RAW, 1993, BIOCHEM J, V295, P141, DOI 10.1042/bj2950141; Velten M, 2010, J APPL PHYSIOL, V108, P1347, DOI 10.1152/japplphysiol.01392.2009; Vogel ER, 2015, CAN J PHYSIOL PHARM, V93, P119, DOI 10.1139/cjpp-2014-0387; Weaver TE, 2001, ANNU REV PHYSIOL, V63, P555, DOI 10.1146/annurev.physiol.63.1.555; Weaver TE, 2002, SEMIN CELL DEV BIOL, V13, P263, DOI 10.1016/S1084952102000551; Willfuhr A, 2015, AM J PHYSIOL-LUNG C, V309, pL1286, DOI 10.1152/ajplung.00410.2014; Woyda K, 2009, EUR RESPIR J, V33, P861, DOI 10.1183/09031936.00109008; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Yee M, 2011, AM J PATHOL, V178, P2601, DOI 10.1016/j.ajpath.2011.02.010; Zeitlin J, 2010, J PEDIATR-US, V157, P733, DOI 10.1016/j.jpeds.2010.05.002; Zhang XY, 2011, RESP CARE, V56, P1009, DOI 10.4187/respcare.01032	84	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175804	10.1371/journal.pone.0175804	http://dx.doi.org/10.1371/journal.pone.0175804			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426693	Green Published, Green Submitted, gold			2022-12-26	WOS:000399875900051
J	Kim, HS; Lee, K; Bae, S; Park, J; Lee, CK; Kim, M; Kim, E; Kim, M; Kim, S; Kim, C; Kim, JS				Kim, Heon Seok; Lee, Kyungjin; Bae, Sangsu; Park, Jeongbin; Lee, Chong-Kyo; Kim, Meehyein; Kim, Eunji; Kim, Minju; Kim, Seokjoong; Kim, Chonsaeng; Kim, Jin-Soo			CRISPR/Cas9-mediated gene knockout screens and target identification via whole-genome sequencing uncover host genes required for picornavirus infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CRISPR; Cas; host-pathogen interaction; poliovirus; RNA virus; sialic acid; CRISPR screen; Enterovirus D68; whole-genome sequencing	RNA-GUIDED ENDONUCLEASES; HUMAN-CELLS; ENTEROVIRUS D68; LIBRARY; GLYCOSYLATION; RESISTANCE; COMPLEX	Several groups have used genome-wide libraries of lentiviruses encoding small guide RNAs (sgRNAs) for genetic screens. In most cases, sgRNA expression cassettes are integrated into cells by using lentiviruses, and target genes are statistically estimated by the readout of sgRNA sequences after targeted sequencing. We present a new virus-free method for human gene knockout screens using a genome-wide library of CRISPR/Cas9 sgRNAs based on plasmids and target gene identification via whole-genome sequencing (WGS) confirmation of authentic mutations rather than statistical estimation through targeted amplicon sequencing. We used 30,840 pairs of individually synthesized oligonucleotides to construct the genome-scale sgRNA library, collectively targeting 10,280 human genes (i.e. three sgRNAs per gene). These plasmid libraries were co-transfected with a Cas9-expression plasmid into human cells, which were then treated with cytotoxic drugs or viruses. Only cells lacking key factors essential for cytotoxic drug metabolism or viral infection were able to survive. Genomic DNA isolated from cells that survived these challenges was subjected to WGS to directly identify CRISPR/Cas9-mediated causal mutations essential for cell survival. With this approach, we were able to identify known and novel genes essential for viral infection in human cells. We propose that genome-wide sgRNA screens based on plasmids coupled with WGS are powerful tools for forward genetics studies and drug target discovery.	[Kim, Heon Seok; Kim, Jin-Soo] Inst for Basic Sci Korea, Ctr Genome Engn, Seoul 151747, South Korea; [Kim, Heon Seok; Kim, Jin-Soo] Seoul Natl Univ, Dept Chem, Seoul 151747, South Korea; [Lee, Kyungjin; Lee, Chong-Kyo; Kim, Chonsaeng] Korea Res Inst Chem Technol, Ctr Convergent Res Emerging Virus Infect, Daejeon 34114, South Korea; [Kim, Meehyein] Korea Res Inst Chem Technol, Virus Res & Testing Ctr, Daejeon 34114, South Korea; [Bae, Sangsu; Park, Jeongbin] Hanyang Univ, Dept Chem, Seoul 04763, South Korea; [Kim, Eunji; Kim, Minju; Kim, Seokjoong] ToolGen Inc, Byucksan Kyoungin Digital Valley 2 Cha, Seoul 153023, South Korea	Institute for Basic Science - Korea (IBS); Seoul National University (SNU); Korea Research Institute of Chemical Technology (KRICT); Korea Research Institute of Chemical Technology (KRICT); Hanyang University	Kim, JS (corresponding author), Inst for Basic Sci Korea, Ctr Genome Engn, Seoul 151747, South Korea.; Kim, JS (corresponding author), Seoul Natl Univ, Dept Chem, Seoul 151747, South Korea.; Kim, C (corresponding author), Korea Res Inst Chem Technol, Ctr Convergent Res Emerging Virus Infect, Daejeon 34114, South Korea.	chonskim@krict.re.kr; jskim01@snu.ac.kr	Bae, Sangsu/E-5324-2017; Park, Jeongbin/ABC-5703-2021; KIM, Jin-Soo/M-6918-2013; Park, Jeongbin/AAL-4022-2021	Bae, Sangsu/0000-0003-3615-8566; KIM, Jin-Soo/0000-0003-4847-1306; Park, Jeongbin/0000-0002-9064-4912; Kim, Meehyein/0000-0002-2851-5298	IBS Grant [IBS-R021-D1]; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning Grant [2016R1C1B2009585]; National Research Council of Science and Technology by the Korean government Grant [CRC-16-01-KRICT]	IBS Grant; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning Grant; National Research Council of Science and Technology by the Korean government Grant	This work was supported by IBS Grant IBS-R021-D1 (to J. S. K.), Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT, and Future Planning Grant 2016R1C1B2009585, and National Research Council of Science and Technology by the Korean government Grant CRC-16-01-KRICT (to C. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Baggen J, 2016, P NATL ACAD SCI USA, V113, P1399, DOI 10.1073/pnas.1524498113; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Foulquier F, 2006, P NATL ACAD SCI USA, V103, P3764, DOI 10.1073/pnas.0507685103; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/nmeth.3284, 10.1038/NMETH.3284]; Kim JH, 2002, ANTIVIR RES, V54, P163, DOI 10.1016/S0166-3542(01)00221-2; Kim Y, 2013, NAT BIOTECHNOL, V31, P251, DOI 10.1038/nbt.2517; Kim YK, 2013, NAT STRUCT MOL BIOL, V20, P1458, DOI 10.1038/nsmb.2701; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Liu Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9865; Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049; Pallansch M., 2007, ENTEROVIRUSES POLIOV; Park J, 2015, BIOINFORMATICS, V31, P4014, DOI 10.1093/bioinformatics/btv537; Principi N, 2015, EXPERT REV RESP MED, V9, P711, DOI 10.1586/17476348.2015.1109451; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sadat MA, 2014, NEW ENGL J MED, V370, P1615, DOI 10.1056/NEJMoa1302846; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Ungar D, 2002, J CELL BIOL, V157, P405, DOI 10.1083/jcb.200202016; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	22	26	28	4	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10664	10671		10.1074/jbc.M117.782425	http://dx.doi.org/10.1074/jbc.M117.782425			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28446605	Green Published, hybrid			2022-12-26	WOS:000404115400025
J	Inoue, M; Fukui, K; Fujii, Y; Nakagawa, N; Yano, T; Kuramitsu, S; Masui, R				Inoue, Masao; Fukui, Kenji; Fujii, Yuki; Nakagawa, Noriko; Yano, Takato; Kuramitsu, Seiki; Masui, Ryoji			The Lon protease-like domain in the bacterial RecA paralog RadA is required for DNA binding and repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; ESCHERICHIA-COLI; HOMOLOGOUS RECOMBINATION; GENE-TRANSFER; DEINOCOCCUS-RADIODURANS; THERMUS-THERMOPHILUS; CATALYZED-REACTIONS; MISMATCH REPAIR; LA PROTEASE; SPECIFICITY	Homologous recombination (HR) plays an essential role in the maintenance of genome integrity. RecA/Rad51 paralogs have been recognized as an important factor of HR. Among them, only one bacterial RecA/Rad51 paralog, RadA, is involved in HR as an accessory factor of RecA recombinase. RadA has a unique Lon protease-like domain (LonC) at its C terminus, in addition to a RecA-like ATPase domain. Unlike Lon protease, RadA's LonC domain does not show protease activity but is still essential for RadA-mediated DNA repair. Reconciling these two facts has been difficult because RadA's tertiary structure and molecular function are unknown. Here, we describe the hexameric ring structure of RadA's LonC domain, as determined by X-ray crystallography. The structure revealed the two positively charged regions unique to the LonC domain of RadA are located at the intersubunit cleft and the central hole of a hexameric ring. Surprisingly, a functional domain analysis demonstrated the LonC domain of RadA binds DNA, with site-directed mutagenesis showing that the two positively charged regions are critical for this DNA-binding activity. Interestingly, only the intersubunit cleft was required for the DNA-dependent stimulation of ATPase activity of RadA, and at least the central hole was essential for DNA repair function. Our data provide the structural and functional features of the LonC domain and their function in RadA-mediated DNA repair.	[Inoue, Masao; Nakagawa, Noriko; Kuramitsu, Seiki] Osaka Univ, Grad Sch Sci, Dept Biol Sci, 1-1 Machikaneyama Cho, Toyonaka, Osaka 5600043, Japan; [Fukui, Kenji; Yano, Takato] Osaka Med Coll, Dept Biochem, 2-7 Daigakumachi, Takatsuki, Osaka 5698686, Japan; [Fujii, Yuki] Osaka Univ, Grad Sch Frontier Biosci, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan; [Masui, Ryoji] Osaka City Univ, Grad Sch Sci, Sumiyoshi Ku, 3-3-138 Sugimoto, Osaka 5588585, Japan	Osaka University; Osaka Medical College; Osaka University; Osaka Metropolitan University	Masui, R (corresponding author), Osaka City Univ, Grad Sch Sci, Sumiyoshi Ku, 3-3-138 Sugimoto, Osaka 5588585, Japan.	rmasui@sci.osaka-cu.ac.jp		Fujii, Yuki/0000-0002-8992-9902; Fukui, Kenji/0000-0003-2463-7578; Inoue, Masao/0000-0001-5484-0767				Aihara H, 1999, J MOL BIOL, V290, P495, DOI 10.1006/jmbi.1999.2904; AMERIK AY, 1991, FEBS LETT, V287, P211, DOI 10.1016/0014-5793(91)80053-6; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beam CE, 2002, J BACTERIOL, V184, P6836, DOI 10.1128/JB.184.24.6836-6844.2002; Bell JC, 2016, TRENDS BIOCHEM SCI, V41, P491, DOI 10.1016/j.tibs.2016.04.002; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Botos I, 2004, J BIOL CHEM, V279, P8140, DOI 10.1074/jbc.M312243200; Brigulla M, 2010, APPL MICROBIOL BIOT, V86, P1027, DOI 10.1007/s00253-010-2489-3; Brimacombe CA, 2015, J BACTERIOL, V197, P2653, DOI 10.1128/JB.00332-15; Brodersen DE, 2002, J MOL BIOL, V316, P725, DOI 10.1006/jmbi.2001.5359; Carrasco B, 2004, J BACTERIOL, V186, P5557, DOI 10.1128/JB.186.17.5557-5566.2004; Chen LT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000858; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Cooper DL, 2016, ELIFE, V5, DOI 10.7554/eLife.10807; Cooper DL, 2015, MOL MICROBIOL, V95, P769, DOI 10.1111/mmi.12899; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Cromie GA, 2001, MOL CELL, V8, P1163, DOI 10.1016/S1097-2765(01)00419-1; DIVER WP, 1982, INT J RADIAT BIOL, V42, P339, DOI 10.1080/09553008214551251; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erill I, 2004, NUCLEIC ACIDS RES, V32, P6617, DOI 10.1093/nar/gkh996; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fukui K, 2008, J BIOL CHEM, V283, P12136, DOI 10.1074/jbc.M800110200; Gwinn ML, 1998, J BACTERIOL, V180, P746, DOI 10.1128/JB.180.3.746-748.1998; Hashimoto Y, 2001, FEBS LETT, V506, P231, DOI 10.1016/S0014-5793(01)02926-X; Jovanovic M, 2002, NUCLEIC ACIDS RES, V30, P5065, DOI 10.1093/nar/gkf670; Kinebuchi T, 2005, J BIOL CHEM, V280, P28382, DOI 10.1074/jbc.M503372200; Krejci L, 2012, NUCLEIC ACIDS RES, V40, P5795, DOI 10.1093/nar/gks270; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kruger E, 1997, MICROBIOL-SGM, V143, P1309, DOI 10.1099/00221287-143-4-1309; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; KURAMITSU S, 1990, BIOCHEMISTRY-US, V29, P5469, DOI 10.1021/bi00475a010; Kurumizaka H, 1996, J BIOL CHEM, V271, P33515, DOI 10.1074/jbc.271.52.33515; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee AYL, 2014, ACTA CRYSTALLOGR D, V70, P218, DOI 10.1107/S139900471302631X; Lee AYL, 2004, J BIOL CHEM, V279, P34903, DOI 10.1074/jbc.M403562200; Lin YC, 2009, BIOCHEM BIOPH RES CO, V388, P62, DOI 10.1016/j.bbrc.2009.07.118; Lin ZG, 2006, P NATL ACAD SCI USA, V103, P10328, DOI 10.1073/pnas.0604232103; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lovett S, 2006, DNA REPAIR, V5, P1421, DOI 10.1016/j.dnarep.2006.06.008; Maraboeuf F, 1995, J BIOL CHEM, V270, P30927, DOI 10.1074/jbc.270.52.30927; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pinti M, 2016, BBA-BIOENERGETICS, V1857, P1300, DOI 10.1016/j.bbabio.2016.03.025; Rasulova FS, 1998, FEBS LETT, V432, P179, DOI 10.1016/S0014-5793(98)00859-X; Robertson A, 2006, J BIOL CHEM, V281, P8399, DOI 10.1074/jbc.M509184200; Rotanova TV, 2004, EUR J BIOCHEM, V271, P4865, DOI 10.1111/j.1432-1033.2004.04452.x; Rudyak SG, 2001, BIOCHEMISTRY-US, V40, P9317, DOI 10.1021/bi0102508; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shin DS, 2004, DNA REPAIR, V3, P863, DOI 10.1016/j.dnarep.2004.03.022; Shinohara T, 2015, NUCLEIC ACIDS RES, V43, P973, DOI 10.1093/nar/gku1364; Sillitoe I, 2015, NUCLEIC ACIDS RES, V43, pD376, DOI 10.1093/nar/gku947; Slade D, 2009, CELL, V136, P1044, DOI 10.1016/j.cell.2009.01.018; Song YH, 1996, J BACTERIOL, V178, P5045, DOI 10.1128/jb.178.16.5045-5048.1996; Suwaki N, 2011, SEMIN CELL DEV BIOL, V22, P898, DOI 10.1016/j.semcdb.2011.07.019; Taylor MRG, 2015, CELL, V162, P271, DOI 10.1016/j.cell.2015.06.015; Thacker J, 2005, CANCER LETT, V219, P125, DOI 10.1016/j.canlet.2004.08.018; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Van Melderen L, 2009, RES MICROBIOL, V160, P645, DOI 10.1016/j.resmic.2009.08.021; Vieux EF, 2013, P NATL ACAD SCI USA, V110, pE2002, DOI 10.1073/pnas.1307066110; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhou Q, 2006, CHINESE SCI BULL, V51, P2993, DOI 10.1007/s11434-006-2209-7	67	8	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9801	9814		10.1074/jbc.M116.770180	http://dx.doi.org/10.1074/jbc.M116.770180			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28432121	Green Published, hybrid			2022-12-26	WOS:000403113000028
J	Cozzi, GD; Levinson, RT; Toole, H; Snyder, MR; Deng, A; Crispens, MA; Khabele, D; Beeghly-Fadiel, A				Cozzi, Gabriella D.; Levinson, Rebecca T.; Toole, Hilary; Snyder, Malcolm-Robert; Deng, Angie; Crispens, Marta A.; Khabele, Dineo; Beeghly-Fadiel, Alicia			Blood type, ABO genetic variants, and ovarian cancer survival	PLOS ONE			English	Article							BREAST-CANCER; VENOUS THROMBOEMBOLISM; GENOME-WIDE; RISK; THROMBOCYTOSIS; ASSOCIATION; PROGNOSIS; SELECTIN; IMPACT; LOCI	Objective Blood type A and the A1 allele have been associated with increased ovarian cancer risk. With only two small studies published to date, evidence for an association between ABO blood type and ovarian cancer survival is limited. Methods We conducted a retrospective cohort study of Tumor Registry confirmed ovarian cancer cases from the Vanderbilt University Medical Center with blood type from linked laboratory reports and ABO variants from linked Illumina Exome BeadChip data. Associations with overall survival (OS) were quantified by hazard ratios (HR) and confidence intervals (CI) from proportional hazards regression models; covariates included age, race, stage, grade, histologic subtype, and year of diagnosis. Results ABO phenotype (N = 694) and/or genotype (N = 154) data were available for 713 predominantly Caucasian (89.3%) cases. In multivariable models, blood type A had significantly better OS compared to either O (HR: 0.75, 95% CI: 0.60-0.93) or all non-A (HR: 0.77, 95% CI: 0.63-0.94) cases. Similarly, missense rs1053878 minor allele carriers (A2) had better OS (HR: 0.50, 95% CI: 0.25-0.99). Among Caucasians, this phenotype association was strengthened, but the genotype association was attenuated; instead, four variants sharing moderate linkage disequilibrium with the O variant were associated with better OS (HR: 0.62, 95% CI: 0.390.99) in unadjusted models. Conclusions Blood type A was significantly associated with longer ovarian cancer survival in the largest such study to date. This finding was supported by genetic analysis, which implicated the A2 allele, although O related variants also had suggestive associations. Further research on ABO and ovarian cancer survival is warranted.	[Cozzi, Gabriella D.; Snyder, Malcolm-Robert; Deng, Angie; Beeghly-Fadiel, Alicia] Vanderbilt Univ, Med Ctr, Dept Med, Div Epidemiol, Nashville, TN 37235 USA; [Levinson, Rebecca T.] Vanderbilt Univ, Sch Med, Vanderbilt Genet Inst, Nashville, TN 37212 USA; [Toole, Hilary] Meharry Med Coll, Nashville, TN 37208 USA; [Crispens, Marta A.; Khabele, Dineo] Vanderbilt Univ, Med Ctr, Dept Obstet & Gynecol, Nashville, TN 37232 USA; [Crispens, Marta A.; Khabele, Dineo; Beeghly-Fadiel, Alicia] Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Meharry Medical College; Vanderbilt University; Vanderbilt University	Beeghly-Fadiel, A (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Epidemiol, Nashville, TN 37235 USA.; Beeghly-Fadiel, A (corresponding author), Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA.	alicia.beeghly@vanderbilt.edu		Levinson, Rebecca/0000-0002-2775-7543; Deng, Angie/0000-0002-3954-6911	National Institutes of Health [UUTR000445]; United States Department of Defense [W81XWH-14-1-0104]; National Cancer Institute [T32GM080178]; National Center for Research Resources [1S10RR025141-01]; Department of Defense Ovarian Cancer Research Program Pilot Award [W81XWH-14-1-0104]; CTSA from NCATS/NIH [UL1TR000445]; NATIONAL CANCER INSTITUTE [U54CA163069] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080178] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007586] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Department of Defense Ovarian Cancer Research Program Pilot Award; CTSA from NCATS/NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by the National Institutes of Health UUTR000445 (https://www.nih.gov/); United States Department of Defense-W81XWH-14-1-0104 (www.defense.gov/) to ABF; National Cancer Institute-T32GM080178 (https.// www.cancer.gov/) to RTL; National Center for Research Resources-1S10RR025141-01 (https://www.nih.gov/research-training/research-resources). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Beeghly-Fadiel and this research were supported in part by a Department of Defense Ovarian Cancer Research Program Pilot Award (W81XWH-14-1-0104). Rebecca T. Levinson was supported by T32GM080178. Datasets were obtained from the Vanderbilt University Medical Center Synthetic Derivative and BioVU which are supported by institutional funding, the 1S10RR025141-01 instrumentation award, and by the CTSA grant UL1TR000445 from NCATS/NIH. In addition, the authors gratefully acknowledge the members and supporters of the Vanderbilt Ovarian Cancer Alliance (VOCAL).	Barbalic M, 2010, HUM MOL GENET, V19, P1863, DOI 10.1093/hmg/ddq061; Ben QW, 2011, INT J CANCER, V128, P1179, DOI 10.1002/ijc.25426; BJARNASON O, 1987, ACTA PATH MICRO IM A, V95, P185; BJORKHOLM E, 1984, INT J EPIDEMIOL, V13, P15, DOI 10.1093/ije/13.1.15; Chang SJ, 2012, GYNECOL ONCOL, V125, P483, DOI 10.1016/j.ygyno.2012.02.024; Cihan YB, 2014, ASIAN PAC J CANCER P, V15, P4055, DOI 10.7314/APJCP.2014.15.9.4055; COSTANTINI M, 1990, ONCOLOGY, V47, P308; Cozzi GD, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2660-z; Dumitrescu L, 2010, GENET MED, V12, P648, DOI 10.1097/GIM.0b013e3181efe2df; Franchini M, 2016, BLOOD TRANSFUS-ITALY, V14, P434, DOI 10.2450/2015.0164-15; Gates MA, 2012, INT J CANCER, V130, P2129, DOI 10.1002/ijc.26220; Guo Y, 2014, NAT PROTOC, V9, P2643, DOI 10.1038/nprot.2014.174; Hakomori S, 1999, BBA-GEN SUBJECTS, V1473, P247, DOI 10.1016/S0304-4165(99)00183-X; Hamosh A, 2002, NUCLEIC ACIDS RES, V30, P52, DOI 10.1093/nar/30.1.52; Heath OM, 2016, THROMB RES, V137, P30, DOI 10.1016/j.thromres.2015.11.030; HOLDSWORTH PJ, 1985, BRIT MED J, V290, P671, DOI 10.1136/bmj.290.6469.671; Klimant E, 2011, CLIN MED RES, V9, P111, DOI 10.3121/cmr.2011.907; Kommoss S, 2016, BRIT J CANCER, V115, P993, DOI 10.1038/bjc.2016.273; Le Pendu J, 2001, APMIS, V109, P9; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Marinaccio M, 1995, Minerva Ginecol, V47, P69; MATSUI T, 1992, J BIOL CHEM, V267, P8723; Montoro-Garcia S, 2016, SEMIN THROMB HEMOST, V42, P242, DOI 10.1055/s-0035-1570079; Ohira T, 2007, J THROMB HAEMOST, V5, P1455, DOI 10.1111/j.1538-7836.2007.02579.x; Ozel AB, 2016, J THROMB HAEMOST, V14, P1888, DOI 10.1111/jth.13401; Pare A G, 2008, PLOS GENET, V4; Paterson AD, 2009, ARTERIOSCL THROM VAS, V29, P1958, DOI 10.1161/ATVBAHA.109.192971; Poole EM, 2012, CANCER CAUSE CONTROL, V23, P1805, DOI 10.1007/s10552-012-0059-y; Qi L, 2010, HUM MOL GENET, V19, P1856, DOI 10.1093/hmg/ddq057; Rahbari NN, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-319; RIECKMANN P, 1995, J NEUROIMMUNOL, V60, P9, DOI 10.1016/0165-5728(95)00047-6; Rizzato C, 2013, ONCOL REP, V29, P1637, DOI 10.3892/or.2013.2285; Rodriguez AO, 2007, GYNECOL ONCOL, V105, P784, DOI 10.1016/j.ygyno.2007.02.024; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Stone RL, 2012, NEW ENGL J MED, V366, P610, DOI 10.1056/NEJMoa1110352; Tregouet DA, 2009, BLOOD, V113, P5298, DOI 10.1182/blood-2008-11-190389; Trousseau A, 1867, LECT CLIN MED DELIVE; Wang DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041984; Yamamoto F, 2012, TRANSFUS MED REV, V26, P103, DOI 10.1016/j.tmrv.2011.08.002; Yu J, 2012, ANN SURG ONCOL, V19, P3159, DOI 10.1245/s10434-012-2533-x; Zhang HR, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/641917; Zhou J, 2015, J CANCER, V6, P970, DOI 10.7150/jca.12471	43	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0175119	10.1371/journal.pone.0175119	http://dx.doi.org/10.1371/journal.pone.0175119			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448592	gold, Green Published, Green Submitted			2022-12-26	WOS:000400383600007
J	Olsen, S; Krause, K				Olsen, Stian; Krause, Kirsten			Activity of xyloglucan endotransglucosylases/hydrolases suggests a role during host invasion by the parasitic plant Cuscuta reflexa	PLOS ONE			English	Article							HOLOPARASITIC ANGIOSPERM CUSCUTA; CELL-WALL; FLOWERING PLANT; XET ACTIVITY; DODDER; ARABIDOPSIS; HAUSTORIA; JAPONICA; ENZYMES; FAMILY	The parasitic vines of the genus Cuscuta form haustoria that grow into other plants and connect with their vascular system, thus allowing the parasite to feed on its host. A major obstacle that meets the infection organ as it penetrates the host tissue is the rigid plant cell wall. In the present study, we examined the activity of xyloglucan endotransglucosylases/hydrolases (XTHs) during the host-invasive growth of the haustorium. The level of xyloglucan endotransglucosylation (XET) activity was found to peak at the penetrating stage of Cuscuta reflexa on its host Pelargonium zonale. In vivo colocalization of XET activity and donor substrate demonstrated XET activity at the border between host and parasite. A test for secretion of XET-active enzymes from haustoria of C. reflexa corroborated this and further indicated that the xyloglucan-modifying enzymes originated from the parasite. A known inhibitor of XET, Coomassie Brilliant Blue R250, was shown to reduce the level of XET in penetrating haustoria of C. reflexa. Moreover, the coating of P. zonale petioles with the inhibitor compound lowered the number of successful haustorial invasions of this otherwise compatible host plant. The presented data indicate that the activity of Cuscuta XTHs at the host-parasite interface is essential to penetration of host plant tissue.	[Olsen, Stian; Krause, Kirsten] UiT Arctic Univ Norway, Fac Biosci Fisheries & Econ, Dept Arctic & Marine Biol, Tromso, Norway	UiT The Arctic University of Tromso	Olsen, S (corresponding author), UiT Arctic Univ Norway, Fac Biosci Fisheries & Econ, Dept Arctic & Marine Biol, Tromso, Norway.	stian.olsen@uit.no	Krause, Kirsten/D-1765-2010	Krause, Kirsten/0000-0001-9739-2466	UiT The Arctic University of Norway	UiT The Arctic University of Norway	Funding was provided by UiT The Arctic University of Norway in the form of a PhD stipend and running money for Stian Olsen. The manuscript is part of his doctoral thesis.	Becnel J, 2006, PLANT MOL BIOL, V61, P451, DOI 10.1007/s11103-006-0021-z; Bleischwitz M, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-227; Chebli Y, 2017, CURR OPIN CELL BIOL, V44, P28, DOI 10.1016/j.ceb.2017.01.002; Chormova D, 2015, PHYTOCHEMISTRY, V117, P220, DOI 10.1016/j.phytochem.2015.06.016; Cosgrove DJ, 2016, J EXP BOT, V67, P463, DOI 10.1093/jxb/erv511; Dawson Jean H., 1994, Reviews of Weed Science, V6, P265; Eklof JM, 2010, PLANT PHYSIOL, V153, P456, DOI 10.1104/pp.110.156844; Fry SC, 1997, PLANT J, V11, P1141, DOI 10.1046/j.1365-313X.1997.11051141.x; Hong L, 2011, PAK J BOT, V43, P1853; Johnsen HR, 2015, NEW PHYTOL, V207, P805, DOI 10.1111/nph.13378; Lee KB, 2007, AM J BOT, V94, P737, DOI 10.3732/ajb.94.5.737; Lee KB, 2009, J PLANT BIOL, V52, P355, DOI 10.1007/s12374-009-9046-6; Malinovsky FG, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00178; Maris A, 2009, J EXP BOT, V60, P3959, DOI 10.1093/jxb/erp229; Mitsumasu K, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00617; NAGAR R, 1984, J EXP BOT, V35, P1104, DOI 10.1093/jxb/35.8.1104; Olsen S, 2016, J EXP BOT, V67, P695, DOI 10.1093/jxb/erv482; Qin L, 2004, NATURE, V427, P30, DOI 10.1038/427030a; Ranjan A, 2014, PLANT PHYSIOL, V166, P1186, DOI 10.1104/pp.113.234864; Rose JKC, 2002, PLANT CELL PHYSIOL, V43, P1421, DOI 10.1093/pcp/pcf171; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Tada Y, 1996, PLANT CELL PHYSIOL, V37, P1049, DOI 10.1093/oxfordjournals.pcp.a029052; Takeda T, 2002, P NATL ACAD SCI USA, V99, P9055, DOI 10.1073/pnas.132080299; Van Sandt VST, 2007, ANN BOT-LONDON, V100, P1467, DOI 10.1093/aob/mcm248; Vaughn KC, 2003, PROTOPLASMA, V220, P189, DOI 10.1007/s00709-002-0038-3; Vaughn KC, 2006, INT J PLANT SCI, V167, P1099, DOI 10.1086/507872; Vissenberg K, 2000, PLANT CELL, V12, P1229, DOI 10.1105/tpc.12.7.1229; Yokoyama R, 2010, PLANT J, V64, P645, DOI 10.1111/j.1365-313X.2010.04351.x; Yoshida S, 2016, ANNU REV PLANT BIOL, V67, P643, DOI 10.1146/annurev-arplant-043015-111702	29	12	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176754	10.1371/journal.pone.0176754	http://dx.doi.org/10.1371/journal.pone.0176754			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448560	Green Published, gold, Green Submitted			2022-12-26	WOS:000400383600127
J	Lee, BH; Neela, PH; Kent, MS; Zehnder, AM				Lee, Becky H.; Neela, Poornima H.; Kent, Michael S.; Zehnder, Ashley M.			IQGAP1 is an oncogenic target in canine melanoma	PLOS ONE			English	Article							MALIGNANT MELANOMAS; EXPRESSION PATTERN; KINASE INTERACTION; CELL-LINES; CANCER; INHIBITOR; TUMOR; DOGS; OVEREXPRESSION; CARCINOMAS	Canine oral mucosal melanoma is an aggressive malignant neoplasm and is characterized by local infiltration and a high metastatic potential. The disease progression is similar to that of human oral melanomas. Whereas human cutaneous melanoma is primarily driven by activating mutations in Braf (60%) or Nras (20%), human mucosal melanoma harbors these mutations much less frequently. This makes therapeutic targeting and research modeling of the oral form potentially different from that of the cutaneous form in humans. Similarly, research has found only rare Nras mutations and no activating Braf mutations in canine oral melanomas, but they are still reliant on MAPK signaling. IQGAP1 is a signaling scaffold that regulates oncogenic ERK1/2 MAPK signaling in human Ras- and Raf-driven cancers, including melanomas. To investigate whether IQGAP1 is a potential target in canine melanoma, we examined the expression and localization of IQGAP1 in primary canine melanomas and canine oral melanoma cell lines obtained from the University of California-Davis. Using CRISPR/Cas9 knockout of IQGAP1, we examined effects on downstream ERK1/2 pathway activity and assayed proliferation of cell lines when treated with a peptide that blocks the interaction between IQGAP1 and ERK1/2. We observed that canine IQGAP1 is expressed and localizes to a similar extent in both human and canine melanoma by qPCR, Western blot, and immunofluorescence. Deletion of IQGAP1 reduces MAPK pathway activation in cell lines, similar to effects seen in human Braf (V600E) cell lines. Additionally, we demonstrated reduced proliferation when these cells are treated with a blocking peptide in vitro.	[Lee, Becky H.] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA; [Neela, Poornima H.; Zehnder, Ashley M.] Stanford Univ, Program Epithelial Biol, Stanford, CA 94305 USA; [Kent, Michael S.] Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA; [Lee, Becky H.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Zehnder, Ashley M.] Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA	University of California System; University of California Davis; Stanford University; University of California System; University of California Davis; Washington State University; Stanford University	Zehnder, AM (corresponding author), Stanford Univ, Program Epithelial Biol, Stanford, CA 94305 USA.; Zehnder, AM (corresponding author), Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA.	azehnder.dvm@grnail.corn		Kent, Michael/0000-0002-7703-7720				Aina OH, 2011, VET IMMUNOL IMMUNOP, V143, P11, DOI 10.1016/j.vetimm.2011.05.018; [Anonymous], NIH SUPPORTED CLIN T; Fowles JS, 2015, VET COMP ONCOL, V13, P288, DOI 10.1111/vco.12044; Gillard M, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12170; Hayashi H, 2010, INT J CANCER, V126, P2563, DOI 10.1002/ijc.24987; Jameson KL, 2013, NAT MED, V19, P626, DOI 10.1038/nm.3165; Jin J, 2012, LARYNGOSCOPE, V122, P2640, DOI 10.1002/lary.23541; Johnson M, 2009, CELL SIGNAL, V21, P1471, DOI 10.1016/j.cellsig.2009.02.023; Kent MS, 2009, AM J VET RES, V70, P263, DOI 10.2460/ajvr.70.2.263; Koenig A, 2002, VET PATHOL, V39, P458, DOI 10.1354/vp.39-4-458; Kol A, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa9116; Kurenova E, 2014, CELL CYCLE, V13, P2542, DOI 10.4161/15384101.2015.941760; Kurenova E, 2013, ONCOTARGET, V4, P1632, DOI 10.18632/oncotarget.1365; Liu LS, 2013, INT J DERMATOL, V52, P523, DOI 10.1111/j.1365-4632.2012.05829.x; Luan Z, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-38; Mayr B, 2003, VET J, V165, P169, DOI 10.1016/S1090-0233(02)00245-9; Nabeshima K, 2002, CANCER LETT, V176, P101, DOI 10.1016/S0304-3835(01)00742-X; Nakamura H, 2005, ONCOL REP, V13, P427; Phillips JC, 2012, AM J VET RES, V73, P272, DOI 10.2460/ajvr.73.2.272; Proulx DR, 2003, VET RADIOL ULTRASOUN, V44, P352, DOI 10.1111/j.1740-8261.2003.tb00468.x; Ridky TW, 2010, NAT MED, V16, P1450, DOI 10.1038/nm.2265; Scholl FA, 2007, DEV CELL, V12, P615, DOI 10.1016/j.devcel.2007.03.009; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shelly S, 2005, MAMM GENOME, V16, P211, DOI 10.1007/s00335-004-2441-x; Simpson RM, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12185; Yamaguchi T, 2011, INT J ONCOL, V39, P23, DOI 10.3892/ijo.2011.1015	26	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176370	10.1371/journal.pone.0176370	http://dx.doi.org/10.1371/journal.pone.0176370			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445541	Green Published, gold			2022-12-26	WOS:000400309200053
J	Boussida, S; Traore, AS; Durif, F				Boussida, Salem; Traore, Amidou S.; Durif, Franck			Mapping of the brain hemodynamic responses to sensorimotor stimulation in a rodent model: A BOLD fMRI study	PLOS ONE			English	Article							FUNCTIONAL MRI; SOMATOSENSORY STIMULATION; RAT-BRAIN; ISOFLURANE; ACTIVATION; FOREPAW; SIGNAL; REPRESENTATION; HALOTHANE; HINDPAW	Blood Oxygenation Level Dependent functional MRI (BOLD fMRI) during electrical paw stimulation has been widely used in studies aimed at the understanding of the somatosensory network in rats. However, despite the well-established anatomical connections between cortical and subcortical structures of the sensorimotor system, most of these functional studies have been concentrated on the cortical effects of sensory electrical stimulation. BOLD fMRI study of the integration of a sensorimotor input across the sensorimotor network requires an appropriate methodology to elicit functional activation in cortical and subcortical areas owing to the regional differences in both neuronal and vascular architectures between these brain regions. Here, using a combination of low level anesthesia, long pulse duration of the electrical stimulation along with improved spatial and temporal signal to noise ratios, we provide a functional description of the main cortical and subcortical structures of the sensorimotor rat brain. With this calibrated fMRI protocol, unilateral non-noxious sensorimotor electrical hind-paw stimulation resulted in robust positive activations in the contralateral sensorimotor cortex and bilaterally in the sensorimotor thalamus nuclei, whereas negative activations were observed bilaterally in the dorsolateral caudate-putamen. These results demonstrate that, once the experimental setup allowing necessary spatial and temporal signal to noise ratios is reached, hemodynamic changes related to neuronal activity, as preserved by the combination of a soft anesthesia with a soft muscle relaxation, can be measured within the sensorimotor network. Moreover, the observed responses suggest that increasing pulse duration of the electrical stimulus adds a proprioceptive component to the sensory input that activates sensorimotor network in the brain, and that these activation patterns are similar to those induced by digits paw's movements. These findings may find application in fMRI studies of sensorimotor disorders within cortico-basal network in rodents.	[Boussida, Salem; Traore, Amidou S.] INRA, UR370, QuaPA, St Genes Champanelle, France; [Durif, Franck] CHU, Neurol A, Clermont Ferrand, France	INRAE; CHU Clermont Ferrand	Traore, AS (corresponding author), INRA, UR370, QuaPA, St Genes Champanelle, France.	amidou.traore@inra.fr	Durif, Franck/CAA-1077-2022; TRAORE, Amidou/D-9387-2019	TRAORE, Amidou/0000-0002-3574-3475				ALKIRE MT, 1995, ANESTHESIOLOGY, V82, P393, DOI 10.1097/00000542-199502000-00010; [Anonymous], 1990, SCIENCE, V250, P1457; Baudewig J, 2003, MAGN RESON IMAGING, V21, P1121, DOI 10.1016/j.mri.2003.08.013; Bock C, 1998, NMR BIOMED, V11, P115, DOI 10.1002/(SICI)1099-1492(199805)11:3<115::AID-NBM526>3.0.CO;2-K; Bourgeon S, 2004, BEHAV BRAIN RES, V153, P217, DOI 10.1016/j.bbr.2003.12.002; Brinker G, 1999, MAGNET RESON MED, V41, P469, DOI 10.1002/(SICI)1522-2594(199903)41:3<469::AID-MRM7>3.0.CO;2-9; Burke M, 2000, MAGNET RESON MED, V44, P317, DOI 10.1002/1522-2594(200008)44:2<317::AID-MRM20>3.0.CO;2-R; CHAPIN JK, 1984, J COMP NEUROL, V229, P199, DOI 10.1002/cne.902290206; Cho YR, 2007, MAGN RESON MED, V58, P901, DOI 10.1002/mrm.21408; Desmond JE, 2002, J NEUROSCI METH, V118, P115, DOI 10.1016/S0165-0270(02)00121-8; Devonshire IM, 2012, NEUROIMAGE, V59, P1997, DOI 10.1016/j.neuroimage.2011.09.050; Ebner F. F., 2015, RAT NERVOUS SYSTEM, P675; Erro ME, 2002, NEUROSCI RES, V42, P45, DOI 10.1016/S0168-0102(01)00302-9; Erro ME, 2001, HISTOCHEM CELL BIOL, V115, P447; FORSTER A, 1982, ANESTHESIOLOGY, V56, P453, DOI 10.1097/00000542-198206000-00009; Francis JT, 2008, J NEUROPHYSIOL, V99, P2291, DOI 10.1152/jn.01206.2007; Grill WM, 1996, IEEE T BIO-MED ENG, V43, P161, DOI 10.1109/10.481985; Grune M, 1999, MAGNET RESON MED, V42, P118, DOI 10.1002/(SICI)1522-2594(199907)42:1<118::AID-MRM16>3.0.CO;2-T; Gyngell ML, 1996, MAGNET RESON MED, V36, P13, DOI 10.1002/mrm.1910360104; Harel N, 2002, J CEREBR BLOOD F MET, V22, P908, DOI 10.1097/00004647-200208000-00002; Hayes DJ, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00027; Imas OA, 2005, ANESTHESIOLOGY, V102, P937, DOI 10.1097/00000542-200505000-00012; Keilholz SD, 2004, MAGN RESON MED, V52, P89, DOI 10.1002/mrm.20114; LEE JG, 1994, ANESTH ANALG, V79, P58; Li CX, 2014, BRAIN CONNECT, V4, P760, DOI 10.1089/brain.2014.0326; Lilja J, 2006, J NEUROSCI, V26, P6330, DOI 10.1523/JNEUROSCI.0626-06.2006; Liu ZHM, 2004, MAGN RESON MED, V52, P277, DOI 10.1002/mrm.20148; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; LOW JST, 1986, J COMP NEUROL, V243, P510, DOI 10.1002/cne.902430406; Mandeville JB, 1999, MAGN RESON MED, V42, P944, DOI 10.1002/(SICI)1522-2594(199911)42:5<944::AID-MRM15>3.0.CO;2-W; Masamoto K, 2007, CEREB CORTEX, V17, P942, DOI 10.1093/cercor/bhl005; Masamoto K, 2009, EUR J NEUROSCI, V30, P242, DOI 10.1111/j.1460-9568.2009.06812.x; Mishra AM, 2011, J NEUROSCI, V31, P15053, DOI 10.1523/JNEUROSCI.0101-11.2011; O'Herron P, 2016, NATURE, V534, P378, DOI 10.1038/nature17965; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Orth M, 2006, ANESTH ANALG, V102, P1709, DOI 10.1213/01.ane.0000205752.00303.94; Parrish TB, 2000, MAGNET RESON MED, V44, P925, DOI 10.1002/1522-2594(200012)44:6<925::AID-MRM14>3.0.CO;2-M; Paxinos G., 2015, RAT NERVOUS SYSTEM, V4th; Peeters RR, 1999, EUR J NEUROSCI, V11, P2720, DOI 10.1046/j.1460-9568.1999.00687.x; Raspopovic S, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-17; Schlegel F, 2015, NEUROIMAGE, V116, P40, DOI 10.1016/j.neuroimage.2015.05.013; Schridde U, 2008, CEREB CORTEX, V18, P1814, DOI 10.1093/cercor/bhm208; Silva AC, 2002, P NATL ACAD SCI USA, V99, P15182, DOI 10.1073/pnas.222561899; Sloan HL, 2010, NEUROIMAGE, V53, P399, DOI 10.1016/j.neuroimage.2010.07.014; Spenger C, 2000, EXP NEUROL, V166, P246, DOI 10.1006/exnr.2000.7524; Triantafyllou C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024519; Van Camp N, 2006, NMR BIOMED, V19, P10, DOI [10.1002/nbm0986, 10.1002/nbm.986]; van Meer MPA, 2011, J CEREBR BLOOD F MET, V31, P1583, DOI 10.1038/jcbfm.2011.61; Vertes RP, 2015, RAT NERVOUS SYSTEM, P335; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Wang K, 2011, NMR BIOMED, V24, P61, DOI 10.1002/nbm.1556; Weber R, 2006, NEUROIMAGE, V29, P1303, DOI 10.1016/j.neuroimage.2005.08.028; Yang XJ, 1996, P NATL ACAD SCI USA, V93, P475, DOI 10.1073/pnas.93.1.475; Yang XJ, 1997, MAGNET RESON MED, V38, P874, DOI 10.1002/mrm.1910380604; Younce JR, 2014, JOVE-J VIS EXP, DOI 10.3791/51271	56	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176512	10.1371/journal.pone.0176512	http://dx.doi.org/10.1371/journal.pone.0176512			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441420	Green Submitted, Green Published, gold			2022-12-26	WOS:000400308800065
J	Chen, Z; Sun, Y; Yang, XJ; Wu, ZF; Guo, KF; Niu, XR; Wang, QS; Ruan, JS; Bu, WJ; Gao, S				Chen, Ze; Sun, Yu; Yang, Xiaojun; Wu, Zhenfeng; Guo, Kaifei; Niu, Xiaoran; Wang, Qingsong; Ruan, Jishou; Bu, Wenjun; Gao, Shan			Two featured series of rRNA-derived RNA fragments (rRFs) constitute a novel class of small RNAs	PLOS ONE			English	Article							SIRNAS	In this study, we reported two featured series of rRNA-derived RNA fragments (rRFs) from the small RNA sequencing (sRNA-seq) data of Amblyomma testudinarium using the Illunima platform. Two series of rRFs (rRF5 and rRF3) were precisely aligned to the 5' and 3' ends of the 5.8S and 28S rRNA gene. The rRF5 and rRF3 series were significantly more highly expressed than the rRFs located in the body of the rRNA genes. These series contained perfectly aligned reads, the lengths of which varied progressively with 1-bp differences. The rRF5 and rRF3 series in the same expression pattern exist ubiquitously from ticks to human. The cellular experiments showed the RNAi knockdown of one 20-nt rRF3 induced the cell apoptosis and inhibited the cell proliferation. In addition, the RNAi knockdown resulted in a significant decrease of H1299 cells in the G2 phase of the cell cycle. These results indicated the rRF5 and rRF3 series were not random intermediates or products during rRNA degradation, but could constitute a new class of small RNAs that deserves further investigation.	[Chen, Ze] Chinese Acad Agr Sci, State Key Lab Vet Etiol Biol, Lanzhou Vet Res Inst, Lanzhou, Gansu, Peoples R China; [Sun, Yu; Niu, Xiaoran; Bu, Wenjun; Gao, Shan] Nankai Univ, Coll Life Sci, Tianjin, Peoples R China; [Yang, Xiaojun] Southwest Forestry Univ, Fac Ecotourism, Kunming, Yunnan, Peoples R China; [Wu, Zhenfeng] Nankai Univ, Sch Math Sci, Tianjin, Peoples R China; [Wang, Qingsong] Tianjin Med Univ, Tianjin Res Ctr Basic Med Sci, Tianjin, Peoples R China; [Gao, Shan] Nankai Univ, Inst Stat, Tianjin, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Nankai University; Southwest Forestry University - China; Nankai University; Tianjin Medical University; Nankai University	Bu, WJ; Gao, S (corresponding author), Nankai Univ, Coll Life Sci, Tianjin, Peoples R China.; Gao, S (corresponding author), Nankai Univ, Inst Stat, Tianjin, Peoples R China.	wenjunbu@nankai.edu.cn; gao_shan@mail.nankai.edu.cn	Guo, Kai-Fei/ABG-2655-2021	Guo, Kai-Fei/0000-0001-8118-0012; Sun, Yu/0000-0003-4269-7187; , Ze/0000-0001-8236-5764; Gao, Shan/0000-0002-8919-1338	Fundamental Research Funds for the Central Universities (for Nankai University); National Natural Science Foundation of China [31471967, 31260106]; Natural Science Foundation of China [81472052]	Fundamental Research Funds for the Central Universities (for Nankai University); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from Fundamental Research Funds for the Central Universities (for Nankai University) to Shan Gao, National Natural Science Foundation of China (31471967) to Ze Chen, National Natural Science Foundation of China (31260106) to Xiaojun Yang, and Natural Science Foundation of China (81472052) to Qingsong Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Cao QH, 2016, TROP PLANT BIOL, V9, P63, DOI 10.1007/s12042-016-9162-7; Elbarbary RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005908; Gao S., 2014, P INT WINTER WORKSHO, P1, DOI DOI 10.3780/J.ISSN.1000-758X.2014.01.009; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Lee HC, 2009, NATURE, V459, P274, DOI 10.1038/nature08041; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Lodish H, 2000, MOL CELL BIOL, V4, P120; Mi Zhang, 2014, 2014 IEEE International Conference on Bioinformatics and Biomedicine (BIBM), P44, DOI 10.1109/BIBM.2014.6999309; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; REDDY R, 1981, J BIOL CHEM, V256, P8452; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; Wang F, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2596782; Wang YZ, 2016, GENES-BASEL, V7, DOI 10.3390/genes7020007; Wei W, 2012, CELL, V149, P101, DOI 10.1016/j.cell.2012.03.002; WEINBERG RA, 1968, J MOL BIOL, V38, P289, DOI 10.1016/0022-2836(68)90387-2	18	27	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176458	10.1371/journal.pone.0176458	http://dx.doi.org/10.1371/journal.pone.0176458			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441451	Green Published, gold, Green Submitted			2022-12-26	WOS:000400308800058
J	Shimozuru, M; Yamanaka, M; Nakanishi, M; Moriwaki, J; Mori, F; Tsujino, M; Shirane, Y; Ishinazaka, T; Kasai, S; Nose, T; Masuda, Y; Tsubota, T				Shimozuru, Michito; Yamanaka, Masami; Nakanishi, Masanao; Moriwaki, Jun; Mori, Fumihiko; Tsujino, Masakatsu; Shirane, Yuri; Ishinazaka, Tsuyoshi; Kasai, Shinsuke; Nose, Takane; Masuda, Yasushi; Tsubota, Toshio			Reproductive parameters and cub survival of brown bears in the Rusha area of the Shiretoko Peninsula, Hokkaido, Japan	PLOS ONE			English	Article							GRIZZLY BEARS; BLACK BEAR; EASTERN HOKKAIDO; NATIONAL-PARK; URSUS-ARCTOS; POPULATION; INFANTICIDE; IDENTIFICATION; CONSERVATION; DEMOGRAPHICS	servation and management of wildlife. In this study, we investigated the demographic parameters, including age of primiparity, litter size, inter-birth interval, reproductive rate, and cub survival rate, of Hokkaido brown bears (Ursus arctos yesoensis) in the Rusha area on the Shiretoko Peninsula, Hokkaido, Japan, based on a long-term, individual-based monitoring survey. A total of 15 philopatric females were observed nearly every year from 2006 to 2016, and these observations were used to estimate reproductive parameters. The mean age of primiparity was 5.3 +/- 0.2 (SE) years (n = 7, 95% CI = 5.0-5.6). We observed 81 cubs in 46 litters from 15 bears. Litter size ranged from one to three cubs, and averaged 1.76 +/- 0.08 (SE) cubs/litter (95% CI = 1.61-1.91). Inter-birth intervals ranged from 1 to 4 years, and the mean value was estimated as 2.43 (95% CI = 2.16-2.76) and 2.53 (95% CI = 2.26-2.85) years in all litters and in litters that survived at least their first year, respectively. The reproductive rate was estimated from 0.70 to 0.76 young born/year/reproductive adult female, depending on the method of calculation. The cub survival rate between 0.5 and 1.5 years ranged from 60 to 73%. Most cub disappearances occurred in July and August, suggesting that cub mortality is mainly due to poor nutrition in the summer. All reproductive parameters observed in the Rusha area on the Shiretoko Peninsula fell within the range reported in Europe and North America, and were among the lowest or shortest age of primiparity, litter size, and inter-birth intervals, and ranked at a high level for reproductive rate.	[Shimozuru, Michito; Moriwaki, Jun; Mori, Fumihiko; Tsujino, Masakatsu; Shirane, Yuri; Tsubota, Toshio] Hokkaido Univ, Grad Sch Vet Med, Dept Environm Vet Sci, Sapporo, Hokkaido, Japan; [Yamanaka, Masami] Shiretoko Museum, Shari, Japan; [Nakanishi, Masanao; Ishinazaka, Tsuyoshi; Kasai, Shinsuke; Nose, Takane; Masuda, Yasushi] Shiretoko Nat Fdn, Shari, Japan	Hokkaido University	Shimozuru, M (corresponding author), Hokkaido Univ, Grad Sch Vet Med, Dept Environm Vet Sci, Sapporo, Hokkaido, Japan.	shimozuru@vetmed.hokudai.ac.jp			Mitsui & Co., Ltd. Environment Fund [R14-0026]; Daikin Industries, Ltd.	Mitsui & Co., Ltd. Environment Fund; Daikin Industries, Ltd.	This study was funded by The Mitsui & Co., Ltd. Environment Fund (MS received the funding, grant No. R14-0026, https://www.mitsui.com/jp/en/csr/contribution/environment/fund/index.html) and Daikin Industries, Ltd. (http://www.daikin.co.jp/csr/shiretoko/). The funders had no role in study design, data collection and analysis,	Bunnell FL, 1981, DYNAMICS LARGE MAMMA, P78; Clapham M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035404; Craighead J.J., 1995, GRIZZLY BEARS YELLOW; CRAIGHEAD JJ, 1976, INT C BEAR RES MAN, V3, P337; Dahle B, 2003, J MAMMAL, V84, P536, DOI 10.1644/1545-1542(2003)084<0536:FBIBBA>2.0.CO;2; EILER JH, 1989, J WILDLIFE MANAGE, V53, P353, DOI 10.2307/3801137; ELOWE KD, 1989, J WILDLIFE MANAGE, V53, P962, DOI 10.2307/3809596; Gardner CL, 2014, URSUS, V25, P121, DOI 10.2192/URSUS-D-14-00015.1; Garshelis DL, 2005, J WILDLIFE MANAGE, V69, P277, DOI 10.2193/0022-541X(2005)069<0277:GBDIAA>2.0.CO;2; Garshelis DL, 1998, URSUS-SERIES, V10, P437; Higashide D, 2012, J ZOOL, V288, P199, DOI 10.1111/j.1469-7998.2012.00942.x; Hilderbrand GV, 1999, CAN J ZOOL, V77, P132, DOI 10.1139/cjz-77-1-132; Hokkaido Government, 2017, BROWN BEAR MAN PLAN; HRDY SB, 1979, ETHOL SOCIOBIOL, V1, P13, DOI 10.1016/0162-3095(79)90004-9; Itoh T, 2013, ACTA THERIOL, V58, P127, DOI 10.1007/s13364-012-0095-8; Itoh T, 2009, J FOREST RES-JPN, V14, P117, DOI 10.1007/s10310-009-0110-3; King TR, 1944, J AGRIC RES, V69, P0033; Kohira M., 2006, WILDLIFE SHIRETOKO Y, P238; Kohira M, 2010, URSUS, V21, P192, DOI 10.2192/09SC030.1; Kohira M, 2009, URSUS, V20, P12, DOI 10.2192/1537-6176-20.1.12; Lopez-Alfaro C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128088; Mano T, 2002, J MAMMAL, V83, P1026, DOI 10.1644/1545-1542(2002)083<1026:RCOBBO>2.0.CO;2; MCLELLAN B, 1994, INT BEAR MS, P15; McLellan BN, 2005, URSUS, V16, P141, DOI 10.2192/1537-6176(2005)016[0141:SSIIGB]2.0.CO;2; MCLELLAN BN, 1989, CAN J ZOOL, V67, P1865, DOI 10.1139/z89-266; McLellan BN, 2015, J WILDLIFE MANAGE, V79, P749, DOI 10.1002/jwmg.896; Miller SD, 1988, IMPACTS INCREASED HU; Miller Sterling D., 2003, Ursus (Knoxville), V14, P130; Moriwaki J, 2016, URSUS, V27, P99, DOI 10.2192/URSUS-D-16-00005.1; Nawaz MA, 2008, BIOL CONSERV, V141, P2230, DOI 10.1016/j.biocon.2008.06.012; Odden M, 2014, OECOLOGIA, V175, P1, DOI 10.1007/s00442-014-2892-z; POLLOCK KH, 1989, J WILDLIFE MANAGE, V53, P7, DOI 10.2307/3801296; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Rogers L., 1976, 41 N AM WILDL NAT RE; Saether BE, 1998, OIKOS, V83, P403, DOI 10.2307/3546856; Sato Yoshikazu, 2004, Mammal Study, V29, P47, DOI 10.3106/mammalstudy.29.47; Schwartz C.C. S.D., 2003, WILD MAMMALS N AM BI, P556; Schwartz CC, 2006, WILDLIFE MONOGR, P1; Schwartz Charles C., 2003, Ursus (Knoxville), V14, P109; Sellers R.A., 1994, INT C BEAR RES MANAG, V9, P283, DOI [10.2307/3872712, DOI 10.2307/3872712]; Spady TJ, 2007, MAMMAL REV, V37, P21, DOI 10.1111/j.1365-2907.2007.00096.x; Steyaert SMJG, 2012, MAMMAL REV, V42, P12, DOI 10.1111/j.1365-2907.2011.00184.x; Stringham S. F., 1980, INT C BEAR RES MANAG, V4, P337; Stringham SF, 1990, BEARS THEIR BIOL MAN, V8, P433, DOI DOI 10.2307/3872948; Swenson JE, 2001, URSUS-SERIES, V12, P69; Swenson JE, 1997, NATURE, V386, P450, DOI 10.1038/386450a0; TSUBOTA T, 1990, INT C BEAR, V8, P125; Tsubota T, 1991, WILDLIFE CONSERVATIO, P214; Tsubota Toshio, 1993, Journal of Reproduction and Development, V39, P325, DOI 10.1262/jrd.39.325; Yamamoto K, 2002, J VET MED SCI, V64, P505, DOI 10.1292/jvms.64.505; Yokoyama Y, 2010, NIPPON SUISAN GAKK, V76, P383, DOI 10.2331/suisan.76.383; Zedrosser A, 2011, BIOL CONSERV, V144, P2163, DOI 10.1016/j.biocon.2011.05.005; Zedrosser A, 2009, OECOLOGIA, V160, P847, DOI 10.1007/s00442-009-1343-8	53	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176251	10.1371/journal.pone.0176251	http://dx.doi.org/10.1371/journal.pone.0176251			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441423	gold, Green Published, Green Submitted			2022-12-26	WOS:000400308800037
J	Dhiman, SS; Zhao, X; Li, JL; Kim, D; Kalia, VC; Kim, IW; Kim, JY; Lee, JK				Dhiman, Saurabh Sudha; Zhao, Xin; Li, Jinglin; Kim, Dongwook; Kalia, Vipin C.; Kim, In-Won; Kim, Jae Young; Lee, Jung-Kul			Metal accumulation by sunflower (Helianthus annuus L.) and the efficacy of its biomass in enzymatic saccharification	PLOS ONE			English	Article							ETHANOL-PRODUCTION; SUGAR YIELDS; HYDROLYSIS; PHYTOREMEDIATION; LIGNOCELLULASES; DETOXIFICATION; PRETREATMENT; STALKS; ACID; PHYTOEXTRACTION	Accumulation of metal contaminants in soil as a result of various industrial and anthropogenic activities has reduced soil fertility significantly. Phytoextraction of metal contaminants can improve soil fertility and provide inexpensive feedstock for biorefineries. We investigated the hyperaccumulation capacity of sunflower (Helianthus annuus) biomass by cultivating these plants in various concentrations of metal contaminants. Sunflowers were grown in soils contaminated with various levels of heavy metals (10-2,000 mg/kg dry soil). The degree of metal uptake by different parts of the biomass and the residual concentration in the soil were estimated through inductively coupled plasma mass spectrometry. An almost 2.5-fold hyperaccumulation of Zn2+ was observed in the leaf and flower biomass compared with the concentration in the soil. For the subsequent saccharification of biomass with hyperaccumulated contaminants, a fungal lignocellulosic consortium was used. The fungal consortium cocktail retained more than 95% filter paper activity with 100 mM Ni2+ ions even after 36 h. The highest saccharification yield (SY, 87.4%) was observed with Ni2+ as the contaminant (10 mg/kg dry wt), whereas Pb2+ (251.9 mg/kg dry wt) was the strongest inhibitor of biomass hydrolysis, resulting in only a 30% SY. Importantly, the enzyme cocktail produced by the fungal consortium resulted in almost the same SY (%) as that obtained from a combination of commercial cellulase and beta-glucosidase. Significant sugar conversion (61.7%) from H. annuus biomass hydrolysate occurred, resulting in the production of 11.4 g/L of bioethanol. This is the first study to assess the suitability of phytoremediated sunflower biomass for bioethanol production.	[Dhiman, Saurabh Sudha; Li, Jinglin; Kim, In-Won; Lee, Jung-Kul] Konkuk Univ, Dept Chem Engn, Seoul, South Korea; [Zhao, Xin; Kim, Jae Young] Seoul Natl Univ, Dept Civil & Environm Engn, Seoul, South Korea; [Kim, Dongwook] Phygen, Daejeon, South Korea; [Kalia, Vipin C.] Delhi Univ Campus, CSIR, IGIB, Mall Rd, Delhi, India	Konkuk University; Seoul National University (SNU); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Kim, IW; Lee, JK (corresponding author), Konkuk Univ, Dept Chem Engn, Seoul, South Korea.; Kim, JY (corresponding author), Seoul Natl Univ, Dept Civil & Environm Engn, Seoul, South Korea.	inwon@konkuk.ac.kr; jaeykim@snu.ac.kr; jkrhee@konkuk.ac.kr	Lee, Jungkukl/D-9104-2011	Zhao, Xin/0000-0002-9580-5092; Dhiman, Saurabh/0000-0001-8727-2946	Korea Ministry of Environment as GAIA Project [G112-00055-0023-0]; Energy Efficiency & Resources Core Technology Program of the KETEP [20153010092130, 20153030091450]	Korea Ministry of Environment as GAIA Project(Ministry of Environment (ME), Republic of Korea); Energy Efficiency & Resources Core Technology Program of the KETEP	This research was supported by Korea Ministry of Environment as GAIA Project (G112-00055-0023-0). This study was also supported by the Energy Efficiency & Resources Core Technology Program of the KETEP (20153010092130 and 20153030091450). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesodun JK, 2010, WATER AIR SOIL POLL, V207, P195, DOI 10.1007/s11270-009-0128-3; Alkorta I., 2004, Reviews in Environmental Science and Bio/Technology, V3, P71, DOI 10.1023/B:RESB.0000040059.70899.3d; Amna, 2015, INT J PHYTOREMEDIAT, V17, P981, DOI 10.1080/15226514.2014.989311; An J, 2012, J HAZARD MATER, V203, P69, DOI 10.1016/j.jhazmat.2011.11.085; [Anonymous], 1992, J AM OIL CHEM SOC, V69, P890; Camargo D, 2014, BIOPROC BIOSYST ENG, V37, P2235, DOI 10.1007/s00449-014-1201-x; Cantarella M, 2004, PROCESS BIOCHEM, V39, P1533, DOI 10.1016/S0032-9592(03)00285-1; Chandel AK, 2007, BIORESOURCE TECHNOL, V98, P1947, DOI 10.1016/j.biortech.2006.07.047; Dashtban M, 2009, INT J BIOL SCI, V5, P578, DOI 10.7150/ijbs.5.578; Dhiman SS, 2016, FUEL, V183, P107, DOI 10.1016/j.fuel.2016.06.025; Dhiman SS, 2015, BIORESOURCE TECHNOL, V179, P50, DOI 10.1016/j.biortech.2014.11.059; Dhiman SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102581; Dhiman SS, 2013, APPL MICROBIOL BIOT, V97, P1081, DOI 10.1007/s00253-012-4381-9; Gaur R, 2015, INT J POLYM SCI, V2015, DOI 10.1155/2015/986324; Guo B, 2007, ENVIRON POLLUT, V147, P743, DOI 10.1016/j.envpol.2006.09.007; Hu JG, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-112; Jagtap SS, 2013, BIORESOURCE TECHNOL, V133, P307, DOI 10.1016/j.biortech.2013.01.118; Jagtap SS, 2012, BIORESOURCE TECHNOL, V120, P264, DOI 10.1016/j.biortech.2012.06.002; Jeya M, 2012, BIORESOURCE TECHNOL, V117, P310, DOI 10.1016/j.biortech.2012.03.047; Jung CD, 2013, BIORESOURCE TECHNOL, V138, P1, DOI 10.1016/j.biortech.2013.03.033; Jurado M, 2009, BIORESOURCE TECHNOL, V100, P6378, DOI 10.1016/j.biortech.2009.07.049; Krgovic R, 2015, ENVIRON SCI POLLUT R, V22, P10506, DOI 10.1007/s11356-015-4192-5; Lin CC, 2009, ENVIRON EXP BOT, V65, P410, DOI 10.1016/j.envexpbot.2008.12.003; Liu DZ, 2007, J ANTIBIOT, V60, P332, DOI 10.1038/ja.2007.44; Lopes CA, 2015, ECOTOX ENVIRON SAFE, V119, P170, DOI 10.1016/j.ecoenv.2015.05.016; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Pilanee Vaithanomsat SC, 2009, ENG TECHNOLOGY, V3, P4; Ramachandran P, 2015, BIOPROC BIOSYST ENG, V38, P1645, DOI 10.1007/s00449-015-1406-7; Ruiz E, 2008, ENZYME MICROB TECH, V42, P160, DOI 10.1016/j.enzmictec.2007.09.002; Ruiz E, 2006, APPL BIOCHEM BIOTECH, V130, P631, DOI 10.1385/ABAB:130:1:631; Sharma SK, 2004, BIOMASS BIOENERG, V27, P399, DOI 10.1016/j.biombioe.2004.03.005; Sharma SK, 2002, BIOMASS BIOENERG, V23, P237, DOI 10.1016/S0961-9534(02)00050-8; Singleton V L, 1969, Adv Food Res Suppl, V1, P1; Sluiter A, 2008, DETERMINATION STRUCT, DOI DOI 10.3390/POLYM2040728; Tandjung AS, 2005, BIOMACROMOLECULES, V6, P1654, DOI 10.1021/bm049220l; Taniguchi M, 2005, J BIOSCI BIOENG, V100, P637, DOI 10.1263/jbb.100.637; Tejirian A, 2010, APPL ENVIRON MICROB, V76, P7673, DOI 10.1128/AEM.01376-10; Turgut C, 2004, ENVIRON POLLUT, V131, P147, DOI 10.1016/j.envpol.2004.01.017; Ullah R, 2011, AFR J BIOTECHNOL, V10, P17192, DOI 10.5897/AJB11.1832; Valls C, 2010, J HAZARD MATER, V177, P586, DOI 10.1016/j.jhazmat.2009.12.073; van der Ent A, 2015, J CHEM ECOL, V41, P396, DOI 10.1007/s10886-015-0573-y; VANASSCHE F, 1990, PLANT CELL ENVIRON, V13, P195, DOI 10.1111/j.1365-3040.1990.tb01304.x; Vintila T, 2016, J CHEM TECHNOL BIOT, V91, P1607, DOI 10.1002/jctb.4902; Yang HP, 2007, FUEL, V86, P1781, DOI 10.1016/j.fuel.2006.12.013; Zeng Rong, 2016, Bioengineering-Basel, V3, P13, DOI 10.3390/bioengineering3020013	45	25	26	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0175845	10.1371/journal.pone.0175845	http://dx.doi.org/10.1371/journal.pone.0175845			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437478	Green Published, gold, Green Submitted			2022-12-26	WOS:000400287600015
J	Oke, TA; Hager, HA				Oke, Tobi A.; Hager, Heather A.			Assessing environmental attributes and effects of climate change on Sphagnum peatland distributions in North America using single- and multi-species models	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; DOMINATED PEATLANDS; WATER-BALANCE; CARBON ACCUMULATION; DECOMPOSITION; PHOTOSYNTHESIS; DYNAMICS; PATTERNS; MAXIMUM; GROWTH	The fate of Northern peatlands under climate change is important because of their contribution to global carbon (C) storage. Peatlands are maintained via greater plant productivity (especially of Sphagnum species) than decomposition, and the processes involved are strongly mediated by climate. Although some studies predict that warming will relax constraints on decomposition, leading to decreased C sequestration, others predict increases in productivity and thus increases in C sequestration. We explored the lack of congruence between these predictions using single-species and integrated species distribution models as proxies for understanding the environmental correlates of North American Sphagnum peatland occurrence and how projected changes to the environment might influence these peatlands under climate change. Using Maximum entropy and BIOMOD modelling platforms, we generated single and integrated species distribution models for four common Sphagnum species in North America under current climate and a 2050 climate scenario projected by three general circulation models. We evaluated the environmental correlates of the models and explored the disparities in niche breadth, niche overlap, and climate suitability among current and future models. The models consistently show that Sphagnum peatland distribution is influenced by the balance between soil moisture deficit and temperature of the driest quarter-year. The models identify the east and west coasts of North America as the core climate space for Sphagnum peatland distribution. The models show that, at least in the immediate future, the area of suitable climate for Sphagnum peatland could expand. This result suggests that projected warming would be balanced effectively by the anticipated increase in precipitation, which would increase Sphagnum productivity.	[Oke, Tobi A.; Hager, Heather A.] Univ Guelph, Dept Integrat Biol, Guelph, ON, Canada	University of Guelph	Oke, TA (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON, Canada.	ooke@uoguelph.ca	Hager, Heather/A-2984-2014	Hager, Heather/0000-0002-0066-6844				Aerts R, 1999, ECOLOGY, V80, P2170, DOI 10.1890/0012-9658(1999)080[2170:PMCONC]2.0.CO;2; ANDRUS RE, 1986, CAN J BOT, V64, P416, DOI 10.1139/b86-057; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; BROCCOLI AJ, 1992, J CLIMATE, V5, P1181, DOI 10.1175/1520-0442(1992)005<1181:TEOOOM>2.0.CO;2; Charman D., 2002, Peatlands and environmental change; Charman DJ, 2013, BIOGEOSCIENCES, V10, P929, DOI 10.5194/bg-10-929-2013; Charman DJ, 2007, HOLOCENE, V17, P217, DOI 10.1177/0959683607075836; Charman DJ, 2015, QUATERNARY SCI REV, V121, P110, DOI 10.1016/j.quascirev.2015.05.012; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Dorrepaal E, 2009, NATURE, V460, P616, DOI 10.1038/nature08216; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elumeeva TG, 2011, J VEG SCI, V22, P152, DOI 10.1111/j.1654-1103.2010.01237.x; Engler R, 2011, GLOBAL CHANGE BIOL, V17, P2330, DOI 10.1111/j.1365-2486.2010.02393.x; Freeman C, 2004, SOIL BIOL BIOCHEM, V36, P1663, DOI 10.1016/j.soilbio.2004.07.012; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Frolking S, 2010, EARTH SYST DYNAM, V1, P1, DOI 10.5194/esd-1-1-2010; Gajewski K, 2001, GLOBAL BIOGEOCHEM CY, V15, P297, DOI 10.1029/2000GB001286; Gignac L, 1993, ADV BRYOLOGY, V5, P187; Gignac LD, 2000, J BIOGEOGR, V27, P1139, DOI 10.1046/j.1365-2699.2000.00458.x; GLIME JM, 1982, AM MIDL NAT, V108, P209, DOI 10.2307/2425482; Gorham E, 2007, QUATERNARY SCI REV, V26, P300, DOI 10.1016/j.quascirev.2006.08.008; Gunnarsson U, 2005, J BRYOL, V27, P269, DOI 10.1179/174328205X70029; Hager HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100032; Hajek T, 2008, ANN BOT-LONDON, V101, P165, DOI 10.1093/aob/mcm287; Hajkova P, 2007, J BRYOL, V29, P18, DOI 10.1179/174328207X160577; Halsey L, 1997, WETLANDS, V17, P243, DOI 10.1007/BF03161413; Halsey LA, 2000, BRYOLOGIST, V103, P334, DOI 10.1639/0007-2745(2000)103[0334:SDPINA]2.0.CO;2; HASTIE T, 1994, J AM STAT ASSOC, V89, P1255, DOI 10.2307/2290989; Hayward, 1982, BRYOPHYTE ECOLOGY, P229, DOI DOI 10.1007/978-94-009-5891-3_8; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Ise T, 2008, NAT GEOSCI, V1, P763, DOI 10.1038/ngeo331; JENKINSON DS, 1991, NATURE, V351, P304, DOI 10.1038/351304a0; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3; Lang SI, 2009, J ECOL, V97, P299, DOI 10.1111/j.1365-2745.2008.01472.x; Lavoie M, 2004, ENVIRON REV, V13, P21; LI YH, 1991, CAN J BOT, V69, P2643, DOI 10.1139/b91-331; Limpens J, 2008, BIOGEOSCIENCES, V5, P1475, DOI 10.5194/bg-5-1475-2008; Loisel J, 2012, BIOGEOSCIENCES, V9, P2737, DOI 10.5194/bg-9-2737-2012; Loisel J., 2012, Biogeosciences, V9, P2737, DOI 10.5194/bg-9-2737-2012; MacDonald GM, 2006, SCIENCE, V314, P285, DOI 10.1126/science.1131722; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Oke OA, 2014, ECOGRAPHY, V37, P614, DOI 10.1111/j.1600-0587.2013.00459.x; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Platts PJ, 2013, ECOGRAPHY, V36, P518, DOI 10.1111/j.1600-0587.2012.07805.x; Rasmussen S., 1994, ACTA HORTIC, P243; ROCHEFORT L, 1990, ECOLOGY, V71, P1986, DOI 10.2307/1937607; Rydin H, 2006; Rydin Hakan, 2006, V188, P47; Schipperges B, 1998, NEW PHYTOL, V140, P677, DOI 10.1046/j.1469-8137.1998.00311.x; Skrzypek G, 2008, GEOCHEM J, V42, P481, DOI 10.2343/geochemj.42.481; Slatyer RA, 2013, ECOL LETT, V16, P1104, DOI 10.1111/ele.12140; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Thuiller W., 2014, PACKAGE BIOMOD2 ENSE; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; TITUS JE, 1984, ECOLOGY, V65, P1765, DOI 10.2307/1937772; TITUS JE, 1983, ECOLOGY, V64, P1109, DOI 10.2307/1937821; Trabucco A, 2008, AGR ECOSYST ENVIRON, V126, P81, DOI 10.1016/j.agee.2008.01.015; VANBREEMEN N, 1995, TRENDS ECOL EVOL, V10, P270, DOI 10.1016/0169-5347(95)90007-1; Vitt DH, 2000, CAN J EARTH SCI, V37, P683, DOI 10.1139/e99-097; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Yu ZC, 2009, GEOPHYS MONOGR SER, V184, P55, DOI 10.1029/2008GM000822; Zoltai SC, 1996, NATO ASI SER SER I, V40, P47	67	17	18	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175978	10.1371/journal.pone.0175978	http://dx.doi.org/10.1371/journal.pone.0175978			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426754	Green Submitted, gold, Green Published			2022-12-26	WOS:000399875900080
J	Sterbenc, A; Hosnjak, L; Chouhy, D; Bolatti, EM; Ostrbenk, A; Seme, K; Kocjan, BJ; Luzar, B; Giri, AA; Poljak, M				Sterbenc, Anja; Hosnjak, Lea; Chouhy, Diego; Bolatti, Elisa M.; Ostrbenk, Anja; Seme, Katja; Kocjan, Bostjan J.; Luzar, Bostjan; Giri, Adriana A.; Poljak, Mario			Molecular characterization, tissue tropism, and genetic variability of the novel Mupapillomavirus type HPV204 and phylogenetically related types HPV1 and HPV63	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPES; GAMMAPAPILLOMAVIRUS GENERA; VIRAL REPLICATION; CUTANEOUS WARTS; CELL CARCINOMA; NORMAL SKIN; DNA; PROTEIN; INFECTION; E1	HPV204 is the only newly identified Mupapillomavirus (Mu-PV) type in more than a decade. To comprehensively characterize HPV204, we performed a detailed molecular analysis of the viral genome and evaluated its clinical relevance in comparison to the other Mu-PVs, HPV1 and HPV63. The 7,227-bp long genome of HPV204 exhibits typical genomic organization of Mu-PVs with eight open reading frames (ORFs) (E6, E7, E1, E2, E8, E4, L2, and L1). We developed three type-specific quantitative real-time PCRs and used them to test a representative collection (n = 1,006) of various HPV-associated benign and malignant neoplasms, as well as samples of clinically normal cutaneous, mucosal, and mucocutaneous origins. HPV204, HPV1, and HPV63 were detected in 1.1%, 2.7%, and 1.9% of samples tested, respectively, and were present in skin and mucosa, suggesting dual tissue tropism of all Mu-PVs. To evaluate the etiological role of Mu-PVs in the development of HPV-associated neoplasms, Mu-PV viral loads per single cell were estimated. HPV1 and HPV63 were present in high viral copy numbers in 3/43 and 1/43 cutaneous warts, respectively, and were identified as the most likely causative agents of these warts. HPV204 viral load was extremely low in a single HPV204-positive cutaneous wart (7.4 x 10(-7) viral copies/cell). Hence, etiological association between HPV204 and the development of cutaneous warts could not be established. To the best of our knowledge, this is the first study to evaluate the genetic variability of Mu-PVs by sequencing complete LCR genomic regions of HPV204, HPV1, and HPV63. We detected several nucleotide substitutions and deletions within the LCR genomic regions of Mu-PVs and identified two genetic variants of HPV204 and HPV63 and five genetic variants of HPV1.	[Sterbenc, Anja; Hosnjak, Lea; Ostrbenk, Anja; Seme, Katja; Kocjan, Bostjan J.; Poljak, Mario] Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia; [Chouhy, Diego; Bolatti, Elisa M.; Giri, Adriana A.] Rosario Natl Univ, Sch Biochem & Pharmaceut Sci, Virol Area, Rosario, Santa Fe, Argentina; [Luzar, Bostjan] Univ Ljubljana, Fac Med, Inst Pathol, Ljubljana, Slovenia	University of Ljubljana; National University of Rosario; University of Ljubljana	Poljak, M (corresponding author), Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia.	mario.poljak@mf.uni-lj.si	Luzar, Bostjan/ACR-4860-2022; Bolatti, Elisa/AAH-7486-2021; Giri, Adriana/GLU-6290-2022; luzar, bostjan/AGY-8991-2022	luzar, bostjan/0000-0003-2534-8671; Bolatti, Elisa/0000-0001-6467-0650	Slovenian Research Agency (ARRS); Slovenian-Argentinian Bilateral Project [BI-AR-15-17-005]; CoheaHr Project (European Commission FP7 Program) [603019]; Young Researcher Training Program	Slovenian Research Agency (ARRS)(Slovenian Research Agency - Slovenia); Slovenian-Argentinian Bilateral Project; CoheaHr Project (European Commission FP7 Program); Young Researcher Training Program	This study is a result of doctoral research and is financially supported by the Slovenian Research Agency (ARRS), which funded AS through the Young Researcher Training Program, and in part by the Slovenian-Argentinian Bilateral Project BI-AR-15-17-005. In addition, LH, AO, and MP obtained funding through the CoheaHr Project (European Commission FP7 Program, grant number: 603019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergvall M, 2013, VIROLOGY, V445, P35, DOI 10.1016/j.virol.2013.07.020; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bernard HU, 2005, J CLIN VIROL, V32, pS1, DOI 10.1016/j.jcv.2004.10.021; Bolatti EM, 2016, INFECT GENET EVOL, V42, P20, DOI 10.1016/j.meegid.2016.04.018; Bornberg-Bauer E, 1998, NUCLEIC ACIDS RES, V26, P2740, DOI 10.1093/nar/26.11.2740; Bottalico D, 2011, J INFECT DIS, V204, P787, DOI 10.1093/infdis/jir383; Bronnimann MP, 2013, J VIROL, V87, P464, DOI 10.1128/JVI.01539-12; Bruggink SC, 2012, J CLIN VIROL, V55, P250, DOI 10.1016/j.jcv.2012.07.014; Burk Robert D, 2011, Acta Dermatovenerol Alp Pannonica Adriat, V20, P113; Burk RD, 2013, VIROLOGY, V445, P232, DOI 10.1016/j.virol.2013.07.018; Bzhalava D, 2015, VIROLOGY, V476, P341, DOI 10.1016/j.virol.2014.12.028; Chen G, 2002, MOL CELL BIOL, V22, P7712, DOI 10.1128/MCB.22.21.7712-7720.2002; Chouhy D, 2010, VIROLOGY, V397, P205, DOI 10.1016/j.virol.2009.11.020; Cubie HA, 2013, VIROLOGY, V445, P21, DOI 10.1016/j.virol.2013.06.007; DANOS O, 1980, EUR J BIOCHEM, V109, P457, DOI 10.1111/j.1432-1033.1980.tb04815.x; DANOS O, 1982, EMBO J, V1, P231, DOI 10.1002/j.1460-2075.1982.tb01152.x; Daugaard I, 2015, EXP MOL PATHOL, V99, P632, DOI 10.1016/j.yexmp.2015.11.007; de Koning MNC, 2015, BRIT J DERMATOL, V172, P196, DOI 10.1111/bjd.13216; de Villiers EM, 2013, VIROLOGY, V445, P2, DOI 10.1016/j.virol.2013.04.023; Deng WT, 2004, J VIROL, V78, P13954, DOI 10.1128/JVI.78.24.13954-13965.2004; Doorbar J., 1996, HUMAN PAPILLOMAVIRUS, P58; Dreer M, 2017, VIRUS RES, V231, P96, DOI 10.1016/j.virusres.2016.11.005; Dreer M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005556; EGAWA K, 1993, VIROLOGY, V194, P789, DOI 10.1006/viro.1993.1320; Egawa K, 2005, BRIT J DERMATOL, V152, P993, DOI 10.1111/j.1365-2133.2005.06390.x; Egawa N, 2015, VIRUSES-BASEL, V7, P3863, DOI 10.3390/v7072802; Favre M, 1998, J INVEST DERMATOL, V110, P311, DOI 10.1046/j.1523-1747.1998.00164.x; Forslund O, 2003, J VIROL METHODS, V110, P129, DOI 10.1016/S0166-0934(03)00109-5; Forslund O, 1999, J GEN VIROL, V80, P2437, DOI 10.1099/0022-1317-80-9-2437; Forslund O, 2013, J INFECT DIS, V208, P1335, DOI 10.1093/infdis/jit326; Fradet-Turcotte A, 2010, J VIROL, V84, P11747, DOI 10.1128/JVI.01445-10; Hawkins MG, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-137; Hazard K, 2006, INT J CANCER, V119, P1073, DOI 10.1002/ijc.21920; HEILMAN CA, 1980, J VIROL, V36, P395, DOI 10.1128/JVI.36.2.395-407.1980; Hosnjak L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119154; Iannacone MR, 2013, J INVEST DERMATOL, V133, P1512, DOI 10.1038/jid.2012.478; Johansson C, 2013, NAT REV MICROBIOL, V11, P239, DOI 10.1038/nrmicro2984; Kalantari M, 2009, VIROLOGY, V390, P261, DOI 10.1016/j.virol.2009.05.006; Kocjan BJ, 2015, CLIN MICROBIOL INFEC, V21, P808, DOI 10.1016/j.cmi.2015.05.011; Kocjan BJ, 2015, ACTA DERMATOVEN ALP, V24, P21, DOI 10.15570/actaapa.2015.7; Kohler A, 2009, BRIT J DERMATOL, V161, P528, DOI 10.1111/j.1365-2133.2009.09297.x; Kovanda A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022414; Lacey CJN, 2005, J CLIN VIROL, V32, pS82, DOI 10.1016/j.jcv.2004.10.020; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lee TY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S1-S3; Lipari F, 2001, BIOCHEMISTRY-US, V40, P1196, DOI 10.1021/bi001837+; Liu ZJ, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0583-6; Ma TL, 1999, P NATL ACAD SCI USA, V96, P382, DOI 10.1073/pnas.96.2.382; Ma YF, 2014, J VIROL, V88, P4786, DOI 10.1128/JVI.00093-14; Mantovani F, 2001, ONCOGENE, V20, P7874, DOI 10.1038/sj.onc.1204869; McLaughlin-Drubin ME, 2009, VIROLOGY, V384, P335, DOI 10.1016/j.virol.2008.10.006; Mischo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062584; Mlakar J, 2015, BRIT J OPHTHALMOL, V99, P431, DOI 10.1136/bjophthalmol-2014-306087; Neale RE, 2013, CANCER EPIDEM BIOMAR, V22, P719, DOI 10.1158/1055-9965.EPI-12-0917-T; O'Connor M, 1995, HUMAN PAPILLOMAVIRUS, pIII21; Ostrbenk A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138628; Prescott EL, 2014, J VIROL, V88, P12599, DOI 10.1128/JVI.02029-14; Schneider I, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-186; Straub E, 2014, J VIROL, V88, P937, DOI 10.1128/JVI.02296-13; Titolo S, 1999, J VIROL, V73, P5282, DOI 10.1128/JVI.73.7.5282-5293.1999; Ure AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089342; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Wang JW, 2013, VIROLOGY, V445, P175, DOI 10.1016/j.virol.2013.04.017	63	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175892	10.1371/journal.pone.0175892	http://dx.doi.org/10.1371/journal.pone.0175892			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426749	Green Published, gold			2022-12-26	WOS:000399875900065
J	Bedi, B; Maurice, NM; Ciavatta, VT; Lynn, KS; Yuan, ZH; Molina, SA; Joo, M; Tyor, WR; Goldberg, JB; Koval, M; Hart, CM; Sadikot, RT				Bedi, Brahmchetna; Maurice, Nicholas M.; Ciavatta, Vincent T.; Lynn, K. Sabrina; Yuan, Zhihong; Molina, Samuel A.; Joo, Myungsoo; Tyor, William R.; Goldberg, Joanna B.; Koval, Michael; Hart, C. Michael; Sadikot, Ruxana T.			Peroxisome proliferator-activated receptor-gamma agonists attenuate biofilm formation by Pseudomonas aeruginosa	FASEB JOURNAL			English	Article						Pseudomonas aeruginosa; biofilms; PPAR gamma; lung epithelium	KAPPA-B ACTIVATION; PPAR-GAMMA; EPITHELIAL-CELLS; HOST-DEFENSE; EXPRESSION; INFLAMMATION; INDUCTION; PATHWAY; ROLES; CYCLOOXYGENASE-2	Pseudomonas aeruginosa is a significant contributor to recalcitrant multidrug-resistant infections, especially in immunocompromised and hospitalized patients. The pathogenic profile of P. aeruginosa is related to its ability to secrete a variety of virulence factors and to promote biofilm formation. Quorum sensing (QS) is a mechanism where in P. aeruginosa secretes small diffusible molecules, specifically acyl homo serine lactones, such as N-(3-oxo-dodecanoyl)l-homoserine lactone (3O-C12-HSL), that promote biofilm formation and virulence via interbacterial communication. Strategies that strengthen the host's ability to inhibit bacterial virulence would enhance host defenses and improve the treatment of resistant infections. We have recently shown that peroxisome proliferator-activated receptor gamma (PPAR gamma) agonists are potent immunostimulators that play a pivotal role in host response to virulent P. aeruginosa. Here, we show that QS genes in P. aeruginosa (strain PAO1) and 3O-C12-HSL attenuate PPAR gamma expression in bronchial epithelial cells. PAO1 and 3O-C12-HSL induce barrier derangements in bronchial epithelial cells by lowering the expression of junctional proteins, such as zonula occludens-1, occludin, and claudin-4. Expression of these proteins was restored in cells that were treated with pioglitazone, a PPAR gamma agonist, before infection with PAO1 and 3O-C12-HSL. Barrier function and bacterial permeation studies that have been performed in primary human epithelial cells showed that PPAR gamma agonists are able to restore barrier integrity and function that are disrupted by PAO1 and 3O-C12-HSL. Mechanistically, we show that these effects are dependent on the induction of paraoxonase-2, a QS hydrolyzing enzyme, that mitigates the effects of QS molecules. Importantly, our data show that pioglitazone, a PPAR gamma agonist, significantly inhibits biofilm formation on epithelial cells by a mechanism that is mediated via paraoxonase-2. These findings elucidate a novel role for PPAR gamma in host defense against P. aeruginosa. Strategies that activate PPAR gamma can provide a therapeutic complement for treatment of resistant P. aeruginosa infections.	[Bedi, Brahmchetna; Maurice, Nicholas M.; Ciavatta, Vincent T.; Yuan, Zhihong; Tyor, William R.; Hart, C. Michael; Sadikot, Ruxana T.] Atlanta Vet Affairs Med Ctr, Decatur, GA USA; [Bedi, Brahmchetna; Maurice, Nicholas M.; Lynn, K. Sabrina; Yuan, Zhihong; Molina, Samuel A.; Koval, Michael; Hart, C. Michael; Sadikot, Ruxana T.] Emory Univ, Div Pulm Allergy Crit Care & Sleep Med, Atlanta, GA 30322 USA; [Ciavatta, Vincent T.] Emory Univ, Dept Ophthalmol, Atlanta, GA 30322 USA; [Tyor, William R.] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA; [Goldberg, Joanna B.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Koval, Michael] Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA; [Koval, Michael] Emory Univ, Emory Childrens Ctr Cyst Fibrosis & Airway Dis Re, Atlanta, GA 30322 USA; [Joo, Myungsoo] Pusan Univ, Dept Immunol, Yangsan, South Korea	US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Emory University; Emory University; Emory University; Emory University; Emory University; Emory University; Pusan National University; Pusan National University Hospital	Sadikot, RT (corresponding author), Emory Univ, Atlanta Vet Affairs Med Ctr, Div Pulm Allergy Crit Care & Sleep Med, 1670 Clairmont Rd, Decatur, GA 30033 USA.	ruxana.sadikot@emory.edu	Koval, Michael/C-6366-2015	Koval, Michael/0000-0002-5422-5614; Yuan, Zhihong/0000-0002-2300-0463	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [R01-HL116958]; U.S. Veterans Health Administration Merit Award [5I01BX001786-05]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116958, R01HL102167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008367] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001786] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); U.S. Veterans Health Administration Merit Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	Cells were provided by the CF@LANTA RDP Experimental Models Core (CF@LANTA RDP Center Grant MCCART15R0) as part of the Emory Children's Center for Cystic Fibrosis and Airways Disease Research. M.K. was supported by U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grant R01-HL116958. B.B., Z.Y., N.M.M. and R.T.S. were supported by U.S. Veterans Health Administration Merit Award: 5I01BX001786-05.	Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Bedi B, 2016, INFECT IMMUN, V84, P1975, DOI 10.1128/IAI.00164-16; Camp HS, 1999, ENDOCRINOLOGY, V140, P392, DOI 10.1210/en.140.1.392; Chen SM, 2008, CLIN EXP IMMUNOL, V153, P420, DOI 10.1111/j.1365-2249.2008.03707.x; Cho HY, 2010, AM J RESP CRIT CARE, V182, P170, DOI 10.1164/rccm.200907-1047OC; Corzo C, 2013, DIABETES METAB J, V37, P395, DOI 10.4093/dmj.2013.37.6.395; Coste A, 2008, J IMMUNOL, V180, P4939, DOI 10.4049/jimmunol.180.7.4939; Cummins PM, 2012, MOL CELL BIOL, V32, P242, DOI 10.1128/MCB.06029-11; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; Daynes RA, 2002, NAT REV IMMUNOL, V2, P748, DOI 10.1038/nri912; de Kievit TR, 2009, ENVIRON MICROBIOL, V11, P279, DOI 10.1111/j.1462-2920.2008.01792.x; De Paula Rogerio A., 2015, BIOMED RES, V2015; Dekkers JF, 2012, TRENDS MOL MED, V18, P283, DOI 10.1016/j.molmed.2012.03.004; Devarajan A, 2013, MOL GENET METAB, V110, P362, DOI 10.1016/j.ymgme.2013.07.003; Fan X, 2011, ALCOHOL CLIN EXP RES, V35, P1866, DOI 10.1111/j.1530-0277.2011.01531.x; Fanning AS, 2012, MOL BIOL CELL, V23, P577, DOI 10.1091/mbc.E11-09-0791; Floyd ZE, 2004, OBES RES, V12, P921, DOI 10.1038/oby.2004.112; Fricks-Lima J, 2011, INT J ANTIMICROB AG, V37, P309, DOI 10.1016/j.ijantimicag.2010.12.017; Gautier EL, 2012, J IMMUNOL, V189, P2614, DOI 10.4049/jimmunol.1200495; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; Hendricks MR, 2016, P NATL ACAD SCI USA, V113, P1642, DOI 10.1073/pnas.1516979113; Higgins G, 2016, AM J PHYSIOL-LUNG C, V310, pL1053, DOI 10.1152/ajplung.00368.2015; Horke S, 2015, INFECT IMMUN, V83, P3369, DOI 10.1128/IAI.00141-15; Jennewein C, 2010, J BIOL CHEM, V285, P11846, DOI 10.1074/jbc.M109.066399; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Joo M, 2007, J IMMUNOL, V179, P2565, DOI 10.4049/jimmunol.179.4.2565; Kleinhenz JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139756; Kojima T, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/947072; Koval M, 2013, ANNU REV PHYSIOL, V75, P551, DOI 10.1146/annurev-physiol-030212-183809; Lakshmi SP, 2014, J BIOL CHEM, V289, P6383, DOI 10.1074/jbc.M113.536805; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Liu YR, 2011, J EXP MED, V208, P1473, DOI 10.1084/jem.20102041; Losa D, 2015, AM J RESP CELL MOL, V53, P265, DOI 10.1165/rcmb.2014-0405OC; Lu XH, 2013, FREE RADICAL BIO MED, V63, P151, DOI 10.1016/j.freeradbiomed.2013.05.013; Lu XH, 2010, AM J PHYSIOL-LUNG C, V299, pL559, DOI 10.1152/ajplung.00090.2010; Molina SA, 2015, AM J PHYSIOL-LUNG C, V309, pL475, DOI 10.1152/ajplung.00060.2015; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Ogasawara N, 2010, PHARMACOL RES, V61, P489, DOI 10.1016/j.phrs.2010.03.002; Park GY, 2007, CLIN EXP IMMUNOL, V150, P245, DOI 10.1111/j.1365-2249.2007.03478.x; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; PETERSEN NT, 1981, ACTA PAEDIATR SCAND, V70, P623, DOI 10.1111/j.1651-2227.1981.tb05757.x; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Rasamiravaka T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/759348; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; Sadikot RT, 2004, J IMMUNOL, V172, P1801, DOI 10.4049/jimmunol.172.3.1801; Sadikot RT, 2003, J IMMUNOL, V170, P1091, DOI 10.4049/jimmunol.170.2.1091; Sadikot RT, 2001, AM J RESP CRIT CARE, V164, P873, DOI 10.1164/ajrccm.164.5.2008059; Sadikot RT, 2007, EUR J IMMUNOL, V37, P1001, DOI 10.1002/eji.200636636; Sadikot RT, 2006, J IMMUNOL, V176, P4923, DOI 10.4049/jimmunol.176.8.4923; Schlingmann B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12276; SCHNEEBERGER EE, 1992, AM J PHYSIOL, V262, pL647, DOI 10.1152/ajplung.1992.262.6.L647; Shiner M, 2007, ATHEROSCLEROSIS, V195, P313, DOI 10.1016/j.atherosclerosis.2007.01.007; Simet SM, 2012, ALCOHOL CLIN EXP RES, V36, P432, DOI 10.1111/j.1530-0277.2011.01640.x; Singh PK, 2002, NATURE, V417, P552, DOI 10.1038/417552a; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Stoltz DA, 2007, AM J PHYSIOL-LUNG C, V292, pL852, DOI 10.1152/ajplung.00370.2006; Syed MA, 2010, EXP CELL RES, V316, P3140, DOI 10.1016/j.yexcr.2010.08.009; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; van Beekum O, 2009, OBESITY, V17, P213, DOI 10.1038/oby.2008.473; Van Delden C, 1998, EMERG INFECT DIS, V4, P551, DOI 10.3201/eid0404.980405; Vikstrom E, 2010, EUR J CELL BIOL, V89, P584, DOI 10.1016/j.ejcb.2010.03.002; Wahjudi M, 2011, MICROBIOL-SGM, V157, P2042, DOI 10.1099/mic.0.043935-0; Walker TS, 2005, INFECT IMMUN, V73, P3693, DOI 10.1128/IAI.73.6.3693-3701.2005; Yamashita D, 2004, GENES CELLS, V9, P1017, DOI 10.1111/j.1365-2443.2004.00786.x; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Yuan ZH, 2017, SCI REP-UK, V7, DOI 10.1038/srep42028; Yuan ZH, 2013, J IMMUNOL, V191, P3810, DOI 10.4049/jimmunol.1300883; Zhang LJ, 2015, SCIENCE, V347, P67, DOI 10.1126/science.1260972	70	22	22	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3608	3621		10.1096/fj.201700075R	http://dx.doi.org/10.1096/fj.201700075R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28442545	Green Published			2022-12-26	WOS:000405932400033
J	Reiman, M; Laan, M; Rull, K; Sober, S				Reiman, Mario; Laan, Maris; Rull, Kristiina; Sober, Siim			Effects of RNA integrity on transcript quantification by total RNA sequencing of clinically collected human placental samples	FASEB JOURNAL			English	Article						RNA-Seq; RNA degradation; RIN; gene expression	FACTOR-BINDING PROTEIN-1; MESSENGER-RNA; GENE-EXPRESSION; MICROARRAY ANALYSIS; GENOME-WIDE; QUALITY; SEQ; PROFILE; SITE	RNA degradation is a ubiquitous process that occurs in living and dead cells, as well as during handling and storage of extracted RNA. Reduced RNA quality caused by degradation is an established source of uncertainty for all RNA-based gene expression quantification techniques. RNA sequencing is an increasingly preferred method for transcriptome analyses, and dependence of its results on input RNA integrity is of significant practical importance. This study aimed to characterize the effects of varying input RNA integrity [estimated as RNA integrity number (RIN)] on transcript level estimates and delineate the characteristic differences between transcripts that differ in degradation rate. The study used ribodepleted total RNA sequencing data from a real-life clinically collected set (n=32) of human solid tissue (placenta) samples. RIN-dependent alterations in gene expression profiles were quantified by using DESeq2 software. Our results indicate that small differences in RNA integrity affect gene expression quantification by introducing a moderate and pervasive bias in expression level estimates that significantly affected 8.1% of studied genes. The rapidly degrading transcript pool was enriched in pseudogenes, short noncoding RNAs, and transcripts with extended 39 untranslated regions. Typical slowly degrading transcripts (median length, 2389 nt) represented protein coding genes with 4-10 exons and high guanine-cytosine content.	[Reiman, Mario; Laan, Maris; Rull, Kristiina; Sober, Siim] Univ Tartu, Human Mol Genet Res Grp, Inst Mol & Cell Biol, Tartu, Estonia; [Laan, Maris; Sober, Siim] Univ Tartu, Inst Biomed & Translat Med, Tartu, Estonia; [Rull, Kristiina] Univ Tartu, Dept Obstet & Gynecol, Tartu, Estonia; [Rull, Kristiina] Tartu Univ Hosp, Womens Clin, Tartu, Estonia	University of Tartu; University of Tartu; University of Tartu	Sober, S (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Riia St 23, EE-51010 Tartu, Estonia.	siims@ut.ee	Rull, Kristiina/H-9555-2013; Laan, Maris/A-4100-2011	Rull, Kristiina/0000-0002-3396-0716; Laan, Maris/0000-0002-8519-243X	European Union; European Regional Development Fund [3.2.0701.12-0047]; Estonian Research Council [IUT34-12, ETF9030]	European Union(European Commission); European Regional Development Fund(European Commission); Estonian Research Council(Estonian Research Council)	The authors thank Dr. Pille Vaas, Pille Teesalu and the assisting clinical personnel at the Women's Clinic (Tartu University Hospital) for the collection of Reprogrammed Fetal and/or Maternal Metabolism (REPROMETA) study samples. This work was supported by the European Union through the European Regional Development Fund (Project Happy Pregnancy; Grant 3.2.0701.12-0047 to M.L. and K.R.), and Estonian Research Council (Grants IUT34-12 and ETF9030 to M.L.). The authors declare no conflicts of interest.	Adiconis X, 2013, NAT METHODS, V10, P623, DOI 10.1038/nmeth.2483; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bammler T, 2005, NAT METHODS, V2, P351, DOI 10.1038/nmeth0605-477a; Buckberry S, 2014, MOL HUM REPROD, V20, P810, DOI 10.1093/molehr/gau035; Conesa A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0881-8; Conte C, 2002, CYTOGENET GENOME RES, V98, P45, DOI 10.1159/000068546; Duan JB, 2013, SCI REP-UK, V3, DOI 10.1038/srep01318; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Durrenberger PF, 2010, J NEUROPATH EXP NEUR, V69, P70, DOI 10.1097/NEN.0b013e3181c7e32f; Enquobahrie DA, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.022; Feng HJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8816; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Fordyce Sarah L, 2013, Investig Genet, V4, P7, DOI 10.1186/2041-2223-4-7; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Gay E, 2000, BIOCHEM BIOPH RES CO, V267, P509, DOI 10.1006/bbrc.1999.2000; Imbeaud S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni054; Janssen AB, 2015, PLACENTA, V36, P790, DOI 10.1016/j.placenta.2015.06.011; Kappil MA, 2015, EPIGENETICS-US, V10, P842, DOI 10.1080/15592294.2015.1073881; Kersey PJ, 2016, NUCLEIC ACIDS RES, V44, pD574, DOI 10.1093/nar/gkv1209; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koutsaki M, 2011, GROWTH HORM IGF RES, V21, P31, DOI 10.1016/j.ghir.2010.12.002; Li Meijuan, 2008, J Biomol Tech, V19, P122; Li S, 2014, NAT BIOTECHNOL, V32, P915, DOI 10.1038/nbt.2972; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma Y, 2012, ANAL BIOCHEM, V423, P229, DOI 10.1016/j.ab.2012.02.003; Popova T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-91; R Core Team, 2016, R FDN STAT COMP; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Romero IG, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-42; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Sober S, 2015, SCI REP-UK, V5, DOI 10.1038/srep13336; Streit S, 2009, NAT PROTOC, V4, P37, DOI 10.1038/nprot.2008.216; Stuart CA, 1999, METABOLISM, V48, P876, DOI 10.1016/S0026-0495(99)90222-6; Sugawara J, 2000, J CLIN ENDOCR METAB, V85, P3821, DOI 10.1210/jc.85.10.3821; Sundrani DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029855; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wolfle U, 2016, MOLECULES, V21, DOI 10.3390/molecules21030306; Wyatt SM, 2005, PLACENTA, V26, P372, DOI 10.1016/j.placenta.2004.07.003	43	30	30	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3298	3308		10.1096/fj.201601031RR	http://dx.doi.org/10.1096/fj.201601031RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28446590				2022-12-26	WOS:000405932400010
J	Wright, JD; An, SW; Xie, J; Yoon, J; Nischan, N; Kohler, JJ; Oliver, N; Lim, C; Huang, CL				Wright, Jon D.; An, Sung-Wan; Xie, Jian; Yoon, Joonho; Nischan, Nicole; Kohler, Jennifer J.; Oliver, Noelynn; Lim, Carmay; Huang, Chou-Long			Modeled structural basis for the recognition of alpha 2-3-sialyllactose by soluble Klotho	FASEB JOURNAL			English	Article						KL1 domain; TRPC6; PI3K	CATALYTIC MECHANISM; FUNCTIONAL VARIANT; ENHANCES COGNITION; PROTEIN; ASSOCIATION; INSIGHTS; DOCKING; MICE; GENE; POLYMORPHISM	Soluble Klotho (sKlotho) is the shed ectodomain of antiaging membrane Klotho that contains 2 extracellular domains KL1 and KL2, each of which shares sequence homology to glycosyl hydrolases. sKlotho elicits pleiotropic cellular responses with a poorly understood mechanism of action. Notably, in injury settings, sKlotho confers cardiac and renal protection by down-regulating calcium-permeable transient receptor potential canonical type isoform 6 (TRPC6) channels in cardiomyocytes and glomerular podocytes. Inhibition of PI3K-dependent exocytosis of TRPC6 is thought to be the underlying mechanism, and recent studies showed that sKlotho interacts with alpha 2-3-sialyllactose-containing gangliosides enriched in lipid rafts to inhibit raft-dependent PI3K signaling. However, the structural basis for binding and recognition of alpha 2-3-sialyllactose by sKlotho is unknown. Using homology modeling followed by docking, we identified key protein residues in the KL1 domain that are likely involved in binding sialyllactose. Functional experiments based on the ability of Klotho to down-regulate TRPC6 channel activity confirm the importance of these residues. Furthermore, KL1 domain binds alpha 2-3-sialyllactose, downregulates TRPC6 channels, and exerts protection against stress-induced cardiac hypertrophy in mice. Our results support the notion that sialogangliosides and lipid rafts are membrane receptors for sKlotho and that the KL1 domain is sufficient for the tested biologic activities. These findings can help guide the design of a simpler Klotho mimetic.	[Wright, Jon D.; Lim, Carmay] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan; [An, Sung-Wan; Xie, Jian; Yoon, Joonho; Huang, Chou-Long] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX USA; [Nischan, Nicole; Kohler, Jennifer J.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX USA; [Oliver, Noelynn] Boehringer Ingelheim Pharmaceut Inc, Cardiometab Dis Res, 90 E Ridge POB 368, Ridgefield, CT 06877 USA; [Lim, Carmay] Natl Tsing Hua Univ, Dept Chem, Hsinchu, Taiwan	Academia Sinica - Taiwan; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Boehringer Ingelheim; National Tsing Hua University	Lim, C (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan.; Huang, CL (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	carmay@gate.sinica.edu.tw; chou-long.huang@utsouthwestern.edu	Wright, Jon D/C-9541-2019; Lim, Carmay/N-9648-2015; Kohler, Jennifer/B-6589-2009	Lim, Carmay/0000-0001-9077-7769; Xie, Jian/0000-0001-9454-1358; Kohler, Jennifer/0000-0001-5373-3329	Academia Sinica; Ministry of Science and Technology (MOST) of Taiwan [98-2113-M-001-011]; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [DK109887, DK100605]; Welch Foundation [I-1686]; University of Texax Southwestern; Boehringer Ingelheim Pharmaceuticals Inc. (BIPI); German Academic Exchange Service (DAAD); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100605, R01DK109887] Funding Source: NIH RePORTER	Academia Sinica(Academia Sinica - Taiwan); Ministry of Science and Technology (MOST) of Taiwan(Ministry of Science and Technology, Taiwan); U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Welch Foundation(The Welch Foundation); University of Texax Southwestern; Boehringer Ingelheim Pharmaceuticals Inc. (BIPI)(Boehringer Ingelheim); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in part, by the Academia Sinica and Ministry of Science and Technology (MOST) of Taiwan (Grant 98-2113-M-001-011), the U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (Grants DK109887 and DK100605), the Welch Foundation (Grant I-1686), and by a sponsored research agreement between University of Texax Southwestern and Boehringer Ingelheim Pharmaceuticals Inc. (BIPI). BIPI provided purified recombinant KL1 domain protein. N.N. is supported by a postdoctoral fellowship from the German Academic Exchange Service (DAAD). The authors thank M. Diamond and J. Vaquer-Alicea (both from the University of Texas Southwestern Medical Center, Dallas, TX, USA) for provision of the Octet.	Allen WJ, 2015, J COMPUT CHEM, V36, P1132, DOI 10.1002/jcc.23905; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amaya MF, 2004, STRUCTURE, V12, P775, DOI 10.1016/j.str.2004.02.036; Arking DE, 2005, CIRC RES, V96, P412, DOI 10.1161/01.RES.0000157171.04054.30; Arking DE, 2002, P NATL ACAD SCI USA, V99, P856, DOI 10.1073/pnas.022484299; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Connaris H, 2014, P NATL ACAD SCI USA, V111, P6401, DOI 10.1073/pnas.1404205111; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Dalton G, 2017, P NATL ACAD SCI USA, V114, P752, DOI 10.1073/pnas.1620301114; Doi S, 2011, J BIOL CHEM, V286, P8655, DOI 10.1074/jbc.M110.174037; Dubal DB, 2015, J NEUROSCI, V35, P2358, DOI 10.1523/JNEUROSCI.5791-12.2015; Dubal DB, 2014, CELL REP, V7, P1065, DOI 10.1016/j.celrep.2014.03.076; Frisch G. W., 2013, GAUSSIAN 09; Hayashi Y, 2007, J BIOL CHEM, V282, P30889, DOI 10.1074/jbc.M700832200; Imura A, 2004, FEBS LETT, V565, P143, DOI 10.1016/j.febslet.2004.03.090; Ito S, 2002, BBA-GENE STRUCT EXPR, V1576, P341, DOI 10.1016/S0167-4781(02)00281-6; Jeng WY, 2012, ACTA CRYSTALLOGR D, V68, P829, DOI 10.1107/S0907444912013224; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Liu F, 2011, NAT CELL BIOL, V13, P254, DOI 10.1038/ncb2167; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; MENG EC, 1992, J COMPUT CHEM, V13, P505, DOI 10.1002/jcc.540130412; Mills JEJ, 1996, J COMPUT AID MOL DES, V10, P607, DOI 10.1007/BF00134183; Morishita K, 2001, J NUTR, V131, P3182, DOI 10.1093/jn/131.12.3182; Ogata N, 2002, BONE, V31, P37, DOI 10.1016/S8756-3282(02)00786-X; Owen CD, 2015, J BIOL CHEM, V290, P27736, DOI 10.1074/jbc.M115.673632; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; REED AE, 1985, J CHEM PHYS, V83, P735, DOI 10.1063/1.449486; RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055; Ruiz FM, 2015, CHEM-EUR J, V21, P13558, DOI 10.1002/chem.201501961; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; SHOICHET BK, 1992, J COMPUT CHEM, V13, P380, DOI 10.1002/jcc.540130311; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; Tohyama O, 2004, J BIOL CHEM, V279, P9777, DOI 10.1074/jbc.M312392200; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Wolf I, 2008, ONCOGENE, V27, P7094, DOI 10.1038/onc.2008.292; Xie J, 2015, J AM SOC NEPHROL, V26, P1150, DOI 10.1681/ASN.2014040325; Xie J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2240; Yuan P, 2005, STRUCTURE, V13, P803, DOI 10.1016/j.str.2005.02.019; Zhou TBT, 2013, J BIOL CHEM, V288, P36302, DOI 10.1074/jbc.M113.490052	48	18	19	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3574	3586		10.1096/fj.201700043R	http://dx.doi.org/10.1096/fj.201700043R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28442546	Green Published			2022-12-26	WOS:000405932400031
J	Galaz-Montoya, M; Wright, SJ; Rodriguez, GJ; Lichtarge, O; Wensel, TG				Galaz-Montoya, Monica; Wright, Sara J.; Rodriguez, Gustavo J.; Lichtarge, Olivier; Wensel, Theodore G.			beta(2)-Adrenergic receptor activation mobilizes intracellular calcium via a non-canonical cAMP-independent signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE-C; BETA-ARRESTIN; CYCLIC-AMP; G-PROTEINS; ISOPROTERENOL; STIMULATION; PHOSPHORYLATION; PHARMACOLOGY; INCREASES; SUBTYPES	Beta adrenergic receptors (beta ARs) are G-protein-coupled receptors essential for physiological responses to the hormones/neurotransmitters epinephrine and norepinephrine which are found in the nervous system and throughout the body. They are the targets of numerous widely used drugs, especially in the case of the most extensively studied beta AR, beta(2)AR, whose ligands are used for asthma and cardiovascular disease. beta ARs signal through G alpha(s) G-proteins and via activation of adenylyl cyclase and cAMP-dependent protein kinase, but some alternative downstream pathways have also been proposed that could be important for understanding normal physiological functioning of beta AR signaling and its disruption in disease. Using fluorescence-based Ca2+ flux assays combined with pharmacology and gene knock-out methods, we discovered a previously unrecognized endogenous pathway in HEK-293 cells whereby beta(2)AR activation leads to robust Ca2+ mobilization from intracellular stores via activation of phospholipase C and opening of inositol trisphosphate (InsP(3)) receptors. This pathway did not involve cAMP, G alpha(s), or G alpha(i) or the participation of the other members of the canonical beta(2)AR signaling cascade and, therefore, constitutes a novel signaling mechanism for this receptor. This newly uncovered mechanism for Ca2+ mobilization by beta(2)AR has broad implications for adrenergic signaling, cross-talk with other signaling pathways, and the effects of beta AR-directed drugs.	[Galaz-Montoya, Monica; Wright, Sara J.; Rodriguez, Gustavo J.; Lichtarge, Olivier; Wensel, Theodore G.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Lichtarge, Olivier] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Rodriguez, Gustavo J.] Kite Pharma, 2225 Colorado Ave, Santa Monica, CA 90404 USA	Baylor College of Medicine; Baylor College of Medicine	Wensel, TG (corresponding author), 1 Baylor Plaza, Houston, TX 77030 USA.	twensel@bcm.edu		Wensel, Theodore/0000-0003-3518-9352	Cell-Based Assay Screening Service core at Baylor College of Medicine; NIH [P30 CA125123]; NATIONAL CANCER INSTITUTE [P30CA125123, P30CA014236] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [T32EY007102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008280, R01GM066099] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [1356569] Funding Source: National Science Foundation	Cell-Based Assay Screening Service core at Baylor College of Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank Dr. Michael X. Zhu of the University of the Texas Health Science Center at Houston for kindly sharing his HEK-TRPC4 beta and HEK-mu OR-TRBC4 beta cells. Special thanks to Dr. James Mancuso for helpful comments on the manuscript and to Dr. Melina A. Agosto for invaluable help and suggestions throughout the development of this project and preparation of the manuscript. We thank Tyler Hilton of Baylor College of Medicine for preparing CEL1 nuclease. This project was supported by the Cell-Based Assay Screening Service core (with special thanks to Drs. D. Liu and J. Xu) at Baylor College of Medicine with funding from the NIH (P30 CA125123).	Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Betzenhauser MJ, 2009, J BIOL CHEM, V284, P25116, DOI 10.1074/jbc.M109.010132; Bootman Martin D, 2013, Cold Spring Harb Protoc, V2013, P122, DOI 10.1101/pdb.prot072801; BYLUND DB, 1994, PHARMACOL REV, V46, P121; CAMPS M, 1992, EUR J BIOCHEM, V206, P821, DOI 10.1111/j.1432-1033.1992.tb16990.x; COOK DI, 1988, PFLUG ARCH EUR J PHY, V413, P67, DOI 10.1007/BF00581230; Copik AJ, 2009, MOL PHARMACOL, V75, P713, DOI 10.1124/mol.108.050765; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Giembycz MA, 2006, EUR RESPIR J, V27, P1286, DOI 10.1183/09031936.06.00112605; HELMAN J, 1987, EUR J PHARMACOL, V143, P65, DOI 10.1016/0014-2999(87)90735-7; Hoffmann C, 2004, N-S ARCH PHARMACOL, V369, P151, DOI 10.1007/s00210-003-0860-y; HORN VJ, 1988, J BIOL CHEM, V263, P12454; Kang HJ, 2014, J BIOL CHEM, V289, P29961, DOI 10.1074/jbc.M114.574483; Kurian N, 2009, J PHARMACOL EXP THER, V330, P502, DOI 10.1124/jpet.109.153619; Manglik A, 2014, CURR OPIN CELL BIOL, V27, P136, DOI 10.1016/j.ceb.2014.01.008; MILLIGAN G, 1994, BIOCHEM PHARMACOL, V48, P1059; Oestreich EA, 2007, J BIOL CHEM, V282, P5488, DOI 10.1074/jbc.M608495200; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; Pera T, 2014, CURR OPIN PHARMACOL, V16, P72, DOI 10.1016/j.coph.2014.03.005; Pereira L, 2012, J MOL CELL CARDIOL, V52, P283, DOI 10.1016/j.yjmcc.2011.10.016; Qiu P, 2004, BIOTECHNIQUES, V36, P702, DOI 10.2144/04364PF01; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rodriguez GJ, 2010, P NATL ACAD SCI USA, V107, P7787, DOI 10.1073/pnas.0914877107; Schmidt M, 2001, NAT CELL BIOL, V3, P1020, DOI 10.1038/ncb1101-1020; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Soltoff SP, 2010, J BIOL CHEM, V285, P13337, DOI 10.1074/jbc.M110.112094; Stallaert W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029420; Summers RJ, 1997, J AUTON PHARMACOL, V17, P331, DOI 10.1046/j.1365-2680.1997.00055.x; Till BJ, 2004, NUCLEIC ACIDS RES, V32, P2632, DOI 10.1093/nar/gkh599; Tojyo Y, 1998, EUR J PHARMACOL, V360, P73, DOI 10.1016/S0014-2999(98)00651-7; Weitl N, 2008, J PHARMACOL EXP THER, V327, P760, DOI 10.1124/jpet.108.143412; Wenzel-Seifert K, 2000, MOL PHARMACOL, V58, P954, DOI 10.1124/mol.58.5.954; WU DQ, 1995, J BIOL CHEM, V270, P16008, DOI 10.1074/jbc.270.27.16008	35	23	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					9967	9974		10.1074/jbc.M117.787119	http://dx.doi.org/10.1074/jbc.M117.787119			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28442571	Green Published, hybrid			2022-12-26	WOS:000403580600010
J	Batten, J; Lucey, B; McGroarty, F; Peat, M; Urquhart, A				Batten, Jonathan; Lucey, Brian; McGroarty, Frank; Peat, Maurice; Urquhart, Andrew			Stylized facts of intraday precious metals	PLOS ONE			English	Article							STOCK RETURNS; ASYMMETRIC VOLATILITY; TRANSACTIONS DATA; FUTURES MARKETS; NYSE STOCKS; PATTERNS; GOLD; EXCHANGE; LONDON; VOLUME	This paper examines the stylized facts, correlation and interaction between volatility and returns at the 5-minute frequency for gold, silver, platinum and palladium from May 2000 to April 2015. We study the full sample period, as well as three subsamples to determine how high-frequency data of precious metals have developed over time. We find that over the full sample, the number of trades has increased substantially over time for each precious metal, while the bid-ask spread has narrowed over time, indicating an increase in liquidity and price efficiency. We also find strong evidence of periodicity in returns, volatility, volume and bid-ask spread. Returns and volume both experience strong intraday periodicity linked to the opening and closing of major markets around the world while the bid-ask spread is at its lowest when European markets are open. We also show a bilateral Granger causality between returns and volatility of each precious metal, which holds for the vast majority subsamples.	[Batten, Jonathan] Monash Univ, Business Sch, Caulfield, Vic, Australia; [Lucey, Brian] Trinity Coll Dublin, Trinity Business Sch, Dublin, Ireland; [McGroarty, Frank; Urquhart, Andrew] Univ Southampton, Southampton Business Sch, Southampton, Hants, England; [Peat, Maurice] Univ Sydney, Business Sch, Sydney, NSW, Australia	Monash University; Trinity College Dublin; Solent University; University of Southampton; University of Sydney	Lucey, B (corresponding author), Trinity Coll Dublin, Trinity Business Sch, Dublin, Ireland.	blucey@tcd.e; maurice.peat@sydney.edu.au	Batten, Jonathan A/J-3838-2013; lucey, brian/AAY-3885-2021	Batten, Jonathan A/0000-0002-3871-7360; lucey, brian/0000-0002-4052-8235; McGroarty, Frank/0000-0003-2962-0927; URQUHART, ANDREW/0000-0001-8834-4243				Andersen T. G., 2000, J INT FINANC MARK I, V10, P107; Baillie RT, 2007, J FUTURES MARKETS, V27, P643, DOI 10.1002/fut.20267; BAILLIE RT, 1991, REV ECON STUD, V58, P565, DOI 10.2307/2298012; Bekaert G, 2000, REV FINANC STUD, V13, P1, DOI 10.1093/rfs/13.1.1; Black F., 1976, P BUS EC STAT SECT A, P177; Bollerslev T., 2006, J FINANCIAL ECONOMET, V4, P353, DOI DOI 10.1093/JJFINEC/NBJ014; Breedon F, 2013, J MONEY CREDIT BANK, V45, P953, DOI 10.1111/jmcb.12032; BROCK WA, 1992, J ECON DYN CONTROL, V16, P451, DOI 10.1016/0165-1889(92)90045-G; Broussard JP, 2014, J INT FINANC MARK I, V30, P196, DOI 10.1016/j.intfin.2014.03.001; Cai C.X., 2004, J BUS FINANC ACCOUNT, V31, P647, DOI [10.1111/j.0306-686X.2004.00552.x, DOI 10.1111/J. 0306-686X. 2004. 00552. X, DOI 10.1111/J.0306-686X.2004.00552.X]; Cai J, 2001, J FUTURES MARKETS, V21, P257, DOI 10.1002/1096-9934(200103)21:3<257::AID-FUT4>3.0.CO;2-W; Caporin M, 2015, QUANT FINANC, V15, P743, DOI 10.1080/14697688.2014.947313; Chai EFL, 2015, INT REV FINANC ANAL, V41, P206, DOI 10.1016/j.irfa.2015.05.001; Chelley-Steeley P, 2011, INT REV FINANC ANAL, V20, P244, DOI 10.1016/j.irfa.2011.05.001; Dennis P, 2006, J FINANC QUANT ANAL, V41, P381, DOI 10.1017/S0022109000002118; Edwards AK, 2007, J FINANC, V62, P1421, DOI 10.1111/j.1540-6261.2007.01240.x; Ellul A., 2002, DEEP LIQUID MARKETS; Evans KP, 2010, RES INT BUS FINANC, V24, P82, DOI 10.1016/j.ribaf.2009.04.001; Figlewski S., 2000, WORKING PAPER SERIES; GARMAN MB, 1980, J BUS, V53, P67, DOI 10.1086/296072; Giot P., 2005, J PORTFOLIO MANAGE, V26, P12; Goodhart C. A., 1997, J EMPIR FINANC, V4, P73, DOI [10.1016/S0927-5398(97)00003-0, DOI 10.1016/S0927-5398(97)00003-0]; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hafner R., 2007, EUROPEAN J FINANCE, V1, p1 ; HAMAO Y, 1995, REV FINANC STUD, V8, P849, DOI 10.1093/rfs/8.3.849; Hauptfleisch M, 2016, J FUTURES MARKETS, V36, P564, DOI 10.1002/fut.21775; Heston SL, 2010, J FINANC, V65, P1369, DOI 10.1111/j.1540-6261.2010.01573.x; Hol R., 2002, DISCUSSION PAPERS; Jain A, 2016, APPL ECON, V48, P3228, DOI 10.1080/00036846.2015.1136401; Khalifa AAA, 2011, J FUTURES MARKETS, V31, P55, DOI 10.1002/fut.20459; Koutmos G, 2011, J INT MONEY FINANC, V30, P62, DOI 10.1016/j.jimonfin.2010.07.001; LOCKWOOD LJ, 1990, J FINANC, V45, P591; Loon YC, 2016, J FINANC ECON, V119, P645, DOI 10.1016/j.jfineco.2016.01.019; Madhavan A, 1997, REV FINANC STUD, V10, P1035, DOI 10.1093/rfs/10.4.1035; MCINISH TH, 1992, J FINANC, V47, P753, DOI 10.2307/2329122; MCINISH TH, 1990, J BANK FINANC, V14, P441, DOI 10.1016/0378-4266(90)90058-A; MCINISH TH, 1990, J BANK FINANC, V14, P99; Murray S., 2011, LOCO LONDON LIQUIDIT, V63, P9; Naik N.Y., 1999, WORKING PAPER; Ranaldo A, 2009, J BANK FINANC, V33, P2199, DOI 10.1016/j.jbankfin.2009.05.019; Rogers L.C.G., 1991, ANAL APPL PROBABIL, V1, P500; Rogers Leonard Christopher Gordon, 1994, APPL FINANCIAL EC, V4, P241, DOI [10.1080/758526905, DOI 10.1080/758526905]; Wang GJ, 2016, INT REV ECON FINANC, V46, P55, DOI 10.1016/j.iref.2016.08.004; WOOD RA, 1985, J FINANC, V40, P723, DOI 10.1111/j.1540-6261.1985.tb04996.x; World Federation of Exchange, 2011, ANN REPORT	45	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0174232	10.1371/journal.pone.0174232	http://dx.doi.org/10.1371/journal.pone.0174232			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET6EL	28448492	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000400383600002
J	Cherubino, M; Pellegatta, I; Crosio, A; Valdatta, L; Geuna, S; Gornati, R; Tos, P				Cherubino, Mario; Pellegatta, Igor; Crosio, Alessandro; Valdatta, Luigi; Geuna, Stefano; Gornati, Rosalba; Tos, Pierluigi			Use of human fat grafting in the prevention of perineural adherence: Experimental study in athymic mouse	PLOS ONE			English	Article							PERIPHERAL-NERVE REGENERATION; STEM-CELLS; PERCUTANEOUS APONEUROTOMY; BREAST RECONSTRUCTION; PRE-EXPANSION; TENDON REPAIR; EFFICACY; TISSUE; MODEL; SCAR	Perineural adherences represent a problem after surgery involving peripheral neural system. Fat-grafting with adipose derived stem cells (ASCs) with their pro-regenerative characteristics can be important to prevent the neural damage or to facilitate the neural regeneration. Our idea was to use the fat-grafting as an anti-adherence device and test its efficacy on a postsurgical scar animal model and comparing to an antiadhesive gel. 32 athymic mice were operated under magnification, we exposed both sciatic nerves. We randomly divided all sciatic nerves into four experimental groups: burning (1), burning + carboxy-methylcellulose and poly-ethylene oxide (CMC-PEO) (2) + human adipose fat tissue (3), control group (4). Bio-mechanical evaluation was performed to measure the peak force required to pull out the nerve from the muscular bed. Results: in the CMC-PEO group the peak pull out force was 0.37 Newton. In the fat grafted group we registered a peak pull out force of 0.35 N (t Student 0.913). In burning group the force necessary to tear the nerve apart was markedly superior (0.46 N). In control group, we reported the minimal strength (0.31 N) to slide the nerve from the tissue. Histologically, in the group treated with fat-grating, a thinner scar layer was highlighted. Considering the results of this study we can support the efficacy in animal experimental model of fat graft as an anti-adherence device in peripheral nerve surgery.	[Cherubino, Mario; Pellegatta, Igor; Valdatta, Luigi; Gornati, Rosalba] Univ Insubria, Dept Biotechnol & Life Sci, Varese, Italy; [Crosio, Alessandro] CTO Hosp, Reconstruct Microsurg Unit, Traumatol Dept, Turin, Italy; [Geuna, Stefano] Univ Turin, Human Anat Lab, Clin & Biol Sci Dept, AOU San Luigi Gonzaga, Orbassano, Italy; [Tos, Pierluigi] ASST Gaetano Pini, Dept Orthoped Traumatol & Hand Surg, Milan, Italy	University of Insubria; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; ASST Gaetano Pini CTO	Pellegatta, I (corresponding author), Univ Insubria, Dept Biotechnol & Life Sci, Varese, Italy.	igor.pellegatta@me.com	Crosio, Alessandro/Q-7385-2018; Pellegatta, Igor/Q-4141-2019; Cherubino, Mario/N-1780-2019; tos, pierluigi/R-5803-2016	Pellegatta, Igor/0000-0002-7963-4262; Cherubino, Mario/0000-0003-1196-3075; Valdatta, Luigi/0000-0003-1568-2262; Geuna, Stefano/0000-0002-6962-831X; tos, pierluigi/0000-0002-1349-7082				Abe Y, 2005, BRIT J PLAST SURG, V58, P533, DOI 10.1016/j.bjps.2004.05.012; Carriel V, 2011, HISTOCHEM CELL BIOL, V136, P709, DOI 10.1007/s00418-011-0874-3; Cherubino M, 2016, REGEN MED, V11, P261, DOI 10.2217/rme-2015-0010; Crosio A, 2014, J NEUROSCI METH, V233, P73, DOI 10.1016/j.jneumeth.2014.06.008; Del Vecchio D, 2009, ANN PLAS SURG, V62, P523, DOI 10.1097/SAP.0b013e3181a23f08; Dumanian GA, 1999, J HAND SURG-AM, V24A, P30; Faroni A, 2013, INT REV NEUROBIOL, V108, P121, DOI 10.1016/B978-0-12-410499-0.00005-8; Gimble JM, 2011, STEM CELLS, V29, P749, DOI 10.1002/stem.629; Golash A, 2003, J HAND SURG-BRIT EUR, V28B, P113, DOI 10.1016/S0266-7681(02)00249-8; Gouzou Stephanie, 2013, Rev Prat, V63, P1258; Hovius SER, 2011, PLAST RECONSTR SURG, V128, P221, DOI 10.1097/PRS.0b013e31821741ba; Iannace Carlo, 2009, Chir Ital, V61, P67; Isla A, 2003, J Neurosurg Sci, V47, P195; Juhl AA, 2016, J PLAST RECONSTR AES, V69, P1192, DOI 10.1016/j.bjps.2016.07.003; Khouri R, 2009, CLIN PLAST SURG, V36, P269, DOI 10.1016/j.cps.2008.11.009; Khouri RK, 2014, PLAST RECONSTR SURG, V133, P1369, DOI 10.1097/PRS.0000000000000179; Khouri RK, 2014, PLAST RECONSTR SURG, V133, P550, DOI 10.1097/01.prs.0000438044.06387.2a; Khouri RK, 2013, PLAST RECONSTR SURG, V132, P1280, DOI 10.1097/PRS.0b013e3182a4c3a9; Khouri RK, 2012, PLAST RECONSTR SURG, V129, P1173, DOI 10.1097/PRS.0b013e31824a2db6; Klinger M, 2008, AESTHET PLAST SURG, V32, P465, DOI 10.1007/s00266-008-9122-1; Krzesniak NE, 2015, PRS-GLOB OPEN, V3, DOI 10.1097/GOX.0000000000000374; Largo RD, 2014, J PLAST RECONSTR AES, V67, P437, DOI 10.1016/j.bjps.2013.11.011; Liu GB, 2011, ARCH MED SCI, V7, P592, DOI 10.5114/aoms.2011.24127; Liu ZC, 2013, ARCH ORTHOP TRAUM SU, V133, P295, DOI 10.1007/s00402-012-1634-0; Marconi S, 2012, TISSUE ENG PT A, V18, P1264, DOI [10.1089/ten.TEA.2011.0491, 10.1089/ten.tea.2011.0491]; McCall TD, 2001, NEUROSURG CLIN N AM, V12, P329, DOI 10.1016/S1042-3680(18)30058-5; McGonagle L, 2012, J ORTHOP RES, V30, P775, DOI 10.1002/jor.21569; Mohsen-Kanson T, 2013, BIOCHEM BIOPH RES CO, V430, P871, DOI 10.1016/j.bbrc.2012.12.079; Panettiere P, 2009, AESTHET PLAST SURG, V33, P695, DOI 10.1007/s00266-009-9366-4; Pederzini LA, 2013, J ORTHOP TRAUMATOL, V14, P109, DOI 10.1007/s10195-013-0229-z; Philips BJ, 2012, EXPERT OPIN BIOL TH, V12, P155, DOI 10.1517/14712598.2012.644533; Raimondo S, 2009, INT REV NEUROBIOL, V87, P81, DOI 10.1016/S0074-7742(09)87005-0; Riccio M, 2010, J HAND SURG-EUR VOL, V35E, P130, DOI 10.1177/1753193409342044; Shen CC, 2012, J BIOMED MATER RES A, V100A, P48, DOI 10.1002/jbm.a.33227; Tos P, 2016, MUSCLE NERVE, V53, P304, DOI 10.1002/mus.24739	35	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176393	10.1371/journal.pone.0176393	http://dx.doi.org/10.1371/journal.pone.0176393			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445518	Green Published, Green Submitted, gold			2022-12-26	WOS:000400309200056
J	Jentho, E; Bodden, M; Schulz, C; Jung, AL; Seidel, K; Schmeck, B; Bertrams, W				Jentho, Elise; Bodden, Malena; Schulz, Christine; Jung, Anna-Lena; Seidel, Kerstin; Schmeck, Bernd; Bertrams, Wilhelm			microRNA-125a-3p is regulated by MyD88 in Legionella pneumophila infection and targets NTAN1	PLOS ONE			English	Article							LEGIONNAIRES-DISEASE; ACTIVATION; MICRORNAS; PROTEIN; MACROPHAGES; PNEUMONIAE; OUTBREAK; CELLS	Background Legionella pneumophila (L. pneumophila) is a causative agent of severe pneumonia. It is highly adapted to intracellular replication and manipulates host cell functions like vesicle trafficking and mRNA translation to its own advantage. However, it is still unknown to what extent microRNAs (miRNAs) are involved in the Legionella-host cell interaction. Methods WT and MyD88(-/-) murine bone marrow-derived macrophages (BMM) were infected with L. pneumophila, the transcriptome was analyzed by high throughput qPCR array (microRNAs) and conventional qPCR (mRNAs), and mRNA-miRNA interaction was validated by luciferase assays with 3-UTR mutations and western blot. Results L. pneumophila infection caused a pro-inflammatory reaction and significant miRNA changes in murine macrophages. In MyD88(-/-) cells, induction of inflammatory markers, such as Ccxl1/Kc, Il6 and miR-146a-5p was reduced. Induction of miR-125a-3p was completely abrogated in MyD88(-/-) cells. Target prediction analyses revealed N-terminal asparagine amidase 1 (NTAN1), a factor from the n-end rule pathway, to be a putative target of miR125a-3p. This interaction could be confirmed by luciferase assay and western blot. Conclusion Taken together, we characterized the miRNA regulation in L. pneumophila infection with regard to MyD88 signaling and identified NTAN1 as a target of miR-125a-3p. This finding unravels a yet unknown feature of Legionella-host cell interaction, potentially relevant for new treatment options.	[Jentho, Elise; Bodden, Malena; Schulz, Christine; Jung, Anna-Lena; Seidel, Kerstin; Schmeck, Bernd; Bertrams, Wilhelm] Univ Giessen, German Ctr Lung Res, Inst Lung Res iLung, Marburg, Germany; [Jentho, Elise; Bodden, Malena; Schulz, Christine; Jung, Anna-Lena; Seidel, Kerstin; Schmeck, Bernd; Bertrams, Wilhelm] Univ Marburg, Lung Ctr, Philipps Univ Marburg, Marburg, Germany; [Schmeck, Bernd] Philipps Univ Marburg, Univ Med Ctr Marburg, Dept Med Pulm & Crit Care Med, Marburg, Germany; [Jentho, Elise] Jena Univ Hosp, Dept Anesthesiol & Intens Care Med, Jena, Germany; [Bodden, Malena] Inst Tumor Biol & Expt Therapy, Georg Speyer Haus, Frankfurt, Germany; [Schulz, Christine] Life Technol GmbH, Thermo Fisher Sci, Darmstadt, Germany	Justus Liebig University Giessen; Philipps University Marburg; Philipps University Marburg; Friedrich Schiller University of Jena; Thermo Fisher Scientific	Schmeck, B (corresponding author), Univ Giessen, German Ctr Lung Res, Inst Lung Res iLung, Marburg, Germany.; Schmeck, B (corresponding author), Univ Marburg, Lung Ctr, Philipps Univ Marburg, Marburg, Germany.; Schmeck, B (corresponding author), Philipps Univ Marburg, Univ Med Ctr Marburg, Dept Med Pulm & Crit Care Med, Marburg, Germany.	bernd.schmeck@uni-marburg.de		Bertrams, Wilhelm/0000-0002-0180-2529; Jentho, Elisa/0000-0002-4790-7860; Schmeck, Bernd/0000-0002-2767-3606; SEIDEL, KERSTIN/0000-0002-9166-7032	Deutsche Forschungsgesellschaft [TR84]; Bundesministerium fur Bildung und Forschung [e:bio 0316175A, e:Med 01X1304E, Progress FKZ 01KI1010K]; Hessisches Ministerium fur Wissenschaft und Kunst	Deutsche Forschungsgesellschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Hessisches Ministerium fur Wissenschaft und Kunst	The work was in part supported by grants from the Deutsche Forschungsgesellschaft, (TR84), Bundesministerium fur Bildung und Forschung (e:bio 0316175A, e:Med 01X1304E, Progress FKZ 01KI1010K) and Hessisches Ministerium fur Wissenschaft und Kunst (LOEWE UGMLC and LOEWE Medical RNomics) to BS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abshire CF, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006088; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Cantor JR, 2011, BIOCHEMISTRY-US, V50, P3025, DOI 10.1021/bi101832w; Chen K, 2015, SCI REP-UK, V5, DOI 10.1038/srep11909; Du Bois I, 2016, J INFECT DIS, V214, P454, DOI 10.1093/infdis/jiw171; Dvinge H, 2009, BIOINFORMATICS, V25, P3325, DOI 10.1093/bioinformatics/btp578; Fortier A, 2011, IMMUNOBIOLOGY, V216, P1274, DOI 10.1016/j.imbio.2011.06.008; Franco IS, 2009, CELL MICROBIOL, V11, P1435, DOI 10.1111/j.1462-5822.2009.01351.x; FRASER DW, 1977, NEW ENGL J MED, V297, P1189, DOI 10.1056/NEJM197712012972201; Garcia-Fulgueiras A, 2003, EMERG INFECT DIS, V9, P915; Griss K, 2016, J INFECT DIS, V214, P288, DOI 10.1093/infdis/jiw109; Kim JK, 2015, J IMMUNOL, V194, P5355, DOI 10.4049/jimmunol.1402557; Krull M, 2004, INFECT IMMUN, V72, P6615, DOI 10.1128/IAI.72.11.6615-6621.2004; Kubori T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001216; Kuroki T, 2017, EMERG INFECT DIS, V23, P349, DOI 10.3201/eid2302.161012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mallama CA, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00897-16; Moors MA, 1999, CELL MICROBIOL, V1, P249, DOI 10.1046/j.1462-5822.1999.00020.x; Ninio-Many Lihi, 2014, Oncoscience, V1, P250; Opitz B, 2004, J BIOL CHEM, V279, P36426, DOI 10.1074/jbc.M403861200; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Schmeck B, 2007, EUR RESPIR J, V29, P25, DOI 10.1183/09031936.00141005; Schnitger AKD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027435; Schulte LN, 2013, NUCLEIC ACIDS RES, V41, P542, DOI 10.1093/nar/gks1030; Sester DP, 2005, IMMUNOBIOLOGY, V210, P97, DOI 10.1016/j.imbio.2005.05.004; Sijts AJAM, 1997, J BIOL CHEM, V272, P19261, DOI 10.1074/jbc.272.31.19261; Staedel C, 2013, CELL MICROBIOL, V15, P1496, DOI 10.1111/cmi.12159; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Wang Z, 2014, J IMMUNOL, V192, P2349, DOI 10.4049/jimmunol.1302982; Yin F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116759	30	8	8	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176204	10.1371/journal.pone.0176204	http://dx.doi.org/10.1371/journal.pone.0176204			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445535	Green Published, gold, Green Submitted			2022-12-26	WOS:000400309200038
J	Bruce-Keller, AJ; Fernandez-Kim, SO; Townsend, RL; Kruger, C; Carmouche, R; Newman, S; Salbaum, JM; Berthoud, HR				Bruce-Keller, Annadora J.; Fernandez-Kim, Sun-Ok; Townsend, R. Leigh; Kruger, Claudia; Carmouche, Richard; Newman, Susan; Salbaum, J. Michael; Berthoud, Hans-Rudolf			Maternal obese-type gut microbiota differentially impact cognition, anxiety and compulsive behavior in male and female offspring in mice	PLOS ONE			English	Article							DIETARY-FAT INTAKE; INTESTINAL MICROBIOTA; GENE-EXPRESSION; MENTAL-HEALTH; MOUSE MODELS; PREGNANCY; CHILDREN; INFLAMMATION; BUTYRATE; STRESS	Maternal obesity is known to predispose offspring to metabolic and neurodevelopmental abnormalities. While the mechanisms underlying these phenomena are unclear, high fat diets dramatically alter intestinal microbiota, and gut microbiota can impact physiological function. To determine if maternal diet-induced gut dysbiosis can disrupt offspring neurobehavioral function, we transplanted high fat diet-(HFD) or control low fat diet-associated (CD) gut microbiota to conventionally-housed female mice. Recipient mice were then bred and the behavioral phenotype of male and female offspring was tracked. While maternal behavior was unaffected, neonatal offspring from HFD dams vocalized less upon maternal separation than pups from CD dams. Furthermore, weaned male offspring from HFD dams had significant and selective disruptions in exploratory, cognitive, and stereotypical/compulsive behavior compared to male offspring from CD dams; while female offspring from HFD dams had increases in body weight and adiposity. 16S metagenomic analyses confirmed establishment of divergent microbiota in CD and HFD dams, with alterations in diversity and taxonomic distribution throughout pregnancy and lactation. Likewise, significant alterations in gut microbial diversity and distribution were noted in offspring from HFD dams compared to CD dams, and in males compared to females. Regression analyses of behavioral performance against differentially represented taxa suggest that decreased representation of specific members of the Firmicutes phylum predict behavioral decline in male offspring. Collectively, these data establish that high fat diet-induced maternal dysbiosis is sufficient to disrupt behavioral function in murine offspring in a sex-specific manner. Thus these data reinforce the essential link between maternal diet and neurologic programming in offspring and suggest that intestinal dysbiosis could link unhealthy modern diets to the increased prevalence of neurodevelopmental and childhood disorders.	[Bruce-Keller, Annadora J.; Fernandez-Kim, Sun-Ok; Townsend, R. Leigh; Kruger, Claudia; Carmouche, Richard; Newman, Susan; Salbaum, J. Michael; Berthoud, Hans-Rudolf] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Bruce-Keller, AJ (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70803 USA.	annadora.bruce-keller@pbrc.edu	Bruce-Keller, Annadora/N-1954-2017; Berthoud, Hans-Rudolf/N-1950-2017		National Institutes of Health (NIH) [1U54-GM-104940, 3P30-GM118430, 2P30 DK072476, P50AT002776-11]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047348, P30DK072476] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health (NIH) grant 1U54-GM-104940, which funds the Louisiana Clinical and Translational Science Center. This work also utilized Genomics and Animal Behavior/Phenotyping core facilities supported by NIH 3P30-GM118430, NIH 2P30 DK072476, and NIH P50AT002776-11.	Aiken CE, 2013, REPRODUCTION, V145, pR1, DOI 10.1530/REP-11-0489; Angoa-Perez Mariana, 2013, J Vis Exp, P50978, DOI 10.3791/50978; [Anonymous], 2009, NCHS DATA BRIEF; Avila C, 2015, CURR OBES REP, V4, P303, DOI 10.1007/s13679-015-0164-9; Aziz Q, 2013, NEUROGASTROENT MOTIL, V25, P4, DOI 10.1111/nmo.12046; Bajaj JS, 2012, AM J PHYSIOL-GASTR L, V302, pG168, DOI 10.1152/ajpgi.00190.2011; Berg RD, 1996, TRENDS MICROBIOL, V4, P430, DOI 10.1016/0966-842X(96)10057-3; Bested AC, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-4; Bilbo SD, 2010, FASEB J, V24, P2104, DOI 10.1096/fj.09-144014; Boyle CA, 2011, PEDIATRICS, V127, P1034, DOI 10.1542/peds.2010-2989; Bruce-Keller AJ, 2015, BIOL PSYCHIAT, V77, P607, DOI 10.1016/j.biopsych.2014.07.012; Buffington SA, 2016, CELL, V165, P1762, DOI 10.1016/j.cell.2016.06.001; Buie T, 2010, PEDIATRICS, V125, pS19, DOI 10.1542/peds.2009-1878D; Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12. 1519, 10.3748/wjg.v17.i12.1519]; Choleris E, 2001, NEUROSCI BIOBEHAV R, V25, P235, DOI 10.1016/S0149-7634(01)00011-2; Chu DM, 2016, GUT MICROBES, V7, P459, DOI 10.1080/19490976.2016.1241357; Clarke G, 2013, MOL PSYCHIATR, V18, P666, DOI 10.1038/mp.2012.77; Collins SM, 2013, CURR OPIN MICROBIOL, V16, P240, DOI 10.1016/j.mib.2013.06.004; Delorme R, 2013, NAT MED, V19, P685, DOI 10.1038/nm.3193; Dinan TG, 2011, AUST NZ J PSYCHIAT, V45, P1023, DOI 10.3109/00048674.2011.613766; Douglas-Escobar M, 2013, JAMA PEDIATR, V167, P374, DOI 10.1001/jamapediatrics.2013.497; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; El Aidy S, 2016, ADV EXP MED BIOL, V874, P301, DOI 10.1007/978-3-319-20215-0_15; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Finegold SM, 2011, MED HYPOTHESES, V77, P270, DOI 10.1016/j.mehy.2011.04.032; Freeman LR, 2013, FREE RADICAL BIO MED, V56, P226, DOI 10.1016/j.freeradbiomed.2012.08.577; Friedman JE, 2015, DIABETES CARE, V38, P1402, DOI 10.2337/dc15-0628; Gabory A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047986; Galley JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113026; Gallou-Kabani C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014398; Gonzalez Antonio, 2011, Dialogues Clin Neurosci, V13, P55; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Jarchum I, 2011, CURR OPIN IMMUNOL, V23, P353, DOI 10.1016/j.coi.2011.03.001; Johnson EL, 2017, J MOL MED, V95, P1, DOI 10.1007/s00109-016-1492-2; Kang SS, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0156-9; Kim DW, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.117259; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Lerch S, 2016, LAB ANIM-UK, V50, P167, DOI 10.1177/0023677215603260; Li YM, 2015, J AUTISM DEV DISORD; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Luckey T D, 1965, Adv Appl Microbiol, V7, P169, DOI 10.1016/S0065-2164(08)70387-3; Lyall K, 2013, AM J EPIDEMIOL, V178, P209, DOI 10.1093/aje/kws433; Lyte M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003726; Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207; Maftei O, 2015, DIABETIC MED, V32, P174, DOI 10.1111/dme.12637; Mahony SMO, 2015, BIRTH DEFECTS RES C, V105, P296, DOI 10.1002/bdrc.21118; Majidi-Zolbanin J, 2015, NEUROSCIENCE, V294, P69, DOI 10.1016/j.neuroscience.2015.03.016; Maloney CA, 2011, J NUTR, V141, P95, DOI 10.3945/jn.109.119453; Mao J, 2010, P NATL ACAD SCI USA, V107, P5557, DOI 10.1073/pnas.1000440107; Mueller BR, 2007, PHYSIOL BEHAV, V91, P55, DOI 10.1016/j.physbeh.2007.01.017; Murphy EF, 2013, GUT, V62, P220, DOI 10.1136/gutjnl-2011-300705; Myles IA, 2013, J IMMUNOL, V191, P3200, DOI 10.4049/jimmunol.1301057; NJUNGE K, 1991, PHARMACOL BIOCHEM BE, V38, P63, DOI 10.1016/0091-3057(91)90590-X; Ogden CL, 2013, NCHS DATA BRIEF, V131, P1; Ohland CL, 2013, PSYCHONEUROENDOCRINO, V38, P1738, DOI 10.1016/j.psyneuen.2013.02.008; Olfson M, 2014, JAMA PSYCHIAT, V71, P81, DOI 10.1001/jamapsychiatry.2013.3074; Peng LY, 2009, J NUTR, V139, P1619, DOI 10.3945/jn.109.104638; Pinto RQ, 2015, PSYCHIAT GENET, V25, P223, DOI 10.1097/YPG.0000000000000106; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Reikvam DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017996; Alonso VR, 2013, BRIT J NUTR, V109, pS21, DOI 10.1017/S0007114512005235; Rodriguez JS, 2012, INT J DEV NEUROSCI, V30, P75, DOI 10.1016/j.ijdevneu.2011.12.012; Rosenfeld CS, 2015, DRUG METAB DISPOS, V43, P1557, DOI 10.1124/dmd.115.063826; Sacks KN, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.03.030; Scattoni ML, 2009, NEUROSCI BIOBEHAV R, V33, P508, DOI 10.1016/j.neubiorev.2008.08.003; Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI 10.1038/nrc3610; Selkrig J, 2014, GUT MICROBES, V5, P369, DOI 10.4161/gmic.28681; Shih RA, 2004, INT REV PSYCHIATR, V16, P260, DOI 10.1080/09540260400014401; Shoaie S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02532; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Sood R, 2006, P NATL ACAD SCI USA, V103, P5478, DOI 10.1073/pnas.0508035103; Stilling RM, 2016, NEUROCHEM INT, V99, P110, DOI 10.1016/j.neuint.2016.06.011; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sullivan EL, 2014, PHYSIOL BEHAV, V123, P236, DOI 10.1016/j.physbeh.2012.07.014; Sweeney TE, 2013, JAMA SURG, V148, P563, DOI 10.1001/jamasurg.2013.5; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Veena SR, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1011-z; Wang L, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-42; White CL, 2009, NEUROBIOL DIS, V35, P3, DOI 10.1016/j.nbd.2009.04.002; Wilcoxon JS, 2003, AM J PHYSIOL-ENDOC M, V285, pE31, DOI 10.1152/ajpendo.00552.2002; Xuan ICY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104433; Yi P, 2012, VET MICROBIOL, V157, P1, DOI 10.1016/j.vetmic.2011.10.024; Yu ZB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061627; Yuan SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033865; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106	88	41	41	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0175577	10.1371/journal.pone.0175577	http://dx.doi.org/10.1371/journal.pone.0175577			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441394	Green Published, Green Submitted, gold			2022-12-26	WOS:000400308800007
J	Fonceca, AM; Chopra, A; Levy, A; Noakes, PS; Poh, MWP; Bear, NL; Prescott, S; Everard, ML				Fonceca, Angela Mary; Chopra, Abha; Levy, Avram; Noakes, Paul Stanton; Poh, Matthew Wee-Peng; Bear, Natasha Leanne; Prescott, Susan; Everard, Mark Lloyd			Infective respiratory syncytial virus is present in human cord blood samples and most prevalent during winter months	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; HUMAN DENDRITIC CELLS; HIGH-RISK; PERSISTENCE; ASTHMA; ADULTS; PREGNANCY; IMMUNITY; INFANTS; MODEL	Background Human respiratory syncytial virus (RSV) remains the most common cause of severe lower respiratory tract disease amongst infants, and continues to cause annual epidemics of respiratory disease every winter worldwide. Demonstrating placental transmission of viable RSV in human samples is a major paradigm shift in respiratory routes considered likely for RSV transmission. Methods Droplet digital PCR (ddPCR) was used to identify RSV present in cord blood mononucleocytes (CBM). CBMs testing positive for RSV were treated with phytohemagglutinin (PHA), PHA and nitric oxide (NO) or PHA, NO and palivizumab, and co-cultured with HeLa cell monolayers. Subsequent immuno-staining for RSV was used to visualize infective viral plaques. Results RSV was detected in 26 of 45 samples (57.7%) by ddPCR. CBM's collected in winter were more likely to test positive for RSV (17/21 samples, risk = 80%, OR = 7.08; 95% CI 1.80 - 27.80; p = 0.005) compared to non-winter months (9/24 samples, 37.5%). RSV plaques were observed in non-treated and treated co-cultured HeLa monolayers. Conclusions Demonstrating active RSV in CBMs suggests in utero transmission of infective virus to the fetus without causing overt disease. This is likely to have an important impact on immune development as well as future virus-host interactions, thereby warranting further investigation.	[Fonceca, Angela Mary; Poh, Matthew Wee-Peng; Prescott, Susan; Everard, Mark Lloyd] Univ Western Australia, Sch Paediat & Child Hlth, Subiaco, WA, Australia; [Chopra, Abha] Murdoch Univ, Inst Immun & Infect Dis, Murdoch, WA, Australia; [Levy, Avram] Queen Elizabeth II Med Ctr, PathWest Lab Med WA, Nedlands, WA, Australia; [Levy, Avram] Univ Western Australia, Queen Elizabeth II Med Ctr, Sch Pathol & Lab Med, Nedlands, WA, Australia; [Noakes, Paul Stanton; Prescott, Susan] Telethon Kids Inst, Subiaco, WA, Australia; [Bear, Natasha Leanne; Prescott, Susan; Everard, Mark Lloyd] CAHS, Dept Hlth, Subiaco, WA, Australia; [Noakes, Paul Stanton] Univ Notre Dame Australia, Sch Med, Fremantle, WA, Australia	University of Western Australia; Murdoch University; University of Western Australia; University of Western Australia; Telethon Kids Institute; University of Notre Dame Australia	Fonceca, AM (corresponding author), Univ Western Australia, Sch Paediat & Child Hlth, Subiaco, WA, Australia.	angela.fonceca@uwa.edu.au		Poh, Wee Peng/0000-0002-0973-5914; Levy, Avram/0000-0002-0934-2387; Noakes, Paul/0000-0002-2678-1971; Everard, Mark/0000-0003-1571-261X; Chopra, Abha/0000-0001-5008-9080	McCusker Medical Research Foundation; Princess Margaret Hospital for Children Foundation; Wesfarmers Centre for Vaccines and Infectious Diseases	McCusker Medical Research Foundation; Princess Margaret Hospital for Children Foundation; Wesfarmers Centre for Vaccines and Infectious Diseases	This work was supported by McCusker Medical Research Foundation, Princess Margaret Hospital for Children Foundation and Wesfarmers Centre for Vaccines and Infectious Diseases.	Bartz H, 2002, CLIN EXP IMMUNOL, V129, P438, DOI 10.1046/j.1365-2249.2002.01927.x; Bhatt Jayesh M, 2004, Paediatr Respir Rev, V5, P333, DOI 10.1016/j.prrv.2004.07.003; Brownlie J, 1998, CLIN DIAGNOSTIC VIRO, V10; Burt TD, 2013, AM J REPROD IMMUNOL, V69, P346, DOI 10.1111/aji.12083; Calvani M, 2004, ALLERGY, V59, P99, DOI 10.1046/j.1398-9995.2003.00338.x; Commission ALR, 2003, ESS YOURS PROT HUM G, P96; Cubie HA, 1997, PEDIATR PATHOL LAB M, V17, P927, DOI 10.1080/107710497174372; DOMURAT F, 1985, J INFECT DIS, V152, P895, DOI 10.1093/infdis/152.5.895; Dunstan JA, 2003, CLIN EXP ALLERGY, V33, P442, DOI 10.1046/j.1365-2222.2003.01590.x; Everard ML, 2008, RESP SYNCYTIAL VIRUS, P491; Falsey AR, 2006, J MED VIROL, V78, P1493, DOI 10.1002/jmv.20724; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Falsey AR, 2000, CLIN MICROBIOL REV, V13, P371, DOI 10.1128/CMR.13.3.371-384.2000; Fonceca AM, 2015, ERS INT C 2015, V2015; Goic B, 2013, NAT IMMUNOL, V14, P396, DOI 10.1038/ni.2542; Guerrero-Plata A, 2006, AM J RESP CELL MOL, V34, P320, DOI 10.1165/rcmb.2005-0287OC; Hall CB, 2013, CURR TOP MICROBIOL, V372, P39, DOI 10.1007/978-3-642-38919-1_2; HALL CB, 1991, J INFECT DIS, V163, P693, DOI 10.1093/infdis/163.4.693; HEGELE RG, 1994, CHEST, V105, P1848, DOI 10.1378/chest.105.6.1848; Hobson L, 2008, CLIN EXP IMMUNOL, V151, P359, DOI 10.1111/j.1365-2249.2007.03560.x; Huang JQ, 2015, CLIN CHEM, V61, P1408, DOI 10.1373/clinchem.2015.238543; Hughes CH, 1999, CLIN EXP ALLERGY, V29, P1378; Jones A, 2006, CLIN EXP IMMUNOL, V143, P513, DOI 10.1111/j.1365-2249.2005.03004.x; Khan TK, 2015, CURR OPIN ALLERGY CL, V15, P402, DOI 10.1097/ACI.0000000000000209; Mejias A, 2008, PEDIATR INFECT DIS J, V27, pS60, DOI 10.1097/INF.0b013e3181684d52; Murphy VE, 2014, PEDIAT ALLERG IMM-UK, V25, P151, DOI 10.1111/pai.12156; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Piedimonte G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061309; Sande CJ, 2013, J MED VIROL, V85, P2020, DOI 10.1002/jmv.23696; Schwarze J, 2004, AM J RESP CRIT CARE, V169, P801, DOI 10.1164/rccm.200308-1203OC; Seemungal T, 2001, AM J RESP CRIT CARE, V164, P1618, DOI 10.1164/ajrccm.164.9.2105011; Stapleton Jack T, 2014, Trans Am Clin Climatol Assoc, V125, P14; Ugonna K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091855; Wilkinson TMA, 2006, AM J RESP CRIT CARE, V173, P871, DOI 10.1164/rccm.200509-1489OC; Zielinska E, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-84	35	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0173738	10.1371/journal.pone.0173738	http://dx.doi.org/10.1371/journal.pone.0173738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437435	Green Published, gold, Green Submitted			2022-12-26	WOS:000400287600001
J	Koeppen, D; Piepenbrock, C; Kroppenstedt, S; Cabraja, M				Koeppen, Daniel; Piepenbrock, Claudia; Kroppenstedt, Stefan; Cabraja, Mario			The influence of sagittal profile alteration and final lordosis on the clinical outcome of cervical spondylotic myelopathy. A Delta-Omega-analysis	PLOS ONE			English	Article							POSTERIOR LONGITUDINAL LIGAMENT; AOSPINE NORTH-AMERICA; 2-YEAR FOLLOW-UP; RECONSTRUCTIVE TECHNIQUES; SURGICAL-MANAGEMENT; ASYMPTOMATIC ADULTS; SPINAL ALIGNMENT; FUSION SURGERY; T1 SLOPE; ANTERIOR	Purpose Decompression and maintaining or restoring a cervical lordosis are major goals in the surgical treatment of cervical spondylotic myelopathy (CSM). Numerous studies support the assumption that cervical lordosis is a key factor for neurological recovery and pain reduction. However, even kyphotic patients can be asymptomatic. The balance of the spine is subject of an increasing number of publications. The main purpose of the study was to evaluate the validity of lordotic alignment on the course of CSM and to set this parameter in context with well-validated tools, namely the modified Japanese Orthopaedic Association scoring system (mJOAS) and the visual analogue scale (VAS), to predict and measure the clinical outcome after surgery. Methods This is a retrospective study with prospectively collected data of a heterogeneous cohort. The authors analyzed the records of 102 patients suffering from CSM that underwent decompressive surgery and instrumentation. Clinical outcome was assessed by using the mJOAS, VAS and Odom's criteria. The radiological analysis involved comparison of pre- and postoperative radiographs. The patients were divided into subgroups to be able to compare the influence of various amounts of correction (3 Delta-groups: <0 degrees, 1-7 degrees and >= 8 degrees) and final lordosis (4 Omega-groups: 0-7 degrees, 8-14 degrees, 15-21 degrees, >= 22 degrees). Results 219 levels were fused in 102 patients. Surgery improved the clinical outcome of all groups significantly. A lordotic profile was achieved in all analyzed groups. Patients that showed small lordosis after surgery (<8 degrees) did not have an inferior clinical outcome compared to patients with larger cervical lordosis (>4 degrees). The comparison of Odom's criteria showed that preoperatively kyphotic patients benefitted more from surgery than lordotic patients (p = 0.029), but no differences could be seen comparing neck pain and neurological improvement. The improvement of pain and neurological impairment measured by VAS and mJOAS supports the statistical impact and validity of the data despite comparatively small numbers of patients. The lack of postoperative kyphosis is a major limitation of the study to encompass the impact of sagittal alignment on clinical outcome. Conclusions Decompression and stabilization appear to be key elements of surgical treatment of CSM. While the achievement of cervical lordosis remains a major goal of surgery, clinical improvement is not hindered in patients who show small lordosis. However, kyphosis should be eliminated in symptomatic patients. The terms "balance" and "physiologic lordosis" remain complex entities without clear definition. To check the results of our study controlled randomized trials to validate and determine the exact role of cervical balance on the course of CSM would be helpful.	[Koeppen, Daniel] Bundeswehrkrankenhaus Berlin, Dept Orthoped Surg & Traumatol, Berlin, Germany; [Piepenbrock, Claudia; Cabraja, Mario] Vivantes Auguste Viktoria Klinikum, Joint Spine Ctr, Berlin, Germany; [Kroppenstedt, Stefan] Sana Kliniken Sommerfeld, Dept Orthoped Surg, Kremmen, Germany		Cabraja, M (corresponding author), Vivantes Auguste Viktoria Klinikum, Joint Spine Ctr, Berlin, Germany.	mario.cabraja@vivantes.de						Ahn JS, 2010, CLIN ORTHOP SURG, V2, P98, DOI 10.4055/cios.2010.2.2.98; Albert TJ, 1998, SPINE, V23, P1596, DOI 10.1097/00007632-199807150-00017; Ames CP, 2013, SPINE, V38, pS149, DOI 10.1097/BRS.0b013e3182a7f449; Andaluz N, 2012, J NEUROSURG-SPINE, V16, P2, DOI 10.3171/2011.9.SPINE10430; BENZEL EC, 1991, J SPINAL DISORD, V4, P286, DOI 10.1097/00002517-199109000-00005; BOHLMAN HH, 1993, J BONE JOINT SURG AM, V75A, P1298, DOI 10.2106/00004623-199309000-00005; Cabraja M, 2010, CENT EUR NEUROSURG, V71, P59, DOI 10.1055/s-0029-1246135; Cabraja M, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-172; Cabraja M, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.1.FOCUS09253; Cho JH, 2014, SPINE, P39; CONNELL MD, 1992, ORTHOP CLIN N AM, V23, P369; DiAngelo DJ, 2000, SPINE, V25, P783, DOI 10.1097/00007632-200004010-00005; Edwards CC, 2002, SPINE, V27, P1168, DOI 10.1097/00007632-200206010-00007; Emery SE, 1997, SPINE, V22, P2622, DOI 10.1097/00007632-199711150-00008; Fehlings MG, 2013, J BONE JOINT SURG AM, V95A, P1651, DOI 10.2106/JBJS.L.00589; Geisler FH, 1998, SPINE, V23, P911, DOI 10.1097/00007632-199804150-00013; Gu JA, 2015, CLIN NEUROL NEUROSUR, V139, P319, DOI 10.1016/j.clineuro.2015.10.031; Gum JL, 2012, AM J ORTHOP, V41, P81; Hamburger C, 1997, SPINE, V22, P1990, DOI 10.1097/00007632-199709010-00009; Hann S, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.3.FOCUS1429; Hyun SJ, 2016, SPINE, V41, pE396, DOI 10.1097/BRS.0000000000001264; Iyer S, 2016, SPINE, V41, P1826, DOI 10.1097/BRS.0000000000001642; JOHNSTON FG, 1995, J NEUROSURG, V82, P234, DOI 10.3171/jns.1995.82.2.0234; Kaye ID, 2015, EUR SPINE J, V24, P2910, DOI 10.1007/s00586-015-4010-2; Kuntz C, 2008, NEUROSURGERY, V63, pA25, DOI 10.1227/01.NEU.0000313120.81565.D7; Kuntz C, 2007, J NEUROSURG-SPINE, V6, P104, DOI 10.3171/spi.2007.6.2.104; Kurakawa T, 2016, EUR SPINE J, V25, P2060, DOI 10.1007/s00586-016-4548-7; Lawrence BD, 2013, SPINE, V38, pS171, DOI 10.1097/BRS.0b013e3182a7f4ff; Lee CK, 2016, J NEUROSURG-SPINE, V24, P100, DOI 10.3171/2015.4.SPINE141004; Lee JY, 2013, YONSEI MED J, V54, P726, DOI 10.3349/ymj.2013.54.3.726; Lee SH, 2012, J SPINAL DISORD TECH, V25, pE41, DOI 10.1097/BSD.0b013e3182396301; Li XM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140031; Liu Y, 2012, EUR SPINE J, V21, P2428, DOI 10.1007/s00586-012-2323-y; Liu Y, 2012, SPINE, V37, pE1450, DOI 10.1097/BRS.0b013e31826c72b4; Maeno T, 2015, GLOB SPINE J, V5, P118, DOI 10.1055/s-0034-1396759; Manzano GR, 2012, NEUROSURGERY, V70, P264, DOI 10.1227/NEU.0b013e3182305669; Mummaneni PV, 2007, NEUROSURGERY, V60, P82, DOI 10.1227/01.NEU.0000215355.64127.76; ODOM GL, 1958, JAMA-J AM MED ASSOC, V166, P23, DOI 10.1001/jama.1958.02990010025006; Oe S, 2016, SPINE, V41, pE1168, DOI 10.1097/BRS.0000000000001578; Protopsaltis TS, 2015, J NEUROSURG-SPINE, V23, P153, DOI 10.3171/2014.11.SPINE1441; Scheer JK, 2013, J NEUROSURG-SPINE, V19, P141, DOI 10.3171/2013.4.SPINE12838; Shamji MF, 2016, WORLD NEUROSURG, V86, P112, DOI 10.1016/j.wneu.2015.09.044; Shimizu K, 2005, SPINE, V30, P2388, DOI 10.1097/01.brs.0000184378.67465.5c; Smith JS, 2015, J NEUROSURG-SPINE, V23, P349, DOI 10.3171/2014.12.SPINE14777; Smith JS, 2013, SPINE, V38, pS161, DOI 10.1097/BRS.0b013e3182a7eb9e; Suchomel P, 2014, EUR SPINE J, V23, P1124, DOI 10.1007/s00586-014-3223-0; Suda K, 2003, SPINE, V28, P1258, DOI 10.1097/00007632-200306150-00008; Tang JA, 2012, NEUROSURGERY, V71, P662, DOI 10.1227/NEU.0b013e31826100c9; Tetreault LA, 2013, J BONE JOINT SURG AM, V95A, P1659, DOI 10.2106/JBJS.L.01323; Traynelis VC, 2013, SPINE, V38, pS210, DOI 10.1097/BRS.0000000000000009; Wang MY, 2004, SURG NEUROL, V62, P487, DOI 10.1016/j.surneu.2004.02.040; Wu WJ, 2012, EUR SPINE J, V21, P1374, DOI 10.1007/s00586-011-2131-9; Yukawa Y, 2016, EUR SPINE J	53	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0174527	10.1371/journal.pone.0174527	http://dx.doi.org/10.1371/journal.pone.0174527			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430792	Green Published, gold, Green Submitted			2022-12-26	WOS:000399876100005
J	Ransome, E; Geller, JB; Timmers, M; Leray, M; Mahardini, A; Sembiring, A; Collins, AG; Meyer, CP				Ransome, Emma; Geller, Jonathan B.; Timmers, Molly; Leray, Matthieu; Mahardini, Angka; Sembiring, Andrianus; Collins, Allen G.; Meyer, Christopher P.			The importance of standardization for biodiversity comparisons: A case study using autonomous reef monitoring structures (ARMS) and metabarcoding to measure cryptic diversity on Mo'orea coral reefs, French Polynesia	PLOS ONE			English	Article							MARINE BIODIVERSITY; CLIMATE-CHANGE; SAMPLES; PATTERNS; NETWORK	The advancement of metabarcoding techniques, declining costs of high-throughput sequencing and development of systematic sampling devices, such as autonomous reef monitoring structures (ARMS), have provided the means to gather a vast amount of diversity data from cryptic marine communities. However, such increased capability could also lead to analytical challenges if the methods used to examine these communities across local and global scales are not standardized. Here we compare and assess the underlying biases of four ARMS field processing methods, preservation media, and current bioinformatic pipelines in evaluating diversity from cytochrome c oxidase I metabarcoding data. Illustrating the ability of ARMS-based metabarcoding to capture a wide spectrum of biodiversity, 3,372 OTUs and twenty-eight phyla, including 17 of 33 marine metazoan phyla, were detected from 3 ARMS (2.607 m(2) area) collected on coral reefs in Mo'orea, French Polynesia. Significant differences were found between processing and preservation methods, demonstrating the need to standardize methods for biodiversity comparisons. We recommend the use of a standardized protocol (NOAA method) combined with DMSO preservation of tissues for sessile macroorganisms because it gave a more accurate representation of the underlying communities, is cost effective and removes chemical restrictions associated with sample transportation. We found that sequences identified at >= 97% similarity increased more than 7-fold (5.1% to 38.6%) using a geographically local barcode inventory, highlighting the importance of local species inventories. Phylogenetic approaches that assign higher taxonomic ranks accrued phylum identification errors (9.7%) due to sparse taxonomic coverage of the understudied cryptic coral reef community in public databases. However, a >= 85% sequence identity cut-off provided more accurate results (0.7% errors) and enabled phylum level identifications of 86.3% of the sequence reads. With over 1600 ARMS deployed, standardizing methods and improving databases are imperative to provide unprecedented global baseline assessments of understudied cryptic marine species in a rapidly changing world.	[Ransome, Emma; Meyer, Christopher P.] Smithsonian Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC USA; [Geller, Jonathan B.] Moss Landing Marine Labs, Moss Landing, CA USA; [Timmers, Molly] Univ Hawaii, Joint Inst Marine & Atmospher Res, Honolulu, HI USA; [Timmers, Molly] Natl Ocean & Atmospher Adm, Pacif Islands Fisheries Sci Ctr, Ecosyst Sci Div, Honolulu, HI USA; [Leray, Matthieu] Smithsonian Trop Res Inst, Panama City, Panama; [Mahardini, Angka; Sembiring, Andrianus] Indonesian Biodivers Res Ctr, Denpasar, Indonesia; [Sembiring, Andrianus] Udayana Univ, Dept Environm Sci, Denpasar, Indonesia; [Collins, Allen G.] Natl Marine Fisheries Serv, Natl Systemat Lab, Washington, DC USA	Smithsonian Institution; Smithsonian National Museum of Natural History; Moss Landing Marine Laboratories; University of Hawaii System; National Oceanic Atmospheric Admin (NOAA) - USA; Smithsonian Institution; Smithsonian Tropical Research Institute; Universitas Udayana; National Oceanic Atmospheric Admin (NOAA) - USA	Ransome, E (corresponding author), Smithsonian Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC USA.	RansomeE@si.edu	Collins, Allen G/A-7944-2008	Collins, Allen G/0000-0002-3664-9691; Meyer, Christopher/0000-0003-2501-7952; Ransome, Emma/0000-0002-5720-1570; Mahardini, Angka/0000-0001-7812-6015; Leray, Matthieu/0000-0002-7327-1878	National Science Foundation [OISE-1243541]	National Science Foundation(National Science Foundation (NSF))	This work was funded by the National Science Foundation with a "Partnerships for International Research and Education" grant, http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505038 (OISE-1243541). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Rshaidat MMD, 2016, GENOME, V59, P724, DOI 10.1139/gen-2015-0208; Albright R, 2016, NATURE, V531, P362, DOI 10.1038/nature17155; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Davies N, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-2; Davies N, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-5; Davies N, 2012, NATURE, V481, P145, DOI 10.1038/481145a; de Vargas C, 2015, SCIENCE, V348, DOI 10.1126/science.1261605; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Fisher R, 2015, CURR BIOL, V25, P500, DOI 10.1016/j.cub.2014.12.022; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; Foote AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041781; Gaither MR, 2011, CORAL REEFS, V30, P329, DOI 10.1007/s00338-010-0687-1; Geller J, 2013, MOL ECOL RESOUR, V13, P851, DOI 10.1111/1755-0998.12138; Giere O, 2009, MEIOBENTHOLOGY MICRO, DOI 10.1007/978-3-540-68661-3; Glynn PW, 2011, B MAR SCI, V87, P767, DOI 10.5343/bms.2010.1025; Gorley C.K., 2006, GETTING STARTED PRIM; Gorzelak MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134802; Gray MA, 2013, FEMS MICROBIOL ECOL, V83, P468, DOI 10.1111/1574-6941.12008; Hirai J, 2015, J EXP MAR BIOL ECOL, V469, P36, DOI 10.1016/j.jembe.2015.04.011; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hubert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028987; Hurley KKC, 2016, CORAL REEFS, V35, P103, DOI 10.1007/s00338-015-1382-z; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Knowlton Nancy, 2010, P65, DOI 10.1002/9781444325508.ch4; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Kopf A, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0066-5; Leray M, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0331; Leray M, 2015, P NATL ACAD SCI USA, V112, P2076, DOI 10.1073/pnas.1424997112; Leray M, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-34; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Meyer C., 2016, MERRITT COLLECTION M; Munch K, 2008, SYST BIOL, V57, P750, DOI 10.1080/10635150802422316; Pearman JK, 2016, MAR ENVIRON RES, V118, P20, DOI 10.1016/j.marenvres.2016.04.011; Plaisance L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025026; Reaka-Kudla Marjorie L., 1997, P83; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Rocha J, 2014, SCI REP-UK, V4, DOI 10.1038/srep06986; Rogers CS, 2013, ISRN OCEANOGRAPHY, V213, P18; Snelgrove PVR, 1999, BIOSCIENCE, V49, P129, DOI 10.2307/1313538; SUTTLE CA, 1991, APPL ENVIRON MICROB, V57, P721, DOI 10.1128/AEM.57.3.721-726.1991; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Williams ST, 2007, J MOLLUS STUD, V73, P416, DOI 10.1093/mollus/eym039; Zimmerman Todd L., 2004, Gulf and Caribbean Research, V16, P59	47	45	50	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0175066	10.1371/journal.pone.0175066	http://dx.doi.org/10.1371/journal.pone.0175066			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430780	gold, Green Submitted, Green Published			2022-12-26	WOS:000399876100012
J	Bartho, JD; Bellini, D; Wuerges, J; Demitri, N; Toccafondi, M; Schmitt, AO; Zhao, YF; Walsh, MA; Benini, S				Bartho, Joseph D.; Bellini, Dom; Wuerges, Jochen; Demitri, Nicola; Toccafondi, Mirco; Schmitt, Armin O.; Zhao, Youfu; Walsh, Martin A.; Benini, Stefano			The crystal structure of Erwinia amylovora AmyR, a member of the YbjN protein family, shows similarity to type III secretion chaperones but suggests different cellular functions	PLOS ONE			English	Article							RCS PHOSPHORELAY SYSTEM; X-RAY ANALYSIS; SHIGELLA-FLEXNERI; VIRULENCE FACTORS; BIOFILM FORMATION; GENOME SEQUENCE; ANTI-ACTIVATOR; LEVANSUCRASE; EXPRESSION; PATHOGEN	AmyR is a stress and virulence associated protein from the plant pathogenic Enterobacteriaceae species Erwinia amylovora, and is a functionally conserved ortholog of YbjN from Escherichia coli. The crystal structure of E. amylovora AmyR reveals a class I type III secretion chaperone-like fold, despite the lack of sequence similarity between these two classes of protein and lacking any evidence of a secretion-associated role. The results indicate that AmyR, and YbjN proteins in general, function through protein-protein interactions without any enzymatic action. The YbjN proteins of Enterobacteriaceae show remarkably low sequence similarity with other members of the YbjN protein family in Eubacteria, yet a high level of structural conservation is observed. Across the YbjN protein family sequence conservation is limited to residues stabilising the protein core and dimerization interface, while interacting regions are only conserved between closely related species. This study presents the first structure of a YbjN protein from Enterobacteriaceae, the most highly divergent and well-studied subgroup of YbjN proteins, and an in-depth sequence and structural analysis of this important but poorly understood protein family.	[Bartho, Joseph D.; Wuerges, Jochen; Toccafondi, Mirco; Schmitt, Armin O.; Benini, Stefano] Free Univ Bolzano, Fac Sci & Technol, Bioorgan Chem & Biocrystallog Lab B2CI, Piazza Univ 5, Bolzano, Italy; [Bellini, Dom; Walsh, Martin A.] Diamond Light Source, Harwell Sci & Innovat Campus, Didcot, Oxon, England; [Bellini, Dom; Walsh, Martin A.] Res Complex Harwell, Harwell Sci & Innovat Campus, Didcot, Oxon, England; [Demitri, Nicola] Elettra Sincrotrone Trieste, SS 14 Km 163-5 Area Sci Pk, Trieste, Italy; [Schmitt, Armin O.] Georg August Univ Gottingen, Dept Nutztierwissensch, Breeding Informat, Margarethe von Wrangell Weg 7, Gottingen, Germany; [Zhao, Youfu] Univ Illinois, Dept Crop Sci, 1201 W Gregory Dr, Urbana, IL 61801 USA	Free University of Bozen-Bolzano; Diamond Light Source; Elettra Sincrotrone Trieste; University of Gottingen; University of Illinois System; University of Illinois Urbana-Champaign	Benini, S (corresponding author), Free Univ Bolzano, Fac Sci & Technol, Bioorgan Chem & Biocrystallog Lab B2CI, Piazza Univ 5, Bolzano, Italy.	stefano.benini@unibz.it	Demitri, Nicola/O-7469-2015; Benini, Stefano/C-2598-2009; Walsh, Martin A/I-1566-2013	Demitri, Nicola/0000-0003-0288-3233; Benini, Stefano/0000-0001-6299-888X; Walsh, Martin A/0000-0001-5683-1151; Bartho, Joseph Dale/0000-0003-3853-2347; Schmitt, Armin/0000-0002-4910-9467	Free University of Bolzano; Fondazione Libera Universita di Bolzano; Autonomous Province of Bolzano; Faculty of Science and Technology, Free University of Bolzano	Free University of Bolzano; Fondazione Libera Universita di Bolzano; Autonomous Province of Bolzano(Pronvincia Autonoma di Bolzano); Faculty of Science and Technology, Free University of Bolzano	JDB was supported by a predoctoral fellowship from the Free University of Bolzano MT was supported by a postdoctoral fellowship by the Fondazione Libera Universita di Bolzano. The work was supported by the grant: "A structural genomics approach for the study of the virulence and pathogenesis of Erwinia amylovora" from the Autonomous Province of Bolzano and the grant: "GenSelEa" from the Faculty of Science and Technology, Free University of Bolzano. The above mentioned funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." The funder Diamond Light Source Ltd. provided beamtime at the beamlines 104 and 104-1 for data collection, and support in the form of salaries for the authors DB and MAW but did not have any additional role in the study design, data analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abe A, 1999, MOL MICROBIOL, V33, P1162, DOI 10.1046/j.1365-2958.1999.01558.x; Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; BELLEMANN P, 1992, J GEN MICROBIOL, V138, P931, DOI 10.1099/00221287-138-5-931; BERNHARD F, 1993, MOL GEN GENET, V239, P158, DOI 10.1007/BF00281614; BERNHARD F, 1990, MOL PLANT MICROBE IN, V3, P429, DOI 10.1094/MPMI-3-429; Bore E, 2007, MICROBIOL-SGM, V153, P935, DOI 10.1099/mic.0.29288-0; Buttner D, 2012, MICROBIOL MOL BIOL R, V76, P262, DOI 10.1128/MMBR.05017-11; BUGERT P, 1995, MOL MICROBIOL, V15, P917, DOI 10.1111/j.1365-2958.1995.tb02361.x; Byrne RT, 2014, J BACTERIOL, V196, P3534, DOI 10.1128/JB.01589-14; Cambronne ED, 2000, MOL MICROBIOL, V37, P263, DOI 10.1046/j.1365-2958.2000.01974.x; Caputi L, 2013, J AGR FOOD CHEM, V61, P12265, DOI 10.1021/jf4023178; Caputi L, 2013, ACTA CRYSTALLOGR F, V69, P570, DOI 10.1107/S1744309113010750; Chang HY, 1996, MICROB PATHOGENESIS, V20, P255, DOI 10.1006/mpat.1996.0024; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen XN, 2006, BIOCHEM BIOPH RES CO, V345, P834, DOI 10.1016/j.bbrc.2006.04.101; Cooper CA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000751; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dasgupta N, 2004, MOL MICROBIOL, V53, P297, DOI 10.1111/j.1365-2958.2004.04128.x; Dummler A, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-34; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fattori J, 2011, PROTEIN PEPTIDE LETT, V18, P158, DOI 10.2174/092986611794475048; Frey PA, 1996, FASEB J, V10, P461, DOI 10.1096/fasebj.10.4.8647345; FRITHZLINDSTEN E, 1995, MOL MICROBIOL, V16, P635, DOI 10.1111/j.1365-2958.1995.tb02426.x; Fu YX, 1998, J BACTERIOL, V180, P3393, DOI 10.1128/JB.180.13.3393-3399.1998; GROSS M, 1992, PHYSIOL MOL PLANT P, V40, P371, DOI 10.1016/0885-5765(92)90029-U; Hayashi S, 2003, J BIOSCI BIOENG, V95, P379, DOI 10.1263/jbb.95.379; Janjusevic R, 2013, J BACTERIOL, V195, P658, DOI 10.1128/JB.01621-12; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keeney D, 2008, J ANTIMICROB CHEMOTH, V61, P46, DOI 10.1093/jac/dkm397; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Koczan JM, 2011, APPL ENVIRON MICROB, V77, P7031, DOI 10.1128/AEM.05138-11; Koczan JM, 2009, PHYTOPATHOLOGY, V99, P1237, DOI 10.1094/PHYTO-99-11-1237; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lilic M, 2006, MOL CELL, V21, P653, DOI 10.1016/j.molcel.2006.01.026; Lohou D, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00435; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; METZGER M, 1994, J BACTERIOL, V176, P450, DOI 10.1128/JB.176.2.450-459.1994; Moretti S, 2007, NUCLEIC ACIDS RES, V35, pW645, DOI 10.1093/nar/gkm333; Niebuhr K, 2000, MOL MICROBIOL, V38, P8, DOI 10.1046/j.1365-2958.2000.02041.x; Nissinen RM, 2007, MOL PLANT PATHOL, V8, P55, DOI 10.1111/j.1364-3703.2006.00370.x; Norais C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056558; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Parsot C, 2005, MOL MICROBIOL, V56, P1627, DOI 10.1111/j.1365-2958.2005.04645.x; Parsot C, 2003, CURR OPIN MICROBIOL, V6, P7, DOI 10.1016/S1369-5274(02)00002-4; PERSSON C, 1995, MOL MICROBIOL, V18, P135, DOI 10.1111/j.1365-2958.1995.mmi_18010135.x; Phan J, 2004, ACTA CRYSTALLOGR D, V60, P1591, DOI 10.1107/S0907444904017597; Pique N, 2015, INT J MOL SCI, V16, P12836, DOI 10.3390/ijms160612836; Rao XC, 2009, GENE DEV, V23, P1818, DOI 10.1101/gad.1784009; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schubot FD, 2005, J MOL BIOL, V346, P1147, DOI 10.1016/j.jmb.2004.12.036; Sebaihia M, 2010, J Bacteriol, V192, P2020, DOI 10.1128/JB.00022-10; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shen L, 2015, J BIOL CHEM, V290, P28141, DOI 10.1074/jbc.M115.670232; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smits THM, 2010, MOL PLANT MICROBE IN, V23, P384, DOI 10.1094/MPMI-23-4-0384; Smock RG, 2011, J BIOL CHEM, V286, P31821, DOI 10.1074/jbc.M111.265835; Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Toccafondi M, 2014, ACTA CRYSTALLOGR F, V70, P1249, DOI 10.1107/S2053230X14016458; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; van Eerde A, 2004, EMBO REP, V5, P477, DOI 10.1038/sj.embor.7400144; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Vanneste J.L., 2000, FIRE BLIGHT DIS ITS; Vassylyev DG, 1998, J BIOL CHEM, V273, P17604, DOI 10.1074/jbc.273.28.17604; Vrancken K, 2013, MICROBIOL-SGM, V159, P823, DOI 10.1099/mic.0.064881-0; WANG D, 2012, PLOS ONE, V7; Wang D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025011; Wang DP, 2012, MOL PLANT MICROBE IN, V25, P6, DOI 10.1094/MPMI-08-11-0207; Wang DP, 2009, MOL PLANT PATHOL, V10, P277, DOI 10.1111/j.1364-3703.2008.00531.x; WATTIAU P, 1994, P NATL ACAD SCI USA, V91, P10493, DOI 10.1073/pnas.91.22.10493; Wattiau P, 1996, MOL MICROBIOL, V20, P255, DOI 10.1111/j.1365-2958.1996.tb02614.x; Wei CF, 2005, MOL MICROBIOL, V57, P520, DOI 10.1111/j.1365-2958.2005.04704.x; Wei ZM, 2000, MOL PLANT MICROBE IN, V13, P1251, DOI 10.1094/MPMI.2000.13.11.1251; Weikl T, 1999, J MOL BIOL, V293, P685, DOI 10.1006/jmbi.1999.3172; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Woestyn S, 1996, MOL MICROBIOL, V20, P1261, DOI 10.1111/j.1365-2958.1996.tb02645.x; Wuerges J, 2015, J STRUCT BIOL, V191, P290, DOI 10.1016/j.jsb.2015.07.010; Zhao YF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-245	83	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176049	10.1371/journal.pone.0176049	http://dx.doi.org/10.1371/journal.pone.0176049			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426806	gold, Green Submitted, Green Published			2022-12-26	WOS:000399875900094
J	Chen, J; Shi, H; Chen, YL; Fan, SJ; Liu, DY; Li, CH				Chen, Ji; Shi, Hua; Chen, Yonglong; Fan, Shijie; Liu, Dingyi; Li, Chenghua			DNA damage induces expression of WWP1 to target triangle Np63 alpha to degradation	PLOS ONE			English	Article							PROTEIN STABILITY; P53 HOMOLOG; CELL-DIFFERENTIATION; P63 GENE; DELTA-NP63-ALPHA; TRANSCRIPTION; CANCER; PROLIFERATION; APOPTOSIS; SURVIVAL	triangle Np63 alpha plays key roles in cell survival and proliferation. So its expression is always tightly controlled in cells. We previously reported that DNA damage down-regulates transcription of triangle Np63 alpha in FaDu and HaCat cells, which contributes to cell apoptosis. In the present study, we found that DNA damage induces down-regulation of triangle Np63 alpha via facilitating its proteasomal degradation in cell lines such as MDA-MB-231 and MCF10A. Further investigation revealed that transcription of WWP1 is stimulated by DNA damage in these cells. Knockdown of WWP1 abrogates DNA damage-induced down-regulation of triangle Np63 alpha and partially rescues cell apoptosis. Interestingly, DNA damage may stimulate WWP1 through different mechanisms in different cell types: it up-regulates transcription of WWP1 in a p53-dependent manner in MCF10A and HEK293 cells, while miR-452 may be involved in DNA damage-induced up-regulation of WWP1 in MDA-MB-231 cells. Our study demonstrates a novel pathway which regulates triangle Np63 alpha upon cellular response to chemotherapeutic agents.	[Chen, Ji; Chen, Yonglong; Fan, Shijie; Li, Chenghua] Sichuan Univ, Coll Life Sci, Ctr Growth Metab & Aging, Key Lab Biol Resources & Ecol Environm,Minist Edu, Chengdu, Peoples R China; [Chen, Ji; Liu, Dingyi] Seventh Peoples Hosp Chengdu, Dept Med Oncol, Chengdu, Peoples R China; [Shi, Hua] Sichuan Univ, West China Univ Hosp 2, Dept Lab Med, Chengdu, Peoples R China	Sichuan University; Sichuan University	Li, CH (corresponding author), Sichuan Univ, Coll Life Sci, Ctr Growth Metab & Aging, Key Lab Biol Resources & Ecol Environm,Minist Edu, Chengdu, Peoples R China.	lichenghua@scu.edu.cn	Li, Chenghua/L-9825-2019	Li, Chenghua/0000-0003-2978-8762	National Natural Science Foundation of China [31671423]; Science and Technology Department of Sichuan Province [2016JY0152]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Sichuan Province	This work was supported by National Natural Science Foundation of China (#31671423) and and Science and Technology Department of Sichuan Province (#2016JY0152). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Natural Science Foundation of China (#31671423) and and Science and Technology Department of Sichuan Province (#2016JY0152).	Bakkers J, 2005, CELL CYCLE, V4, P790, DOI 10.4161/cc.4.6.1694; Bergholz J, 2014, ONCOGENE, V33, P212, DOI 10.1038/onc.2012.564; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Deutsch GB, 2011, CELL CYCLE, V10, P1884, DOI 10.4161/cc.10.12.15590; Galli F, 2010, J CELL SCI, V123, P2423, DOI 10.1242/jcs.061010; Goto Y, 2016, BRIT J CANCER, V114, P1135, DOI 10.1038/bjc.2016.95; Ihrie RA, 2005, CELL, V120, P843, DOI 10.1016/j.cell.2005.01.008; Keyes WM, 2011, CELL STEM CELL, V8, P164, DOI 10.1016/j.stem.2010.12.009; Li C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.468; Li CH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/175721; Li XR, 2012, BIOCHEM BIOPH RES CO, V423, P338, DOI 10.1016/j.bbrc.2012.05.126; Li Y, 2008, CELL DEATH DIFFER, V15, P1941, DOI 10.1038/cdd.2008.134; Maisse C, 2003, BIOCHEM PHARMACOL, V66, P1555, DOI 10.1016/S0006-2952(03)00511-2; Mangiulli M, 2009, NUCLEIC ACIDS RES, V37, P6092, DOI 10.1093/nar/gkp674; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Murray-Zmijewski F, 2006, CELL DEATH DIFFER, V13, P962, DOI 10.1038/sj.cdd.4401914; Neilsen PM, 2011, ONCOTARGET, V2, P1203; Osada M, 1998, NAT MED, V4, P839, DOI 10.1038/nm0798-839; Peschiaroli A, 2010, BIOCHEM BIOPH RES CO, V402, P425, DOI 10.1016/j.bbrc.2010.10.050; Romano RA, 2012, DEVELOPMENT, V139, P772, DOI 10.1242/dev.071191; Rossi M, 2006, P NATL ACAD SCI USA, V103, P12753, DOI 10.1073/pnas.0603449103; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Trink B, 1998, NAT MED, V4, P747, DOI 10.1038/nm0798-747; van Bokhoven H, 2001, AM J HUM GENET, V69, P481, DOI 10.1086/323123; Wu GJ, 2003, CANCER RES, V63, P2351; Wu GJ, 2005, CANCER RES, V65, P758; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	28	4	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176142	10.1371/journal.pone.0176142	http://dx.doi.org/10.1371/journal.pone.0176142			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426804	gold, Green Submitted, Green Published			2022-12-26	WOS:000399875900106
J	Yu, Q; Tong, C; Luo, MD; Xue, XY; Mei, QY; Ma, LX; Yu, XL; Mao, WX; Kong, LB; Yu, XL; Li, SS				Yu, Qi; Tong, Chong; Luo, Mingdan; Xue, Xiangyan; Mei, Qianyun; Ma, Lixin; Yu, Xiaolan; Mao, Wuxiang; Kong, Lingbao; Yu, Xilan; Li, Shanshan			Regulation of SESAME-mediated H3T11 phosphorylation by glycolytic enzymes and metabolites	PLOS ONE			English	Article							PYRUVATE-KINASE; CANCER METABOLISM; HISTONE H3; GENE; SERINE; YEAST; PKM2	Cancer cells prefer aerobic glycolysis, but little is known about the underlying mechanism. Recent studies showed that the rate-limiting glycolytic enzymes, pyruvate kinase M2 (PKM2) directly phosphorylates H3 at threonine 11 (H3T11) to regulate gene expression and cell proliferation, revealing its non-metabolic functions in connecting glycolysis and histone modifications. We have reported that the yeast homolog of PKM2, Pyk1 phosphorylates H3T11 to regulate gene expression and oxidative stress resistance. But how glycolysis regulates H3T11 phosphorylation remains unclear. Here, using a series of glycolytic enzyme mutants and commercial available metabolites, we investigated the role of glycolytic enzymes and metabolites on H3T11 phosphorylation. Mutation of glycolytic genes including phosphoglucose isomerase (PGI1), enolase (ENO2), triosephosphate isomerase (TPI1), or folate biosynthesis enzyme (FOL3) significantly reduced H3T11 phosphorylation. Further study demonstrated that glycolysis regulates H3T11 phosphorylation by fueling the substrate, phosphoenonylpyruvate and the coactivator, FBP to Pyk1. Thus, our results provide a comprehensive view of how glycolysis modulates H3T11 phosphorylation.	[Yu, Qi; Tong, Chong; Luo, Mingdan; Xue, Xiangyan; Mei, Qianyun; Ma, Lixin; Yu, Xiaolan; Mao, Wuxiang; Yu, Xilan; Li, Shanshan] Hubei Univ, Coll Life Sci, Hubei Collaborat Innovat Ctr Green Transformat Bi, Wuhan, Hunan, Peoples R China; [Kong, Lingbao] Nanchang Univ, Human Aging Res Inst, Dept HumanPopulat Genet, Nanchang, Jiangxi, Peoples R China; [Kong, Lingbao] Nanchang Univ, Sch Life Sci, Nanchang, Jiangxi, Peoples R China	Hubei University; Nanchang University; Nanchang University	Yu, XL; Li, SS (corresponding author), Hubei Univ, Coll Life Sci, Hubei Collaborat Innovat Ctr Green Transformat Bi, Wuhan, Hunan, Peoples R China.	Yuxilan@hubu.edu.cn; shl@hubu.edu.cn	Li, Shanshan/AAF-4758-2020	Li, Shanshan/0000-0002-0359-2369; qi, yu/0000-0001-5704-1792; Li, Shanshan/0000-0002-6424-2792	Hubei Collaborative Innovation Center for Green Transformation of Bio-resources; Hubei University start grant [080-170035]; National Natural Science Foundation of China [31671335, 31600046]; Natural Science Foundation of Hubei Province [2016CFB103]	Hubei Collaborative Innovation Center for Green Transformation of Bio-resources; Hubei University start grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	This project was supported by funding from Hubei Collaborative Innovation Center for Green Transformation of Bio-resources (S.Li), Hubei University start grant (080-170035 to Xilan Yu), National Natural Science Foundation of China (no. 31671335 to S.Li; no. 31600046 to Xilan Yu), and the Natural Science Foundation of Hubei Province (2016CFB103 to Xilan Yu).The funders had no role in study design,data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Professor Markus Ralser (Max Planck Institute for Molecular Genetics, Germany) for providing strains (TEF1pr-PYK1, CYC1pr-PYK1). We thank Professor Zhang Lab in Hubei University for technique support. This project was supported by funding from Hubei Collaborative Innovation Center for Green Transformation of Bio-resources (Shanshan Li), Hubei University start grant (080-170035 to Xilan Yu), Natural Science Foundation of Hubei Province (2016CFB103 to Xilan Yu), National Natural Science Foundation of China (No. 31671335 to Shanshan Li; No. 31600046 to Xilan Yu).	Boles E, 1997, J BACTERIOL, V179, P2987, DOI 10.1128/jb.179.9.2987-2993.1997; Boukouris AE, 2016, TRENDS BIOCHEM SCI, V41, P712, DOI 10.1016/j.tibs.2016.05.013; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Diaz-Ruiz R, 2009, BBA-REV CANCER, V1796, P252, DOI 10.1016/j.bbcan.2009.07.003; Diaz-Ruiz R, 2011, BBA-BIOENERGETICS, V1807, P568, DOI 10.1016/j.bbabio.2010.08.010; Dong L, 2004, J BIOL CHEM, V279, P1577, DOI 10.1074/jbc.C300505200; Fingerman IM, 2005, J BIOL CHEM, V280, P28761, DOI 10.1074/jbc.C500097200; Gruning NM, 2011, CELL METAB, V14, P415, DOI 10.1016/j.cmet.2011.06.017; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jiang L, 2012, NATURE, V489, P511, DOI 10.1038/489511a; Keller KE, 2014, MOL CELL, V53, P700, DOI 10.1016/j.molcel.2014.02.015; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; Li SS, 2015, MOL CELL, V60, P408, DOI 10.1016/j.molcel.2015.09.024; Li SS, 2009, J BIOL CHEM, V284, P9411, DOI 10.1074/jbc.M809617200; Li S, 2008, P NATL ACAD SCI USA, V105, P18243, DOI 10.1073/pnas.0804530105; Liu XS, 2015, ONCOTARGET, V6, P4214, DOI 10.18632/oncotarget.2929; Lu C, 2012, CELL METAB, V16, P9, DOI 10.1016/j.cmet.2012.06.001; MCALISTER L, 1982, J BIOL CHEM, V257, P7181; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Sadhu MJ, 2013, GENETICS, V195, P831, DOI 10.1534/genetics.113.153981; Xu WY, 2016, GENET EPIGENETICS, V8, P43, DOI 10.4137/GEG.S32160; Xu YF, 2012, MOL CELL, V48, P52, DOI 10.1016/j.molcel.2012.07.013; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Ye JB, 2012, P NATL ACAD SCI USA, V109, P6904, DOI 10.1073/pnas.1204176109; Yu X, 2017, ONCOGENE, V36, P2629, DOI 10.1038/onc.2016.410; Yu XL, 2017, ONCOTARGET, V8, P5619, DOI 10.18632/oncotarget.13639	27	15	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175576	10.1371/journal.pone.0175576	http://dx.doi.org/10.1371/journal.pone.0175576			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426732	Green Submitted, Green Published, gold			2022-12-26	WOS:000399875900033
J	Lee, Y; Lee, W; Kanturski, M; Foottit, RG; Akimoto, SI; Lee, S				Lee, Yerim; Lee, Wonhoon; Kanturski, Mariusz; Foottit, Robert G.; Akimoto, Shin-Ichi; Lee, Seunghwan			Cryptic diversity of the subfamily Calaphidinae (Hemiptera: Aphididae) revealed by comprehensive DNA barcoding	PLOS ONE			English	Article							GENETIC-DIVERGENCE; MATE RECOGNITION; IDENTIFICATION; TAXONOMY; LINEAGES; DIPTERA; SPECIFICITY; MORPHOLOGY; SPECIATION; HOMOPTERA	Aphids are a species rich group comprising many important pests. However, species identification can be very difficult for aphids due to their morphological ambiguity. DNA barcoding has been widely adopted for rapid and reliable species identification as well as cryptic species detection. In this study, we investigated cryptic diversity in the subfamily Calaphidinae (Hemiptera: Aphididae) based on 899 sequences of cytochrome c oxidase I (COI) for 115 morphospecies (78 species collected in this study and sequences of 73 species downloaded from Genbank). Among these 115 morphospecies, DNA barcoding results of 90 (78.3%) species were identical to results of morphological identification. However, 25 (21.7%) morphospecies showed discrepancies between DNA barcoding and traditional taxonomy. Among these 25 discordances, a total of 15 cryptic species were identified from 12 morphospecies. We also found three morphologically distinct species pairs that sharing DNA barcoding. Based on molecular operational taxonomic unit (MOTU) estimation, we discussed on species delimitation threshold value for these taxa. Our findings confirm that Calaphidinae has high cryptic diversity even though aphids are relatively well-studied.	[Lee, Yerim; Lee, Seunghwan] Seoul Natl Univ, Lab Insect Biosystemat, Dept Agr Biotechnol, Seoul, South Korea; [Lee, Yerim; Lee, Seunghwan] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Lee, Wonhoon] Gyeongsang Natl Univ, Dept Plant Med, Jinju, South Korea; [Lee, Wonhoon] Gyeongsang Natl Univ, Inst Agr & Life Sci, Jinju, South Korea; [Kanturski, Mariusz] Univ Silesia, Dept Zool, Fac Biol & Environm Protect, Katowice, Poland; [Foottit, Robert G.] Agr & Agri Food Canada, Invertebrate Biodivers, Natl Environm Hlth Program, Ottawa, ON, Canada; [Akimoto, Shin-Ichi] Hokkaido Univ, Lab Systemat Entomol, Dept Ecol & Systemat, Grad Sch Agr,Kita Ku, Sapporo, Hokkaido, Japan	Seoul National University (SNU); Seoul National University (SNU); Gyeongsang National University; Gyeongsang National University; University of Silesia in Katowice; Agriculture & Agri Food Canada; Hokkaido University	Lee, S (corresponding author), Seoul Natl Univ, Lab Insect Biosystemat, Dept Agr Biotechnol, Seoul, South Korea.; Lee, S (corresponding author), Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea.	seung@snu.ac.kr	Lee, Seunghwan/E-4992-2011	Kanturski, Mariusz/0000-0002-1674-1028	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science [NRF-2015R1D1A1A01059031]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science(National Research Foundation of Korea)	This project was funded by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science (NRF-2015R1D1A1A01059031).; We are grateful to Hyoseok Lee for his great support and help particularly collecting samples with Yerim Lee. We thanks to Dr. Hyojoong Kim, Dr. Jaroslav Holman, Dr. Jong-Kook Jung, Dr. Lukasz Depa and Dr. Ram Duwal Keshari. This project was funded by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science (NRF-2015R1D1A1A01059031).	Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; BLACKMAN RL, 1994, EUR J ENTOMOL, V91, P7; Blackman RL, APHIDS WORLDS PLANTS; Blackman RL, 2000, APHIDS WORLDS CROPS, P2; Borowiak-Sobkowiak BE, 2010, APHIDS OTHER HEMIPTE, V16, P2735; Chen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046190; Cocuzza GEM, 2014, MOL ECOL RESOUR, V14, P447, DOI 10.1111/1755-0998.12199; Coeur d'acier A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097620; Cook LG, 2010, INVERTEBR SYST, V24, P322, DOI 10.1071/IS10011; Cottrell TE, 2010, PEST MANAG SCI, V66, P1236, DOI 10.1002/ps.2000; Delmotte F, 2003, EVOLUTION, V57, P1291, DOI 10.1111/j.0014-3820.2003.tb00337.x; Dres M, 2002, PHILOS T R SOC B, V357, P471, DOI 10.1098/rstb.2002.1059; Eastop VF, 1977, WORLDWIDE IMPORTANCE, P3; Favret C., APHID SPECIES FILE V; Federhen S, 2012, NUCLEIC ACIDS RES, V40, pD136, DOI 10.1093/nar/gkr1178; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fontaneto D, 2015, MAR BIODIVERS, V45, P433, DOI 10.1007/s12526-015-0319-7; Foottit RG, 2008, MOL ECOL RESOUR, V8, P1189, DOI 10.1111/j.1755-0998.2008.02297.x; Foottit RG, 2006, P ENTOMOL SOC WASH, V108, P583; Foottit Robert G., 2009, Redia, V92, P87; GULDEMOND JA, 1994, ENTOMOL EXP APPL, V73, P67, DOI 10.1007/BF02382515; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; HALBERT SE, 1990, P ENTOMOL SOC WASH, V92, P672; Halbert SE, 1998, ASIAN WOOLLY HACKBER, P2; Han T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148602; Hardie J, 2013, COMPREHENSIVE INSECT, P441; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Herbert JJ, 2008, ENCY ENTOMOLOGY, P1103; Higuchi H., 1972, Insecta Matsum, V35, P19; Hopkins GW, 2000, EUR J ENTOMOL, V97, P279, DOI 10.14411/eje.2000.044; Johnson SN, 2003, OECOLOGIA, V134, P388, DOI 10.1007/s00442-002-1139-6; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kondo Takumasa, 2014, Insecta Mundi, V362, P1; LAMBERS DHR, 1966, ANNU REV ENTOMOL, V11, P47, DOI 10.1146/annurev.en.11.010166.000403; Lee W, 2015, J ASIA-PAC ENTOMOL, V18, P267, DOI 10.1016/j.aspen.2015.03.003; Lee W, 2011, MOL ECOL RESOUR, V11, P32, DOI 10.1111/j.1755-0998.2010.02877.x; Lee Y, 2015, B ENTOMOL RES, V105, P40, DOI 10.1017/S0007485314000704; Liu QH, 2013, INVERTEBR SYST, V27, P428, DOI 10.1071/IS13014; Margaritopoulos JT, 2000, B ENTOMOL RES, V90, P233, DOI 10.1017/S0007485300000353; MARTIN JH, 1983, TROP PEST MANAGE, V29, P395, DOI 10.1080/09670878309370834; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Messing RH, 2007, BIOL INVASIONS, V9, P601, DOI 10.1007/s10530-006-9045-1; Miyazaki M., 1987, APHIDS THEIR BIOL NA, P27; Moulton MJ, 2010, MOL ECOL RESOUR, V10, P615, DOI 10.1111/j.1755-0998.2009.02823.x; Nebreda M, 2004, VIRUS RES, V100, P83, DOI 10.1016/j.virusres.2003.12.016; Nzelu CO, 2015, ACTA TROP, V145, P45, DOI 10.1016/j.actatropica.2015.02.003; Park DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018749; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P7495, DOI 10.1073/pnas.0811117106; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Quednau FW, 2003, ATLAS DREPANOSIPHI 2, P301; Quednau FW, 1999, ATLAS DREPANOSIPHI 1, P218; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Raupach MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106940; Renaud AK, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-24; ROHITHA BH, 1982, NEW ZEAL ENTOMOL, V7, P317, DOI 10.1080/00779962.1982.9722409; Saitoh T, 2015, MOL ECOL RESOUR, V15, P177, DOI 10.1111/1755-0998.12282; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STERN VERNON M., 1959, HILGARDIA, V29, P81; Stuart BL, 2006, BIOL LETTERS, V2, P470, DOI 10.1098/rsbl.2006.0505; STURMBAUER C, 1992, NATURE, V358, P578, DOI 10.1038/358578a0; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang CQ, 2014, METHODS ECOL EVOL, V5, P1086, DOI 10.1111/2041-210X.12246; Teulon DAJ, 2002, BIOSECURITY APHIDS N, P12; Thieme T, 1996, ENTOMOL EXP APPL, V79, P85, DOI 10.1007/BF00333825; Tsuchida T, 2010, SCIENCE, V330, P1102, DOI 10.1126/science.1195463; Via S, 2000, EVOLUTION, V54, P1626, DOI 10.1111/j.0014-3820.2000.tb00707.x; Watanabe T, 2015, ENTOMOL SCI, V18, P55, DOI 10.1111/ens.12111; Weisser WW, 1999, P ROY SOC B-BIOL SCI, V266, P1175, DOI 10.1098/rspb.1999.0760; Wood BW, 1997, HORTSCIENCE, V32, P1074, DOI 10.21273/HORTSCI.32.6.1074; Wool D, 1997, ANN ENTOMOL SOC AM, V90, P316, DOI 10.1093/aesa/90.3.316; Yao I, 2012, BIOL LETTERS, V8, P624, DOI 10.1098/rsbl.2012.0014; Yao I, 2011, CAN ENTOMOL, V143, P35, DOI 10.4039/n10-050; Zahiri R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092797; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	79	16	18	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176582	10.1371/journal.pone.0176582	http://dx.doi.org/10.1371/journal.pone.0176582			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448639	gold, Green Submitted, Green Published			2022-12-26	WOS:000400383600107
J	Strachecka, A; Chobotow, J; Paleolog, J; Los, A; Schulz, M; Teper, D; Kucharczyk, H; Grzybek, M				Strachecka, Aneta; Chobotow, Jacek; Paleolog, Jerzy; Los, Aleksandra; Schulz, Michal; Teper, Dariusz; Kucharczyk, Halina; Grzybek, Maciej			Insights into the biochemical defence and methylation of the solitary bee Osmia rufa L: A foundation for examining eusociality development	PLOS ONE			English	Article							FAT-BODY CELLS; HONEY-BEE; GENOME SEQUENCE; JUVENILE-HORMONE; OXIDATIVE STRESS; DNA METHYLATION; AEDES-AEGYPTI; LIFE-SPAN; EVOLUTION; DIAPAUSE	We examined age-related biochemical and histological changes in the fat bodies and hemolymph of Osmia rufa males and females. We analysed solitary bees during diapause, in October and in April; as well as the flying insects following diapause, in May and June. The trophocyte sizes, as well as the numbers of lipid droplets were the greatest at the beginning of diapause. Subsequently, they decreased along with age. Triglyceride and glucose concentrations systematically decreased in fat body cells but increased in the hemolymph from October to June. Concentrations/activities of (enzymatic and non-enzymatic) antioxidant and proteolytic systems, as well as phenoloxidase, aspartate aminotransferase, alanine aminotransferase and alkaline phosphatase levels were constant during the diapause, usually lower in the males than the females. Prior to the diapause/overwintering, the concentrations/activities of all the compounds were higher in the fat bodies than in the hemolymph. Later in the spring and in the summer, they increased in the hemolymph and on the body surfaces, while decreasing in the fat bodies. The global DNA methylation levels increased with age. Higher levels were always observed in the males than in the females. The study will promote better understanding of bee evolution and will be useful for the protection and management of solitary bees, with benefits to the environment and agriculture.	[Strachecka, Aneta; Los, Aleksandra; Schulz, Michal] Univ Life Sci Lublin, Fac Biol Anim Sci & Bioecon, Dept Biol Basis Anim Prod, Akad 13, Lublin, Poland; [Chobotow, Jacek] Marie Curie Sklodowska Univ, Fac Biol & Biotechnol, Inst Biol & Biochem, Zool Museum Lab, Akad 19, Lublin, Poland; [Paleolog, Jerzy] Univ Life Sci Lublin, Fac Biol Anim Sci & Bioecon, Dept Zool Anim Ecol & Wildlife Management, Akad 13, Lublin, Poland; [Teper, Dariusz] Apicultural Div Pulawy, Res Inst Hort, Kazimierska 2, Pulawy, Poland; [Kucharczyk, Halina] Marie Curie Sklodowska Univ, Fac Biol & Biotechnol, Inst Biol & Biochem, Dept Zool, Akad 19, Lublin, Poland; [Grzybek, Maciej] Univ Life Sci Lublin, Fac Vet Med, Dept Parasitol & Invas Dis, Akad 12, Lublin, Poland; [Grzybek, Maciej] Polish Acad Sci Jastrzebiec, Inst Genet & Anim Breeding, Dept Mol Biol, Postepu 36A, Magdalenka, Poland	University of Life Sciences in Lublin; Maria Curie-Sklodowska University; University of Life Sciences in Lublin; Research Institute of Horticulture; Maria Curie-Sklodowska University; University of Life Sciences in Lublin; Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Polish Academy of Sciences	Strachecka, A (corresponding author), Univ Life Sci Lublin, Fac Biol Anim Sci & Bioecon, Dept Biol Basis Anim Prod, Akad 13, Lublin, Poland.	aneta.strachecka@up.lublin.pl	Grzybek, Maciej/D-7395-2013; Kucharczyk, Halina/G-6636-2016; Paleolog, Jerzy/U-5290-2018; Teper, Dariusz/S-5267-2018	Grzybek, Maciej/0000-0002-8780-0304; Kucharczyk, Halina/0000-0001-5341-1872; Paleolog, Jerzy/0000-0002-4447-4318; Teper, Dariusz/0000-0003-2950-2816; Strachecka, Aneta/0000-0003-1313-9880	Ministry of Science and Higher Education in Poland; National Centre for Science, Poland PRELUDIUM [2012/07/N/NZ9/02060]; Young Scientists at University of Life Sciences in Lublin, Poland [WCZ/MN/12];  [ZKB/MN/5 2012-2016]	Ministry of Science and Higher Education in Poland(Ministry of Science and Higher Education, Poland); National Centre for Science, Poland PRELUDIUM; Young Scientists at University of Life Sciences in Lublin, Poland; 	This work was carried out as part of the research project ZKB/MN/5 2012-2016, financed by the Ministry of Science and Higher Education in Poland, managed by Aneta Strachecka (http://www.nauka.gov.pI/en/). Maciej Grzybek was funded by National Centre for Science (http://ncn.gov.pI/?language=en), Poland PRELUDIUM Grant no. 2012/07/N/NZ9/02060 and by Funding for Young Scientists (WCZ/MN/12) at University of Life Sciences in Lublin, Poland (http://up.lublin.pl).	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Aebi HE, 1983, METHOD ENZYMAT AN, V3, P277; Amarasinghe HE, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2502; [Anonymous], 1996, ACTA ACAD AGR TECH O, V24, P113; Anson ML, 1938, J GEN PHYSIOL, V22, P79, DOI 10.1085/jgp.22.1.79; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Augustyniak Agnieszka, 2004, Postepy Hig Med Dosw (Online), V58, P194; Badisco L, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00202; Barribeau SM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0628-y; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Bode W, 1999, APMIS, V107, P3, DOI 10.1111/j.1699-0463.1999.tb01520.x; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; Bosch J, 2010, J INSECT PHYSIOL, V56, P1949, DOI 10.1016/j.jinsphys.2010.08.017; Bourke AFG, 2011, P ROY SOC B-BIOL SCI, V278, P3313, DOI 10.1098/rspb.2011.1465; Burzynski S, 2006, GENE SILENCING, P33; Cane JH, 2016, J INSECT PHYSIOL, V95, P105, DOI 10.1016/j.jinsphys.2016.09.011; CHANCE B, 1955, METHOD ENZYMOL, V2, P764, DOI 10.1016/S0076-6879(55)02300-8; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Collins AM, 2004, INSECT MOL BIOL, V13, P141, DOI 10.1111/j.0962-1075.2004.00469.x; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; Cruz-Landim C., 1983, NATURALIA, V8, P7; DAVIES K J A, 1986, Journal of Free Radicals in Biology and Medicine, V2, P155, DOI 10.1016/S0748-5514(86)80066-6; de Oliveira VTP, 2004, IHERINGIA SERIE ZOOL, V94; Dmochowska K, 2012, J APIC SCI, V56, P99, DOI 10.2478/v10289-012-0011-0; Dmochowska-Slezak K, 2015, APIDOLOGIE, V46, P432, DOI 10.1007/s13592-014-0333-y; Dmochowska-Slezak K, 2015, PHYSIOL ENTOMOL, V40, P82, DOI 10.1111/phen.12090; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Fliszkiewicz M, 2012, ENVIRON ENTOMOL, V41, P1621, DOI 10.1603/EN12004; FROHLICH DR, 1989, COMP BIOCHEM PHYS B, V94, P661, DOI 10.1016/0305-0491(89)90146-6; Gaetschenberger H, 2012, J EXP BIOL, V215, P1313, DOI 10.1242/jeb.065276; Gerloff CU, 2003, FUNCT ECOL, V17, P582, DOI 10.1046/j.1365-2435.2003.00769.x; Giejdasz Karol, 2002, Journal of Apicultural Science, V46, P51; Grzywnowicz K, 2009, APIDOLOGIE, V40, P4, DOI 10.1051/apido:2008057; Hahn DA, 2007, J INSECT PHYSIOL, V53, P760, DOI 10.1016/j.jinsphys.2007.03.018; Havukainen H, 2011, J EXP BIOL, V214, P582, DOI 10.1242/jeb.048314; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Hunt BG, 2010, GENOME BIOL EVOL, V2, P719, DOI 10.1093/gbe/evq057; Ivanova E., 2007, J CELL MOL BIOL, V6, P129; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; LEE TM, 1995, PLANT SCI, V106, P43, DOI 10.1016/0168-9452(95)04058-3; Lipinski Z, 2005, J APICULT RES, V44, P126, DOI 10.1080/00218839.2005.11101163; Lockett GA, 2012, GENES BRAIN BEHAV, V11, P235, DOI 10.1111/j.1601-183X.2011.00751.x; Lopez-Uribe MM, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0984; Lyko F, 2011, TRENDS GENET, V27, P127, DOI 10.1016/j.tig.2011.01.003; Munch D, 2008, FUNCT ECOL, V22, P407, DOI 10.1111/j.1365-2435.2008.01419.x; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Oakeshott JG, 2010, INSECT MOL BIOL, V19, P147, DOI 10.1111/j.1365-2583.2009.00961.x; oltowska K, 2014, J APIC SCI, V58; Paes-De-Oliveira VT, 2008, MICRON, V39, P426, DOI 10.1016/j.micron.2007.02.002; Paes-de-Oliveira Vagner Tadeu, 2006, Brazilian Journal of Morphological Sciences, V23, P385; Parker JD, 2004, P NATL ACAD SCI USA, V101, P3486, DOI 10.1073/pnas.0400222101; PODCZASY JJ, 1988, BIOCHEM BIOPH RES CO, V150, P1294, DOI 10.1016/0006-291X(88)90770-X; Pohorecka K, 2014, J APIC SCI, V58, P107, DOI 10.2478/JAS-2014-0027; Poiani SB, 2012, MICRON, V43, P475, DOI 10.1016/j.micron.2011.11.006; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Ptaszynska AA, 2016, PARASITOL RES, V115, P397, DOI 10.1007/s00436-015-4761-z; Ranadive P, 2011, INT PR CHEM BIO ENV, V3, P141; Rangel J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122208; Remolina SC, 2008, AGE, V30, P177, DOI 10.1007/s11357-008-9061-4; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Robinson GE, 2005, NAT REV GENET, V6, P257, DOI 10.1038/nrg1575; Sadd BM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0623-3; Salmon AB, 2010, FREE RADICAL BIO MED, V48, P642, DOI 10.1016/j.freeradbiomed.2009.12.015; Sapcaliu A., 2010, Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca. Animal Science and Biotechnologies, V67, P313; SCHACTERLE GR, 1973, ANAL BIOCHEM, V51, P654, DOI 10.1016/0003-2697(73)90523-X; Schmid MR, 2008, J INSECT PHYSIOL, V54, P439, DOI 10.1016/j.jinsphys.2007.11.002; Sgolastra F, 2016, ECOL ENTOMOL, V41, P201, DOI 10.1111/een.12292; Sgolastra F, 2012, J INSECT PHYSIOL, V58, P924, DOI 10.1016/j.jinsphys.2012.04.008; Sritunyalucksana K, 2000, AQUACULTURE, V191, P53, DOI 10.1016/S0044-8486(00)00411-7; Steinmann N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129956; Strachecka A, 2015, BIOCHEMISTRY-MOSCOW+, V80, P1019, DOI 10.1134/S0006297915080076; Strachecka A, 2014, BIOCHEMISTRY-MOSCOW+, V79, P1192, DOI 10.1134/S0006297914110066; Strachecka A, 2015, J APIC SCI, V59; Strachecka AJ, 2011, CZECH J ANIM SCI, V56, P15, DOI 10.17221/150/2009-CJAS; Strachecka Aneta, 2008, Medycyna Weterynaryjna, V64, P1256; Strachecka A, 2016, ENTOMOL EXP APPL, V160, P57, DOI 10.1111/eea.12451; Strachecka A, 2014, ARCH INSECT BIOCHEM, V86, P165, DOI 10.1002/arch.21159; Strachecka AJ, 2008, J APIC SCI, V52, P49; Strachecka AJ, 2010, POL J ENVIRON STUD, V19, P855; Straub L, 2015, CURR OPIN INSECT SCI, V12, P109, DOI 10.1016/j.cois.2015.10.010; SZATHMARY E, 1995, NATURE, V374, P227, DOI 10.1038/374227a0; Szentgyorgyi H, 2013, APIDOLOGIE, V44, P334, DOI 10.1007/s13592-012-0185-2; Teper D, 2004, J APIC SCI, V48, P69; Teper D, 2009, J APIC SCI, V53, P115; Vavilova V, 2015, PARASITOL RES, V114, P3373, DOI 10.1007/s00436-015-4562-4; WARHOLM M, 1985, METHOD ENZYMOL, V113, P499; Weiner SA, 2012, GENET RES INT, V2012, DOI 10.1155/2012/609810; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Weirich GF, 2002, APIDOLOGIE, V33, P3, DOI 10.1051/apido:2001001; West SA, 2007, CURR BIOL, V17, pR661, DOI 10.1016/j.cub.2007.06.004; Whitehorn PR, 2011, P ROY SOC B-BIOL SCI, V278, P1195, DOI 10.1098/rspb.2010.1550; Wilkaniec Z, 2003, J APICULT RES, V42, P29, DOI 10.1080/00218839.2003.11101084; Wilson-Rich N, 2008, J INSECT PHYSIOL, V54, P1392, DOI 10.1016/j.jinsphys.2008.07.016; Woodard SH, 2011, P NATL ACAD SCI USA, V108, P7472, DOI 10.1073/pnas.1103457108; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Zhou GL, 2004, INSECT BIOCHEM MOLEC, V34, P919, DOI 10.1016/j.ibmb.2004.05.009; Zufelato MS, 2004, INSECT BIOCHEM MOLEC, V34, P1257, DOI 10.1016/j.ibmb.2004.08.005	98	22	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176539	10.1371/journal.pone.0176539	http://dx.doi.org/10.1371/journal.pone.0176539			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448564	Green Submitted, Green Published, gold			2022-12-26	WOS:000400383600100
J	Wang, JM; Pei, LM; Jin, Z; Zhang, KW; Zhang, JR				Wang, Jiemin; Pei, Laming; Jin, Zhe; Zhang, Kewei; Zhang, Juren			Overexpression of the protein phosphatase 2A regulatory subunit a gene ZmPP2AA1 improves low phosphate tolerance by remodeling the root system architecture of maize	PLOS ONE			English	Article							PHOSPHORUS ACQUISITION EFFICIENCY; ZEA-MAYS L.; AUXIN-TRANSPORT; CATALYTIC SUBUNITS; ARABIDOPSIS; AVAILABILITY; STARVATION; RESPONSES; DEFICIENCY; INITIATION	Phosphate (Pi) limitation is a constraint for plant growth and development in many natural and agricultural ecosystems. In this study, a gene encoding Zea mays L. protein phosphatase 2A regulatory subunit A, designated ZmPP2AA1, was induced in roots by low Pi availability. The function of the ZmPP2AA1 gene in maize was analyzed using overexpression and RNA interference. ZmPP2AA1 modulated root gravitropism, negatively regulated primary root (PR) growth, and stimulated the development of lateral roots (LRs). A detailed characterization of the root system architecture (RSA) in response to different Pi concentrations with or without indole-3-acetic acid and 1-N-naphthylphthalamic acid revealed that auxin was involved in the RSA response to low Pi availability. Overexpression of ZmPP2AA1 enhanced tolerance to Pi starvation in transgenic maize in hydroponic and soil pot experiments. An increased dry weight (DW), root-to-shoot ratio, and total P content and concentration, along with a delayed and reduced accumulation of anthocyanin in overex-pressing transgenic maize plants coincided with their highly branched root system and increased Pi uptake capability under low Pi conditions. Inflorescence development of the ZmPP2AA1 overexpressing line was less affected by low Pi stress, resulting in higher grain yield per plant under Pi deprivation. These data reveal the biological function of ZmPP2AA1, provide insights into a linkage between auxin and low Pi responses, and drive new strategies for the efficient utilization of Pi by maize.	[Wang, Jiemin; Pei, Laming; Jin, Zhe; Zhang, Kewei; Zhang, Juren] Shandong Univ, Sch Life Sci, Minist Educ, Key Lab Plant Cell Engn & Germplasm Enhancement, Jinan, Peoples R China; [Pei, Laming] Univ Jinan, Sch Biol Sci & Technol, Dept Biotechnol, Jinan, Peoples R China	Shandong University; University of Jinan	Wang, JM (corresponding author), Shandong Univ, Sch Life Sci, Minist Educ, Key Lab Plant Cell Engn & Germplasm Enhancement, Jinan, Peoples R China.	wangjiemin@mail.sdu.edu.cn	zhang, ke/AAH-8217-2019		National Genetically Modified Organism Major Projects of China [2011ZX08003-005]	National Genetically Modified Organism Major Projects of China	This work was supported by the National Genetically Modified Organism Major Projects of China (2011ZX08003-005) (http://program.most.gov.cn). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamowski M, 2015, PLANT CELL, V27, P20, DOI 10.1105/tpc.114.134874; Al-Ghazi Y, 2003, PLANT CELL ENVIRON, V26, P1053, DOI 10.1046/j.1365-3040.2003.01030.x; Balzan S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00393; Bayuelo-Jimenez J S, 2011, FIELD CROPS RES, V121, P350, DOI DOI 10.1016/J.FCR.2011.01.001; Blakeslee JJ, 2008, PLANT PHYSIOL, V146, P539, DOI 10.1104/pp.107.112995; Bonser AM, 1996, NEW PHYTOL, V132, P281, DOI 10.1111/j.1469-8137.1996.tb01847.x; Carraro N, 2006, PLANT PHYSIOL, V142, P254, DOI 10.1104/pp.106.080119; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; CLAASSEN N, 1974, PLANT PHYSIOL, V54, P564, DOI 10.1104/pp.54.4.564; Deruere J, 1999, PLANT J, V20, P389, DOI 10.1046/j.1365-313x.1999.00607.x; DREW MC, 1978, J EXP BOT, V29, P435, DOI 10.1093/jxb/29.2.435; DREW MC, 1975, NEW PHYTOL, V75, P479, DOI 10.1111/j.1469-8137.1975.tb01409.x; Forestan C, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00016; Forestan C, 2010, PLANT SIGNAL BEHAV, V5, P436, DOI 10.4161/psb.5.4.11339; Forestan C, 2010, PLANT PHYSIOL, V152, P1373, DOI 10.1104/pp.109.150193; Friml J, 2004, SCIENCE, V306, P862, DOI 10.1126/science.1100618; Fu JH, 2012, ANAL SCI, V28, P1081, DOI 10.2116/analsci.28.1081; Garbers C, 1996, EMBO J, V15, P2115, DOI 10.1002/j.1460-2075.1996.tb00565.x; Harris DM, 1999, PLANT PHYSIOL, V121, P609, DOI 10.1104/pp.121.2.609; Hochholdinger F, 2008, CURR OPIN PLANT BIOL, V11, P70, DOI 10.1016/j.pbi.2007.10.002; Huang F, 2010, PLANT CELL, V22, P1129, DOI 10.1105/tpc.109.072678; Jain A, 2007, PLANT PHYSIOL, V144, P232, DOI 10.1104/pp.106.092130; Jansen L, 2012, PHILOS T R SOC B, V367, P1525, DOI 10.1098/rstb.2011.0239; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Johnson JF, 1996, PLANT PHYSIOL, V112, P31, DOI 10.1104/pp.112.1.31; Kwak JM, 2002, PLANT CELL, V14, P2849, DOI 10.1105/tpc.003335; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larsen PB, 2003, PLANT J, V34, P709, DOI 10.1046/j.1365-313X.2003.01762.x; Li B, 2008, PLANT BIOTECHNOL J, V6, P146, DOI 10.1111/j.1467-7652.2007.00301.x; Li KP, 2014, PLANT PHYSIOL BIOCH, V83, P232, DOI 10.1016/j.plaphy.2014.08.007; Li ZX, 2011, PLANTA, V233, P1129, DOI 10.1007/s00425-011-1368-1; Lin HJ, 2013, MOL BIOL REP, V40, P5359, DOI 10.1007/s11033-013-2636-x; Linkohr BI, 2002, PLANT J, V29, P751, DOI 10.1046/j.1365-313X.2002.01251.x; Liu DY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098855; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Bucio J, 2005, PLANT PHYSIOL, V137, P681, DOI 10.1104/pp.104.049577; Lopez-Bucio J, 2003, CURR OPIN PLANT BIOL, V6, P280, DOI 10.1016/S1369-5266(03)00035-9; Lopez-Bucio J, 2002, PLANT PHYSIOL, V129, P244, DOI 10.1104/pp.010934; Luo JH, 2006, PLANT J, V46, P649, DOI 10.1111/j.1365-313X.2006.02730.x; Lynch Jonathan P., 2008, V7, P83; Majer C, 2012, PHILOS T R SOC B, V367, P1542, DOI 10.1098/rstb.2011.0238; Pais SM, 2009, PLANT SIGNAL BEHAV, V4, P1013, DOI 10.4161/psb.4.11.9783; Pais SM, 2009, PLANTA, V230, P13, DOI 10.1007/s00425-009-0923-5; Marschner H, 1995, FUNCTIONS MINERAL NU, P229; Michniewicz M, 2007, CELL, V130, P1044, DOI 10.1016/j.cell.2007.07.033; Miura K, 2011, PLANT PHYSIOL, V155, P1000, DOI 10.1104/pp.110.165191; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Nacry P, 2005, PLANT PHYSIOL, V138, P2061, DOI 10.1104/pp.105.060061; Nicholas KB, 1996, EMBNEW NEWS, V4, P28; Niu YF, 2013, ANN BOT-LONDON, V112, P391, DOI 10.1093/aob/mcs285; Onanuga A. O., 2012, Journal of Agricultural Science (Toronto), V4, P93; Peret B, 2011, TRENDS PLANT SCI, V16, P442, DOI 10.1016/j.tplants.2011.05.006; Perez-Torres CA, 2008, PLANT CELL, V20, P3258, DOI 10.1105/tpc.108.058719; Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3; Postma JA, 2014, PLANT PHYSIOL, V166, P590, DOI 10.1104/pp.113.233916; Rashotte AM, 2001, PLANT CELL, V13, P1683, DOI 10.1105/tpc.13.7.1683; Saleem M, 2010, PLANT PHYSIOL, V152, P4, DOI 10.1104/pp.109.150425; Sambrook J., 2001, MOL CLONING LAB MANU; Shen CJ, 2013, PLANT CELL ENVIRON, V36, P607, DOI 10.1111/pce.12001; Shin H, 2012, PLANT J, V22, P555; Smith S, 2012, PHILOS T R SOC B, V367, P1441, DOI 10.1098/rstb.2011.0234; Sukumar P, 2009, PLANT PHYSIOL, V150, P722, DOI 10.1104/pp.108.131607; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vieten A, 2007, TRENDS PLANT SCI, V12, P160, DOI 10.1016/j.tplants.2007.03.006; von Behrens I, 2011, PLANT J, V66, P341, DOI 10.1111/j.1365-313X.2011.04495.x; Williamson LC, 2001, PLANT PHYSIOL, V126, P875, DOI 10.1104/pp.126.2.875; Woll K, 2005, PLANT PHYSIOL, V139, P1255, DOI 10.1104/pp.105.067330; Xu CZ, 2015, NEW PHYTOL, V207, P1123, DOI 10.1111/nph.13420; Xu CY, 2007, ANN BOT-LONDON, V99, P439, DOI 10.1093/aob/mcl285; Yu RMK, 2003, PLANT MOL BIOL, V51, P295, DOI 10.1023/A:1020771906524; Yue R, 2015, PLOS ONE, V10, P199; Zhang YX, 2015, J EXP BOT, V66, P3855, DOI 10.1093/jxb/erv187; Zhang YX, 2014, J EXP BOT, V65, P4919, DOI 10.1093/jxb/eru249; Zhou HW, 2004, PLANT CELL, V16, P709, DOI 10.1105/tpc.018994; Zhu JM, 2005, FUNCT PLANT BIOL, V32, P749, DOI 10.1071/FP05005; Zhu JM, 2005, PLANT SOIL, V270, P299, DOI 10.1007/s11104-004-1697-y; Zhu JM, 2004, FUNCT PLANT BIOL, V31, P949, DOI 10.1071/FP04046	77	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176538	10.1371/journal.pone.0176538	http://dx.doi.org/10.1371/journal.pone.0176538			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448624	Green Published, gold, Green Submitted			2022-12-26	WOS:000400383600099
J	Viana, MVC; Figueiredo, H; Ramos, R; Guimaraes, LC; Pereira, FL; Dorella, FA; Selim, SAK; Salaheldean, M; Silva, A; Wattam, AR; Azevedo, V				Canario Viana, Marcus Vinicius; Figueiredo, Henrique; Ramos, Rommel; Guimaraes, Luis Carlos; Pereira, Felipe Luiz; Dorella, Fernanda Alves; Selim, Salah Abdel Karim; Salaheldean, Mohammad; Silva, Artur; Wattam, Alice R.; Azevedo, Vasco			Comparative genomic analysis between Corynebacterium pseudotuberculosis strains isolated from buffalo	PLOS ONE			English	Article							MOLYBDENUM COFACTOR; NITRATE REDUCTASE; SEQUENCE; PHAGE; GENE; TOOL; BIOSYNTHESIS; ALGORITHM; REVEALS	Corynebacterium pseudotuberculosis is a Gram-positive, pleomorphic, facultative intracellular pathogen that causes Oedematous Skin Disease (OSD) in buffalo. To better understand the pathogenic mechanisms of OSD, we performed a comparative genomic analysis of 11 strains of C. pseudotuberculosis isolated from different buffalo found to be infected in Egypt during an outbreak that occurred in 2008. Sixteen previously described pathogenicity islands (PiCp) were present in all of the new buffalo strains, but one of them, PiCp12, had an insertion that contained both a corynephage and a diphtheria toxin gene, both of which may play a role in the adaptation of C. pseudotuberculosis to this new host. Synteny analysis showed variations in the site of insertion of the corynephage during the same outbreak. A gene functional comparison showed the presence of a nitrate reductase operon that included genes involved in molybdenum cofactor biosynthesis, which is necessary for a positive nitrate reductase phenotype and is a possible adaptation for intracellular survival. Genomes from the buffalo strains also had fusions in minor pilin genes in the spaA and spaD gene cluster (spaCX and spaYEF), which could suggest either an adaptation to this particular host, or mutation events in the immediate ancestor before this particular epidemic. A phylogenomic analysis confirmed a clear separation between the Ovis and Equi biovars, but also showed what appears to be a clustering by host species within the Equi strains.	[Canario Viana, Marcus Vinicius; Azevedo, Vasco] Univ Fed Minas Gerais, Dept Gen Biol, Belo Horizonte, MG, Brazil; [Canario Viana, Marcus Vinicius; Wattam, Alice R.] Virginia Tech, Biocomplex Inst, Blacksburg, VA USA; [Figueiredo, Henrique; Pereira, Felipe Luiz; Dorella, Fernanda Alves] Univ Fed Minas Gerais, AQUACEN, Natl Reference Lab Aquat Anim Dis, Minist Fisheries & Aquaculture, Belo Horizonte, MG, Brazil; [Ramos, Rommel; Guimaraes, Luis Carlos; Silva, Artur] Fed Univ Para, Ctr Genom & Syst Biol, Belem, Para, Brazil; [Selim, Salah Abdel Karim; Salaheldean, Mohammad] Cairo Univ, Dept Microbiol, Fac Vet Med, Giza, Egypt	Universidade Federal de Minas Gerais; Virginia Polytechnic Institute & State University; Universidade Federal de Minas Gerais; Universidade Federal do Para; Egyptian Knowledge Bank (EKB); Cairo University	Azevedo, V (corresponding author), Univ Fed Minas Gerais, Dept Gen Biol, Belo Horizonte, MG, Brazil.	vasco@icb.ufmg.br	Figueiredo, Henrique César Pereira/M-5310-2017; Azevedo, Vasco/B-1556-2019; Guimarães, Luis/T-7186-2019; Azevedo, Vasco A.C/F-4315-2011; Ramos, Rommel Thiago Juca/L-9329-2013; Luiz Silva, Artur da Costa da/AAI-3516-2021; Pereira, Felipe L/M-5282-2017; Guimaraes, Luis Carlos/J-5689-2015	Figueiredo, Henrique César Pereira/0000-0002-1022-6842; Azevedo, Vasco/0000-0002-4775-2280; Azevedo, Vasco A.C/0000-0002-4775-2280; Ramos, Rommel Thiago Juca/0000-0002-8032-1474; Luiz Silva, Artur da Costa da/0000-0002-4082-1132; Pereira, Felipe L/0000-0001-9326-2365; Guimaraes, Luis Carlos/0000-0002-7147-9448; Canario Viana, Marcus Vinicius/0000-0002-7017-6437	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Ministerio da Pesca e Agricultura; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272201400027C]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministerio da Pesca e Agricultura; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Ministerio da Pesca e Agricultura. A.R. Wattam was supported in part by federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under contract no. HHSN272201400027C.	Ahmed IM, 2012, ALEXANDRIA J VET SCI, V37, P129; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Aly S, 2006, J PATHOL, V210, P298, DOI 10.1002/path.2055; Bachhawat N, 1999, J MOL BIOL, V291, P531, DOI 10.1006/jmbi.1999.2980; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Bernard K, 2012, J CLIN MICROBIOL, V50, P3152, DOI 10.1128/JCM.00796-12; BIBERSTEIN EL, 1971, VET REC, V89, P691, DOI 10.1136/vr.89.26.691; Bragg LM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003031; Brettin T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08365; Bukovska G, 2006, VIROLOGY, V348, P57, DOI 10.1016/j.virol.2005.12.010; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Chen F, 2011, INFECT IMMUN, V79, P2460, DOI 10.1128/IAI.00050-11; Torres LDC, 2013, MEM I OSWALDO CRUZ, V108, P272, DOI 10.1590/S0074-02762013000300003; D'Afonseca V, 2008, GENET MOL RES, V7, P252, DOI 10.4238/vol7-1gmr438; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Davis JJ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00118; Dorella FA, 2006, VET RES, V37, P201, DOI 10.1051/vetres:2005056; Fahey RC, 2001, ANNU REV MICROBIOL, V55, P333, DOI 10.1146/annurev.micro.55.1.333; Fogg PCM, 2014, J MOL BIOL, V426, P2703, DOI 10.1016/j.jmb.2014.05.014; Fritz C, 2002, INFECT IMMUN, V70, P286, DOI 10.1128/IAI.70.1.286-291.2002; Galardini M, 2011, SOURCE CODE BIOL MED, V6, DOI 10.1186/1751-0473-6-11; Ghoneim MA, 2001, J EGYPT VET MED ASS, V61, P165; Guaraldi AL de M, 2014, CORYNEBACTERIUM DIPH, P15; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Holmes RK, 2000, J INFECT DIS, V181, pS156, DOI 10.1086/315554; Huang QQ, 2015, CURR MICROBIOL, V71, P121, DOI 10.1007/s00284-015-0838-2; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Iobbi-Nivol C, 2013, BBA-BIOENERGETICS, V1827, P1086, DOI 10.1016/j.bbabio.2012.11.007; Jackson M, 2000, J BIOL CHEM, V275, P30092, DOI 10.1074/jbc.M004658200; Ramos RTJ, 2013, J MICROBIOL METH, V95, P441, DOI 10.1016/j.mimet.2013.06.006; Ramos RTJ, 2013, MICROB BIOTECHNOL, V6, P150, DOI 10.1111/1751-7915.12006; Leimkiihler S., 2014, ADV BIOL, V2014, P1, DOI DOI 10.1155/2014/808569; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Mandlik A, 2007, MOL MICROBIOL, V64, P111, DOI 10.1111/j.1365-2958.2007.05630.x; Mao CH, 2015, BIOINFORMATICS, V31, P252, DOI 10.1093/bioinformatics/btu631; Mariano DCB, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1344-7; MAXIMESCU P, 1974, J GEN MICROBIOL, V82, P49, DOI 10.1099/00221287-82-1-49; McKean SC, 2007, MICROBIOL-SGM, V153, P2203, DOI 10.1099/mic.0.2007/005926-0; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Moussa IM, 2016, SAUDI J BIOL SCI, V23, P718, DOI 10.1016/j.sjbs.2016.06.005; Movahedzadeh F, 2004, MOL MICROBIOL, V51, P1003, DOI 10.1046/j.1365-2958.2003.03900.x; NCTC 13129 prophage, 2012, BMC MICROBIOL, V12, P72; Newton GL, 2008, MICROBIOL MOL BIOL R, V72, P471, DOI 10.1128/MMBR.00008-08; Oliveira A, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0717-4; Om T, 2012, PLOS ONE, V7; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Rogers EA, 2011, ADHESION PATHOGENIC, P91; Rouli L., 2015, New Microbes and New Infections, V7, P72, DOI 10.1016/j.nmni.2015.06.005; Ruiz JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018551; Selim SA, 2001, J VET MED B, V48, P241, DOI 10.1046/j.1439-0450.2001.00451.x; Selim SA, 2015, SAUDI J BIOL SCI KIN, P0; Silva A, 2012, J BACTERIOL, V194, P6663, DOI 10.1128/JB.01782-12; Silva A, 2011, J BACTERIOL, V193, P323, DOI 10.1128/JB.01211-10; Soares SC, 2016, J BIOTECHNOL, V232, P2, DOI 10.1016/j.jbiotec.2015.09.008; Soares SC, 2013, J BIOTECHNOL, V167, P135, DOI 10.1016/j.jbiotec.2012.11.003; Soares SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053818; SONGER JG, 1988, AM J VET RES, V49, P223; SOTO A, 1994, J CLIN PATHOL, V47, P756, DOI 10.1136/jcp.47.8.756; Spier SJ, 2016, EQUINE VET ED; Sutherland SS, 1996, VET MICROBIOL, V49, P1, DOI 10.1016/0378-1135(95)00146-8; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan W, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012924, 10.1371/journal.pone.0013356]; Tauch A, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv185; Trost E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-728; Vazquez-Torres A, 2016, CURR OPIN MICROBIOL, V29, P1, DOI 10.1016/j.mib.2015.09.002; Wattam AR, 2014, NUCLEIC ACIDS RES, V42, pD581, DOI 10.1093/nar/gkt1099; Williams M, 2014, CRIT REV MICROBIOL, V40, P18, DOI 10.3109/1040841X.2012.749211; Windsor PA, 2016, SMALL RUMINANT RES, V142, P6, DOI 10.1016/j.smallrumres.2016.03.023; Yan N, 2015, ANNU REV BIOPHYS, V44, P257, DOI 10.1146/annurev-biophys-060414-033901; Yeruham I, 2004, VET DERMATOL, V15, P315, DOI 10.1111/j.1365-3164.2004.00388.x; Zakian S, 2010, FEBS J, V277, P1886, DOI 10.1111/j.1742-4658.2010.07611.x; Zheng HJ, 2013, NATURE, V497, P647, DOI 10.1038/nature12139; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	74	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176347	10.1371/journal.pone.0176347	http://dx.doi.org/10.1371/journal.pone.0176347			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445543	Green Submitted, gold, Green Published			2022-12-26	WOS:000400309200049
J	Febo, M; Blum, K; Badgaiyan, RD; Perez, PD; Colon-Perez, LM; Thanos, PK; Ferris, CF; Kulkarni, P; Giordano, J; Baron, D; Gold, MS				Febo, Marcelo; Blum, Kenneth; Badgaiyan, Rajendra D.; Perez, Pablo D.; Colon-Perez, Luis M.; Thanos, Panayotis K.; Ferris, Craig F.; Kulkarni, Praveen; Giordano, John; Baron, David; Gold, Mark S.			Enhanced functional connectivity and volume between cognitive and reward centers of naive rodent brain produced by prodopaminergic agent KB220Z	PLOS ONE			English	Article							DOPAMINE-RECEPTOR GENE; DEFICIENCY-SYNDROME RDS; NUCLEUS-ACCUMBENS; INPATIENT TREATMENT; POLYDRUG ABUSERS; PHASIC DOPAMINE; HIGH-RISK; COCAINE; ASSOCIATION; ALCOHOL	Dopaminergic reward dysfunction in addictive behaviors is well supported in the literature. There is evidence that alterations in synchronous neural activity between brain regions subserving reward and various cognitive functions may significantly contribute to substancerelated disorders. This study presents the first evidence showing that a pro-dopaminergic nutraceutical (KB220Z) significantly enhances, above placebo, functional connectivity between reward and cognitive brain areas in the rat. These include the nucleus accumbens, anterior cingulate gyrus, anterior thalamic nuclei, hippocampus, prelimbic and infralimbic loci. Significant functional connectivity, increased brain connectivity volume recruitment (potentially neuroplasticity), and dopaminergic functionality were found across the brain reward circuitry. Increases in functional connectivity were specific to these regions and were not broadly distributed across the brain. While these initial findings have been observed in drug naive rodents, this robust, yet selective response implies clinical relevance for addicted individuals at risk for relapse, who show reductions in functional connectivity after protracted withdrawal. Future studies will evaluate KB220Z in animal models of addiction.	[Febo, Marcelo; Blum, Kenneth; Perez, Pablo D.; Colon-Perez, Luis M.; Gold, Mark S.] Univ Florida, Coll Med, Dept Psychiat, Gainesville, FL 32611 USA; [Febo, Marcelo; Blum, Kenneth; Perez, Pablo D.; Colon-Perez, Luis M.; Gold, Mark S.] Univ Florida, Coll Med, McKnight Brain Inst, Gainesville, FL 32611 USA; [Blum, Kenneth; Badgaiyan, Rajendra D.] Wright State Univ, Boonshoft Sch Med, Dept Psychiat, Dayton, OH 45435 USA; [Blum, Kenneth; Giordano, John] Natl Inst Holist Addict Studies, Dept Holist Med, North Miami Beach, FL 33162 USA; [Blum, Kenneth] Dominion Diagnost LLC, Div Appl Clin Res & Educ, North Kingstown, RI 02852 USA; [Blum, Kenneth; Baron, David; Gold, Mark S.] Keck Med Univ Southern Calif, Dept Psychiat, Los Angeles, CA 90033 USA; [Thanos, Panayotis K.] Univ Buffalo, Res Inst Addict, Buffalo, NY USA; [Ferris, Craig F.; Kulkarni, Praveen] Northeastern Univ, Ctr Translat Neuroimaging, Dept Psychol & Pharmaceut Sci, Boston, MA 02115 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University System of Ohio; Wright State University Dayton; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Northeastern University	Febo, M; Blum, K (corresponding author), Univ Florida, Coll Med, Dept Psychiat, Gainesville, FL 32611 USA.; Febo, M; Blum, K (corresponding author), Univ Florida, Coll Med, McKnight Brain Inst, Gainesville, FL 32611 USA.; Blum, K (corresponding author), Wright State Univ, Boonshoft Sch Med, Dept Psychiat, Dayton, OH 45435 USA.; Blum, K (corresponding author), Natl Inst Holist Addict Studies, Dept Holist Med, North Miami Beach, FL 33162 USA.; Blum, K (corresponding author), Dominion Diagnost LLC, Div Appl Clin Res & Educ, North Kingstown, RI 02852 USA.; Blum, K (corresponding author), Keck Med Univ Southern Calif, Dept Psychiat, Los Angeles, CA 90033 USA.	febo@ufl.edu; drd2gene@gmail.com	Colon-Perez, Luis/GOV-3520-2022; Febo, Marcelo/X-6769-2019; Badgaiyan, Rajendra D/B-8183-2012	Colon-Perez, Luis/0000-0001-8918-2418; Febo, Marcelo/0000-0001-8981-4163; Kulkarni, Praveen/0000-0002-8876-4544; Blum, Kenneth/0000-0001-6727-803X	University of Florida Foundation; National Institutes of Health grants [1R01NS073884, 1R21MH073624]; LifeExtension Foundation, Ft. Lauderdale, Florida; National Institute for Holistic Addiction Studies;  [R01DA019946];  [R21 DA038009];  [P01HD075750];  [U54CA151881];  [R01HD70888-01A1]	University of Florida Foundation(University of Florida); National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LifeExtension Foundation, Ft. Lauderdale, Florida; National Institute for Holistic Addiction Studies; ; ; ; ; 	The University of Florida Foundation www.uff.ufl.edu/ supported the present research. Marcelo Febo is the recipient of R01DA019946 and R21 DA038009. C.F. Ferris is the recipient of P01HD075750 and U54CA151881. Rajendra D. Badgaiyan is supported by the National Institutes of Health grants www.ncbi.nlm.nih.gov/ 1R01NS073884 and 1R21MH073624; Panayotis Thanos is the recipient of R01HD70888-01A1. Kenneth Blum served as Scientific Director of Path Foundation NY is the recipient of a grant from LifeExtension Foundation, Ft. Lauderdale, Florida awarded to Path Foundation NY www. pathfoundationnv.org. Kenneth Blum Ph.D. is Chief Scientific Advisor and a paid a consultant for Dominion Diagnostics LLC., listed as one of his affiliates. Dr. Blum is a paid consultant as the neuroscience advisor for The Shores Treatment and Recovery Center not listed as an affiliate here. These funders provided support in the form of salaries for authors [MF RDB, PT, KB], but did not have any additional role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript. The National Institute for Holistic Addiction Studies provided some initial funding for the current study; the Institute had no input to the design or interpretation of the present study. The contents of the manuscript are solely the responsibility of the authors and do not represent the official views of the funding agencies.	Administration SAaMHS, 2014, RES 2013 NAT SURV DR; [Anonymous], 2011, GUIDE CARE USE LAB A; Badgaiyan RD, 2014, PROG BRAIN RES, V211, P165, DOI 10.1016/B978-0-444-63425-2.00007-6; Badgaiyan RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028075; Badgaiyan RD, 2010, NEUROREPORT, V21, P1172, DOI 10.1097/WNR.0b013e3283410955; Badgaiyan RD, 2013, J ALCOHOL DRUG DEPEN, V1, P1, DOI DOI 10.4172/2329-6488.1000e101; BLUM K, 1988, ALCOHOL, V5, P481, DOI 10.1016/0741-8329(88)90087-0; BLUM K, 1993, ALCOHOL, V10, P59, DOI 10.1016/0741-8329(93)90054-R; BLUM K, 1991, ALCOHOL, V8, P409, DOI 10.1016/0741-8329(91)90693-Q; BLUM K, 1988, CURR THER RES CLIN E, V43, P1204; BLUM K, 1977, NATURE, V265, P49, DOI 10.1038/265049a0; Blum K, 1997, MOL PSYCHIATR, V2, P239, DOI 10.1038/sj.mp.4000261; Blum K, 1996, J ROY SOC MED, V89, P396, DOI 10.1177/014107689608900711; Blum K, 2016, CURR PHARM DES; Blum K, 2007, MED HYPOTHESES, V69, P1054, DOI 10.1016/j.mehy.2006.12.062; Blum Kenneth, 2015, Addict Genet, V2, P1; Blum K, 2015, J CHILD ADOL PSYCHOP, V25, P286, DOI 10.1089/cap.2014.0146; Blum K, 2015, POSTGRAD MED, V127, P232, DOI 10.1080/00325481.2015.994879; Blum K, 2014, MOL NEUROBIOL, V50, P765, DOI 10.1007/s12035-014-8726-5; Blum Kenneth, 2012, J Addict Res Ther, V3, P139; Blum K, 2012, J PSYCHOACTIVE DRUGS, V44, P134, DOI 10.1080/02791072.2012.685407; Blum K, 2011, MED HYPOTHESES, V76, P576, DOI 10.1016/j.mehy.2011.01.005; Blum K, 2010, POSTGRAD MED, V122, P214, DOI 10.3810/pgm.2010.11.2237; Blum K, 2009, GENE THER MOL BIOL, V13A, P214; Borchert RJ, 2016, NEUROPSYCHOPHARMACOL; Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; Bruijnzeel AW, 2014, INT J NEURO IN PRESS; CADE J R, 1992, Amino Acids (Vienna), V2, P133, DOI 10.1007/BF00806084; Caprioli D, 2015, BIOL PSYCHIAT, V78, P463, DOI 10.1016/j.biopsych.2015.02.018; Caprioli D, 2014, NAT NEUROSCI, V17, P644, DOI 10.1038/nn.3699; Cole DM, 2013, CEREB CORTEX, V23, P1509, DOI 10.1093/cercor/bhs136; Connolly CG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059645; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Cservenka A, 2012, ALCOHOL CLIN EXP RES, V36, P604, DOI 10.1111/j.1530-0277.2011.01650.x; Dahlgren A, 2011, ALCOHOL ALCOHOLISM, V46, P509, DOI 10.1093/alcalc/agr045; EKHOLM S, 1987, EUR J PHARMACOL, V143, P27, DOI 10.1016/0014-2999(87)90731-X; Febo M, 2004, J NEUROSCI METH, V139, P167, DOI 10.1016/j.jneumeth.2004.04.028; Febo Marcelo, 2011, Front Psychiatry, V2, P43, DOI 10.3389/fpsyt.2011.00043; Ferenczi EA, 2016, SCIENCE, V351, DOI 10.1126/science.aac9698; Ferris CF, 2005, J NEUROSCI, V25, P149, DOI 10.1523/JNEUROSCI.3156-04.2005; Ferris CF, 2011, REV NEUROSCIENCE, V22, P665, DOI 10.1515/RNS.2011.050; Gass JT, 2012, ACS CHEM NEUROSCI, V3, P494, DOI 10.1021/cn300013p; Gass N, 2013, EUR NEUROPSYCHOPHARM, V23, P1310, DOI 10.1016/j.euroneuro.2012.10.013; Gu H, 2010, NEUROIMAGE, V53, P593, DOI 10.1016/j.neuroimage.2010.06.066; Howard CD, 2017, NEURON IN PRESS; Hutchison RM, 2010, J NEUROPHYSIOL, V103, P3398, DOI 10.1152/jn.00141.2010; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jonckers E, 2014, MAGN RESON MED, V72, P1103, DOI 10.1002/mrm.24990; Kannurpatti SS, 2008, NEUROIMAGE, V40, P1738, DOI 10.1016/j.neuroimage.2007.05.061; Kelly C, 2011, BIOL PSYCHIAT, V69, P684, DOI 10.1016/j.biopsych.2010.11.022; Konova AB, 2013, JAMA PSYCHIAT, V70, P857, DOI 10.1001/jamapsychiatry.2013.1129; KOSTEN TA, 1991, J NERV MENT DIS, V179, P583, DOI 10.1097/00005053-199110000-00001; Krimer LS, 1998, NAT NEUROSCI, V1, P286, DOI 10.1038/1099; Legault M, 2000, J NEUROSCI, V20, P1635; Lewis BJ, 2013, J NUTR BIOCHEM, V24, P1359, DOI 10.1016/j.jnutbio.2012.11.003; Liang ZF, 2011, J NEUROSCI, V31, P3776, DOI 10.1523/JNEUROSCI.4557-10.2011; Liu X, 2013, BRAIN TOPOGR, V26, P363, DOI 10.1007/s10548-012-0267-5; Liu XA, 2011, CEREB CORTEX, V21, P374, DOI 10.1093/cercor/bhq105; Lu H, 2014, CEREB CORTEX; Lu HB, 2012, P NATL ACAD SCI USA, V109, P3979, DOI [10.1073/pnas.1101934108, 10.1073/pnas.1200506109]; Ma N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016560; Ma N, 2010, NEUROIMAGE, V49, P738, DOI 10.1016/j.neuroimage.2009.08.037; Madularu D, 2015, BRAIN RES, V1618, P100, DOI 10.1016/j.brainres.2015.05.025; Marcello F, 1986, Adv Exp Med Biol, V198 Pt B, P153; Mei W, 2010, NEUROSCIENCE, V170, P808, DOI 10.1016/j.neuroscience.2010.07.033; Meng ZQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007742; Michaelides M, 2013, J CLIN INVEST, V123, P5342, DOI 10.1172/JCI72117; Modestino Edward Justin, 2015, J Reward Defic Syndr, V1, P6, DOI 10.17756/jrds.2015-002; NOBLE EP, 1991, ARCH GEN PSYCHIAT, V48, P648; OATES JA, 1960, SCIENCE, V131, P1890, DOI 10.1126/science.131.3417.1890; Pan WJ, 2011, BRAIN CONNECT, V1, P119, DOI 10.1089/brain.2011.0014; Park SQ, 2010, J NEUROSCI, V30, P7749, DOI 10.1523/JNEUROSCI.5587-09.2010; Pawela CP, 2008, MAGN RESON MED, V59, P1021, DOI 10.1002/mrm.21524; Pitchers KK, 2014, J NEUROSCI, V34, P8825, DOI 10.1523/JNEUROSCI.0133-14.2014; Renthal W, 2008, TRENDS MOL MED, V14, P341, DOI 10.1016/j.molmed.2008.06.004; Rubino T, 2015, BIOL PSYCHIAT; Sanchez-Cardoso P, 2009, NEUROPHARMACOLOGY, V57, P8, DOI 10.1016/j.neuropharm.2009.03.014; Schmidt KF, 2006, PSYCHOPHARMACOLOGY, V185, P479, DOI 10.1007/s00213-006-0319-1; Selemon LD, 2014, CURR PHARM DESIGN, V20, P5194, DOI 10.2174/1381612819666140110122307; Smith DE, 2012, J PSYCHOACTIVE DRUGS, V44, P1, DOI 10.1080/02791072.2012.662105; Sparta DR, 2013, BEHAV BRAIN RES, V255, P19, DOI 10.1016/j.bbr.2013.05.007; Sporns Olaf, 2013, Dialogues Clin Neurosci, V15, P247; Swanson L. W, 1998, BRAIN MAPS STRUCTURE; Thanos PK, 2008, SYNAPSE, V62, P481, DOI 10.1002/syn.20523; Thanos PK, 2013, J NEUROSCI, V33, P6343, DOI 10.1523/JNEUROSCI.4997-12.2013; Thanos PK, 2005, PHARMACOL BIOCHEM BE, V81, P190, DOI 10.1016/j.pbb.2005.03.013; Tomasi D, 2015, HUM BRAIN MAPP, V36, P3154, DOI 10.1002/hbm.22834; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Viswanath H, 2015, NEUROPHARMACOLOGY, V92, P63, DOI 10.1016/j.neuropharm.2014.12.030; Volkow ND, 2009, NEUROPHARMACOLOGY, V56, P3, DOI 10.1016/j.neuropharm.2008.05.022; Volkow ND, 2014, NEW ENGL J MED, V370, P2063, DOI 10.1056/NEJMp1402780; Volkow ND, 2013, CURR OPIN NEUROBIOL, V23, P639, DOI 10.1016/j.conb.2013.01.002; WANG Y, 2013, PLOS ONE, V2013; Weiland BJ, 2013, DRUG ALCOHOL DEPEN, V128, P130, DOI 10.1016/j.drugalcdep.2012.08.019; Willuhn I, 2014, NAT NEUROSCI, V17, P704, DOI 10.1038/nn.3694; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wise RA, 2014, NEUROPSYCHOPHARMACOL, V39, P254, DOI 10.1038/npp.2013.261; Worhunsky PD, 2013, PSYCHOL ADDICT BEHAV, V27, P477, DOI 10.1037/a0029092; Zijistra F, 2008, EUR NEUROPSYCHOPHARM, V18, P262, DOI 10.1016/j.euroneuro.2007.11.002; Zijlstra F, 2009, DRUG ALCOHOL DEPEN, V99, P183, DOI 10.1016/j.drugalcdep.2008.07.012; Zou F, 2015, J NEUROSCI RES, V93, P1693, DOI 10.1002/jnr.23608	102	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0174774	10.1371/journal.pone.0174774	http://dx.doi.org/10.1371/journal.pone.0174774			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET5FI	28445527	Green Published, Green Submitted, gold			2022-12-26	WOS:000400309200008
J	Guisbert, KSK; Guisbert, E				Guisbert, Karen S. Kim; Guisbert, Eric			SF3B1 is a stress-sensitive splicing factor that regulates both HSF1 concentration and activity	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; HEAT-SHOCK; PROTEIN-SYNTHESIS; CANCER GENES; IN-VITRO; U2 SNRNP; TRANSCRIPTION; COMPLEX; PHOSPHORYLATION; PLADIENOLIDE	The heat shock response (HSR) is a well-conserved, cytoprotective stress response that activates the HSF1 transcription factor. During severe stress, cells inhibit mRNA splicing which also serves a cytoprotective function via inhibition of gene expression. Despite their functional interconnectedness, there have not been any previous reports of crosstalk between these two pathways. In a genetic screen, we identified SF3B1, a core component of the U2 snRNP subunit of the spliceosome, as a regulator of the heat shock response in Caenorhabditis elegans. Here, we show that this regulatory connection is conserved in cultured human cells and that there are at least two distinct pathways by which SF3B1 can regulate the HSR. First, inhibition of SF3B1 with moderate levels of Pladienolide B, a previously established small molecule inhibitor of SF3B1, affects the transcriptional activation of HSF1, the transcription factor that mediates the HSR. However, both higher levels of Pladienolide B and SF3B1 siRNA knockdown also change the concentration of HSF1, a form of HSR regulation that has not been previously documented during normal physiology but is observed in some forms of cancer. Intriguingly, mutations in SF3B1 have also been associated with several distinct types of cancer. Finally, we show that regulation of alternative splicing by SF3B1 is sensitive to temperature, providing a new mechanism by which temperature stress can remodel the transcriptome.	[Guisbert, Karen S. Kim; Guisbert, Eric] Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA	Florida Institute of Technology	Guisbert, E (corresponding author), Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA.	eguisbert@fit.edu		Kim Guisbert, Karen/0000-0001-9907-9502; Guisbert, Eric/0000-0003-1901-5598	Open Access Subvention Fund; Florida Tech Libraries	Open Access Subvention Fund; Florida Tech Libraries	Publication of this article was funded in part by the Open Access Subvention Fund and the Florida Tech Libraries.	BOND U, 1988, EMBO J, V7, P3509, DOI 10.1002/j.1460-2075.1988.tb03227.x; Bonnal S, 2012, NAT REV DRUG DISCOV, V11, P847, DOI 10.1038/nrd3823; Corrionero A, 2011, GENE DEV, V25, P445, DOI 10.1101/gad.2014311; Das BK, 1999, MOL CELL BIOL, V19, P6796; deHaro C, 1996, FASEB J, V10, P1378, DOI 10.1096/fasebj.10.12.8903508; Dolatshad H, 2015, LEUKEMIA, V29, P1092, DOI [10.1038/leu.2014.331, 10.1038/leu.2015.178]; Golas MM, 2003, SCIENCE, V300, P980, DOI 10.1126/science.1084155; Gozani O, 1998, MOL CELL BIOL, V18, P4752, DOI 10.1128/MCB.18.8.4752; Guisbert E., 2013, PROTEIN QUALITY CONT, P1; Guisbert E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003466; Hart Y, 2013, MOL CELL, V49, P213, DOI 10.1016/j.molcel.2013.01.004; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Kashyap MK, 2015, HAEMATOLOGICA, V100, P945, DOI 10.3324/haematol.2014.122069; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Mizui Y, 2004, J ANTIBIOT, V57, P188, DOI 10.7164/antibiotics.57.188; NOVER L, 1983, MOL CELL BIOL, V3, P1648, DOI 10.1128/MCB.3.9.1648; Pauling MH, 2000, MOL CELL BIOL, V20, P2176, DOI 10.1128/MCB.20.6.2176-2185.2000; PINTO M, 1991, J BIOL CHEM, V266, P13941; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Raychaudhuri S, 2014, CELL, V156, P975, DOI 10.1016/j.cell.2014.01.055; Ritossa F., 1962, DROSOPHILA, V18, P571; Santagata S, 2011, P NATL ACAD SCI USA, V108, P18378, DOI 10.1073/pnas.1115031108; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; Shi Y, 2007, MOL CELL, V28, P79, DOI 10.1016/j.molcel.2007.08.028; Shin C, 2004, NATURE, V427, P553, DOI 10.1038/nature02288; Thickman KR, 2006, J MOL BIOL, V356, P664, DOI 10.1016/j.jmb.2005.11.067; Vihervaara A, 2014, J CELL SCI, V127, P261, DOI 10.1242/jcs.132605; Wan YZ, 2013, BLOOD, V121, P4627, DOI 10.1182/blood-2013-02-427641; Wang CY, 1998, GENE DEV, V12, P1409, DOI 10.1101/gad.12.10.1409; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Westerheide SD, 2006, J BIOL CHEM, V281, P9616, DOI 10.1074/jbc.M512044200; Will CL, 2002, EMBO J, V21, P4978, DOI 10.1093/emboj/cdf480; Yokoi A, 2011, FEBS J, V278, P4870, DOI 10.1111/j.1742-4658.2011.08387.x; YOST HJ, 1986, CELL, V45, P185, DOI 10.1016/0092-8674(86)90382-X; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	36	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176382	10.1371/journal.pone.0176382	http://dx.doi.org/10.1371/journal.pone.0176382			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445500	Green Submitted, Green Published, gold			2022-12-26	WOS:000400309200055
J	Zhang, X; Liu, WZ; Wang, X				Zhang, Xin; Liu, Wenzhe; Wang, Xin			How the ovules get enclosed in magnoliaceous carpels	PLOS ONE			English	Article							VASCULAR ANATOMY; ANGIOSPERM; FLOWER; MORPHOLOGY; EVOLUTION	Angiosperms distinguish themselves from gymnosperms by their ovules that are enclosed before pollination. However, how the ovules get enclosed in angiosperms remains a mystery, especially for Magnoliaceae. The only key to this mystery is finding a series of carpels transitional from fully closed with enclosed ovules to open with naked ovules. We use routine paraffin section technology, LM, SEM to document the morphology and anatomy of carpel variation in Michelia figo (Magnoliaceae). A series of carpel variations within a single flower of Michelia figo (Magnoliaceae) are documented, in which the ovules are exposed in atypical carpels. These atypical and typical carpels for the first time demonstrate clearly how the naked ovule get enclosed. Each atypical carpel, with naked ovules, clearly comprises two parts, namely, subtending foliar part and branches bearing ovules, suggesting that a typical carpel is actually an end-product of the fusion between the ovuliferous branches and subtending foliar parts. The only difference among these carpels is the extent of fusion between these two parts. This generalization is in full agreement with the molecular genetic studies on angiosperm flowers.	[Zhang, Xin] Northwest A&F Univ, Coll Forestry, Yangling, Peoples R China; [Liu, Wenzhe] Northwest Univ Xian, Coll Life Sci, Xian, Peoples R China; [Wang, Xin] Chinese Acad Sci, State Key Lab Palaeobiol & Stratig, Nanjing Inst Geol & Palaeontol, Nanjing, Jiangsu, Peoples R China	Northwest A&F University - China; Northwest University Xi'an; Chinese Academy of Sciences	Wang, X (corresponding author), Chinese Acad Sci, State Key Lab Palaeobiol & Stratig, Nanjing Inst Geol & Palaeontol, Nanjing, Jiangsu, Peoples R China.	xinwang@nigpas.ac.cn	Zhang, Xin/AAF-3053-2019	Zhang, Xin/0000-0003-0669-8342	National Basic Research Program of China (973 Program) [2012CB821901]; Research Fund for the Doctoral Program of Higher Education of China [Z109021501]; Fundamental Research Funds for the Central Universities [Z109021614]; National Forestry Industry Research Special Funds for Public Welfare Projects (China) [201404302]; National Natural Science Foundation of China [41688103]; Strategic Priority Research Program (B) of Chinese Academy of Sciences [XDB18000000]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Forestry Industry Research Special Funds for Public Welfare Projects (China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program (B) of Chinese Academy of Sciences	This research is supported by the National Basic Research Program of China (973 Program 2012CB821901), Research Fund for the Doctoral Program of Higher Education of China (Z109021501), the Fundamental Research Funds for the Central Universities (Z109021614), National Forestry Industry Research Special Funds for Public Welfare Projects (China) (201404302), National Natural Science Foundation of China (41688103), Strategic Priority Research Program (B) of Chinese Academy of Sciences (Grant No. XDB18000000).; We appreciate the generous support from the Botanical Garden of the Ruhr University Bochum allowing us to collect the material for the present study. This research is supported by the National Basic Research Program of China (973 Program 2012CB821901), Research Fund for the Doctoral Program of Higher Education of China (Z109021501), the Fundamental Research Funds for the Central Universities (Z109021614), National Forestry Industry Research Special Funds for Public Welfare Projects (China) (201404302), National Natural Science Foundation of China (41688103), Strategic Priority Research Program (B) of Chinese Academy of Sciences (Grant No. XDB18000000).	[Anonymous], 1907, J LINN SOC LOND BOT, DOI DOI 10.1111/J.1095-8339.1907.TB01074.X; APG III, 2009, BOT J LINN SOC, V161, P105, DOI DOI 10.1111/J.1095-8339.2009.00996.X; Buzgo M, 2004, INT J PLANT SCI, V165, P925, DOI 10.1086/424024; CANRIGHT JE, 1960, AM J BOT, V47, P145, DOI 10.2307/2439049; Cronquist A., 1988, EVOLUTION CLASSIFICA; Eames AJ, 1961, MORPHOLOGY ANGIOSPER; Eckardt T, 1954, BERICHTE DTSCH BOT G, V67, P113; Endress PK, 2009, AM J BOT, V96, P22, DOI 10.3732/ajb.0800047; Florin R., 1949, ACTA HORTI BERGIANI, V15, P79; Gerstberger P, 1993, B JARDIN BOT NATL BE, V62, P69; Guo XM, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00391; Liu WZ, 2014, BOT STUD, V55, DOI 10.1186/1999-3110-55-28; Mathews S, 2012, NEW PHYTOL, V194, P910, DOI 10.1111/j.1469-8137.2012.04091.x; MEEUSE A.D.J., 1963, ACTA BIOTHEOR, V16, P127, DOI 10.1007/BF01556603; OMORI Y, 1993, J PLANT RES, V106, P249, DOI 10.1007/BF02344593; Roe JL, 1997, PLANT CELL, V9, P335, DOI 10.1105/tpc.9.3.335; Ruzin S.E., 1999, PLANT MICROTECHNIQUE; Skinner DJ, 2004, PLANT CELL, V16, pS32, DOI 10.1105/tpc.015933; Sun G, 1998, SCIENCE, V282, P1692, DOI 10.1126/science.282.5394.1692; Taylor D.W., 1996, FLOWERING PLANT ORIG; Tomlinson PB, 2002, CAN J BOT, V80, P1250, DOI [10.1139/B02-112, 10.1139/b02-112]; Wang X., 2010, THE DAWN ANGIOSPERMS; Wang Xin, 2012, Palaeoworld, V21, P193, DOI 10.1016/j.palwor.2012.10.002; Zhou ZY, 2003, NATURE, V423, P821, DOI 10.1038/423821a	24	15	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0174955	10.1371/journal.pone.0174955	http://dx.doi.org/10.1371/journal.pone.0174955			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430814	Green Published, gold, Green Submitted			2022-12-26	WOS:000399876100009
J	VanderLinden, RT; Hemmis, CW; Yao, TT; Robinson, H; Hill, CP				VanderLinden, Ryan T.; Hemmis, Casey W.; Yao, Tingting; Robinson, Howard; Hill, Christopher P.			Structure and energetics of pairwise interactions between proteasome subunits RPN2, RPN13, and ubiquitin clarify a substrate recruitment mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEUBIQUITINATING ENZYME; 26S PROTEASOME; RECEPTOR RPN13; PROTEIN; ADRM1; ACTIVATION; DOMAIN; OVEREXPRESSION; IDENTIFICATION; AMPLIFICATION	The 26S proteasome is a large cellular assembly that mediates the selective degradation of proteins in the nucleus and cytosol and is an established target for anticancer therapeutics. Protein substrates are typically targeted to the proteasome through modification with a polyubiquitin chain, which can be recognized by several proteasome-associated ubiquitin receptors. One of these receptors, RPN13/ADRM1, is recruited to the proteasome through direct interaction with the large scaffolding protein RPN2 within the 19S regulatory particle. To better understand the interactions between RPN13, RPN2, and ubiquitin, we used human proteins to map the RPN13-binding epitope to the C-terminal 14 residues of RPN2, which, like ubiquitin, binds the N-terminal pleckstrin-like receptor of ubiquitin (PRU) domain of RPN13. We also report the crystal structures of the RPN13 PRU domain in complex with peptides corresponding to the RPN2 C terminus and ubiquitin. Through mutational analysis, we validated the RPN2-binding interface revealed by our structures and quantified binding interactions with surface plasmon resonance and fluorescence polarization. In contrast to a previous report, we find that RPN13 binds ubiquitin with an affinity similar to that of other proteasome-associated ubiquitin receptors and that RPN2, ubiquitin, and the deubiquitylase UCH37 bind to RPN13 with independent energetics. These findings provide a detailed characterization of interactions that are important for proteasome function, indicate ubiquitin affinities that are consistent with the role of RPN13 as a proteasomal ubiquitin receptor, and have major implications for the development of novel anticancer therapeutics.	[VanderLinden, Ryan T.; Hemmis, Casey W.; Hill, Christopher P.] Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA; [Yao, Tingting] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Robinson, Howard] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Utah System of Higher Education; University of Utah; Colorado State University; United States Department of Energy (DOE); Brookhaven National Laboratory	Hill, CP (corresponding author), Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA.	chris@biochem.utah.edu			National Institutes of Health from the NCRR [P41RR012408]; Department of Energy Office of Biological and Environmental Research; National Institutes of Health from NIGMS [P41RR001209]; NCRR; Department of Energy Office of Basic Energy Sciences [DE-AC02-76SF00515]; National Institutes of Health; National Institutes of Health from the NCI [P30CA042014]; NATIONAL CANCER INSTITUTE [P30CA042014, R21CA191929] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209, P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059135, R01GM098401] Funding Source: NIH RePORTER	National Institutes of Health from the NCRR; Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Frank Whitby, Heidi Schubert, Erik Kish-Trier, Kath Ferrell, Binita Shakya, Ira Baci, and Matt Sdano for technical assistance. Wealso thank Mark Peterson for peptide synthesis and Bob Cohen (Colorado State University) for generous gifts and helpful comments on the manuscript. Portions of this research were performed at the National Synchrotron Light Source (NSLS) and the Stanford Synchrotron Radiation Lightsource (SSRL). The NSLS is funded by National Institutes of Health Grant P41RR012408 from the NCRR. The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by National Institutes of Health Grant P41RR001209 from NIGMS and the NCRR. Use of the NSLS and SSRL is supported by the Department of Energy Office of Basic Energy Sciences (SSRL Contract No. DE-AC02-76SF00515). NSLS operations are also supported by the National Institutes of Health. Mass spectrometry validation of purified proteins was performed by the University of Utah Mass Spectrometry and Proteomics Core Facility, which is supported by National Institutes of Health Grant P30CA042014 from the NCI. Sequencing of constructs used in this work was performed at the DNA Sequencing Core Facility, University of Utah.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Al-Shami A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013654; Anchoori RK, 2013, CANCER CELL, V24, P791, DOI 10.1016/j.ccr.2013.11.001; Aufderheide A, 2015, P NATL ACAD SCI USA, V112, P8626, DOI 10.1073/pnas.1510449112; Beck F, 2012, P NATL ACAD SCI USA, V109, P14870, DOI 10.1073/pnas.1213333109; Besche HC, 2014, EMBO J, V33, P1159, DOI 10.1002/embj.201386906; Boudreaux DA, 2010, P NATL ACAD SCI USA, V107, P9117, DOI 10.1073/pnas.0910870107; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen W, 2009, ONCOL REP, V21, P531, DOI 10.3892/or_00000254; Chen X, 2016, CHINA FOUNDRY, V13, P1, DOI 10.1007/s41230-016-5104-0; Chen X, 2010, MOL CELL, V38, P404, DOI 10.1016/j.molcel.2010.04.019; D'Arcy P, 2015, PHARMACOL THERAPEUT, V147, P32, DOI 10.1016/j.pharmthera.2014.11.002; da Fonseca PCA, 2012, MOL CELL, V46, P54, DOI 10.1016/j.molcel.2012.03.026; DeLano W.L., 2015, PYMOL MOL GRAPHICS S; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fatimababy AS, 2010, FEBS J, V277, P796, DOI 10.1111/j.1742-4658.2009.07531.x; Fejzo MS, 2008, GENE CHROMOSOME CANC, V47, P873, DOI 10.1002/gcc.20592; Fejzo MS, 2015, GENE CHROMOSOME CANC, V54, P506, DOI 10.1002/gcc.22262; Fejzo MS, 2013, INT J MOL SCI, V14, P3094, DOI 10.3390/ijms14023094; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Gomez TA, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-33; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; HAAS AL, 1985, J BIOL CHEM, V260, P2464; Hamazaki J, 2007, MOL CELL BIOL, V27, P6629, DOI 10.1128/MCB.00509-07; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; Hamazaki J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005401; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Huang XL, 2016, NAT STRUCT MOL BIOL, V23, P778, DOI 10.1038/nsmb.3273; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jang SH, 2014, CLIN EXP METASTAS, V31, P727, DOI 10.1007/s10585-014-9663-4; Johnston SC, 1999, EMBO J, V18, P3877, DOI 10.1093/emboj/18.14.3877; Kortuem KM, 2013, BLOOD, V121, P893, DOI 10.1182/blood-2012-10-459883; Kumar S, 2008, BLOOD, V112, P2177, DOI 10.1182/blood-2008-07-167767; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Lu SQ, 2013, BIOMARK RES, V1, DOI 10.1186/2050-7771-1-13; Lu XX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140518; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nikolovska-Coleska Z, 2004, ANAL BIOCHEM, V332, P261, DOI 10.1016/j.ab.2004.05.055; Oerlemans R, 2008, BLOOD, V112, P2489, DOI 10.1182/blood-2007-08-104950; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Qiu XB, 2006, EMBO J, V25, P5742, DOI 10.1038/sj.emboj.7601450; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rosenzweig R, 2012, J BIOL CHEM, V287, P14659, DOI 10.1074/jbc.M111.316323; Ryu H, 2014, CELL REP, V7, P1842, DOI 10.1016/j.celrep.2014.05.009; Saeki Y, 2002, BIOCHEM BIOPH RES CO, V296, P813, DOI 10.1016/S0006-291X(02)02002-8; Sahtoe DD, 2015, MOL CELL, V57, P887, DOI 10.1016/j.molcel.2014.12.039; Sakata E, 2012, P NATL ACAD SCI USA, V109, P1479, DOI 10.1073/pnas.1119394109; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Schweitzer A, 2016, P NATL ACAD SCI USA, V113, P7816, DOI 10.1073/pnas.1608050113; Sledz P, 2013, P NATL ACAD SCI USA, V110, P7264, DOI 10.1073/pnas.1305782110; Song Y, 2016, LEUKEMIA, V30, P1877, DOI 10.1038/leu.2016.97; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Szlanka T, 2003, J CELL SCI, V116, P1023, DOI 10.1242/jcs.00332; Trader DJ, 2015, J AM CHEM SOC, V137, P6312, DOI 10.1021/jacs.5b02069; Unverdorben P, 2014, P NATL ACAD SCI USA, V111, P5544, DOI 10.1073/pnas.1403409111; VanderLinden RT, 2015, MOL CELL, V57, P901, DOI 10.1016/j.molcel.2015.01.016; Wang QH, 2005, J MOL BIOL, V348, P727, DOI 10.1016/j.jmb.2005.03.007; Yang X, 2012, ONCOL REP, V28, P283, DOI 10.3892/or.2012.1767; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Zhang D, 2008, J MOL BIOL, V377, P162, DOI 10.1016/j.jmb.2007.12.029; Zheng XH, 2015, ACTA HAEMATOL-BASEL, V134, P88, DOI 10.1159/000369916	70	26	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9493	9504		10.1074/jbc.M117.785287	http://dx.doi.org/10.1074/jbc.M117.785287			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28442575	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000403113000005
J	Lai, AL; Clerico, EM; Blackburn, ME; Patel, NA; Robinson, CV; Borbat, PP; Freed, JH; Gierasch, LM				Lai, Alex L.; Clerico, Eugenia M.; Blackburn, Mandy E.; Patel, Nisha A.; Robinson, Carol V.; Borbat, Peter P.; Freed, Jack H.; Gierasch, Lila M.			Key features of an Hsp70 chaperone allosteric landscape revealed by ion-mobility native mass spectrometry and double electron-electron resonance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						70-kilodalton heat shock protein (Hsp70); allosteric regulation; chaperone DnaK (DnaK); conformational change; molecular chaperone; Hsp70; double electron-electron resonance; energy landscape; ion-mobility mass spectrometry	PAIR DISTANCE DISTRIBUTIONS; COLLISION CROSS-SECTIONS; SUBSTRATE-BINDING DOMAIN; GAS-PHASE; DNAK CHAPERONE; CONFORMATIONAL DYNAMICS; TIKHONOV REGULARIZATION; MOLECULAR CHAPERONES; MITOCHONDRIAL HSP70; MEMBRANE-PROTEINS	Proteins are dynamic entities that populate conformational ensembles, and most functions of proteins depend on their dynamic character. Allostery, in particular, relies on ligand-modulated shifts in these conformational ensembles. Hsp70s are allosteric molecular chaperones with conformational landscapes that involve large rearrangements of their two domains (viz. the nucleotide-binding domain and substrate-binding domain) in response to adenine nucleotides and substrates. However, it remains unclear how the Hsp70 conformational ensemble is populated at each point of the allosteric cycle and how ligands control these populations. We have mapped the conformational species present under different ligand-binding conditions throughout the allosteric cycle of the Escherichia coli Hsp70 DnaK by two complementary methods, ion-mobility mass spectrometry and double electron-electron resonance. Our results obtained under biologically relevant ligand-bound conditions confirm the current picture derived from NMR and crystallographic data of domain docking upon ATP binding and undocking in response to ADP and substrate. Additionally, we find that the helical lid of DnaK is a highly dynamic unit of the structure in all ligand-bound states. Importantly, we demonstrate that DnaK populates a partially docked state in the presence of ATP and substrate and that this state represents an energy minimum on the DnaK allosteric landscape. Because Hsp70s are emerging as potential drug targets for many diseases, fully mapping an allosteric landscape of a molecular chaperone like DnaK will facilitate the development of small molecules that modulate Hsp70 function via allosteric mechanisms.	[Lai, Alex L.; Borbat, Peter P.; Freed, Jack H.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Clerico, Eugenia M.; Gierasch, Lila M.] Univ Massachusetts, Dept Biochem & Mol Biol, Life Sci Lab N331,240 Thatcher Rd, Amherst, MA 01003 USA; [Gierasch, Lila M.] Univ Massachusetts, Dept Chem, Life Sci Lab N331,240 Thatcher Rd, Amherst, MA 01003 USA; [Blackburn, Mandy E.] Univ Cent Missouri, Sch Environm Phys & Appl Sci, Warrensburg, MO 64093 USA; [Patel, Nisha A.; Robinson, Carol V.] Phys & Theoret Chem Lab, South Parks Rd, Oxford OX1 3QZ, England	Cornell University; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University Central Missouri; University of Oxford	Gierasch, LM (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, Life Sci Lab N331,240 Thatcher Rd, Amherst, MA 01003 USA.; Gierasch, LM (corresponding author), Univ Massachusetts, Dept Chem, Life Sci Lab N331,240 Thatcher Rd, Amherst, MA 01003 USA.	gierasch@biochem.umass.edu	Borbat, Petr P/A-8658-2014	robinson, carol/0000-0001-7829-5505	NIBIB/National Institutes of Health (NIH) [R01EB003150]; NIGMS/NIH [P41GM103521]; NIH [R01GM027616, R35GM118161]; Medical Research Council (MRC) [98101]; Wellcome Trust [WT008150, WT099141]; European Research Council (ERC) (IMPRESS) grant; MRC [MR/N020413/1, G1000819] Funding Source: UKRI; Medical Research Council [MR/N020413/1, G1000819] Funding Source: researchfish; Wellcome Trust [104633/Z/14/Z] Funding Source: researchfish; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027616, P41GM103521, R35GM118161] Funding Source: NIH RePORTER	NIBIB/National Institutes of Health (NIH); NIGMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council (ERC) (IMPRESS) grant(European Research Council (ERC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIBIB/National Institutes of Health (NIH), Grant R01EB003150 and NIGMS/NIH Grant P41GM103521 (to J. H. F.); NIH Grants R01GM027616 and R35GM118161 (to L. M. G); and Medical Research Council (MRC) Grant 98101, Wellcome Trust Grants WT008150 and WT099141, and a European Research Council (ERC) (IMPRESS) grant (to C. V. R.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allison TM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9551; Arakawa A, 2011, PROTEIN SCI, V20, P1367, DOI 10.1002/pro.663; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Banerjee R, 2016, FEBS J, V283, P2853, DOI 10.1111/febs.13769; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Borbat PP, 2007, METHOD ENZYMOL, V423, P52, DOI 10.1016/S0076-6879(07)23003-4; Borbat PP, 2014, STRUCT BOND, V152, P1, DOI 10.1007/430_2012_82; Borbat PP, 1997, J MAGN RESON, V127, P155, DOI 10.1006/jmre.1997.1201; Breuker K, 2008, P NATL ACAD SCI USA, V105, P18145, DOI 10.1073/pnas.0807005105; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; BUKAU B, 1990, EMBO J, V9, P4027, DOI 10.1002/j.1460-2075.1990.tb07624.x; Bush MF, 2010, ANAL CHEM, V82, P9557, DOI 10.1021/ac1022953; Chiang YW, 2005, J MAGN RESON, V177, P184, DOI 10.1016/j.jmr.2005.07.021; Chiang YW, 2005, J MAGN RESON, V172, P279, DOI 10.1016/j.jmr.2004.10.012; Clerico EM, 2010, BIOPOLYMERS, V94, P742, DOI 10.1002/bip.21426; Dobo A, 2001, ANAL CHEM, V73, P4763, DOI 10.1021/ac010713f; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Georgieva ER, 2013, NAT STRUCT MOL BIOL, V20, P215, DOI 10.1038/nsmb.2494; Gunasekaran K, 2004, PROTEINS, V57, P433, DOI 10.1002/prot.20232; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716; Jurneczko E, 2011, ANALYST, V136, P20, DOI 10.1039/c0an00373e; Kaltashov IA, 2005, ANAL CHEM, V77, P5370, DOI 10.1021/ac050511+; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; Krug U, 2016, STRUCTURE, V24, P43, DOI 10.1016/j.str.2015.11.007; Laganowsky A, 2014, NATURE, V510, P172, DOI 10.1038/nature13419; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Liu ZL, 2016, PHYS CHEM CHEM PHYS, V18, P5819, DOI 10.1039/c5cp04556h; Mapa K, 2010, MOL CELL, V38, P89, DOI 10.1016/j.molcel.2010.03.010; Marcinowski M, 2011, NAT STRUCT MOL BIOL, V18, P150, DOI 10.1038/nsmb.1970; Marklund EG, 2015, STRUCTURE, V23, P791, DOI 10.1016/j.str.2015.02.010; Mashaghi A, 2016, NATURE, V539, P448, DOI 10.1038/nature20137; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mchaourab HS, 2011, STRUCTURE, V19, P1549, DOI 10.1016/j.str.2011.10.009; Moro F, 2003, FEBS LETT, V533, P119, DOI 10.1016/S0014-5793(02)03752-3; Pacholarz KJ, 2014, ANGEW CHEM INT EDIT, V53, P7765, DOI 10.1002/anie.201402863; Pagel K, 2013, ANGEW CHEM INT EDIT, V52, P361, DOI 10.1002/anie.201203047; PALLEROS DR, 1993, NATURE, V365, P664, DOI 10.1038/365664a0; Pierpaoli EV, 1998, BIOCHEMISTRY-US, V37, P16741, DOI 10.1021/bi981762y; Qi RF, 2013, NAT STRUCT MOL BIOL, V20, P900, DOI 10.1038/nsmb.2583; Ruotolo BT, 2008, NAT PROTOC, V3, P1139, DOI 10.1038/nprot.2008.78; SADIS S, 1992, BIOCHEMISTRY-US, V31, P9406, DOI 10.1021/bi00154a012; Schiffrin B, 2016, NAT STRUCT MOL BIOL, V23, P786, DOI 10.1038/nsmb.3266; Schlecht R, 2011, NAT STRUCT MOL BIOL, V18, P345, DOI 10.1038/nsmb.2006; Sikor M, 2013, EMBO J, V32, P1639, DOI 10.1038/emboj.2013.89; Smock RG, 2011, J BIOL CHEM, V286, P31821, DOI 10.1074/jbc.M111.265835; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Swain JF, 2006, J BIOL CHEM, V281, P1605, DOI 10.1074/jbc.M509356200; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Wrabl JO, 2011, BIOPHYS CHEM, V159, P129, DOI 10.1016/j.bpc.2011.05.020; Zhou M, 2014, NAT CHEM, V6, P208, DOI [10.1038/nchem.1868, 10.1038/NCHEM.1868]; Zhou M, 2011, SCIENCE, V334, P380, DOI 10.1126/science.1210148; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606; Zhuravleva A, 2012, CELL, V151, P1296, DOI 10.1016/j.cell.2012.11.002	54	38	38	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8773	8785		10.1074/jbc.M116.770404	http://dx.doi.org/10.1074/jbc.M116.770404			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28428246	Green Published, hybrid			2022-12-26	WOS:000402153900023
J	Horner, AA; Hoffman, EA; Tye, MR; Hether, TD; Savage, AE				Horner, Ariel A.; Hoffman, Eric A.; Tye, Matthew R.; Hether, Tyler D.; Savage, Anna E.			Cryptic chytridiomycosis linked to climate and genetic variation in amphibian populations of the southeastern United States	PLOS ONE			English	Article							PATHOGEN BATRACHOCHYTRIUM-DENDROBATIDIS; RANAVIRUS INFECTION; EMERGING DISEASE; BOX TURTLES; DYNAMICS; PCR; SUSCEPTIBILITY; TEMPERATURE; PREVALENCE; RESISTANCE	North American amphibians have recently been impacted by two major emerging pathogens, the fungus Batrachochytrium dendrobatidis (Bd) and iridoviruses in the genus Ranavirus (Rv). Environmental factors and host genetics may play important roles in disease dynamics, but few studies incorporate both of these components into their analyses. Here, we investigated the role of environmental and genetic factors in driving Bd and Rv infection prevalence and severity in a biodiversity hot spot, the southeastern United States. We used quantitative PCR to characterize Bd and Rv dynamics in natural populations of three amphibian species: Notophthalmus perstriatus, Hyla squirella and Pseudacris ornata. We combined pathogen data, genetic diversity metrics generated from neutral markers, and environmental variables into general linear models to evaluate how these factors impact infectious disease dynamics. Occurrence, prevalence and intensity of Bd and Rv varied across species and populations, but only one species, Pseudacris ornata, harbored high Bd intensities in the majority of sampled populations. Genetic diversity and climate variables both predicted Bd prevalence, whereas climatic variables alone predicted infection intensity. We conclude that Bd is more abundant in the southeastern United States than previously thought and that genetic and environmental factors are both important for predicting amphibian pathogen dynamics. Incorporating both genetic and environmental information into conservation plans for amphibians is necessary for the development of more effective management strategies to mitigate the impact of emerging infectious diseases.	[Horner, Ariel A.; Hoffman, Eric A.; Savage, Anna E.] Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA; [Tye, Matthew R.] Uppsala Univ, Dept Ecol & Genet, Uppsala, Sweden; [Hether, Tyler D.] Univ Oregon, Inst Ecol & Evolut, Eugene, OR 97403 USA	State University System of Florida; University of Central Florida; Uppsala University; University of Oregon	Savage, AE (corresponding author), Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA.	anna.savage@ucf.edu	Savage, Anna/A-7713-2012	Savage, Anna/0000-0002-4917-8358	US Fish and Wildlife Service; Florida Fish and Wildlife Conservation Commission's Nongame Wildlife Program; Sigma Xi [G200810150636]; University of Central Florida	US Fish and Wildlife Service(US Fish & Wildlife Service); Florida Fish and Wildlife Conservation Commission's Nongame Wildlife Program; Sigma Xi; University of Central Florida	This work was funded by the US Fish and Wildlife Service: EAH, Florida Fish and Wildlife Conservation Commission's Nongame Wildlife Program: EAH, and Sigma Xi Grants-in-Aid: TDH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Zachary Rivas and Sanabel Mahmoud for providing assistance with lab work and Jacob Degner and Sarah May for providing tissue samples. We also thank Taina Torres for assistance with the prevalence figures. This research was supported by grants from the US Fish and Wildlife Service and Florida Fish and Wildlife Conservation Commission's Nongame Wildlife Program to E.A.H., Sigma Xi Grants-in-Aid research #G200810150636 to T.D.H., and the University of Central Florida. All applicable institutional and/or national guidelines for the care and use of animals were followed.	Allender MC, 2013, J VIROL METHODS, V188, P121, DOI 10.1016/j.jviromet.2012.12.012; Altizer S, 2004, J ANIM ECOL, V73, P309, DOI 10.1111/j.0021-8790.2004.00807.x; BARINAGA M, 1990, SCIENCE, V247, P1033, DOI 10.1126/science.247.4946.1033; Bataille A, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.3127; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Brenes RM, 2013, THESIS; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chatfield MWH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044821; Crnokrak P, 2002, EVOLUTION, V56, P2347, DOI 10.1111/j.0014-3820.2002.tb00160.x; Daszak P, 1999, EMERG INFECT DIS, V5, P735, DOI 10.3201/eid0506.990601; Degner JF, 2010, MOL ECOL, V19, P2501, DOI 10.1111/j.1365-294X.2010.04661.x; Echaubard P, 2014, EVOL APPL, V7, P723, DOI 10.1111/eva.12169; Elliot L, 2009, FROGS TOADS N AM; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Garner TWJ, 2006, BIOL LETTERS, V2, P455, DOI 10.1098/rsbl.2006.0494; Gray MJ, 2009, DIS AQUAT ORGAN, V87, P243, DOI 10.3354/dao02138; Green DE, 2002, ANN NY ACAD SCI, V969, P323, DOI 10.1111/j.1749-6632.2002.tb04400.x; GREMILLIONSMITH C, 1988, J WILDLIFE DIS, V24, P620, DOI 10.7589/0090-3558-24.4.620; Gunawardana M, 2014, J MICROBIOL METH, V102, P1, DOI 10.1016/j.mimet.2014.04.005; Hanson C., 2010, SO FORESTS FUTURE; Hether TD, 2012, J EVOLUTION BIOL, V25, P1039, DOI 10.1111/j.1420-9101.2012.02497.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hochachka WM, 2000, P NATL ACAD SCI USA, V97, P5303, DOI 10.1073/pnas.080551197; Hoverman JT, 2011, ECOHEALTH, V8, P301, DOI 10.1007/s10393-011-0717-7; Johnson AJ, 2008, J WILDLIFE DIS, V44, P851, DOI 10.7589/0090-3558-44.4.851; Johnson ML, 2003, DIS AQUAT ORGAN, V57, P255, DOI 10.3354/dao057255; Kinney VC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016708; Kriger KM, 2007, J ZOOL, V271, P352, DOI 10.1111/j.1469-7998.2006.00220.x; Kriger KM, 2007, DIVERS DISTRIB, V13, P781, DOI 10.1111/j.1472-4642.2007.00394.x; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; Landsberg JH, 2013, DIS AQUAT ORGAN, V105, P89, DOI 10.3354/dao02625; Langwig KE, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2335; Lenker MA, 2014, DIS AQUAT ORGAN, V111, P51, DOI 10.3354/dao02760; May SE, 2011, BIOL CONSERV, V144, P1441, DOI 10.1016/j.biocon.2011.01.013; Meagher S, 1999, EVOLUTION, V53, P1318, DOI 10.1111/j.1558-5646.1999.tb04547.x; Means R, 2011, 1 ANN REPORT US FORE; Means R, 2013, 3 ANN REPORT US FORE; Miller D, 2011, VIRUSES-BASEL, V3, P2351, DOI 10.3390/v3112351; Muths E, 2008, BIOL CONSERV, V141, P1484, DOI 10.1016/j.biocon.2008.03.011; Ouellet M, 2005, CONSERV BIOL, V19, P1431, DOI 10.1111/j.1523-1739.2005.00108.x; Pearl CA, 2007, J HERPETOL, V41, P145, DOI 10.1670/0022-1511(2007)41[145:OOTAPB]2.0.CO;2; Pearman PB, 2005, ECOL LETT, V8, P401, DOI 10.1111/j.1461-0248.2005.00735.x; Peterson CE, 2016, ECOHEALTH, P1; Preuss JF, 2016, STUD NEOTROP FAUNA E, V51, P68, DOI 10.1080/01650521.2016.1163857; R CORE TEAM, 2016, R LANG ENV STAT COMP; Ribas L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008408; Richmond JQ, 2009, BIOSCIENCE, V59, P311, DOI 10.1525/bio.2009.59.4.9; Rojas S, 2005, DIS AQUAT ORGAN, V63, P95, DOI 10.3354/dao063095; Rothermel BB, 2008, DIS AQUAT ORGAN, V82, P3, DOI 10.3354/dao01974; Sandkam B, 2015, MOL ECOL, V24, P596, DOI 10.1111/mec.13058; Sapsford SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082425; Savage AE, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.3115; Savage AE, 2015, EVOL APPL, V8, P560, DOI 10.1111/eva.12264; Savage AE, 2011, P NATL ACAD SCI USA, V108, P16705, DOI 10.1073/pnas.1106893108; Savage AE, 2011, BIOL CONSERV, V144, P1910, DOI 10.1016/j.biocon.2011.03.018; Spielman D, 2004, CONSERV GENET, V5, P439, DOI 10.1023/B:COGE.0000041030.76598.cd; Talley BL, 2015, BIOL CONSERV, V182, P254, DOI 10.1016/j.biocon.2014.12.007; Tobler U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010927; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Wiegertjes GF, 1996, DEV COMP IMMUNOL, V20, P365, DOI 10.1016/S0145-305X(96)00032-8; Woodhams DC, 2005, CONSERV BIOL, V19, P1449, DOI 10.1111/j.1523-1739.2005.004403.x; Woodhams DC, 2003, DIS AQUAT ORGAN, V55, P65, DOI 10.3354/dao055065; Woodhams Douglas C., 2008, Herpetological Review, V39, P66	66	16	16	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e175843	10.1371/journal.pone.0175843	http://dx.doi.org/10.1371/journal.pone.0175843			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448517	gold, Green Published, Green Submitted			2022-12-26	WOS:000400383600026
J	Mikha, MM; Benjamin, JG; Vigil, MF; Poss, DJ				Mikha, Maysoon M.; Benjamin, Joseph G.; Vigil, Merle F.; Poss, David J.			Manure and tillage use in remediation of eroded land and impacts on soil chemical properties	PLOS ONE			English	Article							PHYSICAL-PROPERTIES; CROP RESIDUE; CARBON; REMEDIATION/RESTORATION; MINERALIZATION; PRODUCTIVITY; NUTRIENTS; TEXTURE; FORESTS; YIELD	Soil loss through wind and water erosion is an ongoing problem in semiarid regions. A thin layer of top soil loss over a hectare of cropland could be corresponding to tons of productive soil loss per hectare. The objectives of this study were to evaluate the influence of beef feed-lot manure, tillage and legume grass mixtures on changes in soil quality and nutrient components. The study was initiated in 2006 on an eroded site near Akron, Colorado, on a Norka-Colby very-fine sandy loam (fine-silty, mixed, mesic, Aridic, Argiustolls). Tillage treatments were no-tillage, shallow tillage (sweeps operations with V-blade) and deep tillage (DT; mold-board plow operations). In one set of plots, DT was implemented biannually (DT-2); and in another set the DT was done once at the initiation of the experiment in 2006. Amendments consisted of beef manure and urea (46-0-0), N fertilizer. Both amendments were added at low and high rates. A control treatment, with no fertilizer or manure added, was included with no-tillage and shallow tillage only. Six years of manure addition and tillage significantly altered soil chemical properties compared with fertilizer and grass legume mixtures. Across all the tillage treatments, at the 0-30 cm depth, soil pH from 2006 to 2012, was reduced 1.8 fold with high-manure compared with high-fertilizer treatment. Soil EC, Na, and SAR increased by 2.7 fold while soil P increase by 3.5 fold with high-manure treatment compared with low-manure from 2006 to 2012 across all the tillage treatments at the surface 0-30 cm. Soil organic carbon associated with high-manure was 71% higher than low-manure and 230% higher than high-fertilizer treatments in the 0-60 cm depth. Similar patterns were observed with soil total N. Overall, manure amendments greatly improved the soil nutrient status on this eroded site. However, the legume grass mixtures showed little effect on improving soils chemical properties. The micronutrients supplied by manure improved the soil nutrient status compared with inorganic fertilizer, the grass, and the grass-legume treatments. We concluded that more than six years are needed to measure significant improvements in soil quality from specific treatments, specifically fertilizer, grasses, and grasslegume mixtures in such eroded crop land.	[Mikha, Maysoon M.; Benjamin, Joseph G.; Vigil, Merle F.; Poss, David J.] ARS, USDA, Cent Great Plain Res Stn, Akron, CO 80720 USA	United States Department of Agriculture (USDA)	Mikha, MM (corresponding author), ARS, USDA, Cent Great Plain Res Stn, Akron, CO 80720 USA.	Maysoon.Mikha@ars.usda.gov						Acosta-Martinez V, 2011, AGRICULTURE-BASEL, V1, P4, DOI 10.3390/agriculture1010004; American Farmland Trust's Farmland Information, 2014, COMPL AM FARML TRUST; Arriaga FJ, 2003, SOIL SCI, V168, P888, DOI 10.1097/01.ss.0000106403.84926.7e; Ashworth J, 1999, CAN J SOIL SCI, V79, P449, DOI 10.4141/S99-001; Basak BB, 2014, J INDIAN SOC SOIL SC, P62; BEARE MH, 1994, SOIL SCI SOC AM J, V58, P777, DOI 10.2136/sssaj1994.03615995005800030020x; BLEVINS RL, 1993, ADV AGRON, V51, P33, DOI 10.1016/S0065-2113(08)60590-8; Bolan N. S., 2003, Handbook of soil acidity, P29; Das P, 2012, ARCH AGRON SOIL SCI, V58, P745, DOI 10.1080/03650340.2010.540011; Eghball B, 2004, AGRON J, V96, P442, DOI 10.2134/agronj2004.4420; Epstein HE, 1997, ECOLOGY, V78, P2628, DOI 10.1890/0012-9658(1997)078[2628:EOTAST]2.0.CO;2; Fageria NK, 2010, COMMUN SOIL SCI PLAN, V41, P1565, DOI 10.1080/00103624.2010.485237; Ferguson RB, 2005, J ENVIRON QUAL, V34, P1672, DOI 10.2134/jeq2004.0363; Frank K., 1998, RECOMMENDED CHEM SOI, V221, P21; Gilbertson CB, 1979, 1979 USDA; Gill JS, 2009, FIELD CROP RES, V114, P137, DOI 10.1016/j.fcr.2009.07.018; Gratius Susanne, 2006, AGR SALINITY DRAINAG; Grossman R.B., 2002, METHODS SOIL ANAL 4, V5, P201, DOI DOI 10.2136/SSSABOOKSER5.4.C9; Guo XB, 2012, SOIL SCI SOC AM J, V76, P485, DOI 10.2136/sssaj2011.0315; Halvorson AD, 2002, AGRON J, V94, P1429, DOI 10.2134/agronj2002.1429; Hassan W, 2013, ACTA AGR SCAND B-S P, V63, P642, DOI 10.1080/09064710.2013.846398; Izaurralde RC, 2006, AGRON J, V98, P1298, DOI 10.2134/agronj2005.0184; Janzen HH, 2001, CAN J SOIL SCI, V81, P489, DOI 10.4141/S00-054; Larney FJ, 2012, CAN J SOIL SCI, V92, P19, DOI [10.4141/cjss2010-064, 10.4141/CJSS2010-064]; Larney FJ, 2011, CAN J SOIL SCI, V91, P1029, DOI [10.4141/CJSS10065, 10.4141/cjss10065]; Leytem AB, 2005, SOIL SCI SOC AM J, V69, P1516, DOI 10.2136/sssaj2004.0315; Li S, 2007, SOIL TILL RES, V94, P164, DOI 10.1016/j.still.2006.07.019; Manjula N, 2006, GUIDE CONDUCTING SOI; McLean EO, 1982, METHODS SOIL ANAL, V9, P199, DOI DOI 10.2134/AGR0NM0N0GR9.2.2ED.C12; Mikha MM, 2014, AGRON J, V106, P261, DOI 10.2134/agronj2013.0279; Mikha MM, 2014, AGRON J, V106, P252, DOI 10.2134/agronj2013.0278; Mikha MM, 2013, SOIL SCI SOC AM J, V77, P594, DOI 10.2136/sssaj2012.0125; Mikha MM, 2006, RENEW AGR FOOD SYST, V21, P26, DOI 10.1079/RAFS2005123; Miller AJ, 2015, CAN J PLANT SCI, V95, P43, DOI 10.4141/CJPS-2014-225; Paustian K., SOIL ORGANIC MATTER; Paustian K, 1997, MANAGE CONTROLS, P15; Pimentel D, 2013, AGRICULTURE-BASEL, V3, P443, DOI 10.3390/agriculture3030443; Popp JD, 2000, CAN J PLANT SCI, V80, P513, DOI 10.4141/P99-049; Reeder JD, 1998, SOIL TILL RES, V47, P339, DOI 10.1016/S0167-1987(98)00122-6; Roger-Estrade J, 2004, SOIL TILL RES, V79, P33, DOI 10.1016/j.still.2004.03.009; SALA OE, 1988, ECOLOGY, V69, P40, DOI 10.2307/1943158; SAS Institute Inc, 2006, SAS STAT USERS GUIDE; Seguin P, 2001, CAN J PLANT SCI, V81, P255, DOI 10.4141/P00-023; Sistani KR, 2010, SOIL SCI, V175, P593, DOI 10.1097/SS.0b013e3181fbdfee; Six J, 2000, SOIL BIOL BIOCHEM, V32, P2099, DOI 10.1016/S0038-0717(00)00179-6; Skjemstad J.O., 2007, SOIL SAMPLING METHOD, V2nd, P225, DOI [10.1201/9781420005271.ch21, DOI 10.1201/9781420005271]; Smith J.L., 1996, METHODS ASSESSING SO, V49, P41; Solly EF, 2014, PLANT SOIL, V382, P203, DOI 10.1007/s11104-014-2151-4; Sposito G, 1989, CHEM SOILS; STARICKA JA, 1991, SOIL SCI SOC AM J, V55, P1668, DOI 10.2136/sssaj1991.03615995005500060028x; Stewart B. A., 2004, C P ISCO 2004 13 INT; TANAKA DL, 1989, SOIL SCI SOC AM J, V53, P228, DOI 10.2136/sssaj1989.03615995005300010040x; Turner JC, 2010, COMMUN SOIL SCI PLAN, V41, P1043, DOI 10.1080/00103621003687141; [U.S. Department of Agriculture USDA], 2013, SUMM REP 2010 NAT RE; United States Salinity Laboratory Staff, 1954, US DEP AGR HDB, V60; Vigil FM, RES SOIL SCI USDA AR; Warncke D., 1998, POTASSIUM OTHER BASI, VVolume 1001, P31; WEBB WL, 1983, ECOLOGY, V64, P134, DOI 10.2307/1937336; Whitney DA, 1998, RECOMMENDED CHEM SOI, V221, P59; Yan YC, 2013, PLANT SOIL, V369, P585, DOI 10.1007/s11104-013-1606-3	60	11	13	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0175533	10.1371/journal.pone.0175533	http://dx.doi.org/10.1371/journal.pone.0175533			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448510	Green Submitted, Green Published, gold			2022-12-26	WOS:000400383600017
J	Scapin, SMN; Souza, FHM; Zanphorlin, LM; de Almeida, TS; Sade, YB; Cardoso, AM; Pinheiro, GL; Murakami, MT				Naressi Scapin, Sandra Mara; Moreira Souza, Flavio Henrique; Zanphorlin, Leticia Maria; de Almeida, Thamyres Silva; Sade, Youssef Bacila; Cardoso, Alexander Machado; Pinheiro, Guilherme Luiz; Murakami, Mario Tyago			Structure and function of a novel GH8 endoglucanase from the bacterial cellulose synthase complex of Raoultella ornithinolytica	PLOS ONE			English	Article							ACETOBACTER-XYLINUM; ERWINIA-CHRYSANTHEMI; ACTIVE-SITE; CLOSTRIDIUM-THERMOCELLUM; ANGSTROM RESOLUTION; FAMILY-8 XYLANASE; CRYSTAL-STRUCTURE; BIOSYNTHESIS; GENE; EXPRESSION	Cellulose synthesis in bacteria is a complex process involving the concerted action of several enzymes whose genes are often organized in operons. This process influences many fundamental physiological aspects such as bacteria and host interaction, biofilm formation, among others. Although it might sound contradictory, the participation of cellulose-degrading enzymes is critical to this process. The presence of endoglucanases from family 8 of glycosyl hydrolases (GH8) in bacterial cellulose synthase (Bcs) complex has been described in different bacteria, including the model organism Komagataeibacter xylinus; however, their role in this process is not completely understood. In this study, we describe the biochemical characterization and three-dimensional structure of a novel GH8 member from Raoultella ornithinolytica, named AfmE1, which was previously identified by our group from the metagenomic analysis of the giant snail Achatina fulica. Our results demonstrated that AfmE1 is an endo-beta-1,4-glucanase, with maximum activity in acidic to neutral pH over a wide temperature range. This enzyme cleaves cello-oligosaccharides with a degree of polymerization >= 5 and presents six glucosyl-binding subsites. The structural comparison of AfmE1 with other GH8 endoglucanases showed significant structural dissimilarities in the catalytic cleft, particularly in the subsite +3, which correlate with different functional mechanisms, such as the recognition of substrate molecules having different arrangements and crystallinities. Together, these findings provide new insights into molecular and structural features of evolutionarily conserved endoglucanases from the bacterial cellulose biosynthetic machinery.	[Naressi Scapin, Sandra Mara; de Almeida, Thamyres Silva; Sade, Youssef Bacila; Cardoso, Alexander Machado; Pinheiro, Guilherme Luiz] Natl Inst Metrol Qual & Technol, Div Metrol Appl Life Sci, Rio De Janeiro, Brazil; [Moreira Souza, Flavio Henrique; Zanphorlin, Leticia Maria; Murakami, Mario Tyago] Natl Ctr Res Energy & Mat, Brazilian Bioethanol Sci & Technol Lab, Campinas, SP, Brazil	Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO)	Scapin, SMN (corresponding author), Natl Inst Metrol Qual & Technol, Div Metrol Appl Life Sci, Rio De Janeiro, Brazil.; Murakami, MT (corresponding author), Natl Ctr Res Energy & Mat, Brazilian Bioethanol Sci & Technol Lab, Campinas, SP, Brazil.	smscapin@inmetro.gov.br; mario.murakami@bioetanol.org.br	Sade, Youssef/GRX-8801-2022; Cardoso, Alexander/AAX-2505-2021; Cardoso, Alexander/S-6687-2017; Murakami, Mario T/F-5640-2016	Sade, Youssef/0000-0001-6041-0288; Cardoso, Alexander/0000-0003-2974-0232; Murakami, Mario T/0000-0002-0405-8010	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2015/26982-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by the Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, 2015/26982-0) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).; We are grateful to the Brazilian Biosciences National Laboratory (LNBio) and the Brazilian Synchrotron Light Laboratory (LNLS) for the provision of time on the MX2 beamline, Robolab and LEC. We would like to thank the staff of Inmetro and LNBio for technical assistance and insightful discussions, especially Celisa C. Tonoli and Givanil Garrido. This work was funded by the Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).	Adachi W, 2004, J MOL BIOL, V343, P785, DOI 10.1016/j.jmb.2004.08.028; Alzari PM, 1996, STRUCTURE, V4, P265, DOI 10.1016/S0969-2126(96)00031-7; Anbar M, 2010, CHEMCATCHEM, V2, P997, DOI 10.1002/cctc.201000112; Augimeri RV, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01282; Bao W, 2015, GENOME ANNOUNC, V3; Bhat A, 2013, EXTREMOPHILES, V17, P229, DOI 10.1007/s00792-012-0510-8; BOYER MH, 1987, EUR J BIOCHEM, V162, P311, DOI 10.1111/j.1432-1033.1987.tb10602.x; Cacicedo ML, 2016, BIORESOURCE TECHNOL, V213, P172, DOI 10.1016/j.biortech.2016.02.071; Cardoso AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048505; CHEN FTA, 1995, ANAL BIOCHEM, V230, P273, DOI 10.1006/abio.1995.1474; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Collins T, 2005, J MOL BIOL, V354, P425, DOI 10.1016/j.jmb.2005.09.064; De Vos D, 2006, BIOCHEMISTRY-US, V45, P4797, DOI 10.1021/bi052193e; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FIEROBE HP, 1993, EUR J BIOCHEM, V217, P557, DOI 10.1111/j.1432-1033.1993.tb18277.x; Glasner JD, 2011, J BACTERIOL, V193, P2076, DOI 10.1128/JB.01513-10; Guerin DMA, 2002, J MOL BIOL, V316, P1061, DOI 10.1006/jmbi.2001.5404; Hakamada Y, 2002, BBA-GEN SUBJECTS, V1570, P174, DOI 10.1016/S0304-4165(02)00194-0; Hrmova M, 2002, PLANT CELL, V14, P1033, DOI 10.1105/tpc.010442; Huang XL, 2010, J MICROBIOL, V48, P318, DOI 10.1007/s12275-009-0188-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kawano S, 2002, J BIOSCI BIOENG, V94, P275, DOI 10.1263/jbb.94.275; Koo HM, 1998, BIOSCI BIOTECH BIOCH, V62, P2257, DOI 10.1271/bbb.62.2257; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee KY, 2014, MACROMOL BIOSCI, V14, P10, DOI 10.1002/mabi.201300298; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; MATTHYSSE AG, 1995, J BACTERIOL, V177, P1076, DOI 10.1128/jb.177.4.1076-1081.1995; Mazur O, 2011, J BIOL CHEM, V286, P17601, DOI 10.1074/jbc.M111.227660; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNamara JT, 2015, ANNU REV BIOCHEM, V84, P895, DOI 10.1146/annurev-biochem-060614-033930; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; MISAWA N, 1988, J BIOTECHNOL, V7, P167, DOI 10.1016/0168-1656(88)90049-1; Mohammadkazemi F, 2015, CARBOHYD POLYM, V117, P518, DOI 10.1016/j.carbpol.2014.10.008; Molhoj M, 2002, PLANT CELL PHYSIOL, V43, P1399, DOI 10.1093/pcp/pcf163; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakai T, 2013, J BACTERIOL, V195, P958, DOI 10.1128/JB.01473-12; NAKAMURA K, 1986, J BIOTECHNOL, V4, P247, DOI 10.1016/0168-1656(86)90035-0; Ng IS, 2013, BIOCHEM ENG J, V78, P53, DOI 10.1016/j.bej.2013.01.009; Nicol F, 1998, EMBO J, V17, P5563, DOI 10.1093/emboj/17.19.5563; Nobles DR, 2001, PLANT PHYSIOL, V127, P529, DOI 10.1104/pp.010557; OZAKI K, 1991, J GEN MICROBIOL, V137, P41, DOI 10.1099/00221287-137-1-41; Petersen L, 2009, J PHYS CHEM B, V113, P7331, DOI 10.1021/jp811470d; Robledo M, 2008, P NATL ACAD SCI USA, V105, P7064, DOI 10.1073/pnas.0802547105; Robledo M, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-125; Robledo M, 2011, MOL PLANT MICROBE IN, V24, P798, DOI 10.1094/MPMI-10-10-0249; Romling U, 2015, TRENDS MICROBIOL, V23, P545, DOI 10.1016/j.tim.2015.05.005; Schrodinger L.L.C.,, 2015, PYMOL MOL GRAPHICS S; TONOUCHI N, 1995, BIOSCI BIOTECH BIOCH, V59, P805, DOI 10.1271/bbb.59.805; Van Petegem F, 2003, J BIOL CHEM, V278, P7531, DOI 10.1074/jbc.M206862200; Yasutake Y, 2006, PROTEINS, V64, P1069, DOI 10.1002/prot.21052; Yim SM, 2015, PROCESS BIOCHEM, V117, P518; Zhou SD, 2001, APPL ENVIRON MICROB, V67, P6, DOI 10.1128/AEM.67.1.6-14.2001; Zhou SG, 2000, J BACTERIOL, V182, P5676, DOI 10.1128/JB.182.20.5676-5682.2000	53	16	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176550	10.1371/journal.pone.0176550	http://dx.doi.org/10.1371/journal.pone.0176550			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448629	Green Submitted, gold, Green Published			2022-12-26	WOS:000400383600103
J	Cholley-Roulleaul, M; Chenini, S; Beziat, S; Guiraud, L; Jaussent, I; Dauvilliers, Y				Cholley-Roulleaul, Marion; Chenini, Sofiene; Beziat, Severine; Guiraud, Lily; Jaussent, Isabelle; Dauvilliers, Yves			Restless legs syndrome and cardiovascular diseases: A case-control study	PLOS ONE			English	Article							GENERAL-POPULATION; RISK-FACTORS; DIAGNOSTIC-CRITERIA; DAYTIME SLEEPINESS; WOMEN; PREVALENCE; VALIDATION; HYPERTENSION; ASSOCIATION; INSOMNIA	Objective The association between restless legs syndrome (RLS), cardiovascular diseases (CVD) and hypertension is inconsistent. This case-control study examined i) the association between primary RLS, CVD and hypertension by taking into account many potential confounders and ii) the influence of RLS duration, severity and treatment, sleep and depressive symptoms on CVD and hypertension in primary RLS. Methods A standardized questionnaire to assess the RLS phenotype, history of CVD and hypertension, sleep and depressive symptoms, drug intake and demographic/clinical features was sent to the France-Ekbom Patients Association members. A CVD event was defined as a self-reported history of coronary heart disease, heart failure, arrhythmia or stroke. Hypertension was also self-assessed. Current treatment for hypertension and arrhythmia also defined underlying hypertension and arrhythmia. Controls without RLS and without consanguinity were chosen by the patients. Results 487 patients with primary RLS (median age 71 years; 67.4% women) and 354 controls (68 years, 47.7% women) were included. Most of the patients (91.7%) were treated for RLS, especially with dopaminergic agonists. The median age of RLS onset was 45 years. CVD and hypertension were associated with RLS in unadjusted association, but not after adjustment for age, sex and body mass index. Patients with RLS and with CVD and/or hypertension were significantly older, with hypercholesterolemia, sleep apnea and older age at RLS and at daily RLS onset compared with patients without CVD and/or hypertension. No significant difference was found for other RLS features, ferritin levels, daytime sleepiness, insomnia and depressive symptoms. Conclusion Despite some limitations in the design of this study, we found that most of the treated patients for primary RLS had no association with CVD and hypertension after controlling for key potential confounders. Comorbid CVD or hypertension was associated with cardiovascular risk factors, but not with RLS features except for older age at onset.	[Cholley-Roulleaul, Marion; Chenini, Sofiene; Guiraud, Lily; Dauvilliers, Yves] Hop Gui de Chauliac, Neurol, Unite Troubles Sommeil, Montpellier, France; [Beziat, Severine; Jaussent, Isabelle; Dauvilliers, Yves] INSERM, U1061, Montpellier, France; [Beziat, Severine; Jaussent, Isabelle; Dauvilliers, Yves] Univ Montpellier, Montpellier, France	Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier	Dauvilliers, Y (corresponding author), Hop Gui de Chauliac, Neurol, Unite Troubles Sommeil, Montpellier, France.; Dauvilliers, Y (corresponding author), INSERM, U1061, Montpellier, France.; Dauvilliers, Y (corresponding author), Univ Montpellier, Montpellier, France.	ydauvilliers@yahoo..fr	Chenini, S./AAX-9064-2020	Chenini, Sofiene/0000-0002-9545-4958; Jaussent, Isabelle/0000-0002-8205-7590; Dauvilliers, yves/0000-0003-0683-6506				Abetz L, 2005, VALUE HEALTH, V8, P157, DOI 10.1111/j.1524-4733.2005.03010.x; Allen RP, 2014, SLEEP MED, V15, P860, DOI 10.1016/j.sleep.2014.03.025; Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Batool-Anwar S, 2011, HYPERTENSION, V58, P791, DOI 10.1161/HYPERTENSIONAHA.111.174037; Bauer A, 2016, NEUROLOGY, V86, P1785, DOI 10.1212/WNL.0000000000002649; Beck AT, 1996, INVENTAIRE PRESSION; Bouilloux F, 2016, ELIFE, V5, DOI [10.7554/eLifel1627, 10.7554/eLife.11627]; Budhiraja P, 2012, J CLIN SLEEP MED, V8, P119, DOI 10.5664/jcsm.1756; Dauvilliers Y, 2013, CURR OPIN PULM MED, V19, P594, DOI 10.1097/MCP.0b013e328365ab07; De Vito K, 2014, MOVEMENT DISORD, V29, P1044, DOI 10.1002/mds.25860; Empana JP, 2009, STROKE, V40, P1219, DOI 10.1161/STROKEAHA.108.530824; Gao X, 2009, NEUROLOGY, V72, P1255, DOI 10.1212/01.wnl.0000345673.35676.1c; Garcia-Borreguero D, 2007, SLEEP MED, V8, P520, DOI 10.1016/j.sleep.2007.03.022; Haba-Rubio J, 2016, ANN NEUROL, V79, P464, DOI 10.1002/ana.24593; Innes KE, 2012, SLEEP MED REV, V16, P309, DOI 10.1016/j.smrv.2011.04.001; Jaussent I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056048; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Koo BB, 2011, CIRCULATION, V124, P1223, DOI 10.1161/CIRCULATIONAHA.111.038968; Laugsand LE, 2011, CIRCULATION, V124, P2073, DOI 10.1161/CIRCULATIONAHA.111.025858; Li YP, 2012, CIRCULATION, V126, P1689, DOI 10.1161/CIRCULATIONAHA.112.112698; Moller C, 2010, SLEEP MED, V11, P161, DOI 10.1016/j.sleep.2009.04.009; Montplaisir J, 1997, MOVEMENT DISORD, V12, P61, DOI 10.1002/mds.870120111; Ohayon MM, 2002, J PSYCHOSOM RES, V53, P547, DOI 10.1016/S0022-3999(02)00443-9; Pennestri MH, 2007, NEUROLOGY, V68, P1213, DOI 10.1212/01.wnl.0000259036.89411.52; Pepin JL, 2014, SLEEP MED REV, V18, P509, DOI 10.1016/j.smrv.2014.03.003; Schlesinger I, 2009, MOVEMENT DISORD, V24, P1587, DOI 10.1002/mds.22486; Szentkiralyi A, 2013, J SLEEP RES, V22, P434, DOI 10.1111/jsr.12040; Szentkiralyi A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001652; Trenkwalder C, 2016, NEUROLOGY, V86, P1336, DOI 10.1212/WNL.0000000000002542; Van Den Eeden SK, 2015, SLEEP, V38, P1009, DOI 10.5665/sleep.4800; Walters AS, 2003, SLEEP MED, V4, P121, DOI 10.1016/S1389-9457(02)00258-7; Winkelman JW, 2008, NEUROLOGY, V70, P35, DOI 10.1212/01.wnl.0000287072.93277.c9; Winkelmann J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002171; Winter AC, 2013, AM J MED, V126, P220, DOI 10.1016/j.amjmed.2012.06.040; Winter AC, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000866	36	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176552	10.1371/journal.pone.0176552	http://dx.doi.org/10.1371/journal.pone.0176552			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445539	gold, Green Published, Green Submitted			2022-12-26	WOS:000400309200072
J	Donner, SD; Rickbeil, GJM; Heron, SF				Donner, Simon D.; Rickbeil, Gregory J. M.; Heron, Scott F.			A new, high-resolution global mass coral bleaching database	PLOS ONE			English	Article							THERMAL-STRESS; CLIMATE-CHANGE; OCEAN ACIDIFICATION; REEFS; TEMPERATURE; PRODUCTS; RATES	Episodes of mass coral bleaching have been reported in recent decades and have raised concerns about the future of coral reefs on a warming planet. Despite the efforts to enhance and coordinate coral reef monitoring within and across countries, our knowledge of the geographic extent of mass coral bleaching over the past few decades is incomplete. Existing databases, like ReefBase, are limited by the voluntary nature of contributions, geographical biases in data collection, and the variations in the spatial scale of bleaching reports. In this study, we have developed the first-ever gridded, global-scale historical coral bleaching database. First, we conducted a targeted search for bleaching reports not included in ReefBase by personally contacting scientists and divers conducting monitoring in under-reported locations and by extracting data from the literature. This search increased the number of observed bleaching reports by 79%, from 4146 to 7429. Second, we employed spatial interpolation techniques to develop annual 0.04 degrees x 0.04 degrees latitude-longitude global maps of the probability that bleaching occurred for 1985 through 2010. Initial results indicate that the area of coral reefs with a more likely than not (> 50%) or likely (> 66%) probability of bleaching was eight times higher in the second half of the assessed time period, after the 1997/1998 El Nino. The results also indicate that annual maximum Degree Heating Weeks, a measure of thermal stress, for coral reefs with a high probability of bleaching increased over time. The database will help the scientific community more accurately assess the change in the frequency of mass coral bleaching events, validate methods of predicting mass coral bleaching, and test whether coral reefs are adjusting to rising ocean temperatures.	[Donner, Simon D.] Univ British Columbia, Dept Geog, Vancouver, BC, Canada; [Rickbeil, Gregory J. M.] Univ British Columbia, Fac Forestry, Integrated Remote Sensing Studio, Vancouver, BC, Canada; [Heron, Scott F.] Natl Ocean & Atmospher Adm, Coral Reef Watch, Townsville, Qld, Australia; [Heron, Scott F.] Global Sci & Technol Inc, Greenbelt, MD USA; [Heron, Scott F.] James Cook Univ, Dept Phys, Townsville, Qld, Australia; [Heron, Scott F.] James Cook Univ, Marine Geophys Lab, Coll Sci Technol & Engn, Townsville, Qld, Australia	University of British Columbia; University of British Columbia; National Oceanic Atmospheric Admin (NOAA) - USA; National Aeronautics & Space Administration (NASA); James Cook University; James Cook University	Donner, SD (corresponding author), Univ British Columbia, Dept Geog, Vancouver, BC, Canada.	simon.donner@ubc.ca	Heron, Scott F/E-7928-2011	Heron, Scott/0000-0001-5262-6978	NSERC Discovery Grant; UBC AURA award; NOAA Coral Reef Conservation Program	NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); UBC AURA award; NOAA Coral Reef Conservation Program(National Oceanic Atmospheric Admin (NOAA) - USA)	The research was funded by a NSERC Discovery Grant (SD Donner) and UBC AURA award (SD Donner). Support for SF Heron was from the NOAA Coral Reef Conservation Program, via a contract between NOM Coral Reef Watch and Global Science and Technology, Inc. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank E. Heyman, K. Kitching, S. Utami, J. Coffey, and M. Wong for assistance in collecting the bleaching observations. We also thank the large community of scientists, managers, and divers who have contributed bleaching reports both to ReefBase and this effort, including M. Eakin and NOAA Coral Reef Watch, T. McClanahan, J. Maynard, H. Sykes, D. Fenner, and P. Houk. The research is funded by a NSERC Discovery Grant and UBC AURA award. The contents in this manuscript are solely the opinions of the authors and do not constitute a statement of policy, decision, or position on behalf of NOAA or the U.S. Government.	Banholzer S, 2014, GEOPHYS RES LETT, V41, P2093, DOI 10.1002/2014GL059520; Brick JM, 2013, ANN AM ACAD POLIT SS, V645, P36, DOI 10.1177/0002716212456834; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Casey KS, 2010, OCEANOGRAPHY FROM SPACE: REVISITED, P273, DOI 10.1007/978-90-481-8681-5_16; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; Donner SD, 2011, RES B, V587, P25; Donner SD, 2007, P NATL ACAD SCI USA, V104, P5483, DOI 10.1073/pnas.0610122104; Donner SD, 2011, ECOL APPL, V21, P1718, DOI 10.1890/10-0107.1; Donner SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005712; Eakin CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013969; Eakin CM, GLOBAL CORAL BLEACHI; Frieler K, 2013, NAT CLIM CHANGE, V3, P165, DOI 10.1038/NCLIMATE1674; Grottoli A.G., 2014, GLOB CHANG BIOL; Guest JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033353; Heron SF, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8010059; Heron SF, SCI REP IN PRESS; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; King A, BARRIER REEF ATTRIBU; Kleypas JA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032257; Liu G, 2014, REMOTE SENS-BASEL, V6, P11579, DOI 10.3390/rs61111579; Logan C. A., 2012, P 12 INT COR REEF S; Logan CA, 2014, GLOBAL CHANGE BIOL, V20, P125, DOI 10.1111/gcb.12390; McClanahan TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042884; OLEA RA, 1974, J GEOPHYS RES, V79, P695, DOI 10.1029/JB079i005p00695; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Perry CT, 2015, GLOBAL CHANGE BIOL, V21, P1153, DOI 10.1111/gcb.12792; Roff G, 2012, TRENDS ECOL EVOL, V27, P404, DOI 10.1016/j.tree.2012.04.007; SOLOW AR, 1986, MATH GEOL, V18, P335, DOI 10.1007/BF00898037; Suggett DJ, 2011, GLOBAL CHANGE BIOL, V17, P45, DOI 10.1111/j.1365-2486.2009.02155.x; Swain TD, 2016, GLOBAL CHANGE BIOL, V22, P2475, DOI 10.1111/gcb.13276; Thompson DM, 2009, P ROY SOC B-BIOL SCI, V276, P2893, DOI 10.1098/rspb.2009.0591; Tsui OW, 2013, REMOTE SENS ENVIRON, V139, P340, DOI 10.1016/j.rse.2013.08.012; UNEP-WCMC WorldFish Centre WRI TNC, 2010, GLOB DISTR WARM WAT; van Hooidonk R, 2013, NAT CLIM CHANGE, V3, P508, DOI [10.1038/NCLIMATE1829, 10.1038/nclimate1829]; Wilkinson C, 2000, STATUS CORAL REEFS W	35	57	58	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0175490	10.1371/journal.pone.0175490	http://dx.doi.org/10.1371/journal.pone.0175490			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445534	gold, Green Published, Green Accepted			2022-12-26	WOS:000400309200021
J	Grady, C; Touloumi, G; Walker, AS; Smolskis, M; Sharma, S; Babiker, AG; Pantazis, N; Tavel, J; Florence, E; Sanchez, A; Hudson, F; Papadopoulos, A; Emanuel, E; Clewett, M; Munroe, D; Denning, E				Grady, Christine; Touloumi, Giota; Walker, A. Sarah; Smolskis, Mary; Sharma, Shweta; Babiker, Abdel G.; Pantazis, Nikos; Tavel, Jorge; Florence, Eric; Sanchez, Adriana; Hudson, Fleur; Papadopoulos, Antonios; Emanuel, Ezekiel; Clewett, Megan; Munroe, David; Denning, Eileen		INSIGHT START Informed Consent	A randomized trial comparing concise and standard consent forms in the START trial	PLOS ONE			English	Article							INFORMED-CONSENT; CLINICAL-TRIALS; BIOMEDICAL-RESEARCH; READABILITY; PARTICIPANTS; COMPREHENSION; INFORMATION; LONGER; INTERVENTIONS; DOCUMENTS	Background Improving the effectiveness and efficiency of research informed consent is a high priority. Some express concern about longer, more complex, written consent forms creating barriers to participant understanding. A recent meta-analysis concluded that randomized comparisons were needed. Methods We conducted a cluster-randomized non-inferiority comparison of a standard versus concise consent form within a multinational trial studying the timing of starting antiretroviral therapy in HIV+ adults (START). Interested sites were randomized to standard or concise consent forms for all individuals signing START consent. Participants completed a survey measuring comprehension of study information and satisfaction with the consent process. Site personnel reported usual site consent practices. The primary outcome was comprehension of the purpose of randomization (pre-specified 7.5% non-inferiority margin). Results 77 sites (2429 participants) were randomly allocated to use standard consent and 77 sites (2000 participants) concise consent, for an evaluable cohort of 4229. Site and participant characteristics were similar for the two groups. The concise consent was non-inferior to the standard consent on comprehension of randomization (80.2% versus 82%, site adjusted difference: 0.75% (95% CI -3.8%, +5.2%)); and the two groups did not differ significantly on total comprehension score, satisfaction, or voluntariness (p>0.1). Certain independent factors, such as education, influenced comprehension and satisfaction but not differences between consent groups. Conclusions An easier to read, more concise consent form neither hindered nor improved comprehension of study information nor satisfaction with the consent process among a large number of participants. This supports continued efforts to make consent forms more efficient.	[Grady, Christine] NIH, Dept Bioeth, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA; [Touloumi, Giota; Pantazis, Nikos] Univ Athens, Dept Hyg Epidemiol & Med Stat, Med Sch, Athens, Greece; [Walker, A. Sarah; Babiker, Abdel G.; Hudson, Fleur] UCL, MRC Clin Trials Unit, London, England; [Smolskis, Mary] NIAID, Div Clin Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Sharma, Shweta; Denning, Eileen] Univ Minnesota, Div Biostat, Minneapolis, MN USA; [Tavel, Jorge] Genentech Res & Early Dev, San Francisco, CA USA; [Florence, Eric] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Sanchez, Adriana] Washington VA Med Ctr, Washington ICC & Terry Beirn CPCRA CTU, Washington, DC USA; [Papadopoulos, Antonios] Univ Athens, Dept Internal Med 4, Med Sch, Athens, Greece; [Emanuel, Ezekiel] Univ Penn, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA; [Clewett, Megan] Univ New South Wales, Sydney, NSW, Australia; [Munroe, David] Univ Minnesota, START Community Advisory Board CAB, Minneapolis, MN USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National & Kapodistrian University of Athens; Medical Research Council Clinical Trials Unit; University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Minnesota System; University of Minnesota Twin Cities; Roche Holding; Genentech; Institute of Tropical Medicine (ITM); National & Kapodistrian University of Athens; University of Pennsylvania; University of New South Wales Sydney; University of Minnesota System; University of Minnesota Twin Cities	Grady, C (corresponding author), NIH, Dept Bioeth, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA.	cgrady@nih.gov	Walker, Sarah/HDM-8717-2022; PAPADOPOULOS, ANTONIOS/AAD-7808-2019	Florence, Eric/0000-0002-7004-9120; Grady, Christine/0000-0002-9093-4450; Pantazis, Nikos/0000-0002-4196-5066	National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID) [UM1-A1068641, UM1-A1120197]; NIH intramural program through the Clinical Center; US National Institutes of Health (NIH); MRC [MC_EX_UU_G0800814, MC_UU_12023/24] Funding Source: UKRI; Medical Research Council [MC_UU_12023/24, MC_UU_12023/23, MC_EX_UU_G0800814] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI120197, UM1AI068641] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL010531] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH intramural program through the Clinical Center; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CLINICAL CENTER	This study was funded through National Institutes of Health (NIH) and National Institute of Allergy and Infectious Diseases (NIAID) Grants UM1-A1068641 and UM1-A1120197, as well as the NIH intramural program through the Clinical Center. The funder of this substudy, the US National Institutes of Health (NIH), provided support in the form of salaries for some authors [CG, MS], and grant support for some authors [AB, SS, ASW] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section. Genentech Research and Early Development had no role in this study.	Albala Ilene, 2010, IRB, V32, P7; [Anonymous], 2014, FDA INF CONS INF SHE; BAKER MT, 1983, JAMA-J AM MED ASSOC, V250, P2646, DOI 10.1001/jama.250.19.2646; Coyne CA, 2003, J CLIN ONCOL, V21, P836, DOI 10.1200/JCO.2003.07.022; Davis TC, 1998, JNCI-J NATL CANCER I, V90, P668, DOI 10.1093/jnci/90.9.668; Denning E, 2015, HIV MED, V16, P24, DOI 10.1111/hiv.12230; Dresden GM, 2001, ACAD EMERG MED, V8, P246, DOI 10.1111/j.1553-2712.2001.tb01300.x; Emanuel EJ, 2008, HASTINGS CENT REP, V38, P10, DOI 10.1353/hcr.0.0018; Enama ME, 2012, CONTEMP CLIN TRIALS, V33, P895, DOI 10.1016/j.cct.2012.04.005; Flory J, 2004, JAMA-J AM MED ASSOC, V292, P1593, DOI 10.1001/jama.292.13.1593; GROSSMAN SA, 1994, J CLIN ONCOL, V12, P2211, DOI 10.1200/JCO.1994.12.10.2211; Guarino P, 2006, CLIN TRIALS, V3, P19, DOI 10.1191/1740774506cn133oa; Hochhauser M., 2005, APPL CLIN TRIALS; Hochhauser M., 2008, SOCRA SOURCE PUBLICA, V58, P62; Ittenbach RF, 2015, J EMPIR RES HUM RES, V10, P444, DOI 10.1177/1556264615615006; Jefford MH, 2007, J CLIN ONCOL, V25, DOI 10.1200/JCO.2006.10.3341; Joffe S, 2001, J NATL CANCER I, V93, P139, DOI 10.1093/jnci/93.2.139; Kass NE, 2015, CLIN TRIALS, V12, P54, DOI 10.1177/1740774514560831; Kincaid JP, 1975, 875 MEMPH NAV AIR ST; Lorell BH, 2015, CLIN TRIALS, V12, P692, DOI 10.1177/1740774515594362; LOVERDE ME, 1989, J GEN INTERN MED, V4, P410, DOI 10.1007/BF02599693; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Mandava A, 2012, J MED ETHICS, V38, P356, DOI 10.1136/medethics-2011-100178; Matsui K, 2012, J EPIDEMIOL, V22, P308, DOI 10.2188/jea.JE20110104; Murphy DA, 1999, AIDS EDUC PREV, V11, P389; Tam NT, 2015, B WORLD HEALTH ORGAN, V93, P186, DOI 10.2471/BLT.14.141390; Nishimura A, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-28; Paasche-Orlow MK, 2003, NEW ENGL J MED, V348, P721, DOI 10.1056/NEJMsa021212; Paris A, 2010, BRIT J CLIN PHARMACO, V69, P231, DOI 10.1111/j.1365-2125.2009.03565.x; Plaut Victoria C., 2011, LAW HUMAN BEHAV, P1, DOI [10.1007/s10979-011- 9288- y, DOI 10.1007/S10979-011-9288-Y, 10.1007/s10979-011-9288-y]; Resnik DB, 2009, CONTEMP CLIN TRIALS, V30, P114, DOI 10.1016/j.cct.2008.10.004; Sharp SM, 2004, AM J CLIN ONCOL-CANC, V27, P570, DOI 10.1097/01.coc.0000135925.83221.b3; Stunkel Leanne, 2010, IRB, V32, P1; TARNOWSKI KJ, 1990, PEDIATRICS, V85, P58; TAUB HA, 1986, J AM GERIATR SOC, V34, P601, DOI 10.1111/j.1532-5415.1986.tb05766.x; TAUB HA, 1987, EXP AGING RES, V13, P173	36	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0172607	10.1371/journal.pone.0172607	http://dx.doi.org/10.1371/journal.pone.0172607			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET5FI	28445471	Green Published, Green Submitted, gold			2022-12-26	WOS:000400309200001
J	Kim, SJ; Jin, YH; Kim, BS				Kim, Seung Jae; Jin, Young-Hee; Kim, Byung S.			Prostaglandin E2 produced following infection with Theiler's virus promotes the pathogenesis of demyelinating disease	PLOS ONE			English	Article							MURINE ENCEPHALOMYELITIS VIRUS; CD4(+) T-CELLS; MULTIPLE-SCLEROSIS; IMMUNE-RESPONSES; VIRAL-INFECTION; UP-REGULATION; CYTOKINE PRODUCTION; THERAPEUTIC TARGET; ENDOTHELIAL-CELLS; TH17 CELLS	Infection of various cells with Theiler's murine encephalomyelitis virus ( TMEV) activates the TLR- and melanoma differentiation-associated gene 5 (MDA5)-dependent pathways, resulting in the production of IL-1 beta via the activation of caspase-1 upon assembly of the node-like receptor protein 3 (NLRP3) inflammasome. The role of IL-1 beta in the pathogenesis of TMEV-induced demyelinating disease was previously investigated. However, the signaling effects of prostaglandin E2 (PGE(2)) downstream of the NLRP3 inflammasome on the immune responses to viral determinants and the pathogenesis of demyelinating disease are unknown. In this study, we investigated the levels of intermediate molecules leading to PGE(2) signaling and the effects of blocking PGE(2) signaling on the immune response to TMEV infection, viral persistence and the development of demyelinating disease. We demonstrate here that TMEV infection activates the NLRP3 inflammasome and PGE(2) signaling much more vigorously in dendritic cells (DCs) and CD11b(+) cells from susceptible SJL mice than in cells from resistant B6 mice. Inhibition of virus-induced PGE(2) signaling using AH23848 resulted in decreased pathogenesis of demyelinating disease and viral loads in the central nervous system (CNS). In addition, AH23848 treatment caused the elevation of protective early IFN-Y-producing CD4(+) and CD8(+) T cell responses. Because the levels of IFN-beta were lower in AH23848-treated mice but the level of IL-6 was similar, over-production of pathogenic IFN-beta was modulated and the generation of IFN-Y-producing T cell responses was enhanced by the inhibition of PGE(2) signaling. These results strongly suggest that excessive activation of the NLRP3 inflammasome and downstream PGE(2) signaling contribute to the pathogenesis of TMEV-induced demyelinating disease.	[Kim, Seung Jae; Jin, Young-Hee; Kim, Byung S.] Northwestern Univ, Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA; [Kim, Seung Jae] Univ Illinois, Div Rheumatol, 835 S Wolcott Ave, Chicago, IL USA; [Jin, Young-Hee] Korea Inst Oriental Med, Korean Med Applicat Ctr, 70 Cheomdan Ro, Daegu, South Korea	Northwestern University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Korea Institute of Oriental Medicine (KIOM)	Kim, BS (corresponding author), Northwestern Univ, Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA.	bskim@northwestern.edu	JIN, YOUNG-HEE/AAW-3506-2020; Kim, Byung/AAU-7450-2020	JIN, YOUNG-HEE/0000-0001-9916-1418; 	United Stated Public Health Service Grants [R01 NS28752, R01 NS33008]; National Multiple Sclerosis society [RG 4001-A6]	United Stated Public Health Service Grants; National Multiple Sclerosis society(National Multiple Sclerosis Society)	This work was supported by the United Stated Public Health Service Grants (R01 NS28752 and R01 NS33008) and by a grant From the National Multiple Sclerosis society (RG 4001-A6).	Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Arosh JA, 2015, P NATL ACAD SCI USA, V112, P9716, DOI 10.1073/pnas.1507931112; Baratelli F, 2005, J IMMUNOL, V175, P1483, DOI 10.4049/jimmunol.175.3.1483; BRITTAIN RT, 1985, CIRCULATION, V72, P1208, DOI 10.1161/01.CIR.72.6.1208; Caristi S, 2005, J BIOL CHEM, V280, P14433, DOI 10.1074/jbc.M410725200; Carlson NG, 2006, J NEUROIMMUNOL, V174, P21, DOI 10.1016/j.jneuroim.2006.01.008; Caughey GE, 2001, J IMMUNOL, V167, P2831, DOI 10.4049/jimmunol.167.5.2831; Chaudhry U, 2010, EXP NEUROL, V223, P359, DOI 10.1016/j.expneurol.2009.07.027; CRANE MA, 1993, J NEUROIMMUNOL, V45, P67, DOI 10.1016/0165-5728(93)90165-U; Dal Canto Mauro C., 1996, Methods (Orlando), V10, P453, DOI 10.1006/meth.1996.0123; DALCANTO MC, 1977, AM J PATHOL, V88, P497; Delaloye J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000480; Esaki Y, 2010, P NATL ACAD SCI USA, V107, P12233, DOI 10.1073/pnas.0915112107; Fuller AC, 2005, J IMMUNOL, V175, P3955, DOI 10.4049/jimmunol.175.6.3955; Hou WQ, 2007, PLOS PATHOG, V3, P1036, DOI 10.1371/journal.ppat.0030124; Hou WQ, 2014, J VIROL, V88, P8479, DOI 10.1128/JVI.00724-14; Hou WQ, 2009, J EXP MED, V206, P313, DOI 10.1084/jem.20082030; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Jin DQ, 2014, NAT CELL BIOL, V16, P841, DOI 10.1038/ncb3029; Jin YH, 2015, J VIROL, V89, P1867, DOI 10.1128/JVI.02471-14; Jin YH, 2007, J VIROL, V81, P11690, DOI 10.1128/JVI.01034-07; Jin YH, 2013, J VIROL, V87, P11538, DOI 10.1128/JVI.01967-13; Jin YH, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-178; Jin YH, 2012, J VIROL, V86, P1531, DOI 10.1128/JVI.06457-11; Jin YH, 2011, J VIROL, V85, P3033, DOI 10.1128/JVI.02400-10; Jin YH, 2010, J NEUROIMMUNOL, V226, P27, DOI 10.1016/j.jneuroim.2010.05.028; Johnson R T, 1975, Adv Neurol, V13, P1; Joo M, 2007, J IMMUNOL, V179, P2565, DOI 10.4049/jimmunol.179.4.2565; Joseph T, 2012, AM J REPROD IMMUNOL, V67, P482, DOI 10.1111/j.1600-0897.2011.01099.x; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kihara Y, 2009, P NATL ACAD SCI USA, V106, P21807, DOI 10.1073/pnas.0906891106; Kim BS, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-217; Kundu N, 2009, BREAST CANCER RES TR, V117, P235, DOI 10.1007/s10549-008-0180-5; Lin CR, 2006, J PHARMACOL EXP THER, V319, P1096, DOI 10.1124/jpet.106.105569; Martinez A, 2007, HUM IMMUNOL, V68, P685, DOI 10.1016/j.humimm.2007.05.005; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; MCFARLIN DE, 1982, NEW ENGL J MED, V307, P1183, DOI 10.1056/NEJM198211043071905; Mestre L, 2006, BIOCHEM PHARMACOL, V72, P869, DOI 10.1016/j.bcp.2006.06.037; Mohindru M, 2006, EUR J IMMUNOL, V36, P2106, DOI 10.1002/eji.200535785; Mohri I, 2003, GLIA, V42, P263, DOI 10.1002/glia.10183; Molina-Holgado E, 2002, NEUROSCI LETT, V324, P237, DOI 10.1016/S0304-3940(02)00209-4; Murakami M, 2002, PROSTAG OTH LIPID M, V68-9, P383, DOI 10.1016/S0090-6980(02)00043-6; Myoung JJ, 2008, J VIROL, V82, P5606, DOI 10.1128/JVI.02442-07; Napolitani G, 2009, EUR J IMMUNOL, V39, P1301, DOI 10.1002/eji.200838969; Omori K, 2014, BRIT J PHARMACOL, V171, P4879, DOI 10.1111/bph.12815; Palma JP, 2003, J VIROL, V77, P6322, DOI 10.1128/JVI.77.11.6322-6331.2003; Palma JP, 2001, J NEUROIMMUNOL, V117, P166, DOI 10.1016/S0165-5728(01)00326-5; Park JY, 2006, CLIN IMMUNOL, V119, P229, DOI 10.1016/j.clim.2006.01.016; PULLEN LC, 1993, EUR J IMMUNOL, V23, P2287, DOI 10.1002/eji.1830230935; Qian XS, 2013, J IMMUNOL, V190, P5894, DOI 10.4049/jimmunol.1203141; Richards MH, 2011, J AUTOIMMUN, V36, P142, DOI 10.1016/j.jaut.2010.12.005; Samuelsson B, 2007, PHARMACOL REV, V59, P207, DOI 10.1124/pr.59.3.1; Schiffmann S, 2014, BIOCHEM PHARMACOL, V87, P625, DOI 10.1016/j.bcp.2013.12.006; SKIAS DD, 1987, J IMMUNOL, V138, P3254; So EY, 2009, GLIA, V57, P1216, DOI 10.1002/glia.20843; So EY, 2006, GLIA, V53, P858, DOI 10.1002/glia.20346; Soldan SS, 1997, NAT MED, V3, P1394, DOI 10.1038/nm1297-1394; Sreeramkumar V, 2012, IMMUNOL CELL BIOL, V90, P579, DOI 10.1038/icb.2011.75; Stachowska E, 2009, J PHYSIOL PHARMACOL, V60, P77; Steer SA, 2003, VIRAL IMMUNOL, V16, P447, DOI 10.1089/088282403771926283; Subramanian N, 2013, CELL, V153, P348, DOI 10.1016/j.cell.2013.02.054; Thomas DW, 2003, J IMMUNOL, V171, P6389, DOI 10.4049/jimmunol.171.12.6389; Wang HQ, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0264-x; Weinlich R, 2008, CELL DEATH DIFFER, V15, P1901, DOI 10.1038/cdd.2008.128; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968; Yauch RL, 1998, J VIROL, V72, P6169, DOI 10.1128/JVI.72.7.6169-6174.1998	68	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176406	10.1371/journal.pone.0176406	http://dx.doi.org/10.1371/journal.pone.0176406			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445497	Green Published, Green Submitted, gold			2022-12-26	WOS:000400309200057
J	Liu, ZY; Mao, XQ; Song, P				Liu, Zhengyan; Mao, Xianqiang; Song, Peng			GHGs and air pollutants embodied in China's international trade: Temporal and spatial index decomposition analysis	PLOS ONE			English	Article							INPUT-OUTPUT-ANALYSIS; CO2 EMISSIONS; CARBON EMISSIONS; US TRADE; DRIVING FORCES; ENERGY; CONSUMPTION; EXPORTS; DRIVERS; IMPACT	Temporal index decomposition analysis and spatial index decomposition analysis were applied to understand the driving forces of the emissions embodied in China's exports and net exports during 2002 - 2011, respectively. The accumulated emissions embodied in exports accounted for approximately 30% of the total emissions in China; although the contribution of the sectoral total emissions intensity (technique effect) declined, the scale effect was largely responsible for the mounting emissions associated with export, and the composition effect played a largely insignificant role. Calculations of the emissions embodied in net exports suggest that China is generally in an environmentally inferior position compared with its major trade partners. The differences in the economy-wide emission intensities between China and its major trade partners were the biggest contribution to this reality, and the trade balance effect played a less important role. However, a lower degree of specialization in pollution intensive products in exports than in imports helped to reduce slightly the emissions embodied in net exports. The temporal index decomposition analysis results suggest that China should take effective measures to optimize export and supply-side structure and reduce the total emissions intensity. According to spatial index decomposition analysis, it is suggested that a more aggressive import policy was useful for curbing domestic and global emissions, and the transfer of advanced production technologies and emission control technologies from developed to developing countries should be a compulsory global environmental policy option to mitigate the possible leakage of pollution emissions caused by international trade.	[Liu, Zhengyan; Mao, Xianqiang] Beijing Normal Univ, Sch Environm, Beijing, Peoples R China; [Song, Peng] Chongqing Univ, Sch Publ Affairs, Chongqing, Peoples R China	Beijing Normal University; Chongqing University	Mao, XQ (corresponding author), Beijing Normal Univ, Sch Environm, Beijing, Peoples R China.	maoxq@hnu.edu.cn			National Social Science Fund project [11BJY065]; Environmental Protection Gongyi Project [201009051]; Fundamental Research Funds for the Central Universities	National Social Science Fund project; Environmental Protection Gongyi Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Social Science Fund project (Re: 11BJY065), Environmental Protection Gongyi Project (Re: 201009051), and Fundamental Research Funds for the Central Universities.; This study is supported by the National Social Science Fund project (Re:11BJY065) and the Environmental Protection Gongyi Project (Re: 201009051) and the Fundamental Research Funds for the Central Universities. We sincerely thank colleagues in the PRCEE of MEP; Mrs. Li Liping, the Director of the International Environmental Policy Program; and, Mr. Yuan Qingdan, the Deputy Director of PRCEE.	Aichele R, 2012, J ENVIRON ECON MANAG, V63, P336, DOI 10.1016/j.jeem.2011.10.005; Ang BW, 2005, ENERG POLICY, V33, P867, DOI 10.1016/j.enpol.2003.10.010; Ang BW, 2003, ENERG POLICY, V31, P1561, DOI 10.1016/S0301-4215(02)00206-9; Ang BW, 1998, ENERGY, V23, P489, DOI 10.1016/S0360-5442(98)00016-4; Ang BW, 2000, ENERGY, V25, P1149, DOI 10.1016/S0360-5442(00)00039-6; Arto I, 2014, ECOL ECON, V97, P93, DOI 10.1016/j.ecolecon.2013.11.005; Blair P. D., 2009, INPUT OUTPUT ANAL FD, DOI DOI 10.1017/CBO9780511626982; BOYD GA, 1988, ENERG ECON, V10, P309, DOI 10.1016/0140-9883(88)90042-4; British Petroleum (BP), 2012, STAT REV WORLD EN 20; Carr JA, 2012, PLOS ONE, V8, P118; COPELAND BR, 1995, AM ECON REV, V85, P716; COPELAND BR, 1994, Q J ECON, V109, P755, DOI 10.2307/2118421; Davis SJ, 2010, P NATL ACAD SCI USA, V107, P5687, DOI 10.1073/pnas.0906974107; Deng GY, 2016, J CLEAN PROD, V135, P332, DOI 10.1016/j.jclepro.2016.06.114; Dong YL, 2010, ENERG POLICY, V38, P6784, DOI 10.1016/j.enpol.2010.06.050; Du HB, 2011, ENERG POLICY, V39, P5980, DOI 10.1016/j.enpol.2011.06.060; Feng KS, 2013, P NATL ACAD SCI USA, V110, P11654, DOI 10.1073/pnas.1219918110; Gasim AA, 2015, ENERG POLICY, V86, P186, DOI 10.1016/j.enpol.2015.06.043; Greene WH, 2003, J AM STAT ASSOC, V89, P182; Grossman A.B., 1991, ENV IMPACTS N AM FRE; Hoekstra R, 2003, ENERG ECON, V25, P39, DOI 10.1016/S0140-9883(02)00059-2; Hu Tao, 2011, ENV SUSTAIN DEV, V36, P20; IEA, 2009, CO2 EMISSIONS FUEL C; International Energy Agency (IEA), 2011, CO2 EMISSIONS FUEL C; IPCC, 2019, REF 2006 IPCC GUID N, V5, P1; Jakob M, 2013, NAT CLIM CHANGE, V3, P19, DOI 10.1038/nclimate1630; Kagohashi K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132133; Kanemoto K, 2014, GLOBAL ENVIRON CHANG, V24, P52, DOI 10.1016/j.gloenvcha.2013.09.008; Kanemoto K, 2012, ENVIRON SCI TECHNOL, V46, P172, DOI 10.1021/es202239t; Kondo Y, 1998, APPL ENERG, V59, P163, DOI 10.1016/S0306-2619(98)00011-7; LEAMER EE, 1980, J POLIT ECON, V88, P495, DOI 10.1086/260882; Lenzen M., 2004, ECON SYST RES, V16, P391, DOI [DOI 10.1080/0953531042000304272, 10.1080/0953531042000304272]; Lin BQ, 2010, ENERG POLICY, V38, P613, DOI 10.1016/j.enpol.2009.10.014; Liu QL, 2015, ECOL ECON, V113, P39, DOI 10.1016/j.ecolecon.2015.02.026; Liu ZY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132459; Ma S., 2009, CHINA WORLD ECON, V19, P109; Mao XQ, 2014, ENVIRON SCI TECHNOL, V48, P10036, DOI 10.1021/es501729d; Munksgaard J, 2001, ENERG POLICY, V29, P327, DOI 10.1016/S0301-4215(00)00120-8; NBS MEP, 2012, CHIN STAT YB ENV 201; NBSC, 2013, CHIN STAT YB 2013; NBSC (National Bureau of Statistics of China), 2016, CHIN 2012 INP OUTP T; NBSC (National Bureau of Statistics of China), 2013, CHIN 2010 INP OUTP T; Peters GP, 2008, ECOL ECON, V65, P13, DOI 10.1016/j.ecolecon.2007.10.014; Peters GP, 2011, P NATL ACAD SCI USA, V108, P8903, DOI 10.1073/pnas.1006388108; Qi TY, 2014, ENERG ECON, V42, P204, DOI 10.1016/j.eneco.2013.12.011; REITLER W, 1987, ENERG ECON, V9, P145, DOI 10.1016/0140-9883(87)90019-3; Ren SG, 2014, ENERG POLICY, V69, P624, DOI 10.1016/j.enpol.2014.02.032; Sanchez-Choliz J, 2004, ENERG POLICY, V32, P1999, DOI 10.1016/S0301-4215(03)00199-X; Statistics D.O.I., 2011, XIAM STAT YB; Su B, 2016, ENERG ECON, V59, P414, DOI 10.1016/j.eneco.2016.09.006; Su B, 2014, ENERGY, V69, P778, DOI 10.1016/j.energy.2014.03.074; Su B, 2014, APPL ENERG, V114, P377, DOI 10.1016/j.apenergy.2013.09.036; Su B, 2013, ECOL ECON, V88, P119, DOI 10.1016/j.ecolecon.2013.01.017; Tan H, 2013, ENERG POLICY, V61, P1212, DOI 10.1016/j.enpol.2013.06.048; Tang X, 2012, ENERGY, V48, P464, DOI 10.1016/j.energy.2012.10.010; The World Bank, 2015, WORLD DEV INDICATORS; Tian X, 2011, FRONT ENVIRON SCI EN, V5, P445, DOI 10.1007/s11783-011-0330-6; Timmer, 2012, 10 WIOD; Timmer MP, 2015, REV INT ECON, V23, P575, DOI 10.1111/roie.12178; U. S. Census Bureau, 2012, 2012 STAT ABSTR; Wang C, 2005, ENERGY, V30, P73, DOI 10.1016/j.energy.2004.04.002; Weber CL, 2008, ENERG POLICY, V36, P3572, DOI 10.1016/j.enpol.2008.06.009; Weitzel M, 2014, ENERG ECON, V45, P45, DOI 10.1016/j.eneco.2014.06.012; Wiedmann T, 2007, ECOL ECON, V61, P15, DOI 10.1016/j.ecolecon.2006.12.003; Wiedmann T, 2009, ECOL ECON, V69, P211, DOI 10.1016/j.ecolecon.2009.08.026; Wu R, 2016, J CLEAN PROD, V112, P4151, DOI 10.1016/j.jclepro.2015.07.017; Xu M, 2011, ENERG POLICY, V39, P7381, DOI 10.1016/j.enpol.2011.08.068; Xu M, 2009, ENVIRON SCI TECHNOL, V43, P3378, DOI 10.1021/es803142v; Xu Y, 2014, ECOL ECON, V101, P10, DOI 10.1016/j.ecolecon.2014.02.015; Yan YF, 2010, ENERG POLICY, V38, P350, DOI 10.1016/j.enpol.2009.09.025; Yang RR, 2014, ENERG POLICY, V72, P110, DOI 10.1016/j.enpol.2014.04.024; Zhang YG, 2009, ECOL ECON, V68, P2399, DOI 10.1016/j.ecolecon.2009.03.014; Zhang ZH, 2017, RENEW SUST ENERG REV, V68, P492, DOI 10.1016/j.rser.2016.10.009; Zhao YH, 2016, J CLEAN PROD, V131, P678, DOI 10.1016/j.jclepro.2016.04.114; Zhou J, 2015, CHINA J CLEANER PROD, V112, P1767, DOI DOI 10.1016/j.jclepro.2015.08.015	75	15	16	6	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176089	10.1371/journal.pone.0176089	http://dx.doi.org/10.1371/journal.pone.0176089			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET5FE	28441399	Green Published, gold, Green Submitted			2022-12-26	WOS:000400308800024
J	Goncalves, GSR; Cerqueira, PV; Brasil, LS; Santos, MPD				Ribeiro Goncalves, Gabriela Silva; Cerqueira, Pablo Vieira; Brasil, Leandro Schlemmer; Dantas Santos, Marcos Persio			The role of climate and environmental variables in structuring bird assemblages in the Seasonally Dry Tropical Forests (SDTFs)	PLOS ONE			English	Article							BETA-DIVERSITY; COMMUNITY; PATTERNS; NICHE; DISTRIBUTIONS; ABUNDANCE; DYNAMICS; ECOLOGY; AREA	Understanding the processes that influence species diversity is still a challenge in ecological studies. However, there are two main theories to discuss this topic, the niche theory and the neutral theory. Our objective was to understand the importance of environmental and spatial processes in structuring bird communities within the hydrological seasons in dry forest areas in northeastern Brazil. The study was conducted in two National Parks, the Serra da Capivara and Serra das Confusoes National Parks, where 36 areas were sampled in different seasons (dry, dry/rainy transition, rainy, rainy/dry transition), in 2012 and 2013. We found with our results that bird species richness is higher in the rainy season and lower during the dry season, indicating a strong influence of seasonality, a pattern also found for environmental heterogeneity. Richness was explained by local environmental factors, while species composition was explained by environmental and spatial factors. The environmental factors were more important in explaining variations in composition. Climate change predictions have currently pointed out frequent drought events and a rise in global temperature by 2050, which would lead to changes in species behavior and to increasing desertification in some regions, including the Caatinga. In addition, the high deforestation rates and the low level of representativeness of the Caatinga in the conservation units negatively affects bird communities. This scenario has demonstrated how climatic factors affect individuals, and, therefore, should be the starting point for conservation initiatives to be developed in xeric environments.	[Ribeiro Goncalves, Gabriela Silva; Cerqueira, Pablo Vieira; Brasil, Leandro Schlemmer] Univ Fed Para, Curso Posgrad Zool, Museu Paraense Emilio Goeldi, Belem, Para, Brazil; [Dantas Santos, Marcos Persio] Univ Fed Para, Inst Ciencias Biol, Lab Ecol & Zool Vertebrados, Belem, Para, Brazil	Museu Paraense Emilio Goeldi; Universidade Federal do Para; Universidade Federal do Para	Goncalves, GSR (corresponding author), Univ Fed Para, Curso Posgrad Zool, Museu Paraense Emilio Goeldi, Belem, Para, Brazil.	gabrielasrgoncalves@gmail.com	Cerqueira, Pablo Vieira/D-9268-2013; Pérsio, Marcos/B-8653-2016; Brasil, Leandro/T-1628-2019	Pérsio, Marcos/0000-0001-8819-867X; Brasil, Leandro/0000-0002-2725-9181	Capes; CNPQ project "Birds of Caatinga" ("Aves da Caatinga") [CNPQ 552011/2011-8]; Capes Doctoral fellowship	Capes(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPQ project "Birds of Caatinga" ("Aves da Caatinga"); Capes Doctoral fellowship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	G.S.R.G. and M.P.D.S. are thankful to Capes for granting a Doctoral fellowship, to CNPQ for financing the project "Birds of Caatinga" ("Aves da Caatinga", process CNPQ 552011/2011-8) and PROPESP/UFPA by cost aid. Support to P.V.C.'s graduate research was provided by a Capes Doctoral fellowship. L.S.B. is thankful to CNPQ for granting Doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Rodrigo Lima Paz, Andre Santos, Leonardo Moura and Shirliane for helping in data collection. We are also thankful to Andre Pessoa for providing us accommodation in the Serra da Capivara National Park, to Mr. Fernando Tizianel head of the Serra da Capirava National Park for the support in conducting the research in the park, to Mr. Jose Wilmington Ribeiro (Mitinha), head of the Serra das Confusoes National Park for the support in conducting the research in the park. G.S.R.G. and M.P.D.S. is thankful to Capes for granting a Doctoral fellowship, to CNPQ for financing the project "Birds of Caatinga" ("Aves da Caatinga",process CNPQ 552011/2011-8) and PROPESP/UFPA by cost aid. Support to P.V.C.'s graduate research was provided by a Capes Doctoral fellowship. L.S.B. is thankful to CNPQ for granting Doctoral fellowship. Finally, we acknowledge the suggestions of two anonymous reviewers, which improved this manuscript.	Aleixo A, 1999, CONDOR, V101, P537, DOI 10.2307/1370183; Aleixo Alexandre, 1995, Revista Brasileira de Zoologia, V12, P493, DOI 10.1590/S0101-81751995000300004; Alvares CA, 2013, METEOROL Z, V22, P711, DOI 10.1127/0941-2948/2013/0507; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Andrade-Lima D., 1981, REV BRAS BOTA NICA, V4, P149; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Barbosa DCA, 1989, ACTA BOT BRAS, P313; Barbosa MRDV, CAATINGA ESTRUTURA F, P333; de Sousa AEBA, 2012, REV BRAS ORNITOL, V20, P230; Beale CM, 2013, ECOL LETT, V16, P1061, DOI 10.1111/ele.12139; BLONDEL J, 1970, Alauda, V38, P55; Boleli Isabel Cristina, 2012, International Journal of Poultry Science, V11, P517; CASE TJ, 1974, P NATL ACAD SCI USA, V71, P3073, DOI 10.1073/pnas.71.8.3073; CLARKE KR, 1994, MAR BIOL, V118, P167, DOI 10.1007/BF00699231; COLLINS SL, 1991, ECOLOGY, V72, P654, DOI 10.2307/2937205; COLWELL RK, 2000, ESTIMATES STAT ESTIM; Conner Richard N., 1997, Texas Journal of Science, V49, P123; Cubina A, 2001, BIOTROPICA, V33, P260, DOI 10.1111/j.1744-7429.2001.tb00177.x; Delfim FR., 2007, OECOLOGIA BRAS, V11, P365, DOI [10.4257/oeco.2007.1103.07, DOI 10.4257/OECO.2007.1103.07]; DeMarco PJ, 2006, OECOLOGIA BRAS, V8; Develey PF, 2000, J TROP ECOL, V16, P33, DOI 10.1017/S0266467400001255; Diniz JAF, 2003, GLOBAL ECOL BIOGEOGR, V12, P53, DOI 10.1046/j.1466-822X.2003.00322.x; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Driscoll DA, 2009, ECOL MONOGR, V79, P485, DOI 10.1890/08-1114.1; Elphick J., 2007, ATLAS BIRD MIGRATION, P180; Emperaire L., 1989, VEGETATION GESTION R; Feng GL, 2016, PROCEEDINGS 2016 FIRST INTERNATIONAL CONFERENCE ON MULTIMEDIA AND IMAGE PROCESSING (ICMIP 2016), P1, DOI 10.1109/ICMIP.2016.13; Freeman CP, 2015, VEGAN GREEN FOOD A T, P264; FREEMARK KE, 1986, BIOL CONSERV, V36, P115, DOI 10.1016/0006-3207(86)90002-9; FREIRE E.M.X., 2009, RECURSOS NATURAIS CA, P51; Goncalves GR, 2017, J ARID ENVIRON, V140, P6, DOI 10.1016/j.jaridenv.2017.01.004; Goncalves MR, 2003, PLANO MANEJO PARQUE; Griffith DA, 2006, ECOLOGY, V87, P2603, DOI 10.1890/0012-9658(2006)87[2603:SMIETF]2.0.CO;2; GRUBB J C, 1975, Herpetologica, V31, P219; Haegeman B, 2011, J THEOR BIOL, V269, P150, DOI 10.1016/j.jtbi.2010.10.006; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Heavy J., 2014, OECOLOGIA, V174, P1033; Hijmans R.J., **DATA OBJECT**; Hubbell S.P., 2001, UNIFIED NEUTRAL THEO, DOI DOI 10.1111/2041-210X.12067; Hubbell SP, 2005, FUNCT ECOL, V19, P166, DOI 10.1111/j.0269-8463.2005.00965.x; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Illan JG, 2014, GLOBAL CHANGE BIOL, V20, P3351, DOI 10.1111/gcb.12642; Jacomine PKT, 1986, B PESQUISA, V18; Jones J, 2001, AUK, V118, P557, DOI 10.1642/0004-8038(2001)118[0557:HSSIAE]2.0.CO;2; Juen L, 2011, INSECT CONSERV DIVER, V4, P265, DOI 10.1111/j.1752-4598.2010.00130.x; Kaufman P.B., 1999, NATURAL PRODUCTS PLA; Kovarik J, 2013, PATHOBIOLOGY, V80, P275, DOI 10.1159/000346960; LEFEBVRE G, 1994, CAN J ZOOL, V72, P757, DOI 10.1139/z94-102; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Legendre P., 2012, NUMERICAL ECOLOGY; Leibold MA, 2002, OIKOS, V97, P237, DOI 10.1034/j.1600-0706.2002.970210.x; Mac Nally R, 2014, OECOLOGIA, V176, P849, DOI 10.1007/s00442-014-3060-1; Machado ICS, 1997, BIOTROPICA, V29, P57, DOI 10.1111/j.1744-7429.1997.tb00006.x; Marsden SJ, 2002, FOREST ECOL MANAG, V165, P117, DOI 10.1016/S0378-1127(01)00653-3; Martinez-Garza C, 2011, L DEGRAD DEV, V24, P287; Martins LA, 2012, AVALIACAO PROCESSOS; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Morales MB, COMPROMISSOS ADAPTAT; Nabout JC, 2009, ACTA OECOL, V35, P720, DOI 10.1016/j.actao.2009.07.002; Padial AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111227; Paglia P.A., 1995, BRAS REV BRAS ZOOL, V12, P67, DOI DOI 10.1590/S0101-81751995000100010; Parry M. L., 2007, CLIMATE CHANGE 2007; Peck D.V., 2006, W PILOT STUDY FIELD; Pellerin J., 1991, PLANO MANEJO PARQUE; Pennington RT, 2000, NEOTROPICAL SEASONAL, P261; Perez SEA, 2008, ECOLOGIA ONCA PINTAD; Peter M B, 2002, EVOLUTIONARY ECOLOGY; PORTER WP, 1969, ECOL MONOGR, V39, P227, DOI 10.2307/1948545; POULIN B, 1992, ECOLOGY, V73, P2295, DOI 10.2307/1941476; PRADO DE, 1993, ANN MO BOT GARD, V80, P902, DOI 10.2307/2399937; Puttker T, 2015, OIKOS, V124, P206, DOI 10.1111/oik.01018; Quirino ZGM, 2006, FENOLOGIA SISTEMA RE; Ricklefs RE, EC NATUREZA; Santos MPD, 2004, COMUNIDADES AVES DUA, V12, P113; Shimano Y, 2013, REV BRAS ENTOMOL, V57, P359, DOI 10.1590/S0085-56262013005000043; Siepielski AM, 2013, FRESHWATER BIOL, V58, P758, DOI 10.1111/fwb.12082; Sillett TS, 2000, SCIENCE, V288, P2040, DOI 10.1126/science.288.5473.2040; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Sun GQ, 2016, PHYS LIFE REV, V19, P43, DOI 10.1016/j.plrev.2016.08.002; Sun GQ, 2016, NONLINEAR DYNAM, V85, P1, DOI 10.1007/s11071-016-2671-y; Sun GQ, 2014, COMMUN NONLINEAR SCI, V19, P1507, DOI 10.1016/j.cnsns.2013.09.016; Tebbich S, 2004, CONDOR, V106, P95, DOI 10.1650/7293; Tingley MW, 2012, GLOBAL CHANGE BIOL, V18, P3279, DOI 10.1111/j.1365-2486.2012.02784.x; Trovão Dilma M. de B. M., 2007, Rev. bras. eng. agríc. ambient., V11, P307, DOI 10.1590/S1415-43662007000300010; Tubelis DP, 2000, BIRD CONSERV INT, V10, P331, DOI 10.1017/S0959270900000290; Tucker CM, 2016, OIKOS, V125, P778, DOI 10.1111/oik.02803; Van Houtan KS, 2007, ECOL LETT, V10, P219, DOI 10.1111/j.1461-0248.2007.01004.x; Vasconcellos A, 2010, REV BRAS ENTOMOL, P54; Vielliard J. M. E., 2010, ORNITOLOGIA CONSERVA, P47; Villard MA, 1999, CONSERV BIOL, V13, P774, DOI 10.1046/j.1523-1739.1999.98059.x; Weiher E., 1999, ECOLOGICAL ASSEMBLY, DOI DOI 10.1017/CBO9780511542237; Wu MX, 2015, SCI REP-UK, V5, DOI 10.1038/srep10001; Wu Y. F., 2016, 2016 IEEE International Workshop on Electromagnetics (iWEM): Applications and Student Innovation Competition, P1, DOI 10.1109/iWEM.2016.7504911; Zaher H., DIVERSIDADE VERTEBRA; Zar JH., 2010, BIOSTAT ANAL, V5th	95	7	7	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176066	10.1371/journal.pone.0176066	http://dx.doi.org/10.1371/journal.pone.0176066			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441412	Green Published, gold, Green Submitted			2022-12-26	WOS:000400308800022
J	Perri, V; Pellegrino, M; Ceccacci, F; Scipioni, A; Petrini, S; Gianchecchi, E; Lo Russo, A; De Santis, S; Mancini, G; Fierabracci, A				Perri, Valentina; Pellegrino, Marsha; Ceccacci, Francesca; Scipioni, Anita; Petrini, Stefania; Gianchecchi, Elena; Lo Russo, Anna; De Santis, Serena; Mancini, Giovanna; Fierabracci, Alessandra			Use of short interfering RNA delivered by cationic liposomes to enable efficient down-regulation of PTPN22 gene in human T lymphocytes	PLOS ONE			English	Article							LYMPHOID TYROSINE PHOSPHATASE; TYPE-1 DIABETES-MELLITUS; OF-FUNCTION VARIANT; AUTOIMMUNE-DISEASES; CARBON NANOTUBES; GEMINI AMPHIPHILES; CLINICAL-TRIALS; MESSENGER-RNA; DOXORUBICIN; ARTHRITIS	Type 1 diseases based on the selective inhibition of variant PTPN22 allele using lipoplexes of siRNA antisense oligomers.Type 1 diabetes and thyroid disease are T cell-dependent autoimmune endocrinopathies. The standard substitutive administration of the deficient hormones does not halt the autoimmune process; therefore, development of immunotherapies aiming to preserve the residual hormonal cells, is of crucial importance. PTPN22 C1858T mutation encoding for the R620W lymphoid tyrosine phosphatase variant, plays a potential pathophysiological role in autoimmunity. The PTPN22 encoded protein Lyp is a negative regulator of T cell antigen receptor signaling; R620W variant, leading to a gain of function with paradoxical reduced T cell activation, may represent a valid therapeutic target. We aimed to develop novel wild type PTPN22 short interfering RNA duplexes (siRNA) and optimize their delivery into Jurkat T cells and PBMC by using liposomal carriers. Conformational stability, size and polydispersion of siRNA in lipoplexes was measured by CD spectroscopy and DLS. Lipoplexes internalization and toxicity evaluation was assessed by confocal microscopy and flow cytometry analysis. Their effect on Lyp expression was evaluated by means of Western Blot and confocal microscopy. Functional assays through engagement of TCR signaling were established to evaluate biological consequences of down-modulation. Both Jurkat T cells and PBMC were efficiently transfected by stable custom lipoplexes. Jurkat T cell morphology and proliferation was not affected. Lipoplexes incorporation was visualized in CD3+ but also in CD3- peripheral blood immunotypes without signs of toxicity, damage or apoptosis. Efficacy in affecting Lyp protein expression was demonstrated in both transfected Jurkat T cells and PBMC. Moreover, impairment of Lyp inhibitory activity was revealed by increase of IL-2 secretion in culture supernatants of PBMC following anti-CD3/CD28 T cell receptor-driven stimulation. The results of our study open the pathway to future trials for the treatment of autoimmune	[Perri, Valentina; Pellegrino, Marsha; Gianchecchi, Elena; Lo Russo, Anna; Fierabracci, Alessandra] Childrens Hosp Bambino Gesu, Type Diabet Ctr 1, Infectivol & Clin Trials Area, Rome, Italy; [Ceccacci, Francesca] Sapienza Univ, CNR IMC SMR, Rome, Italy; [Scipioni, Anita; De Santis, Serena] Sapienza Univ, Dept Chem, Rome, Italy; [Petrini, Stefania] Childrens Hosp Bambino Gesu, Res Labs, Confocal Microscopy Core Facil, Rome, Italy; [Mancini, Giovanna] CNR, Chem Methodol Inst IMC, Rome, Italy; [Gianchecchi, Elena] Vismederi Srl, Siena, Italy	IRCCS Bambino Gesu; Sapienza University Rome; Sapienza University Rome; IRCCS Bambino Gesu; Consiglio Nazionale delle Ricerche (CNR)	Fierabracci, A (corresponding author), Childrens Hosp Bambino Gesu, Type Diabet Ctr 1, Infectivol & Clin Trials Area, Rome, Italy.	alessandra.fierabracci@opbg.net	Ceccacci, Francesca/AAE-9125-2022; Pellegrino, Marsha/K-4500-2016; Fierabracci, Alessandra/K-5930-2016; Petrini, Stefania/I-1464-2018; De Santis, Serena/AAI-8820-2020	Pellegrino, Marsha/0000-0002-9002-3622; Fierabracci, Alessandra/0000-0003-3078-9754; Petrini, Stefania/0000-0002-3249-0003; De Santis, Serena/0000-0001-9772-2891; Ceccacci, Francesca/0000-0003-3191-8562	Italian Ministry of Health-Ricerca Corrente [201502P003496]	Italian Ministry of Health-Ricerca Corrente(Ministry of Health, Italy)	This work was supported by the Italian Ministry of Health-Ricerca Corrente 201502P003496. AF Principal Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreakos E, 2009, ARTHRITIS RHEUM, V60, P994, DOI 10.1002/art.24434; Atkinson MA, 2013, LANCET DIABETES ENDO, V1, P268, DOI 10.1016/S2213-8587(13)70172-4; Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7; Bello C, 2006, LANGMUIR, V22, P9333, DOI 10.1021/la061230f; Ben Nasr M, 2015, PHARMACOL RES, V98, P31, DOI 10.1016/j.phrs.2014.07.004; Boitard C, 2012, PRESSE MED, V41, pE636, DOI 10.1016/j.lpm.2012.10.003; Bombelli C, 2005, LANGMUIR, V21, P10271, DOI 10.1021/la051324+; Bombelli C, 2005, J MED CHEM, V48, P5378, DOI 10.1021/jm050477r; Bombelli C, 2010, MOL PHARMACEUT, V7, P130, DOI 10.1021/mp900173v; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Cato MH, 2008, J NANOSCI NANOTECHNO, V8, P2259, DOI 10.1166/jnn.2008.501; Chang MS, 2005, CELL SIGNAL, V17, P299, DOI 10.1016/j.cellsig.2004.07.008; Clemente-Casares X, 2014, IMMUNOL LETT, V158, P167, DOI 10.1016/j.imlet.2013.12.018; Daifotis AG, 2013, CLIN IMMUNOL, V149, P268, DOI 10.1016/j.clim.2013.05.001; Del Fattore A, 2015, CELL TRANSPLANT, V24, P2615, DOI 10.3727/096368915X687543; Delogu LG, 2009, BIOCONJUGATE CHEM, V20, P427, DOI 10.1021/bc800540j; Dittmar M, 2010, THYROID, V20, P737, DOI 10.1089/thy.2010.1639; Dutta C, 2016, MOL THER, V24, P770, DOI 10.1038/mt.2016.4; Effraimidis G, 2014, EUR J ENDOCRINOL, V170, pR241, DOI 10.1530/EJE-14-0047; Fierabracci A, 2011, CURR PHARM DESIGN, V17, P3092, DOI 10.2174/138161211798157577; Garciafigueroa Y, 2015, CLIN IMMUNOL, V160, P36, DOI 10.1016/j.clim.2015.03.016; Gianchecchi E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110755; Gianchecchi E, 2013, AUTOIMMUN REV, V12, P1091, DOI 10.1016/j.autrev.2013.05.003; Gianchecchi E, 2013, AUTOIMMUN REV, V12, P717, DOI 10.1016/j.autrev.2012.12.003; Greenbaum CJ, 2012, DIABETES, V61, P1323, DOI 10.2337/db11-1452; Hope MJ, 1992, REDUCTION LIPOSOMES; Hu JX, 2009, NAT BIOTECHNOL, V27, P478, DOI 10.1038/nbt.1539; Joly F, 2011, GYNECOL ONCOL, V122, P226, DOI 10.1016/j.ygyno.2011.04.019; Kakleas K, 2015, AUTOIMMUN REV, V14, P781, DOI 10.1016/j.autrev.2015.05.002; Kudoh K, 2011, GYNECOL ONCOL, V122, P233, DOI 10.1016/j.ygyno.2011.04.046; Laron Z, 2015, PEDIATR ENDOCR REV P, V12, P266; Lin XT, 2016, DIABETES, V65, P2134, DOI 10.2337/db16-0061; Liu XQ, 2015, TRANSL ONCOL, V8, P185, DOI 10.1016/j.tranon.2015.03.010; Lysik MA, 2003, J PHARM SCI, V92, P1559, DOI 10.1002/jps.10399; Maine CJ, 2012, J IMMUNOL, V188, P5267, DOI 10.4049/jimmunol.1200150; Marshall NB, 2007, J IMMUNOL METHODS, V325, P114, DOI 10.1016/j.jim.2007.06.009; Matteucci E, 2015, DRUG DES DEV THER, V9, P3109, DOI 10.2147/DDDT.S79322; McLachlan SM, 2014, ENDOCR REV, V35, P59, DOI 10.1210/er.2013-1055; Mitchell LA, 2009, NAT NANOTECHNOL, V4, P451, DOI [10.1038/nnano.2009.151, 10.1038/NNANO.2009.151]; Mitragotri S, 2011, ARCH PHARM RES, V34, P1887, DOI 10.1007/s12272-011-1109-9; Ogawa T, 2012, AURIS NASUS LARYNX, V39, P224, DOI 10.1016/j.anl.2011.03.006; Opanasopit P, 2011, INT J NANOMED, V6, P975, DOI 10.2147/IJN.S18647; Petre CE, 2007, INT J NANOMED, V2, P277; Pranatharthiharan S, 2013, DRUG DELIV TRANSL RE, V3, P446, DOI 10.1007/s13346-012-0116-9; Pujol-Autonell I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127057; Radetti G, 2014, ENDOCR DEV, V26, P158, DOI 10.1159/000363162; Saenger W., 1984, J CLIN INVEST; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Scherer LJ, 2003, NAT BIOTECHNOL, V21, P1457, DOI 10.1038/nbt915; Schipper ML, 2008, NAT NANOTECHNOL, V3, P216, DOI 10.1038/nnano.2008.68; SEEBACH D, 1977, HELV CHIM ACTA, V60, P301, DOI 10.1002/hlca.19770600202; Serra P, 2015, CLIN IMMUNOL, V160, P3, DOI 10.1016/j.clim.2015.02.003; Sharp RC, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00095; Silva AC, 2015, CURR DRUG METAB, V16, P3, DOI 10.2174/1389200216666150401110211; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673; Vang T, 2012, NAT CHEM BIOL, V8, P437, DOI [10.1038/NCHEMBIO.916, 10.1038/nchembio.916]; Wagner S, 2008, J NEURO-ONCOL, V86, P175, DOI 10.1007/s11060-007-9444-x; Wang YY, 2013, IMMUNITY, V39, P111, DOI 10.1016/j.immuni.2013.06.013; Watts JK, 2012, J PATHOL, V226, P365, DOI 10.1002/path.2993; WEISS A, 1984, J IMMUNOL, V133, P123; Wiebolt J, 2010, EUR J CLIN INVEST, V40, P1144, DOI 10.1111/j.1365-2362.2010.02366.x; Woittiez NJC, 2015, IMMUNOTHERAPY-UK, V7, P163, DOI 10.2217/imt.14.104; Wu DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086677; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763; Yu X, 2007, P NATL ACAD SCI USA, V104, P19767, DOI 10.1073/pnas.0706233104; Zhang JY, 2011, NAT GENET, V43, P902, DOI 10.1038/ng.904; Zheng PL, 2013, DIABETES, V62, P896, DOI 10.2337/db12-0929	68	19	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0175784	10.1371/journal.pone.0175784	http://dx.doi.org/10.1371/journal.pone.0175784			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437437	Green Published, Green Submitted, gold			2022-12-26	WOS:000400287600013
J	Shen, MX; Smith, GN; Rodger, M; White, RR; Walker, MC; Wen, SW				Shen, Minxue; Smith, Graeme N.; Rodger, Marc; White, Ruth Rennicks; Walker, Mark C.; Wen, Shi Wu			Comparison of risk factors and outcomes of gestational hypertension and pre-eclampsia	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; MATERNAL MORBIDITY; ANGIOGENIC FACTORS; EARLY-PREGNANCY; COMPLICATIONS; PATERNITY; COHORT	Background It remains an enigma whether gestational hypertension (GH) and pre-eclampsia (PE) are distinct entities or different spectrum of the same disease. We aimed to compare the risk factors and outcomes between GH and PE. Method A total of 7,633 pregnant women recruited between 12 and 20 weeks of gestation in the Ottawa and Kingston Birth Cohort from 2002 to 2009 were included in the analysis. Cox proportional hazards model was used to identify and compare the risk factors for GH and PE by treating gestational age at delivery as the survival time. Logistic regression model was used to compare outcome. Subgroup analysis was performed for early-and late-onset PE. Results GH and PE shared most risk factors including overweight and obesity, nulliparity, PE history, type 1 and 2 diabetes, and twin birth. Effect size of PE history (RR = 14.1 for GH vs. RR = 6.4 for PE) and twin birth (RR = 4.8 for GH vs. RR = 10.3 for PE) showed substantial difference. Risk factors modified gestational age at delivery in patients with GH and PE in similar pattern. Subgroup analysis showed that early-and late-onset PE shared some risk factors with different effect sizes, whereas folic acid supplementation showed protective effect for early-onset PE only. PE was strongly associated with several adverse outcomes including cesarean section, placental abruption, small for gestational age, preterm birth, and 5 min Apgar score < 7, whereas GH was associated with increased risk of preterm birth only. Conclusions GH and PE shared common risk factors. Differences in effect sizes of risk factors and outcomes indicate that the conditions may have different pathophysiology and mechanism.	[Shen, Minxue] Cent S Univ, Xiangya Hosp, Dept Dermatol, Changsha, Hunan, Peoples R China; [Shen, Minxue; Wen, Shi Wu] Cent S Univ, Xiangya Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China; [Shen, Minxue; White, Ruth Rennicks; Walker, Mark C.; Wen, Shi Wu] Univ Ottawa, Dept Obstet & Gynecol, OMNI Res Grp, Fac Med, Ottawa, ON, Canada; [Shen, Minxue; Rodger, Marc; White, Ruth Rennicks; Walker, Mark C.; Wen, Shi Wu] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Smith, Graeme N.] Queens Univ, Dept Obstet & Gynecol, Kingston, ON, Canada; [Rodger, Marc; Wen, Shi Wu] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Fac Med, Ottawa, ON, Canada; [Rodger, Marc] Univ Ottawa, Dept Med, Fac Med, Ottawa, ON, Canada	Central South University; Central South University; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; Queens University - Canada; University of Ottawa; University of Ottawa	Wen, SW (corresponding author), Cent S Univ, Xiangya Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China.; Wen, SW (corresponding author), Univ Ottawa, Dept Obstet & Gynecol, OMNI Res Grp, Fac Med, Ottawa, ON, Canada.; Wen, SW (corresponding author), Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada.; Wen, SW (corresponding author), Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Fac Med, Ottawa, ON, Canada.	swwen@ohri.ca	Smith, Graeme Neil/ABB-6863-2021; Shen, Minxue/P-5140-2019	Smith, Graeme Neil/0000-0002-3128-4523; Shen, Minxue/0000-0003-0441-9303; Rodger, Marc/0000-0001-8166-3487; Stacey, Dawn/0000-0002-2681-741X	Canadian Institutes of Health Research [M0P53188, M0P 82802, MCT-98030]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research, Grant Nos.: M0P53188, M0P 82802, MCT-98030 to SWW. URL: http://www.cihr-irsc.gc.ca/e/193.html..	Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; Boghossian NS, 2014, ANN EPIDEMIOL, V24, P871, DOI 10.1016/j.annepidem.2014.10.003; Caritis S, 1998, NEW ENGL J MED, V338, P701, DOI 10.1056/NEJM199803123381101; Cecil RL, 2012, GOLDMANS CECIL MED; Conde-Agudelo A, 2000, BRIT MED J, V321, P1255, DOI 10.1136/bmj.321.7271.1255; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Enquobahrie DA, 2004, AM J HYPERTENS, V17, P574, DOI 10.1016/j.amjhyper.2004.03.666; Garg AX, 2015, NEW ENGL J MED, V372, P124, DOI 10.1056/NEJMoa1408932; GARNER PR, 1990, AM J OBSTET GYNECOL, V163, P505, DOI 10.1016/0002-9378(90)91184-E; Garovic VD, 2007, NAT CLIN PRACT NEPHR, V3, P613, DOI 10.1038/ncpneph0623; Klatsky PC, 2010, OBSTET GYNECOL, V116, P1387, DOI 10.1097/AOG.0b013e3181fb8e59; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Levron Y, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.044; Li DK, 2000, AM J EPIDEMIOL, V151, P57, DOI 10.1093/oxfordjournals.aje.a010122; Li X, 2016, PREGNANCY HYPERTENS, V6, P66, DOI 10.1016/j.preghy.2015.11.004; Magee LA, 2014, J OBSTET GYNAECOL CA, V36, P416, DOI 10.1016/S1701-2163(15)30588-0; Martinez-Varea A, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/210241; McDonald SD, 2009, BJOG-INT J OBSTET GY, V116, P1578, DOI 10.1111/j.1471-0528.2009.02317.x; Mustafa R, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/105918; Myatt L, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-015-0595-4; Noori M, 2010, CIRCULATION, V122, P478, DOI 10.1161/CIRCULATIONAHA.109.895458; O'Gorman N, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.08.034; Paternoster DM, 2006, CLIN APPL THROMB-HEM, V12, P330, DOI 10.1177/1076029606291382; Poon LCY, 2010, J HUM HYPERTENS, V24, P104, DOI 10.1038/jhh.2009.45; Poon LC, 2014, OBSTET GYNECOL INT, V2014, DOI 10.1155/2014/297397; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Ros HS, 1998, AM J EPIDEMIOL, V147, P1062; Saudan P, 1998, BRIT J OBSTET GYNAEC, V105, P1177, DOI 10.1111/j.1471-0528.1998.tb09971.x; Shiozaki A, 2013, J OBSTET GYNAECOL RE, V39, P492, DOI 10.1111/j.1447-0756.2012.01990.x; Stergiotou I, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.07.030; Tangeras LH, 2015, ARTERIOSCL THROM VAS, V35, P2478, DOI 10.1161/ATVBAHA.115.305817; Tranquilli AL, 2012, PREGNANCY HYPERTENS, V2, P350, DOI [10.1016/j.preghy.2012.05.006, 10.1016/j.preghy.2012.04.146]; Trupin LS, 1996, EPIDEMIOLOGY, V7, P240, DOI 10.1097/00001648-199605000-00004; Valensise H, 2008, HYPERTENSION, V52, P873, DOI 10.1161/HYPERTENSIONAHA.108.117358; Veerbeek JHW, 2015, HYPERTENSION, V65, P600, DOI 10.1161/HYPERTENSIONAHA.114.04850; Villar J, 2006, AM J OBSTET GYNECOL, V194, P921, DOI 10.1016/j.ajog.2005.10.813; Vrijkotte TGM, 2012, J CLIN ENDOCR METAB, V97, P3917, DOI 10.1210/jc.2012-1295; Walker MC, 2011, J OBSTET GYNAECOL CA, V33, P1124, DOI 10.1016/S1701-2163(16)35080-0; Wang Z, 2013, OBES REV, V14, P508, DOI 10.1111/obr.12025; Wen SW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149818; Wen SW, 2004, AM J OBSTET GYNECOL, V191, P254, DOI 10.1016/j.ajog.2003.12.003; Wright D, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.02.018	43	98	99	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0175914	10.1371/journal.pone.0175914	http://dx.doi.org/10.1371/journal.pone.0175914			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437461	Green Published, gold, Green Submitted			2022-12-26	WOS:000400287600021
J	Tutakhel, OAZ; Moes, AD; Valdez-Flores, MA; Kortenoeven, MLA; von den Vries, M; Jelen, S; Fenton, RA; Zietse, R; Hoenderop, JGJ; Hoorn, EJ; Hilbrands, L; Bindels, RJM				Tutakhel, Omar A. Z.; Moes, Arthur D.; Valdez-Flores, Marco A.; Kortenoeven, Marleen L. A.; v. D. Vries, Mathijs; Jelen, Sabina; Fenton, Robert A.; Zietse, Robert; Hoenderop, Joost G. J.; Hoorn, Ewout J.; Hilbrands, Luuk; Bindels, Rene J. M.			NaCl cotransporter abundance in urinary vesicles is increased by calcineurin inhibitors and predicts thiazide sensitivity	PLOS ONE			English	Article							SODIUM-CHLORIDE COTRANSPORTER; NA+-CL-COTRANSPORTER; DIURETIC TREATMENT; RENAL-TRANSPLANT; CYCLOSPORINE; TACROLIMUS; HYPERTENSION; HYPERKALEMIA; EXOSOMES; ACTIVATION	Animal studies have shown that the calcineurin inhibitors (CNIs) cyclosporine and tacrolimus can activate the thiazide-sensitive NaCl cotransporter (NCC). A common side effect of CNIs is hypertension. Renal salt transporters such as NCC are excreted in urinary extracellular vesicles (uEVs) after internalization into multivesicular bodies. Human studies indicate that CNIs also increase NCC abundance in uEVs, but results are conflicting and no relationship with NCC function has been shown. Therefore, we investigated the effects of CsA and Tac on the abundance of both total NCC (tNCC) and phosphorylated NCC at Thr60 phosphorylation site (pNCC) in uEVs, and assessed whether NCC abundance in uEVs predicts the blood pressure response to thiazide diuretics. Our results show that in kidney transplant recipients treated with cyclosporine (n = 9) or tacrolimus (n = 23), the abundance of both tNCC and pNCC in uEVs is 4-5 fold higher than in CNI-free kidney transplant recipients (n = 13) or healthy volunteers (n = 6). In hypertensive kidney transplant recipients, higher abundances of tNCC and pNCC prior to treatment with thiazides predicted the blood pressure response to thiazides. During thiazide treatment, the abundance of pNCC in uEVs increased in responders (n = 10), but markedly decreased in non-responders (n = 8). Thus, our results show that CNIs increase the abundance of both tNCC and pNCC in uEVs, and these increases correlate with the blood pressure response to thiazides. This implies that assessment of NCC in uEVs could represent an alternate method to guide anti-hypertensive therapy in kidney transplant recipients.	[Tutakhel, Omar A. Z.; Valdez-Flores, Marco A.; Jelen, Sabina; Hoenderop, Joost G. J.; Bindels, Rene J. M.] Radboud Univ Nijmegen Med Ctr, Radboud Inst Mol Life Sci, Dept Physiol, Nijmegen, Netherlands; [Moes, Arthur D.; Zietse, Robert; Hoorn, Ewout J.] Erasmus MC, Dept Internal Med Nephrol & Transplantat, Rotterdam, Netherlands; [Valdez-Flores, Marco A.] Univ Autonoma Sinaloa, Programa Reg Doctorado Biotecnol, Sinaloa, Mexico; [Kortenoeven, Marleen L. A.; Fenton, Robert A.] Aarhus Univ, Ctr Interact Prot Epithelial Transport, Dept Biomed, Aarhus, Denmark; [v. D. Vries, Mathijs; Hilbrands, Luuk] Radboud Univ Nijmegen Med Ctr, Radboud Inst Mol Life Sci, Dept Nephrol, Nijmegen, Netherlands	Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC; Universidad Autonoma de Sinaloa; Aarhus University; Radboud University Nijmegen	Bindels, RJM (corresponding author), Radboud Univ Nijmegen Med Ctr, Radboud Inst Mol Life Sci, Dept Physiol, Nijmegen, Netherlands.	rene.bindels@radboudumc.nl	Hoorn, Ewout/S-4135-2019; Flores, Marco Antonio Valdez/AAG-8838-2020; Fenton, Robert A/ABD-9824-2021; Tutakhel, Omar/AAW-6591-2021; Tutakhel, Omar A.Z./G-3638-2016; Kortenoeven, Marleen/B-8565-2014; Fenton, Robert/AFR-6983-2022; Hilbrands, Luuk/B-4921-2011; Bindels, René JM/B-9824-2013	Hoorn, Ewout/0000-0002-8738-3571; Tutakhel, Omar A.Z./0000-0002-1872-8409; Fenton, Robert/0000-0003-1623-199X; Hilbrands, Luuk/0000-0002-4935-9765; Bindels, René JM/0000-0003-1167-1339; Kortenoeven, Marleen/0000-0001-9962-8276	Dutch Kidney Foundation [PHD12.14, 160104, KSP-14OK19]; EURenOmics from European Union seventh Framework Program (FP7) [305608]; Consejo-Nacional de Ciencia-y-Tecnologia (CONACYT-Mexico); "Doctores-Jovenes" program, Universidad Autonoma de Sinaloa in Mexico; Netherlands Organisation for Scientific Research (NWO) [Veni 916.12.140]; Danish Medical Research Foundation; Lundbeck Foundation; Novo Nordisk Foundation; Danish Medical Research Council; Lundbeck Foundation [R173-2014-1373, R44-2009-4252] Funding Source: researchfish	Dutch Kidney Foundation; EURenOmics from European Union seventh Framework Program (FP7); Consejo-Nacional de Ciencia-y-Tecnologia (CONACYT-Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); "Doctores-Jovenes" program, Universidad Autonoma de Sinaloa in Mexico; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Danish Medical Research Foundation; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden)	This study was supported by Dutch Kidney Foundation (PHD12.14 and 160104) and EURenOmics funding from European Union seventh Framework Program (FP7/2007-2013, agreement no 305608). M.A.V. was funded by Consejo-Nacional de Ciencia-y-Tecnologia (CONACYT-Mexico) and "Doctores-Jovenes" program, Universidad Autonoma de Sinaloa in Mexico. E.J.H. was supported by grants from Netherlands Organisation for Scientific Research (NWO, Veni 916.12.140) and Dutch Kidney Foundation (KSP-14OK19). R.A.F. was supported by Danish Medical Research Foundation, Lundbeck Foundation and Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors thank Hamed Qaderdan for technical assistance and Drs Sjoerd Verkaart and Luke Shelton for critical reading of the manuscript. This study was supported by Dutch Kidney Foundation (PHD12.14 and 160104) and EURenOmics funding from European Union seventh Framework Program (FP7/2007-2013, agreement no 305608). M.A.V. was funded by Consejo-Nacional de Ciencia-y-Tecnologia (CONACYT-Mexico) and "Doctores-J6venes" program, Universidad Autonoma de Sinaloa in Mexico. E.J.H. was supported by grants from Netherlands Organisation for Scientific Research (NWO, Veni 916.12.140) and Dutch Kidney Foundation (KSP-14OK19). R.A.F. was supported by Danish Medical Research Foundation, Lundbeck Foundation and Novo Nordisk Foundation. M.L.A.K. was supported by Danish Medical Research Council.	Alvarez ML, 2012, KIDNEY INT, V82, P1024, DOI 10.1038/ki.2012.256; ARNOLD JE, 1969, AM J MED, V47, P461, DOI 10.1016/0002-9343(69)90230-7; Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; Canzanello V J, 1997, Liver Transpl Surg, V3, P1; Canzanello VJ, 1998, LIVER TRANSPLANT SUR, V4, P328, DOI 10.1002/lt.500040404; CHEN ZF, 1990, J AM SOC NEPHROL, V1, P91; Corbetta S, 2015, NEPHROL DIAL TRANSPL, V30, P621, DOI 10.1093/ndt/gfu362; ELLISON DH, 1987, AM J PHYSIOL, V253, pF546, DOI 10.1152/ajprenal.1987.253.3.F546; Esteva-Font C, 2014, AM J NEPHROL, V39, P528, DOI 10.1159/000362905; FIRST MR, 1994, J AM SOC NEPHROL, V4, pS30; Gonzales PA, 2009, J AM SOC NEPHROL, V20, P363, DOI 10.1681/ASN.2008040406; GORDON RD, 1986, CLIN EXP PHARMACOL P, V13, P329, DOI 10.1111/j.1440-1681.1986.tb00358.x; Halloran PF, 2004, NEW ENGL J MED, V351, P2715, DOI 10.1056/NEJMra033540; Holt S, 2002, TRANSPLANTATION, V73, P673, DOI 10.1097/00007890-200203150-00001; Hoorn EJ, 2005, NEPHROLOGY, V10, P283, DOI 10.1111/j.1440-1797.2005.00387.x; Hoorn EJ, 2012, J NEPHROL, V25, P269, DOI 10.5301/jn.5000174; Hoorn EJ, 2011, NAT MED, V17, P1304, DOI 10.1038/nm.2497; Isobe K, 2013, AM J PHYSIOL-RENAL, V305, pF1374, DOI 10.1152/ajprenal.00208.2013; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Joo KW, 2007, AM J KIDNEY DIS, V50, P765, DOI 10.1053/j.ajkd.2007.07.022; KAMEL KS, 1992, J AM SOC NEPHROL, V2, P1279; Kim GH, 2004, AM J NEPHROL, V24, P595, DOI 10.1159/000082314; Lalioti MD, 2006, NAT GENET, V38, P1124, DOI 10.1038/ng1877; Lazelle RA, 2016, J AM SOC NEPHROL, V27, P1456, DOI 10.1681/ASN.2015040466; Ligtenberg G, 2001, J AM SOC NEPHROL, V12, P368, DOI 10.1681/ASN.V122368; Louis-Dit-Picard H, 2012, NAT GENET, V44, P456, DOI 10.1038/ng.2218; LYSON T, 1993, CIRC RES, V73, P596, DOI 10.1161/01.RES.73.3.596; Mangray M, 2011, AM J KIDNEY DIS, V57, P331, DOI 10.1053/j.ajkd.2010.10.048; Margreiter R, 2002, LANCET, V359, P741, DOI 10.1016/S0140-6736(02)07875-3; Mayan H, 2008, NEPHROL DIAL TRANSPL, V23, P492, DOI 10.1093/ndt/gfm641; Melnikov S, 2011, EUR J CLIN INVEST, V41, P1113, DOI 10.1111/j.1365-2362.2011.02517.x; Moes AD, AM J KIDNEY IN PRESS; MURRAY BM, 1985, KIDNEY INT, V28, P767, DOI 10.1038/ki.1985.196; Na KY, 2003, AM J PHYSIOL-RENAL, V284, pF133, DOI 10.1152/ajprenal.00227.2002; Nijenhuis T, 2005, J CLIN INVEST, V115, P1651, DOI 10.1172/JCI24134; Pacheco-Alvarez D, 2006, J BIOL CHEM, V281, P28755, DOI 10.1074/jbc.M603773200; Pathare G, 2017, AM J PHYSL IN PRESS; PAVER W K, 1964, Med J Aust, V2, P305; Pedersen NB, 2010, KIDNEY INT, V78, P160, DOI 10.1038/ki.2010.130; Pessoa BS, 2013, NAT REV NEPHROL, V9, P26, DOI 10.1038/nrneph.2012.249; Pham SM, 1996, J THORAC CARDIOV SUR, V111, P764, DOI 10.1016/S0022-5223(96)70336-7; Pirsch JD, 1997, TRANSPLANTATION, V63, P977, DOI 10.1097/00007890-199704150-00013; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534; Rengarajan S, 2014, AM J PHYSIOL-RENAL, V306, pF1059, DOI 10.1152/ajprenal.00015.2014; Richardson C, 2008, J CELL SCI, V121, P675, DOI 10.1242/jcs.025312; Rojas-Vega L, 2015, AM J PHYSIOL-RENAL, V309, pE836, DOI 10.1152/ajprenal.00326.2015; Rojas-Vega L, 2015, AM J PHYSIOL-RENAL, V308, pF799, DOI 10.1152/ajprenal.00447.2014; Rozansky DJ, 2009, J CLIN INVEST, V119, P2601, DOI 10.1172/JCI38323; Salih M, 2016, AM J PHYSIOL-RENAL, V310, pF796, DOI 10.1152/ajprenal.00463.2015; Salih M, 2014, AM J PHYSIOL-RENAL, V306, pF1251, DOI 10.1152/ajprenal.00128.2014; SCHAMBELAN M, 1981, KIDNEY INT, V19, P716, DOI 10.1038/ki.1981.72; Schwertfeger E, 2001, J AUTON PHARMACOL, V21, P205, DOI 10.1046/j.1365-2680.2001.00228.x; Shoda W, 2017, KIDNEY INT, V91, P402, DOI 10.1016/j.kint.2016.09.001; Sorensen MV, 2013, KIDNEY INT, V83, P811, DOI 10.1038/ki.2013.14; Terker AS, 2016, J AM SOC NEPHROL, V27, P2436, DOI 10.1681/ASN.2015070815; Tutakhel OAZ, 2016, AM J PHYSIOL-RENAL, V310, pF204, DOI 10.1152/ajprenal.00429.2015; van der Lubbe N, 2012, HYPERTENSION, V60, P741, DOI 10.1161/HYPERTENSIONAHA.112.198135; Veiras LC, 2016, HYPERTENSION, V68, P904, DOI 10.1161/HYPERTENSIONAHA.116.07389; Vicenti F, 2002, TRANSPLANTATION, V73, P775, DOI 10.1097/00007890-200203150-00021; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wolley MJ, 2017, J AM SOC NEPHROL, V28, P56, DOI 10.1681/ASN.2015111221; Yang CL, 2007, J CLIN INVEST, V117, P3403, DOI 10.1172/JCI32033	63	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0176220	10.1371/journal.pone.0176220	http://dx.doi.org/10.1371/journal.pone.0176220			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430812	Green Published, gold			2022-12-26	WOS:000399876100035
J	Cornejo-Romero, A; Vargas-Mendoza, CF; Aguilar-Martinez, GF; Medina-Sanchez, J; Rendon-Aguilar, B; Valverde, PL; Zavala-Hurtado, JA; Serrato, A; Rivas-Arancibia, S; Perez-Hernandez, A; Lopez-Ortega, G; Jimenez-Sierra, C				Cornejo-Romero, Amelia; Fabian Vargas-Mendoza, Carlos; Aguilar-Martinez, Gustavo F.; Medina-Sanchez, Javier; Rendon-Aguilar, Beatriz; Luis Valverde, Pedro; Alejandro Zavala-Hurtado, Jose; Serrato, Alejandra; Rivas-Arancibia, Sombra; Aurelio Perez-Hernandez, Marco; Lopez-Ortega, Gerardo; Jimenez-Sierra, Cecilia			Alternative glacial-interglacial refugia demographic hypotheses tested on Cephalocereus columna-trajani (Cactaceae) in the intertropical Mexican drylands	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; LEPTONYCTERIS-CURASOAE; CLIMATIC OSCILLATIONS; DISJUNCT DISTRIBUTION; NORTH-AMERICA; PHYLOGEOGRAPHY; CHLOROPLAST; HISTORY; SONORAN; CACTUS	Historic demography changes of plant species adapted to New World arid environments could be consistent with either the Glacial Refugium Hypothesis (GRH), which posits that populations contracted to refuges during the cold-dry glacial and expanded in warm-humid interglacial periods, or with the Interglacial Refugium Hypothesis (IRH), which suggests that populations contracted during interglacials and expanded in glacial times. These contrasting hypotheses are developed in the present study for the giant columnar cactus Cephalocereus columna-trajani in the intertropical Mexican drylands where the effects of Late Quaternary climatic changes on phylogeography of cacti remain largely unknown. In order to determine if the historic demography and phylogeographic structure of the species are consistent with either hypothesis, sequences of the chloroplast regions psbA-trnH and trnT-trnL from 110 individuals from 10 populations comprising the full distribution range of this species were analysed. Standard estimators of genetic diversity and structure were calculated. The historic demography was analysed using a Bayesian approach and the palaeodistribution was derived from ecological niche modelling to determine if, in the arid environments of south-central Mexico, glacial-interglacial cycles drove the genetic divergence and diversification of this species. Results reveal low but statistically significant population differentiation (F-ST = 0.124, P < 0.001), although very clear geographic clusters are not formed. Genetic diversity, haplotype network and Approximate Bayesian Computation (ABC) demographic analyses suggest a population expansion estimated to have taken place in the Last Interglacial (123.04 kya, 95% CI 115.3-130.03). The species palaeodistribution is consistent with the ABC analyses and indicates that the potential area of palaedistribution and climatic suitability were larger during the Last Interglacial and Holocene than in the Last Glacial Maximum. Overall, these results suggest that C. columna-trajani experienced an expansion following the warm conditions of interglacials, in accordance with the GRH.	[Cornejo-Romero, Amelia; Fabian Vargas-Mendoza, Carlos; Aguilar-Martinez, Gustavo F.] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Dept Zool, Mexico City, DF, Mexico; [Medina-Sanchez, Javier] Univ Leicester, Dept Geog, Leicester, Leics, England; [Rendon-Aguilar, Beatriz; Luis Valverde, Pedro; Alejandro Zavala-Hurtado, Jose; Aurelio Perez-Hernandez, Marco; Lopez-Ortega, Gerardo; Jimenez-Sierra, Cecilia] Univ Autonoma Metropolitana lztapalapa, Dept Biol, Mexico City, DF, Mexico; [Serrato, Alejandra] Univ Autonoma Metropolitana lztapalapa, Dept Hidrobiol, Mexico City, DF, Mexico; [Rivas-Arancibia, Sombra] Benemerita Univ Autonoma Puebla, Escuela Biol, Puebla, Mexico	Instituto Politecnico Nacional - Mexico; University of Leicester; Universidad Autonoma Metropolitana - Mexico; Universidad Autonoma Metropolitana - Mexico; Benemerita Universidad Autonoma de Puebla	Vargas-Mendoza, CF (corresponding author), Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Dept Zool, Mexico City, DF, Mexico.	carfvargas@yahoo.com		Vargas-Mendoza, Carlos F./0000-0002-3904-9093; Medina-Sanchez, Javier/0000-0002-1929-5238	Consejo Nacional de Ciencia y Tecnologia of Mexico (CONACYT) [252478]; CONACYT [FOSEMARNAT- 2004-01-26]; SIP-IPN [20150755]	Consejo Nacional de Ciencia y Tecnologia of Mexico (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); SIP-IPN	ACR was supported by the Consejo Nacional de Ciencia y Tecnologia of Mexico (CONACYT) with a post-doctoral scholarship (no. 252478). CONACYT provided support for this study by financing the project FOSEMARNAT- 2004-01-26, and SIP-IPN financing the project 20150755.	Allal F, 2011, HEREDITY, V107, P174, DOI 10.1038/hdy.2011.5; Arias S, 2012, FLORA VALLE TEHUACAN; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Barberi M, 2000, J S AM EARTH SCI, V13, P241, DOI 10.1016/S0895-9811(00)00022-5; Barcenas-Arguello ML, 2011, THESIS; Bonatelli IAS, 2014, MOL ECOL, V23, P3044, DOI 10.1111/mec.12780; Butterworth CA, 2004, AM J BOT, V91, P1086, DOI 10.3732/ajb.91.7.1086; Byrne M, 2008, QUATERNARY SCI REV, V27, P2576, DOI 10.1016/j.quascirev.2008.08.032; Caetano S, 2008, MOL ECOL, V17, P3147, DOI 10.1111/j.1365-294X.2008.03817.x; Clark-Tapia R, 2003, HEREDITY, V90, P443, DOI 10.1038/sj.hdy.6800252; Collevatti RG, 2003, MOL ECOL, V12, P105, DOI 10.1046/j.1365-294X.2003.01701.x; Collevatti RG, 2012, ECOL EVOL, V2, P1024, DOI 10.1002/ece3.236; Collevatti RG, 2009, ANN BOT-LONDON, V104, P655, DOI 10.1093/aob/mcp157; Cornuet JM, 2014, BIOINFORMATICS, V30, P1187, DOI 10.1093/bioinformatics/btt763; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Davila P, 2002, BIODIVERS CONSERV, V11, P421, DOI 10.1023/A:1014888822920; De la Maza-Elvira RG, 2001, VALLE TEHUACAN CUICA, P23; Drummond AJ, 2002, BAYESIAN EVOLUTIONAR; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Ezcurra RAE (Universidad Nacional Autonoma de Mexico. Instituto de Ecologia), 1990, G003 SNIBCONABIO; Fehlberg SD, 2009, MOL PHYLOGENET EVOL, V50, P326, DOI 10.1016/j.ympev.2008.11.011; Ornelas JF, 2015, J HERED, V106, P196, DOI 10.1093/jhered/esu113; Gamez N, 2014, J BIOGEOGR, V41, P871, DOI 10.1111/jbi.12249; Garcia E., 2004, SERIE LIBROS, V6; Garrick RC, 2009, MOL ECOL, V18, P1916, DOI 10.1111/j.1365-294X.2009.04148.x; Gibson A.C., 1986, CACTUS PRIMER, DOI DOI 10.4159/HARVARD.9780674281714; Godinez-Alvarez H, 2000, BIOTROPICA, V32, P552, DOI 10.1111/j.1744-7429.2000.tb00502.x; Godinez-Alvarez H, 2002, ECOLOGY, V83, P2617, DOI 10.1890/0012-9658(2002)083[2617:TROSDI]2.0.CO;2; Gutierrez-Flores C, 2016, PERSPECT PLANT ECOL, V22, P1, DOI 10.1016/j.ppees.2016.06.003; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Hernandez-Hernandez T, 2014, NEW PHYTOL, V202, P1382, DOI 10.1111/nph.12752; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Ibrahim KM, 1996, HEREDITY, V77, P282, DOI 10.1038/hdy.1996.142; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kerwin MW, 1999, PALEOCEANOGRAPHY, V14, P200, DOI 10.1029/1998PA900011; Kiehl JT, 2004, J CLIMATE, V17, P3666, DOI 10.1175/1520-0442(2004)017<3666:TCCSMV>2.0.CO;2; Kukla GJ, 2002, QUATERNARY RES, V58, P2, DOI 10.1006/qres.2001.2316; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Meng HH, 2015, J SYST EVOL, V53, P33, DOI 10.1111/jse.12088; Moraes EM, 2005, GENETICA, V125, P311, DOI 10.1007/s10709-005-0716-0; Nason JD, 2002, EVOLUTION, V56, P2214, DOI 10.1111/j.0014-3820.2002.tb00146.x; Nassar JM, 2003, AM J BOT, V90, P1628, DOI 10.3732/ajb.90.11.1628; Nei M., 1987, MOL EVOLUTIONARY GEN; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Orum TV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160899; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pritchard J.K., DOCUMENTATION STRUCT; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A, 2003, TRACER V1 5 0 MCMC T; Ramirez-Arriaga E, 2014, PALYNOLOGY, V38, P1, DOI 10.1080/01916122.2013.802750; Rebernig CA, 2010, MOL PHYLOGENET EVOL, V54, P594, DOI 10.1016/j.ympev.2009.10.010; Riddle BR, 2006, J ARID ENVIRON, V66, P435, DOI 10.1016/j.jaridenv.2006.01.014; Rojas-Martinez A, 1999, J BIOGEOGR, V26, P1065, DOI 10.1046/j.1365-2699.1999.00354.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sahley CT, 1993, J MAMMAL; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Serrano Estrada B, 2010, THESIS; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Sosa V, 2009, J BIOGEOGR, V36, P18, DOI 10.1111/j.1365-2699.2008.01957.x; Steenbergh W.F., 1983, ECOLOGY SAGUARO; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Thompson RS, 2000, J BIOGEOGR, V27, P555, DOI 10.1046/j.1365-2699.2000.00427.x; Turchetto-Zolet AC, 2013, MOL ECOL, V22, P1193, DOI 10.1111/mec.12164; Valiente-Banuet A., 2009, GUIA VEGETACION VALL; ValienteBanuet A, 1996, J TROP ECOL, V12, P103, DOI 10.1017/S0266467400009330; Valverde PL, 2007, PLANT ECOL, V188, P17, DOI 10.1007/s11258-006-9144-1; Van Devender T.R., 1990, PACKRAT MIDDENS LAST; VANDEVENDER TR, 1994, QUATERNARY RES, V41, P99, DOI 10.1006/qres.1994.1011; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Zavala-Hurtado J.A., 1982, BIOTICA, V1, P99	77	14	14	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175905	10.1371/journal.pone.0175905	http://dx.doi.org/10.1371/journal.pone.0175905			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426818	Green Published, Green Submitted, gold			2022-12-26	WOS:000399875900067
J	Hall, SE; Negus, C; Johinke, D; Bathgate, R				Hall, Sally E.; Negus, Cameron; Johinke, Danielle; Bathgate, Roslyn			Adjusting cryodiluent composition for improved post-thaw quality of rabbit spermatozoa	PLOS ONE			English	Article							LOW-DENSITY LIPOPROTEINS; EGG-YOLK; FERTILIZING ABILITY; SPERM; CRYOPRESERVATION; CRYOPROTECTANTS; ACETAMIDE; FROZEN; SEMEN; PARAMETERS	Improved fertility following artificial insemination with frozen-thawed spermatozoa would offer rabbit producers faster genetic improvement. Previous work investigating cryoprotectants for rabbit spermatozoa have reported inconsistent results. Semen was collected from three rabbit bucks by artificial vagina and frozen using a standard procedure with varied cryodiluent components. Post-thaw analysis encompassed motility, sperm kinematic parameters and acrosome and membrane integrity. Spermatozoa were evaluated at 0, 2 and 4 h after thawing. Experiment 1 compared diluents with 3.5% dimethyl sulfoxide (DMSO), 1.5% acetamide, 1.75% DMSO + 0.75% acetamide or 3.5% DMSO + 1.5% acetamide. The treatment that resulted in the highest post-thaw motility (P<0.001) and acrosome integrity (P<0.001) was DMSO alone. Experiment 2 compared 3.5, 7 and 10% DMSO in the cryodiluent. The best post-thaw sperm motility (P< 0.001) and linearity (P =.002) was in 3.5% DMSO, while 10% DMSO afforded higher acrosome/membrane integrity at this last time point (P< 0.05). Experiment 3 varied the cryodiluent to contain either 9 or 17% egg yolk or 9 or 17% low density lipoproteins extracted from whole egg yolk. The treatment with the best post-thaw result was 17% egg yolk (motility, P = 0.01; acrosome/membrane integrity, P< 0.001). Experiment 4 compared different carbohydrates in the cryodiluent; 50 mM glucose (TCG), 25 mM glucose with 25 mM sucrose (TCGS low), or 50 mM glucose with 50 mM sucrose (TCGS high). When data were pooled across time points, TCG had significantly higher motility than TCGS high (P = 0.021), but was not different from TCGS low. However, TCG had fewer spermatozoa with intact acrosomes and membranes than both TCGS low and TCGS high (P =.002). Put together, these results indicate that the best cryodiluent for rabbit spermatozoa frozen under the conditions used in this paper is with 7% DMSO and 17% egg yolk in a base medium containing 25 mM glucose and 25 mM sucrose.	[Hall, Sally E.; Negus, Cameron; Johinke, Danielle; Bathgate, Roslyn] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia	University of Sydney	Bathgate, R (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	roslyn.bathgate@sydney.edu.au	Bathgate, Roslyn/AAC-2504-2019	Bathgate, Roslyn/0000-0002-7922-5610	Rural Industries Research and Development Corporation [PRJ00585]	Rural Industries Research and Development Corporation	This work was supported by the Rural Industries Research and Development Corporation (http://www.rirdc.gov.au/) grant PRJ00585. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad E., 2012, ANIMAL HLTH PRODUCTI, V1, P123; Amiridis GS, 2012, ANIM REPROD SCI, V130, P152, DOI 10.1016/j.anireprosci.2012.01.009; Arriola J, 2001, J ANDROL, V22, P458; Bencharif D, 2008, THERIOGENOLOGY, V70, P1478, DOI 10.1016/j.theriogenology.2008.06.095; Broekhuijse MLWJ, 2012, J ANIM SCI, V90, P779, DOI 10.2527/jas.2011-4311; Chinsomboon S, 1990, J Med Assoc Thai, V73 Suppl 1, P100; CURRY MR, 1995, CRYOBIOLOGY, V32, P175, DOI 10.1006/cryo.1995.1016; Dalimata AM, 1997, THERIOGENOLOGY, V48, P831, DOI 10.1016/S0093-691X(97)00305-1; DICKERSON GE, 1978, ANIM PROD, V27, P367, DOI 10.1017/S0003356100036278; Farshad A, 2011, ASIAN AUSTRAL J ANIM, V24, P181, DOI 10.5713/ajas.2011.10141; Fuller BJ, 2004, CRYOLETTERS, V25, P375; Gillan L, 2005, THERIOGENOLOGY, V63, P445, DOI 10.1016/j.theriogenology.2004.09.024; Gillan L, 2008, ANIM REPROD SCI, V103, P201, DOI 10.1016/j.anireprosci.2006.12.010; Gomez-Fernandez J, 2012, ANIM REPROD SCI, V133, P109, DOI 10.1016/j.anireprosci.2012.06.010; Hino Toshiaki, 2007, Reproductive Medicine and Biology, V6, P229, DOI 10.1111/j.1447-0578.2007.00190.x; Hu JH, 2006, ASIAN AUSTRAL J ANIM, V19, P486, DOI 10.5713/ajas.2006.486; Iaffaldano N, 2014, ANIM REPROD SCI, V151, P220, DOI 10.1016/j.anireprosci.2014.10.020; Iorio M. di, 2014, Italian Journal of Animal Science, V13, P710; Kashiwazaki N, 2006, J REPROD DEVELOP, V52, P511, DOI 10.1262/jrd.18008; Lavara R, 2005, THERIOGENOLOGY, V64, P1130, DOI 10.1016/j.theriogenology.2005.01.009; Moce E, 2010, REPROD DOMEST ANIM, V45, pE1, DOI 10.1111/j.1439-0531.2009.01507.x; Moce E, 2009, ANIM REPROD SCI, V110, P1, DOI 10.1016/j.anireprosci.2008.08.015; Moussa M, 2002, THERIOGENOLOGY, V57, P1695, DOI 10.1016/S0093-691X(02)00682-9; Okuda Y, 2007, EXP ANIM TOKYO, V56, P29, DOI 10.1538/expanim.56.29; Pillet E, 2011, THERIOGENOLOGY, V75, P105, DOI 10.1016/j.theriogenology.2010.07.015; Prayaga K. C., 2000, Asian-Australasian Journal of Animal Sciences, V13, P357; PURSEL VG, 1972, J ANIM SCI, V35, P580; Roca J, 2000, ANIM REPROD SCI, V64, P103, DOI 10.1016/S0378-4320(00)00185-8; Rosato MP, 2013, THERIOGENOLOGY, V79, P508, DOI 10.1016/j.theriogenology.2012.11.008; RUDOLPH AS, 1985, CRYOBIOLOGY, V22, P367, DOI 10.1016/0011-2240(85)90184-1; Si W, 2006, THERIOGENOLOGY, V65, P788, DOI 10.1016/j.theriogenology.2005.06.010; Vicente JS, 1996, REPROD NUTR DEV, V36, P485, DOI 10.1051/rnd:19960504; ViudesdeCastro MP, 1996, ANIM REPROD SCI, V44, P195, DOI 10.1016/0378-4320(96)01550-3; WATSON PF, 1976, J THERM BIOL, V1, P137, DOI 10.1016/0306-4565(76)90003-6	34	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175965	10.1371/journal.pone.0175965	http://dx.doi.org/10.1371/journal.pone.0175965			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426717	Green Published, gold, Green Submitted			2022-12-26	WOS:000399875900076
J	Kempinska-Podhorodecka, A; Milkiewicz, M; Jablonski, D; Milkiewicz, P; Wunsch, E				Kempinska-Podhorodecka, Agnieszka; Milkiewicz, Malgorzata; Jablonski, Dariusz; Milkiewicz, Piotr; Wunsch, Ewa			ApaI polymorphism of vitamin D receptor affects health-related quality of life in patients with primary sclerosing cholangitis	PLOS ONE			English	Article							PRIMARY BILIARY-CIRRHOSIS; BONE-MINERAL DENSITY; DEPRESSIVE SYMPTOMS; GENETIC ASSOCIATION; INHIBITION; HEPATITIS; FATIGUE; VDR	Background Polymorphisms of vitamin D receptor (VDR) contribute to the pathogenesis of multiple autoimmune conditions. Methods We investigated the incidence of VDR polymorphisms (rs1544410-BsmI; rs7975232-ApaI; rs731236-TaqI) in a group of patients with primary sclerosing cholangitis (PSC, n = 275) and in healthy controls (n = 376). Additionally, correlations of the VDR polymorphisms with clinical and biochemical factors of the disease were analysed. Results The genotype and allele distributions of these polymorphisms in PSC patients were similar to those observed in controls. However, the ApaI polymorphism was associated with an impaired health-related quality of life (HRQoL). The generic SF-36 questionnaire showed that the Role-Physical (p = 0.01), Role-Emotional (p = 0.01), Physical Component Summary (p = 0.01) and Mental Component Summary (p = 0.003) scores were significantly affected. Similarly, the disease-specific questionnaires, PBC-40 and PBC-27, demonstrated that carriers of the C allele suffered from more severe Itch (p = 0.03 assessed by PBC-40 and PBC-27), more Fatigue (p = 0.02 assessed by PBC-40 and PBC-27) and Impaired Cognitive Capacity (p = 0.04 and p = 0.03). Correspondingly, individuals who were AA homozygotes (non-carriers of the C allele of ApaI) had higher summary scores for the Physical (p = 0.01) and Mental Components (p = 0.006) measured with SF-36. Moreover, they experienced less itch (p = 0.03) and less Fatigue (p = 0.03) and had better Cognitive Abilities (p = 0.04) as assessed by the PBC-40 and PBC-27 questionnaires. No associations between other VDR polymorphisms and clinical or laboratory findings were made. Conclusion In summary, this study is the first to show that the ApaI polymorphisms in VDR may exert an effect on disease-related symptoms and quality of life in patients with PSC.	[Kempinska-Podhorodecka, Agnieszka; Milkiewicz, Malgorzata] Pomeranian Med Univ, Dept Med Biol, Szczecin, Poland; [Jablonski, Dariusz] Med Univ Warsaw, Dept Gen & Endocrine Surg, Warsaw, Poland; [Milkiewicz, Piotr] Med Univ Warsaw, Dept Gen Transplant & Liver Surg, Liver & Internal Med Unit, Warsaw, Poland; [Wunsch, Ewa] Pomeranian Med Univ, Translat Med Grp, Szczecin, Poland	Pomeranian Medical University; Medical University of Warsaw; Medical University of Warsaw; Pomeranian Medical University	Kempinska-Podhorodecka, A (corresponding author), Pomeranian Med Univ, Dept Med Biol, Szczecin, Poland.	agnieszkakempinska@interia.eu		Milkiewicz, Piotr/0000-0002-1817-0724; Kempinska-Podhorodecka, Agnieszka/0000-0002-7513-8640; Milkiewicz, Malgorzata/0000-0002-2064-0545	Foundation for Polish Science	Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission)	Ewa Wunsch was supported by the Foundation for Polish Science. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agmon-Levin N, 2011, ANN RHEUM DIS, V70, P145, DOI 10.1136/ard.2010.134817; Amital H, 2010, ANN RHEUM DIS, V69, P1155, DOI 10.1136/ard.2009.120329; Arnson Y, 2011, AUTOIMMUN REV, V10, P490, DOI 10.1016/j.autrev.2011.02.002; Arteh J, 2010, DIGEST DIS SCI, V55, P2624, DOI 10.1007/s10620-009-1069-9; Benito de Valle Maria, 2012, Clin Gastroenterol Hepatol, V10, P769, DOI 10.1016/j.cgh.2012.01.025; Beuers U, 2009, J HEPATOL, V51, P237, DOI 10.1016/j.jhep.2009.04.009; Carlberg C, 2003, RECENT RESULTS CANC, V164, P29; Cheung AC, 2016, DIGEST DIS SCI, V61, P1692, DOI 10.1007/s10620-015-4013-1; Eaton JE, 2013, GASTROENTEROLOGY, V145, P521, DOI 10.1053/j.gastro.2013.06.052; Fan LY, 2005, WORLD J GASTROENTERO, V11, P2768, DOI 10.3748/wjg.v11.i18.2768; Gascon-Barre M, 2003, HEPATOLOGY, V37, P1034, DOI 10.1053/jhep.2003.50176; Gatto NM, 2016, J NEUROL SCI, V370, P100, DOI 10.1016/j.jns.2016.09.013; Guardiola J, 2000, GASTROENTEROLOGY, V119, P599, DOI 10.1053/gast.2000.16155; Halmos B, 2000, DIGEST DIS SCI, V45, P1091, DOI 10.1023/A:1005581414918; Hirschfield GM, 2013, LANCET, V382, P1587, DOI 10.1016/S0140-6736(13)60096-3; Hochrath K, 2014, HEPATOL INT, V8, P443, DOI 10.1007/s12072-014-9548-2; Ishikawa L.L., 2016, CLIN REV ALLERGY IMM; Jiang W, 2006, BIOCHEM BIOPH RES CO, V351, P176, DOI 10.1016/j.bbrc.2006.10.027; JORGENSEN RA, 1995, J CLIN GASTROENTEROL, V20, P215, DOI 10.1097/00004836-199504000-00011; Karlsen TH, 2010, GASTROENTEROLOGY, V138, P1102, DOI 10.1053/j.gastro.2009.11.046; Kempinska-Podhorecka A, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/408723; Kempinska-Podhorodecka A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020289; Keyimu K, 2014, INT J CLIN EXP MED, V7, P5282; Kivity S, 2011, CELL MOL IMMUNOL, V8, P243, DOI 10.1038/cmi.2010.73; Kuningas M, 2009, NEUROBIOL AGING, V30, P466, DOI 10.1016/j.neurobiolaging.2007.07.001; Lakatos LP, 2002, EUR J GASTROEN HEPAT, V14, P733, DOI 10.1097/00042737-200207000-00004; Lerner A, 2012, CLIN REV ALLERG IMMU, V42, P322, DOI 10.1007/s12016-010-8237-8; Lim Lei Yuan, 2012, Curr Gastroenterol Rep, V14, P67, DOI 10.1007/s11894-011-0231-7; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; Milkiewicz P, 2004, GUT, V53, P475, DOI 10.1136/gut.2003.025155; Milkiewicz P, 2011, RECENT RESULTS CANC, V185, P117, DOI 10.1007/978-3-642-03503-6_7; Montali L, 2010, DIGEST LIVER DIS, V42, P718, DOI 10.1016/j.dld.2010.01.004; Newton JL, 2006, J HEPATOL, V44, P776, DOI 10.1016/j.jhep.2005.12.012; Peelen E, 2011, AUTOIMMUN REV, V10, P733, DOI 10.1016/j.autrev.2011.05.002; Petta S, 2010, HEPATOLOGY, V51, P1158, DOI 10.1002/hep.23489; Putz-Bankuti C, 2012, LIVER INT, V32, P845, DOI 10.1111/j.1478-3231.2011.02735.x; Raszeja-Wyszomirska J, 2015, LIVER INT, V35, P1764, DOI 10.1111/liv.12730; Resnick RH, 2000, GASTROENTEROLOGY, V119, P1805, DOI 10.1016/S0016-5085(00)70039-4; Rosen Y, 2016, SCAND J RHEUMATOL, V45, P439, DOI 10.3109/03009742.2016.1151072; Roy S, 2014, N AM J MED SCI, V6, P396, DOI 10.4103/1947-2714.139291; Schmidt DR, 2010, J BIOL CHEM, V285, P14486, DOI 10.1074/jbc.M110.116004; Springer JE, 2000, GASTROENTEROLOGY, V118, P145, DOI 10.1016/S0016-5085(00)70423-9; Stokes CS, 2016, CLIN NUTR, V35, P950, DOI 10.1016/j.clnu.2015.07.004; Stokes CS, 2013, LIVER INT, V33, P338, DOI 10.1111/liv.12106; Tanaka A, 2009, J HEPATOL, V50, P1202, DOI 10.1016/j.jhep.2009.01.015; Trepo E, 2013, J HEPATOL, V59, P344, DOI 10.1016/j.jhep.2013.03.024; Uitterlinden AG, 2004, GENE, V338, P143, DOI 10.1016/j.gene.2004.05.014; Vogel A, 2002, HEPATOLOGY, V35, P126, DOI 10.1053/jhep.2002.30084; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wunsch E, 2014, HEPATOLOGY, V60, P931, DOI 10.1002/hep.27074	50	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176264	10.1371/journal.pone.0176264	http://dx.doi.org/10.1371/journal.pone.0176264			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426778	Green Published, Green Submitted, gold			2022-12-26	WOS:000399875900123
J	Liu, GY; Moon, SH; Jenkins, CM; Li, MY; Sims, HF; Guan, SP; Gross, RW				Liu, Gao-Yuan; Moon, Sung Ho; Jenkins, Christopher M.; Li, Maoyin; Sims, Harold F.; Guan, Shaoping; Gross, Richard W.			The phospholipase iPLA(2)gamma is a major mediator releasing oxidized aliphatic chains from cardiolipin, integrating mitochondrial bioenergetics and signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiolipin; lipid metabolism; lipid oxidation; lipid signaling; mass spectrometry (MS)	CALCIUM-INDEPENDENT PHOSPHOLIPASE-A(2)GAMMA; BARTH-SYNDROME; A(2)GAMMA IPLA(2)GAMMA; SHOTGUN LIPIDOMICS; CYTOCHROMES P450; FATTY-ACIDS; BIOSYNTHESIS; METABOLISM; DYSFUNCTION; SUBSTRATE	Cardiolipin (CL) is a dimeric phospholipid with critical roles in mitochondrial bioenergetics and signaling. Recently, inhibition of the release of oxidized fatty acyl chains from CL by the calcium-independent phospholipase A(2) (iPLA(2))-selective inhibitor (R)-BEL suggested that iPLA(2) is responsible for the hydrolysis of oxidized CL and subsequent signaling mediated by the released oxidized fatty acids. However, chemical inhibition by BEL is subject to off-target pharmacologic effects. Accordingly, to unambiguously determine the role of iPLA(2) in the hydrolysis of oxidized CL, we compared alterations in oxidized CLs and the release of oxidized aliphatic chains from CL in experiments with purified recombinant iPLA(2), germ-line iPLA(2)(-/-) mice, cardiac myocyte-specific iPLA(2) transgenic mice, and wild-type mice. Using charge-switch high mass accuracy LC-MS/MS with selected reaction monitoring and product ion accurate masses, we demonstrated that iPLA(2) is the major enzyme responsible for the release of oxidized aliphatic chains from CL. Our results also indicated that iPLA(2) selectively hydrolyzes 9-hydroxy-octadecenoic acid in comparison to 13-hydroxy-octadecenoic acid from oxidized CLs. Moreover, oxidative stress (ADP, NADPH, and Fe3+) resulted in the robust production of oxidized CLs in intact mitochondria from iPLA(2)(-/-) mice. In sharp contrast, oxidized CLs were readily hydrolyzed in mitochondria from wild-type mice during oxidative stress. Finally, we demonstrated that CL activates the iPLA(2)-mediated hydrolysis of arachidonic acid from phosphatidylcholine, thereby integrating the production of lipid messengers from different lipid classes in mitochondria. Collectively, these results demonstrate the integrated roles of CL and iPLA(2) in lipid second-messenger production and mitochondrial bioenergetics during oxidative stress.	[Liu, Gao-Yuan; Gross, Richard W.] Washington Univ, Dept Chem, St Louis, MO 63130 USA; [Moon, Sung Ho; Jenkins, Christopher M.; Li, Maoyin; Sims, Harold F.; Guan, Shaoping; Gross, Richard W.] Washington Univ, Sch Med, Dept Med, Div Bioorgan Chem & Mol Pharmacol, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Sch Med, Ctr Cardiovasc Res, Dept Med, St Louis, MO 63110 USA; [Li, Maoyin] Newomics Inc, 5980 Horton St, Emeryville, CA 94608 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Gross, RW (corresponding author), Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, 660 S Euclid Ave,Campus Box 8020, St Louis, MO 63110 USA.	rgross@wustl.edu		Li, Maoyin/0000-0002-9976-1349	National Institutes of Health [R01HL118639]; LipoSpectrum; Platomics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118639] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LipoSpectrum; Platomics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant R01HL118639. R. W. G.. has financial relationships with LipoSpectrum and Platomics. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acehan D, 2011, BIOPHYS J, V100, P2184, DOI 10.1016/j.bpj.2011.03.031; Alsalem M, 2013, BRIT J PHARMACOL, V168, P1961, DOI 10.1111/bph.12092; Baile MG, 2014, CHEM PHYS LIPIDS, V179, P25, DOI 10.1016/j.chemphyslip.2013.10.008; Balsinde J, 1996, J BIOL CHEM, V271, P31937, DOI 10.1074/jbc.271.50.31937; Bollinger JG, 2010, ANAL CHEM, V82, P6790, DOI 10.1021/ac100720p; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Buland JR, 2016, AM J PHYSIOL-LUNG C, V311, pL303, DOI 10.1152/ajplung.00038.2016; Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003; Claypool SM, 2009, BBA-BIOMEMBRANES, V1788, P2059, DOI 10.1016/j.bbamem.2009.04.020; DANIELS SB, 1983, J BIOL CHEM, V258, P5046; Fauland A, 2013, J SEP SCI, V36, P744, DOI 10.1002/jssc.201200708; Gaspard GJ, 2015, CHEM PHYS LIPIDS, V193, P1, DOI 10.1016/j.chemphyslip.2015.09.005; Green DP, 2016, MOL PAIN, V12, DOI 10.1177/1744806916661725; Gross R W, 1979, Trans Assoc Am Physicians, V92, P136; Han XL, 2007, BIOCHEMISTRY-US, V46, P6417, DOI 10.1021/bi7004015; Han XL, 2005, BIOCHEMISTRY-US, V44, P16684, DOI 10.1021/bi051908a; Houtkooper RH, 2009, BBA-BIOMEMBRANES, V1788, P2003, DOI 10.1016/j.bbamem.2009.07.009; Hsu FF, 2005, J AM SOC MASS SPECTR, V16, P491, DOI 10.1016/j.jasms.2004.12.015; KAYAR SR, 1987, RESP PHYSIOL, V70, P275, DOI 10.1016/0034-5687(87)90010-7; Kiebish MA, 2008, J LIPID RES, V49, P2545, DOI 10.1194/jlr.M800319-JLR200; Kim J, 2011, J LIPID RES, V52, P389, DOI 10.1194/jlr.D010587; Liu XP, 2016, CELL CHEM BIOL, V23, P1217, DOI 10.1016/j.chembiol.2016.08.009; Liu XP, 2013, ANAL BIOCHEM, V442, P40, DOI 10.1016/j.ab.2013.06.014; Mancuso DJ, 2007, J BIOL CHEM, V282, P34611, DOI 10.1074/jbc.M707795200; Mancuso DJ, 2007, J BIOL CHEM, V282, P9216, DOI 10.1074/jbc.M607307200; Mancuso DJ, 2000, J BIOL CHEM, V275, P9937, DOI 10.1074/jbc.275.14.9937; Moon SH, 2016, J BIOL CHEM, V291, P19687, DOI 10.1074/jbc.M116.740597; Moon SH, 2012, J BIOL CHEM, V287, P14880, DOI 10.1074/jbc.M111.336776; NARABAYASHI H, 1982, BIOCHEM J, V202, P97, DOI 10.1042/bj2020097; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; Obinata H, 2005, J BIOL CHEM, V280, P40676, DOI 10.1074/jbc.M507787200; Paradies G, 2002, GENE, V286, P135, DOI 10.1016/S0378-1119(01)00814-9; Paradies G, 2014, BBA-BIOENERGETICS, V1837, P408, DOI 10.1016/j.bbabio.2013.10.006; Patil VA, 2013, ADV EXP MED BIOL, V991, P195, DOI 10.1007/978-94-007-6331-9_11; Patwardhan AM, 2009, P NATL ACAD SCI USA, V106, P18820, DOI 10.1073/pnas.0905415106; Petrosillo G, 2003, FASEB J, V17, P2202, DOI 10.1096/fj.03-0012com; PFEIFER PM, 1972, J BIOL CHEM, V247, P6763; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Raja V, 2017, J BIOL CHEM, V292, P1092, DOI 10.1074/jbc.M116.753624; Raja V, 2014, CHEM PHYS LIPIDS, V179, P49, DOI 10.1016/j.chemphyslip.2013.12.009; Ren MD, 2014, PROG LIPID RES, V55, P1, DOI 10.1016/j.plipres.2014.04.001; Rouzer CA, 2011, CHEM REV, V111, P5899, DOI 10.1021/cr2002799; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022; Schlame M, 2017, BBA-MOL CELL BIOL L, V1862, P3, DOI 10.1016/j.bbalip.2016.08.010; Shen ZN, 2017, J BIOL CHEM, V292, P2916, DOI 10.1074/jbc.M116.753574; Smith WL, 2011, CHEM REV, V111, P5821, DOI 10.1021/cr2002992; Song HW, 2006, BIOCHEMISTRY-US, V45, P1061, DOI 10.1021/bi052065q; Sparagna GC, 2007, J LIPID RES, V48, P1559, DOI 10.1194/jlr.M600551-JLR200; Tyurina YY, 2014, NAT CHEM, V6, P542, DOI [10.1038/NCHEM.1924, 10.1038/nchem.1924]; WHEELDON LW, 1965, J LIPID RES, V6, P481; Xu Y, 2016, NAT CHEM BIOL, V12, P641, DOI [10.1038/NCHEMBIO.2113, 10.1038/nchembio.2113]; Ye CQ, 2014, J BIOL CHEM, V289, P3114, DOI 10.1074/jbc.M113.529487; Yin HY, 2012, FREE RADICAL RES, V46, P959, DOI 10.3109/10715762.2012.676642	54	47	48	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10672	10684		10.1074/jbc.M117.783068	http://dx.doi.org/10.1074/jbc.M117.783068			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28442572	hybrid, Green Published			2022-12-26	WOS:000404115400026
J	D'Amato, R; Proietti, P; Onofri, A; Regni, L; Esposto, S; Servili, M; Businelli, D; Selvaggini, R				D'Amato, Roberto; Proietti, Primo; Onofri, Andrea; Regni, Luca; Esposto, Sonia; Servili, Maurizio; Businelli, Daniela; Selvaggini, Roberto			Biofortification (Se): Does it increase the content of phenolic compounds in virgin olive oil (VOO)	PLOS ONE			English	Article							FUNCTIONAL FOOD TRENDS; SELENIUM; QUALITY; ANTIOXIDANTS; BIOACTIVES; ENRICHMENT; STORAGE; PLANTS	Extra-Virgin Olive Oil (EVOO) is a fundamental component of the Mediterranean diet and it may contain several anti-oxidant substances, such as phenols. Previous research has shown that this food may be enriched in phenols by spraying a sodium-selenate solution (100 mg L-1 Se) onto the crop canopy before flowering. The aim of this research was to evaluate the effect of this Se-fertilization before flowering (cv. Leccino) on the phenolic profile of EVOOs, and test to what extent such effects depend on the weather pattern, as observed in two contrasting experimental seasons (2013 and 2014). Results showed that Se-fertilisation enriched EVOOs both in selenium (up to 120 mu g kg(-1)) and in phenols (up to 401 mg kg(-1)). This latter enrichment was related to an increase in PAL (L-Phenylalanine Ammonia-Lyase) activities and it was largely independent on the climatic pattern. Considering the phenolic profile, oleacein, ligustroside, aglycone and oleocanthal were the most affected compounds and were increased by 57, 50 and 32%, respectively. All these compounds, especially oleacein, have been shown to exert a relevant anti-oxidant activity, contributing both to the shelf-life of EVOOs and to positive effects on human health. It is suggested that Se-fertilisation of olive trees before flowering may be an interesting practice, particularly with poor cultivars and cold and rainy weather patterns, which would normally lead to the production of EVOOs with unfavourable phenolic profile.	[D'Amato, Roberto; Proietti, Primo; Onofri, Andrea; Regni, Luca; Esposto, Sonia; Servili, Maurizio; Businelli, Daniela; Selvaggini, Roberto] Univ Perugia, Dept Agr Food & Environm Sci DSA3, Perugia, Italy	University of Perugia	D'Amato, R (corresponding author), Univ Perugia, Dept Agr Food & Environm Sci DSA3, Perugia, Italy.	robertio.damato@unipg.it	d'amato, roberto/AAG-4218-2019; Proietti, Primo/O-8204-2019; ONOFRI, Andrea/D-1029-2016	Proietti, Primo/0000-0002-6575-7675; d'amato, roberto/0000-0003-3062-1417; ONOFRI, Andrea/0000-0002-6603-329X; Regni, Luca/0000-0001-6639-4637	''Fondazione Cassa di Risparmio di Perugia" (Italy) [2015.0347.021]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e TecnolOgico (CNPq)	''Fondazione Cassa di Risparmio di Perugia" (Italy)(Fondazione Cassa Risparmio Perugia); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e TecnolOgico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The study was kindly supported by the "Fondazione Cassa di Risparmio di Perugia" (Italy), Project: "Selenolivo", project code: 2015.0347.021, Scientific and Technological Research to PP DB MS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscrip.r We are grateful to the Brazilian Biosciences National Laboratory (LNBio) and the Brazilian Synchrotron Light Laboratory (LNLS) for the provision of time on the MX2 beamline, Robolab and LEC. We would like to thank the staff of Inmetro and LNBio for technical assistance and insightful discussions, especially Celisa C. Tonoli and Givanil Garrido. This work was funded by the Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and Conselho Nacional de Desenvolvimento Cientifico e TecnolOgico (CNPq).	[Anonymous], 2007, EUR J PLANT SCI BIOT; Antonini E, 2015, J FOOD COMPOS ANAL, V43, P75, DOI 10.1016/j.jfca.2015.04.015; Artajo LS, 2006, J AGR FOOD CHEM, V54, P6079, DOI 10.1021/jf060874q; Bendich A, 2001, DIETARY REFERENCE IN, DOI [10.1016/s0899-9007(00)00596-7, DOI 10.1016/S0899-9007(00)00596-7]; Berville AJ, 2014, GENETIC ENV FEATURES, V21, P1; Bigliardi B, 2013, TRENDS FOOD SCI TECH, V31, P118, DOI 10.1016/j.tifs.2013.03.006; Bouaziz M, 2008, FOOD CHEM, V108, P253, DOI 10.1016/j.foodchem.2007.10.074; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carrasco-Pancorbo A, 2005, J AGR FOOD CHEM, V53, P8918, DOI 10.1021/jf0515680; Caruso G, 2014, AGR WATER MANAGE, V134, P94, DOI 10.1016/j.agwat.2013.12.003; Chimi H., 1994, OLIVAE, V54, P56; Cicerale S, 2010, INT J MOL SCI, V11, P458, DOI 10.3390/ijms11020458; D'Amato R, 2014, GRASAS ACEITES, V65, DOI 10.3989/gya.097313; Dixon RA, 2002, MOL PLANT PATHOL, V3, P371, DOI 10.1046/j.1364-3703.2002.00131.x; Dutta RK, 2012, FOOD CHEM, V131, P259, DOI 10.1016/j.foodchem.2011.08.075; E Union, 2012, OFF J EUR UNION, V136, P1; Fantozzi P, 1978, IND ALIMENTAIRES, V17, P1335; Ghanbari R, 2012, INT J MOL SCI, V13, P3291, DOI 10.3390/ijms13033291; Hartikainen H, 2005, J TRACE ELEM MED BIO, V18, P309, DOI 10.1016/j.jtemb.2005.02.009; Hyun Min Woo, 2011, Mycobiology, V39, P257, DOI 10.5941/MYCO.2011.39.4.257; Japon-Lujan R, 2008, J AGR FOOD CHEM, V56, P2505, DOI 10.1021/jf0728810; Jezek P, 2011, PLANT SOIL ENVIRON, V57, P315, DOI 10.17221/57/2011-PSE; Laura Rubio A, 2014, J FUNCT FOODS, V10, P139; Legendre P., 2012, NUMERICAL ECOLOGY; Lichtenthaler H.K., 1985, BIOL SOC T, V11, P591, DOI DOI 10.1042/BST0110591; Lister CE, 1996, J AM SOC HORTIC SCI, V121, P281, DOI 10.21273/JASHS.121.2.281; Nadernejad N., 2012, American-Eurasian Journal of Agricultural & Environmental Sciences, V12, P807; Oraghi Ardebili Z, 2015, TURK J BOT, V39, P401, DOI 10.3906/bot-1404-20; Oufedjikh H, 2000, J AGR FOOD CHEM, V48, P559, DOI 10.1021/jf9902402; Pinheiro J, 2001, MIXED EFFECTS MODELS; Proietti P, 2013, SCI HORTIC-AMSTERDAM, V164, P165, DOI 10.1016/j.scienta.2013.09.034; Segade M, 2016, J FUNCT FOODS, V23, P637, DOI 10.1016/j.jff.2016.03.024; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Sloan AE, 2004, FOOD TECHNOL-CHICAGO, V58, P28; Sloan AE, 2002, FOOD TECHNOL-CHICAGO, V56, P32; Sloan AE, 2000, FOOD TECHNOL-CHICAGO, V54, P33; Suarez M, 2010, J AGR FOOD CHEM, V58, P10396, DOI 10.1021/jf102203x; Suarez M, 2011, BRIT J NUTR, V106, P1691, DOI 10.1017/S0007114511002200; Tamaoki M, 2008, PLANT SIGNAL BEHAV, V3, P865, DOI 10.4161/psb.3.10.6050; Uribe E, 2014, CHIL J AGR RES, V74, P293, DOI 10.4067/S0718-58392014000300007; USEPA, 1995, MICROWAVE ASSISTED A; Visioli F, 1998, J AGR FOOD CHEM, V46, P4292, DOI 10.1021/jf980049c; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106	43	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176580	10.1371/journal.pone.0176580	http://dx.doi.org/10.1371/journal.pone.0176580			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448631	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383600106
J	Eriksson, J; Haring, R; Grarup, N; Vandenput, L; Wallaschofski, H; Lorentzen, E; Hansen, T; Mellstrom, D; Pedersen, O; Nauck, M; Lorentzon, M; Husemoen, LLN; Volzke, H; Karlsson, M; Baumeister, SE; Linneberg, A; Ohlsson, C				Eriksson, Joel; Haring, Robin; Grarup, Niels; Vandenput, Liesbeth; Wallaschofski, Henri; Lorentzen, Erik; Hansen, Torben; Mellstrom, Dan; Pedersen, Oluf; Nauck, Matthias; Lorentzon, Mattias; Husemoen, Lise Lotte Nystrup; Voelzke, Henry; Karlsson, Magnus; Baumeister, Sebastian E.; Linneberg, Allan; Ohlsson, Claes			Causal relationship between obesity and serum testosterone status in men: A bi-directional mendelian randomization analysis	PLOS ONE			English	Article							HORMONE-BINDING GLOBULIN; BODY-MASS INDEX; OLDER MEN; FTO GENE; HYPOGONADOTROPIC HYPOGONADISM; MUSCLE STRENGTH; RISK-FACTORS; ELDERLY-MEN; DEFICIENCY; THERAPY	Context Obesity in men is associated with low serum testosterone and both are associated with several diseases and increased mortality. Objectives Examine the direction and causality of the relationship between body mass index (BMI) and serum testosterone. Design Bi-directional Mendelian randomization (MR) analysis on prospective cohorts. Setting Five cohorts from Denmark, Germany and Sweden (Inter99, SHIP, SHIP Trend, GOOD and MrOS Sweden). Participants 7446 Caucasian men, genotyped for 97 BMI-associated SNPs and three testosterone-associated SNPs. Main outcome measures BMI and serum testosterone adjusted for age, smoking, time of blood sampling and site. Results 1 SD genetically instrumented increase in BMI was associated with a 0.25 SD decrease in serum testosterone (IV ratio: -0.25, 95% CI: -0.42-0.09, p = 2.8*10(-3)). For a body weight reduction altering the BMI from 30 to 25 kg/m(2), the effect would equal a 13% increase in serum testosterone. No association was seen for genetically instrumented testosterone with BMI, a finding that was confirmed using large-scale data from the GIANT consortium (n = 104349). Conclusions Our results suggest that there is a causal effect of BMI on serum testosterone in men. Population level interventions to reduce BMI are expected to increase serum testosterone in men.	[Eriksson, Joel; Vandenput, Liesbeth; Mellstrom, Dan; Lorentzon, Mattias; Ohlsson, Claes] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Ctr Bone & Arthrit Res, Gothenburg, Sweden; [Haring, Robin; Wallaschofski, Henri; Nauck, Matthias] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Haring, Robin] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Grarup, Niels; Hansen, Torben; Pedersen, Oluf] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Ctr Basic Metab Res, Copenhagen, Denmark; [Lorentzen, Erik] Univ Gothenburg, Sahlgrenska Acad, Bioinformat Core Facil, Gothenburg, Sweden; [Lorentzon, Mattias] Univ Gothenburg, Inst Med, Dept Internal Med & Clin Nutr, Geriatr Med, Gothenburg, Sweden; [Husemoen, Lise Lotte Nystrup; Linneberg, Allan] Res Ctr Prevent & Hlth, Copenhagen, Denmark; [Voelzke, Henry; Baumeister, Sebastian E.] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Karlsson, Magnus] Lund Univ, Skane Univ Hosp, Dept Orthopaed & Clin Sci, Clin & Mol Osteoporosis Res Unit, Malmo, Sweden; [Baumeister, Sebastian E.] Univ Regensburg, Dept Epidemiol & Prevent Med, Regensburg, Germany; [Linneberg, Allan] Rigshosp, Dept Clin Expt Res, Glostrup, Denmark; [Linneberg, Allan] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark	University of Gothenburg; Greifswald Medical School; Monash University; Novo Nordisk Foundation; University of Copenhagen; University of Gothenburg; University of Gothenburg; Greifswald Medical School; Lund University; Skane University Hospital; University of Regensburg; Rigshospitalet; University of Copenhagen	Ohlsson, C (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Ctr Bone & Arthrit Res, Gothenburg, Sweden.	claes.ohlsson@medic.gu.se	Ohlsson, Claes/AGP-3544-2022; Pedersen, Oluf/AAG-8015-2020; Vandenput, Liesbeth/AAP-3655-2020; Baumeister, Sebastian-Edgar/P-7894-2019; Vandenput, Liesbeth/AAI-4100-2021; Lorentzon, Mattias/W-7878-2019; Pedersen, Oluf/Z-1731-2019; Grarup, Niels/K-2807-2015; Wilkening, Robin/J-5535-2018	Ohlsson, Claes/0000-0002-9633-2805; Vandenput, Liesbeth/0000-0002-1712-6131; Baumeister, Sebastian-Edgar/0000-0002-9391-6602; Vandenput, Liesbeth/0000-0002-1712-6131; Lorentzon, Mattias/0000-0003-0749-1431; Pedersen, Oluf/0000-0002-3321-3972; Grarup, Niels/0000-0001-5526-1070; Wilkening, Robin/0000-0002-8332-5016; Linneberg, Allan/0000-0002-0994-0184; Hansen, Torben/0000-0001-8748-3831	Swedish Research Council; Swedish government; Lundberg Foundation; Torsten Soderberg Foundation; Novo Nordisk Foundation; Knut and Alice Wallenberg Foundation; Novo Nordisk Fonden [NNF14OC0010513, NNF14OC0009883, NNF13OC0005785, NNF13OC0004839, NNF15OC0016220] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish government; Lundberg Foundation(European Commission); Torsten Soderberg Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was supported by the Swedish Research Council and by grants from the Swedish government (under the Avtal om Lakarutbildning och Medicinsk Forskning [Agreement for Medical Education and Research]), the Lundberg Foundation, the Torsten Soderberg Foundation, the Novo Nordisk Foundation and the Knut and Alice Wallenberg Foundation. Data collection in the Inter99 Study was supported economically by The Danish Medical Research Council, The Danish Centre for Evaluation and Health Technology Assessment, Novo Nordisk, Copenhagen County, The Danish Heart Foundation, The Danish Pharmaceutical Association, Augustinus foundation, Ib Henriksen foundation and Becket foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6330; Andersson AM, 2007, J CLIN ENDOCR METAB, V92, P4696, DOI 10.1210/jc.2006-2633; Basaria S, 2010, NEW ENGL J MED, V363, P109, DOI 10.1056/NEJMoa1000485; Berg C, 2005, INT J OBESITY, V29, P916, DOI 10.1038/sj.ijo.0802964; Bhasin S, 2010, J CLIN ENDOCR METAB, V95, P2536, DOI 10.1210/jc.2009-2354; Blackman MB, 2002, JAMA-J AM MED ASSOC, V288, P2282, DOI 10.1001/jama.288.18.2282; Nguyen CP, 2015, NEW ENGL J MED, V373, P689, DOI 10.1056/NEJMp1506632; Corona G, 2013, EUR J ENDOCRINOL, V168, P829, DOI 10.1530/EJE-12-0955; Dandona P, 2011, J CLIN ENDOCR METAB, V96, P2643, DOI 10.1210/jc.2010-2724; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; English KM, 2000, EUR HEART J, V21, P890, DOI 10.1053/euhj.1999.1873; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Freeman G, 2013, INT J EPIDEMIOL, V42, P1157, DOI 10.1093/ije/dyt110; Friedrich N, 2008, J ANDROL, V29, P610, DOI 10.2164/jandrol.108.005561; George JT, 2013, CLIN ENDOCRINOL, V79, P100, DOI 10.1111/cen.12103; George JT, 2010, NEUROENDOCRINOLOGY, V91, P302, DOI 10.1159/000299767; GIAGULLI VA, 1994, J CLIN ENDOCR METAB, V79, P997, DOI 10.1210/jc.79.4.997; Haffner SM, 1996, AM J EPIDEMIOL, V143, P889; Handelsman DJ, 2013, MED J AUSTRALIA, V199, P548; Haring R, 2013, EUR J PREV CARDIOL, V20, P1061, DOI 10.1177/2047487312452965; Haring R, 2010, AGING MALE, V13, P247, DOI 10.3109/13685538.2010.487553; Kenny AM, 2001, J GERONTOL A-BIOL, V56, pM266, DOI 10.1093/gerona/56.5.M266; Laaksonen DE, 2005, J CLIN ENDOCR METAB, V90, P712, DOI 10.1210/jc.2004-0970; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Lorentzon M, 2005, J BONE MINER RES, V20, P1334, DOI 10.1359/JBMR.050404; Mah PM, 2010, MOL CELL ENDOCRINOL, V316, P180, DOI 10.1016/j.mce.2009.06.007; Ohlsson C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002313; Ohlsson C, 2011, J AM COLL CARDIOL, V58, P1674, DOI 10.1016/j.jacc.2011.07.019; Page ST, 2005, J CLIN ENDOCR METAB, V90, P1502, DOI 10.1210/jc.2004-1933; Peng SH, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-71; Rice J., 1995, MATH STAT DATA ANAL; Saad F, 2012, CURR DIABETES REV, V8, P131, DOI 10.2174/157339912799424573; Saad F, 2011, EUR J ENDOCRINOL, V165, P675, DOI 10.1530/EJE-11-0221; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Smith GD, 2011, GENES NUTR, V6, P27, DOI 10.1007/s12263-010-0181-y; Snyder PJ, 1999, J CLIN ENDOCR METAB, V84, P2647, DOI 10.1210/jc.84.8.2647; Song DK, 2014, DIABETES METAB J, V38, P302, DOI 10.4093/dmj.2014.38.4.302; Srinivas-Shankar U, 2010, J CLIN ENDOCR METAB, V95, P639, DOI 10.1210/jc.2009-1251; Taylor PN, 2016, J CLIN ENDOCR METAB, V101, P730, DOI 10.1210/jc.2015-3505; Thienpont LM, 2008, CLIN CHEM, V54, P1290, DOI 10.1373/clinchem.2008.105841; Travison TG, 2007, J CLIN ENDOCR METAB, V92, P549, DOI 10.1210/jc.2006-1859; Vandenput L, 2007, J BONE MINER RES, V22, P220, DOI 10.1359/JBMR.061018; VERMEULEN A, 1993, J CLIN ENDOCR METAB, V76, P1140, DOI 10.1210/jc.76.5.1140; Vigen R, 2013, JAMA-J AM MED ASSOC, V310, P1829, DOI 10.1001/jama.2013.280386; Vimaleswaran KS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001383; Wu FCW, 2008, J CLIN ENDOCR METAB, V93, P2737, DOI 10.1210/jc.2007-1972; Zheng J, 2011, GENET EPIDEMIOL, V35, P102, DOI 10.1002/gepi.20552	50	52	52	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176277	10.1371/journal.pone.0176277	http://dx.doi.org/10.1371/journal.pone.0176277			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448539	Green Published, gold, Green Submitted			2022-12-26	WOS:000400383600055
J	Moots, RJ; Xavier, RM; Mok, CC; Rahman, MU; Tsai, WC; Al-Maini, MH; Pavelka, K; Mahgoub, E; Kotak, S; Korth-Bradley, J; Pedersen, R; Mele, L; Shen, Q; Vlahos, B				Moots, Robert J.; Xavier, Ricardo M.; Mok, Chi Chiu; Rahman, Mahboob U.; Tsai, Wen-Chan; Al-Maini, Mustafa H.; Pavelka, Karel; Mahgoub, Ehab; Kotak, Sameer; Korth-Bradley, Joan; Pedersen, Ron; Mele, Linda; Shen, Qi; Vlahos, Bonnie			The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional study	PLOS ONE			English	Article							INFLAMMATORY DISEASES; FOLLOW-UP; IMMUNOGENICITY; THERAPIES; EFFICACY	Objective To assess the incidence of anti-drug antibodies (ADA) in patients with rheumatoid arthritis (RA) treated with the TNF inhibitors etanercept (ETN), adalimumab (ADL), or infliximab (IFX), and determine the potential relationship with trough drug concentration, efficacy, and patient-reported outcomes. Methods This multi-national, non-interventional, cross-sectional study (NCT01981473) enrolled adult patients with RA treated continuously for 6-24 months with ETN, ADL, or IFX. ADA and trough drug concentrations were measured by independent assays <= 2 days before the next scheduled dose. Efficacy measurements included Disease Activity Score 28-joint count (DAS28), low disease activity (LDA), remission, and erythrocyte sedimentation rate (ESR). Targeted medical histories of injection site/ infusion reactions, serum sickness, and thromboembolic events were collected. Results Baseline demographics of the 595 patients (ETN: n = 200; ADL: n = 199; IFX: n = 196) were similar across groups. The mean duration of treatment was 14.6, 13.5, and 13.1 months for ETN, ADL, and IFX, respectively. All ETN-treated patients tested negative for ADA, whereas 31.2% and 17.4% patients treated with ADL and IFX, respectively, tested positive. In ADL- or IFX-treated patients, those with ADA had significantly lower trough drug concentrations. There were negative correlations between trough drug levels and both CRP and ESR in ADL- and IFX-treated patients. DAS28-ESR LDA and remission rates were higher in patients without ADA. The rate of targeted medical events reported was low. Conclusion ADA were detected in ADL- and IFX-treated but not ETN-treated patients. Patients without ADA generally showed numerically better clinical outcomes than those with ADA.	[Moots, Robert J.] Univ Liverpool, Aintree Univ Hosp, Liverpool, Merseyside, England; [Xavier, Ricardo M.] Hosp Clin, Porto Alegre, RS, Brazil; [Mok, Chi Chiu] Tuen Mun Hosp, Hong Kong, Hong Kong, Peoples R China; [Rahman, Mahboob U.; Mahgoub, Ehab; Kotak, Sameer; Korth-Bradley, Joan; Pedersen, Ron; Mele, Linda; Shen, Qi; Vlahos, Bonnie] Pfizer, Collegeville, PA USA; [Tsai, Wen-Chan] Kaohsiung Med Univ, Kaohsiung, Taiwan; [Al-Maini, Mustafa H.] Mafraq Hosp, Abu Dhabi, U Arab Emirates; [Pavelka, Karel] Inst Rheumatol, Prague, Czech Republic; [Rahman, Mahboob U.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Liverpool; Tuen Mun Hospital; Pfizer; Kaohsiung Medical University; Institute of Rheumatology; University of Pennsylvania; Pennsylvania Medicine	Moots, RJ (corresponding author), Univ Liverpool, Aintree Univ Hosp, Liverpool, Merseyside, England.	R.J.Moots@liverpool.ac.uk	Xavier, Ricardo Machado/G-4426-2012; Pavelka, Karel/E-6578-2017; Moots, Robert/AAM-8091-2020	Xavier, Ricardo Machado/0000-0001-6570-4533; Pavelka, Karel/0000-0003-1952-8422; 	Pfizer	Pfizer(Pfizer)	This study was sponsored and funded by Pfizer. The funder provided support in the form of salaries for authors [EM, SK, JKB, RP, LM, QS, BV], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; Medical writing support was provided by Mukund Nori, PhD, MBA, CMPP, of Engage Scientific Solutions and funded by Pfizer. The authors thank all of the patients who participated in this study and the investigators who conducted the study: M. Ali, F. Ariel, J. Barreira, A. Batalov, S. Bharadwaj, S. A. Bilgen, P. Box, T. Bunch, J. Butler, P. Caldron, J. Cavallasca, M. N. Capozzi, P. Chatpar, M. Churchill, C. Dennehey, S. Dold, E. Erken, H. Feng, R. Griffin, H. Hauptman, R. P. Hidalgo, R. Jajoo, S. Kapil, I. Kazmin, C. Korkmaz, A. Kul, M. Lazaro, M. O. Leal, C. Legerton III, E. Leibowitz, R. Lidman, S. Longley III, D. Machado, P. Maid, S. Mortensen, S. Najam, J. Pachon, R. Palwai, J. Pando, R. Rapoport, R. Rashkov, L. Ruggieri, D. Rosenberg, M. Sabelli, K. Senel, J. Silverfield, E. Simpson, Y. Smallwood-Sherrer, Y. Sokolova, M. St. John, A. Swarup, J. Tesser, L. Wilson, K. Yablanski, J. Zochling.	AbbVie Inc, 2002, HUMIRA AD INJ PRESC; Amgen, 1998, ETANERCEPT PRESCRIBI; Anderson PJ, 2005, SEMIN ARTHRITIS RHEU, V34, P19, DOI 10.1016/j.semarthrit.2005.01.005; Bartelds GM, 2011, JAMA-J AM MED ASSOC, V305, P1460, DOI 10.1001/jama.2011.406; Bendtzen K, 2006, ARTHRITIS RHEUM-US, V54, P3782, DOI 10.1002/art.22214; Conti F, 2013, CLIN TER, V164, pE413, DOI 10.7417/CT.2013.1622; de Vries MK, 2009, ANN RHEUM DIS, V68, P531, DOI 10.1136/ard.2008.089979; Dore RK, 2007, CLIN EXP RHEUMATOL, V25, P40; Finckh A, 2010, JOINT BONE SPINE, V77, P313, DOI 10.1016/j.jbspin.2010.02.021; Garces S, 2013, ANN RHEUM DIS, V72, P1947, DOI 10.1136/annrheumdis-2012-202220; Hwang WYK, 2005, METHODS, V36, P3, DOI 10.1016/j.ymeth.2005.01.001; Janssen Biotech Inc., 1998, REMICADE INFL PRESCR; Korswagen LA, 2011, ARTHRITIS RHEUM-US, V63, P877, DOI 10.1002/art.30209; Kourilovitch M, 2014, J AUTOIMMUN, V48-49, P26, DOI 10.1016/j.jaut.2014.01.027; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Menting SP, 2014, JAMA DERMATOL, V150, P130, DOI 10.1001/jamadermatol.2013.8347; Pascual-Salcedo D, 2011, RHEUMATOLOGY, V50, P1445, DOI 10.1093/rheumatology/ker124; Radstake TRDJ, 2009, ANN RHEUM DIS, V68, P1739, DOI 10.1136/ard.2008.092833; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; van Schouwenburg PA, 2013, NAT REV RHEUMATOL, V9, P164, DOI 10.1038/nrrheum.2013.4; Vincent FB, 2013, ANN RHEUM DIS, V72, P165, DOI 10.1136/annrheumdis-2012-202545	21	75	78	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0175207	10.1371/journal.pone.0175207	http://dx.doi.org/10.1371/journal.pone.0175207			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448562	Green Published, gold, Green Submitted			2022-12-26	WOS:000400383600010
J	Petraglia, A; Leader, JK; Gingo, M; Fitzpatrick, M; Ries, J; Kessinger, C; Lucht, L; Camp, D; Morris, A; Bon, J				Petraglia, Alycia; Leader, Joseph K.; Gingo, Matthew; Fitzpatrick, Meghan; Ries, John; Kessinger, Cathy; Lucht, Lorrie; Camp, Danielle; Morris, Alison; Bon, Jessica			Emphysema is associated with thoracic vertebral bone attenuation on chest CT scan in HIV-infected individuals	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ANTIRETROVIRAL THERAPY ERA; POPULATION-BASED COHORT; QUALITY-OF-LIFE; MINERAL DENSITY; RADIOGRAPHIC EMPHYSEMA; RISK; OSTEOPOROSIS; INFLAMMATION; FRACTURE	Background Age-related chronic diseases are prevalent in HIV-infected persons in the antiretroviral therapy (ART) era. Bone mineral density (BMD) loss and emphysema have separately been shown to occur at a younger age and with lesser risk exposure in HIV-infected compared to HIV-uninfected individuals. In non-HIV infected smokers, emphysema has been shown to independently predict low BMD. We hypothesized that emphysema would independently associate with thoracic vertebral bone attenuation, a surrogate for bone mineral density, in HIV-infected individuals. Methods Clinical, pulmonary function, and radiographic data were analyzed for 164 individuals from the University of Pittsburgh's HIV Lung Research Center cohort. Chest CT scans were used to quantify emphysema and compute Hounsfield Unit (HU) attenuation of the 4 th, 7 th, and 10 th thoracic vertebrae. The association between mean HU attenuation values across the three vertebrae and radiographic emphysema, age, sex, body mass index (BMI), steroid use, viral load, CD4 count, and forced expiratory volume in the first second (FEV1) was assessed by univariate and multivariate analyses. Results In univariate analysis, mean HU attenuation decreased with increasing age (p<0.001), pack years (p = 0.047), and percent emphysema (p<0.001). In a multivariable model, including pack years, age, sex, ART and steroid use, greater emphysema was independently associated with this surrogate marker of BMD in HIV-infected individuals (p = 0.034). Conclusions The association of emphysema with thoracic bone attenuation in HIV-infected individuals is consistent with previous reports in non-HIV infected smokers. These findings suggest that emphysema should be considered a potential marker of osteoporosis risk in HIV-infected individuals.	[Petraglia, Alycia] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Leader, Joseph K.] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA; [Gingo, Matthew; Fitzpatrick, Meghan; Ries, John; Kessinger, Cathy; Lucht, Lorrie; Camp, Danielle; Morris, Alison; Bon, Jessica] Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, 930 Scaife Hall, Pittsburgh, PA 15260 USA; [Morris, Alison] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bon, J (corresponding author), Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, 930 Scaife Hall, Pittsburgh, PA 15260 USA.	bonjm@upmc.edu	Bon, Jessica/AAK-6714-2021		National Institute of Health [K23HL095909, K24HL123342, R01HL090339, 1R01HL083461, F32HL114426]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institute of Health Grants K23HL095909, K24HL123342, R01HL090339, 1R01HL083461, and F32HL114426.	Aberg JA, 2014, CLIN INFECT DIS, V58, pE1, DOI [10.1093/cid/cit665, 10.1093/cid/cit757]; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Armah KA, 2012, CLIN INFECT DIS, V55, P126, DOI 10.1093/cid/cis406; Attia EF, 2014, CHEST, V146, P1543, DOI 10.1378/chest.14-0543; Bhatia R, 2012, J NEUROVIROL, V18, P247, DOI 10.1007/s13365-011-0073-y; Bon J, 2011, AM J RESP CRIT CARE, V183, P885, DOI 10.1164/rccm.201004-0666OC; Bonjoch A, 2010, AIDS, V24, P2827, DOI 10.1097/QAD.0b013e328340a28d; Cazanave C, 2008, AIDS, V22, P395, DOI 10.1097/QAD.0b013e3282f423dd; Crothers K, 2013, AIDS, V27, P1345, DOI 10.1097/QAD.0b013e3283601082; de Luise C, 2008, EUR J EPIDEMIOL, V23, P115, DOI 10.1007/s10654-007-9211-5; de Vries F, 2005, EUR RESPIR J, V25, P879, DOI 10.1183/09031936.05.00058204; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Fausto A, 2006, BONE, V38, P893, DOI 10.1016/j.bone.2005.11.001; Fitzpatrick ME, 2016, NOVEL RELATIONSHIPS; Fitzpatrick ME, 2014, AIDS, V28, P2505, DOI 10.1097/QAD.0000000000000471; Gilbert CR, 2009, CAN RESPIR J, V16, P75, DOI 10.1155/2009/829130; Gingo MR, 2013, CLIN CHEST MED, V34, P273, DOI 10.1016/j.ccm.2013.02.002; Gingo MR, 2010, AM J RESP CRIT CARE, V182, P790, DOI 10.1164/rccm.200912-1858OC; Guaraldi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109027; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Guerri-Fernandez R, 2013, J BONE MINER RES, V28, P1259, DOI 10.1002/jbmr.1874; Jia HG, 2007, QUAL LIFE RES, V16, P961, DOI 10.1007/s11136-007-9214-4; Leader JK, 2016, JAIDS-J ACQ IMM DEF, V71, P420, DOI 10.1097/QAI.0000000000000894; Lombardi I, 2005, OSTEOPOROSIS INT, V16, P1247, DOI 10.1007/s00198-005-1834-3; Negredo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046031; Obel N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022698; Ohara T, 2008, CHEST, V134, P1244, DOI 10.1378/chest.07-3054; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Romme EAPM, 2013, J BONE MINER RES, V28, P1369, DOI 10.1002/jbmr.1873; Romme EAPM, 2012, J BONE MINER RES, V27, P2338, DOI 10.1002/jbmr.1678; Sharma A, 2015, JAIDS-J ACQ IMM DEF, V70, P54, DOI 10.1097/QAI.0000000000000674; Sin DD, 2003, AM J MED, V114, P10, DOI 10.1016/S0002-9343(02)01297-4; Skiest DJ, 1996, AM J MED, V101, P605, DOI 10.1016/S0002-9343(96)00329-4; Yin MT, 2012, J CLIN ENDOCR METAB, V97, P554, DOI 10.1210/jc.2011-2197	34	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176719	10.1371/journal.pone.0176719	http://dx.doi.org/10.1371/journal.pone.0176719			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448615	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383600125
J	Westergren, HU; Michaelsson, E; Blomster, JI; Miliotis, T; Svedlund, S; Gan, LM				Westergren, Helena U.; Michaelsson, Erik; Blomster, Juuso I.; Miliotis, Tasso; Svedlund, Sara; Gan, Li-Ming			Determinants of coronary flow reserve in non-diabetic patients with chest pain without myocardial perfusion defects	PLOS ONE			English	Article							TRANSTHORACIC DOPPLER-ECHOCARDIOGRAPHY; MICROVASCULAR DYSFUNCTION; SUSPECTED ISCHEMIA; ARTERY-DISEASE; INSULIN; RISK; WOMEN; VASODILATION; ASSOCIATION; PREVALENCE	Background Microvascular dysfunction could be responsible for chest pain in patients without myocardial perfusion defects. We evaluated microvascular function using ultrasound-assessed coronary flow reserve (CFR) in patients with chest pain and normal myocardial perfusion scintigram. Secondly, we investigated association between cardiovascular parameters and decreased CFR in a sex specific manner. Methods A total of 202 (128 women) non-diabetic patients with chest pain and suspected myocardial ischemia, but without myocardial perfusion defects on myocardial perfusion scintigram, were enrolled and underwent CFR examination and blood sampling. All patients were followed- up for cardiovascular events. We used a supervised principal component analysis including 66 variables such as clinical parameters, ongoing medication, coronary artery disease history, lipids, metabolic parameters, inflammatory and other cardiovascular parameters. Results During a median follow-up time of 5.4 years, 25 cardiovascular events occurred; (men; 18, women; 7). Average CFR of the study cohort was 2.7 +/- 1.2 and 14% showed impaired CFR< 2.0. In an adjusted Cox regression analysis, CFR< 2.0 independently predicted eventfree survival (HR: 2.5, p = 0.033). In the supervised principal component analysis high insulin resistance assessed by Homeostatic model assessment for insulin resistance was the strongest biochemical marker associated with decreased CFR. Interestingly, upon sex specific multivariable linear regression analysis, the association was only significant in men (beta = -0.132, p = 0.041) while systolic blood pressure remained an independent predictor in women (beta = -0.009, p = 0.011). Conclusions In non-diabetic patients with chest pain without myocardial perfusion defects, low CFR has prognostic value for future cardiovascular events. Insulin resistance appears to be a marker for decreased CFR in men. Indeed, in the context of contribution of traditional risk factors in this patient population, the value of systolic blood pressure seems to be important in the women.	[Westergren, Helena U.; Blomster, Juuso I.; Svedlund, Sara; Gan, Li-Ming] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden; [Westergren, Helena U.; Blomster, Juuso I.; Svedlund, Sara; Gan, Li-Ming] Sahlgrens Univ Hosp, Gothenburg, Sweden; [Westergren, Helena U.; Michaelsson, Erik; Blomster, Juuso I.; Miliotis, Tasso; Gan, Li-Ming] AstraZeneca R&D, Gothenburg, Sweden; [Svedlund, Sara] Sahlgrens Univ Hosp, Dept Clin Physiol, Gothenburg, Sweden; [Gan, Li-Ming] Sahlgrens Univ Hosp, Dept Cardiol, Gothenburg, Sweden	University of Gothenburg; Sahlgrenska University Hospital; AstraZeneca; Sahlgrenska University Hospital; Sahlgrenska University Hospital	Gan, LM (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden.; Gan, LM (corresponding author), Sahlgrens Univ Hosp, Gothenburg, Sweden.; Gan, LM (corresponding author), AstraZeneca R&D, Gothenburg, Sweden.; Gan, LM (corresponding author), Sahlgrens Univ Hosp, Dept Cardiol, Gothenburg, Sweden.	li-ming.gan@gu.se		Michaelsson, Erik/0000-0001-8643-2821	ALF/LUA grant, Swedish federal government; AstraZeneca	ALF/LUA grant, Swedish federal government; AstraZeneca(AstraZeneca)	First author and co-author SS are supported by the agreement concerning research and education of doctors (ALF/LUA grant), Swedish federal government. Co-authors EM, JB, TM and LMG are employed by AstraZeneca R&D Gothenburg. AstraZeneca provided support in the form of biochemical analysis and salaries for authors EM, JB, TM and LMG. AstraZeneca did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. The decision to publish was made based on a consensus from all authors followed by an internal AstraZeneca review of the manuscript.	Barton M, 2009, HYPERTENSION, V54, P11, DOI 10.1161/HYPERTENSIONAHA.108.120022; Camici PG, 2007, NEW ENGL J MED, V356, P830, DOI 10.1056/NEJMra061889; Cortigiani L, 2007, J AM COLL CARDIOL, V50, P1354, DOI 10.1016/j.jacc.2007.06.027; Cortigiani L, 2014, J AM SOC ECHOCARDIOG, V27, P742, DOI 10.1016/j.echo.2014.02.010; Crea F, 2014, EUR HEART J, V35, P1101, DOI 10.1093/eurheartj/eht513; Dagres N, 2004, CLIN ENDOCRINOL, V61, P724, DOI 10.1111/j.1365-2265.2004.02156.x; Dean J, 2015, NAT REV CARDIOL, V12, P406, DOI 10.1038/nrcardio.2015.72; Del Ry S, 2010, CYTOKINE, V49, P325, DOI 10.1016/j.cyto.2009.11.018; Evangelista A, 2008, EUR J ECHOCARDIOGR, V9, P438, DOI 10.1093/ejechocard/jen174; Gast KB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052036; Granger DN, 2010, MICROCIRCULATION, V17, P192, DOI 10.1111/j.1549-8719.2009.00015.x; GROVER A, 1995, HYPERTENSION, V25, P779, DOI 10.1161/01.HYP.25.4.779; Haraldsson I, 2014, INT J CARDIOL, V176, P294, DOI 10.1016/j.ijcard.2014.06.076; Hicks KA, 2015, J AM COLL CARDIOL, V66, P403, DOI 10.1016/j.jacc.2014.12.018; Ikonomidis I, 2015, ATHEROSCLEROSIS, V241, P455, DOI 10.1016/j.atherosclerosis.2015.06.006; Madjid M, 2004, J AM COLL CARDIOL, V44, P1945, DOI 10.1016/j.jacc.2004.07.056; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meimoun P, 2008, EUR J ECHOCARDIOGR, V9, P449, DOI 10.1093/ejechocard/jen004; Metz CNB, 2006, J AM COLL CARDIOL, V47, p21S, DOI 10.1016/j.jacc.2004.12.084; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Murthy VL, 2014, CIRCULATION, V129, P2518, DOI 10.1161/CIRCULATIONAHA.113.008507; Murthy VL, 2012, CIRCULATION, V126, P1858, DOI 10.1161/CIRCULATIONAHA.112.120402; NAHSER PJ, 1995, CIRCULATION, V91, P635, DOI 10.1161/01.CIR.91.3.635; Pepine CJ, 2010, J AM COLL CARDIOL, V55, P2825, DOI 10.1016/j.jacc.2010.01.054; Pories WJ, 2012, DIABETES CARE, V35, P2438, DOI 10.2337/dc12-0684; Preis SR, 2009, CIRCULATION, V119, P1728, DOI 10.1161/CIRCULATIONAHA.108.829176; Pries AR, 2008, CARDIOVASC RES, V80, P165, DOI 10.1093/cvr/cvn136; Quinones MJ, 2004, ANN INTERN MED, V140, P700, DOI 10.7326/0003-4819-140-9-200405040-00009; Rosenson RS, 2011, ATHEROSCLEROSIS, V218, P13, DOI 10.1016/j.atherosclerosis.2011.06.029; Sade LE, 2009, ATHEROSCLEROSIS, V204, P580, DOI 10.1016/j.atherosclerosis.2008.09.038; Sara JD, 2015, JACC-CARDIOVASC INTE, V8, P1445, DOI 10.1016/j.jcin.2015.06.017; Shaw LJ, 2008, CIRCULATION, V117, P1787, DOI 10.1161/CIRCULATIONAHA.107.726562; Sicari R, 2009, AM J CARDIOL, V103, P626, DOI 10.1016/j.amjcard.2008.10.033; STEINBERG HO, 1994, J CLIN INVEST, V94, P1172, DOI 10.1172/JCI117433; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; VANTRAIN KF, 1994, J NUCL MED, V35, P609; WARRAM JH, 1990, ANN INTERN MED, V113, P909, DOI 10.7326/0003-4819-113-12-909; Wessel TR, 2007, CLIN CARDIOL, V30, P69, DOI 10.1002/clc.19; Westergren HU, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130648; Wittfeldt A, 2013, J AM COLL CARDIOL, V61, P723, DOI 10.1016/j.jacc.2012.11.032	40	3	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176511	10.1371/journal.pone.0176511	http://dx.doi.org/10.1371/journal.pone.0176511			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448601	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383600091
J	Gardner, KAJA; Osawa, M; Erickson, HP				Gardner, Kiani A. J. Arkus; Osawa, Masaki; Erickson, Harold P.			Whole genome re-sequencing to identify suppressor mutations of mutant and foreign Escherichia coli FtsZ	PLOS ONE			English	Article							CELL-DIVISION PROTEINS; Z-RING; BACTERIAL CYTOKINESIS; MEMBRANE; GENE; CHROMOSOMES; MATURATION; GROWTH; DOMAIN; ZIPA	FtsZ is an essential protein for bacterial cell division, where it forms the cytoskeletal scaffold and may generate the constriction force. We have found previously that some mutant and foreign FtsZ that do not complement an ftsZ null can function for cell division in E. coli upon acquisition of a suppressor mutation somewhere in the genome. We have now identified, via whole genome re-sequencing, single nucleotide polymorphisms in 11 different suppressor strains. Most of the mutations are in genes of various metabolic pathways, which may modulate cell division indirectly. Mutations in three genes, ispA, accD and nlpI, may be more directly involved in cell division. In addition to the genomic suppressor mutations, we identified intragenic suppressors of three FtsZ point mutants (R174A, E250K and L272V).	[Gardner, Kiani A. J. Arkus; Osawa, Masaki; Erickson, Harold P.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University	Erickson, HP (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	h.erickson@cellbio.duke.edu		Erickson, Harold/0000-0002-9104-8987	NIH [R01 GM66014, F31 GM090677]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066014] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant R01 GM66014 to HPE and F31 GM090677 to KAJAG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsman MEG, 2005, MOL MICROBIOL, V55, P1631, DOI 10.1111/j.1365-2958.2005.04502.x; Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; Buddelmeijer N, 2004, MOL MICROBIOL, V52, P1315, DOI 10.1111/j.1365-2958.2004.04044.x; Buddelmeijer N, 2002, CURR OPIN MICROBIOL, V5, P553, DOI 10.1016/S1369-5274(02)00374-0; DAI K, 1991, J BACTERIOL, V173, P3500, DOI 10.1128/jb.173.11.3500-3506.1991; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; FUJISAKI S, 1990, J BIOCHEM-TOKYO, V108, P995, DOI 10.1093/oxfordjournals.jbchem.a123327; Haeusser DP, 2015, MOL MICROBIOL, V97, P988, DOI 10.1111/mmi.13081; Haeusser DP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004217; Haney SA, 2001, J BIOL CHEM, V16, P16; Hayashi K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100049; Hill NS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003663; Hosfield DJ, 2004, J BIOL CHEM, V279, P8526, DOI 10.1074/jbc.C300511200; JOLY A, 1993, J BIOL CHEM, V268, P26983; Kawai Y, 2015, CURR BIOL, V25, P1613, DOI 10.1016/j.cub.2015.04.031; Koppelman CM, 2004, MOL MICROBIOL, V51, P645, DOI 10.1046/j.1365-2958.2003.03876.x; Leaver M, 2009, NATURE, V457, P849, DOI 10.1038/nature07742; Li Y, 2013, SCIENCE, V341, P392, DOI 10.1126/science.1239248; Lu C, 2001, BMC Microbiol, V1, P7, DOI 10.1186/1471-2180-1-7; Lutkenhaus J, 2012, CYTOSKELETON, V69, P778, DOI 10.1002/cm.21054; Ma XL, 1999, J BACTERIOL, V181, P7531, DOI 10.1128/JB.181.24.7531-7544.1999; Mercier R, 2013, CELL, V152, P997, DOI 10.1016/j.cell.2013.01.043; Mingorance J, 2010, TRENDS MICROBIOL, V18, P348, DOI 10.1016/j.tim.2010.06.001; Monahan LG, 2016, TRENDS MICROBIOL, V24, P181, DOI 10.1016/j.tim.2015.11.007; Moore DA, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00553-16; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Ohara M, 1999, J BACTERIOL, V181, P4318, DOI 10.1128/JB.181.14.4318-4325.1999; Osawa M, 2005, MICROBIOL-SGM, V151, P4033, DOI 10.1099/mic.0.28219-0; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Osawa M, 2006, J BACTERIOL, V188, P7132, DOI 10.1128/JB.00647-06; Osawa M, 2013, P NATL ACAD SCI USA, V110, P11000, DOI 10.1073/pnas.1222254110; Pichoff S, 2005, MOL MICROBIOL, V55, P1722, DOI 10.1111/j.1365-2958.2005.04522.x; Pichoff S, 2002, EMBO J, V21, P685, DOI 10.1093/emboj/21.4.685; Redick SD, 2005, J BACTERIOL, V187, P2727, DOI 10.1128/JB.187.8.2727-2736.2005; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shiomi D, 2013, MOL MICROBIOL; Shiomi D, 2011, MICROBIOL IMMUNOL, V55, P885, DOI 10.1111/j.1348-0421.2011.00391.x; Skovgaard O, 2011, GENOME RES, V21, P1388, DOI 10.1101/gr.117416.110; Srivatsan A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000139; Stricker J, 2003, J BACTERIOL, V185, P4796, DOI 10.1128/JB.185.16.4796-4805.2003; Yao ZZ, 2012, P NATL ACAD SCI USA, V109, pE2561, DOI 10.1073/pnas.1209742109	43	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176643	10.1371/journal.pone.0176643	http://dx.doi.org/10.1371/journal.pone.0176643			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445510	Green Published, Green Submitted, gold			2022-12-26	WOS:000400309200077
J	Yang, WT; Gao, F; Zhang, P; Pang, SC; Cui, YH; Liu, LX; Wei, GH; Yan, B				Yang, Wentao; Gao, Feng; Zhang, Pei; Pang, Shuchao; Cui, Yinghua; Liu, Lixin; Wei, Guanghe; Yan, Bo			Functional genetic variants within the SIRT2 gene promoter in acute myocardial infarction	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; OXIDATIVE STRESS; HISTONE DEACETYLASE; TUMOR-SUPPRESSOR; MICROTUBULE INHIBITORS; CARDIOVASCULAR-DISEASE; CALORIC RESTRICTION; PARKINSONS-DISEASE; ENDOTHELIAL-CELLS; MITOTIC ARREST	Coronary artery disease (CAD), including acute myocardial infarction (AMI) is the complication of atherosclerosis. Recently, genome-wide association studies have identified a large number of CAD-related genetic variants. However, only 10% of CAD cases could be explained. Low frequent and rare genetic variants have been recently proposed to be main causes for CAD. SIRT2 is a member of sirtuin family, NAD(+)-dependent class III deacetylases. SIRT2 is involved in genomic stability, metabolism, inflammation, oxidative stress and autophagy, as well as in platelet function. Thus, we hypothesized that genetic variants in SIRT2 gene may contribute to AMI. In this study, SIRT2 gene promoter was analyzed in large cohorts of AMI patients (n = 375) and ethnic- matched controls (n = 377). Three novel heterozygous DSVs (g.38900888_ 91delTAAA, g.38900270A>G and g.38899853C>T) were identified in three AMI patients, but in none of controls. These DSVs significantly altered the transcriptional activity of the SIRT2 gene promoter ( P< 0.05) in both HEK-293 and H9c2 cells. Five novel heterozygous DSVS (g.38900562C>T, g.38900413A>C, g.38900030G>A, g.38899925A>C and g.38899852C>T) were only found in controls, which did not significantly affected SIRT2 gene promoter activity (P>0.05). In addition, four novel heterozygous DSVs and five SNPs were found in both AMI patients and control with similar frequencies (P>0.05), two SNPs of which were examined and did not affect SIRT2 gene promoter activity (P>0.05). Taken together, the DSVs identified in AMI patients may change SIRT2 level by affecting the transcriptional activity of SIRT2 gene promoter, contributing to the AMI development as a rare risk factor.	[Yang, Wentao; Gao, Feng] Shandong Univ, Dept Med, Sch Med, Jinan, Shandong, Peoples R China; [Zhang, Pei] Xinxiang Med Univ, Coll Clin Med, Xinxiang, Henan, Peoples R China; [Pang, Shuchao; Yan, Bo] Jining Med Univ, Shandong Prov Key Lab Cardiac Dis Diag & Treatmen, Affiliated Hosp, Jining, Shandong, Peoples R China; [Cui, Yinghua; Liu, Lixin; Wei, Guanghe] Jining Med Univ, Div Cardiol, Affiliated Hosp, Jining, Shandong, Peoples R China; [Yan, Bo] Jining Med Univ, Shandong Prov SinoUS Cooperat Res Ctr Translat Me, Affiliated Hosp, Jining, Shandong, Peoples R China	Shandong University; Xinxiang Medical University; Jining Medical University; Jining Medical University; Jining Medical University	Yan, B (corresponding author), Jining Med Univ, Shandong Prov Key Lab Cardiac Dis Diag & Treatmen, Affiliated Hosp, Jining, Shandong, Peoples R China.; Yan, B (corresponding author), Jining Med Univ, Shandong Prov SinoUS Cooperat Res Ctr Translat Me, Affiliated Hosp, Jining, Shandong, Peoples R China.	yanbo@mail.jnmc.edu.cn	Pang, Shuchao/H-7951-2013	Pang, Shuchao/0000-0003-0495-4250; Yan, Bo/0000-0003-1391-5683	National Natural Science Foundation of China [81370271, 81670341, 81400291]; Shandong Taishan Scholar Program, China [tshw201502063]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Taishan Scholar Program, China	Financial Support from this study was recieved from the National Natural Science Foundation of China (grants 81370271, 81670341, and 81400291) and the Shandong Taishan Scholar Program, China tshw201502063 to Dr. Bo Yan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar G, 1999, GENE, V234, P161, DOI 10.1016/S0378-1119(99)00162-6; Anwar T, 2016, CELL CYCLE, V15, P1883, DOI 10.1080/15384101.2016.1189041; Assimes TL, 2016, J AM COLL CARDIOL, V68, P2797, DOI 10.1016/j.jacc.2016.10.039; Bae NS, 2004, J BIOCHEM, V135, P695, DOI 10.1093/jb/mvh084; Bjorkegren JLM, 2015, J AM COLL CARDIOL, V65, P830, DOI 10.1016/j.jacc.2014.12.033; Black JC, 2008, MOL CELL, V32, P449, DOI 10.1016/j.molcel.2008.09.018; Budayeva HG, 2016, MOL CELL PROTEOMICS, V15, P3107, DOI 10.1074/mcp.M116.061333; Choi JE, 2014, CURR OPIN GENET DEV, V26, P24, DOI 10.1016/j.gde.2014.05.005; Connelly MA, 2016, TRANSL RES, V173, P7, DOI 10.1016/j.trsl.2016.01.006; Correia M, 2017, BBA-GEN SUBJECTS, V1861, P3444, DOI 10.1016/j.bbagen.2016.09.008; Crocco P, 2016, J GERONTOL A-BIOL, V71, P586, DOI 10.1093/gerona/glv058; Crujeiras AB, 2008, EUR J CLIN INVEST, V38, P672, DOI 10.1111/j.1365-2362.2008.01998.x; Cui YH, 2012, BIOCHEM BIOPH RES CO, V426, P232, DOI 10.1016/j.bbrc.2012.08.071; Donmez G, 2013, EMBO MOL MED, V5, P344, DOI 10.1002/emmm.201302451; Eskandarian HA, 2013, SCIENCE, V341, P525, DOI 10.1126/science.1238858; Ferguson BS, 2015, J MOL CELL CARDIOL, V83, P14, DOI 10.1016/j.yjmcc.2015.03.010; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Gal J, 2012, NEUROCHEM INT, V61, P992, DOI 10.1016/j.neuint.2012.07.010; Gatica D, 2015, CIRC RES, V116, P456, DOI 10.1161/CIRCRESAHA.114.303788; German NJ, 2015, CURR BIOL, V25, pR569, DOI 10.1016/j.cub.2015.05.012; Giblin W, 2014, TRENDS GENET, V30, P271, DOI 10.1016/j.tig.2014.04.007; Gomes P, 2015, TRENDS PHARMACOL SCI, V36, P756, DOI 10.1016/j.tips.2015.08.001; Grbesa I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124670; Haketa A, 2013, TRANSL RES, V161, P57, DOI 10.1016/j.trsl.2012.07.002; Hall JA, 2013, J CLIN INVEST, V123, P973, DOI 10.1172/JCI64094; Hashimoto-Komatsu A, 2011, HYPERTENS RES, V34, P949, DOI 10.1038/hr.2011.64; Hong SK, 2014, J BIOL CHEM, V289, P13132, DOI 10.1074/jbc.M113.520734; Inoue T, 2007, CELL CYCLE, V6, P1011, DOI 10.4161/cc.6.9.4219; Inoue T, 2014, FEBS J, V281, P2623, DOI 10.1111/febs.12810; Inoue T, 2009, CELL CYCLE, V8, P1279, DOI 10.4161/cc.8.8.8245; Jin YH, 2008, BIOCHEM BIOPH RES CO, V368, P690, DOI 10.1016/j.bbrc.2008.01.114; Jing EX, 2007, CELL METAB, V6, P105, DOI 10.1016/j.cmet.2007.07.003; Kaufmann T, 2016, SIRT2 REGULATES NUCL, V129, P4607; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; Kim MJ, 2013, FREE RADICAL BIO MED, V63, P432, DOI 10.1016/j.freeradbiomed.2013.06.005; Krishnan J, 2012, GENE DEV, V26, P259, DOI 10.1101/gad.180406.111; Kumari S, 2015, J BIOL CHEM, V290, P12290, DOI 10.1074/jbc.M114.615948; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Lettre G, 2014, J MED GENET, V51, P705, DOI 10.1136/jmedgenet-2014-102437; Li SZ, 2016, AM J TRANSL RES, V8, P993; Lin RT, 2013, MOL CELL, V51, P506, DOI 10.1016/j.molcel.2013.07.002; Liu G, 2016, ANTIOXID REDOX SIGNA; Liu JN, 2013, INT J MOL SCI, V14, P5633, DOI 10.3390/ijms14035633; Lorenzen JM, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0245-9; Luna B, 2015, MOL NEUROBIOL, V52, P1341, DOI 10.1007/s12035-014-8930-3; Luthi-Carter R, 2010, P NATL ACAD SCI USA, V107, P7927, DOI 10.1073/pnas.1002924107; Lynn EG, 2008, FEBS LETT, V582, P2857, DOI 10.1016/j.febslet.2008.07.016; Matsushima S, 2015, AM J PHYSIOL-HEART C, V309, pH1375, DOI 10.1152/ajpheart.00053.2015; McGlynn LM, 2014, EUR J CANCER, V50, P290, DOI 10.1016/j.ejca.2013.10.005; McLendon PM, 2014, P NATL ACAD SCI USA, V111, pE5178, DOI 10.1073/pnas.1415589111; McPherson R, 2016, CIRC RES, V118, P564, DOI 10.1161/CIRCRESAHA.115.306566; Mortuza R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054514; Moscardo A, 2015, J THROMB HAEMOST, V13, P1335, DOI 10.1111/jth.13004; Naini SM, 2015, MOL CELL BIOL, V35, P3768, DOI 10.1128/MCB.00184-15; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; North BJ, 2014, EMBO J, V33, P1438, DOI 10.15252/embj.201386907; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Pandithage R, 2008, J CELL BIOL, V180, P915, DOI 10.1083/jcb.200707126; Park JM, 2015, SCI REP-UK, V5, DOI 10.1038/srep17395; Park SH, 2016, CANCER RES, V76, P3802, DOI 10.1158/0008-5472.CAN-15-2498; Pillai VB, 2014, CIRC RES, V114, P368, DOI 10.1161/CIRCRESAHA.113.300536; Puthanveetil P, 2013, CARDIOVASC RES, V97, P393, DOI 10.1093/cvr/cvs426; Roos CM, 2013, AM J PHYSIOL-HEART C, V305, pH1428, DOI 10.1152/ajpheart.00735.2012; Rothgiesser KM, 2010, J CELL SCI, V123, P4251, DOI 10.1242/jcs.073783; Sebastian C, 2015, SEMIN CELL DEV BIOL, V43, P33, DOI 10.1016/j.semcdb.2015.07.008; Serrano L, 2013, GENE DEV, V27, P639, DOI 10.1101/gad.211342.112; Suematsu T, 2014, BIOCHEM BIOPH RES CO, V453, P588, DOI 10.1016/j.bbrc.2014.09.128; Theendakara V, 2013, P NATL ACAD SCI USA, V110, P18303, DOI 10.1073/pnas.1314145110; Vaquero A, 2006, GENE DEV, V20, P1256, DOI 10.1101/gad.1412706; Vijg J, 2013, ANNU REV PHYSIOL, V75, P645, DOI 10.1146/annurev-physiol-030212-183715; Voelter-Mahlknecht S, 2005, INT J ONCOL, V27, P1187; Wang F, 2007, AGING CELL, V6, P505, DOI 10.1111/j.1474-9726.2007.00304.x; Wang LK, 2016, GENET TEST MOL BIOMA, V20, P185, DOI 10.1089/gtmb.2015.0188; Wang XF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160431; Wang YP, 2014, EMBO J, V33, P1304, DOI 10.1002/embj.201387224; Wei WJ, 2014, NEUROMOL MED, V16, P448, DOI 10.1007/s12017-014-8291-0; Winnik S, 2015, EUR HEART J, V36, P3404, DOI 10.1093/eurheartj/ehv290; Xu YP, 2014, CANCER RES, V74, P3630, DOI 10.1158/0008-5472.CAN-13-3615; Yin XY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153815; Yu W, 2014, MOL MED REP, V9, P1218, DOI 10.3892/mmr.2014.1944; Yuan F, 2016, J NEUROCHEM, V136, P581, DOI 10.1111/jnc.13423; Yuan J, 2009, CELL CYCLE, V8, P1747, DOI 10.4161/cc.8.11.8620; Yuan Q, 2015, EUR J PHARMACOL, V764, P554, DOI 10.1016/j.ejphar.2015.07.045; Yudoh Kazuo, 2015, Curr Aging Sci, V8, P256; Zhang H, 2013, P NATL ACAD SCI USA, V110, P13546, DOI 10.1073/pnas.1301463110; Zhao D, 2013, CANCER CELL, V23, P464, DOI 10.1016/j.ccr.2013.02.005; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069; Zitta K, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0403-6	88	16	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176245	10.1371/journal.pone.0176245	http://dx.doi.org/10.1371/journal.pone.0176245			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445509	Green Published, gold, Green Submitted			2022-12-26	WOS:000400309200041
J	Lal, B; Gautam, P; Panda, BB; Raja, R; Singh, T; Tripathi, R; Shahid, M; Nayak, AK				Lal, B.; Gautam, Priyanka; Panda, B. B.; Raja, R.; Singh, Teekam; Tripathi, R.; Shahid, M.; Nayak, A. K.			Crop and varietal diversification of rainfed rice based cropping systems for higher productivity and profitability in Eastern India	PLOS ONE			English	Article							CLIMATE-CHANGE; MATTER; OPPORTUNITIES; ADAPTATION; STRATEGIES; GROWTH; YIELDS; AREAS; GRAIN	Rice-rice system and rice fallows are no longer productive in Southeast Asia. Crop and varietal diversification of the rice based cropping systems may improve the productivity and profitability of the systems. Diversification is also a viable option to mitigate the risk of climate change. In Eastern India, farmers cultivate rice during rainy season (June-September) and land leftovers fallow after rice harvest in the post-rainy season (November-May) due to lack of sufficient rainfall or irrigation amenities. However, in lowland areas, sufficient residual soil moistures are available in rice fallow in the post-rainy season (November-March), which can be utilized for raising second crops in the region. Implementation of suitable crop/varietal diversification is thus very much vital to achieve this objective. To assess the yield performance of rice varieties under timely and late sown conditions and to evaluate the performance of dry season crops following them, three different duration rice cultivars were transplanted in July and August. In dry season several non-rice crops were sown in rice fallow to constitute a cropping system. The results revealed that tiller occurrence, biomass accumulation, dry matter remobilization, crop growth rate, and ultimately yield were significantly decreased under late transplanting. On an average, around 30% yield reduction obtained under late sowing may be due to low temperature stress and high rainfall at reproductive stages of the crop. Dry season crops following short duration rice cultivars performed better in terms of grain yield. In the dry season, toria was profitable when sown earlier and if sowing was delayed greengram was suitable. Highest system productivity and profitability under timely sown rice may be due to higher dry matter remobilization from source to sink. A significant correlation was observed between biomass production and grain yield. We infer that late transplanting decrease the tiller occurrence and assimilate remobilization efficiency, which may be responsible for the reduced grain yield.	[Lal, B.; Gautam, Priyanka; Panda, B. B.; Raja, R.; Tripathi, R.; Shahid, M.; Nayak, A. K.] ICAR Natl Rice Res Inst, Crop Prod Div, Cuttack, Orissa, India; [Singh, Teekam] RRLRRS, Gerua, Assam, India	Indian Council of Agricultural Research (ICAR); ICAR - National Rice Research Institute	Lal, B (corresponding author), ICAR Natl Rice Res Inst, Crop Prod Div, Cuttack, Orissa, India.	blalsgnr@gmail.com	Lal, B./ABC-1426-2020; Gautam, Priyanka/AAU-3483-2021; Shahid, Dr Mohammad/F-4359-2015	Nayak, A. K./0000-0002-2257-3243; Shahid, Dr Mohammad/0000-0001-6961-2708				Ahmadi A., 2004, Iranian Journal of Agricultural Sciences, V35, P921; Cassman KG, 1996, PLANT SOIL, V182, P267, DOI 10.1007/BF00029058; Chen CB, 2007, J AGROTECH EC, V1, P48; Davis AS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047149, 10.1371/journal.pone.0047981]; Gebrehiwot T, 2013, ENVIRON MANAGE, V52, P1; Ghosh D. C., 1998, Environment and Ecology, V16, P446; Hassan Gul, 2003, Scientific Khyber, V16, P129; Hossain M, 1997, SYST APPR S, V5, P263; Kabisch N, 2016, ECOL SOC, V21, DOI 10.5751/ES-08373-210239; Kar G, 2004, AGR WATER MANAGE, V67, P47, DOI 10.1016/j.agwat.2003.12.005; Kirchhof G, 2000, SOIL TILL RES, V56, P51, DOI 10.1016/S0167-1987(00)00122-7; Kumari BP, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031133; Liu Q. H., 2015, PLOS ONE, V10; Magor N.P., 1984, THESIS U SYDNEY SYDN, P3; Masutomi Y, 2009, AGR ECOSYST ENVIRON, V131, P281, DOI 10.1016/j.agee.2009.02.004; Matsushima S., 1966, P CROP SCI SOC JPN, V34, P478; MoA, 2013, REP EXP GROUP PULS, P9; Mujeri MK, 2012, GLOBAL RES CAPACITY, V8, P389; Nahar K, 2009, ACAD J PLANT SCI, V2, P132; Olekar J. N., 2000, Karnataka Journal of Agricultural Sciences, V13, P897; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; Ramanathan V, 2005, P NATL ACAD SCI USA, V102, P5326, DOI 10.1073/pnas.0500656102; Rashid MH, 2012, INT C ENV AGR FOOD S, P13; Rotter R, 1999, CLIMATIC CHANGE, V43, P651, DOI 10.1023/A:1005541132734; Samant TK, 2015, J AGR FORESTRY ENV S, V1, P13; Singh AK, 2014, RICE SCI, V21, P299, DOI 10.1016/S1672-6308(13)60190-0; Subbarao G.V., 2001, SPATIAL DISTRIBUTION, P316; Sun YF, 1995, CHINA RICE, V5, P38; Wassmann R, 2009, ADV AGRON, V101, P59, DOI 10.1016/S0065-2113(08)00802-X; Xiong J, 2013, AGRON J, V105, P1142, DOI 10.2134/agronj2012.0297; Yang JC, 2002, CROP SCI, V42, P766, DOI 10.2135/cropsci2002.0766; YOSHIDA S, 1981, FUNDAMENTALS RICE CR, P267; Yoshida S, 1978, RES PAPER SERIES, V20; Zentner RP, 2002, AGRON J, V94, P216, DOI 10.2134/agronj2002.0216	34	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e017570	10.1371/journal.pone.0175709	http://dx.doi.org/10.1371/journal.pone.0175709			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437487	Green Published, Green Submitted, gold			2022-12-26	WOS:000400287600010
J	Phoompoung, P; Ankasekwinai, N; Pithukpakorn, M; Foongladda, S; Umrod, P; Suktitipat, B; Mahasirimongkol, S; KiertiburanakuI, S; Suputtamongkoll, Y				Phoompoung, Pakpoom; Ankasekwinai, Nasikarn; Pithukpakorn, Manop; Foongladda, Suporn; Umrod, Pinklow; Suktitipat, Bhoom; Mahasirimongkol, Surakameth; Kiertiburanakul, Sasisopin; Suputtamongkol, Yupin			Factors associated with acquired Anti IFN-gamma autoantibody in patients with nontuberculous mycobacterial infection	PLOS ONE			English	Article							ADULT-ONSET IMMUNODEFICIENCY; AVIUM COMPLEX INFECTION; HIV; THAILAND; TAIWAN	Background The clinical syndrome of disseminated nontuberculous mycobacterial (NTM) infection in patients who were previously healthy is now well recognized to be associated with an acquired autoantibody to Interferon gamma (Anti IFN-gamma autoantibody). However, the risk factors of this syndrome remain unknown. Method We performed an unmatched case control study among patients with NTM diseases who were diagnosed and treated at Siriraj Hospital, Bangkok, Thailand. Anti-IFN autoantibody was detected by enzyme-linked immunosorbent assay (ELISA) method. Cases were patients with NTM diseases and detectable anti IFN-gamma autoantibody. Controls were randomly selected from those with undetectable anti IFN-gamma autoantibody. Data from both groups including demographic data, clinical presentation, laboratory results, other risk factors and HLA genotypes were collected. Univariate and multivariate analyses were performed to identify independent risk factors for this syndrome. Results 70 cases (mean age 50 +/- 11 years) and 70 controls (mean age 58 +/- 18 years) were enrolled into the study. Mycobacterial abscessus was the most common NTM pathogen found in both groups (72.9% in cases and 41.4% in controls respectively). However, disseminated NTM disease was significantly more common in cases (92.9%) than in the controls (14.3%, p<0.001). Binary logistic regression analysis showed that previous OIs (adjusted OR14.87, 95% CI 2.36-93.86), birthplace outside Central region (adjusted OR 19.19, 95% CI 3.86-95.35), lack of comorbidities lead to immunosuppression, such as HIV infection or diabetes mellitus (adjusted OR 23.68, 95% CI 4.01-139.94), and presence of HLA DRB1*15/16 (adjusted OR 153.28, 95% CI 16.87-139.88) were independent factors associated with this syndrome. Conclusion Patients with NTM disease associated with anti IFN-gamma autoantibody are almost always previously healthy and HIV negative. Most of these patients presented with disseminated NTM disease with generalized lymphadenitis and often with reactive skin lesions. Factors associated with detectable anti IFN-gamma autoantibody are HLA-DRB1 and DQB1 alleles, and history of previous OIs in patients without comorbidity that leads to immunosuppression. Further studies are needed to better understand these associations and to improve the treatment outcome.	[Phoompoung, Pakpoom; Ankasekwinai, Nasikarn; Pithukpakorn, Manop; Suputtamongkol, Yupin] Mahidol Univ, Siriraj Hosp, Dept Med, Fac Med, Bangkok, Thailand; [Foongladda, Suporn] Mahidol Univ, Siriraj Hosp, Dept Microbiol, Fac Med, Bangkok, Thailand; [Umrod, Pinklow] Mahidol Univ, Siriraj Hosp, Dept Immunol, Fac Med, Bangkok, Thailand; [Suktitipat, Bhoom] Mahidol Univ, Siriraj Hosp, Dept Biochem, Fac Med, Bangkok, Thailand; [Mahasirimongkol, Surakameth] Minist Publ Hlth, Dept Med Sci, Nonthaburi, Thailand; [Kiertiburanakul, Sasisopin] Mahidol Univ, Ramathibodi Hosp, Dept Med, Fac Med, Bangkok, Thailand	Mahidol University; Mahidol University; Mahidol University; Mahidol University; Ministry of Public Health - Thailand; Mahidol University	Suputtamongkoll, Y (corresponding author), Mahidol Univ, Siriraj Hosp, Dept Med, Fac Med, Bangkok, Thailand.	yupin.sup@mahidol.ac.th	Pithukpakorn, Manop/K-9825-2013; Suktitipat, Bhoom/H-4239-2019	Pithukpakorn, Manop/0000-0003-3611-5718; Suktitipat, Bhoom/0000-0001-8034-7757	Siriraj Research Development Grant [R015634003]; National Science and Technology Development Agency Grant [P-13-00374]; Siriraj Core Research Facility (SiCRF) Grant; Siriraj Chalermphrakiat Grant	Siriraj Research Development Grant; National Science and Technology Development Agency Grant; Siriraj Core Research Facility (SiCRF) Grant; Siriraj Chalermphrakiat Grant	This work was supported by Siriraj Research Development Grant, Grant No. R015634003 (http://www.si.mahidol.ac.th/th/research-academics/research/en_wijai.asp) and National Science and Technology Development Agency Grant, Grant No. P-13-00374 (http://www.nstda.or.th) to YS; Siriraj Core Research Facility (SiCRF) Grant to MP; and Siriraj Chalermphrakiat Grant to PP, MP, NA, BS, SF and YS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Browne SK, 2012, NEW ENGL J MED, V367, P725, DOI 10.1056/NEJMoa1111160; Chan JFW, 2013, DERMATOLOGY, V226, P157, DOI 10.1159/000347112; Chetchotisakd P, 2007, CLIN INFECT DIS, V45, P421, DOI 10.1086/520030; Chetchotisakd P, 2014, SE ASIAN J TROP MED, V45, P1125; Chi CY, 2013, BLOOD, V121, P1357, DOI 10.1182/blood-2012-08-452482; Fitness J, 2002, GENES IMMUN, V3, P441, DOI 10.1038/sj.gene.6363926; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Honda JR, 2015, CLIN CHEST MED, V36, P1, DOI 10.1016/j.ccm.2014.10.001; Kampitak T, 2011, INFECTION, V39, P65, DOI 10.1007/s15010-010-0067-3; Ku CL, 2016, J ALLERGY CLIN IMMUN, V137, P945, DOI 10.1016/j.jaci.2015.09.018; Lai CC, 2006, J INFECTION, V53, P77, DOI 10.1016/j.jinf.2005.10.009; LeBlanc SB, 2000, TISSUE ANTIGENS, V55, P17, DOI 10.1034/j.1399-0039.2000.550103.x; Pithukpakorn M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128481; Romphruk AV, 2010, TISSUE ANTIGENS, V75, P701, DOI 10.1111/j.1399-0039.2010.01448.x; Rossi M, 2001, SWISS MED WKLY, V131, P471; Smith GS, 2016, J INFECTION, V72, P678, DOI 10.1016/j.jinf.2016.03.008; Wongkulab P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076371	17	24	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176342	10.1371/journal.pone.0176342	http://dx.doi.org/10.1371/journal.pone.0176342			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437431	Green Published, gold, Green Submitted			2022-12-26	WOS:000400287600043
J	Yoshioka, M; Iehisa, JCM; Ohno, R; Kimura, T; Enoki, H; Nishimura, S; Nasuda, S; Takumi, S				Yoshioka, Motohiro; Iehisa, Julio C. M.; Ohno, Ryoko; Kimura, Tatsuro; Enoki, Hiroyuki; Nishimura, Satoru; Nasuda, Shuhei; Takumi, Shigeo			Three dominant awnless genes in common wheat: Fine mapping, interaction and contribution to diversity in awn shape and length	PLOS ONE			English	Article							SEED DISPERSAL; BARLEY; MAP; RESISTANCE; GENOME; GRAIN; CHROMOSOME; GENETICS; PROTEIN; SPIKES	The awn is a long needle-like structure formed at the tip of the lemma in the florets of some grass species. It plays a role in seed dispersal and protection against animals, and can contribute to the photosynthetic activity of spikes. Three main dominant inhibitors of awn development (Hd, B1 and B2) are known in hexaploid wheat, but the causal genes have not been cloned yet and a genetic association with awn length diversity has been found only for the B1 allele. To analyze the prevalence of these three awning inhibitors, we attempted to predict the genotypes of 189 hexaploid wheat varieties collected worldwide using markers tightly linked to these loci. Using recombinant inbred lines derived from two common wheat cultivars, Chinese Spring and Mironovskaya 808, both with short awns, and a high-density linkage map, we performed quantitative trait locus analysis to identify tightly linked markers. Because this linkage map was constructed with abundant array-based markers, we converted the linked markers to PCR-based markers and determined the genotypes of 189 hexaploids. A significant genotype-phenotype correlation was observed at the Hd and B1 regions. We also found that interaction among these three awning inhibitors is involved in development of a membranous outgrowth at the base of awn resembling the Hooded mutants of barley. For the hooded awn phenotype, presence of the Hd dominant allele was essential but not sufficient, so B2 and other factors appear to act epistatically to produce the ectopic tissue. On the other hand, the dominant B1 allele acted as a suppressor of the hooded phenotype. These three awning inhibitors largely contribute to the genetic variation in awn length and shape of common wheat.	[Yoshioka, Motohiro; Takumi, Shigeo] Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo, Japan; [Iehisa, Julio C. M.] Univ Nacl Asuncion, Fac Ciencias Quim, Dept Biotechnol, San Lorenzo, Paraguay; [Ohno, Ryoko] Kobe Univ, Grad Sch Sci Technol & Innovat, Kobe, Hyogo, Japan; [Kimura, Tatsuro; Enoki, Hiroyuki] Toyota Motor Co Ltd, Biotechnol & Afforestat Lab, New Business Planning Div, Miyoshi, Aichi, Japan; [Nishimura, Satoru] Toyota Motor Co Ltd, Frontier Res Planning Dept, Frontier Res Ctr, Toyota, Aichi, Japan; [Nasuda, Shuhei] Kyoto Univ, Grad Sch Agr, Kyoto, Japan; [Yoshioka, Motohiro] Kyoto Univ, Grad Sch Agr, Lab Plant Genet, Kyoto, Japan	Kobe University; Universidad Nacional de Asuncion; Kobe University; Toyota Motor Corporation; Toyota Motor Corporation; Kyoto University; Kyoto University	Takumi, S (corresponding author), Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo, Japan.	takumi@kobe-u.ac.jp		Nasuda, Shuhei/0000-0002-9019-8692; Iehisa, Julio/0000-0002-2133-9340	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [16H04862]; Special Coordination Funds for Promoting Science and Technology; Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovative BioProduction Kobe); MEXT, Japan; TOYOTA Motor Corporation	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovative BioProduction Kobe)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); TOYOTA Motor Corporation	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (Grant-in-Aid for Scientific Research (B) No. 16H04862), and by the Special Coordination Funds for Promoting Science and Technology, Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovative BioProduction Kobe), MEXT, Japan. TOYOTA Motor Corporation provides support in the form of salaries for authors [TK, HE, SaN], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bariana HS, 2006, THEOR APPL GENET, V112, P1143, DOI 10.1007/s00122-006-0216-3; Bessho-Uehara K, 2016, P NATL ACAD SCI USA, V113, P8969, DOI 10.1073/pnas.1604849113; Cao LZ, 2016, BREEDING SCI, V66, P260, DOI 10.1270/jsbbs.66.260; Dahlgren R.M.T., 1985, FAMILIES MONOCOTYLED, P520, DOI [10.1007/978-3-642-61663-1, DOI 10.1007/978-3-642-61663-1]; Elbaum R, 2007, SCIENCE, V316, P884, DOI 10.1126/science.1140097; EVANS LT, 1970, AUST J BIOL SCI, V23, P245, DOI 10.1071/BI9700245; EVANS LT, 1972, ANN APPL BIOL, V70, P67, DOI 10.1111/j.1744-7348.1972.tb04689.x; Gervais L, 2003, THEOR APPL GENET, V106, P961, DOI 10.1007/S00122-002-1160-5; Hori K, 2003, THEOR APPL GENET, V107, P806, DOI 10.1007/s00122-003-1342-9; Hua L, 2015, PLANT CELL, V27, P1875, DOI 10.1105/tpc.15.00260; Iehisa JCM, 2014, DNA RES, V21, P555, DOI 10.1093/dnares/dsu020; Kato K, 1998, EUPHYTICA, V101, P91, DOI 10.1023/A:1018372231063; Kobayashi F, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1803-y; Kobayashi F, 2010, THEOR APPL GENET, V121, P629, DOI 10.1007/s00122-010-1335-4; Kofler R, 2007, BIOINFORMATICS, V23, P1683, DOI 10.1093/bioinformatics/btm157; Kosuge K, 2008, EUPHYTICA, V159, P289, DOI 10.1007/s10681-007-9488-1; Lorieux M, 2012, MOL BREEDING, V30, P1231, DOI 10.1007/s11032-012-9706-y; Luo JH, 2013, PLANT CELL, V25, P3360, DOI 10.1105/tpc.113.113589; Luo MC, 2013, P NATL ACAD SCI USA, V110, P7940, DOI 10.1073/pnas.1219082110; Mackay IJ, 2014, G3-GENES GENOM GENET, V4, P1603, DOI 10.1534/g3.114.012963; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; MCDONOUGH WT, 1959, MARYLAND AGR EXP S A, V103, P1; MCINTOSH RA, 1998, P 9 INT WHEAT GEN S, V5, P235; Morimoto R, 2005, PLANT MOL BIOL, V57, P907, DOI 10.1007/s11103-005-3247-2; MULLER KJ, 1995, NATURE, V374, P727, DOI 10.1038/374727a0; Perlitius L, 1903, EINFLUSS BEGRANNUNG; Roig C, 2004, GENETICS, V167, P439, DOI 10.1534/genetics.167.1.439; SEARS ER, 1954, MO AGR EXP STN RES B, P572; SORENSEN AE, 1986, ANNU REV ECOL SYST, V17, P443, DOI 10.1146/annurev.es.17.110186.002303; Sourdille P, 2002, PLANT BREEDING, V121, P320, DOI 10.1046/j.1439-0523.2002.728336.x; Sourdille Pierre, 2004, Functional & Integrative Genomics, V4, P12, DOI 10.1007/s10142-004-0106-1; STEBBINS GL, 1966, GENETICS, V54, P727; TAKAHASHI N, 1986, Reports of the Institute for Agricultural Research Tohoku University, V35, P21; TAKAHASHI R., 1953, Berichte des Ohara Instituts fur Landwirtschaftliche Biologie, Okayama Universitat, V10, P29; Takenaka S, 2014, WHEAT INFORM SERV, V118, P23; Takumi S, 2000, GENE, V249, P171, DOI 10.1016/S0378-1119(00)00164-5; Toriba T, 2014, PLANT J, V77, P616, DOI 10.1111/tpj.12411; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; VERVELDE G. J., 1953, Netherlands Journal of Agricultural Science, V1, P2; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Watkins AE, 1940, J GENET, V40, P243, DOI 10.1007/BF02982493; Yuo T, 2012, J EXP BOT, V63, P5223, DOI 10.1093/jxb/ers182	43	31	37	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176148	10.1371/journal.pone.0176148	http://dx.doi.org/10.1371/journal.pone.0176148			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437453	Green Submitted, Green Published, gold			2022-12-26	WOS:000400287600030
J	Bezan, A; Posch, F; Ploner, F; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Gary, T; Samonigg, H; Beyer, J; Winder, T; Hermanns, T; Fankhauser, CD; Gerger, A; Stotz, M				Bezan, Angelika; Posch, Florian; Ploner, Ferdinand; Bauernhofer, Thomas; Pichler, Martin; Szkandera, Joanna; Hutterer, Georg C.; Pummer, Karl; Gary, Thomas; Samonigg, Hellmut; Beyer, Joerg; Winder, Thomas; Hermanns, Thomas; Fankhauser, Christian D.; Gerger, Armin; Stotz, Michael			Risk stratification for venous thromboembolism in patients with testicular germ cell tumors	PLOS ONE			English	Article							CANCER-PATIENTS; EUROPEAN CONSENSUS; AMERICAN SOCIETY; COMPETING RISKS; CHEMOTHERAPY; DIAGNOSIS; RECOMMENDATIONS; PROPHYLAXIS; THROMBOSIS; GUIDELINE	Background Patients with testicular germ cell tumors (TGCT) have an increased risk for venous thromboembolism (VTE). We identified risk factors for VTE in this patient cohort and developed a clinical risk model. Methods In this retrospective cohort study at the Medical University of Graz we included 657 consecutive TGCT patients across all clinical stages. A predictive model for VTE was developed and externally validated in 349 TGCT patients treated at the University Hospital Zurich. Results Venous thromboembolic events occurred in 34 (5.2%) patients in the Graz cohort. In univariable competing risk analysis, higher clinical stage (cS) and a retroperitoneal lymphadenopathy (RPLN) were the strongest predictors of VTE (p<0.0001). As the presence of a RPLN with more than 5cm in greatest dimension without coexisting visceral metastases is classified as cS IIC, we constructed an empirical VTE risk model with the following four categories (12-month-cumulative incidence): cS IA-B 8/463 patients (1.7%), cS IS-IIB 5/86 patients (5.9%), cS IIC 3/21 patients (14.3%) and cS IIIA-C 15/70 patients (21.4%). This risk model was externally validated in the Zurich cohort (12-month-cumulative incidence): cS IA-B (0.5%), cS IS-IIB (6.0%), cS IIC (11.1%) and cS IIIA-C (19.1%). Our model had a significantly higher discriminatory performance than a previously published classifier (RPLN-VTE-risk-classifier) which is based on the size of RPLN alone (AUC-ROC: 0.75 vs. 0.63, p = 0.007). Conclusions According to our risk stratification, TGCT patients with cS IIC and cS III disease have a very high risk of VTE and may benefit from primary thromboprophylaxis for the duration of chemotherapy.	[Bezan, Angelika; Posch, Florian; Ploner, Ferdinand; Bauernhofer, Thomas; Pichler, Martin; Szkandera, Joanna; Samonigg, Hellmut; Gerger, Armin] Med Univ Graz, Dept Internal Med, Div Clin Oncol, Graz, Austria; [Bezan, Angelika; Posch, Florian; Gerger, Armin; Stotz, Michael] Med Univ Graz, Res Unit Genet Epidemiol & Pharmacogenet, Graz, Austria; [Bauernhofer, Thomas; Gerger, Armin] Ctr Biomarker Res Med CBmed, Graz, Austria; [Pichler, Martin] Univ Texas, MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX USA; [Hutterer, Georg C.; Pummer, Karl] Med Univ Graz, Dept Urol, Graz, Austria; [Gary, Thomas] Med Univ Graz, Dept Internal Med, Div Angiol, Graz, Austria; [Beyer, Joerg; Winder, Thomas] Univ Zurich, Univ Hosp Zurich, Dept Oncol, Zurich, Switzerland; [Hermanns, Thomas; Fankhauser, Christian D.] Univ Zurich, Univ Hosp Zurich, Dept Urol, Zurich, Switzerland	Medical University of Graz; Medical University of Graz; University of Texas System; UTMD Anderson Cancer Center; Medical University of Graz; Medical University of Graz; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Gerger, A (corresponding author), Med Univ Graz, Dept Internal Med, Div Clin Oncol, Graz, Austria.; Gerger, A (corresponding author), Med Univ Graz, Res Unit Genet Epidemiol & Pharmacogenet, Graz, Austria.; Gerger, A (corresponding author), Ctr Biomarker Res Med CBmed, Graz, Austria.; Fankhauser, CD (corresponding author), Univ Zurich, Univ Hosp Zurich, Dept Urol, Zurich, Switzerland.	christian.fankhauser@usz.ch; armin.gerger@medunigraz.at	Beyer, Joerg/I-9954-2017; Bauernhofer, Thomas/AAF-4905-2020; Fankhauser, Christian Daniel/I-4672-2017	Beyer, Joerg/0000-0003-1755-9700; Fankhauser, Christian Daniel/0000-0002-4073-5488; Pichler, Martin/0000-0002-8701-9462; Posch, Florian/0000-0002-0448-6314; Terbuch, Angelika/0000-0003-2918-1370; Szkandera, Joanna/0000-0002-2217-893X				Agnelli G, 2012, NEW ENGL J MED, V366, P601, DOI 10.1056/NEJMoa1108898; Agnelli G, 2009, LANCET ONCOL, V10, P943, DOI 10.1016/S1470-2045(09)70232-3; Beyer J, 2013, ANN ONCOL, V24, P878, DOI 10.1093/annonc/mds579; Bezan A, 2014, ANTICANCER RES, V34, P2709; Cathomas R, 2010, SWISS MED WKLY, V140, P356, DOI smw-12993; Chaturvedi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094048; Chew HK, 2006, ARCH INTERN MED, V166, P458; Cleves MA, 2002, STATA J, V2, P301, DOI 10.1177/1536867X0200200307; Coviello V, 2004, STATA J, V4, P103, DOI 10.1177/1536867X0400400201; Dignam JJ, 2008, J CLIN ONCOL, V26, P4027, DOI 10.1200/JCO.2007.12.9866; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gary T, 2012, BRIT J CANCER, V107, P1244, DOI 10.1038/bjc.2012.401; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Haugnes HS, 2012, J CLIN ONCOL, V30, P3752, DOI 10.1200/JCO.2012.43.4431; Honecker F, 2013, ONKOLOGIE, V36, P663, DOI 10.1159/000355652; Khorana AA, 2008, BLOOD, V111, P4902, DOI 10.1182/blood-2007-10-116327; Khorana AA, 2009, J CLIN ONCOL, V27, P4839, DOI 10.1200/JCO.2009.22.3271; Kristinsson SY, 2010, HEMATOL-AM SOC HEMAT, P437, DOI 10.1182/asheducation-2010.1.437; Lyman GH, 2007, J CLIN ONCOL, V25, P5490, DOI 10.1200/JCO.2007.14.1283; Lyman GH, 2015, J CLIN ONCOL, V33, P654, DOI 10.1200/JCO.2014.59.7351; Mead GM, 1997, J CLIN ONCOL, V15, P594; Moore RA, 2011, J CLIN ONCOL, V29, P3466, DOI 10.1200/JCO.2011.35.5669; Ozturk C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141244; Posch F, 2016, THROMB HAEMOST; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Rustin GJ, 2007, J CLIN ONCOL, V25, P1310, DOI 10.1200/JCO.2006.08.4889; Schmoll HJ, 2004, ANN ONCOL, V15, P1377, DOI 10.1093/annonc/mdh301; Schmoll HJ, 1999, KOMPENDIUM INTERNIST; Sorensen HT, 2000, NEW ENGL J MED, V343, P1846, DOI 10.1056/NEJM200012213432504; Srikanthan A, 2015, J CLIN ONCOL, V33, P582, DOI 10.1200/JCO.2014.58.6537; Wymer KM, 2017, J UROLOGY, V197, P684, DOI 10.1016/j.juro.2016.09.073	31	30	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0176283	10.1371/journal.pone.0176283	http://dx.doi.org/10.1371/journal.pone.0176283			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430804	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000399876100038
J	Rahman, MM; Lim, UT				Rahman, M. Mahbubur; Lim, Un Taek			Evaluation of mature soybean pods as a food source for two pod-sucking bugs, Riptortus pedestris (Hemiptera: Alydidae) and Halyomorpha halys (Hemiptera: Pentatomidae)	PLOS ONE			English	Article							GREEN STINK BUG; STYLET PENETRATION; SEASONAL ABUNDANCE; HETEROPTERA; YIELD; PERFORMANCE; JACKKNIFE; DYNAMICS; QUALITY; IMPACT	Riptortus pedestris (Fabricius) and Halyomorpha halys (Stal) cause injury to soybeans by piercing and sucking pods and seeds. Growers believe that new damage decreases near to harvest despite the occurrence of these bugs at that time. As this question has never been assessed, we evaluated two diets: a) mature soybean pods (dried shell + dried soybean seeds) and b) dried soybean seeds for the two bugs by assessing their biological, behavioral, and morphological attributes on each diet in laboratory. While nymphs of both species were able to develop and adults able to reproduce on the tested diets, bugs fed on pods had longer development times and 2.2 to 5.0 times higher mortality rates than bugs fed on seeds. Furthermore, adult longevity of R. pedestris and H. halys fed on pods was 8.4 and 7.5 days shorter, respectively, than that of bugs fed on seeds. However, pod feeding had no effect on adult fecundity or egg viability. In a behavioral choice test, adult R. pedestris preferred seeds over pods and probed seeds longer than pods. On average, adult H. halys also preferred seeds over pods, although 15.6% of H. halys showed the reverse, preferring pods over seeds. The proboscis length and estimated depth of stylet penetration into the host tissue of both nymphs and adults of both species was much greater than the thickness of the pod shell, suggesting that mouthpart structure does not explain the negative effects of pods vs. seeds. In conclusion, mature soybean pods were found to be a suitable food source for both R. pedestris and H. halys despite some negative effects, and thus careful attention should be paid to the population levels of these two bugs approaching harvest to reduce economic damage in soybean.	[Rahman, M. Mahbubur] Bangladesh Agr Res Inst, Barisal, Bangladesh; [Lim, Un Taek] Andong Natl Univ, Dept Bioresource Sci, Andong, South Korea; [Lim, Un Taek] Andong Natl Univ, Inst Agr Sci & Technol, Andong, South Korea	Bangladesh Agricultural Research Institute (BARI); Andong National University; Andong National University	Lim, UT (corresponding author), Andong Natl Univ, Dept Bioresource Sci, Andong, South Korea.; Lim, UT (corresponding author), Andong Natl Univ, Inst Agr Sci & Technol, Andong, South Korea.	utlim@andong.ac.kr		Lim, Un Taek/0000-0002-6704-0627	Cooperative Research Program for Agricultural & Technology Development, Rural Development Administration, Republic of Korea [PJ010841092015]	Cooperative Research Program for Agricultural & Technology Development, Rural Development Administration, Republic of Korea	This work was supported by the Cooperative Research Program for Agricultural & Technology Development (Project no. PJ010841092015), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebes-Doria AL, 2016, ENVIRON ENTOMOL, V45, P663, DOI 10.1093/ee/nvw018; Bae SD, 2012, J ASIA-PAC ENTOMOL, V15, P148, DOI 10.1016/j.aspen.2011.09.001; Baur ME, 2000, ENVIRON ENTOMOL, V29, P312, DOI 10.1603/0046-225X(2000)029[0312:APIESP]2.0.CO;2; Bundy CS, 2000, J ECON ENTOMOL, V93, P697, DOI 10.1603/0022-0493-93.3.697; Capeleti I, 2005, SEED SCI TECHNOL, V33, P511, DOI 10.15258/sst.2005.33.2.25; Chung B. K., 1995, J AGR SCI, V37, P376; DAUGHERTY DM, 1964, J ECON ENTOMOL, V57, P719, DOI 10.1093/jee/57.5.719; Do Bae S, 2014, J ASIA-PAC ENTOMOL, V17, P477, DOI 10.1016/j.aspen.2014.04.006; Esquivel JF, 2015, ENVIRON ENTOMOL, V44, P619, DOI 10.1093/ee/nvv027; Esquivel JF, 2011, ENTOMOL EXP APPL, V140, P163, DOI 10.1111/j.1570-7458.2011.01148.x; FEHR W. R., 1977, STAGES SOYBEAN DEV; Hedstrom CS, 2014, J ECON ENTOMOL, V107, P1858, DOI 10.1603/EC14263; Hoebeke ER, 2003, P ENTOMOL SOC WASH, V105, P225; Kang Chang Hoon, 2003, Korean Journal of Applied Entomology, V42, P269; Kim E, 2014, J ASIA-PAC ENTOMOL, V17, P521, DOI 10.1016/j.aspen.2014.04.013; Kim S, 2010, APPL ENTOMOL ZOOL, V45, P457, DOI 10.1303/aez.2010.457; Kim Su Bin, 2015, Korean Journal of Applied Entomology, V54, P121, DOI 10.5656/KSAE.2015.04.0.010; Kimura S, 2008, JPN J APPL ENTOMOL Z, V52, P13, DOI 10.1303/jjaez.2008.13; KOGAN M, 1987, ANNU REV ENTOMOL, V32, P507, DOI 10.1146/annurev.en.32.010187.002451; KONO S, 1989, JPN J APPL ENTOMOL Z, V33, P128, DOI 10.1303/jjaez.33.128; Maia AHN, 2000, J ECON ENTOMOL, V93, P511, DOI 10.1603/0022-0493-93.2.511; MCPHERSON RM, 1979, J ECON ENTOMOL, V72, P188, DOI 10.1093/jee/72.2.188; McPherson RM, 1996, J ENTOMOL SCI, V31, P199, DOI 10.18474/0749-8004-31.2.199; MCPHERSON RM, 1993, J ENTOMOL SCI, V28, P61, DOI 10.18474/0749-8004-28.1.61; MEYER JS, 1986, ECOLOGY, V67, P1156, DOI 10.2307/1938671; Miles P.W., 1972, Advances Insect Physiol, V9, P183, DOI 10.1016/S0065-2806(08)60277-5; MINER FLOYD D., 1966, ARKANSAS EXP STABULL, V708, P1; MORRIS R. F., 1954, CANADIAN JOUR ZOOL, V32, P283, DOI 10.1139/z54-027; Oliveira EDM, 2003, BRAZ ARCH BIOL TECHN, V46, P187, DOI 10.1590/S1516-89132003000200008; PANIZZI AR, 1993, J ECON ENTOMOL, V86, P1088, DOI 10.1093/jee/86.4.1088; Zobiole LHS, 2010, PESTIC BIOCHEM PHYS, V97, P182, DOI 10.1016/j.pestbp.2010.01.004; Santos CH, 1998, ANN ENTOMOL SOC AM, V91, P445, DOI 10.1093/aesa/91.4.445; SAS Institute, 2000, SAS US GUID STAT; SCHUMANN FW, 1982, J ECON ENTOMOL, V75, P748, DOI 10.1093/jee/75.4.748; Sharma A, 2014, B ENTOMOL RES, V104, P117, DOI 10.1017/S0007485313000618; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; SIMPSON SJ, 1982, PHYSIOL ENTOMOL, V7, P325, DOI 10.1111/j.1365-3032.1982.tb00305.x; Son ChangKi, 2000, Korean Journal of Crop Science, V45, P405; TALEKAR NS, 1995, ZOOL STUD, V34, P111; TODD JW, 1974, J ECON ENTOMOL, V67, P421, DOI 10.1093/jee/67.3.421; Todd JW, 1981, P S SOYB SEED QUAL S, P46; Walling LL, 2008, PLANT PHYSIOL, V146, P859, DOI 10.1104/pp.107.113142; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	43	18	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0176187	10.1371/journal.pone.0176187	http://dx.doi.org/10.1371/journal.pone.0176187			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430798	Green Submitted, Green Published, gold			2022-12-26	WOS:000399876100031
J	Cuerda-Galindo, E; Lopez-Munoz, F; Krischel, M; Ley, A				Cuerda-Galindo, Esther; Lopez-Munoz, Francisco; Krischel, Matthis; Ley, Astrid			Study of deaths by suicide of homosexual prisoners in Nazi Sachsenhausen concentration camp	PLOS ONE			English	Article							MENTAL-HEALTH; METAANALYSIS; POPULATIONS; INMATES; STRESS; ADULTS; RISK; GAY	Living conditions in Nazi concentration camps were harsh and inhumane, leading many prisoners to commit suicide. Sachsenhausen (Oranienburg, Germany) was a concentration camp that operated from 1936 to 1945. More than 200,000 people were detained there under Nazi rule. This study analyzes deaths classified as suicides by inmates in this camp, classified as homosexuals, both according to the surviving Nazi files. This collective was especially repressed by the Nazi authorities. Data was collected from the archives of Sachsenhausen Memorial and the International Tracing Service in Bad Arolsen. Original death certificates and autopsy reports were reviewed. Until the end of World War II, there are 14 death certificates which state "suicide" as cause of death of prisoners classified as homosexuals, all of them men aged between 23 and 59 years and of various religions and social strata. Based on a population of 1,200 prisoners classified as homosexuals, this allows us to calculate a suicide rate of 1,167/100,000 (over the period of eight years) for this population, a rate 10 times higher than for global inmates (111/100,000). However, our study has several limitations: not all suicides are registered; some murders were covered-up as suicides; most documents were lost during the war or destroyed by the Nazis when leaving the camps and not much data is available from other camps to compare. We conclude that committing suicides in Sachsenhausen was a common practice, although accurate data may be impossible to obtain.	[Cuerda-Galindo, Esther] Rey Juan Carlos Univ, Dept Human Anat & Embryol, Madrid, Spain; [Lopez-Munoz, Francisco] Camilo Jose Cela Univ, Fac Hlth Sci, Madrid, Spain; [Lopez-Munoz, Francisco] Hosp 12 Octubre Res Inst i 12, Neuropsychopharmacol Unit, Madrid, Spain; [Krischel, Matthis] Heinrich Heine Univ Dusseldorf, Inst Hist Philosophy & Eth Med, Dusseldorf, Germany; [Ley, Astrid] Mem & Museum Sachsenhausen, Oranienburg, Germany	Universidad Rey Juan Carlos; Camilo Jose Cela University; Heinrich Heine University Dusseldorf	Lopez-Munoz, F (corresponding author), Camilo Jose Cela Univ, Fac Hlth Sci, Madrid, Spain.; Lopez-Munoz, F (corresponding author), Hosp 12 Octubre Res Inst i 12, Neuropsychopharmacol Unit, Madrid, Spain.	flopez@ucje.edu	López-Muñoz, Francisco/AAA-6933-2019	López-Muñoz, Francisco/0000-0002-5188-6038	Camilo Jose Cela University (II Convocatoria de Ayudas a la Investigacion Competitiva) [UCJC2013-47]	Camilo Jose Cela University (II Convocatoria de Ayudas a la Investigacion Competitiva)	This project was supported by a grant (UCJC2013-47) of the Camilo Jose Cela University (II Convocatoria de Ayudas a la Investigacion Competitiva). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagley C, 1997, Crisis, V18, P24, DOI 10.1027/0227-5910.18.1.24; Biedron R, 2014, PROMEMORIA PERIODICA; Bock G., 2010, ZWANGSSTERILISATION, V2nd; Bronisch T, 1996, ARCH SUICIDE RES, V2, P129, DOI 10.1080/13811119608251963; BRONISCH T, 1995, FORTSCHR NEUROL PSYC, V63, P139, DOI 10.1055/s-2007-996612; Brown P., 2008, PRO MEMORIA, V28, P34; Buge E, 2010, 1470 KZ GEHEIMNISE H; CHODOFF P, 1970, ARCH GEN PSYCHIAT, V22, P78; Clarke DE, 2006, J TRAUMA STRESS, V19, P417, DOI 10.1002/jts.20127; Cuerda-Galindo E, 2016, PSYCHIAT Q; Fazel S, 2008, J CLIN PSYCHIAT, V69, P1721, DOI 10.4088/JCP.v69n1107; Fruhwald S, 2005, LANCET, V366, P1242, DOI 10.1016/S0140-6736(05)67327-8; GILES GJ, 1992, J CONTEMP HIST, V27, P41, DOI 10.1177/002200949202700103; Goeschel C, 2010, J CONTEMP HIST, V45, P628, DOI 10.1177/0022009410366558; Goeschel Christian., 2009, SUICIDE NAZI GERMANY; Goldsmith S.K., 2002, REDUCING SUICIDE NAT; Grau G, 2011, LEXIKON HOMOSEXUELLE; Haas AP, 2010, J HOMOSEXUAL, V58, P10, DOI 10.1080/00918369.2011.534038; Haerberle E, 1980, J HOMOSEXUAL, V6, P135; Hatzenbuehler ML, 2009, PSYCHOL BULL, V135, P707, DOI 10.1037/a0016441; Heger H, 2011, MANNER ROSA WINKEL B; Hess R, 2000, COMMANDANT AUSCHWITZ; Hottes TS, 2016, AM J PUBLIC HEALTH, V106, pE1, DOI 10.2105/AJPH.2016.303088; Jellonnek Burkhard, 1990, HOMOSEXUELLE UNTER H; Jensen EN, 2002, J HIST SEXUALITY, V11, P319, DOI 10.1353/sex.2002.0008; Krischel M, 2011, UROLOGEN NATIONALSOZ, V1, P203; Krischel Matthis, 2014, UROLOGIE NATIONALSOZ; Krysinska K, 2002, POL PSYCHOL B, V33, P21; Krysinska K., 2006, DIALOGUE UNIVERSALIS, V16, P141, DOI [DOI 10.5840/DU2006165/676, 10.5840/du2006165/676]; LAUTMANN R, 1990, J HOMOSEXUAL, V19, P67, DOI 10.1300/J082v19n01_04; LAUTMANN R, 1981, J HOMOSEXUAL, V6, P141, DOI 10.1300/J082v06n01_13; Lester D., 1990, GENET SOC GEN PSYCH, V116, P21; Ley Astrid, 2004, ZWANGSSTERILISATION; Lopez-Munoz F, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00088; Lopez-Munoz F, 2008, BRAIN RES BULL, V77, P388, DOI 10.1016/j.brainresbull.2008.09.002; Meyer IH, 2003, PSYCHOL BULL, V129, P674, DOI 10.1037/0033-2909.129.5.674; Muller J., 2000, HOMOSEXUELLE MANNER; Mussmann O, 1998, GEDENKSTATTENRUNDBRI, V81, P37; Niederkrotenthaler T, 2012, J EPIDEMIOL COMMUN H, V66, P1037, DOI 10.1136/jech-2011-200707; Oosterhuis H, 1997, J CONTEMP HIST, V32, P187, DOI 10.1177/002200949703200204; Oron I, 2012, INT J ENV RES PUB HE, V9, P1927, DOI 10.3390/ijerph9051927; Ploderl M, 2015, INT REV PSYCHIATR, V27, P367, DOI 10.3109/09540261.2015.1083949; Rahe T, 2010, NATIONALSOZIALISTISC; Roll W, 1996, J HOMOSEXUAL, V31, P1, DOI 10.1300/J082v31n04_01; RYN Z, 1986, SUICIDE LIFE-THREAT, V16, P419; Ryn Z, 1983, AM J SOC PSYCHIAT, V3, P32; Stall R., 2008, UNEQUAL OPPORTUNITY; Wieland Gunther, 1993, SYSTEM NS KONZENTRAT; Wienau R, 2005, ORT TERRORS GESCH NA, VI, P165	49	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176007	10.1371/journal.pone.0176007	http://dx.doi.org/10.1371/journal.pone.0176007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KM	28426734	Green Submitted, Green Published, gold			2022-12-26	WOS:000399875900085
J	Lind, T; Ohman, C; Calounova, G; Rasmusson, A; Andersson, G; Pejler, G; Melhus, H				Lind, Thomas; Ohman, Caroline; Calounova, Gabriela; Rasmusson, Annica; Andersson, Goran; Pejler, Gunnar; Melhus, Hakan			Excessive dietary intake of vitamin A reduces skull bone thickness in mice	PLOS ONE			English	Article							RETINOIC ACID; HYPERVITAMINOSIS-A; RECEPTOR ACTIVATOR; TNF-ALPHA; OSTEOCLASTS; RESORPTION; CELLS; OSTEOBLASTS; RANKL; RAT	Calvarial thinning and skull bone defects have been reported in infants with hypervitaminosis A. These findings have also been described in humans, mice and zebrafish with loss-of-function mutations in the enzyme CYP26B1 that degrades retinoic acid (RA), the active metabolite of vitamin A, indicating that these effects are indeed caused by too high levels of vitamin A and that evolutionary conserved mechanisms are involved. To explore these mechanisms, we have fed young mice excessive doses of vitamin A for one week and then analyzed the skull bones using micro computed tomography, histomorphometry, histology and immunohistochemistry. In addition, we have examined the effect of RA on gene expression in osteoblasts in vitro. Compared to a standard diet, a high dietary intake of vitamin A resulted in a rapid and significant reduction in calvarial bone density and suture diastasis. The bone formation rate was almost halved. There was also increased staining of tartrate resistant acid phosphatase in osteocytes and an increased perilacunar matrix area, indicating osteocytic osteolysis. Consistent with this, RA induced genes associated with bone degradation in osteoblasts in vitro. Moreover, and in contrast to other known bone resorption stimulators, vitamin A induced osteoclastic bone resorption on the endocranial surfaces.	[Lind, Thomas; Calounova, Gabriela; Rasmusson, Annica; Melhus, Hakan] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Ohman, Caroline] Uppsala Univ, Div Appl Mat Sci, Dept Engn Sci, Angstrom Lab, Uppsala, Sweden; [Andersson, Goran] Karolinska Univ Hosp Huddinge, Karolinska Inst, Div Pathol, Dept Lab Med, Stockholm, Sweden; [Pejler, Gunnar] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Pejler, Gunnar] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden	Uppsala University; Uppsala University; Karolinska Institutet; Karolinska University Hospital; Uppsala University; Swedish University of Agricultural Sciences	Lind, T (corresponding author), Uppsala Univ, Dept Med Sci, Uppsala, Sweden.	thomas.lind@medsci.ee.se		Rasmusson, Annica/0000-0002-7228-7755; Lind, Thomas/0000-0003-2791-688X; Ohman Magi, Caroline/0000-0003-2709-9541	Svenska Lakaresallskapet and Medicinska for skningsradet	Svenska Lakaresallskapet and Medicinska for skningsradet	This work was supported by the Svenska Lakaresallskapet and Medicinska for skningsradet. The funders had no role in study design,data collection andanalysis,decision to publish,or preparation of the manuscript.	ARENA JM, 1951, PEDIATRICS, V8, P788; BAIR G, 1951, JAMA-J AM MED ASSOC, V146, P1573, DOI 10.1001/jama.1951.03670170027006; Barnicot N, 1956, BIOCHEMISTRY PHYSIOL, P507; Beste LA, 2016, NEW ENGL J MED, V374, P873, DOI 10.1056/NEJMcps1405984; Binkley N, 2000, NUTR REV, V58, P138, DOI 10.1111/j.1753-4887.2000.tb01848.x; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Cackowski FC, 2010, BLOOD, V115, P140, DOI 10.1182/blood-2009-08-237628; Conaway HH, 2009, FASEB J, V23, P3526, DOI 10.1096/fj.09-132548; DELAISSE JM, 1988, ENDOCRINOLOGY, V123, P264, DOI 10.1210/endo-123-1-264; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; DHEM A, 1984, FOOD CHEM TOXICOL, V22, P199, DOI 10.1016/0278-6915(84)90127-3; Erben RG, 2012, METHODS MOL BIOL, V816, P279, DOI 10.1007/978-1-61779-415-5_19; Feskanich D, 2002, JAMA-J AM MED ASSOC, V287, P47, DOI 10.1001/jama.287.1.47; GERBER A, 1954, AM J MED, V16, P729, DOI 10.1016/0002-9343(54)90281-8; Hollberg K, 2008, BONE, V42, P1111, DOI 10.1016/j.bone.2008.01.019; HOUGH S, 1988, ENDOCRINOLOGY, V122, P2933, DOI 10.1210/endo-122-6-2933; Hu LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013305; Itoh K, 2000, J BONE MINER RES, V15, P1766, DOI 10.1359/jbmr.2000.15.9.1766; Jacobson A, 2004, BIOCHEM BIOPH RES CO, V322, P162, DOI 10.1016/j.bbrc.2004.07.092; Jeradi S, 2016, DEVELOPMENT, V143, P1205, DOI 10.1242/dev.129189; Jimi E, 1996, ENDOCRINOLOGY, V137, P2187; JOWSEY J, 1968, J CLIN ENDOCR METAB, V28, P1833, DOI 10.1210/jcem-28-12-1833; Kindle L, 2006, J BONE MINER RES, V21, P193, DOI 10.1359/JBMR.051027; KINDMARK A, 1995, CALCIFIED TISSUE INT, V57, P242, DOI 10.1007/BF00310266; Laue K, 2011, AM J HUM GENET, V89, P595, DOI 10.1016/j.ajhg.2011.09.015; Lieben L, 2012, J CLIN INVEST, V122, P1803, DOI 10.1172/JCI45890; Lind T, 2005, BONE, V36, P408, DOI 10.1016/j.bone.2004.11.008; Lind T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082388; Lind T, 2012, CALCIFIED TISSUE INT, V90, P219, DOI 10.1007/s00223-011-9561-6; Lind T, 2011, BONE, V48, P496, DOI 10.1016/j.bone.2010.10.169; Maclean G, 2009, DEV DYNAM, V238, P732, DOI 10.1002/dvdy.21878; Melhus H, 1998, ANN INTERN MED, V129, P770, DOI 10.7326/0003-4819-129-10-199811150-00003; Melhus H, 2003, NUTR ASPECTS BONE HL, P369; Michaelsson K, 2003, NEW ENGL J MED, V348, P287, DOI 10.1056/NEJMoa021171; MILLER JH, 1985, AM J ROENTGENOL, V144, P767, DOI 10.2214/ajr.144.4.767; Morony S, 1999, J BONE MINER RES, V14, P1478, DOI 10.1359/jbmr.1999.14.9.1478; Muto A, 2011, J BONE MINER RES, V26, P2978, DOI 10.1002/jbmr.490; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; OREFFO ROC, 1988, J BONE MINER RES, V3, P203; PARTRIDGE NC, 1987, ENDOCRINOLOGY, V120, P1956, DOI 10.1210/endo-120-5-1956; PERSSON B, 1965, ACTA PAEDIATR SCAND, V54, P49, DOI 10.1111/j.1651-2227.1965.tb06345.x; Qing H, 2012, J BONE MINER RES, V27, P1018, DOI 10.1002/jbmr.1567; Ramkumar HL, 2016, SURV OPHTHALMOL, V61, P506, DOI 10.1016/j.survophthal.2015.11.007; REYNOLDS J J, 1970, Calcified Tissue Research, V4, P339; Solberg LB, 2015, HISTOCHEM CELL BIOL, V143, P195, DOI 10.1007/s00418-014-1272-4; TOGARI A, 1991, GEN PHARMACOL, V22, P287, DOI 10.1016/0306-3623(91)90450-K; VARGHESE S, 1994, ENDOCRINOLOGY, V134, P2438, DOI 10.1210/en.134.6.2438; WALSH CA, 1991, J BONE MINER RES, V6, P661; WOODARD WK, 1961, J PEDIATR-US, V59, P260, DOI 10.1016/S0022-3476(61)80090-5; Xie H, 2014, NAT MED, V20, P1270, DOI 10.1038/nm.3668; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yamamoto Y, 2006, ENDOCRINOLOGY, V147, P3366, DOI 10.1210/en.2006-0216; ZAMBONINZALLONE A, 1988, J BONE MINER RES, V3, P517	54	12	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176217	10.1371/journal.pone.0176217	http://dx.doi.org/10.1371/journal.pone.0176217			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426756	Green Published, Green Submitted, gold			2022-12-26	WOS:000399875900119
J	McKay, TB; Hjortdal, J; Priyadarsini, S; Karamichos, D				McKay, Tina B.; Hjortdal, Jesper; Priyadarsini, Shrestha; Karamichos, Dimitrios			Acute hypoxia influences collagen and matrix metalloproteinase expression by human keratoconus cells in vitro	PLOS ONE			English	Article							CONTACT-LENS WEAR; FATTY-ACID OXIDATION; MALONYL-COA; CORNEAL THICKNESS; INDUCIBLE FACTOR; STRESS; RESPONSES; OXYGEN; EDEMA; GELATINASE	Keratoconus (KC) is a progressive corneal ectasia linked to thinning of the central cornea. Hard contact lenses, rigid gas permeable lenses, and scleral lenses are the primary treatment modalities for early to mid-stages of KC to correct refractive error and astigmatism that develops as a result of an irregular corneal structure. These treatments are associated with significant drawbacks, including reduced availability of the tear film and oxygen to the corneal epithelium and stroma. However, it remains unknown whether hypoxia affects corneal integrity in the KC pathobiology. A number of studies have associated elevated oxidative stress with KC both in vitro and ex vivo. We hypothesized that KC-derived corneal fibroblasts are more susceptible to hypoxia-induced oxidative stress compared to healthy controls leading to exacerbation of corneal thinning in KC. This study investigated the effects of hypoxia on ECM secretion, assembly, and matrix metalloproteinase (MMP) expression in human corneal fibroblasts from healthy controls (HCFs) and KC patients (HKCs) in vitro. HCFs and HKCs were cultured in 3D constructs for 3 weeks and maintained or transferred to normoxic (21% O-2) or hypoxic (2% O-2) conditions, respectively, for 1 additional week. At the 4 week time-point, constructs were isolated and probed for Collagen I, III, and V, keratocan and MMP-1, -2, -3, -9, and -13, as well as hypoxia markers, hypoxia inducible factor-1a and lactoferrin. Conditioned media was also collected and probed for Collagen I, III, and V by Western blot. Thickness of the ECM assembled by HCFs and HKCs was measured using immunofluorescence microscopy. Results showed that hypoxia significantly reduced Collagen I secretion in HKCs, as well as upregulated the expression of MMP-1 and -2 with no significant effects on MMP-3, -9, or -13. ECM thickness was reduced in both cell types following 1 week in a low oxygen environment. Our study shows that hypoxia influences collagen and MMP expression by HKCs, which may have consequential effects on ECM structure in the context of KC.	[McKay, Tina B.; Karamichos, Dimitrios] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Hjortdal, Jesper] Aarhus Univ Hosp, Dept Ophthalmol, Aarhus, Denmark; [Priyadarsini, Shrestha; Karamichos, Dimitrios] Univ Oklahoma, Hlth Sci Ctr, Dean McGee Eye Inst, Dept Ophthalmol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Aarhus University; University of Oklahoma System; University of Oklahoma Health Sciences Center	Karamichos, D (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA.; Karamichos, D (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dean McGee Eye Inst, Dept Ophthalmol, Oklahoma City, OK 73104 USA.	dimitrios-karamichos@ouhsc.edu		karamichos, dimitrios/0000-0002-8761-3824	Research to Prevent Blindness (New York, NY USA); NEI/DMEI Cellular Imaging Core Facility at OUHSC [NIH: P30EY021725];  [P30EY021725];  [5R01EY023568]; NATIONAL EYE INSTITUTE [P30EY021725, R01EY023568] Funding Source: NIH RePORTER	Research to Prevent Blindness (New York, NY USA)(Research to Prevent Blindness (RPB)); NEI/DMEI Cellular Imaging Core Facility at OUHSC; ; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by P30EY021725, 5R01EY023568 (DK), and an unrestricted grant (DMEI) from Research to Prevent Blindness (New York, NY USA). We acknowledge the assistance and support of the NEI/DMEI Cellular Imaging Core Facility at OUHSC (NIH: P30EY021725-Center Core Grant for Vision Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was published as a chapter in the dissertation of T.B. McKay at the University of Oklahoma Health Sciences Center.; This work was supported by P30EY021725, 5R01EY023568 (DK), and an unrestricted grant (DMEI) from Research to Prevent Blindness (NewYork, NY USA). We acknowledge the assistance and support of the NEI/DMEI Cellular Imaging Core Facility at OUHSC (NIH:P30EY021725-Center Core Grant for Vision Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay GK, 2006, DIABETES, V55, P2277, DOI 10.2337/db06-0062; BONANNO JA, 1987, INVEST OPHTH VIS SCI, V28, P1514; BRUCE AS, 1990, SURV OPHTHALMOL, V35, P25, DOI 10.1016/0039-6257(90)90046-X; Chwa M, 2008, INVEST OPHTH VIS SCI, V49, P4361, DOI 10.1167/iovs.08-1969; Chwa M, 2006, INVEST OPHTH VIS SCI, V47, P1902, DOI 10.1167/iovs.05-0828; Collier SA, 2000, CURR EYE RES, V21, P662, DOI 10.1076/0271-3683(200008)21:2;1-V;FT662; Collier SA, 2001, CLIN EXP OPHTHALMOL, V29, P340, DOI 10.1046/j.1442-9071.2001.d01-17.x; Coskunseven E, 2007, AM J OPHTHALMOL, V144, P387, DOI 10.1016/j.ajo.2007.05.035; Fini ME, 1998, ARCH DERMATOL RES, V290, pS12, DOI 10.1007/PL00007449; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Funderburgh JL, 2003, J BIOL CHEM, V278, P45629, DOI 10.1074/jbc.M303292200; Funderburgh JL, 2001, J BIOL CHEM, V276, P44173, DOI 10.1074/jbc.M107596200; Gaskin JCF, 2015, INVEST OPHTH VIS SCI, V56, P5831, DOI 10.1167/iovs.14-15123; GASSET AR, 1978, AM J OPHTHALMOL, V85, P339, DOI 10.1016/S0002-9394(14)77725-6; Giasson CJ, 2016, OPTOM VIS SCI; GROMACKI SJ, 1994, OPTOMETRY VISION SCI, V71, P437, DOI 10.1097/00006324-199407000-00003; HARTSTEIN J, 1968, ARCH OPHTHALMOL-CHIC, V80, P345, DOI 10.1001/archopht.1968.00980050347009; HOLDEN BA, 1984, INVEST OPHTH VIS SCI, V25, P1161; Iskeleli Guzin, 2002, CLAO Journal, V28, P174; Karamichos D, 2015, EXP EYE RES, V132, P1, DOI 10.1016/j.exer.2015.01.007; Karamichos D, 2014, SCI REP-UK, V4, DOI 10.1038/srep04608; Karamichos D, 2011, J TISSUE ENG REGEN M, V5, pE228, DOI 10.1002/term.429; Karamichos D, 2012, J FUNCT BIOMATER, V3, P760, DOI 10.3390/jfb3040760; Kenney MC, 1997, CORNEA, V16, P345; Kenney MC, 2005, INVEST OPHTH VIS SCI, V46, P823, DOI 10.1167/iovs.04-0549; KOCH JM, 1991, CORNEA, V10, P123, DOI 10.1097/00003226-199103000-00006; LAHOOD D, 1991, OPTOMETRY VISION SCI, V68, P877, DOI 10.1097/00006324-199111000-00008; Lim N, 2002, EYE, V16, P54, DOI 10.1038/sj.eye.6700061; Liu CY, 2003, J BIOL CHEM, V278, P21672, DOI 10.1074/jbc.M301169200; Liu ZG, 2000, OPHTHALMOLOGY, V107, P105, DOI 10.1016/S0161-6420(99)00027-5; Loor G, 2008, CELL DEATH DIFFER, V15, P686, DOI 10.1038/cdd.2008.13; MACSAI MS, 1990, ARCH OPHTHALMOL-CHIC, V108, P534, DOI 10.1001/archopht.1990.01070060082054; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; MCGARRY JD, 1977, J CLIN INVEST, V60, P265, DOI 10.1172/JCI108764; Mckay TB, 2015, SCI REP-UK, V5, DOI 10.1038/srep09003; McKay TB, 2016, SCI REP-UK, V6, DOI 10.1038/srep25534; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mohan R, 1998, J BIOL CHEM, V273, P25903, DOI 10.1074/jbc.273.40.25903; Pflugfelder SC, 2002, OPHTHALMOLOGY, V109, P2336, DOI 10.1016/S0161-6420(02)01276-9; Pizer ES, 2000, CANCER RES, V60, P213; Prentki M, 2002, DIABETES, V51, pS405, DOI 10.2337/diabetes.51.2007.S405; Pullum KW, 2005, CORNEA, V24, P269, DOI 10.1097/01.ico.0000148311.94180.6b; Rathi VM, 2013, INDIAN J OPHTHALMOL, V61, P410, DOI 10.4103/0301-4738.116066; Ruderman N, 2004, NAT REV DRUG DISCOV, V3, P340, DOI 10.1038/nrd1344; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Seppala HPS, 2006, CORNEA, V25, P325, DOI 10.1097/01.ico.0000183534.22522.39; Shetty R, 2015, INVEST OPHTH VIS SCI, V56, P738, DOI 10.1167/iovs.14-14831; Shimmura S, 1998, INVEST OPHTH VIS SCI, V39, P1346; Shoham A, 2008, FREE RADICAL BIO MED, V45, P1047, DOI 10.1016/j.freeradbiomed.2008.07.021; Smith VA, 2000, EUR J OPHTHALMOL, V10, P215, DOI 10.1177/112067210001000305; SMITH VA, 1995, EYE, V9, P429, DOI 10.1038/eye.1995.100; Tuori AJ, 1997, CURR EYE RES, V16, P792, DOI 10.1076/ceyr.16.8.792.8989; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; WEISSMAN BA, 1981, INVEST OPHTH VIS SCI, V20, P123; WILSON SE, 1990, OPHTHALMOLOGY, V97, P734	56	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176017	10.1371/journal.pone.0176017	http://dx.doi.org/10.1371/journal.pone.0176017			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426715	Green Submitted, Green Published, gold			2022-12-26	WOS:000399875900086
J	Yen, YH; Chen, JB; Cheng, BC; Chen, JF; Chang, KC; Tseng, PL; Wu, CK; Tsai, MC; Lin, MT; Hu, TH				Yen, Yi-Hao; Chen, Jin-Bor; Cheng, Ben-Chung; Chen, Jung-Fu; Chang, Kuo-Chin; Tseng, Po-Lin; Wu, Cheng-Kun; Tsai, Ming-Chao; Lin, Ming-Tsung; Hu, Tsung-Hui			Using controlled attenuation parameter combined with ultrasound to survey non-alcoholic fatty liver disease in hemodialysis patients: A prospective cohort study	PLOS ONE			English	Article							METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; HEPATIC STEATOSIS; RISK-FACTORS; DIAGNOSIS; SEVERITY; ASSOCIATION; MARKERS; BIOPSY	Background and aims Controlled attenuation parameter (CAP) is a non-invasive method for measuring hepatic steatosis (HS). Non-alcoholic fatty liver disease (NAFLD) is closely related to cardiovascular diseases (CVDs). CVDs are the leading cause of morbidity and mortality in hemodialysis patients. The aim of this study was to investigate the prevalence of NAFLD in hemodialysis patients. Method We prospectively enrolled patients undergoing chronic hemodialysis, as well as patients with normal renal function who served as controls. The control group patients were referred by an endocrinologist to be tested for NAFLD; most of these patients had diabetes, hypertension, or dyslipidemia. We excluded those with excess alcohol intake, use of drugs known to induce HS, chronic viral hepatitis, or CAP failure. CAP >= 238 dB/m was used as a cutoff suggesting HS. An increased liver kidney contrast, as defined by ultrasound, was used to make the diagnosis of HS. Results Three hundred and forty-three hemodialysis patients and 252 control group patients were enrolled. Among the hemodialysis patients, 192 (56.0%) had CAP- or ultrasound-identified HS compared with 91 (26.5%) who only had ultrasound-identified HS (P < 0.001). Among the control group patients, 212 (84.1%) had CAP- or ultrasound-identified HS compared with 180 (71.4%) who only had ultrasound-identified HS (P < 0.001). Conclusions The prevalence of NAFLD in the hemodialysis patients was 56%. The number of diagnoses of NAFLD made by using CAP combined with ultrasound was more than 2 times the number made with ultrasound alone in the hemodialysis patients. Therefore, we suggest the use of CAP combined with ultrasound to screen for NAFLD in hemodialysis patients.	[Yen, Yi-Hao; Chang, Kuo-Chin; Tseng, Po-Lin; Wu, Cheng-Kun; Tsai, Ming-Chao; Lin, Ming-Tsung; Hu, Tsung-Hui] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepato Gastroenterol, Kaohsiung, Taiwan; [Yen, Yi-Hao; Chen, Jin-Bor; Cheng, Ben-Chung; Chen, Jung-Fu; Chang, Kuo-Chin; Tseng, Po-Lin; Wu, Cheng-Kun; Tsai, Ming-Chao; Lin, Ming-Tsung; Hu, Tsung-Hui] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Chen, Jin-Bor; Cheng, Ben-Chung] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan; [Cheng, Ben-Chung] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Endocrinol & Metab, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Hu, TH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepato Gastroenterol, Kaohsiung, Taiwan.; Chen, JB; Hu, TH (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.; Chen, JB (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan.	chenjb1019@gmail.com; dr.hu@msa.hinet.net	Tsai, Ming Chao/ABA-9806-2020	, Ming-Chao/0000-0002-3613-2051	Chang Gung Memorial Hospital-Kaohsiung Medical Center; Taiwan [CMRPG8B1171]	Chang Gung Memorial Hospital-Kaohsiung Medical Center; Taiwan	This work was supported by Grant CMRPG8B1171 from Chang Gung Memorial Hospital-Kaohsiung Medical Center; Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Brophy DF, 2007, THROMB RES, V119, P723, DOI 10.1016/j.thromres.2006.02.013; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Chen CH, 2015, HEMATOLOGY, V20, P304, DOI 10.1179/1607845414Y.0000000199; Cheng YF, 2014, TRANSPLANTATION, V97, pS3, DOI [10.1097/TP.0000000000000060, 10.1097/01.tp.0000446265.42019.f3]; D'Adamo E, 2010, DIABETES CARE, V33, P1817, DOI 10.2337/dc10-0284; Dasarathy S, 2009, J HEPATOL, V51, P1061, DOI 10.1016/j.jhep.2009.09.001; de Ledinghen V, 2014, J HEPATOL, V60, P1026, DOI 10.1016/j.jhep.2013.12.018; Hamad Asma A, 2012, Arab J Gastroenterol, V13, P161, DOI 10.1016/j.ajg.2012.06.010; Hamaguchi M, 2007, AM J GASTROENTEROL, V102, P2708, DOI 10.1111/j.1572-0241.2007.01526.x; Hanley AJG, 2005, DIABETES, V54, P3140, DOI 10.2337/diabetes.54.11.3140; Kotronen A, 2009, DIABETOLOGIA, V52, P684, DOI 10.1007/s00125-009-1282-2; Kotronen A, 2008, ARTERIOSCL THROM VAS, V28, P27, DOI 10.1161/ATVBAHA.107.147538; Lai Yu-Cheng, 2013, Nephron Clin Pract, V124, P218, DOI 10.1159/000357952; Lee K, 2013, METAB SYNDR RELAT D, V11, P229, DOI 10.1089/met.2012.0153; Locatelli F, 2003, NEPHROL DIAL TRANSPL, V18, P2, DOI 10.1093/ndt/gfg1072; Longenecker JC, 2002, J AM SOC NEPHROL, V13, P1918, DOI 10.1097/01.ASN.0000019641.41496.1E; Marchesini G, 2016, J HEPATOL, V64, P1388, DOI 10.1016/j.jhep.2015.11.004; Mikolasevic I, 2014, MED HYPOTHESES, V82, P205, DOI 10.1016/j.mehy.2013.11.039; Mikolasevic I, 2015, HEMODIAL INT, V19, P472, DOI 10.1111/hdi.12280; Mikolasevic I, 2015, WIEN KLIN WOCHENSCHR, V127, P451, DOI 10.1007/s00508-015-0757-z; Mikolasevic I, 2014, BLOOD PURIFICAT, V37, P259, DOI 10.1159/000360270; Mikolasevic I, 2014, CLIN INTERV AGING, V9, P1295, DOI 10.2147/CIA.S65382; Pacifico L, 2011, WORLD J GASTROENTERO, V17, P3082, DOI 10.3748/wjg.v17.i26.3082; Petta S, 2016, HEPATOLOGY; Petta S, 2015, HEPATOLOGY, V62, P1101, DOI 10.1002/hep.27844; PICCININO F, 1986, J HEPATOL, V2, P165, DOI 10.1016/S0168-8278(86)80075-7; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Sasso M, 2010, ULTRASOUND MED BIOL, V36, P1825, DOI 10.1016/j.ultrasmedbio.2010.07.005; Schwimmer JB, 2008, CIRCULATION, V118, P277, DOI 10.1161/CIRCULATIONAHA.107.739920; Shi KQ, 2014, J GASTROEN HEPATOL, V29, P1149, DOI 10.1111/jgh.12519; Sniderman AD, 2010, CLIN J AM SOC NEPHRO, V5, P335, DOI 10.2215/CJN.06300909; Stenvinkel P, 1999, KIDNEY INT, V55, P1899, DOI 10.1046/j.1523-1755.1999.00422.x; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Vanholder R, 2005, NEPHROL DIAL TRANSPL, V20, P1048, DOI 10.1093/ndt/gfh813; Yilmaz Y, 2013, EUR J GASTROEN HEPAT, V25, P1330, DOI 10.1097/MEG.0b013e3283623a16	37	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176027	10.1371/journal.pone.0176027	http://dx.doi.org/10.1371/journal.pone.0176027			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426815	Green Published, gold, Green Submitted			2022-12-26	WOS:000399875900088
J	Zhang, ZF; Gillespie, C; Bowman, B; Yang, QH				Zhang, Zefeng; Gillespie, Cathleen; Bowman, Barbara; Yang, Quanhe			Prediction of atherosclerotic cardiovascular disease mortality in a nationally representative cohort using a set of risk factors from pooled cohort risk equations	PLOS ONE			English	Article							STATINS; PREVENTION; GUIDELINES	The American College of Cardiology/American Heart Association developed Pooled Cohort equations to estimate atherosclerotic cardiovascular disease (ASCVD) risk. It is unclear how well the equations predict ASCVD mortality in a nationally representative cohort. We used the National Health and Nutrition Examination Survey (NHANES) 1988-1994 and Linked Mortality through 2006 (n = 6,644). Among participants aged 40-79 years without ASCVD at baseline, we used Cox proportional hazard models to estimate the 10-year probability of ASCVD death by sex and race-ethnicity (non-Hispanic white (NHW), non-Hispanic black (NHB) and Mexican American (MA)). We estimated the discrimination and calibration for each sex-race-ethnicity model. We documented 288 ASCVD deaths during 62,335 person years. The Pooled Cohort equations demonstrated moderate to good discrimination for ASCVD mortality, with modified C-statistics of 0.716 (95% CI 0.663-0.770), 0.794 (0.734-0.854), and 0.733 (0.654-0.811) for NHW, NHB and MA men, respectively. The corresponding C-statistics for women were 0.781 (0.718-0.844), 0.702 (0.633-0.771), and 0.789 (CI 0.721-0.857). Modified Hosmer-Lemeshow chi(2) suggested adequate calibration for NHW, NHB and MA men, and MA women (p-values: 0.128, 0.295, 0.104 and 0.163 respectively). The calibration was inadequate for NHW and NHB women (p < 0.05). In this nationally representative cohort, the Pooled Cohort equations performed adequately to predict 10-year ASCVD mortality for NHW and NHB men, and MA population, but not for NHW and NHB women.	[Zhang, Zefeng; Gillespie, Cathleen; Bowman, Barbara; Yang, Quanhe] Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Zhang, ZF (corresponding author), Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.	zzhang3@cdc.gov						Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cook NR, 2014, JAMA INTERN MED, V174, P1964, DOI 10.1001/jamainternmed.2014.5336; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Ioannidis JPA, 2014, JAMA-J AM MED ASSOC, V311, P463, DOI 10.1001/jama.2013.284657; Kavousi M, 2014, JAMA-J AM MED ASSOC, V311, P1416, DOI 10.1001/jama.2014.2632; Keaney JF, 2014, NEW ENGL J MED, V370, P275, DOI 10.1056/NEJMms1314569; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Lenzer J, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6989; MCCARTHY M, 2013, BMJ-BRIT MED J, V347, DOI DOI 10.1136/BMJ.F6858; Muntner P, 2014, JAMA-J AM MED ASSOC, V311, P1406, DOI 10.1001/jama.2014.2630; National Center for Health Statistics CDC, 1998, PLAN OP 3 NAT HLTH N; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Psaty BM, 2014, JAMA-J AM MED ASSOC, V311, P461, DOI 10.1001/jama.2013.284203; Rana JS, 2016, J AM COLL CARDIOL, V67, P2118, DOI 10.1016/j.jacc.2016.02.055; Ridker PM, 2013, LANCET, V382, P1762, DOI 10.1016/S0140-6736(13)62388-0; Royston P, 2006, STATA J, V6, P83, DOI 10.1177/1536867X0600600105; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a	19	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175822	10.1371/journal.pone.0175822	http://dx.doi.org/10.1371/journal.pone.0175822			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426694	Green Published, gold, Green Submitted			2022-12-26	WOS:000399875900054
J	Vivo, M; Fontana, R; Ranieri, M; Capasso, G; Angrisano, T; Pollice, A; Calabro, V; La Mantia, G				Vivo, M.; Fontana, R.; Ranieri, M.; Capasso, G.; Angrisano, T.; Pollice, A.; Calabro, V.; La Mantia, G.			p14ARF interacts with the focal adhesion kinase and protects cells from anoikis	ONCOGENE			English	Article							ARF TUMOR-SUPPRESSOR; DAP-KINASE; MOTOR COMPLEX; DNA-DAMAGE; IN-VIVO; CANCER; SURVIVAL; PHOSPHORYLATION; PROGRESSION; APOPTOSIS	The ARF protein functions as an important sensor of hyper-proliferative stimuli restricting cell proliferation through both p53-dependent and - independent pathways. Although to date the majority of studies on ARF have focused on its anti-proliferative role, few studies have addressed whether ARF may also have pro-survival functions. Here we show for the first time that during the process of adhesion and spreading ARF re-localizes to sites of active actin polymerization and to focal adhesion points where it interacts with the phosphorylated focal adhesion kinase. In line with its recruitment to focal adhesions, we observe that hampering ARF function in cancer cells leads to gross defects in cytoskeleton organization resulting in apoptosis through a mechanism dependent on the Death-Associated Protein Kinase. Our data uncover a novel function for p14ARF in protecting cells from anoikis that may reflect its role in anchorage independence, a hallmark of malignant tumor cells.	[Vivo, M.; Fontana, R.; Ranieri, M.; Capasso, G.; Angrisano, T.; Pollice, A.; Calabro, V.; La Mantia, G.] Univ Naples Federico II, Dipartimento Biol, Via Cinthia, I-80126 Naples, Italy	University of Naples Federico II	Vivo, M; La Mantia, G (corresponding author), Univ Naples Federico II, Dipartimento Biol, Via Cinthia, I-80126 Naples, Italy.	maria.vivo@unina.it; lamantia@unina.it	Angrisano, Tiziana/AAC-5353-2022; Vivo, Maria/S-3390-2017; Fontana, Rosa/AAD-7852-2019; Calabro, Viola/H-6156-2013	Vivo, Maria/0000-0003-2458-4226; Fontana, Rosa/0000-0003-0445-6016; Ranieri, Michela/0000-0002-3833-3594; Calabro, Viola/0000-0002-6508-8889	L.R.5; PO FESR 'DiMo'; PO FESR 'Movie'	L.R.5; PO FESR 'DiMo'; PO FESR 'Movie'	We thank Dr Carlo Di Cristo and Dr Tiziana Parisi for critical revision of the manuscript. We thank Dr Valeria R Villella for providing HeLa cells, Dr Giovanna Benvenuto (Confocal Microscopy Service at the Stazione Zoologica Anton Dohrn, Naples) and Dr Per Guldberg for kindly providing GFP-tagged ARF mutants. This work was supported by grants awarded to GLM and AP from L.R.5 (2007), to VC and GLM from PO FESR 2007-2013 'DiMo' and 'Movie', respectively.	Buchheit CL, 2014, NAT REV CANCER, V14, P632, DOI 10.1038/nrc3789; Budina-Kolomets A, 2013, AUTOPHAGY, V9, P1553, DOI 10.4161/auto.25831; Chen RH, 2006, J BIOMED SCI, V13, P193, DOI 10.1007/s11373-005-9063-5; Chen ZB, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000053; Chiba K, 1998, TOXICOL IN VITRO, V12, P251, DOI 10.1016/S0887-2333(97)00107-0; Christensen C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6348; Churchman ML, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002157; Cohen O, 1997, EMBO J, V16, P998, DOI 10.1093/emboj/16.5.998; Fan HP, 2013, J BIOL CHEM, V288, P3322, DOI 10.1074/jbc.M112.420497; Ferru A, 2006, BRIT J CANCER, V95, P1670, DOI 10.1038/sj.bjc.6603479; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gromley A, 2009, P NATL ACAD SCI USA, V106, P6285, DOI 10.1073/pnas.0902310106; Guo FK, 2004, MOL CELL BIOL, V24, P1426, DOI 10.1128/MCB.24.3.1426-1438.2004; Guo FK, 2003, J BIOL CHEM, V278, P14414, DOI 10.1074/jbc.M300341200; Humbey O, 2008, CANCER RES, V68, P9608, DOI 10.1158/0008-5472.CAN-08-2263; Inbal B, 1997, NATURE, V390, P180, DOI 10.1038/36599; Ivanovska J, 2014, APOPTOSIS, V19, P329, DOI 10.1007/s10495-013-0916-5; Johnson CL, 2002, MOL CANCER THER, V1, P861; Kadare G, 2003, J BIOL CHEM, V278, P47434, DOI 10.1074/jbc.M308562200; Kamijo T, 1999, CANCER RES, V59, P2217; Kobayashi T, 2013, MOL CANCER RES, V11, P828, DOI 10.1158/1541-7786.MCR-13-0207; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kotsinas A, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00236; Kuo JC, 2003, J CELL SCI, V116, P4777, DOI 10.1242/jcs.00794; Li CL, 2013, P NATL ACAD SCI USA, V110, pE1112, DOI 10.1073/pnas.1302184110; Llanos S, 2001, NAT CELL BIOL, V3, P445, DOI 10.1038/35074506; Ozenne P, 2010, INT J CANCER, V127, P2239, DOI 10.1002/ijc.25511; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pimkina J, 2009, J BIOL CHEM, V284, P2803, DOI 10.1074/jbc.M804705200; Pollice A, 2008, FEBS LETT, V582, P3257, DOI 10.1016/j.febslet.2008.09.026; Puthalakath H, 2001, SCIENCE, V293, P1829, DOI 10.1126/science.1062257; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Reef S, 2006, MOL CELL, V22, P463, DOI 10.1016/j.molcel.2006.04.014; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Sanchez-Aguilera A, 2002, BLOOD, V99, P1411, DOI 10.1182/blood.V99.4.1411; Schlaepfer DD, 1996, MOL CELL BIOL, V16, P5623; Serrels B, 2007, NAT CELL BIOL, V9, P1046, DOI 10.1038/ncb1626; Sosa MS, 2014, NAT REV CANCER, V14, P611, DOI 10.1038/nrc3793; Sulzmaier FJ, 2014, NAT REV CANCER, V14, P598, DOI 10.1038/nrc3792; Tago K, 2005, P NATL ACAD SCI USA, V102, P7689, DOI 10.1073/pnas.0502978102; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Tancioni I, 2014, MOL CANCER THER, V13, P2050, DOI 10.1158/1535-7163.MCT-13-1063; Vivo M, 2001, J BIOL CHEM, V276, P14161, DOI 10.1074/jbc.M006845200; Vivo M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117252; Vivo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053631; Vivo M, 2009, CELL CYCLE, V8, P3545, DOI 10.4161/cc.8.21.9954; Wang WJ, 2002, J CELL BIOL, V159, P169, DOI 10.1083/jcb.200204050; Weber JD, 2000, MOL CELL BIOL, V20, P2517, DOI 10.1128/MCB.20.7.2517-2528.2000; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Westhoff MA, 2004, MOL CELL BIOL, V24, P8113, DOI 10.1128/MCB.24.18.8113-8133.2004; Xie YQ, 2014, MOL ONCOL, V8, P1355, DOI 10.1016/j.molonc.2014.05.006; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4	55	27	27	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 24	2017	36	34					4913	4928		10.1038/onc.2017.104	http://dx.doi.org/10.1038/onc.2017.104			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FE5EI	28436949	Green Published, hybrid			2022-12-26	WOS:000408234400008
J	Pattabiraman, G; Panchal, R; Medvedev, AE				Pattabiraman, Goutham; Panchal, Rahul; Medvedev, Andrei E.			The R753Q polymorphism in Toll-like receptor 2 (TLR2) attenuates innate immune responses to mycobacteria and impairs MyD88 adapter recruitment to TLR2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						innate immunity; macrophage; signal transduction; SNP; Toll-like receptor (TLR)	NF-KAPPA-B; TYROSINE PHOSPHORYLATION; ARG753GLN POLYMORPHISM; BORRELIA-BURGDORFERI; CELLULAR ACTIVATION; GENE-EXPRESSION; TUBERCULOSIS; MACROPHAGES; PHAGOCYTOSIS; RECOGNITION	Toll-like receptor 2 (TLR2) plays a critical role in host defenses against mycobacterial infections. The R753Q TLR2 polymorphism has been associated with increased incidence of tuberculosis and infections with non-tuberculous mycobacteria in human populations, but the mechanisms by which this polymorphism affects TLR2 signaling are unclear. In this study, we determined the impact of the R753Q TLR2 polymorphism on macrophage sensing of Mycobacterium smegmatis. Upon infection with M. smegmatis, macrophages from knock-in mice harboring R753Q TLR2 expressed lower levels of TNF-, IL-1, IL-6, and IL-10 compared with cells from WT mice, but both R753Q TLR2- and WT-derived macrophages exhibited comparable bacterial burdens. The decreased cytokine responses in R753Q TLR2-expressing macrophages were accompanied by impaired phosphorylation of IL-1R-associated kinase 1 (IRAK-1), p38, ERK1/2 MAPKs, and p65 NF-B, suggesting that the R753Q TLR2 polymorphism alters the functions of the myeloid differentiation primary response protein 88 (MyD88)-IRAK-dependent signaling axis. Supporting this notion, HEK293 cells stably transfected with YFP-tagged R753Q TLR2 displayed reduced recruitment of MyD88 to TLR2, decreased NF-B activation, and impaired IL-8 expression upon exposure to M. smegmatis. Collectively, our results indicate that the R753Q polymorphism alters TLR2 signaling competence, leading to impaired MyD88-TLR2 assembly, reduced phosphorylation of IRAK-1, diminished activation of MAPKs and NF-B, and deficient induction of cytokines in macrophages infected with M. smegmatis.	[Pattabiraman, Goutham; Panchal, Rahul; Medvedev, Andrei E.] Univ Connecticut, Ctr Hlth, Dept Immunol, L Bldg,Rm 3019,263 Farmington Ave, Farmington, CT 06030 USA	University of Connecticut	Medvedev, AE (corresponding author), Univ Connecticut, Ctr Hlth, Dept Immunol, L Bldg,Rm 3019,263 Farmington Ave, Farmington, CT 06030 USA.	medvedev@uchc.edu		Pattabiraman, Goutham/0000-0002-5196-8279	National Institutes of Health [R56 AI097210]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI097210] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in whole by National Institutes of Health Grant R56 AI097210 (to A. E. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Anes E, 2006, CELL MICROBIOL, V8, P939, DOI 10.1111/j.1462-5822.2005.00675.x; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Ben-Ali M, 2004, CLIN DIAGN LAB IMMUN, V11, P625, DOI 10.1128/CDLI.11.3.625-626.2004; Berdeli A, 2005, J MOL MED, V83, P535, DOI 10.1007/s00109-005-0677-x; Berrington WR, 2007, IMMUNOL REV, V219, P167, DOI 10.1111/j.1600-065X.2007.00545.x; Bhide MR, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-21; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Briken V, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00062; Bulut Y, 2001, J IMMUNOL, V167, P987, DOI 10.4049/jimmunol.167.2.987; Chattopadhyay S, 2014, CYTOKINE GROWTH F R, V25, P533, DOI 10.1016/j.cytogfr.2014.06.002; Divangahi M, 2008, J IMMUNOL, V181, P7157, DOI 10.4049/jimmunol.181.10.7157; Dorhoi A, 2016, SEMIN IMMUNOPATHOL, V38, P153, DOI 10.1007/s00281-015-0531-3; Doyle SE, 2004, J EXP MED, V199, P81, DOI 10.1084/jem.20031237; Drage MG, 2009, CELL IMMUNOL, V258, P29, DOI 10.1016/j.cellimm.2009.03.008; Ferwerda G, 2005, PLOS PATHOG, V1, P279, DOI 10.1371/journal.ppat.0010034; Figueroa L, 2012, J IMMUNOL, V188, P4506, DOI 10.4049/jimmunol.1200202; Flynn JL, 2011, MUCOSAL IMMUNOL, V4, P271, DOI 10.1038/mi.2011.14; Fujiwara N, 2012, TUBERCULOSIS, V92, P187, DOI 10.1016/j.tube.2011.10.001; Gianni T, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004477; Haehnel V, 2002, J IMMUNOL, V168, P5629, DOI 10.4049/jimmunol.168.11.5629; Heldwein KA, 2003, J LEUKOCYTE BIOL, V74, P277, DOI 10.1189/jlb.0103026; Herrtwich L, 2016, CELL, V167, P1264, DOI 10.1016/j.cell.2016.09.054; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kang TJ, 2004, IMMUNOLOGY, V112, P674, DOI 10.1111/j.1365-2567.2004.01926.x; Kapetanovic R, 2007, INFECT IMMUN, V75, P830, DOI 10.1128/IAI.01199-06; Kaufmann SHE, 2006, IMMUNITY, V24, P351, DOI 10.1016/j.immuni.2006.04.003; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kleinnijenhuis J, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/405310; Ladel CH, 1997, INFECT IMMUN, V65, P4843, DOI 10.1128/IAI.65.11.4843-4849.1997; Letiembre M, 2005, INFECT IMMUN, V73, P8397, DOI 10.1128/IAI.73.12.8397-8401.2005; Li XX, 2008, EUR J IMMUNOL, V38, P614, DOI 10.1002/eji.200838161; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Liu Y, 2001, INFECT IMMUN, V69, P2788, DOI 10.1128/IAI.69.5.2788-2796.2001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luther K, 2007, CELL MICROBIOL, V9, P368, DOI 10.1111/j.1462-5822.2006.00796.x; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; Means TK, 1999, J IMMUNOL, V163, P3920; Musikacharoen T, 2001, J IMMUNOL, V166, P4516, DOI 10.4049/jimmunol.166.7.4516; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Ogus AC, 2004, EUR RESPIR J, V23, P219, DOI 10.1183/09031936.03.00061703; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Poyhonen L, 2015, ACTA PAEDIATR, V104, P485, DOI 10.1111/apa.12927; Rahman MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086886; Rehli M, 2002, TRENDS IMMUNOL, V23, P375, DOI 10.1016/S1471-4906(02)02259-7; Reiling N, 2002, J IMMUNOL, V169, P3480, DOI 10.4049/jimmunol.169.7.3480; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Sampaio EP, 2008, AM J RESP CELL MOL, V39, P431, DOI 10.1165/rcmb.2007-0413OC; Schroder NWJ, 2005, J IMMUNOL, V175, P2534, DOI 10.4049/jimmunol.175.4.2534; Shen YN, 2010, INFECT IMMUN, V78, P2857, DOI 10.1128/IAI.01138-09; Singh RP, 2009, INDIAN J MICROBIOL, V49, P276, DOI 10.1007/s12088-009-0045-6; Soylu A, 2011, INFLAMMATION, V34, P379, DOI 10.1007/s10753-010-9245-9; Stamm CE, 2015, IMMUNOL REV, V264, P204, DOI 10.1111/imr.12263; Thuong Nguyen Thuy Thuong, 2008, PLoS Pathog, V4, pe1000229, DOI 10.1371/journal.ppat.1000229; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; Wang TY, 2000, J IMMUNOL, V165, P6308, DOI 10.4049/jimmunol.165.11.6308; Xiong YB, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.375493; Yam Wing-Cheong, 2013, Methods Mol Biol, V943, P171, DOI 10.1007/978-1-60327-353-4_12; Yim JJ, 2008, HUM IMMUNOL, V69, P572, DOI 10.1016/j.humimm.2008.06.003; Yim JJ, 2004, FEMS IMMUNOL MED MIC, V40, P163, DOI 10.1016/S0928-8244(03)00342-0	60	16	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10685	10695		10.1074/jbc.M117.784470	http://dx.doi.org/10.1074/jbc.M117.784470			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28442574	Green Published, hybrid			2022-12-26	WOS:000404115400027
J	Chang, C; Hsieh, MK; Chang, WY; Chiang, AJ; Chen, JB				Chang, Chung; Hsieh, Meng-Ke; Chang, Wen-Yi; Chiang, An Jen; Chen, Jiabin			Determining the optimal number and location of cutoff points with application to data of cervical cancer	PLOS ONE			English	Article							BODY-MASS INDEX; OPTIMAL CUTPOINTS; MORTALITY; OBESITY; GUIDELINES; OVERWEIGHT; SURVIVAL	It is often helpful to classify biomarker values into groups of different risk levels to facilitate evaluation of a biological, physiological, or pathological state. Stratification of patients into two risk groups is commonly seen, but there is always need for more than two groups for fine assessment. So far, there are no standard methods or tools to help decide how many cutoff points are optimal. In this study, we developed a comprehensive package that included methods to determine both the optimal number and locations of cutoff points for both survival data and dichotomized outcome. We illustrated workflow of this package with data from 797 patients with cervical cancer. By analyzing several risk factors of cervical cancer such as tumor size, body mass index (BMI), number of lymph nodes involved and depth of stromal invasion, in relation to survival and clinical outcome such as lymph nodal metastasis and lymphovascular invasion, we demonstrated that the best choice for BMI and stromal invasion was two cutoff points and one for the others. This study provided a useful tool to facilitate medical decisions and the analyses on cervical cancer may also be of interest to gynecologists. The package can be freely downloaded.	[Chang, Chung; Hsieh, Meng-Ke; Chang, Wen-Yi] Natl Sun Yat Sen Univ, Dept Appl Math, Kaohsiung, Taiwan; [Chiang, An Jen] Kaohsiung Vet Gen Hosp, Dept Obstet & Gynecol, Kaohsiung, Taiwan; [Chiang, An Jen] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung, Taiwan; [Chen, Jiabin] Natl Sun Yat Sen Univ, Multidisciplinary Sci Res Ctr, Kaohsiung, Taiwan; [Chen, Jiabin] Dayeh Univ, Changhua, Taiwan	National Sun Yat Sen University; Kaohsiung Veterans General Hospital; National Sun Yat Sen University; National Sun Yat Sen University; Da Yeh University	Chiang, AJ (corresponding author), Kaohsiung Vet Gen Hosp, Dept Obstet & Gynecol, Kaohsiung, Taiwan.; Chiang, AJ (corresponding author), Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung, Taiwan.; Chen, JB (corresponding author), Natl Sun Yat Sen Univ, Multidisciplinary Sci Res Ctr, Kaohsiung, Taiwan.; Chen, JB (corresponding author), Dayeh Univ, Changhua, Taiwan.	ajchiang490111@gmail.com; jiabinchung@gmail.com			Ministry of Science and Technology of Republic of China [104-2118-M-110 -001, 104-2118-M-110-001]; Kaohsiung Veteran General Hospital [VGHKS105-104, VGHNSU103-006]; KSVGH [VGHKS105-104, VGHNSU103-006]	Ministry of Science and Technology of Republic of China(Ministry of Science and Technology, Taiwan); Kaohsiung Veteran General Hospital; KSVGH	This work was supported by Grant # 104-2118-M-110 -001, from the Ministry of Science and Technology of Republic of China (CC); and Grants # VGHKS105-104 and VGHNSU103-006, from Kaohsiung Veteran General Hospital (AC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was supported in part by a grant from the Ministry of Science and Technology of ROC (104-2118-M-110-001) and two grants from KSVGH (VGHKS105-104 and VGHNSU103-006). The earlier manuscript was improved with help of reviewers' comments.	[Anonymous], 2010, R LANGUAGE ENV STAT; Araujo A, 2015, SMOOTH HAZARD RATIO; Arbyn M, 2011, ANN ONCOL, V22, P2675, DOI 10.1093/annonc/mdr015; Budczies J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051862; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Camp RL, 2004, CLIN CANCER RES, V10, P7252, DOI 10.1158/1078-0432.CCR-04-0713; Center MM, 2012, EUR UROL, V61, P1079, DOI 10.1016/j.eururo.2012.02.054; Clark LH, 2016, GYNECOL ONCOL, V141, P497, DOI 10.1016/j.ygyno.2016.03.035; Colombo N, 2012, ANN ONCOL, V23, P27, DOI 10.1093/annonc/mds268; Friedlander M, 2002, ONCOLOGIST, V7, P342; Kizer NT, 2011, CANCER-AM CANCER SOC, V117, P948, DOI 10.1002/cncr.25544; Lopez-Raton M, 2014, J STAT SOFTW, V61, P1; Matsunaga T, 2015, THORAC CARDIOV SURG, V63, P551, DOI 10.1055/s-0035-1554964; Mazumdar M, 2000, STAT MED, V19, P113, DOI 10.1002/(SICI)1097-0258(20000115)19:1<113::AID-SIM245>3.0.CO;2-O; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Therneau T, 2016, SURVIVAL ANAL; World Health Organization, 2006, BMI CLASSIFICATION; Xu XS, 2016, ONCOTARGET, V7, P5023, DOI 10.18632/oncotarget.6517	18	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176231	10.1371/journal.pone.0176231	http://dx.doi.org/10.1371/journal.pone.0176231			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448533	Green Published, gold, Green Submitted			2022-12-26	WOS:000400383600049
J	Dandouh, E; Gomez-Gil, R; Pacho, S; Mingorance, J; Daoud, Z; Suarez, M				Dandouh, Elias; Gomez-Gil, Rosa; Pacho, Sonsoles; Mingorance, Jesus; Daoud, Ziad; Suarez, Monica			Clonality, virulence determinants, and profiles of resistance of clinical Acinetobacter baumannii isolates obtained from a Spanish hospital	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; MULTIPLEX PCR; CARBAPENEMASE; OUTBREAK; IDENTIFICATION; INSIGHTS; CLONES; IMPACT; ASSAY	Introduction Acinetobacter baumannii is a nosocomial pathogen that is showing increasing rates of carbapenem resistance. Multi-Drug Resistant (MDR) International Clones (ICs), associated with certain oxacillinases, are being reported globally. This organism also harbors numerous virulence determinants. In this study, we aim at characterizing A. baumannii isolated from a Spanish hospital in terms of antimicrobial susceptibility, clonality, carbapenemase genes harbored, and virulence determinants expressed. Materials and methods Fifty nine clinical bloodstream isolates were obtained from 2009 until 2013. Antimicrobial Susceptibility Testing was performed according to the CLSI guidelines. PFGE and tri-locus PCR typing were then performed in order to determine local and international clonality. PCRs for the detection of common carbapenemases were also performed. Production of hemolysis, biofilms, siderophores, surface motility, and proteolysis were determined phenotypically. Doubling times for selected strains were also calculated. Finally, statistical analysis for detecting associations between these factors was conducted. Results and discussion Carbapenem non-susceptibility was 84.75%, suggesting the immediate need for intervention. PFGE showed the distribution of the majority of the isolates among 7 clusters. Although all three ICs were detected, IC II was predominant at 71.19%. bla(OXA-24-like) was the most prevalent carbapenemase (62.71%), followed by bla(OXA-58-like) (13.56%), and bla(OXA-23-like) (11.86%). Strains pertaining to IC II, and those harboring bla(OXA-24-like), were positively associated with a-hemolysis, production of strong biofilms, and siderophore production. Harboring bla(OXA-23-like) and bla(OXA-58-like) was associated with attenuated virulence. These associations suggest that an interplay exists between these factors that could be locally exploited. Conclusions An alarmingly high rate of carbapenem non-susceptibility has been detected in this study. There was a predominance of IC II and bla(OXA-24-like), and those factors were associated with heightened expression of virulence determinants. This association could be exploited for modifying treatment regimens and for improving on infection control protocols in this hospital.	[Dandouh, Elias; Pacho, Sonsoles; Suarez, Monica] Univ Complutense Madrid, Dept Anim Hlth, Fac Vet, Madrid, Spain; [Gomez-Gil, Rosa; Mingorance, Jesus] Hosp Univ La Paz, IdiPAZ, Serv Microbiol, Madrid, Spain; [Daoud, Ziad] Univ Balamand, Dept Clin Microbiol, Fac Med, Balamand, Lebanon	Complutense University of Madrid; Hospital Universitario La Paz; University Balamand	Dandouh, E (corresponding author), Univ Complutense Madrid, Dept Anim Hlth, Fac Vet, Madrid, Spain.	elie_dandouh@hotmail.com	Daoud, Ziad/A-7942-2011; Daoud, Ziad/AAW-7121-2021; Mingorance, Jesus/B-7562-2009; Dahdouh, Elias/AAG-8801-2019; Daoud, Ziad/M-3458-2019	Daoud, Ziad/0000-0001-7139-6282; Mingorance, Jesus/0000-0001-6173-5711; Dahdouh, Elias/0000-0003-2309-4129; Daoud, Ziad/0000-0001-7139-6282				Andersson DI, 2011, FEMS MICROBIOL REV, V35, P901, DOI 10.1111/j.1574-6976.2011.00289.x; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Antunes LCS, 2014, PATHOG DIS, V71, P292, DOI 10.1111/2049-632X.12125; Antunes LCS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022674; Beceiro A, 2013, CLIN MICROBIOL REV, V26, P185, DOI 10.1128/CMR.00059-12; Bonnin RA, 2011, CLIN MICROBIOL INFEC, V17, P1524, DOI 10.1111/j.1469-0691.2011.03622.x; Chen ZJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17091; Cisneros JM, 2005, CLIN MICROBIOL INFEC, V11, P874, DOI 10.1111/j.1469-0691.2005.01256.x; Clemmer KM, 2011, MICROBIOL-SGM, V157, P2534, DOI 10.1099/mic.0.049791-0; Clinical and Laboratory Standards Institute, 2014, M100S24 CLIN LAB STA; Dandouh E, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00163; Diancourt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010034; Eijkelkamp BA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-126; Fernandez-Cuenca F, 2011, INT J ANTIMICROB AG, V38, P548, DOI 10.1016/j.ijantimicag.2011.08.002; Fishbain J, 2010, CLIN INFECT DIS, V51, P79, DOI 10.1086/653120; Gordon NC, 2010, INT J ANTIMICROB AG, V35, P219, DOI 10.1016/j.ijantimicag.2009.10.024; Hall BG, 2014, MOL BIOL EVOL, V31, P232, DOI 10.1093/molbev/mst187; Howard A, 2012, VIRULENCE, V3, P243, DOI 10.4161/viru.19700; Karah N, 2012, DRUG RESIST UPDATE, V15, P237, DOI 10.1016/j.drup.2012.06.001; Lemos EV, 2014, CLIN MICROBIOL INFEC, V20, P416, DOI 10.1111/1469-0691.12363; Lopez-Rojas R, 2013, ANTIMICROB AGENTS CH, V57, P4587, DOI 10.1128/AAC.00543-13; Louden BC, 2011, J MICROBIOL BIOL EDU, V12, P51, DOI 10.1128/jmbe.v12i1.249; Machuca A, 2003, LETT APPL MICROBIOL, V36, P177, DOI 10.1046/j.1472-765X.2003.01290.x; Mai-Almirall M, 2016, CLIN MICROBIOLOGY IN; Merino M, 2014, MICROB DRUG RESIST, V20, P259, DOI 10.1089/mdr.2013.0127; Namendys-Silva Silvio A, 2015, World J Crit Care Med, V4, P258, DOI 10.5492/wjccm.v4.i3.258; Nowak P, 2016, FOLIA HISTOCHEM CYTO, V54, P61, DOI 10.5603/FHC.a2016.0009; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Peleg AY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046984; Perez F, 2010, J ANTIMICROB CHEMOTH, V65, P1807, DOI 10.1093/jac/dkq191; Poirel L, 2011, DIAGN MICR INFEC DIS, V70, P119, DOI 10.1016/j.diagmicrobio.2010.12.002; RICHARDSON BC, 1978, NEW ZEAL J DAIRY SCI, V13, P172; Romero-Gomez MP, 2012, J INFECTION, V65, P513, DOI 10.1016/j.jinf.2012.08.013; RONCATESTONI S, 1983, CLIN CHEM, V29, P1093; Sechi LA, 2004, MED SCI MONITOR, V10, pBR180; Seifert H, 2005, J CLIN MICROBIOL, V43, P4328, DOI 10.1128/JCM.43.9.4328-4335.2005; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; Tarnberg M, 2016, INT J INFECT DIS IJI; Tayabali AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037024; Tena D, 2013, JPN J INFECT DIS, V66, P323, DOI 10.7883/yoken.66.323; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Tomaschek F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153014; Turton JF, 2007, CLIN MICROBIOL INFEC, V13, P807, DOI 10.1111/j.1469-0691.2007.01759.x; Turton JF, 2006, J CLIN MICROBIOL, V44, P2974, DOI 10.1128/JCM.01021-06; Villalon P, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0383-y; Villalon P, 2011, J CLIN MICROBIOL, V49, P875, DOI 10.1128/JCM.01026-10; Villar M, 2014, MEDICINE, V93, P202, DOI 10.1097/MD.0000000000000036	47	15	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176824	10.1371/journal.pone.0176824	http://dx.doi.org/10.1371/journal.pone.0176824			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448572	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383600128
J	Guani-Guerra, E; Jimenez-Romero, AI; Garcia-Ramirez, UN; Velazquez-Avalos, JM; Martinez-Guzman, E; Sandoval-Ramirez, E; Camacho-Meza, I				Guani-Guerra, Eduardo; Isabel Jimenez-Romero, Ana; Noel Garcia-Ramirez, Ulises; Manuel Velazquez-Avalos, Jose; Martinez-Guzman, Edgar; Sandoval-Ramirez, Eunice; Camacho-Meza, Ignacio			Disease burden for patients with primary immunodeficiency diseases identified at reference hospitals in Guanajuato, Mexico	PLOS ONE			English	Article							INTRAVENOUS IMMUNOGLOBULIN; PREVENTION; PREVALENCE; PNEUMONIA; EFFICACY	Background In addition to the deleterious effect on health, there is considerable economic and psychosocial morbidity associated with primary immunodeficiency diseases (PID). Also, the cost of a late diagnosis frequently results in a heavy disease burden on the patient. The objective of this study was to collect and analyze data on patients with PID in the state of Guanajuato in Mexico, to indirectly estimate the burden of the disease. Methods An observational, longitudinal, and comparative study was conducted. A total of 44 patients were included and grouped according to the updated classification of PID. Results The median time elapsed from the onset of symptoms to the reference and diagnosis by a tertiary hospital was of 2.17 (IQR = 6.44) years. Before diagnosis, the number of hospitalizations/ year per patient was 0.86 IQR = 2.28), the number of visit to emergency room/ year per patient was 0.92 (IQR = 1.77), the number of doctor's visits/year per patient was 15 (IQR = 11.25), whereas the school/ work absence days per patient were reported in 52.72 (IQR = 56.35) days per year. After diagnosis, 20 patients (45.45%) received IVIG replacement therapy, and all of them presented a significant improvement (p <0.05) in all the mentioned variables. Characteristically, even when patients with PID received IVIG, there was still an important disease burden when comparing them against healthy controls. Complications secondary to PID were detected in 19 patients (43.18%). The reported overall mortality rate was 6.82% (n = 3). Conclusions We were able to indirectly estimate an important disease burden in patients with PID; which is considered to be preventable, at least in part, with effective interventions like health planning, research, collaboration with primary care providers, and generation of policies and practices, in order to improve the quality of life and care of families with PID.	[Guani-Guerra, Eduardo; Martinez-Guzman, Edgar] Hosp Reg Alta Especialidad Bajio, Dept Immunol, Leon Guanajuato, Spain; [Guani-Guerra, Eduardo] Hosp Aranda Parra, Dept Immunoalergol, Leon Guanajuato, Spain; [Isabel Jimenez-Romero, Ana] Hosp Angeles Leon, Dept Immunoallergol Pediat, Leon Guanajuato, Spain; [Noel Garcia-Ramirez, Ulises; Manuel Velazquez-Avalos, Jose] IMSS, Ctr Med Nacl Bajio, Dept Immunoallergol, Leon Guanajuato, Spain; [Sandoval-Ramirez, Eunice; Camacho-Meza, Ignacio] Hosp Pediat Leon, Dept Immunoallergol Pediat, Leon Guanajuato, Spain		Guani-Guerra, E (corresponding author), Hosp Reg Alta Especialidad Bajio, Dept Immunol, Leon Guanajuato, Spain.; Guani-Guerra, E (corresponding author), Hosp Aranda Parra, Dept Immunoalergol, Leon Guanajuato, Spain.	eduardoguani@yahoo.com.mx						Affentranger P, 1993, Immunodeficiency, V4, P193; Aghamohammadi A, 2004, FEMS IMMUNOL MED MIC, V40, P113, DOI 10.1016/S0928-8244(03)00304-3; Aghamohammadi A, 2010, RESPIROLOGY, V15, P289, DOI 10.1111/j.1440-1843.2009.01679.x; Alvarez-Cardona A, 2016, J CLIN IMMUNOL, V36, P173, DOI 10.1007/s10875-016-0242-0; Boyle JM, 2007, J CLIN IMMUNOL, V27, P497, DOI 10.1007/s10875-007-9103-1; Busse PJ, 2002, J ALLERGY CLIN IMMUN, V109, P1001, DOI 10.1067/mai.2002.124999; Chan SK, 2015, IMMUNOL ALLERGY CLIN, V35, P767, DOI 10.1016/j.iac.2015.07.008; de Vries E, 2006, CLIN EXP IMMUNOL, V145, P204, DOI 10.1111/j.1365-2249.2006.03138.x; Dinakar C, 2006, ANN ALLERG ASTHMA IM, V96, P260, DOI 10.1016/S1081-1206(10)61234-3; Gathmann B, 2013, CLIN EXP IMMUNOL, V173, P372, DOI 10.1111/cei.12105; Gathmann B, 2009, CLIN EXP IMMUNOL, V157, P3, DOI 10.1111/j.1365-2249.2009.03954.x; Guani-Guerra E, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/187254; HAYAKAWA H, 1981, J CLIN IMMUNOL, V1, P31, DOI 10.1007/BF00915474; Immune Deficiency Foundation, PRIM IMM DEF DIS AM; Kirkpatrick P, 2007, J CLIN IMMUNOL, V27, P517, DOI 10.1007/s10875-007-9105-z; Lim D. L., 2003, SMJ Singapore Medical Journal, V44, P579; Lim MS, 2004, J MOL DIAGN, V6, P59, DOI 10.1016/S1525-1578(10)60493-X; Lingman-Framme J, 2013, DRUGS, V73, P1307, DOI 10.1007/s40265-013-0094-3; Reyes SOL, 2016, J CLIN IMMUNOL, V36, P56, DOI 10.1007/s10875-015-0226-5; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P495; Ochs Hans D, 2013, PRIMARY IMMUNODEFICI; Picard C, 2015, J CLIN IMMUNOL, V35, P696, DOI 10.1007/s10875-015-0201-1; Raje N, 2015, IMMUNOL ALLERGY CLIN, V35, P599, DOI 10.1016/j.iac.2015.07.001; Ramirez-Vargas N, 2014, ALLERGOL IMMUNOPATH, V42, P235, DOI 10.1016/j.aller.2013.01.007; Rhim JW, 2012, J KOREAN MED SCI, V27, P788, DOI 10.3346/jkms.2012.27.7.788; Vultaggio A, 2015, CLIN DRUG INVEST, V35, P179, DOI 10.1007/s40261-015-0270-1; Wall LA, 2015, IMMUNOL ALLERGY CLIN, V35, P659, DOI 10.1016/j.iac.2015.07.003; Wang Li Yan, 2005, Prev Chronic Dis, V2, pA11; Wang LL, 2011, J CLIN IMMUNOL, V31, P297, DOI 10.1007/s10875-010-9493-3	29	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e175867	10.1371/journal.pone.0175867	http://dx.doi.org/10.1371/journal.pone.0175867			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448570	Green Published, gold			2022-12-26	WOS:000400383600028
J	Jeong, C; Peter, BM; Basnyat, B; Neupane, M; Beall, CM; Childs, G; Craig, SR; Novembre, J; Di Rienzo, A				Jeong, Choongwon; Peter, Benjamin M.; Basnyat, Buddha; Neupane, Maniraj; Beall, Cynthia M.; Childs, Geoff; Craig, Sienna R.; Novembre, John; Di Rienzo, Anna			A longitudinal cline characterizes the genetic structure of human populations in the Tibetan plateau	PLOS ONE			English	Article							HIGH-ALTITUDE ADAPTATION; EAST-ASIA; HISTORY; ADMIXTURE; JAPANESE; ORIGINS	Indigenous populations of the Tibetan plateau have attracted much attention for their good performance at extreme high altitude. Most genetic studies of Tibetan adaptations have used genetic variation data at the genome scale, while genetic inferences about their demography and population structure are largely based on uniparental markers. To provide genome-wide information on population structure, we analyzed new and published data of 338 individuals from indigenous populations across the plateau in conjunction with worldwide genetic variation data. We found a clear signal of genetic stratification across the eastwest axis within Tibetan samples. Samples from more eastern locations tend to have higher genetic affinity with lowland East Asians, which can be explained by more gene flow from lowland East Asia onto the plateau. Our findings corroborate a previous report of admixture signals in Tibetans, which were based on a subset of the samples analyzed here, but add evidence for isolation by distance in a broader geospatial context.	[Jeong, Choongwon; Peter, Benjamin M.; Novembre, John; Di Rienzo, Anna] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Basnyat, Buddha] Univ Oxford, Clin Res Unit, Patan Hosp, Kathmandu, Nepal; [Neupane, Maniraj] Mt Med Soc Nepal, Kathmandu, Nepal; [Beall, Cynthia M.] Case Western Reserve Univ, Dept Anthropol, Cleveland, OH 44106 USA; [Childs, Geoff] Washington Univ, Dept Anthropol, St Louis, MO 63130 USA; [Craig, Sienna R.] Dartmouth Coll, Dept Anthropol, Hanover, NH 03755 USA; [Jeong, Choongwon] Max Planck Inst Sci Human Hist, Res Grp Eurasia3angle, Jena, Germany; [Jeong, Choongwon] Max Planck Inst Sci Human Hist, Dept Archaeogenet, Jena, Germany	University of Chicago; University of Oxford; Case Western Reserve University; Washington University (WUSTL); Dartmouth College	Di Rienzo, A (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	dirienzo@bsd.uchicago.edu		Di Rienzo, Anna/0000-0002-8982-9098; Jeong, Choongwon/0000-0003-3049-2352	National Institute of Health grant [R01HL119577]; Biological Sciences Division at the University of Chicago; Institute for Translational Medicine, CTSA grant from the National Institutes of Health [UL1 TR000430]; Cancer Center Support Grant [P30 CA014599]; NATIONAL CANCER INSTITUTE [P30CA014599] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119577] Funding Source: NIH RePORTER; Direct For Social, Behav & Economic Scie [1153911] Funding Source: National Science Foundation	National Institute of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biological Sciences Division at the University of Chicago(University of Chicago); Institute for Translational Medicine, CTSA grant from the National Institutes of Health; Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This work was supported in part by the National Institute of Health grant R01HL119577 to AD. The Center for Research Informatics is funded by the Biological Sciences Division at the University of Chicago with additional funding provided by the Institute for Translational Medicine, CTSA grant number UL1 TR000430 from the National Institutes of Health. Genome-wide genotyping was performed at the Genomics Facility in the University of Chicago, with support from the Cancer Center Support Grant (P30 CA014599). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Shuhua Xu, Li Jin and Abigail Bigham for sharing of Tibetan genotype data. The Center for Research Informatics is funded by the Biological Sciences Division at the University of Chicago with additional funding provided by the Institute for Translational Medicine, CTSA grant number UL1 TR000430 from the National Institutes of Health. Genome-wide genotyping was performed at the Genomics Facility in the University of Chicago, with support from the Cancer Center Support Grant (P30 CA014599).	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Becker RA, 1995, AT T BELL LAB STAT R, V95, P2; Bigham A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001116; Bradburd GS, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005703; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Guedes JAD, 2015, P NATL ACAD SCI USA, V112, P5625, DOI 10.1073/pnas.1423708112; Hammer MF, 2006, J HUM GENET, V51, P47, DOI 10.1007/s10038-005-0322-0; Huerta-Sanchez E, 2014, NATURE, V512, P194, DOI 10.1038/nature13408; Jeong C, 2016, P NATL ACAD SCI USA, V113, P7485, DOI 10.1073/pnas.1520844113; Jeong CW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4281; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lorenzo FR, 2014, NAT GENET, V46, P951, DOI 10.1038/ng.3067; Oppitz M., 1974, KAILASH, V2, P121; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Petkova D, 2016, NAT GENET, V48, P94, DOI 10.1038/ng.3464; Qi XB, 2013, MOL BIOL EVOL, V30, P1761, DOI 10.1093/molbev/mst093; Shi H, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-45; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Stoneking M, 2010, CURR BIOL, V20, pR188, DOI 10.1016/j.cub.2009.11.052; Wang BB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017002; Wuren T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088252; Xiang K, 2013, MOL BIOL EVOL, V30, P1889, DOI 10.1093/molbev/mst090; Xu SH, 2011, MOL BIOL EVOL, V28, P1003, DOI 10.1093/molbev/msq277; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371	29	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e175885	10.1371/journal.pone.0175885	http://dx.doi.org/10.1371/journal.pone.0175885			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448508	gold, Green Published, Green Submitted			2022-12-26	WOS:000400383600030
J	Jost, K; Pramana, I; Delgado-Eckert, E; Kumar, N; Datta, AN; Frey, U; Schulzke, SM				Jost, Kerstin; Pramana, Isabelle; Delgado-Eckert, Edgar; Kumar, Nitin; Datta, Alexandre N.; Frey, Urs; Schulzke, Sven M.			Dynamics and complexity of body temperature in preterm infants nursed in incubators	PLOS ONE			English	Article							HEART-RATE CHARACTERISTICS; BIRTH-WEIGHT INFANTS; NEONATAL SEPSIS; SAMPLE ENTROPY; NEWBORN-INFANT; MATURATION; SURVIVAL; DISEASE; LIFE	Background Poor control of body temperature is associated with mortality and major morbidity in preterm infants. We aimed to quantify its dynamics and complexity to evaluate whether indices from fluctuation analyses of temperature time series obtained within the first five days of life are associated with gestational age (GA) and body size at birth, and presence and severity of typical comorbidities of preterm birth. Methods We recorded 3h-time series of body temperature using a skin electrode in incubator-nursed preterm infants. We calculated mean and coefficient of variation of body temperature, scaling exponent alpha (T-alpha) derived from detrended fluctuation analysis, and sample entropy (T-SampEn) of temperature fluctuations. Data were analysed by multilevel multivariable linear regression. Results Data of satisfactory technical quality were obtained from 285/357 measurements (80%) in 73/90 infants (81%) with a mean (range) GA of 30.1 (24.0-34.0) weeks. We found a positive association of Talpha with increasing levels of respiratory support after adjusting for GA and birth weight z-score (p<0.001; R-2 = 0.38). Conclusion Dynamics and complexity of body temperature in incubator-nursed preterm infants show considerable associations with GA and respiratory morbidity. Talpha may be a useful marker of autonomic maturity and severity of disease in preterm infants.	[Jost, Kerstin] Univ Basel, Dept Biomed Engn, Basel, Switzerland; [Jost, Kerstin; Pramana, Isabelle; Schulzke, Sven M.] Univ Basel, Childrens Hosp UKBB, Dept Neonatol, Basel, Switzerland; [Delgado-Eckert, Edgar; Kumar, Nitin] Univ Basel, Childrens Hosp UKBB, Computat Physiol & Biostat, Basel, Switzerland; [Datta, Alexandre N.; Frey, Urs] Univ Basel, Childrens Hosp UKBB, Dept Pediat, Basel, Switzerland	University of Basel; University of Basel; University of Basel; University of Basel	Jost, K (corresponding author), Univ Basel, Dept Biomed Engn, Basel, Switzerland.; Jost, K (corresponding author), Univ Basel, Childrens Hosp UKBB, Dept Neonatol, Basel, Switzerland.	kerstin.joot@ukbb.ch	Schulzke, Sven/ABA-2339-2020; Delgado-Eckert, Edgar/AEV-0018-2022	Delgado-Eckert, Edgar/0000-0001-6415-4971; Schulzke, Sven/0000-0002-5475-6239; Jost, Kerstin/0000-0001-5634-0774	Swiss National Science Foundation [141206]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation; Grant Number: 141206 (ww.snf.ch). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL EF, 1983, J PEDIATR-US, V103, P954, DOI 10.1016/S0022-3476(83)80729-X; Borghi-Silva A, 2015, EUR J PHYS REHAB MED, V51, P211; Bruck K, 1983, HUMAN PHYSL, P531; Cohen J., 2003, APPL MULTIPLE REGRES; Degorre C, 2015, ACTA PAEDIATR, V104, P581, DOI 10.1111/apa.12965; Deguines C, 2012, ACTA PAEDIATR, V101, P230, DOI 10.1111/j.1651-2227.2011.02492.x; Dollberg S, 2000, AM J PERINAT, V17, P47, DOI 10.1055/s-2000-7293; FLEMING PJ, 1993, ACTA PAEDIATR, V82, P57, DOI 10.1111/j.1651-2227.1993.tb12878.x; Frey U, 2005, NATURE, V438, P667, DOI 10.1038/nature04176; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; GOLDBERGER AL, 1987, ANN NY ACAD SCI, V504, P195, DOI 10.1111/j.1749-6632.1987.tb48733.x; Griffin MP, 2007, PEDIATR RES, V61, P222, DOI 10.1203/01.pdr.0000252438.65759.af; Griffin MP, 2004, PEDIATR RES, V55, P782, DOI 10.1203/01.PDR.0000119366.21770.9E; Hegger R, 1999, CHAOS, V9, P413, DOI 10.1063/1.166424; Hillsdale N, 1988, JC STAT POWER ANAL B; KANTZ H, 1995, CHAOS, V5, P143, DOI 10.1063/1.166096; Kantz H., 2004, NONLINEAR TIME SERIE; Knobel RB, 2009, J PERINATOL, V29, P814, DOI 10.1038/jp.2009.99; Lake DE, 2002, AM J PHYSIOL-REG I, V283, pR789, DOI 10.1152/ajpregu.00069.2002; Lyon AJ, 1997, ARCH DIS CHILD-FETAL, V76, pF47, DOI 10.1136/fn.76.1.F47; Mirmiran M, 2003, PEDIATR RES, V53, P933, DOI 10.1203/01.PDR.0000061541.94620.12; Moorman JR, 2011, PHYSIOL MEAS, V32, P1821, DOI 10.1088/0967-3334/32/11/S08; Museux N, 2008, MED PHYS, V35, P89, DOI 10.1118/1.2815966; Nakamura T, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.055201; New K, 2012, ARCH DIS CHILD-FETAL, V97, pF88, DOI 10.1136/adc.2011.213587; New K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004214.pub4; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; R Core Team, 2013, R LANG ENV STAT COMP; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; SAUER PJJ, 1984, PEDIATR RES, V18, P254, DOI 10.1203/00006450-198403000-00007; SILVERMAN WA, 1958, PEDIATRICS, V22, P876; SILVERMAN WA, 1966, NEW ENGL J MED, V274, P92, DOI 10.1056/NEJM196601132740207; SILVERMAN WA, 1966, NEW ENGL J MED, V274, P146, DOI 10.1056/NEJM196601202740306; Sinclair JC, 2002, COCHRANE DB SYST REV, V1, pD001074, DOI DOI 10.1002/14651858.CD001074; Stephan-Blanchard E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068211; Stern G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006431; Thomas K A, 1999, J Perinatol, V19, P264, DOI 10.1038/sj.jp.7200183; Thomas Karen A, 2003, J Perinatol, V23, P640, DOI 10.1038/sj.jp.7211002; van der Spek RDG, 2009, ACTA PAEDIATR, V98, P282, DOI 10.1111/j.1651-2227.2008.01063.x; Varela M, 2006, AM J RESP CRIT CARE, V174, P290, DOI 10.1164/rccm.200601-058OC; World Health Organization. Maternal and Newborn Health/Safe Motherhood, 1997, THERM PROT NEWB PRAC; Zeileis A, 2005, J STAT SOFTW, V14	42	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176670	10.1371/journal.pone.0176670	http://dx.doi.org/10.1371/journal.pone.0176670			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448569	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000400383600119
J	Bowman, EL; Liu, L				Bowman, Ellen Lambert; Liu, Lei			Individuals with severely impaired vision can learn useful orientation and mobility skills in virtual streets and can use them to improve real street safety	PLOS ONE			English	Article							VISUAL IMPAIRMENT; UNITED-STATES; REHABILITATION; SIMULATION; BALANCE; PEOPLE; BLIND	Virtual reality has great potential in training road safety skills to individuals with low vision but the feasibility of such training has not been demonstrated. We tested the hypotheses that low vision individuals could learn useful skills in virtual streets and could apply them to improve real street safety. Twelve participants, whose vision was too poor to use the pedestrian signals were taught by a certified orientation and mobility specialist to determine the safest time to cross the street using the visual and auditory signals made by the start of previously stopped cars at a traffic-light controlled street intersection. Four participants were trained in real streets and eight in virtual streets presented on 3 projection screens. The crossing timing of all participants was evaluated in real streets before and after training. The participants were instructed to say "GO" at the time when they felt the safest to cross the street. A safety score was derived to quantify the GO calls based on its occurrence in the pedestrian phase ( when the pedestrian sign did not show DON'T WALK). Before training, > 50% of the GO calls from all participants fell in the DON'T WALK phase of the traffic cycle and thus were totally unsafe. 20% of the GO calls fell in the latter half of the pedestrian phase. These calls were unsafe because one initiated crossing this late might not have sufficient time to walk across the street. After training, 90% of the GO calls fell in the early half of the pedestrian phase. These calls were safer because one initiated crossing in the pedestrian phase and had at least half of the pedestrian phase for walking across. Similar safety changes occurred in both virtual street and real street trained participants. An ANOVA showed a significant increase of the safety scores after training and there was no difference in this safety improvement between the virtual street and real street trained participants. This study demonstrated that virtual reality-based orientation and mobility training could be as efficient as real street training in improving street safety in individuals with severely impaired vision.	[Bowman, Ellen Lambert; Liu, Lei] Univ Alabama Birmingham, Sch Optometry, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Liu, L (corresponding author), Univ Alabama Birmingham, Sch Optometry, Birmingham, AL 35294 USA.	liul7788@uab.edu		Liu, Lei/0000-0002-1332-9724	Fellowship from the National Leadership Consortium in Sensory Disabilities; National Eye Institute [1R21EY019549, P30 EY003039]; NATIONAL EYE INSTITUTE [P30EY003039] Funding Source: NIH RePORTER	Fellowship from the National Leadership Consortium in Sensory Disabilities; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	ELB was supported by a Fellowship from the National Leadership Consortium in Sensory Disabilities. This work was supported by grants from the National Eye Institute (1R21EY019549 to LL and P30 EY003039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alliance for Aging Research, 2012, SILV BOOK VIS LOSS, VII; Botella C, 2004, ST HEAL T, V99, P37; Burdea GC, 2003, METHOD INFORM MED, V42, P519; Connors EC, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00223; Gallagher AG, 2005, ANN SURG, V241, P364, DOI 10.1097/01.sla.0000151982.85062.80; Grantcharov TP, 2008, NAT CLIN PRACT GASTR, V5, P232, DOI 10.1038/ncpgasthep1101; Jacobson W., 2013, ART SCI TEACHING ORI; Kalia AA, 2008, PERCEPTION, V37, P1677, DOI 10.1068/p5915; Katz N, 2005, DISABIL REHABIL, V27, P1235, DOI 10.1080/09638280500076079; Khalifa YM, 2006, SURV OPHTHALMOL, V51, P259, DOI 10.1016/j.survophthal.2006.02.005; Klinger E, 2004, ST HEAL T, V99, P91; LaGrow SJ., 1994, ORIENTATION MOBILITY; Lahav O., 2012, P INT C DIS VIRT REA, P393; Lam YS, 2004, P 5 INT C DIS VIRT R, P27; Lee HKM, 2003, AGE AGEING, V32, P643, DOI 10.1093/ageing/afg110; Maureen A, 2016, LOW VISION LEGAL BLI; McComas J, 2002, CYBERPSYCHOL BEHAV, V5, P185, DOI 10.1089/109493102760147150; McLay RN, 2011, CYBERPSYCH BEH SOC N, V14, P223, DOI 10.1089/cyber.2011.0003; Morganti F, 2004, ST HEAL T, V99, P55; National Eye Institute, 2010, BLINDNESS; National Eye Institute, 2010, LOW VIS BETH; Owsley C, 2009, ARCH OPHTHALMOL-CHIC, V127, P681, DOI 10.1001/archophthalmol.2009.55; Saposnik G, 2010, STROKE, V41, P1477, DOI 10.1161/STROKEAHA.110.584979; Schout BMA, 2010, SURG ENDOSC, V24, P536, DOI 10.1007/s00464-009-0634-9; Schwebel DC, 2010, INJURY PREV, V16, pE1, DOI 10.1136/ip.2009.025288; Seki Y, 2011, IEEE T NEUR SYS REH, V19, P95, DOI 10.1109/TNSRE.2010.2064791; Sveistrup H, 2003, CYBERPSYCHOL BEHAV, V6, P245, DOI 10.1089/109493103322011524; U.S. DEP'T OF TRANSP. FED. HIGHWAY ADMIN., 2009, MAN UN TRAFF CONTR D; Wada T, 2009, J AM GERIATR SOC, V57, P2369, DOI 10.1111/j.1532-5415.2009.02591.x; Willis JR, 2013, JAMA OPHTHALMOL, V131, P1049, DOI 10.1001/jamaophthalmol.2013.316	30	16	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176534	10.1371/journal.pone.0176534	http://dx.doi.org/10.1371/journal.pone.0176534			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445540	gold, Green Published, Green Submitted			2022-12-26	WOS:000400309200070
J	Heroux, ME; Loo, CK; Taylor, JL; Gandevia, SC				Heroux, Martin E.; Loo, Colleen K.; Taylor, Janet L.; Gandevia, Simon C.			Questionable science and reproducibility in electrical brain stimulation research	PLOS ONE			English	Article							FAILURE; BIAS; METAANALYSIS; INFERENCES; HEALTHY; TDCS	Electrical brain stimulation (EBS) is a trendy new technique used to change brain function and treat neurological, psychiatric and psychological disorders. We were curious whether the published literature, which is dominated by positive results, reflects the experience of researchers using EBS. Specifically, we wanted to know whether researchers are able to reproduce published EBS effects and whether they engage in, but fail to report, questionable research practices. We invited 976 researchers to complete an online survey. We also audited 100 randomly-selected published EBS papers. A total of 154 researchers completed the survey. Survey respondents had a median of 3 [1 to 6, IQR] published EBS papers (1180 total) and 2 [1 to 3] unpublished ones (380 total). With anodal and cathodal EBS, the two most widely used techniques, 45-50% of researchers reported being able to routinely reproduce published results. When asked about how study sample size was determined, 69% of respondents reported using the sample size of published studies, while 61% had used power calculations, and 32% had based their decision on pilot data. In contrast, our audit found only 6 papers where power calculations were used and a single paper in which pilot data was used. When asked about questionable research practices, survey respondents were aware of other researchers who selectively reported study outcomes (41%) and experimental conditions (36%), adjusted statistical analysis to optimise results (43%), and engaged in other shady practices (20%). Fewer respondents admitted to engaging in these practices themselves, although 25% admitted to adjusting statistical analysis to optimize results. There was strong agreement that such practices should be reported in research papers; however, our audit found only two such admissions. The present survey confirms that questionable research practices and poor reproducibility are present in EBS studies. The belief that EBS is effective needs to be replaced by a more rigorous approach so that reproducible brain stimulation methods can be devised and applied.	[Heroux, Martin E.; Taylor, Janet L.; Gandevia, Simon C.] Neurosci Res Australia, Randwick, NSW, Australia; [Heroux, Martin E.; Taylor, Janet L.; Gandevia, Simon C.] Univ New South Wale, Sch Med Sci, Sydney, NSW, Australia; [Loo, Colleen K.] Univ New South Wales, Sch Psychiat, Sydney, NSW, Australia; [Loo, Colleen K.] Univ New South Wales, Black Dog Inst, Sydney, NSW, Australia; [Loo, Colleen K.] St George Hosp, Dept Psychiat, Sydney, NSW, Australia; [Gandevia, Simon C.] Univ New South Wales, Prince Wales Clin Sch, Sydney, NSW, Australia	Neuroscience Research Australia; University of New South Wales Sydney; Black Dog Institute; University of New South Wales Sydney; St George Hospital; University of New South Wales Sydney	Gandevia, SC (corresponding author), Neurosci Res Australia, Randwick, NSW, Australia.; Gandevia, SC (corresponding author), Univ New South Wale, Sch Med Sci, Sydney, NSW, Australia.; Gandevia, SC (corresponding author), Univ New South Wales, Prince Wales Clin Sch, Sydney, NSW, Australia.	s.gandevia@neura.edu.au	Heroux, Martin/AAD-7694-2021; Taylor, Janet/C-9667-2011; Gandevia, Simon/D-5009-2011	Heroux, Martin/0000-0002-3354-7104; Taylor, Janet/0000-0001-8976-5162; Gandevia, Simon/0000-0002-1345-3821	National Health and Medical Research Council [APP1055084]; NHMRC grant	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NHMRC grant(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council (https://www.nhmrc.gov.au/),APP1055084. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank Dr. Andrew Cartwright for help implementing the online survey. This work was supported by an NHMRC grant (JLT, SCG).	Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Anderson MS, 2007, SCI ENG ETHICS, V13, P387, DOI 10.1007/s11948-007-9047-0; [Anonymous], 2016, PLOS BIOL, V14; Asendorpf JB, 2013, EUR J PERSONALITY, V27, P108, DOI 10.1002/per.1919; Baker M, 2016, NATURE, V533, P452, DOI 10.1038/533452a; Boutron I, 2010, JAMA-J AM MED ASSOC, V303, P2058, DOI 10.1001/jama.2010.651; Brunoni AR, 2016, BRIT J PSYCHIAT, V208, P522, DOI 10.1192/bjp.bp.115.164715; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Chambers CD, 2016, EUR J NEUROSCI; Chambers CD, 2013, CORTEX, V49, P609, DOI 10.1016/j.cortex.2012.12.016; Cumming G, 2016, INTRO NEW STAT; Curran-Everett D, 2004, AM J PHYSIOL-REG I, V287, pR247, DOI 10.1152/ajpregu.00346.2004; Curran-Everett D, 2017, J APPL PHYSIOL, V122, P91, DOI 10.1152/japplphysiol.00937.2016; Dedoncker J, 2016, BRAIN STIMUL, V9, P501, DOI 10.1016/j.brs.2016.04.006; Dubljevic V, 2014, NEURON, V82, P731, DOI 10.1016/j.neuron.2014.05.003; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Elsner B, 2016, COCHRANE DB SYST REV, V5; Elsner Bernhard, 2016, Cochrane Database Syst Rev, V7, pCD010916, DOI 10.1002/14651858.CD010916.pub2; Elsner B, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009645.pub3; Eysenbach G, 2002, J MED INTERNET RES, V4, DOI 10.2196/jmir.4.2.e13; Fiedler K, 2016, SOC PSYCHOL PERS SCI, V7, P45, DOI 10.1177/1948550615612150; Forstmeier W, 2017, BIOL REV, V92, P1941, DOI 10.1111/brv.12315; Franco A, 2014, SCIENCE, V345, P1502, DOI 10.1126/science.1255484; Halsey LG, 2015, NAT METHODS, V12, P179, DOI 10.1038/nmeth.3288; Hamada M, 2013, CEREB CORTEX, V23, P1593, DOI 10.1093/cercor/bhs147; Head ML, 2015, PLOS BIOL, V13, DOI [10.1371/journal.pbio.1002106, DOI 10.1371/JOURNAL.PBIO.1002106]; Heroux M, 2016, J NEUROPHYSIOL, V116, P1536, DOI 10.1152/jn.00550.2016; Heroux ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144151; Horvath JC, 2016, EXP BRAIN RES, V234, P2629, DOI 10.1007/s00221-016-4667-8; Horvath JC, 2015, NEUROPSYCHOLOGIA, V66, P213, DOI 10.1016/j.neuropsychologia.2014.11.021; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; John LK, 2012, PSYCHOL SCI, V23, P524, DOI 10.1177/0956797611430953; Johnson VE, 2013, P NATL ACAD SCI USA, V110, P19313, DOI 10.1073/pnas.1313476110; Kerr N L, 1998, Pers Soc Psychol Rev, V2, P196, DOI 10.1207/s15327957pspr0203_4; Koenigs M, 2009, CLIN NEUROPHYSIOL, V120, P80, DOI 10.1016/j.clinph.2008.10.010; Kreuter F, 2008, PUBLIC OPIN QUART, V72, P847, DOI 10.1093/poq/nfn063; Krumpal I, 2013, QUAL QUANT, V47, P2025, DOI 10.1007/s11135-011-9640-9; Lowe CJ, 2017, PSYCHOSOM MED, V79, P2, DOI 10.1097/PSY.0000000000000368; Mancuso LE, 2016, J COGNITIVE NEUROSCI, V28, P1063, DOI 10.1162/jocn_a_00956; Martinson BC, 2005, NATURE, V435, P737, DOI 10.1038/435737a; Nosek BA, 2015, SCIENCE, V348, P1422, DOI 10.1126/science.aab2374; O'Connell NE, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008208.pub3; Parkin BL, 2015, NEURON, V87, P932, DOI 10.1016/j.neuron.2015.07.032; Paulhus DL, 2002, ROLE OF CONSTRUCTS IN PYSCHOLOGICAL AND EDUCATIONAL MEASUREMENT, P49; Poldrack RA, 2017, NAT REV NEUROSCI, V18, P115, DOI 10.1038/nrn.2016.167; Schooler J, 2011, NATURE, V470, P437, DOI 10.1038/470437a; Shirahige L, 2016, HEADACHE, V56, P1565, DOI 10.1111/head.12981; Sills SJ, 2002, SOC SCI COMPUT REV, V20, P22, DOI 10.1177/089443930202000103; Smaldino PE, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160384; STERLING TD, 1959, J AM STAT ASSOC, V54, P30, DOI 10.2307/2282137; Sullivan PF, 2007, BIOL PSYCHIAT, V61, P1121, DOI 10.1016/j.biopsych.2006.11.010; The Academy of Medical Sciences, REPR REL BIOM RES IM; van de Mortel TF, 2008, AUST J ADV NURS, V25, P40; van Dijk D, 2014, CURR BIOL, V24, pR516, DOI 10.1016/j.cub.2014.04.039; Wicherts JM, 2006, AM PSYCHOL, V61, P726, DOI 10.1037/0003-066X.61.7.726; Wiethoff S, 2014, BRAIN STIMUL, V7, P468, DOI 10.1016/j.brs.2014.02.003; Zhu CE, 2017, J REHABIL MED, V49, P2, DOI 10.2340/16501977-2179	60	39	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0175635	10.1371/journal.pone.0175635	http://dx.doi.org/10.1371/journal.pone.0175635			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET5FI	28445482	Green Submitted, Green Published, gold			2022-12-26	WOS:000400309200025
J	Onuki, R; Yamaguchi, R; Shibuya, T; Kanehisa, M; Goto, S				Onuki, Ritsuko; Yamaguchi, Rui; Shibuya, Tetsuo; Kanehisa, Minoru; Goto, Susumu			Revealing phenotype-associated functional differences by genome-wide scan of ancient haplotype blocks	PLOS ONE			English	Article							RECENT POSITIVE SELECTION; POPULATION DIFFERENTIATION; NATURAL-SELECTION; GENETIC ARCHITECTURE; CANCER-RISK; DISEASE; LOCI; METAANALYSIS; VARIANTS; NEANDERTHAL	Genome-wide scans for positive selection have become important for genomic medicine, and many studies aim to find genomic regions affected by positive selection that are associated with risk allele variations among populations. Most such studies are designed to detect recent positive selection. However, we hypothesize that ancient positive selection is also important for adaptation to pathogens, and has affected current immune-mediated common diseases. Based on this hypothesis, we developed a novel linkage disequilibrium-based pipeline, which aims to detect regions associated with ancient positive selection across populations from single nucleotide polymorphism (SNP) data. By applying this pipeline to the genotypes in the International HapMap project database, we show that genes in the detected regions are enriched in pathways related to the immune system and infectious diseases. The detected regions also contain SNPs reported to be associated with cancers and metabolic diseases, obesity-related traits, type 2 diabetes, and allergic sensitization. These SNPs were further mapped to biological pathways to determine the associations between phenotypes and molecular functions. Assessments of candidate regions to identify functions associated with variations in incidence rates of these diseases are needed in the future.	[Onuki, Ritsuko] Natl Agr & Food Res Org NARO, Adv Anal Ctr, Bioinformat Team, 2-1-2 Kannondai, Tsukuba, Ibaraki, Japan; [Yamaguchi, Rui; Shibuya, Tetsuo] Univ Tokyo, Human Genome Ctr, Inst Med Sci, Minato Ku, 4-6-1 Shirokanedai, Tokyo, Japan; [Kanehisa, Minoru; Goto, Susumu] Kyoto Univ, Bioinformat Ctr, Inst Chem Res, Uji, Kyoto, Japan	National Agriculture & Food Research Organization - Japan; University of Tokyo; Kyoto University	Goto, S (corresponding author), Kyoto Univ, Bioinformat Ctr, Inst Chem Res, Uji, Kyoto, Japan.	goto@kuicr.kyoto-u.ac.dp	Kanehisa, Minoru/R-3081-2018		JSPS KAKENHI [26280105]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by JSPS KAKENHI (Grant number 26280105). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Masaaki Kotera for helpful discussions. We also thank Dr. Hiroaki Sakai for useful discussions and comments on this manuscript. The experiments in this work were done on the Super Computer System of the Human Genome Center, Institute of Medical Science, University of Tokyo. This work was supported in part by JSPS KAKENHI (Grant number 26280105).	Adeyemo A, 2010, PUBLIC HEALTH GENOMI, V13, P72, DOI 10.1159/000218711; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Amato R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007927; Bains Ripudaman K., 2013, Evolution Medicine and Public Health, P118, DOI 10.1093/emph/eot010; Bambha K, 2012, HEPATOLOGY, V55, P769, DOI 10.1002/hep.24726; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Benjamin DJ, 2012, P NATL ACAD SCI USA, V109, P8026, DOI 10.1073/pnas.1120666109; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Bonnelykke K, 2013, NAT GENET, V45, P902, DOI 10.1038/ng.2694; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Casto AM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001266; Chen H, 2010, GENOME RES, V20, P393, DOI 10.1101/gr.100545.109; Chen R, 2012, PLOS GENET, V8, P100, DOI 10.1371/journal.pgen.1002621; Clark SL, 2012, PSYCHOL MED, V42, P1151, DOI 10.1017/S003329171100239X; Comuzzie AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051954; Danik JS, 2009, CIRC-CARDIOVASC GENE, V2, P134, DOI 10.1161/CIRCGENETICS.108.825273; Ellinghaus E, 2012, LEUKEMIA, V26, P902, DOI 10.1038/leu.2011.302; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Fejerman L, 2010, CANCER EPIDEM BIOMAR, V19, P1074, DOI 10.1158/1055-9965.EPI-09-1193; Foroud T, 2012, STROKE, V43, P2846, DOI 10.1161/STROKEAHA.112.656397; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fumagalli M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002355; Gao XY, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-34; Gao XY, 2009, HUM HERED, V68, P182, DOI 10.1159/000224638; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Gu S, 2007, EUR J HUM GENET, V15, P302, DOI 10.1038/sj.ejhg.5201751; HEDRICK PW, 1987, GENETICS, V117, P331; Hesselink DA, 2003, CLIN PHARMACOL THER, V74, P245, DOI 10.1016/S0009-9236(03)00168-1; Huang BH, 2015, INNATE IMMUN-LONDON, V21, P463, DOI 10.1177/1753425914547744; Josephson F, 2007, CLIN PHARMACOL THER, V81, P708, DOI 10.1038/sj.clpt.6100117; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kang TW, 2010, HUM MOL GENET, V19, P3672, DOI 10.1093/hmg/ddq281; Karlsson EK, 2014, NAT REV GENET, V15, P379, DOI 10.1038/nrg3734; Kim S, 2015, GENE, V556, P199, DOI 10.1016/j.gene.2014.11.059; Kimura R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000286; Klimentidis YC, 2011, HUM GENET, V129, P407, DOI 10.1007/s00439-010-0935-z; Kwasniak LA, 2011, INT J DERMATOL, V50, P645, DOI 10.1111/j.1365-4632.2010.04826.x; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; LEWONTIN RC, 1964, GENETICS, V49, P49; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Liu XY, 2013, AM J HUM GENET, V92, P866, DOI 10.1016/j.ajhg.2013.04.021; Long JR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002532; Luisi P, 2012, MOL BIOL EVOL, V29, P1379, DOI 10.1093/molbev/msr298; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Marigorta UM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-55; McGue M, 2013, BEHAV GENET, V43, P363, DOI 10.1007/s10519-013-9606-x; Medland SE, 2009, AM J HUM GENET, V85, P750, DOI 10.1016/j.ajhg.2009.10.009; Myles S, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-22; Niikura M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/383962; Oleksyk TK, 2005, GENES IMMUN, V6, P347, DOI 10.1038/sj.gene.6364188; Onuki R, 2012, J COMPUT BIOL, V19, P55, DOI 10.1089/cmb.2010.0227; Pearlman BL, 2006, CLIN INFECT DIS, V42, P82, DOI 10.1086/498512; Pereira VA, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0548-z; PEYRON F, 1994, CLIN EXP IMMUNOL, V95, P300, DOI 10.1111/j.1365-2249.1994.tb06527.x; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Racimo F, 2016, GENETICS, V202, P733, DOI 10.1534/genetics.115.178095; Sabater-Lleal M, 2013, CIRCULATION, V128, P1310, DOI 10.1161/CIRCULATIONAHA.113.002251; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Setiawan VW, 2007, AM J EPIDEMIOL, V165, P262, DOI 10.1093/aje/kwk010; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Stafford HS, 2008, J UROLOGY, V179, P1704, DOI 10.1016/j.juro.2008.01.027; Tang K, 2007, PLOS BIOL, V5, P1587, DOI 10.1371/journal.pbio.0050171; Thompson EE, 2004, AM J HUM GENET, V75, P1059, DOI 10.1086/426406; Uno S, 2010, NAT GENET, V42, P707, DOI 10.1038/ng.612; Vernot B, 2014, SCIENCE, V343, P1017, DOI 10.1126/science.1245938; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Young JH, 2005, PLOS GENET, V1, P730, DOI 10.1371/journal.pgen.0010082; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007	77	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176530	10.1371/journal.pone.0176530	http://dx.doi.org/10.1371/journal.pone.0176530			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445522	gold, Green Published, Green Submitted			2022-12-26	WOS:000400309200069
J	Schneider, R; Bellenberg, B; Hoepner, R; Kolb, EM; Ellrichmann, G; Haghikia, A; Gold, R; Lukas, C				Schneider, Ruth; Bellenberg, Barbara; Hoepner, Robert; Kolb, Eva-Maria; Ellrichmann, Gisa; Haghikia, Aiden; Gold, Ralf; Lukas, Carsten			Metabolic profiles by H-1-magnetic resonance spectroscopy in natalizumab-associated post-PML lesions of multiple sclerosis patients who survived progressive multifocal leukoencephalopathy (PML)	PLOS ONE			English	Article							APPEARING WHITE-MATTER	Purpose Early diagnosis and treatment of multiple sclerosis-related progressive multifocal leukoencephalopathy (PML) significantly improve clinical outcomes. However, there is a lack of information regarding the restart of immunomodulatory therapy in the post-PML setting, when multiple sclerosis activity reappears. We aimed at the examination of metabolic differences using H-1-magnetic resonance spectroscopy (H-1-MRS) in multiple sclerosis patients at various post-PML stages and at the exploration of differences according to their disease and JC virus (JCV) status. Methods H-1-MRS of PML lesions was carried out on 15 relapsing-remitting multiple sclerosis patients with natalizumab-associated PML. Patients were grouped according to their stage after PML infection as early post-PML, less than 19 months after PML onset (n = 5), or late postPML group, more than 23 months after PML onset (n = 10). The latter group was further categorized according to persisting JCV load in the cerebrospinal fluid. Results Early post-PML patients showed significantly higher Lipid/Creatine ratios within PML lesions than late post-PML (p = 0.036). Furthermore, N-Acetyl-Aspartate/Creatine and N-AcetylAspartate/ Choline were significantly reduced in early post-PML and late post-PML lesions relative to normal-appearing white matter. In late post-PML, virus-positive patients showed significantly higher ratios of Choline/Creatine (p = 0.019) and consequently a reduced NAcetyl- Aspartate/Choline ratio (p = 0.010) in contrast to virus-negative patients. In late post-PML patients with persisting viral load, an elevated Choline/Creatine ratio correlated significantly with higher disability. Conclusions H-1-MRS may provide additional information related to underlying PML disease activity in various post-PML stages. In particular, Choline/Creatine levels, Lipid levels, and N-AcetylAspartate/Choline are relevant markers in the post-PML setting, taking also the JCV status into account.	[Schneider, Ruth; Hoepner, Robert; Kolb, Eva-Maria; Ellrichmann, Gisa; Haghikia, Aiden; Gold, Ralf] Ruhr Univ Bochum, St Josef Hospital, Dept Neurol, Bochum, Germany; [Bellenberg, Barbara; Lukas, Carsten] Ruhr Univ Bochum, St Josef Hospital, Dept Diagnost & Intervent Radiol & Nucl Med, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Schneider, R (corresponding author), Ruhr Univ Bochum, St Josef Hospital, Dept Neurol, Bochum, Germany.	ruth.schneider@rub.de	Bellenberg, Barbara/ABI-6463-2020; Lukas, Carsten/A-9767-2015	Lukas, Carsten/0000-0002-8562-9697; Bellenberg, Barbara/0000-0001-7484-6787; Schneider, Ruth/0000-0002-0997-2725; Hoepner, Robert/0000-0002-0115-7021	DFG Open Access Publication Funds of the Ruhr-Universitat Bochum	DFG Open Access Publication Funds of the Ruhr-Universitat Bochum	We acknowledge support by the DFG Open Access Publication Funds of the Ruhr-Universitat Bochum.	Berger JR, 2013, NEUROLOGY, V80, P1430, DOI 10.1212/WNL.0b013e31828c2fa1; Berghoff M, 2014, CLIN NEURORADIOL, V24, P173, DOI 10.1007/s00062-013-0216-z; Brickelmaier M, 2009, ANTIMICROB AGENTS CH, V53, P1840, DOI 10.1128/AAC.01614-08; Cinque P, 2009, LANCET INFECT DIS, V9, P625, DOI 10.1016/S1473-3099(09)70226-9; Dahlhaus S, 2013, J NEUROL NEUROSUR PS, V84, P1068, DOI 10.1136/jnnp-2013-304897; De Stefano N, 2005, J NEUROL SCI, V233, P203, DOI 10.1016/j.jns.2005.03.018; De Stefano N, 2007, J NEUROIMAGING, V17, p31S, DOI 10.1111/j.1552-6569.2007.00134.x; Delikatny EJ, 2011, NMR BIOMED, V24, P592, DOI 10.1002/nbm.1661; Dingley A J, 1994, Immunomethods, V4, P127, DOI 10.1006/immu.1994.1014; Elphick GF, 2004, SCIENCE, V306, P1380, DOI 10.1126/science.1103492; Filippi C G, 2011, AJNR Am J Neuroradiol, V32, pE156, DOI 10.3174/ajnr.A2305; Fleischer V, 2016, RADIOLOGY, V281, P536, DOI 10.1148/radiol.2016151654; Gheuens S, 2012, NEUROLOGY, V78, P1390, DOI [10.1212/WNL.0b013e318253d61e, 10.1212/01.wnl.0000423208.11698.16]; Gheuens S, 2012, NEUROLOGY, V79, P1041, DOI 10.1212/WNL.0b013e318268465b; He J, 2005, RADIOLOGY, V234, P211, DOI 10.1148/radiol.2341031895; Hoepner R, 2016, J NEUROL NEUROSUR PS, V87, P224, DOI 10.1136/jnnp-2014-310287; Hoepner R, 2016, MULTIPLE SCLEROSIS; Hoepner R, 2014, THER ADV NEUROL DISO, V7, P289, DOI 10.1177/1756285614556287; Iranzo A, 1999, J NEUROL NEUROSUR PS, V66, P520, DOI 10.1136/jnnp.66.4.520; Karnofsky DA, 1949, EVALUATION CHEMOTHER, P191; King N J, 1994, Immunomethods, V4, P188, DOI 10.1006/immu.1994.1019; Koopmans RA, 1993, LANCET, P341; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lin Alexander, 2005, NeuroRx, V2, P197, DOI 10.1602/neurorx.2.2.197; Linker RA, 2016, THER ADV CHRONIC DIS, V7, P198, DOI 10.1177/2040622316653307; Manenti G, 2013, CASE REP RADIOL, V2013; Mazzoni LN, 2010, RADIOL MED, V115, P125, DOI 10.1007/s11547-009-0408-4; Mohan S, 2010, NEURORADIOL J, V23, P269, DOI 10.1177/197140091002300302; Pavlovic D, 2015, THER ADV NEUROL DISO, V8, P255, DOI 10.1177/1756285615602832; Rudick R, 2013, JAMA NEUROL, V70, P172, DOI 10.1001/jamaneurol.2013.598; Sinnecker T, 2016, CASE REP NEUROL MED, V2016, DOI 10.1155/2016/5876798; Sinnecker T, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000171; Tuan DS, 2015, J NEUROVIROL, V21, P637, DOI [10.1007/s13365-015-0316-4, 10.1007/s13365-015]; Vermersch P, 2011, NEUROLOGY, V76, P1697, DOI 10.1212/WNL.0b013e31821a446b; Wenning W, 2009, NEW ENGL J MED, V361, P1075, DOI 10.1056/NEJMoa0810257; Wolinsky JS, 2002, CURR OPIN NEUROL, V15, P247, DOI 10.1097/00019052-200206000-00004	36	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176415	10.1371/journal.pone.0176415	http://dx.doi.org/10.1371/journal.pone.0176415			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445498	Green Submitted, Green Published, gold			2022-12-26	WOS:000400309200058
J	Warren, CM; Wilson, RC; van der Wee, NJ; Giltay, EJ; van Noorden, MS; Cohen, JD; Nieuwenhuis, S				Warren, Christopher M.; Wilson, Robert C.; van der Wee, Nic J.; Giltay, Eric J.; van Noorden, Martijn S.; Cohen, Jonathan D.; Nieuwenhuis, Sander			The effect of atomoxetine on random and directed exploration in humans	PLOS ONE			English	Article							LOCUS-COERULEUS; NORADRENERGIC SYSTEM; EXTRACELLULAR LEVELS; PREFRONTAL CORTEX; NEURONAL-ACTIVITY; PUPIL DIAMETER; ADAPTIVE GAIN; NEURAL GAIN; TRADE-OFF; NOREPINEPHRINE	The adaptive regulation of the trade-off between pursuing a known reward ( exploitation) and sampling lesser-known options in search of something better ( exploration) is critical for optimal performance. Theory and recent empirical work suggest that humans use at least two strategies for solving this dilemma: a directed strategy in which choices are explicitly biased toward information seeking, and a random strategy in which decision noise leads to exploration by chance. Here we examined the hypothesis that random exploration is governed by the neuromodulatory locus coeruleus-norepinephrine system. We administered atomoxetine, a norepinephrine transporter blocker that increases extracellular levels of norepinephrine throughout the cortex, to 22 healthy human participants in a double-blind crossover design. We examined the effect of treatment on performance in a gambling task designed to produce distinct measures of directed exploration and random exploration. In line with our hypothesis we found an effect of atomoxetine on random, but not directed exploration. However, contrary to expectation, atomoxetine reduced rather than increased random exploration. We offer three potential explanations of our findings, involving the non-linear relationship between tonic NE and cognitive performance, the interaction of atomoxetine with other neuromodulators, and the possibility that atomoxetine affected phasic norepinephrine activity more so than tonic norepinephrine activity.	[Warren, Christopher M.; Nieuwenhuis, Sander] Leiden Univ, Inst Psychol, Leiden, Netherlands; [Warren, Christopher M.; van der Wee, Nic J.; Nieuwenhuis, Sander] Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands; [Wilson, Robert C.] Univ Arizona, Dept Psychol, Tucson, AZ 85721 USA; [Wilson, Robert C.] Univ Arizona, Cognit Sci Program, Tucson, AZ USA; [van der Wee, Nic J.; Giltay, Eric J.; van Noorden, Martijn S.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands; [Cohen, Jonathan D.] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Cohen, Jonathan D.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Arizona; University of Arizona; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Princeton University; Princeton University	Warren, CM (corresponding author), Leiden Univ, Inst Psychol, Leiden, Netherlands.; Warren, CM (corresponding author), Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands.	cwarren2@bowdoin.edu	Warren, Christopher/N-9383-2019	Warren, Christopher/0000-0002-2541-7246	European Research Council [StG_2011 283314]	European Research Council(European Research Council (ERC)European Commission)	This research was supported by a Consolidator Grant of the European Research Council, number StG_2011 283314 to (CW) and by a Consolidator Grant of the European Research Council, number StG_2011 283314 to (SN). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Auer P, 2002, MACH LEARN, V47, P235, DOI 10.1023/A:1013689704352; Bari A, 2013, NEUROPHARMACOLOGY, V64, P53, DOI 10.1016/j.neuropharm.2012.07.020; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Boehm U, 2016, IMPORTANCE AVOIDING; Bridle J. S., 1990, PROC 2 INT C NEURAL, P211, DOI [10.5555/2969830, DOI 10.5555/2969830]; Bubeck S, 2012, FOUND TRENDS MACH LE, V5, P1, DOI 10.1561/2200000024; Bymaster FP, 2002, NEUROPSYCHOPHARMACOL, V27, P699, DOI 10.1016/S0893-133X(02)00346-9; CAMERER C, 1992, J RISK UNCERTAINTY, V5, P325, DOI 10.1007/BF00122575; Castelino CB, 2006, 2006 NEUROSCIENCE ME; Cavanagh JF, 2014, J EXP PSYCHOL GEN, V143, P1476, DOI 10.1037/a0035813; Chamberlain SR, 2007, J PSYCHOPHARMACOL, V21, P545, DOI 10.1177/0269881106075274; Cohen JD, 2007, PHILOS T R SOC B, V362, P933, DOI 10.1098/rstb.2007.2098; Efron B, 1977, STEINS PARADOX STAT; Eldar E, 2016, PSYCHOL SCI, V27, P1632, DOI 10.1177/0956797616665578; Eldar E, 2013, NAT NEUROSCI, V16, P1146, DOI 10.1038/nn.3428; Frank MJ, 2009, NAT NEUROSCI, V12, P1062, DOI 10.1038/nn.2342; Gilzenrat MS, 2010, COGN AFFECT BEHAV NE, V10, P252, DOI 10.3758/CABN.10.2.252; Gilzenrat MS, 2002, NEURAL NETWORKS, V15, P647, DOI 10.1016/S0893-6080(02)00055-2; Gittins J., 1974, PROGR STAT, P241; GITTINS JC, 1979, J ROY STAT SOC B MET, V41, P148; Heil SH, 2002, DRUG ALCOHOL DEPEN, V67, P149, DOI 10.1016/S0376-8716(02)00053-4; Invernizzi RW, 2004, PROG NEURO-PSYCHOPH, V28, P819, DOI 10.1016/j.pnpbp.2004.05.026; Jepma M, 2011, J COGNITIVE NEUROSCI, V23, P1587, DOI 10.1162/jocn.2010.21548; Jepma M, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00170; Joshi S, 2016, NEURON, V89, P221, DOI 10.1016/j.neuron.2015.11.028; Kaelbling LP, 1996, J ARTIF INTELL RES, V4, P237, DOI 10.1613/jair.301; KAHN BE, 1988, J CONSUM RES, V15, P265, DOI 10.1086/209163; Kane GA, 2015, 2015 NEUROSCIENCE ME; Kayser AS, 2015, NEUROPSYCHOPHARMACOL, V40, P454, DOI 10.1038/npp.2014.193; Koda K, 2010, J NEUROCHEM, V114, P259, DOI 10.1111/j.1471-4159.2010.06750.x; Kruschke JK, 2013, J EXP PSYCHOL GEN, V142, P573, DOI 10.1037/a0029146; Luksys G, 2009, NAT NEUROSCI, V12, P1180, DOI 10.1038/nn.2374; Murphy PR, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003854; Murphy PR, 2014, HUM BRAIN MAPP, V35, P4140, DOI 10.1002/hbm.22466; Nieuwenhuis S, 2011, PSYCHOPHYSIOLOGY, V48, P162, DOI 10.1111/j.1469-8986.2010.01057.x; RAJKOWSKI J, 1994, BRAIN RES BULL, V35, P607, DOI 10.1016/0361-9230(94)90175-9; Sauer JM, 2005, CLIN PHARMACOKINET, V44, P571, DOI 10.2165/00003088-200544060-00002; Schwartz S, 2014, J AM ACAD CHILD PSY, V53, P174, DOI 10.1016/j.jaac.2013.11.005; SERVANSCHREIBER D, 1990, SCIENCE, V249, P892, DOI 10.1126/science.2392679; Somerville LH, 2017, J EXP PSYCHOL GEN, V146, P155, DOI 10.1037/xge0000250; Strauss GP, 2011, BIOL PSYCHIAT, V69, P424, DOI 10.1016/j.biopsych.2010.10.015; Swanson CJ, 2006, NEUROPHARMACOLOGY, V50, P755, DOI 10.1016/j.neuropharm.2005.11.022; Tervo DGR, 2014, CELL, V159, P21, DOI 10.1016/j.cell.2014.08.037; Thompson WR, 1933, BIOMETRIKA, V25, P285, DOI 10.2307/2332286; Usher M, 1999, SCIENCE, V283, P549, DOI 10.1126/science.283.5401.549; VALENTINO RJ, 1988, J NEUROSCI, V8, P1016; Wagenmakers E.J, 2014, BAYESIAN COGNITIVE M, DOI DOI 10.1017/CBO9781139087759; Warren CM, 2016, J NEUROSCI, V36, P5699, DOI 10.1523/JNEUROSCI.3475-15.2016; Watkins C.J.C.H., 1989, LEARNING DELAYED REW; Wilson RC, 2014, J EXP PSYCHOL GEN, V143, P2074, DOI 10.1037/a0038199; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026; Zajkowski WK, 2016, CAUSAL ROLE RIGHT FR	56	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176034	10.1371/journal.pone.0176034	http://dx.doi.org/10.1371/journal.pone.0176034			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET5FI	28445519	gold, Green Published, Green Submitted			2022-12-26	WOS:000400309200032
J	Choi, EY; Kang, HG; Lee, CH; Yeo, A; Noh, HM; Gu, N; Kim, MJ; Song, JS; Kim, HC; Lee, HK				Choi, Eun Young; Kang, Hyun Goo; Lee, Chul Hee; Yeo, Areum; Noh, Hye Mi; Gu, Nayeong; Kim, Myoung Joon; Song, Jong Suk; Kim, Hyeon Chang; Lee, Hyung Keun			Langerhans cells prevent subbasal nerve damage and upregulate neurotrophic factors in dry eye disease	PLOS ONE			English	Article							CONFOCAL MICROSCOPIC EVALUATION; DENDRITIC CELL; CORNEAL; DENSITY; CYTOKINES; RECEPTOR; STRESS; TEARS; REGENERATION; INFLAMMATION	The functional role of Langerhans cells (LCs) in ocular surface inflammation and nerve damage in dry eye (DE) disease has yet to be determined. This study was performed to investigate this relationship through both clinical study on DE patients and in vivo mouse models with induced DE disease. In a cross-sectional case-control study (54 eyes of DE patients; 34 eyes of control patients), average cell density, area, and process length of LCs were measured using confocal microscopy. Data were analyzed to determine whether changes in LCs are correlated with subbasal nerve plexus (SNP) parameters (nerve density, beading, and tortuosity). In DE patients, SNP density marginally decreased and nerve beading and tortuosity were significantly increased compared to the control group. The total number of LCs significantly increased in DE patients, and some LCs with elongated processes were found to be attached to nerve fibers. Interestingly, nerve loss and deformation were correlated with inactivation of LCs. In an in vivo experiment to elucidate the role of LCs in ocular surface inflammation and corneal nerve loss, we used a genetically modified mouse model (CD207-DTR) that reduced the population of CD207 (Langerin) expressing cells by injection of diphtheria toxin. In CD207-depleted mice with DE disease (CD207-dDTR+DE), corneal nerves in the central region were significantly decreased, an effect that was not observed in wild-type (WT)+ DE mice. In CD207-dDTR+DE mice, infiltration of CD4+, CD19+, CD45+, and CD11b+ cells into the ocular surface was increased, as confirmed by flow cytometry. Increased IL-17 and IFN-gamma mRNA levels, and decreased expression of neurotrophic factors and neurotransmitters, were also found in the CD207-dDTR+DE mice. These data support a functional role for LCs in negatively regulating ocular surface inflammation and exhibiting a neuroprotective function in DE disease.	[Choi, Eun Young; Kang, Hyun Goo; Lee, Chul Hee; Yeo, Areum; Noh, Hye Mi; Gu, Nayeong; Lee, Hyung Keun] Yonsei Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Kim, Myoung Joon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Ophthalmol, Seoul, South Korea; [Song, Jong Suk] Korea Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Kim, Hyeon Chang] Yonsei Univ, Coll Med, Dept Prevent Med & Publ Hlth, Seoul, South Korea	Yonsei University; Yonsei University Health System; University of Ulsan; Asan Medical Center; Korea University; Korea University Medicine (KU Medicine); Yonsei University; Yonsei University Health System	Lee, HK (corresponding author), Yonsei Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea.	shadik@yuhs.ac	, James/ABG-8160-2020; Kang, Hyun Goo/C-5569-2018; Kim, Hyeon Chang/F-8796-2019; Choi, Eun Young/Y-5204-2018	Kang, Hyun Goo/0000-0001-8359-9618; Kim, Hyeon Chang/0000-0001-7867-1240; Lee, Chul Hee/0000-0002-4107-4677; Choi, Eun Young/0000-0002-1668-6452	faculty research grant, Yonsei University College of Medicine [6-2011-0111]; Korean Health Technology Research and Development Project; Ministry of Health and Welfare [HI13C0055-010016]; Basic Science Research Program through the National Research Foundation of Korea; Ministry of Science, Information and Communication Technology and Future Planning [NRF-2015R1A2A2A04002684]	faculty research grant, Yonsei University College of Medicine; Korean Health Technology Research and Development Project; Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Science, Information and Communication Technology and Future Planning	This study was supported by a faculty research grant, Yonsei University College of Medicine for 2011 (6-2011-0111), a grant from the Korean Health Technology Research and Development Project, the Ministry of Health and Welfare (HI13C0055-010016), and the Basic Science Research Program through the National Research Foundation of Korea, the Ministry of Science, Information and Communication Technology and Future Planning (NRF-2015R1A2A2A04002684).	Barabino S, 2005, INVEST OPHTH VIS SCI, V46, P2766, DOI 10.1167/iovs.04-1326; Bron AJ, 2003, CORNEA, V22, P640, DOI 10.1097/00003226-200310000-00008; Choi EY, 2015, CORNEAL MICROSTRUCTU, V56, P680; Chotikavanich S, 2009, INVEST OPHTH VIS SCI, V50, P3203, DOI 10.1167/iovs.08-2476; Coursey TG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078508; Dastjerdi Mohammad H, 2009, Int Ophthalmol Clin, V49, P11, DOI 10.1097/IIO.0b013e31819242c9; de Brouwer SJM, 2014, RHEUMATOLOGY, V53, P1844, DOI 10.1093/rheumatology/keu221; Doss ALN, 2014, NEUROSCI LETT, V578, P55, DOI 10.1016/j.neulet.2014.06.036; Eichenfield LF, 2015, J DRUGS DERMATOL, V14, P263; Forrester JV, 2010, IMMUNOL REV, V234, P282, DOI 10.1111/j.0105-2896.2009.00873.x; Forsythe P, 2012, CHEM IMMUNOL ALLERGY, V98, P196, DOI 10.1159/000336523; Hall JMF, 2012, DERMAT RES PRACT, V2012, DOI 10.1155/2012/403908; Hamrah Pedram, 2007, Chem Immunol Allergy, V92, P58, DOI 10.1159/000099254; Hattori T, 2011, INVEST OPHTH VIS SCI, V52, P4598, DOI 10.1167/iovs.10-6741; He JC, 2015, INVEST OPHTH VIS SCI, V56, P3505, DOI 10.1167/iovs.15-16755; HOSOI J, 1993, NATURE, V363, P159, DOI 10.1038/363159a0; Igyarto BZ, 2009, J IMMUNOL, V183, P5085, DOI 10.4049/jimmunol.0901884; Ji YW, 2014, INVESTIGATIVE OPHTHA, V55; Joachim RA, 2008, AM J PATHOL, V173, P1379, DOI 10.2353/ajpath.2008.080105; Kheirkhah A, 2015, INVEST OPHTH VIS SCI, V56, P7179, DOI 10.1167/iovs.15-17433; Kheirkhah A, 2015, OPHTHALMOLOGY, V122, P662, DOI 10.1016/j.ophtha.2014.11.006; King JK, 2015, J IMMUNOL, V195, P464, DOI 10.4049/jimmunol.1402735; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Lam H, 2009, AM J OPHTHALMOL, V147, P198, DOI 10.1016/j.ajo.2008.08.032; Lambiase A, 2011, ARCH OPHTHALMOL-CHIC, V129, P981, DOI 10.1001/archophthalmol.2011.200; Lee HK, 2006, OPHTHALMOLOGY, V113, P198, DOI 10.1016/j.ophtha.2005.09.033; Liang CM, 2014, CYTOTHERAPY, V16, P1371, DOI 10.1016/j.jcyt.2014.05.015; Machetta F, 2014, OPEN OPHTHALMOL J, V8, P51, DOI 10.2174/1874364101408010051; Madva EN, 2013, BRAIN BEHAV IMMUN, V34, P1, DOI 10.1016/j.bbi.2013.03.006; Malissen B, 2014, NAT REV IMMUNOL, V14, P417, DOI 10.1038/nri3683; Marsovszky L, 2013, INNATE IMMUN-LONDON, V19, P348, DOI 10.1177/1753425912461677; Massingale ML, 2009, CORNEA, V28, P1023, DOI 10.1097/ICO.0b013e3181a16578; Mathers AR, 2009, J IMMUNOL, V182, P921, DOI 10.4049/jimmunol.182.2.921; Mehling A, 2001, J EXP MED, V194, P615, DOI 10.1084/jem.194.5.615; Meng ID, 2013, EXP EYE RES, V117, P79, DOI 10.1016/j.exer.2013.08.011; Merad M, 2008, NAT REV IMMUNOL, V8, P935, DOI 10.1038/nri2455; Mikami N, 2011, J IMMUNOL, V186, P6886, DOI 10.4049/jimmunol.1100028; Nichols KK, 2011, INVEST OPHTH VIS SCI, V52, P1922, DOI 10.1167/iovs.10-6997a; Oliveira-Soto L, 2001, CORNEA, V20, P374, DOI 10.1097/00003226-200105000-00008; Peters EMJ, 2012, ANN NY ACAD SCI, V1262, P118, DOI 10.1111/j.1749-6632.2012.06647.x; Pflugfelder SC, 2013, EXP EYE RES, V117, P118, DOI 10.1016/j.exer.2013.08.013; Renn CN, 2006, J IMMUNOL, V177, P298, DOI 10.4049/jimmunol.177.1.298; Saban DR, 2014, OCUL SURF, V12, P87, DOI 10.1016/j.jtos.2013.10.007; Seiffert K, 2006, ANN NY ACAD SCI, V1088, P195, DOI 10.1196/annals.1366.011; Shim J, 2012, OPHTHALMOLOGY, V119, P2211, DOI 10.1016/j.ophtha.2012.05.038; Shornick LP, 2001, CELL IMMUNOL, V211, P105, DOI 10.1006/cimm.2001.1834; Steinhoff M, 2013, J AM ACAD DERMATOL, V69, pS15, DOI 10.1016/j.jaad.2013.04.045; Tan X, 2014, EYE, V28, P608, DOI 10.1038/eye.2014.38; Tuisku IS, 2008, EXP EYE RES, V86, P879, DOI 10.1016/j.exer.2008.03.002; Valladeau J, 2000, IMMUNITY, V12, P71, DOI 10.1016/S1074-7613(00)80160-0; van der Vlist M, 2010, IMMUNOL CELL BIOL, V88, P410, DOI 10.1038/icb.2010.32; Zhivov A, 2007, CORNEA, V26, P47, DOI 10.1097/ICO.0b013e31802e3b55	52	27	29	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176153	10.1371/journal.pone.0176153	http://dx.doi.org/10.1371/journal.pone.0176153			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441413	Green Published, gold, Green Submitted			2022-12-26	WOS:000400308800029
J	Park, HYL; Ha, MJ; Shin, SY				Park, Hae-Young Lopilly; Ha, Min Ji; Shin, Sun Young			The effect of parental factors in children with large cup-to-disc ratios	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; FIBER LAYER THICKNESS; CLINICAL CHARACTERISTICS; POPULATION; MEGALOPAPILLA; HERITABILITY; APPEARANCE; GLAUCOMA; TWIN; EYE	Background To investigate large cup-to-disc ratios (CDR) in children and to determine the relationship between parental CDR and clinical characteristics associated with glaucoma. Methods Two hundred thirty six children aged 6 to 12 years with CDR >= 0.6 were enrolled in this study. Subjects were classified into two groups based on parental CDR: disc suspect children with disc suspect (CDR >= 0.6) parents and disc suspect children without disc suspect parents. Ocular variables were compared between the two groups. Results Of the 236 disc suspect children, 100 (42.4%) had at least one disc suspect parent. Intraocular pressure (IOP) was higher in disc suspect children with disc suspect parents (16.52 +/- 2.66 mmHg) than in disc suspect children without disc suspect parents (14.38 +/- 2.30 mmHg, p = 0.023). In the group with disc suspect parents, vertical CDR significantly correlated with IOP (R = -0.325, p = 0.001), average retinal nerve fiber layer (RNFL) thickness (R = -0.319, p = 0.001), rim area (R = -0.740, p = 0.001), and cup volume (R = 0.499, p = 0.001). However, spherical equivalent (R = 0.333, p = 0.001), AL (R = -0.223, p = 0.009), and disc area (R = 0.325, p = 0.001) significantly correlated with vertical CDR in disc suspect children without disc suspect parents, in contrast to those with disc suspect parents. Larger vertical CDR was associated with the presence of disc suspect parents (p = 0.001), larger disc area (p = 0.001), thinner rim area (p = 0.001), larger average CDR (p = 0.001), and larger cup volume (p = 0.021). Conclusions and relevance Family history of large CDR was a significant factor associated with large vertical CDR in children. In children with disc suspect parents, there were significant correlations between IOP and average RNFL thickness and vertical CDR.	[Park, Hae-Young Lopilly; Ha, Min Ji; Shin, Sun Young] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Ophthalmol & Visual Sci, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital	Shin, SY (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Ophthalmol & Visual Sci, Seoul, South Korea.	eyeshin@catholic.ac.kr						ALEXANDER KL, 1978, J AM OPTOM ASSOC, V49, P1056; Aponte EP, 2010, ARCH OPHTHALMOL-CHIC, V128, P478, DOI 10.1001/archophthalmol.2010.41; Costa AMC, 2014, J GLAUCOMA, V23, P368, DOI 10.1097/IJG.0b013e318279b3af; Creavin AL, 2016, SYST REV, V5, DOI 10.1186/s13643-016-0247-z; Fleiss J.L., 2013, STAT METHODS RATES P; Flores-Rodriguez P, 2012, OPHTHALMOLOGICA, V228, P59, DOI 10.1159/000337842; FRANCESCHETTI A, 1950, AM J OPHTHALMOL, V33, P227, DOI 10.1016/0002-9394(50)90841-5; He MG, 2008, INVEST OPHTH VIS SCI, V49, P1350, DOI 10.1167/iovs.07-1146; Healey P, 2008, INVEST OPHTH VIS SCI, V49, P77, DOI 10.1167/iovs.07-0962; Huynh SC, 2006, OPHTHALMOLOGY, V113, P1583, DOI 10.1016/j.ophtha.2006.02.067; Inuzuka H, 2015, J GLAUCOMA; Jacobson L, 1997, ARCH OPHTHALMOL-CHIC, V115, P1263, DOI 10.1001/archopht.1997.01100160433007; Kang MT, 2016, CLIN EXPT OPHTHALMOL; Lasseck J, 2008, GRAEF ARCH CLIN EXP, V246, P1463, DOI 10.1007/s00417-008-0863-y; Lee HS, 2015, ACTA OPHTHALMOL, V93, pE301, DOI 10.1111/aos.12545; MARRAFFA M, 1995, DOC OPHTHALMOL, V89, P383, DOI 10.1007/BF01203713; McMonnies CW., 2016, J OPTOMETRY; Mwanza JC, 2011, OPHTHALMOLOGY, V118, P241, DOI 10.1016/j.ophtha.2010.06.036; O'Gallagher MK, 2012, EUR J OPHTHALMOL, V22, P840, DOI 10.5301/ejo.5000142; Pakravan M, 2017, ACTA OPHTHALMOL, V95, pE144, DOI 10.1111/aos.13231; Piette SD, 2006, CURR OPIN OPHTHALMOL, V17, P1, DOI 10.1097/01.icu.0000193072.17122.f3; Ramrattan RS, 1999, OPHTHALMOLOGY, V106, P1588, DOI 10.1016/S0161-6420(99)90457-8; Randhawa S, 2007, ARCH OPHTHALMOL-CHIC, V125, P1134, DOI 10.1001/archopht.125.8.1134; Salchow DJ, 2006, OPHTHALMOLOGY, V113, P786, DOI 10.1016/j.ophtha.2006.01.036; Samarawickrama C, 2012, BRIT J OPHTHALMOL, V96, P68, DOI 10.1136/bjo.2010.197426; Sampaolesi Roberto, 2001, International Ophthalmology, V23, P251, DOI 10.1023/A:1014409404579; Siatkowski RM, 2013, J AAPOS, V17, P129, DOI 10.1016/j.jaapos.2012.10.022; VARMA R, 1994, ARCH OPHTHALMOL-CHIC, V112, P1068, DOI 10.1001/archopht.1994.01090200074026	28	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0175900	10.1371/journal.pone.0175900	http://dx.doi.org/10.1371/journal.pone.0175900			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441443	Green Published, gold, Green Submitted			2022-12-26	WOS:000400308800011
J	de Souza, GR; Hounkpe, BW; Fiusa, MML; Colella, MP; Annichino-Bizzacchi, JM; Traina, F; Costa, FF; De Paula, EV				de Souza, Gleice Regina; Hounkpe, Bidossessi Wilfried; Luz Fiusa, Maiara Marx; Colella, Marina Pereira; Annichino-Bizzacchi, Joyce M.; Traina, Fabiola; Costa, Fernando Ferreira; De Paula, Erich Vinicius			Tissue factor-dependent coagulation activation by heme: A thromboelastometry study	PLOS ONE			English	Article							SICKLE-CELL-DISEASE; SEVERE HEMOPHILIA-A; VENOUS THROMBOEMBOLISM; THROMBIN GENERATION; INNATE IMMUNITY; WHOLE-BLOOD; FACTOR-VIIA; HEMATIN; MICE; HYPERCOAGULABILITY	Heme has been characterized as potent trigger of inflammation. In hemostasis, although heme has been shown to both induce and inhibit different compartments of hemostasis, its net effect on the hemostatic balance, and the biological relevance of these effects remain to be determined. Herein we evaluated the effect of heme on hemostasis using a global assay able to generate clinically relevant data in several other complex hemostatic diseases. Citrated whole blood samples from healthy participants were stimulated by heme or vehicle and incubated for 4h at 37 degrees C. Rotational thromboelastometry was immediately performed. The participation of tissue factor in coagulation activation was evaluated using inhibitory antibody. Heme was able of inducing ex vivo coagulation activation in whole blood, affecting predominantly parameters associated with the initial phases of clot formation. This activation effect was at least partially dependent on hematopoietic tissue factor, since the effects of heme were partially abrogated by the inhibition of human tissue factor. In conclusion, using a global hemostasis assay, our study confirmed that heme is able to activate coagulation in whole blood, in a tissue factor-dependent way. These findings could explain the disturbance in hemostatic balance observed in conditions associated with the release of heme such as sickle cell disease.	[de Souza, Gleice Regina; Hounkpe, Bidossessi Wilfried; Luz Fiusa, Maiara Marx; Annichino-Bizzacchi, Joyce M.; Costa, Fernando Ferreira; De Paula, Erich Vinicius] Univ Estadual Campinas, Fac Med Sci, Campinas, SP, Brazil; [Colella, Marina Pereira; Annichino-Bizzacchi, Joyce M.; Costa, Fernando Ferreira; De Paula, Erich Vinicius] Univ Estadual Campinas, Hematol & Hemotherapy Ctr, Campinas, SP, Brazil; [Traina, Fabiola] Univ Sao Paulo, Ribeirao Preto, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade de Sao Paulo	Hounkpe, BW (corresponding author), Univ Estadual Campinas, Fac Med Sci, Campinas, SP, Brazil.	bidossessi1@live.fr	Costa, Fernando F/D-1566-2012; De Paula, Erich Vinicius/C-5943-2012; Traina, Fabiola/U-1451-2019; Hounkpe, Bidossessi/ABD-9587-2021; Traina, Fabiola/L-3809-2014; CTC USP, CEPID 13 18/J-8951-2014	Costa, Fernando F/0000-0002-4632-572X; De Paula, Erich Vinicius/0000-0003-1539-7912; Traina, Fabiola/0000-0003-4258-289X; Hounkpe, Bidossessi/0000-0002-9992-1939; Traina, Fabiola/0000-0003-4258-289X; CTC USP, CEPID 13 18/0000-0002-7123-9524	Fapesp [2013/09319-0, 2014/00984-3, 2015/24666-3]; CNPq-Brazil [2014/457780]	Fapesp(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was financially supported by Fapesp grants 2013/09319-0, 2014/00984-3 and 2015/24666-3; and CNPq-Brazil grant 2014/457780. The Hematology and Hemotherapy Center-Hemocentro UNICAMP, forms part of the National Institute of Science and Technology of Blood, Brazil (INCT do SangueCNPq / MCT / FAPESP). The funders had no role in study design,data collection and analysis, decision to publish, or preparation of the manuscript.	Adisa OA, 2013, BRIT J HAEMATOL, V162, P702, DOI 10.1111/bjh.12445; Arumugam PI, 2015, BLOOD, V126, P1844, DOI 10.1182/blood-2015-01-625707; Belcher JD, 2014, BLOOD, V123, P377, DOI 10.1182/blood-2013-04-495887; Chantrathammachart P, 2012, BLOOD, V120, P636, DOI 10.1182/blood-2012-04-424143; Colella MP, 2012, J THROMB HAEMOST, V10, P1967, DOI 10.1111/j.1538-7836.2012.04861.x; Colella MP, 2015, HAEMATOLOGICA, V100, P469, DOI 10.3324/haematol.2014.114587; Dutra FF, 2014, P NATL ACAD SCI USA, V111, pE4110, DOI 10.1073/pnas.1405023111; Engelmann B, 2013, NAT REV IMMUNOL, V13, P34, DOI 10.1038/nri3345; Fernandez PL, 2010, J BIOL CHEM, V285, P32844, DOI 10.1074/jbc.M110.146076; Figueiredo RT, 2007, J BIOL CHEM, V282, P20221, DOI 10.1074/jbc.M610737200; Gerotziafas GT, 2012, THROMB HAEMOSTASIS, V107, P1044, DOI 10.1160/TH11-10-0689; GLUECK R, 1983, BLOOD, V61, P243; Gorlinger K, 2016, TRAUMA INDUCED COAGU, P267; GREEN D, 1983, J LAB CLIN MED, V102, P361; HILLMEN P, 1995, NEW ENGL J MED, V333, P1253, DOI 10.1056/NEJM199511093331904; Hounkpe BW, 2015, SCI REP-UK, V5, DOI 10.1038/srep17822; Kaplan D, 2015, CHEST, V148, P1224, DOI 10.1378/chest.15-0287; Lim MY, 2013, CURR OPIN HEMATOL, V20, P472, DOI 10.1097/MOH.0b013e328363442f; MCCOLL KEL, 1981, Q J MED, V50, P161; Meszaros K, MONOCYTE TISSUE FACT; MORRIS DL, 1981, ANN INTERN MED, V95, P700, DOI 10.7326/0003-4819-95-6-700; MULLEREBERHARD U, 1968, BLOOD, V32, P811, DOI 10.1182/blood.V32.5.811.811; Naik RP, 2014, J THROMB HAEMOST, V12, P2010, DOI 10.1111/jth.12744; NEELY SM, 1984, BRIT J HAEMATOL, V58, P305, DOI 10.1111/j.1365-2141.1984.tb06089.x; Nielsen VG, 2011, BLOOD COAGUL FIBRIN, V22, P443, DOI 10.1097/MBC.0b013e328345c069; Nogami K, 2016, BRIT J HAEMATOL, V174, P503, DOI 10.1111/bjh.14148; Noubouossie D, 2015, BLOOD REV; Oh JY, 2016, REDOX BIOL, V9, P167, DOI 10.1016/j.redox.2016.08.003; Pawlinski R, 2010, BLOOD, V116, P806, DOI 10.1182/blood-2009-12-259267; Rea CJ, 2014, J THROMB HAEMOST, V12, P159, DOI 10.1111/jth.12478; Rea CJ, 2011, J THROMB HAEMOST, V9, P510, DOI 10.1111/j.1538-7836.2010.04171.x; Rehani T, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.2215.2215; Repesse Y, 2012, J THROMB HAEMOST, V10, P1062, DOI 10.1111/j.1538-7836.2012.04724.x; Roumenina LT, 2016, TRENDS MOL MED, V22, P200, DOI 10.1016/j.molmed.2016.01.004; Schneider T, 2015, HAMOSTASEOLOGIE, V35, P181, DOI 10.5482/HAMO-14-08-0033; Schoergenhofer C, 2017, CLIN EXP MED, P1; Setty BNY, 2008, J THROMB HAEMOST, V6, P2202, DOI 10.1111/j.1538-7836.2008.03177.x; Skaf E, 2005, AM J CARDIOL, V96, P1731, DOI 10.1016/j.amjcard.2005.07.097; Soares MP, 2016, CURR OPIN IMMUNOL, V38, P94, DOI 10.1016/j.coi.2015.11.006; Sorensen B, 2003, J THROMB HAEMOST, V1, P551, DOI 10.1046/j.1538-7836.2003.00075.x; Sorensen B, 2007, BRIT J HAEMATOL, V137, P158, DOI 10.1111/j.1365-2141.2007.06534.x; Sparkenbaugh E, 2013, BRIT J HAEMATOL, V162, P3, DOI 10.1111/bjh.12336; Sparkenbaugh EM, 2015, HAEMATOLOGICA, V100, P308, DOI 10.3324/haematol.2014.114728; Tarzia Vincenzo, 2015, World J Cardiol, V7, P571, DOI 10.4330/wjc.v7.i9.571; Tjonnfjord GE, 2015, HAEMOPHILIA, V21, P275; Tolosano E, 2010, ANTIOXID REDOX SIGN, V12, P305, DOI 10.1089/ars.2009.2787; Van Geffen M, 2012, THROMB RES, P681; Vasconcellos LRC, 2016, P NATL ACAD SCI USA; Whelihan MF, 2016, J THROMB HAEMOST, V14, P1941, DOI 10.1111/jth.13416; Whiting D, 2014, AM J HEMATOL, V89, P228, DOI 10.1002/ajh.23599; Yee DL, 2005, ARCH PATHOL LAB MED, V129, P760	51	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176505	10.1371/journal.pone.0176505	http://dx.doi.org/10.1371/journal.pone.0176505			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437457	Green Published, Green Submitted, gold			2022-12-26	WOS:000400287600051
J	McNairy, ML; Joseph, P; Unterbrink, M; Galbaud, S; Mathon, JE; Rivera, V; Jannat-Khah, D; Reif, L; Koenig, SP; Domercant, JW; Johnson, W; Fitzgerald, DW; Pape, JW				McNairy, Margaret L.; Joseph, Patrice; Unterbrink, Michelle; Galbaud, Stanislas; Mathon, Jean-Edouard; Rivera, Vanessa; Jannat-Khah, Deanna; Reif, Lindsey; Koenig, Serena P.; Domercant, Jean Wysler; Johnson, Warren; Fitzgerald, Daniel W.; Pape, Jean W.			Outcomes after antiretroviral therapy during the expansion of HIV services in Haiti	PLOS ONE			English	Article							ELECTRONIC MEDICAL-RECORD; TREATMENT PROGRAMS; FOLLOW-UP; HIV-1-INFECTED PATIENTS; INFECTED PATIENTS; ADULT PATIENTS; LATIN-AMERICA; 1ST YEAR; CARE; MORTALITY	Background We report patient outcomes after antiretroviral therapy (ART) initiation in a network of HIV facilities in Haiti, including temporal trends and differences across clinics, during the expansion of HIV services in the country. Methods We assessed outcomes at 12 months after ART initiation (baseline) using routinely collected data on adults (>= 15 years) in 11 HIV facilities from July 2007-December 2013. Outcomes include death (ascertained from medical records), lost to follow-up (LTF) defined as no visit > 365 days from ART initiation, and retention defined as being alive and attending care >= 365 days from ART initiation. Outcomes were compared across calendar year of ART initiation and across facilities. Risk factors for death and LTF were assessed using Cox proportional hazards and competing risk regression models. Results Cumulatively, 9,718 adults initiated ART with median age 37 years (IQR 3-46). Median CD4 count was 254 cells/ uL (IQR 139-350). Twelve months after ART initiation, 4.4% (95% CI 4.0-4.8) of patients died, 21.7% (95% CI 20.9-22.6) were LTF, and 73.9% (95% CI 73.0-74.8) were retained in care. Twelve-month mortality decreased from 13.8% among adults who started ART in 2007 to 4.4% in 2013 (p< 0.001). Twelve-month LTF after ART start was 29.2% in 2007, 18.7% in 2008, and increased to 30.1% in 2013 (p< 0.001). Overall, twelve-month retention after ART start did not change over time but varied widely across facilities from 61.1% to 86.5%. Conclusion Expansion of HIV services across Haiti has been successful with increasing numbers of patients initiating ART and decreasing twelve-month mortality rates. However, overall retention has not improved, despite differences across facilities, suggesting additional strategies to improve engagement in care are needed.	[McNairy, Margaret L.; Reif, Lindsey; Johnson, Warren; Fitzgerald, Daniel W.; Pape, Jean W.] Weill Cornell Med Coll, Ctr Global Hlth, New York, NY 10065 USA; [McNairy, Margaret L.; Unterbrink, Michelle; Jannat-Khah, Deanna] Weill Cornell Med Coll, Div Gen Med, New York, NY 10065 USA; [Joseph, Patrice; Galbaud, Stanislas; Mathon, Jean-Edouard; Rivera, Vanessa; Pape, Jean W.] Haitian Study Grp Kaposis Sarcoma & Opportunist I, Port Au Prince, Haiti; [Koenig, Serena P.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA; [Domercant, Jean Wysler] Ctr Dis Control & Prevent, Port Au Prince, Haiti	Cornell University; Cornell University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	McNairy, ML (corresponding author), Weill Cornell Med Coll, Ctr Global Hlth, New York, NY 10065 USA.; McNairy, ML (corresponding author), Weill Cornell Med Coll, Div Gen Med, New York, NY 10065 USA.	Mam9365@med.cornell.edu	Jannat-Khah, Deanna/L-9701-2019	Jannat-Khah, Deanna/0000-0002-1091-379X	Centers for Disease Control Grants [U2GGH000545, U2GGH000541]; National Institutes of Allergy and Infectious Diseases [R01A1104344]; President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention under the terms of the cooperative agreements [U2GGH000545, U2GGH000541]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069421, K24AI098627, R01AI104344] Funding Source: NIH RePORTER	Centers for Disease Control Grants; National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention under the terms of the cooperative agreements; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this analysis is supported by Centers for Disease Control Grants U2GGH000545 and U2GGH000541 and the National Institutes of Allergy and Infectious Diseases grant number R01A1104344. CDC Disclaimer: The findings and conclusion of this report or (research, article, publication, poster etc.) are those of the author(s) and do not necessarily represent the official position of the Centers for Disease Control and Prevention. PEPFAR Attribution: This report or (research, article, publication, poster etc.) has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention under the terms of the cooperative agreements: U2GGH000545 and U2GGH000541.	Aliyu MH, 2015, PATHOG GLOB HEALTH, V109, P75, DOI 10.1179/2047773215Y.0000000007; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Auld AF, 2014, MMWR-MORBID MORTAL W, V63, P1097; Auld AF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098183; Auld AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018453; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Carriquiry G, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20016; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; Coviello V, 2004, STATA J, V4, P103, DOI 10.1177/1536867X0400400201; Farahani M, 2016, TROP MED INT HEALTH, V21, P18, DOI 10.1111/tmi.12623; Farmer P, 2001, B WORLD HEALTH ORGAN, V79, P1145; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fox MP, 2015, JAIDS-J ACQ IMM DEF, V69, P98, DOI 10.1097/QAI.0000000000000553; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Geng EH, 2016, CLIN INFECT DIS, V62, P935, DOI 10.1093/cid/civ1004; Grimsrud A, 2014, JAIDS-J ACQ IMM DEF, V67, pE55, DOI 10.1097/QAI.0000000000000268; Johnson LF, 2014, AM J EPIDEMIOL, V180, P1208, DOI 10.1093/aje/kwu295; Johnson LF, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001418; Koenig SP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146903; Koenig SP, 2012, JAIDS-J ACQ IMM DEF, V59, pE60, DOI 10.1097/QAI.0b013e318245d3c1; Koole O, 2014, TROP MED INT HEALTH, V19, P1397, DOI 10.1111/tmi.12386; Leger P, 2009, NEW ENGL J MED, V361, P828, DOI 10.1056/NEJMc0809485; Matheson AI, 2012, INT J MED INFORM, V81, P244, DOI 10.1016/j.ijmedinf.2012.01.011; McGowan CC, 2007, INT J EPIDEMIOL, V36, P969, DOI 10.1093/ije/dym073; McNairy ML, 2015, JAIDS-J ACQ IMM DEF, V70, pE44, DOI 10.1097/QAI.0000000000000745; Moise C BC, 2016, C RETR OPP INF BOST; Nglazi MD, 2011, JAIDS-J ACQ IMM DEF, V56, pE1, DOI 10.1097/QAI.0b013e3181ff0bdc; Pape JW, 2014, JAIDS-J ACQ IMM DEF, V65, pS5, DOI 10.1097/QAI.0000000000000031; Pierre S, 2016, NEW ENGL J MED, V374, P397, DOI 10.1056/NEJMc1508934; Puttkammer N, 2016, INT J MED INFORM, V86, P104, DOI 10.1016/j.ijmedinf.2015.11.003; Puttkammer N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112261; Reif LK, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20859; Rouzier V, 2014, ANTIVIR THER, V19, P91, DOI 10.3851/IMP2904; Severe P, 2005, NEW ENGL J MED, V353, P2325, DOI 10.1056/NEJMoa051908; Tuboi SH, 2009, JAIDS-J ACQ IMM DEF, V51, P615, DOI 10.1097/QAI.0b013e3181a44f0a; UNAIDS, 2021, YOUNG PEOPL HIV; UNAIDS, 2014, DECL ENG VIH SIDA RA; UNAIDS, 2014, HAIT EP FACT SHEET; WHO, 2016, WHO BMI CLASS; *WHO, SUMM COUNTR PROF HIV; WHO, 2006, AN THER HIV INF AD A; World Health Organization, 2009, RAP ADV ANT THER HIV	45	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0175521	10.1371/journal.pone.0175521	http://dx.doi.org/10.1371/journal.pone.0175521			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437477	Green Published, Green Submitted, gold			2022-12-26	WOS:000400287600008
J	Pileggi, SM; Jordan, H; Clennon, JA; Whitney, E; Benbow, ME; Merritt, R; McIntosh, M; Kimbirauskas, R; Small, P; Boakye, D; Quaye, C; Qi, JG; Campbell, L; Gronseth, J; Ampadu, E; Opare, W; Waller, LA				Pileggi, Shannon M.; Jordan, Heather; Clennon, Julie A.; Whitney, Ellen; Benbow, M. Eric; Merritt, Richard; McIntosh, Mollie; Kimbirauskas, Ryan; Small, Pamela; Boakye, Daniel; Quaye, Charles; Qi, Jiaguo; Campbell, Lindsay; Gronseth, Jenni; Ampadu, Edwin; Opare, William; Waller, Lance A.			Landscape and environmental influences on Mycobacterium ulcerans distribution among aquatic sites in Ghana	PLOS ONE			English	Article							BURULI ULCER; RISK-FACTORS; DISEASE; INFECTION; TRANSMISSION; DYNAMICS; INSECTS; OUTBREAK; ECOLOGY; GROWTH	Buruli ulcer, caused by Mycobacterium ulcerans, is highly endemic in West Africa. While the mode of transmission is unknown, many studies associate Buruli ulcer with different types of water exposure. We present results from the largest study to date to test for M. ulcerans in aquatic sites and identify environmental attributes associated with its presence. Environmental samples from 98 aquatic sites in the Greater Accra, Ashanti, and Volta regions of Ghana were tested for the presence of M. ulcerans DNA by polymerase chain reaction. The proportion of aquatic sites positive for M. ulcerans varied by region: Ashanti 66% (N = 39), Greater Accra 34% (N = 29), and Volta 0% (N = 30). We explored the spatial distribution of M. ulcerans positive and negative water bodies and found no significant clusters. We also determined both highly localized water attributes and broad scale remotely sensed land cover and terrain environmental characteristics associated with M. ulcerans presence through logistic regression. Our results concur with published results regarding conditions suitable for M. ulcerans growth and associations with Buruli ulcer disease burden with regards to water characteristics and disturbed environments, but differ from others with regards to spatial associations and topographic effects such as elevation and wetness. While our results suggest M. ulcerans is an environmental organism existing in a specific ecological niche, they also reveal variation in the elements defining this niche across the sites considered. In addition, despite the causal association between Buruli ulcer and M.ulcerans, we observed no significant statistical association between case reports of Buruli ulcer and presence of M. ulcerans in nearby waterbodies.	[Pileggi, Shannon M.] Calif Polytech State Univ San Luis Obispo, Dept Stat, San Luis Obispo, CA 93407 USA; [Jordan, Heather] Mississippi State Univ, Dept Biol Sci, Starkville, MS USA; [Clennon, Julie A.; Waller, Lance A.] Emory Univ, Dept Biostat & Bioinformat, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Whitney, Ellen] Emory Univ, Int Assoc Natl Publ Hlth Inst Off, Atlanta, GA 30322 USA; [Benbow, M. Eric; Merritt, Richard; Kimbirauskas, Ryan] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; [Benbow, M. Eric] Michigan State Univ, Dept Osteopath Med Specialties, E Lansing, MI 48824 USA; [McIntosh, Mollie] Xavier Univ, Dept Biol, Cincinnati, OH 45207 USA; [Small, Pamela] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Boakye, Daniel; Quaye, Charles] Univ Ghana, Noguchi Mem Inst Med Res, Dept Parasitol, Accra, Ghana; [Qi, Jiaguo; Gronseth, Jenni] Michigan State Univ, Ctr Global Change & Earth Observat, E Lansing, MI 48824 USA; [Campbell, Lindsay] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Ampadu, Edwin; Opare, William] Natl Buruli Ulcer Control Programme, Accra, Ghana	California State University System; California Polytechnic State University San Luis Obispo; Mississippi State University; Emory University; Rollins School Public Health; Emory University; Michigan State University; Michigan State University; Xavier University; University of Tennessee System; University of Tennessee Knoxville; University of Ghana; Michigan State University; University of Kansas	Pileggi, SM (corresponding author), Calif Polytech State Univ San Luis Obispo, Dept Stat, San Luis Obispo, CA 93407 USA.	spileggi@calpoly.edu	Qi, Jiaguo/AAC-4106-2020; Waller, Lance A./AAA-1012-2021; Benbow, Mark/V-5895-2019; aubertin, rebeckah/O-9624-2015	aubertin, rebeckah/0000-0002-0558-7571	World Health Organization; Fogarty International Center through the NIH/NSF Ecology of Infectious Diseases Program [R01TW007550]; National Institute of Environmental Health Sciences [R01ES015525];  [R03A1062719]	World Health Organization(World Health Organization); Fogarty International Center through the NIH/NSF Ecology of Infectious Diseases Program; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); 	This work was supported by the World Health Organization and the project described was funded by Grant Number R01TW007550 from the Fogarty International Center through the NIH/NSF Ecology of Infectious Diseases Program, and grant number R03A1062719 to RWM, MEB, JQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also supported by the National Institute of Environmental Health Sciences R01ES015525 to Lance Waller. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiga H, 2004, AM J TROP MED HYG, V71, P387, DOI 10.4269/ajtmh.2004.71.387; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; [Anonymous], 2004, QUAL ASS QUAL CONTR; BARKER DJP, 1973, T ROY SOC TROP MED H, V67, P43, DOI 10.1016/0035-9203(73)90317-9; Benbow ME, 2008, EMERG INFECT DIS, V14, P1247, DOI 10.3201/eid1408.071503; Benbow ME, 2014, ECOHEALTH, V11, P168, DOI 10.1007/s10393-013-0886-7; Beven KJ., 1979, HYDROL SCI J, V24, P43, DOI [10.1080/ 02626667909491834, 10.1080/02626667909491834, DOI 10.1080/02626667909491834]; BOISVERT H, 1977, B SOC PATHOL EXOT, V70, P125; Brou T, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000271; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Campbell LP, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004123; Collett D., 2003, MODELING BINARY DATA; Diggle PJ, 2007, ANN TROP MED PARASIT, V101, P499, DOI [10.1179/136485913X13789813917463, 10.1179/136485907X229121]; Diggle PJ, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-48536-2; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Duker AA, 2006, ENVIRON INT, V32, P567, DOI 10.1016/j.envint.2006.01.002; Duker AA, 2006, INT J APPL EARTH OBS, V8, P126, DOI 10.1016/j.jag.2005.06.013; Eddyani M, 2004, APPL ENVIRON MICROB, V70, P5679, DOI 10.1128/AEM.70.9.5679-5681.2004; Garchitorena A, 2014, PLOS NEG TROP DIS, V8; Guerra M, 2002, EMERG INFECT DIS, V8, P289, DOI 10.3201/eid0803.010166; Hagarty J, 2015, J HYDROL-REG STUD, V3, P457, DOI 10.1016/j.ejrh.2015.03.006; Hausermann H, 2012, ECOHEALTH, V9, P251, DOI 10.1007/s10393-012-0780-8; HAYMAN JA, 1991, MED J AUSTRALIA, V155, P130, DOI 10.5694/j.1326-5377.1991.tb142151.x; Horsburgh C. Robert Jr., 1997, P119; Jenkin GA, 2003, J BACTERIOL, V185, P6870, DOI 10.1128/JB.185.23.6870-6882.2003; Johnson PDR, 2007, EMERG INFECT DIS, V13, P1653, DOI 10.3201/eid1311.061369; Kenu E, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003279; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kulldorff M, 2009, SATSCAN 8 0 SOFTWARE; Lamour K, 2006, MYCOLOGIA, V98, P514, DOI 10.3852/mycologia.98.3.514; Landier J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003123; Landsat ETM, 2000, USGS SIOUX FALLS; Mantey S, 2014, INT J SCI RES, V3, P1714; Marion E, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000731; Marsollier L, 2004, APPL ENVIRON MICROB, V70, P1097, DOI 10.1128/AEM.70.2.1097-1103.2004; Marsollier L, 2002, APPL ENVIRON MICROB, V68, P4623, DOI 10.1128/AEM.68.9.4623-4628.2002; McIntosh M, 2014, ECOHEALTH, V11, P184, DOI 10.1007/s10393-013-0898-3; Merritt RW, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000911; Merritt RW, 2005, FRONT ECOL ENVIRON, V3, P323, DOI 10.1890/1540-9295(2005)003[0323:UAEDAW]2.0.CO;2; Meyers WM, 1996, BRIT J DERMATOL, V134, P1116, DOI 10.1111/j.1365-2133.1996.tb07955.x; MITCHELL PJ, 1984, PATHOLOGY, V16, P256, DOI 10.3109/00313028409068533; Mosi L, 2008, APPL ENVIRON MICROB, V74, P7036, DOI 10.1128/AEM.01234-08; Palomino JC, 1998, J CLIN MICROBIOL, V36, P3420, DOI 10.1128/JCM.36.11.3420-3422.1998; Pascual M, 2000, SCIENCE, V289, P1766, DOI 10.1126/science.289.5485.1766; Pileggi S, DRYAD DIGITAL REPOSI; Portaels F, 1999, LANCET, V353, P986, DOI 10.1016/S0140-6736(98)05177-0; Portaels F, 2001, REV SCI TECH OIE, V20, P252, DOI 10.20506/rst.20.1.1270; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RADFORD AJ, 1975, AUST NZ J MED, V5, P162, DOI 10.1111/j.1445-5994.1975.tb03649.x; Raghunathan PL, 2005, CLIN INFECT DIS, V40, P1445, DOI 10.1086/429623; REVILL WDL, 1972, BRIT J PREV SOC MED, V26, P23; Ross BC, 1997, APPL ENVIRON MICROB, V63, P4135, DOI 10.1128/AEM.63.10.4135-4138.1997; Stinear T, 2000, APPL ENVIRON MICROB, V66, P3206, DOI 10.1128/AEM.66.8.3206-3213.2000; Stinear TP, 2004, P NATL ACAD SCI USA, V101, P1345, DOI 10.1073/pnas.0305877101; Thangaraj HS, 1999, T ROY SOC TROP MED H, V93, P337, DOI 10.1016/S0035-9203(99)90104-9; van der Werf TS, 2005, B WORLD HEALTH ORGAN, V83, P785; Wagner T, 2008, ECOHEALTH, V5, P69, DOI 10.1007/s10393-007-0148-7; Wagner T, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-25; Waller L.A., 2004, APPL SPATIAL STAT PU; WHO, 2021, BURULI ULCER MYCOBAC; Williamson H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088007; Williamson HR, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000205; Williamson HR, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001506; Wu JY, 2016, AM J TROP MED HYG, V95, P63, DOI 10.4269/ajtmh.15-0647; Yeboah-Manu D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001460	65	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176375	10.1371/journal.pone.0176375	http://dx.doi.org/10.1371/journal.pone.0176375			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437439	Green Published, Green Submitted, gold			2022-12-26	WOS:000400287600045
J	Droop, J; Szarvas, T; Schulz, WA; Niedworok, C; Niegisch, G; Scheckenbach, K; Hoffmann, MJ				Droop, Johanna; Szarvas, Tibor; Schulz, Wolfgang A.; Niedworok, Christian; Niegisch, Guenter; Scheckenbach, Kathrin; Hoffmann, Michele J.			Diagnostic and prognostic value of long noncoding RNAs as biomarkers in urothelial carcinoma	PLOS ONE			English	Article							CANCER CELL-PROLIFERATION; BLADDER-CANCER; GENE-EXPRESSION; UP-REGULATION; IDENTIFICATION; METASTASIS; ANRIL; TUG1; CONTRIBUTES; SIGNATURE	Many long noncoding RNAs (lncRNAs) are deregulated in cancer and contribute to oncogenesis. In urothelial carcinoma (UC), several lncRNAs have been reported to be overexpressed and proposed as biomarkers. As most reports have not been confirmed independently in large tissue sets, we aimed to validate the diagnostic and prognostic value of lncRNA upregulation in independent cohorts of UC patients. Thus, expression of seven lncRNA candidates (GAS5, H19, linc-UBC1, MALAT1, ncRAN, TUG1, UCA1) was measured by RT-qPCR in cell lines and tissues and correlated to clinicopathological parameters including follow-up data (set 1: N n = 10; T n = 106). Additionally, publicly available TCGA data was investigated for differential expression in UC tissues (set 2: N n = 19; T n = 252,) and correlation to overall survival (OS). All proposed candidates tended to be upregulated in tumour tissues, with the exception of MALAT1, which was rather diminished in cancer tissues of both data sets. However, strong overexpression was generally limited to individual tumour tissues and statistically significant overexpression was only observed for UCA1, TUG1, ncRAN and linc-UBC1 in tissue set 2, but for no candidate in set 1. Altered expression of individual lncRNAs was associated with overall survival, but not consistently between both patient cohorts. Interestingly, lower expression of TUG1 in a subset of UC patients with muscle-invasive tumours was significantly correlated with worse OS in both cohorts. Further analysis revealed that tumours with low TUG1 expression are characterized by a basal-squamous-like subtype signature accounting for the association with poor outcome. In conclusion, our study demonstrates that overexpression of the candidate lncRNAs is found in many UC cases, but does not occur consistently and strongly enough to provide reliable diagnostic or prognostic value as an individual biomarker. Subtype-dependent expression patterns of lncRNAs like TUG1 could become useful to stratify patients by molecular subtype, thus aiding personalized treatments.	[Droop, Johanna; Schulz, Wolfgang A.; Niegisch, Guenter; Hoffmann, Michele J.] Heinrich Heine Univ Duesseldorf, Med Fac, Dept Urol, Dusseldorf, Germany; [Szarvas, Tibor; Niedworok, Christian] Univ Duisburg Essen, Med Fac, Dept Urol, Essen, Germany; [Szarvas, Tibor] Semmelweis Univ Budapest, Dept Urol, Budapest, Hungary; [Scheckenbach, Kathrin] Heinrich Heine Univ Duesseldorf, Med Fac, Dept Otolaryngol, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; University of Duisburg Essen; Semmelweis University; Heinrich Heine University Dusseldorf	Hoffmann, MJ (corresponding author), Heinrich Heine Univ Duesseldorf, Med Fac, Dept Urol, Dusseldorf, Germany.	michele.hoffmann@hhu.de	Schulz, Wolfgang/N-3402-2019; Niegisch, Günter/AAX-3069-2021; SZARVAS, t./L-4422-2017; Hoffmann, Michele J./AAL-1028-2020; Niegisch, Günter/GSD-3569-2022	Schulz, Wolfgang/0000-0002-2196-463X; Niegisch, Günter/0000-0001-6929-8691; SZARVAS, t./0000-0002-6321-0799; 	Duesseldorf School of Oncology (Comprehensive Cancer Centre Duesseldorf/Deutsche Krebshilfe); Duesseldorf School of Oncology (Medical Faculty Heinrich-Heine-University Duesseldorf)	Duesseldorf School of Oncology (Comprehensive Cancer Centre Duesseldorf/Deutsche Krebshilfe); Duesseldorf School of Oncology (Medical Faculty Heinrich-Heine-University Duesseldorf)	Johanna Droop is supported by a fellowship of the Duesseldorf School of Oncology (funded by the Comprehensive Cancer Centre Duesseldorf/Deutsche Krebshilfe and the Medical Faculty Heinrich-Heine-University Duesseldorf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIEL I, 1995, UROLOGY, V45, P335, DOI 10.1016/0090-4295(95)80030-1; Buttigliero C, 2017, CANCER TREAT REV, V54, P1, DOI 10.1016/j.ctrv.2017.01.002; Cao Q, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/796786; Chapman EJ, 2009, GENE CHROMOSOME CANC, V48, P694, DOI 10.1002/gcc.20672; Chen JJ, 2016, J CANCER, V7, P1842, DOI 10.7150/jca.15876; Dadhania V, 2016, EBIOMEDICINE, V12, P105, DOI 10.1016/j.ebiom.2016.08.036; Earl J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1450-3; Eissa S, 2015, TUMOR BIOL, V36, P9545, DOI 10.1007/s13277-015-3722-6; Eissmann M, 2012, RNA BIOL, V9, P1076, DOI 10.4161/rna.21089; Fan Y, 2014, CLIN CANCER RES, V20, P1531, DOI 10.1158/1078-0432.CCR-13-1455; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Greife A, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-29; Haemmerle M, 2015, INT J MOL SCI, V16, P1395, DOI 10.3390/ijms16011395; Han YH, 2013, J SURG ONCOL, V107, P555, DOI 10.1002/jso.23264; Han YH, 2013, UROLOGY, V81, DOI 10.1016/j.urology.2012.08.044; He W, 2013, BBA-MOL BASIS DIS, V1832, P1528, DOI 10.1016/j.bbadis.2013.05.010; Hedegaard J, 2016, CANCER CELL, V30, P1; Heubach J, 2015, MOL CANCER, V14, P361; Hoffmann Michele J., 2015, Non-Coding RNA, V1, P266, DOI 10.3390/ncrna1030266; Iliev R, 2016, TUMOUR BIOL; Lerner SP, 2016, BLADDER CANCER, V2, P37, DOI 10.3233/BLC-150037; Li J, 2015, CANCER RES, V75, P3728, DOI 10.1158/0008-5472.CAN-15-0273; Li SS, 2015, 2015 11TH INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE AND SECURITY (CIS), P1, DOI 10.1109/CIS.2015.9; Liu Z, 2013, PLOS ONE, V2013, P8, DOI DOI 10.1371/J0URNAL.P0NE.0083549; Luo M, 2013, FEBS J, V280, P1709, DOI 10.1111/febs.12185; Martens-Uzunova ES, 2014, EUR UROL, V65, P1140, DOI 10.1016/j.eururo.2013.12.003; Martinez-Fernandez M, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0141-x; Mengual L, 2010, CLIN CANCER RES, V16, P2624, DOI 10.1158/1078-0432.CCR-09-3373; Milowich D, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1092-6; Ohl F, 2006, J UROLOGY, V175, P1915, DOI 10.1016/S0022-5347(05)00919-5; Qi P, 2015, MOL CARCINOGEN, V54, P742, DOI 10.1002/mc.22137; Ronnau CGH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/591703; Srivastava AK, 2014, TUMOR BIOL, V35, P11435, DOI 10.1007/s13277-014-2474-z; Tan JM, 2015, FEBS LETT, V589, P3175, DOI 10.1016/j.febslet.2015.08.020; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang XS, 2006, CLIN CANCER RES, V12, P4851, DOI 10.1158/1078-0432.CCR-06-0134; Wu Y, 2015, TUMOR BIOL, P1; Yan J, 2016, MOL CLIN ONCOL, V4, P100, DOI 10.3892/mco.2015.657; Yan TH, 2014, TUMOR BIOL, V35, P10249, DOI 10.1007/s13277-014-2344-8; Ying L, 2013, MOL BIOSYST, V9, P407, DOI 10.1039/c2mb25386k; Ying L, 2012, MOL BIOSYST, V8, P2289, DOI 10.1039/c2mb25070e; Yu M, 2009, INT J ONCOL, V34, P931, DOI 10.3892/ijo_00000219; Zhang EB, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.201; Zhu HX, 2015, BIOCHEM BIOPH RES CO, V467, P223, DOI 10.1016/j.bbrc.2015.10.002; Zhu YY, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2010.09.022	45	39	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0176287	10.1371/journal.pone.0176287	http://dx.doi.org/10.1371/journal.pone.0176287			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430799	Green Published, gold, Green Submitted			2022-12-26	WOS:000399876100039
J	Francois, L; Wijnrocx, K; Colinet, FG; Gengler, N; Hulsegge, B; Windig, JJ; Buys, N; Janssens, S				Francois, Liesbeth; Wijnrocx, Katrien; Colinet, Frederic G.; Gengler, Nicolas; Hulsegge, Bettine; Windig, Jack J.; Buys, Nadine; Janssens, Steven			Genomics of a revived breed: Case study of the Belgian campine cattle	PLOS ONE			English	Article							GENETIC DIVERSITY; POPULATION; INTROGRESSION; HOMOZYGOSITY; VORDERWALD; HINTERWALD; AUROCHS; ORIGIN; RUNS	Through centuries of both natural and artificial selection, a variety of local cattle populations arose with highly specific phenotypes. However, the intensification and expansion of scale in animal production systems led to the predominance of a few highly productive cattle breeds. The loss of local populations is often considered irreversible and with them specific qualities and rare variants could be lost as well. Over these last years, the interest in these local breeds has increased again leading to increasing efforts to conserve these breeds or even revive lost populations, e.g. through the use of crosses with similar breeds. However, the remaining populations are expected to contain crossbred individuals resulting from introgressions. They are likely to carry exogenous genes that affect the breed's authenticity on a genomic level. Using the revived Campine breed as a case study, 289 individuals registered as purebreds were genotyped on the Illumina BovineSNP50. In addition, genomic information on the Illumina BovineHD and Illumina BovineSNP50 of ten breeds was available to assess the current population structure, genetic diversity, and introgression with phenotypically similar and/or historically related breeds. Introgression with Holstein and beef cattle genotypes was limited to only a few farms. While the current population shows a substantial amount of within-breed variation, the majority of genotypes can be separated from other breeds in the study, supporting the re-establishment of the Campine breed. The majority of the population is genetically close to the Deep Red (NL), Improved Red (NL) and Eastern Belgium Red and White (BE) cattle, breeds known for their historical ties to the Campine breed. This would support an open herdbook policy, thereby increasing the population size and consequently providing a more secure future for the breed.	[Francois, Liesbeth; Wijnrocx, Katrien; Buys, Nadine; Janssens, Steven] Katholieke Univ Leuven, Res Grp Livestock Genet, Dept Biosyst, Leuven, Belgium; [Colinet, Frederic G.; Gengler, Nicolas] Univ Liege, Gembloux Agrobio Tech Agr, Agr Bioengn & Chem Dept, Gembloux, Belgium; [Hulsegge, Bettine; Windig, Jack J.] Wageningen Univ & Res, Ctr Genet Resources, Netherlands CGN, Wageningen, Netherlands; [Hulsegge, Bettine; Windig, Jack J.] Wageningen Univ & Res, Anim Breeding & Genom Ctr, Wageningen, Netherlands	KU Leuven; University of Liege; Wageningen University & Research; Wageningen University & Research	Janssens, S (corresponding author), Katholieke Univ Leuven, Res Grp Livestock Genet, Dept Biosyst, Leuven, Belgium.	steven.janssens@kuleuven.be	Gengler, Nicolas/B-9002-2011; Janssens, Steven/ABE-6370-2020	Gengler, Nicolas/0000-0002-5981-5509; Janssens, Steven/0000-0002-5588-3889; Buys, Nadine/0000-0002-7313-3088	Department of Agricultural and Fisheries, Government of Flanders	Department of Agricultural and Fisheries, Government of Flanders	This work was financially supported by the Department of Agricultural and Fisheries, Government of Flanders. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts J, 2012, LEVEND ERFGOED BOERD, P48; Ajmone-Marsan P, 2010, EVOL ANTHROPOL, V19, P148, DOI 10.1002/evan.20267; Amador C, 2011, CONSERV GENET, V12, P1565, DOI 10.1007/s10592-011-0255-4; Bay E, 2009, 87004 EU GENRES EURE; Bennewitz J, 2008, J DAIRY SCI, V91, P2512, DOI 10.3168/jds.2007-0924; Bowling A, 2000, GENETICS OF THE HORSE, pVII; Bradley DG, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P317; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; FAO, 2013, VIV C3NS AN GEN RES; Felius M., 2014, J AGR SCI, V153, P152; Felius M., 2016, THESIS; Frateur L., 1915, APERC SITUATION LEVA; Gautier M, 2010, PLOS ONE, V5; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Glowatzki-Mullis ML, 2006, ANIM GENET, V37, P33, DOI 10.1111/j.1365-2052.2005.01376.x; Hartwig S, 2015, J DAIRY SCI, V98, P2033, DOI 10.3168/jds.2014-8571; Hartwig S, 2013, ZUCHTUNGSKUNDE, V85, P270; Hiemstra SJ, 2010, LOCAL CATTLE BREEDS IN EUROPE: DEVELOPMENT OF POLICIES AND STRATEGIES FOR SELF-SUSTAINING BREEDS, P1, DOI 10.3921/978-90-8686-697-7; Hoving-Bolink R, 2009, 87004 EU GENRES EURE; Howrigan DP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-460; Hulsegge B, 2017, J ANIM BREED GENET, V134, P69, DOI 10.1111/jbg.12233; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Lambert-Derkimba A, 2006, PROD ANIM, V19, P357; Lauvie A, 2008, LIVEST SCI, V118, P113, DOI 10.1016/j.livsci.2008.01.004; Leroy G, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0131-7; Medugorac I, 2009, MOL ECOL, V18, P3394, DOI 10.1111/j.1365-294X.2009.04286.x; Oldenbroek K, 2007, UTILISATION AND CONSERVATION OF FARM ANIMAL GENETIC RESOURCES, P1; Palstra FP, 2012, ECOL EVOL, V2, P2357, DOI 10.1002/ece3.329; Pariset L, 2010, J ANIM BREED GENET, V127, P481, DOI 10.1111/j.1439-0388.2010.00868.x; Park SDE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0790-2; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purfield DC, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-70; R Development Core Team, 2016, R LANG ENV STAT COMP; Raj A, 2014, GENETICS, V197, P573, DOI 10.1534/genetics.114.164350; Rischkowsky B., 2007, STATE WORLDS ANIMAL; Van Nieuwenhuyze D, 1959, LANDBOUWTIJDSCHRIFT, V4-5, P1; Vaughan TA, 2010, MAMMALIAN DOMESTICAT, P611; Waples R.S., 1991, Reports of the International Whaling Commission Special Issue, P279; Waples RS, 2006, CONSERV GENET, V7, P167, DOI 10.1007/s10592-005-9100-y; WEIR BS, 1980, GENETICS, V95, P477; Wojcik JM, 2009, J ZOOL, V277, P81, DOI 10.1111/j.1469-7998.2008.00515.x	42	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175916	10.1371/journal.pone.0175916	http://dx.doi.org/10.1371/journal.pone.0175916			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426822	Green Submitted, Green Published, gold			2022-12-26	WOS:000399875900070
J	Katsura, T; Kawamori, D; Aida, E; Matsuoka, T; Shimomura, I				Katsura, Takashi; Kawamori, Dan; Aida, Eri; Matsuoka, Taka-aki; Shimomura, Iichiro			Glucotoxicity induces abnormal glucagon secretion through impaired insulin signaling in InR1G cells	PLOS ONE			English	Article							PANCREATIC ALPHA-CELLS; HIGH GLUCOSE-CONCENTRATIONS; BETA-CELL; GENE-TRANSCRIPTION; DIABETES-MELLITUS; MAP KINASES; IN-VIVO; RECEPTOR; RELEASE; INHIBITION	The significance of glucagon in the pathophysiology of diabetes mellitus is widely recognized, but the mechanisms underlying dysregulated glucagon secretion are still unclear. Here, we explored the molecular mechanisms of glucagon dysregulation, using an in vitro model. Hamster-derived glucagon-secreting InR1G cells were exposed to high glucose (25 mM) levels for 12 h before analyzing glucagon secretion and the activity of components involved in insulin signaling. High-glucose treatment induced increased glucagon secretion in InR1G cells, which represents a hallmark of diabetes mellitus. This treatment reduced the phosphorylation of Akt, indicating the deterioration of insulin signaling. Simultaneously, oxidative stress and JNK activity were shown to be increased. The inhibition of JNK signaling resulted in the amelioration of high-glucose level-induced glucagon secretion. Abnormally elevated glucagon secretion in diabetes can be reproduced by high-glucose treatment of InR1G cells, and the involvement of high glucose-oxidative stress-JNK-insulin signaling pathway axis has been demonstrated. These data elucidate, at least partly, the previously unclear mechanism of abnormal glucagon secretion, providing insights into a potential novel approach to diabetes treatment, targeting glucagon.	[Katsura, Takashi; Kawamori, Dan; Aida, Eri; Matsuoka, Taka-aki; Shimomura, Iichiro] Osaka Univ, Grad Sch Med, Dept Metab Med, Osaka, Japan	Osaka University	Kawamori, D (corresponding author), Osaka Univ, Grad Sch Med, Dept Metab Med, Osaka, Japan.	kawamorid@endmet.med.osaka-u.ac.jp			JSPS KAKENHI of the Ministry of Education, Culture, Sports, Science & Technology of Japan [26461336]; Kowa Life Science Foundation; Banyu Life Science Foundation Internationa; Suzuken Memorial Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Japan Diabetes Foundation	JSPS KAKENHI of the Ministry of Education, Culture, Sports, Science & Technology of Japan; Kowa Life Science Foundation; Banyu Life Science Foundation Internationa; Suzuken Memorial Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Japan Diabetes Foundation	The research is partially supported by JSPS KAKENHI (grant number 26461336) of the Ministry of Education, Culture, Sports, Science & Technology of Japan, and research grants from Kowa Life Science Foundation, Banyu Life Science Foundation International, Suzuken Memorial Foundation, Mochida Memorial Foundation for Medical and Pharmaceutical Research, and Japan Diabetes Foundation (to DK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Ahren B, 2000, DIABETOLOGIA, V43, P393, DOI 10.1007/s001250051322; Akiyama M, 2013, DIABETES, V62, P2439, DOI 10.2337/db12-1747; Albrechtsen NJW, 2014, DIABETOLOGIA, V57, P1919, DOI 10.1007/s00125-014-3283-z; ASPLIN CM, 1981, J CLIN INVEST, V68, P314, DOI 10.1172/JCI110251; BHATHENA SJ, 1982, DIABETES, V31, P521, DOI 10.2337/diabetes.31.6.521; BLOOM SR, 1978, J PHYSIOL-LONDON, V280, P9, DOI 10.1113/jphysiol.1978.sp012369; Campbell JE, 2015, NAT REV ENDOCRINOL, V11, P329, DOI 10.1038/nrendo.2015.51; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Diao JY, 2005, J BIOL CHEM, V280, P33487, DOI 10.1074/jbc.M506276200; Dumonteil E, 1999, ENDOCRINOLOGY, V140, P4644, DOI 10.1210/en.140.10.4644; Franklin I, 2005, DIABETES, V54, P1808, DOI 10.2337/diabetes.54.6.1808; GERICH JE, 1975, J CLIN ENDOCR METAB, V41, P1178, DOI 10.1210/jcem-41-6-1178; GERICH JE, 1973, SCIENCE, V182, P171, DOI 10.1126/science.182.4108.171; GERICH JE, 1974, DIABETES, V23, P876, DOI 10.2337/diab.23.11.876; GREENBAUM CJ, 1991, J CLIN INVEST, V88, P767, DOI 10.1172/JCI115375; Gromada J, 2007, ENDOCR REV, V28, P84, DOI 10.1210/er.2006-0007; Hare KJ, 2010, DIABETES, V59, P1765, DOI 10.2337/db09-1414; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Kaneto H, 2007, ANTIOXID REDOX SIGN, V9, P355, DOI 10.1089/ars.2006.1465; KATSURA M, 1993, DIABETES RES CLIN PR, V20, P93, DOI 10.1016/0168-8227(93)90002-M; Kawamori D, 2006, J BIOL CHEM, V281, P1091, DOI 10.1074/jbc.M508510200; Kawamori D, 2011, DIABETES OBES METAB, V13, P21, DOI 10.1111/j.1463-1326.2011.01442.x; Kawamori D, 2010, ADV EXP MED BIOL, V654, P421, DOI 10.1007/978-90-481-3271-3_18; Kawamori D, 2009, CELL METAB, V9, P350, DOI 10.1016/j.cmet.2009.02.007; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Le Marchand SJ, 2010, J BIOL CHEM, V285, P14389, DOI 10.1074/jbc.M109.069195; Leung YM, 2006, ENDOCRINOLOGY, V147, P2155, DOI 10.1210/en.2005-1249; Marty N, 2005, J CLIN INVEST, V115, P3545, DOI 10.1172/JCI26309; MARUYAMA H, 1984, J CLIN INVEST, V74, P2296, DOI 10.1172/JCI111658; McGirr R, 2005, ENDOCRINOLOGY, V146, P4514, DOI 10.1210/en.2005-0402; Minden A, 1997, BBA-REV CANCER, V1333, pF85, DOI 10.1016/S0304-419X(97)00018-8; Neuman JC, 2014, JOVE-J VIS EXP, DOI 10.3791/50374; PATEL YC, 1982, SCIENCE, V217, P1155, DOI 10.1126/science.6126003; PHILIPPE J, 1989, J CLIN INVEST, V84, P672, DOI 10.1172/JCI114214; Raeymaekers L, 2000, MOL BIOTECHNOL, V15, P115, DOI 10.1385/MB:15:2:115; Ravier MA, 2005, DIABETES, V54, P1789, DOI 10.2337/diabetes.54.6.1789; Ritz-Laser B, 2003, DIABETOLOGIA, V46, P810, DOI 10.1007/s00125-003-1115-7; RORSMAN P, 1989, NATURE, V341, P233, DOI 10.1038/341233a0; Salehi A, 2006, DIABETES, V55, P2318, DOI 10.2337/db06-0080; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; SHICHIRI M, 1979, DIABETES, V28, P272, DOI 10.2337/diabetes.28.4.272; UNGER RH, 1977, ANNU REV MED, V28, P119, DOI 10.1146/annurev.me.28.020177.001003; Vasu S, 2015, EXP CELL RES, V336, P100, DOI 10.1016/j.yexcr.2015.05.022; WEIR GC, 1976, DIABETES, V25, P275, DOI 10.2337/diabetes.25.4.275; Xu E, 2006, CELL METAB, V3, P47, DOI 10.1016/j.cmet.2005.11.015	46	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176271	10.1371/journal.pone.0176271	http://dx.doi.org/10.1371/journal.pone.0176271			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426798	Green Submitted, Green Published, gold			2022-12-26	WOS:000399875900125
J	Lau, HK; Wu, ER; Chen, MK; Hsieh, MJ; Yang, SF; Wang, LY; Chou, YE				Lau, Hon-Kit; Wu, Edie-Rosmin; Chen, Mu-Kuan; Hsieh, Ming-Ju; Yang, Shun-Fa; Wang, Lyu-Yao; Chou, Ying-Erh			Effect of genetic variation in microRNA binding site in WNT1-inducible signaling pathway protein 1 gene on oral squamous cell carcinoma susceptibility	PLOS ONE			English	Article							CCN FAMILY; LUNG-CANCER; POLYMORPHISMS; WISP1; EXPRESSION; ASSOCIATION; CONSUMPTION; TAIWAN; OSTEOARTHRITIS; METASTASIS	Background Oral squamous cell carcinoma (OSCC), which is the most common head and neck cancer, accounts for 1%-2% of all human malignancies and is characterized by poor prognosis and reduced survival rates. WNT1-inducible signaling pathway protein 1 (WISP1), a cysteine-rich protein belonging to the Cyr61, CTGF, Nov (CCN) family of matricellular proteins, has many developmental functions and may be involved in carcinogenesis. This study investigated WISP1 single-nucleotide polymorphisms (SNPs) to elucidate OSCC susceptibility and clinicopathologic characteristics. Methodology/Principal findings Real-time polymerase chain reaction was used to analyze 6 SNPs of WISP1 in 900 OSCC patients and 1200 cancer-free controls. The results showed that WISP1 rs2929970 polymorphism carriers with at least one G allele were susceptible to OSCC. Moreover, compared with smokers, non-smoker patients with higher frequencies of WISP1 rs2929970 (AG + GG) variants had a late stage (stages III and IV) and a large tumor size. In addition, OSCC patients who were betel quid chewers and carried WISP1 rs16893344 (CT + TT) variants had a low risk of lymph node metastasis. Conclusion Our results demonstrate that a joint effect of WISP1 rs2929970 with smoking as well as WISP1 rs16893344 with betel nut chewing causally contributes to the occurrence of OSCC. WISP1 polymorphism may serve as a marker or a therapeutic target in OSCC.	[Lau, Hon-Kit; Chen, Mu-Kuan; Hsieh, Ming-Ju; Yang, Shun-Fa; Wang, Lyu-Yao] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Lau, Hon-Kit] Asia Univ Hosp, Dept Anaesthesiol, Taichung, Taiwan; [Wu, Edie-Rosmin] Tungs Taichung MetroHarbor Hosp, Dept Surg, Div Gen Surg, Taichung, Taiwan; [Chen, Mu-Kuan; Hsieh, Ming-Ju] Changhua Christian Hosp, Canc Res Ctr, Changhua, Taiwan; [Chen, Mu-Kuan] Changhua Christian Hosp, Dept Otorhinolaryngol Head & Neck Surg, Changhua, Taiwan; [Hsieh, Ming-Ju] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan; [Yang, Shun-Fa; Chou, Ying-Erh] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Chou, Ying-Erh] Chung Shan Med Univ, Sch Med, Taichung, Taiwan	Chung Shan Medical University; Tungs' Taichung MetroHarbor Hospital; Changhua Christian Hospital; Changhua Christian Hospital; China Medical University Taiwan; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University	Chou, YE (corresponding author), Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan.; Chou, YE (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.	intointo814@gmail.com	Yang, Shun-Fa/AAN-1519-2020; Hsieh, Ming-Ju/GQB-3025-2022	Yang, Shun-Fa/0000-0002-0365-7927; Hsieh, Ming-Ju/0000-0001-9726-3234	Chung Shan Medical University Hospital Taiwan [CSH-2017E -001-Y2]	Chung Shan Medical University Hospital Taiwan	This study was supported by CSH-2017E -001-Y2 from Chung Shan Medical University Hospital Taiwan, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chakrabarti S, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0483-4; Chen JJ, 2015, J COASTAL RES, P1, DOI 10.2112/SI73-001.1; Chen J, 2014, INT J MOL SCI, V15, P21011, DOI 10.3390/ijms151121011; Chen PP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000534; Cheng HL, 2016, ONCOTARGET, V7, P69384, DOI 10.18632/oncotarget.12082; Chou CH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171583; Chuang JY, 2015, ONCOTARGET, V6, P4239, DOI 10.18632/oncotarget.2978; Chuang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078022; Chung TT, 2011, CARCINOGENESIS, V32, P1063, DOI 10.1093/carcin/bgr083; Clausen MJAM, 2016, GENE CHROMOSOME CANC, V55, P45, DOI 10.1002/gcc.22310; Fernandez-Torres J, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0678-z; Frank B, 2010, CARCINOGENESIS, V31, P1381, DOI 10.1093/carcin/bgq082; Gurbuz I, 2015, INT J BIOCHEM CELL B, V62, P142, DOI 10.1016/j.biocel.2015.03.007; Haddad RI, 2008, NEW ENGL J MED, V359, P1143, DOI 10.1056/NEJMra0707975; Ho HY, 2016, J PINEAL RES, V61, P479, DOI 10.1111/jpi.12365; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Inkson CA, 2008, J CELL BIOCHEM, V104, P1865, DOI 10.1002/jcb.21754; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Kim SY, 2011, ANN SURG ONCOL, V18, P2310, DOI 10.1245/s10434-011-1614-6; KO YC, 1995, J ORAL PATHOL MED, V24, P450, DOI 10.1111/j.1600-0714.1995.tb01132.x; Li J, 2015, INT J MOL MED, V36, P1451, DOI 10.3892/ijmm.2015.2390; Lu CT, 1996, J ORAL PATHOL MED, V25, P245, DOI 10.1111/j.1600-0714.1996.tb01379.x; Mercer KE, 2014, CANCER PREV RES, V7, P675, DOI 10.1158/1940-6207.CAPR-13-0444-T; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Nagai Y, 2011, ANTICANCER RES, V31, P991; Perbal B, 2001, J CLIN PATHOL-MOL PA, V54, P57, DOI 10.1136/mp.54.2.57; Rogers SN, 2009, ORAL ONCOL, V45, P201, DOI 10.1016/j.oraloncology.2008.05.008; Sauna ZE, 2007, CANCER RES, V67, P9609, DOI 10.1158/0008-5472.CAN-07-2377; Su CW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002092; Su SC, 2017, THERANOSTICS, V7, P1088, DOI 10.7150/thno.18551; Su SC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159585; Tao J, 2016, ONCOTARGET; Urano T, 2007, J BONE MINER METAB, V25, P253, DOI 10.1007/s00774-007-0757-9; Wang SH, 2013, GENET MOL RES, V12, P1829, DOI 10.4238/2013.January.4.1; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wu J., 2016, ONCOTARGET; Yamada Y, 2009, HYPERTENS RES, V32, P325, DOI 10.1038/hr.2009.23; Yen TT, 2008, EUR ARCH OTO-RHINO-L, V265, P1403, DOI 10.1007/s00405-008-0659-z; Zhang HF, 2015, ONCOTARGET, V6, P6218, DOI 10.18632/oncotarget.3358	40	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176246	10.1371/journal.pone.0176246	http://dx.doi.org/10.1371/journal.pone.0176246			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426731	Green Submitted, Green Published, gold			2022-12-26	WOS:000399875900121
J	Masuda, T; Song, W; Nakanishi, H; Lei, W; Noor, AM; Arai, F				Masuda, Taisuke; Song, Woneui; Nakanishi, Hayao; Lei, Wu; Noor, Anas Mohd; Arai, Fumihito			Rare cell isolation and recovery on open-channel microfluidic chip	PLOS ONE			English	Article							CIRCULATING TUMOR-CELLS; CYTOKERATIN-POSITIVE CELLS; CANCER-PATIENTS; BREAST-CANCER; GENOMIC ANALYSIS; FLOW-CYTOMETRY; CAPTURE; BLOOD; DEVICE	The ability to accurately detect and analyze rare cells in a cell population is critical not only for the study of disease progression but also for next flow cytometry systems in clinical application. Here, we report the development of a prototype device, the 'Rare cell sorter', for isolating and recovering single rare cells from whole blood samples. On this device, we utilized an open-channel microfluidic chip for rare cell isolation. And the advantage of open-channel allows us to recover the isolated rare cell directly from the chip. We set the circulating tumor cell (CTC) as a target cell. For the clinical experiment, CTCs were isolated from blood samples collected from patients with metastatic breast cancer and healthy volunteers. There was a significant difference in the number of CTCs between the patients with metastatic breast cancer and healthy volunteers. To evaluate the damage to cells during isolation and recovery, we performed an RNA integrity assay using RNA extracted from CTCs recovered from the chip and found that our process for single CTC isolation and recovery is mild enough for gene analysis of CTCs.	[Masuda, Taisuke; Song, Woneui; Lei, Wu; Noor, Anas Mohd; Arai, Fumihito] Nagoya Univ, Grad Sch Engn, Dept Micronano Syst Engn, Nagoya, Aichi, Japan; [Nakanishi, Hayao] Aichi Hosp, Aichi Canc Ctr, Lab Pathol & Clin Res, Nagoya, Aichi, Japan	Nagoya University; Aichi Cancer Center	Masuda, T (corresponding author), Nagoya Univ, Grad Sch Engn, Dept Micronano Syst Engn, Nagoya, Aichi, Japan.	masuda@mech.nagoya-u.ac.jp		Masuda, Taisuke/0000-0002-7853-9511	Development Project for Extremely Early Diagnostics Technologies for Human Diseases of Aichi Prefecture in Japan	Development Project for Extremely Early Diagnostics Technologies for Human Diseases of Aichi Prefecture in Japan	This work was supported in part by the Development Project for Extremely Early Diagnostics Technologies for Human Diseases of Aichi Prefecture in Japan (http://www.astf-khajp/project/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker TM, 2014, INT J CANCER, V134, P2523, DOI 10.1002/ijc.28516; Born P, 2011, LANGMUIR, V27, P8621, DOI 10.1021/la2006138; Cantor CR, 2000, TRENDS BIOTECHNOL, V18, P6, DOI 10.1016/S0167-7799(99)01394-3; Cheng IF, 2007, BIOMICROFLUIDICS, V1, DOI 10.1063/1.2723669; COHEN J, 2001, J HUMAN DEV, V2, P239; de Bono JS, 2007, CLIN CANCER RES, V13, P3611, DOI 10.1158/1078-0432.CCR-07-0268; Di Carlo D, 2006, ANAL CHEM, V78, P7918; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Glinskii AB, 2003, CANCER RES, V63, P4239; Glinsky GV, 2006, CELL CYCLE, V5, P191, DOI 10.4161/cc.5.2.2320; Gratama JW, 2000, J IMMUNOL METHODS, V239, P13, DOI 10.1016/S0022-1759(00)00154-X; Gudjonsson T, 2002, GENE DEV, V16, P693, DOI 10.1101/gad.952602; Hu YJ, 2010, CYTOM PART A, V77A, P213, DOI 10.1002/cyto.a.20838; Huang T, 2014, BIOSENS BIOELECTRON, V51, P213, DOI 10.1016/j.bios.2013.07.044; Inglis DW, 2004, APPL PHYS LETT, V85, P5093, DOI 10.1063/1.1823015; Ji HM, 2008, BIOMED MICRODEVICES, V10, P251, DOI 10.1007/s10544-007-9131-x; Lidstrom ME, 2010, NAT CHEM BIOL, V6, P705, DOI [10.1038/nchembio.436, 10.1038/NCHEMBIO.436]; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Miyamoto DT, 2012, CANCER DISCOV, V2, P995, DOI 10.1158/2159-8290.CD-12-0222; Mocellin S, 2006, TRENDS MOL MED, V12, P130, DOI 10.1016/j.molmed.2006.01.006; Mocellin S, 2004, INT J CANCER, V111, P741, DOI 10.1002/ijc.20347; Mohamed H, 2007, J CHROMATOGR A, V1162, P187, DOI 10.1016/j.chroma.2007.06.025; Mueller O., 2004, AGIL APPL NOTE, V2011, P1, DOI DOI 10.1186/1471-2199-7-3; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Nakanishi H, 2003, CANCER SCI, V94, P112, DOI 10.1111/j.1349-7006.2003.tb01361.x; Pestrin M, 2009, BREAST CANCER RES TR, V118, P523, DOI 10.1007/s10549-009-0461-7; Pinedo Rivera T, 2008, J VAC SCI TECHNOL B, V26, P2513, DOI 10.1116/1.3021396; Pratt ED, 2011, CHEM ENG SCI, V66, P1508, DOI 10.1016/j.ces.2010.09.012; Sarioglu AF, 2015, NAT METHODS, V12, P685, DOI [10.1038/NMETH.3404, 10.1038/nmeth.3404]; Schardt JA, 2005, CANCER CELL, V8, P227, DOI 10.1016/j.ccr.2005.08.003; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Smirnov DA, 2005, CANCER RES, V65, P4993, DOI 10.1158/0008-5472.CAN-04-4330; Tarhan MO, 2013, ASIAN PAC J CANCER P, V14, P1725, DOI 10.7314/APJCP.2013.14.3.1725; Wang DJ, 2010, TRENDS BIOTECHNOL, V28, P281, DOI 10.1016/j.tibtech.2010.03.002; Watanabe M, 2014, CYTOM PART A, V85, P206, DOI 10.1002/cyto.a.22422; Witzig TE, 2002, CLIN CANCER RES, V8, P1085; Zheng S, 2007, J CHROMATOGR A, V1162, P154, DOI 10.1016/j.chroma.2007.05.064	37	10	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0174937	10.1371/journal.pone.0174937	http://dx.doi.org/10.1371/journal.pone.0174937			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426707	Green Published, Green Submitted, gold			2022-12-26	WOS:000399875900015
J	Steppeler, C; Sodring, M; Egelandsdal, B; Kirkhus, B; Oostindjer, M; Alvseike, O; Gangsei, LE; Hovland, EM; Pierre, F; Paulsen, JE				Steppeler, Christina; Sodring, Marianne; Egelandsdal, Bjorg; Kirkhus, Bente; Oostindjer, Marije; Alvseike, Ole; Gangsei, Lars Erik; Hovland, Ellen-Margrethe; Pierre, Fabrice; Paulsen, Jan Erik			Effects of dietary beef, pork, chicken and salmon on intestinal carcinogenesis in A/J Min/ plus mice	PLOS ONE			English	Article							ABERRANT CRYPT FOCI; COLORECTAL-CANCER RISK; MUCIN-DEPLETED FOCI; RED MEAT INTAKE; ARACHIDONIC-ACID; FISH CONSUMPTION; FATTY-ACIDS; SIALIC-ACID; HEME IRON; RAT COLON	The International Agency for Research on Cancer has classified red meat as "probably carcinogenic to humans" (Group 2A). In mechanistic studies exploring the link between intake of red meat and CRC, heme iron, the pigment of red meat, is proposed to play a central role as a catalyzer of luminal lipid peroxidation and cytotoxicity. In the present work, the novel A/J Min/+ mouse was used to investigate the effects of dietary beef, pork, chicken, or salmon (40% muscle food (dry weight) and 60% powder diet) on Apc-driven intestinal carcinogenesis, from week 3-13 of age. Muscle food diets did not differentially affect carcinogenesis in the colon (flat ACF and tumors). In the small intestine, salmon intake resulted in a lower tumor size and load than did meat from terrestrial animals (beef, pork or chicken), while no differences were observed between the effects of white meat (chicken) and red meat (pork and beef). Additional results indicated that intestinal carcinogenesis was not related to dietary n-6 polyunsaturated fatty acids, intestinal formation of lipid peroxidation products (thiobarbituric acid reactive substances, TBARS), or cytotoxic effects of fecal water on Apc(-/+) cells. Notably, the amount of heme reaching the colon appeared to be relatively low in this study. The greatest tumor load was induced by the reference diet RM1, underlining the importance of the basic diets in experimental CRC. The present study in A/J Min/+ mice does not support the hypothesis of a role of red meat in intestinal carcinogenesis.	[Steppeler, Christina; Sodring, Marianne; Paulsen, Jan Erik] Norwegian Univ Life Sci, Dept Food Safety & Infect Biol, Oslo, Norway; [Egelandsdal, Bjorg; Oostindjer, Marije] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway; [Kirkhus, Bente] Norwegian Inst Food Fisheries & Aquaculture Res, Nofima, As, Norway; [Alvseike, Ole; Gangsei, Lars Erik; Hovland, Ellen-Margrethe] Animalia Norwegian Meat & Poultry Res Ctr, Oslo, Norway; [Pierre, Fabrice] Univ Toulouse, INRA UMR Toxalim 1331, Res Ctr Food Toxicol, Toulouse, France	Norwegian University of Life Sciences; Norwegian University of Life Sciences; Nofima; INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Steppeler, C (corresponding author), Norwegian Univ Life Sci, Dept Food Safety & Infect Biol, Oslo, Norway.	christina.steppeler@nmbu.no		Sodring, Marianne/0000-0003-0236-8549	Norwegian Agriculture Agency; Animalia-Norwegian Meat and Poultry Research Center; National Levy on Meat and Egg; French National Institute for Agricultural Research (INRA); Ministry of Education and Research	Norwegian Agriculture Agency; Animalia-Norwegian Meat and Poultry Research Center; National Levy on Meat and Egg; French National Institute for Agricultural Research (INRA); Ministry of Education and Research	CS was financed by the Norwegian Agriculture Agency (100%, but with the restriction that 1/5 is jointly reimbursed by the Norwegian Meat Industry and the National Levy on Meat and Egg). MS was financed by the Norwegian Agriculture Agency (100%, but with the restriction that 1/4 is jointly reimbursed by the Norwegian Meat Industry). BG was financed by the Ministry of Education and Research (100%). BK was financed by the Norwegian Agriculture Agency (100%, but with the restriction that 1/5 is jointly reimbursed by the Norwegian Meat Industry and the National Levy on Meat and Egg). MO was financed by the Norwegian Agriculture Agency (100%, but with the restriction that 1/5 is jointly reimbursed by the Norwegian Meat Industry and the National Levy on Meat and Egg). OA, LEG and EMH were financed by Animalia-Norwegian Meat and Poultry Research Center (100%), mainly financed by the National Levy on Meat and Egg. FP was financed by the French National Institute for Agricultural Research (INRA) (100%). JEP were financed by the Ministry of Education and Research (100%). The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ajioka RS, 2007, BLOOD CELL MOL DIS, V39, P199, DOI 10.1016/j.bcmd.2007.03.007; Alisson-Silva F, 2016, MOL ASPECTS MED, V51, P16, DOI 10.1016/j.mam.2016.07.002; Anderson GJ, 2005, BIOMETALS, V18, P339, DOI 10.1007/s10534-005-3708-8; Bastide NM, 2015, CANCER RES, V75, P870, DOI 10.1158/0008-5472.CAN-14-2554; Bernstein C, 2011, ARCH TOXICOL, V85, P863, DOI 10.1007/s00204-011-0648-7; Bouvard V, 2015, LANCET ONCOL, V16, P1599, DOI 10.1016/S1470-2045(15)00444-1; Cao C, 2014, J NUTR, V144, P1710, DOI 10.3945/jn.114.197939; Chan DSM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020456, 10.1371/journal.pone.0027218]; Chen GC, 2015, CANCER CAUSE CONTROL, V26, P133, DOI 10.1007/s10552-014-0492-1; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Cross AJ, 2010, CANCER RES, V70, P2406, DOI 10.1158/0008-5472.CAN-09-3929; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; Dunican DS, 2002, ONCOGENE, V21, P3253, DOI 10.1038/sj.onc.1205431; English DR, 2004, CANCER EPIDEM BIOMAR, V13, P1509; Fillebeen C, 2015, HAEMATOLOGICA, V100, pE334, DOI 10.3324/haematol.2015.126870; Forest V, 2003, CELL IMMUNOL, V223, P70, DOI 10.1016/S0008-8749(03)00149-7; Geelen A, 2007, AM J EPIDEMIOL, V166, P1116, DOI 10.1093/aje/kwm197; Gueraud F, 2015, FREE RADICAL BIO MED, V83, P192, DOI 10.1016/j.freeradbiomed.2015.02.023; Harizi H, 2008, TRENDS MOL MED, V14, P461, DOI 10.1016/j.molmed.2008.08.005; Hedlund M, 2007, MOL CELL BIOL, V27, P4340, DOI 10.1128/MCB.00379-07; Ijssennagger N, 2013, CARCINOGENESIS, V34, P1628, DOI 10.1093/carcin/bgt084; Irigaray P, 2010, CARCINOGENESIS, V31, P135, DOI 10.1093/carcin/bgp252; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Mollersen L, 2004, ANTICANCER RES, V24, P2595; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Myhre JB, 2016, FOOD NUTR RES, V60, DOI 10.3402/fnr.v60.29555; Norat T, 2005, J NATL CANCER I, V97, P906, DOI 10.1093/jnci/dji164; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Paulsen JE, 1997, CARCINOGENESIS, V18, P1905, DOI 10.1093/carcin/18.10.1905; Petrik MBH, 2000, J NUTR, V130, P1153, DOI 10.1093/jn/130.5.1153; Pierre F, 2004, J NUTR, V134, P2711, DOI 10.1093/jn/134.10.2711; Pierre F, 2003, CARCINOGENESIS, V24, P1683, DOI 10.1093/carcin/bgg130; Pierre F, 2008, BRIT J NUTR, V99, P1000, DOI 10.1017/S0007114507843558; Pierre FHF, 2010, NUTR CANCER, V62, P567, DOI 10.1080/01635580903532408; Radulescu S, 2012, CELL REP, V2, P270, DOI 10.1016/j.celrep.2012.07.003; Santarelli RL, 2008, NUTR CANCER, V60, P131, DOI 10.1080/01635580701684872; Santarelli RL, 2013, INT J CANCER, V133, P2533, DOI 10.1002/ijc.28286; Sesink ALA, 2001, CARCINOGENESIS, V22, P1653, DOI 10.1093/carcin/22.10.1653; Sodring M, 2016, ANTICANCER RES, V36, P2745; Sodring M, 2016, INT J CANCER, V138, P1936, DOI 10.1002/ijc.29928; Sodring M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122880; Song MY, 2014, INT J CANCER, V135, P2413, DOI 10.1002/ijc.28878; Sorland GH, 2004, MEAT SCI, V66, P543, DOI 10.1016/S0309-1740(03)00157-8; Steppeler C, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2874-0; Steppeler C, 2016, J AGR FOOD CHEM, V64, P487, DOI 10.1021/acs.jafc.5b04201; Svendsen C, 2012, LAB ANIM-UK, V46, P207, DOI 10.1258/la.2012.011055; VANDENBERG JWO, 1988, CLIN CHEM, V34, P2125; WCRF/ AICR, 2007, FOOD NUTR PHYS ACT P; WCRF/AICR, 2011, CONT UPD PROJ REP FO; Whelan J, 2004, J NUTR, V134, p3421S, DOI 10.1093/jn/134.12.3421S; Winter J, 2014, MOL NUTR FOOD RES, V58, P550, DOI 10.1002/mnfr.201300430; Wu SJ, 2012, AM J MED, V125, P551, DOI 10.1016/j.amjmed.2012.01.022	53	4	4	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176001	10.1371/journal.pone.0176001	http://dx.doi.org/10.1371/journal.pone.0176001			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426718	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000399875900083
J	Zhao, WQ; Zhao, X; Zhou, T; Wu, DH; Tang, BJ; Wei, H				Zhao, Wenqian; Zhao, Xiang; Zhou, Tao; Wu, Donghai; Tang, Bijian; Wei, Hong			Climatic factors driving vegetation declines in the 2005 and 2010 Amazon droughts	PLOS ONE			English	Article							CANOPY STRUCTURE; FOREST; VARIABILITY; DYNAMICS; MODIS; WATER; NDVI; SOIL; SEASONALITY; PHENOLOGY	Along with global climate change, the occurrence of extreme droughts in recent years has had a serious impact on the Amazon region. Current studies on the driving factors of the 2005 and 2010 Amazon droughts has focused on the influence of precipitation, whereas the impacts of temperature and radiation have received less attention. This study aims to explore the climate-driven factors of Amazonian vegetation decline during the extreme droughts using vegetation index, precipitation, temperature and radiation datasets. First, time-lag effects of Amazonian vegetation responses to precipitation, radiation and temperature were analyzed. Then, a multiple linear regression model was established to estimate the contributions of climatic factors to vegetation greenness, from which the dominant climate- driving factors were determined. Finally, the climate-driven factors of Amazonian vegetation greenness decline during the 2005 and 2010 extreme droughts were explored. The results showed that (i) in the Amazon vegetation greenness responded to precipitation, radiation and temperature, with apparent time lags for most averaging interval periods associated with vegetation index responses of 0-4, 0-9 and 0-6 months, respectively; (ii) on average, the three climatic factors without time lags explained 27.28 +/- 21.73% (mean +/- 1 SD) of vegetation index variation in the Amazon basin, and this value increased by 12.22% and reached 39.50 +/- 27.85% when time lags were considered; (iii) vegetation greenness in this region in non-drought years was primarily affected by precipitation and shortwave radiation, and these two factors altogether accounted for 93.47% of the total explanation; and (iv) in the common epicenter of the two droughts, pixels with a significant variation in precipitation, radiation and temperature accounted for 36.68%, 40.07% and 10.40%, respectively, of all pixels showing a significant decrease in vegetation index in 2005, and 15.69%, 2.01% and 45.25% in 2010, respectively. Overall, vegetation greenness declines during the 2005 and 2010 extreme droughts were adversely influenced by precipitation, radiation and temperature; this study provides evidence of the influence of multiple climatic factors on vegetation during the 2005 and 2010 Amazon droughts.	[Zhao, Wenqian; Zhao, Xiang; Zhou, Tao] Beijing Normal Univ, State Key Lab Earth Surface Processes & Resource, Beijing, Peoples R China; [Zhao, Wenqian; Zhao, Xiang; Tang, Bijian; Wei, Hong] Beijing Normal Univ, Fac Geog Sci, Coll Remote Sensing Sci & Engn, State Key Lab Remote Sensing Sci, Beijing, Peoples R China; [Zhao, Wenqian; Zhao, Xiang] JCGCS, Beijing, Peoples R China; [Zhao, Wenqian] Shaanxi Jinkong Compass Informat Serv CO LTD, Xian, Peoples R China; [Zhao, Xiang] Beijing Engn Res Ctr Global Land Remote Sensing, Beijing, Peoples R China; [Zhou, Tao] Beijing Normal Univ, Minist Educ, Environm Change & Nat Disaster, Beijing, Peoples R China; [Wu, Donghai] Peking Univ, Coll Urban & Environm Sci, Beijing, Peoples R China	Beijing Normal University; Beijing Normal University; Beijing Normal University; Peking University	Zhao, X (corresponding author), Beijing Normal Univ, State Key Lab Earth Surface Processes & Resource, Beijing, Peoples R China.; Zhao, X (corresponding author), Beijing Normal Univ, Fac Geog Sci, Coll Remote Sensing Sci & Engn, State Key Lab Remote Sensing Sci, Beijing, Peoples R China.; Zhao, X (corresponding author), JCGCS, Beijing, Peoples R China.; Zhao, X (corresponding author), Beijing Engn Res Ctr Global Land Remote Sensing, Beijing, Peoples R China.	zhaoxiang@bnu.edu.cn	Wu, Donghai/L-9819-2019; Wu, Donghai/ADP-9152-2022	Wu, Donghai/0000-0002-4638-3743; Wu, Donghai/0000-0002-4638-3743	National Key Research and Development Program of China [2016YFA0600103]; State Key Laboratory of Earth Surface Processes and Resource Ecology	National Key Research and Development Program of China; State Key Laboratory of Earth Surface Processes and Resource Ecology	This study was supported by the National Key Research and Development Program of China (NO. 2016YFA0600103) and Project Supported by State Key Laboratory of Earth Surface Processes and Resource Ecology.; This study was supported by the National Key Research and Development Program of China (NO. 2016YFA0600103) and the Project Supported by State Key Laboratory of Earth Surface Processes and Resource Ecology. All authors want to thank the anonymous referees for their valuable suggestions and comments.	Anderson LO, 2010, NEW PHYTOL, V187, P733, DOI 10.1111/j.1469-8137.2010.03355.x; Boker SM, 2002, PSYCHOL METHODS, V7, P338, DOI 10.1037//1082-989X.7.3.338; Brando PM, 2010, P NATL ACAD SCI USA, V107, P14685, DOI 10.1073/pnas.0908741107; Brando PM, 2014, P NATL ACAD SCI USA, V111, P6347, DOI 10.1073/pnas.1305499111; Chen T, 2014, REMOTE SENS ENVIRON, V140, P330, DOI 10.1016/j.rse.2013.08.022; Cook KH, 2008, J CLIMATE, V21, P542, DOI 10.1175/2007JCLI1838.1; Cox PM, 2008, NATURE, V453, P212, DOI 10.1038/nature06960; da Rocha HR, 2004, ECOL APPL, V14, pS22; de Jong R, 2013, GLOBAL CHANGE BIOL, V19, P1953, DOI 10.1111/gcb.12193; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Fensholt R, 2009, REMOTE SENS ENVIRON, V113, P1886, DOI 10.1016/j.rse.2009.04.004; Friedl MA, 2002, REMOTE SENS ENVIRON, V83, P287, DOI 10.1016/S0034-4257(02)00078-0; Friedl MA, 2010, REMOTE SENS ENVIRON, V114, P168, DOI 10.1016/j.rse.2009.08.016; Gloor M, 2015, GLOBAL BIOGEOCHEM CY, V29, P1384, DOI 10.1002/2014GB005080; Gonzalez R.C., 2009, DIGITAL IMAGE PROCES, V2nd; Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711; Hilker T, 2014, P NATL ACAD SCI USA, V111, P16041, DOI 10.1073/pnas.1404870111; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Huete AR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025583; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; Hutyra LR, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000365; Kitoh A, 2011, J GEOPHYS RES ATMOSP, V116; Kuzyakov Y, 2010, GLOBAL CHANGE BIOL, V16, P3386, DOI 10.1111/j.1365-2486.2010.02179.x; Lewis SL, 2011, SCIENCE, V331, P554, DOI 10.1126/science.1200807; Lyapustin A, 2014, ATMOS MEAS TECH, V7, P4353, DOI 10.5194/amt-7-4353-2014; Malhi Y, 2004, PHILOS T R SOC B, V359, P311, DOI 10.1098/rstb.2003.1433; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Marengo JA, 2008, J CLIMATE, V21, P495, DOI 10.1175/2007JCLI1600.1; Marengo JA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047436; Melaas EK, 2013, REMOTE SENS ENVIRON, V132, P176, DOI 10.1016/j.rse.2013.01.011; MELILLO JM, 1993, NATURE, V363, P234, DOI 10.1038/363234a0; Morton DC, 2014, NATURE, V506, P221, DOI 10.1038/nature13006; Oliveira RS, 2005, OECOLOGIA, V145, P354, DOI 10.1007/s00442-005-0108-2; Oliveira RS, 2005, FUNCT ECOL, V19, P574, DOI 10.1111/j.1365-2435.2005.01003.x; Peng SS, 2013, NATURE, V501, P88, DOI 10.1038/nature12434; Rammig A., 2014, BIOGEOSCIENCES DISCU, V11, P2537, DOI [10.5194/bgd-11-2537-2014, DOI 10.5194/BGD-11-2537-2014]; Saatchi S, 2013, P NATL ACAD SCI USA, V110, P565, DOI 10.1073/pnas.1204651110; Saleska SR, 2007, SCIENCE, V318, P612, DOI 10.1126/science.1146663; Samanta A, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001818; Samanta A, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL042154; Sombroek W, 2001, AMBIO, V30, P388, DOI 10.1639/0044-7447(2001)030[0388:SATPOA]2.0.CO;2; Soudani K, 2012, REMOTE SENS ENVIRON, V123, P234, DOI 10.1016/j.rse.2012.03.012; Vicente-Serrano SM, 2013, P NATL ACAD SCI USA, V110, P52, DOI 10.1073/pnas.1207068110; Wang XH, 2011, P NATL ACAD SCI USA, V108, P1240, DOI 10.1073/pnas.1014425108; Wu DH, 2015, GLOBAL CHANGE BIOL, V21, P3520, DOI 10.1111/gcb.12945; Wu J, 2016, SCIENCE, V351, P972, DOI 10.1126/science.aad5068; Xu L, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048049	47	26	27	7	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175379	10.1371/journal.pone.0175379	http://dx.doi.org/10.1371/journal.pone.0175379			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426691	Green Submitted, Green Published, gold			2022-12-26	WOS:000399875900028
J	Yamazaki, R; Kasuya, Y; Fujita, T; Umezawa, H; Yanagihara, M; Nakamura, H; Yoshino, I; Tatsumi, K; Murayama, T				Yamazaki, Risa; Kasuya, Yoshitoshi; Fujita, Tetsuo; Umezawa, Hiroki; Yanagihara, Madoka; Nakamura, Hiroyuki; Yoshino, Ichiro; Tatsumi, Koichiro; Murayama, Toshihiko			Antifibrotic effects of cyclosporine A on TGF-beta 1-treated lung fibroblasts and lungs from bleomycin-treated mice: role of hypoxia-inducible factor-1 alpha	FASEB JOURNAL			English	Article						pulmonary fibrosis; immunosuppressants; dedifferentiation	IDIOPATHIC PULMONARY-FIBROSIS; SMOOTH MUSCLE ACTIN; TGF-BETA; MYOFIBROBLAST DIFFERENTIATION; PROSTAGLANDIN E-2; HIF-1-ALPHA; AZATHIOPRINE; MACROPHAGES; INHIBITION; PREDNISONE	Idiopathic pulmonary fibrosis (IPF) is a chronic lung disorder that is characterized by aberrant tissue remodeling and the formation of fibroblastic foci that are composed of fibrogenic myofibroblasts. TGF-beta 1 is one of the factors that are responsible for fibrosis as it promotes fibroblast to myofibroblast differentiation (FMD) and is associated with up-regulation of a-smooth muscle actin. Therefore, inhibition of FMD may represent an effective strategy for the treatment of IPF. Here, we describe the treatment of human lung fibroblasts (WI-38 and HFL-1 cells) with cyclosporine A (CsA), which reduces TGF-beta 1-induced FMD via degradation of hypoxia-inducible factor-1 alpha (HIF-1 alpha). In addition, in primary myofibroblast-like cells that were obtained from a patient with pulmonary fibrosis, treatment with CsA and an HIF-1 alpha inhibitor (HIFi) decreased the expression levels of a-smooth muscle actin and fibronectin, which indicated that CsA and HIFi promote dedifferentiation of myofibroblasts. In mice intratracheally administered CsA or HIFi at an early fibrotic stage [ 7, 8, and 9 d postinstillation (dpi) of bleomycin], marked alleviation of lung fibrosis was observed at 14 dpi. These results suggest that CsA exhibits antifibrotic effects by degrading HIF-1 alpha and that the CsA-HIF-1 alpha axis provides new insights into therapeutic options for the treatment of IPF.	[Yamazaki, Risa; Yanagihara, Madoka; Nakamura, Hiroyuki; Murayama, Toshihiko] Chiba Univ, Chem Pharmacol Lab, Grad Sch Pharmaceut Sci, Chiba, Chiba, Japan; [Kasuya, Yoshitoshi; Fujita, Tetsuo; Umezawa, Hiroki] Chiba Univ, Dept Mol Pharmacol & Biochem, Grad Sch Med, Chiba, Chiba, Japan; [Kasuya, Yoshitoshi; Umezawa, Hiroki] Chiba Univ, Dept Biomed Sci, Grad Sch Med, Chiba, Chiba, Japan; [Fujita, Tetsuo; Umezawa, Hiroki; Tatsumi, Koichiro] Chiba Univ, Dept Respirol, Grad Sch Med, Chiba, Chiba, Japan; [Yoshino, Ichiro] Chiba Univ, Dept Gen Thorac Surg, Grad Sch Med, Chiba, Chiba, Japan	Chiba University; Chiba University; Chiba University; Chiba University; Chiba University	Kasuya, Y (corresponding author), Chiba Univ, Dept Biomed Sci, Grad Sch Med, Chuo Ku, Inohana 1-8-1, Chiba, Chiba 2608675, Japan.; Murayama, T (corresponding author), Chiba Univ, Chem Pharmacol Lab, Grad Sch Pharmaceut Sci, Chuo Ku, Inohana 1-8-1, Chiba, Chiba 2608675, Japan.	kasuya@faculty.chiba-u.jp; murayama-toshi@faculty.chiba-u.jp	Nakamura, Hiroyuki/B-4089-2015; Ichiro, Yoshino/HCH-1137-2022; Nakamura, Hiroyuki/AFV-2078-2022	Nakamura, Hiroyuki/0000-0001-6328-9727; Nakamura, Hiroyuki/0000-0001-6328-9727; Kasuya, Yoshitoshi/0000-0003-0614-5836; Yamazaki, Risa/0000-0001-9717-6763	Ministry of Education, Culture, Sports, Sciences, and Technology, Japan [23590106, 24390137]; Sasakawa Scientific Research Grant from Japan Science Society [26-509]	Ministry of Education, Culture, Sports, Sciences, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sasakawa Scientific Research Grant from Japan Science Society	This work was supported by Grants 23590106 (to T.M.) and 24390137 (to Y.K.) from the Ministry of Education, Culture, Sports, Sciences, and Technology, Japan, and the Sasakawa Scientific Research Grant 26-509 (to R.Y.) from The Japan Science Society. The authors thank Drs. Tatsuo Kawashima and Yasuo Matsuzawa (Sakura Hospital Toho University, Sakura, Japan) for supplying reagents and information. The authors also thank Dr. Masahiko Hatano (Chiba University) for conceptual advice.	Abdul-Hafez A, 2009, FASEB J, V23, P1655, DOI 10.1096/fj.08-114611; Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; Bardos JI, 2005, BBA-REV CANCER, V1755, P107, DOI 10.1016/j.bbcan.2005.05.001; Berchner-Pfannschmidt U, 2008, J BIOL CHEM, V283, P31745, DOI 10.1074/jbc.M804390200; D'Angelo G, 2003, J BIOL CHEM, V278, P15406, DOI 10.1074/jbc.M211293200; Dackor RT, 2011, AM J PHYSIOL-LUNG C, V301, pL645, DOI 10.1152/ajplung.00176.2011; Driesen RB, 2014, CARDIOVASC RES, V101, P411, DOI 10.1093/cvr/cvt338; du Bois RM, 2010, NAT REV DRUG DISCOV, V9, P129, DOI 10.1038/nrd2958; Evans RA, 2003, EXP CELL RES, V282, P90, DOI 10.1016/S0014-4827(02)00015-0; Garrison G, 2013, AM J RESP CELL MOL, V48, P550, DOI 10.1165/rcmb.2012-0262OC; Geng JJ, 2014, BBA-MOL BASIS DIS, V1842, P1770, DOI 10.1016/j.bbadis.2014.06.008; GURUJEYALAKSHMI G, 1995, EXP LUNG RES, V21, P791, DOI 10.3109/01902149509050842; Han WQ, 2013, BBA-MOL CELL RES, V1833, P1454, DOI 10.1016/j.bbamcr.2013.02.029; Hashimoto S, 2001, AM J RESP CRIT CARE, V163, P152, DOI 10.1164/ajrccm.163.1.2005069; Hecker L, 2011, EXP CELL RES, V317, P1914, DOI 10.1016/j.yexcr.2011.03.016; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hu B, 2003, AM J RESP CELL MOL, V29, P397, DOI 10.1165/rcmb.2003-0063OC; Huebner RH, 2008, BIOTECHNIQUES, V44, P507, DOI 10.2144/000112729; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kawashima T, 2012, EUR J PHARMACOL, V696, P120, DOI 10.1016/j.ejphar.2012.09.038; Kendall RT, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00123; Kim KE, 2008, IMMUNOPHARM IMMUNOT, V30, P105, DOI [10.1080/08923970701812662, 10.1080/08923970701812662 ]; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; King TE, 2001, AM J RESP CRIT CARE, V164, P1171, DOI 10.1164/ajrccm.164.7.2003140; King TE, 2001, AM J RESP CRIT CARE, V164, P1025, DOI 10.1164/ajrccm.164.6.2001056; Kobayashi T, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0261-z; Kosla J, 2013, EUR J CELL BIOL, V92, P363, DOI 10.1016/j.ejcb.2013.10.013; Kottmann RM, 2012, AM J RESP CRIT CARE, V186, P740, DOI 10.1164/rccm.201201-0084OC; McMahon S, 2006, J BIOL CHEM, V281, P24171, DOI 10.1074/jbc.M604507200; Meltzer EB, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-8; Papiris SA, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0146-4; Penke LRK, 2014, J BIOL CHEM, V289, P17151, DOI 10.1074/jbc.M114.558130; RAGHU G, 1991, AM REV RESPIR DIS, V144, P291, DOI 10.1164/ajrccm/144.2.291; Raghu G, 2012, NEW ENGL J MED, V366, P1968, DOI 10.1056/NEJMoa1113354; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Reddy AT, 2014, FASEB J, V28, P5299, DOI 10.1096/fj.14-256263; Sakamoto S, 2010, INTERNAL MED, V49, P109, DOI 10.2169/internalmedicine.49.2359; Staitieh BS, 2015, ANN MED, V47, P100, DOI 10.3109/07853890.2014.991751; Tanaka K, 2014, LAB INVEST, V94, P1247, DOI 10.1038/labinvest.2014.109; Thannickal Victor J, 2006, Proc Am Thorac Soc, V3, P350, DOI 10.1513/pats.200601-001TK; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Ueno M, 2011, AM J PHYSIOL-LUNG C, V300, pL740, DOI 10.1152/ajplung.00146.2010; Verma S, 2007, NEW ENGL J MED, V356, P1370, DOI 10.1056/NEJMcibr070490; Watanabe T, 2014, ARCH ORAL BIOL, V59, P595, DOI 10.1016/j.archoralbio.2014.03.003; Wettlaufer SH, 2016, AM J RESP CELL MOL, V54, P114, DOI 10.1165/rcmb.2014-0468OC; Yamauchi K, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-131; Zhou QY, 2011, FASEB J, V25, P3032, DOI 10.1096/fj.10-177824; Zhu Y, 2016, J CELL MOL MED, V20, P688, DOI 10.1111/jcmm.12769	48	24	25	0	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3359	3371		10.1096/fj.201601357R	http://dx.doi.org/10.1096/fj.201601357R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28446589				2022-12-26	WOS:000405932400015
J	Dariolli, R; Naghetini, MV; Marques, EF; Takimura, CK; Jensen, LS; Kiers, B; Tsutsui, JM; Mathias, W; Neto, PAL; Krieger, JE				Dariolli, Rafael; Naghetini, Marcus V.; Marques, Euclydes F.; Takimura, Celso K.; Jensen, Leonardo S.; Kiers, Bianca; Tsutsui, Jeane M.; Mathias, Wilson, Jr.; Lemos Neto, Pedro A.; Krieger, Jose E.			Allogeneic pASC transplantation in humanized pigs attenuates cardiac remodeling post-myocardial infarction	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; MYOCARDIAL CONTRAST ECHOCARDIOGRAPHY; LEFT-VENTRICULAR FUNCTION; HEART-DISEASE; CELLULAR CARDIOMYOPLASTY; BLOOD-FLOW; IN-VITRO; PROLIFERATION; THERAPY; ANGIOGENESIS	Cell therapy repair strategies using adult mesenchymal stromal cells have shown promising evidence to prevent cardiac deterioration in rodents even in the absence of robust differentiation of the cells into cardiomyocytes. We tested whether increasing doses of porcine adipose- tissue derived mesenchymal stem cells (pASCs) increase cardiac tissue perfusion in pigs post-myocardial infarction (MI) receiving angiotensin-converting-enzyme inhibitor (ACE inhibitors) and Beta-blockers similarly to patients. Female pigs were subjected to MI induction by sponge permanent occlusion of left circumflex coronary artery (LCx) generating approximately 10% of injured LV area with minimum hemodynamic impact. We assessed tissue perfusion by real time myocardial perfusion echocardiography (RTMPE) using commercial microbubbles before and following pASCs treatment. Four weeks after the occlusion of the left circumflex artery, we transplanted placebo or pASCs (1, 2 and 4x10 6 cells/Kg BW) into the myocardium. The highest dose of pASCs increased myocardial vessel number and blood flow in the border (56% and 3.7-fold, respectively) and in the remote area (54% and 3.9-fold, respectively) while the non-perfused scar area decreased (up to 38%). We also found an increase of immature collagen fibers, although the increase in total tissue collagen and types I and III was similar in all groups. Our results provide evidence that pASCsinduced stimulation of tissue perfusion and accumulation of immature collagen fibers attenuates adverse remodeling post-MI beyond the normal beneficial effects associated with ACE inhibition and beta-blockade.	[Dariolli, Rafael; Naghetini, Marcus V.; Marques, Euclydes F.; Takimura, Celso K.; Jensen, Leonardo S.; Kiers, Bianca; Tsutsui, Jeane M.; Mathias, Wilson, Jr.; Lemos Neto, Pedro A.; Krieger, Jose E.] Univ Sao Paulo, Med Sch, Heart Inst InCor, Sao Paulo, Brazil	Universidade de Sao Paulo	Krieger, JE (corresponding author), Univ Sao Paulo, Med Sch, Heart Inst InCor, Sao Paulo, Brazil.	krieger@incor.usp.br	Mathias, Wilson/A-4772-2008; Lemos, Pedro A./G-5758-2013; Dariolli, Rafael/I-3672-2015; Tsutsui, Jeane/C-6051-2013	Mathias, Wilson/0000-0003-0201-6754; Lemos, Pedro A./0000-0002-6782-750X; Krieger, Jose E/0000-0001-5464-1792; Dariolli, Rafael/0000-0003-0957-1259	Fundacao Zerbini; Sao Paulo Research Foundation [FAPESP 13/17368-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [404733-2012-3]; CAPES PROBITEC [23038-4156-2012-80]; Ministerio da Saude do Brasil; FAPESP	Fundacao Zerbini; Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES PROBITEC(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Ministerio da Saude do Brasil; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by grants to J. E.K. from Fundacao Zerbini; Sao Paulo Research Foundation [FAPESP 13/17368-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [404733-2012-3]; CAPES PROBITEC [23038-4156-2012-80] and Ministerio da Saude do Brasil [MS-DECIT-PROADI_SUS - H. Samaritano]. R.D. was a recipient of a post-doctoral fellowship from FAPESP.	Abdelmoneim SS, 2011, DIABETES VASC DIS RE, V8, P254, DOI 10.1177/1479164111419973; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; Bin JP, 2003, J AM SOC ECHOCARDIOG, V16, P871, DOI 10.1067/S0894-7317(03)00423-1; Butler D, 2011, NATURE, V477, P260, DOI 10.1038/477260a; Brescane RC, 2009, REV ESP CARDIOL, V62, P235; Chen DH, 2005, CURR BIOL, V15, P179, DOI 10.1016/j.cub.2005.01.004; Chen PP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103587; Chen YH, 2014, SCI CHINA LIFE SCI, V57, P195, DOI 10.1007/s11427-013-4605-y; Clarke SA, 2016, J MOL CELL CARDIOL, V93, P115, DOI 10.1016/j.yjmcc.2015.11.028; Costanzo MR, 2010, J HEART LUNG TRANSPL, V29, P914, DOI 10.1016/j.healun.2010.05.034; Dai B, 2011, J AM COLL CARDIOL, V58, P2118, DOI 10.1016/j.jacc.2011.06.062; Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056; Danoviz ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012077; Dariolli R, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12121; Dariolli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067939; Dobrucki LW, 2010, J MOL CELL CARDIOL, V48, P1071, DOI 10.1016/j.yjmcc.2009.10.008; dos Santos L, 2010, INT J CARDIOL, V145, P34, DOI 10.1016/j.ijcard.2009.06.008; Ebelt H, 2007, STEM CELLS, V25, P236, DOI 10.1634/stemcells.2006-0374; Eding JEC, 2015, CIRC RES, V116, P80, DOI 10.1161/CIRCRESAHA.116.304872; Funakoshi S, 2016, SCI REP-UK, V6, DOI 10.1038/srep19111; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Hatzistergos KE, 2010, CIRC RES, V107, P913, DOI 10.1161/CIRCRESAHA.110.222703; HEYNDRICKX GR, 1978, AM J PHYSIOL, V234, pH653, DOI 10.1152/ajpheart.1978.234.6.H653; Karantalis V, 2015, J AM COLL CARDIOL, V66, P1990, DOI 10.1016/j.jacc.2015.08.879; Katayama Y, 2010, ANN THORAC CARDIOVAS, V16, P174; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420; Langen M, 2010, MEAT SCI, V86, P821, DOI 10.1016/j.meatsci.2010.07.003; Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010; Li DY, 2013, CLIN CARDIOL, V36, P468, DOI 10.1002/clc.22142; Malliaras Konstantinos, 2012, Circulation, V125, P100, DOI 10.1161/CIRCULATIONAHA.111.042598; McIntosh KR, 2009, TISSUE ENG PT A, V15, P2677, DOI 10.1089/ten.TEA.2008.0566; Modonesi E, 2010, CURR CARDIOL REV, V6, P24, DOI 10.2174/157340310790231653; Moran AE, 2014, CIRCULATION, V129, P1483, DOI 10.1161/CIRCULATIONAHA.113.004042; Mummery CL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000558; Nakamuta JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006005; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Pathan F, 2015, PROG CARDIOVASC DIS, V57, P632, DOI 10.1016/j.pcad.2015.03.005; Poh KK, 2007, INT J CARDIOL, V117, P360, DOI 10.1016/j.ijcard.2006.04.092; Poncelet AJ, 2010, EUR J CARDIO-THORAC, V38, P781, DOI 10.1016/j.ejcts.2010.03.035; Puissant N, 2005, BRIT J HAEMATOL, V129, P118, DOI 10.1111/j.1365-2141.2005.05409.x; Quevedo HC, 2009, P NATL ACAD SCI USA, V106, P14022, DOI 10.1073/pnas.0903201106; Regieli JJ, 2009, INT J CARDIOL, V132, P257, DOI 10.1016/j.ijcard.2007.11.100; REIMER KA, 1977, CIRCULATION, V56, P786, DOI 10.1161/01.CIR.56.5.786; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Ruiz-Villalba A, 2015, J AM COLL CARDIOL, V65, P2057, DOI 10.1016/j.jacc.2015.03.520; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Senior R, 2013, J AM COLL CARDIOL, V62, P1353, DOI 10.1016/j.jacc.2013.04.082; Stewart S, 2005, J HEART LUNG TRANSPL, V24, P1710, DOI 10.1016/j.healun.2005.03.019; Tao ZX, 2011, P NATL ACAD SCI USA, V108, P2064, DOI 10.1073/pnas.1018925108; Verma A, 2008, JACC-CARDIOVASC IMAG, V1, P582, DOI 10.1016/j.jcmg.2008.05.012; Wei K, 1998, CIRCULATION, V97, P473; WHITE HD, 1987, CIRCULATION, V76, P44, DOI 10.1161/01.CIR.76.1.44; WHITTAKER P, 1994, BASIC RES CARDIOL, V89, P397, DOI 10.1007/BF00788278; Wollert KC, 2005, CIRC RES, V96, P151, DOI 10.1161/01.RES.0000155333.69009.63; Xiong Q, 2013, CIRCULATION, V127, P997, DOI 10.1161/CIRCULATIONAHA.112.000641	57	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176412	10.1371/journal.pone.0176412	http://dx.doi.org/10.1371/journal.pone.0176412			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448588	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383600076
J	Falk, J; Mendler, M; Drossel, B				Falk, Johannes; Mendler, Marc; Drossel, Barbara			A minimal model of burst-noise induced bistability	PLOS ONE			English	Article							CHEMICAL-REACTION SYSTEMS; PHASE-TRANSITIONS; FLUCTUATIONS; OSCILLATIONS; BIFURCATION	We investigate the influence of intrinsic noise on stable states of a one-dimensional dynamical system that shows in its deterministic version a saddle-node bifurcation between monostable and bistable behaviour. The system is a modified version of the Schlogl model, which is a chemical reaction system with only one type of molecule. The strength of the intrinsic noise is varied without changing the deterministic description by introducing bursts in the autocatalytic production step. We study the transitions between monostable and bistable behavior in this system by evaluating the number of maxima of the stationary probability distribution. We find that changing the size of bursts can destroy and even induce saddle-node bifurcations. This means that a bursty production of molecules can qualitatively change the dynamics of a chemical reaction system even when the deterministic description remains unchanged.	[Falk, Johannes; Mendler, Marc; Drossel, Barbara] Tech Univ Darmstadt, Inst Festkorperphys, Hsch Str 6, D-64289 Darmstadt, Germany	Technical University of Darmstadt	Falk, J (corresponding author), Tech Univ Darmstadt, Inst Festkorperphys, Hsch Str 6, D-64289 Darmstadt, Germany.	falk@fkp.tu-darmstadt.de		Falk, Johannes/0000-0001-8496-6221	Hessen State Ministry of Higher Education, Research and the Arts (HMWK) via the "LOEWE CompuGene" project; Perimeter Institute of Theoretical Physics; Government of Canada through the Department of Innovation, Science and Economic Development; Province of Ontario through the Ministry of Research, Innovation and Science	Hessen State Ministry of Higher Education, Research and the Arts (HMWK) via the "LOEWE CompuGene" project; Perimeter Institute of Theoretical Physics; Government of Canada through the Department of Innovation, Science and Economic Development; Province of Ontario through the Ministry of Research, Innovation and Science	JF acknowledges funding by the Hessen State Ministry of Higher Education, Research and the Arts (HMWK) via the "LOEWE CompuGene" project. BD was supported in part by Perimeter Institute of Theoretical Physics. Perimeter Institute is supported by the Government of Canada through the Department of Innovation, Science and Economic Development and by the Province of Ontario through the Ministry of Research, Innovation and Science.	Arnold L., 2003, RANDOM DYNAMICAL SYS; Assaf M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.248102; Be'er S, 2016, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2016/11/113501; Biancalani T, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.038101; Bishop LM, 2010, BIOPHYS J, V98, P1, DOI 10.1016/j.bpj.2009.09.055; Black AJ, 2012, TRENDS ECOL EVOL, V27, P337, DOI 10.1016/j.tree.2012.01.014; Bokes P, 2016, ARXIV160208568QBIO; Bokes P, 2013, B MATH BIOL, V75, P351, DOI 10.1007/s11538-013-9811-z; Breslauer DN, 2006, MOL BIOSYST, V2, P97, DOI 10.1039/b515632g; Du C, 2016, ARXIV161007213QBIOST; Duncan A, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.042111; DURRETT R, 1994, THEOR POPUL BIOL, V46, P363, DOI 10.1006/tpbi.1994.1032; Endres RG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121681; Erban R, 2009, SIAM J APPL MATH, V70, P984, DOI 10.1137/080731360; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; Gardiner C, 2009, STOCHASTIC METHODS H; Gaspard P, 2004, J CHEM PHYS, V120, P8898, DOI 10.1063/1.1688758; Gillespie D. T., 1991, MARKOV PROCESSES INT; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GILLESPIE DT, 1992, PHYSICA A, V188, P404, DOI 10.1016/0378-4371(92)90283-V; Gomez-Uribe CA, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408422; GRASSBERGER P, 1982, Z PHYS B CON MAT, V47, P365, DOI 10.1007/BF01313803; Grima R, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3454685; Guckenheimer J., 2002, NONLINEAR OSCILLATIO; HANGGI P, 1982, PHYS REP, V88, P207, DOI 10.1016/0370-1573(82)90045-X; Horsthemke W., 1984, SPRINGER SERIES SYNE; Humphries MM, 2000, ECOLOGY, V81, P2867, DOI 10.2307/177347; Irving R. S, 2003, INTEGERS POLYNOMIALS; Karmakar R, 2007, PHYS BIOL, V4, P29, DOI 10.1088/1478-3975/4/1/004; KENDALL DG, 1949, J R STAT SOC B, V11, P230; KNOTT KF, 1978, SOLID STATE ELECTRON, V21, P1039, DOI 10.1016/0038-1101(78)90182-X; Lin YT, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2015.0772; McSweeney JK, 2014, ANN APPL PROBAB, V24, P1226, DOI 10.1214/13-AAP946; NAGEL K, 1992, J PHYS I, V2, P2221, DOI 10.1051/jp1:1992277; Nebe-von-Caron G, 2000, J MICROBIOL METH, V42, P97, DOI 10.1016/S0167-7012(00)00181-0; Paulsson J, 2000, P NATL ACAD SCI USA, V97, P7148, DOI 10.1073/pnas.110057697; Paulsson J, 2000, PHYS REV LETT, V84, P5447, DOI 10.1103/PhysRevLett.84.5447; Qian H, 2002, P NATL ACAD SCI USA, V99, P10376, DOI 10.1073/pnas.152007599; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Ramaswamy R, 2011, SCI REP-UK, V1, DOI 10.1038/srep00154; Ramsey Stephen, 2005, Journal of Bioinformatics and Computational Biology, V3, P415, DOI 10.1142/S0219720005001132; Risken PDH, 1984, FOKKER PLANCK EQUATI; Samoilov M, 2005, P NATL ACAD SCI USA, V102, P2310, DOI 10.1073/pnas.0406841102; SCHLOGL F, 1972, Z PHYS, V253, P147, DOI 10.1007/BF01379769; Scott M, 2007, P NATL ACAD SCI USA, V104, P7402, DOI 10.1073/pnas.0610468104; Thomas P, 2013, J THEOR BIOL, V335, P222, DOI 10.1016/j.jtbi.2013.06.021; Tsimring LS, 2014, NOISE BIOL REPORTS P, V77; VanKampen NG, 2007, NORTH-HOLL PERS LIBR, P1; Vellela M, 2009, J R SOC INTERFACE, V6, P925, DOI 10.1098/rsif.2008.0476; WIESENFELD K, 1995, NATURE, V373, P33, DOI 10.1038/373033a0; Wilhelm T, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-90; ZAKLIKIEWICZ AM, 1981, SOLID STATE ELECTRON, V24, P1, DOI 10.1016/0038-1101(81)90205-7	52	12	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176410	10.1371/journal.pone.0176410	http://dx.doi.org/10.1371/journal.pone.0176410			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448638	Green Published, gold, Green Submitted			2022-12-26	WOS:000400383600075
J	Ritsma, L; Dey-Guha, I; Talele, N; Sole, X; Salony; Chowdhury, J; Ross, KN; Ramaswamy, S				Ritsma, Laila; Dey-Guha, Ipsita; Talele, Nilesh; Sole, Xavier; Salony; Chowdhury, Joeeta; Ross, Kenneth N.; Ramaswamy, Sridhar			Integrin beta 1 activation induces an anti-melanoma host response	PLOS ONE			English	Article							INHIBITS TUMOR-GROWTH; REGULATORY T-CELLS; TGF-BETA; ACQUIRED-RESISTANCE; MELANOMA PATIENTS; IMMUNE CELLS; EXPRESSION; RECEPTOR; CANCER; PATHWAY	TGF-beta is a cytokine thought to function as a tumor promoter in advanced malignancies. In this setting, TGF-beta increases cancer cell proliferation, survival, and migration, and orchestrates complex, pro-tumorigenic changes in the tumor microenvironment. Here, we find that in melanoma, integrin beta 1-mediated TGF-beta activation may also produce tumor suppression via an altered host response. In the A375 human melanoma cell nu/nu xenograft model, we demonstrate that cell surface integrin beta 1-activation increases TGF-beta activity, resulting in stromal activation, neo-angiogenesis and, unexpectedly for this nude mouse model, increase in the number of intra-tumoral CD8(+) T lymphocytes within the tumor microenvironment. This is associated with attenuation of tumor growth and long-term survival benefit. Correspondingly, in human melanomas, TGF-beta 1 correlates with integrin beta 1/TGF-beta 1 activation and the expression of markers for vasculature and stromal activation. Surprisingly, this integrin beta 1/TGF-beta 1 transcriptional footprint also correlates with the expression of markers for tumor-infiltrating lymphocytes, multiple immune checkpoints and regulatory pathways, and, importantly, better long-term survival of patients. These correlations are unique to melanoma, in that we do not observe similar associations between beta 1 integrin/TGF-beta 1 activation and better long-term survival in other human tumor types. These results suggest that activation of TGF-beta 1 in melanoma may be associated with the generation of an anti-tumor host response that warrants further study.	[Ritsma, Laila; Dey-Guha, Ipsita; Talele, Nilesh; Sole, Xavier; Salony; Chowdhury, Joeeta; Ross, Kenneth N.; Ramaswamy, Sridhar] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA; [Ritsma, Laila; Dey-Guha, Ipsita; Talele, Nilesh; Sole, Xavier; Salony; Ross, Kenneth N.; Ramaswamy, Sridhar] Harvard Med Sch, Boston, MA 02115 USA; [Ramaswamy, Sridhar] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Ramaswamy, Sridhar] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Ramaswamy, Sridhar] Harvard Ludwig Ctr Canc Res, Cambridge, MA 02139 USA; [Ritsma, Laila] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Canc Genom Ctr Netherlands, Leiden, Netherlands	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Ramaswamy, S (corresponding author), Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA.; Ramaswamy, S (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Ramaswamy, S (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.; Ramaswamy, S (corresponding author), Harvard Stem Cell Inst, Cambridge, MA 02138 USA.; Ramaswamy, S (corresponding author), Harvard Ludwig Ctr Canc Res, Cambridge, MA 02139 USA.	Sridhar@mgh.harvard.edu	Talele, Nilesh Prakash/GRE-5860-2022; Ritsma, Laila/AAZ-6620-2020; Solé, Xavier/AAF-3015-2019	Talele, Nilesh Prakash/0000-0003-2758-8599; Ritsma, Laila/0000-0002-0214-2008; Solé, Xavier/0000-0002-2197-3325	Netherlands Organization for Scientific Research (NWO) [825.13.016]; Susan G. Komen foundation [PDF15329694]; Bolsa de Ampliacion de Estudios, Institute de Salud Carlos III, Ministerio de Economia y Competitividad [BA12/00021]; National Cancer Institute [R01 CA185086, C06 CA05926]; Susan G. Komen for the Cure [IIR 12223648]; Harvard-Ludwig Center for Cancer Research; Stand Up to Cancer Innovative Research Grant [SU2C-AACR-IRG0911]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Susan G. Komen foundation(Susan G. Komen Breast Cancer Foundation); Bolsa de Ampliacion de Estudios, Institute de Salud Carlos III, Ministerio de Economia y Competitividad; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Harvard-Ludwig Center for Cancer Research; Stand Up to Cancer Innovative Research Grant	LR was supported by a Rubicon grant from the Netherlands Organization for Scientific Research (NWO; 825.13.016), http://www.nwo.nl/ onderzoek-en-resultaten/programmas/rubicon, and a Postdoctoral Fellowship from the Susan G. Komen foundation (PDF15329694), http //ww5. komen.org/ResearchGrants/FundingOpportunities. html.XS was supported by the Bolsa de Ampliacion de Estudios, Institute de Salud Carlos III, Ministerio de Economia y Competitividad (BA12/00021), http://www.isciii.es/ISCIII/es/ contenidos/fd-investigacion/fd-financiacion/ convocatorias-ayudas-accion-estrategica-salud.shtml. SR was supported by awards from the National Cancer Institute (R01 CA185086, C06 CA05926), htlp://www.cancer.gov/, Susan G. Komen for the Cure (IIR 12223648), http://ww5. komen.org/ResearchGrants/FundingOpportunities. html, and Harvard-Ludwig Center for Cancer Research (to S. Ramaswamy), http://www.ludwigcancerresearch.org/location/harvard-center. SR was also supported by a Stand Up to Cancer Innovative Research Grant (SU2C-AACR-IRG0911), http://www.aacr.org/Funding/Pages/ Funding-Detail.aspx?ItemID=52#.V9W60jh942w. Stand Up To Cancer is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research.	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Annes JP, 2004, J CELL BIOL, V165, P723, DOI 10.1083/jcb.200312172; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; ARROYO AG, 1992, J CELL BIOL, V117, P659, DOI 10.1083/jcb.117.3.659; ARROYO AG, 1993, J BIOL CHEM, V268, P9863; Astier AL, 2003, BLOOD, V101, P1118, DOI 10.1182/blood-2002-05-1519; Berking C, 2001, CANCER RES, V61, P8306; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Chen B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042598; Condeelis J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003848; Dey-Guha I, 2015, MOL CANC RES; Diaz-Valdes N, 2011, CANCER RES, V71, P812, DOI 10.1158/0008-5472.CAN-10-2698; Doyle AD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9720; Drabsch Y, 2012, CANCER METAST REV, V31, P553, DOI 10.1007/s10555-012-9375-7; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Flavell RA, 2010, NAT REV IMMUNOL, V10, P554, DOI 10.1038/nri2808; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Harlin H, 2009, CANCER RES, V69, P3077, DOI 10.1158/0008-5472.CAN-08-2281; Hersh EM, 2010, CANCER-AM CANCER SOC, V116, P155, DOI 10.1002/cncr.24720; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; IKEHARA S, 1984, P NATL ACAD SCI-BIOL, V81, P886, DOI 10.1073/pnas.81.3.886; JAKUBOWSKI A, 1995, CELL ADHES COMMUN, V3, P131, DOI 10.3109/15419069509081282; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107; Li HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep16552; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Liu SX, 2010, J CELL SCI, V123, P3674, DOI 10.1242/jcs.070672; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; MALECKAR JR, 1987, J IMMUNOL, V138, P3873; Margadant C, 2010, EMBO REP, V11, P97, DOI 10.1038/embor.2009.276; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mohammad KS, 2011, CANCER RES, V71, P175, DOI 10.1158/0008-5472.CAN-10-2651; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morris JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090353; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Ouyang WM, 2013, IMMUNITY, V39, P335, DOI 10.1016/j.immuni.2013.07.016; Penafuerte C, 2011, J IMMUNOL, V186, P6933, DOI 10.4049/jimmunol.1003816; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Puzanov I, 2015, EUR J CANCER, V51, P1435, DOI 10.1016/j.ejca.2015.04.010; Ramont L, 2003, EXP CELL RES, V291, P1, DOI 10.1016/S0014-4827(03)00336-7; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Shi HB, 2014, CANCER DISCOV, V4, P80, DOI 10.1158/2159-8290.CD-13-0642; Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tandon M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119346; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Travis MA, 2014, ANNU REV IMMUNOL, V32, P51, DOI 10.1146/annurev-immunol-032713-120257; Van Allen EM, 2014, CANCER DISCOV, V4, P94, DOI 10.1158/2159-8290.CD-13-0617; Wagle N, 2014, CANCER DISCOV, V4, P61, DOI 10.1158/2159-8290.CD-13-0631; Whilding LM, 2017, MOL THER, V25, P259, DOI 10.1016/j.ymthe.2016.10.012; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Zhang N, 2013, IMMUNITY, V39, P687, DOI 10.1016/j.immuni.2013.08.019; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216	58	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0175300	10.1371/journal.pone.0175300	http://dx.doi.org/10.1371/journal.pone.0175300			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448494	Green Published, gold, Green Submitted			2022-12-26	WOS:000400383600012
J	Rodriguez-Cueto, C; Hernandez-Galvez, M; Hillard, CJ; Maciel, P; Valdeolivas, S; Ramos, JA; Gomez-Ruiz, M; Fernandez-Ruiz, J				Rodriguez-Cueto, Carmen; Hernandez-Galvez, Mariluz; Hillard, Cecilia J.; Maciel, Patricia; Valdeolivas, Sara; Ramos, Jose A.; Gomez-Ruiz, Maria; Fernandez-Ruiz, Javier			Altered striatal endocannabinoid signaling in a transgenic mouse model of spinocerebellar ataxia type-3	PLOS ONE			English	Article							MACHADO-JOSEPH-DISEASE; CANNABINOID CB2 RECEPTOR; HUNTINGTONS-DISEASE; SPINAL-CORD; DYSTONIA; CEREBELLUM; SYSTEM; DISORDERS; TARGET; DYSREGULATION	Spinocerebellar ataxia type-3 (SCA-3) is the most prevalent autosomal dominant inherited ataxia. We recently found that the endocannabinoid system is altered in the post-mortem cerebellum of SCA-3 patients, and similar results were also found in the cerebellar and brainstem nuclei of a SCA-3 transgenic mouse model. Given that the neuropathology of SCA-3 is not restricted to these two brain regions but rather, it is also evident in other structures (e.g., the basal ganglia), we studied the possible changes to endocannabinoid signaling in the striatum of these transgenic mice. SCA-3 mutant mice suffer defects in motor coordination, balance and they have an abnormal gait, reflecting a cerebellar/brainstem neuropathology. However, they also show dystonia-like behavior (limb clasping) that may be related to the malfunction/deterioration of specific neurons in the striatum. Indeed, we found a loss of striatal projecting neurons in SCA-3 mutant mice, accompanied by a reduction in glial glutamate transporters that could potentially aggravate excitotoxic damage. In terms of endocannabinoid signaling, no changes in CB2 receptors were evident, yet an important reduction in CB1 receptors was detected by qPCR and immunostaining. The reduction in CB1 receptors was presumed to occur in striatal afferent and efferent neurons, also potentially aggravating excitotoxicity. We also measured the endocannabinoid lipids in the striatum and despite a marked increase in the FAAH enzyme in this area, no overall changes in these lipids were found. Collectively, these studies confirm that the striatal endocannabinoid system is altered in SCA-3 mutant mice, adding to the equivalent changes found in other strongly affected CNS structures in this type of ataxia (i.e.: the cerebellum and brainstem). These data open the way to search for drugs that might correct these changes.	[Rodriguez-Cueto, Carmen; Hernandez-Galvez, Mariluz; Valdeolivas, Sara; Ramos, Jose A.; Gomez-Ruiz, Maria; Fernandez-Ruiz, Javier] Univ Complutense, Fac Med, Dept Bioquim & Biol Mol, Inst Univ Invest Neuroquim, Madrid, Spain; [Rodriguez-Cueto, Carmen; Hernandez-Galvez, Mariluz; Valdeolivas, Sara; Ramos, Jose A.; Gomez-Ruiz, Maria; Fernandez-Ruiz, Javier] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Rodriguez-Cueto, Carmen; Hernandez-Galvez, Mariluz; Valdeolivas, Sara; Ramos, Jose A.; Gomez-Ruiz, Maria; Fernandez-Ruiz, Javier] Inst Ramon y Cajal Invest Sanitaria, Madrid, Spain; [Hernandez-Galvez, Mariluz; Gomez-Ruiz, Maria] Univ Complutense, Fac Psicol, Dept Psicobiol, Madrid, Spain; [Hillard, Cecilia J.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Maciel, Patricia] Univ Minho, Sch Med, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Maciel, Patricia] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal	Complutense University of Madrid; CIBERNED; Complutense University of Madrid; Medical College of Wisconsin; Universidade do Minho	Gomez-Ruiz, M; Fernandez-Ruiz, J (corresponding author), Univ Complutense, Fac Med, Dept Bioquim & Biol Mol, Inst Univ Invest Neuroquim, Madrid, Spain.; Gomez-Ruiz, M; Fernandez-Ruiz, J (corresponding author), Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain.; Gomez-Ruiz, M; Fernandez-Ruiz, J (corresponding author), Inst Ramon y Cajal Invest Sanitaria, Madrid, Spain.; Gomez-Ruiz, M (corresponding author), Univ Complutense, Fac Psicol, Dept Psicobiol, Madrid, Spain.	msgr@med.ucm.es; jjfr@med.ucm.es	Rodriguez-Cueto, Carmen/I-2686-2015; Maciel, Patrícia/B-5989-2009; Maciel, Patricia/AAH-2102-2020; Hillard, Cecilia J/O-6693-2018; Hernández, mari luz/H-8969-2015; FERNANDEZ RUIZ, JOSE JAVIER/S-3875-2018; Gomez Ruiz, Maria/H-8958-2015	Maciel, Patrícia/0000-0002-0920-6350; Maciel, Patricia/0000-0002-0920-6350; Hernández, mari luz/0000-0001-8799-0593; FERNANDEZ RUIZ, JOSE JAVIER/0000-0002-4490-0604; Gomez Ruiz, Maria/0000-0002-0295-8285; rodriguez cueto, carmen/0000-0002-3891-4049	MICINN [SAF2009-11847, SAF2015-68580-C2-1-R]; CIBERNED [CB06/05/0089]; Fundacion Eugenio Rodriguez Pascual; Research and Education Component of the Advancing a Healthier Wisconsin Endowment at the Medical College of Wisconsin; Fundacao para a Ciencia e Tecnologia [POCI-01-0145-FEDER-016818 (PTDC/NEU-NMC/3648/2014)]; Portuguese North Regional Operational Program (ON.2 - O Novo Norte) under the National Strategic Reference Framework (QREN), through the European Regional Development Fund (FEDER); FPI Program-Ministry of Science	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); CIBERNED(Instituto de Salud Carlos III); Fundacion Eugenio Rodriguez Pascual; Research and Education Component of the Advancing a Healthier Wisconsin Endowment at the Medical College of Wisconsin; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Portuguese North Regional Operational Program (ON.2 - O Novo Norte) under the National Strategic Reference Framework (QREN), through the European Regional Development Fund (FEDER); FPI Program-Ministry of Science(National Health and Medical Research Council (NHMRC) of Australia)	This study has been supported: (i) by MICINN (SAF2009-11847 and SAF2015-68580-C2-1-R), CIBERNED (CB06/05/0089) and "Fundacion Eugenio Rodriguez Pascual", to JFR; (ii) by the Research and Education Component of the Advancing a Healthier Wisconsin Endowment at the Medical College of Wisconsin, to CJH; and (iii) by Fundacao para a Ciencia e Tecnologia through the project POCI-01-0145-FEDER-016818 (PTDC/NEU-NMC/3648/2014) and co-financed by the Portuguese North Regional Operational Program (ON.2 - O Novo Norte) under the National Strategic Reference Framework (QREN), through the European Regional Development Fund (FEDER), to PM. Carmen Rodriguez-Cueto was a predoctoral fellow supported by FPI Program-Ministry of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Carmen Rodriguez-Cueto was a predoctoral fellow supported by FPI Program-Ministry of Science. The authors are indebted to Yolanda Garcia-Movellan for administrative support.	Alves S, 2008, HUM MOL GENET, V17, P2071, DOI 10.1093/hmg/ddn106; Arevalo-Martin A, 2016, PROG NEURO-PSYCHOPH, V64, P190, DOI 10.1016/j.pnpbp.2015.03.008; Bisogno T, 2016, PHARMACOL RES, V111, P721, DOI 10.1016/j.phrs.2016.07.021; Blazquez C, 2011, BRAIN, V134, P119, DOI 10.1093/brain/awq278; Bonnet C, 2012, J NEUROL, V259, P2460, DOI 10.1007/s00415-012-6531-5; Chou AH, 2008, NEUROBIOL DIS, V31, P89, DOI 10.1016/j.nbd.2008.03.011; Di Marzo V, 2015, NAT REV NEUROSCI, V16, P30, DOI 10.1038/nrn3876; Durr A, 2010, LANCET NEUROL, V9, P885, DOI 10.1016/S1474-4422(10)70183-6; Espejo-Porras F, 2015, J NEUROIMMUNE PHARM, V10, P233, DOI 10.1007/s11481-015-9602-4; Fernandez-Ruiz J, 2001, BRIT J PHARMACOL, V163, P1365; Fernandez-Ruiz J, 2007, TRENDS PHARMACOL SCI, V28, P39, DOI 10.1016/j.tips.2006.11.001; Fernandez-Ruiz J, 2015, NEUROTHERAPEUTICS, V12, P793, DOI 10.1007/s13311-015-0381-7; Fernandez-Ruiz J, 2015, HANDB EXP PHARMACOL, V231, P233, DOI 10.1007/978-3-319-20825-1_8; Fernandez-Ruiz J, 2010, EXPERT OPIN THER TAR, V14, P387, DOI 10.1517/14728221003709792; Filip P, 2013, CLIN NEUROPHYSIOL, V124, P1269, DOI 10.1016/j.clinph.2013.01.003; Fratkin Jonathan D, 2012, Handb Clin Neurol, V103, P111, DOI 10.1016/B978-0-444-51892-7.00005-X; Fusco FR, 2004, SYNAPSE, V53, P159, DOI 10.1002/syn.20047; Gomez-Galvez Y, 2016, PROG NEURO-PSYCHOPH, V64, P200, DOI 10.1016/j.pnpbp.2015.03.017; Jabusch HC, 2004, MOVEMENT DISORD, V19, P990, DOI 10.1002/mds.20214; Jacobi H, 2013, LANCET NEUROL, V12, P650, DOI 10.1016/S1474-4422(13)70104-2; Jaunarajs KLE, 2015, PROG NEUROBIOL, V127, P91, DOI 10.1016/j.pneurobio.2015.02.002; Klockgether T, 2011, CURR OPIN NEUROL, V24, P339, DOI 10.1097/WCO.0b013e32834875ba; Koeppen AH, 2005, CEREBELLUM, V4, P62, DOI 10.1080/14734220510007950; Lehericy S, 2013, MOVEMENT DISORD, V28, P944, DOI 10.1002/mds.25527; Maroof N, 2013, BIOCHEM SOC T, V41, P1583, DOI 10.1042/BST20130140; Matilla-Duenas A, 2012, ADV EXP MED BIOL, V724, P172, DOI 10.1007/978-1-4614-0653-2_14; Moris D, 2015, EXPERT OPIN THER TAR, V19, P1261, DOI 10.1517/14728222.2015.1043268; Murata Y, 1998, ARCH NEUROL-CHICAGO, V55, P33, DOI 10.1001/archneur.55.1.33; Palazuelos J, 2009, BRAIN, V132, P3152, DOI 10.1093/brain/awp239; Patel S, 2003, BRIT J PHARMACOL, V139, P1005, DOI 10.1038/sj.bjp.0705334; Paulson Henry, 2012, Handb Clin Neurol, V103, P437, DOI 10.1016/B978-0-444-51892-7.00027-9; Richter A, 2002, EUR J PHARMACOL, V454, P145, DOI 10.1016/S0014-2999(02)02477-9; Riess O, 2008, CEREBELLUM, V7, P125, DOI 10.1007/s12311-008-0013-4; Rodriguez-Cueto C, 2016, NEUROSCIENCE, V339, P191, DOI 10.1016/j.neuroscience.2016.09.046; Rodriuez-Cueto C, 2014, PATHOBIOLOGY, V81, P149, DOI 10.1159/000358127; Rodriguez-Cueto C, 2014, BRIT J PHARMACOL, V171, P1472, DOI 10.1111/bph.12283; Rub U, 2013, PROG NEUROBIOL, V104, P38, DOI 10.1016/j.pneurobio.2013.01.001; Sagredo O, 2009, GLIA, V57, P1154, DOI 10.1002/glia.20838; Seidel K, 2016, NEUROPATH APPL NEURO, V42, P153, DOI 10.1111/nan.12253; Seidel K, 2012, ACTA NEUROPATHOL, V124, P1, DOI 10.1007/s00401-012-1000-x; Silva-Fernandes A, 2014, NEUROTHERAPEUTICS, V11, P433, DOI 10.1007/s13311-013-0255-9; Yiangou Y, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-12	42	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176521	10.1371/journal.pone.0176521	http://dx.doi.org/10.1371/journal.pone.0176521			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448548	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383600094
J	Xie, F; Li, G; Wang, YL; Zhang, YH; Zhou, L; Wang, CC; Liu, SH; Liu, SG; Wang, CL				Xie, Fang; Li, Gang; Wang, Yalei; Zhang, Yanhe; Zhou, Long; Wang, Chengcheng; Liu, Shuanghong; Liu, Siguo; Wang, Chunlai			Pyridoxal phosphate synthases PdxS/PdxT are required for Actinobacillus pleuropneumoniae viability, stress tolerance and virulence	PLOS ONE			English	Article							BACILLUS-SUBTILIS; VITAMIN-B-6 BIOSYNTHESIS; ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; 5'-PHOSPHATE BIOSYNTHESIS; SALVAGE PATHWAY; MURINE MODEL; INFECTION; GENES; COLONIZATION	Pyridoxal 5'-phosphate (PLP) is an essential cofactor for numerous enzymes involved in a diversity of cellular processes in living organisms. Previous analysis of the Actinobacillus pleuropneumoniae S-8 genome sequence revealed the presence of pdxS and pdxT genes, which are implicated in deoxyxylulose 5-phosphate (DXP)-independent pathway of PLP biosynthesis; however, little is known about their roles in A. pleuropneumoniae pathogenicity. Our data demonstrated that A. pleuropneumoniae could synthesize PLP by PdxS and PdxT enzymes. Disruption of the pdxS and pdxT genes rendered the pathogen auxotrophic for PLP, and the defective growth as a result of these mutants was chemically compensated by the addition of PLP, suggesting the importance of PLP production for A. pleuropneumoniae growth and viability. Additionally, the pdxS and pdxT deletion mutants displayed morphological defects as indicated by irregular and aberrant shapes in the absence of PLP. The reduced growth of the pdxS and pdxT deletion mutants under osmotic and oxidative stress conditions suggests that the PLP synthases PdxS/PdxT are associated with the stress tolerance of A. pleuropneumoniae. Furthermore, disruption of the PLP biosynthesis pathway led to reduced colonization and attenuated virulence of A. pleuropneumoniae in the BALB/c mouse model. The data presented in this study reveal the critical role of PLP synthases PdxS/ PdxT in viability, stress tolerance, and virulence of A. pleuropneumoniae.	[Xie, Fang; Li, Gang; Zhang, Yanhe; Zhou, Long; Wang, Chengcheng; Liu, Shuanghong; Liu, Siguo; Wang, Chunlai] Chinese Acad Agr Sci, State Key Lab Vet Biotechnol, Div Bacterial Dis, Harbin Vet Res Inst, Harbin, Peoples R China; [Wang, Yalei] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS	Wang, CL (corresponding author), Chinese Acad Agr Sci, State Key Lab Vet Biotechnol, Div Bacterial Dis, Harbin Vet Res Inst, Harbin, Peoples R China.	chunlai.w@hvri.ac.cn		Xie, Fang/0000-0003-2041-2208	Fund for Agro-scientific Research in the Public Interest [201303034]; National Natural Science Foundation of China [31100103]; Natural Science Foundation of Heilongjiang Province of China [C2016067, QC2016044]; project of Harbin Science and Technology innovative talents [2015RQQYJ073]; State's Key Project of Research and Development Plan [2016YFD0500700]; Special Fund for Agro-scientific Research in the Public Interest [201303034]	Fund for Agro-scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province of China(Natural Science Foundation of Heilongjiang Province); project of Harbin Science and Technology innovative talents; State's Key Project of Research and Development Plan; Special Fund for Agro-scientific Research in the Public Interest	This research was supported by grants from Fund for Agro-scientific Research in the Public Interest (201303034, http://www.moa.gov.cn/), SGL, National Natural Science Foundation of China (No. 31100103, ham://www.nsfc.gov.cn), FX, Natural Science Foundation of Heilongjiang Province of China (No. C2016067, http://www.hlikit.gov.cn/), CLW, Natural Science Foundation of Heilongjiang Province of China (No. QC2016044, http://www.hljkjt.gov.cn/),FX, the project of Harbin Science and Technology innovative talents (No. 2015RQQYJ073, http:://www.hrbinfo.gov.cn/), CLW, the State's Key Project of Research and Development Plan (No. 2016YFD0500700, http://www.most.gov.cn/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by grants from Special Fund for Agro-scientific Research in the Public Interest (201303034), National Natural Science Foundation of China (31100103), Natural Science Foundation of Heilongjiang Province of China (C2016067 and QC2016044), and the project of Harbin Science and Technology innovative talents (2015RQQYJ073), and the State's Key Project of Research and Development Plan (2016YFD0500700). We thank Paul R. Langford, Janine T. Bosse, and Yanwen Li (Section of Paediatrics, Department of Medicine, Imperial College London, St. Mary's Campus, United Kingdom) for language polishing and the valuable suggestions on the manuscript.	Asakura H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070418; Baltes N, 2003, FEMS MICROBIOL LETT, V220, P41, DOI 10.1016/S0378-1097(03)00064-8; Belitsky BR, 2004, J BACTERIOL, V186, P1191, DOI 10.1128/JB.186.4.1191-1196.2004; Bosse JT, 2002, MICROBES INFECT, V4, P225, DOI 10.1016/S1286-4579(01)01534-9; Chen H, 2005, PLANT J, V44, P396, DOI 10.1111/j.1365-313X.2005.02538.x; Chen LP, 2014, PROTEIN EXPRES PURIF, V104, P50, DOI 10.1016/j.pep.2014.09.003; Chiang CH, 2009, VACCINE, V27, P4565, DOI 10.1016/j.vaccine.2009.05.058; Chiers K, 2010, VET RES, V41, DOI 10.1051/vetres/2010037; Dehio C, 1997, J BACTERIOL, V179, P538, DOI 10.1128/jb.179.2.538-540.1997; Densiow SA, 2007, PLANT PHYSIOL BIOCH, V45, P152, DOI 10.1016/j.plaphy.2007.01.007; Dick T, 2010, MOL MICROBIOL, V78, P980, DOI 10.1111/j.1365-2958.2010.07381.x; El Qaidi S, 2013, J BACTERIOL, V195, P2187, DOI 10.1128/JB.00041-13; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Fitzpatrick TB, 2007, BIOCHEM J, V407, P1, DOI 10.1042/BJ20070765; Gonzalez E, 2007, PLANT PHYSIOL, V145, P985, DOI 10.1104/pp.107.105189; Grubman A, 2010, MBIO, V1, DOI 10.1128/mBio.00112-10; Knockel J, 2012, BIOCHEM J, V443, P397, DOI 10.1042/BJ20111542; Li G, 2012, J BACTERIOL, V194, P6606, DOI 10.1128/JB.01650-12; Ma WC, 2015, SCI REP-UK, V5, DOI 10.1038/srep15630; Mooney S, 2009, MOLECULES, V14, P329, DOI 10.3390/molecules14010329; Mukherjee T, 2011, BBA-PROTEINS PROTEOM, V1814, P1585, DOI 10.1016/j.bbapap.2011.06.018; Nemzek JA, 2004, SHOCK, V21, P17, DOI 10.1097/01.shk.0000101667.49265.fd; Neuwirth M, 2007, BIOCHEMISTRY-US, V46, P5131, DOI 10.1021/bi602602x; Nielsen KK, 2005, APPL ENVIRON MICROB, V71, P2949, DOI 10.1128/AEM.71.6.2949-2954.2005; Oswald W, 1999, FEMS MICROBIOL LETT, V179, P153, DOI 10.1111/j.1574-6968.1999.tb08721.x; Percudani R, 2003, EMBO REP, V4, P850, DOI 10.1038/sj.embor.embor914; Percudani R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-273; Raschle T, 2005, J BIOL CHEM, V280, P32291, DOI 10.1074/jbc.M501356200; REED L. J., 1938, AMER JOUR HYG, V27, P493; Seo KW, 2013, VET IMMUNOL IMMUNOP, V151, P102, DOI 10.1016/j.vetimm.2012.10.011; Sheng HQ, 2008, APPL ENVIRON MICROB, V74, P5015, DOI 10.1128/AEM.00743-08; Strohmeier M, 2006, P NATL ACAD SCI USA, V103, P19284, DOI 10.1073/pnas.0604950103; Tambasco-Studart M, 2005, P NATL ACAD SCI USA, V102, P13687, DOI 10.1073/pnas.0506228102; VANDEKAMP JL, 1995, NUTR RES, V15, P415, DOI 10.1016/0271-5317(95)00009-7; Wagner TK, 2006, FEMS IMMUNOL MED MIC, V48, P192, DOI 10.1111/j.1574-695X.2006.00147.x; Wallner S, 2009, BIOCHEMISTRY-US, V48, P1928, DOI 10.1021/bi801887r; WILLSON PJ, 1989, ANTIMICROB AGENTS CH, V33, P1627, DOI 10.1128/AAC.33.9.1627; Xie F, 2013, PLOS ONE, V8; Yang Y, 1998, J BACTERIOL, V180, P1814, DOI 10.1128/JB.180.7.1814-1821.1998	39	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176374	10.1371/journal.pone.0176374	http://dx.doi.org/10.1371/journal.pone.0176374			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448619	Green Published, gold, Green Submitted			2022-12-26	WOS:000400383600069
J	Boyette, LB; Macedo, C; Hadi, K; Elinoff, BD; Walters, JT; Ramaswamil, B; Chalasani, G; Taboas, JM; Lakkis, FG; Metes, DM				Boyette, Lisa B.; Macedo, Camila; Hadi, Kevin; Elinoff, Beth D.; Walters, John T.; Ramaswamil, Bala; Chalasani, Geetha; Taboas, Juan M.; Lakkis, Fadi G.; Metes, Diana M.			Phenotype, function, and differentiation potential of human monocyte subsets	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; COLONY-STIMULATING FACTOR; HUMAN PERIPHERAL-BLOOD; TISSUE-REPAIR; PROFILING REVEALS; PROGENITOR CELLS; IN-VITRO; INFECTION; ALPHA; MONOCYTES/MACROPHAGES	Human monocytes have been grouped into classical (CD14(++) CD16(-)), non-classical (CD14(dim) CD16(++)), and intermediate (CD14(++)CD16(+)) subsets. Documentation of normal function and variation in this complement of subtypes, particularly their differentiation potential to dendritic cells (DC) or macrophages, remains incomplete. We therefore phenotyped monocytes from peripheral blood of healthy subjects and performed functional studies on high-speed sorted subsets. Subset frequencies were found to be tightly controlled over time and across individuals. Subsets were distinct in their secretion of TNF alpha, IL-6, and IL-1 beta in response to TLR agonists, with classical monocytes being the most producers and non-classical monocytes the least. Monocytes, particularly those of the non-classical subtype, secreted interferon-a (IFN-alpha) in response to intracellular TLR3 stimulation. After incubation with IL-4 and GM-CSF, classical monocytes acquired monocyte-derived DC (mo-DC) markers and morphology and stimulated allogeneic T cell proliferation in MLR; intermediate and non-classical monocytes did not. After incubation with IL-3 and Flt3 ligand, no subset differentiated to plasmacytoid DC. After incubation with GM-CSF (M1 induction) or macrophage colony-stimulating factor (M-CSF) (M2 induction), all subsets acquired macrophage morphology, secreted macrophage-associated cytokines, and displayed enhanced phagocytosis. From these studies we conclude that classical monocytes are the principal source of mo-DCs, but all subsets can differentiate to macrophages. We also found that monocytes, in particular the non-classical subset, represent an alternate source of type I IFN secretion in response to virus-associated TLR agonists.	[Boyette, Lisa B.; Macedo, Camila; Hadi, Kevin; Elinoff, Beth D.; Walters, John T.; Ramaswamil, Bala; Chalasani, Geetha; Lakkis, Fadi G.; Metes, Diana M.] Univ Pittsburgh, Sch Med, Thomas E Starzl Transplantat Inst, Dept Surg, Pittsburgh, PA 15260 USA; [Chalasani, Geetha; Lakkis, Fadi G.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA; [Taboas, Juan M.] Univ Pittsburgh, Sch Dent Med, Dept Oral Biol, Pittsburgh, PA USA; [Taboas, Juan M.] Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, Pittsburgh, PA USA; [Taboas, Juan M.] Univ Pittsburgh, Sch Med, McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Lakkis, Fadi G.; Metes, Diana M.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lakkis, FG; Metes, DM (corresponding author), Univ Pittsburgh, Sch Med, Thomas E Starzl Transplantat Inst, Dept Surg, Pittsburgh, PA 15260 USA.; Lakkis, FG (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA.; Lakkis, FG; Metes, DM (corresponding author), Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA USA.	lakkisf@upmc.edu; metesdm@upmc.edu	Macedo, Camila/AAH-1781-2019	Hadi, Kevin/0000-0003-4271-6261; Walters, James/0000-0002-6980-4053	National Institute of Allergy and Infectious Diseases [R01 AI 096553]; American Society of Nephrology Postdoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI096553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR062598] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Society of Nephrology Postdoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institute of Allergy and Infectious Diseases grant R01 AI 096553 (FGL and DMM); American Society of Nephrology Postdoctoral Fellowship (LBB).; This work was supported by an American Society of Nephrology Postdoctoral Fellowship (LB) and by the National Institute of Allergy and Infectious Diseases grant R01 AI 096553 (FGL and DMM).	Ancuta P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-403; Anghelina M, 2006, AM J PATHOL, V168, P529, DOI 10.2353/ajpath.2006.050255; Apostolakis S, 2010, CARDIOVASC RES, V85, P649, DOI 10.1093/cvr/cvp327; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Barclay AN, 2014, ANNU REV IMMUNOL, V32, P25, DOI 10.1146/annurev-immunol-032713-120142; Bigley V, 2011, J EXP MED, V208, P227, DOI 10.1084/jem.20101459; Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010; Collin M, 2011, NAT REV IMMUNOL, V11, P575, DOI 10.1038/nri3046; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Demoulin S, 2012, EXP HEMATOL, V40, P268, DOI 10.1016/j.exphem.2012.01.002; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Hill LM, 2010, J IMMUNOL, V185, P3028, DOI 10.4049/jimmunol.1001298; Hoechst B, 2011, BLOOD, V117, P6532, DOI 10.1182/blood-2010-11-317321; Ingersoll MA, 2011, TRENDS IMMUNOL, V32, P470, DOI 10.1016/j.it.2011.05.001; Jagannathan R, 2014, J PERIODONTOL, V85, P852, DOI 10.1902/jop.2013.120658; Kim WK, 2010, J LEUKOCYTE BIOL, V87, P557, DOI 10.1189/jlb.0209082; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Kyogoku C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083776; LARSEN E, 1989, CELL, V59, P305, DOI 10.1016/0092-8674(89)90292-4; Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005; Mills CD, 2012, CRIT REV IMMUNOL, V32, P463, DOI 10.1615/CritRevImmunol.v32.i6.10; Mitchell AJ, 2014, CELL IMMUNOL, V291, P22, DOI 10.1016/j.cellimm.2014.05.010; Muthuswamy R, 2015, J IMMUNOTHER CANCER, V3, DOI 10.1186/s40425-015-0050-8; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Novais FO, 2014, J INFECT DIS, V209, P1288, DOI 10.1093/infdis/jiu013; Oberbarnscheidt MH, 2014, J CLIN INVEST, V124, P3579, DOI 10.1172/JCI74370; Onai N, 2013, IMMUNITY, V38, P943, DOI 10.1016/j.immuni.2013.04.006; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; PAWLOWSKI NA, 1983, J EXP MED, V158, P393, DOI 10.1084/jem.158.2.393; Robbins SH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r17; Saha P, 2011, IMMUNOL CELL BIOL, V89, P2, DOI 10.1038/icb.2010.130; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sanchez-Torres C, 2001, INT IMMUNOL, V13, P1571, DOI 10.1093/intimm/13.12.1571; Satpathy AT, 2012, NAT IMMUNOL, V13, P1145, DOI 10.1038/ni.2467; Semnani RT, 2014, INFECT IMMUN, V82, P4438, DOI 10.1128/IAI.01973-14; THOMAS R, 1994, J IMMUNOL, V153, P4016; Varol C, 2009, IMMUNOL CELL BIOL, V87, P30, DOI 10.1038/icb.2008.90; Venturini J, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0552-x; Vremec D, 1997, EUR J IMMUNOL, V27, P40, DOI 10.1002/eji.1830270107; Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355; Yang JY, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-1; Yona S, 2010, CURR OPIN HEMATOL, V17, P53, DOI 10.1097/MOH.0b013e3283324f80; Zheng JJ, 2014, CELL MOL IMMUNOL, V11, P294, DOI 10.1038/cmi.2013.70; Zhou LJ, 1996, P NATL ACAD SCI USA, V93, P2588, DOI 10.1073/pnas.93.6.2588; Ziegler-Heitbrock L, 2014, CELL IMMUNOL, V289, P135, DOI 10.1016/j.cellimm.2014.03.019; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558; Zimmermann HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011049	49	186	193	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176460	10.1371/journal.pone.0176460	http://dx.doi.org/10.1371/journal.pone.0176460			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445506	Green Published, Green Submitted, gold			2022-12-26	WOS:000400309200065
J	Pelot, KA; Hagelthorn, DM; Addison, JB; Zerbe, P				Pelot, Kyle A.; Hagelthorn, David M.; Addison, J. Bennett; Zerbe, Philipp			Biosynthesis of the oxygenated diterpene nezukol in the medicinal plant Isodon rubescens is catalyzed by a pair of diterpene synthases	PLOS ONE			English	Article							ENT-KAURENE SYNTHASE; COPALYL DIPHOSPHATE SYNTHASES; FUNCTIONAL-CHARACTERIZATION; PHYSCOMITRELLA-PATENS; MANOYL OXIDE; AMINO-ACID; METABOLISM; DISCOVERY; PATHWAY; GENE	Plants produce an immense diversity of natural products (i.e. secondary or specialized metabolites) that offer a rich source of known and potentially new pharmaceuticals and other desirable bioproducts. The Traditional Chinese Medicinal plant Isodon rubescens (Lamiaceae) contains an array of bioactive labdane-related diterpenoid natural products. Of these, the ent-kauranoid oridonin is the most prominent specialized metabolite that has been extensively studied for its potent antimicrobial and anticancer efficacy. Mining of a previously established transcriptome of I. rubescens leaf tissue identified seven diterpene synthase (diTPSs) candidates. Here we report the functional characterization of four I. rubescens diTPSs. IrTPS5 and IrTPS3 were identified as an ent-copalyl diphosphate (CPP) synthase and a (+)-CPP synthase, respectively. Distinct transcript abundance of IrTPS5 and the predicted ent-CPP synthase IrTPS1 suggested a role of IrTPS5 in specialized entkaurene metabolism possibly en route to oridonin. Nicotiana benthamiana co-expression assays demonstrated that IrTPS4 functions sequentially with IrTPS3 to form miltiradiene. In addition, IrTPS2 converted the IrTPS3 product (+)-CPP into the hydroxylated tricyclic diterpene nezukol not previously identified in I. rubescens. Metabolite profiling verified the presence of nezukol in I. rubescens leaf tissue. The proposed IrTPS2-catalyzed reaction mechanism proceeds via the common ionization of the diphosphate group of (+)-CPP, followed by formation of an intermediary pimar-15-en-8-yl(+) carbocation and neutralization of the carbocation by water capture at C-8 to yield nezukol, as confirmed by nuclear magnetic resonance (NMR) analysis. Oxygenation activity is rare for the family of class I diTPSs and offers new catalysts for developing metabolic engineering platforms to produce a broader spectrum of bioactive diterpenoid natural products.	[Pelot, Kyle A.; Hagelthorn, David M.; Zerbe, Philipp] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA; [Addison, J. Bennett] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Zerbe, P (corresponding author), Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA.	pzerbe@ucdavis.edu		Addison, Bennett/0000-0003-0763-3137	University of California-Davis Academic Senate Faculty Research Grant; NSF Graduate Research Fellowship Program	University of California-Davis Academic Senate Faculty Research Grant; NSF Graduate Research Fellowship Program(National Science Foundation (NSF))	Financial support for this work by a University of California-Davis Academic Senate Faculty Research Grant (to PZ) and a NSF Graduate Research Fellowship Program (to KAP) is gratefully acknowledged.	Adams R. P., 1997, Journal of Essential Oil Research, V9, P303; ALADESANMI AJ, 1988, TETRAHEDRON, V44, P3749, DOI 10.1016/S0040-4020(01)86004-X; Andersen-Ranberg J, 2016, ANGEW CHEM INT EDIT, V55, P2142, DOI 10.1002/anie.201510650; Bozic D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124106; Bruckner K, 2014, PHYTOCHEMISTRY, V101, P52, DOI 10.1016/j.phytochem.2014.01.021; Caniard A, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-119; Criswell J, 2012, ORG LETT, V14, P5828, DOI 10.1021/ol3026022; Cui GH, 2015, PLANT PHYSIOL, V169, P1607, DOI 10.1104/pp.15.00695; De Luca V, 2012, SCIENCE, V336, P1658, DOI 10.1126/science.1217410; Facchini PJ, 2012, TRENDS BIOTECHNOL, V30, P127, DOI 10.1016/j.tibtech.2011.10.001; Falara V, 2010, PLANT PHYSIOL, V154, P301, DOI 10.1104/pp.110.159566; Gao W, 2009, ORG LETT, V11, P5170, DOI 10.1021/ol902051v; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Guo J, 2016, NEW PHYTOL, V210, P525, DOI 10.1111/nph.13790; Harris LJ, 2005, PLANT MOL BIOL, V59, P881, DOI 10.1007/s11103-005-1674-8; Hayashi K, 2006, FEBS LETT, V580, P6175, DOI 10.1016/j.febslet.2006.10.018; Hershey DM, 2014, J BACTERIOL, V196, P100, DOI 10.1128/JB.01031-13; Hong YJ, 2014, NAT CHEM, V6, P104, DOI [10.1038/NCHEM.1843, 10.1038/nchem.1843]; Ignea C, 2016, P NATL ACAD SCI USA, V113, P3681, DOI 10.1073/pnas.1523787113; Ikezoe T, 2003, INT J ONCOL, V23, P1187; Irmisch S, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0647-6; Jia M, 2017, ACS CHEM BIOL, V12, P862, DOI 10.1021/acschembio.6b01075; Kawaide H, 2011, FEBS J, V278, P123, DOI 10.1111/j.1742-4658.2010.07938.x; Keeling CI, 2011, J BIOL CHEM, V286, P21145, DOI 10.1074/jbc.M111.245951; Li D, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050635; Li JL, 2012, PHYTOCHEMISTRY, V76, P32, DOI 10.1016/j.phytochem.2011.12.021; LORIMER SD, 1987, PHYTOCHEMISTRY, V26, P3207, DOI 10.1016/S0031-9422(00)82471-1; Lu X, 2015, NEW PHYTOL, V206, P295, DOI 10.1111/nph.13187; Luo D, 2016, P NATL ACAD SCI USA, V113, pE5082, DOI 10.1073/pnas.1607504113; Mafu S, 2015, CHEM COMMUN, V51, P13485, DOI 10.1039/c5cc05754j; Mafu S, 2011, CHEMBIOCHEM, V12, P1984, DOI 10.1002/cbic.201100336; Morrone D, 2009, FEBS LETT, V583, P475, DOI 10.1016/j.febslet.2008.12.052; Morrone D, 2011, BIOCHEM J, V435, P589, DOI 10.1042/BJ20101429; Morrone D, 2010, APPL MICROBIOL BIOT, V85, P1893, DOI 10.1007/s00253-009-2219-x; Nielsen MT, 2014, APPL ENVIRON MICROB, V80, P7258, DOI 10.1128/AEM.02301-14; Pateraki I, 2015, ADV BIOCHEM ENG BIOT, V148, P107, DOI 10.1007/10_2014_301; Pateraki I, 2014, PLANT PHYSIOL, V164, P1222, DOI 10.1104/pp.113.228429; Pelot KA, 2017, PLANT J, V89, P885, DOI 10.1111/tpj.13427; Peters R. J., 2016, FRONT FRONT PLANT SC, V7, P7; Peters RJ, 2010, NAT PROD REP, V27, P1521, DOI 10.1039/c0np00019a; Potter K, 2014, ANGEW CHEM INT EDIT, V53, P7198, DOI 10.1002/anie.201402911; Richman AS, 1999, PLANT J, V19, P411, DOI 10.1046/j.1365-313X.1999.00531.x; Sallaud C, 2012, PLANT J, V72, P1, DOI 10.1111/j.1365-313X.2012.05068.x; SCHEFFRAHN RH, 1988, J CHEM ECOL, V14, P765, DOI 10.1007/BF01018771; Su WC, 1996, PHYTOCHEMISTRY, V41, P255, DOI 10.1016/0031-9422(95)00417-3; Sun HD, 2006, NAT PROD REP, V23, P673, DOI 10.1039/b604174d; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Williams DC, 2000, ARCH BIOCHEM BIOPHYS, V379, P137, DOI 10.1006/abbi.2000.1865; Wu YS, 2012, PHYTOCHEMISTRY, V84, P40, DOI 10.1016/j.phytochem.2012.08.022; Wurtzel ET, 2016, SCIENCE, V353, P1232, DOI 10.1126/science.aad2062; Xu MM, 2007, PHYTOCHEMISTRY, V68, P312, DOI 10.1016/j.phytochem.2006.10.016; Xu MM, 2017, J NAT PROD, V80, P328, DOI 10.1021/acs.jnatprod.6b00764; Xu MM, 2014, J NAT PROD, V77, P2144, DOI 10.1021/np500422d; Xu ST, 2017, J MED CHEM, V60, P1449, DOI 10.1021/acs.jmedchem.6b01652; Zerbe P, 2015, PLANT J, V83, P783, DOI 10.1111/tpj.12925; Zerbe P, 2015, TRENDS BIOTECHNOL, V33, P419, DOI 10.1016/j.tibtech.2015.04.006; Zerbe P, 2014, PLANT J, V79, P914, DOI 10.1111/tpj.12589; Zerbe P, 2013, PLANT PHYSIOL, V162, P1073, DOI 10.1104/pp.113.218347; Zerbe P, 2012, J BIOL CHEM, V287, P12121, DOI 10.1074/jbc.M111.317669; Zerbe P, 2012, PHYTOCHEMISTRY, V74, P30, DOI 10.1016/j.phytochem.2011.11.004; Zi JC, 2014, ANNU REV PLANT BIOL, V65, P259, DOI 10.1146/annurev-arplant-050213-035705; Zou J, 2012, ORG BIOMOL CHEM, V10, P5039, DOI 10.1039/c2ob25192b; Zou JA, 2011, ORG LETT, V13, P1406, DOI 10.1021/ol200086k	63	20	27	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176507	10.1371/journal.pone.0176507	http://dx.doi.org/10.1371/journal.pone.0176507			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445526	Green Published, Green Submitted, gold			2022-12-26	WOS:000400309200067
J	Cara-Fuentes, G; Segarra, A; Silva-Sanchez, C; Wang, HM; Lanaspa, MA; Johnson, RJ; Garin, EH				Cara-Fuentes, Gabriel; Segarra, Alfons; Silva-Sanchez, Cecilia; Wang, Heiman; Lanaspa, Miguel A.; Johnson, Richard J.; Garin, Eduardo H.			Angiopoietin-like-4 and minimal change disease	PLOS ONE			English	Article							PODOCYTE-SECRETED ANGIOPOIETIN-LIKE-4; NEPHROTIC SYNDROME	Background Minimal Change Disease (MCD) is the most common type of nephrotic syndrome in children. Angiopoietin-like-4 (Angplt4) has been proposed as mediator of proteinuria in MCD. The aim of this study was to evaluate the role of Angptl4 as a biomarker in MCD. Methods Patients with biopsy-proven primary MCD, focal segmental glomerulosclerosis, membranous nephropathy (60, 52 and 52 respectively) and 18 control subjects had urinary and serum Angptl4 measured by Elisa. Frozen kidney tissue sections were stained for Angptl4. Results Angptl4 was not identified in glomeruli of MCD patients in relapse. Urinary Angptl4 levels were elevated in MCD in relapse as well as in patients with massive proteinuria due to other glomerular diseases. Conclusion Neither serum nor urine Angptl4 appear to be good biomarkers in MCD. Elevated urinary Angptl4 n glomerular disease appears to reflect the degree of proteinuria rather than any specific disease.	[Cara-Fuentes, Gabriel; Wang, Heiman; Garin, Eduardo H.] Univ Florida, Dept Pediat, Div Pediat Nephrol, Gainesville, FL 32610 USA; [Segarra, Alfons] Hosp Valle De Hebron, Div Nephrol, Barcelona, Spain; [Silva-Sanchez, Cecilia] Univ Florida, Prote & Mass Spectrometry, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL USA; [Lanaspa, Miguel A.; Johnson, Richard J.] Univ Colorado, Dept Med, Div Renal Dis & Hypertens, Denver, CO USA	State University System of Florida; University of Florida; Hospital Universitari Vall d'Hebron; State University System of Florida; University of Florida; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Garin, EH (corresponding author), Univ Florida, Dept Pediat, Div Pediat Nephrol, Gainesville, FL 32610 USA.	garineh@peds.ufl.edu	Lanaspa, Miguel/AAO-4971-2020; Segarra, Alfons/R-9077-2019	Segarra, Alfons/0000-0002-4349-2856; Cara-Fuentes, Gabriel/0000-0002-4164-3251	NIH [R01DK080764]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by NIH R01DK080764 to E.H.G. and R.J.J.	[Anonymous], 1981, KIDNEY INT, V20, P765; Araya CE, 2006, PEDIATR NEPHROL, V21, P603, DOI 10.1007/s00467-006-0026-5; Cazes A, 2006, CIRC RES, V99, P1207, DOI 10.1161/01.RES.0000250758.63358.91; Chomel C, 2009, FASEB J, V23, P940, DOI 10.1096/fj.08-115170; Chugh SS, 2012, AM J KIDNEY DIS, V59, P284, DOI 10.1053/j.ajkd.2011.07.024; Clement LC, 2014, NAT MED, V20, P37, DOI 10.1038/nm.3396; Clement LC, 2011, NAT MED, V17, P117, DOI 10.1038/nm.2261; D'Agati VD, 2004, AM J KIDNEY DIS, V43, P368, DOI 10.1053/j.ajkd.2003.10.024; D'Agati VD, 2016, AM J PHYSIOL-RENAL, V310, pF810, DOI 10.1152/ajprenal.00037.2016; Jonker JT, 2013, AM J CLIN NUTR, V97, P255, DOI 10.3945/ajcn.112.043687; Kersten S, 2009, ARTERIOSCL THROM VAS, V29, P969, DOI 10.1161/ATVBAHA.108.182147; Li J., 2015, J CHEMOTHER, V2015, P10, DOI DOI 10.1371/J0URNAL.P0NE.0131820; Ma J, 2015, ENDOCRINE, V49, P373, DOI 10.1007/s12020-014-0486-5; Peng L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106164; Robciuc MR, 2010, J LIPID RES, V51, P824, DOI 10.1194/jlr.M002618; SHALHOUB RJ, 1974, LANCET, V2, P556; Tjeerdema N, 2014, BMJ OPEN DIAB RES CA, V2, DOI 10.1136/bmjdrc-2014-000034; van der Kolk BW, 2016, J CLIN ENDOCR METAB; Yang YH, 2008, ARTERIOSCL THROM VAS, V28, P835, DOI 10.1161/ATVBAHA.107.157776; 1981, J PEDIAT, V98, P561	20	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176198	10.1371/journal.pone.0176198	http://dx.doi.org/10.1371/journal.pone.0176198			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441404	gold, Green Published, Green Submitted			2022-12-26	WOS:000400308800033
J	He, T; Mortensen, X; Wang, P; Tian, N				He, Tao; Mortensen, Xavier; Wang, Ping; Tian, Ning			The effects of immune protein CD3 zeta development and degeneration of retinal neurons after optic nerve injury	PLOS ONE			English	Article							CHOLINERGIC AMACRINE CELLS; CLASS-I MOLECULES; DEVELOPING RAT RETINA; RABBIT RETINA; SYNAPTIC PLASTICITY; GANGLION-CELLS; ZETA-CHAIN; EXPRESSION; GLAUCOMA; MOUSE	Major histocompatibility complex (MHC) class I molecules and their receptors play fundamental roles in neuronal death during diseases. T-cell receptors (TCR) function as MHCI receptor on T-cells and both MHCI and a key component of TCR, CD3 zeta, are expressed by mouse retinal ganglion cells (RGCs) and displaced amacrine cells. Mutation of these molecules compromises the development of RGCs. We investigated whether CD3 zeta regulates the development and degeneration of amacrine cells after RGC death. Surprisingly, mutation of CD3 zeta not only impairs the proper development of amacrine cells expressing CD3 zeta but also those not expressing CD3 zeta. In contrast to effects of MHCI and its receptor, PirB, on other neurons, mutation of CD3 zeta has no effect on RGC death and starburst amacrine cells degeneration after optic nerve crush. Thus, unlike MHCI and PirB, CD3 zeta regulates the development of RGCs and amacrine cells but not their degeneration after optic nerve crush.	[He, Tao] Wuhan Univ, Eye Ctr Remin Hosp, Wuhan, Hubei, Peoples R China; [He, Tao; Mortensen, Xavier; Wang, Ping; Tian, Ning] Univ Utah, Sch Med, Dept Ophthalmol, Salt Lake City, UT USA; [He, Tao; Mortensen, Xavier; Wang, Ping; Tian, Ning] Univ Utah, Sch Med, Visual Sci John Moran Eye Ctr, Salt Lake City, UT USA; [Tian, Ning] VA Salt Lake City Hlth Care Syst, Salt Lake City, UT USA	Wuhan University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs	Tian, N (corresponding author), Univ Utah, Sch Med, Dept Ophthalmol, Salt Lake City, UT USA.; Tian, N (corresponding author), Univ Utah, Sch Med, Visual Sci John Moran Eye Ctr, Salt Lake City, UT USA.; Tian, N (corresponding author), VA Salt Lake City Hlth Care Syst, Salt Lake City, UT USA.	ning.tian@hsc.utah.edu		Mortensen, Xavier/0000-0001-6253-2051	NIH [R01 EY012345, P30 EY014800]; VA [1 I01 BX002412]; Research to Prevent Blindness (RPB); Funds from the John Moran Eye Center; China Scholarship Council (CSC) [201406275047]; NATIONAL EYE INSTITUTE [R01EY012345, P30EY014800] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002412] Funding Source: NIH RePORTER; VA [5I01BX002412-02] Funding Source: Federal RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA(US Department of Veterans Affairs); Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB)); Funds from the John Moran Eye Center; China Scholarship Council (CSC)(China Scholarship Council); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Veterans Affairs(US Department of Veterans Affairs); VA(US Department of Veterans Affairs)	This work was supported by NIH grants R01 EY012345 and P30 EY014800, VA grant 1 I01 BX002412, Research to Prevent Blindness (RPB), Funds from the John Moran Eye Center and China Scholarship Council (CSC) 201406275047.	Adelson JD, 2012, NEURON, V73, P1100, DOI 10.1016/j.neuron.2012.01.020; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Bach M, 2013, CELL TISSUE RES, V353, P287, DOI 10.1007/s00441-013-1598-6; Baldridge WH, 1996, J NEUROSCI, V16, P5060; Baniyash M, 2004, NAT REV IMMUNOL, V4, P675, DOI 10.1038/nri1434; Bosco A, 1999, J NEUROSCI RES, V57, P759, DOI 10.1002/(SICI)1097-4547(19990915)57:6<759::AID-JNR1>3.3.CO;2-P; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; Boulanger LM, 2001, CURR OPIN NEUROBIOL, V11, P568, DOI 10.1016/S0959-4388(00)00251-8; BRANDON C, 1987, BRAIN RES, V401, P385, DOI 10.1016/0006-8993(87)91426-0; BRECHA N, 1988, P NATL ACAD SCI USA, V85, P6187, DOI 10.1073/pnas.85.16.6187; Cellerino A, 1998, J NEUROSCI, V18, P3351; Cellerino A, 1997, J COMP NEUROL, V386, P149; CohenCory S, 1996, DEV BIOL, V179, P102, DOI 10.1006/dbio.1996.0244; Dijk F, 2004, BRAIN RES, V1026, P205, DOI 10.1016/j.brainres.2004.08.014; FAMIGLIETTI EV, 1983, BRAIN RES, V261, P138, DOI 10.1016/0006-8993(83)91293-3; FAMIGLIETTI EV, 1987, BRAIN RES, V413, P398, DOI 10.1016/0006-8993(87)91037-7; FAMIGLIETTI EV, 1991, J COMP NEUROL, V309, P40, DOI 10.1002/cne.903090105; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Fujita Y, 2011, EMBO J, V30, P1389, DOI 10.1038/emboj.2011.55; HAYDEN SA, 1980, SCIENCE, V210, P435, DOI 10.1126/science.7433984; HORSBURGH GM, 1987, J COMP NEUROL, V263, P553, DOI 10.1002/cne.902630407; Huang Z, 2005, J CELL BIOL, V170, P527, DOI 10.1083/jcb.200505075; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Joseph MS, 2011, J NEUROSCI RES, V89, P365, DOI 10.1002/jnr.22557; Kao YH, 2006, VISUAL NEUROSCI, V23, P931, DOI 10.1017/S0952523806230293; Kielczewski JL, 2005, INVEST OPHTH VIS SCI, V46, P3188, DOI 10.1167/iovs.05-0321; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Levai O, 2003, HISTOCHEM CELL BIOL, V120, P483, DOI 10.1007/s00418-003-0594-4; Liu Y, 2014, INVEST OPHTH VIS SCI, V55, P3766, DOI 10.1167/iovs.14-13895; LOVE PE, 1993, SCIENCE, V261, P918, DOI 10.1126/science.7688481; Lowell B. B., 2006, DEV PHENOTYPE CHAT I; May CA, 2004, J GLAUCOMA, V13, P496, DOI 10.1097/01.ijg.0000137435.83307.fd; McConnell MJ, 2009, P NATL ACAD SCI USA, V106, P6784, DOI 10.1073/pnas.0902018106; Moon JI, 2005, CELL TISSUE RES, V320, P51, DOI 10.1007/s00441-004-1062-8; Nadal-Nicolas FM, 2015, INVEST OPHTH VIS SCI, V56, P6095, DOI 10.1167/iovs.15-17195; Nakamura Y, 2011, J BIOL CHEM, V286, P1876, DOI 10.1074/jbc.M110.163493; Oliveira ALR, 2004, P NATL ACAD SCI USA, V101, P17843, DOI 10.1073/pnas.0408154101; OMALLEY DM, 1989, P NATL ACAD SCI USA, V86, P3414, DOI 10.1073/pnas.86.9.3414; Omoto S, 2010, J NEUROSCI, V30, P13045, DOI 10.1523/JNEUROSCI.3228-10.2010; Ortin-Martinez A, 2015, EXP EYE RES, V132, P17, DOI 10.1016/j.exer.2015.01.006; OSBORNE NN, 1985, BRAIN RES, V343, P230, DOI 10.1016/0006-8993(85)90739-5; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P4095, DOI 10.1523/JNEUROSCI.5508-05.2006; de Lara MJP, 2014, EXP EYE RES, V122, P40, DOI 10.1016/j.exer.2014.02.022; PERRY VH, 1980, PROC R SOC SER B-BIO, V208, P415, DOI 10.1098/rspb.1980.0060; Rickman DW, 1996, P NATL ACAD SCI USA, V93, P12564, DOI 10.1073/pnas.93.22.12564; RICKMAN DW, 1995, VISUAL NEUROSCI, V12, P215, DOI 10.1017/S0952523800007896; Sabha M, 2008, SYNAPSE, V62, P137, DOI 10.1002/syn.20475; Song S, 2016, NAT MED, V22, P397, DOI 10.1038/nm.4052; Syken J, 2006, SCIENCE, V313, P1795, DOI 10.1126/science.1128232; TANAKA T, 1989, J IMMUNOL, V142, P2791; TAUCHI M, 1984, PROC R SOC SER B-BIO, V223, P101, DOI 10.1098/rspb.1984.0085; Thams S, 2009, J NEUROSCI, V29, P13503, DOI 10.1523/JNEUROSCI.0981-09.2009; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Valiente-Soriano FJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121134; VANEY DI, 1981, J COMP NEUROL, V199, P373, DOI 10.1002/cne.901990305; VANEY DI, 1988, BRAIN RES, V438, P369, DOI 10.1016/0006-8993(88)91366-2; VICKERS JC, 1995, BRAIN RES, V680, P23, DOI 10.1016/0006-8993(95)00211-8; Vidal-Sanz M, 2012, PROG RETIN EYE RES, V31, P1, DOI 10.1016/j.preteyeres.2011.08.001; Washburn LR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018439; Williams RR, 2001, VISUAL NEUROSCI, V18, P233, DOI 10.1017/S0952523801182088; WU DK, 1993, DEV BRAIN RES, V74, P253, DOI 10.1016/0165-3806(93)90011-X; Wu ZP, 2011, IMMUNOL LETT, V135, P118, DOI 10.1016/j.imlet.2010.10.011; Xu HP, 2007, J COMP NEUROL, V503, P244, DOI 10.1002/cne.21379; Xu HP, 2014, J COMP NEUROL, V522, P3403, DOI 10.1002/cne.23609; Xu HP, 2010, NEURON, V65, P503, DOI 10.1016/j.neuron.2010.01.035; Yamasaki EN, 1997, EUR J NEUROSCI, V9, P1885, DOI 10.1111/j.1460-9568.1997.tb00755.x; YOUNG RW, 1984, J COMP NEUROL, V229, P362, DOI 10.1002/cne.902290307	68	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0175522	10.1371/journal.pone.0175522	http://dx.doi.org/10.1371/journal.pone.0175522			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441398	Green Published, Green Submitted, gold			2022-12-26	WOS:000400308800005
J	Lilja, KC; Zhang, N; Magli, A; Gunduz, V; Bowman, CJ; Arpke, RW; Darabi, R; Kyba, M; Perlingeiro, R; Dynlacht, BD				Lilja, Karin C.; Zhang, Nan; Magli, Alessandro; Gunduz, Volkan; Bowman, Christopher J.; Arpke, Robert W.; Darabi, Radbod; Kyba, Michael; Perlingeiro, Rita; Dynlacht, Brian D.			Pax7 remodels the chromatin landscape in skeletal muscle stem cells	PLOS ONE			English	Article							H3K4 MONOMETHYLATION; SATELLITE CELLS; PROGENITORS; MYOGENESIS; CULTURE; GENES; REGENERATION; RECRUITMENT; DERIVATION; MLL3/MLL4	Pluripotent stem cells (PSC) hold great promise for the treatment of human skeletal muscle diseases. However, it remains challenging to convert PSC to skeletal muscle cells, and the mechanisms by which the master regulatory transcription factor, Pax7, promotes muscle stem (satellite) cell identity are not yet understood. We have taken advantage of PSC-derived skeletal muscle precursor cells (iPax7), wherein the induced expression of Pax7 robustly initiates the muscle program and enables the in vitro generation of precursors that seed the satellite cell compartment upon transplantation. Remarkably, we found that chromatin accessibility in myogenic precursors pre-figures subsequent activation of myogenic differentiation genes. We also found that Pax7 binding is generally restricted to euchromatic regions and excluded from H3K27 tri-methylated regions in muscle cells, suggesting that recruitment of this factor is circumscribed by chromatin state. Further, we show that Pax7 binding induces dramatic, localized remodeling of chromatin characterized by the acquisition of histone marks associated with enhancer activity and induction of chromatin accessibility in both muscle precursors and lineage-committed myoblasts. Conversely, removal of Pax7 leads to rapid reversal of these features on a subset of enhancers. Interestingly, another cluster of Pax7 binding sites is associated with a durably accessible and remodeled chromatin state after removal of Pax7, and persistent enhancer accessibility is associated with subsequent, proximal binding by the muscle regulatory factors, MyoD1 and myogenin. Our studies provide new insights into the epigenetic landscape of skeletal muscle stem cells and precursors and the role of Pax7 in satellite cell specification.	[Lilja, Karin C.; Zhang, Nan; Gunduz, Volkan; Bowman, Christopher J.; Dynlacht, Brian D.] NYU, Sch Med, Dept Pathol, Inst Canc, New York, NY 10003 USA; [Magli, Alessandro; Perlingeiro, Rita] Univ Minnesota, Lillehei Heart Inst, Minneapolis, MN USA; [Arpke, Robert W.; Kyba, Michael] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Darabi, Radbod] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA	New York University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Health Science Center Houston	Dynlacht, BD (corresponding author), NYU, Sch Med, Dept Pathol, Inst Canc, New York, NY 10003 USA.	Brian.Dynlacht@nyumc.org	Magli, Alessandro/K-5961-2019	Magli, Alessandro/0000-0003-3874-2838; Lilja, Karin/0000-0001-5925-1240; Kyba, Michael/0000-0002-5579-7534; Arpke, Robert W/0000-0002-0876-078X; Zhang, Nan/0000-0002-4134-7911	NIH [5R01GM067132, 1R21AR068786-01A1, R01AR055299, P30CA016087]; Regenerative Medicine Minnesota [MRM 2015 PDSCH 003]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR068786, R01AR055299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067132, T32GM007308] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Regenerative Medicine Minnesota; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH (Grants: 5R01GM067132 and 1R21AR068786-01A1 to BDD, R01AR055299 to RP, and P30CA016087 [https://www.nih.gov] to New York University School of Medicine's Genome Technology Center). AM was supported by a Regenerative Medicine Minnesota grant (MRM 2015 PDSCH 003; [http://www.regenmedmn.org]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank members of the Dynlacht laboratory for helpful advice and encouragement. We thank R. Raviram, members of the Skok laboratory, I. Dolgalev, B. Aranda-Orgilles, Eric Wang, and members of the Aifantis laboratory for advice on ATAC-seq library preparation and RNA-seq analysis. We thank A. Heguy, P. Zappile, P. Meyn, and the NYU GTC (supported by NIH grant P30CA016087) for assistance with high-throughput sequencing. We thank the Developmental Studies Hybridoma Bank for supplying key antibodies. This work was supported by grants from the NIH to B.D.D. (5R01GM067132 and 1R21AR068786-01A1) and R. P. (R01AR055299) A.M. was supported by a Regenerative Medicine Minnesota grant (MRM 2015 PDSCH 003).	Asp P, 2011, P NATL ACAD SCI USA, V108, pE149, DOI 10.1073/pnas.1102223108; Blum R, 2012, GENE DEV, V26, P2763, DOI 10.1101/gad.200113.112; Bosnakovski D, 2008, STEM CELLS, V26, P3194, DOI 10.1634/stemcells.2007-1017; Bowman CJ, 2014, NAT CELL BIOL, V16, P1202, DOI 10.1038/ncb3062; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; Budry L, 2012, GENE DEV, V26, P2299, DOI 10.1101/gad.200436.112; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chang NC, 2014, CURR TOP DEV BIOL, V107, P161, DOI 10.1016/B978-0-12-416022-4.00006-8; Cheng J, 2014, MOL CELL, V53, P979, DOI 10.1016/j.molcel.2014.02.032; Darabi R, 2008, NAT MED, V14, P134, DOI 10.1038/nm1705; Darabi R, 2012, CELL STEM CELL, V10, P610, DOI 10.1016/j.stem.2012.02.015; Darabi R, 2011, STEM CELL REV REP, V7, P948, DOI 10.1007/s12015-011-9258-2; Darabi R, 2011, STEM CELLS, V29, P777, DOI 10.1002/stem.625; Diao YR, 2012, CELL STEM CELL, V11, P231, DOI 10.1016/j.stem.2012.05.022; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Herz HM, 2012, GENE DEV, V26, P2604, DOI 10.1101/gad.201327.112; Himeda CL, 2013, DEV BIOL, V383, P7, DOI 10.1016/j.ydbio.2013.09.006; Hoffman BG, 2010, GENOME RES, V20, P1037, DOI 10.1101/gr.104356.109; Hosoyama T, 2014, STEM CELL TRANSL MED, V3, P564, DOI 10.5966/sctm.2013-0143; Hu DQ, 2013, MOL CELL BIOL, V33, P4745, DOI 10.1128/MCB.01181-13; Kawabe YI, 2012, CELL STEM CELL, V11, P333, DOI 10.1016/j.stem.2012.07.001; Lee JM, 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/782041, 10.1155/2013/758731]; Liu L, 2013, CELL REP, V4, P189, DOI 10.1016/j.celrep.2013.05.043; Magli A, 2013, STEM CELLS, V31, P59, DOI 10.1002/stem.1254; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Micsinai M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks048; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sato T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000897; Shelton M, 2014, STEM CELL REP, V3, P516, DOI 10.1016/j.stemcr.2014.07.001; Sherwood RI, 2014, NAT BIOTECHNOL, V32, P171, DOI 10.1038/nbt.2798; Soleimani VD, 2012, DEV CELL, V22, P1208, DOI 10.1016/j.devcel.2012.03.014; Sousa-Victor P, 2015, TRENDS ENDOCRIN MET, V26, P287, DOI 10.1016/j.tem.2015.03.006; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wu JY, 2016, NATURE, V534, P652, DOI 10.1038/nature18606; Xu C, 2013, CELL, V155, P909, DOI 10.1016/j.cell.2013.10.023	39	25	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176190	10.1371/journal.pone.0176190	http://dx.doi.org/10.1371/journal.pone.0176190			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441415	Green Published, gold, Green Submitted			2022-12-26	WOS:000400308800030
J	Zhou, WH; Song, FF; Wu, QJ; Liu, R; Wang, LL; Liu, CC; Peng, Y; Mao, SQ; Feng, J; Chen, CS				Zhou, Wenhui; Song, Fangfang; Wu, Qiuju; Liu, Rong; Wang, Lulu; Liu, Cuicui; Peng, You; Mao, Shuqin; Feng, Jing; Chen, Ceshi			miR-217 inhibits triple-negative breast cancer cell growth, migration, and invasion through targeting KLF5	PLOS ONE			English	Article							PANCREATIC DUCTAL ADENOCARCINOMA; TRANSCRIPTION FACTOR; PROTEASOME DEGRADATION; PROLIFERATION; SURVIVAL; MICRORNA-217; CARCINOMA; EXPRESSION; KINASE	Triple negative breast cancer (TNBC) is one of the most aggressive breast cancers without effective targeted therapies. Numerous studies have implied that KLF5 plays an important roles in TNBC. How is KLF5 regulated by microRNAs has not been well studied. Here, we demonstrated that miR-217 down-regulates the expression of KLF5 and KLF5's downstream target gene FGF-BP and Cyclin D1 in TNBC cell lines HCC1806 and HCC1937. Consequently, miR-217 suppresses TNBC cell growth, migration, and invasion. MiR-217 suppresses TNBC, at least partially, through down-regulating the KLF5 expression. These results suggest that the miR-217-KLF5 axis might serve as a potential target for treatment of TNBC.	[Zhou, Wenhui; Feng, Jing] Southern Med Univ, Clin Coll 3, Guangzhou, Guangdong, Peoples R China; [Zhou, Wenhui; Wang, Lulu; Liu, Cuicui; Peng, You; Feng, Jing] Southern Med Univ, Affiliated Fengxian Hosp, Dept Lab Med, Shanghai, Peoples R China; [Zhou, Wenhui; Wang, Lulu; Liu, Cuicui; Peng, You; Feng, Jing] Southern Med Univ, Affiliated Fengxian Hosp, Cent Lab, Shanghai, Peoples R China; [Zhou, Wenhui; Song, Fangfang; Wu, Qiuju; Liu, Rong; Chen, Ceshi] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan Province, Peoples R China; [Zhou, Wenhui; Song, Fangfang; Wu, Qiuju; Liu, Rong; Chen, Ceshi] Chinese Acad Sci, Kunming Inst Zool, Kunming, Yunnan Province, Peoples R China; [Song, Fangfang; Wu, Qiuju] Jinzhou Med Univ, Affiliated Fengxian Hosp, Dept Lab Med, Shanghai, Peoples R China; [Song, Fangfang; Wu, Qiuju] Jinzhou Med Univ, Affiliated Fengxian Hosp, Cent Lab, Shanghai, Peoples R China; [Mao, Shuqin] Hubei Univ Med, Affiliated Taihe Hosp, Shiyan, Hubei Province, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Chinese Academy of Sciences; Chinese Academy of Sciences; Kunming Institute of Zoology; Jinzhou Medical University; Jinzhou Medical University; Hubei University of Medicine	Feng, J (corresponding author), Southern Med Univ, Clin Coll 3, Guangzhou, Guangdong, Peoples R China.; Feng, J (corresponding author), Southern Med Univ, Affiliated Fengxian Hosp, Dept Lab Med, Shanghai, Peoples R China.; Feng, J (corresponding author), Southern Med Univ, Affiliated Fengxian Hosp, Cent Lab, Shanghai, Peoples R China.; Chen, CS (corresponding author), Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan Province, Peoples R China.; Chen, CS (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Kunming, Yunnan Province, Peoples R China.	fengjing8801530@163.com; chenc@mail.kiz.ac.cn			Strategic Priority Research Program of the Chinese Academy of Sciences [XDA12010303]; National Key Basic Research Program of China [2013CB910900]; National Nature Science Foundation of China [81325016, U1602221, 81672624]; Shanghai health system outstanding academic leader training program [XBR2013114]; Yunnan Applied Basic Research Key Projects [2015FA027]; Shanghai Municipal Commission of Health and Family Planning [20164Y0274]; Shanghai Fengxian District Health and Family Planning Commission Project [20131414]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Key Basic Research Program of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai health system outstanding academic leader training program; Yunnan Applied Basic Research Key Projects; Shanghai Municipal Commission of Health and Family Planning; Shanghai Fengxian District Health and Family Planning Commission Project	This study was supported by Strategic Priority Research Program of the Chinese Academy of Sciences (XDA12010303 to Chen, C), the National Key Basic Research Program of China (2013CB910900 to Chen, C), National Nature Science Foundation of China (81325016 and U1602221 to Chen, C and 81672624 to Feng, J), Shanghai health system outstanding academic leader training program (XBR2013114 to Feng, J), Yunnan Applied Basic Research Key Projects (2015FA027 to Liu, R), Shanghai Municipal Commission of Health and Family Planning (20164Y0274 to Liu, C) and Shanghai Fengxian District Health and Family Planning Commission Project (20131414 to Peng, Y). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bialkowska A, 2010, PROBE REPORTS NIH MO; Bialkowska A, 2010, CELL BIOL INT; Bouchie A, 2013, NAT BIOTECHNOL, V31, P577, DOI 10.1038/nbt0713-577; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chen CS, 2005, ONCOGENE, V24, P3319, DOI 10.1038/sj.onc.1208497; Chen DL, 2015, ONCOTARGET, V6, P10868, DOI 10.18632/oncotarget.3451; Conkright MD, 1999, NUCLEIC ACIDS RES, V27, P1263, DOI 10.1093/nar/27.5.1263; de Sabando AR, 2016, MOL CANCER THER, V15, P72, DOI 10.1158/1535-7163.MCT-15-0600; de Yebenes VG, 2014, BLOOD, V124, P229, DOI 10.1182/blood-2013-12-543611; Deng SC, 2014, CANCER LETT, V355, P184, DOI 10.1016/j.canlet.2014.08.007; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Dong JT, 2009, CELL MOL LIFE SCI, V66, P2691, DOI 10.1007/s00018-009-0045-z; Gao Y, 2014, INT J MOL SCI, V15, P15173, DOI 10.3390/ijms150915173; Gao Y, 2015, CURR TOP MED CHEM, V15, P699, DOI 10.2174/1568026615666150302105052; Hayes J, 2014, TRENDS MOL MED, V20, P460, DOI 10.1016/j.molmed.2014.06.005; Jia L, 2016, ONCOGENE, V35, P2040, DOI 10.1038/onc.2015.263; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Li H, 2013, NEOPLASMA, V60, P511, DOI 10.4149/neo_2013_066; Li J., 2016, IEEE T COMPUT, V1, P1, DOI DOI 10.1038/0NC.2016.90; Liu R, 2016, THERANOSTICS, V6, P533, DOI 10.7150/thno.14315; Liu R, 2013, VITAM HORM, V93, P213, DOI 10.1016/B978-0-12-416673-8.00002-2; Liu R, 2011, MOL ENDOCRINOL, V25, P1137, DOI 10.1210/me.2010-0497; Liu R, 2009, J BIOL CHEM, V284, P16791, DOI 10.1074/jbc.M808919200; Menghini R, 2009, CIRCULATION, V120, P1524, DOI 10.1161/CIRCULATIONAHA.109.864629; Nishioka C, 2014, CANCER SCI, V105, P297, DOI 10.1111/cas.12339; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Su J, 2014, MOL CELL BIOCHEM, V392, P289, DOI 10.1007/s11010-014-2039-x; Szafranska AE, 2007, ONCOGENE, V26, P4442, DOI 10.1038/sj.onc.1210228; Tong D, 2006, CLIN CANCER RES, V12, P2442, DOI 10.1158/1078-0432.CCR-05-0964; Wang CY, 2015, ONCOTARGET, V6, P17685, DOI 10.18632/oncotarget.3779; Wang XY, 2015, J BIOL CHEM, V290, P3925, DOI 10.1074/jbc.M114.596866; Wei RX, 2015, BIOMED PHARMACOTHER, V72, P158, DOI 10.1016/j.biopha.2015.04.012; Xi S, 2015, ONCOGENE, V34, P5548, DOI 10.1038/onc.2015.10; Xia HJ, 2013, J BIOL CHEM, V288, P26731, DOI 10.1074/jbc.M113.483958; Xue Y, 2013, CANCER GENET-NY, V206, P217, DOI 10.1016/j.cancergen.2013.05.020; Zhang Q, 2015, J CANCER, V6, P184, DOI 10.7150/jca.10822; Zhang SH, 2017, BIOMED PHARMACOTHER, V85, P541, DOI 10.1016/j.biopha.2016.11.062; Zhao D, 2012, CARCINOGENESIS, V33, P59, DOI 10.1093/carcin/bgr242; Zhao D, 2010, CANCER RES, V70, P4728, DOI 10.1158/0008-5472.CAN-10-0040; Zhao WG, 2010, CARCINOGENESIS, V31, P1726, DOI 10.1093/carcin/bgq160; Zheng HQ, 2009, ONCOGENE, V28, P3702, DOI 10.1038/onc.2009.235; Zhi X, 2012, AM J PATHOL, V180, P2452, DOI 10.1016/j.ajpath.2012.02.025; Zhu YG, 2016, AM J TRANSL RES, V8, P1482	45	38	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176395	10.1371/journal.pone.0176395	http://dx.doi.org/10.1371/journal.pone.0176395			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437471	Green Published, gold, Green Submitted			2022-12-26	WOS:000400287600046
J	Lombardi, G; Di Gregori, V; Girometti, N; Tadolini, M; Bisognin, F; Dal Monte, P				Lombardi, Giulia; Di Gregori, Valentina; Girometti, Nicolo; Tadolini, Marina; Bisognin, Francesco; Dal Monte, Paola			Diagnosis of smear-negative tuberculosis is greatly improved by Xpert MTB/RIF	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; RIFAMPIN RESISTANCE; GENEXPERT MTB/RIF; ACCURACY; ASSAY; EXTRAPULMONARY	Background Diagnosis of pulmonary (PTB) and extra-pulmonary tuberculosis (EPTB) in smear-negative patients can be difficult. We assessed retrospectively the performance of Xpert MTB/RIF system (Xpert, Cepheid) in diagnosing smear-negative tuberculosis (TB), which represents the most common form of TB in a low incidence setting. Methods Performance of Xpert was compared to acid-fast microscopic examination using Ziehl-Neelsen (ZN) stain in patients with culture-confirmed TB. Results 386 Mycobacterium tuberculosis (MTB) culture-positive samples were detected out of 5170 specimens tested with smear microscopy, Xpert and culture: 323 were both culture- and Xpert-positive, and 63 culture-positive only. Of these, 234 (60.6%) were smear-negative. In addition Xpert detected 40 probable TB cases, based on clinical findings, which were culture-negative. Compared to culture, Xpert showed an overall sensitivity of 83.7% and a specificity of 99.1%; sensitivity was higher for respiratory samples (86.5%) than for non-respiratory samples (76.8%). Xpert sensitivity for smear-negative culture-confirmed TB was 73.1% and was not influenced by TB localization. As sensitivity of microscopy alone was poor (39.4%), Xpert improved both diagnosis of pulmonary TB (Delta = 36.5%) and extra-pulmonary TB (Delta = 63.4%). Conclusions Xpert MTB/RIF is a sensitive method for rapid diagnosis of TB compared to the conventional ZN staining. Xpert can serve as a sensitive and time-saving diagnostic method for microbiological diagnosis of smear-negative TB in countries with a low TB prevalence.	[Lombardi, Giulia; Bisognin, Francesco; Dal Monte, Paola] Alma Mater Studiorum Univ Bologna, Dept Expt Diagnost & Specialty Med, Unit Microbiol, S Orsola Malpighi Univ Hosp, Bologna, Italy; [Di Gregori, Valentina] Alma Mater Studiorum Univ Bologna, Sect Hyg & Publ Hlth, Dept Biomed & Neuromotor Sci, Bologna, Italy; [Girometti, Nicolo; Tadolini, Marina] Alma Mater Studiorum Univ Bologna, Dept Med & Surg Sci, Unit Infect Dis, S Orsola Malpighi Univ Hosp, Bologna, Italy	IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna	Lombardi, G (corresponding author), Alma Mater Studiorum Univ Bologna, Dept Expt Diagnost & Specialty Med, Unit Microbiol, S Orsola Malpighi Univ Hosp, Bologna, Italy.	g.lombardi@unibo.it	LOMBARDI, GIULIA/HGC-4356-2022	LOMBARDI, GIULIA/0000-0001-6423-8358; Tadolini, Marina/0000-0002-1005-7532; BISOGNIN, FRANCESCO/0000-0002-3254-9239; Girometti, Nicolo'/0000-0002-2960-2748; DAL MONTE, PAOLA/0000-0003-2326-7464				[Anonymous], 2012, FUTURE MICROBIOL, V7, P1024; [Anonymous], 2011, FUTURE MICROBIOL, V6, P1067; Blakemore R, 2010, J CLIN MICROBIOL, V48, P2495, DOI 10.1128/JCM.00128-10; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Borrini BM, 2013, EPIDEMIOLOGIA TUBERC; Ramirez HLB, 2014, INT J TUBERC LUNG D, V18, P435, DOI 10.5588/ijtld.13.0747; Cepheid, 2016, XPERT MTB RIF PACK I; Clinical and Laboratory Standards Institute (CLSI), 2008, LAB DET ID MYC APPR; European Centre for Disease Prevention and Control, TUB SURV MON EUR 201; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Hillemann D, 2011, J CLIN MICROBIOL, V49, P1202, DOI 10.1128/JCM.02268-10; Kaur R, 2016, J GLOB INFECT DIS, V8, P32, DOI 10.4103/0974-777X.176143; Le Palud P, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-137; Li Q, 2016, BIOMED ENVIRON SCI, V29, P248, DOI 10.3967/bes2016.032; Lombardi G, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-340; Luetkemeyer AF, 2016, CLIN INFECT DIS, V62, P1081, DOI 10.1093/cid/ciw035; Marlowe EM, 2011, J CLIN MICROBIOL, V49, P1621, DOI 10.1128/JCM.02214-10; Maynard-Smith L, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0709-7; Meyer-Rath G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036966; Moure R, 2011, J CLIN MICROBIOL, V49, P1137, DOI 10.1128/JCM.01831-10; Munoz L, 2013, DIAGN MICR INFEC DIS, V75, P325, DOI 10.1016/j.diagmicrobio.2012.11.011; Opota O, 2016, CLIN MICROBIOL INFEC, V22, P613, DOI 10.1016/j.cmi.2016.04.010; Reechaipichitkul W, 2016, SE ASIAN J TROP MED, V47, P457; Sharma SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141011; Sohn H, 2014, CLIN INFECT DIS, V58, P970, DOI 10.1093/cid/ciu022; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Tadesse M, 2016, INT J MYCOBACT, V5, P211, DOI 10.1016/j.ijmyco.2016.03.005; Tortoli E, 2012, EUR RESPIR J, V40, P442, DOI 10.1183/09031936.00176311; Walusimbi S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-507; Wei GM, 2016, J THORAC DIS, V8, DOI 10.21037/jtd.2016.04.19; Weitzman I, 2010, CLIN MICROBIOLOGY PR, P721; World Health Organization, ANT RES GLOB REP SUR; Zeka AN, 2011, J CLIN MICROBIOL, V49, P4138, DOI 10.1128/JCM.05434-11	34	43	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0176186	10.1371/journal.pone.0176186	http://dx.doi.org/10.1371/journal.pone.0176186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430807	gold, Green Published, Green Submitted			2022-12-26	WOS:000399876100030
J	Ng, CH; Lee, SL; Tnah, LH; Ng, KKS; Lee, CT; Diway, B; Khoo, E				Ng, Chin Hong; Lee, Soon Leong; Tnah, Lee Hong; Ng, Kevin Kit Siong; Lee, Chai Ting; Diway, Bibian; Khoo, Eyen			Geographic origin and individual assignment of Shorea platyclados (Dipterocarpaceae) for forensic identification	PLOS ONE			English	Article							TIMBER IDENTIFICATION; GENETIC-STRUCTURE; DNA VARIATION; CHLOROPLAST; WOOD; DISPERSAL; FRAMEWORK; MARKERS; AREA; OAKS	The development of timber tracking methods based on genetic markers can provide scientific evidence to verify the origin of timber products and fulfill the growing requirement for sustainable forestry practices. In this study, the origin of an important Dark Red Meranti wood, Shorea platyclados, was studied by using the combination of seven chloroplast DNA and 15 short tandem repeats (STRs) markers. A total of 27 natural populations of S. platyclados were sampled throughout Malaysia to establish population level and individual level identification databases. A haplotype map was generated from chloroplast DNA sequencing for population identification, resulting in 29 multilocus haplotypes, based on 39 informative intraspecific variable sites. Subsequently, a DNA profiling database was developed from 15 STRs allowing for individual identification in Malaysia. Cluster analysis divided the 27 populations into two genetic clusters, corresponding to the region of Eastern and Western Malaysia. The conservativeness tests showed that the Malaysia database is conservative after removal of bias from population subdivision and sampling effects. Independent self-assignment tests correctly assigned individuals to the database in an overall 60.60-94.95% of cases for identified populations, and in 98.99-99.23% of cases for identified regions. Both the chloroplast DNA database and the STRs appear to be useful for tracking timber originating in Malaysia. Hence, this DNA-based method could serve as an effective addition tool to the existing forensic timber identification system for ensuring the sustainably management of this species into the future.	[Ng, Chin Hong; Lee, Soon Leong; Tnah, Lee Hong; Ng, Kevin Kit Siong; Lee, Chai Ting] Forest Res Inst Malaysia, Div Forestry Biotechnol, Kepong, Selangor, Malaysia; [Diway, Bibian] Sarawak Forestry Corp, Kuching, Sarawak, Malaysia; [Khoo, Eyen] Forest Res Ctr, Sandakan, Sabah, Malaysia	Institute Penyelidikan Perhutanan Malaysia; Pusat Penyelidikan Hutan	Ng, CH (corresponding author), Forest Res Inst Malaysia, Div Forestry Biotechnol, Kepong, Selangor, Malaysia.	chinhong@frim.gov.my	Hong, Ng Chin/AAL-2377-2021; LEE, Soon Leong/AGZ-1887-2022	Ng, Chin Hong/0000-0001-5860-5553; Lee, Chai Ting/0000-0002-1736-7226	Ministry of Agriculture and Agro-Based Industry Malaysia [050310SF1035]	Ministry of Agriculture and Agro-Based Industry Malaysia	This study was made possible by financial support from the Ministry of Agriculture and Agro-Based Industry Malaysia (project number 050310SF1035).	AUGSPURGER CK, 1987, ECOLOGY, V68, P27, DOI 10.2307/1938802; Ayres KL, 1999, FORENSIC SCI INT, V103, P207, DOI 10.1016/S0379-0738(99)00087-0; BALDING DJ, 1994, FORENSIC SCI INT, V64, P125, DOI 10.1016/0379-0738(94)90222-4; Butler JM, 2005, FORENSIC DNA TYPING; Cabral EC, 2012, J MASS SPECTROM, V47, P1, DOI 10.1002/jms.2016; Carlquist S., 2001, COMP WOOD ANATOMY SY; Chan H. T., 1980, Malaysian Forester, V43, P132; Chua LSL, 2010, MALAYSIA PLANT RED L; CORRIVEAU JL, 1988, AM J BOT, V75, P1443, DOI 10.2307/2444695; Dawnay N, 2008, FORENSIC SCI INT-GEN, V2, P47, DOI 10.1016/j.fsigen.2007.08.006; Cunha FAFD, 2016, ECOL ECON, V130, P209, DOI 10.1016/j.ecolecon.2016.07.007; Deguilloux MF, 2003, MOL ECOL, V12, P1629, DOI 10.1046/j.1365-294X.2003.01836.x; Dormontt EE, 2015, BIOL CONSERV, V191, P790, DOI 10.1016/j.biocon.2015.06.038; Dumolin-Lapegue S, 1999, EVOLUTION, V53, P1406, DOI 10.1111/j.1558-5646.1999.tb05405.x; Dutech C, 2003, EVOLUTION, V57, P2753, DOI 10.1111/j.0014-3820.2003.tb01517.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Elliott C, 2001, J EUR PUBLIC POLICY, V8, P642, DOI 10.1080/13501760110064438; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ferris C, 1998, HEREDITY, V80, P584, DOI 10.1046/j.1365-2540.1998.00342.x; Foreman LA, 1998, FORENSIC SCI INT, V95, P27, DOI 10.1016/S0379-0738(98)00079-6; Fry B, 2007, STABLE ISOTOPE ECOLO; FSC, 2014, OV REC TRENDS CURR S; Gan KS, 2004, COMMON COMMERCIAL TI; Gill P, 2003, FORENSIC SCI INT, V131, P184, DOI 10.1016/S0379-0738(02)00423-1; Goncalves MP, 2012, JUSTICE FORESTS IMPR; Hardy OJ, 2006, MOL ECOL, V15, P559, DOI 10.1111/j.1365-294X.2005.02785.x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heinze B, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-4; ITTO, 2012, TRACK SUST REV EL SE; Jobling MA, 2004, NAT REV GENET, V5, P739, DOI 10.1038/nrg1455; Keenan RJ, 2015, FOREST ECOL MANAG, V352, P9, DOI 10.1016/j.foreco.2015.06.014; Kirk H, 2011, INT J MOL SCI, V12, P3966, DOI 10.3390/ijms12063966; Kissinger G, 2012, DRIVERS DEFORESTATIO; Kozak RA, 2004, FOREST PROD J, V54, P21; Lewis PO, 2001, GENETIC DATA ANAL GD; Linacre A, 2011, FORENSIC SCI INT-GEN, V5, P501, DOI 10.1016/j.fsigen.2010.10.017; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; Lowe AJ, 2010, SILVAE GENET, V59, P263, DOI 10.1515/sg-2010-0037; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Ng CFS, 2013, INT J BIOMETEOROL, V2013, P1, DOI DOI 10.3732/APPS.1200538; Ng CH, 2009, CONSERV GENET RESOUR, V1, P317, DOI 10.1007/s12686-009-9073-0; Ng CH, 2012, J FOREST RES-JPN, V17, P479, DOI 10.1007/s10310-011-0318-x; Ng KKS, 2016, FORENSIC SCI INT-GEN, V23, P197, DOI 10.1016/j.fsigen.2016.05.002; NRC, 1996, EV FOR DNA EV COMM D; Ogden R, 2015, FORENSIC SCI INT-GEN, V18, P152, DOI 10.1016/j.fsigen.2015.02.008; Park SDE, EXCEL MICROSATELLITE; Petit RJ, 2002, FOREST ECOL MANAG, V156, P5, DOI 10.1016/S0378-1127(01)00645-4; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pritchard JK, 2000, GENETICS, V155, P945; Ramsey CB, 2008, ARCHAEOMETRY, V50, P249, DOI [10.1111/J.1475-4754.2008.00394.X, 10.1111/j.1475-4754.2008.00394.x]; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Sjerps M, 2003, STAT NEERL, V57, P368, DOI 10.1111/1467-9574.00236; Speer J.H., 2010, FUNDAMENTALS TREE RI; Symington CF, 2004, FORESTERS MANUAL DIP; Tereba A, 1999, PROFILES DNA, P14; Tnah LH, 2013, J HERED, V104, P115, DOI 10.1093/jhered/ess076; Tnah LH, 2010, FOREST ECOL MANAG, V259, P1436, DOI 10.1016/j.foreco.2010.01.017; Tnah LH, 2009, FOREST ECOL MANAG, V258, P1918, DOI 10.1016/j.foreco.2009.07.029; Triggs CM, 2002, FORENSIC SCI INT, V128, P108, DOI 10.1016/S0379-0738(02)00168-8; Tsuchikawa S, 2013, APPL SPECTROSC REV, V48, P560, DOI 10.1080/05704928.2011.621079; UNODC, 2016, BEST PRACT GUID FOR; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	63	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0176158	10.1371/journal.pone.0176158	http://dx.doi.org/10.1371/journal.pone.0176158			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430826	Green Published, gold, Green Submitted			2022-12-26	WOS:000399876100029
J	Gnavi, G; Garzoli, L; Polil, A; Prigione, V; Burgaud, G; Varese, GC				Gnavi, Giorgio; Garzoli, Laura; Polil, Anna; Prigione, Valeria; Burgaud, Gaetan; Varese, Giovanna Cristina			The culturable mycobiota of Flabellia petiolata: First survey of marine fungi associated to a Mediterranean green alga	PLOS ONE			English	Article							PHYLOGENETIC DIVERSITY; MYCOSPHAERELLA-SPP.; PRIMER SETS; PENICILLIUM; SYSTEMATICS; GENERA; PEZIZOMYCOTINA; ANTIBACTERIAL; HYPOCREALES; ASCOMYCOTA	Algae-inhabiting marine fungi represent a taxonomically and ecologically interesting group of microorganisms still largely neglected, especially in temperate regions. The aim of this study was to isolate and to identify the culturable mycobiota associated with Flabellia petiolata, a green alga frequently retrieved in the Mediterranean basin. Twenty algal thalli were collected from two different sampling sites in the Mediterranean Sea (Elba Island, Italy). A polyphasic approach showed the presence of a relevant alga-associated mycobiota with 64 taxa identified. The fungal isolates belonged mainly to Ascomycota (61 taxa), while only three Basidiomycota were detected. The phylogenetic position of sterile mycelia and cryptic taxa, inferred on the basis of LSU partial region, highlighted the presence of putative new phylogenetic lineages within Dothideomycetes and Sordariomycetes. This work represents the first quali-quantitative analysis of the culturable mycobiota associated to a green alga in the Mediterranean Sea.	[Gnavi, Giorgio; Garzoli, Laura; Polil, Anna; Prigione, Valeria; Varese, Giovanna Cristina] Univ Turin, MUT, Dept Life Sci & Syst Biol, Turin, Italy; [Burgaud, Gaetan] Univ Brest, EA 3882, Lab Univ Biodiversite & Ecol Microbienne, Technopole Brest Iroise, Plouzane, France	University of Turin; Universite de Bretagne Occidentale	Varese, GC (corresponding author), Univ Turin, MUT, Dept Life Sci & Syst Biol, Turin, Italy.	cristina.varese@unito.it	Prigione, Valeria/K-6145-2019; Garzoli, Laura/AAX-8010-2020; Gnavi, Giorgio/B-8624-2014	Garzoli, Laura/0000-0003-1353-9120; Poli, Anna/0000-0002-4027-1476; Burgaud, Gaetan/0000-0001-7741-4429; Gnavi, Giorgio/0000-0003-4725-5337				Baldrian P, 2008, FEMS MICROBIOL REV, V32, P501, DOI 10.1111/j.1574-6976.2008.00106.x; BALLESTEROS E, 1992, BOT MAR, V35, P481, DOI 10.1515/botm.1992.35.6.481; Bensch K, 2012, STUD MYCOL, P1, DOI 10.3114/sim0003; Bovio E, 2017, SCI TOTAL ENVIRON, V576, P310, DOI 10.1016/j.scitotenv.2016.10.064; Bugni TS, 2004, NAT PROD REP, V21, P143, DOI 10.1039/b301926h; Cabrita MT, 2010, MAR DRUGS, V8, P2301, DOI 10.3390/md8082301; Cannon PF, 2007, FUNGAL FAMILIES OF T; Carbone I, 1999, MYCOLOGIA, V91, P553, DOI 10.2307/3761358; Cicatiello P, 2016, INT J BIOL MACROMOL, V92, P1229, DOI 10.1016/j.ijbiomac.2016.08.037; Clarke K.R., 2014, CHANGE MARINE COMMUN; Crous PW, 2007, STUD MYCOL, P33, DOI 10.3114/sim.2007.58.02; Crous PW, 2009, STUD MYCOL, P17, DOI 10.3114/sim.2009.64.02; Crous PW, 2009, PERSOONIA, V23, P99, DOI 10.3767/003158509X479487; Crous PW, 2007, FUNGAL DIVERS, V26, P143; Crous PW, 2006, STUD MYCOL, P99, DOI 10.3114/sim.55.1.99; Cubero OF, 1999, PLANT SYST EVOL, V216, P243, DOI 10.1007/BF01084401; Flewelling AJ, 2015, CURR SCI INDIA, V109, P88; GALLARDO T, 1993, BOT MAR, V36, P399, DOI 10.1515/botm.1993.36.5.399; Garzoli L, 2015, MAR ECOL-EVOL PERSP, V36, P959, DOI 10.1111/maec.12189; Genovese G, 2009, MAR DRUGS, V7, P361, DOI 10.3390/md7030361; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Gnavi G, 2016, RES MICROBIOL, V167, P492, DOI 10.1016/j.resmic.2016.04.009; Gnavi G, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-508; Goncalves VN, 2013, POLAR BIOL, V36, P1823, DOI 10.1007/s00300-013-1403-8; Gouba N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106994; Gouba N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059474; Greiner K, 2014, IMA FUNGUS, V5, P161, DOI 10.5598/imafungus.2014.05.02.01; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harvey JBJ, 2010, FUNGAL BIOL-UK, V114, P82, DOI 10.1016/j.mycres.2009.10.009; Holler U, 2000, MYCOL RES, V104, P1354, DOI 10.1017/S0953756200003117; Hyde KD, 2013, FUNGAL DIVERS, V63, P1, DOI 10.1007/s13225-013-0263-4; Isola D, 2016, FUNGAL DIVERS, V76, P75, DOI 10.1007/s13225-015-0342-9; Jones EBG, 2015, FUNGAL DIVERS, V73, P1, DOI 10.1007/s13225-015-0339-4; Jones EBG, 2012, MAR FRESHW BOTANY, P329; Jones EBG, 2012, MAR FRESHW BOTANY; Jones EBG, 2011, BOT MAR, V54, P343, DOI 10.1515/BOT.2011.043; Kirk P., 2008, Ainsworth and Bisby�s Dictionary of the Fungi, DOI 10.1079/9780851998268.0000; LaBarre S, 2014, OUTSTANDING MARINE MOLECULES: CHEMISTRY, BIOLOGY, ANALYSIS, P1, DOI 10.1002/9783527681501; LAPEYRE B, 1993, NUCLEIC ACIDS RES, V21, P3322, DOI 10.1093/nar/21.14.3322; Liu JK, 2014, PHYTOTAXA, V181, P1; Mahapatra S, 2016, SPR SER ADV MICROELE, V52, P1, DOI 10.1007/978-81-322-2508-9_1; Manohar CS, 2013, FEMS MICROBIOL LETT, V341, P69, DOI 10.1111/1574-6968.12087; Nai C, 2013, FUNGAL GENET BIOL, V56, P54, DOI 10.1016/j.fgb.2013.04.001; Nekoduka S, 2010, MYCOSCIENCE, V51, P123, DOI 10.1007/s10267-009-0021-3; NIZAMUDDIN M, 1987, NOVA HEDWIGIA, V44, P175; Nurra N, 2009, THESIS; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Overy David P, 2014, Mycology, V5, P145; Pang KL, 2010, BOT MAR, V53, P493, DOI 10.1515/BOT.2010.061; Panno L, 2014, THESIS; Panno L, 2013, NEW BIOTECHNOL, V30, P685, DOI 10.1016/j.nbt.2013.01.010; Park MS, 2014, MYCOBIOLOGY, V42, P109, DOI 10.5941/MYCO.2014.42.2.109; Park MS, 2014, ANTON LEEUW INT J G, V106, P331, DOI 10.1007/s10482-014-0205-5; Perez CA, 2009, FOREST PATHOL, V39, P349, DOI 10.1111/j.1439-0329.2009.00598.x; Perez MJ, 2016, MAR DRUGS, V14, DOI 10.3390/md14030052; Personnic S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098994; Qin XY, 2015, MAR BIOTECHNOL, V17, P99, DOI 10.1007/s10126-014-9598-4; Redou V, 2015, APPL ENVIRON MICROB, V81, P3571, DOI 10.1128/AEM.04064-14; Richards TA, 2012, ANNU REV MAR SCI, V4, P495, DOI 10.1146/annurev-marine-120710-100802; Rossman AY, 1999, STUD MYCOL, P1; Sakayaroj J, 2012, MAR FRESHW BOTANY, P291; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Seifert KA, 2011, PERSOONIA, V27, P119, DOI 10.3767/003158511X617435; Sonjak S, 2006, MICROB ECOL, V52, P207, DOI 10.1007/s00248-006-9086-0; Suetrong S, 2009, STUD MYCOL, P155, DOI 10.3114/sim.2009.64.09; Suryanarayanan T S, 2012, Prog Mol Subcell Biol, V53, P53, DOI 10.1007/978-3-642-23342-5_3; Suryanarayanan T.S, 2014, OCEANOGRAPHY, V2, P2; Suryanarayanan TS, 2010, BOT MAR, V53, P457, DOI 10.1515/BOT.2010.045; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang AMC, 2007, ANTON LEEUW INT J G, V91, P327, DOI 10.1007/s10482-006-9120-8; Videira SIR, 2015, PERSOONIA, V34, P50, DOI 10.3767/003158515X685670; Wang JF, 2015, PLANTA MED, V81, P160, DOI 10.1055/s-0034-1383403; Wang Z, 2006, MYCOLOGIA, V98, P1065, DOI 10.3852/mycologia.98.6.1065; Wang Z, 2006, MOL PHYLOGENET EVOL, V41, P295, DOI 10.1016/j.ympev.2006.05.031; Watanabe T, 2012, MYCOSCIENCE, V53, P45, DOI 10.1007/s10267-011-0132-5; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Xu LJ, 2015, MAR DRUGS, V13, P3479, DOI 10.3390/md13063479; Zhang N, 2006, MYCOLOGIA, V98, P1076, DOI 10.3852/mycologia.98.6.1076; Zhang Y, 2012, FUNGAL DIVERS, V53, P1, DOI 10.1007/s13225-011-0117-x; Zuccaro A., 2005, FUNGAL COMMUNITY ITS, P533; Zuccaro A, 2008, APPL ENVIRON MICROB, V74, P931, DOI 10.1128/AEM.01158-07	81	45	48	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175941	10.1371/journal.pone.0175941	http://dx.doi.org/10.1371/journal.pone.0175941			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426712	Green Submitted, gold, Green Published			2022-12-26	WOS:000399875900072
J	Gupta, S; Seydel, K; Miranda-Roman, MA; Feintuch, CM; Saidi, A; Kim, RS; Birbeck, GL; Taylor, T; Daily, JP				Gupta, Sanchit; Seydel, Karl; Miranda-Roman, Miguel A.; Feintuch, Catherine M.; Saidi, Alex; Kim, Ryung S.; Birbeck, Gretchen L.; Taylor, Terrie; Daily, Johanna P.			Extensive alterations of blood metabolites in pediatric cerebral malaria	PLOS ONE			English	Article							BILE-ACID; ENDOTHELIAL DYSFUNCTION; OXIDATIVE STRESS; PARASITE; PHENYLALANINE; GLUTAMINE; EPILEPSY; OUTCOMES; ALPHA	Cerebral malaria (CM) presents as an encephalopathy and is due to infection with Plasmodium falciparum. Patients are comatose, often with fever, recurrent seizures and this condition is associated with a high mortality rate. The etiology of the coma and seizures are poorly understood. Circulating small molecules and lipids have bioactive functions and alterations in their concentrations have been implicated in seizure disorders and other forms of encephalopathy. We carried out a comprehensive analysis of blood metabolites during CM to explore a biochemical basis of this encephalopathy. A paired metabolomics analysis was performed on the plasma samples of Malawian children (n = 11) during CM and at convalescence thirty days later, to identify differentially abundant molecules associated with CM. We also report plasma molecules associated with CM mortality (n = 4) compared to survival (n = 19). Plasma metabolites were identified through ultra high performance liquid chromatography/tandem mass spectrometry and gas chromatography/mass spectrometry to maximize compound detection and accuracy and then compared to a library for identification. We detected a total of 432 small molecules in the plasma and 247 metabolites were significantly differentially abundant between CM and convalescence (p < 0.05, FDR < 0.10). These represented global changes across many classes of molecules including lipids, amino acids and hemoglobin metabolites. We observed significant changes in molecules that could impact neurologic function during CM; these include increased levels of kynurenate and decreased indolepropionate, glutamate, arginine and glutamine. Moreover, 1-methylimidazoleacetate, kyurenate, arachidonic acid and dimethylarginine were associated with mortality (p < 0.05, fold change > 1.2). These results highlight the broad changes in blood chemistry during CM. We have identified metabolites that may impact central nervous system physiology and disease outcomes and can be further explored for their mechanistic roles into the pathophysiology of CM.	[Gupta, Sanchit; Miranda-Roman, Miguel A.; Daily, Johanna P.] Albert Einstein Coll Med, Dept Med, Div Infect Dis, Bronx, NY 10467 USA; [Seydel, Karl; Saidi, Alex; Taylor, Terrie] Univ Malawi, Coll Med, Blantyre Malaria Project, Blantyre, Malawi; [Seydel, Karl; Taylor, Terrie] Michigan State Univ, Coll Osteopath Med, Dept Osteopath Med Specialties, E Lansing, MI 48824 USA; [Feintuch, Catherine M.; Daily, Johanna P.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Kim, Ryung S.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Birbeck, Gretchen L.] Univ Rochester, Dept Neurol, Epilepsy Div, Rochester, NY USA	Yeshiva University; Albert Einstein College of Medicine; University of Malawi; Michigan State University; Michigan State University College of Osteopathic Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Rochester	Daily, JP (corresponding author), Albert Einstein Coll Med, Dept Med, Div Infect Dis, Bronx, NY 10467 USA.; Daily, JP (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA.	jdaily@einstein.yu.edu		Miranda-Roman, Miguel/0000-0003-4914-848X	NIH-NIAID [1R011AI077623, 1RC1AI086224]; NIH/National Center for Advancing Translational Science (NCATS) Einstein-Montefiore CTSA [UL1TR001073]; Stable Isotope and Metabolomics Core Facility of the Diabetes Research and Training Center (DRTC) of the Albert Einstein College of Medicine NIH/NCI grant [P60DK020541]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI070117, R01AI034969] Funding Source: NIH RePORTER	NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/National Center for Advancing Translational Science (NCATS) Einstein-Montefiore CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Stable Isotope and Metabolomics Core Facility of the Diabetes Research and Training Center (DRTC) of the Albert Einstein College of Medicine NIH/NCI grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors received support from NIH-NIAID grants 1R011AI077623 and 1RC1AI086224 to JPD; NIH/National Center for Advancing Translational Science (NCATS) Einstein-Montefiore CTSA Grant Number UL1TR001073 (supported SG); and Stable Isotope and Metabolomics Core Facility of the Diabetes Research and Training Center (DRTC) of the Albert Einstein College of Medicine NIH/NCI grant P60DK020541 for lipid analysis.	Beghdadi W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006004; Birbeck GL, 2010, LANCET NEUROL, V9, P1173, DOI 10.1016/S1474-4422(10)70270-2; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; Chyan YJ, 1999, J BIOL CHEM, V274, P21937, DOI 10.1074/jbc.274.31.21937; Davis JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017260; Enwonwu CO, 2000, J NEURAL TRANSM, V107, P1273, DOI 10.1007/s007020070017; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Ghosh S, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1256-z; Gordon EB, 2015, P NATL ACAD SCI USA, V112, P13075, DOI 10.1073/pnas.1516544112; Grau GER, 2012, FUTURE MICROBIOL, V7, P291, DOI [10.2217/FMB.11.155, 10.2217/fmb.11.155]; GREENWOOD J, 1991, J CEREBR BLOOD F MET, V11, P644, DOI 10.1038/jcbfm.1991.116; Hofmann AF, 2014, J LIPID RES, V55, P1553, DOI 10.1194/jlr.R049437; Hwang IK, 2009, J NEUROSCI RES, V87, P2126, DOI 10.1002/jnr.22030; Idro R, 2010, PEDIATR RES, V68, P267, DOI 10.1203/00006450-201011001-00524; Itoe MA, 2014, CELL HOST MICROBE, V16, P778, DOI 10.1016/j.chom.2014.11.006; Keene CD, 2002, P NATL ACAD SCI USA, V99, P10671, DOI 10.1073/pnas.162362299; Lakshmanan V, 2012, J INFECT DIS, V206, P238, DOI 10.1093/infdis/jis339; Langley RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005893; Li TG, 2014, PHARMACOL REV, V66, P948, DOI 10.1124/pr.113.008201; Lopansri BK, 2006, INFECT IMMUN, V74, P3355, DOI 10.1128/IAI.02106-05; MAGGIORE G, 1991, J PEDIATR GASTR NUTR, V12, P21, DOI 10.1097/00005176-199101000-00005; Mickiewicz B, 2013, AM J RESP CRIT CARE, V187, P967, DOI 10.1164/rccm.201209-1726OC; MITCHELL GA, 1995, CLIN INVEST MED, V18, P193; MORITA T, 1978, Gastroenterologia Japonica, V13, P491; Palmela I, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00080; Papetti L, 2013, BRAIN DEV-JPN, V35, P827, DOI 10.1016/j.braindev.2012.11.010; Pappa V, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1036-1; Patel M, 2004, FREE RADICAL BIO MED, V37, P1951, DOI 10.1016/j.freeradbiomed.2004.08.021; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Romisch-Margl W, 2012, METABOLOMICS, V8, P133, DOI 10.1007/s11306-011-0293-4; Rogers AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087538; Schwarcz R, 2004, CURR OPIN PHARMACOL, V4, P12, DOI 10.1016/j.coph.2003.10.006; SHERMAN IW, 1977, B WORLD HEALTH ORGAN, V55, P265; SHERMAN IW, 1979, MICROBIOL REV, V43, P453, DOI 10.1128/MMBR.43.4.453-495.1979; Sibal L, 2010, CURR CARDIOL REV, V6, P82, DOI 10.2174/157340310791162659; SPITTLER A, 1995, BLOOD, V86, P1564, DOI 10.1182/blood.V86.4.1564.bloodjournal8641564; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; Waisbren SE, 2007, MOL GENET METAB, V92, P63, DOI 10.1016/j.ymgme.2007.05.006; Whitten R, 2011, HUM PATHOL, V42, P1230, DOI 10.1016/j.humpath.2010.11.019; World Health Organization, 2015, WORLD MAL REP 2015; Yeo TW, 2007, J EXP MED, V204, P2693, DOI 10.1084/jem.20070819; Yeo TW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000868	42	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175686	10.1371/journal.pone.0175686	http://dx.doi.org/10.1371/journal.pone.0175686			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426698	Green Published, gold, Green Submitted			2022-12-26	WOS:000399875900039
J	Liu, CB; Liu, ZJ; Wang, J				Liu, Chuanbo; Liu, Zuojia; Wang, Jin			Uncovering the molecular and physiological processes of anticancer leads binding human serum albumin: A physical insight into drug efficacy	PLOS ONE			English	Article							PROTEIN-BINDING; INTERMEDIATE; ACCUMULATION; CONFORMATION; RESONANCE; AFFINITY; HSA	Human serum albumin (HSA) has its ability to bind drug molecules and influence their efficacies. Although anticancer leads NSC48693 and NSC290956 functioned at the same mechanism, the drug efficacies were obviously distinct. To gain insight into the distinct drug efficacy, the molecular and physiological processes of anticancer leads binding HSA have been investigated via a combined experimental and theoretical approach. The binding site, as characterized by fluorescence quenching and molecular modeling, is found to be located at site II in subdomain III A for NSC48693 with tight binding and at site FA1 in subdomain I B for NSC290956 with negatively cooperative binding, respectively. As indicated by the thermodynamic analysis, NSC48693 binds to HSA with an enthalpy driven mechanism, while NSC290956 binding with HSA is entropically driven. The further kinetic analysis indicates that the association rates appear to be similar to these two anticancer leads, however, the dissociation rate of NSC48693 is approximately 5-fold slower than that of NSC290956. For NSC48693, the pharmacodynamic efficacy is less than that of NSC290956, while its pharmacokinetic behavior is better than that of NSC290956. These parameters influence the pharmacodynamic efficacy and pharmacokinetic behavior, which will give further impacts on drug efficacy in vivo.	[Liu, Chuanbo; Liu, Zuojia; Wang, Jin] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun, Jilin, Peoples R China; [Liu, Chuanbo] Univ Chinese Acad Sci, Beijing, Peoples R China; [Liu, Chuanbo; Wang, Jin] SUNY Stony Brook, Dept Chem & Phys, Stony Brook, NY 11794 USA	Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Liu, ZJ; Wang, J (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun, Jilin, Peoples R China.; Wang, J (corresponding author), SUNY Stony Brook, Dept Chem & Phys, Stony Brook, NY 11794 USA.	zjliu@ciac.ac.cn; jin.wang.1@stonybrook.edu		Liu, Zuojia/0000-0002-1770-3998	National Natural Science Foundation of China [81573448, 91430217]; Ministry of Science and Technology of China [2016YFA0203200, 2013YQ170585]; Natural Science Foundation of Jilin Province [20150101009JC]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of Jilin Province	This study was supported by the National Natural Science Foundation of China (grant No. 81573448 and 91430217) and Ministry of Science and Technology of China (grant No. 2016YFA0203200 and 2013YQ170585). This study was partly supported by the Natural Science Foundation of Jilin Province (grant No. 20150101009JC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Zied OK, 2011, CHEMPHYSCHEM, V12, P270, DOI 10.1002/cphc.201000742; Ahmad B, 2006, BIOMACROMOLECULES, V7, P1350, DOI 10.1021/bm050996b; Ahmadi SK, 2015, J BIOMOL STRUCT DYN, V33, P1880, DOI 10.1080/07391102.2014.977351; Aime S, 2002, J BIOL INORG CHEM, V7, P58, DOI 10.1007/s007750100265; Ascenzi P, 2014, J MOL STRUCT, V1077, P4, DOI 10.1016/j.molstruc.2013.09.053; Berezhkovskiy LM, 2010, J PHARM SCI-US, V99, P2153, DOI 10.1002/jps.21958; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chamani J, 2011, J PHARMACEUT BIOMED, V55, P114, DOI 10.1016/j.jpba.2010.12.029; Chatterjee T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037468; Connelly Patrick R., 1994, Current Opinion in Biotechnology, V5, P381, DOI 10.1016/0958-1669(94)90046-9; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; Fabini E, 2016, J PHARMACEUT BIOMED, V122, P166, DOI 10.1016/j.jpba.2016.01.051; Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002; Fang J, 2011, ADV DRUG DELIVER REV, V63, P136, DOI 10.1016/j.addr.2010.04.009; Fortugno C, 2014, J PHARMACEUT BIOMED, V95, P151, DOI 10.1016/j.jpba.2014.03.002; Fu L, 2014, J LUMIN, V149, P208, DOI 10.1016/j.jlumin.2014.01.023; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; He WY, 2006, J PHOTOCH PHOTOBIO A, V182, P158, DOI 10.1016/j.jphotochem.2006.02.004; He WY, 2005, BIOORGAN MED CHEM, V13, P1837, DOI 10.1016/j.bmc.2004.11.038; Iyer AK, 2006, DRUG DISCOV TODAY, V11, P812, DOI 10.1016/j.drudis.2006.07.005; Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6; Li HM, 2007, SPECTROCHIM ACTA A, V68, P1263, DOI 10.1016/j.saa.2007.02.002; Liu ZD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050367; Liu ZJ, 2012, CHEM RES CHINESE U, V28, P287; Liu ZJ, 2009, BIOPHYS J, V96, P3917, DOI 10.1016/j.bpj.2008.12.3965; Marouzi S, 2017, INT J BIOL MACROMOL, V97, P688, DOI 10.1016/j.ijbiomac.2017.01.047; Martini JWR, 2016, J MATH BIOL, V72, P1747, DOI 10.1007/s00285-015-0922-z; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Moghaddam MM, 2014, LUMINESCENCE, V29, P314, DOI 10.1002/bio.2546; Moosavi-Movahedi AA, 2005, COLLOID SURFACE B, V43, P150, DOI 10.1016/j.colsurfb.2005.04.008; Moosavi-Movahedi AA, 2003, J PROTEIN CHEM, V22, P23, DOI 10.1023/A:1023011609931; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Muller PY, 2012, NAT REV DRUG DISCOV, V11, P751, DOI 10.1038/nrd3801; Nobeli I, 2009, NAT BIOTECHNOL, V27, P157, DOI 10.1038/nbt1519; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ross NT, 2007, BIOCHEM BIOPH RES CO, V362, P1073, DOI 10.1016/j.bbrc.2007.08.123; Rossi AM, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2011.305; Sattar Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084045; Schmidt S, 2010, J PHARM SCI-US, V99, P1107, DOI 10.1002/jps.21916; SEYMOUR LW, 1995, EUR J CANCER, V31A, P766, DOI 10.1016/0959-8049(94)00514-6; Sharif-Barfeh Z, 2017, J SOLUTION CHEM, V46, P488, DOI 10.1007/s10953-017-0590-2; Smith DA, 2010, NAT REV DRUG DISCOV, V9, P929, DOI 10.1038/nrd3287; Wang J, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.198101; Williams MA, 2013, PROTEIN LIGAND INTER, P6; Zhang HX, 2016, SPECTROCHIM ACTA A, V161, P88, DOI 10.1016/j.saa.2016.02.014; Zhao WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066362; Zheng XL, 2013, CURR PHARM DESIGN, V19, P2246, DOI 10.2174/1381612811319120012	48	54	57	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176208	10.1371/journal.pone.0176208	http://dx.doi.org/10.1371/journal.pone.0176208			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426740	Green Published, Green Submitted, gold			2022-12-26	WOS:000399875900118
J	von Morgen, P; Burdova, K; Flower, TG; O'Reilly, NJ; Boulton, SJ; Smerdon, SJ; Macurek, L; Horejsi, Z				von Morgen, P.; Burdova, K.; Flower, T. G.; O'Reilly, N. J.; Boulton, S. J.; Smerdon, S. J.; Macurek, L.; Horejsi, Z.			MRE11 stability is regulated by CK2-dependent interaction with R2TP complex	ONCOGENE			English	Article							STRAND BREAK REPAIR; CLINICAL PRESENTATION; DNA; PHOSPHORYLATION; HSP90; PROTEIN; COCHAPERONE; CHAPERONE; MEDIATE; GENES	The MRN (MRE11-RAD50-NBS1) complex is essential for repair of DNA double-strand breaks and stalled replication forks. Mutations of the MRN complex subunit MRE11 cause the hereditary cancer-susceptibility disease ataxia-telangiectasia-like disorder (ATLD). Here we show that MRE11 directly interacts with PIH1D1, a subunit of heat-shock protein 90 cochaperone R2TP complex, which is required for the assembly of large protein complexes, such as RNA polymerase II, small nucleolar ribonucleoproteins and mammalian target of rapamycin complex 1. The MRE11-PIH1D1 interaction is dependent on casein kinase 2 (CK2) phosphorylation of two acidic sequences within the MRE11 C terminus containing serines 558/561 and 688/689. Conversely, the PIH1D1 phospho-binding domain PIH-N is required for association with MRE11 phosphorylated by CK2. Consistent with these findings, depletion of PIH1D1 resulted in MRE11 destabilization and affected DNA-damage repair processes dependent on MRE11. Additionally, mutations of serines 688/689, which abolish PIH1D1 binding, also resulted in decreased MRE11 stability. As depletion of R2TP frequently leads to instability of its substrates and as truncation mutation of MRE11 lacking serines 688/689 leads to decreased levels of the MRN complex both in ATLD patients and an ATLD mouse model, our results suggest that the MRN complex is a novel R2TP complex substrate and that their interaction is regulated by CK2 phosphorylation.	[von Morgen, P.; Burdova, K.; Macurek, L.; Horejsi, Z.] ASCR, Inst Mol Genet, Dept Canc Cell Biol, Videnska 1083, Prague 14200 4, Czech Republic; [von Morgen, P.] Charles Univ Prague, Fac Sci, Prague, Czech Republic; [Flower, T. G.; Smerdon, S. J.] Francis Crick Inst, Struct Biol DNA Damage Signalling Lab, London, England; [O'Reilly, N. J.] Francis Crick Inst, Peptide Chem, London, England; [Boulton, S. J.] Francis Crick Inst, DSB Repair Metab Lab, London, England; [Horejsi, Z.] Queen Mary Univ London, Barts Canc Inst, Ctr Mol Oncol, John Vane Ctr, Charterhouse Sq, London, England	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Charles University Prague; Francis Crick Institute; Francis Crick Institute; Francis Crick Institute; University of London; Queen Mary University London	Macurek, L (corresponding author), ASCR, Inst Mol Genet, Dept Canc Cell Biol, Videnska 1083, Prague 14200 4, Czech Republic.; Horejsi, Z (corresponding author), Queen Mary Univ London, Barts Canc Inst, Ctr Mol Oncol, John Vane Ctr, Charterhouse Sq, London, England.	libor.macurek@img.cas.cz; z.horejsi@qmul.ac.uk	Macurek, Libor/C-7865-2014; von Morgen, Patrick/P-6869-2019; Von Morgen, Patrick/M-7566-2017	Macurek, Libor/0000-0002-0987-1238; von Morgen, Patrick/0000-0002-0614-6292; Von Morgen, Patrick/0000-0002-0614-6292; O'Reilly, Nicola/0000-0002-4204-6491; Burdova, Kamila/0000-0003-4402-3688; Flower, Thomas/0000-0002-7890-6473; Smerdon, Stephen/0000-0001-5688-8465; Licenikova Horejsi, Zuzana/0000-0002-9943-1649	Czech Science Foundation [14-34264S]; Institutional grant of IMG [RVO 68378050]; Wellcome Trust [200462/Z/16/Z, FC001156, FC001048, WT104558]; Grant Agency of the Charles University [309015]; Francis Crick Institute - Cancer Research UK [FC001156, FC001048]; UK Medical Research Council [FC001156, FC001048]; European Research Council [ERC 268639]; Cancer Research UK [11581] Funding Source: researchfish; Medical Research Council [MC_U117584228, U117531954, 1254166] Funding Source: researchfish; The Francis Crick Institute [10267, 10156, 10048, 10013] Funding Source: researchfish; MRC [MC_U117584228] Funding Source: UKRI	Czech Science Foundation(Grant Agency of the Czech Republic); Institutional grant of IMG; Wellcome Trust(Wellcome TrustEuropean Commission); Grant Agency of the Charles University; Francis Crick Institute - Cancer Research UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	All cell lines were from the Cell Services of the Friancis Crick Institute and were regularly tested for mycoplasma infection. This work was supported by the Czech Science Foundation (14-34264S), Institutional grant of IMG (RVO 68378050) and the Wellcome Trust (200462/Z/16/Z). PM was partially supported by the Grant Agency of the Charles University (309015). SJS, TF and SJB are supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001156 and FC001048), the UK Medical Research Council (FC001156 and FC001048) and the Wellcome Trust (FC001156 and FC001048). SJB was also supported by Wellcome Trust (WT104558) and European Research Council (ERC 268639).	Aparicio T, 2016, J CELL BIOL, V212, P399, DOI 10.1083/jcb.201504005; Bartkova J, 2008, MOL ONCOL, V2, P296, DOI 10.1016/j.molonc.2008.09.007; Benbahouche NE, 2014, J BIOL CHEM, V289, P6236, DOI 10.1074/jbc.M113.499608; Bennardo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000683; Boulon S, 2010, MOL CELL, V39, P912, DOI 10.1016/j.molcel.2010.08.023; Buis J, 2012, NAT STRUCT MOL BIOL, V19, P246, DOI 10.1038/nsmb.2212; Cannavo E, 2014, NATURE, V514, P122, DOI 10.1038/nature13771; Chen C, 2013, P NATL ACAD SCI USA, V110, P20605, DOI 10.1073/pnas.1306328110; Chubb D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11883; Danielsen JMR, 2009, J BIOL CHEM, V284, P4140, DOI 10.1074/jbc.M808174200; Dery U, 2008, MOL CELL BIOL, V28, P3058, DOI 10.1128/MCB.02025-07; Deshpande RA, 2016, MOL CELL, V64, P593, DOI 10.1016/j.molcel.2016.10.010; Gunn Amanda, 2012, Methods Mol Biol, V920, P379, DOI 10.1007/978-1-61779-998-3_27; Heikkinen K, 2006, CARCINOGENESIS, V27, P1593, DOI 10.1093/carcin/bgi360; Horejsi Z, 2014, CELL REP, V7, P19, DOI 10.1016/j.celrep.2014.03.013; Horejsi Z, 2010, MOL CELL, V39, P839, DOI 10.1016/j.molcel.2010.08.037; Kiianitsa K, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt171; Kijas AW, 2015, NUCLEIC ACIDS RES, V43, P8352, DOI 10.1093/nar/gkv754; Kim SG, 2013, MOL CELLS, V35, P463, DOI 10.1007/s10059-013-0138-2; Kleibl Z, 2016, BREAST, V28, P136, DOI 10.1016/j.breast.2016.05.006; Lamarche BJ, 2010, FEBS LETT, V584, P3682, DOI 10.1016/j.febslet.2010.07.029; Luo H, 2014, NUCLEIC ACIDS RES, V42, pD574, DOI 10.1093/nar/gkt1131; Machado-Pinilla R, 2012, RNA, V18, P1833, DOI 10.1261/rna.034942.112; Hoa NN, 2016, MOL CELL, V64, P1010, DOI 10.1016/j.molcel.2016.11.028; Pal M, 2014, STRUCTURE, V22, P805, DOI 10.1016/j.str.2014.04.001; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Rao F, 2014, MOL CELL, V54, P119, DOI 10.1016/j.molcel.2014.02.020; Regal JA, 2013, HUM MOL GENET, V22, P5146, DOI 10.1093/hmg/ddt368; Rosenbaum J, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003906; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Taylor AMR, 2004, DNA REPAIR, V3, P1219, DOI 10.1016/j.dnarep.2004.04.009; Theunissen JWF, 2003, MOL CELL, V12, P1511, DOI 10.1016/S1097-2765(03)00455-6; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Williams GJ, 2010, DNA REPAIR, V9, P1299, DOI 10.1016/j.dnarep.2010.10.001; Yu ZB, 2012, CELL RES, V22, P305, DOI 10.1038/cr.2011.128; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zhao RM, 2008, J CELL BIOL, V180, P563, DOI 10.1083/jcb.200709061	37	26	26	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 24	2017	36	34					4943	4950		10.1038/onc.2017.99	http://dx.doi.org/10.1038/onc.2017.99			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FE5EI	28436950	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000408234400010
J	Korge, P; John, SA; Calmettes, G; Weiss, JN				Korge, Paavo; John, Scott A.; Calmettes, Guillaume; Weiss, James N.			Reactive oxygen species production induced by pore opening in cardiac mitochondria: The role of complex II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION; SUCCINATE-DEHYDROGENASE; ROS PRODUCTION; SUPEROXIDE-PRODUCTION; FUMARATE REDUCTASE; REPERFUSION; ISCHEMIA; MECHANISM; HEART; INHIBITION	Succinate-driven reverse electron transport (RET) through complex I is hypothesized to be a major source of reactive oxygen species (ROS) that induces permeability transition pore (PTP) opening and damages the heart during ischemia/reperfusion. Because RET can only generate ROS when mitochondria are fully polarized, this mechanism is self-limiting once PTP opens during reperfusion. In the accompanying article (Korge, P., Calmettes, G., John, S. A., and Weiss, J. N. (2017) J. Biol. Chem. 292, 9882-9895), we showed that ROS production after PTP opening can be sustained when complex III is damaged (simulated by antimycin). Here we show that complex II can also contribute to sustained ROS production in isolated rabbit cardiac mitochondria following inner membrane pore formation induced by either alamethicin or calcium-induced PTP opening. Two conditions are required to maximize malonate-sensitive ROS production by complex II in isolated mitochondria: (a) complex II inhibition by atpenin A5 or complex III inhibition by stigmatellin that results in succinate-dependent reduction of the dicarboxylate-binding site of complex II (site IIf); (b) pore opening in the inner membrane resulting in rapid efflux of succinate/fumarate and other dicarboxylates capable of competitively binding to site IIf. The decrease in matrix [dicarboxylate] allows O-2 access to reduced site IIf, thereby making electron donation to O-2 possible, explaining the rapid increase in ROS production provided that site IIf is reduced. Because ischemia is known to inhibit complexes II and III and increase matrix succinate/fumarate levels, we hypothesize that by allowing dicarboxylate efflux from the matrix, PTP opening during reperfusion may activate sustained ROS production by this mechanism after RET-driven ROS production has ceased.	Univ Calif Los Angeles, David Geffen Sch Med, UCLA Cardiovasc Res Lab, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Med Cardiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Weiss, JN (corresponding author), UCLA, Sch Med, Dept Med Cardiol, Los Angeles, CA 90095 USA.	jweiss@mednet.ucla.edu		John, Scott/0000-0002-1232-9140	National Institutes of Health from NHLBI [R01 HL101228, R01 HL117385]; American Heart Association Western States Affiliate [11POST6110007]; American Heart Association [16SDG31180036]; Laubisch and Kawata Endowments; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101228, R01HL117385] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association Western States Affiliate(American Heart Association); American Heart Association(American Heart Association); Laubisch and Kawata Endowments; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants R01 HL101228 and R01 HL117385 from the NHLBI, American Heart Association Western States Affiliate Post-doctoral Research Fellowship 11POST6110007, American Heart Association Scientist Development Grant 16SDG31180036, and the Laubisch and Kawata Endowments. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ACKRELL BAC, 1974, J BIOL CHEM, V249, P2021; Aidakkak M, 2008, CARDIOVASC RES, V77, P406, DOI 10.1016/j.cardiores.2007.08.008; Aldakkak M, 2008, J CARDIOVASC PHARM, V52, P236, DOI 10.1097/FJC.0b013e3181831337; Andrienko T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167300; Ashrafian H, 2012, CELL METAB, V15, P361, DOI 10.1016/j.cmet.2012.01.017; Berkich DA, 2003, ARCH BIOCHEM BIOPHYS, V420, P279, DOI 10.1016/j.abb.2003.09.021; Calmettes G, 2012, J PHYSIOL-LONDON, V590, P3403, DOI 10.1113/jphysiol.2012.239376; Chen CL, 2008, J BIOL CHEM, V283, P27991, DOI 10.1074/jbc.M802691200; Chen YR, 2007, J BIOL CHEM, V282, P32640, DOI 10.1074/jbc.M702294200; Chouchani ET, 2016, CELL METAB, V23, P254, DOI 10.1016/j.cmet.2015.12.009; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Drose S, 2013, BBA-BIOENERGETICS, V1827, P578, DOI 10.1016/j.bbabio.2013.01.004; EFRON B, 1991, SCIENCE, V253, P390, DOI 10.1126/science.253.5018.390; Gostimskaya IS, 2003, ANAL BIOCHEM, V313, P46, DOI 10.1016/S0003-2697(02)00534-1; GRIFFITHS EJ, 1995, BIOCHEM J, V307, P93, DOI 10.1042/bj3070093; Grivennikova VG, 2017, BBA-BIOENERGETICS, V1858, P109, DOI 10.1016/j.bbabio.2016.10.008; Grivennikova VG, 2010, BBA-BIOENERGETICS, V1797, P939, DOI 10.1016/j.bbabio.2010.02.013; Halestrap AP, 2004, CARDIOVASC RES, V61, P372, DOI 10.1016/S0008-6363(03)00533-9; He LH, 2002, FEBS LETT, V512, P1, DOI 10.1016/S0014-5793(01)03314-2; Hirst J, 2008, BIOCHEM SOC T, V36, P976, DOI 10.1042/BST0360976; IMLAY JA, 1995, J BIOL CHEM, V270, P19767; Iverson TM, 2013, BBA-BIOENERGETICS, V1827, P648, DOI 10.1016/j.bbabio.2012.09.008; Kato M, 2009, CARDIOVASC RES, V83, P335, DOI 10.1093/cvr/cvp094; Korge P, 2001, AM J PHYSIOL-CELL PH, V280, pC517, DOI 10.1152/ajpcell.2001.280.3.C517; Korge P, 2008, CIRC RES, V103, P873, DOI 10.1161/CIRCRESAHA.108.180869; Korge P, 2017, J BIOL CHEM, V292, P9882, DOI 10.1074/jbc.M116.768317; Korge P, 2016, FREE RADICAL BIO MED, V96, P22, DOI 10.1016/j.freeradbiomed.2016.04.002; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Korshunov SS, 1998, FEBS LETT, V435, P215, DOI 10.1016/S0014-5793(98)01073-4; KSENZENKO M, 1984, FEBS LETT, V175, P105, DOI 10.1016/0014-5793(84)80579-7; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Lesnefsky EJ, 2001, ARCH BIOCHEM BIOPHYS, V385, P117, DOI 10.1006/abbi.2000.2066; Levraut J, 2003, AM J PHYSIOL-HEART C, V284, pH549, DOI 10.1152/ajpheart.00708.2002; Lukyanova LD, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00320; Matsumoto-Ida M, 2006, CIRCULATION, V114, P1497, DOI 10.1161/CIRCULATIONAHA.106.628834; Messner KR, 2002, J BIOL CHEM, V277, P42563, DOI 10.1074/jbc.M204958200; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Petrosillo G, 2005, BBA-BIOENERGETICS, V1710, P78, DOI 10.1016/j.bbabio.2005.10.003; Quinlan CL, 2012, J BIOL CHEM, V287, P27255, DOI 10.1074/jbc.M112.374629; Riess ML, 2002, AM J PHYSIOL-HEART C, V283, pH53, DOI 10.1152/ajpheart.01057.2001; Siebels I, 2013, BBA-BIOENERGETICS, V1827, P1156, DOI 10.1016/j.bbabio.2013.06.005; Slodzinski MK, 2008, J MOL CELL CARDIOL, V45, P650, DOI 10.1016/j.yjmcc.2008.07.017; Starkov AA, 2001, BIOCHEM BIOPH RES CO, V281, P645, DOI 10.1006/bbrc.2001.4409; Stepanova A, 2016, BBA-BIOENERGETICS, V1857, P1561, DOI 10.1016/j.bbabio.2016.06.002; Tretter L, 2004, J NEUROSCI, V24, P7771, DOI 10.1523/JNEUROSCI.1842-04.2004; Tretter L, 2012, FREE RADICAL BIO MED, V53, P2119, DOI 10.1016/j.freeradbiomed.2012.09.029; Valls-Lacalle L, 2016, CARDIOVASC RES, V109, P374, DOI 10.1093/cvr/cvv279; VEITCH K, 1992, BIOCHEM J, V281, P709, DOI 10.1042/bj2810709; Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x; Wojtovich AP, 2008, BBA-BIOENERGETICS, V1777, P882, DOI 10.1016/j.bbabio.2008.03.025; Wojtovich AP, 2009, BASIC RES CARDIOL, V104, P121, DOI 10.1007/s00395-009-0001-y; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	52	35	35	0	64	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					9896	9905		10.1074/jbc.M116.768325	http://dx.doi.org/10.1074/jbc.M116.768325			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28450394	Green Published, hybrid			2022-12-26	WOS:000403580600004
J	Yao, ZQ; Lei, W; Duan, R; Li, YY; Luo, L; Boyce, BF				Yao, Zhenqiang; Lei, Wei; Duan, Rong; Li, Yanyun; Luo, Lu; Boyce, Brendan F.			RANKL cytokine enhances TNF-induced osteoclastogenesis independently of TNF receptor associated factor (TRAF) 6 by degrading TRAF3 in osteoclast precursors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; GROWTH-FACTOR-BETA; BONE-RESORPTION; TGF-BETA; DEFECTIVE INTERLEUKIN-1; RHEUMATOID-ARTHRITIS; T-CELLS; C-FOS; ACTIVATION	Cytokines, including receptor activator of nuclear factor kappa B ligand (RANKL) and TNF, induce increased osteoclast (OC) formation and bone loss in postmenopausal osteoporosis and inflammatory arthritides. RANKL and TNF can independently induce OC formation in vitro from WT OC precursors via TNF receptor-associated factor (TRAF) adaptor proteins, which bind to their receptors. Of these, only TRAF6 is required for RANKL-induced osteoclastogenesis in vitro. However, the molecular mechanisms involved remain incompletely understood. Here we report that RANKL induced the formation of bone-resorbing OCs from TRAF6(-/-) OC precursors when cultured on bone slices but not on plastic. The mechanisms involved increased TNF production by TRAF6(-/-) OC precursors resulting from their interaction with bone matrix and release of active TGF beta from the resorbed bone, coupled with RANKL-induced autophagolysosomal degradation of TRAF3, a known inhibitor of OC formation. Consistent with these findings, RANKL enhanced TNF-induced OC formation from TRAF6(-/-) OC precursors. Moreover, TNF induced significantly more OCs from mice with TRAF3 conditionally deleted in myeloid lineage cells, and it did not inhibit RANKL-induced OC formation from these cells. TRAF6(-/-) OC precursors that overexpressed TRAF3 or were treated with the autophagolysosome inhibitor chloroquine formed significantly fewer OCs in response to TNF alone or in combination with RANKL. We conclude that RANKL can enhance TNF-induced OC formation independently of TRAF6 by degrading TRAF3. These findings suggest that preventing TRAF3 degradation with drugs like chloroquine could reduce excessive OC formation in diseases in which bone resorption is increased in response to elevated production of these cytokines.	[Yao, Zhenqiang; Lei, Wei; Duan, Rong; Li, Yanyun; Luo, Lu; Boyce, Brendan F.] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Yao, Zhenqiang; Boyce, Brendan F.] Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Rochester, NY 14642 USA; [Lei, Wei] Henan Univ, Affiliated Hosp 1, Dept Med Imaging, 357 Ximen St, Kaifeng 475001, Henan, Peoples R China	University of Rochester; University of Rochester; Henan University	Yao, ZQ; Boyce, BF (corresponding author), Dept Pathol & Lab Med, 601 Elmwood Ave,Box 626, Rochester, NY 14642 USA.	zhenqiang_yao@urmc.rochester.edu; Brendan_Boyce@urmc.rochester.edu		Yao, Zhenqiang/0000-0002-4664-3648; Luo, Lu/0000-0002-6749-6616	NIAMS, National Institutes of Health [R01AR43510, P30 AR069655, 1S10RR027340]; NIA, National Institutes of Health [R01AG049994]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043510, P30AR069655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG049994] Funding Source: NIH RePORTER	NIAMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIAMS, National Institutes of Health Grant R01AR43510 (to B. F. B.) and NIA, National Institutes of Health Grant R01AG049994 (to B. F. B. and Z. Y.). This work was also supported by NIAMS Grants P30 AR069655 and 1S10RR027340 (to. B. F. B) from the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbas S, 2003, CYTOKINE, V22, P33, DOI 10.1016/S1043-4666(03)00106-6; Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Agbanoma G, 2012, J IMMUNOL, V188, P1307, DOI 10.4049/jimmunol.1100625; Atkins GJ, 2003, J BONE MINER RES, V18, P1088, DOI 10.1359/jbmr.2003.18.6.1088; Azuma Y, 2000, J BIOL CHEM, V275, P4858, DOI 10.1074/jbc.275.7.4858; Baer M, 1998, MOL CELL BIOL, V18, P5678, DOI 10.1128/MCB.18.10.5678; Bertrand MJM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022356; Besse A, 2007, J BIOL CHEM, V282, P3918, DOI 10.1074/jbc.M608867200; Boyce BF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2165; Boyce BF, 2015, ENDOCRINOL METAB, V30, P35, DOI 10.3803/EnM.2015.30.1.35; Boyce BF, 2013, J BONE MINER RES, V28, P711, DOI 10.1002/jbmr.1885; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Danks L, 2016, ANN RHEUM DIS, V75, P1187, DOI 10.1136/annrheumdis-2014-207137; Feldmann M, 2002, NAT REV IMMUNOL, V2, P364, DOI 10.1038/nri802; Fuller K, 2002, ENDOCRINOLOGY, V143, P1108, DOI 10.1210/en.143.3.1108; Funakoshi-Tago M, 2009, CYTOKINE, V45, P72, DOI 10.1016/j.cyto.2008.10.010; Galibert L, 1998, J BIOL CHEM, V273, P34120, DOI 10.1074/jbc.273.51.34120; Gravallese EM, 2001, ARTHRITIS RES, V3, P6, DOI 10.1186/ar134; Itonaga I, 2004, BONE, V34, P57, DOI 10.1016/j.bone.2003.08.008; Kawai T, 2006, AM J PATHOL, V169, P987, DOI 10.2353/ajpath.2006.060180; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; KHALIL N, 1989, J EXP MED, V170, P727, DOI 10.1084/jem.170.3.727; Kim HH, 1999, FEBS LETT, V443, P297, DOI 10.1016/S0014-5793(98)01731-1; Kim N, 2005, J EXP MED, V202, P589, DOI 10.1084/jem.20050978; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Kobayashi T, 2003, IMMUNITY, V19, P353, DOI 10.1016/S1074-7613(03)00230-9; Kullberg MC, 2005, EUR J IMMUNOL, V35, P2886, DOI 10.1002/eji.200526106; Lamothe B, 2007, BIOCHEM BIOPH RES CO, V359, P1044, DOI 10.1016/j.bbrc.2007.06.017; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Matsuzawa A, 2008, SCIENCE, V321, P663, DOI 10.1126/science.1157340; Mease PJ, 2002, ANN RHEUM DIS, V61, P298, DOI 10.1136/ard.61.4.298; Meednu N, 2016, ARTHRITIS RHEUMATOL, V68, P805, DOI 10.1002/art.39489; MIYAZONO K, 1991, EMBO J, V10, P1091, DOI 10.1002/j.1460-2075.1991.tb08049.x; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Nakhaei P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000650; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Novack DV, 2003, J EXP MED, V198, P771, DOI 10.1084/jem.20030116; OREFFO ROC, 1989, BIOCHEM BIOPH RES CO, V158, P817, DOI 10.1016/0006-291X(89)92795-2; OURSLER MJ, 1994, J BONE MINER RES, V9, P443; Pihusch V, 2005, THROMB RES, V116, P233, DOI 10.1016/j.thromres.2004.12.010; Ruocco MG, 2007, ADV EXP MED BIOL, V602, P125; Ruocco MG, 2005, J EXP MED, V201, P1677, DOI 10.1084/jem.20042081; Salmon CR, 2013, J PROTEOMICS, V91, P544, DOI 10.1016/j.jprot.2013.08.016; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Toossi Z, 1996, J IMMUNOL, V156, P3461; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394; Wong BR, 1998, J BIOL CHEM, V273, P28355, DOI 10.1074/jbc.273.43.28355; Xiao YC, 2013, NAT MED, V19, P595, DOI 10.1038/nm.3111; Xiu Y, 2014, J CLIN INVEST, V124, P297, DOI 10.1172/JCI66947; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yamashita T, 2007, J BIOL CHEM, V282, P18245, DOI 10.1074/jbc.M610701200; Yang C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015383; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yao ZQ, 2008, J BIOL CHEM, V283, P9917, DOI 10.1074/jbc.M706415200; Yao ZQ, 2009, J CLIN INVEST, V119, P3024, DOI 10.1172/JCI38716; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zhao BH, 2012, J EXP MED, V209, P319, DOI 10.1084/jem.20111566; Zhao BH, 2009, NAT MED, V15, P1066, DOI 10.1038/nm.2007; Zhao ZJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135728	65	41	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10169	10179		10.1074/jbc.M116.771816	http://dx.doi.org/10.1074/jbc.M116.771816			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28438834	Green Published, hybrid			2022-12-26	WOS:000403580600027
J	Bradshaw, NJ; Yerabham, ASK; Marreiros, R; Zhang, T; Nagel-Steger, L; Korth, C				Bradshaw, Nicholas J.; Yerabham, Antony S. K.; Marreiros, Rita; Zhang, Tao; Nagel-Steger, Luitgard; Korth, Carsten			An unpredicted aggregation-critical region of the actin-polymerizing protein TRIOBP-1/Tara, determined by elucidation of its domain structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR-DICHROISM SPECTROSCOPY; SECONDARY STRUCTURE ANALYSES; BINDING-PROTEIN; MENTAL DISEASE; COILED COILS; PREDICTION; SCHIZOPHRENIA; EXPRESSION; SEQUENCE; TARA	Aggregation of specific proteins in the brains of patients with chronic mental illness as a result of disruptions in proteostasis is an emerging theme in the study of schizophrenia in particular. Proteins including DISC1 (disrupted in schizophrenia 1) and dysbindin-1B are found in insoluble forms within brain homogenates from such patients. We recently identified TRIOBP-1 (Trio-binding protein 1, also known as Tara) to be another such protein through an epitope discovery and proteomics approach by comparing post-mortem brain material from schizophrenia patients and control individuals. We hypothesized that this was likely to occur as a result of a specific subcellular process and that it, therefore, should be possible to identify a region of the TRIOBP-1 protein that is essential for its aggregation to occur. Here, we probe the domain organization of TRIOBP-1, finding it to possess two distinct coiled-coil domains: the central and C-terminal domains. The central domain inhibits the depolymerization of F-actin and is also responsible for oligomerization of TRIOBP-1. Along with an N-terminal pleckstrin homology domain, the central domain affects neurite outgrowth. In neuroblastoma cells it was found that the aggregation propensity of TRIOBP-1 arises from its central domain, with a short "linker" region narrowed to within amino acids 324-348, between its first two coiled coils, as essential for the formation of TRIOBP-1 aggregates. TRIOBP-1 aggregation, therefore, appears to occur through one or more specific cellular mechanisms, which therefore have the potential to be of physiological relevance for the biological process underlying the development of chronic mental illness.	[Bradshaw, Nicholas J.; Yerabham, Antony S. K.; Marreiros, Rita; Korth, Carsten] Heinrich Heine Univ, Dept Neuropathol, D-40225 Dusseldorf, Germany; [Zhang, Tao; Nagel-Steger, Luitgard] Heinrich Heine Univ, Inst Phys Biol, D-40225 Dusseldorf, Germany; [Zhang, Tao; Nagel-Steger, Luitgard] Forschungszentrum Julich, Inst Complex Syst, Struct Biochem ICS 6, D-52425 Julich, Germany; [Bradshaw, Nicholas J.] Univ Rijeka, Dept Biotechnol, Rijeka 51000, Croatia	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; University of Rijeka	Bradshaw, NJ (corresponding author), Univ Rijeka, Dept Biotechnol, Rijeka 51000, Croatia.; Bradshaw, NJ (corresponding author), Sveuciliste Rijeci, Odjel Biotehnol, Radmile Matejcic 2, Rijeka 51000, Croatia.; Korth, C (corresponding author), Heinrich Heine Univ Dusseldorf, Inst Neuropathol, Moorenstr 5, D-40225 Dusseldorf, Germany.	nicholas.bradshaw@hhu.de; ckorth@hhu.de	Zhang, Tao/O-6541-2019; Nagel-Steger, Luitgard/H-6415-2013; Bradshaw, Nicholas J./A-5625-2009	Zhang, Tao/0000-0003-2970-0468; Nagel-Steger, Luitgard/0000-0001-5232-2149; Bradshaw, Nicholas J./0000-0001-5581-8828; Yerabham, Antony Sravan Kumar/0000-0003-4194-8386	Fritz Thyssen Stiftung [10.14.2.140]; Heinrich Heine University, Dusseldorf; Forschungskommission der Medizinischen Fakultat [9772547]; EU [60761]; Brain Behavior Research Foundation [20350]	Fritz Thyssen Stiftung; Heinrich Heine University, Dusseldorf; Forschungskommission der Medizinischen Fakultat; EU(European Commission); Brain Behavior Research Foundation(NARSAD)	This work was supported by the Fritz Thyssen Stiftung (10.14.2.140; to N. J. B.), the Heinrich Heine University, Dusseldorf (graduate school "iBrain" (to C. K.) and Grant 9772547 from the Forschungskommission der Medizinischen Fakultat; to N. J. B.), the EU Seventh Framework Program (MC-IN "INSENS" 60761; to C. K.), and the Brain Behavior Research Foundation (NARSAD Independent Investigator Award 20350 (to C. K.)). The authors declare that they have no conflicts of interest with the contents of this article.	Abdul-Gader A, 2011, BIOINFORMATICS, V27, P1630, DOI 10.1093/bioinformatics/btr234; Bader V, 2012, HUM MOL GENET, V21, P4406, DOI 10.1093/hmg/dds273; Bao JJ, 2013, BIOCHEMISTRY-US, V52, P5256, DOI 10.1021/bi400585h; Bradshaw NJ, 2017, CELL MOL LIFE SCI, V74, P1191, DOI 10.1007/s00018-016-2395-7; Bradshaw NJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111196; Brandon NJ, 2005, MOL CELL NEUROSCI, V28, P613, DOI 10.1016/j.mcn.2004.11.003; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Cenni V, 2003, CELL MOL LIFE SCI, V60, P2710, DOI 10.1007/s00018-003-3349-4; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Fang YP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-314; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Garbuzynskiy SO, 2010, BIOINFORMATICS, V26, P326, DOI 10.1093/bioinformatics/btp691; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Hong JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep31827; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kazmierczak M, 2017, J NEUROSCI, V37, P3447, DOI 10.1523/JNEUROSCI.2711-16.2017; Kitajiri S, 2010, CELL, V141, P786, DOI 10.1016/j.cell.2010.03.049; Korth C, 2012, PRION, V6, P134, DOI 10.4161/pri.18989; Lee SH, 2011, J CELL PHYSIOL, V226, P1850, DOI 10.1002/jcp.22510; Lee YJ, 2012, BBA-MOL CELL RES, V1823, P971, DOI 10.1016/j.bbamcr.2011.12.011; Leliveld SR, 2008, J NEUROSCI, V28, P3839, DOI 10.1523/JNEUROSCI.5389-07.2008; Leliveld SR, 2009, BIOCHEMISTRY-US, V48, P7746, DOI 10.1021/bi900901e; Li XX, 2007, PROTEIN EXPRES PURIF, V55, P84, DOI 10.1016/j.pep.2007.05.004; Linding R, 2004, J MOL BIOL, V342, P345, DOI 10.1016/j.jmb.2004.06.088; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; Maycox PR, 2009, MOL PSYCHIATR, V14, P1083, DOI 10.1038/mp.2009.18; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Nucifora Leslie G, 2016, Mol Neuropsychiatry, V2, P133; Ottis P, 2011, BIOL PSYCHIAT, V70, P604, DOI 10.1016/j.biopsych.2011.03.027; Riazuddin S, 2006, AM J HUM GENET, V78, P137, DOI 10.1086/499164; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seipel K, 2001, J CELL SCI, V114, P389; Shahin H, 2006, AM J HUM GENET, V78, P144, DOI 10.1086/499495; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simpson JC, 2000, EMBO REP, V1, P287, DOI 10.1093/embo-reports/kvd058; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Tamura M, 2011, PROTEIN EXPRES PURIF, V78, P1, DOI 10.1016/j.pep.2010.09.007; Trossbach SV, 2016, MOL PSYCHIATR, V21, P1561, DOI 10.1038/mp.2015.194; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Yang W, 2016, NEUROSCIENCE, V333, P78, DOI 10.1016/j.neuroscience.2016.07.008; Yano T, 2011, J CELL BIOL, V193, P319, DOI 10.1083/jcb.201009100; Yu J, 2008, BIOCHEM BIOPH RES CO, V367, P805, DOI 10.1016/j.bbrc.2008.01.022; Yu L, 2014, MOL PSYCHIATR, V19, P7, DOI 10.1038/mp.2012.192; Zhu CY, 2015, NEUROSCIENCE, V291, P301, DOI 10.1016/j.neuroscience.2015.02.016; Zhu Y, 2012, J NANOMATER, V2012, DOI 10.1155/2012/307496	48	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9583	9598		10.1074/jbc.M116.767939	http://dx.doi.org/10.1074/jbc.M116.767939			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28438837	Green Published, hybrid			2022-12-26	WOS:000403113000011
J	Lin, LF; Lo, LHY; Lyu, Q; Lai, KO				Lin, Lianfeng; Lo, Louisa Hoi-Ying; Lyu, Quanwei; Lai, Kwok-On			Determination of dendritic spine morphology by the striatin scaffold protein STRN4 through interaction with the phosphatase PP2A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRAGILE-X-SYNDROME; MESSENGER-RNA TRANSPORT; HIPPOCAMPAL-NEURONS; SYNAPTIC PLASTICITY; IN-VIVO; STRUCTURAL PLASTICITY; STE20-LIKE KINASE; AMPA RECEPTOR; PHOSPHORYLATION; AUTISM	Dendritic spines are heterogeneous and exist with various morphologies. Altered spine morphology might underlie the cognitive deficits in neurodevelopmental disorders such as autism, but how different subtypes of dendritic spines are selectively maintained along development is still poorly understood. Spine maturation requires spontaneous activity of N-methyl-D-aspartate (NMDA) receptor and local dendritic protein synthesis. STRN4 (also called zinedin) belongs to the striatin family of scaffold proteins, and some of the potential striatin-interacting proteins are encoded by autism risk genes. Although previous studies have demonstrated their localization in dendritic spines, the function of various striatin family members in the neuron remains unknown. Here, we demonstrate that Strn4 mRNA is present in neuronal dendrites, and the local expression of STRN4 protein depends on NMDA receptor activation. Notably, STRN4 is preferentially expressed in mushroom spines, and STRN4 specifically maintains mushroom spines but not thin spines and filopodia through interaction with the phosphatase PP2A. Our findings have therefore unraveled the local expression of STRN4 as a novel mechanism for the control of dendritic spine morphology.	[Lin, Lianfeng; Lo, Louisa Hoi-Ying; Lyu, Quanwei; Lai, Kwok-On] Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Lai, Kwok-On] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Lai, KO (corresponding author), Univ Hong Kong, Fac Med, Sch Biomed Sci, 21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.	laiko@hku.hk	Lai, Kwok On/ABC-8046-2021; Lai, Kwok-On/L-7468-2019	Lai, Kwok-On/0000-0002-4069-054X	Research Grants Council of Hong Kong General Research Fund [16100814, 17135816]; Early Career Scheme [27119715]; University of Hong Kong Seed Funding Programme for Basic Research [201407159004, 201511159170]	Research Grants Council of Hong Kong General Research Fund(Hong Kong Research Grants Council); Early Career Scheme; University of Hong Kong Seed Funding Programme for Basic Research(University of Hong Kong)	This work was supported by Research Grants Council of Hong Kong General Research Fund 16100814 and 17135816, Early Career Scheme Grant 27119715, and the University of Hong Kong Seed Funding Programme for Basic Research Grants 201407159004 and 201511159170. The authors declare that they have no conflicts of interest with the contents of this article.	An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Bar J, 2016, SCI REP-UK, V6, DOI 10.1038/srep37136; Benoist M, 2006, J PHYSIOL-PARIS, V99, P146, DOI 10.1016/j.jphysparis.2005.12.006; Benoist M, 2008, J NEUROCHEM, V106, P969, DOI 10.1111/j.1471-4159.2008.05448.x; Bhattacharya A, 2012, NEURON, V76, P325, DOI 10.1016/j.neuron.2012.07.022; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Butko MT, 2013, P NATL ACAD SCI USA, V110, pE726, DOI 10.1073/pnas.1300424110; Cajigas IJ, 2012, NEURON, V74, P453, DOI 10.1016/j.neuron.2012.02.036; Chen YK, 2012, MOL BIOL CELL, V23, P4383, DOI 10.1091/mbc.E12-05-0365; Chen YK, 2012, J NEUROSCI, V32, P1043, DOI 10.1523/JNEUROSCI.4405-11.2012; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; de Anda FC, 2012, NAT NEUROSCI, V15, P1022, DOI 10.1038/nn.3141; Dictenberg JB, 2008, DEV CELL, V14, P926, DOI 10.1016/j.devcel.2008.04.003; Doyle M, 2011, EMBO J, V30, P3540, DOI 10.1038/emboj.2011.278; Gaillard S, 2006, TRAFFIC, V7, P74, DOI 10.1111/j.1600-0854.2005.00363.x; Gardoni F, 2012, J CELL SCI, V125, P1401, DOI 10.1242/jcs.097576; Gordon J, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-54; Gross GG, 2013, NEURON, V78, P971, DOI 10.1016/j.neuron.2013.04.017; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Hwang JY, 2014, INT J BIOCHEM CELL B, V47, P118, DOI 10.1016/j.biocel.2013.11.021; Irwin SA, 2000, CEREB CORTEX, V10, P1038, DOI 10.1093/cercor/10.10.1038; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Kaminsky EB, 2011, GENET MED, V13, P777, DOI 10.1097/GIM.0b013e31822c79f9; Kang MG, 2009, P NATL ACAD SCI USA, V106, P3549, DOI 10.1073/pnas.0812861106; Kim H, 2016, J NEUROSCI, V36, P4888, DOI 10.1523/JNEUROSCI.4204-15.2016; Kim SH, 2008, P NATL ACAD SCI USA, V105, P4429, DOI 10.1073/pnas.0800257105; Lai KO, 2015, J BIOL CHEM, V290, P14637, DOI 10.1074/jbc.M114.627117; Lai KO, 2013, BBA-MOL BASIS DIS, V1832, P2257, DOI 10.1016/j.bbadis.2013.08.012; Lai KO, 2012, NAT NEUROSCI, V15, P1506, DOI 10.1038/nn.3237; Lai KO, 2009, BBA-MOL BASIS DIS, V1792, P741, DOI 10.1016/j.bbadis.2009.05.001; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liang ZY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13282; Liu XR, 2016, ADV MATER SCI ENG, V2016, DOI 10.1155/2016/7013032; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; McNair K, 2010, J NEUROSCI, V30, P3508, DOI 10.1523/JNEUROSCI.5386-09.2010; Moreno CS, 2000, J BIOL CHEM, V275, P5257, DOI 10.1074/jbc.275.8.5257; Muddashetty RS, 2011, MOL CELL, V42, P673, DOI 10.1016/j.molcel.2011.05.006; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Orefice LL, 2013, J NEUROSCI, V33, P11618, DOI 10.1523/JNEUROSCI.0012-13.2013; PAPA M, 1995, J NEUROSCI, V15, P1; Papa M, 1996, NEUROSCIENCE, V71, P1005, DOI 10.1016/0306-4522(95)00490-4; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Phillips M, 2015, NEUROSCI LETT, V601, P30, DOI 10.1016/j.neulet.2015.01.011; Pombo CM, 1996, EMBO J, V15, P4537, DOI 10.1002/j.1460-2075.1996.tb00831.x; Poon MM, 2006, J NEUROSCI, V26, P13390, DOI 10.1523/JNEUROSCI.3432-06.2006; Rochefort NL, 2012, EMBO REP, V13, P699, DOI 10.1038/embor.2012.102; Schouten M, 2014, JOVE-J VIS EXP, DOI 10.3791/51276; Spiga S, 2014, P NATL ACAD SCI USA, V111, pE3745, DOI 10.1073/pnas.1406768111; Spires TL, 2005, CEREB CORTEX, V15, P385, DOI 10.1093/cercor/bhh141; Strack S, 1997, J NEUROCHEM, V68, P2119; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; Taylor AM, 2009, J NEUROSCI, V29, P4697, DOI 10.1523/JNEUROSCI.6130-08.2009; Ultanir SK, 2014, NEURON, V84, P968, DOI 10.1016/j.neuron.2014.10.025; Verpelli C, 2010, J NEUROSCI, V30, P5830, DOI 10.1523/JNEUROSCI.0119-10.2010; Walsh CA, 2008, CELL, V135, P396, DOI 10.1016/j.cell.2008.10.015; Weyer SW, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-36; Yang K, 2013, BRAIN STRUCT FUNCT, V218, P669, DOI 10.1007/s00429-012-0420-7; Yoon YJ, 2016, P NATL ACAD SCI USA, V113, pE6877, DOI 10.1073/pnas.1614267113; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zagrebelsky M, 2005, J NEUROSCI, V25, P9989, DOI 10.1523/JNEUROSCI.2492-05.2005; Zhong J, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-17; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	66	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9451	9464		10.1074/jbc.M116.772442	http://dx.doi.org/10.1074/jbc.M116.772442			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28442576	hybrid, Green Published			2022-12-26	WOS:000403113000002
J	Barbier, E; Rochelet, M; Gal, L; Boschiroli, ML; Hartmann, A				Barbier, Elodie; Rochelet, Murielle; Gal, Laurent; Boschiroli, Maria Laura; Hartmann, Alain			Impact of temperature and soil type on Mycobacterium bovis survival in the environment	PLOS ONE			English	Article							MOLECULAR-DETECTION; RISK-FACTORS; DEER; PARATUBERCULOSIS; TRANSMISSION; INFECTION; CATTLE; VIABILITY; RECOVERY; CULTURE	Mycobacterium bovis, the causative agent of the bovine tuberculosis (bTB), mainly affects cattle, its natural reservoir, but also a wide range of domestic and wild mammals. Besides direct transmission via contaminated aerosols, indirect transmission of the M. bovis between wildlife and livestock might occur by inhalation or ingestion of environmental substrates contaminated through infected animal shedding. We monitored the survival of M. bovis in two soil samples chosen for their contrasted physical and-chemical properties (i.e. pH, clay content). The population of M. bovis spiked in sterile soils was enumerated by a culture-based method after 14, 30, 60, 90, 120 and 150 days of incubation at 4 degrees C and 22 degrees C. A qPCR based assay targeting the IS1561' locus was also performed to monitor M. bovis in both sterile and biotic spiked soils. The analysis of survival profiles using culture-based method showed that M. bovis survived longer at lower temperature (4 degrees C versus 22 degrees C) whereas the impact of soil characteristics on M. bovis persistence was not obvious. Furthermore, qPCR-based assay detected M. bovis for a longer period of time than the culture based method with higher gene copy numbers observed in sterile soils than in biotic ones. Impact of soil type on M. bovis persistence need to be deepened in order to fill the gap of knowledge concerning indirect transmission of the disease.	[Barbier, Elodie; Rochelet, Murielle; Gal, Laurent; Hartmann, Alain] Univ Bourgogne Franche Comte, AgroSup Dijon, Agroecol, INRA, Dijon, France; [Boschiroli, Maria Laura] Univ Paris Est, Lab Natl Reference TB, Lab Sante Anim, Unite Zoonoses Bacteriennes,ANSES, Maisons Alfort, France	INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Sante Animale de Maisons-Alfort; Ecole Nationale Veterinaire d'Alfort (ENVA)	Hartmann, A (corresponding author), Univ Bourgogne Franche Comte, AgroSup Dijon, Agroecol, INRA, Dijon, France.	alain.hartmann@inra.fr	Hartmann, Alain/B-7862-2018; gal, laurent/A-2824-2011; Boschiroli, Maria Laura/AAR-3319-2021; Barbier, Elodie/ABF-6914-2021	Hartmann, Alain/0000-0001-6034-5068; gal, laurent/0000-0001-6598-7262; 	Conseil Regional de Bourgogne Franche Comte and FEADER [2012-9205AA0033S04910]; Conseil Departmental de la Cote d'Or; Laboratoire Departemental d'Analyse de la Cote d'Or	Conseil Regional de Bourgogne Franche Comte and FEADER; Conseil Departmental de la Cote d'Or; Laboratoire Departemental d'Analyse de la Cote d'Or	Elodier Barbier had a Doctoral fellowship financed by the Conseil Regional de Bourgogne Franche Comte and FEADER Grant# 2012-9205AA0033S04910. This work was also supported by The Conseil Departmental de la Cote d'Or, the Laboratoire Departemental d'Analyse de la Cote d'Or. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.The order of reference cited has been corrected, some numbers carried over during successive amendments were removed.; Elodier Barbier had a Doctoral fellowship financed by the Conseil Regional de Bourgogne Franche Comte and FEADER. This work was also supported by The Conseil Departmental de la Cote d'Or, the Laboratoire Departemental d'Analyse de la Cote d'Or. The authors wish to thank Dr. Eric Gueneau (Director of the Laboratoire Departemental de la Cote d'Or) and Pr. Catherine Neuwirth (Bacteriology Department, University Hospital Dijon) for their invaluable help and discussions.	Adams AP, 2013, APPL ENVIRON MICROB, V79, P6501, DOI 10.1128/AEM.02032-13; Alvarez AH, 2009, VET RES, V40, DOI 10.1051/vetres/2009005; Barasona JA, 2015, TRANSBOUND EMERG DIS; Barbier E, 2016, J APPL MICROBIOL; Biet F, 2005, VET RES, V36, P411, DOI 10.1051/vetres:2005001; Corner LAL, 2012, VET J, V194, P166, DOI 10.1016/j.tvjl.2012.03.013; Courtenay O., 2006, BIOL LETT, V71, P1946; DUFFIELD BJ, 1985, VET MICROBIOL, V10, P193, DOI 10.1016/0378-1135(85)90021-5; Fine Amanda E, 2011, Vet Med Int, V2011, P765430, DOI 10.4061/2011/765430; Ghodbane R, 2014, MICROBIOL-SGM, V160, P496, DOI 10.1099/mic.0.073379-0; Hauer A, 2015, PLOS ONE, V6, P1; Jackson R, 1995, NEW ZEAL VET J, V43, P346, DOI 10.1080/00480169./1995.35918; Johnson-Ifearulundu Y, 1999, AM J VET RES, V60, P589; LITTLE TWA, 1982, VET REC, V111, P550; Locatelli A, 2013, J MICROBIOL METH, V93, P242, DOI 10.1016/j.mimet.2013.03.017; MORRIS RS, 1994, VET MICROBIOL, V40, P153, DOI 10.1016/0378-1135(94)90053-1; Palmer MV, 2013, TRANSBOUND EMERG DIS, V60, P1, DOI 10.1111/tbed.12115; Palmer MV, 2006, J WILDLIFE DIS, V42, P853, DOI 10.7589/0090-3558-42.4.853; Palmer MV, 2004, AM J VET RES, V65, P1483, DOI 10.2460/ajvr.2004.65.1483; Palmer MV, 2001, AM J VET RES, V62, P692, DOI 10.2460/ajvr.2001.62.692; Perez-Lago L, 2014, RES VET SCI, V97, pS94, DOI 10.1016/j.rvsc.2013.11.008; Phillips CJC, 2003, RES VET SCI, V74, P1, DOI 10.1016/S0034-5288(02)00145-5; Reviriego FJ, 2000, PREV VET MED, V43, P43, DOI 10.1016/S0167-5877(99)00069-0; Santos N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142079; Sweeney FP, 2007, APPL ENVIRON MICROB, V73, P7471, DOI 10.1128/AEM.00978-07; Sweeney FP, 2006, LETT APPL MICROBIOL, V43, P364, DOI 10.1111/j.1472-765X.2006.01983.x; Tanner M, 1999, ONDERSTEPOORT J VET, V66, P185; Vicente J, 2007, VET RES, V38, P451, DOI 10.1051/vetres:2007002; Walter WD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090925; Ward MP, 2004, AM J VET RES, V65, P10, DOI 10.2460/ajvr.2004.65.10; Whittington RJ, 2004, APPL ENVIRON MICROB, V70, P2989, DOI 10.1128/AEM.70.5.2989-3004.2004; Williams RS, 1930, J HYG-CAMBRIDGE, V30, P413, DOI 10.1017/S0022172400010561; Young JS, 2005, APPL ENVIRON MICROB, V71, P1946, DOI 10.1128/AEM.71.4.1946-1952.2005; Zheng QW, 2013, J FOOD PROTECT, V76, P1963, DOI 10.4315/0362-028X.JFP-13-041	34	15	15	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176315	10.1371/journal.pone.0176315	http://dx.doi.org/10.1371/journal.pone.0176315			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448585	Green Submitted, Green Published, gold			2022-12-26	WOS:000400383600058
J	Fernstrom, J; Westrin, A; Grudet, C; Traskman-Bendz, L; Brundin, L; Lindqvist, D				Fernstrom, Johan; Westrin, Asa; Grudet, Cecile; Traskman-Bendz, Lil; Brundin, Lena; Lindqvist, Daniel			Six autoantibodies associated with autoimmune encephalitis are not detectable in the cerebrospinal fluid of suicide attempters	PLOS ONE			English	Article							RECEPTOR-ENCEPHALITIS; NMDA RECEPTOR; IMMUNOGLOBULIN-G; ANTIBODY-TITERS; FOLLOW-UP; SCHIZOPHRENIA; PREVALENCE; DEPRESSION; DISEASE; DISORDERS	Previous findings suggest a link between neuroinflammatory processes and suicidality. Despite several lines of evidence supporting this link, including increased pro-inflammatory markers in blood-, cerebrospinal fluid (CSF)-and in post-mortem brain samples from suicidal individuals, the underlying mechanisms remain poorly understood. In this pilot study, we explored the possibility that autoimmune encephalopathies might be found among suicide attempters. We analysed the presence of six different autoantibodies (N-methyl-Daspartate receptor, the a-amino-3-hydroxy-5-methyl-4-isoxazol-propionic acid receptor, the.-amino-butyric acid B-receptor, the leucine-rich, glioma-inactivated 1, the contactin-associated protein-like 2, and the dipeptidyl-peptidase-like protein-6), all previously associated with psychopathology, in CSF samples from 29 unmedicated suicide attempters. Five of these subjects had high CSF/serum albumin ratio, indicative of increased blood-brain-barrier permeability. We were not able to detect any of these autoantibodies in the CSF samples. These pilot data do not support a role for autoimmune encephalopathies in suicidal behaviour, although the presence of lower levels of these autoantibodies cannot be ruled out in these patients.	[Fernstrom, Johan; Westrin, Asa; Grudet, Cecile; Traskman-Bendz, Lil; Lindqvist, Daniel] Lund Univ, Dept Clin Sci Lund, Psychiat, Lund, Sweden; [Fernstrom, Johan; Westrin, Asa; Lindqvist, Daniel] Psychiat Clin, Div Psychiat, Lund, Sweden; [Brundin, Lena] Van Andel Res Inst, Ctr Neurodegenerat Sci, Lab Psychiat & Behav Med, Grand Rapids, MI USA; [Lindqvist, Daniel] Univ Calif San Francisco, Sch Med, Dept Psychiat, San Francisco, CA USA	Lund University; Van Andel Institute; University of California System; University of California San Francisco	Fernstrom, J (corresponding author), Lund Univ, Dept Clin Sci Lund, Psychiat, Lund, Sweden.; Fernstrom, J (corresponding author), Psychiat Clin, Div Psychiat, Lund, Sweden.	johan.fernstrom@med.lu.se		Brundin, Lena/0000-0002-8327-6242; Grudet, Cecile/0000-0001-6648-0236; Fernstrom, Johan/0000-0002-3346-0439	Swedish Research Council [2015-00387]; Marie Sklodowska Curie Actions [INCA 600398]; Swedish Society of Medicine; Soderstrom-Konigska Foundation; Sjobring Foundation; OM Persson Foundation; province of Scania (Sweden) state grants (ALF)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Marie Sklodowska Curie Actions; Swedish Society of Medicine; Soderstrom-Konigska Foundation; Sjobring Foundation; OM Persson Foundation; province of Scania (Sweden) state grants (ALF)	This study was supported by the Swedish Research Council (registration number 2015-00387) (DL), Marie Sklodowska Curie Actions, Cofund (Project INCA 600398) (DL), the Swedish Society of Medicine (DL), the Soderstrom-Konigska Foundation (DL), the Sjobring Foundation (DL), OM Persson Foundation and the province of Scania (Sweden) state grants (ALF) (DL, AW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Swedish Research Council (registration number 2015-00387), Marie Sklodowska Curie Actions, Cofund (Project INCA 600398), the Swedish Society of Medicine, the Soderstrom-Konigska Foundation, the Sjobring Foundation, OM Persson Foundation and the province of Scania (Sweden) state grants (ALF).	Arling TA, 2009, J NERV MENT DIS, V197, P905, DOI 10.1097/NMD.0b013e3181c29a23; BayardBurfield L, 1996, EUR NEUROPSYCHOPHARM, V6, P195, DOI 10.1016/0924-977X(96)00020-X; Beck AT, 1973, SUICIDE PREVENTION 7, P7; Bergquist J, 2002, EUR NEUROPSYCHOPHARM, V12, P153, DOI 10.1016/S0924-977X(02)00002-0; Black C, 2015, BIOL PSYCHIAT, V78, P28, DOI 10.1016/j.biopsych.2014.10.014; BLENNOW K, 1993, EUR NEUROL, V33, P129, DOI 10.1159/000116919; Brundin L, 2015, ACTA PSYCHIAT SCAND, V132, P192, DOI 10.1111/acps.12458; Dalmau J, 2007, ANN NEUROL, V61, P25, DOI 10.1002/ana.21050; Dieperink E, 2004, GEN HOSP PSYCHIAT, V26, P237, DOI 10.1016/j.genhosppsych.2004.01.003; Fredrikson S, 2003, NEUROEPIDEMIOLOGY, V22, P146, DOI 10.1159/000068746; Gresa-Arribas N, 2014, LANCET NEUROL, V13, P167, DOI 10.1016/S1474-4422(13)70282-5; Hammer C, 2014, MOL PSYCHIATR, V19, P1143, DOI 10.1038/mp.2013.110; Isung J, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.113; Janelidze S, 2011, BRAIN BEHAV IMMUN, V25, P335, DOI 10.1016/j.bbi.2010.10.010; JANSSEN HLA, 1994, J HEPATOL, V21, P241, DOI 10.1016/S0168-8278(05)80402-7; Kayser MS, 2011, CURR PSYCHIATRY REV, V7, P189, DOI 10.2174/157340011797183184; Kayser MS, 2011, J NEUROPSYCH CLIN N, V23, P90, DOI 10.1176/appi.neuropsych.23.1.90; Kruse JL, 2015, PSYCHOSOMATICS, V56, P227, DOI 10.1016/j.psym.2015.01.003; Kuo CJ, 2010, AM J PSYCHIAT, V167, P1092, DOI 10.1176/appi.ajp.2010.09101455; Leypoldt F, 2015, ANN NY ACAD SCI, V1338, P94, DOI 10.1111/nyas.12553; Lindqvist D, 2009, BIOL PSYCHIAT, V66, P287, DOI 10.1016/j.biopsych.2009.01.030; Ludvigsson JF, 2011, DIGEST LIVER DIS, V43, P616, DOI 10.1016/j.dld.2011.02.009; Masdeu JC, 2012, AM J PSYCHIAT, V169, P1120, DOI 10.1176/appi.ajp.2012.12050646; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; NASSBERGER L, 1993, ACTA PSYCHIAT SCAND, V88, P48, DOI 10.1111/j.1600-0447.1993.tb03412.x; Pedersen MG, 2012, ARCH GEN PSYCHIAT, V69, P1123, DOI 10.1001/archgenpsychiatry.2012.668; Postolache TT, 2005, MOL PSYCHIATR, V10, P232, DOI 10.1038/sj.mp.4001620; Raison CL, 2005, J CLIN PSYCHIAT, V66, P41, DOI 10.4088/JCP.v66n0106; Rhoads J, 2011, SCHIZOPHR RES, V129, P213, DOI 10.1016/j.schres.2010.12.018; Spitzer RL, 1987, DIAGNOSTIC STAT MANU, Vxxix; Steiner J, 2008, J PSYCHIATR RES, V42, P151, DOI 10.1016/j.jpsychires.2006.10.013; Steiner J, 2013, JAMA PSYCHIAT, V70, P271, DOI 10.1001/2013.jamapsychiatry.86; Tonelli LH, 2008, ACTA PSYCHIAT SCAND, V117, P198, DOI 10.1111/j.1600-0447.2007.01128.x; TRASKMAN L, 1981, ARCH GEN PSYCHIAT, V38, P631; Wandinger K-P, 2011, NEUE SEROLOGISCHE MA, P329; Wingfield T, 2011, QJM-INT J MED, V104, P921, DOI 10.1093/qjmed/hcr111; Xie LF, 2012, RHEUMATOL INT, V32, P2707, DOI 10.1007/s00296-011-2043-3; Zandi MS, 2011, J NEUROL, V258, P686, DOI 10.1007/s00415-010-5788-9; Zhang YF, 2012, J CLIN PSYCHIAT, V73, P1069, DOI 10.4088/JCP.11m07532	39	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176358	10.1371/journal.pone.0176358	http://dx.doi.org/10.1371/journal.pone.0176358			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET6EL	28448609	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383600067
J	Raymond, CK; Hernandez, J; Karr, R; Hill, K; Li, M				Raymond, Christopher K.; Hernandez, Jennifer; Karr, Reynold; Hill, Kay; Li, Mark			Collection of cell-free DNA for genomic analysis of solid tumors in a clinical laboratory setting	PLOS ONE			English	Article							CIRCULATING DNA; CANCER-PATIENTS; PLASMA; LONG	The breadth of diagnostic procedures that utilize cell free DNA (cfDNA) from human plasma has increased dramatically in recent years. Here, we confirm that tumor-derived cfDNA fragments are similar in size distribution to cfDNA derived from normal tissues. Therefore, collection procedures optimized with healthy donor specimens are likely to be applicable to the diagnosis and monitoring of many different cancer types. We verify that the distribution and DNA sequences of fragmentation sites in cfDNA from both normal-germline and tumor-derived cfDNA are non-random. A broad survey of cfDNA from healthy donors suggests that average individuals possess similar to 6 ng of cfDNA per mL of plasma. Importantly, the cfDNA present in plasma samples that were initially collected as whole blood in K2-EDTA tubes and subsequently processed by centrifugation is stable for several days at ambient temperatures. This observation has the potential to significantly reduce the cost and logistical complexity of shipping clinical samples from the site of collection to centers proficient in diagnostic analysis. Finally, plasma samples collected with high-volume plasma collection devices possess abundant quantities of cfDNA. Since the quantity of analyzed cfDNA is directly proportional to sensitivity of diagnostic assays, this method of plasma collection, where available, could enable highly sensitive post-treatment disease monitoring and early detection of cancer in at-risk individuals.	[Raymond, Christopher K.; Hernandez, Jennifer; Li, Mark] Resolut Biosci, Bellevue, WA 98005 USA; [Karr, Reynold; Hill, Kay] PlasmaLab Int, Everett, WA USA; [Karr, Reynold] Univ Washington, Dept Rheumatol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Raymond, CK (corresponding author), Resolut Biosci, Bellevue, WA 98005 USA.	craymond@resolutionbio.com			Plasma Lab International; Resolution Bioscience	Plasma Lab International; Resolution Bioscience	Funding for this study was provided jointly by Plasma Lab International and by Resolution Bioscience. These entities provided the resources necessary to conduct this study in the form of materials, supplies and salaries. All of the authors are employees and/or owners of these entities, as detailed below. All of the authors listed below made substantial contributions to the study. CKR is a co-founder and employee of Resolution Bioscience, and has an ownership stake in RB. JH is an employee of Resolution Bioscience and has an ownership stake in RB. RK is an owner and employee of Plasma Lab International and has an ownership stake in PLI. KH is an owner and director of Plasma Lab International and has an ownership stake in PLI. ML is a co-founder and employee of Resolution Bioscience and has an ownership stake in RB. The funder provided support in the form of salaries for authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Benlloch S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089518; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Bronkhorst AJ, 2016, BBA-MOL CELL RES, V1863, P157, DOI 10.1016/j.bbamcr.2015.10.022; Chandrananda D, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0107-z; Delgado PO, 2013, TUMOR BIOL, V34, P983, DOI 10.1007/s13277-012-0634-6; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Jahr S, 2001, CANCER RES, V61, P1659; Jiang PY, 2016, TRENDS GENET, V32, P360, DOI 10.1016/j.tig.2016.03.009; Jiang PY, 2015, P NATL ACAD SCI USA, V112, pE1317, DOI 10.1073/pnas.1500076112; Kang Q, 2016, CLIN BIOCHEM, V49, P1354, DOI 10.1016/j.clinbiochem.2016.03.012; LEON SA, 1977, CANCER RES, V37, P646; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Medina Diaz I, 2016, PLOS ONE, V11; Oxnard GR, 2016, JAMA ONCOL; Paweletz CP, 2016, CLIN CANCER RES, V22, P915, DOI 10.1158/1078-0432.CCR-15-1627-T; Shoemaker DD, 1996, NAT GENET, V14, P450, DOI 10.1038/ng1296-450; Snyder MW, 2016, CELL, V164, P57, DOI 10.1016/j.cell.2015.11.050; Sozzi G, 2001, CANCER RES, V61, P4675; Thierry AR, 2016, CANCER METAST REV, V35, P347, DOI 10.1007/s10555-016-9629-x; Underhill HR, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006162	20	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176241	10.1371/journal.pone.0176241	http://dx.doi.org/10.1371/journal.pone.0176241			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448587	Green Published, gold			2022-12-26	WOS:000400383600051
J	Yin, W; Clare, K; Zhang, QJ; Volkow, ND; Du, CW				Yin, Wei; Clare, Kevin; Zhang, Qiujia; Volkow, Nora D.; Du, Congwu			Chronic cocaine induces HIF-VEGF pathway activation along with angiogenesis in the brain	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CEREBRAL-BLOOD-FLOW; FACTOR EXPRESSION; NITRIC-OXIDE; THERAPEUTIC ANGIOGENESIS; ISCHEMIA; DYSFUNCTION; MYOCARDIUM; ABSTINENCE; RECEPTORS	Cocaine induces vasoconstriction in cerebral vessels, which with repeated use can result in transient ischemic attacks and cerebral strokes. However, the neuroadaptations that follow cocaine's vasoconstricting effects are not well understood. Here, we investigated the effects of chronic cocaine exposure (2 and 4 weeks) on markers of vascular function and morphology in the rat brain. For this purpose we measured nitric oxide (NO) concentration in plasma, brain neuronal nitric oxide synthase (nNOS or NOS1), HIF-1 alpha, and VEGF expression in different brain regions, i.e., middle prefrontal cortex, somatosensory cortex, nucleus accumbens, and dorsal striatum, using ELISA or Western blot. Additionally, microvascular density in these brain regions was measured using immunofluorescence microscopy. We showed that chronic cocaine significantly affected NOS1, HIF-1 alpha and VEGF expression, in a regionand cocaine treatment-time-dependent manner. Cerebral microvascular density increased significantly in parallel to these neurochemical changes. Furthermore, significant correlations were detected between VEGF expression and microvascular density in cortical regions (middle prefrontal cortex and somatosensory cortex), but not in striatal regions (nucleus accumbens and dorsal striatum). These results suggest that following chronic cocaine use, as cerebral ischemia developed, NOS1, the regulatory protein to counteract blood vessel constriction, was upregulated; meanwhile, the HIF-VEGF pathway was activated to increase microvascular density (i.e., angiogenesis) and thus restore local blood flow and oxygen supply. These physiological responses were triggered presumably as an adaptation to minimize ischemic injury caused by cocaine. Therefore, effectively promoting such physiological responses may provide novel and effective therapeutic solutions to treat cocaine-induced cerebral ischemia and stroke.	[Yin, Wei; Clare, Kevin; Zhang, Qiujia; Du, Congwu] SUNY Stony Brook, Biomed Engn Dept, Stony Brook, NY 11794 USA; [Volkow, Nora D.] NIAAA, NIH, Bethesda, MD USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Yin, W (corresponding author), SUNY Stony Brook, Biomed Engn Dept, Stony Brook, NY 11794 USA.	wei.yin@stonybrook.edu			National Institutes of Health (NIH) [1R01DA029718, R21DA042597]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA029718, R21DA042597] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study is in part supported by National Institutes of Health (NIH) grants 1R01DA029718 (CD & YP), R21DA042597 (YP & CD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Agharahimi M, 2014, FASEB J S, V28; Argaw AT, 2012, J CLIN INVEST, V122, P2454, DOI 10.1172/JCI60842; BANAI S, 1994, CIRCULATION, V89, P2183, DOI 10.1161/01.CIR.89.5.2183; Beck H, 2009, ACTA NEUROPATHOL, V117, P481, DOI 10.1007/s00401-009-0483-6; BOOCOCK CA, 1995, JNCI-J NATL CANCER I, V87, P506, DOI 10.1093/jnci/87.7.506; Chaitanya GV, 2013, AM J PATHOL, V183, P1010, DOI 10.1016/j.ajpath.2013.06.009; CHEN HH, 1994, STROKE, V25, P1651, DOI 10.1161/01.STR.25.8.1651; Dery MAC, 2005, INT J BIOCHEM CELL B, V37, P535, DOI 10.1016/j.biocel.2004.08.012; Dore-Duffy P, 2007, NEUROL RES, V29, P395, DOI 10.1179/016164107X204729; Fan YF, 2007, J NEUROIMMUNE PHARM, V2, P284, DOI 10.1007/s11481-007-9073-3; FRANK S, 1995, J BIOL CHEM, V270, P12607, DOI 10.1074/jbc.270.21.12607; Garry PS, 2015, EXP NEUROL, V263, P235, DOI 10.1016/j.expneurol.2014.10.017; Gerstner ER, 2009, NAT REV CLIN ONCOL, V6, P229, DOI 10.1038/nrclinonc.2009.14; Guo H, 2016, NEURAL REGEN RES, V11, P174, DOI 10.4103/1673-5374.175067; Hai J, 2003, NEUROSURGERY, V53, P963, DOI 10.1227/01.NEU.0000083594.10117.7A; Hayashi T, 2006, CURR NEUROVASC RES, V3, P119, DOI 10.2174/156720206776875902; He ZH, 2006, ARTERIOSCL THROM VAS, V26, P787, DOI 10.1161/01.ATV.0000209500.15801.4e; IIJIMA K, 1993, KIDNEY INT, V44, P959, DOI 10.1038/ki.1993.337; Itakura J, 2000, INT J CANCER, V85, P27; Johnson B, 1998, NEUROPSYCHOPHARMACOL, V18, P377; Josko J, 2004, MED SCI MONITOR, V10, pRA89; KAROUM F, 1994, BRIT J PHARMACOL, V113, P1391; Koh WCA, 2008, BIOSENS BIOELECTRON, V23, P1374, DOI 10.1016/j.bios.2007.12.008; Kosten TR, 1998, DRUG ALCOHOL DEPEN, V50, P187, DOI 10.1016/S0376-8716(98)00038-6; KRUPINSKI J, 1994, STROKE, V25, P1794, DOI 10.1161/01.STR.25.9.1794; Lai H, 2015, J ADDICT MED, V9, P331, DOI 10.1097/ADM.0000000000000140; Lee Dong Kun, 2011, Exp Neurobiol, V20, P116, DOI 10.5607/en.2011.20.2.116; Lee DK, 2010, PSYCHOPHARMACOLOGY, V208, P245, DOI 10.1007/s00213-009-1724-z; LEVINE SR, 1988, STROKE, V19, P779, DOI 10.1161/01.STR.19.6.779; LEVINE SR, 1991, NEUROLOGY, V41, P1173, DOI 10.1212/WNL.41.8.1173; Marti HH, 2000, AM J PATHOL, V156, P965, DOI 10.1016/S0002-9440(10)64964-4; Massardo T, 2015, J ADDICT MED, V9, P139, DOI 10.1097/ADM.0000000000000109; Mo W, 1998, AM J HYPERTENS, V11, P708, DOI 10.1016/S0895-7061(98)00041-7; Ren H, 2012, MOL PSYCHIATR, V17, P1017, DOI 10.1038/mp.2011.160; Sammut S, 2008, SYNAPSE, V62, P710, DOI 10.1002/syn.20537; Scott A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011863; Siuta M, 2013, NEUROLOGY RES INT, V2013, P11; SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410, DOI 10.1002/jlb.55.3.410; TAKESHITA S, 1994, J CLIN INVEST, V93, P662, DOI 10.1172/JCI117018; Treadwell SD, 2007, POSTGRAD MED J, V83, P389, DOI 10.1136/pgmj.2006.055970; Tsuchiya T, 1997, BRAIN RES, V776, P68, DOI 10.1016/S0006-8993(97)00942-6; Verheul HMW, 1997, CLIN CANCER RES, V3, P2187; Vitcheva V, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/157876; VOLKOW ND, 1988, BRIT J PSYCHIAT, V152, P641, DOI 10.1192/bjp.152.5.641; Weidemann A, 2010, GLIA, V58, P1177, DOI 10.1002/glia.20997; You J, 2014, BIOMED OPT EXPRESS, V5, P3217, DOI 10.1364/BOE.5.003217; Zhang AM, 2012, MOL MED REP, V6, P1315, DOI 10.3892/mmr.2012.1069; Zhang QJ, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.2.026006; Zhao H, 2011, HUM GENE THER, V22, P207, DOI 10.1089/hum.2010.111; Ziello Jennifer E, 2007, Yale J Biol Med, V80, P51	50	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0175499	10.1371/journal.pone.0175499	http://dx.doi.org/10.1371/journal.pone.0175499			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448515	Green Submitted, Green Published, gold			2022-12-26	WOS:000400383600015
J	Pedroso, J; Toral, N; Gubert, MB				Pedroso, Jessica; Toral, Natacha; Gubert, Muriel Bauermann			Maternal perception of children's nutritional status in the Federal District, Brazil	PLOS ONE			English	Article							SELF-REPORTED WEIGHT; MOTHERS PERCEPTIONS; FEEDING PRACTICES; DETERMINANTS; ASSOCIATION; OVERWEIGHT; CHILDHOOD; VALIDITY; OBESITY; HEIGHT	Maternal perception of child's nutritional status has a potential impact on the identification, prevention, and treatment of childhood overweight. Thus, the aim of this study was to evaluate the prevalence of misperception and factors associated with maternal perception of the nutritional status of first-to third-grade elementary school students from private schools in the Federal District, Brazil. This cross- sectional study was conducted with 554 mother-child pairs. Children's nutritional status was assessed by measuring their weight and height. The mothers completed an online questionnaire about sociodemographic data, maternal nutritional status, maternal perception of her own nutritional status (silhouette scale for female adults), and maternal perception of child's nutritional status (silhouette scale for children). Only 30.0% of the mothers were successful in choosing the most appropriate silhouette to represent child's nutritional status. Highly educated mothers (Adjusted OR = 1.51) and mothers of male children (Adjusted OR = 2.53) or of non-overweight children (Adjusted OR = 1.65) were more likely to underestimate child's nutritional status. Conversely, mothers below 35 years of age (Adjusted OR = 1.85) and mothers of female children (Adjusted OR = 2.24) or of overweight children (Adjusted OR = 1.94) were more likely to overestimate child's nutritional status. There was a high prevalence of misperception, which shows the need for interventions for children that take into account the relevance of mother's role and the adequate recognition of child's nutritional status.	[Pedroso, Jessica; Toral, Natacha; Gubert, Muriel Bauermann] Univ Brasilia, Postgrad Program Human Nutr, Brasilia, DF, Brazil	Universidade de Brasilia	Pedroso, J (corresponding author), Univ Brasilia, Postgrad Program Human Nutr, Brasilia, DF, Brazil.	jessicapedroso1211@gmail.com		Pedroso, Jessica/0000-0001-5446-4319; Gubert, Muriel/0000-0002-0103-4187				Alm S, 2015, APPETITE, V89, P112, DOI 10.1016/j.appet.2015.02.002; Rivera JA, 2014, LANCET DIABETES ENDO, V2, P321, DOI 10.1016/S2213-8587(13)70173-6; Aparicio G, 2013, ATENCION PRIMARIA S2, V45; Arpini LdSB, 2014, REV BRASILEIRA PESQU, V16, P140; Bernardo Carla de O., 2012, Rev. bras. epidemiol., V15, P651, DOI 10.1590/S1415-790X2012000300018; Binkin N, 2013, NUTR METAB CARDIOVAS, V23, P410, DOI 10.1016/j.numecd.2011.09.006; Molina MDB, 2009, CAD SAUDE PUBLICA, V25, P2285, DOI 10.1590/S0102-311X2009001000018; Camara Interministerial de Seguranca Alimentar e Nutricional (CAISAN), 2014, ESTR INT PREV CONTR; Conde WL, 2014, AM J CLIN NUTR, V100, p1617S, DOI 10.3945/ajcn.114.084764; da Fonseca MDJM, 2004, REV SAUDE PUBL, V38, P392; Francescatto C, 2014, J PEDIAT-BRAZIL, V90, P332, DOI 10.1016/j.jped.2014.01.009; Giacomossi MC, REV NUTR; Peixoto MDG, 2006, REV SAUDE PUBL, V40, P1065, DOI 10.1590/S0034-89102006000700015; Guevara-Cruz M, 2012, NUTR HOSP, V27, P209, DOI [10.3305/nh.2012.27.1.5411, 10.1590/S0212-16112012000100026]; Hochdorn A, 2016, J HLTH PSYCHOL  1106; Hochdorn A, 2014, INDIAN J PEDIATR, V81, pS39, DOI 10.1007/s12098-014-1464-x; Instituto Brasileiro de Geografia e Estat A o stica, 2010, CENS DEM 2010 ED; Instituto Brasileiro de Geografia e Estat o A stica, 2010, PESQ ORC FAM 2008 20; Instituto Brasileiro de Geografia e Estatistica, 2010, CENS DEM 2010 CAR GE; Kakeshita Idalina Shiraishi, 2009, Psic.: Teor. e Pesq., V25, P263, DOI 10.1590/S0102-37722009000200015; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Larsen PS, 2015, HARVARD REV PSYCHIAT, V23, P395, DOI 10.1097/HRP.0000000000000073; Lazzeri G, 2006, J Prev Med Hyg, V47, P16; LdSB Arpini, 2015, DEMETRA, V10, P891; Loth KA, 2013, APPETITE, V60, P140, DOI 10.1016/j.appet.2012.09.019; Manios Y, 2010, J AM DIET ASSOC, V110, P1527, DOI 10.1016/j.jada.2010.07.004; McCabe MP, 2005, J APPL DEV PSYCHOL, V26, P559, DOI 10.1016/j.appdev.2005.06.007; Ministerio da Educac, 2015, CART NAC AL ESC; Ministerio da Saude Ministerio da Educac, 2015, CAD GEST PROGR SAUD; Ministerio da Saude Nacional de Saude Supplementar, 2015, VIG FAT RISC PROT DO; Moraes André Guerra Esteves de, 2014, Nova econ., V24, P409, DOI 10.1590/0103-6351/1564; Parkinson KN, 2013, CHILD CARE HLTH DEV, V39, P722, DOI 10.1111/cch.12000; Rietmeijer-Mentink M, 2013, MATERN CHILD NUTR, V9, P3, DOI 10.1111/j.1740-8709.2012.00462.x; Rosas LG, 2010, MATERN CHILD HLTH J, V14, P886, DOI 10.1007/s10995-009-0534-6; Sahoo Krushnapriya, 2015, J Family Med Prim Care, V4, P187, DOI 10.4103/2249-4863.154628; Scaglioni S, 2011, AM J CLIN NUTR, V94, p2006S, DOI 10.3945/ajcn.110.001685; Trude ACB, PRATICA ATIVIDADE FI; Warschburger P, 2009, PEDIATRICS, V124, pE60, DOI 10.1542/peds.2008-1845; Webber L, 2010, AM J CLIN NUTR, V92, P1423, DOI 10.3945/ajcn.2010.30112; WHO, 2009, ANTHROPLUS PERS COMP; WHO, 1997, WHO TECHN REP SER; World Health Organization, 2018, OB OV FACT SHEET 311; World Health Organization (WHO), 2007, GROWTH REF 5 19 YEAR	43	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176344	10.1371/journal.pone.0176344	http://dx.doi.org/10.1371/journal.pone.0176344			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET5FI	28445494	Green Published, gold, Green Submitted			2022-12-26	WOS:000400309200047
J	Gunnala, V; Melnick, A; Irani, M; Reichman, D; Schattman, G; Davis, O; Rosenwaks, Z				Gunnala, Vinay; Melnick, Alexis; Irani, Mohamad; Reichman, David; Schattman, Glenn; Davis, Owen; Rosenwaks, Zev			Sliding scale HCG trigger yields equivalent pregnancy outcomes and reduces ovarian hyperstimulation syndrome: Analysis of 10,427 IVF-ICSI cycles	PLOS ONE			English	Article							HUMAN CHORIONIC-GONADOTROPIN; IN-VITRO FERTILIZATION; FINAL OOCYTE MATURATION; GNRH AGONIST; PREVENTION; HORMONE; PROGRAM	Objective To evaluate pregnancy outcomes and the incidence of ovarian hyperstimulation syndrome (OHSS) using a sliding scale hCG protocol to trigger oocyte maturity and establish a threshold level of serum b-hCG associated with optimal oocyte maturity. Design Retrospective cohort. Setting Academic medical center. Patients Fresh IVF cycles from 9/2004-12/2011. Intervention 10,427 fresh IVF-ICSI cycles met inclusion criteria. hCG was administered according to E2 level at trigger: 10,000IU vs. 5,000IU vs. 4,000IU vs. 3,300IU vs. dual trigger (2mg leuprolide acetate + 1,500IU hCG). Serum absorption of hCG was assessed according to dose and BMI. Main outcome measures Oocyte maturity was analyzed according to post-trigger serum b-hCG. Fertilization, clinical pregnancy, live birth and OHSS rates were examined by hCG trigger dose. Results Post-trigger serum b-hCG 20-30, 30-40, and 40-50 mIU/mL was associated with reduced oocyte maturity as compared b-hCG >50 (67.8% vs. 71.4% vs. 73.3% vs. 78.9%, respectively, P<0.05). b-hCG 20-50 mIU/mL was associated with a 40.1% reduction in live birth (OR 0.59, 95% CI 0.41-0.87). No differences in IVF outcomes per retrieval were seen for varying doses of hCG or dual trigger when controlling for patient age. The incidence of moderate to severe OHSS was 0.13% (n = 14) and severe OHSS was 0.03% (n = 4) of cycles. Conclusions Moderate stimulation with sliding scale hCG at trigger and fresh transfer is associated with low rates of OHSS and favorable pregnancy rates. Doses as low as 3,300IU alone or dual trigger with 1,500IU are sufficient to facilitate oocyte maturity.	[Gunnala, Vinay; Melnick, Alexis; Irani, Mohamad; Reichman, David; Schattman, Glenn; Davis, Owen; Rosenwaks, Zev] Weill Cornell Med, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY 10065 USA; [Rosenwaks, Zev] Weill Cornell Med, Dept Reprod Med, New York, NY USA	Cornell University; Cornell University	Gunnala, V (corresponding author), Weill Cornell Med, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY 10065 USA.	vig9035@med.cornell.edu		Gunnala, Vinay/0000-0003-4231-6989				ABDALLA HI, 1987, FERTIL STERIL, V48, P958; Aboulghar MA, 2003, HUM REPROD UPDATE, V9, P275, DOI 10.1093/humupd/dmg018; Al-Hassan S, 1998, J ASSIST REPROD GEN, V15, P583, DOI 10.1023/A:1020325125881; Chen Dehan, 2003, Reprod Biomed Online, V7, P43; Dhont M, 1998, FERTIL STERIL, V70, P847, DOI 10.1016/S0015-0282(98)00280-5; Griesinger G, 2006, HUM REPROD UPDATE, V12, P159, DOI 10.1093/humupd/dmi045; Haas J, 2014, REPROD BIOMED ONLINE, V29, P216, DOI 10.1016/j.rbmo.2014.04.015; Huang JYJ, 2014, METHODS MOL BIOL, V1154, P171, DOI 10.1007/978-1-4939-0659-8_8; Humaidan P, 2011, HUM REPROD UPDATE, V17, P510, DOI 10.1093/humupd/dmr008; Isik AZ, 2001, EUR J OBSTET GYN R B, V97, P208, DOI 10.1016/S0301-2115(00)00539-X; Kashyap S, 2010, SEMIN REPROD MED, V28, P475, DOI 10.1055/s-0030-1265674; Kolibianakis EM, 2007, FERTIL STERIL, V88, P1382, DOI 10.1016/j.fertnstert.2006.12.058; Lin HY, 2011, EUR J OBSTET GYN R B, V159, P143, DOI 10.1016/j.ejogrb.2011.07.009; Mathur RS, 2000, BRIT J OBSTET GYNAEC, V107, P943, DOI 10.1111/j.1471-0528.2000.tb10393.x; Meyer L, 2015, FERTIL STERIL, V104, P637, DOI 10.1016/j.fertnstert.2015.06.011; Nastri CO, 2015, ULTRASOUND OBST GYN, V45, P377, DOI 10.1002/uog.14684; Olivennes F, 2010, SEMIN REPROD MED, V28, P463, DOI 10.1055/s-0030-1265672; Orvieto R, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-77; Reichman D, 2014, METHODS MOL BIOL, V1154, P289, DOI 10.1007/978-1-4939-0659-8_13; Schmidt DW, 2004, FERTIL STERIL, V82, P841, DOI 10.1016/j.fertnstert.2004.03.055; Smith V, 2015, REV ARTICLE PREVENTI, P1; WIKLAND M, 1995, HUM REPROD, V10, P1667, DOI 10.1093/oxfordjournals.humrep.a136152	22	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176019	10.1371/journal.pone.0176019	http://dx.doi.org/10.1371/journal.pone.0176019			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441461	gold, Green Submitted, Green Published			2022-12-26	WOS:000400308800019
J	Rhodin, M; Egenvall, A; Andersen, PH; Pfau, T				Rhodin, Marie; Egenvall, Agneta; Andersen, Pia Haubro; Pfau, Thilo			Head and pelvic movement asymmetries at trot in riding horses in training and perceived as free from lameness by the owner	PLOS ONE			English	Article							HIND-LIMB LAMENESS; SWEDISH HORSES; REPEATABILITY; SYMMETRY; MOTION; SYSTEM	Recent studies evaluating horses in training and considered free from lameness by their owners have identified a large proportion of horses with motion asymmetries. However the prevalence, type and magnitude of asymmetries when trotting in a straight line or on the lunge have not been investigated. The aim of this study was to objectively investigate the presence of motion asymmetries in riding horses in training by identifying the side and quantifying the degree and type (impact, pushoff) of forelimb and hind limb asymmetries found during straight line trot and on the lunge. In a cross-sectional study, vertical head and pelvic movement symmetry was measured in 222 Warmblood type riding horses, all without perceived performance issues and considered free from lameness by their owners. Body-mounted uni-axial accelerometers were used and differences between maximum and minimum head (HDmax, HDmin) and pelvic (PDmax, PDmin) vertical displacement between left and right forelimb and hind limb stances were calculated during straight line trot and on the lunge. Previously reported symmetry thresholds were used. The thresholds for symmetry were exceeded in 161 horses for at least one variable while trotting in a straight line, HDmin (n = 58, mean 14.3 mm, SD 7.1), HDmax (n = 41, mean 12.7 mm, SD 5.5), PDmax (n = 87, mean 6.5 mm, SD 3.10), PDmin (n = 79, mean 5.7 mm, SD 2.1). Contralateral and ipsilateral concurrent forelimb and hind limb asymmetries were detected in 41 and 49 horses, respectively. There was a linear association between the straight line PDmin values and the values on the lunge with the lame limb to the inside of the circle. A large proportion (72.5%) of horses in training which were perceived as free from lameness by their owner showed movement asymmetries above previously reported asymmetry thresholds during straight line trot. It is not known to what extent these asymmetries are related to pain or to mechanical abnormalities. Therefore, one of the most important questions that must be addressed is how objective asymmetry scores can be translated into pain, orthopedic abnormality, or any type of unsoundness.	[Rhodin, Marie; Egenvall, Agneta; Andersen, Pia Haubro] Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden; [Pfau, Thilo] Univ London, Dept Clin Sci & Serv, Royal Vet Coll, Hawkshead Lane, Hatfield, Herts, England	Swedish University of Agricultural Sciences; University of London; University of London Royal Veterinary College	Rhodin, M (corresponding author), Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden.	marie.rhodin@slu.se	Andersen, Pia Haubro/B-7077-2015; Rhodin, Marie/AAD-7266-2020	Andersen, Pia Haubro/0000-0002-6039-7439; Rhodin, Marie/0000-0003-0575-2765	Swedish Norwegian Foundation for Equine Research [H1347029]; Swedish Research Council Formas [2014-12003-28225-26]	Swedish Norwegian Foundation for Equine Research; Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	Funded by H1347029, Swedish Norwegian Foundation for Equine Research, http://hastforskning.se/. Marie Rhodin received the funding. 2014-12003-28225-26, The Swedish Research Council Formas, http://www.forms.se/. Marie Rhodin received the funding.	Arkell M, 2006, VET REC, V159, P346, DOI 10.1136/vr.159.11.346; Bell RP, 2016, AM J VET RES, V77, P337, DOI 10.2460/ajvr.77.4.337; Buchner HHF, 1996, EQUINE VET J, V28, P71, DOI 10.1111/j.2042-3306.1996.tb01592.x; Dyson S, 2011, EQUINE VET J, V43, P379, DOI 10.1111/j.2042-3306.2011.00391.x; Dyson S, 2016, J EQUINE VET SCI, V38, P1, DOI 10.1016/j.jevs.2015.12.012; Egenvall A, 2006, VET REC, V158, P397, DOI 10.1136/vr.158.12.397; Greve L, 2014, EQUINE VET J, V46, P687, DOI 10.1111/evj.12222; Hammarberg M, 2016, EQUINE VET J, V48, P78, DOI 10.1111/evj.12385; Hewetson M, 2006, VET REC, V158, P852, DOI 10.1136/vr.158.25.852; Keegan KG, 2010, EQUINE VET J, V42, P92, DOI 10.2746/042516409X479568; Keegan KG, 2011, AM J VET RES, V72, P1156, DOI 10.2460/ajvr.72.9.1156; Landman MAAM, 2004, VET REC, V155, P165, DOI 10.1136/vr.155.6.165; Licka T, 2004, EQUINE VET J, V36, P734, DOI 10.2746/0425164044848028; Maliye S, 2016, JAVMA-J AM VET MED A, V249, P940, DOI 10.2460/javma.249.8.940; Maliye S, 2015, VET J, V204, P208, DOI 10.1016/j.tvjl.2015.03.005; McCracken MJ, 2012, EQUINE VET J, V44, P652, DOI 10.1111/j.2042-3306.2012.00571.x; Murray R C, 2006, Equine Vet J Suppl, P411; Parkes RSV, 2009, EQUINE VET J, V41, P112, DOI 10.2746/042516408X343000; Peham C, 2001, VET J, V162, P153, DOI 10.1053/tvjl.2001.0593; Penell JC, 2005, VET REC, V157, P470, DOI 10.1136/vr.157.16.470; Pfau T, 2005, J EXP BIOL, V208, P2503, DOI 10.1242/jeb.01658; Pfau T, 2016, EQUINE VET J, V48, P517, DOI 10.1111/evj.12467; Pfau T, 2016, EQUINE VET J, V48, P83, DOI 10.1111/evj.12374; Pfau T, 2015, EQUINE VET J; Pfau T, 2012, AM J VET RES, V73, P1890, DOI 10.2460/ajvr.73.12.1890; Rhodin M, 2016, EQUINE VET J, V48, P315, DOI 10.1111/evj.12446; Rhodin M, 2013, VET J, V198, pE39, DOI 10.1016/j.tvjl.2013.09.031; Robartes H, 2013, VET J, V198, pE52, DOI 10.1016/j.tvjl.2013.09.033; Roepstorff L, 2009, EQUINE VET J, V41, P292, DOI 10.2746/042516409X397127; ST Baxter GM, 2011, LAMENESS IN HORSES, p[115, 479]; Wallin L., 2012, LIVSLANGD UTSLAGSORS; Warner SM, 2010, EQUINE VET J, V42, P417, DOI 10.1111/j.2042-3306.2010.00200.x	32	40	40	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176253	10.1371/journal.pone.0176253	http://dx.doi.org/10.1371/journal.pone.0176253			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441406	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000400308800038
J	Teparrukkul, P; Hantrakun, V; Day, NPJ; West, TE; Limmathurotsakul, D				Teparrukkul, Prapit; Hantrakun, Viriya; Day, Nicholas P. J.; West, T. Eoin; Limmathurotsakul, Direk			Management and outcomes of severe dengue patients presenting with sepsis in a tropical country	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; FEBRILE ILLNESSES; ADULT PATIENTS; SEPTIC SHOCK; GUIDELINES; CAMPAIGN	Background Dengue is a common cause of infection in adults in tropical countries. Sepsis is a syndrome of systemic manifestations induced by infection of any organisms; including bacterial, fungal and viral agents. Here, we investigated the diagnosis, management and outcomes of dengue patients presenting with sepsis in a prospective study of community-acquired sepsis in Thailand. Methods From June to December 2015, 874 adult patients ( age >= 18 years) with suspected or documented community-acquired infection, with >= 3 diagnostic criteria for sepsis according to the Surviving Sepsis Campaign 2012, and within 24 hours of admission were evaluated. Serum was stored and later tested for dengue PCR assays. Results A total of 126 patients had dengue PCR assays positive ( 2 DENV-1, 12 DENV-2, 24 DENV-3 and 88 DENV-4), and 5 of them ( 4%) died. We found that attending physicians suspected dengue infection on admission in 84 patients ( 67%), and recorded dengue infection as the final diagnosis in 96 patients ( 76%). Four of five fatal cases were diagnosed and treated as septic shock not due to dengue. In multivariable analysis, there was a trend showing that age >= 60 years, hypoxemia and misdiagnosis of dengue by attending physicians were associated with 28-day mortality. Conclusions A number of adult patients who died of dengue are misdiagnosed as severe sepsis and septic shock. Diagnosis of dengue based on clinical features alone is difficult. Rapid diagnostic tests for dengue may need to be routinely used in adult patients presenting with sepsis and septic shock in tropical countries. This approach could improve diagnosis and management of those patients.	[Teparrukkul, Prapit] Sunpasithiprasong Hosp, Med Dept, Ubon Ratchathani, Thailand; [Hantrakun, Viriya; Day, Nicholas P. J.; Limmathurotsakul, Direk] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Day, Nicholas P. J.; Limmathurotsakul, Direk] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England; [West, T. Eoin] Univ Washington, Dept Med, Div Pulm & Crit Care Med, Seattle, WA 98195 USA; [West, T. Eoin] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [West, T. Eoin] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand; [Limmathurotsakul, Direk] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Mahidol University; Mahidol University	Limmathurotsakul, D (corresponding author), Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand.; Limmathurotsakul, D (corresponding author), Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England.; Limmathurotsakul, D (corresponding author), Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand.	direk@tropmedres.ac		Limmathurotsakul, Direk/0000-0001-7240-5320; West, T Eoin/0000-0001-5503-7204; Hantrakun, Viriya/0000-0002-6727-3404; /0000-0002-1075-4135	Wellcome Trust [106698/B/14/Z, 101103/Z/13/Z]; National Heart, Lung and Blood Institute, National Institutes of Health [R01HL113382]; Defense Threat Reduction Agency, USA [W911QY-16-C-0017]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113382] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); National Heart, Lung and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Defense Threat Reduction Agency, USA(United States Department of DefenseDefense Threat Reduction Agency); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The prospective sepsis study was funded by the Wellcome Trust (106698/B/14/Z) and National Heart, Lung and Blood Institute, National Institutes of Health (R01HL113382). The dengue PCR assays were funded by Defense Threat Reduction Agency, USA (W911QY-16-C-0017). DL is supported by an intermediate fellowship from the Wellcome Trust (101103/Z/13/Z).	Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bureau of Epidemiology Ministry of Public Health Thailand, 2015, ANN EP SURV REP; Chan CYY, 2015, FUTURE MICROBIOL, V10, P2017, DOI 10.2217/fmb.15.105; Chareonsook O, 1999, EPIDEMIOL INFECT, V122, P161, DOI 10.1017/S0950268898001617; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Dellinger RP, 2004, INTENS CARE MED, V30, P536, DOI 10.1007/s00134-004-2210-z; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755; Gregory CJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001400; Hosmer D.W., 2005, APPL LOGISTIC REGRES; Jayashree K, 2011, INDIAN J HEMATOL BLO, V27, P127, DOI 10.1007/s12288-011-0075-1; Karyanti MR, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-412; Lahiri M, 2008, T ROY SOC TROP MED H, V102, P1011, DOI 10.1016/j.trstmh.2008.06.005; Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205; Mayxay M, 2013, LANCET GLOB HEALTH, V1, pE46, DOI 10.1016/S2214-109X(13)70008-1; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Navarrete-Espinosa J, 2005, SALUD PUBLICA MEXICO, V47, P193, DOI 10.1590/S0036-36342005000300002; Pang JX, 2016, CURR OPIN CRIT CARE, V22, P485, DOI 10.1097/MCC.0000000000000339; Lam PK, 2013, CLIN INFECT DIS, V57, P1577, DOI 10.1093/cid/cit594; Punjabi NH, 2012, AM J TROP MED HYG, V86, P46, DOI 10.4269/ajtmh.2012.10-0497; Rajapakse Senaka, 2012, Infect Drug Resist, V5, P103, DOI 10.2147/IDR.S22613; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Soares CN, 2011, J NEUROL SCI, V303, P75, DOI 10.1016/j.jns.2011.01.012; Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8; Thein TL, 2017, J MICROBIOL IMMUNOL, V50, P314, DOI 10.1016/j.jmii.2015.06.008; Alera MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004337; Thisyakorn Usa, 2015, Southeast Asian J Trop Med Public Health, V46 Suppl 1, P118; Trunfio M, 2016, INFECTION; van Crevel R, 2016, LANCET DIABETES ENDO; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Whitehorn J, 2016, CLIN INFECT DIS, V62, P468, DOI 10.1093/cid/civ949; WHO, 2013, WHO TECH REP SER, V982, P1; WHO, 2009, WHO TECH REP SER, V958, P1; Wills BA, 2005, NEW ENGL J MED, V353, P877, DOI 10.1056/NEJMoa044057; Woon YL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004575; World Health Organization, 2020, IMAI DISTR CLIN MAN	36	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176233	10.1371/journal.pone.0176233	http://dx.doi.org/10.1371/journal.pone.0176233			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437459	Green Submitted, Green Published, gold			2022-12-26	WOS:000400287600038
J	Wachter, RM				Wachter, Rebekka M.			A peptide adhesive molded by magnesium glues Rubisco's subunits together	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Rubisco enzymes play central roles in carbon fixation, with potential importance in biotechnology, but have eluded a full description of their multistep assembly and function. A new article describes the fascinating discovery that some archaeal Rubiscos contain a built-in assembly domain inserted into an otherwise canonical Rubisco fold, providing a tremendous expansion of our understanding of the diversity of naturally occurring Rubiscos.	[Wachter, Rebekka M.] Arizona State Univ, Sch Mol Sci, Tempe, AZ 85287 USA; [Wachter, Rebekka M.] Arizona State Univ, Ctr Bioenergy & Photosynth, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Wachter, RM (corresponding author), Arizona State Univ, Sch Mol Sci, Tempe, AZ 85287 USA.; Wachter, RM (corresponding author), Arizona State Univ, Ctr Bioenergy & Photosynth, Tempe, AZ 85287 USA.	rwachter@asu.edu			U.S. Department of Energy Office of Basic Energy Sciences, Photosynthetic Systems Grant [DE-FG02-09-ER16123]	U.S. Department of Energy Office of Basic Energy Sciences, Photosynthetic Systems Grant(United States Department of Energy (DOE))	This work was supported by a grant from the U.S. Department of Energy Office of Basic Energy Sciences, Photosynthetic Systems Grant DE-FG02-09-ER16123 (to R. M. W.). The author declares that she has no conflicts of interest with the contents of this article.	Alonso H, 2009, J BIOL CHEM, V284, P33876, DOI 10.1074/jbc.M109.050989; Andersson I, 2008, J EXP BOT, V59, P1555, DOI 10.1093/jxb/ern091; Bracher A, 2017, ANNU REV PLANT BIOL, V68, P29, DOI 10.1146/annurev-arplant-043015-111633; Durao P, 2015, NAT CHEM BIOL, V11, P148, DOI [10.1038/NCHEMBIO.1715, 10.1038/nchembio.1715]; Finn MW, 2003, J BACTERIOL, V185, P3049, DOI 10.1128/JB.185.10.3049-3059.2003; Gunn LH, 2017, J BIOL CHEM, V292, P6838, DOI 10.1074/jbc.M116.767145; Lin MT, 2014, NATURE, V513, P547, DOI 10.1038/nature13776; Sato T, 2007, SCIENCE, V315, P1003, DOI 10.1126/science.1135999	8	0	0	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6851	6852		10.1074/jbc.H116.767145	http://dx.doi.org/10.1074/jbc.H116.767145			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28432177	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000399813400034
J	Ye, XB; Torabi, M; Lix, LM; Mahmud, SM				Ye, Xibiao; Torabi, Mahmoud; Lix, Lisa M.; Mahmud, Salaheddin M.			Time and spatial trends in lymphoid leukemia and lymphoma incidence and survival among children and adolescents in Manitoba, Canada: 1984-2013	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE LYMPHOCYTIC-LEUKEMIA; CHILDHOOD-CANCER INCIDENCE; NON-HODGKINS-LYMPHOMA; SOCIOECONOMIC-STATUS; GEOGRAPHICAL VARIATION; EUROPEAN CHILDREN; PERIOD ANALYSIS; YOUNG-ADULTS; DISEASE	Objectives To test for time and spatial trends in lymphoid malignancies, including lymphoid leukemia (LL), Hodgkin lymphoma (HL), and non-Hodgkin lymphoma (NHL), in children and adolescents in the province of Manitoba, Canada. Methods Incident cases diagnosed between 1984 and 2013 were identified from the Manitoba Cancer Registry. We assessed time trends in age-standardized incidence rates using joinpoint regression and in 5-year relative survival using Poisson regression model. Kulldorff's scan method was used to assess spatial variation and clustering. Results Age-standardized incidence rates (per million person-years) in males and females were 34.0 (95% confidence interval [CI] 28.9-39.1) and 26.2 (95% CI 21.5-30.7) for LL, 10.5 (95% CI 7.7-13.3) and 12.5 (95% CI 9.4-15.7) for HL, 12.5 (95% CI 9.3-15.4) and 7.7 (95% CI 5.2-10.2) for NHL (except for Burkitt lymphomas), and 3.2 (95% CI 1.6-4.7) and 1.5 (95% CI 0.4-2.5) for Burkitt lymphomas. Age-and sex-standardized LL incidence rate increased 1.4% (95% CI 0.3%-2.5%) per year, while the changes for HL and NHL incidence rates were not statistically significant. There were geographic differences in age-standardized incidence rates for LL, HL, and NHL and spatial clusters were detected in southern part of the province. Five-year relative survival has improved over time and there was no difference between rural and urban areas. Conclusions Lymphoid leukemia incidence rate increased over time and varied by geographic area. Further research should examine the factors contributing to these trends.	[Ye, Xibiao; Torabi, Mahmoud; Lix, Lisa M.; Mahmud, Salaheddin M.] Univ Manitoba, Rady Fac Hlth Sci, Max Rady Coll Med, Dept Community Hlth Sci, Winnipeg, MB, Canada; [Ye, Xibiao; Lix, Lisa M.; Mahmud, Salaheddin M.] Univ Manitoba, George & Fay Yee Ctr Healthcare Innovat, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba	Ye, XB (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Max Rady Coll Med, Dept Community Hlth Sci, Winnipeg, MB, Canada.; Ye, XB (corresponding author), Univ Manitoba, George & Fay Yee Ctr Healthcare Innovat, Winnipeg, MB, Canada.	xibiao.ye@gmail.com		Torabi, Mahmoud/0000-0001-7448-7729	Manitoba Medical Service Foundation [317309]; Manitoba Centre for Health Policy [2015-028 (HIPC 2015/2016-04)]	Manitoba Medical Service Foundation; Manitoba Centre for Health Policy	This research was funded by the Manitoba Medical Service Foundation (# 317309). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the Manitoba Centre for Health Policy for use of data contained in the Population Health Research Data Repository under project 2015-028 (HIPC 2015/2016-04). The results and conclusions are those of the authors and no official endorsement by the Manitoba Centre for Health Policy, Manitoba Health, Healthy Living, and Seniors, or other data providers is intended or should be inferred.	Adam M, 2008, RADIAT PROT DOSIM, V132, P246, DOI 10.1093/rpd/ncn261; Adam M, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00139; [Anonymous], 2016, JOINP REGR PROGR VER; Bao PP, 2010, PEDIATR BLOOD CANCER, V54, P1009, DOI 10.1002/pbc.22383; Borugian MJ, 2005, EPIDEMIOLOGY, V16, P526, DOI 10.1097/01.ede.0000164813.46859.63; Brenner H, 2004, EUR J CANCER, V40, P326, DOI 10.1016/j.ejca.2003.10.013; Brown LM, 2015, INT J CANC; Brownell M, 2001, ASSESSING HLTH CHILD; CancerCare Manitoba, 2012, MAN CANC STRAT 2012; Chen AC, 2015, PACKAGE SPATIALEPI; Children's Oncology Group, 2014, LONG TERM FOLL UP GU; Clavel J, 2006, EUR J CANCER, V42, P2037, DOI 10.1016/j.ejca.2006.05.012; CLAYTON D, 1987, BIOMETRICS, V43, P671, DOI 10.2307/2532003; Clegg LX, 2002, J NATL CANCER I, V94, P1537; Coebergh JWW, 2006, EUR J CANCER, V42, P2019, DOI 10.1016/j.ejca.2006.06.005; Copeland G, 2013, CANC N AM 2006 2010, V1; Cox D. R., 1984, ANAL SURVIVAL DATA; Ederer F., 1959, INSTRUCTIONS IBM 650; Ellison L., 2015, HLTH GLANCE CHILDHOO; Feltbower RG, 2009, EUR J CANCER, V45, P420, DOI 10.1016/j.ejca.2008.09.020; Greaves Mel, 2003, Rev Clin Exp Hematol, V7, P233; HARVEY EB, 1985, NEW ENGL J MED, V312, P541, DOI 10.1056/NEJM198502283120903; HERBST AL, 1971, NEW ENGL J MED, V284, P878, DOI 10.1056/NEJM197104222841604; Holleczek B, 2009, METHOD INFORM MED, V48, P123, DOI 10.3414/ME0563; Holleczek B, 2013, COMPUT METH PROG BIO, V110, P192, DOI 10.1016/j.cmpb.2012.10.004; Hung GY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133051; Izarzugaza MI, 2006, EUR J CANCER, V42, P2050, DOI 10.1016/j.ejca.2006.05.005; Jarrett RF, 2003, J CLIN PATHOL, V56, P811, DOI 10.1136/jcp.56.11.811; Kaatsch P, 2010, CANCER TREAT REV, V36, P277, DOI 10.1016/j.ctrv.2010.02.003; Katz AJ, 2015, CANCER CAUSE CONTROL, V26, P1627, DOI 10.1007/s10552-015-0657-6; Kent EE, 2015, CANCER CAUSE CONTROL, V26, P1153, DOI 10.1007/s10552-015-0609-1; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Kroll ME, 2011, BRIT J CANCER, V105, P1783, DOI 10.1038/bjc.2011.415; Kulkarni K, 2011, PEDIAT HEMATOL ONCOL; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Linet MS, 2015, INT J CANCER, V138, P1862; Liu SL, 2003, HEMATOL ONCOL, V21, P57, DOI 10.1002/hon.703; Mbulaiteye Sam M., 2014, Journal of the National Cancer Institute Monographs, P106, DOI 10.1093/jncimonographs/lgu003; Mbulaiteye SM, 2012, AM J HEMATOL, V87, P573, DOI 10.1002/ajh.23187; Mezei G, 2006, AM J EPIDEMIOL, V164, P170, DOI 10.1093/aje/kwj118; Michelozzi P, 2002, AM J EPIDEMIOL, V155, P1096, DOI 10.1093/aje/155.12.1096; Milne E, 2008, INT J CANCER, V122, P1130, DOI 10.1002/ijc.23226; Mitra D, 2012, TRENDS INCIDENCE CHI, P131; Njoku K, 2013, BRIT J CANCER, V108, P2339, DOI 10.1038/bjc.2013.222; Parkin DM, 1998, IAR C SCI PUBL, V2, P1; Paulo Brazil, 2008, INT J CANCER, V123, P1907; Poole C, 2006, INT J EPIDEMIOL, V35, P370, DOI 10.1093/ije/dyi248; Ribeiro KB, 2008, INT J CANCER, V123, P1907, DOI 10.1002/ijc.23738; Schillinger JA, 1999, ARCH DIS CHILD, V80, P311, DOI 10.1136/adc.80.4.311; Smith MA, 2014, CANCER-AM CANCER SOC, V120, P2497, DOI 10.1002/cncr.28748; Spector LG, 2015, PEDIATR CLIN N AM, V62, P11, DOI 10.1016/j.pcl.2014.09.013; Stammers DM, 2014, PEDIATR BLOOD CANCER, V61, P2164, DOI 10.1002/pbc.25005; Steliarova-Foucher E, 2005, CANCER-AM CANCER SOC, V103, P1457, DOI 10.1002/cncr.20910; Steliarova-Foucher E, 2004, LANCET, V364, P2097, DOI 10.1016/S0140-6736(04)17550-8; Stolley PD, 1995, ENVIRON HEALTH PERSP, V103, P191, DOI 10.2307/3432309; Swaminathan R, 2011, IARC Sci Publ, P7; Torabi M, 2015, J PAEDIATR CHILD H, V51, P1121, DOI 10.1111/jpc.12930; Walters S, 2011, J EPIDEMIOL COMMUN H, V65, P1044, DOI 10.1136/jech.2010.126656; Ward E, 2014, CA-CANCER J CLIN, V64, P83, DOI 10.3322/caac.21219; World Health Organization, 2000, INT CLASSIFICATION D; Xavier AC, 2010, HAEMATOL-HEMATOL J, V95, P1043, DOI 10.3324/haematol.2010.024968; Youlden DR, 2012, CANCER EPIDEMIOL, V36, P476, DOI 10.1016/j.canep.2012.06.001; Youlden DR, 2012, PEDIATR BLOOD CANCER, V58, P390, DOI 10.1002/pbc.23115; Youlden DR, 2011, CANCER EPIDEM BIOMAR, V20, P1649, DOI 10.1158/1055-9965.EPI-11-0432; Zhang ZK, 2010, J PROBAB STAT, V2010, DOI 10.1155/2010/642379	65	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0175701	10.1371/journal.pone.0175701	http://dx.doi.org/10.1371/journal.pone.0175701			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430788	gold, Green Published, Green Submitted			2022-12-26	WOS:000399876100014
J	Cuecas, A; Kanoksilapatham, W; Gonzalez, JM				Cuecas, Alba; Kanoksilapatham, Wirojne; Gonzalez, Juan M.			Evidence of horizontal gene transfer by transposase gene analyses in Fervidobacterium species	PLOS ONE			English	Article							BACTERIAL; DIVERSITY; ALIGNMENT; EXCHANGE; SEQUENCE; ELEMENTS; GENOME; LIVES; NOV	Horizontal Gene Transfer (HGT) plays an important role in the physiology and evolution of microorganisms above all thermophilic prokaryotes. Some members of the Phylum Thermotogae (i.e., Thermotoga spp.) have been reported to present genomes constituted by a mosaic of genes from a variety of origins. This study presents a novel approach to search on the potential plasticity of Fervidobacterium genomes using putative transposase-encoding genes as the target of analysis. Transposases are key proteins involved in genomic DNA rearrangements. A comprehensive comparative analysis, including phylogeny, non-metric multidimensional scaling analysis of tetranucleotide frequencies, repetitive flanking sequences and divergence estimates, was performed on the transposase genes detected in four Fervidobacterium genomes: F. nodosum, F. pennivorans, F. islandicum and a new isolate (Fervidobacterium sp. FC2004). Transposase sequences were classified in different groups by their degree of similarity. The different methods used in this study pointed that over half of the transposase genes represented putative HGT events with closest relative sequences within the phylum Firmicutes, being Caldicellulosiruptor the genus showing highest gene sequence proximity. These results confirmed a direct evolutionary relationship through HGT between specific Fervidobacterium species and thermophilic Firmicutes leading to potential gene sequence and functionality sharing to thrive under similar environmental conditions. Transposase-encoding genes represent suitable targets to approach the plasticity and potential mosaicism of bacterial genomes.	[Cuecas, Alba; Gonzalez, Juan M.] CSIC, IRNAS, Spanish Council Res, Inst Nat Resources & Agrobiol, Avda Rena Mercedes 10, Seville, Spain; [Kanoksilapatham, Wirojne] Silpakorn Univ, Fac Sci, Dept Microbiol, Nakhon Pathom, Thailand	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Sevilla (IRNAS); Silpakorn University	Gonzalez, JM (corresponding author), CSIC, IRNAS, Spanish Council Res, Inst Nat Resources & Agrobiol, Avda Rena Mercedes 10, Seville, Spain.	jmgrau@irnase.csic.es	Cuecas, Alba/HHS-5405-2022	Cuecas, Alba/0000-0001-7567-4964; Gonzalez, Juan Miguel/0000-0003-4746-6775	Spanish Ministry of Economy and Competitiveness [CSD2009-00006, CGL2014-58762-P]; Regional Government of Andalusia [RNM2529, BIO288]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Regional Government of Andalusia(Junta de Andalucia)	This study was supported by funding through projects from the Spanish Ministry of Economy and Competitiveness (CSD2009-00006 and CGL2014-58762-P) and the Regional Government of Andalusia (RNM2529 and BIO288). The participation of FEDER funds is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by funding through projects from the Spanish Ministry of Economy and Competitiveness (CSD2009-00006 and CGL2014-58762-P) and the Regional Government of Andalusia (RNM2529 and BIO288). The participation of FEDER funds is acknowledged.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aravind L, 1998, TRENDS GENET, V14, P442, DOI 10.1016/S0168-9525(98)01553-4; Boto L, 2010, P ROY SOC B-BIOL SCI, V277, P819, DOI 10.1098/rspb.2009.1679; Curtis TP, 2002, P NATL ACAD SCI USA, V99, P10494, DOI 10.1073/pnas.142680199; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Dufraigne C, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni004; Friedrich AB, 1996, APPL ENVIRON MICROB, V62, P2875, DOI 10.1128/AEM.62.8.2875-2882.1996; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; Hooper SD, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r45; HUBER R, 1990, ARCH MICROBIOL, V154, P105, DOI 10.1007/BF00423318; Kanoksilapatham W, 2016, INT J SYST EVOL MICR, V66, P5023, DOI 10.1099/ijsem.0.001463; Keller M, 2004, NAT REV MICROBIOL, V2, P141, DOI 10.1038/nrmicro819; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Lee YJ, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/s40793-015-0063-4; LORENZ MG, 1994, MICROBIOL REV, V58, P563, DOI 10.1128/MMBR.58.3.563-602.1994; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Nesbo CL, 2009, J BACTERIOL, V191, P1974, DOI 10.1128/JB.01448-08; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Oksanen J., 2022, VEGAN COMMUNITY ECOL; PATEL BKC, 1985, ARCH MICROBIOL, V141, P63, DOI 10.1007/BF00446741; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Siguier P, 2014, FEMS MICROBIOL REV, V38, P865, DOI 10.1111/1574-6976.12067; Snyder L., 2007, MOL GENETICS BACTERI, VThird; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Techtmann SM, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00132; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Wolferen M, 2013, EXTREMOPHILES, V17, P545, DOI 10.1007/s00792-013-0552-6; Wagner A, 2006, MOL BIOL EVOL, V23, P723, DOI 10.1093/molbev/msj085; West SA, 2007, ANNU REV ECOL EVOL S, V38, P53, DOI 10.1146/annurev.ecolsys.38.091206.095740; Wiedenbeck J, 2011, FEMS MICROBIOL REV, V35, P957, DOI 10.1111/j.1574-6976.2011.00292.x; Zhaxybayeva O, 2009, P NATL ACAD SCI USA, V106, P5865, DOI 10.1073/pnas.0901260106	31	14	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0173961	10.1371/journal.pone.0173961	http://dx.doi.org/10.1371/journal.pone.0173961			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426805	Green Submitted, Green Published, gold			2022-12-26	WOS:000399875900006
J	Lee, MY; Ha, SE; Park, C; Park, PJ; Fuchs, R; Wei, L; Jorgensen, BG; Redelman, D; Ward, SM; Sanders, KM; Ro, S				Lee, Moon Young; Ha, Se Eun; Park, Chanjae; Park, Paul J.; Fuchs, Robert; Wei, Lai; Jorgensen, Brian G.; Redelman, Doug; Ward, Sean M.; Sanders, Kenton M.; Ro, Seungil			Transcriptome of interstitial cells of Cajal reveals unique and selective gene signatures	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; MOUSE SMALL-INTESTINE; SMOOTH-MUSCLE-CELLS; C-KIT; GASTROINTESTINAL-TRACT; GROWTH-FACTOR; ELECTRICAL-ACTIVITY; PACEMAKER ACTIVITY; MURINE INTESTINE; SLOW WAVES	Transcriptome-scale data can reveal essential clues into understanding the underlying molecular mechanisms behind specific cellular functions and biological processes. Transcriptomics is a continually growing field of research utilized in biomarker discovery. The transcriptomic profile of interstitial cells of Cajal (ICC), which serve as slow-wave electrical pacemakers for gastrointestinal (GI) smooth muscle, has yet to be uncovered. Using copGFP-labeled ICC mice and flow cytometry, we isolated ICC populations from the murine small intestine and colon and obtained their transcriptomes. In analyzing the transcriptome, we identified a unique set of ICC-restricted markers including transcription factors, epigenetic enzymes/regulators, growth factors, receptors, protein kinases/phosphatases, and ion channels/transporters. This analysis provides new and unique insights into the cellular and biological functions of ICC in GI physiology. Additionally, we constructed an interactive ICC genome browser (http://med.unr.edu/physio/transcriptome) based on the UCSC genome database. To our knowledge, this is the first online resource that provides a comprehensive library of all known genetic transcripts expressed in primary ICC. Our genome browser offers a new perspective into the alternative expression of genes in ICC and provides a valuable reference for future functional studies.	[Lee, Moon Young; Ha, Se Eun; Park, Chanjae; Park, Paul J.; Fuchs, Robert; Wei, Lai; Jorgensen, Brian G.; Redelman, Doug; Ward, Sean M.; Sanders, Kenton M.; Ro, Seungil] Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Reno, NV USA; [Lee, Moon Young] Wonkwang Univ, Wonkwang Digest Dis Res Inst, Dept Physiol, Iksan, South Korea; [Lee, Moon Young] Wonkwang Univ, Sch Med, Wonkwang Digest Dis Res Inst, Iksan, South Korea	Nevada System of Higher Education (NSHE); University of Nevada Reno; Wonkwang University; Wonkwang University	Ro, S (corresponding author), Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Reno, NV USA.	sro@med.unr.edu	Wei, Lai/GQH-9760-2022	Ro, Seungil/0000-0003-0861-8334	National Institutes of Health (NIH) [DK091752, DK094886, DK041315]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103055, R01DK094886] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health (NIH) [DK091752 and DK094886 to S. Ro, DK041315 to K.M. Sanders and S.Ro]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Baruscotti M, 2011, P NATL ACAD SCI USA, V108, P1705, DOI 10.1073/pnas.1010122108; Benner EJ, 2013, NATURE, V497, P369, DOI 10.1038/nature12069; Brown GR, 2015, NUCLEIC ACIDS RES, V43, pD36, DOI 10.1093/nar/gku1055; Brunner JD, 2014, NATURE, V516, P207, DOI 10.1038/nature13984; Chen J, 2008, NEUROGASTROENT MOTIL, V20, P829, DOI 10.1111/j.1365-2982.2008.01149.x; Congote LF, 2004, BIOCHEM BIOPH RES CO, V324, P673, DOI 10.1016/j.bbrc.2004.09.107; DIFRANCESCO D, 1991, J PHYSIOL-LONDON, V434, P23, DOI 10.1113/jphysiol.1991.sp018457; DiFrancesco D, 2010, HEART RHYTHM, V7, P276, DOI 10.1016/j.hrthm.2009.10.030; Dolphin AC, 2006, BRIT J PHARMACOL, V147, pS56, DOI 10.1038/sj.bjp.0706442; Forrest ARR, 2003, GENOME RES, V13, P1443, DOI 10.1101/gr.954803; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hirst GDS, 2002, J PHYSIOL-LONDON, V540, P1003, DOI 10.1113/jphysiol.2001.013672; Hudson NPH, 1999, RES VET SCI, V66, P265, DOI 10.1053/rvsc.1998.0297; HUIZINGA JD, 1995, NATURE, V373, P347, DOI 10.1038/373347a0; Huizinga JD, 2002, GASTROENTEROLOGY, V123, P1627, DOI 10.1053/gast.2002.36549; Hwang SJ, 2009, J PHYSIOL-LONDON, V587, P4887, DOI 10.1113/jphysiol.2009.176198; Iino S, 2009, ARCH HISTOL CYTOL, V72, P107, DOI 10.1679/aohc.72.107; Iino S, 2009, HISTOCHEM CELL BIOL, V131, P691, DOI 10.1007/s00418-009-0580-6; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kang MG, 2001, J BIOL CHEM, V276, P32917, DOI 10.1074/jbc.M100787200; Kaupp UB, 2001, ANNU REV PHYSIOL, V63, P235, DOI 10.1146/annurev.physiol.63.1.235; Kito Y, 2005, AM J PHYSIOL-CELL PH, V288, pC710, DOI 10.1152/ajpcell.00361.2004; Kito Y, 2003, J PHYSIOL-LONDON, V553, P803, DOI 10.1113/jphysiol.2003.051334; Komuro T, 1996, J AUTONOM NERV SYST, V61, P169, DOI 10.1016/S0165-1838(96)00078-1; Kunzelmann K, 2011, BIOL CHEM, V392, P125, DOI 10.1515/BC.2011.010; Kunzelmann K, 2009, CELL CALCIUM, V46, P233, DOI 10.1016/j.ceca.2009.09.003; Kurahashi M, 2014, AM J PHYSIOL-CELL PH, V307, pC561, DOI 10.1152/ajpcell.00080.2014; Lammers WJEP, 2008, EXP PHYSIOL, V93, P334, DOI 10.1113/expphysiol.2007.039180; LAWLER J, 1995, J BIOL CHEM, V270, P2809, DOI 10.1074/jbc.270.6.2809; Lee MY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133751; MAEDA H, 1992, DEVELOPMENT, V116, P369; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Moss FJ, 2002, EMBO J, V21, P1514, DOI 10.1093/emboj/21.7.1514; Mouse ENCODE Consortium, 2012, Genome Biol, V13, P418, DOI 10.1186/gb-2012-13-8-418; Nanba D, 2004, CYTOKINE GROWTH F R, V15, P13, DOI 10.1016/j.cytogfr.2003.10.002; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Park C, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.353; Park C, 2015, J NEUROGASTROENTEROL, V21, P589, DOI 10.5056/jnm15063; Park C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018628; Pluskota E, 2005, BLOOD, V106, P3970, DOI 10.1182/blood-2005-03-1292; Quattrone A, 2012, J PATHOL, V228, P565, DOI 10.1002/path.4071; Raab G, 1997, BBA-REV CANCER, V1333, pF179, DOI 10.1016/S0304-419X(97)00024-3; Ro S, 2010, GASTROENTEROLOGY, V138, P1068, DOI 10.1053/j.gastro.2009.11.007; Romert P, 1998, HISTOCHEM CELL BIOL, V109, P195, DOI 10.1007/s004180050218; Sanders KM, 2012, NAT REV GASTRO HEPAT, V9, P633, DOI 10.1038/nrgastro.2012.168; Sanders KM, 2012, EXP PHYSIOL, V97, P200, DOI 10.1113/expphysiol.2011.058248; Sanders KM, 2010, J PHYSIOL-LONDON, V588, P4621, DOI 10.1113/jphysiol.2010.196030; Sanders KM, 2006, ANNU REV PHYSIOL, V68, P307, DOI 10.1146/annurev.physiol.68.040504.094718; Shahi PK, 2014, J GASTROENTEROL, V49, P1001, DOI 10.1007/s00535-013-0849-3; Si XM, 2012, DIGESTION, V85, P266, DOI 10.1159/000337077; Southwell BR, 2003, NEUROGASTROENT MOTIL, V15, P139, DOI 10.1046/j.1365-2982.2003.00394.x; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Studniarczyk D, 2013, NAT NEUROSCI, V16, P1266, DOI 10.1038/nn.3473; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; TORIHASHI S, 1995, CELL TISSUE RES, V280, P97, DOI 10.1007/s004410050334; Torihashi S, 1999, GASTROENTEROLOGY, V117, P140, DOI 10.1016/S0016-5085(99)70560-3; van Helden DF, 2003, J PHYSIOL-LONDON, V548, P271, DOI 10.1113/jphysiol.2002.033720; Vanderwinden JM, 1999, MICROSC RES TECHNIQ, V47, P344, DOI 10.1002/(SICI)1097-0029(19991201)47:5<344::AID-JEMT6>3.0.CO;2-1; Ward SM, 2006, J PHYSIOL-LONDON, V573, P147, DOI 10.1113/jphysiol.2006.105189; WARD SM, 1994, J PHYSIOL-LONDON, V480, P91, DOI 10.1113/jphysiol.1994.sp020343; Ward SM, 2002, AM J PHYSIOL-GASTR L, V283, pG445, DOI 10.1152/ajpgi.00475.2001; Ward SM, 2001, AM J PHYSIOL-GASTR L, V281, pG602, DOI 10.1152/ajpgi.2001.281.3.G602; Wu JJ, 2000, J NEUROSCI RES, V59, P384, DOI 10.1002/(SICI)1097-4547(20000201)59:3<384::AID-JNR13>3.0.CO;2-4; Zhu MH, 2011, J PHYSIOL-LONDON, V589, P4565, DOI 10.1113/jphysiol.2011.211094; Zhu MH, 2009, J PHYSIOL-LONDON, V587, P4905, DOI 10.1113/jphysiol.2009.176206	68	53	53	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176031	10.1371/journal.pone.0176031	http://dx.doi.org/10.1371/journal.pone.0176031			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426719	gold, Green Published, Green Submitted			2022-12-26	WOS:000399875900090
J	Rudigier, LJ; Dame, C; Scholz, H; Kirschner, KM				Rudigier, Lucas J.; Dame, Christof; Scholz, Holger; Kirschner, Karin M.			Ex vivo cultures combined with vivo-morpholino induced gene knockdown provide a system to assess the role of WT1 and GATA4 during gonad differentiation	PLOS ONE			English	Article							WILMS-TUMOR SUPPRESSOR; TRANSCRIPTION FACTOR GATA4; FETAL LEYDIG-CELLS; SEX DETERMINATION; MOUSE TESTIS; KIDNEY DEVELOPMENT; SIGNALING PATHWAY; PROGENITOR CELLS; CANDIDATE GENES; SF1 EXPRESSION	Gonad morphogenesis relies on the correct spatiotemporal expression of a number of genes that together fulfill the differentiation of the bipotential gonad into testes or ovaries. As such, the transcription factors WT1 and GATA4 are pivotal for proper gonadal development. Here we address the contributions of GATA4 and WT1 to the sex differentiation phase in testes and ovaries. We applied an ex vivo technique for cultivating gonads in hanging droplets of media that were supplemented with vivo-morpholinos to knockdown WT1 and GATA4 either alone or in combination at the same developmental stage. We show that WT1 is equally important for both, the initial establishment and the maintenance of the sex-specific gene expression signature in testes and ovaries. We further identified Foxl2 as a novel putative downstream target gene of WT1. Moreover, knockdown of WT1 reduced mRNA levels of several molecular components of the hedgehog signaling pathway in XY gonads, whereas Gata4 vivo-morpholino treatment increased transcripts of Dhh and Ptch1 in embryonic testes. The data suggest that for its proper function, WT1 relies on the correct expression of the GATA4 protein. Furthermore, GATA4 down-regulates several ovarian promoting genes in testes, such as Ctnnb1, Fst, and Bmp2, suggesting that this repression is required for maintaining the male phenotype. In conclusion, this study provides novel insights into the role of WT1 and GATA4 during the sex differentiation phase and represents an approach that can be applied to assess other proteins with as yet unknown functions during gonadal development.	[Rudigier, Lucas J.; Scholz, Holger; Kirschner, Karin M.] Charite, Inst Vegetat Physiol, Campus Charite Mitte, Berlin, Germany; [Dame, Christof] Charite, Klin Neonatol, Campus Virchow Klinikum, Berlin, Germany; [Rudigier, Lucas J.] Humboldt Univ, Inst Biol, IRI Life Sci, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin	Scholz, H (corresponding author), Charite, Inst Vegetat Physiol, Campus Charite Mitte, Berlin, Germany.	holger.scholz@charite.de		Kirschner, Karin/0000-0003-0226-8636	Deutsche Forschungsgemeinschaft [SCHO 634/8-1, DA 484/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by grants by the Deutsche Forschungsgemeinschaft (SCHO 634/8-1 to HS and DA 484/3-1 to CD), http://www.dfg.de/.	Barsoum I, 2011, BIOL REPROD, V84, P894, DOI 10.1095/biolreprod.110.088997; Barsoum IB, 2009, DEV BIOL, V329, P96, DOI 10.1016/j.ydbio.2009.02.025; Beverdam A, 2006, HUM MOL GENET, V15, P417, DOI 10.1093/hmg/ddi463; Bitgood MJ, 1996, CURR BIOL, V6, P298, DOI 10.1016/S0960-9822(02)00480-3; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Bradford ST, 2009, HUM MOL GENET, V18, P3429, DOI 10.1093/hmg/ddp283; Bunce C, 2016, CURR TOP DEV BIOL, V116, P153, DOI 10.1016/bs.ctdb.2015.10.001; Chassot AA, 2014, REPRODUCTION, V148, pR97, DOI 10.1530/REP-14-0177; Chen MX, 2014, SHOCK VIB, V2014, DOI 10.1155/2014/954253; Chen M, 2017, DEVELOPMENT, V144, P44, DOI 10.1242/dev.144105; Clapcote SJ, 2005, BIOTECHNIQUES, V38, P702, DOI 10.2144/05385BM05; Clark AM, 2000, BIOL REPROD, V63, P1825, DOI 10.1095/biolreprod63.6.1825; Cool J, 2009, SEMIN REPROD MED, V27, P5, DOI 10.1055/s-0028-1108005; Dame C, 2006, BLOOD, V107, P4282, DOI 10.1182/blood-2005-07-2889; Efimenko E, 2013, DEV BIOL, V381, P144, DOI 10.1016/j.ydbio.2013.06.004; Eggers S, 2015, EUR J HUM GENET, V23, P486, DOI 10.1038/ejhg.2014.130; Franco HL, 2012, CHROMOSOME RES, V20, P247, DOI 10.1007/s10577-011-9254-z; Gao F, 2006, P NATL ACAD SCI USA, V103, P11987, DOI 10.1073/pnas.0600994103; Gao YK, 2014, DEVELOPMENT, V141, P2271, DOI 10.1242/dev.105676; HACKER A, 1995, DEVELOPMENT, V121, P1603; Hammes A, 2001, CELL, V106, P319, DOI 10.1016/S0092-8674(01)00453-6; Hartwig S, 2010, DEVELOPMENT, V137, P1189, DOI 10.1242/dev.045732; Hu YC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003629; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Jacobi CLJ, 2013, J BIOL CHEM, V288, P18811, DOI 10.1074/jbc.M113.464644; Jameson SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002575; Kashimada K, 2011, ENDOCRINOLOGY, V152, P272, DOI 10.1210/en.2010-0636; Kirschner KM, 2008, FASEB J, V22, P2690, DOI 10.1096/fj.07-097576; Klattig J, 2007, SEX DEV, V1, P238, DOI 10.1159/000104774; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Liu CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010382; Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193; Manuylov NL, 2011, DEV BIOL, V353, P229, DOI 10.1016/j.ydbio.2011.02.032; Martens LK, 2007, J BIOL CHEM, V282, P14379, DOI 10.1074/jbc.M609857200; Mazaud-Guittot S, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.113290; McClelland KS, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.115.128918; McClelland KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114932; Miyamoto Y, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-44; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Motamedi FJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5444; Munger SC, 2012, WIRES SYST BIOL MED, V4, P401, DOI 10.1002/wsbm.1172; Pierucci-Alves F, 2001, BIOL REPROD, V65, P1392, DOI 10.1095/biolreprod65.5.1392; R Core Team, 2013, R LANG ENV STAT COMP; Ryan J, 2011, SEX DEV, V5, P7, DOI 10.1159/000322162; Svingen T, 2009, SEX DEV, V3, P194, DOI 10.1159/000228720; Svingen T, 2013, GENE DEV, V27, P2409, DOI 10.1101/gad.228080.113; Svingen T, 2009, DEV DYNAM, V238, P956, DOI 10.1002/dvdy.21919; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Takasawa K, 2014, FASEB J, V28, P2020, DOI 10.1096/fj.13-246108; Tanaka SS, 2014, CELL MOL LIFE SCI, V71, P4781, DOI 10.1007/s00018-014-1703-3; Tevosian SG, 2002, DEVELOPMENT, V129, P4627; Thurisch B, 2009, J MOL ENDOCRINOL, V43, P157, DOI 10.1677/JME-09-0030; Uda M, 2004, HUM MOL GENET, V13, P1171, DOI 10.1093/hmg/ddh124; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Viger RS, 1998, DEVELOPMENT, V125, P2665; von Salisch S, 2011, J CELL MOL MED, V15, P1963, DOI 10.1111/j.1582-4934.2010.01193.x; Wagner KD, 2002, FASEB J, V16, P1117, DOI 10.1096/fj.01-0986fje; Wagner KD, 2002, EMBO J, V21, P1398, DOI 10.1093/emboj/21.6.1398; Watt AJ, 2004, P NATL ACAD SCI USA, V101, P12573, DOI 10.1073/pnas.0400752101; Wen Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167920; Wen Q, 2014, AM J PHYSIOL-ENDOC M, V307, pE1131, DOI 10.1152/ajpendo.00425.2014; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilhelm D, 2002, GENE DEV, V16, P1839, DOI 10.1101/gad.220102; Yao HHC, 2004, DEV DYNAM, V230, P210, DOI 10.1002/dvdy.20042; Yao HHC, 2002, GENE DEV, V16, P1433, DOI 10.1101/gad.981202	65	12	12	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176296	10.1371/journal.pone.0176296	http://dx.doi.org/10.1371/journal.pone.0176296			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426816	Green Published, Green Submitted, gold			2022-12-26	WOS:000399875900127
J	Shi, Y; Zhang, Y; Lou, JZ				Shi, Yi; Zhang, Yong; Lou, Jizhong			The influence of cell membrane and SNAP25 linker loop on the dynamics and unzipping of SNARE complex	PLOS ONE			English	Article							PARTICLE MESH EWALD; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; ALL-ATOM; FUSION; SYNAPTOTAGMIN; SNAP-25; PROTEIN; SIMULATIONS; EXOCYTOSIS	The soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complex is composed of three neuronal proteins VAMP2, Syntaxin and SNAP25, which plays a core role during the process of membrane fusion. The zipping assembly of the SNARE complex releases energies and drives the vesicle and cell membrane into close proximity. In this study, we use all-atom molecular dynamics simulations to probe the dynamics of SNARE and its unzipping process in the context of membrane at the atomistic details. Our results indicated that the NTD of SNARE core domain is relatively more stable than CTD, which is in agreement with previous experiments. More importantly, possible interactions between the linker loop (LL) region of SNAP25 and VAMP2 are observed, suggests that the LL region may facilitate VAMP2 binding and SNARE initiation. The forced unzipping of SNARE in the presence of membrane and LL of SNAP25 reveals the possible pathway for energy generation of SNARE zipping, provides information to understand how force may regulate the cooperativity between the membrane and the SNARE complex.	[Shi, Yi] Univ Sci & Technol China, Sch Life Sci, Hefei, Anhui, Peoples R China; [Shi, Yi; Zhang, Yong; Lou, Jizhong] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Key Lab RNA Biol, Beijing, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Lou, JZ (corresponding author), Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Key Lab RNA Biol, Beijing, Peoples R China.	jlou@ibp.ac.cn		Shi, Yi/0000-0002-6281-8911	National Basic Research Program of China [2014C6910202]; National Natural Science Foundation of China [31222022, 11302240]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China 2014C6910202 (to JL) (program.most.gov.cn) and National Natural Science Foundation of China grants 31222022 (to JL) and 11302240 (to YZ) (isisn. nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajohrs M, 2005, BIOCHEM J, V392, P283, DOI 10.1042/BJ20050583; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bock LV, 2010, BIOPHYS J, V99, P1221, DOI 10.1016/j.bpj.2010.06.019; Bykhovskaia M, 2013, BIOPHYS J, V105, P679, DOI 10.1016/j.bpj.2013.06.018; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Durrieu MP, 2008, BIOPHYS J, V94, P3436, DOI 10.1529/biophysj.107.123117; Durrieu MP, 2009, CHEMPHYSCHEM, V10, P1548, DOI 10.1002/cphc.200900216; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Gao Y, 2012, SCIENCE, V337, P1340, DOI 10.1126/science.1224492; Gonelle-Gispert C, 2000, J CELL SCI, V113, P3197; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Li F, 2014, J AM CHEM SOC, V136, P3456, DOI 10.1021/ja410690m; Liang BY, 2013, P NATL ACAD SCI USA, V110, P19384, DOI 10.1073/pnas.1314699110; Ma C, 2013, SCIENCE, V339, P421, DOI 10.1126/science.1230473; Ma L, 2015, ELIFE, V4, P4; Malinin VS, 2004, BRACHYTHERAPY, V86, P334; Min D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2692; Misura KMS, 2001, J BIOL CHEM, V276, P41301, DOI 10.1074/jbc.M106853200; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Risselada HJ, 2012, CURR OPIN STRUC BIOL, V22, P187, DOI 10.1016/j.sbi.2012.01.007; Risselada HJ, 2011, CHEMBIOCHEM, V12, P1049, DOI 10.1002/cbic.201100020; Rizo J, 2006, TRENDS CELL BIOL, V16, P339, DOI 10.1016/j.tcb.2006.04.006; Rizo J, 2015, ANNU REV BIOPHYS, V44, P339, DOI 10.1146/annurev-biophys-060414-034057; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sorensen JB, 2009, ANNU REV CELL DEV BI, V25, P513, DOI 10.1146/annurev.cellbio.24.110707.175239; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tekpinar M, 2014, J MOL MODEL, V20, DOI 10.1007/s00894-014-2381-7; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Veit M, 1996, FEBS LETT, V385, P119, DOI 10.1016/0014-5793(96)00362-6; Vogel K, 2000, J BIOL CHEM, V275, P2959, DOI 10.1074/jbc.275.4.2959; Wang L, 2008, MOL BIOL CELL, V19, P3944, DOI 10.1091/mbc.E08-04-0344; Wang SY, 2016, INT J DISTRIB SENS N, DOI 10.1155/2016/3159805; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Zheng WJ, 2014, PROTEINS, V82, P1376, DOI 10.1002/prot.24505; Zhou P, 2013, NEURON, V80, P470, DOI 10.1016/j.neuron.2013.09.010; Zhou QJ, 2015, NATURE, V525, P62, DOI 10.1038/nature14975	42	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176235	10.1371/journal.pone.0176235	http://dx.doi.org/10.1371/journal.pone.0176235			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426820	Green Published, gold, Green Submitted			2022-12-26	WOS:000399875900120
J	Pan, XF; De Aragao, CDP; Velasco-Martin, JP; Priestman, DA; Wu, HY; Takahashi, K; Yamaguchi, K; Sturiale, L; Garozzo, D; Platt, FM; Lamarche-Vane, N; Morales, CR; Miyagi, T; Pshezhetsky, AV				Pan, Xuefang; Para De Aragao, Camila De Britto; Velasco-Martin, Juan P.; Priestman, David A.; Wu, Harry Y.; Takahashi, Kohta; Yamaguchi, Kazunori; Sturiale, Luisella; Garozzo, Domenico; Platt, Frances M.; Lamarche-Vane, Nathalie; Morales, Carlos R.; Miyagi, Taeko; Pshezhetsky, Alexey V.			Neuraminidases 3 and 4 regulate neuronal function by catabolizing brain gangliosides	FASEB JOURNAL			English	Article						sialidase; lipofuscin; lysosomal storage; gangliosidosis; Tay-Sach disease; neuroinflammation	SIALIDASE ACTIVITY; NERVOUS-SYSTEM; PROTEIN; ACID; MICE; IDENTIFICATION; BINDING; ROLES	Gangliosides (sialylated glycolipids) play an essential role in the CNS by regulating recognition and signaling in neurons. Metabolic blocks in processing and catabolism of gangliosides result in the development of severe neurologic disorders, including gangliosidoses manifesting with neurodegeneration and neuro-inflammation. We demonstrate that 2 mammalian enzymes, neuraminidases 3 and 4, play important roles in catabolic processing of brain gangliosides by cleaving terminal sialic acid residues in their glycan chains. In neuraminidase 3 and 4 double-knockout mice, G(M3) ganglioside is stored in microglia, vascular pericytes, and neurons, causing micro- and astrogliosis, neuroinflammation, accumulation of lipofuscin bodies, and memory loss, whereas their cortical and hippocampal neurons have lower rate of neuritogenesis in vitro. Double-knockout mice also have reduced levels of G(M1) ganglioside and myelin in neuronal axons. Furthermore, neuraminidase 3 deficiency drastically increased storage of G(M2) in the brain tissues of an asymptomatic mouse model of Tay-Sachs disease, a severe human gangliosidosis, indicating that this enzyme is responsible for the metabolic bypass of beta-hexosaminidase A deficiency. Together, our results provide the first in vivo evidence that neuraminidases 3 and 4 have important roles in CNS function by catabolizing gangliosides and preventing their storage in lipofuscin bodies.	[Pan, Xuefang; Para De Aragao, Camila De Britto; Wu, Harry Y.; Pshezhetsky, Alexey V.] Univ Montreal, St Justine Univ Hosp, Res Ctr, Montreal, PQ, Canada; [Para De Aragao, Camila De Britto; Lamarche-Vane, Nathalie; Morales, Carlos R.; Pshezhetsky, Alexey V.] McGill Univ, Ctr Hlth, Res Inst, Dept Anat & Cell Biol, Montreal, PQ, Canada; [Velasco-Martin, Juan P.] Univ Autonoma Madrid, Fac Med, Dept Anat Histol & Neurociencia, Madrid, Spain; [Priestman, David A.; Platt, Frances M.] Univ Oxford, Dept Pharmacol, Oxford, England; [Takahashi, Kohta] Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Sendai, Miyagi, Japan; [Yamaguchi, Kazunori; Miyagi, Taeko] Miyagi Canc Ctr, Res Inst, Natori, Miyagi, Japan; [Sturiale, Luisella; Garozzo, Domenico] CNR, Inst Polymers Composites & Biomat, Catania, Italy	Universite de Montreal; McGill University; Autonomous University of Madrid; University of Oxford; Tohoku Medical & Pharmaceutical University; Miyagi Cancer Center; Consiglio Nazionale delle Ricerche (CNR); Istituto per i Polimeri, Compositi e Biomateriali (IPCB-CNR)	Pshezhetsky, AV (corresponding author), CHU St Justine, Dept Med Genet, 3175 Cote Ste Catherine, Montreal, PQ H3T 1C5, Canada.	alexei.pchejetski@umontreal.ca	Garozzo, Domenico/I-8839-2014	Garozzo, Domenico/0000-0002-9087-9818; Platt, Frances/0000-0001-7614-0403	Canadian Institutes of Health Research [111068]; Grants-in-Aid for Scientific Research [15K06848] Funding Source: KAKEN	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Canadian Institutes of Health Research Grant 111068 from (to A.V.P). The authors thank Claire O'Leary (University of Manchester, Manchester, United Kingdom) for help with setting up the Y-maze test; Dr. Graziella Di Cristo [Centre Hospitalier Universitaire (CHU) Sainte-Justine] for helpful advice; Dr. Mila Ashmarina (CHU Ste-Justine), for critical reading of the manuscript; Dr. Nobuo Hanai, Dr. Akiko Furuya, and Kyowa Hakko Kirin Co., Ltd. (Tokyo, Japan), for a generous gift of monoclonal antibodies against G<INF>M2</INF> ganglioside; and Carmen Movila (CHU Ste-Justine), for help in preparation of the manuscript.	Akkerman S, 2012, BEHAV BRAIN RES, V232, P335, DOI 10.1016/j.bbr.2012.03.022; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Carvelli L, 2015, HISTOL HISTOPATHOL, V30, P647, DOI 10.14670/HH-30.647; Collins BE, 1997, J BIOL CHEM, V272, P16889, DOI 10.1074/jbc.272.27.16889; Da Silva JS, 2005, NAT NEUROSCI, V8, P606, DOI 10.1038/nn1442; de Geest N, 2002, HUM MOL GENET, V11, P1455, DOI 10.1093/hmg/11.12.1455; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Grabrucker A, 2009, CELL TISSUE RES, V338, P333, DOI 10.1007/s00441-009-0881-z; Gravel R. A., 2001, METABOLIC MOL BASES, V3, P3827; Gray Douglas A, 2005, Sci Aging Knowledge Environ, V2005, pre1, DOI 10.1126/sageke.2005.5.re1; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P225, DOI 10.1073/pnas.012540899; Hata K, 2015, CANCER SCI, V106, P383, DOI 10.1111/cas.12627; Ichikawa N, 2009, J CELL SCI, V122, P289, DOI 10.1242/jcs.030338; Kawai H, 2001, J BIOL CHEM, V276, P6885, DOI 10.1074/jbc.C000847200; Lema PP, 2004, J VET PHARMACOL THER, V27, P321, DOI 10.1111/j.1365-2885.2004.00597.x; Manzi A. E., 2003, CURRENT PROTOCOLS MO, V3; Martins C, 2015, BRAIN, V138, P336, DOI 10.1093/brain/awu355; Miyagi T, 2012, GLYCOBIOLOGY, V22, P880, DOI 10.1093/glycob/cws057; Monti E, 2015, TOP CURR CHEM, V366, P183, DOI 10.1007/128_2012_328; Neville DCA, 2004, ANAL BIOCHEM, V331, P275, DOI 10.1016/j.ab.2004.03.051; Palmano K, 2015, NUTRIENTS, V7, P3891, DOI 10.3390/nu7053891; Pshezhetsky AV, 2013, BIOCHEMISTRY-MOSCOW+, V78, P736, DOI 10.1134/S0006297913070067; Pshezhetsky AV, 2001, PROG NUCLEIC ACID RE, V69, P81, DOI 10.1016/S0079-6603(01)69045-7; Rodriguez JA, 2001, J NEUROSCI, V21, P8387, DOI 10.1523/JNEUROSCI.21-21-08387.2001; Sandhoff K, 2013, J NEUROSCI, V33, P10195, DOI 10.1523/JNEUROSCI.0822-13.2013; Schnaar RL, 2014, PHYSIOL REV, V94, P461, DOI 10.1152/physrev.00033.2013; SCHNEIDERJAKOB HR, 1991, BIOL CHEM H-S, V372, P443, DOI 10.1515/bchm3.1991.372.1.443; Seyrantepe V, 2008, HUM MOL GENET, V17, P1556, DOI 10.1093/hmg/ddn043; Seyrantepe V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001118; Smutova V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106320; Sturgill ER, 2012, GLYCOBIOLOGY, V22, P1289, DOI 10.1093/glycob/cws103; Takahashi K, 2012, J BIOL CHEM, V287, P14816, DOI 10.1074/jbc.M111.324186; TETTAMAN.G, 1973, BIOCHIM BIOPHYS ACTA, V296, P160, DOI 10.1016/0005-2760(73)90055-6; Yamaguchi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041132; YAMANAKA S, 1994, P NATL ACAD SCI USA, V91, P9975, DOI 10.1073/pnas.91.21.9975; YAMANO T, 1983, ACTA NEUROPATHOL, V61, P15, DOI 10.1007/BF00688381; YU RK, 1988, J NEUROCHEM, V50, P1825, DOI 10.1111/j.1471-4159.1988.tb02484.x; Yu RK, 2012, NEUROCHEM RES, V37, P1230, DOI 10.1007/s11064-012-0744-y; Zhao Q, 2000, J BIOL CHEM, V275, P24829, DOI 10.1074/jbc.M003497200	39	35	34	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3467	3483		10.1096/fj.201601299R	http://dx.doi.org/10.1096/fj.201601299R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28442549				2022-12-26	WOS:000405932400024
J	Toriyama, M; Toriyama, M; Wallingford, JB; Finnell, RH				Toriyama, Manami; Toriyama, Michinori; Wallingford, John B.; Finnell, Richard H.			Folate-dependent methylation of septins governs ciliogenesis during neural tube closure	FASEB JOURNAL			English	Article						folate transport; epigenetics; septin2; neural tube defect	EARLY EMBRYONIC-DEVELOPMENT; PLANAR CELL POLARITY; MEMBRANE-TRANSPORT; DNA METHYLATION; PRIMARY CILIUM; DEFECTS; METABOLISM; MICE; GENE; NEURULATION	Periconception maternal folic acid(vitamin B-9) supplementation can reduce the prevalence of neural tube defects (NTDs), although just how folates benefit the developing embryo and promote closing of the neural tube and other morphologic processes during development remains unknown. Folate contributes to a 1-carbon metabolism, which is essential for purine biosynthesis and methionine recycling and affects methylation of DNA, histones, and nonhistone proteins. Herein, we used animal models and cultured mammalian cells to demonstrate that disruption of the methylation pathway mediated by folate compromises normal neural tube closure (NTC) and ciliogenesis. We demonstrate that the embryos with NTD failed to adequately methylate septin2, a key regulator of cilium structure and function. We report that methylation of septin2 affected its GTP binding activity and formation of the septin2-6-7 complex. We propose that folic acid promotes normal NTC in some embryos by regulating the methylation of septin2, which is critical for normal cilium formation during early embryonic development.	[Toriyama, Manami; Finnell, Richard H.] Univ Texas Austin, Dell Med Sch, Dell Pediat Res Inst, Dept Pediat, Austin, TX 78712 USA; [Toriyama, Michinori; Wallingford, John B.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Toriyama, Manami] Osaka Univ, Grad Sch Pharmaceut Sci, Osaka, Japan	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Osaka University	Finnell, RH (corresponding author), Univ Texas Austin, Dell Med Sch, Dell Pediat Res Inst, 1400 Barbara Jordan Blvd, Austin, TX 78723 USA.	rfinnell@austin.utexas.edu	Finnell, Richard/D-8174-2018	Finnell, Richard/0000-0002-5962-8754; TORIYAMA, Michinori/0000-0003-2551-4334; Toriyama, Manami/0000-0002-2754-293X	U.S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01HD067244, R01HD083809, R01HD081216]; NIH National Institute of Neurological Disorders and Stroke [R01NS076465]; National Institute of Environmental Health Sciences [R01ES021006]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD067244, R01HD085901, R01HD083809, R01HD081216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076465] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [17H05003] Funding Source: KAKEN	U.S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development; NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank the Proteomics Facility at The University of Texas at Austin who performed MS/MS analysis. This work was supported, in part, by U.S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development Grants P01HD067244, R01HD083809, and R01HD081216; NIH National Institute of Neurological Disorders and Stroke Grant R01NS076465, and National Institute of Environmental Health Sciences Grant R01ES021006 (to R.H.F). The authors declare no conflicts of interest.	Bai SM, 2005, MOL CELL BIOL, V25, P751, DOI 10.1128/MCB.25.2.751-766.2005; BARTEL RL, 1984, MOL PHARMACOL, V25, P418; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Brault V, 2001, DEVELOPMENT, V128, P1253; Bueno O, 2016, J NUTR, V146, P1, DOI 10.3945/jn.115.223685; Cearns MD, 2016, J ANAT, V229, P63, DOI 10.1111/joa.12468; Chih B, 2012, NAT CELL BIOL, V14, P61, DOI 10.1038/ncb2410; Copp AJ, 2003, NAT REV GENET, V4, P784, DOI 10.1038/nrg1181; Cormier CY, 2010, NUCLEIC ACIDS RES, V38, pD743, DOI 10.1093/nar/gkp999; Cox BJ, 2010, GENOME RES, V20, P1154, DOI 10.1101/gr.105106.110; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Fukuda T, 2011, MOL CELL NEUROSCI, V46, P614, DOI 10.1016/j.mcn.2011.01.001; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; GOLDEN JA, 1993, TERATOLOGY, V47, P73, DOI 10.1002/tera.1420470112; Greene NDE, 2014, ANNU REV NEUROSCI, V37, P221, DOI 10.1146/annurev-neuro-062012-170354; Horswill MA, 2008, EXP EYE RES, V86, P586, DOI 10.1016/j.exer.2008.01.003; Hu QC, 2010, SCIENCE, V329, P436, DOI 10.1126/science.1191054; Ichi S, 2010, J BIOL CHEM, V285, P36922, DOI 10.1074/jbc.M110.126714; KARFUNKEL P, 1974, INT REV CYTOL, V38, P245, DOI 10.1016/S0074-7696(08)60927-4; Khoshnood B, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5949; Kim SK, 2010, SCIENCE, V329, P1337, DOI 10.1126/science.1191184; Kobayakawa S, 2007, GENES CELLS, V12, P447, DOI 10.1111/j.1365-2443.2007.01063.x; Kwon GS, 2009, GENESIS, V47, P447, DOI 10.1002/dvg.20522; Liu JF, 2016, BIRTH DEFECTS RES A, V106, P267, DOI 10.1002/bdra.23486; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; MacFarlane AJ, 2015, MUTAT RES-FUND MOL M, V779, P105, DOI 10.1016/j.mrfmmm.2015.06.012; Martiniova L, 2015, AM J CLIN NUTR, V101, P860, DOI 10.3945/ajcn.114.097279; Matherly LH, 2003, VITAM HORM, V66, P403, DOI 10.1016/S0083-6729(03)01012-4; MILLER JW, 1994, BIOCHEM J, V298, P415, DOI 10.1042/bj2980415; Mostowy S, 2012, NAT REV MOL CELL BIO, V13, P183, DOI 10.1038/nrm3284; MULLER F, 1987, ANAT EMBRYOL, V176, P413, DOI 10.1007/BF00310083; Murdoch JN, 2010, BIRTH DEFECTS RES A, V88, P633, DOI 10.1002/bdra.20686; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pan LH, 2002, J IMMUNOL, V168, P3923, DOI 10.4049/jimmunol.168.8.3923; Pang CNI, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-92; Piedrahita JA, 1999, NAT GENET, V23, P228, DOI 10.1038/13861; Rampersaud GC, 2000, AM J CLIN NUTR, V72, P998; Salih Mustafa A M, 2014, Sudan J Paediatr, V14, P49; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Sirajuddin M, 2007, NATURE, V449, P311, DOI 10.1038/nature06052; Sirotnak FM, 1999, ANNU REV NUTR, V19, P91, DOI 10.1146/annurev.nutr.19.1.91; Toriyama M, 2012, J BIOL CHEM, V287, P12691, DOI 10.1074/jbc.M111.316307; Waes JGV, 2008, BIRTH DEFECTS RES A, V82, P494, DOI 10.1002/bdra.20453; Wallingford JB, 2013, SCIENCE, V339, P1011, DOI 10.1126/science.1222002; Wallingford JB, 2012, ANNU REV CELL DEV BI, V28, P627, DOI 10.1146/annurev-cellbio-092910-154208; Zou ZY, 2004, J BIOL CHEM, V279, P34302, DOI 10.1074/jbc.M405608200	49	24	26	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3622	3635		10.1096/fj.201700092R	http://dx.doi.org/10.1096/fj.201700092R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28432198	Green Published			2022-12-26	WOS:000405932400034
J	Chi, XJ; Zhao, X; Wang, W; Niu, YQ; Cheng, M; Liu, XY; Cui, S; Yang, W				Chi, Xiaojing; Zhao, Xia; Wang, Wei; Niu, Yuqiang; Cheng, Min; Liu, Xiuying; Cui, Sheng; Yang, Wei			Fusion expression of Occludin extracellular loops and an alpha-helical bundle: A new research model for tight junction	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HIV-1 ENTRY; INFECTION; INHIBITION; GP41; CLAUDIN-1; RECEPTOR; CELLS; CORE	Tight junctions (TJs) are the outermost structures of intercellular junctions and are highly specialized membrane domains involved in many important cellular processes. However, most TJ proteins are four-time transmembrane proteins and are difficult to express in their correct soluble form, which limits their functional study and therapeutic application. Human occludin (OCLN) is a major component of TJs and an essential co-receptor for hepatitis C virus (HCV) cell entry. To explore expression strategy for recombinant TJ proteins possessing integrated and functional extracellular loops, OCLN was here used as a model molecule, and several prokaryotic fusion constructs were designed by docking OCLN extracellular loops (ECLs) to HIV-1 gp41 NHR and CHR six-helical bundle (6HV1); then their biophysical features and anti-HCV activity were evaluated. The proteins were successfully expressed and purified in E. coli, and the double-loop constructs (D1ECL1S+D2ECL2 as a representative) were found to have more potent HCV neutralizing activity than single-loop constructs at non-cytotoxic concentrations. Circular dichroism studies indicate that D1ECL1S+D2ECL2 adopt stable a-helical folds consistent with design. Thermal denaturation assay indicated that D1ECL1S+D2ECL2 is highly stable at 80 degrees C (melting temperature, T-m, of 89.08 +/- 2.0 degrees C) and comparable in stability to the 6HV1 scaffold. Moreover, the time-of-addition experiment revealed that D1ECL1S+D2ECL2 predominantly functioned during the early stages of HCV entry. Taken together, these findings provide a novel strategy for recombinant TJ protein expression in vitro, which may shed light on functional and structural studies for TJs and may provide a new avenue to drug development.	[Chi, Xiaojing; Zhao, Xia; Wang, Wei; Niu, Yuqiang; Cheng, Min; Liu, Xiuying; Cui, Sheng; Yang, Wei] Chinese Acad Med Sci, MOH Key Lab Syst Biol Pathogens, Inst Pathogen Biol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS	Cui, S; Yang, W (corresponding author), Chinese Acad Med Sci, MOH Key Lab Syst Biol Pathogens, Inst Pathogen Biol, Beijing, Peoples R China.	cui.sheng@ipbcams.ac.cn; wyang@ipb.pumc.edu.cn	Cui, Sheng/AAQ-1721-2020; Sheng, CUI/M-6405-2013	Sheng, CUI/0000-0001-6329-3582	National Basic Research Program of China [2015CB554301]; National Natural Science Foundation of China [81672030, 81471954, 81271831]; CAMS Initiative for Innovative Medicine [2016-I2M-3-020]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAMS Initiative for Innovative Medicine	This work was supported by National Basic Research Program of China (2015CB554301), National Natural Science Foundation of China (81672030, 81471954 and 81271831), and CAMS Initiative for Innovative Medicine (2016-I2M-3-020).	Albecka A, 2012, HEPATOLOGY, V55, P998, DOI 10.1002/hep.25501; Blasig IE, 2011, ANTIOXID REDOX SIGN, V15, P1195, DOI 10.1089/ars.2010.3542; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Deming P, 2016, PHARMACOTHERAPY, V36, P203, DOI 10.1002/phar.1700; Dorner M, 2011, NATURE, V474, P208, DOI 10.1038/nature10168; Eckert DM, 1999, CELL, V99, P103, DOI 10.1016/S0092-8674(00)80066-5; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Feeney ER, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g3308; Frey G, 2006, P NATL ACAD SCI USA, V103, P13938, DOI 10.1073/pnas.0601036103; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Liu SF, 2009, J VIROL, V83, P2011, DOI 10.1128/JVI.01888-08; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P599, DOI 10.1016/S0968-0004(02)02229-6; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Shirasago Y, 2016, BIOL PHARM BULL, V39, P839, DOI 10.1248/bpb.b15-01023; Si YH, 2012, HEPATOLOGY, V56, P507, DOI 10.1002/hep.25685; Steed E, 2010, TRENDS CELL BIOL, V20, P142, DOI 10.1016/j.tcb.2009.12.002; Steger HK, 2006, J BIOL CHEM, V281, P25813, DOI 10.1074/jbc.M601457200; Torres-Flores JM, 2015, VIRUSES-BASEL, V7, P5145, DOI 10.3390/v7092865; Yang W, 2008, J BIOL CHEM, V283, P8643, DOI 10.1074/jbc.M709824200	26	4	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0175516	10.1371/journal.pone.0175516	http://dx.doi.org/10.1371/journal.pone.0175516			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448574	Green Submitted, gold, Green Published			2022-12-26	WOS:000400383600016
J	Ali, BH; Karaca, T; Al Suleimani, Y; Al Za'abi, M; Al Kalbani, J; Ashique, M; Nemmar, A				Ali, Badreldin H.; Karaca, Turan; Al Suleimani, Yousuf; Al Za'abi, Mohammed; Al Kalbani, Jamila; Ashique, Mohammed; Nemmar, Abderrahim			The effect of swimming exercise on adenineinduced kidney disease in rats, and the influence of curcumin or lisinopril thereon	PLOS ONE			English	Article							5/6 NEPHRECTOMIZED RATS; CHRONIC-RENAL-FAILURE; OXIDATIVE STRESS; CARDIOVASCULAR PROTECTION; SEDENTARY BEHAVIORS; PHYSICAL-ACTIVITY; HYPERTENSION; INFLAMMATION; FIBROSIS; INJURY	Patients with chronic kidney disease (CKD) have been reported to benefit from different types of exercises. It has also been shown that the ACE inhibitor lisinopril, and the natural product curcumin are also beneficial in different models of CKD in rats. We assessed the influence of moderate swimming exercise (SE) on rats with adenine- induced CKD, and tested the possible effects of lisinopril and/or curcumin thereon using several physiological, biochemical, histopathological and immunohistochemical parameters. Rats (either sedentary or subjected to SE) were randomly divided into several groups, and given for five weeks either normal food or food mixed with adenine (0.25% w/w) to induce CKD. Some of these groups were also concomitantly treated orally with curcumin (75 mg/kg), or lisinopril (10 mg/kg) and were subjected to moderate SE (45 min/day three days each week). Rats fed adenine showed the typical biochemical, histopathological signs of CKD such as elevations in blood pressure, urinary albumin / creatinine ratio, and plasma urea, creatinine, indoxyl sulfate and phosphorus. SE, curcumin or lisinopril, given singly, significantly ameliorated all the adenine-induced actions. Administering curcumin or lisinopril with SE improved the histopathology of the kidneys, a salutary effect not seen with SE alone. Combining SE to the nephroprotective agents' curcumin or lisinopril might offer additional nephroprotection.	[Ali, Badreldin H.; Al Suleimani, Yousuf; Al Za'abi, Mohammed; Al Kalbani, Jamila; Ashique, Mohammed] Sultan Qaboos Univ, Dept Pharmacol & Clin Pharm, Coll Med & Hlth Sci, Al Khoud, Oman; [Karaca, Turan] Trakya Univ, Dept Histol Embryol, Fac Med, Balkan Campus, Edirne, Turkey; [Nemmar, Abderrahim] United Arab Emirates Univ, Dept Physiol, Coll Med & Hlth Sci, Al Ain, U Arab Emirates	Sultan Qaboos University; Trakya University; United Arab Emirates University	Ali, BH (corresponding author), Sultan Qaboos Univ, Dept Pharmacol & Clin Pharm, Coll Med & Hlth Sci, Al Khoud, Oman.	akthmali@squ.edu.om	KARACA, Turan/ABD-6669-2020; Za'abi, Mohammed Al/C-6591-2013	KARACA, Turan/0000-0002-2500-7781; Za'abi, Mohammed Al/0000-0002-2019-1022; Ali, Badreldin/0000-0001-6491-6278; Ashique, Mohammed/0000-0002-3132-1478	Research Council of Oman [REC/MED/PHARM/13/01]	Research Council of Oman(Ministry of Higher Education, Research & Innovation, OmanThe Research Council Oman)	This study was financially supported by the Research Council of Oman (REC/MED/PHARM/13/01). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Suleimani YM, 2017, ENVIRON TOXICOL, V32, P541, DOI 10.1002/tox.22258; Al Za'abi M, 2017, PHYSIOL RES, V66, P263, DOI 10.33549/physiolres.933374; Al Za'abi M, 2015, AM J TRANSL RES, V7, P28; Al Za'abi M, 2013, J CHROMATOGR SCI, V51, P40, DOI 10.1093/chromsci/bms103; Ali BH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102528; Ali BH, 2013, J PHARMACOL TOX MET, V68, P384, DOI 10.1016/j.vascn.2013.05.001; Ali BH, 2011, PHYTOMEDICINE, V18, P1176, DOI 10.1016/j.phymed.2011.03.005; Ali BH, 2010, EXP BIOL MED, V235, P373, DOI 10.1258/ebm.2009.009214; Ali BH, 2005, FUND CLIN PHARMACOL, V19, P473, DOI 10.1111/j.1472-8206.2005.00343.x; Ali BH, 2016, FASEB J S, V30, p771 8; Banday AA, 2011, HYPERTENSION, V57, P452, DOI 10.1161/HYPERTENSIONAHA.110.162339; Barcellos FC, 2015, CLIN KIDNEY J, V8, P753, DOI 10.1093/ckj/sfv099; Barhoumi T, 2014, J HYPERTENS, V32, P784, DOI 10.1097/HJH.0000000000000101; Beetham KS, 2016, J SPORTS ME IN PRESS; Bugyei-Twum A, 2016, SCI REP-UK, V6, DOI 10.1038/srep39551; Cechella JL, 2014, AMINO ACIDS, V46, P1187, DOI 10.1007/s00726-014-1679-1; Chen KC, 2014, EUR J PREV CARDIOL, V21, P507, DOI 10.1177/2047487312462827; Despres JP, 2016, CAN J CARDIOL, V32, P505, DOI 10.1016/j.cjca.2015.12.006; Fang F, 2013, AM J PHYSIOL-RENAL, V304, pF1366, DOI 10.1152/ajprenal.00137.2012; Feere DA, 2015, BRIT J PHARMACOL, V172, P201, DOI 10.1111/bph.12932; Ferrari GO, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-69; Gencer B, 2014, CUTAN OCUL TOXICOL, V33, P283, DOI 10.3109/15569527.2013.857677; Ghosh SS, 2012, AM J PHYSIOL-RENAL, V302, pF439, DOI 10.1152/ajprenal.00356.2010; Heiwe S, 2014, AM J KIDNEY DIS, V64, P383, DOI 10.1053/j.ajkd.2014.03.020; Howden EJ, 2016, AUTON NEUROSCI-BASIC; Howden EJ, 2015, CURR OPIN NEPHROL HY, V24, P480, DOI 10.1097/MNH.0000000000000165; Izumi A, 2016, REV RECENT CLIN TRIA, V11, P333, DOI 10.2174/1574887111666160724182015; Kaltsatou A, 2016, CURR PHARM DESIGN, V22, P3700, DOI 10.2174/1381612822666160322144936; Kim EJ, 2013, J GINSENG RES, V37, P87, DOI 10.5142/jgr.2013.37.87; Kim Y, 2013, INT J EPIDEMIOL, V42, P1040, DOI 10.1093/ije/dyt108; Kumral ZNO, 2016, J PHYSIOL PHARMACOL, V67, P45; Lau WL, 2015, NEPHRON, V130, P92, DOI 10.1159/000381990; Lazar JM, 2013, INT J CARDIOL, V168, P19, DOI 10.1016/j.ijcard.2013.03.063; Lu Y, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0263-y; Nelson A, 2016, OPEN HEART, V3, DOI 10.1136/openhrt-2015-000370; Pechter U, 2003, INT J REHABIL RES, V26, P153, DOI 10.1097/01.mrr.0000070755.63544.5a; Pena-Polanco JE, 2016, SEMIN NEPHROL, V36, P331, DOI 10.1016/j.semnephrol.2016.05.009; Peng C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038614; Perico N, 2016, INTERN EMERG MED, V11, P385, DOI 10.1007/s11739-016-1425-7; Raag M, INT J REHABLI RES; Sakr HF, 2013, J PHYSIOL PHARMACOL, V64, P231; Soni RK, 2010, CURR OPIN NEPHROL HY, V19, P153, DOI 10.1097/MNH.0b013e328335f939; Sutariya B, 2017, J ETHNOPHARMACOL, V198, P432, DOI 10.1016/j.jep.2016.12.048; Tokoroyama T, 2016, NEPHROL DIAL TRANSPL; Topcu-Tarladacalisir Y, 2016, REN FAIL, V19, P1; Ulu N, 2013, J PHARMACOL EXP THER, V345, P393, DOI 10.1124/jpet.113.203497; Vaziri ND, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114881; Vettoretti S, 2016, AM J PHYSIOL-RENAL, V310, pF1047, DOI 10.1152/ajprenal.00325.2015; Waly MI, 2013, TOXICOL IN VITRO, V27, P2299, DOI 10.1016/j.tiv.2013.09.023; Wouters OJ, 2015, NAT REV NEPHROL, V11, P491, DOI 10.1038/nrneph.2015.85; Xia J, 2016, J INTEGR MED-JIM, V14, P165, DOI 10.1016/S2095-4964(16)60256-X; Ziada AM, 2009, J HYPERTENS, V27, P1309, DOI 10.1097/HJH.0b013e328329fb55; Zoccali C, 2014, NEPHROL DIAL TRANSPL, V29, P483, DOI 10.1093/ndt/gfu029	53	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176316	10.1371/journal.pone.0176316	http://dx.doi.org/10.1371/journal.pone.0176316			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445490	gold, Green Published, Green Submitted			2022-12-26	WOS:000400309200045
J	Lee, KB; Kelbauskas, L; Brunner, A; Meldrum, DR				Lee, Kristen B.; Kelbauskas, Laimonas; Brunner, Alan; Meldrum, Deirdre R.			A versatile method for dynamically controlled patterning of small populations of epithelial cells on substrates via non-contact piezoelectric inkjet printing	PLOS ONE			English	Article							MAMMALIAN-CELLS; CANCER; MICROARRAYS; METASTASIS; EVOLUTION	Intercellular interactions play a central role at the tissue and whole organism level modulating key cellular functions in normal and disease states. Studies of cell-cell communications are challenging due to ensemble averaging effects brought about by intrinsic heterogeneity in cellular function which requires such studies to be conducted with small populations of cells. Most of the current methods for producing and studying such small cell populations are complex to implement and require skilled personnel limiting their widespread utility in biomedical research labs. We present a simple and rapid method to produce small populations with varying size of epithelial cells (10-50 cells/population) with high-throughput (similar to 1 population/second) on flat surfaces via patterning of extracellular matrix (ECM) proteins and random seeding of cells. We demonstrate that despite inherent limitations of non-contact, drop-on-demand piezoelectric inkjet printing for protein patterning, varying mixtures of ECM proteins can be deposited with high reproducibility and level of control on glass substrates using a set of dynamically adjustable optimized deposition parameters. We demonstrate high consistency for the number of cells per population (similar to 1 cell standard error of mean), the population's size (similar to 0.2 coefficient of variation) and shape, as well as accurate spatial placement of and distance between colonies of a panel of metaplastic and dysplastic esophageal epithelial cells with differing adhesion and motility characteristics. The number of cells per colony, colony size and shape can be varied by dynamically varying the amount of ECM proteins deposited per spatial location and the number of spatial locations on the substrate. The method is applicable to a broad range of biological and biomedical studies including cell-cell communications, cellular microenvironment, migration, and stimulus response.	[Lee, Kristen B.; Kelbauskas, Laimonas; Brunner, Alan; Meldrum, Deirdre R.] Arizona State Univ, Biodesign Inst, Tempe, AZ 85281 USA	Arizona State University; Arizona State University-Tempe	Kelbauskas, L; Meldrum, DR (corresponding author), Arizona State Univ, Biodesign Inst, Tempe, AZ 85281 USA.	lkelbaus@asu.edu; deirdre.meldrum@asu.edu			NIH Center of Excellence in Genomic Science (CEGS) [5P50 HG002360]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002360] Funding Source: NIH RePORTER	NIH Center of Excellence in Genomic Science (CEGS); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by an NIH Center of Excellence in Genomic Science (CEGS) grant 5P50 HG002360 awarded to D.R.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Sandhya Gangaraju for all cell culture needs. This work was supported by an NIH Center of Excellence in Genomic Science (CEGS) grant 5P50 HG002360 awarded to D.R.M.	Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Barcellos-Hoff MH, 2013, NAT REV CANCER, V13, P511, DOI 10.1038/nrc3536; Fujita S, 2013, LAB CHIP, V13, P77, DOI 10.1039/c2lc40709d; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Guldner IH, 2015, INTEGR BIOL-UK, V7, P153, DOI 10.1039/c4ib00192c; Kang J, 2014, METHOD CELL BIOL, V119, P55, DOI 10.1016/B978-0-12-416742-1.00004-4; Kelbauskas L, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.3.037008; Kshitiz, 2015, INTEGR BIOL-UK, V7, P364, DOI 10.1039/c4ib00209a; Lidstrom ME, 2003, NAT REV MICROBIOL, V1, P158, DOI 10.1038/nrmicro755; Marusyk A, 2014, NATURE, V514, P54, DOI 10.1038/nature13556; Matsusaki M, 2013, ADV HEALTHC MATER, V2, P534, DOI 10.1002/adhm.201200299; Ostuni E, 2000, LANGMUIR, V16, P7811, DOI 10.1021/la000382m; Palanca-Wessels MC, 1998, GASTROENTEROLOGY, V114, P295, DOI 10.1016/S0016-5085(98)70480-9; Palanca-Wessels MCA, 2003, CARCINOGENESIS, V24, P1183, DOI 10.1093/carcin/bgg076; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Romanov V, 2014, ANALYST, V139, P1303, DOI 10.1039/c3an01577g; Roth EA, 2004, BIOMATERIALS, V25, P3707, DOI 10.1016/j.biomaterials.2003.10.052; Shimizu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091875; Tse C, 2016, BIOFABRICATION, V8, DOI 10.1088/1758-5090/8/1/015017; Turcu F, 2003, J NEUROSCI METH, V131, P141, DOI 10.1016/j.jneumeth.2003.08.001; Wilson DS, 2002, CURR OPIN CHEM BIOL, V6, P81, DOI 10.1016/S1367-5931(01)00281-2; Xu T, 2005, BIOMATERIALS, V26, P93, DOI 10.1016/j.biomaterials.2004.04.011; Zhang K, 2014, P NATL ACAD SCI USA, V111, P2948, DOI 10.1073/pnas.1313661111	23	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176079	10.1371/journal.pone.0176079	http://dx.doi.org/10.1371/journal.pone.0176079			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445488	Green Published, gold, Green Submitted			2022-12-26	WOS:000400309200033
J	Welinder, C; Pawlowski, K; Szasz, AM; Yakovleva, M; Sugihara, Y; Malm, J; Jonsson, G; Ingvar, C; Lundgren, L; Baldetorp, B; Olsson, H; Rezeli, M; Laurell, T; Wieslander, E; Marko-Varga, G				Welinder, Charlotte; Pawlowski, Krzysztof; Szasz, A. Marcell; Yakovleva, Maria; Sugihara, Yutaka; Malm, Johan; Jonsson, Goren; Ingvar, Christian; Lundgren, Lotta; Baldetorp, Bo; Olsson, Hakan; Rezeli, Melinda; Laurell, Thomas; Wieslander, Elisabet; Marko-Varga, Gyorgy			Correlation of histopathologic characteristics to protein expression and function in malignant melanoma	PLOS ONE			English	Article							TERT PROMOTER MUTATIONS; METASTATIC MELANOMA; THERAPEUTIC TARGET; PYRUVATE-KINASE; STAGE-I; C-MYC; BRAF; PROGRESSION; CANCER; CELLS	Background Metastatic melanoma is still one of the most prevalent skin cancers, which upon progression has neither a prognostic marker nor a specific and lasting treatment. Proteomic analysis is a versatile approach with high throughput data and results that can be used for characterizing tissue samples. However, such analysis is hampered by the complexity of the disease, heterogeneity of patients, tumors, and samples themselves. With the long term aim of quest for better diagnostics biomarkers, as well as predictive and prognostic markers, we focused on relating high resolution proteomics data to careful histopathological evaluation of the tumor samples and patient survival information. Patients and methods Regional lymph node metastases obtained from ten patients with metastatic melanoma (stage III) were analyzed by histopathology and proteomics using mass spectrometry. Out of the ten patients, six had clinical follow-up data. The protein deep mining mass spectrometry data was related to the histopathology tumor tissue sections adjacent to the area used for deep-mining. Clinical follow-up data provided information on disease progression which could be linked to protein expression aiming to identify tissue-based specific protein markers for metastatic melanoma and prognostic factors for prediction of progression of stage III disease. Results In this feasibility study, several proteins were identified that positively correlated to tumor tissue content including IF6, ARF4, MUC18, UBC12, CSPG4, PCNA, PMEL and MAGD2. The study also identified MYC, HNF4A and TGFB1 as top upstream regulators correlating to tumor tissue content. Other proteins were inversely correlated to tumor tissue content, the most significant being; TENX, EHD2, ZA2G, AOC3, FETUA and THRB. A number of proteins were significantly related to clinical outcome, among these, HEXB, PKM and GPNMB stood out, as hallmarks of processes involved in progression from stage III to stage IV disease and poor survival. Conclusion In this feasibility study, promising results show the feasibility of relating proteomics to histopathology and clinical outcome, and insight thus can be gained into the molecular processes driving the disease. The combined analysis of histological features including the sample cellular composition with protein expression of each metastasis enabled the identification of novel, differentially expressed proteins. Further studies are necessary to determine whether these putative biomarkers can be utilized in diagnostics and prognostic prediction of metastatic melanoma.	[Welinder, Charlotte; Szasz, A. Marcell; Sugihara, Yutaka; Jonsson, Goren; Lundgren, Lotta; Baldetorp, Bo; Olsson, Hakan; Wieslander, Elisabet] Lund Univ, Dept Clin Sci Lund, Div Oncol & Pathol, Lund, Sweden; [Welinder, Charlotte; Szasz, A. Marcell; Yakovleva, Maria; Malm, Johan; Laurell, Thomas; Marko-Varga, Gyorgy] Lund Univ, Biomed Ctr D13, Ctr Excellence Biol & Med Mass Spectrometry CEBMM, Lund, Sweden; [Pawlowski, Krzysztof] Warsaw Univ Life Sci, Dept Expt Design & Bioinformat, Fac Agr & Biol, Warsaw, Poland; [Pawlowski, Krzysztof; Malm, Johan] Lund Univ, Dept Translat Med, Malmo, Sweden; [Szasz, A. Marcell] Semmelweis Univ, Dept Pathol 2, Budapest, Hungary; [Ingvar, Christian] Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund, Dept Surg, Lund, Sweden; [Lundgren, Lotta; Olsson, Hakan] Skane Univ Hosp, Dept Oncol, Lund, Sweden; [Olsson, Hakan] Lund Univ, Dept Clin Sci, Canc Epidemiol, Lund, Sweden; [Rezeli, Melinda; Laurell, Thomas; Marko-Varga, Gyorgy] Lund Univ, Dept Biomed Engn, Clin Prot Sci & Imaging, Biomed Ctr,BMC D13, Lund, Sweden; [Marko-Varga, Gyorgy] Tokyo Med Univ, Dept Surg 1, Tokyo, Japan	Lund University; Lund University; Warsaw University of Life Sciences; Lund University; Semmelweis University; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Lund University; Tokyo Medical University	Marko-Varga, G (corresponding author), Lund Univ, Biomed Ctr D13, Ctr Excellence Biol & Med Mass Spectrometry CEBMM, Lund, Sweden.; Marko-Varga, G (corresponding author), Lund Univ, Dept Biomed Engn, Clin Prot Sci & Imaging, Biomed Ctr,BMC D13, Lund, Sweden.; Marko-Varga, G (corresponding author), Tokyo Med Univ, Dept Surg 1, Tokyo, Japan.	Gyorgy.Marko-Varga@bme.lth.se	Welinder, Charlotte/G-1144-2014; Laurell, Thomas/B-5524-2013; Baldetorp, Bo/HDM-9924-2022; Ingvar, Christian/AAE-9841-2019; Pawłowski, Krzysztof/C-2949-2013	Welinder, Charlotte/0000-0001-9626-0576; Laurell, Thomas/0000-0002-2486-3607; Pawłowski, Krzysztof/0000-0002-5367-0935; Olsson, Hakan/0000-0002-8794-9635	Mrs. Berta Kamprad Foundation; Vinnova; Inga-Britt and Arne Lundbergs Foundation; Crafoord Foundation; European Research Council Advanced Grant	Mrs. Berta Kamprad Foundation; Vinnova(Vinnova); Inga-Britt and Arne Lundbergs Foundation; Crafoord Foundation; European Research Council Advanced Grant(European Research Council (ERC))	This study was supported by grants from Mrs. Berta Kamprad Foundation, Vinnova, Inga-Britt and Arne Lundbergs Foundation, The Crafoord Foundation, and European Research Council Advanced Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Ascierto PA, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-85; BALCH CM, 1978, ANN SURG, V188, P732, DOI 10.1097/00000658-197812000-00004; Berwick M, 2016, CANCER TREAT RES, V167, P17, DOI 10.1007/978-3-319-22539-5_2; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; BRESLOW A, 1970, ANN SURG, V172, P902, DOI 10.1097/00000658-197011000-00017; Bucheit AD, 2013, CANCER-AM CANCER SOC, V119, P3821, DOI 10.1002/cncr.28306; Byrum Stephanie D, 2013, J Proteomics Bioinform, V6, P43; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Cirenajwis H, 2015, ONCOTARGET, V6, P12297, DOI 10.18632/oncotarget.3655; ELDH J, 1978, SCAND J PLAST RECONS, V12, P243, DOI 10.3109/02844317809013000; Eriksson H, 2016, INT J CANCER, V138, P2829, DOI 10.1002/ijc.30023; Fico A, 2015, CANCER BIOL THER, V16, P1375, DOI 10.1080/15384047.2015.1030546; Galon J, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-205; Gao GW, 2015, ONCOTARGETS THER, V8, P2933, DOI 10.2147/OTT.S88873; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harbst K, 2012, CLIN CANCER RES, V18, P4026, DOI 10.1158/1078-0432.CCR-12-0343; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Israelsen WJ, 2015, SEMIN CELL DEV BIOL, V43, P43, DOI 10.1016/j.semcdb.2015.08.004; Jakob JA, 2012, CANCER-AM CANCER SOC, V118, P4014, DOI 10.1002/cncr.26724; Jayagopal A, 2011, INVEST OPHTH VIS SCI, V52, P588, DOI 10.1167/iovs.10-5746; Jonsson G, 2010, CLIN CANCER RES, V16, P3356, DOI 10.1158/1078-0432.CCR-09-2509; Kamburov A, 2011, NUCLEIC ACIDS RES, V39, pD712, DOI 10.1093/nar/gkq1156; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Kim DW, 2016, CANCER; Kim S, 2011, NAT REV CANCER, V11, P708, DOI 10.1038/nrc3124; LEHMANN JM, 1989, P NATL ACAD SCI USA, V86, P9891, DOI 10.1073/pnas.86.24.9891; Lillie RD, 1965, HISTOPATHOLOGIC TECH; Maric G, 2013, ONCOTARGETS THER, V6, P839, DOI 10.2147/OTT.S44906; Meckbach D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086194; Merrill RM, 2016, CANCERS, V8, DOI 10.3390/cancers8020020; Morton DL, 2012, CLIN EXP METASTAS, V29, P699, DOI 10.1007/s10585-012-9503-3; Nabizadeh JA, 2016, J IMMUNOL, V196, P4783, DOI 10.4049/jimmunol.1600210; Ohkawa Y, 2010, J BIOL CHEM, V285, P27213, DOI 10.1074/jbc.M109.087791; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Price MA, 2011, PIGM CELL MELANOMA R, V24, P1148, DOI 10.1111/j.1755-148X.2011.00929.x; Qu X, 2014, J INVEST DERMATOL, V134, P159, DOI 10.1038/jid.2013.281; Rizos H, 2014, CLIN CANCER RES, V20, P1965, DOI 10.1158/1078-0432.CCR-13-3122; Rodrigues MF, 2016, BIOCHEM J, V473, P703, DOI 10.1042/BJ20150645; SADANO H, 1992, JPN J CANCER RES, V83, P625, DOI 10.1111/j.1349-7006.1992.tb00135.x; Schlaak M, 2013, BRIT J DERMATOL, V168, P708, DOI 10.1111/bjd.12140; Sugihara Y, 2014, PROTEOMICS, V14, P1963, DOI 10.1002/pmic.201300476; Sun C, 2014, NATURE, V508, P118, DOI 10.1038/nature13121; Tas F, 2012, J ONCOL, V2012, DOI 10.1155/2012/647684; Thiam A, 2016, J MED ECON, V19, P259, DOI 10.3111/13696998.2015.1115764; Tringali C, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-560; Valsecchi ME, 2011, J CLIN ONCOL, V29, P1479, DOI 10.1200/JCO.2010.33.1884; VANDERESCH EP, 1981, CANCER-AM CANCER SOC, V48, P1668; Wang SJ, 2015, INT J CLIN EXP PATHO, V8, P14441; Welinder C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123661; Wengrod J, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa0899	54	18	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176167	10.1371/journal.pone.0176167	http://dx.doi.org/10.1371/journal.pone.0176167			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445515	gold, Green Published, Green Submitted			2022-12-26	WOS:000400309200037
J	Becker, MH; Gratwicke, B				Becker, Matthew H.; Gratwicke, Brian			Minimum lethal concentration of sodium hypochlorite for the amphibian pathogen Batrachochytrium dendrobatidis	PLOS ONE			English	Article							DISINFECTANTS	Sodium hypochlorite (NaOCl) is the active ingredient in household bleach and is commonly used as a disinfectant to clean equipment contaminated by the amphibian pathogen Batra-chochytrium dendrobatidis (Bd) in lab husbandry and field studies. We conducted a series of replicated exposure trials using a single Global Pandemic Lineage Bd isolate from Panama (JEL 310) and concentrations of NaOCl ranging from 0.006% to 0.6% for exposure times ranging from 30 seconds to 15 minutes to determine the minimum lethal concentration of NaOCl for this isolate of Bd. Sodium hypochlorite completely killed Bd at a concentration of 0.03% during a 15-minute exposure time, while 0.12% NaOCl was effective at all exposure times (30s-15min).	[Becker, Matthew H.; Gratwicke, Brian] Smithsonian Conservat Biol Inst, Natl Zool Pk, Washington, DC 20008 USA; [Becker, Matthew H.] Liberty Univ, Dept Biol & Chem, Lynchburg, VA USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Liberty University	Gratwicke, B (corresponding author), Smithsonian Conservat Biol Inst, Natl Zool Pk, Washington, DC 20008 USA.	gratwickeb@si.edu		Gratwicke, Brian/0000-0002-7332-4060	U.S. Fish and Wildlife Service Division of International Conservation Amphibians in Decline Fund [FY2014, F14AP00750]; Smithsonian Institution Fellowship; Smithsonian Institution Fellowship Program; United States Fish and Wildlife Service CEACF Award [F14AP00750]	U.S. Fish and Wildlife Service Division of International Conservation Amphibians in Decline Fund; Smithsonian Institution Fellowship(Smithsonian InstitutionSmithsonian National Museum of Natural History); Smithsonian Institution Fellowship Program(Smithsonian InstitutionSmithsonian National Museum of Natural History); United States Fish and Wildlife Service CEACF Award	We are grateful for funding from the U.S. Fish and Wildlife Service Division of International Conservation Amphibians in Decline Fund FY2014, F14AP00750. https://www.fws.gov/international (to BG and MHB) and the Smithsonian Institution Fellowship (MHB) http://www.smithsonianofi.com/fellowship-opportunities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was financially supported by the Smithsonian Institution Fellowship Program and the United States Fish and Wildlife Service CEACF Award F14AP00750. We thank J. Becker and J. Walke for valuable comments and review of the manuscript.	Becker MH, 2011, ECOHEALTH, V8, P501, DOI 10.1007/s10393-012-0743-0; Becker MH, 2015, MOL ECOLOGY; Brem F., 2007, FIELD SAMPLING PROTO; Bryan LK, 2009, DIS AQUAT ORGAN, V84, P89, DOI 10.3354/dao02036; Cashins SD, 2008, DIS AQUAT ORGAN, V80, P63, DOI 10.3354/dao01919; Gagliardo R., 2008, International Zoo Yearbook, V42, P125, DOI 10.1111/j.1748-1090.2008.00043.x; Gold KK, 2013, DIS AQUAT ORGAN, V107, P77, DOI 10.3354/dao02670; Johnson ML, 2003, DIS AQUAT ORGAN, V57, P255, DOI 10.3354/dao057255; Pessier AP, 2009, P IUCN SSC CONS BREE; Rosenblum EB, 2013, P NATL ACAD SCI USA, V110, P9385, DOI 10.1073/pnas.1300130110	10	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176439	10.1371/journal.pone.0176439	http://dx.doi.org/10.1371/journal.pone.0176439			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441417	Green Submitted, Green Published, gold			2022-12-26	WOS:000400308800055
J	Boestfleisch, C; Papenbrock, J				Boestfleisch, Christian; Papenbrock, Jutta			Changes in secondary metabolites in the halophytic putative crop species Crithmum maritimum L., Triglochin maritima L. and Halimione portulacoides (L.) Aellen as reaction to mild salinity	PLOS ONE			English	Article							TOTAL ANTIOXIDANT CAPACITY; SALT-MARSH PLANTS; VITAMIN-C; ABIOTIC STRESS; ORAC ASSAYS; RESPONSES; FRAP; ACCUMULATION; CAROTENOIDS; VEGETABLES	It is assumed that salinity enhances the concentration of valuable metabolites in halophytes. The objective was to find a salt concentration and a point in time at which the yield for the valuable metabolites was maximal. Therefore, three different halophyte species were grown under different salinities and harvested over a period from shortly after stress induction up to three weeks. Various reaction patterns were found in the metabolite composition of the analyzed plant material. Halimione portulacoides showed a "short term response", indicated by an increase in all metabolites analyzed after a few hours, whereas Crithmum maritimum showed a "long term response" through accumulation of proline starting after days. Triglochin maritima did not change in metabolite concentration, but like the other plant species the biomass was reduced by salinity. Generally, a higher production in secondary metabolites by higher salinity was outbalanced by a reduction in biomass production. Concentrations of analyzed antioxidants showed a similar reaction and correlated with each other.	[Boestfleisch, Christian; Papenbrock, Jutta] Leibniz Univ Hannover, Inst Bot, Hannover, Germany	Leibniz University Hannover	Papenbrock, J (corresponding author), Leibniz Univ Hannover, Inst Bot, Hannover, Germany.	Jutta.Papenbrock@botanik.uni-hannover.de			Open Access Fund of the Leibniz Universitat Hannover	Open Access Fund of the Leibniz Universitat Hannover	We thank PD Dr. Frank Schaarschmidt, Institute for Biostatistics, Leibniz Universitat Hannover, for help with the statistics and Annekathrin Rumlow and Jana Theilmann, Institute of Botany, Leibniz Universitat Hannover, for contributing ICP-OES data. The publication of this article was funded by the Open Access Fund of the Leibniz Universitat Hannover.	ADAM P, 1977, NEW PHYTOL, V78, P237, DOI 10.1111/j.1469-8137.1977.tb01561.x; [Anonymous], 1972, MINERAL NUTR PLANTS; Athar H. R., 2009, V44, P1; Atia A, 2011, J MED PLANTS RES, V5, P3564; Ben Amor N, 2005, PLANT SCI, V168, P889, DOI 10.1016/j.plantsci.2004.11.002; Ben Hamed Karim, 2004, Tropical Ecology, V45, P151; Boestfleisch C, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plu046; Breckle SW, 2002, SALINITY: ENVIRONMENT - PLANTS - MOLECULES, P53; Carillo P., 2011, PROMETHEUSWIKI CONTR; Claeys H, 2014, PLANT PHYSIOL, V165, P519, DOI 10.1104/pp.113.234641; Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a; Dat J, 2000, CELL MOL LIFE SCI, V57, P779, DOI 10.1007/s000180050041; de la Rosa L.A., 2010, FRUIT VEGETABLE PHYT; Del Rio D, 2013, ANTIOXID REDOX SIGN, V18, P1818, DOI 10.1089/ars.2012.4581; Dewanto V, 2002, J AGR FOOD CHEM, V50, P3010, DOI 10.1021/jf0115589; Diggelen J, 2006, NEW PHYTOL, V103, P573; Duarte B, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00746; Dudonne S, 2009, J AGR FOOD CHEM, V57, P1768, DOI 10.1021/jf803011r; Eren H, 2015, ANN APPL BIOL, V167, P208, DOI 10.1111/aab.12219; FAO, 2011, STAT WORLDS LAND WAT, P54; Fiedor J, 2014, NUTRIENTS, V6, P466, DOI 10.3390/nu6020466; FRANKE W, 1982, ECON BOT, V36, P163, DOI 10.1007/BF02858711; Gil MI, 2002, J AGR FOOD CHEM, V50, P4976, DOI 10.1021/jf020136b; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Gillespie KM, 2007, NAT PROTOC, V2, P867, DOI 10.1038/nprot.2007.100; Gillespie KM, 2007, NAT PROTOC, V2, P871, DOI 10.1038/nprot.2007.101; GOAS G, 1982, PHYSIOL PLANTARUM, V55, P383, DOI 10.1111/j.1399-3054.1982.tb00309.x; GORHAM J, 1980, PLANT CELL ENVIRON, V3, P309, DOI 10.1111/1365-3040.ep11581858; Guil JL, 1997, PLANT FOOD HUM NUTR, V51, P99, DOI 10.1023/A:1007988815888; Gurkok T, 2015, PLANT MOL BIOL REP, V33, P673, DOI 10.1007/s11105-014-0772-7; Hameed A, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv004; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Huang DJ, 2002, J AGR FOOD CHEM, V50, P4437, DOI 10.1021/jf0201529; Jacobo-Velazquez DA, J FOOD SCI, V74, pR107; KAMPFENKEL K, 1995, ANAL BIOCHEM, V225, P165, DOI 10.1006/abio.1995.1127; Kevers C, 2007, J AGR FOOD CHEM, V55, P8596, DOI 10.1021/jf071736j; Koyro H.-W., 2010, HDB PLANT CROP STRES, P1051; Liebezeit G, 1999, J BIOTECHNOL, V70, P77, DOI 10.1016/S0168-1656(99)00061-9; Liu ZJ, 1998, TREE PHYSIOL, V18, P265; Mabey R., 2012, FOOD FOR FREE; Menezes-Benavente L, 2004, PLANT SCI, V166, P323, DOI 10.1016/j.plantsci.2003.10.001; Ou BX, 2002, J AGR FOOD CHEM, V50, P3122, DOI 10.1021/jf0116606; Panta S, 2014, ENVIRON EXP BOT, V107, P71, DOI 10.1016/j.envexpbot.2014.05.006; Prior RL, 1998, J AGR FOOD CHEM, V46, P2686, DOI 10.1021/jf980145d; Redondo-Gomez S, 2007, ANN BOT-LONDON, V100, P555, DOI 10.1093/aob/mcm119; Rodrigues MJ, 2014, MAR DRUGS, V12, P2228, DOI 10.3390/md12042228; Rodriguez-Mateos A, 2014, J AGR FOOD CHEM, V62, P3842, DOI 10.1021/jf403757g; Seal CE, 2010, SEED SCI RES, V20, P47, DOI 10.1017/S0960258509990250; Selmar D, 2013, IND CROP PROD, V42, P558, DOI 10.1016/j.indcrop.2012.06.020; Shannon MC, 1999, SCI HORTIC-AMSTERDAM, V78, P5, DOI 10.1016/S0304-4238(98)00189-7; Slama I, 2015, ANN BOT-LONDON, V115, P433, DOI 10.1093/aob/mcu239; STEINBERG PD, 1995, OECOLOGIA, V102, P169, DOI 10.1007/BF00333248; Stevens R, 2006, J AGR FOOD CHEM, V54, P6159, DOI 10.1021/jf061241e; STEWART GR, 1974, PLANTA, V120, P279, DOI 10.1007/BF00390296; STOREY R, 1977, OECOLOGIA, V27, P319, DOI 10.1007/BF00345565; Thaipong K, 2006, J FOOD COMPOS ANAL, V19, P669, DOI 10.1016/j.jfca.2006.01.003; Ventura Y, 2015, ANN BOT-LONDON, V115, P529, DOI 10.1093/aob/mcu173; Weese A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00009; Wenzel A, 2015, METABOLOMICS, V11, P454, DOI 10.1007/s11306-014-0708-0; Wu XL, 2004, J FOOD COMPOS ANAL, V17, P407, DOI 10.1016/j.jfca.2004.03.001; Wu XL, 2004, J AGR FOOD CHEM, V52, P4026, DOI 10.1021/jf049696w; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	62	34	34	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176303	10.1371/journal.pone.0176303	http://dx.doi.org/10.1371/journal.pone.0176303			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441407	gold, Green Published, Green Submitted			2022-12-26	WOS:000400308800041
J	Ichikawa, HT; Cooper, JC; Lo, L; Potter, J; Terns, RM; Terns, MP				Ichikawa, H. Travis; Cooper, John C.; Lo, Leja; Potter, Jason; Terns, Rebecca M.; Terns, Michael P.			Programmable type III-A CRISPR-Cas DNA targeting modules	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; RNA CLEAVAGE; CSM COMPLEX; IMMUNITY; DEGRADATION; BIOLOGY; SYSTEMS; DEFENSE	The CRISPR-Cas systems provide invader defense in a wide variety of prokaryotes, as well as technologies for many powerful applications. The Type III-A or Csm CRISPR-Cas system is one of the most widely distributed across prokaryotic phyla, and cleaves targeted DNA and RNA molecules. In this work, we have constructed modules of Csm systems from 3 bacterial species and heterologously expressed the functional modules in E. coli. The modules include a Cas6 protein and a CRISPR locus for crRNA production, and Csm effector complex proteins. The expressed modules from L. lactis, S. epidermidis and S. thermophilus specifically eliminate invading plasmids recognized by the crRNAs of the systems. Characteristically, activation of plasmid targeting activity depends on transcription of the plasmid sequence recognized by the crRNA. Activity was not observed when transcription of the crRNA target sequence was blocked, or when the opposite strand or a non-target sequence was transcribed. Moreover, the Csm module can be programmed to recognize plasmids with novel target sequences by addition of appropriate crRNA coding sequences to the module. These systems provide a platform for investigation of Type III-A CRISPR-Cas systems in E. coli, and for introduction of programmable transcription-activated DNA targeting into novel organisms.	[Ichikawa, H. Travis; Cooper, John C.; Lo, Leja; Terns, Rebecca M.; Terns, Michael P.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Potter, Jason] Thermo Fisher Sci, Carlsbad, CA USA; [Terns, Michael P.] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Terns, Michael P.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; Thermo Fisher Scientific; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Terns, RM; Terns, MP (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.; Terns, MP (corresponding author), Univ Georgia, Dept Genet, Athens, GA 30602 USA.; Terns, MP (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.	rterns@bmb.uga.edu; mterns@uga.edu		Terns, Michael/0000-0001-8330-1789	Life Technologies/Thermo Fisher Scientific; National Institutes of Health [R01 GM099876, R35 GM118160]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118160] Funding Source: NIH RePORTER	Life Technologies/Thermo Fisher Scientific; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was generously funded by a Sponsored Research Agreement from Life Technologies/Thermo Fisher Scientific, and the National Institutes of Health R01 GM099876 to MPT and RMT, and R35 GM118160 to MPT. (tittps /Avww nig rT1S nih goy/Pages/default aspx). Life Technologies/Thermo Fisher Scientific. The funder provided support in the form of salaries for authors [HTI, JCC and LJ]. The specific roles of these authors are articulated in the 'author contributions' section. Life Technologies/Thermo Fisher Scientific played a role in study design, data analysis, decision to publish and preparation of the manuscript.	Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cong L, 2015, METHODS MOL BIOL, V1239, P197, DOI 10.1007/978-1-4939-1862-1_10; Elmore JR, 2016, GENE DEV, V30, P447, DOI 10.1101/gad.272153.115; Estrella MA, 2016, GENE DEV, V30, P460, DOI 10.1101/gad.273722.115; Goldberg GW, 2014, NATURE; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hatoum-Aslan A, 2014, J BACTERIOL, V196, P310, DOI 10.1128/JB.01130-13; Jackson RN, 2015, MOL CELL, V58, P722, DOI 10.1016/j.molcel.2015.05.023; Jiang FG, 2015, CURR OPIN STRUC BIOL, V30, P100, DOI 10.1016/j.sbi.2015.02.002; Jiang WY, 2016, CELL, V164, P710, DOI 10.1016/j.cell.2015.12.053; Jung TY, 2015, STRUCTURE, V23, P782, DOI 10.1016/j.str.2015.01.021; Kazlauskiene M, 2016, MOL CELL, V62, P295, DOI 10.1016/j.molcel.2016.03.024; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Millen AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051663; NAKANO Y, 1995, GENE, V162, P157, DOI 10.1016/0378-1119(95)00320-6; Numata T, 2015, J MOL BIOL, V427, P259, DOI 10.1016/j.jmb.2014.09.029; Ramia NF, 2014, NUCLEIC ACIDS RES, V42, P1129, DOI 10.1093/nar/gkt914; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Staals RHJ, 2014, MOL CELL, V56, P518, DOI 10.1016/j.molcel.2014.10.005; Tamulaitis G, 2014, MOL CELL, V56, P506, DOI 10.1016/j.molcel.2014.09.027; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Terns RM, 2014, TRENDS GENET, V30, P111, DOI 10.1016/j.tig.2014.01.003; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Vestergaard G, 2014, RNA BIOL, V11, P156, DOI 10.4161/rna.27990; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035	29	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176221	10.1371/journal.pone.0176221	http://dx.doi.org/10.1371/journal.pone.0176221			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441427	gold, Green Published, Green Submitted			2022-12-26	WOS:000400308800035
J	Boo, S; Oh, H; Froelicher, ES; Suh, CH				Boo, Sunjoo; Oh, Hyunjin; Froelicher, Erika S.; Suh, Chang-Hee			Knowledge and perception of cardiovascular disease risk among patients with rheumatoid arthritis	PLOS ONE			English	Article							HEALTH-ASSESSMENT QUESTIONNAIRE; CORONARY-HEART-DISEASE; WOMENS AWARENESS; PREVENTION; EXERCISE; HYPERTENSION; POPULATION; VALIDATION; GUIDELINES; EDUCATION	Patients with rheumatoid arthritis are at increased risk for cardiovascular disease. The prerequisites for reducing the risk of cardiovascular disease are adequate levels of knowledge and being aware of the risk. In this study, the levels of knowledge about cardiovascular disease among patients with rheumatoid arthritis and the perception were evaluated in relation to their actual 10-year risk of cardiovascular disease. This cross-sectional study of 200 patients with rheumatoid arthritis was conducted in a university-affiliated hospital in South Korea. The patients' actual risk of cardiovascular disease was estimated using the Framingham Risk Score. The most common risk factor was physical inactivity, with 77% of the patients not engaging in regular exercise. The patients lacked knowledge about the effects of physical inactivity and anti-inflammatory medication on the development of cardiovascular disease. Misperceptions about the risk of cardiovascular disease were common, i.e., 19.5% of the patients underestimated their risk and 41% overestimated. Hypertension, diabetes, obesity, and smoking were the most prevalent among the patients who underestimated their risk, and these same patients had the lowest level of knowledge about cardiovascular disease. This study demonstrated the rheumatoid arthritis patients' lack of knowledge about the effects of physical inactivity and anti-inflammatory medications on the development of cardiovascular disease, and their misperception of cardiovascular risk was common. As a preventive measure, educational programs about cardiovascular disease should be tailored specifically for patients with rheumatoid arthritis, and behavioral interventions, including routine exercise, should be made available at the time of diagnosis.	[Boo, Sunjoo] Ajou Univ, Coll Nursing, Inst Nursing Sci, Suwon, Gyeonggi Do, South Korea; [Oh, Hyunjin] Gachon Univ, Coll Nursing, Incheon, South Korea; [Froelicher, Erika S.] Univ Calif San Francisco, Sch Nursing & Med, San Francisco, CA 94143 USA; [Suh, Chang-Hee] Ajou Univ, Sch Med, Dept Rheumatol, Suwon, Gyeonggi Do, South Korea	Ajou University; Gachon University; University of California System; University of California San Francisco; Ajou University	Suh, CH (corresponding author), Ajou Univ, Sch Med, Dept Rheumatol, Suwon, Gyeonggi Do, South Korea.	chsuh@ajou.ac.kr	Suh, Chang-Hee/H-9723-2019	Suh, Chang-Hee/0000-0001-6156-393X	new faculty research fund of Ajou University School of Medicine [M2015C046000080]	new faculty research fund of Ajou University School of Medicine	This work was supported by the new faculty research fund of Ajou University School of Medicine (M2015C046000080) (SB). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arts EEA, 2015, ANN RHEUM DIS, V74, P668, DOI 10.1136/annrheumdis-2013-204024; Aubry MC, 2007, J RHEUMATOL, V34, P937; Balanescu Serban, 2010, Maedica (Bucur), V5, P292; Barzi F, 2007, J EPIDEMIOL COMMUN H, V61, P115, DOI 10.1136/jech.2005.044842; Boo S, 2012, ASIAN NURS RES, V6, P49, DOI 10.1016/j.anr.2012.05.002; Choi EJ, 2010, INT J NURS STUD, V47, P452, DOI 10.1016/j.ijnurstu.2009.09.002; Dessein PH, 2004, J RHEUMATOL, V31, P867; Ferrer RA, 2015, CURR OPIN PSYCHOL, V5, P85, DOI 10.1016/j.copsyc.2015.03.012; Frijling BD, 2004, PATIENT EDUC COUNS, V52, P47, DOI 10.1016/S0738-3991(02)00248-3; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Homko J, 2008, J CARDIOVASC NURS, V23, P332, DOI 10.1097/01.JCN.0000317432.44586.aa; Jee SH, 2005, AM J EPIDEMIOL, V162, P42, DOI 10.1093/aje/kwi166; John H, 2007, RHEUMATOLOGY, V46, P1513, DOI 10.1093/rheumatology/kem176; John H, 2009, PATIENT EDUC COUNS, V77, P136, DOI 10.1016/j.pec.2009.03.014; Katapodi MC, 2004, PREV MED, V38, P388, DOI 10.1016/j.ypmed.2003.11.012; Kievit W, ARTHRITIS C IN PRESS; Kim C, 2007, DIABETES CARE, V30, P2281, DOI 10.2337/dc07-0618; Kim EM, 2011, KOREAN CIRC J, V41, P259, DOI 10.4070/kcj.2011.41.5.259; Ko Y, 2016, JPN J NURS SCI, V13, P65, DOI 10.1111/jjns.12087; Lee JH, 2014, KOREAN J INTERN MED, V29, P76, DOI 10.3904/kjim.2014.29.1.76; Lee SS, 2006, CLIN RHEUMATOL, V25, P353, DOI 10.1007/s10067-005-0049-5; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; Lynch EB, 2006, AM J EPIDEMIOL, V164, P1171, DOI 10.1093/aje/kwj334; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P402, DOI 10.1002/art.20853; Metsios GS, 2008, RHEUMATOLOGY, V47, P239, DOI 10.1093/rheumatology/kem260; Metsios GS, 2014, ANN RHEUM DIS, V73, P748, DOI 10.1136/annrheumdis-2013-203291; Michos ED, 2006, ATHEROSCLEROSIS, V184, P201, DOI 10.1016/j.atherosclerosis.2005.04.004; Mosca L, 2006, CIRCULATION, V113, P525, DOI 10.1161/CIRCULATIONAHA.105.588103; Mosca L, 2011, J AM COLL CARDIOL, V57, P1404, DOI [10.1016/j.jacc.2011.02.005, 10.1161/CIR.0b013e31820faaf8]; Niedermann K, 2004, ARTHRIT RHEUM-ARTHR, V51, P388, DOI 10.1002/art.20399; Panoulas VF, 2008, RHEUMATOLOGY, V47, P72, DOI 10.1093/rheumatology/kem311; Park SH, 2008, J KOREAN ACAD NURS, V38, P403, DOI 10.4040/jkan.2008.38.3.403; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Peters MJL, 2010, ANN RHEUM DIS, V69, P325, DOI 10.1136/ard.2009.113696; Pincus T, 1999, ARTHRITIS RHEUM-US, V42, P2220, DOI 10.1002/1529-0131(199910)42:10<2220::AID-ANR26>3.0.CO;2-5; Riemsma RP, 2004, ARTHRIT RHEUM-ARTHR, V51, P1045, DOI 10.1002/art.20823; Rosenstock I.M., 1990, HLTH BEHAV HLTH ED T, P39; Segan CJ, 2004, HEALTH PSYCHOL, V23, P86, DOI 10.1037/0278-6133.23.1.86; Sheeran P, 2014, PSYCHOL BULL, V140, P511, DOI 10.1037/a0033065; Sibley C, 2006, J WOMENS HEALTH, V15, P54, DOI 10.1089/jwh.2006.15.54; Solomon DH, 2003, CIRCULATION, V107, P1303, DOI 10.1161/01.CIR.0000054612.26458.B2; Stavropoulos-Kalinoglou A, 2013, ANN RHEUM DIS, V72, P1819, DOI 10.1136/annrheumdis-2012-202075; Sung YK, 2012, SEMIN ARTHRITIS RHEU, V41, P745, DOI 10.1016/j.semarthrit.2011.09.007; 허남욱, 2008, [Journal of Rheumatic Diseases, 대한류마티스학회지], V15, P11; World Health Organization, AS PAC PERSP RED OB	45	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176291	10.1371/journal.pone.0176291	http://dx.doi.org/10.1371/journal.pone.0176291			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET4XE	28437445	Green Published, Green Submitted, gold			2022-12-26	WOS:000400287600041
J	Wang, ZK; Liu, H; Dou, MM; Du, X; Hu, JJ; Su, N; Wang, Y; Zhang, R; Li, CQ				Wang, Zongkui; Liu, Hua; Dou, Miaomiao; Du, Xi; Hu, Jijun; Su, Na; Wang, Ya; Zhang, Rong; Li, Chongqing			The quality changes in fresh frozen plasma of the blood donors at high altitude	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; FACTOR-VIII; AGE; PARAMETERS; FIBRINOGEN; INCREASES; PLATELET; RISK; SEX	Objective According to the international guidelines, fresh frozen plasma (FFP) is unanimously used to treat coagulation disorders. The quality of FFP is critical for the clinical transfusion. Till now, few studies have integratedly evaluated the differences of FFP from blood donors at between high altitude (HA) and low altitude (LA). Besides, there were no special quality standards for HA FFP in China. Materials and methods Up to 41 HA (Lhasa, 3700 m) and 46 LA (Chengdu, 500 m) blood donors were included in our study to estimate the differences of FFP from HA and LA blood donors. The concentration of total plasma proteins, prothrombin time (PT), activated partial thromboplastin time (aPTT), thrombin time (TT), fibrinogen (Fbg), factor (F) II, FV, FVII, FVIII, FIX, FX, FXI, FXII, D-dimer, protein C (PC), protein S (PS), antithrombin III (ATIII) and von Willebrand factor antigen (vWF:Ag) were determined, respectively. Result As compared with FFP of LA blood donors, the total protein content of HA blood donors showed a significant decrease (65.2 +/- 8.9 vs.57.2 +/- 6.3 g/L; p < 0.001); PT, aPTT, TT were significantly increased (p < 0.001); the levels of FII, FV, FVII, FVIII, FIX, FX, FXI, FXII and vWF: Ag were notably decreased (all p < 0.05), whereas Fbg and D-dimer were dramaticly increased (p = 0.038). Additionly, in HA blood donors, vWF: Ag and FVIII: C of O-group was significantly lower (p < 0.05) than that of non-O-group. It should be noted that FVIII: C of HA blood donors (0.64 +/- 0.10 IU/mL) was lower than the current Chinese quality requirements for FFP (>= 0.7 IU/ml). No significant differences were observed in PC, PS and ATIII. Conclusion In general, our findings showed that the quality of FFP was significantly different between HA and LA blood donors, and the current Chinese quality requirements of FFP are not suitable for HA FFP. Therefore, setting up a special quality requirement for HA is quite necessary and meaningful.	[Wang, Zongkui; Dou, Miaomiao; Du, Xi; Su, Na; Wang, Ya; Zhang, Rong; Li, Chongqing] Chinese Acad Med Sci, Inst Blood Transfus, Chengdu, Peoples R China; [Liu, Hua] Tibet Autonomous Reg Blood Ctr, Lhasa, Tibet, Peoples R China; [Hu, Jijun] Guizhou Taibang Biol Prod Co Ltd, Guiyang, Guizhou, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Blood Transfusion - CAMS	Zhang, R; Li, CQ (corresponding author), Chinese Acad Med Sci, Inst Blood Transfus, Chengdu, Peoples R China.	kylie2009@foxmail.com; lichangqing268@163.com	Wang, Zongkui/K-6815-2019; Wang, Zongkui/F-8131-2017	Wang, Zongkui/0000-0002-5764-7660; Wang, Zongkui/0000-0002-5764-7660; Zhang, Rong/0000-0003-4480-7191	Provincial Science and Technology [2014SZ0123]; Guizhou Taibang Biological Products Co., Ltd	Provincial Science and Technology; Guizhou Taibang Biological Products Co., Ltd	Provincial Science and Technology, the funder of 2014SZ0123, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Guizhou Taibang Biological Products Co., Ltd provided support in the form of salaries for JJ Hu, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CONLAN MG, 1993, THROMB HAEMOSTASIS, V70, P380; Favaloro EJ, 2005, AM J CLIN PATHOL, V124, P910, DOI 10.1309/W76QF806CE80CL2T; Frisancho AR, 2013, AM J HUM BIOL, V25, P151, DOI 10.1002/ajhb.22367; Gambhir RPS., 2014, IND J VASC ENDOVASC, V1, P20, DOI [10.4103/0972-0820.142362, DOI 10.4103/0972-0820.142362]; Hefti JP, 2010, SWISS MED WKLY, V140, P111, DOI smw-12910; Iorio A, 2008, BLOOD TRANSFUS-ITALY, V6, P211, DOI 10.2450/2008.0042-07; Jha SK, 2002, HIGH ALT MED BIOL, V3, P21, DOI 10.1089/152702902753639513; Kohler HP, 2013, BLOOD, V121, P1931, DOI 10.1182/blood-2013-01-479055; Kokame K, 2011, J THROMB HAEMOST, V9, P1426, DOI 10.1111/j.1538-7836.2011.04333.x; Kotwal J, 2007, THROMB RES, V120, P391, DOI 10.1016/j.thromres.2006.09.013; Liu Y, 2014, MILITARY MED RES, V1, DOI 10.1186/2054-9369-1-19; MAHER JT, 1976, J APPL PHYSIOL, V41, P702, DOI 10.1152/jappl.1976.41.5.702; Miller CH, 2003, J THROMB HAEMOST, V1, P2191, DOI 10.1046/j.1538-7836.2003.00367.x; National Health and Family Planning Commission of the People's Republic of China, 2011, WHOL BLOOD COMP DON; National Health and Family Planning Commission of the People's Republic of China, 2000, TECHN CRIT CLIN BLOO; National Health and Family Planning Commission of the People's Republic of China, 2012, QUAL REQ WHOL BLOOD; Schofield WN, 2003, MED J AUSTRALIA, V178, P117, DOI 10.5694/j.1326-5377.2003.tb05101.x; SINGH I, 1972, BRIT HEART J, V34, P611; Stanworth SJ, 2011, TRANSFUSION, V51, P62, DOI 10.1111/j.1537-2995.2010.02798.x; Theusinger OM, 2010, THROMB HAEMOSTASIS, V104, P385, DOI 10.1160/TH09-12-0858; Vij AG, 2009, PLATELETS, V20, P421, DOI 10.1080/09537100903116516; Wang ZK, 2017, PEERJ, V5, DOI 10.7717/peerj.3156; Weitz CA, 2004, AM J HUM BIOL, V16, P405, DOI 10.1002/ajhb.20042	23	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0176390	10.1371/journal.pone.0176390	http://dx.doi.org/10.1371/journal.pone.0176390			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430802	Green Submitted, Green Published, gold			2022-12-26	WOS:000399876100044
J	Raballah, E; Kempaiah, P; Karim, Z; Orinda, GO; Otieno, MF; Perkins, DJ; Ong'echa, JM				Raballah, Evans; Kempaiah, Prakasha; Karim, Zachary; Orinda, George O.; Otieno, Michael F.; Perkins, Douglas J.; Ong'echa, John Michael			CD4 T-cell expression of IFN-gamma and IL-17 in pediatric malarial anemia	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; TUMOR-NECROSIS-FACTOR; INTERFERON-GAMMA; KENYAN CHILDREN; REGULATORY CYTOKINES; CEREBRAL MALARIA; CENTRAL MEMORY; AGE PATTERNS; IN-VIVO; TRANSMISSION	In Plasmodium falciparum holoendemic transmission regions of western Kenya, life-threatening pediatric malaria manifests primarily as severe malarial anemia (SMA, Hb <= 6.0 g/dL with any density parasitemia). To determine the role that CD4+ T-cell-driven inflammatory responses have in the pathogenesis of SMA, peripheral CD4+ T-cell populations and their intracellular production of pro-inflammatory cytokines (IFN-gamma and IL-17) were characterized in children aged 12-36 months of age stratified into two groups: non-severe malarial anemia (non-SMA, Hb <= 6.0 g/dL, n = 50) and SMA (n = 39). In addition, circulating IFN-gamma and IL-17 were measured as part of a Cytokine 25-plex Antibody Bead Kit, Human (BioSource (TM) International). Children with SMA had higher overall proportions of circulating lymphocytes (P = 0.003) and elevated proportions of lymphocytes expressing IFN-gamma (P = 0.014) and comparable IL-17 (P = 0.101). In addition, SMA was characterized by decreased memory-like T-cells (CD4+ CD45RA-) expressing IL-17 (P = 0.009) and lower mean fluorescence intensity in memory-like CD4+ T-cells for both IFN-gamma (P = 0.063) and IL-17 (P = 0.006). Circulating concentrations of IFN-gamma were higher in children with SMA (P = 0.009), while IL-17 levels were comparable between the groups (P = 0.164). Furthermore, circulating levels of IFN-gamma were negatively correlated with IL-17 levels in both groups of children (SMA: r = -0.610, P = 0.007; and non-SMA: r = -0.516, P = 0.001), while production of both cytokines by lymphocytes were positively correlated (SMA: r = 0.349, P = 0.037; and non-SMA: r = 0.475, P = 0.001). In addition, this correlation was only maintained by the memory-like CD4+ T cells (r = 0.365, P = 0.002) but not the naive-like CD4+ T cells. However, circulating levels of IFN-gamma were only associated with naive-like CD4+ T cells producing IFN-gamma. (r = 0.547, P = 0.028), while circulating levels of IL-17 were not associated with any of the cell populations. Taken together, these results suggest that enhanced severity of malarial anemia is associated with higher overall levels of circulating lymphocytes, enhanced intracellular production of IFN-gamma by peripheral lymphocytes and high circulating IFN-gamma levels. In addition, the observed inverse relationship between the circulating levels of IFN-gamma and IL-17 together with the reduction in the levels of memory-like CD4+ T cells expressing IL-17 in children with SMA may suggest possible relocation of these cells in the deeper tissues for their pathological effect.	[Raballah, Evans; Perkins, Douglas J.; Ong'echa, John Michael] Univ New Mexico, Labs Parasit & Viral Dis, Ctr Global Hlth Res, Kenya Med Res Inst, Kisumu, Kenya; [Raballah, Evans] Masinde Muliro Univ Sci & Technol, Dept Med Lab Sci, Kakamega, Kenya; [Raballah, Evans; Orinda, George O.] Kenyatta Univ, Dept Biochem & Biotechnol, Nairobi, Kenya; [Kempaiah, Prakasha; Karim, Zachary; Perkins, Douglas J.] Univ New Mexico, Hlth Sci Ctr, Dept Internal Med, Ctr Global Hlth, Albuquerque, NM 87131 USA; [Otieno, Michael F.] Kenyatta Univ, Dept Med Lab Sci, Nairobi, Kenya	Kenya Medical Research Institute; Kenyatta University; University of New Mexico; University of New Mexico's Health Sciences Center; Kenyatta University	Ong'echa, JM (corresponding author), Univ New Mexico, Labs Parasit & Viral Dis, Ctr Global Hlth Res, Kenya Med Res Inst, Kisumu, Kenya.	michaelongecha@yahoo.com	Kempaiah, Prakasha/ABC-6485-2020; Raballah, Evans/AAJ-6604-2021	Kempaiah, Prakasha/0000-0002-2901-0339; Raballah, Evans/0000-0002-3304-6836; Ong'echa, John/0000-0003-3928-6774	National Institutes of Health [R01 AI51305-07, TW05884-07]; Fogarty International Center grant [R01 TW007631-03]; FOGARTY INTERNATIONAL CENTER [D43TW005884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051305] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center grant; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the Fogarty International Center grant R01 TW007631-03 (JMO) and National Institutes of Health grants R01 AI51305-07 (DJP) and TW05884-07 (DJP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDALLA SH, 1984, T ROY SOC TROP MED H, V78, P60, DOI 10.1016/0035-9203(84)90173-1; Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; [Anonymous], 2008, WORLD MAL REP 2008; Armah HB, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-147; Ayimba E, 2011, CLIN EXP IMMUNOL, V166, P218, DOI 10.1111/j.1365-2249.2011.04474.x; Berkley J, 1999, T ROY SOC TROP MED H, V93, P283, DOI 10.1016/S0035-9203(99)90024-X; Biemba G, 1998, TROP MED INT HEALTH, V3, P60, DOI 10.1046/j.1365-3156.1998.00168.x; Bloland PB, 1999, AM J TROP MED HYG, V60, P641, DOI 10.4269/ajtmh.1999.60.641; BLOLAND PB, 1993, J INFECT DIS, V167, P932, DOI 10.1093/infdis/167.4.932; Boyle MJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005041; BYRD TF, 1993, J CLIN INVEST, V91, P969, DOI 10.1172/JCI116318; Camacho LH, 1998, ANN TROP MED PARASIT, V92, P525, DOI 10.1080/00034989859221; Chang KH, 2004, INT J PARASITOL, V34, P1501, DOI 10.1016/j.ijpara.2004.10.008; Chelimo K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024852; CLARK IA, 1988, BRIT J HAEMATOL, V70, P99, DOI 10.1111/j.1365-2141.1988.tb02440.x; Day NPJ, 1999, J INFECT DIS, V180, P1288, DOI 10.1086/315016; de Bruin AM, 2014, BLOOD, V124, P2479, DOI 10.1182/blood-2014-04-568451; Ekvall H, 2003, CURR OPIN HEMATOL, V10, P108, DOI 10.1097/00062752-200303000-00002; Ekvall Hakan, 2001, American Journal of Tropical Medicine and Hygiene, V64, P58; Fendel R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010038; Gitau EN, 2014, J IMMUNOL, V192, P1753, DOI 10.4049/jimmunol.1200547; Helleberg M, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-56; Helmby H, 2009, J IMMUNOL, V182, P5663, DOI 10.4049/jimmunol.0803790; Hillman R., 1996, RED CELL MANUAL; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Ishida H, 2010, BIOCHEM BIOPH RES CO, V402, P790, DOI 10.1016/j.bbrc.2010.10.114; Jagannathan P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003864; Jason J, 2001, CLIN EXP IMMUNOL, V126, P466, DOI 10.1046/j.1365-2249.2001.01707.x; Keller CC, 2006, INFECT IMMUN, V74, P5249, DOI 10.1128/IAI.00843-06; Keswani T, 2014, EXP PARASITOL, V141, P82, DOI 10.1016/j.exppara.2014.03.003; Kitua AY, 1997, TROP MED INT HEALTH, V2, P325; Ladhani S, 2002, BRIT J HAEMATOL, V119, P839, DOI 10.1046/j.1365-2141.2002.03904.x; LANGHORNE J, 1989, IMMUNOL REV, V112, P71, DOI 10.1111/j.1600-065X.1989.tb00553.x; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Leavy O, 2011, NAT REV IMMUNOL, V11, P160, DOI 10.1038/nri2942; Liu TP, 2013, J IMMUNOL, V191, P178, DOI 10.4049/jimmunol.1201190; Luty AJF, 2000, INFECT IMMUN, V68, P3909, DOI 10.1128/IAI.68.7.3909-3915.2000; Luty AJF, 1999, J INFECT DIS, V179, P980, DOI 10.1086/314689; Luxemburger C, 1998, T ROY SOC TROP MED H, V92, P45, DOI 10.1016/S0035-9203(98)90950-6; MAMUS SW, 1985, J CLIN INVEST, V75, P1496, DOI 10.1172/JCI111853; Mandala WL, 2016, CLIN VACCINE IMMUNOL, V23, P95, DOI 10.1128/CVI.00564-15; McCall MBB, 2010, J INFECT DIS, V201, P142, DOI 10.1086/648596; McElroy PD, 1999, AM J TROP MED HYG, V61, P932, DOI 10.4269/ajtmh.1999.61.932; MEANS RT, 1992, BLOOD, V80, P1639; MEDING SJ, 1990, INFECT IMMUN, V58, P3671, DOI 10.1128/IAI.58.11.3671-3678.1990; Megnekou R, 2015, SCAND J IMMUNOL, V81, P508, DOI 10.1111/sji.12286; Menendez C, 2000, PARASITOL TODAY, V16, P469, DOI 10.1016/S0169-4758(00)01774-9; Mullarky IK, 2007, INFECT IMMUN, V75, P2630, DOI 10.1128/IAI.01836-06; Novelli EM, 2010, BRIT J HAEMATOL, V149, P711, DOI 10.1111/j.1365-2141.2010.08147.x; Obonyo CO, 2007, ANN TROP MED PARASIT, V101, P281, DOI 10.1179/136485907X176337; Okiro EA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-285; Okiro EA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-4; Ong'echa JM, 2006, AM J TROP MED HYG, V74, P376, DOI 10.4269/ajtmh.2006.74.376; Ong'echa JMO, 2003, AM J TROP MED HYG, V68, P590, DOI 10.4269/ajtmh.2003.68.590; Ong'echa JM, 2008, CLIN IMMUNOL, V126, P211, DOI 10.1016/j.clim.2007.08.007; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Otieno RO, 2006, AIDS, V20, P275, DOI 10.1097/01.aids.0000200533.56490.b7; Ouma C, 2012, HUM GENET, V131, P289, DOI 10.1007/s00439-011-1076-8; Perez-Mazliah D, 2015, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00671; Perkins DJ, 2011, INT J BIOL SCI, V7, P1427, DOI 10.7150/ijbs.7.1427; Perkmann T, 2005, CYTOKINE, V29, P153, DOI 10.1016/j.cyto.2004.10.008; Phawong C, 2010, IMMUNOGENETICS, V62, P345, DOI 10.1007/s00251-010-0439-y; PHILLIPS RE, 1992, BAILLIERE CLIN HAEM, V5, P315, DOI 10.1016/S0950-3536(11)80022-3; Portugal S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004079; Robinson LJ, 2009, INFECT IMMUN, V77, P3033, DOI 10.1128/IAI.00211-09; Roca-Feltrer A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-282; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Spiegel A, 2003, T ROY SOC TROP MED H, V97, P198, DOI 10.1016/S0035-9203(03)90117-9; Stephens R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001208; Su Z, 2000, INFECT IMMUN, V68, P4399, DOI 10.1128/IAI.68.8.4399-4406.2000; Silva ALT, 2013, MICROBES INFECT, V15, P837, DOI 10.1016/j.micinf.2013.07.009; Thawani N, 2006, EXP HEMATOL, V34, P1451, DOI 10.1016/j.exphem.2006.06.014; TROYEBLOMBERG M, 1989, J IMMUNOL, V143, P3043; Villegas-Mendez A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003293; Were T, 2011, J CLIN MICROBIOL, V49, P671, DOI 10.1128/JCM.01864-10; Were T, 2006, HAEMATOLOGICA, V91, P1396; WHO, 2015, WORLD MAL REP 2015; Wickramasinghe SN, 2000, BEST PRACT RES CL HA, V13, P277, DOI 10.1053/beha.1999.0072	80	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175864	10.1371/journal.pone.0175864	http://dx.doi.org/10.1371/journal.pone.0175864			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426727	Green Published, Green Submitted, gold			2022-12-26	WOS:000399875900059
J	Schumacher, SE; Shim, BY; Corso, G; Ryu, MH; Kang, YK; Roviello, F; Saksena, G; Peng, SY; Shivdasani, RA; Bass, AJ; Beroukhim, R				Schumacher, Steven E.; Shim, Byoung Yong; Corso, Giovanni; Ryu, Min-Hee; Kang, Yoon-Koo; Roviello, Franco; Saksena, Gordon; Peng, Shouyong; Shivdasani, Ramesh A.; Bass, Adam J.; Beroukhim, Rameen			Somatic copy number alterations in gastric adenocarcinomas among Asian and Western patients	PLOS ONE			English	Article							MICROSATELLITE INSTABILITY; UNITED-STATES; HELICOBACTER-PYLORI; D2 LYMPHADENECTOMY; SURVIVAL BENEFIT; CANCER; CARCINOMA; PATTERNS; CARDIA; MUTATIONS	Gastric cancer, a leading worldwide cause of cancer mortality, shows high geographic and ethnic variation in incidence rates, which are highest in East Asia. The anatomic locations and clinical behavior also differ by geography, leading to the controversial idea that Eastern and Western forms of the disease are distinct. In view of these differences, we investigated whether gastric cancers from Eastern and Western patients show distinct genomic profiles. We used high-density profiling of somatic copy-number aberrations to analyze the largest collection to date of gastric adenocarcinomas and utilized genotyping data to rigorously annotate ethnic status. The size of this collection allowed us to accurately identify regions of significant copy-number alteration and separately to evaluate tumors arising in Eastern and Western patients. Among molecular subtypes classified by The Cancer Genome Atlas, the frequency of gastric cancers showing chromosomal instability was modestly higher in Western patients. After accounting for this difference, however, gastric cancers arising in Easterners and Westerners have highly similar somatic copy-number patterns. Only one genomic event, focal deletion of the phosphatase gene PTPRD, was significantly enriched in Western cases, though also detected in Eastern cases. Thus, despite the different risk factors and clinical features, gastric cancer appears to be a fundamentally similar disease in both populations and the divergent clinical outcomes cannot be ascribed to different underlying structural somatic genetic aberrations.	[Schumacher, Steven E.; Shim, Byoung Yong; Peng, Shouyong; Shivdasani, Ramesh A.; Bass, Adam J.; Beroukhim, Rameen] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Schumacher, Steven E.; Saksena, Gordon; Bass, Adam J.; Beroukhim, Rameen] Broad Inst MIT & Harvard, Canc Program, Cambridge, MA 02142 USA; [Corso, Giovanni; Roviello, Franco] Univ Hosp, Dept Human Pathol, Siena, Italy; [Ryu, Min-Hee; Kang, Yoon-Koo] Univ Ulsan, Coll Med, Dept Oncol, Asan Med Ctr, Seoul, South Korea; [Shivdasani, Ramesh A.; Bass, Adam J.; Beroukhim, Rameen] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Shivdasani, Ramesh A.; Bass, Adam J.; Beroukhim, Rameen] Harvard Med Sch, Boston, MA 02115 USA; [Shim, Byoung Yong] Catholic Univ Korea, St Vincents Hosp, Suwon, South Korea	Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Siena; University Hospital of Siena; University of Ulsan; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Catholic University of Korea	Shivdasani, RA; Bass, AJ; Beroukhim, R (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Bass, AJ; Beroukhim, R (corresponding author), Broad Inst MIT & Harvard, Canc Program, Cambridge, MA 02142 USA.; Shivdasani, RA; Bass, AJ; Beroukhim, R (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.; Shivdasani, RA; Bass, AJ; Beroukhim, R (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	ramesh_shivdasani@dfci.harvard.edu; adam_bass@dfci.harvard.edu; rameen_beroukhim@dfci.harvard.edu	Roviello, Franco/K-5707-2016; Corso, Giovanni/AAN-5976-2020		National Institutes of Health Specialized Programs of Research Excellence [P50CA127003]; American Cancer Society Research Scholar Grant; Dana-Farber Cancer Institute/Novartis Drug Discovery Program	National Institutes of Health Specialized Programs of Research Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Research Scholar Grant(American Cancer Society); Dana-Farber Cancer Institute/Novartis Drug Discovery Program	AJB received funding from National Institutes of Health Specialized Programs of Research Excellence grant P50CA127003 (https://grants.nih.gov) and an American Cancer Society Research Scholar Grant (http://www.cancer.org). RAS and RB received funding from the Dana-Farber Cancer Institute/Novartis Drug Discovery Program (http://www.dana-farber.org/,https://www.nibr.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290; Bickenbach K, 2012, J GASTRIC CANCER, V12, P55, DOI 10.5230/jgc.2012.12.2.55; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Bonenkamp JJ, 1999, NEW ENGL J MED, V340, P908, DOI 10.1056/NEJM199903253401202; Carter S. L., 2011, PREPRINT; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Conteduca V, 2013, INT J ONCOL, V42, P5, DOI 10.3892/ijo.2012.1701; CORREA P, 1995, AM J SURG PATHOL, V19, pS37; Cuschieri A, 1999, BRIT J CANCER, V79, P1522, DOI 10.1038/sj.bjc.6690243; Deng NT, 2012, GUT, V61, P673, DOI 10.1136/gutjnl-2011-301839; Dicken BJ, 2005, ANN SURG, V241, P27, DOI 10.1097/01.sla.0000149300.28588.23; Dulak AM, 2012, CANCER RES, V72, P4383, DOI 10.1158/0008-5472.CAN-11-3893; Falchetti M, 2008, HUM PATHOL, V39, P925, DOI 10.1016/j.humpath.2007.10.024; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Gill S, 2003, J CLIN ONCOL, V21, P2070, DOI 10.1200/JCO.2003.11.054; Gong YX, 2014, NAT GENET, V46, P588, DOI 10.1038/ng.2981; Grogg KL, 2003, MODERN PATHOL, V16, P641, DOI 10.1097/01.MP.0000076980.73826.C0; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Kamangar F, 2006, JNCI-J NATL CANCER I, V98, P1445, DOI 10.1093/jnci/djj393; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lin SJ, 2014, GUT; Macdonald JS, 2011, J CLIN ONCOL, V29, P4348, DOI 10.1200/JCO.2011.37.5691; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Miyagi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055155; Noguchi Y, 2000, CANCER-AM CANCER SOC, V89, P2237, DOI 10.1002/1097-0142(20001201)89:11<2237::AID-CNCR12>3.3.CO;2-0; Onate-Ocana LF, 2000, ANN SURG ONCOL, V7, P210, DOI 10.1007/BF02523656; Otsuji E, 2000, AM J SURG, V180, P127, DOI 10.1016/S0002-9610(00)00436-0; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rothenberg SM, 2010, CANCER RES, V70, P2158, DOI 10.1158/0008-5472.CAN-09-3458; Roviello F, 2002, ANN SURG ONCOL, V9, P894, DOI 10.1007/BF02557527; Russo A, 2001, CANCER, V92, P294, DOI 10.1002/1097-0142(20010715)92:2<294::AID-CNCR1322>3.0.CO;2-9; Saito H, 2006, WORLD J SURG, V30, P1864, DOI 10.1007/s00268-005-0582-z; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Shi YY, 2011, NAT GENET, V43, P1215, DOI 10.1038/ng.978; Shim JH, 2014, ANN SURG ONCOL, V21, P2332, DOI 10.1245/s10434-014-3608-7; Smith DI, 2006, CANCER LETT, V232, P48, DOI 10.1016/j.canlet.2005.06.049; Song HR, 2013, MOL CARCINOGEN, V52, P155, DOI 10.1002/mc.22063; Theuer CP, 2000, CANCER, V89, P1883, DOI 10.1002/1097-0142(20001101)89:9<1883::AID-CNCR3>3.3.CO;2-8; Theuer CP, 2002, ARCH SURG-CHICAGO, V137, P960, DOI 10.1001/archsurg.137.8.960; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; van Beek J, 2004, J CLIN ONCOL, V22, P664, DOI 10.1200/JCO.2004.08.061; Veeriah S, 2010, CELL CYCLE, V9, P1451, DOI 10.4161/cc.9.8.11583; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760	48	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176045	10.1371/journal.pone.0176045	http://dx.doi.org/10.1371/journal.pone.0176045			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426752	Green Published, gold			2022-12-26	WOS:000399875900091
J	Tyutyaev, P; Grissmer, S				Tyutyaev, Pavel; Grissmer, Stephan			Observation of sigma-pore currents in mutant hKv1.2_V370C potassium channels	PLOS ONE			English	Article							K+ CHANNEL; VOLTAGE; SELECTIVITY; MUTATIONS; STATE; CELLS; N629D	Current through the sigma-pore was first detected in hKv1.3_V388C channels, where the V388C mutation in hKv1.3 channels opened a new pathway (sigma-pore) behind the central alpha-pore. Typical for this mutant channel was inward current at potentials more negative than -100 mV when the central alpha-pore was closed. The alpha-pore blockers such as TEA(+) and peptide toxins (CTX, MTX) could not reduce current through the sigma-pore of hKv1.3_V388C channels. This new pathway would proceed in parallel to the alpha-pore in the S6-S6 interface gap. To see whether this phenomenon is restricted to hKv1.3 channels we mutated hKv1.2 at the homologue position (hKv1.2_V370C). By overexpression of hKv1.2_V370C mutant channels in COS-7 cells we could show typical sigma-currents. The electrophysiological properties of the sigma-pore in hKv1.3_V388C and hKv1.2_V370C mutant channels were similar. The sigma-pore of hKv1.2_V370C channels was most permeable to Na+ and Li+ whereas Cl- and protons did not influence current through the sigma-pore. Tetraethylammonium (TEA(+)), charybdotoxin (CTX) and maurotoxin (MTX), known alpha-pore blockers, could not reduce current through the sigma-pore of hKv1.2_V370C channels. Taken together we conclude that the observation of sigma-pore currents is not restricted to Kv1.3 potassium channels but can also be observed in a closely related potassium channel. This finding could have implications in the treatment of different ion channel diseases linked to mutations of the respective channels in regions close to homologue position investigated by us.	[Tyutyaev, Pavel; Grissmer, Stephan] Ulm Univ, Inst Appl Physiol, Ulm, Germany	Ulm University	Grissmer, S (corresponding author), Ulm Univ, Inst Appl Physiol, Ulm, Germany.	stephan.grissmer@uni-ulm.de			Deutsche Forschungsgemeinschaft [Gr848/17-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was supported by funds from the Deutsche Forschungsgemeinschaft (Gr848/17-1; www.dfg.de) to SG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campos FV, 2007, P NATL ACAD SCI USA, V104, P7904, DOI 10.1073/pnas.0702638104; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hille B., ION CHANNELS EXCITAB, P131; Kraus RL, 1998, J BIOL CHEM, V273, P5586, DOI 10.1074/jbc.273.10.5586; Lees-Miller JP, 2000, CIRC RES, V86, P507, DOI 10.1161/01.RES.86.5.507; Lehmann-Horn F, 1999, PHYSIOL REV, V79, P1317, DOI 10.1152/physrev.1999.79.4.1317; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; Prutting S, 2011, J BIOL CHEM, V286, P20031, DOI 10.1074/jbc.M110.185405; Rauer H, 1999, BRIT J PHARMACOL, V127, P1065, DOI 10.1038/sj.bjp.0702599; Sokolov S, 2007, NATURE, V446, P76, DOI 10.1038/nature05598; Soler-Llavina GJ, 2006, NEURON, V52, P623, DOI 10.1016/j.neuron.2006.10.005; Teng GQ, 2004, CARDIOVASC RES, V61, P268, DOI 10.1016/j.cardiores.2003.11.016; Tombola F, 2005, NEURON, V48, P719, DOI 10.1016/j.neuron.2005.11.024; Tombola F, 2007, NATURE, V445, P546, DOI 10.1038/nature05396; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837	16	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176078	10.1371/journal.pone.0176078	http://dx.doi.org/10.1371/journal.pone.0176078			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426823	Green Submitted, Green Published, gold			2022-12-26	WOS:000399875900099
J	Lei, W; Mullen, N; McCarthy, S; Brann, C; Richard, P; Cormier, J; Edwards, K; Bilsky, EJ; Streicher, JM				Lei, Wei; Mullen, Nathan; McCarthy, Sarah; Brann, Courtney; Richard, Philomena; Cormier, James; Edwards, Katie; Bilsky, Edward J.; Streicher, John M.			Heat-shock protein 90 (Hsp90) promotes opioid-induced anti-nociception by an ERK mitogen-activated protein kinase (MAPK) mechanism in mouse brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						brain; extracellular-signal-regulated kinase (ERK); heat-shock protein 90 (Hsp90); opiate opioid; pain; 17-AAG; anti-nociception; -opioid receptor	NEUROPATHIC PAIN; BIASED LIGAND; IN-VIVO; MORPHINE; RECEPTOR; TOLERANCE; DEPENDENCE; TRV130; MICE; SENSITIZATION	Recent advances in developing opioid treatments for pain with reduced side effects have focused on the signaling cascades of the -opioid receptor (MOR). However, few such signaling targets have been identified for exploitation. To address this need, we explored the role of heat-shock protein 90 (Hsp90) in opioid-induced MOR signaling and pain, which has only been studied in four previous articles. First, in four cell models of MOR signaling, we found that Hsp90 inhibition for 24 h with the inhibitor 17-N-allylamino-17-demethoxygeldanamycin (17-AAG) had different effects on protein expression and opioid signaling in each line, suggesting that cell models may not be reliable for predicting pharmacology with this protein. We thus developed an in vivo model using CD-1 mice with an intracerebroventricular injection of 17-AAG for 24 h. We found that Hsp90 inhibition strongly blocked morphine-induced anti-nociception in models of post-surgical and HIV neuropathic pain but only slightly blocked anti-nociception in a naive tail-flick model, while enhancing morphine-induced precipitated withdrawal. Seeking a mechanism for these changes, we found that Hsp90 inhibition blocks ERK MAPK activation in the periaqueductal gray and caudal brain stem. We tested these signaling changes by inhibiting ERK in the above-mentioned pain models and found that ERK inhibition could account for all of the changes in anti-nociception induced by Hsp90 inhibition. Taken together, these findings suggest that Hsp90 promotes opioid-induced anti-nociception by an ERK mechanism in mouse brain and that Hsp90 could be a future target for improving the therapeutic index of opioid drugs.	[Lei, Wei; Streicher, John M.] Univ Arizona, Coll Med, Dept Pharmacol, Box 245050,Life Sci North 563,1501 N Campbell Ave, Tucson, AZ 85724 USA; [Mullen, Nathan; McCarthy, Sarah; Brann, Courtney; Richard, Philomena; Cormier, James; Edwards, Katie; Bilsky, Edward J.] Univ New England, Coll Osteopath Med, Dept Biomed Sci, Biddeford, ME 04005 USA; [Bilsky, Edward J.] Pacific Northwest Univ, Coll Osteopath Med, Dept Biomed Sci, Yakima, WA 98901 USA	University of Arizona; University of New England - Maine	Streicher, JM (corresponding author), Univ Arizona, Coll Med, Dept Pharmacol, Box 245050,Life Sci North 563,1501 N Campbell Ave, Tucson, AZ 85724 USA.	jstreicher@email.arizona.edu	McCarthy, Sarah/HCI-8963-2022	Streicher, John/0000-0002-4173-7362; Lei, Wei/0000-0002-0374-8642	University of New England; University of Arizona; National Institutes of Health Pilot Project Grant under an institutional COBRE award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103643] Funding Source: NIH RePORTER	University of New England; University of Arizona; National Institutes of Health Pilot Project Grant under an institutional COBRE award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the University of New England and the University of Arizona and by National Institutes of Health Pilot Project Grant P20GM103643 (Ian Meng PI) under an institutional COBRE award. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abul-Husn NS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025535; Ananthan S, 2012, J MED CHEM, V55, P8350, DOI 10.1021/jm300686p; Assimon VA, 2013, CURR PHARM DESIGN, V19, P404; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Zeni ALB, 2012, PHARMACOL BIOCHEM BE, V103, P181, DOI 10.1016/j.pbb.2012.08.020; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Breivik H, 2009, ANN ONCOL, V20, P1420, DOI 10.1093/annonc/mdp001; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen XT, 2013, J MED CHEM, V56, P8019, DOI 10.1021/jm4010829; Chen Y, 2008, J NEUROSCI, V28, P5836, DOI 10.1523/JNEUROSCI.4170-07.2008; Dai RP, 2011, ANESTHESIOLOGY, V115, P604, DOI 10.1097/ALN.0b013e3182242045; DeWire SM, 2013, J PHARMACOL EXP THER, V344, P708, DOI 10.1124/jpet.112.201616; Gaskin DJ, 2012, J PAIN, V13, P715, DOI 10.1016/j.jpain.2012.03.009; Gudasheva TA, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0198-z; Hutchinson MR, 2009, NEUROSCIENCE, V164, P1821, DOI 10.1016/j.neuroscience.2009.09.046; Jhaveri K, 2014, EXPERT OPIN INV DRUG, V23, P611, DOI 10.1517/13543784.2014.902442; Kim N, 2015, NEUROSCIENCE, V284, P912, DOI 10.1016/j.neuroscience.2014.11.010; Koshimizu T, 2010, BIOCHEM BIOPH RES CO, V392, P603, DOI 10.1016/j.bbrc.2010.01.089; Kovelowski CJ, 2000, PAIN, V87, P265, DOI 10.1016/S0304-3959(00)00290-6; Li Jing, 2013, Biomed J, V36, P106, DOI 10.4103/2319-4170.113230; Lowery JJ, 2011, J PHARMACOL EXP THER, V336, P767, DOI 10.1124/jpet.110.172866; Macey TA, 2009, J PHARMACOL EXP THER, V331, P412, DOI 10.1124/jpet.109.152157; McConnell JR, 2013, BIOORG MED CHEM LETT, V23, P1923, DOI 10.1016/j.bmcl.2013.02.014; Mouledous L, 2007, PHARMACOL BIOCHEM BE, V88, P39, DOI 10.1016/j.pbb.2007.07.002; National Clinical Guideline Centre for Acute and Chronic Conditions (Great Britain), 2012, OP PALL CAR SAF EFF; Odunuga OO, 2004, BIOESSAYS, V26, P1058, DOI 10.1002/bies.20107; Ossipov MH, 2000, ANN NY ACAD SCI, V909, P12; Ota A, 2010, CIRC RES, V106, P1404, DOI 10.1161/CIRCRESAHA.109.213769; Pogatzki EM, 2003, ANESTHESIOLOGY, V99, P1023, DOI 10.1097/00000542-200310000-00041; Qin WJ, 2013, INT J NEUROPSYCHOPH, V16, P647, DOI 10.1017/S1461145712000557; Raehal KM, 2011, NEUROPHARMACOLOGY, V60, P58, DOI 10.1016/j.neuropharm.2010.08.003; Raehal KM, 2005, J PHARMACOL EXP THER, V314, P1195, DOI 10.1124/jpet.105.087254; Schmid CL, 2010, J NEUROSCI, V30, P13513, DOI 10.1523/JNEUROSCI.1665-10.2010; Soergel DG, 2014, PAIN, V155, P1829, DOI 10.1016/j.pain.2014.06.011; Tillu DV, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-5; TRAYNOR J, 2012, Patent No. 121173; Urban MJ, 2010, ASN NEURO, V2, DOI 10.1042/AN20100015; Vanderah TW, 2008, EUR J PHARMACOL, V583, P62, DOI 10.1016/j.ejphar.2008.01.011; Viscusi ER, 2016, PAIN, V157, P264, DOI 10.1097/j.pain.0000000000000363; Wang Q, 2013, MOL PHARMACOL, V83, P512, DOI 10.1124/mol.112.081992; Wang WQ, 2016, CANCER SCI, V107, P782, DOI 10.1111/cas.12934; Woodcock J, 2007, NAT REV DRUG DISCOV, V6, P703, DOI 10.1038/nrd2335; Yuan SB, 2014, ANN NEUROL, V75, P837, DOI 10.1002/ana.24139; Yue X, 2006, EUR J PHARMACOL, V540, P57, DOI 10.1016/j.ejphar.2006.04.033; Zhao RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009934	45	30	31	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10414	10428		10.1074/jbc.M116.769489	http://dx.doi.org/10.1074/jbc.M116.769489			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28450396	hybrid, Green Published			2022-12-26	WOS:000404115400008
J	Alsaid, H; Skedzielewski, T; Rambo, MV; Hunsinger, K; Hoang, B; Fieles, W; Long, ER; Tunstead, J; Vugts, DJ; Cleveland, M; Clarke, N; Matheny, C; Jucker, BM				Alsaid, Hasan; Skedzielewski, Tinamarie; Rambo, Mary V.; Hunsinger, Kristen; Hoang, Bao; Fieles, William; Long, Edward R.; Tunstead, James; Vugts, Danielle J.; Cleveland, Matthew; Clarke, Neil; Matheny, Christopher; Jucker, Beat M.			Non invasive imaging assessment of the biodistribution of GSK2849330, an ADCC and CDC optimized anti HER3 mAb, and its role in tumor macrophage recruitment in human tumor-bearing mice	PLOS ONE			English	Article							POSITRON EMISSION TOMOGRAPHY; IN-VIVO; MONOCLONAL-ANTIBODY; THERAPEUTIC ANTIBODY; BREAST-CANCER; SOLID TUMORS; PHASE-I; FERUMOXYTOL; RECEPTOR; DISEASE	The purpose of this work was to use various molecular imaging techniques to non-invasively assess GSK2849330 (anti HER3 ADCC and CDC enhanced 'AccretaMab' monoclonal antibody) pharmacokinetics and pharmacodynamics in human xenograft tumor-bearing mice. Immuno-PET biodistribution imaging of radiolabeled Zr-89-GSK2849330 was assessed in mice with HER3 negative (MIA-PaCa-2) and positive (CHL-1) human xenograft tumors. Dose dependency of GSK2849330 disposition was assessed using varying doses of unlabeled GSK2849330 co-injected with Zr-89-GSK2849330. In-vivo NIRF optical imaging and ex-vivo confocal microscopy were used to assess the biodistribution of GSK2849330 and the HER3 receptor occupancy in HER3 positive xenograft tumors (BxPC3, and CHL-1). Ferumoxytol (USPIO) contrast-enhanced MRI was used to investigate the effects of GSK2849330 on tumor macrophage content in CHL-1 xenograft bearing mice. Immuno-PET imaging was used to monitor the whole body drug biodistribution and CHL-1 xenograft tumor uptake up to 144 hours post injection of Zr-89-GSK2849330. Both hepatic and tumor uptake were dose dependent and saturable. The optical imaging data in the BxPC3 xenograft tumor confirmed the tumor dose response finding in the Immuno-PET study. Confocal microscopy showed a distinguished cytoplasmic punctate staining pattern within individual CHL-1 cells. GSK2849330 inhibited tumor growth and this was associated with a significant decrease in MRI signal to noise ratio after USPIO injection and with a significant increase in tumor macrophages as confirmed by a quantitative immunohistochemistry analysis. By providing both dose response and time course data from both Zr-89 and fluorescently labeled GSK2849330, complementary imaging studies were used to characterize GSK2849330 biodistribution and tumor uptake in vivo. Ferumoxytol-enhanced MRI was used to monitor aspects of the immune system response to GSK2849330. Together these approaches potentially provide clinically translatable, non-invasive techniques to support dose optimization, and assess immune activation and anti-tumor responses.	[Alsaid, Hasan; Skedzielewski, Tinamarie; Rambo, Mary V.; Hunsinger, Kristen; Jucker, Beat M.] GlaxoSmithKline, Platform Technol & Sci, Bioimaging, King Of Prussia, PA 19406 USA; [Hoang, Bao; Fieles, William; Tunstead, James] GlaxoSmithKline, Target Sci Target & Pathway, King Of Prussia, PA USA; [Long, Edward R.] GlaxoSmithKline, Platform Technol & Sci, Integrated Biol Platform Sci, King Of Prussia, PA USA; [Vugts, Danielle J.] Vrije Univ Amsterdam Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands; [Cleveland, Matthew] GlaxoSmithKline, Platform Technol & Sci, Bioimaging, Stevenage, Herts, England; [Clarke, Neil] GlaxoSmithKline, Biopharm Mol Discovery, Stevenage, Herts, England; [Matheny, Christopher] GlaxoSmithKline, Platform Technol & Sci, Immunogin & Biomarkers, King Of Prussia, PA USA	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Alsaid, H (corresponding author), GlaxoSmithKline, Platform Technol & Sci, Bioimaging, King Of Prussia, PA 19406 USA.	hasan.5.alsaid@gsk.com		Matheny, Christopher/0000-0001-7860-2173; Alsaid, Hasan/0000-0001-6600-2146	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	The authors received no specific funding for this work. GlaxoSmithKline provided support in the form of salaries for authors [HA, TS, MVR, KH, BH, WF, ERL, JT, MC, NC, CM, and BMJ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Aghighi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142665; Alsaid H, 2013, INT SOC MAG RESON ME; Arnoletti JP, 2004, J GASTROINTEST SURG, V8, P960, DOI 10.1016/j.gassur.2004.09.021; Bashir MR, 2015, J MAGN RESON IMAGING, V41, P884, DOI 10.1002/jmri.24691; Borjesson PK, 2003, CLIN CANC RES, V9, p3961S; Borjesson PKE, 2006, CLIN CANCER RES, V12, P2133, DOI 10.1158/1078-0432.CCR-05-2137; Clarke N, 2014, EUR J CANCER, V50, P98, DOI 10.1016/S0959-8049(14)70426-5; Daldrup-Link HE, 2011, CLIN CANCER RES, V17, P5695, DOI 10.1158/1078-0432.CCR-10-3420; Dijkers EC, 2010, CLIN PHARMACOL THER, V87, P586, DOI 10.1038/clpt.2010.12; Dijkers ECF, 2009, J NUCL MED, V50, P974, DOI 10.2967/jnumed.108.060392; Eppig JT, 2015, NUCLEIC ACIDS RES, V43, pD726, DOI 10.1093/nar/gku967; Freise AC, 2015, MOL IMMUNOL, V67, P142, DOI 10.1016/j.molimm.2015.04.001; Garner AP, 2013, CANCER RES, V73, P6024, DOI 10.1158/0008-5472.CAN-13-1198; Hsieh AC, 2007, BRIT J CANCER, V97, P453, DOI 10.1038/sj.bjc.6603910; Jauw YWS, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00131; LoRusso P, 2013, CLIN CANCER RES, V19, P3078, DOI 10.1158/1078-0432.CCR-12-3051; Matthews Paul M, 2013, Drug Discov Today Technol, V10, pe343, DOI 10.1016/j.ddtec.2012.04.004; MAXWELL JL, 1990, BIOCHEM J, V267, P155, DOI 10.1042/bj2670155; Mirschberger C, 2013, CANCER RES, V73, P5183, DOI 10.1158/0008-5472.CAN-13-0099; Ocana A, 2013, JNCI-J NATL CANCER I, V105, P266, DOI 10.1093/jnci/djs501; Overdijk MB, 2015, MABS-AUSTIN, V7, P311, DOI 10.1080/19420862.2015.1007813; Sharp T., 2011, P WORLD MOL IM C; Shi Y, 2015, J IMMUNOL, V194, P4379, DOI 10.4049/jimmunol.1402891; Thurber GM, 2011, MOL IMAGING BIOL, V13, P623, DOI 10.1007/s11307-010-0397-7; Turkbey B, 2015, AM J ROENTGENOL, V205, P64, DOI 10.2214/AJR.14.13009; van de Ven SMWY, 2012, CLIN CANCER RES, V18, P1073, DOI 10.1158/1078-0432.CCR-10-3213; Van Dongen GAMS, 2015, Q J NUCL MED MOL IM, V59, P18; van Scheltinga AGTT, 2014, MABS-AUSTIN, V6, P1051, DOI 10.4161/mabs.29097; Vosjan MJWD, 2010, NAT PROTOC, V5, P739, DOI 10.1038/nprot.2010.13; Vugts DJ, 2014, MABS-AUSTIN, V6, P567, DOI 10.4161/mabs.27415; Walker JP, 2015, ANN VASC SURG, V29, P63, DOI 10.1016/j.avsg.2014.09.003; Wieduwilt MJ, 2008, CELL MOL LIFE SCI, V65, P1566, DOI 10.1007/s00018-008-7440-8; Yuan Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130209	33	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176075	10.1371/journal.pone.0176075	http://dx.doi.org/10.1371/journal.pone.0176075			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448604	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383600037
J	Langer, A; Moldovan, A; Harmath, C; Joyce, SA; Clarke, DJ; Heermann, R				Langer, Angela; Moldovan, Adriana; Harmath, Christian; Joyce, Susan A.; Clarke, David J.; Heermann, Ralf			HexA is a versatile regulator involved in the control of phenotypic heterogeneity of Photorhabdus luminescens	PLOS ONE			English	Article							BACTERIAL SIGNALING MOLECULES; ESCHERICHIA-COLI; YERSINIA-PSEUDOTUBERCULOSIS; LYSR HOMOLOG; GENE; XENORHABDUS; VIRULENCE; MOTILITY; LRHA; RNA	Phenotypic heterogeneity in microbial communities enables genetically identical organisms to behave differently even under the same environmental conditions. Photorhabdus luminescens, a bioluminescent Gram-negative bacterium, contains a complex life cycle, which involves a symbiotic interaction with nematodes as well as a pathogenic association with insect larvae. P. luminescens exists in two distinct phenotypic cell types, designated as the primary (1 degrees) and secondary (2 degrees) cells. The 1 degrees cells are bioluminescent, pigmented and can support nematode growth and development. Individual 1 degrees cells undergo phenotypic switching after prolonged cultivation and convert to 2 degrees cells, which lack the 1 degrees specific phenotypes. The LysR- type regulator HexA has been described as major regulator of this switching process. Here we show that HexA controls phenotypic heterogeneity in a versatile way, directly and indirectly. Expression of hexA is enhanced in 2 degrees cells, and the corresponding regulator inhibits 1 degrees specific traits in 2 degrees cells. HexA does not directly affect bioluminescence, a predominant 1 degrees specific phenotype. Since the respective luxCDABE operon is repressed at the post-transcriptional level and transcriptional levels of the RNA chaperone gene hfq are also enhanced in 2 degrees cells, small regulatory RNAs are presumably involved that are under control of HexA. Another phenotypic trait that is specific for 1 degrees cells is quorum sensing mediated cell clumping. The corresponding pcfABCDEF operon could be identified as the first direct target of HexA, since the regulator binds to the pcfA promoter region and thereby blocks expression of the target operon. In summary, our data show that HexA fulfills the task as repressor of 1 degrees specific features in 2 degrees cells in a versatile way and gives first insights into the complexity of regulating phenotypic heterogeneity in Photorhabdus bacteria.	[Langer, Angela; Moldovan, Adriana; Harmath, Christian; Heermann, Ralf] Ludwig Maximilians Univ Munchen, Biozentrum Martinsried, Bereich Mikrobiol, Munich, Germany; [Joyce, Susan A.; Clarke, David J.] Univ Coll Cork, Sch Microbiol, Cork, Ireland; [Joyce, Susan A.; Clarke, David J.] Univ Coll Cork, Microbiome Inst, Cork, Ireland	University of Munich; University College Cork; University College Cork	Heermann, R (corresponding author), Ludwig Maximilians Univ Munchen, Biozentrum Martinsried, Bereich Mikrobiol, Munich, Germany.	heermann@lmu.de	Clarke, David J/I-7859-2014; Heermann, Ralf/CAF-8609-2022; Heermann, Ralf/E-1793-2013; Joyce, Susan/ABE-2616-2020	Heermann, Ralf/0000-0003-0631-6156; Joyce, Susan/0000-0003-4771-3123; Clarke, David/0000-0001-9082-0501	Deutsche Forschungsgemeinschaft [SPP1617, HE-5247/5-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (SPP1617, HE-5247/5-1).; This work was supported by the Deutsche Forschungsgemeinschaft (SPP1617, HE-5247/5-1). We thank Dr. Sophie Brameyer (LMU Munchen, Germany) for providing the E. coli Delta lrhA strain and the plasmids listed in the Supporting Information. We are grateful to Dr. Helge B. Bode (Goethe-Universitat Frankfurt am Main, Germany) for fruitful discussions. SPR assays were performed in the Bioanalytics core facility of the LMU Biocenter. The authors declare no conflicts of interest.	AKHURST RJ, 1980, J GEN MICROBIOL, V121, P303; BOEMARE NE, 1988, J GEN MICROBIOL, V134, P751; Boivin S, 2013, PROTEIN EXPRES PURIF, V91, P192, DOI 10.1016/j.pep.2013.08.002; Brachmann AO, 2007, CHEMBIOCHEM, V8, P1721, DOI 10.1002/cbic.200700300; Brachmann AO, 2013, NAT CHEM BIOL, V9, P573, DOI [10.1038/NCHEMBIO.1295, 10.1038/nchembio.1295]; Brameyer S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124093; Brameyer S, 2015, P NATL ACAD SCI USA, V112, P572, DOI 10.1073/pnas.1417685112; Burke AK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145358; Ciche TA, 2003, APPL ENVIRON MICROB, V69, P1890, DOI 10.1128/AEM.69.4.1890-1897.2003; Easom CA, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-168; Engel Y, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00209; Gibson KE, 1999, J BACTERIOL, V181, P563, DOI 10.1128/JB.181.2.563-571.1999; Glaeser A, 2015, BIOTECHNIQUES, V59, P74, DOI 10.2144/000114317; Han RC, 2000, J INVERTEBR PATHOL, V75, P55, DOI 10.1006/jipa.1999.4900; Harris SJ, 1998, MOL MICROBIOL, V28, P705, DOI 10.1046/j.1365-2958.1998.00825.x; Heermann R, 2000, J BIOL CHEM, V275, P17080, DOI 10.1074/jbc.M000093200; Heinrich AK, 2016, HETEROGENEOUS REGULA, V2, P1; Heroven AK, 2006, MOL MICROBIOL, V62, P1469, DOI 10.1111/j.1365-2958.2006.05458.x; Hunke S, 2012, FEMS MICROBIOL LETT, V326, P12, DOI 10.1111/j.1574-6968.2011.02436.x; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Joyce SA, 2006, CURR OPIN MICROBIOL, V9, P127, DOI 10.1016/j.mib.2006.01.004; Joyce SA, 2003, MOL MICROBIOL, V47, P1445, DOI 10.1046/j.1365-2958.2003.03389.x; Keene DR, 2002, MOL CELL, V9, P23; Kontnik R, 2010, ACS CHEM BIOL, V5, P659, DOI 10.1021/cb100117k; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lehnen D, 2002, MOL MICROBIOL, V45, P521, DOI 10.1046/j.1365-2958.2002.03032.x; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Mukherjee A, 2000, ENVIRON MICROBIOL, V2, P203, DOI 10.1046/j.1462-2920.2000.00093.x; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Peterson CN, 2006, J BACTERIOL, V188, P3175, DOI 10.1128/JB.188.9.3175-3181.2006; Quade N, 2011, ACTA CRYSTALLOGR D, V67, P81, DOI 10.1107/S0907444910049681; Ramachandran R, 2014, APPL ENVIRON MICROB, V80, P5790, DOI 10.1128/AEM.01489-14; Ruiz J, 2011, J BACTERIOL, V193, P2536, DOI 10.1128/JB.00815-10; Schu DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107687; SMIGIELSKI AJ, 1994, APPL ENVIRON MICROB, V60, P120, DOI 10.1128/AEM.60.1.120-125.1994; Thoma S, 2009, FEMS MICROBIOL LETT, V294, P127, DOI 10.1111/j.1574-6968.2009.01556.x; Tobias NJ, 2017, ENVIRON MICROBIOL, V19, P119, DOI 10.1111/1462-2920.13502; Tran EEH, 2009, APPL ENVIRON MICROB, V75, P3998, DOI 10.1128/AEM.02657-08; Turlin E, 2006, PROTEOMICS, V6, P2705, DOI 10.1002/pmic.200500646; Valentin-Hansen P, 2004, MOL MICROBIOL, V51, P1525, DOI 10.1111/j.1365-2958.2003.03935.x; Vecerek B, 2005, RNA, V11, P976, DOI 10.1261/rna.2360205; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Wee KE, 2000, MICROBIOL-UK, V146, P3141, DOI 10.1099/00221287-146-12-3141	43	8	9	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176535	10.1371/journal.pone.0176535	http://dx.doi.org/10.1371/journal.pone.0176535			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448559	gold, Green Published, Green Submitted			2022-12-26	WOS:000400383600097
J	Li, YW; Caballero, D; Ponsetto, J; Chen, A; Zhu, CL; Guo, J; Demay, M; Juppner, H; Bergwitz, C				Li, Yuwen; Caballero, Daniel; Ponsetto, Julian; Chen, Alyssa; Zhu, Chuanlong; Guo, Jun; Demay, Marie; Juppner, Harald; Bergwitz, Clemens			Response of Npt2a knockout mice to dietary calcium and phosphorus	PLOS ONE			English	Article							HEREDITARY HYPOPHOSPHATEMIC RICKETS; SODIUM-PHOSPHATE COTRANSPORTER; X-LINKED HYPOPHOSPHATEMIA; RENAL CALCIFICATION; NEPHROCALCINOSIS; HYPERCALCIURIA; MUTATIONS; KIDNEY; NEPHROLITHIASIS; GENE	Mutations in the renal sodium-dependent phosphate co-transporters NPT2a and NPT2c have been reported in patients with renal stone disease and nephrocalcinosis, but the relative contribution of genotype, dietary calcium and phosphate to the formation of renal mineral deposits is unclear. We previously reported that renal calcium phosphate deposits persist and/or reappear in older Npt2a(-/-) mice supplemented with phosphate despite resolution of hypercalciuria while no deposits are seen in wild-type (WT) mice on the same diet. Addition of calcium to their diets further increased calcium phosphate deposits in Npt2a(-/-), but not WT mice. The response of PTH to dietary phosphate of Npt2a(-/-)was blunted when compared to WT mice and the response of the urinary calcium x phosphorus product to the addition of calcium and phosphate to the diet of Npt2a(-/-) was increased. These finding suggests that Npt2a(-/-)mice respond differently to dietary phosphate when compared to WT mice. Further evaluation in the Npt2a(-/-)cohort on different diets suggests that urinary calcium excretion, plasma phosphate and FGF23 levels appear to be positively correlated to renal mineral deposit formation while urine phosphate levels and the urine anion gap, an indirect measure of ammonia excretion, appear to be inversely correlated. Our observations in Npt2a(-/-) mice, if confirmed in humans, may be relevant for the optimization of existing and the development of novel therapies to prevent nephrolithiasis and nephrocalcinosis in human carriers of NPT2a and NPT2c mutations.	[Li, Yuwen; Guo, Jun; Demay, Marie; Juppner, Harald] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Li, Yuwen; Zhu, Chuanlong; Guo, Jun; Demay, Marie; Juppner, Harald] Harvard Med Sch, Boston, MA USA; [Li, Yuwen] Nanjing Med Univ, Affiliated Hosp 1, Dept Pediat, Nanjing, Jiangsu, Peoples R China; [Caballero, Daniel; Ponsetto, Julian; Chen, Alyssa; Bergwitz, Clemens] Yale Univ, Sch Med, Sect Endocrinol, New Haven, CT 06520 USA; [Zhu, Chuanlong] Massachusetts Gen Hosp, Gastroenterol Unit, Boston, MA 02114 USA; [Zhu, Chuanlong] Nanjing Med Univ, Affiliated Hosp 1, Dept Infect Dis, Nanjing, Jiangsu, Peoples R China; [Juppner, Harald] Massachusetts Gen Hosp, Pediat Nephrol Unit, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Nanjing Medical University; Yale University; Harvard University; Massachusetts General Hospital; Nanjing Medical University; Harvard University; Massachusetts General Hospital	Bergwitz, C (corresponding author), Yale Univ, Sch Med, Sect Endocrinol, New Haven, CT 06520 USA.	clemens.bergwitz@yale.edu	Li, yu/HHZ-5236-2022; li, yuwen/HGU-6435-2022; Caballero, Daniel/GXV-3082-2022; Zhu, Chuanlong/GPF-5191-2022	Caballero, Daniel/0000-0001-9232-8991	National Institutes of Health [R01-DK46718-20, P01-DK11794]; National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases Grant [5K08-DK078361]; Center for Skeletal Research Core NIH [P30 AR066261]; National Kidney Foundation; American Society for Clinical Investigation; National Natural Science Foundation of China grant [81271713]; Scientific research fund of Anhui Medical University [2011xkj074]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR066261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059635, R01DK046718, P01DK011794, K08DK078361, P30DK079310] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases Grant; Center for Skeletal Research Core NIH; National Kidney Foundation; American Society for Clinical Investigation; National Natural Science Foundation of China grant(National Natural Science Foundation of China (NSFC)); Scientific research fund of Anhui Medical University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01-DK46718-20 and P01-DK11794, project IV (to HJ), National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases Grant 5K08-DK078361 (to CB), Center for Skeletal Research Core NIH P30 AR066261 (to MD), Young Investigator Awards by the National Kidney Foundation, and the American Society for Clinical Investigation (to CB), National Natural Science Foundation of China grant 81271713 (to CZ) and the Scientific research fund of Anhui Medical University 2011xkj074 (to YL). We are grateful to the Yale Mouse Metabolic Phenotyping Center NIH U24 DK-059635 and the Yale O'Brien Center Renal Physiology Core NIH P30DK079310 for help with biochemical analysis, the Yale Dept. of Orthopaedics Histology and Histomorphometry Laboratory for help with histological and the Yale Center for Cellular and Molecular Imaging (YCCMI) for electron microscopic analysis and the Yale School of Medicine Dept. Biostatistics for help with statistical analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Institutes of Health Grants R01-DK46718-20 and P01-DK11794, project IV (to H.J.), National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases Grant 5K08-DK078361 (to C.B.), Center for Skeletal Research Core NIH P30 AR066261 (to M.D.), Young Investigator Awards by the National Kidney Foundation, and the American Society for Clinical Investigation (to C.B.), National Natural Science Foundation of China grant 81271713 (to C.Z.) and the Scientific research fund of Anhui Medical University 2011xkj074 (to Y.L.). We are grateful to the Yale Mouse Metabolic Phenotyping Center NIH U24 DK-059635 and the Yale O'Brien Center Renal Physiology Core NIH P30DK079310 for help with biochemical analysis, the Yale Dept. of Orthopaedics Histology and Histomorphometry Laboratory for help with histological and the Yale Center for Cellular and Molecular Imaging (YCCMI) for electron microscopic analysis and Xiaoquin Yu, Ph.D., at the Yale School of Medicine Dept. Biostatistics for help with statistical analysis.	Albright RA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10006; ALON U, 1992, J PEDIATR-US, V120, P899, DOI 10.1016/S0022-3476(05)81957-2; Arcidiacono T, 2014, AM J NEPHROL, V40, P499, DOI 10.1159/000369833; Beck L, 1998, P NATL ACAD SCI USA, V95, P5372, DOI 10.1073/pnas.95.9.5372; Beharrie A, 2002, J AM SOC NEPHROL, V13, p160A; Bergwitz C, 2006, AM J HUM GENET, V78, P179, DOI 10.1086/499409; Boger CA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002292; Caballero D, 2016, AM J PHYSL RENAL PHY; Carpenter TO, 2014, J CLIN INVEST, V124, P1587, DOI 10.1172/JCI72829; Carpenter TO, 2011, J BONE MINER RES, V26, P1381, DOI 10.1002/jbmr.340; Chau H, 2003, J BONE MINER RES, V18, P644, DOI 10.1359/jbmr.2003.18.4.644; Dasgupta D, 2014, J AM SOC NEPHROL, V25, P2366, DOI 10.1681/ASN.2013101085; Dinour D, 2016, PEDIATR NEPHROL, V31, P2289, DOI 10.1007/s00467-016-3443-0; Gonlusen G, 2006, ARCH PATHOL LAB MED, V130, P101; Halbritter J, 2015, J AM SOC NEPHROL, V26, P543, DOI 10.1681/ASN.2014040388; Hunter GK, 2013, CALCIFIED TISSUE INT, V93, P348, DOI 10.1007/s00223-013-9698-6; Imel EA, 2006, J CLIN ENDOCR METAB, V91, P2055, DOI 10.1210/jc.2005-2105; Khan SR, 2011, J UROLOGY, V186, P1107, DOI 10.1016/j.juro.2011.04.109; Li QL, 2014, LAB INVEST, V94, P623, DOI 10.1038/labinvest.2014.52; Li YC, 1998, ENDOCRINOLOGY, V139, P4391, DOI 10.1210/en.139.10.4391; Lorenz-Depiereux B, 2006, AM J HUM GENET, V78, P193, DOI 10.1086/499410; Maeda A, 2013, P NATL ACAD SCI USA, V110, P5864, DOI 10.1073/pnas.1301674110; Magen D, 2010, NEW ENGL J MED, V362, P1102, DOI 10.1056/NEJMoa0905647; Pattaro C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10023; Prie D, 2002, NEW ENGL J MED, V347, P983, DOI 10.1056/NEJMoa020028; Qi ZH, 2004, AM J PHYSIOL-RENAL, V286, pF590, DOI 10.1152/ajprenal.00324.2003; Reddy P, 2009, INT J CLIN PRACT, V63, P1516, DOI 10.1111/j.1742-1241.2009.02000.x; Rittling SR, 1998, J BONE MINER RES, V13, P1101, DOI 10.1359/jbmr.1998.13.7.1101; Sayer JA, 2004, CLIN SCI, V106, P549, DOI 10.1042/CS20040048; Schlingmann KP, 2015, J AM SOC NEPHROL; Segawa H, 2009, AM J PHYSIOL-RENAL, V297, pF671, DOI 10.1152/ajprenal.00156.2009; Sharma S, 2015, CLIN EXP NEPHROL, V19, P556, DOI 10.1007/s10157-015-1119-x; Tenenhouse HS, 2004, AM J PHYSIOL-RENAL, V286, pF675, DOI 10.1152/ajprenal.00362.2003; TIEDER M, 1992, NEPHRON, V62, P176, DOI 10.1159/000187029; Worcester EM, 2008, PRIMARY CARE, V35, P369, DOI 10.1016/j.pop.2008.01.005	36	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176232	10.1371/journal.pone.0176232	http://dx.doi.org/10.1371/journal.pone.0176232			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448530	Green Published, gold, Green Submitted			2022-12-26	WOS:000400383600050
J	Mujar, NMM; Dahlui, M; Emran, NA; Hadi, IA; Wai, YY; Arulanantham, S; Hooi, CC; Taib, NAM				Mujar, Noor Mastura Mohd; Dahlui, Maznah; Emran, Nor Aina; Hadi, Imisairi Abdul; Wai, Yan Yang; Arulanantham, Sarojah; Hooi, Chea Chan; Taib, Nur Aishah Mohd			Complementary and alternative medicine (CAM) use and delays in presentation and diagnosis of breast cancer patients in public hospitals in Malaysia	PLOS ONE			English	Article							SINGLE INSTITUTION; WOMEN; SURVIVAL; BARRIERS; HEALTH; PRAYER; TIME	Complementary and alternative medicine (CAM) is widely used among the breast cancer patients in Malaysia. Delays in presentation, diagnosis and treatment have been shown to impact the disease prognosis. There is considerable use of CAM amongst breast cancer patients. CAM use has been cited as a cause of delay in diagnosis and treatments in qualitative studies, however there had not been any confirmatory study that confirms its impact on delays. The purpose of this study was to evaluate whether the use of CAM among newly diagnosed breast cancer patients was associated with delays in presentation, diagnosis or treatment of breast cancer. This multi-centre cross-sectional study evaluating the time points of the individual breast cancer patients' journey from first visit, resolution of diagnosis and treatments was conducted in six public hospitals in Malaysia. All newly diagnosed breast cancer patients from 1st January to 31st December 2012 were recruited. Data were collected through medical records review and patient interview by using a structured questionnaire. Complementary and alternative medicine (CAM) was defined as the use of any methods and products not included in conventional allopathic medicine before commencement of treatments. Presentation delay was defined as time taken from symptom discovery to first presentation of more than 3 months. The time points were categorised to diagnosis delay was defined as time taken from first presentation to diagnosis of more than 1 month and treatment delay was defined as time taken from diagnosis to initial treatment of more than 1 month. Multiple logistic regression was used for analysis. A total number of 340 patients participated in this study. The prevalence of CAM use was 46.5% (n = 158). Malay ethnicity (OR 3.32; 95% CI: 1.85, 5.97) and not interpreting symptom as cancerous (OR 1.79; 95% CI: 1.10, 2.92) were significantly associated with CAM use. The use of CAM was associated with delays in presentation (OR 1.65; 95% CI: 1.05, 2.59), diagnosis (OR 2.42; 95% CI: 1.56, 3.77) and treatment of breast cancer (OR 1.74; 95% CI: 1.11, 2.72) on univariate analyses. However, after adjusting with other covariates, CAM use was associated with delays in presentation (OR 1.71; 95% CI: 1.05, 2.78) and diagnosis (OR 2.58; 95% CI: 1.59, 4.17) but not for treatment of breast cancer (OR 1.58; 95% CI: 0.98, 2.55). The prevalence of CAM use among the breast cancer patients was high. Women of Malay ethnicity and not interpreting symptom as cancerous were significantly associated with CAM use. The use of CAM is significantly associated with delay in presentation and resolution of diagnosis. This study suggests further evaluation of access to breast cancer care is needed as poor access may cause the use of CAM. However, since public hospitals in Malaysia are heavily subsidized and readily available to the population, CAM use may impact delays in presentation and diagnosis.	[Mujar, Noor Mastura Mohd] Univ Sci Malaysia, Cluster Hlth Lifestyle, Adv Med & Dent Inst, George Town, Malaysia; [Dahlui, Maznah] Univ Malaya, Dept Social & Prevent Med, Fac Med, Kuala Lumpur, Malaysia; [Emran, Nor Aina; Hadi, Imisairi Abdul; Wai, Yan Yang; Arulanantham, Sarojah; Hooi, Chea Chan] Minist Hlth, Putrajaya, Malaysia; [Taib, Nur Aishah Mohd] Univ Malaya, Dept Surg, Fac Med, Kuala Lumpur, Malaysia	Universiti Sains Malaysia; Universiti Malaya; Kementerian Kesihatan Malaysia; Universiti Malaya	Mujar, NMM (corresponding author), Univ Sci Malaysia, Cluster Hlth Lifestyle, Adv Med & Dent Inst, George Town, Malaysia.	mastura_mujar@yahoo.com	Dahlui, Maznah/F-9665-2010; Taib, Nur Aishah Mohd/B-2370-2010; DAHLUI, MAZNAH/B-8976-2010	Taib, Nur Aishah Mohd/0000-0001-8419-0478; DAHLUI, MAZNAH/0000-0003-4923-9410; Mohd Mujar, Noor Mastura/0000-0003-1773-5292	Peruntukan Penyelidikan Pascasiswazah (PPP) from the University of Malaya [UM.TNC2/IPPP/UPGP/638/PPP]; Kuala Lumpur and High Impact Research (HIR) from the Ministry of Higher Education of Malaysia [UM.C/HIR/MOHE/06]	Peruntukan Penyelidikan Pascasiswazah (PPP) from the University of Malaya; Kuala Lumpur and High Impact Research (HIR) from the Ministry of Higher Education of Malaysia	This work was supported by the Peruntukan Penyelidikan Pascasiswazah (PPP) Grant (UM.TNC2/IPPP/UPGP/638/PPP) from the University of Malaya, Kuala Lumpur and High Impact Research (HIR) Grant (UM.C/HIR/MOHE/06) from the Ministry of Higher Education of Malaysia.	Abdullah A, 2013, ASIAN PAC J CANCER P, V14, P7143, DOI 10.7314/APJCP.2013.14.12.7143; Abuduli M., 2011, MALAYS J PUBLIC HLTH, V11, P1; Al-Naggar RA., 2013, WORLD J MED SCI, V8, P157; Al-Naggar RA, 2012, ASIAN PAC J CANCER P, V13, P3595, DOI 10.7314/APJCP.2012.13.8.3595; ANDERSEN BL, 1995, BRIT J SOC PSYCHOL, V34, P33, DOI 10.1111/j.2044-8309.1995.tb01047.x; [Anonymous], 2009, REP COMM SURV; Azhar Y, 2015, PREDICTORS COMPLEMEN; Barber MD, 2004, BRIT J SURG, V91, P49, DOI 10.1002/bjs.4436; Bhoo-Pathy N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030995; Bish A, 2005, J PSYCHOSOM RES, V58, P321, DOI 10.1016/j.jpsychores.2004.10.007; Bright K, 2011, BREAST, V20, pS54, DOI 10.1016/j.breast.2011.02.012; Burgess CC, 1998, BRIT J CANCER, V77, P1343, DOI 10.1038/bjc.1998.224; Cheng ML, 2015, JOHOR MED J MALAYSIA, V70, P148; Chow WH, 2010, ANN ACAD MED SINGAP, V39, P129; Chui PL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139952; Chui PL, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-425; Elmore JG, 2011, JAMA-J AM MED ASSOC, V293, P1245; Ermiah Eramah, 2012, BMC Res Notes, V5, P452, DOI 10.1186/1756-0500-5-452; Farooqui M, 2015, J TRADIT COMPLEMENT, P8; Ghazali SM, 2013, ASIAN PAC J CANCER P, V14, P1141, DOI 10.7314/APJCP.2013.14.2.1141; Hamidah A, 2009, PEDIATR BLOOD CANCER, V52, P70, DOI 10.1002/pbc.21798; Harirchi I, 2005, PUBLIC HEALTH, V119, P885, DOI 10.1016/j.puhe.2004.11.005; Hasan Syed Shahzad, 2009, Complement Ther Clin Pract, V15, P152, DOI 10.1016/j.ctcp.2009.02.003; Helyer LK, 2006, USE COMPLEMENTARY AL, V8, P1; Huo Q, 2015, ANN SURG ONCOL, V22, P883, DOI 10.1245/s10434-014-4076-9; Hwang JH, 2015, EVIDENCE BASED COMPL, V2015; Ibrahim NA, 2012, BREAST, V21, P416, DOI 10.1016/j.breast.2012.02.006; Knight Aishah, 2015, Asian Pac J Cancer Prev, V16, P3125; Leong BDK, 2007, ASIAN PAC J CANCER P, V8, P525; Lim GCC, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-212; Lim JNW, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009863; Martins T, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-197; Muhamad M, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/689168; Norsa'adah B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-141; Norsa'adah B, 2012, ASIAN PAC J CANCER P, V13, P3723, DOI 10.7314/APJCP.2012.13.8.3723; Perez Gloria, 2008, Cancer Detect Prev, V32, P267, DOI 10.1016/j.cdp.2008.05.006; Plotogea A, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-125; Poum A, 2012, ASIAN PAC J CANCER P, V13, P791, DOI 10.7314/APJCP.2012.13.3.791; Puataweepong P, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/670408; Raja L, 2013, COMPLEMENTARY ALTERN, V13, P11; Rastad H, 2012, ASIAN PAC J CANCER P, V13, P4511, DOI 10.7314/APJCP.2012.13.9.4511; Richards MA, 1999, LANCET, V353, P1119, DOI 10.1016/S0140-6736(99)02143-1; Richardson MA, 2000, J CLIN ONCOL, V18, P2505, DOI 10.1200/JCO.2000.18.13.2505; Saibul N, 2012, ASIAN PAC J CANCER P, V13, P4081, DOI 10.7314/APJCP.2012.13.8.4081; Shandiz FH, 2012, EUR J CANCER, V48, pS80; Taib NA, 2007, ASIAN PAC J CANCER P, V8, P141; Taib NA, 2014, WORLD J SURG, V38, P1676, DOI 10.1007/s00268-013-2339-4; Taib NA, 2011, ASIAN PAC J CANCER P, V12, P1601; Taib NA, 2011, ASIAN PAC J CANCER P, V12, P345; Tas F, 2016, PREVALENCE DETERMINA; Weinmann S, 2005, CHARACTERISTICS WOME, P33; Whitford' HS, 2011, CANCER FORUM, V35, P27; Yew VWC, 2015, COMPLEMENTARY ALTERN, V1, P183	53	32	32	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176394	10.1371/journal.pone.0176394	http://dx.doi.org/10.1371/journal.pone.0176394			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448541	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383600073
J	Ma, YM; Shukla, V; Merewitz, EB				Ma, Yingmei; Shukla, Vijaya; Merewitz, Emily B.			Transcriptome analysis of creeping bentgrass exposed to drought stress and polyamine treatment	PLOS ONE			English	Article							RNA-SEQ DATA; PHOSPHOENOLPYRUVATE CARBOXYLASE; GENE-EXPRESSION; KYOTO ENCYCLOPEDIA; POTASSIUM CHANNEL; STOMATAL CLOSURE; PLANT-RESPONSES; TALL FESCUE; GUARD-CELLS; IPT GENE	Creeping bentgrass is an important cool-season turfgrass species sensitive to drought. Treatment with polyamines (PAs) has been shown to improve drought tolerance; however, the mechanism is not yet fully understood. Therefore, this study aimed to evaluate transcriptome changes of creeping bentgrass in response to drought and exogenous spermidine (Spd) application using RNA sequencing (RNA-Seq). The high-quality sequences were assembled and 18,682 out of 49,190 (38%) were detected as coding sequences. A total of 22% and 19% of genes were found to be either up-or down-regulated due to drought while 20% and 34% genes were either up-or down-regulated in response to Spd application under drought conditions, respectively. Gene ontology (GO) and enrichment analysis were used to interpret the biological processes of transcripts and relative transcript abundance. Enriched or differentially expressed transcripts due to drought stress and/or Spd application were primarily associated with energy metabolism, transport, antioxidants, photosynthesis, signaling, stress defense, and cellular response to water deprivation. This research is the first to provide transcriptome data for creeping bentgrass under an abiotic stress using RNA-Seq analysis. Differentially expressed transcripts identified here could be further investigated for use as molecular markers or for functional analysis in responses to drought and Spd.	[Ma, Yingmei; Shukla, Vijaya; Merewitz, Emily B.] Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA	Michigan State University	Merewitz, EB (corresponding author), Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA.	merewitz@msu.edu	Ma, Yingmei/J-7409-2019					Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; Alcazar R, 2005, PLANT J, V43, P425, DOI 10.1111/j.1365-313X.2005.02465.x; ANDREWS TJ, 1988, J BIOL CHEM, V263, P12213; [Anonymous], 2014, FRONT PLANT SCI, V5, P687; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Araneda L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079425; Araujo WL, 2012, PLANT CELL ENVIRON, V35, P1, DOI 10.1111/j.1365-3040.2011.02332.x; Bluthgen Nils, 2005, Genome Inform, V16, P106; Borghi L, 2015, BIOCHEM SOC T, V43, P924, DOI 10.1042/BST20150106; Bourque S, 2002, PLANT PHYSIOL, V130, P2177, DOI 10.1104/pp.009449; Brinia F, 2007, PLANT SCI; Britto DT, 2005, PLANT CELL ENVIRON, V28, P1396, DOI 10.1111/j.1365-3040.2005.01372.x; Bunsupa S, 2012, PLANT CELL, V24, P1202, DOI 10.1105/tpc.112.095885; Bushman BS, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2379-x; Campalans A, 1999, PLANT PHYSIOL BIOCH, V37, P327, DOI 10.1016/S0981-9428(99)80039-4; Chakraborty N, 2006, THEOR APPL GENET, V113, P1421, DOI 10.1007/s00122-006-0387-y; Chakraborty N, 2005, THEOR APPL GENET, V111, P795, DOI 10.1007/s00122-005-2065-x; Chan ZL, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.4161/15592324.2014.991577; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Chen LQ, 2012, SCIENCE, V335, P207, DOI 10.1126/science.1213351; Cheng MC, 2013, PLANT PHYSIOL, V162, P1566, DOI [10.1104/pp.113.221911, 10.1104]; Choi DW, 1999, THEOR APPL GENET, V98, P1234, DOI 10.1007/s001220051189; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Cornic G, 2002, ANN BOT-LONDON, V89, P887, DOI 10.1093/aob/mcf064; Cousins AB, 2007, PLANT PHYSIOL, V145, P1006, DOI 10.1104/pp.107.103390; Critchley JH, 2001, PLANT J, V26, P89, DOI 10.1046/j.1365-313x.2001.01012.x; Deyholos MK, 2010, PLANT CELL ENVIRON, V33, P648, DOI 10.1111/j.1365-3040.2009.02092.x; Dicko MH, 2006, FEBS J, V273, P2293, DOI 10.1111/j.1742-4658.2006.05243.x; Douce R, 1999, CURR OPIN PLANT BIOL, V2, P214, DOI 10.1016/S1369-5266(99)80038-7; Du HY, 2015, PLANT GROWTH REGUL, V75, P1, DOI 10.1007/s10725-014-9925-9; Eini O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058713; FEIRER RP, 1984, SCIENCE, V223, P1433, DOI 10.1126/science.223.4643.1433; Ferla MP, 2014, MICROBIOL-SGM, V160, P1571, DOI 10.1099/mic.0.077826-0; Fischer WN, 2002, PLANT J, V29, P717, DOI 10.1046/j.1365-313X.2002.01248.x; Fry J., 2004, APPL TURFGRASS SCI P; Fu DL, 2007, PLANT CELL REP, V26, P467, DOI 10.1007/s00299-006-0258-7; Fu JM, 2010, J AM SOC HORTIC SCI, V135, P506, DOI 10.21273/JASHS.135.6.506; Gan L, 2016, PLOS ONE; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gill SS, 2010, PLANT SIGNAL BEHAV, V5, P26, DOI 10.4161/psb.5.1.10291; Golembiewski RC, 1997, CROP SCI, V37, P212, DOI 10.2135/cropsci1997.0011183X003700010036x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grondin A, 2015, PLANT CELL, V27, P1945, DOI 10.1105/tpc.15.00421; Groppa MD, 2001, PLANT SCI, V161, P481, DOI 10.1016/S0168-9452(01)00432-0; Guo SG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-454; GUTTERIDGE S, 1991, J BIOL CHEM, V266, P7359; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hamdani S, 2011, J PHOTOCH PHOTOBIO B, V104, P314, DOI 10.1016/j.jphotobiol.2011.02.007; Hare PD, 1999, J EXP BOT, V50, P413, DOI 10.1093/jexbot/50.333.413; Harpel MR, 1995, BIOCHEM; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hatmi S, 2015, J EXP BOT, V66, P775, DOI 10.1093/jxb/eru436; Hesse H, 2004, J EXP BOT, V55, P1283, DOI 10.1093/jxb/erh136; Hirner A, 2006, PLANT CELL, V18, P1931, DOI 10.1105/tpc.106.041012; Hirsch RE, 1998, SCIENCE, V280, P918, DOI 10.1126/science.280.5365.918; Hong ZL, 2000, PLANT PHYSIOL, V122, P1129, DOI 10.1104/pp.122.4.1129; Houde M, 2004, PLANT BIOTECHNOL J, V2, P381, DOI 10.1111/j.1467-7652.2004.00082.x; Hu LX, 2010, J PLANT PHYSIOL, V167, P103, DOI 10.1016/j.jplph.2009.07.008; Huang BR, 2014, CRIT REV PLANT SCI, V33, P141, DOI 10.1080/07352689.2014.870411; Ioannidis NE, 2007, BBA-BIOENERGETICS, V1767, P1372, DOI 10.1016/j.bbabio.2007.10.002; Jiang Y, 2007, J EXP BOT, V58, P3591, DOI 10.1093/jxb/erm207; Jiang YW, 2002, CROP SCI, V42, P202, DOI 10.2135/cropsci2002.0202; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; KANG J, 2011, PLANT ABC TRANSPORTE; KING SW, 1992, PLANT MOL BIOL, V18, P119, DOI 10.1007/BF00018462; KLAPHECK S, 1992, BOT ACTA, V105, P174, DOI 10.1111/j.1438-8677.1992.tb00284.x; Kopriva S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00163; Kostov RV, 1997, PHOTOSYNTH RES, V54, P127, DOI 10.1023/A:1005967106993; LARSON RA, 1988, PHYTOCHEMISTRY, V27, P969, DOI 10.1016/0031-9422(88)80254-1; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li X.N., 2016, DROUGHT STRESS TOLER, V1, P17, DOI 10.1007/978-3-319-28899-4; Li Xiong, 2016, Plant Diversity, V38, P101, DOI 10.1016/j.pld.2016.03.002; Li Z, 2015, PLOS ONE; Li Z, 2015, PLANT GROWTH REGUL, V76, P71, DOI 10.1007/s10725-014-9978-9; Lin RC, 2008, MOL PLANT, V1, P42, DOI 10.1093/mp/ssm004; Liu FL, 2006, J BIOL CHEM, V281, P27405, DOI 10.1074/jbc.M604548200; Liu K, 2000, PLANT PHYSIOL, V124, P1315, DOI 10.1104/pp.124.3.1315; Lu YB, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00585; Ma Y, 2016, J AM SOC HORTIC SCI, V141, P94; Marco F, 2011, OMICS, V15, P775, DOI 10.1089/omi.2011.0084; Martinelli T, 2007, J EXP BOT, V58, P3037, DOI 10.1093/jxb/erm161; Merewitz E., 2013, INT TURFGRASS SOC, V12, P375; Merewitz EB, 2016, CAB REV, V11, P3; Merewitz EB, 2012, J EXP BOT, V63, P1315, DOI 10.1093/jxb/err372; Merewitz EB, 2011, J EXP BOT, V62, P5311, DOI 10.1093/jxb/err166; Minocha R, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00175; MIYAZAKI JH, 1987, PLANT PHYSIOL, V84, P277, DOI 10.1104/pp.84.2.277; Arraes FBM, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0597-z; Mou ZL, 2002, PLANT CELL, V14, P2031, DOI 10.1105/tpc.001701; Moulin M, 2000, PLANT PHYSIOL BIOCH, V38, P577, DOI 10.1016/S0981-9428(00)00777-4; Munemasa S, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00472; Nishizawa A, 2008, PLANT PHYSIOL, V147, P1251, DOI 10.1104/pp.108.122465; Nogues S, 1998, PLANT PHYSIOL, V117, P173, DOI 10.1104/pp.117.1.173; O'Rourke JA, 2013, PLANT PHYSIOL, V161, P705, DOI 10.1104/pp.112.209254; OGREN WL, 1984, ANNU REV PLANT PHYS, V35, P415, DOI 10.1146/annurev.pp.35.060184.002215; Orshinsky AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041150; Pal M, 2015, PLANT SCI, V237, P16, DOI 10.1016/j.plantsci.2015.05.003; Pighin JA, 2004, SCIENCE, V306, P702, DOI 10.1126/science.1102331; Pottosin I, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00154; Qian BY, 2015, J PLANT PHYSIOL, V175, P9, DOI 10.1016/j.jplph.2014.09.019; Ramakrishna A, 2011, PLANT SIGNAL BEHAV, V6, P1720, DOI 10.4161/psb.6.11.17613; Reguera M, 2013, PLANT PHYSIOL, V163, P1609, DOI 10.1104/pp.113.227702; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roje S, 2006, PHYTOCHEMISTRY, V67, P1686, DOI 10.1016/j.phytochem.2006.04.019; Rong W, 2014, PLANT BIOTECHNOL J, V12, P468, DOI 10.1111/pbi.12153; Savoi S, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0760-1; Seki M, 2007, CURR OPIN PLANT BIOL, V10, P296, DOI 10.1016/j.pbi.2007.04.014; Shen WJ, 2015, PHOTOSYNTHETICA, V53, P436, DOI 10.1007/s11099-015-0111-8; Shi H, 2012, PLOS ONE; Shukla V, 2015, J AM SOC HORTIC SCI, V140, P94, DOI 10.21273/JASHS.140.1.94; Stael S, 2011, FEBS LETT, V585, P3935, DOI 10.1016/j.febslet.2011.10.039; Stevens JR, 2008, THESIS; Stevens R, 2000, Brief Bioinform, V1, P398; Szalai G, 2009, J PLANT GROWTH REGUL, V28, P66, DOI 10.1007/s00344-008-9075-2; Tombesi S, 2015, SCI REP-UK, V5, DOI 10.1038/srep12449; Tran L.S., 2016, DROUGHT STRESS TOLER, V1, P77, DOI DOI 10.1007/978-3-319-28899-4_4; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; Veljovic-Jovanovic S, 2006, J EXP BOT, V57, P1759, DOI 10.1093/jxb/erl007; VERBRUGGEN N, 1993, PLANT PHYSIOL, V103, P771, DOI 10.1104/pp.103.3.771; Vergara GV, 2004, CROP SCI, V44, P884, DOI 10.2135/cropsci2004.0884; Vergara GV, 2003, CROP SCI, V43, P2162, DOI 10.2135/cropsci2003.2162; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; Verslues PE, 2010, ARABIDOPSIS BOOK; Wan Ping, 2011, Genomics Proteomics & Bioinformatics, V9, P37, DOI 10.1016/S1672-0229(11)60006-5; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weber A, 2000, PLANT CELL, V12, P787, DOI 10.1105/tpc.12.5.787; Wilkinson S, 2010, PLANT CELL ENVIRON, V33, P510, DOI 10.1111/j.1365-3040.2009.02052.x; Wingler A, 1999, PLANT CELL ENVIRON, V22, P361, DOI 10.1046/j.1365-3040.1999.00410.x; Xing JP, 2009, J AM SOC HORTIC SCI, V134, P602, DOI 10.21273/JASHS.134.6.602; Yamaguchi K, 2007, BIOCHEM BIOPH RES CO, V352, P486, DOI 10.1016/j.bbrc.2006.11.041; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang HM, 2010, MOL PLANT MICROBE IN, V23, P1097, DOI 10.1094/MPMI-23-8-1097; Zhang R, 2013, J GINSENG RES, V37, P361, DOI 10.5142/jgr.2013.37.361; Zhang XZ, 2009, CROP SCI, V49, P1893, DOI 10.2135/cropsci2008.09.0521	137	18	20	10	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0175848	10.1371/journal.pone.0175848	http://dx.doi.org/10.1371/journal.pone.0175848			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445484	Green Published, Green Submitted, gold			2022-12-26	WOS:000400309200030
J	Martin-Fernandez, L; Gavidia-Bovadilla, G; Corrales, I; Brunel, H; Ramirez, L; Lopez, S; Souto, JC; Vidal, F; Soria, JM				Martin-Fernandez, Laura; Gavidia-Bovadilla, Giovana; Corrales, Irene; Brunel, Helena; Ramirez, Lorena; Lopez, Sonia; Carlos Souto, Juan; Vidal, Francisco; Manuel Soria, Jose			Next generation sequencing to dissect the genetic architecture of KNG1 and F11 loci using factor XI levels as an intermediate phenotype of thrombosis	PLOS ONE			English	Article							DEEP-VEIN THROMBOSIS; PARTIAL THROMBOPLASTIN TIME; QUANTITATIVE-TRAIT LOCUS; GENOME-WIDE ASSOCIATION; VENOUS THROMBOSIS; VARIANTS; RISK; SUSCEPTIBILITY; IDENTIFICATION; POPULATION	Venous thromboembolism is a complex disease with a high heritability. There are significant associations among Factor XI (FXI) levels and SNPs in the KNG1 and F11 loci. Our aim was to identify the genetic variation of KNG1 and F11 that might account for the variability of FXI levels. The KNG1 and F11 loci were sequenced completely in 110 unrelated individuals from the GAIT-2 (Genetic Analysis of Idiopathic Thrombophilia 2) Project using Next Generation Sequencing on an Illumina MiSeq. The GAIT-2 Project is a study of 935 individuals in 35 extended Spanish families selected through a proband with idiopathic thrombophilia. Among the 110 individuals, a subset of 40 individuals was chosen as a discovery sample for identifying variants. A total of 762 genetic variants were detected. Several significant associations were established among common variants and low-frequency variants sets in KNG1 and F11 with FXI levels using the PLINK and SKAT packages. Among these associations, those of rs710446 and five low-frequency variant sets in KNG1 with FXI level variation were significant after multiple testing correction and permutation. Also, two putative pathogenic mutations related to high and low FXI levels were identified by data filtering and in silico predictions. This study of KNG1 and F11 loci should help to understand the connection between genotypic variation and variation in FXI levels. The functional genetic variants should be useful as markers of thromboembolic risk.	[Martin-Fernandez, Laura; Gavidia-Bovadilla, Giovana; Brunel, Helena; Lopez, Sonia; Manuel Soria, Jose] Biomed Res Inst St Pau IIB St Pau, Unit Genom Complex Dis, Barcelona, Spain; [Gavidia-Bovadilla, Giovana] Univ Politecn Cataluna, Dept ESAII, Ctr Biomed Engn Res CREB, Barcelona, Spain; [Corrales, Irene; Ramirez, Lorena; Vidal, Francisco] Congenital Coagulopathies Blood & Tissue Bank, Barcelona, Spain; [Corrales, Irene; Ramirez, Lorena; Vidal, Francisco] Univ Autanoma Barcelona VHI R UAB, Mol Diag & Therapy, Vail dHebron Res Inst, Barcelona, Spain; [Carlos Souto, Juan] Hosp Santa Creu & Sant Pau, IIB St Pau, Unit Hemostasis & Thrombosis, Dept Hematol, Barcelona, Spain; [Vidal, Francisco] CIBER Enfermedades Cardiovasc, Barcelona, Spain	Universitat Politecnica de Catalunya; Hospital of Santa Creu i Sant Pau; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV	Soria, JM (corresponding author), Biomed Res Inst St Pau IIB St Pau, Unit Genom Complex Dis, Barcelona, Spain.	JSona@santpau.cat	Lopez, Sonia/AAC-8830-2019; Soria Fernández, José Manuel/AAD-6761-2019	Lopez, Sonia/0000-0002-5023-5153; Soria Fernández, José Manuel/0000-0002-6226-4293; Corrales Insa, Irene/0000-0002-0647-0340; Gavidia, Giovana/0000-0002-5743-1800; Vidal, Francisco/0000-0001-8089-4945; Martin-Fernandez, Laura/0000-0002-8909-508X	Fondo Europeo de Desarrollo Regional (FEDER); Institute de Salud Carlos III Fondo de Investigacion Sanitaria [PI 11/0184, PI 12/01494, PI 15/00269]; Red Investigacion Cardiovascular [RD12/0042/0032, RD12/0042/0053]; Ayudas Predoctorales de Formacion en Investigacion en Salud (PFIS) [FI12/00322]	Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); Institute de Salud Carlos III Fondo de Investigacion Sanitaria; Red Investigacion Cardiovascular; Ayudas Predoctorales de Formacion en Investigacion en Salud (PFIS)	We are deeply grateful to the families who participated in this study. Also, we would like to thank Professor Bill Stone for reviewing the manuscript. CIBERCV is an initiative of ISCIII co-financed by Fondo Europeo de Desarrollo Regional (FEDER) a way to build Europe.; This study was supported by funds from the Institute de Salud Carlos III Fondo de Investigacion Sanitaria PI 11/0184, PI 12/01494 and PI 15/00269 and Red Investigacion Cardiovascular RD12/0042/0032 and RD12/0042/0053. Laura Martin-Fernandez was supported by Ayudas Predoctorales de Formacion en Investigacion en Salud (PFIS) FI12/00322. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bezemer ID, 2008, JAMA-J AM MED ASSOC, V299, P1306, DOI 10.1001/jama.299.11.1306; Buil A, 2010, BLOOD, V115, P4644, DOI 10.1182/blood-2010-01-263038; Camacho M, 2012, ATHEROSCLEROSIS, V224, P129, DOI 10.1016/j.atherosclerosis.2012.07.001; Collins SC, 2010, AM J MED GENET A, V152A, P2512, DOI 10.1002/ajmg.a.33626; Corrales I, 2011, J THROMB HAEMOST, V9, P679, DOI 10.1111/j.1538-7836.2011.04204.x; de Haan HG, 2012, BLOOD, V120, P656, DOI 10.1182/blood-2011-12-397752; Gehring NH, 2001, NAT GENET, V28, P389, DOI 10.1038/ng578; Harismendy O, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r118; Heit JA, 2004, J THROMB HAEMOST, V2, P731, DOI 10.1111/j.1538-7933.2004.00660.x; Houlihan LM, 2010, AM J HUM GENET, V86, P626, DOI 10.1016/j.ajhg.2010.02.016; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Lee Seunggeun, 2015, SKAT SNP SET SEQUENC; Li Y, 2009, J THROMB HAEMOST, V7, P1802, DOI 10.1111/j.1538-7836.2009.03544.x; Lotta LA, 2013, J THROMB HAEMOST, V11, P1228, DOI 10.1111/jth.12291; Lotta LA, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-7; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Soria JM, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001060; Soria JM, 2009, HUM BIOL, V81, P853, DOI 10.3378/027.081.0627; Martin-Fernandez L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146922; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Morange PE, 2011, BLOOD, V117, P3692, DOI 10.1182/blood-2010-11-319053; Pelak K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001111; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quelin F, 2006, BLOOD COAGUL FIBRIN, V17, P69, DOI 10.1097/01.mbc.0000198054.50257.96; Rosendaal FR, 2009, J THROMB HAEMOST S1, V7; Rosendaal Frits R, 2005, Hematology Am Soc Hematol Educ Program, P1; Sabater-Lleal M, 2012, ARTERIOSCL THROM VAS, V32, P2008, DOI 10.1161/ATVBAHA.112.248492; Soria JM, 2002, AM J HUM GENET, V70, P567, DOI 10.1086/339259; Souto JC, 2000, CIRCULATION, V101, P1546, DOI 10.1161/01.CIR.101.13.1546; Souto JC, 2002, PATHOPHYSIOL HAEMO T, V32, P338, DOI 10.1159/000073593; Souto JC, 2000, AM J HUM GENET, V67, P1452, DOI 10.1086/316903; Tang WH, 2012, AM J HUM GENET, V91, P152, DOI 10.1016/j.ajhg.2012.05.009; Thery JC, 2011, EUR J HUM GENET, V19, P1052, DOI 10.1038/ejhg.2011.100; Tirado I, 2004, THROMB HAEMOSTASIS, V91, P899, DOI 10.1160/TH03-10-0620; Venselaar H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-548; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Zhang H, 2010, BLOOD, V116, P4684, DOI 10.1182/blood-2010-04-277798	40	3	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176301	10.1371/journal.pone.0176301	http://dx.doi.org/10.1371/journal.pone.0176301			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445521	gold, Green Submitted, Green Published			2022-12-26	WOS:000400309200043
J	Nishimori, A; Konnai, S; Okagawa, T; Maekawa, N; Ikebuchi, R; Goto, S; Sajiki, Y; Suzuki, Y; Kohara, J; Ogasawara, S; Kato, Y; Murata, S; Ohashi, K				Nishimori, Asami; Konnai, Satoru; Okagawa, Tomohiro; Maekawa, Naoya; Ikebuchi, Ryoyo; Goto, Shinya; Sajiki, Yamato; Suzuki, Yasuhiko; Kohara, Junko; Ogasawara, Satoshi; Kato, Yukinari; Murata, Shiro; Ohashi, Kazuhiko			In vitro and in vivo antivirus activity of an anti-programmed death-ligand 1 (PD-L1) ratbovine chimeric antibody against bovine leukemia virus infection	PLOS ONE			English	Article							T-CELL EXHAUSTION; CHRONIC VIRAL-INFECTION; LYMPHOCYTE SUBPOPULATIONS; CLINICAL-SIGNIFICANCE; ANTI-PD-L1 ANTIBODY; THERAPEUTIC TARGET; IMMUNE-RESPONSES; MILK-PRODUCTION; DAIRY-CATTLE; B7-H1 PD-L1	Programmed death-1 (PD-1), an immunoinhibitory receptor on T cells, is known to be involved in immune evasion through its binding to PD-ligand 1 (PD-L1) in many chronic diseases. We previously found that PD-L1 expression was upregulated in cattle infected with bovine leukemia virus (BLV) and that an antibody that blocked the PD-1/PD-L1 interaction reactivated T-cell function in vitro. Therefore, this study assessed its antivirus activities in vivo. First, we inoculated the anti-bovine PD-L1 rat monoclonal antibody 4G12 into a BLV-infected cow. However, this did not induce T-cell proliferation or reduction of BLV provirus loads during the test period, and only bound to circulating IgM(+) B cells until one week post-inoculation. We hypothesized that this lack of in vivo effects was due to its lower stability in cattle and so established an anti-PD-L1 rat-bovine chimeric antibody (Boch4G12). Boch4G12 was able to bind specifically with bovine PD-L1, interrupt the PD-1/PD-L1 interaction, and activate the immune response in both healthy and BLV-infected cattle in vitro. Therefore, we experimentally infected a healthy calf with BLV and inoculated it intravenously with 1 mg/kg of Boch4G12 once it reached the aleukemic (AL) stage. Cultivation of peripheral blood mononuclear cells (PBMCs) isolated from the tested calf indicated that the proliferation of CD4(+) T cells was increased by Boch4G12 inoculation, while BLV provirus loads were significantly reduced, clearly demonstrating that this treatment induced antivirus activities. Therefore, further studies using a large number of animals are required to support its efficacy for clinical application.	[Nishimori, Asami; Konnai, Satoru; Okagawa, Tomohiro; Maekawa, Naoya; Ikebuchi, Ryoyo; Goto, Shinya; Sajiki, Yamato; Murata, Shiro; Ohashi, Kazuhiko] Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Sapporo, Hokkaido, Japan; [Suzuki, Yasuhiko] Hokkaido Univ, Div Bioresources, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Suzuki, Yasuhiko] Hokkaido Univ, Global Inst Collaborat Res & Educ GI CoRE, Global Stn Zoonosis Control, Sapporo, Hokkaido, Japan; [Kohara, Junko] Hokkaido Res Org, Agr Res Dept, Anim Res Ctr, Shintoku, Hokkaido, Japan; [Ogasawara, Satoshi; Kato, Yukinari] Tohoku Univ, Grad Sch Med, Sendai, Miyagi, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Tohoku University	Konnai, S (corresponding author), Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Sapporo, Hokkaido, Japan.	konnai@vetmed.hokudai.ac.jp	Okagawa, Tomohiro/AAX-1284-2021; Suzuki, Yasuhiko/F-6890-2012; Ikebuchi, Ryoyo/AAG-1138-2019	Ikebuchi, Ryoyo/0000-0003-0231-7733; Kato, Yukinari/0000-0001-5385-8201; Satoru, Konnai/0000-0002-3230-7109	SPS KAKENHI grant [25257415]; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry, Japan [26058B]; Grants-in-Aid for Scientific Research [15J01886, 16K18798] Funding Source: KAKEN	SPS KAKENHI grant; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	SPS KAKENHI grant, 25257415, https://www.jsps.go.jp/english/e-grants/ (to S.K.). The grants from the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry, Japan, 26058B (to S.K.). The Promotion of Basic Research Activities for Innovative Biosciences from the National Agriculture and Food Research Organization, Bio-oriented Technology Research Advancement Institution, 16817557 (to S.K.). The Platform for Drug Discovery, Informatics, and Structural Life Science (PDIS) from Japan Agency for Medical Research and development, AMED (to Y.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadzadeh M, 2009, BLOOD, V114, P1537, DOI 10.1182/blood-2008-12-195792; Aida Y, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00328; Armour KL, 1999, EUR J IMMUNOL, V29, P2613, DOI 10.1002/(SICI)1521-4141(199908)29:08<2613::AID-IMMU2613>3.0.CO;2-J; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Beldi-Ferchiou A, 2016, ONCOTARGET, V7, P72961, DOI 10.18632/oncotarget.12150; Benavides Benavides Bibiana, 2013, Rev. Lasallista Investig., V10, P18; Benson DM, 2010, BLOOD, V116, P2286, DOI 10.1182/blood-2010-02-271874; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Boni C, 2007, J VIROL, V81, P4215, DOI 10.1128/JVI.02844-06; Bradbury A, 2010, ANTIBODY ENGINEERING, VOL 1, SECOND EDITION, P15, DOI 10.1007/978-3-642-01144-3_2; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Chase CCL, 2008, VET CLIN N AM-FOOD A, V24, P87, DOI 10.1016/j.cvfa.2007.11.001; Das S, 2006, J IMMUNOL, V176, P3000, DOI 10.4049/jimmunol.176.5.3000; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Finnefrock AC, 2009, J IMMUNOL, V182, P980, DOI 10.4049/jimmunol.182.2.980; Gillet N, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-18; Gillet NA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003687; Giuliani M., 2017, ONCOTARGET; Hasenkrug KJ, 2000, VIROLOGY, V272, P244, DOI 10.1006/viro.2000.0387; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Ikebuchi R, 2014, IMMUNOLOGY, V142, P551, DOI 10.1111/imm.12243; Ikebuchi R, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-59; Ikebuchi R, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-103; Ikebuchi R, 2010, MICROBIOL IMMUNOL, V54, P291, DOI 10.1111/j.1348-0421.2010.00208.x; Inman BA, 2007, CANCER-AM CANCER SOC, V109, P1499, DOI 10.1002/cncr.22588; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Kampen AH, 2006, VET IMMUNOL IMMUNOP, V113, P53, DOI 10.1016/j.vetimm.2006.04.001; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Konnai S, 2013, COMP IMMUNOL MICROB, V36, P63, DOI 10.1016/j.cimid.2012.09.005; Kozako T, 2009, LEUKEMIA, V23, P375, DOI 10.1038/leu.2008.272; Kozako T, 2011, HUM IMMUNOL, V72, P1001, DOI 10.1016/j.humimm.2011.07.308; Lee E, 2016, INFECT GENET EVOL, V41, P245, DOI 10.1016/j.meegid.2016.04.010; Maekawa N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157176; Maekawa N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098415; Mekata H, 2015, VET REC, V176, P254, DOI 10.1136/vr.102464; Morovati H, 2012, TROP ANIM HEALTH PRO, V44, P1127, DOI 10.1007/s11250-011-0062-4; Murakami K, 2013, J VET MED SCI, V75, P1123, DOI 10.1292/jvms.12-0374; Nakanishi J, 2007, CANCER IMMUNOL IMMUN, V56, P1173, DOI 10.1007/s00262-006-0266-z; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Nomi T, 2007, CLIN CANCER RES, V13, P2151, DOI 10.1158/1078-0432.CCR-06-2746; Norby B, 2016, J DAIRY SCI, V99, P2043, DOI 10.3168/jds.2015-10089; Ohira K, 2016, IMMUN INFLAMM DIS, V4, P52, DOI 10.1002/iid3.93; Okagawa T, 2016, INFECT IMMUN, V84, P2779, DOI 10.1128/IAI.00278-16; Okagawa T, 2016, INFECT IMMUN, V84, P77, DOI 10.1128/IAI.01014-15; Okagawa T, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-45; Paris RM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144767; Rajao DS, 2014, SEMIN-CIENC AGRAR, V35, P891, DOI 10.5433/1679-0359.2014v35n2p891; Ruzina M N, 2013, Genetika, V49, P975; Sheridan C, 2014, NAT BIOTECHNOL, V32, P847, DOI 10.1038/nbt0914-847; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Strome SE, 2003, CANCER RES, V63, P6501; Sunshine J, 2015, CURR OPIN PHARMACOL, V23, P32, DOI 10.1016/j.coph.2015.05.011; Suzuki S, 2015, VET IMMUNOL IMMUNOP, V163, P115, DOI 10.1016/j.vetimm.2014.10.006; Sznol M, 2013, CLIN CANCER RES, V19, P1021, DOI 10.1158/1078-0432.CCR-12-2063; Thompson RH, 2004, P NATL ACAD SCI USA, V101, P17174, DOI 10.1073/pnas.0406351101; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; VanLeeuwen JA, 2005, CAN VET J, V46, P56; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wu CP, 2006, ACTA HISTOCHEM, V108, P19, DOI 10.1016/j.acthis.2006.01.003; Yang Y, 2016, J DAIRY SCI, V99, P3688, DOI 10.3168/jds.2015-10580	63	23	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0174916	10.1371/journal.pone.0174916	http://dx.doi.org/10.1371/journal.pone.0174916			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445479	gold, Green Published, Green Submitted			2022-12-26	WOS:000400309200014
J	Bauer, D; Redmon, N; Mazzio, E; Soliman, KF				Bauer, David; Redmon, Natalie; Mazzio, Elizabeth; Soliman, Karam F.			Apigenin inhibits TNF alpha/IL-1 alpha-induced CCL2 release through IKBK-epsilon signaling in MDA-MB-231 human breast cancer cells	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; GROWTH-INHIBITION; CARCINOMA-CELLS; TNF-ALPHA; EXPRESSION; APOPTOSIS; NEUTROPHILS; SUPPRESSES; INDUCTION; PROSTATE	Mortality associated with breast cancer is attributable to aggressive metastasis, to which TNF alpha plays a central orchestrating role. TNF alpha acts on breast tumor TNF receptors evoking the release of chemotactic proteins (e.g. MCP-1/CCL2). These proteins direct inward infiltration/migration of tumor-associated macrophages (TAMs), tumor-associated neutrophils (TANs), myeloid-derived suppressor cells (MDSCs), T-regulatory cells (Tregs), T helper IL-17-producing cells (Th17s), metastasis-associated macrophages (MAMs) and cancer-associated fibroblasts (CAFs). Tumor embedded infiltrates collectively enable immune evasion, tumor growth, angiogenesis, and metastasis. In the current study, we investigate the potential of apigenin, a known anti-inflammatory constituent of parsley, to downregulate TNF alpha mediated release of chemokines from human triple-negative cells (MDA-MB-231 cells). The results show that TNF alpha stimulation leads to large rise of CCL2, granulocyte macrophage colony-stimulating factor (GMCSF), IL-1 alpha and IL-6, all suppressed by apigenin. While many aspects of the transcriptome for NFkB signaling were evaluated, the data show signaling patterns associated with CCL2 were blocked by apigenin and mediated through suppressed mRNA and protein synthesis of IKBKe. Moreover, the data show that the attenuation of CCL2 by apigenin in the presence TNF alpha paralleled the suppression of phosphorylated extracellular signal-regulated kinase 1 (ERK 1/2). In summary, the obtained findings suggest that there exists a TNF alpha evoked release of CCL2 and other LSP recruiting cytokines from human breast cancer cells, which can be attenuated by apigenin.	[Bauer, David; Redmon, Natalie; Mazzio, Elizabeth; Soliman, Karam F.] Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32301 USA	State University System of Florida; Florida A&M University	Soliman, KF (corresponding author), Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32301 USA.	karam.soliman@famu.edu			National Institute of Minority Health and Health Disparities of the National Institutes of Health [G12 MD007582, P20 MD006738]	National Institute of Minority Health and Health Disparities of the National Institutes of Health	This research was supported by the National Institute of Minority Health and Health Disparities of the National Institutes of Health through Grant Number G12 MD007582 and Grant Number P20 MD006738.	Angelini A, 2010, J BIOL REG HOMEOS AG, V24, P197; [Anonymous], 2005, Health News, V11, P2; Barbie TU, 2014, J CLIN INVEST, V124, P5411, DOI 10.1172/JCI75661; Ben-Baruch A, 2012, CANCER MICROENVIRON, V5, P151, DOI 10.1007/s12307-011-0094-3; Cao XC, 2013, CHINESE J CANCER RES, V25, P212, DOI 10.3978/j.issn.1000-9604.2013.04.01; Chen D, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1797; Chen SS, 2012, DISCOV MED, V14, P327; Choi EJ, 2009, J CLIN BIOCHEM NUTR, V44, P260, DOI 10.3164/jcbn.08-230; Choi EJ, 2009, J NUTR BIOCHEM, V20, P285, DOI 10.1016/j.jnutbio.2008.03.005; Choi HJ, 2016, BIOCHEM BIOPH RES CO, V470, P101, DOI 10.1016/j.bbrc.2016.01.002; Chun E, 2015, CELL REP, V12, P244, DOI 10.1016/j.celrep.2015.06.024; Deryugina EI, 2014, NEOPLASIA, V16, P771, DOI 10.1016/j.neo.2014.08.013; Devaud C, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/2162402X.2014.975572; Ferrucci V, 2016, N-S ARCH PHARMACOL, V389, P131, DOI 10.1007/s00210-015-1191-5; Fujimoto H, 2009, INT J CANCER, V125, P1276, DOI 10.1002/ijc.24378; Guo JP, 2011, J BIOL CHEM, V286, P37389, DOI 10.1074/jbc.M111.287433; Harrison ME, 2014, EXP MOL PATHOL, V97, P211, DOI 10.1016/j.yexmp.2014.07.006; Hollmen M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09188; Ibrahim SA, 2015, ONCOTARGET, V6, P33033, DOI 10.18632/oncotarget.5439; Jang JY, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-421; Jehs T, 2014, INVEST OPHTH VIS SCI, V55, P5169, DOI 10.1167/iovs.14-14394; Jiang Zhe, 2014, Oncoscience, V1, P180; Katanov C, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0080-7; Kimura Y, 2015, EUR J PHARMACOL, V746, P115, DOI 10.1016/j.ejphar.2014.10.048; Kindlund B, 2016, GASTRIC CANC; Kitamura T, 2015, J EXP MED, V212, P1043, DOI 10.1084/jem.20141836; Li CH, 2013, J NUTR BIOCHEM, V24, P1766, DOI 10.1016/j.jnutbio.2013.03.006; Lin CH, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1965-7; Liu DW, 2016, CURR PHARM BIOTECHNO, V17, P486, DOI 10.2174/1389201017666160301102713; Mafuvadze B, 2012, HORM CANCER-US, V3, P160, DOI 10.1007/s12672-012-0114-x; Mafuvadze B, 2010, MENOPAUSE, V17, P1055, DOI 10.1097/gme.0b013e3181dd052f; Malek E, 2016, BLOOD REV; McClellan JL, 2012, AM J PHYSIOL-GASTR L, V303, pG1087, DOI 10.1152/ajpgi.00252.2012; Mirzoeva S, 2014, MOL CARCINOGEN, V53, P598, DOI 10.1002/mc.22005; Mishra P, 2011, J LEUKOCYTE BIOL, V89, P31, DOI 10.1189/jlb.0310182; Moses K, 2016, SEMIN IMMUNOL; Nabavi SM, 2015, ANTI-CANCER AGENT ME, V15, P728, DOI 10.2174/1871520615666150304120643; Noolu B, 2016, ANTICANCER AGENTS ME; Papi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054968; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Rego SL, 2014, ANGIOGENESIS, V17, P573, DOI 10.1007/s10456-013-9405-2; Schmall A, 2015, AM J RESP CRIT CARE, V191, P437, DOI 10.1164/rccm.201406-1137OC; Seo HS, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150165; Seo HS, 2015, MOL MED REP, V12, P2977, DOI 10.3892/mmr.2015.3698; Seo HS, 2012, MOL CELL BIOCHEM, V366, P319, DOI 10.1007/s11010-012-1310-2; Seo HS, 2011, NUTR RES, V31, P139, DOI 10.1016/j.nutres.2011.01.011; Shen RR, 2012, MOL CELL BIOL, V32, P4756, DOI 10.1128/MCB.00468-12; Shukla S, 2015, ONCOTARGET, V6, P31216, DOI 10.18632/oncotarget.5157; Shukla S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138710; Shukla S, 2010, PHARM RES-DORDR, V27, P962, DOI 10.1007/s11095-010-0089-7; Soria G, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-130; Steiner JL, 2012, INT J BIOL MARKER, V27, P179, DOI 10.5301/JBM.2012.9345; Sun L, 2016, ONCOTARGET; Tabaries S, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0558-3; Trivanovic D, 2016, IUBMB LIFE, V68, P190, DOI 10.1002/iub.1473; Tseng TH, 2016, ENV TOXICOL; Ueno T, 2000, CLIN CANCER RES, V6, P3282; van Meeuwen JA, 2007, TOXICOL APPL PHARM, V221, P372, DOI 10.1016/j.taap.2007.03.016; Vrakas CN, 2015, IMMUNOL INVEST, V44, P174, DOI 10.3109/08820139.2014.952818; Wang QR, 2011, ONCOL LETT, V2, P43, DOI 10.3892/ol.2010.215; Wang Y, 2016, CELL PHYSIOL BIOCHEM, V38, P306, DOI 10.1159/000438631; Xu YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029169; Yan C, 2015, J HEPATOL, V63, P420, DOI 10.1016/j.jhep.2015.03.024; Yumimoto K, 2015, J CLIN INVEST, V125, P621, DOI 10.1172/JCI78782; Zhou AY, 2013, CELL REP, V3, P724, DOI 10.1016/j.celrep.2013.01.031; Zhou SL, 2016, GASTROENTEROLOGY; Zollo M, 2012, CLIN EXP METASTAS, V29, P585, DOI 10.1007/s10585-012-9473-5	67	50	51	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0175558	10.1371/journal.pone.0175558	http://dx.doi.org/10.1371/journal.pone.0175558			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441391	Green Published, Green Submitted, gold			2022-12-26	WOS:000400308800006
J	Vali, P; Chandrasekharan, P; Rawat, M; Gugino, S; Koenigsknecht, C; Helman, J; Mathew, B; Berkelhamer, S; Nair, J; Wyckoff, M; Lakshminrusimha, S				Vali, Payam; Chandrasekharan, Praveen; Rawat, Munmun; Gugino, Sylvia; Koenigsknecht, Carmon; Helman, Justin; Mathew, Bobby; Berkelhamer, Sara; Nair, Jayasree; Wyckoff, Myra; Lakshminrusimha, Satyan			Hemodynamics and gas exchange during chest compressions in neonatal resuscitation	PLOS ONE			English	Article							CARDIOPULMONARY-RESUSCITATION; CARDIAC-ARREST; PERINATAL ASPHYXIA; SWINE MODEL; LAMBS; EPINEPHRINE; VENTILATION; HYPOXIA; CPR	Purpose Current knowledge about pulmonary/systemic hemodynamics and gas exchange during neonatal resuscitation in a model of transitioning fetal circulation with fetal shunts and fluid-filled alveoli is limited. Using a fetal lamb asphyxia model, we sought to determine whether hemodynamic or gas-exchange parameters predicted successful return of spontaneous circulation (ROSC). Methods The umbilical cord was occluded in 22 lambs to induce asphyxial cardiac arrest. Following five minutes of asystole, resuscitation as per AHA-Neonatal Resuscitation Program guidelines was initiated. Hemodynamic parameters and serial arterial blood gases were assessed during resuscitation. Results ROSC occurred in 18 lambs (82%) at a median (IQR) time of 120 (105-180) seconds. There were no differences in hemodynamic parameters at baseline and at any given time point during resuscitation between the lambs that achieved ROSC and those that did not. Blood gases at arrest prior to resuscitation were comparable between groups. However, lambs that achieved ROSC had lower PaO2, higher PaCO2, and lower lactate during resuscitation. Increase in diastolic blood pressures induced by epinephrine in lambs that achieved ROSC (11 +/- 4 mmHg) did not differ from those that were not resuscitated (10 +/- 6 mmHg). Low diastolic blood pressures were adequate to achieve ROSC. Conclusions Hemodynamic parameters in a neonatal lamb asphyxia model with transitioning circulation did not predict success of ROSC. Lactic acidosis, higher PaO2 and lower PaCO2 observed in the lambs that did not achieve ROSC may represent a state of inadequate tissue perfusion and/or mitochondrial dysfunction.	[Vali, Payam] Univ Calif Davis, Pediat, Sacramento, CA 95817 USA; [Chandrasekharan, Praveen; Rawat, Munmun; Gugino, Sylvia; Koenigsknecht, Carmon; Helman, Justin; Mathew, Bobby; Berkelhamer, Sara; Nair, Jayasree; Lakshminrusimha, Satyan] SUNY Buffalo, Pediat, Buffalo, NY USA; [Wyckoff, Myra] UT Southwestern, Pediat, Dallas, TX USA	University of California System; University of California Davis; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Texas System; University of Texas Southwestern Medical Center Dallas	Vali, P (corresponding author), Univ Calif Davis, Pediat, Sacramento, CA 95817 USA.	pvali@ucdavis.edu	Chandrasekharan, Praveen/X-1729-2019	Chandrasekharan, Praveen/0000-0001-8727-3017; Rawat, Munmun/0000-0001-9703-9857; Nair, Jayasree/0000-0003-3846-2027; Lakshminrusimha, Satyan/0000-0001-6098-2155	Canadian Paediatric Society -Neonatal Resuscitation Program Research Grant; American Academy of Pediatrics - Neonatal Resuscitation Program Young Investigator Award; NICHD [HD072929]	Canadian Paediatric Society -Neonatal Resuscitation Program Research Grant; American Academy of Pediatrics - Neonatal Resuscitation Program Young Investigator Award; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by the Canadian Paediatric Society -Neonatal Resuscitation Program Research Grant (SL), American Academy of Pediatrics - Neonatal Resuscitation Program Young Investigator Award (PV) and NICHD HD072929 (SL). The funders had no role study design, data collection ana analysis, decision to publish, or preparation of the manuscript.	Berg RA, 1999, CRIT CARE MED, V27, P1893, DOI 10.1097/00003246-199909000-00030; Chandrasekharan P, 2017, PEDIAT RES; Crile G, 1906, J EXP MED, V8, P713, DOI 10.1084/jem.8.6.713; Harrington DJ, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.10.877; Houri P K, 1997, Prehosp Emerg Care, V1, P65, DOI 10.1080/10903129708958789; Kapadia VS, 2013, J PEDIATR-US, V163, P949, DOI 10.1016/j.jpeds.2013.04.043; Klingenberg C, 2013, ARCH DIS CHILD-FETAL, V98, pF222, DOI 10.1136/archdischild-2012-301787; KOUWENHOVEN WB, 1960, JAMA-J AM MED ASSOC, V173, P1064, DOI 10.1001/jama.1960.03020280004002; Kuligowskia J, 2017, REDOX BIOL, V12, P1, DOI 10.1016/j.redox.2017.02.002; Perlman JM, 2015, PEDIATRICS; PREZIOSI MP, 1993, CRIT CARE MED, V21, P1901, DOI 10.1097/00003246-199312000-00018; Ramanathan T, 2005, BJA EDUC, V5, P61, DOI 10.1093/bjaceaccp/mki012; REDDING JS, 1963, ANESTHESIOLOGY, V24, P203, DOI 10.1097/00000542-196303000-00008; ROSENBERG AA, 1986, PEDIATR RES, V20, P778, DOI 10.1203/00006450-198608000-00016; ROSENBERG AA, 1989, STROKE, V20, P674, DOI 10.1161/01.STR.20.5.674; Schmolzer GM, 2014, RESUSCITATION, V85, P270, DOI 10.1016/j.resuscitation.2013.10.011; Sobotka KS, 2015, PEDIAT RES; Solberg R, 2016, PEDIATR RES, V80, P284, DOI 10.1038/pr.2016.66; Solevag AL, 2011, ARCH DIS CHILD-FETAL, V96, pF417, DOI 10.1136/adc.2010.200386; Solevag AL, 2010, RESUSCITATION, V81, P1571, DOI 10.1016/j.resuscitation.2010.06.007; Sutton RM, 2014, RESUSCITATION, V85, P983, DOI 10.1016/j.resuscitation.2014.04.015; Sutton RM, 2013, RESUSCITATION, V84, P696, DOI 10.1016/j.resuscitation.2012.10.023; TRAUB E, 1983, J PERINAT MED, V11, P103, DOI 10.1515/jpme.1983.11.2.103; Weiner GM, 2012, CLIN PERINATOL, V39, P843, DOI 10.1016/j.clp.2012.09.005; Wyckoff MH, 2008, SEMIN FETAL NEONAT M, V13, P410, DOI 10.1016/j.siny.2008.04.012; Wyckoff MH, 2015, CIRCULATION, V132, pS543, DOI 10.1161/CIR.0000000000000267; Wyckoff MH, 2012, J PEDIATR-US, V160, P239, DOI 10.1016/j.jpeds.2011.07.041	27	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176478	10.1371/journal.pone.0176478	http://dx.doi.org/10.1371/journal.pone.0176478			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441439	gold, Green Published, Green Submitted			2022-12-26	WOS:000400308800063
J	Zhang, HF; Wei, CH; Yang, XZ; Chen, HJ; Yang, YC; Mo, YL; Li, H; Zhang, Y; Ma, JX; Yang, JQ; Zhang, X				Zhang, Haifei; Wei, Chunhua; Yang, Xiaozhen; Chen, Hejie; Yang, Yongchao; Mo, Yanling; Li, Hao; Zhang, Yong; Ma, Jianxiang; Yang, Jianqiang; Zhang, Xian			Genome-wide identification and expression analysis of calcium-dependent protein kinase and its related kinase gene families in melon (Cucumis melo L.)	PLOS ONE			English	Article							DROUGHT STRESS TOLERANCE; ABSCISIC-ACID; FUNCTIONAL-CHARACTERIZATION; SIGNAL-TRANSDUCTION; CONFERS SALT; RICE; CDPK; REGULATOR; EVOLUTION; COLD	The calcium-dependent protein kinase (CDPK) is a ser/thr protein kinase that plays vital roles in plant growth, development, and responses to multiple stresses. Despite an important member of the stress responsive gene family, little is known about the evolutionary history and expression patterns of CDPK genes in melon. Herein, a total of 18 CDPK genes and 7 CDPK-related protein kinases (CRK) genes were identified in the melon genome via bioinformatic analysis, which were unevenly distributed across eleven chromosomes with an apparent exception for chromosome 3. Comparative syntenic analysis between Cucumis melo L. and Arabidopsis thaliana revealed that 13 CmCDPKs and 19 AtCPKs existed in 20 corresponding syntenic blocks. In addition, based on gene structure and phylogenetic analyses, all CmCDPKs were divided into four groups (CDPK I-IV) and CmCRKs clustered into one group (CRK I). Interestingly, group CDPK IV was clearly distinct from the other three CDPK groups, but clustered with CRK I on the phylogenetic tree, implying their origination from a common ancestor. Furthermore, CmCDPKand CmCRK genes were differentially expressed in response to various stimuli, such as biotic stress (Podosphaera xanthii), abiotic stress (salt and cold), and hormone (abscisic acid) treatment. To our knowledge, this is the first report on CDPK and CRK gene families in melon, which provides a basic foundation for functional characterizations of CmCDPK and CmCRK genes in the future.	[Zhang, Haifei; Wei, Chunhua; Yang, Xiaozhen; Chen, Hejie; Yang, Yongchao; Mo, Yanling; Li, Hao; Zhang, Yong; Ma, Jianxiang; Yang, Jianqiang; Zhang, Xian] Northwest A&F Univ, Dept Hort, Yangling, Peoples R China; [Yang, Yongchao] Wenshan Acad Agr Sci, Wenshan, Peoples R China	Northwest A&F University - China	Zhang, X (corresponding author), Northwest A&F Univ, Dept Hort, Yangling, Peoples R China.	zhangxian098@126.com			Scientific Startup Foundation for Doctors of Northwest AF University [Z109021604]; Basal Research Foundation of Northwest AF University [Z109021612]; Shaanxi Provincial Science and Technology Research and Development Project Fund, China [2015NY091]; Modern Agro-industry Technology Research System of China [CARS-26-18]	Scientific Startup Foundation for Doctors of Northwest AF University; Basal Research Foundation of Northwest AF University; Shaanxi Provincial Science and Technology Research and Development Project Fund, China; Modern Agro-industry Technology Research System of China	This work was supported by Scientific Startup Foundation for Doctors of Northwest A&F University (Z109021604), Basal Research Foundation of Northwest A&F University (Z109021612), the Shaanxi Provincial Science and Technology Research and Development Project Fund, China (No. 2015NY091), and the Modern Agro-industry Technology Research System of China (No. CARS-26-18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi F, 2004, PLANT MOL BIOL, V55, P541, DOI 10.1007/s11103-004-1178-y; Alex B, 2004, NUCLEIC ACIDS RES, V38, P211; Anil VS, 2000, PLANT PHYSIOL, V122, P1035, DOI 10.1104/pp.122.4.1035; Asano T, 2005, PLANT CELL PHYSIOL, V46, P356, DOI 10.1093/pcp/pci035; Asano T, 2012, PLANT J, V69, P26, DOI 10.1111/j.1365-313X.2011.04766.x; Asano T, 2011, PLANT MOL BIOL, V75, P179, DOI 10.1007/s11103-010-9717-1; Ben-Ari G, 2012, PLANT CELL REP, V31, P1357, DOI 10.1007/s00299-012-1292-2; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bouche N, 2005, ANNU REV PLANT BIOL, V56, P435, DOI 10.1146/annurev.arplant.56.032604.144224; Boudsocq M, 2013, TRENDS PLANT SCI, V18, P30, DOI 10.1016/j.tplants.2012.08.008; Boudsocq M, 2010, NATURE, V464, P418, DOI 10.1038/nature08794; Cai HY, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00737; Campo S, 2014, PLANT PHYSIOL, V165, P688, DOI 10.1104/pp.113.230268; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Chehab EW, 2004, PLANT PHYSIOL, V135, P1430, DOI 10.1104/pp.103.035238; Cheng H, 2013, MOL BIOL REP, V40, P2609, DOI 10.1007/s11033-012-2347-8; Cheng H, 2012, MOL BIOL REP, V39, P1903, DOI 10.1007/s11033-011-0936-6; Cheng SH, 2002, PLANT PHYSIOL, V129, P469, DOI 10.1104/pp.005645; Choi HI, 2005, PLANT PHYSIOL, V139, P1750, DOI 10.1104/pp.105.069757; Coca M, 2010, PLANT J, V63, P526, DOI 10.1111/j.1365-313X.2010.04255.x; Dammann C, 2003, PLANT PHYSIOL, V132, P1840, DOI 10.1104/pp.103.020008; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Ding YF, 2013, J EXP BOT, V64, P871, DOI 10.1093/jxb/ers366; Emanuel Epstein, 1972, PLANT PHYSL MINERAL; Garcia-Mas J, 2012, P NATL ACAD SCI USA, V109, P11872, DOI 10.1073/pnas.1205415109; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Guo CL, 2014, J EXP BOT, V65, P1513, DOI 10.1093/jxb/eru007; Hamel LP, 2014, TRENDS PLANT SCI, V19, P79, DOI 10.1016/j.tplants.2013.10.009; Harmon Alice C, 2003, Gravit Space Biol Bull, V16, P83; Harper JF, 2005, NAT REV MOL CELL BIO, V6, P555, DOI 10.1038/nrm1679; HARPER JF, 1994, BIOCHEMISTRY-US, V33, P7267, DOI 10.1021/bi00189a031; Hepler PK, 2005, PLANT CELL, V17, P2142, DOI 10.1105/tpc.105.032508; Hrabak EM, 2003, PLANT PHYSIOL, V132, P666, DOI 10.1104/pp.102.011999; Jiang SS, 2013, PLANT PHYSIOL BIOCH, V71, P112, DOI 10.1016/j.plaphy.2013.07.004; Klimecka M, 2007, ACTA BIOCHIM POL, V54, P219, DOI 10.18388/abp.2007_3242; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Li AL, 2008, PLANT MOL BIOL, V66, P429, DOI 10.1007/s11103-007-9281-5; Liese A, 2013, BBA-MOL CELL RES, V1833, P1582, DOI 10.1016/j.bbamcr.2012.10.024; Liu CY, 2014, MOL BIOL REP, V41, P6769, DOI 10.1007/s11033-014-3563-1; Liu HL, 2016, FUNCT INTEGR GENOMIC, V16, P481, DOI 10.1007/s10142-016-0498-8; Liu W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098189; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu SX, 2013, PLANT MOL BIOL, V82, P267, DOI 10.1007/s11103-013-0061-0; Lu SX, 2002, PLANT PHYSIOL, V128, P1008, DOI 10.1104/pp.010770; Luan S, 2002, PLANT CELL, V14, pS389, DOI 10.1105/tpc.001115; Ludwig AA, 2004, J EXP BOT, V55, P181, DOI 10.1093/jxb/erh008; Ma SY, 2007, PLANT MOL BIOL, V65, P511, DOI 10.1007/s11103-007-9187-2; Martin ML, 2000, PLANT J, V24, P429, DOI 10.1046/j.1365-313x.2000.00889.x; MCCURDY DW, 1992, PLANTA, V188, P54, DOI 10.1007/BF00198939; Myers C, 2009, PLANT J, V59, P528, DOI 10.1111/j.1365-313X.2009.03894.x; Rastogi S, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-28; Ray S, 2007, MOL GENET GENOMICS, V278, P493, DOI 10.1007/s00438-007-0267-4; Roy SW, 2006, NAT REV GENET, V7, P211, DOI 10.1038/nrg1807; Saijo Y, 2000, PLANT J, V23, P319, DOI 10.1046/j.1365-313x.2000.00787.x; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Shi W, 2013, BMC GENOMICS, V14, DOI [10.1186/1471-2164-14-103, 10.1186/1471-2164-14-433]; Sirhindi G, 2016, J PLANT BIOCHEM BIOT, V25, P301, DOI 10.1007/s13562-015-0342-6; Sverdlov AV, 2005, NUCLEIC ACIDS RES, V33, P1741, DOI 10.1093/nar/gki316; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Valmonte GR, 2014, PLANT CELL PHYSIOL, V55, P551, DOI 10.1093/pcp/pct200; Vision TJ, 2000, SCIENCE, V290, P2114, DOI 10.1126/science.290.5499.2114; Wang JP, 2016, MOL GENET GENOMICS, V291, P661, DOI 10.1007/s00438-015-1137-0; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1132, 10.1093/nar/gkr1293]; Weckwerth P, 2015, PLANT CELL ENVIRON, V38, P544, DOI 10.1111/pce.12414; Wei SY, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-133; Xu GX, 2012, P NATL ACAD SCI USA, V109, P1187, DOI 10.1073/pnas.1109047109; Xu J, 2010, PLANTA, V231, P1251, DOI 10.1007/s00425-010-1122-0; Xu XW, 2015, MOL GENET GENOMICS, V290, P1403, DOI 10.1007/s00438-015-1002-1; Yang DH, 2012, PLANT PHYSIOL, V159, P1591, DOI 10.1104/pp.112.199018; Ye SF, 2009, PLANT MOL BIOL, V70, P311, DOI 10.1007/s11103-009-9475-0; Zhang HF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-211; Zhang K, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0552-z; Zhang M, 2005, BBA-GENE STRUCT EXPR, V1729, P174, DOI 10.1016/j.bbaexp.2005.04.006; Zhang YJ, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-1; Zhao R, 2011, NEW PHYTOL, V192, P61, DOI 10.1111/j.1469-8137.2011.03793.x; Zhu SY, 2007, PLANT CELL, V19, P3019, DOI 10.1105/tpc.107.050666; Zielinski RE, 1998, ANNU REV PLANT PHYS, V49, P697, DOI 10.1146/annurev.arplant.49.1.697; Zou JJ, 2010, PLANT PHYSIOL, V154, P1232, DOI 10.1104/pp.110.157545; Zuo R, 2013, MOL BIOL REP, V40, P2645, DOI 10.1007/s11033-012-2351-z	79	26	30	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176352	10.1371/journal.pone.0176352	http://dx.doi.org/10.1371/journal.pone.0176352			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437432	Green Submitted, Green Published, gold			2022-12-26	WOS:000400287600044
J	Butcher, NJ; Merico, D; Zarrei, M; Ogura, L; Marshall, CR; Chow, EWC; Lang, AE; Scherer, SW; Bassett, AS				Butcher, Nancy J.; Merico, Daniele; Zarrei, Mehdi; Ogura, Lucas; Marshall, Christian R.; Chow, Eva W. C.; Lang, Anthony E.; Scherer, Stephen W.; Bassett, Anne S.			Whole-genome sequencing suggests mechanisms for 22q11.2 deletion-associated Parkinson's disease	PLOS ONE			English	Article							LOW-COPY REPEATS; GENE PRIORITIZATION; FUNCTIONAL IMPACT; VITAMIN-D; SCHIZOPHRENIA; RISK; ADULTS; COOCCURRENCE; PHENOTYPE; LOCUS	Objectives To investigate disease risk mechanisms of early-onset Parkinson's disease (PD) associated with the recurrent 22q11.2 deletion, a genetic risk factor for early-onset PD. Methods In a proof-of-principle study, we used whole-genome sequencing (WGS) to investigate sequence variants in nine adults with 22q11.2DS, three with neuropathologically confirmed early-onset PD and six without PD. Adopting an approach used recently to study schizophrenia in 22q11.2DS, here we tested candidate gene-sets relevant to PD. Results No mutations common to the cases with PD were found in the intact 22q11.2 region. While all were negative for rare mutations in a gene-set comprising PD disease-causing and risk genes, another candidate gene-set of 1000 genes functionally relevant to PD presented a nominally significant (P = 0.03) enrichment of rare putatively damaging missense variants in the PD cases. Polygenic score results, based on common variants associated with PD risk, were non-significantly greater in those with PD. Conclusions The results of this first-ever pilot study of WGS in PD suggest that the cumulative burden of genome-wide sequence variants may contribute to expression of early-onset PD in the presence of threshold-lowering dosage effects of a 22q11.2 deletion. We found no evidence that expression of PD in 22q11.2DS is mediated by a recessive locus on the intact 22q11.2 chromosome or mutations in known PD genes. These findings offer initial evidence of the potential effects of multiple within-individual rare variants on the expression of PD and the utility of next generation sequencing for studying the etiology of PD.	[Butcher, Nancy J.; Ogura, Lucas; Chow, Eva W. C.; Bassett, Anne S.] Ctr Addict & Mental Hlth, Clin Genet Res Program, Toronto, ON, Canada; [Butcher, Nancy J.; Chow, Eva W. C.; Bassett, Anne S.] Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Toronto, ON, Canada; [Butcher, Nancy J.; Lang, Anthony E.; Scherer, Stephen W.; Bassett, Anne S.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Merico, Daniele; Zarrei, Mehdi; Marshall, Christian R.; Scherer, Stephen W.] Hosp Sick Children, Ctr Appl Genom, Toronto, ON, Canada; [Merico, Daniele; Zarrei, Mehdi; Marshall, Christian R.; Scherer, Stephen W.] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON, Canada; [Marshall, Christian R.; Scherer, Stephen W.] Univ Toronto, McLaughlin Ctr, Toronto, ON, Canada; [Marshall, Christian R.; Scherer, Stephen W.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Chow, Eva W. C.; Bassett, Anne S.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Lang, Anthony E.] Univ Toronto, Div Neurol, Dept Med, Toronto, ON, Canada; [Lang, Anthony E.] Univ Toronto, Dept Med, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; [Lang, Anthony E.] Univ Hlth Network, Toronto Western Hosp, Res Inst, Toronto, ON, Canada; [Lang, Anthony E.] Toronto Western Hosp, Edmond J Safra Program Parkinsons Dis, Toronto, ON, Canada; [Bassett, Anne S.] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada; [Bassett, Anne S.] Univ Hlth Network, Dalglish Clin Adults Delet Syndrome 22q 22q11 2, Toronto, ON, Canada; [Bassett, Anne S.] Univ Hlth Network, Dept Psychiat, Toronto, ON, Canada; [Bassett, Anne S.] Univ Hlth Network, Div Cardiol, Dept Med, Toronto, ON, Canada; [Butcher, Nancy J.] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Bassett, AS (corresponding author), Ctr Addict & Mental Hlth, Clin Genet Res Program, Toronto, ON, Canada.; Bassett, AS (corresponding author), Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Toronto, ON, Canada.; Bassett, AS (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.; Bassett, AS (corresponding author), Univ Toronto, Dept Psychiat, Toronto, ON, Canada.; Bassett, AS (corresponding author), Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada.; Bassett, AS (corresponding author), Univ Hlth Network, Dalglish Clin Adults Delet Syndrome 22q 22q11 2, Toronto, ON, Canada.; Bassett, AS (corresponding author), Univ Hlth Network, Dept Psychiat, Toronto, ON, Canada.; Bassett, AS (corresponding author), Univ Hlth Network, Div Cardiol, Dept Med, Toronto, ON, Canada.	anne.bassett@utoronto.ca	Scherer, Stephen W./B-3785-2013; Lang, Anthony/ABF-8114-2021	Scherer, Stephen W./0000-0002-8326-1999; Merico, Daniele/0000-0002-3728-4401; Butcher, Nancy/0000-0002-5152-0108; Lang, Anthony/0000-0003-1229-3667	Canadian Institutes of Health Research [97800, 111238]; Genome Canada/Ontario Genomics Institute; Canada Research Chairs program; Brain Canada Mental Health Training Award; Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada/Ontario Genomics Institute(Genome Canada); Canada Research Chairs program(Canada Research Chairs); Brain Canada Mental Health Training Award; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research (A.S.B, MOP #97800, MOP #111238), Canada Research Chairs program (A.S.B), a Brain Canada Mental Health Training Award (N.J.B), a Canadian Institutes of Health Research Frederick Banting and Charles Best Canada Graduate Scholarship (N.J.B), and Science and Technology Innovation Centre funding from Genome Canada/Ontario Genomics Institute (D.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Bassett AS, 2011, J PEDIATR-US, V159, P332, DOI 10.1016/j.jpeds.2011.02.039; Bassett AS, 2008, HUM MOL GENET, V17, P4045, DOI 10.1093/hmg/ddn307; Bassett AS, 2003, AM J PSYCHIAT, V160, P1580, DOI 10.1176/appi.ajp.160.9.1580; Blake JA, 2013, NUCLEIC ACIDS RES, V41, pD530, DOI 10.1093/nar/gks1050; Booij J, 2010, AM J MED GENET A, V152A, P2937, DOI 10.1002/ajmg.a.33665; Butcher N, 2015, MOVEMENT DISORD, V30, pS1035; Butcher N, 2017, NEUROIMAGIN IN PRESS; Butcher NJ, 2013, JAMA NEUROL, V70, P1359, DOI 10.1001/jamaneurol.2013.3646; Butcher NJ, 2012, GENET MED, V14, P836, DOI 10.1038/gim.2012.66; Chauveau C, 2014, HUM MUTAT, V35, P1046, DOI 10.1002/humu.22611; D'Andrea MR, 2001, NEUROSCI LETT, V306, P137, DOI 10.1016/S0304-3940(01)01811-0; Edelmann L, 1999, AM J HUM GENET, V64, P1076, DOI 10.1086/302343; Foo JN, 2016, MOVEMENT DISORD, V31, P1924, DOI 10.1002/mds.26822; Fung WLA, 2015, GENET MED, V17, P599, DOI 10.1038/gim.2014.175; Gothelf D, 2008, DEV DISABIL RES REV, V14, P59, DOI 10.1002/ddrr.9; Guna A, 2015, J NEURODEV DISORD, V7, DOI 10.1186/s11689-015-9113-x; Hicks David G, 2010, BMC Cancer, V10, P108, DOI 10.1186/1471-2407-10-108; Kajiwara K, 1996, BIOCHEM BIOPH RES CO, V222, P144, DOI 10.1006/bbrc.1996.0712; Karayiorgou M, 2010, NAT REV NEUROSCI, V11, P402, DOI 10.1038/nrn2841; Kelley L, 2016, J DEV ORIG HLTH DIS, V7, P616, DOI 10.1017/S2040174416000428; Kiehl TR, 2009, CEREB CORTEX, V19, P153, DOI 10.1093/cercor/bhn066; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Klein C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a008888; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lill CM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002548; Lubbe SJ, 2016, HUM MOL GENET; McDonald-McGinn DM, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.71; Merico D, 2015, G3-GENES GENOM GENET, V5, P2453, DOI 10.1534/g3.115.021345; Merico D, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00238; Mok KY, 2016, LANCET NEUROL, V15, P585, DOI 10.1016/S1474-4422(16)00071-5; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Ogaki K, 2014, PARKINSONISM RELAT D, V20, P945, DOI 10.1016/j.parkreldis.2014.06.020; Oki M, 2016, INTERNAL MED, V55, P303, DOI 10.2169/internalmedicine.55.5485; Ou XM, 2004, J BIOL CHEM, V279, P21021, DOI 10.1074/jbc.M312638200; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Pollard R, 2016, PARKINSONISM RELAT D, V25, P110, DOI 10.1016/j.parkreldis.2016.01.027; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rehman AF, 2015, MOVEMENT DISORD, V30, P1289, DOI 10.1002/mds.26305; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; Simunovic F, 2009, BRAIN, V132, P1795, DOI 10.1093/brain/awn323; Son CG, 2005, GENOME RES, V15, P443, DOI 10.1101/gr.3124505; Spataro N, 2015, HUM MOL GENET, V24, P2023, DOI 10.1093/hmg/ddu616; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Tranchevent LC, 2008, NUCLEIC ACIDS RES, V36, pW377, DOI 10.1093/nar/gkn325; Tranchevent LC, 2016, NUCLEIC ACIDS RES, V44, pW117, DOI 10.1093/nar/gkw365; Van L, 2016, GENET MED, V18, P350, DOI 10.1038/gim.2015.84; Verhoeven WM, 2015, PHARMACOPSYCHIATRY; Vogels A, 2002, ANN GENET-PARIS, V45, P89, DOI 10.1016/S0003-3995(02)01114-0; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang LY, 2015, MOVEMENT DISORD, V30, P560, DOI 10.1002/mds.26117; Weksberg R, 2007, HUM GENET, V120, P837, DOI 10.1007/s00439-006-0242-x; Yuen RKC, 2015, NAT MED, V21, P185, DOI 10.1038/nm.3792; Zaleski C, 2009, AM J MED GENET A, V149A, P525, DOI 10.1002/ajmg.a.32650	59	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0173944	10.1371/journal.pone.0173944	http://dx.doi.org/10.1371/journal.pone.0173944			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430790	Green Published, Green Submitted, gold			2022-12-26	WOS:000399876100003
J	Mangoni, O; Saggiomo, V; Bolinesi, F; Margiotta, F; Budillon, G; Cotroneo, Y; Misic, C; Rivaro, P; Saggiomo, M				Mangoni, Olga; Saggiomo, Vincenzo; Bolinesi, Francesco; Margiotta, Francesca; Budillon, Giorgio; Cotroneo, Yuri; Misic, Cristina; Rivaro, Paola; Saggiomo, Maria			Phytoplankton blooms during austral summer in the Ross Sea, Antarctica: Driving factors and trophic implications	PLOS ONE			English	Article							FRAGILARIOPSIS-CYLINDRUS BACILLARIOPHYCEAE; NET COMMUNITY PRODUCTION; SOUTHERN-OCEAN; PHAEOCYSTIS-ANTARCTICA; QUANTUM YIELD; MESOSCALE VARIABILITY; TAXA PHOTOSYNTHESIS; IRON LIMITATION; CLIMATE-CHANGE; CARBON EXPORT	During the austral summer of 2014, an oceanographic cruise was conducted in the Ross Sea in the framework of the RoME (Ross Sea Mesoscale Experiment) Project. Forty-three hydrological stations were sampled within three different areas: the northern Ross Sea (RoME 1), Terra Nova Bay (RoME 2), and the southern Ross Sea (RoME 3). The ecological and photophysiological characteristics of the phytoplankton were investigated (i.e., size structure, functional groups, PSII maximum quantum efficiency, photoprotective pigments), as related to hydrographic and chemical features. The aim was to identify the mechanisms that modulate phytoplankton blooms, and consequently, the fate of organic materials produced by the blooms. The observed biomass standing stocks were very high (e.g., integrated chlorophyll-a up to 371 mg m(-2) in the top 100 m). Large differences in phytoplankton community composition, relative contribution of functional groups and photosynthetic parameters were observed among the three subsystems. The diatoms (in different physiological status) were the dominant taxa in RoME 1 and RoME 3; in RoME 1, a post-bloom phase was identified, whereas in RoME 3, an active phytoplankton bloom occurred. In RoME 2, diatoms co-occurred with Phaeocystis antarctica, but were vertically segregated by the upper mixed layer, with senescent diatoms dominating in the upper layer, and P. antarctica blooming in the deeper layer. The dominance of the phytoplankton micro-fraction over the whole area and the high Chl-a suggested the prevalence of non-grazed large cells, independent of the distribution of the two functional groups. These data emphasise the occurrence of significant temporal changes in the phytoplankton biomass in the Ross Sea during austral summer. The mechanisms that drive such changes and the fate of the carbon production are probably related to the variations in the limiting factors induced by the concurrent hydrological modifications to the Ross Sea, and they remain to be fully clarified. The comparison of conditions observed during summer 2014 and those reported for previous years reveal considerably different ecological assets that might be the result of current climate change. This suggests that further changes can be expected in the future, even at larger oceanic scales.	[Mangoni, Olga; Bolinesi, Francesco] Univ Napoli Federico II, Dipartimento Biol, Naples, Italy; [Saggiomo, Vincenzo; Margiotta, Francesca; Saggiomo, Maria] Stn Zool Anton Dohrn, Naples, Italy; [Budillon, Giorgio; Cotroneo, Yuri] Univ Parthenope, Dipartimento Sci & Tecnol, Naples, Italy; [Misic, Cristina] Univ Genoa, Dipartimento Sci Terra Ambiente & Vita, Genoa, Italy; [Rivaro, Paola] Univ Genoa, Dipartimento Chim & Chim Ind, Genoa, Italy	University of Naples Federico II; Stazione Zoologica Anton Dohrn di Napoli; Parthenope University Naples; University of Genoa; University of Genoa	Mangoni, O (corresponding author), Univ Napoli Federico II, Dipartimento Biol, Naples, Italy.	olga.mangoni@unina.it	Cotroneo, Yuri/M-4010-2019	Cotroneo, Yuri/0000-0002-0099-0142; Margiotta, Francesca/0000-0003-0757-5934; MANGONI, Olga/0000-0001-7789-0820; Saggiomo, Maria/0000-0001-5794-0050	Italian National Program for Antarctic Research (PNRA) [2013/AN2.04]; Italian National Programme for Antarctic Research	Italian National Program for Antarctic Research (PNRA); Italian National Programme for Antarctic Research	This work was carried in the framework of the Project Ross Sea Mesoscale Experiments (RoME) funded by the Italian National Program for Antarctic Research (PNRA, 2013/AN2.04).; This study was carried out in the framework of the activities of the Italian National Programme for Antarctic Research, which provided financial and logistic support. We thank the officers, crew, and technical personnel on board the R/V Italica for their support during the seagoing operations. The authors are grateful to Federico Angelini and Giuseppe Arena for their help during the cruise, and Augusto Passarelli for logistic support in Italy. We are grateful to Antonio Pusceddu for valuable and constructive comments on the manuscript, and to anonymous referees for their suggestions. The authors thanks Fred Davey for according the use of Ross Sea bathymetry data [doi:10.1594/IEDA/100405].	Alderkamp AC, 2012, J PHYCOL, V48, P45, DOI 10.1111/j.1529-8817.2011.01098.x; Arrigo K. R., 2003, J GEOPHYS RES, V108; Arrigo KR, 2015, J GEOPHYS RES-OCEANS, V120, P5545, DOI 10.1002/2015JC010888; Arrigo KR, 2010, INTEGR COMP BIOL, V50, P950, DOI 10.1093/icb/icq021; Arrigo KR, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035624; Arrigo KR, 1999, SCIENCE, V283, P365, DOI 10.1126/science.283.5400.365; Arrigo KR, 1998, J GEOPHYS RES-OCEANS, V103, P15587, DOI 10.1029/98JC00930; Aulicino G, 2014, IEEE T GEOSCI REMOTE, V52, P4122, DOI 10.1109/TGRS.2013.2279799; Bertrand EM, 2007, LIMNOL OCEANOGR, V52, P1079, DOI 10.4319/lo.2007.52.3.1079; Boyd PW, 2008, BIOGEOSCIENCES, V5, P847, DOI 10.5194/bg-5-847-2008; Boyd PW, 2015, NATURE CLIMATE CHANG, V6, P202; Budillon G., 2000, ANTARCTIC SCI, V12, P501; Caron DA, 2000, DEEP-SEA RES, V47, P15; Carrada G. C, 2000, ROSS SEA ECOLOGY ITA, P205; Catalano G, 2010, CARBON NUTR FLUXES C, P303; Cerrone D, 2017, J CLIMATE; Cheah W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072165; Collos Y, 2005, HYDROBIOLOGIA, V550, P83, DOI 10.1007/s10750-005-4365-1; Constable AJ, 2014, GLOBAL CHANGE BIOL, V20, P3004, DOI 10.1111/gcb.12623; Cotroneo Y, 2013, J GEOPHYS RES-OCEANS, V118, P2653, DOI 10.1002/jgrc.20193; Danovaro R, 2005, SCI TOTAL ENVIRON, V353, P189, DOI 10.1016/j.scitotenv.2005.09.029; de Baar HJW, 1999, MAR CHEM, V66, P1, DOI 10.1016/S0304-4203(99)00022-5; de Poll WHV, 2011, MAR ECOL PROG SER, V426, P119, DOI 10.3354/meps09000; Del Negro P, 2005, SCI TOTAL ENVIRON, V353, P258, DOI 10.1016/j.scitotenv.2005.09.018; Demmig-Adams B, 2006, PHYSIOL PLANTARUM, V127, P670, DOI 10.1111/j.1399-3054.2006.00698.x; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; DiTullio Giacomo R., 2003, Antarctic Research Series, V78, P279; DiTullio GR, 1996, J GEOPHYS RES-OCEANS, V101, P18467, DOI 10.1029/96JC00034; DiTullio GR, 2000, NATURE, V404, P595, DOI 10.1038/35007061; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Feng Y, 2010, DEEP-SEA RES PT I, V57, P368, DOI 10.1016/j.dsr.2009.10.013; Fragoso GM, 2012, J MARINE SYST, V89, P19, DOI 10.1016/j.jmarsys.2011.07.008; Franck VM, 2000, DEEP-SEA RES PT II, V47, P3315; Frolicher TL, 2015, J CLIMATE, V28, P862, DOI 10.1175/JCLI-D-14-00117.1; Fusco G, 2009, CONT SHELF RES, V29, P1887, DOI 10.1016/j.csr.2009.07.006; Garrison David L., 2003, Antarctic Research Series, V78, P53; Guglielmo L, 2011, POLAR BIOL, V34, P1301, DOI 10.1007/s00300-011-1031-0; Gutt J, 2015, GLOBAL CHANGE BIOL, V21, P1434, DOI 10.1111/gcb.12794; Hansen H.P., 1983, METHODS SEAWATER ANA, V2nd ed., P347; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; Hatta M, 2017, J MARINE SYST, V166, P61, DOI 10.1016/j.jmarsys.2016.07.009; HEDGES JI, 1984, LIMNOL OCEANOGR, V29, P657, DOI 10.4319/lo.1984.29.3.0657; Hiscock MR, 2008, P NATL ACAD SCI USA, V105, P4775, DOI 10.1073/pnas.0705006105; HOLM-HANSEN OSMUND, 1965, J CONS CONS PERMS INTE EXPLOR MER, V30, P3; Hutchins DA, 1998, NATURE, V393, P561, DOI 10.1038/31203; Jakob T, 2001, J PLANT PHYSIOL, V158, P383, DOI 10.1078/0176-1617-00288; Kennicutt MC, 2015, ANTARCT SCI, V27, P3, DOI 10.1017/S0954102014000674; Kennicutt MC, 2014, NATURE, V512, P23, DOI 10.1038/512023a; Kohut JT, 2017, J MARINE SYST, V166, P50, DOI 10.1016/j.jmarsys.2016.06.009; Lancelot C, 2000, DEEP-SEA RES PT I, V47, P1621, DOI 10.1016/S0967-0637(00)00005-4; Liu X, 2012, J MARINE SYST, V94, P135, DOI 10.1016/j.jmarsys.2011.11.013; Mackey MD, 1996, MAR ECOL PROG SER, V144, P265, DOI 10.3354/meps144265; Mangoni O, 2004, DEEP-SEA RES PT I, V51, P1601, DOI 10.1016/j.dsr.2004.07.006; Mangoni O, 2009, POLAR BIOL, V32, P311, DOI 10.1007/s00300-008-0507-z; Mastrandrea M.D., 2014, IPCC CLIMATE CHANGE, P1132; Mathot S, 2000, J PHYCOL, V36, P1049, DOI 10.1046/j.1529-8817.2000.99078.x; McMinn A, 2004, J MAR BIOL ASSOC UK, V84, P865, DOI 10.1017/S0025315404010112h; Mills MM, 2010, J PHYCOL, V46, P1114, DOI 10.1111/j.1529-8817.2010.00923.x; Misic C, 2017, J MARINE SYST, V166, P132, DOI 10.1016/j.jmarsys.2016.06.012; Murchie EH, 2013, J EXP BOT, V64, P3983, DOI 10.1093/jxb/ert208; Nitsche F, 2013, INTEGRATED EARTH DAT; Parkhill JP, 2001, J PHYCOL, V37, P517, DOI 10.1046/j.1529-8817.2001.037004517.x; Pasqual C, 2015, J MARINE SYST, V148, P142, DOI 10.1016/j.jmarsys.2015.02.006; Peloquin JA, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003816; Rivaro P, 2015, 22 C ASS IT OC LIMN; Rivaro P, 2017, J MARINE SYST, V166, P144, DOI 10.1016/j.jmarsys.2015.11.002; Rivaro P, 2012, DEEP-SEA RES PT I, V62, P97, DOI 10.1016/j.dsr.2011.12.008; Rusciano E, 2013, CONT SHELF RES, V61-62, P112, DOI 10.1016/j.csr.2013.04.002; Saggiomo V, 2002, DEEP-SEA RES PT II, V49, P1787, DOI 10.1016/S0967-0645(02)00012-7; Saggiomo V, 1998, J MARINE SYST, V17, P115, DOI 10.1016/S0924-7963(98)00033-5; Saggiomo V., 2000, ROSS SEA ECOLOGY, P247; Saggiomo V, 2011, POLAR BIOL, V34, P1255, DOI 10.1007/s00300-011-1038-6; Schine CMS, 2015, J GEOPHYS RES; Schlitzer R., 2020, OCEAN DATA VIEW; SCHREIBER U, 1986, PHOTOSYNTH RES, V10, P51, DOI 10.1007/BF00024185; Sedwick PN, 2007, BIOGEOCHEMISTRY, V83, P83, DOI 10.1007/s10533-007-9081-7; Sedwick PN, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006553; Shields AR, 2009, J PLANKTON RES, V31, P701, DOI 10.1093/plankt/fbp022; SHUMAN FR, 1975, LIMNOL OCEANOGR, V20, P580, DOI 10.4319/lo.1975.20.4.0580; Smith WO, 2006, DEEP-SEA RES PT II, V53, P815, DOI 10.1016/j.dsr2.2006.02.014; Smith WO, 2014, ANNU REV MAR SCI, V6, P469, DOI 10.1146/annurev-marine-010213-135114; Smith WO, 2010, J MARINE SYST, V82, P177, DOI 10.1016/j.jmarsys.2010.04.014; Smith WO, 2003, DEEP-SEA RES PT II, V50, P605, DOI 10.1016/S0967-0645(02)00586-6; Smith WO, 2001, DEEP-SEA RES PT I, V48, P137, DOI 10.1016/S0967-0637(00)00045-5; Staehr PA, 2002, MAR ECOL PROG SER, V238, P47, DOI 10.3354/meps238047; Strutton PG, 2000, DEEP-SEA RES PT II, V47, P2327, DOI 10.1016/S0967-0645(00)00028-X; Strzepek RF, 2012, LIMNOL OCEANOGR, V57, P1182, DOI 10.4319/lo.2012.57.4.1182; Sweeney C, 2000, DEEP-SEA RES PT II, V47, P3369, DOI 10.1016/S0967-0645(00)00072-2; Trivelpiece WZ, 2011, P NATL ACAD SCI USA, V108, P7625, DOI 10.1073/pnas.1016560108; Turner J, 2014, POLAR REC, V50, P237, DOI 10.1017/S0032247413000296; Utermohl H., 1958, MITT INT VER THEOR, V9, P1, DOI DOI 10.1080/05384680.1958.11904091; van de Poll WHV, 2009, J PHOTOCH PHOTOBIO B, V94, P32, DOI 10.1016/j.jphotobiol.2008.09.003; van Leeuwe MA, 2007, BIOGEOCHEMISTRY, V83, P61, DOI 10.1007/s10533-007-9083-5; Vidussi F, 1996, J PLANKTON RES, V18, P2377, DOI 10.1093/plankt/18.12.2377; Wright SW, 2010, DEEP-SEA RES PT II, V57, P758, DOI 10.1016/j.dsr2.2009.06.015; Xavier JC, 2016, FRONTIERS MAR SCI; Xu K, 2014, LIMNOL OCEANOGR, V59, P1919, DOI 10.4319/lo.2014.59.6.1919	97	49	49	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0176033	10.1371/journal.pone.0176033	http://dx.doi.org/10.1371/journal.pone.0176033			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430813	Green Submitted, Green Published, gold			2022-12-26	WOS:000399876100026
J	Emberson, LL; Zinszer, BD; Raizada, RDS; Aslin, RN				Emberson, Lauren L.; Zinszer, Benjamin D.; Raizada, Rajeev D. S.; Aslin, Richard N.			Decoding the infant mind: Multivariate pattern analysis (MVPA) using fNIRS	PLOS ONE			English	Article							INFORMATION; CORTEX	The MRI environment restricts the types of populations and tasks that can be studied by cognitive neuroscientists (e.g., young infants, face-to-face communication). FNIRS is a neuroimaging modality that records the same physiological signal as fMRI but without the constraints of MRI, and with better spatial localization than EEG. However, research in the fNIRS community largely lacks the analytic sophistication of analogous fMRI work, restricting the application of this imaging technology. The current paper presents a method of multivariate pattern analysis for fNIRS that allows the authors to decode the infant mind (a key fNIRS population). Specifically, multivariate pattern analysis (MVPA) employs a correlationbased decoding method where a group model is constructed for all infants except one; both average patterns (i.e., infant-level) and single trial patterns (i.e., trial-level) of activation are decoded. Between subjects decoding is a particularly difficult task, because each infant has their own somewhat idiosyncratic patterns of neural activation. The fact that our method succeeds at across-subject decoding demonstrates the presence of group-level multi-channel regularities across infants. The code for implementing these analyses has been made readily available online to facilitate the quick adoption of this method to advance the methodological tools available to the fNIRS researcher.	[Emberson, Lauren L.] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Emberson, Lauren L.; Zinszer, Benjamin D.; Raizada, Rajeev D. S.; Aslin, Richard N.] Univ Rochester, Brain & Cognit Sci Dept, Rochester, NY 14627 USA; [Emberson, Lauren L.; Zinszer, Benjamin D.; Raizada, Rajeev D. S.; Aslin, Richard N.] Univ Rochester, Rochester Ctr Brain Imaging, Rochester, NY 14620 USA	Princeton University; University of Rochester; University of Rochester	Emberson, LL (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.; Emberson, LL (corresponding author), Univ Rochester, Brain & Cognit Sci Dept, Rochester, NY 14627 USA.; Emberson, LL (corresponding author), Univ Rochester, Rochester Ctr Brain Imaging, Rochester, NY 14620 USA.	lauren.emberson@princeton.edu		Raizada, Rajeev/0000-0002-2784-1964	NICHD Grant [K99 HD076166-01A1, 4R00HD076166-02]; Canadian Institutes of Health Research (CIHR) postdoctoral fellowship [201210MFE-290131-231192]; NSF [1228261, EAGER BCS-1514351]; National Institutes of Health, Child Health and Development (NICHD) [K99 HD076166-01A1, 4R00HD076166-02]; Canadian Institute of Health Research (CIHR postdoctoral fellowship) [201210MFE-290131-231192]; National Science Foundation (NSF US Award) [1228261, EAGER BCS-1514351]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD088731, K99HD076166, R01HD037082, R00HD076166] Funding Source: NIH RePORTER	NICHD Grant; Canadian Institutes of Health Research (CIHR) postdoctoral fellowship(Canadian Institutes of Health Research (CIHR)); NSF(National Science Foundation (NSF)); National Institutes of Health, Child Health and Development (NICHD); Canadian Institute of Health Research (CIHR postdoctoral fellowship)(Canadian Institutes of Health Research (CIHR)); National Science Foundation (NSF US Award)(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors wish to thank all the caregivers and infants who volunteered their time to make this research possible as well as Holly Palmeri, Ashley Rizzieri, Eric Partridge, Kelsey Spear and the rest of the research assistants in the Rochester Baby Lab. This work was supported by an NICHD Grant K99 HD076166-01A1, 4R00HD076166-02, and a Canadian Institutes of Health Research (CIHR) postdoctoral fellowship, 201210MFE-290131-231192, to (to L.L.E.), NSF Award 1228261 (to R.R) and NSF EAGER BCS-1514351 (to R.N.A.).; This work was funded by the National Institutes of Health, Child Health and Development (NICHD, Grant K99 HD076166-01A1, 4R00HD076166-02), the Canadian Institute of Health Research (CIHR postdoctoral fellowship 201210MFE-290131-231192 to L.L.E.) and the National Science Foundation (NSF US Award, 1228261 to R.R. and EAGER BCS-1514351 to R.N. A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AJ, 2016, NEUROIMAGE, V128, P44, DOI 10.1016/j.neuroimage.2015.12.035; Aslin RN, 2015, ANNU REV PSYCHOL, V66, P349, DOI 10.1146/annurev-psych-010213-115108; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bogler C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101729; Cichy RM, 2014, NAT NEUROSCI, V17, P455, DOI 10.1038/nn.3635; Emberson LL, 2015, P NATL ACAD SCI USA, V112, P9585, DOI 10.1073/pnas.1510343112; Emberson LL, 2017, DEV COGN NEUROS-NETH, V23, P26, DOI 10.1016/j.dcn.2016.11.002; Emberson LL, 2015, P NATL ACAD SCI USA, P1; Formisano E, 2008, SCIENCE, V322, P970, DOI 10.1126/science.1164318; Gervain J, 2011, DEV COGN NEUROS-NETH, V1, P22, DOI 10.1016/j.dcn.2010.07.004; Haynes JD, 2015, NEURON, V87, P257, DOI 10.1016/j.neuron.2015.05.025; Heger D, 2013, INT CONF AFFECT, P832, DOI 10.1109/ACII.2013.156; Hosseini SMH, 2011, NEUROREPORT, V22, P269, DOI 10.1097/WNR.0b013e3283451f8f; Huppert TJ, 2009, APPL OPTICS, V48, pD280, DOI 10.1364/AO.48.00D280; Ichikawa H, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00480; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; Kok P, 2014, J COGNITIVE NEUROSCI, V26, P1546, DOI 10.1162/jocn_a_00562; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Kriegeskorte Nikolaus, 2008, Front Syst Neurosci, V2, P4, DOI 10.3389/neuro.06.004.2008; Lemm S, 2011, NEUROIMAGE, V56, P387, DOI 10.1016/j.neuroimage.2010.11.004; Liu HS, 2009, NEURON, V62, P281, DOI 10.1016/j.neuron.2009.02.025; Lloyd-Fox S, 2014, NEUROPHOTONICS, V1, DOI 10.1117/1.NPh.1.2.025006; Luu S, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016003; Misawa T, 2014, P INT C ADMETA PLUS, P4; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Nichols T., 2004, HUM BRAIN MAPP, V15, P887, DOI [10.1016/B978-012264841-0/50048-2, DOI 10.1016/B978-012264841-0/50048-2]; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Pereira Francisco, 2009, Neuroimage, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Raizada RDS, 2010, CEREB CORTEX, V20, P1, DOI 10.1093/cercor/bhp076; Serences JT, 2012, NEUROPSYCHOLOGIA, V50, P435, DOI 10.1016/j.neuropsychologia.2011.07.013; Simanova I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014465; Tak S, 2014, NEUROIMAGE, V85, P72, DOI 10.1016/j.neuroimage.2013.06.016; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Zinszer BD, 2014, J NEUROLINGUIST, P1	34	23	23	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0172500	10.1371/journal.pone.0172500	http://dx.doi.org/10.1371/journal.pone.0172500			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KM	28426802	Green Published, Green Submitted, gold			2022-12-26	WOS:000399875900003
J	Hankins, SC; Brimhall, BB; Kankanala, V; Austin, GL				Hankins, Sam C.; Brimhall, Bryan B.; Kankanala, Vineel; Austin, Gregory L.			A low-volume polyethylene glycol solution was associated with an increased suboptimal bowel preparation rate but had similar recommendations for an early repeat colonoscopy, procedure times, and adenoma detection rates	PLOS ONE			English	Article							COLORECTAL-CANCER; CONTROLLED-TRIAL; CLEANSING PRIOR; ASCORBIC-ACID; PEG	Background/Aims Low-volume polyethylene glycol (PEG) bowel preparations are better tolerated by patients than high-volume preparations and may achieve similar preparation quality. However, there is little data comparing their effects on a recommendation for an early repeat colonoscopy (because of a suboptimal preparation), procedure times, adenoma detection rate (ADR), and advanced adenoma detection rate (AADR). Methods This is a retrospective cohort study of outpatient colonoscopies performed during a oneyear period at a single academic medical center in which low-volume MoviPrep (R) (n = 1841) or high-volume Colyte (R) (n = 1337) was used. All preparations were split-dosed. Appropriate covariates were included in regression models assessing suboptimal preparation quality (fair, poor, or inadequate), procedure times, recommendation for an early repeat colonoscopy, ADR, and AADR. Results MoviPrep (R) was associated with an increase in having a suboptimal bowel preparation (OR 1.36; 95% CI: 1.06-1.76), but it was not associated with differences in insertion (p = 0.43), withdrawal (p = 0.22), or total procedure times (p = 0.10). The adjusted percentage with a suboptimal preparation was 11.7% for patients using MoviPrep (R) and 8.8% for patients using Colyte (R). MoviPrep (R) was not associated with a significant difference in overall ADR (OR 0.93; 95% CI: 0.78-1.11), AADR (OR 1.18; 95% CI: 0.87-1.62), or recommendation for early repeat colonoscopy (OR 1.16; 95% CI: 0.72-1.88). Conclusions MoviPrep (R) was associated with a small absolute increase in having a suboptimal preparation, but did not affect recommendations for an early repeat colonoscopy, procedure times, or adenoma detection rates. Mechanisms to reduce financial barriers limiting low- volume preparations should be considered because of their favorable tolerability profile.	[Hankins, Sam C.] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Brimhall, Bryan B.; Austin, Gregory L.] Univ Colorado, Div Gastroenterol & Hepatol, Anschutz Med Campus, Aurora, CO USA; [Kankanala, Vineel] Univ Illinois, Div Gastroenterol & Hepatol, Chicago, IL USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Austin, GL (corresponding author), Univ Colorado, Div Gastroenterol & Hepatol, Anschutz Med Campus, Aurora, CO USA.	gregory.austin@ucdenver.edu	Austin, Gregory/AAY-1052-2020	Austin, Gregory/0000-0001-9994-0323				Atreja A, 2010, CLEV CLIN J MED, V77, P317, DOI 10.3949/ccjm.77a.09122; Austin GL, 2004, AM J TRANSPLANT, V4, P788, DOI 10.1111/j.1600-6143.2004.00388.x; Bitoun A, 2006, ALIMENT PHARM THERAP, V24, P1631, DOI 10.1111/j.1365-2036.2006.03167.x; Brimhall BB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155208; Centers for Disease Control and Prevention, 2015, UN STAT CANC STAT US; Cesaro P, 2013, DIGEST LIVER DIS, V45, P23, DOI 10.1016/j.dld.2012.07.011; Chokshi RV, 2012, GASTROINTEST ENDOSC, V75, P1197, DOI 10.1016/j.gie.2012.01.005; Corley DA, 2014, NEW ENGL J MED, V370, P1298, DOI 10.1056/NEJMoa1309086; Corporaal S, 2010, SCAND J GASTROENTERO, V45, P1380, DOI 10.3109/00365521003734158; DiPalma JA, 2003, AM J GASTROENTEROL, V98, P2187, DOI 10.1016/S0002-9270(03)00696-8; Ell C, 2008, AM J GASTROENTEROL, V103, P883, DOI 10.1111/j.1572-0241.2007.01708.x; Gurudu SR, 2010, AM J GASTROENTEROL, V105, P2318, DOI 10.1038/ajg.2010.235; Henley SJ, 2010, MMWR SURVEIL SUMM, V59, P1; Jones RM, 2010, AM J PREV MED, V38, P508, DOI 10.1016/j.amepre.2010.01.021; Mahadev S, 2014, J CLIN GASTROENTEROL; Marmo R, 2010, GASTROINTEST ENDOSC, V72, P313, DOI 10.1016/j.gie.2010.02.048; MICHAEL KA, 1985, CLIN PHARMACY, V4, P414; Ponchon T, 2013, DIGEST LIVER DIS, V45, P820, DOI 10.1016/j.dld.2013.04.009; Shapiro JA, 2012, CANCER EPIDEM BIOMAR, V21, P895, DOI 10.1158/1055-9965.EPI-12-0192	19	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176265	10.1371/journal.pone.0176265	http://dx.doi.org/10.1371/journal.pone.0176265			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448598	gold, Green Published, Green Submitted			2022-12-26	WOS:000400383600054
J	Maghsoudlou, S; Cnattingius, S; Montgomery, S; Aarabi, M; Semnani, S; Wikstrom, AK; Bahmanyar, S				Maghsoudlou, Siavash; Cnattingius, Sven; Montgomery, Scott; Aarabi, Mohsen; Semnani, Shahriar; Wikstrom, Anna-Karin; Bahmanyar, Shahram			Opium use during pregnancy and risk of preterm delivery: A population-based cohort study	PLOS ONE			English	Article							GESTATIONAL-AGE; MATERNAL CHARACTERISTICS; BIRTH-WEIGHT; EPIDEMIOLOGY; GOLESTAN; VALIDITY; EXPOSURE; SMOKING; DISEASE; INFANT	Background Use of narcotic or "recreational" drugs has been associated with adverse pregnancy outcomes such as preterm delivery. However, the associations might be confounded by other factors related to high-risk behaviours. This is the first study to investigate the association between traditional opium use during pregnancy and risk of preterm delivery. Method and findings We performed a population-based cohort study in the rural areas of the Golestan province, Iran between 2008 and 2010. We randomly selected 920 women who used (usually smoked) opium during pregnancy and 920 women who did not. Logistic regression models were used to estimate odds ratios (OR) and 95% confidence intervals (CI) for the associations between the opium use during pregnancy and preterm delivery and adjustment was made for potential confounding factors. This study shows compared with non-use of opium and tobacco, use of only opium during pregnancy was associated with an increased risk of preterm delivery (OR = 1.56; 95% CI 1.05-2.32), and the risk was more than two-fold increased among dual users of opium and tobacco (OR = 2.31; 95% CI 1.37-3.90). We observed that opium use only was associated with a doubled risk for preterm caesarean delivery (OR = 2.05; 95% CI 1.10-3.82) but not for preterm vaginal delivery (OR = 1.25; 95% CI 0.75-2.07). Dual use of opium and tobacco was associated with a substantially increased risk of vaginal preterm delivery (OR = 2.58; 95% CI 1.41-4.71). Conclusions Opium use during pregnancy among non-tobacco smokers is associated with an increased risk of preterm caesarean delivery, indicating an increased risk of a compromised foetus before or during labour. Women who use both opium and smoked during pregnancy have an increased risk of preterm vaginal delivery, indicating an increased risk of spontaneous preterm delivery.	[Maghsoudlou, Siavash; Cnattingius, Sven; Montgomery, Scott; Wikstrom, Anna-Karin; Bahmanyar, Shahram] Karolinska Inst, Clin Epidemiol Unit, Dept Med, Solna, Sweden; [Montgomery, Scott] Orebro Univ, Clin Epidemiol & Biostat, Sch Med Sci, Orebro, Sweden; [Montgomery, Scott] UCL, Dept Epidemiol & Publ Hlth, London, England; [Aarabi, Mohsen] Mazandaran Univ Med Sci, Fac Med, Sari, Iran; [Semnani, Shahriar] Golestan Univ Med Sci, Fac Med, Gorgan, Iran; [Wikstrom, Anna-Karin] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Bahmanyar, Shahram] Karolinska Inst, Ctr Pharmacoepidemiol, Dept Med, Solna, Sweden	Karolinska Institutet; Orebro University; University of London; University College London; Mazandaran University Medical Sciences; Golestan University of Medical Sciences; Uppsala University; Karolinska Institutet	Maghsoudlou, S (corresponding author), Karolinska Inst, Clin Epidemiol Unit, Dept Med, Solna, Sweden.	Sivash.Maghsoudlou@ki.se	Maghsoudlou, Siavash ./I-1801-2019; Montgomery, Scott/AAN-2546-2020; Aarabi, Mohsen/A-8856-2008	Maghsoudlou, Siavash ./0000-0002-7721-9583; Montgomery, Scott/0000-0001-6328-5494; Aarabi, Mohsen/0000-0001-7293-6201; Bahmanyar, Shahram/0000-0002-9205-6540	Karolinska Institute	Karolinska Institute(Karolinska Institutet)	This work was entirely funded by internal funding of Karolinska Institute.	Abnet CC, 2004, CANCER EPIDEM BIOMAR, V13, P1068; Almario CV, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.05.052; Bandstra ES, 2010, J ADDICT DIS, V29, P245, DOI 10.1080/10550881003684871; Baraldi E, 2007, NEW ENGL J MED, V357, P1946, DOI 10.1056/NEJMra067279; BOER K, 1994, ACTA PAEDIATR, V83, P65, DOI 10.1111/j.1651-2227.1994.tb13386.x; Brunton L., 2011, GOODMAN GILMANS PHAR; Cnattingius S, 2004, NICOTINE TOB RES, V6, pS125, DOI 10.1080/14622200410001669187; Cnattingius S, 2013, JAMA-J AM MED ASSOC, V309, P2362, DOI 10.1001/jama.2013.6295; de Jong F, 2012, HYPERTENSION, V59, P226, DOI 10.1161/HYPERTENSIONAHA.111.181784; Fajemirokun-Odudeyi O, 2006, EUR J OBSTET GYN R B, V126, P170, DOI 10.1016/j.ejogrb.2005.08.010; Florica M, 2006, INT J GYNECOL OBSTET, V92, P181, DOI 10.1016/j.ijgo.2005.10.016; Ghaffari Nejad Alireza, 2009, Addict Health, V1, P20; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Holbrook BD, 2014, OBSTET GYN CLIN N AM, V41, P229, DOI 10.1016/j.ogc.2014.02.008; Huestis MA, 2002, FORENSIC SCI INT, V128, P20, DOI 10.1016/S0379-0738(02)00160-3; Kaijser M, 2008, CIRCULATION, V117, P405, DOI 10.1161/CIRCULATIONAHA.107.710715; Keegan J, 2010, J ADDICT DIS, V29, P175, DOI 10.1080/10550881003684723; Khademi H, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2502; Kramer MS, 2000, JAMA-J AM MED ASSOC, V284, P843, DOI 10.1001/jama.284.7.843; KRAMER MS, 1988, JAMA-J AM MED ASSOC, V260, P3306, DOI 10.1001/jama.260.22.3306; Kyrklund-Blomberg NB, 1998, AM J OBSTET GYNECOL, V179, P1051, DOI 10.1016/S0002-9378(98)70214-5; Lee T, 2001, CLIN PERINATOL, V28, P721, DOI 10.1016/S0095-5108(03)00073-3; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Ludlow JP, 2004, AUST NZ J OBSTET GYN, V44, P302, DOI 10.1111/j.1479-828X.2004.00221.x; Maghsoudlou S, 2015, ACTA OBSTET GYN SCAN, V94, P1095, DOI 10.1111/aogs.12699; Mikolajczyk RT, 2011, LANCET, V377, P1855, DOI 10.1016/S0140-6736(11)60364-4; Pinto SM, 2010, EUR J OBSTET GYN R B, V150, P137, DOI 10.1016/j.ejogrb.2010.02.026; Raisdana F, 2002, ANN AM ACAD POLIT SS, V582, P149; Rashidian A, 2010, ISLAMIC REPUBLIC IRA; Reading R, 2002, CHILD CARE HLTH DEV, V28, P121; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Surkan PJ, 2004, NEW ENGL J MED, V350, P777, DOI 10.1056/NEJMoa031587; Vucinovic M, 2008, YONSEI MED J, V49, P705, DOI 10.3349/ymj.2008.49.5.705	33	6	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176588	10.1371/journal.pone.0176588	http://dx.doi.org/10.1371/journal.pone.0176588			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET6EL	28448546	gold, Green Published, Green Submitted			2022-12-26	WOS:000400383600109
J	Kwak, HJ; Yang, D; Hwang, Y; Jun, HS; Cheon, HG				Kwak, Hyun Jeong; Yang, Dongki; Hwang, Yongha; Jun, Hee-Sook; Cheon, Hyae Gyeong			Baicalein protects rat insulinoma INS-1 cells from palmitate-induced lipotoxicity by inducing HO-1	PLOS ONE			English	Article							HEME OXYGENASE-1; BETA-CELL; INDUCED APOPTOSIS; STRESS; INHIBITION; EXPRESSION; INJURY; MICE; SENSITIVITY; INDUCTION	Objective beta-Cell dysfunction plays a central role in the pathogenesis of type 2 diabetes (T2D), and the identification of novel approaches to improve beta-cell function is essential to treat this disease. Baicalein, a flavonoid originally isolated from the root of Scutellaria Baicalensis, has been shown to have beneficial effects on beta-cell function. Here, the authors investigated the molecular mechanism responsible for the protective effects of baicalein against palmitate (PA)-induced impaired beta-cell function, and placed focus on the role of heme oxygenase (HO)-1. Methods Rat pancreatic beta-cell line INS-1 cells or mouse pancreatic islets were cultured with PA (500 mu M) to induce lipotoxicity in the presence or absence of baicalein (50 mu M), and the expressions of the ER stress markers, ATF-3, CHOP and GRP78 were detected by Western blotting and/or qPCR. The involvement of HO-1 was evaluated by HO-1 siRNA transfection and using the HO-1 inhibitor ZnPP. Results Baicalein reduced PA-induced ER stress and inflammation and enhanced insulin secretion, and these effects were associated with the induction of HO-1. Furthermore, these protective effects were attenuated by ZnPP and by HO-1 siRNA. Pretreatment of PD98059 (an ERK inhibitor) significantly inhibited the protective effects of baicalein and blocked HO-1 induction. On the other hand, CO production by RuCO (a CO donor) ameliorated PA-induced ER stress, suggesting that CO production followed by HO-1 induction may contribute to the protective effects of baicalein against PA-induced beta-cell dysfunction. Conclusion Baicalein protects pancreatic beta-cells from PA-induced ER stress and inflammation via an ERK-HO-1 dependent pathway. The authors suggest HO-1 induction in pancreatic beta-cells appears to be a promising therapeutic strategy for T2D.	[Kwak, Hyun Jeong; Cheon, Hyae Gyeong] Gachon Univ, Coll Med, Dept Pharmacol, Incheon, South Korea; [Yang, Dongki] Gachon Univ, Coll Med, Dept Physiol, Incheon, South Korea; [Hwang, Yongha; Jun, Hee-Sook] Gachon Univ, Coll Pharm, Incheon, South Korea; [Hwang, Yongha; Jun, Hee-Sook] Gachon Univ, Gachon Inst Pharmaceut Sci, Incheon, South Korea; [Cheon, Hyae Gyeong] Gil Med Ctr, Gachon Med Res Inst, Incheon, South Korea	Gachon University; Gachon University; Gachon University; Gachon University	Cheon, HG (corresponding author), Gachon Univ, Coll Med, Dept Pharmacol, Incheon, South Korea.; Cheon, HG (corresponding author), Gil Med Ctr, Gachon Med Res Inst, Incheon, South Korea.	hgcheon@gachor.ac.kr		Jun, Hee-Sook/0000-0002-1166-4932	Korean Health Technology RAMP;D Project through the Korean Health Industry Development Institute (KHIDI), - Ministry of Health AMP; Welfare, Republic of Korea [HI14C1135]; Basic Science Research Program through the National Research Foundation of Korea (NRF), - Ministry of Education [2015R1D1A1A01058235]	Korean Health Technology RAMP;D Project through the Korean Health Industry Development Institute (KHIDI), - Ministry of Health AMP; Welfare, Republic of Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF), - Ministry of Education	This research was supported by a grant from the Korean Health Technology R&D Project through the Korean Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C1135), and by Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education (Grant no. 2015R1D1A1A01058235). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Aggeli IKS, 2006, CELL SIGNAL, V18, P1801, DOI 10.1016/j.cellsig.2006.02.001; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Back SH, 2012, EXP DIABETES RES, V2012; Benvenisti-Zarom L, 2006, NEUROSCI LETT, V398, P230, DOI 10.1016/j.neulet.2006.01.003; Burgess A, 2010, HYPERTENSION, V56, P1124, DOI 10.1161/HYPERTENSIONAHA.110.151423; Chen M, 2005, DIABETOLOGIA, V48, P486, DOI 10.1007/s00125-005-1673-y; Cheng ZY, 2009, NAT MED, V15, P1307, DOI 10.1038/nm.2049; Cui GZ, 2015, J CARDIOVASC PHARM, V65, P39, DOI 10.1097/FJC.0000000000000161; Deschamps JD, 2006, BIOORGAN MED CHEM, V14, P4295, DOI 10.1016/j.bmc.2006.01.057; Dong HS, 2014, ENDOCRINOLOGY, V155, P818, DOI 10.1210/en.2013-1667; Exner M, 2001, J ENDOVASC THER, V8, P433, DOI 10.1583/1545-1550(2001)008<0433:HOGPMP>2.0.CO;2; Fu Y, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/846742; Giacca A, 2011, AM J PHYSIOL-ENDOC M, V300, pE255, DOI 10.1152/ajpendo.00416.2010; Green CD, 2011, AM J PHYSIOL-ENDOC M, V300, pE640, DOI 10.1152/ajpendo.00544.2010; Hosick PA, 2016, ADIPOCYTE, V5, P1, DOI 10.1080/21623945.2015.1038443; Jais A, 2014, CELL, V158, P25, DOI 10.1016/j.cell.2014.04.043; Kapturczak MH, 2004, AM J PATHOL, V165, P1045, DOI 10.1016/S0002-9440(10)63365-2; Kwak HJ, 2006, TOXICOL APPL PHARM, V217, P176, DOI 10.1016/j.taap.2006.08.010; Lanone S, 2005, FASEB J, V19, P1890, DOI 10.1096/fj.04-2368fje; Lee JC, 2014, BRIT J PHARMACOL, V171, P237, DOI 10.1111/bph.12440; Li M, 2008, DIABETES, V57, P1526, DOI 10.2337/db07-1764; Lin HY, 2007, BBA-MOL CELL RES, V1773, P1073, DOI 10.1016/j.bbamcr.2007.04.008; Liu AD, 2016, SCI REP-UK, V6, DOI 10.1038/srep25042; Naik JS, 2003, AM J PHYSIOL-HEART C, V285, pH220, DOI 10.1152/ajpheart.01131.2002; Ndisang JF, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/359732; Nikolic I, 2015, IMMUNOL LETT, V165, P39, DOI 10.1016/j.imlet.2015.03.009; Nikolic I, 2014, DIABETOLOGIA, V57, P980, DOI 10.1007/s00125-014-3170-7; Pu P, 2012, MOL CELL ENDOCRINOL, V362, P128, DOI 10.1016/j.mce.2012.06.002; Shao ZH, 1999, J MOL CELL CARDIOL, V31, P1885, DOI 10.1006/jmcc.1999.1021; Sramek J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091400; Stavniichuk R, 2011, EXP NEUROL, V230, P106, DOI 10.1016/j.expneurol.2011.04.002; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Wang WZW, 2004, HEPATOLOGY, V40, P424, DOI 10.1002/hep.20334; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Yang LP, 2009, INVEST OPHTH VIS SCI, V50, P2319, DOI 10.1167/iovs.08-2642; Ye J, 1998, ENDOCRINOLOGY, V139, P4155, DOI 10.1210/en.139.10.4155; Zhang XC, 2006, FASEB J, V20, P2156, DOI 10.1096/fj.06-5668fje	38	17	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176432	10.1371/journal.pone.0176432	http://dx.doi.org/10.1371/journal.pone.0176432			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445528	Green Published, gold, Green Submitted			2022-12-26	WOS:000400309200060
J	Haudenshield, JS; Song, JY; Hartman, GL				Haudenshield, James S.; Song, Jeong Y.; Hartman, Glen L.			A novel, multiplexed, probe-based quantitative PCR assay for the soybean root-and stem-rot pathogen, Phytophthora sojae, utilizes its transposable element	PLOS ONE			English	Article							DNA; AMPLIFICATION; RESISTANCE; SEQUENCE; DISEASE	Phytophthora root rot of soybean [Glycine max (L.) Merr.] is caused by the oomycete Phytophthora sojae (Kaufm. & Gerd.). P. sojae has a narrow host range, consisting primarily of soybean, and it is a serious pathogen worldwide. It exists in root and stem tissues as mycelium, wherein it can form oospores which subsequently germinate to release motile, infectious zoospores. Molecular assays detecting DNA of P. sojae are useful in disease diagnostics, and for determining the presence of the organism in host tissues, soils, and runoff or ponded water from potentially infested fields. Such assays as published have utilized ITS sequences from the nuclear ribosomal RNA genes in conventional PCR or dye-binding quantitative PCR (Q-PCR) but are not amenable to multiplexing, and some of these assays did not utilize control strategies for type I or type II errors. In this study, we describe primers and a bifunctional probe with specificity to a gypsy-like retroelement in the P. sojae genome to create a fluorogenic 5'-exonuclease linear hydrolysis assay, with a multiplexed internal control reaction detecting an exogenous target to validate negative calls, and with uracildeglycosylase- mediated protection against carryover contamination. The assay specifically detected 13 different P. sojae isolates, and excluded 17 other Phytophthora species along with 20 non-Phytophthora fungal and oomycete species pathogenic on soybean. A diagnostic limit of detection of 34 fg total P. sojae DNA was observed in serial dilutions, equivalent to 0.3 genome, and a practical detection sensitivity of four zoospores per sample was achieved, despite losses during DNA extraction.	[Haudenshield, James S.; Hartman, Glen L.] Univ Illinois, USDA, ARS, Urbana, IL 61801 USA; [Haudenshield, James S.; Song, Jeong Y.; Hartman, Glen L.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Song, Jeong Y.] Chungnam Natl Univ, Dept Appl Biol, Daejeon, South Korea	United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Chungnam National University	Hartman, GL (corresponding author), Univ Illinois, USDA, ARS, Urbana, IL 61801 USA.; Hartman, GL (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.	ghartman@illinois.edu			United States Department of Agriculture, Agricultural Research Service, Project [5012-22000-021-00D]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [KRF-2005-214-000157]	United States Department of Agriculture, Agricultural Research Service, Project; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	Funding for salaries for JYS and GLH came from the United States Department of Agriculture, Agricultural Research Service, Project Number 5012-22000-021-00D. Funding for JYS came from the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (KRF-2005-214-000157). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athow KL, 1987, SOYBEANS IMPROVEMENT, V687, P727; Bienapfl JC, 2011, FUNGAL BIOL-UK, V115, P733, DOI 10.1016/j.funbio.2011.05.007; Catal M, 2013, EUR J PLANT PATHOL, V137, P859, DOI 10.1007/s10658-013-0297-1; CHEN DW, 1970, MYCOLOGIA, V62, P397, DOI 10.2307/3757597; Dai TT, 2013, PLANT PATHOL, V62, P719, DOI 10.1111/j.1365-3059.2012.02672.x; Dorrance A.E., 2015, COMPENDIUM SOYBEAN D, P73; Haudenshield JS, 2010, PHYTOPATHOLOGY, V100, pS48; Haudenshield JS, 2011, PLANT DIS, V95, P343, DOI 10.1094/PDIS-01-10-0023; Haudenshield JS, 2015, COMPENDIUM SOYBEAN D, P131; HILDEBRAND A. A., 1959, CANADIAN JOUR BOT, V37, P927, DOI 10.1139/b59-079; Jiang JL, 2005, APPL ENVIRON MICROB, V71, P1135, DOI 10.1128/AEM.71.3.1135-1141.2005; JONES JP, 1969, PHYTOPATHOLOGY, V59, P504; Judelson HS, 2002, MOL BIOL EVOL, V19, P1313, DOI 10.1093/oxfordjournals.molbev.a004192; Kandel YR, 2015, PHYTOPATHOLOGY, V105, P1601, DOI 10.1094/PHYTO-04-15-0096-R; KLEIN HH, 1959, PHYTOPATHOLOGY, V49, P380; Moa Y, 1991, EXP MYCOL, V15, P283; Sinclair JB., 1985, BASIC PLANT PATHOLOG; Slaminko TL, 2010, PLANT DIS, V94, P368, DOI 10.1094/PDIS-94-3-0368; SLUSHER RL, 1973, PHYTOPATHOLOGY, V63, P1168, DOI 10.1094/Phyto-63-1168; Song J, 2007, PHYTOPATHOLOGY, V97, pS110; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Wang YC, 2006, PHYTOPATHOLOGY, V96, P1315, DOI 10.1094/PHYTO-96-1315; Wen JZ, 2014, J GEN PLANT PATHOL, V80, P415, DOI 10.1007/s10327-014-0530-6; Zhao W, 2015, J PLANT DIS PROTECT, V122, P66, DOI 10.1007/BF03356533	24	6	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176567	10.1371/journal.pone.0176567	http://dx.doi.org/10.1371/journal.pone.0176567			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441441	gold, Green Published, Green Submitted			2022-12-26	WOS:000400308800067
J	Nikolakopoulou, AM; Zhao, Z; Montagne, A; Zlokovic, BV				Nikolakopoulou, Angellki Maria; Zhao, Zhen; Montagne, Axel; Zlokovic, Berislav V.			Regional early and progressive loss of brain pericytes but not vascular smooth muscle cells in adult mice with disrupted platelet-derived growth factor receptor-beta signaling	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; PDGF-B; CAPILLARY PERICYTES; BARRIER BREAKDOWN; MOUSE MODELS; DYSFUNCTION; REDUCTIONS; ASTROCYTES; PROTEIN; HEALTH	Pericytes regulate key neurovascular functions of the brain. Studies in pericyte-deficient transgenic mice with aberrant signaling between endothelial-derived platelet-derived growth factor BB (PDGF-BB) and platelet-derived growth factor receptor beta (PDGFR beta) in pericytes have contributed to better understanding of the role of pericytes in the brain. Here, we studied Pdgfr beta(F7/F7) mice, which carry seven point mutations that disrupt PDGFR beta signaling causing loss of pericytes and vascular smooth muscle cells (VSMCs) in the developing brain. We asked whether these mice have a stable or progressive vascular phenotype after birth, and whether both pericyte and VSMCs populations are affected in the adult brain. We found an early and progressive region-dependent loss of brain pericytes, microvascular reductions and blood-brain barrier (BBB) breakdown, which were more pronounced in the cortex, hippocampus and striatum than in the thalamus, whereas VSMCs population remained unaffected at the time when pericyte loss was already established. For example, compared to age-matched controls, Pdgfr beta(F7/F7) mice between 4-6 and 36-48 weeks of age developed a region-dependent loss in pericyte coverage (22-46, 24-44 and 4-31%) and cell numbers (36-49, 34-64 and 11-36%), reduction in capillary length (20-39, 13-46 and 1-30%), and an increase in extravascular fibrinogen-derived deposits (3.4-5.2, 2.8-4.1 and 0-3.6-fold) demonstrating BBB breakdown in the cortex, hippocampus and thalamus, respectively. Capillary reductions and BBB breakdown correlated with loss of pericyte coverage. Our data suggest that Pdgfr beta(F7/F7) mice develop an aggressive and rapid vascular phenotype without appreciable early involvement of VSMCs, therefore providing a valuable model to study regional effects of pericyte loss on brain vascular and neuronal functions. This model could be a useful tool for future studies directed at understanding the role of pericytes in the pathogenesis of neurological disorders associated with pericyte loss such as vascular dementia, Alzheimer's disease, amyotrophic lateral sclerosis, stroke and human immunodeficiency virus-associated neurocognitive disorder.	[Zlokovic, Berislav V.] Univ Southern Calif, Dept Physiol & Biophys, Keck Sch Med, Los Angeles, CA 90007 USA; Univ Southern Calif, Zilkha Neurogenet Inst, Keck Sch Med, Los Angeles, CA USA	University of Southern California; University of Southern California	Zlokovic, BV (corresponding author), Univ Southern Calif, Dept Physiol & Biophys, Keck Sch Med, Los Angeles, CA 90007 USA.	zlokovic@usc.edu	Montagne, Axel/AAV-4343-2020; zhao, zhen/A-2080-2012; Zlokovic, Berislav/ABE-7362-2020	Montagne, Axel/0000-0001-5564-985X; zhao, zhen/0000-0001-8967-5570; Zlokovic, Berislav/0000-0002-6802-8232	National Institutes of Health [AG039452, AG023084, NS034467, NS100459]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034467, R01NS100459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG023084, R01AG039452, RF1AG039452, P01AG052350, P50AG005142] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the National Institutes of Health (https://www.nih.gov/)grants AG039452, AG023084, NS034467 and NS100459 to B.V.Z. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Attwell D, 2016, J CEREBR BLOOD F MET, V36, P451, DOI 10.1177/0271678X15610340; Baloyannis SJ, 2012, J NEUROL SCI, V322, P117, DOI 10.1016/j.jns.2012.07.010; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; DALLAL GE, 1986, AM STAT, V40, P294, DOI 10.2307/2684607; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Farkas E, 2001, PROG NEUROBIOL, V64, P575, DOI 10.1016/S0301-0082(00)00068-X; Ghosh M, 2015, ANN NEUROL, V78, P887, DOI 10.1002/ana.24512; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Halliday MR, 2016, J CEREBR BLOOD F MET, V36, P216, DOI 10.1038/jcbfm.2015.44; Hartmann DA, 2015, NEUROPHOTONICS, V2, DOI 10.1117/1.NPh.2.4.041402; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Iadecola C, 1998, NAT NEUROSCI, V1, P263, DOI 10.1038/1074; Iadecola C, 1999, NAT NEUROSCI, V2, P157, DOI 10.1038/5715; Ishii Y, 2008, MOL CELL NEUROSCI, V37, P507, DOI 10.1016/j.mcn.2007.11.006; Keller A, 2013, NAT GENET, V45, P1077, DOI 10.1038/ng.2723; Kisler K, 2017, NAT NEUROSC IN PRESS; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Masamoto K, 2009, EUR J NEUROSCI, V30, P242, DOI 10.1111/j.1460-9568.2009.06812.x; Mishra A, 2016, NAT NEUROSCI, V19, P1619, DOI 10.1038/nn.4428; Montagne A, 2015, NEURON, V85, P296, DOI 10.1016/j.neuron.2014.12.032; Niu F, 2014, J NEUROSCI, V34, P11812, DOI 10.1523/JNEUROSCI.1139-14.2014; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Paul J, 2007, J EXP MED, V204, P1999, DOI 10.1084/jem.20070304; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Sagare AP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3932; Sengillo JD, 2013, BRAIN PATHOL, V23, P303, DOI 10.1111/bpa.12004; Sweeney MD, 2016, NAT NEUROSCI, V19, P771, DOI 10.1038/nn.4288; Tallquist MD, 2003, PLOS BIOL, V1, P288, DOI 10.1371/journal.pbio.0000052; Thiyagarajan M, 2008, J NEUROSCI, V28, P12788, DOI 10.1523/JNEUROSCI.3485-08.2008; Underly RG, 2017, J NEUROSCI, V37, P129, DOI 10.1523/JNEUROSCI.2891-16.2016; Vanlandewijck M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143407; Wennstrom M, 2014, INT J TRYPTOPHAN RES, V7, P1, DOI [10.4137/IJTRTR.S13958, 10.4137/IJTR.S13958]; Winkler EA, 2015, NAT NEUROSCI, V18, P521, DOI 10.1038/nn.3966; Winkler EA, 2013, ACTA NEUROPATHOL, V125, P111, DOI 10.1007/s00401-012-1039-8; Winkler EA, 2012, J CEREBR BLOOD F MET, V32, P1841, DOI 10.1038/jcbfm.2012.113; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Winkler EA, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-32; Yemisci M, 2009, NAT MED, V15, P1031, DOI 10.1038/nm.2022; Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067	43	59	60	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176225	10.1371/journal.pone.0176225	http://dx.doi.org/10.1371/journal.pone.0176225			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441414	gold, Green Published, Green Submitted			2022-12-26	WOS:000400308800036
J	Witman, JD; Smith, F; Novak, M				Witman, Jon D.; Smith, Franz; Novak, Mark			Experimental demonstration of a trophic cascade in the Galapagos rocky subtidal: Effects of consumer identity and behavior	PLOS ONE			English	Article							MEDIATED INDIRECT INTERACTIONS; INCREASES PREDATION; INTERFERENCE; PREY; BIODIVERSITY; COMMUNITIES; ECOSYSTEMS; COMPLEXITY; PATTERNS; STRENGTH	In diverse tropical webs, trophic cascades are presumed to be rare, as species interactions may dampen top-down control and reduce their prevalence. To test this hypothesis, we used an open experimental design in the Galapagos rocky subtidal that enabled a diverse guild of fish species, in the presence of each other and top predators (sea lions and sharks), to attack two species of sea urchins grazing on benthic algae. Time-lapse photography of experiments on natural and experimental substrates revealed strong species identity effects: only two predator species-blunthead triggerfish (Pseudobalistes naufragium) and finescale triggerfish (Balistes polylepis)-drove a diurnal trophic cascade extending to algae, and they preferred large pencil urchins (Eucidaris galapagensis) over green urchins (Lytechinus semituberculatus). Triggerfish predation effects were strong, causing a 24-fold reduction of pencil urchin densities during the initial 21 hours of a trophic cascade experiment. A trophic cascade was demonstrated for pencil urchins, but not for green urchins, by significantly higher percent cover of urchin-grazed algae in cages that excluded predatory fish than in predator access (fence) treatments. Pencil urchins were more abundant at night when triggerfish were absent, suggesting that this species persists by exploiting a nocturnal predation refuge. Time-series of pencil urchin survivorship further demonstrated per capita interference effects of hogfish and top predators. These interference effects respectively weakened and extended the trophic cascade to a fourth trophic level through behavioral modifications of the triggerfish-urchin interaction. We conclude that interference behaviors capable of modifying interaction strength warrant greater attention as mechanisms for altering top-down control, particularly in speciose food webs.	[Witman, Jon D.; Smith, Franz] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Novak, Mark] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA	Brown University; Oregon State University	Witman, JD (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.	Jon_Witman@brown.edu		Novak, Mark/0000-0002-7881-4253	United States National Science Foundation [OCE 1061475, OCE-1041454]	United States National Science Foundation(National Science Foundation (NSF))	This work was funded by United States National Science Foundation Award Number OCE 1061475 to J. Witman and United States National Science Foundation Award Number OCE-1041454 to M. Novak. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arditi R., 2012, SPECIES INTERACT; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; BEDDINGTON JR, 1975, J ANIM ECOL, V44, P331, DOI 10.2307/3866; Bolker B, 2003, ECOLOGY, V84, P1101, DOI 10.1890/0012-9658(2003)084[1101:CTAESO]2.0.CO;2; Bolker B, 2008, ECOLOGICAL MODELS DA; Brandt L., 2011, THESIS; Brandt M., 2002, RESERVA MARINA GAL P, P396; Brandt M, 2012, ECOLOGY, V93, P868, DOI 10.1890/10-1785.1; Burkepile DE, 2007, OECOLOGIA, V154, P167, DOI 10.1007/s00442-007-0801-4; Burkholder DA, 2013, J ANIM ECOL, V82, P1192, DOI 10.1111/1365-2656.12097; Byrnes JE, 2009, ECOLOGY, V90, P2879, DOI 10.1890/08-1073.1; CARPENTER RC, 1984, MAR BIOL, V82, P101, DOI 10.1007/BF00392768; Carr L., 2016, THESIS; Carr LA, 2013, PEERJ, V1, DOI 10.7717/peerj.109; Carrion-Cortez JA, 2010, J MAR BIOL ASSOC UK, V90, P1005, DOI 10.1017/S0025315410000226; Casey JM, 2016, OECOLOGIA; Connell SD, 2002, J FISH BIOL, V60, P1551, DOI 10.1006/jfbi.2002.2001; Dayton P. K., 1979, ECOLOGICAL PROCESSES, P3; DEANGELIS DL, 1975, ECOLOGY, V56, P881, DOI 10.2307/1936298; Dee LE, 2012, J EXP MAR BIOL ECOL, V416, P135, DOI 10.1016/j.jembe.2012.02.016; Dill LM, 2003, ECOLOGY, V84, P1151, DOI 10.1890/0012-9658(2003)084[1151:BMIIIM]2.0.CO;2; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Dulvy NK, 2004, ECOL LETT, V7, P410, DOI 10.1111/j.1461-0248.2004.00593.x; Dyer LA, 1999, P NATL ACAD SCI USA, V96, P5072, DOI 10.1073/pnas.96.9.5072; Edgar GJ, 2011, GLOBAL ECOL BIOGEOGR, V20, P730, DOI 10.1111/j.1466-8238.2010.00642.x; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Englund G, 1997, ECOLOGY, V78, P2316; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; Frank KT, 2007, TRENDS ECOL EVOL, V22, P236, DOI 10.1016/j.tree.2007.03.002; Heithaus MR, 2007, J ANIM ECOL, V76, P837, DOI 10.1111/j.1365-2656.2007.01260.x; Hixon Mark A., 2002, P303, DOI 10.1016/B978-012615185-5/50018-9; Irving AD, 2009, J ECOL, V97, P337, DOI 10.1111/j.1365-2745.2008.01467.x; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; McClanahan TR, 2016, ECOLOGY, V97, P1862, DOI 10.1890/15-1492.1; McClanahan TR, 2000, BIOL CONSERV, V94, P191, DOI 10.1016/S0006-3207(99)00176-7; Minderman J, 2006, J ANIM ECOL, V75, P713, DOI 10.1111/j.1365-2656.2006.01092.x; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; NELSON BV, 1979, MAR BIOL, V51, P251, DOI 10.1007/BF00386805; Novak M, 2010, OIKOS, V119, P1057, DOI 10.1111/j.1600-0706.2009.18147.x; O'Leary JK, 2010, ECOLOGY, V91, P3584, DOI 10.1890/09-2059.1; Peacor SD, 1997, ECOLOGY, V78, P1146, DOI 10.1890/0012-9658(1997)078[1146:TMIIIA]2.0.CO;2; Peckarsky BL, 2008, ECOLOGY, V89, P2416, DOI 10.1890/07-1131.1; PECKARSKY BL, 1991, OECOLOGIA, V85, P521, DOI 10.1007/BF00323764; Pimm SL, 2002, FOOD WEBS; Pinnegar JK, 2000, ENVIRON CONSERV, V27, P179, DOI 10.1017/S0376892900000205; Polis GA, 2000, TRENDS ECOL EVOL, V15, P473, DOI 10.1016/S0169-5347(00)01971-6; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Ripple WJ, 2006, BIOL CONSERV, V133, P397, DOI 10.1016/j.biocon.2006.07.002; Ruppert JLW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074648; Sandin Stuart A., 2010, P71; Schmitz OJ., 2010, RESOLVING ECOSYSTEM; Shurin Jonathan B., 2010, P319; Siddon CE, 2004, ECOLOGY, V85, P2938, DOI 10.1890/03-0519; Siddon CE, 2003, MAR ECOL PROG SER, V261, P99, DOI 10.3354/meps261099; Sih A, 1998, TRENDS ECOL EVOL, V13, P350, DOI 10.1016/S0169-5347(98)01437-2; Sinclair A.R.E., 2010, P255; Sonnenholzner JI, 2009, MAR ECOL PROG SER, V375, P209, DOI 10.3354/meps07890; Stillman RA, 1997, J ANIM ECOL, V66, P692, DOI 10.2307/5922; STRONG DR, 1992, ECOLOGY, V73, P747, DOI 10.2307/1940154; Stuart-Smith RD, 2013, NATURE, V501, P539, DOI 10.1038/nature12529; Triplet P, 1999, J ANIM ECOL, V68, P254, DOI 10.1046/j.1365-2656.1999.00280.x; Trussell GC, 2006, ECOLOGY, V87, P2979, DOI 10.1890/0012-9658(2006)87[2979:TFOBER]2.0.CO;2; Tuya F, 2004, HELGOLAND MAR RES, V58, P26, DOI 10.1007/s10152-003-0164-0; Vinueza LR, 2014, ECOL MONOGR, V84, P411, DOI 10.1890/13-0169.1; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; WITMAN JD, 1992, OECOLOGIA, V90, P305, DOI 10.1007/BF00317686; Witman JD, 2015, ECOL MONOGR, V85, P475, DOI 10.1890/14-2265.1; Witman JD, 2010, ECOL MONOGR, V80, P153, DOI 10.1890/08-1922.1	69	8	8	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0175705	10.1371/journal.pone.0175705	http://dx.doi.org/10.1371/journal.pone.0175705			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430794	Green Published, Green Submitted, gold			2022-12-26	WOS:000399876100015
J	Agrawal, N; Maatta, JAE; Kulomaa, MS; Hytonen, VP; Johnson, MS; Airenne, TT				Agrawal, Nitin; Maatta, Juha A. E.; Kulomaa, Markku S.; Hytonen, Vesa P.; Johnson, Mark S.; Airenne, Tomi T.			Structural characterization of core-bradavidin in complex with biotin	PLOS ONE			English	Article							BRADYRHIZOBIUM-JAPONICUM; CHICKEN AVIDIN; AFFINITY PEPTIDE; BINDING PROTEINS; STREPTAVIDIN; CONSTRUCTION; REFINEMENT; BACTERIUM; SEQUENCE; ARP/WARP	Bradavidin is a tetrameric biotin-binding protein similar to chicken avidin and bacterial streptavidin, and was originally cloned from the nitrogen-fixing bacteria Bradyrhizobium diazoefficiens. We have previously reported the crystal structure of the full-length, wild-type (wt) bradavidin with 138 amino acids, where the C-terminal residues Gly129-Lys138 ("Brad-tag") act as an intrinsic ligand (i.e. Gly129-Lys138 bind into the biotin-binding site of an adjacent subunit within the same tetramer) and has potential as an affinity tag for biotechnological purposes. Here, the X-ray structure of core-bradavidin lacking the C-terminal residues Gly114-Lys138, and hence missing the Brad-tag, was crystallized in complex with biotin at 1.60 angstrom resolution [PDB:4BBO]. We also report a homology model of rhodavidin, an avidin-like protein from Rhodopseudomonas palustris, and of an avidin-like protein from Bradyrhizobium sp. Ai1a-2, both of which have the Brad-tag sequence at their C-terminus. Moreover, core-bradavidin V1, an engineered variant of the original core-bradavidin, was also expressed at high levels in E. coli, as well as a double mutant (Cys39Ala and Cys69Ala) of core-bradavidin (CC mutant). Our data help us to further engineer the core-bradavidin- Brad-tag pair for biotechnological assays and chemical biology applications, and provide deeper insight into the biotin-binding mode of bradavidin.	[Agrawal, Nitin; Johnson, Mark S.; Airenne, Tomi T.] Abo Akad Univ, Struct Bioinformat Lab, Biochem, Fac Sci & Engn, Turku, Finland; [Maatta, Juha A. E.; Kulomaa, Markku S.; Hytonen, Vesa P.] Univ Tampere, Fac Med & Life Sci, Tampere, Finland; [Maatta, Juha A. E.; Kulomaa, Markku S.; Hytonen, Vesa P.] Univ Tampere, BioMediTech, Tampere, Finland; [Maatta, Juha A. E.; Hytonen, Vesa P.] Fimlab Labs, Tampere, Finland	Abo Akademi University; Tampere University; Tampere University	Airenne, TT (corresponding author), Abo Akad Univ, Struct Bioinformat Lab, Biochem, Fac Sci & Engn, Turku, Finland.	tomi.airenne@abo.fi	Hytonen, Vesa P./E-8855-2013	Hytonen, Vesa P./0000-0002-9357-1480; Agrawal, Nitin/0000-0002-9482-3440	Academy of Finland [257814, 272283, 290506, 261285, 272288]; Sigrid Juselius Foundation; Joe Pentti, and Tor Borg Memorial Fund; Academy of Finland FIRI program [141398]; Fimlab Laboratories (Tampere, Finland)	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Joe Pentti, and Tor Borg Memorial Fund; Academy of Finland FIRI program; Fimlab Laboratories (Tampere, Finland)	This work was supported by grant funding from the Academy of Finland (257814 (MSJ), 272283 (MSJ), 290506 (VPH), 261285 (MSK), and 272288 (MSK)); Sigrid Juselius Foundation; Joe Pentti, and Tor Borg Memorial Fund; Academy of Finland FIRI program (141398) and Abo Akademi Center of Excellence in Cell Stress and Aging. The funders had no influence in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Fimlab Laboratories (Tampere, Finland) provided support in the form of salaries for author VPH and in the form of research materials for the group lead by VPH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Avraham O, 2015, J STRUCT BIOL, V191, P139, DOI 10.1016/j.jsb.2015.06.020; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; BARNARD G, 1986, METHOD ENZYMOL, V133, P284; BAYER EA, 1989, BIOCHEM J, V259, P369, DOI 10.1042/bj2590369; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; DAKSHINAMURTI K, 1985, ANN NY ACAD SCI, V447, P38, DOI 10.1111/j.1749-6632.1985.tb18424.x; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DeMonte D, 2013, PROTEINS, V81, P1621, DOI 10.1002/prot.24320; DETITTA GT, 1976, J AM CHEM SOC, V98, P1920, DOI 10.1021/ja00423a045; DIAMANDIS EP, 1991, CLIN CHEM, V37, P625; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GOPE ML, 1987, NUCLEIC ACIDS RES, V15, P3595, DOI 10.1093/nar/15.8.3595; Green N M, 1975, Adv Protein Chem, V29, P85, DOI 10.1016/S0065-3233(08)60411-8; Helppolainen SH, 2008, BBA-PROTEINS PROTEOM, V1784, P1002, DOI 10.1016/j.bbapap.2008.04.010; Helppolainen SH, 2007, BIOCHEM J, V405, P397, DOI 10.1042/BJ20070076; Hytonen VP, 2005, J BIOL CHEM, V280, P10228, DOI 10.1074/jbc.M414196200; Hytonen VR, 2004, BIOCHEM J, V384, P385, DOI 10.1042/BJ20041114; JOHNSON MS, 1993, J MOL BIOL, V233, P716, DOI 10.1006/jmbi.1993.1548; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; Korndorfer IP, 2002, PROTEIN SCI, V11, P883, DOI 10.1110/ps.4150102; KORPELA JK, 1981, EXPERIENTIA, V37, P1065, DOI 10.1007/BF02085010; Laitinen OH, 2006, CELL MOL LIFE SCI, V63, P2992, DOI 10.1007/s00018-006-6288-z; Laitinen OH, 2003, J BIOL CHEM, V278, P4010, DOI 10.1074/jbc.M205844200; Laitinen OH, 2007, TRENDS BIOTECHNOL, V25, P269, DOI 10.1016/j.tibtech.2007.04.001; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Larimer FW, 2004, NAT BIOTECHNOL, V22, P55, DOI 10.1038/nbt923; Le Trong L, 2006, J MOL BIOL, V356, P738, DOI 10.1016/j.jmb.2005.11.086; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Lehtonen SI, 2016, ACS CHEM BIOL, V11, P211, DOI 10.1021/acschembio.5b00906; Leppiniemi J, 2013, PROTEIN SCI, V22, P980, DOI 10.1002/pro.2281; Leppiniemi J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035962; LIVNAH O, 1993, P NATL ACAD SCI USA, V90, P5076, DOI 10.1073/pnas.90.11.5076; Maatta JAE, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-63; Delamuta JRM, 2013, INT J SYST EVOL MICR, V63, P3342, DOI 10.1099/ijs.0.049130-0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meir A, 2012, J BIOL CHEM, V287, P17951, DOI 10.1074/jbc.M112.357186; Meir A, 2009, J MOL BIOL, V386, P379, DOI 10.1016/j.jmb.2008.11.061; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nordlund HR, 2005, BIOCHEM J, V392, P485, DOI 10.1042/BJ20051038; Nordlund HR, 2005, J BIOL CHEM, V280, P13250, DOI 10.1074/jbc.M414336200; Nordlund HR, 2004, J BIOL CHEM, V279, P36715, DOI 10.1074/jbc.M403496200; PAHLER A, 1987, J BIOL CHEM, V262, P13933; Perbandt M, 2007, PROTEINS, V67, P1147, DOI 10.1002/prot.21236; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; PUGLIESE L, 1993, J MOL BIOL, V231, P698, DOI 10.1006/jmbi.1993.1321; Repo S, 2006, CHEM BIOL, V13, P1029, DOI 10.1016/j.chembiol.2006.08.006; Riihimaki TA, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-64; Rosebrough SF, 1996, J NUCL MED, V37, P1380; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SANO T, 1995, J BIOL CHEM, V270, P28204; Sardo A, 2011, PROTEIN EXPRES PURIF, V77, P131, DOI 10.1016/j.pep.2011.01.003; Schmidt TGM, 1996, J MOL BIOL, V255, P753, DOI 10.1006/jmbi.1996.0061; Schrodinger L., 2020, PYMOL; Siqueira AF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-420; Takakura Y, 2009, FEBS J, V276, P1383, DOI 10.1111/j.1742-4658.2009.06879.x; Taskinen B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077207; TUOHIMAA P, 1989, International Journal of Developmental Biology, V33, P125; Wu SC, 2005, J BIOL CHEM, V280, P23225, DOI 10.1074/jbc.M501733200; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	69	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176086	10.1371/journal.pone.0176086	http://dx.doi.org/10.1371/journal.pone.0176086			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426764	Green Published, gold			2022-12-26	WOS:000399875900101
J	Gohring, AR; Reuter, S; Clemente, JH; Cheng, XL; Theobald, J; Wolfi, S; Mrowka, R				Goehring, Axel R.; Reuter, Stefanie; Clemente, Joachim H.; Cheng, Xinlai; Theobald, Jannick; Wolfi, Stefan; Mrowka, Ralf			Human microRNA-299-3p decreases invasive behavior of cancer cells by downregulation of Oct4 expression and causes apoptosis	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; POSTTRANSCRIPTIONAL REGULATION; MICRO RNAS; PLURIPOTENCY; GENES; LINES; RESISTANCE; CARCINOMA; MIGRATION; MOUSE	Purpose Oct4 was reported to be one of the most important pluripotency transcription factors in the biology of stem cells including cancer stem cells, and progressed malignant cells. Here we report the investigation of gene expression control of Oct4 by selected human microRNAs and the physiological effect of Oct4 silencing in invasive cancer cells. Methods and results High throughput luciferase activity assay revealed the microRNA-299-3p to be the most effective in reducing gene expression of Oct4, which was confirmed by Western blot analysis and Oct4 promoter activity in a target luciferase assay. Furthermore, it could be demonstrated that downregulation of Oct4 by microRNAs-299-3p in breast cancer and fibrosarcoma cells lead to a decreased invasiveness in a microfluidic chip assay. Additionally, microRNA-299-3p causes apoptosis in cancer cells. Comparison with Oct4 specific siRNA transfection confirmed that this effect is primary due to the blockade of Oct4 expression. Conclusion The results suggest that microRNA-299-3p is an interesting target for potential clinical use. It may be able to decrease invasive behaviour of carcinoma cells; or even kill these cells by causing apoptosis.	[Goehring, Axel R.; Reuter, Stefanie; Mrowka, Ralf] Univ Klinikum Jena, Klin Innere Med 3, Expt Nephrol, Jena, Germany; [Clemente, Joachim H.] Univ Klinikum Jena, Klin Innere Med 2, Abt Hamatol & Internist Onkol, Jena, Germany; [Cheng, Xinlai; Theobald, Jannick; Wolfi, Stefan] Heidelberg Univ, Abt Pharmazeut Biol, Inst Pharm & Mol Biotechnol, Heidelberg, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Ruprecht Karls University Heidelberg	Gohring, AR (corresponding author), Univ Klinikum Jena, Klin Innere Med 3, Expt Nephrol, Jena, Germany.	goehring-axel@gmx.de	Cheng, Xinlai/L-6134-2015; Mrowka, Ralf/AAW-1480-2021	Cheng, Xinlai/0000-0001-6441-3742; Mrowka, Ralf/0000-0002-0991-3418; Gohring, Axel Robert/0000-0002-7176-8506; Clement, Joachim H./0000-0002-6601-2456; Reuter nee Strobel, Stefanie/0000-0002-3805-4632	Federal German Ministry of Education and Research (BMBF) within the Medical Systems Biology Project: Drug-iPS [FKZ 0315389A]; SysToxChip BMBF [FKZ: 031A303A]; German Ministry for Education and Research BMBF in the Program MedSys, Drug-iPS [FKZ 0315389A]	Federal German Ministry of Education and Research (BMBF) within the Medical Systems Biology Project: Drug-iPS; SysToxChip BMBF; German Ministry for Education and Research BMBF in the Program MedSys, Drug-iPS	This work was supported by the Federal German Ministry of Education and Research (BMBF; http://www.bmbf.de/), within the Medical Systems Biology Project: Drug-iPS, FKZ 0315389A and B, and SysToxChip BMBF FKZ: 031A303A and E to RM and SW.; We would like to thank Christine Reinhold and Silke Nossmann for their excellent technical assistance. This work was supported by the German Ministry for Education and Research BMBF in the Program MedSys, Drug-iPS, FKZ 0315389A and B, and SysToxChip BMBF FKZ: 031A303A and E to RM and SW. We would like to thank Holger Becker from Microfluidic ChipShop GmbH for providing the microfluidic templates for the Chip assay. Furthermore, we want to thank Dr. Anita Voigt from the University Children's hospital, Jena, for providing KG-1 cells.	Adammek M, 2013, FERTIL STERIL, V99, P1346, DOI 10.1016/j.fertnstert.2012.11.055; Beebe DJ, 2002, ANNU REV BIOMED ENG, V4, P261, DOI 10.1146/annurev.bioeng.4.112601.125916; Cao H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002820; Chang CC, 2008, CANCER RES, V68, P6281, DOI 10.1158/0008-5472.CAN-08-0094; Dai XZ, 2013, ONCOL REP, V29, P155, DOI 10.3892/or.2012.2086; Domingo-Domenech J, 2012, CANCER CELL, V22, P373, DOI 10.1016/j.ccr.2012.07.016; Fernandez M, 2004, J MOL ENDOCRINOL, V33, P155, DOI 10.1677/jme.0.0330155; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; FURLEY AJ, 1986, BLOOD, V68, P1101; Guled M, 2009, GENE CHROMOSOME CANC, V48, P615, DOI 10.1002/gcc.20669; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Hilmi C, 2008, J INVEST DERMATOL, V128, P1499, DOI 10.1038/sj.jid.5701185; Jong HL, 2013, PHYSIOL GENOMICS, V45, P256, DOI 10.1152/physiolgenomics.00071.2012; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lee NS, 2008, BIOCHEM BIOPH RES CO, V377, P434, DOI 10.1016/j.bbrc.2008.09.159; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lichner Z, 2011, DIFFERENTIATION, V81, P11, DOI 10.1016/j.diff.2010.08.002; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Liu R, 2015, CANC RES; Luningschror P, 2012, STEM CELLS, V30, P655, DOI 10.1002/stem.1033; MANZ A, 1993, HRC-J HIGH RES CHROM, V16, P433; Pawell RS, 2015, MICROFLUID NANOFLUID, V18, P657, DOI 10.1007/s10404-014-1464-1; Peng X., 2012, ONCOL REP; Razak SRA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073532; Rijlaarsdam MA, 2011, BRIT J CANCER, V105, P854, DOI 10.1038/bjc.2011.270; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; TESHIMA S, 1988, LAB INVEST, V59, P328; Wu G, 2015, DISCOV MED, V20, P219; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yu B.-L., 2015, APF HARD MASK DISTOR, P1; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Ziolkowska K, 2011, NEW J CHEM, V35, P979, DOI 10.1039/c0nj00709a	35	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0174912	10.1371/journal.pone.0174912	http://dx.doi.org/10.1371/journal.pone.0174912			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426762	Green Submitted, gold, Green Published			2022-12-26	WOS:000399875900014
J	Palmgren, M; Engstrom, K; Hallstrom, BM; Wahlberg, K; Sondergaard, DA; Sall, T; Vahter, M; Broberg, K				Palmgren, Michael; Engstrom, Karin; Hallstrom, Bjorn M.; Wahlberg, Karin; Sondergaard, Dan Ariel; Sall, Torbjorn; Vahter, Marie; Broberg, Karin			AS3MT-mediated tolerance to arsenic evolved by multiple independent horizontal gene transfers from bacteria to eukaryotes	PLOS ONE			English	Article							ENZYMATIC METHYLATION; TRIMETHYLARSINE GAS; GENOME REVEALS; BASAL METAZOAN; IN-VITRO; METHYLTRANSFERASE; EVOLUTION; ACID; SEQUENCE; PATHWAY	Organisms have evolved the ability to tolerate toxic substances in their environments, often by producing metabolic enzymes that efficiently detoxify the toxicant. Inorganic arsenic is one of the most toxic and carcinogenic substances in the environment, but many organisms, including humans, metabolise inorganic arsenic to less toxic metabolites. This multistep process produces mono-, di-, and trimethylated arsenic metabolites, which the organism excretes. In humans, arsenite methyltransferase (AS3MT) appears to be the main metabolic enzyme that methylates arsenic. In this study, we examined the evolutionary origin of AS3MT and assessed the ability of different genotypes to produce methylated arsenic metabolites. Phylogenetic analysis suggests that multiple, independent horizontal gene transfers between different bacteria, and from bacteria to eukaryotes, increased tolerance to environmental arsenic during evolution. These findings are supported by the observation that genetic variation in AS3MT correlates with the capacity to methylate arsenic. Adaptation to arsenic thus serves as a model for how organisms evolve to survive under toxic conditions.	[Palmgren, Michael; Engstrom, Karin; Vahter, Marie; Broberg, Karin] Karolinska Inst, Inst Environm Med, Unit Met & Hlth, Stockholm, Sweden; [Palmgren, Michael] Univ Copenhagen, Dept Plant & Environm Sci, Ctr Membrane Pumps Cells & Dis PUMPKIN, Frederiksberg, Denmark; [Engstrom, Karin; Wahlberg, Karin] Lund Univ, Div Occupat & Environm Med, Lab Med, Lund, Sweden; [Hallstrom, Bjorn M.] KTH Royal Inst Technol, Sci Life Lab, Stockholm, Sweden; [Sondergaard, Dan Ariel] Aarhus Univ, Ctr Bioinformat BiRC, Aarhus, Denmark; [Sall, Torbjorn] Lund Univ, Dept Biol, Lund, Sweden	Karolinska Institutet; University of Copenhagen; Lund University; Royal Institute of Technology; Aarhus University; Lund University	Broberg, K (corresponding author), Karolinska Inst, Inst Environm Med, Unit Met & Hlth, Stockholm, Sweden.	karin.broberg@ki.se	Vahter, Marie/HGB-1674-2022; Palmgren, Michael/A-9808-2013	Palmgren, Michael/0000-0002-9982-6114; Broberg, Karin/0000-0002-5862-468X	Swedish Council for Working Life and Social Research; Karolinska Institutet; Eric Philip So Erensen's Foundation; Danish National Research Foundation; Kungliga Fysiografiska Sallskapetto	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Karolinska Institutet(Karolinska Institutet); Eric Philip So Erensen's Foundation; Danish National Research Foundation(Danmarks Grundforskningsfond); Kungliga Fysiografiska Sallskapetto	This work was supported by grants from the Swedish Council for Working Life and Social Research to K.B., the Karolinska Institutet to M.V. and K.B, Eric Philip So Erensen's Foundation to K.B., the Danish National Research Foundation to M.P., and Kungliga Fysiografiska Sallskapetto K.B.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Ajees AA, 2015, GEOMICROBIOL J, V32, P570, DOI 10.1080/01490451.2014.908983; Ajees AA, 2012, BIOCHEMISTRY-US, V51, P5476, DOI 10.1021/bi3004632; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Antonelli R, 2014, ENVIRON RES, V132, P156, DOI 10.1016/j.envres.2014.03.012; Arguello JM, 2007, BIOMETALS, V20, P233, DOI 10.1007/s10534-006-9055-6; BALDAUF SL, 1993, P NATL ACAD SCI USA, V90, P11558, DOI 10.1073/pnas.90.24.11558; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; CARLIN A, 1995, J BACTERIOL, V177, P981, DOI 10.1128/jb.177.4.981-986.1995; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; CAVALIERSMITH T, 1995, P ROY SOC B-BIOL SCI, V261, P1, DOI 10.1098/rspb.1995.0108; CHALLENGER F, 1955, Q REV CHEM SOC, V9, P255, DOI 10.1039/qr9550900255; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Chen J, 2013, APPL ENVIRON MICROB, V79, P4493, DOI 10.1128/AEM.01133-13; Conaco C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151092; COX DP, 1973, B ENVIRON CONTAM TOX, V9, P84, DOI 10.1007/BF01684760; Da Lage JL, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-40; Dheeman DS, 2014, CHEM RES TOXICOL, V27, P1979, DOI 10.1021/tx500313k; Ding L, 2012, TOXICOL APPL PHARM, V264, P121, DOI 10.1016/j.taap.2012.07.024; Drobna Z, 2004, TOXICOL APPL PHARM, V201, P166, DOI 10.1016/j.taap.2004.05.004; Drobna Z, 2009, CHEM RES TOXICOL, V22, P1713, DOI 10.1021/tx900179r; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Engstrom K, 2011, ENVIRON HEALTH PERSP, V119, P182, DOI 10.1289/ehp.1002471; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Forterre P, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00717; Fraune S, 2007, P NATL ACAD SCI USA, V104, P13146, DOI 10.1073/pnas.0703375104; Friedman R, 2012, CURR MICROBIOL, V65, P639, DOI 10.1007/s00284-012-0205-5; Fritz-Laylin LK, 2010, CELL, V140, P631, DOI 10.1016/j.cell.2010.01.032; Gardner RM, 2011, REPROD TOXICOL, V31, P210, DOI 10.1016/j.reprotox.2010.11.002; Hanikenne M, 2008, NATURE, V453, P391, DOI 10.1038/nature06877; Hayakawa T, 2005, ARCH TOXICOL, V79, P183, DOI 10.1007/s00204-004-0620-x; Healy SM, 1997, MUTAT RES-REV MUTAT, V386, P229, DOI 10.1016/S1383-5742(97)00014-8; Hirano S, 2004, TOXICOL APPL PHARM, V198, P458, DOI 10.1016/j.taap.2003.10.023; Hori K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4978; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IARC, 2012, REV HUM CARC ARS M C, V100C; Jia Y, 2013, ENVIRON SCI TECHNOL, V47, P3141, DOI 10.1021/es303649v; Koch I, 2015, METALLOMICS, V7, P1274, DOI 10.1039/c5mt00078e; Kondrashov FA, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-31; Ku C, 2015, P NATL ACAD SCI USA, V112, P10139, DOI 10.1073/pnas.1421385112; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Li XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084231; Lin S, 2002, J BIOL CHEM, V277, P10795, DOI 10.1074/jbc.M110246200; MARAFANTE E, 1984, CHEM-BIOL INTERACT, V50, P49, DOI 10.1016/0009-2797(84)90131-5; MARGULIS L, 1978, CURR MICROBIOL, V1, P227, DOI 10.1007/BF02602848; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Mass MJ, 2001, CHEM RES TOXICOL, V14, P355, DOI 10.1021/tx000251l; Maull EA, 2012, ENVIRON HEALTH PERSP, V120, P1658, DOI 10.1289/ehp.1104579; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Melnick JG, 2007, SCIENCE, V317, P225, DOI 10.1126/science.1144314; Miller M.A., 2010, P GAT COMP ENV WORKS; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Moon K, 2012, CURR ATHEROSCLER REP, V14, P542, DOI 10.1007/s11883-012-0280-x; Moreau H, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r74; Myashita S, 2011, BIOSCI BIOTECH BIOCH, V75, P522, DOI 10.1271/bbb.100751; Najarro MA, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005663; Naranmandura H, 2012, TOXICOL SCI, V128, P137, DOI 10.1093/toxsci/kfs154; Pierce BL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002522; Qin J, 2006, P NATL ACAD SCI USA, V103, P2075, DOI 10.1073/pnas.0506836103; Rahman A, 2011, ENVIRON HEALTH PERSP, V119, P719, DOI 10.1289/ehp.1002265; Rahman A, 2010, EPIDEMIOLOGY, V21, P797, DOI 10.1097/EDE.0b013e3181f56a0d; Read BA, 2013, NATURE, V499, P209, DOI 10.1038/nature12221; Schlebusch CM, 2015, MOL BIOL EVOL, V32, P1544, DOI 10.1093/molbev/msv046; Schlebusch CM, 2013, ENVIRON HEALTH PERSP, V121, P53, DOI 10.1289/ehp.1205504; Schonknecht G, 2014, BIOESSAYS, V36, P9, DOI 10.1002/bies.201300095; Schonknecht G, 2013, SCIENCE, V339, P1207, DOI 10.1126/science.1231707; Smith AH, 2006, ENVIRON HEALTH PERSP, V114, P1293, DOI 10.1289/ehp.8832; Song WY, 2014, P NATL ACAD SCI USA, V111, P15699, DOI 10.1073/pnas.1414968111; Song WY, 2010, P NATL ACAD SCI USA, V107, P21187, DOI 10.1073/pnas.1013964107; Soucy SM, 2015, NAT REV GENET, V16, P472, DOI 10.1038/nrg3962; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Starcevic A, 2008, P NATL ACAD SCI USA, V105, P2533, DOI 10.1073/pnas.0707388105; Steenkamp ET, 2006, MOL BIOL EVOL, V23, P93, DOI 10.1093/molbev/msj011; Suzuki K, 2015, RES MICROBIOL, V166, P753, DOI 10.1016/j.resmic.2015.08.001; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomas DJ, 2007, EXP BIOL MED, V232, P3; Thomas DJ., 2013, ENCY METALLOPROTEINS, P138, DOI [10.1007/978-1-4614-1533-6_449, DOI 10.1007/978-1-4614-1533-6]; VAHTER M, 1984, ARCH ENVIRON CON TOX, V13, P259, DOI 10.1007/BF01055275; Vahter M, 2002, TOXICOLOGY, V181, P211, DOI 10.1016/S0300-483X(02)00285-8; VAHTER M, 1995, TOXICOL APPL PHARM, V133, P262, DOI 10.1006/taap.1995.1150; VAHTER M, 1985, ARCH TOXICOL, V57, P119, DOI 10.1007/BF00343121; Vahter Marie, 1999, Science Progress, V82, P69; WAINRIGHT PO, 1993, SCIENCE, V260, P340, DOI 10.1126/science.8469985; Wang QQ, 2015, CHEM RES TOXICOL, V28, P351, DOI 10.1021/tx500286t; Wisecaver JH, 2016, MOL BIOL EVOL, V33, P1979, DOI 10.1093/molbev/msw073; Woese C, 1998, P NATL ACAD SCI USA, V95, P6854, DOI 10.1073/pnas.95.12.6854; Ye J, 2012, TRENDS PLANT SCI, V17, P155, DOI 10.1016/j.tplants.2011.12.003; Zakharyan RA, 1996, TOXICOL APPL PHARM, V140, P77, DOI 10.1006/taap.1996.0199; Zhang SY, 2013, CHEMOSPHERE, V93, P47, DOI 10.1016/j.chemosphere.2013.04.063; Zhao FJ, 2013, ENVIRON SCI TECHNOL, V47, P3957, DOI 10.1021/es304295n	91	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175422	10.1371/journal.pone.0175422	http://dx.doi.org/10.1371/journal.pone.0175422			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426741	Green Published, gold, Green Submitted			2022-12-26	WOS:000399875900029
J	Wang, K; Li, YL; Han, R; Cai, GF; He, C; Wang, GL; Jia, D				Wang, Kun; Li, Yanlin; Han, Rui; Cai, Guofeng; He, Chuan; Wang, Guoliang; Jia, Di			T140 blocks the SDF-1/CXCR4 signaling pathway and prevents cartilage degeneration in an osteoarthritis disease model	PLOS ONE			English	Article							FACTOR-I; MATRIX METALLOPROTEINASES; KNEE OSTEOARTHRITIS; HUMAN CHONDROCYTES; CXCR4; ATTENUATION; ARTHRITIS; SDF-1; OA; PATHOGENESIS	Osteoarthritis (OA) is one of the most common diseases affecting older people; however, there remains no effective targeted drug to combat OA. The aims of this study were (1) to explore the effect of T140 in regulating degeneration of articular cartilage in vivo by targeted blocking of the SDF-1/CXCR4 signaling pathway, and (2) to provide experimental evidence for the development of a novel OA-targeted pharmacotherapy. Thirty-six healthy Hartley guinea pigs were randomly divided into three groups: a T140-treated group (n = 12), a phosphate buffer saline control group (n = 12) and an untreated control group (n = 12). At 2, 4, 6, 8, 10 and 12 weeks of treatment, SDF-1 in serum was quantified by enzyme-linked immunosorbent assay. At 12 weeks of treatment, the cartilage from knee tibial plateau in the knee joint was collected for H&E, Safranin-O staining and Mankin grading; measurement for mRNA levels of matrix metalloproteinases (MMP-3, MMP-9 and MMP-13), aggrecan (ACAN) and collagen II (Col II) using RT-PCR; and measurement for Col II protein levels by western blot. Results showed that SDF-1 in serum increased in the T140 group and increased in the control groups. H&E and Safranin-O staining revealed less cartilage loss in T140-treated animals compared to controls. The mRNA levels of MMP-3, MMP-9 and MMP-13 in cartilage were much lower in the T140 group than other groups, but mRNA levels of ACAN and Col II in cartilage were higher in the T140-treated group. Col II protein levels in the T140 group and control groups were different. T140 can downregulate the expression of matrix-degrading enzyme and lessen the degeneration of cartilage by blocking the SDF-1/CRCR4 signaling pathway in vivo. This mechanism may present a pharmacological target for the treatment of OA.	[Wang, Kun; Li, Yanlin; Cai, Guofeng; He, Chuan; Wang, Guoliang; Jia, Di] Kunming Med Univ, Dept Sports Med, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China; [Han, Rui] Kunming Med Univ, Dept Diabetol, Affiliated Hosp 1, Kunming, Peoples R China	Kunming Medical University; Kunming Medical University	Li, YL (corresponding author), Kunming Med Univ, Dept Sports Med, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China.	852387873@qq.com			National Natural Science Foundation of China [81460340]; innovative team project in Yunnan province [2014HC018]; Program for Outstanding Medical Academic Leader in Yunnan province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); innovative team project in Yunnan province; Program for Outstanding Medical Academic Leader in Yunnan province	This study was supported by the National Natural Science Foundation of China (No: 81460340) and innovative team project in Yunnan province (No: 2014HC018). This study was also supported by Program for Outstanding Medical Academic Leader in Yunnan province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Natural Science Foundation of China (No: 81460340) and innovative team project in Yunnan province (No: 2014HC018). This study was also supported by Program for Outstanding Medical Academic Leader in Yunnan province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulais PE, 2009, BIOCHEM PHARMACOL, V78, P1382, DOI 10.1016/j.bcp.2009.07.007; Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817; Chen HT, 2011, J CELL BIOCHEM, V112, P1219, DOI 10.1002/jcb.23043; Chiu YC, 2007, MOL PHARMACOL, V72, P695, DOI 10.1124/mol.107.036541; Cho HJ, 2016, KNEE, V23, P29, DOI 10.1016/j.knee.2015.09.003; Filardo G, 2016, KNEE SURG SPORT TR A, V24, P1775, DOI 10.1007/s00167-016-4089-y; He W, 2016, J ARTHROPLASTY, V31, P373, DOI 10.1016/j.arth.2015.08.018; Hemshekhar M, 2013, EUR J NUTR, V52, P1787, DOI 10.1007/s00394-012-0482-6; Hummel S, 2014, CURR OPIN HEMATOL, V21, P29, DOI 10.1097/MOH.0000000000000002; Kanbe K, 2004, J BONE JOINT SURG BR, V86B, P296, DOI 10.1302/0301-620X.86B2.14474; Kanbe K, 2002, ARTHRITIS RHEUM-US, V46, P130, DOI 10.1002/1529-0131(200201)46:1<130::AID-ART10020>3.0.CO;2-D; Le Clanche S, 2016, BIOCHIMIE, V121, P238, DOI 10.1016/j.biochi.2015.12.008; Li PC, 2016, MOL MED REP, V14, P1475, DOI 10.3892/mmr.2016.5419; Lu L, 2015, J DENT RES, V94, P1601, DOI 10.1177/0022034515604621; Masuda R, 2012, BIOCONJUGATE CHEM, V23, P1259, DOI 10.1021/bc300084h; Nanki Toshihiro, 2016, Nihon Rinsho Meneki Gakkai Kaishi, V39, P172, DOI 10.2177/jsci.39.172; Narumi T, 2013, CHEMMEDCHEM, V8, P118, DOI 10.1002/cmdc.201200390; Narumi T, 2012, BIOORG MED CHEM LETT, V22, P4169, DOI 10.1016/j.bmcl.2012.04.032; Nummenmaa E, 2015, SCAND J RHEUMATOL, V44, P321, DOI 10.3109/03009742.2014.1000372; Pearson RG, 2011, OSTEOARTHR CARTILAGE, V19, P324, DOI 10.1016/j.joca.2010.12.005; Poulet B, 2016, CURR OPIN PHARMACOL, V28, P8, DOI 10.1016/j.coph.2016.02.009; Santoro A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135979; Sharma L, 2016, OSTEOARTHR CARTILAGE, V24, P36, DOI 10.1016/j.joca.2015.07.026; Stone AV, 2014, OSTEOARTHR CARTILAGE, V22, P264, DOI 10.1016/j.joca.2013.11.002; Tamamura H, 2000, BIOORG MED CHEM LETT, V10, P2633, DOI 10.1016/S0960-894X(00)00535-7; Thomas NP, 2015, J ORTHOP RES, V33, P1071, DOI 10.1002/jor.22862; Turkiewicz A, 2015, RHEUMATOLOGY, V54, P827, DOI 10.1093/rheumatology/keu409; Villalvilla A, 2014, EXPERT OPIN THER TAR, V18, P1077, DOI 10.1517/14728222.2014.930440; Wang XY, 2016, NEURAL NETWORKS, V74, P1, DOI 10.1016/j.neunet.2015.10.012; Wei FY, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3930; Wilkinson RA, 2011, ANTIMICROB AGENTS CH, V55, P255, DOI 10.1128/AAC.00709-10; Zwickl H, 2016, CARTILAGE, V7, P185, DOI 10.1177/1947603515615388	32	16	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176048	10.1371/journal.pone.0176048	http://dx.doi.org/10.1371/journal.pone.0176048			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426786	gold, Green Published, Green Submitted			2022-12-26	WOS:000399875900093
J	Zand, MS; Trayhan, M; Farooq, SA; Fucile, C; Ghoshal, G; White, RJ; Quill, CM; Rosenberg, A; Barbosa, HS; Bush, K; Chafi, H; Boudreau, T				Zand, Martin S.; Trayhan, Melissa; Farooq, Samir A.; Fucile, Christopher; Ghoshal, Gourab; White, Robert J.; Quill, Caroline M.; Rosenberg, Alexander; Barbosa, Hugo Serrano; Bush, Kristen; Chafi, Hassan; Boudreau, Timothy			Properties of healthcare teaming networks as a function of network construction algorithms	PLOS ONE			English	Article							SOCIAL NETWORKS; PATTERNS; PROFESSIONALS; EMERGENCE	Network models of healthcare systems can be used to examine how providers collaborate, communicate, refer patients to each other, and to map how patients traverse the network of providers. Most healthcare service network models have been constructed from patient claims data, using billing claims to link a patient with a specific provider in time. The data sets can be quite large (10(6)-10(8) individual claims per year), making standard methods for network construction computationally challenging and thus requiring the use of alternate construction algorithms. While these alternate methods have seen increasing use in generating healthcare networks, there is little to no literature comparing the differences in the structural properties of the generated networks, which as we demonstrate, can be dramatically different. To address this issue, we compared the properties of healthcare networks constructed using different algorithms from 2013 Medicare Part B outpatient claims data. Three different algorithms were compared: binning, sliding frame, and trace-route. Unipartite networks linking either providers or healthcare organizations by shared patients were built using each method. We find that each algorithm produced networks with substantially different topological properties, as reflected by numbers of edges, network density, assortativity, clustering coefficients and other structural measures. Provider networks adhered to a power law, while organization networks were best fit by a power law with exponential cutoff. Censoring networks to exclude edges with less than 11 shared patients, a common de-identification practice for healthcare network data, markedly reduced edge numbers and network density, and greatly altered measures of vertex prominence such as the betweenness centrality. Data analysis identified patterns in the distance patients travel between network providers, and a striking set of teaming relationships between providers in the Northeast United States and Florida, likely due to seasonal residence patterns of Medicare beneficiaries. We conclude that the choice of network construction algorithm is critical for healthcare network analysis, and discuss the implications of our findings for selecting the algorithm best suited to the type of analysis to be performed.	[Zand, Martin S.; Trayhan, Melissa; Farooq, Samir A.; Fucile, Christopher; White, Robert J.; Quill, Caroline M.; Rosenberg, Alexander; Bush, Kristen] Univ Rochester, Med Ctr, Rochester Ctr Hlth Informat, Rochester, NY 14642 USA; [Zand, Martin S.; Bush, Kristen] Univ Rochester, Med Ctr, Clin Translat Sci Inst, Rochester, NY 14642 USA; [Zand, Martin S.; Trayhan, Melissa; Farooq, Samir A.; White, Robert J.] Univ Rochester, Med Ctr, Dept Med, Div Nephrol, Rochester, NY 14642 USA; [Fucile, Christopher; Rosenberg, Alexander] Univ Rochester, Med Ctr, Dept Med, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA; [Ghoshal, Gourab; Barbosa, Hugo Serrano] Univ Rochester, Dept Phys, Rochester, NY USA; [Quill, Caroline M.] Univ Rochester, Med Ctr, Dept Med, Div Pulm & Crit Care Med, Rochester, NY 14642 USA; [Chafi, Hassan; Boudreau, Timothy] Oracle Labs, Belmont, CA USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester; Oracle	Zand, MS (corresponding author), Univ Rochester, Med Ctr, Rochester Ctr Hlth Informat, Rochester, NY 14642 USA.; Zand, MS (corresponding author), Univ Rochester, Med Ctr, Clin Translat Sci Inst, Rochester, NY 14642 USA.; Zand, MS (corresponding author), Univ Rochester, Med Ctr, Dept Med, Div Nephrol, Rochester, NY 14642 USA.	martin_zand@urmc.rochester.edu		Ghoshal, Gourab/0000-0001-7593-5626; Zand, Martin/0000-0002-7095-8682; Barbosa, Hugo/0000-0002-3927-969X; WHITE, ROBERT J/0000-0002-4289-1046	National Institute of Health [UL1 TR000042, U54 TR001625, KL2 TR001999, TL1 TR002000, R01AI098112, R01AI069351]; Philip Templeton Foundation; University of Rochester Center for Health Informatics; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002001, TL1TR000096, KL2TR001999, TL1TR002000] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philip Templeton Foundation; University of Rochester Center for Health Informatics; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by research grants from National Institute of Health: UL1 TR000042 and U54 TR001625 (MZ, CQ, MT, RW, and KB), KL2 TR001999 (CQ), TL1 TR002000 (KB), R01AI098112 and R01AI069351 (MZ), from the Philip Templeton Foundation (MZ, RW, MT, SF), and from the University of Rochester Center for Health Informatics (MZ, RW, AR, CF, SF, MT). The University of Rochester Center for Health Informatics worked collaboratively with Oracle Labs, who provided no additional funding for this research and whose contributions were equalin this work. Oracle Labs provided support in the form of salaries for authors [TB,HC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Fred Trotter, Orna Intrator, Ann Dozier and Katia Noyes for spirited discussions on healthcare networks that greatly enhanced this manuscript. This work was supported in part by research grants from National Institute of Health: UL1 TR000042 and U54 TR001625 (MZ, CQ, MT, RW, and KB), KL2 TR001999 (CQ), TL1 TR002000 ( KB), R01AI098112 and R01AI069351 (MZ), from the Philip Templeton Foundation (MZ, RW, MT, SF), and from the University of Rochester Center for Health Informatics (MZ, RW, AR, CF, SF, MT). The University of Rochester Center for Health Informatics worked collaboratively with Oracle Labs, who provided no additional funding for this research and whose contributions were equal in this work. The affiliation did not influence, nor does it alter, adherence to PLOS ONE policies on sharing data and materials.	Almansoori W, 2012, NETW MODEL ANAL HLTH, V1, P27, DOI 10.1007/s13721-012-0005-7; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barnett ML, 2011, HEALTH SERV RES, V46, P1592, DOI 10.1111/j.1475-6773.2011.01262.x; Begley C. G., 2014, CIRC RES, V116, P116, DOI DOI 10.1161/CIRCRESAHA.114.303819; Blanchet K, 2012, HEALTH POLICY PLANN, V27, P438, DOI 10.1093/heapol/czr055; Bourgeois FT, 2015, PEDIATR DRUGS, V17, P401, DOI 10.1007/s40272-015-0139-z; Buluc A, 2012, SIAM J SCI COMPUT, V34, pC170, DOI 10.1137/110848244; Burch H, 1999, COMPUTER, V32, P97, DOI 10.1109/2.755008; Burgard AP, 2004, GENOME RES, V14, P301, DOI 10.1101/gr.1926504; Calvert KL, 1997, IEEE COMMUN MAG, V35, P160, DOI 10.1109/35.587723; Center for Medicare Services, 2016, PHYS SHAR PAT PATT T; Center for Medicare Services, 2016, SYNTH PUBL US FIL; Center for Medicare Services, 2016, NAT PROV ID NPI FIL; Center for Medicare Services Research Assistance Data Center, 2016, MEDICARE LTD DAT SET; Centers for Medicare and Medicaid Services, 2012, CHRON COND MED BEN C; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cunningham FC, 2012, BMJ QUAL SAF, V21, P239, DOI 10.1136/bmjqs-2011-000187; de Montjoye YA, 2015, SCIENCE, V347, P536, DOI 10.1126/science.1256297; ERDOS P, 1960, B INT STATIST INST, V38, P343; Eubank S., 2004, P 15 ANN ACM SIAM S, P718; Fath BD, 2007, ECOL MODEL, V208, P49, DOI 10.1016/j.ecolmodel.2007.04.029; Fattore G, 2009, HEALTH POLICY, V92, P141, DOI 10.1016/j.healthpol.2009.03.005; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Garlaschelli D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.268701; Gilbert JR, 2010, ARXIV10062183; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Govindan R., 2000, Proceedings IEEE INFOCOM 2000. Conference on Computer Communications. Nineteenth Annual Joint Conference of the IEEE Computer and Communications Societies (Cat. No.00CH37064), P1371, DOI 10.1109/INFCOM.2000.832534; Gray JE, 2010, PEDIATRICS, V125, pE1460, DOI 10.1542/peds.2009-2621; Grayson J, 2015, J AM COLL RADIOL, V12, P1413, DOI 10.1016/j.jacr.2015.09.017; Gundlapalli Adi, 2009, AMIA Annu Symp Proc, V2009, P213; Ho K., 2005, INSURER PROVIDER NET; Holder LB, 2016, ACM SIGKDD EXPLORATI, V18, P39, DOI DOI 10.1145/2980765.2980770; Iwashyna TJ, 2009, MED CARE, V47, P787, DOI 10.1097/MLR.0b013e318197b1f5; Jang HL, 2012, HEALTHC INFORM RES, V18, P44, DOI 10.4258/hir.2012.18.1.44; Karimi F, 2013, PHYSICA A, V392, P3476, DOI 10.1016/j.physa.2013.03.050; Klibi W, 2013, OR SPECTRUM, V35, P867, DOI 10.1007/s00291-013-0327-6; Landon BE, 2012, JAMA-J AM MED ASSOC, V308, P265, DOI 10.1001/jama.2012.7615; Lebacque JP, 2002, FIRST ORDER MACROSCO, P119; Luhn HP, 1960, US patent, Patent No. [2,950,048, 2950048]; Mandl Kenneth D, 2015, BMJ Outcomes, V2015, P6; Mandl KD, 2014, J GEN INTERN MED, V29, P1499, DOI 10.1007/s11606-014-2964-0; MARSDEN PV, 1993, SOC NETWORKS, V15, P399, DOI 10.1016/0378-8733(93)90014-C; McNutt M, 2014, SCIENCE, V346, P679, DOI 10.1126/science.aaa1724; Mensah E, 2014, HEALTH INFORM SER, P107, DOI 10.1007/978-1-4471-4237-9_7; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; North American Association of Central Cancer Registries, 2016, GEOSP LOC US PROV; Olson RS, 2015, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.4; Ong MS, 2015, J GEN INTERN MED, P1; Padmanabhan VN, 2001, ACM SIGCOMM COMP COM, V31, P173, DOI 10.1145/964723.383073; Pollack CE, 2014, VALUE HEALTH, V17, P611, DOI 10.1016/j.jval.2014.04.011; Pujol J. M., 2002, Proceedings of the First International Joint Conference on Autonomous Agents and Multiagent Systems, P467; Scholz M., 2015, J DATA MINING DIGITA, V2015; Schumaker Alice M, 2002, J Health Hum Serv Adm, V25, P371; Scott J, 2005, ANN FAM MED, V3, P443, DOI 10.1370/afm.344; Seidel R., 1992, Proceedings of the Twenty-Fourth Annual ACM Symposium on the Theory of Computing, P745, DOI 10.1145/129712.129784; Stewart SA, 2012, J MED INTERNET RES, V14, P245, DOI 10.2196/jmir.1982; Trotter F., 2012, DOCGRAPH OPEN SOCIAL; Uddin S, 2012, AUSTR WORKSH HLTH IN, V129, P67; Uddin S, 2013, STAT MED, V32, P3539, DOI 10.1002/sim.5770; Uddin S, 2012, EUR J PUBLIC HEALTH, V22, P629, DOI 10.1093/eurpub/ckr153; Um J, 2009, P NATL ACAD SCI USA, V106, P14236, DOI 10.1073/pnas.0901898106; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Watts DJ, 2002, SCIENCE, V296, P1302, DOI 10.1126/science.1070120; Wensing M, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-67; West E, 1999, SOC SCI MED, V48, P633, DOI 10.1016/S0277-9536(98)00361-X; West E, 2005, CAN J NURS RES, V37, P132; Yan XY, 2013, SCI REP-UK, V3, DOI 10.1038/srep02678; ZipInfo, 2016, ZIP COD MAPP FIL	72	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175876	10.1371/journal.pone.0175876	http://dx.doi.org/10.1371/journal.pone.0175876			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KM	28426795	Green Published, gold, Green Submitted			2022-12-26	WOS:000399875900062
J	Fereig, RM; Kuroda, Y; Terkawi, MA; Mahmoud, ME; Nishikawa, Y				Fereig, Ragab M.; Kuroda, Yasuhiro; Terkawi, Mohamad Alaa; Mahmoud, Motamed Elsayed; Nishikawa, Yoshifumi			Immunization with Toxoplasma gondii peroxiredoxin 1 induces protective immunity against toxoplasmosis in mice	PLOS ONE			English	Article							NF-KAPPA-B; DENSE GRANULE PROTEIN-7; DNA VACCINE; RECOMBINANT ANTIGENS; VIRULENCE FACTOR; MACROPHAGES; INFECTION; RESPONSES; PARASITE; MURINE	To develop a vaccine against Toxoplasma gondii, a vaccine antigen with immune-stimulating activity is required. In the present study, we investigated the immunogenicity and prophylactic potential of T. gondii peroxiredoxin 1 (TgPrx1). The TgPrx1 was detected in the ascitic fluid of mice 6 days postinfection, while specific antibody levels were low in the sera of chronically infected mice. Treatment of murine peritoneal macrophages with recombinant TgPrx1 triggered IL-12p40 and IL-6 production, but not IL-10 production. In response to TgPrx1, activation of NF-kappa B and IL-6 production were confirmed in mouse macrophage cell line (RAW 264.7). These results suggest the immune-stimulating potentials of TgPrx1. Immunization of mice with recombinant TgPrx1 stimulated specific antibody production (IgG1 and IgG2c). Moreover, spleen cell proliferation and interferon-gamma production significantly increased in the TgPrx1-sensitized cells from mice immunized with the same antigen. Immunization with TgPrx1 also increased mouse survival and decreased cerebral parasite burden against lethal T. gondii infection. Thus, our results suggest that TgPrx1 efficiently induces humoral and cellular immune responses and is useful as a new vaccine antigen against toxoplasmosis.	[Fereig, Ragab M.; Terkawi, Mohamad Alaa; Mahmoud, Motamed Elsayed; Nishikawa, Yoshifumi] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Inada Cho, Obihiro, Hokkaido, Japan; [Fereig, Ragab M.] South Valley Univ, Fac Vet Med, Dept Anim Med, Qena City, Qena, Egypt; [Kuroda, Yasuhiro] Tokai Univ, Dept Appl Biochem, Hiratsuka, Kanagawa, Japan; [Mahmoud, Motamed Elsayed] Sohag Univ, Fac Vet Med, Dept Anim Behav Management Genet & Breeding, Sohag City, Sohag, Egypt	Obihiro University of Agriculture & Veterinary Medicine; Egyptian Knowledge Bank (EKB); South Valley University Egypt; Tokai University; Egyptian Knowledge Bank (EKB); Sohag University	Nishikawa, Y (corresponding author), Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Inada Cho, Obihiro, Hokkaido, Japan.	nisikawa@obihiro.ac.jp	Fereig, Ragab/AAA-2500-2022	Terkawi, Alaa/0000-0002-5481-8516; , motamed/0000-0003-0034-1043; Fereig, Ragab Makhlouf/0000-0003-1845-1312	Japan Society for the Promotion of Science NEXT Program [2011/LS003]; Ministry of Education, Culture, Sports, Science, and Technology [15H04589]; Grants-in-Aid for Scientific Research [17K10993] Funding Source: KAKEN	Japan Society for the Promotion of Science NEXT Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science NEXT Program 2011/LS003 (Dr Yoshifumi Nishikawa); Ministry of Education, Culture, Sports, Science, and Technology 15H04589 (Dr Yoshifumi Nishikawa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerman SE, 2005, J BIOL CHEM, V280, P564, DOI 10.1074/jbc.M406367200; Almeida F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144507; Anand SB, 2008, ACTA TROP, V107, P106, DOI 10.1016/j.actatropica.2008.04.018; Rodriguez JB, 2012, EXPERT OPIN THER PAT, V22, P311, DOI 10.1517/13543776.2012.668886; Butcher BA, 2001, J IMMUNOL, V167, P2193, DOI 10.4049/jimmunol.167.4.2193; BUXTON D, 1993, PARASITOL TODAY, V9, P335, DOI 10.1016/0169-4758(93)90236-9; Campos-Neto A, 2001, INFECT IMMUN, V69, P4103, DOI 10.1128/IAI.69.6.4103-4108.2001; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7017, DOI 10.1073/pnas.91.15.7017; Contini C, 2005, INT J PARASITOL, V35, P275, DOI 10.1016/j.ijpara.2004.11.016; Cui X, 2012, VACCINE, V30, P2282, DOI 10.1016/j.vaccine.2012.01.073; Denkers EY, 2004, IMMUNOL REV, V201, P191, DOI 10.1111/j.0105-2896.2004.00180.x; Deponte M, 2005, MOL BIOCHEM PARASIT, V140, P87, DOI 10.1016/j.molbiopara.2004.12.008; Dobbin CA, 2002, J IMMUNOL, V169, P958, DOI 10.4049/jimmunol.169.2.958; Du J, 2014, J BIOL CHEM, V289, P12578, DOI 10.1074/jbc.M113.544718; Dupont CD, 2012, SEMIN IMMUNOPATHOL, V34, P793, DOI 10.1007/s00281-012-0339-3; Dziadek B, 2009, EXP PARASITOL, V123, P81, DOI 10.1016/j.exppara.2009.06.002; Fatoohi AF, 2002, CLIN DIAGN LAB IMMUN, V9, P704, DOI 10.1128/CDLI.9.3.704-707.2002; Fereig RM, 2016, PARASITOL INT, V65, P741, DOI 10.1016/j.parint.2016.09.008; Fereig RM, 2016, METHODS MOL BIOL, V1404, P153, DOI 10.1007/978-1-4939-3389-1_10; Furuta T, 2008, EUR J IMMUNOL, V38, P1341, DOI 10.1002/eji.200738059; GAZZINELLI RT, 1993, P NATL ACAD SCI USA, V90, P6115, DOI 10.1073/pnas.90.13.6115; Gong P, 2013, PARASITE IMMUNOL, V35, P140, DOI 10.1111/pim.12024; Harris TH, 2010, J NEUROIMMUNOL, V222, P19, DOI 10.1016/j.jneuroim.2009.12.009; Hassan IA, 2014, EXP PARASITOL, V146, P1, DOI 10.1016/j.exppara.2014.08.011; Henriquez FL, 2010, TRENDS PARASITOL, V26, P550, DOI 10.1016/j.pt.2010.06.004; Ibrahim HM, 2009, INFECT IMMUN, V77, P3686, DOI 10.1128/IAI.00361-09; Innes EA, 2009, MEM I OSWALDO CRUZ, V104, P246, DOI 10.1590/S0074-02762009000200018; Israili ZH., 2014, PLOS ONE, V9; Jones JL, 2012, CLIN INFECT DIS, V55, P845, DOI 10.1093/cid/cis508; Kono K, 1996, EUR J IMMUNOL, V26, P1308, DOI 10.1002/eji.1830260620; Kur J, 2009, EXPERT REV VACCINES, V8, P791, DOI [10.1586/erv.09.27, 10.1586/ERV.09.27]; Kwok LY, 2004, MOL MICROBIOL, V51, P47, DOI 10.1046/j.1365-2958.2003.03823.x; Mahmoud ME, 2015, CELL MICROBIOL, V65, P741; Marshall ES, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-80; McGonigle S, 1998, PARASITOL TODAY, V14, P139, DOI 10.1016/S0169-4758(97)01211-8; Mendes RE, 2010, VACCINE, V28, P2832, DOI 10.1016/j.vaccine.2010.01.055; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Mills CD, 2012, CRIT REV IMMUNOL, V32, P463, DOI 10.1615/CritRevImmunol.v32.i6.10; Morgado P, 2014, INFECT IMMUN, V82, P4047, DOI 10.1128/IAI.01615-14; Nishikawa Y, 2009, CLIN VACCINE IMMUNOL, V16, P792, DOI 10.1128/CVI.00032-09; Patil V, 2014, INT J PARASITOL, V44, P161, DOI 10.1016/j.ijpara.2013.08.003; Peters PJ, 2007, DRUG SAFETY, V30, P481, DOI 10.2165/00002018-200730060-00003; Radke JR, 2001, MOL BIOCHEM PARASIT, V115, P165, DOI 10.1016/S0166-6851(01)00284-5; Riddell JR, 2010, J IMMUNOL, V184, P1022, DOI 10.4049/jimmunol.0901945; Robert-Gangneux F, 2012, CLIN MICROBIOL REV, V25, P264, DOI 10.1128/CMR.05013-11; Rosowski EE, 2011, J EXP MED, V208, P195, DOI 10.1084/jem.20100717; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Shapira S, 2005, J CELL SCI, V118, P3501, DOI 10.1242/jcs.02428; Shichita T, 2012, NAT MED, V18, P911, DOI 10.1038/nm.2749; Son Eui-Sun, 2001, Korean Journal of Parasitology, V39, P133, DOI 10.3347/kjp.2001.39.2.133; Tanaka S, 2014, VACCINE, V32, P1781, DOI 10.1016/j.vaccine.2014.01.095; Tanaka S, 2013, INFECT IMMUN, V81, P3609, DOI 10.1128/IAI.00439-13; Tao Q, 2013, PARASITOL RES, V112, P2871, DOI 10.1007/s00436-013-3458-4; Tato CM, 2003, J IMMUNOL, V170, P3139, DOI 10.4049/jimmunol.170.6.3139; Terkawi MA, 2013, CLIN VACCINE IMMUNOL, V20, P596, DOI 10.1128/CVI.00747-12; Wang CQ, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-6; Wang HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070884; Yang CS, 2016, INFECT IMMUN, V84, P339, DOI 10.1128/IAI.00734-15; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Zhang NZ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-512; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	61	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176324	10.1371/journal.pone.0176324	http://dx.doi.org/10.1371/journal.pone.0176324			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448521	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383600061
J	Gebremicael, G; Belay, Y; Girma, F; Abreha, Y; Gebreegziabxier, A; Tesfaye, S; Messele, Z; Assefa, Y; Bellete, B; Kassa, D; Vojnov, L				Gebremicael, Gebremedhin; Belay, Yohanes; Girma, Fitsum; Abreha, Yemane; Gebreegziabxier, Atsbeha; Tesfaye, Simret; Messele, Zelalem; Assefa, Yibeltal; Bellete, Bahrie; Kassa, Desta; Vojnov, Lara			The performance of BD FACSPresto (TM) for CD4 T-cell count, CD4% and hemoglobin concentration test in Ethiopia	PLOS ONE			English	Article							LYMPHOCYTES	Introduction In Ethiopia, CD4+ T-cell counting is still required for all patients at baseline before antiretroviral therapy (ART) and to determine eligibility and follow-up of opportunistic infection prophylaxis. However, access to CD4+ T-cell count in rural health facilities remains a major challenge in Ethiopia like other resource-limited settings. Methodology Both capillary and venous blood was drawn from each of 325 study participant recruited in Addis Ababa and surroundings. The CD4+ T-cell count, CD4%, and hemoglobin (Hgb) were tested at one of the four study health facilities using capillary blood and BD FACSPresto (TM) device. These tests were also done at the national HIV reference laboratory, using venous blood with BD FACSCalibur (TM), Sysmex XT-1800i (TM), and BD FACSPresto (TM). Results BD FACSPresto (TM) had an absolute mean bias of -13.3 cells/mu l (-2.99%) and 28.3 cells/mu l (6.4%) using venous and capillary blood, respectively, compared with BD FACSCalibur (TM). The absolute CD4 assay on the BD FACSPresto (TM) had a regression coefficient (R-2) of 0.87 and 0.92 using capillary blood and venous blood samples, respectively, compared with BD FACSCalibur (TM). The percentage similarity of the BD FACSPresto (TM) using capillary and venous blood was 105.2% and 99.3%, respectively. The sensitivity of the FACSPresto (TM) using threshold of 500 cells/mu l for ART eligibility using capillary and venous blood was 87.9 and 94.3%, while the specificity was 91.4 and 83.8%, respectively. Furthermore, the BD FACSPresto (TM) had an absolute mean bias of -0.2 dl/mu l (0.0%) (95% LOA: -1.7, 1.3) and -0.59 dl/mu l (0.1%) (95% LOA: -1.49, 0.31) for Hgb using capillary and venous blood compared with the Sysmex XT-1800i (TM), respectively. Conclusion Our results showed acceptable agreement between the BD FACSPresto (TM) and BD FACS-Calibur (TM) for CD4+ T-cell counting and CD4%; and between the BD FACSPresto (TM) and Sysmex XT-1800i (TM) for measuring Hgb concentration.	[Gebremicael, Gebremedhin; Belay, Yohanes; Girma, Fitsum; Abreha, Yemane; Gebreegziabxier, Atsbeha; Tesfaye, Simret; Assefa, Yibeltal; Kassa, Desta] Ethiopian Publ Hlth Inst, HIV & TB Dis Res Directorate, Addis Ababa, Ethiopia; [Messele, Zelalem; Bellete, Bahrie] Clinton Hlth Access Initiat Inc, Addis Ababa, Ethiopia; [Vojnov, Lara] Clinton Hlth Access Initiat, Boston, MA USA		Gebremicael, G (corresponding author), Ethiopian Publ Hlth Inst, HIV & TB Dis Res Directorate, Addis Ababa, Ethiopia.	Kudus12@gmail.com	Assefa, Yibeltal/ABI-8057-2020; Assefa, Yibeltal/N-5984-2016	Assefa, Yibeltal/0000-0003-2393-1492; Assefa, Yibeltal/0000-0003-2393-1492; Gebremicael, Gebremedhin/0000-0001-6726-9600; Vojnov, Lara/0000-0003-0488-1012	UNITAID	UNITAID	This study was funded by UNITAID. The authors affiliated with the Clinton Health Access Initiative, Inc., an affiliated entity of the Clinton Foundation, did not fund this specific study. UNITAID had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of items, car rent, and supplies, etc. and salaries for the field staff at the site and driver staffs but not for the authors.	Assefa Y, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000056; BD, 2014, BD FACSPRESTO TM NEA; (BD) BD, 2007, BD FACSCALIBUR INSTR; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bwana P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145586; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; FMOH, 2013, GUID IMPL POC CD4 TE; GIORGI JV, 1993, ANN NY ACAD SCI, V677, P126, DOI 10.1111/j.1749-6632.1993.tb38771.x; Jani IV, 2011, AIDS, V25, P807, DOI 10.1097/QAD.0b013e328344f424; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Ministry of Health (MoH), 2016, SUPPL 2014 NAT COMPR; Scott LE, 2003, CYTOM PART B-CLIN CY, V54B, P46, DOI 10.1002/cyto.b.10016; Sterling TR, 2001, AIDS, V15, P2251, DOI 10.1097/00002030-200111230-00006; Sysmex cooperation, 2012, XT 2000I TM XT1800IT; UNITAID, 2015, HIV AIDS DIAGN TECHN; Wade D, 2014, JAIDS-J ACQ IMM DEF, V66, pE98, DOI 10.1097/QAI.0000000000000214; WHO, 2010, ANT THER HIV INF AD; WHO, 2016, CONGUID UANT DRU; WHO (World Health Organization), 2011, TACKL ANT RES FOOD S, V3, P1; World Health Organization, 2013, CONSOLIDATED GUIDELI; World Health Organization (WHO), 2014, WHO LIST PREQ VITR D; Wynberg E, 2014, JIAS, V17, P1, DOI DOI 10.7448/IAS.17.1.18809	23	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176323	10.1371/journal.pone.0176323	http://dx.doi.org/10.1371/journal.pone.0176323			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448581	gold, Green Published			2022-12-26	WOS:000400383600060
J	Lemani, C; Tang, JH; Kopp, D; Phiri, B; Kumvula, C; Chikosi, L; Mwale, M; Rosenberg, NE				Lemani, Clara; Tang, Jennifer H.; Kopp, Dawn; Phiri, Billy; Kumvula, Chrissy; Chikosi, Loyce; Mwale, Mwawi; Rosenberg, Nora E.			Contraceptive uptake after training community health workers in couples counseling: A cluster randomized trial	PLOS ONE			English	Article							YOUNG MARRIED-COUPLES; INTERVENTIONS; SERVICES; DELIVERY	Background Young women in Malawi face many challenges in accessing family planning (FP), including distance to the health facility and partner disapproval. Our primary objective was to assess if training HSAs in couples counseling would increase modern FP uptake among young women. Methods In this cluster randomized controlled trial, 30 HSAs from Lilongwe, Malawi received training in FP. The HSAs were then randomized 1: 1 to receive or not receive additional training in couples counseling. All HSAs were asked to provide FP counseling to women in their communities and record their contraceptive uptake over 6 months. Sexually-active women <30 years of age who had never used a modern FP method were included in this analysis. Generalized estimating equations with an exchangeable correlation matrix to account for clustering by HSA were used to estimate risk differences (RDs) and 95% confidence intervals (CIs). Results 430 (53%) young women were counseled by the 15 HSAs who received couples counseling training, and 378 (47%) were counseled by the 15 HSAs who did not. 115 (26%) from the couples counseling group had male partners present during their first visit, compared to only 6 (2%) from the other group (RD: 0.21, 95% CI: 0.09 to 0.33, p<0.01). Nearly all (99.5%) initiated a modern FP method, with no difference between groups (p = 0.09). Women in the couples counseling group were 8% more likely to receive male condoms (RD: 0.08, 95% CI: -7% to 23%, p = 0.28) and 8% more likely to receive dual methods (RD: 0.08, 95% CI: -0.065, 0.232, p = 0.274). Conclusion Training HSAs in FP led to high modern FP uptake among young women who had never used FP. Couples counseling training increased male involvement with a trend towards higher male condom uptake.	[Lemani, Clara; Tang, Jennifer H.; Kopp, Dawn; Phiri, Billy; Rosenberg, Nora E.] UNC Project Malawi, Lilongwe, Malawi; [Tang, Jennifer H.] Univ North Carolina Chapel Hill, Sch Med, Dept Obstet & Gynecol, Chapel Hill, NC 27514 USA; [Kumvula, Chrissy; Chikosi, Loyce] Hlth Ctr, Area 25, Lilongwe, Malawi; [Mwale, Mwawi] Lilongwe Dist Hlth Off, Lilongwe, Malawi; [Rosenberg, Nora E.] Univ North Carolina Chapel Hill, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Tang, JH (corresponding author), UNC Project Malawi, Lilongwe, Malawi.; Tang, JH (corresponding author), Univ North Carolina Chapel Hill, Sch Med, Dept Obstet & Gynecol, Chapel Hill, NC 27514 USA.	jennifer_tang@med.unc.edu			Bill and Melinda Gates Foundation [OPP1098307]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the Bill and Melinda Gates Foundation (OPP1098307). The funder had no role in study design, data collection and analysis, decision to publish, preparation of the manuscript.	Abt Associates, 2015, COUNS WOM COUPL FAM; Advancing Partners Communities, 2014, COUNTR PROF MAL COMM; Ankomah A, 2011, J CONTRACEPTION, P95; Becker S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1309; Blumenthal PD, 2011, HUM REPROD UPDATE, V17, P121, DOI 10.1093/humupd/dmq026; Daniel EE, 2008, INT FAM PLAN PERSPEC, V34, P189, DOI [10.1363/3418908, 10.1363/ifpp.34.189.08]; Darteh EKM, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-23; FHI 360, 2013, INCR MAL INV FAM PLA; FHI360, 2010, EV COMM BAS DISTR DM; Gueye A, 2015, INT PERSPECT SEX R H, V41, P191, DOI 10.1363/4119115; Haddad L, 2013, AIDS, V27, pS93, DOI 10.1097/QAD.0000000000000039; MacQuarrie KLD, 2014, UNMET NEED FAMILY PL; Megquier S., 2014, REPROD TRANSITIONS U; MicrosoftCorporation, 2010, MICR ACC; National Statistical Office (NSO) [Malawi] and ICF Macro, 2011, MAL DEM HLTH SURV; Nyirenda L., 2014, REPORT CONTEXT ANAL; Phillips JF, 2003, INT FAM PLAN PERSPEC, V29, P138, DOI 10.2307/3181080; Raj A, 2015, PLOS ONE, V11; Richardson F, 2009, COMMUNITY BASED DIST; Sarkar A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2352-7; Shattuck D, 2011, AM J PUBLIC HLTH, V101; Tilahun T, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2057-y	22	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e175879	10.1371/journal.pone.0175879	http://dx.doi.org/10.1371/journal.pone.0175879			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET6EL	28448502	Green Published, gold, Green Submitted			2022-12-26	WOS:000400383600029
J	Yi, L; Pimentel, H; Pachter, L				Yi, Lynn; Pimentel, Harold; Pachter, Lior			Zika infection of neural progenitor cells perturbs transcription in neurodevelopmental pathways	PLOS ONE			English	Article							EXPRESSION; GENE	Background A recent study of the gene expression patterns of Zika virus (ZIKV) infected human neural progenitor cells (hNPCs) revealed transcriptional dysregulation and identified cell cyclerelated pathways that are affected by infection. However deeper exploration of the information present in the RNA-Seq data can be used to further elucidate the manner in which Zika infection of hNPCs affects the transcriptome, refining pathway predictions and revealing isoform-specific dynamics. Methodology/ Principal findings We analyzed data published by Tang et al. using state-of-the-art tools for transcriptome analysis. By accounting for the experimental design and estimation of technical and inferential variance we were able to pinpoint Zika infection affected pathways that highlight Zika's neural tropism. The examination of differential genes reveals cases of isoform divergence. Conclusions Transcriptome analysis of Zika infected hNPCs has the potential to identify the molecular signatures of Zika infected neural cells. These signatures may be useful for diagnostics and for the resolution of infection pathways that can be used to harvest specific targets for further study.	[Yi, Lynn; Pachter, Lior] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Yi, Lynn] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Pimentel, Harold] Stanford Univ, Dept Genet, Palo Alto, CA 94304 USA; [Pachter, Lior] CALTECH, Comp & Math Sci, Pasadena, CA 91125 USA	California Institute of Technology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Stanford University; California Institute of Technology	Pachter, L (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.; Pachter, L (corresponding author), CALTECH, Comp & Math Sci, Pasadena, CA 91125 USA.	lpachter@caltech.edu		Pimentel, Harold/0000-0001-8556-2499; Pachter, Lior/0000-0002-9164-6231	UCLA/Caltech Medical Scientist Training Program; Walter and Sylvia Treadway Endowment; NIH T32 (NRSA); NIH [R01 DK094699]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042] Funding Source: NIH RePORTER	UCLA/Caltech Medical Scientist Training Program; Walter and Sylvia Treadway Endowment; NIH T32 (NRSA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	LY was supported by funding from the UCLA/Caltech Medical Scientist Training Program, The Walter and Sylvia Treadway Endowment, and the NIH T32 (NRSA). LP was partially funded by NIH R01 DK094699. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bindea G, 2013, BIOINFORMATICS, V29, P661, DOI 10.1093/bioinformatics/btt019; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Longo DL, 2016, NEW ENGL J MED, V374, P276, DOI 10.1056/NEJMe1516564; Pimentel HJ, 058164 BIORXIV; Rolfe AJ, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0110-x; Stelzer Gil, 2016, Curr Protoc Bioinformatics, V54, DOI 10.1002/cpbi.5; Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang Zichen, 2016, F1000Res, V5, P1574, DOI 10.12688/f1000research.9110.1	11	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e175744	10.1371/journal.pone.0175744	http://dx.doi.org/10.1371/journal.pone.0175744			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448519	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000400383600023
J	Tan, ZJ; Ye, ZC; Zhang, J; Chen, YR; Cheng, CL; Wang, C; Liu, X; Lou, TQ; Peng, H				Tan, Zhijun; Ye, Zengchun; Zhang, Jun; Chen, Yanru; Cheng, Cailian; Wang, Cheng; Liu, Xun; Lou, Tanqi; Peng, Hui			Serum irisin levels correlated to peritoneal dialysis adequacy in nondiabetic peritoneal dialysis patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CIRCULATING IRISIN; INSULIN-RESISTANCE; BODY-COMPOSITION; ADIPOSE-TISSUE; MYOKINE IRISIN; EXERCISE; FNDC5; HEMODIALYSIS; ASSOCIATION	Background Irisin is a recently discovered myokine thought to be involved in multiple metabolism abnormalities in most dialysis patients. However, the myokine has not been thoroughly studied in peritoneal dialysis. This study aimed to evaluate serum irisin levels and establish their relation to dialysis adequacy, insulin resistance, and bone metabolism status in patients on peritoneal dialysis. Methods A total of 59 nondiabetic prevalent peritoneal dialysis patients and 52 age-and sex-matched healthy controls were enrolled in this cross-sectional study. Serum irisin concentration was assessed by enzyme-linked immunosorbent assay. The correlations between serum irisin and dialysis adequacy, clinical, and metabolic variables were investigated. Results Serum irisin levels were lower in nondiabetic peritoneal dialysis patients (17.02ng/ml) compared with healthy controls (22.17ng/ml, P<0.001). Multivariate regression analysis revealed that fasting glucose levels were correlated inversely with serum irisin levels in peritoneal dialysis patients. Serum irisin levels were associated with neither insulin resistance nor bone metabolism in our patients. Serum irisin levels were positively associated with peritoneal Kt/V-urea (beta = 4.933, 95% confidence interval [CI] = 0.536-9.331, P = 0.029) and peritoneal C-Cr (beta = 0.259, 95% CI = 0.053-0.465, P = 0.015) among peritoneal dialysis patients. Conclusions The study demonstrated that non-diabetic peritoneal dialysis patients have lower serum irisin levels, and the levels were correlated with peritoneal dialysis adequacy, indicating adequate dialysis may improve irisin secretion. Additional studies are needed to provide a confirmation.	[Tan, Zhijun; Ye, Zengchun; Zhang, Jun; Chen, Yanru; Cheng, Cailian; Wang, Cheng; Liu, Xun; Lou, Tanqi; Peng, Hui] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Med, Div Nephrol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Lou, TQ; Peng, H (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Med, Div Nephrol, Guangzhou, Guangdong, Peoples R China.	lou.tq@163.com; elizapeng10@gmail.com			National Natural Science Funds of China [81170678, 81670675]; Guangdong Provincial Science and Technology Plan projects [2014A020212074]	National Natural Science Funds of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Science and Technology Plan projects	This work was supported by The National Natural Science Funds of China - No. 81170678, 81670675; Guangdong Provincial Science and Technology Plan projects -2014A020212074.	Albrecht E, 2015, SCI REP-UK, V5, DOI 10.1038/srep08889; Anastasilakis AD, 2014, OSTEOPOROSIS INT, V25, P1633, DOI 10.1007/s00198-014-2673-x; BAKAL U, 2016, BIOCH INSIGHTS, V9; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Bouillanne O, 2005, AM J CLIN NUTR, V82, P777, DOI 10.1093/ajcn/82.4.777; Cereda E, 2009, CURR OPIN CLIN NUTR, V12, P1, DOI 10.1097/MCO.0b013e3283186f59; Choi HY, 2014, J CLIN ENDOCR METAB, V99, P2778, DOI 10.1210/jc.2014-1195; Choi YK, 2013, DIABETES RES CLIN PR, V100, P96, DOI 10.1016/j.diabres.2013.01.007; Colaianni G, 2015, P NATL ACAD SCI USA, V112, P12157, DOI 10.1073/pnas.1516622112; Dukkipati R, 2009, SEMIN NEPHROL, V29, P39, DOI 10.1016/j.semnephrol.2008.10.006; Ebert T, 2016, INT J OBESITY, V40, P260, DOI 10.1038/ijo.2015.157; Ebert T, 2014, EUR J ENDOCRINOL, V170, P501, DOI 10.1530/EJE-13-1053; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fortes PC, 2009, PERITON DIALYSIS INT, V29, pS145; Fouque D, 2008, KIDNEY INT, V73, P391, DOI 10.1038/sj.ki.5002585; Hu WC, 2016, ANN CLIN BIOCHEM, V53, P67, DOI 10.1177/0004563215582072; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Kaluzna M, 2016, POL ARCH MED WEWN, V126, P474, DOI 10.20452/pamw.3466; Kim JC, 2013, J AM SOC NEPHROL, V24, P337, DOI 10.1681/ASN.2012010047; Kovesdy CP, 2013, AM J CLIN NUTR, V97, P1163, DOI 10.3945/ajcn.112.036418; Kurdiova T, 2014, J PHYSIOL-LONDON, V592, P1091, DOI 10.1113/jphysiol.2013.264655; Lee MJ, 2015, ATHEROSCLEROSIS, V242, P476, DOI 10.1016/j.atherosclerosis.2015.08.002; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liu JJ, 2014, J DIABETES COMPLICAT, V28, P208, DOI 10.1016/j.jdiacomp.2013.09.011; Liu JJ, 2013, J DIABETES COMPLICAT, V27, P365, DOI 10.1016/j.jdiacomp.2013.03.002; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Malluche HH, 2013, NAT REV NEPHROL, V9, P671, DOI 10.1038/nrneph.2013.198; Moorthi RN, 2013, KIDNEY INT, V84, P886, DOI 10.1038/ki.2013.254; Moraes C, 2013, HORM METAB RES, V45, P900, DOI 10.1055/s-0033-1354402; Pham H, 2011, CURR OPIN NEPHROL HY, V20, P640, DOI 10.1097/MNH.0b013e32834b23c1; Roca-Rivada A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060563; Rodriguez-Carmona A, 2016, NEFROLOGIA, V36, P496, DOI 10.1016/j.nefro.2016.05.019; Sanchis-Gomar F, 2014, HORM METAB RES, V46, P591, DOI 10.1055/s-0033-1363283; Timmons JA, 2012, NATURE, V488, pE9, DOI 10.1038/nature11364; Wang LS, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/2616539; Wen MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064025; Zoccali C, 2012, CURR OPIN NEPHROL HY, V21, P641, DOI 10.1097/MNH.0b013e328358a02b	37	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176137	10.1371/journal.pone.0176137	http://dx.doi.org/10.1371/journal.pone.0176137			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445520	Green Published, Green Submitted, gold			2022-12-26	WOS:000400309200035
J	Gonzalez-Maya, JF; Martinez-Meyer, E; Medellin, R; Ceballos, G				Gonzalez-Maya, Jose F.; Martinez-Meyer, Enrique; Medellin, Rodrigo; Ceballos, Gerardo			Distribution of mammal functional diversity in the Neotropical realm: Influence of land-use and extinction risk	PLOS ONE			English	Article							SPECIES RICHNESS; CONSERVATION PRIORITIES; PHYLOGENETIC DIVERSITY; MEGADIVERSE MEXICO; BODY-SIZE; WORLDS; PATTERNS; TRAITS; BIODIVERSITY; REDUNDANCY	Functional diversity represents a measure of diversity that incorporates the role of species in an ecosystem, and therefore its dynamics and resilience. Assessing its drivers and spatial variation represents an important step forward in our understanding of functional ecosystem dynamics and it is also necessary to achieve a comprehensive conservation planning. In this paper, we assessed mammal functional diversity for the 218 ecoregions within the Neotropical realm. We evaluated the overall influence and spatial variation of species richness, ecoregion extent, intervention and species at risk on functional diversity. Using ordinary least squares and geographically weighted regression modeling approaches, we found that intervened areas and threatened and non-threatened species are the most influential overall drivers of functional diversity. However, we also detected that these variables do not operate equally across scales. Our local analyses indicated both that the variation explained and local coefficients vary spatially depending on the ecoregion and major habitat type. As estimates of functional diversity are based on current distribution of all mammals, negative influence of intervened areas and positive influence of non-threatened species may reflect a potential degradation of functional processes for some ecosystems. Most generally, the negative influence of intervention together with the influence of threatened species indicates that some areas are currently more susceptible to functional diversity loss. Our results help to pinpoint key areas requiring urgent conservation action to reduce natural land-cover loss and areas where threatened species play influential roles on ecosystem functioning.	[Gonzalez-Maya, Jose F.; Medellin, Rodrigo; Ceballos, Gerardo] Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City, DF, Mexico; [Gonzalez-Maya, Jose F.] ProCAT Colombia, Proyecto Conservac Aguas & Tierras, Carrera 13 96-82,Of 205, Bogota, Colombia; [Martinez-Meyer, Enrique] Univ Nacl Autonoma Mexico, Inst Biol, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Gonzalez-Maya, JF (corresponding author), Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City, DF, Mexico.; Gonzalez-Maya, JF (corresponding author), ProCAT Colombia, Proyecto Conservac Aguas & Tierras, Carrera 13 96-82,Of 205, Bogota, Colombia.	jfgonzalezmaya@gmail.com	González-Maya, José F./B-6913-2011	González-Maya, José F./0000-0002-8942-5157; Martinez-Meyer, Enrique/0000-0003-1184-9264	National Council of Science and Technology (CONACyT) [255983]; UNAM [255983]	National Council of Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); UNAM(Universidad Nacional Autonoma de Mexico)	JFG-M acknowledges the scholarship and financial support provided by the National Council of Science and Technology (CONACyT), and UNAM (scholarship 255983); This paper is a partial fulfillment of the Graduate Doctoral Degree Program in Biomedical Sciences (Programa de Doctorado en Ciencias Biomedicas) of the National Autonomous University of Mexico (UNAM) of the first author. JFG-M acknowledges the scholarship and financial support provided by the National Council of Science and Technology (CONACyT; scholarship 255983), and UNAM. Thanks to J. Belant for continued support throughout the research and to the Jesus E. Maldonado and reviewers for insightful comments that significantly improved the manuscript. All data analyzed in this paper are available in the Supporting Information file.	Albuquerque F, 2015, J BIOGEOGRAPHY; Armsworth PR, 2007, CONSERV BIOL, V21, P1383, DOI 10.1111/j.1523-1739.2007.00821.x; Barragan F, 2011, PLOS ONE, V6; Belmaker J, 2013, AM NAT, V181, P464, DOI 10.1086/669906; Biswas SR, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00206.1; Biswas SR, 2010, ECOLOGY, V91, P28, DOI 10.1890/08-0887.1; Blaum N, 2011, BIODIVERS CONSERV, V20, P2333, DOI 10.1007/s10531-011-9995-1; Boitani L, 2011, PHILOS T R SOC B, V366, P2623, DOI 10.1098/rstb.2011.0117; Bonnot TW, 2011, BIOL CONSERV, V144, P2041, DOI 10.1016/j.biocon.2011.04.026; Brown JH, 2014, J BIOGEOGR, V41, P8, DOI 10.1111/jbi.12228; Brunsdon C, 1998, J ROY STAT SOC D-STA, V47, P431, DOI 10.1111/1467-9884.00145; Brunsdon C, 1996, GEOGR ANAL, V28, P281, DOI 10.1111/j.1538-4632.1996.tb00936.x; Buisson L, 2013, GLOBAL CHANGE BIOL, V19, P387, DOI 10.1111/gcb.12056; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Calba S, 2014, GLOBAL ECOL BIOGEOGR, V23, P669, DOI 10.1111/geb.12148; Cardoso P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021710; Casanoves F., 2011, CATIE, P119; Cattarino L, 2014, GLOBAL ECOL BIOGEOGR; Ceballos G, 2005, SCIENCE, V309, P603, DOI 10.1126/science.1114015; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Ceballos G, 1998, ECOL APPL, V8, P8, DOI 10.1890/1051-0761(1998)008[0008:ACPIMM]2.0.CO;2; Ceballos G, 2007, ECOL APPL, V17, P569, DOI 10.1890/06-0134; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; Davidson AD, 2009, P NATL ACAD SCI USA, V106, P10702, DOI 10.1073/pnas.0901956106; Dias ATC, 2013, J ECOL, V101, P29, DOI 10.1111/1365-2745.12024; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Diaz S, 2013, ECOL EVOL, V3, P2958, DOI 10.1002/ece3.601; Environmental Systems Research Institute, 2013, ARCGIS 10 2 1; ESA, 2009, GLOBCOVER 2009; Etter A, 2000, AMBIO, V29, P432, DOI 10.1639/0044-7447(2000)029[0432:POLTIC]2.0.CO;2; Farias AA, 2014, J MAMMALIAN EVOLUTIO; Fitzpatrick U, 2007, CONSERV BIOL, V21, P1324, DOI 10.1111/j.1523-1739.2007.00782.x; Flynn DFB, 2009, ECOL LETT, V12, P22, DOI 10.1111/j.1461-0248.2008.01255.x; Fonseca CR, 2001, J ECOL, V89, P118, DOI 10.1046/j.1365-2745.2001.00528.x; Fotheringham A.S., 2002, GEOGRAPHICALLY WEIGH; Franzen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037359; Freudenberger L, 2012, ECOL COMPLEX, V12, P13, DOI 10.1016/j.ecocom.2012.08.002; Gauthier P, 2010, BIOL CONSERV, V143, P1501, DOI 10.1016/j.biocon.2010.03.032; Gonzalez-Maya JF, 2016, ANIM BIODIV CONSERV, V39, P77, DOI 10.32800/abc.2016.39.0077; Gonzalez-Maya J F, 2015, CONSERVACION DIVESID; Gonzalez-Maya JF, 2016, DIVERS DISTRIB, V22, P43, DOI 10.1111/ddi.12373; Gonzalez-Maya Jose F., 2012, Revista Biodiversidad Neotropical, V2, P5; Gonzalez-Maya JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124480; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Hoffmann M, 2011, PHILOS T R SOC B, V366, P2598, DOI 10.1098/rstb.2011.0116; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Hutcheson G. D., 2011, SAGE DICT QUANTITATI, P224; IUCN, 2012, IUCN RED LIST THREAT; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Kaufman L., 2005, FINDING GROUPS DATA; Le Saout S, 2013, SCIENCE, V342, P803, DOI 10.1126/science.1239268; Lees AC, 2012, REV BRAS ORNITOL, V20, P93; Mason NWH, 2013, J VEG SCI, V24, P794, DOI 10.1111/jvs.12013; Mason NWH, 2005, OIKOS, V111, P112, DOI 10.1111/j.0030-1299.2005.13886.x; Menon S, 2001, CONSERV BIOL, V15, P501, DOI 10.1046/j.1523-1739.2001.015002501.x; Messier J, 2010, ECOL LETT, V13, P838, DOI 10.1111/j.1461-0248.2010.01476.x; Monnet AC, 2014, GLOBAL ECOL BIOGEOGR, V23, P780, DOI 10.1111/geb.12179; Mouchet MA, 2010, FUNCT ECOL, V24, P867, DOI 10.1111/j.1365-2435.2010.01695.x; Mouillot D, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001569; Newbold T, 2014, GLOBAL ECOL BIOGEOGR, V23, P1073, DOI 10.1111/geb.12186; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Pardo B., 2002, Computer Music Journal, V26, P27, DOI 10.1162/014892602760137167; Petchey OL, 2002, P ROY SOC B-BIOL SCI, V269, P1721, DOI 10.1098/rspb.2002.2073; Petchey OL, 2003, OIKOS, V101, P323, DOI 10.1034/j.1600-0706.2003.11828.x; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Peterson G, 1998, ECOSYSTEMS, V1, P6, DOI 10.1007/s100219900002; R team development core, 2008, R LANG ENV STAT COMP; Rondinini C, 2011, PHILOS T R SOC B, V366, P2591, DOI 10.1098/rstb.2011.0111; Rondinini C, 2011, PHILOS T R SOC B, V366, P2633, DOI 10.1098/rstb.2011.0113; Safi K, 2011, PHILOS T R SOC B, V366, P2536, DOI 10.1098/rstb.2011.0024; Sanchez-Cuervo AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043943; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Schmera D, 2009, OIKOS, V118, P961, DOI 10.1111/j.1600-0706.2009.17076.x; Smith FA, 2004, AM NAT, V163, P672, DOI 10.1086/382898; Smith FA, 2011, PHILOS T R SOC B, V366, P2364, DOI 10.1098/rstb.2011.0067; Spasojevic MJ, 2014, ECOGRAPHY; Stein A, 2014, ECOL LETT; Sundstrom SM, 2012, CONSERV BIOL, V26, P305, DOI 10.1111/j.1523-1739.2011.01822.x; Swenson NG, 2012, GLOBAL ECOL BIOGEOGR, V21, P798, DOI 10.1111/j.1466-8238.2011.00727.x; Visconti P, 2011, PHILOS T R SOC B, V366, P2693, DOI 10.1098/rstb.2011.0105; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Zar JH, 1974, BIOSTATISTICAL ANAL	84	24	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0175931	10.1371/journal.pone.0175931	http://dx.doi.org/10.1371/journal.pone.0175931			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441467	Green Submitted, Green Published, gold			2022-12-26	WOS:000400308800014
J	Lu, TT; Gu, M; Zhao, Y; Zheng, XY; Xing, CZ				Lu, Tingting; Gu, Ming; Zhao, Yan; Zheng, Xinyu; Xing, Chengzhong			Autophagy contributes to falcarindiol-induced cell death in breast cancer cells with enhanced endoplasmic reticulum stress	PLOS ONE			English	Article							POLYACETYLENES; IDENTIFICATION; CONSTITUENTS; PROTEINS; THERAPY; PATHWAY; ATG3	Falcarindiol (FAD) is a natural polyyne have been found in many food and dietary plants. It has been found to have various beneficial biological activities. In this study, we demonstrated its anticancer function and mechanism in breast cancer cells. We found that FAD preferentially induces cell death in breast cancer cells. FAD-induced cell death is caspase-dependent. However, FAD induces autophagy to contribute to the cell death. Blocking autophagy by either chemical inhibitors or genetic knockout of autophagy signaling component inhibits FAD-induced cell death. We further found that FAD-induced cell death is mediated by the induction of endoplasmic reticulum stress. We also identified that FAD has synergistic effect with approved cancer drugs 5-FU and Bortezomib in killing breast cancer cells. Summarily, these data demonstrate that FAD has strong and specific anticancer effect in breast cancer cells, and provide some insights about the roles of autophagy in FAD-induced cell death.	[Lu, Tingting; Xing, Chengzhong] China Med Univ, Hosp 1, Dept Anorectal Surg, Shenyang, Peoples R China; [Gu, Ming; Zhao, Yan; Zheng, Xinyu] China Med Univ, Hosp 1, Dept Breast Surg, Shenyang, Peoples R China	China Medical University; China Medical University	Xing, CZ (corresponding author), China Med Univ, Hosp 1, Dept Anorectal Surg, Shenyang, Peoples R China.; Zheng, XY (corresponding author), China Med Univ, Hosp 1, Dept Breast Surg, Shenyang, Peoples R China.	xyzheng001@gmail.com; xcz1966@126.com	Zheng, Xinyu/O-9847-2018	Zheng, Xinyu/0000-0001-8425-3379				Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Cragg GM, 2009, CHEM REV, V109, P3012, DOI 10.1021/cr900019j; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Espert L, 2006, J CLIN INVEST, V116, P2161, DOI 10.1172/JCI26185; Hait WN, 2009, CANCER RES, V69, P1263, DOI 10.1158/0008-5472.CAN-08-3836; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Jin HR, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.122; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liu Y, 2015, CELL DEATH DIFFER, V22, P367, DOI 10.1038/cdd.2014.143; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Metzger BT, 2008, J AGR FOOD CHEM, V56, P3554, DOI 10.1021/jf073494t; Minto RE, 2008, PROG LIPID RES, V47, P233, DOI 10.1016/j.plipres.2008.02.002; Ohnuma T, 2011, BIOL PHARM BULL, V34, P371, DOI 10.1248/bpb.34.371; Orlowski RZ, 2003, BREAST CANCER RES, V5, P1, DOI 10.1186/bcr460; Radoshevich L, 2010, CELL, V142, P590, DOI 10.1016/j.cell.2010.07.018; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shun ALKS, 2006, ANGEW CHEM INT EDIT, V45, P1034, DOI 10.1002/anie.200502071; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Stavri M, 2005, PHYTOTHER RES, V19, P938, DOI 10.1002/ptr.1758; Sun S, 2010, J ETHNOPHARMACOL, V132, P280, DOI 10.1016/j.jep.2010.08.026; Tasdemir Ezgi, 2008, V445, P29, DOI 10.1007/978-1-59745-157-4_3; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang CZ, 2013, PHYTOMEDICINE, V20, P999, DOI 10.1016/j.phymed.2013.04.013; Yamada Y, 2007, J BIOL CHEM, V282, P8036, DOI 10.1074/jbc.M611473200; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482	32	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176348	10.1371/journal.pone.0176348	http://dx.doi.org/10.1371/journal.pone.0176348			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441457	Green Published, gold, Green Submitted			2022-12-26	WOS:000400308800050
J	Tenenbaum, A; Nordeman, L; Sunnerhagen, KS; Gunnarsson, R				Tenenbaum, Artur; Nordeman, Lena; Sunnerhagen, Katharina S.; Gunnarsson, Ronny			Gender differences in care-seeking behavior and healthcare consumption immediately after whiplash trauma	PLOS ONE			English	Article							QUEBEC CLASSIFICATION; DISORDERS; ACCIDENTS; WOMEN; SYMPTOMS; DRIVERS; PROGRAM; RISK; PAIN	Objective The aim was to study gender differences in care-seeking behavior and treatment provided immediately after whiplash trauma. Methods Participants were residents from a defined geographical area, Skaraborg County in the southwestern part of Sweden. A cohort of 3,368 persons exposed to whiplash trauma and attending a healthcare facility immediately after the trauma between 1999 and 2008 were identified in a database. Information about gender, age, time elapsed prior to seeking care, type of healthcare contact, initial treatment provided and eventual hospitalization time was retrieved. Results Women sought care later than men (p = 0.00074). Women consulted primary healthcare first more often than men, who more often first sought hospital care (p = 0.0060). There were no gender differences regarding the type of treatment after trauma. Women had longer hospital admission than men (p = 0.022), indicating their injuries were at least similar to or worse than men's. Conclusion Women sought healthcare later than men after whiplash trauma. Although not directly investigated in this study, it raises the question if this may reduce their probability of getting financial compensation compared to men.	[Tenenbaum, Artur] Halsan & Arbetslivet, Occupat Hlth Care Unit, Gothenburg, Sweden; [Tenenbaum, Artur; Gunnarsson, Ronny] Univ Gothenburg, Sahlgrenska Acad, Dept Publ Hlth & Community Med, Inst Med, Gothenburg, Sweden; [Nordeman, Lena; Gunnarsson, Ronny] Res & Dev Ctr Sodra Alvsborg Narhalsan, Primary Hlth Care, Gothenburg, Sweden; [Nordeman, Lena] Univ Gothenburg, Unit Physiotherapy, Dept Hlth & Rehabil, Inst Neurosci & Physiol, Gothenburg, Sweden; [Sunnerhagen, Katharina S.] Univ Gothenburg, Inst Clin Neurosci Rehabil Med, Gothenburg, Sweden; [Gunnarsson, Ronny] James Cook Univ, Coll Med & Dent, Cairns Clin Sch, Cairns, Qld, Australia	University of Gothenburg; University of Gothenburg; University of Gothenburg; James Cook University	Tenenbaum, A (corresponding author), Halsan & Arbetslivet, Occupat Hlth Care Unit, Gothenburg, Sweden.; Tenenbaum, A (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Publ Hlth & Community Med, Inst Med, Gothenburg, Sweden.	artur.tenenbaum@vgregion.se	Sunnerhagen, Katharina Stibrant/AAE-2405-2020; Gunnarsson, Ronny/AAH-4811-2019	Sunnerhagen, Katharina Stibrant/0000-0002-5940-4400; Gunnarsson, Ronny/0000-0001-9183-3072; Tenenbaum, Artur/0000-0003-0907-8536				BARNSLEY L, 1994, PAIN, V58, P283, DOI 10.1016/0304-3959(94)90123-6; Bittner Vera, 2003, J Am Med Womens Assoc (1972), V58, P227; Blom G., 1958, STAT ESTIMATES TRANS; Borenstein P, 2010, ACTA NEUROL SCAND, V122, P278, DOI 10.1111/j.1600-0404.2009.01305.x; Burgess JA, 1996, J AM DENT ASSOC, V127, P1767, DOI 10.14219/jada.archive.1996.0138; Caulin-Glaser T, 2001, J Cardiopulm Rehabil, V21, P24, DOI 10.1097/00008483-200101000-00006; Connell R., 2002, GENDER SHORT INTRO P; Dobson A, 1999, ACCIDENT ANAL PREV, V31, P525, DOI 10.1016/S0001-4575(99)00009-3; Eck JC, 2001, AM J MED, V110, P651, DOI 10.1016/S0002-9343(01)00680-5; Falk B, 2007, TRANSPORT RES F-TRAF, V10, P414, DOI 10.1016/j.trf.2007.04.001; Friberg IO, 2016, SCAND J PUBLIC HEALT, V44, P264, DOI 10.1177/1403494815618843; Frontiereconomic, MOT INS COMP SYST FO; GALASKO CSB, 1993, INJURY, V24, P155, DOI 10.1016/0020-1383(93)90279-F; Galdas PM, 2005, J ADV NURS, V49, P616, DOI 10.1111/j.1365-2648.2004.03331.x; Hartling L, 2001, SPINE, V26, P36, DOI 10.1097/00007632-200101010-00008; Herrstrom P, 2000, SCAND J PRIM HEALTH, V18, P154; Holm LW, 2009, J MANIP PHYSIOL THER, V32, pS61, DOI 10.1016/j.jmpt.2008.11.011; Jansen GB, 2008, EUR SPINE J, V17; Jensen Troels Staehelin, 2010, Ugeskr Laeger, V172, P1812; Martin JL, 2008, INJURY PREV, V14, P185, DOI 10.1136/ip.2007.016600; Mellner C, 2006, INT J BEHAV MED, V13, P1, DOI 10.1207/s15327558ijbm1301_1; Nyberg F, 2008, INT J DERMATOL, V47, P144, DOI 10.1111/j.1365-4632.2008.03485.x; Parkosewich JA, 2008, CARDIOL REV, V16, P36, DOI 10.1097/CRD.0b013e31815aff8b; Petrea RE, 2009, STROKE, V40, P1032, DOI 10.1161/STROKEAHA.108.542894; Raine R, 2000, J Health Serv Res Policy, V5, P237; Richter M, 2000, EUR SPINE J, V9, P109, DOI 10.1007/s005860050220; Rosenfeld M, 2003, SPINE, V28, P2491, DOI 10.1097/01.BRS.0000090822.96814.13; SchenckGustafsson K, 2012, HANDBOOK OF CLINICAL GENDER MEDICINE, P1; Spitzer WO, 1995, SPINE S8, V20, P1, DOI DOI 10.1097/00007632-199504151-00001; Sterner Y, 2004, J REHABIL MED, V36, P193, DOI 10.1080/16501970410030742; Sterner Y, 2003, J SPINAL DISORD TECH, V16, P195, DOI 10.1097/00024720-200304000-00013; Sterner Y, 2001, DISABIL REHABIL, V23, P422; Tenenbaum A, 2002, J REHABIL MED, V34, P114, DOI 10.1080/165019702753714138; Tenenbaum A, 2015, ANN COMMUNITY MED PR, V1, P1003; The Australasian Faculty of Occupational Medicine, ROYAL AUSTR COLL PHY; Tjell C., 2002, J WHIPLASH RELAT DIS, V1, P9, DOI DOI 10.3109/J180V01N02_02; Vendrig AA, 2000, SPINE, V25, P238, DOI 10.1097/00007632-200001150-00016; Verhagen AP, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003338.pub3	38	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176328	10.1371/journal.pone.0176328	http://dx.doi.org/10.1371/journal.pone.0176328			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET5FE	28441465	Green Published, Green Accepted, gold			2022-12-26	WOS:000400308800047
J	Huang, HH; Chen, WC; Lin, CW; Lin, YT; Ning, HC; Chang, YC; Yang, TC				Huang, Hsin-Hui; Chen, Wei-Ching; Lin, Cheng-Wen; Lin, Yi-Tsung; Ning, Hsiao-Chen; Chang, Yi-Chih; Yang, Tsuey-Ching			Relationship of the CreBC two-component regulatory system and inner membrane protein CreD with swimming motility in Stenotrophomonas maltophilia	PLOS ONE			English	Article							BETA-LACTAMASE EXPRESSION; PSEUDOMONAS-AERUGINOSA; AEROMONAS-HYDROPHILA; GENE-EXPRESSION; INDUCTION; PATHOGEN; GROWTH; MOTOR; L1	The CreBC two-component system (TCS) is a conserved regulatory system found in Escherichia coli, Aeromonas spp., Pseudomonas aeruginosa, and Stenotrophomonas maltophilia. In this study, we determined how CreBC TCS regulates secreted protease activities and swimming motility using creB, creC, and creBC in-frame deletion mutants (KJ triangle CreB, KJ triangle CreC, and KJ triangle BC) of S. maltophilia KJ. Compared to wild-type KJ, KJ triangle CreB had a comparable secreted protease activity; however, the secreted protease activities were obviously reduced in KJ triangle CreC and KJ triangle BC, suggesting that CreC works together with another unidentified response regulator (not CreB) to regulate secreted protease activity. Single gene inactivation of creB or creC resulted in mutants with an enhanced swimming motility, and this phenotype was exacerbated in a double mutant KJ triangle BC. To elucidate the underlying mechanism responsible for the triangle creBC-mediated swimming enhancement, flagella morphology observation, RNA-seq based transcriptome assay, qRT-PCR, and membrane integrity and potential assessment were performed. Flagella morphological observation ruled out the possibility that swimming enhancement was due to altered flagella morphology. CreBC inactivation upregulated the expression of creD and flagella-associated genes encoding the basal body-and motor-associated proteins. Furthermore, KJ triangle BC had an increased membrane susceptibility to Triton X-100 and CreD upregulation in KJ triangle BC partially alleviated the compromise of membrane integrity. The impact of creBC TCS on bacterial membrane potential was assessed by carbonyl cyanide m-chlorophenyl hydrazine (CCCP50) concentration at which 50% of bacterial swimming is inhibited. CCCP50 of wildtype KJ increased when creBC was deleted, indicating an association between the higher membrane potential of KJ triangle BC cells and enhanced motility. Upregulation of the basal body- and motor-associated genes of flagella in KJ triangle BC cells may explain the increased	[Huang, Hsin-Hui; Chen, Wei-Ching; Yang, Tsuey-Ching] Natl Yang Ming Univ, Dept Biotechnol & Lab Sci Med, Taipei, Taiwan; [Chen, Wei-Ching] Super Lab Co Ltd, New Taipei, Taiwan; [Lin, Cheng-Wen; Chang, Yi-Chih] China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan; [Lin, Yi-Tsung] Taipei Vet Gen Hosp, Dept Med, Div Infect Dis, Taipei, Taiwan; [Lin, Yi-Tsung] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Ning, Hsiao-Chen] Chang Gung Mem Hosp, Dept Lab Med, Linkou Branch, Taoyuan, Taiwan; [Ning, Hsiao-Chen] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan	National Yang Ming Chiao Tung University; China Medical University Taiwan; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital; Chang Gung University	Yang, TC (corresponding author), Natl Yang Ming Univ, Dept Biotechnol & Lab Sci Med, Taipei, Taiwan.; Chang, YC (corresponding author), China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan.	yichih@mail.cmw.edu.tw; tcyang@ym.edu.tw			Ministry of Science and Technology of Taiwan [MOST 104-2320-B-010-023-MY3]; Professor Tsuei-Chu Mong Merit Scholarship [40419001]; High-throughput Genome and Big Data Analysis Core Facility of National Core Facility Program for Biotechnology, Taiwan [MOST 104-2319-B-010-001]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Professor Tsuei-Chu Mong Merit Scholarship; High-throughput Genome and Big Data Analysis Core Facility of National Core Facility Program for Biotechnology, Taiwan	This work was supported by grant MOST 104-2320-B-010-023-MY3 from Ministry of Science and Technology of Taiwan and grant 40419001 from Professor Tsuei-Chu Mong Merit Scholarship. The authors acknowledge the High-throughput Genome and Big Data Analysis Core Facility of National Core Facility Program for Biotechnology, Taiwan (MOST 104-2319-B-010-001), for sequencing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alksne LE, 1997, J BACTERIOL, V179, P2006, DOI 10.1128/jb.179.6.2006-2013.1997; Avison MB, 2001, J BIOL CHEM, V276, P26955, DOI 10.1074/jbc.M011186200; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Brooke JS, 2012, CLIN MICROBIOL REV, V25, P2, DOI 10.1128/CMR.00019-11; Chaban B, 2015, SEMIN CELL DEV BIOL, V46, P91, DOI 10.1016/j.semcdb.2015.10.032; Crossman LC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r74; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Hu RM, 2008, ANTIMICROB AGENTS CH, V52, P1198, DOI 10.1128/AAC.00682-07; Huang HH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145009; Huang YW, 2015, ANTIMICROB AGENTS CH, V59, P6866, DOI 10.1128/AAC.05179-14; Kanda E, 2011, MOL GENET GENOMICS, V285, P163, DOI 10.1007/s00438-010-0594-8; Khajanchi BK, 2012, MICROBIOL-SGM, V158, P259, DOI 10.1099/mic.0.051805-0; Kim JS, 2014, PLANT PATHOLOGY J, V30, P215, DOI 10.5423/PPJ.NT.11.2013.0109; Krell T, 2010, ANNU REV MICROBIOL, V64, P539, DOI 10.1146/annurev.micro.112408.134054; Li XZ, 2002, ANTIMICROB AGENTS CH, V46, P333, DOI 10.1128/AAC.46.2.333-343.2002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez-Granero F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031765; Merry CR, 2015, CURR MICROBIOL, V70, P556, DOI 10.1007/s00284-014-0744-z; Morimoto YV, 2014, BIOMOLECULES, V4, P217, DOI 10.3390/biom4010217; Moya B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000353; Murray TS, 2006, J BACTERIOL, V188, P6995, DOI 10.1128/JB.00790-06; Niumsup P, 2003, J ANTIMICROB CHEMOTH, V51, P1351, DOI 10.1093/jac/dkg247; Ottemann KM, 1997, MOL MICROBIOL, V24, P1109, DOI 10.1046/j.1365-2958.1997.4281787.x; Rott P, 2013, MICROBIOL-SGM, V159, P1149, DOI 10.1099/mic.0.065748-0; Tayler AE, 2010, MICROBIOL-SGM, V156, P2327, DOI 10.1099/mic.0.035220-0; Terashima H, 2008, INT REV CEL MOL BIO, V270, P39, DOI 10.1016/S1937-6448(08)01402-0; Toutain CM, 2005, J BACTERIOL, V187, P771, DOI 10.1128/JB.187.2.771-777.2005; Wu CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160943; Yang TC, 2009, ANTIMICROB AGENTS CH, V53, P2902, DOI 10.1128/AAC.01513-08; Zamorano L, 2014, ANTIMICROB AGENTS CH, V58, P5084, DOI 10.1128/AAC.02556-14; Zheng L, 2016, APPL ENVIRON MICROB, V82, P2444, DOI 10.1128/AEM.03951-15	31	7	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0174704	10.1371/journal.pone.0174704	http://dx.doi.org/10.1371/journal.pone.0174704			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437463	Green Submitted, Green Published, gold			2022-12-26	WOS:000400287600003
J	Inglese, M; Petracca, M; Mormina, E; Achiron, A; Straus-Farber, R; Miron, S; Fabian, M; Krieger, S; Miller, A; Lublin, F; Sormani, MP				Inglese, Matilde; Petracca, Maria; Mormina, Enricomaria; Achiron, Anat; Straus-Farber, Rebecca; Miron, Shmuel; Fabian, Michelle; Krieger, Stephen; Miller, Aaron; Lublin, Fred; Sormani, Maria Pia			Cerebellar volume as imaging outcome in progressive multiple sclerosis	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; GRAY-MATTER ATROPHY; CORTICAL PATHOLOGY; CEREBRAL-CORTEX; DEMYELINATION; INFLAMMATION; EXTENT; DAMAGE	Background and purpose To assess whether cerebellar volumes changes could represent a sensitive outcome measure in primary-progressive MS. Material and methods Changes in cerebellar volumes over one-year follow-up, estimated in 26 primary-progressive MS patients and 20 controls with Freesurfer longitudinal pipeline, were assessed using Wilcoxon test and tested for their correlation with disability worsening by a logistic regression. Clinical worsening was defined as EDSS score increase or change of >20% for 25-foot walk test or 9-hole peg test scores at follow-up. Sample sizes for given treatment effects and power were calculated. The findings were validated in an independent cohort of 20 primary-progressive MS patients. Results Significant changes were detected in brain T1 lesion volume (p<0.01), cerebellar T2 and T1 lesion volume (p<0.01 and p<0.05), cerebellar volume, cerebellar cortex volume, and cerebellar WM volume (p<0.001). Only cerebellar volume and cerebellar cortex volume percentage change were significantly reduced in clinically progressed patients when compared to patients who did not progress (p<0.01; respectively AUC of 0.91 and 0.96). Cerebellar volume percentage changes were consistent in the exploration and validation cohorts (cerebellar volume -1.90 +/- 1.11% vs -1.47 +/- 2.30%; cerebellar cortex volume -1.68 +/- 1.41% vs -1.56 +/- 2.23%). Based on our results the numbers of patients required to detect a 30% effect are 81 per arm for cerebellar volume and 162 per arm for cerebellar cortex volume (90% power, type 1 error alpha = 0.05). Conclusions Our results suggest a role for cerebellar cortex volume and cerebellar volume as potential short-term imaging metrics to monitor treatment effect in primary-progressive MS clinical trials.	[Inglese, Matilde; Petracca, Maria; Mormina, Enricomaria; Fabian, Michelle; Krieger, Stephen; Miller, Aaron; Lublin, Fred] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Inglese, Matilde] Icahn Sch Med Mt Sinai, Dept Radiol, New York, NY 10029 USA; [Inglese, Matilde] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Inglese, Matilde] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet & Mother C, Genoa, Italy; [Inglese, Matilde] IRCCS Azienda Osped Univ San Martino IST, Genoa, Italy; [Mormina, Enricomaria] Univ Messina, Dept Biomed Sci & Morphol & Funct Images, Messina, Italy; [Achiron, Anat; Miron, Shmuel] Sheba Med Ctr, Multiple Sclerosis Ctr, Tel Hashomer, Israel; [Achiron, Anat] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Straus-Farber, Rebecca] Columbia Univ, Dept Neurol, New York, NY USA; [Sormani, Maria Pia] Univ Genoa, Biostat Unit, Genoa, Italy	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Genoa; University of Genoa; IRCCS AOU San Martino IST; University of Messina; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Columbia University; University of Genoa	Inglese, M (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA.; Inglese, M (corresponding author), Icahn Sch Med Mt Sinai, Dept Radiol, New York, NY 10029 USA.; Inglese, M (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA.; Inglese, M (corresponding author), Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet & Mother C, Genoa, Italy.; Inglese, M (corresponding author), IRCCS Azienda Osped Univ San Martino IST, Genoa, Italy.	matilde.inglese@mssm.edu	Mormina, Enricomaria/K-4664-2016; Sormani, Maria Pia/ABH-8756-2020; Inglese, Matilde/AAH-3189-2020; Petracca, Maria/AAB-8562-2019; Lublin, Fred/L-8405-2017	Mormina, Enricomaria/0000-0003-2716-5772; Inglese, Matilde/0000-0002-9610-0297; Petracca, Maria/0000-0001-9429-2769; SORMANI, MARIA PIA/0000-0001-6892-104X	Novartis Pharmaceuticals [CFTY2ODUSNC15T]; National Multiple Sclerosis Society [NMSS RG 5120A3/1]; Noto Foundation; research fellowship from Fondazione Italiana Sclerosi Multipla [2013/13/7]	Novartis Pharmaceuticals(Novartis); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Noto Foundation; research fellowship from Fondazione Italiana Sclerosi Multipla	This study was supported in part by Novartis Pharmaceuticals (CFTY2ODUSNC15T), National Multiple Sclerosis Society (NMSS RG 5120A3/1), and the Noto Foundation to MI and by a research fellowship from Fondazione Italiana Sclerosi Multipla (2013/13/7) to MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson VM, 2011, MULT SCLER J, V17, P1079, DOI 10.1177/1352458511403528; Anderson VM, 2009, MULT SCLER, V15, P811, DOI 10.1177/1352458508101934; Bogovic JA, 2013, NEUROIMAGE, V64, P616, DOI 10.1016/j.neuroimage.2012.08.075; Calabrese M, 2015, PLOS ONE, V10, P1; Calabrese M, 2010, J NEUROL NEUROSUR PS, V81, P401, DOI 10.1136/jnnp.2009.177733; Ceccarelli A, 2009, HUM BRAIN MAPP, V30, P3009, DOI 10.1002/hbm.20725; Choi SR, 2012, BRAIN, V135, P2925, DOI 10.1093/brain/aws189; Eshaghi A, 2014, NEUROIMAGE, V86, P257, DOI 10.1016/j.neuroimage.2013.09.059; Favata A, 2016, MULT SCLER J, P1; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Ghassemi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085741; Gilmore CP, 2009, J NEUROL NEUROSUR PS, V80, P182, DOI 10.1136/jnnp.2008.148767; Howell OW, 2015, NEUROPATH APPL NEURO, V41, P798, DOI 10.1111/nan.12199; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Kutzelnigg A, 2007, BRAIN PATHOL, V17, P38, DOI 10.1111/j.1750-3639.2006.00041.x; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Mainero C, 2015, BRAIN, V138, P932, DOI 10.1093/brain/awv011; Mesaros S, 2008, ARCH NEUROL-CHICAGO, V65, P1223, DOI 10.1001/archneur.65.9.1223; MILLER DH, 1991, J NEUROL NEUROSUR PS, V54, P683, DOI 10.1136/jnnp.54.8.683; Ontaneda D, 2015, LANCET NEUROL, V14, P208, DOI 10.1016/S1474-4422(14)70264-9; Park MTM, 2014, NEUROIMAGE, V95, P217, DOI 10.1016/j.neuroimage.2014.03.037; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Ramasamy DP, 2009, J NEUROL SCI, V282, P47, DOI 10.1016/j.jns.2008.12.034; Redondo J, 2015, BRAIN PATHOL, V25, P692, DOI 10.1111/bpa.12230; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Rodrigues KD, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00021; Sepulcre J, 2006, ARCH NEUROL-CHICAGO, V63, P1175, DOI 10.1001/archneur.63.8.1175; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Weier K, 2014, PLOS ONE, P9; Weier K, 2014, HUM BRAIN MAPP, V35, P5026, DOI 10.1002/hbm.22529	30	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176519	10.1371/journal.pone.0176519	http://dx.doi.org/10.1371/journal.pone.0176519			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437430	Green Published, gold			2022-12-26	WOS:000400287600052
J	Lv, PF; Zhuang, Y; Deng, J; Su, W				Lv, Pengfei; Zhuang, Yuan; Deng, Jian; Su, Wei			Study on lockage safety of LNG-fueled ships based on FSA	PLOS ONE			English	Article							GAS	In the present study, formal safety assessment (FSA) is introduced to investigate lockage safety of LNG-fueled ships. Risk sources during lockage of LNG-fueled ships in four typical scenarios, namely, navigation between two dams, lockage, anchorage, and fueling, are identified, and studied in combination with fundamental leakage probabilities of various components of LNG storage tanks, and simulation results of accident consequences. Some suggestions for lockage safety management of LNG-fueled ships are then proposed. The present research results have certain practical significance for promoting applications of LNG-fueled ships along Chuanjiang River and in Three Gorges Reservoir Region.	[Lv, Pengfei; Zhuang, Yuan; Deng, Jian; Su, Wei] Wuhan Univ Technol, Sch Nav, Wuhan, Hubei, Peoples R China	Wuhan University of Technology	Su, W (corresponding author), Wuhan Univ Technol, Sch Nav, Wuhan, Hubei, Peoples R China.	suweihyxy@whut.edu.cn			National Science and Technology Support Program [2015BAG20B01]	National Science and Technology Support Program	This study was supported by the National Science and Technology Support Program (2015BAG20B01), received by JD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2014, J MAR SCI TECH-JAPAN, V19, P470, DOI 10.1007/s00773-014-0262-5; American Bureau of Shipping (ABS), 2011, GUID PROP AUX SYST G; Andersen M.-L., 2011, COSTS BENEFITS LNG S; [Anonymous], 2012, RISK ASSESSMENT CONS; Busini V, 2012, IND ENG CHEM RES, V51, P7643, DOI 10.1021/ie201591b; Casal J., 2013, J HAZARD MATER, P181; Casal J., 2013, J HAZARD MATER, P246; Fang QG, 2004, FSA ITS APPL SAFETY; Gavelli F, 2010, J HAZARD MATER, V180, P332, DOI 10.1016/j.jhazmat.2010.04.035; IMO, 2006, IGC COD INT COD CONS; Komal, 2015, J NAT GAS SCI ENG, V23, P148, DOI 10.1016/j.jngse.2015.01.030; Lee S, 2015, J NAT GAS SCI ENG, V27, P1788, DOI 10.1016/j.jngse.2015.11.003; National Development and Reform Commission of PRC, 2008, RISK BAS INSP BAS RE; Nwaoha TC, 2011, P I MECH ENG E-J PRO, V225, P40, DOI 10.1243/09544089JPME336; Qi RF, 2010, J HAZARD MATER, V183, P51, DOI 10.1016/j.jhazmat.2010.06.090; Qiu L., 2014, TRAFFIC INFORM SECUR, V32, P110, DOI [10.3963/j.issn.1674-4861.2014.03.022, DOI 10.3963/J.ISSN.1674-4861.2014.03.022.]; SINTEF, 2002, HDB PREP SINTEF TECH; Skjong R., 2005, D452 SAFEFOR; Song S., 2011, FSA METHODOLOGY ITS; State Administration of Work Safety, 2015, PROV RUL SUP MAN MAJ; Tarek Elsayed, 2013, SHIPS OFFSHORE STRUC, V1, P1; [王大庆 Wang Daqing], 2014, [中国安全科学学报, China Safety Science Journal（CSSJ）], V24, P96; Wang J, 2001, SAFETY SCI, V38, P19, DOI 10.1016/S0925-7535(00)00052-7; Wang SY, 2014, TRANSPORT REV, V34, P749, DOI 10.1080/01441647.2014.981884; Yu W., 2013, RES APPL RISK ASSESS; Zhang Q., 2014, QUANTITATIVE EVALUAT	26	4	4	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0174448	10.1371/journal.pone.0174448	http://dx.doi.org/10.1371/journal.pone.0174448			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437482	gold, Green Published, Green Submitted			2022-12-26	WOS:000400287600002
J	Oh, J; Lee, S; Lee, H; Cho, JY; Yoon, SH; Jang, IJ; Yu, KS; Lim, KS				Oh, Jaeseong; Lee, SeungHwan; Lee, Howard; Cho, Joo-Youn; Yoon, Seo Hyun; Jang, In-Jin; Yu, Kyung-Sang; Lim, Kyoung Soo			The novel carboxylesterase 1 variant c.662A>G may decrease the bioactivation of oseltamivir in humans	PLOS ONE			English	Article							SINGLE NUCLEOTIDE VARIATION; CATALYTIC-PROPERTIES; PRODRUG OSELTAMIVIR; PHARMACOKINETICS; METABOLISM; CARBOXYLATE; CLOPIDOGREL; ACTIVATION; INFLUENZA; ISOZYMES	Background Human carboxylesterase 1 (CES1) is a serine esterase that hydrolyses various exogenous and endogenous compounds including oseltamivir, a prodrug used to treat influenza. A novel CES1 c.662A>G single nucleotide polymorphism (SNP) was predicted to decrease CES1 enzymatic activity in an in silico analysis. This study evaluated the effect of the c.662A>G SNP on the pharmacokinetics (PK) of oseltamivir in humans. Methods A single oral dose of oseltamivir at 75 mg was administered to 20 healthy subjects, 8 heterozygous c.662A>G carriers (c.662AG) and 12 non-carriers (c.662AA). The concentrations of oseltamivir and its active metabolite, oseltamivir carboxylate, were measured in plasma and urine using a validated liquid chromatography-tandem mass spectrometry (LC-MS/MS) method. The PK parameters were calculated using a noncompartmental method. The geometric mean ratios (GMR, c.662AG to c.662AA) of the PK parameters and their 90% confidence intervals (CI) were calculated. Results The systemic exposure to oseltamivir, as assessed by the AUC(0-48h) of oseltamivir, was increased by 10% in c.662AG subjects, whereas the AUC(0-48h) of oseltamivir carboxylate was 5% lower in c.662AG subjects. The GMR and 90% CI of the metabolic ratio (AUC(0-48h),(Oseltamivir carboxylate)/AUC(0-48h,Oseltamivir)) was 0.87 (0.66-1.14). The amount of unchanged oseltamivir excreted in the urine was increased by 15% in subjects with the c.662AG genotype. Conclusions This result suggests that CES1 enzymatic activity may be decreased in these heterozygous allele carriers, although further studies are warranted to investigate the clinical implications of this genetic variation on CES1 substrate drugs.	[Oh, Jaeseong; Lee, SeungHwan; Lee, Howard; Cho, Joo-Youn; Yoon, Seo Hyun; Jang, In-Jin; Yu, Kyung-Sang] Seoul Natl Univ, Coll Med & Hosp, Dept Clin Pharmacol & Therapeut, Seoul, South Korea; [Lee, Howard] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Transdisciplinary Studies, Seoul, South Korea; [Lim, Kyoung Soo] CHA Univ, Sch Med, Dept Clin Pharmacol & Therapeut, Seongnam, South Korea; [Lim, Kyoung Soo] CHA Bundang Med Ctr, Seongnam, South Korea	Seoul National University (SNU); Seoul National University (SNU); Pochon Cha University	Lim, KS (corresponding author), CHA Univ, Sch Med, Dept Clin Pharmacol & Therapeut, Seongnam, South Korea.; Lim, KS (corresponding author), CHA Bundang Med Ctr, Seongnam, South Korea.	dr.kyoungsoo.lim@gmail.com	Cho, Joo-Youn/J-5672-2012; Cho, Joo-Youn/ABC-2044-2021	Cho, Joo-Youn/0000-0001-9270-8273; Cho, Joo-Youn/0000-0001-9270-8273; Oh, Jaeseong/0000-0001-6275-8587	Basic Science Research Program through the National Research Foundation, Republic of Korea [NRF-2012R1A1A2000823]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C2750]	Basic Science Research Program through the National Research Foundation, Republic of Korea; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This study was supported by a research grant from the Basic Science Research Program through the National Research Foundation [Grant NRF-2012R1A1A2000823], Republic of Korea (www.nrf.re.kr/). This study was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) [Grant HI14C2750], funded by the Ministry of Health & Welfare, Republic of Korea (http://www.khidi.or.kr/eps).	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alam M, 2002, BIOCHEMISTRY-US, V41, P6679, DOI 10.1021/bi0255625; Beaumont K, 2003, CURR DRUG METAB, V4, P461, DOI 10.2174/1389200033489253; Bencharit S, 2003, NAT STRUCT BIOL, V10, P349, DOI 10.1038/nsb919; Cha Yu-Jung, 2014, Translational and Clinical Pharmacology, V22, P30; Davies BE, 2010, J ANTIMICROB CHEMOTH, V65, pII5, DOI 10.1093/jac/dkq015; Gabrielsson Johan, 2012, Methods Mol Biol, V929, P377; Hayden FG, 1999, JAMA-J AM MED ASSOC, V282, P1240, DOI 10.1001/jama.282.13.1240; He G, 1999, CLIN PHARMACOKINET, V37, P471, DOI 10.2165/00003088-199937060-00003; Hosokawa M, 2008, MOLECULES, V13, P412, DOI 10.3390/molecules13020412; Imai T, 2006, DRUG METAB PHARMACOK, V21, P173, DOI 10.2133/dmpk.21.173; Izumi Y, 2007, NEUROSCI LETT, V426, P54, DOI 10.1016/j.neulet.2007.08.054; Jhee SS, 2008, ANTIMICROB AGENTS CH, V52, P3687, DOI 10.1128/AAC.00327-08; Laizure SC, 2003, DRUG METAB DISPOS, V31, P16, DOI 10.1124/dmd.31.1.16; Lewis JP, 2013, PHARMACOGENET GENOM, V23, P1, DOI 10.1097/FPC.0b013e32835aa8a2; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Nemoda Z, 2009, NEUROPHARMACOLOGY, V57, P731, DOI 10.1016/j.neuropharm.2009.08.014; Ohura K, 2014, DRUG METAB DISPOS, V42, P264, DOI 10.1124/dmd.113.054551; Redinbo MR, 2003, BIOCHEM SOC T, V31, P620, DOI 10.1042/BST0310620; Rowland M, 2011, CLIN PHARMACOKINETIC; Sai K, 2010, BRIT J CLIN PHARMACO, V70, P222, DOI 10.1111/j.1365-2125.2010.03695.x; SHAND DG, 1970, CLIN PHARMACOL THER, V11, P112; Standing JF, 2012, ANTIMICROB AGENTS CH, V56, P3833, DOI 10.1128/AAC.00290-12; Sun ZJ, 2004, J PHARMACOL EXP THER, V310, P469, DOI 10.1124/jpet.104.067116; Suzaki Y, 2013, EUR J CLIN PHARMACOL, V69, P21, DOI 10.1007/s00228-012-1315-5; Tarkiainen EK, 2015, CLIN PHARMACOL THER, V97, P650, DOI 10.1002/cpt.101; Tarkiainen EK, 2012, CLIN PHARMACOL THER, V92, P68, DOI 10.1038/clpt.2012.13; Tarkiainen EK, 2015, BRIT J CLIN PHARMACO, V80, P1131, DOI 10.1111/bcp.12667; Vistoli G, 2010, BIOORGAN MED CHEM, V18, P320, DOI 10.1016/j.bmc.2009.10.052; Zhu HJ, 2008, AM J HUM GENET, V82, P1241, DOI 10.1016/j.ajhg.2008.04.015; Zhu HJ, 2013, J PHARMACOL EXP THER, V344, P665, DOI 10.1124/jpet.112.201640; Zhu HJ, 2009, DRUG METAB DISPOS, V37, P1819, DOI 10.1124/dmd.109.028209; Zhu HJ, 2009, DRUG METAB DISPOS, V37, P264, DOI 10.1124/dmd.108.024943	34	14	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176320	10.1371/journal.pone.0176320	http://dx.doi.org/10.1371/journal.pone.0176320			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437488	gold, Green Submitted, Green Published			2022-12-26	WOS:000400287600042
J	Frostegard, J; Su, J; Sing, S; Hua, X; Vikstrom, M; Leander, K; Gigante, B; de Faire, U; Frostegard, AG				Frostegard, Johan; Su, Jun; Sing, Sudhir; Hua, Xiang; Vikstrom, Max; Leander, Karin; Gigante, Bruna; de Faire, Ulf; Frostegard, Anna G.			IgM antibodies to oxidized phosphatidylserine as protection markers in cardiovascular disease among 60-year olds	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; ATHEROSCLEROTIC PLAQUES; RISK-FACTORS; CELLS; EXTERNALIZATION; CLEARANCE; APOPTOSIS; PHOSPHORYLCHOLINE; CARDIOLIPIN; PREVALENCE	Objective Phosphatidylserine is exposed on apoptotic cells and is prone to oxidation (OxPS). Here we analyze the association of IgM antibodies against OxPS (anti-OxPS) with the risk of cardiovascular disease (CVD). Methods Among sixty-year olds from Stockholm County in Sweden, previously screened for cardiovascular risk factors (2039 men, 2193 women), there were 210 incident CVD-cases identified during a 5-year follow-up. Using a nested case-control design, 622 age-and sex-matched controls were selected. Odds ratios (OR) with 95% intervals (CI) were calculated by conditional logistic regression. IgM anti-OxPS was measured by ELISA. Phagocytosis of apoptotic Jurkat-cells by macrophages was studied by flow cytometry. Results Anti-OxPS levels were lower among cases (median (interquartile range): 80.7 (60.9-101.0 vs. 84.6 (65.8-109.6); p = 0.047); among men (76.6 (55.8-99.2) vs. 82.0 (63.1-105.1); p = 0.022) and among women 89.6 (72.3-110.1) vs. 89.8 (69.9-114.4); p = 0.79). After adjustment for smoking, BMI, diabetes mellitus type II, hypercholesterolaemia and hypertension, and dividing into quartiles, using the highest quartile (quartile 4) as reference, quartile 3 was associated with a OR of 1.74 (CI 1.08-2.81). Quartiles 2 and 1 had similar associations, the later reaching statistical significance. Among men associations were stronger whereas no significant associations were observed in women. The OR of MI/angina comparing quartile 3 with quartile 4 was 2.31 (CI 1.30-4.11). The OR for quartile 2 and 1, respectively, were similar as for quartile 3. Total IgM increased uptake of apoptotic cells, which was reversed if incubated with OxPS. Conclusions IgM anti-OxPS is a novel potential protection marker for CVD, in particular in men. Increased phagocytosis of dying/dead cells could be one potential underlying mechanism.	[Frostegard, Johan; Su, Jun; Sing, Sudhir; Hua, Xiang; Frostegard, Anna G.] Karolinska Inst, Unit Immunol & Chron Dis, Inst Environm Med, Stockholm, Sweden; [Frostegard, Johan] Karolinska Univ Hosp, Dept Emergency Med, Stockholm, Sweden; [Vikstrom, Max; Leander, Karin; Gigante, Bruna; de Faire, Ulf] Karolinska Inst, Unit Cardiovasc Epidemiol, Inst Environm Med, Stockholm, Sweden; [Gigante, Bruna] Danderyd Hosp, Dept Cardiovasc Clin Sci, Stockholm, Sweden; [de Faire, Ulf] Karolinska Univ Hosp, Dept Cardiol, Solna, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Danderyds Hospital; Karolinska Institutet; Karolinska University Hospital	Frostegard, J (corresponding author), Karolinska Inst, Unit Immunol & Chron Dis, Inst Environm Med, Stockholm, Sweden.; Frostegard, J (corresponding author), Karolinska Univ Hosp, Dept Emergency Med, Stockholm, Sweden.	johan.frostegard@ki.se	Gigante, Bruna/I-9252-2012; Leander, Karin/C-7261-2017	Leander, Karin/0000-0002-1404-9222; Gigante, Bruna/0000-0003-4508-7990	HjaErt-Lungfonden [20150622]; Reumatikerforbundet [66081]; Swedish Heart Lung Foundation [20150622]; Swedish Association against Rheumatism [66081]	HjaErt-Lungfonden; Reumatikerforbundet; Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Swedish Association against Rheumatism	This study was funded by grant number 20150622 from Hjart-Lungfonden and grant number 66081 from Reumatikerforbundet to Prof. Johan Frostegard. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by by grants to JF: the Swedish Heart Lung Foundation grant number 20150622; https://www.hjart-lungfonden.se), Swedish Association against Rheumatism grant number 66081; https://www.reumatikerforbundet.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anania C, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3193; Arroyo A, 2002, J BIOL CHEM, V277, P49965, DOI 10.1074/jbc.M204513200; Carlsson AC, 2008, AM J HYPERTENS, V21, P771, DOI 10.1038/ajh.2008.167; de Faire U, 2010, J AUTOIMMUN, V34, P73, DOI 10.1016/j.jaut.2009.05.003; Fabisiak J. P., 2005, METHOD MOL BIOL, V291; Fiskesund R, 2010, STROKE, V41, P607, DOI 10.1161/STROKEAHA.109.558742; Frostegard AG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111764; Frostegard J, 1999, ATHEROSCLEROSIS, V145, P33, DOI 10.1016/S0021-9150(99)00011-8; Frostegard J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-117; Frostegard J, 2010, CLIN IMMUNOL, V134, P47, DOI 10.1016/j.clim.2009.08.013; Greenberg ME, 2006, J EXP MED, V203, P2613, DOI 10.1084/jem.20060370; Halldin M, 2007, NUTR METAB CARDIOVAS, V17, P349, DOI 10.1016/j.numecd.2006.01.002; Jiang JF, 2004, LIPIDS, V39, P1133, DOI 10.1007/s11745-004-1340-1; Jitkaew S, 2009, J LEUKOCYTE BIOL, V85, P427, DOI 10.1189/jlb.0408232; Kagan VE, 2002, J IMMUNOL, V169, P487, DOI 10.4049/jimmunol.169.1.487; Kaptoge S, 2014, EUR HEART J, V35, P578, DOI 10.1093/eurheartj/eht367; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Ridker PM, 2001, JAMA-J AM MED ASSOC, V285, P2481, DOI 10.1001/jama.285.19.2481; Silvestre-Roig C, 2014, CIRC RES, V114, P214, DOI 10.1161/CIRCRESAHA.114.302355; Sjoberg BG, 2009, ATHEROSCLEROSIS, V203, P528, DOI 10.1016/j.atherosclerosis.2008.07.009; Su J, 2008, RHEUMATOLOGY, V47, P1144, DOI 10.1093/rheumatology/ken120; Su J, 2013, J RHEUMATOL; Su J, 2013, J RHEUMATOL, V40, P1856, DOI 10.3899/jrheum.121173; Su J, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-1; Tyurin VA, 2012, BIOCHEMISTRY-US, V51, P9736, DOI 10.1021/bi301024e; Zalewski A, 2006, CLIN CHEM, V52, P1645, DOI 10.1373/clinchem.2006.070672	27	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0171195	10.1371/journal.pone.0171195	http://dx.doi.org/10.1371/journal.pone.0171195			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430795	Green Submitted, Green Published, gold			2022-12-26	WOS:000399876100002
J	Hsu, YH; Yang, YY; Huwang, MH; Weng, YH; Jou, IM; Wu, PT; Lin, TY; Wu, LW; Chang, MS				Hsu, Yu-Hsiang; Yang, Ya-Yu; Huwang, Man-Hsiang; Weng, Yun-Han; Jou, I-Ming; Wu, Po-Tin; Lin, Tain-Yu; Wu, Li-Wha; Chang, Ming-Shi			Anti-IL-20 monoclonal antibody inhibited inflammation and protected against cartilage destruction in murine models of osteoarthritis	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; NECROSIS-FACTOR-ALPHA; EXPERIMENTAL ARTHRITIS; RHEUMATOID-ARTHRITIS; GENE-EXPRESSION; II COLLAGEN; IL-20; INTERLEUKIN-20; CHONDROCYTES; DISEASE	Osteoarthritis (OA) is a degenerative joint disease characterized by progressive destruction of articular cartilage. Interleukin (IL)-20 is a proinflammatory cytokine involved in the pathogenesis of rheumatoid arthritis. We investigated the role of IL-20 in OA and evaluated whether anti-IL-20 antibody (7E) treatment attenuates disease severity in murine models of surgery-induced OA. Immunohistochemical staining was used to detect IL-20 and its receptors expression in synovial tissue and cartilage from OA patients, and in OA synovial fibroblasts (OASFs) and chondrocytes (OACCs) from rodents with surgery-induced OA. RTQ-PCR and western blotting were used to determine IL-20-regulated OA-associated gene expression in OASFs and OACCs. OA rats and OA mice were treated with 7E. Arthritis severity was determined based on the degree of cartilage damage and the arthritis severity score. We found that IL-20 and its receptors were expressed in OASFs and OACCs. IL-20 induced TNF-alpha, IL-1 beta, MMP-1, and MMP-13 expression by activating ERK-1/2 and JNK signals in OASFs. IL-20 not only upregulated MCP-1, IL-6, MMP-1, and MMP-13 expression, but also downregulated aggrecan, type 2 collagen, TGF-beta, and BMP-2 expression in OACCs. Arthritis severity was significantly lower in 7E-treated OA rats, and 7E- or MSC-treated OA mice. Therefore, we concluded that IL-20 was involved in the progression and development of OA through inducing proinflammatory cytokines and OA-associated gene expression in OASFs and OACCs. 7E reduced the severity of arthritis in murine models of surgery-induced OA. Our findings provide evidence that IL-20 is a novel target and that 7E is a potential therapeutic agent for OA.	[Hsu, Yu-Hsiang; Lin, Tain-Yu] Natl Cheng Kung Univ, Coll Med, Inst Clin Med, Tainan, Taiwan; [Hsu, Yu-Hsiang] Natl Cheng Kung Univ Hosp, Res Ctr Clin Med, Tainan, Taiwan; [Hsu, Yu-Hsiang; Weng, Yun-Han; Chang, Ming-Shi] Natl Cheng Kung Univ, Res Ctr New Antibody Drug, Tainan, Taiwan; [Yang, Ya-Yu; Huwang, Man-Hsiang; Weng, Yun-Han; Chang, Ming-Shi] Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan, Taiwan; [Jou, I-Ming; Wu, Po-Tin] Natl Cheng Kung Univ Hosp, Dept Orthoped, Tainan, Taiwan; [Wu, Li-Wha] Natl Cheng Kung Univ, Inst Mol Med, Coll Med, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University	Chang, MS (corresponding author), Natl Cheng Kung Univ, Res Ctr New Antibody Drug, Tainan, Taiwan.; Chang, MS (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan, Taiwan.	mschang@mail.ncku.edu.tw	Wu, Li-Wha/AAH-7768-2021	Wu, Li-Wha/0000-0001-7010-6220	Ministry of Science and Technology of Taiwan [104-2311-B-006-007-MY2]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Ministry of Science and Technology of Taiwan (104-2311-B-006-007-MY2) (https://www.most.gov.tw). The funders had no role in study design,data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Barna M, 2007, DEV CELL, V12, P931, DOI 10.1016/j.devcel.2007.04.016; Berenbaum F, 2013, OSTEOARTHR CARTILAGE, V21, P16, DOI 10.1016/j.joca.2012.11.012; Blagojevic M, 2010, OSTEOARTHR CARTILAGE, V18, P24, DOI 10.1016/j.joca.2009.08.010; Blumberg H, 2001, CELL, V104, P9, DOI 10.1016/S0092-8674(01)00187-8; Castaneda S, 2014, RHEUMATOLOGY, V53, P1, DOI 10.1093/rheumatology/ket247; Chen WY, 2006, ARTERIOSCL THROM VAS, V26, P2090, DOI 10.1161/01.ATV.0000232502.88144.6f; Chen WY, 2009, J IMMUNOL, V182, P5003, DOI 10.4049/jimmunol.0803653; Chimal-Monroy J, 1999, INT J DEV BIOL, V43, P59; Daheshia M, 2008, J RHEUMATOL, V35, P2306, DOI 10.3899/jrheum.080346; de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3; Leite ACRD, 2014, OSTEOARTHR CARTILAGE, V22, P1878, DOI 10.1016/j.joca.2014.07.019; Djouad F, 2006, REGEN MED, V1, P529, DOI 10.2217/17460751.1.4.529; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Frazer A, 1994, Osteoarthritis Cartilage, V2, P235; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Goldring MB, 2012, THER ADV MUSCULOSKEL, V4, P269, DOI 10.1177/1759720X12448454; GOLDRING MB, 1994, J CELL BIOCHEM, V54, P85, DOI 10.1002/jcb.240540110; Hsu YH, 2006, ARTHRITIS RHEUM-US, V54, P2722, DOI 10.1002/art.22039; Hsu YH, 2014, CELL TRANSPLANT, V23, P631, DOI 10.3727/096368914X678319; Hsu YH, 2012, RHEUMATOLOGY, V51, P434, DOI 10.1093/rheumatology/ker127; Hsu YH, 2011, J EXP MED, V208, P1849, DOI 10.1084/jem.20102234; Hsu YH, 2010, ARTHRITIS RHEUM-US, V62, P3311, DOI 10.1002/art.27689; Huang KY, 2008, SPINE, V33, P2034, DOI 10.1097/BRS.0b013e31817eb872; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Kayakabe M, 2006, CYTOTHERAPY, V8, P343, DOI 10.1080/14653240600845070; Kondo M, 2014, INT J MOL SCI, V15, P21270, DOI 10.3390/ijms151121270; Kragstrup TW, 2008, CYTOKINE, V41, P16, DOI 10.1016/j.cyto.2007.10.004; Lampropoulou-Adamidou Kalliopi, 2014, Eur J Orthop Surg Traumatol, V24, P263, DOI 10.1007/s00590-013-1205-2; LEFEBVRE V, 1990, BIOCHIM BIOPHYS ACTA, V1052, P366, DOI 10.1016/0167-4889(90)90145-4; Li HH, 2008, GENES IMMUN, V9, P395, DOI 10.1038/gene.2008.28; Little CBS, 2008, CURRENT RHEUMATOLOGY, V4; Loeser RF, 2006, ARTHRITIS RHEUM-US, V54, P1357, DOI 10.1002/art.21813; Luyten FP, 2004, CURR OPIN RHEUMATOL, V16, P599, DOI 10.1097/01.bor.0000130284.64686.63; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; Pfander D, 2007, CURR OPIN RHEUMATOL, V19, P457, DOI 10.1097/BOR.0b013e3282ba5693; Punzi L, 2010, SWISS MED WKLY, V140, P16, DOI 10.4414/smw.2010.13098; Rengel Y, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2304; SAKLATVALA J, 1986, NATURE, V322, P547, DOI 10.1038/322547a0; Sakurai N, 2008, RHEUMATOLOGY, V47, P815, DOI 10.1093/rheumatology/ken061; Schelbergen RF, 2014, OSTEOARTHR CARTILAGE, V22, P1158, DOI 10.1016/j.joca.2014.05.022; Senolt L, 2015, ARTHRITIS RHEUMATOL, V67, P1438, DOI 10.1002/art.39083; Steinert AF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2195; ter Huurne M, 2012, ARTHRITIS RHEUM-US, V64, P3604, DOI 10.1002/art.34626; Tritsaris K, 2007, P NATL ACAD SCI USA, V104, P15364, DOI 10.1073/pnas.0707302104; Wei CC, 2005, CLIN IMMUNOL, V117, P65, DOI 10.1016/j.clim.2005.06.012; Wei CC, 2008, BIOCHEM BIOPH RES CO, V374, P448, DOI 10.1016/j.bbrc.2008.07.039; Wei X, 2013, ACTA PHARMACOL SIN, V34, P747, DOI 10.1038/aps.2013.50; Zhao YP, 2014, JOVE-J VIS EXP, DOI 10.3791/50924	51	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175802	10.1371/journal.pone.0175802	http://dx.doi.org/10.1371/journal.pone.0175802			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426699	Green Submitted, Green Published, gold			2022-12-26	WOS:000399875900050
J	Peng, Y; Yan, S; Chen, DQ; Cui, XQ; Jiao, K				Peng, Yin; Yan, Shun; Chen, Dongquan; Cui, Xiangqin; Jiao, Kai			Pdgfrb is a direct regulatory target of TGF beta signaling in atrioventricular cushion mesenchymal cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CARDIAC DEVELOPMENT; VALVE DEVELOPMENT; HEART DEVELOPMENT; EMBRYONIC HEART; CANCER-CELLS; MICE; TRANSCRIPTION; RECEPTOR; TRANSFORMATION	Cushion formation is the initial step for the development of valvuloseptal structures in mammalian hearts. TGF beta signaling plays critical roles in multiple steps of cushion morphogenesis. We used a newly developed conditional immortal atrioventricular cushion mesenchymal cell line, tsA58-AVM, to identify the TGF beta regulatory target genes through microarray analysis. Expression of similar to 1350 genes was significantly altered by TGF beta 1 treatment. Subsequent bioinformatic analysis of TGF beta activated genes revealed that PDGF-BB signaling is the top hit as the potential upstream regulator. Among the 37 target molecules, 10 genes known to be involved in valve development and hemostasis were selected for quantitative reverse transcription polymerase chain reaction (qRT-PCR) analysis. Our results confirmed that they are all upregulated by TGF beta 1 stimulation in tsA58-AVM cells and in primary atrioventricular cushion cells. We focused on examining regulation of Pdgfrb by TGF beta 1, which encodes a tyrosine kinase receptor for PDGF-BB. We found that the similar to 150bp Pdgfrb promoter can respond to TGF beta stimulation and that this response relies on the two SP1 binding sites within the promoter. Co-immunoprecipitation analysis confirmed SP1 interacts with SMAD2 in a TGF beta-dependent fashion. Furthermore, SMAD2 is associated with the Pdgfrb promoter and this association is diminished by knocking down expression of Sp1. Our data therefore collectively suggest that upon TGF beta stimulation, SP1 recruits SMAD2 to the promoter of Pdgfrb to up-regulate its expression and thus Pdgfrb is a direct downstream target of the TGF beta/SMAD2 signaling.	[Peng, Yin; Yan, Shun; Jiao, Kai] Univ Alabama Birmingham, Div Res, Dept Genet, Birmingham, AL 35294 USA; [Chen, Dongquan] Univ Alabama Birmingham, Dept Med, Div Prevent Med, Birmingham, AL 35294 USA; [Cui, Xiangqin] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Jiao, K (corresponding author), Univ Alabama Birmingham, Div Res, Dept Genet, Birmingham, AL 35294 USA.	kjiao@uab.edu		yan, Shun/0000-0001-8994-5542; Jiao, Kai/0000-0002-5415-9020	NIH [1R01HL095783, 1R03HD082634]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD082634] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103434] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support was provided by NIH 1R01HL095783 and NIH 1R03HD082634 [https://www.nih.gov/grants-funding]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong EJ, 2004, CIRC RES, V95, P459, DOI 10.1161/01.RES.0000141146.95728.da; Azhar M, 2011, DEV DYNAM, V240, P2127, DOI 10.1002/dvdy.22702; Barnett Joey V., 2003, Birth Defects Research, V69, P58, DOI 10.1002/bdrc.10006; Bartram U, 2001, CIRCULATION, V103, P2745; Bjarnegard M, 2004, DEVELOPMENT, V131, P1847, DOI 10.1242/dev.01080; Boyer AS, 1999, DEV BIOL, V208, P530, DOI 10.1006/dbio.1999.9211; Brown CB, 1999, SCIENCE, V283, P2080, DOI 10.1126/science.283.5410.2080; Brown CB, 1996, DEV BIOL, V174, P248, DOI 10.1006/dbio.1996.0070; Butcher JT, 2007, PHILOS T R SOC B, V362, P1489, DOI 10.1098/rstb.2007.2130; Calkoen EE, 2016, INT J CARDIOL, V202, P784, DOI 10.1016/j.ijcard.2015.09.081; Camenisch TD, 2002, DEV BIOL, V248, P170, DOI 10.1006/dbio.2002.0731; Datto M, 2000, CYTOKINE GROWTH F R, V11, P37, DOI 10.1016/S1359-6101(99)00027-1; de Caestecker M, 2004, CYTOKINE GROWTH F R, V15, P1, DOI 10.1016/j.cytogfr.2003.10.004; de la Cruz MV, 2001, CARDIOL YOUNG, V11, P588, DOI 10.1017/S1047951101000932; Demoulin JB, 2014, CYTOKINE GROWTH F R, V25, P273, DOI 10.1016/j.cytogfr.2014.03.003; DICKSON MC, 1995, DEVELOPMENT, V121, P1845; El Mai M, 2014, CELL REP, V9, P1047, DOI 10.1016/j.celrep.2014.09.038; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gittenberger-De Groot AC, 2005, PEDIATR RES, V57, P169, DOI 10.1203/01.PDR.0000148710.69159.61; Hata A, 2016, COLD SPRING HARBOR P, V8; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Hinton RB, 2011, ANNU REV PHYSIOL, V73, P29, DOI 10.1146/annurev-physiol-012110-142145; Jiao K, 2006, DEVELOPMENT, V133, P4585, DOI 10.1242/dev.02597; Jungert K, 2006, CARCINOGENESIS, V27, P2392, DOI 10.1093/carcin/bgl078; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Lee J, 2016, AM J PHYSIOL-CELL PH, V310, pC436, DOI 10.1152/ajpcell.00423.2014; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Lin CJ, 2012, DEVELOPMENT, V139, P3277, DOI 10.1242/dev.063495; Liu CS, 2014, AM J PHYSIOL-GASTR L, V307, pG749, DOI 10.1152/ajpgi.00138.2014; Liu YL, 2014, HUM MOL GENET, V23, P2145, DOI 10.1093/hmg/ddt610; Macias MJ, 2015, TRENDS BIOCHEM SCI, V40, P296, DOI 10.1016/j.tibs.2015.03.012; Markwald RR, 2010, ANN NY ACAD SCI, V1188, P177, DOI 10.1111/j.1749-6632.2009.05098.x; Martin-Garrido A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079657; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Molander C, 2001, MOL BIOL REP, V28, P223, DOI 10.1023/A:1015701232589; Morikawa M, 2013, ONCOGENE, V32, P1609, DOI 10.1038/onc.2012.191; Moskowitz IP, 2011, P NATL ACAD SCI USA, V108, P4006, DOI 10.1073/pnas.1019025108; Nakajima Y, 2000, ANAT RECORD, V258, P119, DOI 10.1002/(SICI)1097-0185(20000201)258:2<119::AID-AR1>3.0.CO;2-U; Pardali K, 2000, J BIOL CHEM, V275, P29244, DOI 10.1074/jbc.M909467199; Paulsson J, 2014, FUTURE ONCOL, V10, P1695, DOI [10.2217/FON.14.83, 10.2217/fon.14.83]; Peng Y, 2016, CARDIOVASC RES; Peng Y, 2016, CARDIOVASC RES, V112, P532, DOI 10.1093/cvr/cvw200; Peng Y, 2014, CARDIOVASC RES, V103, P258, DOI 10.1093/cvr/cvu126; Person AD, 2005, INT REV CYTOL, V243, P287, DOI 10.1016/S0074-7696(05)43005-3; POTTS JD, 1989, DEV BIOL, V134, P392, DOI 10.1016/0012-1606(89)90111-5; Ramsdell AF, 1997, DEV BIOL, V188, P64, DOI 10.1006/dbio.1997.8637; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Schroeder JA, 2003, J MOL MED-JMM, V81, P392, DOI 10.1007/s00109-003-0456-5; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Song LY, 2011, DEV DYNAM, V240, P211, DOI 10.1002/dvdy.22493; Sridurongrit S, 2008, DEV BIOL, V322, P208, DOI 10.1016/j.ydbio.2008.07.038; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Van den Akker NMS, 2008, DEV DYNAM, V237, P494, DOI 10.1002/dvdy.21436; Wagner M, 2007, EXP BIOL MED, V232, P866; Wang JK, 2005, DEV BIOL, V286, P299, DOI 10.1016/j.ydbio.2005.07.035	57	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175791	10.1371/journal.pone.0175791	http://dx.doi.org/10.1371/journal.pone.0175791			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426709	Green Submitted, gold, Green Published			2022-12-26	WOS:000399875900047
J	Wang, SY; Xu, XT; Shrestha, N; Zimmermann, NE; Tang, ZY; Wang, ZH				Wang, Siyang; Xu, Xiaoting; Shrestha, Nawal; Zimmermann, Niklaus E.; Tang, Zhiyao; Wang, Zhiheng			Response of spatial vegetation distribution in China to climate changes since the Last Glacial Maximum (LGM)	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; QUATERNARY CLIMATE; DIVERSITY; PALAEOVEGETATION; PREDICTION; FORESTS; POLLEN; MIDHOLOCENE; GEOGRAPHY; RICHNESS	Analyzing how climate change affects vegetation distribution is one of the central issues of global change ecology as this has important implications for the carbon budget of terrestrial vegetation. Mapping vegetation distribution under historical climate scenarios is essential for understanding the response of vegetation distribution to future climatic changes. The reconstructions of palaeovegetation based on pollen data provide a useful method to understand the relationship between climate and vegetation distribution. However, this method is limited in time and space. Here, using species distribution model (SDM) approaches, we explored the climatic determinants of contemporary vegetation distribution and reconstructed the distribution of Chinese vegetation during the Last Glacial Maximum (LGM, 18,000 C-14 yr BP) and Middle-Holocene (MH, 6000 C-14 yr BP). The dynamics of vegetation distribution since the LGM reconstructed by SDMs were largely consistent with those based on pollen data, suggesting that the SDM approach is a useful tool for studying historical vegetation dynamics and its response to climate change across time and space. Comparison between the modeled contemporary potential natural vegetation distribution and the observed contemporary distribution suggests that temperate deciduous forests, subtropical evergreen broadleaf forests, temperate deciduous shrublands and temperate steppe have low range fillings and are strongly influenced by human activities. In general, the Tibetan Plateau, North and Northeast China, and the areas near the 30 degrees N in Central and Southeast China appeared to have experienced the highest turnover in vegetation due to climate change from the LGM to the present.	[Wang, Siyang; Xu, Xiaoting; Shrestha, Nawal; Tang, Zhiyao; Wang, Zhiheng] Peking Univ, Dept Ecol, Beijing, Peoples R China; [Wang, Siyang; Xu, Xiaoting; Shrestha, Nawal; Tang, Zhiyao; Wang, Zhiheng] Peking Univ, Key Lab Earth Surface Proc, Minist Educ, Coll Urban & Environm Sci, Beijing, Peoples R China; [Zimmermann, Niklaus E.] Swiss Fed Res Inst WSL, Dynam Macroecol, Birmensdorf, Switzerland	Peking University; Peking University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research	Wang, ZH (corresponding author), Peking Univ, Dept Ecol, Beijing, Peoples R China.; Wang, ZH (corresponding author), Peking Univ, Key Lab Earth Surface Proc, Minist Educ, Coll Urban & Environm Sci, Beijing, Peoples R China.	zhiheng.wang@pku.edu.en	Zimmermann, Niklaus E./A-4276-2008; Tang, Zhiyao/B-8795-2008; Wang, Zhiheng/G-1750-2010; Shrestha, Nawal/ABA-3021-2020	Zimmermann, Niklaus E./0000-0003-3099-9604; Wang, Zhiheng/0000-0003-0808-7780; Shrestha, Nawal/0000-0002-6866-5100	National Natural Science Foundation of China [31522012, 31470564, 3132106, 31400467]; Recruitment Program of Global Youth Experts	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Recruitment Program of Global Youth Experts	This work was supported by the National Natural Science Foundation of China (31522012, 31470564, 3132106, 31400467) and the Recruitment Program of Global Youth Experts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Jian Ni for his help with pollen data. This work was supported by the National Natural Science Foundation of China (31522012, 31470564, 31321061, 31400467) and the Recruitment Program of Global Youth Experts.	Adams J, 1998, REV ATLAS PALAEOVEGE; Anadon JD, 2014, J ECOL, V102, P1363, DOI 10.1111/1365-2745.12325; [Anonymous], [No title captured]; Araujo MB, 2008, ECOGRAPHY, V31, P8, DOI 10.1111/j.2007.0906-7590.05318.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Bala G, 2007, P NATL ACAD SCI USA, V104, P6550, DOI 10.1073/pnas.0608998104; Barros V., 2015, CLIMATE CHANGE 201 A; Bennie J, 2008, ECOL MODEL, V216, P47, DOI 10.1016/j.ecolmodel.2008.04.010; Blois JL, 2013, ECOGRAPHY, V36, P460, DOI 10.1111/j.1600-0587.2012.07852.x; Box EO, 1996, J VEG SCI, V7, P309, DOI 10.2307/3236274; BRZEZIECKI B, 1993, J VEG SCI, V4, P499, DOI 10.2307/3236077; Clark PU, 2012, P NATL ACAD SCI USA, V109, pE1134, DOI 10.1073/pnas.1116619109; Claussen M, 2009, CLIM PAST, V5, P203, DOI 10.5194/cp-5-203-2009; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; CROWLEY TJ, 1995, GLOBAL BIOGEOCHEM CY, V9, P377, DOI 10.1029/95GB01107; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Elmendorf SC, 2012, ECOL LETT, V15, P164, DOI 10.1111/j.1461-0248.2011.01716.x; Enquist CAF, 2002, J BIOGEOGR, V29, P519, DOI 10.1046/j.1365-2699.2002.00695.x; FANG J-Y, 1989, Ecological Research, V4, P71, DOI 10.1007/BF02346944; Fang JY, 2003, FRONT ECOL ENVIRON, V1, P293; Fuller TL, 1998, ECOSYSTEMS, V1, P76; Garcia RA, 2012, GLOBAL CHANGE BIOL, V18, P1253, DOI 10.1111/j.1365-2486.2011.02605.x; GARCIAMONTIEL DC, 1994, FOREST ECOL MANAG, V63, P57, DOI 10.1016/0378-1127(94)90246-1; Gent PR, 2011, J CLIMATE, V24, P4973, DOI 10.1175/2011JCLI4083.1; Gerten D, 2004, J HYDROL, V286, P249, DOI 10.1016/j.jhydrol.2003.09.029; GOOD R. D'O., 1931, NEW PHYTOL, V30, P149, DOI 10.1111/j.1469-8137.1931.tb07414.x; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guisan A, 2011, J BIOGEOGR, V38, P1433, DOI 10.1111/j.1365-2699.2011.02550.x; Harrison SP, 2001, NATURE, V413, P129, DOI 10.1038/35093166; Hawkins BA, 2001, TRENDS ECOL EVOL, V16, P470, DOI 10.1016/S0169-5347(01)02197-8; Hickler T, 2012, GLOBAL ECOL BIOGEOGR, V21, P50, DOI 10.1111/j.1466-8238.2010.00613.x; Hijmans R.J., 2013, DISMO SPECIES DISTRI, V0, P8; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; HOLDRIDGE LR, 1947, SCIENCE, V105, P367, DOI 10.1126/science.105.2727.367; Ichii K, 2002, INT J REMOTE SENS, V23, P3873, DOI 10.1080/01431160110119416; Jiang DB, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002167; Kimura MK, 2014, ANN BOT-LONDON, V114, P1687, DOI 10.1093/aob/mcu197; Kira T., 1945, NEW CLASSIFICATION C; Li S, 1991, SCI GEOGRAPHICA SINI, V4, P306; Li Y, 2015, NATURE COMMUNICATION, P6; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Liu HY, 2013, J PALAEOGEOG-ENGLISH, V2, P297, DOI 10.3724/SP.J.1261.2013.00032; Liu JQ, 2012, J SYST EVOL, V50, P267, DOI 10.1111/j.1759-6831.2012.00214.x; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Loehle C, 2007, CLIM PAST, V3, P109, DOI 10.5194/cp-3-109-2007; Lopez-Pujol J, 2011, J BIOGEOGR, V38, P1267, DOI 10.1111/j.1365-2699.2011.02504.x; Marchant R, 2009, POLLEN BASED BIOME R; Ni J, 2010, PALAEOGEOGR PALAEOCL, V289, P44, DOI 10.1016/j.palaeo.2010.02.008; Nogues-Bravo D, 2008, NATURE, V453, P216, DOI 10.1038/nature06812; OVERPECK JT, 1990, CLIMATE INDUCED CHAN; Oyama MD, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018600; Pearman PB, 2008, ECOL LETT, V11, P357, DOI 10.1111/j.1461-0248.2007.01150.x; Perkins SR, 2003, PLANT ECOL, V168, P107, DOI 10.1023/A:1024447305422; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Piao SL, 2009, NATURE, V458, P1009, DOI 10.1038/nature07944; PRENTICE IC, 1992, J BIOGEOGR, V19, P117, DOI 10.2307/2845499; Prentice IC, 2000, J BIOGEOGR, V27, P507, DOI 10.1046/j.1365-2699.2000.00425.x; Prieto-Torres DA, 2016, GLOBAL CHANGE BIOL, V22, P364, DOI 10.1111/gcb.13090; Qian H, 2000, NATURE, V407, P180, DOI 10.1038/35025052; Qiu YX, 2011, MOL PHYLOGENET EVOL, V59, P225, DOI 10.1016/j.ympev.2011.01.012; RCore Team, 2020, R LANG ENV STAT COMP; Rubel F, 2010, METEOROL Z, V19, P135, DOI 10.1127/0941-2948/2010/0430; Sandel B, 2011, SCIENCE, V334, P660, DOI 10.1126/science.1210173; Segurado P, 2004, J BIOGEOGR, V31, P1555, DOI 10.1111/j.1365-2699.2004.01076.x; Shabanov NV, 2002, IEEE T GEOSCI REMOTE, V40, P115, DOI 10.1109/36.981354; Sitch S, 2003, GLOBAL CHANGE BIOL, V9, P161, DOI 10.1046/j.1365-2486.2003.00569.x; Speier M., 1994, VEGETATIONSKUNDLICHE; STEPHENSON NL, 1990, AM NAT, V135, P649, DOI 10.1086/285067; Sun XJ, 1997, QUATERN INT, V37, P25, DOI 10.1016/1040-6182(96)00008-0; Svenning JC, 2004, ECOL LETT, V7, P565, DOI 10.1111/j.1461-0248.2004.00614.x; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tang CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep43822; Tarasov PE, 2000, J BIOGEOGR, V27, P609, DOI 10.1046/j.1365-2699.2000.00429.x; Tsuyama I, 2014, J FOREST RES-JPN, V19, P154, DOI 10.1007/s10310-013-0399-9; Viera AJ, 2005, FAM MED, V37, P360; von Humboldt A, ESSAI GEOGRAPHIE PLA; Watanabe S, 2011, GEOSCI MODEL DEV, V4, P845, DOI 10.5194/gmd-4-845-2011; Wei XX, 2004, MOL ECOL, V13, P3115, DOI 10.1111/j.1365-294X.2004.02299.x; Williams JW, 2000, J BIOGEOGR, V27, P585, DOI 10.1046/j.1365-2699.2000.00428.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Worth JRP, 2013, BIOL J LINN SOC, V108, P263, DOI 10.1111/j.1095-8312.2012.02017.x; Yang FS, 2008, MOL ECOL, V17, P5135, DOI 10.1111/j.1365-294X.2008.03976.x; Yang X, 1994, ACTA PALAEONTOLOGICA, V34, P647; Yu G, 2000, J BIOGEOGR, V27, P635, DOI 10.1046/j.1365-2699.2000.00431.x; Zhao Y, 2009, EARTH-SCI REV, V97, P242, DOI 10.1016/j.earscirev.2009.10.007; Zimmermann NE, 1999, J VEG SCI, V10, P469, DOI 10.2307/3237182	89	31	34	9	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175742	10.1371/journal.pone.0175742	http://dx.doi.org/10.1371/journal.pone.0175742			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426780	Green Published, gold, Green Submitted			2022-12-26	WOS:000399875900042
J	Chatterjee, A; Komshian, S; Sansbury, BE; Wu, B; Mottola, G; Chen, M; Spite, M; Conte, MS				Chatterjee, Anuran; Komshian, Sevan; Sansbury, Brian E.; Wu, Bian; Mottola, Giorgio; Chen, Mian; Spite, Matthew; Conte, Michael S.			Biosynthesis of proresolving lipid mediators by vascular cells and tissues	FASEB JOURNAL			English	Article						resolution of inflammation; resolvins; omega-3 fatty acids	RESOLVIN D1; DOCOSAHEXAENOIC ACID; 5-LIPOXYGENASE EXPRESSION; ANTIINFLAMMATORY ACTIONS; ACUTE-INFLAMMATION; FATTY-ACIDS; HUMAN BLOOD; FISH-OIL; RESOLUTION; SUPPLEMENTATION	Recent evidence suggests that specialized proresolving lipid mediators (SPMs) generated from docosahexaenoic acid (DHA) can modulate the vascular injury response. However, cellular sources for these autacoids within the vessel wall remain unclear. Here, we investigated whether isolated vascular cells and tissues can produce SPMs and assessed expression and subcellular localization of the key SPM biosynthetic enzyme 5-lipoxygenase (LOX) in vascular cells. Intact human arteries incubated with DHA ex vivo produced 17-hydroxy DHA (17-HDHA) and D-series resolvins, as assessed by liquid chromatography-tandem mass spectrometry. Addition of 17-HDHA to humanarteries similarly increased resolvin production. Primary cultures of human saphenous vein endothelial cells (ECs) and vascular smooth muscle cells (VSMCs) converted 17-HDHA to SPMs, including resolvin D1 (RvD1) and other D-series resolvins and protectins. This was accompanied by a rapid translocation of 5-LOX from nucleus to cytoplasm in both ECs and VSMCs, potentially facilitating SPM biosynthesis. Conditioned medium from cells exposed to 17-HDHA inhibited monocyte adhesion to TNF-alpha-stimulated EC monolayers. These downstream effects were partially reversed by antibodies against the RvD1 receptors ALX/FPR2 and GPR32. These results suggest that autocrine and/or paracrine signaling via locally generated SPMs in the vasculature may represent a novel homeostatic mechanism of relevance to vascular health and disease.	[Chatterjee, Anuran; Wu, Bian; Mottola, Giorgio; Chen, Mian; Conte, Michael S.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA USA; [Chatterjee, Anuran; Wu, Bian; Mottola, Giorgio; Chen, Mian; Conte, Michael S.] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA; [Komshian, Sevan] Boston Univ, Sch Med, Boston, MA 02118 USA; [Sansbury, Brian E.; Spite, Matthew] Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, 75 Francis St, Boston, MA 02115 USA; [Sansbury, Brian E.; Spite, Matthew] Harvard Med Sch, Boston, MA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Boston University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Conte, MS (corresponding author), 400 Parnassus Ave, San Francisco, CA 94143 USA.	michael.conte2@ucsf.edu	Mottola, Giorgio/AAO-4375-2021	Mottola, Giorgio/0000-0003-0670-8619	American Heart Association [13SDG16940069]; U.S. National Institutes of Health (NIH) Heart, Lung, and Blood Institute [HL119508, HL106173]; NIH National Institute of General Medical Sciences Grant [GM095467]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119508, R01HL106173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM095467] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); U.S. National Institutes of Health (NIH) Heart, Lung, and Blood Institute; NIH National Institute of General Medical Sciences Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Heart Association Grant 13SDG16940069 (to A.C.), and by U.S. National Institutes of Health (NIH) Heart, Lung, and Blood Institute Grants HL119508 (to M.S.C.) and HL106173, and NIH National Institute of General Medical Sciences Grant GM095467 (to M.S.). A.C. and S.K. are cofirst authors. The authors declare no conflicts of interest.	Akagi D, 2015, FASEB J, V29, P2504, DOI 10.1096/fj.14-265363; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Bisgaard H, 2016, NEW ENGL J MED, V375, P2530, DOI 10.1056/NEJMoa1503734; Buckley CD, 2013, NAT REV IMMUNOL, V13, P59, DOI 10.1038/nri3362; Calder PC, 2015, BBA-MOL CELL BIOL L, V1851, P469, DOI 10.1016/j.bbalip.2014.08.010; Chatterjee A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113480; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Chiu CY, 2012, INFLAMM RES, V61, P967, DOI 10.1007/s00011-012-0489-8; Chu SJ, 2000, J IMMUNOL, V165, P4640, DOI 10.4049/jimmunol.165.8.4640; Cipollone F, 2005, ARTERIOSCL THROM VAS, V25, P1665, DOI 10.1161/01.ATV.0000172632.96987.2d; CLARIA J, 1995, P NATL ACAD SCI USA, V92, P9475, DOI 10.1073/pnas.92.21.9475; Colas RA, 2014, AM J PHYSIOL-CELL PH, V307, pC39, DOI 10.1152/ajpcell.00024.2014; Dalli J, 2015, NAT MED, V21, P1071, DOI 10.1038/nm.3911; De Ley M, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005986.pub2; Fredman G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12859; Fredman G, 2014, P NATL ACAD SCI USA, V111, P14530, DOI 10.1073/pnas.1410851111; Geppert J, 2005, LIPIDS, V40, P807, DOI 10.1007/s11745-005-1442-9; Gilbert B, 2015, BBA-GENE REGUL MECH, V1849, P1003, DOI 10.1016/j.bbagrm.2015.06.004; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Kasuga K, 2008, J IMMUNOL, V181, P8677, DOI 10.4049/jimmunol.181.12.8677; Kim N, 2016, EUR J IMMUNOL, V46, P81, DOI 10.1002/eji.201545673; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Lance KD, 2017, J BIOMED MATER RES A, V105, P31, DOI 10.1002/jbm.a.35861; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Mas E, 2012, CLIN CHEM, V58, P1476, DOI 10.1373/clinchem.2012.190199; Massaro M, 2008, PROSTAG LEUKOTR ESS, V79, P109, DOI 10.1016/j.plefa.2008.09.009; Miyahara T, 2013, FASEB J, V27, P2220, DOI 10.1096/fj.12-225615; Neuhofer A, 2013, DIABETES, V62, P1945, DOI 10.2337/db12-0828; Norling LV, 2012, ARTERIOSCL THROM VAS, V32, P1970, DOI 10.1161/ATVBAHA.112.249508; Osher E, 2006, MOL CELL ENDOCRINOL, V252, P201, DOI 10.1016/j.mce.2006.03.038; Pope NH, 2016, FASEB J, V30, P4192, DOI 10.1096/fj.201600144RR; Pruss H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055859; Qiu H, 2008, J EXP MED, V205, P19, DOI 10.1084/jem.20070201; Radmark O, 2015, BBA-MOL CELL BIOL L, V1851, P331, DOI 10.1016/j.bbalip.2014.08.012; Raederstorff D, 1996, INT ARCH ALLERGY IMM, V111, P284, DOI 10.1159/000237379; Ramon S, 2012, J IMMUNOL, V189, P1036, DOI 10.4049/jimmunol.1103483; Sansbury BE, 2016, CIRC RES, V119, P113, DOI 10.1161/CIRCRESAHA.116.307308; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2006, J IMMUNOL, V176, P1848, DOI 10.4049/jimmunol.176.3.1848; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Silverman ES, 1998, AM J RESP CELL MOL, V19, P316, DOI 10.1165/ajrcmb.19.2.3154; Spite M, 2014, CELL METAB, V19, P21, DOI 10.1016/j.cmet.2013.10.006; Tanaskovic S, 2011, ANGIOLOGY, V62, P535, DOI 10.1177/0003319710398010; Tiesset H, 2009, J NUTR, V139, P82, DOI 10.3945/jn.108.096115; Turner D, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006443; Turner D, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006320.pub3; Wang XZ, 2015, J LIPID RES, V56, P674, DOI 10.1194/jlr.P055418; Weintraub WS, 2007, AM J CARDIOL, V100, p3K, DOI 10.1016/j.amjcard.2007.06.002; Wright L, 1998, AM J RESP CRIT CARE, V157, P219, DOI 10.1164/ajrccm.157.1.9704003; Wu B, 2017, J VASC SURG, V65, P207, DOI 10.1016/j.jvs.2016.01.030; Yang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080048; Yurko-Mauro K, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0109-z; Zhang YY, 2002, BIOCHEM J, V361, P267, DOI 10.1042/0264-6021:3610267	54	27	29	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3393	3402		10.1096/fj.201700082R	http://dx.doi.org/10.1096/fj.201700082R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28442547	Green Published			2022-12-26	WOS:000405932400018
J	Liang, D; Leung, RKK; Lee, SS; Kam, KM				Liang, Dachao; Leung, Ross Ka Kit; Lee, Shui Shan; Kam, Kai Man			Insights into intercontinental spread of Zika virus	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; NUCLEOTIDE SUBSTITUTIONS; RECONSTRUCTION; INFERENCE; OUTBREAK; BIOLOGY; NUMBER	The epidemic of Zika virus (ZIKV) infection in South America has led to World Health Organization's declaration of a Public Health Emergency of International Concern. To further inform effective public health policy, an understanding of ZIKV's transmission mechanisms is crucial. To characterize the intercontinental transmission of ZIKV, we compiled and analyzed more than 250 gene sequences together with their sequence-related geographic and temporal information, sampled across 27 countries spanning from 1947 to 2016. After filtering and selecting appropriate sequences, extensive phylogenetic analyses were performed. Although phylogeographic reconstruction supported the transmission route of the virus in Africa, South-eastern Asia, Oceania and Latin America, we discovered that the Eastern Africa origin of ZIKV was disputable. On a molecular level, purifying selection was found to be largely responsible for the evolution of non-structural protein 5 and envelope protein E. Our dataset and ancestral sequences reconstruction analysis captured previously unidentified amino acid changes during evolution. Finally, based on the estimation of the time to the most recent common ancestors for the non-structural protein 5 gene, we hypothesized potential specific historic events that occurred in the 1940s and might have facilitated the spread of Zika virus from Africa to South-eastern Asia. Our findings provide new insights into the transmission characteristics of ZIKV, while further genetic and serologic studies are warranted to support the design of tailored prevention strategies.	[Liang, Dachao; Leung, Ross Ka Kit; Lee, Shui Shan; Kam, Kai Man] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Leung, Ross Ka Kit] Guangzhou Med Univ, Affiliated Hosp 1, Natl Clin Res Ctr Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China	Chinese University of Hong Kong; Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Kam, KM (corresponding author), Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China.	kmkam@cuhk.edu.hk	Lee, Shui Shan/B-9374-2008; KAM, Kai Man/K-4546-2012	Lee, Shui Shan/0000-0003-1448-765X; KAM, Kai Man/0000-0003-0579-0307				Ashkenazy H, 2012, NUCLEIC ACIDS RES, V40, pW580, DOI 10.1093/nar/gks498; Behnam MAM, 2016, J MED CHEM, V59, P5622, DOI 10.1021/acs.jmedchem.5b01653; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022; Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2; Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006; Cox Bryan D., 2015, Antiviral Chemistry & Chemotherapy, V24, P118, DOI 10.1177/2040206616653873; Cunha MS, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00032-16; Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Duong V, 2017, INT J INFECT DIS, V54, P121, DOI 10.1016/j.ijid.2016.11.420; Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252; Giovanetti M, 2016, ASIAN PAC J TROP MED, V9, P445, DOI 10.1016/j.apjtm.2016.03.028; Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477; Hattori T, 1953, COMPLETE HIST GREATE; Heled J, 2012, SYST BIOL, V61, P138, DOI 10.1093/sysbio/syr087; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Kumar S., 2016, MOL BIOL EVOLUTION, V33, DOI [DOI 10.1093/M0LBEV/MSW054, https://doi.org/10.1093/molbev/msw054, 10.1093/molbev/msw054]; Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687; Li Z, 2008, J MED CHEM, V51, P4660, DOI 10.1021/jm800412d; Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9; MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Moureau G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117849; Murrell B, 2015, MOL BIOL EVOL, V32, P1365, DOI 10.1093/molbev/msv035; Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761; Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720; Orsborne J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152805; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; PUFFER RL, 1994, LIBR J, V119, P110; Pupko T, 2000, MOL BIOL EVOL, V17, P890, DOI 10.1093/oxfordjournals.molbev.a026369; Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e; Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929; Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316; Smith MD, 2015, MOL BIOL EVOL, V32, P1342, DOI 10.1093/molbev/msv022; SMITHBURN KC, 1954, J IMMUNOL, V72, P248; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; United Nations. Statistical Division, 1999, STAND COUNTR AR COD, Vvii; USCDC, 2016, ADV PEOPL LIV TRAV B; van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899; Vincetti P, 2015, J MED CHEM, V58, P4964, DOI 10.1021/acs.jmedchem.5b00108; Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010; Wu CH, 2013, MOL BIOL EVOL, V30, P669, DOI 10.1093/molbev/mss258; Yang ZH, 2006, MOL BIOL EVOL, V23, P212, DOI 10.1093/molbev/msj024; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48	63	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176710	10.1371/journal.pone.0176710	http://dx.doi.org/10.1371/journal.pone.0176710			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448611	gold, Green Published, Green Submitted			2022-12-26	WOS:000400383600122
J	Nardo, L; Maspero, A; Penoni, A; Palmisano, G; Ferrari, E; Saladini, M				Nardo, Luca; Maspero, Angelo; Penoni, Andrea; Palmisano, Giovanni; Ferrari, Erika; Saladini, Monica			Excited state dynamics of bis-dehydroxycurcumin tert-butyl ester, a diketo-shifted derivative of the photosensitizer curcumin	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; ANTIOXIDANT ACTIVITY; HYDROGEN; RESONANCE; BACTERIA; BETA; DEGRADATION; PARAMETERS; BOND; NMR	Bis-dehydroxycurcumin tert-butyl ester (K2T23) is a derivative of the natural spice curcumin. Curcumin is widely studied for its multiple therapeutic properties, including photosensitized cytotoxicity. However, the full exploitation of curcumin phototoxic potential is hindered by the extreme instability of its excited state, caused by very efficient non radiative decay by means of transfer of the enolic proton to the nearby keto oxygen. K2T23 is designed to exhibit a tautomeric equilibrium shifted toward the diketo conformers with respect to natural curcumin. This property should endow K2T23 with superior excited-state stability when excited in the UVB band, i.e., in correspondence of the diketo conformers absorption peaks, making this compound an interesting candidate for topical photodynamic therapy of, e.g., skin tumors or oral infections. In this work, the tautomeric equilibrium of K2T23 between the keto-enolic and diketo conformers is assessed in the ground state in several organic solvents by UV-visible absorption and by nuclear magnetic resonance. The same tautomeric equilibrium is also probed in the excited-state in the same environments by means of steady-state fluorescence and time-correlated single-photon counting measurements. These techniques are also exploited to elucidate the excited state dynamics and excited-state deactivation pathways of K2T23, which are compared to those determined for several other curcuminoids characterized in previous works of ours. The ability of K2T23 in photosensitizing the production of singlet oxygen is compared with that of curcumin.	[Nardo, Luca] Univ Milano Bicocca, Dept Med & Surg, Monza, Monza & Brianza, Italy; [Maspero, Angelo; Penoni, Andrea; Palmisano, Giovanni] Univ Insubria, Dept Sci & High Technol, Como, Italy; [Ferrari, Erika; Saladini, Monica] Univ Modena & Reggio Emilia, Dept Chem & Geol Sci, Modena, Italy	University of Milano-Bicocca; University of Insubria; Universita di Modena e Reggio Emilia	Nardo, L (corresponding author), Univ Milano Bicocca, Dept Med & Surg, Monza, Monza & Brianza, Italy.	luca.nardo@unimib.it	Ferrari, Erika/F-7742-2012	Ferrari, Erika/0000-0001-7627-2502; Nardo, Luca/0000-0002-8013-2905				Balasubramanian K, 2006, J AGR FOOD CHEM, V54, P3512, DOI 10.1021/jf0603533; Benassi R, 2008, J MOL STRUCT, V892, P168, DOI 10.1016/j.molstruc.2008.05.024; Berlman I. B, 1971, HDB FLUORESCENCE SPE; BERTOLASI V, 1991, J AM CHEM SOC, V113, P4917, DOI 10.1021/ja00013a030; Bruzell EM, 2005, PHOTOCH PHOTOBIO SCI, V4, P523, DOI 10.1039/b503397g; Caminati W, 2006, J AM CHEM SOC, V128, P854, DOI 10.1021/ja055333g; Chainani-Wu N, 2003, J ALTERN COMPLEM MED, V9, P161, DOI 10.1089/107555303321223035; DAHL TA, 1989, ARCH MICROBIOL, V151, P183, DOI 10.1007/BF00414437; DAHL TA, 1994, PHOTOCHEM PHOTOBIOL, V59, P290, DOI 10.1111/j.1751-1097.1994.tb05036.x; DANNENBERG JJ, 1994, J PHYS CHEM-US, V98, P6714, DOI 10.1021/j100078a011; EGAN W, 1977, J AM CHEM SOC, V99, P4568, DOI 10.1021/ja00456a005; EMSLEY J, 1984, STRUCT BOND, V57, P147; Ferrari E, 2011, J MED CHEM, V54, P8066, DOI 10.1021/jm200872q; Galer P, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-107; GILLI G, 1989, J AM CHEM SOC, V111, P1023, DOI 10.1021/ja00185a035; Gilli G., 1990, CHEM ENOLS, P713; Gomes A, 2005, J BIOCHEM BIOPH METH, V65, P45, DOI 10.1016/j.jbbm.2005.10.003; GORBITZ CH, 1993, ACTA CHEM SCAND, V47, P509, DOI 10.3891/acta.chem.scand.47-0509; GORBITZ CH, 1986, ACTA CHEM SCAND B, V40, P420, DOI 10.3891/acta.chem.scand.40b-0420; Haukvik T, 2011, PHARMAZIE, V66, P69, DOI 10.1691/ph.2011.0154; Haukvik T, 2010, PHARMAZIE, V65, P600, DOI 10.1691/ph.2010.0048; Haukvik T, 2009, PHARMAZIE, V64, P666, DOI 10.1691/ph.2009.9130; Hegge AB, 2013, EUR J PHARM BIOPHARM, V83, P95, DOI 10.1016/j.ejpb.2012.09.011; Hegge AB, 2012, EUR J PHARM SCI, V47, P65, DOI 10.1016/j.ejps.2012.05.002; Hegge AB, 2012, J PHARM SCI-US, V101, P1524, DOI 10.1002/jps.23046; Hegge AB, 2011, J PHARM SCI-US, V100, P174, DOI 10.1002/jps.22263; KAMLET MJ, 1983, J ORG CHEM, V48, P2877, DOI 10.1021/jo00165a018; KARLSEN J, 1988, ACTA CHEM SCAND B, V42, P23, DOI 10.3891/acta.chem.scand.42b-0023; Lamperti M, 2014, MOLECULES, V19, P13282, DOI 10.3390/molecules190913282; Lilletvedt M, 2010, J PHOTOCH PHOTOBIO A, V214, P40, DOI 10.1016/j.jphotochem.2010.06.004; LOWREY AH, 1971, J AM CHEM SOC, V93, P6399, DOI 10.1021/ja00753a011; MOSTAD A, 1984, ACTA CHEM SCAND B, V38, P479, DOI 10.3891/acta.chem.scand.38b-0479; MOSTAD A, 1983, ACTA CHEM SCAND B, V37, P901, DOI 10.3891/acta.chem.scand.37b-0901; Nardo L, 2012, J FLUORESC, V22, P597, DOI 10.1007/s10895-011-0995-z; Nardo L, 2010, HYDROGEN BONDING TRA, P353; Nardo L., 2012, CURCUMIN BIOSYNTHESI, P81; Nardo L, 2008, SPECTROSC-INT J, V22, P187, DOI 10.1155/2008/928407; Nardo L, 2012, J PHYS CHEM A, V116, P9321, DOI 10.1021/jp307928a; Nardo L, 2011, J FLUORESC, V21, P627, DOI 10.1007/s10895-010-0750-x; Nardo L, 2009, J PHOTOCH PHOTOBIO B, V97, P77, DOI 10.1016/j.jphotobiol.2009.08.004; Nieto CI, 2016, STRUCT CHEM, V27, P705, DOI 10.1007/s11224-015-0704-7; Payton F, 2007, J NAT PROD, V70, P143, DOI 10.1021/np060263s; Priyadarsini KI, 2003, FREE RADICAL BIO MED, V35, P475, DOI 10.1016/S0891-5849(03)00325-3; SCHAICH KM, 1994, ACS SYM SER, V547, P204; Singh R, 2013, PHOTOCH PHOTOBIO SCI, V12, P559, DOI 10.1039/c2pp25249j; Srinivasan R, 2004, J AM CHEM SOC, V126, P2266, DOI 10.1021/ja031927c; TONNESEN HH, 1985, Z LEBENSM UNTERS FOR, V180, P402, DOI 10.1007/BF01027775; TONNESEN HH, 1987, J PHARM SCI, V76, P371, DOI 10.1002/jps.2600760506; TONNESEN HH, 1983, ACTA CHEM SCAND B, V37, P179, DOI 10.3891/acta.chem.scand.37b-0179; TONNESEN HH, 1982, ACTA CHEM SCAND B, V36, P475, DOI 10.3891/acta.chem.scand.36b-0475; TONNESEN HH, 1985, Z LEBENSM UNTERS FOR, V180, P132, DOI 10.1007/BF01042637; Toullec J, 1990, CHEM ENOLS, P324; Wright JS, 2002, J MOL STRUC-THEOCHEM, V591, P207, DOI 10.1016/S0166-1280(02)00242-7	53	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0175225	10.1371/journal.pone.0175225	http://dx.doi.org/10.1371/journal.pone.0175225			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448635	Green Published, gold, Green Submitted			2022-12-26	WOS:000400383600011
J	Arias-Gonzalez, JE; Fung, T; Seymour, RM; Garza-Perez, JR; Acosta-Gonzalez, G; Bozec, YM; Johnson, CR				Ernesto Arias-Gonzalez, Jesus; Fung, Tak; Seymour, Robert M.; Rodrigo Garza-Perez, Joaquin; Acosta-Gonzalez, Gilberto; Bozec, Yves-Marie; Johnson, Craig R.			A coral-algal phase shift in Mesoamerica not driven by changes in herbivorous fish abundance	PLOS ONE			English	Article							MACROALGAL BLOOMS; NUTRIENT ENRICHMENT; SPATIAL-PATTERNS; LIMITED GROWTH; REEF; RESILIENCE; DYNAMICS; IMPACTS; COMMUNITIES; COMPETITION	Coral-algal phase shifts in which coral cover declines to low levels and is replaced by algae have often been documented on coral reefs worldwide. This has motivated coral reef management responses that include restriction and regulation of fishing, e.g. herbivorous fish species. However, there is evidence that eutrophication and sedimentation can be at least as important as a reduction in herbivory in causing phase shifts. These threats arise from coastal development leading to increased nutrient and sediment loads, which stimulate algal growth and negatively impact corals respectively. Here, we first present results of a dynamic process-based model demonstrating that in addition to overharvesting of herbivorous fish, bottom-up processes have the potential to precipitate coral-algal phase shifts on Mesoamerican reefs. We then provide an empirical example that exemplifies this on coral reefs off Mahahual in Mexico, where a shift from coral to algal dominance occurred over 14 years, during which there was little change in herbivore biomass but considerable development of tourist infrastructure. Our results indicate that coastal development can compromise the resilience of coral reefs and that watershed and coastal zone management together with the maintenance of functional levels of fish herbivory are critical for the persistence of coral reefs in Mesoamerica.	[Ernesto Arias-Gonzalez, Jesus] IPN, Lab Ecol Ecosistemas Arrecifes Coralinos, Ctr Invest & Estudios Avanzados, Dept Recursos Mar,Unidad Merida, Carr Ant Progreso Km 6,AP 73 Cordemex, Merida, Yucatan, Mexico; [Fung, Tak] Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore, Singapore; [Seymour, Robert M.] UCL, Ctr Math & Phys Life Sci & Expt Biol, London, England; [Seymour, Robert M.] UCL, Dept Math, London, England; [Rodrigo Garza-Perez, Joaquin] Univ Nacl Autonoma Mexico, Fac Ciencias, Unidad Multidisciplinaria Docencia & Invest Sisal, Puerto Abrigo S-N, Sisal, Yucatan, Mexico; [Acosta-Gonzalez, Gilberto] Ctr Invest Cient Yucatan AC, Unidad Ciencias Agua, Calle 8 29 Mza 39 SM 64, Cancun, Q Roo Cp, Mexico; [Bozec, Yves-Marie] Univ Queensland, Marine Spatial Ecol Lab, Sch Biol Sci, St Lucia, Qld, Australia; [Bozec, Yves-Marie] Univ Queensland, Australian Res Council Ctr Excellence Coral Reef, St Lucia, Qld, Australia; [Johnson, Craig R.] Univ Tasmania, Inst Marine & Antarctic Studies, Private Bag 129, Hobart, Tas, Australia	Instituto Politecnico Nacional - Mexico; National University of Singapore; University of London; University College London; University of London; University College London; Universidad Nacional Autonoma de Mexico; Centro de Investigacion Cientifica de Yucatan; University of Queensland; University of Queensland; University of Tasmania	Arias-Gonzalez, JE (corresponding author), IPN, Lab Ecol Ecosistemas Arrecifes Coralinos, Ctr Invest & Estudios Avanzados, Dept Recursos Mar,Unidad Merida, Carr Ant Progreso Km 6,AP 73 Cordemex, Merida, Yucatan, Mexico.	earias@cinvestav.mx	Bozec, Yves-Marie/J-7168-2013	Bozec, Yves-Marie/0000-0002-7190-5187; Arias-Gonzalez, Jesus Ernesto/0000-0003-4601-710X; Garza, Rodrigo/0000-0003-4209-3738	Consejo Nacional de Ciencia Tecnologia grant; National University of Singapore grants [WBS R-154-000-603-112, R-154-000-560-651, R-154-000-A10-720, R-154-000-A10-597]	Consejo Nacional de Ciencia Tecnologia grant; National University of Singapore grants(National University of Singapore)	JEAG was supported by Consejo Nacional de Ciencia Tecnologia grant (http://www.conacyt.gob.mx); and TF by National University of Singapore grants WBS R-154-000-603-112, R-154-000-560-651, R-154-000-A10-720, and R-154-000-A10-597.	Acosta-Gonzalez G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065665; AguilarPerera A, 1996, ENVIRON BIOL FISH, V45, P351, DOI 10.1007/BF00002527; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Arias-Gonzalez JE, 2006, MAR ECOL PROG SER, V320, P29, DOI 10.3354/meps320029; Babcock R, 2002, P 9 INT COR REEF S B, P245; Baker DM, 2010, LIMNOL OCEANOGR, V55, P2139, DOI 10.4319/lo.2010.55.5.2139; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Birrell CL, 2008, OCEANOGR MAR BIOL, V46, P25; Birrell CL, 2005, MAR POLLUT BULL, V51, P408, DOI 10.1016/j.marpolbul.2004.10.022; Bozec YM, 2008, P 11 INT COR REEF S, P69; Bozec YM, 2016, P NATL ACAD SCI USA, V113, P4536, DOI 10.1073/pnas.1601529113; Bruno JF, 2003, ECOL LETT, V6, P1056, DOI 10.1046/j.1461-0248.2003.00544.x; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; Burke L., 2011, REEFS RISK REVISITED; BYTHELL JC, 1993, CORAL REEFS, V12, P143, DOI 10.1007/BF00334474; Carruthers TJB, 2005, ESTUAR COAST SHELF S, V64, P191, DOI 10.1016/j.ecss.2005.01.015; Cinner J., 2000, THESIS; Claro R, 2001, ECOLOGY MARINE FISHE; CORTES J, 1985, B MAR SCI, V36, P339; DELGADO O, 1994, CORAL REEFS, V13, P151, DOI 10.1007/BF00301191; Diaz-Ortega G, 2014, NAT RESOUR, V05, P561; Diaz-Pulido G, 2002, MAR ECOL PROG SER, V232, P115, DOI 10.3354/meps232115; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; Dudgeon SR, 2010, MAR ECOL PROG SER, V413, P201, DOI 10.3354/meps08751; Duprey NN., 2016, GLOBAL CHANGE BIOL; Edwards CB, 2016, P ROYAL SOC B, V281; Fabinyi M, 2014, CONSERV SOC, V12, P218, DOI 10.4103/0972-4923.138423; Fung T, 2011, ECOLOGY, V92, P967, DOI 10.1890/10-0378.1; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gonzalez-Gandara C., 2003, Naga, V26, P14; Gurney GG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080137; Hernandez-Terrones LM, 2015, CONT SHELF RES, V102, P62, DOI 10.1016/j.csr.2015.04.015; *HRI, 2008, EC REP CARD MES REEF; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; JACKSON JBC, 1986, B MAR SCI, V39, P588; Jompa J, 2002, J EXP MAR BIOL ECOL, V271, P25, DOI 10.1016/S0022-0981(02)00040-0; KLUMPP DW, 1989, J EXP MAR BIOL ECOL, V131, P1, DOI 10.1016/0022-0981(89)90008-7; Lapointe BE, 2005, HARMFUL ALGAE, V4, P1092, DOI 10.1016/j.hal.2005.06.004; Lapointe BE, 2005, HARMFUL ALGAE, V4, P1106, DOI 10.1016/j.hal.2005.06.002; Lapointe BE, 1997, LIMNOL OCEANOGR, V42, P1119, DOI 10.4319/lo.1997.42.5_part_2.1119; Larned ST, 1998, MAR BIOL, V132, P409, DOI 10.1007/s002270050407; Leal-Bautista RM., 2011, TROPICAL SUBTROPICAL, V13; lvarez-Filip L, 2015, REPORT CARD MESOAMER; Mangi SC, 2007, OCEAN COAST MANAGE, V50, P463, DOI 10.1016/j.ocecoaman.2006.10.003; Castro-Perez JM, 2011, HIDROBIOLOGICA, V21, P197; Martinez-Rendis A, 2016, MAR ECOL-EVOL PERSP, V37, P697, DOI 10.1111/maec.12334; McCook L.J., 2007, CLIMATE CHANGE GREAT, P75; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; Medina-Moreno SA, 2014, REV MEX ING QUIM, V13, P509; Melbourne-Thomas J, 2011, ECOL APPL, V21, P1380, DOI 10.1890/09-1564.1; Merino M., 1992, SCI TOTAL ENVIRON, V26, P861; Metcalfe CD, 2011, ENVIRON POLLUT, V159, P991, DOI 10.1016/j.envpol.2010.11.031; Miller D, 1982, THESIS; Mora C, 2006, SCIENCE, V312, P1750, DOI 10.1126/science.1125295; Mumby PJ, 2007, NATURE, V450, P98, DOI 10.1038/nature06252; Mumby PJ, 2006, ECOL MODEL, V196, P131, DOI 10.1016/j.ecolmodel.2005.11.035; Mumby PJ, 2006, ECOL APPL, V16, P747, DOI 10.1890/1051-0761(2006)016[0747:TIOEGS]2.0.CO;2; Mutchler T, 2007, ESTUAR COAST SHELF S, V74, P449, DOI 10.1016/j.ecss.2007.04.005; Nugues MM, 2006, MAR ECOL PROG SER, V315, P75, DOI 10.3354/meps315075; Nugues MM, 2003, CORAL REEFS, V22, P507, DOI 10.1007/s00338-003-0338-x; Nugues MM, 2004, ECOL LETT, V7, P919, DOI 10.1111/j.1461-0248.2004.00651.x; Nunez-Lara E, 2005, J EXP MAR BIOL ECOL, V324, P157, DOI 10.1016/j.jembe.2005.04.011; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Richmond Robert H., 1997, P175; Russ G.R., 1988, P37; Schaffelke B, 1998, MAR ECOL PROG SER, V164, P199, DOI 10.3354/meps164199; STENECK RS, 1994, OIKOS, V69, P476, DOI 10.2307/3545860; Suchley A, 2016, PEERJ, V4, DOI 10.7717/peerj.2084; Sutherland KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023468; Sutherland KP, 2010, ENVIRON MICROBIOL, V12, P1122, DOI 10.1111/j.1462-2920.2010.02152.x; Thurber RLV, 2014, GLOBAL CHANGE BIOL, V20, P544, DOI 10.1111/gcb.12450; Thurber RV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044246; Torres RM, 2005, ANN ASSOC AM GEOGR, V95, P314, DOI 10.1111/j.1467-8306.2005.00462.x; Torres-Alvarado M.R., 2012, CONTACTOS, V85, P42; Wear SL, 2015, SEWAGE POLLUTION MIT; Weynberg KD, 2015, SCI REP-UK, V5, DOI 10.1038/srep17889	78	57	57	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0174855	10.1371/journal.pone.0174855	http://dx.doi.org/10.1371/journal.pone.0174855			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445546	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000400309200012
J	Liu, YL; Wu, S; Liu, ZZ; Chao, H				Liu, Yongli; Wu, Shuai; Liu, Zhizhong; Chao, Hao			A fuzzy co-clustering algorithm for biomedical data	PLOS ONE			English	Article							INFORMATION BOTTLENECK; DOCUMENTS	Fuzzy co-clustering extends co-clustering by assigning membership functions to both the objects and the features, and is helpful to improve clustering accurarcy of biomedical data. In this paper, we introduce a new fuzzy co-clustering algorithm based on information bottleneck named ibFCC. The ibFCC formulates an objective function which includes a distance function that employs information bottleneck theory to measure the distance between feature data point and the feature cluster centroid. Many experiments were conducted on five biomedical datasets, and the ibFCC was compared with such prominent fuzzy (co-)clustering algorithms as FCM, FCCM, RFCC and FCCI. Experimental results showed that ibFCC could yield high quality clusters and was better than all these methods in terms of accuracy.	[Liu, Yongli; Wu, Shuai; Liu, Zhizhong; Chao, Hao] Henan Polytech Univ, Sch Comp Sci & Technol, Jiaozuo, Henan, Peoples R China	Henan Polytechnic University	Liu, YL (corresponding author), Henan Polytech Univ, Sch Comp Sci & Technol, Jiaozuo, Henan, Peoples R China.	yongli.buaa@gmail.com			Natural Science Foundation of China [61202286]; Foundation for University Key Teacher by Henan Province [015GGJS-068]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for University Key Teacher by Henan Province	The authors gratefully acknowledge that this research work was supported by fundings from Natural Science Foundation of China under Frant no. 61202286 (http://www.nsfc.gov.cn/) and Foundation for University Key Teacher by Henan Province under Grant no. 2015GGJS-068(http:// www.haedu.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bache Kevin, 2013, UCI MACHINE LEARNING; Bezdek J. C., 1981, PATTERN RECOGN, V22, P203; Chen XJ, 2013, IEEE T KNOWL DATA EN, V25, P932, DOI 10.1109/TKDE.2011.262; de Carvalho FD, 2015, NEUROCOMPUTING, V163, P115, DOI 10.1016/j.neucom.2014.11.083; Deng ZH, 2016, INFORM SCIENCES, V348, P84, DOI 10.1016/j.ins.2016.01.101; Gupta N, 2010, PATTERN RECOGN, V43, P2692, DOI 10.1016/j.patcog.2010.03.002; Hammouda KM, 2004, IEEE T KNOWL DATA EN, V16, P1279, DOI 10.1109/TKDE.2004.58; Hanmandlu M, 2013, NEUROCOMPUTING, V120, P235, DOI 10.1016/j.neucom.2012.09.043; Hersh W, 1994, OHSUMED INTERACTIVE, P192; Honda K, 2012, INT J COMPUTER SCI N; HONG ZQ, 1991, PATTERN RECOGN, V24, P317, DOI 10.1016/0031-3203(91)90074-F; Jiang YZ, 2015, IEEE T CYBERNETICS, V45, P688, DOI 10.1109/TCYB.2014.2334595; Liu Y, 2012, RES INCREMENTAL CLUS, P2803; Liu YL, 2016, J BEIJING U POSTS TE; Liu YL, 2016, J BIOMED INFORM, V62, P48, DOI 10.1016/j.jbi.2016.05.009; Liu YF, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/795101; Mei JP, 2014, IEEE INT FUZZY SYST, P1518, DOI 10.1109/FUZZ-IEEE.2014.6891554; Oh CH, 2001, FUZZY CLUSTERING CAT, V2154, P2154; Rashedi E, 2015, NEUROCOMPUTING, V148, P487, DOI 10.1016/j.neucom.2014.07.014; Saha A, 2015, NEUROCOMPUTING, V166, P422, DOI 10.1016/j.neucom.2015.03.037; Slonim N, 2000, DOCUMENT CLUSTERING, P208; Slonim N, 2002, UNSUPERVISED DOCUMEN, P129; Tjhi WC, 2006, PATTERN RECOGN LETT, V27, P151, DOI 10.1016/j.patrec.2005.07.012; Tjhi WC, 2007, ROBUST FUZZY COCLUST, P1; Tjhi WC, 2007, PATTERN RECOGN, V40, P3452, DOI 10.1016/j.patcog.2007.04.017; Ucar D, 2006, LECT NOTES COMPUTER, V363, P371; Wan XJ, 2007, INFORM SCIENCES, V177, P3718, DOI 10.1016/j.ins.2007.02.045; Wikaisuksakul S, 2014, APPL SOFT COMPUT, V24, P679, DOI 10.1016/j.asoc.2014.08.036; Yan Y, 2013, FUZZY SET SYST, V215, P74, DOI 10.1016/j.fss.2012.10.016; Ye YD, 2015, PATTERN RECOGN LETT, V51, P70, DOI 10.1016/j.patrec.2014.08.007	30	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176536	10.1371/journal.pone.0176536	http://dx.doi.org/10.1371/journal.pone.0176536			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445496	Green Published, gold, Green Submitted			2022-12-26	WOS:000400309200071
J	Dharmarajan, K; Foster, J; Coylewright, M; Green, P; Vavalle, JP; Faheem, O; Huang, PH; Krishnaswamy, A; Thourani, VH; McCoy, LA; Wang, TY				Dharmarajan, Kumar; Foster, Jill; Coylewright, Megan; Green, Philip; Vavalle, John P.; Faheem, Osman; Huang, Pei-Hsiu; Krishnaswamy, Amar; Thourani, Vinod H.; McCoy, Lisa A.; Wang, Tracy Y.			The medically managed patient with severe symptomatic aortic stenosis in the TAVR era: Patient characteristics, reasons for medical management, and quality of shared decision making at heart valve treatment centers	PLOS ONE			English	Article							OF-LIFE CARE; INTERMEDIATE-RISK; ELDERLY-PATIENTS; PALLIATIVE CARE; NATURAL-HISTORY; BAD-NEWS; TRANSCATHETER; REPLACEMENT; OUTCOMES; COMMUNICATION	Background Little is known about patients with severe symptomatic aortic stenosis (AS) who receive medical management despite evaluation at a heart valve treatment center. Objective We identified patient characteristics associated with medical management, physicianreported reasons for selecting medical management, and patients' perceptions of their involvement and satisfaction with treatment selection. Methods and results Of 454 patients evaluated for AS at 9 established heart valve treatment centers from December 12, 2013 to August 19, 2014, we included 407 with severe symptomatic AS. Information was collected using medical record review and survey of patients and treating physicians. Of 407 patients, 212 received transcatheter aortic valve replacement (TAVR), 124 received surgical aortic valve replacement (SAVR), and 71 received medical management (no SAVR/TAVR). Thirty-day predicted mortality was higher in patients receiving TAVR (8.7%) or medical management (9.8%) compared with SAVR (3.4%) (P< 0.001). Physician- reported reasons for medical management included patient preference (31.0%), medical futility (19.7%), inoperability/anatomic infeasibility (11.3%), and inadequate vascular access (8.5%). Compared with patients receiving AVR, medically managed patients were less likely to report that they received enough information about the pros and cons of treatment options (P = 0.03), that their physicians involved them in treatment decisions (P< 0.001), and that final decisions were the right ones (P< 0.001). Conclusions Patient preference was the most common physician-reported reason for selecting non-invasive AS management, yet patients not undergoing AVR after valve center evaluation reported being less likely to receive sufficient education about treatment options and more likely to feel uncertain about final treatment decisions. Greater attention to shared decision making may improve the experience of care for this vulnerable group of patients.	[Dharmarajan, Kumar] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Dharmarajan, Kumar] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA; [Foster, Jill] Amer Coll Cardiol, Washington, DC USA; [Coylewright, Megan] Dartmouth Hitchcock Med Ctr, Sect Cardiovasc Med, Lebanon, NH 03766 USA; [Green, Philip] Columbia Univ, Div Cardiol, Ctr Intervent Vasc Therapy, Med Ctr, New York, NY USA; [Vavalle, John P.] Univ North Carolina Chapel Hill, Div Cardiol, Dept Med, Chapel Hill, NC USA; [Faheem, Osman] Prima Care Cardiol, Fall River, MA USA; [Huang, Pei-Hsiu] Sutter Heart & Vasc Inst, Sacramento, CA USA; [Krishnaswamy, Amar] Cleveland Clin, Dept Cardiovasc Med, Div Intervent Cardiol, Inst Heart & Vasc, Cleveland, OH 44106 USA; [Thourani, Vinod H.] Emory Univ, Sch Med, Div Cardiothorac Surg, Atlanta, GA 30322 USA; [McCoy, Lisa A.; Wang, Tracy Y.] Duke Clin Res Inst, Durham, NC USA	Yale University; American College of Cardiology; Dartmouth College; Columbia University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Cleveland Clinic Foundation; Emory University; Duke University	Dharmarajan, K (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA.; Dharmarajan, K (corresponding author), Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA.	kumar.dharmarajan@yale.edu	thourani, vinod/AAP-5968-2020	Douglas, Pamela/0000-0001-9876-4049	Edwards Lifesciences Fund; Edwards Lifesciences; Boston Scientific; Medtronic; St. Jude Medical; National Institute on Aging [K23AG048331]; American Federation for Aging Research; National Institute on Aging via the Yale Claude D. Pepper Older Americans Independence Center [P30AG021342]; National Heart, Lung, and Blood Institute [K23HL12114]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL121142] Funding Source: NIH RePORTER	Edwards Lifesciences Fund; Edwards Lifesciences; Boston Scientific(Boston Scientific); Medtronic(Medtronic); St. Jude Medical(St. Jude Medical); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Federation for Aging Research; National Institute on Aging via the Yale Claude D. Pepper Older Americans Independence Center; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by unrestricted educational grants to the ACC from the Edwards Lifesciences Fund, Edwards Lifesciences, Boston Scientific (to KD), Medtronic (to KD), and St. Jude Medical (to KD). Dr. Dharmarajan is supported by grant K23AG048331 from the National Institute on Aging and the American Federation for Aging Research through the Paul B. Beeson Career Development Award Program. He is also supported by grant P30AG021342 from the National Institute on Aging via the Yale Claude D. Pepper Older Americans Independence Center. Dr. Green is supported by grant K23HL12114 from the National Heart, Lung, and Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Edwards Lifesciences Fund; Edwards Lifesciences; Boston Scientific; Medtronic; St. Jude Medical; the National Institute on Aging; the National Heart, Lung, and Blood Institute; or the American Federation for Aging Research.	Adams DH, 2014, NEW ENGL J MED, V370, P1790, DOI 10.1056/NEJMoa1400590; Adams K, 2012, J AM GERIATR SOC, V60, P2333, DOI 10.1111/j.1532-5415.2012.04240.x; Adler ED, 2009, CIRCULATION, V120, P2597, DOI 10.1161/CIRCULATIONAHA.109.869123; Allen LA, 2012, CIRCULATION, V125, P1928, DOI 10.1161/CIR.0b013e31824f2173; Bach DS, 2007, J AM COLL CARDIOL, V50, P2018, DOI 10.1016/j.jacc.2007.08.011; Back A, 2010, MASTERING COMMUNICAT; Back AL, 2007, ARCH INTERN MED, V167, P453, DOI 10.1001/archinte.167.5.453; Bouma BJ, 1999, HEART, V82, P143, DOI 10.1136/hrt.82.2.143; Carroll JD, 2013, J AM COLL CARDIOL, V62, P1026, DOI 10.1016/j.jacc.2013.03.060; Charlson E, 2006, J HEART VALVE DIS, V15, P312; CHEITLIN MD, 1979, AM HEART J, V98, P689, DOI 10.1016/0002-8703(79)90465-4; CHIZNER MA, 1980, AM HEART J, V99, P419, DOI 10.1016/0002-8703(80)90375-0; Coylewright M, 2016, HEALTH EXPECT, V19, P1036, DOI 10.1111/hex.12393; Coylewright M, 2015, J AM COLL CARDIOL, V65, P1472, DOI 10.1016/j.jacc.2015.02.033; El-Jawahri A, 2010, J CLIN ONCOL, V28, P305, DOI 10.1200/JCO.2009.24.7502; Fang JC, 2015, J CARD FAIL, V21, P519, DOI 10.1016/j.cardfail.2015.04.013; Fujimori M, 2014, J CLIN ONCOL, V32, P2166, DOI 10.1200/JCO.2013.51.2756; Gilard M, 2012, NEW ENGL J MED, V366, P1705, DOI 10.1056/NEJMoa1114705; Goodlin SJ, 2009, J AM COLL CARDIOL, V54, P386, DOI 10.1016/j.jacc.2009.02.078; Harold JG, 2014, J AM COLL CARDIOL, V63, pE57, DOI 10.1016/j.jacc.2014.02.536; Holmes DR, 2015, JAMA-J AM MED ASSOC, V313, P1019, DOI 10.1001/jama.2015.1474; Institute of Medicine, 2014, DYING AM IMPR QUAL H; Iung B, 2005, EUR HEART J, V26, P2714, DOI 10.1093/eurheartj/ehi471; Iung B, 2003, EUR HEART J, V24, P1231, DOI 10.1016/S0195-668X(03)00201-X; Kelley AS, 2012, J AM GERIATR SOC, V60, P332, DOI 10.1111/j.1532-5415.2011.03787.x; Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384; Lauck S, 2014, EUR J CARDIOVASC NUR, V13, P177, DOI 10.1177/1474515114520770; Leon MB, 2016, NEW ENGL J MED, V374, P1609, DOI 10.1056/NEJMoa1514616; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Mack MJ, 2013, JAMA-J AM MED ASSOC, V310, P2069, DOI 10.1001/jama.2013.282043; Makkar RR, 2012, NEW ENGL J MED, V366, P1696, DOI 10.1056/NEJMoa1202277; Moore PM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003751.pub3; OTTO CM, 1989, J AM COLL CARDIOL, V13, P545, DOI 10.1016/0735-1097(89)90590-1; ROSS J, 1968, CIRCULATION, V38, pV61, DOI 10.1161/01.CIR.38.1S5.V-61; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Thomas M, 2011, CIRCULATION, V124, P425, DOI 10.1161/CIRCULATIONAHA.110.001545; Thourani VH, 2016, LANCET, V387, P2218, DOI 10.1016/S0140-6736(16)30073-3; Thourani VH, 2015, ANN THORAC SURG, V99, P55, DOI 10.1016/j.athoracsur.2014.06.050; Tulsky JA, 2015, JAMA INTERN MED, V175, P840, DOI 10.1001/jamainternmed.2014.8425; van Geldorp MWA, 2009, EUR J CARDIO-THORAC, V35, P953, DOI 10.1016/j.ejcts.2009.01.043; Varadarajan P, 2006, ANN THORAC SURG, V82, P2111, DOI 10.1016/j.athoracsur.2006.07.048; Volandes AE, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2159; Wachterman MW, 2016, JAMA INTERN MED, V176, P1095, DOI 10.1001/jamainternmed.2016.1200; Whellan DJ, 2014, J CARD FAIL, V20, P121, DOI 10.1016/j.cardfail.2013.12.003	44	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0175926	10.1371/journal.pone.0175926	http://dx.doi.org/10.1371/journal.pone.0175926			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KN	28430791	gold, Green Published			2022-12-26	WOS:000399876100022
J	Gopal, A; Chidambaram, IS; Devaraj, N; Devaraj, H				Gopal, Ashidha; Chidambaram, Iyer Soumya; Devaraj, Niranjali; Devaraj, Halagowder			Shigella dysenteriae infection activates proinflammatory response through beta-catenin/NF-kappa B signaling pathway	PLOS ONE			English	Article							INTESTINAL STEM-CELLS; EPITHELIAL-CELLS; MESSENGER-RNA; INTERLEUKIN-8; INFLAMMATION; MACROPHAGES; EXPRESSION; DIFFERENTIATION; CROSSTALK; CANCER	Shigella dysenteriae (S.dysenteriae) the causative agent of bacillary dysentery invades the human colonic epithelium resulting in severe intestinal inflammatory response and epithelial destruction. However, the mechanism by which S.dysenteriae infection regulates proinflammatory cytokines during intestinal inflammation is still obscure. In this study, we evaluated whether the interaction of beta-catenin and NF-kappa B regulates proinflammatory cytokines TNF-alpha and IL-8 by modulating GSK-3 beta activity during S.dysenteriae infection in rat ileal loop model. Here we demonstrated that S.dysenteriae infection stimulate beta-catenin degradation which in turn decreased the association between NF-kappa B and beta-catenin. Also, we showed that S.dysenteriae infection increased GSK-3 beta kinase activity which in turn phosphorylates beta-catenin for its degradation by ubiquitination and upregulates IL-8 through NF-kappa B activation thereby leading to inflammation. Thus these findings revealed the role of beta-catenin/NF-kappa B and GSK-3 beta in modulating the inflammatory response during bacterial infection and also showed that beta-catenin acts as a critical regulator of inflammation.	[Gopal, Ashidha; Chidambaram, Iyer Soumya; Devaraj, Halagowder] Univ Madras, Dept Zool, Unit Biochem, Madras, Tamil Nadu, India; [Devaraj, Niranjali] Univ Madras, Dept Biochem, Madras, Tamil Nadu, India; [Chidambaram, Iyer Soumya] Penn State Univ, Dept Pharmacol, Coll Med, Hershey, PA USA	University of Madras; University of Madras; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Devaraj, H (corresponding author), Univ Madras, Dept Zool, Unit Biochem, Madras, Tamil Nadu, India.	hdrajum@yahoo.com						BARKER JNWN, 1991, AM J PATHOL, V139, P869; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; Duan YL, 2007, LAB INVEST, V87, P613, DOI 10.1038/labinvest.3700545; ECKMANN L, 1993, INFECT IMMUN, V61, P4569, DOI 10.1128/IAI.61.11.4569-4574.1993; GILLITZER R, 1991, J INVEST DERMATOL, V97, P73, DOI 10.1111/1523-1747.ep12478128; Gomez HF, 2002, INFECT IMMUN, V70, P7050, DOI 10.1128/IAI.70.12.7050-7053.2002; Gopal A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111408; Gustafson B, 2006, J BIOL CHEM, V281, P9507, DOI 10.1074/jbc.M512077200; Halleskog C, 2011, GLIA, V59, P119, DOI 10.1002/glia.21081; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Liu XY, 2010, FEBS LETT, V584, P911, DOI 10.1016/j.febslet.2010.01.024; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; MATSUSHIMA K, 1988, J EXP MED, V167, P1883, DOI 10.1084/jem.167.6.1883; MOOLENBEEK C, 1981, LAB ANIM, V15, P57, DOI 10.1258/002367781780958577; Nava P, 2010, IMMUNITY, V32, P392, DOI 10.1016/j.immuni.2010.03.001; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; Neumann J, 2010, FASEB J, V24, P4599, DOI 10.1096/fj.10-160994; Prakash R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027046; Raja SB, 2012, J CELL SCI, V125, P703, DOI 10.1242/jcs.092148; Rogler G, 1998, GASTROENTEROLOGY, V115, P357, DOI 10.1016/S0016-5085(98)70202-1; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sansonetti PJ, 1999, INFECT IMMUN, V67, P1471, DOI 10.1128/IAI.67.3.1471-1480.1999; Sauvonnet N, 2002, MOL MICROBIOL, V45, P805, DOI 10.1046/j.1365-2958.2002.03053.x; Scoville DH, 2008, GASTROENTEROLOGY, V134, P849, DOI 10.1053/j.gastro.2008.01.079; Sen M, 2008, J IMMUNOL, V181, P4441, DOI 10.4049/jimmunol.181.7.4441; Shaikh N, 2003, MICROB PATHOGENESIS, V35, P107, DOI 10.1016/S0882-4010(03)00093-7; Silva-Garcia O, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/310183; Sun J, 2005, AM J PHYSIOL-GASTR L, V289, pG129, DOI 10.1152/ajpgi.00515.2004; Sun J, 2004, AM J PHYSIOL-GASTR L, V287, pG220, DOI 10.1152/ajpgi.00498.2003; Udhayakumar G, 2011, MOL CELL BIOCHEM, V357, P283, DOI 10.1007/s11010-011-0899-x; Umar S, 2009, J BIOL CHEM, V284, P22274, DOI 10.1074/jbc.M109.020941; Wang H, 2009, J OPTOELECTRON BIOME, V1, P1; Wang XH, 2004, ARTERIOSCL THROM VAS, V24, P85, DOI 10.1161/01.ATV.0000104012.40720.c4; You J, 2008, DIGEST DIS SCI, V53, P1013, DOI 10.1007/s10620-007-9973-3	37	5	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0174943	10.1371/journal.pone.0174943	http://dx.doi.org/10.1371/journal.pone.0174943			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430783	Green Published, gold, Green Submitted			2022-12-26	WOS:000399876100008
J	Vicente, A; Ruiz, AJO; Paz, BMG; Lopez, JG; Bravo-Gonzalez, LA				Vicente, Ascension; Ortiz Ruiz, Antonio Jose; Gonzalez Paz, Belen Manuela; Garcia Lopez, Jose; Bravo-Gonzalez, Luis-Alberto			Efficacy of fluoride varnishes for preventing enamel demineralization after interproximal enamel reduction. Qualitative and quantitative evaluation	PLOS ONE			English	Article							HYDROXYAPATITE; RELEASE	Objectives To evaluate quantitatively and qualitatively the changes produced to enamel after interproximal reduction and subjected to demineralization cycles, after applying a fluoride varnish (Profluorid) and a fluoride varnish containing tricalcium phosphate modified by fumaric acid (Clinpro White). Materials and methods 138 interproximal dental surfaces were divided into six groups: 1) Intact enamel; 2) Intact enamel + demineralization cycles (DC); 3) Interproximal Reduction (IR); 4) IR + DC; 5) IR + Profluorid + DC; 6) IR + Clinpro White + DC. IR was performed with a 0.5 mm cylindrical diamond bur. The weight percentage of calcium (Ca), phosphorous (P) and fluoride (F) were quantified by energy-dispersive X-ray spectrometry (EDX). Samples were examined under scanning electron microscopy (SEM). Results The weight percentage of Ca was significantly higher (p < 0.05) in Groups 1, 2 and 5 than Groups 4 and 6. No significant differences were detected in the weight percentage of Ca between Group 3 and the other groups (p > 0.05). The weight percentage of P was similar among all six groups (p > 0.05). F was detected on 65% of Group 6 surfaces. SEM images of Groups 4 and 6 showed signs of demineralization, while Group 5 did not. Conclusions Profluorid application acts as a barrier against the demineralization of interproximally reduced enamel.	[Vicente, Ascension; Gonzalez Paz, Belen Manuela; Garcia Lopez, Jose; Bravo-Gonzalez, Luis-Alberto] Univ Murcia, Hosp Morales Meseguer, Dept Orthodont, Fac Med, 2a Planta,C Marques de los Velez S-N, Murcia, Spain; [Ortiz Ruiz, Antonio Jose] Univ Murcia, Hosp Morales Meseguer, Dept Integral Pediat Dent, Fac Med, 2a Planta,C Marques de los Velez S-N, Murcia, Spain	University of Murcia; University of Murcia	Vicente, A (corresponding author), Univ Murcia, Hosp Morales Meseguer, Dept Orthodont, Fac Med, 2a Planta,C Marques de los Velez S-N, Murcia, Spain.	ascenvi@um.es	BRAVO-GONZÁLEZ, LUIS-ALBERTO/S-5963-2016; Ortiz-Ruiz, Antonio J/M-2458-2018; Vicente, Ascensión/ABG-2404-2020	BRAVO-GONZÁLEZ, LUIS-ALBERTO/0000-0002-5141-4145; Ortiz-Ruiz, Antonio J/0000-0001-9113-8416; Vicente, Ascensión/0000-0002-7257-5124				Arman A, 2006, AM J ORTHOD DENTOFAC, V130, DOI 10.1016/j.ajodo.2006.01.021; Baumgartner S, 2015, PROG ORTHOD, V16, DOI 10.1186/s40510-014-0071-8; Bolis C, 2015, ORAL HLTH PREV DENT, V13, P545, DOI 10.3290/j.ohpd.a34373; Bonetti GA, 2014, SCANNING, V36, P356, DOI 10.1002/sca.21125; Cochrane N, 2014, AUST DENT J, V59, P100, DOI 10.1111/adj.12144; Cosio DJ, 2011, ORAL, V35, P642; Elkassas D, 2014, J DENT, V42, P466, DOI 10.1016/j.jdent.2013.12.017; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Giulio AB, 2009, J DENT, V37, P228, DOI 10.1016/j.jdent.2008.11.015; He B, 2011, ARCH ORAL BIOL, V56, P997, DOI 10.1016/j.archoralbio.2011.02.015; He B, 2010, ARCH ORAL BIOL, V55, P134, DOI 10.1016/j.archoralbio.2009.12.005; He T, 2016, AM J ORTHOD DENTOFAC, V149, P810, DOI 10.1016/j.ajodo.2015.12.010; Hellak AF, 2015, CLIN ORAL INVEST, V19, P1965, DOI 10.1007/s00784-015-1429-0; Jarjoura K, 2006, AM J ORTHOD DENTOFAC, V130, P26, DOI 10.1016/j.ajodo.2004.08.024; Kirschneck C, 2016, CLIN ORAL INVESTIG; Klockars A, 1986, SAGE U PAPER SERIES, P07; Lapenaite Egle, 2014, Stomatologija, V16, P19; Livas C, 2013, OPEN DENT J, V7, P146, DOI 10.2174/1874210601307010146; Llena-Puy Carmen, 2006, Med Oral Patol Oral Cir Bucal, V11, pE449; Medieiros MI Dantasde, 2016, BRAZ ORAL RES, V30, pe75; Mehta A, 2015, AM J ORTHOD DENTOFAC, V148, P814, DOI 10.1016/j.ajodo.2015.05.022; Oncag G, 2005, ANGLE ORTHOD, V75, P247; Paganelli C, 2015, SCANNING, V37, P73, DOI 10.1002/sca.21181; Patil Namrata, 2013, J Conserv Dent, V16, P116, DOI 10.4103/0972-0707.108185; Peng Y, 2016, DENT MATER J, V35, P756, DOI 10.4012/dmj.2015-398; Perrini F, 2016, AM J ORTHOD DENTOFAC, V149, P238, DOI 10.1016/j.ajodo.2015.07.039; Rossouw P Emile, 2003, J Can Dent Assoc, V69, P378; Shen P, 2015, AUST DENT J; Sheridan J J, 1985, J Clin Orthod, V19, P43; Wei J, 2011, J MATER SCI-MATER M, V22, P1607, DOI 10.1007/s10856-011-4327-2; Yoda A, 2006, DENT MATER J, V25, P261, DOI 10.4012/dmj.25.261; Zingler S, 2016, CLIN ORAL INVEST, V20, P933, DOI 10.1007/s00784-015-1585-2	32	15	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0176389	10.1371/journal.pone.0176389	http://dx.doi.org/10.1371/journal.pone.0176389			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430810	gold, Green Submitted, Green Published			2022-12-26	WOS:000399876100043
J	Volpini, LPB; Boldrini, NAT; de Freitas, LB; Miranda, AE; Spano, LC				Bondi Volpini, Lays Paula; Tosato Boldrini, Neide Aparecida; de Freitas, Luciana Bueno; Miranda, Angelica Espinosa; Spano, Liliana Cruz			The high prevalence of HPV and HPV16 European variants in cervical and anal samples of HIV-seropositive women with normal Pap test results	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPES; ONCOGENIC HUMAN-PAPILLOMAVIRUS; INFECTED WOMEN; NUCLEOTIDE-SEQUENCE; CANCER; RISK; AMPLIFICATION; TYPE-16; LESIONS	Human Immunodeficiency Virus (HIV)-seropositive women are more likely to have anogenital cancer, and high risk-HPV (HR-HPV) infection is the main associated factor. Between August 2013 and December 2015, we conducted a descriptive study to determine the HPV genotypes and HPV16 variants in cervical and anal samples of HIV-seropositive women with a normal Pap test. The viral DNA was amplified by PCR using the PGMY09/11 set of primers. Reverse line blot (RLB), restriction fragment length polymorphism (RFLP) and sequencing assays were used to determine the HPV genotypes. HPV16 variants were identified by gene sequencing. We found a high frequency of HR-HPV (60.3%; 76/126) at the anogenital site among HIV-seropositive women and without association with anal intercourse. HPV16 and European variant predominated among the HR-HPV. Mixed infections with at least three different HPV types were common, particularly at the anal site. CD4+ T-cell counts below 500 cells/mm(3), a HIV viral load above 50 copies/mL and an age of 18 to 35 years old were all related to HPV anal infection. Our study showed a high frequency of HR-HPV in both cervical and anal sites of women with negative cytology belonging to a risk group for the development of anogenital cancer.	[Bondi Volpini, Lays Paula; Tosato Boldrini, Neide Aparecida; de Freitas, Luciana Bueno; Miranda, Angelica Espinosa; Spano, Liliana Cruz] Univ Fed Espirito Santo, Postgrad Program Infect Dis, Vitoria, Brazil; [Miranda, Angelica Espinosa] Univ Fed Espirito Santo, Ctr Hlth Sci, Dept Social Med, Vitoria, Brazil; [Spano, Liliana Cruz] Univ Fed Espirito Santo, Ctr Hlth Sci, Dept Pathol, Vitoria, Brazil	Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo	Volpini, LPB (corresponding author), Univ Fed Espirito Santo, Postgrad Program Infect Dis, Vitoria, Brazil.	layspaula90@gmail.com	Miranda, Angelica/AAE-5571-2021	Miranda, Angelica/0000-0002-5556-8379	Research Foundation of Espirito Santo State - FAPES [54677300/2011]; CAPES Foundation; Ministry of Education of Brazil	Research Foundation of Espirito Santo State - FAPES; CAPES Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Ministry of Education of Brazil	This work was supported by the Research Foundation of Espirito Santo State - FAPES 54677300/2011 (https://fapes.es.gov.br/). The first author had a scholarship from CAPES Foundation, Ministry of Education of Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anttila A, 2009, EUR J CANCER, V45, P2685, DOI 10.1016/j.ejca.2009.07.017; BERNARD HU, 1994, J INFECT DIS, V170, P1077, DOI 10.1093/infdis/170.5.1077; Brasil Ministerio da Saude, 2015, PROTOCOLO CLINICO E; Brasil Ministerio da Saude/INCa, 2006, J BRAS PATOL MED LAB, V42, P351, DOI DOI 10.1590/S1676-24442006000500008; Bruni L., 2016, SUMMARY REPORT; Burk RD, 2013, VIROLOGY, V445, P232, DOI 10.1016/j.virol.2013.07.018; Cambou MC, 2015, AIDS PATIENT CARE ST, V29, P4, DOI 10.1089/apc.2014.0166; Castle PE, 2012, VACCINE, V30, pF117, DOI 10.1016/j.vaccine.2012.05.071; Chen ZG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020183; Chen ZG, 2015, METHODS MOL BIOL, V1249, P3, DOI 10.1007/978-1-4939-2013-6_1; Clifford GM, 2006, AIDS, V20, P2337, DOI 10.1097/01.aids.0000253361.63578.14; Cornet I, 2013, BRIT J CANCER, V108, P240, DOI 10.1038/bjc.2012.508; Cox T, 2006, GYNECOL ONCOL, V103, P8, DOI 10.1016/j.ygyno.2006.07.030; Cuzick J, 2003, LANCET, V362, P1871, DOI 10.1016/S0140-6736(03)14955-0; Denny LA, 2005, BEST PRACT RES CL OB, V19, P501, DOI 10.1016/j.bpobgyn.2005.02.004; Estrade C, 2011, J CLIN MICROBIOL, V49, P3474, DOI 10.1128/JCM.05039-11; Freitas LB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100746; Frisch M, 2000, JNCI-J NATL CANCER I, V92, P1500, DOI 10.1093/jnci/92.18.1500; Goncalves Maria Alice G, 2008, Infect Agent Cancer, V3, P5, DOI 10.1186/1750-9378-3-5; Goodman MT, 2011, J INFECT DIS, V203, P335, DOI 10.1093/infdis/jiq058; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hessol NA, 2013, AIDS, V27, P1743, DOI 10.1097/QAD.0b013e3283601b09; HO L, 1993, J VIROL, V67, P6413, DOI 10.1128/JVI.67.11.6413-6423.1993; Hoots BE, 2009, INT J CANCER, V124, P2375, DOI 10.1002/ijc.24215; Huang S Z, 1989, Yi Chuan Xue Bao, V16, P475; Keller MJ, 2015, CLIN INFECT DIS, V61, P1573, DOI 10.1093/cid/civ569; Kitchener HC, 2006, VACCINE, V24, P63, DOI 10.1016/j.vaccine.2006.05.113; Kojic EM, 2011, SEX TRANSM DIS, V38, P253, DOI 10.1097/OLQ.0b013e3181f70253; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Moscicki AB, 2012, VACCINE, V30, pF24, DOI 10.1016/j.vaccine.2012.05.089; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Palefsky JM, 2001, J INFECT DIS, V183, P383, DOI 10.1086/318071; Palefsky JM, 1998, AIDS, V12, P495, DOI 10.1097/00002030-199805000-00011; Palefsky JM, 2003, JNCI MONOGRAPHS, V2003, P41, DOI DOI 10.1093/0XF0RDJ0URNALS.JNCIM0N0GRAPHS.A003481; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Sichero L, 2007, INT J CANCER, V120, P1763, DOI 10.1002/ijc.22481; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Torres M, 2015, J CLIN VIROL, V67, P47, DOI 10.1016/j.jcv.2015.04.005; Vanni T, 2012, INT J CANCER, V131, pE96, DOI 10.1002/ijc.26472; Wells JS, 2014, AIDS PATIENT CARE ST, V28, P350, DOI 10.1089/apc.2013.0358; World Health Organization, 2013, WHO GUIDELINES FOR S; YAMADA T, 1995, J VIROL, V69, P7743, DOI 10.1128/JVI.69.12.7743-7753.1995	44	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176422	10.1371/journal.pone.0176422	http://dx.doi.org/10.1371/journal.pone.0176422			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426837	Green Published, gold, Green Submitted			2022-12-26	WOS:000399875900130
J	Franco-Echevarria, E; Sanz-Aparicio, J; Brearley, CA; Gonzalez-Rubio, JM; Gonzalez, B				Franco-Echevarria, Elsa; Sanz-Aparicio, Julia; Brearley, Charles A.; Gonzalez-Rubio, Juana M.; Gonzalez, Beatriz			The crystal structure of mammalian inositol 1,3,4,5,6-pentakisphosphate 2-kinase reveals a new zinc-binding site and key features for protein function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; enzyme mutation; inositol phosphate; structure-function; zinc; IP5 2-kinase; inositol hexakisphosphate	SUBSTRATE-BINDING; MOLECULAR REPLACEMENT; RECIPROCAL-SPACE; KINASE FAMILY; HEXAKISPHOSPHATE; PHOSPHATE; SPECIFICITY; RECOGNITION; SEQUENCE; RNA	Inositol 1,3,4,5,6-pentakisphosphate 2-kinases (IP5 2-Ks) are part of a family of enzymes in charge of synthesizing inositol hexakisphosphate (IP6) in eukaryotic cells. This protein and its product IP6 present many roles in cells, participating in mRNA export, embryonic development, and apoptosis. We reported previously that the full-length IP5 2-K from Arabidopsis thaliana is a zinc metallo-enzyme, including two separated lobes (the N- and C-lobes). We have also shown conformational changes in IP5 2-K and have identified the residues involved in substrate recognition and catalysis. However, the specific features of mammalian IP5 2-Ks remain unknown. To this end, we report here the first structure for a murine IP5 2-K in complex with ATP/IP5 or IP6. Our structural findings indicated that the general folding in N- and C-lobes is conserved with A. thaliana IP5 2-K. A helical scaffold in the C-lobe constitutes the inositol phosphate-binding site, which, along with the participation of the N-lobe, endows high specificity to this protein. However, we also noted large structural differences between the orthologues from these two eukaryotic kingdoms. These differences include a novel zinc-binding site and regions unique to the mammalian IP5 2-K, as an unexpected basic patch on the protein surface. In conclusion, our findings have uncovered distinct features of a mammalian IP5 2-K and set the stage for investigations into protein-protein or protein-RNA interactions important for IP5 2-K function and activity.	[Franco-Echevarria, Elsa; Sanz-Aparicio, Julia; Gonzalez-Rubio, Juana M.; Gonzalez, Beatriz] CSIC, Inst Quim Fis Rocasolano, Dept Cristalog & Biol Estruct, Serrano 119, E-28006 Madrid, Spain; [Brearley, Charles A.] Univ East Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of East Anglia	Gonzalez, B (corresponding author), CSIC, Inst Quim Fis Rocasolano, Dept Cristalog & Biol Estruct, Serrano 119, E-28006 Madrid, Spain.	xbeatriz@iqfr.csic.es	Sanz-Aparicio, Julia/F-6201-2013; Rubio, Juana Maria Gonzalez/AAQ-1604-2020; Gonzalez, Beatriz/M-1219-2014	Sanz-Aparicio, Julia/0000-0002-6849-8621; Gonzalez, Beatriz/0000-0002-0710-0202; Brearley, Charles/0000-0001-6179-9109; Gonzalez Rubio, Juana Maria/0000-0001-6979-2964	French Infrastructure for Integrated Structural Biology FRISBI [ANR-10-INSB-05]; Instruct, a Landmark ESFRI project; BBSRC [BB/M022978/1, BB/N002024/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/N002024/1, BB/M022978/1] Funding Source: researchfish	French Infrastructure for Integrated Structural Biology FRISBI; Instruct, a Landmark ESFRI project; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Data collection was performed at the XALOC-BL13 beamline at ALBA Synchrotron with the collaboration of ALBA staff. We thank Graham Chilvers, UEA SCI Faculty Analytical Facility, for assistance with ICP-OES. We acknowledge the support and the use of resources of the French Infrastructure for Integrated Structural Biology FRISBI ANR-10-INSB-05 and of Instruct, a Landmark ESFRI project.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alcazar-Roman AR, 2006, NAT CELL BIOL, V8, P711, DOI 10.1038/ncb1427; Angulo I, 2011, GLYCOBIOLOGY, V21, P1349, DOI 10.1093/glycob/cwr074; Barker CJ, 2009, CELL MOL LIFE SCI, V66, P3851, DOI 10.1007/s00018-009-0115-2; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; Boularan C, 2007, P NATL ACAD SCI USA, V104, P18061, DOI 10.1073/pnas.0705550104; Brehm MA, 2007, BIOCHEM J, V408, P335, DOI 10.1042/BJ20070382; Brehm MA, 2013, J CELL SCI, V126, P437, DOI 10.1242/jcs.110031; Byrum J, 2004, NUCLEIC ACIDS RES, V32, P2776, DOI 10.1093/nar/gkh592; Caddick SEK, 2008, FEBS LETT, V582, P1731, DOI 10.1016/j.febslet.2008.04.034; Chakraborty A, 2008, P NATL ACAD SCI USA, V105, P1134, DOI 10.1073/pnas.0711168105; Cheek S, 2002, J MOL BIOL, V320, P855, DOI 10.1016/S0022-2836(02)00538-7; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Cowtan K, 2000, ACTA CRYSTALLOGR D, V56, P1612, DOI 10.1107/S0907444900013263; DeLano WL, 2002, PYMOL MOLECULAR GRAP; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Franco-Echevarria E, 2017, PROTEIN J, V36, P240, DOI 10.1007/s10930-017-9717-y; Gonzalez B, 2004, MOL CELL, V15, P689, DOI 10.1016/j.molcel.2004.08.004; Gonzalez B, 2010, P NATL ACAD SCI USA, V107, P9608, DOI 10.1073/pnas.0912979107; Gosein V, 2013, J BIOL CHEM, V288, P36788, DOI 10.1074/jbc.M113.512731; Gosein V, 2013, J BIOL CHEM, V288, P26908, DOI 10.1074/jbc.M113.487777; Gosein V, 2012, PROTEIN SCI, V21, P737, DOI 10.1002/pro.2049; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Holmes W, 2006, J BIOL CHEM, V281, P38109, DOI 10.1074/jbc.M606883200; Banos-Sanz JI, 2012, J BIOL CHEM, V287, P29237, DOI 10.1074/jbc.M112.363671; IRVINE RF, 1986, NATURE, V320, P631, DOI 10.1038/320631a0; Juanhuix J, 2014, J SYNCHROTRON RADIAT, V21, P679, DOI 10.1107/S160057751400825X; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Onnebo SMN, 2007, CELL, V129, P647, DOI 10.1016/j.cell.2007.05.002; Ouyang ZQ, 2016, MOL CELL, V62, P248, DOI 10.1016/j.molcel.2016.02.033; PHILLIPPY BQ, 1994, J BIOL CHEM, V269, P28393; PHILLIPPY BQ, 1988, ANAL BIOCHEM, V175, P162, DOI 10.1016/0003-2697(88)90374-0; Qian X, 2005, BIOCHEM J, V389, P389, DOI 10.1042/BJ20050297; Saiardi A, 2000, J BIOL CHEM, V275, P24686, DOI 10.1074/jbc.M002750200; Scherer PC, 2016, P NATL ACAD SCI USA, V113, P3503, DOI 10.1073/pnas.1525580113; Shears SB, 2004, BIOCHEM J, V377, P265, DOI 10.1042/BJ20031428; Shears SB, 2001, CELL SIGNAL, V13, P151, DOI 10.1016/S0898-6568(01)00129-2; STEPHENS LR, 1991, BIOCHEM J, V275, P485, DOI 10.1042/bj2750485; Sweetman D, 2006, BIOCHEM J, V394, P95, DOI 10.1042/BJ20051331; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P1863, DOI 10.1107/S0907444999010033; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Verbsky J, 2005, P NATL ACAD SCI USA, V102, P8448, DOI 10.1073/pnas.0503656102; Verbsky JW, 2002, J BIOL CHEM, V277, P31857, DOI 10.1074/jbc.M205682200; Wang HC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5178; Wang HC, 2012, NAT CHEM BIOL, V8, P111, DOI 10.1038/nchembio.733; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	57	4	6	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10534	10548		10.1074/jbc.M117.780395	http://dx.doi.org/10.1074/jbc.M117.780395			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28450399	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000404115400015
J	Zhu, XJ; Yuan, XY; Wang, M; Fang, YK; Liu, YD; Zhang, XY; Yang, XQ; Li, Y; Li, JY; Li, FX; Dai, ZM; Qiu, MS; Zhang, Z; Zhang, ZY				Zhu, Xiao-Jing; Yuan, Xueyan; Wang, Min; Fang, Yukun; Liu, Yudong; Zhang, Xiaoyun; Yang, Xueqin; Li, Yan; Li, Jianying; Li, Feixue; Dai, Zhong-Min; Qiu, Mengsheng; Zhang, Ze; Zhang, Zunyi			A Wnt/Notch/Pax7 signaling network supports tissue integrity in tongue development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL INTERACTIONS; PROGENITOR CELLS; STEM-CELLS; WNT; NOTCH; PAX7; ACTIVATION; EXPRESSION; DIFFERENTIATION; PROLIFERATION	The tongue is one of the major structures involved in human food intake and speech. Tongue malformations such as aglossia, microglossia, and ankyloglossia are congenital birth defects, greatly affecting individuals' quality of life. However, the molecular basis of the tissue-tissue interactions that ensure tissue morphogenesis to form a functional tongue remains largely unknown. Here we show that ShhCre-mediated epithelial deletion of Wntless (Wls), the key regulator for intracellular Wnt trafficking, leads to lingual hypoplasia in mice. Disruption of epithelial Wnt production by Wls deletion in epithelial cells led to a failure in lingual epidermal stratification and loss of the lamina propria and the underlying superior longitudinal muscle in developing mouse tongues. These defective phenotypes resulted from a reduction in epithelial basal cells positive for the basal epidermal marker protein p63 and from impaired proliferation and differentiation in connective tissue and paired box 3 (Pax3)-and Pax7-positive muscle progenitor cells. We also found that epithelial Wnt production is required for activation of the Notch signaling pathway, which promotes proliferation of myogenic progenitor cells. Notch signaling in turn negatively regulated Wnt signaling during tongue morphogenesis. We further show that Pax7 is a direct Notch target gene in the embryonic tongue. In summary, our findings demonstrate a key role for the lingual epithelial signals in supporting the integrity of the lamina propria and muscular tissue during tongue development and that a Wnt/Notch/Pax7 genetic hierarchy is involved in this development.	[Zhu, Xiao-Jing; Yuan, Xueyan; Wang, Min; Fang, Yukun; Liu, Yudong; Zhang, Xiaoyun; Yang, Xueqin; Li, Yan; Li, Jianying; Li, Feixue; Dai, Zhong-Min; Qiu, Mengsheng; Zhang, Zunyi] Hangzhou Normal Univ, Key Lab Mammalian Organogenesis & Regenerat, Coll Life & Environm Sci, Inst Life Sci, Hangzhou 310036, Zhejiang, Peoples R China; [Zhang, Ze] Tulane Univ, Tulane Med Ctr, Dept Ophthalmol, New Orleans, LA 70115 USA; [Liu, Yudong] Chonbuk Natl Univ, Sch Dent, Cluster Craniofacial Dev & Regenerat Res, Inst Oral Biosci, Jeonju 561756, South Korea; [Liu, Yudong] Chonbuk Natl Univ, Sch Dent, Program BK21, Jeonju 561756, South Korea	Hangzhou Normal University; Tulane University; Jeonbuk National University; Jeonbuk National University	Zhang, ZY (corresponding author), Hangzhou Normal Univ, Key Lab Mammalian Organogenesis & Regenerat, Coll Life & Environm Sci, Inst Life Sci, Hangzhou 310036, Zhejiang, Peoples R China.	zunyi_zhang@idrbio.org		Dai, Zhong-Min/0000-0003-4083-1901	Natural Scientific Foundation of China [31371471, 81670971]; Science and Technology Plan Program of Zhejiang Province [2017C37163]; Natural Scientific Foundation of Zhejiang Province [LY16C120002, LY15C090008, LY15C120001]	Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Plan Program of Zhejiang Province; Natural Scientific Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by Natural Scientific Foundation of China Grants 31371471 and 81670971; Science and Technology Plan Program of Zhejiang Province Grant 2017C37163; and Natural Scientific Foundation of Zhejiang Province Grants LY16C120002, LY15C090008, and LY15C120001. The authors declare that they have no conflicts of interest with the contents of this article.	Bailey EF, 2004, J APPL PHYSIOL, V96, P440, DOI 10.1152/japplphysiol.00733.2003; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Blanpain C, 2007, CELL, V128, P445, DOI 10.1016/j.cell.2007.01.014; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Cheng X, 2008, DEVELOPMENT, V135, P3447, DOI 10.1242/dev.025916; Cisternas P, 2014, MOL NEUROBIOL, V49, P574, DOI 10.1007/s12035-013-8540-5; Collins CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004475; Collu GM, 2014, CELL MOL LIFE SCI, V71, P3553, DOI 10.1007/s00018-014-1644-x; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Estrach S, 2006, DEVELOPMENT, V133, P4427, DOI 10.1242/dev.02644; Galceran J, 2004, GENE DEV, V18, P2718, DOI 10.1101/gad.1249504; Han D, 2012, DEVELOPMENT, V139, P1640, DOI 10.1242/dev.076653; Hayward P, 2008, DEVELOPMENT, V135, P411, DOI 10.1242/dev.000505; Hosokawa R, 2010, DEV BIOL, V341, P186, DOI 10.1016/j.ydbio.2010.02.030; Iwasaki S, 2002, J ANAT, V201, P1, DOI 10.1046/j.1469-7580.2002.00073.x; Iwata J, 2013, J BIOL CHEM, V288, P29760, DOI 10.1074/jbc.M113.493551; Iwatsuki K, 2007, P NATL ACAD SCI USA, V104, P2253, DOI 10.1073/pnas.0607399104; Kishimoto J, 1999, P NATL ACAD SCI USA, V96, P7336, DOI 10.1073/pnas.96.13.7336; Klein T, 1999, DEVELOPMENT, V126, P913; Komiya Yuko, 2008, Organogenesis, V4, P68; Li FX, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00590-16; Lin CX, 2011, DEV BIOL, V356, P40, DOI 10.1016/j.ydbio.2011.05.002; Liu F, 2007, NAT GENET, V39, P106, DOI 10.1038/ng1932; Liu JR, 2011, TISSUE ENG PART B-RE, V17, P25, DOI [10.1089/ten.teb.2010.0489, 10.1089/ten.TEB.2010.0489]; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mansouri A, 2001, DEVELOPMENT, V128, P1995; Mennerich D, 2001, EMBO J, V20, P7174, DOI 10.1093/emboj/20.24.7174; Messina G, 2009, GENE DEV, V23, P902, DOI 10.1101/gad.1797009; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Nayak L, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0299-7; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Padilla-Benavides T, 2015, J CELL PHYSIOL, V230, P2990, DOI 10.1002/jcp.25031; Parada C, 2012, J DENT RES, V91, P528, DOI 10.1177/0022034511434055; Parada C, 2015, CURR TOP DEV BIOL, V115, P31, DOI 10.1016/bs.ctdb.2015.07.023; Powell DW, 2011, ANNU REV PHYSIOL, V73, P213, DOI 10.1146/annurev.physiol.70.113006.100646; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Relaix F, 2004, GENE DEV, V18, P1088, DOI 10.1101/gad.301004; Ribatti D, 2014, INT J DEV BIOL, V58, P303, DOI 10.1387/ijdb.140143dr; Rodilla V, 2009, P NATL ACAD SCI USA, V106, P6315, DOI 10.1073/pnas.0813221106; Santosh ABR, 2014, ONCOL REV, V8, P1, DOI 10.4081/oncol.2014.239; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410; Vasyutina E, 2007, P NATL ACAD SCI USA, V104, P4443, DOI 10.1073/pnas.0610647104; von Maltzahn J, 2012, TRENDS CELL BIOL, V22, P602, DOI 10.1016/j.tcb.2012.07.008; Wang RH, 2016, ONCOTARGET, V7, P5754, DOI 10.18632/oncotarget.6805; Wang XW, 2012, NUCLEIC ACIDS RES, V40, pD1144, DOI 10.1093/nar/gkr1013; Wen YF, 2012, MOL CELL BIOL, V32, P2300, DOI 10.1128/MCB.06753-11; Yokoyama S, 2011, CELL MOL LIFE SCI, V68, P1843, DOI 10.1007/s00018-011-0629-2; Zhou HM, 2008, DEV BIOL, V315, P369, DOI 10.1016/j.ydbio.2007.12.020; Zhu X, 2014, J DENT RES, V93, P582, DOI 10.1177/0022034514531985; Zhu XJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004687; Zhu XJ, 2013, J BIOL CHEM, V288, P12080, DOI 10.1074/jbc.M113.462473	52	23	24	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9409	9419		10.1074/jbc.M117.789438	http://dx.doi.org/10.1074/jbc.M117.789438			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28438836	Green Published, hybrid			2022-12-26	WOS:000402538900033
J	Hylands, M; Godbout, MP; Mayer, SK; Fraser, WD; Vanasse, A; Leclair, MA; Turgeon, AF; Lauzier, F; Charbonney, E; Trottier, V; Razek, TS; Roy, A; D'Aragon, F; Belley-Cote, E; Day, AG; Le Guillan, S; Sabbagh, R; Lamontagne, F				Hylands, Mathieu; Godbout, Marie-Pier; Mayer, Sandeep K.; Fraser, William D.; Vanasse, Alain; Leclair, Marc-Andre; Turgeon, Alexis F.; Lauzier, Francois; Charbonney, Emmanuel; Trottier, Vincent; Razek, Tarek S.; Roy, Andre; D'Aragon, Frederick; Belley-Cote, Emilie; Day, Andrew G.; Le Guillan, Soazig; Sabbagh, Robert; Lamontagne, Francois			Vasopressor use following traumatic injury - A single center retrospective study	PLOS ONE			English	Article							HYPOTENSIVE RESUSCITATION; EMERGENCY-DEPARTMENT; FLUID RESUSCITATION; HEMORRHAGIC-SHOCK; MULTIPLE TRAUMA; BRAIN-INJURY; COAGULOPATHY; SYSTEM; IMPACT; INDEX	Objectives Vasopressors are not recommended by current trauma guidelines, but recent reports indicate that they are commonly used. We aimed to describe the early hemodynamic management of trauma patients outside densely populated urban centers. Methods We conducted a single-center retrospective cohort study in a Canadian regional trauma center. All adult patients treated for traumatic injury in 2013 who died within 24 hours of admission or were transferred to the intensive care unit were included. A systolic blood pressure < 90 mmHg, a mean arterial pressure < 60 mmHg, the use of vasopressors or >= 2 L of intravenous fluids defined hemodynamic instability. Main outcome measures were use of intravenous fluids and vasopressors prior to surgical or endovascular management. Results Of 111 eligible patients, 63 met our criteria for hemodynamic instability. Of these, 60 (95%) had sustained blunt injury and 22 (35%) had concomitant severe traumatic brain injury. The subgroup of patients referred from a primary or secondary hospital (20 of 63, 32%) had significantly longer transport times (243 vs. 61 min, p < 0.01). Vasopressors, used in 26 patients (41%), were independently associated with severe traumatic brain injury (odds ratio 10.2, 95% CI 2.7-38.5). Conclusions In this cohort, most trauma patients had suffered multiple blunt injuries. Patients were likely to receive vasopressors during the early phase of trauma care, particularly if they exhibited signs of neurologic injury. While these results may be context-specific, determining the risk-benefit trade-offs of fluid resuscitation, vasopressors and permissive hypotension in specific patients subgroups constitutes a priority for trauma research going forwards.	[Hylands, Mathieu; Godbout, Marie-Pier; Mayer, Sandeep K.] Univ Sherbrooke, Div Gen Surg, Sherbrooke, PQ, Canada; [Fraser, William D.; Vanasse, Alain; D'Aragon, Frederick; Belley-Cote, Emilie; Sabbagh, Robert; Lamontagne, Francois] Univ Sherbrooke, Ctr hosp, Ctr Rech, Sherbrooke, PQ, Canada; [Fraser, William D.] Univ Sherbrooke, Dept Obstet & Gynecol, Sherbrooke, PQ, Canada; [Vanasse, Alain] Univ Sherbrooke, Dept Family Med & Emergency Med, Sherbrooke, PQ, Canada; [Leclair, Marc-Andre; Belley-Cote, Emilie; Lamontagne, Francois] Univ Sherbrooke, Dept Med, Sherbrooke, PQ, Canada; [Turgeon, Alexis F.] Univ Laval, Dept Anesthesia & Crit Care, Quebec City, PQ, Canada; [Turgeon, Alexis F.; Lauzier, Francois; Trottier, Vincent] Univ Quebec, Ctr hosp, Ctr Rech, Quebec City, PQ, Canada; [Lauzier, Francois] Univ Laval, Dept Med, Quebec City, PQ, Canada; [Charbonney, Emmanuel] Univ Montreal, Dept Crit Care, Montreal, PQ, Canada; [Charbonney, Emmanuel] Hop Sacre Coeur, Ctr Rech, Montreal, PQ, Canada; [Trottier, Vincent] Univ Laval, Dept Gen Surg, Quebec City, PQ, Canada; [Razek, Tarek S.] MUHC Montreal Gen Hosp, Dept Gen Surg, Dept Trauma Surg, Montreal, PQ, Canada; [Roy, Andre] Univ Montreal, Dept Physiatry, Montreal, PQ, Canada; [Roy, Andre] Univ Montreal, Ctr Hosp, Ctr Rech, Montreal, PQ, Canada; [D'Aragon, Frederick] Univ Sherbrooke, Dept Anesthesiol, Sherbrooke, PQ, Canada; [Day, Andrew G.] Queens Univ, Dept Community Hlth & Epidemiol, Kingston, ON, Canada; [Le Guillan, Soazig] Sacre Coeur Hosp Montreal, Div Traumatol, Div Gen Surg, Montreal, PQ, Canada; [Sabbagh, Robert] Univ Sherbrooke, Dept Urol, Sherbrooke, PQ, Canada	University of Sherbrooke; University of Sherbrooke; University of Sherbrooke; University of Sherbrooke; University of Sherbrooke; Laval University; Laval University; University of Quebec; Laval University; Universite de Montreal; Universite de Montreal; Laval University; Universite de Montreal; Universite de Montreal; University of Sherbrooke; Queens University - Canada; Universite de Montreal; University of Sherbrooke	Lamontagne, F (corresponding author), Univ Sherbrooke, Ctr hosp, Ctr Rech, Sherbrooke, PQ, Canada.; Lamontagne, F (corresponding author), Univ Sherbrooke, Dept Med, Sherbrooke, PQ, Canada.	Francois.Lamontagne@usherbrooke.ca	Lauzier, Francois/B-9237-2015	Lauzier, Francois/0000-0002-6530-5513; Lamontagne, Francois/0000-0002-0360-3427	Department of Surgery of the CIUSSS de l'Estrie CHUS [FRChir-1403, FRChir-1524]	Department of Surgery of the CIUSSS de l'Estrie CHUS	This study was supported by the Department of Surgery of the CIUSSS de l'Estrie CHUS (grant numbers FRChir-1403, FRChir-1524). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; Beloncle F, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-13; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cohn SM, 2011, WORLD J SURG, V35, P430, DOI 10.1007/s00268-010-0875-8; Dutton RP, 2002, J TRAUMA, V52, P1141, DOI 10.1097/00005373-200206000-00020; Hill AD, 2014, J TRAUMA ACUTE CARE, V77, P608, DOI 10.1097/TA.0000000000000412; Jones AE, 2009, CRIT CARE MED, V37, P1649, DOI 10.1097/CCM.0b013e31819def97; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; KOEHLER JJ, 1986, ANN EMERG MED, V15, P178, DOI 10.1016/S0196-0644(86)80016-6; Kristiansen T, 2010, INJURY, V41, P444, DOI 10.1016/j.injury.2009.05.027; Kwan I, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002245.pub2; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lavoie A, 2013, ETMIS, V9, P1; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Maegele M, 2007, INJURY, V38, P298, DOI 10.1016/j.injury.2006.10.003; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Morrison CA, 2011, J TRAUMA, V70, P652, DOI 10.1097/TA.0b013e31820e77ea; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Norton R, 2013, NEW ENGL J MED, V368, P1723, DOI 10.1056/NEJMra1109343; Palm K, 2012, J TRAUMA ACUTE CARE, V73, pS465, DOI 10.1097/TA.0b013e31827548a9; Palm K, 2012, J TRAUMA ACUTE CARE, V73, pS459, DOI 10.1097/TA.0b013e3182754887; Palmer C, 2007, ANN P ASS ADV AUT ME; Plurad DS, 2011, J TRAUMA, V71, P565, DOI 10.1097/TA.0b013e3182213d52; RADY MY, 1992, AM J EMERG MED, V10, P538, DOI 10.1016/0735-6757(92)90178-Z; REGEL G, 1995, J TRAUMA, V38, P70, DOI 10.1097/00005373-199501000-00020; Rotondo MF, 2012, ATLS ADV TRAUMA LIFE; Spahn DR, 2013, CRIT CARE, V17, DOI 10.1186/cc12685; Sperry JL, 2008, J TRAUMA, V64, P9, DOI 10.1097/TA.0b013e31815dd029; Teixeira PGR, 2007, J TRAUMA, V63, P1338, DOI 10.1097/TA.0b013e31815078ae; Tien HC, 2007, J TRAUMA, V62, P142, DOI 10.1097/01.ta.0000251558.38388.47; Wang CH, 2014, CRIT CARE MED, V42, P954, DOI 10.1097/CCM.0000000000000050; Yin W, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-S1-S6	34	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176587	10.1371/journal.pone.0176587	http://dx.doi.org/10.1371/journal.pone.0176587			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448605	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383600108
J	Kuwabara, M; Niwa, K; Ohtahara, A; Hamada, T; Miyazaki, S; Mizuta, E; Ogino, K; Hisatome, I				Kuwabara, Masanari; Niwa, Koichiro; Ohtahara, Akira; Hamada, Toshihiro; Miyazaki, Satoshi; Mizuta, Einosuke; Ogino, Kazuhide; Hisatome, Ichiro			Prevalence and complications of hypouricemia in a general population: A large-scale cross-sectional study in Japan	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; SERUM URIC-ACID; EXERCISE; DYSFUNCTION; MUTATION; FAMILY; TYPE-2	Backgrounds Hypouricemia was reported as a risk factor for exercise-induced acute renal injury (EIAKI) and urinary stones. However, the prevalence of kidney diseases among hypouricemic subjects has not been evaluated. This study was conducted to clarify the prevalence of hypouricemia and the association of hypouricemia with kidney diseases by using a large-scale Japanese population data. Methods This study is a retrospective cross-sectional study at the Center for Preventive Medicine, St. Luke's International Hospital, Tokyo, Japan, and Sanin Rousai Hospital, Yonago, Japan. We analyzed the medical records of 90,143 Japanese subjects at the center in St. Luke's International Hospital, Tokyo, and 4,837 subjects in Sanin Rousai Hospital, Yonago, who underwent annual regular health check-up between January 2004 and June 2010. We defined hypouricemia as serum uric acid level of <= 2.0 mg/dL. We checked the medical history of all the study subjects and compared the rates of complications including urinary stones and kidney diseases among those with or without hypouricemia. Results The prevalence of hypouricemia was 0.19% in St. Luke's International Hospital, Tokyo, and 0.58% in Sanin Rousai Hospital, Yonago. The prevalence of hypouricemia in women was larger than that in men both in Tokyo (0.31% vs 0.068%, p<0.001) and in Yonago (1.237% vs 0.318%, p<0.001). Among 172 hypouricemic subjects (30 men), the rates of previous urinary stones and kidney diseases (including nephritis/nephrosis) were 1.2% (3.3% men, 0.7% women) and 2.3% (10% men, 0.7% women), respectively. Hypouricemic men had a 9-fold higher rate of previously having kidney diseases compared to non-hypouricemic men (p<0.001). However, the rates of other diseases including urinary stones were not significantly different between the two groups. Conclusions Hypouricemia was associated with a history of kidney disease especially in men.	[Kuwabara, Masanari] Toranomon Gen Hosp, Dept Cardiol, Tokyo, Japan; [Kuwabara, Masanari] Univ Colorado Denver, Sch Med, Div Renal Dis & Hypertens, Aurora, CO USA; [Kuwabara, Masanari; Niwa, Koichiro] St Lukes Int Hosp, Dept Cardiol, Cardiovasc Ctr, Tokyo, Japan; [Ohtahara, Akira; Mizuta, Einosuke] Sanin Rosai Hosp, Dept Cardiol, Yonago, Tottori, Japan; [Hamada, Toshihiro] Tottori Univ, Fac Med, Dept Community Based Family Med, Yonago, Tottori, Japan; [Miyazaki, Satoshi] Masao Fujii Mem Hosp, Dept Cardiovasc Med, Kurayoshi, Tottori, Japan; [Ogino, Kazuhide] Tottori Univ Hosp, Dept Clin Lab, Yonago, Tottori, Japan; [Hisatome, Ichiro] Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Div Regenerat Med & Therapeut, Yonago, Tottori, Japan	Toranomon Hospital; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; St. Luke's International Hospital; Tottori University; Tottori University; Tottori University	Kuwabara, M (corresponding author), Toranomon Gen Hosp, Dept Cardiol, Tokyo, Japan.; Kuwabara, M (corresponding author), Univ Colorado Denver, Sch Med, Div Renal Dis & Hypertens, Aurora, CO USA.; Kuwabara, M (corresponding author), St Lukes Int Hosp, Dept Cardiol, Cardiovasc Ctr, Tokyo, Japan.	kuwamasa728@gmail.com	Kuwabara, Masanari/O-9844-2017	Kuwabara, Masanari/0000-0002-6601-4347				Amway, THIS DOES NOT ALT OU; BENISHAY D, 1961, AM J MED, V31, P793, DOI 10.1016/0002-9343(61)90163-2; Bhasin B, 2014, AM J MED, V127, pE3, DOI 10.1016/j.amjmed.2013.08.025; deAloysio D, 1996, GYNECOL OBSTET INVES, V42, P120, DOI 10.1159/000291918; DENT CE, 1954, LANCET, V1, P182, DOI 10.1016/S0140-6736(54)91257-X; Dinour D, 2012, NEPHROL DIAL TRANSPL, V27, P1035, DOI 10.1093/ndt/gfr419; Dinour D, 2010, J AM SOC NEPHROL, V21, P64, DOI 10.1681/ASN.2009040406; Enomoto A, 2002, NATURE, V417, P447, DOI 10.1038/nature742; HISATOME I, 1989, NEPHRON, V51, P13, DOI 10.1159/000185233; Ichida K, 2008, CLIN GENET, V74, P243, DOI 10.1111/j.1399-0004.2008.01021.x; Ishikawa I, 2002, NEPHRON, V91, P559, DOI 10.1159/000065013; Kawamura Y, 2011, NUCLEOS NUCLEOT NUCL, V30, P1105, DOI 10.1080/15257770.2011.623685; Kikuchi Y, 2000, CLIN NEPHROL, V53, P467; Kuwabara M, 2016, INT J CARDIOL; Kuwabara M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169137; Kuwabara M, 2015, PULSE, V3, P242, DOI 10.1159/000443769; Kuwabara M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009870; Kuwabara M, 2014, HYPERTENS RES, V37, P785, DOI 10.1038/hr.2014.75; Matsuo H, 2008, AM J HUM GENET, V83, P744, DOI 10.1016/j.ajhg.2008.11.001; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Mumford SL, 2013, HUM REPROD, V28, P1853, DOI 10.1093/humrep/det085; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Ohta T, 2004, NEPHROL DIAL TRANSPL, V19, P1447, DOI 10.1093/ndt/gfh094; PRAETORIUS E, 1950, J LAB CLIN MED, V35, P865; Sasaki Y, 1998, HUM GENET, V103, P81, DOI 10.1007/s004390050787; Shimamoto K, 2014, HYPERTENS RES, V37, P256, DOI [10.1038/hr.2014.20, 10.1038/hr.2014.18]; Son CN, 2016, KOREAN J INTERN MED, V31, P971, DOI 10.3904/kjim.2015.125; STEELE TH, 1979, NEW ENGL J MED, V301, P549, DOI 10.1056/NEJM197909063011011; Stiburkova B, 2011, MOL GENET METAB, V102, P430, DOI 10.1016/j.ymgme.2010.12.016; Sugihara S, 2015, CIRC J, V79, P1125, DOI 10.1253/circj.CJ-14-1267; Teramoto T, 2013, J ATHEROSCLER THROMB, V20, P517, DOI 10.5551/jat.15792; Wakasugi M, 2015, AM J NEPHROL, V41, P138, DOI 10.1159/000381106	32	31	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176055	10.1371/journal.pone.0176055	http://dx.doi.org/10.1371/journal.pone.0176055			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448596	gold, Green Published, Green Submitted			2022-12-26	WOS:000400383600035
J	Oreska, MPJ; McGlathery, KJ; Porter, JH				Oreska, Matthew P. J.; McGlathery, Karen J.; Porter, John H.			Seagrass blue carbon spatial patterns at the meadow-scale	PLOS ONE			English	Article							SUSPENDED SEDIMENT TRANSPORT; SHALLOW COASTAL BAYS; POSIDONIA-OCEANICA; ORGANIC-CARBON; FLOW; BED; HYDRODYNAMICS; SUSPENSION; VEGETATION; RECOVERY	Most information on seagrass carbon burial derives from point measurements, which are sometimes scaled by meadow area to estimate carbon stocks; however, sediment organic carbon (C-org) concentrations may vary with distance from the meadow edge, resulting in spatial gradients that affect the accuracy of stock estimates. We mapped sediment C-org concentrations throughout a large (6 km(2)) restored seagrass meadow to determine whether C-org distribution patterns exist at different spatial scales. The meadow originated from <= 1-acre plots seeded between 2001 and 2004, so we expected C-org to vary spatially according to the known meadow age at sample sites and with proximity to the meadow edge. Applying spatial autoregressive models allowed us to control for spatial autocorrelation and quantify the relative effects of edge proximity and age on C-org concentrations. We found that edge proximity, not age, significantly predicted the meadow-scale C-org distribution. We also evaluated relationships between C-org and a variety of specific explanatory variables, including site relative exposure, shoot density, sediment grain size, and bathymetry. Factors known to affect carbon burial at the plot-scale, such as meadow age and shoot density, were not significant controls on the meadow-scale C-org distribution. Strong correlations between C-org, grain size, and edge proximity suggest that current attenuation increases fine-sediment deposition and, therefore, carbon burial with distance into the meadow. By mapping the sediment C-org pool, we provide the first accurate quantification of an enhanced carbon stock attributable to seagrass restoration. The top 12 cm of the bed contain 3660 t C-org, approximately 1200 t more C-org than an equal area of bare sediment. Most of that net increase is concentrated in a meadow area with low tidal current velocities. Managers should account for the effects of meadow configuration and current velocity when estimating seagrass blue carbon stocks. Our results suggest that a large, contiguous meadow should store more blue carbon than an equal area of small meadow patches.	[Oreska, Matthew P. J.; McGlathery, Karen J.; Porter, John H.] Univ Virginia, Dept Environm Sci, Clark Hall, Charlottesville, VA 22903 USA	University of Virginia	Oreska, MPJ (corresponding author), Univ Virginia, Dept Environm Sci, Clark Hall, Charlottesville, VA 22903 USA.	mpo4zx@virginia.edu		Oreska, Matthew/0000-0003-4550-7553; Porter, John/0000-0003-3118-5784	National Science Foundation Virginia Coast Reserve Long Term Ecological Research Grant [DEB-1237733]; University of Virginia Office of the Vice President and Department of Environmental Sciences; University of Virginia Jefferson Scholars Foundation; Virginia Sea Grant	National Science Foundation Virginia Coast Reserve Long Term Ecological Research Grant; University of Virginia Office of the Vice President and Department of Environmental Sciences; University of Virginia Jefferson Scholars Foundation; Virginia Sea Grant	Funding was provided by National Science Foundation Virginia Coast Reserve Long Term Ecological Research Grant DEB-1237733, the University of Virginia Office of the Vice President and Department of Environmental Sciences (MPJO), the University of Virginia Jefferson Scholars Foundation (MPJO), and by Virginia Sea Grant (MPJO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amores Carredano Juan Bosco, 2015, ADV WATER RESOUR, P1; [Anonymous], 2014, SAV CHESAPEAKE BAY C; Bell SS, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P625; Bradley K, 2009, J GEOPHYS RES-EARTH, V114, DOI 10.1029/2007JF000951; Carr J, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001103; Chen SN, 2007, ESTUAR COAST, V30, P296, DOI 10.1007/BF02700172; de Boer WF, 2007, HYDROBIOLOGIA, V591, P5, DOI 10.1007/s10750-007-0780-9; Duarte CM, 2013, J APPL ECOL, V50, P1341, DOI 10.1111/1365-2664.12155; Duarte CM, 2013, OCEAN COAST MANAGE, V83, P32, DOI 10.1016/j.ocecoaman.2011.09.001; Duarte CM, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003793; Duarte CM, 1999, AQUAT BOT, V65, P159, DOI 10.1016/S0304-3770(99)00038-8; Duarte CM, 2005, BIOGEOSCIENCES, V2, P1, DOI 10.5194/bg-2-1-2005; Emmer I., 2015, METHODOLOGY TIDAL WE; Fagherazzi S, 2009, J GEOPHYS RES-EARTH, V114, DOI 10.1029/2008JF001139; Fonseca MS, 1998, MAR ECOL PROG SER, V171, P109, DOI 10.3354/meps171109; Fourqurean JW, 2012, NAT GEOSCI, V5, P505, DOI 10.1038/ngeo1477; Genovesi B, 2013, HARMFUL ALGAE, V25, P15, DOI 10.1016/j.hal.2013.02.002; Granata TC, 2001, MAR ECOL PROG SER, V218, P95, DOI 10.3354/meps218095; Greiner JT, 2016, MAR ECOL PROG SER, V551, P95, DOI 10.3354/meps11722; Greiner JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072469; Greiner JT, 2013, THESIS; Gruber RK, 2010, LIMNOL OCEANOGR, V55, P2285, DOI 10.4319/lo.2010.55.6.2285; Hansen JCR, 2013, ESTUAR COAST, V36, P1099, DOI 10.1007/s12237-013-9620-5; Hansen JCR, 2012, MAR ECOL PROG SER, V448, P271, DOI 10.3354/meps09225; Hendriks IE, 2008, MAR ECOL PROG SER, V356, P163, DOI 10.3354/meps07316; Howard J., 2014, COASTAL BLUE CARBON; Johannessen SC, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/11/113001; Kennedy H, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003848; Koch EW, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P193; Lavery PS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073748; Lawson SE, 2007, ESTUAR COAST, V30, P102, DOI 10.1007/BF02782971; Lawson SE, 2012, MAR ECOL PROG SER, V448, P259, DOI 10.3354/meps09579; Lefebvre A, 2010, CONT SHELF RES, V30, P1783, DOI 10.1016/j.csr.2010.08.006; Lopez F, 1998, WATER RESOUR RES, V34, P2341, DOI 10.1029/98WR01922; Macreadie PI, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1537; Marba N, 2015, J ECOL, V103, P296, DOI 10.1111/1365-2745.12370; Mariotti G, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG002064; Mateo MA, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P159; McGlathery K., 2013, GROUND BOIMASS CANOP; McGlathery KJ, 2007, MAR ECOL PROG SER, V348, P1, DOI 10.3354/meps07132; McGlathery KJ, 2012, MAR ECOL PROG SER, V448, P209, DOI 10.3354/meps09574; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; Mendez FJ, 1999, J GEOPHYS RES-OCEANS, V104, P18383, DOI 10.1029/1999JC900119; Moore KA, 2012, MAR ECOL PROG SER, V448, P247, DOI 10.3354/meps09578; MORIARTY DJW, 1986, J EXP MAR BIOL ECOL, V96, P115, DOI 10.1016/0022-0981(86)90237-6; Murray B. C., 2011, R1104 NI DUK U; Nellemann C., 2009, BLUE CARBON RAPID RE; Orth RJ, 2006, AQUAT BOT, V84, P26, DOI 10.1016/j.aquabot.2005.07.007; Orth RJ, 2012, MAR ECOL PROG SER, V448, P177, DOI 10.3354/meps09522; Orth RJ, 2010, ESTUAR COAST, V33, P1144, DOI [10.1007/s12237-009-9234-0, 10.1007/s12237-010-9311-4]; Pendleton L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043542; Reidenbach M, 2014, WIND SPEED DIRECTION; Ricart AM, 2015, MAR POLLUT BULL, V100, P476, DOI 10.1016/j.marpolbul.2015.09.032; Richardson D, 2014, INTEGRATED TOPOGRAPH, DOI [10.6073/pasta/beb98b208602e0d137acd8497edc3c2d, 10.6073]; Samper-Villarreal J, 2016, LIMNOL OCEANOGR, V61, P938, DOI 10.1002/lno.10262; Serrano O., 2015, BIOGEOSCI DISCUSS, V12, P18913, DOI [10.5194/bgd-12-18913-2015, DOI 10.5194/BGD-12-18913-2015]; SMITH SV, 1981, SCIENCE, V211, P838, DOI 10.1126/science.211.4484.838; The R Project for Statistical Computing, 2014, R PROJECT STAT COMPU; Verified Carbon Standard, 2015, METH STRAT PROJ X ST; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Wiberg PL, 2015, LIMNOL OCEANOGR-METH, V13, P746, DOI 10.1002/lom3.10063; Widdows J, 2008, MAR ECOL PROG SER, V358, P125, DOI 10.3354/meps07338; Zhang XF, 2010, INT J REMOTE SENS, V31, P4579, DOI 10.1080/01431161.2010.485141; Zupo V, 2006, AQUAT BOT, V84, P101, DOI 10.1016/j.aquabot.2005.08.006	64	57	57	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176630	10.1371/journal.pone.0176630	http://dx.doi.org/10.1371/journal.pone.0176630			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448617	Green Submitted, Green Published, gold			2022-12-26	WOS:000400383600115
J	Mat, AM; Dunster, GP; Sbragaglia, V; Aguzzi, J; de la Iglesia, HO				Mat, Audrey M.; Dunster, Gideon P.; Sbragaglia, Valerio; Aguzzi, Jacopo; de la Iglesia, Horacio O.			Influence of temperature on daily locomotor activity in the crab Uca pugilator	PLOS ONE			English	Article							OYSTER CRASSOSTREA-GIGAS; SAND FIDDLER-CRABS; TEMPORAL NICHE; CIRCADIAN-RHYTHMS; CARCINUS-MAENAS; DIURNALITY; RESPONSES; BEHAVIOR; MARGINS; SEARCH	Animals living in the intertidal zone are exposed to prominent temperature changes. To cope with the energetic demands of environmental thermal challenges, ectotherms rely mainly on behavioral responses, which may change depending on the time of the day and seasonally. Here, we analyze how temperature shapes crabs' behavior at 2 different times of the year and show that a transition from constant cold (13.5 degrees C) to constant warm (17.5 degrees C) water temperature leads to increased locomotor activity levels throughout the day in fiddler crabs (Uca pugilator) collected during the summer. In contrast, the same transition in environmental temperature leads to a decrease in the amplitude of the daily locomotor activity rhythm in crabs collected during the winter. In other words, colder temperatures during the cold season favor a more prominent diurnal behavior. We interpret this winter-summer difference in the response of daily locomotor activity to temperature changes within the framework of the circadian thermoenergetics hypothesis, which predicts that a less favorable energetic balance would promote a more diurnal activity pattern. During the winter, when the energetic balance is likely less favorable, crabs would save energy by being more active during the expected high-temperature phase of the day-light phase-and less during the expected low-temperature phase of the day-dark phase. Our results suggest that endogenous rhythms in intertidal ectotherms generate adaptive behavioral programs to cope with thermoregulatory demands of the intertidal habitat.	[Mat, Audrey M.; Dunster, Gideon P.; de la Iglesia, Horacio O.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Sbragaglia, Valerio; Aguzzi, Jacopo] CSIC, ICM, Inst Marine Sci, Barcelona, Spain; [Mat, Audrey M.] Univ Bretagne Occidentale, Lab Sci Environm Marin LEMAR, Inst Univ Europeen Mer, CNRS,IRD,Ifremer,UMR 6539, Plouzane, France; [Sbragaglia, Valerio] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Biol & Ecol Fishes, Berlin, Germany	University of Washington; University of Washington Seattle; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB)	Mat, AM; de la Iglesia, HO (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.; Mat, AM (corresponding author), Univ Bretagne Occidentale, Lab Sci Environm Marin LEMAR, Inst Univ Europeen Mer, CNRS,IRD,Ifremer,UMR 6539, Plouzane, France.	audrey.mat@hotmail.com; horaciod@uw.edu	sbragaglia, valerio/AAB-1507-2019; Mat, Audrey M/GVS-6454-2022; sbragaglia, valerio/ABA-7409-2020; Aguzzi, Jacopo/D-6574-2012	sbragaglia, valerio/0000-0002-4775-7049; Aguzzi, Jacopo/0000-0002-1484-8219; , Audrey/0000-0003-2930-6268	Fellowship of the Belgian American Educational Foundation; FPI grant by the Spanish Ministry of Research Science and Technology of the project RITFIM [CTM2010-16274]; National Science Foundation [IOS0618029, IOS0909716]	Fellowship of the Belgian American Educational Foundation; FPI grant by the Spanish Ministry of Research Science and Technology of the project RITFIM; National Science Foundation(National Science Foundation (NSF))	AMM was supported by a Fellowship of the Belgian American Educational Foundation; VS was supported by a FPI grant by the Spanish Ministry of Research Science and Technology in the frame of the project RITFIM (CTM2010-16274); HOD was supported by National Science Foundation IOS0618029 and IOS0909716. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; AM was supported by a Fellowship of the Belgian American Educational Foundation; VS was supported by a FPI grant by the Spanish Ministry of Research Science and Technology in the frame of the project RITFIM (CTM2010-16274); HOD was supported by NSF IOS0618029 and IOS0909716. We are grateful to Dr. Corrado Costa and Dr. Paolo Menesatti (CRA-ING, Italy) for the development of MATLAB functions to track locomotor activity of crabs. Authors also thank Dr. Roelof Hut for the discussion on the preliminary results.	Aguzzi J, 2011, FRONT BIOSCI-LANDMRK, V16, P131, DOI 10.2741/3680; Aguzzi J, 2010, ADV MAR BIOL, V58, P155, DOI 10.1016/S0065.2881(10)58003.9; Allen BJ, 2012, J EXP MAR BIOL ECOL, V438, P93, DOI 10.1016/j.jembe.2012.09.009; ATKINSON RJ, 1973, HELGOLAND WISS MEER, V24, P192, DOI 10.1007/BF01609511; BARNWELL FH, 1966, BIOL BULL, V130, P1, DOI 10.2307/1539948; Castillo-Ruiz A, 2012, PROG BRAIN RES, V199, P267, DOI 10.1016/B978-0-444-59427-3.00016-2; Chabot CC, 2004, BIOL BULL-US, V207, P72, DOI 10.2307/1543630; Chabot CC, 2011, MAR FRESHW BEHAV PHY, V44, P43, DOI 10.1080/10236244.2010.541992; Crane J., 1975, FIDDLER CRABS WORLD, V1st, DOI [10.1515/9781400867936, DOI 10.1515/9781400867936]; Daan Serge, 2001, Handbook of Behavioral Neurobiology, V12, P7; de la Iglesia HO, 2013, CURR BIOL, V23, pR921, DOI 10.1016/j.cub.2013.09.006; Dong CH, 2015, FISH SHELLFISH IMMUN, V45, P641, DOI 10.1016/j.fsi.2015.05.025; Goldman Bruce, 2004, P107; Hut RA, 2012, PROG BRAIN RES, V199, P281, DOI 10.1016/B978-0-444-59427-3.00017-4; Hut RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017527; Jimenez AG, 2007, J THERM BIOL, V32, P308, DOI 10.1016/j.jtherbio.2007.03.002; Johnson Carl Hirschie, 2004, P67; Chiesa JJ, 2010, J BIOL RHYTHM, V25, P277, DOI 10.1177/0748730410376159; Last KS, 2009, CHRONOBIOL INT, V26, P167, DOI 10.1080/07420520902774524; Mat AM, 2014, MAR BIOL, V161, P89, DOI 10.1007/s00227-013-2317-2; Mat AM, 2012, CHRONOBIOL INT, V29, P857, DOI 10.3109/07420528.2012.699126; Naylor E, 2010, CHRONOBIOLOGY MARINE; Oczkowski A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141529; Paaijmans KP, 2013, GLOBAL CHANGE BIOL, V19, P2373, DOI 10.1111/gcb.12240; Palmer JD, 1995, BIOL RHYTHMS CLOCKS; REID DG, 1990, J BIOL RHYTHM, V5, P333, DOI 10.1177/074873049000500405; Riede SJ, 2017, J EXP BIOL, V220, P738, DOI 10.1242/jeb.130757; Ruppert EE, 1994, INVERTEBRATE ZOOLOGY; Sbragaglia V, 2013, J EXP MAR BIOL ECOL, V446, P177, DOI 10.1016/j.jembe.2013.05.018; Silbiger N, 2008, J EXP MAR BIOL ECOL, V355, P41, DOI 10.1016/j.jembe.2007.11.014; Smarr BL, 2013, INTEGR COMP BIOL, V53, P165, DOI 10.1093/icb/ict055; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; Stillman JH, 2004, MAR BIOL, V144, P473, DOI 10.1007/s00227-003-1213-6; Sunday JM, 2014, P NATL ACAD SCI USA, V111, P5610, DOI 10.1073/pnas.1316145111; TEAL JM, 1958, ECOLOGY, V39, P185, DOI 10.2307/1931862; Tessmar-Raible K, 2011, BIOESSAYS, V33, P165, DOI 10.1002/bies.201000096; Tilden AR, 2003, J EXP ZOOL PART A, V297A, P80, DOI 10.1002/jez.a.10230; van der Vinne V, 2015, J EXP BIOL, V218, P2585, DOI 10.1242/jeb.119354; van der Vinne V, 2014, P NATL ACAD SCI USA, V111, P15256, DOI 10.1073/pnas.1413135111; WARMAN CG, 1995, J EXP MAR BIOL ECOL, V189, P93, DOI 10.1016/0022-0981(95)00014-I; WILKENS JL, 1965, BIOL BULL, V128, P133, DOI 10.2307/1539396; WILLIAMS BG, 1969, J EXP BIOL, V51, P715; Windsor A, 2005, J THERM BIOL, V30, P37, DOI 10.1016/j.jtherbio.2004.06.006	43	10	10	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0175403	10.1371/journal.pone.0175403	http://dx.doi.org/10.1371/journal.pone.0175403			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445533	gold, Green Published			2022-12-26	WOS:000400309200019
J	Michalski, D; Pitsch, R; Pillai, DR; Mages, B; Aleithe, S; Grosche, J; Martens, H; Schlachetzki, F; Hartig, W				Michalski, Dominik; Pitsch, Roman; Pillai, Deepu R.; Mages, Bianca; Aleithe, Susanne; Grosche, Jens; Martens, Henrik; Schlachetzki, Felix; Haertig, Wolfgang			Delayed histochemical alterations within the neurovascular unit due to transient focal cerebral ischemia and experimental treatment with neurotrophic factors	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; EPITHELIUM-DERIVED FACTOR; ENDOTHELIAL GROWTH-FACTOR; REACTIVE ASTROCYTES; ARTERY OCCLUSION; STROKE; INJURY; DISRUPTION; NEUROPROTECTION; MECHANISMS	Current stroke therapy is focused on recanalizing strategies, but neuroprotective co-treatments are still lacking. Modern concepts of the ischemia-affected neurovascular unit (NVU) and surrounding penumbra emphasize the complexity during the transition from initial damaging to regenerative processes. While early treatment with neurotrophic factors was shown to result in lesion size reduction and blood-brain barrier (BBB) stabilization, cellular consequences from these treatments are poorly understood. This study explored delayed cellular responses not only to ischemic stroke, but also to an early treatment with neurotrophic factors. Rats underwent 60 minutes of focal cerebral ischemia. Fluorescence labeling was applied to sections from brains perfused 7 days after ischemia. Analyses focused on NVU constituents including the vasculature, astrocytes and microglia in the ischemic striatum, the border zone and the contralateral hemisphere. In addition to histochemical signs of BBB breakdown, a strong up-regulation of collagen IV and microglia activation occurred within the ischemic core with simultaneous degradation of astrocytes and their endfeet. Activated astroglia were mainly depicted at the border zone in terms of a glial scar formation. Early treatment with pigment epithelium-derived factor (PEDF) resulted in an attenuation of the usually up-regulated collagen IV-immunoreactivity. However, glial activation was not influenced by treatment with PEDF or the epidermal growth factor (EGF). In conclusion, these data on ischemia-induced cellular reactions within the NVU might help to develop treatments addressing the transition from injury towards regeneration. Thereby, the integrity of the vasculature in close relation to neighboring structures like astrocytes appears as a promising target.	[Michalski, Dominik; Mages, Bianca; Aleithe, Susanne] Univ Leipzig, Dept Neurol, Liebigstr 20, Leipzig, Germany; [Pitsch, Roman; Mages, Bianca; Aleithe, Susanne; Haertig, Wolfgang] Univ Leipzig, Paul Flechsig Inst Brain Res, Liebigstr 19, Leipzig, Germany; [Pillai, Deepu R.; Schlachetzki, Felix] Univ Regensburg, Dept Neurol, Univ Str 84, Regensburg, Germany; [Pillai, Deepu R.; Schlachetzki, Felix] Clin Neurol Rehabil II, Univ Str 84, Regensburg, Germany; [Pillai, Deepu R.] Forschungszentrum Julich, Inst Neurosci & Med INM 4, Julich, Germany; [Grosche, Jens] Effigos GmbH, Deutsch Pl 4, Leipzig, Germany; [Martens, Henrik] Synapt Syst, Gottingen, Germany	Leipzig University; Leipzig University; University of Regensburg; Helmholtz Association; Research Center Julich	Michalski, D (corresponding author), Univ Leipzig, Dept Neurol, Liebigstr 20, Leipzig, Germany.	dominik.michalski@medizin.uni-leipzig.de		Mages, Bianca/0000-0002-4761-2608	Europaischer Sozialfonds (ESF) [100270131]; University of Leipzig	Europaischer Sozialfonds (ESF)(European Commission); University of Leipzig	The study was mainly performed without external funding. During the revision process, some parts were supported by the Europaischer Sozialfonds (ESF, grant 100270131 to Dominik Michalski). Dr. Carsten Hobohm (University of Leipzig) is acknowledged for financial support during the early phase of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Sarah Hoffmann (University of Leipzig) for assistance in imaging acquisition. Dr. Carsten Hobohm (University of Leipzig) is acknowledged for financial support during the early phase of the study.	Alvarez JI, 2013, GLIA, V61, P1939, DOI 10.1002/glia.22575; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Arai K, 2009, FEBS J, V276, P4644, DOI 10.1111/j.1742-4658.2009.07176.x; Argaw AT, 2012, J CLIN INVEST, V122, P2454, DOI 10.1172/JCI60842; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; Barreto George, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P164; Belayev L, 1996, BRAIN RES, V739, P88, DOI 10.1016/S0006-8993(96)00815-3; Biber K, 2014, GLIA, V62, P841, DOI 10.1002/glia.22654; Campbell BCV, 2015, LANCET NEUROL, V14, P846, DOI 10.1016/S1474-4422(15)00140-4; Chamorro A, 2016, LANCET NEUROL, V15, P869, DOI 10.1016/S1474-4422(16)00114-9; Chi OZ, 2007, EXP NEUROL, V204, P283, DOI 10.1016/j.expneurol.2006.11.001; Choudhury GR, 2016, NEUROBIOL DIS, V85, P234, DOI 10.1016/j.nbd.2015.05.003; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; del Zoppo Gregory J, 2008, Rev Neurol Dis, V5 Suppl 1, pS12; Ding S, 2014, NEURAL REGEN RES, V9, P2048, DOI 10.4103/1673-5374.147929; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Dirnagl U, 2012, ANN NY ACAD SCI, V1268, P21, DOI 10.1111/j.1749-6632.2012.06691.x; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Endres M, 2008, CEREBROVASC DIS, V25, P268, DOI 10.1159/000118039; Fernandez-Klett F, 2014, BRAIN PATHOL, V24, P404, DOI 10.1111/bpa.12162; Friedrich B, 2015, STROKE, V46, P692, DOI 10.1161/STROKEAHA.114.008454; Go AS, 2013, CIRCULATION, V127, P143, DOI 10.1161/CIR.0b013e318282ab8f; Hacke Werner, 2008, N Engl J Med, V359, P1317, DOI 10.1056/NEJMoa0804656; Hefti F, 1997, ANNU REV PHARMACOL, V37, P239, DOI 10.1146/annurev.pharmtox.37.1.239; HEISS WD, 1994, CURR OPIN NEUROL, V7, P11, DOI 10.1097/00019052-199402000-00004; Heiss WD, 2016, CEREBROVASC DIS, V41, P1, DOI 10.1159/000441627; Huang LJ, 2014, INT J MED SCI, V11, P344, DOI 10.7150/ijms.8140; Inagaki Y, 2003, DIABETOLOGIA, V46, P284, DOI 10.1007/s00125-002-1013-4; Ito U, 2011, J CEREBR BLOOD F MET, V31, P328, DOI 10.1038/jcbfm.2010.97; Kaur C, 2008, CURR NEUROVASC RES, V5, P71, DOI 10.2174/156720208783565645; Kwon I, 2009, J NEUROSCI RES, V87, P668, DOI 10.1002/jnr.21877; Lo EH, 2008, NAT MED, V14, P497, DOI 10.1038/nm1735; Lo EH, 2016, J INVEST MED, V64, P827, DOI 10.1136/jim-2016-000104; Lo EH, 2009, STROKE, V40, pS2, DOI 10.1161/STROKEAHA.108.534404; Lok J, 2007, NEUROCHEM RES, V32, P2032, DOI 10.1007/s11064-007-9342-9; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Meairs S, 2006, CEREBROVASC DIS, V22, P75, DOI 10.1159/000093098; Morris DC, 2003, BRAIN RES, V972, P31, DOI 10.1016/S0006-8993(03)02433-8; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Pekny M, 2016, BBA-MOL BASIS DIS, V1862, P483, DOI 10.1016/j.bbadis.2015.11.014; Pekny M, 2016, ACTA NEUROPATHOL, V131, P323, DOI 10.1007/s00401-015-1513-1; Peng H, 1998, J CEREBR BLOOD F MET, V18, P349, DOI 10.1097/00004647-199804000-00002; Pillai DR, 2013, J CEREBR BLOOD F MET, V33, P557, DOI 10.1038/jcbfm.2012.201; Pillai DR, 2009, J CEREBR BLOOD F MET, V29, P1846, DOI 10.1038/jcbfm.2009.106; Salhia B, 2000, BRAIN RES, V883, P87, DOI 10.1016/S0006-8993(00)02825-0; Savitz SI, 2007, ANN NEUROL, V61, P396, DOI 10.1002/ana.21127; Schwartz M, 2006, TRENDS NEUROSCI, V29, P68, DOI 10.1016/j.tins.2005.12.005; Stobart JL, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00038; Streit WJ, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0142-6; Sugita Y, 1997, J NEUROSCI RES, V49, P710, DOI 10.1002/(SICI)1097-4547(19970915)49:6<710::AID-JNR5>3.0.CO;2-A; Taguchi Y, 2004, ARCH HISTOL CYTOL, V67, P253, DOI 10.1679/aohc.67.253; Xing CH, 2012, NEUROL RES, V34, P325, DOI 10.1179/1743132812Y.0000000019; Yabe T, 2010, CURR MOL MED, V10, P259, DOI 10.2174/156652410791065354; YING Z, 1993, J CEREBR BLOOD F MET, V13, P378, DOI 10.1038/jcbfm.1993.51; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911; Zhang L, 2012, TRENDS PHARMACOL SCI, V33, P415, DOI 10.1016/j.tips.2012.04.006; Zhang SX, 2006, J MOL ENDOCRINOL, V37, P1, DOI 10.1677/jme.1.02008; Zhang SX, 2006, FASEB J, V20, P323, DOI 10.1096/fj.05-4313fje; Zhang Y, 2001, STROKE, V32, P1378, DOI 10.1161/01.STR.32.6.1378; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4; Zhao BQ, 2006, NAT MED, V12, P441, DOI 10.1038/nm1387	64	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0174996	10.1371/journal.pone.0174996	http://dx.doi.org/10.1371/journal.pone.0174996			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445478	gold, Green Submitted, Green Published			2022-12-26	WOS:000400309200015
J	Yadav, MK; Aravindan, S; Ngangkham, U; Bag, HNSMK; Adak, T; Munda, S; Samantaray, S; Jena, M				Yadav, Manoj Kumar; Aravindan, S.; Ngangkham, Umakanta; Bag, H. N. Shubudhi Manas Kumar; Adak, Totan; Munda, Sushmita; Samantaray, Sanghamitra; Jena, Mayabini			Use of molecular markers in identification and characterization of resistance to rice blast in India	PLOS ONE			English	Article							BROAD-SPECTRUM RESISTANCE; ORYZA-SATIVA L.; PYRICULARIA-GRISEA; GENE PI9; SOFTWARE; SITE; LANDRACES; VIRULENCE; PROGRESS; TRAITS	Rice blast disease caused by Magnaporthe oryzae is one of the most destructive disease causing huge losses to rice yield in different parts of the world. Therefore, an attempt has been made to find out the resistance by screening and studying the genetic diversity of eighty released rice varieties by National Rice Research Institute, Cuttack (NRVs) using molecular markers linked to twelve major blast resistance (R) genes viz Pib, Piz, Piz-t, Pik, Pik-p,Pikm Pik-h, Pita/Pita-2, Pi2, Pi9, Pi1 and Pi5. Out of which, nineteen varieties (23.75%) showed resistance, twenty one were moderately resistant (26.25%) while remaining forty varieties (50%) showed susceptible in uniform blast nursery. Rice varieties possessing blast resistance genes varied from four to twelve and the frequencies of the resistance genes ranged from 0 to 100%. The cluster analysis grouped the eighty NRVs into two major clusters at 63% level of genetic similarity coefficient. The PIC value for seventeen markers varied from 0 to 0.37 at an average of 0.20. Out of seventeen markers, only five markers, 195R-1, Pi9-i, Pita3, YL155/YL87 and 40N23r corresponded to three broad spectrum R genes viz. Pi9, Pita/Pita2 and Pi5 were found to be significantly associated with the blast disease with explaining phenotypic variance from 3.5% to 7.7%. The population structure analysis and PCoA divided the entire 80 NRVs into two sub-groups. The outcome of this study would help to formulate strategies for improving rice blast resistance through genetic studies, plant-pathogen interaction, identification of novel R genes, development of new resistant varieties through marker-assisted breeding for improving rice blast resistance in India and worldwide.	[Yadav, Manoj Kumar; Aravindan, S.; Ngangkham, Umakanta; Bag, H. N. Shubudhi Manas Kumar; Adak, Totan; Munda, Sushmita; Samantaray, Sanghamitra; Jena, Mayabini] ICAR Natl Rice Res Inst, Cuttack, Odisha, India	Indian Council of Agricultural Research (ICAR); ICAR - National Rice Research Institute	Yadav, MK (corresponding author), ICAR Natl Rice Res Inst, Cuttack, Odisha, India.	m.yadav14@gmail.com	umakanta, ngangkham/J-8368-2019; Adak, Totan/K-4221-2012; Bag, Manas Kumar/ABA-4776-2021	umakanta, ngangkham/0000-0001-5792-0615; Adak, Totan/0000-0001-5971-1008; Bag, Manas Kumar/0000-0002-5429-2497	Indian Council of Agricultural Research National Rice Research Institute [3.1]	Indian Council of Agricultural Research National Rice Research Institute	Indian Council of Agricultural Research National Rice Research Institute (Project-3.1).	Ashikawa I, 2008, GENETICS, V180, P2267, DOI 10.1534/genetics.108.095034; Ashkani S, 2016, CRIT REV BIOTECHNOL, V36, P353, DOI 10.3109/07388551.2014.961403; Babu BK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099182; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; CHEN DH, 1995, PHYTOPATHOLOGY, V85, P1011, DOI 10.1094/Phyto-85-1011; CORREAVICTORIA FJ, 1993, PLANT DIS, V77, P1029, DOI 10.1094/PD-77-1029; Das G, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00698; Borba TCD, 2010, GENET MOL BIOL, V33, P515, DOI 10.1590/S1415-47572010005000065; Divya B, 2014, EUPHYTICA, V200, P61, DOI 10.1007/s10681-014-1146-9; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Elert E, 2014, NATURE, V514, pS50, DOI 10.1038/514S50a; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Fuentes JL, 2008, EUPHYTICA, V160, P295, DOI 10.1007/s10681-007-9497-0; Gouda PK, 2013, PLANT BREEDING, V132, P61, DOI 10.1111/pbr.12017; Hayashi K, 2006, THEOR APPL GENET, V113, P251, DOI 10.1007/s00122-006-0290-6; Hittalmani S, 2000, THEOR APPL GENET, V100, P1121, DOI 10.1007/s001220051395; Imam J, 2014, EUPHYTICA, V196, P199, DOI 10.1007/s10681-013-1024-x; Imam J, 2013, P NATL A SCI INDIA B, V83, P499, DOI 10.1007/s40011-013-0186-6; Ingole KD, 2014, INDIAN J GENET PL BR, V74, P378, DOI 10.5958/0975-6906.2014.00857.8; Jeon JS, 2003, MOL GENET GENOMICS, V269, P280, DOI 10.1007/s00438-003-0834-2; Jia YL, 2004, EUPHYTICA, V138, P97, DOI 10.1023/B:EUPH.0000047079.42768.4d; Jia YL, 2002, CROP SCI, V42, P2145, DOI 10.2135/cropsci2002.2145; JOHNSON R, 1981, PHYTOPATHOLOGY, V71, P567, DOI 10.1094/Phyto-71-567; Khush GS, 2005, PLANT MOL BIOL, V59, P1, DOI 10.1007/s11103-005-2159-5; Liu JL, 2010, MOL PLANT PATHOL, V11, P419, DOI [10.1111/J.1364-3703.2009.00607.X, 10.1111/j.1364-3703.2009.00607.x]; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu Y, 2013, THEOR APPL GENET, V126, P985, DOI 10.1007/s00122-012-2031-3; Mahender A., 2012, African Journal of Biotechnology, V11, P1321; Ou SH, 1985, RICE DIS; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pritchard JK, 2000, GENETICS, V155, P945; Qu SH, 2006, GENETICS, V172, P1901, DOI 10.1534/genetics.105.044891; Rohlf F.J., 1992, APPL BIOSTATISTICS; RoyChowdhury M, 2012, EUPHYTICA, V184, P35, DOI 10.1007/s10681-011-0481-3; Sharma TR, 2012, AGR RES, V1, P37, DOI 10.1007/s40003-011-0003-5; Sharma TR, 2005, MOL GENET GENOMICS, V274, P569, DOI 10.1007/s00438-005-0035-2; Shikari AB, 2013, INDIAN J GENET PL BR, V73, P131, DOI 10.5958/j.0975-6906.73.2.020; Singh AK, 2015, PLANT PATHOLOGY J, V31, P12, DOI 10.5423/PPJ.OA.06.2014.0054; Skamnioti P, 2009, TRENDS BIOTECHNOL, V27, P141, DOI 10.1016/j.tibtech.2008.12.002; Sneath Peter H.A, 1973, NUMERICAL TAXONOMY; Tian DG, 2016, RICE, V9, DOI 10.1186/s12284-016-0091-8; Wang CW, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-8; [王聪 Wang Cong], 2002, [导弹与航天运载技术, Missiles and Space Vehicles], V0, P12; Yang JY, 2008, RICE SCI, V15, P311, DOI 10.1016/S1672-6308(09)60009-3; Yang Y., 2016, EUROPEAN J PLANT PAT, V2016, P1, DOI DOI 10.2352/ISSN.2470-1173.2016.18.DPMI-031; ZEIGLER RS, 1995, PHYTOPATHOLOGY, V85, P443, DOI 10.1094/Phyto-85-443; Zeigler RS, 1994, INT RICE RES I; Zheng WJ, 2016, THEOR APPL GENET, V129, P1035, DOI 10.1007/s00122-016-2681-7; Zhu D, 2016, RICE, V9, DOI 10.1186/s12284-016-0116-3	51	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176236	10.1371/journal.pone.0176236	http://dx.doi.org/10.1371/journal.pone.0176236			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445532	Green Published, gold, Green Submitted			2022-12-26	WOS:000400309200040
J	Bas-Hoogendam, JM; van Steenbergen, H; Kreuk, T; van der Wee, NJA; Westenberg, PM				Bas-Hoogendam, Janna Marie; van Steenbergen, Henk; Kreuk, Tanja; van der Wee, Nic J. A.; Westenberg, P. Michiel			How embarrassing! The behavioral and neural correlates of processing social norm violations	PLOS ONE			English	Article							MORAL EMOTIONS; DECISION-MAKING; BRAIN IMAGES; FMRI; ROBUST; GUILT; SELF; METAANALYSIS; JUDGMENTS; ANXIETY	Social norms are important for human social interactions, and violations of these norms are evaluated partly on the intention of the actor. Here, we describe the revised Social Norm Processing Task (SNPT-R), a paradigm enabling the study of behavioral and neural responses to intended and unintended social norm violations among both adults and adolescents. We investigated how participants (adolescents and adults, n = 87) rate intentional and unintentional social norm violations with respect to inappropriateness and embarrassment, and we examined the brain activation patterns underlying the processing of these transgressions in an independent sample of 21 adults using functional Magnetic Resonance Imaging (fMRI). We hypothesized to find activation within the medial prefrontal cortex, temporo-parietal cortex and orbitofrontal cortex in response to both intentional and unintentional social norm violations, with more pronounced activation for the intentional social norm violations in these regions and in the amygdala. Participants' ratings confirmed the hypothesis that the three types of stories are evaluated differently with respect to intentionality: intentional social norm violations were rated as the most inappropriate and most embarrassing. Furthermore, fMRI results showed that reading stories on intentional and unintentional social norm violations evoked activation within the frontal pole, the paracingulate gyrus and the superior frontal gyrus. In addition, processing unintentional social norm violations was associated with activation in, among others, the orbitofrontal cortex, middle frontal gyrus and superior parietal lobule, while reading intentional social norm violations was related to activation in the left amygdala. These regions have been previously implicated in thinking about one's self, thinking about others and moral reasoning. Together, these findings indicate that the SNPT-R could serve as a useful paradigm for examining social norm processing, both at the behavioral and the neural level.	[Bas-Hoogendam, Janna Marie; van Steenbergen, Henk; Kreuk, Tanja; Westenberg, P. Michiel] Leiden Univ, Inst Psychol, Leiden, Netherlands; [Bas-Hoogendam, Janna Marie; van der Wee, Nic J. A.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands; [Bas-Hoogendam, Janna Marie; van Steenbergen, Henk; van der Wee, Nic J. A.; Westenberg, P. Michiel] Leiden Inst Brain & Cognit, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC)	Bas-Hoogendam, JM (corresponding author), Leiden Univ, Inst Psychol, Leiden, Netherlands.; Bas-Hoogendam, JM (corresponding author), Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands.; Bas-Hoogendam, JM (corresponding author), Leiden Inst Brain & Cognit, Leiden, Netherlands.	j.m.hoogendam@fsw.leidenuniv.nl	Bas-Hoogendam, Janna Marie/M-9927-2014; van Steenbergen, Henk/B-4512-2008; Westenberg, P. Michiel/AAA-6390-2021	Bas-Hoogendam, Janna Marie/0000-0001-8982-1670; van Steenbergen, Henk/0000-0003-1917-6412; 	Leiden University Research Profile 'Health, Prevention and the Human Life Cycle'	Leiden University Research Profile 'Health, Prevention and the Human Life Cycle'	JMBH is funded by the Leiden University Research Profile Health, Prevention and the Human Life Cycle. The funding source had no involvement in study design, data collection, data analysis, writing this paper nor in the decision to submit this work for publication.	Andersson J.L.R, 2007, TR07JA2 FMRIB; Bas-Hoogendam JM, 2017, DATABASE OPEN SCI FR; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Berthoz S, 2006, NEUROIMAGE, V31, P945, DOI 10.1016/j.neuroimage.2005.12.039; Berthoz S, 2002, BRAIN, V125, P1696, DOI 10.1093/brain/awf190; Bicchieri C., 2006, GRAMMAR SOC; Blair KS, 2010, AM J PSYCHIAT, V167, P1526, DOI 10.1176/appi.ajp.2010.09121797; Borg JS, 2006, J COGNITIVE NEUROSCI, V18, P803, DOI 10.1162/jocn.2006.18.5.803; Brennan G., 2013, EXPLAINING NORMS; Carleton RN, 2006, DEPRESS ANXIETY, V23, P297, DOI 10.1002/da.20142; Chakroff A, 2016, SOC COGN AFFECT NEUR, V11, P476, DOI 10.1093/scan/nsv131; Cialdini RB, 2004, ANNU REV PSYCHOL, V55, P591, DOI 10.1146/annurev.psych.55.090902.142015; Colombo M, 2014, BIOL PHILOS, V29, P71, DOI 10.1007/s10539-013-9385-z; Cova F, 2012, MIND LANG, V27, P378, DOI 10.1111/j.1468-0017.2012.01449.x; Crone EA, 2012, NAT REV NEUROSCI, V13, P636, DOI 10.1038/nrn3313; Denny BT, 2012, J COGNITIVE NEUROSCI, V24, P1742, DOI 10.1162/jocn_a_00233; Eisenberg N, 2000, ANNU REV PSYCHOL, V51, P665, DOI 10.1146/annurev.psych.51.1.665; Feinberg M, 2012, J PERS SOC PSYCHOL, V102, P81, DOI 10.1037/a0025403; Finger EC, 2006, NEUROIMAGE, V33, P414, DOI 10.1016/j.neuroimage.2006.06.011; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gorgolewski KJ, 2015, FRONT NEUROINFORM, V9, DOI 10.3389/fninf.2015.00008; Haidt J, 2003, SER AFFECTIVE SCI, P852; Haller SPW, 2015, DEV COGN NEUROS-NETH, V13, P11, DOI 10.1016/j.dcn.2015.02.002; Heimberg RG, 1999, PSYCHOL MED, V29, P199, DOI 10.1017/S0033291798007879; Insel TR, 2014, AM J PSYCHIAT, V171, P395, DOI 10.1176/appi.ajp.2014.14020138; Jankowski KF, 2014, PSYCHIAT CLIN NEUROS, V68, P319, DOI 10.1111/pcn.12182; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jennings PL, 2015, J ORGAN BEHAV, V36, pS104, DOI 10.1002/job.1919; Knobe J, 2003, ANALYSIS, V63, P190, DOI 10.1111/1467-8284.00419; Knutson KM, 2010, SOC COGN AFFECT NEUR, V5, P378, DOI 10.1093/scan/nsq005; Krettenauer T, 2014, J YOUTH ADOLESCENCE, V43, P583, DOI 10.1007/s10964-013-9994-5; La Greca AM, 1998, J ABNORM CHILD PSYCH, V26, P83, DOI 10.1023/A:1022684520514; Lahat A, 2012, COGNITIVE DEV, V27, P181, DOI 10.1016/j.cogdev.2012.02.002; Lisciandra C, 2013, REV PHILOS PSYCHOL, V4, P751, DOI 10.1007/s13164-013-0161-4; Malle BF, 1997, J EXP SOC PSYCHOL, V33, P101, DOI 10.1006/jesp.1996.1314; Mclatchie N, 2016, SOC COGN AFFECT NEUR, V11, P703, DOI 10.1093/scan/nsw001; Miller R.S., 2007, SELF CONSCIOUS EMOTI, P245; Moll J, 2002, NEUROIMAGE, V16, P696, DOI 10.1006/nimg.2002.1118; Moll J, 2002, J NEUROSCI, V22, P2730, DOI 10.1523/JNEUROSCI.22-07-02730.2002; Moll J, 2009, NEUROSCI BIOBEHAV R, V33, P456, DOI 10.1016/j.neubiorev.2008.12.001; Morey RA, 2012, NEUROIMAGE, V60, P683, DOI 10.1016/j.neuroimage.2011.12.069; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; O'Callaghan C, 2016, BRAIN, P139; Rapee RM, 2004, CLIN PSYCHOL REV, V24, P737, DOI 10.1016/j.cpr.2004.06.004; Robins RW, 2009, SOC PERSONAL PSYCHOL, V3, P887, DOI 10.1111/j.1751-9004.2009.00217.x; Ruff CC, 2013, SCIENCE, V342, P482, DOI 10.1126/science.1241399; Sanfey AG, 2014, TRENDS COGN SCI, V18, P172, DOI 10.1016/j.tics.2014.01.011; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Spitzer M, 2007, NEURON, V56, P185, DOI 10.1016/j.neuron.2007.09.011; Stein MB, 2008, LANCET, V371, P1115, DOI 10.1016/S0140-6736(08)60488-2; Takahashi H, 2004, NEUROIMAGE, V23, P967, DOI 10.1016/j.neuroimage.2004.07.054; Tangney JP, 2007, ANNU REV PSYCHOL, V58, P345, DOI 10.1146/annurev.psych.56.091103.070145; van Kleef GA, 2015, CURR OPIN PSYCHOL, V6, P25, DOI 10.1016/j.copsyc.2015.03.013; Woolrich M, 2008, NEUROIMAGE, V41, P286, DOI 10.1016/j.neuroimage.2008.02.042; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Worsley KJ, 2001, FUNCTIONAL MRI INTRO; You D, 2011, ETHICS BEHAV, V21, P263, DOI 10.1080/10508422.2011.585591; Zahn R, 2009, CEREB CORTEX, V19, P276, DOI 10.1093/cercor/bhn080; Zhang Y, 2016, J NEUROSCI, V36, P9217, DOI 10.1523/JNEUROSCI.0595-16.2016	63	20	20	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176326	10.1371/journal.pone.0176326	http://dx.doi.org/10.1371/journal.pone.0176326			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET5FE	28441460	Green Published, gold			2022-12-26	WOS:000400308800045
J	Cerqueira, DM; Bodnar, AJ; Phua, YL; Freer, R; Hemker, SL; Walensky, LD; Hukriede, NA; Ho, J				Cerqueira, Debora M.; Bodnar, Andrew J.; Phua, Yu Leng; Freer, Rachel; Hemker, Shelby L.; Walensky, Loren D.; Hukriede, Neil A.; Ho, Jacqueline			Bim gene dosage is critical in modulating nephron progenitor survival in the absence of microRNAs during kidney development	FASEB JOURNAL			English	Article						nephrogenesis; metanephros; Bcl-2L11; Dicer; apoptosis	APOPTOTIC PROTEIN BIM; BCL-2 RELATIVE BIM; CELL-DEATH; TRANSCRIPTIONAL REGULATION; BH3-ONLY PROTEINS; LYMPHOBLASTIC-LEUKEMIA; METANEPHRIC MESENCHYME; POLYCYSTIC KIDNEY; OXIDATIVE STRESS; MAMMALIAN KIDNEY	Low nephron endowment at birth has been associated with an increased risk for developing hypertension and chronic kidney disease. We demonstrated in an earlier study that conditional deletion of the microRNA (miRNA)-processing enzyme Dicer from nephron progenitors results in premature depletion of the progenitors and increased expression of the proapoptotic protein Bim (also known as Bcl-2L11). In this study, we generated a compound mouse model with conditional deletion of both Dicer and Bim, to determine the biologic significance of increased Bim expression in Dicer-deficient nephron progenitors. The loss of Bim partially restored the number of nephron progenitors and improved nephron formation. The number of progenitors undergoing apoptosis was significantly reduced in kidneys with loss of a single allele, or both alleles, of Bim compared to mutant kidneys. Furthermore, 2 miRNAs expressed in nephron progenitors (miR-17 and miR-106b) regulated Bim levels in vitro and in vivo. Together, these data suggest that miRNA-mediated regulation of Bim controls nephron progenitor survival during nephrogenesis, as one potential means of regulating nephron endowment.	[Cerqueira, Debora M.; Bodnar, Andrew J.; Phua, Yu Leng; Freer, Rachel; Hemker, Shelby L.; Ho, Jacqueline] Univ Pittsburgh, Sch Med, Dept Pediat, Div Nephrol, Pittsburgh, PA 15261 USA; [Hukriede, Neil A.] Univ Pittsburgh, Dept Dev Biol, Pittsburgh, PA USA; [Walensky, Loren D.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Walensky, Loren D.] Dana Farber Canc Inst, Linde Program Canc Chem Biol, Boston, MA 02115 USA; [Walensky, Loren D.] Harvard Med Sch, Boston Childrens Hosp, Dept Pediat, Boston, MA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard Medical School	Ho, J (corresponding author), UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Div Nephrol,Rangos Res Ctr, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	jacqueline.ho2@chp.edu	Cerqueira, Debora Malta/CAF-4323-2022; Ho, Jackie/AAP-1531-2021; Cerqueira, Debora Malta/AAB-6204-2020	Ho, Jackie/0000-0001-7115-1381; Hemker, Shelby/0000-0002-9135-7042; Phua, Yu Leng/0000-0002-3428-8669; Malta Cerqueira Sant'Anna Santos, Debora/0000-0001-9773-4606	U. S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [P30DK079307]; Children's Hospital of Pittsburgh of UPMC's Histology Core Laboratory; University of Pittsburgh Flow Cytometry Core Laboratory; NIH NIDDK [DK087922, DK103776]; NIH, NIDDK [DK069403, DK079307, T32 DK061296]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD053287]; Children's Hospital of Pittsburgh Research Advisory Council Postdoctoral Fellowship; George B. Rathmann Research Fellowship by American Society of Nephrology Ben J. Lipps Research Fellowship Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD053287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK087922, R01DK069403, P30DK079307, R01DK103776, R00DK087922, T32DK061296] Funding Source: NIH RePORTER	U. S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Children's Hospital of Pittsburgh of UPMC's Histology Core Laboratory; University of Pittsburgh Flow Cytometry Core Laboratory; NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Children's Hospital of Pittsburgh Research Advisory Council Postdoctoral Fellowship; George B. Rathmann Research Fellowship by American Society of Nephrology Ben J. Lipps Research Fellowship Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. Oliver Wessely (Cleveland Clinic Lerner Research Institute, Cleveland, OH, USA) for intellectual input; the Kidney Imaging Core of the Pittsburgh Center for Kidney Research for providing expert pathological and 3-dimensional stereological support [funded by U. S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grant P30DK079307]; the Children's Hospital of Pittsburgh of UPMC's Histology Core Laboratory, University of Pittsburgh Flow Cytometry Core Laboratory; the Kansas State University Veterinary Diagnostic Laboratories for technical assistance; and the University of Pittsburgh Cell Culture and Cytogenetics Facility for cell line authentication. This work was supported by NIH NIDDK Grants DK087922 and DK103776 (to J.H.); NIH, NIDDK Grants DK069403, DK079307, and Eunice Kennedy Shriver National Institute of Child Health and Human Development HD053287 (to N.A.H.); NIH, NIDDK Grant T32 DK061296 (to S.L.H.); a Children's Hospital of Pittsburgh Research Advisory Council Postdoctoral Fellowship (to D.M.C.); and a George B. Rathmann Research Fellowship supported by the American Society of Nephrology Ben J. Lipps Research Fellowship Program (to Y.L.P.). L.D.W is a scientific advisory member and consultant for Aileron Therapeutics. The remaining authors declare no conflicts of interest.	Aerbajinai W, 2003, BLOOD, V102, P712, DOI 10.1182/blood-2002-11-3324; Akiyama T, 2009, MOL CANCER THER, V8, P3173, DOI 10.1158/1535-7163.MCT-09-0685; Barak H, 2012, DEV CELL, V22, P1191, DOI 10.1016/j.devcel.2012.04.018; Barreyro FJ, 2007, J BIOL CHEM, V282, P27141, DOI 10.1074/jbc.M704391200; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Barthson J, 2011, J BIOL CHEM, V286, P39632, DOI 10.1074/jbc.M111.253591; Bernardo-Garcia FJ, 2016, DEVELOPMENT, V143, P1413, DOI 10.1242/dev.128801; Bertram JF, 2014, PEDIATR NEPHROL, V29, P575, DOI 10.1007/s00467-013-2600-y; Biswas SC, 2007, J BIOL CHEM, V282, P29368, DOI 10.1074/jbc.M702634200; Biswas SC, 2007, J NEUROSCI, V27, P893, DOI 10.1523/JNEUROSCI.3524-06.2007; Bonev Boyan, 2012, Methods Mol Biol, V917, P445, DOI 10.1007/978-1-61779-992-1_25; Bouillet P, 2001, DEV CELL, V1, P645, DOI 10.1016/S1534-5807(01)00083-1; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2001, MAMM GENOME, V12, P163, DOI 10.1007/s003350010242; BRENNER BM, 1988, AM J HYPERTENS, V1, P335, DOI 10.1093/ajh/1.4.335; Brunjes PC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138541; Brunskill EW, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-15; Campone M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-110; Castoldi M, 2006, RNA, V12, P913, DOI 10.1261/rna.2332406; Castoldi M, 2007, METHODS, V43, P146, DOI 10.1016/j.ymeth.2007.04.009; Cebrian C, 2014, CELL REP, V7, P127, DOI 10.1016/j.celrep.2014.02.033; Chen M, 2007, BLOOD, V109, P4360, DOI 10.1182/blood-2006-11-056424; Chen S, 2015, DEV CELL, V35, P49, DOI 10.1016/j.devcel.2015.09.009; Chi LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065448; Chu JYS, 2014, AM J PHYSIOL-RENAL, V306, pF764, DOI 10.1152/ajprenal.00426.2013; Cullen-McEwen Luise A, 2012, Methods Mol Biol, V886, P333, DOI 10.1007/978-1-61779-851-1_30; Davila D, 2014, MOL BIOL CELL, V25, P3413, DOI 10.1091/mbc.E13-08-0495; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Dressler GR, 2009, DEVELOPMENT, V136, P3863, DOI 10.1242/dev.034876; Eichhorn JM, 2014, EXP CELL RES, V322, P415, DOI 10.1016/j.yexcr.2014.02.010; Essafi A, 2005, ONCOGENE, V24, P2317, DOI 10.1038/sj.onc.1208421; Fuchs C, 2012, HUM MOL GENET, V21, P1049, DOI 10.1093/hmg/ddr535; Gebeshuber CA, 2013, NAT MED, V19, P481, DOI 10.1038/nm.3142; Georgas K, 2009, DEV BIOL, V332, P273, DOI 10.1016/j.ydbio.2009.05.578; Giam M, 2008, ONCOGENE, V27, pS128, DOI 10.1038/onc.2009.50; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Gogada R, 2013, J BIOL CHEM, V288, P368, DOI 10.1074/jbc.M112.386102; Grieshammer U, 2005, DEVELOPMENT, V132, P3847, DOI 10.1242/dev.01944; Guo CE, 2015, J CELL MOL MED, V19, P103, DOI 10.1111/jcmm.12393; Harada M, 2012, LEUKEMIA LYMPHOMA, V53, P2041, DOI 10.3109/10428194.2012.678004; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Hartman HA, 2007, DEV BIOL, V310, P379, DOI 10.1016/j.ydbio.2007.08.021; Hendrickx A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074305; Hershko T, 2004, J BIOL CHEM, V279, P8627, DOI 10.1074/jbc.M312866200; HINCHLIFFE SA, 1991, LAB INVEST, V64, P777; Ho J, 2011, J AM SOC NEPHROL, V22, P1053, DOI 10.1681/ASN.2010080841; Hubner A, 2008, MOL CELL, V30, P415, DOI 10.1016/j.molcel.2008.03.025; Hutcheson J, 2008, IMMUNITY, V28, P206, DOI 10.1016/j.immuni.2007.12.015; Ingelfinger JR, 2008, ADV CHRONIC KIDNEY D, V15, P107, DOI 10.1053/j.ackd.2008.01.003; KAMADA S, 1995, CANCER RES, V55, P354; Kan T, 2009, GASTROENTEROLOGY, V136, P1689, DOI 10.1053/j.gastro.2009.02.002; Katz SG, 2014, BLOOD, V123, P884, DOI 10.1182/blood-2013-04-499079; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Kohler UA, 2014, HEPATOLOGY, V60, P670, DOI 10.1002/hep.26964; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; LaBelle JL, 2012, J CLIN INVEST, V122, P2018, DOI 10.1172/JCI46231; Lechner MS, 1997, MECH DEVELOP, V62, P105, DOI 10.1016/S0925-4773(97)00667-9; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Leon R, 2010, EUR J NEUROSCI, V31, P1915, DOI 10.1111/j.1460-9568.2010.07215.x; Ley R, 2005, CELL DEATH DIFFER, V12, P1008, DOI 10.1038/sj.cdd.4401688; Liu R, 2015, ONCOTARGET, V6, P43831, DOI 10.18632/oncotarget.6257; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu JH, 2006, FEBS LETT, V580, P3539, DOI 10.1016/j.febslet.2006.05.031; Luyckx VA, 2010, J AM SOC NEPHROL, V21, P898, DOI 10.1681/ASN.2009121248; Mao ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068206; Marrone AK, 2014, J AM SOC NEPHROL, V25, P1440, DOI 10.1681/ASN.2013040390; Matsui H, 2007, MOL CELL, V25, P99, DOI 10.1016/j.molcel.2006.12.007; Montagne C, 2014, DEVELOPMENT, V141, P2014, DOI 10.1242/dev.104240; Nagalakshmi VK, 2011, KIDNEY INT, V79, P317, DOI 10.1038/ki.2010.385; NAKAYAMA K, 1994, P NATL ACAD SCI USA, V91, P3700, DOI 10.1073/pnas.91.9.3700; Neves J, 2011, DEVELOPMENT, V138, P735, DOI 10.1242/dev.060657; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; Nishinakamura R, 2001, DEVELOPMENT, V128, P3105; Perantoni AO, 2005, DEVELOPMENT, V132, P3859, DOI 10.1242/dev.01945; Perier C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009332; Poladia DP, 2006, DEV BIOL, V291, P325, DOI 10.1016/j.ydbio.2005.12.034; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Qian L, 2011, J EXP MED, V208, P549, DOI 10.1084/jem.20101547; Quinlan J, 2007, J AM SOC NEPHROL, V18, P1915, DOI 10.1681/ASN.2006101107; Ren DC, 2014, DIABETES, V63, P3378, DOI 10.2337/db13-1814; Ridinger-Saison M, 2013, CELL DEATH DIFFER, V20, P1268, DOI 10.1038/cdd.2013.88; Romaker D, 2014, P NATL ACAD SCI USA, V111, P6335, DOI 10.1073/pnas.1320577111; ROTHENPIELER UW, 1993, DEVELOPMENT, V119, P711; Rumballe BA, 2011, DEV BIOL, V360, P110, DOI 10.1016/j.ydbio.2011.09.011; Sanphui P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.148; SAXEN L, 1987, PEDIATR NEPHROL, V1, P385, DOI 10.1007/BF00849241; Schuchardt A, 1996, DEVELOPMENT, V122, P1919; Self M, 2006, EMBO J, V25, P5214, DOI 10.1038/sj.emboj.7601381; Sims-Lucas S, 2011, DEV DYNAM, V240, P240, DOI 10.1002/dvdy.22501; Sionov RV, 2015, ONCOTARGET, V6, P23058, DOI 10.18632/oncotarget.5492; Sive HL, 1998, EARLY DEV XENOPUS LA; SORENSON CM, 1995, AM J PHYSIOL-RENAL, V268, pF73, DOI 10.1152/ajprenal.1995.268.1.F73; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; Takasato M, 2014, NAT CELL BIOL, V16, P118, DOI 10.1038/ncb2894; Takeuchi O, 2005, P NATL ACAD SCI USA, V102, P11272, DOI 10.1073/pnas.0504783102; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Vize P.D., 2003, KIDNEY NORMAL DEV CO; Wali JA, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.88; Wang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085389; Weber S, 2008, J AM SOC NEPHROL, V19, P891, DOI 10.1681/ASN.2006111282; Wilczynska A, 2015, CELL DEATH DIFFER, V22, P22, DOI 10.1038/cdd.2014.112; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xiao GY, 2016, SCI REP-UK, V6, DOI 10.1038/srep23120; Yang Y, 2009, NEOPLASIA, V11, P313, DOI 10.1593/neo.81358; Zhang LZ, 2004, J BIOL CHEM, V279, P20858, DOI 10.1074/jbc.M310643200; Zhang Z, 2008, J AM SOC NEPHROL, V19, P2027, DOI 10.1681/ASN.2007101098; Zhong B, 2012, NAT IMMUNOL, V13, P1110, DOI 10.1038/ni.2427	108	12	13	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3540	3554		10.1096/fj.201700010R	http://dx.doi.org/10.1096/fj.201700010R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28446592	Green Published			2022-12-26	WOS:000405932400029
J	Motomura, T; Suga, M; Hienerwadel, R; Nakagawa, A; Lai, TL; Nitschke, W; Kuma, T; Sugiura, M; Boussac, A; Shen, JR				Motomura, Taiki; Suga, Michihiro; Hienerwadel, Rainer; Nakagawa, Akiko; Thanh-Lan Lai; Nitschke, Wolfgang; Kuma, Takahiro; Sugiura, Miwa; Boussac, Alain; Shen, Jian-Ren			Crystal structure and redox properties of a novel cyanobacterial heme protein with a His/Cys heme axial ligation and a Per-Arnt-Sim (PAS)-like domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EVOLVING PHOTOSYSTEM-II; THERMOSYNECHOCOCCUS-ELONGATUS; D1 PROTEIN; ANGSTROM RESOLUTION; SECONDARY-STRUCTURE; GENE-EXPRESSION; PAS DOMAINS; AMINO-ACID; PSBA GENES; 2 FORMS	Photosystem II catalyzes light-induced water oxidation leading to the generation of dioxygen indispensable for sustaining aerobic life on Earth. The Photosystem II reaction center is composed of D1 and D2 proteins encoded by psbA and psbD genes, respectively. In cyanobacteria, different psbA genes are present in the genome. The thermophilic cyanobacterium Thermosynechococcus elongatus contains three psbA genes: psbA1, psbA2, and psbA3, and a new c-type heme protein, Tll0287, was found to be expressed in a strain expressing the psbA2 gene only, but the structure and function of Tll0287 are unknown. Here we solved the crystal structure of Tll0287 at a 2.0 angstrom resolution. The overall structure of Tll0287 was found to be similar to some kinases and sensor proteins with a Per-Arnt-Sim-like domain rather than to other c-type cytochromes. The fifth and sixth axial ligands for the heme were Cys and His, instead of the His/Met or His/His ligand pairs observed for most of the c-type hemes. The redox potential, E-1/2, of Tll0287 was -255 +/- 20 mV versus normal hydrogen electrode at pH values above 7.5. Below this pH value, the E1/2 increased by approximate to 57 mV/pH unit at 15 degrees C, suggesting the involvement of a protonatable group with a pK(red) = 7.2 +/- 0.3. Possible functions of Tll0287 as a redox sensor under microaerobic conditions or a cytochrome subunit of an H2S-oxidizing system are discussed in view of the environmental conditions in which psbA2 is expressed, as well as phylogenetic analysis, structural, and sequence homologies.	[Motomura, Taiki; Shen, Jian-Ren] Univ Hyogo, Grad Sch Life Sci, Dept Picobiol, Kamigori, Hyogo 6781297, Japan; [Motomura, Taiki; Suga, Michihiro; Nakagawa, Akiko; Kuma, Takahiro; Shen, Jian-Ren] Okayama Univ, Res Inst Interdisciplinary Sci, Okayama 7008530, Japan; [Motomura, Taiki; Suga, Michihiro; Nakagawa, Akiko; Kuma, Takahiro; Shen, Jian-Ren] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Hienerwadel, Rainer] CNRS CEA Aix Marseille Univ, Fac Sci Luminy, UMR 7265, Lab Genet & Biophys Plantes, F-13288 Marseille, France; [Nakagawa, Akiko; Sugiura, Miwa] Ehime Univ, Proteosci Res Ctr, Matsuyama, Ehime 7908577, Japan; [Thanh-Lan Lai; Boussac, Alain] CEA Saclay, UMR 9198, CNRS, iBiTec S,SB2SM, F-91191 Gif Sur Yvette, France; [Nitschke, Wolfgang] CNRS, UMR 7281, Lab Bioenerget & Ingn Prot, F-13402 Marseille 20, France	University of Hyogo; Okayama University; Okayama University; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite; Ehime University; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Shen, JR (corresponding author), Univ Hyogo, Grad Sch Life Sci, Dept Picobiol, Kamigori, Hyogo 6781297, Japan.; Shen, JR (corresponding author), Okayama Univ, Res Inst Interdisciplinary Sci, Okayama 7008530, Japan.; Shen, JR (corresponding author), Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan.	shen@cc.okayama-u.ac.jp	Shen, Jian-Ren/B-2558-2011; Nitschke, Wolfgang/C-4812-2012	Nitschke, Wolfgang/0000-0003-2084-3032; Motomura, Taiki/0000-0002-9646-7347	University of Hyogo; Okayama University; KAKENHI [JP24000018, JP26840023, JP15H01642, JP16H06162]; Japan Society for the Promotion of Science [JP16H06296]; Inamori Foundation grant; Japan Science and Technology Agency [4018]; Bioenergy Program of CEA-DSV; Grants-in-Aid for Scientific Research [16H06162] Funding Source: KAKEN	University of Hyogo; Okayama University; KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Inamori Foundation grant; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Bioenergy Program of CEA-DSV; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a program for Leading Graduate Schools, "Next Generation Picobiology Pioneered by Photon Sciences" at the University of Hyogo, a program for promoting the enhancement of research universities at Okayama University; KAKENHI Grants JP24000018 (to J.-R. S.) and JP26840023, JP15H01642, JP16H06162, and JP16H06296 (to M. Suga) from Japan Society for the Promotion of Science; an Inamori Foundation grant (to M. Suga); Japan Science and Technology Agency (JST)-PRESTO Program 4018 (to M. Sugiura); and the Bioenergy Program of CEA-DSV (to T.-L. L. and A. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alric J, 2004, J BIOL CHEM, V279, P26090, DOI 10.1074/jbc.M400361200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARIELI B, 1994, J BIOL CHEM, V269, P5705; Boussac A, 2013, BBA-BIOENERGETICS, V1827, P1174, DOI 10.1016/j.bbabio.2013.06.002; Boussac A, 2011, BBA-BIOENERGETICS, V1807, P119, DOI 10.1016/j.bbabio.2010.10.004; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Burton MJ, 2016, P NATL ACAD SCI USA, V113, P3785, DOI 10.1073/pnas.1600211113; BUSTOS SA, 1990, J BACTERIOL, V172, P1998, DOI 10.1128/jb.172.4.1998-2004.1990; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Campbell D, 1998, P NATL ACAD SCI USA, V95, P364, DOI 10.1073/pnas.95.1.364; CAMPBELL D, 1995, EMBO J, V14, P5457, DOI 10.1002/j.1460-2075.1995.tb00232.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheung J, 2010, CURR OPIN MICROBIOL, V13, P116, DOI 10.1016/j.mib.2010.01.016; Crosthwaite SK, 1997, SCIENCE, V276, P763, DOI 10.1126/science.276.5313.763; Diaz-Moreno I, 2014, BBA-BIOENERGETICS, V1837, P1305, DOI 10.1016/j.bbabio.2014.03.009; Dunlap JC, 1996, ANNU REV GENET, V30, P579, DOI 10.1146/annurev.genet.30.1.579; Dutton P L, 1978, Methods Enzymol, V54, P411; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Glekas GD, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.413518; GOLDEN SS, 1995, J BACTERIOL, V177, P1651, DOI 10.1128/jb.177.7.1651-1654.1995; Grein F, 2010, BIOCHEMISTRY-US, V49, P8290, DOI 10.1021/bi1007673; Henry JT, 2011, ANNU REV MICROBIOL, V65, P261, DOI 10.1146/annurev-micro-121809-151631; Hirano Y, 2012, BIOCHEMISTRY-US, V51, P6556, DOI 10.1021/bi3005522; HOFFMAN EC, 1991, SCIENCE, V252, P954, DOI 10.1126/science.1852076; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kappler U, 2013, CELL MOL LIFE SCI, V70, P977, DOI 10.1007/s00018-012-1098-y; Katoh H, 2001, PLANT CELL PHYSIOL, V42, P599, DOI 10.1093/pcp/pce074; Kawakami K, 2011, J PHOTOCH PHOTOBIO B, V104, P9, DOI 10.1016/j.jphotobiol.2011.03.017; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kerfeld CA, 2003, J BIOL INORG CHEM, V8, P707, DOI 10.1007/s00775-003-0469-0; Kerfeld CA, 2003, PLANT CELL PHYSIOL, V44, P697, DOI 10.1093/pcp/pcg084; Kirilovsky D, 2004, J BIOL CHEM, V279, P52869, DOI 10.1074/jbc.M408206200; Kneuper H., 2010, SENSORY MECH BACTERI; Kos PB, 2008, BBA-BIOENERGETICS, V1777, P74, DOI 10.1016/j.bbabio.2007.10.015; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Meier M, 2001, EMBO J, V20, P3910, DOI 10.1093/emboj/20.15.3910; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P2124, DOI 10.1073/pnas.1015154108; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Mulo P, 2009, CELL MOL LIFE SCI, V66, P3697, DOI 10.1007/s00018-009-0103-6; Nakamura Y, 2002, DNA RES, V9, P123, DOI 10.1093/dnares/9.4.123; NAMBU JR, 1991, CELL, V67, P1157, DOI 10.1016/0092-8674(91)90292-7; PEISACH J, 1973, ANN NY ACAD SCI, V206, P310, DOI 10.1111/j.1749-6632.1973.tb43219.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pokkuluri PR, 2008, J MOL BIOL, V377, P1498, DOI 10.1016/j.jmb.2008.01.087; SANDER J, 2008, PHOTOSYNTHESIS ENERG, P745; SCHAEFER MR, 1989, J BIOL CHEM, V264, P7412; SCHAEFER MR, 1989, J BACTERIOL, V171, P3973, DOI 10.1128/jb.171.7.3973-3981.1989; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shen JR, 2015, ANNU REV PLANT BIOL, V66, P23, DOI 10.1146/annurev-arplant-050312-120129; SHEN JR, 1993, J BIOL CHEM, V268, P20408; SHEN JR, 1993, BIOCHEMISTRY-US, V32, P1825, DOI 10.1021/bi00058a017; Shen JR, 2000, BIOCHEMISTRY-US, V39, P14739, DOI 10.1021/bi001402m; Sicora CI, 2006, BBA-BIOENERGETICS, V1757, P47, DOI 10.1016/j.bbabio.2005.11.002; Sicora CI, 2009, BBA-BIOENERGETICS, V1787, P105, DOI 10.1016/j.bbabio.2008.12.002; Sippola K, 1999, PLANT MOL BIOL, V41, P425, DOI 10.1023/A:1006347808475; Smith AT, 2012, J BIOL INORG CHEM, V17, P1071, DOI 10.1007/s00775-012-0920-1; Suga M, 2015, NATURE, V517, P99, DOI 10.1038/nature13991; Suga M, 2013, FEBS LETT, V587, P3267, DOI 10.1016/j.febslet.2013.08.023; Sugiura M, 2008, BBA-BIOENERGETICS, V1777, P331, DOI 10.1016/j.bbabio.2008.01.007; Sugiura M, 2014, BBA-BIOENERGETICS, V1837, P1922, DOI 10.1016/j.bbabio.2014.08.008; Sugiura M, 2014, RES CHEM INTERMEDIAT, V40, P3219, DOI 10.1007/s11164-014-1828-x; Sugiura M, 2014, BBA-BIOENERGETICS, V1837, P1427, DOI 10.1016/j.bbabio.2013.12.011; Sugiura M, 2013, BIOCHEMISTRY-US, V52, P9426, DOI 10.1021/bi401213m; Sugiura M, 2012, J BIOL CHEM, V287, P13336, DOI 10.1074/jbc.M112.340323; Sugiura M, 2010, BBA-BIOENERGETICS, V1797, P1491, DOI 10.1016/j.bbabio.2010.03.022; Summerfield TC, 2008, BIOCHEMISTRY-US, V47, P12939, DOI 10.1021/bi8018916; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Touw WG, 2015, NUCLEIC ACIDS RES, V43, pD364, DOI 10.1093/nar/gku1028; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Ukita S, 2010, FEMS MICROBIOL LETT, V313, P61, DOI 10.1111/j.1574-6968.2010.02122.x; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Van Driessche G, 2006, FEBS J, V273, P2801, DOI 10.1111/j.1742-4658.2006.05296.x; Vita N, 2013, ANAL CHEM, V85, P2891, DOI 10.1021/ac303511g; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Walker FA, 1999, COORDIN CHEM REV, V185-6, P471, DOI 10.1016/S0010-8545(99)00029-6; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu R, 2013, PROTEIN SCI, V22, P564, DOI 10.1002/pro.2237; Wydrzynski T, 2005, PHOTOSYSTEM, DOI [10.1007/1-4020-4254-X_6, DOI 10.1007/1-4020-4254-X_6]; Zhong FF, 2014, P NATL ACAD SCI USA, V111, pE306, DOI 10.1073/pnas.1317173111	85	9	9	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9599	9612		10.1074/jbc.M116.746263	http://dx.doi.org/10.1074/jbc.M116.746263			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28428249	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000403113000012
J	Skegro, D; Stutz, C; Ollier, R; Svensson, E; Wassmann, P; Bourquin, F; Monney, T; Gn, S; Blein, S				Skegro, Darko; Stutz, Cian; Ollier, Romain; Svensson, Emelie; Wassmann, Paul; Bourquin, Florence; Monney, Thierry; Gn, Sunitha; Blein, Stanislas			Immunoglobulin domain interface exchange as a platform technology for the generation of Fc heterodimers and bispecific antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IGG ANTIBODIES; DESIGN; INFORMATION; HOMODIMER; PROGRESS; IMGT(R); CELLS; RISE	Bispecific antibodies (bsAbs) are of significant importance to the development of novel antibody-based therapies, and heavy chain (Hc) heterodimers represent a major class of bispecific drug candidates. Current technologies for the generation of Hc heterodimers are suboptimal and often suffer from contamination by homodimers posing purification challenges. Here, we introduce a new technology based on biomimicry wherein the protein-protein interfaces of two different immunoglobulin (Ig) constant domain pairs are exchanged in part or fully to design new heterodimeric domains. The method can be applied across Igs to design Fc heterodimers and bsAbs. We investigated interfaces from human IgA CH3, IgD CH3, IgG1 CH3, IgM CH4, T-cell receptor (TCR) alpha/beta, and TCR gamma/delta constant domain pairs, and we found that they successfully drive human IgG1 CH3 or IgM CH4 heterodimerization to levels similar to or above those of reference methods. A comprehensive interface exchange between the TCR alpha/beta constant domain pair and the IgG1 CH3 homodimer was evidenced by X-ray crystallography and used to engineer examples of bsAbs for cancer therapy. Parental antibody pairs were rapidly reformatted into scalable bsAbs that were free of homodimer traces by combining interface exchange, asymmetric Protein A binding, and the scFv x Fab format. In summary, we successfully built several new CH3- or CH4-based heterodimers that may prove useful for designing new bsAb-based therapeutics, and we anticipate that our approach could be broadly implemented across the Ig constant domain family. To our knowledge, CH4-based heterodimers have not been previously reported.	[Skegro, Darko; Stutz, Cian; Ollier, Romain; Svensson, Emelie; Wassmann, Paul; Bourquin, Florence; Monney, Thierry; Blein, Stanislas] Glenmark Pharmaceut SA, Biol Res, Dept Antibody Engn, Chemin Combeta 5, CH-2300 La Chaux De Fonds, Switzerland; [Gn, Sunitha] Glenmark Pharmaceut Ltd, Glenmark Res Ctr, Dept Drug Metab & Pharmacokinet, MIDC, Plot A-607, Mahape 400709, Navi Mumbai, India	Glenmark Pharmaceuticals Limited	Blein, S (corresponding author), Glenmark Pharmaceut SA, Biol Res, Dept Antibody Engn, Chemin Combeta 5, CH-2300 La Chaux De Fonds, Switzerland.	stanislas.blein@glenmarkpharma.com		Monney, Thierry/0000-0002-8566-541X; Wassmann, Paul/0000-0001-7391-1065				Abdiche YN, 2015, MABS-AUSTIN, V7, P331, DOI 10.1080/19420862.2015.1008353; Atwell S, 1997, J MOL BIOL, V270, P26, DOI 10.1006/jmbi.1997.1116; Carter P, 2001, J IMMUNOL METHODS, V248, P7, DOI 10.1016/S0022-1759(00)00339-2; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Davis JH, 2010, PROTEIN ENG DES SEL, V23, P195, DOI 10.1093/protein/gzp094; Dimasi N, 2009, J MOL BIOL, V393, P672, DOI 10.1016/j.jmb.2009.08.032; Fuh G., 2010, PCT Patent No, Patent No. [WO2010/108127, 2010108127]; Garber E, 2007, BIOCHEM BIOPH RES CO, V355, P751, DOI 10.1016/j.bbrc.2007.02.042; Garber K, 2014, NAT REV DRUG DISCOV, V13, P799, DOI 10.1038/nrd4478; Goldstein N. I., 1996, PCT Patent No, Patent No. [WO1996/040210, 1996040210]; Gunasekaran K, 2010, J BIOL CHEM, V285, P19637, DOI 10.1074/jbc.M110.117382; Jackman J, 2010, J BIOL CHEM, V285, P20850, DOI 10.1074/jbc.M110.113910; Jimeno A, 2016, CANCER-AM CANCER SOC, V122, P3803, DOI 10.1002/cncr.30256; Junttila TT, 2014, CANCER RES, V74, P5561, DOI 10.1158/0008-5472.CAN-13-3622-T; Klein C, 2016, MABS-AUSTIN, V8, P1010, DOI 10.1080/19420862.2016.1197457; Klein C, 2012, MABS-AUSTIN, V4, P653, DOI 10.4161/mabs.21379; Kol A, 2014, PHARMACOL THERAPEUT, V143, P1, DOI 10.1016/j.pharmthera.2014.01.005; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Lefranc MP, 2015, NUCLEIC ACIDS RES, V43, pD413, DOI 10.1093/nar/gku1056; Lefranc MP, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00022; Lewis SM, 2014, NAT BIOTECHNOL, V32, P191, DOI 10.1038/nbt.2797; LINDHOFER H, 1995, J IMMUNOL, V155, P219; Merchant AM, 1998, NAT BIOTECHNOL, V16, P677, DOI 10.1038/nbt0798-677; Moretti P, 2013, BMC P, V7, P9; Rothe M., 2007, PCT Patent No, Patent No. [WO2007/077028, 2007077028]; Sampei Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057479; Schaefer G, 2011, CANCER CELL, V20, P472, DOI 10.1016/j.ccr.2011.09.003; Schaefer W, 2011, P NATL ACAD SCI USA, V108, P11187, DOI 10.1073/pnas.1019002108; Sheridan C, 2016, NAT BIOTECHNOL, V34, P1215, DOI 10.1038/nbt1216-1215; Sheridan C, 2015, NAT BIOTECHNOL, V33, P219, DOI 10.1038/nbt0315-219; Skubak P, 2004, ACTA CRYSTALLOGR D, V60, P2196, DOI 10.1107/S0907444904019079; Smith EJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17943; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Tustian AD, 2016, MABS-AUSTIN, V8, P828, DOI 10.1080/19420862.2016.1160192; Vidarsson G, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00520; Von Kreudenstein TS, 2013, MABS-AUSTIN, V5, P646, DOI 10.4161/mabs.25632; Weiner GJ, 2015, NAT REV CANCER, V15, P361, DOI 10.1038/nrc3930; Xu YR, 2015, MABS-AUSTIN, V7, P231, DOI 10.4161/19420862.2015.989013	39	21	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9745	9759		10.1074/jbc.M117.782433	http://dx.doi.org/10.1074/jbc.M117.782433			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28450393	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000403113000024
J	Scherdel, P; Reynaud, R; Pietrement, C; Salaun, JF; Bellaiche, M; Arnould, M; Chevallier, B; Piloquet, H; Jobez, E; Cheymol, J; Bichara, E; Heude, B; Chalumeau, M				Scherdel, Pauline; Reynaud, Rachel; Pietrement, Christine; Salaun, Jean-Francois; Bellaiche, Marc; Arnould, Michel; Chevallier, Bertrand; Piloquet, Hugues; Jobez, Emmanuel; Cheymol, Jacques; Bichara, Emmanuelle; Heude, Barbara; Chalumeau, Martin		EBGM III Study Grp	Priority target conditions for algorithms for monitoring children's growth: Interdisciplinary consensus	PLOS ONE			English	Article							DIAGNOSIS; POPULATION; PREVALENCE; DEFICIENCY; DISEASE	Background Growth monitoring of apparently healthy children aims at early detection of serious conditions through the use of both clinical expertise and algorithms that define abnormal growth. Optimization of growth monitoring requires standardization of the definition of abnormal growth, and the selection of the priority target conditions is a prerequisite of such standardization. Objective To obtain a consensus about the priority target conditions for algorithms monitoring children's growth. Methods We applied a formal consensus method with a modified version of the RAND/UCLA method, based on three phases (preparatory, literature review, and rating), with the participation of expert advisory groups from the relevant professional medical societies (ranging from primary care providers to hospital subspecialists) as well as parent associations. We asked experts in the pilot (n = 11), reading (n = 8) and rating (n = 60) groups to complete the list of diagnostic classification of the European Society for Paediatric Endocrinology and then to select the conditions meeting the four predefined criteria of an ideal type of priority target condition. Results Strong agreement was obtained for the 8 conditions selected by the experts among the 133 possible: celiac disease, Crohn disease, craniopharyngioma, juvenile nephronophthisis, Turner syndrome, growth hormone deficiency with pituitary stalk interruption syndrome, infantile cystinosis, and hypothalamic-optochiasmatic astrocytoma (in decreasing order of agreement). Conclusion This national consensus can be used to evaluate the algorithms currently suggested for growth monitoring. The method used for this national consensus could be re-used to obtain an international consensus.	[Scherdel, Pauline; Heude, Barbara] INSERM, Paris Descartes Univ, Epidemiol & Biostat Sorbonne Paris Cite Ctr CRESS, Early Origins Childs Hlth & Dev Team ORCHaD,UMR11, Paris, France; [Scherdel, Pauline; Chalumeau, Martin] INSERM, Paris Descartes Univ, Epidemiol & Biostat Sorbonne Paris Cite Ctr CRESS, Obstet Perinatal & Pediat Epidemiol Res Team EPOP, Paris, France; [Scherdel, Pauline] Paris South Univ, Paris, France; [Reynaud, Rachel] Aix Marseille Univ, CNRS, CRN2M, Soc Francaise Endocrinol & Diabetol Pediat,UMR 72, Marseille, France; [Pietrement, Christine] Univ Hosp Reims, Fac Med, Dept Pediat, Lab Biochem & Mol Biol,Nephrol Unit,Soc Nephrol P, Reims, France; [Salaun, Jean-Francois] Assoc Francaise Pediat Ambulatoire, Pediat Off, Commiss Rech, St Brieuc, France; [Bellaiche, Marc] Hop Robert Debre, AP HP, Grp Francophone Hepatogastroenterol & Nutr Pediat, Paris, France; [Bellaiche, Marc] Hop Robert Debre, AP HP, Dept Pediat Gastroenterol & Nutr, Paris, France; [Arnould, Michel] Univ Orleans, UMR CNRS 7311, Inst Chim Organ & Analyt, Soc Francaise Med Gen,Commiss Rech, Orleans, France; [Chevallier, Bertrand] Ambroise Pare Hosp, Dept Pediat & Pediat Emergency, Grp Pediat Gen, Soc Francaise Pediat, Boulogne, France; [Piloquet, Hugues] Hop Mere Enfants, Div Pediat Gastroenterol, Grp Francophone Hepatogastroenterol & Nutr Pediat, Nantes, France; [Jobez, Emmanuel] Soc Format Therapeut Gen, Commiss Rech, Paris, France; [Cheymol, Jacques] Soc Francaise Pediat, Commiss Sante Publ & Pediat Sociale, Clichy, France; [Bichara, Emmanuelle; Chalumeau, Martin] Paris Descartes Univ, Necker Childrens Hosp, AP HP, Dept Gen Pediat, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; CHU de Reims; Universite de Reims Champagne-Ardenne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Scherdel, P (corresponding author), INSERM, Paris Descartes Univ, Epidemiol & Biostat Sorbonne Paris Cite Ctr CRESS, Early Origins Childs Hlth & Dev Team ORCHaD,UMR11, Paris, France.; Scherdel, P (corresponding author), INSERM, Paris Descartes Univ, Epidemiol & Biostat Sorbonne Paris Cite Ctr CRESS, Obstet Perinatal & Pediat Epidemiol Res Team EPOP, Paris, France.; Scherdel, P (corresponding author), Paris South Univ, Paris, France.	pauline.scherdel@inserm.fr	Heude, Barbara/G-3095-2016; Heude, Barbara/GLU-9626-2022; reynaud, rachel/AAC-2167-2019	Heude, Barbara/0000-0002-1565-1629; Heude, Barbara/0000-0002-1565-1629; Scherdel, Pauline/0000-0003-4517-9430	Paris-South (Paris 11) University (Ecole Doctorale de Sante Publique) [570]; Laboratoires Guigoz - Societe Frangaise de Pediatrie - Groupe de Pediatrie Generale - Groupe de Recherches Epidemiologiques en Pediatrie; Association Frangaise de Pediatrie Ambulatoire Commission recherche clinique	Paris-South (Paris 11) University (Ecole Doctorale de Sante Publique); Laboratoires Guigoz - Societe Frangaise de Pediatrie - Groupe de Pediatrie Generale - Groupe de Recherches Epidemiologiques en Pediatrie; Association Frangaise de Pediatrie Ambulatoire Commission recherche clinique	PS was supported by unrestricted educational grants from Paris-South (Paris 11) University (Ecole Doctorale de Sante Publique no 570), Laboratoires Guigoz - Societe Frangaise de Pediatrie - Groupe de Pediatrie Generale - Groupe de Recherches Epidemiologiques en Pediatrie, and Association Frangaise de Pediatrie Ambulatoire Commission recherche clinique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank parent associations representatives (Catherine Chenu, L'Etoile de Martin; Catherine Vergely ISIS; Philippe Salva, Craniopharyngiome Solidarite) and experts (Veronique Abadie, MD, Pascale Arnould, MD, Remy Assathiany, MD, Antoine de Beco, MD, Benedicte Blanc, MD, Helene Bony, MD, Claire Bouvattier, MD, Jacques Cheymol, MD, Liliane Cret, MD, Dominique Debray, MD, Georges Deschenes, MD, Veronique Desvignes, MD, Beatrice Dubern, MD, Pierre Foucaud, MD, Catherine Gabard, MD, Remi Gatard, MD, Nathalie Gelbert, MD, Vincent Guigonis, MD, Cecile Guiheneuf, MD, Emmanuel Grimprel, MD, Isabelle Hau, MD, Sylvie Hubinois, MD, Gladys Ibanez, MD, Juliane Leger, MD, Agnes Linglart, MD, Michel Navel, MD, Irene Netchine, MD, Laura Petitcollot, MD, Olivier Puel, MD, Frank Ruemelle, MD, Gwenaelle Roussey, MD, Catherine Salinier, MD, Brigitte Samson, MD, Georges Thiebault, MD, Andreas Werner, MD, and Stephanie Willot, MD). We would like to thank Paris-South (Paris 11) University (Ecole Doctorale de Sante Publique no 570), Laboratoires Guigoz-Societe Francaise de Pediatrie-Groupe de Pediatrie Generale-Groupe de Recherches Epidemiologiques en Pediatrie, and Association Francaise de Pediatrie Ambulatoire-Commission recherche clinique for their financial support to PS.	Brasme JF, 2012, LANCET ONCOL, V13, pE445, DOI 10.1016/S1470-2045(12)70361-3; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; de Muinck Keizer-Schrama S M, 1998, Ned Tijdschr Geneeskd, V142, P2519; de Vries L, 2009, ARCH DIS CHILD, V94, P33, DOI 10.1136/adc.2007.134841; Fayter D, 2007, HEALTH TECHNOL ASSES, V11, P1; Fitch K., 2001, RAND UCLA APPROPRIAT; Garner P, 2000, ARCH DIS CHILD, V82, P197, DOI 10.1136/adc.82.3.197; Gascoin-Lachambre G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016367; Gohlke BC, 2002, EUR J PEDIATR, V161, P250, DOI 10.1007/s00431-002-0952-6; Hall DMB, 2000, ARCH DIS CHILD, V82, P10, DOI 10.1136/adc.82.1.10; Hjelm N, 2016, 6 ANN C EUR AC PAED; Kemper AR, 2011, PEDIATRICS, V128, pE1259, DOI 10.1542/peds.2011-1317; Khoshnood B, 2012, HEART, V98, P1667, DOI 10.1136/heartjnl-2012-302543; Koletzko S, 2012, J PEDIATR GASTR NUTR, V55, P221, DOI 10.1097/MPG.0b013e31825c9482; LEGER J, 1990, EUR J PEDIATR, V149, P605, DOI 10.1007/BF02034742; LINDSAY R, 1994, J PEDIATR-US, V125, P29, DOI 10.1016/S0022-3476(94)70117-2; Louvel M, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-29; Munck A, 2008, J PEDIATR-US, V153, P228, DOI 10.1016/j.jpeds.2008.02.028; ORTH DN, 1995, NEW ENGL J MED, V332, P791, DOI 10.1056/NEJM199503233321207; ROSENDAHL H, 1990, EUR J OBSTET GYN R B, V36, P27, DOI 10.1016/0028-2243(90)90046-4; Saari A, 2015, JAMA PEDIATR, V169, DOI 10.1001/jamapediatrics.2015.25; Sankilampi U, 2013, JAMA-J AM MED ASSOC, V310, P1071, DOI 10.1001/jama.2013.218793; Scherdel P, 2014, ARCH PEDIATR, V21, pH53; Scherdel P, 2015, HORM RES PAEDIAT, V84, P490; Scherdel P, 2016, LANCET DIABETES ENDO, V4, P447, DOI 10.1016/S2213-8587(15)00392-7; Scherdel P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070871; Taylor M, 2012, J PEDIATR-US, V161, P855, DOI 10.1016/j.jpeds.2012.05.014; Timmer A, 2011, J PEDIATR-US, V158, P467, DOI 10.1016/j.jpeds.2010.09.014; Wilson JMG, 1968, J R COLL GEN PRACT; Wit JM, 2007, HORM RES, V68, pVII; World Health Organization, 1999, MAN SEV MALN MAN PHY	31	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176464	10.1371/journal.pone.0176464	http://dx.doi.org/10.1371/journal.pone.0176464			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448550	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383600084
J	You, M; Yamane, T; Tomita, H; Sugano, E; Akashi, T				You, Mengbo; Yamane, Toshiyuki; Tomita, Hiroshi; Sugano, Eriko; Akashi, Takuya			A novel rat head gaze determination system based on optomotor responses	PLOS ONE			English	Article							VISION; ROD	The optomotor response of animals is commonly used to measure their visual performance, e.g., rats of different genetically altered strains or various drug tests. With the presentation of stimuli using computer screens or projectors, the common idea focuses on measuring the eye movement or head and/or body movement to characterize changes of the head gaze. However, traditional methods rely on either the invasive fixation of animals, or the judgment of a human observer who reports the stimulus-tracking movements. In this paper, we propose a novel head gaze determination system to automatically track the head movement of rats without artificial markers. The experiments were done to demonstrate the process of optimizing parameters in image processing. As a result, the head angle curve of the proposed method is consistent with that of ground-truth data annotated manually according to predefined rules. Hence, the proposed method provides a simple, convenient, and objective solution to automatically generate the head gaze orientations from massive amounts of recorded data for further visual performance analysis.	[You, Mengbo; Akashi, Takuya] Iwate Univ, Grad Sch Engn, Dept Design & Media Technol, Morioka, Iwate, Japan; [Yamane, Toshiyuki; Tomita, Hiroshi; Sugano, Eriko] Iwate Univ, Dept Chem & Biol Sci, Fac Sci & Engn, Morioka, Iwate, Japan	Iwate University; Iwate University	Akashi, T (corresponding author), Iwate Univ, Grad Sch Engn, Dept Design & Media Technol, Morioka, Iwate, Japan.	akashi@iwate-u.ac.jp	Tomita, Hiroshi/O-2135-2018	Tomita, Hiroshi/0000-0003-1051-2301; Akashi, Takuya/0000-0001-9177-7306	Practical Research for Innovative Cancer Control project from the Japan Agency for Medical Research and Development, AMED [15lm0103007j0004]; JSPS KAKENHI [JP16H05485, JP16K15729, JP16K11314, JP16K01647]	Practical Research for Innovative Cancer Control project from the Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Practical Research for Innovative Cancer Control project from the Japan Agency for Medical Research and Development, AMED (no.15lm0103007j0004) and by JSPS KAKENHI Grant Numbers JP16H05485, JP16K15729, JP16K11314, and JP16K01647. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by the Practical Research for Innovative Cancer Control project from the Japan Agency for Medical Research and Development, AMED (no.15lm0103007j0004) and by JSPS KAKENHI Grant Numbers JP16H05485, JP16K15729, JP16K11314, and JP16K01647.	Abdejalil J, 2005, VISION RES, V45, P1439, DOI 10.1016/j.visres.2004.12.015; Altimus CM, 2010, NAT NEUROSCI, V13, P1107, DOI 10.1038/nn.2617; Baker M, 2013, NATURE, V502, P156, DOI 10.1038/502156a; Brecht M, 1997, BEHAV BRAIN RES, V84, P81, DOI 10.1016/S0166-4328(97)83328-1; Cahill H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002055; Dedek K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001714; GOLDOWITZ D, 1992, TECHNIQUES GENETIC A; Kretschmer F, 2015, J NEUROSCI METH, V256, P91, DOI 10.1016/j.jneumeth.2015.08.007; Kretschmer F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078058; Kretschmer F, 2012, 2012 5TH INTERNATIONAL CONGRESS ON IMAGE AND SIGNAL PROCESSING (CISP), P1209, DOI 10.1109/CISP.2012.6470026; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pinto LH, 2000, MAMM GENOME, V11, P531, DOI 10.1007/s003350010102; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Puk O, 2008, FRONT BIOSCI-LANDMRK, V13, P6269, DOI 10.2741/3153; Sezgin M, 2004, J ELECTRON IMAGING, V13, P146, DOI 10.1117/1.1631315; Tabata H, 2010, J VISION, V10, DOI 10.1167/10.1.13; TAKAHASHI JS, 1994, SCIENCE, V264, P1724, DOI 10.1126/science.8209253; Tomita H, 2014, MOL THER, V22, P1434, DOI 10.1038/mt.2014.81; Tomita H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007679; Umino Y, 2008, J NEUROSCI, V28, P189, DOI 10.1523/JNEUROSCI.3551-07.2008; Umino Y, 2012, J NEUROSCI, V32, P14364, DOI 10.1523/JNEUROSCI.1296-12.2012	21	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176633	10.1371/journal.pone.0176633	http://dx.doi.org/10.1371/journal.pone.0176633			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445553	gold, Green Published, Green Submitted			2022-12-26	WOS:000400309200076
J	Adejumo, AC; Alliu, S; Ajayi, TO; Adejumo, KL; Adegbale, OM; Onyeakusi, NE; Akinjero, AM; Durojaiye, M; Bukong, TN				Adejumo, Adeyinka Charles; Alliu, Samson; Ajayi, Tokunbo Opeyemi; Adejumo, Kelechi Lauretta; Adegbale, Oluwole Muyiwa; Onyeakusi, Nnaemeka Egbuna; Akinjero, Akintunde Micheal; Durojaiye, Modupeoluwa; Bukong, Terence Ndonyi			Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study	PLOS ONE			English	Article							BODY-MASS INDEX; INSULIN-RESISTANCE; MARIJUANA USE; EPIDEMIOLOGY; RISK; EXERCISE; OBESITY; NAFLD; ATHEROSCLEROSIS; STEATOHEPATITIS	Cannabis use is associated with reduced prevalence of obesity and diabetes mellitus (DM) in humans and mouse disease models. Obesity and DM are a well-established independent risk factor for non-alcoholic fatty liver disease (NAFLD), the most prevalent liver disease globally. The effects of cannabis use on NAFLD prevalence in humans remains ill-defined. Our objective is to determine the relationship between cannabis use and the prevalence of NAFLD in humans. We conducted a population-based case-control study of 5,950,391 patients using the 2014 Healthcare Cost and Utilization Project (HCUP), Nationwide Inpatient Survey (NIS) discharge records of patients 18 years and older. After identifying patients with NAFLD (1% of all patients), we next identified three exposure groups: non-cannabis users (98.04%), non-dependent cannabis users (1.74%), and dependent cannabis users (0.22%). We adjusted for potential demographics and patient related confounders and used multivariate logistic regression (SAS 9.4) to determine the odds of developing NAFLD with respects to cannabis use. Our findings revealed that cannabis users (dependent and non-dependent) showed significantly lower NAFLD prevalence compared to non-users (AOR: 0.82[0.76-0.88]; p<0.0001). The prevalence of NAFLD was 15% lower in non-dependent users (AOR: 0.85[0.79-0.92]; p<0.0001) and 52% lower in dependent users (AOR: 0.49 [0.36-0.65]; p<0.0001). Among cannabis users, dependent patients had 43% significantly lower prevalence of NAFLD compared to non-dependent patients (AOR: 0.57[0.42-0.77]; p<0.0001). Our observations suggest that cannabis use is associated with lower prevalence of NAFLD in patients. These novel findings suggest additional molecular mechanistic studies to explore the potential role of cannabis use in NAFLD development.	[Adejumo, Adeyinka Charles; Bukong, Terence Ndonyi] Univ Massachusetts, Med Sch, Dept Med, Worcester, MA 01655 USA; [Adejumo, Adeyinka Charles] Univ Massachusetts Lowell, Biomed Engn & Biotechnol Program, Lowell, MA USA; [Alliu, Samson] Maimonides Hosp, Dept Med, Brooklyn, NY 11219 USA; [Ajayi, Tokunbo Opeyemi] Howard Cty Gen Hosp, Johns Hopkins Med, Columbia, MD USA; [Adejumo, Kelechi Lauretta] Univ Massachusetts Lowell, Publ Hlth Program, Lowell, MA USA; [Adegbale, Oluwole Muyiwa; Akinjero, Akintunde Micheal] Englewood Hosp & Med Ctr, Dept Med, Englewood, NJ USA; [Onyeakusi, Nnaemeka Egbuna] Bronx Lebanon Hosp Ctr, Dept Pediat, Bronx, NY 10456 USA; [Durojaiye, Modupeoluwa] Univ Alabama Birmingham, Dept Maternal & Child Hlth, Birmingham, AL USA; [Bukong, Terence Ndonyi] Inst Natl Res Sci, INRS Inst Armand Frappier, Laval, PQ, Canada	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Lowell; Maimonides Medical Center; Johns Hopkins University; Johns Hopkins Medicine; University of Massachusetts System; University of Massachusetts Lowell; Englewood Hospital & Medical Center; BronxCare Health System; University of Alabama System; University of Alabama Birmingham; University of Quebec; Institut national de la recherche scientifique (INRS)	Bukong, TN (corresponding author), Univ Massachusetts, Med Sch, Dept Med, Worcester, MA 01655 USA.; Bukong, TN (corresponding author), Inst Natl Res Sci, INRS Inst Armand Frappier, Laval, PQ, Canada.	terencendonyi.bukong@iaf.inrs.ca	Adejumo, Adeyinka/AAQ-1547-2020; Alliu, Samson/AAA-3051-2020	Onyeakusi, Nnaemeka/0000-0003-1660-5621	INRS-Institut Armand-Frappier, Institut National de la Reserche Scientifique, Boulevard des Prairies, Laval (Quebec) H7V 1B7 Canada	INRS-Institut Armand-Frappier, Institut National de la Reserche Scientifique, Boulevard des Prairies, Laval (Quebec) H7V 1B7 Canada	This work was funded by a start-up grant to BTN by INRS-Institut Armand-Frappier, Institut National de la Reserche Scientifique, 531 Boulevard des Prairies, Laval (Quebec) H7V 1B7 Canada. The funder had no role in the project design, execution, data interpretation or decision to publish.	Allen JH, 2004, GUT, V53, P1566, DOI 10.1136/gut.2003.036350; [Anonymous], 2012, J GASTROEN HEPATOL, V1, P315; Azzam H, 2015, WORLD J HEPATOL, V7, P1369, DOI 10.4254/wjh.v7.i10.1369; Batetta B, 2009, J NUTR, V139, P1495, DOI 10.3945/jn.109.104844; Batkai S, 2007, FASEB J, V21, P1788, DOI 10.1096/fj.06-7451com; Bellentani S, 2017, LIVER INT, V37, P81, DOI 10.1111/liv.13299; Bellentani S, 2010, DIGEST DIS, V28, P155, DOI 10.1159/000282080; Bertolotti M, 2014, WORLD J GASTROENTERO, V20, P14185, DOI 10.3748/wjg.v20.i39.14185; Bird Y, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0237-0; Burstein S, 2015, BIOORGAN MED CHEM, V23, P1377, DOI 10.1016/j.bmc.2015.01.059; Charlton M, 2008, HEPATOLOGY, V47, P1431, DOI 10.1002/hep.22246; Chen CH, 2006, J CLIN GASTROENTEROL, V40, P745, DOI 10.1097/00004836-200609000-00016; Chen K, 1997, DRUG ALCOHOL DEPEN, V46, P53, DOI 10.1016/S0376-8716(97)00047-1; Cohen D, 2016, J PEDIATR NURS, V31, P152, DOI 10.1016/j.pedn.2015.10.009; Dagogo-Jack S., 2016, DIABETES RISKS PRESC; Eguchi Y, 2006, J GASTROENTEROL, V41, P462, DOI 10.1007/s00535-006-1790-5; Eguchi Y, 2012, J GASTROENTEROL, V47, P586, DOI 10.1007/s00535-012-0533-z; Foster T, 2013, DIGEST DIS SCI, V58, P2392, DOI 10.1007/s10620-013-2652-7; Ganz M, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0552-7; Giroud C, 2002, CHIMIA, V56, P80, DOI 10.2533/000942902777680702; Guerriero G, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2016.00019, 10.3389/fpls.2016.00463]; Hallsworth K, 2011, GUT, V60, P1278, DOI 10.1136/gut.2011.242073; Houchen R, 2014, HCUP METHODS SERIES; Hruby A, 2015, PHARMACOECONOMICS, V33, P673, DOI 10.1007/s40273-014-0243-x; Hunter Gary R, 2010, Int J Body Compos Res, V8, P103; Julien B, 2005, GASTROENTEROLOGY, V128, P742, DOI 10.1053/j.gastro.2004.12.050; Katz K, 2010, J OBES, V2010, DOI 10.1155/2010/496829; Kawaguchi T, 2011, J GASTROENTEROL, V46, P746, DOI 10.1007/s00535-011-0378-x; Keating SE, 2015, J HEPATOL, V63, P174, DOI 10.1016/j.jhep.2015.02.022; Kojima S, 2003, J GASTROENTEROL, V38, P954, DOI 10.1007/s00535-003-1178-8; Le Strat Y, 2011, AM J EPIDEMIOL, V174, P929, DOI 10.1093/aje/kwr200; Levin Kate Ann, 2006, Evid Based Dent, V7, P24, DOI 10.1038/sj.ebd.6400375; Levine JA, 2011, DIABETES, V60, P2667, DOI 10.2337/db11-1118; Lonardo A, 2006, WORLD J GASTROENTERO, V12, P5826, DOI 10.3748/wjg.v12.i36.5826; Lonardo A, 2013, CURR PHARM DESIGN, V19, P5177, DOI 10.2174/1381612811319290003; Loomba R, 2015, J HEPATOL, V63, P10, DOI 10.1016/j.jhep.2015.03.009; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Loomis AK, 2016, J CLIN ENDOCR METAB, V101, P945, DOI 10.1210/jc.2015-3444; Martinasek MP, 2016, RESP CARE, V61, P1543, DOI 10.4187/respcare.04846; McPartland J. M., 2001, Journal of Cannabis Therapeutics, V1, P103, DOI 10.1300/J175v01n03_08; Muller-Vahl Kirsten R, 2008, Expert Rev Neurother, V8, P1037, DOI 10.1586/14737175.8.7.1037; NOMURA H, 1988, JPN J MED, V27, P142, DOI 10.2169/internalmedicine1962.27.142; Oh S, 2014, THER CLIN RISK MANAG, V10, P925, DOI 10.2147/TCRM.S68322; Okafor PN, 2016, J HEPATOL, V64, P946, DOI 10.1016/j.jhep.2015.12.019; Olsen MA, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1501-7; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Parker HM, 2012, J HEPATOL, V56, P944, DOI 10.1016/j.jhep.2011.08.018; Patsenker Eleonora, 2016, Clin Liver Dis (Hoboken), V7, P21, DOI 10.1002/cld.527; Penner EA, 2013, AM J MED, V126, P583, DOI 10.1016/j.amjmed.2013.03.002; Pertwee R.G., 1998, ADV CANNABINOID RECE, P148; Piomelli D, 2016, CANNABIS CANNABINOID, V1, P1, DOI [10.1089/can.2015.29003.ebr, 10.1089/can.2015.29002.edi]; Rajavashisth TB, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000494; Rossi F, 2016, J CLIN ENDOCR METAB, V101, P3469, DOI 10.1210/jc.2015-4381; Schoenman JA, 2007, MED CARE RES REV, V64, P449, DOI 10.1177/1077558707301963; Shaw FE, 2014, LANCET, V384, P75, DOI 10.1016/S0140-6736(14)60259-2; Shen L, 2003, WORLD J GASTROENTERO, V9, P1106; Sidney S, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0795-6; Substance Abuse and Mental Health Services Administration, HHS PUBL; Swift W, 2009, ADDICTION, V104, P806, DOI 10.1111/j.1360-0443.2009.02534.x; Teixeira-Clerc F, 2006, NAT MED, V12, P671, DOI 10.1038/nm1421; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; Trebicka J, 2011, LIVER INT, V31, P862, DOI 10.1111/j.1478-3231.2011.02496.x; United Nations Office on Drugs and Crime, 2012, WORLD DRUG REP 2012; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Whitsett M, 2015, WORLD J HEPATOL, V7, P2041, DOI 10.4254/wjh.v7.i16.2041; Younossi ZM, 2012, MEDICINE, V91, P319, DOI 10.1097/MD.0b013e3182779d49	66	48	48	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176416	10.1371/journal.pone.0176416	http://dx.doi.org/10.1371/journal.pone.0176416			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441459	gold, Green Published, Green Accepted			2022-12-26	WOS:000400308800053
J	Bailey, G; Healy, A; Young, BD; Sharma, E; Meadows, J; Chung, HJ; Wu, WC; Choudhary, G; Morrison, AR				Bailey, Grant; Healy, Abigail; Young, Bryan D.; Sharma, Esseim; Meadows, Judith; Chung, Hyung J.; Wu, Wen-Chih; Choudhary, Gaurav; Morrison, Alan R.			Relative predictive value of lung cancer screening CT versus myocardial perfusion attenuation correction CT in the evaluation of coronary calcium	PLOS ONE			English	Article							ARTERY CALCIUM; IONIZING-RADIATION; HEART-DISEASE; CALCIFICATION; RISK; TOMOGRAPHY; MORTALITY; PLAQUE; QUANTIFICATION; SPECT/CT	Coronary artery calcium scores (CACS) from lung cancer screening computed tomography (LCSCT) or myocardial perfusion attenuation correction computed tomography (ACCT) are not routinely performed or reported. CACS from LCSCT and ACCT have not been directly compared in the same patient population. We identified 66 patients who underwent both LCSCT (non-gated) and ECG-gated cardiac CT (CCT) within a 2-year span. Of this population, 40 subjects had also undergone ACCT. Using the Agatston method, CACS for 264 individual vessels from the LCSCT population and for 160 vessels from ACCT population were calculated and evaluated for agreement with ECG-gated CCT as the gold standard. Secondary analysis included a comparison of individual vessel contribution to variations in agreement and a comparison of total CACS from CCT, LCSCT, and ACCT for respective MACE prediction. CACS from LCSCT demonstrated a strong Pearson correlation, r = 0.9017 (0.876-0.9223), with good agreement when compared to CACS from CCT. CACS from ACCT demonstrated a significantly (P < 0.00001) weaker correlation, r = 0.5593 (0.4401-0.6592). On an individual vessel basis, CACS from all major vessels (LM, LAD, LCX, and RCA) contributed to the weaker correlation. For total vessel CACS, LCSCT demonstrated comparable area under the curve (AUC) for the receiver operating characteristic (ROC) curve (LCSCT AUC = 0.8133 and CCT AUC = 0.8302, P = 0.691) for prediction of MACE. Although ACCT demonstrated a similar AUC (ACCT AUC = 0.7969, P = 0.662) for MACE prediction the cutoff value for elevated risk was extremely low. In conclusion, LCSCT outperformed ACCT at calcium scoring by providing better agreement and comparable risk assessment to CCT despite the absence of ECG-gating. It is therefore reasonable to use LCSCT images to derive and report Agatston-based CACS for cardiovascular risk assessment, whereas the use of ACCT images to report Agatston-based CACS is not currently practical.	[Bailey, Grant; Healy, Abigail; Young, Bryan D.; Meadows, Judith; Morrison, Alan R.] VA Connecticut Healthcare Syst, Dept Internal Med, Sect Cardiovasc Med, West Haven, CT 06111 USA; [Bailey, Grant; Young, Bryan D.; Meadows, Judith; Chung, Hyung J.; Morrison, Alan R.] Yale Univ, Yale Cardiovasc Res Ctr, Sch Med, Dept Internal Med,Sect Cardiovasc Med, New Haven, CT 06520 USA; [Healy, Abigail; Sharma, Esseim; Wu, Wen-Chih; Choudhary, Gaurav; Morrison, Alan R.] Providence VA Med Ctr, Dept Internal Med, Sect Cardiovasc Med, Providence, RI 02908 USA; [Healy, Abigail; Sharma, Esseim; Wu, Wen-Chih; Choudhary, Gaurav; Morrison, Alan R.] Brown Univ, Alpert Med Sch, Dept Internal Med, Sect Cardiovasc Med, Providence, RI 02912 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Brown University	Morrison, AR (corresponding author), VA Connecticut Healthcare Syst, Dept Internal Med, Sect Cardiovasc Med, West Haven, CT 06111 USA.; Morrison, AR (corresponding author), Yale Univ, Yale Cardiovasc Res Ctr, Sch Med, Dept Internal Med,Sect Cardiovasc Med, New Haven, CT 06520 USA.; Morrison, AR (corresponding author), Providence VA Med Ctr, Dept Internal Med, Sect Cardiovasc Med, Providence, RI 02908 USA.; Morrison, AR (corresponding author), Brown Univ, Alpert Med Sch, Dept Internal Med, Sect Cardiovasc Med, Providence, RI 02912 USA.	judith.meadows@yale.edu; alan_morrison@.brown.edu	Morrison, Alan R./ABH-3831-2020; Choudhary, Gaurav/M-1643-2019	Morrison, Alan R./0000-0002-2412-7669; Choudhary, Gaurav/0000-0001-9343-5481; Chun, Hyung/0000-0003-3508-2678; Sharma, Esseim/0000-0003-4091-5208	United States Department of Veterans Affairs Biomedical Laboratory Research and Development Program [71K2BX002527]; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [P20GM103652]; Actelion ENTELLIGENCE Young Investigator Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103652] Funding Source: NIH RePORTER	United States Department of Veterans Affairs Biomedical Laboratory Research and Development Program; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health; Actelion ENTELLIGENCE Young Investigator Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Career Development Award Number 71K2BX002527 from the United States Department of Veterans Affairs Biomedical Laboratory Research and Development Program (A.R.M.). The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government. Research reported in this publication was supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM103652. This work was also supported in part by the Actelion ENTELLIGENCE Young Investigator Award (A.R. M.).	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Aberle DR, 2010, JNCI-J NATL CANCER I, V102, P1771, DOI 10.1093/jnci/djq434; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Bateman TM, 2006, J NUCL CARDIOL, V13, P24, DOI 10.1016/j.nuclcard.2005.12.004; Bengel FM, 2009, J AM COLL CARDIOL, V54, P1, DOI 10.1016/j.jacc.2009.02.065; Buck AK, 2008, J NUCL MED, V49, P1305, DOI 10.2967/jnumed.107.050195; Budoff MJ, 2011, J CARDIOVASC COMPUT, V5, P113, DOI 10.1016/j.jcct.2010.11.002; Budoff MJ, 2001, INT J CARDIOL, V77, P181, DOI 10.1016/S0167-5273(00)00449-6; Cancer Facts & Figures 2015, 2015, 09202015 AM CANC SOC; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Chen J, 2010, J AM COLL CARDIOL, V56, P702, DOI 10.1016/j.jacc.2010.05.014; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Critchley JA, 2003, JAMA-J AM MED ASSOC, V290, P86, DOI 10.1001/jama.290.1.86; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; Di Carli MF, 2009, CARDIOL CLIN, V27, P257, DOI 10.1016/j.ccl.2008.12.001; Dorbala S, 2013, J NUCL MED, V54, P1485, DOI 10.2967/jnumed.112.105155; Ehara S, 2004, CIRCULATION, V110, P3424, DOI 10.1161/01.CIR.0000148131.41425.E9; Einstein AJ, 2010, J AM COLL CARDIOL, V56, P1914, DOI 10.1016/j.jacc.2010.05.057; Gerber TC, 2009, CIRCULATION, V119, P1056, DOI 10.1161/CIRCULATIONAHA.108.191650; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Hecht HS, 2015, JACC-CARDIOVASC IMAG, V8, P580, DOI 10.1016/j.jcmg.2015.02.006; Hughes-Austin JM, 2016, JACC-CARDIOVASC IMAG, V9, P152, DOI 10.1016/j.jcmg.2015.06.030; Humphrey LL, 2013, ANN INTERN MED, V159, P411, DOI 10.7326/0003-4819-159-6-201309170-00690; Husmann L, 2007, RADIOLOGY, V245, P567, DOI 10.1148/radiol.2451061791; Jacobs PC, 2012, AM J ROENTGENOL, V198, P505, DOI 10.2214/AJR.10.5577; Kaster TS, 2015, J NUCL CARDIOL, V22, P419, DOI 10.1007/s12350-014-0026-y; Kim SM, 2008, AM J ROENTGENOL, V190, P917, DOI 10.2214/AJR.07.2979; Mets OM, 2013, JACC-CARDIOVASC IMAG, V6, P899, DOI 10.1016/j.jcmg.2013.02.008; Motoyama S, 2009, J AM COLL CARDIOL, V54, P49, DOI 10.1016/j.jacc.2009.02.068; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771; Mylonas I, 2012, EUR HEART J-CARD IMG, V13, P786, DOI 10.1093/ehjci/jes079; Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461; Puchner SB, 2014, J AM COLL CARDIOL, V64, P684, DOI 10.1016/j.jacc.2014.05.039; Rennenberg RJMW, 2009, VASC HEALTH RISK MAN, V5, P185; Sharma D, 2015, ARCH MED SCI, V11, P1033, DOI 10.5114/aoms.2015.54859; Sung JH, 2016, BR J MED MED RES, V11; Takx RAP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091239; van den Bergh KAM, 2010, BRIT J CANCER, V102, P27, DOI 10.1038/sj.bjc.6605459; Villines TC, 2011, J AM COLL CARDIOL, V58, P2533, DOI 10.1016/j.jacc.2011.10.851; WHO, 2012, 10 LEAD CAUS DEATH W; Wu MT, 2008, AM J ROENTGENOL, V190, P923, DOI 10.2214/AJR.07.2974; Xie XQ, 2013, CIRC-CARDIOVASC IMAG, V6, P514, DOI 10.1161/CIRCIMAGING.113.000092	42	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0175678	10.1371/journal.pone.0175678	http://dx.doi.org/10.1371/journal.pone.0175678			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437443	Green Published, Green Submitted, gold			2022-12-26	WOS:000400287600009
J	Holloway, DM; Spirov, AV				Holloway, David M.; Spirov, Alexander V.			Transcriptional bursting in Drosophila development: Stochastic dynamics of eve stripe 2 expression	PLOS ONE			English	Article							GENE-EXPRESSION; REACTION-DIFFUSION; EMBRYO; KINETICS; ELEMENTS; NOISE	Anterior-posterior (AP) body segmentation of the fruit fly (Drosophila) is first seen in the 7stripe spatial expression patterns of the pair-rule genes, which regulate downstream genes determining specific segment identities. Regulation of pair-rule expression has been extensively studied for the even-skipped (eve) gene. Recent live imaging, of a reporter for the 2nd eve stripe, has demonstrated the stochastic nature of this process, with `bursts' in the number of RNA transcripts being made over time. We developed a stochastic model of the spatial and temporal expression of eve stripe 2 (binding by transcriptional activators (Bicoid and Hunchback proteins) and repressors (Giant and Kruppel proteins), transcriptional initiation and termination; with all rate parameters constrained by features of the experimental data) in order to analyze the noisy experimental time series and test hypotheses for how eve transcription is regulated. These include whether eve transcription is simply OFF or ON, with a single ON rate, or whether it proceeds by a more complex mechanism, with multiple ON rates. We find that both mechanisms can produce long (multi-minute) RNA bursts, but that the short-time (minute-to-minute) statistics of the data is indicative of eve being transcribed with at least two distinct ON rates, consistent with data on the joint activation of eve by Bicoid and Hunchback. We also predict distinct statistical signatures for cases in which eve is repressed (e.g. along the edges of the stripe) vs. cases in which activation is reduced (e.g. by mutagenesis of transcription factor binding sites). Fundamental developmental processes such as gene transcription are intrinsically noisy; our approach presents a new way to quantify and analyze time series data during developmental patterning in order to understand regulatory mechanisms and how they propagate noise and impact embryonic robustness.	[Holloway, David M.] British Columbia Inst Technol, Math Dept, Burnaby, BC, Canada; [Holloway, David M.] Univ Victoria, Biol Dept, Victoria, BC, Canada; [Spirov, Alexander V.] SUNY Stony Brook, Comp Sci, Stony Brook, NY 11794 USA; [Spirov, Alexander V.] SUNY Stony Brook, Ctr Excellence Wireless & Informat Technol, Stony Brook, NY 11794 USA; [Spirov, Alexander V.] Sechenov Inst Evolutionary Physiol & Biochem, St Petersburg, Russia	British Columbia Institute of Technology; University of Victoria; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry	Holloway, DM (corresponding author), British Columbia Inst Technol, Math Dept, Burnaby, BC, Canada.; Holloway, DM (corresponding author), Univ Victoria, Biol Dept, Victoria, BC, Canada.	David_Holloway@bcit.ca	Spirov, Alexander V/G-4806-2010; Holloway, David/B-1075-2015	Spirov, Alexander V/0000-0002-0509-6203; Holloway, Courtney Jean/0000-0003-3661-1957; Holloway, David/0000-0002-3865-0725	U.S. National Institutes of Health [GM072022]	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This worked was supported by the U.S. National Institutes of Health, GM072022, www.nih.gov.	Arnosti DN, 1996, DEVELOPMENT, V122, P205; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Bothma JP, 2014, P NATL ACAD SCI USA, V111, P10598, DOI 10.1073/pnas.1410022111; Choubey S, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004345; Corrigan AM, 2016, ELIFE, V5, DOI 10.7554/eLife.13051; Elf J, 2003, P SOC PHOTO-OPT INS, V5110, P114, DOI 10.1117/12.497009; ELF J, 2004, SYST BIOL, V2, P230, DOI DOI 10.1049/SB:20045021; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Garcia HG, 2013, CURR BIOL, V23, P2140, DOI 10.1016/j.cub.2013.08.054; Gilbert S.F., 2016, DEV BIOL, V11th ed.; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; GOTO T, 1989, CELL, V57, P413, DOI 10.1016/0092-8674(89)90916-1; HARDING K, 1989, EMBO J, V8, P1205, DOI 10.1002/j.1460-2075.1989.tb03493.x; Hattne J, 2005, BIOINFORMATICS, V21, P2923, DOI 10.1093/bioinformatics/bti431; Holloway DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118450; Holloway DM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001069; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Janssens H, 2006, NAT GENET, V38, P1159, DOI 10.1038/ng1886; Larson DR, 2011, SCIENCE, V332, P475, DOI 10.1126/science.1202142; Lawrence Peter A, 1993, MAKING FLY GENETICS, V6; Levine M, 2010, CURR BIOL, V20, pR754, DOI 10.1016/j.cub.2010.06.070; Lucas T, 2013, CURR BIOL, V23, P2135, DOI 10.1016/j.cub.2013.08.053; Munsky B, 2015, METHODS, V85, P12, DOI 10.1016/j.ymeth.2015.06.009; Munsky B, 2012, SCIENCE, V336, P183, DOI 10.1126/science.1216379; NUSSLEINVOLHARD C, 1985, COLD SPRING HARB SYM, V50, P145, DOI 10.1101/SQB.1985.050.01.020; Pisarev A, 2009, NUCLEIC ACIDS RES, V37, pD560, DOI 10.1093/nar/gkn717; Prata GN, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.022403; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; SMALL S, 1991, GENE DEV, V5, P827, DOI 10.1101/gad.5.5.827; SMALL S, 1992, EMBO J, V11, P4047, DOI 10.1002/j.1460-2075.1992.tb05498.x; STANOJEVIC D, 1991, SCIENCE, V254, P1385, DOI 10.1126/science.1683715; Surkova S, 2008, DEV BIOL, V313, P844, DOI 10.1016/j.ydbio.2007.10.037; Xu H, 2015, NAT METHODS, V12, P739, DOI [10.1038/NMETH.3446, 10.1038/nmeth.3446]; Yunger S, 2010, NAT METHODS, V7, P631, DOI [10.1038/nmeth.1482, 10.1038/NMETH.1482]	34	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176228	10.1371/journal.pone.0176228	http://dx.doi.org/10.1371/journal.pone.0176228			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437444	Green Published, gold, Green Submitted			2022-12-26	WOS:000400287600036
J	Miyata, H; Koseki, H; Takizawa, K; Kasuya, H; Nozaki, K; Narumiya, S; Aoki, T				Miyata, Haruka; Koseki, Hirokazu; Takizawa, Katsumi; Kasuya, Hidetoshi; Nozaki, Kazuhiko; Narumiya, Shuh; Aoki, Tomohiro			T cell function is dispensable for intracranial aneurysm formation and progression	PLOS ONE			English	Article							INDUCED CEREBRAL ANEURYSMS; SUBARACHNOID HEMORRHAGE; RUPTURE; ATHEROSCLEROSIS; RATS; INFLAMMATION; PREVALENCE; MECHANISMS; ALPHA; JAPAN	Given the social importance of intracranial aneurysm as a major cause of a lethal subarachnoid hemorrhage, clarification of mechanisms underlying the pathogenesis of this disease is essential for improving poor prognosis once after rupture. Previous histopathological analyses of human aneurysm walls have revealed the presence of T cells in lesions suggesting involvement of this type of cell in the pathogenesis. However, it remains unclear whether T cell actively participates in intracranial aneurysm progression. To examine whether T cell is involved in aneurysm progression, intracranial aneurysm model of rat was used. In this model, aneurysm is induced by increase in hemodynamic force loaded on bifurcation site of intracranial arteries where aneurysms are developed. Deficiency in T cells and pharmacological inhibition of T cell function were applied to this model. CD3-positive T cells were present in human aneurysm walls, whose number was significantly larger compared with that in control arterial walls. Deficiency in T cells in rats and pharmacological inhibition of T cell function by oral administration of Cyclosporine A both failed to affect intracranial aneurysm progression, degenerative changes of arterial walls and macrophage infiltration in lesions. Although T cells are detectable in intracranial aneurysm walls, their function is dispensable for macrophage-mediated inflammation and degenerative changes in arterial walls, which presumably leads to intracranial aneurysm progression.	[Miyata, Haruka; Koseki, Hirokazu; Narumiya, Shuh; Aoki, Tomohiro] Kyoto Univ, Grad Sch Med, Innovat Ctr Immunoregulat Technol & Therapeut AK, Kyoto, Japan; [Miyata, Haruka; Nozaki, Kazuhiko] Shiga Univ Med Sci, Dept Neurosurg, Shiga, Japan; [Miyata, Haruka; Koseki, Hirokazu; Aoki, Tomohiro] Kyoto Univ, Grad Sch Med, Japan Agcy Med Res & Dev AMED, Core Res Evolut Sci & Technol, Kyoto, Japan; [Koseki, Hirokazu; Kasuya, Hidetoshi] Tokyo Womens Med Univ, Med Ctr East, Dept Neurosurg, Tokyo, Japan; [Takizawa, Katsumi] Japan Red Cross Asahikawa Hosp, Dept Neurosurg, Asahikawa, Hokkaido, Japan	Kyoto University; Shiga University of Medical Science; Japan Science & Technology Agency (JST); Kyoto University; Tokyo Women's Medical University	Aoki, T (corresponding author), Kyoto Univ, Grad Sch Med, Innovat Ctr Immunoregulat Technol & Therapeut AK, Kyoto, Japan.; Aoki, T (corresponding author), Kyoto Univ, Grad Sch Med, Japan Agcy Med Res & Dev AMED, Core Res Evolut Sci & Technol, Kyoto, Japan.	tomoaoki@kuhp.kyoto-u.ac.jp		Aoki, Tomohiro/0000-0002-1578-1394	Ministry of Education, Culture, Sports, Science and Technology of Japan [16K10719]; Grants-in-Aid for Scientific Research [17H01531] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (#16K10719, T.A.).; This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (#16K10719, T.A.). We thank T. Kurita and Y. Imai for their technical and K. Shiota, H. Kaimori, A. Washimi and T.Arai for their secretarial assistance. We also thank the invaluable help from the Center for Anatomical, Pathological and Forensic Medical Research at Kyoto University Graduate School of Medicine for immunostaining of human samples and from Japan Red Cross Asahikawa Hospital for preparing human specimen.	Aoki T, 2011, BRIT J PHARMACOL, V163, P1237, DOI 10.1111/j.1476-5381.2011.01358.x; Aoki T, 2007, STROKE, V38, P162, DOI 10.1161/01.STR.0000252129.18605.c8; Aoki T, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-34; Aoki T, 2012, TRENDS PHARMACOL SCI, V33, P304, DOI 10.1016/j.tips.2012.02.004; Aoki T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/535921; Aoki T, 2009, STROKE, V40, P942, DOI 10.1161/STROKEAHA.108.532556; Chyatte D, 1999, NEUROSURGERY, V45, P1137, DOI 10.1097/00006123-199911000-00024; Foks AC, 2015, ARTERIOSCL THROM VAS, V35, P280, DOI 10.1161/ATVBAHA.114.303568; Frosen J, 2006, NEUROSURGERY, V58, P534, DOI 10.1227/01.NEU.0000197332.55054.C8; Frosen J, 2004, STROKE, V35, P2287, DOI 10.1161/01.STR.0000140636.30204.da; Frosen J, 2012, ACTA NEUROPATHOL, V123, P773, DOI 10.1007/s00401-011-0939-3; Fukuda Miyuki, 2015, Acta Neurochir Suppl, V120, P13, DOI 10.1007/978-3-319-04981-6_2; Hasan DM, 2011, STROKE, V42, P3156, DOI 10.1161/STROKEAHA.111.619411; HASHIMOTO N, 1978, SURG NEUROL, V10, P3; Hedrick CC, 2015, ARTERIOSCL THROM VAS, V35, P253, DOI 10.1161/ATVBAHA.114.305144; Iwamoto H, 1999, STROKE, V30, P1390, DOI 10.1161/01.STR.30.7.1390; Kanematsu Y, 2011, STROKE, V42, P173, DOI 10.1161/STROKEAHA.110.590976; Meng X, 2016, NAT REV CARDIOL, V13, P167, DOI 10.1038/nrcardio.2015.169; Morita A, 2012, NEW ENGL J MED, V366, P2474, DOI 10.1056/NEJMoa1113260; NAGATA I, 1980, SURG NEUROL, V14, P477; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; Piantino JA, 2013, PEDIATR NEUROL, V48, P130, DOI 10.1016/j.pediatrneurol.2012.10.004; Rader DJ, 2008, NATURE, V451, P904, DOI 10.1038/nature06796; Rinkel GJE, 1998, STROKE, V29, P251, DOI 10.1161/01.STR.29.1.251; Sawyer DM, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0654-z; Sonobe M, 2010, STROKE, V41, P1969, DOI 10.1161/STROKEAHA.110.585059; Starke RM, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-77; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; Wermer MJH, 2007, NEUROSURGERY, V60, P91, DOI 10.1227/01.NEU.0000249215.19591.86; Witztum JL, 2014, ANNU REV PATHOL-MECH, V9, P73, DOI 10.1146/annurev-pathol-020712-163936; Yokoi T, 2014, J NEUROSURG, V120, P1193, DOI 10.3171/2014.1.JNS13818; Yoshimura Y, 2014, J STROKE CEREBROVASC, V23, P343, DOI 10.1016/j.jstrokecerebrovasdis.2013.04.022	32	21	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0175421	10.1371/journal.pone.0175421	http://dx.doi.org/10.1371/journal.pone.0175421			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437485	Green Published, Green Submitted, gold			2022-12-26	WOS:000400287600007
J	Rodrigues, RFN; Almeida, LR; dos Santos, FG; Carvalho, PS; de Souza, WC; Moreira, KS; de Aquino, GLB; Valverde, C; Napolitano, HB; Baseia, B				Rodrigues, Rosemberg F. N.; Almeida, Leonardo R.; dos Santos, Florisberto G.; Carvalho, Paulo S., Jr.; de Souza, Wanderson C.; Moreira, Kleber S.; de Aquino, Gilberto L. B.; Valverde, Clodoaldo; Napolitano, Hamilton B.; Baseia, Basilio			Solid state characterization and theoretical study of non-linear optical properties of a Fluoro-N-Acylhydrazide derivative	PLOS ONE			English	Article							F HYDROGEN-BONDS; DIPOLE-MOMENT ENHANCEMENT; MOLECULAR-CRYSTALS; HYPERPOLARIZABILITY; ASSEMBLIES; GEOMETRY; DESIGN; GROWTH; WATER; FIELD	In this work we determine the linear and non-linear optical properties of a Fluoro-N-Acylhydrazide derivative (FBHZ), using a combined supermolecule approach and an iterative scheme of electrostatic polarization, where the atoms of neighbouring molecules are represented by point charges. Our results for non-linear optics (NLO) are comparable to those found experimentally, suggesting that FBHZ constitutes an attractive object for future studies and for use as an interesting material for third-order NLO applications. The dynamic electrical properties of FBHZ in different solvent media are reported. Its molecular properties are closely related to supramolecular features; accordingly, we analysed all its crystal structure properties via intermolecular interactions in the solid state, using X-ray crystallography data and Hirshfeld surface (HS), including thermogravimetric analysis (TGA), differential scanning calorimetry (DSC) and hot-stage microscopy (HSM), where the results reveal crystal stability in respect to temperature variation.	[Rodrigues, Rosemberg F. N.; Almeida, Leonardo R.; de Souza, Wanderson C.; Moreira, Kleber S.; de Aquino, Gilberto L. B.; Valverde, Clodoaldo; Napolitano, Hamilton B.] Univ Estadual Goias, Campus Ciencias Exatas & Tecnol, Anapolis, Go, Brazil; [Rodrigues, Rosemberg F. N.; dos Santos, Florisberto G.; Valverde, Clodoaldo] Univ Paulista UNIP, Goiania, Go, Brazil; [Almeida, Leonardo R.; Carvalho, Paulo S., Jr.] Univ Sao Paulo, Inst Fis Sao Carlos, Sao Carlos, SP, Brazil; [Baseia, Basilio] Univ Fed Goias, Inst Fis, Goiania, Go, Brazil; [Baseia, Basilio] Univ Fed Paraiba, Dept Fis, Joao Pessoa, Paraiba, Brazil	Universidade Estadual de Goias; Universidade Paulista; Universidade de Sao Paulo; Universidade Federal de Goias; Universidade Federal da Paraiba	Valverde, C (corresponding author), Univ Estadual Goias, Campus Ciencias Exatas & Tecnol, Anapolis, Go, Brazil.; Valverde, C (corresponding author), Univ Paulista UNIP, Goiania, Go, Brazil.	valverde@ueg.br	de Souza, Wanderson/AAR-8593-2021; Carvalho Jr, Paulo S./G-8049-2016; Baseia, Basilio/AAM-4614-2020; Baseia, Basilio/AAJ-8355-2020; Aquino, Gilberto L B/O-5203-2014; Aquino, Gilberto Lucio Benedito/I-3780-2015; , Gilberto/W-8821-2019; Valverde, Clodoaldo/O-3547-2019; Napolitano, Hamilton Barbosa/ABC-1986-2020; Valverde, Clodoaldo/L-8548-2015	Carvalho Jr, Paulo S./0000-0002-5551-9155; Baseia, Basilio/0000-0002-2464-9889; Aquino, Gilberto L B/0000-0001-9397-7803; Aquino, Gilberto Lucio Benedito/0000-0001-9397-7803; , Gilberto/0000-0001-9397-7803; Valverde, Clodoaldo/0000-0002-1656-4981; Almeida, Leonardo/0000-0002-6737-0642	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES); Fundacao de Apoio a Pesquisa do Estado de Goias (FAPEG)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Apoio a Pesquisa do Estado de Goias (FAPEG)(Fundacao de Amparo a Pesquisa do Estado do Goias (FAPEG))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES), and the Fundacao de Apoio a Pesquisa do Estado de Goias (FAPEG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors would like to thank the following Brazilian agencies for financial support: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES) and Fundacao de Apoio a Pesquisa do Estado de Goias (FAPEG).	Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; [Anonymous], 2006, CHEM PHYS LETT, V429, P119; [Anonymous], 2007, BRUK APEX2; [Anonymous], 2006, J PHYS CHEM A, V110, P8970; Arshad MN, 2015, MOLECULES, V20, P5851, DOI 10.3390/molecules20045851; Bamba M, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.021802; Batsanov SS, 2001, INORG MATER+, V37, P871, DOI 10.1023/A:1011625728803; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; Boyd RW, 2014, OPT COMMUN, V326, P74, DOI 10.1016/j.optcom.2014.03.005; Calhorda MJ, 2000, CHEM COMMUN, P801, DOI 10.1039/a900221i; Carcelli M, 2016, SCI REP-UK, V6, DOI 10.1038/srep31500; Castro AN, 2016, CHEM PHYS LETT, V653, P122, DOI 10.1016/j.cplett.2016.04.070; Champagne B, 2003, ADV CHEM PHYS, V126, P41, DOI 10.1002/0471428019.ch2; De Proft F, 2007, FARADAY DISCUSS, V135, P151, DOI 10.1039/b605302p; Desiraju G.R., 2001, WEAK HYDROGEN BOND S, Vvol. 9; Desiraju GR, 2013, J AM CHEM SOC, V135, P9952, DOI 10.1021/ja403264c; Desiraju GR, 2011, ANGEW CHEM INT EDIT, V50, P52, DOI 10.1002/anie.201002960; Desiraju GR, 2011, CRYSTAL ENG TXB, P1; do Amaral DN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085380; Dolomanov OV, 2009, J APPL CRYSTALLOGR, V42, P339, DOI 10.1107/S0021889808042726; Espinosa E, 1996, ACTA CRYSTALLOGR B, V52, P519, DOI 10.1107/S0108768195015205; Farrugia LJ, 2012, J APPL CRYSTALLOGR, V45, P849, DOI 10.1107/S0021889812029111; Feng Q, 2016, J MATER CHEM C, V4, P8552, DOI 10.1039/c6tc01549b; Ferretti S, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/2/025012; Fonseca TL, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3501237; GAVEZZOTTI A, 1994, J PHYS CHEM-US, V98, P4831, DOI 10.1021/j100069a010; GAVEZZOTTI A, 1994, ACCOUNTS CHEM RES, V27, P309, DOI 10.1021/ar00046a004; Gavezzotti A., 1998, CRYSTALLOGR REV, V7, P5, DOI DOI 10.1080/08893119808035402; Georg HC, 2006, CHEM PHYS LETT, V429, P119, DOI 10.1016/j.cplett.2006.08.047; Gerace D, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.031803; Guillaume M, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3104629; Hagberg DP, 2007, J ORG CHEM, V72, P9550, DOI 10.1021/jo701592x; Irvine WTM, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.057405; Jayatilaka D, 2003, LECT NOTES COMPUT SC, V2660, P142; Jayatilaka D, 2005, TONTO SYSTEM COMPU; Jayatilaka D, 2006, ACTA CRYSTALLOGR A, V62, pS90, DOI 10.1107/S0108767306098199; Johnson JC, 2016, J MATER CHEM C, V4, P4847, DOI 10.1039/c6tc01436d; KANIS DR, 1994, CHEM REV, V94, P195, DOI 10.1021/cr00025a007; Kanoun MB, 2010, CHEM PHYS LETT, V487, P256, DOI 10.1016/j.cplett.2010.01.021; Karakas A, 2012, PHOTONICS LETT POL, V4, P17, DOI 10.4302/plp.2012.1.07; Karthigha S, 2016, RSC ADV, V6, P33159, DOI 10.1039/c6ra05055g; Kongsted J, 2004, J CHEM PHYS, V120, P3787, DOI 10.1063/1.1642593; Kryachko E, 2004, J PHYS CHEM A, V108, P2527, DOI 10.1021/jp0365108; Lee KM, 2004, J CHEM PHYS, V120, P8645, DOI 10.1063/1.1697380; Lian ZX, 2015, RSC ADV, V5, P82781, DOI 10.1039/c5ra14734d; Licandro E, 2004, EUR J ORG CHEM, V2004, P665, DOI 10.1002/ejoc.200300416; Macrae CF, 2008, J APPL CRYSTALLOGR, V41, P466, DOI 10.1107/S0021889807067908; Macrae CF, 2020, J APPL CRYSTALLOGR, V53, P226, DOI 10.1107/S1600576719014092; MEC P, 2012, J THEOR COMPUT CHEM, V11, P209; Mukhopadhyay S, 2012, CHEM SCI, V3, P3103, DOI 10.1039/c2sc20861j; Narayanan S, 2015, NEW J CHEM, V39, P2795, DOI 10.1039/c4nj01899k; Nardelli M., 1995, J APPL CRYSTALLOGR, V28, P659, DOI [10.1107/s0021889895007138, 10.1107/S0021889895007138, DOI 10.1107/S0021889895007138]; Nishio M, 2009, CRYSTENGCOMM, V11, P1757, DOI 10.1039/b902318f; Picon-Ferrer I, 2009, J INORG BIOCHEM, V103, P94, DOI 10.1016/j.jinorgbio.2008.09.014; Prasad AA, 2015, SPECTROCHIM ACTA A, V140, P311, DOI 10.1016/j.saa.2014.12.011; Rao G.R., 2015, OPT PHOTONICS J, V05, P91, DOI [DOI 10.4236/OPJ.2015.53008, DOI 10.4236/0PJ.2015.53008]; Rodrigues DA, 2016, J MED CHEM, V59, P655, DOI 10.1021/acs.jmedchem.5b01525; Rohde D, 2006, LANGMUIR, V22, P4750, DOI 10.1021/la053138+; Samson ZL, 2011, OPT LETT, V36, P250, DOI 10.1364/OL.36.000250; Santos OL, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4937481; Schonleber A, 2014, ACTA CRYSTALLOGR B, V70, P652, DOI 10.1107/S2052520614007707; Seidler T, 2015, PHYS CHEM CHEM PHYS, V17, P19546, DOI 10.1039/c5cp03248b; Seidler T, 2014, ADV OPT MATER, V2, P1000, DOI 10.1002/adom.201400245; Seidler T, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4894483; Seidler T, 2014, J CHEM THEORY COMPUT, V10, P2114, DOI 10.1021/ct5001654; Seidler T, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4819769; Seo JT, 2006, J PHYS CONF SER, V38, P91, DOI 10.1088/1742-6596/38/1/023; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930]; Shen HZ, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.063808; Shen HZ, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.023849; Silva AG, 2005, BIOORGAN MED CHEM, V13, P3431, DOI 10.1016/j.bmc.2005.03.003; Spackman MA, 2007, CHEMPHYSCHEM, V8, P2051, DOI 10.1002/cphc.200700339; Spackman MA, 2007, CHEM PHYS LETT, V443, P87, DOI 10.1016/j.cplett.2007.06.058; Spada L, 2014, PHYS CHEM CHEM PHYS, V16, P2149, DOI 10.1039/c3cp54430c; Sugiura M, 2005, ANGEW CHEM INT EDIT, V44, P5176, DOI 10.1002/anie.200500691; Sun ZH, 2011, NEW J CHEM, V35, P2804, DOI 10.1039/c1nj20420c; Takahashi O, 2010, CHEM REV, V110, P6049, DOI 10.1021/cr100072x; Tiekink E.R.T., 2012, IMPORTANCE PI INTERA; Wang D, 2016, ROYAL SOC CHEM, V7, P3714, DOI DOI 10.1039/C6PY00106H; Wolff S.K, 2012, CRYSTALEXPLORER VER; Wolstenholme DJ, 2006, J PHYS CHEM A, V110, P8970, DOI 10.1021/jp061205i; Xu XW, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.043822; Xu XW, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.033809; Xu XW, 2013, J PHYS B-AT MOL OPT, V46, DOI 10.1088/0953-4075/46/3/035502; Zhang B, 2012, CHEM PHARM BULL, V60, P1046, DOI 10.1248/cpb.c12-00234; Zhang G, 2007, J PHYS CHEM A, V111, P1554, DOI 10.1021/jp061633o; Zhang W, 2014, PHYS REV A, V89, DOI [10.1103/physRevA.89.043832, 10.1103/PhysRevA.89.043832]; Zhang X, 2014, J MATER CHEM C, V2, P6966, DOI 10.1039/c4tc00856a; Zhao X, 2003, J AM CHEM SOC, V125, P15128, DOI 10.1021/ja037312x; Zhou YH, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.023838; Zyss J, 1987, QUANT ELE	91	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0175859	10.1371/journal.pone.0175859	http://dx.doi.org/10.1371/journal.pone.0175859			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437446	Green Published, Green Submitted, gold			2022-12-26	WOS:000400287600017
J	Chang, WH; Niu, DM; Lu, CY; Lin, SY; Liu, TC; Chang, JG				Chang, Wen-Hsin; Niu, Dau-Ming; Lu, Chi-Yu; Lin, Shyr-Yi; Liu, Ta-Chih; Chang, Jan-Gowth			Modulation the alternative splicing of GLA (IVS4+919G > A) in Fabry disease	PLOS ONE			English	Article							RNA-POLYMERASE-II; GALACTOSIDASE-A GENE; HISTONE MODIFICATIONS; CHROMATIN; HSP70; HYPERACETYLATION; RECOGNITION; MECHANISMS; PREDICTION; INCLUSION	While a base substitution in intron 4 of GLA (IVS4+919G>A) that causes aberrant alternative splicing resulting in Fabry disease has been reported, its molecular mechanism remains unclear. Here we reported that upon IVS4+919G>A transversion, H3K36me3 was enriched across the alternatively spliced region. PSIP1, an adapter of H3K36me3, together with Hsp70 and NONO were recruited and formed a complex with SF2/ASF and SRp20, which further promoted GLA splicing. Amiloride, a splicing regulator in cancer cells, could reverse aberrant histone modification patterns and disrupt the association of splicing complex with GLA. It could also reverse aberrant GLA splicing in a PP1-dependant manner. Our findings revealed the alternative splicing mechanism of GLA (IVS4+919G>A), and a potential treatment for this specific genetic type of Fabry disease by amiloride in the future.	[Chang, Wen-Hsin; Lin, Shyr-Yi] Taipei Med Univ Hosp, Dept Primary Care Med, Taipei, Taiwan; [Niu, Dau-Ming] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Niu, Dau-Ming] Taipei Vet Gen Hosp, Dept Pediat, Taipei, Taiwan; [Lu, Chi-Yu] Kaohsiung Med Univ, Dept Biochem, Coll Med, Kaohsiung, Taiwan; [Lu, Chi-Yu] Kaohsiung Med Univ, Res Ctr Environm Med, Kaohsiung, Taiwan; [Lin, Shyr-Yi] Taipei Med Univ, Sch Med, Dept Gen Med, Coll Med, Taipei, Taiwan; [Liu, Ta-Chih] Kaohsiung Med Univ, Grad Inst Clin Med, Coll Med, Kaohsiung, Taiwan; [Liu, Ta-Chih] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Hematol & Oncol, Dept Internal Med, Kaohsiung, Taiwan; [Chang, Jan-Gowth] China Med Univ Hosp, Epigenome Res Ctr, Taichung, Taiwan; [Chang, Jan-Gowth] China Med Univ Hosp, Dept Lab Med, Taichung, Taiwan; [Chang, Jan-Gowth] China Med Univ, Sch Med, Taichung, Taiwan; [Chang, Jan-Gowth] Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan	Taipei Medical University; Taipei Medical University Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Taipei Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Asia University Taiwan	Lin, SY (corresponding author), Taipei Med Univ Hosp, Dept Primary Care Med, Taipei, Taiwan.; Lin, SY (corresponding author), Taipei Med Univ, Sch Med, Dept Gen Med, Coll Med, Taipei, Taiwan.; Liu, TC (corresponding author), Kaohsiung Med Univ, Grad Inst Clin Med, Coll Med, Kaohsiung, Taiwan.; Liu, TC (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Hematol & Oncol, Dept Internal Med, Kaohsiung, Taiwan.; Chang, JG (corresponding author), China Med Univ Hosp, Epigenome Res Ctr, Taichung, Taiwan.; Chang, JG (corresponding author), China Med Univ Hosp, Dept Lab Med, Taichung, Taiwan.; Chang, JG (corresponding author), China Med Univ, Sch Med, Taichung, Taiwan.; Chang, JG (corresponding author), Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan.	sylin@tmu.edu.tw; d730093@kmu.edu.tw; d6781@mail.cmuh.org.tw			Ministry of Science and Technology, Taiwan [103-2320-B-039-050-MY3]; Jin-lung-yuan Foundation; China Medical University Hospital [DM R-106-104]; Taipei Veterans General Hospital [VGHUST102-G7-4-1]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Jin-lung-yuan Foundation; China Medical University Hospital; Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This study was supported by grants from the Ministry of Science and Technology, Taiwan (103-2320-B-039-050-MY3), Jin-lung-yuan Foundation, 2015 to 2016 (SYL), China Medical University Hospital (DM R-106-104), and Taipei Veterans General Hospital (VGHUST102-G7-4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	[Anonymous], 2014, METABOLIC MOL BASES; Benbahouche NE, 2014, J BIOL CHEM, V289, P6236, DOI 10.1074/jbc.M113.499608; Braunschweig U, 2013, CELL, V152, P1252, DOI 10.1016/j.cell.2013.02.034; Brown SJ, 2012, HUM MOL GENET, V21, pR90, DOI 10.1093/hmg/dds353; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chang JG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018643; Chang WH, 2011, CANCER RES, V71, P383, DOI 10.1158/0008-5472.CAN-10-1037; COHEN P, 1989, FEBS LETT, V250, P596, DOI 10.1016/0014-5793(89)80803-8; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; DESNICK RJ, 1973, J LAB CLIN MED, V81, P157; Emili A, 2002, RNA, V8, P1102, DOI 10.1017/S1355838202025037; Hertel KJ, 2008, J BIOL CHEM, V283, P1211, DOI 10.1074/jbc.R700035200; Hnilicova J, 2011, NUCLEUS-PHILA, V2, P182, DOI 10.4161/nucl.2.3.15876; Hnilicova J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016727; Iizuka M, 2003, CURR OPIN GENET DEV, V13, P154, DOI 10.1016/S0959-437X(03)00020-0; Ishii S, 2002, AM J HUM GENET, V70, P994, DOI 10.1086/339431; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Lai LW, 2003, CLIN GENET, V63, P476, DOI 10.1034/j.1399-0004.2003.00077.x; Lee Y, 2015, ANNU REV BIOCHEM, V84, P291, DOI 10.1146/annurev-biochem-060614-034316; Linhart A, 2007, EUR HEART J, V28, P1228, DOI 10.1093/eurheartj/ehm153; Liu LL, 2011, MOL ENDOCRINOL, V25, P1197, DOI 10.1210/me.2010-0517; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; Manzoor R, 2014, J BIOL CHEM, V289, P7599, DOI 10.1074/jbc.M113.507798; Matera AG, 2014, NAT REV MOL CELL BIO, V15, P108, DOI 10.1038/nrm3742; Moreno NN, 2015, FEBS LETT, V589, P3370, DOI 10.1016/j.febslet.2015.08.002; Pratt WB, 2004, ESSAYS BIOCHEM, V40, P41, DOI 10.1042/bse0400041; Saint-Andre V, 2011, NAT STRUCT MOL BIOL, V18, P337, DOI 10.1038/nsmb.1995; Schor Ignacio E, 2013, Cancer Treat Res, V158, P1, DOI 10.1007/978-3-642-31659-3_1; Schor IE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048084; Schwartz S, 2010, EMBO J, V29, P1629, DOI 10.1038/emboj.2010.71; Seydelmann N, 2015, BEST PRACT RES CL EN, V29, P195, DOI 10.1016/j.beem.2014.10.003; Sharma A, 2015, NUCLEUS-PHILA, V6, P273, DOI 10.1080/19491034.2015.1081324; Shindo Y, 2013, FEBS LETT, V587, P516, DOI 10.1016/j.febslet.2013.01.032; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Teves SS, 2011, GENE DEV, V25, P2387, DOI [10.1101/gad.177675.111, 10.1101/gad.178079.111]; VOGEL JL, 1995, CURR BIOL, V5, P306, DOI 10.1016/S0960-9822(95)00061-3; Wang HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037764; Zhang SR, 2006, MOL MICROBIOL, V62, P1090, DOI 10.1111/j.1365-2958.2006.05422.x; Zhou HL, 2014, NUCLEIC ACIDS RES, V42, P701, DOI 10.1093/nar/gkt875; Zhou HL, 2011, P NATL ACAD SCI USA, V108, pE627, DOI 10.1073/pnas.1103344108; Zhou ZH, 2012, MOL CELL, V47, P422, DOI 10.1016/j.molcel.2012.05.014; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	43	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0175929	10.1371/journal.pone.0175929	http://dx.doi.org/10.1371/journal.pone.0175929			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430823	gold, Green Published, Green Submitted			2022-12-26	WOS:000399876100023
J	Stribos, EGD; Nielsen, SH; Brix, S; Karsdal, MA; Seelen, MA; van Goor, H; Bakker, SJL; Olinga, P; Mutsaers, HAM; Genovese, F				Stribos, Elisabeth G. D.; Nielsen, Signe Holm; Brix, Susanne; Karsdal, Morten Asser; Seelen, Marc A.; van Goor, Harry; Bakker, Stephan J. L.; Olinga, Peter; Mutsaers, Henricus A. M.; Genovese, Federica			Non-invasive quantification of collagen turnover in renal transplant recipients	PLOS ONE			English	Article							INTERSTITIAL FIBROSIS; IV COLLAGEN; EXTRACELLULAR-MATRIX; KIDNEY-DISEASES; URINARY; VI; MARKERS; MUSCLE; NEPHROPATHY; ASSOCIATION	Kidney allograft failure due to chronic injury/rejection remains the main cause of graft loss in renal transplant recipients (RTR). Here, we investigated whether specific biomarkers of extracellular matrix (ECM) turnover are associated with allograft function and chronic kidney disease (CKD) stage in RTR. Seventy-eight patients who attended the University Medical Center Groningen for a routine check-up after kidney transplantation were enrolled in the study. Plasma and/or 24h-urine samples were collected and specific matrix-metalloproteinase- generated neo-epitope fragments of collagens were measured by enzyme-linked immunosorbent assay. Our results demonstrated that urinary levels of C3M, a marker for collagen type III degradation, correlated with estimated glomerular filtration rate (eGFR; r = 0.58, p< 0.0001), with lower levels detected in the urine of patients with advanced CKD. In addition, plasma levels of Pro-C6, a marker for collagen type VI formation, significantly increased with disease progression and correlated with eGFR (r = -0.72, p< 0.0001). Conversely, plasma C3M and urinary Pro-C6 levels showed no correlation with renal function. We identified two neo-epitope biomarkers of tissue turnover associated with ECM remodeling and fibrosis that can stratify patients by CKD stage. This is as promising first step towards non-invasive monitoring of ECM turnover in the kidneys.	[Stribos, Elisabeth G. D.; Olinga, Peter; Mutsaers, Henricus A. M.] Univ Groningen, Groningen Res Inst Pharm, Dept Pharmaceut Technol & Biopharm, Groningen, Netherlands; [Stribos, Elisabeth G. D.; Bakker, Stephan J. L.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, Groningen, Netherlands; [Nielsen, Signe Holm; Karsdal, Morten Asser; Genovese, Federica] Nord Biosci AS, Herlev, Denmark; [Nielsen, Signe Holm; Brix, Susanne] Tech Univ Denmark, Dept Biotechnol & Biomed, Lyngby, Denmark; [van Goor, Harry] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Div Pathol, Groningen, Netherlands	University of Groningen; University of Groningen; Nordic Bioscience; Technical University of Denmark; University of Groningen	Olinga, P (corresponding author), Univ Groningen, Groningen Res Inst Pharm, Dept Pharmaceut Technol & Biopharm, Groningen, Netherlands.; Nielsen, SH (corresponding author), Nord Biosci AS, Herlev, Denmark.; Nielsen, SH (corresponding author), Tech Univ Denmark, Dept Biotechnol & Biomed, Lyngby, Denmark.	shn@nordicbio.com; p.olinga@rug.nl	Pedersen, Susanne Brix/B-3484-2009; Holm, Signe/GLT-8793-2022; Mutsaers, Henricus/AAK-6321-2020	Pedersen, Susanne Brix/0000-0001-8951-6705; Holm, Signe/0000-0002-4612-1014; Mutsaers, Henricus/0000-0002-9553-8860; van Goor, Harry/0000-0002-6670-1577; Genovese, Federica/0000-0003-1984-1881; Karsdal, Morten/0000-0001-5026-8740; Olinga, Peter/0000-0003-4855-8452	Danish Research Fund (Den Danske Forsknings fond); Netherlands Organization for Health Research and Development (ZonMw) [114021010]	Danish Research Fund (Den Danske Forsknings fond); Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This work was supported by the Danish Research Fund (Den Danske Forsknings fond) and the Netherlands Organization for Health Research and Development (ZonMw; grant number 114021010, PO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Racca MA, 2015, TRANSPL INT, V28, P71, DOI 10.1111/tri.12445; Araki S, 2010, DIABETES CARE, V33, P1805, DOI 10.2337/dc10-0199; Barascuk N, 2010, CLIN BIOCHEM, V43, P899, DOI 10.1016/j.clinbiochem.2010.03.012; Bonnemann CG, 2011, NAT REV NEUROL, V7, P379, DOI 10.1038/nrneurol.2011.81; Bonnemann Carsten G, 2011, Handb Clin Neurol, V101, P81, DOI 10.1016/B978-0-08-045031-5.00005-0; Boor P, 2015, AM J TRANSPLANT, V15, P863, DOI 10.1111/ajt.13180; Catania JM, 2007, AM J PHYSIOL-RENAL, V292, pF905, DOI 10.1152/ajprenal.00421.2006; de Jong S, 2011, J CARDIOVASC PHARM, V57, P522, DOI 10.1097/FJC.0b013e31821823d9; Eddy AA, 2000, KIDNEY INT, V58, P618, DOI 10.1046/j.1523-1755.2000.00208.x; El Ghoul B, 2010, CLIN J AM SOC NEPHRO, V5, P205, DOI 10.2215/CJN.06610909; Farris AB, 2012, CURR OPIN NEPHROL HY, V21, P289, DOI 10.1097/MNH.0b013e3283521cfa; Fitzgerald J, 2013, CONNECT TISSUE RES, V54, P345, DOI 10.3109/03008207.2013.822865; Furumatsu Y, 2011, NEPHRON CLIN PRACT, V117, pC160, DOI 10.1159/000319794; Gara SK, 2011, MATRIX BIOL, V30, P248, DOI 10.1016/j.matbio.2011.03.006; Genovese F, 2016, NEPHROL DIAL TRANSPL, V31, P472, DOI 10.1093/ndt/gfv301; Genovese F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111134; Groma V, 1998, NEPHROL DIAL TRANSPL, V13, P305, DOI 10.1093/oxfordjournals.ndt.a027823; Jenkins RG, 2015, LANCET RESP MED, V3, P462, DOI 10.1016/S2213-2600(15)00048-X; Karsdal MA, 2013, ASSAY DRUG DEV TECHN, V11, P70, DOI 10.1089/adt.2012.474; Kawamura E, 2015, MOD RHEUMATOL, V25, P571, DOI 10.3109/14397595.2014.1001474; Leeming DJ, 2013, ALIMENT PHARM THER, V38, P1086, DOI 10.1111/apt.12484; Leeming DJ, 2011, BIOMARKERS, V16, P616, DOI 10.3109/1354750X.2011.620628; LEMLEY KV, 1991, KIDNEY INT, V39, P370, DOI 10.1038/ki.1991.49; Lennon R, 2014, J AM SOC NEPHROL, V25, P939, DOI 10.1681/ASN.2013030233; Ling XB, 2010, J AM SOC NEPHROL, V21, P646, DOI 10.1681/ASN.2009080876; Mazanowska O, 2011, TRANSPL P, V43, P3000, DOI 10.1016/j.transproceed.2011.08.012; Morita M, 2011, AM J KIDNEY DIS, V58, P915, DOI 10.1053/j.ajkd.2011.04.019; Nielsen MJ, 2015, LIVER INT, V35, P429, DOI 10.1111/liv.12700; Nielsen MJ, 2013, AM J TRANSL RES, V5, P303; Okonogi H, 2001, CLIN NEPHROL, V55, P357; Papasotiriou M, 2015, NEPHROL DIAL TRANSPL, V30, P1112, DOI 10.1093/ndt/gfv063; Sand JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084934; Scian MJ, 2011, TRANSPLANTATION, V91, P657, DOI 10.1097/TP.0b013e3182094a5a; Sellares J, 2012, AM J TRANSPLANT, V12, P388, DOI 10.1111/j.1600-6143.2011.03840.x; Seron D, 2000, TRANSPLANTATION, V69, P1849; Soylemezoglu O, 1997, NEPHROL DIAL TRANSPL, V12, P1883, DOI 10.1093/ndt/12.9.1883; Sun S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144525; Teppo AM, 2003, TRANSPLANTATION, V75, P2113, DOI 10.1097/01.TP.0000066809.60389.48; Veidal SS, 2012, CLIN BIOCHEM, V45, P541, DOI 10.1016/j.clinbiochem.2012.02.007; Veidal SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024753; Vleming LJ, 1997, CLIN NEPHROL, V47, P158; Wong W, 2010, AM J TRANSPLANT, V10, P2463, DOI 10.1111/j.1600-6143.2010.03290.x	42	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0175898	10.1371/journal.pone.0175898	http://dx.doi.org/10.1371/journal.pone.0175898			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430784	gold, Green Published, Green Submitted			2022-12-26	WOS:000399876100020
J	de Oliveira-Fonoff, AM; Mady, C; Pessoa, FG; Fonseca, KCB; Salemi, VMC; Fernandes, F; Saldiva, PHN; Ramires, FJA				de Oliveira-Fonoff, A. M.; Mady, C.; Pessoa, F. G.; Fonseca, K. C. B.; Salemi, V. M. C.; Fernandes, F.; Saldiva, P. H. N.; Ramires, F. J. A.			The role of air pollution in myocardial remodeling	PLOS ONE			English	Article							PARTICULATE MATTER EXPOSURE; OXIDATIVE STRESS; HEART-FAILURE; INFLAMMATION; DYSFUNCTION; MECHANISMS; INFARCTION; PARTICLES; CYTOKINES; KINASE	Background Excessive air pollution in urban environments can impact morbidity and mortality. The authors evaluated the role of particulate matter(2.5) (PM2.5) in structural, geometric, and functional remodeling in hearts, using an experimental model of myocardial infarction. Methods and findings Seventy-five rats were divided into 5 groups: control (CG), CG exposed to PM2.5 pollution (CGP), myocardial infarcted group (MI), infarcted group immediately exposed to pollution (IGP-I), and infarcted group previously exposed to pollution and kept exposed after infarction (IGP-II). Greater deposition of interstitial collagen occurred in the left ventricle in CGP, MI, IGP-I, and IGP-II groups compared with that in controls (p = 0.002 CG vs CGP and p<0.0001 CG vs MI, IGP-I, and IGP-II). In the right ventricle, greater collagen deposition existed in CGP, MI, IGP-I, and IGP-II compared with that in CG (p<0.021 CG vs CGP and p<0.0001 CG vs MI, IGP-I, and IGP-II). At the end of the study, CG had a higher mean shortening fraction than the other groups had (p <= 0.03). Left ventricular systolic diameter was lower in CG than in infarcted groups (p <= 0.003). The infarcted groups had greater expression of TGF-beta (p <= 0.04). PM2.5 increased the expression of TGF-beta in the IGP-II compared with the MI group (p = 0.004). The TNF-alpha gene was overexpressed in the IGP-II compared with the CGP group (p = 0.012). INF-gamma gene expression was greater in IGP-II (p <= 0.01). Oxidative stress analysis showed a higher glutathione concentration in CGP (p = 0.03), MI (p = 0.014), and IGP-I (p = 0.008) compared with that in CG. Conclusions PM2.5 stimulates the deposition of fibrosis in the myocardium of healthy hearts, but not in infarcted hearts. PM2.5 modulates the inflammatory response, which was greater in the IGP-II group. It also modulates oxidative stress in healthy hearts but not in infarcted hearts.	[de Oliveira-Fonoff, A. M.; Mady, C.; Pessoa, F. G.; Fonseca, K. C. B.; Salemi, V. M. C.; Fernandes, F.; Ramires, F. J. A.] Univ Sao Paulo, Heart Inst InCor, Cardiomyopathy Unit, Sao Paulo, Brazil; [de Oliveira-Fonoff, A. M.; Saldiva, P. H. N.] Univ Sao Paulo, Med Sch, Dept Pathol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Ramires, FJA (corresponding author), Univ Sao Paulo, Heart Inst InCor, Cardiomyopathy Unit, Sao Paulo, Brazil.	felix.ramires@incor.usp.br	Fernandes, Fábio/D-5994-2012; Ramires, Felix JA/D-5996-2012; Fonseca, Keila Cardoso Barbosa/N-2484-2014; Pessoa, Fernanda G/N-1315-2014; Mady, Charles/C-8870-2012; Salemi, Vera/AAY-5024-2020; Saldiva, Paulo HN/D-7385-2012	Fernandes, Fábio/0000-0002-9323-8805; Ramires, Felix JA/0000-0003-2437-2485; Pessoa, Fernanda G/0000-0002-8781-495X; Mady, Charles/0000-0002-8838-199X; Saldiva, Paulo HN/0000-0003-2005-8253	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - Brazil (FAPESP) [2010/11541-4]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - Brazil (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by grants from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - Brazil (FAPESP). 2010/11541-4.	Ahn J, 2012, CURR HYPERTENS REP, V14, P510, DOI 10.1007/s11906-012-0309-0; Cozzi E, 2006, AM J PHYSIOL-HEART C, V291, pH894, DOI 10.1152/ajpheart.01362.2005; Davel AP, 2012, TOXICOLOGY, V295, P39, DOI 10.1016/j.tox.2012.02.004; Deswal A, 2001, CIRCULATION, V103, P2055; Frantz S, 2009, CARDIOVASC RES, V81, P474, DOI 10.1093/cvr/cvn292; Frimm CD, 1997, J LAB CLIN MED, V129, P439, DOI 10.1016/S0022-2143(97)90077-9; Georges S, 2005, ENVIRON MANAGE, V35, P667, DOI 10.1007/s00267-004-0042-9; Hsieh YL, 2013, INHAL TOXICOL, V25, P455, DOI 10.3109/08958378.2013.804609; Kim JB, 2012, TOXICOL APPL PHARM, V259, P66, DOI 10.1016/j.taap.2011.12.007; Kodavanti UP, 2003, TOXICOL SCI, V71, P237, DOI 10.1093/toxsci/71.2.237; Koike MK, 2007, INT J EXP PATHOL, V88, P279, DOI 10.1111/j.1365-2613.2007.00540.x; Lee WH, 2014, NEUROBIOL AGING, V35, P1459, DOI 10.1016/j.neurobiolaging.2013.12.002; Mann DL, 2002, CIRC RES, V91, P988, DOI 10.1161/01.RES.0000043825.01705.1B; Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa; Nichols CE, 2015, AM J PHYSIOL-HEART C, V309, pH2017, DOI 10.1152/ajpheart.00353.2015; Potenza MA, 2009, AM J PHYSIOL-ENDOC M, V297, pE685, DOI 10.1152/ajpendo.00291.2009; Risom L, 2005, MUTAT RES-FUND MOL M, V592, P119, DOI 10.1016/j.mrfmmm.2005.06.012; Routledge HC, 2005, OCCUP MED-OXFORD, V55, P439, DOI 10.1093/occmed/kqi136; Salemi Vera M C, 2005, Eur J Echocardiogr, V6, P41, DOI 10.1016/j.euje.2004.06.001; Segura A, 2014, HEART FAIL REV, V19, P173, DOI 10.1007/s10741-012-9365-4; Shinde AV, 2014, J MOL CELL CARDIOL, V70, P74, DOI 10.1016/j.yjmcc.2013.11.015; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Todandsdal AI, 2008, TOXICOLOGY, V247, P23, DOI 10.1016/j.tox.2008.01.019; Valavanidis A, 2008, J ENVIRON SCI HEAL C, V26, P339, DOI 10.1080/10590500802494538; Valavanidis A, 2013, INT J ENV RES PUB HE, V10, P3886, DOI 10.3390/ijerph10093886; Wold LE, 2012, CIRC-HEART FAIL, V5, P452, DOI 10.1161/CIRCHEARTFAILURE.112.966580; Xu XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071414; Ying ZK, 2009, AM J PHYSIOL-HEART C, V296, pH1540, DOI 10.1152/ajpheart.01270.2008	28	16	17	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176084	10.1371/journal.pone.0176084	http://dx.doi.org/10.1371/journal.pone.0176084			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426774	Green Published, Green Submitted, gold			2022-12-26	WOS:000399875900100
J	Liu, JH; Wang, L; Wang, YL; Zhang, WJ; Cao, YL				Liu, Jianhua; Wang, Lu; Wang, Yaoling; Zhang, Wenjie; Cao, Yilin			Phenotypic characterization and anticancer capacity of CD8+cytokine-induced killer cells after antigen-induced expansion	PLOS ONE			English	Article							CD8(+) T-CELLS; SEVERE COMBINED IMMUNODEFICIENCY; CANCER STEM-CELLS; IN-VIVO; HEPATOCELLULAR-CARCINOMA; ANTITUMOR-ACTIVITY; POOR-PROGNOSIS; NKG2D LIGANDS; CYTOTOXICITY; EXPRESSION	Cytokine-induced killer cells (CIK) have been used in clinic for adoptive immunotherapy in a variety of malignant tumors and have improved the prognosis of cancer patients. However, there are individual differences in the CIK cell preparations including the obvious differences in the ratio of effector CIK cells among different cancer patients. Infusion of such heterogeneous immune cell preparation is an important factor that would affect the therapeutic efficacy. We report here the enrichment and expansion of CD8+ cells from CIK cells cultured for one week using magnetic activated cell sorting ( MACS). These enriched CD8+ CIK cells expressed T cell marker CD3 and antigen recognition receptor NKG2D. Phenotypic analysis showed that CD8+ CIK cells contained 32.4% of CD3+ CD56+ natural killer (NK)-like T cells, 23.6% of CD45RO+ CD28+, and 50.5% of CD45RA+ CD27+ memory T cells. In vitro cytotoxic activity assay demonstrated that the enriched CD8+ CIK cells had significant cytotoxic activity against K562 cells and five ovarian cancer cell lines. Intriguingly, CD8+ CIK cells had strong cytotoxic activity against OVCAR3 cells that has weak binding capability to NKG2D. Flow cytometry and quantitative RT-PCR analysis revealed that OVCAR3 cells expressed HLA-I and OCT4 and Sox2, suggesting that CD8+ CIK cells recognize surface antigen via specific T cell receptor and effectively kill the target cells. The results suggest that transplantation of such in vitro enriched and expanded OCT4-specific CD8+ CIK cells may improve the specific immune defense mechanism against cancer stem cells, providing a novel avenue of cancer stem cell targeted immunotherapy for clinical treatment of ovarian cancer.	[Liu, Jianhua; Wang, Lu; Wang, Yaoling; Zhang, Wenjie; Cao, Yilin] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Plast Surg, Shanghai, Peoples R China	Shanghai Jiao Tong University	Zhang, WJ; Cao, YL (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Plast Surg, Shanghai, Peoples R China.	wenjieboshi@aliyun.com; drcaoyilin@163.com						Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Dhodapkar KM, 2010, P NATL ACAD SCI USA, V107, P8718, DOI 10.1073/pnas.0915086107; Di JB, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.24271; Franceschetti M, 2009, EXP HEMATOL, V37, P616, DOI 10.1016/j.exphem.2009.01.010; Henson SM, 2012, CURR OPIN IMMUNOL, V24, P476, DOI 10.1016/j.coi.2012.04.001; Hoyle C, 1998, BLOOD, V92, P3318, DOI 10.1182/blood.V92.9.3318.421k39_3318_3327; Huang BC, 2011, J IMMUNOTHER, V34, P289, DOI 10.1097/CJI.0b013e31820e1b0d; Huang JP, 2006, J IMMUNOL, V176, P7726, DOI 10.4049/jimmunol.176.12.7726; Huang JP, 2005, J IMMUNOTHER, V28, P258, DOI 10.1097/01.cji.0000158855.92792.7a; Introna M, 2006, BONE MARROW TRANSPL, V38, P621, DOI 10.1038/sj.bmt.1705503; Karimi M, 2005, J IMMUNOL, V175, P7819, DOI 10.4049/jimmunol.175.12.7819; Li K, 2009, CANCER IMMUNOL IMMUN, V58, P641, DOI 10.1007/s00262-008-0585-3; Li RM, 2012, CANCER IMMUNOL IMMUN, V61, P2125, DOI 10.1007/s00262-012-1260-2; Linn YC, 2002, BRIT J HAEMATOL, V116, P78, DOI 10.1046/j.1365-2141.2002.03247.x; Linn YC, 2009, IMMUNOLOGY, V126, P423, DOI 10.1111/j.1365-2567.2008.02910.x; LU PH, 1994, J IMMUNOL, V153, P1687; McGilvray RW, 2010, INT J CANCER, V127, P1412, DOI 10.1002/ijc.25156; Nishimura R, 2008, BLOOD, V112, P2563, DOI 10.1182/blood-2007-06-092817; Nolte MA, 2005, NAT IMMUNOL, V6, P412, DOI 10.1038/ni1174; Olioso P, 2009, HEMATOL ONCOL, V27, P130, DOI 10.1002/hon.886; Rizzino A, 2013, STEM CELLS, V31, P1033, DOI 10.1002/stem.1352; Rong XX, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1086060; Samardzija C, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-37; Schmidt R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-251; SCHMIDTWOLF IGH, 1991, J EXP MED, V174, P139, DOI 10.1084/jem.174.1.139; Schmitz M, 2007, BRIT J CANCER, V96, P1293, DOI 10.1038/sj.bjc.6603696; Shi M, 2004, WORLD J GASTROENTERO, V10, P1146; Thorne SH, 2006, SCIENCE, V311, P1780, DOI 10.1126/science.1121411; Verneris MR, 2004, BLOOD, V103, P3065, DOI 10.1182/blood-2003-06-2125; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Wang FS, 2002, WORLD J GASTROENTERO, V8, P464, DOI 10.3748/wjg.v8.i3.464; Zikherman J, 2008, IMMUNITY, V29, P839, DOI 10.1016/j.immuni.2008.12.005	32	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175704	10.1371/journal.pone.0175704	http://dx.doi.org/10.1371/journal.pone.0175704			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426690	Green Published, gold, Green Submitted			2022-12-26	WOS:000399875900041
J	Monnin, D; Kremer, N; Desouhant, E; Vavre, F				Monnin, David; Kremer, Natacha; Desouhant, Emmanuel; Vavre, Fabrice			Impact of Wolbachia on oxidative stress sensitivity in the parasitic wasp Asobara japonica	PLOS ONE			English	Article							HOST; HOMEOSTASIS; DEPENDENCE; INDUCTION; VIRUS	The oxidative homeostasis is the balance between reactive oxygen species and antioxidant molecules. In addition to be considered as a key factor underlying life-history traits evolution, the oxidative homeostasis has been shown to be involved in many host-symbiont associations. Previous studies suggest an interaction between the bacterial endosymbiont Wolbachia and the oxidative homeostasis of some insect hosts. This interaction is likely to exert a strong influence on the host evolution, as it has been proposed in the wasp Asobara tabida, whose dependence upon Wolbachia is due to the evolutionary loss of its ability to regulate the oxidative homeostasis in the absence of the symbiont. Although such cases of complete dependence are rare, cases of insects having lost only a part of their autonomy over the control of the oxidative homeostasis might be more common. If so, one can expect that insects having coevolved with Wolbachia will be more sensitive to oxidative stress when cured of their symbionts. We tested this hypothesis by studying the effects of an experimentally-induced oxidative stress on various life-history traits of Asobara japonica, a species closely related to A. tabida. For most of the life-history traits studied, the sensitivity of the wasps to oxidative stress did not correlate with their infection status. The only exception was the parasitic success. However, contrarily to our expectation, the sensitivity to oxidative stress was increased, rather than decreased, when Wolbachia was present. This result suggests that Wolbachia does not participate to mitigate oxidative stress in A. japonica, and that on the contrary its presence might still be costly in stressful environments.	[Monnin, David; Kremer, Natacha; Desouhant, Emmanuel; Vavre, Fabrice] Univ Lyon 1, CNRS, UMR 5558, Lab Biornetrie & Biol Evolut, Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup	Monnin, D (corresponding author), Univ Lyon 1, CNRS, UMR 5558, Lab Biornetrie & Biol Evolut, Villeurbanne, France.	david.monnin@hotmail.fr	vavre, fabrice/N-2945-2017; Kremer, Natacha/AAC-2877-2019	vavre, fabrice/0000-0003-0909-2936; Kremer, Natacha/0000-0001-5678-9416; DESOUHANT, Emmanuel/0000-0003-0317-4463	Agence Nationale de la Recherche Program 'ImmunSymbArt' [ANR-2010-BLAN- 170101]; Marie Curie Actions [FP7-PEOPLE-2010-IOF/272684/SymbiOx]	Agence Nationale de la Recherche Program 'ImmunSymbArt'(French National Research Agency (ANR)); Marie Curie Actions(European Commission)	This work was supported by the Agence Nationale de la Recherche (http://www.agence-nationale-recherche.fr) Program 'ImmunSymbArt', ANR-2010-BLAN- 170101 to FV and the Marie Curie Actions, FP7-PEOPLE-2010-IOF/272684/SymbiOx to NK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Andrews ES, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003075; BOULETREAU M, 1986, ENTOMOL EXP APPL, V41, P107, DOI 10.1007/BF00195565; Brennan LJ, 2012, INSECT MOL BIOL, V21, P510, DOI 10.1111/j.1365-2583.2012.01155.x; Brennan LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002083; Costantini D., 2014, OXIDATIVE STRESS HOR; DAVID JEAN, 1965, BULL BIOL FRANCE BELG, V99, P369; Dedeine F, 2001, P NATL ACAD SCI USA, V98, P6247, DOI 10.1073/pnas.101304298; Fallon AM, 2013, IN VITRO CELL DEV-AN, V49, P501, DOI 10.1007/s11626-013-9634-0; Harrison XA, 2015, PEERJ, V3, DOI 10.7717/peerj.1114; HASSAN HM, 1977, J BIOL CHEM, V252, P7667; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Kremer N, 2009, HEREDITY, V103, P248, DOI 10.1038/hdy.2009.63; Kremer N, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S7; Kremer N, 2010, EVOLUTION, V64, P2969, DOI 10.1111/j.1558-5646.2010.01034.x; Kremer N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000630; Mitsui H, 2007, J NAT HIST, V41, P1731, DOI 10.1080/00222930701504797; Mone A Y, 2014, P R SOC A, V281; Monnin D, 2016, J EVOLUTION BIOL, V29, P1211, DOI 10.1111/jeb.12863; Murata Y, 2009, EUR J ENTOMOL, V106, P171, DOI 10.14411/eje.2009.020; Nathan C, 2013, NAT REV IMMUNOL, V13, P349, DOI 10.1038/nri3423; Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108; Pannebakker BA, 2007, P NATL ACAD SCI USA, V104, P213, DOI 10.1073/pnas.0607845104; Poinsot D, 1997, EVOLUTION, V51, P180, DOI 10.1111/j.1558-5646.1997.tb02399.x; R Core Team, 2016, R LANG ENV STAT COMP; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Weeks AR, 2007, PLOS BIOL, V5, P997, DOI 10.1371/journal.pbio.0050114; Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969; Wong ZS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025430; Zug R, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01201	31	1	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175974	10.1371/journal.pone.0175974	http://dx.doi.org/10.1371/journal.pone.0175974			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426794	Green Published, gold, Green Submitted			2022-12-26	WOS:000399875900078
J	Rani, S; Sreenivasaiah, PK; Kim, JO; Lee, MY; Kang, WS; Kim, YS; Ahn, Y; Park, WJ; Cho, C; Kim, DH				Rani, Shilpa; Sreenivasaiah, Pradeep Kumar; Kim, Jin Ock; Lee, Mi Young; Kang, Wan Seok; Kim, Yong Sook; Ahn, Youngkeun; Park, Woo Jin; Cho, Chunghee; Kim, Do Han			Tauroursodeoxycholic acid (TUDCA) attenuates pressure overload-induced cardiac remodeling by reducing endoplasmic reticulum stress	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; TRANSGENIC MICE; HEART-FAILURE; DILATED CARDIOMYOPATHY; CHEMICAL CHAPERONES; THERAPEUTIC TARGET; APOPTOSIS; HYPERTROPHY; DYSFUNCTION; MYOCARDIUM	Pressure overload in the heart induces pathological hypertrophy and is associated with cardiac dysfunction. Apoptosis and fibrosis signaling initiated by the endoplasmic reticulum stress (ERS) is known to contribute to these maladaptive effects. The aim of this study was to investigate whether reduction of ERS by a known chemical chaperone, tauroursodeoxycholic acid (TUDCA) can attenuate pressure overload-induced cardiac remodeling in a mouse model of transverse aortic constriction (TAC). Oral administration of TUDCA at a dose of 300 mg/kg body weight (BW) in the TUDCA-TAC group reduced ERS markers (GRP78, p-PERK, and p-elf2 alpha), compared to the Vehicle (Veh)-TAC group. TUDCA administration, for 4 weeks after TAC significantly reduced cardiac hypertrophy as shown by the reduced heart weight (HW) to BW ratio, and expression of hypertrophic marker genes (ANF, BNP, and alpha-SKA). Masson's trichrome staining showed that myocardial fibrosis and collagen deposition were also significantly reduced in the TUDCA-TAC group. We also found that TUDCA significantly decreased expression of TGF-beta signaling proteins and collagen isoforms. TUDCA administration also reduced cardiac apoptosis and the related proteins in the TUDCA-TAC group. Microarray analysis followed by gene ontology (GO) and pathway analysis demonstrated that extracellular matrix genes responsible for hypertrophy and fibrosis, and mitochondrial genes responsible for apoptosis and fatty acid metabolism were significantly altered in the Veh-TAC group, but the alterations were normalized in the TUDCA-TAC group, suggesting potential of TUDCA in treatment of heart diseases related to pressure-overload.	[Rani, Shilpa; Sreenivasaiah, Pradeep Kumar; Kim, Jin Ock; Lee, Mi Young; Park, Woo Jin; Cho, Chunghee; Kim, Do Han] GIST, Sch Life Sci, Gwangju, South Korea; [Kang, Wan Seok; Kim, Yong Sook; Ahn, Youngkeun] Chonnam Natl Univ Hosp, Dept Cardiol, Gwangju, South Korea	Gwangju Institute of Science & Technology (GIST); Chonnam National University; Chonnam National University Hospital	Kim, DH (corresponding author), GIST, Sch Life Sci, Gwangju, South Korea.	dhkim@gist.ac.kr		Kim, Jin Ock/0000-0002-5323-7808	GIST Research Institute (GRI) grant - GIST; NRF grant - Korean Ministry of Science, ICT & Future Planning [NRF-2013M3A9A7046297]	GIST Research Institute (GRI) grant - GIST; NRF grant - Korean Ministry of Science, ICT & Future Planning	This work was supported by GIST Research Institute (GRI) grant funded by GIST in 2017, and the NRF grant funded by the Korean Ministry of Science, ICT & Future Planning (NRF-2013M3A9A7046297).	Baek HA, 2012, AM J RESP CELL MOL, V46, P731, DOI 10.1165/rcmb.2011-0121OC; Mosbah I, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.29; Ceylan-Isik AF, 2011, J MOL CELL CARDIOL, V50, P107, DOI 10.1016/j.yjmcc.2010.10.023; Chen Y, 2008, AM J NEPHROL, V28, P1014, DOI 10.1159/000148209; Cowan KN, 1999, CIRC RES, V84, P1223, DOI 10.1161/01.RES.84.10.1223; de Almeida SF, 2007, J BIOL CHEM, V282, P27905, DOI 10.1074/jbc.M702672200; Ding W, 2016, CELL PHYSIOL BIOCHEM, V38, P141, DOI 10.1159/000438616; Dixon IMC, 1997, J MOL CELL CARDIOL, V29, P1837, DOI 10.1006/jmcc.1997.0420; Drack AV, 2012, INVEST OPHTH VIS SCI, V53, P100, DOI 10.1167/iovs.11-8544; Finckenberg P, 2003, AM J PATHOL, V163, P355, DOI 10.1016/S0002-9440(10)63659-0; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Fu HY, 2008, CARDIOVASC RES, V79, P600, DOI 10.1093/cvr/cvn128; Fu HY, 2010, CIRCULATION, V122, P361, DOI 10.1161/CIRCULATIONAHA.109.917914; Groenendyk J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159682; Groenendyk J, 2010, CIRC RES, V107, P1185, DOI 10.1161/CIRCRESAHA.110.227033; Hamada H, 2004, MOL CELL BIOL, V24, P8007, DOI 10.1128/MCB.24.18.8007-8017.2004; Hamid T, 2011, CARDIOVASC RES, V89, P129, DOI 10.1093/cvr/cvq274; He ZH, 2005, J BIOL CHEM, V280, P15719, DOI 10.1074/jbc.M413493200; Jeong D, 2006, CIRC RES, V99, P307, DOI 10.1161/01.RES.0000234780.06115.2c; KATZ AM, 1994, ANN INTERN MED, V121, P363, DOI 10.7326/0003-4819-121-5-199409010-00009; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Koitabashi N, 2011, J CLIN INVEST, V121, P2301, DOI 10.1172/JCI44824; Kuwahara F, 2002, CIRCULATION, V106, P130, DOI 10.1161/01.CIR.0000020689.12472.E0; Li YY, 2000, P NATL ACAD SCI USA, V97, P12746, DOI 10.1073/pnas.97.23.12746; Lo AC, 2013, NEUROBIOL DIS, V50, P21, DOI 10.1016/j.nbd.2012.09.003; Minamino T, 2010, CIRC RES, V107, P1071, DOI 10.1161/CIRCRESAHA.110.227819; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Nakajima H, 2000, CIRC RES, V86, P571, DOI 10.1161/01.RES.86.5.571; Narula J, 2000, CURR OPIN CARDIOL, V15, P183, DOI 10.1097/00001573-200005000-00011; Okada K, 2004, CIRCULATION, V110, P705, DOI 10.1161/01.CIR.0000137836.95625.D4; Papp E, 2006, HANDB EXP PHARM, V172, P405; Park CS, 2012, BIOCHEM BIOPH RES CO, V421, P578, DOI 10.1016/j.bbrc.2012.04.048; Polyakova V, 2004, J AM COLL CARDIOL, V44, P1609, DOI 10.1016/j.jacc.2004.07.023; Rivard AL, 2007, AM J CHINESE MED, V35, P279, DOI 10.1142/S0192415X07004813; Rosenkranz S, 2002, AM J PHYSIOL-HEART C, V283, pH1253, DOI 10.1152/ajpheart.00578.2001; Szabo Z, 2014, HYPERTENSION, V63, P1235, DOI 10.1161/HYPERTENSIONAHA.114.03279; Thomas CV, 1998, CIRCULATION, V97, P1708, DOI 10.1161/01.CIR.97.17.1708; Turdi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063615; Vettorazzi JF, 2016, METABOLISM, V65, P54, DOI 10.1016/j.metabol.2015.10.021; Yie Q, 2002, HEPATOLOGY, V36, P592, DOI 10.1053/jhep.2002.35441; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Zhou LY, 2013, INT J CARDIOL, V167, P1118, DOI 10.1016/j.ijcard.2012.09.082	42	36	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176071	10.1371/journal.pone.0176071	http://dx.doi.org/10.1371/journal.pone.0176071			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426781	Green Published, Green Submitted, gold			2022-12-26	WOS:000399875900097
J	Saarinen, L; Nummela, P; Thiel, A; Lehtonen, R; Jarvinen, P; Jarvinen, H; Aaltonen, LA; Lepisto, A; Hautaniemi, S; Ristimaki, A				Saarinen, Lilli; Nummela, Pirjo; Thiel, Alexandra; Lehtonen, Rainer; Jarvinen, Petrus; Jarvinen, Heikki; Aaltonen, Lauri A.; Lepisto, Anna; Hautaniemi, Sampsa; Ristimaki, Ari			Multiple components of PKA and TGF-beta pathways are mutated in pseudomyxoma peritonei	PLOS ONE			English	Article							APPENDICEAL MUCINOUS NEOPLASMS; PROTEIN-KINASE; SOMATIC MUTATIONS; CARNEY COMPLEX; HUMAN CANCER; SEQUENCE; ORIGIN; IDENTIFICATION; GENOME; GRADE	Pseudomyxoma peritonei (PMP) is a subtype of mucinous adenocarcinoma mainly restricted to the peritoneal cavity and most commonly originating from the appendix. The genetic background of PMP is poorly understood and no targeted treatments are currently available for this fatal disease. While RAS signaling pathway is affected in most if not all PMP cases and over half of them also have a mutation in the GNAS gene, other genetic alterations and affected pathways are, to a large degree, poorly known. In this study, we sequenced whole coding genome of nine PMP tumors and paired normal tissues in order to identify additional, commonly mutated genes and signaling pathways affected in PMP. These exome sequencing results were validated with an ultra-deep amplicon sequencing method, leading to 14 validated variants. The validated results contain seven genes that contribute to the protein kinase A (PKA) pathway. PKA pathway, which also contains GNAS, is a major player of overproduction of mucin, which is the characteristic feature of PMP. In addition to PKA pathway, we identified mutations in six genes that belong to the transforming growth factor beta (TGF-beta) pathway, which is a key regulator of cell proliferation. Since either GNAS mutation or an alternative mutation in the PKA pathway was identified in 8/9 patients, inhibition of the PKA pathway might reduce mucin production in most of the PMP patients and potentially suppress disease progression.	[Saarinen, Lilli; Nummela, Pirjo; Thiel, Alexandra; Lehtonen, Rainer; Aaltonen, Lauri A.; Hautaniemi, Sampsa; Ristimaki, Ari] Univ Helsinki, Genome Scale Biol Res Program, Res Programs Unit, Helsinki, Finland; [Jarvinen, Petrus; Jarvinen, Heikki; Lepisto, Anna] Helsinki Univ Hosp, Dept Surg, Helsinki, Finland; [Jarvinen, Petrus] Helsinki Univ Hosp, Dept Urol, Helsinki, Finland; [Aaltonen, Lauri A.] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Ristimaki, Ari] Helsinki Univ Hosp, HUSLAB, Dept Pathol, Helsinki, Finland; [Ristimaki, Ari] Univ Helsinki, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Ristimaki, A (corresponding author), Univ Helsinki, Genome Scale Biol Res Program, Res Programs Unit, Helsinki, Finland.; Ristimaki, A (corresponding author), Helsinki Univ Hosp, HUSLAB, Dept Pathol, Helsinki, Finland.; Ristimaki, A (corresponding author), Univ Helsinki, Helsinki, Finland.	ari.ristimaki@helsinki.fi	Aaltonen, Lauri/A-5375-2010; Hautaniemi, Sampsa/A-3122-2009; Hautaniemi, Sampsa/CAG-0362-2022	Aaltonen, Lauri/0000-0001-6839-4286; Hautaniemi, Sampsa/0000-0002-7749-2694; Hautaniemi, Sampsa/0000-0002-7749-2694; Lehtonen, Rainer Juhani/0000-0002-8343-0318; Ristimaki, Ari/0000-0002-5373-9234; Jarvinen, Petrus/0000-0002-3751-4609; Lepisto, Anna Henriikka/0000-0002-5866-4059	University of Helsinki; Sigrid Juselius Foundation; Finnish Cancer Organizations; Helsinki University Central Hospital Research Funds; Academy of Finland (Center of Excellence in Cancer Genetics Research); Ida Montin Foundation; Cancer Society of Finland; Orion Research Foundation; K. Albin Johansson Foundation; Cancer Foundation Finland sr [150127] Funding Source: researchfish	University of Helsinki; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cancer Organizations; Helsinki University Central Hospital Research Funds; Academy of Finland (Center of Excellence in Cancer Genetics Research); Ida Montin Foundation; Cancer Society of Finland; Orion Research Foundation; K. Albin Johansson Foundation; Cancer Foundation Finland sr	This study was supported by University of Helsinki, Sigrid Juselius Foundation, the Finnish Cancer Organizations, Helsinki University Central Hospital Research Funds, the Academy of Finland (Center of Excellence in Cancer Genetics Research), Ida Montin Foundation (LS), Cancer Society of Finland (LS), Orion Research Foundation (LS), and K. Albin Johansson Foundation (LS). The funding sources had no involvement in planning, execution, or reporting of this research.	Alakus H, 2014, GENOME MED, V6, DOI 10.1186/gm559; Amini A, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-71; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bradbury NA, 2000, J CELL PHYSIOL, V185, P408, DOI 10.1002/1097-4652(200012)185:3<408::AID-JCP11>3.0.CO;2-2; Brodin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070388; Carr NJ, 2010, WHO CLASSIFICATION T, P122; Carr NJ, 2012, J CLIN PATHOL, V65, P919, DOI 10.1136/jclinpath-2012-200843; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Davison JM, 2014, MODERN PATHOL, V27, P1521, DOI 10.1038/modpathol.2014.37; Fassunke J, 2015, INT J MOL MED, V36, P1233, DOI 10.3892/ijmm.2015.2339; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gaujoux S, 2011, J CLIN ENDOCR METAB, V96, pE1888, DOI 10.1210/jc.2011-1433; Helleday T, 2014, NAT REV GENET, V15, P585, DOI 10.1038/nrg3729; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jarvinen P, 2013, SCAND J SURG, V102, P145, DOI 10.1177/1457496913490463; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu X, 2014, CLIN CHEM, V60, P1004, DOI 10.1373/clinchem.2014.225565; Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MURPHYULLRICH JE, 1992, MOL BIOL CELL, V3, P181, DOI 10.1091/mbc.3.2.181; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nishikawa G, 2013, BRIT J CANCER, V108, P951, DOI 10.1038/bjc.2013.47; Noguchi R, 2015, CANCER MED-US, V4, P1809, DOI 10.1002/cam4.542; Nummela P, 2015, INT J CANCER, V136, pE282, DOI 10.1002/ijc.29245; O'Connell JT, 2002, MODERN PATHOL, V15, P958, DOI 10.1097/01.MP.0000026617.52466.9F; ONO M, 1988, J BIOL CHEM, V263, P5884; Ovaska K, 2010, GENOME MED, V2, DOI 10.1186/gm186; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Qiu WL, 2016, GASTROENTEROLOGY, V150, P218, DOI 10.1053/j.gastro.2015.09.013; Rhayem Y, 2015, J BIOL CHEM, V290, P27816, DOI 10.1074/jbc.M115.656553; Robinson-White A, 2003, HUM MOL GENET, V12, P1475, DOI 10.1093/hmg/ddg160; Saharinen J, 2000, MOL BIOL CELL, V11, P2691, DOI 10.1091/mbc.11.8.2691; Shen Y, 2001, P NATL ACAD SCI USA, V98, P13613, DOI 10.1073/pnas.231499098; Shetty S, 2013, J SURG RES, V180, P97, DOI 10.1016/j.jss.2012.10.053; Sio TT, 2014, J HUM GENET, V59, P124, DOI 10.1038/jhg.2013.132; Smeenk RM, 2008, EJSO-EUR J SURG ONC, V34, P196, DOI 10.1016/j.ejso.2007.04.002; SUGARBAKER PH, 1987, DIS COLON RECTUM, V30, P772, DOI 10.1007/BF02554625; Szych C, 1999, AM J PATHOL, V154, P1849, DOI 10.1016/S0002-9440(10)65442-9; Thiel A, 2015, HUM PATHOL, V46, P169, DOI 10.1016/j.humpath.2014.08.018; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Trobridge P, 2009, GASTROENTEROLOGY, V136, P1680, DOI 10.1053/j.gastro.2009.01.066; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wang SS, 1998, SCIENCE, V282, P284, DOI 10.1126/science.282.5387.284; Wong SQ, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-23; Yang H, 2015, NAT PROTOC, V10, P1556, DOI 10.1038/nprot.2015.105; Yost SE, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks299	54	12	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0174898	10.1371/journal.pone.0174898	http://dx.doi.org/10.1371/journal.pone.0174898			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426742	Green Published, gold, Green Submitted			2022-12-26	WOS:000399875900013
J	Talmage, GD; Coppes, OJM; Javed, A; Bernard, J				Talmage, Garrick D.; Coppes, Oscar J. M.; Javed, Adil; Bernard, Jacqueline			Natalizumab stabilizes physical, cognitive, MRI, and OCT markers of disease activity: A prospective, non-randomized pilot study	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; MULTIPLE-SCLEROSIS; BRAIN ATROPHY; IMPAIRMENT; DISABILITY; DYSFUNCTION; OUTCOMES; IMPACT; RISK	Natalizumab is an effective therapy for multiple sclerosis (MS). Its effectiveness has been demonstrated in several clinical and imaging studies. The objective of this study was to further demonstrate the efficacy of natalizumab using a comprehensive battery of clinical and imaging markers in the same cohort of patients followed longitudinally, hence capturing the multi-faceted nature of the MS disease process. A prospective, open-label, pilot study of 20 MS patients treated with natalizumab was conducted. High resolution MRI, Symbol-Digit Modalities Test (SDMT), and Optical Coherence Tomography (OCT) scans were obtained at baseline, 48, and 96 weeks. 15 patients completed the study. Natalizumab treatment decreased Expanded Disability Status Scale score (EDSS) and no change in SDMT, Brain Parenchymal Fraction (BPF), or any of the OCT markers of retinal degeneration was observed. Thalamic and whole brain volume as assessed by Percentage Brain Volume Change (PBVC) showed continuous deterioration. Higher baseline T2 lesion load correlated with increased rate of PBVC at 96-weeks (r = 0.566, R-2 = 0.320, p = 0.035) and thalamic volume loss (r = -0.586, R-2 = 0.344, p = 0.027). Most patients, 93%, achieved no evidence of disease activity (NEDA) at 2 years, likely due to early disease duration and lower initial baseline lesion load. This study further demonstrates stabilization of clinical and imaging markers of disease activity during natalizumab treatment.	[Talmage, Garrick D.; Coppes, Oscar J. M.; Javed, Adil; Bernard, Jacqueline] Univ Colorado, Dept Ear Nose & Throat, Aurora, CO 80045 USA; [Bernard, Jacqueline] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Oregon Health & Science University	Bernard, J (corresponding author), Univ Colorado, Dept Ear Nose & Throat, Aurora, CO 80045 USA.; Bernard, J (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA.	jtbernard06@comcast.net			Biogen; Idec [US-TYS-09-10019]; Calvin Fentress Senior Research Fellowship at the University of Chicago; NIH [NIH CTSA UL1 TR000430]	Biogen(Biogen); Idec; Calvin Fentress Senior Research Fellowship at the University of Chicago; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	JB received funding from Biogen, Idec (http://www.biogen.com) under grant number US-TYS-09-10019. GT received funding from the Calvin Fentress Senior Research Fellowship at the University of Chicago (https://pritzker.uchicago. edu/). Data duration was performed using RED Cap at the University of Chicago, which was funded by the NIH (http://www.ncats.nih.gov/ctsa) under grant number NIH CTSA UL1 TR000430. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alroughani R, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0762-5; Baroncini D, 2016, MULT SCLER J, V22, P1315, DOI 10.1177/1352458516650736; Batista S, 2012, J NEUROL, V259, P139, DOI 10.1007/s00415-011-6147-1; Battaglini M, 2012, HUM BRAIN MAPP, V33, P2062, DOI 10.1002/hbm.21344; Bloomgren G, 2012, NEW ENGL J MED, V366, P1870, DOI 10.1056/NEJMoa1107829; Ciampi E, 2016, MULT SCLER IN PRESS; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Coyle PK, 2009, MULT SCLER J, V15, pS26, DOI 10.1177/1352458509347131; Matta APD, 2016, EXPERT REV NEUROTHER, V16, P1279, DOI 10.1080/14737175.2016.1202763; Dupuy SL, 2015, EUR J RADIOL, V84, P1564, DOI 10.1016/j.ejrad.2015.05.004; Erlanger DM, 2014, J NEUROL SCI, V340, P123, DOI 10.1016/j.jns.2014.03.009; Fan Q, 2011, INVEST OPHTH VIS SCI, V52, P6059, DOI 10.1167/iovs.10-7108; Gunnarsson M, 2011, ANN NEUROL, V69, P83, DOI 10.1002/ana.22247; Jeffery DR, 2013, THER ADV CHRONIC DIS, V4, P45, DOI 10.1177/2040622312466279; Kunkel A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00097; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lublin FD, 2014, MULT SCLER RELAT DIS, V3, P705, DOI 10.1016/j.msard.2014.08.005; Miller DH, 2007, NEUROLOGY, V68, P1390, DOI 10.1212/01.wnl.0000260064.77700.fd; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Plavina T, 2014, ANN NEUROL, V76, P802, DOI 10.1002/ana.24286; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Popescu V, 2013, J NEUROL NEUROSUR PS, V84, P1082, DOI 10.1136/jnnp-2012-304094; Radue EW, 2010, J NEUROL SCI, V292, P28, DOI 10.1016/j.jns.2010.02.012; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; RAO SM, 1991, NEUROLOGY, V41, P692, DOI 10.1212/WNL.41.5.692; Sepulcre J, 2006, MULT SCLER J, V12, P187, DOI 10.1191/1352458506ms1258oa; Shiee N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037049; Smith A, 1973, W PSYCHOL SERVICES F; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Steckova T, 2014, J NEUROL SCI, V342, P62, DOI 10.1016/j.jns.2014.04.026; Toledo J, 2008, MULT SCLER J, V14, P906, DOI 10.1177/1352458508090221; Vollmer T, 2016, NEUROL SCI, V37, P165, DOI 10.1007/s10072-015-2400-1; Yu HJ, 2012, NEUROIMAGE, V59, P3713, DOI 10.1016/j.neuroimage.2011.10.053; Ziemssen T, 2016, J NEUROL, V263, P1053, DOI 10.1007/s00415-015-7986-y; Zivadinov R, 2016, EUR J NEUROL, V23, P1101, DOI 10.1111/ene.12992	37	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0173299	10.1371/journal.pone.0173299	http://dx.doi.org/10.1371/journal.pone.0173299			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426702	Green Submitted, Green Published, gold			2022-12-26	WOS:000399875900004
J	Roux, A; Loranger, A; Lavoie, JN; Marceau, N				Roux, Alexandra; Loranger, Anne; Lavoie, Josee N.; Marceau, Normand			Keratin 8/18 regulation of insulin receptor signaling and trafficking in hepatocytes through a concerted phosphoinositide-dependent Akt and Rab5 modulation	FASEB JOURNAL			English	Article						intermediate filament; PIP signaling; PI3K; endosomes; microtubules	INTERMEDIATE-FILAMENTS; MEMBRANE-TRANSPORT; GLUCOSE-METABOLISM; EARLY ENDOSOME; PHOSPHORYLATION; ACTIVATION; IMPACT; CELLS; CYTOSKELETAL; ORGANIZATION	Keratins (Ks) are epithelial cell intermediate filament (IF) proteins that are expressed as pairs in a differentiation-regulated manner. Hepatocyte IFs are made only of K8/K18 pairs, which means that a K8 loss in K8-null mice leads to degradation of K18. Functionally, there is accumulating evidence that IFs contribute to signaling platforms. Here, we investigate the role of K8/K18 IFs in the regulation of insulin receptor (IR) signaling and trafficking in hepatocytes. We find that the IR substrate 1 (IRS1)/PI3K/Akt signaling cascade-downstream of IR-displays prolonged activation in K8-null compared with wild-type hepatocytes. Assessment of the Akt/mammalian target of rapamycin complex 1-mediated feedback loop to IRS1/PI3K, in the absence or presence of drug inhibitors, further supports a preferential K8/K18 IF intervention at the surface membrane. In K8-null hepatocytes, IR trafficking vesicles that are labeled by Rab5/EEA1/phosphatidylinositol 3-phosphate accumulate at a juxtanuclear region via a microtubule-dependent process. Moreover, interference with phosphatidylinositol 4,5-biphosphate signaling aggravates IR/Rab5 accumulation. Overall, results uncover K8/K18 IF regulation of IR signaling via a concerted modulation of phosphatidylinositol 4,5-biphosphate-dependent IRS1/PI3K/Akt signaling and Rab5/phosphatidylinositol 3-phosphate/microtubule trafficking in hepatocytes.	Univ Laval, Ctr Rech Canc, Quebec City, PQ, Canada; Univ Laval, Ctr Hosp Univ Quebec, Ctr Rech, Hotel Dieu Quebec, Quebec City, PQ, Canada	Laval University; Laval University	Marceau, N (corresponding author), CHU Quebec, Ctr Rech, 9 McMahon, Quebec City, PQ G1R 2J6, Canada.	normand.marceau@crchudequebec.ulaval.ca		Lavoie, Josee N/0000-0001-6912-1132	Canadian Institutes of Health Research [MOP 15529]; Fondation du Centre Hospitalier Universitaire de Quebec-Universite Laval Grant [2698]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fondation du Centre Hospitalier Universitaire de Quebec-Universite Laval Grant	This work was supported by the Canadian Institutes of Health Research (Grant MOP 15529; to N.M.), and the Fondation du Centre Hospitalier Universitaire de Quebec-Universite Laval (Grant 2698; to N.M.). The authors thank H. Baribault (Surrozen Biotechnology, San Francisco, CA, USA) for the original WT and K8-null mouse colonies, and J. Huot and S. Gilbert [both from Centre de Recherche du Centre Hospitalier Universitaire (CRCHU) de Quebec-Universite Laval] for critical reading of the manuscript. The authors declare no conflicts of interest.	Alam CM, 2013, J CELL SCI, V126, P5635, DOI 10.1242/jcs.132795; Balbis A, 2004, J BIOL CHEM, V279, P39348, DOI 10.1074/jbc.M404280200; Betz C, 2013, J CELL BIOL, V203, P563, DOI 10.1083/jcb.201306041; Betz C, 2013, P NATL ACAD SCI USA, V110, P12526, DOI 10.1073/pnas.1302455110; Bordeleau F, 2010, MOL BIOL CELL, V21, P1698, DOI 10.1091/mbc.E09-05-0373; Braunger JA, 2014, J BIOL CHEM, V289, P9833, DOI 10.1074/jbc.M113.530659; Bruckner BR, 2015, SCI REP-UK, V5, DOI 10.1038/srep14700; Chen XM, 2001, EMBO REP, V2, P842, DOI 10.1093/embo-reports/kve179; Chen XM, 2001, EMBO REP, V2, P68, DOI 10.1093/embo-reports/kve005; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; de Lartigue J, 2009, TRAFFIC, V10, P883, DOI 10.1111/j.1600-0854.2009.00915.x; Desbuquois Bernard, 2014, Biologie Aujourd hui, V208, P137, DOI 10.1051/jbio/2014016; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Eriksson JE, 2009, J CLIN INVEST, V119, P1763, DOI 10.1172/JCI38339; Foti M, 2004, NOVART FDN SYMP, V262; Foti M, 2004, NOVART FDN SYMP, V262, P265; Foti Michelangelo, 2004, Novartis Found Symp, V262, P125; Gao XX, 2011, P NATL ACAD SCI USA, V108, P14509, DOI 10.1073/pnas.1019386108; Gilbert S, 2008, APOPTOSIS, V13, P1479, DOI 10.1007/s10495-008-0274-x; Gilbert S, 2016, J CELL SCI, V129, P3262, DOI 10.1242/jcs.171124; Gilbert S, 2012, APOPTOSIS, V17, P880, DOI 10.1007/s10495-012-0733-2; He T, 2002, J BIOL CHEM, V277, P10767, DOI 10.1074/jbc.M111436200; Hirosako K, 2004, BIOCHEM BIOPH RES CO, V316, P845, DOI 10.1016/j.bbrc.2004.02.119; Hoepfner S, 2005, CELL, V121, P437, DOI 10.1016/j.cell.2005.02.017; Holthuis JCM, 2003, MOL MEMBR BIOL, V20, P231, DOI 10.1080/0988768031000100768; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Hunker CM, 2006, ARCH BIOCHEM BIOPHYS, V449, P130, DOI 10.1016/j.abb.2006.01.020; Hunt SD, 2011, BIOCHEM SOC T, V39, P1179, DOI 10.1042/BST0391179; Ikonomov OC, 2006, AM J PHYSIOL-CELL PH, V291, pC393, DOI 10.1152/ajpcell.00019.2006; Jean S, 2012, NAT REV MOL CELL BIO, V13, P463, DOI 10.1038/nrm3379; Jozic Ivan, 2011, Curr Cell Biochem, V1, P20; Kido Y, 2000, DIABETES, V49, P589, DOI 10.2337/diabetes.49.4.589; Klopfenstein DR, 2002, CELL, V109, P347, DOI 10.1016/S0092-8674(02)00708-0; Ku NO, 2006, J CELL BIOL, V174, P115, DOI 10.1083/jcb.200602146; Ku NO, 2010, NAT CELL BIOL, V12, P876, DOI 10.1038/ncb2091; Ku NO, 1997, J BIOL CHEM, V272, P7556, DOI 10.1074/jbc.272.11.7556; Ku NO, 2004, J CELL BIOL, V166, P479, DOI 10.1083/jcb.200402051; Laketa V, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004532; Lasserre R, 2008, NAT CHEM BIOL, V4, P538, DOI 10.1038/nchembio.103; Lawe DC, 2002, J BIOL CHEM, V277, P8611, DOI 10.1074/jbc.M109239200; Loranger A, 1997, AM J PATHOL, V151, P1673; Loranger A, 2006, EXP CELL RES, V312, P4108, DOI 10.1016/j.yexcr.2006.09.031; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Marceau N, 2004, METHOD CELL BIOL, V78, P95; Marceau N, 2001, BIOCHEM CELL BIOL, V79, P543, DOI 10.1139/bcb-79-5-543; Marceau N., 2014, INTERMEDIATE FILAMEN; Mathew J, 2008, FREE RADICAL BIO MED, V45, P413, DOI 10.1016/j.freeradbiomed.2008.04.031; Mathew J, 2013, EXP CELL RES, V319, P474, DOI 10.1016/j.yexcr.2012.11.011; McNamara CR, 2011, FUTURE MED CHEM, V3, P549, DOI [10.4155/fmc.11.12, 10.4155/FMC.11.12]; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; Omary MB, 2009, J CLIN INVEST, V119, P1794, DOI 10.1172/JCI37762; Omary MB, 2009, J CLIN INVEST, V119, P1756, DOI 10.1172/JCI39894; OMARY MB, 1992, J CELL BIOL, V117, P583, DOI 10.1083/jcb.117.3.583; Picas Laura, 2016, F1000Res, V5, DOI 10.12688/f1000research.7537.1; Posor Y, 2015, BBA-MOL CELL BIOL L, V1851, P794, DOI 10.1016/j.bbalip.2014.09.014; Preta G, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0102-1; Ricoult SJH, 2013, EMBO REP, V14, P242, DOI 10.1038/embor.2013.5; Roux A, 2016, FASEB J, V30, P491, DOI 10.1096/fj.15-277905; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; Siddle K, 2011, J MOL ENDOCRINOL, V47, pR1, DOI 10.1530/JME-11-0022; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Skjeldal FM, 2012, J CELL SCI, V125, P1910, DOI 10.1242/jcs.092569; Su X, 2006, J BIOL CHEM, V281, P27982, DOI 10.1074/jbc.M602873200; Toivola DM, 2015, CURR OPIN CELL BIOL, V32, P73, DOI 10.1016/j.ceb.2014.12.008; Toivola DM, 2001, HEPATOLOGY, V34, P1174, DOI 10.1053/jhep.2001.29374; Vainio S, 2002, EMBO REP, V3, P95, DOI 10.1093/embo-reports/kvf010; Virkamaki A, 1999, J CLIN INVEST, V103, P931, DOI 10.1172/JCI6609; Zajac AL, 2013, CURR BIOL, V23, P1173, DOI 10.1016/j.cub.2013.05.015	71	6	6	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3555	3573		10.1096/fj.201700036R	http://dx.doi.org/10.1096/fj.201700036R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28442548				2022-12-26	WOS:000405932400030
J	Clark, S; Petersen, JE; Frantz, CM; Roose, D; Ginn, J; Daneri, DR				Clark, Shane; Petersen, John E.; Frantz, Cindy M.; Roose, Deborah; Ginn, Joel; Daneri, Daniel Rosenberg			Teaching systems thinking to 4th and 5th graders using Environmental Dashboard display technology	PLOS ONE			English	Article							CONTEXT; SCHOOL; SKILLS	Tackling complex environmental challenges requires the capacity to understand how relationships and interactions between parts result in dynamic behavior of whole systems. There has been convincing research that these "systems thinking" skills can be learned. However, there is little research on methods for teaching these skills to children or assessing their impact. The Environmental Dashboard is a technology that uses "sociotechnical" feedback-information feedback designed to affect thought and behavior. Environmental Dashboard (ED) combines real-time information on community resource use with images and words that reflect pro-environmental actions of community members. Prior research indicates that ED supports the development of systems thinking in adults. To assess its impact on children, the technology was installed in a primary school and children were passively exposed to ED displays. This resulted in no measurable impact on systems thinking skills. The next stage of this research examined the impact of actively integrating ED into lessons on electricity in 4th and 5th grade. This active integration enhanced both content-related systems thinking skills and content retention.	[Clark, Shane; Petersen, John E.] Oberlin Coll, Environm Studies Program, Adam Joseph Lewis Ctr, Oberlin, OH 44074 USA; [Frantz, Cindy M.; Ginn, Joel] Oberlin Coll, Dept Psychol, Severance Lab, Oberlin, OH 44074 USA; [Roose, Deborah] Oberlin Coll, Educ, AJLC Annex, Oberlin, OH 44074 USA; [Daneri, Daniel Rosenberg] Cornell Univ, Dept Nat Resources, Fernow Hall, Ithaca, NY 14853 USA	Oberlin College; Oberlin College; Oberlin College; Cornell University	Petersen, JE (corresponding author), Oberlin Coll, Environm Studies Program, Adam Joseph Lewis Ctr, Oberlin, OH 44074 USA.	john.petersen@oberlin.edu	Petersen, John/H-3820-2013	Petersen, John/0000-0002-6907-8418	Great Lakes Protection Fund [901]; Ohio Environmental Education Fund [F14G-009]; Divn Of Social and Economic Sciences [1534479] Funding Source: National Science Foundation	Great Lakes Protection Fund; Ohio Environmental Education Fund; Divn Of Social and Economic Sciences(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This work was supported by the Great Lakes Protection Fund under grant #901; and The Ohio Environmental Education Fund under grant #F14G-009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assaraf OBZ, 2005, J RES SCI TEACH, V42, P518, DOI 10.1002/tea.20061; Bouillion LM, 2001, J RES SCI TEACH, V38, P878, DOI 10.1002/tea.1037.abs; Checkland P., 1981, SYSTEMS THINKING SYS; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cushing D.F., 2007, ENV ED RES, DOI [10.1080/13504620701581539, DOI 10.1080/13504620701581539]; Damerell P, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/015016; Fazey I, 2010, ECOL SOC, V15; Hipkins R, 2008, J BIOL EDUC, V42, P73, DOI 10.1080/00219266.2008.9656114; Hung W, 2008, BRIT J EDUC TECHNOL, V39, P1099, DOI 10.1111/j.1467-8535.2007.00791.x; Hursh D, 2013, J EDUC POLICY, V28, P574, DOI 10.1080/02680939.2012.758829; IBO, 2009, CURR FRAM INT PRIM E; Maddux WW, 2006, PERS SOC PSYCHOL B, V32, P669, DOI 10.1177/0146167205283840; Mayer FS, 2004, J ENVIRON PSYCHOL, V24, P503, DOI 10.1016/j.jenvp.2004.10.001; Meijers F, 2016, RESOURCES-BASEL, V5, DOI 10.3390/resources5010011; Nichols SL, 2008, PHI DELTA KAPPAN, V89, P672, DOI 10.1177/003172170808900913; Petersen JE, 2014, SOLUTIONS, V5, P79; Petersen JE, 2017, HDB THEORY PRACTICE; Rutherford J., 1990, SCI ALL AM; Sauve L., 2005, CAN J ENVIRON EDUC, V10, P11; Short PC, 2009, J ENVIRON EDUC, V41, P7, DOI 10.1080/00958960903206781; SONGER NB, 1991, J RES SCI TEACH, V28, P761, DOI 10.1002/tea.3660280905; Spring J., 2015, AM ED; Sterling S., 2014, ED SUSTAINABILITY, DOI 10.4324/9781315070650; Thibodeau PH, 2016, SYST RES BEHAV SCI, V33, P753, DOI 10.1002/sres.2388; Tidball K. G., 2010, CITIES ENV, V3, P20; Wang MJ, 2006, ENGAGED LEARNING WITH EMERGING TECHNOLOGIES, P225, DOI 10.1007/1-4020-3669-8_11; Weiss RP, 2000, TRAINING DEV, V54, P44	27	7	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176322	10.1371/journal.pone.0176322	http://dx.doi.org/10.1371/journal.pone.0176322			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET6EL	28448586	gold, Green Published, Green Submitted			2022-12-26	WOS:000400383600059
J	Famiglietti, AL; Wei, Z; Beres, TM; Milac, AL; Tran, DT; Patel, D; Angerer, RC; Angerer, LM; Tabak, LA				Famiglietti, Amber L.; Wei, Zheng; Beres, Thomas M.; Milac, Adina L.; Tran, Duy T.; Patel, Divya; Angerer, Robert C.; Angerer, Lynne M.; Tabak, Lawrence A.			Characterization and expression analysis of Galnts in developing Strongylocentrotus purpuratus embryos	PLOS ONE			English	Article							SEA-URCHIN EMBRYOS; O-GLYCOSYLATION; UDP-GALNAC; N-ACETYLGALACTOSAMINYLTRANSFERASE; LECTIN DOMAINS; LINKED GLYCOPROTEINS; GENE FAMILY; SEQUENCE; HYBRIDIZATION; ALGORITHMS	Mucin-type O-glycosylation is a ubiquitous posttranslational modification in which N-Acetylgalactosamine (GalNAc) is added to the hydroxyl group of select serine or threonine residues of a protein by the family of UDP-GalNAc: Polypeptide N-Acetylgalactosaminyltransferases (GalNAc-Ts; EC 2.4.1.41). Previous studies demonstrate that O-glycosylation plays essential roles in protein function, cell-cell interactions, cell polarity and differentiation in developing mouse and Drosophila embryos. Although this type of protein modification is highly conserved among higher eukaryotes, little is known about this family of enzymes in echinoderms, basal deuterostome relatives of the chordates. To investigate the potential role of GalNAc-Ts in echinoderms, we have begun the characterization of this enzyme family in the purple sea urchin, S. purpuratus. We have fully or partially cloned a total of 13 genes (SpGalnts) encoding putative sea urchin SpGalNAc-Ts, and have confirmed enzymatic activity of five recombinant proteins. Amino acid alignments revealed high sequence similarity among sea urchin and mammalian glycosyltransferases, suggesting the presence of putative orthologues. Structural models underscored these similarities and helped reconcile some of the substrate preferences observed. Temporal and spatial expression of SpGalnt transcripts, was studied by whole-mount in situ hybridization. We found that many of these genes are transcribed early in developing embryos, often with restricted expression to the endomesodermal region. Multicolor fluorescent in situ hybridization (FISH) demonstrated that transcripts encoding SpGalnt7-2 co-localized with both Endo16 (a gene expressed in the endoderm), and Gcm (a gene expressed in secondary mesenchyme cells) at the early blastula stage, 20 hours post fertilization (hpf). At late blastula stage (28 hpf), SpGalnt7-2 message co-expresses with Gcm, suggesting that it may play a role in secondary mesenchyme development. We also discovered that morpholino-mediated knockdown of SpGalnt13 transcripts, results in a deficiency of embryonic skeleton and neurons, suggesting that mucin-type O-glycans play essential roles during embryonic development in S. purpuratus.	[Famiglietti, Amber L.; Beres, Thomas M.; Tran, Duy T.; Patel, Divya; Tabak, Lawrence A.] Natl Inst Dent & Craniofacial Res, Sect Biol Chem, NIH, Bethesda, MD 20892 USA; [Wei, Zheng; Angerer, Robert C.; Angerer, Lynne M.] Natl Inst Dent & Craniofacial Res, Dev Mech Sect, NIH, Bethesda, MD USA; [Milac, Adina L.] Romanian Acad, Inst Biochem, Dept Bioinformat & Struct Biochem, Splaiul Independentei 296, Bucharest, Romania	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Romanian Academy of Sciences; Institute of Biochemistry, Bucharest	Tabak, LA (corresponding author), Natl Inst Dent & Craniofacial Res, Sect Biol Chem, NIH, Bethesda, MD 20892 USA.	Lawrence.Tabak@nih.gov	Milac, Adina/C-1070-2011	Milac, Adina/0000-0003-1845-4281; Tabak, Lawrence/0000-0002-4261-7856	Intramural Research Program of the National Institutes of Health, NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000739, ZIADE000712] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Intramural Research Program of the National Institutes of Health, NIDCR.	ALBONE EF, 1994, J BIOL CHEM, V269, P16845; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Cameron RA, 2009, NUCLEIC ACIDS RES, V37, pD750, DOI 10.1093/nar/gkn887; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Criscuolo A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-166; DUPERAT VG, 1995, BIOCHEM J, V305, P211, DOI 10.1042/bj3050211; Eargle J, 2006, BIOINFORMATICS, V22, P504, DOI 10.1093/bioinformatics/bti825; Ettensohn CA, 1997, MORPHOGENESIS SKELET; Fritz TA, 2006, J BIOL CHEM, V281, P8613, DOI 10.1074/jbc.M513590200; Garcia-Boronat M, 2008, NUCLEIC ACIDS RES, V36, pW35, DOI 10.1093/nar/gkn211; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gerken TA, 2006, J BIOL CHEM, V281, P32403, DOI 10.1074/jbc.M605149200; Gerken TA, 2013, J BIOL CHEM, V288, P19900, DOI 10.1074/jbc.M113.477877; Gerken TA, 2011, J BIOL CHEM, V286, P14493, DOI 10.1074/jbc.M111.218701; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hagen FK, 1997, J BIOL CHEM, V272, P13843, DOI 10.1074/jbc.272.21.13843; HEIFETZ A, 1979, J BIOL CHEM, V254, P6119; Hirohashi N, 2001, DEV GROWTH DIFFER, V43, P247, DOI 10.1046/j.1440-169x.2001.00571.x; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jain G, 2016, BIOCHEMISTRY; Killian CE, 2010, GENE EXPR PATTERNS, V10, P135, DOI 10.1016/j.gep.2010.01.002; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LAU JTY, 1983, P NATL ACAD SCI-BIOL, V80, P1028, DOI 10.1073/pnas.80.4.1028; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lira-Navarrete E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7937; Logan CY, 1999, CELL LINEAGE DETERMI; Lord E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029903; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Minokawa T, 2004, GENE EXPR PATTERNS, V4, P449, DOI 10.1016/j.modgep.2004.01.009; Raman J, 2008, J BIOL CHEM, V283, P22942, DOI 10.1074/jbc.M803387200; Ransick A, 2002, DEV BIOL, V246, P132, DOI 10.1006/dbio.2002.0607; RANSICK A, 1993, MECH DEVELOP, V42, P117, DOI 10.1016/0925-4773(93)90001-E; Roberts E, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-382; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHNEIDER EG, 1978, J BIOL CHEM, V253, P2348; Sethi AJ, 2014, METHODS MOL BIOL, V1128, P249, DOI 10.1007/978-1-62703-974-1_17; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Staudacher E, 2015, MOLECULES, V20, P10622, DOI 10.3390/molecules200610622; Ten Hagen KG, 2003, J BIOL CHEM, V278, P35039, DOI 10.1074/jbc.M303836200; Tian E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115861; Tian E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1874; Topaz O, 2004, NAT GENET, V36, P579, DOI 10.1038/ng1358; Tran DT, 2013, J BIOL CHEM, V288, P6921, DOI 10.1074/jbc.R112.418558; Tu Q, 2014, DEV BIOL, V385, P160, DOI 10.1016/j.ydbio.2013.11.019; UniProt C, 2015, NUCL ACIDS RES, V43; Vacquier VD, 2012, BIOCHEM BIOPH RES CO, V425, P583, DOI 10.1016/j.bbrc.2012.07.132; Wei Z, 2009, DEVELOPMENT, V136, P1179, DOI 10.1242/dev.032300; WELPLY JK, 1985, DEV BIOL, V107, P252, DOI 10.1016/0012-1606(85)90393-8; Xia LJ, 2004, J CELL BIOL, V164, P451, DOI 10.1083/jcb.200311112; Zhang LP, 2014, P NATL ACAD SCI USA, V111, P7296, DOI 10.1073/pnas.1322264111	54	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176479	10.1371/journal.pone.0176479	http://dx.doi.org/10.1371/journal.pone.0176479			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448610	gold, Green Published, Green Submitted			2022-12-26	WOS:000400383600086
J	Lazaro, B; Villa, JA; Santin, O; Cabezas, M; Milagre, CDF; de la Cruz, F; Moncalian, G				Lazaro, Beatriz; Villa, Juan A.; Santin, Omar; Cabezas, Matilde; Milagre, Cintia D. F.; de la Cruz, Fernando; Moncalian, Gabriel			Heterologous expression of a thermophilic diacylglycerol acyltransferase triggers triglyceride accumulation in Escherichia coli	PLOS ONE			English	Article							TRIACYLGLYCEROL BIOSYNTHESIS; WAX ESTER; BACTERIAL ACYLTRANSFERASES; CHEMICAL-SHIFTS; IDENTIFICATION; SEQUENCE; NMR; PROKARYOTES; MUTAGENESIS; PROTEINS	Triglycerides (TAGs), the major storage molecules of metabolic energy and source of fatty acids, are produced as single cell oil by some oleogenic microorganisms. However, these microorganisms require strict culture conditions, show low carbon source flexibilities, lack efficient genetic modification tools and in some cases pose safety concerns. TAGs have essential applications such as behaving as a source for added-value fatty acids or giving rise to the production of biodiesel. Hence, new alternative methods are urgently required for obtaining these oils. In this work we describe TAG accumulation in the industrially appropriate microorganism Escherichia coli expressing the heterologous enzyme tDGAT, a wax ester synthase/triacylglycerol: acylCoA acyltranferase (WS/DGAT). With this purpose, we introduce a codon-optimized gene from the thermophilic actinomycete Thermomonospora curvata coding for a WS/DGAT into different E. coli strains, describe the metabolic effects associated to the expression of this protein and evaluate neutral lipid accumulation. We observe a direct relation between the expression of this WS/DGAT and TAG production within a wide range of culture conditions. More than 30% TAGs were detected within the bacterial neutral lipids in 90 minutes after induction. TAGs were observed to be associated with the hydrophobic enzyme while forming round intracytoplasmic bodies, which could represent a bottleneck for lipid accumulation in E. coli. We detected an increase of almost 3-fold in the monounsaturated fatty acids (MUFA) occurring in the recombinant strains. These MUFA were predominant in the accumulated TAGs achieving 46% of the TAG fatty acids. These results set the basis for further research on the achievement of a suitable method towards the sustainable production of these neutral lipids.	[Lazaro, Beatriz; Villa, Juan A.; Santin, Omar; Cabezas, Matilde; de la Cruz, Fernando; Moncalian, Gabriel] Univ Cantabria, Dept Biol Mol, Santander, Cantabria, Spain; [Lazaro, Beatriz; Villa, Juan A.; Santin, Omar; Cabezas, Matilde; de la Cruz, Fernando; Moncalian, Gabriel] Univ Cantabria, CSIC, Inst Biomed & Biotecnol Cantabria IBBTEC, Santander, Cantabria, Spain; [Milagre, Cintia D. F.] Univ Estadual Paulista UNESP, Inst Chem, Dept Organ Chem, Rua Prof Francisco Degni, Araraquara, SP, Brazil; [Villa, Juan A.] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO USA; [Villa, Juan A.] St Louis Univ, Sch Med, Ctr Liver, St Louis, MO USA	Universidad de Cantabria; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Universidade Estadual Paulista; Saint Louis University; Saint Louis University	Moncalian, G (corresponding author), Univ Cantabria, Dept Biol Mol, Santander, Cantabria, Spain.; Moncalian, G (corresponding author), Univ Cantabria, CSIC, Inst Biomed & Biotecnol Cantabria IBBTEC, Santander, Cantabria, Spain.	gabriel.moncalian@unican.es	Moncalian, Gabriel/K-3493-2014; Milagre, Cintia D F/B-8497-2012; de la Cruz, Fernando/L-2812-2014	Moncalian, Gabriel/0000-0002-3007-6490; Milagre, Cintia D F/0000-0001-5627-8616; de la Cruz, Fernando/0000-0003-4758-6857; Lazaro Pinto, Beatriz/0000-0001-6837-2941	Spanish Ministry of Science and Innovation [BIO2010-14809]; Spanish Ministry of Economy and Competitiveness [BFU2014-55534-C2-2-P]; Sao Paulo Research Foundation (FAPESP); European Commission [IB14DM0176]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Economy and Competitiveness(Spanish Government); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was financed by Grants BIO2010-14809 from the Spanish Ministry of Science and Innovation and BFU2014-55534-C2-2-P from the Spanish Ministry of Economy and Competitiveness to GM, Sao Paulo Research Foundation (FAPESP) to CM and IB14DM0176 from the European Commission to BL.; We are grateful to Biomar Microbial Technologies (Leon, Spain) for GC analysis of the samples and CDB (Valladolid, Spain) for UPLC-MS analysis. We thank to Maria Aramburu (School of Medicine, University of Cantabria, Santander, Spain) for the assistance with flow cytometry, Inigo Casafont (School of Medicine, University of Cantabria, Santander, Spain) for help with the microscope and image analysis, Lucineia Vizzotto and Nivaldo Boralle (Institute of Chemistry, UNESP-Araraquara, SP) for training and assistance in NMR experiments. This work was financed by Grants BIO2010-14809 from the Spanish Ministry of Science and Innovation and BFU2014-55534-C2-2-P from the Spanish Ministry of Economy and Competitiveness to GM, Sao Paulo Research Foundation (FAPESP) to CM and IB14DM0176 from the European Commission to BL.	Alonso-Salces RM, 2012, OLIVE OIL - CONSTITUENTS, QUALITY, HEALTH PROPERTIES AND BIOCONVERSIONS, P185; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarez HM, 2002, APPL MICROBIOL BIOT, V60, P367, DOI 10.1007/s00253-002-1135-0; Alvarez HM, 2000, APPL MICROBIOL BIOT, V54, P218, DOI 10.1007/s002530050012; [Anonymous], SPECTROMETRIC IDENTI; Arabolaza A, 2008, APPL ENVIRON MICROB, V74, P2573, DOI 10.1128/AEM.02638-07; Atomi H, 2005, CURR OPIN CHEM BIOL, V9, P166, DOI 10.1016/j.cbpa.2005.02.013; Cagnon C, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-178; Cao YJ, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-59; Chertkov O, 2011, STAND GENOMIC SCI, V4, P13, DOI 10.4056/sigs.1453580; Coleman RG, 2010, PROTEINS, V78, P420, DOI 10.1002/prot.22558; Comba S, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0172-0; Comba S, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-9; Ding YF, 2012, J LIPID RES, V53, P399, DOI 10.1194/jlr.M021899; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Duan YK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020265; Gottlieb HE, 1997, J ORG CHEM, V62, P7512, DOI 10.1021/jo971176v; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; Hoffman RE, 2006, MAGN RESON CHEM, V44, P606, DOI 10.1002/mrc.1801; Holtzapple E, 2007, J BACTERIOL, V189, P3804, DOI 10.1128/JB.01932-06; Janssen HJ, 2014, APPL MICROBIOL BIOT, V98, P1913, DOI 10.1007/s00253-013-5460-2; Ramos MJ, 2009, BIORESOURCE TECHNOL, V100, P261, DOI 10.1016/j.biortech.2008.06.039; Kalscheuer R, 2006, APPL ENVIRON MICROB, V72, P1373, DOI 10.1128/AEM.72.2.1373-1379.2006; Kalscheuer R, 2003, J BIOL CHEM, V278, P8075, DOI 10.1074/jbc.M210533200; Kalscheuer R, 2007, J BACTERIOL, V189, P918, DOI 10.1128/JB.01292-06; Kalscheuer R, 2006, MICROBIOL-SGM, V152, P2529, DOI 10.1099/mic.0.29028-0; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kerviel V, 2014, J APPL PHYCOL; Khlebnikov A, 2001, MICROBIOL-SGM, V147, P3241, DOI 10.1099/00221287-147-12-3241; Knothe G, 2005, FUEL PROCESS TECHNOL, V86, P1059, DOI 10.1016/j.fuproc.2004.11.002; Leonard J., 2013, ADV PRACTICAL ORGANI; Lin FM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078595; Listenberger LL, 2007, CURR PROTOC CELL BIO; Lu CF, 2009, P NATL ACAD SCI USA, V106, P18837, DOI 10.1073/pnas.0908848106; Mansilla MC, 2004, J BACTERIOL, V186, P6681, DOI 10.1128/JB.186.20.6681-6688.2004; Miller L, 1985, HEWLETT PACKARD APPL, V228, P241; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rottig A, 2016, EUR J LIPID SCI TECH, V118, P124, DOI 10.1002/ejlt.201500200; Rottig A, 2015, METAB ENG, V32, P195, DOI 10.1016/j.ymben.2015.09.016; Rottig A, 2013, MICROBIOL MOL BIOL R, V77, P277, DOI 10.1128/MMBR.00010-13; Rottig A, 2013, EUR J LIPID SCI TECH, V115, P394, DOI 10.1002/ejlt.201200401; Rucker J, 2013, APPL MICROBIOL BIOT, V97, P2753, DOI 10.1007/s00253-013-4714-3; Sambrook, 2001, MOL CLONING, V1; Santala S, 2014, ACS SYNTH BIOL, V3, P145, DOI 10.1021/sb4000788; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Stoveken T, 2008, ANGEW CHEM INT EDIT, V47, P3688, DOI 10.1002/anie.200705265; Stoeveken T, 2009, EUR J LIPID SCI TECH, V111, P112, DOI 10.1002/ejlt.200800167; Stoveken T, 2005, J BACTERIOL, V187, P1369, DOI 10.1128/JB.187.4.1369-1376.2005; Vanhercke T, 2013, FEBS LETT, V587, P364, DOI 10.1016/j.febslet.2012.12.018; Villa JA, 2014, APPL ENVIRON MICROB, V80, P1132, DOI 10.1128/AEM.03433-13; Vlahov G, 1999, PROG NUCL MAG RES SP, V35, P341, DOI 10.1016/S0079-6565(99)00015-1; Waeltermann Marc, 2006, V1, P137, DOI 10.1007/7171_006; Waltermann M, 2005, MOL MICROBIOL, V55, P750, DOI 10.1111/j.1365-2958.2004.04441.x	57	7	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176520	10.1371/journal.pone.0176520	http://dx.doi.org/10.1371/journal.pone.0176520			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448543	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383600093
J	Roomp, K; Kristinsson, H; Schvartz, D; Ubhayasekera, K; Sargsyan, E; Manukyan, L; Chowdhury, A; Manell, H; Satagopam, V; Groebe, K; Schneider, R; Bergquist, J; Sanchez, JC; Bergsten, P				Roomp, Kirsten; Kristinsson, Hjalti; Schvartz, Domitille; Ubhayasekera, Kumari; Sargsyan, Ernest; Manukyan, Levon; Chowdhury, Azazul; Manell, Hannes; Satagopam, Venkata; Groebe, Karlfried; Schneider, Reinhard; Bergquist, Jonas; Sanchez, Jean-Charles; Bergsten, Peter			Combined lipidomic and proteomic analysis of isolated human islets exposed to palmitate reveals time-dependent changes in insulin secretion and lipid metabolism	PLOS ONE			English	Article							SERUM PROINSULIN LEVELS; FATTY-ACID; PANCREATIC-ISLETS; BETA-CELLS; DIABETES-MELLITUS; CHOLESTEROL ACCUMULATION; ISOBARIC TAGS; GLUCOSE; LIPOTOXICITY; EXPRESSION	Studies on the pathophysiology of type 2 diabetes mellitus (T2DM) have linked the accumulation of lipid metabolites to the development of beta-cell dysfunction and impaired insulin secretion. In most in vitro models of T2DM, rodent islets or beta-cell lines are used and typically focus is on specific cellular pathways or organs. Our aim was to, firstly, develop a combined lipidomics and proteomics approach for lipotoxicity in isolated human islets and, secondly, investigate if the approach could delineate novel and/or confirm reported mechanisms of lipotoxicity. To this end isolated human pancreatic islets, exposed to chronically elevated palmitate concentrations for 0, 2 and 7 days, were functionally characterized and their levels of multiple targeted lipid and untargeted protein species determined. Glucosestimulated insulin secretion from the islets increased on day 2 and decreased on day 7. At day 7 islet insulin content decreased and the proinsulin to insulin content ratio doubled. Amounts of cholesterol, stearic acid, C16 dihydroceramide and C24: 1 sphingomyelin, obtained from the lipidomic screen, increased time-dependently in the palmitate-exposed islets. The proteomic screen identified matching changes in proteins involved in lipid biosynthesis indicating up-regulated cholesterol and lipid biosynthesis in the islets. Furthermore, proteins associated with immature secretory granules were decreased when palmitate exposure time was increased despite their high affinity for cholesterol. Proteins associated with mature secretory granules remained unchanged. Pathway analysis based on the protein and lipid expression profiles implicated autocrine effects of insulin in lipotoxicity. Taken together the study demonstrates that combining different omics approaches has potential in mapping of multiple simultaneous cellular events. However, it also shows that challenges exist for effectively combining lipidomics and proteomics in primary cells. Our findings provide insight into how saturated fatty acids contribute to islet cell dysfunction by affecting the granule maturation process and confirmation in human islets of some previous findings from rodent islet and cell-line studies.	[Roomp, Kirsten; Satagopam, Venkata; Schneider, Reinhard] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Esch Belval, Luxembourg; [Kristinsson, Hjalti; Sargsyan, Ernest; Manukyan, Levon; Chowdhury, Azazul; Manell, Hannes; Bergsten, Peter] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden; [Schvartz, Domitille; Sanchez, Jean-Charles] Univ Geneva, Human Prot Sci Dept, Ctr Med Univ, Geneva, Switzerland; [Ubhayasekera, Kumari; Bergquist, Jonas] Uppsala Univ, Dept Chem, Analyt Chem, Uppsala, Sweden; [Ubhayasekera, Kumari; Bergquist, Jonas] Uppsala Univ, Sci Life Lab, Uppsala, Sweden; [Groebe, Karlfried] Pivot Biomed Sci GmbH, Trier, Germany	University of Luxembourg; Uppsala University; University of Geneva; Uppsala University; Uppsala University	Roomp, K (corresponding author), Univ Luxembourg, Luxembourg Ctr Syst Biomed, Esch Belval, Luxembourg.	kroomp@googlemail.com	Schneider, Reinhard/C-5441-2009; Manell, Hannes/AAD-3080-2022	Schneider, Reinhard/0000-0002-8278-1618; Manukyan, Levon/0000-0003-3314-5284; Satagopam, Venkata/0000-0002-6532-5880; Bergquist, Jonas/0000-0002-4597-041X	European Commission FP7-project [279153]	European Commission FP7-project	The funder Pivot Biomedical Science GmbH provided support in the form of supplying author Karlfried Groebe's (KG) position as a Senior Scientist (KG's salary was refunded by EU project Beta-JuDO), but did not have any additional role in the study design, data collection and analysis,decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section. This study was also funded by the European Commission FP7-project 279153 (to HK).	Andersson SA, 2012, MOL CELL ENDOCRINOL, V364, P36, DOI 10.1016/j.mce.2012.08.009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERGSTEN P, 1993, DIABETES, V42, P670, DOI 10.2337/diabetes.42.5.670; Bollheimer LC, 1998, J CLIN INVEST, V101, P1094, DOI 10.1172/JCI420; Breitwieser FP, 2011, J PROTEOME RES, V10, P2758, DOI 10.1021/pr1012784; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; CHAN JM, 1994, DIABETES CARE, V17, P961, DOI 10.2337/diacare.17.9.961; Chowdhury A, 2013, J PROTEOME RES, V12, P5954, DOI 10.1021/pr400864w; Cnop M, 2014, DIABETES, V63, P1978, DOI 10.2337/db13-1383; Cowan CA, 2002, TRENDS CELL BIOL, V12, P339, DOI 10.1016/S0962-8924(02)02317-6; Dayon L, 2008, ANAL CHEM, V80, P2921, DOI 10.1021/ac702422x; El-Assaad W, 2010, ENDOCRINOLOGY, V151, P3061, DOI 10.1210/en.2009-1238; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; Ferdaoussi M, 2012, DIABETOLOGIA, V55, P2682, DOI 10.1007/s00125-012-2650-x; Gluck F, 2013, J PROTEOMICS, V79, P146, DOI 10.1016/j.jprot.2012.12.012; Gohring I, 2014, J BIOL CHEM, V289, P3786, DOI 10.1074/jbc.M113.507335; Hong J, 2009, DIABETES OBES METAB, V11, P397, DOI 10.1111/j.1463-1326.2008.00971.x; Hutchens T, 2015, DIABETES, V64, P3839, DOI 10.2337/db15-0488; Ishikawa M, 2008, J LIPID RES, V49, P2524, DOI 10.1194/jlr.M800238-JLR200; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kelpe CL, 2003, J BIOL CHEM, V278, P30015, DOI 10.1074/jbc.M302548200; Koenig T, 2008, J PROTEOME RES, V7, P3708, DOI 10.1021/pr700859x; Kristinsson H, 2013, ENDOCRINOLOGY, V154, P4078, DOI 10.1210/en.2013-1352; Kruit JK, 2011, DIABETES, V60, P3186, DOI 10.2337/db11-0081; Kulkarni RN, 2007, CELL, V129, P241, DOI 10.1016/j.cell.2007.04.006; Lin N, 2012, ENDOCRINE, V42, P107, DOI 10.1007/s12020-012-9633-z; Lorenzo C, 2003, DIABETES CARE, V26, P3153, DOI 10.2337/diacare.26.11.3153; Maedler K, 2001, DIABETES, V50, P69, DOI 10.2337/diabetes.50.1.69; Malmgren S, 2013, J BIOL CHEM, V288, P11973, DOI 10.1074/jbc.M112.422527; Manukyan L, 2015, ENDOCRINOLOGY, V156, P802, DOI 10.1210/en.2014-1467; MARTIN BC, 1992, LANCET, V340, P925, DOI 10.1016/0140-6736(92)92814-V; MYKKANEN L, 1995, DIABETOLOGIA, V38, P1176, DOI 10.1007/BF00422366; PAOLISSO G, 1995, DIABETOLOGIA, V38, P1295; Pedrioli PGA, 2010, METHODS MOL BIOL, V604, P213, DOI 10.1007/978-1-60761-444-9_15; Sargsyan E, 2008, J ENDOCRINOL, V199, P41, DOI 10.1677/JOE-08-0251; Sargsyan E, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-115; Sarojini J, 2012, J AM OIL CHEM SOC, V89, P1427; Segall L, 1999, AM J PHYSIOL-ENDOC M, V277, pE521, DOI 10.1152/ajpendo.1999.277.3.E521; Staaf J, 2016, PEDIAT RES; Sun YX, 2014, EXP THER MED, V8, P991, DOI 10.3892/etm.2014.1812; Tachibana K, 2015, HORM METAB RES, V47, P176, DOI 10.1055/s-0034-1389990; Tang N, 2014, BIOCHEM BIOPH RES CO, V450, P318, DOI 10.1016/j.bbrc.2014.05.113; Ubhayasekera SJKA, 2013, ANAL BIOANAL CHEM, V405, P1929, DOI 10.1007/s00216-012-6658-3; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; WARD WK, 1987, DIABETOLOGIA, V30, P698, DOI 10.1007/BF00296991; YOSHIOKA N, 1988, DIABETOLOGIA, V31, P355, DOI 10.1007/BF02341503; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042	49	26	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176391	10.1371/journal.pone.0176391	http://dx.doi.org/10.1371/journal.pone.0176391			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448538	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383600072
J	Yarygin, K; Tyakht, A; Larin, A; Kostryukova, E; Kolchenko, S; Bitner, V; Alexeev, D				Yarygin, Konstantin; Tyakht, Alexander; Larin, Andrey; Kostryukova, Elena; Kolchenko, Sergei; Bitner, Vilgelm; Alexeev, Dmitry			Abundance profiling of specific gene groups using precomputed gut metagenomes yields novel biological hypotheses	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; FUNCTIONAL METAGENOMICS; RESISTANCE GENES; MICROBIOTA; BACTERIA; METABOLISM; SEQUENCES; BUTYRATE; CATALOG; DISEASE	The gut microbiota is essentially a multifunctional bioreactor within a human being. The exploration of its enormous metabolic potential provides insights into the mechanisms underlying microbial ecology and interactions with the host. The data obtained using "shotgun" metagenomics capture information about the whole spectrum of microbial functions. However, each new study presenting new sequencing data tends to extract only a little of the information concerning the metabolic potential and often omits specific functions. A meta-analysis of the available data with an emphasis on biomedically relevant gene groups can unveil new global trends in the gut microbiota. As a step toward the reuse of metagenomic data, we developed a method for the quantitative profiling of user-defined groups of genes in human gut metagenomes. This method is based on the quick analysis of a gene coverage matrix obtained by pre-mapping the metagenomic reads to a global gut microbial catalogue. The method was applied to profile the abundance of several gene groups related to antibiotic resistance, phages, biosynthesis clusters and carbohydrate degradation in 784 metagenomes from healthy populations worldwide and patients with inflammatory bowel diseases and obesity. We discovered country-wise functional specifics in gut resistome and virome compositions. The most distinct features of the disease microbiota were found for Crohn's disease, followed by ulcerative colitis and obesity. Profiling of the genes belonging to crAssphage showed that its abundance varied across the world populations and was not associated with clinical status. We demonstrated temporal resilience of crAssphage and the influence of the sample preparation protocol on its detected abundance. Our approach offers a convenient method to add value to accumulated "shotgun" metagenomic data by helping researchers state and assess novel biological hypotheses.	[Yarygin, Konstantin; Tyakht, Alexander; Larin, Andrey; Kostryukova, Elena; Alexeev, Dmitry] Fed Res & Clin Ctr Phys Chem Med FRCC CPM, Malaya Pirogovskaya 1a, Moscow 119435, Russia; [Yarygin, Konstantin; Tyakht, Alexander; Kostryukova, Elena; Kolchenko, Sergei; Bitner, Vilgelm; Alexeev, Dmitry] Moscow Inst Phys & Technol, Inst Lane 9, Dolgoprudnyi 141700, Moscow Region, Russia; [Kolchenko, Sergei] HPC HUB LLC, Prospect Mira 112,Bld12, Moscow 129626, Russia	Lopukhin Federal Research & Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency; Moscow Institute of Physics & Technology	Yarygin, K (corresponding author), Fed Res & Clin Ctr Phys Chem Med FRCC CPM, Malaya Pirogovskaya 1a, Moscow 119435, Russia.; Yarygin, K (corresponding author), Moscow Inst Phys & Technol, Inst Lane 9, Dolgoprudnyi 141700, Moscow Region, Russia.	yarygin@phystech.edu	Tyakht, Alexander/O-1327-2015; Alexeev, Dmitry/A-6167-2013	Alexeev, Dmitry/0000-0003-0783-1176	Ministry of Education and Science of the Russian Federation [RFMEFI57514X0075]; HPC HUB LLC, a commercial company	Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); HPC HUB LLC, a commercial company	This work was supported by Ministry of Education and Science of the Russian Federation (RFMEFI57514X0075). Ministry of Education and Science of the Russian Federation URL: MNHo6pHayKN.pdp. Authors SK and VB received support in the form of salary from HPC HUB LLC, a commercial company, for this study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This work was supported by Ministry of Education and Science of the Russian Federation (RFMEFI57514X0075). We thank Dania Molodtsova for language editing.	Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358; Altman T, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-112; [Anonymous], 2021, LANG ENV STAT COMP; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Dignass A, 2012, J CROHNS COLITIS, V6, P991, DOI 10.1016/j.crohns.2012.09.002; Donia MS, 2014, CELL, V158, P1402, DOI 10.1016/j.cell.2014.08.032; Duncan SH, 2007, APPL ENVIRON MICROB, V73, P1073, DOI 10.1128/AEM.02340-06; Dutilh BE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5498; Eklund A., 2016, INT CONF IMAG PROC; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Forsberg KJ, 2012, SCIENCE, V337, P1107, DOI 10.1126/science.1220761; Forslund K, 2013, GENOME RES, V23, P1163, DOI 10.1101/gr.155465.113; Fouhy F, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-25; Gloux K, 2011, P NATL ACAD SCI USA, V108, P4539, DOI 10.1073/pnas.1000066107; Guardabassi L, 2005, ANTIMICROB AGENTS CH, V49, P4227, DOI 10.1128/AAC.49.10.4227-4233.2005; LeBlanc JG, 2013, CURR OPIN BIOTECH, V24, P160, DOI 10.1016/j.copbio.2012.08.005; Hu Y, 2013, NATURE COMMUNICATION, V4; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jarocki P, 2013, CURR MICROBIOL, V67, P286, DOI 10.1007/s00284-013-0362-1; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; La Rosa P, 2011, HMP HYPOTHESIS TESTI; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052; Meijer K, 2010, CURR OPIN CLIN NUTR, V13, P715, DOI 10.1097/MCO.0b013e32833eebe5; Modi SR, 2013, NATURE, V499, P219, DOI 10.1038/nature12212; MOLLY K, 1993, APPL MICROBIOL BIOT, V39, P254, DOI 10.1007/BF00228615; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Mori T, 2008, APPL ENVIRON MICROB, V74, P6803, DOI 10.1128/AEM.00873-08; Mullany P, 2014, VIRULENCE, V5, P443, DOI 10.4161/viru.28196; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; Norman JM, 2015, CELL, V160, P447, DOI 10.1016/j.cell.2015.01.002; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Reynolds L, 2009, HEALTH POLICY, V90, P32, DOI 10.1016/j.healthpol.2008.09.002; Richter DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003373; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Scott KP, 2013, PHARMACOL RES, V69, P52, DOI 10.1016/j.phrs.2012.10.020; Seemann T., 2014, BIOINFORMATICS; Serwer P, 2004, VIROLOGY, V329, P412, DOI 10.1016/j.virol.2004.08.021; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Stratchounski LS, 2003, CLIN INFECT DIS, V37, P498, DOI 10.1086/376905; Tasse L, 2010, GENOME RES, V20, P1605, DOI 10.1101/gr.108332.110; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589; Tyakht AV, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3469; Waller AS, 2014, ISME J, V8, P1391, DOI 10.1038/ismej.2014.30; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Ye YZ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-159	54	19	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176154	10.1371/journal.pone.0176154	http://dx.doi.org/10.1371/journal.pone.0176154			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448616	Green Submitted, gold, Green Published			2022-12-26	WOS:000400383600042
J	Pan, XH; Zhou, J; Yao, X; Shu, J; Liu, JF; Yang, JY; Pang, RQ; Ruan, GP				Pan, Xing-hua; Zhou, Jing; Yao, Xiang; Shu, Jun; Liu, Ju-fen; Yang, Jian-yong; Pang, Rong-qing; Ruan, Guang-ping			Transplantation of induced mesenchymal stem cells for treating chronic renal insufficiency	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; CHRONIC KIDNEY-DISEASE; STROMAL CELLS; FAILURE; FIBROSIS; DIFFERENTIATION; INJURY; MODEL	Discovering a new cell transplantation approach for treating chronic renal insufficiency is a goal of many nephrologists. In vitro-cultured peripheral blood mononuclear cells (PBMCs) were reprogrammed into induced mesenchymal stem cells (iMSCs) by using natural inducing agents made in our laboratory. The stem cell phenotype of the iMSCs was then identified. Unilateral ureteral obstruction (UUO) was used to create an animal model of chronic renal insufficiency characterized by renal interstitial fibrosis. The induced and non-induced PBMCs were transplanted, and the efficacy of iMSCs in treating chronic renal insufficiency was evaluated using a variety of methods. The ultimate goal was to explore the effects of iMSC transplantation on the treatment of chronic renal insufficiency, with the aim of providing a new therapeutic modality for this disease.	[Pan, Xing-hua; Zhou, Jing; Yao, Xiang; Shu, Jun; Liu, Ju-fen; Yang, Jian-yong; Pang, Rong-qing; Ruan, Guang-ping] Kunming Gen Hosp Peoples Liberat Army, Cell Biol Therapy Ctr, Kunming, Yunnan Province, Peoples R China; [Pan, Xing-hua; Zhou, Jing; Yao, Xiang; Shu, Jun; Liu, Ju-fen; Yang, Jian-yong; Pang, Rong-qing; Ruan, Guang-ping] Stem Cells & Immune Cells Biomed Tech Integrated, Kunming, Yunnan Province, Peoples R China; [Pan, Xing-hua; Zhou, Jing; Yao, Xiang; Shu, Jun; Liu, Ju-fen; Yang, Jian-yong; Pang, Rong-qing; Ruan, Guang-ping] Cell Therapy Technol Transfer Med Key Lab Yunnan, Kunming, Yunnan Province, Peoples R China		Ruan, GP (corresponding author), Kunming Gen Hosp Peoples Liberat Army, Cell Biol Therapy Ctr, Kunming, Yunnan Province, Peoples R China.; Ruan, GP (corresponding author), Stem Cells & Immune Cells Biomed Tech Integrated, Kunming, Yunnan Province, Peoples R China.; Ruan, GP (corresponding author), Cell Therapy Technol Transfer Med Key Lab Yunnan, Kunming, Yunnan Province, Peoples R China.	ruangp@126.com			National Support Program [2014BAI01B01]; Yunnan Provincial Science and Technology Project [2013CA005]; Yunnan Province Health Science and Technology Project [2016NS012]	National Support Program; Yunnan Provincial Science and Technology Project; Yunnan Province Health Science and Technology Project	This work was supported by the National Support Program (2014BAI01B01, awarded to Dr. Pan), the Yunnan Provincial Science and Technology Project (2013CA005, awarded to Dr. Pan) and the Yunnan Province Health Science and Technology Project (2016NS012, awarded to Dr. Ruan). We thank American Journal Experts for assisting in the preparation of this manuscript.; This work was supported by the National Support Program (2014BAI01B01, awarded to Dr. Pan), the Yunnan Provincial Science and Technology Project (2013CA005, awarded to Dr. Pan) and the Yunnan Province Health Science and Technology Project (2016NS012, awarded to Dr. Ruan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asanuma H, 2010, J UROLOGY, V184, P26, DOI 10.1016/j.juro.2010.03.050; Asawa S, 2007, J GASTROEN HEPATOL, V22, P2001, DOI 10.1111/j.1440-1746.2006.04708.x; Bahlmann FH, 2010, NEPHROL DIAL TRANSPL, V25, P341, DOI 10.1093/ndt/gfp643; Caldas HC, 2008, TRANSPL P, V40, P853, DOI 10.1016/j.transproceed.2008.03.009; Choi S, 2009, STEM CELLS DEV, V18, P521, DOI 10.1089/scd.2008.0097; Conforti A, 2014, STEM CELLS DEV, V23, P2591, DOI 10.1089/scd.2014.0091; Eirin A, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt472; Griffin TP, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0734-6; Hu ZJ, 2012, KIDNEY BLOOD PRESS R, V36, P85, DOI 10.1159/000341485; Imai N, 2009, SEMIN DIALYSIS, V22, P629, DOI 10.1111/j.1525-139X.2009.00654.x; Lee TY, 1999, ANN PLAS SURG, V43, P179; Majore I, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-6; Qian H, 2008, INT J MOL MED, V22, P325, DOI 10.3892/ijmm_00000026; Ruan GP, 2012, CYTOTECHNOLOGY, V64, P541, DOI 10.1007/s10616-012-9431-8; Sangidorj O, 2010, AM J PHYSIOL-RENAL, V299, pF325, DOI 10.1152/ajprenal.00019.2010; Semedo P, 2009, STEM CELLS, V27, P3063, DOI 10.1002/stem.214; Togel F, 2009, STEM CELLS DEV, V18, P475, DOI 10.1089/scd.2008.0092; Volovelsky O, 2016, CURR OPIN ORGAN TRAN, V21, P574, DOI 10.1097/MOT.0000000000000362; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yongjun W., 2003, CHINESE INTEGRATIVE, V1, P273; Yu B, 2015, INT J CARDIOL, V182, P349, DOI 10.1016/j.ijcard.2014.12.043; Zhang LX, 2016, NEW ENGL J MED, V375, P905, DOI 10.1056/NEJMc1602469; Zou Jie, 2008, Zhongguo Zhong Xi Yi Jie He Za Zhi, V28, P146	23	4	4	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176273	10.1371/journal.pone.0176273	http://dx.doi.org/10.1371/journal.pone.0176273			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445516	Green Published, gold, Green Submitted			2022-12-26	WOS:000400309200042
J	Sanna, PP; Repunte-Canonigo, V; Masliah, E; Lefebvre, C				Sanna, Pietro Paolo; Repunte-Canonigo, Vez; Masliah, Eliezer; Lefebvre, Celine			Gene expression patterns associated with neurological disease in human HIV infection	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; AIDS DEMENTIA COMPLEX; WHITE-MATTER HYPERINTENSITIES; COGNITIVE IMPAIRMENT; MULTIPLE-SCLEROSIS; INTERFERON-ALPHA; NEUROCOGNITIVE IMPAIRMENT; IMMUNODEFICIENCY-SYNDROME; CEREBROSPINAL-FLUID; ALZHEIMER-DISEASE	The pathogenesis and nosology of HIV-associated neurological disease (HAND) remain incompletely understood. Here, to provide new insight into the molecular events leading to neurocognitive impairments (NCI) in HIV infection, we analyzed pathway dysregulations in gene expression profiles of HIV-infected patients with or without NCI and HIV encephalitis (HIVE) and control subjects. The Gene Set Enrichment Analysis (GSEA) algorithm was used for pathway analyses in conjunction with the Molecular Signatures Database collection of canonical pathways (MSigDb). We analyzed pathway dysregulations in gene expression profiles of patients from the National NeuroAIDS Tissue Consortium (NNTC), which consists of samples from 3 different brain regions, including white matter, basal ganglia and frontal cortex of HIV-infected and control patients. While HIVE is characterized by widespread, uncontrolled inflammation and tissue damage, substantial gene expression evidence of induction of interferon (IFN), cytokines and tissue injury is apparent in all brain regions studied, even in the absence of NCI. Various degrees of white matter changes were present in all HIV-infected subjects and were the primary manifestation in patients with NCI in the absence of HIVE. In particular, NCI in patients without HIVE in the NNTC sample is associated with white matter expression of chemokines, cytokines and beta-defensins, without significant activation of IFN. Altogether, the results identified distinct pathways differentially regulated over the course of neurological disease in HIV infection and provide a new perspective on the dynamics of pathogenic processes in the course of HIV neurological disease in humans. These results also demonstrate the power of the systems biology analyses and indicate that the establishment of larger human gene expression profile datasets will have the potential to provide novel mechanistic insight into the pathogenesis of neurological disease in HIV infection and identify better therapeutic targets for NCI.	[Sanna, Pietro Paolo; Repunte-Canonigo, Vez; Lefebvre, Celine] Scripps Res Inst, Dept Immunol & Mol & Cellular Neurosci, La Jolla, CA 92037 USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Lefebvre, Celine] Inst Gustave Roussy, INSERM, Unit U981, Villejuif, France; [Masliah, Eliezer] NIA, NIH, Bethesda, MD 20892 USA	Scripps Research Institute; University of California System; University of California San Diego; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Sanna, PP (corresponding author), Scripps Res Inst, Dept Immunol & Mol & Cellular Neurosci, La Jolla, CA 92037 USA.	psanna@scripps.edu			National Institute on Drug Abuse [DA041750, DA043268]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA021667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA041750, R01DA043268] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funded by National Institute on Drug Abuse DA041750 and DA043268 https://www.drugabuse.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ande A, 2015, AIDS RES THER, V12, DOI 10.1186/s12981-015-0071-x; AYLWARD EH, 1995, AM J PSYCHIAT, V152, P987; Blank T, 2016, IMMUNITY, V44, P901, DOI 10.1016/j.immuni.2016.04.005; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Brew BJ, 2004, AIDS, V18, pS75, DOI 10.1097/00002030-200401001-00011; Brickman AM, 2008, ARCH NEUROL-CHICAGO, V65, P1202, DOI 10.1001/archneur.65.9.1202; Brook M, 2016, P NATL ACAD SCI USA, V113, P4350, DOI 10.1073/pnas.1601831113; BURRONE OR, 1982, EMBO J, V1, P345, DOI 10.1002/j.1460-2075.1982.tb01172.x; Calabresi PA, 1997, ANN NEUROL, V41, P669, DOI 10.1002/ana.410410517; Campbell IL, 1999, BRAIN RES, V835, P46, DOI 10.1016/S0006-8993(99)01328-1; Conant K, 2012, CURR HIV RES, V10, P384, DOI 10.2174/157016212802138733; Cysique LA, 2004, J NEUROVIROL, V10, P350, DOI 10.1080/13550280490521078; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; Desplats P, 2013, NEUROLOGY, V80, P1415, DOI 10.1212/WNL.0b013e31828c2e9e; Dziembowska M, 2012, INT J BIOCHEM CELL B, V44, P709, DOI 10.1016/j.biocel.2012.01.023; Ellis R, 2007, NAT REV NEUROSCI, V8, P33, DOI 10.1038/nrn2040; Everall I, 2009, J NEUROVIROL, V1, P11; Everall IP, 2005, NEUROTOX RES, V8, P51, DOI 10.1007/BF03033819; Everall IP, 1999, BRAIN PATHOL, V9, P209; Filiano AJ, 2016, NATURE; Gao HM, 2008, TRENDS IMMUNOL, V29, P357, DOI 10.1016/j.it.2008.05.002; Gelman BB, 2013, JAIDS-J ACQ IMM DEF, V62, P487, DOI 10.1097/QAI.0b013e31827f1bdb; Gelman BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046178; Gersten M, 2009, J NEUROSCI, V29, P12467, DOI 10.1523/JNEUROSCI.3180-09.2009; Gongvatana A, 2009, J NEUROVIROL, V15, P187, DOI 10.1080/13550280902769756; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Hofer MJ, 2013, CYTOKINE GROWTH F R, V24, P257, DOI 10.1016/j.cytogfr.2013.03.006; Ipser JC, 2015, J INT NEUROPSYCH SOC, V21, P203, DOI 10.1017/S1355617715000156; Kandiah N, 2013, PARKINSONISM RELAT D, V19, P680, DOI 10.1016/j.parkreldis.2013.03.008; Kraft-Terry SD, 2009, NEURON, V64, P133, DOI 10.1016/j.neuron.2009.09.042; Krivine A, 1999, J NEUROVIROL, V5, P500, DOI 10.3109/13550289909045379; Kuper M, 2011, J NEUROL, V258, P1066, DOI 10.1007/s00415-010-5883-y; Lalli MA, 2015, MOL PSYCHIATR, V20, P1294, DOI 10.1038/mp.2015.131; Levine AJ, 2016, J NEUROVIROL, V22, P431, DOI 10.1007/s13365-015-0410-7; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lim WK, 2007, BIOINFORMATICS, V23, pI282, DOI 10.1093/bioinformatics/btm201; Louboutin JP, 2012, SCI WORLD J, P1, DOI 10.1100/2012/482575; Marciniak E, 2015, SCI REP-UK, V5, DOI 10.1038/srep15862; Masliah E, 1997, ANN NEUROL, V42, P963, DOI 10.1002/ana.410420618; McArthur JC, 2004, J NEUROIMMUNOL, V157, P3, DOI 10.1016/j.jneuroim.2004.08.042; MCARTHUR JC, 1993, NEUROLOGY, V43, P2245, DOI 10.1212/WNL.43.11.2245; McManus C, 1998, J NEUROIMMUNOL, V86, P20, DOI 10.1016/S0165-5728(98)00002-2; McPhail Megan E, 2011, Curr HIV/AIDS Rep, V8, P249, DOI 10.1007/s11904-011-0091-7; Najera JA, 2016, BMC IMMUNOL, V17, DOI 10.1186/s12865-016-0145-0; Neuenburg JK, 2002, JAIDS-J ACQ IMM DEF, V31, P171, DOI 10.1097/00126334-200210010-00007; Nottet HSLM, 1999, J NEUROVIROL, V5, P659, DOI 10.3109/13550289909021294; Perrella O, 2001, EUR CYTOKINE NETW, V12, P51; Persidsky Y, 2003, J LEUKOCYTE BIOL, V74, P691, DOI 10.1189/jlb.0503205; Provenzano FA, 2013, JAMA NEUROL, V70, P455, DOI 10.1001/jamaneurol.2013.1321; Rho MB, 1995, BRAIN BEHAV IMMUN, V9, P366, DOI 10.1006/brbi.1995.1034; Ryan LA, 2002, CELL MOL BIOL, V48, P137; Schippling S, 2016, J NEUROL, V263, P1418, DOI 10.1007/s00415-016-8146-8; Schrier RD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116526; Shapshak P, 2004, FRONT BIOSCI-LANDMRK, V9, P1073, DOI 10.2741/1271; Simioni S, 2010, AIDS, V24, P1243, DOI 10.1097/QAD.0b013e3283354a7b; Steinbrink F, 2013, EUR J NEUROL, V20, P420, DOI 10.1111/ene.12006; Stuart MJ, 2014, NEUROSCI BIOBEHAV R, V42, P93, DOI 10.1016/j.neubiorev.2014.02.001; Stubbe-Drager B, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-23; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thames AD, 2015, AIDS, V29, P1483, DOI 10.1097/QAD.0000000000000706; Tozzi V, 2005, AIDS RES HUM RETROV, V21, P706, DOI 10.1089/aid.2005.21.706; TYOR WR, 1992, ANN NEUROL, V31, P349, DOI 10.1002/ana.410310402; Webster NL, 2006, J LEUKOCYTE BIOL, V80, P1052, DOI 10.1189/jlb.0306152; Williams WM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-127; Zheng JL, 2001, NEUROTOX RES, V3, P461, DOI 10.1007/BF03033204; Zyskind JW, 2015, J NEUROCHEM, V132, P742, DOI 10.1111/jnc.12956	66	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0175316	10.1371/journal.pone.0175316	http://dx.doi.org/10.1371/journal.pone.0175316			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445538	Green Published, Green Submitted, gold			2022-12-26	WOS:000400309200017
J	Pfannmuller, A; Leufken, J; Studt, L; Michielse, CB; Sieber, CMK; Guidener, U; Hawat, S; Hippler, M; Fufezan, C; Tudzynski, B				Pfannmueller, Andreas; Leufken, Johannes; Studt, Lena; Michielse, Caroline B.; Sieber, Christian M. K.; Gueidener, Ulrich; Hawat, Susan; Hippler, Michael; Fufezan, Christian; Tudzynski, Bettina			Comparative transcriptome and proteome analysis reveals a global impact of the nitrogen regulators AreA and AreB on secondary metabolism in Fusarium fujikuroi	PLOS ONE			English	Article							GATA FACTOR AREA; GIBBERELLIN BIOSYNTHETIC-PATHWAY; IN-VIVO BINDING; ASPERGILLUS-NIDULANS; GENE-CLUSTER; SACCHAROMYCES-CEREVISIAE; PENICILLIUM-CHRYSOGENUM; ARGININE CATABOLISM; PYTHON MODULE; NITRATE	The biosynthesis of multiple secondary metabolites in the phytopathogenic ascomycete Fusarium fujikuroi is strongly affected by nitrogen availability. Here, we present the first genome-wide transcriptome and proteome analysis that compared the wild type and deletion mutants of the two major nitrogen regulators AreA and AreB. We show that AreB acts not simply as an antagonist of AreA counteracting the expression of AreA target genes as suggested based on the yeast model. Both GATA transcription factors affect a large and diverse set of common as well as specific target genes and proteins, acting as activators and repressors. We demonstrate that AreA and AreB are not only involved in fungal nitrogen metabolism, but also in the control of several complex cellular processes like carbon metabolism, transport and secondary metabolism. We show that both GATA transcription factors can be considered as master regulators of secondary metabolism as they affect the expression of more than half of the 47 putative secondary metabolite clusters identified in the genome of F. fujikuroi. While AreA acts as a positive regulator of many clusters under nitrogen-limiting conditions, AreB is able to activate and repress gene clusters (e.g. bikaverin) under nitrogen limitation and sufficiency. In addition, ChIP analyses revealed that loss of AreA or AreB causes histone modifications at some of the regulated gene clusters.	[Pfannmueller, Andreas; Studt, Lena; Michielse, Caroline B.; Tudzynski, Bettina] Wesffalische Wilhelms Univ Munster, Inst Biol & Biotechnol Plants, Mol Biol & Biotechnol Fungi, Munster, Germany; [Leufken, Johannes; Fufezan, Christian] Wesffalische Wilhelms Univ Munster, Inst Biol & Biotechnol Plants, Computat Biol, Munster, Germany; [Studt, Lena] BOKU Univ Nat Resources & Life Sci, Div Microbial Genet & Pathogen Interact, Dept Appl Genet & Cell Biol, Campus Tulin, Vienna, Austria; [Sieber, Christian M. K.; Gueidener, Ulrich] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, Neuherberg, Germany; [Gueidener, Ulrich] Tech Univ Munich, Dept Genome Oriented Bioinformat, Wissensch Zentrum Weihenstephan, Freising Weihenstephan, Germany; [Hawat, Susan; Hippler, Michael] Wesffalische Wilhelms Univ Munster, Inst Biol & Biotechnol Plants, Plant Biochem & Biotechnol, Munster, Germany; [Michielse, Caroline B.] DuPont Ind Biosci, Wageningen, Netherlands; [Sieber, Christian M. K.] US DOE, Joint Genome Inst, Walnut Creek, CA USA	University of Natural Resources & Life Sciences, Vienna; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI	Tudzynski, B (corresponding author), Wesffalische Wilhelms Univ Munster, Inst Biol & Biotechnol Plants, Mol Biol & Biotechnol Fungi, Munster, Germany.	Bettina.Tudzynski@uni-muenster.de	Güldener, Ulrich/G-5227-2012; Studt, Lena/AAE-3991-2021	Güldener, Ulrich/0000-0001-5052-8610; Michael, Hippler/0000-0001-9670-6101; Studt-Reinhold, Lena/0000-0002-8738-2106; Leufken, Johannes/0000-0001-6343-2431; Sieber, Christian/0000-0002-9560-0281	Deutsche Forschungsgemeinschaft [TU101/12-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This project was funded by the Deutsche Forschungsgemeinschaft (www.dfg.de), Grant Number TU101/12-2, BT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARST HN, 1973, MOL GEN GENET, V126, P111, DOI 10.1007/BF00330988; Bald T, 2012, BIOINFORMATICS, V28, P1052, DOI 10.1093/bioinformatics/bts066; Barth J, 2014, MOL CELL PROTEOMICS, V13, P969, DOI 10.1074/mcp.M113.032771; Berger H, 2006, MOL MICROBIOL, V59, P433, DOI 10.1111/j.1365-2958.2005.04957.x; Berger H, 2008, MOL MICROBIOL, V69, P1385, DOI 10.1111/j.1365-2958.2008.06359.x; Bergner SV, 2015, PLANT PHYSIOL, V168, P615, DOI 10.1104/pp.15.00072; Bibbins M, 2002, MOL GENET GENOMICS, V267, P498, DOI 10.1007/s00438-002-0682-5; Bomke C, 2009, PHYTOCHEMISTRY, V70, P1876, DOI 10.1016/j.phytochem.2009.05.020; Caddick MX, 1998, J BACTERIOL, V180, P5762, DOI 10.1128/JB.180.21.5762-5764.1998; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Conlon H, 2001, MOL MICROBIOL, V40, P361, DOI 10.1046/j.1365-2958.2001.02399.x; Cook RJ., 1981, FUSARIUM DIS BIOL TA, P104; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Davis MA, 1996, J BACTERIOL, V178, P3406, DOI 10.1128/jb.178.11.3406-3409.1996; Desjardins AE, 1997, APPL ENVIRON MICROB, V63, P1838, DOI 10.1128/AEM.63.5.1838-1842.1997; Deutsch E, 2008, PROTEOMICS, V8, P2776, DOI 10.1002/pmic.200890049; Dzikowska A, 2003, FUNGAL GENET BIOL, V38, P175, DOI 10.1016/S1087-1845(02)00522-4; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; FU YH, 1990, MOL MICROBIOL, V4, P1847, DOI 10.1111/j.1365-2958.1990.tb02033.x; Gacek-Matthews A, 2015, MOL MICROBIOL, V96, P839, DOI 10.1111/mmi.12977; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; GEISSMAN TA, 1966, PHYTOCHEMISTRY, V5, P933, DOI 10.1016/S0031-9422(00)82790-9; Georis I, 2009, GENETICS, V181, P861, DOI 10.1534/genetics.108.099051; Giese H, 2013, FUNGAL BIOL-UK, V117, P814, DOI 10.1016/j.funbio.2013.10.006; Haas H, 1997, J BIOL CHEM, V272, P22576, DOI 10.1074/jbc.272.36.22576; HAAS H, 1995, CURR GENET, V28, P177, DOI 10.1007/BF00315785; Hohner R, 2013, MOL CELL PROTEOMICS, V12, P2774, DOI 10.1074/mcp.M113.029991; Kall L, 2008, J PROTEOME RES, V7, P29, DOI 10.1021/pr700600n; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kalli A, 2012, PROTEOMICS, V12, P21, DOI 10.1002/pmic.201100464; Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323; Kim S, 2010, MOL CELL PROTEOMICS, V9, P2840, DOI 10.1074/mcp.M110.003731; Kouzminova E, 2001, EMBO J, V20, P4309, DOI 10.1093/emboj/20.15.4309; Krappmann S, 2005, MED MYCOL, V43, pS31, DOI 10.1080/13693780400024271; Kremer LPM, 2016, J PROTEOME RES, V15, P788, DOI 10.1021/acs.jproteome.5b00860; KUDLA B, 1990, EMBO J, V9, P1355, DOI 10.1002/j.1460-2075.1990.tb08250.x; Kukuczka B, 2014, PLANT PHYSIOL, V165, P1604, DOI 10.1104/pp.114.240648; Kurat CF, 2014, P NATL ACAD SCI USA, V111, P14124, DOI 10.1073/pnas.1414024111; Kurosawa E., 1926, T NAT HIST SOC FORMO, V16, P213; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Legube G, 2003, EMBO REP, V4, P944, DOI 10.1038/sj.embor.embor941; Letting DL, 2003, MOL CELL BIOL, V23, P1334, DOI 10.1128/MCB.23.4.1334-1340.2003; Li JY, 2013, FUNGAL GENET BIOL, V61, P69, DOI 10.1016/j.fgb.2013.10.006; Lopez-Berges MS, 2014, FUNGAL GENET BIOL, V62, P78, DOI 10.1016/j.fgb.2013.11.002; Macios M, 2012, FUNGAL GENET BIOL, V49, P189, DOI 10.1016/j.fgb.2012.01.004; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Marroquin-Guzman M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004851; Martens L, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.000133; Marzluf GA, 1997, MICROBIOL MOL BIOL R, V61, P17, DOI 10.1128/.61.1.17-32.1997; Ment D, 2015, MOL PLANT MICROBE IN, V28, P154, DOI 10.1094/MPMI-09-14-0252-R; MERIKA M, 1993, MOL CELL BIOL, V13, P3999, DOI 10.1128/MCB.13.7.3999; Michielse CB, 2014, MOL MICROBIOL, V91, P472, DOI 10.1111/mmi.12472; Min K, 2012, FEMS MICROBIOL LETT, V334, P66, DOI 10.1111/j.1574-6968.2012.02620.x; Muro-Pastor MI, 2004, EUKARYOT CELL, V3, P393, DOI 10.1128/EC.3.2.393-405.2004; Muro-Pastor MI, 1999, EMBO J, V18, P1584, DOI 10.1093/emboj/18.6.1584; Narendja F, 2002, MOL MICROBIOL, V44, P573, DOI 10.1046/j.1365-2958.2002.02911.x; Nazari F, 2015, IRAN J PHARM RES, V14, P505; Niehaus EM, 2016, ENVIRON MICROBIOL, V18, P4282, DOI 10.1111/1462-2920.13576; Niehaus EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103336; Niehaus EM, 2014, APPL MICROBIOL BIOT, V98, P1749, DOI 10.1007/s00253-013-5453-1; Niehaus EM, 2013, CHEM BIOL, V20, P1055, DOI 10.1016/j.chembiol.2013.07.004; Poggeler S, 2003, CURR GENET, V43, P54, DOI 10.1007/s00294-003-0370-y; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Proctor RH, 1999, FUNGAL GENET BIOL, V27, P100, DOI 10.1006/fgbi.1999.1141; Ravagnani A, 1997, EMBO J, V16, P3974, DOI 10.1093/emboj/16.13.3974; Rosler SM, 2016, APPL MICROBIOL BIOT, V100, P5869, DOI 10.1007/s00253-016-7426-7; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schumacher J, 2012, FUNGAL GENET BIOL, V49, P483, DOI 10.1016/j.fgb.2012.03.005; Seo JA, 2001, FUNGAL GENET BIOL, V34, P155, DOI 10.1006/fgbi.2001.1299; Small AJ, 2001, MOL GENET GENOMICS, V265, P636, DOI 10.1007/s004380100456; Staben C, 1989, FUNGAL GENET NEWSL, V36, P79, DOI DOI 10.4148/1941-4765.1519; Studt L, 2016, ENVIRON MICROBIOL, V18, P936, DOI 10.1111/1462-2920.13150; Studt L, 2012, APPL ENVIRON MICROB, V78, P4468, DOI 10.1128/AEM.00823-12; Todd RB, 2005, EUKARYOT CELL, V4, P1646, DOI 10.1128/EC.4.10.1646-1653.2005; Tudzynski B, 1996, MICROBIOL-SGM, V142, P533, DOI 10.1099/13500872-142-3-533; Tudzynski B, 1998, FUNGAL GENET BIOL, V25, P157, DOI 10.1006/fgbi.1998.1095; Tudzynski B, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00656; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wiemann P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003475; Wiemann P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037519; Wiemann P, 2009, MOL MICROBIOL, V72, P931, DOI 10.1111/j.1365-2958.2009.06695.x; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Wisniewski JR, 2011, ANAL BIOCHEM, V410, P307, DOI 10.1016/j.ab.2010.12.004; Wong KH, 2008, EUKARYOT CELL, V7, P917, DOI 10.1128/EC.00076-08; Wong KH, 2009, MICROBIOL-SGM, V155, P3868, DOI 10.1099/mic.0.031252-0; Yabuta T., 1935, AGR HORTIC, V10, P17; Yates F, 1934, J AM STAT ASSOC, V29, P51, DOI 10.2307/2278459	89	24	28	10	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176194	10.1371/journal.pone.0176194	http://dx.doi.org/10.1371/journal.pone.0176194			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441411	Green Submitted, Green Published, gold			2022-12-26	WOS:000400308800032
J	Plochocki, JH; Ruiz, S; Rodriguez-Sosa, JR; Hall, MI				Plochocki, Jeffrey H.; Ruiz, Saul; Rodriguez-Sosa, Jose R.; Hall, Margaret I.			Histological study of white rhinoceros integument	PLOS ONE			English	Article							CERATOTHERIUM-SIMUM; FIBER ARRANGEMENT; SKIN; EPIDERMIS; PIG; HIPPOPOTAMUS; ELASTICITY; PHYSIOLOGY; ANATOMY	In this study, we report findings from a microscopic analysis of the white rhinoceros (Ceratotherium simum) integumentary ultrastructure. Skin samples from the cheek, shoulder, flank and rump were taken from a 46-year-old female southern white rhinoceros and examined using H&E and elastic histological stains. The epidermis was thickest in the flank (1.003 mm) followed by the rump, cheek and shoulder. The stratum corneum comprised more than half the epidermal thickness. Numerous melanin granules were found in the basal and spinosum layers. The epidermal-dermal junction was characterized by abundant papillary folds increasing surface contact between integument layers. Most of the dermal thickness consisted of organized collagen bundles with scattered elastic fibers. Collagen fiber bundles were thickest in the flank (210.9 mu m) followed by shoulder, rump and cheek. Simple coiled sweat glands were present in the dermis, but hair and sebaceous glands were absent. Together, these data suggest the white rhinoceros has a unique integumentary system among large terrestrial herbivores.	[Plochocki, Jeffrey H.; Ruiz, Saul; Rodriguez-Sosa, Jose R.; Hall, Margaret I.] Midwestern Univ, Dept Anat, Glendale, AZ 85308 USA; [Plochocki, Jeffrey H.; Hall, Margaret I.] Midwestern Univ, Arizona Coll Osteopath Med, Glendale, AZ 85308 USA; [Rodriguez-Sosa, Jose R.; Hall, Margaret I.] Midwestern Univ, Coll Vet Med, Glendale, AZ USA	Midwestern University; Midwestern University; Midwestern University	Plochocki, JH (corresponding author), Midwestern Univ, Dept Anat, Glendale, AZ 85308 USA.	jplochocki@midwestern.edu		Plochocki, Jeffrey/0000-0002-9054-2078				ALLBROOK DAVID, 1962, PROC ZOOL SOC LONDON, V139, P67; CAVE A. J. E., 1959, PROC ZOOL SOC LONDON, V132, P99; CAVE AJE, 1958, NATURE, V182, P196, DOI 10.1038/182196a0; CAVE AJE, 1969, J ZOOL, V157, P247, DOI 10.1111/j.1469-7998.1969.tb01700.x; DOWNING DT, 1992, J LIPID RES, V33, P301; Dunkin RC, 2013, J EXP BIOL, V216, P2939, DOI 10.1242/jeb.080218; Eckhart L, 2008, P NATL ACAD SCI USA, V105, P18419, DOI 10.1073/pnas.0805154105; Fuller A., 2016, CLIM CHANG RESPONSES, V3, P10, DOI [10.1186/s40665-016-0024-1, DOI 10.1186/S40665-016-0024-1]; Gartner LP, 2012, COLOR ATLAS TEXT HIS; Hadley NF, 2016, ADV LIPID RES SKIN L, V24, P303; HEDBERG CL, 1988, J INVEST DERMATOL, V90, P225, DOI 10.1111/1523-1747.ep12462257; Hiley PG, 1977, AFR J ECOL, V15, P337; Hill RV, 2006, J MORPHOL, V267, P1441, DOI 10.1002/jmor.10490; HORSTMANN E, 1966, Z ZELLFORSCH MIK ANA, V75, P146, DOI 10.1007/BF00407152; Hutchins M., 2006, International Zoo Yearbook, V40, P150, DOI 10.1111/j.1748-1090.2006.00150.x; Imokawa G, 2015, INT J MOL SCI, V16, P7753, DOI 10.3390/ijms16047753; Krmpotic CM, 2009, ACTA ZOOL-STOCKHOLM, V90, P339, DOI 10.1111/j.1463-6395.2008.00359.x; LILLYWHITE HB, 1987, J ZOOL, V211, P727; LUCK CP, 1964, Q J EXP PHYSIOL CMS, V49, P1; MEYER W, 1981, ARCH DERMATOL RES, V270, P391, DOI 10.1007/BF00403783; MEYER W, 1982, J ANAT, V134, P139; Nowak R.M., 1999, WALKERS MAMMALS WORL, V1; Owen-Smith N.R., 1988, MEGAHERBIVORES INFLU; OWENSMIT.N, 1971, NATURE, V231, P294, DOI 10.1038/231294a0; Pawlina W., 2016, HISTOLOGY TEXT ATLAS, V6th ed; Sarna M, 2014, EXP DERMATOL, V23, P813, DOI 10.1111/exd.12535; SHADWICK RE, 1992, PHILOS T ROY SOC B, V337, P419, DOI 10.1098/rstb.1992.0118; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Slominski AT, 2012, SENSING ENV REGULATI, P1; Slotow R., 2001, Koedoe, V44, P85; Smith F, 1890, J Anat Physiol, V24, P493; SPEARMAN R I C, 1970, Zoologica Africana, V5, P327; Stommel C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157145; Watson REB, 2014, ANTIOXID REDOX SIGN, V21, P1063, DOI 10.1089/ars.2013.5653; WRIGHT PG, 1987, S AFR J ZOOL, V22, P237; WRIGHT PG, 1984, S AFR J ZOOL, V19, P270	36	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176327	10.1371/journal.pone.0176327	http://dx.doi.org/10.1371/journal.pone.0176327			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441468	Green Published, Green Submitted, gold			2022-12-26	WOS:000400308800046
J	Funakoshi, M; Azami, Y; Matsumoto, H; Ikota, A; Ito, K; Okimoto, H; Shimizu, N; Tsujimura, F; Fukuda, H; Miyagi, C; Osawa, S; Osawa, R; Miura, J				Funakoshi, Mitsuhiko; Azami, Yasushi; Matsumoto, Hisashi; Ikota, Akemi; Ito, Koichi; Okimoto, Hisashi; Shimizu, Nobuaki; Tsujimura, Fumihiro; Fukuda, Hiroshi; Miyagi, Chozi; Osawa, Sayaka; Osawa, Ryo; Miura, Jiro			Socioeconomic status and type 2 diabetes complications among young adult patients in Japan	PLOS ONE			English	Article							RISK-FACTORS; SOCIAL INEQUALITIES; WHITEHALL II; HEALTH; PREVALENCE; ASSOCIATION; OUTCOMES; EPIDEMIOLOGY; DEPRIVATION; MELLITUS	Objective To assess the relationship between socioeconomic status (SES) and complications of type 2 diabetes among young adults in Japan. Design A cross-sectional study. Setting Outpatient wards of 96 member hospitals and clinics of the Japan Federation of Democratic Medical Institutions. Participants A total of 782 outpatients with type 2 diabetes (525 males, 257 females), aged 20-40 years as of March 31, 2012. After excluding 110 participants whose retinopathy diagnosis was in question, 672 participants were analyzed. Measurements We examined the relations between SES (educational level, income, type of public health-care insurance, and employment status) and diabetes complications (retinopathy and nephropathy) using a multivariate logistic regression analysis. Results The prevalence of type 2 diabetic retinopathy was 23.2%, while that of nephropathy was 8.9%. The odds of having retinopathy were higher among junior high school graduates (OR 1.91, 95% CI 1.09-3.34), patients receiving public assistance (OR 2.19, 95% CI 1.20-3.95), and patients with irregular (OR 1.72, 95% CI 1.03-2.86) or no employment (OR 2.23, 95% CI 1.36-3.68), compared to those with a higher SES, even after covariate adjustment (e.g., age, gender, body mass index). Similarly, the odds of having nephropathy were higher among patients with middle (OR 3.61, 95% CI 1.69-8.27) or low income levels (OR 2.53, 95% CI 1.11-6.07), even after covariate adjustment. Conclusions Low SES was associated with a greater likelihood of type 2 diabetes complications in young adults. These findings suggest the necessity of health policies that mitigate socioeconomic disparity and thereby reduce the prevalence of diabetic complications.	[Funakoshi, Mitsuhiko] Chidoribashi Gen Hosp, Prevent Med, Fukuoka, Japan; [Azami, Yasushi] Jouhoku Hosp, Internal Med, Kanazawa, Ishikawa, Japan; [Matsumoto, Hisashi] Kuwamizu Hosp, Internal Med, Kumamoto, Japan; [Ikota, Akemi] Kin Ikyo Chuo Hosp, Diabet Endocrine, Sapporo, Hokkaido, Japan; [Ito, Koichi] Nakano Kyoritsu Hosp, Internal Med, Tokyo, Japan; [Okimoto, Hisashi] Saka Gen Hosp, Diabet & Metab, Shiogama, Japan; [Shimizu, Nobuaki] Kamiina Co Op Hosp, Internal Med, Minowa, Japan; [Tsujimura, Fumihiro] Tanaka Clin, Internal Med, Bihoro, Japan; [Fukuda, Hiroshi] Juntendo Univ Hosp, Gen Med, Tokyo, Japan; [Miyagi, Chozi] Tachikawa Sogo Hosp, Endocrine Metab, Tachikawa, Tokyo, Japan; [Osawa, Sayaka; Osawa, Ryo] Univ Tsukuba Hosp, Gen Med & Primary Care, Tsukuba, Ibaraki, Japan; [Miura, Jiro] Kissyouin Hosp, Internal Med, Kyoto, Japan	Juntendo University; University of Tsukuba	Funakoshi, M (corresponding author), Chidoribashi Gen Hosp, Prevent Med, Fukuoka, Japan.	funakosi@wc4.so-net.ne.jp	Miura, Jiro/AAF-8083-2021	Miura, Jiro/0000-0002-0000-025X				Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029; [Anonymous], 2014, RAT ACC PUBL ASS AGE; Ashman J. J., 2014, NCHS DATA BRIEF, V161, P1; Bachmann MO, 2003, DIABETIC MED, V20, P921, DOI 10.1046/j.1464-5491.2003.01050.x; Bihan H, 2005, DIABETES CARE, V28, P2680, DOI 10.2337/diacare.28.11.2680; Commission on Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Constantino MI, 2013, DIABETES CARE, V36, P3863, DOI 10.2337/dc12-2455; Dinca-Panaitescu S, 2011, HEALTH POLICY, V99, P116, DOI 10.1016/j.healthpol.2010.07.018; Fano V, 2013, EUR J PUBLIC HEALTH, V23, P991, DOI 10.1093/eurpub/cks168; Fukuda Yoshiharu, 2012, Environmental Health and Preventive Medicine, V17, P299, DOI 10.1007/s12199-011-0254-6; Funatogawa I, 2009, INT J EPIDEMIOL, V38, P83, DOI 10.1093/ije/dyn182; Gary-Webb TL, 2013, CURR DIABETES REP, V13, P850, DOI 10.1007/s11892-013-0427-3; Grintsova O, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-43; Hayashino Y, 2010, ARCH ENVIRON OCCUP H, V65, P224, DOI 10.1080/19338244.2010.486423; Hideyo T., 2009, KOSHU EISEI, V73, P546; Hwang J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005710; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Kim SR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117034; Kondo Katsunori, 2011, Nihon Koshu Eisei Zasshi, V58, P550; Kondo N, 2012, J EPIDEMIOL, V22, P2, DOI 10.2188/jea.JE20110116; Kumari M, 2004, ARCH INTERN MED, V164, P1873, DOI 10.1001/archinte.164.17.1873; Labour Force Surve, 2016, STAT BUR MIN INT AFF; Larranaga I, 2005, DIABETIC MED, V22, P1047, DOI 10.1111/j.1464-5491.2005.01598.x; Lee TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027670; Low L, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007290; Mackenbach JP, 1996, AM J PUBLIC HEALTH, V86, P706, DOI 10.2105/AJPH.86.5.706; McFarlane P, 2013, CAN J DIABETES, V37, pS129, DOI 10.1016/j.jcjd.2013.01.037; Ministry of Health Labor and Welfare, 2011, 2011 REP RED INC; Ministry of Health Labour and Welfare, 2015, ANN HLTH LAB WELF RE; Murata C, 2010, INT J ENV RES PUB HE, V7, P1330, DOI 10.3390/ijerph7041330; Nagaya T, 2006, DIABETES RES CLIN PR, V74, P169, DOI 10.1016/j.diabres.2006.03.010; Nation FaAOotU, 2012, MIN HLTH LAB WELF, P7; Nishi N, 2004, SOC SCI MED, V58, P1159, DOI 10.1016/S0277-9536(03)00287-9; Parving H. H, 2011, BRENNER RECTORS KIDN, V2, P1411; Reisig V, 2007, INT J PUBLIC HEALTH, V52, P158, DOI 10.1007/s00038-007-5077-2; Scanlon PH, 2008, J MED SCREEN, V15, P118, DOI 10.1258/jms.2008.008013; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Secrest AM, 2011, ANN EPIDEMIOL, V21, P374, DOI 10.1016/j.annepidem.2011.02.007; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Stringhini S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5452; Tang M, 2003, INT J EPIDEMIOL, V32, P381, DOI 10.1093/ije/dyg075; Uchida Y, 2011, J TOKYO WOM MED U, V81, pE154; Walker RJ, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-82; Wilmot E, 2014, THER ADV CHRONIC DIS, V5, P234, DOI 10.1177/2040622314548679; Woodward M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006408	45	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176087	10.1371/journal.pone.0176087	http://dx.doi.org/10.1371/journal.pone.0176087			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET4XE	28437472	gold, Green Published			2022-12-26	WOS:000400287600029
J	Guan, ZY; Feng, YT; Song, AP; Shi, XM; Mao, YC; Chen, SM; Jiang, JF; Ding, L; Chen, FD				Guan, Zhiyong; Feng, Yitong; Song, Aiping; Shi, Xiaomeng; Mao, Yachao; Chen, Sumei; Jiang, Jiafu; Ding, Lian; Chen, Fadi			Expression profiling of Chrysanthemum crassum under salinity stress and the initiation of morphological changes	PLOS ONE			English	Article							SALT-STRESS; CELL-WALL; SALICORNIA-EUROPAEA; OSMOTIC ADJUSTMENT; OXIDATIVE STRESS; GENE-EXPRESSION; PHOTOSYSTEM-I; PLANTS; TOLERANCE; MECHANISM	Chrysanthemum crassum is a decaploid species of Chrysanthemum with high stress tolerance that allows survival under salinity stress while maintaining a relatively ideal growth rate. We previously recorded morphological changes after salt treatment, such as the expansion of leaf cells. To explore the underlying salinity tolerance mechanisms, we used an Illumina platform and obtained three sequencing libraries from samples collected after 0 h, 12 h and 24 h of salt treatment. Following de novo assembly, 154,944 transcripts were generated, and 97,833 (63.14%) transcripts were annotated, including 55 Gene Ontology (GO) terms and 128 Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. The expression profile of C. crassum was globally altered after salt treatment. We selected functional genes and pathways that may contribute to salinity tolerance and identified some factors involved in the salinity tolerance strategies of C. crassum, such as signal transduction, transcription factors and plant hormone regulation, enhancement of energy metabolism, functional proteins and osmolyte synthesis, reactive oxygen species (ROS) scavenging, photosystem protection and recovery, and cell wall protein modifications. Forty-six genes were selected for quantitative real-time polymerase chain reaction detection, and their expression patterns were shown to be consistent with the changes in their transcript abundance determined by RNA sequencing.	[Guan, Zhiyong; Feng, Yitong; Song, Aiping; Shi, Xiaomeng; Mao, Yachao; Chen, Sumei; Jiang, Jiafu; Ding, Lian; Chen, Fadi] Inst Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China		Guan, ZY (corresponding author), Inst Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China.	guanzhy@nja.edu.cn			948 Project of the Ministry of Agriculture [2016-X18]; Fund for Independent Innovation of Agricultural Sciences in Jiangsu Province [CX (16) 1025]; Fundamental Research Funds for the Central Universities [KYCYL201501]	948 Project of the Ministry of Agriculture; Fund for Independent Innovation of Agricultural Sciences in Jiangsu Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the 948 Project of the Ministry of Agriculture (2016-X18), the Fund for Independent Innovation of Agricultural Sciences in Jiangsu Province [CX (16) 1025], and the Fundamental Research Funds for the Central Universities (KYCYL201501).	Acconcia F, 2009, EXP CELL RES, V315, P1610, DOI 10.1016/j.yexcr.2008.10.014; An J, 2014, MOL BIOL REP, V41, P4155, DOI 10.1007/s11033-014-3287-2; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Brenner WG, 2005, PLANT J, V44, P314, DOI 10.1111/j.1365-313X.2005.02530.x; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Cameron M, 2004, IEEE ACM T COMPUT BI, V1, P116, DOI 10.1109/TCBB.2004.32; CASSAB GI, 1987, J CELL BIOL, V105, P2581, DOI 10.1083/jcb.105.6.2581; Chapman EJ, 2009, ANNU REV GENET, V43, P265, DOI 10.1146/annurev-genet-102108-134148; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Davey MW, 1999, PLANT PHYSIOL, V121, P535, DOI 10.1104/pp.121.2.535; Fahad S, 2015, PLANT GROWTH REGUL, V75, P391, DOI 10.1007/s10725-014-0013-y; Fan QQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150572; Fei J, 2016, J PLANT RES; Fillingame RH, 1996, CURR OPIN STRUC BIOL, V6, P491, DOI 10.1016/S0959-440X(96)80114-X; Fincher GB, 2003, INORG CHEM, V34, P47; Foyer CH, 2005, PLANT CELL ENVIRON, V28, P1056, DOI 10.1111/j.1365-3040.2005.01327.x; Gao CY, 2015, INT J MOL SCI, V16, P2052, DOI 10.3390/ijms16012052; Ghuge Sandip A., 2015, Plants-Basel, V4, P489, DOI 10.3390/plants4030489; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haiminen N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S6-S18; Hill AE, 2004, J MEMBRANE BIOL, V197, P1, DOI 10.1007/s00232-003-0639-6; Hirano K, 2007, PLANT CELL, V19, P3058, DOI 10.1105/tpc.107.051524; Hu YX, 2000, PLANT J, V24, P693, DOI 10.1046/j.1365-313x.2000.00915.x; Ihalainen JA, 2005, FEBS LETT, V579, P4787, DOI 10.1016/j.febslet.2005.06.091; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Johnson C, 2003, PLANT CELL, V15, P1846, DOI 10.1105/tpc.012211; Kader JC, 1996, ANNU REV PLANT PHYS, V47, P627, DOI 10.1146/annurev.arplant.47.1.627; Katsir L, 2008, CURR OPIN PLANT BIOL, V11, P428, DOI 10.1016/j.pbi.2008.05.004; Kim TW, 2010, ANNU REV PLANT BIOL, V61, P681, DOI 10.1146/annurev.arplant.043008.092057; KUNTE HJ, 1993, J MICROBIOL METH, V17, P129; Li QY, 2015, J EXP BOT, V66, P5821, DOI 10.1093/jxb/erv287; Long WH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116217; LUCK G, 1994, PHYTOCHEMISTRY, V37, P357, DOI 10.1016/0031-9422(94)85061-5; MELLON JE, 1982, PLANT PHYSIOL, V70, P401, DOI 10.1104/pp.70.2.401; Moghaieb REA, 2004, PLANT SCI, V166, P1345, DOI 10.1016/j.plantsci.2004.01.016; Muller R, 2007, PLANT PHYSIOL, V143, P156, DOI 10.1104/pp.106.090167; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Muries B, 2011, MOL BIOSYST, V7, P1322, DOI 10.1039/c0mb00285b; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Ottow EA, 2005, PLANT PHYSIOL, V139, P1762, DOI 10.1104/pp.105.069971; Pastori GM, 2003, PLANT CELL, V15, P939, DOI 10.1105/tpc.010538; Porto BN, 2013, J AGRON CROP SCI, V199, P134, DOI 10.1111/j.1439-037X.2012.00535.x; Quinet M, 2010, J EXP BOT, V61, P2719, DOI 10.1093/jxb/erq118; Rengasamy P, 2010, FUNCT PLANT BIOL, V37, P613, DOI 10.1071/FP09249; Roy SJ, 2014, CURR OPIN BIOTECH, V26, P115, DOI 10.1016/j.copbio.2013.12.004; Rozen S, 2000, Methods Mol Biol, V132, P365; Ryser U, 1997, PLANT J, V12, P97, DOI 10.1046/j.1365-313X.1997.12010097.x; Savci S, 2012, APCBEE PROC, V1, P287, DOI 10.1016/j.apcbee.2012.03.047; Shi Y, 2013, REV ESP DERECHO CONS, V59, P681; Shi YT, 2012, PLANT CELL, V24, P2578, DOI 10.1105/tpc.112.098640; SMITH RC, 1991, BIOCHEM J, V279, P529, DOI 10.1042/bj2790529; Song A, 2012, PLANT BIOLOGY, V14, P706, DOI 10.1111/j.1438-8677.2011.00560.x; Song AP, 2016, PLANT PHYSIOL BIOCH, V102, P10, DOI 10.1016/j.plaphy.2016.02.009; Song AP, 2014, INT J MOL SCI, V15, P14442, DOI 10.3390/ijms150814442; STITT M, 1993, PHILOS T R SOC B, V342, P225, DOI 10.1098/rstb.1993.0151; Strickler SR, 2012, AM J BOT, V99, P257, DOI 10.3732/ajb.1100292; Tolleter D, 2007, PLANT CELL, V19, P1580, DOI 10.1105/tpc.107.050104; Wang B, 1993, AM J MED GENET, V48, P40; Wang HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062293; Wang JC, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1373-z; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Y, 2015, BIOMED RES INT, V2015, P6, DOI DOI 10.1128/MBI0.01280-15; Wang YY, 2001, J CHEM ECOL, V27, P327, DOI 10.1023/A:1005632506230; Wei Z, 2012, PLOS ONE, V7; WHITE AJ, 1994, J EXP BOT, V45, P1885, DOI 10.1093/jxb/45.12.1885; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wu GY, 1998, J NUTR, V128, P1249, DOI 10.1093/jn/128.8.1249; [吴锡冬 Wu Xidong], 2006, [农业环境科学学报, Journal of Agro-environment science], V25, P312; XU W, 1995, PLANT CELL, V7, P1555, DOI 10.1105/tpc.7.10.1555; Yadav S, 2011, J ENVIRON BIOL, V32, P667; Yang LA, 2010, J EXP BOT, V61, P2519, DOI 10.1093/jxb/erq084; Yao J, 2008, RUSS J PLANT PHYSL+, V55, P232, DOI 10.1134/S1021443708020106; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zahra J, 2014, ACTA PHYSIOL PLANT, V36, P1261, DOI 10.1007/s11738-014-1506-z; Zhao Y, 2013, CELL RES, V23, P1380, DOI 10.1038/cr.2013.149; Zheng QS, 2009, J PLANT NUTR SOIL SC, V172, P875, DOI 10.1002/jpln.200900122	76	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0175972	10.1371/journal.pone.0175972	http://dx.doi.org/10.1371/journal.pone.0175972			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437448	Green Published, gold, Green Submitted			2022-12-26	WOS:000400287600025
J	Wang, WD; Xin, HW; Fang, XC; Dou, HT; Liu, FY; Huang, D; Han, SM; Fei, GJ; Zhu, LM; Zha, SH; Zhang, H; Ke, MY				Wang, Weida; Xin, Haiwei; Fang, Xiucai; Dou, Hongtao; Liu, Fangyi; Huang, Dan; Han, Shaomei; Fei, Guijun; Zhu, Liming; Zha, Shenghua; Zhang, Hong; Ke, Meiyun			Isomalto-oligosaccharides ameliorate visceral hyperalgesia with repair damage of ileal epithelial ultrastructure in rats	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; DOUBLE-BLIND; LACTULOSE INGESTION; ABDOMINAL-PAIN; NEW-MODEL; HYPERSENSITIVITY; STRESS; PROBIOTICS; MURINE; BIFIDOBACTERIA	Background Treatment of irritable bowel syndrome (IBS) with probiotics has achieved effectiveness to a certain extent. Whether prebiotics will work is still unclear. This study aimed to investigate the therapeutic effects of the prebiotic isomalto-oligosaccharides (IMO) on visceral hypersensitivity (VHS) in rats and to explore potential mechanism. Methods Water avoidance stress (WAS) was used to induce VHS in rats. The score for the abdominal withdrawal reflex (AWR) was determined while colorectal distension and compared between VHS group and control group in order to validate VHS preparation. Rats with VHS were then divided into an IMO-treated group (intragastric 5% IMO, 2 mL/d, 14 days) and a water-control group (intragastric water). After treatment, AWR score and intestinal transit rate (ITR) were determined, stool culture was performed, the ultrastructure of the ileum epithelium was observed with scanning electron microscopy (SEM), and serum cytokines were measured. Results WAS significantly increased AWR score responding to colorectal distension, and lowered the pain threshold. IMO treatment improved VHS with a reduction in AWR score on graded colorectal distension and an increase in pain threshold. SEM showed damages on the ileal epithelial ultrastructure in VHS rats, which was attenuated by IMO treatment. ITR, fecal microbiota and serum cytokine levels were comparable among control group, water-control group, and IMO-treated rats. Conclusion In this randomized placebo-controlled study, the results showed that IMO ameliorated WAS-induced visceral hyperalgesia in rats, this effect may be attributed to the repair of damages on intestinal epithelial ultrastructure.	[Wang, Weida; Xin, Haiwei; Fang, Xiucai; Liu, Fangyi; Fei, Guijun; Zhu, Liming; Ke, Meiyun] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Gastroenterol, Beijing, Peoples R China; [Wang, Weida; Xin, Haiwei; Fang, Xiucai; Dou, Hongtao; Liu, Fangyi; Fei, Guijun; Zhu, Liming; Ke, Meiyun] Peking Union Med Coll, Beijing, Peoples R China; [Dou, Hongtao] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Clin Lab, Beijing, Peoples R China; [Huang, Dan] Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Gastroenterol, Nanning, Peoples R China; [Han, Shaomei] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Epidemiol & Stat, Beijing, Peoples R China; [Han, Shaomei] Peking Union Med Coll, Sch Basic Med, Beijing, Peoples R China; [Zha, Shenghua; Zhang, Hong] Beijing Tongrentang Hlth Pharmaceut Co Ltd, Beijing, Peoples R China; [Wang, Weida] Sun Yat Sen Univ, Canc Ctr, Dept Hemotol & Oncol, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; State Key Lab Oncology South China; Sun Yat Sen University	Fang, XC (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Gastroenterol, Beijing, Peoples R China.; Fang, XC (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.	fangxiucai2@aliyun.com	Wang, Weida/HGV-1933-2022		National High-tech R&D Program ("863" Program) [2010AA023007]; National Key Technologies R&D Program in the 11th Five Year Plan period [2007BA104B01]	National High-tech R&D Program ("863" Program); National Key Technologies R&D Program in the 11th Five Year Plan period(National Key Technology R&D Program)	This work was funded by the National High-tech R&D Program ("863" Program, 2010AA023007) and the National Key Technologies R&D Program in the 11th Five Year Plan period (2007BA104B01) to author XF (http://www.most.gov.cn/eng/programmes1/200610/t20061009_36225.htm, http://www.most.gov.cn/eng/programmes1/200610/t20061009_36224.	Agostini S, 2012, NEUROGASTROENT MOTIL, V24, DOI 10.1111/j.1365-2982.2011.01865.x; Ait-Belgnaoui A, 2006, GUT, V55, P1090, DOI 10.1136/gut.2005.084194; Ait-Belgnaoui A, 2009, NEUROGASTROENT MOTIL, V21, P585, DOI 10.1111/j.1365-2982.2009.01280.x; Akbar A, 2009, ALIMENT PHARM THER, V30, P423, DOI 10.1111/j.1365-2036.2009.04056.x; Al-Chaer ED, 2000, GASTROENTEROLOGY, V119, P1276, DOI 10.1053/gast.2000.19576; Aziz Q, 2013, NEUROGASTROENT MOTIL, V25, P4, DOI 10.1111/nmo.12046; Boudeau J, 2003, ALIMENT PHARM THER, V18, P45, DOI 10.1046/j.1365-2036.2003.01638.x; Bouhnik Y, 2004, AM J CLIN NUTR, V80, P1658, DOI 10.1093/ajcn/80.6.1658; Bouhnik Y, 2004, EUR J CLIN NUTR, V58, P462, DOI 10.1038/sj.ejcn.1601829; Bradesi S, 2005, AM J PHYSIOL-GASTR L, V289, pG42, DOI 10.1152/ajpgi.00500.2004; Charbonneau D, 2013, GUT MICROBES, V4, P201, DOI 10.4161/gmic.24196; Christodoulides S, 2016, ALIMENT PHARM THER, V44, P103, DOI 10.1111/apt.13662; Dai C, 2012, MOL CELL BIOCHEM, V362, P43, DOI 10.1007/s11010-011-1126-5; Di Giacinto C, 2005, J IMMUNOL, V174, P3237, DOI 10.4049/jimmunol.174.6.3237; FLORENT C, 1985, J CLIN INVEST, V75, P608, DOI 10.1172/JCI111738; Ford AC, 2009, CLIN GASTROENTEROL H, V7, P1279, DOI 10.1016/j.cgh.2009.06.031; Ghoshal Uday C, 2010, J Neurogastroenterol Motil, V16, P40, DOI 10.5056/jnm.2010.16.1.40; Giannetti E, 2017, J CLIN GASTROENTEROL, V51, pE5, DOI 10.1097/MCG.0000000000000528; Goffin D, 2011, CRIT REV FOOD SCI, V51, P394, DOI 10.1080/10408391003628955; Horvath A, 2011, ALIMENT PHARM THER, V33, P1302, DOI 10.1111/j.1365-2036.2011.04665.x; Ketabi A, 2011, J APPL MICROBIOL, V110, P1297, DOI 10.1111/j.1365-2672.2011.04984.x; Koleva P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111717; Kolmeder Carolin A., 2016, PLOS ONE, V11; Lindsay B, 2013, J CLIN MICROBIOL, V51, P3263, DOI 10.1128/JCM.01342-13; Liu WF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108474; Lorenzo-Zuniga V, 2014, WORLD J GASTROENTERO, V20, P8709, DOI 10.3748/wjg.v20.i26.8709; Ludidi S, 2014, NEUROGASTROENT MOTIL, V26, P1104, DOI 10.1111/nmo.12365; Ludidi S, 2012, NEUROGASTROENT MOTIL, V24, P729, DOI 10.1111/j.1365-2982.2012.01926.x; Madsen K, 2001, GASTROENTEROLOGY, V121, P580, DOI 10.1053/gast.2001.27224; Mezzasalma V, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4740907; Mizubuchi H, 2005, J NUTR, V135, P2857, DOI 10.1093/jn/135.12.2857; Rachmilewitz D, 2004, GASTROENTEROLOGY, V126, P520, DOI 10.1053/j.gastro.2003.11.019; Rousseaux C, 2007, NAT MED, V13, P35, DOI 10.1038/nm1521; Santos J, 2001, GUT, V48, P630, DOI 10.1136/gut.48.5.630; Spiller R, 2008, ALIMENT PHARM THER, V28, P385, DOI 10.1111/j.1365-2036.2008.03750.x; Tilg H, 2016, GUT, V65, P2035, DOI 10.1136/gutjnl-2016-312729; Verdu EF, 2006, GUT, V55, P182, DOI 10.1136/gut.2005.066100; Wang H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090153; Wasilewski A, 2015, INFLAMM BOWEL DIS, V21, P1674, DOI 10.1097/MIB.0000000000000364; Whelan K, 2011, CURR OPIN CLIN NUTR, V14, P581, DOI 10.1097/MCO.0b013e32834b8082; Xu DB, 2014, GASTROENTEROLOGY, V146, P484, DOI 10.1053/j.gastro.2013.10.026; Yen CH, 2011, NUTRITION, V27, P445, DOI 10.1016/j.nut.2010.05.012	42	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0175276	10.1371/journal.pone.0175276	http://dx.doi.org/10.1371/journal.pone.0175276			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437458	gold, Green Published, Green Submitted			2022-12-26	WOS:000400287600006
J	Davies, AM; Allan, EG; Keeble, AH; Delgado, J; Cossins, BP; Mitropoulou, AN; Pang, MOY; Ceska, T; Beavil, AJ; Craggs, G; Westwood, M; Henry, AJ; McDonnell, JM; Sutton, BJ				Davies, Anna M.; Allan, Elizabeth G.; Keeble, Anthony H.; Delgado, Jean; Cossins, Benjamin P.; Mitropoulou, Alkistis N.; Pang, Marie O. Y.; Ceska, Tom; Beavil, Andrew J.; Craggs, Graham; Westwood, Marta; Henry, Alistair J.; McDonnell, James M.; Sutton, Brian J.			Allosteric mechanism of action of the therapeutic anti-IgE antibody omalizumab	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-EPSILON-RI; CONFORMATIONAL-CHANGES; MONOCLONAL-ANTIBODY; RECEPTOR COMPLEXES; CRYSTAL-STRUCTURE; MAMMALIAN-CELLS; AFFINITY; BINDING; DOMAIN; BENT	Immunoglobulin E and its interactions with receptors Fc is an element of RI and CD23 play a central role in allergic disease. Omalizumab, a clinically approved therapeutic antibody, inhibits the interaction between IgE and Fc is an element of RI, preventing mast cell and basophil activation, and blocks IgE binding to CD23 on B cells and anti-gen-presenting cells. We solved the crystal structure of the complex between an omalizumab-derived Fab and IgE-Fc, with one Fab bound to each C is an element of 3 domain. Free IgE-Fc adopts an acutely bent structure, but in the complex it is only partially bent, with large-scale conformational changes in the C is an element of 3 domains that inhibit the interaction with Fc is an element of RI. CD23 binding is inhibited sterically due to overlapping binding sites on each C is an element of 3 domain. Studies of omalizumab Fab binding in solution demonstrate the allosteric basis for Fc is an element of RI inhibition and, together with the structure, reveal how omalizumab may accelerate dissociation of receptor-bound IgE from Fc is an element of RI, exploiting the intrinsic flexibility and allosteric potential of IgE.	[Davies, Anna M.; Allan, Elizabeth G.; Keeble, Anthony H.; Mitropoulou, Alkistis N.; Pang, Marie O. Y.; Beavil, Andrew J.; McDonnell, James M.; Sutton, Brian J.] Kings Coll London, Randall Div Cell & Mol Biophys, New Hunts House,Guys Campus, London SE1 1UL, England; [Davies, Anna M.; Allan, Elizabeth G.; Keeble, Anthony H.; Mitropoulou, Alkistis N.; Pang, Marie O. Y.; Beavil, Andrew J.; McDonnell, James M.; Sutton, Brian J.] MRC, London SE1 1UL, England; [Davies, Anna M.; Allan, Elizabeth G.; Keeble, Anthony H.; Mitropoulou, Alkistis N.; Pang, Marie O. Y.; Beavil, Andrew J.; McDonnell, James M.; Sutton, Brian J.] Asthma UK Ctr Allerg Mech Asthma, London SE1 1UL, England; [Delgado, Jean; Cossins, Benjamin P.; Ceska, Tom; Craggs, Graham; Westwood, Marta; Henry, Alistair J.] UCB Celltech, 208 Bath Rd, Slough SL1 3WE, Berks, England	University of London; King's College London; University of London; King's College London; Celltech Group Ltd	McDonnell, JM; Sutton, BJ (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, New Hunts House,Guys Campus, London SE1 1UL, England.	james.mcdonnell@kcl.ac.uk; brian.sutton@kcl.ac.uk	Davies, Anna Marie/G-4575-2014	Davies, Anna Marie/0000-0003-1498-1594; Keeble, Anthony/0000-0002-4873-6960; Beavil, Andrew/0000-0002-0768-122X; Mitropoulou, Alkistis/0000-0002-1319-1294	Wellcome Trust [085944]; Medical Research Council [G0200486, G1000758, G1100090] Funding Source: researchfish; Asthma UK [MRC-AsthmaUKCentre, MRC-Asthma UK Centre] Funding Source: researchfish; MRC [G0200486, G1100090] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Diamond Light Source for access to beamlines I02 and I03 (Proposal No. MX1220) that contributed to the results presented here. We thank Marty Rajaratnam (King's College London) for use of the in-house X-ray facility. We thank Katherine Cain and Pallavi Bhatta for molecular biology support, Hanna Hailu for protein expression, and Amanda Oxbrow and Sue Cross for protein purification. The Centre for Biomolecular Spectroscopy, King's College London, was established with Capital Award 085944 from the Wellcome Trust.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; BEAVIL AJ, 1995, BIOCHEMISTRY-US, V34, P14449, DOI 10.1021/bi00044a023; Borthakur S, 2012, J BIOL CHEM, V287, P31457, DOI 10.1074/jbc.C112.397059; Borthakur S, 2011, BIOCHEMISTRY-US, V50, P4608, DOI 10.1021/bi200019y; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; COHEN ES, 2014, MABS, V0006; DAVIS KG, 1990, BIOCHEM SOC T, V18, P935, DOI 10.1042/bst0180935; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dhaliwal B, 2014, ACTA CRYSTALLOGR F, V70, P305, DOI 10.1107/S2053230X14003355; Drinkwater N, 2014, NAT STRUCT MOL BIOL, V21, P397, DOI 10.1038/nsmb.2795; Eggel A, 2014, J ALLERGY CLIN IMMUN, V133, P1709, DOI 10.1016/j.jaci.2014.02.005; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fersht A., 1999, STRUCTURE MECH PROTE, P103; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Hodis E, 2007, TRENDS BIOCHEM SCI, V32, P199, DOI 10.1016/j.tibs.2007.03.008; Holdom MD, 2011, NAT STRUCT MOL BIOL, V18, P571, DOI 10.1038/nsmb.2044; Holgate S, 2005, J ALLERGY CLIN IMMUN, V115, P459, DOI 10.1016/j.jaci.2004.11.053; Holgate ST, 2014, WORLD ALLERGY ORGAN, V7, DOI 10.1186/1939-4551-7-17; HOLOWKA D, 1985, BIOCHEMISTRY-US, V24, P6260, DOI 10.1021/bi00343a033; HOLOWKA D, 1983, BIOCHEMISTRY-US, V22, P3475, DOI 10.1021/bi00283a026; Howarth M, 2008, NAT PROTOC, V3, P534, DOI 10.1038/nprot.2008.20; Hunt J, 2012, J BIOL CHEM, V287, P17459, DOI 10.1074/jbc.M111.331967; Jensen RK, 2015, ACTA CRYSTALLOGR F, V71, P419, DOI 10.1107/S2053230X15004100; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim B, 2012, NATURE, V491, P613, DOI 10.1038/nature11546; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lowe PJ, 2009, BRIT J CLIN PHARMACO, V68, P61, DOI 10.1111/j.1365-2125.2009.03401.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Price NE, 2005, J BIOL CHEM, V280, P2324, DOI 10.1074/jbc.M409458200; Shi JG, 1997, BIOCHEMISTRY-US, V36, P2112, DOI 10.1021/bi961231e; Shiung YY, 2012, IMMUNOBIOLOGY, V217, P676, DOI 10.1016/j.imbio.2011.11.006; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Sutton BJ, 2015, IMMUNOL REV, V268, P222, DOI 10.1111/imr.12340; Urzhumtseva L, 2009, ACTA CRYSTALLOGR D, V65, P297, DOI 10.1107/S0907444908044296; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wan T, 2002, NAT IMMUNOL, V3, P681, DOI 10.1038/ni811; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Wright JD, 2015, SCI REP-UK, V5, DOI 10.1038/srep11581; Wurzburg B. A., 2009, J MOL BIOL; YOUNG RJ, 1995, PROTEIN ENG, V8, P193, DOI 10.1093/protein/8.2.193; Yuan DP, 2013, J BIOL CHEM, V288, P21667, DOI 10.1074/jbc.M113.480657; Zheng L, 2008, BIOCHEM BIOPH RES CO, V375, P619, DOI 10.1016/j.bbrc.2008.08.055; ZHENG Y, 1992, BIOCHEMISTRY-US, V31, P7446, DOI 10.1021/bi00148a004; ZHENG Y, 1991, BIOCHEMISTRY-US, V30, P9125, DOI 10.1021/bi00102a002	49	48	49	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					9975	9987		10.1074/jbc.M117.776476	http://dx.doi.org/10.1074/jbc.M117.776476			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28438838	Green Published, hybrid			2022-12-26	WOS:000403580600011
J	Davidson, S; Pretty, C; Pironet, A; Desaive, T; Janssen, N; Lambermont, B; Morimont, P; Chase, JG				Davidson, Shaun; Pretty, Chris; Pironet, Antoine; Desaive, Thomas; Janssen, Nathalie; Lambermont, Bernard; Morimont, Philippe; Chase, J. Geoffrey			Minimally invasive estimation of ventricular dead space volume through use of Frank-Starling curves	PLOS ONE			English	Article							CANINE LEFT-VENTRICLE; PRESSURE; HEART; LOAD; CONTRACTILITY; SENSITIVITY; LINEARITY; METRICS; RATIO	This paper develops a means of more easily and less invasively estimating ventricular dead space volume (Vd), an important, but difficult to measure physiological parameter. Vd represents a subject and condition dependent portion of measured ventricular volume that is not actively participating in ventricular function. It is employed in models based on the time varying elastance concept, which see widespread use in haemodynamic studies, and may have direct diagnostic use. The proposed method involves linear extrapolation of a Frank-Starling curve (stroke volume vs end-diastolic volume) and its end-systolic equivalent (stroke volume vs end-systolic volume), developed across normal clinical procedures such as recruitment manoeuvres, to their point of intersection with the y-axis (where stroke volume is 0) to determine Vd. To demonstrate the broad applicability of the method, it was validated across a cohort of six sedated and anaesthetised male Pietrain pigs, encompassing a variety of cardiac states from healthy baseline behaviour to circulatory failure due to septic shock induced by endotoxin infusion. Linear extrapolation of the curves was supported by strong linear correlation coefficients of R = 0.78 and R = 0.80 average for pre- and post-endotoxin infusion respectively, as well as good agreement between the two linearly extrapolated y-intercepts (Vd) for each subject (no more than 7.8% variation). Method validity was further supported by the physiologically reasonable Vd values produced, equivalent to 44.3-53.1% and 49.3-82.6% of baseline end-systolic volume before and after endotoxin infusion respectively. This method has the potential to allow Vd to be estimated without a particularly demanding, specialised protocol in an experimental environment. Further, due to the common use of both mechanical ventilation and recruitment manoeuvres in intensive care, this method, subject to the availability of multi-beat echocardiography, has the potential to allow for estimation of Vd in a clinical environment.	[Davidson, Shaun; Pretty, Chris; Chase, J. Geoffrey] Univ Canterbury, Dept Mech Engn, Christchurch, New Zealand; [Pironet, Antoine; Desaive, Thomas] Univ Liege, GIGA Cardiovasc Sci, Liege, Belgium; [Janssen, Nathalie; Lambermont, Bernard; Morimont, Philippe] Ctr Hosp Univ Liege, Liege, Belgium	University of Canterbury; University of Liege; University of Liege	Davidson, S (corresponding author), Univ Canterbury, Dept Mech Engn, Christchurch, New Zealand.	shaun.davidson@pg.canterbury.ac.nz		Davidson, Shaun/0000-0002-5868-8640	Engineering Technology-based Innovation in Medicine (eTIME) consortium grant [eTIME 318943]; EU FP7 International Research Staff Exchange Schem (IRSES) grant [PIRSES-GA-2012-318943]; Fonds de la Recherche Scientifique (F.R.S) grant; University of Canterbury 'Canterbury Scholarship' grant	Engineering Technology-based Innovation in Medicine (eTIME) consortium grant; EU FP7 International Research Staff Exchange Schem (IRSES) grant; Fonds de la Recherche Scientifique (F.R.S) grant(Fonds de la Recherche Scientifique - FNRS); University of Canterbury 'Canterbury Scholarship' grant	This work was supported by the Engineering Technology-based Innovation in Medicine (eTIME) consortium grant [eTIME 318943]; the EU FP7 International Research Staff Exchange Schem (IRSES) grant [#PIRSES-GA-2012-318943]; the Fonds de la Recherche Scientifique (F.R.S) grant; and the University of Canterbury 'Canterbury Scholarship' grant.	Davidson S, 2015, C P IEEE ENG MED BIO; Faes TJC, 2015, CLIN MED INSIGHTS-CA, V9, P73, DOI 10.4137/CMC.S18748; Fernandes CJ, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/896430; GLOWER DD, 1985, CIRCULATION, V71, P994, DOI 10.1161/01.CIR.71.5.994; Golub GH, 1979, TOTAL LEAST SQUARES, P69; GROSSMAN W, 1977, CIRCULATION, V56, P845, DOI 10.1161/01.CIR.56.5.845; Hunter JD, 2010, BRIT J ANAESTH, V104, P3, DOI 10.1093/bja/aep339; JARDIN F, 1981, NEW ENGL J MED, V304, P387, DOI 10.1056/NEJM198102123040703; Kamoi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102476; KASS DA, 1987, CIRCULATION, V76, P1422, DOI 10.1161/01.CIR.76.6.1422; Kirkpatrick E, 2014, PEDIAT CONGENITAL CA, P879; MEHMEL HC, 1981, CIRCULATION, V63, P1216, DOI 10.1161/01.CIR.63.6.1216; Nguyen HB, 2006, ANN EMERG MED, V48, P28, DOI 10.1016/j.annemergmed.2006.02.015; Paulus WJ, 2007, EUR HEART J; Pironet AD, 2013, MODEL BASED COMPUTAT; Randles R. H., 1988, ENCY STAT SCI; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; SAGAWA K, 1981, CIRCULATION, V63, P1223, DOI 10.1161/01.CIR.63.6.1223; SARNOFF SJ, 1954, CIRCULATION, V9, P706, DOI 10.1161/01.CIR.9.5.706; Sato T, 1998, AM J PHYSIOL-HEART C, V274, pH1429, DOI 10.1152/ajpheart.1998.274.5.H1429; Stevenson D, 2012, BIOMEDICAL ENG, V11, P1; Stevenson D, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-73; SUGA H, 1974, CIRC RES, V35, P117, DOI 10.1161/01.RES.35.1.117; SUGA H, 1973, CIRC RES, V32, P314, DOI 10.1161/01.RES.32.3.314; Sunagawa K, 1980, CORONARY PERFUSION P; VANDERVELDE ET, 1991, CIRCULATION, V83, P315, DOI 10.1161/01.CIR.83.1.315; Vincent Jean-Louis, 2004, Crit Care Med, V32, pS451, DOI 10.1097/01.CCM.0000142984.44321.A4	27	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176302	10.1371/journal.pone.0176302	http://dx.doi.org/10.1371/journal.pone.0176302			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448528	gold, Green Published, Green Submitted			2022-12-26	WOS:000400383600057
J	Farahat, M; Sathi, GA; Hara, ES; Taketa, H; Kuboki, T; Matsumoto, T				Farahat, Mahmoud; Sathi, Gulsan Ara; Hara, Emilio Satoshi; Taketa, Hiroaki; Kuboki, Takuo; Matsumoto, Takuya			MSCs feeder layers induce SMG self-organization and branching morphogenesis	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; MESENCHYMAL STEM-CELLS; SALIVARY-GLAND REGENERATION; BIOENGINEERED ORGAN GERM; MEMBRANE-LIKE SUBSTRATUM; EPITHELIAL-CELLS; CULTURE; TISSUES; FILTER	Dysfunction of salivary glands leads to several oral health problems, including dental caries, mastication and swallowing dysfunctions and multiple oral infections. Conventional treatments for such condition fell short of providing satisfying therapeutic results. Recent advances in organ regeneration therapy which utilize tissue stem cells to fabricate bioengineered 3D organ buds, have introduced a promising therapeutic tool for full functional organ regeneration. However, finding a sustainable and easily accessible cell source for such approaches is still challenging, especially in case of severely atrophied tissues such as irradiated salivary glands. In response to this, we hypothesized that bone marrow derived mesenchymal stem cells (MSCs) could be used as feeder cells to induce salivary epithelial tissues/cells branching. Indeed, in 2D cultures, MSCs supported branching of embryonic submandibular salivary gland (SMG) epithelium. Interestingly, this enhancing effect was dependent on the initial number of MSC feeder cells. In addition, MSCs supported the selfassembly of SMG epithelial progenitor cells into well-patterned and branched 3D salivary organoids. Therefore, these findings propose MSCs as a valuable candidate cell source for induced SMG epithelial branching, which can potentially be applied in future methods for SMG regeneration approaches.	[Farahat, Mahmoud; Hara, Emilio Satoshi; Taketa, Hiroaki; Matsumoto, Takuya] Okayama Univ, Dept Biomat, Okayama, Japan; [Farahat, Mahmoud; Kuboki, Takuo] Okayama Univ, Dept Oral Rehabil & Regenerat Med, Okayama, Japan; [Sathi, Gulsan Ara] Yamagata Univ, Grad Sch Sci & Engn, Dept Biosyst Engn, Yamagata, Japan; [Taketa, Hiroaki] Okayama Univ, Ctr Dev Med & Hlth Care Educ, Okayama, Japan	Okayama University; Okayama University; Yamagata University; Okayama University	Matsumoto, T (corresponding author), Okayama Univ, Dept Biomat, Okayama, Japan.	tmatsu@md.okayama-u.ac.jp	Hara, Emilio Satoshi/ABA-9954-2021; Hara, Emilio S/B-3922-2017	Hara, Emilio Satoshi/0000-0001-7374-3487; Hara, Emilio S/0000-0001-7374-3487; Farahat, Mahmoud/0000-0002-1085-2405; Kuboki, Takuo/0000-0003-3756-2835; Kazi, Gulsan Ara Sathi/0000-0002-5124-0376	JSPS [25293402, 16H05533];  [26106718]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas 26106718 and JSPS Grant in Aid for Scientific Research 25293402 and 16H05533 received by T. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyer Nardi N, 2006, HANDB EXP PHARM, V174, P249; Camazine S., 2001, SELF ORG BIOL SYSTEM, DOI DOI 10.1515/9780691212920; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; CUTLER L S, 1991, Critical Reviews in Oral Biology and Medicine, V2, P1; Edgar M., 2004, SALIVA ORAL HLTH; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Furue M, 1999, IN VITRO CELL DEV-AN, V35, P131; GROBSTEIN C, 1953, NATURE, V172, P869, DOI 10.1038/172869a0; GROBSTEIN C, 1953, SCIENCE, V118, P52, DOI 10.1126/science.118.3054.52; Heisenberg CP, 2013, CELL, V153, P948, DOI 10.1016/j.cell.2013.05.008; Ikari T, 2003, DEV DYNAM, V228, P173, DOI 10.1002/dvdy.10377; KUSAKABE M, 1985, DEV BIOL, V110, P382, DOI 10.1016/0012-1606(85)90097-1; Llames S, 2015, TISSUE ENG PART B-RE, V21, P345, DOI [10.1089/ten.teb.2014.0547, 10.1089/ten.TEB.2014.0547]; Mao AS, 2015, P NATL ACAD SCI USA, V112, P14452, DOI 10.1073/pnas.1508520112; MONTESANO R, 1991, CELL, V67, P901, DOI 10.1016/0092-8674(91)90363-4; Nakao K, 2007, NAT METHODS, V4, P227, DOI 10.1038/nmeth1012; Nelson CM, 2006, SCIENCE, V314, P298, DOI 10.1126/science.1131000; NOGAWA H, 1991, DEVELOPMENT, V112, P855; Ochoa-Espinosa A, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008243; Ogawa M, 2015, ODONTOLOGY, V103, P248, DOI 10.1007/s10266-015-0210-9; Ogawa M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3498; Omoto M, 2009, INVEST OPHTH VIS SCI, V50, P2109, DOI 10.1167/iovs.08-2262; Patel VN, 2006, DIFFERENTIATION, V74, P349, DOI 10.1111/j.1432-0436.2006.00088.x; Sasai Y, 2013, NATURE, V493, P318, DOI 10.1038/nature11859; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Sordi Valeria, 2010, Rev Diabet Stud, V7, P132, DOI 10.1900/RDS.2010.7.132; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TAKAHASHI Y, 1991, DEVELOPMENT, V111, P327; Takebe T, 2015, CELL STEM CELL, V16, P556, DOI 10.1016/j.stem.2015.03.004; Tatsuishi Y, 2009, INT J MOL MED, V24, P361, DOI 10.3892/ijmm_00000240; Tucker AS, 2007, SEMIN CELL DEV BIOL, V18, P237, DOI 10.1016/j.semcdb.2007.01.006; Tucker AS, 2010, FRONT ORAL BIOL, V14, P21, DOI 10.1159/000313705; Vissink A, 2010, INT J RADIAT ONCOL, V78, P983, DOI 10.1016/j.ijrobp.2010.06.052; Wei C, 2007, TISSUE ENG, V13, P721, DOI 10.1089/ten.2006.0123	36	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176453	10.1371/journal.pone.0176453	http://dx.doi.org/10.1371/journal.pone.0176453			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448600	Green Submitted, Green Published, gold			2022-12-26	WOS:000400383600083
J	Huang, WY; Chang, CC; Chen, DR; Kor, CT; Chen, TY; Wu, HM				Huang, Wan-Yu; Chang, Chia-Chu; Chen, Dar-Ren; Kor, Chew-Teng; Chen, Ting-Yu; Wu, Hung-Ming			Circulating leptin and adiponectin are associated with insulin resistance in healthy postmenopausal women with hot flashes	PLOS ONE			English	Article							MENOPAUSAL VASOMOTOR SYMPTOMS; CARDIOVASCULAR-DISEASE; RISK; ADIPOCYTOKINES; ADIPOKINES; RATIO	Introduction Hot flashes have been postulated to be linked to the development of metabolic disorders. This study aimed to evaluate the relationship between hot flashes, adipocyte-derived hormones, and insulin resistance in healthy, non-obese postmenopausal women. Participants and design In this cross-sectional study, a total of 151 women aged 45 - 60 years were stratified into one of three groups according to hot-flash status over the past three months: never experienced hot flashes (Group N), mild-to-moderate hot flashes (Group M), and severe hot flashes (Group S). Variables measured in this study included clinical parameters, hot flash experience, fasting levels of circulating glucose, lipid profiles, plasma insulin, and adipocytederived hormones. Multiple linear regression analysis was used to evaluate the associations of hot flashes with adipocyte-derived hormones, and with insulin resistance. Settings The study was performed in a hospital medical center. Results The mean (standard deviation) of body-mass index was 22.8(2.7) for Group N, 22.6(2.6) for Group M, and 23.5(2.4) for Group S, respectively. Women in Group S displayed statistically significantly higher levels of leptin, fasting glucose, and insulin, and lower levels of adiponectin than those in Groups M and N. Multivariate linear regression analysis revealed that hotflash severity was significantly associated with higher leptin levels, lower adiponectin levels, and higher leptin-to-adiponectin ratio. Univariate linear regression analysis revealed that hot-flash severity was strongly associated with a higher HOMA-IR index (% difference, 58.03%; 95% confidence interval, 31.00 = 90.64; p < 0.001). The association between hot flashes and HOMA-IR index was attenuated after adjusting for leptin or adiponectin and was no longer significant after simultaneously adjusting for leptin and adiponectin. Conclusion The present study provides evidence that hot flashes are associated with insulin resistance in postmenopausal women. It further suggests that hot flash association with insulin resistance is dependent on the combination of leptin and adiponectin variables.	[Huang, Wan-Yu] Natl Cheng Kung Univ, Inst Basic Med Sci, Coll Med, Tainan, Taiwan; [Chang, Chia-Chu] Changhua Christian Hosp, Dept Nephrol, Changhua, Taiwan; [Chen, Dar-Ren] Changhua Christian Hosp, Comprehens Breast Canc Ctr, Changhua, Taiwan; [Kor, Chew-Teng] Changhua Christian Hosp, Internal Med Res Ctr, Changhua, Taiwan; [Chen, Ting-Yu; Wu, Hung-Ming] Changhua Christian Hosp, Inflammat Res & Drug Dev Ctr, Changhua, Taiwan; [Wu, Hung-Ming] Changhua Christian Hosp, Dept Neurol, Changhua, Taiwan; [Wu, Hung-Ming] China Med Univ, Grad Inst Acupuncture Sci, Taichung, Taiwan	National Cheng Kung University; Changhua Christian Hospital; Changhua Christian Hospital; Changhua Christian Hospital; Changhua Christian Hospital; Changhua Christian Hospital; China Medical University Taiwan	Wu, HM (corresponding author), Changhua Christian Hosp, Inflammat Res & Drug Dev Ctr, Changhua, Taiwan.; Wu, HM (corresponding author), Changhua Christian Hosp, Dept Neurol, Changhua, Taiwan.; Wu, HM (corresponding author), China Med Univ, Grad Inst Acupuncture Sci, Taichung, Taiwan.	18288@cch.org.tw	Chen, Ting-Yu/AAD-8375-2021		Ministry of Science and Technology, Taiwan [MOST 105-2314-6-371-004]; Changhua Christian Hospital Research Foundation, Taiwan [100-CCH-IRP-50, 105-CCH-IRP-092, 105-CCH-PRJ-006]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Changhua Christian Hospital Research Foundation, Taiwan	This work was supported by the Ministry of Science and Technology, Taiwan (MOST 105-2314-6-371-004) to HMW, and the Changhua Christian Hospital Research Foundation, Taiwan (100-CCH-IRP-50, 105-CCH-IRP-092, and 105-CCH-PRJ-006) to HMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrinier N, 2010, MATURITAS, V65, P237, DOI 10.1016/j.maturitas.2009.11.023; Alexander C, 2010, FERTIL STERIL, V94, P1037, DOI 10.1016/j.fertnstert.2009.04.001; Asimakopoulos B, 2009, ENDOCR J, V56, P425, DOI 10.1507/endocrj.K08E-222; Avis NE, 2015, JAMA INTERN MED, V175, P531, DOI 10.1001/jamainternmed.2014.8063; Bechlioulis A, 2010, J CLIN ENDOCR METAB, V95, P1199, DOI 10.1210/jc.2009-2262; Esteve E, 2009, DIABETES CARE, V32, pS362, DOI 10.2337/dc09-S340; Finucane FM, 2009, DIABETOLOGIA, V52, P2345, DOI 10.1007/s00125-009-1508-3; Hardie L, 1997, CLIN ENDOCRINOL, V47, P101, DOI 10.1046/j.1365-2265.1997.2441017.x; Hitchcock CL, 2012, MENOPAUSE, V19, P1208, DOI 10.1097/gme.0b013e31825541cc; Howard BV, 2003, METABOLISM, V52, P362, DOI 10.1053/meta.2003.50057; Jackson MB, 2006, CLIN SCI, V110, P143, DOI 10.1042/CS20050243; Kwon Hyokjoon, 2013, Front Endocrinol (Lausanne), V4, P71, DOI 10.3389/fendo.2013.00071; Lecke SB, 2011, BRAZ J MED BIOL RES, V44, P381, DOI [10.1590/S0100-879X2011007500035, 10.1590/S0100-879X2011000500001]; Makki Kassem, 2013, ISRN Inflamm, V2013, P139239, DOI 10.1155/2013/139239; Ohayon MM, 2006, ARCH INTERN MED, V166, P1262, DOI 10.1001/archinte.166.12.1262; Pagidipati NJ, 2013, CIRCULATION, V127, P749, DOI 10.1161/CIRCULATIONAHA.112.128413; Perez-Lopez FR, 2009, FERTIL STERIL, V92, P1171, DOI 10.1016/j.fertnstert.2009.06.032; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Rossouw JE, 2007, JAMA-J AM MED ASSOC, V297, P1465, DOI 10.1001/jama.297.13.1465; Satoh N, 2004, DIABETES CARE, V27, P2488, DOI 10.2337/diacare.27.10.2488; Sloan JA, 2001, J CLIN ONCOL, V19, P4280, DOI 10.1200/JCO.2001.19.23.4280; Sowers MR, 2008, MATURITAS, V59, P149, DOI 10.1016/j.maturitas.2007.12.006; Szmuilowicz ED, 2012, NAT REV ENDOCRINOL, V8, P701, DOI 10.1038/nrendo.2012.184; Szmuilowicz ED, 2011, MENOPAUSE, V18, P603, DOI 10.1097/gme.0b013e3182014849; Thurston RC, 2008, CIRCULATION, V118, P1234, DOI 10.1161/CIRCULATIONAHA.108.776823; Thurston RC, 2011, OBSTET GYN CLIN N AM, V38, P489, DOI 10.1016/j.ogc.2011.05.006; Thurston RC, 2013, FERTIL STERIL, V100, P793, DOI 10.1016/j.fertnstert.2013.05.005; Thurston RC, 2012, J CLIN ENDOCR METAB, V97, P3487, DOI 10.1210/jc.2012-1410; Thurston RC, 2012, OBSTET GYNECOL, V119, P753, DOI 10.1097/AOG.0b013e31824a09ec; Zhuo Q, 2009, DIABETES RES CLIN PR, V84, P27, DOI 10.1016/j.diabres.2008.12.019	30	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176430	10.1371/journal.pone.0176430	http://dx.doi.org/10.1371/journal.pone.0176430			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448547	gold, Green Published, Green Submitted			2022-12-26	WOS:000400383600079
J	Kumar, NP; Banurekha, VV; Nair, D; Babu, S				Kumar, Nathella Pavan; Banurekha, Vaithilingam V.; Nair, Dina; Babu, Subash			Diminished plasma levels of common gamma-chain cytokines in pulmonary tuberculosis and reversal following treatment	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; IMMUNE-RESPONSE; T-CELLS; IN-VIVO; IL-7; INFECTION; CD4(+); MEMORY; NAIVE; DIFFERENTIATION	Background The immune response to tuberculosis (TB) is T cell dependent. T cells are the major facilitators of protection and effector functions with CD4(+) T cells being the most important players, followed by CD8(+) T cells. The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 play a vital role in peripheral T cell growth and survival. However, the role of common gamma-chain cytokines in pulmonary TB (PTB) is poorly understood. Aim and methods To examine the association of circulating common.-chain cytokines with TB disease or infection, we examined the systemic levels of IL-2, IL-7, IL-15, and IL-21 in individuals with PTB, latent TB (LTB) or no TB infection (NTB). We also examined the levels of these cytokines in PTB individuals before and after anti-tuberculosis treatment. Results Circulating levels of IL-2, IL-7 and IL-21 were significantly diminished in PTB compared to LTB or NTB individuals. Moreover, TB antigen stimulated whole blood also exhibited diminished levels of common gamma-chain cytokines in PTB compared to LTB or NTB individuals. The plasma levels of common gamma-chain cytokines exhibited no significant association with the severity or extent of TB disease or with bacterial burdens. However, upon standard anti-TB treatment, both the systemic as well as the TB antigen stimulated levels of IL-2, IL-7 and IL21 were significantly increased in PTB individuals. Conclusion Therefore our data demonstrate that diminished levels of common gamma-chain cytokines are a common characteristic of PTB and potentially highlight the importance of boosting these responses to improve treatment outcomes.	[Kumar, Nathella Pavan; Babu, Subash] Natl Inst Hlth, NIRT, Int Ctr Excellence Res, Chennai, Tamil Nadu, India; [Banurekha, Vaithilingam V.; Nair, Dina] Natl Inst Res TB, Madras, Tamil Nadu, India; [Babu, Subash] NIAID, Parasit Dis Lab, NIH, Bethesda, MD USA	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kumar, NP (corresponding author), Natl Inst Hlth, NIRT, Int Ctr Excellence Res, Chennai, Tamil Nadu, India.	pavankumarn@nirt.res.in	Babu, Subash/GXG-4746-2022; Kumar, Nathella Pavan/AAU-2328-2021		Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001065] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2512-y; Aktas E, 2009, SCAND J IMMUNOL, V70, P300, DOI 10.1111/j.1365-3083.2009.02294.x; Amicosante M, 2003, J INFECT DIS, V188, P661, DOI 10.1086/377454; Anbarasu D, 2013, CYTOKINE, V61, P747, DOI 10.1016/j.cyto.2012.12.031; Anuradha R, 2016, INFECT IMMUN, V84, P425, DOI 10.1128/IAI.01354-15; Bhatt K, 2004, J IMMUNOL, V172, P2748, DOI 10.4049/jimmunol.172.5.2748; Blattman JN, 2003, NAT MED, V9, P540, DOI 10.1038/nm866; Booty MG, SCI REP, V6, P36720; Brighenti S, 2012, J INFECT DIS, V205, pS316, DOI 10.1093/infdis/jis043; Chackerian AA, 2002, INFECT IMMUN, V70, P4501, DOI 10.1128/IAI.70.8.4501-4509.2002; Chen CY, 2012, J IMMUNOL, V188, P4278, DOI 10.4049/jimmunol.1101291; Chevalier MF, 2011, J VIROL, V85, P733, DOI 10.1128/JVI.02030-10; Cooper AM, 2011, MUCOSAL IMMUNOL, V4, P252, DOI 10.1038/mi.2011.13; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Doherty TM, 1996, J IMMUNOL, V156, P735; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; FERRARI G, 1995, CLIN EXP IMMUNOL, V101, P239; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Frahm M, 2011, TUBERCULOSIS, V91, P250, DOI 10.1016/j.tube.2011.02.006; Geginat J, 2001, J EXP MED, V194, P1711, DOI 10.1084/jem.194.12.1711; Gu XXJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000300; Habib T, 2003, J ALLERGY CLIN IMMUN, V112, P1033, DOI 10.1016/j.jaci.2003.08.039; Iannello A, 2010, J IMMUNOL, V184, P114, DOI 10.4049/jimmunol.0901967; Katti MK, 2011, ARCH MED RES, V42, P199, DOI 10.1016/j.arcmed.2011.04.012; KAUFMANN SHE, 1995, IMMUNOL TODAY, V16, P338, DOI 10.1016/0167-5699(95)80151-0; Kerzerho J, 2016, JAIDS-J ACQ IMM DEF, V71, P172, DOI 10.1097/QAI.0000000000000832; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kumar NP, 2011, CLIN VACCINE IMMUNOL, V18, P1856, DOI 10.1128/CVI.05366-11; Kumar Nathella Pavan, 2013, Ann Am Thorac Soc, V10, P441, DOI 10.1513/AnnalsATS.201305-112OC; Kumar NP, PLOS ONE, V9; Kumar NP, PLOS ONE, V11; Leonard WJ, 2005, NAT REV IMMUNOL, V5, P688, DOI 10.1038/nri1688; LEVETON C, 1989, INFECT IMMUN, V57, P390, DOI 10.1128/IAI.57.2.390-395.1989; Levy Y, 2006, M S-MED SCI, V22, P751, DOI 10.1051/medsci/20062289751; Levy Y, 2009, J CLIN INVEST, V119, P997, DOI 10.1172/JCI38052; Liao W, 2011, CURR OPIN IMMUNOL, V23, P598, DOI 10.1016/j.coi.2011.08.003; Lim MS, 2004, J MOL DIAGN, V6, P59, DOI 10.1016/S1525-1578(10)60493-X; Lori F, 2006, SPRINGER SEMIN IMMUN, V28, P231, DOI 10.1007/s00281-006-0047-y; Ma A, 2000, J EXP MED, V191, P753, DOI 10.1084/jem.191.5.753; Maeurer MJ, 2000, INFECT IMMUN, V68, P2962, DOI 10.1128/IAI.68.5.2962-2970.2000; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; Mehta DS, 2004, IMMUNOL REV, V202, P84, DOI 10.1111/j.0105-2896.2004.00201.x; Melchionda F, 2005, J CLIN INVEST, V115, P1177, DOI 10.1172/JCI200523134; Mohan T, 2013, INDIAN J MED RES, V138, P779; Ozaki K, 2000, P NATL ACAD SCI USA, V97, P11439, DOI 10.1073/pnas.200360997; Pellegrini M, 2011, CELL, V144, P601, DOI 10.1016/j.cell.2011.01.011; Pydi SS, 2011, TUBERCULOSIS, V91, P136, DOI 10.1016/j.tube.2010.12.003; Rosenberg SA, 2006, J IMMUNOTHER, V29, P313, DOI 10.1097/01.cji.0000210386.55951.c2; Saunders BM, 2002, CELL IMMUNOL, V216, P65, DOI 10.1016/S0008-8749(02)00510-5; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; SIELING PA, 1995, J IMMUNOL, V154, P2775; Singh V, 2010, J INFECT DIS, V202, P480, DOI 10.1086/653827; Suzukawa M, PLOS ONE, V11; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Toe JG, 2013, MOL IMMUNOL, V56, P38, DOI 10.1016/j.molimm.2013.04.008; Waitt CJ, BMC INFECT DIS, V15, P513; Walker NF, 2013, FUTURE VIROL, V8, P57, DOI 10.2217/FVL.12.123; Wang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051338; Webb LMC, 1999, IMMUNOLOGY, V98, P400, DOI 10.1046/j.1365-2567.1999.00906.x; Wei M, 2015, GENET MOL RES, V14, P17182, DOI 10.4238/2015.December.16.18; Zuniga J, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/193923	61	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176495	10.1371/journal.pone.0176495	http://dx.doi.org/10.1371/journal.pone.0176495			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448542	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000400383600089
J	Naour, S; Espinoza, BM; Aedo, JE; Zuloaga, R; Maldonado, J; Bastias-Molina, M; Silva, H; Meneses, C; Gallardo-Escarate, C; Molina, A; Valdes, JA				Naour, Sebastian; Espinoza, Brisa M.; Aedo, Jorge E.; Zuloaga, Rodrigo; Maldonado, Jonathan; Bastias-Molina, Macarena; Silva, Herman; Meneses, Claudio; Gallardo-Escarate, Cristian; Molina, Alfredo; Antonio Valdes, Juan			Transcriptomic analysis of the hepatic response to stress in the red cusk-eel (Genypterus chilensis): Insights into lipid metabolism, oxidative stress and liver steatosis	PLOS ONE			English	Article							RAINBOW-TROUT; GLUCOSE-METABOLISM; GENE-EXPRESSION; ONCORHYNCHUS-MYKISS; FATTY-ACIDS; PPAR-ALPHA; CORTISOL; FISH; TRANSPORT	Teleosts exhibit a broad divergence in their adaptive response to stress, depending on the magnitude, duration, and frequency of stressors and the species receiving the stimulus. We have previously reported that the red cusk-eel (Genypterus chilensis), an important marine farmed fish, shows a physiological response to stress that results in increased skeletal muscle atrophy mediated by over-expression of components of the ubiquitin proteasome and autophagy-lysosomal systems. To better understand the systemic effects of stress on the red cusk-eel metabolism, the present study assessed the transcriptomic hepatic response to repetitive handling-stress. Using high-throughput RNA-seq, 259 up-regulated transcripts were found, mostly associated with angiogenesis, gluconeogenesis, and triacylglyceride catabolism. Conversely, 293 transcripts were down-regulated, associated to cholesterol biosynthesis, PPARa signaling, fatty acid biosynthesis, and glycolysis. This gene signature was concordant with hepatic metabolite levels and hepatic oxidative damage. Moreover, the increased plasmatic levels of AST (aspartate aminotransferase), ALT (alanine aminotransferase) and AP (alkaline phosphatase), as well as liver histology suggest stress-induced liver steatosis. This study offers an integrative molecular and biochemical analysis of the hepatic response to handling-stress, and reveals unknown aspects of lipid metabolism in a non-model teleost.	[Naour, Sebastian; Espinoza, Brisa M.; Aedo, Jorge E.; Zuloaga, Rodrigo; Molina, Alfredo; Antonio Valdes, Juan] Univ Andres Bello, Fac Ciencias Biol, Lab Biotecnol Mol, Santiago, Chile; [Naour, Sebastian; Espinoza, Brisa M.; Aedo, Jorge E.; Zuloaga, Rodrigo; Gallardo-Escarate, Cristian; Molina, Alfredo; Antonio Valdes, Juan] Interdisciplinary Ctr Aquaculture Res INCAR, Concepcion, Chile; [Maldonado, Jonathan; Silva, Herman] Univ Chile, Fac Ciencias Agron, Dept Prod Agr, Lab Genom Func & Bioinformat, Av Santa Rosa, Santiago, Chile; [Bastias-Molina, Macarena; Meneses, Claudio] Univ Andres Bello, Fac Ciencias Biol, Ctr Biotecnol Vegetal, FONDAP Ctr Genome Regulat, Santiago, Chile; [Gallardo-Escarate, Cristian] Univ Concepcion, Lab Biotechnol & Aquat Genom, Concepcion, Chile; [Molina, Alfredo; Antonio Valdes, Juan] Univ Andres Bello, Ctr Invest Marina Quintay CIMARQ, Fac Ecol & Recursos Nat, Valparaiso, Chile	Universidad Andres Bello; Universidad de Chile; Universidad Andres Bello; Universidad de Concepcion; Universidad Andres Bello	Molina, A; Valdes, JA (corresponding author), Univ Andres Bello, Fac Ciencias Biol, Lab Biotecnol Mol, Santiago, Chile.; Molina, A; Valdes, JA (corresponding author), Interdisciplinary Ctr Aquaculture Res INCAR, Concepcion, Chile.; Molina, A; Valdes, JA (corresponding author), Univ Andres Bello, Ctr Invest Marina Quintay CIMARQ, Fac Ecol & Recursos Nat, Valparaiso, Chile.	amolina@unab.cl; jvaldes@unab.cl	Gallardo-Escárate, Cristian/AAE-8980-2022; Maldonado, Jonathan E/J-6429-2012; Silva, Herman P/C-7252-2012; Aedo, Jorge/AAA-4414-2021	Gallardo-Escárate, Cristian/0000-0002-7094-6702; Maldonado, Jonathan E/0000-0002-9967-0885; Silva, Herman P/0000-0003-1007-7442; Aedo, Jorge/0000-0002-2968-9222; Meneses, Claudio/0000-0002-6452-8950; Zuloaga, Rodrigo/0000-0002-7820-7509; Bastias, Macarena/0000-0002-1176-8600	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1130545]; Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias [FONDAP INCAR 15110027]; FONDAP Center for Genome Regulation [CRG 15090007]	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias; FONDAP Center for Genome Regulation(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP)	This work was supported by: Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) Grant 1130545 (to AM); Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias: FONDAP INCAR 15110027 (to JAV and AM); and FONDAP Center for Genome Regulation CRG 15090007 (to CM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acerete L, 2004, AQUACULTURE, V237, P167, DOI 10.1016/j.aquaculture.2004.03.018; Aedo JE, 2014, MAR GENOM, V18, P105, DOI 10.1016/j.margen.2014.08.001; Aedo JE, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2232-7; Aluru N, 2009, GEN COMP ENDOCR, V164, P142, DOI 10.1016/j.ygcen.2009.03.020; Barton BA, 2002, INTEGR COMP BIOL, V42, P517, DOI 10.1093/icb/42.3.517; Bechmann LP, 2012, J HEPATOL, V56, P952, DOI 10.1016/j.jhep.2011.08.025; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Calduch-Giner JA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-193; Cordeiro OD, 2012, MAR BIOTECHNOL, V14, P714, DOI 10.1007/s10126-012-9437-4; Den Broeder MJ, 2015, PPAR RES, V2015, DOI 10.1155/2015/358029; Dhanasiri AKS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065028; Du FK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-558; Eissa N, 2016, REV AQUACULT, V8, P61, DOI 10.1111/raq.12081; Ellis T, 2012, FISH PHYSIOL BIOCHEM, V38, P163, DOI 10.1007/s10695-011-9568-y; Faught E, 2016, COMP BIOCH PHYSL B B; Fuchs CD, 2014, TRENDS ENDOCRIN MET, V25, P576, DOI 10.1016/j.tem.2014.08.001; Gabska M, 2003, COMP BIOCH PHYSL B, V135, P485; Gilmour KM, 2012, PHYSIOL BIOCHEM ZOOL, V85, P309, DOI 10.1086/666497; Giudetti AM, 1998, BIOCHEM MOL BIOL INT, V44, P515; Harper C, 2009, ILAR J, V50, P387, DOI 10.1093/ilar.50.4.387; Holmes RS, 2012, 3 BIOTECH, V2, P263, DOI 10.1007/s13205-012-0087-z; Hosoya S, 2007, COMP BIOCHEM PHYS A, V146, P78, DOI 10.1016/j.cbpa.2006.09.003; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Liu SK, 2013, PHYSIOL GENOMICS, V45, P462, DOI 10.1152/physiolgenomics.00026.2013; Liu SX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088492; Lopez-Patino MA, 2014, COMP BIOCHEM PHYS A, V168, P40, DOI 10.1016/j.cbpa.2013.10.027; Madison BN, 2015, J ENDOCRINOL, V226, P103, DOI 10.1530/JOE-15-0186; Milligan CL, 2003, J EXP BIOL, V206, P3167, DOI 10.1242/jeb.00538; Momoda TS, 2007, COMP BIOCHEM PHYS D, V2, P303, DOI 10.1016/j.cbd.2007.06.002; Moon TW, 2004, COMP BIOCHEM PHYS B, V139, P335, DOI 10.1016/j.cbpc.2004.06.003; Nakano T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071421; Olivares-Rubio HF, 2016, ENVIRON POLLUT, V218, P297, DOI 10.1016/j.envpol.2016.07.005; Pankhurst NW, 2011, GEN COMP ENDOCR, V170, P265, DOI 10.1016/j.ygcen.2010.07.017; Polakof S, 2012, J COMP PHYSIOL B, V182, P1015, DOI 10.1007/s00360-012-0658-7; Qian B, 2016, PLOS ONE, V11; Qin SM, 2016, LIPIDS, V51, P797, DOI 10.1007/s11745-016-4160-y; Rodriguez-Sureda V, 2005, ANAL BIOCHEM, V343, P277, DOI 10.1016/j.ab.2005.05.009; Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Spisni E, 1998, J FISH DIS, V21, P177, DOI [10.1111/j.1365-2761.1998.00089.x, 10.1046/j.1365-2761.1998.00089.x]; Sun J, 2016, COMP BIOCHEM PHYS B, V198, P110, DOI 10.1016/j.cbpb.2016.04.008; Teles M, 2013, MAR BIOTECHNOL, V15, P104, DOI 10.1007/s10126-012-9467-y; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Urbatzka R, 2015, AQUAT TOXICOL, V164, P155, DOI 10.1016/j.aquatox.2015.05.004; Vega R, 2015, LAT AM J AQUAT RES, V43, P344, DOI 10.3856/vol43-issue2-fulltext-11; Vega R, 2012, LAT AM J AQUAT RES, V40, P187, DOI 10.3856/vol40-issue1-fulltext-18; Wang JC, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-19; Wiseman S, 2007, COMP BIOCHEM PHYS D, V2, P234, DOI 10.1016/j.cbd.2007.04.005; Woods CP, 2015, J STEROID BIOCHEM, V154, P94, DOI 10.1016/j.jsbmb.2015.07.020; Yarahmadi P, 2015, AQUACULT INT, V23, P55, DOI 10.1007/s10499-014-9797-z	50	15	15	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176447	10.1371/journal.pone.0176447	http://dx.doi.org/10.1371/journal.pone.0176447			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448552	Green Submitted, Green Published, gold			2022-12-26	WOS:000400383600081
J	Pandit, NR; Mulder, J; Hale, SE; Schmidt, HP; Cornelissen, G				Pandit, Naba Raj; Mulder, Jan; Hale, Sarah Elisabeth; Schmidt, Hans Peter; Cornelissen, Gerard			Biochar from "Kon Tiki" flame curtain and other kilns: Effects of nutrient enrichment and kiln type on crop yield and soil chemistry	PLOS ONE			English	Article							BLACK CARBON; CHEMICAL-PROPERTIES; PLANT-GROWTH; CHARCOAL; PYROLYSIS; TEMPERATURE; ADSORPTION; DESORPTION; SEDIMENTS; SORPTION	Biochar application to soils has been investigated as a means of improving soil fertility and mitigating climate change through soil carbon sequestration. In the present work, the invasive shrub "Eupatorium adenophorum" was utilized as a sustainable feedstock for making biochar under different pyrolysis conditions in Nepal. Biochar was produced using several different types of kilns; four sub types of flame curtain kilns (deep-cone metal kiln, steel shielded soil pit, conical soil pit and steel small cone), brick-made traditional kiln, traditional earth-mound kiln and top lift up draft (TLUD). The resultant biochars showed consistent pH (9.1 +/- 0.3), cation exchange capacities (133 +/- 37 cmolc kg(-1)), organic carbon contents (73.9 +/- 6.4%) and surface areas (35 to 215 m(2)/g) for all kiln types. A pot trial with maize was carried out to investigate the effect on maize biomass production of the biochars made with various kilns, applied at 1% and 4% dosages. Biochars were either pretreated with hot or cold mineral nutrient enrichment (mixing with a nutrient solution before or after cooling down, respectively), or added separately from the same nutrient dosages to the soil. Significantly higher CEC (P<0.05), lower Al/Ca ratios (P<0.05), and high OC% (P<0.001) were observed for both dosages of biochar as compared to non-amended control soils. Importantly, the study showed that biochar made by flame curtain kilns resulted in the same agronomic effect as biochar made by the other kilns (P>0.05). At a dosage of 1% biochar, the hot nutrient-enriched biochar led to significant increases of 153% in above ground biomass production compared to cold nutrient-enriched biochar and 209% compared to biochar added separately from the nutrients. Liquid nutrient enhancement of biochar thus improved fertilizer effectiveness compared to separate application of biochar and fertilizer.	[Pandit, Naba Raj; Mulder, Jan; Cornelissen, Gerard] Norwegian Univ Life Sci NMBU, Inst Environm Sci IMV, As, Norway; [Pandit, Naba Raj] Nepal Agroforestry Fdn, Kathmandu, Nepal; [Hale, Sarah Elisabeth; Cornelissen, Gerard] Norwegian Geotech Inst, Oslo, Norway; [Schmidt, Hans Peter] Ithaka Inst Carbon Strategies, Ancienne Eglise 9, Arbaz, Switzerland	Norwegian University of Life Sciences; Norwegian Geotechnical Institute, NGI	Cornelissen, G (corresponding author), Norwegian Univ Life Sci NMBU, Inst Environm Sci IMV, As, Norway.; Cornelissen, G (corresponding author), Norwegian Geotech Inst, Oslo, Norway.	gco@ngi.no	Schmidt, Hans Peter/AAJ-1031-2020; Pandit, Naba Raj/AAF-2877-2020	Schmidt, Hans Peter/0000-0001-8275-7506; Pandit, Naba Raj/0000-0002-2140-7024; Hale, Sarah E./0000-0002-7743-9199	Research Council of Norway (Fripro stipend) [217918]; Nordic Development Fund [TA-7984 NEP]; Government of Nepal under the administrative lead of Landell Mills Ltd, UK [TA-7984 NEP]	Research Council of Norway (Fripro stipend)(Research Council of Norway); Nordic Development Fund; Government of Nepal under the administrative lead of Landell Mills Ltd, UK	This study was conducted with the main financial support from the Research Council of Norway (Fripro stipend 217918 to GCo). The results of this paper were further part of the Asia Development Bank project TA-7984 NEP: Mainstreaming Climate Change Risk Management in Development, financed by the Nordic Development Fund and the Government of Nepal under the administrative lead of Landell Mills Ltd, UK. The funders had no role in the study design, data collection and analysis, decision to publish and preparation of the manuscript.	Adam JC, 2009, RENEW ENERG, V34, P1923, DOI 10.1016/j.renene.2008.12.009; Agyarko-Mintah E, 2016, WASTE MANAG; Alling V, 2014, J PLANT NUTR SOIL SC, V177, P671, DOI 10.1002/jpln.201400109; Amonette J, 2015, BIOCHAR ENV MANAGEME, P165, DOI DOI 10.4324/9780203762264; Atkinson CJ, 2010, PLANT SOIL, V337, P1, DOI 10.1007/s11104-010-0464-5; Bailis R, 2013, ENERGY SUSTAIN DEV, V17, P189, DOI 10.1016/j.esd.2012.10.008; Brian C, 1986, LAND SYSTEM REPORT S; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Butnan S, 2015, GEODERMA, V237, P105, DOI 10.1016/j.geoderma.2014.08.010; Chan KY, 2007, AUST J SOIL RES, V45, P629, DOI 10.1071/SR07109; Chen DY, 2015, FUEL, V148, P79, DOI 10.1016/j.fuel.2015.01.092; Cheng CH, 2006, ORG GEOCHEM, V37, P1477, DOI 10.1016/j.orggeochem.2006.06.022; Cornelissen G, 1997, ENVIRON SCI TECHNOL, V31, P454, DOI 10.1021/es960300+; Cornelissen G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154617; Cornelissen G, 2013, AGRONOMY-BASEL, V3, P256, DOI 10.3390/agronomy3020256; Crombie K, 2013, GCB BIOENERGY, V5, P122, DOI 10.1111/gcbb.12030; Deal C, 2012, BIOMASS BIOENERG, V37, P161, DOI 10.1016/j.biombioe.2011.12.017; Deenik JL, 2010, SOIL SCI SOC AM J, V74, P1259, DOI 10.2136/sssaj2009.0115; Downie A., 2011, ENV SCI TECHNOL; Glaser B, 2002, BIOL FERT SOILS, V35, P219, DOI 10.1007/s00374-002-0466-4; Gundale MJ, 2007, BIOL FERT SOILS, V43, P303, DOI 10.1007/s00374-006-0106-5; Haefele SM, 2011, FIELD CROP RES, V121, P430, DOI 10.1016/j.fcr.2011.01.014; Haider G, 2016, J ENVIRON QUAL, V45, P1196, DOI 10.2134/jeq2015.10.0529; Hale SE, 2013, CHEMOSPHERE, V91, P1612, DOI 10.1016/j.chemosphere.2012.12.057; Hamer U, 2004, ORG GEOCHEM, V35, P823, DOI 10.1016/j.orggeochem.2004.03.003; Hammond J, 2013, CARBON MANAG, V4, P159, DOI [10.4155/CMT.13.3, 10.4155/cmt.13.3]; Hu Q, 2003, AQUEOUS PHASE DIFFUS; Jeffery S, 2015, GCB BIOENERGY, V7, P1, DOI 10.1111/gcbb.12132; Jiang GZ, 2010, ENERG FUEL, V24, P4470, DOI 10.1021/ef100363c; Kammann CI, 2015, SCI REP-UK, V5, DOI 10.1038/srep11080; Kleineidam S, 2002, ENVIRON SCI TECHNOL, V36, P4689, DOI 10.1021/es010293b; Laird D, 2010, GEODERMA, V158, P436, DOI 10.1016/j.geoderma.2010.05.012; Laird DA, 2008, AGRON J, V100, P178, DOI 10.2134/agronj2007.0161; Lehmann J, 2007, FRONT ECOL ENVIRON, V5, P381, DOI 10.1890/1540-9295(2007)5[381:BITB]2.0.CO;2; Lehmann J, 2011, SOIL BIOL BIOCHEM, V43, P1812, DOI 10.1016/j.soilbio.2011.04.022; Lehmann J, 2006, BOOK SOIL P, V113, P517, DOI 10.1201/9781420017113.ch36; Liang B, 2006, SOIL SCI SOC AM J, V70, P1719, DOI 10.2136/sssaj2005.0383; Liu XY, 2013, PLANT SOIL, V373, P583, DOI 10.1007/s11104-013-1806-x; Manickam T, 2015, SUSTAINABILITY-BASEL, V7, P16756, DOI 10.3390/su71215842; Martinsen V, SOIL TILLAGE RES; Masek O, 2013, FUEL, V103, P151, DOI 10.1016/j.fuel.2011.08.044; McLaughlin H., 2010, 1G TOUCAN TLUD BIOCH; Nguyen BT, 2008, BIOGEOCHEMISTRY, V89, P295, DOI 10.1007/s10533-008-9220-9; Nguyen TH, 2004, ORG GEOCHEM, V35, P217, DOI 10.1016/j.orggeochem.2003.09.005; Schmidt H.-P., 2014, BIOCHAR J, V1, P14; Schmidt HP, 2015, AGRICULTURE-BASEL, V5, P723, DOI 10.3390/agriculture5030723; Schmidt MWI, 2000, GLOBAL BIOGEOCHEM CY, V14, P777, DOI 10.1029/1999GB001208; Schreier H, 1994, SOIL USE MANAGE, P10; Shrestha K., 2009, J NATURAL HIST MUSEU, V23, P108, DOI [10.3126/jnhm.v23i0.1848, DOI 10.3126/JNHM.V23I0.1848]; Singh B, 2010, AUST J SOIL RES, V48, P516, DOI 10.1071/SR10058; Singh BP, 2010, J ENVIRON QUAL, V39, P1224, DOI 10.2134/jeq2009.0138; Smebye A, 2016, CHEMOSPHERE, V142, P100, DOI 10.1016/j.chemosphere.2015.04.087; Smith KR, 2003, INT J HYG ENVIR HEAL, V206, P279, DOI 10.1078/1438-4639-00224; Sparrevik M, 2015, BIOMASS BIOENERG, V72, P65, DOI 10.1016/j.biombioe.2014.11.016; Spokas KA, 2012, J ENVIRON QUAL, V41, P973, DOI 10.2134/jeq2011.0069; Steiner C, 2007, PLANT SOIL, V291, P275, DOI 10.1007/s11104-007-9193-9; Vaccari FP, 2011, EUR J AGRON, V34, P231, DOI 10.1016/j.eja.2011.01.006; Van Zwieten L, 2010, PLANT SOIL, V327, P235, DOI 10.1007/s11104-009-0050-x; Ventura M, 2013, J ENVIRON QUAL, V42, P76, DOI 10.2134/jeq2012.0250; Werth CJ, 1997, ENVIRON SCI TECHNOL, V31, P697, DOI 10.1021/es960231z; Yamato M, 2006, SOIL SCI PLANT NUTR, V52, P489, DOI 10.1111/j.1747-0765.2006.00065.x	61	32	33	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176378	10.1371/journal.pone.0176378	http://dx.doi.org/10.1371/journal.pone.0176378			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448621	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000400383600070
J	Negin, B; Shemer, O; Sorek, Y; Williams, LE				Negin, Boaz; Shemer, Or; Sorek, Yonatan; Williams, Leor Eshed			Shoot stem cell specification in roots by the WUSCHEL transcription factor	PLOS ONE			English	Article							RECEPTOR-LIKE KINASE; APICAL MERISTEM; GENE ENCODES; ARABIDOPSIS; CYTOKININ; NICHE; MAINTENANCE; HOMEOSTASIS; MECHANISM; PROTEIN	The WUSCHEL homeobox transcription factor is required to specify stem-cell identity at the shoot apical meristem and its ectopic expression is sufficient to induce de novo shoot meristem formation. Yet, the manner by which WUS promotes stem-cell fate is not yet fully understood. In the present research we address this question by inducing WUS function outside of its domain. We show that activation of WUS function in the root inhibits the responses to exogenous auxin and suppresses the initiation and growth of lateral roots. Using time lapse movies to follow the cell-cycle marker CYCB1; 1:: GFP, we also show that activation of WUS function suppresses cell division and cell elongation. In addition, activation of WUS represses the auxin-induced expression of the PLETHORA1 root identity gene and promotes shoot fate. Shoot apical meristem formation requires a high cytokinin-to-auxin ratio. Our findings provide evidence for the manner by which WUS specifies stem-cell identity: by affecting auxin responses, by reducing the cell mitotic activity and by repressing other developmental pathways. At the meristem, the stem-cells which are characterized by low division rate are surrounded by the highly proliferative meristematic cells. Our results also provide a model for WUS establishing the differential mitotic rates between two cell populations at the minute structure of the meristem.	[Negin, Boaz; Shemer, Or; Sorek, Yonatan; Williams, Leor Eshed] Hebrew Univ Jerusalem, Robert H Smith Inst Plant Sci & Genet Agr, Fac Agr Food & Environm, Rehovot, Israel	Hebrew University of Jerusalem	Williams, LE (corresponding author), Hebrew Univ Jerusalem, Robert H Smith Inst Plant Sci & Genet Agr, Fac Agr Food & Environm, Rehovot, Israel.	leor.williams@mail.huji.ac.il		Eshed Williams, Leor/0000-0002-2766-2608	Vaadia-BARD [IS-4336-10R]; MARIE CURIE IRG [249270]	Vaadia-BARD(US-Israel Binational Science Foundation); MARIE CURIE IRG(European Commission)	This work was supported by: Vaadia-BARD [IS-4336-10R to O.S.]; MARIE CURIE IRG [249270 to B.N]	Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Baurle I, 2005, PLANT CELL, V17, P2271, DOI 10.1105/tpc.105.032623; Bhargava A, 2013, PLANT PHYSIOL, V162, P272, DOI 10.1104/pp.113.217026; Brand U, 2002, PLANT PHYSIOL, V129, P565, DOI 10.1104/pp.001867; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Brenner WG, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-112; Busch W, 2010, DEV CELL, V18, P849, DOI 10.1016/j.devcel.2010.03.012; Causier B, 2012, PLANT PHYSIOL, V158, P423, DOI 10.1104/pp.111.186999; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Daum G, 2014, P NATL ACAD SCI USA, V111, P14619, DOI 10.1073/pnas.1406446111; Fletcher JC, 2002, ANNU REV PLANT BIOL, V53, P45, DOI 10.1146/annurev.arplant.53.092701.143332; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Forzani C, 2014, CURR BIOL, V24, P1939, DOI 10.1016/j.cub.2014.07.019; Fukaki H, 2009, PLANT MOL BIOL, V69, P437, DOI 10.1007/s11103-008-9417-2; Gaj MD, 2011, METHODS MOL BIOL, V710, P257, DOI 10.1007/978-1-61737-988-8_18; Galinha C, 2007, NATURE, V449, P1053, DOI 10.1038/nature06206; Gallois JL, 2004, GENE DEV, V18, P375, DOI 10.1101/gad.291204; Gordon SP, 2007, DEVELOPMENT, V134, P3539, DOI 10.1242/dev.010298; Huang X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113768; Jeong S, 1999, PLANT CELL, V11, P1925, DOI 10.1105/tpc.11.10.1925; Kareem A, 2015, CURR BIOL, V25, P1017, DOI 10.1016/j.cub.2015.02.022; Kieffer M, 2006, PLANT CELL, V18, P560, DOI 10.1105/tpc.105.039107; Laplaze L, 2007, PLANT CELL, V19, P3889, DOI 10.1105/tpc.107.055863; Laufs P, 1998, PLANT CELL, V10, P1375, DOI 10.1105/tpc.10.8.1375; Laux T, 1996, DEVELOPMENT, V122, P87; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Lenhard M, 2002, DEVELOPMENT, V129, P3195; Mahonen AP, 2014, NATURE, V515, P125, DOI 10.1038/nature13663; Mandel T, 2016, DEVELOPMENT, V143, P1612, DOI 10.1242/dev.129973; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Muller B, 2008, NATURE, V453, P1094, DOI 10.1038/nature06943; Petersson SV, 2009, PLANT CELL, V21, P1659, DOI 10.1105/tpc.109.066480; Sarkar AK, 2007, NATURE, V446, P811, DOI 10.1038/nature05703; Schaller GE, 2015, PLANT CELL, V27, P44, DOI 10.1105/tpc.114.133595; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; Smith ZR, 2010, NATURE, V464, P423, DOI 10.1038/nature08843; Soyars CL, 2016, CURR OPIN PLANT BIOL, V29, P163, DOI 10.1016/j.pbi.2015.12.002; Su YH, 2011, MOL PLANT, V4, P616, DOI 10.1093/mp/ssr007; Talbot MJ, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-36; Trotochaud AE, 1999, PLANT CELL, V11, P393, DOI 10.1105/tpc.11.3.393; Ubeda-Tomas S, 2009, CURR BIOL, V19, P1194, DOI 10.1016/j.cub.2009.06.023; Uchida N, 2013, PLANT CELL PHYSIOL, V54, P343, DOI 10.1093/pcp/pcs109; Yadav RK, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.8; Yadav RK, 2012, PLANT SIGNAL BEHAV, V7, P592, DOI 10.4161/psb.19793; Yadav RK, 2011, GENE DEV, V25, P2025, DOI 10.1101/gad.17258511; Yadav RK, 2010, DEVELOPMENT, V137, P3581, DOI 10.1242/dev.054973; Zuo JR, 2002, PLANT J, V30, P349, DOI 10.1046/j.1365-313X.2002.01289.x	49	19	19	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176093	10.1371/journal.pone.0176093	http://dx.doi.org/10.1371/journal.pone.0176093			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445492	gold, Green Published, Green Submitted			2022-12-26	WOS:000400309200034
J	Dunsky, A; Abu-Rukun, M; Tsuk, S; Dwolatzky, T; Carasso, R; Netz, Y				Dunsky, Ayelet; Abu-Rukun, Mona; Tsuk, Sharon; Dwolatzky, Tzvi; Carasso, Rafi; Netz, Yael			The effects of a resistance vs. an aerobic single session on attention and executive functioning in adults	PLOS ONE			English	Article							MIDDLE-AGED ADULTS; EXERCISE-INDUCED AROUSAL; OLDER-ADULTS; COGNITIVE PERFORMANCE; PHYSICAL-ACTIVITY; SHORT-TERM; MEMORY; STRENGTH; FITNESS; ADAPTATIONS	Evidence from recent studies showed that acute aerobic exercise results in improvements in different cognitive functions. The goal of this study was to assess the influence of acute bouts of aerobic versus resistance exercise on attention and executive function in adults. Thirty-nine physically active adults (age = 52 +/- 8 yr) served as participants. Each participant visited the laboratory four times: on the first visit participants performed a cognitive test (NeuroTrax) followed by an aerobic fitness assessment, as well as maximal strength test composed of six exercises. During visits 2 - 4, participants completed the cognitive test before and after the experimental condition, which consisted of either 25 min of aerobic exercise or resistance exercise, or watching a recorded interview show in a seated position (control condition). Findings indicated significantly higher changes in scores of attention after acute aerobic exercise (mean change 3.46, 95% CI -0.32, 7.27) than following the control condition (mean change -0.64, 95% CI -2.23, 0.96). The changes following resistance exercise (mean change -0.67, 95% CI -4.47, 3.13) were not significantly different from the changes following the control condition. Executive function scores showed a marginally significant improvement following acute aerobic (mean change 4.06, 95% CI 1.68, 6.44) and resistance exercise (mean change 3.69, 95% CI 0.78, 6.60), but not after control (mean change 0.91, 95% CI -1.21, 3.02). We suggest that adults should consider augmenting both modalities into their training routines, which may improve their cognition in addition to providing other physical benefits.	[Dunsky, Ayelet; Abu-Rukun, Mona; Tsuk, Sharon; Netz, Yael] Zinman Coll Phys Educ & Sport Sci, Wingate Inst, Netanya, Israel; [Dwolatzky, Tzvi] Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel; [Carasso, Rafi] Hillel Yaffe Med Ctr, Hadera, Israel	Ben Gurion University	Dunsky, A (corresponding author), Zinman Coll Phys Educ & Sport Sci, Wingate Inst, Netanya, Israel.	ayelet@wincol.ac.il	Dwolatzky, Tzvi/P-4752-2019	Dwolatzky, Tzvi/0000-0002-3861-2278				Alomari MA, 2013, BEHAV BRAIN RES, V247, P34, DOI 10.1016/j.bbr.2013.03.007; American College of Sports Medicine's (ACSM's), 2010, AM COLL SPORTS MED A; Audiffren M, 2009, ACTA PSYCHOL, V132, P85, DOI 10.1016/j.actpsy.2009.06.008; Borg G., 1986, PERCEPTION EXERTION, P3; Brink TL., 1982, CLIN GERON, V1, P37, DOI [10.1300/J018v01n01_06, DOI 10.1300/J018V01N01_06]; Byun KH, 2014, NEUROIMAGE, V98, P336, DOI 10.1016/j.neuroimage.2014.04.067; Candow DG, 2007, J STRENGTH COND RES, V21, P204, DOI 10.1519/00124278-200702000-00037; Cassilhas RC, 2007, MED SCI SPORT EXER, V39, P1401, DOI 10.1249/mss.0b013e318060111f; Chang YK, 2014, J SCI MED SPORT, V17, P51, DOI 10.1016/j.jsams.2013.02.007; Chang YK, 2009, RES Q EXERCISE SPORT, V80, P78; Chang YK, 2009, PSYCHOL SPORT EXERC, V10, P19, DOI 10.1016/j.psychsport.2008.05.004; Coles K, 2008, J SPORT SCI, V26, P333, DOI 10.1080/02640410701591417; Dwolatzky Tzvi, 2003, BMC Geriatr, V3, P4, DOI 10.1186/1471-2318-3-4; Etnier JL, 2009, J SPORT EXERCISE PSY, V31, P469, DOI 10.1123/jsep.31.4.469; Etnier JL, 1997, J SPORT EXERCISE PSY, V19, P249, DOI 10.1123/jsep.19.3.249; Fjell AM, 2010, REV NEUROSCIENCE, V21, P187, DOI 10.1515/revneuro.2010.21.3.187; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Funahashi S, 2001, NEUROSCI RES, V39, P147, DOI 10.1016/S0168-0102(00)00224-8; Hausdorff JM, 2006, EXP AGING RES, V32, P411, DOI 10.1080/03610730600875817; Hillman CH, 2003, INT J PSYCHOPHYSIOL, V48, P307, DOI 10.1016/S0167-8760(03)00080-1; Hogan CL, 2013, PSYCHOL AGING, V28, P587, DOI 10.1037/a0032634; Hogervorst E, 1996, PERCEPT MOTOR SKILL, V83, P479, DOI 10.2466/pms.1996.83.2.479; Kamijo K, 2009, J GERONTOL B-PSYCHOL, V64, P356, DOI 10.1093/geronb/gbp030; KARVONEN MJ, 1957, ANN MED EXP BIOL FEN, V35, P307; Kraemer WJ, 2005, SPORTS MED, V35, P339, DOI 10.2165/00007256-200535040-00004; Lachman ME, 2006, J AGING PHYS ACTIV, V14, P59, DOI 10.1123/japa.14.1.59; Lambourne K, 2010, BRAIN RES, V1341, P12, DOI 10.1016/j.brainres.2010.03.091; Lampit A, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00014; Lin TW, 2012, NEUROBIOL LEARN MEM, V97, P140, DOI 10.1016/j.nlm.2011.10.006; Liu-Ambrose T, 2010, ARCH INTERN MED, V170, P170, DOI 10.1001/archinternmed.2009.494; Lutz W, 2008, VIENNA YB POPULATION, P221; McMorris T, 2000, INT J SPORT PSYCHOL, V31, P66; McMorris T, 2015, J SPORT HEALTH SCI, V4, P4, DOI 10.1016/j.jshs.2014.08.003; McMorris T, 2011, PHYSIOL BEHAV, V102, P421, DOI 10.1016/j.physbeh.2010.12.007; Nanda B, 2013, J CLIN DIAGN RES, V7, P1883, DOI 10.7860/JCDR/2013/5855.3341; Netz Y, 2007, INT J SPORTS MED, V28, P82, DOI 10.1055/s-2006-924027; Netz Y, 2016, BRAIN COGNITION, V109, P59, DOI 10.1016/j.bandc.2016.08.002; Netz Y, 2015, ISR J PSYCHIATR REL, V52, P55; Peiffer R, 2015, J SPORT SCI MED, V14, P574; Pereira M.I.R., 2003, BRAZ J SPORTS MED, V9, P336, DOI [10.1590/S1517-86922003000500007, DOI 10.1590/S1517-86922003000500007]; Pesce C, 2011, J SPORT EXERCISE PSY, V33, P609, DOI 10.1123/jsep.33.5.609; Pontifex M, 2009, SPORT EXERC, V28, P587; Ritchie SJ, 2015, J NEUROSCI, V35, P8672, DOI 10.1523/JNEUROSCI.0862-15.2015; Alves CRR, 2012, J SPORT EXERCISE PSY, V34, P539, DOI 10.1123/jsep.34.4.539; Rosano C, 2010, J GERONTOL A-BIOL, V65, P639, DOI 10.1093/gerona/glq038; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Strauss E, 2006, COMPENDIUM NEUROPSYC; Tomporowski PD, 2003, ACTA PSYCHOL, V112, P297, DOI 10.1016/S0001-6918(02)00134-8; Voss MW, 2013, HUM BRAIN MAPP, V34, P2972, DOI 10.1002/hbm.22119; Yuki A, 2012, MED SCI SPORT EXER, V44, P2362, DOI 10.1249/MSS.0b013e3182667d1d	50	38	39	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176092	10.1371/journal.pone.0176092	http://dx.doi.org/10.1371/journal.pone.0176092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET5FE	28441442	gold, Green Published			2022-12-26	WOS:000400308800025
J	Dysthe, JC; Carim, KJ; Ruggles, M; McKelvey, KS; Young, MK; Schwartz, MK				Dysthe, Joseph C.; Carim, Kellie J.; Ruggles, Michael; McKelvey, Kevin S.; Young, Michael K.; Schwartz, Michael K.			Environmental DNA assays for the sister taxa sauger (Sander canadensis) and walleye (Sander vitreus)	PLOS ONE			English	Article							PERCIDAE	Sauger (Sander canadensis) and walleye (S. vitreus) are percid fishes that naturally co-occur throughout much of the eastern United States. The native range of sauger extends into the upper Missouri River drainage where walleye did not historically occur, but have been stocked as a sport fish. Sauger populations have been declining due to habitat loss, fragmentation, and competition with non-native species, such as walleye. To effectively manage sauger populations, it is necessary to identify areas where sauger occur, and particularly where they co- occur with walleye. We developed quantitative PCR assays that can detect sauger and walleye DNA in filtered water samples. Each assay efficiently detected low quantities of target DNA and failed to detect DNA of non-target species with which they commonly co- occur.	[Dysthe, Joseph C.; Carim, Kellie J.; McKelvey, Kevin S.; Young, Michael K.; Schwartz, Michael K.] US Forest Serv, USDA, Natl Genom Ctr Wildlife & Fish Conservat, Rocky Mt Res Stn, Missoula, MT 59804 USA; [Ruggles, Michael] Montana Dept Fish Wildlife & Parks, Reg 5, Billings, MT USA	United States Department of Agriculture (USDA); United States Forest Service	Dysthe, JC (corresponding author), US Forest Serv, USDA, Natl Genom Ctr Wildlife & Fish Conservat, Rocky Mt Res Stn, Missoula, MT 59804 USA.	jdysthe@fs.fed.us		Dysthe, Joseph/0000-0002-6790-7841	Walleyes Unlimited of Montana	Walleyes Unlimited of Montana	This work was completed through funding issued to MR by Walleyes Unlimited of Montana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellgraph BJ, 2008, T AM FISH SOC, V137, P790, DOI 10.1577/T07-102.1; Billington N, 1997, T AM FISH SOC, V126, P804, DOI 10.1577/1548-8659(1997)126&lt;0804:GAPCOW&gt;2.3.CO;2; Bingham DM, 2012, CONSERV GENET, V13, P509, DOI 10.1007/s10592-011-0303-0; Bozek MA, 2011, BIOLOGY, MANAGEMENT, AND CULTURE OF WALLEYE AND SAUGER, P133; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carim KJ, 2016, CONSERV GENET RESOUR, V8, P197, DOI 10.1007/s12686-016-0531-1; Carim KJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161664; Carim KJ, 2016, TECH REP; Carufel LH, 1963, J WILDLIFE MANAGE, V27, P450; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Dreves DP, 2014, NATIVE WALLEYE MANAG, P16; Goldberg CS, 2013, FRESHW SCI, V32, P792, DOI 10.1899/13-046.1; Graeb BDS, 2010, N AM J FISH MANAGE, V30, P887, DOI 10.1577/M09-091.1; Haponski AE, 2013, BIOL J LINN SOC, V110, P156, DOI 10.1111/bij.12114; Johnston TA, 2012, J GREAT LAKES RES, V38, P35, DOI 10.1016/j.jglr.2010.06.009; Kyle CJ, 2007, FORENSIC SCI INT, V166, P68, DOI 10.1016/j.forsciint.2006.03.025; McKelvey KS, 2016, J FISH BIOL, V88, P1215, DOI 10.1111/jfb.12863; McMahon Thomas E., 2001, Intermountain Journal of Sciences, V7, P1; Near TJ, 2002, COPEIA, P1; NELSON WR, 1977, J FISH RES BOARD CAN, V34, P1748, DOI 10.1139/f77-240; Page LM, 2011, FIELD GUIDE FRESHWAT; Palmer George C., 2006, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V60, P125; Pegg Mark A., 1997, North American Journal of Fisheries Management, V17, P763, DOI 10.1577/1548-8675(1997)017<0763:MOSITL>2.3.CO;2; R Core Development Team, 2013, R LANG ENV STAT COMP; Schneider JC, 2007, 41 MICH DEP NAT RES; Sigsgaard EE, 2015, BIOL CONSERV, V183, P46, DOI 10.1016/j.biocon.2014.11.023; Sloss BL, 2004, MOL PHYLOGENET EVOL, V32, P545, DOI 10.1016/j.ympev.2004.01.011; Stepien CA, 2009, MOL ECOL, V18, P3411, DOI 10.1111/j.1365-294X.2009.04291.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; White MM, 2012, AM MIDL NAT, V167, P373, DOI 10.1674/0003-0031-167.2.373; White MM, 1993, USES EFFECTS CULTURE, P52; Wilcox TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142008; Wilcox TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059520; Wright ES, 2014, ENVIRON MICROBIOL, V16, P1354, DOI 10.1111/1462-2920.12259	34	0	0	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176459	10.1371/journal.pone.0176459	http://dx.doi.org/10.1371/journal.pone.0176459			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441436	Green Submitted, Green Published, gold			2022-12-26	WOS:000400308800059
J	Lu, XL; Ding, Y; Niu, QN; Xuan, SJ; Yang, Y; Jin, YL; Wang, H				Lu, Xiaolin; Ding, Yin; Niu, Qiannan; Xuan, Shijie; Yang, Yan; Jin, Yulong; Wang, Huan			ClC-3 chloride channel mediates the role of parathyroid hormone [1-34] on osteogenic differentiation of osteoblasts	PLOS ONE			English	Article							MATRIX GLA PROTEIN; ANABOLIC ACTION; MC3T3-E1 CELLS; KINASE-C; OSTEOPOROSIS; INTERMITTENT; TERIPARATIDE; RUNX2; WNT; PTH	Introduction Different concentrations of parathyroid hormone [ 1-34] ( PTH [ 1-34]) can have totally opposite effects on osteoblasts. Intermittent stimulation with PTH can significantly increase bone mineral density in vitro, mainly through the protein kinase A ( PKA) signaling pathway, which phosphorylates runt-related transcription factor 2 ( Runx2). The ClC-3 chloride channel, an important anion channel, can also promote osteogenesis via the Runx2 pathway based on recent studies. The purpose of our study, therefore, is to research whether the ClC-3 chloride channel has an effect on PTH osteodifferentiation in MC3T3-E1 cells. Methods and results A cell counting kit ( CCK-8) and real-time PCR were used to investigate the impact of different PTH stimulation modes on MC3T3-E1 cell proliferation and osteogenesis-related gene expression, respectively. We found that the minimum inhibitory concentration of PTH was 10(-9) M, and the expression of alkaline phosphatase ( Alpl) and Runx2 were at the highest levels when treated with 10-9 M PTH. Next, we used real-time PCR and immunofluorescence technique to detect changes in ClC-3 in MC3T3-E1 cells under PTH treatment. The results showed higher expression of the ClC-3 chloride channel at 10-9 M intermittent PTH administration than in the other groups. Finally, we used the ClC-3 siRNA technique to examine the role of the ClC-3 chloride channel in the effect of PTH on the osteogenesis of osteoblasts, and we found an obvious decrease in the expression of bone sialoprotein ( Ibsp), osteocalcin ( Bglap), osterix ( Sp7), Alpl and Runx2, the formation of mineralization nodules as well. Conclusions From the above data, we conclude that the expression of ClC-3 chloride channels in osteoblasts helps them respond to PTH stimulation, which mediates osteogenic differentiation.	[Lu, Xiaolin; Ding, Yin; Niu, Qiannan; Xuan, Shijie; Yang, Yan; Wang, Huan] Fourth Mil Med Univ, Sch Stomatol, Dept Orthodont, State Key Lab Mil Stomatol, Xian, Shaanxi, Peoples R China; [Jin, Yulong] Fourth Mil Med Univ, Dept Hematol, Xian, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Wang, H (corresponding author), Fourth Mil Med Univ, Sch Stomatol, Dept Orthodont, State Key Lab Mil Stomatol, Xian, Shaanxi, Peoples R China.	wanghuan8001@hotmail.com	lu, xl/HDO-8340-2022		National Nature Science Foundation of China [81200648]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science Foundation of China (Grant No. 81200648, http://www.nsfc.gov.cn). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander IM, 2009, NURSE PRACT, V34, P30, DOI 10.1097/01.NPR.0000352286.81981.0e; Ardura JA, 2013, KIDNEY INT, V83, P825, DOI 10.1038/ki.2012.476; Bellido T, 2003, J BIOL CHEM, V278, P50259, DOI 10.1074/jbc.M307444200; Chen BL, 2016, EXP THER MED, V11, P2399, DOI 10.3892/etm.2016.3177; Crane JL, 2014, J CLIN INVEST, V124, P466, DOI 10.1172/JCI70050; Dempster DW, 2016, J CLIN ENDOCR METAB, V101, P1353, DOI 10.1210/jc.2015-4181; Duan D, 1999, ILLUMINATING ENG I J, P164; Fakhry Maya, 2013, World J Stem Cells, V5, P136, DOI 10.4252/wjsc.v5.i4.136; Fei YR, 2012, J CELL PHYSIOL, V227, P3539, DOI 10.1002/jcp.24075; Gopalakrishnan R, 2005, CELLS TISSUES ORGANS, V181, P166, DOI 10.1159/000091378; Gordon JAR, 2009, CELLS TISSUES ORGANS, V189, P138, DOI 10.1159/000151728; Guida G, 2011, AGING CLIN EXP RES, V23, P8; Ishizuya T, 1997, J CLIN INVEST, V99, P2961, DOI 10.1172/JCI119491; JENNINGS ML, 1990, J GEN PHYSIOL, V95, P1021, DOI 10.1085/jgp.95.6.1021; Jhaveri S, 2015, J CLIN DIAGN RES, V9; Kaback LA, 2008, J CELL BIOCHEM, V105, P219, DOI 10.1002/jcb.21816; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; Kates SL, 2016, INJURY, V47, pS65, DOI 10.1016/S0020-1383(16)30015-8; Komm BS, 2015, EXPERT REV CLIN PHAR, V8, P769, DOI 10.1586/17512433.2015.1099432; Krishnan V, 2003, MOL ENDOCRINOL, V17, P423, DOI 10.1210/me.2002-0225; Larrouture QC, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12607; Li XH, 2002, AM J PHYSIOL-CELL PH, V282, pC1483, DOI 10.1152/ajpcell.00504.2001; Lindsay R, 2016, OSTEOPOROSIS INT, V27, P2395, DOI 10.1007/s00198-016-3534-6; Liu Q, 2012, BIOCHEM BIOPH RES CO, V424, P182, DOI 10.1016/j.bbrc.2012.06.106; Lossdorfer S, 2011, J PERIODONTAL RES, V46, P318, DOI 10.1111/j.1600-0765.2011.01345.x; Lumetti S, 2016, J MATER SCI-MATER M, V27, DOI 10.1007/s10856-016-5678-5; Merciris D, 2007, AM J PATHOL, V170, P1676, DOI 10.2353/ajpath.2007.061069; NEMANI R, 1991, ARCH BIOCHEM BIOPHYS, V285, P153, DOI 10.1016/0003-9861(91)90343-H; Okamoto F, 2008, AM J PHYSIOL-CELL PH, V294, pC693, DOI 10.1152/ajpcell.00251.2007; Pengjam Y, 2016, BIOMOL THER, V24, P123, DOI 10.4062/biomolther.2015.106; Qin L, 2004, TRENDS ENDOCRIN MET, V15, P60, DOI 10.1016/j.tem.2004.01.006; Riazanski V, 2011, NAT NEUROSCI, V14, P487, DOI 10.1038/nn.2775; Shimizu M, 2016, BIOL PHARM BULL, V39, P625, DOI 10.1248/bpb.b15-00756; Sowa H, 2003, J BIOL CHEM, V278, P52240, DOI 10.1074/jbc.M302566200; Stauber T, 2012, COMPR PHYSIOL, V2, P1701, DOI 10.1002/cphy.c110038; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Suttamanatwong S, 2009, J CELL BIOCHEM, V107, P284, DOI 10.1002/jcb.22124; Suzuki A, 2008, J CELL BIOCHEM, V104, P304, DOI 10.1002/jcb.21626; Tian Y, 2011, MOL CELL BIOCHEM, V355, P211, DOI 10.1007/s11010-011-0856-8; Tremollieres FA, 2014, MATURITAS, V79, P343, DOI 10.1016/j.maturitas.2014.08.001; Wang D, 2016, J CELLULAR BIOCH; Wang H, 2015, BIOCHEM CELL BIOL, V93, P558, DOI 10.1139/bcb-2015-0018; Wang HA, 2010, J CELL BIOCHEM, V111, P49, DOI 10.1002/jcb.22658; Wang HA, 2010, MOL CELL BIOCHEM, V342, P191, DOI 10.1007/s11010-010-0483-9; Xu ZX, 2016, DRUG DES DEV THER, V10, P509, DOI 10.2147/DDDT.S84264; Yang CM, 2009, BIOCHEM BIOPH RES CO, V380, P791, DOI 10.1016/j.bbrc.2009.01.167	46	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0176196	10.1371/journal.pone.0176196	http://dx.doi.org/10.1371/journal.pone.0176196			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437476	Green Published, gold, Green Submitted			2022-12-26	WOS:000400287600032
J	Tung, EWY; Ahmed, S; Peshdary, V; Atlas, E				Tung, Emily W. Y.; Ahmed, Shaimaa; Peshdary, Vian; Atlas, Ella			Firemaster (R) 550 and its components isopropylated triphenyl phosphate and triphenyl phosphate enhance adipogenesis and transcriptional activity of peroxisome proliferator activated receptor (Ppar gamma) on the adipocyte protein 2 (aP2) promoter	PLOS ONE			English	Article							ORGANOPHOSPHATE FLAME RETARDANTS; ACID-BINDING PROTEINS; EXPOSURE; TOXICITY; MIXTURE; DIFFERENTIATION; IDENTIFICATION; ALPHA; DUST; TBPH	Firemaster (R) 550 (FM550) is a chemical mixture currently used as an additive flame retardant in commercial products, and is comprised of 2-ethylhexyl-2,3,4,5-tertrabromobenzoate (TBB), bis(2-ethylhexyl) tetrabromophthalate (TBPH), triphenyl phosphate (TPP), and isopropylated triphenyl phosphate (IPTP). Animal and in vitro studies suggest that FM550, TPP and IPTP may have adipogenic effects and may exert these effects through PPAR. activation. Using murine 3T3-L1 preadipocytes, we investigated the detailed expression of transcription factors and adipogenic markers in response to FM550 and its components. Further we investigated the mechanism of action of the peroxisome proliferator- activated receptor gamma (PPAR.) on downstream targets of the receptor by focussing on the mature adipocyte marker, adipocyte protein 2 (aP2). In addition, we set to elucidate the components responsible for the adipogenic effects seen in the FM550 mixture. We show that FM550 and its components TPP, IPTP, and TBPH, but not TBB induced lipid accumulation in a dose-dependent manner. Interestingly, despite displaying enhanced lipid accumulation, TBPH did not alter the mRNA or protein expression of terminal differentiation markers. In contrast, FM550, TPP, and IPTP treatment enhanced lipid accumulation, and mRNA and protein expression of terminal differentiation markers. To further delineate the mechanisms of action of FM550 and its components we focussed on aP2 promoter activity. For this purpose we used the enhancer region of the mouse aP2 promoter using a 584-bp reporter construct containing an active PPRE located 5.4 kb away from the transcription start site of aP2. Exposure to FM550, IPTP, and TPP significantly increased PPAR. mediated aP2 enhancer activity. Furthermore, we show that TPP-and IPTP-dependent upregulation of aP2 was significantly inhibited by the selective PPAR. antagonist GW9662. In addition, chromatin immunoprecipitation experiments showed that IPTP and TPP treatment led to the recruitment of PPAR. to the regulatory region of ap2.	[Tung, Emily W. Y.; Ahmed, Shaimaa; Peshdary, Vian; Atlas, Ella] Hlth Canada, Environm Hlth Sci & Res Bur, Ottawa, ON, Canada	Health Canada	Atlas, E (corresponding author), Hlth Canada, Environm Hlth Sci & Res Bur, Ottawa, ON, Canada.	ella.atlas@canada.ca			Health Canada Chemical Management Plan	Health Canada Chemical Management Plan	This work was supported by the Health Canada Chemical Management Plan.	Bakillah A, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0061-6; Biasiotto G, 2016, TOXICOL APPL PHARM, V297, P32, DOI 10.1016/j.taap.2016.02.023; Boucher JG, 2016, ENDOCRINOLOGY, V157, P1397, DOI 10.1210/en.2015-1872; Feige JN, 2007, J BIOL CHEM, V282, P19152, DOI 10.1074/jbc.M702724200; Fu MG, 2005, MOL ENDOCRINOL, V19, P2437, DOI 10.1210/me.2004-0539; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Grun F, 2006, MOL ENDOCRINOL, V20, P2141, DOI 10.1210/me.2005-0367; HAUNER H, 1990, ENDOCRINOLOGY, V127, P865, DOI 10.1210/endo-127-2-865; Hoffman K, 2015, ENVIRON HEALTH PERSP, V123, P160, DOI 10.1289/ehp.1408669; Hoffman K, 2014, ENVIRON HEALTH PERSP, V122, P963, DOI 10.1289/ehp.1308028; Holtcamp W, 2012, ENVIRON HEALTH PERSP, V120, pA62, DOI 10.1289/ehp.120-a62; Honkakoski P, 2004, BIOCHEM PHARMACOL, V67, P97, DOI 10.1016/j.bcp.2003.08.037; Ikonomov OC, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12812; Janesick A, 2011, BIRTH DEFECTS RES C, V93, P34, DOI 10.1002/bdrc.20197; Kimmel AR, 2016, ANNU REV NUTR, V36, P471, DOI 10.1146/annurev-nutr-071813-105410; Li X, 2011, J STEROID BIOCHEM, V127, P9, DOI 10.1016/j.jsbmb.2011.03.012; Liu LY, 2015, J CHROMATOGR A, V1406, P251, DOI 10.1016/j.chroma.2015.06.003; Makowski L, 2005, CURR OPIN LIPIDOL, V16, P543, DOI 10.1097/01.mol.0000180166.08196.07; Matthews J, 2007, BIOCHEM J, V406, P343, DOI 10.1042/BJ20070585; McGee SP, 2013, TOXICOL SCI, V133, P144, DOI 10.1093/toxsci/kft020; Meeker JD, 2010, ENVIRON HEALTH PERSP, V118, P318, DOI 10.1289/ehp.0901332; Mendelsohn E, 2016, ENVIRON INT, V86, P45, DOI 10.1016/j.envint.2015.10.005; Mizouchi S, 2015, CHEMOSPHERE, V123, P17, DOI 10.1016/j.chemosphere.2014.11.028; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Patisaul HB, 2013, J BIOCHEM MOL TOXIC, V27, P124, DOI 10.1002/jbt.21439; Peng H, 2015, ENVIRON SCI TECHNOL, V49, P2999, DOI 10.1021/es505743d; Pillai HK, 2014, ENVIRON HEALTH PERSP, V122, P1225, DOI 10.1289/ehp.1408111; Roberts SC, 2012, CHEM RES TOXICOL, V25, P1435, DOI 10.1021/tx300086x; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Smathers Rebecca L., 2011, Human Genomics, V5, P170; Springer C, 2012, ENVIRON HEALTH PERSP, V120, P1711, DOI 10.1289/ehp.1204932; Stapleton HM, 2008, ENVIRON SCI TECHNOL, V42, P6910, DOI 10.1021/es801070p; Stapleton HM, 2011, ENVIRON SCI TECHNOL, V45, P5323, DOI 10.1021/es2007462; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; TONTONOZ P, 1994, NUCLEIC ACIDS RES, V22, P5628, DOI 10.1093/nar/22.25.5628; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P6970, DOI 10.1073/pnas.0602178103; Tung EWY, 2016, BIRTH DEFECTS RES B, V107, P157, DOI 10.1002/bdrb.21180; Tung EWY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094583; Wei GL, 2015, ENVIRON POLLUT, V196, P29, DOI 10.1016/j.envpol.2014.09.012; Yang WS, 1998, J LIPID RES, V39, P2054	43	32	33	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0175855	10.1371/journal.pone.0175855	http://dx.doi.org/10.1371/journal.pone.0175855			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437481	gold, Green Submitted, Green Published			2022-12-26	WOS:000400287600016
J	Aivazidis, S; Coughlan, CM; Rauniyar, AK; Jiang, H; Liggett, LA; Maclean, KN; Roede, JR				Aivazidis, Stefanos; Coughlan, Christina M.; Rauniyar, Abhishek K.; Jiang, Hua; Liggett, L. Alexander; Maclean, Kenneth N.; Roede, James R.			The burden of trisomy 21 disrupts the proteostasis network in Down syndrome	PLOS ONE			English	Article							UNFOLDED-PROTEIN-RESPONSE; ENDOPLASMIC-RETICULUM STRESS; ER STRESS; OXIDATIVE STRESS; PROTEASOMAL INHIBITION; PROTEOTOXIC STRESS; QUALITY-CONTROL; ACTIVATION; EXPRESSION; INSIGHTS	Down syndrome (DS) is a genetic disorder caused by trisomy of chromosome 21. Abnormalities in chromosome number have the potential to lead to disruption of the proteostasis network (PN) and accumulation of misfolded proteins. DS individuals suffer from several comorbidities, and we hypothesized that disruption of proteostasis could contribute to the observed pathology and decreased cell viability in DS. Our results confirm the presence of a disrupted PN in DS, as several of its elements, including the unfolded protein response, chaperone system, and proteasomal degradation exhibited significant alterations compared to euploid controls in both cell and mouse models. Additionally, when cell models were treated with compounds that promote disrupted proteostasis, we observed diminished levels of cell viability in DS compared to controls. Collectively our findings provide a cellular-level characterization of PN dysfunction in DS and an improved understanding of the potential pathogenic mechanisms contributing to disrupted cellular physiology in DS. Lastly, this study highlights the future potential of designing therapeutic strategies that mitigate protein quality control dysfunction.	[Aivazidis, Stefanos; Rauniyar, Abhishek K.; Roede, James R.] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Aurora, CO 80045 USA; [Coughlan, Christina M.] Univ Colorado, Sch Med, Dept Neurol, Aurora, CO USA; [Coughlan, Christina M.; Jiang, Hua; Liggett, L. Alexander; Maclean, Kenneth N.] Univ Colorado, Linda Crn Inst Down Syndrome, Aurora, CO USA; [Jiang, Hua; Liggett, L. Alexander; Maclean, Kenneth N.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Roede, JR (corresponding author), Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Aurora, CO 80045 USA.	james.roede@ucdenver.edu		Aivazids, Stefanos/0000-0003-0421-1473	Linda Crnic Institute for Down Syndrome; National Institute of Environmental Health Sciences [ES027593]; NATIONAL CANCER INSTITUTE [F31CA196231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES027593] Funding Source: NIH RePORTER	Linda Crnic Institute for Down Syndrome; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	A Grand Challenge Grant from the Linda Crnic Institute for Down Syndrome was awarded to KNM and grant funds from the National Institute of Environmental Health Sciences (ES027593) were used to support some of this research. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Also, funds allocated to JRR for laboratory start-up were used to support a majority of this work.	Aitken RJ, 2013, DIABETES CARE, V36, P1181, DOI 10.2337/dc12-1712; Alexander M, 2016, DEV MED CHILD NEUROL, V58, P246, DOI 10.1111/dmcn.12868; Amm I, 2014, BBA-MOL CELL RES, V1843, P182, DOI 10.1016/j.bbamcr.2013.06.031; Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Ansari N, 2013, CURR DRUG TARGETS, V14, P114, DOI 10.2174/138945013804806532; Anwar AJ, 1998, DIABETIC MED, V15, P160, DOI 10.1002/(SICI)1096-9136(199802)15:2<160::AID-DIA537>3.0.CO;2-J; Arensdorf Angela M., 2013, Frontiers in Genetics, V4, P256, DOI 10.3389/fgene.2013.00256; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Baryshev M, 2004, J MOL ENDOCRINOL, V32, P903, DOI 10.1677/jme.0.0320903; Beck JS, 2016, CURR ALZHEIMER RES, V13, P610, DOI 10.2174/1567205013666151221145445; Berthoud VM, 2016, J BIOL CHEM; Bimonte-Nelson HA, 2003, BEHAV BRAIN RES, V139, P47, DOI 10.1016/S0166-4328(02)00082-7; Brehme M, 2014, CELL REP, V9, P1135, DOI 10.1016/j.celrep.2014.09.042; Brickell P M, 1992, Methods Mol Biol, V8, P213, DOI 10.1385/0-89603-191-8:213; Carrard G, 2002, INT J BIOCHEM CELL B, V34, P1461, DOI 10.1016/S1357-2725(02)00085-7; Chan JY, 2015, MOL CELL ENDOCRINOL, V413, P189, DOI 10.1016/j.mce.2015.06.025; Cheng WP, 2008, CARDIOVASC RES, V77, P551, DOI 10.1093/cvr/cvm057; Chondrogianni N, 2014, FREE RADICAL BIO MED, V71, P303, DOI 10.1016/j.freeradbiomed.2014.03.031; Dephoure N, 2014, ELIFE, V3, DOI 10.7554/eLife.03023; Di Domenico F, 2013, BBA-MOL BASIS DIS, V1832, P1249, DOI 10.1016/j.bbadis.2013.04.013; Donnelly N, 2014, EMBO J, V33, P2374, DOI 10.15252/embj.201488648; Diaz-Villanueva JF, 2015, INT J MOL SCI, V16, P17193, DOI 10.3390/ijms160817193; Garlet TR, 2013, LIFE SCI, V93, P558, DOI 10.1016/j.lfs.2013.08.017; Ghribi O, 2003, J NEUROPATH EXP NEUR, V62, P1144, DOI 10.1093/jnen/62.11.1144; Gidalevitz T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a009704; Gimeno A, 2014, BBA-MOL BASIS DIS, V1842, P116, DOI 10.1016/j.bbadis.2013.10.014; Gomez JA, 2016, ELIFE, V5, DOI 10.7554/eLife.20390; Govoni S, 1996, NEUROLOGY, V47, P1069, DOI 10.1212/WNL.47.4.1069; Graber E, 2012, ENDOCRIN METAB CLIN, V41, P735, DOI 10.1016/j.ecl.2012.08.008; Grune T, 2005, FREE RADICAL BIO MED, V39, P1208, DOI 10.1016/j.freeradbiomed.2005.06.009; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Ishii T, 2005, BIOCHEMISTRY-US, V44, P13893, DOI 10.1021/bi051336u; Jaisson S, 2014, DIABETOLOGIA, V57, P1517, DOI 10.1007/s00125-014-3257-1; Jensen KM, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5596; Jiang Y, 2010, P NATL ACAD SCI USA, V107, P1630, DOI 10.1073/pnas.0908953107; Karagoz GE, 2015, TRENDS BIOCHEM SCI, V40, P117, DOI 10.1016/j.tibs.2014.12.002; Kim JS, 2014, J NEURAL TRANSM, V121, P1233, DOI 10.1007/s00702-014-1208-0; Kim R, 2006, APOPTOSIS, V11, P5, DOI 10.1007/s10495-005-3088-0; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kirstein J, 2015, EMBO J, V34, P2334, DOI 10.15252/embj.201591711; Krinsky-McHale SJ, 2014, J APPL RES INTELLECT, V27, P247, DOI 10.1111/jar.12062; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Lefter S, 2011, J CLIN NEUROPHYSIOL, V28, P469, DOI 10.1097/WNP.0b013e318230da76; Liu GL, 2011, BRAIN RES BULL, V84, P94, DOI 10.1016/j.brainresbull.2010.10.004; Lockstone HE, 2007, GENOMICS, V90, P647, DOI 10.1016/j.ygeno.2007.08.005; Logue SE, 2013, APOPTOSIS, V18, P537, DOI 10.1007/s10495-013-0818-6; Lott IT, 2012, J ALZHEIMERS DIS, V29, P177, DOI 10.3233/JAD-2012-111613; Martinez G, 2016, CELL REP, V14, P1382, DOI 10.1016/j.celrep.2016.01.028; Masouleh BK, 2014, P NATL ACAD SCI USA, V111, pE2219, DOI 10.1073/pnas.1400958111; Mateos MK, 2015, TRANSL PEDIATR, V4, P76, DOI 10.3978/j.issn.2224-4336.2015.03.03; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; Melville CA, 2005, J INTELL DISABIL RES, V49, P125, DOI 10.1111/j.1365-2788.2004.00616.x; Morano KA, 2007, ANN NY ACAD SCI, V1113, P1, DOI 10.1196/annals.1391.018; Mota SI, 2015, BBA-MOL BASIS DIS, V1852, P1428, DOI 10.1016/j.bbadis.2015.03.015; Muchova J, 2014, PHYSIOL RES, V63, P535, DOI 10.33549/physiolres.932722; Nakanishi K, 2005, J CELL BIOL, V169, P555, DOI 10.1083/jcb.200412024; Orlicky DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066837; Oromendia AB, 2012, GENE DEV, V26, P2696, DOI 10.1101/gad.207407.112; Osorio F, 2014, NAT IMMUNOL, V15, P248, DOI 10.1038/ni.2808; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Palsamy P, 2014, BBA-MOL BASIS DIS, V1842, P1794, DOI 10.1016/j.bbadis.2014.06.028; Parcellier A, 2003, MOL CELL BIOL, V23, P5790, DOI 10.1128/MCB.23.16.5790-5802.2003; Patterson D, 2009, HUM GENET, V126, P195, DOI 10.1007/s00439-009-0696-8; Perluigi M, 2014, BBA-MOL BASIS DIS, V1842, P1144, DOI 10.1016/j.bbadis.2014.04.007; Perluigi M, 2014, PROTEOM CLIN APPL, V8, P73, DOI 10.1002/prca.201300066; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; RAHMANI Z, 1989, P NATL ACAD SCI USA, V86, P5958, DOI 10.1073/pnas.86.15.5958; Reinhardt S, 2014, FASEB J, V28, P978, DOI 10.1096/fj.13-234864; Rodriguez-Sureda V, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/509241; Roede JR, 2014, REDOX BIOL, V2, P651, DOI 10.1016/j.redox.2014.04.007; Roper RJ, 2006, PLOS GENET, V2, P231, DOI 10.1371/journal.pgen.0020050; Ruparelia A, 2013, DEV DISABIL RES REV, V18, P43, DOI 10.1002/ddrr.1127; Sarto C, 2000, ELECTROPHORESIS, V21, P1218, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1218::AID-ELPS1218>3.3.CO;2-8; Savva GM, 2010, PRENATAL DIAG, V30, P57, DOI 10.1002/pd.2403; Schreiber A, 2014, BBA-MOL CELL RES, V1843, P163, DOI 10.1016/j.bbamcr.2013.03.019; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Seth A, 1999, CELL DEATH DIFFER, V6, P902, DOI 10.1038/sj.cdd.4400567; Shimura H, 2004, J BIOL CHEM, V279, P17957, DOI 10.1074/jbc.M400351200; Spellman C, 2013, GENE, V512, P219, DOI 10.1016/j.gene.2012.10.051; Stingele S, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.40; Sun JH, 2015, MOL ASPECTS MED, V42, P105, DOI 10.1016/j.mam.2015.01.001; Sun YW, 2011, J PROTEOMICS, V74, P547, DOI 10.1016/j.jprot.2011.01.009; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tlili A, 2012, MOL NEUROBIOL, V46, P297, DOI 10.1007/s12035-012-8284-7; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Vidal RL, 2012, HUM MOL GENET, V21, P2245, DOI 10.1093/hmg/dds040; Videla LA, 2015, FREE RADICAL BIO MED, V89, P401, DOI 10.1016/j.freeradbiomed.2015.09.004; Vilardell M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-229; Vilchez D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6659; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Wiseman FK, 2015, NAT REV NEUROSCI, V16, P564, DOI 10.1038/nrn3983; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Xiong R, 2013, CHEM-BIOL INTERACT, V204, P116, DOI 10.1016/j.cbi.2013.04.016; Yamamoto A, 2006, J NEUROPATH EXP NEUR, V65, P217, DOI 10.1097/01.jnen.0000202886.22082.2a; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130705; Yoo BC, 2001, ELECTROPHORESIS, V22, P1233, DOI 10.1002/1522-2683()22:6<1233::AID-ELPS1233>3.0.CO;2-M; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yu T, 2010, BRAIN RES, V1366, P162, DOI 10.1016/j.brainres.2010.09.107; Zhou Y, 2004, NEUROSCIENCE, V128, P281, DOI 10.1016/j.neuroscience.2004.06.048	101	28	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0176307	10.1371/journal.pone.0176307	http://dx.doi.org/10.1371/journal.pone.0176307			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430800	Green Submitted, Green Published, gold			2022-12-26	WOS:000399876100040
J	Hernandez-Martinez, S; Sanchez-Zavaleta, M; Brito, K; Herrera-Ortiz, A; Ons, S; Noriega, FG				Hernandez-Martinez, Salvador; Sanchez-Zavaleta, Minerva; Brito, Kevin; Herrera-Ortiz, Antonia; Ons, Sheila; Noriega, Fernando G.			Allatotropin: A pleiotropic neuropeptide that elicits mosquito immune responses	PLOS ONE			English	Article							ANOPHELES-ALBIMANUS DIPTERA; MANDUCA-SEXTA ALLATOTROPIN; NITRIC-OXIDE PRODUCTION; AEDES-AEGYPTI; PLASMODIUM-BERGHEI; BACTERIAL LIPOPOLYSACCHARIDE; FUNCTIONAL-CHARACTERIZATION; MACROPHAGE ACTIVATION; JUVENILE-HORMONE; NERVOUS-SYSTEM	Allatotropins (AT) are neuropeptides with pleotropic functions on a variety of insect tissues. They affect processes such as juvenile hormone biosynthesis, cardiac rhythm, oviduct and hindgut contractions, nutrient absorption and circadian cycle. The present work provides experimental evidence that AT elicits immune responses in two important mosquito disease vectors, Anopheles albimanus and Aedes aegypti. Hemocytes and an immune-competent mosquito cell line responded to AT by showing strong morphological changes and increasing bacterial phagocytic activity. Phenoloxidase activity in hemolymph was also increased in Ae. aegypti mosquitoes treated with AT but not in An. albimanus, suggesting differences in the AT-dependent immune activation in the two species. In addition, two important insect immune markers, nitric oxide levels and expression of antimicrobial peptide genes, were increased in An. albimanus guts after AT treatment. AT conjugated to quantum dot nano-crystals (QDots) specifically labeled hemocytes in vivo in both mosquito species, implying molecular interactions between AT and hemocytes. The results of our studies suggest a new role for AT in the modulation of the immune response in mosquitoes.	[Hernandez-Martinez, Salvador; Sanchez-Zavaleta, Minerva; Brito, Kevin; Herrera-Ortiz, Antonia] Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico; [Ons, Sheila] Univ Nacl La Plata, Ctr Reg Estudios Genom, Lab Neurobiol Insectos, La Plata, Buenos Aires, Argentina; [Noriega, Fernando G.] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [Noriega, Fernando G.] Florida Int Univ, Biomol Sci Inst, Miami, FL 33199 USA	Instituto Nacional de Salud Publica; National University of La Plata; State University System of Florida; Florida International University; State University System of Florida; Florida International University	Hernandez-Martinez, S (corresponding author), Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico.	shernandez@insp.mx	Ons, Sheila/ABI-2195-2020	Hernandez-Martinez, Salvador/0000-0003-1276-9397; Herrera Ortiz, Antonia/0000-0001-6307-0370	Consejo Nacional de Ciencia y Tecnologia Mexico [258239]; National Institutes of Health USA [2R01AI045545-16]; CONACyT [12471]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045545] Funding Source: NIH RePORTER	Consejo Nacional de Ciencia y Tecnologia Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Institutes of Health USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Consejo Nacional de Ciencia y Tecnologia Mexico, grant 258239 to SH-M, the National Institutes of Health USA, grant 2R01AI045545-16 to FGN, and CONACyT for the fellowship 12471 to MS-Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Consejo Nacional de Ciencia y Tecnologia Mexico, grant 258239 to SH-M, the National Institutes of Health USA, grant 2R01AI045545-16 to FGN, and CONACyT for the fellowship 12471 to MS-Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON WA, 1971, J CELL BIOL, V50, P201, DOI 10.1083/jcb.50.1.201; Baggerman G, 2002, J BIOL CHEM, V277, P40368, DOI 10.1074/jbc.M206257200; Bello FJ, 1997, MEM I OSWALDO CRUZ, V92, P123, DOI 10.1590/S0074-02761997000100027; Bryant WB, 2016, DEV COMP IMMUNOL, V55, P119, DOI 10.1016/j.dci.2015.10.020; Bryant WB, 2014, J EXP BIOL, V217, P1238, DOI 10.1242/jeb.094573; Clayton AM, 2014, J INNATE IMMUN, V6, P169, DOI 10.1159/000353602; Contreras-Garduno J, 2015, DEV COMP IMMUNOL, V52, P172, DOI 10.1016/j.dci.2015.05.004; Eckmann L, 2000, J IMMUNOL, V164, P1478, DOI 10.4049/jimmunol.164.3.1478; Elekonich MM, 2003, PEPTIDES, V24, P1623, DOI 10.1016/j.peptides.2003.08.011; Alzugaray ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077520; Fraiture M, 2009, CELL HOST MICROBE, V5, P273, DOI 10.1016/j.chom.2009.01.005; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; Goldsworthy G, 2003, J INSECT PHYSIOL, V49, P795, DOI 10.1016/S0022-1910(03)00118-5; Goldsworthy G, 2002, J INSECT PHYSIOL, V48, P601, DOI 10.1016/S0022-1910(02)00085-9; Hernandez S, 1999, J MED ENTOMOL, V36, P426, DOI 10.1093/jmedent/36.4.426; Hernandez-Martinez S, 2005, CELL TISSUE RES, V321, P105, DOI 10.1007/s00441-005-1133-5; Hernandez-Martinez S, 2002, J MED ENTOMOL, V39, P61, DOI 10.1603/0022-2585-39.1.61; Hernandez-Martinez S, 2007, J INSECT PHYSIOL, V53, P230, DOI 10.1016/j.jinsphys.2006.08.009; Hernandez-Martinez S, 2013, ARCH INSECT BIOCHEM, V84, P1, DOI 10.1002/arch.21108; Hernandez-Martinez S, 2013, CELL TISSUE RES, V351, P127, DOI 10.1007/s00441-012-1505-6; Herrera-Ortiz A, 2004, INSECT BIOCHEM MOLEC, V34, P893, DOI 10.1016/j.ibmb.2004.05.007; Herrera-Ortiz A, 2011, DEV COMP IMMUNOL, V35, P44, DOI 10.1016/j.dci.2010.08.004; Hillyer JF, 2014, CURR OPIN INSECT SCI, V3, P14, DOI 10.1016/j.cois.2014.07.002; Horodyski FM., 2013, HDB BIOL ACTIVE PEPT, P197; Horton AA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-574; HOUK EJ, 1981, ACTA TROP, V38, P163; KATAOKA H, 1989, SCIENCE, V243, P1481, DOI 10.1126/science.243.4897.1481; King JG, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-55; King JG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003058; LANZ H, 1993, DEV COMP IMMUNOL, V17, P399, DOI 10.1016/0145-305X(93)90031-K; League GP, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0305-y; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Li YP, 2003, J EXP BIOL, V206, P1825, DOI 10.1242/jeb.00371; Lombardo F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003145; Moita LF, 2005, IMMUNITY, V23, P65, DOI 10.1016/j.immuni.2005.05.006; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nassel DR, 2002, PROG NEUROBIOL, V68, P1, DOI 10.1016/S0301-0082(02)00057-6; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Nouzova M, 2012, PEPTIDES, V34, P201, DOI 10.1016/j.peptides.2011.07.025; Ons S, 2011, INSECT MOL BIOL, V20, P29, DOI 10.1111/j.1365-2583.2010.01050.x; Petricevich VL, 2008, CLIN EXP IMMUNOL, V154, P415, DOI 10.1111/j.1365-2249.2008.03754.x; Predel R, 2010, J PROTEOME RES, V9, P2006, DOI 10.1021/pr901187p; Rachinsky A, 2003, ARCH INSECT BIOCHEM, V54, P121, DOI 10.1002/arch.10107; REDDY JT, 1990, J INSECT PHYSIOL, V36, P397, DOI 10.1016/0022-1910(90)90057-M; Riehle MA, 2002, SCIENCE, V298, P172, DOI 10.1126/science.1076827; Saraiva RG, 2016, DEV COMP IMMUNOL, V64, P53, DOI 10.1016/j.dci.2016.01.015; Sigle LT, 2016, DEV COMP IMMUNOL, V55, P90, DOI 10.1016/j.dci.2015.10.018; Skinner JR, 1997, CELL TISSUE RES, V290, P119, DOI 10.1007/s004410050914; STEFANO GB, 1989, P NATL ACAD SCI USA, V86, P626, DOI 10.1073/pnas.86.2.626; Strand Michael R., 2008, Insect Science, V15, P1, DOI 10.1111/j.1744-7917.2008.00183.x; Tafalla C, 2002, COMP BIOCHEM PHYS B, V132, P423, DOI 10.1016/S1096-4959(02)00050-7; Veenstra JA, 1999, PEPTIDES, V20, P1145, DOI 10.1016/S0196-9781(99)00117-5; Wenzel J, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00071	53	14	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175759	10.1371/journal.pone.0175759	http://dx.doi.org/10.1371/journal.pone.0175759			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426765	Green Published, gold, Green Submitted			2022-12-26	WOS:000399875900045
J	Marini, MA; Fiorentino, TV; Succurro, E; Pedace, E; Andreozzi, F; Sciacqua, A; Perticone, F; Sesti, G				Marini, Maria Adelaide; Fiorentino, Teresa Vanessa; Succurro, Elena; Pedace, Elisabetta; Andreozzi, Francesco; Sciacqua, Angela; Perticone, Francesco; Sesti, Giorgio			Association between hemoglobin glycation index with insulin resistance and carotid atherosclerosis in non-diabetic individuals	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; C-REACTIVE PROTEIN; MEAN BLOOD-GLUCOSE; END-PRODUCTS; BIOLOGICAL VARIATION; RISK-FACTOR; MICROVASCULAR COMPLICATIONS; CARDIOVASCULAR-DISEASE; FASTING GLUCOSE; MEDIA THICKNESS	Hemoglobin glycation index (HGI), defined as the difference between the observed HbA1c value and the value of HbA1c predicted from plasma glucose levels, represents a measure of the degree of non-enzymatic glycation of hemoglobin and it has been found to be positively associated with micro-and macro-vascular complications in subjects with type 2 diabetes. To investigate the pathophysiological abnormalities responsible for the increased cardiovascular risk of patients with higher HGI, we evaluated the association of HGI with cardio-metabolic characteristics in nondiabetic offspring of type 2 diabetic individuals. Insulin sensitivity, measured by a hyperinsulinemic-euglycemic clamp, cardio-metabolic risk factors including lipid profile, uric acid and inflammatory factors, and ultrasound measurement of carotid intima-media thickness (IMT) were assessed in 387 nondiabetic individuals. Participants were stratified in tertiles according to HGI (high, moderate and low). As compared with subjects with low HGI, those with high HGI displayed an unfavorable cardio-metabolic risk profile having significantly higher values of BMI, waist circumference, triglycerides, uric acid, fasting insulin, inflammatory markers, such as high sensitivity C reactive protein, erythrocytes sedimentation rate, complement C3, fibrinogen, and white blood cell count, and carotid IMT, and lower HDL and insulin-stimulated glucose disposal. In a linear regression analysis model including several atherosclerotic risk factors such as gender, age, BMI, inflammatory factors, lipid profile, insulin-stimulated glucose disposal, fasting insulin, uric acid, and blood pressure, HGI was the major predictor of IMT (beta = 0.35; P = 0.001). In a logistic regression analysis adjusted for confounders, individuals with high HGI showed a 2.7-fold increased risk of vascular atherosclerosis (OR 2.72, 95% CI 1.01-7.37) as compared with subjects with low HGI. The present findings support the notion that HGI may be a useful tool to identify a subset of nondiabetic individuals conceivably harboring a higher risk of cardiovascular disease.	[Marini, Maria Adelaide; Perticone, Francesco; Sesti, Giorgio] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy; [Fiorentino, Teresa Vanessa; Succurro, Elena; Pedace, Elisabetta; Andreozzi, Francesco; Sciacqua, Angela] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Viale Europa, Catanzaro, Italy	University of Rome Tor Vergata; Magna Graecia University of Catanzaro	Sesti, G (corresponding author), Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy.	sesti@unicz.it	Succurro, Elena/K-4138-2016; Fiorentino, Teresa Vanessa/AAP-1855-2020; Perticone, Francesco/I-4260-2017; Andreozzi, Francesco/J-4073-2018	Succurro, Elena/0000-0003-2578-692X; Andreozzi, Francesco/0000-0001-9375-1513				American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Cai WJ, 2012, P NATL ACAD SCI USA, V109, P15888, DOI 10.1073/pnas.1205847109; Cardellini M, 2007, AM J PHYSIOL-ENDOC M, V292, pE347, DOI 10.1152/ajpendo.00291.2006; Cipollone F, 2003, CIRCULATION, V108, P1070, DOI 10.1161/01.CIR.0000086014.80477.0D; Cohen RM, 2006, DIABETES CARE, V29, P1739, DOI 10.2337/dc06-0286; Felipe DL, 2011, DIABETES CARE, V34, P1816, DOI 10.2337/dc11-0049; Fukudome M, 2009, INTERNAL MED, V48, P273, DOI 10.2169/internalmedicine.48.1544; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; GONEN B, 1977, LANCET, V2, P734; Gould BJ, 1997, CLIN CHIM ACTA, V260, P49, DOI 10.1016/S0009-8981(96)06508-4; Hempe JM, 2015, DIABETES CARE, V38, P1067, DOI 10.2337/dc14-1844; Hempe JM, 2010, DIABETES CARE, V33, P1449, DOI 10.2337/dc09-1498; Hempe JM, 2002, J DIABETES COMPLICAT, V16, P313, DOI 10.1016/S1056-8727(01)00227-6; Herman WH, 2007, DIABETES CARE, V30, P2453, DOI 10.2337/dc06-2003; Herman WH, 2012, J CLIN ENDOCR METAB, V97, P1067, DOI 10.1210/jc.2011-1894; Howard G, 1996, CIRCULATION, V93, P1809, DOI 10.1161/01.CIR.93.10.1809; Kilhovd BK, 2007, DIABETOLOGIA, V50, P1409, DOI 10.1007/s00125-007-0687-z; Kilhovd BK, 2005, ARTERIOSCL THROM VAS, V25, P815, DOI 10.1161/01.ATV.0000158380.44231.fe; Kilpatrick ES, 1998, DIABETES CARE, V21, P261, DOI 10.2337/diacare.21.2.261; Kim JI, 2005, DIABETES, V54, pA244; Laakso M, 2008, DIABETOLOGIA, V51, P502, DOI 10.1007/s00125-007-0899-2; Leslie RDG, 2003, DIABETES, V52, P2441, DOI 10.2337/diabetes.52.9.2441; Marini MA, 2014, NUTR METAB CARDIOVAS, V24, P27, DOI 10.1016/j.numecd.2013.01.011; Marini MA, 2012, DIABETES CARE, V35, P1144, DOI 10.2337/dc11-2032; McCarter RJ, 2004, DIABETES CARE, V27, P1259, DOI 10.2337/diacare.27.6.1259; NATHAN DM, 1984, NEW ENGL J MED, V310, P341, DOI 10.1056/NEJM198402093100602; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Pani LN, 2008, DIABETES CARE, V31, P1991, DOI 10.2337/dc08-0577; Park S, 1996, DIABETES CARE, V19, P450, DOI 10.2337/diacare.19.5.450; PHILLIPOU G, 1993, CLIN CHEM, V39, P2305; Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Rodriguez-Segade S, 2012, DIABETES CARE, V35, P2447, DOI 10.2337/dc11-2450; Rohlfing C, 2002, CLIN CHEM, V48, P1116; Rojas A, 2014, INT REV IMMUNOL, V33, P67, DOI 10.3109/08830185.2013.849702; Rutter MK, 2005, DIABETES, V54, P3252, DOI 10.2337/diabetes.54.11.3252; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Sesti G, 2014, NUTR METAB CARDIOVAS, V24, P1365, DOI 10.1016/j.numecd.2014.06.012; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Soros AA, 2010, PEDIATR DIABETES, V11, P455, DOI 10.1111/j.1399-5448.2009.00630.x; Staiger H, 2008, DIABETES, V57, P514, DOI 10.2337/db07-1254; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Uribarri J, 2011, DIABETES CARE, V34, P1610, DOI 10.2337/dc11-0091; Verma S, 2002, CIRCULATION, V106, P913, DOI 10.1161/01.CIR.0000029802.88087.5E; Vlassara H, 2002, P NATL ACAD SCI USA, V99, P15596, DOI 10.1073/pnas.242407999; Vlassara H, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-013-0453-1; Wilson DM, 2008, DIABETES CARE, V31, P381, DOI 10.2337/dc07-1835; Wilson DM, 2011, DIABETES CARE, V34, P1315, DOI 10.2337/dc10-1661; YUDKIN JS, 1990, DIABETOLOGIA, V33, P208, DOI 10.1007/BF00404798; Zafon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066696	52	35	38	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175547	10.1371/journal.pone.0175547	http://dx.doi.org/10.1371/journal.pone.0175547			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426788	Green Published, gold			2022-12-26	WOS:000399875900031
J	Wang, L; Cao, M; Wei, QL; Zhao, ZH; Xiang, Q; Wang, HJ; Zhang, HT; Lai, GQ				Wang, Lei; Cao, Min; Wei, Qing Lu; Zhao, Zhong Hua; Xiang, Qin; Wang, Hui Juan; Zhang, Hua Tang; Lai, Guo Qi			A new model mimicking persistent HBV e antigen-negative infection using covalently closed circular DNA in immunocompetent mice	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; ROLLING CIRCLE AMPLIFICATION; CORE PROMOTER; PRECORE; REPLICATION; EXPRESSION; MANAGEMENT; MUTATIONS; CCCDNA; TRANSCRIPTION	Despite the availability of an effective vaccine, hepatitis B virus (HBV) infection remains a major health problem. HBV e antigen (HBeAg)-negative strains have become prevalent. Previously, no animal model mimicked the clinical course of HBeAg-negative HBV infection. To establish an HBeAg-negative HBV infection model, the 3.2-kb full-length genome of HBeAg-negative HBV was cloned from a clinical sample and then circularized to form covalently closed circular (cccDNA). The resulting cccDNA was introduced into the liver of C57BL/6J mice through hydrodynamic injection. Persistence of the HBeAg-negative infection was monitored at predetermined time points using HBV-specific markers including HBV surface antigen (HBsAg), HBeAg, and HBV core antigen (HBcAg) as well as DNA copies. Throughout the study, pAAV-HBV1.2 was used as a control. In mice injected with HBeAg-negative cccDNA, the HBV infection rate was 100% at the initial stage. HBsAg levels increased up to 1 week, at which point levels peaked and dropped quickly thereafter. In 60% of injected mice, HBsAg and HBcAg persisted for more than 10 weeks. High numbers of HBV DNA copies were detected in the serum and liver. Moreover, cccDNA persisted in the liver tissue of HBeAg-negative mice. In contrast to the pAAV-HBV 1.2 injected mice, no HBeAg was found in mice injected with HBeAg-negative HBV throughout the study period. These results demonstrate the first successful establishment of a model of HBeAg-negative HBV-persistent infection in immunocompetent mice. Compared to pAAV-HBV1.2-injected mice, the infection persistence and levels of serum virological and biochemical markers were approximately equal in the model mice. This model will be useful for mechanistic studies on HBeAg-negative HBV infection and will facilitate the evaluation of new antiviral drugs.	[Wang, Lei; Cao, Min; Xiang, Qin; Wang, Hui Juan; Lai, Guo Qi] Chongqing Med Univ, Lab Anim Ctr, Chongqing, Peoples R China; [Wei, Qing Lu; Zhao, Zhong Hua; Zhang, Hua Tang] Chongqing Acad Sci & Technol, Chongqing, Peoples R China	Chongqing Medical University	Lai, GQ (corresponding author), Chongqing Med Univ, Lab Anim Ctr, Chongqing, Peoples R China.; Zhang, HT (corresponding author), Chongqing Acad Sci & Technol, Chongqing, Peoples R China.	zht@cast.gov.cn; laiguoqi@163.com	wang, huimin/HDM-8421-2022; wang, hui/GRS-4730-2022		National Natural Science Foundation of China [8157041877]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 8157041877). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEASLEY RP, 1981, LANCET, V2, P1129; BRUNETTO MR, 1990, J HEPATOL, V10, P258, DOI 10.1016/0168-8278(90)90062-V; Buckwold VE, 1996, J VIROL, V70, P5845, DOI 10.1128/JVI.70.9.5845-5851.1996; Caligiuri P, 2016, WORLD J GASTROENTERO, V22, P145, DOI 10.3748/wjg.v22.i1.145; Cheng L, 2015, ANTIVIR RES, V121, P1, DOI 10.1016/j.antiviral.2015.06.012; Funk ML, 2002, J VIRAL HEPATITIS, V9, P52, DOI 10.1046/j.1365-2893.2002.00304.x; GANEM D, 1987, ANNU REV BIOCHEM, V56, P651, DOI 10.1146/annurev.biochem.56.1.651; GUNTHER S, 1995, J VIROL, V69, P5437; Guo XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep25552; Hadziyannis SJ, 2001, HEPATOLOGY, V34, P617, DOI 10.1053/jhep.2001.27834; Hadziyannis SJ, 2006, SEMIN LIVER DIS, V26, P130, DOI 10.1055/s-2006-939751; Hadziyannis SJ, 2007, EXPERT OPIN INV DRUG, V16, P777, DOI 10.1517/13543784.16.6.777; Hibbitt OC, 2007, J GENE MED, V9, P488, DOI 10.1002/jgm.1041; Hunt CM, 2000, HEPATOLOGY, V31, P1037, DOI 10.1053/he.2000.6709; Inoue J, 2011, J INFECT DIS, V204, P1017, DOI 10.1093/infdis/jir485; Keeffe EB, 2004, CLIN GASTROENTEROL H, V2, P87, DOI 10.1016/S1542-3565(03)00312-4; Kim H, 2016, WORLD J GASTROENTERO, V22, P4287, DOI 10.3748/wjg.v22.i17.4287; Lai GQ, 2014, MOL MED REP, V10, P1245, DOI 10.3892/mmr.2014.2372; Lebosse F, 2016, J HEPATOLOGY; Levrero M, 2009, J HEPATOL, V51, P581, DOI 10.1016/j.jhep.2009.05.022; Li F, 2016, SCI REP-UK, V6, DOI 10.1038/srep36483; Li XS, 2015, INT J MOL SCI, V16, P5141, DOI 10.3390/ijms16035141; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Locarnini S, 2003, SEMIN LIVER DIS, V23, P5, DOI 10.1055/s-2003-37587; Lupberger J, 2007, WORLD J GASTROENTERO, V13, P74, DOI 10.3748/wjg.v13.i1.74; Margeridon S, 2008, ANTIMICROB AGENTS CH, V52, P3068, DOI 10.1128/AAC.01318-07; Moriyama K, 1996, VIROLOGY, V226, P269, DOI 10.1006/viro.1996.0655; Qi ZH, 2014, J VIROL, V88, P8045, DOI 10.1128/JVI.01024-14; Qin YL, 2011, J CLIN MICROBIOL, V49, P1226, DOI 10.1128/JCM.02340-10; Saikia N, 2007, POSTGRAD MED J, V83, P32, DOI 10.1136/pgmj.2006.044826; Samal J, 2015, VIROLOGY, V484, P234, DOI 10.1016/j.virol.2015.06.011; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Shen T, 2014, WORLD J GASTROENTERO, V20, P5435, DOI 10.3748/wjg.v20.i18.5435; Shintani M, 2010, ONCOL REP, V23, P1345, DOI 10.3892/or_00000770; Tohme RA, 2013, J CLIN VIROL, V58, P396, DOI 10.1016/j.jcv.2013.08.012; Wang FS, 2014, HEPATOLOGY, V60, P2099, DOI 10.1002/hep.27406; Wooddell CI, 2008, J GENE MED, V10, P551, DOI 10.1002/jgm.1179; Yeh ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122259; Zhang ZH, 2016, WORLD J GASTROENTERO, V22, P126, DOI 10.3748/wjg.v22.i1.126; Zhong YW, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0608-y; Zhong YW, 2011, CLIN CHIM ACTA, V412, P1905, DOI 10.1016/j.cca.2011.06.031; Zoulim F, 2005, J HEPATOL, V42, P302, DOI 10.1016/j.jhep.2004.12.015	42	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175992	10.1371/journal.pone.0175992	http://dx.doi.org/10.1371/journal.pone.0175992			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426720	Green Published, gold, Green Submitted			2022-12-26	WOS:000399875900082
J	Li, J; Huang, Q; Long, X; Guo, X; Sun, X; Jin, X; Li, Z; Ren, T; Yuan, P; Huang, X; Zhang, H; Xing, J				Li, J.; Huang, Q.; Long, X.; Guo, X.; Sun, X.; Jin, X.; Li, Z.; Ren, T.; Yuan, P.; Huang, X.; Zhang, H.; Xing, J.			Mitochondrial elongation-mediated glucose metabolism reprogramming is essential for tumour cell survival during energy stress	ONCOGENE			English	Article							CANCER-CELLS; FISSION; PHOSPHORYLATION; DYNAMICS; SIRTUINS; HYPOXIA; FUSION; DEGRADATION; STARVATION; AUTOPHAGY	To date, mechanisms of tumour cell survival under energy stress are not well understood. Cumulative evidence is beginning to reveal that specific mitochondrial morphologies are often associated with energetic states and survival of cells. However, the functional roles of mitochondria in the metabolic adaptation of tumour cells to energy stress remain to be elucidated. In this study, we first investigated the changes in mitochondrial morphology induced by nutrition deprivation in tumour cells, and the underlying molecular mechanism. We then systematically explored glucose metabolism reprogramming by energy stress-induced alteration of mitochondrial morphology and its effect on tumour cell survival. Our results showed that starvation treatment resulted in a dramatic mitochondrial elongation, which was mainly mediated by DRP1(S637) phosphorylation through protein kinase A activation and subsequent suppression of mitochondrial translocation of DRP1. We further observed that tumour cells under an energy stress condition exhibited a clear shift from glycolysis towards oxidative phosphorylation, which was reversed by the recovery of mitochondrial fission induced by forced expression of mutant DRP1(S637A). Mechanistically, energy stress-induced mitochondrial elongation facilitated cristae formation and assembly of respiratory complexes to enhance oxidative phosphorylation, which in turn exhibited a feedback inhibitory effect on glycolysis through NAD(+)-dependent SIRT1 activation. In addition, our data indicated that DRP1(S637)-mediated mitochondrial elongation under energy stress was essential for tumour cell survival both in vitro and in vivo and predicted poor prognosis of hepatocellular carcinoma patients. Overall, our study demonstrates that remodelling of mitochondrial morphology plays a critical role in tumour cell adaptation to energy stress by reprogramming glucose metabolism.	[Li, J.; Huang, Q.; Long, X.; Guo, X.; Sun, X.; Li, Z.; Ren, T.; Huang, X.; Xing, J.] Fourth Mil Med Univ, State Key Lab Canc Biol, 169 Changle West Rd, Xian 710032, Shaanxi, Peoples R China; [Li, J.; Huang, Q.; Long, X.; Guo, X.; Sun, X.; Li, Z.; Ren, T.; Huang, X.; Xing, J.] Fourth Mil Med Univ, Expt Teaching Ctr Basic Med, 169 Changle West Rd, Xian 710032, Shaanxi, Peoples R China; [Jin, X.] Fourth Mil Med Univ, Xijing Hosp, Dept Pharm, Xian, Shaanxi, Peoples R China; [Yuan, P.; Zhang, H.] Fourth Mil Med Univ, Tangdu Hosp, Dept Pain Treatment, Xian, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Xing, J (corresponding author), Fourth Mil Med Univ, State Key Lab Canc Biol, 169 Changle West Rd, Xian 710032, Shaanxi, Peoples R China.; Xing, J (corresponding author), Fourth Mil Med Univ, Expt Teaching Ctr Basic Med, 169 Changle West Rd, Xian 710032, Shaanxi, Peoples R China.	xingjl@fmmu.edu.cn			National Natural Science Foundation of China [81320108021, 81572304]; National Basic Research Program of China [2015CB553703]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (grants 81320108021 and 81572304) and National Basic Research Program (grant 2015CB553703) of China.	Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Birsoy K, 2014, NATURE, V508, P108, DOI 10.1038/nature13110; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Ferretti AC, 2016, ONCOTARGET, V7, P17815, DOI 10.18632/oncotarget.7404; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Guido C, 2012, ONCOTARGET, V3, P798, DOI 10.18632/oncotarget.574; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hong J, 2014, J BIOL CHEM, V289, P20012, DOI 10.1074/jbc.M114.560078; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Huang Q., 2016, AUTOPHAGY, P1; Huang QC, 2014, J HEPATOL, V61, P859, DOI 10.1016/j.jhep.2014.04.035; Ikeda Y, 2015, CIRC RES, V116, P264, DOI 10.1161/CIRCRESAHA.116.303356; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Jakobs S, 2003, J CELL SCI, V116, P2005, DOI 10.1242/jcs.00423; Kashatus JA, 2015, MOL CELL, V57, P537, DOI 10.1016/j.molcel.2015.01.002; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Liu ZG, 2015, SPR TRACTS MECH ENG, P1, DOI 10.1007/978-3-662-45673-6_1; Loh JK, 2015, BBA-MOL CELL RES, V1853, P1796, DOI 10.1016/j.bbamcr.2015.04.013; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Molina AJA, 2009, DIABETES, V58, P2303, DOI 10.2337/db07-1781; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Rahman S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-11; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Serasinghe MN, 2015, MOL CELL, V57, P521, DOI 10.1016/j.molcel.2015.01.003; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Toda C, 2016, CELL, V164, P872, DOI 10.1016/j.cell.2016.02.010; Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138; Verdin E, 2014, NAT MED, V20, P25, DOI 10.1038/nm.3447; Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213; Yoon H, 2014, BIOCHEM BIOPH RES CO, V444, P36, DOI 10.1016/j.bbrc.2014.01.001; Zeng W, 2015, CANCER LETT, V356, P263, DOI 10.1016/j.canlet.2014.01.032	38	68	69	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 24	2017	36	34					4901	4912		10.1038/onc.2017.98	http://dx.doi.org/10.1038/onc.2017.98			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FE5EI	28436948				2022-12-26	WOS:000408234400007
J	Guasp, P; Barnea, E; Gonzalez-Escribano, MF; Jimenez-Reinoso, A; Regueiro, JR; Admon, A; de Castro, JAL				Guasp, Pablo; Barnea, Eilon; Francisca Gonzalez-Escribano, M.; Jimenez-Reinoso, Anais; Regueiro, Jose R.; Admon, Arie; Lopez de Castro, Jose A.			The Behcet's disease-associated variant of the aminopeptidase ERAP1 shapes a low-affinity HLA-B*51 peptidome by differential subpeptidome processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURAL-KILLER-CELLS; HLA CLASS-I; ENDOPLASMIC-RETICULUM; FUNCTIONAL INTERACTION; PRESENTED PEPTIDES; CRYSTAL-STRUCTURES; MOLECULES; BINDING; HLA-B27; ALLELES	A low-activity variant of endoplasmic reticulum aminopeptidase 1 (ERAP1), Hap10, is associated with the autoinflammatory disorder Behcet's disease (BD) in epistasis with HLA-B*51, which is the main risk factor for this disorder. The role of Hap10 in BD pathogenesis is unknown. We sought to define the effects of Hap10 on the HLA-B*51 peptidome and to distinguish these effects from those due to HLA-B*51 polymorphisms unrelated to disease. The peptidome of the BD-associated HLA-B*51:08 subtype expressed in a Hap10-positive cell line was isolated, characterized by mass spectrometry, and compared with the HLA-B*51:01 peptidome from cells expressing more active ERAP1 allotypes. We additionally performed synthetic peptide digestions with recombinant ERAP1 variants and estimated peptide-binding affinity with standard algorithms. In the BD-associated ERAP1 context of B*51:08, longer peptides were generated; of the two major HLA-B*51 subpeptidomes with Pro-2 and Ala-2, the former one was significantly reduced, and the latter was increased and showed more ERAP1-susceptible N-terminal residues. These effects were readily explained by the low activity of Hap10 and the differential susceptibility of X-Pro and X-Ala bonds to ERAP1 trimming and together resulted in a significantly altered peptidome with lower affinity. The differences due to ERAP1 were clearly distinguished from those due to HLA-B*51 subtype polymorphism, which affected residue frequencies at internal positions of the peptide ligands. The alterations in the nature and affinity of HLA-B*51.peptide complexes probably affect T-cell and natural killer cell recognition, providing a sound basis for the joint association of ERAP1 and HLA-B*51 with BD.	[Guasp, Pablo; Lopez de Castro, Jose A.] CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; [Guasp, Pablo; Lopez de Castro, Jose A.] Univ Autonoma, Madrid 28049, Spain; [Barnea, Eilon; Admon, Arie] Technion Israel Inst Technol, Fac Biol, IL-3200003 Haifa, Israel; [Francisca Gonzalez-Escribano, M.] Hosp Univ Virgen Rocio IBiS, CSIC, US, Serv Inmunol, Seville 41013, Spain; [Jimenez-Reinoso, Anais; Regueiro, Jose R.] Univ Complutense Madrid, Sch Med, Dept Immunol, Hosp Octubre 12,Hlth Res Inst Imas12, Madrid 28040, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; Technion Israel Institute of Technology; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Complutense University of Madrid; Hospital Universitario 12 de Octubre	de Castro, JAL (corresponding author), Univ Autonoma, Ctr Biol Mol Severo Ochoa, Nicolas Cabrera 1, Madrid 28049, Spain.	aldecastro@cbm.csic.es	Jiménez Reinoso, Anaïs/K-2453-2014; González-Escribano, María Francisca/X-5554-2019; Regueiro, Jose/B-5499-2014	Jiménez Reinoso, Anaïs/0000-0001-8229-1881; Admon, Arie/0000-0003-0504-3950; Guasp, Pablo/0000-0002-3655-916X; Regueiro, Jose/0000-0001-8442-7762	Plan Nacional de I+D+i Research [SAF2014/51931-R]; Binational Science Foundation [2009393]; Complutense University [SAF2014-54708R, SAF2016-81876-REDT (Plan Nacional de I+D+i), 920631]; Ministry of Health, Social Services and Equality [FIS PI13/01118]; Fundacion Ramon Areces; Spanish Government [BES-2015-072729]	Plan Nacional de I+D+i Research; Binational Science Foundation(US-Israel Binational Science Foundation); Complutense University; Ministry of Health, Social Services and Equality; Fundacion Ramon Areces; Spanish Government(Spanish GovernmentEuropean Commission)	This work was supported by Plan Nacional de I+D+i Research Grant SAF2014/51931-R (to J. A. L. C.); Binational Science Foundation Grant 2009393 (to A. A.); Complutense University Grants SAF2014-54708R, SAF2016-81876-REDT (Plan Nacional de I+D+i), and 920631 (to J. R. R.); Ministry of Health, Social Services and Equality Grant FIS PI13/01118 (to M. F. G. E.); and an institutional grant of the Fundacion Ramon Areces to the Centro de Biologia Molecular Severo Ochoa. The authors declare that they have no conflicts of interest with the contents of this article.r Fellow of the Spanish Government (Grant BES-2015-072729).	Andres AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001157; [Anonymous], 2017, Arthritis Rheumatol, V69, P686, DOI 10.1002/art.40073; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; Cifaldi L, 2015, CANCER RES, V75, P824, DOI 10.1158/0008-5472.CAN-14-1643; COWAN EP, 1987, P NATL ACAD SCI USA, V84, P5014, DOI 10.1073/pnas.84.14.5014; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; de Menthon M, 2009, ARTHRIT CARE RES, V61, P1287, DOI 10.1002/art.24642; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Evnouchidou I, 2011, J IMMUNOL, V186, P1909, DOI 10.4049/jimmunol.1003337; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; FALK K, 1995, IMMUNOGENETICS, V41, P165, DOI 10.1007/BF00182333; FLEISCHHAUER K, 1994, TISSUE ANTIGENS, V44, P311, DOI 10.1111/j.1399-0039.1994.tb02401.x; Garcia F, 1998, TISSUE ANTIGENS, V51, P1; Garcia-Medel N, 2012, MOL CELL PROTEOMICS, V11, P1416, DOI 10.1074/mcp.M112.019588; Gonzalez-Escribano MF, 1998, TISSUE ANTIGENS, V52, P78; Goto Y, 2006, FEBS LETT, V580, P1833, DOI 10.1016/j.febslet.2006.02.041; Guasp P, 2016, ARTHRITIS RHEUMATOL, V68, P505, DOI 10.1002/art.39430; HAMZAOUI K, 1988, CLIN EXP IMMUNOL, V71, P126; Hasan MS, 2017, CLIN EXP IMMUNOL, V188, P311, DOI 10.1111/cei.12939; Hearn A, 2009, J IMMUNOL, V183, P5526, DOI 10.4049/jimmunol.0803663; Hillen N, 2008, EUR J IMMUNOL, V38, P2993, DOI 10.1002/eji.200838632; Ishihama Y, 2002, J CHROMATOGR A, V979, P233, DOI 10.1016/S0021-9673(02)01402-4; Karosiene E, 2012, IMMUNOGENETICS, V64, P177, DOI 10.1007/s00251-011-0579-8; Kera J, 1999, TISSUE ANTIGENS, V54, P565, DOI 10.1034/j.1399-0039.1999.540605.x; Kirino Y, 2013, NAT GENET, V45, P202, DOI 10.1038/ng.2520; Kochan G, 2011, P NATL ACAD SCI USA, V108, P7745, DOI 10.1073/pnas.1101262108; Kotter I, 2001, TISSUE ANTIGENS, V58, P166, DOI 10.1034/j.1399-0039.2001.580304.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; de Castro JAL, 2016, MOL IMMUNOL, V77, P193, DOI 10.1016/j.molimm.2016.08.005; Maenaka K, 2000, J IMMUNOL, V165, P3260, DOI 10.4049/jimmunol.165.6.3260; Martin-Esteban A, 2016, ARTHRITIS RHEUMATOL, V68, P2466, DOI 10.1002/art.39734; Martin-Esteban A, 2014, J BIOL CHEM, V289, P3978, DOI 10.1074/jbc.M113.529610; Mizuki N, 2001, TISSUE ANTIGENS, V57, P457, DOI 10.1034/j.1399-0039.2001.057005457.x; Mizuki N, 2002, TISSUE ANTIGENS, V59, P118, DOI 10.1034/j.1399-0039.2002.590207.x; Ombrello MJ, 2015, CURR OPIN RHEUMATOL, V27, P349, DOI 10.1097/BOR.0000000000000189; Paul M, 2001, TISSUE ANTIGENS, V58, P185, DOI 10.1034/j.1399-0039.2001.580307.x; Rasmussen M, 2014, J IMMUNOL, V193, P4790, DOI 10.4049/jimmunol.1401689; Reeves E, 2013, J IMMUNOL, V191, P35, DOI 10.4049/jimmunol.1300598; Sakaguchi T, 1997, IMMUNOGENETICS, V45, P259, DOI 10.1007/s002510050201; Sakaguchi T, 1997, IMMUNOGENETICS, V46, P245, DOI 10.1007/s002510050269; Sakane T, 1999, NEW ENGL J MED, V341, P1284, DOI 10.1056/NEJM199910213411707; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; Stamogiannos A, 2015, MOL IMMUNOL, V67, P426, DOI 10.1016/j.molimm.2015.07.010; SUZUKI Y, 1992, J RHEUMATOL, V19, P588; Takeuchi M, 2016, ANN RHEUM DIS, V75, P2208, DOI 10.1136/annrheumdis-2015-209059; Vilches C, 1997, TISSUE ANTIGENS, V50, P38, DOI 10.1111/j.1399-0039.1997.tb02831.x; Yabuki K, 1999, TISSUE ANTIGENS, V54, P273, DOI 10.1034/j.1399-0039.1999.540308.x; Yamaguchi Y, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3005; Yasuoka H, 2004, ARTHRITIS RHEUM-US, V50, P3658, DOI 10.1002/art.20597	52	34	35	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9680	9689		10.1074/jbc.M117.789180	http://dx.doi.org/10.1074/jbc.M117.789180			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28446606	Green Published, hybrid			2022-12-26	WOS:000403113000018
J	Kiessling, S; Ucar, A; Chowdhury, K; Oster, H; Eichele, G				Kiessling, Silke; Ucar, Ahmet; Chowdhury, Kamal; Oster, Henrik; Eichele, Gregor			Genetic background-dependent effects of murine micro RNAs on circadian clock function	PLOS ONE			English	Article							EXPRESSION DIFFERENCES; NOCTURNAL RODENTS; CONSTANT LIGHT; MPER2 PROTEIN; RHYTHM; CLUSTER; ATLAS; RATS; MICRORNA-212; OSCILLATOR	MicroRNAs (miRs) are important regulators of a wide range of biological processes. Antagomir studies suggest an implication of miR-132 in the functionality of the mammalian circadian clock. miR-212 and miR-132 are tandemly processed from the same transcript and share the same seed region. We found the clock modulator miR-132 and miR-212 to be expressed rhythmically in the central circadian clock. Consequently, mRNAs implicated in circadian functions may likely be targeted by both miRs. To further characterize the circadian role we generated mice with stable deletion of the miR-132/212 locus and compared the circadian behavior of mutant and wild-type control animals on two genetic backgrounds frequently used in chronobiological research, C57BL/6N and 129/Sv. Surprisingly, the wheel-running activity phenotype of miR mutant mice was highly background specific. A prolonged circadian free-running period in constant darkness was found in 129/Sv, but not in C57BL/6N miR-132/212 knockout mice. In contrast, in C57BL/6N, but not in 129/Sv miRNA132/212 knockout mice a lengthened free-running period was observed in constant light conditions. Furthermore, miR-132/212 knockout mice on 129/Sv background exhibited enhanced photic phase shifts of locomotor activity accompanied by reduced light induction of Period gene transcription in the SCN. This phenotype was absent in miRNA-132/212 knockout mice on a C57BL/6N background. Together, our results reveal a strain and light regimen-specific function of miR-132/212 in the circadian clock machinery suggesting that miR-132 and miR-212 act as background-dependent circadian rhythm modulators.	[Kiessling, Silke; Oster, Henrik; Eichele, Gregor] Max Planck Inst Biophys Chem, Dept Genes & Behav, Gottingen, Germany; [Kiessling, Silke] Tech Univ Munich, Nutr & Immunol, Freising Weihenstephan, Germany; [Ucar, Ahmet; Chowdhury, Kamal] Max Planck Inst Biophys Chem, Dept Mol Cell Biol, Gottingen, Germany; [Ucar, Ahmet] Univ Manchester, Fac Biol Med & Hlth, Div Clin & Mol Canc Sci, Manchester, Lancs, England; [Oster, Henrik] Univ Lubeck, Chronophysiol Grp, Med Dept 1, Lubeck, Germany	Max Planck Society; Technical University of Munich; Max Planck Society; University of Manchester; University of Lubeck	Kiessling, S (corresponding author), Max Planck Inst Biophys Chem, Dept Genes & Behav, Gottingen, Germany.; Kiessling, S (corresponding author), Tech Univ Munich, Nutr & Immunol, Freising Weihenstephan, Germany.	silke.kiessling@tum.de	Kiessling, Silke/AAZ-3854-2020; Oster, Henrik/O-4426-2019	Oster, Henrik/0000-0002-1414-7068; Ucar, Ahmet/0000-0002-6551-3486; Kiessling, Silke/0000-0002-6293-6328	Max-Planck Society; German Research Foundation (DFG); Technische Universitat Munchen	Max-Planck Society(Max Planck Society); German Research Foundation (DFG)(German Research Foundation (DFG)); Technische Universitat Munchen	This work was supported by the Max-Planck Society (GE); the German Research Foundation (DFG) and the Technische Universitat Munchen within the funding programme Open Access Publishing (SK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Alvarez-Saavedra M, 2011, HUM MOL GENET, V20, P731, DOI 10.1093/hmg/ddq519; ASCHOFF J, 1960, COLD SPRING HARB SYM, V25, P11, DOI 10.1101/SQB.1960.025.01.004; Bandiera S, 2010, CLIN GENET, V77, P306, DOI 10.1111/j.1399-0004.2010.01370.x; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Carson JP, 2005, J MICROSC-OXFORD, V217, P275, DOI 10.1111/j.1365-2818.2005.01450.x; Chen RM, 2013, CURR BIOL, V23, P1959, DOI 10.1016/j.cub.2013.08.005; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; DAAN S, 1976, J COMP PHYSIOL, V106, P253, DOI 10.1007/BF01417857; Ding X, 2015, NEUROSCI LETT, V591, P75, DOI 10.1016/j.neulet.2015.02.026; Dixon DP, 2003, PHYSIOL BEHAV, V80, P273, DOI 10.1016/j.physbeh.2003.08.008; Eichele G, 2011, METHODS, V53, P417, DOI 10.1016/j.ymeth.2010.12.020; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gao Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep30070; Hazarika S, 2013, CIRCULATION, V127, P1818, DOI 10.1161/CIRCULATIONAHA.112.000860; Hirota T, 2004, ZOOL SCI, V21, P359, DOI 10.2108/zsj.21.359; Im HI, 2010, NAT NEUROSCI, V13, P1120, DOI 10.1038/nn.2615; JOHNSON RF, 1988, BRAIN RES, V462, P301, DOI 10.1016/0006-8993(88)90558-6; Jud C, 2005, BIOL PROCED ONLINE, V7, P101, DOI 10.1251/bpo109; Karali M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-715; Kraus Petra, 2012, BMC Res Notes, V5, P232, DOI 10.1186/1756-0500-5-232; Kumarswamy R, 2014, EUR HEART J, V35, P3224, DOI 10.1093/eurheartj/ehu344; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Q, 2015, NEUROBIOL DIS, V77, P155, DOI 10.1016/j.nbd.2015.03.009; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Masubuchi S, 2005, J NEUROSCI, V25, P4719, DOI 10.1523/JNEUROSCI.4761-04.2005; Mehta A, 2015, IMMUNITY, V42, P1021, DOI 10.1016/j.immuni.2015.05.017; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Munoz M, 2005, J BIOL RHYTHM, V20, P3, DOI 10.1177/0748730404272858; Na YJ, 2009, EXP MOL MED, V41, P638, DOI 10.3858/emm.2009.41.9.070; Nagel R, 2009, FEBS J, V276, P5447, DOI 10.1111/j.1742-4658.2009.07229.x; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; Parsons MJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-476; Parsons MJ, 2008, MAMM GENOME, V19, P552, DOI 10.1007/s00335-008-9116-y; Pegoraro M, 2008, J GENET, V87, P505, DOI 10.1007/s12041-008-0073-8; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P223, DOI 10.1007/BF01417856; Remenyi J, 2010, BIOCHEM J, V428, P281, DOI 10.1042/BJ20100024; Shende VR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022586; Shimomura K, 2013, ELIFE, V2, DOI 10.7554/eLife.00426; Steinlechner S, 2002, J BIOL RHYTHM, V17, P202, DOI 10.1177/07430402017003003; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Suzuki Y, 2003, DNA RES, V10, P263, DOI 10.1093/dnares/10.6.263; Ucar A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2090; Ucar A, 2010, NAT GENET, V42, P1101, DOI 10.1038/ng.709; Vitaterna MH, 2006, P NATL ACAD SCI USA, V103, P9327, DOI 10.1073/pnas.0603601103; Wanet A, 2012, NUCLEIC ACIDS RES, V40, P4742, DOI 10.1093/nar/gks151; Yan L, 2002, EUR J NEUROSCI, V16, P1531, DOI 10.1046/j.1460-9568.2002.02224.x; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111; Zhao EP, 2009, MAMM GENOME, V20, P476, DOI 10.1007/s00335-009-9217-2	51	11	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176547	10.1371/journal.pone.0176547	http://dx.doi.org/10.1371/journal.pone.0176547			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448626	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383600101
J	Sharma, A; Vatapalli, R; Abdelfatah, E; McMahon, KW; Kerner, Z; Guzzetta, AA; Singh, J; Zahnow, C; Baylin, SB; Yerram, S; Hu, Y; Azad, N; Ahuja, N				Sharma, Anup; Vatapalli, Rajita; Abdelfatah, Eihab; McMahon, K. Wyatt; Kerner, Zachary; Guzzetta, Angela A.; Singh, Jasvinder; Zahnow, Cynthia; Baylin, Stephen B.; Yerram, Sashidhar; Hu, Yue; Azad, Nilofer; Ahuja, Nita			Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells	PLOS ONE			English	Article							EPIGENETIC THERAPY; SOLID TUMORS; MYELODYSPLASTIC SYNDROME; DIFFERENTIAL EXPRESSION; MICROARRAY DATA; COLON-CANCER; MULTICENTER; AZACITIDINE; COMBINATION; DECITABINE	Colorectal cancer (CRC) is the second leading cause of cancer death in the United States. In the metastatic setting, the majority of patients respond to initial therapies but eventually develop resistance and progress. In this study, we test the hypothesis that priming with epigenetic therapy sensitizes CRC cell lines, which were previously resistant to subsequent chemotherapeutic agents. When multiple CRC cell lines are first exposed to 500 nM of the DNA demethylating agent, 5-aza-cytidine (AZA) in-vitro, and the cells then established as in-vivo xenografts in untreated NOD-SCID mice; there is an enhanced response to cytotoxic chemotherapy with agents commonly used in CRC treatment. For irinotecan (IRI), growth diminished by 16-62 fold as assessed, by both proliferation (IC50) and anchorage independent cell growth soft agar assays. Treatment of resistant HCT116 cell line along with in-vivo, for CRC line xenografts, AZA plus IRI again exhibits this synergistic response with significant improvement in survival and tumor regression in the mice. Genome-wide expression correlates changes in pathways for cell adhesion and DNA repair with the above responses. A Phase 1/2 clinical trial testing this concept is already underway testing the clinical efficacy of this concept in IRI resistant, metastatic CRC (NCT01896856).	[Sharma, Anup; Vatapalli, Rajita; Abdelfatah, Eihab; McMahon, K. Wyatt; Kerner, Zachary; Guzzetta, Angela A.; Singh, Jasvinder; Yerram, Sashidhar; Hu, Yue; Azad, Nilofer; Ahuja, Nita] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Zahnow, Cynthia; Baylin, Stephen B.; Azad, Nilofer; Ahuja, Nita] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Hu, Yue] Third Mil Med Univ, Daping Hosp, Dept Gastrointestinal Surg, Chongqing, Peoples R China; [Ahuja, Nita] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Army Medical University; Johns Hopkins University	Ahuja, N (corresponding author), Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA.; Ahuja, N (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA.; Ahuja, N (corresponding author), Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA.	nahuja1@jhmi.edu	SINGH, JASVINDER/S-8678-2019; Vatapalli, Rajita/AAN-1397-2021	Kerner, Zachary/0000-0002-5623-0089	National Cancer Institute [K23 CM 27141]; Van Andel Research Instituter thru the Van Andel Research Institute - Stand Up To Cancer Epigenetics Dream Team; T32 grant	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Van Andel Research Instituter thru the Van Andel Research Institute - Stand Up To Cancer Epigenetics Dream Team; T32 grant	We gratefully acknowledge T32 grant funding mechanism, to support EA for this study. A portion of this work was also funded by K23 CM 27141 from National Cancer Institute. Research funding was provided by Van Andel Research Instituter thru the Van Andel Research Institute - Stand Up To Cancer Epigenetics Dream Team. Stand Up to Cancer is a program of the Entertainment Industry Foundation, administered by AACR.	Abdelfatah E, 2016, THER ADV GASTROENTER, V9, P560, DOI 10.1177/1756283X16644247; Ahuja N, 2016, ANNU REV MED, V67, P73, DOI 10.1146/annurev-med-111314-035900; Ahuja N, 2014, J CLIN INVEST, V124, P56, DOI 10.1172/JCI69736; Azad N, 2013, NAT REV CLIN ONCOL, V10, P256, DOI 10.1038/nrclinonc.2013.42; Azad Nilofer Saba E-K AB, 2013, AMERICAN SOCIETY OF; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Crea F, 2009, MOL CANCER THER, V8, P1964, DOI 10.1158/1535-7163.MCT-09-0027; Flis S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092305; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Hatziapostolou M, 2011, CELL MOL LIFE SCI, V68, P1681, DOI 10.1007/s00018-010-0624-z; Hong X, 2010, J SURG ONCOL, V101, P564, DOI 10.1002/jso.21538; Issa JPJ, 2007, CLIN CANCER RES, V13, P1634, DOI 10.1158/1078-0432.CCR-06-2076; Issa JPJ, 2015, LANCET ONCOL, V16, P1099, DOI 10.1016/S1470-2045(15)00038-8; Jones PA, 2016, NAT REV GENET, V17, P630, DOI 10.1038/nrg.2016.93; Juergens RA, 2011, CANCER DISCOV, V1, P598, DOI 10.1158/2159-8290.CD-11-0214; Kaminskas E, 2005, ONCOLOGIST, V10, P176, DOI 10.1634/theoncologist.10-3-176; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1794, DOI 10.1002/cncr.21792; Labianca R, 2010, CRIT REV ONCOL HEMAT, V74, P106, DOI 10.1016/j.critrevonc.2010.01.010; Lenz HJ, 2015, CANCER TREAT REV, V41, P777, DOI 10.1016/j.ctrv.2015.06.001; Li HL, 2014, ONCOTARGET, V5, P587, DOI 10.18632/oncotarget.1782; Liu T, 2016, ONCOTARGET, DOI 10.18632/oncotarget.1346527888803; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Matei D, 2012, CANCER RES, V72, P2197, DOI 10.1158/0008-5472.CAN-11-3909; Qin L, 2014, MOL PHARMACOL, V86, P561, DOI 10.1124/mol.114.092544; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Silverman LR, 2002, J CLIN ONCOL, V20, P2429, DOI 10.1200/JCO.2002.04.117; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Smyth GK, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-165; Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607; Sundermeyer Mark L, 2005, Clin Colorectal Cancer, V5, P108, DOI 10.3816/CCC.2005.n.022; Tsai HC, 2012, CANCER CELL, V21, P430, DOI 10.1016/j.ccr.2011.12.029; Valdespino V, 2015, CANCER MANAG RES, V7, P241, DOI 10.2147/CMAR.S70358; Valerie Lee JW, 2016, P 107 ANN M AM ASS C; Vishnubalaji R, 2016, CANCER CELL INT, V16, DOI 10.1186/s12935-016-0355-9; Xu Y, 2002, ANN ONCOL, V13, P1841, DOI 10.1093/annonc/mdf337	40	22	22	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176139	10.1371/journal.pone.0176139	http://dx.doi.org/10.1371/journal.pone.0176139			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445481	Green Published, Green Submitted, gold			2022-12-26	WOS:000400309200036
J	Teklemariam, M; Assefa, A; Kassa, M; Mohammed, H; Mamo, H				Teklemariam, Michael; Assefa, Ashenafi; Kassa, Moges; Mohammed, Hussien; Mamo, Hassen			Therapeutic efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in a high-transmission area in northwest Ethiopia	PLOS ONE			English	Article							PLUS SULFADOXINE-PYRIMETHAMINE; DIHYDROARTEMISININ-PIPERAQUINE; ARTEMISININ DERIVATIVES; TREATMENT FAILURE; IN-VIVO; ARTESUNATE; TRAVELER; ARTEMETHER/LUMEFANTRINE; COARTEM(R); RESISTANCE	Malaria, particularly due to Plasmodium falciparum, remains a major public health threat in Ethiopia. Artemether-lumefantine (AL) has been the first-line antimalarial drug against uncomplicated P. falciparum malaria in the country since 2004. Regular monitoring of antimalarial drugs is recommended by the World Health Organization (WHO) to help early detection of drug resistant strains of the parasite and contain their rapid spread. The objective of this study was to assess the therapeutic efficacy of AL in a high-transmission setting in Ethiopia. The study site was Setit Humera, northwest Ethiopia. Single-arm prospective study of a 28-day follow-up was conducted from October 2014 to January 2015 according to the revised WHO 2009 drug efficacy study protocol. Study end-points were classified into primary end-point and secondary end-point. While the primary end-point was the day-28 adequate clinical and parasitological response the secondary end-points were clinical and parasitological evaluations (parasite, fever and gametocyte clearance rate, incidence of drug adverse events) and the relative increment in hemoglobin (Hb)level from baseline to day (D) 14 and D28. A total of 92 patients were enrolled and 79 had completed the 28-day follow-up period. The overall cure rate was 98.8% with 95% confidence interval of 0.915- 0.998 without polymerase chain reaction correction. The parasite clearance rate was high with fast resolution of clinical symptoms; 100% of the study participants cleared parasitaemia and fever on D3. Gametocyte carriage was reduced from 7% on D0 to 1% on D3 and complete clearance was achieved on D14. Mean Hb concentration significantly increased on D28 compared to that on D14. There was no serious adverse event. AL was efficacious and safe in a high-transmission setting for treatment of uncomplicated falciparum malaria.	[Teklemariam, Michael; Mamo, Hassen] Addis Ababa Univ, Coll Nat Sci, Dept Microbial Cellular & Mol Biol, Addis Ababa, Ethiopia; [Assefa, Ashenafi; Kassa, Moges; Mohammed, Hussien] Ethiopian Publ Hlth Inst, Bacterial Parasit & Zoonot Dis Res Directorate, Addis Ababa, Ethiopia	Addis Ababa University	Mamo, H (corresponding author), Addis Ababa Univ, Coll Nat Sci, Dept Microbial Cellular & Mol Biol, Addis Ababa, Ethiopia.	binmamo@yahoo.com	Mamo, Hassen/AAX-3481-2020	Mamo, Hassen/0000-0001-9541-8976				Adeel AA, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1339-x; Adeel AA, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0970-2; [Anonymous], 2003, ASS MON ANT DRUG EFF; [Anonymous], 2015, GUID TREATM MAL; [Anonymous], 2004, MAL DIAGN TREATM GUI; Anthony NA, 2013, REV SOC BRAS MED TRO, V46, P525; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Assefa A, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-1; Chotivanich K, 2006, ANTIMICROB AGENTS CH, V50, P1927, DOI 10.1128/AAC.01472-05; [CSA Central Statistical Agency of Ethiopia], 2015, NAT STAT ABSTR; Dalrymple U, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0372-x; Djimde A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S1-S4; Dorsey G, 2007, JAMA-J AM MED ASSOC, V297, P2210, DOI 10.1001/jama.297.20.2210; Ebstie YA, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0744-x; Farnert A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-176; Federal Ministry of Health, 2014, NAT MAL PROGR MON EV; Fillinger U, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-353; FMoH, 2010, NAT MAL GUID; Getnet G, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0775-3; Giden D, 2015, THESIS; Gobbi F, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1572-3; Gray AM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0881-2; Hamde F, 2011, THESIS; Hastings IM, 2002, PHILOS T ROY SOC B, V357, P505, DOI 10.1098/rstb.2001.1036; Hemingway J, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002380; Hwang J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-209; Jima D, 2005, E AFR MED J, V82, P390; Kamau E, 2015, J INFECT DIS, V211, P1352, DOI 10.1093/infdis/jiu608; Kassa M, 2010, STUDY EFFICACY COART; Kefyalew T, 2009, PARASITE, V16, P129, DOI 10.1051/parasite/2009162129; Kinfu Gebremedhin, 2012, Malar Res Treat, V2012, P548710, DOI 10.1155/2012/548710; Lemma M, 2012, THESIS; Lu F, EMERGENCE INDIGENOUS; Mekonnen SK, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0826-9; Mengesha T, 2000, ETHIOP J HLTH SCI, V10, P137; Mizuno Y, 2009, JPN J INFECT DIS, V62, P139; Muller IB, 2010, FUTURE MICROBIOL, V5, P1857, DOI 10.2217/FMB.10.136; Nega D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154618; Ngasala EB, 2011, CID, V52, P873; Noedl H, 2010, CLIN INFECT DIS, V51, pE82, DOI 10.1086/657120; Nosten F, 2007, AM J TROP MED HYG, V77, P181, DOI 10.4269/ajtmh.2007.77.181; Nzila AM, 2000, J INFECT DIS, V181, P2023, DOI 10.1086/315520; Okell LC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-125; Pfeil J, 2015, AM J TROP MED HYG, V93, P961, DOI 10.4269/ajtmh.15-0162; Price RN, 1996, LANCET, V347, P1654, DOI 10.1016/S0140-6736(96)91488-9; Pukrittayakamee S, 2004, ANTIMICROB AGENTS CH, V48, P1329, DOI 10.1128/AAC.48.4.1329-1334.2004; Rehman K, 2014, INT J INFECT DIS, V29, P268, DOI 10.1016/j.ijid.2014.09.007; Repetto EC, 2011, MEDITERR J HEMATOL I, V3, DOI 10.4084/MJHID.2011.041; Seboxa T, 1997, E AFR MED J, V74, P780; Shayo A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-376; Sirima SB, 2016, LANCET INFECT DIS, V16, P1123, DOI 10.1016/S1473-3099(16)30020-2; Taylor SM, 2015, J INFECT DIS, V211, P680, DOI 10.1093/infdis/jiu467; Warsame M, 2017, EFFICACY ARTESUNATE; WEZAM A, 1994, ETHIOPIAN MED J, V32, P41; White NJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-9; WHO, 2001, DRUG RES MAL; WHO, 2015, WORLD MAL REP 2015; WHO, 2015, STAT REP ART RES; Wongsrichanalai C, 2013, CLIN MICROBIOL INFEC, V19, P908, DOI 10.1111/1469-0691.12316; World Health Organization, 2009, METH SURV ANT DRUG E; World Health Organization, 2010, BAS MAL MICR 1; Wudneh F, 2016, THER CLIN RISK MANAG, V12, P1293, DOI 10.2147/TCRM.S113603	62	18	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176004	10.1371/journal.pone.0176004	http://dx.doi.org/10.1371/journal.pone.0176004			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445503	Green Published, Green Submitted, gold			2022-12-26	WOS:000400309200031
J	Wang, Z; Zhou, XS; Zhao, WC; Liu, F; Ni, HB; Yu, ZW				Wang, Zhu; Zhou, Xingshe; Zhao, Weichao; Liu, Fan; Ni, Hongbo; Yu, Zhiwen			Assessing the severity of sleep apnea syndrome based on ballistocardiogram	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; MODELS	Background Sleep Apnea Syndrome (SAS) is a common sleep-related breathing disorder, which affects about 4-7% males and 2-4% females all around the world. Different approaches have been adopted to diagnose SAS and measure its severity, including the gold standard Polysomnography (PSG) in sleep study field as well as several alternative techniques such as single channel ECG, pulse oximeter and so on. However, many shortcomings still limit their generalization in home environment. In this study, we aim to propose an efficient approach to automatically assess the severity of sleep apnea syndrome based on the ballistocardiogram (BCG) signal, which is non-intrusive and suitable for in home environment. Methods We develop an unobtrusive sleep monitoring system to capture the BCG signals, based on which we put forward a three-stage sleep apnea syndrome severity assessment framework, i.e., data preprocessing, sleep-related breathing events (SBEs) detection, and sleep apnea syndrome severity evaluation. First, in the data preprocessing stage, to overcome the limits of BCG signals (e.g., low precision and reliability), we utilize wavelet decomposition to obtain the outline information of heartbeats, and apply a RR correction algorithm to handle missing or spurious RR intervals. Afterwards, in the event detection stage, we propose an automatic sleep-related breathing event detection algorithm named Physio_ICSS based on the iterative cumulative sums of squares (i.e., the ICSS algorithm), which is originally used to detect structural breakpoints in a time series. In particular, to efficiently detect sleep-related breathing events in the obtained time series of RR intervals, the proposed algorithm not only explores the practical factors of sleep-related breathing events (e.g., the limit of lasting duration and possible occurrence sleep stages) but also overcomes the event segmentation issue (e.g., equal-length segmentation method might divide one sleep-related breathing event into different fragments and lead to incorrect results) of existing approaches. Finally, by fusing features extracted from multiple domains, we can identify sleep-related breathing events and assess the severity level of sleep apnea syndrome effectively. Conclusions Experimental results on 136 individuals of different sleep apnea syndrome severities validate the effectiveness of the proposed framework, with the accuracy of 94.12% (128/136).	[Wang, Zhu; Zhou, Xingshe; Zhao, Weichao; Liu, Fan; Ni, Hongbo; Yu, Zhiwen] Northwestern Polytech Univ, Sch Comp Sci, Xian, Shaanxi, Peoples R China	Northwestern Polytechnical University	Wang, Z; Zhou, XS; Yu, ZW (corresponding author), Northwestern Polytech Univ, Sch Comp Sci, Xian, Shaanxi, Peoples R China.	wangzhu@nwpu.edu.cn; zhouxs@nwpu.edu.cn; zhiwenyu@nwpu.edu.cn	zhou, xing/GQP-4516-2022; zhou, xt/GWZ-9212-2022	Yu, Zhiwen/0000-0002-9905-3238	National Natural Science Foundation of China [61332013, 61402369]; National Key Research and Development Program of China [2016YFB1001400]; Natural Science Foundation of Shaanxi Province [2015JQ6237]; Fundamental Research Funds for Central Universities [3102014JSJ0004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province); Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported in part by the National Natural Science Foundation of China (No. 61332013, 61402369), the National Key Research and Development Program of China (No. 2016YFB1001400), the Natural Science Foundation of Shaanxi Province (No. 2015JQ6237), and the Fundamental Research Funds for Central Universities (No. 3102014JSJ0004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank all their colleges for the discussion and suggestion. This work was supported in part by the National Key Research and Development Program of China (No. 2016YFB1001400), the National Natural Science Foundation of China (No. 61332013, 61402369), the Natural Science Foundation of Shaanxi Province (No. 2015JQ6237), and the Fundamental Research Funds for Central Universities (No. 3102014JSJ0004).	A. A. o. S. Medicine, 2007, AASM MANUAL SCORING; Acharya UR, 2006, MED BIOL ENG COMPUT, V44, P1031, DOI 10.1007/s11517-006-0119-0; Alvarez D, 2010, IEEE T BIO-MED ENG, V57, P2816, DOI 10.1109/TBME.2010.2056924; Bianchi AM, 2013, IEEE ENG MED BIO, P6579, DOI 10.1109/EMBC.2013.6611063; Bloch K E, 1997, Technol Health Care, V5, P285; Boardman A, 2002, PHYSIOL MEAS, V23, P325, DOI 10.1088/0967-3334/23/2/308; Bsoul M, 2011, IEEE T INF TECHNOL B, V15, P416, DOI 10.1109/TITB.2010.2087386; Chen, 2013, J NANOMATER, V2013, P1, DOI DOI 10.1016/J.BI0RTECH.2013.01.071); Chen LL, 2015, IEEE T AUTOM SCI ENG, V12, P106, DOI 10.1109/TASE.2014.2345667; Chen SW, 2002, IEEE T BIO-MED ENG, V49, P736, DOI 10.1109/TBME.2002.1010859; Chouchou F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086434; DEUCHAR DC, 1967, BRIT HEART J, V29, P285; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Ewing BT, 2005, J BANK FINANC, V29, P2655, DOI 10.1016/j.jbankfin.2004.10.002; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; Giovangrandi L, 2011, IEEE ENG MED BIO, P4279, DOI 10.1109/IEMBS.2011.6091062; Golemati S., 2010, 10 IEEE INT C INF TE, P1; GUILLEMINAULT C, 1976, ANNU REV MED, V27, P465, DOI 10.1146/annurev.me.27.020176.002341; Hearst MA, 1998, IEEE INTELL SYST APP, V13, P18, DOI 10.1109/5254.708428; Jin JY, 2015, IEEE T BIOMED CIRC S, V9, P96, DOI 10.1109/TBCAS.2014.2314301; Kantelhardt JW, 2001, PHYSICA A, V295, P441, DOI 10.1016/S0378-4371(01)00144-3; Kasai T, 2011, J AM COLL CARDIOL, V57, P119, DOI 10.1016/j.jacc.2010.08.627; Keissar K, 2009, PHILOS T R SOC A, V367, P1393, DOI 10.1098/rsta.2008.0273; Kim J, 2004, AM J RESP CRIT CARE, V170, P1108, DOI 10.1164/rccm.200404-519OC; Koley BL, 2013, IEEE T BIO-MED ENG, V60, P3354, DOI 10.1109/TBME.2013.2282337; Lam B, 2007, INT J TUBERC LUNG D, V11, P2; Lavie L, 2009, EUR RESPIR J, V33, P1467, DOI 10.1183/09031936.00086608; [李为民 Li Weimin], 2015, [中国老年学杂志, Chinese Journal of Gerontology], V35, P1160; Malhotra A, 2002, LANCET, V360, P237, DOI 10.1016/S0140-6736(02)09464-3; Martinez-Vargas JD, 2012, EXPERT SYST APPL, V39, P9118, DOI 10.1016/j.eswa.2012.02.043; Meng Xiao, 2012, 2012 5th International Conference on BioMedical Engineering and Informatics (BMEI), P558, DOI 10.1109/BMEI.2012.6512919; Migliorini M, 2010, IEEE ENG MED BIO, P3273, DOI 10.1109/IEMBS.2010.5627217; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Rapach DE, 2008, J APPL ECONOMET, V23, P65, DOI 10.1002/jae.976; REDLINE S, 1991, CHEST, V100, P1281, DOI 10.1378/chest.100.5.1281; Sole-Casals J, 2014, APPL SOFT COMPUT, V23, P346, DOI 10.1016/j.asoc.2014.06.017; Vanravenswaaijarts CMA, 1993, ANN INTERN MED, V118, P436, DOI 10.7326/0003-4819-118-6-199303150-00008; Vapnik V, 2000, NEURAL COMPUT, V12, P2013, DOI 10.1162/089976600300015042; Marcos JV, 2011, IEEE ENG MED BIO, P1745, DOI 10.1109/IEMBS.2011.6090499; Xie BL, 2012, IEEE T INF TECHNOL B, V16, P469, DOI 10.1109/TITB.2012.2188299; Young T, 2003, AM J RESP CRIT CARE, V167, P1181, DOI 10.1164/rccm.200209-1055OC; Zaffaroni A, 2009, IEEE ENG MED BIO, P7091, DOI 10.1109/IEMBS.2009.5332909; Zhao WC, 2015, IEEE ENG MED BIO, P4536, DOI 10.1109/EMBC.2015.7319403	43	17	17	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0175351	10.1371/journal.pone.0175351	http://dx.doi.org/10.1371/journal.pone.0175351			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445548	gold, Green Submitted, Green Published			2022-12-26	WOS:000400309200018
J	Zygiel, EM; Noren, KA; Adamkiewicz, MA; Aprile, RJ; Bowditch, HK; Carroll, CL; Cerezo, MAS; Dagher, AM; Hebert, CR; Hebert, LE; Mahame, GM; Milne, SC; Silvestri, KM; Sutherland, SE; Sylvia, AM; Taveira, CN; VanValkenburgh, DJ; Noren, CJ; Hall, MF				Zygiel, Emily M.; Noren, Karen A.; Adamkiewicz, Marta A.; Aprile, Richard J.; Bowditch, Heather K.; Carroll, Christine L.; Cerezo, Maria Abigail S.; Dagher, Adelle M.; Hebert, Courtney R.; Hebert, Lauren E.; Mahame, Gloria M.; Milne, Stephanie C.; Silvestri, Kelly M.; Sutherland, Sara E.; Sylvia, Alexandria M.; Taveira, Caitlyn N.; VanValkenburgh, David J.; Noren, Christopher J.; Hall, Marilena Fitzsimons			Various mutations compensate for a deleterious lacZ alpha insert in the replication enhancer of M13 bacteriophage	PLOS ONE			English	Article							GENE-V PROTEIN; INTEGRATION HOST FACTOR; MESSENGER-RNA STRUCTURE; DNA-BINDING-PROTEIN; INITIATOR PROTEIN; FILAMENTOUS-PHAGE; ESCHERICHIA-COLI; II PROTEIN; TRANSLATIONAL CONTROL; PEPTIDE LIBRARIES	M13 and other members of the Ff class of filamentous bacteriophages have been extensively employed in myriad applications. The Ph.D. series of phage-displayed peptide libraries were constructed from the M13-based vector M13KE. As a direct descendent of M13mp19, M13KE contains the lacZ alpha insert in the intergenic region between genes IV and II, where it interrupts the replication enhancer of the (+) strand origin. Phage carrying this 816-nucleotide insert are viable, but propagate in E. coli at a reduced rate compared to wild-type M13 phage, presumably due to a replication defect caused by the insert. We have previously reported thirteen compensatory mutations in the 5'-untranslated region of gene II, which encodes the replication initiator protein gIIp. Here we report several additional mutations in M13KE that restore a wild-type propagation rate. Several clones from constrained-loop variable peptide libraries were found to have ejected the majority of lacZ alpha gene in order to reconstruct the replication enhancer, albeit with a small scar. In addition, new point mutations in the gene II 5'-untranslated region or the gene IV coding sequence have been spontaneously observed or synthetically engineered. Through phage propagation assays, we demonstrate that all these genetic modifications compensate for the replication defect in M13KE and restore the wild-type propagation rate. We discuss the mechanisms by which the insertion and ejection of the lacZ alpha gene, as well as the mutations in the regulatory region of gene II, influence the efficiency of replication initiation at the (+) strand origin. We also examine the presence and relevance of fast-propagating mutants in phage-displayed peptide libraries.	[Zygiel, Emily M.; Adamkiewicz, Marta A.; Aprile, Richard J.; Bowditch, Heather K.; Carroll, Christine L.; Cerezo, Maria Abigail S.; Dagher, Adelle M.; Hebert, Courtney R.; Hebert, Lauren E.; Mahame, Gloria M.; Milne, Stephanie C.; Silvestri, Kelly M.; Sutherland, Sara E.; Sylvia, Alexandria M.; Taveira, Caitlyn N.; VanValkenburgh, David J.; Hall, Marilena Fitzsimons] Stonehill Coll, Dept Chem, Easton, MA 02357 USA; [Noren, Karen A.; Noren, Christopher J.] New England Biolabs Inc, Ipswich, MA USA	New England Biolabs	Hall, MF (corresponding author), Stonehill Coll, Dept Chem, Easton, MA 02357 USA.	mhall@stonehill.edu			Stonehill Undergraduate Research Experience; Stonehill College Undergraduate Research Grants	Stonehill Undergraduate Research Experience; Stonehill College Undergraduate Research Grants	This work was funded by the Stonehill Undergraduate Research Experience (E.M.Z., R.J.A., H.K.B., C.L.C., M.A.S.C., A.M.D., G.M.M., S.C.M., K.M.S., A.M.S., C.N.T., D.J.V.) and Stonehill College Undergraduate Research Grants (M.A.A., C.R.H., L.E.H., S.E.S.). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Two co-authors are scientists at New England Biolabs, Inc. (NEB), which provided support in the form of salaries for K.A.N. and C.J.N. as well as some of the reagents. NEB itself did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Additionally, the research is not related to any of the company's products in production or development. The specific roles of all authors are articulated in the 'author contributions' section.	Asano S, 1999, NUCLEIC ACIDS RES, V27, P1882, DOI 10.1093/nar/27.8.1882; Askora A, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00217; Boni IV, 2006, MOL BIOL+, V40, P658; Brammer LA, 2008, ANAL BIOCHEM, V373, P88, DOI 10.1016/j.ab.2007.10.015; Cao BR, 2016, ACCOUNTS CHEM RES, V49, P1111, DOI 10.1021/acs.accounts.5b00557; de Smit MH, 1998, COLD SPRING HARBOR M, P495; DOTTO GP, 1984, NATURE, V311, P279, DOI 10.1038/311279a0; DOTTO GP, 1984, J MOL BIOL, V172, P507, DOI 10.1016/S0022-2836(84)80020-0; DOTTO GP, 1982, J MOL BIOL, V162, P335, DOI 10.1016/0022-2836(82)90530-7; DOTTO GP, 1984, P NATL ACAD SCI-BIOL, V81, P1336, DOI 10.1073/pnas.81.5.1336; DRLICA K, 1987, MICROBIOL REV, V51, P301, DOI 10.1128/MMBR.51.3.301-319.1987; FREUNDLICH M, 1992, MOL MICROBIOL, V6, P2557, DOI 10.1111/j.1365-2958.1992.tb01432.x; FULFORD W, 1988, J MOL BIOL, V203, P49, DOI 10.1016/0022-2836(88)90090-3; FULFORD W, 1988, J MOL BIOL, V203, P39, DOI 10.1016/0022-2836(88)90089-7; GEIDER K, 1982, J BIOL CHEM, V257, P6488; GOLD L, 1988, ANNU REV BIOCHEM, V57, P199, DOI 10.1146/annurev.bi.57.070188.001215; GREENSTEIN D, 1988, P NATL ACAD SCI USA, V85, P6262, DOI 10.1073/pnas.85.17.6262; GREENSTEIN D, 1990, J MOL BIOL, V211, P91, DOI 10.1016/0022-2836(90)90013-C; GREENSTEIN D, 1987, J MOL BIOL, V197, P157, DOI 10.1016/0022-2836(87)90115-X; GRONENBORN B, 1978, NATURE, V272, P375, DOI 10.1038/272375a0; Hamzeh-Mivehroud M, 2013, DRUG DISCOV TODAY, V18, P1144, DOI 10.1016/j.drudis.2013.09.001; HARTH G, 1981, EUR J BIOCHEM, V119, P663, DOI 10.1111/j.1432-1033.1981.tb05659.x; Henry KA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00755; HIGASHITANI A, 1992, NUCLEIC ACIDS RES, V20, P2685, DOI 10.1093/nar/20.11.2685; HIGASHITANI A, 1994, J MOL BIOL, V237, P388, DOI 10.1006/jmbi.1994.1242; Higashitani N, 1996, GENES CELLS, V1, P829, DOI 10.1046/j.1365-2443.1996.d01-279.x; JOHNSTON S, 1984, J MOL BIOL, V177, P685, DOI 10.1016/0022-2836(84)90044-5; KIM MH, 1985, J VIROL, V53, P871, DOI 10.1128/JVI.53.3.871-878.1985; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Mai-Prochnow A, 2015, FEMS MICROBIOL REV, V39, P465, DOI 10.1093/femsre/fuu007; Marvin DA, 2014, PROG BIOPHYS MOL BIO, V114, P80, DOI 10.1016/j.pbiomolbio.2014.02.003; Matochko WL, 2013, NUCL ACIDS RES; MAZUR BJ, 1973, J MOL BIOL, V78, P285, DOI 10.1016/0022-2836(73)90117-4; MAZUR BJ, 1975, VIROLOGY, V68, P490, DOI 10.1016/0042-6822(75)90289-5; MCCARTHY JEG, 1990, TRENDS GENET, V6, P78, DOI 10.1016/0168-9525(90)90098-Q; Menendez A, 2005, ANAL BIOCHEM, V336, P145, DOI 10.1016/j.ab.2004.09.048; Messing J, 1993, Methods Mol Biol, V23, P9; MESSING J, 1977, P NATL ACAD SCI USA, V74, P3642, DOI 10.1073/pnas.74.9.3642; MESSING J, 1991, GENE, V100, P3, DOI 10.1016/0378-1119(91)90344-B; Messing J, 2016, GENE, V583, P85, DOI 10.1016/j.gene.2016.02.005; MEYER TF, 1982, NATURE, V296, P828, DOI 10.1038/296828a0; MEYER TF, 1979, NATURE, V278, P365, DOI 10.1038/278365a0; MICHEL B, 1989, NUCLEIC ACIDS RES, V17, P7333, DOI 10.1093/nar/17.18.7333; MICHEL B, 1989, P NATL ACAD SCI USA, V86, P4002, DOI 10.1073/pnas.86.11.4002; MODEL P, 1982, CELL, V29, P329, DOI 10.1016/0092-8674(82)90149-0; Morag O, 2015, P NATL ACAD SCI USA, V112, P971, DOI 10.1073/pnas.1415393112; Nakamoto T, 2006, BIOCHEM BIOPH RES CO, V341, P675, DOI 10.1016/j.bbrc.2006.01.019; Nguyen KTH, 2014, ANAL BIOCHEM, V462, P35, DOI 10.1016/j.ab.2014.06.007; Noren KA, 2001, METHODS, V23, P169, DOI 10.1006/meth.2000.1118; Noren KA, 2001, PHAGE DISPLAY LAB MA; NORRANDER J, 1983, GENE, V26, P101, DOI 10.1016/0378-1119(83)90040-9; Oliver AW, 2000, J MOL BIOL, V301, P575, DOI 10.1006/jmbi.2000.3991; Oliver AW, 1999, BIOCHEM J, V339, P525, DOI 10.1042/0264-6021:3390525; Peris JB, 2010, GENETICS, V185, P603, DOI 10.1534/genetics.110.115162; Rakonjac J, 2011, CURR ISSUES MOL BIOL, V13, P51, DOI 10.21775/cimb.013.051; RUSSEL M, 1995, TRENDS MICROBIOL, V3, P223, DOI 10.1016/S0966-842X(00)88929-5; Sattarl S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00316; Shapiro JW, 2016, PEERJ, V4, DOI 10.7717/peerj.2060; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; Smeal SW, 2017, VIROLOGY, V500, P275, DOI 10.1016/j.virol.2016.08.015; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; STEITZ JA, 1975, P NATL ACAD SCI USA, V72, P4734, DOI 10.1073/pnas.72.12.4734; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Swinger KK, 2004, CURR OPIN STRUC BIOL, V14, P28, DOI 10.1016/j.sbi.2003.12.003; Szot-Karpinska K, 2016, BIOCONJUGATE CHEM, V27, P2900, DOI 10.1021/acs.bioconjchem.6b00555; Thomas WD, 2010, ANAL BIOCHEM, V407, P237, DOI 10.1016/j.ab.2010.07.037; VANWEZENBEEK PMGF, 1980, GENE, V11, P129, DOI 10.1016/0378-1119(80)90093-1; Webster R., 2001, PHAGE DISPLAY LAB MA; YEN TSB, 1982, CELL, V29, P337, DOI 10.1016/0092-8674(82)90150-7; ZAMAN GJR, 1990, EUR J BIOCHEM, V189, P119, DOI 10.1111/j.1432-1033.1990.tb15467.x; ZAMAN GJR, 1992, J BACTERIOL, V174, P595, DOI 10.1128/jb.174.2.595-600.1992; ZINDER ND, 1985, MICROBIOL REV, V49, P101, DOI 10.1128/MMBR.49.2.101-106.1985; ZINDER ND, 1982, GENE, V19, P1, DOI 10.1016/0378-1119(82)90183-4	74	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176421	10.1371/journal.pone.0176421	http://dx.doi.org/10.1371/journal.pone.0176421			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445507	Green Published, Green Submitted, gold			2022-12-26	WOS:000400309200059
J	Eguchi, K; Honig, LS; Lee, JH; Hoshide, S; Kario, K				Eguchi, Kazuo; Honig, Lawrence S.; Lee, Joseph H.; Hoshide, Satoshi; kario, Kazuomi			Short telomere length is associated with renal impairment in Japanese subjects with cardiovascular risk	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; FLOW-MEDIATED VASODILATION; AUGMENTATION INDEX; DISEASE; PRESSURE; BLOOD; HEART; ATHEROSCLEROSIS; REPRODUCIBILITY; DYSFUNCTION	Introduction Short telomere length has been suggested to be associated with atherosclerotic changes in Western populations. We examined the relationships between leukocyte telomere length and cardiovascular and renal function in a Japanese cohort. Participants and methods We enrolled 770 subjects who each had at least one cardiovascular risk factor. The mean age was 59.5 +/- 12.2 years; mean BMI was 25.1 +/- 4.6 kg/m(2). We measured leukocyte telomere length (LTL) by quantitative PCR (T/S ratio), and measured other biomarkers from blood and urine samples. In addition, we assessed surrogate markers of arterial stiffness, cardiovascular organ damage and kidney function, including flow-mediated vasodilation (FMD), pulse wave velocity (PWV), carotid artery augmentation index (CAAI), and urinary albumin creatinine ratio (UACR) and eGFR. Results Leukocyte telomere length (T/S ratio) was inversely associated with age (r = -0.194, P<0.001), and was lower in men (1.13 +/- 0.29%) than in women (1.20 +/- 0.31%, P = 0.002). T/S ratio was positively associated with BMI in women (r = 0.11, P = 0.047), but not in men. LTL did not show a significant relationship to cardiovascular surrogate markers, including arterial stiffness, FMD, and PWV, but did show some relationship to CAAI, which was inversely associated with T/S ratio only in men (r = -0.159, P = 0.015). LTL did show a significant positive association with renal function measured by eGFR (r = 0.16, P<0.001) both in men and women. Conclusions In this Japanese sample of persons with increased cardiovascular risk, telomere length showed a relationship of longer telomere length to better renal function, but did not overall show convincing association with cardiovascular measures of arterial stiffness and target organ damage.	[Eguchi, Kazuo; Hoshide, Satoshi; kario, Kazuomi] Jichi Med Univ, Dept Med, Div Cardiovasc Med, Shimotsuke, Tochigi, Japan; [Honig, Lawrence S.] Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; [Lee, Joseph H.] Columbia Univ, Sergievsky Ctr, Taub Inst, New York, NY USA	Jichi Medical University; Columbia University; Columbia University	Eguchi, K (corresponding author), Jichi Med Univ, Dept Med, Div Cardiovasc Med, Shimotsuke, Tochigi, Japan.	ke112@jichi.ac.jp	Lee, Joseph H/D-2441-2012	Lee, Joseph H/0000-0002-2000-4821	JSPS KAKENHI [JP 22590793]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number JP 22590793, Grant-in-Aid for Scientific Research (C) from 2010 to 2013.; This work was supported by JSPS KAKENHI Grant Number JP 22590793, Grant-in-Aid for Scientific Research (C) from 2010 to 2013. The authors thank the subjects for their participation in this study. The authors also thank Dr. Yukihiro Hojo, Ms. Rumiko Ochiai, Ms. Takako Takagi, and Ms. Junko Tsujimura for the DNA isolation, and Ms. Kimiyo Saito, Ms. Mayumi Yahata, Ms. Mitsuko Sato, and Ms. Yasuko Ohtsuki for the laboratory examinations and data management of this study.	Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Bansal N, 2012, AM J NEPHROL, V36, P405, DOI 10.1159/000343495; Benetos A, 2001, HYPERTENSION, V37, P381, DOI 10.1161/01.HYP.37.2.381; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Butt HZ, 2010, EUR J VASC ENDOVASC, V40, P17, DOI 10.1016/j.ejvs.2010.04.012; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Ding H, 2012, STROKE, V43, P658, DOI 10.1161/STROKEAHA.111.637207; Eguchi K, 2016, ATHEROSCLEROSIS, V246, P338, DOI 10.1016/j.atherosclerosis.2016.01.034; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Farzaneh-Far R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008612; Fuster JJ, 2007, J HYPERTENS, V25, P2185, DOI 10.1097/HJH.0b013e3282ef6196; Honig LS, 2006, ANN NEUROL, V60, P181, DOI 10.1002/ana.20894; Kabutoya T, 2012, J AM SOC HYPERTENS, V6, P109, DOI 10.1016/j.jash.2011.11.005; Matsui Y, 2004, HYPERTENS RES, V27, P851, DOI 10.1291/hypres.27.851; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Matsuzawa Yuji., 2005, J JPN SOC INT MED, V94, P188, DOI [10.5551/jat.12.301, DOI 10.5551/JAT.12.301]; Morimoto Y, 2014, INT J OBESITY, V38, P1416, DOI 10.1038/ijo.2014.25; Mukherjee M, 2009, HEART, V95, P669, DOI 10.1136/hrt.2008.150250; Nakashima H, 2004, HYPERTENS RES, V27, P319, DOI 10.1291/hypres.27.319; Nezu T, 2015, EBIOMEDICINE, V2, P960, DOI 10.1016/j.ebiom.2015.05.025; Nilsson PM, 2009, HYPERTENSION, V54, P3, DOI 10.1161/HYPERTENSIONAHA.109.129114; Olovnikov AM, 1996, EXP GERONTOL, V31, P443, DOI 10.1016/0531-5565(96)00005-8; Raschenberger J, 2015, SCI REP-UK, V5, DOI 10.1038/srep11887; Raymond AR, 2015, AM J HYPERTENS, V28, P623, DOI 10.1093/ajh/hpu212; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Samani NJ, 2001, LANCET, V358, P472, DOI 10.1016/S0140-6736(01)05633-1; Shimamoto K, 2014, HYPERTENS RES, V37, P256, DOI [10.1038/hr.2014.20, 10.1038/hr.2014.18]; Tabara Y, 2014, HYPERTENSION, V64, P1212, DOI 10.1161/HYPERTENSIONAHA.114.04277; Takazawa K, 2007, HYPERTENS RES, V30, P219, DOI 10.1291/hypres.30.219; Tanaka H, 2009, J HYPERTENS, V27, P2022, DOI 10.1097/HJH.0b013e32832e94e7; Teramoto T, 2013, J ATHEROSCLER THROMB, V20, P517, DOI 10.5551/jat.15792; Tomiyama H, 2008, HYPERTENS RES, V31, P2019, DOI 10.1291/hypres.31.2019; Wong LSM, 2009, CLIN RES CARDIOL, V98, P629, DOI 10.1007/s00392-009-0048-7; Wu AH, 2005, CARCINOGENESIS, V26, P976, DOI 10.1093/carcin/bgi028; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359; Yang HC, 2014, KIDNEY INT SUPPL, V4, P75, DOI 10.1038/kisup.2014.14; Yang ZW, 2009, HYPERTENSION, V53, P639, DOI 10.1161/HYPERTENSIONAHA.108.123752; Zhang WG, 2014, HEART LUNG CIRC, V23, P883, DOI 10.1016/j.hlc.2013.12.016; Zhao JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079993	42	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176138	10.1371/journal.pone.0176138	http://dx.doi.org/10.1371/journal.pone.0176138			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441430	gold, Green Submitted, Green Published			2022-12-26	WOS:000400308800028
J	Minocha, S; Boll, W; Noll, M				Minocha, Shilpi; Boll, Werner; Noll, Markus			Crucial roles of Pox neuro in the developing ellipsoid body and antennal lobes of the Drosophila brain	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; OLFACTORY LOCAL INTERNEURONS; MALE COURTSHIP BEHAVIOR; CENTRAL COMPLEX; POSTEMBRYONIC NEUROBLASTS; SCHISTOCERCA-GREGARIA; TRANSCRIPTION FACTORS; WIRING SPECIFICITY; ORIENTATION MEMORY; GENETIC-ANALYSIS	The paired box gene Pox neuro (Poxn) is expressed in two bilaterally symmetric neuronal clusters of the developing adult Drosophila brain, a protocerebral dorsal cluster (DC) and a deutocerebral ventral cluster (VC). We show that all cells that express Poxn in the developing brain are postmitotic neurons. During embryogenesis, the DC and VC consist of only 20 and 12 neurons that express Poxn, designated embryonic Poxn-neurons. The number of Poxn-neurons increases only during the third larval instar, when the DC and VC increase dramatically to about 242 and 109 Poxn-neurons, respectively, virtually all of which survive to the adult stage, while no new Poxn-neurons are added during metamorphosis. Although the vast majority of Poxn-neurons express Poxn only during third instar, about half of them are born by the end of embryogenesis, as demonstrated by the absence of BrdU incorporation during larval stages. At late third instar, embryonic Poxn-neurons, which begin to express Poxn during embryogenesis, can be easily distinguished from embryonic-born and larval-born Poxn-neurons, which begin to express Poxn only during third instar, (i) by the absence of Pros, (ii) their overt differentiation of axons and neurites, and (iii) the strikingly larger diameter of their cell bodies still apparent in the adult brain. The embryonic Poxn-neurons are primary neurons that lay out the pioneering tracts for the secondary Poxn-neurons, which differentiate projections and axons that follow those of the primary neurons during metamorphosis. The DC and the VC participate only in two neuropils of the adult brain. The DC forms most, if not all, of the neurons that connect the bulb (lateral triangle) with the ellipsoid body, a prominent neuropil of the central complex, while the VC forms most of the ventral projection neurons of the antennal lobe, which connect it ipsilaterally to the lateral horn, bypassing the mushroom bodies. In addition, Poxn-neurons of the VC are ventral local interneurons of the antennal lobe. In the absence of Poxn protein in the developing brain, embryonic Poxn-neurons stall their projections and cannot find their proper target neuropils, the bulb and ellipsoid body in the case of the DC, or the antennal lobe and lateral horn in the case of the VC, whereby the absence of the ellipsoid body neuropil is particularly striking. Poxn is thus crucial for pathfinding both in the DC and VC. Additional implications of our results are discussed.	[Minocha, Shilpi; Boll, Werner; Noll, Markus] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Minocha, Shilpi] Univ Lausanne, Ctr Integrat Genom, Genopode, Lausanne, Switzerland	University of Zurich; University of Lausanne	Noll, M (corresponding author), Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland.	markus.noll@imis.uzh.ch		Minocha, Shilpi/0000-0001-8229-1443	Swiss National Science Foundation [3100A0-105823]; Kanton ZuErich, Switzerlad	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Kanton ZuErich, Switzerlad	This work was funded by Swiss National Science Foundation grant 3100A0-105823 (to MN) and by the Kanton ZuErich, Switzerlad.	Awasaki T, 1997, J NEUROBIOL, V32, P707, DOI 10.1002/(SICI)1097-4695(19970620)32:7<707::AID-NEU6>3.0.CO;2-8; Awasaki T, 2001, DEV GENES EVOL, V211, P20, DOI 10.1007/s004270000119; BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; Bearer EL, 2003, CURR PROTOC MOL BIOL, V14, P1; Boll W, 2002, DEVELOPMENT, V129, P5667, DOI 10.1242/dev.00157; BOPP D, 1989, EMBO J, V8, P3447, DOI 10.1002/j.1460-2075.1989.tb08509.x; Carmona R, 2007, J MICROSC-OXFORD, V225, P96, DOI 10.1111/j.1365-2818.2007.01719.x; Ceron J, 2001, DEV BIOL, V230, P125, DOI 10.1006/dbio.2000.0110; Choksi SP, 2006, DEV CELL, V11, P775, DOI 10.1016/j.devcel.2006.09.015; Chou YH, 2010, NAT NEUROSCI, V13, P439, DOI 10.1038/nn.2489; CHULAGRAFF Q, 1991, DEVELOPMENT, P79; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Colonques J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019342; Consoulas C, 2000, BRAIN RES BULL, V53, P571, DOI 10.1016/S0361-9230(00)00391-9; Consoulas C, 2002, J NEUROSCI, V22, P4906, DOI 10.1523/JNEUROSCI.22-12-04906.2002; DAMBLYCHAUDIERE C, 1992, CELL, V69, P159, DOI 10.1016/0092-8674(92)90127-X; Das A, 2013, DEV BIOL, V373, P322, DOI 10.1016/j.ydbio.2012.11.003; Das Abhijit, 2011, Neural Syst Circuits, V1, P4, DOI 10.1186/2042-1001-1-4; Das A, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-33; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; Dumstrei K, 2003, J COMP NEUROL, V455, P451, DOI 10.1002/cne.10484; Eliceiri KW, 2005, PHOTOCHEM PHOTOBIOL, V81, P1116, DOI 10.1562/2004-11-22-IR-377; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; HALTER DA, 1995, DEVELOPMENT, V121, P317; HANESCH U, 1989, CELL TISSUE RES, V257, P343, DOI 10.1007/BF00261838; HARTENSTEIN V, 1987, ROUX ARCH DEV BIOL, V196, P473, DOI 10.1007/BF00399871; Hirth F, 2003, DEVELOPMENT, V130, P2365, DOI 10.1242/dev.00438; Hofbauer A, 1991, THESIS; Homberg U, 1999, J COMP NEUROL, V409, P495, DOI 10.1002/(SICI)1096-9861(19990705)409:3<495::AID-CNE12>3.0.CO;2-F; Homberg U., 1987, P347; Homberg U, 2008, ARTHROPOD STRUCT DEV, V37, P347, DOI 10.1016/j.asd.2008.01.008; ILIUS M, 1994, J NEUROGENET, V9, P189, DOI 10.3109/01677069409167279; Ito K, 1997, CELL TISSUE RES, V290, P1, DOI 10.1007/s004410050901; Ito K, 1997, DEVELOPMENT, V124, P761; ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q; Ito M, 2013, CURR BIOL, V23, P644, DOI 10.1016/j.cub.2013.03.015; Jager R.F., 1987, Drosophila Information Service, P162; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Jiang YR, 2015, DEV BIOL, V397, P162, DOI 10.1016/j.ydbio.2014.10.013; Komiyama T, 2003, CELL, V112, P157, DOI 10.1016/S0092-8674(03)00030-8; Komiyama T, 2007, CURR BIOL, V17, P278, DOI 10.1016/j.cub.2006.11.067; Krstic D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004457; Kuntz S, 2012, LEARN MEMORY, V19, P337, DOI 10.1101/lm.026369.112; Lachmanovich E, 2003, J MICROSC-OXFORD, V212, P122, DOI 10.1046/j.1365-2818.2003.01239.x; Lai SL, 2008, DEVELOPMENT, V135, P2883, DOI 10.1242/dev.024380; Larsen C, 2009, DEV BIOL, V335, P289, DOI 10.1016/j.ydbio.2009.06.015; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Levine Richard B., 1995, Current Opinion in Neurobiology, V5, P28, DOI 10.1016/0959-4388(95)80083-2; Li L, 2000, GENE DEV, V14, P147; Lin SW, 2010, DEVELOPMENT, V137, P43, DOI 10.1242/dev.041699; Loesel R, 2002, ARTHROPOD STRUCT DEV, V31, P77, DOI 10.1016/S1467-8039(02)00017-8; Lovick JK, 2013, DEV BIOL, V384, P228, DOI 10.1016/j.ydbio.2013.07.008; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Marin EC, 2005, DEVELOPMENT, V132, P725, DOI 10.1242/dev.01614; Martin J-R, 2001, POWER LAW DISTRIBUTI; Martin-Pena A, 2014, EUR J NEUROSCI, V39, P1586, DOI 10.1111/ejn.12537; Masuda-Nakagawa LM, 2005, P NATL ACAD SCI USA, V102, P19027, DOI 10.1073/pnas.0509643102; Maurange C, 2008, CELL, V133, P891, DOI 10.1016/j.cell.2008.03.034; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McGuire SE, 2004, SCI STKE, P16, DOI DOI 10.1126/28822202004P16; Muller M, 1997, CELL TISSUE RES, V288, P159, DOI 10.1007/s004410050803; Nassif C, 1998, J COMP NEUROL, V402, P10; Nassif C, 2003, J COMP NEUROL, V455, P417, DOI 10.1002/cne.10482; Neuser K, 2008, NATURE, V453, P1244, DOI 10.1038/nature07003; NOLL M, 1993, CURR OPIN GENET DEV, V3, P595, DOI 10.1016/0959-437X(93)90095-7; Okada R, 2009, J COMP NEUROL, V514, P74, DOI 10.1002/cne.21971; Pereanu W, 2006, J NEUROSCI, V26, P5534, DOI 10.1523/JNEUROSCI.4708-05.2006; Pereanu W, 2010, J COMP NEUROL, V518, P2996, DOI 10.1002/cne.22376; Power ME, 1943, J MORPHOL, V72, P517, DOI 10.1002/jmor.1050720306; PROKOP A, 1991, DEVELOPMENT, V111, P79; Python F, 2002, J COMP NEUROL, V453, P157, DOI 10.1002/cne.10383; Python F, 2002, J COMP NEUROL, V445, P374, DOI 10.1002/cne.10188; Ramaekers A, 2005, CURR BIOL, V15, P982, DOI 10.1016/j.cub.2005.04.032; Renn SCP, 1999, J NEUROBIOL, V41, P189; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; Spindler SR, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-16; Spindler SR, 2010, DEV GENES EVOL, V220, P1, DOI 10.1007/s00427-010-0323-7; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Strausfeld NJ, 2009, P ROY SOC B-BIOL SCI, V276, P1929, DOI 10.1098/rspb.2008.1471; Strausfeld NJ, 1998, BRAIN BEHAV EVOLUT, V52, P186, DOI 10.1159/000006563; Strausfeld NJ, 1999, PROG BRAIN RES, V123, P273, DOI 10.1016/S0079-6123(08)62863-0; STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Tanaka NK, 2012, J COMP NEUROL, V520, P4067, DOI 10.1002/cne.23142; Thran J, 2013, CURR BIOL, V23, P1756, DOI 10.1016/j.cub.2013.07.034; Tissot M, 2000, PROG NEUROBIOL, V62, P89, DOI 10.1016/S0301-0082(99)00069-6; Truman JW, 2010, DEVELOPMENT, V137, P53, DOI 10.1242/dev.041749; TRUMAN JW, 1990, J NEUROBIOL, V21, P1072, DOI 10.1002/neu.480210711; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; Truman JW, 1996, DEV NEUROSCI-BASEL, V18, P87, DOI 10.1159/000111398; Urbach R, 2003, DEVELOPMENT, V130, P3589, DOI 10.1242/dev.00528; Urbach R, 2003, DEVELOPMENT, V130, P3621, DOI 10.1242/dev.00533; Urbach R, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-23; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; WILLIAMS JLD, 1975, J ZOOL, V176, P67; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wolff T, 2015, J COMP NEUROL, V523, P997, DOI 10.1002/cne.23705; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Wong DC, 2013, DEV BIOL, V384, P258, DOI 10.1016/j.ydbio.2013.07.009; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981; Yang JS, 2013, J COMP NEUROL, V521, P2645, DOI 10.1002/cne.23339; Young JM, 2010, J COMP NEUROL, V518, P1500, DOI 10.1002/cne.22284; Younossi-Hartenstein A, 2003, J COMP NEUROL, V455, P435, DOI 10.1002/cne.10483; Younossi-Hartenstein A, 2006, J COMP NEUROL, V497, P981, DOI 10.1002/cne.20884; YounossiHartenstein A, 1996, J COMP NEUROL, V370, P313, DOI 10.1002/(SICI)1096-9861(19960701)370:3<313::AID-CNE3>3.0.CO;2-7; Yu HH, 2013, CURR BIOL, V23, P633, DOI 10.1016/j.cub.2013.02.057; Zhou BH, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-39; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652; Zhu SJ, 2006, CELL, V127, P409, DOI 10.1016/j.cell.2006.08.045; Zito K, 1997, NEURON, V19, P1007, DOI 10.1016/S0896-6273(00)80393-1	116	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176002	10.1371/journal.pone.0176002	http://dx.doi.org/10.1371/journal.pone.0176002			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441464	gold, Green Published, Green Submitted			2022-12-26	WOS:000400308800016
J	Gehring, KB; Heufelder, K; Depner, H; Kersting, I; Sigrist, SJ; Eisenhardt, D				Gehring, Katrin B.; Heufelder, Karin; Depner, Harald; Kersting, Isabella; Sigrist, Stephan J.; Eisenhardt, Dorothea			Age-associated increase of the active zone protein Bruchpilot within the honeybee mushroom body	PLOS ONE			English	Article							DIVISION-OF-LABOR; APIS-MELLIFERA; INSECT BRAIN; IDENTIFIED SYNAPSES; JUVENILE-HORMONE; BEE BRAIN; BODIES; DROSOPHILA; PLASTICITY; EXPERIENCE	In honeybees, age-associated structural modifications can be observed in the mushroom bodies. Prominent examples are the synaptic complexes (microglomeruli, MG) in the mushroom body calyces, which were shown to alter their size and density with age. It is not known whether the amount of intracellular synaptic proteins in the MG is altered as well. The presynaptic protein Bruchpilot (BRP) is localized at active zones and is involved in regulating the probability of neurotransmitter release in the fruit fly, Drosophila melanogaster. Here, we explored the localization of the honeybee BRP (Apis mellifera BRP, AmBRP) in the bee brain and examined age-related changes in the AmBRP abundance in the central bee brain and in microglomeruli of the mushroom body calyces. We report predominant AmBRP localization near the membrane of presynaptic boutons within the mushroom body MG. The relative amount of AmBRP was increased in the central brain of two-week old bees whereas the amount of Synapsin, another presynaptic protein involved in the regulation of neurotransmitter release, shows an increase during the first two weeks followed by a decrease. In addition, we demonstrate an age-associated modulation of AmBRP located near the membrane of presynaptic boutons within MG located in mushroom body calyces where sensory input is conveyed to mushroom body intrinsic neurons. We discuss that the observed age-associated AmBRP modulation might be related to maturation processes or to homeostatic mechanisms that might help to maintain synaptic functionality in old animals.	[Gehring, Katrin B.; Heufelder, Karin; Kersting, Isabella; Eisenhardt, Dorothea] Free Univ Berlin, Inst Biol Neurobiol, Berlin, Germany; [Depner, Harald; Sigrist, Stephan J.] Free Univ Berlin, Inst Biol Genet, Takustr 6, Berlin, Germany	Free University of Berlin; Free University of Berlin	Eisenhardt, D (corresponding author), Free Univ Berlin, Inst Biol Neurobiol, Berlin, Germany.	dorothea.eisenhardt@fu-berlin.de			German Federal Ministry of Education and Research (BMBF) under Grant within the Bernstein Focus Neuronal Basis of Learning [01GQ0941]; Deutsche Forschungsgemeinschaft (DFG), Biogenic amines in insects: coordination of physiological processes and behavior [El 512/1, El 512/2-1, FOR 1363]	German Federal Ministry of Education and Research (BMBF) under Grant within the Bernstein Focus Neuronal Basis of Learning; Deutsche Forschungsgemeinschaft (DFG), Biogenic amines in insects: coordination of physiological processes and behavior	This study was supported by the German Federal Ministry of Education and Research (BMBF) under Grant No. 01GQ0941 awarded to D. E. within the Bernstein Focus Neuronal Basis of Learning and by the Deutsche Forschungsgemeinschaft (DFG) under Grant No. El 512/1 awarded to D.E. and Grant No. El 512/2-1 awarded to D.E. as part of the joint project FOR 1363 Biogenic amines in insects: coordination of physiological processes and behavior. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Christine Quentin, Institute for Genetics, Freie Universitat Berlin, and Thorsten Mielke, Max Planck Institute of Molecular Genetics Berlin, for their support and ongoing fruitful discussion on the analysis of AmBRP localization in the honeybee brain. This study was supported by the German Federal Ministry of Education and Research (BMBF) under Grant No. 01GQ0941 awarded to DE within the Bernstein Focus Neuronal Basis of Learning and by the Deutsche Forschungsgemeinschaft (DFG) under Grant No. EI 512/1 awarded to DE and Grant No. EI 512/2-1 awarded to DE as part of the joint project FOR 1363 Biogenic amines in insects: coordination of physiological processes and behavior.	Abel R, 2001, J COMP NEUROL, V437, P363, DOI 10.1002/cne.1289; Dickman DK, 2006, CURR BIOL, V16, P591, DOI 10.1016/j.cub.2006.02.058; Dickman DK, 2005, CELL, V123, P521, DOI 10.1016/j.cell.2005.09.026; DURST C, 1994, BEHAV NEURAL BIOL, V62, P259, DOI 10.1016/S0163-1047(05)80025-1; Ehmer B, 2002, J COMP NEUROL, V451, P362, DOI 10.1002/cne.10355; Eisenhardt D, 2014, LEARN MEMORY, V21, P534, DOI 10.1101/lm.033118.113; Fahrbach SE, 1998, LEARN MEMORY, V5, P115; Farris SM, 2001, J NEUROSCI, V21, P6395, DOI 10.1523/JNEUROSCI.21-16-06395.2001; Fouquet W, 2009, J CELL BIOL, V186, P129, DOI 10.1083/jcb.200812150; Frambach I, 2004, J COMP NEUROL, V475, P303, DOI 10.1002/cne.20165; Ganeshina O, 2001, J COMP NEUROL, V437, P335, DOI 10.1002/cne.1287; Ganeshina O, 2006, J COMP NEUROL, V497, P876, DOI 10.1002/cne.21033; GASCUEL J, 1991, J NEUROBIOL, V22, P795, DOI 10.1002/neu.480220802; Gehring KB, 2016, J COMP NEUROL, V524, P1165, DOI 10.1002/cne.23894; Gray DT, 2015, NEUROSCIENCE, V309, P17, DOI 10.1016/j.neuroscience.2015.08.001; Grillo F. W., 2015, J CHEM NEUROANAT; Groh C, 2004, P NATL ACAD SCI USA, V101, P4268, DOI 10.1073/pnas.0400773101; Groh C, 2012, J COMP NEUROL, V520, P3509, DOI 10.1002/cne.23102; Gronenberg W, 2001, J COMP NEUROL, V435, P474, DOI 10.1002/cne.1045; Gupta VK, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002563; Hallermann S, 2010, J NEUROSCI, V30, P14340, DOI 10.1523/JNEUROSCI.2495-10.2010; Hofbauer A, 2009, J NEUROGENET, V23, P78, DOI 10.1080/01677060802471627; Huang JK, 2013, NEUROBIOL DIS, V51, P161, DOI 10.1016/j.nbd.2012.11.006; Ito K, 2014, NEURON, V81, P755, DOI 10.1016/j.neuron.2013.12.017; Kirschner S, 2006, J COMP NEUROL, V499, P933, DOI 10.1002/cne.21158; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Klagges BRE, 1996, J NEUROSCI, V16, P3154; Knapek S, 2011, J NEUROSCI, V31, P3453, DOI 10.1523/JNEUROSCI.2585-10.2011; Krofczik S, 2008, DEV NEUROBIOL, V68, P1007, DOI 10.1002/dneu.20640; Leitinger G, 2012, J COMP NEUROL, V520, P384, DOI 10.1002/cne.22744; MASSON C, 1984, J INSECT PHYSIOL, V30, P7, DOI 10.1016/0022-1910(84)90104-5; Matkovic T, 2013, J CELL BIOL, V202, P667, DOI 10.1083/jcb.201301072; Melom JE, 2013, J NEUROSCI, V33, P17253, DOI 10.1523/JNEUROSCI.3334-13.2013; Muenz TS, 2015, DEV NEUROBIOL, V75, P1368, DOI 10.1002/dneu.22290; Mussig L, 2010, J NEUROSCI, V30, P7817, DOI 10.1523/JNEUROSCI.5543-09.2010; Pasch E, 2011, J COMP NEUROL, V519, P3700, DOI 10.1002/cne.22683; Peled ES, 2014, CURR BIOL, V24, P484, DOI 10.1016/j.cub.2014.01.022; Petralia RS, 2014, AGEING RES REV, V14, P31, DOI 10.1016/j.arr.2014.01.003; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; RYBAK J, 1993, J COMP NEUROL, V334, P444, DOI 10.1002/cne.903340309; Scholl C, 2014, DEV NEUROBIOL, V74, P1141, DOI 10.1002/dneu.22195; Schroter U, 2003, J COMP NEUROL, V465, P168, DOI 10.1002/cne.10843; Schurmann FW, 2016, ARTHROPOD STRUCT DEV, V45, P399, DOI 10.1016/j.asd.2016.08.005; SEELEY TD, 1982, BEHAV ECOL SOCIOBIOL, V11, P287, DOI 10.1007/BF00299306; Strausfeld NJ, 2002, J COMP NEUROL, V450, P4, DOI 10.1002/cne.10285; Terman A, 2005, BIOGERONTOLOGY, V6, P205, DOI 10.1007/s10522-005-7956-3; TRUJILLOCENOZ O, 1962, J ULTRA MOL STRUCT R, V7, P389, DOI 10.1016/S0022-5320(62)90035-7; Ullrich A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004407; van der Zee EA, 2015, NEUROSCI BIOBEHAV R, V50, P77, DOI 10.1016/j.neubiorev.2014.06.012; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Wagner N, 2015, J COMP NEUROL, V523, P2457, DOI 10.1002/cne.23798; Wang SP, 2005, J INSECT PHYSIOL, V51, P1244, DOI 10.1016/j.jinsphys.2005.07.003; Winston ML, 1987, APIS MELLIFERA; WITHERS GS, 1995, J NEUROBIOL, V26, P130, DOI 10.1002/neu.480260111; WITHERS GS, 1993, NATURE, V364, P238, DOI 10.1038/364238a0; Yusuyama K, 2002, J COMP NEUROL, V445, P211, DOI 10.1002/cne.10155	57	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0175894	10.1371/journal.pone.0175894	http://dx.doi.org/10.1371/journal.pone.0175894			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437454	Green Published, gold, Green Submitted			2022-12-26	WOS:000400287600019
J	Yamori, Y; Sagara, M; Arai, Y; Kobayashi, H; Kishimoto, K; Matsuno, I; Mori, H; Mori, M				Yamori, Yukio; Sagara, Miki; Arai, Yoshimi; Kobayashi, Hitomi; Kishimoto, Kazumi; Matsuno, Ikuko; Mori, Hideki; Mori, Mari			Soy and fish as features of the Japanese diet and cardiovascular disease risks	PLOS ONE			English	Article							MIDDLE-AGED SUBJECTS; BLOOD-PRESSURE; METABOLIC SYNDROME; PRODUCT KINAKO; UNITED-STATES; 24-H URINE; WOMEN; ATHEROSCLEROSIS; HOMOCYSTEINE; TAURINE	In the World Health Organization (WHO)-coordinated Cardiovascular Disease and Alimentary Comparison Study, isoflavones (I; biomarker for dietary soy) and taurine (T; biomarker for dietary fish) in 24-hour-urine (24U) were inversely related to coronary heart disease (CHD) mortality. High levels of these biomarkers are found in Japanese people, whose CHD mortality is lowest among developed countries. We analyzed the association of these biomarkers with cardiovascular disease risk in the Japanese to know their health effects within one ethnic population. First, to compare the Japanese intake of I and T with international intakes, the ratios of 24UI and 24UT to creatinine from the WHO Study were divided into quintiles for analysis. The ratio for the Japanese was the highest in the highest quintiles for both I and T, reaching 88.1%, far higher than the average ratio for the Japanese (26.3%) in the total study population. Second, 553 inhabitants of Hyogo Prefecture, Japan, aged 30 to 79 years underwent 24-U collection and blood analyses. The 24UT and 24UI were divided into tertiles and adjusted for age and sex. The highest T tertile, compared with the lowest tertile, showed significantly higher levels of high-density lipoprotein-cholesterol (HDL-C), total cholesterol, 24U sodium (Na) and potassium (K). The highest I tertile showed significantly higher folate, 24UNa and 24UK compared with the lowest tertile. The highest tertile of both T and I showed significantly higher HDL-C, folate, and 24UNa and 24UK compared with the lowest tertile. Thus, greater consumption of fish and soy were significantly associated with higher HDL-C and folate levels, possibly a contributor to Japan having the lowest CHD mortality and longest life expectancy among developed countries. As these intakes were also associated with a high intake of salt, a low-salt intake of fish and soy should be recommended for healthy life expectancy.	[Yamori, Yukio; Mori, Hideki; Mori, Mari] Mukogawa Womens Univ, Inst World Hlth Dev, Nishinomiya, Hyogo, Japan; [Yamori, Yukio; Sagara, Miki] Res Inst Prod & Dev, Lab Prevent Nutr Med, Kyoto, Japan; [Yamori, Yukio; Arai, Yoshimi; Kobayashi, Hitomi; Kishimoto, Kazumi; Matsuno, Ikuko] Hyogo Prefecture Hlth Promot Assoc, Kobe, Hyogo, Japan	Mukogawa Women's University	Yamori, Y (corresponding author), Mukogawa Womens Univ, Inst World Hlth Dev, Nishinomiya, Hyogo, Japan.; Yamori, Y (corresponding author), Res Inst Prod & Dev, Lab Prevent Nutr Med, Kyoto, Japan.; Yamori, Y (corresponding author), Hyogo Prefecture Hlth Promot Assoc, Kobe, Hyogo, Japan.	yamori@cardiacstudy.com			JSPS KAKENHI [A20256001]; Hyogo Health Promotion Association; HPHPA	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Hyogo Health Promotion Association; HPHPA	This work was supported by JSPS KAKENHI Grant Number A20256001 and by Hyogo Health Promotion Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We express our appreciation to all participants in the WHO-CARDIAC Study and the Hyogo Prefecture Health Promotion Association (HPHPA) for conducting the health examinations. This work was supported by JSPS KAKENHI Grant Number A20256001 and by HPHPA.	ABBOTT RD, 1988, ARTERIOSCLEROSIS, V8, P207, DOI 10.1161/01.ATV.8.3.207; Acharjee S, 2015, METABOLISM, V64, P236, DOI 10.1016/j.metabol.2014.09.005; Aiello A, 2016, IMMUN AGEING, V13, DOI 10.1186/s12979-016-0071-2; [Anonymous], REP FOOD SELF SUFF R; Simao ANC, 2014, NUTRITION, V30, P112, DOI 10.1016/j.nut.2013.05.024; Simao ANC, 2012, BRIT J NUTR, V108, P1435, DOI 10.1017/S0007114511006921; Cui RZ, 2010, STROKE, V41, P1285, DOI 10.1161/STROKEAHA.110.578906; Davinelli S, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-9; Emilio R, 2014, ADV NUTR, V5, p330S; Haynes WG, 2002, CARDIOVASC DRUG THER, V16, P391, DOI 10.1023/A:1022130217463; Hermansen K, 2001, DIABETES CARE, V24, P228, DOI 10.2337/diacare.24.2.228; Jacobson TA, 2008, AM J CLIN NUTR, V87, p1981S, DOI 10.1093/ajcn/87.6.1981S; Jenkins DJA, 2002, AM J CLIN NUTR, V76, P365, DOI 10.1093/ajcn/76.2.365; MacArtain P, 2007, NUTR REV, V65, P535, DOI 10.1111/j.1753-4887.2007.tb00278.x; Matsumura Y, 2001, ASIA PAC J CLIN NUTR, V10, pS40, DOI 10.1046/j.1440-6047.2001.0100s1S40.x; McCully KS, 2015, EXPERT REV CLIN PHAR, V8, P211, DOI 10.1586/17512433.2015.1010516; Mori M, 2007, THER RES, V28, P1788; Mori TA, 1999, HYPERTENSION, V34, P253, DOI 10.1161/01.HYP.34.2.253; Naar AM, 2013, ARTERIOSCL THROM VAS, V33, P447, DOI 10.1161/ATVBAHA.112.301021; Nagata C, 2003, J NUTR, V133, P797, DOI 10.1093/jn/133.3.797; Pallauf K, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/707421; Quinlivan EP, 2003, AM J CLIN NUTR, V77, P221, DOI 10.1093/ajcn/77.1.221; Sagara M, 2015, ADV EXP MED BIOL, V803, P623, DOI 10.1007/978-3-319-15126-7_50; Sagara M, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/809198; Sharifi-Zahabi Elham, 2015, Clin Nutr Res, V4, P225, DOI 10.7762/cnr.2015.4.4.225; United Nations Development Programme, HUM DEV REP 2015 INT; Weber P, 2000, NUTR METAB CARDIOVAS, V10, P28; WHO, 2016, WORLD HLTH STAT 2016; World Health Organization, WORLD HLTH STAT 2016; YAMORI Y, 1984, CLIN EXP HYPERTENS A, V6, P1161, DOI 10.3109/10641968409039588; Yamori Y, 1996, ADV EXP MED BIOL, V403, P623; Yamori Y, 2008, P INT S FOOD CULT DE, P23; Yamori Yukio, 2006, Exp Clin Cardiol, V11, P94; Yamori Y, 2006, J HYPERTENS, V24, P1499, DOI 10.1097/01.hjh.0000239284.12691.2e; Yamori Y, 2015, HYPERTENS RES, V38, P219, DOI 10.1038/hr.2014.158; Yamori Y, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S6; Yamori Y, 2006, NUTR DIS PREV, P107; Yang QH, 2006, CIRCULATION, V113, P1335, DOI 10.1161/CIRCULATIONAHA.105.570846	38	18	19	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0176039	10.1371/journal.pone.0176039	http://dx.doi.org/10.1371/journal.pone.0176039			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430815	Green Published, gold, Green Submitted			2022-12-26	WOS:000399876100027
J	Yang, L; Mu, YP; Cui, HW; Liang, YB; Su, XL				Yang, Ling; Mu, Yongping; Cui, Hongwei; Liang, Yabing; Su, Xiulan			MiR-9-3p augments apoptosis induced by H2O2 through down regulation of Herpud1 in glioma	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; OXIDATIVE STRESS; TUMOR-SUPPRESSOR; CANCER CELLS; STEM-CELLS; GLIOBLASTOMA; INHIBITION; EXPRESSION; PATHWAY; PROLIFERATION	MicroRNAs are short, single-stranded non-coding RNA molecules that function as regulators of tumor progression in various cancers, including glioma. The present study sought to investigate the biological functions of miR-9-3p in glioma progression. The results of a microRNA microarray indicated that microRNA-9-3p (miR-9-3p, miR-9*) is down-regulated in high-grade (grades III and IV) gliomas compared with non-tumor tissues. These results were confirmed with real-time PCR. The miR-9-3p expression level was associated with age and tumor grade. Herpud1 was regulated by miR-9-3p in glioma cells and tissues and was identified as a miR-9-3p target with luciferase reporter assays. Glioma cells transfected with miR-9-3p mimics or HERPUD1-RNAi had more apoptotic cells than them in control after induced by H2O2. Our results indicated that low expression of miR-9-3p results in a high level of Herpud1, which may protect against apoptosis in glioma.	[Yang, Ling; Cui, Hongwei; Liang, Yabing; Su, Xiulan] Inner Mongolia Med Univ, Clin Med Res Ctr, Affiliated Hosp, Hohhot, Inner Mongolia, Peoples R China; [Mu, Yongping] Inner Mongolia Med Univ, Dept Clin Lab, Affiliated Peoples Hosp, Hohhot, Inner Mongolia, Peoples R China	Inner Mongolia Medical University; Inner Mongolia Medical University	Su, XL (corresponding author), Inner Mongolia Med Univ, Clin Med Res Ctr, Affiliated Hosp, Hohhot, Inner Mongolia, Peoples R China.	xlsu2015@163.com			Autonomous Tumor Innovation Team; Laboratory of Ministry Funding [X201005, X201002]	Autonomous Tumor Innovation Team; Laboratory of Ministry Funding	Our study was supported by Autonomous Tumor Innovation Team (No Funding Number) and Laboratory of Ministry Funding (X201005 and X201002) to XS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buckner JC, 2007, MAYO CLIN PROC, V82, P1271, DOI 10.4065/82.10.1271; Fang L, 2011, ONCOGENE, V30, P806, DOI 10.1038/onc.2010.465; Higashi T, 2015, BRIT J CANCER, V113, P252, DOI 10.1038/bjc.2015.170; Kokame K, 2000, J BIOL CHEM, V275, P32846, DOI 10.1074/jbc.M002063200; Li SZ, 2014, BIOCHEM BIOPH RES CO, V444, P6, DOI 10.1016/j.bbrc.2013.12.136; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Ma XY, 2009, J CLIN NEUROSCI, V16, P1595, DOI 10.1016/j.jocn.2009.02.036; Mateescu B, 2011, NAT MED, V17, P1627, DOI 10.1038/nm.2512; Mesegueri S, 2015, HUM MOL GENET, V24, P167, DOI 10.1093/hmg/ddu427; Miller CR, 2007, ARCH PATHOL LAB MED, V131, P397; Morry J, 2017, REDOX BIOL, V11, P240, DOI 10.1016/j.redox.2016.12.011; Ohtsuka M, 2015, J CLIN MED, V4, P1651, DOI 10.3390/jcm4081651; Okuda-Shimizu Y, 2007, MOL CELL, V28, P544, DOI 10.1016/j.molcel.2007.09.012; Papagiannakopoulos T, 2012, ONCOGENE, V31, P1884, DOI 10.1038/onc.2011.380; Paredes F, 2016, FREE RADICAL BIO MED, V90, P206, DOI 10.1016/j.freeradbiomed.2015.11.024; Peiris-Pages M, 2015, CELL METAB, V22, P956, DOI 10.1016/j.cmet.2015.11.008; Pogue AI, 2011, J INORG BIOCHEM, V105, P1434, DOI 10.1016/j.jinorgbio.2011.05.012; Quiroga C, 2013, BBA-MOL CELL RES, V1833, P3295, DOI 10.1016/j.bbamcr.2013.09.006; Richter K, 2015, REDOX BIOL, V6, P344, DOI 10.1016/j.redox.2015.08.015; Saleh AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024429; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Schraivogel D, 2011, EMBO J, V30, P4309, DOI 10.1038/emboj.2011.301; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Schumacker PT, 2015, CANCER CELL, V27, P156, DOI 10.1016/j.ccell.2015.01.007; Speranza MC, 2012, ONCOTARGET, V3, P724; Sun YN, 2015, MOL MED REP, V12, P7742, DOI 10.3892/mmr.2015.4373; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Tu YY, 2013, CANCER RES, V73, P6046, DOI 10.1158/0008-5472.CAN-13-0358; Ullrich Nicole J, 2006, Curr Oncol Rep, V8, P423, DOI 10.1007/s11912-006-0070-0; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; van Laar T, 2000, FEBS LETT, V469, P123, DOI 10.1016/S0014-5793(00)01253-9; Wang F, 2016, J RECEPT SIGNAL TRAN, V1, P1, DOI DOI 10.1016/J2TM0SENV.2016.09.014; Wang LN, 2015, GENE, V572, P252, DOI 10.1016/j.gene.2015.07.017; Yang W, 2014, EXP CELL RES, V326, P22, DOI 10.1016/j.yexcr.2014.05.022; Yang YP, 2012, BIOMATERIALS, V33, P1462, DOI 10.1016/j.biomaterials.2011.10.071; Zawistowski JS, 2013, MOL CELL BIOL, V33, P2260, DOI 10.1128/MCB.00269-13; Zhang XM, 2012, CANCER RES, V72, P4707, DOI 10.1158/0008-5472.CAN-12-0639	38	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0174839	10.1371/journal.pone.0174839	http://dx.doi.org/10.1371/journal.pone.0174839			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430789	Green Submitted, Green Published, gold			2022-12-26	WOS:000399876100006
J	Li, GH; Zhang, YX				Li, Gui-Hua; Zhang, Yong-Xin			Dynamic behaviors of a modified SIR model in epidemic diseases using nonlinear incidence and recovery rates	PLOS ONE			English	Article							TRANSMISSION DYNAMICS; BIFURCATIONS; OUTBREAK	The transmission of infectious diseases has been studied by mathematical methods since 1760s, among which SIR model shows its advantage in its epidemiological description of spread mechanisms. Here we established a modified SIR model with nonlinear incidence and recovery rates, to understand the influence by any government intervention and hospitalization condition variation in the spread of diseases. By analyzing the existence and stability of the equilibria, we found that the basic reproduction number R-0 is not a threshold parameter, and our model undergoes backward bifurcation when there is limited number of hospital beds. When the saturated coefficient a is set to zero, it is discovered that the model undergoes the Saddle-Node bifurcation, Hopf bifurcation, and Bogdanov-Takens bifurcation of codimension 2. The bifurcation diagram can further be drawn near the cusp type of the Bogdanov-Takens bifurcation of codimension 3 by numerical simulation. We also found a critical value of the hospital beds b(c) at R-0 < 1 and sufficiently small a, which suggests that the disease can be eliminated at the hospitals where the number of beds is larger than bc. The same dynamic behaviors exist even when a not equal 0. Therefore, it can be concluded that a sufficient number of the beds is critical to control the epidemic.	[Li, Gui-Hua; Zhang, Yong-Xin] North Univ China, Dept Math, Taiyuan 030051, Shanxi, Peoples R China	North University of China	Li, GH (corresponding author), North Univ China, Dept Math, Taiyuan 030051, Shanxi, Peoples R China.	liguihua@nuc.edu.cn			National Science Foundation of China [11331009]; Scientific Activities of Selected Returned Overseas Professionals in Shanxi Province; National Sciences Foundation of Shanxi Province [2015011009]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Activities of Selected Returned Overseas Professionals in Shanxi Province(Scientific Research Foundation for the Returned Overseas Chinese Scholars); National Sciences Foundation of Shanxi Province	This work is supported by the National Science Foundation of China (11331009), Research Project Supported by Fund Program for the Scientific Activities of Selected Returned Overseas Professionals in Shanxi Province and the National Sciences Foundation of Shanxi Province (2015011009).	Brauer F, 2001, MATHEMATICAL MODELS; Cui JA, 2008, ROCKY MT J MATH, V38, P1323, DOI 10.1216/RMJ-2008-38-5-1323; Cui JG, 2008, J DYN DIFFER EQU, V20, P31, DOI 10.1007/s10884-007-9075-0; DUMORTIER F, 1987, ERGOD THEOR DYN SYST, V7, P375, DOI 10.1017/S0143385700004119; Dushoff F, 1998, JOURNAL OF MATHEMATI, V36, P227; Gumel AB, 2004, P ROY SOC B-BIOL SCI, V271, P2223, DOI 10.1098/rspb.2004.2800; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Huang JC, 2014, J DIFFER EQUATIONS, V257, P1721, DOI 10.1016/j.jde.2014.04.024; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Li L, 2016, J BIOL SYST, V24, P519, DOI 10.1142/S0218339016500261; Li L, 2015, APPL MATH COMPUT, V258, P342, DOI 10.1016/j.amc.2015.02.006; Li MT, 2017, J MATH ANAL APPL, V446, P1292, DOI 10.1016/j.jmaa.2016.09.043; Li MT, 2014, APPL MATH COMPUT, V237, P582, DOI 10.1016/j.amc.2014.03.094; Liu R., 2007, COMP MATH MATH PHYS, V8, P153, DOI [10.1080/17486700701425870, DOI 10.1080/17486700701425870]; LIU WM, 1986, J MATH BIOL, V23, P187, DOI 10.1007/BF00276956; LIU WM, 1987, J MATH BIOL, V25, P359, DOI 10.1007/BF00277162; Shan CH, 2014, J DIFFER EQUATIONS, V257, P1662, DOI 10.1016/j.jde.2014.05.030; Sun GQ, 2017, COMMUN NONLINEAR SCI, V45, P235, DOI 10.1016/j.cnsns.2016.10.007; Sun GQ, 2014, APPL MATH COMPUT, V246, P336, DOI 10.1016/j.amc.2014.08.028; Tang SY, 2012, J THEOR BIOL, V295, P47, DOI 10.1016/j.jtbi.2011.10.035; Wang WD, 2004, J MATH ANAL APPL, V291, P775, DOI 10.1016/j.jmaa.2003.11.043; Wang W, 2006, MATH BIOSCI, V201, P58, DOI 10.1016/j.mbs.2005.12.022; Wu YF, 2016, J FRANKLIN I, V353, P4772, DOI 10.1016/j.jfranklin.2016.09.012; Xia ZQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13857; Xiao DM, 2007, MATH BIOSCI, V208, P419, DOI 10.1016/j.mbs.2006.09.025; Xiao Y., 2015, SCI REPORTS, V5; Zhang J, 2005, APPL MATH COMPUT, V162, P909, DOI 10.1016/j.amc.2003.12.131	27	35	35	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175789	10.1371/journal.pone.0175789	http://dx.doi.org/10.1371/journal.pone.0175789			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426775	Green Published, Green Submitted, gold			2022-12-26	WOS:000399875900046
J	Li, XH; Zhang, JL; Li, BF; Yi, DH; Zhang, CS; Sun, N; Lv, W; Jiao, A				Li, Xiaohang; Zhang, Jialin; Li, Baifeng; Yi, Dehui; Zhang, Chengshuo; Sun, Ning; Lv, Wu; Jiao, Ao			Diagnosis, treatment and prognosis of small bowel volvulus in adults: A monocentric summary of a rare small intestinal obstruction	PLOS ONE			English	Article							MIDGUT VOLVULUS; MALROTATION; MANAGEMENT	Objectives Small bowel volvulus is a rare disease, which is also challenging to diagnose. The aims of this study were to characterize the clinical and radiological features associated with small bowel volvulus and treatment and to identify risk factors for associated small bowel necrosis. Methods Patients with small bowel volvulus who underwent operations from January 2001 to December 2015 at the First Affiliated Hospital of China Medical University (Shenyang, China) were reviewed. Clinical, surgical and postsurgical data were registered and analyzed. Results Thirty-one patients were included for analysis. Fifteen patients were female (48.4%), with an average age of 47.7 years (18-79 years). The clinical signs and symptoms were unspecific and resembled intestinal obstruction. Clinical examination revealed abdominal distension and/or diffuse tenderness with or without signs of peritonitis. The use of CT scans, X-rays or ultrasound did not differ significantly between patients. In 9 of 20 patients that received abdominal CT scans, "whirlpool sign" on the CT scan was present. Secondary small bowel volvulus was present in 58.1% of patients, and causes included bands (3), adhesion (7), congenital anomalies (7) and stromal tumor (1). Out of the 31 patients, 15 with gangrenous small bowel had to undergo intestinal resection. Intestinal gangrene was present with higher neutrophils count (p< 0.0001) and the presence of bloody ascites (p = 0.004). Three patients died of septic shock (9.68%), and the recurrence rate was 3.23%. Conclusions To complete an early and accurate diagnosis, a CT scan plus physical exam seems to be the best plan. After diagnosis, an urgent laparotomy must be performed to avoid intestinal necrosis and perforation. After surgery, more than 90% of the patients can expect to have a favorable prognosis.	[Li, Xiaohang; Zhang, Jialin; Li, Baifeng; Yi, Dehui; Zhang, Chengshuo; Sun, Ning; Lv, Wu; Jiao, Ao] China Med Univ, Affiliated Hosp 1, Dept Gen Surg, Shenyang, Liaoning, Peoples R China	China Medical University	Zhang, JL (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Gen Surg, Shenyang, Liaoning, Peoples R China.	jlz2200@126.com						Birnbaum DJ, 2013, J EMERG MED, V44, pE329, DOI 10.1016/j.jemermed.2012.08.023; Brinda MAA, 2015, J CLIN DIAGN RES, V9, pPD08, DOI 10.7860/JCDR/2015/16252.6799; DUKE JH, 1977, ARCH SURG-CHICAGO, V112, P685; Gamblin T Clark, 2003, Curr Surg, V60, P517, DOI 10.1016/S0149-7944(03)00030-8; Gurleyik E, 1998, EUR J SURG, V164, P51, DOI 10.1080/110241598750004959; Huang JC, 2005, J GASTROEN HEPATOL, V20, P1906, DOI 10.1111/j.1440-1746.2005.03945.x; Iwuagwu O, 1999, J ROY COLL SURG EDIN, V44, P150; Kim KH, 2007, SURG LAPARO ENDO PER, V17, P335, DOI 10.1097/SLE.0b013e31806c7d04; Papadimitriou G, 2011, J GASTROINTEST SURG, V15, P1889, DOI 10.1007/s11605-011-1534-6; ROGGO A, 1992, ANN SURG, V216, P135, DOI 10.1097/00000658-199208000-00003; ROWSOM JT, 1987, J CLIN GASTROENTEROL, V9, P212, DOI 10.1097/00004836-198704000-00021; Ruiz-Tovar J, 2009, AM SURGEON, V75, P1179; Takemura M, 2000, J GASTROENTEROL, V35, P52, DOI 10.1007/PL00009976; Tamura J, 2014, WEST J EMERG MED, V15, P359, DOI 10.5811/westjem.2014.4.20679; Zheng ZH, 2014, INT J CLIN EXP MED, V7, P1614	15	14	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175866	10.1371/journal.pone.0175866	http://dx.doi.org/10.1371/journal.pone.0175866			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426721	Green Published, Green Submitted, gold			2022-12-26	WOS:000399875900060
J	Yaguchi, S; Yaguchi, S; Yagi-Yaguchi, Y; Kozawa, T; Bissen-Miyajima, H				Yaguchi, Saori; Yaguchi, Shigeo; Yagi-Yaguchi, Yukari; Kozawa, Tadahiko; Bissen-Miyajima, Hiroko			Objective classification of zonular weakness based on lens movement at the start of capsulorhexis	PLOS ONE			English	Article							CAPSULAR TENSION RINGS; INTRAOCULAR-LENS; CRYSTALLINE LENS; ANTERIOR CAPSULE; PHACOEMULSIFICATION; PSEUDOEXFOLIATION; IMPLANTATION; DISLOCATION; MANAGEMENT; CATARACT	Purpose To quantify zonular weakness based on lens movement at the start of continuous curvilinear capsulorhexis (CCC) and establish a classification system for it. Setting Kozawa Eye Hospital and Diabetes Center, Mito, Japan. Design Retrospective interventional case series. Methods We examined 402 consecutive eyes of 316 patients who underwent CCC, phacoemulsification and aspiration (PEA), and intraocular lens (IOL) implantation. The movement of the lens capsule was measured using images from video recordings of the CCC procedure. Zonular weakness was classified based on the shifted distance: Grade I, less than 0.20 mm; Grade II, 0.20-0.39 mm; and Grade III, greater than 0.40 mm. For each of these grades, we examined the use of the capsule stabilization device during PEA, the surgical procedure for lens removal, and IOL fixation. Results We classified 276 eyes (68.6%) as Grade I, 102 eyes (25.4%) as Grade II, and 24 eyes (6.0%) as Grade III. As the grade increased, the use of the capsule stabilization device in PEA and scleral suture fixation of IOL increased. Conclusions Zonular weakness was quantified by measuring the movement of the lens capsule. An objective classification of zonular weakness based on lens movement may be useful for selecting the appropriate device and procedure during cataract surgery.	[Yaguchi, Saori; Bissen-Miyajima, Hiroko] Tokyo Dent Coll Suidobashi Hosp, Dept Ophthalmol, Tokyo, Japan; [Yaguchi, Saori; Yaguchi, Shigeo; Kozawa, Tadahiko] Kozawa Eye Hosp & Diabet Ctr, Mito, Ibaraki, Japan; [Yagi-Yaguchi, Yukari] Ichikawa Gen Hosp, Tokyo Dent Coll, Dept Ophthalmol, Chiba, Japan	Tokyo Dental College; Tokyo Dental College	Yaguchi, S (corresponding author), Kozawa Eye Hosp & Diabet Ctr, Mito, Ibaraki, Japan.	yaguchis@hotmail.ca.jp	Negishi, Kazuno/AAG-3260-2021	Negishi, Kazuno/0000-0002-2892-9810				Ahmed IIK, 2005, OPHTHALMOLOGY, V112, P1725, DOI 10.1016/j.ophtha.2005.05.006; ASSIA EI, 1991, INVEST OPHTH VIS SCI, V32, P2835; Blecher MH, 2008, CURR OPIN OPHTHALMOL, V19, P31, DOI 10.1097/ICU.0b013e3282f2ccc8; Bron AJ, 1997, WOLFFS ANATOMY EYE O, P411; CANAVAN YM, 1982, BRIT J OPHTHALMOL, V66, P549, DOI 10.1136/bjo.66.9.549; HARA T, 1991, OPHTHALMIC SURG LAS, V22, P358; Hasanee K, 2006, CURR OPIN OPHTHALMOL, V17, P31; Hasanee Khalid, 2006, Ophthalmol Clin North Am, V19, P507; Hayashi H, 1998, BRIT J OPHTHALMOL, V82, P1429, DOI 10.1136/bjo.82.12.1429; Hoffman RS, 2013, J CATARACT REFR SURG, V39, P1904, DOI 10.1016/j.jcrs.2013.09.005; Jacob S, 2003, J CATARACT REFR SURG, V29, P315, DOI 10.1016/S0886-3350(02)01534-1; Ladewig MS, 2006, OPHTHALMOLOGE, V103, P777, DOI 10.1007/s00347-006-1386-8; Mackool RJ, 2009, J CATARACT REFR SURG, V35, P1323, DOI 10.1016/j.jcrs.2009.02.041; Najjar Dany M, 2011, J Med Case Rep, V5, P65, DOI 10.1186/1752-1947-5-65; Nishimura E, 2006, J CATARACT REFR SURG, V32, P392, DOI 10.1016/j.jcrs.2005.12.097; Peter NM, 2005, EUR J OPHTHALMOL, V15, P409, DOI 10.1177/112067210501500316; RAITTA C, 1986, ACTA OPHTHALMOL, V64, P130; ROSS R, 1969, J CELL BIOL, V40, P366, DOI 10.1083/jcb.40.2.366; Shingleton BJ, 2016, ACTA OPHTHALMOL; Shingleton BJ, 2009, J CATARACT REFR SURG, V35, P1101, DOI 10.1016/j.jcrs.2009.03.011; Soda M, 2015, J CATARACT REFR SURG, V41, P1132, DOI 10.1016/j.jcrs.2015.05.007; Yaguchi S, J CLIN EXP OPHTHALMO, V6, P407; Yaguchi S, 2011, J CATARACT REFR SURG, V37, P1386, DOI 10.1016/j.jcrs.2011.06.015; Yaguchi Y, J CLIN EXP OPHTHALMO, V7, P541; Yasuda A, 2000, AM J OPHTHALMOL, V130, P836, DOI 10.1016/S0002-9394(00)00630-9	25	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176169	10.1371/journal.pone.0176169	http://dx.doi.org/10.1371/journal.pone.0176169			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426745	Green Submitted, gold, Green Published			2022-12-26	WOS:000399875900114
J	Lopez-Cardona, AP; Perez-Cerezales, S; Fernandez-Gonzalez, R; Laguna-Barraza, R; Pericuesta, E; Agirregoitia, N; Gutierrez-Adan, A; Agirregoitia, E				Lopez-Cardona, Angela Patricia; Perez-Cerezales, Serafin; Fernandez-Gonzalez, Raul; Laguna-Barraza, Ricardo; Pericuesta, Eva; Agirregoitia, Naiara; Gutierrez-Adan, Alfonso; Agirregoitia, Ekaitz			CB1 cannabinoid receptor drives oocyte maturation and embryo development via PI3K/Akt and MAPK pathways	FASEB JOURNAL			English	Article						fertility; assisted reproductive technology; embryology	PROTEIN-KINASE-B; MEIOTIC MATURATION; MOUSE OOCYTES; ENDOCANNABINOID SYSTEM; MAMMALIAN OOCYTES; ANANDAMIDE LEVELS; ACTIVATION; EXPRESSION; OVARY; AKT	Endocannabinoids have been recognized as mediators of practically all reproductive events in mammals. However, little is known about the role of this system in oocyte maturation. In a mouse model, we observed that activation of cannabinoid receptor 1 (CB1) during in vitro oocyte maturation modulated the phosphorylation status of Akt and ERK1/2 and enhanced the subsequent embryo production. In the absence of CB1, in vivo oocyte maturation was impaired and embryo development delayed. Cannabinoid receptor 2 (CB2) was unable to rescue these effects. Finally, we confirmed abnormal oocyte maturation rather than impaired embryonic transport through the oviduct in CB1 knockouts. Our data suggest that cannabinoid agonists may be useful in vitro maturation supplements. For in vitro fertilization patients intolerant to gonadotropins, this could be a promising and only option.	[Lopez-Cardona, Angela Patricia; Perez-Cerezales, Serafin; Fernandez-Gonzalez, Raul; Laguna-Barraza, Ricardo; Pericuesta, Eva; Gutierrez-Adan, Alfonso] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Anim Reprod, Madrid, Spain; [Lopez-Cardona, Angela Patricia] Univ Antioquia, Grp Invest GI Biogenesis, Medellin, Colombia; [Agirregoitia, Naiara; Agirregoitia, Ekaitz] Univ Basque Country UPV EHU, Dept Physiol, Fac Med & Nursing, Leioa, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Universidad de Antioquia; University of Basque Country	Agirregoitia, E (corresponding author), Univ Basque Country, Dept Physiol, Fac Med & Nursing, Leioa, Bizkaia, Spain.	e.agirregoitia@ehu.eus	Gutierrez-Adan, Alfonso/A-1485-2014; Lopez-Cardona, Angela Patricia A/I-1111-2015; Perez-Cerezales, Serafin/F-8494-2014; Blanco, Leire/O-5114-2017	Gutierrez-Adan, Alfonso/0000-0001-9893-9179; Perez-Cerezales, Serafin/0000-0003-2119-6228; Fernandez Gonzalez, Raul/0000-0003-1989-2945; Lopez Cardona, Angela Patricia/0000-0003-4803-2557	Spanish Ministry of Science and Innovation [AGL2012-39652-C02-01, AGL2015-66145-R]; University of the Basque Country [GIU14/26]; Basque government [KK-2016/00026]; Universidad de Antioquia (COLCIENCIAS) through Francisco Jose de Caldas fellowship [512/2010]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); University of the Basque Country; Basque government(Basque Government); Universidad de Antioquia (COLCIENCIAS) through Francisco Jose de Caldas fellowship	This work received financial support from the Spanish Ministry of Science and Innovation (Grants AGL2012-39652-C02-01 and AGL2015-66145-R), University of the Basque Country (Grant GIU14/26), and the Basque government (KK-2016/00026). A.P.L.-C. acknowledges the financial support of the Universidad de Antioquia (COLCIENCIAS) through the Francisco Jose de Caldas fellowship (512/2010). The authors thank I. Galve-Roperh and G. Velasco (Universidad Complutense de Madrid, Madrid, Spain) for donating Cnr12/2 and Cnr22/2 mice which were used to set up a permanent colony and establish the Cnr12/2/Cnr22/2 double-KO mouse model in our laboratory. The authors also thank S. Giker (University of the Basque Country) for personal and technical support, and R. Andrade (University of the Basque Country) for his assistance with confocal microscopy analysis.	Agirregoitia E, 2016, CELL TISSUE RES, V365, P393, DOI 10.1007/s00441-016-2381-2; Agirregoitia E, 2015, FERTIL STERIL, V104, P753, DOI 10.1016/j.fertnstert.2015.06.013; Bagavandoss P, 2010, ANAT REC, V293, P1425, DOI 10.1002/ar.21181; Buckley  NE, 2000, EUR J PHARMACOL, V396, P141, DOI 10.1016/S0014-2999(00)00211-9; Cahill CM, 2007, TRENDS PHARMACOL SCI, V28, P23, DOI 10.1016/j.tips.2006.11.003; Cecconi S, 2014, EUR J OBSTET GYN R B, V178, P6, DOI 10.1016/j.ejogrb.2014.04.011; Cecconi S, 2012, INT J DEV BIOL, V56, P809, DOI 10.1387/ijdb.120146sc; Chang Eun Mi, 2014, Clin Exp Reprod Med, V41, P41, DOI 10.5653/cerm.2014.41.2.41; Chen J, 2013, NAT CELL BIOL, V15, P1415, DOI 10.1038/ncb2873; Chian RC, 2004, REPROD BIOMED ONLINE, V8, P148, DOI 10.1016/S1472-6483(10)60511-1; Coticchio G, 2015, HUM REPROD UPDATE, V21, P427, DOI 10.1093/humupd/dmv011; Coy P, 2008, REPRODUCTION, V135, P19, DOI 10.1530/REP-07-0280; Dalton GD, 2012, BRIT J PHARMACOL, V165, P2497, DOI 10.1111/j.1476-5381.2011.01455.x; El-Talatini MR, 2009, HUM REPROD, V24, P1989, DOI 10.1093/humrep/dep065; El-Talatini MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004579; Ernst J, 2016, MOL CELL ENDOCRINOL, V423, P67, DOI 10.1016/j.mce.2016.01.006; Freudzon L, 2005, J CELL BIOL, V171, P255, DOI 10.1083/jcb.200506194; Gebeh AK, 2012, J CLIN ENDOCR METAB, V97, P2827, DOI 10.1210/jc.2012-1780; Gutierrez-Adan A, 2000, TRANSGENIC RES, V9, P81, DOI 10.1023/A:1008926022370; Han SJ, 2005, CURR BIOL, V15, P1670, DOI 10.1016/j.cub.2005.07.056; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Kalinowski RR, 2003, DEV BIOL, V253, P139, DOI 10.1006/dbio.2002.0860; Kalous J, 2009, REPRODUCTION, V138, P645, DOI 10.1530/REP-08-0461; Kupka MS, 2014, HUM REPROD, V29, P2099, DOI 10.1093/humrep/deu175; Lopez-Cardona AP, 2016, REPRODUCTION, V152, P603, DOI 10.1530/REP-16-0199; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Mehlmann LM, 2005, REPRODUCTION, V130, P791, DOI 10.1530/rep.1.00793; Mehlmann LM, 2004, SCIENCE, V306, P1947, DOI 10.1126/science.1103974; Miller MR, 2016, SCIENCE, V352, P555, DOI 10.1126/science.aad6887; Moos J, 1996, J CELL SCI, V109, P739; Nader S, 2010, MINERVA ENDOCRINOL, V35, P211; Nikseresht M., 2015, J CLIN DIAGN RES, V9; Okumura E, 2002, NAT CELL BIOL, V4, P111, DOI 10.1038/ncb741; Paria BC, 2001, J BIOL CHEM, V276, P20523, DOI 10.1074/jbc.M100679200; Peralta L, 2011, REPROD BIOMED ONLINE, V23, P372, DOI 10.1016/j.rbmo.2011.05.011; Phillips KP, 2002, DEV BIOL, V247, P210, DOI 10.1006/dbio.2002.0680; Picton H, 1998, MOL CELL ENDOCRINOL, V145, P27, DOI 10.1016/S0303-7207(98)00166-X; QUINN P, 1982, J REPROD FERTIL, V66, P161; Rapino C, 2014, HUM REPROD UPDATE, V20, P501, DOI 10.1093/humupd/dmu004; REICH R, 1982, BIOL REPROD, V27, P223, DOI 10.1095/biolreprod27.1.223; Sanchez F, 2012, BBA-MOL BASIS DIS, V1822, P1896, DOI 10.1016/j.bbadis.2012.05.013; Schindler K, 2011, RESULTS PROBL CELL D, V53, P309, DOI 10.1007/978-3-642-19065-0_14; Schmitt A, 2002, J CELL SCI, V115, P2457; Schuel H, 2002, CHEM PHYS LIPIDS, V121, P211, DOI 10.1016/S0009-3084(02)00158-5; Schuel H, 2006, J CLIN INVEST, V116, P2087, DOI 10.1172/JCI29424; SHILLING F, 1989, DEV BIOL, V133, P605, DOI 10.1016/0012-1606(89)90063-8; Simonds WF, 1999, TRENDS PHARMACOL SCI, V20, P66, DOI 10.1016/S0165-6147(99)01307-3; Sun XF, 2012, ACS CHEM NEUROSCI, V3, P349, DOI 10.1021/cn300014e; Tomek W, 2005, REPRODUCTION, V130, P423, DOI 10.1530/rep.1.00754; Wang HB, 2006, ENDOCR REV, V27, P427, DOI 10.1210/er.2006-0006; Wang HB, 2004, NAT MED, V10, P1074, DOI 10.1038/nm1104; Wang HB, 2003, P NATL ACAD SCI USA, V100, P14914, DOI 10.1073/pnas.2436379100	52	32	33	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3372	3382		10.1096/fj.201601382RR	http://dx.doi.org/10.1096/fj.201601382RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28428264				2022-12-26	WOS:000405932400016
J	Cabrera, AR; Shirk, PD; Teal, PEA				Cabrera, Ana R.; Shirk, Paul D.; Teal, Peter E. A.			A feeding protocol for delivery of agents to assess development in Varroa mites	PLOS ONE			English	Article							APIS-MELLIFERA L; DEFORMED WING VIRUS; HONEY-BEE; JACOBSONI OUD; DESTRUCTOR ANDERSON; ECTOPARASITIC MITE; DRONE BROOD; HOST; WORKER; VITELLOGENESIS	A novel feeding protocol for delivery of bio-active agents to Varroa mites was developed by providing mites with honey bee larva hemolymph supplemented with cultured insect cells and selected materials delivered on a fibrous cotton substrate. Mites were starved, fed on treated hemolymph to deliver selected agents and then returned to bee larvae. Transcript levels of two reference genes, actin and glyceraldehyde 3-phosphate dehydrogenase (GAPDH), as well as for nine selected genes involved in reproductive processes showed that the starvation and feeding protocol periods did not pose a high level of stress to the mites as transcript levels remained comparable between phoretic mites and those completing the protocol. The feeding protocol was used to deliver molecules such as hormone analogs or plasmids. Mites fed with Tebufenozide, an ecdysone analog, had higher transcript levels of shade than untreated or solvent treated mites. In order to extend this feeding protocol, cultured insect cells were incorporated to a final ratio of 1 part cells and 2 parts hemolymph. Although supplementation with Bombyx mori Bm5 cells increased the amount of hemolymph consumed per mite, there was a significant decrease in the percentage of mites that fed and survived. On the other hand, Drosophila melanogaster S2 cells reduced significantly the percentage of mites that fed and survived as well as the amount of hemolymph consumed. The feeding protocol provides a dynamic platform with which to challenge the Varroa mite to establish efficacy of control agents for this devastating honey bee pest.	[Cabrera, Ana R.] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA; [Shirk, Paul D.; Teal, Peter E. A.] USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA; [Cabrera, Ana R.] Bayer CropSci, Res Triangle Pk, NC USA	State University System of Florida; University of Florida; United States Department of Agriculture (USDA); Bayer AG; Bayer CropScience	Shirk, PD (corresponding author), USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA.	paul.shirk@ars.usda.gov			USDA, ARS, Insect Behavior and Biocontrol Research Unit, Center for Medical Agricultural and Veterinary Entomology, Gainesville, FL; USDA, ARS, Chemistry Research Unit, Center for Medical Agricultural and Veterinary Entomology, Gainesville, FL	USDA, ARS, Insect Behavior and Biocontrol Research Unit, Center for Medical Agricultural and Veterinary Entomology, Gainesville, FL; USDA, ARS, Chemistry Research Unit, Center for Medical Agricultural and Veterinary Entomology, Gainesville, FL	Funding for this project came from the USDA, ARS, Insect Behavior and Biocontrol Research Unit and Chemistry Research Unit, Center for Medical Agricultural and Veterinary Entomology, Gainesville, FL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annoscia D, 2012, J INSECT PHYSIOL, V58, P1548, DOI 10.1016/j.jinsphys.2012.09.008; [Anonymous], 2015, COLONY LOSS 2014 201; BOOT WJ, 1995, APIDOLOGIE, V26, P109, DOI 10.1051/apido:19950204; BOOT WJ, 1994, EXP APPL ACAROL, V18, P371, DOI 10.1007/BF00116318; BOOT WJ, 1992, EXP APPL ACAROL, V16, P295, DOI 10.1007/BF01218571; Bossin H, 2007, INSECT MOL BIOL, V16, P37, DOI 10.1111/j.1365-2583.2006.00693.x; Bowen-Walker PL, 1999, J INVERTEBR PATHOL, V73, P101, DOI 10.1006/jipa.1998.4807; Bowen-Walker PL, 2001, ENTOMOL EXP APPL, V101, P207, DOI 10.1023/A:1019254727879; Brown MR, 2009, ANNU REV ENTOMOL, V54, P105, DOI 10.1146/annurev.ento.53.103106.093334; BRUCE WA, 1988, APIDOLOGIE, V19, P209, DOI 10.1051/apido:19880209; BRUCE WA, 1991, APIDOLOGIE, V22, P503, DOI 10.1051/apido:19910503; Cabrera AR, 2015, INSECT MOL BIOL, V24, P277, DOI 10.1111/imb.12155; Cabrera AR, 2013, INSECT MOL BIOL, V22, P505, DOI 10.1111/imb.12040; Cabrera AR, 2014, ARCH INSECT BIOCHEM, V85, P61, DOI 10.1002/arch.21143; Campbell EM, 2016, INSECT BIOCHEM MOLEC, V70, P116, DOI 10.1016/j.ibmb.2015.12.007; Campbell EM, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-73; Carlson G.R., 2000, ACS SYM SER, P8, DOI [10.1021/bk-2000-0767.ch002, DOI 10.1021/BK-2000-0767.CH002]; Cordon ARC, 2013, INSECT MOL BIOL, V22, P88, DOI 10.1111/imb.12006; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; DEGUZMAN LI, 1993, EXP APPL ACAROL, V17, P283, DOI 10.1007/BF02337278; Di Prisco G, 2016, P NATL ACAD SCI USA, V113, P3203, DOI 10.1073/pnas.1523515113; Dietemann V, 2012, J APICULT RES, V51, P125, DOI 10.3896/IBRA.1.51.1.15; Evans JD, 2011, TRENDS MICROBIOL, V19, P614, DOI 10.1016/j.tim.2011.09.003; Francis RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057540; Garedew A, 2004, APIDOLOGIE, V35, P419, DOI 10.1051/apido:2004032; Garrido C, 2000, APIDOLOGIE, V31, P559, DOI 10.1051/apido:2000146; Garrido C, 2003, EXP APPL ACAROL, V31, P269, DOI 10.1023/B:APPA.0000010386.10686.9f; Goblirsch M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058165, 10.1371/journal.pone.0069831]; Gromyko G., 1982, PCHELEVODSTVO, V5, P16; Hami M., 2005, Communications in Agricultural and Applied Biological Sciences, V70, P767; Hartwig A, 1987, P 31 INT C AP; Hunter WB, 2010, IN VITRO CELL DEV-AN, V46, P83, DOI 10.1007/s11626-009-9246-x; IFANTIDIS MD, 1983, J APICULT RES, V22, P200, DOI 10.1080/00218839.1983.11100588; KRAUS B, 1986, APIDOLOGIE, V17, P257, DOI 10.1051/apido:19860307; KRAUS B, 1993, J APICULT RES, V32, P57, DOI 10.1080/00218839.1993.11101288; Kuenen LPS, 1997, J INSECT BEHAV, V10, P213, DOI 10.1007/BF02765554; Le Conte Y, 2010, APIDOLOGIE, V41, P353, DOI 10.1051/apido/2010017; Lee KV, 2015, APIDOLOGIE, V46, P292, DOI 10.1007/s13592-015-0356-z; Macedo PA, 2002, J APICULT RES, V41, P3, DOI 10.1080/00218839.2002.11101062; Martin S, 1998, ECOL MODEL, V109, P267, DOI 10.1016/S0304-3800(98)00059-3; MARTIN SJ, 1994, EXP APPL ACAROL, V18, P87, DOI 10.1007/BF00055033; Martin SJ, 2001, J APPL ECOL, V38, P1082, DOI 10.1046/j.1365-2664.2001.00662.x; MARTIN SJ, 1995, EXP APPL ACAROL, V19, P199, DOI 10.1007/BF00130823; Martin SJ, 2013, J APICULT RES, V52; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Nazzi F, 2016, ANNU REV ENTOMOL, V61, P417, DOI 10.1146/annurev-ento-010715-023731; Ogihara K, 2007, GEN COMP ENDOCR, V150, P371, DOI 10.1016/j.ygcen.2006.09.007; Ogihara MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124953; Rees HH, 2004, PARASITOLOGY, V129, pS127, DOI 10.1017/S003118200400530X; REHM SM, 1989, APIDOLOGIE, V20, P339, DOI 10.1051/apido:19890406; Rewitz KF, 2007, INSECT BIOCHEM MOLEC, V37, P741, DOI 10.1016/j.ibmb.2007.02.012; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Ryabov EV, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004230; Sammataro D, 2000, ANNU REV ENTOMOL, V45, P519, DOI 10.1146/annurev.ento.45.1.519; Sanchez-Bayo F, 2016, ENVIRON INT, V89-90, P7, DOI 10.1016/j.envint.2016.01.009; Schafer MO, 2010, J ECON ENTOMOL, V103, P10, DOI 10.1603/EC09233; Shirk PD, 2007, INSECT MOL BIOL, V16, P623, DOI 10.1111/j.1365-2583.2007.00759.x; SHIRK PD, 1990, ARCH INSECT BIOCHEM, V15, P183, DOI 10.1002/arch.940150306; Singh NK, 2016, INSECT MOL BIOL, V25, P181, DOI 10.1111/imb.12212; SMAGGHE G, 1994, PESTIC SCI, V42, P85, DOI 10.1002/ps.2780420204; STEINER J, 1995, EXP APPL ACAROL, V19, P411, DOI 10.1007/BF00145158; STEINER J, 1994, INVERTEBR REPROD DEV, V25, P175, DOI 10.1080/07924259.1994.9672384; Tabart J, 2013, EXP APPL ACAROL, V61, P107, DOI 10.1007/s10493-013-9675-9; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; WEINBERG KP, 1985, APIDOLOGIE, V16, P421, DOI 10.1051/apido:19850407; Wilfert L, 2016, SCIENCE, V351, P594, DOI 10.1126/science.aac9976; Yang X, 2007, PARASITOLOGY, V134, P405, DOI 10.1017/S0031182006000710; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102	70	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176097	10.1371/journal.pone.0176097	http://dx.doi.org/10.1371/journal.pone.0176097			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448606	gold, Green Published, Green Submitted			2022-12-26	WOS:000400383600038
J	Kumari, A; Singh, D; Ramaswamy, S; Ramanathan, G				Kumari, Archana; Singh, Deepak; Ramaswamy, S.; Ramanathan, Gurunath			Structural and functional studies of ferredoxin and oxygenase components of 3-nitrotoluene dioxygenase from Diaphorobacter sp strain DS2	PLOS ONE			English	Article							ACTIVE-SITE RESIDUES; NAPHTHALENE DIOXYGENASE; 2-NITROTOLUENE DIOXYGENASE; NITROBENZENE DIOXYGENASE; SATURATION MUTAGENESIS; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; ALPHA-SUBUNIT; JS42; BIODEGRADATION	3-nitrotoluene dioxygenase (3NTDO) from Diaphorobacter sp. strain DS2 catalyses the conversion of 3-nitrotoluene (3NT) into a mixture of 3-and 4-methylcatechols with release of nitrite. We report here, X-ray crystal structures of oxygenase and ferredoxin components of 3NTDO at 2.9 angstrom and 2.4 angstrom, respectively. The residues responsible for nitrite release in 3NTDO were further probed by four single and two double mutations in the catalytic site of a-subunit of the dioxygenase. Modification of Val 350 to Phe, Ile 204 to Ala, and Asn258 to Val by site directed mutagenesis resulted in inactive enzymes revealing the importance of these residues in catalysis. Docking studies of meta nitrotoluene to the active site of 3NTDO suggested possible orientations of binding that favor the formation of 3-methylcatechol (3MC) over 4-methylcatechol energetically. The electron transfer pathway from ferredoxin subunit to the active site of the oxygenase subunit is also proposed.	[Kumari, Archana; Singh, Deepak; Ramanathan, Gurunath] Indian Inst Technol, Dept Chem, Kanpur, Uttar Pradesh, India; [Ramaswamy, S.] Tata Inst Fundamental Res, Inst Stem Cell Biol & Regenerat Med, Natl Ctr Biol Sci, Bangalore, Karnataka, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Ramanathan, G (corresponding author), Indian Inst Technol, Dept Chem, Kanpur, Uttar Pradesh, India.	gurunath@iitk.ac.in	Ramanathan, Gurunath/AAR-3650-2020; Subramanian, Ramaswamy/Q-8671-2019; Ramanathan, Gurunath/B-4757-2011	Ramanathan, Gurunath/0000-0003-4627-1677; Subramanian, Ramaswamy/0000-0002-6709-190X; Ramanathan, Gurunath/0000-0003-4627-1677; Kumari, Archana/0000-0003-4094-2521	DBT [BT/PR5801/INF/22/156/2012, BT/PR12422/MED/31/287/2014]	DBT(Department of Biotechnology (DBT) India)	Support was provided by DBT BT/PR5801/INF/22/156/2012 and BT/PR12422/MED/31/287/2014.; We thank the X-Ray facility at molecular biophysics unit, I.I.Sc., Bangalore for screening of crystals and thank Dr. Rosmarie Friemann for all data collection at ESRF. S. Ramaswamy would like to thank DBT for the grant on Rieske Oxygenases BT/PR5801/INF/22/156/2012 and B-Life Grant BT/PR12422/MED/31/287/2014. We thank the anonymous reviewers for their incisive comments.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ashikawa Y, 2006, STRUCTURE, V14, P1779, DOI 10.1016/j.str.2006.10.004; Brown EN, 2008, J BIOL INORG CHEM, V13, P1301, DOI 10.1007/s00775-008-0413-4; Carrell CJ, 1997, STRUCTURE, V5, P1613, DOI 10.1016/S0969-2126(97)00309-2; Colbert CL, 2000, STRUCTURE, V8, P1267, DOI 10.1016/S0969-2126(00)00536-0; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferraro DJ, 2006, J BACTERIOL, V188, P6986, DOI 10.1128/JB.00707-06; Ferraro DJ, 2005, BIOCHEM BIOPH RES CO, V338, P175, DOI 10.1016/j.bbrc.2005.08.222; Friemann R, 2005, J MOL BIOL, V348, P1139, DOI 10.1016/j.jmb.2005.03.052; Friemann R, 2009, ACTA CRYSTALLOGR D, V65, P24, DOI 10.1107/S0907444908036524; HAIGLER BE, 1994, APPL ENVIRON MICROB, V60, P3466, DOI 10.1128/AEM.60.9.3466-3469.1994; Iwata S, 1996, STRUCTURE, V4, P567, DOI 10.1016/S0969-2126(96)00062-7; Johnson GR, 2002, J BACTERIOL, V184, P4219, DOI 10.1128/JB.184.15.4219-4232.2002; Ju KS, 2010, MICROBIOL MOL BIOL R, V74, P250, DOI 10.1128/MMBR.00006-10; Ju KS, 2006, APPL ENVIRON MICROB, V72, P1817, DOI 10.1128/AEM.72.3.1817-1824.2006; Kauppi B, 1998, STRUCTURE, V6, P571, DOI 10.1016/S0969-2126(98)00059-8; Keenan BG, 2005, J BACTERIOL, V187, P3302, DOI 10.1128/JB.187.10.3302-3310.2005; Keenan BG, 2004, APPL ENVIRON MICROB, V70, P3222, DOI 10.1128/AEM.70.6.3222-3231.2004; Lee KS, 2005, J IND MICROBIOL BIOT, V32, P465, DOI 10.1007/s10295-005-0021-z; Leungsakul T, 2005, BIOTECHNOL BIOENG, V92, P416, DOI 10.1002/bit.20602; Macchiarulo A, 2007, BBA-PROTEINS PROTEOM, V1774, P1058, DOI 10.1016/j.bbapap.2007.06.007; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nam JW, 2005, PROTEINS, V58, P779, DOI 10.1002/prot.20374; NISHINO SF, 1995, APPL ENVIRON MICROB, V61, P2308, DOI 10.1128/AEM.61.6.2308-2313.1995; Nishino SF, 2000, APPL ENVIRON MICROB, V66, P2139, DOI 10.1128/AEM.66.5.2139-2147.2000; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Parales JV, 1996, GENE, V181, P57, DOI 10.1016/S0378-1119(96)00462-3; Parales JV, 1998, J BACTERIOL, V180, P1194, DOI 10.1128/JB.180.5.1194-1199.1998; Parales RE, 2005, APPL ENVIRON MICROB, V71, P3806, DOI 10.1128/AEM.71.7.3806-3814.2005; Parales RE, 1999, J BACTERIOL, V181, P1831, DOI 10.1128/JB.181.6.1831-1837.1999; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; Que L, 2000, NAT STRUCT BIOL, V7, P182, DOI 10.1038/73270; Singh D., 2015, WASTEWATER TREATMENT, P51, DOI [10.5772/61253, DOI 10.5772/61253]; Singh D, 2014, BIODEGRADATION, V25, P479, DOI 10.1007/s10532-013-9675-9; Singh D, 2014, BIOCHEM BIOPH RES CO, V445, P36, DOI 10.1016/j.bbrc.2014.01.113; Singh D, 2013, BIODEGRADATION, V24, P645, DOI 10.1007/s10532-012-9612-3; Suen WC, 1996, J BACTERIOL, V178, P4926, DOI 10.1128/jb.178.16.4926-4934.1996; Yu CL, 2001, J IND MICROBIOL BIOT, V27, P94, DOI 10.1038/sj.jim.7000168	40	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176398	10.1371/journal.pone.0176398	http://dx.doi.org/10.1371/journal.pone.0176398			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448625	gold, Green Submitted, Green Published			2022-12-26	WOS:000400383600074
J	Nahab, FB; Kundu, P; Maurer, C; Shen, Q; Hallett, M				Nahab, Fatta B.; Kundu, Prantik; Maurer, Carine; Shen, Qian; Hallett, Mark			Impaired sense of agency in functional movement disorders: An fMRI study	PLOS ONE			English	Article							SELF-AGENCY; PSYCHOGENIC TREMOR; EXPERIENCE; INTENTION; PERCEPTION; AWARENESS; NEUROLOGY; VOLITION; WILL	The sense of agency (SA) is an established framework that refers to our ability to exert and perceive control over our own actions. Having an intact SA provides the basis for the human perception of voluntariness, while impairments in SA are hypothesized to lead to the perception of movements being involuntary that may be seen many neurological or psychiatric disorders. Individuals with functional movement disorders (FMD) experience a lack of control over their movements, yet these movements appear voluntary by physiology. We used fMRI to explore whether alterations in SA in an FMD population could explain why these patients feel their movements are involuntary. We compared the FMD group to a control group that was previously collected using an ecologically valid, virtual-reality movement paradigm that could modulate SA. We found selective dysfunction of the SA neural network, whereby the dorsolateral prefrontal cortex and pre-supplementary motor area on the right did not respond differentially to the loss of movement control. These findings provide some of the strongest evidence to date for a physiological basis underlying these disabling disorders.	[Nahab, Fatta B.; Shen, Qian] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Kundu, Prantik] Mt Sinai Hosp, Dept Radiol, New York, NY 10029 USA; [Kundu, Prantik] Mt Sinai Hosp, Dept Psychiat, New York, NY 10029 USA; [Maurer, Carine; Hallett, Mark] NINDS, Human Motor Control Sect, Med Neurol Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA	University of California System; University of California San Diego; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); NIH National Institute of Neurological Disorders & Stroke (NINDS)	Nahab, FB (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	fnahab@ucsd.edu		Nahab, Fatta/0000-0002-2452-4939; Maurer, Carine/0000-0002-7892-7127	Intramural program of the National Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002667] Funding Source: NIH RePORTER	Intramural program of the National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by the Intramural program of the National Institute of Neurological Disorders and Stroke. No relevant conflicts of interest are present.	BATES JF, 1993, J COMP NEUROL, V336, P211, DOI 10.1002/cne.903360205; Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; Blakemore SJ, 2000, PSYCHOL MED, V30, P1131, DOI 10.1017/S0033291799002676; Brown P, 2001, MOVEMENT DISORD, V16, P595, DOI 10.1002/mds.1145; Cohen MS, 1997, NEUROIMAGE, V6, P93, DOI 10.1006/nimg.1997.0278; Edwards MJ, 2012, LANCET NEUROL, V11, P250, DOI 10.1016/S1474-4422(11)70310-6; Edwards MJ, 2011, NEUROPSYCHOLOGIA, V49, P2791, DOI 10.1016/j.neuropsychologia.2011.05.021; Fahn S, 1988, Adv Neurol, V50, P431; Farrer C, 2003, NEUROIMAGE, V18, P324, DOI 10.1016/S1053-8119(02)00041-1; Farrer C, 2002, NEUROIMAGE, V15, P596, DOI 10.1006/nimg.2001.1009; Farrer C, 2008, CEREB CORTEX, V18, P254, DOI 10.1093/cercor/bhm050; Fink GR, 1999, BRAIN, V122, P497, DOI 10.1093/brain/122.3.497; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Frith CD, 2000, PHILOS T R SOC B, V355, P1771, DOI 10.1098/rstb.2000.0734; Fukushima H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072267; Funk CM, 2009, HDB NEUROSCIENCE BEH, V1, P482; Haggard P, 2008, NAT REV NEUROSCI, V9, P934, DOI 10.1038/nrn2497; Hallett M, 2007, CLIN NEUROPHYSIOL, V118, P1179, DOI 10.1016/j.clinph.2007.03.019; Kang SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135261; Koechlin E, 2007, TRENDS COGN SCI, V11, P229, DOI 10.1016/j.tics.2007.04.005; Kranick S, 2011, MOVEMENT DISORD, V26, P1844, DOI 10.1002/mds.23830; Kranick SM, 2013, EXP BRAIN RES, V229, P313, DOI 10.1007/s00221-013-3399-2; Kuhn S, 2013, CORTEX, V49, P1935, DOI 10.1016/j.cortex.2012.09.002; Lau HC, 2004, SCIENCE, V303, P1208, DOI 10.1126/science.1090973; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; Maurer CW, 2016, NEUROLOGY, V87, P564, DOI 10.1212/WNL.0000000000002940; Metcalfe J, 2007, J EXP PSYCHOL GEN, V136, P184, DOI 10.1037/0096-3445.136.2.184; Morgante F, 2012, MOVEMENT DISORD, V27, P548, DOI 10.1002/mds.24903; Nahab FB, 2011, CEREB CORTEX, V21, P48, DOI 10.1093/cercor/bhq059; Parees I, 2014, BRAIN, V137, P2916, DOI 10.1093/brain/awu237; Parees I, 2012, BRAIN, V135, P117, DOI 10.1093/brain/awr292; Shibasaki H, 2006, CLIN NEUROPHYSIOL, V117, P2341, DOI 10.1016/j.clinph.2006.04.025; Shill H, 2006, MOVEMENT DISORD, V21, P1163, DOI 10.1002/mds.20921; Sirigu A, 1999, BRAIN, V122, P1867, DOI 10.1093/brain/122.10.1867; Spaniel F, 2016, SCHIZOPHRENIA BULL, V42, P916, DOI 10.1093/schbul/sbv188; Stone J, 2010, CLIN NEUROL NEUROSUR, V112, P747, DOI 10.1016/j.clineuro.2010.05.011; Taren AA, 2011, J NEUROSCI, V31, P5026, DOI 10.1523/JNEUROSCI.5762-10.2011; Voon V, 2010, NEUROLOGY, V74, P223, DOI 10.1212/WNL.0b013e3181ca00e9; Williams D T, 1995, Adv Neurol, V65, P231	39	34	35	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0172502	10.1371/journal.pone.0172502	http://dx.doi.org/10.1371/journal.pone.0172502			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448504	Green Published, gold			2022-12-26	WOS:000400383600001
J	Oh, TR; Kim, CS; Bae, EH; Ma, SK; Hang, SH; Sung, SA; Lee, K; Oh, KH; Ahn, C; Kim, SW				Oh, Tae Ryom; Kim, Chang Seong; Bae, Eun Hui; Ma, Seong Kwon; Hang, Seung Hyeok; Sung, Su-Ah; Lee, Kyubeck; Oh, Kook Hwan; Ahn, Curie; Kim, Soo Wan		KNOW-CKD Investigator Grp	Association between vitamin D deficiency and health-related quality of life in patients with chronic kidney disease from the KNOW-CKD study	PLOS ONE			English	Article							STAGE RENAL-DISEASE; MORTALITY; OUTCOMES	Vitamin D deficiency is a growing health problem in both the general population and in patients with chronic kidney disease (CKD). However, the relationship between serum 25 hydroxyvitamin D levels and health-related quality of life in CKD is not well established. This study examined the association between vitamin D deficiency and quality of life in pre-dialysis CKD patients. Serum 25 hydroxyvitamin D levels and the Korean version of the Kidney Disease Quality of Life short form were obtained for 1844 pre-dialysis CKD patients in the prospective KoreaN cohort Study for Outcomes in patients With Chronic Kidney Disease (KNOW-CKD). The baseline estimated glomerular filtration rate was 50.26 +/- 0.71 mL/min/ 1.73 m(2). We identified 1294 (70.2%) patients with vitamin D deficiency, defined as a 25 hydroxyvitamin D level < 20 ng/ml. The scores of the kidney disease component summary, physical component summary, and mental component summary in the vitamin D deficiency group were significantly lower compared to the scores of those without vitamin D deficiency. The serum 25 hydroxyvitamin D level was independently associated with the kidney disease component summary and mental component summary scores (beta= 0.147, p= 0.003 and beta= 0.151, p= 0.047). In conclusion, there was a significant association between serum 25 hydroxyvitamin D levels and kidney disease component summary and mental component summary scores in pre-dialysis CKD patients.	[Oh, Tae Ryom; Kim, Chang Seong; Bae, Eun Hui; Ma, Seong Kwon; Kim, Soo Wan] Chonnam Natl Univ, Med Sch, Dept Internal Med, Gwangju, South Korea; [Hang, Seung Hyeok] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Sung, Su-Ah] Eulji Univ, Dept Internal Med, Seoul, South Korea; [Lee, Kyubeck] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Internal Med, Seoul, South Korea; [Oh, Kook Hwan; Ahn, Curie] Seoul Natl Univ, Dept Internal Med, Seoul, South Korea	Chonnam National University; Yonsei University; Yonsei University Health System; Eulji University; Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU)	Kim, SW (corresponding author), Chonnam Natl Univ, Med Sch, Dept Internal Med, Gwangju, South Korea.	skimw@chonnam.ac.kr		Oh, Tae Ryom/0000-0002-3713-0939	Research of Korea Centers for Disease Control and Prevention [2011E3300300, 2012E3301100, 2013E3301600]; Pioneer Research Center Program through the National Research Foundation of Korea - Ministry of Science, ICT Future Planning [2014M3C1A3053036]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning [2016R1A2B4007870]	Research of Korea Centers for Disease Control and Prevention; Pioneer Research Center Program through the National Research Foundation of Korea - Ministry of Science, ICT Future Planning; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning	This research was supported by grants 2011E3300300, 2012E3301100 and 2013E3301600 from Research of Korea Centers for Disease Control and Prevention, by the Pioneer Research Center Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT &Future Planning (2014M3C1A3053036) and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and future Planning (2016R1A2B4007870). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2011, NEPHROL DIAL TRANSPL, V26, P3683, DOI 10.1093/ndt/gfr098; Andress D, 2007, DRUGS, V67, P1999, DOI 10.2165/00003495-200767140-00003; Bikle DD, 2008, CURR OPIN NEPHROL HY, V17, P348, DOI 10.1097/MNH.0b013e3282ff64a3; DeOreo PB, 1997, AM J KIDNEY DIS, V30, P204, DOI 10.1016/S0272-6386(97)90053-6; Fukuhara S, 2003, KIDNEY INT, V64, P1903, DOI 10.1046/j.1523-1755.2003.00289.x; Gordon PL, 2007, J RENAL NUTR, V17, P397, DOI 10.1053/j.jrn.2007.06.001; HAYS RD, 1994, QUAL LIFE RES, V3, P329, DOI 10.1007/BF00451725; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J INVEST MED, V59, P872, DOI 10.2310/JIM.0b013e318214ea2d; Korevaar JC, 2000, PERITON DIALYSIS INT, V20, P69; LaClair RE, 2005, AM J KIDNEY DIS, V45, P1026, DOI 10.1053/j.ajkd.2005.02.029; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Loos C, 2003, J AM GERIATR SOC, V51, P229, DOI 10.1046/j.1532-5415.2003.51062.x; Lowrie EG, 2003, AM J KIDNEY DIS, V41, P1286, DOI 10.1016/S0272-6386(03)00361-5; Madhan K, 2010, NEPHROLOGY, V15, pS32, DOI 10.1111/j.1440-1797.2010.01229.x; Mehrotra R, 2009, KIDNEY INT, V76, P977, DOI 10.1038/ki.2009.288; Mori A, 2013, CLIN DRUG INVEST, V33, P837, DOI 10.1007/s40261-013-0132-7; Oh KH, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-80; Park HJ, 2007, TOHOKU J EXP MED, V211, P321, DOI 10.1620/tjem.211.321; Rocco MV, 1997, AM J KIDNEY DIS, V29, P888, DOI 10.1016/S0272-6386(97)90463-7; Slominski AT, 2016, EXP DERMATOL, V25, P231, DOI 10.1111/exd.12872; Tong A, 2013, J PEDIATR-US, V163, P1179, DOI 10.1016/j.jpeds.2013.04.066; Urena-Torres P, 2011, AM J KIDNEY DIS, V58, P544, DOI 10.1053/j.ajkd.2011.04.029; Wang CW, 2016, CURR OSTEOPOROS REP, V14, P284, DOI 10.1007/s11914-016-0330-3; Yorifuji J, 2008, J CLIN ENDOCR METAB, V93, P1784, DOI 10.1210/jc.2007-2254	25	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0174282	10.1371/journal.pone.0174282	http://dx.doi.org/10.1371/journal.pone.0174282			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448520	gold, Green Published, Green Submitted			2022-12-26	WOS:000400383600004
J	Sun, WT; Yu, DD; Dong, ML; Zhao, J; Wang, XP; Zhang, HJ; Zhang, JF				Sun, Wenting; Yu, Dade; Dong, Mingliang; Zhao, Jian; Wang, Xiaoping; Zhang, Hongjing; Zhang, Jinfeng			Evaluation of efficiency of controlled pollination based parentage analysis in a Larix gmelinii var. principis-rupprechtii Mayr. seed orchard	PLOS ONE			English	Article							PEDIGREE RECONSTRUCTION; GENETIC DIVERSITY; CONTAMINATION; SUCCESS	Controlled pollination (CP) is an important tool for breeding programs to improve seed quality, as it rapidly generates desirable genotypes and maximizes genetic gains. However, few studies have evaluated the success rate of CP, especially in Larix gmelinii var. principis-rupprechtii Mayr. seed orchards. In this study, we estimated the rate of correct parentage in 257 CP progeny in an L. gmelinii var. principis-rupprechtii seed orchard from ten candidate parents using 13 microsatellites. The parentage exclusion probabilities of all combined loci in the single parent and parent pair tests were > 0.99, which was sufficient to distinguish the relatedness of the sampled individuals. Comparing the maximum likelihood-based parentage analysis results with breeding records revealed that the percentages of correctly identified maternal and paternal parents were 22.6% and 35.0% at 95% CL, respectively, suggestive of parent mislabeling and pollen contamination in the CP population. We conducted a pedigree reconstruction by identifying the expected parents and assigned maternity, paternity, and parent pairs to 176 (68.5%), 199 (77.4%), and 132 (51.4%) progeny, respectively. This study provides a reference for future selection of elite genotypes for commercial production. To increase the efficiency of CP, molecular markers should be used to correctly identify individuals in seed orchards before conducting CP.	[Sun, Wenting; Yu, Dade; Dong, Mingliang; Zhao, Jian; Zhang, Jinfeng] Beijing Forestry Univ, State Forestry Adm, Coll Biol Sci & Biotechnol, Natl Engn Lab Tree Breeding,Key Lab Genet & Biote, Beijing, Peoples R China; [Wang, Xiaoping] Beijing Municipal Bur Landscape & Forestry, Beijing, Peoples R China; [Zhang, Hongjing] Hebei Forestry Res Inst, Shijiazhuang, Peoples R China	Beijing Forestry University	Zhang, JF (corresponding author), Beijing Forestry Univ, State Forestry Adm, Coll Biol Sci & Biotechnol, Natl Engn Lab Tree Breeding,Key Lab Genet & Biote, Beijing, Peoples R China.	zjf@bjfu.edu.cn	wang, xiao/HGB-7081-2022	wang, xiao/0000-0002-4088-3341	Medium and Long Scientific Research Project for Young Teachers in Beijing Forestry University [2015ZCQ-SW-02]; Program for Changjiang Scholars and Innovative Research Team in University [IRT13047]; Project of National Natural Science Foundation of China [31370658]; Project of Beijing Gardening and Greening Bureau [CEG-2016-01-3]; Project of Hebei Science and Technology [16226309D]	Medium and Long Scientific Research Project for Young Teachers in Beijing Forestry University; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Beijing Gardening and Greening Bureau; Project of Hebei Science and Technology	This work was supported by Medium and Long Scientific Research Project for Young Teachers in Beijing Forestry University (2015ZCQ-SW-02); the Program for Changjiang Scholars and Innovative Research Team in University (IRT13047); the Project of National Natural Science Foundation of China (No.31370658); the Project of Beijing Gardening and Greening Bureau (CEG-2016-01-3); the Project of Hebei Science and Technology (16226309D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai C, 2004, STUDIES GENETIC DIVE; Alcaraz ML, 2014, SCI HORTIC-AMSTERDAM, V180, P79, DOI 10.1016/j.scienta.2014.10.022; Blouin MS, 2003, TRENDS ECOL EVOL, V18, P503, DOI 10.1016/S0169-5347(03)00225-8; Di XY, 2014, BIOCHEM SYST ECOL, V54, P71, DOI 10.1016/j.bse.2013.12.035; Dinarti D, 2015, BREEDING SCI, V65, P438, DOI 10.1270/jsbbs.65.438; Dong ML, 2016, GENETIC DIVERSITY PO, V17, P616; Doyle J. J., 1987, PHYTOCHEM B, P11; El-Kassaby YA, 1986, SILVAE GENETIC, V35, P5; El-Kassaby YA, 1989, SCAND J FOREST RES, V4, P41, DOI 10.1080/02827588909382544; El-Kassaby YA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025737; El-Kassaby YA, 2010, J HERED, V101, P164, DOI 10.1093/jhered/esp126; [范英明 Fan Yingming], 2014, [植物遗传资源学报, Journal of Plant Genetic Resources], V15, P465; Fernandes L, 2008, ANN FOREST SCI, V65, DOI 10.1051/forest:2008049; Funda T, 2014, CAN J FOREST RES, V44, P1; Funda T, 2008, ANN FOREST SCI, V65, DOI 10.1051/forest:2008055; Funda T, 2011, CAN J FOREST RES, V41, P380, DOI 10.1139/X10-190; Grattapaglia D, 2014, TREE GENET GENOMES, V10, P1631, DOI 10.1007/s11295-014-0784-3; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Lai BS, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2010044; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Namkoong G., 1988, MONOGRAPHS THEORETIC; Nishio S, 2014, TREE GENET GENOMES, V10, P1171, DOI 10.1007/s11295-014-0751-z; Padi FK, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0875-9; Plomion C, 2001, CAN J FOREST RES, V31, P1816, DOI 10.1139/cjfr-31-10-1816; Qu BL, 2015, HEBEI J FORESTRY ORC, V1, P41; Summers K, 1997, BEHAV ECOL, V8, P260, DOI 10.1093/beheco/8.3.260; Tan Xiao-Mei, 2011, Chinese Journal of Plant Ecology, V35, P937, DOI 10.3724/SP.J.1258.2011.00937; Tarn TR, 1992, BREEDING POTATOES LO; Telfer EJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130601; Torimaru T. X, 2009, SILVAE GENET, V58, P5; Bonine CAV, 2015, SCI FOR, V43, P657; Wang H, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-014-0804-3; Wang SQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099842; Wang XR, 2010, TREE GENET GENOMES, V6, P227, DOI 10.1007/s11295-009-0243-8; Weinman LR, 2015, MOL ECOL RESOUR, V15, P502, DOI 10.1111/1755-0998.12330; Xin S, 2009, STUDIES PARENTAGE CO; Yeh F, 2000, MICROSOFT WINDOWS BA; [于大德 Yu Dade], 2014, [植物遗传资源学报, Journal of Plant Genetic Resources], V15, P940; Yu DD, 2014, GENETIC DIVERSITY PA; Zhang DM, 2009, CHINESE J PLANT ECOL, V33; Zhao JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123694	41	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176483	10.1371/journal.pone.0176483	http://dx.doi.org/10.1371/journal.pone.0176483			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448554	Green Submitted, Green Published, gold			2022-12-26	WOS:000400383600087
J	Tymecka-Mulik, J; Boss, L; Maciag-Dorszynska, M; Rodrigues, JFM; Gaffke, L; Wosinski, A; Cech, GM; Szalewska-Palasz, A; Wegrzyn, G; Glinkowska, M				Tymecka-Mulik, Joanna; Boss, Lidia; Maciag-Dorszynska, Monika; Rodrigues, Joao F. Matias; Gaffke, Lidia; Wosinski, Anna; Cech, Grzegorz M.; Szalewska-Palasz, Agnieszka; Wegrzyn, Grzegorz; Glinkowska, Monika			Suppression of the Escherichia coli dnaA46 mutation by changes in the activities of the pyruvate-acetate node links DNA replication regulation to central carbon metabolism	PLOS ONE			English	Article							CELL-SIZE; ACETYL-PHOSPHATE; GENE KNOCKOUT; E. COLI; CHROMOSOME-REPLICATION; PROTEIN ACETYLATION; LYSINE ACETYLATION; ENZYME-ACTIVITIES; INITIATION; CYCLE	To ensure faithful transmission of genetic material to progeny cells, DNA replication is tightly regulated, mainly at the initiation step. Escherichia coli cells regulate the frequency of initiation according to growth conditions. Results of the classical, as well as the latest studies, suggest that the DNA replication in E. coli starts at a predefined, constant cell volume per chromosome but the mechanisms coordinating DNA replication with cell growth are still not fully understood. Results of recent investigations have revealed a role of metabolic pathway proteins in the control of cell division and a direct link between metabolism and DNA replication has also been suggested both in Bacillus subtilis and E. coli cells. In this work we show that defects in the acetate overflow pathway suppress the temperature-sensitivity of a defective replication initiator-DnaA under acetogenic growth conditions. Transcriptomic and metabolic analyses imply that this suppression is correlated with pyruvate accumulation, resulting from alterations in the pyruvate dehydrogenase (PDH) activity. Consequently, deletion of genes encoding the pyruvate dehydrogenase subunits likewise resulted in suppression of the thermal-sensitive growth of the dnaA46 strain. We propose that the suppressor effect may be directly related to the PDH complex activity, providing a link between an enzyme of the central carbon metabolism and DNA replication.	[Tymecka-Mulik, Joanna; Gaffke, Lidia; Wosinski, Anna; Wegrzyn, Grzegorz] Univ Gdansk, Dept Mol Biol, Gdansk, Poland; [Boss, Lidia; Maciag-Dorszynska, Monika; Cech, Grzegorz M.; Szalewska-Palasz, Agnieszka; Glinkowska, Monika] Univ Gdansk, Dept Bacterial Mol Genet, Gdansk, Poland; [Rodrigues, Joao F. Matias] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; University of Gdansk; University of Zurich	Glinkowska, M (corresponding author), Univ Gdansk, Dept Bacterial Mol Genet, Gdansk, Poland.	monika.glinkowska@biol.ug.edu.pl	Gaffke, Lidia/AAV-1526-2021; Wegrzyn, Grzegorz/AAL-1179-2020; Tymecka-Mulik, Joanna/AGW-8508-2022; Wegrzyn, Grzegorz/ABD-6699-2020; Szalewska-Palasz, Agnieszka/AAI-4826-2020; Boss, Lidia/ACW-3955-2022	Gaffke, Lidia/0000-0002-0820-7204; Wegrzyn, Grzegorz/0000-0003-4042-7466; Boss, Lidia/0000-0002-0748-4429; Cech, Grzegorz M./0000-0001-8055-4262; Szalewska-Palasz, Agnieszka/0000-0001-8013-4057; Maciag-Dorszynska, Monika/0000-0002-1734-5721; Matias Rodrigues, Joao F/0000-0001-8413-9920	National Science Center [UMO-2012/04/M/NZ2/00122, NCN 2012/05/N/NZ1/00535]	National Science Center(National Science Centre, Poland)	This work was supported by the National Science Center grants: UMO-2012/04/M/NZ2/00122 (G.W.) and NCN 2012/05/N/NZ1/00535 (M.M.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranovich A, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150175; ATLUNG T, 1984, MOL GEN GENET, V197, P125, DOI 10.1007/BF00327932; Baba Tomoya, 2008, V416, P171, DOI 10.1007/978-1-59745-321-9_11; Basan M, 2015, NATURE, V528, P99, DOI 10.1038/nature15765; Battesti A, 2015, P NATL ACAD SCI USA, V112, P5159, DOI 10.1073/pnas.1504639112; Beaufay F, 2015, EMBO J, V34, P1786, DOI 10.15252/embj.201490730; Berrios- Rivera SJ, 2002, METAB ENG, V4, P238, DOI 10.1006/mben.2002.0229; Blot N, 2006, EMBO REP, V7, P710, DOI 10.1038/sj.embor.7400729; Bordes P, 2003, MOL MICROBIOL, V48, P561, DOI 10.1046/j.1365-2958.2003.03461.x; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Carr KM, 1996, MOL MICROBIOL, V20, P1307, DOI 10.1111/j.1365-2958.1996.tb02649.x; Chang DE, 1999, J BACTERIOL, V181, P6656, DOI 10.1128/JB.181.21.6656-6663.1999; Chien AC, 2012, MOL MICROBIOL, V86, P594, DOI 10.1111/mmi.12007; COOPER S, 1968, J MOL BIOL, V31, P519, DOI 10.1016/0022-2836(68)90425-7; DONACHIE WD, 1968, NATURE, V219, P1077, DOI 10.1038/2191077a0; El-Mansi M, 2005, RES MICROBIOL, V156, P874, DOI 10.1016/j.resmic.2005.04.008; Flatten I, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005276; Fujimitsu K, 2009, GENE DEV, V23, P1221, DOI 10.1101/gad.1775809; GENTRY DR, 1993, J BACTERIOL, V175, P7982, DOI 10.1128/JB.175.24.7982-7989.1993; Glinkowska M, 2001, MICROBIOL-SGM, V147, P1923, DOI 10.1099/00221287-147-7-1923; Haeusser DP, 2008, CURR OPIN MICROBIOL, V11, P94, DOI 10.1016/j.mib.2008.02.008; Hill NS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003663; Hommais F, 2004, MICROBIOL-SGM, V150, P61, DOI 10.1099/mic.0.26659-0; Huergo LF, 2015, MICROBIOL MOL BIOL R, V79, P419, DOI 10.1128/MMBR.00038-15; Jameson KH, 2017, GENES-BASEL, V8, DOI 10.3390/genes8010022; Janniere L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000447; JENSEN KF, 1993, J BACTERIOL, V175, P3401, DOI 10.1128/jb.175.11.3401-3407.1993; Kasho K, 2013, P NATL ACAD SCI USA, V110, P936, DOI 10.1073/pnas.1212070110; Katayama T, 1998, CELL, V94, P61, DOI 10.1016/S0092-8674(00)81222-2; Kato J, 2001, EMBO J, V20, P4253, DOI 10.1093/emboj/20.15.4253; Keyamura K, 2007, GENE DEV, V21, P2083, DOI 10.1101/gad.1561207; Kim Y, 2008, J BACTERIOL, V190, P3851, DOI 10.1128/JB.00104-08; Kirkpatrick C, 2001, J BACTERIOL, V183, P6466, DOI 10.1128/JB.183.21.6466-6477.2001; Klein AH, 2007, J BACTERIOL, V189, P5574, DOI 10.1128/JB.00564-07; Kondo T, 2000, BIOCHEM J, V348, P375, DOI 10.1042/0264-6021:3480375; Kuhn ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094816; LAFFAN JJ, 1988, P NATL ACAD SCI USA, V85, P7452, DOI 10.1073/pnas.85.20.7452; Leonard AC, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00545; Li M, 2006, J BIOTECHNOL, V122, P254, DOI 10.1016/j.jbiotec.2005.09.016; Likhoshvai VA, 2014, J BIOINF COMPUT BIOL, V12, DOI 10.1142/S0219720014500097; Liu F, 2014, PLOS ONE, V9; LOUARN J, 1984, MOL GEN GENET, V195, P170, DOI 10.1007/BF00332741; LU M, 1994, CELL, V77, P413, DOI 10.1016/0092-8674(94)90156-2; Maciag M, 2012, MUTAT RES-FUND MOL M, V731, P99, DOI 10.1016/j.mrfmmm.2011.12.005; Maciag M, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-19; MEURY J, 1991, J BACTERIOL, V173, P4404, DOI 10.1128/JB.173.14.4404-4410.1991; Monahan LG, 2016, TRENDS MICROBIOL, V24, P181, DOI 10.1016/j.tim.2015.11.007; Monahan LG, 2014, MBIO, V5, DOI 10.1128/mBio.00935-14; Murray H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004731; Noirot-Gros MF, 2002, P NATL ACAD SCI USA, V99, P8342, DOI 10.1073/pnas.122040799; Nozaki S, 2009, GENES CELLS, V14, P329, DOI 10.1111/j.1365-2443.2008.01269.x; Nyborg M, 2000, MOL MICROBIOL, V35, P1202, DOI 10.1046/j.1365-2958.2000.01790.x; Oh MK, 2002, J BIOL CHEM, V277, P13175, DOI 10.1074/jbc.M110809200; Ohba A, 1997, FEBS LETT, V404, P125, DOI 10.1016/S0014-5793(97)00108-7; Ojima Y, 2012, BIOTECHNOL LETT, V34, P889, DOI 10.1007/s10529-011-0842-y; Rabinowitz JD, 2007, ANAL CHEM, V79, P6167, DOI 10.1021/ac070470c; Radhakrishnan SK, 2010, DEV CELL, V18, P90, DOI 10.1016/j.devcel.2009.10.024; Rahman M, 2006, BIOTECHNOL BIOENG, V94, P585, DOI 10.1002/bit.20858; Saxena R, 2013, INT J MOL SCI, V14, P8517, DOI 10.3390/ijms14048517; Schilling B, 2015, MOL MICROBIOL, V98, P847, DOI 10.1111/mmi.13161; Sevin DC, 2014, NAT CHEM BIOL, V10, P266, DOI 10.1038/nchembio.1437; Shi ZY, 2014, PROTEIN CELL, V5, P761, DOI 10.1007/s13238-014-0074-8; Speck C, 1999, EMBO J, V18, P6169, DOI 10.1093/emboj/18.21.6169; Stein A, 2000, J BACTERIOL, V182, P2119, DOI 10.1128/JB.182.8.2119-2124.2000; Takada H, 2014, MOL MICROBIOL, V91, P242, DOI 10.1111/mmi.12457; Traxler MF, 2011, MOL MICROBIOL, V79, P830, DOI 10.1111/j.1365-2958.2010.07498.x; Wallden M, 2016, CELL, V166, P729, DOI 10.1016/j.cell.2016.06.052; Wang JD, 2009, NAT REV MICROBIOL, V7, P822, DOI 10.1038/nrmicro2202; Weart RB, 2007, CELL, V130, P335, DOI 10.1016/j.cell.2007.05.043; Weinert BT, 2013, MOL CELL, V51, P265, DOI 10.1016/j.molcel.2013.06.003; Wolfe AJ, 2003, MOL MICROBIOL, V48, P977, DOI 10.1046/j.1365-2958.2003.03457.x; Wolfe AJ, 2016, CURR GENET, V62, P335, DOI 10.1007/s00294-015-0552-4; Yao ZZ, 2012, P NATL ACAD SCI USA, V109, pE2561, DOI 10.1073/pnas.1209742109; Zhang QF, 2016, SCI REP-UK, V6, DOI 10.1038/srep30837; Zheng H, 2016, P NATL ACAD SCI USA, V113, P15000, DOI 10.1073/pnas.1617932114	75	11	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176050	10.1371/journal.pone.0176050	http://dx.doi.org/10.1371/journal.pone.0176050			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448512	Green Published, gold			2022-12-26	WOS:000400383600034
J	List, A; Rosenberg, MD; Sherman, A; Esterman, M				List, Alexandra; Rosenberg, Monica D.; Sherman, Aleksandra; Esterman, Michael			Pattern classification of EEG signals reveals perceptual and attentional states	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; HUMAN BRAIN; DECISION-MAKING; ELECTROPHYSIOLOGICAL EVIDENCE; NEURAL MECHANISMS; WORKING-MEMORY; MODULATION; STIMULI; HUMANS; FMRI	Pattern classification techniques have been widely used to differentiate neural activity associated with different perceptual, attentional, or other cognitive states, often using fMRI, but more recently with EEG as well. Although these methods have identified EEG patterns (i.e., scalp topographies of EEG signals occurring at certain latencies) that decode perceptual and attentional states on a trial-by-trial basis, they have yet to be applied to the spatial scope of attention toward global or local features of the display. Here, we initially used pattern classification to replicate and extend the findings that perceptual states could be reliably decoded from EEG. We found that visual perceptual states, including stimulus location and object category, could be decoded with high accuracy peaking between 125-250 ms, and that the discriminative spatiotemporal patterns mirrored and extended our (and other well-established) ERP results. Next, we used pattern classification to investigate whether spatiotemporal EEG signals could reliably predict attentional states, and particularly, the scope of attention. The EEG data were reliably differentiated for local versus global attention on a trial- by- trial basis, emerging as a specific spatiotemporal activation pattern over posterior electrode sites during the 250-750 ms interval after stimulus onset. In sum, we demonstrate that multivariate pattern analysis of EEG, which reveals unique spatiotemporal patterns of neural activity distinguishing between behavioral states, is a sensitive tool for characterizing the neural correlates of perception and attention.	[List, Alexandra] Hamilton Coll, Dept Psychol, Clinton, NY 13323 USA; [List, Alexandra] Hamilton Coll, Neurosci Program, Clinton, NY 13323 USA; [Rosenberg, Monica D.] Yale Univ, Dept Psychol, New Haven, CT USA; [Sherman, Aleksandra] Occidental Coll, Dept Cognit Sci, Los Angeles, CA 90041 USA; [Esterman, Michael] VA Boston Healthcare Syst, Res Serv, Boston, MA USA; [Esterman, Michael] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA	Hamilton College; Hamilton College; Yale University; Occidental College; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University	List, A (corresponding author), Hamilton Coll, Dept Psychol, Clinton, NY 13323 USA.; List, A (corresponding author), Hamilton Coll, Neurosci Program, Clinton, NY 13323 USA.	alist@hamilton.edu	Rosenberg, Monica D./J-6487-2019	Rosenberg, Monica D./0000-0001-6179-4025	National Institutes of Health [R01 EY018197-0251]; National Science Foundation Graduate Research Fellowship; Veterans Affairs Clinical Science Research and Development Career Development Award [1IK2CX000706-01A2]; Veterans Affairs [IK2CX000706] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Veterans Affairs Clinical Science Research and Development Career Development Award; Veterans Affairs(US Department of Veterans Affairs)	National Institutes of Health R01 EY018197-0251 (supported AL); National Science Foundation Graduate Research Fellowship (to MR); Veterans Affairs Clinical Science Research and Development Career Development Award 1IK2CX000706-01A2 (to ME). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREASSI JL, 1975, PSYCHOPHYSIOLOGY, V12, P541, DOI 10.1111/j.1469-8986.1975.tb00043.x; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; Blank H, 2013, J NEUROSCI, V33, P3939, DOI 10.1523/JNEUROSCI.4151-12.2013; Busch NA, J NEUROSCIENCE, V29, P7869; Capotosto P, 2009, J NEUROSCI, V29, P5863, DOI 10.1523/JNEUROSCI.0539-09.2009; Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; Das K, 2010, ADV UNDERSTANDING HU; Das K, 2010, NEUROIMAGE, V51, P1425, DOI 10.1016/j.neuroimage.2010.03.030; Delorme A, 2010, J NEUROSCI METH, V134, P9; Esterman M, 2009, P NATL ACAD SCI USA, V106, P17974, DOI 10.1073/pnas.0903593106; Foster JJ, 2016, J NEUROPHYSIOL, V115, P168, DOI 10.1152/jn.00860.2015; Fries P, 2015, NEURON, V88, P220, DOI 10.1016/j.neuron.2015.09.034; Garcia JO, 2013, CURR BIOL, V23, P515, DOI 10.1016/j.cub.2013.02.013; Georghiades AS, 2001, IEEE T PATTERN ANAL, V23, P643, DOI 10.1109/34.927464; Han SH, 2006, BRAIN RES, V1076, P193, DOI 10.1016/j.brainres.2006.01.028; Harris AM, 2017, NEUROIMAGE, V152, P171, DOI 10.1016/j.neuroimage.2017.03.008; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; HEINZE HJ, 1993, NEUROPSYCHOLOGIA, V31, P841, DOI 10.1016/0028-3932(93)90132-J; Hjorth B., 1980, AM J EEG TECHNOL, P121, DOI 10.1080/00029238.1980.11080015; Jiang Y, 2005, CLIN NEUROPHYSIOL, V116, P1444, DOI 10.1016/j.clinph.2005.02.014; Johannes S, 1996, NEUROSCI LETT, V210, P111, DOI 10.1016/0304-3940(96)12686-0; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kasper R., 2010, ADV UNDERSTANDING HU, P42; Ke YF, 2014, BIO-MED MATER ENG, V24, P349, DOI 10.3233/BME-130817; Landau AN, 2015, CURR BIOL, V25, P2332, DOI 10.1016/j.cub.2015.07.048; Lee TS, 1998, VISION RES, V38, P2429, DOI 10.1016/S0042-6989(97)00464-1; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P1000, DOI 10.1037/0096-1523.20.5.1000; Luck SJ., 2012, OXFORD HDB EVENT REL, P329; LUCK Steven J., INTRO EVENT RELATED; MANGUN GR, 1995, PSYCHOPHYSIOLOGY, V32, P4, DOI 10.1111/j.1469-8986.1995.tb03400.x; Mathewson KE, 2011, PSYCHOPHYSIOLOGY, V48, pS50; Mossbridge JA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00655; Naselaris T, 2011, NEUROIMAGE, V56, P400, DOI 10.1016/j.neuroimage.2010.07.073; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Philiastides MG, 2006, J NEUROSCI, V26, P8965, DOI 10.1523/JNEUROSCI.1655-06.2006; Philiastides MG, 2006, CEREB CORTEX, V16, P509, DOI 10.1093/cercor/bhi130; Proverbio AM, 1998, COGNITIVE BRAIN RES, V6, P321, DOI 10.1016/S0926-6410(97)00039-6; Ratcliff R, 2009, P NATL ACAD SCI USA, V106, P6539, DOI 10.1073/pnas.0812589106; ROBSON JG, 1966, J OPT SOC AM, V56, P1141, DOI 10.1364/JOSA.56.001141; ROCKLAND KS, 1994, CEREB CORTEX, V4, P300, DOI 10.1093/cercor/4.3.300; Rossion B., 2012, OXFORD HDB EVENT REL, P115, DOI DOI 10.1093/OXFORDHB/9780195374148.013.0064; Rossion B, 2008, NEUROIMAGE, V39, P1959, DOI 10.1016/j.neuroimage.2007.10.011; Rossion Bruno, 2002, Behav Cogn Neurosci Rev, V1, P63, DOI 10.1177/1534582302001001004; RUGG MD, 1984, NEUROPSYCHOLOGIA, V22, P215, DOI 10.1016/0028-3932(84)90064-2; Simpson WA, 2005, NEUROSCI LETT, V375, P23, DOI 10.1016/j.neulet.2004.10.059; Smulders F.T.Y., 2012, OXFORD HDB EVENT REL, P209; Tang AC, 2005, NEUROIMAGE, V25, P539, DOI 10.1016/j.neuroimage.2004.11.027; Tenke CE, 2012, CLIN NEUROPHYSIOL, V123, P2328, DOI 10.1016/j.clinph.2012.06.005; Thiery T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160304; Tong F, 2012, ANNU REV PSYCHOL, V63, P483, DOI 10.1146/annurev-psych-120710-100412; Treder MS, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/2/026009; Treder MS, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-28; VANNES FL, 1967, J OPT SOC AM, V57, P401, DOI 10.1364/JOSA.57.000401; VanRullen R, 2005, P NATL ACAD SCI USA, V102, P5291, DOI 10.1073/pnas.0409172102; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Xu YQ, 2013, PSYCHOL SCI, V24, P1368, DOI 10.1177/0956797612471685; Yamaguchi S, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-09-j0002.2000; Yovel G, 2005, CURR BIOL, V15, P2256, DOI 10.1016/j.cub.2005.10.072; Zhang D, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/1/016010; Zipser K, 1996, J NEUROSCI, V16, P7376	61	9	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176349	10.1371/journal.pone.0176349	http://dx.doi.org/10.1371/journal.pone.0176349			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FI	28445551	Green Submitted, Green Published, gold			2022-12-26	WOS:000400309200050
J	Sanchis, MLB; Cesani, MF; Oyhenart, EE				Bergel Sanchis, Maria Laura; Florencia Cesani, Maria; Edith Oyhenart, Evelia			Contexts of occurrence of child malnutrition in the district of Villaguay, Entre Rios, Argentina. A multivariate analysis	PLOS ONE			English	Article							NUTRITION TRANSITION; BODY-COMPOSITION; SOCIOECONOMIC-STATUS; OBESITY; UNDERNUTRITION; GROWTH; SCHOOLCHILDREN; COUNTRIES; BURDEN; HEALTH	The analysis of nutritional status is anthropologically important to address the complex interaction of biological, social, political, economic and cultural factors. To deepen the knowledge about contexts of occurrence of child malnutrition, we analyzed nutritional status in relation to socio-environmental conditions of residence in children between three and six years from Villaguay, Entre RoAos, Argentina. We performed a cross-sectional study of 1,435 school children of both sexes. Body weight and height were measured and prevalence of low height/age (LH/A), low weight/age (LW/A), low BMI/age (LBMI/A), overweight (Ow) and obesity (Ob) was calculated using World Health Organization reference charts. Socio-environmental information was obtained through a semi-structured survey and processed by Categorical Principal Component Analysis (CatPCA). Anthropometric data showed 1.5% LW/A, 5.2% LH/A; 0.6% LBMI/A, 20.9% Ow and 10.9% Ob. CatPCA allowed us to define four groups (G1-G4) with better (G2), middle (G1) and worst (G4) urban socio-environmental conditions and one with rural characteristics (G3). G4 presented the highest LH/A prevalence and G2 the highest Ow and Ob prevalence (P<0.05). It is concluded that since the distribution of malnutrition was not even it may dependent on the context in which children grow up. Thus, the higher the socio-economic level, the higher the incidence of overweight and obesity. Conversely, at the other end of the social scale, undernutrition and increasing weight excess remained major health problems.	[Bergel Sanchis, Maria Laura; Florencia Cesani, Maria; Edith Oyhenart, Evelia] UNLP, Fac Ciencias Vet, UNLP CONICET La Plata, IGEVET Inst Genet Vet Ing Fernando Noel Dulout, La Plata, Buenos Aires, Argentina; [Edith Oyhenart, Evelia] UNLP, Fac Ciencias Nat & Museo, Catedra Antropol Biol 4, La Plata, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; National University of La Plata; Museo La Plata	Sanchis, MLB (corresponding author), UNLP, Fac Ciencias Vet, UNLP CONICET La Plata, IGEVET Inst Genet Vet Ing Fernando Noel Dulout, La Plata, Buenos Aires, Argentina.	lbergel@igevet.gob.ar	Cesani, María Florencia/AAE-8475-2021	Bergel Sanchis, Maria Laura/0000-0002-4293-9855				Adjemian D, 2007, ARCH LATINOAM NUTR, V57, P125; Aguirre P., 2005, ESTRATEGIAS CONSUMO; Álvarez-Castaño Luz Stella, 2012, Rev. Gerenc. Polit. Salud, V11, P98; [Anonymous], 2002, NUTR TRANSITION DIET; Bejarano Ignacio, 2005, Arch. argent. pediatr., V103, P101; Bergel Sanchís María L, 2016, Rev Arg Antrop Biol, V18, DOI 10.17139/ raab.2016.0018.02.09; Bolzán Andrés, 2005, Arch. argent. pediatr., V103, P545; Caballero B, 2005, NEW ENGL J MED, V352, P1514, DOI 10.1056/NEJMp048310; Carvalho A. T., 2014, J HUMAN GROWTH DEV, V24, P221; Cesani MF, 2010, ARCH ARGENT PEDIATR, V108, P294, DOI 10.1590/S0325-00752010000400002; CESNI/SAOTA, 2012, HAC MAP OB ARG; Cole TJ, 2003, ECON HUM BIOL, V1, P161, DOI 10.1016/S1570-677X(02)00033-3; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Dinsa GD, 2012, OBES REV, V13, P1067, DOI 10.1111/j.1467-789X.2012.01017.x; Doak CM, 2005, INT J OBESITY, V29, P129, DOI 10.1038/sj.ijo.0802824; Duran P, 2009, ARCH ARGENT PEDIATR, V107, P397, DOI 10.1590/S0325-00752009000500005; Ferreira VA, 2006, REV PORTUGUESA SAUDE, V24, P71; FERREIRA Viviane Gualberto, 2003, THESIS, P87; Gardner G, 2000, NOURISHING UNDERFED; Garraza M, 2016, AM J HUM BIOL, V28, P796, DOI 10.1002/ajhb.22869; Laurentin Alexander, 2007, An Venez Nutr, V20, P47; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Lomaglio DB, 2012, NUTR CLIN DIET HOSP, V32, P30; Martorell R, 1998, J NUTR, V128, P1464, DOI 10.1093/jn/128.9.1464; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Monteiro CA, 2004, AM J PUBLIC HEALTH, V94, P433, DOI 10.2105/AJPH.94.3.433; Monteiro CA, 2002, PUBLIC HEALTH NUTR, V5, P105, DOI 10.1079/PHN2001281; Motta M E, 2001, J Pediatr (Rio J), V77, P288; OMS, 1995, INF SAL MUND 1995 RE; OPS, 2008, MALN INF YOUNG CHILD; Ortale S, 2002, THESIS; Oyhenart E, 2008, REV ARGENTINA ANTROP, V10, P1; Oyhenart EE, 2005, REV ARG ANTROP BIOL, V7, P35; Oyhenart EE, 2008, AM J HUM BIOL, V20, P399, DOI 10.1002/ajhb.20738; Oyhenart EE, 2007, REV PANAM SALUD PUBL, V22, P194, DOI 10.1590/S1020-49892007000800006; Paraje G., 2008, CEPAL SERIE POLITICA; Pedraza DF, 2009, SAUDE SOC-SAO PAULO, V18, P103, DOI 10.1590/S0104-12902009000100011; Pena M, 2001, Rev Panam Salud Publica, V10, P75; Pena M., 2000, Obesity and poverty: a new public health challenge., P3; Pena M, 2005, REV FUTUROS, V3; PETERSON RA, 1994, J CONSUM RES, V21, P381, DOI 10.1086/209405; Poletti Oscar H., 2007, Arch. argent. pediatr., V105, P293; Popkin B. M., 1998, ENCY HUMAN NUTR, P1562; Popkin BM, 2009, NESTLE NUTR WORKS SE, V63, P1, DOI 10.1159/000209967; Prieto L, 1998, MED CLIN-BARCELONA, V110, P142; Caro AR, 2009, REV ESP SALUD PUBLIC, V83, P25, DOI 10.1590/s1135-57272009000100003; Sanchis M L Bergel, 2014, THESIS; Stunkard AJ, 2000, OBESIDAD POBREZA NUE, P27; Tanner J M, 1987, Acta Paediatr Jpn, V29, P96; UNICEF, 2011, EST MUND INF; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Wanderley EN, 2010, CIENC SAUDE COLETIVA, V15, P185, DOI 10.1590/S1413-81232010000100024; World Health Organization, 2008, OB OV; Zonta M. L., 2011, Nutricion Clinica y Dietetica Hospitalaria, V31, P48	54	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176346	10.1371/journal.pone.0176346	http://dx.doi.org/10.1371/journal.pone.0176346			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET5FE	28441444	Green Published, gold			2022-12-26	WOS:000400308800049
J	Oldrini, G; Huertas, A; Renard-Oldrini, S; Taste-George, H; Vogin, G; Laurent, V; Salleron, J; Henrot, P				Oldrini, Guillaume; Huertas, Andres; Renard-Oldrini, Sophie; Taste-George, Helene; Vogin, Guillaume; Laurent, Valerie; Salleron, Julia; Henrot, Philippe			Tumor response assessment by MRI following stereotactic body radiation therapy for hepatocellular carcinoma	PLOS ONE			English	Article							ABLATIVE RADIOTHERAPY; LIVER; FEASIBILITY; CYBERKNIFE; EFFICACY	Background To evaluate the MRI features of a tumor response, local control, and predictive factors of local control after stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma (HCC). Methods Thirty-five consecutive patients with 48 HCCs who were treated by SBRT were included in this retrospective study. All patients provided written informed consent to be treated by SBRT, and prior to inclusion they authorized use of the treatment data for further studies. The assessment was made using MRI, with determination of local and hepatic responses according to Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST (mRECIST) criteria during a two-year follow-up. Results The local response rate according to mRECIST was higher than with RECIST. A tumor diameter less than 20 mm at baseline was an independent predictive factor for RECIST and mRECIST responses, as was diffusion-weighted signal for RECIST. During follow-up, a tumor diameter of <20 mm (p = 0.034) and absence of a high intensity on T2-weighted (p = 0.006) and diffusion-weighted images (p = 0.039) were associated with a better response according to RECIST. Post-treatment changes include peritumoral ring-like enhanced changes with high intensity on T2-weighted images. Conclusions SBRT is a promising technique for the treatment of inoperable HCC. Post-treatment changes on MRI images can resemble tumor progression and as such must be adequately distinguished.The regression of tumorous enhancement is variable over time, although diffusion-weighted and T2-weighted intensities are predictive factors for tumor RECIST responses on subsequent MRIs. They hence provide a way to reliably predict treatment responses.	[Oldrini, Guillaume; Henrot, Philippe] Inst Cancerol Lorraine, Serv Imagerie, Vandoeuvre Les Nancy, France; [Huertas, Andres; Renard-Oldrini, Sophie; Taste-George, Helene; Vogin, Guillaume] Inst Cancerol Lorraine, Serv Radiotherapie, Vandoeuvre Les Nancy, France; [Laurent, Valerie] CHU Nancy, Dept Radiol Adulte, Vandoeuvre Les Nancy, France; [Salleron, Julia] Inst Cancerol Lorraine, Cellule Data Biostat, Vandoeuvre Les Nancy, France	UNICANCER; Institut de cancerologie de Lorraine (ICL); UNICANCER; Institut de cancerologie de Lorraine (ICL); CHU de Nancy; UNICANCER; Institut de cancerologie de Lorraine (ICL)	Oldrini, G (corresponding author), Inst Cancerol Lorraine, Serv Imagerie, Vandoeuvre Les Nancy, France.	g.oldrini@nancy.unicancer.fr	Laurent, Valerie/AAA-9259-2022; Oldrini, Guillaume/O-5198-2017	Oldrini, Guillaume/0000-0002-5638-3560; Vogin, Guillaume/0000-0002-8114-5900				Adler JR, 2009, NEUROSURGERY, V64, pA1, DOI 10.1227/01.NEU.0000312703.46158.54; Adler JR, 1997, STEREOT FUNCT NEUROS, V69, P124, DOI 10.1159/000099863; Bae SH, 2013, J KOREAN MED SCI, V28, P213, DOI 10.3346/jkms.2013.28.2.213; Benson AB, 2009, J NATL COMPR CANC NE, V7, P350, DOI 10.6004/jnccn.2009.0027; Bibault JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077472; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; De Bari B, 2011, CANCER RADIOTHER, V15, P43, DOI 10.1016/j.canrad.2010.11.009; Facciuto ME, 2011, J SURG ONCOL, V105, P692, DOI DOI 10.1002/JS0.22104; Huang WY, 2012, INT J RADIAT ONCOL, V84, P355, DOI 10.1016/j.ijrobp.2011.11.058; Kwon JH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-475; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Lo CH, 2014, EUR J GASTROEN HEPAT, V26, P345, DOI 10.1097/MEG.0000000000000032; Maddala YK, 2004, LIVER TRANSPLANT, V10, P449, DOI 10.1002/lt.20099; Maturen KE, 2013, RADIOGRAPHICS, V33, P599, DOI 10.1148/rg.332125119; Mornex F, 2006, INT J RADIAT ONCOL, V66, P1152, DOI 10.1016/j.ijrobp.2006.06.015; Oldrini G, 2015, DIAGN INTERV IMAG, V96, P589, DOI 10.1016/j.diii.2014.01.010; Park MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090327; Price TR, 2012, CANCER-AM CANCER SOC, V118, P3191, DOI 10.1002/cncr.26404; Sanuki N, 2013, AM J ROENTGENOL, V201, pW812, DOI 10.2214/AJR.12.10169; Sanyal AJ, 2010, ONCOLOGIST, V15, P14, DOI 10.1634/theoncologist.2010-S4-14; Shim JH, 2012, RADIOLOGY, V262, P708, DOI 10.1148/radiol.11110282; Song PP, 2012, LIVER INT, V32, P1053, DOI 10.1111/j.1478-3231.2012.02792.x; Yoon SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079854	24	22	23	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176118	10.1371/journal.pone.0176118	http://dx.doi.org/10.1371/journal.pone.0176118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441447	gold, Green Published, Green Submitted			2022-12-26	WOS:000400308800026
J	Carroll, MJ; Brown, N; Goodall, C; Downs, AM; Sheenan, TH; Anderson, KE				Carroll, Mark J.; Brown, Nicholas; Goodall, Craig; Downs, Alexandra M.; Sheenan, Timothy H.; Anderson, Kirk E.			Honey bees preferentially consume freshly-stored pollen	PLOS ONE			English	Article							APIS-MELLIFERA L; FORAGING PREFERENCES; NUTRITIONAL CONTENT; WORKER HONEYBEES; PHEROMONE; COLONIES; CARBOHYDRATE; HYMENOPTERA; FORAGERS; BALANCE	Honey bees (Apis mellifera) collect and store both honey and pollen in preserved forms. Pollen storage involves the addition of honey or nectar and oral secretions to pollen granules. It is controversial whether the duration of pollen storage alters the palatability or nutritive value of the pollen storage medium. We examined how bees utilize different-aged stored pollen during an extended pollen flow. The deposition of pollen into wax cells and subsequent consumption were monitored daily on 18 brood frames from 6 colonies over an 8d observation period. Despite a greater abundance of older stored pollen cells on brood frames, bees showed a marked preference for the consumption of freshly-stored pollen. Two to four day-old pollen cell contents were significantly more likely to be consumed, while pollen cell contents more than seven days old were eaten at much lower rates. Similar experiments that controlled for cell abundance and spatial effects using cage assays yielded the same result. One day-old stored pollen was consumed approximately three times more often than 10d-old stored pollen, and two times more often than 5d-old stored pollen. These consumption preferences for freshly-stored pollen occurred despite a lack of clear developmental advantages. Young adult workers reared for 7 days on 1d-, 5d-, or 10d-old stored pollen showed no difference in body mass, stored pollen consumption, hindgut fecal material accumulation, or hypopharyngeal gland (HPG) protein titers, suggesting that different-aged pollen stores did not vary in their nutritional value to adult bees. These findings are inconsistent with the hypothesis promoting a period of microbially-mediated, "beebread maturation" that results in greater palatability or nutritive value for aged pollen stores. Rather, stored pollen that is not eaten in the first few days accumulates as excess stores preserved in a less preferred, but nutritionally-similar state.	[Carroll, Mark J.; Brown, Nicholas; Goodall, Craig; Sheenan, Timothy H.; Anderson, Kirk E.] USDA ARS, Carl Hayden Bee Res Ctr, Tucson, AZ 85719 USA; [Carroll, Mark J.; Downs, Alexandra M.; Anderson, Kirk E.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Anderson, Kirk E.] Univ Arizona, Ctr Insect Sci, Tucson, AZ 85721 USA; [Goodall, Craig] Univ Arizona, Coll Med, Tucson, AZ USA; [Downs, Alexandra M.] Univ Calif Santa Barbara, Dept Mech Engn, Santa Barbara, CA 93106 USA	United States Department of Agriculture (USDA); University of Arizona; University of Arizona; University of Arizona; University of California System; University of California Santa Barbara	Carroll, MJ (corresponding author), USDA ARS, Carl Hayden Bee Res Ctr, Tucson, AZ 85719 USA.; Carroll, MJ (corresponding author), Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA.	Mark.Carroll@ars.usda.gov		Downs, Alex/0000-0002-7220-231X	University of Arizona UBRP scholarship; USDA-ARS, an equal opportunity employer and provider	University of Arizona UBRP scholarship; USDA-ARS, an equal opportunity employer and provider	The author(s) received no specific funding for this work. AD was supported by an University of Arizona UBRP scholarship during this study.; We would like to thank Austin Brown for technical support. This work was supported by the USDA-ARS, an equal opportunity employer and provider.	Alaux C, 2010, BIOL LETTERS, V6, P562, DOI 10.1098/rsbl.2009.0986; Alqarni A. S., 2006, Journal of Biological Sciences, V6, P734; Anderson KE, 2011, INSECT SOC, V58, P431, DOI 10.1007/s00040-011-0194-6; Anderson KE, 2014, MOL ECOL, V23, P5904, DOI 10.1111/mec.12966; Arenas A, 2014, J INSECT PHYSIOL, V66, P28, DOI 10.1016/j.jinsphys.2014.05.010; Arenas A, 2012, ANIM BEHAV, V83, P1023, DOI 10.1016/j.anbehav.2012.01.026; Behrends A, 2007, EXP GERONTOL, V42, P1146, DOI 10.1016/j.exger.2007.09.003; Behrends A, 2012, J EXP BIOL, V215, P1076, DOI 10.1242/jeb.063297; BOELTER AM, 1984, AM BEE J, V124, P609; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; Chittka L, 2006, CURR OPIN PLANT BIOL, V9, P428, DOI 10.1016/j.pbi.2006.05.002; Cook SM, 2005, PHYSIOL ENTOMOL, V30, P164, DOI 10.1111/j.1365-3032.2005.00445.x; Cook SM, 2003, ECOL ENTOMOL, V28, P622, DOI 10.1046/j.1365-2311.2003.00548.x; Corby-Harris V, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-134; CRAILSHEIM K, 1992, J COMP PHYSIOL B, V162, P681, DOI 10.1007/BF00301617; Crailsheim K, 1998, APIDOLOGIE, V29, P97, DOI 10.1051/apido:19980106; CRAILSHEIM K, 1991, J COMP PHYSIOL B, V161, P55, DOI 10.1007/BF00258746; CRAILSHEIM K, 1992, J INSECT PHYSIOL, V38, P409, DOI 10.1016/0022-1910(92)90117-V; CRAILSHEIM K, 1990, ZOOL JAHRB ALLG ZOOL, V94, P303; de GROOT A. P., 1953, PHYSIOL COMPARATA ET OECOL, V3, P197; Di Pasquale G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072016; Dobson HEM, 2000, PLANT SYST EVOL, V222, P63, DOI 10.1007/BF00984096; DUSTMANN JH, 1988, APIDOLOGIE, V19, P245, DOI 10.1051/apido:19880304; EISHCHEN FA, 1982, J APICULT RES, V21, P19, DOI 10.1080/00218839.1982.11100511; Evans JD, 2010, J INVERTEBR PATHOL, V103, pS62, DOI 10.1016/j.jip.2009.06.019; Free J. B., 1987, PHEROMONES SOCIAL BE; Gilliam M, 1997, FEMS MICROBIOL LETT, V155, P1; Harano K, 2014, NATURWISSENSCHAFTEN, V101, P595, DOI 10.1007/s00114-014-1185-z; HAYDAK MH, 1970, ANNU REV ENTOMOL, V15, P143, DOI 10.1146/annurev.en.15.010170.001043; Haydak MH, 1935, J ECON ENTOMOL, V28, P657, DOI 10.1093/jee/28.4.657; Hendriksma HP, 2016, BEHAV ECOL SOCIOBIOL, V70, P509, DOI 10.1007/s00265-016-2067-5; Herbert E.W., 1992, HIVE HONEY BEE, P197; HERBERT EW, 1978, APIDOLOGIE, V9, P33, DOI 10.1051/apido:19780103; HIGO HA, 1992, CAN ENTOMOL, V124, P409, DOI 10.4039/Ent124409-2; Hrassnigg N, 1998, J INSECT PHYSIOL, V44, P929, DOI 10.1016/S0022-1910(98)00058-4; Human H, 2006, PHYTOCHEMISTRY, V67, P1486, DOI 10.1016/j.phytochem.2006.05.023; JAY SC, 1964, CAN J ZOOLOG, V42, P455, DOI 10.1139/z64-039; Judd Timothy M., 2011, P1; KUNERT K, 1988, J APICULT RES, V27, P13, DOI 10.1080/00218839.1988.11100775; Le Conte Y, 2001, P ROY SOC B-BIOL SCI, V268, P163, DOI 10.1098/rspb.2000.1345; Leoncini I, 2004, P NATL ACAD SCI USA, V101, P17559, DOI 10.1073/pnas.0407652101; LOPER GM, 1980, APIDOLOGIE, V11, P63, DOI 10.1051/apido:19800108; Maes PW, 2016, MOL ECOL, V25, P5439, DOI 10.1111/mec.13862; Maisonnasse A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013531; Mattila HR, 2007, ECOL ENTOMOL, V32, P496, DOI 10.1111/j.1365-2311.2007.00904.x; Maurizio A, 1954, POLLENERNAHRUNG LEBE, V68, P115; MCNALLY LC, 1992, INSECT SOC, V39, P167, DOI 10.1007/BF01249292; Naiem ES, 1999, J COMP PHYSIOL B, V169, P271, DOI 10.1007/s003600050221; Nicolson SW, 2011, AFR ZOOL, V46, P197, DOI 10.3377/004.046.0201; O'Neal R. J., 1984, Desert Plants, V6, P81; Pankiw T, 1998, BEHAV ECOL SOCIOBIOL, V44, P193, DOI 10.1007/s002650050531; Pankiw T, 2007, J INSECT BEHAV, V20, P173, DOI 10.1007/s10905-007-9071-6; Pernal SF, 2000, APIDOLOGIE, V31, P387, DOI 10.1051/apido:2000130; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; ROSCH G. A., 1930, ZEITSCHR WISSENSCH BIOL ABT C ZEITSCHR VERGLEICH PHYSIOL, V12, P1, DOI 10.1007/BF00339476; Roulston TH, 2000, PLANT SYST EVOL, V222, P187, DOI 10.1007/BF00984102; Sagili RR, 2009, J INSECT BEHAV, V22, P339, DOI 10.1007/s10905-009-9176-1; Saraiva MA, 2015, ANTON LEEUW INT J G, V107, P921, DOI 10.1007/s10482-015-0384-8; Scheiner R, 2004, APIDOLOGIE, V35, P133, DOI 10.1051/apido:2004001; Schmickl T, 2002, BEHAV ECOL SOCIOBIOL, V51, P415, DOI 10.1007/s00265-002-0457-3; Schmickl T, 2001, J COMP PHYSIOL A, V187, P541, DOI 10.1007/s003590100226; SCHMIDT JO, 1987, ANN ENTOMOL SOC AM, V80, P176, DOI 10.1093/aesa/80.2.176; SCHMIDT JO, 1984, SOUTHWEST ENTOMOL, V9, P41; SCHMIDT LS, 1995, J ECON ENTOMOL, V88, P1591, DOI 10.1093/jee/88.6.1591; Schulz DJ, 2002, INSECT SOC, V49, P50, DOI 10.1007/s00040-002-8279-x; Seeley T., 1995, WISDOM HIVE SOCIAL P; Shreve F., 1964, VEGETATION FLORA SON; Slessor KN, 2005, J CHEM ECOL, V31, P2731, DOI 10.1007/s10886-005-7623-9; SPIVAK M, 1992, J APPL ECOL, V29, P150, DOI 10.2307/2404358; STANDIFER L N, 1973, American Bee Journal, V113, P94; Toth AL, 2005, J EXP BIOL, V208, P4641, DOI 10.1242/jeb.01956; Vanengelsdorp D, 2009, J INVERTEBR PATHOL, V101, P147, DOI 10.1016/j.jip.2009.03.008; Vasquez A, 2011, MICROBIOLOGY TODAY, V38, P226; Vasquez A, 2009, J APICULT RES, V48, P189, DOI 10.3896/IBRA.1.48.3.07; Vaudo AD, 2016, P NATL ACAD SCI USA, V113, pE4035, DOI 10.1073/pnas.1606101113; Winston M., 1987, The biology of the honey bee.; WINSTON ML, 1992, ANNU REV ENTOMOL, V37, P173, DOI 10.1146/annurev.en.37.010192.001133; Zar J.H., 2010, BIOSTAT ANAL	79	43	43	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0175933	10.1371/journal.pone.0175933	http://dx.doi.org/10.1371/journal.pone.0175933			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430801	Green Published, Green Submitted, gold			2022-12-26	WOS:000399876100024
J	Fu, WW; Fu, TS; Jing, R; McFaull, SR; Cusimano, MD				Fu, Wayne W.; Fu, Terence S.; Jing, Rowan; McFaull, Steven R.; Cusimano, Michael D.			Predictors of falls and mortality among elderly adults with traumatic brain injury: A nationwide, population-based study	PLOS ONE			English	Article							OLDER-ADULTS; MULTIFACTORIAL INTERVENTION; REDUCE FALLS; RISK; AGE; HOSPITALIZATION; EPIDEMIOLOGY; METAANALYSIS; PREVENTION; SEVERITY	Background Elderly adults are at particular risk of sustaining a traumatic brain injury (TBI), and tend to suffer worse outcomes compared to other age groups. Falls are the leading cause of TBI among the elderly. Methods We examined nationwide trends in TBI hospitalizations among elderly adults (ages 65 and older) between April 2006 and March 2011 using a population-based database that is mandatory for all hospitals in Canada. Trends in admission rates were analyzed using linear regression. Predictors of falls and in-hospital mortality were identified using logistic regression. Results Between 2006 and 2011, there were 43,823 TBI hospitalizations resulting in 6,939 deaths among elderly adults in Canada. Over the five-year study period, the overall rate of TBI admissions increased by an average of 6% per year from 173.2 to 214.7 per 100,000, while the rate of fall-related TBI increased by 7% annually from 138.6 to 179.2 per 100,000. There were significant trends towards increasing age and comorbidity level (p< 0.001 and p = 0.002). Advanced age, comorbidity, and injury severity were independent predictors of both TBI-related falls and mortality on multivariate analysis. Conclusion Prevention efforts should be targeted towards vulnerable demographics including the "older old" (ages 85 and older) and those with multiple medical comorbidities. Additionally, hospitals and long-term care facilities should be prepared to manage the burgeoning population of older patients with more complex comorbidities.	[Fu, Wayne W.] Albany Med Coll, Albany, NY USA; [Fu, Terence S.; Jing, Rowan; Cusimano, Michael D.] St Michaels Hosp, Dept Surg, Div Neurosurg, Toronto, ON, Canada; [Fu, Terence S.; Jing, Rowan; Cusimano, Michael D.] Keenan Res Ctr, Li Ka Shing Knowledge Inst, Injury Prevent Res Off, Toronto, ON, Canada; [Fu, Terence S.; Jing, Rowan; Cusimano, Michael D.] Univ Toronto, Toronto, ON, Canada; [McFaull, Steven R.] Publ Hlth Agcy Canada, Hlth Surveillance & Epidemiol Div, Injury Sect, Ottawa, ON, Canada; [Cusimano, Michael D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	Albany Medical College; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University of Toronto; Public Health Agency of Canada; University of Toronto	Cusimano, MD (corresponding author), St Michaels Hosp, Dept Surg, Div Neurosurg, Toronto, ON, Canada.; Cusimano, MD (corresponding author), Keenan Res Ctr, Li Ka Shing Knowledge Inst, Injury Prevent Res Off, Toronto, ON, Canada.; Cusimano, MD (corresponding author), Univ Toronto, Toronto, ON, Canada.; Cusimano, MD (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	injuryprevention@smh.ca	Cusimano, Michael/X-4059-2019; Cusimano, Michael/GWR-1025-2022		Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research [TIR-103946]; Ontario Neurotrauma Foundation	Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research(Canadian Institutes of Health Research (CIHR)); Ontario Neurotrauma Foundation	This research was supported by the Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research #TIR-103946 and the Ontario Neurotrauma Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose AF, 2013, MATURITAS, V75, P51, DOI 10.1016/j.maturitas.2013.02.009; Bohnert N., 2014, POPULATION PROJECTIO; Campbell AJ, 2007, AGE AGEING, V36, P656, DOI 10.1093/ageing/afm122; Centers for Disease Control and Prevention, 2010, EXT CAUS INJ MORT MA; Chan V, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-97; Chang JT, 2004, BRIT MED J, V328, P680, DOI 10.1136/bmj.328.7441.680; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CIoHI, 2012, CIHI DAT QUAL STUD 2; Colantonio A, 2010, CAN J NEUROL SCI, V37, P783, DOI 10.1017/S0317167100051441; Colantonio A, 2009, J TRAUMA, V66, P179, DOI 10.1097/TA.0b013e3181715d66; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Coronado VG, 2012, EPIDEMIOLOGY PREVENT, P45; Cryer C, 2006, INJURY PREV, V12, P67, DOI 10.1136/ip.2006.011668; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; de Vries OJ, 2010, ARCH INTERN MED, V170, P1110, DOI 10.1001/archinternmed.2010.169; Donohue JT, 2007, J TRAUMA, V62, P419, DOI 10.1097/01.ta.0000219286.88179.18; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Fletcher AE, 2007, BRAIN INJURY, V21, P691, DOI 10.1080/02699050701426873; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Fu TS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145469; Giannoudis PV, 2009, INJURY, V40, P362, DOI 10.1016/j.injury.2008.10.016; Gillespie LD, 2012, COCHRANE DATABASE SY, V9; Hajjar Emily R, 2007, Am J Geriatr Pharmacother, V5, P345, DOI 10.1016/j.amjopharm.2007.12.002; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Huang AR, 2012, DRUG AGING, V29, P359, DOI 10.2165/11599460-000000000-00000; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kenny RAM, 2011, J AM GERIATR SOC, V59, P148, DOI 10.1111/j.1532-5415.2010.03234.x; Korhonen N, 2013, JAMA-J AM MED ASSOC, V309, P1891, DOI 10.1001/jama.2013.3356; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Murphy TE, 2014, J GERONTOL GERIATR R, V3, P3; Ortman J. M., 2014, AGING NATION OLDER P, P25; Perula LA, 2012, ARCH PHYS MED REHAB, V93, P1677, DOI 10.1016/j.apmr.2012.03.035; Petridou ET, 2009, J AGING HEALTH, V21, P713, DOI 10.1177/0898264309338298; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Ramanathan DM, 2012, J NEUROTRAUM, V29, P1371, DOI 10.1089/neu.2011.2197; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Selassie AW, 2014, J HEAD TRAUMA REHAB, V29, pE8, DOI 10.1097/HTR.0b013e3182976ad3; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; Stephenson S, 2004, INJURY PREV, V10, P379, DOI 10.1136/ip.2004.005561; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thurman DJ., 1995, STANDARDS SURVEILLAN; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151	46	41	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0175868	10.1371/journal.pone.0175868	http://dx.doi.org/10.1371/journal.pone.0175868			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KN	28430782	Green Published, gold, Green Submitted			2022-12-26	WOS:000399876100019
J	Grabias, B; Verma, N; Zheng, H; Tripathi, AK; Mlambo, G; Morin, MJ; Locke, E; Kumar, S				Grabias, Bryan; Verma, Nitin; Zheng, Hong; Tripathi, Abhai K.; Mlambo, Godfree; Morin, Merribeth J.; Locke, Emily; Kumar, Sanjai			A no film slot blot for the detection of developing P. falciparum oocysts in mosquitoes	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; PLASMODIUM-FALCIPARUM; CIRCUMSPOROZOITE PROTEIN; MALARIA TRANSMISSION; PCR ASSAY; VIVAX; ANTIGEN; VACCINE; IDENTIFICATION; SPOROZOITES	Non-microscopy-based assays for sensitive and rapid detection of Plasmodium infection in mosquitoes are needed to allow rapid and high throughput measurement of transmission intensity and malaria control program effectiveness. Here, we report on a modified enhanced chemiluminescence-based slot blot assay for detection of Plasmodium falciparum (Pf) circumsporozite protein (PfCSP) expressed on parasite oocysts developing inside the mosquito midgut. This modified assay has several novel features that include eliminating the need for exposure to autoradiography (AR) film, as well as utilizing a novel high affinity anti-CSP antibody, and optimizing assay procedures resulting in significant reduction in the time required to perform the assay. The chemiluminescent signal for the detection of PfCSP in mosquito samples was captured digitally utilizing the C-Digit blot scanner that, allowed the detection of 0.01 pg of recombinant P. falciparum CSP and as few as 0.02 P. falciparum oocysts in a little over two hours. The earlier ECL-SB detected rCSP and oocysts and took approximately 5 h to perform. Whole mosquito lysates from both high and low prevalence-infected mosquito populations were prepared and evaluated for PfCSP detection on the ECL-SB by both AR film and digital data capture and analysis. There was a 100% agreement between the AR film and the C-Digit scanner methods for PfCSP detection in randomly sampled mosquitoes. This novel "No Film" Slot Blot assay obviates the need for AR film exposure and development and significantly reduces the assay time enabling widespread use in field settings.	[Grabias, Bryan; Verma, Nitin; Zheng, Hong; Kumar, Sanjai] US FDA, Lab Emerging Pathogens, Div Emerging & Transfus Transmitted Dis, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Tripathi, Abhai K.; Mlambo, Godfree] Johns Hopkins Univ, Johns Hopkins Malaria Res Inst, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Tripathi, Abhai K.; Mlambo, Godfree] Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Morin, Merribeth J.; Locke, Emily] PATH Malaria Vaccine Initiat, Washington, DC USA	US Food & Drug Administration (FDA); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Kumar, S (corresponding author), US FDA, Lab Emerging Pathogens, Div Emerging & Transfus Transmitted Dis, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	Sanjay.Kumar@fda.hhs.gov		Tripathi, Abhai/0000-0001-9848-0142	PATH	PATH	Work on this study was supported through PATH. Representatives of PATH listed as coauthors on this manuscript contributed to the preparation of this manuscript.	Bashar K, 2013, ACTA TROP, V125, P220, DOI 10.1016/j.actatropica.2012.10.004; BEIER JC, 1987, AM J TROP MED HYG, V36, P459, DOI 10.4269/ajtmh.1987.36.459; Bell AS, 2004, INT J PARASITOL, V34, P795, DOI 10.1016/j.ijpara.2004.03.008; Chowdhury DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006352; Churcher TS, 2012, INT J PARASITOL, V42, P1037, DOI 10.1016/j.ijpara.2012.09.002; Collins KM, 2004, ANN TROP MED PARASIT, V98, P469, DOI 10.1179/000349804225003479; De Arruda ME, 2004, ANN TROP MED PARASIT, V98, P121, DOI 10.1179/000349804225003181; Eamkum P, 2014, PARASITOL INT, V63, P442, DOI 10.1016/j.parint.2013.11.001; Ferrer P, 2015, ANTIMICROB AGENTS CH, V59, P1418, DOI 10.1128/AAC.04642-14; Grabias B, 2015, J MICROBIOL METH, V108, P19, DOI 10.1016/j.mimet.2014.10.006; Healer J, 1997, INFECT IMMUN, V65, P3017, DOI 10.1128/IAI.65.8.3017-3023.1997; KASLOW DC, 1994, INFECT IMMUN, V62, P5576, DOI 10.1128/IAI.62.12.5576-5580.1994; Kohler G, 2005, J IMMUNOL, V174, P2453; Kumar R, 2013, VACCINE, V31, P3140, DOI 10.1016/j.vaccine.2013.05.006; Kumar S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115807; Kumar S, 2013, J IMMUNOL METHODS, V390, P99, DOI 10.1016/j.jim.2013.02.001; Miura K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057909; NARDIN EH, 1982, J EXP MED, V156, P20, DOI 10.1084/jem.156.1.20; Rathore D, 2003, J BIOL CHEM, V278, P40905, DOI 10.1074/jbc.M306250200; Roeffen W, 1996, PARASITE IMMUNOL, V18, P103, DOI 10.1046/j.1365-3024.1996.d01-54.x; Sandeu MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052719; Stone WJ, 2014, THE JOURNAL OF INFEC; Usui M, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-118; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WIRTZ RA, 1985, AM J TROP MED HYG, V34, P1048, DOI 10.4269/ajtmh.1985.34.1048; Wu YM, 2006, P NATL ACAD SCI USA, V103, P18243, DOI 10.1073/pnas.0608545103	26	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0174229	10.1371/journal.pone.0174229	http://dx.doi.org/10.1371/journal.pone.0174229			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430778	Green Published, Green Submitted, gold			2022-12-26	WOS:000399876100004
J	Aaron, CP; Hoffman, EA; Lima, JAC; Kawut, SM; Bertoni, AG; Vogel-Claussen, J; Habibi, M; Hueper, K; Jacobs, DR; Kalhan, R; Michos, ED; Post, WS; Prince, MR; Smith, BM; Ambale-Venkatesh, B; Liu, CY; Zemrak, F; Watson, KE; Budoff, M; Bluemke, DA; Barr, RG				Aaron, Carrie P.; Hoffman, Eric A.; Lima, Joao A. C.; Kawut, Steven M.; Bertoni, Alain G.; Vogel-Claussen, Jens; Habibi, Mohammadali; Hueper, Katja; Jacobs, David R., Jr.; Kalhan, Ravi; Michos, Erin D.; Post, Wendy S.; Prince, Martin R.; Smith, Benjamin M.; Ambale-Venkatesh, Bharath; Liu, Chia-Ying; Zemrak, Filip; Watson, Karol E.; Budoff, Matthew; Bluemke, David A.; Barr, R. Graham			Pulmonary vascular volume, impaired left ventricular filling and dyspnea: The MESA Lung Study	PLOS ONE			English	Article							HEART-FAILURE; BLOOD-VOLUME; MYOCARDIAL FIBROSIS; COMPUTED-TOMOGRAPHY; CIGARETTE-SMOKING; ATHEROSCLEROSIS; EMPHYSEMA; DISEASE; ASSOCIATION; EXERCISE	Background Evaluation of impaired left ventricular (LV) filling has focused on intrinsic causes of LV dysfunction; however, pulmonary vascular changes may contribute to reduced LV filling and dyspnea. We hypothesized that lower total pulmonary vascular volume (TPVV) on computed tomography (CT) would be associated with dyspnea and decrements in LV end-diastolic volume, particularly among ever-smokers. Methods The Multi-Ethnic Study of Atherosclerosis recruited adults without clinical cardiovascular disease in 2000-02. In 2010-12, TPVV was ascertained as the volume of arteries and veins in the lungs detectable on non-contrast chest CT (vessels >= 1 mm diameter). Cardiac measures were assessed by magnetic resonance imaging (MRI). Dyspnea was selfreported. Results Of 2303 participants, 53% had ever smoked cigarettes. Among ever-smokers, a lower TPVV was associated with a lower LV end-diastolic volume (6.9 mL per SD TPVV), stroke volume, and cardiac output and with dyspnea (all P-values <0.001). Findings were similar among those without lung disease and those with 0-10 pack-years but were mostly non-significant among never-smokers. TPVV was associated smaller left atrial volume but not with LV ejection fraction or MRI measures of impaired LV relaxation. In a second sample of ever-smokers, a lower pulmonary microvascular blood volume on contrast-enhanced MRI was also associated with a lower LV end-diastolic volume (P-value = 0.008). Conclusion Reductions in pulmonary vascular volume were associated with lower LV filling and dyspnea among ever-smokers, including those without lung disease, suggesting that smoking-related pulmonary vascular changes may contribute to symptoms and impair cardiac filling and function without evidence of impaired LV relaxation.	[Aaron, Carrie P.; Smith, Benjamin M.; Barr, R. Graham] Columbia Univ, Dept Med, Coll Phys & Surg, New York, NY USA; [Hoffman, Eric A.] Univ Iowa, Dept Radiol, Iowa City, IA USA; [Lima, Joao A. C.; Habibi, Mohammadali; Michos, Erin D.; Post, Wendy S.; Ambale-Venkatesh, Bharath; Liu, Chia-Ying] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD USA; [Kawut, Steven M.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA USA; [Kawut, Steven M.] Univ Penn, Perelman Sch Med, Dept Epidemiol, Philadelphia, PA USA; [Bertoni, Alain G.] Wake Forest Univ, Sch Med, Dept Med & Epidemiol & Prevent, Winston Salem, NC USA; [Vogel-Claussen, Jens; Hueper, Katja] Hannover Med Sch, Dept Radiol, Hannover, Germany; [Jacobs, David R., Jr.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Kalhan, Ravi] Northwestern Univ, Feinberg Sch Med, Asthma & COPD Program, Chicago, IL USA; [Michos, Erin D.; Post, Wendy S.] Johns Hopkins Bloomberg, Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Prince, Martin R.] Columbia Univ, Dept Radiol, Coll Phys & Surg, New York, NY USA; [Smith, Benjamin M.] McGill Univ, Hlth Ctr, Dept Med, Montreal, PQ, Canada; [Liu, Chia-Ying; Zemrak, Filip; Bluemke, David A.] NIH, Ctr Clin, Radiol & Imaging Sci, Bethesda, MD USA; [Watson, Karol E.; Budoff, Matthew] Univ Calif Los Angeles, Dept Med, Los Angeles, CA USA; [Barr, R. Graham] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	Columbia University; University of Iowa; Johns Hopkins University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Wake Forest University; Hannover Medical School; University of Minnesota System; University of Minnesota Twin Cities; Northwestern University; Feinberg School of Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Columbia University; McGill University; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); University of California System; University of California Los Angeles; Columbia University	Aaron, CP (corresponding author), Columbia Univ, Dept Med, Coll Phys & Surg, New York, NY USA.	cp2346@columbia.edu	Watson, Karol/ABD-7425-2021; Habibi, Mohammadali/AAT-8531-2021; Vogel-Claussen, Jens/Q-3374-2019; Budoff, Matthew/ABD-5175-2021; Bluemke, David/GYU-8169-2022; Ambale Venkatesh, Bharath/F-4941-2016	Budoff, Matthew/0000-0002-9616-1946; Jacobs, David/0000-0002-7232-0543; Pistenmaa, Carrie/0000-0003-1563-1916; Hoffman, Eric/0000-0001-8456-9437; Bluemke, David/0000-0002-8323-8086; Bertoni, Alain/0000-0002-7503-6273; Zemrak, Filip/0000-0001-6730-4955; Ambale Venkatesh, Bharath/0000-0002-2330-2373; Kalhan, Ravi/0000-0003-2443-0876; Vogel-Claussen, Jens/0000-0001-5595-6948	National Institutes of Health/National Heart, Lung and Blood Institute [R01-HL077612, R01-HL093081, N01-HC95159-HC95169, UL1-TR000040]; US Environmental Protection Agency [R831697]; Quebec Health Research Fund (BMS); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122477, R01HL077612, R01HL093081, K24HL103844, R01HL112986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	National Institutes of Health/National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US Environmental Protection Agency(United States Environmental Protection Agency); Quebec Health Research Fund (BMS); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by the National Institutes of Health/National Heart, Lung and Blood Institute R01-HL077612 (RGB), R01-HL093081 (RGB), N01-HC95159-HC95169, UL1-TR000040; US Environmental Protection Agency R831697; Quebec Health Research Fund (BMS). The protocols of MESA and all studies described were approved by the National Heart Lung and Blood Institute. The authors, together with other MESA investigators, collected and analyzed the data, and wrote and submitted the manuscript for publication. NHLBI staff monitored study performance routinely and participated in internal manuscript review before submission.	Ambale-Venkatesh B, 2014, EUR HEART J-CARD IMG, V15, P442, DOI 10.1093/ehjci/jet189; Andersen MJ, 2014, CIRC-HEART FAIL, V7, P911, DOI 10.1161/CIRCHEARTFAILURE.114.001575; [Anonymous], 2008, MESA MAN OP; Bertoni AG, 2009, AM J EPIDEMIOL, V169, P444, DOI 10.1093/aje/kwn350; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Bild DE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094916; Borlaug BA, 2014, NAT REV CARDIOL, V11, P507, DOI 10.1038/nrcardio.2014.83; Boussuges A, 2000, AM J RESP CRIT CARE, V162, P670, DOI 10.1164/ajrccm.162.2.9908056; COMSTOCK GW, 1979, AM REV RESPIR DIS, V119, P45; Cuttica MJ, 2015, AM J RESP CRIT CARE, V192, P76, DOI 10.1164/rccm.201501-0116OC; Donekal S, 2014, CIRC-CARDIOVASC IMAG, V7, P292, DOI 10.1161/CIRCIMAGING.113.001073; Estepar RSJ, 2013, AM J RESP CRIT CARE, V188, P231, DOI 10.1164/rccm.201301-0162OC; Fontana M, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-88; GIUNTINI C, 1963, J CLIN INVEST, V42, P1589, DOI 10.1172/JCI104844; Grau M, 2013, CHEST, V144, P136, DOI 10.1378/chest.12-1779; Habibi M, 2014, JACC-CARDIOVASC IMAG, V7, P570, DOI 10.1016/j.jcmg.2014.01.016; Hankinson JL, 2010, CHEST, V137, P138, DOI 10.1378/chest.09-0919; Hoffman Eric A, 2014, Ann Am Thorac Soc, V11, P898, DOI 10.1513/AnnalsATS.201310-364OC; Hueper K, 2015, AM J RESP CRIT CARE, V192, P570, DOI 10.1164/rccm.201411-2120OC; Hueper K, 2013, INVEST RADIOL, V48, P223, DOI 10.1097/RLI.0b013e318281057d; Ijzerman RG, 2003, CLIN SCI, V104, P247, DOI 10.1042/CS20020318; Iyer KS, 2016, AM J RESP CRIT CARE, V193, P652, DOI 10.1164/rccm.201506-1196OC; Jorgensen K, 2007, CHEST, V131, P1050, DOI 10.1378/chest.06-2245; Kaess BM, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002693; Kaufmann MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056826; Kaufmann PA, 2000, CIRCULATION, V102, P1233, DOI 10.1161/01.CIR.102.11.1233; Kawut SM, 2014, J AM COLL CARDIOL, V64, P2000, DOI 10.1016/j.jacc.2014.07.991; Lederer DJ, 2009, AM J RESP CRIT CARE, V180, P407, DOI 10.1164/rccm.200812-1966OC; Liu C.-Y., 2013, J CARDIOVASC MAGN R, V15, pO62; Liu CY, 2013, J AM COLL CARDIOL, V62, P1280, DOI 10.1016/j.jacc.2013.05.078; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; MAHLER DA, 1988, CHEST, V93, P580, DOI 10.1378/chest.93.3.580; McAllister DA, 2007, AM J RESP CRIT CARE, V176, P1208, DOI 10.1164/rccm.200707-1080OC; Mentz RJ, 2014, J AM COLL CARDIOL, V64, P2281, DOI 10.1016/j.jacc.2014.08.036; Meyer T, 2013, ANN INTERN MED, V158, DOI 10.7326/0003-4819-158-1-201301010-01001; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; MILNOR WR, 1960, CIRCULATION, V22, P130, DOI 10.1161/01.CIR.22.1.130; Mohammed SF, 2015, CIRCULATION, V131, P550, DOI 10.1161/CIRCULATIONAHA.114.009625; MOTLEY HL, 1947, AM J PHYSIOL, V150, P315, DOI 10.1152/ajplegacy.1947.150.2.315; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; NOOTENS M, 1995, AM J CARDIOL, V75, P374, DOI 10.1016/S0002-9149(99)80557-8; Oelsner EC, 2014, AM J MED; Ohyama Y, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.115.004426; Osman NF, 2000, IEEE T MED IMAGING, V19, P186, DOI 10.1109/42.845177; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Rodriguez J, 2010, ANN INTERN MED, V152, P201, DOI 10.7326/0003-4819-152-4-201002160-00004; Rommel KP, 2016, J AM COLL CARDIOL, V67, P1815, DOI 10.1016/j.jacc.2016.02.018; SAMET P, 1966, CIRCULATION, V33, P847, DOI 10.1161/01.CIR.33.6.847; Santos S, 2002, EUR RESPIR J, V19, P632, DOI 10.1183/09031936.02.00245902; SAXTON GA, 1956, J CLIN INVEST, V35, P611, DOI 10.1172/JCI103316; Schane RE, 2010, CIRCULATION, V121, P1518, DOI 10.1161/CIRCULATIONAHA.109.904235; Shikata H, 2009, INT J BIOMED IMAGING, V2009, DOI 10.1155/2009/636240; Sibley CT, 2012, RADIOLOGY, V265, P724, DOI 10.1148/radiol.12112721; Sieren JP, 2016, AM J RESP CRIT CARE, V194, P794, DOI 10.1164/rccm.201506-1208PP; Smith BM, 2013, CHEST, V144, P1143, DOI 10.1378/chest.13-0183; Smith BM, 2013, CIRCULATION, V127, P1503, DOI 10.1161/CIRCULATIONAHA.113.001653; Smith NL, 1999, J CLIN EPIDEMIOL, V52, P143, DOI 10.1016/S0895-4356(98)00141-3; Stone IS, 2016, AM J RESP CRIT CARE, V193, P717, DOI 10.1164/rccm.201508-1647OC; Sun XG, 2001, CIRCULATION, V104, P429, DOI 10.1161/hc2901.093198; Tomiyama H, 2010, J AM COLL CARDIOL, V55, P1979, DOI 10.1016/j.jacc.2009.12.042; Weibel E.R., 1963, MORPHOMETRY HUMAN LU, DOI DOI 10.1007/978-3-642-87553-3; Yamato H, 1996, LAB INVEST, V75, P211; Yi CJ, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0121-5; Young AA, 2000, RADIOLOGY, V216, P597, DOI 10.1148/radiology.216.2.r00au14597	65	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176180	10.1371/journal.pone.0176180	http://dx.doi.org/10.1371/journal.pone.0176180			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426728	gold, Green Published, Green Submitted			2022-12-26	WOS:000399875900116
J	Hong, SE; Kim, TY; Yoo, JH; Kim, JK; Kim, SG; Kim, HJ; Song, YR				Hong, Seong Eun; Kim, Tae-Young; Yoo, Je-Hyun; Kim, Jwa-Kyung; Kim, Sung Gyun; Kim, Hyung Jik; Song, Young Rim			Acute kidney injury can predict in-hospital and long-term mortality in elderly patients undergoing hip fracture surgery	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; RENAL DYSFUNCTION; EXCESS MORTALITY; RISK; POPULATION; DISEASE; ADULTS; NECK; MEN; AGE	Background Hip fracture is a common health problem in the elderly that is associated with increased mortality. Acute kidney injury (AKI) is a frequent complication in elderly patients undergoing surgery and is associated with the clinical outcome. We evaluated the incidence and risk factors of AKI in elderly patients undergoing hip fracture surgery and the impact of AKI on short-and long-term clinical outcomes. Methods We performed a retrospective cohort study of 450 elderly patients who underwent hip fracture surgery between January 2010 and December 2012. We defined AKI according to the Acute Kidney Injury Network (AKIN) criteria and investigated the effect of AKI on the duration of hospital stay and in-hospital and long-term mortality. Results Of the 450 patients, 95 (21.1%) developed AKI during hospitalization and 178 (39.6%) died, with a mean follow-up of 3.6 +/- 1.0 years. The baseline serum creatinine level, use of angiotensin-converting enzyme inhibitors or angiotensin-II receptor antagonists, red blood cell transfusion volume, and history of coronary artery disease were independent risk factors for AKI. Patients with AKI during hospitalization had significantly longer hospital stays and higher in-hospital and long-term mortality than those without AKI. Multivariate analysis revealed that age, history of coronary artery disease, serum albumin level, and AKI were independent predictors of long-term mortality. Conclusions AKI is a frequent complication in elderly patients undergoing hip fracture surgery and is independently associated with increased in-hospital and long-term mortality.	[Hong, Seong Eun; Kim, Jwa-Kyung; Kim, Sung Gyun; Kim, Hyung Jik; Song, Young Rim] Hallym Univ, Dept Internal Med, Sacred Heart Hosp, Anyang, South Korea; [Kim, Tae-Young; Yoo, Je-Hyun] Hallym Univ, Sacred Heart Hosp, Dept Orthoped Surg, Anyang, South Korea; [Kim, Jwa-Kyung; Kim, Sung Gyun; Kim, Hyung Jik; Song, Young Rim] Hallym Univ, Kidney Res Inst, Seoul, South Korea	Hallym University; Hallym University; Hallym University	Song, YR (corresponding author), Hallym Univ, Dept Internal Med, Sacred Heart Hosp, Anyang, South Korea.; Song, YR (corresponding author), Hallym Univ, Kidney Res Inst, Seoul, South Korea.	yrisong@hanmail.net	Barretti, Pasqual/K-4156-2012	Barretti, Pasqual/0000-0003-4979-4836				Abdel-Kader K, 2009, CLIN GERIATR MED, V25, P331, DOI 10.1016/j.cger.2009.04.001; Anderson S, 2011, J AM SOC NEPHROL, V22, P28, DOI 10.1681/ASN.2010090934; Bennet SJ, 2010, INJURY, V41, P335, DOI 10.1016/j.injury.2009.07.009; Bihorac A, 2009, ANN SURG, V249, P851, DOI 10.1097/SLA.0b013e3181a40a0b; Cameron ID, 2010, HIP FRACTURE CAUSES; Carpintero P, 2014, WORLD J ORTHOP, V5, P402, DOI 10.5312/wjo.v5.i4.402; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; de Geus HRH, 2012, CLIN KIDNEY J, V5, P102, DOI 10.1093/ckj/sfs008; Eren Z, 2012, EUR GERIATR MED, V3, P345, DOI 10.1016/j.eurger.2012.07.456; Forsen L, 1999, OSTEOPOROSIS INT, V10, P73, DOI 10.1007/s001980050197; Goldwasser P, 1997, J CLIN EPIDEMIOL, V50, P693, DOI 10.1016/S0895-4356(97)00015-2; Haentjens P, 2010, ANN INTERN MED, V152, P380, DOI 10.7326/0003-4819-152-6-201003160-00008; Hagino T, 2013, ARCH ORTHOP TRAUM SU, V133, P507, DOI 10.1007/s00402-013-1693-x; Harty John, 2014, Ulster Med J, V83, P149; Hobson CE, 2009, CIRCULATION, V119, P2444, DOI 10.1161/CIRCULATIONAHA.108.800011; Kayatas K, 2014, RENAL FAILURE, V36, P1273, DOI 10.3109/0886022X.2014.934693; Khan SK, 2013, AGE AGEING, V42, P76, DOI 10.1093/ageing/afs152; Levey AS, 2015, JAMA-J AM MED ASSOC, V313, P837, DOI 10.1001/jama.2015.0602; Lewis JR, 2006, INJURY, V37, P698, DOI 10.1016/j.injury.2006.04.121; Maaravi Y, 2007, QJM-INT J MED, V100, P441, DOI 10.1093/qjmed/hcm043; Maaravi Y, 2006, QJM-INT J MED, V99, P97, DOI 10.1093/qjmed/hcl002; Macedo E, 2010, NEPHROL DIAL TRANSPL; Martensson J, 2014, CURR OPIN CRIT CARE, V20, P451, DOI 10.1097/MCC.0000000000000107; Michels WM, 2010, CLIN J AM SOC NEPHRO, V5, P1003, DOI 10.2215/CJN.06870909; Newsome BB, 2008, ARCH INTERN MED, V168, P609, DOI 10.1001/archinte.168.6.609; Petersen MB, 2006, INJURY, V37, P705, DOI 10.1016/j.injury.2006.02.046; Pioli G, 2006, AGING CLIN EXP RES, V18, P381; Rosner MH, 2009, ACUTE KIDNEY INJURY; Sever MS, 2011, NEPHROL DIAL TRANSPL, V26, P515, DOI 10.1093/ndt/gfq426; Seyedi HR, 2015, ARCH BONE JT SURG-AB, V3, P51; Talsnes O, 2012, ARCH ORTHOP TRAUM SU, V132, P1753, DOI 10.1007/s00402-012-1611-7; Ulucay C, 2013, GERIATRIC ORTHOPAEDI; Vanmassenhove J, 2013, NEPHROL DIAL TRANSPL, V28, P254, DOI 10.1093/ndt/gfs380; Yun Y-S, 2013, KOREAN J MED, V84, P818	35	23	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176259	10.1371/journal.pone.0176259	http://dx.doi.org/10.1371/journal.pone.0176259			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426743	Green Published, Green Submitted, gold			2022-12-26	WOS:000399875900122
J	Zhang, X; Chu, Q; Guo, G; Dong, GH; Li, XZ; Zhang, Q; Zhang, SL; Zhang, ZW; Wang, YC				Zhang, Xu; Chu, Qin; Guo, Gang; Dong, Ganghui; Li, Xizhi; Zhang, Qin; Zhang, Shengli; Zhang, Zhiwu; Wang, Yachun			Genome-wide association studies identified multiple genetic loci for body size at four growth stages in Chinese Holstein cattle	PLOS ONE			English	Article							CONDITION SCORE; HEART-GIRTH; PARAMETER-ESTIMATION; CONFORMATION TRAITS; MOLECULAR-CLONING; FRIESIAN CATTLE; PROMOTER REGION; MILK-PRODUCTION; BONE-GROWTH; DAIRY	The growth and maturity of cattle body size affect not only feed efficiency, but also productivity and longevity. Dissecting the genetic architecture of body size is critical for cattle breeding to improve both efficiency and productivity. The volume and weight of body size are indicated by several measurements. Among them, Heart Girth (HG) and Hip Height (HH) are the most important traits. They are widely used as predictors of body weight (BW). Few association studies have been conducted for HG and HH in cattle focusing on single growth stage. In this study, we extended the Genome-wide association studies to a full spectrum of four growth stages (6-, 12-, 18-, and 24-months after birth) in Chinese Holstein heifers. The whole genomic single nucleotide polymorphisms (SNPs) were obtained from the Illumina BovineSNP50 v2 BeadChip genotyped on 3,325 individuals. Estimated breeding values (EBVs) were derived for both HG and HH at the four different ages and analyzed separately for GWAS by using the Fixed and random model Circuitous Probability Unification (Farm-CPU) method. In total, 27 SNPs were identified to be significantly associated with HG and HH at different growth stages. We found 66 candidate genes located nearby the associated SNPs, including nine genes that were known as highly related to development and skeletal and muscular growth. In addition, biological function analysis was performed by Ingenuity Pathway Analysis and an interaction network related to development was obtained, which contained 16 genes out of the 66 candidates. The set of putative genes provided valuable resources and can help elucidate the genomic architecture and mechanisms underlying growth traits in dairy cattle.	[Zhang, Xu; Zhang, Qin; Zhang, Shengli; Wang, Yachun] China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Key Lab Agr Anim Genet & Breeding, Beijing, Peoples R China; [Zhang, Xu; Zhang, Zhiwu] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; [Chu, Qin] Beijing Acad Agr & Forestry Sci, Inst Anim Husb & Vet Med, Beijing, Peoples R China; [Guo, Gang; Dong, Ganghui; Li, Xizhi] Beijing Sunlon Livestock Dev Co Ltd, Beijing, Peoples R China	China Agricultural University; Washington State University; Beijing Academy of Agriculture & Forestry	Wang, YC (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Key Lab Agr Anim Genet & Breeding, Beijing, Peoples R China.; Zhang, ZW (corresponding author), Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA.	zhiwu.zhang@wsw.edu; wangyachun@cau.edu.cn	Zhang, Zhiwu/P-6156-2016; Zhang, zs/GXN-3521-2022	Zhang, Zhiwu/0000-0002-5784-9684; 	earmarked fund for Modern Agro-industry Technology Research System [CARS-37]; Agricultural Research Center at Washington State University, College of Agricultural, Human, and Natural Resource Sciences [17A-3019-8663]; Washington Grain Commission [126593]; China Scholarship Council [201406350114]; Program for Changjiang Scholar and Innovation Research Team in University [IRT1191]; Beijing Sunlon Livestock Development Co. Ltd.	earmarked fund for Modern Agro-industry Technology Research System; Agricultural Research Center at Washington State University, College of Agricultural, Human, and Natural Resource Sciences; Washington Grain Commission; China Scholarship Council(China Scholarship Council); Program for Changjiang Scholar and Innovation Research Team in University; Beijing Sunlon Livestock Development Co. Ltd.	This work was financially supported by the earmarked fund for Modern Agro-industry Technology Research System (CARS-37), the Agricultural Research Center at Washington State University, College of Agricultural, Human, and Natural Resource Sciences (17A-3019-8663), Washington Grain Commission (126593), China Scholarship Council (201406350114), and the Program for Changjiang Scholar and Innovation Research Team in University (IRT1191). Beijing Sunlon Livestock Development Co. Ltd. provided support in the form of salaries for authors GG, GD, and XL and assisted in measurement and data collection for this study. The funder had no additional role in study design, decision to publish, or preparation of the manuscript.	Amann R, 2014, DEV BIOL, V394, P228, DOI 10.1016/j.ydbio.2014.08.016; Bardakcioglu HE, 2011, J ANIM VET ADV, V10, P1735; Behrens A, 2003, DEVELOPMENT, V130, P103, DOI 10.1242/dev.00186; Bilal G, 2016, CAN J ANIM SCI, V96, P434, DOI 10.1139/cjas-2015-0127; Bluteau G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105210; Bolormaa S., 2009, Matching genetics and environment: a new look at an old topic. Proceedings of the 18th Conference of the Association for the Advancement of Animal Breeding and Genetics, Barossa Valley, South Australia, Australia, 28 September-1 October, 2009, P125; Buzanskas ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094802; Catela C, 2009, DIS MODEL MECH, V2, P283, DOI 10.1242/dmm.002287; Clempson AM, 2011, J DAIRY SCI, V94, P3618, DOI 10.3168/jds.2010-3626; COFFIN JD, 1995, MOL BIOL CELL, V6, P1861, DOI 10.1091/mbc.6.12.1861; Cole JB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-408; Copf T, 2015, EUR J NEUROSCI, V42, P2234, DOI 10.1111/ejn.13002; Dahl JP, 2000, BIOCHEMISTRY-US, V39, P14877, DOI 10.1021/bi001073y; de Haas Y, 2007, J ANIM BREED GENET, V124, P12, DOI 10.1111/j.1439-0388.2007.00630.x; Dechow CD, 2003, J DAIRY SCI, V86, P2236, DOI 10.3168/jds.S0022-0302(03)73814-4; Dekkers J. C. M., 2004, J ANIM SCI, V82, pE313; Deng YJ, 2016, CELL REP, V14, P2224, DOI 10.1016/j.celrep.2016.02.021; Engling A, 2002, J CELL SCI, V115, P3619, DOI 10.1242/jcs.00036; Farooq M, 2016, J HUM GENET, V61, P271, DOI 10.1038/jhg.2015.138; Florkiewicz RZ, 1998, J BIOL CHEM, V273, P544, DOI 10.1074/jbc.273.1.544; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; Fu WX, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0430-1; Gallo L, 2001, J DAIRY SCI, V84, P2321, DOI 10.3168/jds.S0022-0302(01)74680-2; Gilmour AR, 1995, BIOMETRICS, V51, P1440, DOI 10.2307/2533274; HAGGER C, 1991, LIVEST PROD SCI, V28, P265, DOI 10.1016/0301-6226(91)90147-I; Haile-Mariam M, 2013, J ANIM BREED GENET, V130, P20, DOI 10.1111/j.1439-0388.2013.01001.x; Heinrichs AJ, 2007, PREV VET MED, V78, P333, DOI 10.1016/j.prevetmed.2006.11.002; Heinrichs AJ, 1998, J ANIM SCI, V76, P1254; Huang W, 2010, ANIM GENET, V41, P570, DOI 10.1111/j.1365-2052.2010.02046.x; Hussain MS, 2012, AM J HUM GENET, V90, P871, DOI 10.1016/j.ajhg.2012.03.016; Jahuey-Martinez FJ, 2016, J ANIM SCI, V94, P4570, DOI 10.2527/jas.2016-0359; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Kadarmideen HN, 2003, J DAIRY SCI, V86, P3685, DOI 10.3168/jds.S0022-0302(03)73974-5; Kashyap N, 2015, VET WORLD, V8, P892, DOI 10.14202/vetworld.2015.892-897; Koenen EPC, 1998, J DAIRY SCI, V81, P1709, DOI 10.3168/jds.S0022-0302(98)75738-8; Kraatz S, 2016, STRUCTURE, V24, P1358, DOI 10.1016/j.str.2016.06.011; Laue K, 2008, DEVELOPMENT, V135, P3775, DOI 10.1242/dev.021238; Lesosky M, 2012, TROP ANIM HEALTH PRO, V45, P311, DOI 10.1007/s11250-012-0220-3; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Liu XL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005767; Liu YF, 2011, GENET MOL RES, V10, P1777, DOI 10.4238/vol10-3gmr1466; Liu YZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006827; Liu Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166146; Lu D, 2013, J ANIM SCI, V91, P3612, DOI 10.2527/jas.2012-5716; Lu Y, 2015, DEV GROWTH DIFFER, V57, P614, DOI 10.1111/dgd.12250; Lu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079495; Luco SM, 2016, BMC MED GENET, V17, DOI 10.1186/s12881-016-0276-4; Madsen P., 2013, USERS GUIDE DMU VERS; Marques F, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006307; Matoso E, 2014, MOL CYTOGENET, V7, DOI 10.1186/s13039-014-0087-2; Meredith BK, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-21; Minegishi Y, 2014, BIOCHEM BIOPH RES CO, V454, P12, DOI 10.1016/j.bbrc.2014.10.001; Munim T, 2013, ANIM SCI J, V84, P206, DOI 10.1111/asj.12005; Niu TH, 2015, HUM MOL GENET, V24, P4710, DOI 10.1093/hmg/ddv144; Pryce JE, 2011, GENETICS, V187, P981, DOI 10.1534/genetics.110.123943; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Randhawa IAS, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-34; Reijntjes S, 2007, INT J DEV BIOL, V51, P351, DOI 10.1387/ijdb.062258sr; [任小丽 Ren Xiaoli], 2013, [中国农业科学, Scientia Agricultura Sinica], V46, P5020; Ross AC, 2011, ANNU REV NUTR, V31, P65, DOI 10.1146/annurev-nutr-072610-145127; Sahana G, 2010, ANIM GENET, V41, P579, DOI 10.1111/j.1365-2052.2010.02064.x; Santana ML, 2013, LIVEST SCI, V154, P13, DOI 10.1016/j.livsci.2013.02.018; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; Szklarczyk R, 2016, NUCLEIC ACIDS RES, V44, pD567, DOI 10.1093/nar/gkv1228; Tao S, 2012, J DAIRY SCI, V95, P7128, DOI 10.3168/jds.2012-5697; Thomasen JR, 2008, J DAIRY SCI, V91, P2098, DOI 10.3168/jds.2007-0602; Trueb B, 2011, CELL MOL LIFE SCI, V68, P951, DOI 10.1007/s00018-010-0576-3; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; VanRaden PM, 2004, J DAIRY SCI, V87, P3125, DOI 10.3168/jds.S0022-0302(04)73447-5; Wen J, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-100; Winsor CP, 1932, P NATL ACAD SCI USA, V18, P1, DOI 10.1073/pnas.18.1.1; Wu XP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-897; Yang X, 1899, INT J MOL MED, V38, P30; Yang YQ, 2013, GENET MOL RES, V12, P3651, DOI 10.4238/2013.September.13.9; Yu Y, 2010, CHINA ANIM HUSB VET, V37, P106; Zacherl S, 2015, J BIOL CHEM, V290, P3654, DOI 10.1074/jbc.M114.590067; Zhao FP, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0127-3	78	15	16	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175971	10.1371/journal.pone.0175971	http://dx.doi.org/10.1371/journal.pone.0175971			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426785	Green Published, gold, Green Submitted			2022-12-26	WOS:000399875900077
J	Hsu, YL; Hung, JY; Chang, WA; Lin, YS; Pan, YC; Tsai, PH; Wu, CY; Kuo, PL				Hsu, Y-L; Hung, J-Y; Chang, W-A; Lin, Y-S; Pan, Y-C; Tsai, P-H; Wu, C-Y; Kuo, P-L			Hypoxic lung cancer-secreted exosomal miR-23a increased angiogenesis and vascular permeability by targeting prolyl hydroxylase and tight junction protein ZO-1	ONCOGENE			English	Article							FACTOR-1-ALPHA MESSENGER-RNA; PROSTATE-CANCER; UP-REGULATION; CELLS; HIF-1-ALPHA; METASTASIS; EXPRESSION; PHD2; TRANSCRIPTION; MICRORNAS	Hypoxia plays a critical role during the evolution of malignant cells and tumour microenvironment (TME). Tumour-derived exosomes contain informative microRNAs involved in the interaction of cancer and stromal cells, thus contributing to tissue remodelling of tumour microenvironment. This study aims to clarify how hypoxia affects tumour angiogenesis through exosomes shed from lung cancer cells. Lung cancer cells produce more exosomes under hypoxic conditions than do parental cells under normoxic conditions. miR-23a was significantly upregulated in exosomes from lung cancer under hypoxic conditions. Exosomal miR-23a directly suppressed its target prolyl hydroxylase 1 and 2 (PHD1 and 2), leading to the accumulation of hypoxia-inducible factor-1 alpha (HIF-1 alpha) in endothelial cells. Consequently, hypoxic lung cancer cells enhanced angiogenesis by exosomes derived from hypoxic cancer under both normoxic and hypoxic conditions. In addition, exosomal miR-23a also inhibits tight junction protein ZO-1, thereby increasing vascular permeability and cancer transendothelial migration. Inhibition of miR-23a by inhibitor administration decreased angiogenesis and tumour growth in a mouse model. Furthermore, elevated levels of circulating miR-23a are found in the sera of lung cancer patients, and miR-23a levels are positively correlated with proangiogenic activities. Taken together, our study reveals the clinical relevance and prognostic value of cancer-derived exosomal miR-23a under hypoxic conditions, and investigates a unique intercellular communication, mediated by cancer-derived exosomes, which modulates tumour vasculature.	[Hsu, Y-L] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Hung, J-Y; Chang, W-A] Kaohsiung Med Univ Hosp, Div Pulm & Crit Care Med, Kaohsiung, Taiwan; [Hung, J-Y] Kaohsiung Med Univ, Sch Med, Coll Med, Kaohsiung, Taiwan; [Chang, W-A; Lin, Y-S; Pan, Y-C; Tsai, P-H; Wu, C-Y; Kuo, P-L] Kaohsiung Med Univ, Grad Inst Clin Med, Coll Med, 100,Shih Chuan 1st Rd, Kaohsiung 807, Taiwan; [Kuo, P-L] Natl Sun Yat Sen Univ, Inst Med Sci & Technol, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; National Sun Yat Sen University	Kuo, PL (corresponding author), Kaohsiung Med Univ, Grad Inst Clin Med, Coll Med, 100,Shih Chuan 1st Rd, Kaohsiung 807, Taiwan.	kuopolin@seed.net.tw			Ministry of Science and Technology [MOST 104-2314-B-037-053-MY4, MOST 104-2320-B-037-014-MY3, MOST 103-2320-B-037-006-MY3]; Kaohsiung Medical University 'Aim for the Top Journals Grant' [KMU-DT106005]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Kaohsiung Medical University 'Aim for the Top Journals Grant'	This study was supported by grants from the Ministry of Science and Technology (MOST 104-2314-B-037-053-MY4; MOST 104-2320-B-037-014-MY3; MOST 103-2320-B-037-006-MY3), and the Kaohsiung Medical University 'Aim for the Top Journals Grant' (Grant No. KMU-DT106005).	Anderson JD, 2016, STEM CELLS, V34, P601, DOI 10.1002/stem.2298; Arjaans M, 2016, ONCOTARGET, V7, P21247, DOI 10.18632/oncotarget.6918; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Borges FT, 2013, J AM SOC NEPHROL, V24, P385, DOI 10.1681/ASN.2012101031; Branco-Price C, 2012, CANCER CELL, V21, P52, DOI 10.1016/j.ccr.2011.11.017; Crosby ME, 2009, CANCER RES, V69, P1221, DOI 10.1158/0008-5472.CAN-08-2516; Cui H, 2015, ONCOGENE, V34, P3640, DOI 10.1038/onc.2014.300; del Peso L, 2003, J BIOL CHEM, V278, P48690, DOI 10.1074/jbc.M308862200; Ding GP, 2015, ONCOTARGET, V6, P29877, DOI 10.18632/oncotarget.4924; Foster JG, 2014, FUTURE ONCOL, V10, P2659, DOI 10.2217/fon.14.201; Galaup A, 2006, P NATL ACAD SCI USA, V103, P18721, DOI 10.1073/pnas.0609025103; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Hosseini-Beheshti E, 2016, ONCOTARGET, V7, P14639, DOI 10.18632/oncotarget.7052; Kohlhapp FJ, 2015, ONCOGENE, V34, P5857, DOI 10.1038/onc.2015.89; Kosaka N, 2013, J BIOL CHEM, V288, P10849, DOI 10.1074/jbc.M112.446831; Koshikawa N, 2003, ONCOGENE, V22, P6717, DOI 10.1038/sj.onc.1206765; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Li L, 2016, CANCER RES, V76, P1770, DOI 10.1158/0008-5472.CAN-15-1625; Li XJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11017; Ma Y, 2014, ONCOTARGET, V5, P9169, DOI 10.18632/oncotarget.2396; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; Pefanis E, 2015, CELL, V161, P774, DOI 10.1016/j.cell.2015.04.034; Pientka FK, 2012, J CELL SCI, V125, P5168, DOI 10.1242/jcs.109041; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Rankin EB, 2016, SCIENCE, V352, P175, DOI 10.1126/science.aaf4405; Rodriguez PL, 2014, INT J CANCER, V134, P1034, DOI 10.1002/ijc.28433; Sanchez CA, 2016, ONCOTARGET, V7, P3993, DOI 10.18632/oncotarget.6540; Schumacher D, 2013, CANCER CELL, V24, P130, DOI 10.1016/j.ccr.2013.05.008; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Song D, 2014, J BIOL CHEM, V289, P14656, DOI 10.1074/jbc.M113.541227; Tichet M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7993; Tornavaca O, 2015, J CELL BIOL, V208, P821, DOI 10.1083/jcb.201404140; Trikha P, 2016, ONCOGENE, V35, P3636, DOI 10.1038/onc.2015.429; Wang Q, 2014, GENE, V541, P69, DOI 10.1016/j.gene.2014.03.025; Wang SW, 2015, CARCINOGENESIS, V36, P104, DOI 10.1093/carcin/bgu218; Wang T, 2014, P NATL ACAD SCI USA, V111, pE3234, DOI 10.1073/pnas.1410041111; Wu YC, 2016, ONCOGENE, V35, P2123, DOI 10.1038/onc.2015.274; Yamakawa M, 2003, CIRC RES, V93, P664, DOI 10.1161/01.RES.0000093984.48643.D7; Yohena T, 2009, J THORAC ONCOL, V4, P284, DOI 10.1097/JTO.0b013e31819852d5; Zhang D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.240; Zhao HY, 2016, ELIFE, V5, DOI 10.7554/eLife.10250; Zhou WY, 2014, CANCER CELL, V25, P501, DOI 10.1016/j.ccr.2014.03.007	42	339	357	11	110	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 24	2017	36	34					4929	4942		10.1038/onc.2017.105	http://dx.doi.org/10.1038/onc.2017.105			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FE5EI	28436951				2022-12-26	WOS:000408234400009
J	Rathore, U; Saha, P; Kesavardhana, S; Kumar, AA; Datta, R; Devanarayanan, S; Das, R; Mascola, JR; Varadarajan, R				Rathore, Ujjwal; Saha, Piyali; Kesavardhana, Sannula; Kumar, Aditya Arun; Datta, Rohini; Devanarayanan, Sivasankar; Das, Raksha; Mascola, John R.; Varadarajan, Raghavan			Glycosylation of the core of the HIV-1 envelope subunit protein gp120 is not required for native trimer formation or viral infectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; N-LINKED GLYCOSYLATION; BROADLY NEUTRALIZING ANTIBODIES; CRYO-EM STRUCTURE; B-CELL RESPONSES; STRUCTURAL BASIS; POTENT NEUTRALIZATION; MONOCLONAL-ANTIBODY; DEPENDENT EPITOPE; CRYSTAL-STRUCTURE	The gp120 subunit of the HIV-1 envelope (Env) protein is heavily glycosylated at similar to 25 glycosylation sites, of which similar to 7-8 are located in the V1/V2 and V3 variable loops and the others in the remaining core gp120 region. Glycans partially shield Env from recognition by the host immune system and also are believed to be indispensable for proper folding of gp120 and for viral infectivity. Previous attempts to alter glycosylation sites in Env typically involved mutating the glycosylated asparagine residues to structurally similar glutamines or alanines. Here, we confirmed that such mutations at multiple glycosylation sites greatly diminish viral infectivity and result in significantly reduced binding to both neutralizing and non-neutralizing antibodies. Therefore, using an alternative approach, we combined evolutionary information with structure-guided design and yeast surface display to produce properly cleaved HIV-1 Env variants that lack all 15 core gp120 glycans, yet retain conformational integrity and multiple-cycle viral infectivity and bind to several broadly neutralizing antibodies (bNAbs), including trimer-specific antibodies and a germline-reverted version of the bNAb VRC01. Our observations demonstrate that core gp120 glycans are not essential for folding, and hence their likely primary role is enabling immune evasion. We also show that our glycan removal approach is not strain restricted. Glycan-deficient Env derivatives can be used as priming immunogens because they should engage and activate a more divergent set of germlines than fully glycosylated Env. In conclusion, these results clarify the role of core gp120 glycosylation and illustrate a general method for designing glycan-free folded protein derivatives.	[Rathore, Ujjwal; Saha, Piyali; Kesavardhana, Sannula; Kumar, Aditya Arun; Datta, Rohini; Devanarayanan, Sivasankar; Das, Raksha; Varadarajan, Raghavan] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20814 USA; [Varadarajan, Raghavan] Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560064, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Varadarajan, R (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.; Varadarajan, R (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560064, Karnataka, India.	varadar@mbu.iisc.ernet.in	Mascola, John/AAI-7193-2021; Datta, Rohini/ABB-7867-2020; Rathore, Ujjwal/AAD-9974-2021	Rathore, Ujjwal/0000-0002-0329-7431; Datta, Rohini/0000-0003-2693-1922	National Institutes of Health from NIAID [R01A1118366-01]; Department of Biotechnology and Department of Science and Technology, Government of India [BT/PR4791/MED/29/465/2012]; Council of Scientific and Industrial Research, Government of India; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118366] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Biotechnology and Department of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaDepartment of Science & Technology (India)); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant R01A1118366-01 from NIAID and Department of Biotechnology and Department of Science and Technology, Government of India, Grant BT/PR4791/MED/29/465/2012. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipients of a fellowship from the Council of Scientific and Industrial Research, Government of India.	Arakawa T, 2010, J PHARM SCI-US, V99, P1674, DOI 10.1002/jps.21974; BACK NKT, 1994, VIROLOGY, V199, P431, DOI 10.1006/viro.1994.1141; Behrens AJ, 2016, CELL REP, V14, P2695, DOI 10.1016/j.celrep.2016.02.058; Berlioz-Torrent C, 1999, J VIROL, V73, P1350, DOI 10.1128/JVI.73.2.1350-1361.1999; Bhattacharyya S, 2013, J BIOL CHEM, V288, P9815, DOI 10.1074/jbc.M112.425959; Bhattacharyya S, 2010, J BIOL CHEM, V285, P27100, DOI 10.1074/jbc.M110.152272; Binley JM, 2010, J VIROL, V84, P5637, DOI 10.1128/JVI.00105-10; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; Bohne-Lang A, 2005, NUCLEIC ACIDS RES, V33, pW214, DOI 10.1093/nar/gki385; Bolmstedt A, 1996, J ACQ IMMUN DEF SYND, V12, P213, DOI 10.1097/00042560-199607000-00001; Bowley DR, 2007, PROTEIN ENG DES SEL, V20, P81, DOI 10.1093/protein/gzl057; Briney B, 2016, CELL, V166, P1459, DOI 10.1016/j.cell.2016.08.005; Bunnik EM, 2010, NAT MED, V16, P995, DOI 10.1038/nm.2203; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Choi BK, 2003, P NATL ACAD SCI USA, V100, P5022, DOI 10.1073/pnas.0931263100; Cole KS, 2004, J VIROL, V78, P1525, DOI 10.1128/JVI.78.3.1525-1539.2004; Connor RI, 1998, J VIROL, V72, P1552, DOI 10.1128/JVI.72.2.1552-1576.1998; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Dacheux L, 2004, J VIROL, V78, P12625, DOI 10.1128/JVI.78.22.12625-12637.2004; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Derdeyn CA, 2008, CURR OPIN HIV AIDS, V3, P16, DOI 10.1097/COH.0b013e3282f2982c; Doores KJ, 2010, J VIROL, V84, P10510, DOI 10.1128/JVI.00552-10; Dosenovic P, 2015, CELL, V161, P1505, DOI 10.1016/j.cell.2015.06.003; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; FENOUILLET E, 1994, TRENDS BIOCHEM SCI, V19, P65, DOI 10.1016/0968-0004(94)90034-5; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Freund NT, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005238; Frost SDW, 2005, P NATL ACAD SCI USA, V102, P18514, DOI 10.1073/pnas.0504658102; Gagneux P, 1999, GLYCOBIOLOGY, V9, P747, DOI 10.1093/glycob/9.8.747; Gai SA, 2007, CURR OPIN STRUC BIOL, V17, P467, DOI 10.1016/j.sbi.2007.08.012; Ghimire D, 2017, SCI REP-UK, V7, DOI 10.1038/srep43711; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; Go EP, 2013, J PROTEOME RES, V12, P1223, DOI 10.1021/pr300870t; Go EP, 2011, J VIROL, V85, P8270, DOI 10.1128/JVI.05053-11; Graham BS, 1998, J INFECT DIS, V177, P310, DOI 10.1086/514209; Grundner C, 2005, VIROLOGY, V331, P33, DOI 10.1016/j.virol.2004.09.022; Grundner C, 2004, VIROLOGY, V330, P233, DOI 10.1016/j.virol.2004.08.037; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hoot S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003106; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang X, 2012, VIROLOGY, V423, P97, DOI 10.1016/j.virol.2011.11.023; Ibarra-Molero B, 1999, BIOCHEMISTRY-US, V38, P8138, DOI 10.1021/bi9905819; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Jardine JG, 2016, SCIENCE, V351, P1458, DOI 10.1126/science.aad9195; Jardine JG, 2015, SCIENCE, V349, P156, DOI 10.1126/science.aac5894; Joseph SB, 2015, NAT REV MICROBIOL, V13, P414, DOI 10.1038/nrmicro3471; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kesavardhana S, 2014, J VIROL, V88, P9590, DOI 10.1128/JVI.00494-14; Kim YS, 2006, PROTEINS, V62, P1026, DOI 10.1002/prot.20618; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Koch M, 2003, VIROLOGY, V313, P387, DOI 10.1016/S0042-6822(03)00294-0; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kuiken C, 2010, HIV SEQUENCE COMPEND; Kulp DW, 2013, CURR OPIN VIROL, V3, P322, DOI 10.1016/j.coviro.2013.05.010; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; LABRANCHE CC, 1995, J VIROL, V69, P5217, DOI 10.1128/JVI.69.9.5217-5227.1995; Leaman DP, 2010, J VIROL, V84, P3382, DOI 10.1128/JVI.02363-09; Lee JH, 2016, SCIENCE, V351, P1043, DOI 10.1126/science.aad2450; LEE WR, 1992, P NATL ACAD SCI USA, V89, P2213, DOI 10.1073/pnas.89.6.2213; Lehmann M, 2001, CURR OPIN BIOTECH, V12, P371, DOI 10.1016/S0958-1669(00)00229-9; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; LI Y, 1993, J VIROL, V67, P584, DOI 10.1128/JVI.67.1.584-588.1993; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Ma BJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002200; Mata-Fink J, 2013, J MOL BIOL, V425, P444, DOI 10.1016/j.jmb.2012.11.010; McCaffrey RA, 2004, J VIROL, V78, P3279, DOI 10.1128/JVI.78.7.3279-3295.2004; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; McGuire AT, 2013, J EXP MED, V210, P655, DOI 10.1084/jem.20122824; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Moore Michael D., 2009, V485, P87, DOI 10.1007/978-1-59745-170-3_7; Moore PL, 2012, NAT MED, V18, P1688, DOI 10.1038/nm.2985; Mouquet H, 2013, NATURE, V496, P441, DOI 10.1038/nature12091; Murad W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S12; Nawaz F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001301; Ohgimoto S, 1998, J VIROL, V72, P8365, DOI 10.1128/JVI.72.10.8365-8370.1998; Olofsson S, 1998, SCAND J INFECT DIS, V30, P435, DOI 10.1080/00365549850161386; Onda M, 2008, P NATL ACAD SCI USA, V105, P11311, DOI 10.1073/pnas.0804851105; Overbaugh J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007039; Pancera M, 2005, VIROLOGY, V332, P145, DOI 10.1016/j.virol.2004.10.042; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pancera M, 2013, NAT STRUCT MOL BIOL, V20, P804, DOI 10.1038/nsmb.2600; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Pantophlet R, 2004, PROTEIN ENG DES SEL, V17, P749, DOI 10.1093/protein/gzh085; Parren PWHI, 1997, IMMUNOL LETT, V57, P105, DOI 10.1016/S0165-2478(97)00043-6; PEDEN K, 1991, VIROLOGY, V185, P661, DOI 10.1016/0042-6822(91)90537-L; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pejchal R, 2010, P NATL ACAD SCI USA, V107, P11483, DOI 10.1073/pnas.1004600107; Ping LH, 2013, J VIROL, V87, P7218, DOI 10.1128/JVI.03577-12; Pritchard LK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8479; Rathore U, 2014, BBA-PROTEINS PROTEOM, V1844, P1891, DOI 10.1016/j.bbapap.2014.05.010; Reitter JN, 1998, NAT MED, V4, P679, DOI 10.1038/nm0698-679; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Sagt CMJ, 2000, APPL ENVIRON MICROB, V66, P4940, DOI 10.1128/AEM.66.11.4940-4944.2000; Saha P, 2011, BIOCHEMISTRY-US, V50, P7891, DOI 10.1021/bi200870r; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scanlan CN, 2007, NATURE, V446, P1038, DOI 10.1038/nature05818; Scharf L, 2014, CELL REP, V7, P785, DOI 10.1016/j.celrep.2014.04.001; Scharf L, 2013, P NATL ACAD SCI USA, V110, P6049, DOI 10.1073/pnas.1303682110; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Schiffner T, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-72; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Shcherbakov DN, 2015, ACTA NATURAE, V7, P11, DOI 10.32607/20758251-2015-7-4-11-21; Shusta EV, 1999, J MOL BIOL, V292, P949, DOI 10.1006/jmbi.1999.3130; Si ZH, 2001, J VIROL, V75, P4208, DOI 10.1128/JVI.75.9.4208-4218.2001; Sok D, 2016, SCIENCE, V353, P1557, DOI 10.1126/science.aah3945; Stansell E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124784; Stansell Elizabeth, 2010, Yale Journal of Biology and Medicine, V83, P201; Steichen JM, 2016, IMMUNITY, V45, P483, DOI 10.1016/j.immuni.2016.08.016; Stewart-Jones GBE, 2016, CELL, V165, P813, DOI 10.1016/j.cell.2016.04.010; THALI M, 1991, J VIROL, V65, P5007, DOI 10.1128/JVI.65.9.5007-5012.1991; Tian M, 2016, CELL, V166, P1471, DOI 10.1016/j.cell.2016.07.029; Timilsina U, 2016, SCI REP-UK, V6, DOI 10.1038/srep27403; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; van den Kerkhof TLGM, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-102; van Gils MJ, 2013, VIROLOGY, V435, P46, DOI 10.1016/j.virol.2012.10.004; Varadarajan R, 2005, J VIROL, V79, P1713, DOI 10.1128/JVI.79.3.1713-1723.2005; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang CC, 2009, P NATL ACAD SCI USA, V106, P18137, DOI 10.1073/pnas.0909696106; Wang WB, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-14; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; West AP, 2012, P NATL ACAD SCI USA, V109, pE2083, DOI 10.1073/pnas.1208984109; Wibmer CK, 2016, J VIROL, V90, P10220, DOI 10.1128/JVI.01357-16; Wibmer CK, 2015, CURR OPIN HIV AIDS, V10, P135, DOI 10.1097/COH.0000000000000153; Wu SJ, 2010, PROTEIN ENG DES SEL, V23, P643, DOI 10.1093/protein/gzq037; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; WU Z, 1995, J VIROL, V69, P2271, DOI 10.1128/JVI.69.4.2271-2278.1995; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	143	19	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10197	10219		10.1074/jbc.M117.788919	http://dx.doi.org/10.1074/jbc.M117.788919			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28446609	Green Published, hybrid			2022-12-26	WOS:000403580600029
J	Li, Z; Shanmuganathan, A; Ruetz, M; Yamada, K; Lesniak, NA; Krautler, B; Brunold, TC; Koutmos, M; Banerjee, R				Li, Zhu; Shanmuganathan, Aranganathan; Ruetz, Markus; Yamada, Kazuhiro; Lesniak, Nicholas A.; Kraeutler, Bernhard; Brunold, Thomas C.; Koutmos, Markos; Banerjee, Ruma			Coordination chemistry controls the thiol oxidase activity of the B-12-trafficking protein CblC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN METHIONINE SYNTHASE; ZETA VALENCE QUALITY; GAUSSIAN-BASIS SETS; KOHN-SHAM THEORY; B-12 TRAFFICKING; CORRELATION-ENERGY; ATOMS LI; COBALAMIN; DENSITY; ADENOSYLCOBALAMIN	The cobalamin or B-12 cofactor supports sulfur and one-carbon metabolism and the catabolism of odd-chain fatty acids, branched-chain amino acids, and cholesterol. CblC is a B(12-)processing enzyme involved in an early cytoplasmic step in the cofactor-trafficking pathway. It catalyzes the glutathione (GSH)-dependent dealkylation of alkylcobalamins and the reductive decyanation of cyanocobalamin. CblC from Caenorhabditis elegans (ceCblC) also exhibits a robust thiol oxidase activity, converting reduced GSH to oxidized GSSG with concomitant scrubbing of ambient dissolved O-2. The mechanism of thiol oxidation catalyzed by ceCblC is not known. In this study, we demonstrate that novel coordination chemistry accessible to ceCblC-bound cobalamin supports its thiol oxidase activity via a glutathionyl-cobalamin intermediate. Deglutathionylation of glutathionyl-cobalamin by a second molecule of GSH yields GSSG. The crystal structure of ceCblC provides insights into how architectural differences at the alpha-and beta-faces of cobalamin promote the thiol oxidase activity of ceCblC but mute it in wild-type human CblC. The R161G and R161Q mutations in human CblC unmask its latent thiol oxidase activity and are correlated with increased cellular oxidative stress disease. In summary, we have uncovered key architectural features in the cobalamin-binding pocket that support unusual cob(II)alamin coordination chemistry and enable the thiol oxidase activity of ceCblC.	[Li, Zhu; Ruetz, Markus; Lesniak, Nicholas A.; Banerjee, Ruma] Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Shanmuganathan, Aranganathan; Yamada, Kazuhiro; Koutmos, Markos] Uniformed Serv Univ Hlth Sci, Dept Biochem, Bethesda, MD 20814 USA; [Kraeutler, Bernhard] Univ Innsbruck, Inst Organ Chem, Innrain 80-82, A-6020 Innsbruck, Austria; [Kraeutler, Bernhard] Univ Innsbruck, Ctr Mol Biosci, Innrain 80-82, A-6020 Innsbruck, Austria; [Brunold, Thomas C.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	University of Michigan System; University of Michigan; Uniformed Services University of the Health Sciences - USA; University of Innsbruck; University of Innsbruck; University of Wisconsin System; University of Wisconsin Madison	Banerjee, R (corresponding author), Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu		Li, Zhu/0000-0003-1536-9401; Koutmos, Markos/0000-0003-0933-6312	NCI, National Institutes of Health (NIH) [ACB-12002]; NIGMS, NIH [AGM-12006]; Argonne National Laboratory [AC02-06CH11357]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045776] Funding Source: NIH RePORTER	NCI, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Argonne National Laboratory(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	GM/CA at the Advanced Photon Source is funded by NCI, National Institutes of Health (NIH), Grant ACB-12002 and NIGMS, NIH, Grant AGM-12006. This research utilized resources at the Advanced Photon Source, operated for the United States Department of Energy Office of Science by Argonne National Laboratory under contract DE-AC02-06CH11357.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; Banerjee R, 2006, ACS CHEM BIOL, V1, P149, DOI 10.1021/cb6001174; Banerjee R, 2009, CURR OPIN CHEM BIOL, V13, P484, DOI 10.1016/j.cbpa.2009.07.007; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Blaszczyk AJ, 2016, J AM CHEM SOC, V138, P3416, DOI 10.1021/jacs.5b12592; Chen HP, 1997, BIOCHEMISTRY-US, V36, P14939, DOI 10.1021/bi971374g; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FRASCA V, 1988, BIOCHEMISTRY-US, V27, P8458, DOI 10.1021/bi00422a025; Froese DS, 2012, BIOCHEMISTRY-US, V51, P5083, DOI 10.1021/bi300150y; Gherasim C, 2015, J BIOL CHEM, V290, P11393, DOI 10.1074/jbc.M115.637132; Gherasim C, 2013, J BIOL CHEM, V288, P13186, DOI 10.1074/jbc.R113.458810; Gulati S, 1996, HUM MOL GENET, V5, P1859, DOI 10.1093/hmg/5.12.1859; HOFFMAN MZ, 1973, J PHYS CHEM-US, V77, P990, DOI 10.1021/j100627a005; ISHIDA A, 1993, J NUTR SCI VITAMINOL, V39, P115, DOI 10.3177/jnsv.39.115; JACOBSEN DW, 1984, BIOCHEMISTRY-US, V23, P2017, DOI 10.1021/bi00304a021; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim J, 2008, P NATL ACAD SCI USA, V105, P14551, DOI 10.1073/pnas.0805989105; Kim J, 2009, J BIOL CHEM, V284, P33418, DOI 10.1074/jbc.M109.057877; Koutmos M, 2011, J BIOL CHEM, V286, P29780, DOI 10.1074/jbc.M111.261370; KRAUTLER B, 1989, J AM CHEM SOC, V111, P8936; KRAUTLER B, 1987, HELV CHIM ACTA, V70, P1268, DOI 10.1002/hlca.19870700506; KUTZELNIGG W, 1990, IGLO METHOD AB INITI, V23; Leclerc D, 1996, HUM MOL GENET, V5, P1867, DOI 10.1093/hmg/5.12.1867; LEDLEY FD, 1988, AM J HUM GENET, V42, P839; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Lerner-Ellis JP, 2006, NAT GENET, V38, P93, DOI 10.1038/ng1683; LEXA D, 1983, ACCOUNTS CHEM RES, V16, P235, DOI 10.1021/ar00091a001; LEXA D, 1976, J AM CHEM SOC, V98, P2652, DOI 10.1021/ja00425a039; Li Z, 2014, J AM CHEM SOC, V136, P16108, DOI 10.1021/ja5077316; Li Z, 2014, J BIOL CHEM, V289, P16487, DOI 10.1074/jbc.M114.567339; Madej E, 2007, ARCH BIOCHEM BIOPHYS, V462, P94, DOI 10.1016/j.abb.2007.03.002; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Neese F, 2002, INORG CHIM ACTA, V337, P181, DOI 10.1016/S0020-1693(02)01031-9; Neese F, 2003, J CHEM PHYS, V118, P3939, DOI 10.1063/1.1540619; Neese F, 2001, J CHEM PHYS, V115, P11080, DOI 10.1063/1.1419058; Neese F., 2014, ORCA AB INITIO DENSI; Nilges MJ., 1979, THESIS, P1; PERDEW JP, 1986, PHYS REV B, V33, P8822, DOI 10.1103/PhysRevB.33.8822; PILBROW JR, 1982, B12, P431; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Richard E, 2009, HUM MUTAT, V30, P1558, DOI 10.1002/humu.21107; Ruetz M, 2013, ANGEW CHEM INT EDIT, V52, P2606, DOI 10.1002/anie.201209651; SCHAFER A, 1994, J CHEM PHYS, V100, P5829, DOI 10.1063/1.467146; SCHAFER A, 1992, J CHEM PHYS, V97, P2571, DOI 10.1063/1.463096; Stich TA, 2005, J AM CHEM SOC, V127, P8710, DOI 10.1021/ja042142p; Suarez-Moreira E, 2006, DALTON T, P5269, DOI 10.1039/b610158e; Suarez-Moreira E, 2009, J AM CHEM SOC, V131, P15078, DOI 10.1021/ja904670x; Weigend F, 2005, PHYS CHEM CHEM PHYS, V7, P3297, DOI 10.1039/b508541a; WOOD PM, 1988, BIOCHEM J, V253, P287, DOI 10.1042/bj2530287; Zheng DH, 1997, J ELECTROANAL CHEM, V429, P61, DOI 10.1016/S0022-0728(96)05021-8	55	13	13	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9733	9744		10.1074/jbc.M117.788554	http://dx.doi.org/10.1074/jbc.M117.788554			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28442570	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000403113000023
J	Saint-Pol, J; Billard, M; Dornier, E; Eschenbrenner, E; Danglot, L; Boucheix, C; Charrin, S; Rubinstein, E				Saint-Pol, Julien; Billard, Martine; Dornier, Emmanuel; Eschenbrenner, Etienne; Danglot, Lydia; Boucheix, Claude; Charrin, Stephanie; Rubinstein, Eric			New insights into the tetraspanin Tspan5 using novel monoclonal antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METALLOPROTEASE 10 ADAM10; TRANSMEMBRANE DOMAINS; STRUCTURAL DOMAINS; NOTCH ACTIVATION; ALPHA-SECRETASE; INTEGRIN; CD151; EXPRESSION; PROTEIN; ALPHA-3-BETA-1	Tspan5 is a member of a subgroup of tetraspanins referred to as TspanC8. These tetraspanins directly interact with the metalloprotease ADAM10, regulate its exit from the endoplasmic reticulum and subsequent trafficking, and differentially regulate its ability to cleave various substrates and activate Notch signaling. The study of Tspan5 has been limited by the lack of good antibodies. This study provides new insights into Tspan5 using new monoclonal antibodies (mAbs), including two mAbs recognizing both Tspan5 and the highly similar tetraspanin Tspan17. Using these mAbs, we show that endogenous Tspan5 associates with ADAM10 in human cell lines and in mouse tissues where it is the most abundant, such as the brain, the lung, the kidney, or the intestine. We also uncover two TspanC8-specific motifs in the large extracellular domain of Tspan5 that are important for ADAM10 interaction and exit from the endoplasmic reticulum. One of the anti-Tspan5 mAbs does not recognize Tspan5 associated with ADAM10, providing a convenient way to measure the fraction of Tspan5 not associated with ADAM10. This fraction is minor in the cell lines tested, and it increases upon transfection of cells with TspanC8 tetraspanins such as Tspan15 or Tspan33 that inhibit Notch signaling. Finally, two antibodies inhibit ligand-induced Notch signaling, and this effect is stronger in cells depleted of the TspanC8 tetraspanin Tspan14, further indicating that Tspan5 and Tspan14 can compensate for each other in Notch signaling.	[Saint-Pol, Julien; Billard, Martine; Eschenbrenner, Etienne; Boucheix, Claude; Charrin, Stephanie; Rubinstein, Eric] INSERM, U935, 14 Av Paul Vaillant Couturier, F-94807 Villejuif, France; [Saint-Pol, Julien; Billard, Martine; Dornier, Emmanuel; Eschenbrenner, Etienne; Boucheix, Claude; Charrin, Stephanie; Rubinstein, Eric] Univ Paris Sud, Inst Andre Lwoff, F-94807 Villejuif, France; [Dornier, Emmanuel] INSERM, U1004, F-94807 Villejuif, France; [Danglot, Lydia] Univ Paris Diderot, CNRS, UMR7592, Sorbonne Paris Cite,Inst Jacques Monod, F-75205 Paris, France; [Danglot, Lydia] INSERM, ERL U950, F-75205 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Rubinstein, E (corresponding author), INSERM, U935, 14 Av Paul Vaillant Couturier, F-94807 Villejuif, France.	eric.rubinstein@inserm.fr	DANGLOT, Lydia/G-5684-2013; CHARRIN, Stephanie/B-2892-2019; Rubinstein, Eric/B-4650-2019; Dornier, Emmanuel/GWZ-2821-2022	DANGLOT, Lydia/0000-0001-6190-6605; Rubinstein, Eric/0000-0001-7623-9665; Dornier, Emmanuel/0000-0002-3482-8637; Boucheix, Claude/0000-0003-4184-7008; Saint-Pol, Julien/0000-0002-2676-0791; Charrin, Stephanie/0000-0002-4942-3990	INSERM; NRB-Vaincre le Cancer; Institut National du Cancer; Institut du Cancer et d'Immunogenetique	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); NRB-Vaincre le Cancer; Institut National du Cancer(Institut National du Cancer (INCA) France); Institut du Cancer et d'Immunogenetique	This work was supported in part by core funding from INSERM and by specific grants from the NRB-Vaincre le Cancer, Institut du Cancer et d'Immunogenetique, and the Institut National du Cancer. The authors declare that they have no conflicts of interest with the contents of this article.	Anders A, 2001, FASEB J, V15, P1837, DOI 10.1096/fj.01-0007fje; Arduise C, 2008, J IMMUNOL, V181, P7002, DOI 10.4049/jimmunol.181.10.7002; Baldwin G, 2008, J BIOL CHEM, V283, P35445, DOI 10.1074/jbc.M806394200; Berditchevski F, 2001, J BIOL CHEM, V276, P41165, DOI 10.1074/jbc.M104041200; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Bozkulak EC, 2009, MOL CELL BIOL, V29, P5679, DOI 10.1128/MCB.00406-09; Charrin S, 2003, BIOCHEM J, V373, P409, DOI 10.1042/BJ20030343; Charrin S, 2001, J BIOL CHEM, V276, P14329, DOI 10.1074/jbc.M011297200; Charrin S, 2014, J CELL SCI, V127, P3641, DOI 10.1242/jcs.154906; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Dornier E, 2012, J CELL BIOL, V199, P481, DOI 10.1083/jcb.201201133; Gidalevitz T, 2013, BBA-MOL CELL RES, V1833, P2410, DOI 10.1016/j.bbamcr.2013.03.007; Groot AJ, 2014, MOL CELL BIOL, V34, P2822, DOI 10.1128/MCB.00206-14; Haining EJ, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.416503; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Homsi Y, 2014, BIOPHYS J, V107, P100, DOI 10.1016/j.bpj.2014.05.028; Huang SF, 2005, GENOMICS, V86, P674, DOI 10.1016/j.ygeno.2005.08.004; Jouannet S, 2016, CELL MOL LIFE SCI, V73, P1895, DOI 10.1007/s00018-015-2111-z; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lichtenthaler SF, 2011, J NEUROCHEM, V116, P10, DOI 10.1111/j.1471-4159.2010.07081.x; Moretti J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000545; Noy PJ, 2016, J BIOL CHEM, V291, P3145, DOI 10.1074/jbc.M115.703058; Palmer TD, 2014, CANCER RES, V74, P173, DOI 10.1158/0008-5472.CAN-13-0275; Prox J, 2012, CELL MOL LIFE SCI, V69, P2919, DOI 10.1007/s00018-012-0960-2; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; Seigneuret M, 2006, BIOPHYS J, V90, P212, DOI 10.1529/biophysj.105.069666; Seigneuret M, 2001, J BIOL CHEM, V276, P40055, DOI 10.1074/jbc.M105557200; Serru V, 1999, BIOCHEM J, V340, P103, DOI 10.1042/0264-6021:3400103; Serru V, 2000, BBA-PROTEIN STRUCT M, V1478, P159, DOI 10.1016/S0167-4838(00)00022-4; Shoham T, 2006, MOL CELL BIOL, V26, P1373, DOI 10.1128/MCB.26.4.1373-1385.2006; Silvie O, 2006, J CELL SCI, V119, P1992, DOI 10.1242/jcs.02911; Six EM, 2004, J BIOL CHEM, V279, P55818, DOI 10.1074/jbc.M408022200; Sterk LMT, 2002, J CELL SCI, V115, P1161; Todd SC, 1998, BBA-GENE STRUCT EXPR, V1399, P101, DOI 10.1016/S0167-4781(98)00087-6; Tu LY, 2006, J CELL SCI, V119, P5077, DOI 10.1242/jcs.03285; Tu LY, 2002, MOL BIOL CELL, V13, P4221, DOI 10.1091/mbc.E02-04-0211; van Tetering G, 2009, J BIOL CHEM, V284, P31018, DOI 10.1074/jbc.M109.006775; Yalaoui S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000010; Yamada M, 2008, BIOCHEM J, V415, P417, DOI 10.1042/BJ20071625; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Yauch RL, 2000, J BIOL CHEM, V275, P9230, DOI 10.1074/jbc.275.13.9230; Zimmerman B, 2016, CELL, V167, P1041, DOI 10.1016/j.cell.2016.09.056; Zurek N, 2011, TRAFFIC, V12, P28, DOI 10.1111/j.1600-0854.2010.01134.x	45	17	17	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9551	9566		10.1074/jbc.M116.765669	http://dx.doi.org/10.1074/jbc.M116.765669			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28428248	Green Published, hybrid			2022-12-26	WOS:000403113000009
J	Alimohammadi, M; Lahiani, MH; McGehee, D; Khodakovskaya, M				Alimohammadi, Mohammad; Lahiani, Mohamed Hassen; McGehee, Diamond; Khodakovskaya, Mariya			Polyphenolic extract of InsP 5-ptase expressing tomato plants reduce the proliferation of MCF-7 breast cancer cells	PLOS ONE			English	Article							PHARMACEUTICAL PROTEINS; DIETARY FLAVONOIDS; GENE-EXPRESSION; DOWN-REGULATION; HEALTH; METABOANALYST; ANTIOXIDANTS; ARABIDOPSIS; APOPTOSIS; FOOD	In recent years, by extensive achievements in understanding the mechanisms and the pathways affected by cancer, the focus of cancer research is shifting from developing new chemotherapy methods to using natural compounds with therapeutic properties to reduce the adverse effects of synthetic drugs on human health. We used fruit extracts from previously generated human type I InsP 5-ptase gene expressing transgenic tomato plants for assessment of the anti-cancer activity of established genetically modified tomato lines. Cellular assays (MTT, Fluorescent microscopy, Flow Cytometry analysis) were used to confirm that InsP 5-ptase fruit extract was more effective for reducing the proliferation of breast cancer cells compared to wild-type tomato fruit extract. Metabolome analysis of InsP 5-ptase expressing tomato fruits performed by LC-MS identified tomato metabolites that may play a key role in the increased anti-cancer activity observed for the transgenic fruits. Total transcriptome analysis of cancer cells (MCF-7 line) exposed to an extract of transgenic fruits revealed a number of differently regulated genes in the cells treated with transgenic extract compared to untreated cells or cells treated with wild-type tomato extract. Together, this data demonstrate the potential role of the plant derived metabolites in suppressing cell viability of cancer cells and further prove the potential application of plant genetic engineering in the cancer research and drug discovery.	[Alimohammadi, Mohammad; Lahiani, Mohamed Hassen; McGehee, Diamond; Khodakovskaya, Mariya] Univ Arkansas, Dept Biol, Little Rock, AR 72204 USA; [Khodakovskaya, Mariya] Russian Acad Sci, Inst Biol & Soil Sci, Far Eastern Branch, Vladivostok, Russia	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; Russian Academy of Sciences; Federal Scientific Center of the East Asia Terrestrial Biodiversity, Far Eastern Branch of the Russian Academy of Sciences	Khodakovskaya, M (corresponding author), Univ Arkansas, Dept Biol, Little Rock, AR 72204 USA.; Khodakovskaya, M (corresponding author), Russian Acad Sci, Inst Biol & Soil Sci, Far Eastern Branch, Vladivostok, Russia.	mvkhodakovsk@ualr.edu	Alimohammadi, Mohammad/I-6462-2019	Lahiani, Mohamed H./0000-0003-0551-2606	National Space Grant College Fellowship Program (NNXISAR7H) through Research Infrastructure Award provided by Arkansas Space Grant Consortium	National Space Grant College Fellowship Program (NNXISAR7H) through Research Infrastructure Award provided by Arkansas Space Grant Consortium	Authors are grateful to Arkansas Space Grant Consortium for providing a stipend to Diamond McGehee. This project was supported by National Space Grant College Fellowship Program (NNXISAR7H) through Research Infrastructure Award provided by Arkansas Space Grant Consortium (award to MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Abaza MSI, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0194-0; Agati G, 2012, PLANT SCI, V196, P67, DOI 10.1016/j.plantsci.2012.07.014; Ainsworth EA, 2007, NAT PROTOC, V2, P875, DOI 10.1038/nprot.2007.102; Alimohammadi M, 2012, J EXP BOT, V63, P825, DOI 10.1093/jxb/err306; Arts ICW, 2005, AM J CLIN NUTR, V81, p317S, DOI 10.1093/ajcn/81.1.317S; Aruoma OI, 1998, J AM OIL CHEM SOC, V75, P199, DOI 10.1007/s11746-998-0032-9; Barr FG, 1999, CANCER RES, V59, p1711S; Batra P, 2013, 3 BIOTECH, V3, P439, DOI 10.1007/s13205-013-0117-5; Boik J., 2001, J NAT PROD; Borrow J, 1996, NAT GENET, V12, P159, DOI 10.1038/ng0296-159; Bruno AK, 2004, J EXP BOT, V55, P2541, DOI 10.1093/jxb/erh273; Canene-Adams K, 2005, J NUTR, V135, P1226, DOI 10.1093/jn/135.5.1226; Chahar Maheep K, 2011, Pharmacogn Rev, V5, P1, DOI 10.4103/0973-7847.79093; Chan FL, 2000, CANCER LETT, V160, P219, DOI 10.1016/S0304-3835(00)00591-7; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Cuzick J, 2009, LANCET ONCOL, V10, P501, DOI 10.1016/S1470-2045(09)70035-X; Diantini A, 2012, ONCOL LETT, V3, P1069, DOI 10.3892/ol.2012.596; Fankhauser C, 2002, PLANTA, V216, P1, DOI 10.1007/s00425-002-0831-4; Filkowski J, 2004, PLANT J, V38, P60, DOI 10.1111/j.1365-313X.2004.02020.x; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Gojo I, 2002, CLIN CANCER RES, V8, P3527; Gomez-Romero M, 2010, PHYTOCHEMISTRY, V71, P1848, DOI 10.1016/j.phytochem.2010.08.002; Grennan AK, 2009, PLANT PHYSIOL, V151, P1701, DOI 10.1104/pp.109.900308; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; Hollman PCH, 1999, FOOD CHEM TOXICOL, V37, P937, DOI 10.1016/S0278-6915(99)00079-4; Iijima Y, 2008, PLANT J, V54, P949, DOI 10.1111/j.1365-313X.2008.03434.x; Imai Y, 2004, CANCER RES, V64, P4346, DOI 10.1158/0008-5472.CAN-04-0078; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Jiao YL, 2007, NAT REV GENET, V8, P217, DOI 10.1038/nrg2049; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanno S, 2005, BIOL PHARM BULL, V28, P527, DOI 10.1248/bpb.28.527; Keijer J, 2008, CURR OPIN LIPIDOL, V19, P4, DOI 10.1097/MOL.0b013e3282f39f95; Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323; Khan N, 2008, ANTIOXID REDOX SIGN, V10, P475, DOI 10.1089/ars.2007.1740; Khodakovskaya M, 2010, PLANT BIOTECHNOL J, V8, P170, DOI 10.1111/j.1467-7652.2009.00472.x; Kim BW, 2008, CANCER BIOL THER, V7, P1080, DOI 10.4161/cbt.7.7.6164; Kleine T, 2007, PLANT PHYSIOL, V144, P1391, DOI 10.1104/pp.107.098293; KUBASEK WL, 1992, PLANT CELL, V4, P1229, DOI 10.1105/tpc.4.10.1229; Lam PYP, 1999, MOL CELL BIOL, V19, P594; Langner E, 2012, WSPOLCZESNA ONKOL, V16, P394, DOI 10.5114/wo.2012.31767; Liu YS, 2003, PLANT BIOTECHNOL J, V1, P195, DOI 10.1046/j.1467-7652.2003.00018.x; Ma JKC, 2003, NAT REV GENET, V4, P794, DOI 10.1038/nrg1177; Moco S, 2006, PLANT PHYSIOL, V141, P1205, DOI 10.1104/pp.106.078428; Parr AJ, 2000, J SCI FOOD AGR, V80, P985, DOI [10.1002/(SICI)1097-0010(20000515)80:7<985::AID-JSFA572>3.0.CO;2-7, 10.1002/(SICI)1097-0010(20000515)80:7&lt;985::AID-JSFA572&gt;3.0.CO;2-7]; Patel JM, 2008, REV POTENTIAL HLTH B; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; RICEEVANS CA, 1995, FREE RADICAL RES, V22, P375, DOI 10.3109/10715769509145649; Rigano MM, 2013, INT J MOL SCI, V14, P2753, DOI 10.3390/ijms14022753; Rischer H, 2013, CURR PHARM DESIGN, V19, P5640, DOI 10.2174/1381612811319310017; Rosati C, 2000, PLANT J, V24, P413, DOI 10.1046/j.1365-313x.2000.00880.x; Ross JA, 2002, ANNU REV NUTR, V22, P19, DOI 10.1146/annurev.nutr.22.111401.144957; SALAH N, 1995, ARCH BIOCHEM BIOPHYS, V322, P339, DOI 10.1006/abbi.1995.1473; Santangelo Carmela, 2007, Ann Ist Super Sanita, V43, P394; Shen YC, 2007, J AGR FOOD CHEM, V55, P6475, DOI 10.1021/jf070799z; Shinbo Y, 2006, BIOTECH AGR FOREST, V57, P165; SLINKARD K, 1977, AM J ENOL VITICULT, V28, P49; Stoclet J. -C., 2011, ANNALES PHARMACEUTIQUES FRANCAISES, V69, P78, DOI 10.1016/j.pharma.2010.11.004; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Tian WX, 2006, CURR MED CHEM, V13, P967, DOI 10.2174/092986706776361012; Tsao AS, 2004, CA-CANCER J CLIN, V54, P150, DOI 10.3322/canjclin.54.3.150; Twyman RM, 2003, TRENDS BIOTECHNOL, V21, P570, DOI 10.1016/j.tibtech.2003.10.002; Ververidis Filippos, 2007, Biotechnology Journal, V2, P1214, DOI 10.1002/biot.200700084; Wallstrom P, 2000, PUBLIC HEALTH NUTR, V3, P263, DOI 10.1017/S1368980000000306; Wenzel H, 2000, CANCER RES, V60, P3823; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Xiao ZP, 2011, MINI-REV MED CHEM, V11, P169, DOI 10.2174/138955711794519546; Yao LH, 2004, PLANT FOOD HUM NUTR, V59, P113, DOI 10.1007/s11130-004-0049-7; Zand RSR, 2000, BREAST CANCER RES TR, V62, P35, DOI 10.1023/A:1006422302173; Zhang SZ, 2004, MOL PHARMACOL, V65, P1208, DOI 10.1124/mol.65.5.1208	72	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e175778	10.1371/journal.pone.0175778	http://dx.doi.org/10.1371/journal.pone.0175778			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448505	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383600025
J	Tsuji, S; Ushio, M; Sakurai, S; Minamoto, T; Yamanaka, H				Tsuji, Satsuki; Ushio, Masayuki; Sakurai, Sho; Minamoto, Toshifumi; Yamanaka, Hiroki			Water temperature-dependent degradation of environmental DNA and its relation to bacterial abundance	PLOS ONE			English	Article							PERSISTENCE; EDNA	Environmental DNA (eDNA) is DNA shed by organisms into surrounding environments such as soil and water. The new methods using eDNA as a marker for species detection are being rapidly developed. Here we explore basic knowledge regarding the dependence of the eDNA degradation rate on time and water temperature, and the relationship between eDNA degradation and bacterial abundance. This subject has not been well clarified, even though it is essential for improving the reliability of eDNA analysis. To determine the time-and water temperature-dependent degradation of eDNA, river water was sampled and eDNA concentrations were determined for ayu sweetfish (Plecoglossus altivelis altivelis) and common carp (Cyprinus carpio) at seven time points, over a 48-h period, and at three different water temperatures. The degradation of eDNA was modeled for each species using an existing exponential decay model with an extension to include water temperature effects. The degradation models were constructed for ayu sweetfish as N-t = 229,901.2 x exp [- (0.01062 x k - 0.07081) x t] and for common carp as N-t = 2,558.0 x exp [- (0.01075 x k - 0.07372) x t]. Nt is the DNA concentration at time t (elapsed time in hours) and k is the water temperature (degrees C). We also measured the concentration of eDNA derived from purified genomic DNA of the common carp, which was spiked into aquarium water without the target species, and we measured the bacterial abundance in the sample water after 12 and 24 h of incubation. Environmental DNA degradation was accelerated at higher water temperatures (generalized linear model, GLM; p < 0.001), but bacterial abundance did not have a significant effect on eDNA degradation (GLM, p = 0.097). These results suggest that the proper treatment of this temperature effect in data interpretations and adjustments would increase the reliability of eDNA analysis in future studies.	[Tsuji, Satsuki; Sakurai, Sho] Ryukoku Univ, Grad Sch Sci & Technol, 1-5 Yokotani,Seta Oe Cho, Otsu, Shiga, Japan; [Ushio, Masayuki] Ryukoku Univ, Joint Res Ctr Sci & Technol, Otsu, Shiga, Japan; [Ushio, Masayuki] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan; [Ushio, Masayuki] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Japan; [Minamoto, Toshifumi] Kobe Univ, Grad Sch Human Dev & Environm, Nada Ku, Kobe, Hyogo, Japan; [Yamanaka, Hiroki] Ryukoku Univ, Fac Sci & Technol, Seta Oe Cho, Otsu, Shiga, Japan	Ryukoku University; Ryukoku University; Kyoto University; Japan Science & Technology Agency (JST); Kobe University; Ryukoku University	Tsuji, S (corresponding author), Ryukoku Univ, Grad Sch Sci & Technol, 1-5 Yokotani,Seta Oe Cho, Otsu, Shiga, Japan.	satsuki.may425@gmail.com	Ushio, Masayuki/F-8667-2010; Minamoto, Toshifumi/C-6453-2009	Ushio, Masayuki/0000-0003-4831-7181; Minamoto, Toshifumi/0000-0002-5379-1622	CREST program from the Japan Science and Technology Agency [JPMJCR13A2]; Environment Research and Technology Development Fund of the Ministry of the Environment [41602]; Ministry of Education, Culture, Sports, Science [16K18610, 26840152]; Ryukoku University Technology Fund; Grants-in-Aid for Scientific Research [17H03735] Funding Source: KAKEN	CREST program from the Japan Science and Technology Agency; Environment Research and Technology Development Fund of the Ministry of the Environment; Ministry of Education, Culture, Sports, Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ryukoku University Technology Fund; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded by the CREST program (JPMJCR13A2) from the Japan Science and Technology Agency (http://www.jst.go.jp/ kisoken/cresten/project/33/e33_13.html). This study was partly supported by the Environment Research and Technology Development Fund (41602) of the Ministry of the Environment, the Grant-in-Aid for Young Scientists B to HY (26840152, https://kaken.nil.ac.jp/search/?kw=26840152 and 16K18610, https://kaken.nil.ac.jp/ search/?kw=16K18610) from the Ministry of Education, Culture, Sports, Science, and Ryukoku University Technology Fund to HY (http://www. kenkyu.ryukoku.ac. jp/yosiki/seta/yosi html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Doi H, 2017, FRESHWATER BIOL, V62, P30, DOI 10.1111/fwb.12846; Eichmiller JJ, 2016, ENVIRON SCI TECHNOL, V50, P1859, DOI 10.1021/acs.est.5b05672; Endoh Shuichi, 2007, Japanese Journal of Limnology, V68, P15, DOI 10.3739/rikusui.68.15; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Fukumoto S, 2015, J APPL ECOL, V52, P358, DOI 10.1111/1365-2664.12392; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Kelly RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086175; Lodge DM, 2012, MOL ECOL, V21, P2555, DOI 10.1111/j.1365-294X.2012.05600.x; Maruyama A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114639; Minamoto T, 2012, LIMNOLOGY, V13, P193, DOI 10.1007/s10201-011-0362-4; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Sigsgaard EE, 2015, BIOL CONSERV, V183, P46, DOI 10.1016/j.biocon.2014.11.023; Stotzky G, 2000, J ENVIRON QUAL, V29, P691, DOI 10.2134/jeq2000.00472425002900030003x; Takahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056584; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Tsuji S, 2016, LIMNOL; Turner CR, 2014, METHODS ECOL EVOL, V5, P676, DOI 10.1111/2041-210X.12206; Ushio M, 2016, BIORXIV; Yamamoto S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149786; Yamanaka H, 2016, ECOL INDIC, V62, P147, DOI 10.1016/j.ecolind.2015.11.022	24	78	87	8	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176608	10.1371/journal.pone.0176608	http://dx.doi.org/10.1371/journal.pone.0176608			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EL	28448613	gold, Green Published, Green Submitted			2022-12-26	WOS:000400383600112
J	Meyer, L; Leymarie, O; Chevalier, C; Esnault, E; Moroldo, M; Da Costal, B; Georgeault, S; Roingeard', P; Delmasl, B; Quere, P; Le Goffic, R				Meyer, Lea; Leymarie, Olivier; Chevalier, Christophe; Esnault, Evelyne; Moroldo, Marco; Da Costal, Bruno; Georgeault, Sonia; Roingeard', Philippe; Delmasl, Bernard; Quere, Pascale; Le Goffic, Ronan			Transcriptomic profiling of a chicken lung epithelial cell line (CLEC213) reveals a mitochondrial respiratory chain activity boost during influenza virus infection	PLOS ONE			English	Article							A VIRUS; INNATE IMMUNITY; MESSENGER-RNA; EXPRESSION; PROTEIN; REPLICATION; GLYCOLYSIS; INFLAMMATION; CASPASE-1; NLRP3	Avian Influenza virus (AIV) is a major concern for the global poultry industry. Since 2012, several countries have reported AIV outbreaks among domestic poultry. These outbreaks had tremendous impact on poultry production and socio-economic repercussion on farmers. In addition, the constant emergence of highly pathogenic AIV also poses a significant risk to human health. In this study, we used a chicken lung epithelial cell line (CLEC213) to gain a better understanding of the molecular consequences of low pathogenic AIV infection in their natural host. Using a transcriptome profiling approach based on microarrays, we identified a cluster of mitochondrial genes highly induced during the infection. Interestingly, most of the regulated genes are encoded by the mitochondrial genome and are involved in the oxidative phosphorylation metabolic pathway. The biological consequences of this transcriptomic induction result in a 2.5- to 4-fold increase of the ATP concentration within the infected cells. PB1-F2, a viral protein that targets the mitochondria was not found associated to the boost of activity of the respiratory chain. We next explored the possibility that ATP may act as a host-derived danger signal (through production of extracellular ATP) or as a boost to increase AIV replication. We observed that, despite the activation of the P2X7 purinergic receptor pathway, a 1mM ATP addition in the cell culture medium had no effect on the virus replication in our epithelial cell model. Finally, we found that oligomycin, a drug that inhibits the oxidative phosphorylation process, drastically reduced the AIV replication in CLEC213 cells, without apparent cellular toxicity. Collectively, our results suggest that AIV is able to boost the metabolic capacities of its avian host in order to provide the important energy needs required to produce progeny virus.	[Meyer, Lea; Leymarie, Olivier; Chevalier, Christophe; Da Costal, Bruno; Delmasl, Bernard; Le Goffic, Ronan] Univ Paris Saclay, VIM, INRA, Jouy En Josas, France; [Esnault, Evelyne; Quere, Pascale] Univ Francois Rabelais Tours, ISP, INRA, UMR 1282, Nouzilly, France; [Moroldo, Marco] CRB GADIE INRA, Ctr Ressources Biol Genom Anim Domest & Interet E, Domaine Vilvert, Jouy En Josas, France; [Georgeault, Sonia; Roingeard', Philippe] Univ Tours, Plateforme IBiSA Microscopie Elect, Tours, France; [Georgeault, Sonia; Roingeard', Philippe] CHRU Tours, Tours, France; [Roingeard', Philippe] Univ Tours, INSERM U966, Tours, France; [Leymarie, Olivier] Univ Paris 05, Inst Cochin, INSERM U1016, CNRS UMR8104, Paris, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; INRAE; Universite de Tours; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Le Goffic, R (corresponding author), Univ Paris Saclay, VIM, INRA, Jouy En Josas, France.	ronan.le-goffic@inra.fr	Chevalier, Christophe/C-2575-2009; Chevalier, Christophe/AAW-5560-2020; Quéré, Pascale/G-6590-2019; LE GOFFIC, Ronan/M-3099-2019; Meyer, Léa/AAH-5321-2020; Chevalier, Christophe/AAK-4461-2020; LE GOFFIC, Ronan/B-7649-2008	Chevalier, Christophe/0000-0003-3231-9027; Quéré, Pascale/0000-0001-7763-3867; LE GOFFIC, Ronan/0000-0002-2012-0064; Meyer, Léa/0000-0002-3405-7967; LE GOFFIC, Ronan/0000-0002-2012-0064; Leymarie, Olivier/0000-0001-8670-3089	Conseil regional dIle-de-France [dim100157]; Animal Health Division of INRA; DIM Malinf doctoral fellowships - Conseil regional dIle-de-France	Conseil regional dIle-de-France(Region Ile-de-France); Animal Health Division of INRA; DIM Malinf doctoral fellowships - Conseil regional dIle-de-France	This work was partially funded by the Conseil regional dIle-de-France through DIM Malinf ("Domaine d'Interet Majeur Maladies Infectieuses, parasitaires et nosocomiales emergentes", Grant#: dim100157). LM was supported by a grant of the Animal Health Division of INRA, OL was supported by DIM Malinf doctoral fellowships awarded by the Conseil regional dIle-de-France.	Barber MRW, 2010, P NATL ACAD SCI USA, V107, P5913, DOI 10.1073/pnas.1001755107; Barbera-Cremades M, 2012, FASEB J, V26, P2951, DOI 10.1096/fj.12-205765; Bird S, 2002, CYTOKINE GROWTH F R, V13, P483, DOI 10.1016/S1359-6101(02)00028-X; Burnstock G, 2016, PURINERG SIGNAL, V12, P59, DOI 10.1007/s11302-015-9493-0; Cardona CJ, 2009, COMP IMMUNOL MICROB, V32, P255, DOI 10.1016/j.cimid.2008.01.001; Cauwels A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.70; Chang CW, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-80; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Chevalier C, 2010, J BIOL CHEM, V285, P13233, DOI 10.1074/jbc.M109.067710; Chmielewski R, 2011, ANNU REV FOOD SCI T, V2, P37, DOI 10.1146/annurev-food-022510-133710; Denes A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.86; Esnault E, 2011, VIRUS RES, V159, P32, DOI 10.1016/j.virusres.2011.04.022; Fontaine KA, 2015, J VIROL, V89, P2358, DOI 10.1128/JVI.02309-14; Huang SW, 2016, IMMUNOL CELL BIOL; Jang HJ, 2015, POULTRY SCI, V94, P1190, DOI 10.3382/ps/pev033; Johnson AL, 1998, GENE, V219, P55, DOI 10.1016/S0378-1119(98)00373-4; Le Goffic R, 2011, AM J RESP CELL MOL, V45, P1125, DOI 10.1165/rcmb.2010-0516OC; Le Goffic R, 2010, J IMMUNOL, V185, P4812, DOI 10.4049/jimmunol.0903952; Lee BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035812; Leymarie O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100679; Liniger M, 2012, J VIROL, V86, P705, DOI 10.1128/JVI.00742-11; Pourcelot M, 2014, FEBS J, V281, P3791, DOI 10.1111/febs.12940; Reemers SS, 2009, J GEN VIROL, V90, P2134, DOI 10.1099/vir.0.012401-0; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Soubies SM, 2013, J GEN VIROL, V94, P50, DOI 10.1099/vir.0.045153-0; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; TeSlaa T, 2014, METHOD ENZYMOL, V542, P91, DOI 10.1016/B978-0-12-416618-9.00005-4; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Varga ZT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002067; Wiley JS, 2011, TISSUE ANTIGENS, V78, P321, DOI 10.1111/j.1399-0039.2011.01780.x; Wise HM, 2009, J VIROL, V83, P8021, DOI 10.1128/JVI.00826-09; Wu XP, 2013, J PROTEOMICS, V91, P136, DOI 10.1016/j.jprot.2013.06.037; Xiao L, 2014, ONCOGENE, V33, P4568, DOI 10.1038/onc.2014.32; Ye JH, 2015, VET RES COMMUN, V39, P171, DOI 10.1007/s11259-015-9641-6; Yen HL, 2009, CURR TOP MICROBIOL, V333, P3, DOI 10.1007/978-3-540-92165-3_1; Yogev O, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004400; Zaffuto KM, 2008, AVIAN PATHOL, V37, P25, DOI 10.1080/03079450701774850; Zamarin Dmitriy, 2005, PLoS Pathogens, V1, P40	38	10	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176355	10.1371/journal.pone.0176355	http://dx.doi.org/10.1371/journal.pone.0176355			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441462	gold, Green Submitted, Green Published			2022-12-26	WOS:000400308800051
J	Seifert, L; Cordier, R; Orth, D; Courtine, Y; Croft, JL				Seifert, Ludovic; Cordier, Romain; Orth, Dominic; Courtine, Yoan; Croft, James L.			Role of route previewing strategies on climbing fluency and exploratory movements	PLOS ONE			English	Article							SPORT; AFFORDANCES; BEHAVIOR; SKILL	This study examined the role of route previewing strategies on climbing fluency and on exploratory movements of the limbs, in order to understand whether previewing helps people to perceive and to realize affordances. Eight inexperienced and ten experienced climbers previewed a 10 m high route of 5b difficulty on French scale, then climbed it with a toprope as fluently as possible. Gaze behavior was collected from an eye tracking system during the preview and allowed us to determine the number of times they scanned the route, and which of four route previewing strategies (fragmentary, ascending, zigzagging, and sequence-of-blocks) they used. Five inertial measurement units (IMU) (3D accelerometer, 3D gyroscope, 3D magnetometer) were attached to the hip, both feet, and forearms to analyze the vertical acceleration and direction of each limb and hip during the ascent. We were able to detect movement and immobility phases of each IMU using segmentation and classification processes. Depending on whether the limbs and/or hip were moving, five states of behavior were detected: immobility, postural regulation, hold exploration, hold change, and hold traction. Using cluster analysis we identified four clusters of gaze behavior during route previewing depending on route preview duration, number of scan paths, fixations duration, ascending, zigzagging, and sequence-of-blocks strategies. The number of scan paths was positively correlated with relative duration of exploration and negatively correlated with relative duration of hold changes during the ascent. Additionally, a high relative duration of sequence-of-blocks strategy and zigzagging strategy were associated with a high relative duration of immobility during the ascent. Route previewing might help to pick up functional information about reachable, graspable, and usable holds, in order to chain movements together and to find the route. In other words, route previewing might contribute to perceiving and realizing nested affordances.	[Seifert, Ludovic; Cordier, Romain; Courtine, Yoan] Univ Rouen Normandy, Fac Sport Sci, EA 3832, CETAPS, Rouen, France; [Orth, Dominic] Vrije Univ Amsterdam, Fac Behav & Movement Sci, MOVE Res Inst, Amsterdam, Netherlands; [Croft, James L.] Edith Cowan Univ, Sch Med & Hlth Sci, Ctr Exercise & Sports Sci Res, Perth, WA, Australia	Vrije Universiteit Amsterdam; Edith Cowan University	Seifert, L (corresponding author), Univ Rouen Normandy, Fac Sport Sci, EA 3832, CETAPS, Rouen, France.	ludovic.seifert@univ-rouen.fr	SEIFERT, Ludovic/AAI-7486-2020	SEIFERT, Ludovic/0000-0003-1712-5013; Orth, D.O./0000-0001-8844-3815	CPER/FEDER, GRR Logistic, Mobility and Numeric [RISC 1880 - FEDER 33172]; French National Agency of Research [ANR-13-JSH2-0004]; Edith Cowan University	CPER/FEDER, GRR Logistic, Mobility and Numeric; French National Agency of Research(French National Research Agency (ANR)); Edith Cowan University	This project received the support of the CPER/FEDER, GRR Logistic, Mobility and Numeric RISC 1880 - FEDER 33172 for (LS). This project also received the funding of the French National Agency of Research (ID: ANR-13-JSH2-0004 DynaMov) for (LS) and Edith Cowan University for (JLC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.	Blasing BE, 2014, FRONT PSYCHOL, V5, DOI [10.3389/fpsyg.2014.01008, 10.3389/fpsyg.2014.01500]; Boschker MSJ, 2002, Q J EXP PSYCHOL-A, V55, P775, DOI 10.1080/02724980143000622; Boschker MSJ, 2002, J MOTOR BEHAV, V34, P25, DOI 10.1080/00222890209601928; Boschker MSJ, 2002, PERCEPT MOTOR SKILL, V95, P3, DOI 10.2466/PMS.95.4.3-9; Boulanger J, 2016, IEEE SENS J, V16, P742, DOI 10.1109/JSEN.2015.2481511; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Button C, 2017, ROUT RES SPORT EXERC, P210; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; CORDIER P, 1993, INT J SPORT PSYCHOL, V24, P370; CORDIER P, 1994, HUM MOVEMENT SCI, V13, P745, DOI 10.1016/0167-9457(94)90016-7; DELIGNIERES D, 1993, INT J SPORT PSYCHOL, V24, P404; Dicks M, 2016, SPORT MED; Draper N, 2011, J SPORT SCI, V29, P851, DOI 10.1080/02640414.2011.565362; Duda R.O., 2006, PATTERN CLASSIFICATI; Everitt B. S., 2001, CLUSTER ANAL; Fajen BR, 2009, INT J SPORT PSYCHOL, V40, P79; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; GIBSON EJ, 1988, ANNU REV PSYCHOL, V39, P1, DOI 10.1146/annurev.ps.39.020188.000245; Gibson J.J., 1986, ECOLOGICAL APPROACH; Goldberg JH, 1999, INT J IND ERGONOM, V24, P631, DOI 10.1016/S0169-8141(98)00068-7; Grushko AI, 2014, PROCD SOC BEHV, V146, P169, DOI 10.1016/j.sbspro.2014.08.075; Horst E., 2008, TRAINING CLIMBING DE; Johnson H.W., 1961, PERCEPT MOTOR SKILLS, V13, P163; Kaijun Wang, 2009, Data Science Journal, V8, P88, DOI 10.2481/dsj.007-020; Mann DTY, 2007, J SPORT EXERCISE PSY, V29, P457, DOI 10.1123/jsep.29.4.457; Nieuwenhuys A, 2008, J SPORT EXERCISE PSY, V30, P171, DOI 10.1123/jsep.30.2.171; NOUGIER V, 1993, INT J SPORT PSYCHOL, V24, P379; Orth D, 2017, ROUT RES SPORT EXERC, P196; Orth D, 2016, SPORTS MED, V46, P255, DOI 10.1007/s40279-015-0417-5; Pezzulo G, 2010, BRAIN COGNITION, V73, P68, DOI 10.1016/j.bandc.2010.03.002; Rein Robert, 2010, Motor Control, V14, P211; Salvucci D.D., 2000, P 2000 S EYE TRACK R, P71, DOI [10.1145/355017.355028, DOI 10.1145/355017.355028]; Sanchez X, 2012, SCAND J MED SCI SPOR, V22, P67, DOI 10.1111/j.1600-0838.2010.01151.x; Seifert L., 2014, SPORTS TECHNOL, V7, P166, DOI DOI 10.1080/19346182.2014.968250; Seifert L, 2014, J APPL BIOMECH, V30, P619, DOI [10.1123/JAB.2014-0052, 10.1123/jab.2014-0052]; Seifert L, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01819; Seifert L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089865; Sibella F, 2007, HUM MOVEMENT SCI, V26, P841, DOI 10.1016/j.humov.2007.05.008; Smyth MM, 1998, APPL COGNITIVE PSYCH, V12, P145, DOI 10.1002/(SICI)1099-0720(199804)12:2<145::AID-ACP505>3.0.CO;2-Z; Wagman JB, 2010, PSYCHON B REV, V17, P905, DOI 10.3758/PBR.17.6.905; Withagen R, 2012, NEW IDEAS PSYCHOL, V30, P250, DOI 10.1016/j.newideapsych.2011.12.003; Zhao Y, 2005, MOL BIOTECHNOL, V31, P55, DOI 10.1385/MB:31:1:055	42	30	30	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176306	10.1371/journal.pone.0176306	http://dx.doi.org/10.1371/journal.pone.0176306			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET5FE	28441425	Green Published, Green Submitted, gold			2022-12-26	WOS:000400308800042
J	Shuryak, I				Shuryak, Igor			Quantitative modeling of responses to chronic ionizing radiation exposure using targeted and non-targeted effects	PLOS ONE			English	Article							CHERNOBYL EXCLUSION ZONE; DEINOCOCCUS-RADIODURANS; CELLS; RESISTANCE; DAMAGE; RATES; IRRADIATION; CULTURE; STRESS; RISKS	The biological effects of chronic ionizing radiation exposure can be difficult to study, but important to understand in order to protect the health of occupationally-exposed persons and victims of radiological accidents or malicious events. They include targeted effects (TE) caused by ionizations within/close to nuclear DNA, and non-targeted effects (NTE) caused by damage to other cell structures and/or activation of stress-signaling pathways in distant cells. Data on radiation damage in animal populations exposed over multiple generations to wide ranges of dose rates after the Chernobyl nuclear-power-plant accident are very useful for enhancing our understanding of these processes. We used a mechanistically-motivated mathematical model which includes TE and NTE to analyze a large published data set on chromosomal aberrations in pond snail (Lymnaea stagnalis) embryos collected over 16 years from water bodies contaminated by Chernobyl fallout, and from control locations. The fraction of embryo cells with aberrations increased dramatically (> 10-fold) and non-linearly over a dose rate range of 0.03-420 mu Gy/h (0.00026-3.7 Gy/year). NTE were very important for describing the non-linearity of this radiation response: the TE-only model (without NTE) performed dramatically worse than the TE+NTE model. NTE were predicted to reach 1/2 of maximal intensity at 2.5 mu Gy/h (0.022 Gy/year) and to contribute >90% to the radiation response slope at dose rates < 11 mu Gy/h (0.1 Gy/year). Internally-incorporated Sr-90 was possibly more effective per unit dose than other radionuclides. The radiation response shape for chromosomal aberrations in snail embryos was consistent with data for a different end-point: the fraction of young amoebocytes in adult snail haemolymph. Therefore, radiation may affect different snail life stages by similar mechanisms. The importance of NTE in our model-based analysis suggests that the search for modulators of NTE-related signaling pathways could be a promising strategy for mitigating the deleterious effects of chronic irradiation.	[Shuryak, Igor] Columbia Univ, Ctr Radiol Res, New York, NY 10032 USA	Columbia University	Shuryak, I (corresponding author), Columbia Univ, Ctr Radiol Res, New York, NY 10032 USA.	is144@cumc.columbia.edu						Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Alonzo F, 2008, J ENVIRON RADIOACTIV, V99, P1464, DOI 10.1016/j.jenvrad.2007.11.021; Brenner DJ, 2003, HEALTH PHYS, V85, P103, DOI 10.1097/00004032-200307000-00018; Brenner DJ, 2001, RADIAT RES, V155, P402, DOI 10.1667/0033-7587(2001)155[0402:TBEIRO]2.0.CO;2; Buonanno M, 2011, RADIAT RES, V175, P405, DOI 10.1667/RR2461.1; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Cardis E, 2007, RADIAT RES, V167, P396, DOI 10.1667/RR0553.1; Cucinotta FA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096099; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; EDWARDS AA, 1979, RADIAT ENVIRON BIOPH, V16, P89, DOI 10.1007/BF01323216; Einor D, 2016, SCI TOTAL ENVIRON, V548, P463, DOI 10.1016/j.scitotenv.2016.01.027; Frantsevich L, 2007, ANIMAL RADIOECOLOGY; Friedland W, 2011, RADIAT PROT DOSIM, V143, P542, DOI 10.1093/rpd/ncq383; Garnier-Laplace J, 2013, J ENVIRON RADIOACTIV, V121, P12, DOI 10.1016/j.jenvrad.2012.01.013; Golubev A., 2005, RADIOPROTECTION, V40, pS511, DOI [10.1051/radiopro, DOI 10.1051/RADIOPRO]; Gudkov DI, 2016, J ENVIRON RADIOACTIV, V151, P438, DOI 10.1016/j.jenvrad.2015.09.004; Gudkov D, 2006, NATO SEC SCI B PHYS, V9, P69, DOI 10.1007/1-4020-4956-0_6; Hall EJ, 2006, RADIOBIOLOGY RADIOLO, V6th; Harris DR, 2009, J BACTERIOL, V191, P5240, DOI 10.1128/JB.00502-09; Hei Tom K, 2011, Curr Mol Pharmacol, V4, P96; Hertel-Aas T, 2007, RADIAT RES, V168, P515, DOI 10.1667/RR1012.1; Kovalchuk I, 2007, MUTAT RES-FUND MOL M, V624, P101, DOI 10.1016/j.mrfmmm.2007.04.009; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Lawrence CT, 2001, SIAM J OPTIMIZ, V11, P1092, DOI 10.1137/S1052623498344562; Loucas BD, 2013, RADIAT RES, V179, P9, DOI 10.1667/RR3089.1; LUBIN JH, 1995, HEALTH PHYS, V69, P494, DOI 10.1097/00004032-199510000-00007; Miller DL, 2003, J VASC INTERV RADIOL, V14, P711, DOI 10.1097/01.RVI.0000079980.80153.4B; MITCHELL JB, 1979, RADIAT RES, V79, P537, DOI 10.2307/3575179; Moller AP, 2015, SCI REP-UK, V5, DOI 10.1038/srep08363; Moller AP, 2012, OECOLOGIA, V170, P1155, DOI 10.1007/s00442-012-2374-0; Mollert AP, 2016, TRENDS ECOL EVOL, V31, P281, DOI 10.1016/j.tree.2016.01.005; Mothersill C, 2006, DOSE RESPONSE, V4; Murphy JF, 2011, J ENVIRON RADIOACTIV, V102, P688, DOI 10.1016/j.jenvrad.2011.04.007; Nikjoo H, 2003, INT J RADIAT BIOL, V79, P43, DOI 10.1080/0955300021000034701; Pinto M, 2005, RADIAT RES, V164, P73, DOI 10.1667/RR3394; Puskin JS, 2003, HEALTH PHYS, V84, P526, DOI 10.1097/00004032-200304000-00012; Sasaki K, 2012, COMP MATH MATH PHYS, V2012; Sawant SG, 2001, RADIAT RES, V156, P177, DOI 10.1667/0033-7587(2001)156[0177:ARATBE]2.0.CO;2; Schmid E, 1996, RADIAT ENV BIOPH, V35; Shuryak I, 2007, RADIAT RES, V168, P741, DOI 10.1667/RR1117.1; Shuryak I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147696; Shuryak I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028559; STEEL GG, 1987, RADIOTHER ONCOL, V9, P299; Tugay TI, 2011, HEALTH PHYS, V101, P375, DOI 10.1097/HP.0b013e3181f56bf8; Venkateswaran A, 2000, APPL ENVIRON MICROB, V66, P2620, DOI 10.1128/AEM.66.6.2620-2626.2000; Venzon D, 1988, APPL STAT, P87; Ward J., 2009, INT J RAD BIOL; Zaitsev AS, 2014, PEDOBIOLOGIA, V57, P5, DOI 10.1016/j.pedobi.2013.09.005	49	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176476	10.1371/journal.pone.0176476	http://dx.doi.org/10.1371/journal.pone.0176476			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET5FE	28441437	Green Published, gold, Green Submitted			2022-12-26	WOS:000400308800062
J	Quang, TT; Kim, HY; Bao, FS; Papay, FA; Edwards, WB; Liu, Y				Quang, Tri T.; Kim, Hye-Yeong; Bao, Forrest Sheng; Papay, Francis A.; Edwards, W. Barry; Liu, Yang			Fluorescence Imaging Topography Scanning System for intraoperative multimodal imaging	PLOS ONE			English	Article							SENTINEL LYMPH-NODES; INDOCYANINE GREEN; GUIDED SURGERY; IN-VIVO; BREAST-CANCER; TOMOGRAPHY; SPECT	Fluorescence imaging is a powerful technique with diverse applications in intraoperative settings. Visualization of three dimensional (3D) structures and depth assessment of lesions, however, are oftentimes limited in planar fluorescence imaging systems. In this study, a novel Fluorescence Imaging Topography Scanning ( FITS) system has been developed, which offers color reflectance imaging, fluorescence imaging and surface topography scanning capabilities. The system is compact and portable, and thus suitable for deployment in the operating room without disturbing the surgical flow. For system performance, parameters including near infrared fluorescence detection limit, contrast transfer functions and topography depth resolution were characterized. The developed system was tested in chicken tissues ex vivo with simulated tumors for intraoperative imaging. We subsequently conducted in vivo multimodal imaging of sentinel lymph nodes in mice using FITS and PET/CT. The PET/CT/optical multimodal images were co-registered and conveniently presented to users to guide surgeries. Our results show that the developed system can facilitate multimodal intraoperative imaging.	[Quang, Tri T.; Liu, Yang] Univ Akron, Dept Biomed Engn, Akron, OH 44325 USA; [Kim, Hye-Yeong; Edwards, W. Barry] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA; [Bao, Forrest Sheng] Univ Akron, Dept Elect & Comp Engn, Akron, OH 44325 USA; [Papay, Francis A.] Cleveland Clin, Dermatol & Plast Surg Inst, Cleveland, OH 44106 USA	University System of Ohio; University of Akron; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Ohio; University of Akron; Cleveland Clinic Foundation	Liu, Y (corresponding author), Univ Akron, Dept Biomed Engn, Akron, OH 44325 USA.; Edwards, WB (corresponding author), Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA.	edwardsw@upmc.edu; yliu@uakron.edu	Edwards, Wilson/AAD-8002-2021	Edwards, Wilson/0000-0002-6070-8778	Ohio Department of Development Third Frontier Grant [TVSF 15-0123]; LEAP Award [F14-10-LIU-WEB]; University of Akron Startup Funds	Ohio Department of Development Third Frontier Grant; LEAP Award; University of Akron Startup Funds	This study was supported in part by grants from the Ohio Department of Development Third Frontier Grant (TVSF 15-0123), the LEAP Award (F14-10-LIU-WEB) and the University of Akron Startup Funds.; This study was supported in part by grants from the Ohio Department of Development Third Frontier Grant (TVSF 15-0123), the LEAP Award (F14-10-LIU-WEB) and the University of Akron Startup Funds. We thank Dr. Bing Yu and Vivek Nagarajan for their assistance.	Ale A, 2012, NAT METHODS, V9, P615, DOI [10.1038/NMETH.2014, 10.1038/nmeth.2014]; Bostanci E., 2015, ARXIV151203156; Cao LJ, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.6.066015; Chi C, 2014, THERANOSTICS, V4, P1072, DOI 10.7150/thno.9899; Cignoni P, 2008, EUR IT CHAPT C JUL 2; Geng J, 2011, ADV OPT PHOTONICS, V3, P128, DOI 10.1364/AOP.3.000128; Gilmore DM, 2013, J THORAC CARDIOV SUR, V146, P562, DOI 10.1016/j.jtcvs.2013.04.010; Goshtasby A., 2005, 2 D 3 D IMAGE REGIST; Guo WB, 2014, TUMOR BIOL, V35, P3073, DOI 10.1007/s13277-013-1399-2; Handgraaf H.J., 2015, MINIM INVASIV THER, P1; Handgraaf HJM, 2014, GYNECOL ONCOL, V135, P606, DOI 10.1016/j.ygyno.2014.08.005; Inokuchi S., 1984, Seventh International Conference on Pattern Recognition (Cat. No. 84CH2046-1), P806; Jewell EL, 2014, GYNECOL ONCOL, V133, P274, DOI 10.1016/j.ygyno.2014.02.028; Laios Alexandros, 2015, BMC Res Notes, V8, P608, DOI 10.1186/s13104-015-1576-z; Li CQ, 2011, J NUCL MED, V52, P1268, DOI 10.2967/jnumed.110.082859; Liu JTC, 2014, NEUROSURGERY, V75, P61, DOI 10.1227/NEU.0000000000000344; Lutje S, 2014, CANCER RES, V74, P6216, DOI 10.1158/0008-5472.CAN-14-0594; Mohajerani P, 2014, IEEE T MED IMAGING, V33, P1434, DOI 10.1109/TMI.2014.2313405; Oh Y, 2013, J THORAC CARDIOV SUR, V146, P1509, DOI 10.1016/j.jtcvs.2013.02.044; Smith AM, 2009, NAT NANOTECHNOL, V4, P710, DOI 10.1038/nnano.2009.326; Solomon M, 2013, J NUCL MED, V54, P639, DOI 10.2967/jnumed.112.105742; Stuker F, 2011, IEEE T MED IMAGING, V30, P1265, DOI 10.1109/TMI.2011.2112669; van der Vorst JR, 2013, ORAL ONCOL, V49, P15, DOI 10.1016/j.oraloncology.2012.07.017; van Oosterom MN, 2014, EJNMMI RES, V4, DOI 10.1186/s13550-014-0056-0; Verbeek FPR, 2014, BREAST CANCER RES TR, V143, P333, DOI 10.1007/s10549-013-2802-9; Vonwil D, 2014, MOL IMAGING BIOL, V16, P350, DOI 10.1007/s11307-013-0698-8; Yi XM, 2014, INT J NANOMED, V9, P1347, DOI 10.2147/IJN.S60206; Zhang GL, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.4.040505	28	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2017	12	4							e0174928	10.1371/journal.pone.0174928	http://dx.doi.org/10.1371/journal.pone.0174928			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET4XE	28437441	Green Published, gold, Green Submitted			2022-12-26	WOS:000400287600004
J	Trotta, F; Spila-Alegiani, S; Da Cas, R; Rajevic, M; Conti, V; Venegoni, M; Rossi, M; Traversa, G				Trotta, Francesco; Spila-Alegiani, Stefania; Da Cas, Roberto; Rajevic, Maja; Conti, Valentino; Venegoni, Mauro; Rossi, Mariangela; Traversa, Giuseppe			Cardiovascular safety of tiotropium Respimat vs HandiHaler in the routine clinical practice: A population-based cohort study	PLOS ONE			English	Article							TIOSPIR TRIAL; MIST INHALER; RISK; MORTALITY; COPD; MEDICATIONS; INCREASES; DEATH; PRO	The cardiovascular safety of tiotropium Respimat formulation in the routine clinical practice is still an open issue. Our aim was to compare the risk of acute myocardial infarction and heart rhythm disorders in incident users of either tiotropium Respimat or HandiHaler. The study population comprises patients aged >= 45 years, resident in two Italian regions with a first prescription of tiotropium (HandiHaler or Respimat) between 01/07/2011-30/11/2013. The cohort was identified through the database of prescriptions reimbursed by the Italian National Health Service. Comorbidities and clinical outcomes were obtained from hospital records. The primary outcome was the first hospitalization for acute myocardial infarction and/or for heart rhythm disorders during the exposure period. Hazard ratios were estimated in the propensity score-matched groups through Cox regression. After matching, 31,334 patients with incident prescription of tiotropium were included. The two groups were balanced with regard to baseline characteristics. Similar incidence rates of the primary outcome between Respimat and HandiHaler users were identified (adjusted hazard ratio 1.02, 95% CI 0.82-1.28). No risk difference between Respimat and HandiHaler emerged when considering clinical events separately. This large cohort study showed a comparable acute cardiovascular safety profile of the two tiotropium formulations.	[Trotta, Francesco] Lazio Reg Hlth Serv, Dept Epidemiol, Rome, Italy; [Spila-Alegiani, Stefania; Da Cas, Roberto; Traversa, Giuseppe] Natl Inst Hlth, Natl Ctr Epidemiol, Pharmacoepidemiol Unit, Rome, Italy; [Rajevic, Maja] Univ Roma La Sapienza, Pharmaceut Sci Drug Chem & Technol Dept, Rome, Italy; [Conti, Valentino; Venegoni, Mauro] Gen Directorate Hlth, Reg Ctr Pharmacovigilance, Milan, Italy; [Rossi, Mariangela] Gen Directorate Hlth, Unit Pharmaceut Governance, Perugia, Italy	Istituto Superiore di Sanita (ISS); Sapienza University Rome	Spila-Alegiani, S (corresponding author), Natl Inst Hlth, Natl Ctr Epidemiol, Pharmacoepidemiol Unit, Rome, Italy.	stefania.spila@iss.it	Trotta, Francesco/G-8702-2013; Venegoni, Mauro/H-3416-2019	Trotta, Francesco/0000-0001-6889-8484; Venegoni, Mauro/0000-0002-5462-5327	Umbria Regional Health Authority	Umbria Regional Health Authority	Only public employees of the National or Regional health authorities were involved in conceiving, planning, and conducting the study; partial financial support was received from the Umbria Regional Health Authority. The corresponding author had full access to all study data and approved the manuscript for publication.	[Anonymous], SPIR RESP SUMM PROD; Bateman ED, 2013, EUR RESPIR J, V42, P590, DOI 10.1183/09031936.00042213; Beasley R, 2013, EUR RESPIR J, V42, P584, DOI 10.1183/09031936.00042113; Beasley R, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7390; Dong YH, 2013, THORAX, V68, P48, DOI 10.1136/thoraxjnl-2012-201926; EVERITT DE, 1990, ANN INTERN MED, V112, P120, DOI 10.7326/0003-4819-112-2-120; Halpin DMG, 2015, INT J CHRONIC OBSTR, V10, P239, DOI 10.2147/COPD.S75146; Jenkins CR, 2013, NEW ENGL J MED, V369, P1555, DOI 10.1056/NEJMe1310107; Jenkins CR, 2013, THORAX, V68, P5, DOI 10.1136/thoraxjnl-2012-202482; Kruis AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090145; Loke YK, 2014, NEW ENGL J MED, V370, P480, DOI 10.1056/NEJMc1314411; Pulmonary-Allergy Drugs Advisory Committee. US Food and Drug Administration. Clinical briefing document, 2009, OVERVIEW OF THE FDA; r Summary of Product Characteristics, SUMM PROD CHAR; Schmiedl S, 2016, BRIT J CLIN PHARMACO, V81, P379, DOI 10.1111/bcp.12808; Scichilone N, 2014, RESPIRATION, V87, P11, DOI 10.1159/000355082; Singh S, 2013, THORAX, V68, P114, DOI 10.1136/thoraxjnl-2011-201275; The Medicines Utilisation Monitoring Centre, 2015, NAT REP MED US IT; Trotta F, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006619; Verhamme KMC, 2013, EUR RESPIR J, V42, P606, DOI 10.1183/09031936.00005813; Wise R, 2015, NPJ PRIM CARE RESP M, V25, DOI 10.1038/npjpcrm.2015.67; Wise RA, 2013, NEW ENGL J MED, V369, P1491, DOI 10.1056/NEJMoa1303342	21	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0176276	10.1371/journal.pone.0176276	http://dx.doi.org/10.1371/journal.pone.0176276			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KN	28430820	Green Published, gold, Green Submitted			2022-12-26	WOS:000399876100037
J	Laurent, S; Salamin, N; Robinson-Rechavi, M				Laurent, Sacha; Salamin, Nicolas; Robinson-Rechavi, Marc			No evidence for the radiation time lag model after whole genome duplications in Teleostei	PLOS ONE			English	Article							RECIPROCAL GENE LOSS; DIVERSIFICATION; FISH; EVOLUTION; EXTINCTION; SPECIATION; DIVERGENCE; POLYPLOIDY; RESOLUTION; PHYLOGENY	The short and long term effects of polyploidization on the evolutionary fate of lineages is still unclear despite much interest. First recognized in land plants, it has become clear that polyploidization is widespread in eukaryotes, notably at the origin of vertebrates and teleost fishes. Many hypotheses have been proposed to link the species richness of lineages and whole genome duplications. For instance, the radiation time lag model suggests that paleopolyploidy would favour the apparition of new phenotypic traits, although the radiation of the lineage would not occur before a later dispersion event. Some results indicate that this model may be observed during land plant evolution. In this work, we test predictions of the radiation time lag model using both fossil data and molecular phylogenies in ancient and more recent teleost whole genome duplications. We fail to find any evidence of delayed increase of the species number after any of these events and conclude that paleopolyploidization still remains to be unambiguously linked to taxonomic diversity in teleosts.	[Laurent, Sacha; Salamin, Nicolas; Robinson-Rechavi, Marc] Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland; [Laurent, Sacha; Salamin, Nicolas; Robinson-Rechavi, Marc] Swiss Inst Bioinformat, Lausanne, Switzerland	University of Lausanne; Swiss Institute of Bioinformatics	Robinson-Rechavi, M (corresponding author), Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland.; Robinson-Rechavi, M (corresponding author), Swiss Inst Bioinformat, Lausanne, Switzerland.	marc.robinson-rechavi@unil.ch	Robinson-Rechavi, Marc/E-9727-2011	Robinson-Rechavi, Marc/0000-0002-3437-3329; Salamin, Nicolas/0000-0002-3963-4954	ProDoc of the Swiss National Science Fondation [134931]; Etat de Vaud	ProDoc of the Swiss National Science Fondation; Etat de Vaud	This work was supported by the ProDoc grant number 134931 of the Swiss National Science Fondation; and Etat de Vaud. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the ProDoc grant number 134931 of the Swiss National Science Fondation; and Etat de Vaud. The computations were performed at the Vital-IT (http://www.vital-it.ch) Center for high-performance computing of the Swiss Institute of Bioinformatics. We would like to thank Christian Parisod and Nils Arrigo for comments on an earlier version of the manuscript.	Alexandrou MA, 2013, MOL PHYLOGENET EVOL, V69, P514, DOI 10.1016/j.ympev.2013.07.026; Barker MS, 2009, GENOME BIOL EVOL, V1, P391, DOI 10.1093/gbe/evp040; Beaulieu JM, 2016, SYST BIOL, V65, P583, DOI 10.1093/sysbio/syw022; BENTON MJ, 1995, SCIENCE, V268, P52, DOI 10.1126/science.7701342; Berthelot C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4657; Betancur-R R, 2013, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.53ba26640df0ccaee75bb165c8c26288; Braasch I, 2016, NAT GENET, V48, P427, DOI 10.1038/ng.3526; Campbell MA, 2013, GENE, V530, P57, DOI 10.1016/j.gene.2013.07.068; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; Collares-Pereira MJ, 2013, CYTOGENET GENOME RES, V140, P97, DOI 10.1159/000351729; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Condamine FL, 2016, SCI REP-UK, V6, DOI 10.1038/srep19208; Crow KD, 2006, MOL BIOL EVOL, V23, P887, DOI 10.1093/molbev/msj083; Dodsworth S, 2015, BOTANICAL JOURNAL OF; Donoghue PCJ, 2005, TRENDS ECOL EVOL, V20, P312, DOI 10.1016/j.tree.2005.04.008; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Froese R., 2021, FISHBASE; Givnish TJ, 2015, P ROY SOC B-BIOL SCI, V282, P171, DOI 10.1098/rspb.2015.1553; Guinot G, 2015, BIOL REV, V41; Havelka M, 2011, FOLIA ZOOL, V60, P93; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Hurley IA, 2007, P ROY SOC B-BIOL SCI, V274, P489, DOI 10.1098/rspb.2006.3749; Laurent S, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0432-z; Li Z, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1501084; Lien S, 2016, NATURE, V533, P200, DOI 10.1038/nature17164; Mable BK, 2011, J ZOOL, V284, P151, DOI 10.1111/j.1469-7998.2011.00829.x; Maclean CJ, 2011, EVOLUTION, V65, P932, DOI 10.1111/j.1558-5646.2010.01171.x; Macqueen DJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2881; Maddison WP, 2007, SYST BIOL, V56, P701, DOI 10.1080/10635150701607033; May MR, 2016, SYST BIOL; Moriyama Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10397; Morlon H, 2014, ECOL LETT, V17, P508, DOI 10.1111/ele.12251; Muir CD, 2015, AM NAT, V185, P70, DOI 10.1086/679108; Near TJ, 2012, P NATL ACAD SCI USA, V109, P13698, DOI 10.1073/pnas.1206625109; O'Meara BC., 2011, ANNUAL REVIEW OF ECO, V43; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Paradis E, 2013, MOL PHYLOGENET EVOL, V67, P436, DOI 10.1016/j.ympev.2013.02.008; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; RAUP DM, 1985, PALEOBIOLOGY, V11, P42, DOI 10.1017/S0094837300011386; Robertson FM, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1241-z; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Santini F, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-194; Scannell DR, 2006, NATURE, V440, P341, DOI 10.1038/nature04562; Schranz ME, 2012, CURR OPIN PLANT BIOL, V15, P147, DOI 10.1016/j.pbi.2012.03.011; Scott AD, 2015, BIORXIV; Shi FX, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0669-0; Silvestro D, 2016, PHILOSOPHICAL TRANSA, V371; Silvestro D, 2014, SYST BIOL, P1; Slechtova V, 2006, MOL PHYLOGENET EVOL, V39, P529, DOI 10.1016/j.ympev.2005.09.018; Smith DM, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0060; Stadler T, 2011, P NATL ACAD SCI USA, V108, P6187, DOI 10.1073/pnas.1016876108; Tank DC, 2015, NEW PHYTOL, V207, P454, DOI 10.1111/nph.13491; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Vogel G, 1998, SCIENCE, V281, P1119, DOI 10.1126/science.281.5380.1119; Volff JN, 2005, HEREDITY, V94, P280, DOI 10.1038/sj.hdy.6800635; Wagner PJ, 2014, P NATL ACAD SCI USA, V111, P16419, DOI 10.1073/pnas.1406304111; Wittbrodt J, 1998, BIOESSAYS, V20, P511, DOI 10.1002/(SICI)1521-1878(199806)20:6&lt;511::AID-BIES10&gt;3.0.CO;2-3; Xu P, 2014, NAT GENET, V46, P1212, DOI 10.1038/ng.3098; Zhan SH, DATA FROM COMPARATIV; Zhang S, 2018, J INTELL MANUF, V29, P585, DOI 10.1007/s10845-014-1023-3	60	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0176384	10.1371/journal.pone.0176384	http://dx.doi.org/10.1371/journal.pone.0176384			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426792	gold, Green Submitted, Green Published			2022-12-26	WOS:000399875900129
J	Peters, M; Scharmga, A; de Jong, J; van Tubergen, A; Geusens, P; Arts, JJ; Loeffen, D; Weijers, R; van Rietbergen, B; van den Bergh, J				Peters, M.; Scharmga, A.; de Jong, J.; van Tubergen, A.; Geusens, P.; Arts, J. J.; Loeffen, D.; Weijers, R.; van Rietbergen, B.; van den Bergh, J.			An automated algorithm for the detection of cortical interruptions on high resolution peripheral quantitative computed tomography images of finger joints	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS PATIENTS; BONE EROSIONS; MICRO-CT; HR-PQCT; MICROARCHITECTURE; QUALITY; QUANTIFICATION; SEGMENTATION; RADIOGRAPHY; REPAIR	Objectives To introduce a fully-automated algorithm for the detection of small cortical interruptions (>= 0.246mm in diameter) on high resolution peripheral quantitative computed tomography (HR-pQCT) images, and to investigate the additional value of manual correction of the automatically obtained contours (semi-automated procedure). Methods Ten metacarpophalangeal joints from seven patients with rheumatoid arthritis (RA) and three healthy controls were imaged with HR-pQCT. The images were evaluated by an algorithm according to the fully-and semi-automated procedure for the number and surface of interruptions per joint. Reliability between the fully-and semi-automated procedure and between two independent operators was tested using intra-class correlation coefficient (ICC) and the proportion of matching interruptions. Validity of single interruptions detected was tested by comparing it to visual scoring, as gold standard. The positive predictive value (PPV) and sensitivity were calculated. Results The median number of interruptions per joint was 14 (range 2 to 59) and did not significantly differ between the fully-and semi-automated procedure (p = 0.37). The median interruption surface per joint was significantly higher with the fully-vs. semi-automated procedure (respectively, 8.6mm(2) vs. 5.8mm(2) and 6.1mm(2), p = 0.01). Reliability was almost perfect between the fully-and semi-automated procedure for both the number and surface of interruptions (ICC >= 0.95) and the proportion of matching interruptions was high (>= 76%). Also the inter-operator reliability was almost perfect (ICC >= 0.97, proportion of matching interruptions 92%). The PPV ranged from 27.6% to 29.9%, and sensitivity from 69.7% to 76.3%. Most interruptions detected with the algorithm, did show an interruption on a 2D grayscale image. However, this interruption did not meet the criteria of an interruption with visual scoring. Conclusion The algorithm for HR-pQCT images detects cortical interruptions, and its interruption surface. Reliability and validity was comparable for the fully- and semi-automated procedures. However, we advise the use of the semi-automated procedure to assure quality. The algorithm is a promising tool for a sensitive and objective assessment of cortical interruptions in finger joints assessed by HR-pQCT.	[Peters, M.; Scharmga, A.; van Tubergen, A.; Geusens, P.; van den Bergh, J.] Maastricht Univ, Med Ctr, Div Rheumatol, Dept Internal Med, Maastricht, Netherlands; [Peters, M.; Scharmga, A.; van Tubergen, A.; Geusens, P.] Maastricht Univ, Sch Publ Hlth & Primary Care, CAPHRI, Maastricht, Netherlands; [Peters, M.; Scharmga, A.; van den Bergh, J.] Maastricht Univ, NUTRIM Sch Nutr & Translat Res Metab, Maastricht, Netherlands; [de Jong, J.; Loeffen, D.; Weijers, R.] Maastricht Univ, Dept Radiol, Med Ctr, Maastricht, Netherlands; [Geusens, P.; van den Bergh, J.] Hasselt Univ, Fac Med & Life Sci, Hasselt, Belgium; [Arts, J. J.; van Rietbergen, B.] Maastricht Univ, Dept Orthopaed Surg, Med Ctr, Maastricht, Netherlands; [Arts, J. J.; van Rietbergen, B.] Eindhoven Univ Technol, Fac Biomed Engn, Eindhoven, Netherlands; [van den Bergh, J.] VieCuri Med Ctr, Dept Internal Med, Venlo, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Hasselt University; Maastricht University; Eindhoven University of Technology; VieCuri Medical Center	Peters, M (corresponding author), Maastricht Univ, Med Ctr, Div Rheumatol, Dept Internal Med, Maastricht, Netherlands.; Peters, M (corresponding author), Maastricht Univ, Sch Publ Hlth & Primary Care, CAPHRI, Maastricht, Netherlands.; Peters, M (corresponding author), Maastricht Univ, NUTRIM Sch Nutr & Translat Res Metab, Maastricht, Netherlands.	michiel.peters@maastrichtuniversity.nl	van Tubergen, Astrid/AAY-7065-2020; Arts, Chris/ABH-5550-2020	van Tubergen, Astrid/0000-0001-8477-0683; Arts, Chris/0000-0002-2947-8564; van den Bergh, Joop/0000-0003-3984-2232	Weijerhorst Foundation (JvdB); Pfizer [WS2056904]	Weijerhorst Foundation (JvdB); Pfizer(Pfizer)	This work was supported by: Weijerhorst Foundation (JvdB), http//www.deweijerhorst.nl/ weijerhorst/home. funding that was used to purchase the HR-pQCT scanner and pay half of the PhD student salaries of MP and AS. It was also supported by Pfizer (PG), grant number: WS2056904, http//www.pfizer.nl/. This funding was used to perform our study (NL42300.068.12 / METC 12-2-037) of HR-pQCT imaging in patients with RA compared to conventional imaging techniques.	Albrecht A, 2013, ANN RHEUM DIS, V72, P1351, DOI 10.1136/annrheumdis-2012-201982; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Aschenberg S, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4235; Baillet A, 2011, RHEUMATOLOGY, V50, P1137, DOI 10.1093/rheumatology/keq437; Barnabe C, 2013, CLIN EXP RHEUMATOL, V31, P243; Barnabe C, 2016, J RHEUMATOL, V43, P1935, DOI 10.3899/jrheum.160648; Buie HR, 2007, BONE, V41, P505, DOI 10.1016/j.bone.2007.07.007; Burghardt AJ, 2010, BONE, V47, P519, DOI 10.1016/j.bone.2010.05.034; Dohn UM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2378; Ejbjerg B, 2004, ARTHRITIS RHEUM, V50, P1097, DOI 10.1002/art.20135; Finzel S, 2013, ANN RHEUM DIS, V72, P396, DOI 10.1136/annrheumdis-2011-201075; Finzel S, 2011, ANN RHEUM DIS, V70, P1587, DOI 10.1136/ard.2010.148395; Finzel S, 2011, ARTHRITIS RHEUM-US, V63, P1231, DOI 10.1002/art.30285; Finzel S, 2011, ANN RHEUM DIS, V70, P122, DOI 10.1136/ard.2010.132423; Fouque-Aubert A, 2010, ANN RHEUM DIS, V69, P1671, DOI 10.1136/ard.2009.114512; Geusens P, 2014, NAT REV RHEUMATOL, V10, P304, DOI 10.1038/nrrheum.2014.23; Geusens P, 2014, RHEUMATOLOGY, V53, P4, DOI 10.1093/rheumatology/ket358; Hulsmans HMJ, 2000, ARTHRITIS RHEUM, V43, P1927, DOI 10.1002/1529-0131(200009)43:9<1927::AID-ANR3>3.0.CO;2-B; Kocijan R, 2014, J BONE MINER RES, V29, P1005, DOI 10.1002/jbmr.2109; Laib A, 1998, Technol Health Care, V6, P329; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lillegraven S, 2012, NAT REV RHEUMATOL, V8, P117, DOI 10.1038/nrrheum.2011.202; Liu XS, 2010, J BONE MINER RES, V25, P746, DOI 10.1359/jbmr.090822; MacNeil JA, 2007, MED ENG PHYS, V29, P1096, DOI 10.1016/j.medengphy.2006.11.002; Pialat JB, 2012, BONE, V50, P111, DOI 10.1016/j.bone.2011.10.003; Scharmga A, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1148-y; Schett G, 2012, NAT REV RHEUMATOL, V8, P656, DOI 10.1038/nrrheum.2012.153; Srikhum W, 2013, J RHEUMATOL, V40, P408, DOI 10.3899/jrheum.120780; Stach CM, 2010, ARTHRITIS RHEUM-US, V62, P330, DOI 10.1002/art.27252; Topfer D, 2014, RHEUMATOLOGY, V53, P65, DOI 10.1093/rheumatology/ket259; VANDERHEIJDE DMFM, 1992, BRIT J RHEUMATOL, V31, P519; Zebaze R, 2015, J BONE MINER RES, V30, P24, DOI 10.1002/jbmr.2419	32	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2017	12	4							e0175829	10.1371/journal.pone.0175829	http://dx.doi.org/10.1371/journal.pone.0175829			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KM	28426705	Green Submitted, Green Published, gold			2022-12-26	WOS:000399875900055
J	Hong, M; Jung, J; Park, HS; Lee, SM; Jeong, NJ; Kim, SH; Lee, KW; Lee, JA; Kim, MS				Hong, Moonju; Jung, Jeeyoun; Park, Hee-Sook; Lee, So Min; Jeong, Nam-Joo; Kim, Soon-Hee; Lee, Kyoung-Won; Lee, Ju-A; Kim, Myung-Sunny			Shaofu Zhuyu decoction ameliorates obesity-mediated hepatic steatosis and systemic inflammation by regulating metabolic pathways	PLOS ONE			English	Article							FATTY LIVER-DISEASE; NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; NONALCOHOLIC STEATOHEPATITIS; ACTIVE FRACTION; BLOOD-STASIS; TNF-ALPHA; MEDICINE; RATS; IDENTIFICATION	Shaofu Zhuyu decoction (SFZYD, also known as Sobokchugeo-tang), a classical prescription drug in traditional East Asian medicine, has been used to treat blood stasis syndrome (BSS). Hepatic steatosis is the result of excess caloric intake, and its pathogenesis involves internal retention of phlegm and dampness, blood stasis, and liver Qi stagnation. To evaluate the effects of treatment with SFZYD on obesity-induced inflammation and hepatic steatosis, we fed male C57BL/6N mice a high fat diet (HFD) for 8 weeks and then treated them with SFZYD by oral gavage for an additional 4 weeks. The results of histological and biochemical examinations indicated that SFZYD treatment ameliorates systemic inflammation and hepatic steatosis. A partial least squares-discriminant analysis (PLS-DA) scores plot of serum metabolites showed that HFD mice began to produce metabolites similar to those of normal chow (NC) mice after SFZYD administration. We noted significant alterations in the levels of twenty-seven metabolites, alterations indicating that SFZYD regulates the TCA cycle, the pentose phosphate pathway and aromatic amino acid metabolism. Increases in the levels of TCA cycle intermediate metabolites, such as 2-oxoglutaric acid, isocitric acid, and malic acid, in the serum of obese mice were significantly reversed after SFZYD treatment. In addition to inducing changes in the above metabolites, treatment with SFZYD also recovered the expression of genes related to hepatic mitochondrial dysfunction, including Ucp2, Cpt1 alpha, and Ppargc1 alpha, as well as the expression of genes involved in lipid metabolism and inflammation, without affecting glucose uptake or insulin signaling. Taken together, these findings suggest that treatment with SFZYD ameliorated obesity-induced systemic inflammation and hepatic steatosis by regulating inflammatory cytokine and adipokine levels in the circulation and various tissues. Moreover, treatment with SFZYD also reversed alterations in the levels of metabolites of the TCA cycle, the pentose phosphate pathway and aromatic amino acid metabolism.	[Hong, Moonju; Park, Hee-Sook; Jeong, Nam-Joo; Kim, Soon-Hee; Lee, Kyoung-Won; Kim, Myung-Sunny] Korea Food Res Inst, Div Metab & Nutr, Gyeonggi Do, South Korea; [Hong, Moonju; Kim, Myung-Sunny] Korea Univ Sci & Technol, Dept Food Biotechnol, Gyeonggi Do, South Korea; [Jung, Jeeyoun; Lee, So Min; Lee, Ju-A] Korea Inst Oriental Med, KM Fundamental Res Div, Daejeon, South Korea	Korea Food Research Institute (KFRI); Korea Institute of Oriental Medicine (KIOM)	Kim, MS (corresponding author), Korea Food Res Inst, Div Metab & Nutr, Gyeonggi Do, South Korea.; Kim, MS (corresponding author), Korea Univ Sci & Technol, Dept Food Biotechnol, Gyeonggi Do, South Korea.	truka@kfri.re.kr	Jung, Jeeyoun/G-8438-2018	Hong, Moonju/0000-0001-7688-6803	Korea Institute of Oriental Medicine [K15113, K15114]; Korea Food Research Institute [E0150302-2]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE024748] Funding Source: NIH RePORTER	Korea Institute of Oriental Medicine; Korea Food Research Institute; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Korea Institute of Oriental Medicine (K15113 and K15114) and the Korea Food Research Institute (E0150302-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Korea Institute of Oriental Medicine (K15113 and K15114) and the Korea Food Research Institute (E0150302-2). We thank Drs. K.S. Sung and C.E. Lee for providing technical support for the animal experiments.	Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Crespo J, 2001, HEPATOLOGY, V34, P1158, DOI 10.1053/jhep.2001.29628; Dietrich P, 2014, BEST PRACT RES CL GA, V28, P637, DOI 10.1016/j.bpg.2014.07.008; Dong H, 2012, CHIN J INTEGR MED, V18, P152, DOI 10.1007/s11655-012-0993-2; El-Benna J, 2005, ARCH IMMUNOL THER EX, V53, P199; Eriksson L, 2008, J CHEMOMETR, V22, P594, DOI 10.1002/cem.1187; Fan M., 2011, BEIJING J TRADIT CHI, V30, P455; Freemerman AJ, 2014, J BIOL CHEM, V289, P7884, DOI 10.1074/jbc.M113.522037; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Grattagliano I, 2012, CLIN BIOCHEM, V45, P610, DOI 10.1016/j.clinbiochem.2012.03.024; Guo N, 2014, J CHROMATOGR A, V1362, P89, DOI 10.1016/j.chroma.2014.08.028; Gupte P, 2004, J GASTROEN HEPATOL, V19, P854, DOI 10.1111/j.1440-1746.2004.03312.x; Huang XC, 2016, J ETHNOPHARMACOL, V186, P234, DOI 10.1016/j.jep.2016.03.067; Hui JM, 2004, HEPATOLOGY, V40, P46, DOI 10.1002/hep.20280; Jia W, 2006, PHYTOTHER RES, V20, P819, DOI 10.1002/ptr.1905; Kim M, 2002, J COMMUN HEALTH, V27, P109, DOI 10.1023/A:1014509200352; Kim MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082847; Kim SH, 2016, J ETHNOPHARMACOL, V192, P201, DOI 10.1016/j.jep.2016.07.023; KUNJARA S, 1993, BIOCHEM MED METAB B, V49, P217, DOI 10.1006/bmmb.1993.1024; Lan K, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/819147; Li SM, 2014, CHIN J INTEGR MED, V20, P483, DOI 10.1007/s11655-014-1803-9; Li ZP, 2003, HEPATOLOGY, V37, P343, DOI 10.1053/jhep.2003.50048; Liu CG, 2013, BIOL PHARM BULL, V36, P1700; Liu L, 2010, MOLECULES, V15, P5066, DOI 10.3390/molecules15085066; Mills E, 2014, TRENDS CELL BIOL, V24, P313, DOI 10.1016/j.tcb.2013.11.008; Park HS, 2016, MOL NUTR FOOD RES, V60, P1944, DOI 10.1002/mnfr.201500689; Rodriguez-Gallego E, 2015, INT J OBESITY, V39, P279, DOI 10.1038/ijo.2014.53; Su SL, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/901943; Su SL, 2010, AM J CHINESE MED, V38, P777, DOI 10.1142/S0192415X10008238; Sunny NE, 2011, CELL METAB, V14, P804, DOI 10.1016/j.cmet.2011.11.004; Tan GG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034157; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; WANLESS IR, 1990, HEPATOLOGY, V12, P1106, DOI 10.1002/hep.1840120505; Westerbacka J, 2007, DIABETES, V56, P2759, DOI 10.2337/db07-0156; Xu HY, 2002, DIABETES, V51, P1876, DOI 10.2337/diabetes.51.6.1876; Yonghe CMY, 2007, J TRADITIONAL CHINES, V27, P115; Zhang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep19288; Zhao XJ, 2008, J CHROMATOGR B, V873, P151, DOI 10.1016/j.jchromb.2008.08.010	39	26	27	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178514	10.1371/journal.pone.0178514	http://dx.doi.org/10.1371/journal.pone.0178514			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28441416	Green Submitted, Green Published, gold			2022-12-26	WOS:000402611800069
